id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
8070016|NCT04646109|19897182|P2|NOT COMPLETED|Overall Study||6
8070017|NCT04646109|19897183|P1|NOT COMPLETED|Overall Study||0
8070018|NCT04646109|19897182|P2|COMPLETED|Overall Study||30
8070019|NCT04646109|19897183|P1|COMPLETED|Overall Study||30
8070020|NCT04646109|19897182|P2|STARTED|Overall Study||36
8070021|NCT04646109|19897183|P1|STARTED|Overall Study||30
8070022|NCT04608500|19897244|P2|NOT COMPLETED|Overall Study||18
8070023|NCT04608500|19897245|P1|NOT COMPLETED|Overall Study||35
8070024|NCT04608500|19897244|P2|COMPLETED|Overall Study||239
8070025|NCT04608500|19897245|P1|COMPLETED|Overall Study||479
8070026|NCT04608500|19897244|P2|STARTED|Overall Study||257
8070027|NCT04608500|19897245|P1|STARTED|Overall Study||514
8070028|NCT04578496|19897263|P1|NOT COMPLETED|Overall Study||4
8070029|NCT04578496|19897263|P1|COMPLETED|Overall Study||12
8070030|NCT04578496|19897263|P1|STARTED|Overall Study||16
8070031|NCT04574999|19897270|P2|NOT COMPLETED|Overall Study||5
8070032|NCT04574999|19897271|P1|NOT COMPLETED|Overall Study||9
8070033|NCT04574999|19897270|P2|COMPLETED|Overall Study||48
8070034|NCT04574999|19897271|P1|COMPLETED|Overall Study||105
8070035|NCT04574999|19897270|P2|STARTED|Overall Study||53
8070036|NCT04574999|19897271|P1|STARTED|Overall Study||114
8070037|NCT04555525|19897289|P2|NOT COMPLETED|Overall Study||0
8070038|NCT04555525|19897290|P1|NOT COMPLETED|Overall Study||3
8070039|NCT04555525|19897289|P2|COMPLETED|Overall Study||25
8070040|NCT04555525|19897290|P1|COMPLETED|Overall Study||72
8070041|NCT04555525|19897289|P2|STARTED|Overall Study||25
8070042|NCT04555525|19897290|P1|STARTED|Overall Study||75
8070043|NCT04553497|19897308|P2|NOT COMPLETED|Overall Study||1
8070044|NCT04553497|19897309|P1|NOT COMPLETED|Overall Study||2
8070045|NCT04553497|19897308|P2|COMPLETED|Overall Study||17
8070046|NCT04553497|19897309|P1|COMPLETED|Overall Study||15
8070047|NCT04553497|19897308|P2|STARTED|Overall Study||18
8070048|NCT04553497|19897309|P1|STARTED|Overall Study||17
8070049|NCT04548622|19897319|P1|NOT COMPLETED|Overall Study||0
8070050|NCT04548622|19897319|P1|COMPLETED|Overall Study||15
8070051|NCT04548622|19897319|P1|STARTED|Overall Study||15
8070052|NCT04542694|19897327|P2|NOT COMPLETED|Overall Study||0
8070053|NCT04542694|19897328|P1|NOT COMPLETED|Overall Study||4
8070054|NCT04542694|19897327|P2|COMPLETED|Overall Study||100
8070055|NCT04542694|19897328|P1|COMPLETED|Overall Study||96
8070056|NCT04542694|19897327|P2|STARTED|Overall Study||100
8070057|NCT04542694|19897328|P1|STARTED|Overall Study||100
8070058|NCT04542226|19897356|P1|NOT COMPLETED|Overall Study||0
8070059|NCT04542226|19897356|P1|COMPLETED|Overall Study||81
8070060|NCT04542226|19897356|P1|STARTED|Overall Study||81
8070061|NCT04534491|19897368|P1|NOT COMPLETED|Overall Study||152
8070062|NCT04534491|19897368|P1|COMPLETED|Overall Study||703
8070063|NCT04534491|19897368|P1|Treated|Overall Study||727
8070064|NCT04534491|19897368|P1|STARTED|Overall Study||855
8070065|NCT04534465|19897377|P5|NOT COMPLETED|Overall Study||0
8070066|NCT04534465|19897378|P4|NOT COMPLETED|Overall Study||0
8070067|NCT04534465|19897379|P3|NOT COMPLETED|Overall Study||0
8070068|NCT04534465|19897380|P2|NOT COMPLETED|Overall Study||0
8070069|NCT04534465|19897381|P1|NOT COMPLETED|Overall Study||0
8070070|NCT04534465|19897377|P5|COMPLETED|Overall Study||10
8070071|NCT04534465|19897378|P4|COMPLETED|Overall Study||10
8070072|NCT04534465|19897379|P3|COMPLETED|Overall Study||10
8070073|NCT04534465|19897380|P2|COMPLETED|Overall Study||10
8070074|NCT04534465|19897381|P1|COMPLETED|Overall Study||10
8070075|NCT04534465|19897377|P5|STARTED|Overall Study||10
8070076|NCT04534465|19897378|P4|STARTED|Overall Study||10
8070077|NCT04534465|19897379|P3|STARTED|Overall Study||10
8070078|NCT04534465|19897380|P2|STARTED|Overall Study||10
8070079|NCT04534465|19897381|P1|STARTED|Overall Study||10
8070080|NCT04532164|19897463|P1|NOT COMPLETED|Overall Study||24
8070081|NCT04532164|19897463|P1|COMPLETED|Overall Study||113
8070082|NCT04532164|19897463|P1|Treated|Overall Study||132
8070083|NCT04532164|19897463|P1|STARTED|Overall Study||137
8070084|NCT04531813|19897474|P1|NOT COMPLETED|Overall Study||2
8070085|NCT04531813|19897474|P1|COMPLETED|Overall Study||30
8070086|NCT04531813|19897474|P1|Treated|Overall Study||31
8070087|NCT04531813|19897474|P1|STARTED|Overall Study||32
8070088|NCT04531540|19897478|P1|NOT COMPLETED|Overall Study||9
8070089|NCT04531540|19897478|P1|COMPLETED|Overall Study||216
8070090|NCT04531540|19897478|P1|Treated|Overall Study||222
8070091|NCT04531540|19897478|P1|STARTED|Overall Study||225
8070092|NCT04531527|19897485|P1|NOT COMPLETED|Overall Study||3
8070093|NCT04531527|19897485|P1|COMPLETED|Overall Study||29
8070094|NCT04531527|19897485|P1|Treated|Overall Study||29
8070095|NCT04531527|19897485|P1|STARTED|Overall Study||32
8070096|NCT04523831|19897492|P2|NOT COMPLETED|Overall Study||20
8070097|NCT04523831|19897493|P1|NOT COMPLETED|Overall Study||17
8070098|NCT04523831|19897492|P2|COMPLETED|Overall Study||180
8070099|NCT04523831|19897493|P1|COMPLETED|Overall Study||183
8070100|NCT04523831|19897492|P2|STARTED|Overall Study||200
8070101|NCT04523831|19897493|P1|STARTED|Overall Study||200
8070102|NCT04521777|19897505|P1|NOT COMPLETED|Overall Study||4
8070103|NCT04521777|19897505|P1|COMPLETED|Overall Study||20
8070104|NCT04521777|19897505|P1|STARTED|Overall Study||24
8070105|NCT04512482|19897516|P2|NOT COMPLETED|Second Intervention (1 Day)||1
8070106|NCT04512482|19897517|P1|NOT COMPLETED|Second Intervention (1 Day)||2
8070107|NCT04512482|19897516|P2|COMPLETED|Second Intervention (1 Day)||20
8070108|NCT04512482|19897517|P1|COMPLETED|Second Intervention (1 Day)||22
8070109|NCT04512482|19897516|P2|Post-Waterpik Photographs|Second Intervention (1 Day)||20
8070110|NCT04512482|19897517|P1|Post-Waterpik Photographs|Second Intervention (1 Day)||22
8070111|NCT04512482|19897516|P2|Waterpik Utilization|Second Intervention (1 Day)||20
8070112|NCT04512482|19897517|P1|Waterpik Utilization|Second Intervention (1 Day)||22
8070113|NCT04512482|19897516|P2|Post-toothbrush Photographs|Second Intervention (1 Day)||20
8070114|NCT04512482|19897517|P1|Post-toothbrush Photographs|Second Intervention (1 Day)||22
8070115|NCT04512482|19897516|P2|Toothbrush Utilization|Second Intervention (1 Day)||20
8070116|NCT04512482|19897517|P1|Toothbrush Utilization|Second Intervention (1 Day)||22
8070117|NCT04512482|19897516|P2|Post-rinse Photographs|Second Intervention (1 Day)||20
8070118|NCT04512482|19897517|P1|Post-rinse Photographs|Second Intervention (1 Day)||22
8070119|NCT04512482|19897516|P2|Received Intervention|Second Intervention (1 Day)||20
8070120|NCT04512482|19897517|P1|Received Intervention|Second Intervention (1 Day)||22
8070121|NCT04512482|19897516|P2|Baseline Photographs|Second Intervention (1 Day)||20
8070122|NCT04512482|19897517|P1|Baseline Photographs|Second Intervention (1 Day)||22
8070123|NCT04512482|19897516|P2|Baseline Plaque Assessment|Second Intervention (1 Day)||20
8070124|NCT04512482|19897517|P1|Baseline Plaque Assessment|Second Intervention (1 Day)||22
8070125|NCT04512482|19897516|P2|STARTED|Second Intervention (1 Day)||21
8070126|NCT04512482|19897517|P1|STARTED|Second Intervention (1 Day)||24
8070127|NCT04512482|19897516|P2|NOT COMPLETED|Washout (1 Week)||0
8070128|NCT04512482|19897517|P1|NOT COMPLETED|Washout (1 Week)||0
8070129|NCT04512482|19897516|P2|COMPLETED|Washout (1 Week)||21
8070130|NCT04512482|19897517|P1|COMPLETED|Washout (1 Week)||24
8070131|NCT04512482|19897516|P2|STARTED|Washout (1 Week)||21
8070132|NCT04512482|19897517|P1|STARTED|Washout (1 Week)||24
8070133|NCT04512482|19897516|P2|NOT COMPLETED|First Intervention (1 Day)||0
8070134|NCT04512482|19897517|P1|NOT COMPLETED|First Intervention (1 Day)||0
8070135|NCT04512482|19897516|P2|COMPLETED|First Intervention (1 Day)||21
8070136|NCT04512482|19897517|P1|COMPLETED|First Intervention (1 Day)||24
8070137|NCT04512482|19897516|P2|Post-Waterpik Photographs|First Intervention (1 Day)||21
8070138|NCT04512482|19897517|P1|Post-Waterpik Photographs|First Intervention (1 Day)||24
8070139|NCT04512482|19897516|P2|Waterpik Utilization|First Intervention (1 Day)||21
8070140|NCT04512482|19897517|P1|Waterpik Utilization|First Intervention (1 Day)||24
8070141|NCT04512482|19897516|P2|Post-toothbrush Photographs|First Intervention (1 Day)||21
8070142|NCT04512482|19897517|P1|Post-toothbrush Photographs|First Intervention (1 Day)||24
8070143|NCT04512482|19897516|P2|Toothbrush Utilization|First Intervention (1 Day)||21
8070144|NCT04512482|19897517|P1|Toothbrush Utilization|First Intervention (1 Day)||24
8070145|NCT04512482|19897516|P2|Post-rinse Photographs|First Intervention (1 Day)||21
8070146|NCT04512482|19897517|P1|Post-rinse Photographs|First Intervention (1 Day)||24
8070147|NCT04512482|19897516|P2|Received Rinse Intervention|First Intervention (1 Day)||21
8070148|NCT04512482|19897517|P1|Received Rinse Intervention|First Intervention (1 Day)||24
8070149|NCT04512482|19897516|P2|Baseline Photographs|First Intervention (1 Day)||21
8070150|NCT04512482|19897517|P1|Baseline Photographs|First Intervention (1 Day)||24
8070151|NCT04512482|19897516|P2|Baseline Plaque Assessment|First Intervention (1 Day)||21
8070152|NCT04512482|19897517|P1|Baseline Plaque Assessment|First Intervention (1 Day)||24
8070153|NCT04512482|19897516|P2|STARTED|First Intervention (1 Day)||21
8070154|NCT04512482|19897517|P1|STARTED|First Intervention (1 Day)||24
8070155|NCT04502979|19897525|P2|NOT COMPLETED|Overall Study||4
8070156|NCT04502979|19897526|P1|NOT COMPLETED|Overall Study||3
8070157|NCT04502979|19897525|P2|COMPLETED|Overall Study||30
8070158|NCT04502979|19897526|P1|COMPLETED|Overall Study||34
8070159|NCT04502979|19897525|P2|STARTED|Overall Study||34
8070160|NCT04502979|19897526|P1|STARTED|Overall Study||37
8070161|NCT04495712|19897536|P2|NOT COMPLETED|Overall Study||0
8070162|NCT04495712|19897537|P1|NOT COMPLETED|Overall Study||0
8070163|NCT04495712|19897536|P2|COMPLETED|Overall Study||46
8070164|NCT04495712|19897537|P1|COMPLETED|Overall Study||44
8070165|NCT04495712|19897536|P2|STARTED|Overall Study||46
8070166|NCT04495712|19897537|P1|STARTED|Overall Study||44
8070167|NCT04491994|19897555|P2|NOT COMPLETED|Overall Study||11
8070168|NCT04491994|19897556|P1|NOT COMPLETED|Overall Study||29
8070169|NCT04491994|19897555|P2|COMPLETED|Overall Study||349
8070170|NCT04491994|19897556|P1|COMPLETED|Overall Study||151
8070171|NCT04491994|19897555|P2|STARTED|Overall Study||360
8070172|NCT04491994|19897556|P1|STARTED|Overall Study||180
8070173|NCT04491240|19897565|P3|NOT COMPLETED|Overall Study||0
8070174|NCT04491240|19897566|P2|NOT COMPLETED|Overall Study||0
8070175|NCT04491240|19897567|P1|NOT COMPLETED|Overall Study||0
8070176|NCT04491240|19897565|P3|COMPLETED|Overall Study||10
8070177|NCT04491240|19897566|P2|COMPLETED|Overall Study||10
8070178|NCT04491240|19897567|P1|COMPLETED|Overall Study||10
8070179|NCT04491240|19897565|P3|STARTED|Overall Study||10
8070180|NCT04491240|19897566|P2|STARTED|Overall Study||10
8070181|NCT04491240|19897567|P1|STARTED|Overall Study||10
8070182|NCT04483011|19897592|P2|NOT COMPLETED|Intervention Period 2 (8 Days)||0
8070183|NCT04483011|19897593|P1|NOT COMPLETED|Intervention Period 2 (8 Days)||0
8070184|NCT04483011|19897592|P2|COMPLETED|Intervention Period 2 (8 Days)||8
8070185|NCT04483011|19897593|P1|COMPLETED|Intervention Period 2 (8 Days)||9
8070186|NCT04483011|19897592|P2|STARTED|Intervention Period 2 (8 Days)||8
8070187|NCT04483011|19897593|P1|STARTED|Intervention Period 2 (8 Days)||9
8070188|NCT04483011|19897592|P2|NOT COMPLETED|Washout (7 Days)||1
8070189|NCT04483011|19897593|P1|NOT COMPLETED|Washout (7 Days)||0
8070190|NCT04483011|19897592|P2|COMPLETED|Washout (7 Days)||8
8070191|NCT04483011|19897593|P1|COMPLETED|Washout (7 Days)||9
8070192|NCT04483011|19897592|P2|STARTED|Washout (7 Days)||9
8070193|NCT04483011|19897593|P1|STARTED|Washout (7 Days)||9
8070194|NCT04483011|19897592|P2|NOT COMPLETED|Intervention Period 1 (8 Days)||0
8070195|NCT04483011|19897593|P1|NOT COMPLETED|Intervention Period 1 (8 Days)||0
8070196|NCT04483011|19897592|P2|COMPLETED|Intervention Period 1 (8 Days)||9
8070197|NCT04483011|19897593|P1|COMPLETED|Intervention Period 1 (8 Days)||9
8070198|NCT04483011|19897592|P2|STARTED|Intervention Period 1 (8 Days)||9
8070199|NCT04483011|19897593|P1|STARTED|Intervention Period 1 (8 Days)||9
8070200|NCT04474405|19897627|P6|NOT COMPLETED|Overall Study||0
8070201|NCT04474405|19897628|P5|NOT COMPLETED|Overall Study||4
8070202|NCT04474405|19897629|P4|NOT COMPLETED|Overall Study||0
8070203|NCT04474405|19897630|P3|NOT COMPLETED|Overall Study||1
8070204|NCT04474405|19897631|P2|NOT COMPLETED|Overall Study||0
8070205|NCT04474405|19897632|P1|NOT COMPLETED|Overall Study||0
8070206|NCT04474405|19897627|P6|COMPLETED|Overall Study||7
8070207|NCT04474405|19897628|P5|COMPLETED|Overall Study||9
8070208|NCT04474405|19897629|P4|COMPLETED|Overall Study||4
8070209|NCT04474405|19897630|P3|COMPLETED|Overall Study||4
8070210|NCT04474405|19897631|P2|COMPLETED|Overall Study||3
8070211|NCT04474405|19897632|P1|COMPLETED|Overall Study||4
8070212|NCT04474405|19897627|P6|Florbetapir PET Scan|Overall Study||4
8070213|NCT04474405|19897628|P5|Florbetapir PET Scan|Overall Study||0
8070214|NCT04474405|19897629|P4|Florbetapir PET Scan|Overall Study||4
8070215|NCT04474405|19897630|P3|Florbetapir PET Scan|Overall Study||0
8070216|NCT04474405|19897631|P2|Florbetapir PET Scan|Overall Study||3
8070217|NCT04474405|19897632|P1|Florbetapir PET Scan|Overall Study||4
8070218|NCT04474405|19897627|P6|Flortaucipir PET Scan|Overall Study||0
8070219|NCT04474405|19897628|P5|Flortaucipir PET Scan|Overall Study||9
8070220|NCT04474405|19897629|P4|Flortaucipir PET Scan|Overall Study||4
8070221|NCT04474405|19897630|P3|Flortaucipir PET Scan|Overall Study||4
8070222|NCT04474405|19897631|P2|Flortaucipir PET Scan|Overall Study||3
8070223|NCT04474405|19897632|P1|Flortaucipir PET Scan|Overall Study||4
8070224|NCT04474405|19897627|P6|STARTED|Overall Study||7
8070225|NCT04474405|19897628|P5|STARTED|Overall Study||13
8070226|NCT04474405|19897629|P4|STARTED|Overall Study||4
8070227|NCT04474405|19897630|P3|STARTED|Overall Study||5
8070228|NCT04474405|19897631|P2|STARTED|Overall Study||3
8070229|NCT04474405|19897632|P1|STARTED|Overall Study||4
8070233|NCT04468347|19897659|P4|NOT COMPLETED|Overall Study||4
8070234|NCT04468347|19897660|P3|NOT COMPLETED|Overall Study||6
8070235|NCT04468347|19897661|P2|NOT COMPLETED|Overall Study||1
8070236|NCT04468347|19897662|P1|NOT COMPLETED|Overall Study||2
8070237|NCT04468347|19897659|P4|COMPLETED|Overall Study||21
8070238|NCT04468347|19897660|P3|COMPLETED|Overall Study||41
8070239|NCT04468347|19897661|P2|COMPLETED|Overall Study||10
8070240|NCT04468347|19897662|P1|COMPLETED|Overall Study||4
8070241|NCT04468347|19897659|P4|Baseline Flortacuipir PET Scan|Overall Study||25
8070242|NCT04468347|19897660|P3|Baseline Flortacuipir PET Scan|Overall Study||45
8070243|NCT04468347|19897661|P2|Baseline Flortacuipir PET Scan|Overall Study||11
8070244|NCT04468347|19897662|P1|Baseline Flortacuipir PET Scan|Overall Study||5
8070245|NCT04468347|19897659|P4|STARTED|Overall Study||25
8070246|NCT04468347|19897660|P3|STARTED|Overall Study||47
8070247|NCT04468347|19897661|P2|STARTED|Overall Study||11
8070248|NCT04468347|19897662|P1|STARTED|Overall Study||6
8070249|NCT04462731|19897684|P2|NOT COMPLETED|Overall Study||46
8070250|NCT04462731|19897685|P1|NOT COMPLETED|Overall Study||56
8070251|NCT04462731|19897684|P2|COMPLETED|Overall Study||51
8070252|NCT04462731|19897685|P1|COMPLETED|Overall Study||41
8070253|NCT04462731|19897684|P2|STARTED|Overall Study||97
8070254|NCT04462731|19897685|P1|STARTED|Overall Study||97
8070255|NCT04454138|19897693|P2|NOT COMPLETED|Overall Study||0
8070256|NCT04454138|19897694|P1|NOT COMPLETED|Overall Study||0
8070257|NCT04454138|19897693|P2|COMPLETED|Overall Study||77
8070258|NCT04454138|19897694|P1|COMPLETED|Overall Study||65
8070259|NCT04454138|19897693|P2|STARTED|Overall Study||77
8070260|NCT04454138|19897694|P1|STARTED|Overall Study||65
8070261|NCT04450823|19897714|P1|NOT COMPLETED|Overall Study||3
8070262|NCT04450823|19897714|P1|COMPLETED|Overall Study||58
8070263|NCT04450823|19897714|P1|STARTED|Overall Study||61
8070264|NCT04448210|19897733|P2|NOT COMPLETED|Overall Study||0
8070265|NCT04448210|19897734|P1|NOT COMPLETED|Overall Study||0
8070266|NCT04448210|19897733|P2|COMPLETED|Overall Study||20
8070267|NCT04448210|19897734|P1|COMPLETED|Overall Study||22
8070268|NCT04448210|19897733|P2|STARTED|Overall Study||20
8070269|NCT04448210|19897734|P1|STARTED|Overall Study||22
8070270|NCT04446247|19897756|P1|NOT COMPLETED|Overall Study||0
8070271|NCT04446247|19897756|P1|COMPLETED|Overall Study||14
8070272|NCT04446247|19897756|P1|STARTED|Overall Study||14
8070279|NCT04435808|19897789|P2|NOT COMPLETED|Overall Study||1
8070280|NCT04435808|19897790|P1|NOT COMPLETED|Overall Study||0
8070281|NCT04435808|19897789|P2|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
8070282|NCT04435808|19897790|P1|COMPLETED|Overall Study||0
8070283|NCT04435808|19897789|P2|STARTED|Overall Study||1
8070284|NCT04435808|19897790|P1|STARTED|Overall Study||0
8070285|NCT04425863|19897799|P3|NOT COMPLETED|Overall Study||1
8070286|NCT04425863|19897800|P2|NOT COMPLETED|Overall Study||0
8070287|NCT04425863|19897801|P1|NOT COMPLETED|Overall Study||0
8070288|NCT04425863|19897799|P3|COMPLETED|Overall Study||19
8070289|NCT04425863|19897800|P2|COMPLETED|Overall Study||12
8070290|NCT04425863|19897801|P1|COMPLETED|Overall Study||135
8070291|NCT04425863|19897799|P3|STARTED|Overall Study||20
8070292|NCT04425863|19897800|P2|STARTED|Overall Study||12
8070293|NCT04425863|19897801|P1|STARTED|Overall Study||135
8070294|NCT04425850|19897823|P2|NOT COMPLETED|Overall Study||0
8070295|NCT04425850|19897824|P1|NOT COMPLETED|Overall Study||0
8070296|NCT04425850|19897823|P2|COMPLETED|Overall Study||98
8070297|NCT04425850|19897824|P1|COMPLETED|Overall Study||131
8070298|NCT04425850|19897823|P2|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
8070299|NCT04425850|19897824|P1|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
8070300|NCT04422561|19897834|P2|NOT COMPLETED|Overall Study||11
8070301|NCT04422561|19897835|P1|NOT COMPLETED|Overall Study||25
8070302|NCT04422561|19897834|P2|COMPLETED|Overall Study||101
8070303|NCT04422561|19897835|P1|COMPLETED|Overall Study||203
8070304|NCT04422561|19897834|P2|STARTED|Overall Study||112
8070305|NCT04422561|19897835|P1|STARTED|Overall Study||228
8070306|NCT04410159|19897845|P4|NOT COMPLETED|Overall Study||0
8070307|NCT04410159|19897846|P3|NOT COMPLETED|Overall Study||0
8070308|NCT04410159|19897847|P2|NOT COMPLETED|Overall Study||0
8070309|NCT04410159|19897848|P1|NOT COMPLETED|Overall Study||0
8070310|NCT04410159|19897845|P4|COMPLETED|Overall Study||5
8070311|NCT04410159|19897846|P3|COMPLETED|Overall Study||5
8070312|NCT04410159|19897847|P2|COMPLETED|Overall Study||5
8070313|NCT04410159|19897848|P1|COMPLETED|Overall Study||5
8070314|NCT04410159|19897845|P4|STARTED|Overall Study||5
8070315|NCT04410159|19897846|P3|STARTED|Overall Study||5
8070316|NCT04410159|19897847|P2|STARTED|Overall Study||5
8070317|NCT04410159|19897848|P1|STARTED|Overall Study||5
8070318|NCT04406194|19897876|P2|NOT COMPLETED|Period 2||0
8070319|NCT04406194|19897877|P1|NOT COMPLETED|Period 2||0
8070320|NCT04406194|19897876|P2|COMPLETED|Period 2||14
8070321|NCT04406194|19897877|P1|COMPLETED|Period 2||15
8070322|NCT04406194|19897876|P2|STARTED|Period 2||14
8070323|NCT04406194|19897877|P1|STARTED|Period 2||15
8070324|NCT04406194|19897876|P2|NOT COMPLETED|Period 1||1
8070325|NCT04406194|19897877|P1|NOT COMPLETED|Period 1||0
8070326|NCT04406194|19897876|P2|COMPLETED|Period 1||14
8070327|NCT04406194|19897877|P1|COMPLETED|Period 1||15
8070328|NCT04406194|19897876|P2|STARTED|Period 1||15
8070329|NCT04406194|19897877|P1|STARTED|Period 1||15
8070330|NCT04404907|19897891|P2|NOT COMPLETED|Overall Study||0
8070331|NCT04404907|19897892|P1|NOT COMPLETED|Overall Study||0
8070332|NCT04404907|19897891|P2|COMPLETED|Overall Study||95
8070333|NCT04404907|19897892|P1|COMPLETED|Overall Study||442
8070334|NCT04404907|19897891|P2|Frequent Tan|Overall Study||7
8070335|NCT04404907|19897892|P1|Frequent Tan|Overall Study||0
8070336|NCT04404907|19897891|P2|Occasional Tan|Overall Study||88
8070337|NCT04404907|19897892|P1|Occasional Tan|Overall Study||0
8070338|NCT04404907|19897891|P2|STARTED|Overall Study||95
8070339|NCT04404907|19897892|P1|STARTED|Overall Study||442
8070340|NCT04403399|19897900|P2|NOT COMPLETED|Period 2||1
8070341|NCT04403399|19897901|P1|NOT COMPLETED|Period 2||0
8070342|NCT04403399|19897900|P2|COMPLETED|Period 2||15
8070343|NCT04403399|19897901|P1|COMPLETED|Period 2||18
8070344|NCT04403399|19897900|P2|STARTED|Period 2||16
8070345|NCT04403399|19897901|P1|STARTED|Period 2||18
8070346|NCT04403399|19897900|P2|NOT COMPLETED|Period 1||0
8070347|NCT04403399|19897901|P1|NOT COMPLETED|Period 1||0
8070348|NCT04403399|19897900|P2|COMPLETED|Period 1||16
8070349|NCT04403399|19897901|P1|COMPLETED|Period 1||18
8070350|NCT04403399|19897900|P2|STARTED|Period 1||16
8070351|NCT04403399|19897901|P1|STARTED|Period 1||18
8070352|NCT04403113|19897913|P2|NOT COMPLETED|Overall Study||0
8070353|NCT04403113|19897914|P1|NOT COMPLETED|Overall Study||0
8070354|NCT04403113|19897913|P2|COMPLETED|Overall Study||20
8070355|NCT04403113|19897914|P1|COMPLETED|Overall Study||20
8070356|NCT04403113|19897913|P2|STARTED|Overall Study||20
8070357|NCT04403113|19897914|P1|STARTED|Overall Study||20
8070358|NCT04400682|19897934|P2|NOT COMPLETED|Period 2||0
8070359|NCT04400682|19897935|P1|NOT COMPLETED|Period 2||0
8070360|NCT04400682|19897934|P2|COMPLETED|Period 2||11
8070361|NCT04400682|19897935|P1|COMPLETED|Period 2||14
8070362|NCT04400682|19897934|P2|STARTED|Period 2||11
8070363|NCT04400682|19897935|P1|STARTED|Period 2||14
8070364|NCT04400682|19897934|P2|NOT COMPLETED|Period 1||4
8070365|NCT04400682|19897935|P1|NOT COMPLETED|Period 1||1
8070366|NCT04400682|19897934|P2|COMPLETED|Period 1||11
8070367|NCT04400682|19897935|P1|COMPLETED|Period 1||14
8070368|NCT04400682|19897934|P2|STARTED|Period 1||15
8070369|NCT04400682|19897935|P1|STARTED|Period 1||15
8070370|NCT04399161|19897950|P3|NOT COMPLETED|Overall Study||2
8070371|NCT04399161|19897951|P2|NOT COMPLETED|Overall Study||2
8070372|NCT04399161|19897952|P1|NOT COMPLETED|Overall Study||2
8070373|NCT04399161|19897950|P3|COMPLETED|Overall Study||18
8070374|NCT04399161|19897951|P2|COMPLETED|Overall Study||18
8070375|NCT04399161|19897952|P1|COMPLETED|Overall Study||18
8070376|NCT04399161|19897950|P3|STARTED|Overall Study||20
8070377|NCT04399161|19897951|P2|STARTED|Overall Study||20
8070378|NCT04399161|19897952|P1|STARTED|Overall Study||20
8070379|NCT04397094|19897962|P2|NOT COMPLETED|Overall Study||0
8070380|NCT04397094|19897963|P1|NOT COMPLETED|Overall Study||0
8070381|NCT04397094|19897962|P2|COMPLETED|Overall Study||30
8070382|NCT04397094|19897963|P1|COMPLETED|Overall Study||30
8070383|NCT04397094|19897962|P2|STARTED|Overall Study||30
8070384|NCT04397094|19897963|P1|STARTED|Overall Study||30
8070385|NCT04393493|19897973|P2|NOT COMPLETED|First 4 Days of Intervention||7
8070386|NCT04393493|19897974|P1|NOT COMPLETED|First 4 Days of Intervention||5
8070387|NCT04393493|19897973|P2|COMPLETED|First 4 Days of Intervention||33
8070388|NCT04393493|19897974|P1|COMPLETED|First 4 Days of Intervention||35
8070389|NCT04393493|19897973|P2|STARTED|First 4 Days of Intervention||40
8070390|NCT04393493|19897974|P1|STARTED|First 4 Days of Intervention||40
8070391|NCT04393493|19897973|P2|NOT COMPLETED|Follow up||0
8070392|NCT04393493|19897974|P1|NOT COMPLETED|Follow up||0
8070393|NCT04393493|19897973|P2|COMPLETED|Follow up||40
8070394|NCT04393493|19897974|P1|COMPLETED|Follow up||40
8070395|NCT04393493|19897973|P2|STARTED|Follow up||40
8070396|NCT04393493|19897974|P1|STARTED|Follow up||40
8070397|NCT04390022|19898028|P2|NOT COMPLETED|Overall Study||0
8070398|NCT04390022|19898029|P1|NOT COMPLETED|Overall Study||0
8070399|NCT04390022|19898028|P2|COMPLETED|Overall Study||12
8070400|NCT04390022|19898029|P1|COMPLETED|Overall Study||12
8070401|NCT04390022|19898028|P2|STARTED|Overall Study||12
8070402|NCT04390022|19898029|P1|STARTED|Overall Study||12
8070403|NCT04385238|19898045|P2|NOT COMPLETED|Overall Study||0
8070404|NCT04385238|19898046|P1|NOT COMPLETED|Overall Study||0
8070405|NCT04385238|19898045|P2|COMPLETED|Overall Study||1182
8070406|NCT04385238|19898046|P1|COMPLETED|Overall Study||5712
8070407|NCT04385238|19898045|P2|STARTED|Overall Study||1182
8070408|NCT04385238|19898046|P1|STARTED|Overall Study||5712
8070409|NCT04383132|19898056|P2|NOT COMPLETED|Overall Study||0
8070410|NCT04383132|19898057|P1|NOT COMPLETED|Overall Study||0
8070411|NCT04383132|19898056|P2|COMPLETED|Overall Study||173
8070412|NCT04383132|19898057|P1|COMPLETED|Overall Study||173
8070413|NCT04383132|19898056|P2|STARTED|Overall Study||173
8070414|NCT04383132|19898057|P1|STARTED|Overall Study||173
8070415|NCT04376060|19898075|P1|NOT COMPLETED|Overall Study||1
8070416|NCT04376060|19898075|P1|COMPLETED|Overall Study||14
8070417|NCT04376060|19898075|P1|STARTED|Overall Study||15
8070418|NCT04374500|19898089|P3|NOT COMPLETED|Overall Study||0
8070419|NCT04374500|19898090|P2|NOT COMPLETED|Overall Study||0
8070420|NCT04374500|19898091|P1|NOT COMPLETED|Overall Study||0
8070421|NCT04374500|19898089|P3|COMPLETED|Overall Study||83
8070422|NCT04374500|19898090|P2|COMPLETED|Overall Study||10
8070423|NCT04374500|19898091|P1|COMPLETED|Overall Study||10
8070424|NCT04374500|19898089|P3|STARTED|Overall Study||83
8070425|NCT04374500|19898090|P2|STARTED|Overall Study||10
8070426|NCT04374500|19898091|P1|STARTED|Overall Study||10
8070427|NCT04366583|19898110|P2|NOT COMPLETED|Overall Study||0
8070428|NCT04366583|19898111|P1|NOT COMPLETED|Overall Study||0
8070429|NCT04366583|19898110|P2|COMPLETED|Overall Study||84
8070430|NCT04366583|19898111|P1|COMPLETED|Overall Study||82
8070431|NCT04366583|19898110|P2|STARTED|Overall Study||84
8070432|NCT04366583|19898111|P1|STARTED|Overall Study||82
8070436|NCT04363879|19898128|P2|NOT COMPLETED|Overall Study||0
8070437|NCT04363879|19898129|P1|NOT COMPLETED|Overall Study||0
8070438|NCT04363879|19898128|P2|COMPLETED|Overall Study||92
8070439|NCT04363879|19898129|P1|COMPLETED|Overall Study||78
8070440|NCT04363879|19898128|P2|STARTED|Overall Study||92
8070441|NCT04363879|19898129|P1|STARTED|Overall Study||78
8070442|NCT04359771|19898143|P2|NOT COMPLETED|Overall Study||2
8070443|NCT04359771|19898144|P1|NOT COMPLETED|Overall Study||2
8070444|NCT04359771|19898143|P2|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
8070445|NCT04359771|19898144|P1|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
8070446|NCT04359771|19898143|P2|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
8070447|NCT04359771|19898144|P1|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
8070448|NCT04358991|19898152|P1|NOT COMPLETED|Overall Study||0
8070449|NCT04358991|19898152|P1|COMPLETED|Overall Study||20
8070450|NCT04358991|19898152|P1|STARTED|Overall Study||20
8070451|NCT04355663|19898159|P3|NOT COMPLETED|Overall Study||4
8070452|NCT04355663|19898160|P2|NOT COMPLETED|Overall Study||15
8070453|NCT04355663|19898161|P1|NOT COMPLETED|Overall Study||2
8070454|NCT04355663|19898159|P3|COMPLETED|Overall Study||17
8070455|NCT04355663|19898160|P2|COMPLETED|Overall Study||14
8070456|NCT04355663|19898161|P1|COMPLETED|Overall Study||40
8070457|NCT04355663|19898159|P3|STARTED|Overall Study||21
8070458|NCT04355663|19898160|P2|STARTED|Overall Study||29
8070459|NCT04355663|19898161|P1|STARTED|Overall Study||42
8070460|NCT04352660|19898183|P2|NOT COMPLETED|Overall Study||10
8070461|NCT04352660|19898184|P1|NOT COMPLETED|Overall Study||14
8070462|NCT04352660|19898183|P2|COMPLETED|Overall Study||40
8070463|NCT04352660|19898184|P1|COMPLETED|Overall Study||36
8070464|NCT04352660|19898183|P2|STARTED|Overall Study||50
8070465|NCT04352660|19898184|P1|STARTED|Overall Study||50
8070466|NCT04350788|19898204|P2|NOT COMPLETED|Overall Study||6
8070467|NCT04350788|19898205|P1|NOT COMPLETED|Overall Study||12
8070468|NCT04350788|19898204|P2|COMPLETED|Overall Study||56
8070469|NCT04350788|19898205|P1|COMPLETED|Overall Study||50
8070470|NCT04350788|19898204|P2|STARTED|Overall Study||62
8070471|NCT04350788|19898205|P1|STARTED|Overall Study||62
8070472|NCT04350307|19898248|P2|NOT COMPLETED|Overall Study||0
8070473|NCT04350307|19898249|P1|NOT COMPLETED|Overall Study||0
8070474|NCT04350307|19898248|P2|COMPLETED|Overall Study||78
8070475|NCT04350307|19898249|P1|COMPLETED|Overall Study||84
8070476|NCT04350307|19898248|P2|STARTED|Overall Study||78
8070477|NCT04350307|19898249|P1|STARTED|Overall Study||84
8070478|NCT04349917|19898259|P2|NOT COMPLETED|Second Intervention (2-4 Hours)||0
8070479|NCT04349917|19898260|P1|NOT COMPLETED|Second Intervention (2-4 Hours)||0
8070480|NCT04349917|19898259|P2|COMPLETED|Second Intervention (2-4 Hours)||16
8070481|NCT04349917|19898260|P1|COMPLETED|Second Intervention (2-4 Hours)||19
8070482|NCT04349917|19898259|P2|Received Intervention|Second Intervention (2-4 Hours)||16
8070483|NCT04349917|19898260|P1|Received Intervention|Second Intervention (2-4 Hours)||19
8070484|NCT04349917|19898259|P2|STARTED|Second Intervention (2-4 Hours)||16
8070485|NCT04349917|19898260|P1|STARTED|Second Intervention (2-4 Hours)||19
8070486|NCT04349917|19898259|P2|NOT COMPLETED|Washout Period (4-20 Days)||0
8070487|NCT04349917|19898260|P1|NOT COMPLETED|Washout Period (4-20 Days)||0
8070488|NCT04349917|19898259|P2|COMPLETED|Washout Period (4-20 Days)||16
8070489|NCT04349917|19898260|P1|COMPLETED|Washout Period (4-20 Days)||19
8070490|NCT04349917|19898259|P2|STARTED|Washout Period (4-20 Days)||16
8070491|NCT04349917|19898260|P1|STARTED|Washout Period (4-20 Days)||19
8070492|NCT04349917|19898259|P2|NOT COMPLETED|First Intervention (2-4 Hours)||2
8070493|NCT04349917|19898260|P1|NOT COMPLETED|First Intervention (2-4 Hours)||0
8070494|NCT04349917|19898259|P2|COMPLETED|First Intervention (2-4 Hours)||16
8070495|NCT04349917|19898260|P1|COMPLETED|First Intervention (2-4 Hours)||19
8070496|NCT04349917|19898259|P2|Received Intervention|First Intervention (2-4 Hours)||17
8070497|NCT04349917|19898260|P1|Received Intervention|First Intervention (2-4 Hours)||19
8070498|NCT04349917|19898259|P2|STARTED|First Intervention (2-4 Hours)||18
8070499|NCT04349917|19898260|P1|STARTED|First Intervention (2-4 Hours)||19
8070500|NCT04348851|19898281|P4|NOT COMPLETED|Post-Test 2||1
8070501|NCT04348851|19898282|P3|NOT COMPLETED|Post-Test 2||0
8070502|NCT04348851|19898283|P2|NOT COMPLETED|Post-Test 2||1
8070503|NCT04348851|19898284|P1|NOT COMPLETED|Post-Test 2||0
8070504|NCT04348851|19898281|P4|COMPLETED|Post-Test 2||13
8070505|NCT04348851|19898282|P3|COMPLETED|Post-Test 2||13
8070506|NCT04348851|19898283|P2|COMPLETED|Post-Test 2||10
8070507|NCT04348851|19898284|P1|COMPLETED|Post-Test 2||13
8070508|NCT04348851|19898281|P4|STARTED|Post-Test 2||14
8070509|NCT04348851|19898282|P3|STARTED|Post-Test 2||13
8070510|NCT04348851|19898283|P2|STARTED|Post-Test 2||11
8070511|NCT04348851|19898284|P1|STARTED|Post-Test 2||13
8070512|NCT04348851|19898281|P4|NOT COMPLETED|Post-Test 1||0
8070513|NCT04348851|19898282|P3|NOT COMPLETED|Post-Test 1||0
8070514|NCT04348851|19898283|P2|NOT COMPLETED|Post-Test 1||2
8070515|NCT04348851|19898284|P1|NOT COMPLETED|Post-Test 1||0
8070516|NCT04348851|19898281|P4|COMPLETED|Post-Test 1||14
8070517|NCT04348851|19898282|P3|COMPLETED|Post-Test 1||13
8070518|NCT04348851|19898283|P2|COMPLETED|Post-Test 1||11
8070519|NCT04348851|19898284|P1|COMPLETED|Post-Test 1||13
8070520|NCT04348851|19898281|P4|STARTED|Post-Test 1||14
8070521|NCT04348851|19898282|P3|STARTED|Post-Test 1||13
8070522|NCT04348851|19898283|P2|STARTED|Post-Test 1||13
8070523|NCT04348851|19898284|P1|STARTED|Post-Test 1||13
8070524|NCT04348357|19898364|P2|NOT COMPLETED|Overall Study||12
8070525|NCT04348357|19898365|P1|NOT COMPLETED|Overall Study||0
8070526|NCT04348357|19898364|P2|COMPLETED|Overall Study||16
8070527|NCT04348357|19898365|P1|COMPLETED|Overall Study||25
8070528|NCT04348357|19898364|P2|STARTED|Overall Study||28
8070529|NCT04348357|19898365|P1|STARTED|Overall Study||25
8070530|NCT04343261|19898391|P1|NOT COMPLETED|Overall Study||8
8070531|NCT04343261|19898391|P1|COMPLETED|Overall Study||40
8070532|NCT04343261|19898391|P1|STARTED|Overall Study||48
8070533|NCT04343222|19898400|P3|NOT COMPLETED|Overall Study||0
8070534|NCT04343222|19898401|P2|NOT COMPLETED|Overall Study||0
8070535|NCT04343222|19898402|P1|NOT COMPLETED|Overall Study||0
8070536|NCT04343222|19898400|P3|COMPLETED|Overall Study||15
8070537|NCT04343222|19898401|P2|COMPLETED|Overall Study||15
8070538|NCT04343222|19898402|P1|COMPLETED|Overall Study||16
8070539|NCT04343222|19898400|P3|STARTED|Overall Study||15
8070540|NCT04343222|19898401|P2|STARTED|Overall Study||15
8070541|NCT04343222|19898402|P1|STARTED|Overall Study||16
8070542|NCT04343092|19898425|P1|NOT COMPLETED|Overall Study||0
8070543|NCT04343092|19898425|P1|COMPLETED|Overall Study||16
8070544|NCT04343092|19898425|P1|STARTED|Overall Study||16
8070545|NCT04339296|19898432|P2|NOT COMPLETED|Overall Study||9
8070546|NCT04339296|19898433|P1|NOT COMPLETED|Overall Study||8
8070547|NCT04339296|19898432|P2|COMPLETED|Overall Study||17
8070548|NCT04339296|19898433|P1|COMPLETED|Overall Study||16
8070549|NCT04339296|19898432|P2|Received Allocated Intervention|Overall Study||24
8070550|NCT04339296|19898433|P1|Received Allocated Intervention|Overall Study||21
8070551|NCT04339296|19898432|P2|Completed Baseline|Overall Study||25
8070552|NCT04339296|19898433|P1|Completed Baseline|Overall Study||23
8070553|NCT04339296|19898432|P2|STARTED|Overall Study||26
8070554|NCT04339296|19898433|P1|STARTED|Overall Study||24
8070555|NCT04336475|19898443|P2|NOT COMPLETED|Overall Study||2
8070556|NCT04336475|19898444|P1|NOT COMPLETED|Overall Study||2
8070557|NCT04336475|19898443|P2|COMPLETED|Overall Study||28
8070558|NCT04336475|19898444|P1|COMPLETED|Overall Study||28
8070559|NCT04336475|19898443|P2|STARTED|Overall Study||30
8070560|NCT04336475|19898444|P1|STARTED|Overall Study||30
8070569|NCT04329923|19898465|P6|NOT COMPLETED|Overall Study||5
8070644|NCT04032613|19898607|P2|NOT COMPLETED|Overall Study||2
8070645|NCT04032613|19898608|P1|NOT COMPLETED|Overall Study||5
8070646|NCT04032613|19898607|P2|COMPLETED|Overall Study||23
8070647|NCT04032613|19898608|P1|COMPLETED|Overall Study||16
8070648|NCT04032613|19898607|P2|STARTED|Overall Study||25
8070649|NCT04032613|19898608|P1|STARTED|Overall Study||21
8070650|NCT04025684|19898620|P4|NOT COMPLETED|Overall Study||1
8070651|NCT04025684|19898621|P3|NOT COMPLETED|Overall Study||0
8070652|NCT04025684|19898622|P2|NOT COMPLETED|Overall Study||4
8070653|NCT04025684|19898623|P1|NOT COMPLETED|Overall Study||2
8070654|NCT04025684|19898620|P4|COMPLETED|Overall Study||20
8070655|NCT04025684|19898621|P3|COMPLETED|Overall Study||20
8070656|NCT04025684|19898622|P2|COMPLETED|Overall Study||15
8070657|NCT04025684|19898623|P1|COMPLETED|Overall Study||18
8070658|NCT04025684|19898620|P4|STARTED|Overall Study||21
8070659|NCT04025684|19898621|P3|STARTED|Overall Study||20
8070660|NCT04025684|19898622|P2|STARTED|Overall Study||19
8070661|NCT04025684|19898623|P1|STARTED|Overall Study||20
8070570|NCT04329923|19898466|P5|NOT COMPLETED|Overall Study||2
8070571|NCT04329923|19898467|P4|NOT COMPLETED|Overall Study||1
8070572|NCT04329923|19898468|P3|NOT COMPLETED|Overall Study||1
8070573|NCT04329923|19898469|P2|NOT COMPLETED|Overall Study||4
8070574|NCT04329923|19898470|P1|NOT COMPLETED|Overall Study||1
8070575|NCT04329923|19898465|P6|COMPLETED|Overall Study||61
8070576|NCT04329923|19898466|P5|COMPLETED|Overall Study||64
8070577|NCT04329923|19898467|P4|COMPLETED|Overall Study||2
8070578|NCT04329923|19898468|P3|COMPLETED|Overall Study||3
8070579|NCT04329923|19898469|P2|COMPLETED|Overall Study||13
8070580|NCT04329923|19898470|P1|COMPLETED|Overall Study||16
8070581|NCT04329923|19898465|P6|STARTED|Overall Study||66
8070582|NCT04329923|19898466|P5|STARTED|Overall Study||66
8070583|NCT04329923|19898467|P4|STARTED|Overall Study||3
8070584|NCT04329923|19898468|P3|STARTED|Overall Study||4
8070585|NCT04329923|19898469|P2|STARTED|Overall Study||17
8070586|NCT04329923|19898470|P1|STARTED|Overall Study||17
8070593|NCT04326842|19898510|P2|NOT COMPLETED|Overall Study||58
8070594|NCT04326842|19898511|P1|NOT COMPLETED|Overall Study||9
8070595|NCT04326842|19898510|P2|COMPLETED|Overall Study||31
8070596|NCT04326842|19898511|P1|COMPLETED|Overall Study||31
8070597|NCT04326842|19898510|P2|STARTED|Overall Study||89
8070598|NCT04326842|19898511|P1|STARTED|Overall Study||40
8070599|NCT04325542|19898529|P1|NOT COMPLETED|Overall Study||1
8070600|NCT04325542|19898529|P1|COMPLETED|Overall Study||742
8070601|NCT04325542|19898529|P1|STARTED|Overall Study|one participant withdraw consent during the study|743
8070602|NCT04323592|19898535|P2|NOT COMPLETED|Overall Study||0
8070603|NCT04323592|19898536|P1|NOT COMPLETED|Overall Study||0
8070604|NCT04323592|19898535|P2|COMPLETED|Overall Study||90
8070605|NCT04323592|19898536|P1|COMPLETED|Overall Study||83
8070606|NCT04323592|19898535|P2|STARTED|Overall Study||90
8070607|NCT04323592|19898536|P1|STARTED|Overall Study||83
8070608|NCT04322968|19898556|P4|NOT COMPLETED|Overall Study||0
8070609|NCT04322968|19898557|P3|NOT COMPLETED|Overall Study||0
8070610|NCT04322968|19898558|P2|NOT COMPLETED|Overall Study||1
8070611|NCT04322968|19898559|P1|NOT COMPLETED|Overall Study||1
8070612|NCT04322968|19898556|P4|COMPLETED|Overall Study||10
8070613|NCT04322968|19898557|P3|COMPLETED|Overall Study||10
8070614|NCT04322968|19898558|P2|COMPLETED|Overall Study||9
8070615|NCT04322968|19898559|P1|COMPLETED|Overall Study||10
8070616|NCT04322968|19898556|P4|STARTED|Overall Study||10
8070617|NCT04322968|19898557|P3|STARTED|Overall Study||10
8070618|NCT04322968|19898558|P2|STARTED|Overall Study||10
8070619|NCT04322968|19898559|P1|STARTED|Overall Study||11
8070620|NCT04322526|19898587|P2|NOT COMPLETED|Second Intervention (1day)||0
8070621|NCT04322526|19898588|P1|NOT COMPLETED|Second Intervention (1day)||0
8070622|NCT04322526|19898587|P2|COMPLETED|Second Intervention (1day)||9
8070623|NCT04322526|19898588|P1|COMPLETED|Second Intervention (1day)||11
8070624|NCT04322526|19898587|P2|STARTED|Second Intervention (1day)||9
8070625|NCT04322526|19898588|P1|STARTED|Second Intervention (1day)||11
8070626|NCT04322526|19898587|P2|NOT COMPLETED|Washout (1 Week)||2
8070627|NCT04322526|19898588|P1|NOT COMPLETED|Washout (1 Week)||1
8070628|NCT04322526|19898587|P2|COMPLETED|Washout (1 Week)||9
8070629|NCT04322526|19898588|P1|COMPLETED|Washout (1 Week)||11
8070630|NCT04322526|19898587|P2|STARTED|Washout (1 Week)||11
8070631|NCT04322526|19898588|P1|STARTED|Washout (1 Week)||12
8070632|NCT04322526|19898587|P2|NOT COMPLETED|First Intervention (1 Day)||1
8070633|NCT04322526|19898588|P1|NOT COMPLETED|First Intervention (1 Day)||1
8070634|NCT04322526|19898587|P2|COMPLETED|First Intervention (1 Day)||11
8070635|NCT04322526|19898588|P1|COMPLETED|First Intervention (1 Day)||12
8070636|NCT04322526|19898587|P2|STARTED|First Intervention (1 Day)||12
8070637|NCT04322526|19898588|P1|STARTED|First Intervention (1 Day)||13
8070638|NCT04322500|19898596|P2|NOT COMPLETED|Overall Study||0
8070639|NCT04322500|19898597|P1|NOT COMPLETED|Overall Study||0
8070640|NCT04322500|19898596|P2|COMPLETED|Overall Study||13
8070641|NCT04322500|19898597|P1|COMPLETED|Overall Study||13
8070642|NCT04322500|19898596|P2|STARTED|Overall Study||13
8070643|NCT04322500|19898597|P1|STARTED|Overall Study||13
8070662|NCT04318535|19898697|P3|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
8070663|NCT04318535|19898698|P2|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
8070664|NCT04318535|19898699|P1|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
8070665|NCT04318535|19898697|P3|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
8070666|NCT04318535|19898698|P2|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
8070667|NCT04318535|19898699|P1|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
8070668|NCT04318535|19898697|P3|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
8070669|NCT04318535|19898698|P2|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
8070670|NCT04318535|19898699|P1|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
8070671|NCT04318535|19898697|P3|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
8070672|NCT04318535|19898698|P2|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
8070673|NCT04318535|19898699|P1|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
8070674|NCT04318535|19898697|P3|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
8070675|NCT04318535|19898698|P2|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
8070676|NCT04318535|19898699|P1|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
8070677|NCT04318535|19898697|P3|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
8070678|NCT04318535|19898698|P2|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
8070679|NCT04318535|19898699|P1|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
8070680|NCT04318535|19898697|P3|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
8070681|NCT04318535|19898698|P2|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
8070682|NCT04318535|19898699|P1|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
8070683|NCT04318535|19898697|P3|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
8070684|NCT04318535|19898698|P2|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
8070685|NCT04318535|19898699|P1|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
8070686|NCT04318535|19898697|P3|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
8070687|NCT04318535|19898698|P2|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
8070688|NCT04318535|19898699|P1|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
8070689|NCT04318535|19898697|P3|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
8070690|NCT04318535|19898698|P2|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
8070691|NCT04318535|19898699|P1|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
8070692|NCT04318535|19898697|P3|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
8070693|NCT04318535|19898698|P2|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
8070694|NCT04318535|19898699|P1|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
8070695|NCT04318535|19898697|P3|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
8070696|NCT04318535|19898698|P2|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
8070697|NCT04318535|19898699|P1|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
8070698|NCT04318535|19898697|P3|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
8070699|NCT04318535|19898698|P2|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
8070700|NCT04318535|19898699|P1|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
8070701|NCT04318535|19898697|P3|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
8070702|NCT04318535|19898698|P2|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
8070703|NCT04318535|19898699|P1|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
8070704|NCT04318535|19898697|P3|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8070705|NCT04318535|19898698|P2|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8070706|NCT04318535|19898699|P1|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8070707|NCT04316260|19898738|P2|NOT COMPLETED|Overall Study||0
8070708|NCT04316260|19898739|P1|NOT COMPLETED|Overall Study||0
8070709|NCT04316260|19898738|P2|COMPLETED|Overall Study||17
8070710|NCT04316260|19898739|P1|COMPLETED|Overall Study||34
8070711|NCT04316260|19898738|P2|STARTED|Overall Study||17
8070712|NCT04316260|19898739|P1|STARTED|Overall Study||34
8070776|NCT04308239|19898883|P2|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
8070777|NCT04308239|19898884|P1|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
8070778|NCT04308239|19898883|P2|COMPLETED|Post-intervention Evaluation (1 Week)||10
8070779|NCT04308239|19898884|P1|COMPLETED|Post-intervention Evaluation (1 Week)||19
8070780|NCT04308239|19898883|P2|STARTED|Post-intervention Evaluation (1 Week)||14
8070781|NCT04308239|19898884|P1|STARTED|Post-intervention Evaluation (1 Week)||20
8070782|NCT04308239|19898883|P2|NOT COMPLETED|Intervention (2 Weeks)||0
8070783|NCT04308239|19898884|P1|NOT COMPLETED|Intervention (2 Weeks)||0
8070784|NCT04308239|19898883|P2|COMPLETED|Intervention (2 Weeks)||14
8070785|NCT04308239|19898884|P1|COMPLETED|Intervention (2 Weeks)||20
8070786|NCT04308239|19898883|P2|STARTED|Intervention (2 Weeks)||14
8070787|NCT04308239|19898884|P1|STARTED|Intervention (2 Weeks)||20
8070788|NCT04308239|19898883|P2|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
8070789|NCT04308239|19898884|P1|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
8070790|NCT04308239|19898883|P2|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
8070791|NCT04308239|19898884|P1|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
8070792|NCT04308239|19898883|P2|STARTED|Pre-intervention Evaluation (1 Week)||14
8070793|NCT04308239|19898884|P1|STARTED|Pre-intervention Evaluation (1 Week)||20
8070809|NCT03719612|19898919|P1|NOT COMPLETED|Overall Study||12
8070810|NCT03719612|19898919|P1|COMPLETED|Overall Study||148
8070811|NCT03719612|19898919|P1|STARTED|Overall Study||160
8070815|NCT03641716|19898947|P1|NOT COMPLETED|Overall Study||5
8070816|NCT03641716|19898947|P1|COMPLETED|Overall Study||15
8070817|NCT03641716|19898947|P1|STARTED|Overall Study||20
8070818|NCT03637842|19898955|P2|NOT COMPLETED|Overall Study||0
8070819|NCT03637842|19898956|P1|NOT COMPLETED|Overall Study||0
8070820|NCT03637842|19898955|P2|COMPLETED|Overall Study||2
8070821|NCT03637842|19898956|P1|COMPLETED|Overall Study||2
8070822|NCT03637842|19898955|P2|STARTED|Overall Study||2
8070823|NCT03637842|19898956|P1|STARTED|Overall Study||2
8070824|NCT03615404|19898962|P1|NOT COMPLETED|Overall Study||2
8070825|NCT03615404|19898962|P1|COMPLETED|Overall Study||9
8070826|NCT03615404|19898962|P1|STARTED|Overall Study||11
8070827|NCT03577171|19898969|P2|NOT COMPLETED|Overall Study||0
8070828|NCT03577171|19898970|P1|NOT COMPLETED|Overall Study||0
8070829|NCT03577171|19898969|P2|COMPLETED|Overall Study||12
8070830|NCT03577171|19898970|P1|COMPLETED|Overall Study||13
8070831|NCT03577171|19898969|P2|STARTED|Overall Study||12
8070832|NCT03577171|19898970|P1|STARTED|Overall Study||13
8070839|NCT04296448|19899037|P2|NOT COMPLETED|Overall Study||0
8070840|NCT04296448|19899038|P1|NOT COMPLETED|Overall Study||0
8070841|NCT04296448|19899037|P2|COMPLETED|Overall Study||99
8070842|NCT04296448|19899038|P1|COMPLETED|Overall Study||98
8070843|NCT04296448|19899037|P2|STARTED|Overall Study||99
8070844|NCT04296448|19899038|P1|STARTED|Overall Study||98
8070845|NCT04296227|19899050|P1|NOT COMPLETED|Overall Study||0
8070846|NCT04296227|19899050|P1|COMPLETED|Overall Study||85
8070847|NCT04296227|19899050|P1|STARTED|Overall Study||85
8070851|NCT04295356|19899068|P2|NOT COMPLETED|Overall Study||4
8070852|NCT04295356|19899069|P1|NOT COMPLETED|Overall Study||1
8070853|NCT04295356|19899068|P2|COMPLETED|Overall Study||83
8070854|NCT04295356|19899069|P1|COMPLETED|Overall Study||92
8070855|NCT04295356|19899068|P2|STARTED|Overall Study||87
8070856|NCT04295356|19899069|P1|STARTED|Overall Study||93
8070890|NCT03466099|19899159|P3|NOT COMPLETED|Overall Study||17
8070891|NCT03466099|19899160|P2|NOT COMPLETED|Overall Study||14
8070892|NCT03466099|19899161|P1|NOT COMPLETED|Overall Study||17
8070893|NCT03466099|19899159|P3|COMPLETED|Overall Study||28
8070894|NCT03466099|19899160|P2|COMPLETED|Overall Study||30
8070895|NCT03466099|19899161|P1|COMPLETED|Overall Study||24
8070896|NCT03466099|19899159|P3|Treated|Overall Study||44
8070897|NCT03466099|19899160|P2|Treated|Overall Study||44
8070898|NCT03466099|19899161|P1|Treated|Overall Study||41
8070899|NCT03466099|19899159|P3|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
8070900|NCT03466099|19899160|P2|STARTED|Overall Study||44
8070901|NCT03466099|19899161|P1|STARTED|Overall Study||41
8070926|NCT03435614|19899208|P2|NOT COMPLETED|Overall Study||0
8070927|NCT03435614|19899209|P1|NOT COMPLETED|Overall Study||0
8070928|NCT03435614|19899208|P2|COMPLETED|Overall Study||23
8070929|NCT03435614|19899209|P1|COMPLETED|Overall Study||6
8070930|NCT03435614|19899208|P2|STARTED|Overall Study||23
8070931|NCT03435614|19899209|P1|STARTED|Overall Study||6
8070941|NCT03417141|19899235|P1|NOT COMPLETED|Overall Study||4
8070942|NCT03417141|19899235|P1|COMPLETED|Overall Study||8
8070943|NCT03417141|19899235|P1|STARTED|Overall Study||12
8070968|NCT03357952|19899311|P2|NOT COMPLETED|Overall Study||1
8070969|NCT03357952|19899312|P1|NOT COMPLETED|Overall Study||9
8070970|NCT03357952|19899311|P2|COMPLETED|Overall Study||0
8070971|NCT03357952|19899312|P1|COMPLETED|Overall Study||0
8070972|NCT03357952|19899311|P2|STARTED|Overall Study||1
8070973|NCT03357952|19899312|P1|STARTED|Overall Study||9
8070983|NCT03346070|19899343|P5|NOT COMPLETED|Overall Study||5
8070984|NCT03346070|19899344|P4|NOT COMPLETED|Overall Study||6
8070985|NCT03346070|19899345|P3|NOT COMPLETED|Overall Study||4
8070986|NCT03346070|19899346|P2|NOT COMPLETED|Overall Study||4
8070987|NCT03346070|19899347|P1|NOT COMPLETED|Overall Study||3
8070988|NCT03346070|19899343|P5|COMPLETED|Overall Study||37
8070989|NCT03346070|19899344|P4|COMPLETED|Overall Study||36
8070990|NCT03346070|19899345|P3|COMPLETED|Overall Study||37
8070991|NCT03346070|19899346|P2|COMPLETED|Overall Study||37
8070992|NCT03346070|19899347|P1|COMPLETED|Overall Study||38
8070993|NCT03346070|19899343|P5|Treated|Overall Study||38
8070994|NCT03346070|19899344|P4|Treated|Overall Study||36
8070995|NCT03346070|19899345|P3|Treated|Overall Study||38
8070996|NCT03346070|19899346|P2|Treated|Overall Study||38
8070997|NCT03346070|19899347|P1|Treated|Overall Study||38
8070998|NCT03346070|19899343|P5|STARTED|Overall Study||42
8070999|NCT03346070|19899344|P4|STARTED|Overall Study||42
8071000|NCT03346070|19899345|P3|STARTED|Overall Study||41
8071001|NCT03346070|19899346|P2|STARTED|Overall Study||41
8071002|NCT03346070|19899347|P1|STARTED|Overall Study||41
8070902|NCT04292899|19899174|P4|NOT COMPLETED|Overall Study||645
8070903|NCT04292899|19899175|P3|NOT COMPLETED|Overall Study||223
8070904|NCT04292899|19899176|P2|NOT COMPLETED|Overall Study||33
8070905|NCT04292899|19899177|P1|NOT COMPLETED|Overall Study||32
8070906|NCT04292899|19899174|P4|COMPLETED|Overall Study||2952
8070907|NCT04292899|19899175|P3|COMPLETED|Overall Study||621
8070908|NCT04292899|19899176|P2|COMPLETED|Overall Study||164
8070909|NCT04292899|19899177|P1|COMPLETED|Overall Study||168
8070910|NCT04292899|19899174|P4|STARTED|Overall Study||3597
8070911|NCT04292899|19899175|P3|STARTED|Overall Study||844
8070912|NCT04292899|19899176|P2|STARTED|Overall Study||197
8070913|NCT04292899|19899177|P1|STARTED|Overall Study||200
8070914|NCT04292730|19899191|P4|NOT COMPLETED|Overall Study||80
8070915|NCT04292730|19899192|P3|NOT COMPLETED|Overall Study||22
8070916|NCT04292730|19899193|P2|NOT COMPLETED|Overall Study||21
8070917|NCT04292730|19899194|P1|NOT COMPLETED|Overall Study||20
8070918|NCT04292730|19899191|P4|COMPLETED|Overall Study||437
8070919|NCT04292730|19899192|P3|COMPLETED|Overall Study||178
8070920|NCT04292730|19899193|P2|COMPLETED|Overall Study||176
8070921|NCT04292730|19899194|P1|COMPLETED|Overall Study||179
8070922|NCT04292730|19899191|P4|STARTED|Overall Study||517
8070923|NCT04292730|19899192|P3|STARTED|Overall Study||200
8070924|NCT04292730|19899193|P2|STARTED|Overall Study||197
8070925|NCT04292730|19899194|P1|STARTED|Overall Study||199
8070932|NCT04292639|19899214|P1|NOT COMPLETED|Overall Study||0
8070933|NCT04292639|19899214|P1|COMPLETED|Overall Study||20
8070934|NCT04292639|19899214|P1|STARTED|Overall Study||20
8070935|NCT04292171|19899220|P2|NOT COMPLETED|Overall Study||1
8070936|NCT04292171|19899221|P1|NOT COMPLETED|Overall Study||2
8070937|NCT04292171|19899220|P2|COMPLETED|Overall Study||109
8070938|NCT04292171|19899221|P1|COMPLETED|Overall Study||107
8070939|NCT04292171|19899220|P2|STARTED|Overall Study||110
8070940|NCT04292171|19899221|P1|STARTED|Overall Study||109
8070974|NCT04289714|19899322|P3|NOT COMPLETED|Overall Study||6
8070975|NCT04289714|19899323|P2|NOT COMPLETED|Overall Study||5
8070976|NCT04289714|19899324|P1|NOT COMPLETED|Overall Study||6
8070977|NCT04289714|19899322|P3|COMPLETED|Overall Study||4
8070978|NCT04289714|19899323|P2|COMPLETED|Overall Study||6
8070979|NCT04289714|19899324|P1|COMPLETED|Overall Study||8
8070980|NCT04289714|19899322|P3|STARTED|Overall Study||10
8070981|NCT04289714|19899323|P2|STARTED|Overall Study||11
8070982|NCT04289714|19899324|P1|STARTED|Overall Study||14
8071017|NCT03287635|19899456|P1|NOT COMPLETED|Overall Study||7
8071018|NCT03287635|19899456|P1|COMPLETED|Overall Study||12
8071019|NCT03287635|19899456|P1|STARTED|Overall Study||19
8071020|NCT03287219|19899464|P2|NOT COMPLETED|Overall Study||2
8071021|NCT03287219|19899465|P1|NOT COMPLETED|Overall Study||0
8071022|NCT03287219|19899464|P2|COMPLETED|Overall Study||88
8071023|NCT03287219|19899465|P1|COMPLETED|Overall Study||24
8071024|NCT03287219|19899464|P2|STARTED|Overall Study||90
8071025|NCT03287219|19899465|P1|STARTED|Overall Study||24
8071032|NCT04287517|19899539|P2|NOT COMPLETED|Overall Study||1
8071033|NCT04287517|19899540|P1|NOT COMPLETED|Overall Study||1
8071034|NCT04287517|19899539|P2|COMPLETED|Overall Study||18
8071035|NCT04287517|19899540|P1|COMPLETED|Overall Study||18
8071036|NCT04287517|19899539|P2|STARTED|Overall Study||19
8071037|NCT04287517|19899540|P1|STARTED|Overall Study||19
8071041|NCT04285411|19899578|P1|NOT COMPLETED|Overall Study||0
8071042|NCT04285411|19899578|P1|COMPLETED|Overall Study||10
8071043|NCT04285411|19899578|P1|STARTED|Overall Study||10
8071044|NCT04284930|19899586|P3|NOT COMPLETED|Overall Study||0
8071045|NCT04284930|19899587|P2|NOT COMPLETED|Overall Study||0
8071046|NCT04284930|19899588|P1|NOT COMPLETED|Overall Study||0
8071047|NCT04284930|19899586|P3|COMPLETED|Overall Study||8
8071048|NCT04284930|19899587|P2|COMPLETED|Overall Study||5
8071049|NCT04284930|19899588|P1|COMPLETED|Overall Study||8
8071050|NCT04284930|19899586|P3|STARTED|Overall Study||8
8071051|NCT04284930|19899587|P2|STARTED|Overall Study||5
8071052|NCT04284930|19899588|P1|STARTED|Overall Study||8
8071053|NCT03198871|19899598|P2|NOT COMPLETED|Overall Study||12
8071054|NCT03198871|19899599|P1|NOT COMPLETED|Overall Study||14
8071055|NCT03198871|19899598|P2|COMPLETED|Overall Study||78
8071056|NCT03198871|19899599|P1|COMPLETED|Overall Study||76
8071057|NCT03198871|19899598|P2|STARTED|Overall Study||90
8071058|NCT03198871|19899599|P1|STARTED|Overall Study||90
8071059|NCT03198715|19899634|P5|NOT COMPLETED|Overall Study||2
8071060|NCT03198715|19899635|P4|NOT COMPLETED|Overall Study||0
8071061|NCT03198715|19899636|P3|NOT COMPLETED|Overall Study||2
8071062|NCT03198715|19899637|P2|NOT COMPLETED|Overall Study||1
8071063|NCT03198715|19899638|P1|NOT COMPLETED|Overall Study||0
8071064|NCT03198715|19899634|P5|COMPLETED|Overall Study||7
8071065|NCT03198715|19899635|P4|COMPLETED|Overall Study||3
8071066|NCT03198715|19899636|P3|COMPLETED|Overall Study||10
8071067|NCT03198715|19899637|P2|COMPLETED|Overall Study||11
8071068|NCT03198715|19899638|P1|COMPLETED|Overall Study||6
8071069|NCT03198715|19899634|P5|STARTED|Overall Study||9
8071070|NCT03198715|19899635|P4|STARTED|Overall Study||3
8071071|NCT03198715|19899636|P3|STARTED|Overall Study||12
8071072|NCT03198715|19899637|P2|STARTED|Overall Study||12
8071073|NCT03198715|19899638|P1|STARTED|Overall Study||6
8071165|NCT02975297|19899979|P2|NOT COMPLETED|Overall Study||6
8071166|NCT02975297|19899980|P1|NOT COMPLETED|Overall Study||7
8071135|NCT04281901|19899849|P2|NOT COMPLETED|Overall Study||1
8071136|NCT04281901|19899850|P1|NOT COMPLETED|Overall Study||1
8071137|NCT04281901|19899849|P2|COMPLETED|Overall Study||11
8071138|NCT04281901|19899850|P1|COMPLETED|Overall Study||11
8071139|NCT04281901|19899849|P2|3. Check-up|Overall Study||11
8071140|NCT04281901|19899850|P1|3. Check-up|Overall Study||11
8071141|NCT04281901|19899849|P2|2. Check-up|Overall Study||11
8071142|NCT04281901|19899850|P1|2. Check-up|Overall Study||11
8071143|NCT04281901|19899849|P2|STARTED|Overall Study||12
8071144|NCT04281901|19899850|P1|STARTED|Overall Study||12
8071148|NCT04280705|19899871|P2|NOT COMPLETED|Overall Study||24
8071149|NCT04280705|19899872|P1|NOT COMPLETED|Overall Study||13
8071150|NCT04280705|19899871|P2|COMPLETED|Overall Study||517
8071151|NCT04280705|19899872|P1|COMPLETED|Overall Study||508
8071152|NCT04280705|19899871|P2|Received Treatment|Overall Study||531
8071153|NCT04280705|19899872|P1|Received Treatment|Overall Study||517
8071154|NCT04280705|19899871|P2|STARTED|Overall Study||541
8071155|NCT04280705|19899872|P1|STARTED|Overall Study||521
8071156|NCT04280653|19899956|P1|NOT COMPLETED|Overall Study||0
8071157|NCT04280653|19899956|P1|COMPLETED|Overall Study||15
8071158|NCT04280653|19899956|P1|STARTED|Overall Study||15
8071167|NCT02975297|19899979|P2|COMPLETED|Overall Study||35
8071168|NCT02975297|19899980|P1|COMPLETED|Overall Study||34
8071169|NCT02975297|19899979|P2|STARTED|Overall Study||41
8071170|NCT02975297|19899980|P1|STARTED|Overall Study||41
8071171|NCT02951195|19900010|P8|NOT COMPLETED|Overall Study||0
8071172|NCT02951195|19900011|P7|NOT COMPLETED|Overall Study||0
8071173|NCT02951195|19900012|P6|NOT COMPLETED|Overall Study||0
8071174|NCT02951195|19900013|P5|NOT COMPLETED|Overall Study||0
8071175|NCT02951195|19900014|P4|NOT COMPLETED|Overall Study||0
8071176|NCT02951195|19900015|P3|NOT COMPLETED|Overall Study||0
8071177|NCT02951195|19900016|P2|NOT COMPLETED|Overall Study||0
8071178|NCT02951195|19900017|P1|NOT COMPLETED|Overall Study||0
8071179|NCT02951195|19900010|P8|COMPLETED|Overall Study||21
8071180|NCT02951195|19900011|P7|COMPLETED|Overall Study||7
8071181|NCT02951195|19900012|P6|COMPLETED|Overall Study||10
8071182|NCT02951195|19900013|P5|COMPLETED|Overall Study||4
8071183|NCT02951195|19900014|P4|COMPLETED|Overall Study||10
8071184|NCT02951195|19900015|P3|COMPLETED|Overall Study||10
8071185|NCT02951195|19900016|P2|COMPLETED|Overall Study||6
8071186|NCT02951195|19900017|P1|COMPLETED|Overall Study||8
8071187|NCT02951195|19900010|P8|STARTED|Overall Study||21
8071188|NCT02951195|19900011|P7|STARTED|Overall Study||7
8071189|NCT02951195|19900012|P6|STARTED|Overall Study||10
8071190|NCT02951195|19900013|P5|STARTED|Overall Study||4
8071191|NCT02951195|19900014|P4|STARTED|Overall Study||10
8071192|NCT02951195|19900015|P3|STARTED|Overall Study||10
8071193|NCT02951195|19900016|P2|STARTED|Overall Study||6
8071194|NCT02951195|19900017|P1|STARTED|Overall Study||8
8071229|NCT02798211|19900142|P6|NOT COMPLETED|Period 2||6
8071230|NCT02798211|19900143|P5|NOT COMPLETED|Period 2||8
8071231|NCT02798211|19900144|P4|NOT COMPLETED|Period 2||7
8071232|NCT02798211|19900145|P3|NOT COMPLETED|Period 2||0
8071233|NCT02798211|19900146|P2|NOT COMPLETED|Period 2||0
8071234|NCT02798211|19900147|P1|NOT COMPLETED|Period 2||14
8071235|NCT02798211|19900142|P6|COMPLETED|Period 2||40
8071236|NCT02798211|19900143|P5|COMPLETED|Period 2||34
8071237|NCT02798211|19900144|P4|COMPLETED|Period 2||43
8071238|NCT02798211|19900145|P3|COMPLETED|Period 2||0
8071239|NCT02798211|19900146|P2|COMPLETED|Period 2||0
8071240|NCT02798211|19900147|P1|COMPLETED|Period 2||83
8071241|NCT02798211|19900142|P6|STARTED|Period 2||46
8071242|NCT02798211|19900143|P5|STARTED|Period 2||42
8071243|NCT02798211|19900144|P4|STARTED|Period 2||50
8071244|NCT02798211|19900145|P3|STARTED|Period 2||0
8071245|NCT02798211|19900146|P2|STARTED|Period 2||0
8071246|NCT02798211|19900147|P1|STARTED|Period 2||97
8071247|NCT02798211|19900142|P6|NOT COMPLETED|Period 1||0
8071248|NCT02798211|19900143|P5|NOT COMPLETED|Period 1||0
8071249|NCT02798211|19900144|P4|NOT COMPLETED|Period 1||0
8071250|NCT02798211|19900145|P3|NOT COMPLETED|Period 1||6
8071251|NCT02798211|19900146|P2|NOT COMPLETED|Period 1||10
8071252|NCT02798211|19900147|P1|NOT COMPLETED|Period 1||6
8071253|NCT02798211|19900142|P6|COMPLETED|Period 1||0
8071254|NCT02798211|19900143|P5|COMPLETED|Period 1||0
8071255|NCT02798211|19900144|P4|COMPLETED|Period 1||0
8071256|NCT02798211|19900145|P3|COMPLETED|Period 1||46
8071257|NCT02798211|19900146|P2|COMPLETED|Period 1||93
8071258|NCT02798211|19900147|P1|COMPLETED|Period 1||97
8071259|NCT02798211|19900142|P6|STARTED|Period 1||0
8071260|NCT02798211|19900143|P5|STARTED|Period 1||0
8071261|NCT02798211|19900144|P4|STARTED|Period 1||0
8071262|NCT02798211|19900145|P3|STARTED|Period 1||52
8071263|NCT02798211|19900146|P2|STARTED|Period 1||103
8071264|NCT02798211|19900147|P1|STARTED|Period 1||103
8071268|NCT04274556|19900226|P1|NOT COMPLETED|Overall Study||0
8071269|NCT04274556|19900226|P1|COMPLETED|Overall Study||86
8071270|NCT04274556|19900226|P1|STARTED|Overall Study||86
8071271|NCT02730793|19900264|P2|NOT COMPLETED|Overall Study||2
8071272|NCT02730793|19900265|P1|NOT COMPLETED|Overall Study||0
8071273|NCT02730793|19900264|P2|COMPLETED|Overall Study||1
8071274|NCT02730793|19900265|P1|COMPLETED|Overall Study||2
8071275|NCT02730793|19900264|P2|STARTED|Overall Study||3
8071276|NCT02730793|19900265|P1|STARTED|Overall Study||2
8071283|NCT02721355|19900316|P2|NOT COMPLETED|Overall Study||1
8071284|NCT02721355|19900317|P1|NOT COMPLETED|Overall Study||6
8071285|NCT02721355|19900316|P2|COMPLETED|Overall Study||41
8071286|NCT02721355|19900317|P1|COMPLETED|Overall Study||36
8071287|NCT02721355|19900316|P2|STARTED|Overall Study||42
8071288|NCT02721355|19900317|P1|STARTED|Overall Study||42
8071295|NCT04272775|19900341|P2|NOT COMPLETED|Overall Study||7
8071296|NCT04272775|19900342|P1|NOT COMPLETED|Overall Study||7
8071297|NCT04272775|19900341|P2|COMPLETED|Overall Study||0
8071298|NCT04272775|19900342|P1|COMPLETED|Overall Study||0
8071299|NCT04272775|19900341|P2|STARTED|Overall Study||7
8071300|NCT04272775|19900342|P1|STARTED|Overall Study||7
8071328|NCT02617628|19900531|P2|NOT COMPLETED|Overall Study||61
8071329|NCT02617628|19900532|P1|NOT COMPLETED|Overall Study||62
8071330|NCT02617628|19900531|P2|COMPLETED|Overall Study||11
8071331|NCT02617628|19900532|P1|COMPLETED|Overall Study||12
8071332|NCT02617628|19900531|P2|STARTED|Overall Study||72
8071333|NCT02617628|19900532|P1|STARTED|Overall Study||74
8071334|NCT04271020|19900540|P1|NOT COMPLETED|Overall Study||0
8071335|NCT04271020|19900540|P1|COMPLETED|Overall Study||12
8071336|NCT04271020|19900540|P1|STARTED|Overall Study||12
8071337|NCT02526277|19900550|P4|NOT COMPLETED|Overall Study||0
8071338|NCT02526277|19900551|P3|NOT COMPLETED|Overall Study||0
8071339|NCT02526277|19900552|P2|NOT COMPLETED|Overall Study||0
8071340|NCT02526277|19900553|P1|NOT COMPLETED|Overall Study||0
8071341|NCT02526277|19900550|P4|COMPLETED|Overall Study||7
8071342|NCT02526277|19900551|P3|COMPLETED|Overall Study||7
8071343|NCT02526277|19900552|P2|COMPLETED|Overall Study||6
8071344|NCT02526277|19900553|P1|COMPLETED|Overall Study||8
8071345|NCT02526277|19900550|P4|STARTED|Overall Study||7
8071346|NCT02526277|19900551|P3|STARTED|Overall Study||7
8071347|NCT02526277|19900552|P2|STARTED|Overall Study||6
8071348|NCT02526277|19900553|P1|STARTED|Overall Study||8
8071349|NCT04270292|19900571|P1|NOT COMPLETED|Overall Study||0
8071350|NCT04270292|19900571|P1|COMPLETED|Overall Study||164
8071351|NCT04270292|19900571|P1|STARTED|Overall Study||164
8071352|NCT02476916|19900580|P2|NOT COMPLETED|Extension Period||18
8071353|NCT02476916|19900581|P1|NOT COMPLETED|Extension Period||18
8071354|NCT02476916|19900580|P2|COMPLETED|Extension Period||0
8071355|NCT02476916|19900581|P1|COMPLETED|Extension Period||0
8071356|NCT02476916|19900580|P2|STARTED|Extension Period||18
8071357|NCT02476916|19900581|P1|STARTED|Extension Period||18
8071358|NCT02476916|19900580|P2|NOT COMPLETED|Core Period||3
8071359|NCT02476916|19900581|P1|NOT COMPLETED|Core Period||6
8071360|NCT02476916|19900580|P2|COMPLETED|Core Period||22
8071361|NCT02476916|19900581|P1|COMPLETED|Core Period||21
8071362|NCT02476916|19900580|P2|STARTED|Core Period||25
8071363|NCT02476916|19900581|P1|STARTED|Core Period||27
8071371|NCT02371369|19900654|P2|NOT COMPLETED|Part 2||4
8071372|NCT02371369|19900655|P1|NOT COMPLETED|Part 2||9
8071373|NCT02371369|19900654|P2|COMPLETED|Part 2||26
8071374|NCT02371369|19900655|P1|COMPLETED|Part 2||39
8071375|NCT02371369|19900654|P2|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
8071376|NCT02371369|19900655|P1|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
8071377|NCT02371369|19900654|P2|NOT COMPLETED|Part 1||11
8071378|NCT02371369|19900655|P1|NOT COMPLETED|Part 1||9
8071379|NCT02371369|19900654|P2|COMPLETED|Part 1||48
8071380|NCT02371369|19900655|P1|COMPLETED|Part 1||52
8071381|NCT02371369|19900654|P2|STARTED|Part 1||59
8071382|NCT02371369|19900655|P1|STARTED|Part 1||61
8071389|NCT02357979|19900711|P2|NOT COMPLETED|Overall Study||5
8071390|NCT02357979|19900712|P1|NOT COMPLETED|Overall Study||5
8071391|NCT02357979|19900711|P2|COMPLETED|Overall Study||55
8071392|NCT02357979|19900712|P1|COMPLETED|Overall Study||55
8071393|NCT02357979|19900711|P2|STARTED|Overall Study||60
8071394|NCT02357979|19900712|P1|STARTED|Overall Study||60
8071401|NCT02340676|19900769|P1|NOT COMPLETED|Overall Study||0
8071402|NCT02340676|19900769|P1|COMPLETED|Overall Study||25
8071403|NCT02340676|19900769|P1|STARTED|Overall Study||25
8071404|NCT02338960|19900782|P2|NOT COMPLETED|Open Label Extension||79
8071405|NCT02338960|19900783|P1|NOT COMPLETED|Open Label Extension||114
8071406|NCT02338960|19900782|P2|COMPLETED|Open Label Extension||51
8071407|NCT02338960|19900783|P1|COMPLETED|Open Label Extension||77
8071408|NCT02338960|19900782|P2|STARTED|Open Label Extension||130
8071409|NCT02338960|19900783|P1|STARTED|Open Label Extension||191
8071410|NCT02338960|19900782|P2|NOT COMPLETED|Core Study||135
8071411|NCT02338960|19900783|P1|NOT COMPLETED|Core Study||87
8071412|NCT02338960|19900782|P2|COMPLETED|Core Study||173
8071413|NCT02338960|19900783|P1|COMPLETED|Core Study||219
8071414|NCT02338960|19900782|P2|Received Intervention|Core Study||301
8071415|NCT02338960|19900783|P1|Received Intervention|Core Study||303
8071416|NCT02338960|19900782|P2|STARTED|Core Study||308
8071417|NCT02338960|19900783|P1|STARTED|Core Study||306
8071444|NCT02245815|19900917|P2|NOT COMPLETED|Overall Study||0
8071445|NCT02245815|19900918|P1|NOT COMPLETED|Overall Study||0
8071446|NCT02245815|19900917|P2|COMPLETED|Overall Study||45
8071447|NCT02245815|19900918|P1|COMPLETED|Overall Study||45
8071448|NCT02245815|19900917|P2|STARTED|Overall Study||45
8071449|NCT02245815|19900918|P1|STARTED|Overall Study||45
8071450|NCT02213380|19900928|P2|NOT COMPLETED|Per-protocol Analysis||36
8071451|NCT02213380|19900929|P1|NOT COMPLETED|Per-protocol Analysis||32
8071452|NCT02213380|19900928|P2|COMPLETED|Per-protocol Analysis||435
8071453|NCT02213380|19900929|P1|COMPLETED|Per-protocol Analysis||439
8071454|NCT02213380|19900928|P2|STARTED|Per-protocol Analysis||471
8071455|NCT02213380|19900929|P1|STARTED|Per-protocol Analysis||471
8071456|NCT02213380|19900928|P2|NOT COMPLETED|Underwent Randomization||3
8071457|NCT02213380|19900929|P1|NOT COMPLETED|Underwent Randomization||5
8071458|NCT02213380|19900928|P2|COMPLETED|Underwent Randomization||471
8071459|NCT02213380|19900929|P1|COMPLETED|Underwent Randomization||471
8071460|NCT02213380|19900928|P2|STARTED|Underwent Randomization||474
8071461|NCT02213380|19900929|P1|STARTED|Underwent Randomization||476
8071462|NCT02180867|19900958|P7|NOT COMPLETED|Overall Study||5
8071463|NCT02180867|19900959|P6|NOT COMPLETED|Overall Study||3
8071464|NCT02180867|19900960|P5|NOT COMPLETED|Overall Study||27
8071465|NCT02180867|19900961|P4|NOT COMPLETED|Overall Study||26
8071466|NCT02180867|19900962|P3|NOT COMPLETED|Overall Study||4
8071467|NCT02180867|19900963|P2|NOT COMPLETED|Overall Study||11
8071468|NCT02180867|19900964|P1|NOT COMPLETED|Overall Study||6
8071469|NCT02180867|19900958|P7|COMPLETED|Overall Study||1
8071470|NCT02180867|19900959|P6|COMPLETED|Overall Study||3
8071471|NCT02180867|19900960|P5|COMPLETED|Overall Study||21
8071472|NCT02180867|19900961|P4|COMPLETED|Overall Study||23
8071473|NCT02180867|19900962|P3|COMPLETED|Overall Study||6
8071474|NCT02180867|19900963|P2|COMPLETED|Overall Study||0
8071475|NCT02180867|19900964|P1|COMPLETED|Overall Study||4
8071476|NCT02180867|19900958|P7|Adult Patients|Overall Study||6
8071364|NCT04269629|19900623|P1|NOT COMPLETED|Overall Study||239
8071365|NCT04269629|19900623|P1|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
8071366|NCT04269629|19900623|P1|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
8071367|NCT04269629|19900623|P1|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
8071383|NCT04267770|19900679|P2|NOT COMPLETED|Overall Study||0
8071384|NCT04267770|19900680|P1|NOT COMPLETED|Overall Study||0
8071385|NCT04267770|19900679|P2|COMPLETED|Overall Study||8
8071386|NCT04267770|19900680|P1|COMPLETED|Overall Study||9
8071387|NCT04267770|19900679|P2|STARTED|Overall Study||8
8071388|NCT04267770|19900680|P1|STARTED|Overall Study||9
8071395|NCT04267380|19900724|P2|NOT COMPLETED|Overall Study||0
8071396|NCT04267380|19900725|P1|NOT COMPLETED|Overall Study||0
8071397|NCT04267380|19900724|P2|COMPLETED|Overall Study||149
8071398|NCT04267380|19900725|P1|COMPLETED|Overall Study||149
8071399|NCT04267380|19900724|P2|STARTED|Overall Study||149
8071400|NCT04267380|19900725|P1|STARTED|Overall Study||149
8071418|NCT04266925|19900821|P2|NOT COMPLETED|3 Referee Game (~1 Hour)||0
8071419|NCT04266925|19900822|P1|NOT COMPLETED|3 Referee Game (~1 Hour)||0
8071420|NCT04266925|19900821|P2|COMPLETED|3 Referee Game (~1 Hour)||26
8071421|NCT04266925|19900822|P1|COMPLETED|3 Referee Game (~1 Hour)||23
8071422|NCT04266925|19900821|P2|STARTED|3 Referee Game (~1 Hour)||26
8071423|NCT04266925|19900822|P1|STARTED|3 Referee Game (~1 Hour)||23
8071424|NCT04266925|19900821|P2|NOT COMPLETED|1 Referee Game (~1 Hour)||0
8071425|NCT04266925|19900822|P1|NOT COMPLETED|1 Referee Game (~1 Hour)||0
8071426|NCT04266925|19900821|P2|COMPLETED|1 Referee Game (~1 Hour)||26
8071427|NCT04266925|19900822|P1|COMPLETED|1 Referee Game (~1 Hour)||23
8071428|NCT04266925|19900821|P2|STARTED|1 Referee Game (~1 Hour)||26
8071429|NCT04266925|19900822|P1|STARTED|1 Referee Game (~1 Hour)||23
8071477|NCT02180867|19900959|P6|Adult Patients|Overall Study||5
8071478|NCT02180867|19900960|P5|Adult Patients|Overall Study||29
8071479|NCT02180867|19900961|P4|Adult Patients|Overall Study||31
8071480|NCT02180867|19900962|P3|Adult Patients|Overall Study||7
8071481|NCT02180867|19900963|P2|Adult Patients|Overall Study||7
8071482|NCT02180867|19900964|P1|Adult Patients|Overall Study||4
8071483|NCT02180867|19900958|P7|Pediatric Patients|Overall Study||0
8071484|NCT02180867|19900959|P6|Pediatric Patients|Overall Study||1
8071485|NCT02180867|19900960|P5|Pediatric Patients|Overall Study||19
8071486|NCT02180867|19900961|P4|Pediatric Patients|Overall Study||18
8071487|NCT02180867|19900962|P3|Pediatric Patients|Overall Study||3
8071488|NCT02180867|19900963|P2|Pediatric Patients|Overall Study||4
8071489|NCT02180867|19900964|P1|Pediatric Patients|Overall Study||6
8071490|NCT02180867|19900958|P7|STARTED|Overall Study||6
8071491|NCT02180867|19900959|P6|STARTED|Overall Study||6
8071492|NCT02180867|19900960|P5|STARTED|Overall Study||48
8071493|NCT02180867|19900961|P4|STARTED|Overall Study||49
8071494|NCT02180867|19900962|P3|STARTED|Overall Study||10
8071495|NCT02180867|19900963|P2|STARTED|Overall Study||11
8071496|NCT02180867|19900964|P1|STARTED|Overall Study||10
8071497|NCT02180165|19900997|P4|NOT COMPLETED|Overall Study||6
8071498|NCT02180165|19900998|P3|NOT COMPLETED|Overall Study||29
8071499|NCT02180165|19900999|P2|NOT COMPLETED|Overall Study||1
8071500|NCT02180165|19901000|P1|NOT COMPLETED|Overall Study||11
8071501|NCT02180165|19900997|P4|COMPLETED|Overall Study||25
8071502|NCT02180165|19900998|P3|COMPLETED|Overall Study||34
8071503|NCT02180165|19900999|P2|COMPLETED|Overall Study||6
8071504|NCT02180165|19901000|P1|COMPLETED|Overall Study||4
8071505|NCT02180165|19900997|P4|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
8071506|NCT02180165|19900998|P3|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
8071507|NCT02180165|19900999|P2|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
8071508|NCT02180165|19901000|P1|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
8071509|NCT02180165|19900997|P4|Treated Participants|Overall Study||31
8071510|NCT02180165|19900998|P3|Treated Participants|Overall Study||62
8071511|NCT02180165|19900999|P2|Treated Participants|Overall Study||7
8071512|NCT02180165|19901000|P1|Treated Participants|Overall Study||15
8071513|NCT02180165|19900997|P4|STARTED|Overall Study||31
8071514|NCT02180165|19900998|P3|STARTED|Overall Study||63
8071515|NCT02180165|19900999|P2|STARTED|Overall Study||7
8071516|NCT02180165|19901000|P1|STARTED|Overall Study||15
8071538|NCT02137837|19901147|P3|NOT COMPLETED|Overall Study||12
8071539|NCT02137837|19901148|P2|NOT COMPLETED|Overall Study||12
8071540|NCT02137837|19901149|P1|NOT COMPLETED|Overall Study||13
8071541|NCT02137837|19901147|P3|COMPLETED|Overall Study||0
8071542|NCT02137837|19901148|P2|COMPLETED|Overall Study||0
8071543|NCT02137837|19901149|P1|COMPLETED|Overall Study||0
8071544|NCT02137837|19901147|P3|Received Protocol Therapy|Overall Study||12
8071545|NCT02137837|19901148|P2|Received Protocol Therapy|Overall Study||11
8071546|NCT02137837|19901149|P1|Received Protocol Therapy|Overall Study||13
8071547|NCT02137837|19901147|P3|STARTED|Overall Study||12
8071548|NCT02137837|19901148|P2|STARTED|Overall Study||12
8071549|NCT02137837|19901149|P1|STARTED|Overall Study||13
8071550|NCT02132754|19901209|P34|NOT COMPLETED|Overall Study||23
8071551|NCT02132754|19901210|P33|NOT COMPLETED|Overall Study||4
8071552|NCT02132754|19901211|P32|NOT COMPLETED|Overall Study||3
8071553|NCT02132754|19901212|P31|NOT COMPLETED|Overall Study||3
8071554|NCT02132754|19901213|P30|NOT COMPLETED|Overall Study||3
8071555|NCT02132754|19901214|P29|NOT COMPLETED|Overall Study||3
8071556|NCT02132754|19901215|P28|NOT COMPLETED|Overall Study||3
8071557|NCT02132754|19901216|P27|NOT COMPLETED|Overall Study||4
8071558|NCT02132754|19901217|P26|NOT COMPLETED|Overall Study||3
8071559|NCT02132754|19901218|P25|NOT COMPLETED|Overall Study||3
8071560|NCT02132754|19901219|P24|NOT COMPLETED|Overall Study||3
8071561|NCT02132754|19901220|P23|NOT COMPLETED|Overall Study||3
8071562|NCT02132754|19901221|P22|NOT COMPLETED|Overall Study||5
8071563|NCT02132754|19901222|P21|NOT COMPLETED|Overall Study||3
8071564|NCT02132754|19901223|P20|NOT COMPLETED|Overall Study||4
8071565|NCT02132754|19901224|P19|NOT COMPLETED|Overall Study||3
8071566|NCT02132754|19901225|P18|NOT COMPLETED|Overall Study||3
8071567|NCT02132754|19901226|P17|NOT COMPLETED|Overall Study||4
8071568|NCT02132754|19901227|P16|NOT COMPLETED|Overall Study||5
8071569|NCT02132754|19901228|P15|NOT COMPLETED|Overall Study||3
8071570|NCT02132754|19901229|P14|NOT COMPLETED|Overall Study||3
8071571|NCT02132754|19901230|P13|NOT COMPLETED|Overall Study||4
8071572|NCT02132754|19901231|P12|NOT COMPLETED|Overall Study||3
8071573|NCT02132754|19901232|P11|NOT COMPLETED|Overall Study||3
8071574|NCT02132754|19901233|P10|NOT COMPLETED|Overall Study||6
8071575|NCT02132754|19901234|P9|NOT COMPLETED|Overall Study||1
8071576|NCT02132754|19901235|P8|NOT COMPLETED|Overall Study||1
8071577|NCT02132754|19901236|P7|NOT COMPLETED|Overall Study||1
8071578|NCT02132754|19901237|P6|NOT COMPLETED|Overall Study||1
8071579|NCT02132754|19901238|P5|NOT COMPLETED|Overall Study||1
8071580|NCT02132754|19901239|P4|NOT COMPLETED|Overall Study||1
8071581|NCT02132754|19901240|P3|NOT COMPLETED|Overall Study||1
8071582|NCT02132754|19901241|P2|NOT COMPLETED|Overall Study||1
8071583|NCT02132754|19901242|P1|NOT COMPLETED|Overall Study||1
8071584|NCT02132754|19901209|P34|COMPLETED|Overall Study||0
8071585|NCT02132754|19901210|P33|COMPLETED|Overall Study||0
8071586|NCT02132754|19901211|P32|COMPLETED|Overall Study||0
8071587|NCT02132754|19901212|P31|COMPLETED|Overall Study||0
8071588|NCT02132754|19901213|P30|COMPLETED|Overall Study||0
8071589|NCT02132754|19901214|P29|COMPLETED|Overall Study||0
8071590|NCT02132754|19901215|P28|COMPLETED|Overall Study||0
8071591|NCT02132754|19901216|P27|COMPLETED|Overall Study||0
8071592|NCT02132754|19901217|P26|COMPLETED|Overall Study||0
8071593|NCT02132754|19901218|P25|COMPLETED|Overall Study||0
8071594|NCT02132754|19901219|P24|COMPLETED|Overall Study||0
8071595|NCT02132754|19901220|P23|COMPLETED|Overall Study||0
8071596|NCT02132754|19901221|P22|COMPLETED|Overall Study||0
8071597|NCT02132754|19901222|P21|COMPLETED|Overall Study||0
8071598|NCT02132754|19901223|P20|COMPLETED|Overall Study||0
8071599|NCT02132754|19901224|P19|COMPLETED|Overall Study||0
8071600|NCT02132754|19901225|P18|COMPLETED|Overall Study||0
8071601|NCT02132754|19901226|P17|COMPLETED|Overall Study||0
8071602|NCT02132754|19901227|P16|COMPLETED|Overall Study||0
8071603|NCT02132754|19901228|P15|COMPLETED|Overall Study||0
8071604|NCT02132754|19901229|P14|COMPLETED|Overall Study||0
8071605|NCT02132754|19901230|P13|COMPLETED|Overall Study||0
8071606|NCT02132754|19901231|P12|COMPLETED|Overall Study||0
8071607|NCT02132754|19901232|P11|COMPLETED|Overall Study||0
8071608|NCT02132754|19901233|P10|COMPLETED|Overall Study||0
8071609|NCT02132754|19901234|P9|COMPLETED|Overall Study||0
8071610|NCT02132754|19901235|P8|COMPLETED|Overall Study||0
8071611|NCT02132754|19901236|P7|COMPLETED|Overall Study||0
8071612|NCT02132754|19901237|P6|COMPLETED|Overall Study||0
8071613|NCT02132754|19901238|P5|COMPLETED|Overall Study||0
8071614|NCT02132754|19901239|P4|COMPLETED|Overall Study||0
8071615|NCT02132754|19901240|P3|COMPLETED|Overall Study||0
8071616|NCT02132754|19901241|P2|COMPLETED|Overall Study||0
8071617|NCT02132754|19901242|P1|COMPLETED|Overall Study||0
8071618|NCT02132754|19901209|P34|Treated|Overall Study||23
8071619|NCT02132754|19901210|P33|Treated|Overall Study||4
8071620|NCT02132754|19901211|P32|Treated|Overall Study||3
8071621|NCT02132754|19901212|P31|Treated|Overall Study||3
8071622|NCT02132754|19901213|P30|Treated|Overall Study||3
8071623|NCT02132754|19901214|P29|Treated|Overall Study||3
8071624|NCT02132754|19901215|P28|Treated|Overall Study||3
8071625|NCT02132754|19901216|P27|Treated|Overall Study||4
8071626|NCT02132754|19901217|P26|Treated|Overall Study||3
8071627|NCT02132754|19901218|P25|Treated|Overall Study||3
8071628|NCT02132754|19901219|P24|Treated|Overall Study||3
8071629|NCT02132754|19901220|P23|Treated|Overall Study||3
8071630|NCT02132754|19901221|P22|Treated|Overall Study||4
8071631|NCT02132754|19901222|P21|Treated|Overall Study||3
8071632|NCT02132754|19901223|P20|Treated|Overall Study||3
8071633|NCT02132754|19901224|P19|Treated|Overall Study||3
8071634|NCT02132754|19901225|P18|Treated|Overall Study||3
8071635|NCT02132754|19901226|P17|Treated|Overall Study||4
8071636|NCT02132754|19901227|P16|Treated|Overall Study||5
8071637|NCT02132754|19901228|P15|Treated|Overall Study||3
8071638|NCT02132754|19901229|P14|Treated|Overall Study||3
8071639|NCT02132754|19901230|P13|Treated|Overall Study||3
8071640|NCT02132754|19901231|P12|Treated|Overall Study||3
8071641|NCT02132754|19901232|P11|Treated|Overall Study||3
8071642|NCT02132754|19901233|P10|Treated|Overall Study||6
8071643|NCT02132754|19901234|P9|Treated|Overall Study||1
8071644|NCT02132754|19901235|P8|Treated|Overall Study||1
8071645|NCT02132754|19901236|P7|Treated|Overall Study||1
8071646|NCT02132754|19901237|P6|Treated|Overall Study||1
8071647|NCT02132754|19901238|P5|Treated|Overall Study||1
8071648|NCT02132754|19901239|P4|Treated|Overall Study||1
8071649|NCT02132754|19901240|P3|Treated|Overall Study||1
8071650|NCT02132754|19901241|P2|Treated|Overall Study||1
8071651|NCT02132754|19901242|P1|Treated|Overall Study||1
8071652|NCT02132754|19901209|P34|STARTED|Overall Study||23
8071653|NCT02132754|19901210|P33|STARTED|Overall Study||4
8071654|NCT02132754|19901211|P32|STARTED|Overall Study||3
8071655|NCT02132754|19901212|P31|STARTED|Overall Study||3
8071656|NCT02132754|19901213|P30|STARTED|Overall Study||3
8071657|NCT02132754|19901214|P29|STARTED|Overall Study||3
8071658|NCT02132754|19901215|P28|STARTED|Overall Study||3
8071659|NCT02132754|19901216|P27|STARTED|Overall Study||4
8071660|NCT02132754|19901217|P26|STARTED|Overall Study||3
8071661|NCT02132754|19901218|P25|STARTED|Overall Study||3
8071662|NCT02132754|19901219|P24|STARTED|Overall Study||3
8071663|NCT02132754|19901220|P23|STARTED|Overall Study||3
8071664|NCT02132754|19901221|P22|STARTED|Overall Study||5
8071665|NCT02132754|19901222|P21|STARTED|Overall Study||3
8071666|NCT02132754|19901223|P20|STARTED|Overall Study||4
8071667|NCT02132754|19901224|P19|STARTED|Overall Study||3
8071668|NCT02132754|19901225|P18|STARTED|Overall Study||3
8071669|NCT02132754|19901226|P17|STARTED|Overall Study||4
8071670|NCT02132754|19901227|P16|STARTED|Overall Study||5
8071671|NCT02132754|19901228|P15|STARTED|Overall Study||3
8071672|NCT02132754|19901229|P14|STARTED|Overall Study||3
8071673|NCT02132754|19901230|P13|STARTED|Overall Study||4
8071674|NCT02132754|19901231|P12|STARTED|Overall Study||3
8071675|NCT02132754|19901232|P11|STARTED|Overall Study||3
8071676|NCT02132754|19901233|P10|STARTED|Overall Study||6
8071677|NCT02132754|19901234|P9|STARTED|Overall Study||1
8071678|NCT02132754|19901235|P8|STARTED|Overall Study||1
8071679|NCT02132754|19901236|P7|STARTED|Overall Study||1
8071680|NCT02132754|19901237|P6|STARTED|Overall Study||1
8071681|NCT02132754|19901238|P5|STARTED|Overall Study||1
8071682|NCT02132754|19901239|P4|STARTED|Overall Study||1
8071683|NCT02132754|19901240|P3|STARTED|Overall Study||1
8071684|NCT02132754|19901241|P2|STARTED|Overall Study||1
8071685|NCT02132754|19901242|P1|STARTED|Overall Study||1
8071686|NCT02036853|19901966|P2|NOT COMPLETED|Overall Study||6
8071687|NCT02036853|19901967|P1|NOT COMPLETED|Overall Study||0
8071688|NCT02036853|19901966|P2|COMPLETED|Overall Study||8
8071689|NCT02036853|19901967|P1|COMPLETED|Overall Study||6
8071690|NCT02036853|19901966|P2|STARTED|Overall Study||14
8071691|NCT02036853|19901967|P1|STARTED|Overall Study||6
8071725|NCT01838044|19902071|P2|NOT COMPLETED|Overall Study||16
8071726|NCT01838044|19902072|P1|NOT COMPLETED|Overall Study||8
8071727|NCT01838044|19902071|P2|COMPLETED|Overall Study||75
8071728|NCT01838044|19902072|P1|COMPLETED|Overall Study||81
8071729|NCT01838044|19902071|P2|STARTED|Overall Study||91
8071730|NCT01838044|19902072|P1|STARTED|Overall Study||89
8071736|NCT01806623|19902107|P1|NOT COMPLETED|Overall Study||58
8071737|NCT01806623|19902107|P1|COMPLETED|Overall Study||99
8071738|NCT01806623|19902107|P1|STARTED|Overall Study||157
8071751|NCT01727791|19902146|P1|NOT COMPLETED|Overall Study||0
8071752|NCT01727791|19902146|P1|COMPLETED|Overall Study||10
8071753|NCT01727791|19902146|P1|STARTED|Overall Study||10
8071754|NCT01701362|19902178|P2|NOT COMPLETED|Overall Study||56
8071755|NCT01701362|19902179|P1|NOT COMPLETED|Overall Study||42
8071756|NCT01701362|19902178|P2|COMPLETED|Overall Study||211
8071757|NCT01701362|19902179|P1|COMPLETED|Overall Study||233
8071758|NCT01701362|19902178|P2|TREATED|Overall Study||265
8071759|NCT01701362|19902179|P1|TREATED|Overall Study||274
8071760|NCT01701362|19902178|P2|STARTED|Overall Study||267
8071761|NCT01701362|19902179|P1|STARTED|Overall Study||275
8071762|NCT01680458|19902207|P1|NOT COMPLETED|Overall Study||3
8071763|NCT01680458|19902207|P1|COMPLETED|Overall Study||27
8071764|NCT01680458|19902207|P1|STARTED|Overall Study||30
8071765|NCT01659255|19902233|P17|NOT COMPLETED|Overall Study||3
8071766|NCT01659255|19902234|P16|NOT COMPLETED|Overall Study||5
8071767|NCT01659255|19902235|P15|NOT COMPLETED|Overall Study||8
8071768|NCT01659255|19902236|P14|NOT COMPLETED|Overall Study||18
8071769|NCT01659255|19902237|P13|NOT COMPLETED|Overall Study||8
8071770|NCT01659255|19902238|P12|NOT COMPLETED|Overall Study||4
8071771|NCT01659255|19902239|P11|NOT COMPLETED|Overall Study||3
8071772|NCT01659255|19902240|P10|NOT COMPLETED|Overall Study||3
8071773|NCT01659255|19902241|P9|NOT COMPLETED|Overall Study||1
8071774|NCT01659255|19902242|P8|NOT COMPLETED|Overall Study||2
8071775|NCT01659255|19902243|P7|NOT COMPLETED|Overall Study||2
8071776|NCT01659255|19902244|P6|NOT COMPLETED|Overall Study||1
8071777|NCT01659255|19902245|P5|NOT COMPLETED|Overall Study||0
8071778|NCT01659255|19902246|P4|NOT COMPLETED|Overall Study||0
8071779|NCT01659255|19902247|P3|NOT COMPLETED|Overall Study||0
8071780|NCT01659255|19902248|P2|NOT COMPLETED|Overall Study||1
8071781|NCT01659255|19902249|P1|NOT COMPLETED|Overall Study||2
8071782|NCT01659255|19902233|P17|COMPLETED|Overall Study||0
8071783|NCT01659255|19902234|P16|COMPLETED|Overall Study||4
8071784|NCT01659255|19902235|P15|COMPLETED|Overall Study||2
8071785|NCT01659255|19902236|P14|COMPLETED|Overall Study||3
8071786|NCT01659255|19902237|P13|COMPLETED|Overall Study||0
8071787|NCT01659255|19902238|P12|COMPLETED|Overall Study||1
8071788|NCT01659255|19902239|P11|COMPLETED|Overall Study||0
8071789|NCT01659255|19902240|P10|COMPLETED|Overall Study||0
8071790|NCT01659255|19902241|P9|COMPLETED|Overall Study||2
8071791|NCT01659255|19902242|P8|COMPLETED|Overall Study||1
8071792|NCT01659255|19902243|P7|COMPLETED|Overall Study||1
8071793|NCT01659255|19902244|P6|COMPLETED|Overall Study||2
8071794|NCT01659255|19902245|P5|COMPLETED|Overall Study||3
8071795|NCT01659255|19902246|P4|COMPLETED|Overall Study||3
8071796|NCT01659255|19902247|P3|COMPLETED|Overall Study||4
8071797|NCT01659255|19902248|P2|COMPLETED|Overall Study||2
8071798|NCT01659255|19902249|P1|COMPLETED|Overall Study||1
8071799|NCT01659255|19902233|P17|STARTED|Overall Study||3
8071800|NCT01659255|19902234|P16|STARTED|Overall Study||9
8071801|NCT01659255|19902235|P15|STARTED|Overall Study||10
8071802|NCT01659255|19902236|P14|STARTED|Overall Study||21
8071803|NCT01659255|19902237|P13|STARTED|Overall Study||8
8071804|NCT01659255|19902238|P12|STARTED|Overall Study||5
8071805|NCT01659255|19902239|P11|STARTED|Overall Study||3
8071806|NCT01659255|19902240|P10|STARTED|Overall Study||3
8071807|NCT01659255|19902241|P9|STARTED|Overall Study||3
8071808|NCT01659255|19902242|P8|STARTED|Overall Study||3
8071809|NCT01659255|19902243|P7|STARTED|Overall Study||3
8071810|NCT01659255|19902244|P6|STARTED|Overall Study||3
8071811|NCT01659255|19902245|P5|STARTED|Overall Study||3
8071812|NCT01659255|19902246|P4|STARTED|Overall Study||3
8071813|NCT01659255|19902247|P3|STARTED|Overall Study||4
8071814|NCT01659255|19902248|P2|STARTED|Overall Study||3
8071815|NCT01659255|19902249|P1|STARTED|Overall Study||3
8071816|NCT01645306|19902302|P3|NOT COMPLETED|Overall Study||5
8071817|NCT01645306|19902303|P2|NOT COMPLETED|Overall Study||4
8071818|NCT01645306|19902304|P1|NOT COMPLETED|Overall Study||2
8071819|NCT01645306|19902302|P3|COMPLETED|Overall Study||48
8071820|NCT01645306|19902303|P2|COMPLETED|Overall Study||50
8071821|NCT01645306|19902304|P1|COMPLETED|Overall Study||49
8071822|NCT01645306|19902302|P3|STARTED|Overall Study||53
8071823|NCT01645306|19902303|P2|STARTED|Overall Study||54
8071824|NCT01645306|19902304|P1|STARTED|Overall Study||51
8071825|NCT01545934|19902329|P2|NOT COMPLETED|Overall Study||3
8071826|NCT01545934|19902330|P1|NOT COMPLETED|Overall Study||5
8071827|NCT01545934|19902329|P2|COMPLETED|Overall Study||129
8071828|NCT01545934|19902330|P1|COMPLETED|Overall Study||127
8071829|NCT01545934|19902329|P2|STARTED|Overall Study||132
8071830|NCT01545934|19902330|P1|STARTED|Overall Study||132
8071831|NCT01524796|19902344|P1|NOT COMPLETED|Overall Study||28
8071832|NCT01524796|19902344|P1|COMPLETED|Overall Study||100
8071833|NCT01524796|19902344|P1|STARTED|Overall Study||128
8071834|NCT01488578|19902357|P1|NOT COMPLETED|Overall Study||1836
8071835|NCT01488578|19902357|P1|COMPLETED|Overall Study||9321
8071836|NCT01488578|19902357|P1|STARTED|Overall Study||11157
8071837|NCT01485887|19902391|P1|NOT COMPLETED|Overall Study||12
8071838|NCT01485887|19902391|P1|COMPLETED|Overall Study||38
8071839|NCT01485887|19902391|P1|STARTED|Overall Study||50
8071840|NCT01474772|19902405|P2|NOT COMPLETED|Follow-up||1
8071841|NCT01474772|19902406|P1|NOT COMPLETED|Follow-up||0
8071842|NCT01474772|19902405|P2|COMPLETED|Follow-up||86
8071843|NCT01474772|19902406|P1|COMPLETED|Follow-up||77
8071844|NCT01474772|19902405|P2|STARTED|Follow-up||87
8071845|NCT01474772|19902406|P1|STARTED|Follow-up||77
8071846|NCT01474772|19902405|P2|NOT COMPLETED|Period 2||10
8071847|NCT01474772|19902406|P1|NOT COMPLETED|Period 2||9
8071848|NCT01474772|19902405|P2|COMPLETED|Period 2||87
8071849|NCT01474772|19902406|P1|COMPLETED|Period 2||77
8071850|NCT01474772|19902405|P2|STARTED|Period 2||97
8071851|NCT01474772|19902406|P1|STARTED|Period 2||86
8071852|NCT01474772|19902405|P2|NOT COMPLETED|Washout||2
8071853|NCT01474772|19902406|P1|NOT COMPLETED|Washout||3
8071854|NCT01474772|19902405|P2|COMPLETED|Washout||97
8071855|NCT01474772|19902406|P1|COMPLETED|Washout||86
8071856|NCT01474772|19902405|P2|STARTED|Washout||99
8071857|NCT01474772|19902406|P1|STARTED|Washout||89
8071858|NCT01474772|19902405|P2|NOT COMPLETED|Period 1||3
8071859|NCT01474772|19902406|P1|NOT COMPLETED|Period 1||12
8071860|NCT01474772|19902405|P2|COMPLETED|Period 1||99
8071861|NCT01474772|19902406|P1|COMPLETED|Period 1||89
8071862|NCT01474772|19902405|P2|STARTED|Period 1|STARTED=treated|102
8071863|NCT01474772|19902406|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
8071870|NCT01455428|19902465|P2|NOT COMPLETED|Overall Study||18
8071871|NCT01455428|19902466|P1|NOT COMPLETED|Overall Study||14
8071872|NCT01455428|19902465|P2|COMPLETED|Overall Study||92
8071873|NCT01455428|19902466|P1|COMPLETED|Overall Study||98
8071874|NCT01455428|19902465|P2|Treated|Overall Study||109
8071875|NCT01455428|19902466|P1|Treated|Overall Study||111
8071876|NCT01455428|19902465|P2|STARTED|Overall Study||110
8071877|NCT01455428|19902466|P1|STARTED|Overall Study||112
8071878|NCT01455415|19902522|P2|NOT COMPLETED|Follow-up||2
8071879|NCT01455415|19902523|P1|NOT COMPLETED|Follow-up||3
8071880|NCT01455415|19902522|P2|COMPLETED|Follow-up||104
8071881|NCT01455415|19902523|P1|COMPLETED|Follow-up||111
8071882|NCT01455415|19902522|P2|STARTED|Follow-up||106
8071883|NCT01455415|19902523|P1|STARTED|Follow-up||114
8071884|NCT01455415|19902522|P2|NOT COMPLETED|Period 2||10
8071885|NCT01455415|19902523|P1|NOT COMPLETED|Period 2||13
8071886|NCT01455415|19902522|P2|COMPLETED|Period 2||106
8071887|NCT01455415|19902523|P1|COMPLETED|Period 2||114
8071888|NCT01455415|19902522|P2|STARTED|Period 2||116
8071889|NCT01455415|19902523|P1|STARTED|Period 2||127
8071890|NCT01455415|19902522|P2|NOT COMPLETED|Washout||7
8071891|NCT01455415|19902523|P1|NOT COMPLETED|Washout||8
8071892|NCT01455415|19902522|P2|COMPLETED|Washout||116
8071893|NCT01455415|19902523|P1|COMPLETED|Washout||127
8071894|NCT01455415|19902522|P2|STARTED|Washout||123
8071895|NCT01455415|19902523|P1|STARTED|Washout||135
8071896|NCT01455415|19902522|P2|NOT COMPLETED|Period 1||24
8071897|NCT01455415|19902523|P1|NOT COMPLETED|Period 1||19
8071898|NCT01455415|19902522|P2|COMPLETED|Period 1||123
8071899|NCT01455415|19902523|P1|COMPLETED|Period 1||135
8071900|NCT01455415|19902522|P2|STARTED|Period 1|Started=Treated|147
8071901|NCT01455415|19902523|P1|STARTED|Period 1|Started=Treated|154
8071902|NCT01441440|19902576|P3|NOT COMPLETED|Overall Study||22
8071903|NCT01441440|19902577|P2|NOT COMPLETED|Overall Study||23
8071904|NCT01441440|19902578|P1|NOT COMPLETED|Overall Study||17
8071905|NCT01441440|19902576|P3|COMPLETED|Overall Study||158
8071906|NCT01441440|19902577|P2|COMPLETED|Overall Study||151
8071907|NCT01441440|19902578|P1|COMPLETED|Overall Study||166
8071908|NCT01441440|19902576|P3|STARTED|Overall Study|Safety analysis set|180
8071909|NCT01441440|19902577|P2|STARTED|Overall Study|Safety analysis set|174
8071910|NCT01441440|19902578|P1|STARTED|Overall Study|Safety analysis set|183
8071911|NCT01424722|19902601|P1|NOT COMPLETED|Overall Study||2258
8071912|NCT01424722|19902601|P1|COMPLETED|Overall Study||0
8071913|NCT01424722|19902601|P1|STARTED|Overall Study||2258
8071914|NCT01387607|19902607|P2|NOT COMPLETED|Overall Study||45
8071915|NCT01387607|19902608|P1|NOT COMPLETED|Overall Study||51
8071916|NCT01387607|19902607|P2|COMPLETED|Overall Study||125
8071917|NCT01387607|19902608|P1|COMPLETED|Overall Study||122
8071918|NCT01387607|19902607|P2|Received Treatment|Overall Study||164
8071919|NCT01387607|19902608|P1|Received Treatment|Overall Study||170
8071920|NCT01387607|19902607|P2|STARTED|Overall Study||170
8071921|NCT01387607|19902608|P1|STARTED|Overall Study||173
8071928|NCT01366092|19902699|P1|NOT COMPLETED|Overall Study||4
8071929|NCT01366092|19902699|P1|COMPLETED|Overall Study||31
8071930|NCT01366092|19902699|P1|STARTED|Overall Study||35
8071931|NCT01355068|19902708|P2|NOT COMPLETED|Second Intervention Period||0
8071932|NCT01355068|19902709|P1|NOT COMPLETED|Second Intervention Period||0
8071933|NCT01355068|19902708|P2|COMPLETED|Second Intervention Period||11
8071934|NCT01355068|19902709|P1|COMPLETED|Second Intervention Period||13
8071935|NCT01355068|19902708|P2|STARTED|Second Intervention Period||11
8071936|NCT01355068|19902709|P1|STARTED|Second Intervention Period||13
8071937|NCT01355068|19902708|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8071938|NCT01355068|19902709|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8071939|NCT01355068|19902708|P2|COMPLETED|Washout Period (at Least 7 Days)||11
8071940|NCT01355068|19902709|P1|COMPLETED|Washout Period (at Least 7 Days)||13
8071941|NCT01355068|19902708|P2|STARTED|Washout Period (at Least 7 Days)||11
8071942|NCT01355068|19902709|P1|STARTED|Washout Period (at Least 7 Days)||13
8071943|NCT01355068|19902708|P2|NOT COMPLETED|First Intervention Period||2
8071944|NCT01355068|19902709|P1|NOT COMPLETED|First Intervention Period||0
8071945|NCT01355068|19902708|P2|COMPLETED|First Intervention Period||11
8071946|NCT01355068|19902709|P1|COMPLETED|First Intervention Period||13
8071947|NCT01355068|19902708|P2|STARTED|First Intervention Period||13
8071948|NCT01355068|19902709|P1|STARTED|First Intervention Period||13
8071949|NCT01336634|19902728|P3|NOT COMPLETED|Overall Study||36
8071950|NCT01336634|19902729|P2|NOT COMPLETED|Overall Study||57
8071951|NCT01336634|19902730|P1|NOT COMPLETED|Overall Study||84
8071952|NCT01336634|19902728|P3|COMPLETED|Overall Study||0
8071953|NCT01336634|19902729|P2|COMPLETED|Overall Study||0
8071954|NCT01336634|19902730|P1|COMPLETED|Overall Study||0
8071955|NCT01336634|19902728|P3|STARTED|Overall Study||36
8071956|NCT01336634|19902729|P2|STARTED|Overall Study||57
8071957|NCT01336634|19902730|P1|STARTED|Overall Study||84
8071958|NCT01332149|19902773|P2|NOT COMPLETED|Overall Study||38
8071959|NCT01332149|19902774|P1|NOT COMPLETED|Overall Study||30
8071960|NCT01332149|19902773|P2|COMPLETED|Overall Study||271
8071961|NCT01332149|19902774|P1|COMPLETED|Overall Study||284
8071962|NCT01332149|19902773|P2|Treated|Overall Study||307
8071963|NCT01332149|19902774|P1|Treated|Overall Study||313
8071964|NCT01332149|19902773|P2|STARTED|Overall Study|Assigned to study treatment.|309
8071965|NCT01332149|19902774|P1|STARTED|Overall Study|Assigned to study treatment.|314
8071966|NCT01302938|19902830|P2|NOT COMPLETED|Overall Study||0
8071967|NCT01302938|19902831|P1|NOT COMPLETED|Overall Study||2
8071968|NCT01302938|19902830|P2|COMPLETED|Overall Study||6
8071969|NCT01302938|19902831|P1|COMPLETED|Overall Study||10
8071970|NCT01302938|19902830|P2|STARTED|Overall Study||6
8071971|NCT01302938|19902831|P1|STARTED|Overall Study||12
8071998|NCT01270828|19902900|P3|NOT COMPLETED|Double Blind Phase||0
8071999|NCT01270828|19902901|P2|NOT COMPLETED|Double Blind Phase||45
8072000|NCT01270828|19902902|P1|NOT COMPLETED|Double Blind Phase||26
8072001|NCT01270828|19902900|P3|COMPLETED|Double Blind Phase||0
8072002|NCT01270828|19902901|P2|COMPLETED|Double Blind Phase||160
8072003|NCT01270828|19902902|P1|COMPLETED|Double Blind Phase||182
8072004|NCT01270828|19902900|P3|STARTED|Double Blind Phase||0
8072005|NCT01270828|19902901|P2|STARTED|Double Blind Phase||205
8072006|NCT01270828|19902902|P1|STARTED|Double Blind Phase||208
8072007|NCT01270828|19902900|P3|NOT COMPLETED|Pregabalin CR SB||146
8072008|NCT01270828|19902901|P2|NOT COMPLETED|Pregabalin CR SB||0
8072009|NCT01270828|19902902|P1|NOT COMPLETED|Pregabalin CR SB||0
8072010|NCT01270828|19902900|P3|COMPLETED|Pregabalin CR SB||660
8072011|NCT01270828|19902901|P2|COMPLETED|Pregabalin CR SB||0
8072012|NCT01270828|19902902|P1|COMPLETED|Pregabalin CR SB||0
8072013|NCT01270828|19902900|P3|STARTED|Pregabalin CR SB||806
8072014|NCT01270828|19902901|P2|STARTED|Pregabalin CR SB||0
8072015|NCT01270828|19902902|P1|STARTED|Pregabalin CR SB||0
8072016|NCT01252563|19902942|P1|NOT COMPLETED|Overall Study||432
8072017|NCT01252563|19902942|P1|COMPLETED|Overall Study||13343
8072018|NCT01252563|19902942|P1|STARTED|Overall Study||13775
8072019|NCT01202227|19902979|P1|NOT COMPLETED|Overall Study||19
8072020|NCT01202227|19902979|P1|COMPLETED|Overall Study||84
8072021|NCT01202227|19902979|P1|STARTED|Overall Study|Treated|103
8072022|NCT01190007|19902998|P1|NOT COMPLETED|Overall Study||14
8072023|NCT01190007|19902998|P1|COMPLETED|Overall Study||145
8072024|NCT01190007|19902998|P1|STARTED|Overall Study|Treated|159
8072025|NCT01177293|19903013|P2|NOT COMPLETED|Second Intervention Period||0
8072026|NCT01177293|19903014|P1|NOT COMPLETED|Second Intervention Period||0
8072027|NCT01177293|19903013|P2|COMPLETED|Second Intervention Period||6
8072028|NCT01177293|19903014|P1|COMPLETED|Second Intervention Period||7
8072029|NCT01177293|19903013|P2|STARTED|Second Intervention Period||6
8072030|NCT01177293|19903014|P1|STARTED|Second Intervention Period||7
8072031|NCT01177293|19903013|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
8072032|NCT01177293|19903014|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
8072033|NCT01177293|19903013|P2|COMPLETED|Washout Period (of 14 Days)||6
8072034|NCT01177293|19903014|P1|COMPLETED|Washout Period (of 14 Days)||7
8072035|NCT01177293|19903013|P2|STARTED|Washout Period (of 14 Days)||7
8072036|NCT01177293|19903014|P1|STARTED|Washout Period (of 14 Days)||7
8072037|NCT01177293|19903013|P2|NOT COMPLETED|First Intervention Period||0
8072038|NCT01177293|19903014|P1|NOT COMPLETED|First Intervention Period||0
8072039|NCT01177293|19903013|P2|COMPLETED|First Intervention Period||7
8072040|NCT01177293|19903014|P1|COMPLETED|First Intervention Period||7
8072041|NCT01177293|19903013|P2|STARTED|First Intervention Period||7
8072042|NCT01177293|19903014|P1|STARTED|First Intervention Period||7
8072043|NCT01145417|19903030|P2|NOT COMPLETED|Overall Study||47
8072044|NCT01145417|19903031|P1|NOT COMPLETED|Overall Study||41
8072045|NCT01145417|19903030|P2|COMPLETED|Overall Study||62
8072046|NCT01145417|19903031|P1|COMPLETED|Overall Study||67
8072047|NCT01145417|19903030|P2|STARTED|Overall Study||109
8072048|NCT01145417|19903031|P1|STARTED|Overall Study||108
8072049|NCT01139515|19903053|P4|NOT COMPLETED|Fourth Intervention Period||0
8072050|NCT01139515|19903054|P3|NOT COMPLETED|Fourth Intervention Period||0
8072051|NCT01139515|19903055|P2|NOT COMPLETED|Fourth Intervention Period||0
8072052|NCT01139515|19903056|P1|NOT COMPLETED|Fourth Intervention Period||0
8072053|NCT01139515|19903053|P4|COMPLETED|Fourth Intervention Period||4
8072054|NCT01139515|19903054|P3|COMPLETED|Fourth Intervention Period||4
8072055|NCT01139515|19903055|P2|COMPLETED|Fourth Intervention Period||4
8072056|NCT01139515|19903056|P1|COMPLETED|Fourth Intervention Period||4
8072057|NCT01139515|19903053|P4|STARTED|Fourth Intervention Period||4
8072058|NCT01139515|19903054|P3|STARTED|Fourth Intervention Period||4
8072059|NCT01139515|19903055|P2|STARTED|Fourth Intervention Period||4
8072060|NCT01139515|19903056|P1|STARTED|Fourth Intervention Period||4
8072061|NCT01139515|19903053|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072062|NCT01139515|19903054|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072063|NCT01139515|19903055|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072064|NCT01139515|19903056|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072065|NCT01139515|19903053|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
8072066|NCT01139515|19903054|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
8072067|NCT01139515|19903055|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
8072068|NCT01139515|19903056|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
8072069|NCT01139515|19903053|P4|STARTED|Washout Period 3 (46 Hrs)||4
8072070|NCT01139515|19903054|P3|STARTED|Washout Period 3 (46 Hrs)||4
8072071|NCT01139515|19903055|P2|STARTED|Washout Period 3 (46 Hrs)||4
8072072|NCT01139515|19903056|P1|STARTED|Washout Period 3 (46 Hrs)||4
8072073|NCT01139515|19903053|P4|NOT COMPLETED|Third Intervention Period||0
8072074|NCT01139515|19903054|P3|NOT COMPLETED|Third Intervention Period||0
8072075|NCT01139515|19903055|P2|NOT COMPLETED|Third Intervention Period||0
8072076|NCT01139515|19903056|P1|NOT COMPLETED|Third Intervention Period||0
8072077|NCT01139515|19903053|P4|COMPLETED|Third Intervention Period||4
8072078|NCT01139515|19903054|P3|COMPLETED|Third Intervention Period||4
8072079|NCT01139515|19903055|P2|COMPLETED|Third Intervention Period||4
8072080|NCT01139515|19903056|P1|COMPLETED|Third Intervention Period||4
8072081|NCT01139515|19903053|P4|STARTED|Third Intervention Period||4
8072082|NCT01139515|19903054|P3|STARTED|Third Intervention Period||4
8072083|NCT01139515|19903055|P2|STARTED|Third Intervention Period||4
8072084|NCT01139515|19903056|P1|STARTED|Third Intervention Period||4
8072085|NCT01139515|19903053|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072086|NCT01139515|19903054|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072087|NCT01139515|19903055|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072088|NCT01139515|19903056|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072089|NCT01139515|19903053|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
8072090|NCT01139515|19903054|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
8072091|NCT01139515|19903055|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
8072092|NCT01139515|19903056|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
8072093|NCT01139515|19903053|P4|STARTED|Washout Period 2 (46 Hrs)||4
8072094|NCT01139515|19903054|P3|STARTED|Washout Period 2 (46 Hrs)||4
8072095|NCT01139515|19903055|P2|STARTED|Washout Period 2 (46 Hrs)||4
8072096|NCT01139515|19903056|P1|STARTED|Washout Period 2 (46 Hrs)||4
8072097|NCT01139515|19903053|P4|NOT COMPLETED|Second Intervention Period||0
8072098|NCT01139515|19903054|P3|NOT COMPLETED|Second Intervention Period||0
8072099|NCT01139515|19903055|P2|NOT COMPLETED|Second Intervention Period||0
8072100|NCT01139515|19903056|P1|NOT COMPLETED|Second Intervention Period||0
8072101|NCT01139515|19903053|P4|COMPLETED|Second Intervention Period||4
8072102|NCT01139515|19903054|P3|COMPLETED|Second Intervention Period||4
8072103|NCT01139515|19903055|P2|COMPLETED|Second Intervention Period||4
8072104|NCT01139515|19903056|P1|COMPLETED|Second Intervention Period||4
8072105|NCT01139515|19903053|P4|STARTED|Second Intervention Period||4
8072106|NCT01139515|19903054|P3|STARTED|Second Intervention Period||4
8072107|NCT01139515|19903055|P2|STARTED|Second Intervention Period||4
8072108|NCT01139515|19903056|P1|STARTED|Second Intervention Period||4
8072109|NCT01139515|19903053|P4|NOT COMPLETED|Washout Period I (46hrs)||0
8072110|NCT01139515|19903054|P3|NOT COMPLETED|Washout Period I (46hrs)||0
8072111|NCT01139515|19903055|P2|NOT COMPLETED|Washout Period I (46hrs)||0
8072112|NCT01139515|19903056|P1|NOT COMPLETED|Washout Period I (46hrs)||0
8072113|NCT01139515|19903053|P4|COMPLETED|Washout Period I (46hrs)||4
8072114|NCT01139515|19903054|P3|COMPLETED|Washout Period I (46hrs)||4
8072115|NCT01139515|19903055|P2|COMPLETED|Washout Period I (46hrs)||4
8072116|NCT01139515|19903056|P1|COMPLETED|Washout Period I (46hrs)||4
8072117|NCT01139515|19903053|P4|STARTED|Washout Period I (46hrs)||4
8072118|NCT01139515|19903054|P3|STARTED|Washout Period I (46hrs)||4
8072119|NCT01139515|19903055|P2|STARTED|Washout Period I (46hrs)||4
8072120|NCT01139515|19903056|P1|STARTED|Washout Period I (46hrs)||4
8072121|NCT01139515|19903053|P4|NOT COMPLETED|First Intervention Period||0
8072122|NCT01139515|19903054|P3|NOT COMPLETED|First Intervention Period||0
8072123|NCT01139515|19903055|P2|NOT COMPLETED|First Intervention Period||0
8072124|NCT01139515|19903056|P1|NOT COMPLETED|First Intervention Period||0
8072125|NCT01139515|19903053|P4|COMPLETED|First Intervention Period||4
8072126|NCT01139515|19903054|P3|COMPLETED|First Intervention Period||4
8072127|NCT01139515|19903055|P2|COMPLETED|First Intervention Period||4
8072128|NCT01139515|19903056|P1|COMPLETED|First Intervention Period||4
8072129|NCT01139515|19903053|P4|STARTED|First Intervention Period||4
8072130|NCT01139515|19903054|P3|STARTED|First Intervention Period||4
8072131|NCT01139515|19903055|P2|STARTED|First Intervention Period||4
8072132|NCT01139515|19903056|P1|STARTED|First Intervention Period||4
8072133|NCT01138826|19903082|P6|NOT COMPLETED|Third Intervention Period||0
8072134|NCT01138826|19903083|P5|NOT COMPLETED|Third Intervention Period||0
8072135|NCT01138826|19903084|P4|NOT COMPLETED|Third Intervention Period||0
8072136|NCT01138826|19903085|P3|NOT COMPLETED|Third Intervention Period||0
8072137|NCT01138826|19903086|P2|NOT COMPLETED|Third Intervention Period||0
8072138|NCT01138826|19903087|P1|NOT COMPLETED|Third Intervention Period||0
8072139|NCT01138826|19903082|P6|COMPLETED|Third Intervention Period||3
8072140|NCT01138826|19903083|P5|COMPLETED|Third Intervention Period||2
8072141|NCT01138826|19903084|P4|COMPLETED|Third Intervention Period||3
8072142|NCT01138826|19903085|P3|COMPLETED|Third Intervention Period||3
8072143|NCT01138826|19903086|P2|COMPLETED|Third Intervention Period||2
8072144|NCT01138826|19903087|P1|COMPLETED|Third Intervention Period||2
8072145|NCT01138826|19903082|P6|STARTED|Third Intervention Period||3
8072146|NCT01138826|19903083|P5|STARTED|Third Intervention Period||2
8072147|NCT01138826|19903084|P4|STARTED|Third Intervention Period||3
8072148|NCT01138826|19903085|P3|STARTED|Third Intervention Period||3
8072149|NCT01138826|19903086|P2|STARTED|Third Intervention Period||2
8072150|NCT01138826|19903087|P1|STARTED|Third Intervention Period||2
8072151|NCT01138826|19903082|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072152|NCT01138826|19903083|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072153|NCT01138826|19903084|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072154|NCT01138826|19903085|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072155|NCT01138826|19903086|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072156|NCT01138826|19903087|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072157|NCT01138826|19903082|P6|COMPLETED|Washout Period II (of 16 Days)||3
8072158|NCT01138826|19903083|P5|COMPLETED|Washout Period II (of 16 Days)||2
8072159|NCT01138826|19903084|P4|COMPLETED|Washout Period II (of 16 Days)||3
8072160|NCT01138826|19903085|P3|COMPLETED|Washout Period II (of 16 Days)||3
8072161|NCT01138826|19903086|P2|COMPLETED|Washout Period II (of 16 Days)||2
8072162|NCT01138826|19903087|P1|COMPLETED|Washout Period II (of 16 Days)||2
8072163|NCT01138826|19903082|P6|STARTED|Washout Period II (of 16 Days)||3
8072164|NCT01138826|19903083|P5|STARTED|Washout Period II (of 16 Days)||2
8072165|NCT01138826|19903084|P4|STARTED|Washout Period II (of 16 Days)||3
8072166|NCT01138826|19903085|P3|STARTED|Washout Period II (of 16 Days)||3
8072167|NCT01138826|19903086|P2|STARTED|Washout Period II (of 16 Days)||2
8072168|NCT01138826|19903087|P1|STARTED|Washout Period II (of 16 Days)||2
8072169|NCT01138826|19903082|P6|NOT COMPLETED|Second Intervention Period||0
8072170|NCT01138826|19903083|P5|NOT COMPLETED|Second Intervention Period||0
8072171|NCT01138826|19903084|P4|NOT COMPLETED|Second Intervention Period||0
8072172|NCT01138826|19903085|P3|NOT COMPLETED|Second Intervention Period||0
8072173|NCT01138826|19903086|P2|NOT COMPLETED|Second Intervention Period||0
8072174|NCT01138826|19903087|P1|NOT COMPLETED|Second Intervention Period||0
8072175|NCT01138826|19903082|P6|COMPLETED|Second Intervention Period||3
8072176|NCT01138826|19903083|P5|COMPLETED|Second Intervention Period||2
8072177|NCT01138826|19903084|P4|COMPLETED|Second Intervention Period||3
8072178|NCT01138826|19903085|P3|COMPLETED|Second Intervention Period||3
8072179|NCT01138826|19903086|P2|COMPLETED|Second Intervention Period||2
8072180|NCT01138826|19903087|P1|COMPLETED|Second Intervention Period||2
8072181|NCT01138826|19903082|P6|STARTED|Second Intervention Period||3
8072182|NCT01138826|19903083|P5|STARTED|Second Intervention Period||2
8072183|NCT01138826|19903084|P4|STARTED|Second Intervention Period||3
8072184|NCT01138826|19903085|P3|STARTED|Second Intervention Period||3
8072185|NCT01138826|19903086|P2|STARTED|Second Intervention Period||2
8072186|NCT01138826|19903087|P1|STARTED|Second Intervention Period||2
8072187|NCT01138826|19903082|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
8072188|NCT01138826|19903083|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
8072189|NCT01138826|19903084|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
8072190|NCT01138826|19903085|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
8072191|NCT01138826|19903086|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
8072192|NCT01138826|19903087|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
8072193|NCT01138826|19903082|P6|COMPLETED|Washout Period I (of 16 Days)||3
8072194|NCT01138826|19903083|P5|COMPLETED|Washout Period I (of 16 Days)||2
8072195|NCT01138826|19903084|P4|COMPLETED|Washout Period I (of 16 Days)||3
8072196|NCT01138826|19903085|P3|COMPLETED|Washout Period I (of 16 Days)||3
8072197|NCT01138826|19903086|P2|COMPLETED|Washout Period I (of 16 Days)||2
8072198|NCT01138826|19903087|P1|COMPLETED|Washout Period I (of 16 Days)||2
8072199|NCT01138826|19903082|P6|STARTED|Washout Period I (of 16 Days)||3
8072200|NCT01138826|19903083|P5|STARTED|Washout Period I (of 16 Days)||3
8072201|NCT01138826|19903084|P4|STARTED|Washout Period I (of 16 Days)||3
8072202|NCT01138826|19903085|P3|STARTED|Washout Period I (of 16 Days)||3
8072203|NCT01138826|19903086|P2|STARTED|Washout Period I (of 16 Days)||3
8072204|NCT01138826|19903087|P1|STARTED|Washout Period I (of 16 Days)||3
8072205|NCT01138826|19903082|P6|NOT COMPLETED|First Intervention Period||0
8072206|NCT01138826|19903083|P5|NOT COMPLETED|First Intervention Period||0
8072207|NCT01138826|19903084|P4|NOT COMPLETED|First Intervention Period||0
8072208|NCT01138826|19903085|P3|NOT COMPLETED|First Intervention Period||0
8072209|NCT01138826|19903086|P2|NOT COMPLETED|First Intervention Period||0
8072210|NCT01138826|19903087|P1|NOT COMPLETED|First Intervention Period||0
8072211|NCT01138826|19903082|P6|COMPLETED|First Intervention Period||3
8072212|NCT01138826|19903083|P5|COMPLETED|First Intervention Period||3
8072213|NCT01138826|19903084|P4|COMPLETED|First Intervention Period||3
8072214|NCT01138826|19903085|P3|COMPLETED|First Intervention Period||3
8072215|NCT01138826|19903086|P2|COMPLETED|First Intervention Period||3
8072216|NCT01138826|19903087|P1|COMPLETED|First Intervention Period||3
8072217|NCT01138826|19903082|P6|STARTED|First Intervention Period||3
8072218|NCT01138826|19903083|P5|STARTED|First Intervention Period||3
8072219|NCT01138826|19903084|P4|STARTED|First Intervention Period||3
8072220|NCT01138826|19903085|P3|STARTED|First Intervention Period||3
8072221|NCT01138826|19903086|P2|STARTED|First Intervention Period||3
8072222|NCT01138826|19903087|P1|STARTED|First Intervention Period||3
8072223|NCT01107743|19903107|P1|NOT COMPLETED|Overall Study||46
8072224|NCT01107743|19903107|P1|COMPLETED|Overall Study||1245
8072225|NCT01107743|19903107|P1|STARTED|Overall Study||1291
8072226|NCT01049217|19903195|P2|NOT COMPLETED|Overall Study||63
8072227|NCT01049217|19903196|P1|NOT COMPLETED|Overall Study||56
8072228|NCT01049217|19903195|P2|COMPLETED|Overall Study||131
8072229|NCT01049217|19903196|P1|COMPLETED|Overall Study||127
8072230|NCT01049217|19903195|P2|Treated|Overall Study||192
8072231|NCT01049217|19903196|P1|Treated|Overall Study||183
8072232|NCT01049217|19903195|P2|STARTED|Overall Study||194
8072233|NCT01049217|19903196|P1|STARTED|Overall Study||183
8072234|NCT01020526|19903266|P1|NOT COMPLETED|Overall Study||14
8072235|NCT01020526|19903266|P1|COMPLETED|Overall Study||49
8072236|NCT01020526|19903266|P1|STARTED|Overall Study||63
8072237|NCT01020474|19903272|P2|NOT COMPLETED|Overall Study||17
8072238|NCT01020474|19903273|P1|NOT COMPLETED|Overall Study||10
8072239|NCT01020474|19903272|P2|COMPLETED|Overall Study||36
8072240|NCT01020474|19903273|P1|COMPLETED|Overall Study||44
8072241|NCT01020474|19903272|P2|STARTED|Overall Study||53
8072242|NCT01020474|19903273|P1|STARTED|Overall Study||54
8072243|NCT01004614|19903297|P4|NOT COMPLETED|Second Intervention||0
8072244|NCT01004614|19903298|P3|NOT COMPLETED|Second Intervention||0
8072245|NCT01004614|19903299|P2|NOT COMPLETED|Second Intervention||0
8072246|NCT01004614|19903300|P1|NOT COMPLETED|Second Intervention||0
8072247|NCT01004614|19903297|P4|COMPLETED|Second Intervention||12
8072248|NCT01004614|19903298|P3|COMPLETED|Second Intervention||12
8072249|NCT01004614|19903299|P2|COMPLETED|Second Intervention||11
8072250|NCT01004614|19903300|P1|COMPLETED|Second Intervention||12
8072251|NCT01004614|19903297|P4|STARTED|Second Intervention||12
8072252|NCT01004614|19903298|P3|STARTED|Second Intervention||12
8072253|NCT01004614|19903299|P2|STARTED|Second Intervention||11
8072254|NCT01004614|19903300|P1|STARTED|Second Intervention||12
8072255|NCT01004614|19903297|P4|NOT COMPLETED|Washout||0
8072256|NCT01004614|19903298|P3|NOT COMPLETED|Washout||0
8072257|NCT01004614|19903299|P2|NOT COMPLETED|Washout||1
8072258|NCT01004614|19903300|P1|NOT COMPLETED|Washout||0
8072259|NCT01004614|19903297|P4|COMPLETED|Washout||12
8072260|NCT01004614|19903298|P3|COMPLETED|Washout||12
8072261|NCT01004614|19903299|P2|COMPLETED|Washout||11
8072262|NCT01004614|19903300|P1|COMPLETED|Washout||12
8072263|NCT01004614|19903297|P4|STARTED|Washout||12
8072264|NCT01004614|19903298|P3|STARTED|Washout||12
8072265|NCT01004614|19903299|P2|STARTED|Washout||12
8072266|NCT01004614|19903300|P1|STARTED|Washout||12
8072267|NCT01004614|19903297|P4|NOT COMPLETED|First Intervention||0
8072268|NCT01004614|19903298|P3|NOT COMPLETED|First Intervention||0
8072269|NCT01004614|19903299|P2|NOT COMPLETED|First Intervention||0
8072270|NCT01004614|19903300|P1|NOT COMPLETED|First Intervention||0
8072271|NCT01004614|19903297|P4|COMPLETED|First Intervention||12
8072272|NCT01004614|19903298|P3|COMPLETED|First Intervention||12
8072273|NCT01004614|19903299|P2|COMPLETED|First Intervention||12
8072274|NCT01004614|19903300|P1|COMPLETED|First Intervention||12
8072275|NCT01004614|19903297|P4|STARTED|First Intervention||12
8072276|NCT01004614|19903298|P3|STARTED|First Intervention||12
8072277|NCT01004614|19903299|P2|STARTED|First Intervention||12
8072278|NCT01004614|19903300|P1|STARTED|First Intervention||12
8072279|NCT01004029|19903336|P2|NOT COMPLETED|Overall Study||73
8072280|NCT01004029|19903337|P1|NOT COMPLETED|Overall Study||48
8072281|NCT01004029|19903336|P2|COMPLETED|Overall Study||1057
8072282|NCT01004029|19903337|P1|COMPLETED|Overall Study||530
8072283|NCT01004029|19903336|P2|Safety Population|Overall Study||1128
8072284|NCT01004029|19903337|P1|Safety Population|Overall Study||578
8072285|NCT01004029|19903336|P2|STARTED|Overall Study||1130
8072286|NCT01004029|19903337|P1|STARTED|Overall Study||578
8072287|NCT01003886|19903355|P1|NOT COMPLETED|Overall Study||230
8072288|NCT01003886|19903355|P1|COMPLETED|Overall Study||759
8072289|NCT01003886|19903355|P1|STARTED|Overall Study||989
8072290|NCT00936611|19903364|P1|NOT COMPLETED|Overall Study||39
8072291|NCT00936611|19903364|P1|COMPLETED|Overall Study||0
8072292|NCT00936611|19903364|P1|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
8072293|NCT00936611|19903364|P1|Treated|Overall Study||36
8072294|NCT00936611|19903364|P1|STARTED|Overall Study||39
8072295|NCT04252092|19903375|P2|NOT COMPLETED|Overall Study||0
8072296|NCT04252092|19903376|P1|NOT COMPLETED|Overall Study||0
8072297|NCT04252092|19903375|P2|COMPLETED|Overall Study||15
8072298|NCT04252092|19903376|P1|COMPLETED|Overall Study||15
8072299|NCT04252092|19903375|P2|STARTED|Overall Study||15
8072300|NCT04252092|19903376|P1|STARTED|Overall Study||15
8072307|NCT04251884|19903419|P2|NOT COMPLETED|Overall Study||0
8072308|NCT04251884|19903420|P1|NOT COMPLETED|Overall Study||0
8072309|NCT04251884|19903419|P2|COMPLETED|Overall Study||26
8072310|NCT04251884|19903420|P1|COMPLETED|Overall Study||23
8072311|NCT04251884|19903419|P2|STARTED|Overall Study||26
8072312|NCT04251884|19903420|P1|STARTED|Overall Study||23
8072331|NCT04250987|19903492|P1|NOT COMPLETED|Overall Study||0
8072332|NCT04250987|19903492|P1|COMPLETED|Overall Study||12
8072333|NCT04250987|19903492|P1|STARTED|Overall Study||12
8072313|NCT00920621|19903438|P4|NOT COMPLETED|Overall Study||35
8072314|NCT00920621|19903439|P3|NOT COMPLETED|Overall Study||35
8072315|NCT00920621|19903440|P2|NOT COMPLETED|Overall Study||45
8072316|NCT00920621|19903441|P1|NOT COMPLETED|Overall Study||54
8072317|NCT00920621|19903438|P4|COMPLETED|Overall Study||401
8072318|NCT00920621|19903439|P3|COMPLETED|Overall Study||405
8072319|NCT00920621|19903440|P2|COMPLETED|Overall Study||391
8072320|NCT00920621|19903441|P1|COMPLETED|Overall Study||386
8072321|NCT00920621|19903438|P4|STARTED|Overall Study||436
8072322|NCT00920621|19903439|P3|STARTED|Overall Study||440
8072323|NCT00920621|19903440|P2|STARTED|Overall Study||436
8072324|NCT00920621|19903441|P1|STARTED|Overall Study||440
8072325|NCT00905437|19903473|P2|NOT COMPLETED|Overall Study||10
8072326|NCT00905437|19903474|P1|NOT COMPLETED|Overall Study||8
8072327|NCT00905437|19903473|P2|COMPLETED|Overall Study||27
8072328|NCT00905437|19903474|P1|COMPLETED|Overall Study||27
8072329|NCT00905437|19903473|P2|STARTED|Overall Study||37
8072330|NCT00905437|19903474|P1|STARTED|Overall Study||35
8072339|NCT00698828|19903551|P3|NOT COMPLETED|Overall Study||11
8072340|NCT00698828|19903552|P2|NOT COMPLETED|Overall Study||15
8072341|NCT00698828|19903553|P1|NOT COMPLETED|Overall Study||9
8072342|NCT00698828|19903551|P3|COMPLETED|Overall Study||65
8072343|NCT00698828|19903552|P2|COMPLETED|Overall Study||60
8072344|NCT00698828|19903553|P1|COMPLETED|Overall Study||67
8072345|NCT00698828|19903551|P3|STARTED|Overall Study||76
8072346|NCT00698828|19903552|P2|STARTED|Overall Study||75
8072347|NCT00698828|19903553|P1|STARTED|Overall Study||76
8072351|NCT00624780|19903610|P6|NOT COMPLETED|Follow-up (Week 26)||0
8072352|NCT00624780|19903611|P5|NOT COMPLETED|Follow-up (Week 26)||2
8072353|NCT00624780|19903612|P4|NOT COMPLETED|Follow-up (Week 26)||0
8072354|NCT00624780|19903613|P3|NOT COMPLETED|Follow-up (Week 26)||2
8072355|NCT00624780|19903614|P2|NOT COMPLETED|Follow-up (Week 26)||1
8072356|NCT00624780|19903615|P1|NOT COMPLETED|Follow-up (Week 26)||2
8072357|NCT00624780|19903610|P6|COMPLETED|Follow-up (Week 26)||29
8072358|NCT00624780|19903611|P5|COMPLETED|Follow-up (Week 26)||93
8072359|NCT00624780|19903612|P4|COMPLETED|Follow-up (Week 26)||26
8072360|NCT00624780|19903613|P3|COMPLETED|Follow-up (Week 26)||89
8072361|NCT00624780|19903614|P2|COMPLETED|Follow-up (Week 26)||27
8072362|NCT00624780|19903615|P1|COMPLETED|Follow-up (Week 26)||102
8072363|NCT00624780|19903610|P6|STARTED|Follow-up (Week 26)||29
8072364|NCT00624780|19903611|P5|STARTED|Follow-up (Week 26)||95
8072365|NCT00624780|19903612|P4|STARTED|Follow-up (Week 26)||26
8072366|NCT00624780|19903613|P3|STARTED|Follow-up (Week 26)||91
8072367|NCT00624780|19903614|P2|STARTED|Follow-up (Week 26)||28
8072368|NCT00624780|19903615|P1|STARTED|Follow-up (Week 26)||104
8072369|NCT00624780|19903610|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
8072370|NCT00624780|19903611|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
8072371|NCT00624780|19903612|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
8072372|NCT00624780|19903613|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
8072373|NCT00624780|19903614|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
8072374|NCT00624780|19903615|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
8072375|NCT00624780|19903610|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
8072376|NCT00624780|19903611|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
8072377|NCT00624780|19903612|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
8072378|NCT00624780|19903613|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
8072379|NCT00624780|19903614|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
8072380|NCT00624780|19903615|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
8072381|NCT00624780|19903610|P6|STARTED|Treatment Discontinuation (Week 25)||30
8072382|NCT00624780|19903611|P5|STARTED|Treatment Discontinuation (Week 25)||95
8072383|NCT00624780|19903612|P4|STARTED|Treatment Discontinuation (Week 25)||27
8072384|NCT00624780|19903613|P3|STARTED|Treatment Discontinuation (Week 25)||94
8072385|NCT00624780|19903614|P2|STARTED|Treatment Discontinuation (Week 25)||28
8072386|NCT00624780|19903615|P1|STARTED|Treatment Discontinuation (Week 25)||106
8072387|NCT00624780|19903610|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
8072388|NCT00624780|19903611|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
8072389|NCT00624780|19903612|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
8072390|NCT00624780|19903613|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
8072391|NCT00624780|19903614|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
8072392|NCT00624780|19903615|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
8072393|NCT00624780|19903610|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
8072394|NCT00624780|19903611|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
8072395|NCT00624780|19903612|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
8072396|NCT00624780|19903613|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
8072397|NCT00624780|19903614|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
8072398|NCT00624780|19903615|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
8072399|NCT00624780|19903610|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
8072400|NCT00624780|19903611|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
8072401|NCT00624780|19903612|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
8072402|NCT00624780|19903613|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
8072403|NCT00624780|19903614|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
8072404|NCT00624780|19903615|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
8072405|NCT00624780|19903610|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
8072406|NCT00624780|19903611|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
8072407|NCT00624780|19903612|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
8072408|NCT00624780|19903613|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
8072409|NCT00624780|19903614|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
8072410|NCT00624780|19903615|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
8072411|NCT00624780|19903610|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
8072412|NCT00624780|19903611|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
8072413|NCT00624780|19903612|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
8072414|NCT00624780|19903613|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
8072415|NCT00624780|19903614|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
8072416|NCT00624780|19903615|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
8072417|NCT00624780|19903610|P6|STARTED|Treatment Optimization (Up to Week 12)||50
8072418|NCT00624780|19903611|P5|STARTED|Treatment Optimization (Up to Week 12)||153
8072419|NCT00624780|19903612|P4|STARTED|Treatment Optimization (Up to Week 12)||52
8072420|NCT00624780|19903613|P3|STARTED|Treatment Optimization (Up to Week 12)||154
8072421|NCT00624780|19903614|P2|STARTED|Treatment Optimization (Up to Week 12)||52
8072422|NCT00624780|19903615|P1|STARTED|Treatment Optimization (Up to Week 12)||154
8072423|NCT00624234|19903803|P6|NOT COMPLETED|Overall Study||0
8072424|NCT00624234|19903804|P5|NOT COMPLETED|Overall Study||0
8072425|NCT00624234|19903805|P4|NOT COMPLETED|Overall Study||0
8072426|NCT00624234|19903806|P3|NOT COMPLETED|Overall Study||0
8072427|NCT00624234|19903807|P2|NOT COMPLETED|Overall Study||0
8072428|NCT00624234|19903808|P1|NOT COMPLETED|Overall Study||0
8072429|NCT00624234|19903803|P6|COMPLETED|Overall Study||14
8072430|NCT00624234|19903804|P5|COMPLETED|Overall Study||18
8072431|NCT00624234|19903805|P4|COMPLETED|Overall Study||14
8072432|NCT00624234|19903806|P3|COMPLETED|Overall Study||26
8072433|NCT00624234|19903807|P2|COMPLETED|Overall Study||9
8072434|NCT00624234|19903808|P1|COMPLETED|Overall Study||8
8072435|NCT00624234|19903803|P6|STARTED|Overall Study||14
8072436|NCT00624234|19903804|P5|STARTED|Overall Study||18
8072437|NCT00624234|19903805|P4|STARTED|Overall Study||14
8072438|NCT00624234|19903806|P3|STARTED|Overall Study||26
8072439|NCT00624234|19903807|P2|STARTED|Overall Study||9
8072440|NCT00624234|19903808|P1|STARTED|Overall Study||8
8072441|NCT00605917|19903822|P1|NOT COMPLETED|Overall Study||79
8072442|NCT00605917|19903822|P1|COMPLETED|Overall Study||908
8072443|NCT00605917|19903822|P1|STARTED|Overall Study||987
8072444|NCT00605865|19903861|P1|NOT COMPLETED|Overall Study||115
8072445|NCT00605865|19903861|P1|COMPLETED|Overall Study||2157
8072446|NCT00605865|19903861|P1|STARTED|Overall Study||2272
8072447|NCT00605813|19903900|P1|NOT COMPLETED|Overall Study||25
8072448|NCT00605813|19903900|P1|COMPLETED|Overall Study||517
8072449|NCT00605813|19903900|P1|STARTED|Overall Study||542
8072450|NCT00579254|19903913|P1|NOT COMPLETED|Overall Study||112
8072451|NCT00579254|19903913|P1|COMPLETED|Overall Study||0
8072452|NCT00579254|19903913|P1|STARTED|Overall Study||112
8072541|NCT00537238|19903968|P2|NOT COMPLETED|Overall Study||173
8072542|NCT00537238|19903969|P1|NOT COMPLETED|Overall Study||174
8072543|NCT00537238|19903968|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
8072544|NCT00537238|19903969|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
8072545|NCT00537238|19903968|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
8072546|NCT00537238|19903969|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
8072547|NCT00537238|19903968|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
8072548|NCT00537238|19903969|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
8072549|NCT00537238|19903968|P2|Completed Titration Phase|Overall Study||236
8072550|NCT00537238|19903969|P1|Completed Titration Phase|Overall Study||226
8072551|NCT00537238|19903968|P2|STARTED|Overall Study||255
8072552|NCT00537238|19903969|P1|STARTED|Overall Study||254
8072553|NCT00530946|19903993|P4|NOT COMPLETED|Overall Study||2
8072554|NCT00530946|19903994|P3|NOT COMPLETED|Overall Study||1
8072555|NCT00530946|19903995|P2|NOT COMPLETED|Overall Study||2
8072556|NCT00530946|19903996|P1|NOT COMPLETED|Overall Study||2
8072557|NCT00530946|19903993|P4|COMPLETED|Overall Study||38
8072558|NCT00530946|19903994|P3|COMPLETED|Overall Study||40
8072559|NCT00530946|19903995|P2|COMPLETED|Overall Study||39
8072560|NCT00530946|19903996|P1|COMPLETED|Overall Study||41
8072561|NCT00530946|19903993|P4|STARTED|Overall Study||40
8072562|NCT00530946|19903994|P3|STARTED|Overall Study||41
8072563|NCT00530946|19903995|P2|STARTED|Overall Study||41
8072564|NCT00530946|19903996|P1|STARTED|Overall Study||43
8072577|NCT00407537|19904062|P2|NOT COMPLETED|Overall Study||44
8072578|NCT00407537|19904063|P1|NOT COMPLETED|Overall Study||93
8072579|NCT00407537|19904062|P2|COMPLETED|Overall Study||638
8072580|NCT00407537|19904063|P1|COMPLETED|Overall Study||686
8072581|NCT00407537|19904062|P2|Eligible for Efficacy Analysis|Overall Study||657
8072582|NCT00407537|19904063|P1|Eligible for Efficacy Analysis|Overall Study||760
8072583|NCT00407537|19904062|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
8072584|NCT00407537|19904063|P1|STARTED|Overall Study||779
8072585|NCT00381940|19904111|P1|NOT COMPLETED|Overall Study||5
8072586|NCT00381940|19904111|P1|COMPLETED|Overall Study||21
8072587|NCT00381940|19904111|P1|STARTED|Overall Study||26
8072588|NCT00280059|19904122|P2|NOT COMPLETED|Extension Phase||38
8072589|NCT00280059|19904123|P1|NOT COMPLETED|Extension Phase||49
8072590|NCT00280059|19904122|P2|COMPLETED|Extension Phase||177
8072591|NCT00280059|19904123|P1|COMPLETED|Extension Phase||145
8072592|NCT00280059|19904122|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
8072593|NCT00280059|19904123|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
8072594|NCT00280059|19904122|P2|NOT COMPLETED|Efficacy Assessment Phase||80
8072595|NCT00280059|19904123|P1|NOT COMPLETED|Efficacy Assessment Phase||94
8072596|NCT00280059|19904122|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
8072597|NCT00280059|19904123|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
8072598|NCT00280059|19904122|P2|STARTED|Efficacy Assessment Phase||330
8072599|NCT00280059|19904123|P1|STARTED|Efficacy Assessment Phase||330
8072606|NCT00090844|19904224|P2|NOT COMPLETED|Overall Study||1
8072607|NCT00090844|19904225|P1|NOT COMPLETED|Overall Study||1
8072608|NCT00090844|19904224|P2|COMPLETED|Overall Study||21
8072609|NCT00090844|19904225|P1|COMPLETED|Overall Study||26
8072610|NCT00090844|19904224|P2|STARTED|Overall Study||22
8072611|NCT00090844|19904225|P1|STARTED|Overall Study||27
8072615|NCT04243421|19904237|P1|NOT COMPLETED|Overall Study||0
8072616|NCT04243421|19904237|P1|COMPLETED|Overall Study||30
8072617|NCT04243421|19904237|P1|STARTED|Overall Study||30
8072618|NCT04243369|19904242|P1|NOT COMPLETED|Overall Study||0
8072619|NCT04243369|19904242|P1|COMPLETED|Overall Study||30
8072620|NCT04243369|19904242|P1|STARTED|Overall Study||30
8072621|NCT04241146|19904255|P2|NOT COMPLETED|Overall Study||0
8072622|NCT04241146|19904256|P1|NOT COMPLETED|Overall Study||0
8072623|NCT04241146|19904255|P2|COMPLETED|Overall Study||28
8072624|NCT04241146|19904256|P1|COMPLETED|Overall Study||24
8072625|NCT04241146|19904255|P2|STARTED|Overall Study||28
8072626|NCT04241146|19904256|P1|STARTED|Overall Study||24
8072627|NCT04238429|19904266|P2|NOT COMPLETED|Overall Study||2
8072628|NCT04238429|19904267|P1|NOT COMPLETED|Overall Study||3
8072629|NCT04238429|19904266|P2|COMPLETED|Overall Study||41
8072630|NCT04238429|19904267|P1|COMPLETED|Overall Study||40
8072631|NCT04238429|19904266|P2|STARTED|Overall Study||43
8072632|NCT04238429|19904267|P1|STARTED|Overall Study||43
8072633|NCT04234425|19904283|P1|NOT COMPLETED|Overall Study||0
8072634|NCT04234425|19904283|P1|COMPLETED|Overall Study||18
8072635|NCT04234425|19904283|P1|Midpoint-Week 4|Overall Study||18
8072636|NCT04234425|19904283|P1|STARTED|Overall Study||18
8072637|NCT04232137|19904293|P2|NOT COMPLETED|Overall Study||0
8072638|NCT04232137|19904294|P1|NOT COMPLETED|Overall Study||0
8072639|NCT04232137|19904293|P2|COMPLETED|Overall Study||185
8072640|NCT04232137|19904294|P1|COMPLETED|Overall Study||254
8072641|NCT04232137|19904293|P2|STARTED|Overall Study||185
8072642|NCT04232137|19904294|P1|STARTED|Overall Study||254
8072643|NCT04224753|19904300|P1|NOT COMPLETED|Overall Study||0
8072644|NCT04224753|19904300|P1|COMPLETED|Overall Study||51
8072645|NCT04224753|19904300|P1|STARTED|Overall Study||51
8072646|NCT04223232|19904304|P1|NOT COMPLETED|Overall Study||1
8072647|NCT04223232|19904304|P1|COMPLETED|Overall Study||5
8072648|NCT04223232|19904304|P1|STARTED|Overall Study||6
8072649|NCT04222699|19904333|P1|NOT COMPLETED|Overall Study||2
8072650|NCT04222699|19904333|P1|COMPLETED|Overall Study||26
8072651|NCT04222699|19904333|P1|STARTED|Overall Study||28
8072652|NCT04218799|19904340|P1|NOT COMPLETED|Overall Study||0
8072653|NCT04218799|19904340|P1|COMPLETED|Overall Study||7
8072654|NCT04218799|19904340|P1|STARTED|Overall Study||7
8072655|NCT04214951|19904349|P2|NOT COMPLETED|Overall Study||40
8072656|NCT04214951|19904350|P1|NOT COMPLETED|Overall Study||40
8072657|NCT04214951|19904349|P2|COMPLETED|Overall Study||10
8072658|NCT04214951|19904350|P1|COMPLETED|Overall Study||10
8072659|NCT04214951|19904349|P2|STARTED|Overall Study||50
8072660|NCT04214951|19904350|P1|STARTED|Overall Study||50
8072661|NCT04214600|19904368|P2|NOT COMPLETED|Overall Study||14
8072662|NCT04214600|19904369|P1|NOT COMPLETED|Overall Study||9
8072663|NCT04214600|19904368|P2|COMPLETED|Overall Study||36
8072664|NCT04214600|19904369|P1|COMPLETED|Overall Study||41
8072665|NCT04214600|19904368|P2|STARTED|Overall Study||50
8072666|NCT04214600|19904369|P1|STARTED|Overall Study||50
8072667|NCT04214080|19904379|P2|NOT COMPLETED|Overall Study||0
8072668|NCT04214080|19904380|P1|NOT COMPLETED|Overall Study||0
8072669|NCT04214080|19904379|P2|COMPLETED|Overall Study||20
8072670|NCT04214080|19904380|P1|COMPLETED|Overall Study||20
8072671|NCT04214080|19904379|P2|STARTED|Overall Study||20
8072672|NCT04214080|19904380|P1|STARTED|Overall Study||20
8072673|NCT04209335|19904398|P1|NOT COMPLETED|Overall Study||0
8072674|NCT04209335|19904398|P1|COMPLETED|Overall Study||48
8072675|NCT04209335|19904398|P1|STARTED|Overall Study||48
8072676|NCT04206800|19904407|P2|NOT COMPLETED|Overall Study||0
8072677|NCT04206800|19904408|P1|NOT COMPLETED|Overall Study||0
8072678|NCT04206800|19904407|P2|COMPLETED|Overall Study||1
8072679|NCT04206800|19904408|P1|COMPLETED|Overall Study||4
8072680|NCT04206800|19904407|P2|STARTED|Overall Study||1
8072681|NCT04206800|19904408|P1|STARTED|Overall Study||4
8072682|NCT04205669|19904416|P2|NOT COMPLETED|Overall Study||12
8072683|NCT04205669|19904417|P1|NOT COMPLETED|Overall Study||13
8072684|NCT04205669|19904416|P2|COMPLETED|Overall Study||45
8072685|NCT04205669|19904417|P1|COMPLETED|Overall Study||34
8072686|NCT04205669|19904416|P2|STARTED|Overall Study||57
8072687|NCT04205669|19904417|P1|STARTED|Overall Study||47
8072688|NCT04204200|19904426|P3|NOT COMPLETED|Overall Study||0
8072689|NCT04204200|19904427|P2|NOT COMPLETED|Overall Study||0
8072690|NCT04204200|19904428|P1|NOT COMPLETED|Overall Study||0
8072691|NCT04204200|19904426|P3|COMPLETED|Overall Study||22
8072692|NCT04204200|19904427|P2|COMPLETED|Overall Study||22
8072693|NCT04204200|19904428|P1|COMPLETED|Overall Study||22
8072694|NCT04204200|19904426|P3|STARTED|Overall Study||22
8072695|NCT04204200|19904427|P2|STARTED|Overall Study||22
8072696|NCT04204200|19904428|P1|STARTED|Overall Study||22
8072697|NCT04195893|19904445|P2|NOT COMPLETED|Second Intervention||0
8072698|NCT04195893|19904446|P1|NOT COMPLETED|Second Intervention||1
8072699|NCT04195893|19904445|P2|COMPLETED|Second Intervention||29
8072700|NCT04195893|19904446|P1|COMPLETED|Second Intervention||26
8072701|NCT04195893|19904445|P2|STARTED|Second Intervention||29
8072702|NCT04195893|19904446|P1|STARTED|Second Intervention||27
8072703|NCT04195893|19904445|P2|NOT COMPLETED|First Intervention||0
8072704|NCT04195893|19904446|P1|NOT COMPLETED|First Intervention||0
8072705|NCT04195893|19904445|P2|COMPLETED|First Intervention||29
8072706|NCT04195893|19904446|P1|COMPLETED|First Intervention||27
8072707|NCT04195893|19904445|P2|STARTED|First Intervention||29
8072708|NCT04195893|19904446|P1|STARTED|First Intervention||27
8072709|NCT04195880|19904490|P2|NOT COMPLETED|Overall Study||0
8072710|NCT04195880|19904491|P1|NOT COMPLETED|Overall Study||0
8072711|NCT04195880|19904490|P2|COMPLETED|Overall Study||3338
8072712|NCT04195880|19904491|P1|COMPLETED|Overall Study||3205
8072713|NCT04195880|19904490|P2|STARTED|Overall Study||3338
8072714|NCT04195880|19904491|P1|STARTED|Overall Study||3205
8072715|NCT04194151|19904505|P6|NOT COMPLETED|Overall Study||1
8072716|NCT04194151|19904506|P5|NOT COMPLETED|Overall Study||0
8072717|NCT04194151|19904507|P4|NOT COMPLETED|Overall Study||1
8072718|NCT04194151|19904508|P3|NOT COMPLETED|Overall Study||1
8072719|NCT04194151|19904509|P2|NOT COMPLETED|Overall Study||2
8072720|NCT04194151|19904510|P1|NOT COMPLETED|Overall Study||1
8072721|NCT04194151|19904505|P6|COMPLETED|Overall Study||31
8072722|NCT04194151|19904506|P5|COMPLETED|Overall Study||32
8072723|NCT04194151|19904507|P4|COMPLETED|Overall Study||31
8072724|NCT04194151|19904508|P3|COMPLETED|Overall Study||31
8072725|NCT04194151|19904509|P2|COMPLETED|Overall Study||30
8072726|NCT04194151|19904510|P1|COMPLETED|Overall Study||31
8072727|NCT04194151|19904505|P6|STARTED|Overall Study||32
8072728|NCT04194151|19904506|P5|STARTED|Overall Study||32
8072729|NCT04194151|19904507|P4|STARTED|Overall Study||32
8072730|NCT04194151|19904508|P3|STARTED|Overall Study||32
8072731|NCT04194151|19904509|P2|STARTED|Overall Study||32
8072732|NCT04194151|19904510|P1|STARTED|Overall Study||32
8072733|NCT04186806|19904550|P2|NOT COMPLETED|Period 2: 7 Days||0
8072734|NCT04186806|19904551|P1|NOT COMPLETED|Period 2: 7 Days||0
8072735|NCT04186806|19904550|P2|COMPLETED|Period 2: 7 Days||20
8072736|NCT04186806|19904551|P1|COMPLETED|Period 2: 7 Days||19
8072737|NCT04186806|19904550|P2|STARTED|Period 2: 7 Days||20
8072738|NCT04186806|19904551|P1|STARTED|Period 2: 7 Days||19
8072739|NCT04186806|19904550|P2|NOT COMPLETED|Washout Period: at Least 2 Days||0
8072740|NCT04186806|19904551|P1|NOT COMPLETED|Washout Period: at Least 2 Days||0
8072741|NCT04186806|19904550|P2|COMPLETED|Washout Period: at Least 2 Days||20
8072742|NCT04186806|19904551|P1|COMPLETED|Washout Period: at Least 2 Days||19
8072743|NCT04186806|19904550|P2|STARTED|Washout Period: at Least 2 Days||20
8072744|NCT04186806|19904551|P1|STARTED|Washout Period: at Least 2 Days||19
8072745|NCT04186806|19904550|P2|NOT COMPLETED|Period 1: 7 Days||0
8072746|NCT04186806|19904551|P1|NOT COMPLETED|Period 1: 7 Days||1
8072747|NCT04186806|19904550|P2|COMPLETED|Period 1: 7 Days||20
8072748|NCT04186806|19904551|P1|COMPLETED|Period 1: 7 Days||19
8072749|NCT04186806|19904550|P2|STARTED|Period 1: 7 Days||20
8072750|NCT04186806|19904551|P1|STARTED|Period 1: 7 Days||20
8072751|NCT04186780|19904641|P2|NOT COMPLETED|Overall Study||7
8072752|NCT04186780|19904642|P1|NOT COMPLETED|Overall Study||14
8072753|NCT04186780|19904641|P2|COMPLETED|Overall Study||25
8072754|NCT04186780|19904642|P1|COMPLETED|Overall Study||22
8072755|NCT04186780|19904641|P2|STARTED|Overall Study||32
8072756|NCT04186780|19904642|P1|STARTED|Overall Study||36
8072757|NCT04184297|19904658|P2|NOT COMPLETED|Overall Study||0
8072758|NCT04184297|19904659|P1|NOT COMPLETED|Overall Study||0
8072759|NCT04184297|19904658|P2|COMPLETED|Overall Study||24326
8072760|NCT04184297|19904659|P1|COMPLETED|Overall Study||2864
8072761|NCT04184297|19904658|P2|STARTED|Overall Study||24326
8072762|NCT04184297|19904659|P1|STARTED|Overall Study||2864
8072763|NCT04184271|19904669|P1|NOT COMPLETED|Overall Study||0
8072764|NCT04184271|19904669|P1|COMPLETED|Overall Study||16
8072765|NCT04184271|19904669|P1|STARTED|Overall Study||16
8072766|NCT04183231|19904678|P1|NOT COMPLETED|Overall Study||0
8072767|NCT04183231|19904678|P1|COMPLETED|Overall Study||16
8072768|NCT04183231|19904678|P1|STARTED|Overall Study||16
8072769|NCT04182217|19904694|P1|NOT COMPLETED|Overall Study||0
8072770|NCT04182217|19904694|P1|COMPLETED|Overall Study||91
8072771|NCT04182217|19904694|P1|STARTED|Overall Study||91
8072772|NCT04179838|19904707|P2|NOT COMPLETED|Second Intervention (1 Day)||1
8072773|NCT04179838|19904708|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8072774|NCT04179838|19904707|P2|COMPLETED|Second Intervention (1 Day)||12
8072775|NCT04179838|19904708|P1|COMPLETED|Second Intervention (1 Day)||13
8072776|NCT04179838|19904707|P2|STARTED|Second Intervention (1 Day)||13
8072777|NCT04179838|19904708|P1|STARTED|Second Intervention (1 Day)||13
8072778|NCT04179838|19904707|P2|NOT COMPLETED|Washout (4 Weeks)||0
8072779|NCT04179838|19904708|P1|NOT COMPLETED|Washout (4 Weeks)||0
8072780|NCT04179838|19904707|P2|COMPLETED|Washout (4 Weeks)||13
8072781|NCT04179838|19904708|P1|COMPLETED|Washout (4 Weeks)||13
8072782|NCT04179838|19904707|P2|STARTED|Washout (4 Weeks)||13
8072783|NCT04179838|19904708|P1|STARTED|Washout (4 Weeks)||13
8072784|NCT04179838|19904707|P2|NOT COMPLETED|First Intervention (1 Day)||3
8072785|NCT04179838|19904708|P1|NOT COMPLETED|First Intervention (1 Day)||0
8072786|NCT04179838|19904707|P2|COMPLETED|First Intervention (1 Day)||13
8072787|NCT04179838|19904708|P1|COMPLETED|First Intervention (1 Day)||13
8072788|NCT04179838|19904707|P2|STARTED|First Intervention (1 Day)||16
8072789|NCT04179838|19904708|P1|STARTED|First Intervention (1 Day)||13
8072790|NCT04178590|19904726|P1|NOT COMPLETED|Overall Study||2
8072791|NCT04178590|19904726|P1|COMPLETED|Overall Study||30
8072792|NCT04178590|19904726|P1|STARTED|Overall Study||32
8072793|NCT04176406|19904834|P4|NOT COMPLETED|Overall Study||0
8072794|NCT04176406|19904835|P3|NOT COMPLETED|Overall Study||0
8072795|NCT04176406|19904836|P2|NOT COMPLETED|Overall Study||0
8072796|NCT04176406|19904837|P1|NOT COMPLETED|Overall Study||0
8072797|NCT04176406|19904834|P4|COMPLETED|Overall Study||0
8072798|NCT04176406|19904835|P3|COMPLETED|Overall Study||0
8072799|NCT04176406|19904836|P2|COMPLETED|Overall Study||0
8072800|NCT04176406|19904837|P1|COMPLETED|Overall Study||0
8072801|NCT04176406|19904834|P4|STARTED|Overall Study||0
8072802|NCT04176406|19904835|P3|STARTED|Overall Study||0
8072803|NCT04176406|19904836|P2|STARTED|Overall Study||0
8072804|NCT04176406|19904837|P1|STARTED|Overall Study||0
8072805|NCT04173741|19904850|P2|NOT COMPLETED|Overall Study||1
8072806|NCT04173741|19904851|P1|NOT COMPLETED|Overall Study||1
8072807|NCT04173741|19904850|P2|COMPLETED|Overall Study||22
8072808|NCT04173741|19904851|P1|COMPLETED|Overall Study||22
8072809|NCT04173741|19904850|P2|STARTED|Overall Study||23
8072810|NCT04173741|19904851|P1|STARTED|Overall Study||23
8072811|NCT04171102|19904860|P3|NOT COMPLETED|Overall Study||0
8072812|NCT04171102|19904861|P2|NOT COMPLETED|Overall Study||0
8072813|NCT04171102|19904862|P1|NOT COMPLETED|Overall Study||0
8072814|NCT04171102|19904860|P3|COMPLETED|Overall Study||6
8072815|NCT04171102|19904861|P2|COMPLETED|Overall Study||5
8072816|NCT04171102|19904862|P1|COMPLETED|Overall Study||4
8072817|NCT04171102|19904860|P3|STARTED|Overall Study||6
8072818|NCT04171102|19904861|P2|STARTED|Overall Study||5
8072819|NCT04171102|19904862|P1|STARTED|Overall Study||4
8072832|NCT04169113|19904897|P2|NOT COMPLETED|Overall Study||6
8072833|NCT04169113|19904898|P1|NOT COMPLETED|Overall Study||5
8072834|NCT04169113|19904897|P2|COMPLETED|Overall Study||53
8072835|NCT04169113|19904898|P1|COMPLETED|Overall Study||47
8072836|NCT04169113|19904897|P2|STARTED|Overall Study||59
8072837|NCT04169113|19904898|P1|STARTED|Overall Study||52
8072838|NCT04161079|19904940|P1|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
8072925|NCT04143945|19905207|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072839|NCT04161079|19904940|P1|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
8072840|NCT04161079|19904940|P1|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
8072841|NCT04161079|19904940|P1|NOT COMPLETED|Clinical Investigation 2010-040||1
8072842|NCT04161079|19904940|P1|COMPLETED|Clinical Investigation 2010-040||11
8072843|NCT04161079|19904940|P1|STARTED|Clinical Investigation 2010-040||12
8072844|NCT04158466|19904962|P2|NOT COMPLETED|Overall Study||1
8072845|NCT04158466|19904963|P1|NOT COMPLETED|Overall Study||3
8072846|NCT04158466|19904962|P2|COMPLETED|Overall Study||126
8072847|NCT04158466|19904963|P1|COMPLETED|Overall Study||121
8072848|NCT04158466|19904962|P2|STARTED|Overall Study||127
8072849|NCT04158466|19904963|P1|STARTED|Overall Study||124
8072850|NCT04150861|19904974|P3|NOT COMPLETED|Overall Study||0
8072851|NCT04150861|19904975|P2|NOT COMPLETED|Overall Study||0
8072852|NCT04150861|19904976|P1|NOT COMPLETED|Overall Study||0
8072853|NCT04150861|19904974|P3|COMPLETED|Overall Study||8
8072854|NCT04150861|19904975|P2|COMPLETED|Overall Study||8
8072855|NCT04150861|19904976|P1|COMPLETED|Overall Study||8
8072856|NCT04150861|19904974|P3|STARTED|Overall Study||8
8072857|NCT04150861|19904975|P2|STARTED|Overall Study||8
8072858|NCT04150861|19904976|P1|STARTED|Overall Study||8
8072859|NCT04150224|19905026|P6|NOT COMPLETED|Overall Study||0
8072860|NCT04150224|19905027|P5|NOT COMPLETED|Overall Study||0
8072861|NCT04150224|19905028|P4|NOT COMPLETED|Overall Study||0
8072862|NCT04150224|19905029|P3|NOT COMPLETED|Overall Study||0
8072863|NCT04150224|19905030|P2|NOT COMPLETED|Overall Study||0
8072864|NCT04150224|19905031|P1|NOT COMPLETED|Overall Study||0
8072865|NCT04150224|19905026|P6|COMPLETED|Overall Study|Period 2: Multple Dosing|10
8072866|NCT04150224|19905027|P5|COMPLETED|Overall Study||10
8072867|NCT04150224|19905028|P4|COMPLETED|Overall Study||10
8072868|NCT04150224|19905029|P3|COMPLETED|Overall Study||10
8072869|NCT04150224|19905030|P2|COMPLETED|Overall Study||10
8072870|NCT04150224|19905031|P1|COMPLETED|Overall Study||10
8072871|NCT04150224|19905026|P6|STARTED|Overall Study|Period 2: Multple Dosing|10
8072872|NCT04150224|19905027|P5|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072873|NCT04150224|19905028|P4|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072874|NCT04150224|19905029|P3|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072875|NCT04150224|19905030|P2|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072876|NCT04150224|19905031|P1|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072883|NCT04149405|19905153|P4|NOT COMPLETED|Overall Study||0
8072884|NCT04149405|19905154|P3|NOT COMPLETED|Overall Study||0
8072885|NCT04149405|19905155|P2|NOT COMPLETED|Overall Study||0
8072886|NCT04149405|19905156|P1|NOT COMPLETED|Overall Study||0
8072887|NCT04149405|19905153|P4|COMPLETED|Overall Study||10
8072888|NCT04149405|19905154|P3|COMPLETED|Overall Study||11
8072889|NCT04149405|19905155|P2|COMPLETED|Overall Study||10
8072890|NCT04149405|19905156|P1|COMPLETED|Overall Study||12
8072891|NCT04149405|19905153|P4|STARTED|Overall Study||10
8072892|NCT04149405|19905154|P3|STARTED|Overall Study||11
8072893|NCT04149405|19905155|P2|STARTED|Overall Study||10
8072894|NCT04149405|19905156|P1|STARTED|Overall Study||12
8072895|NCT04149353|19905178|P1|NOT COMPLETED|Overall Study||1
8072896|NCT04149353|19905178|P1|COMPLETED|Overall Study||0
8072897|NCT04149353|19905178|P1|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
8072898|NCT04148651|19905183|P1|NOT COMPLETED|Overall Study||2
8072899|NCT04148651|19905183|P1|COMPLETED|Overall Study|2 subjects didn't complete final follow-up due to COVID-19 pandemic|10
8072900|NCT04148651|19905183|P1|STARTED|Overall Study||12
8072901|NCT04144088|19905194|P3|NOT COMPLETED|Overall Study||7
8072902|NCT04144088|19905195|P2|NOT COMPLETED|Overall Study||5
8072903|NCT04144088|19905196|P1|NOT COMPLETED|Overall Study||6
8072904|NCT04144088|19905194|P3|COMPLETED|Overall Study||13
8072905|NCT04144088|19905195|P2|COMPLETED|Overall Study||15
8072906|NCT04144088|19905196|P1|COMPLETED|Overall Study||14
8072907|NCT04144088|19905194|P3|STARTED|Overall Study||20
8072908|NCT04144088|19905195|P2|STARTED|Overall Study||20
8072909|NCT04144088|19905196|P1|STARTED|Overall Study||20
8072910|NCT04143945|19905204|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072911|NCT04143945|19905205|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072912|NCT04143945|19905206|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072913|NCT04143945|19905207|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072914|NCT04143945|19905204|P4|COMPLETED|Treatment Period 2 (Day 1)||26
8072915|NCT04143945|19905205|P3|COMPLETED|Treatment Period 2 (Day 1)||26
8072916|NCT04143945|19905206|P2|COMPLETED|Treatment Period 2 (Day 1)||26
8072917|NCT04143945|19905207|P1|COMPLETED|Treatment Period 2 (Day 1)||26
8072918|NCT04143945|19905204|P4|STARTED|Treatment Period 2 (Day 1)||26
8072919|NCT04143945|19905205|P3|STARTED|Treatment Period 2 (Day 1)||26
8072920|NCT04143945|19905206|P2|STARTED|Treatment Period 2 (Day 1)||26
8072921|NCT04143945|19905207|P1|STARTED|Treatment Period 2 (Day 1)||26
8072922|NCT04143945|19905204|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072923|NCT04143945|19905205|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072924|NCT04143945|19905206|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072926|NCT04143945|19905204|P4|COMPLETED|Treatment Period 1 (Day 1)||26
8072927|NCT04143945|19905205|P3|COMPLETED|Treatment Period 1 (Day 1)||26
8072928|NCT04143945|19905206|P2|COMPLETED|Treatment Period 1 (Day 1)||26
8072929|NCT04143945|19905207|P1|COMPLETED|Treatment Period 1 (Day 1)||26
8072930|NCT04143945|19905204|P4|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072931|NCT04143945|19905205|P3|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072932|NCT04143945|19905206|P2|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072933|NCT04143945|19905207|P1|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072934|NCT04143945|19905204|P4|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072935|NCT04143945|19905205|P3|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072936|NCT04143945|19905206|P2|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072937|NCT04143945|19905207|P1|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072938|NCT04143945|19905204|P4|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072939|NCT04143945|19905205|P3|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072940|NCT04143945|19905206|P2|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072941|NCT04143945|19905207|P1|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072942|NCT04143945|19905204|P4|STARTED|Treatment Period 1 (Day 1)||26
8072943|NCT04143945|19905205|P3|STARTED|Treatment Period 1 (Day 1)||26
8072944|NCT04143945|19905206|P2|STARTED|Treatment Period 1 (Day 1)||26
8072945|NCT04143945|19905207|P1|STARTED|Treatment Period 1 (Day 1)||26
8072946|NCT04143373|19905212|P2|NOT COMPLETED|Overall Study||0
8072947|NCT04143373|19905213|P1|NOT COMPLETED|Overall Study||0
8072948|NCT04143373|19905212|P2|COMPLETED|Overall Study||20
8072949|NCT04143373|19905213|P1|COMPLETED|Overall Study||20
8072950|NCT04143373|19905212|P2|STARTED|Overall Study||20
8072951|NCT04143373|19905213|P1|STARTED|Overall Study||20
8072952|NCT04142216|19905222|P2|NOT COMPLETED|Overall Study||6
8072953|NCT04142216|19905223|P1|NOT COMPLETED|Overall Study||6
8072954|NCT04142216|19905222|P2|COMPLETED|Overall Study||22
8072955|NCT04142216|19905223|P1|COMPLETED|Overall Study||22
8072956|NCT04142216|19905222|P2|STARTED|Overall Study||28
8072957|NCT04142216|19905223|P1|STARTED|Overall Study||28
8072958|NCT04140890|19905245|P2|NOT COMPLETED|Overall Study||1
8072959|NCT04140890|19905246|P1|NOT COMPLETED|Overall Study||0
8072960|NCT04140890|19905245|P2|COMPLETED|Overall Study||11
8072961|NCT04140890|19905246|P1|COMPLETED|Overall Study||9
8072962|NCT04140890|19905245|P2|STARTED|Overall Study||12
8072963|NCT04140890|19905246|P1|STARTED|Overall Study||9
8072964|NCT04138810|19905274|P2|NOT COMPLETED|Overall Study||1
8072965|NCT04138810|19905275|P1|NOT COMPLETED|Overall Study||1
8072966|NCT04138810|19905274|P2|COMPLETED|Overall Study||26
8072967|NCT04138810|19905275|P1|COMPLETED|Overall Study||26
8072968|NCT04138810|19905274|P2|STARTED|Overall Study||27
8072969|NCT04138810|19905275|P1|STARTED|Overall Study||27
8072970|NCT04138758|19905283|P2|NOT COMPLETED|Overall Study||0
8072971|NCT04138758|19905284|P1|NOT COMPLETED|Overall Study||0
8072972|NCT04138758|19905283|P2|COMPLETED|Overall Study||40353
8072973|NCT04138758|19905284|P1|COMPLETED|Overall Study||2600
8072974|NCT04138758|19905283|P2|STARTED|Overall Study||40353
8072975|NCT04138758|19905284|P1|STARTED|Overall Study||2600
8072976|NCT04137627|19905302|P2|NOT COMPLETED|Overall Study||13
8072977|NCT04137627|19905303|P1|NOT COMPLETED|Overall Study||12
8072978|NCT04137627|19905302|P2|COMPLETED|Overall Study||12
8072979|NCT04137627|19905303|P1|COMPLETED|Overall Study||13
8072980|NCT04137627|19905302|P2|STARTED|Overall Study||25
8072981|NCT04137627|19905303|P1|STARTED|Overall Study||25
8072982|NCT04136145|19905319|P2|NOT COMPLETED|Overall Study||0
8072983|NCT04136145|19905320|P1|NOT COMPLETED|Overall Study||0
8072984|NCT04136145|19905319|P2|COMPLETED|Overall Study||24
8072985|NCT04136145|19905320|P1|COMPLETED|Overall Study||12
8072986|NCT04136145|19905319|P2|STARTED|Overall Study||24
8072987|NCT04136145|19905320|P1|STARTED|Overall Study||12
8072988|NCT04131556|19905340|P1|NOT COMPLETED|Overall Study||2
8072989|NCT04131556|19905340|P1|COMPLETED|Overall Study||18
8072990|NCT04131556|19905340|P1|STARTED|Overall Study||20
8072991|NCT04130425|19905371|P1|NOT COMPLETED|Overall Study||0
8072992|NCT04130425|19905371|P1|COMPLETED|Overall Study||30
8072993|NCT04130425|19905371|P1|STARTED|Overall Study||30
8072994|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072995|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072996|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072997|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072998|NCT04128293|19905386|P4|COMPLETED|Treatment Period 4 (1 Day)||0
8072999|NCT04128293|19905387|P3|COMPLETED|Treatment Period 4 (1 Day)||0
8073000|NCT04128293|19905388|P2|COMPLETED|Treatment Period 4 (1 Day)||0
8073001|NCT04128293|19905389|P1|COMPLETED|Treatment Period 4 (1 Day)||0
8073002|NCT04128293|19905386|P4|STARTED|Treatment Period 4 (1 Day)||0
8073003|NCT04128293|19905387|P3|STARTED|Treatment Period 4 (1 Day)||0
8073004|NCT04128293|19905388|P2|STARTED|Treatment Period 4 (1 Day)||0
8073005|NCT04128293|19905389|P1|STARTED|Treatment Period 4 (1 Day)||0
8073006|NCT04128293|19905386|P4|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073007|NCT04128293|19905387|P3|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073008|NCT04128293|19905388|P2|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073009|NCT04128293|19905389|P1|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073010|NCT04128293|19905386|P4|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073011|NCT04128293|19905387|P3|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073012|NCT04128293|19905388|P2|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073013|NCT04128293|19905389|P1|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073014|NCT04128293|19905386|P4|STARTED|Washout Period 3 (Up to 7 Days)||0
8073015|NCT04128293|19905387|P3|STARTED|Washout Period 3 (Up to 7 Days)||0
8073016|NCT04128293|19905388|P2|STARTED|Washout Period 3 (Up to 7 Days)||0
8073017|NCT04128293|19905389|P1|STARTED|Washout Period 3 (Up to 7 Days)||0
8073018|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073019|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073020|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073021|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073022|NCT04128293|19905386|P4|COMPLETED|Treatment Period 3 (1 Day)||0
8073023|NCT04128293|19905387|P3|COMPLETED|Treatment Period 3 (1 Day)||0
8073024|NCT04128293|19905388|P2|COMPLETED|Treatment Period 3 (1 Day)||0
8073025|NCT04128293|19905389|P1|COMPLETED|Treatment Period 3 (1 Day)||0
8073026|NCT04128293|19905386|P4|STARTED|Treatment Period 3 (1 Day)||0
8073027|NCT04128293|19905387|P3|STARTED|Treatment Period 3 (1 Day)||0
8073028|NCT04128293|19905388|P2|STARTED|Treatment Period 3 (1 Day)||0
8073029|NCT04128293|19905389|P1|STARTED|Treatment Period 3 (1 Day)||0
8073030|NCT04128293|19905386|P4|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073031|NCT04128293|19905387|P3|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073032|NCT04128293|19905388|P2|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073033|NCT04128293|19905389|P1|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073034|NCT04128293|19905386|P4|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073035|NCT04128293|19905387|P3|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073036|NCT04128293|19905388|P2|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073037|NCT04128293|19905389|P1|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073038|NCT04128293|19905386|P4|STARTED|Washout Period 2 (Up to 7 Days)||4
8073039|NCT04128293|19905387|P3|STARTED|Washout Period 2 (Up to 7 Days)||4
8073040|NCT04128293|19905388|P2|STARTED|Washout Period 2 (Up to 7 Days)||4
8073041|NCT04128293|19905389|P1|STARTED|Washout Period 2 (Up to 7 Days)||4
8073042|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073043|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073044|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073045|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073046|NCT04128293|19905386|P4|COMPLETED|Treatment Period 2 (1 Day)||4
8073047|NCT04128293|19905387|P3|COMPLETED|Treatment Period 2 (1 Day)||4
8073048|NCT04128293|19905388|P2|COMPLETED|Treatment Period 2 (1 Day)||4
8073049|NCT04128293|19905389|P1|COMPLETED|Treatment Period 2 (1 Day)||4
8073050|NCT04128293|19905386|P4|STARTED|Treatment Period 2 (1 Day)||4
8073051|NCT04128293|19905387|P3|STARTED|Treatment Period 2 (1 Day)||4
8073052|NCT04128293|19905388|P2|STARTED|Treatment Period 2 (1 Day)||4
8073053|NCT04128293|19905389|P1|STARTED|Treatment Period 2 (1 Day)||4
8073054|NCT04128293|19905386|P4|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073055|NCT04128293|19905387|P3|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073056|NCT04128293|19905388|P2|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073057|NCT04128293|19905389|P1|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073058|NCT04128293|19905386|P4|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073059|NCT04128293|19905387|P3|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073060|NCT04128293|19905388|P2|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073061|NCT04128293|19905389|P1|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073062|NCT04128293|19905386|P4|STARTED|Washout Period 1 (Up to 7 Days)||4
8073063|NCT04128293|19905387|P3|STARTED|Washout Period 1 (Up to 7 Days)||4
8073064|NCT04128293|19905388|P2|STARTED|Washout Period 1 (Up to 7 Days)||4
8073065|NCT04128293|19905389|P1|STARTED|Washout Period 1 (Up to 7 Days)||4
8073066|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073067|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073068|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073069|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073070|NCT04128293|19905386|P4|COMPLETED|Treatment Period 1 (1 Day)||4
8073071|NCT04128293|19905387|P3|COMPLETED|Treatment Period 1 (1 Day)||4
8073072|NCT04128293|19905388|P2|COMPLETED|Treatment Period 1 (1 Day)||4
8073073|NCT04128293|19905389|P1|COMPLETED|Treatment Period 1 (1 Day)||4
8073074|NCT04128293|19905386|P4|STARTED|Treatment Period 1 (1 Day)||4
8073075|NCT04128293|19905387|P3|STARTED|Treatment Period 1 (1 Day)||4
8073076|NCT04128293|19905388|P2|STARTED|Treatment Period 1 (1 Day)||4
8073077|NCT04128293|19905389|P1|STARTED|Treatment Period 1 (1 Day)||4
8073078|NCT04123665|19905589|P2|NOT COMPLETED|Overall Study||0
8073079|NCT04123665|19905590|P1|NOT COMPLETED|Overall Study||8
8073080|NCT04123665|19905589|P2|COMPLETED|Overall Study||48
8073081|NCT04123665|19905590|P1|COMPLETED|Overall Study||42
8073082|NCT04123665|19905589|P2|STARTED|Overall Study||48
8073083|NCT04123665|19905590|P1|STARTED|Overall Study||50
8073084|NCT04122534|19905612|P1|NOT COMPLETED|Overall Study||4
8073085|NCT04122534|19905612|P1|COMPLETED|Overall Study||44
8073086|NCT04122534|19905612|P1|STARTED|Overall Study||48
8073087|NCT04121078|19905619|P2|NOT COMPLETED|Study Period 2 (1 Day)||0
8073088|NCT04121078|19905620|P1|NOT COMPLETED|Study Period 2 (1 Day)||0
8073089|NCT04121078|19905619|P2|COMPLETED|Study Period 2 (1 Day)||6
8073090|NCT04121078|19905620|P1|COMPLETED|Study Period 2 (1 Day)||6
8073091|NCT04121078|19905619|P2|STARTED|Study Period 2 (1 Day)||6
8073092|NCT04121078|19905620|P1|STARTED|Study Period 2 (1 Day)||6
8073093|NCT04121078|19905619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8073094|NCT04121078|19905620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8073095|NCT04121078|19905619|P2|COMPLETED|Washout Period (at Least 7 Days)||6
8073096|NCT04121078|19905620|P1|COMPLETED|Washout Period (at Least 7 Days)||6
8073097|NCT04121078|19905619|P2|STARTED|Washout Period (at Least 7 Days)||6
8073098|NCT04121078|19905620|P1|STARTED|Washout Period (at Least 7 Days)||6
8073099|NCT04121078|19905619|P2|NOT COMPLETED|Study Period 1 (1 Day)||0
8073100|NCT04121078|19905620|P1|NOT COMPLETED|Study Period 1 (1 Day)||0
8073101|NCT04121078|19905619|P2|COMPLETED|Study Period 1 (1 Day)||6
8073102|NCT04121078|19905620|P1|COMPLETED|Study Period 1 (1 Day)||6
8073103|NCT04121078|19905619|P2|STARTED|Study Period 1 (1 Day)||6
8073104|NCT04121078|19905620|P1|STARTED|Study Period 1 (1 Day)||6
8073105|NCT04113785|19905638|P1|NOT COMPLETED|Overall Study||0
8073106|NCT04113785|19905638|P1|COMPLETED|Overall Study||21
8073107|NCT04113785|19905638|P1|STARTED|Overall Study||21
8073108|NCT04112160|19905647|P2|NOT COMPLETED|Overall Study||0
8073109|NCT04112160|19905648|P1|NOT COMPLETED|Overall Study||1
8073110|NCT04112160|19905647|P2|COMPLETED|Overall Study||62
8073111|NCT04112160|19905648|P1|COMPLETED|Overall Study||62
8073112|NCT04112160|19905647|P2|STARTED|Overall Study||62
8073113|NCT04112160|19905648|P1|STARTED|Overall Study||63
8073114|NCT04112069|19905664|P2|NOT COMPLETED|Overall Study||0
8073115|NCT04112069|19905665|P1|NOT COMPLETED|Overall Study||0
8073116|NCT04112069|19905664|P2|COMPLETED|Overall Study||10
8073117|NCT04112069|19905665|P1|COMPLETED|Overall Study||10
8073118|NCT04112069|19905664|P2|STARTED|Overall Study||10
8073119|NCT04112069|19905665|P1|STARTED|Overall Study||10
8073120|NCT04109703|19905687|P2|NOT COMPLETED|Overall Study||0
8073121|NCT04109703|19905688|P1|NOT COMPLETED|Overall Study||0
8073122|NCT04109703|19905687|P2|COMPLETED|Overall Study||51
8073123|NCT04109703|19905688|P1|COMPLETED|Overall Study||49
8073124|NCT04109703|19905687|P2|STARTED|Overall Study||51
8073125|NCT04109703|19905688|P1|STARTED|Overall Study||49
8073126|NCT04109222|19905699|P3|NOT COMPLETED|Overall Study||0
8073127|NCT04109222|19905700|P2|NOT COMPLETED|Overall Study||0
8073128|NCT04109222|19905701|P1|NOT COMPLETED|Overall Study||1
8073129|NCT04109222|19905699|P3|COMPLETED|Overall Study||30
8073130|NCT04109222|19905700|P2|COMPLETED|Overall Study||30
8073131|NCT04109222|19905701|P1|COMPLETED|Overall Study||29
8073132|NCT04109222|19905699|P3|STARTED|Overall Study||30
8073133|NCT04109222|19905700|P2|STARTED|Overall Study||30
8073134|NCT04109222|19905701|P1|STARTED|Overall Study||30
8073135|NCT04106817|19905712|P3|NOT COMPLETED|Overall Study||0
8073136|NCT04106817|19905713|P2|NOT COMPLETED|Overall Study||0
8073137|NCT04106817|19905714|P1|NOT COMPLETED|Overall Study||1
8073138|NCT04106817|19905712|P3|COMPLETED|Overall Study||12
8073139|NCT04106817|19905713|P2|COMPLETED|Overall Study||11
8073140|NCT04106817|19905714|P1|COMPLETED|Overall Study||11
8073141|NCT04106817|19905712|P3|STARTED|Overall Study||12
8073142|NCT04106817|19905713|P2|STARTED|Overall Study||11
8073143|NCT04106817|19905714|P1|STARTED|Overall Study||12
8073144|NCT04098809|19905730|P2|NOT COMPLETED|Overall Study||4
8073145|NCT04098809|19905731|P1|NOT COMPLETED|Overall Study||3
8073146|NCT04098809|19905730|P2|COMPLETED|Overall Study||21
8073147|NCT04098809|19905731|P1|COMPLETED|Overall Study||24
8073148|NCT04098809|19905730|P2|STARTED|Overall Study||25
8073149|NCT04098809|19905731|P1|STARTED|Overall Study||27
8073150|NCT04095286|19905757|P6|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073151|NCT04095286|19905758|P5|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073152|NCT04095286|19905759|P4|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073153|NCT04095286|19905760|P3|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073154|NCT04095286|19905761|P2|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073155|NCT04095286|19905762|P1|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073156|NCT04095286|19905757|P6|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
8073157|NCT04095286|19905758|P5|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
8073158|NCT04095286|19905759|P4|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
8073159|NCT04095286|19905760|P3|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
8073160|NCT04095286|19905761|P2|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
8073161|NCT04095286|19905762|P1|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
8073162|NCT04095286|19905757|P6|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
8073163|NCT04095286|19905758|P5|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
8073164|NCT04095286|19905759|P4|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
8073165|NCT04095286|19905760|P3|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
8073166|NCT04095286|19905761|P2|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
8073167|NCT04095286|19905762|P1|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
8073168|NCT04095286|19905757|P6|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073169|NCT04095286|19905758|P5|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
8073170|NCT04095286|19905759|P4|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073171|NCT04095286|19905760|P3|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
8073172|NCT04095286|19905761|P2|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073173|NCT04095286|19905762|P1|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073174|NCT04095286|19905757|P6|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
8073175|NCT04095286|19905758|P5|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
8073176|NCT04095286|19905759|P4|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
8073177|NCT04095286|19905760|P3|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
8073178|NCT04095286|19905761|P2|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
8073179|NCT04095286|19905762|P1|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
8073180|NCT04095286|19905757|P6|STARTED|Period 2 (4 Days) + Washout (7days)||5
8073181|NCT04095286|19905758|P5|STARTED|Period 2 (4 Days) + Washout (7days)||5
8073182|NCT04095286|19905759|P4|STARTED|Period 2 (4 Days) + Washout (7days)||5
8073183|NCT04095286|19905760|P3|STARTED|Period 2 (4 Days) + Washout (7days)||4
8073184|NCT04095286|19905761|P2|STARTED|Period 2 (4 Days) + Washout (7days)||4
8073185|NCT04095286|19905762|P1|STARTED|Period 2 (4 Days) + Washout (7days)||3
8073186|NCT04095286|19905757|P6|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
8073187|NCT04095286|19905758|P5|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
8073188|NCT04095286|19905759|P4|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
8073189|NCT04095286|19905760|P3|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
8073190|NCT04095286|19905761|P2|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
8073191|NCT04095286|19905762|P1|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
8073192|NCT04095286|19905757|P6|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
8073193|NCT04095286|19905758|P5|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
8073194|NCT04095286|19905759|P4|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
8073195|NCT04095286|19905760|P3|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
8073196|NCT04095286|19905761|P2|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
8073197|NCT04095286|19905762|P1|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
8073198|NCT04095286|19905757|P6|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073199|NCT04095286|19905758|P5|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073200|NCT04095286|19905759|P4|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073201|NCT04095286|19905760|P3|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073202|NCT04095286|19905761|P2|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073203|NCT04095286|19905762|P1|STARTED|Period 1 (4 Days) + Washout (7days)||4
8073204|NCT04091659|19905805|P2|NOT COMPLETED|Overall Study||1
8073205|NCT04091659|19905806|P1|NOT COMPLETED|Overall Study||3
8073206|NCT04091659|19905805|P2|COMPLETED|Overall Study||57
8073207|NCT04091659|19905806|P1|COMPLETED|Overall Study||37
8073208|NCT04091659|19905805|P2|STARTED|Overall Study||58
8073209|NCT04091659|19905806|P1|STARTED|Overall Study||40
8073210|NCT04090164|19905816|P2|NOT COMPLETED|Overall Study||0
8073211|NCT04090164|19905817|P1|NOT COMPLETED|Overall Study||245
8073212|NCT04090164|19905816|P2|COMPLETED|Overall Study||145
8073213|NCT04090164|19905817|P1|COMPLETED|Overall Study|Number of patients analyzed.|405
8073214|NCT04090164|19905816|P2|STARTED|Overall Study||145
8073215|NCT04090164|19905817|P1|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
8073216|NCT04086641|19905826|P2|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
8073217|NCT04086641|19905827|P1|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
8073218|NCT04086641|19905826|P2|COMPLETED|Foot 2 (Two Week Utilization)||1
8073219|NCT04086641|19905827|P1|COMPLETED|Foot 2 (Two Week Utilization)||1
8073220|NCT04086641|19905826|P2|STARTED|Foot 2 (Two Week Utilization)||1
8073221|NCT04086641|19905827|P1|STARTED|Foot 2 (Two Week Utilization)||1
8073222|NCT04086641|19905826|P2|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
8073223|NCT04086641|19905827|P1|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
8073224|NCT04086641|19905826|P2|COMPLETED|Foot 1 (Two Week Utilization)||1
8073225|NCT04086641|19905827|P1|COMPLETED|Foot 1 (Two Week Utilization)||1
8073226|NCT04086641|19905826|P2|STARTED|Foot 1 (Two Week Utilization)||3
8073227|NCT04086641|19905827|P1|STARTED|Foot 1 (Two Week Utilization)||2
8073228|NCT04086576|19905849|P2|NOT COMPLETED|Overall Study||0
8073229|NCT04086576|19905850|P1|NOT COMPLETED|Overall Study||0
8073230|NCT04086576|19905849|P2|COMPLETED|Overall Study||10
8073231|NCT04086576|19905850|P1|COMPLETED|Overall Study||10
8073232|NCT04086576|19905849|P2|STARTED|Overall Study||10
8073233|NCT04086576|19905850|P1|STARTED|Overall Study||10
8073234|NCT04086433|19905871|P2|NOT COMPLETED|Overall Study||0
8073235|NCT04086433|19905872|P1|NOT COMPLETED|Overall Study||0
8073236|NCT04086433|19905871|P2|COMPLETED|Overall Study||18
8073237|NCT04086433|19905872|P1|COMPLETED|Overall Study||17
8073238|NCT04086433|19905871|P2|STARTED|Overall Study||18
8073239|NCT04086433|19905872|P1|STARTED|Overall Study||17
8073240|NCT04086407|19905878|P1|NOT COMPLETED|Overall Study||0
8073241|NCT04086407|19905878|P1|COMPLETED|Overall Study||8
8073242|NCT04086407|19905878|P1|STARTED|Overall Study||8
8073243|NCT04083404|19905885|P1|NOT COMPLETED|Overall Study||0
8073244|NCT04083404|19905885|P1|COMPLETED|Overall Study||202
8073245|NCT04083404|19905885|P1|STARTED|Overall Study||202
8073246|NCT04082819|19905893|P3|NOT COMPLETED|Overall Study||0
8073247|NCT04082819|19905894|P2|NOT COMPLETED|Overall Study||0
8073248|NCT04082819|19905895|P1|NOT COMPLETED|Overall Study||0
8073249|NCT04082819|19905893|P3|COMPLETED|Overall Study||3
8073250|NCT04082819|19905894|P2|COMPLETED|Overall Study||54
8073251|NCT04082819|19905895|P1|COMPLETED|Overall Study||37
8073252|NCT04082819|19905893|P3|STARTED|Overall Study||3
8073253|NCT04082819|19905894|P2|STARTED|Overall Study||54
8073254|NCT04082819|19905895|P1|STARTED|Overall Study||37
8073255|NCT04081961|19905909|P3|NOT COMPLETED|Overall Study||0
8073256|NCT04081961|19905910|P2|NOT COMPLETED|Overall Study||0
8073257|NCT04081961|19905911|P1|NOT COMPLETED|Overall Study||0
8073258|NCT04081961|19905909|P3|COMPLETED|Overall Study||9
8073259|NCT04081961|19905910|P2|COMPLETED|Overall Study||9
8073260|NCT04081961|19905911|P1|COMPLETED|Overall Study||9
8073261|NCT04081961|19905909|P3|STARTED|Overall Study||9
8073262|NCT04081961|19905910|P2|STARTED|Overall Study||9
8073263|NCT04081961|19905911|P1|STARTED|Overall Study||9
8073264|NCT04080882|19905927|P2|NOT COMPLETED|Overall Study||2
8073265|NCT04080882|19905928|P1|NOT COMPLETED|Overall Study||2
8073266|NCT04080882|19905927|P2|COMPLETED|Overall Study||58
8073267|NCT04080882|19905928|P1|COMPLETED|Overall Study||18
8073268|NCT04080882|19905927|P2|STARTED|Overall Study||60
8073269|NCT04080882|19905928|P1|STARTED|Overall Study||20
8073270|NCT04080297|19905936|P2|NOT COMPLETED|Overall Study||3
8073271|NCT04080297|19905937|P1|NOT COMPLETED|Overall Study||2
8073272|NCT04080297|19905936|P2|COMPLETED|Overall Study||8
8073273|NCT04080297|19905937|P1|COMPLETED|Overall Study||8
8073274|NCT04080297|19905936|P2|STARTED|Overall Study||11
8073275|NCT04080297|19905937|P1|STARTED|Overall Study||10
8073276|NCT04079790|19905959|P4|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073277|NCT04079790|19905960|P3|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073278|NCT04079790|19905961|P2|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073279|NCT04079790|19905962|P1|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073280|NCT04079790|19905959|P4|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
8073281|NCT04079790|19905960|P3|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
8073282|NCT04079790|19905961|P2|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073283|NCT04079790|19905962|P1|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073284|NCT04079790|19905959|P4|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
8073285|NCT04079790|19905960|P3|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
8073286|NCT04079790|19905961|P2|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
8073287|NCT04079790|19905962|P1|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
8073288|NCT04079790|19905959|P4|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073289|NCT04079790|19905960|P3|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
8073290|NCT04079790|19905961|P2|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073291|NCT04079790|19905962|P1|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073292|NCT04079790|19905959|P4|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
8073293|NCT04079790|19905960|P3|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
8073294|NCT04079790|19905961|P2|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073295|NCT04079790|19905962|P1|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073296|NCT04079790|19905959|P4|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
8073297|NCT04079790|19905960|P3|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
8073298|NCT04079790|19905961|P2|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
8073299|NCT04079790|19905962|P1|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
8073300|NCT04079790|19905959|P4|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073301|NCT04079790|19905960|P3|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073302|NCT04079790|19905961|P2|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073303|NCT04079790|19905962|P1|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073304|NCT04079790|19905959|P4|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073305|NCT04079790|19905960|P3|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073306|NCT04079790|19905961|P2|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
8073307|NCT04079790|19905962|P1|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
8073308|NCT04079790|19905959|P4|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
8073309|NCT04079790|19905960|P3|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
8073310|NCT04079790|19905961|P2|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
8073311|NCT04079790|19905962|P1|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
8073312|NCT04079790|19905959|P4|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073313|NCT04079790|19905960|P3|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073314|NCT04079790|19905961|P2|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073315|NCT04079790|19905962|P1|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073316|NCT04079790|19905959|P4|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073317|NCT04079790|19905960|P3|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073318|NCT04079790|19905961|P2|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
8073319|NCT04079790|19905962|P1|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
8073320|NCT04079790|19905959|P4|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
8073321|NCT04079790|19905960|P3|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
8073322|NCT04079790|19905961|P2|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
8073323|NCT04079790|19905962|P1|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
8073324|NCT04079790|19905959|P4|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073325|NCT04079790|19905960|P3|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073326|NCT04079790|19905961|P2|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073327|NCT04079790|19905962|P1|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
8073328|NCT04079790|19905959|P4|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073329|NCT04079790|19905960|P3|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073330|NCT04079790|19905961|P2|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
8073331|NCT04079790|19905962|P1|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
8073332|NCT04079790|19905959|P4|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
8073333|NCT04079790|19905960|P3|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
8073334|NCT04079790|19905961|P2|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
8073335|NCT04079790|19905962|P1|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
8073336|NCT04079127|19906100|P1|NOT COMPLETED|Overall Study||61
8073337|NCT04079127|19906100|P1|COMPLETED|Overall Study|89 cases have completed the study, and all 10 year data of 81 were available for analysis.|89
8073338|NCT04079127|19906100|P1|STARTED|Overall Study||150
8073339|NCT04079114|19906106|P1|NOT COMPLETED|Overall Study||166
8073340|NCT04079114|19906106|P1|COMPLETED|Overall Study|Study prematurely terminated.|0
8073341|NCT04079114|19906106|P1|STARTED|Overall Study||166
8073351|NCT04072432|19906144|P3|NOT COMPLETED|Overall Study||0
8073352|NCT04072432|19906145|P2|NOT COMPLETED|Overall Study||0
8073353|NCT04072432|19906146|P1|NOT COMPLETED|Overall Study||0
8073354|NCT04072432|19906144|P3|COMPLETED|Overall Study||6
8073355|NCT04072432|19906145|P2|COMPLETED|Overall Study||6
8073356|NCT04072432|19906146|P1|COMPLETED|Overall Study||6
8073357|NCT04072432|19906144|P3|STARTED|Overall Study||6
8073358|NCT04072432|19906145|P2|STARTED|Overall Study||6
8073359|NCT04072432|19906146|P1|STARTED|Overall Study||6
8073360|NCT04071392|19906156|P2|NOT COMPLETED|Overall Study||2
8073361|NCT04071392|19906157|P1|NOT COMPLETED|Overall Study||2
8073362|NCT04071392|19906156|P2|COMPLETED|Overall Study||10
8073363|NCT04071392|19906157|P1|COMPLETED|Overall Study||10
8073364|NCT04071392|19906156|P2|STARTED|Overall Study||12
8073365|NCT04071392|19906157|P1|STARTED|Overall Study||12
8073366|NCT04069715|19906167|P2|NOT COMPLETED|Overall Study||5
8073367|NCT04069715|19906168|P1|NOT COMPLETED|Overall Study||5
8073368|NCT04069715|19906167|P2|COMPLETED|Overall Study||43
8073369|NCT04069715|19906168|P1|COMPLETED|Overall Study||42
8073370|NCT04069715|19906167|P2|STARTED|Overall Study||48
8073371|NCT04069715|19906168|P1|STARTED|Overall Study||47
8073372|NCT04069221|19906198|P4|NOT COMPLETED|Overall Study||0
8073373|NCT04069221|19906199|P3|NOT COMPLETED|Overall Study||0
8073374|NCT04069221|19906200|P2|NOT COMPLETED|Overall Study||0
8073375|NCT04069221|19906201|P1|NOT COMPLETED|Overall Study||0
8073376|NCT04069221|19906198|P4|COMPLETED|Overall Study||6
8073377|NCT04069221|19906199|P3|COMPLETED|Overall Study||6
8073378|NCT04069221|19906200|P2|COMPLETED|Overall Study||6
8073379|NCT04069221|19906201|P1|COMPLETED|Overall Study||8
8073380|NCT04069221|19906198|P4|STARTED|Overall Study||6
8073381|NCT04069221|19906199|P3|STARTED|Overall Study||6
8073382|NCT04069221|19906200|P2|STARTED|Overall Study||6
8073383|NCT04069221|19906201|P1|STARTED|Overall Study||8
8073384|NCT04067401|19906222|P2|NOT COMPLETED|Overall Study||0
8073385|NCT04067401|19906223|P1|NOT COMPLETED|Overall Study||8
8073386|NCT04067401|19906222|P2|COMPLETED|Overall Study||737
8073387|NCT04067401|19906223|P1|COMPLETED|Overall Study||740
8073388|NCT04067401|19906222|P2|6 Month Survey Completion|Overall Study||618
8073389|NCT04067401|19906223|P1|6 Month Survey Completion|Overall Study||629
8073390|NCT04067401|19906222|P2|1 Month Survey Completion|Overall Study||694
8073391|NCT04067401|19906223|P1|1 Month Survey Completion|Overall Study||697
8073392|NCT04067401|19906222|P2|Baseline Survey Completion|Overall Study||735
8073393|NCT04067401|19906223|P1|Baseline Survey Completion|Overall Study||746
8073394|NCT04067401|19906222|P2|STARTED|Overall Study||737
8073395|NCT04067401|19906223|P1|STARTED|Overall Study||748
8073396|NCT04067141|19906243|P2|NOT COMPLETED|Second Intervention||2
8073397|NCT04067141|19906244|P1|NOT COMPLETED|Second Intervention||0
8073398|NCT04067141|19906243|P2|COMPLETED|Second Intervention||31
8073399|NCT04067141|19906244|P1|COMPLETED|Second Intervention||34
8073400|NCT04067141|19906243|P2|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
8073401|NCT04067141|19906244|P1|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
8073402|NCT04067141|19906243|P2|NOT COMPLETED|First Intervention||1
8073403|NCT04067141|19906244|P1|NOT COMPLETED|First Intervention||0
8073404|NCT04067141|19906243|P2|COMPLETED|First Intervention||34
8073405|NCT04067141|19906244|P1|COMPLETED|First Intervention||35
8073406|NCT04067141|19906243|P2|STARTED|First Intervention||35
8073407|NCT04067141|19906244|P1|STARTED|First Intervention||35
8073408|NCT04066647|19906290|P1|NOT COMPLETED|Overall Study||0
8073409|NCT04066647|19906290|P1|COMPLETED|Overall Study||7
8073410|NCT04066647|19906290|P1|STARTED|Overall Study||7
8073411|NCT04065074|19906294|P1|NOT COMPLETED|Overall Study||2
8073412|NCT04065074|19906294|P1|COMPLETED|Overall Study||14
8073413|NCT04065074|19906294|P1|STARTED|Overall Study||16
8073414|NCT04061694|19906300|P2|NOT COMPLETED|Overall Study||0
8073415|NCT04061694|19906301|P1|NOT COMPLETED|Overall Study||2
8073416|NCT04061694|19906300|P2|COMPLETED|Overall Study||25
8073417|NCT04061694|19906301|P1|COMPLETED|Overall Study||19
8073418|NCT04061694|19906300|P2|STARTED|Overall Study||25
8073419|NCT04061694|19906301|P1|STARTED|Overall Study||21
8073423|NCT04057235|19906319|P1|NOT COMPLETED|Overall Study||0
8073424|NCT04057235|19906319|P1|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
8073425|NCT04057235|19906319|P1|Had VAS Leg Data|Overall Study||45
8073426|NCT04057235|19906319|P1|Had VAS Back Data|Overall Study||45
8073427|NCT04057235|19906319|P1|Had ODI Data|Overall Study||43
8073428|NCT04057235|19906319|P1|Had Radiographic Data|Overall Study||58
8073429|NCT04057235|19906319|P1|STARTED|Overall Study||129
8073430|NCT04055675|19906328|P2|NOT COMPLETED|Overall Study||0
8073431|NCT04055675|19906329|P1|NOT COMPLETED|Overall Study||0
8073432|NCT04055675|19906328|P2|COMPLETED|Overall Study||104
8073433|NCT04055675|19906329|P1|COMPLETED|Overall Study||96
8073434|NCT04055675|19906328|P2|STARTED|Overall Study||104
8073435|NCT04055675|19906329|P1|STARTED|Overall Study||96
8073436|NCT04054011|19906335|P1|NOT COMPLETED|Overall Study||3
8073437|NCT04054011|19906335|P1|COMPLETED|Overall Study||12
8073438|NCT04054011|19906335|P1|STARTED|Overall Study||15
8073439|NCT04053465|19906345|P2|NOT COMPLETED|Overall Study||4
8073440|NCT04053465|19906346|P1|NOT COMPLETED|Overall Study||4
8073441|NCT04053465|19906345|P2|COMPLETED|Overall Study||8
8073442|NCT04053465|19906346|P1|COMPLETED|Overall Study||18
8073443|NCT04053465|19906345|P2|STARTED|Overall Study||12
8073444|NCT04053465|19906346|P1|STARTED|Overall Study||22
8073445|NCT04053270|19906356|P2|NOT COMPLETED|Overall Study||5
8073446|NCT04053270|19906357|P1|NOT COMPLETED|Overall Study||2
8073447|NCT04053270|19906356|P2|COMPLETED|Overall Study||46
8073448|NCT04053270|19906357|P1|COMPLETED|Overall Study||47
8073449|NCT04053270|19906356|P2|STARTED|Overall Study||51
8073450|NCT04053270|19906357|P1|STARTED|Overall Study||49
8073451|NCT04053023|19906375|P2|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073452|NCT04053023|19906376|P1|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073453|NCT04053023|19906375|P2|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073454|NCT04053023|19906376|P1|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073455|NCT04053023|19906375|P2|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
8073456|NCT04053023|19906376|P1|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
8073457|NCT04053023|19906375|P2|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073458|NCT04053023|19906376|P1|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073459|NCT04053023|19906375|P2|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073460|NCT04053023|19906376|P1|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073461|NCT04053023|19906375|P2|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
8073462|NCT04053023|19906376|P1|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
8073463|NCT04053023|19906375|P2|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
8073464|NCT04053023|19906376|P1|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
8073465|NCT04053023|19906375|P2|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
8073466|NCT04053023|19906376|P1|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
8073467|NCT04053023|19906375|P2|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
8073468|NCT04053023|19906376|P1|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
8073469|NCT04053023|19906375|P2|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
8073470|NCT04053023|19906376|P1|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
8073471|NCT04053023|19906375|P2|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
8073472|NCT04053023|19906376|P1|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
8073473|NCT04053023|19906375|P2|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
8073474|NCT04053023|19906376|P1|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
8073475|NCT04051710|19906541|P3|NOT COMPLETED|Overall Study||4
8073476|NCT04051710|19906542|P2|NOT COMPLETED|Overall Study||8
8073477|NCT04051710|19906543|P1|NOT COMPLETED|Overall Study||4
8073478|NCT04051710|19906541|P3|COMPLETED|Overall Study||306
8073479|NCT04051710|19906542|P2|COMPLETED|Overall Study||612
8073480|NCT04051710|19906543|P1|COMPLETED|Overall Study||616
8073481|NCT04051710|19906541|P3|STARTED|Overall Study||310
8073482|NCT04051710|19906542|P2|STARTED|Overall Study||620
8073483|NCT04051710|19906543|P1|STARTED|Overall Study||620
8073484|NCT04051684|19906553|P2|NOT COMPLETED|Overall Study||0
8073485|NCT04051684|19906554|P1|NOT COMPLETED|Overall Study||0
8073486|NCT04051684|19906553|P2|COMPLETED|Overall Study||11
8073487|NCT04051684|19906554|P1|COMPLETED|Overall Study||12
8073488|NCT04051684|19906553|P2|STARTED|Overall Study||11
8073489|NCT04051684|19906554|P1|STARTED|Overall Study||12
8073490|NCT04050722|19906568|P2|NOT COMPLETED|Overall Study||0
8073491|NCT04050722|19906569|P1|NOT COMPLETED|Overall Study||1
8073492|NCT04050722|19906568|P2|COMPLETED|Overall Study||65
8073493|NCT04050722|19906569|P1|COMPLETED|Overall Study||64
8073494|NCT04050722|19906568|P2|STARTED|Overall Study||65
8073495|NCT04050722|19906569|P1|STARTED|Overall Study||65
8073496|NCT04050618|19906587|P2|NOT COMPLETED|Second Intervention||0
8073497|NCT04050618|19906588|P1|NOT COMPLETED|Second Intervention||1
8073498|NCT04050618|19906587|P2|COMPLETED|Second Intervention||56
8073499|NCT04050618|19906588|P1|COMPLETED|Second Intervention||55
8073500|NCT04050618|19906587|P2|STARTED|Second Intervention||56
8073501|NCT04050618|19906588|P1|STARTED|Second Intervention||56
8073502|NCT04050618|19906587|P2|NOT COMPLETED|First Intervention||0
8073503|NCT04050618|19906588|P1|NOT COMPLETED|First Intervention||2
8073504|NCT04050618|19906587|P2|COMPLETED|First Intervention||56
8073505|NCT04050618|19906588|P1|COMPLETED|First Intervention||56
8073506|NCT04050618|19906587|P2|STARTED|First Intervention||56
8073507|NCT04050618|19906588|P1|STARTED|First Intervention||58
8073508|NCT04050605|19906726|P1|NOT COMPLETED|Overall Study||0
8073509|NCT04050605|19906726|P1|COMPLETED|Overall Study||40
8073510|NCT04050605|19906726|P1|STARTED|Overall Study||40
8073511|NCT04049578|19906756|P1|NOT COMPLETED|Overall Study||1
8073512|NCT04049578|19906756|P1|COMPLETED|Overall Study||1
8073513|NCT04049578|19906756|P1|STARTED|Overall Study||2
8073514|NCT04049552|19906766|P1|NOT COMPLETED|Overall Study||1
8073515|NCT04049552|19906766|P1|COMPLETED|Overall Study||3
8073516|NCT04049552|19906766|P1|STARTED|Overall Study||4
8073517|NCT04048681|19906774|P5|NOT COMPLETED|Overall Study||0
8073518|NCT04048681|19906775|P4|NOT COMPLETED|Overall Study||1
8073519|NCT04048681|19906776|P3|NOT COMPLETED|Overall Study||0
8073520|NCT04048681|19906777|P2|NOT COMPLETED|Overall Study||0
8073521|NCT04048681|19906778|P1|NOT COMPLETED|Overall Study||0
8073522|NCT04048681|19906774|P5|COMPLETED|Overall Study||1
8073523|NCT04048681|19906775|P4|COMPLETED|Overall Study||0
8073524|NCT04048681|19906776|P3|COMPLETED|Overall Study||1
8073525|NCT04048681|19906777|P2|COMPLETED|Overall Study||1
8073526|NCT04048681|19906778|P1|COMPLETED|Overall Study||1
8073527|NCT04048681|19906774|P5|STARTED|Overall Study||1
8073528|NCT04048681|19906775|P4|STARTED|Overall Study||1
8073529|NCT04048681|19906776|P3|STARTED|Overall Study||1
8073530|NCT04048681|19906777|P2|STARTED|Overall Study||1
8073531|NCT04048681|19906778|P1|STARTED|Overall Study||1
8073532|NCT04047342|19906791|P2|NOT COMPLETED|Overall Study||0
8073533|NCT04047342|19906792|P1|NOT COMPLETED|Overall Study||0
8073534|NCT04047342|19906791|P2|COMPLETED|Overall Study||415
8073535|NCT04047342|19906792|P1|COMPLETED|Overall Study||409
8073536|NCT04047342|19906791|P2|STARTED|Overall Study||415
8073537|NCT04047342|19906792|P1|STARTED|Overall Study||409
8073538|NCT04047121|19906806|P6|NOT COMPLETED|Overall Study||0
8073539|NCT04047121|19906807|P5|NOT COMPLETED|Overall Study||0
8073540|NCT04047121|19906808|P4|NOT COMPLETED|Overall Study||0
8073541|NCT04047121|19906809|P3|NOT COMPLETED|Overall Study||0
8073542|NCT04047121|19906810|P2|NOT COMPLETED|Overall Study||0
8073543|NCT04047121|19906811|P1|NOT COMPLETED|Overall Study||0
8073544|NCT04047121|19906806|P6|COMPLETED|Overall Study||262
8073545|NCT04047121|19906807|P5|COMPLETED|Overall Study||112
8073546|NCT04047121|19906808|P4|COMPLETED|Overall Study||287
8073547|NCT04047121|19906809|P3|COMPLETED|Overall Study||79
8073548|NCT04047121|19906810|P2|COMPLETED|Overall Study||299
8073549|NCT04047121|19906811|P1|COMPLETED|Overall Study||310
8073550|NCT04047121|19906806|P6|STARTED|Overall Study||262
8073551|NCT04047121|19906807|P5|STARTED|Overall Study||112
8073552|NCT04047121|19906808|P4|STARTED|Overall Study||287
8073553|NCT04047121|19906809|P3|STARTED|Overall Study||79
8073554|NCT04047121|19906810|P2|STARTED|Overall Study||299
8073555|NCT04047121|19906811|P1|STARTED|Overall Study||310
8073556|NCT04045964|19907073|P2|NOT COMPLETED|Overall Study||1
8073557|NCT04045964|19907074|P1|NOT COMPLETED|Overall Study||1
8073558|NCT04045964|19907073|P2|COMPLETED|Overall Study||15
8073559|NCT04045964|19907074|P1|COMPLETED|Overall Study||15
8073560|NCT04045964|19907073|P2|Follow up Visit 2|Overall Study||15
8073561|NCT04045964|19907074|P1|Follow up Visit 2|Overall Study||15
8073562|NCT04045964|19907073|P2|Follow up Visit 1|Overall Study||15
8073563|NCT04045964|19907074|P1|Follow up Visit 1|Overall Study||15
8073564|NCT04045964|19907073|P2|Intervention Visit(s)|Overall Study||16
8073565|NCT04045964|19907074|P1|Intervention Visit(s)|Overall Study||15
8073566|NCT04045964|19907073|P2|STARTED|Overall Study||16
8073567|NCT04045964|19907074|P1|STARTED|Overall Study||16
8073568|NCT04043416|19907105|P2|NOT COMPLETED|Campaign 2||0
8073569|NCT04043416|19907106|P1|NOT COMPLETED|Campaign 2||0
8073570|NCT04043416|19907105|P2|COMPLETED|Campaign 2||13
8073571|NCT04043416|19907106|P1|COMPLETED|Campaign 2||14
8073572|NCT04043416|19907105|P2|STARTED|Campaign 2||13
8073573|NCT04043416|19907106|P1|STARTED|Campaign 2||14
8073574|NCT04043416|19907105|P2|NOT COMPLETED|Washout||1
8073575|NCT04043416|19907106|P1|NOT COMPLETED|Washout||0
8073576|NCT04043416|19907105|P2|COMPLETED|Washout||13
8073577|NCT04043416|19907106|P1|COMPLETED|Washout||14
8073578|NCT04043416|19907105|P2|STARTED|Washout||14
8073579|NCT04043416|19907106|P1|STARTED|Washout||14
8073580|NCT04043416|19907105|P2|NOT COMPLETED|Campaign 1||0
8073581|NCT04043416|19907106|P1|NOT COMPLETED|Campaign 1||0
8073582|NCT04043416|19907105|P2|COMPLETED|Campaign 1||14
8073583|NCT04043416|19907106|P1|COMPLETED|Campaign 1||14
8073584|NCT04043416|19907105|P2|STARTED|Campaign 1||14
8073585|NCT04043416|19907106|P1|STARTED|Campaign 1||14
8073586|NCT04042324|19907140|P3|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073587|NCT04042324|19907141|P2|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073588|NCT04042324|19907142|P1|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073589|NCT04042324|19907140|P3|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
8073590|NCT04042324|19907141|P2|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073591|NCT04042324|19907142|P1|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073592|NCT04042324|19907140|P3|STARTED|Triferic Pre-dialyzer (Day 5)||12
8073593|NCT04042324|19907141|P2|STARTED|Triferic Pre-dialyzer (Day 5)||0
8073594|NCT04042324|19907142|P1|STARTED|Triferic Pre-dialyzer (Day 5)||0
8073595|NCT04042324|19907140|P3|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073596|NCT04042324|19907141|P2|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073597|NCT04042324|19907142|P1|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073598|NCT04042324|19907140|P3|COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073599|NCT04042324|19907141|P2|COMPLETED|Triferic Post-dialyzer (Day 3)||12
8073600|NCT04042324|19907142|P1|COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073601|NCT04042324|19907140|P3|STARTED|Triferic Post-dialyzer (Day 3)||0
8073602|NCT04042324|19907141|P2|STARTED|Triferic Post-dialyzer (Day 3)||12
8073603|NCT04042324|19907142|P1|STARTED|Triferic Post-dialyzer (Day 3)||0
8073604|NCT04042324|19907140|P3|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073605|NCT04042324|19907141|P2|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073606|NCT04042324|19907142|P1|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073607|NCT04042324|19907140|P3|COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073608|NCT04042324|19907141|P2|COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073609|NCT04042324|19907142|P1|COMPLETED|UFH and Triferic Admixture (Day 1)||12
8073610|NCT04042324|19907140|P3|STARTED|UFH and Triferic Admixture (Day 1)||0
8073611|NCT04042324|19907141|P2|STARTED|UFH and Triferic Admixture (Day 1)||0
8073612|NCT04042324|19907142|P1|STARTED|UFH and Triferic Admixture (Day 1)||12
8073613|NCT04041453|19907166|P4|NOT COMPLETED|Overall Study||18
8073614|NCT04041453|19907167|P3|NOT COMPLETED|Overall Study||5
8073615|NCT04041453|19907168|P2|NOT COMPLETED|Overall Study||22
8073616|NCT04041453|19907169|P1|NOT COMPLETED|Overall Study||14
8073617|NCT04041453|19907166|P4|COMPLETED|Overall Study||40
8073618|NCT04041453|19907167|P3|COMPLETED|Overall Study||18
8073619|NCT04041453|19907168|P2|COMPLETED|Overall Study||35
8073620|NCT04041453|19907169|P1|COMPLETED|Overall Study||24
8073621|NCT04041453|19907166|P4|Safety Population|Overall Study||58
8073622|NCT04041453|19907167|P3|Safety Population|Overall Study||23
8073623|NCT04041453|19907168|P2|Safety Population|Overall Study||56
8073624|NCT04041453|19907169|P1|Safety Population|Overall Study||38
8073625|NCT04041453|19907166|P4|STARTED|Overall Study||58
8073626|NCT04041453|19907167|P3|STARTED|Overall Study||23
8073627|NCT04041453|19907168|P2|STARTED|Overall Study||57
8073628|NCT04041453|19907169|P1|STARTED|Overall Study||38
8073629|NCT04041219|19907183|P1|NOT COMPLETED|Overall Study||0
8073630|NCT04041219|19907183|P1|COMPLETED|Overall Study||10
8073631|NCT04041219|19907183|P1|STARTED|Overall Study||10
8073632|NCT04041037|19907188|P1|NOT COMPLETED|Overall Study||0
8073633|NCT04041037|19907188|P1|COMPLETED|Overall Study||2
8073634|NCT04041037|19907188|P1|STARTED|Overall Study||2
8073635|NCT04039867|19907195|P1|NOT COMPLETED|Overall Study||0
8073636|NCT04039867|19907195|P1|COMPLETED|Overall Study||17
8073637|NCT04039867|19907195|P1|STARTED|Overall Study||17
8073638|NCT04039412|19907204|P3|NOT COMPLETED|Overall Study||2
8073639|NCT04039412|19907205|P2|NOT COMPLETED|Overall Study||3
8073640|NCT04039412|19907206|P1|NOT COMPLETED|Overall Study||1
8073641|NCT04039412|19907204|P3|COMPLETED|Overall Study||108
8073642|NCT04039412|19907205|P2|COMPLETED|Overall Study||107
8073643|NCT04039412|19907206|P1|COMPLETED|Overall Study||109
8073644|NCT04039412|19907204|P3|STARTED|Overall Study||110
8073645|NCT04039412|19907205|P2|STARTED|Overall Study||110
8073646|NCT04039412|19907206|P1|STARTED|Overall Study||110
8073647|NCT04037748|19907222|P2|NOT COMPLETED|Treatment Period 2||1
8073648|NCT04037748|19907223|P1|NOT COMPLETED|Treatment Period 2||2
8073649|NCT04037748|19907222|P2|COMPLETED|Treatment Period 2||29
8073650|NCT04037748|19907223|P1|COMPLETED|Treatment Period 2||26
8073651|NCT04037748|19907222|P2|STARTED|Treatment Period 2||30
8073652|NCT04037748|19907223|P1|STARTED|Treatment Period 2||28
8073653|NCT04037748|19907222|P2|NOT COMPLETED|Treatment Period 1||6
8073654|NCT04037748|19907223|P1|NOT COMPLETED|Treatment Period 1||8
8073655|NCT04037748|19907222|P2|COMPLETED|Treatment Period 1||30
8073656|NCT04037748|19907223|P1|COMPLETED|Treatment Period 1||28
8073657|NCT04037748|19907222|P2|STARTED|Treatment Period 1||36
8073658|NCT04037748|19907223|P1|STARTED|Treatment Period 1||36
8073659|NCT04036838|19907237|P1|NOT COMPLETED|Overall Study||91
8073660|NCT04036838|19907237|P1|COMPLETED|Overall Study||324
8073661|NCT04036838|19907237|P1|STARTED|Overall Study||415
8073662|NCT04036110|19907244|P3|NOT COMPLETED|Overall Study||2
8073663|NCT04036110|19907245|P2|NOT COMPLETED|Overall Study||7
8073664|NCT04036110|19907246|P1|NOT COMPLETED|Overall Study||7
8073665|NCT04036110|19907244|P3|COMPLETED|Overall Study||10
8073666|NCT04036110|19907245|P2|COMPLETED|Overall Study||5
8073667|NCT04036110|19907246|P1|COMPLETED|Overall Study||5
8073668|NCT04036110|19907244|P3|STARTED|Overall Study||12
8073669|NCT04036110|19907245|P2|STARTED|Overall Study||12
8073670|NCT04036110|19907246|P1|STARTED|Overall Study||12
8073671|NCT04035577|19907269|P1|NOT COMPLETED|Overall Study||2
8073672|NCT04035577|19907269|P1|COMPLETED|Overall Study||19
8073673|NCT04035577|19907269|P1|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
8073674|NCT04035564|19907289|P2|NOT COMPLETED|Overall Study||6
8073675|NCT04035564|19907290|P1|NOT COMPLETED|Overall Study||4
8073676|NCT04035564|19907289|P2|COMPLETED|Overall Study||19
8073677|NCT04035564|19907290|P1|COMPLETED|Overall Study||23
8073678|NCT04035564|19907289|P2|STARTED|Overall Study||25
8073679|NCT04035564|19907290|P1|STARTED|Overall Study||27
8073680|NCT04034043|19907312|P1|NOT COMPLETED|Overall Study||0
8073681|NCT04034043|19907312|P1|COMPLETED|Overall Study||68
8073682|NCT04034043|19907312|P1|STARTED|Overall Study||68
8073683|NCT04032652|19907321|P2|NOT COMPLETED|Overall Study||1
8073684|NCT04032652|19907322|P1|NOT COMPLETED|Overall Study||1
8073685|NCT04032652|19907321|P2|COMPLETED|Overall Study||0
8073686|NCT04032652|19907322|P1|COMPLETED|Overall Study||0
8073687|NCT04032652|19907321|P2|STARTED|Overall Study||1
8073688|NCT04032652|19907322|P1|STARTED|Overall Study||1
8073689|NCT04027803|19907332|P2|NOT COMPLETED|Overall Study||0
8073690|NCT04027803|19907333|P1|NOT COMPLETED|Overall Study||0
8073691|NCT04027803|19907332|P2|COMPLETED|Overall Study||39
8073692|NCT04027803|19907333|P1|COMPLETED|Overall Study||39
8073693|NCT04027803|19907332|P2|STARTED|Overall Study||39
8073694|NCT04027803|19907333|P1|STARTED|Overall Study||39
8073695|NCT04027218|19907371|P6|NOT COMPLETED|Overall Study||0
8073696|NCT04027218|19907372|P5|NOT COMPLETED|Overall Study||0
8073697|NCT04027218|19907373|P4|NOT COMPLETED|Overall Study||0
8073698|NCT04027218|19907374|P3|NOT COMPLETED|Overall Study||0
8073699|NCT04027218|19907375|P2|NOT COMPLETED|Overall Study||3
8073700|NCT04027218|19907376|P1|NOT COMPLETED|Overall Study||0
8073701|NCT04027218|19907371|P6|COMPLETED|Overall Study||11
8073702|NCT04027218|19907372|P5|COMPLETED|Overall Study||10
8073703|NCT04027218|19907373|P4|COMPLETED|Overall Study||11
8073704|NCT04027218|19907374|P3|COMPLETED|Overall Study||9
8073705|NCT04027218|19907375|P2|COMPLETED|Overall Study||8
8073706|NCT04027218|19907376|P1|COMPLETED|Overall Study||10
8073707|NCT04027218|19907371|P6|STARTED|Overall Study||11
8073708|NCT04027218|19907372|P5|STARTED|Overall Study||10
8073709|NCT04027218|19907373|P4|STARTED|Overall Study||11
8073710|NCT04027218|19907374|P3|STARTED|Overall Study||9
8073711|NCT04027218|19907375|P2|STARTED|Overall Study||11
8073712|NCT04027218|19907376|P1|STARTED|Overall Study||10
8073713|NCT04024501|19907406|P1|NOT COMPLETED|Overall Study||0
8073714|NCT04024501|19907406|P1|COMPLETED|Overall Study||25
8073715|NCT04024501|19907406|P1|STARTED|Overall Study||25
8073716|NCT04024228|19907475|P2|NOT COMPLETED|Overall Study||6
8073717|NCT04024228|19907476|P1|NOT COMPLETED|Overall Study||4
8073718|NCT04024228|19907475|P2|COMPLETED|Overall Study||759
8073719|NCT04024228|19907476|P1|COMPLETED|Overall Study||770
8073810|NCT04016259|19907692|P2|NOT COMPLETED|Overall Study||0
8073720|NCT04024228|19907475|P2|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
8073721|NCT04024228|19907476|P1|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
8073722|NCT04024228|19907475|P2|Vaccinated|Overall Study||761
8073723|NCT04024228|19907476|P1|Vaccinated|Overall Study||772
8073724|NCT04024228|19907475|P2|STARTED|Overall Study||765
8073725|NCT04024228|19907476|P1|STARTED|Overall Study||774
8073726|NCT04023695|19907510|P2|NOT COMPLETED|Overall Study||0
8073727|NCT04023695|19907511|P1|NOT COMPLETED|Overall Study||0
8073728|NCT04023695|19907510|P2|COMPLETED|Overall Study||53
8073729|NCT04023695|19907511|P1|COMPLETED|Overall Study||57
8073730|NCT04023695|19907510|P2|STARTED|Overall Study||53
8073731|NCT04023695|19907511|P1|STARTED|Overall Study||57
8073732|NCT04023578|19907519|P1|NOT COMPLETED|Overall Study||2
8073733|NCT04023578|19907519|P1|COMPLETED|Overall Study||13
8073734|NCT04023578|19907519|P1|STARTED|Overall Study||15
8073735|NCT04022668|19907527|P3|NOT COMPLETED|Overall Study||0
8073736|NCT04022668|19907528|P2|NOT COMPLETED|Overall Study||27
8073737|NCT04022668|19907529|P1|NOT COMPLETED|Overall Study||14
8073738|NCT04022668|19907527|P3|COMPLETED|Overall Study||1000
8073739|NCT04022668|19907528|P2|COMPLETED|Overall Study||973
8073740|NCT04022668|19907529|P1|COMPLETED|Overall Study||986
8073741|NCT04022668|19907527|P3|STARTED|Overall Study||1000
8073742|NCT04022668|19907528|P2|STARTED|Overall Study||1000
8073743|NCT04022668|19907529|P1|STARTED|Overall Study||1000
8073744|NCT04020822|19907552|P1|NOT COMPLETED|Overall Study||0
8073745|NCT04020822|19907552|P1|COMPLETED|Overall Study||19
8073746|NCT04020822|19907552|P1|STARTED|Overall Study||19
8073747|NCT04019990|19907556|P2|NOT COMPLETED|Overall Study||3
8073748|NCT04019990|19907557|P1|NOT COMPLETED|Overall Study||1
8073749|NCT04019990|19907556|P2|COMPLETED|Overall Study||12
8073750|NCT04019990|19907557|P1|COMPLETED|Overall Study||12
8073751|NCT04019990|19907556|P2|STARTED|Overall Study||15
8073752|NCT04019990|19907557|P1|STARTED|Overall Study||13
8073753|NCT04018664|19907572|P8|NOT COMPLETED|Overall Study||0
8073754|NCT04018664|19907573|P7|NOT COMPLETED|Overall Study||0
8073755|NCT04018664|19907574|P6|NOT COMPLETED|Overall Study||0
8073756|NCT04018664|19907575|P5|NOT COMPLETED|Overall Study||0
8073757|NCT04018664|19907576|P4|NOT COMPLETED|Overall Study||0
8073758|NCT04018664|19907577|P3|NOT COMPLETED|Overall Study||0
8073759|NCT04018664|19907578|P2|NOT COMPLETED|Overall Study||0
8073760|NCT04018664|19907579|P1|NOT COMPLETED|Overall Study||0
8073761|NCT04018664|19907572|P8|COMPLETED|Overall Study||6
8073762|NCT04018664|19907573|P7|COMPLETED|Overall Study||6
8073763|NCT04018664|19907574|P6|COMPLETED|Overall Study||6
8073764|NCT04018664|19907575|P5|COMPLETED|Overall Study||6
8073765|NCT04018664|19907576|P4|COMPLETED|Overall Study||6
8073766|NCT04018664|19907577|P3|COMPLETED|Overall Study||6
8073767|NCT04018664|19907578|P2|COMPLETED|Overall Study||6
8073768|NCT04018664|19907579|P1|COMPLETED|Overall Study||14
8073769|NCT04018664|19907572|P8|STARTED|Overall Study||6
8073770|NCT04018664|19907573|P7|STARTED|Overall Study||6
8073771|NCT04018664|19907574|P6|STARTED|Overall Study||6
8073772|NCT04018664|19907575|P5|STARTED|Overall Study||6
8073773|NCT04018664|19907576|P4|STARTED|Overall Study||6
8073774|NCT04018664|19907577|P3|STARTED|Overall Study||6
8073775|NCT04018664|19907578|P2|STARTED|Overall Study||6
8073776|NCT04018664|19907579|P1|STARTED|Overall Study||14
8073777|NCT04018001|19907599|P2|NOT COMPLETED|Overall Study||0
8073778|NCT04018001|19907600|P1|NOT COMPLETED|Overall Study||0
8073779|NCT04018001|19907599|P2|COMPLETED|Overall Study||379
8073780|NCT04018001|19907600|P1|COMPLETED|Overall Study||678
8073781|NCT04018001|19907599|P2|STARTED|Overall Study||379
8073782|NCT04018001|19907600|P1|STARTED|Overall Study||678
8073783|NCT04017611|19907630|P1|NOT COMPLETED|Overall Study||1
8073784|NCT04017611|19907630|P1|COMPLETED|Overall Study||12
8073785|NCT04017611|19907630|P1|STARTED|Overall Study||13
8073786|NCT04016623|19907634|P1|NOT COMPLETED|Pair 4 Test /Control Follow up||0
8073787|NCT04016623|19907634|P1|COMPLETED|Pair 4 Test /Control Follow up||10
8073788|NCT04016623|19907634|P1|STARTED|Pair 4 Test /Control Follow up||10
8073789|NCT04016623|19907634|P1|NOT COMPLETED|Pair 4 Test / Control Dispense||0
8073790|NCT04016623|19907634|P1|COMPLETED|Pair 4 Test / Control Dispense||10
8073791|NCT04016623|19907634|P1|STARTED|Pair 4 Test / Control Dispense||10
8073792|NCT04016623|19907634|P1|NOT COMPLETED|Pair 3 Test /Control Follow up||0
8073793|NCT04016623|19907634|P1|COMPLETED|Pair 3 Test /Control Follow up||10
8073794|NCT04016623|19907634|P1|STARTED|Pair 3 Test /Control Follow up||10
8073795|NCT04016623|19907634|P1|NOT COMPLETED|Pair 3 Test / Control Dispense||0
8073796|NCT04016623|19907634|P1|COMPLETED|Pair 3 Test / Control Dispense||10
8073797|NCT04016623|19907634|P1|STARTED|Pair 3 Test / Control Dispense||10
8073798|NCT04016623|19907634|P1|NOT COMPLETED|Pair 2 Test /Control Follow up||0
8073799|NCT04016623|19907634|P1|COMPLETED|Pair 2 Test /Control Follow up||10
8073800|NCT04016623|19907634|P1|STARTED|Pair 2 Test /Control Follow up||10
8073801|NCT04016623|19907634|P1|NOT COMPLETED|Pair 2 Test / Control Dispense||0
8073802|NCT04016623|19907634|P1|COMPLETED|Pair 2 Test / Control Dispense||10
8073803|NCT04016623|19907634|P1|STARTED|Pair 2 Test / Control Dispense||10
8073804|NCT04016623|19907634|P1|NOT COMPLETED|Pair 1 Test /Control Follow up||0
8073805|NCT04016623|19907634|P1|COMPLETED|Pair 1 Test /Control Follow up||10
8073806|NCT04016623|19907634|P1|STARTED|Pair 1 Test /Control Follow up||10
8073807|NCT04016623|19907634|P1|NOT COMPLETED|Pair 1 Test / Control Dispense||0
8073808|NCT04016623|19907634|P1|COMPLETED|Pair 1 Test / Control Dispense||10
8073809|NCT04016623|19907634|P1|STARTED|Pair 1 Test / Control Dispense||10
8073811|NCT04016259|19907693|P1|NOT COMPLETED|Overall Study||0
8073812|NCT04016259|19907692|P2|COMPLETED|Overall Study||15
8073813|NCT04016259|19907693|P1|COMPLETED|Overall Study||15
8073814|NCT04016259|19907692|P2|STARTED|Overall Study||15
8073815|NCT04016259|19907693|P1|STARTED|Overall Study||15
8073816|NCT04015232|19907729|P2|NOT COMPLETED|Overall Study||7
8073817|NCT04015232|19907730|P1|NOT COMPLETED|Overall Study||11
8073818|NCT04015232|19907729|P2|COMPLETED|Overall Study||93
8073819|NCT04015232|19907730|P1|COMPLETED|Overall Study||89
8073820|NCT04015232|19907729|P2|STARTED|Overall Study||100
8073821|NCT04015232|19907730|P1|STARTED|Overall Study||100
8073822|NCT04014062|19907802|P2|NOT COMPLETED|Period II: Crossover Dosing||0
8073823|NCT04014062|19907803|P1|NOT COMPLETED|Period II: Crossover Dosing||0
8073824|NCT04014062|19907802|P2|COMPLETED|Period II: Crossover Dosing||65
8073825|NCT04014062|19907803|P1|COMPLETED|Period II: Crossover Dosing||64
8073826|NCT04014062|19907802|P2|STARTED|Period II: Crossover Dosing||65
8073827|NCT04014062|19907803|P1|STARTED|Period II: Crossover Dosing||64
8073828|NCT04014062|19907802|P2|NOT COMPLETED|Period I: Dosing||6
8073829|NCT04014062|19907803|P1|NOT COMPLETED|Period I: Dosing||7
8073830|NCT04014062|19907802|P2|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
8073831|NCT04014062|19907803|P1|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
8073832|NCT04014062|19907802|P2|STARTED|Period I: Dosing||71
8073833|NCT04014062|19907803|P1|STARTED|Period I: Dosing||71
8073834|NCT04013789|19907841|P2|NOT COMPLETED|Second Wear Period (1 Week)||0
8073835|NCT04013789|19907842|P1|NOT COMPLETED|Second Wear Period (1 Week)||0
8073836|NCT04013789|19907841|P2|COMPLETED|Second Wear Period (1 Week)||34
8073837|NCT04013789|19907842|P1|COMPLETED|Second Wear Period (1 Week)||32
8073838|NCT04013789|19907841|P2|STARTED|Second Wear Period (1 Week)||34
8073839|NCT04013789|19907842|P1|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
8073840|NCT04013789|19907841|P2|NOT COMPLETED|First Wear Period (1 Week)||0
8073841|NCT04013789|19907842|P1|NOT COMPLETED|First Wear Period (1 Week)||0
8073842|NCT04013789|19907841|P2|COMPLETED|First Wear Period (1 Week)||34
8073843|NCT04013789|19907842|P1|COMPLETED|First Wear Period (1 Week)||33
8073844|NCT04013789|19907841|P2|STARTED|First Wear Period (1 Week)||34
8073845|NCT04013789|19907842|P1|STARTED|First Wear Period (1 Week)||33
8073846|NCT04012970|19907852|P2|NOT COMPLETED|Control Session, 30 Minutes||0
8073847|NCT04012970|19907853|P1|NOT COMPLETED|Control Session, 30 Minutes||0
8073848|NCT04012970|19907852|P2|COMPLETED|Control Session, 30 Minutes||14
8073849|NCT04012970|19907853|P1|COMPLETED|Control Session, 30 Minutes||26
8073850|NCT04012970|19907852|P2|STARTED|Control Session, 30 Minutes||14
8073851|NCT04012970|19907853|P1|STARTED|Control Session, 30 Minutes||26
8073852|NCT04012970|19907852|P2|NOT COMPLETED|Intervention Session, 30 Minutes||0
8073853|NCT04012970|19907853|P1|NOT COMPLETED|Intervention Session, 30 Minutes||0
8073854|NCT04012970|19907852|P2|COMPLETED|Intervention Session, 30 Minutes||14
8073855|NCT04012970|19907853|P1|COMPLETED|Intervention Session, 30 Minutes||26
8073856|NCT04012970|19907852|P2|STARTED|Intervention Session, 30 Minutes||14
8073857|NCT04012970|19907853|P1|STARTED|Intervention Session, 30 Minutes||26
8073858|NCT04011592|19907867|P2|NOT COMPLETED|Overall Study||0
8073859|NCT04011592|19907868|P1|NOT COMPLETED|Overall Study||0
8073860|NCT04011592|19907867|P2|COMPLETED|Overall Study||0
8073861|NCT04011592|19907868|P1|COMPLETED|Overall Study||1
8073862|NCT04011592|19907867|P2|STARTED|Overall Study||0
8073863|NCT04011592|19907868|P1|STARTED|Overall Study||1
8073864|NCT04010370|19907886|P1|NOT COMPLETED|Overall Study||0
8073865|NCT04010370|19907886|P1|COMPLETED|Overall Study||25
8073866|NCT04010370|19907886|P1|STARTED|Overall Study||25
8073867|NCT04007159|19907904|P1|NOT COMPLETED|Challenge Phase||3
8073868|NCT04007159|19907904|P1|COMPLETED|Challenge Phase||255
8073869|NCT04007159|19907904|P1|STARTED|Challenge Phase||258
8073870|NCT04007159|19907904|P1|NOT COMPLETED|Rest Phase||0
8073871|NCT04007159|19907904|P1|COMPLETED|Rest Phase||258
8073872|NCT04007159|19907904|P1|STARTED|Rest Phase||258
8073873|NCT04007159|19907904|P1|NOT COMPLETED|Induction Phase||22
8073874|NCT04007159|19907904|P1|COMPLETED|Induction Phase||258
8073875|NCT04007159|19907904|P1|STARTED|Induction Phase||280
8073876|NCT04007107|19907919|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8073877|NCT04007107|19907920|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8073878|NCT04007107|19907921|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||1
8073879|NCT04007107|19907922|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8073880|NCT04007107|19907919|P4|COMPLETED|Treatment Period 2 (Day 1)||26
8073881|NCT04007107|19907920|P3|COMPLETED|Treatment Period 2 (Day 1)||25
8073882|NCT04007107|19907921|P2|COMPLETED|Treatment Period 2 (Day 1)||25
8073883|NCT04007107|19907922|P1|COMPLETED|Treatment Period 2 (Day 1)||26
8073884|NCT04007107|19907919|P4|STARTED|Treatment Period 2 (Day 1)||26
8073885|NCT04007107|19907920|P3|STARTED|Treatment Period 2 (Day 1)||25
8073886|NCT04007107|19907921|P2|STARTED|Treatment Period 2 (Day 1)||26
8073887|NCT04007107|19907922|P1|STARTED|Treatment Period 2 (Day 1)||26
8073888|NCT04007107|19907919|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073889|NCT04007107|19907920|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073890|NCT04007107|19907921|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073891|NCT04007107|19907922|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073892|NCT04007107|19907919|P4|COMPLETED|Treatment Period 1 (Day 1)||26
8073893|NCT04007107|19907920|P3|COMPLETED|Treatment Period 1 (Day 1)||25
8073894|NCT04007107|19907921|P2|COMPLETED|Treatment Period 1 (Day 1)||26
8073895|NCT04007107|19907922|P1|COMPLETED|Treatment Period 1 (Day 1)||26
8073896|NCT04007107|19907919|P4|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
8073897|NCT04007107|19907920|P3|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
8073898|NCT04007107|19907921|P2|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
8073899|NCT04007107|19907922|P1|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
8073900|NCT04007107|19907919|P4|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8073901|NCT04007107|19907920|P3|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
8073902|NCT04007107|19907921|P2|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8073903|NCT04007107|19907922|P1|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8073904|NCT04007107|19907919|P4|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8073905|NCT04007107|19907920|P3|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
8073906|NCT04007107|19907921|P2|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8073907|NCT04007107|19907922|P1|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8073908|NCT04007107|19907919|P4|STARTED|Treatment Period 1 (Day 1)||26
8073909|NCT04007107|19907920|P3|STARTED|Treatment Period 1 (Day 1)||25
8073910|NCT04007107|19907921|P2|STARTED|Treatment Period 1 (Day 1)||26
8073911|NCT04007107|19907922|P1|STARTED|Treatment Period 1 (Day 1)||26
8073912|NCT04006795|19907927|P1|NOT COMPLETED|Challenge Phase||0
8073913|NCT04006795|19907927|P1|COMPLETED|Challenge Phase||37
8073914|NCT04006795|19907927|P1|STARTED|Challenge Phase||37
8073915|NCT04006795|19907927|P1|NOT COMPLETED|Rest Phase||0
8073916|NCT04006795|19907927|P1|COMPLETED|Rest Phase||37
8073917|NCT04006795|19907927|P1|STARTED|Rest Phase||37
8073918|NCT04006795|19907927|P1|NOT COMPLETED|Induction Phase||0
8073919|NCT04006795|19907927|P1|COMPLETED|Induction Phase||37
8073920|NCT04006795|19907927|P1|STARTED|Induction Phase||37
8073921|NCT04006366|19907950|P1|NOT COMPLETED|Overall Study||1
8073922|NCT04006366|19907950|P1|COMPLETED|Overall Study||5
8073923|NCT04006366|19907950|P1|STARTED|Overall Study||6
8073924|NCT04005885|19907956|P2|NOT COMPLETED|Third Intervention||0
8073925|NCT04005885|19907957|P1|NOT COMPLETED|Third Intervention||0
8073926|NCT04005885|19907956|P2|COMPLETED|Third Intervention||26
8073927|NCT04005885|19907957|P1|COMPLETED|Third Intervention||25
8073928|NCT04005885|19907956|P2|STARTED|Third Intervention||26
8073929|NCT04005885|19907957|P1|STARTED|Third Intervention||25
8073930|NCT04005885|19907956|P2|NOT COMPLETED|Second Intervention||2
8073931|NCT04005885|19907957|P1|NOT COMPLETED|Second Intervention||0
8073932|NCT04005885|19907956|P2|COMPLETED|Second Intervention||26
8073933|NCT04005885|19907957|P1|COMPLETED|Second Intervention||25
8073934|NCT04005885|19907956|P2|STARTED|Second Intervention||28
8073935|NCT04005885|19907957|P1|STARTED|Second Intervention||25
8073936|NCT04005885|19907956|P2|NOT COMPLETED|First Intervention||1
8073937|NCT04005885|19907957|P1|NOT COMPLETED|First Intervention||1
8073938|NCT04005885|19907956|P2|COMPLETED|First Intervention||28
8073939|NCT04005885|19907957|P1|COMPLETED|First Intervention||25
8073940|NCT04005885|19907956|P2|STARTED|First Intervention||29
8073941|NCT04005885|19907957|P1|STARTED|First Intervention||26
8073942|NCT04005391|19908003|P2|NOT COMPLETED|Overall Study||0
8073943|NCT04005391|19908004|P1|NOT COMPLETED|Overall Study||7
8073944|NCT04005391|19908003|P2|COMPLETED|Overall Study||100
8073945|NCT04005391|19908004|P1|COMPLETED|Overall Study||101
8073946|NCT04005391|19908003|P2|STARTED|Overall Study|10/23/18|100
8073947|NCT04005391|19908004|P1|STARTED|Overall Study|10/23/18|108
8073948|NCT04002973|19908012|P1|NOT COMPLETED|Overall Study||0
8073949|NCT04002973|19908012|P1|COMPLETED|Overall Study||11
8073950|NCT04002973|19908012|P1|STARTED|Overall Study||11
8073951|NCT04002960|19908016|P1|NOT COMPLETED|Overall Study||2
8073952|NCT04002960|19908016|P1|COMPLETED|Overall Study||21
8073953|NCT04002960|19908016|P1|STARTED|Overall Study||23
8073954|NCT04002791|19908022|P2|NOT COMPLETED|Overall Study||0
8073955|NCT04002791|19908023|P1|NOT COMPLETED|Overall Study||0
8073956|NCT04002791|19908022|P2|COMPLETED|Overall Study||126
8073957|NCT04002791|19908023|P1|COMPLETED|Overall Study||127
8073958|NCT04002791|19908022|P2|STARTED|Overall Study||126
8073959|NCT04002791|19908023|P1|STARTED|Overall Study||127
8073960|NCT04002648|19908033|P2|NOT COMPLETED|Overall Study||0
8073961|NCT04002648|19908034|P1|NOT COMPLETED|Overall Study||2
8073962|NCT04002648|19908033|P2|COMPLETED|Overall Study||104
8073963|NCT04002648|19908034|P1|COMPLETED|Overall Study||102
8073964|NCT04002648|19908033|P2|STARTED|Overall Study||104
8073965|NCT04002648|19908034|P1|STARTED|Overall Study||104
8073966|NCT04000815|19908045|P3|NOT COMPLETED|Overall Study||7
8073967|NCT04000815|19908046|P2|NOT COMPLETED|Overall Study||5
8073968|NCT04000815|19908047|P1|NOT COMPLETED|Overall Study||14
8073969|NCT04000815|19908045|P3|COMPLETED|Overall Study||15
8073970|NCT04000815|19908046|P2|COMPLETED|Overall Study||15
8073971|NCT04000815|19908047|P1|COMPLETED|Overall Study||15
8073972|NCT04000815|19908045|P3|STARTED|Overall Study||22
8073973|NCT04000815|19908046|P2|STARTED|Overall Study||20
8073974|NCT04000815|19908047|P1|STARTED|Overall Study||29
8073975|NCT04000373|19908061|P1|NOT COMPLETED|Overall Study||0
8073976|NCT04000373|19908061|P1|COMPLETED|Overall Study||5
8073977|NCT04000373|19908061|P1|STARTED|Overall Study||5
8073978|NCT03997825|19908067|P1|NOT COMPLETED|Overall Study||17
8073979|NCT03997825|19908067|P1|COMPLETED|Overall Study||100
8073980|NCT03997825|19908067|P1|STARTED|Overall Study||117
8073981|NCT03995680|19908078|P2|NOT COMPLETED|Overall Study||2
8073982|NCT03995680|19908079|P1|NOT COMPLETED|Overall Study||2
8073983|NCT03995680|19908078|P2|COMPLETED|Overall Study||196
8073984|NCT03995680|19908079|P1|COMPLETED|Overall Study||197
8073985|NCT03995680|19908078|P2|STARTED|Overall Study||198
8073986|NCT03995680|19908079|P1|STARTED|Overall Study||199
8073987|NCT03993392|19908101|P1|NOT COMPLETED|Overall Study||6
8073988|NCT03993392|19908101|P1|COMPLETED|Overall Study||20
8073989|NCT03993392|19908101|P1|Treated With SUBLOCADE|Overall Study||24
8073990|NCT03993392|19908101|P1|STARTED|Overall Study||26
8073991|NCT03993210|19908114|P2|NOT COMPLETED|Overall Study||0
8073992|NCT03993210|19908115|P1|NOT COMPLETED|Overall Study||0
8073993|NCT03993210|19908114|P2|COMPLETED|Overall Study||0
8073994|NCT03993210|19908115|P1|COMPLETED|Overall Study||1
8073995|NCT03993210|19908114|P2|STARTED|Overall Study||0
8073996|NCT03993210|19908115|P1|STARTED|Overall Study||1
8073997|NCT03992482|19908139|P2|NOT COMPLETED|Overall Study||0
8073998|NCT03992482|19908140|P1|NOT COMPLETED|Overall Study||0
8073999|NCT03992482|19908139|P2|COMPLETED|Overall Study||14
8074000|NCT03992482|19908140|P1|COMPLETED|Overall Study||13
8074001|NCT03992482|19908139|P2|STARTED|Overall Study||14
8074002|NCT03992482|19908140|P1|STARTED|Overall Study||13
8074003|NCT03992014|19908150|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8074004|NCT03992014|19908150|P1|COMPLETED|Treatment Period 2 (8 Days)||6
8074005|NCT03992014|19908150|P1|STARTED|Treatment Period 2 (8 Days)||6
8074006|NCT03992014|19908150|P1|NOT COMPLETED|Washout Period (7 Days)||0
8074007|NCT03992014|19908150|P1|COMPLETED|Washout Period (7 Days)||6
8074008|NCT03992014|19908150|P1|STARTED|Washout Period (7 Days)||6
8074009|NCT03992014|19908150|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8074010|NCT03992014|19908150|P1|COMPLETED|Treatment Period 1 (8 Days)||6
8074011|NCT03992014|19908150|P1|STARTED|Treatment Period 1 (8 Days)||6
8074012|NCT03991715|19908209|P1|NOT COMPLETED|Overall Study||0
8074013|NCT03991715|19908209|P1|COMPLETED|Overall Study||5
8074014|NCT03991715|19908209|P1|STARTED|Overall Study||5
8074015|NCT03989570|19908221|P3|NOT COMPLETED|Overall Study||0
8074016|NCT03989570|19908222|P2|NOT COMPLETED|Overall Study||0
8074017|NCT03989570|19908223|P1|NOT COMPLETED|Overall Study||0
8074018|NCT03989570|19908221|P3|COMPLETED|Overall Study||31
8074019|NCT03989570|19908222|P2|COMPLETED|Overall Study||31
8074020|NCT03989570|19908223|P1|COMPLETED|Overall Study||31
8074021|NCT03989570|19908221|P3|STARTED|Overall Study||31
8074022|NCT03989570|19908222|P2|STARTED|Overall Study||31
8074023|NCT03989570|19908223|P1|STARTED|Overall Study||31
8074024|NCT03989427|19908239|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8074025|NCT03989427|19908240|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8074026|NCT03989427|19908239|P2|COMPLETED|Second Intervention (2 Weeks)||15
8074027|NCT03989427|19908240|P1|COMPLETED|Second Intervention (2 Weeks)||15
8074028|NCT03989427|19908239|P2|STARTED|Second Intervention (2 Weeks)||15
8074029|NCT03989427|19908240|P1|STARTED|Second Intervention (2 Weeks)||15
8074030|NCT03989427|19908239|P2|NOT COMPLETED|Washout (1 Week)||0
8074031|NCT03989427|19908240|P1|NOT COMPLETED|Washout (1 Week)||0
8074032|NCT03989427|19908239|P2|COMPLETED|Washout (1 Week)||15
8074033|NCT03989427|19908240|P1|COMPLETED|Washout (1 Week)||15
8074034|NCT03989427|19908239|P2|STARTED|Washout (1 Week)||15
8074035|NCT03989427|19908240|P1|STARTED|Washout (1 Week)||15
8074036|NCT03989427|19908239|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8074037|NCT03989427|19908240|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8074038|NCT03989427|19908239|P2|COMPLETED|First Intervention (2 Weeks)||15
8074039|NCT03989427|19908240|P1|COMPLETED|First Intervention (2 Weeks)||15
8074040|NCT03989427|19908239|P2|STARTED|First Intervention (2 Weeks)||15
8074041|NCT03989427|19908240|P1|STARTED|First Intervention (2 Weeks)||15
8074042|NCT03988907|19908249|P2|NOT COMPLETED|Overall Study||1
8074043|NCT03988907|19908250|P1|NOT COMPLETED|Overall Study||0
8074044|NCT03988907|19908249|P2|COMPLETED|Overall Study||26
8074045|NCT03988907|19908250|P1|COMPLETED|Overall Study||8
8074046|NCT03988907|19908249|P2|STARTED|Overall Study||27
8074047|NCT03988907|19908250|P1|STARTED|Overall Study||8
8074048|NCT03988426|19908282|P1|NOT COMPLETED|Overall Study||1
8074049|NCT03988426|19908282|P1|COMPLETED|Overall Study||24
8074050|NCT03988426|19908282|P1|STARTED|Overall Study||25
8074051|NCT03988088|19908306|P4|NOT COMPLETED|Open-Label Addendum||0
8074052|NCT03988088|19908307|P3|NOT COMPLETED|Open-Label Addendum||1
8074053|NCT03988088|19908308|P2|NOT COMPLETED|Open-Label Addendum||0
8074054|NCT03988088|19908309|P1|NOT COMPLETED|Open-Label Addendum||0
8074055|NCT03988088|19908306|P4|COMPLETED|Open-Label Addendum||2
8074056|NCT03988088|19908307|P3|COMPLETED|Open-Label Addendum||1
8074057|NCT03988088|19908308|P2|COMPLETED|Open-Label Addendum||0
8074058|NCT03988088|19908309|P1|COMPLETED|Open-Label Addendum||0
8074059|NCT03988088|19908306|P4|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
8074060|NCT03988088|19908307|P3|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
8074061|NCT03988088|19908308|P2|STARTED|Open-Label Addendum||0
8074062|NCT03988088|19908309|P1|STARTED|Open-Label Addendum||0
8074063|NCT03988088|19908306|P4|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
8074064|NCT03988088|19908307|P3|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
8074065|NCT03988088|19908308|P2|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
8074066|NCT03988088|19908309|P1|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
8074067|NCT03988088|19908306|P4|COMPLETED|Single-Dose Pharmacokinetic Study||0
8074068|NCT03988088|19908307|P3|COMPLETED|Single-Dose Pharmacokinetic Study||0
8074069|NCT03988088|19908308|P2|COMPLETED|Single-Dose Pharmacokinetic Study||6
8074070|NCT03988088|19908309|P1|COMPLETED|Single-Dose Pharmacokinetic Study||11
8074071|NCT03988088|19908306|P4|STARTED|Single-Dose Pharmacokinetic Study||0
8074072|NCT03988088|19908307|P3|STARTED|Single-Dose Pharmacokinetic Study||0
8074073|NCT03988088|19908308|P2|STARTED|Single-Dose Pharmacokinetic Study||7
8074074|NCT03988088|19908309|P1|STARTED|Single-Dose Pharmacokinetic Study||11
8074075|NCT03985657|19908319|P2|NOT COMPLETED|Intervention 2 (One Night)||0
8074076|NCT03985657|19908320|P1|NOT COMPLETED|Intervention 2 (One Night)||0
8074077|NCT03985657|19908319|P2|COMPLETED|Intervention 2 (One Night)||10
8074078|NCT03985657|19908320|P1|COMPLETED|Intervention 2 (One Night)||20
8074079|NCT03985657|19908319|P2|STARTED|Intervention 2 (One Night)||10
8074080|NCT03985657|19908320|P1|STARTED|Intervention 2 (One Night)||20
8074081|NCT03985657|19908319|P2|NOT COMPLETED|Washout (Up to 1 Week)||0
8074082|NCT03985657|19908320|P1|NOT COMPLETED|Washout (Up to 1 Week)||0
8074083|NCT03985657|19908319|P2|COMPLETED|Washout (Up to 1 Week)||10
8074084|NCT03985657|19908320|P1|COMPLETED|Washout (Up to 1 Week)||20
8074085|NCT03985657|19908319|P2|STARTED|Washout (Up to 1 Week)||10
8074086|NCT03985657|19908320|P1|STARTED|Washout (Up to 1 Week)||20
8074087|NCT03985657|19908319|P2|NOT COMPLETED|Intervention 1 (One Night)||1
8074088|NCT03985657|19908320|P1|NOT COMPLETED|Intervention 1 (One Night)||0
8074089|NCT03985657|19908319|P2|COMPLETED|Intervention 1 (One Night)||10
8074090|NCT03985657|19908320|P1|COMPLETED|Intervention 1 (One Night)||20
8074091|NCT03985657|19908319|P2|STARTED|Intervention 1 (One Night)||11
8074092|NCT03985657|19908320|P1|STARTED|Intervention 1 (One Night)||20
8074093|NCT03984838|19908332|P1|NOT COMPLETED|Overall Study||0
8074094|NCT03984838|19908332|P1|COMPLETED|Overall Study||16
8074095|NCT03984838|19908332|P1|STARTED|Overall Study||16
8074096|NCT03984825|19908392|P1|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
8074097|NCT03984825|19908392|P1|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
8074098|NCT03984825|19908392|P1|STARTED|Treatment Period 2 (Day 11 to 21)||21
8074099|NCT03984825|19908392|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
8074100|NCT03984825|19908392|P1|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
8074101|NCT03984825|19908392|P1|STARTED|Treatment Period 1 (Day 1 to 10)||23
8074102|NCT03984825|19908392|P1|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
8074103|NCT03984825|19908392|P1|COMPLETED|Run-in Period (Day -3 to -1)||23
8074104|NCT03984825|19908392|P1|STARTED|Run-in Period (Day -3 to -1)||23
8074105|NCT03983317|19908506|P1|NOT COMPLETED|Overall Study||5
8074106|NCT03983317|19908506|P1|COMPLETED|Overall Study||20
8074107|NCT03983317|19908506|P1|STARTED|Overall Study||25
8074108|NCT03982433|19908513|P1|NOT COMPLETED|Overall Study||1
8074109|NCT03982433|19908513|P1|COMPLETED|Overall Study||7
8074110|NCT03982433|19908513|P1|STARTED|Overall Study||8
8074111|NCT03979807|19908526|P2|NOT COMPLETED|Overall Study||0
8074112|NCT03979807|19908527|P1|NOT COMPLETED|Overall Study||0
8074113|NCT03979807|19908526|P2|COMPLETED|Overall Study||7420
8074114|NCT03979807|19908527|P1|COMPLETED|Overall Study||3876
8074115|NCT03979807|19908526|P2|STARTED|Overall Study||7420
8074116|NCT03979807|19908527|P1|STARTED|Overall Study||3876
8074117|NCT03979079|19908533|P1|NOT COMPLETED|Overall Study||0
8074118|NCT03979079|19908533|P1|COMPLETED|Overall Study||2384
8074119|NCT03979079|19908533|P1|STARTED|Overall Study||2384
8074120|NCT03979066|19908541|P2|NOT COMPLETED|Overall Study||0
8074121|NCT03979066|19908542|P1|NOT COMPLETED|Overall Study||0
8074122|NCT03979066|19908541|P2|COMPLETED|Overall Study||0
8074123|NCT03979066|19908542|P1|COMPLETED|Overall Study||0
8074124|NCT03979066|19908541|P2|STARTED|Overall Study||0
8074125|NCT03979066|19908542|P1|STARTED|Overall Study||0
8074126|NCT03977935|19908558|P2|NOT COMPLETED|Overall Study||0
8074127|NCT03977935|19908559|P1|NOT COMPLETED|Overall Study||0
8074128|NCT03977935|19908558|P2|COMPLETED|Overall Study||40
8074129|NCT03977935|19908559|P1|COMPLETED|Overall Study||40
8074130|NCT03977935|19908558|P2|STARTED|Overall Study||40
8074131|NCT03977935|19908559|P1|STARTED|Overall Study||40
8074132|NCT03977818|19908585|P1|NOT COMPLETED|Overall Study||0
8074133|NCT03977818|19908585|P1|COMPLETED|Overall Study||2165
8074134|NCT03977818|19908585|P1|STARTED|Overall Study||2165
8074135|NCT03977727|19908591|P2|NOT COMPLETED|Second Treatment||3
8074136|NCT03977727|19908592|P1|NOT COMPLETED|Second Treatment||0
8074137|NCT03977727|19908591|P2|COMPLETED|Second Treatment||17
8074138|NCT03977727|19908592|P1|COMPLETED|Second Treatment||20
8074139|NCT03977727|19908591|P2|STARTED|Second Treatment||20
8074140|NCT03977727|19908592|P1|STARTED|Second Treatment||20
8074141|NCT03977727|19908591|P2|NOT COMPLETED|First Treatment||0
8074142|NCT03977727|19908592|P1|NOT COMPLETED|First Treatment||0
8074143|NCT03977727|19908591|P2|COMPLETED|First Treatment||20
8074144|NCT03977727|19908592|P1|COMPLETED|First Treatment||20
8074145|NCT03977727|19908591|P2|Received Treatment|First Treatment||20
8074146|NCT03977727|19908592|P1|Received Treatment|First Treatment||20
8074147|NCT03977727|19908591|P2|STARTED|First Treatment||20
8074148|NCT03977727|19908592|P1|STARTED|First Treatment||20
8074149|NCT03976531|19908636|P1|NOT COMPLETED|Overall Study||0
8074150|NCT03976531|19908636|P1|COMPLETED|Overall Study||42
8074151|NCT03976531|19908636|P1|STARTED|Overall Study||42
8074152|NCT03976466|19908649|P2|NOT COMPLETED|Overall Study||3
8074153|NCT03976466|19908650|P1|NOT COMPLETED|Overall Study||1
8074154|NCT03976466|19908649|P2|COMPLETED|Overall Study||40
8074155|NCT03976466|19908650|P1|COMPLETED|Overall Study||43
8074156|NCT03976466|19908649|P2|STARTED|Overall Study||43
8074157|NCT03976466|19908650|P1|STARTED|Overall Study||44
8074158|NCT03975790|19908661|P3|NOT COMPLETED|Overall Study||0
8074159|NCT03975790|19908662|P2|NOT COMPLETED|Overall Study||0
8074160|NCT03975790|19908663|P1|NOT COMPLETED|Overall Study||0
8074161|NCT03975790|19908661|P3|COMPLETED|Overall Study||48
8074162|NCT03975790|19908662|P2|COMPLETED|Overall Study||94
8074163|NCT03975790|19908663|P1|COMPLETED|Overall Study||337
8074164|NCT03975790|19908661|P3|STARTED|Overall Study||48
8074165|NCT03975790|19908662|P2|STARTED|Overall Study||94
8074166|NCT03975790|19908663|P1|STARTED|Overall Study||337
8074167|NCT03974802|19908876|P1|NOT COMPLETED|Overall Study||0
8074168|NCT03974802|19908876|P1|COMPLETED|Overall Study||41
8074169|NCT03974802|19908876|P1|STARTED|Overall Study||41
8074170|NCT03973905|19908913|P2|NOT COMPLETED|Overall Study||0
8074171|NCT03973905|19908914|P1|NOT COMPLETED|Overall Study||0
8074172|NCT03973905|19908913|P2|COMPLETED|Overall Study||183
8074173|NCT03973905|19908914|P1|COMPLETED|Overall Study||107
8074174|NCT03973905|19908913|P2|STARTED|Overall Study||183
8074175|NCT03973905|19908914|P1|STARTED|Overall Study||107
8074176|NCT03972137|19908926|P1|NOT COMPLETED|Overall Study||6
8074177|NCT03972137|19908926|P1|COMPLETED|Overall Study||4
8074178|NCT03972137|19908926|P1|Follow-up Completed|Overall Study||4
8074179|NCT03972137|19908926|P1|Treatment Completed|Overall Study||6
8074180|NCT03972137|19908926|P1|Enrolled|Overall Study||10
8074181|NCT03972137|19908926|P1|STARTED|Overall Study||10
8074182|NCT03970824|19908951|P3|NOT COMPLETED|Overall Study||4
8074183|NCT03970824|19908952|P2|NOT COMPLETED|Overall Study||3
8074184|NCT03970824|19908953|P1|NOT COMPLETED|Overall Study||2
8074185|NCT03970824|19908951|P3|COMPLETED|Overall Study||102
8074186|NCT03970824|19908952|P2|COMPLETED|Overall Study||100
8074187|NCT03970824|19908953|P1|COMPLETED|Overall Study||101
8074188|NCT03970824|19908951|P3|STARTED|Overall Study||106
8074189|NCT03970824|19908952|P2|STARTED|Overall Study||103
8074190|NCT03970824|19908953|P1|STARTED|Overall Study||103
8074197|NCT03966365|19908994|P2|NOT COMPLETED|Overall Study||0
8074198|NCT03966365|19908995|P1|NOT COMPLETED|Overall Study||1
8074199|NCT03966365|19908994|P2|COMPLETED|Overall Study||12
8074200|NCT03966365|19908995|P1|COMPLETED|Overall Study||11
8074201|NCT03966365|19908994|P2|STARTED|Overall Study||12
8074202|NCT03966365|19908995|P1|STARTED|Overall Study||12
8074203|NCT03965754|19909017|P4|NOT COMPLETED|Overall Study||0
8074204|NCT03965754|19909018|P3|NOT COMPLETED|Overall Study||0
8074205|NCT03965754|19909019|P2|NOT COMPLETED|Overall Study||0
8074206|NCT03965754|19909020|P1|NOT COMPLETED|Overall Study||0
8074207|NCT03965754|19909017|P4|COMPLETED|Overall Study||1425
8074208|NCT03965754|19909018|P3|COMPLETED|Overall Study||1425
8074209|NCT03965754|19909019|P2|COMPLETED|Overall Study||1425
8074210|NCT03965754|19909020|P1|COMPLETED|Overall Study||1422
8074211|NCT03965754|19909017|P4|STARTED|Overall Study||1425
8074212|NCT03965754|19909018|P3|STARTED|Overall Study||1425
8074213|NCT03965754|19909019|P2|STARTED|Overall Study||1425
8074214|NCT03965754|19909020|P1|STARTED|Overall Study||1422
8074215|NCT03965533|19909041|P7|NOT COMPLETED|Part B (112 Days)||0
8074216|NCT03965533|19909042|P6|NOT COMPLETED|Part B (112 Days)||0
8074217|NCT03965533|19909043|P5|NOT COMPLETED|Part B (112 Days)||0
8074218|NCT03965533|19909044|P4|NOT COMPLETED|Part B (112 Days)||0
8074219|NCT03965533|19909045|P3|NOT COMPLETED|Part B (112 Days)||0
8074220|NCT03965533|19909046|P2|NOT COMPLETED|Part B (112 Days)||0
8074221|NCT03965533|19909047|P1|NOT COMPLETED|Part B (112 Days)||0
8074222|NCT03965533|19909041|P7|COMPLETED|Part B (112 Days)||8
8074223|NCT03965533|19909042|P6|COMPLETED|Part B (112 Days)||8
8074224|NCT03965533|19909043|P5|COMPLETED|Part B (112 Days)||4
8074225|NCT03965533|19909044|P4|COMPLETED|Part B (112 Days)||0
8074226|NCT03965533|19909045|P3|COMPLETED|Part B (112 Days)||0
8074227|NCT03965533|19909046|P2|COMPLETED|Part B (112 Days)||0
8074228|NCT03965533|19909047|P1|COMPLETED|Part B (112 Days)||0
8074229|NCT03965533|19909041|P7|STARTED|Part B (112 Days)||8
8074230|NCT03965533|19909042|P6|STARTED|Part B (112 Days)||8
8074231|NCT03965533|19909043|P5|STARTED|Part B (112 Days)||4
8074232|NCT03965533|19909044|P4|STARTED|Part B (112 Days)||0
8074233|NCT03965533|19909045|P3|STARTED|Part B (112 Days)||0
8074234|NCT03965533|19909046|P2|STARTED|Part B (112 Days)||0
8074235|NCT03965533|19909047|P1|STARTED|Part B (112 Days)||0
8074236|NCT03965533|19909041|P7|NOT COMPLETED|Part A (112 Days)||0
8074237|NCT03965533|19909042|P6|NOT COMPLETED|Part A (112 Days)||0
8074238|NCT03965533|19909043|P5|NOT COMPLETED|Part A (112 Days)||0
8074239|NCT03965533|19909044|P4|NOT COMPLETED|Part A (112 Days)||0
8074240|NCT03965533|19909045|P3|NOT COMPLETED|Part A (112 Days)||0
8074241|NCT03965533|19909046|P2|NOT COMPLETED|Part A (112 Days)||0
8074242|NCT03965533|19909047|P1|NOT COMPLETED|Part A (112 Days)||0
8074243|NCT03965533|19909041|P7|COMPLETED|Part A (112 Days)||0
8074244|NCT03965533|19909042|P6|COMPLETED|Part A (112 Days)||0
8074245|NCT03965533|19909043|P5|COMPLETED|Part A (112 Days)||0
8074246|NCT03965533|19909044|P4|COMPLETED|Part A (112 Days)||6
8074247|NCT03965533|19909045|P3|COMPLETED|Part A (112 Days)||2
8074248|NCT03965533|19909046|P2|COMPLETED|Part A (112 Days)||6
8074249|NCT03965533|19909047|P1|COMPLETED|Part A (112 Days)||2
8074250|NCT03965533|19909041|P7|STARTED|Part A (112 Days)||0
8074251|NCT03965533|19909042|P6|STARTED|Part A (112 Days)||0
8074252|NCT03965533|19909043|P5|STARTED|Part A (112 Days)||0
8074253|NCT03965533|19909044|P4|STARTED|Part A (112 Days)||6
8074254|NCT03965533|19909045|P3|STARTED|Part A (112 Days)||2
8074255|NCT03965533|19909046|P2|STARTED|Part A (112 Days)||6
8074256|NCT03965533|19909047|P1|STARTED|Part A (112 Days)||2
8074257|NCT03965403|19909130|P1|NOT COMPLETED|Overall Study||1
8074258|NCT03965403|19909130|P1|COMPLETED|Overall Study||6
8074259|NCT03965403|19909130|P1|STARTED|Overall Study||7
8074260|NCT03965052|19909143|P2|NOT COMPLETED|Overall Study||0
8074261|NCT03965052|19909144|P1|NOT COMPLETED|Overall Study||1
8074262|NCT03965052|19909143|P2|COMPLETED|Overall Study||12
8074263|NCT03965052|19909144|P1|COMPLETED|Overall Study||11
8074264|NCT03965052|19909143|P2|STARTED|Overall Study||12
8074265|NCT03965052|19909144|P1|STARTED|Overall Study||12
8074266|NCT03965039|19909166|P4|NOT COMPLETED|Overall Study||1
8074267|NCT03965039|19909167|P3|NOT COMPLETED|Overall Study||0
8074268|NCT03965039|19909168|P2|NOT COMPLETED|Overall Study||1
8074269|NCT03965039|19909169|P1|NOT COMPLETED|Overall Study||0
8074270|NCT03965039|19909166|P4|COMPLETED|Overall Study||29
8074271|NCT03965039|19909167|P3|COMPLETED|Overall Study||30
8074272|NCT03965039|19909168|P2|COMPLETED|Overall Study||29
8074273|NCT03965039|19909169|P1|COMPLETED|Overall Study||30
8074274|NCT03965039|19909166|P4|STARTED|Overall Study||30
8074275|NCT03965039|19909167|P3|STARTED|Overall Study||30
8074276|NCT03965039|19909168|P2|STARTED|Overall Study||30
8074277|NCT03965039|19909169|P1|STARTED|Overall Study||30
8074278|NCT03964220|19909225|P2|NOT COMPLETED|Overall Study||0
8074279|NCT03964220|19909226|P1|NOT COMPLETED|Overall Study||0
8074280|NCT03964220|19909225|P2|COMPLETED|Overall Study||5238
8074281|NCT03964220|19909226|P1|COMPLETED|Overall Study||2619
8074282|NCT03964220|19909225|P2|STARTED|Overall Study||5238
8074283|NCT03964220|19909226|P1|STARTED|Overall Study||2619
8074284|NCT03962790|19909240|P2|NOT COMPLETED|Period 2||0
8074285|NCT03962790|19909241|P1|NOT COMPLETED|Period 2||0
8074286|NCT03962790|19909240|P2|COMPLETED|Period 2||44
8074287|NCT03962790|19909241|P1|COMPLETED|Period 2||45
8074288|NCT03962790|19909240|P2|STARTED|Period 2||44
8074289|NCT03962790|19909241|P1|STARTED|Period 2||45
8074290|NCT03962790|19909240|P2|NOT COMPLETED|Period 1||2
8074291|NCT03962790|19909241|P1|NOT COMPLETED|Period 1||3
8074292|NCT03962790|19909240|P2|COMPLETED|Period 1||44
8074293|NCT03962790|19909241|P1|COMPLETED|Period 1||45
8074294|NCT03962790|19909240|P2|STARTED|Period 1||46
8074295|NCT03962790|19909241|P1|STARTED|Period 1||48
8074296|NCT03962634|19909255|P2|NOT COMPLETED|Overall Study||0
8074297|NCT03962634|19909256|P1|NOT COMPLETED|Overall Study||0
8074298|NCT03962634|19909255|P2|COMPLETED|Overall Study||2
8074299|NCT03962634|19909256|P1|COMPLETED|Overall Study||1
8074300|NCT03962634|19909255|P2|STARTED|Overall Study||2
8074301|NCT03962634|19909256|P1|STARTED|Overall Study||1
8074302|NCT03961308|19909276|P2|NOT COMPLETED|Overall Study||2
8074303|NCT03961308|19909277|P1|NOT COMPLETED|Overall Study||2
8074304|NCT03961308|19909276|P2|COMPLETED|Overall Study||100
8074305|NCT03961308|19909277|P1|COMPLETED|Overall Study||100
8074306|NCT03961308|19909276|P2|STARTED|Overall Study||102
8074307|NCT03961308|19909277|P1|STARTED|Overall Study||102
8074308|NCT03961295|19909289|P2|NOT COMPLETED|Overall Study||0
8074309|NCT03961295|19909290|P1|NOT COMPLETED|Overall Study||0
8074310|NCT03961295|19909289|P2|COMPLETED|Overall Study||12
8074311|NCT03961295|19909290|P1|COMPLETED|Overall Study||12
8074312|NCT03961295|19909289|P2|STARTED|Overall Study||12
8074313|NCT03961295|19909290|P1|STARTED|Overall Study||12
8074314|NCT03961100|19909305|P5|NOT COMPLETED|Part 2||0
8074315|NCT03961100|19909306|P4|NOT COMPLETED|Part 2||0
8074316|NCT03961100|19909307|P3|NOT COMPLETED|Part 2||0
8074317|NCT03961100|19909308|P2|NOT COMPLETED|Part 2||0
8074318|NCT03961100|19909309|P1|NOT COMPLETED|Part 2||0
8074319|NCT03961100|19909305|P5|COMPLETED|Part 2||8
8074320|NCT03961100|19909306|P4|COMPLETED|Part 2||8
8074321|NCT03961100|19909307|P3|COMPLETED|Part 2||0
8074322|NCT03961100|19909308|P2|COMPLETED|Part 2||0
8074323|NCT03961100|19909309|P1|COMPLETED|Part 2||0
8074324|NCT03961100|19909305|P5|STARTED|Part 2||8
8074325|NCT03961100|19909306|P4|STARTED|Part 2||8
8074326|NCT03961100|19909307|P3|STARTED|Part 2||0
8074327|NCT03961100|19909308|P2|STARTED|Part 2||0
8074328|NCT03961100|19909309|P1|STARTED|Part 2||0
8074329|NCT03961100|19909305|P5|NOT COMPLETED|Part 1||0
8074330|NCT03961100|19909306|P4|NOT COMPLETED|Part 1||0
8074331|NCT03961100|19909307|P3|NOT COMPLETED|Part 1||0
8074332|NCT03961100|19909308|P2|NOT COMPLETED|Part 1||0
8074333|NCT03961100|19909309|P1|NOT COMPLETED|Part 1||0
8074334|NCT03961100|19909305|P5|COMPLETED|Part 1||0
8074335|NCT03961100|19909306|P4|COMPLETED|Part 1||0
8074336|NCT03961100|19909307|P3|COMPLETED|Part 1||5
8074337|NCT03961100|19909308|P2|COMPLETED|Part 1||5
8074338|NCT03961100|19909309|P1|COMPLETED|Part 1||5
8074339|NCT03961100|19909305|P5|STARTED|Part 1||0
8074340|NCT03961100|19909306|P4|STARTED|Part 1||0
8074341|NCT03961100|19909307|P3|STARTED|Part 1||5
8074342|NCT03961100|19909308|P2|STARTED|Part 1||5
8074343|NCT03961100|19909309|P1|STARTED|Part 1||5
8074344|NCT03959332|19909343|P2|NOT COMPLETED|Overall Study||0
8074345|NCT03959332|19909344|P1|NOT COMPLETED|Overall Study||0
8074346|NCT03959332|19909343|P2|COMPLETED|Overall Study||16
8074347|NCT03959332|19909344|P1|COMPLETED|Overall Study||16
8074348|NCT03959332|19909343|P2|STARTED|Overall Study||16
8074349|NCT03959332|19909344|P1|STARTED|Overall Study||16
8074350|NCT03958071|19909371|P3|NOT COMPLETED|Overall Study||0
8074351|NCT03958071|19909372|P2|NOT COMPLETED|Overall Study||0
8074352|NCT03958071|19909373|P1|NOT COMPLETED|Overall Study||0
8074353|NCT03958071|19909371|P3|COMPLETED|Overall Study||12494
8074354|NCT03958071|19909372|P2|COMPLETED|Overall Study||423
8074355|NCT03958071|19909373|P1|COMPLETED|Overall Study||347
8074356|NCT03958071|19909371|P3|STARTED|Overall Study||12494
8074357|NCT03958071|19909372|P2|STARTED|Overall Study||423
8074358|NCT03958071|19909373|P1|STARTED|Overall Study||347
8074359|NCT03954626|19909397|P1|NOT COMPLETED|Overall Study||0
8074360|NCT03954626|19909397|P1|COMPLETED|Overall Study||14
8074361|NCT03954626|19909397|P1|STARTED|Overall Study||14
8074362|NCT03954158|19909405|P4|NOT COMPLETED|Overall Study||0
8074363|NCT03954158|19909406|P3|NOT COMPLETED|Overall Study||0
8074364|NCT03954158|19909407|P2|NOT COMPLETED|Overall Study||0
8074365|NCT03954158|19909408|P1|NOT COMPLETED|Overall Study||0
8074366|NCT03954158|19909405|P4|COMPLETED|Overall Study||20
8074367|NCT03954158|19909406|P3|COMPLETED|Overall Study||20
8074368|NCT03954158|19909407|P2|COMPLETED|Overall Study||21
8074369|NCT03954158|19909408|P1|COMPLETED|Overall Study||20
8074370|NCT03954158|19909405|P4|STARTED|Overall Study||20
8074371|NCT03954158|19909406|P3|STARTED|Overall Study||20
8074372|NCT03954158|19909407|P2|STARTED|Overall Study||21
8074373|NCT03954158|19909408|P1|STARTED|Overall Study||20
8074374|NCT03953820|19909470|P3|NOT COMPLETED|DBF Following High-Fat Meal||0
8074375|NCT03953820|19909471|P2|NOT COMPLETED|DBF Following High-Fat Meal||0
8074376|NCT03953820|19909472|P1|NOT COMPLETED|DBF Following High-Fat Meal||0
8074377|NCT03953820|19909470|P3|COMPLETED|DBF Following High-Fat Meal||10
8074378|NCT03953820|19909471|P2|COMPLETED|DBF Following High-Fat Meal||0
8074379|NCT03953820|19909472|P1|COMPLETED|DBF Following High-Fat Meal||0
8074380|NCT03953820|19909470|P3|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
8074381|NCT03953820|19909471|P2|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
8074382|NCT03953820|19909472|P1|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
8074383|NCT03953820|19909470|P3|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
8074384|NCT03953820|19909471|P2|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
8074385|NCT03953820|19909472|P1|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
8074386|NCT03953820|19909470|P3|COMPLETED|Two-Sequence, Two-Way Crossover||0
8074387|NCT03953820|19909471|P2|COMPLETED|Two-Sequence, Two-Way Crossover||16
8074388|NCT03953820|19909472|P1|COMPLETED|Two-Sequence, Two-Way Crossover||13
8074389|NCT03953820|19909470|P3|STARTED|Two-Sequence, Two-Way Crossover||0
8074390|NCT03953820|19909471|P2|STARTED|Two-Sequence, Two-Way Crossover||16
8074391|NCT03953820|19909472|P1|STARTED|Two-Sequence, Two-Way Crossover||15
8074392|NCT03953183|19909488|P2|NOT COMPLETED|Overall Study||2
8074393|NCT03953183|19909489|P1|NOT COMPLETED|Overall Study||0
8074394|NCT03953183|19909488|P2|COMPLETED|Overall Study||28
8074395|NCT03953183|19909489|P1|COMPLETED|Overall Study||30
8074396|NCT03953183|19909488|P2|STARTED|Overall Study||30
8074397|NCT03953183|19909489|P1|STARTED|Overall Study||30
8074398|NCT03951805|19909529|P4|NOT COMPLETED|Overall Study||0
8074399|NCT03951805|19909530|P3|NOT COMPLETED|Overall Study||0
8074400|NCT03951805|19909531|P2|NOT COMPLETED|Overall Study||0
8074401|NCT03951805|19909532|P1|NOT COMPLETED|Overall Study||1
8074402|NCT03951805|19909529|P4|COMPLETED|Overall Study||51
8074403|NCT03951805|19909530|P3|COMPLETED|Overall Study||52
8074404|NCT03951805|19909531|P2|COMPLETED|Overall Study||51
8074405|NCT03951805|19909532|P1|COMPLETED|Overall Study||50
8074406|NCT03951805|19909529|P4|Safety Analysis Set (SAS)|Overall Study||51
8074407|NCT03951805|19909530|P3|Safety Analysis Set (SAS)|Overall Study||52
8074408|NCT03951805|19909531|P2|Safety Analysis Set (SAS)|Overall Study||51
8074409|NCT03951805|19909532|P1|Safety Analysis Set (SAS)|Overall Study||51
8074410|NCT03951805|19909529|P4|Full Analysis Set (FAS)|Overall Study||51
8074411|NCT03951805|19909530|P3|Full Analysis Set (FAS)|Overall Study||52
8074412|NCT03951805|19909531|P2|Full Analysis Set (FAS)|Overall Study||51
8074413|NCT03951805|19909532|P1|Full Analysis Set (FAS)|Overall Study||51
8074414|NCT03951805|19909529|P4|STARTED|Overall Study||51
8074415|NCT03951805|19909530|P3|STARTED|Overall Study||52
8074416|NCT03951805|19909531|P2|STARTED|Overall Study||51
8074417|NCT03951805|19909532|P1|STARTED|Overall Study||51
8074418|NCT03951610|19909574|P2|NOT COMPLETED|Second Intervention||0
8074419|NCT03951610|19909575|P1|NOT COMPLETED|Second Intervention||0
8074420|NCT03951610|19909574|P2|COMPLETED|Second Intervention||25
8074421|NCT03951610|19909575|P1|COMPLETED|Second Intervention||27
8074422|NCT03951610|19909574|P2|STARTED|Second Intervention||25
8074423|NCT03951610|19909575|P1|STARTED|Second Intervention||27
8074424|NCT03951610|19909574|P2|NOT COMPLETED|First Intervention||0
8074425|NCT03951610|19909575|P1|NOT COMPLETED|First Intervention||0
8074426|NCT03951610|19909574|P2|COMPLETED|First Intervention||25
8074427|NCT03951610|19909575|P1|COMPLETED|First Intervention||27
8074428|NCT03951610|19909574|P2|STARTED|First Intervention||25
8074429|NCT03951610|19909575|P1|STARTED|First Intervention||27
8074430|NCT03950674|19909613|P2|NOT COMPLETED|Overall Study||15
8074431|NCT03950674|19909614|P1|NOT COMPLETED|Overall Study||25
8074432|NCT03950674|19909613|P2|COMPLETED|Overall Study||0
8074433|NCT03950674|19909614|P1|COMPLETED|Overall Study||0
8074434|NCT03950674|19909613|P2|Switched to Pembrolizumab|Overall Study||4
8074435|NCT03950674|19909614|P1|Switched to Pembrolizumab|Overall Study||0
8074436|NCT03950674|19909613|P2|Treated|Overall Study||15
8074437|NCT03950674|19909614|P1|Treated|Overall Study||25
8074438|NCT03950674|19909613|P2|STARTED|Overall Study||15
8074439|NCT03950674|19909614|P1|STARTED|Overall Study||25
8074440|NCT03949621|19909635|P2|NOT COMPLETED|Overall Study||0
8074441|NCT03949621|19909636|P1|NOT COMPLETED|Overall Study||0
8074442|NCT03949621|19909635|P2|COMPLETED|Overall Study||12
8074443|NCT03949621|19909636|P1|COMPLETED|Overall Study||12
8074444|NCT03949621|19909635|P2|STARTED|Overall Study||12
8074445|NCT03949621|19909636|P1|STARTED|Overall Study||12
8074446|NCT03948581|19909648|P2|NOT COMPLETED|Overall Study||1
8074447|NCT03948581|19909649|P1|NOT COMPLETED|Overall Study||0
8074448|NCT03948581|19909648|P2|COMPLETED|Overall Study||50
8074449|NCT03948581|19909649|P1|COMPLETED|Overall Study||51
8074450|NCT03948581|19909648|P2|STARTED|Overall Study||51
8074451|NCT03948581|19909649|P1|STARTED|Overall Study||51
8074452|NCT03946124|19909659|P1|NOT COMPLETED|Overall Study||19
8074453|NCT03946124|19909659|P1|COMPLETED|Overall Study||55
8074454|NCT03946124|19909659|P1|STARTED|Overall Study||74
8074455|NCT03943095|19909665|P2|NOT COMPLETED|Overall Study||1
8074456|NCT03943095|19909666|P1|NOT COMPLETED|Overall Study||1
8074457|NCT03943095|19909665|P2|COMPLETED|Overall Study||51
8074458|NCT03943095|19909666|P1|COMPLETED|Overall Study||51
8074459|NCT03943095|19909665|P2|STARTED|Overall Study||52
8074460|NCT03943095|19909666|P1|STARTED|Overall Study||52
8074461|NCT03937479|19909715|P5|NOT COMPLETED|Overall Study||5
8074462|NCT03937479|19909716|P4|NOT COMPLETED|Overall Study||6
8074463|NCT03937479|19909717|P3|NOT COMPLETED|Overall Study||7
8074464|NCT03937479|19909718|P2|NOT COMPLETED|Overall Study||15
8074465|NCT03937479|19909719|P1|NOT COMPLETED|Overall Study||10
8074466|NCT03937479|19909715|P5|COMPLETED|Overall Study||79
8074467|NCT03937479|19909716|P4|COMPLETED|Overall Study||76
8074468|NCT03937479|19909717|P3|COMPLETED|Overall Study||75
8074469|NCT03937479|19909718|P2|COMPLETED|Overall Study||70
8074470|NCT03937479|19909719|P1|COMPLETED|Overall Study||73
8074471|NCT03937479|19909715|P5|Received Treatment|Overall Study||84
8074472|NCT03937479|19909716|P4|Received Treatment|Overall Study||82
8074473|NCT03937479|19909717|P3|Received Treatment|Overall Study||81
8074474|NCT03937479|19909718|P2|Received Treatment|Overall Study||83
8074475|NCT03937479|19909719|P1|Received Treatment|Overall Study||83
8074476|NCT03937479|19909715|P5|STARTED|Overall Study||84
8074477|NCT03937479|19909716|P4|STARTED|Overall Study||82
8074478|NCT03937479|19909717|P3|STARTED|Overall Study||82
8074479|NCT03937479|19909718|P2|STARTED|Overall Study||85
8074480|NCT03937479|19909719|P1|STARTED|Overall Study||83
8074481|NCT03936608|19909813|P2|NOT COMPLETED|Overall Study||2
8074482|NCT03936608|19909814|P1|NOT COMPLETED|Overall Study||2
8074483|NCT03936608|19909813|P2|COMPLETED|Overall Study||0
8074484|NCT03936608|19909814|P1|COMPLETED|Overall Study||0
8074485|NCT03936608|19909813|P2|STARTED|Overall Study||2
8074486|NCT03936608|19909814|P1|STARTED|Overall Study||2
8074487|NCT03936244|19909822|P2|NOT COMPLETED|Overall Study||4
8074488|NCT03936244|19909823|P1|NOT COMPLETED|Overall Study||12
8074489|NCT03936244|19909822|P2|COMPLETED|Overall Study||39
8074490|NCT03936244|19909823|P1|COMPLETED|Overall Study||45
8074491|NCT03936244|19909822|P2|STARTED|Overall Study||43
8074492|NCT03936244|19909823|P1|STARTED|Overall Study||57
8074493|NCT03933774|19909891|P2|NOT COMPLETED|Overall Study||2
8074494|NCT03933774|19909892|P1|NOT COMPLETED|Overall Study||2
8074495|NCT03933774|19909891|P2|COMPLETED|Overall Study||11
8074496|NCT03933774|19909892|P1|COMPLETED|Overall Study||10
8074497|NCT03933774|19909891|P2|STARTED|Overall Study||13
8074498|NCT03933774|19909892|P1|STARTED|Overall Study||12
8074499|NCT03933618|19909906|P6|NOT COMPLETED|Week 16 to Week 24||0
8074500|NCT03933618|19909907|P5|NOT COMPLETED|Week 16 to Week 24||0
8074501|NCT03933618|19909908|P4|NOT COMPLETED|Week 16 to Week 24||0
8074502|NCT03933618|19909909|P3|NOT COMPLETED|Week 16 to Week 24||0
8074503|NCT03933618|19909910|P2|NOT COMPLETED|Week 16 to Week 24||0
8074504|NCT03933618|19909911|P1|NOT COMPLETED|Week 16 to Week 24||0
8074505|NCT03933618|19909906|P6|COMPLETED|Week 16 to Week 24||4
8074506|NCT03933618|19909907|P5|COMPLETED|Week 16 to Week 24||4
8074507|NCT03933618|19909908|P4|COMPLETED|Week 16 to Week 24||4
8074508|NCT03933618|19909909|P3|COMPLETED|Week 16 to Week 24||4
8074509|NCT03933618|19909910|P2|COMPLETED|Week 16 to Week 24||4
8074510|NCT03933618|19909911|P1|COMPLETED|Week 16 to Week 24||4
8074511|NCT03933618|19909906|P6|STARTED|Week 16 to Week 24||4
8074512|NCT03933618|19909907|P5|STARTED|Week 16 to Week 24||4
8074513|NCT03933618|19909908|P4|STARTED|Week 16 to Week 24||4
8074514|NCT03933618|19909909|P3|STARTED|Week 16 to Week 24||4
8074515|NCT03933618|19909910|P2|STARTED|Week 16 to Week 24||4
8074516|NCT03933618|19909911|P1|STARTED|Week 16 to Week 24||4
8074517|NCT03933618|19909906|P6|NOT COMPLETED|Week 8 to Week 16||0
8074518|NCT03933618|19909907|P5|NOT COMPLETED|Week 8 to Week 16||0
8074519|NCT03933618|19909908|P4|NOT COMPLETED|Week 8 to Week 16||0
8074520|NCT03933618|19909909|P3|NOT COMPLETED|Week 8 to Week 16||0
8074521|NCT03933618|19909910|P2|NOT COMPLETED|Week 8 to Week 16||0
8074522|NCT03933618|19909911|P1|NOT COMPLETED|Week 8 to Week 16||0
8074523|NCT03933618|19909906|P6|COMPLETED|Week 8 to Week 16||4
8074524|NCT03933618|19909907|P5|COMPLETED|Week 8 to Week 16||4
8074525|NCT03933618|19909908|P4|COMPLETED|Week 8 to Week 16||4
8074526|NCT03933618|19909909|P3|COMPLETED|Week 8 to Week 16||4
8074527|NCT03933618|19909910|P2|COMPLETED|Week 8 to Week 16||4
8074528|NCT03933618|19909911|P1|COMPLETED|Week 8 to Week 16||4
8074529|NCT03933618|19909906|P6|STARTED|Week 8 to Week 16||4
8074530|NCT03933618|19909907|P5|STARTED|Week 8 to Week 16||4
8074531|NCT03933618|19909908|P4|STARTED|Week 8 to Week 16||4
8074532|NCT03933618|19909909|P3|STARTED|Week 8 to Week 16||4
8074533|NCT03933618|19909910|P2|STARTED|Week 8 to Week 16||4
8074534|NCT03933618|19909911|P1|STARTED|Week 8 to Week 16||4
8074535|NCT03933618|19909906|P6|NOT COMPLETED|Baseline to Week 8||0
8074536|NCT03933618|19909907|P5|NOT COMPLETED|Baseline to Week 8||0
8074537|NCT03933618|19909908|P4|NOT COMPLETED|Baseline to Week 8||0
8074538|NCT03933618|19909909|P3|NOT COMPLETED|Baseline to Week 8||0
8074539|NCT03933618|19909910|P2|NOT COMPLETED|Baseline to Week 8||0
8074540|NCT03933618|19909911|P1|NOT COMPLETED|Baseline to Week 8||0
8074541|NCT03933618|19909906|P6|COMPLETED|Baseline to Week 8||4
8074542|NCT03933618|19909907|P5|COMPLETED|Baseline to Week 8||4
8074543|NCT03933618|19909908|P4|COMPLETED|Baseline to Week 8||4
8074544|NCT03933618|19909909|P3|COMPLETED|Baseline to Week 8||4
8074545|NCT03933618|19909910|P2|COMPLETED|Baseline to Week 8||4
8074546|NCT03933618|19909911|P1|COMPLETED|Baseline to Week 8||4
8074547|NCT03933618|19909906|P6|STARTED|Baseline to Week 8||4
8074548|NCT03933618|19909907|P5|STARTED|Baseline to Week 8||4
8074549|NCT03933618|19909908|P4|STARTED|Baseline to Week 8||4
8074550|NCT03933618|19909909|P3|STARTED|Baseline to Week 8||4
8074551|NCT03933618|19909910|P2|STARTED|Baseline to Week 8||4
8074552|NCT03933618|19909911|P1|STARTED|Baseline to Week 8||4
8074553|NCT03933618|19909906|P6|NOT COMPLETED|Baseline||0
8074554|NCT03933618|19909907|P5|NOT COMPLETED|Baseline||0
8074555|NCT03933618|19909908|P4|NOT COMPLETED|Baseline||0
8074556|NCT03933618|19909909|P3|NOT COMPLETED|Baseline||0
8074557|NCT03933618|19909910|P2|NOT COMPLETED|Baseline||0
8074558|NCT03933618|19909911|P1|NOT COMPLETED|Baseline||0
8074559|NCT03933618|19909906|P6|COMPLETED|Baseline||4
8074560|NCT03933618|19909907|P5|COMPLETED|Baseline||4
8074561|NCT03933618|19909908|P4|COMPLETED|Baseline||4
8074562|NCT03933618|19909909|P3|COMPLETED|Baseline||4
8074563|NCT03933618|19909910|P2|COMPLETED|Baseline||4
8074564|NCT03933618|19909911|P1|COMPLETED|Baseline||4
8074565|NCT03933618|19909906|P6|STARTED|Baseline||4
8074566|NCT03933618|19909907|P5|STARTED|Baseline||4
8074567|NCT03933618|19909908|P4|STARTED|Baseline||4
8074568|NCT03933618|19909909|P3|STARTED|Baseline||4
8074569|NCT03933618|19909910|P2|STARTED|Baseline||4
8074570|NCT03933618|19909911|P1|STARTED|Baseline||4
8074571|NCT03933462|19910159|P2|NOT COMPLETED|Overall Study||0
8074572|NCT03933462|19910160|P1|NOT COMPLETED|Overall Study||2
8074573|NCT03933462|19910159|P2|COMPLETED|Overall Study||10
8074574|NCT03933462|19910160|P1|COMPLETED|Overall Study||8
8074575|NCT03933462|19910159|P2|Crossover|Overall Study||10
8074576|NCT03933462|19910160|P1|Crossover|Overall Study||8
8074577|NCT03933462|19910159|P2|STARTED|Overall Study||10
8074578|NCT03933462|19910160|P1|STARTED|Overall Study||10
8074579|NCT03933449|19910184|P2|NOT COMPLETED|Overall Study||61
8074580|NCT03933449|19910185|P1|NOT COMPLETED|Overall Study||62
8074581|NCT03933449|19910184|P2|COMPLETED|Overall Study||0
8074582|NCT03933449|19910185|P1|COMPLETED|Overall Study||0
8074583|NCT03933449|19910184|P2|Treated|Overall Study||59
8074584|NCT03933449|19910185|P1|Treated|Overall Study||62
8074585|NCT03933449|19910184|P2|STARTED|Overall Study||61
8074586|NCT03933449|19910185|P1|STARTED|Overall Study||62
8074587|NCT03930641|19910207|P1|NOT COMPLETED|Overall Study||0
8074588|NCT03930641|19910207|P1|COMPLETED|Overall Study||34
8074589|NCT03930641|19910207|P1|STARTED|Overall Study||34
8074590|NCT03928522|19910216|P5|NOT COMPLETED|Overall Study||0
8074591|NCT03928522|19910217|P4|NOT COMPLETED|Overall Study||0
8074592|NCT03928522|19910218|P3|NOT COMPLETED|Overall Study||0
8074593|NCT03928522|19910219|P2|NOT COMPLETED|Overall Study||0
8074594|NCT03928522|19910220|P1|NOT COMPLETED|Overall Study||0
8074595|NCT03928522|19910216|P5|COMPLETED|Overall Study||12
8074596|NCT03928522|19910217|P4|COMPLETED|Overall Study||12
8074597|NCT03928522|19910218|P3|COMPLETED|Overall Study||12
8074598|NCT03928522|19910219|P2|COMPLETED|Overall Study||12
8074599|NCT03928522|19910220|P1|COMPLETED|Overall Study||12
8074600|NCT03928522|19910216|P5|STARTED|Overall Study||12
8074601|NCT03928522|19910217|P4|STARTED|Overall Study||12
8074602|NCT03928522|19910218|P3|STARTED|Overall Study||12
8074603|NCT03928522|19910219|P2|STARTED|Overall Study||12
8074604|NCT03928522|19910220|P1|STARTED|Overall Study||12
8074605|NCT03928327|19910234|P2|NOT COMPLETED|Period 2||0
8074606|NCT03928327|19910235|P1|NOT COMPLETED|Period 2||0
8074607|NCT03928327|19910234|P2|COMPLETED|Period 2||12
8074608|NCT03928327|19910235|P1|COMPLETED|Period 2||12
8074609|NCT03928327|19910234|P2|STARTED|Period 2||12
8074610|NCT03928327|19910235|P1|STARTED|Period 2||12
8074611|NCT03928327|19910234|P2|NOT COMPLETED|Washout Period||0
8074612|NCT03928327|19910235|P1|NOT COMPLETED|Washout Period||0
8074613|NCT03928327|19910234|P2|COMPLETED|Washout Period||12
8074614|NCT03928327|19910235|P1|COMPLETED|Washout Period||12
8074615|NCT03928327|19910234|P2|STARTED|Washout Period||12
8074616|NCT03928327|19910235|P1|STARTED|Washout Period||12
8074617|NCT03928327|19910234|P2|NOT COMPLETED|Period 1||0
8074618|NCT03928327|19910235|P1|NOT COMPLETED|Period 1||0
8074619|NCT03928327|19910234|P2|COMPLETED|Period 1||12
8074620|NCT03928327|19910235|P1|COMPLETED|Period 1||12
8074621|NCT03928327|19910234|P2|STARTED|Period 1||12
8074622|NCT03928327|19910235|P1|STARTED|Period 1||12
8074623|NCT03927950|19910261|P1|NOT COMPLETED|Overall Study||9
8074624|NCT03927950|19910261|P1|COMPLETED|Overall Study||126
8074625|NCT03927950|19910261|P1|STARTED|Overall Study||135
8074626|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 4||0
8074627|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 4||0
8074628|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 4||0
8074629|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 4||0
8074630|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 4||0
8074631|NCT03926065|19910266|P5|COMPLETED|Study Week 4||15
8074632|NCT03926065|19910267|P4|COMPLETED|Study Week 4||18
8074633|NCT03926065|19910268|P3|COMPLETED|Study Week 4||14
8074634|NCT03926065|19910269|P2|COMPLETED|Study Week 4||9
8074635|NCT03926065|19910270|P1|COMPLETED|Study Week 4||11
8074636|NCT03926065|19910266|P5|STARTED|Study Week 4||15
8074637|NCT03926065|19910267|P4|STARTED|Study Week 4||18
8074638|NCT03926065|19910268|P3|STARTED|Study Week 4||14
8074639|NCT03926065|19910269|P2|STARTED|Study Week 4||9
8074640|NCT03926065|19910270|P1|STARTED|Study Week 4||11
8074641|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 3||0
8074642|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 3||0
8074643|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 3||0
8074644|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 3||0
8074645|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 3||0
8074646|NCT03926065|19910266|P5|COMPLETED|Study Week 3||15
8074647|NCT03926065|19910267|P4|COMPLETED|Study Week 3||18
8074648|NCT03926065|19910268|P3|COMPLETED|Study Week 3||14
8074649|NCT03926065|19910269|P2|COMPLETED|Study Week 3||9
8074650|NCT03926065|19910270|P1|COMPLETED|Study Week 3||11
8074651|NCT03926065|19910266|P5|STARTED|Study Week 3||15
8074652|NCT03926065|19910267|P4|STARTED|Study Week 3||18
8074653|NCT03926065|19910268|P3|STARTED|Study Week 3||14
8074654|NCT03926065|19910269|P2|STARTED|Study Week 3||9
8074655|NCT03926065|19910270|P1|STARTED|Study Week 3||11
8074656|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 2||0
8074657|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 2||0
8074658|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 2||0
8074659|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 2||0
8074660|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 2||0
8074661|NCT03926065|19910266|P5|COMPLETED|Study Week 2||15
8074662|NCT03926065|19910267|P4|COMPLETED|Study Week 2||18
8074663|NCT03926065|19910268|P3|COMPLETED|Study Week 2||14
8074664|NCT03926065|19910269|P2|COMPLETED|Study Week 2||9
8074665|NCT03926065|19910270|P1|COMPLETED|Study Week 2||11
8074666|NCT03926065|19910266|P5|STARTED|Study Week 2||15
8074667|NCT03926065|19910267|P4|STARTED|Study Week 2||18
8074668|NCT03926065|19910268|P3|STARTED|Study Week 2||14
8074669|NCT03926065|19910269|P2|STARTED|Study Week 2||9
8074670|NCT03926065|19910270|P1|STARTED|Study Week 2||11
8074671|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 1||0
8074672|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 1||0
8074673|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 1||0
8074674|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 1||0
8074675|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 1||0
8074676|NCT03926065|19910266|P5|COMPLETED|Study Week 1||15
8074677|NCT03926065|19910267|P4|COMPLETED|Study Week 1||18
8074678|NCT03926065|19910268|P3|COMPLETED|Study Week 1||14
8074679|NCT03926065|19910269|P2|COMPLETED|Study Week 1||9
8074680|NCT03926065|19910270|P1|COMPLETED|Study Week 1||11
8074681|NCT03926065|19910266|P5|STARTED|Study Week 1||15
8074682|NCT03926065|19910267|P4|STARTED|Study Week 1||18
8074683|NCT03926065|19910268|P3|STARTED|Study Week 1||14
8074684|NCT03926065|19910269|P2|STARTED|Study Week 1||9
8074685|NCT03926065|19910270|P1|STARTED|Study Week 1||11
8074686|NCT03923933|19910294|P2|NOT COMPLETED|Overall Study||1
8074687|NCT03923933|19910295|P1|NOT COMPLETED|Overall Study||1
8074688|NCT03923933|19910294|P2|COMPLETED|Overall Study||16
8074689|NCT03923933|19910295|P1|COMPLETED|Overall Study||16
8074690|NCT03923933|19910294|P2|STARTED|Overall Study||17
8074691|NCT03923933|19910295|P1|STARTED|Overall Study||17
8074692|NCT03923530|19910313|P1|NOT COMPLETED|Overall Study||4
8074693|NCT03923530|19910313|P1|COMPLETED|Overall Study||8
8074694|NCT03923530|19910313|P1|STARTED|Overall Study||12
8074695|NCT03922750|19910326|P3|NOT COMPLETED|Overall Study||1
8074696|NCT03922750|19910327|P2|NOT COMPLETED|Overall Study||1
8074697|NCT03922750|19910328|P1|NOT COMPLETED|Overall Study||0
8074698|NCT03922750|19910326|P3|COMPLETED|Overall Study||49
8074699|NCT03922750|19910327|P2|COMPLETED|Overall Study||53
8074700|NCT03922750|19910328|P1|COMPLETED|Overall Study||50
8074701|NCT03922750|19910326|P3|Safety Analysis Set (SAS)|Overall Study||50
8074702|NCT03922750|19910327|P2|Safety Analysis Set (SAS)|Overall Study||54
8074703|NCT03922750|19910328|P1|Safety Analysis Set (SAS)|Overall Study||50
8074704|NCT03922750|19910326|P3|Full Analysis Set (FAS)|Overall Study||50
8074705|NCT03922750|19910327|P2|Full Analysis Set (FAS)|Overall Study||54
8074706|NCT03922750|19910328|P1|Full Analysis Set (FAS)|Overall Study||50
8074707|NCT03922750|19910326|P3|STARTED|Overall Study||50
8074708|NCT03922750|19910327|P2|STARTED|Overall Study||54
8074709|NCT03922750|19910328|P1|STARTED|Overall Study||50
8074710|NCT03921723|19910360|P1|NOT COMPLETED|Period 3 (4 Days)||1
8074711|NCT03921723|19910360|P1|COMPLETED|Period 3 (4 Days)||18
8074712|NCT03921723|19910360|P1|STARTED|Period 3 (4 Days)||19
8074713|NCT03921723|19910360|P1|NOT COMPLETED|Period 2 (4 Days)||3
8074714|NCT03921723|19910360|P1|COMPLETED|Period 2 (4 Days)||19
8074715|NCT03921723|19910360|P1|STARTED|Period 2 (4 Days)||22
8074716|NCT03921723|19910360|P1|NOT COMPLETED|Period 1 (4 Days)||0
8074717|NCT03921723|19910360|P1|COMPLETED|Period 1 (4 Days)||22
8074718|NCT03921723|19910360|P1|STARTED|Period 1 (4 Days)||22
8074719|NCT03921190|19910430|P2|NOT COMPLETED|Overall Study||0
8074720|NCT03921190|19910431|P1|NOT COMPLETED|Overall Study||0
8074721|NCT03921190|19910430|P2|COMPLETED|Overall Study||64
8074722|NCT03921190|19910431|P1|COMPLETED|Overall Study||56
8074723|NCT03921190|19910430|P2|STARTED|Overall Study||64
8074724|NCT03921190|19910431|P1|STARTED|Overall Study||56
8074725|NCT03919422|19910443|P2|NOT COMPLETED|Overall Study||0
8074726|NCT03919422|19910444|P1|NOT COMPLETED|Overall Study||0
8074727|NCT03919422|19910443|P2|COMPLETED|Overall Study||40
8074728|NCT03919422|19910444|P1|COMPLETED|Overall Study||40
8074729|NCT03919422|19910443|P2|STARTED|Overall Study||40
8074730|NCT03919422|19910444|P1|STARTED|Overall Study||40
8074731|NCT03918239|19910466|P2|NOT COMPLETED|Overall Study||7
8074732|NCT03918239|19910467|P1|NOT COMPLETED|Overall Study||10
8074733|NCT03918239|19910466|P2|COMPLETED|Overall Study||89
8074734|NCT03918239|19910467|P1|COMPLETED|Overall Study||84
8074735|NCT03918239|19910466|P2|STARTED|Overall Study||96
8074736|NCT03918239|19910467|P1|STARTED|Overall Study||94
8074737|NCT03914950|19910491|P1|NOT COMPLETED|Overall Study||54
8074738|NCT03914950|19910491|P1|COMPLETED|Overall Study||120
8074739|NCT03914950|19910491|P1|STARTED|Overall Study||174
8074740|NCT03914417|19910501|P1|NOT COMPLETED|Overall Study||2
8074741|NCT03914417|19910501|P1|COMPLETED|Overall Study||19
8074742|NCT03914417|19910501|P1|STARTED|Overall Study||21
8074761|NCT03911960|19910527|P2|NOT COMPLETED|Overall Study||3
8074762|NCT03911960|19910528|P1|NOT COMPLETED|Overall Study||5
8074763|NCT03911960|19910527|P2|COMPLETED|Overall Study||2
8074764|NCT03911960|19910528|P1|COMPLETED|Overall Study||4
8074765|NCT03911960|19910527|P2|STARTED|Overall Study||5
8074766|NCT03911960|19910528|P1|STARTED|Overall Study||9
8074767|NCT03911752|19910550|P3|NOT COMPLETED|Overall Study||0
8074768|NCT03911752|19910551|P2|NOT COMPLETED|Overall Study||0
8074769|NCT03911752|19910552|P1|NOT COMPLETED|Overall Study||0
8074770|NCT03911752|19910550|P3|COMPLETED|Overall Study||2
8074771|NCT03911752|19910551|P2|COMPLETED|Overall Study||2
8074772|NCT03911752|19910552|P1|COMPLETED|Overall Study||8
8074773|NCT03911752|19910550|P3|STARTED|Overall Study||2
8074774|NCT03911752|19910551|P2|STARTED|Overall Study||2
8074775|NCT03911752|19910552|P1|STARTED|Overall Study||8
8074776|NCT03911401|19910572|P3|NOT COMPLETED|Overall Study||25
8074777|NCT03911401|19910573|P2|NOT COMPLETED|Overall Study||9
8074778|NCT03911401|19910574|P1|NOT COMPLETED|Overall Study||7
8074779|NCT03911401|19910572|P3|COMPLETED|Overall Study||58
8074780|NCT03911401|19910573|P2|COMPLETED|Overall Study||76
8074781|NCT03911401|19910574|P1|COMPLETED|Overall Study||76
8074782|NCT03911401|19910572|P3|STARTED|Overall Study||83
8074783|NCT03911401|19910573|P2|STARTED|Overall Study||85
8074784|NCT03911401|19910574|P1|STARTED|Overall Study||83
8074785|NCT03909763|19910588|P1|NOT COMPLETED|Overall Study||10
8074786|NCT03909763|19910588|P1|COMPLETED|Overall Study||45
8074787|NCT03909763|19910588|P1|STARTED|Overall Study||55
8074788|NCT03909295|19910595|P1|NOT COMPLETED|Overall Study||52
8074789|NCT03909295|19910595|P1|COMPLETED|Overall Study||0
8074790|NCT03909295|19910595|P1|Safety Set (SAF)|Overall Study||52
8074791|NCT03909295|19910595|P1|STARTED|Overall Study||52
8074792|NCT03909009|19910601|P2|NOT COMPLETED|Overall Study||0
8074793|NCT03909009|19910602|P1|NOT COMPLETED|Overall Study||0
8074794|NCT03909009|19910601|P2|COMPLETED|Overall Study||10
8074795|NCT03909009|19910602|P1|COMPLETED|Overall Study||10
8074796|NCT03909009|19910601|P2|STARTED|Overall Study||10
8074797|NCT03909009|19910602|P1|STARTED|Overall Study||10
8074798|NCT03908970|19910624|P2|NOT COMPLETED|Overall Study||47
8074799|NCT03908970|19910625|P1|NOT COMPLETED|Overall Study||17
8074800|NCT03908970|19910624|P2|COMPLETED|Overall Study||135
8074801|NCT03908970|19910625|P1|COMPLETED|Overall Study||165
8074802|NCT03908970|19910624|P2|STARTED|Overall Study||182
8074803|NCT03908970|19910625|P1|STARTED|Overall Study||182
8074804|NCT03907579|19910635|P1|NOT COMPLETED|Overall Study||0
8074805|NCT03907579|19910635|P1|COMPLETED|Overall Study||100
8074806|NCT03907579|19910635|P1|STARTED|Overall Study||100
8074807|NCT03907241|19910644|P1|NOT COMPLETED|Overall Study||4
8074808|NCT03907241|19910644|P1|COMPLETED|Overall Study||23
8074809|NCT03907241|19910644|P1|STARTED|Overall Study||27
8074810|NCT03905642|19910763|P1|NOT COMPLETED|Overall Study||8
8074811|NCT03905642|19910763|P1|COMPLETED|Overall Study||41
8074812|NCT03905642|19910763|P1|STARTED|Overall Study||49
8074813|NCT03904420|19910774|P2|NOT COMPLETED|Overall Study||2
8074814|NCT03904420|19910775|P1|NOT COMPLETED|Overall Study||2
8074815|NCT03904420|19910774|P2|COMPLETED|Overall Study||0
8074816|NCT03904420|19910775|P1|COMPLETED|Overall Study||0
8074817|NCT03904420|19910774|P2|STARTED|Overall Study||2
8074818|NCT03904420|19910775|P1|STARTED|Overall Study||2
8074819|NCT03902613|19910781|P1|NOT COMPLETED|Overall Study||1
8074820|NCT03902613|19910781|P1|COMPLETED|Overall Study||0
8074821|NCT03902613|19910781|P1|STARTED|Overall Study||1
8074822|NCT03902392|19910787|P2|NOT COMPLETED|Overall Study||7
8074823|NCT03902392|19910788|P1|NOT COMPLETED|Overall Study||7
8074824|NCT03902392|19910787|P2|COMPLETED|Overall Study||18
8074825|NCT03902392|19910788|P1|COMPLETED|Overall Study||18
8074826|NCT03902392|19910787|P2|STARTED|Overall Study||25
8074827|NCT03902392|19910788|P1|STARTED|Overall Study||25
8074828|NCT03901313|19910796|P6|NOT COMPLETED|Overall Study||0
8074829|NCT03901313|19910797|P5|NOT COMPLETED|Overall Study||0
8074830|NCT03901313|19910798|P4|NOT COMPLETED|Overall Study||0
8074831|NCT03901313|19910799|P3|NOT COMPLETED|Overall Study||0
8074832|NCT03901313|19910800|P2|NOT COMPLETED|Overall Study||0
8074833|NCT03901313|19910801|P1|NOT COMPLETED|Overall Study||0
8074834|NCT03901313|19910796|P6|COMPLETED|Overall Study||4
8074835|NCT03901313|19910797|P5|COMPLETED|Overall Study||4
8074836|NCT03901313|19910798|P4|COMPLETED|Overall Study||4
8074837|NCT03901313|19910799|P3|COMPLETED|Overall Study||4
8074838|NCT03901313|19910800|P2|COMPLETED|Overall Study||4
8074839|NCT03901313|19910801|P1|COMPLETED|Overall Study||4
8074840|NCT03901313|19910796|P6|STARTED|Overall Study||4
8074841|NCT03901313|19910797|P5|STARTED|Overall Study||4
8074842|NCT03901313|19910798|P4|STARTED|Overall Study||4
8074843|NCT03901313|19910799|P3|STARTED|Overall Study||4
8074844|NCT03901313|19910800|P2|STARTED|Overall Study||4
8074845|NCT03901313|19910801|P1|STARTED|Overall Study||4
8074846|NCT03901105|19910818|P1|NOT COMPLETED|Overall Study||0
8074847|NCT03901105|19910818|P1|COMPLETED|Overall Study||205
8074848|NCT03901105|19910818|P1|STARTED|Overall Study||205
8074849|NCT03901092|19910828|P2|NOT COMPLETED|Overall Study||0
8074850|NCT03901092|19910829|P1|NOT COMPLETED|Overall Study||0
8074851|NCT03901092|19910828|P2|COMPLETED|Overall Study||159
8074852|NCT03901092|19910829|P1|COMPLETED|Overall Study||83
8074853|NCT03901092|19910828|P2|STARTED|Overall Study||159
8074854|NCT03901092|19910829|P1|STARTED|Overall Study||83
8074855|NCT03900299|19910846|P2|NOT COMPLETED|Overall Study||0
8074856|NCT03900299|19910847|P1|NOT COMPLETED|Overall Study||0
8074857|NCT03900299|19910846|P2|COMPLETED|Overall Study||58
8074858|NCT03900299|19910847|P1|COMPLETED|Overall Study||56
8074859|NCT03900299|19910846|P2|STARTED|Overall Study||58
8074860|NCT03900299|19910847|P1|STARTED|Overall Study||56
8074861|NCT03899064|19910854|P1|NOT COMPLETED|Overall Study||7
8074862|NCT03899064|19910854|P1|COMPLETED|Overall Study||51
8074863|NCT03899064|19910854|P1|Control, Irradiation|Overall Study||58
8074864|NCT03899064|19910854|P1|MC2-01 Vehicle, no Irradiation|Overall Study||58
8074865|NCT03899064|19910854|P1|MC2-01 Vehicle, Irradiation|Overall Study||58
8074866|NCT03899064|19910854|P1|MC2-01 Cream, No Irradiation|Overall Study||58
8074867|NCT03899064|19910854|P1|MC2-01 Cream, Irradiation|Overall Study||58
8074868|NCT03899064|19910854|P1|STARTED|Overall Study||58
8074869|NCT03898349|19910862|P2|NOT COMPLETED|Overall Study||610
8074870|NCT03898349|19910863|P1|NOT COMPLETED|Overall Study||110
8074871|NCT03898349|19910862|P2|COMPLETED|Overall Study||15
8074872|NCT03898349|19910863|P1|COMPLETED|Overall Study||15
8074873|NCT03898349|19910862|P2|STARTED|Overall Study||625
8074874|NCT03898349|19910863|P1|STARTED|Overall Study||125
8074875|NCT03897179|19910869|P1|NOT COMPLETED|Overall Study||1
8074876|NCT03897179|19910869|P1|COMPLETED|Overall Study||26
8074877|NCT03897179|19910869|P1|STARTED|Overall Study||27
8074887|NCT03895632|19910890|P1|NOT COMPLETED|Overall Study||0
8074888|NCT03895632|19910890|P1|COMPLETED|Overall Study||25
8074889|NCT03895632|19910890|P1|STARTED|Overall Study||25
8074890|NCT03895307|19910902|P4|NOT COMPLETED|Overall Study||0
8074891|NCT03895307|19910903|P3|NOT COMPLETED|Overall Study||2
8074892|NCT03895307|19910904|P2|NOT COMPLETED|Overall Study||0
8074893|NCT03895307|19910905|P1|NOT COMPLETED|Overall Study||2
8074894|NCT03895307|19910902|P4|COMPLETED|Overall Study||21
8074895|NCT03895307|19910903|P3|COMPLETED|Overall Study||20
8074896|NCT03895307|19910904|P2|COMPLETED|Overall Study||20
8074897|NCT03895307|19910905|P1|COMPLETED|Overall Study||19
8074898|NCT03895307|19910902|P4|STARTED|Overall Study||21
8074899|NCT03895307|19910903|P3|STARTED|Overall Study||22
8074900|NCT03895307|19910904|P2|STARTED|Overall Study||20
8074901|NCT03895307|19910905|P1|STARTED|Overall Study||21
8074902|NCT03894449|19910996|P5|NOT COMPLETED|Overall Study||0
8074903|NCT03894449|19910997|P4|NOT COMPLETED|Overall Study||0
8074904|NCT03894449|19910998|P3|NOT COMPLETED|Overall Study||0
8074905|NCT03894449|19910999|P2|NOT COMPLETED|Overall Study||0
8074906|NCT03894449|19911000|P1|NOT COMPLETED|Overall Study||0
8074907|NCT03894449|19910996|P5|COMPLETED|Overall Study||15
8074908|NCT03894449|19910997|P4|COMPLETED|Overall Study||15
8074909|NCT03894449|19910998|P3|COMPLETED|Overall Study||15
8074910|NCT03894449|19910999|P2|COMPLETED|Overall Study||15
8074911|NCT03894449|19911000|P1|COMPLETED|Overall Study||15
8074912|NCT03894449|19910996|P5|STARTED|Overall Study||15
8074913|NCT03894449|19910997|P4|STARTED|Overall Study||15
8074914|NCT03894449|19910998|P3|STARTED|Overall Study||15
8074915|NCT03894449|19910999|P2|STARTED|Overall Study||15
8074916|NCT03894449|19911000|P1|STARTED|Overall Study||15
8074917|NCT03892564|19911112|P1|NOT COMPLETED|Overall Study||2
8074918|NCT03892564|19911112|P1|COMPLETED|Overall Study||33
8074919|NCT03892564|19911112|P1|Control Site|Overall Study||35
8074920|NCT03892564|19911112|P1|MC2-01 Vehicle + Non-irridiation|Overall Study||35
8074921|NCT03892564|19911112|P1|MC2-01 Vehicle + Irridiation|Overall Study||35
8074922|NCT03892564|19911112|P1|MC2-01 Cream + Non-irridiation|Overall Study||35
8074923|NCT03892564|19911112|P1|MC2-01 Cream + Irridiation|Overall Study||35
8074924|NCT03892564|19911112|P1|STARTED|Overall Study||35
8074925|NCT03891641|19911120|P2|NOT COMPLETED|Overall Study||2
8074926|NCT03891641|19911121|P1|NOT COMPLETED|Overall Study||2
8074927|NCT03891641|19911120|P2|COMPLETED|Overall Study||5
8074928|NCT03891641|19911121|P1|COMPLETED|Overall Study||8
8074929|NCT03891641|19911120|P2|STARTED|Overall Study||7
8074930|NCT03891641|19911121|P1|STARTED|Overall Study||10
8074931|NCT03889444|19911133|P1|NOT COMPLETED|Overall Study||0
8074932|NCT03889444|19911133|P1|COMPLETED|Overall Study||141
8074933|NCT03889444|19911133|P1|STARTED|Overall Study||141
8074934|NCT03889028|19911146|P3|NOT COMPLETED|Overall Study||0
8074935|NCT03889028|19911147|P2|NOT COMPLETED|Overall Study||0
8074936|NCT03889028|19911148|P1|NOT COMPLETED|Overall Study||0
8074937|NCT03889028|19911146|P3|COMPLETED|Overall Study||312
8074938|NCT03889028|19911147|P2|COMPLETED|Overall Study||422
8074939|NCT03889028|19911148|P1|COMPLETED|Overall Study||144
8074940|NCT03889028|19911146|P3|STARTED|Overall Study||312
8074941|NCT03889028|19911147|P2|STARTED|Overall Study||422
8074942|NCT03889028|19911148|P1|STARTED|Overall Study||144
8074943|NCT03888755|19911159|P1|NOT COMPLETED|Overall Study||0
8074944|NCT03888755|19911159|P1|COMPLETED|Overall Study||8
8074945|NCT03888755|19911159|P1|STARTED|Overall Study||8
8074946|NCT03888482|19911182|P2|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
8074947|NCT03888482|19911183|P1|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
8074948|NCT03888482|19911182|P2|COMPLETED|Second Wear (8 -1/+2 Days)||74
8074949|NCT03888482|19911183|P1|COMPLETED|Second Wear (8 -1/+2 Days)||73
8074950|NCT03888482|19911182|P2|STARTED|Second Wear (8 -1/+2 Days)||75
8074951|NCT03888482|19911183|P1|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
8074952|NCT03888482|19911182|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074953|NCT03888482|19911183|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074954|NCT03888482|19911182|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||75
8074955|NCT03888482|19911183|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||76
8074956|NCT03888482|19911182|P2|STARTED|First Wear Period (8 -1/+2 Days)||75
8074957|NCT03888482|19911183|P1|STARTED|First Wear Period (8 -1/+2 Days)||76
8074958|NCT03888469|19911193|P2|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
8074959|NCT03888469|19911194|P1|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
8074960|NCT03888469|19911193|P2|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
8074961|NCT03888469|19911194|P1|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
8074962|NCT03888469|19911193|P2|STARTED|Second Wear Period (8 -1/+2 Days)||46
8074963|NCT03888469|19911194|P1|STARTED|Second Wear Period (8 -1/+2 Days)||46
8074964|NCT03888469|19911193|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074965|NCT03888469|19911194|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074966|NCT03888469|19911193|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||46
8074967|NCT03888469|19911194|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||46
8074968|NCT03888469|19911193|P2|STARTED|First Wear Period (8 -1/+2 Days)||46
8074969|NCT03888469|19911194|P1|STARTED|First Wear Period (8 -1/+2 Days)||46
8074970|NCT03888391|19911202|P1|NOT COMPLETED|Overall Study||15
8074971|NCT03888391|19911202|P1|COMPLETED|Overall Study||3
8074972|NCT03888391|19911202|P1|STARTED|Overall Study||18
8074973|NCT03888274|19911212|P1|NOT COMPLETED|Overall Study||0
8074974|NCT03888274|19911212|P1|COMPLETED|Overall Study||30
8074975|NCT03888274|19911212|P1|STARTED|Overall Study||30
8074976|NCT03887442|19911220|P2|NOT COMPLETED|Overall Study||0
8074977|NCT03887442|19911221|P1|NOT COMPLETED|Overall Study||1
8074978|NCT03887442|19911220|P2|COMPLETED|Overall Study||8
8074979|NCT03887442|19911221|P1|COMPLETED|Overall Study||8
8074980|NCT03887442|19911220|P2|STARTED|Overall Study||8
8074981|NCT03887442|19911221|P1|STARTED|Overall Study||9
8074982|NCT03887429|19911239|P4|NOT COMPLETED|Overall Study||1
8074983|NCT03887429|19911240|P3|NOT COMPLETED|Overall Study||2
8074984|NCT03887429|19911241|P2|NOT COMPLETED|Overall Study||1
8074985|NCT03887429|19911242|P1|NOT COMPLETED|Overall Study||1
8074986|NCT03887429|19911239|P4|COMPLETED|Overall Study||7
8074987|NCT03887429|19911240|P3|COMPLETED|Overall Study||7
8074988|NCT03887429|19911241|P2|COMPLETED|Overall Study||8
8074989|NCT03887429|19911242|P1|COMPLETED|Overall Study||7
8074990|NCT03887429|19911239|P4|Completed Second Intervention (5 Days)|Overall Study||7
8074991|NCT03887429|19911240|P3|Completed Second Intervention (5 Days)|Overall Study||7
8074992|NCT03887429|19911241|P2|Completed Second Intervention (5 Days)|Overall Study||8
8074993|NCT03887429|19911242|P1|Completed Second Intervention (5 Days)|Overall Study||7
8074994|NCT03887429|19911239|P4|Completed Washout (9 Days)|Overall Study||7
8074995|NCT03887429|19911240|P3|Completed Washout (9 Days)|Overall Study||7
8074996|NCT03887429|19911241|P2|Completed Washout (9 Days)|Overall Study||8
8074997|NCT03887429|19911242|P1|Completed Washout (9 Days)|Overall Study||7
8074998|NCT03887429|19911239|P4|Completed First Intervention (5 Days)|Overall Study||7
8074999|NCT03887429|19911240|P3|Completed First Intervention (5 Days)|Overall Study||7
8075000|NCT03887429|19911241|P2|Completed First Intervention (5 Days)|Overall Study||8
8075001|NCT03887429|19911242|P1|Completed First Intervention (5 Days)|Overall Study||7
8075002|NCT03887429|19911239|P4|STARTED|Overall Study||8
8075003|NCT03887429|19911240|P3|STARTED|Overall Study||9
8075004|NCT03887429|19911241|P2|STARTED|Overall Study||9
8075005|NCT03887429|19911242|P1|STARTED|Overall Study||8
8075006|NCT03887286|19911266|P1|NOT COMPLETED|Overall Study||0
8075007|NCT03887286|19911266|P1|COMPLETED|Overall Study||47
8075008|NCT03887286|19911266|P1|STARTED|Overall Study||47
8075009|NCT03886701|19911271|P1|NOT COMPLETED|Period 2: Study Days 7-21||0
8075010|NCT03886701|19911271|P1|COMPLETED|Period 2: Study Days 7-21||11
8075011|NCT03886701|19911271|P1|STARTED|Period 2: Study Days 7-21||11
8075012|NCT03886701|19911271|P1|NOT COMPLETED|Period 1: Study Days 1-4||0
8075013|NCT03886701|19911271|P1|COMPLETED|Period 1: Study Days 1-4||11
8075014|NCT03886701|19911271|P1|STARTED|Period 1: Study Days 1-4||11
8075015|NCT03885726|19911283|P1|NOT COMPLETED|Overall Study||4
8075016|NCT03885726|19911283|P1|COMPLETED|Overall Study||28
8075017|NCT03885726|19911283|P1|STARTED|Overall Study||32
8075018|NCT03883386|19911349|P2|NOT COMPLETED|Washout and Second Assignment||0
8075019|NCT03883386|19911350|P1|NOT COMPLETED|Washout and Second Assignment||0
8075020|NCT03883386|19911349|P2|COMPLETED|Washout and Second Assignment||0
8075021|NCT03883386|19911350|P1|COMPLETED|Washout and Second Assignment||0
8075022|NCT03883386|19911349|P2|STARTED|Washout and Second Assignment||0
8075023|NCT03883386|19911350|P1|STARTED|Washout and Second Assignment||0
8075024|NCT03883386|19911349|P2|NOT COMPLETED|First Assignment||1
8075025|NCT03883386|19911350|P1|NOT COMPLETED|First Assignment||2
8075026|NCT03883386|19911349|P2|COMPLETED|First Assignment||0
8075027|NCT03883386|19911350|P1|COMPLETED|First Assignment||0
8075028|NCT03883386|19911349|P2|Surveys Begun|First Assignment||1
8075029|NCT03883386|19911350|P1|Surveys Begun|First Assignment||1
8075030|NCT03883386|19911349|P2|STARTED|First Assignment||1
8075031|NCT03883386|19911350|P1|STARTED|First Assignment||2
8075032|NCT03882801|19911360|P2|NOT COMPLETED|Period 2||1
8075033|NCT03882801|19911361|P1|NOT COMPLETED|Period 2||0
8075034|NCT03882801|19911360|P2|COMPLETED|Period 2||8
8075035|NCT03882801|19911361|P1|COMPLETED|Period 2||10
8075036|NCT03882801|19911360|P2|STARTED|Period 2||9
8075037|NCT03882801|19911361|P1|STARTED|Period 2||10
8075038|NCT03882801|19911360|P2|NOT COMPLETED|Washout Period||1
8075039|NCT03882801|19911361|P1|NOT COMPLETED|Washout Period||0
8075040|NCT03882801|19911360|P2|COMPLETED|Washout Period||9
8075041|NCT03882801|19911361|P1|COMPLETED|Washout Period||10
8075042|NCT03882801|19911360|P2|STARTED|Washout Period||10
8075043|NCT03882801|19911361|P1|STARTED|Washout Period||10
8075044|NCT03882801|19911360|P2|NOT COMPLETED|Period 1||2
8075045|NCT03882801|19911361|P1|NOT COMPLETED|Period 1||2
8075046|NCT03882801|19911360|P2|COMPLETED|Period 1||10
8075047|NCT03882801|19911361|P1|COMPLETED|Period 1||10
8075048|NCT03882801|19911360|P2|Treated|Period 1||12
8075049|NCT03882801|19911361|P1|Treated|Period 1|1 participant did not receive any dose of study drug|11
8075050|NCT03882801|19911360|P2|STARTED|Period 1||12
8075051|NCT03882801|19911361|P1|STARTED|Period 1||12
8075052|NCT03882424|19911376|P3|NOT COMPLETED|Overall Study||0
8075053|NCT03882424|19911377|P2|NOT COMPLETED|Overall Study||0
8075054|NCT03882424|19911378|P1|NOT COMPLETED|Overall Study||4
8075055|NCT03882424|19911376|P3|COMPLETED|Overall Study||38
8075056|NCT03882424|19911377|P2|COMPLETED|Overall Study||38
8075057|NCT03882424|19911378|P1|COMPLETED|Overall Study||34
8075058|NCT03882424|19911376|P3|STARTED|Overall Study||38
8075059|NCT03882424|19911377|P2|STARTED|Overall Study||38
8075060|NCT03882424|19911378|P1|STARTED|Overall Study||38
8075061|NCT03882047|19911401|P3|NOT COMPLETED|Overall Study||16
8075062|NCT03882047|19911402|P2|NOT COMPLETED|Overall Study||10
8075063|NCT03882047|19911403|P1|NOT COMPLETED|Overall Study||6
8075064|NCT03882047|19911401|P3|COMPLETED|Overall Study||88
8075065|NCT03882047|19911402|P2|COMPLETED|Overall Study||95
8075066|NCT03882047|19911403|P1|COMPLETED|Overall Study||98
8075067|NCT03882047|19911401|P3|Treated|Overall Study||103
8075068|NCT03882047|19911402|P2|Treated|Overall Study||104
8075069|NCT03882047|19911403|P1|Treated|Overall Study||104
8075070|NCT03882047|19911401|P3|STARTED|Overall Study||104
8075071|NCT03882047|19911402|P2|STARTED|Overall Study||105
8075072|NCT03882047|19911403|P1|STARTED|Overall Study||104
8075073|NCT03881670|19911443|P2|NOT COMPLETED|Overall Study||0
8075074|NCT03881670|19911444|P1|NOT COMPLETED|Overall Study||0
8075075|NCT03881670|19911443|P2|COMPLETED|Overall Study||12
8075076|NCT03881670|19911444|P1|COMPLETED|Overall Study||12
8075077|NCT03881670|19911443|P2|Completed Second Intervetion|Overall Study||12
8075078|NCT03881670|19911444|P1|Completed Second Intervetion|Overall Study||12
8075079|NCT03881670|19911443|P2|Completed First Intervention|Overall Study||12
8075080|NCT03881670|19911444|P1|Completed First Intervention|Overall Study||12
8075081|NCT03881670|19911443|P2|STARTED|Overall Study||12
8075082|NCT03881670|19911444|P1|STARTED|Overall Study||12
8075086|NCT03879772|19911480|P5|NOT COMPLETED|Overall Study||8
8075087|NCT03879772|19911481|P4|NOT COMPLETED|Overall Study||8
8075088|NCT03879772|19911482|P3|NOT COMPLETED|Overall Study||10
8075089|NCT03879772|19911483|P2|NOT COMPLETED|Overall Study||3
8075090|NCT03879772|19911484|P1|NOT COMPLETED|Overall Study||4
8075091|NCT03879772|19911480|P5|COMPLETED|Overall Study||128
8075092|NCT03879772|19911481|P4|COMPLETED|Overall Study||130
8075093|NCT03879772|19911482|P3|COMPLETED|Overall Study||123
8075094|NCT03879772|19911483|P2|COMPLETED|Overall Study||132
8075095|NCT03879772|19911484|P1|COMPLETED|Overall Study||133
8075096|NCT03879772|19911480|P5|STARTED|Overall Study||136
8075097|NCT03879772|19911481|P4|STARTED|Overall Study||138
8075098|NCT03879772|19911482|P3|STARTED|Overall Study||133
8075099|NCT03879772|19911483|P2|STARTED|Overall Study||135
8075100|NCT03879772|19911484|P1|STARTED|Overall Study||137
8075101|NCT03878758|19911521|P1|NOT COMPLETED|Overall Study||4
8075102|NCT03878758|19911521|P1|COMPLETED|Overall Study||154
8075103|NCT03878758|19911521|P1|STARTED|Overall Study||158
8075104|NCT03878745|19911544|P1|NOT COMPLETED|Overall Study||0
8075105|NCT03878745|19911544|P1|COMPLETED|Overall Study||55
8075106|NCT03878745|19911544|P1|STARTED|Overall Study||55
8075107|NCT03877432|19911558|P1|NOT COMPLETED|Overall Study||0
8075108|NCT03877432|19911558|P1|COMPLETED|Overall Study||10
8075109|NCT03877432|19911558|P1|STARTED|Overall Study||10
8075110|NCT03876743|19911570|P4|NOT COMPLETED|Overall Study||7
8075111|NCT03876743|19911571|P3|NOT COMPLETED|Overall Study||4
8075112|NCT03876743|19911572|P2|NOT COMPLETED|Overall Study||4
8075113|NCT03876743|19911573|P1|NOT COMPLETED|Overall Study||6
8075114|NCT03876743|19911570|P4|COMPLETED|Overall Study||43
8075115|NCT03876743|19911571|P3|COMPLETED|Overall Study||42
8075116|NCT03876743|19911572|P2|COMPLETED|Overall Study||47
8075117|NCT03876743|19911573|P1|COMPLETED|Overall Study||48
8075118|NCT03876743|19911570|P4|STARTED|Overall Study||50
8075119|NCT03876743|19911571|P3|STARTED|Overall Study||46
8075120|NCT03876743|19911572|P2|STARTED|Overall Study||51
8075121|NCT03876743|19911573|P1|STARTED|Overall Study||54
8075122|NCT03875664|19911637|P2|NOT COMPLETED|Overall Study||0
8075123|NCT03875664|19911638|P1|NOT COMPLETED|Overall Study||0
8075124|NCT03875664|19911637|P2|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
8075125|NCT03875664|19911638|P1|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
8075126|NCT03875664|19911637|P2|STARTED|Overall Study||35
8075127|NCT03875664|19911638|P1|STARTED|Overall Study||37
8075128|NCT03870997|19911668|P6|NOT COMPLETED|Overall Study||10531
8075129|NCT03870997|19911669|P5|NOT COMPLETED|Overall Study||10588
8075130|NCT03870997|19911670|P4|NOT COMPLETED|Overall Study||10947
8075131|NCT03870997|19911671|P3|NOT COMPLETED|Overall Study||10978
8075132|NCT03870997|19911672|P2|NOT COMPLETED|Overall Study||10431
8075133|NCT03870997|19911673|P1|NOT COMPLETED|Overall Study||10544
8075134|NCT03870997|19911668|P6|COMPLETED|Overall Study||5171
8075135|NCT03870997|19911669|P5|COMPLETED|Overall Study||5114
8075136|NCT03870997|19911670|P4|COMPLETED|Overall Study||4810
8075137|NCT03870997|19911671|P3|COMPLETED|Overall Study||4778
8075138|NCT03870997|19911672|P2|COMPLETED|Overall Study||5271
8075139|NCT03870997|19911673|P1|COMPLETED|Overall Study||5158
8075140|NCT03870997|19911668|P6|STARTED|Overall Study||15702
8075141|NCT03870997|19911669|P5|STARTED|Overall Study||15702
8075142|NCT03870997|19911670|P4|STARTED|Overall Study||15757
8075143|NCT03870997|19911671|P3|STARTED|Overall Study||15756
8075144|NCT03870997|19911672|P2|STARTED|Overall Study||15702
8075145|NCT03870997|19911673|P1|STARTED|Overall Study||15702
8075146|NCT03870893|19911684|P2|NOT COMPLETED|Overall Study||1
8075147|NCT03870893|19911685|P1|NOT COMPLETED|Overall Study||0
8075148|NCT03870893|19911684|P2|COMPLETED|Overall Study||23
8075149|NCT03870893|19911685|P1|COMPLETED|Overall Study||23
8075150|NCT03870893|19911684|P2|STARTED|Overall Study||24
8075151|NCT03870893|19911685|P1|STARTED|Overall Study||23
8075152|NCT03870737|19911727|P1|NOT COMPLETED|Overall Study||2
8075153|NCT03870737|19911727|P1|COMPLETED|Overall Study||20
8075154|NCT03870737|19911727|P1|STARTED|Overall Study||22
8075155|NCT03870555|19911740|P3|NOT COMPLETED|Period 3 (2 Days)||0
8075156|NCT03870555|19911741|P2|NOT COMPLETED|Period 3 (2 Days)||0
8075157|NCT03870555|19911742|P1|NOT COMPLETED|Period 3 (2 Days)||1
8075158|NCT03870555|19911740|P3|COMPLETED|Period 3 (2 Days)||2
8075159|NCT03870555|19911741|P2|COMPLETED|Period 3 (2 Days)||2
8075160|NCT03870555|19911742|P1|COMPLETED|Period 3 (2 Days)||1
8075161|NCT03870555|19911740|P3|STARTED|Period 3 (2 Days)||2
8075162|NCT03870555|19911741|P2|STARTED|Period 3 (2 Days)||2
8075163|NCT03870555|19911742|P1|STARTED|Period 3 (2 Days)||2
8075164|NCT03870555|19911740|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075165|NCT03870555|19911741|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075166|NCT03870555|19911742|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075167|NCT03870555|19911740|P3|COMPLETED|Washout Period (at Least 16 Days)||2
8075168|NCT03870555|19911741|P2|COMPLETED|Washout Period (at Least 16 Days)||2
8075169|NCT03870555|19911742|P1|COMPLETED|Washout Period (at Least 16 Days)||2
8075170|NCT03870555|19911740|P3|STARTED|Washout Period (at Least 16 Days)||2
8075171|NCT03870555|19911741|P2|STARTED|Washout Period (at Least 16 Days)||2
8075172|NCT03870555|19911742|P1|STARTED|Washout Period (at Least 16 Days)||2
8075173|NCT03870555|19911740|P3|NOT COMPLETED|Period 2 (2 Days)||0
8075174|NCT03870555|19911741|P2|NOT COMPLETED|Period 2 (2 Days)||0
8075175|NCT03870555|19911742|P1|NOT COMPLETED|Period 2 (2 Days)||0
8075176|NCT03870555|19911740|P3|COMPLETED|Period 2 (2 Days)||2
8075177|NCT03870555|19911741|P2|COMPLETED|Period 2 (2 Days)||2
8075178|NCT03870555|19911742|P1|COMPLETED|Period 2 (2 Days)||2
8075179|NCT03870555|19911740|P3|STARTED|Period 2 (2 Days)||2
8075180|NCT03870555|19911741|P2|STARTED|Period 2 (2 Days)||2
8075181|NCT03870555|19911742|P1|STARTED|Period 2 (2 Days)||2
8075182|NCT03870555|19911740|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075183|NCT03870555|19911741|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075184|NCT03870555|19911742|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075185|NCT03870555|19911740|P3|COMPLETED|Washout Period (at Least 16 Days)||2
8075186|NCT03870555|19911741|P2|COMPLETED|Washout Period (at Least 16 Days)||2
8075187|NCT03870555|19911742|P1|COMPLETED|Washout Period (at Least 16 Days)||2
8075188|NCT03870555|19911740|P3|STARTED|Washout Period (at Least 16 Days)||2
8075189|NCT03870555|19911741|P2|STARTED|Washout Period (at Least 16 Days)||2
8075190|NCT03870555|19911742|P1|STARTED|Washout Period (at Least 16 Days)||2
8075191|NCT03870555|19911740|P3|NOT COMPLETED|Period 1 (2 Days)||0
8075192|NCT03870555|19911741|P2|NOT COMPLETED|Period 1 (2 Days)||0
8075193|NCT03870555|19911742|P1|NOT COMPLETED|Period 1 (2 Days)||0
8075194|NCT03870555|19911740|P3|COMPLETED|Period 1 (2 Days)||2
8075195|NCT03870555|19911741|P2|COMPLETED|Period 1 (2 Days)||2
8075196|NCT03870555|19911742|P1|COMPLETED|Period 1 (2 Days)||2
8075197|NCT03870555|19911740|P3|STARTED|Period 1 (2 Days)||2
8075198|NCT03870555|19911741|P2|STARTED|Period 1 (2 Days)||2
8075199|NCT03870555|19911742|P1|STARTED|Period 1 (2 Days)||2
8075200|NCT03869450|19911810|P3|NOT COMPLETED|Overall Study||0
8075201|NCT03869450|19911811|P2|NOT COMPLETED|Overall Study||2
8075202|NCT03869450|19911812|P1|NOT COMPLETED|Overall Study||1
8075203|NCT03869450|19911810|P3|COMPLETED|Overall Study||34
8075204|NCT03869450|19911811|P2|COMPLETED|Overall Study||23
8075205|NCT03869450|19911812|P1|COMPLETED|Overall Study||30
8075206|NCT03869450|19911810|P3|STARTED|Overall Study||34
8075207|NCT03869450|19911811|P2|STARTED|Overall Study||25
8075208|NCT03869450|19911812|P1|STARTED|Overall Study||31
8075209|NCT03868631|19911828|P2|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
8075210|NCT03868631|19911829|P1|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
8075211|NCT03868631|19911828|P2|COMPLETED|Week 6 to Week 12 (Study Completion)||26
8075212|NCT03868631|19911829|P1|COMPLETED|Week 6 to Week 12 (Study Completion)||22
8075213|NCT03868631|19911828|P2|STARTED|Week 6 to Week 12 (Study Completion)||27
8075214|NCT03868631|19911829|P1|STARTED|Week 6 to Week 12 (Study Completion)||26
8075215|NCT03868631|19911828|P2|NOT COMPLETED|Baseline to Week 6||4
8075216|NCT03868631|19911829|P1|NOT COMPLETED|Baseline to Week 6||4
8075217|NCT03868631|19911828|P2|COMPLETED|Baseline to Week 6||27
8075218|NCT03868631|19911829|P1|COMPLETED|Baseline to Week 6||26
8075219|NCT03868631|19911828|P2|STARTED|Baseline to Week 6||31
8075220|NCT03868631|19911829|P1|STARTED|Baseline to Week 6||30
8075221|NCT03868254|19911843|P2|NOT COMPLETED|Overall Study||0
8075222|NCT03868254|19911844|P1|NOT COMPLETED|Overall Study||0
8075223|NCT03868254|19911843|P2|COMPLETED|Overall Study||76
8075224|NCT03868254|19911844|P1|COMPLETED|Overall Study||98
8075225|NCT03868254|19911843|P2|STARTED|Overall Study||76
8075226|NCT03868254|19911844|P1|STARTED|Overall Study||98
8075227|NCT03866434|19911866|P1|NOT COMPLETED|Overall Study||0
8075228|NCT03866434|19911866|P1|COMPLETED|Overall Study||20
8075229|NCT03866434|19911866|P1|STARTED|Overall Study||20
8075230|NCT03865446|19911884|P2|NOT COMPLETED|Overall Study||0
8075231|NCT03865446|19911885|P1|NOT COMPLETED|Overall Study||0
8075232|NCT03865446|19911884|P2|COMPLETED|Overall Study||8
8075233|NCT03865446|19911885|P1|COMPLETED|Overall Study||8
8075234|NCT03865446|19911884|P2|STARTED|Overall Study||8
8075235|NCT03865446|19911885|P1|STARTED|Overall Study||8
8075236|NCT03865329|19911905|P1|NOT COMPLETED|Overall Study||0
8075237|NCT03865329|19911905|P1|COMPLETED|Overall Study||9
8075238|NCT03865329|19911905|P1|STARTED|Overall Study||9
8075239|NCT03864653|19911917|P1|NOT COMPLETED|Overall Study||1
8075240|NCT03864653|19911917|P1|COMPLETED|Overall Study||38
8075241|NCT03864653|19911917|P1|STARTED|Overall Study||39
8075242|NCT03864627|19911924|P2|NOT COMPLETED|Overall Study||12
8075243|NCT03864627|19911925|P1|NOT COMPLETED|Overall Study||4
8075244|NCT03864627|19911924|P2|COMPLETED|Overall Study||10
8075245|NCT03864627|19911925|P1|COMPLETED|Overall Study||7
8075246|NCT03864627|19911924|P2|STARTED|Overall Study||22
8075247|NCT03864627|19911925|P1|STARTED|Overall Study||11
8075248|NCT03863210|19911934|P1|NOT COMPLETED|Overall Study||2
8075249|NCT03863210|19911934|P1|COMPLETED|Overall Study|September 1st, 2014.|102
8075250|NCT03863210|19911934|P1|STARTED|Overall Study|March 1st, 2014.|104
8075251|NCT03862040|19911943|P1|NOT COMPLETED|Overall Study||0
8075252|NCT03862040|19911943|P1|COMPLETED|Overall Study||7
8075253|NCT03862040|19911943|P1|STARTED|Overall Study||7
8075254|NCT03861845|19911951|P3|NOT COMPLETED|Overall Study||0
8075255|NCT03861845|19911952|P2|NOT COMPLETED|Overall Study||0
8075256|NCT03861845|19911953|P1|NOT COMPLETED|Overall Study||0
8075257|NCT03861845|19911951|P3|COMPLETED|Overall Study||4
8075258|NCT03861845|19911952|P2|COMPLETED|Overall Study||5
8075259|NCT03861845|19911953|P1|COMPLETED|Overall Study||6
8075260|NCT03861845|19911951|P3|STARTED|Overall Study||4
8075261|NCT03861845|19911952|P2|STARTED|Overall Study||5
8075262|NCT03861845|19911953|P1|STARTED|Overall Study||6
8075263|NCT03861559|19911969|P2|NOT COMPLETED|Overall Study||5
8075264|NCT03861559|19911970|P1|NOT COMPLETED|Overall Study||2
8075265|NCT03861559|19911969|P2|COMPLETED|Overall Study||95
8075266|NCT03861559|19911970|P1|COMPLETED|Overall Study||99
8075267|NCT03861559|19911969|P2|STARTED|Overall Study||100
8075268|NCT03861559|19911970|P1|STARTED|Overall Study||101
8075269|NCT03860753|19912018|P2|NOT COMPLETED|Overall Study||0
8075270|NCT03860753|19912019|P1|NOT COMPLETED|Overall Study||0
8075271|NCT03860753|19912018|P2|COMPLETED|Overall Study||0
8075272|NCT03860753|19912019|P1|COMPLETED|Overall Study||4
8075273|NCT03860753|19912018|P2|STARTED|Overall Study||0
8075274|NCT03860753|19912019|P1|STARTED|Overall Study||4
8075275|NCT03859960|19912039|P2|NOT COMPLETED|Overall Study||0
8075276|NCT03859960|19912040|P1|NOT COMPLETED|Overall Study||0
8075277|NCT03859960|19912039|P2|COMPLETED|Overall Study||19
8075278|NCT03859960|19912040|P1|COMPLETED|Overall Study||14
8075279|NCT03859960|19912039|P2|STARTED|Overall Study||19
8075280|NCT03859960|19912040|P1|STARTED|Overall Study||14
8075281|NCT03859622|19912056|P1|NOT COMPLETED|Overall Study||0
8075282|NCT03859622|19912056|P1|COMPLETED|Overall Study||289
8075283|NCT03859622|19912056|P1|STARTED|Overall Study||289
8075284|NCT03858894|19912066|P2|NOT COMPLETED|Overall Study||0
8075285|NCT03858894|19912067|P1|NOT COMPLETED|Overall Study||4
8075286|NCT03858894|19912066|P2|COMPLETED|Overall Study||50
8075287|NCT03858894|19912067|P1|COMPLETED|Overall Study||44
8075288|NCT03858894|19912066|P2|STARTED|Overall Study||50
8075289|NCT03858894|19912067|P1|STARTED|Overall Study||48
8075290|NCT03858335|19912087|P2|NOT COMPLETED|Overall Study||4
8075291|NCT03858335|19912088|P1|NOT COMPLETED|Overall Study||4
8075292|NCT03858335|19912087|P2|COMPLETED|Overall Study||12
8075293|NCT03858335|19912088|P1|COMPLETED|Overall Study||12
8075294|NCT03858335|19912087|P2|STARTED|Overall Study||16
8075295|NCT03858335|19912088|P1|STARTED|Overall Study||16
8075296|NCT03857750|19912108|P2|NOT COMPLETED|Overall Study||0
8075297|NCT03857750|19912109|P1|NOT COMPLETED|Overall Study||0
8075298|NCT03857750|19912108|P2|COMPLETED|Overall Study||16
8075299|NCT03857750|19912109|P1|COMPLETED|Overall Study||16
8075300|NCT03857750|19912108|P2|STARTED|Overall Study||16
8075301|NCT03857750|19912109|P1|STARTED|Overall Study||16
8075302|NCT03857243|19912121|P2|NOT COMPLETED|Overall Study||0
8075303|NCT03857243|19912122|P1|NOT COMPLETED|Overall Study||0
8075304|NCT03857243|19912121|P2|COMPLETED|Overall Study||1
8075305|NCT03857243|19912122|P1|COMPLETED|Overall Study||1
8075306|NCT03857243|19912121|P2|STARTED|Overall Study||1
8075307|NCT03857243|19912122|P1|STARTED|Overall Study||1
8075308|NCT03857230|19912134|P2|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
8075309|NCT03857230|19912135|P1|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
8075310|NCT03857230|19912134|P2|COMPLETED|Period 2 (Gonal-F-Primapur)||12
8075311|NCT03857230|19912135|P1|COMPLETED|Period 2 (Gonal-F-Primapur)||12
8075312|NCT03857230|19912134|P2|STARTED|Period 2 (Gonal-F-Primapur)||12
8075313|NCT03857230|19912135|P1|STARTED|Period 2 (Gonal-F-Primapur)||12
8075314|NCT03857230|19912134|P2|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
8075315|NCT03857230|19912135|P1|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
8075316|NCT03857230|19912134|P2|COMPLETED|Period 1 (Primapur-Gonal-F)||12
8075317|NCT03857230|19912135|P1|COMPLETED|Period 1 (Primapur-Gonal-F)||12
8075318|NCT03857230|19912134|P2|STARTED|Period 1 (Primapur-Gonal-F)||12
8075319|NCT03857230|19912135|P1|STARTED|Period 1 (Primapur-Gonal-F)||12
8075320|NCT03856164|19912151|P2|NOT COMPLETED|Overall Study||0
8075321|NCT03856164|19912152|P1|NOT COMPLETED|Overall Study||0
8075322|NCT03856164|19912151|P2|COMPLETED|Overall Study||55
8075323|NCT03856164|19912152|P1|COMPLETED|Overall Study||55
8075324|NCT03856164|19912151|P2|STARTED|Overall Study||55
8075325|NCT03856164|19912152|P1|STARTED|Overall Study||55
8075326|NCT03855228|19912174|P4|NOT COMPLETED|Overall Study||19
8075327|NCT03855228|19912175|P3|NOT COMPLETED|Overall Study||8
8075328|NCT03855228|19912176|P2|NOT COMPLETED|Overall Study||9
8075329|NCT03855228|19912177|P1|NOT COMPLETED|Overall Study||3
8075330|NCT03855228|19912174|P4|COMPLETED|Overall Study||158
8075331|NCT03855228|19912175|P3|COMPLETED|Overall Study||174
8075332|NCT03855228|19912176|P2|COMPLETED|Overall Study||167
8075333|NCT03855228|19912177|P1|COMPLETED|Overall Study||166
8075334|NCT03855228|19912174|P4|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
8075335|NCT03855228|19912175|P3|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
8075336|NCT03855228|19912176|P2|Treated|Overall Study||176
8075337|NCT03855228|19912177|P1|Treated|Overall Study||169
8075338|NCT03855228|19912174|P4|STARTED|Overall Study||177
8075339|NCT03855228|19912175|P3|STARTED|Overall Study||182
8075340|NCT03855228|19912176|P2|STARTED|Overall Study||176
8075341|NCT03855228|19912177|P1|STARTED|Overall Study||169
8075342|NCT03855189|19912226|P3|NOT COMPLETED|Overall Study||6
8075343|NCT03855189|19912227|P2|NOT COMPLETED|Overall Study||7
8075344|NCT03855189|19912228|P1|NOT COMPLETED|Overall Study||10
8075345|NCT03855189|19912226|P3|COMPLETED|Overall Study||110
8075346|NCT03855189|19912227|P2|COMPLETED|Overall Study||109
8075347|NCT03855189|19912228|P1|COMPLETED|Overall Study||103
8075348|NCT03855189|19912226|P3|Treated|Overall Study||116
8075349|NCT03855189|19912227|P2|Treated|Overall Study||116
8075350|NCT03855189|19912228|P1|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
8075351|NCT03855189|19912226|P3|STARTED|Overall Study||116
8075352|NCT03855189|19912227|P2|STARTED|Overall Study||116
8075353|NCT03855189|19912228|P1|STARTED|Overall Study||113
8075354|NCT03854253|19912319|P2|NOT COMPLETED|Overall Study||0
8075355|NCT03854253|19912320|P1|NOT COMPLETED|Overall Study||1
8075356|NCT03854253|19912319|P2|COMPLETED|Overall Study||50
8075357|NCT03854253|19912320|P1|COMPLETED|Overall Study||49
8075358|NCT03854253|19912319|P2|STARTED|Overall Study||50
8075359|NCT03854253|19912320|P1|STARTED|Overall Study||50
8075360|NCT03851016|19912346|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8075361|NCT03851016|19912347|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8075362|NCT03851016|19912346|P2|COMPLETED|Second Intervention (3 Weeks)||10
8075363|NCT03851016|19912347|P1|COMPLETED|Second Intervention (3 Weeks)||11
8075364|NCT03851016|19912346|P2|STARTED|Second Intervention (3 Weeks)||10
8075365|NCT03851016|19912347|P1|STARTED|Second Intervention (3 Weeks)||11
8075366|NCT03851016|19912346|P2|NOT COMPLETED|Washout (1 Week)||0
8075367|NCT03851016|19912347|P1|NOT COMPLETED|Washout (1 Week)||0
8075368|NCT03851016|19912346|P2|COMPLETED|Washout (1 Week)||10
8075369|NCT03851016|19912347|P1|COMPLETED|Washout (1 Week)||11
8075370|NCT03851016|19912346|P2|STARTED|Washout (1 Week)||10
8075371|NCT03851016|19912347|P1|STARTED|Washout (1 Week)||11
8075372|NCT03851016|19912346|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
8075373|NCT03851016|19912347|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
8075374|NCT03851016|19912346|P2|COMPLETED|First Intervention (3 Weeks)||10
8075375|NCT03851016|19912347|P1|COMPLETED|First Intervention (3 Weeks)||11
8075376|NCT03851016|19912346|P2|STARTED|First Intervention (3 Weeks)||12
8075377|NCT03851016|19912347|P1|STARTED|First Intervention (3 Weeks)||12
8075378|NCT03850496|19912360|P3|NOT COMPLETED|Overall Study||4
8075379|NCT03850496|19912361|P2|NOT COMPLETED|Overall Study||1
8075380|NCT03850496|19912362|P1|NOT COMPLETED|Overall Study||1
8075381|NCT03850496|19912360|P3|COMPLETED|Overall Study||21
8075382|NCT03850496|19912361|P2|COMPLETED|Overall Study||24
8075383|NCT03850496|19912362|P1|COMPLETED|Overall Study||25
8075384|NCT03850496|19912360|P3|STARTED|Overall Study||25
8075385|NCT03850496|19912361|P2|STARTED|Overall Study||25
8075386|NCT03850496|19912362|P1|STARTED|Overall Study||26
8075387|NCT03850444|19912384|P2|NOT COMPLETED|Overall Study||134
8075388|NCT03850444|19912385|P1|NOT COMPLETED|Overall Study||128
8075389|NCT03850444|19912384|P2|COMPLETED|Overall Study||0
8075390|NCT03850444|19912385|P1|COMPLETED|Overall Study||0
8075391|NCT03850444|19912384|P2|STARTED|Overall Study||134
8075392|NCT03850444|19912385|P1|STARTED|Overall Study||128
8075393|NCT03850093|19912414|P3|NOT COMPLETED|Overall Study||2
8075394|NCT03850093|19912415|P2|NOT COMPLETED|Overall Study||0
8075395|NCT03850093|19912416|P1|NOT COMPLETED|Overall Study||1
8075396|NCT03850093|19912414|P3|COMPLETED|Overall Study||17
8075397|NCT03850093|19912415|P2|COMPLETED|Overall Study||22
8075398|NCT03850093|19912416|P1|COMPLETED|Overall Study||21
8075399|NCT03850093|19912414|P3|STARTED|Overall Study||19
8075400|NCT03850093|19912415|P2|STARTED|Overall Study||22
8075401|NCT03850093|19912416|P1|STARTED|Overall Study||22
8075402|NCT03849690|19912451|P1|NOT COMPLETED|Period 2 (6 Days)||0
8075403|NCT03849690|19912451|P1|COMPLETED|Period 2 (6 Days)||12
8075404|NCT03849690|19912451|P1|STARTED|Period 2 (6 Days)||12
8075405|NCT03849690|19912451|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
8075406|NCT03849690|19912451|P1|COMPLETED|Washout Period (at Least 4 Days)||12
8075407|NCT03849690|19912451|P1|STARTED|Washout Period (at Least 4 Days)||12
8075408|NCT03849690|19912451|P1|NOT COMPLETED|Period 1 (3 Days)||0
8075409|NCT03849690|19912451|P1|COMPLETED|Period 1 (3 Days)||12
8075410|NCT03849690|19912451|P1|STARTED|Period 1 (3 Days)||12
8075411|NCT03849300|19912478|P4|NOT COMPLETED|Overall Study||6
8075412|NCT03849300|19912479|P3|NOT COMPLETED|Overall Study||4
8075413|NCT03849300|19912480|P2|NOT COMPLETED|Overall Study||7
8075414|NCT03849300|19912481|P1|NOT COMPLETED|Overall Study||5
8075415|NCT03849300|19912478|P4|COMPLETED|Overall Study||25
8075416|NCT03849300|19912479|P3|COMPLETED|Overall Study||28
8075417|NCT03849300|19912480|P2|COMPLETED|Overall Study||35
8075418|NCT03849300|19912481|P1|COMPLETED|Overall Study||37
8075419|NCT03849300|19912478|P4|STARTED|Overall Study||31
8075420|NCT03849300|19912479|P3|STARTED|Overall Study||32
8075421|NCT03849300|19912480|P2|STARTED|Overall Study||42
8075422|NCT03849300|19912481|P1|STARTED|Overall Study||42
8075423|NCT03848910|19912535|P1|NOT COMPLETED|Overall Study||0
8075424|NCT03848910|19912535|P1|COMPLETED|Overall Study||11
8075425|NCT03848910|19912535|P1|STARTED|Overall Study||11
8075426|NCT03848871|19912552|P1|NOT COMPLETED|Overall Study||0
8075427|NCT03848871|19912552|P1|COMPLETED|Overall Study||20
8075428|NCT03848871|19912552|P1|STARTED|Overall Study||20
8075429|NCT03848455|19912564|P3|NOT COMPLETED|Overall Study||0
8075430|NCT03848455|19912565|P2|NOT COMPLETED|Overall Study||0
8075431|NCT03848455|19912566|P1|NOT COMPLETED|Overall Study||0
8075432|NCT03848455|19912564|P3|COMPLETED|Overall Study||23
8075433|NCT03848455|19912565|P2|COMPLETED|Overall Study||125
8075434|NCT03848455|19912566|P1|COMPLETED|Overall Study||90
8075435|NCT03848455|19912564|P3|STARTED|Overall Study||23
8075436|NCT03848455|19912565|P2|STARTED|Overall Study||125
8075437|NCT03848455|19912566|P1|STARTED|Overall Study||90
8075438|NCT03848416|19912583|P3|NOT COMPLETED|Overall Study||1
8075439|NCT03848416|19912584|P2|NOT COMPLETED|Overall Study||0
8075440|NCT03848416|19912585|P1|NOT COMPLETED|Overall Study||1
8075441|NCT03848416|19912583|P3|COMPLETED|Overall Study||32
8075442|NCT03848416|19912584|P2|COMPLETED|Overall Study||33
8075443|NCT03848416|19912585|P1|COMPLETED|Overall Study||32
8075444|NCT03848416|19912583|P3|Received at Least One Dose of Study Drug|Overall Study||33
8075445|NCT03848416|19912584|P2|Received at Least One Dose of Study Drug|Overall Study||33
8075446|NCT03848416|19912585|P1|Received at Least One Dose of Study Drug|Overall Study||33
8075447|NCT03848416|19912583|P3|STARTED|Overall Study||33
8075448|NCT03848416|19912584|P2|STARTED|Overall Study||33
8075449|NCT03848416|19912585|P1|STARTED|Overall Study||33
8075450|NCT03848403|19912599|P3|NOT COMPLETED|Period 3 (Day 15)||0
8075451|NCT03848403|19912600|P2|NOT COMPLETED|Period 3 (Day 15)||0
8075452|NCT03848403|19912601|P1|NOT COMPLETED|Period 3 (Day 15)||0
8075453|NCT03848403|19912599|P3|COMPLETED|Period 3 (Day 15)||15
8075454|NCT03848403|19912600|P2|COMPLETED|Period 3 (Day 15)||15
8075455|NCT03848403|19912601|P1|COMPLETED|Period 3 (Day 15)||15
8075456|NCT03848403|19912599|P3|STARTED|Period 3 (Day 15)||15
8075457|NCT03848403|19912600|P2|STARTED|Period 3 (Day 15)||15
8075458|NCT03848403|19912601|P1|STARTED|Period 3 (Day 15)||15
8075459|NCT03848403|19912599|P3|NOT COMPLETED|Period 2 (Day 8)||7
8075460|NCT03848403|19912600|P2|NOT COMPLETED|Period 2 (Day 8)||9
8075461|NCT03848403|19912601|P1|NOT COMPLETED|Period 2 (Day 8)||9
8075462|NCT03848403|19912599|P3|COMPLETED|Period 2 (Day 8)||15
8075463|NCT03848403|19912600|P2|COMPLETED|Period 2 (Day 8)||15
8075464|NCT03848403|19912601|P1|COMPLETED|Period 2 (Day 8)||15
8075465|NCT03848403|19912599|P3|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
8075466|NCT03848403|19912600|P2|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
8075467|NCT03848403|19912601|P1|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
8075468|NCT03848403|19912599|P3|STARTED|Period 2 (Day 8)||22
8075469|NCT03848403|19912600|P2|STARTED|Period 2 (Day 8)||24
8075470|NCT03848403|19912601|P1|STARTED|Period 2 (Day 8)||24
8075471|NCT03848403|19912599|P3|NOT COMPLETED|Period 1 (Day 1)||0
8075472|NCT03848403|19912600|P2|NOT COMPLETED|Period 1 (Day 1)||0
8075473|NCT03848403|19912601|P1|NOT COMPLETED|Period 1 (Day 1)||0
8075474|NCT03848403|19912599|P3|COMPLETED|Period 1 (Day 1)||22
8075475|NCT03848403|19912600|P2|COMPLETED|Period 1 (Day 1)||24
8075476|NCT03848403|19912601|P1|COMPLETED|Period 1 (Day 1)||24
8075477|NCT03848403|19912599|P3|Received Intervention|Period 1 (Day 1)||22
8075478|NCT03848403|19912600|P2|Received Intervention|Period 1 (Day 1)||24
8075479|NCT03848403|19912601|P1|Received Intervention|Period 1 (Day 1)||24
8075480|NCT03848403|19912599|P3|STARTED|Period 1 (Day 1)||22
8075481|NCT03848403|19912600|P2|STARTED|Period 1 (Day 1)||24
8075482|NCT03848403|19912601|P1|STARTED|Period 1 (Day 1)||24
8075483|NCT03848221|19912612|P3|NOT COMPLETED|Overall Study||0
8075484|NCT03848221|19912613|P2|NOT COMPLETED|Overall Study||0
8075485|NCT03848221|19912614|P1|NOT COMPLETED|Overall Study||0
8075486|NCT03848221|19912612|P3|COMPLETED|Overall Study||24
8075487|NCT03848221|19912613|P2|COMPLETED|Overall Study||24
8075488|NCT03848221|19912614|P1|COMPLETED|Overall Study||25
8075489|NCT03848221|19912612|P3|STARTED|Overall Study||24
8075490|NCT03848221|19912613|P2|STARTED|Overall Study||24
8075491|NCT03848221|19912614|P1|STARTED|Overall Study||25
8075492|NCT03848208|19912635|P10|NOT COMPLETED|Overall Study||0
8075493|NCT03848208|19912636|P9|NOT COMPLETED|Overall Study||0
8075494|NCT03848208|19912637|P8|NOT COMPLETED|Overall Study||0
8075495|NCT03848208|19912638|P7|NOT COMPLETED|Overall Study||0
8075496|NCT03848208|19912639|P6|NOT COMPLETED|Overall Study||0
8075497|NCT03848208|19912640|P5|NOT COMPLETED|Overall Study||0
8075498|NCT03848208|19912641|P4|NOT COMPLETED|Overall Study||0
8075499|NCT03848208|19912642|P3|NOT COMPLETED|Overall Study||0
8075500|NCT03848208|19912643|P2|NOT COMPLETED|Overall Study||0
8075501|NCT03848208|19912644|P1|NOT COMPLETED|Overall Study||0
8075502|NCT03848208|19912635|P10|COMPLETED|Overall Study||6
8075503|NCT03848208|19912636|P9|COMPLETED|Overall Study||6
8075504|NCT03848208|19912637|P8|COMPLETED|Overall Study||6
8075505|NCT03848208|19912638|P7|COMPLETED|Overall Study||6
8075506|NCT03848208|19912639|P6|COMPLETED|Overall Study||6
8075507|NCT03848208|19912640|P5|COMPLETED|Overall Study||6
8075508|NCT03848208|19912641|P4|COMPLETED|Overall Study||6
8075509|NCT03848208|19912642|P3|COMPLETED|Overall Study||6
8075510|NCT03848208|19912643|P2|COMPLETED|Overall Study||6
8075511|NCT03848208|19912644|P1|COMPLETED|Overall Study||18
8075512|NCT03848208|19912635|P10|STARTED|Overall Study||6
8075513|NCT03848208|19912636|P9|STARTED|Overall Study||6
8075514|NCT03848208|19912637|P8|STARTED|Overall Study||6
8075515|NCT03848208|19912638|P7|STARTED|Overall Study||6
8075516|NCT03848208|19912639|P6|STARTED|Overall Study||6
8075517|NCT03848208|19912640|P5|STARTED|Overall Study||6
8075518|NCT03848208|19912641|P4|STARTED|Overall Study||6
8075519|NCT03848208|19912642|P3|STARTED|Overall Study||6
8075520|NCT03848208|19912643|P2|STARTED|Overall Study||6
8075521|NCT03848208|19912644|P1|STARTED|Overall Study||18
8075522|NCT03847987|19912686|P2|NOT COMPLETED|Overall Study||0
8075523|NCT03847987|19912687|P1|NOT COMPLETED|Overall Study||3
8075524|NCT03847987|19912686|P2|COMPLETED|Overall Study||8
8075525|NCT03847987|19912687|P1|COMPLETED|Overall Study||13
8075526|NCT03847987|19912686|P2|STARTED|Overall Study||8
8075527|NCT03847987|19912687|P1|STARTED|Overall Study||16
8075528|NCT03847610|19912710|P1|NOT COMPLETED|Overall Study||1
8075529|NCT03847610|19912710|P1|COMPLETED|Overall Study||10
8075530|NCT03847610|19912710|P1|STARTED|Overall Study||11
8075531|NCT03847233|19912714|P1|NOT COMPLETED|Overall Study||0
8075532|NCT03847233|19912714|P1|COMPLETED|Overall Study|The number of subjects completed the index procedure.|31
8075533|NCT03847233|19912714|P1|STARTED|Overall Study||31
8075534|NCT03845933|19912723|P2|NOT COMPLETED|Overall Study||0
8075535|NCT03845933|19912724|P1|NOT COMPLETED|Overall Study||0
8075536|NCT03845933|19912723|P2|COMPLETED|Overall Study||131
8075537|NCT03845933|19912724|P1|COMPLETED|Overall Study||131
8075538|NCT03845933|19912723|P2|STARTED|Overall Study||131
8075539|NCT03845933|19912724|P1|STARTED|Overall Study||131
8075540|NCT03844945|19912734|P4|NOT COMPLETED|Overall Study||1
8075541|NCT03844945|19912735|P3|NOT COMPLETED|Overall Study||5
8075542|NCT03844945|19912736|P2|NOT COMPLETED|Overall Study||1
8075543|NCT03844945|19912737|P1|NOT COMPLETED|Overall Study||1
8075544|NCT03844945|19912734|P4|COMPLETED|Overall Study||54
8075545|NCT03844945|19912735|P3|COMPLETED|Overall Study||46
8075546|NCT03844945|19912736|P2|COMPLETED|Overall Study||53
8075547|NCT03844945|19912737|P1|COMPLETED|Overall Study||54
8075548|NCT03844945|19912734|P4|STARTED|Overall Study||55
8075549|NCT03844945|19912735|P3|STARTED|Overall Study||51
8075550|NCT03844945|19912736|P2|STARTED|Overall Study||54
8075551|NCT03844945|19912737|P1|STARTED|Overall Study||55
8075552|NCT03843372|19912749|P2|NOT COMPLETED|Overall Study||2
8075553|NCT03843372|19912750|P1|NOT COMPLETED|Overall Study||2
8075554|NCT03843372|19912749|P2|COMPLETED|Overall Study||16
8075555|NCT03843372|19912750|P1|COMPLETED|Overall Study||12
8075556|NCT03843372|19912749|P2|STARTED|Overall Study||18
8075557|NCT03843372|19912750|P1|STARTED|Overall Study||14
8075558|NCT03842683|19912762|P1|NOT COMPLETED|Overall Study||0
8075559|NCT03842683|19912762|P1|COMPLETED|Overall Study||472
8075560|NCT03842683|19912762|P1|STARTED|Overall Study||472
8075561|NCT03841331|19912769|P2|NOT COMPLETED|Overall Study||10
8075562|NCT03841331|19912770|P1|NOT COMPLETED|Overall Study||9
8075563|NCT03841331|19912769|P2|COMPLETED|Overall Study||106
8075564|NCT03841331|19912770|P1|COMPLETED|Overall Study||108
8075565|NCT03841331|19912769|P2|STARTED|Overall Study||116
8075566|NCT03841331|19912770|P1|STARTED|Overall Study||117
8075567|NCT03840278|19912790|P2|NOT COMPLETED|Overall Study||0
8075568|NCT03840278|19912791|P1|NOT COMPLETED|Overall Study||0
8075569|NCT03840278|19912790|P2|COMPLETED|Overall Study||5
8075570|NCT03840278|19912791|P1|COMPLETED|Overall Study||5
8075571|NCT03840278|19912790|P2|STARTED|Overall Study||5
8075572|NCT03840278|19912791|P1|STARTED|Overall Study||5
8075573|NCT03840135|19912811|P2|NOT COMPLETED|Overall Study||1
8075574|NCT03840135|19912812|P1|NOT COMPLETED|Overall Study||7
8075575|NCT03840135|19912811|P2|COMPLETED|Overall Study||85
8075576|NCT03840135|19912812|P1|COMPLETED|Overall Study||79
8075577|NCT03840135|19912811|P2|STARTED|Overall Study||86
8075578|NCT03840135|19912812|P1|STARTED|Overall Study||86
8075579|NCT03837028|19912842|P4|NOT COMPLETED|Overall Study||7
8075580|NCT03837028|19912843|P3|NOT COMPLETED|Overall Study||13
8075581|NCT03837028|19912844|P2|NOT COMPLETED|Overall Study||11
8075582|NCT03837028|19912845|P1|NOT COMPLETED|Overall Study||16
8075583|NCT03837028|19912842|P4|COMPLETED|Overall Study||18
8075584|NCT03837028|19912843|P3|COMPLETED|Overall Study||20
8075585|NCT03837028|19912844|P2|COMPLETED|Overall Study||23
8075586|NCT03837028|19912845|P1|COMPLETED|Overall Study||19
8075587|NCT03837028|19912842|P4|STARTED|Overall Study||25
8075588|NCT03837028|19912843|P3|STARTED|Overall Study||33
8075589|NCT03837028|19912844|P2|STARTED|Overall Study||34
8075590|NCT03837028|19912845|P1|STARTED|Overall Study||35
8075591|NCT03836859|19912861|P2|NOT COMPLETED|Overall Study||0
8075592|NCT03836859|19912862|P1|NOT COMPLETED|Overall Study||0
8075593|NCT03836859|19912861|P2|COMPLETED|Overall Study||10
8075594|NCT03836859|19912862|P1|COMPLETED|Overall Study||20
8075595|NCT03836859|19912861|P2|STARTED|Overall Study||10
8075596|NCT03836859|19912862|P1|STARTED|Overall Study||20
8075597|NCT03836729|19912898|P1|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
8075598|NCT03836729|19912898|P1|COMPLETED|Treatment Period 2 (Up to Day 7)||15
8075599|NCT03836729|19912898|P1|STARTED|Treatment Period 2 (Up to Day 7)||16
8075600|NCT03836729|19912898|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
8075601|NCT03836729|19912898|P1|COMPLETED|Treatment Period 1 (Up to Day 14)||16
8075602|NCT03836729|19912898|P1|STARTED|Treatment Period 1 (Up to Day 14)||16
8075603|NCT03836664|19913012|P2|NOT COMPLETED|Overall Study||3
8075604|NCT03836664|19913013|P1|NOT COMPLETED|Overall Study||3
8075605|NCT03836664|19913012|P2|COMPLETED|Overall Study||8
8075606|NCT03836664|19913013|P1|COMPLETED|Overall Study||11
8075607|NCT03836664|19913012|P2|STARTED|Overall Study||11
8075608|NCT03836664|19913013|P1|STARTED|Overall Study||14
8075609|NCT03835546|19913026|P3|NOT COMPLETED|Overall Study||0
8075610|NCT03835546|19913027|P2|NOT COMPLETED|Overall Study||0
8075611|NCT03835546|19913028|P1|NOT COMPLETED|Overall Study||3
8075612|NCT03835546|19913026|P3|COMPLETED|Overall Study||15
8075613|NCT03835546|19913027|P2|COMPLETED|Overall Study||15
8075614|NCT03835546|19913028|P1|COMPLETED|Overall Study||12
8075615|NCT03835546|19913026|P3|STARTED|Overall Study||15
8075616|NCT03835546|19913027|P2|STARTED|Overall Study||15
8075617|NCT03835546|19913028|P1|STARTED|Overall Study||15
8075618|NCT03835221|19913054|P1|NOT COMPLETED|Fanfilcon A||0
8075619|NCT03835221|19913054|P1|COMPLETED|Fanfilcon A||42
8075620|NCT03835221|19913054|P1|STARTED|Fanfilcon A||42
8075621|NCT03835221|19913054|P1|NOT COMPLETED|Methafilcon A||1
8075622|NCT03835221|19913054|P1|COMPLETED|Methafilcon A||42
8075623|NCT03835221|19913054|P1|STARTED|Methafilcon A||43
8075624|NCT03835078|19913099|P1|NOT COMPLETED|Overall Study||0
8075625|NCT03835078|19913099|P1|COMPLETED|Overall Study||39
8075626|NCT03835078|19913099|P1|STARTED|Overall Study||39
8075627|NCT03832387|19913136|P2|NOT COMPLETED|Overall Study||7
8075628|NCT03832387|19913137|P1|NOT COMPLETED|Overall Study||5
8075629|NCT03832387|19913136|P2|COMPLETED|Overall Study||32
8075630|NCT03832387|19913137|P1|COMPLETED|Overall Study||33
8075631|NCT03832387|19913136|P2|STARTED|Overall Study||39
8075632|NCT03832387|19913137|P1|STARTED|Overall Study||38
8075633|NCT03832322|19913167|P2|NOT COMPLETED|Overall Study||1
8075634|NCT03832322|19913168|P1|NOT COMPLETED|Overall Study||3
8075635|NCT03832322|19913167|P2|COMPLETED|Overall Study||86
8075636|NCT03832322|19913168|P1|COMPLETED|Overall Study||86
8075637|NCT03832322|19913167|P2|STARTED|Overall Study||87
8075638|NCT03832322|19913168|P1|STARTED|Overall Study||89
8075639|NCT03831971|19913176|P1|NOT COMPLETED|Overall Study||0
8075640|NCT03831971|19913176|P1|COMPLETED|Overall Study||12
8075641|NCT03831971|19913176|P1|STARTED|Overall Study||12
8075642|NCT03831451|19913197|P2|NOT COMPLETED|Overall Study||0
8075643|NCT03831451|19913198|P1|NOT COMPLETED|Overall Study||0
8075644|NCT03831451|19913197|P2|COMPLETED|Overall Study||55
8075645|NCT03831451|19913198|P1|COMPLETED|Overall Study||74
8075646|NCT03831451|19913197|P2|STARTED|Overall Study||55
8075647|NCT03831451|19913198|P1|STARTED|Overall Study||74
8075648|NCT03831282|19913204|P1|NOT COMPLETED|Overall Study||1
8075649|NCT03831282|19913204|P1|COMPLETED|Overall Study||11
8075650|NCT03831282|19913204|P1|STARTED|Overall Study||12
8075651|NCT03830307|19913208|P1|NOT COMPLETED|Overall Study||0
8075652|NCT03830307|19913208|P1|COMPLETED|Overall Study||5
8075653|NCT03830307|19913208|P1|STARTED|Overall Study||5
8075654|NCT03830281|19913231|P2|NOT COMPLETED|Treatment Period (16 Weeks)||17
8075655|NCT03830281|19913232|P1|NOT COMPLETED|Treatment Period (16 Weeks)||12
8075656|NCT03830281|19913231|P2|COMPLETED|Treatment Period (16 Weeks)||198
8075657|NCT03830281|19913232|P1|COMPLETED|Treatment Period (16 Weeks)||205
8075658|NCT03830281|19913231|P2|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
8075659|NCT03830281|19913232|P1|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
8075660|NCT03830281|19913231|P2|NOT COMPLETED|Lead-in Period (2 Weeks)||0
8075661|NCT03830281|19913232|P1|NOT COMPLETED|Lead-in Period (2 Weeks)||39
8075662|NCT03830281|19913231|P2|COMPLETED|Lead-in Period (2 Weeks)||0
8075663|NCT03830281|19913232|P1|COMPLETED|Lead-in Period (2 Weeks)||432
8075664|NCT03830281|19913231|P2|STARTED|Lead-in Period (2 Weeks)||0
8075665|NCT03830281|19913232|P1|STARTED|Lead-in Period (2 Weeks)||471
8075666|NCT03828734|19913263|P2|NOT COMPLETED|Second Intervention||0
8075667|NCT03828734|19913264|P1|NOT COMPLETED|Second Intervention||0
8075668|NCT03828734|19913263|P2|COMPLETED|Second Intervention||24
8075669|NCT03828734|19913264|P1|COMPLETED|Second Intervention||25
8075670|NCT03828734|19913263|P2|STARTED|Second Intervention||24
8075671|NCT03828734|19913264|P1|STARTED|Second Intervention||25
8075672|NCT03828734|19913263|P2|NOT COMPLETED|First Washout (1 Week)||1
8075673|NCT03828734|19913264|P1|NOT COMPLETED|First Washout (1 Week)||0
8075674|NCT03828734|19913263|P2|COMPLETED|First Washout (1 Week)||24
8075675|NCT03828734|19913264|P1|COMPLETED|First Washout (1 Week)||25
8075676|NCT03828734|19913263|P2|STARTED|First Washout (1 Week)||25
8075677|NCT03828734|19913264|P1|STARTED|First Washout (1 Week)||25
8075678|NCT03828734|19913263|P2|NOT COMPLETED|First Intervention||0
8075679|NCT03828734|19913264|P1|NOT COMPLETED|First Intervention||4
8075680|NCT03828734|19913263|P2|COMPLETED|First Intervention||25
8075681|NCT03828734|19913264|P1|COMPLETED|First Intervention||25
8075682|NCT03828734|19913263|P2|STARTED|First Intervention||25
8075683|NCT03828734|19913264|P1|STARTED|First Intervention||29
8075684|NCT03828734|19913263|P2|NOT COMPLETED|Pre-Randomization (1 Week)||1
8075685|NCT03828734|19913264|P1|NOT COMPLETED|Pre-Randomization (1 Week)||3
8075686|NCT03828734|19913263|P2|COMPLETED|Pre-Randomization (1 Week)||25
8075687|NCT03828734|19913264|P1|COMPLETED|Pre-Randomization (1 Week)||29
8075688|NCT03828734|19913263|P2|STARTED|Pre-Randomization (1 Week)||26
8075689|NCT03828734|19913264|P1|STARTED|Pre-Randomization (1 Week)||32
8075690|NCT03828734|19913263|P2|NOT COMPLETED|Baseline||0
8075691|NCT03828734|19913264|P1|NOT COMPLETED|Baseline||0
8075692|NCT03828734|19913263|P2|COMPLETED|Baseline||26
8075693|NCT03828734|19913264|P1|COMPLETED|Baseline||32
8075694|NCT03828734|19913263|P2|STARTED|Baseline||26
8075695|NCT03828734|19913264|P1|STARTED|Baseline||32
8075696|NCT03828617|19913278|P4|NOT COMPLETED|Overall Study||10
8075697|NCT03828617|19913279|P3|NOT COMPLETED|Overall Study||26
8075698|NCT03828617|19913280|P2|NOT COMPLETED|Overall Study||15
8075699|NCT03828617|19913281|P1|NOT COMPLETED|Overall Study||24
8075700|NCT03828617|19913278|P4|COMPLETED|Overall Study||235
8075701|NCT03828617|19913279|P3|COMPLETED|Overall Study||460
8075702|NCT03828617|19913280|P2|COMPLETED|Overall Study||475
8075703|NCT03828617|19913281|P1|COMPLETED|Overall Study||465
8075704|NCT03828617|19913278|P4|Evaluable Immunogenicity Population(EIP)|Overall Study||232
8075705|NCT03828617|19913279|P3|Evaluable Immunogenicity Population(EIP)|Overall Study||456
8075706|NCT03828617|19913280|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||473
8075707|NCT03828617|19913281|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||463
8075708|NCT03828617|19913278|P4|Safety Population|Overall Study||245
8075709|NCT03828617|19913279|P3|Safety Population|Overall Study||486
8075710|NCT03828617|19913280|P2|Safety Population|Overall Study||489
8075711|NCT03828617|19913281|P1|Safety Population|Overall Study||488
8075712|NCT03828617|19913278|P4|Vaccinated|Overall Study||245
8075713|NCT03828617|19913279|P3|Vaccinated|Overall Study||486
8075714|NCT03828617|19913280|P2|Vaccinated|Overall Study||489
8075715|NCT03828617|19913281|P1|Vaccinated|Overall Study||488
8075716|NCT03828617|19913278|P4|STARTED|Overall Study||245
8075717|NCT03828617|19913279|P3|STARTED|Overall Study||486
8075718|NCT03828617|19913280|P2|STARTED|Overall Study||490
8075719|NCT03828617|19913281|P1|STARTED|Overall Study||489
8075720|NCT03828149|19913309|P2|NOT COMPLETED|Second Intervention (Single Dose)||0
8075721|NCT03828149|19913310|P1|NOT COMPLETED|Second Intervention (Single Dose)||0
8075722|NCT03828149|19913309|P2|COMPLETED|Second Intervention (Single Dose)||8
8075723|NCT03828149|19913310|P1|COMPLETED|Second Intervention (Single Dose)||9
8075724|NCT03828149|19913309|P2|STARTED|Second Intervention (Single Dose)||8
8075725|NCT03828149|19913310|P1|STARTED|Second Intervention (Single Dose)||9
8075726|NCT03828149|19913309|P2|NOT COMPLETED|Washout (6 Days)||0
8075727|NCT03828149|19913310|P1|NOT COMPLETED|Washout (6 Days)||0
8075728|NCT03828149|19913309|P2|COMPLETED|Washout (6 Days)||8
8075729|NCT03828149|19913310|P1|COMPLETED|Washout (6 Days)||9
8075730|NCT03828149|19913309|P2|STARTED|Washout (6 Days)||8
8075731|NCT03828149|19913310|P1|STARTED|Washout (6 Days)||9
8075732|NCT03828149|19913309|P2|NOT COMPLETED|First Intervention (Single Dose)||0
8075733|NCT03828149|19913310|P1|NOT COMPLETED|First Intervention (Single Dose)||0
8075734|NCT03828149|19913309|P2|COMPLETED|First Intervention (Single Dose)||8
8075735|NCT03828149|19913310|P1|COMPLETED|First Intervention (Single Dose)||9
8075736|NCT03828149|19913309|P2|STARTED|First Intervention (Single Dose)||8
8075737|NCT03828149|19913310|P1|STARTED|First Intervention (Single Dose)||9
8075738|NCT03827473|19913318|P2|NOT COMPLETED|Overall Study||0
8075739|NCT03827473|19913319|P1|NOT COMPLETED|Overall Study||1
8075740|NCT03827473|19913318|P2|COMPLETED|Overall Study||0
8075741|NCT03827473|19913319|P1|COMPLETED|Overall Study||0
8075742|NCT03827473|19913318|P2|STARTED|Overall Study||0
8075743|NCT03827473|19913319|P1|STARTED|Overall Study||1
8075744|NCT03826914|19913335|P2|NOT COMPLETED|Overall Study||1
8075745|NCT03826914|19913336|P1|NOT COMPLETED|Overall Study||1
8075746|NCT03826914|19913335|P2|COMPLETED|Overall Study||33
8075747|NCT03826914|19913336|P1|COMPLETED|Overall Study||34
8075748|NCT03826914|19913335|P2|STARTED|Overall Study||34
8075749|NCT03826914|19913336|P1|STARTED|Overall Study||35
8075750|NCT03825393|19913346|P2|NOT COMPLETED|Overall Study||0
8075751|NCT03825393|19913347|P1|NOT COMPLETED|Overall Study||0
8075752|NCT03825393|19913346|P2|COMPLETED|Overall Study||100
8075753|NCT03825393|19913347|P1|COMPLETED|Overall Study||100
8075754|NCT03825393|19913346|P2|STARTED|Overall Study||100
8075755|NCT03825393|19913347|P1|STARTED|Overall Study||100
8075756|NCT03825042|19913359|P2|NOT COMPLETED|Overall Study||0
8075757|NCT03825042|19913360|P1|NOT COMPLETED|Overall Study||2
8075758|NCT03825042|19913359|P2|COMPLETED|Overall Study||40
8075759|NCT03825042|19913360|P1|COMPLETED|Overall Study||38
8075760|NCT03825042|19913359|P2|STARTED|Overall Study||40
8075761|NCT03825042|19913360|P1|STARTED|Overall Study||40
8075762|NCT03824912|19913373|P3|NOT COMPLETED|Overall Study||68
8075763|NCT03824912|19913374|P2|NOT COMPLETED|Overall Study||134
8075764|NCT03824912|19913375|P1|NOT COMPLETED|Overall Study||140
8075765|NCT03824912|19913373|P3|COMPLETED|Overall Study||96
8075766|NCT03824912|19913374|P2|COMPLETED|Overall Study||201
8075767|NCT03824912|19913375|P1|COMPLETED|Overall Study||192
8075768|NCT03824912|19913373|P3|STARTED|Overall Study||164
8075769|NCT03824912|19913374|P2|STARTED|Overall Study||335
8075770|NCT03824912|19913375|P1|STARTED|Overall Study||332
8075771|NCT03824236|19913398|P3|NOT COMPLETED|Overall Study||1
8075772|NCT03824236|19913399|P2|NOT COMPLETED|Overall Study||0
8075773|NCT03824236|19913400|P1|NOT COMPLETED|Overall Study||0
8075774|NCT03824236|19913398|P3|COMPLETED|Overall Study||11
8075775|NCT03824236|19913399|P2|COMPLETED|Overall Study||24
8075776|NCT03824236|19913400|P1|COMPLETED|Overall Study||25
8075777|NCT03824236|19913398|P3|STARTED|Overall Study||12
8075778|NCT03824236|19913399|P2|STARTED|Overall Study||24
8075779|NCT03824236|19913400|P1|STARTED|Overall Study||25
8075780|NCT03823937|19913435|P2|NOT COMPLETED|Overall Study||0
8075781|NCT03823937|19913436|P1|NOT COMPLETED|Overall Study||0
8075782|NCT03823937|19913435|P2|COMPLETED|Overall Study||20
8075783|NCT03823937|19913436|P1|COMPLETED|Overall Study||30
8075784|NCT03823937|19913435|P2|STARTED|Overall Study||20
8075785|NCT03823937|19913436|P1|STARTED|Overall Study||30
8075786|NCT03822884|19913458|P6|NOT COMPLETED|Overall Study||0
8075787|NCT03822884|19913459|P5|NOT COMPLETED|Overall Study||1
8075788|NCT03822884|19913460|P4|NOT COMPLETED|Overall Study||0
8075789|NCT03822884|19913461|P3|NOT COMPLETED|Overall Study||0
8075790|NCT03822884|19913462|P2|NOT COMPLETED|Overall Study||0
8075791|NCT03822884|19913463|P1|NOT COMPLETED|Overall Study||0
8075792|NCT03822884|19913458|P6|COMPLETED|Overall Study||4
8075793|NCT03822884|19913459|P5|COMPLETED|Overall Study||3
8075794|NCT03822884|19913460|P4|COMPLETED|Overall Study||4
8075795|NCT03822884|19913461|P3|COMPLETED|Overall Study||4
8075796|NCT03822884|19913462|P2|COMPLETED|Overall Study||4
8075797|NCT03822884|19913463|P1|COMPLETED|Overall Study||4
8075798|NCT03822884|19913458|P6|STARTED|Overall Study||4
8075799|NCT03822884|19913459|P5|STARTED|Overall Study||4
8075800|NCT03822884|19913460|P4|STARTED|Overall Study||4
8075801|NCT03822884|19913461|P3|STARTED|Overall Study||4
8075802|NCT03822884|19913462|P2|STARTED|Overall Study||4
8075803|NCT03822884|19913463|P1|STARTED|Overall Study||4
8075804|NCT03822182|19913495|P3|NOT COMPLETED|Overall Study||1
8075805|NCT03822182|19913496|P2|NOT COMPLETED|Overall Study||1
8075806|NCT03822182|19913497|P1|NOT COMPLETED|Overall Study||0
8075807|NCT03822182|19913495|P3|COMPLETED|Overall Study||26
8075808|NCT03822182|19913496|P2|COMPLETED|Overall Study||24
8075809|NCT03822182|19913497|P1|COMPLETED|Overall Study||26
8075810|NCT03822182|19913495|P3|STARTED|Overall Study||27
8075811|NCT03822182|19913496|P2|STARTED|Overall Study||25
8075812|NCT03822182|19913497|P1|STARTED|Overall Study||26
8075813|NCT03822078|19913514|P6|NOT COMPLETED|Overall Study||0
8075814|NCT03822078|19913515|P5|NOT COMPLETED|Overall Study||1
8075815|NCT03822078|19913516|P4|NOT COMPLETED|Overall Study||2
8075816|NCT03822078|19913517|P3|NOT COMPLETED|Overall Study||0
8075817|NCT03822078|19913518|P2|NOT COMPLETED|Overall Study||0
8075818|NCT03822078|19913519|P1|NOT COMPLETED|Overall Study||2
8075819|NCT03822078|19913514|P6|COMPLETED|Overall Study||6
8075820|NCT03822078|19913515|P5|COMPLETED|Overall Study||6
8075821|NCT03822078|19913516|P4|COMPLETED|Overall Study||6
8075822|NCT03822078|19913517|P3|COMPLETED|Overall Study||6
8075823|NCT03822078|19913518|P2|COMPLETED|Overall Study||6
8075824|NCT03822078|19913519|P1|COMPLETED|Overall Study||10
8075825|NCT03822078|19913514|P6|Received Study Drug|Overall Study||6
8075826|NCT03822078|19913515|P5|Received Study Drug|Overall Study||6
8075827|NCT03822078|19913516|P4|Received Study Drug|Overall Study||6
8075828|NCT03822078|19913517|P3|Received Study Drug|Overall Study||6
8075829|NCT03822078|19913518|P2|Received Study Drug|Overall Study||6
8075830|NCT03822078|19913519|P1|Received Study Drug|Overall Study||10
8075831|NCT03822078|19913514|P6|STARTED|Overall Study||6
8075832|NCT03822078|19913515|P5|STARTED|Overall Study||7
8075833|NCT03822078|19913516|P4|STARTED|Overall Study||8
8075834|NCT03822078|19913517|P3|STARTED|Overall Study||6
8075835|NCT03822078|19913518|P2|STARTED|Overall Study||6
8075836|NCT03822078|19913519|P1|STARTED|Overall Study||12
8075837|NCT03821259|19913577|P1|NOT COMPLETED|Overall Study||0
8075838|NCT03821259|19913577|P1|COMPLETED|Overall Study||88
8075839|NCT03821259|19913577|P1|STARTED|Overall Study||88
8075840|NCT03820544|19913587|P2|NOT COMPLETED|Overall Study||0
8075841|NCT03820544|19913588|P1|NOT COMPLETED|Overall Study||0
8075842|NCT03820544|19913587|P2|COMPLETED|Overall Study||2
8075843|NCT03820544|19913588|P1|COMPLETED|Overall Study||2
8075844|NCT03820544|19913587|P2|STARTED|Overall Study||2
8075845|NCT03820544|19913588|P1|STARTED|Overall Study||2
8075846|NCT03820258|19913596|P1|NOT COMPLETED|Overall Study||0
8075847|NCT03820258|19913596|P1|COMPLETED|Overall Study||21
8075848|NCT03820258|19913596|P1|STARTED|Overall Study||21
8075849|NCT03819491|19913625|P2|NOT COMPLETED|After Randomization||0
8075850|NCT03819491|19913626|P1|NOT COMPLETED|After Randomization||0
8075851|NCT03819491|19913625|P2|COMPLETED|After Randomization||12
8075852|NCT03819491|19913626|P1|COMPLETED|After Randomization||12
8075853|NCT03819491|19913625|P2|STARTED|After Randomization||12
8075854|NCT03819491|19913626|P1|STARTED|After Randomization||12
8075855|NCT03819491|19913625|P2|NOT COMPLETED|Before Randomization||0
8075856|NCT03819491|19913626|P1|NOT COMPLETED|Before Randomization||0
8075857|NCT03819491|19913625|P2|COMPLETED|Before Randomization||0
8075858|NCT03819491|19913626|P1|COMPLETED|Before Randomization||24
8075859|NCT03819491|19913625|P2|STARTED|Before Randomization||0
8075860|NCT03819491|19913626|P1|STARTED|Before Randomization||24
8075861|NCT03818815|19913639|P2|NOT COMPLETED|Overall Study||5
8075862|NCT03818815|19913640|P1|NOT COMPLETED|Overall Study||8
8075863|NCT03818815|19913639|P2|COMPLETED|Overall Study||42
8075864|NCT03818815|19913640|P1|COMPLETED|Overall Study||48
8075865|NCT03818815|19913639|P2|STARTED|Overall Study||47
8075866|NCT03818815|19913640|P1|STARTED|Overall Study||56
8075867|NCT03817879|19913652|P2|NOT COMPLETED|Overall Study||13
8075868|NCT03817879|19913653|P1|NOT COMPLETED|Overall Study||5
8075869|NCT03817879|19913652|P2|COMPLETED|Overall Study||22
8075870|NCT03817879|19913653|P1|COMPLETED|Overall Study||30
8075871|NCT03817879|19913652|P2|STARTED|Overall Study||35
8075872|NCT03817879|19913653|P1|STARTED|Overall Study||35
8075873|NCT03817775|19913661|P2|NOT COMPLETED|Overall Study||0
8075874|NCT03817775|19913662|P1|NOT COMPLETED|Overall Study||0
8075875|NCT03817775|19913661|P2|COMPLETED|Overall Study||54
8075876|NCT03817775|19913662|P1|COMPLETED|Overall Study||22
8075877|NCT03817775|19913661|P2|STARTED|Overall Study||54
8075878|NCT03817775|19913662|P1|STARTED|Overall Study||22
8075879|NCT03816761|19913689|P6|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075880|NCT03816761|19913690|P5|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075881|NCT03816761|19913691|P4|NOT COMPLETED|Second Treatment Period (7 Days)||1
8075882|NCT03816761|19913692|P3|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075883|NCT03816761|19913693|P2|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075884|NCT03816761|19913694|P1|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075885|NCT03816761|19913689|P6|COMPLETED|Second Treatment Period (7 Days)||3
8075886|NCT03816761|19913690|P5|COMPLETED|Second Treatment Period (7 Days)||4
8075887|NCT03816761|19913691|P4|COMPLETED|Second Treatment Period (7 Days)||3
8075888|NCT03816761|19913692|P3|COMPLETED|Second Treatment Period (7 Days)||4
8075889|NCT03816761|19913693|P2|COMPLETED|Second Treatment Period (7 Days)||4
8075890|NCT03816761|19913694|P1|COMPLETED|Second Treatment Period (7 Days)||4
8075891|NCT03816761|19913689|P6|STARTED|Second Treatment Period (7 Days)||3
8075892|NCT03816761|19913690|P5|STARTED|Second Treatment Period (7 Days)||4
8075893|NCT03816761|19913691|P4|STARTED|Second Treatment Period (7 Days)||4
8075894|NCT03816761|19913692|P3|STARTED|Second Treatment Period (7 Days)||4
8075895|NCT03816761|19913693|P2|STARTED|Second Treatment Period (7 Days)||4
8075896|NCT03816761|19913694|P1|STARTED|Second Treatment Period (7 Days)||4
8075897|NCT03816761|19913689|P6|NOT COMPLETED|First Treatment Period (7 Days)||1
8075898|NCT03816761|19913690|P5|NOT COMPLETED|First Treatment Period (7 Days)||0
8075899|NCT03816761|19913691|P4|NOT COMPLETED|First Treatment Period (7 Days)||0
8075900|NCT03816761|19913692|P3|NOT COMPLETED|First Treatment Period (7 Days)||0
8075901|NCT03816761|19913693|P2|NOT COMPLETED|First Treatment Period (7 Days)||0
8075902|NCT03816761|19913694|P1|NOT COMPLETED|First Treatment Period (7 Days)||0
8075903|NCT03816761|19913689|P6|COMPLETED|First Treatment Period (7 Days)||3
8075904|NCT03816761|19913690|P5|COMPLETED|First Treatment Period (7 Days)||4
8075905|NCT03816761|19913691|P4|COMPLETED|First Treatment Period (7 Days)||4
8075906|NCT03816761|19913692|P3|COMPLETED|First Treatment Period (7 Days)||4
8075907|NCT03816761|19913693|P2|COMPLETED|First Treatment Period (7 Days)||4
8075908|NCT03816761|19913694|P1|COMPLETED|First Treatment Period (7 Days)||4
8075909|NCT03816761|19913689|P6|STARTED|First Treatment Period (7 Days)||4
8075910|NCT03816761|19913690|P5|STARTED|First Treatment Period (7 Days)||4
8075911|NCT03816761|19913691|P4|STARTED|First Treatment Period (7 Days)||4
8075912|NCT03816761|19913692|P3|STARTED|First Treatment Period (7 Days)||4
8075913|NCT03816761|19913693|P2|STARTED|First Treatment Period (7 Days)||4
8075914|NCT03816761|19913694|P1|STARTED|First Treatment Period (7 Days)||4
8075915|NCT03816696|19913792|P1|NOT COMPLETED|Period 3 (Up to Day 11)||0
8075916|NCT03816696|19913792|P1|COMPLETED|Period 3 (Up to Day 11)||16
8075917|NCT03816696|19913792|P1|STARTED|Period 3 (Up to Day 11)||16
8075918|NCT03816696|19913792|P1|NOT COMPLETED|Period 2 (Up to Day 7)||0
8075919|NCT03816696|19913792|P1|COMPLETED|Period 2 (Up to Day 7)||16
8075920|NCT03816696|19913792|P1|STARTED|Period 2 (Up to Day 7)||16
8075921|NCT03816696|19913792|P1|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
8075922|NCT03816696|19913792|P1|COMPLETED|Wash Out Period (Days 6 to 9)||16
8075923|NCT03816696|19913792|P1|STARTED|Wash Out Period (Days 6 to 9)||16
8075924|NCT03816696|19913792|P1|NOT COMPLETED|Period 1 (Up to Day 5)||0
8075925|NCT03816696|19913792|P1|COMPLETED|Period 1 (Up to Day 5)||16
8075926|NCT03816696|19913792|P1|STARTED|Period 1 (Up to Day 5)||16
8075927|NCT03815240|19913937|P9|NOT COMPLETED|Intervention Optifoam Dressing||0
8075928|NCT03815240|19913938|P8|NOT COMPLETED|Intervention Optifoam Dressing||0
8075929|NCT03815240|19913939|P7|NOT COMPLETED|Intervention Optifoam Dressing||0
8075930|NCT03815240|19913940|P6|NOT COMPLETED|Intervention Optifoam Dressing||0
8075931|NCT03815240|19913941|P5|NOT COMPLETED|Intervention Optifoam Dressing||0
8075932|NCT03815240|19913942|P4|NOT COMPLETED|Intervention Optifoam Dressing||0
8075933|NCT03815240|19913943|P3|NOT COMPLETED|Intervention Optifoam Dressing||0
8075934|NCT03815240|19913944|P2|NOT COMPLETED|Intervention Optifoam Dressing||0
8075935|NCT03815240|19913945|P1|NOT COMPLETED|Intervention Optifoam Dressing||0
8075936|NCT03815240|19913937|P9|COMPLETED|Intervention Optifoam Dressing||1
8075937|NCT03815240|19913938|P8|COMPLETED|Intervention Optifoam Dressing||1
8075938|NCT03815240|19913939|P7|COMPLETED|Intervention Optifoam Dressing||1
8075939|NCT03815240|19913940|P6|COMPLETED|Intervention Optifoam Dressing||2
8075940|NCT03815240|19913941|P5|COMPLETED|Intervention Optifoam Dressing||1
8075941|NCT03815240|19913942|P4|COMPLETED|Intervention Optifoam Dressing||2
8075942|NCT03815240|19913943|P3|COMPLETED|Intervention Optifoam Dressing||1
8075943|NCT03815240|19913944|P2|COMPLETED|Intervention Optifoam Dressing||1
8075944|NCT03815240|19913945|P1|COMPLETED|Intervention Optifoam Dressing||2
8075945|NCT03815240|19913937|P9|STARTED|Intervention Optifoam Dressing||1
8075946|NCT03815240|19913938|P8|STARTED|Intervention Optifoam Dressing||1
8075947|NCT03815240|19913939|P7|STARTED|Intervention Optifoam Dressing||1
8075948|NCT03815240|19913940|P6|STARTED|Intervention Optifoam Dressing||2
8075949|NCT03815240|19913941|P5|STARTED|Intervention Optifoam Dressing||1
8075950|NCT03815240|19913942|P4|STARTED|Intervention Optifoam Dressing||2
8075951|NCT03815240|19913943|P3|STARTED|Intervention Optifoam Dressing||1
8075952|NCT03815240|19913944|P2|STARTED|Intervention Optifoam Dressing||1
8075953|NCT03815240|19913945|P1|STARTED|Intervention Optifoam Dressing||2
8075954|NCT03815240|19913937|P9|NOT COMPLETED|Intervention Allevyn Dressing||0
8075955|NCT03815240|19913938|P8|NOT COMPLETED|Intervention Allevyn Dressing||0
8075956|NCT03815240|19913939|P7|NOT COMPLETED|Intervention Allevyn Dressing||0
8075957|NCT03815240|19913940|P6|NOT COMPLETED|Intervention Allevyn Dressing||0
8075958|NCT03815240|19913941|P5|NOT COMPLETED|Intervention Allevyn Dressing||0
8075959|NCT03815240|19913942|P4|NOT COMPLETED|Intervention Allevyn Dressing||0
8075960|NCT03815240|19913943|P3|NOT COMPLETED|Intervention Allevyn Dressing||0
8075961|NCT03815240|19913944|P2|NOT COMPLETED|Intervention Allevyn Dressing||0
8075962|NCT03815240|19913945|P1|NOT COMPLETED|Intervention Allevyn Dressing||0
8075963|NCT03815240|19913937|P9|COMPLETED|Intervention Allevyn Dressing||1
8075964|NCT03815240|19913938|P8|COMPLETED|Intervention Allevyn Dressing||1
8075965|NCT03815240|19913939|P7|COMPLETED|Intervention Allevyn Dressing||1
8075966|NCT03815240|19913940|P6|COMPLETED|Intervention Allevyn Dressing||2
8075967|NCT03815240|19913941|P5|COMPLETED|Intervention Allevyn Dressing||1
8075968|NCT03815240|19913942|P4|COMPLETED|Intervention Allevyn Dressing||2
8075969|NCT03815240|19913943|P3|COMPLETED|Intervention Allevyn Dressing||1
8075970|NCT03815240|19913944|P2|COMPLETED|Intervention Allevyn Dressing||1
8075971|NCT03815240|19913945|P1|COMPLETED|Intervention Allevyn Dressing||2
8075972|NCT03815240|19913937|P9|STARTED|Intervention Allevyn Dressing||1
8075973|NCT03815240|19913938|P8|STARTED|Intervention Allevyn Dressing||1
8075974|NCT03815240|19913939|P7|STARTED|Intervention Allevyn Dressing||1
8075975|NCT03815240|19913940|P6|STARTED|Intervention Allevyn Dressing||2
8075976|NCT03815240|19913941|P5|STARTED|Intervention Allevyn Dressing||1
8075977|NCT03815240|19913942|P4|STARTED|Intervention Allevyn Dressing||2
8075978|NCT03815240|19913943|P3|STARTED|Intervention Allevyn Dressing||1
8075979|NCT03815240|19913944|P2|STARTED|Intervention Allevyn Dressing||1
8075980|NCT03815240|19913945|P1|STARTED|Intervention Allevyn Dressing||2
8075981|NCT03815240|19913937|P9|NOT COMPLETED|Intervention Mepilex Dressing||0
8075982|NCT03815240|19913938|P8|NOT COMPLETED|Intervention Mepilex Dressing||0
8075983|NCT03815240|19913939|P7|NOT COMPLETED|Intervention Mepilex Dressing||0
8075984|NCT03815240|19913940|P6|NOT COMPLETED|Intervention Mepilex Dressing||0
8075985|NCT03815240|19913941|P5|NOT COMPLETED|Intervention Mepilex Dressing||0
8075986|NCT03815240|19913942|P4|NOT COMPLETED|Intervention Mepilex Dressing||0
8075987|NCT03815240|19913943|P3|NOT COMPLETED|Intervention Mepilex Dressing||0
8075988|NCT03815240|19913944|P2|NOT COMPLETED|Intervention Mepilex Dressing||0
8075989|NCT03815240|19913945|P1|NOT COMPLETED|Intervention Mepilex Dressing||0
8075990|NCT03815240|19913937|P9|COMPLETED|Intervention Mepilex Dressing||1
8075991|NCT03815240|19913938|P8|COMPLETED|Intervention Mepilex Dressing||1
8075992|NCT03815240|19913939|P7|COMPLETED|Intervention Mepilex Dressing||1
8075993|NCT03815240|19913940|P6|COMPLETED|Intervention Mepilex Dressing||2
8075994|NCT03815240|19913941|P5|COMPLETED|Intervention Mepilex Dressing||1
8075995|NCT03815240|19913942|P4|COMPLETED|Intervention Mepilex Dressing||2
8075996|NCT03815240|19913943|P3|COMPLETED|Intervention Mepilex Dressing||1
8075997|NCT03815240|19913944|P2|COMPLETED|Intervention Mepilex Dressing||1
8075998|NCT03815240|19913945|P1|COMPLETED|Intervention Mepilex Dressing||2
8075999|NCT03815240|19913937|P9|STARTED|Intervention Mepilex Dressing||1
8076000|NCT03815240|19913938|P8|STARTED|Intervention Mepilex Dressing||1
8076001|NCT03815240|19913939|P7|STARTED|Intervention Mepilex Dressing||1
8076002|NCT03815240|19913940|P6|STARTED|Intervention Mepilex Dressing||2
8076003|NCT03815240|19913941|P5|STARTED|Intervention Mepilex Dressing||1
8076004|NCT03815240|19913942|P4|STARTED|Intervention Mepilex Dressing||2
8076005|NCT03815240|19913943|P3|STARTED|Intervention Mepilex Dressing||1
8076006|NCT03815240|19913944|P2|STARTED|Intervention Mepilex Dressing||1
8076007|NCT03815240|19913945|P1|STARTED|Intervention Mepilex Dressing||2
8076008|NCT03815240|19913937|P9|NOT COMPLETED|Intervention no Dressing||0
8076009|NCT03815240|19913938|P8|NOT COMPLETED|Intervention no Dressing||0
8076010|NCT03815240|19913939|P7|NOT COMPLETED|Intervention no Dressing||0
8076011|NCT03815240|19913940|P6|NOT COMPLETED|Intervention no Dressing||0
8076012|NCT03815240|19913941|P5|NOT COMPLETED|Intervention no Dressing||0
8076013|NCT03815240|19913942|P4|NOT COMPLETED|Intervention no Dressing||0
8076014|NCT03815240|19913943|P3|NOT COMPLETED|Intervention no Dressing||0
8076015|NCT03815240|19913944|P2|NOT COMPLETED|Intervention no Dressing||0
8076016|NCT03815240|19913945|P1|NOT COMPLETED|Intervention no Dressing||0
8076017|NCT03815240|19913937|P9|COMPLETED|Intervention no Dressing||1
8076018|NCT03815240|19913938|P8|COMPLETED|Intervention no Dressing||1
8076019|NCT03815240|19913939|P7|COMPLETED|Intervention no Dressing||1
8076020|NCT03815240|19913940|P6|COMPLETED|Intervention no Dressing||2
8076021|NCT03815240|19913941|P5|COMPLETED|Intervention no Dressing||1
8076022|NCT03815240|19913942|P4|COMPLETED|Intervention no Dressing||2
8076023|NCT03815240|19913943|P3|COMPLETED|Intervention no Dressing||1
8076024|NCT03815240|19913944|P2|COMPLETED|Intervention no Dressing||1
8076025|NCT03815240|19913945|P1|COMPLETED|Intervention no Dressing||2
8076026|NCT03815240|19913937|P9|STARTED|Intervention no Dressing||1
8076027|NCT03815240|19913938|P8|STARTED|Intervention no Dressing||1
8076028|NCT03815240|19913939|P7|STARTED|Intervention no Dressing||1
8076029|NCT03815240|19913940|P6|STARTED|Intervention no Dressing||2
8076030|NCT03815240|19913941|P5|STARTED|Intervention no Dressing||1
8076031|NCT03815240|19913942|P4|STARTED|Intervention no Dressing||2
8076032|NCT03815240|19913943|P3|STARTED|Intervention no Dressing||1
8076033|NCT03815240|19913944|P2|STARTED|Intervention no Dressing||1
8076034|NCT03815240|19913945|P1|STARTED|Intervention no Dressing||2
8076035|NCT03813719|19913991|P1|NOT COMPLETED|Overall Study||0
8076036|NCT03813719|19913991|P1|COMPLETED|Overall Study||250
8076037|NCT03813719|19913991|P1|STARTED|Overall Study||250
8076038|NCT03812510|19913997|P1|NOT COMPLETED|Overall Study||152
8076039|NCT03812510|19913997|P1|COMPLETED|Overall Study||274
8076040|NCT03812510|19913997|P1|STARTED|Overall Study||426
8076041|NCT03812328|19914029|P3|NOT COMPLETED|Overall Study||1
8076042|NCT03812328|19914030|P2|NOT COMPLETED|Overall Study||3
8076043|NCT03812328|19914031|P1|NOT COMPLETED|Overall Study||0
8076044|NCT03812328|19914029|P3|COMPLETED|Overall Study||88
8076045|NCT03812328|19914030|P2|COMPLETED|Overall Study||60
8076046|NCT03812328|19914031|P1|COMPLETED|Overall Study||55
8076047|NCT03812328|19914029|P3|Safety Population|Overall Study||88
8076048|NCT03812328|19914030|P2|Safety Population|Overall Study||63
8076049|NCT03812328|19914031|P1|Safety Population|Overall Study||55
8076050|NCT03812328|19914029|P3|Modified Intent-to-Treat (mITT) Population|Overall Study||84
8076051|NCT03812328|19914030|P2|Modified Intent-to-Treat (mITT) Population|Overall Study||61
8076052|NCT03812328|19914031|P1|Modified Intent-to-Treat (mITT) Population|Overall Study||48
8076053|NCT03812328|19914029|P3|STARTED|Overall Study||89
8076054|NCT03812328|19914030|P2|STARTED|Overall Study||63
8076055|NCT03812328|19914031|P1|STARTED|Overall Study||55
8076056|NCT03811093|19914044|P2|NOT COMPLETED|Overall Study||4
8076057|NCT03811093|19914045|P1|NOT COMPLETED|Overall Study||2
8076058|NCT03811093|19914044|P2|COMPLETED|Overall Study||15
8076059|NCT03811093|19914045|P1|COMPLETED|Overall Study||18
8076060|NCT03811093|19914044|P2|STARTED|Overall Study||19
8076061|NCT03811093|19914045|P1|STARTED|Overall Study||20
8076062|NCT03810235|19914057|P2|NOT COMPLETED|Overall Study||0
8076063|NCT03810235|19914058|P1|NOT COMPLETED|Overall Study||2
8076064|NCT03810235|19914057|P2|COMPLETED|Overall Study||31
8076065|NCT03810235|19914058|P1|COMPLETED|Overall Study||30
8076066|NCT03810235|19914057|P2|Participant Data Analyzed|Overall Study||31
8076067|NCT03810235|19914058|P1|Participant Data Analyzed|Overall Study||30
8076068|NCT03810235|19914057|P2|STARTED|Overall Study||31
8076069|NCT03810235|19914058|P1|STARTED|Overall Study||32
8076070|NCT03810183|19914088|P2|NOT COMPLETED|Overall Study||1
8076071|NCT03810183|19914089|P1|NOT COMPLETED|Overall Study||2
8076072|NCT03810183|19914088|P2|COMPLETED|Overall Study||2
8076073|NCT03810183|19914089|P1|COMPLETED|Overall Study||4
8076074|NCT03810183|19914088|P2|STARTED|Overall Study||3
8076075|NCT03810183|19914089|P1|STARTED|Overall Study||6
8076076|NCT03810014|19914100|P4|NOT COMPLETED|Overall Study||2
8076077|NCT03810014|19914101|P3|NOT COMPLETED|Overall Study||0
8076078|NCT03810014|19914102|P2|NOT COMPLETED|Overall Study||2
8076079|NCT03810014|19914103|P1|NOT COMPLETED|Overall Study||2
8076080|NCT03810014|19914100|P4|COMPLETED|Overall Study||211
8076081|NCT03810014|19914101|P3|COMPLETED|Overall Study||210
8076082|NCT03810014|19914102|P2|COMPLETED|Overall Study||202
8076083|NCT03810014|19914103|P1|COMPLETED|Overall Study||213
8076084|NCT03810014|19914100|P4|STARTED|Overall Study||213
8076085|NCT03810014|19914101|P3|STARTED|Overall Study||210
8076086|NCT03810014|19914102|P2|STARTED|Overall Study||204
8076087|NCT03810014|19914103|P1|STARTED|Overall Study||215
8076088|NCT03809910|19914125|P2|NOT COMPLETED|Period 3 (Visit 4)||0
8076089|NCT03809910|19914126|P1|NOT COMPLETED|Period 3 (Visit 4)||0
8076090|NCT03809910|19914125|P2|COMPLETED|Period 3 (Visit 4)||19
8076091|NCT03809910|19914126|P1|COMPLETED|Period 3 (Visit 4)||20
8076092|NCT03809910|19914125|P2|STARTED|Period 3 (Visit 4)||19
8076093|NCT03809910|19914126|P1|STARTED|Period 3 (Visit 4)||20
8076094|NCT03809910|19914125|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
8076095|NCT03809910|19914126|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
8076096|NCT03809910|19914125|P2|COMPLETED|Washout Period 2 (3 Days)||19
8076097|NCT03809910|19914126|P1|COMPLETED|Washout Period 2 (3 Days)||20
8076098|NCT03809910|19914125|P2|STARTED|Washout Period 2 (3 Days)||19
8076099|NCT03809910|19914126|P1|STARTED|Washout Period 2 (3 Days)||20
8076100|NCT03809910|19914125|P2|NOT COMPLETED|Period 2 (Visit 3)||0
8076101|NCT03809910|19914126|P1|NOT COMPLETED|Period 2 (Visit 3)||0
8076102|NCT03809910|19914125|P2|COMPLETED|Period 2 (Visit 3)||19
8076103|NCT03809910|19914126|P1|COMPLETED|Period 2 (Visit 3)||20
8076104|NCT03809910|19914125|P2|STARTED|Period 2 (Visit 3)||19
8076105|NCT03809910|19914126|P1|STARTED|Period 2 (Visit 3)||20
8076106|NCT03809910|19914125|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
8076107|NCT03809910|19914126|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
8076108|NCT03809910|19914125|P2|COMPLETED|Washout Period 1 (3 Days)||19
8076109|NCT03809910|19914126|P1|COMPLETED|Washout Period 1 (3 Days)||20
8076110|NCT03809910|19914125|P2|STARTED|Washout Period 1 (3 Days)||19
8076111|NCT03809910|19914126|P1|STARTED|Washout Period 1 (3 Days)||20
8076112|NCT03809910|19914125|P2|NOT COMPLETED|Period 1 (Visit 2)||0
8076113|NCT03809910|19914126|P1|NOT COMPLETED|Period 1 (Visit 2)||0
8076114|NCT03809910|19914125|P2|COMPLETED|Period 1 (Visit 2)||19
8076115|NCT03809910|19914126|P1|COMPLETED|Period 1 (Visit 2)||20
8076116|NCT03809910|19914125|P2|STARTED|Period 1 (Visit 2)||19
8076117|NCT03809910|19914126|P1|STARTED|Period 1 (Visit 2)||20
8076118|NCT03809611|19914160|P2|NOT COMPLETED|Overall Study||1
8076119|NCT03809611|19914161|P1|NOT COMPLETED|Overall Study||1
8076120|NCT03809611|19914160|P2|COMPLETED|Overall Study||61
8076121|NCT03809611|19914161|P1|COMPLETED|Overall Study||61
8076122|NCT03809611|19914160|P2|STARTED|Overall Study||62
8076123|NCT03809611|19914161|P1|STARTED|Overall Study||62
8076124|NCT03809182|19914174|P2|NOT COMPLETED|Overall Study||0
8076125|NCT03809182|19914175|P1|NOT COMPLETED|Overall Study||0
8076126|NCT03809182|19914174|P2|COMPLETED|Overall Study||20
8076127|NCT03809182|19914175|P1|COMPLETED|Overall Study||20
8076128|NCT03809182|19914174|P2|STARTED|Overall Study||20
8076129|NCT03809182|19914175|P1|STARTED|Overall Study||20
8076130|NCT03809104|19914193|P1|NOT COMPLETED|Overall Study||3
8076131|NCT03809104|19914193|P1|COMPLETED|Overall Study||40
8076132|NCT03809104|19914193|P1|STARTED|Overall Study||43
8076133|NCT03808688|19914204|P2|NOT COMPLETED|Overall Study||23
8076134|NCT03808688|19914205|P1|NOT COMPLETED|Overall Study||18
8076135|NCT03808688|19914204|P2|COMPLETED|Overall Study||138
8076136|NCT03808688|19914205|P1|COMPLETED|Overall Study||81
8076137|NCT03808688|19914204|P2|STARTED|Overall Study||161
8076138|NCT03808688|19914205|P1|STARTED|Overall Study||99
8076139|NCT03808493|19914217|P4|NOT COMPLETED|Overall Study||0
8076140|NCT03808493|19914218|P3|NOT COMPLETED|Overall Study||0
8076141|NCT03808493|19914219|P2|NOT COMPLETED|Overall Study||0
8076142|NCT03808493|19914220|P1|NOT COMPLETED|Overall Study||0
8076143|NCT03808493|19914217|P4|COMPLETED|Overall Study||12
8076144|NCT03808493|19914218|P3|COMPLETED|Overall Study||12
8076145|NCT03808493|19914219|P2|COMPLETED|Overall Study||12
8076146|NCT03808493|19914220|P1|COMPLETED|Overall Study||12
8076147|NCT03808493|19914217|P4|STARTED|Overall Study||12
8076148|NCT03808493|19914218|P3|STARTED|Overall Study||12
8076149|NCT03808493|19914219|P2|STARTED|Overall Study||12
8076150|NCT03808493|19914220|P1|STARTED|Overall Study||12
8076151|NCT03808298|19914250|P1|NOT COMPLETED|Overall Study||8
8076152|NCT03808298|19914250|P1|COMPLETED|Overall Study||49
8076153|NCT03808298|19914250|P1|STARTED|Overall Study||57
8076154|NCT03807739|19914327|P4|NOT COMPLETED|Overall Study||0
8076155|NCT03807739|19914328|P3|NOT COMPLETED|Overall Study||0
8076156|NCT03807739|19914329|P2|NOT COMPLETED|Overall Study||0
8076157|NCT03807739|19914330|P1|NOT COMPLETED|Overall Study||2
8076158|NCT03807739|19914327|P4|COMPLETED|Overall Study||10
8076159|NCT03807739|19914328|P3|COMPLETED|Overall Study||9
8076160|NCT03807739|19914329|P2|COMPLETED|Overall Study||10
8076161|NCT03807739|19914330|P1|COMPLETED|Overall Study||7
8076162|NCT03807739|19914327|P4|STARTED|Overall Study||10
8076163|NCT03807739|19914328|P3|STARTED|Overall Study||9
8076164|NCT03807739|19914329|P2|STARTED|Overall Study||10
8076165|NCT03807739|19914330|P1|STARTED|Overall Study||9
8076166|NCT03807700|19914346|P2|NOT COMPLETED|Overall Study||1
8076167|NCT03807700|19914347|P1|NOT COMPLETED|Overall Study||2
8076168|NCT03807700|19914346|P2|COMPLETED|Overall Study||58
8076169|NCT03807700|19914347|P1|COMPLETED|Overall Study||58
8076170|NCT03807700|19914346|P2|STARTED|Overall Study||59
8076171|NCT03807700|19914347|P1|STARTED|Overall Study||60
8076172|NCT03807544|19914370|P1|NOT COMPLETED|Overall Study||0
8076173|NCT03807544|19914370|P1|COMPLETED|Overall Study||17
8076174|NCT03807544|19914370|P1|STARTED|Overall Study||17
8076184|NCT03807089|19914402|P2|NOT COMPLETED|Overall Study||0
8076185|NCT03807089|19914403|P1|NOT COMPLETED|Overall Study||0
8076186|NCT03807089|19914402|P2|COMPLETED|Overall Study||93
8076187|NCT03807089|19914403|P1|COMPLETED|Overall Study||101
8076188|NCT03807089|19914402|P2|STARTED|Overall Study||93
8076189|NCT03807089|19914403|P1|STARTED|Overall Study||101
8076190|NCT03806790|19914419|P2|NOT COMPLETED|Overall Study||0
8076191|NCT03806790|19914420|P1|NOT COMPLETED|Overall Study||0
8076192|NCT03806790|19914419|P2|COMPLETED|Overall Study||95
8076193|NCT03806790|19914420|P1|COMPLETED|Overall Study||87
8076194|NCT03806790|19914419|P2|STARTED|Overall Study||95
8076195|NCT03806790|19914420|P1|STARTED|Overall Study||87
8076196|NCT03806270|19914435|P3|NOT COMPLETED|Overall Study||0
8076197|NCT03806270|19914436|P2|NOT COMPLETED|Overall Study||0
8076198|NCT03806270|19914437|P1|NOT COMPLETED|Overall Study||0
8076199|NCT03806270|19914435|P3|COMPLETED|Overall Study||15
8076200|NCT03806270|19914436|P2|COMPLETED|Overall Study||15
8076201|NCT03806270|19914437|P1|COMPLETED|Overall Study||15
8076202|NCT03806270|19914435|P3|STARTED|Overall Study||15
8076203|NCT03806270|19914436|P2|STARTED|Overall Study||15
8076204|NCT03806270|19914437|P1|STARTED|Overall Study||15
8076205|NCT03805971|19914463|P1|NOT COMPLETED|Overall Study||3
8076206|NCT03805971|19914463|P1|COMPLETED|Overall Study||62
8076207|NCT03805971|19914463|P1|STARTED|Overall Study||65
8076208|NCT03805672|19914478|P2|NOT COMPLETED|Overall Study||0
8076209|NCT03805672|19914479|P1|NOT COMPLETED|Overall Study||0
8076210|NCT03805672|19914478|P2|COMPLETED|Overall Study||2
8076211|NCT03805672|19914479|P1|COMPLETED|Overall Study||2
8076212|NCT03805672|19914478|P2|STARTED|Overall Study||2
8076213|NCT03805672|19914479|P1|STARTED|Overall Study||2
8076214|NCT03804918|19914485|P1|NOT COMPLETED|Overall Study||1
8076215|NCT03804918|19914485|P1|COMPLETED|Overall Study||16
8076216|NCT03804918|19914485|P1|STARTED|Overall Study||17
8076217|NCT03804710|19914492|P2|NOT COMPLETED|Overall Study||5
8076218|NCT03804710|19914493|P1|NOT COMPLETED|Overall Study||2
8076219|NCT03804710|19914492|P2|COMPLETED|Overall Study||69
8076220|NCT03804710|19914493|P1|COMPLETED|Overall Study||73
8076221|NCT03804710|19914492|P2|STARTED|Overall Study||74
8076222|NCT03804710|19914493|P1|STARTED|Overall Study||75
8076223|NCT03803085|19914550|P2|NOT COMPLETED|Overall Study||2
8076224|NCT03803085|19914551|P1|NOT COMPLETED|Overall Study||2
8076225|NCT03803085|19914550|P2|COMPLETED|Overall Study||28
8076226|NCT03803085|19914551|P1|COMPLETED|Overall Study||28
8076227|NCT03803085|19914550|P2|STARTED|Overall Study||30
8076228|NCT03803085|19914551|P1|STARTED|Overall Study||30
8076229|NCT03802864|19914563|P2|NOT COMPLETED|Overall Study||0
8076230|NCT03802864|19914564|P1|NOT COMPLETED|Overall Study||0
8076231|NCT03802864|19914563|P2|COMPLETED|Overall Study||25
8076232|NCT03802864|19914564|P1|COMPLETED|Overall Study||25
8076233|NCT03802864|19914563|P2|STARTED|Overall Study||25
8076234|NCT03802864|19914564|P1|STARTED|Overall Study||25
8076235|NCT03802565|19914587|P5|NOT COMPLETED|Overall Study||6
8076236|NCT03802565|19914588|P4|NOT COMPLETED|Overall Study||8
8076237|NCT03802565|19914589|P3|NOT COMPLETED|Overall Study||9
8076238|NCT03802565|19914590|P2|NOT COMPLETED|Overall Study||4
8076239|NCT03802565|19914591|P1|NOT COMPLETED|Overall Study||5
8076240|NCT03802565|19914587|P5|COMPLETED|Overall Study||72
8076241|NCT03802565|19914588|P4|COMPLETED|Overall Study||77
8076242|NCT03802565|19914589|P3|COMPLETED|Overall Study||74
8076243|NCT03802565|19914590|P2|COMPLETED|Overall Study||83
8076244|NCT03802565|19914591|P1|COMPLETED|Overall Study||77
8076245|NCT03802565|19914587|P5|STARTED|Overall Study||78
8076246|NCT03802565|19914588|P4|STARTED|Overall Study||85
8076247|NCT03802565|19914589|P3|STARTED|Overall Study||83
8076248|NCT03802565|19914590|P2|STARTED|Overall Study||87
8076249|NCT03802565|19914591|P1|STARTED|Overall Study||82
8076250|NCT03802344|19914606|P3|NOT COMPLETED|Overall Study||13
8076251|NCT03802344|19914607|P2|NOT COMPLETED|Overall Study||6
8076252|NCT03802344|19914608|P1|NOT COMPLETED|Overall Study||8
8076253|NCT03802344|19914606|P3|COMPLETED|Overall Study||55
8076254|NCT03802344|19914607|P2|COMPLETED|Overall Study||203
8076255|NCT03802344|19914608|P1|COMPLETED|Overall Study||205
8076256|NCT03802344|19914606|P3|STARTED|Overall Study||68
8076257|NCT03802344|19914607|P2|STARTED|Overall Study||209
8076258|NCT03802344|19914608|P1|STARTED|Overall Study||213
8076259|NCT03801148|19914623|P4|NOT COMPLETED|Follow-Up (12 Days)||0
8076260|NCT03801148|19914624|P3|NOT COMPLETED|Follow-Up (12 Days)||1
8076261|NCT03801148|19914625|P2|NOT COMPLETED|Follow-Up (12 Days)||1
8076262|NCT03801148|19914626|P1|NOT COMPLETED|Follow-Up (12 Days)||0
8076263|NCT03801148|19914623|P4|COMPLETED|Follow-Up (12 Days)||29
8076264|NCT03801148|19914624|P3|COMPLETED|Follow-Up (12 Days)||28
8076265|NCT03801148|19914625|P2|COMPLETED|Follow-Up (12 Days)||29
8076266|NCT03801148|19914626|P1|COMPLETED|Follow-Up (12 Days)||30
8076267|NCT03801148|19914623|P4|STARTED|Follow-Up (12 Days)||29
8076268|NCT03801148|19914624|P3|STARTED|Follow-Up (12 Days)||29
8076269|NCT03801148|19914625|P2|STARTED|Follow-Up (12 Days)||30
8076270|NCT03801148|19914626|P1|STARTED|Follow-Up (12 Days)||30
8076271|NCT03801148|19914623|P4|NOT COMPLETED|Period 2 (2 Days)||0
8076272|NCT03801148|19914624|P3|NOT COMPLETED|Period 2 (2 Days)||0
8076273|NCT03801148|19914625|P2|NOT COMPLETED|Period 2 (2 Days)||0
8076274|NCT03801148|19914626|P1|NOT COMPLETED|Period 2 (2 Days)||0
8076275|NCT03801148|19914623|P4|COMPLETED|Period 2 (2 Days)||29
8076276|NCT03801148|19914624|P3|COMPLETED|Period 2 (2 Days)||29
8076277|NCT03801148|19914625|P2|COMPLETED|Period 2 (2 Days)||30
8076278|NCT03801148|19914626|P1|COMPLETED|Period 2 (2 Days)||30
8076279|NCT03801148|19914623|P4|STARTED|Period 2 (2 Days)||29
8076280|NCT03801148|19914624|P3|STARTED|Period 2 (2 Days)||29
8076281|NCT03801148|19914625|P2|STARTED|Period 2 (2 Days)||30
8076282|NCT03801148|19914626|P1|STARTED|Period 2 (2 Days)||30
8076283|NCT03801148|19914623|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||1
8076284|NCT03801148|19914624|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||1
8076285|NCT03801148|19914625|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||0
8076286|NCT03801148|19914626|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||0
8076287|NCT03801148|19914623|P4|COMPLETED|Washout Period (at Least 5 Days)||29
8076288|NCT03801148|19914624|P3|COMPLETED|Washout Period (at Least 5 Days)||29
8076289|NCT03801148|19914625|P2|COMPLETED|Washout Period (at Least 5 Days)||30
8076290|NCT03801148|19914626|P1|COMPLETED|Washout Period (at Least 5 Days)||30
8076291|NCT03801148|19914623|P4|STARTED|Washout Period (at Least 5 Days)||30
8076292|NCT03801148|19914624|P3|STARTED|Washout Period (at Least 5 Days)||30
8076293|NCT03801148|19914625|P2|STARTED|Washout Period (at Least 5 Days)||30
8076294|NCT03801148|19914626|P1|STARTED|Washout Period (at Least 5 Days)||30
8076295|NCT03801148|19914623|P4|NOT COMPLETED|Period 1 (2 Days)||0
8076296|NCT03801148|19914624|P3|NOT COMPLETED|Period 1 (2 Days)||0
8076297|NCT03801148|19914625|P2|NOT COMPLETED|Period 1 (2 Days)||1
8076298|NCT03801148|19914626|P1|NOT COMPLETED|Period 1 (2 Days)||1
8076299|NCT03801148|19914623|P4|COMPLETED|Period 1 (2 Days)||30
8076300|NCT03801148|19914624|P3|COMPLETED|Period 1 (2 Days)||30
8076301|NCT03801148|19914625|P2|COMPLETED|Period 1 (2 Days)||30
8076302|NCT03801148|19914626|P1|COMPLETED|Period 1 (2 Days)||30
8076303|NCT03801148|19914623|P4|STARTED|Period 1 (2 Days)||30
8076304|NCT03801148|19914624|P3|STARTED|Period 1 (2 Days)||30
8076305|NCT03801148|19914625|P2|STARTED|Period 1 (2 Days)||31
8076306|NCT03801148|19914626|P1|STARTED|Period 1 (2 Days)||31
8076307|NCT03801044|19914648|P1|NOT COMPLETED|Overall Study||0
8076308|NCT03801044|19914648|P1|COMPLETED|Overall Study||21
8076309|NCT03801044|19914648|P1|STARTED|Overall Study||21
8076310|NCT03800030|19914667|P6|NOT COMPLETED|Third Intervention||0
8076311|NCT03800030|19914668|P5|NOT COMPLETED|Third Intervention||0
8076312|NCT03800030|19914669|P4|NOT COMPLETED|Third Intervention||0
8076313|NCT03800030|19914670|P3|NOT COMPLETED|Third Intervention||0
8076314|NCT03800030|19914671|P2|NOT COMPLETED|Third Intervention||0
8076315|NCT03800030|19914672|P1|NOT COMPLETED|Third Intervention||0
8076316|NCT03800030|19914667|P6|COMPLETED|Third Intervention||4
8076317|NCT03800030|19914668|P5|COMPLETED|Third Intervention||4
8076318|NCT03800030|19914669|P4|COMPLETED|Third Intervention||4
8076319|NCT03800030|19914670|P3|COMPLETED|Third Intervention||4
8076320|NCT03800030|19914671|P2|COMPLETED|Third Intervention||4
8076321|NCT03800030|19914672|P1|COMPLETED|Third Intervention||4
8076322|NCT03800030|19914667|P6|STARTED|Third Intervention||4
8076323|NCT03800030|19914668|P5|STARTED|Third Intervention||4
8076324|NCT03800030|19914669|P4|STARTED|Third Intervention||4
8076325|NCT03800030|19914670|P3|STARTED|Third Intervention||4
8076326|NCT03800030|19914671|P2|STARTED|Third Intervention||4
8076327|NCT03800030|19914672|P1|STARTED|Third Intervention||4
8076328|NCT03800030|19914667|P6|NOT COMPLETED|Second Washout (1 Week)||0
8076329|NCT03800030|19914668|P5|NOT COMPLETED|Second Washout (1 Week)||0
8076330|NCT03800030|19914669|P4|NOT COMPLETED|Second Washout (1 Week)||1
8076331|NCT03800030|19914670|P3|NOT COMPLETED|Second Washout (1 Week)||0
8076332|NCT03800030|19914671|P2|NOT COMPLETED|Second Washout (1 Week)||0
8076333|NCT03800030|19914672|P1|NOT COMPLETED|Second Washout (1 Week)||0
8076334|NCT03800030|19914667|P6|COMPLETED|Second Washout (1 Week)||4
8076335|NCT03800030|19914668|P5|COMPLETED|Second Washout (1 Week)||4
8076336|NCT03800030|19914669|P4|COMPLETED|Second Washout (1 Week)||4
8076337|NCT03800030|19914670|P3|COMPLETED|Second Washout (1 Week)||4
8076338|NCT03800030|19914671|P2|COMPLETED|Second Washout (1 Week)||4
8076339|NCT03800030|19914672|P1|COMPLETED|Second Washout (1 Week)||4
8076340|NCT03800030|19914667|P6|STARTED|Second Washout (1 Week)||4
8076341|NCT03800030|19914668|P5|STARTED|Second Washout (1 Week)||4
8076342|NCT03800030|19914669|P4|STARTED|Second Washout (1 Week)||5
8076343|NCT03800030|19914670|P3|STARTED|Second Washout (1 Week)||4
8076344|NCT03800030|19914671|P2|STARTED|Second Washout (1 Week)||4
8076345|NCT03800030|19914672|P1|STARTED|Second Washout (1 Week)||4
8076346|NCT03800030|19914667|P6|NOT COMPLETED|Second Intervention||0
8076347|NCT03800030|19914668|P5|NOT COMPLETED|Second Intervention||0
8076348|NCT03800030|19914669|P4|NOT COMPLETED|Second Intervention||1
8076349|NCT03800030|19914670|P3|NOT COMPLETED|Second Intervention||0
8076350|NCT03800030|19914671|P2|NOT COMPLETED|Second Intervention||0
8076351|NCT03800030|19914672|P1|NOT COMPLETED|Second Intervention||0
8076352|NCT03800030|19914667|P6|COMPLETED|Second Intervention||4
8076353|NCT03800030|19914668|P5|COMPLETED|Second Intervention||4
8076354|NCT03800030|19914669|P4|COMPLETED|Second Intervention||5
8076355|NCT03800030|19914670|P3|COMPLETED|Second Intervention||4
8076356|NCT03800030|19914671|P2|COMPLETED|Second Intervention||4
8076357|NCT03800030|19914672|P1|COMPLETED|Second Intervention||4
8076358|NCT03800030|19914667|P6|STARTED|Second Intervention||4
8076359|NCT03800030|19914668|P5|STARTED|Second Intervention||4
8076360|NCT03800030|19914669|P4|STARTED|Second Intervention||6
8076361|NCT03800030|19914670|P3|STARTED|Second Intervention||4
8076362|NCT03800030|19914671|P2|STARTED|Second Intervention||4
8076363|NCT03800030|19914672|P1|STARTED|Second Intervention||4
8076364|NCT03800030|19914667|P6|NOT COMPLETED|First Washout (1 Week)||0
8076365|NCT03800030|19914668|P5|NOT COMPLETED|First Washout (1 Week)||0
8076366|NCT03800030|19914669|P4|NOT COMPLETED|First Washout (1 Week)||0
8076367|NCT03800030|19914670|P3|NOT COMPLETED|First Washout (1 Week)||0
8076368|NCT03800030|19914671|P2|NOT COMPLETED|First Washout (1 Week)||0
8076369|NCT03800030|19914672|P1|NOT COMPLETED|First Washout (1 Week)||0
8076370|NCT03800030|19914667|P6|COMPLETED|First Washout (1 Week)||4
8076371|NCT03800030|19914668|P5|COMPLETED|First Washout (1 Week)||4
8076372|NCT03800030|19914669|P4|COMPLETED|First Washout (1 Week)||6
8076373|NCT03800030|19914670|P3|COMPLETED|First Washout (1 Week)||4
8076374|NCT03800030|19914671|P2|COMPLETED|First Washout (1 Week)||4
8076375|NCT03800030|19914672|P1|COMPLETED|First Washout (1 Week)||4
8076376|NCT03800030|19914667|P6|STARTED|First Washout (1 Week)||4
8076377|NCT03800030|19914668|P5|STARTED|First Washout (1 Week)||4
8076378|NCT03800030|19914669|P4|STARTED|First Washout (1 Week)||6
8076379|NCT03800030|19914670|P3|STARTED|First Washout (1 Week)||4
8076380|NCT03800030|19914671|P2|STARTED|First Washout (1 Week)||4
8076381|NCT03800030|19914672|P1|STARTED|First Washout (1 Week)||4
8076382|NCT03800030|19914667|P6|NOT COMPLETED|First Intervention||0
8076383|NCT03800030|19914668|P5|NOT COMPLETED|First Intervention||0
8076384|NCT03800030|19914669|P4|NOT COMPLETED|First Intervention||0
8076385|NCT03800030|19914670|P3|NOT COMPLETED|First Intervention||0
8076386|NCT03800030|19914671|P2|NOT COMPLETED|First Intervention||0
8076387|NCT03800030|19914672|P1|NOT COMPLETED|First Intervention||0
8076388|NCT03800030|19914667|P6|COMPLETED|First Intervention||4
8076389|NCT03800030|19914668|P5|COMPLETED|First Intervention||4
8076390|NCT03800030|19914669|P4|COMPLETED|First Intervention||6
8076391|NCT03800030|19914670|P3|COMPLETED|First Intervention||4
8076392|NCT03800030|19914671|P2|COMPLETED|First Intervention||4
8076393|NCT03800030|19914672|P1|COMPLETED|First Intervention||4
8076394|NCT03800030|19914667|P6|STARTED|First Intervention||4
8076395|NCT03800030|19914668|P5|STARTED|First Intervention||4
8076396|NCT03800030|19914669|P4|STARTED|First Intervention||6
8076397|NCT03800030|19914670|P3|STARTED|First Intervention||4
8076398|NCT03800030|19914671|P2|STARTED|First Intervention||4
8076399|NCT03800030|19914672|P1|STARTED|First Intervention||4
8076400|NCT03800030|19914667|P6|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076401|NCT03800030|19914668|P5|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076402|NCT03800030|19914669|P4|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076403|NCT03800030|19914670|P3|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076404|NCT03800030|19914671|P2|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076405|NCT03800030|19914672|P1|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076406|NCT03800030|19914667|P6|COMPLETED|Pre-Randomization Period (1 Week)||4
8076407|NCT03800030|19914668|P5|COMPLETED|Pre-Randomization Period (1 Week)||4
8076408|NCT03800030|19914669|P4|COMPLETED|Pre-Randomization Period (1 Week)||6
8076409|NCT03800030|19914670|P3|COMPLETED|Pre-Randomization Period (1 Week)||4
8076410|NCT03800030|19914671|P2|COMPLETED|Pre-Randomization Period (1 Week)||4
8076411|NCT03800030|19914672|P1|COMPLETED|Pre-Randomization Period (1 Week)||4
8076412|NCT03800030|19914667|P6|STARTED|Pre-Randomization Period (1 Week)||4
8076413|NCT03800030|19914668|P5|STARTED|Pre-Randomization Period (1 Week)||4
8076414|NCT03800030|19914669|P4|STARTED|Pre-Randomization Period (1 Week)||6
8076415|NCT03800030|19914670|P3|STARTED|Pre-Randomization Period (1 Week)||4
8076416|NCT03800030|19914671|P2|STARTED|Pre-Randomization Period (1 Week)||4
8076417|NCT03800030|19914672|P1|STARTED|Pre-Randomization Period (1 Week)||4
8076418|NCT03800030|19914667|P6|NOT COMPLETED|Baseline||0
8076419|NCT03800030|19914668|P5|NOT COMPLETED|Baseline||0
8076420|NCT03800030|19914669|P4|NOT COMPLETED|Baseline||0
8076421|NCT03800030|19914670|P3|NOT COMPLETED|Baseline||0
8076422|NCT03800030|19914671|P2|NOT COMPLETED|Baseline||0
8076423|NCT03800030|19914672|P1|NOT COMPLETED|Baseline||0
8076424|NCT03800030|19914667|P6|COMPLETED|Baseline||4
8076425|NCT03800030|19914668|P5|COMPLETED|Baseline||4
8076426|NCT03800030|19914669|P4|COMPLETED|Baseline||6
8076427|NCT03800030|19914670|P3|COMPLETED|Baseline||4
8076428|NCT03800030|19914671|P2|COMPLETED|Baseline||4
8076429|NCT03800030|19914672|P1|COMPLETED|Baseline||4
8076430|NCT03800030|19914667|P6|STARTED|Baseline||4
8076431|NCT03800030|19914668|P5|STARTED|Baseline||4
8076432|NCT03800030|19914669|P4|STARTED|Baseline||6
8076433|NCT03800030|19914670|P3|STARTED|Baseline||4
8076434|NCT03800030|19914671|P2|STARTED|Baseline||4
8076435|NCT03800030|19914672|P1|STARTED|Baseline||4
8076439|NCT03799614|19914702|P2|NOT COMPLETED|Overall Study||0
8076440|NCT03799614|19914703|P1|NOT COMPLETED|Overall Study||0
8076441|NCT03799614|19914702|P2|COMPLETED|Overall Study||15
8076442|NCT03799614|19914703|P1|COMPLETED|Overall Study||15
8076443|NCT03799614|19914702|P2|STARTED|Overall Study||15
8076444|NCT03799614|19914703|P1|STARTED|Overall Study||15
8076445|NCT03799484|19914715|P1|NOT COMPLETED|Overall Study||0
8076446|NCT03799484|19914715|P1|COMPLETED|Overall Study||14
8076447|NCT03799484|19914715|P1|STARTED|Overall Study||14
8076448|NCT03799211|19914745|P2|NOT COMPLETED|Overall Study||13
8076449|NCT03799211|19914746|P1|NOT COMPLETED|Overall Study||4
8076450|NCT03799211|19914745|P2|COMPLETED|Overall Study||27
8076451|NCT03799211|19914746|P1|COMPLETED|Overall Study||32
8076452|NCT03799211|19914745|P2|STARTED|Overall Study||40
8076453|NCT03799211|19914746|P1|STARTED|Overall Study||36
8076454|NCT03796260|19914764|P2|NOT COMPLETED|Period 2||0
8076455|NCT03796260|19914765|P1|NOT COMPLETED|Period 2||0
8076456|NCT03796260|19914764|P2|COMPLETED|Period 2||7
8076457|NCT03796260|19914765|P1|COMPLETED|Period 2||7
8076458|NCT03796260|19914764|P2|STARTED|Period 2||7
8076459|NCT03796260|19914765|P1|STARTED|Period 2||7
8076460|NCT03796260|19914764|P2|NOT COMPLETED|Period 1||0
8076461|NCT03796260|19914765|P1|NOT COMPLETED|Period 1||0
8076462|NCT03796260|19914764|P2|COMPLETED|Period 1||7
8076463|NCT03796260|19914765|P1|COMPLETED|Period 1||7
8076464|NCT03796260|19914764|P2|STARTED|Period 1||7
8076465|NCT03796260|19914765|P1|STARTED|Period 1||7
8076466|NCT03796182|19914777|P2|NOT COMPLETED|Period 2||0
8076467|NCT03796182|19914778|P1|NOT COMPLETED|Period 2||0
8076468|NCT03796182|19914777|P2|COMPLETED|Period 2||6
8076469|NCT03796182|19914778|P1|COMPLETED|Period 2||6
8076470|NCT03796182|19914777|P2|STARTED|Period 2||6
8076471|NCT03796182|19914778|P1|STARTED|Period 2||6
8076472|NCT03796182|19914777|P2|NOT COMPLETED|Washout Period||0
8076473|NCT03796182|19914778|P1|NOT COMPLETED|Washout Period||0
8076474|NCT03796182|19914777|P2|COMPLETED|Washout Period||6
8076475|NCT03796182|19914778|P1|COMPLETED|Washout Period||6
8076476|NCT03796182|19914777|P2|STARTED|Washout Period||6
8076477|NCT03796182|19914778|P1|STARTED|Washout Period||6
8076478|NCT03796182|19914777|P2|NOT COMPLETED|Period 1||0
8076479|NCT03796182|19914778|P1|NOT COMPLETED|Period 1||0
8076480|NCT03796182|19914777|P2|COMPLETED|Period 1||6
8076481|NCT03796182|19914778|P1|COMPLETED|Period 1||6
8076482|NCT03796182|19914777|P2|STARTED|Period 1||6
8076483|NCT03796182|19914778|P1|STARTED|Period 1||6
8076484|NCT03796013|19914812|P2|NOT COMPLETED|Period 2||0
8076485|NCT03796013|19914813|P1|NOT COMPLETED|Period 2||0
8076486|NCT03796013|19914812|P2|COMPLETED|Period 2||14
8076487|NCT03796013|19914813|P1|COMPLETED|Period 2||14
8076488|NCT03796013|19914812|P2|STARTED|Period 2||14
8076489|NCT03796013|19914813|P1|STARTED|Period 2||14
8076490|NCT03796013|19914812|P2|NOT COMPLETED|Period 1||0
8076491|NCT03796013|19914813|P1|NOT COMPLETED|Period 1||0
8076492|NCT03796013|19914812|P2|COMPLETED|Period 1||14
8076493|NCT03796013|19914813|P1|COMPLETED|Period 1||14
8076494|NCT03796013|19914812|P2|STARTED|Period 1||14
8076495|NCT03796013|19914813|P1|STARTED|Period 1||14
8076496|NCT03795753|19914825|P2|NOT COMPLETED|Overall Study||0
8076497|NCT03795753|19914826|P1|NOT COMPLETED|Overall Study||0
8076498|NCT03795753|19914825|P2|COMPLETED|Overall Study||13
8076499|NCT03795753|19914826|P1|COMPLETED|Overall Study||23
8076500|NCT03795753|19914825|P2|STARTED|Overall Study||13
8076501|NCT03795753|19914826|P1|STARTED|Overall Study||23
8076502|NCT03794752|19914838|P1|NOT COMPLETED|Overall Study||0
8076503|NCT03794752|19914838|P1|COMPLETED|Overall Study||8
8076504|NCT03794752|19914838|P1|STARTED|Overall Study||8
8076505|NCT03794024|19914848|P2|NOT COMPLETED|Overall Study||0
8076506|NCT03794024|19914849|P1|NOT COMPLETED|Overall Study||1
8076507|NCT03794024|19914848|P2|COMPLETED|Overall Study||0
8076508|NCT03794024|19914849|P1|COMPLETED|Overall Study||0
8076509|NCT03794024|19914848|P2|STARTED|Overall Study||0
8076510|NCT03794024|19914849|P1|STARTED|Overall Study||1
8076511|NCT03793751|19914871|P2|NOT COMPLETED|Overall Study||0
8076512|NCT03793751|19914872|P1|NOT COMPLETED|Overall Study||0
8076513|NCT03793751|19914871|P2|COMPLETED|Overall Study||60
8076514|NCT03793751|19914872|P1|COMPLETED|Overall Study||60
8076515|NCT03793751|19914871|P2|STARTED|Overall Study||60
8076516|NCT03793751|19914872|P1|STARTED|Overall Study||60
8076517|NCT03793556|19914888|P2|NOT COMPLETED|Overall Study||2
8076518|NCT03793556|19914889|P1|NOT COMPLETED|Overall Study||13
8076519|NCT03793556|19914888|P2|COMPLETED|Overall Study||34
8076520|NCT03793556|19914889|P1|COMPLETED|Overall Study||22
8076521|NCT03793556|19914888|P2|STARTED|Overall Study||36
8076522|NCT03793556|19914889|P1|STARTED|Overall Study||35
8076523|NCT03793010|19914933|P2|NOT COMPLETED|Overall Study||27
8076524|NCT03793010|19914934|P1|NOT COMPLETED|Overall Study||28
8076525|NCT03793010|19914933|P2|COMPLETED|Overall Study||8
8076526|NCT03793010|19914934|P1|COMPLETED|Overall Study||7
8076527|NCT03793010|19914933|P2|Randomized But Not Dosed|Overall Study||0
8076528|NCT03793010|19914934|P1|Randomized But Not Dosed|Overall Study||2
8076529|NCT03793010|19914933|P2|STARTED|Overall Study||35
8076530|NCT03793010|19914934|P1|STARTED|Overall Study||35
8076531|NCT03792672|19914944|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8076532|NCT03792672|19914945|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8076533|NCT03792672|19914946|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8076534|NCT03792672|19914947|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8076535|NCT03792672|19914948|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8076536|NCT03792672|19914949|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||1
8076537|NCT03792672|19914944|P6|COMPLETED|Treatment Period 4 (2 Days)||4
8076538|NCT03792672|19914945|P5|COMPLETED|Treatment Period 4 (2 Days)||4
8076539|NCT03792672|19914946|P4|COMPLETED|Treatment Period 4 (2 Days)||2
8076540|NCT03792672|19914947|P3|COMPLETED|Treatment Period 4 (2 Days)||3
8076541|NCT03792672|19914948|P2|COMPLETED|Treatment Period 4 (2 Days)||4
8076542|NCT03792672|19914949|P1|COMPLETED|Treatment Period 4 (2 Days)||2
8076543|NCT03792672|19914944|P6|STARTED|Treatment Period 4 (2 Days)||4
8076544|NCT03792672|19914945|P5|STARTED|Treatment Period 4 (2 Days)||4
8076545|NCT03792672|19914946|P4|STARTED|Treatment Period 4 (2 Days)||2
8076546|NCT03792672|19914947|P3|STARTED|Treatment Period 4 (2 Days)||3
8076547|NCT03792672|19914948|P2|STARTED|Treatment Period 4 (2 Days)||4
8076548|NCT03792672|19914949|P1|STARTED|Treatment Period 4 (2 Days)||3
8076549|NCT03792672|19914944|P6|NOT COMPLETED|Washout Period 3 (10 Days)||0
8076550|NCT03792672|19914945|P5|NOT COMPLETED|Washout Period 3 (10 Days)||0
8076551|NCT03792672|19914946|P4|NOT COMPLETED|Washout Period 3 (10 Days)||2
8076552|NCT03792672|19914947|P3|NOT COMPLETED|Washout Period 3 (10 Days)||1
8076553|NCT03792672|19914948|P2|NOT COMPLETED|Washout Period 3 (10 Days)||0
8076554|NCT03792672|19914949|P1|NOT COMPLETED|Washout Period 3 (10 Days)||1
8076555|NCT03792672|19914944|P6|COMPLETED|Washout Period 3 (10 Days)||4
8076556|NCT03792672|19914945|P5|COMPLETED|Washout Period 3 (10 Days)||4
8076557|NCT03792672|19914946|P4|COMPLETED|Washout Period 3 (10 Days)||2
8076558|NCT03792672|19914947|P3|COMPLETED|Washout Period 3 (10 Days)||3
8076559|NCT03792672|19914948|P2|COMPLETED|Washout Period 3 (10 Days)||4
8076560|NCT03792672|19914949|P1|COMPLETED|Washout Period 3 (10 Days)||3
8076561|NCT03792672|19914944|P6|STARTED|Washout Period 3 (10 Days)||4
8076562|NCT03792672|19914945|P5|STARTED|Washout Period 3 (10 Days)||4
8076563|NCT03792672|19914946|P4|STARTED|Washout Period 3 (10 Days)||4
8076564|NCT03792672|19914947|P3|STARTED|Washout Period 3 (10 Days)||4
8076565|NCT03792672|19914948|P2|STARTED|Washout Period 3 (10 Days)||4
8076566|NCT03792672|19914949|P1|STARTED|Washout Period 3 (10 Days)||4
8076567|NCT03792672|19914944|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8076568|NCT03792672|19914945|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8076569|NCT03792672|19914946|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8076570|NCT03792672|19914947|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8076571|NCT03792672|19914948|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8076572|NCT03792672|19914949|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8076573|NCT03792672|19914944|P6|COMPLETED|Treatment Period 3 (1 Day)||4
8076574|NCT03792672|19914945|P5|COMPLETED|Treatment Period 3 (1 Day)||4
8076575|NCT03792672|19914946|P4|COMPLETED|Treatment Period 3 (1 Day)||4
8076576|NCT03792672|19914947|P3|COMPLETED|Treatment Period 3 (1 Day)||4
8076577|NCT03792672|19914948|P2|COMPLETED|Treatment Period 3 (1 Day)||4
8076578|NCT03792672|19914949|P1|COMPLETED|Treatment Period 3 (1 Day)||4
8076579|NCT03792672|19914944|P6|STARTED|Treatment Period 3 (1 Day)||4
8076580|NCT03792672|19914945|P5|STARTED|Treatment Period 3 (1 Day)||4
8076581|NCT03792672|19914946|P4|STARTED|Treatment Period 3 (1 Day)||4
8076582|NCT03792672|19914947|P3|STARTED|Treatment Period 3 (1 Day)||4
8076583|NCT03792672|19914948|P2|STARTED|Treatment Period 3 (1 Day)||4
8076584|NCT03792672|19914949|P1|STARTED|Treatment Period 3 (1 Day)||4
8076585|NCT03792672|19914944|P6|NOT COMPLETED|Washout Period 2 (10 Days)||0
8076586|NCT03792672|19914945|P5|NOT COMPLETED|Washout Period 2 (10 Days)||0
8076587|NCT03792672|19914946|P4|NOT COMPLETED|Washout Period 2 (10 Days)||0
8076588|NCT03792672|19914947|P3|NOT COMPLETED|Washout Period 2 (10 Days)||0
8076589|NCT03792672|19914948|P2|NOT COMPLETED|Washout Period 2 (10 Days)||0
8076590|NCT03792672|19914949|P1|NOT COMPLETED|Washout Period 2 (10 Days)||0
8076591|NCT03792672|19914944|P6|COMPLETED|Washout Period 2 (10 Days)||4
8076592|NCT03792672|19914945|P5|COMPLETED|Washout Period 2 (10 Days)||4
8076593|NCT03792672|19914946|P4|COMPLETED|Washout Period 2 (10 Days)||4
8076594|NCT03792672|19914947|P3|COMPLETED|Washout Period 2 (10 Days)||4
8076595|NCT03792672|19914948|P2|COMPLETED|Washout Period 2 (10 Days)||4
8076596|NCT03792672|19914949|P1|COMPLETED|Washout Period 2 (10 Days)||4
8076597|NCT03792672|19914944|P6|STARTED|Washout Period 2 (10 Days)||4
8076598|NCT03792672|19914945|P5|STARTED|Washout Period 2 (10 Days)||4
8076599|NCT03792672|19914946|P4|STARTED|Washout Period 2 (10 Days)||4
8076600|NCT03792672|19914947|P3|STARTED|Washout Period 2 (10 Days)||4
8076601|NCT03792672|19914948|P2|STARTED|Washout Period 2 (10 Days)||4
8076602|NCT03792672|19914949|P1|STARTED|Washout Period 2 (10 Days)||4
8076603|NCT03792672|19914944|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8076604|NCT03792672|19914945|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8076605|NCT03792672|19914946|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8076606|NCT03792672|19914947|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8076607|NCT03792672|19914948|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8076608|NCT03792672|19914949|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8076609|NCT03792672|19914944|P6|COMPLETED|Treatment Period 2 (1 Day)||4
8076610|NCT03792672|19914945|P5|COMPLETED|Treatment Period 2 (1 Day)||4
8076611|NCT03792672|19914946|P4|COMPLETED|Treatment Period 2 (1 Day)||4
8076612|NCT03792672|19914947|P3|COMPLETED|Treatment Period 2 (1 Day)||4
8076613|NCT03792672|19914948|P2|COMPLETED|Treatment Period 2 (1 Day)||4
8076614|NCT03792672|19914949|P1|COMPLETED|Treatment Period 2 (1 Day)||4
8076615|NCT03792672|19914944|P6|STARTED|Treatment Period 2 (1 Day)||4
8076616|NCT03792672|19914945|P5|STARTED|Treatment Period 2 (1 Day)||4
8076617|NCT03792672|19914946|P4|STARTED|Treatment Period 2 (1 Day)||4
8076618|NCT03792672|19914947|P3|STARTED|Treatment Period 2 (1 Day)||4
8076619|NCT03792672|19914948|P2|STARTED|Treatment Period 2 (1 Day)||4
8076620|NCT03792672|19914949|P1|STARTED|Treatment Period 2 (1 Day)||4
8076621|NCT03792672|19914944|P6|NOT COMPLETED|Washout Period 1 (10 Days)||0
8076622|NCT03792672|19914945|P5|NOT COMPLETED|Washout Period 1 (10 Days)||0
8076623|NCT03792672|19914946|P4|NOT COMPLETED|Washout Period 1 (10 Days)||0
8076624|NCT03792672|19914947|P3|NOT COMPLETED|Washout Period 1 (10 Days)||0
8076625|NCT03792672|19914948|P2|NOT COMPLETED|Washout Period 1 (10 Days)||0
8076626|NCT03792672|19914949|P1|NOT COMPLETED|Washout Period 1 (10 Days)||0
8076627|NCT03792672|19914944|P6|COMPLETED|Washout Period 1 (10 Days)||4
8076628|NCT03792672|19914945|P5|COMPLETED|Washout Period 1 (10 Days)||4
8076629|NCT03792672|19914946|P4|COMPLETED|Washout Period 1 (10 Days)||4
8076630|NCT03792672|19914947|P3|COMPLETED|Washout Period 1 (10 Days)||4
8076631|NCT03792672|19914948|P2|COMPLETED|Washout Period 1 (10 Days)||4
8076632|NCT03792672|19914949|P1|COMPLETED|Washout Period 1 (10 Days)||4
8076633|NCT03792672|19914944|P6|STARTED|Washout Period 1 (10 Days)||4
8076634|NCT03792672|19914945|P5|STARTED|Washout Period 1 (10 Days)||4
8076635|NCT03792672|19914946|P4|STARTED|Washout Period 1 (10 Days)||4
8076636|NCT03792672|19914947|P3|STARTED|Washout Period 1 (10 Days)||4
8076637|NCT03792672|19914948|P2|STARTED|Washout Period 1 (10 Days)||4
8076638|NCT03792672|19914949|P1|STARTED|Washout Period 1 (10 Days)||4
8076639|NCT03792672|19914944|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8076640|NCT03792672|19914945|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8076641|NCT03792672|19914946|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8076642|NCT03792672|19914947|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8076643|NCT03792672|19914948|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8076644|NCT03792672|19914949|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8076645|NCT03792672|19914944|P6|COMPLETED|Treatment Period 1 (1 Day)||4
8076646|NCT03792672|19914945|P5|COMPLETED|Treatment Period 1 (1 Day)||4
8076647|NCT03792672|19914946|P4|COMPLETED|Treatment Period 1 (1 Day)||4
8076648|NCT03792672|19914947|P3|COMPLETED|Treatment Period 1 (1 Day)||4
8076649|NCT03792672|19914948|P2|COMPLETED|Treatment Period 1 (1 Day)||4
8076650|NCT03792672|19914949|P1|COMPLETED|Treatment Period 1 (1 Day)||4
8076651|NCT03792672|19914944|P6|STARTED|Treatment Period 1 (1 Day)||4
8076652|NCT03792672|19914945|P5|STARTED|Treatment Period 1 (1 Day)||4
8076653|NCT03792672|19914946|P4|STARTED|Treatment Period 1 (1 Day)||4
8076654|NCT03792672|19914947|P3|STARTED|Treatment Period 1 (1 Day)||4
8076655|NCT03792672|19914948|P2|STARTED|Treatment Period 1 (1 Day)||4
8076656|NCT03792672|19914949|P1|STARTED|Treatment Period 1 (1 Day)||4
8076657|NCT03791489|19914969|P1|NOT COMPLETED|90 Days (Primary Endpoint)||0
8076658|NCT03791489|19914969|P1|COMPLETED|90 Days (Primary Endpoint)||30
8076659|NCT03791489|19914969|P1|STARTED|90 Days (Primary Endpoint)||30
8076660|NCT03791489|19914969|P1|NOT COMPLETED|30 Days||0
8076661|NCT03791489|19914969|P1|COMPLETED|30 Days||30
8076662|NCT03791489|19914969|P1|STARTED|30 Days||30
8076663|NCT03790917|19914976|P1|NOT COMPLETED|Overall Study||1
8076664|NCT03790917|19914976|P1|COMPLETED|Overall Study||200
8076665|NCT03790917|19914976|P1|STARTED|Overall Study||201
8076666|NCT03790306|19914986|P1|NOT COMPLETED|Overall Study||0
8076667|NCT03790306|19914986|P1|COMPLETED|Overall Study||207
8076668|NCT03790306|19914986|P1|STARTED|Overall Study||207
8076669|NCT03789474|19915000|P2|NOT COMPLETED|Overall Study||0
8076670|NCT03789474|19915001|P1|NOT COMPLETED|Overall Study||0
8076671|NCT03789474|19915000|P2|COMPLETED|Overall Study||30
8076672|NCT03789474|19915001|P1|COMPLETED|Overall Study||30
8076673|NCT03789474|19915000|P2|STARTED|Overall Study||30
8076674|NCT03789474|19915001|P1|STARTED|Overall Study||30
8076675|NCT03789175|19915097|P1|NOT COMPLETED|Week 12 to Week 24 of NR||0
8076676|NCT03789175|19915097|P1|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
8076677|NCT03789175|19915097|P1|STARTED|Week 12 to Week 24 of NR||1
8076678|NCT03789175|19915097|P1|NOT COMPLETED|Week 0 to Week 12 of NR||0
8076679|NCT03789175|19915097|P1|COMPLETED|Week 0 to Week 12 of NR||1
8076680|NCT03789175|19915097|P1|STARTED|Week 0 to Week 12 of NR||1
8076681|NCT03787472|19915104|P2|NOT COMPLETED|Period 2||0
8076682|NCT03787472|19915105|P1|NOT COMPLETED|Period 2||0
8076683|NCT03787472|19915104|P2|COMPLETED|Period 2||22
8076684|NCT03787472|19915105|P1|COMPLETED|Period 2||23
8076685|NCT03787472|19915104|P2|STARTED|Period 2||22
8076686|NCT03787472|19915105|P1|STARTED|Period 2||23
8076687|NCT03787472|19915104|P2|NOT COMPLETED|Period 1||0
8076688|NCT03787472|19915105|P1|NOT COMPLETED|Period 1||0
8076689|NCT03787472|19915104|P2|COMPLETED|Period 1||22
8076690|NCT03787472|19915105|P1|COMPLETED|Period 1||23
8076691|NCT03787472|19915104|P2|STARTED|Period 1||22
8076692|NCT03787472|19915105|P1|STARTED|Period 1||23
8076693|NCT03787212|19915113|P2|NOT COMPLETED|Period 1||2
8076694|NCT03787212|19915114|P1|NOT COMPLETED|Period 1||2
8076695|NCT03787212|19915113|P2|COMPLETED|Period 1||0
8076696|NCT03787212|19915114|P1|COMPLETED|Period 1||0
8076697|NCT03787212|19915113|P2|STARTED|Period 1||2
8076698|NCT03787212|19915114|P1|STARTED|Period 1||2
8076699|NCT03787212|19915113|P2|NOT COMPLETED|Period 1||0
8076700|NCT03787212|19915114|P1|NOT COMPLETED|Period 1||0
8076701|NCT03787212|19915113|P2|COMPLETED|Period 1||2
8076702|NCT03787212|19915114|P1|COMPLETED|Period 1||2
8076703|NCT03787212|19915113|P2|STARTED|Period 1||2
8076704|NCT03787212|19915114|P1|STARTED|Period 1||2
8076705|NCT03786744|19915122|P2|NOT COMPLETED|Overall Study||0
8076706|NCT03786744|19915123|P1|NOT COMPLETED|Overall Study||0
8076707|NCT03786744|19915122|P2|COMPLETED|Overall Study||10
8076708|NCT03786744|19915123|P1|COMPLETED|Overall Study||10
8076709|NCT03786744|19915122|P2|STARTED|Overall Study||10
8076710|NCT03786744|19915123|P1|STARTED|Overall Study||10
8076711|NCT03786718|19915134|P1|NOT COMPLETED|Overall Study||7
8076712|NCT03786718|19915134|P1|COMPLETED|Overall Study||60
8076713|NCT03786718|19915134|P1|STARTED|Overall Study||67
8076714|NCT03785548|19915151|P2|NOT COMPLETED|Overall Study||0
8076715|NCT03785548|19915152|P1|NOT COMPLETED|Overall Study||2
8076716|NCT03785548|19915151|P2|COMPLETED|Overall Study||74
8076717|NCT03785548|19915152|P1|COMPLETED|Overall Study||71
8076718|NCT03785548|19915151|P2|STARTED|Overall Study||74
8076719|NCT03785548|19915152|P1|STARTED|Overall Study||73
8076720|NCT03784898|19915160|P1|NOT COMPLETED|Overall Study||0
8076721|NCT03784898|19915160|P1|COMPLETED|Overall Study||13
8076722|NCT03784898|19915160|P1|STARTED|Overall Study||13
8076723|NCT03784001|19915167|P3|NOT COMPLETED|Overall Study||1
8076724|NCT03784001|19915168|P2|NOT COMPLETED|Overall Study||0
8076725|NCT03784001|19915169|P1|NOT COMPLETED|Overall Study||2
8076726|NCT03784001|19915167|P3|COMPLETED|Overall Study||40
8076727|NCT03784001|19915168|P2|COMPLETED|Overall Study||38
8076728|NCT03784001|19915169|P1|COMPLETED|Overall Study||44
8076729|NCT03784001|19915167|P3|STARTED|Overall Study||41
8076730|NCT03784001|19915168|P2|STARTED|Overall Study||38
8076731|NCT03784001|19915169|P1|STARTED|Overall Study||46
8076732|NCT03783780|19915201|P1|NOT COMPLETED|Overall Study||1
8076733|NCT03783780|19915201|P1|COMPLETED|Overall Study||20
8076734|NCT03783780|19915201|P1|STARTED|Overall Study||21
8076735|NCT03783039|19915208|P2|NOT COMPLETED|Overall Study||0
8076736|NCT03783039|19915209|P1|NOT COMPLETED|Overall Study||0
8076737|NCT03783039|19915208|P2|COMPLETED|Overall Study||115
8076738|NCT03783039|19915209|P1|COMPLETED|Overall Study||119
8076739|NCT03783039|19915208|P2|STARTED|Overall Study||115
8076740|NCT03783039|19915209|P1|STARTED|Overall Study||119
8076741|NCT03782571|19915215|P4|NOT COMPLETED|Period 4||0
8076742|NCT03782571|19915216|P3|NOT COMPLETED|Period 4||0
8076743|NCT03782571|19915217|P2|NOT COMPLETED|Period 4||0
8076744|NCT03782571|19915218|P1|NOT COMPLETED|Period 4||0
8076745|NCT03782571|19915215|P4|COMPLETED|Period 4||7
8076746|NCT03782571|19915216|P3|COMPLETED|Period 4||6
8076747|NCT03782571|19915217|P2|COMPLETED|Period 4||6
8076748|NCT03782571|19915218|P1|COMPLETED|Period 4||3
8076749|NCT03782571|19915215|P4|STARTED|Period 4||7
8076750|NCT03782571|19915216|P3|STARTED|Period 4||6
8076751|NCT03782571|19915217|P2|STARTED|Period 4||6
8076752|NCT03782571|19915218|P1|STARTED|Period 4||3
8076753|NCT03782571|19915215|P4|NOT COMPLETED|Period 3||0
8076754|NCT03782571|19915216|P3|NOT COMPLETED|Period 3||0
8076755|NCT03782571|19915217|P2|NOT COMPLETED|Period 3||0
8076756|NCT03782571|19915218|P1|NOT COMPLETED|Period 3||2
8076757|NCT03782571|19915215|P4|COMPLETED|Period 3||7
8076758|NCT03782571|19915216|P3|COMPLETED|Period 3||6
8076759|NCT03782571|19915217|P2|COMPLETED|Period 3||6
8076760|NCT03782571|19915218|P1|COMPLETED|Period 3||3
8076761|NCT03782571|19915215|P4|STARTED|Period 3||7
8076762|NCT03782571|19915216|P3|STARTED|Period 3||6
8076763|NCT03782571|19915217|P2|STARTED|Period 3||6
8076764|NCT03782571|19915218|P1|STARTED|Period 3||5
8076765|NCT03782571|19915215|P4|NOT COMPLETED|Period 2||0
8076766|NCT03782571|19915216|P3|NOT COMPLETED|Period 2||0
8076767|NCT03782571|19915217|P2|NOT COMPLETED|Period 2||0
8076768|NCT03782571|19915218|P1|NOT COMPLETED|Period 2||0
8076769|NCT03782571|19915215|P4|COMPLETED|Period 2||7
8076770|NCT03782571|19915216|P3|COMPLETED|Period 2||6
8076771|NCT03782571|19915217|P2|COMPLETED|Period 2||6
8076772|NCT03782571|19915218|P1|COMPLETED|Period 2||5
8076773|NCT03782571|19915215|P4|STARTED|Period 2||7
8076774|NCT03782571|19915216|P3|STARTED|Period 2||6
8076775|NCT03782571|19915217|P2|STARTED|Period 2||6
8076776|NCT03782571|19915218|P1|STARTED|Period 2||5
8076777|NCT03782571|19915215|P4|NOT COMPLETED|Period 1||0
8076778|NCT03782571|19915216|P3|NOT COMPLETED|Period 1||0
8076779|NCT03782571|19915217|P2|NOT COMPLETED|Period 1||0
8076780|NCT03782571|19915218|P1|NOT COMPLETED|Period 1||1
8076781|NCT03782571|19915215|P4|COMPLETED|Period 1||7
8076782|NCT03782571|19915216|P3|COMPLETED|Period 1||6
8076783|NCT03782571|19915217|P2|COMPLETED|Period 1||6
8076784|NCT03782571|19915218|P1|COMPLETED|Period 1||5
8076785|NCT03782571|19915215|P4|STARTED|Period 1||7
8076786|NCT03782571|19915216|P3|STARTED|Period 1||6
8076787|NCT03782571|19915217|P2|STARTED|Period 1||6
8076788|NCT03782571|19915218|P1|STARTED|Period 1||6
8076789|NCT03782233|19915244|P2|NOT COMPLETED|Overall Study||2
8076790|NCT03782233|19915245|P1|NOT COMPLETED|Overall Study||4
8076791|NCT03782233|19915244|P2|COMPLETED|Overall Study||31
8076792|NCT03782233|19915245|P1|COMPLETED|Overall Study||46
8076793|NCT03782233|19915244|P2|STARTED|Overall Study||33
8076794|NCT03782233|19915245|P1|STARTED|Overall Study||50
8076795|NCT03782181|19915289|P2|NOT COMPLETED|Overall Study||0
8076796|NCT03782181|19915290|P1|NOT COMPLETED|Overall Study||0
8076797|NCT03782181|19915289|P2|COMPLETED|Overall Study||20
8076798|NCT03782181|19915290|P1|COMPLETED|Overall Study||20
8076799|NCT03782181|19915289|P2|STARTED|Overall Study||20
8076800|NCT03782181|19915290|P1|STARTED|Overall Study||20
8076801|NCT03781375|19915316|P2|NOT COMPLETED|Open-label Phase||3
8076802|NCT03781375|19915317|P1|NOT COMPLETED|Open-label Phase||3
8076803|NCT03781375|19915316|P2|COMPLETED|Open-label Phase||6
8076804|NCT03781375|19915317|P1|COMPLETED|Open-label Phase||8
8076805|NCT03781375|19915316|P2|Received Study Drug|Open-label Phase||9
8076806|NCT03781375|19915317|P1|Received Study Drug|Open-label Phase||10
8076807|NCT03781375|19915316|P2|STARTED|Open-label Phase||9
8076808|NCT03781375|19915317|P1|STARTED|Open-label Phase||11
8076809|NCT03781375|19915316|P2|NOT COMPLETED|Double-blind Phase||6
8076810|NCT03781375|19915317|P1|NOT COMPLETED|Double-blind Phase||7
8076811|NCT03781375|19915316|P2|COMPLETED|Double-blind Phase||7
8076812|NCT03781375|19915317|P1|COMPLETED|Double-blind Phase||5
8076813|NCT03781375|19915316|P2|Received Study Drug|Double-blind Phase||13
8076814|NCT03781375|19915317|P1|Received Study Drug|Double-blind Phase||12
8076815|NCT03781375|19915316|P2|STARTED|Double-blind Phase||13
8076816|NCT03781375|19915317|P1|STARTED|Double-blind Phase||12
8076817|NCT03780959|19915331|P3|NOT COMPLETED|Part 2||6
8076818|NCT03780959|19915332|P2|NOT COMPLETED|Part 2||19
8076819|NCT03780959|19915333|P1|NOT COMPLETED|Part 2||0
8076820|NCT03780959|19915331|P3|COMPLETED|Part 2||19
8076821|NCT03780959|19915332|P2|COMPLETED|Part 2||7
8076822|NCT03780959|19915333|P1|COMPLETED|Part 2||0
8076823|NCT03780959|19915331|P3|STARTED|Part 2||25
8076824|NCT03780959|19915332|P2|STARTED|Part 2||26
8076825|NCT03780959|19915333|P1|STARTED|Part 2||0
8076826|NCT03780959|19915331|P3|NOT COMPLETED|Part 1||0
8076827|NCT03780959|19915332|P2|NOT COMPLETED|Part 1||0
8076828|NCT03780959|19915333|P1|NOT COMPLETED|Part 1||5
8076829|NCT03780959|19915331|P3|COMPLETED|Part 1||0
8076830|NCT03780959|19915332|P2|COMPLETED|Part 1||0
8076831|NCT03780959|19915333|P1|COMPLETED|Part 1||64
8076832|NCT03780959|19915331|P3|STARTED|Part 1||0
8076833|NCT03780959|19915332|P2|STARTED|Part 1||0
8076834|NCT03780959|19915333|P1|STARTED|Part 1||69
8076835|NCT03780400|19915345|P1|NOT COMPLETED|Overall Study||7
8076836|NCT03780400|19915345|P1|COMPLETED|Overall Study||53
8076837|NCT03780400|19915345|P1|STARTED|Overall Study||60
8076838|NCT03780010|19915355|P2|NOT COMPLETED|Overall Study||0
8076839|NCT03780010|19915356|P1|NOT COMPLETED|Overall Study||0
8076840|NCT03780010|19915355|P2|COMPLETED|Overall Study||12
8076841|NCT03780010|19915356|P1|COMPLETED|Overall Study||3
8076842|NCT03780010|19915355|P2|STARTED|Overall Study||12
8076843|NCT03780010|19915356|P1|STARTED|Overall Study||3
8076844|NCT03779724|19915383|P2|NOT COMPLETED|Overall Study||4
8076845|NCT03779724|19915384|P1|NOT COMPLETED|Overall Study||6
8076846|NCT03779724|19915383|P2|COMPLETED|Overall Study||21
8076847|NCT03779724|19915384|P1|COMPLETED|Overall Study||19
8076848|NCT03779724|19915383|P2|STARTED|Overall Study||25
8076849|NCT03779724|19915384|P1|STARTED|Overall Study||25
8076850|NCT03779503|19915408|P2|NOT COMPLETED|Second Intervention||0
8076851|NCT03779503|19915409|P1|NOT COMPLETED|Second Intervention||0
8076852|NCT03779503|19915408|P2|COMPLETED|Second Intervention||26
8076853|NCT03779503|19915409|P1|COMPLETED|Second Intervention||27
8076854|NCT03779503|19915408|P2|STARTED|Second Intervention||26
8076855|NCT03779503|19915409|P1|STARTED|Second Intervention||27
8076856|NCT03779503|19915408|P2|NOT COMPLETED|First Intervention||1
8076857|NCT03779503|19915409|P1|NOT COMPLETED|First Intervention||1
8076858|NCT03779503|19915408|P2|COMPLETED|First Intervention||26
8076859|NCT03779503|19915409|P1|COMPLETED|First Intervention||27
8076860|NCT03779503|19915408|P2|STARTED|First Intervention||27
8076861|NCT03779503|19915409|P1|STARTED|First Intervention||28
8076862|NCT03778190|19915433|P1|NOT COMPLETED|Overall Study||0
8076863|NCT03778190|19915433|P1|COMPLETED|Overall Study||10
8076864|NCT03778190|19915433|P1|STARTED|Overall Study||10
8076865|NCT03777865|19915438|P1|NOT COMPLETED|Overall Study||0
8076866|NCT03777865|19915438|P1|COMPLETED|Overall Study||100
8076867|NCT03777865|19915438|P1|STARTED|Overall Study||100
8076868|NCT03776175|19915448|P4|NOT COMPLETED|Follow-Up Period (35 Days)||2
8076869|NCT03776175|19915449|P3|NOT COMPLETED|Follow-Up Period (35 Days)||0
8076870|NCT03776175|19915450|P2|NOT COMPLETED|Follow-Up Period (35 Days)||0
8076871|NCT03776175|19915451|P1|NOT COMPLETED|Follow-Up Period (35 Days)||0
8076872|NCT03776175|19915448|P4|COMPLETED|Follow-Up Period (35 Days)||24
8076873|NCT03776175|19915449|P3|COMPLETED|Follow-Up Period (35 Days)||24
8076874|NCT03776175|19915450|P2|COMPLETED|Follow-Up Period (35 Days)||22
8076875|NCT03776175|19915451|P1|COMPLETED|Follow-Up Period (35 Days)||13
8076876|NCT03776175|19915448|P4|STARTED|Follow-Up Period (35 Days)||26
8076877|NCT03776175|19915449|P3|STARTED|Follow-Up Period (35 Days)||24
8076878|NCT03776175|19915450|P2|STARTED|Follow-Up Period (35 Days)||22
8076879|NCT03776175|19915451|P1|STARTED|Follow-Up Period (35 Days)||13
8076880|NCT03776175|19915448|P4|NOT COMPLETED|Treatment Period (42 Days)||2
8076881|NCT03776175|19915449|P3|NOT COMPLETED|Treatment Period (42 Days)||4
8076882|NCT03776175|19915450|P2|NOT COMPLETED|Treatment Period (42 Days)||7
8076883|NCT03776175|19915451|P1|NOT COMPLETED|Treatment Period (42 Days)||1
8076884|NCT03776175|19915448|P4|COMPLETED|Treatment Period (42 Days)||26
8076885|NCT03776175|19915449|P3|COMPLETED|Treatment Period (42 Days)||24
8076886|NCT03776175|19915450|P2|COMPLETED|Treatment Period (42 Days)||22
8076887|NCT03776175|19915451|P1|COMPLETED|Treatment Period (42 Days)||13
8076888|NCT03776175|19915448|P4|Treated|Treatment Period (42 Days)||28
8076889|NCT03776175|19915449|P3|Treated|Treatment Period (42 Days)||28
8076890|NCT03776175|19915450|P2|Treated|Treatment Period (42 Days)||29
8076891|NCT03776175|19915451|P1|Treated|Treatment Period (42 Days)||14
8076892|NCT03776175|19915448|P4|STARTED|Treatment Period (42 Days)||28
8076893|NCT03776175|19915449|P3|STARTED|Treatment Period (42 Days)||28
8076894|NCT03776175|19915450|P2|STARTED|Treatment Period (42 Days)||29
8076895|NCT03776175|19915451|P1|STARTED|Treatment Period (42 Days)||14
8076896|NCT03774823|19915483|P2|NOT COMPLETED|Overall Study||1
8076897|NCT03774823|19915484|P1|NOT COMPLETED|Overall Study||1
8076898|NCT03774823|19915483|P2|COMPLETED|Overall Study||4
8076899|NCT03774823|19915484|P1|COMPLETED|Overall Study||4
8076900|NCT03774823|19915483|P2|STARTED|Overall Study||5
8076901|NCT03774823|19915484|P1|STARTED|Overall Study||5
8076902|NCT03774745|19915512|P2|NOT COMPLETED|Overall Study||4
8076903|NCT03774745|19915513|P1|NOT COMPLETED|Overall Study||2
8076904|NCT03774745|19915512|P2|COMPLETED|Overall Study||2
8076905|NCT03774745|19915513|P1|COMPLETED|Overall Study||4
8076906|NCT03774745|19915512|P2|Follow-up 2|Overall Study||2
8076907|NCT03774745|19915513|P1|Follow-up 2|Overall Study||4
8076908|NCT03774745|19915512|P2|Follow-Up 1|Overall Study||6
8076909|NCT03774745|19915513|P1|Follow-Up 1|Overall Study||5
8076910|NCT03774745|19915512|P2|STARTED|Overall Study||6
8076911|NCT03774745|19915513|P1|STARTED|Overall Study||6
8076912|NCT03774576|19915527|P1|NOT COMPLETED|Period 2||1
8076913|NCT03774576|19915527|P1|COMPLETED|Period 2||13
8076914|NCT03774576|19915527|P1|STARTED|Period 2||14
8076915|NCT03774576|19915527|P1|NOT COMPLETED|Period 1||0
8076916|NCT03774576|19915527|P1|COMPLETED|Period 1||14
8076917|NCT03774576|19915527|P1|STARTED|Period 1||14
8076918|NCT03773133|19915540|P1|NOT COMPLETED|Overall Study||8
8076919|NCT03773133|19915540|P1|COMPLETED|Overall Study||0
8076920|NCT03773133|19915540|P1|Received the Therapeutic IRPP|Overall Study||0
8076921|NCT03773133|19915540|P1|Received the Screening IIP|Overall Study||8
8076922|NCT03773133|19915540|P1|STARTED|Overall Study||8
8076923|NCT03772522|19915547|P2|NOT COMPLETED|Post-intervention Follow-up||0
8076924|NCT03772522|19915548|P1|NOT COMPLETED|Post-intervention Follow-up||1
8076925|NCT03772522|19915547|P2|COMPLETED|Post-intervention Follow-up||11
8076926|NCT03772522|19915548|P1|COMPLETED|Post-intervention Follow-up||7
8076927|NCT03772522|19915547|P2|STARTED|Post-intervention Follow-up||11
8076928|NCT03772522|19915548|P1|STARTED|Post-intervention Follow-up||8
8076929|NCT03772522|19915547|P2|NOT COMPLETED|Intervention||0
8076930|NCT03772522|19915548|P1|NOT COMPLETED|Intervention||1
8076931|NCT03772522|19915547|P2|COMPLETED|Intervention||11
8076932|NCT03772522|19915548|P1|COMPLETED|Intervention||8
8076933|NCT03772522|19915547|P2|STARTED|Intervention||11
8076934|NCT03772522|19915548|P1|STARTED|Intervention||9
8076935|NCT03772522|19915547|P2|NOT COMPLETED|Pre-intervention||4
8076936|NCT03772522|19915548|P1|NOT COMPLETED|Pre-intervention||3
8076937|NCT03772522|19915547|P2|COMPLETED|Pre-intervention||11
8076938|NCT03772522|19915548|P1|COMPLETED|Pre-intervention||9
8076939|NCT03772522|19915547|P2|STARTED|Pre-intervention||15
8076940|NCT03772522|19915548|P1|STARTED|Pre-intervention||12
8076941|NCT03772327|19915571|P2|NOT COMPLETED|Overall Study||7
8076942|NCT03772327|19915572|P1|NOT COMPLETED|Overall Study||5
8076943|NCT03772327|19915571|P2|COMPLETED|Overall Study||26
8076944|NCT03772327|19915572|P1|COMPLETED|Overall Study||25
8076945|NCT03772327|19915571|P2|Week 0 Visit|Overall Study||33
8076946|NCT03772327|19915572|P1|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
8076947|NCT03772327|19915571|P2|STARTED|Overall Study||33
8076948|NCT03772327|19915572|P1|STARTED|Overall Study||30
8076949|NCT03771560|19915588|P1|NOT COMPLETED|Overall Study||6
8076950|NCT03771560|19915588|P1|COMPLETED|Overall Study||12
8076951|NCT03771560|19915588|P1|STARTED|Overall Study||18
8076952|NCT03771274|19915596|P1|NOT COMPLETED|Overall Study||0
8076953|NCT03771274|19915596|P1|COMPLETED|Overall Study||39
8076954|NCT03771274|19915596|P1|STARTED|Overall Study||39
8076955|NCT03769207|19915603|P1|NOT COMPLETED|Overall Study||11
8076956|NCT03769207|19915603|P1|COMPLETED|Overall Study||6
8076957|NCT03769207|19915603|P1|Attended Second Study Visit|Overall Study||6
8076958|NCT03769207|19915603|P1|ECG Patch Returned and Readable|Overall Study||9
8076959|NCT03769207|19915603|P1|ECG Patch Shipped|Overall Study||11
8076960|NCT03769207|19915603|P1|Attended First Study Visit|Overall Study||11
8076961|NCT03769207|19915603|P1|STARTED|Overall Study||17
8076962|NCT03768856|19915609|P1|NOT COMPLETED|Overall Study||0
8076963|NCT03768856|19915609|P1|COMPLETED|Overall Study||5
8076964|NCT03768856|19915609|P1|STARTED|Overall Study||5
8076965|NCT03767894|19915618|P1|NOT COMPLETED|Overall Study||1
8076966|NCT03767894|19915618|P1|COMPLETED|Overall Study||11
8076967|NCT03767894|19915618|P1|STARTED|Overall Study||12
8076968|NCT03767062|19915629|P2|NOT COMPLETED|Overall Study||4
8076969|NCT03767062|19915630|P1|NOT COMPLETED|Overall Study||8
8076970|NCT03767062|19915629|P2|COMPLETED|Overall Study||41
8076971|NCT03767062|19915630|P1|COMPLETED|Overall Study||37
8076972|NCT03767062|19915629|P2|STARTED|Overall Study||45
8076973|NCT03767062|19915630|P1|STARTED|Overall Study||45
8076974|NCT03766646|19915640|P2|NOT COMPLETED|Overall Study||3
8076975|NCT03766646|19915641|P1|NOT COMPLETED|Overall Study||1
8076976|NCT03766646|19915640|P2|COMPLETED|Overall Study||12
8076977|NCT03766646|19915641|P1|COMPLETED|Overall Study||18
8076978|NCT03766646|19915640|P2|STARTED|Overall Study||15
8076979|NCT03766646|19915641|P1|STARTED|Overall Study||19
8076980|NCT03766373|19915649|P2|NOT COMPLETED|Overall Study||0
8076981|NCT03766373|19915650|P1|NOT COMPLETED|Overall Study||0
8076982|NCT03766373|19915649|P2|COMPLETED|Overall Study||12
8076983|NCT03766373|19915650|P1|COMPLETED|Overall Study||12
8076984|NCT03766373|19915649|P2|STARTED|Overall Study||12
8076985|NCT03766373|19915650|P1|STARTED|Overall Study||12
8076986|NCT03766165|19915658|P2|NOT COMPLETED|Overall Study||0
8076987|NCT03766165|19915659|P1|NOT COMPLETED|Overall Study||0
8076988|NCT03766165|19915658|P2|COMPLETED|Overall Study||19
8076989|NCT03766165|19915659|P1|COMPLETED|Overall Study||19
8076990|NCT03766165|19915658|P2|STARTED|Overall Study||19
8076991|NCT03766165|19915659|P1|STARTED|Overall Study||19
8076992|NCT03765996|19915685|P2|NOT COMPLETED|Overall Study||0
8076993|NCT03765996|19915686|P1|NOT COMPLETED|Overall Study||4
8076994|NCT03765996|19915685|P2|COMPLETED|Overall Study||18
8076995|NCT03765996|19915686|P1|COMPLETED|Overall Study||14
8076996|NCT03765996|19915685|P2|STARTED|Overall Study||18
8076997|NCT03765996|19915686|P1|STARTED|Overall Study||18
8076998|NCT03765762|19915694|P2|NOT COMPLETED|Overall Study||0
8076999|NCT03765762|19915695|P1|NOT COMPLETED|Overall Study||0
8077000|NCT03765762|19915694|P2|COMPLETED|Overall Study||8
8077001|NCT03765762|19915695|P1|COMPLETED|Overall Study||18
8077002|NCT03765762|19915694|P2|STARTED|Overall Study||8
8077003|NCT03765762|19915695|P1|STARTED|Overall Study||18
8077004|NCT03765502|19915718|P5|NOT COMPLETED|Simulation 2||0
8077005|NCT03765502|19915719|P4|NOT COMPLETED|Simulation 2||0
8077006|NCT03765502|19915720|P3|NOT COMPLETED|Simulation 2||0
8077007|NCT03765502|19915721|P2|NOT COMPLETED|Simulation 2||0
8077008|NCT03765502|19915722|P1|NOT COMPLETED|Simulation 2||0
8077009|NCT03765502|19915718|P5|COMPLETED|Simulation 2||17
8077010|NCT03765502|19915719|P4|COMPLETED|Simulation 2||16
8077011|NCT03765502|19915720|P3|COMPLETED|Simulation 2||32
8077012|NCT03765502|19915721|P2|COMPLETED|Simulation 2||12
8077013|NCT03765502|19915722|P1|COMPLETED|Simulation 2||20
8077014|NCT03765502|19915718|P5|STARTED|Simulation 2||17
8077015|NCT03765502|19915719|P4|STARTED|Simulation 2||16
8077016|NCT03765502|19915720|P3|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
8077017|NCT03765502|19915721|P2|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
8077018|NCT03765502|19915722|P1|STARTED|Simulation 2||20
8077019|NCT03765502|19915718|P5|NOT COMPLETED|Simulation 1||0
8077020|NCT03765502|19915719|P4|NOT COMPLETED|Simulation 1||0
8077021|NCT03765502|19915720|P3|NOT COMPLETED|Simulation 1||0
8077022|NCT03765502|19915721|P2|NOT COMPLETED|Simulation 1||0
8077023|NCT03765502|19915722|P1|NOT COMPLETED|Simulation 1||0
8077024|NCT03765502|19915718|P5|COMPLETED|Simulation 1||17
8077025|NCT03765502|19915719|P4|COMPLETED|Simulation 1||16
8077026|NCT03765502|19915720|P3|COMPLETED|Simulation 1||33
8077027|NCT03765502|19915721|P2|COMPLETED|Simulation 1||13
8077028|NCT03765502|19915722|P1|COMPLETED|Simulation 1||20
8077029|NCT03765502|19915718|P5|STARTED|Simulation 1||17
8077030|NCT03765502|19915719|P4|STARTED|Simulation 1||16
8077031|NCT03765502|19915720|P3|STARTED|Simulation 1||33
8077032|NCT03765502|19915721|P2|STARTED|Simulation 1||13
8077033|NCT03765502|19915722|P1|STARTED|Simulation 1||20
8077034|NCT03765164|19915744|P2|NOT COMPLETED|Post-intervention||72
8077035|NCT03765164|19915745|P1|NOT COMPLETED|Post-intervention||73
8077036|NCT03765164|19915744|P2|COMPLETED|Post-intervention||0
8077037|NCT03765164|19915745|P1|COMPLETED|Post-intervention||0
8077038|NCT03765164|19915744|P2|STARTED|Post-intervention||72
8077039|NCT03765164|19915745|P1|STARTED|Post-intervention||73
8077040|NCT03765164|19915744|P2|NOT COMPLETED|Pre-intervention||6
8077041|NCT03765164|19915745|P1|NOT COMPLETED|Pre-intervention||5
8077042|NCT03765164|19915744|P2|COMPLETED|Pre-intervention||72
8077043|NCT03765164|19915745|P1|COMPLETED|Pre-intervention||73
8077044|NCT03765164|19915744|P2|STARTED|Pre-intervention||78
8077045|NCT03765164|19915745|P1|STARTED|Pre-intervention||78
8077046|NCT03765138|19915755|P1|NOT COMPLETED|Overall Study||1
8077047|NCT03765138|19915755|P1|COMPLETED|Overall Study||0
8077048|NCT03765138|19915755|P1|STARTED|Overall Study||1
8077049|NCT03764813|19915765|P4|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8077050|NCT03764813|19915766|P3|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8077051|NCT03764813|19915767|P2|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8077052|NCT03764813|19915768|P1|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8077053|NCT03764813|19915765|P4|COMPLETED|From Enrollment to the Last HbF Test||5
8077054|NCT03764813|19915766|P3|COMPLETED|From Enrollment to the Last HbF Test||4
8077055|NCT03764813|19915767|P2|COMPLETED|From Enrollment to the Last HbF Test||3
8077056|NCT03764813|19915768|P1|COMPLETED|From Enrollment to the Last HbF Test||13
8077057|NCT03764813|19915765|P4|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
8077058|NCT03764813|19915766|P3|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
8077059|NCT03764813|19915767|P2|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
8077060|NCT03764813|19915768|P1|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
8077061|NCT03764813|19915765|P4|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
8077062|NCT03764813|19915766|P3|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
8077063|NCT03764813|19915767|P2|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
8077064|NCT03764813|19915768|P1|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
8077065|NCT03764813|19915765|P4|COMPLETED|From Enrollment to the Age of 32 Weeks||4
8077066|NCT03764813|19915766|P3|COMPLETED|From Enrollment to the Age of 32 Weeks||3
8077067|NCT03764813|19915767|P2|COMPLETED|From Enrollment to the Age of 32 Weeks||2
8077068|NCT03764813|19915768|P1|COMPLETED|From Enrollment to the Age of 32 Weeks||14
8077069|NCT03764813|19915765|P4|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
8077070|NCT03764813|19915766|P3|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
8077071|NCT03764813|19915767|P2|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
8077072|NCT03764813|19915768|P1|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
8077073|NCT03764449|19915788|P2|NOT COMPLETED|Overall Study||0
8077074|NCT03764449|19915789|P1|NOT COMPLETED|Overall Study||0
8077075|NCT03764449|19915788|P2|COMPLETED|Overall Study||8
8077076|NCT03764449|19915789|P1|COMPLETED|Overall Study||8
8077077|NCT03764449|19915788|P2|STARTED|Overall Study||8
8077078|NCT03764449|19915789|P1|STARTED|Overall Study||8
8077079|NCT03763058|19915879|P1|NOT COMPLETED|Overall Study||2
8077080|NCT03763058|19915879|P1|COMPLETED|Overall Study||18
8077081|NCT03763058|19915879|P1|STARTED|Overall Study||20
8077082|NCT03762668|19915889|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
8077083|NCT03762668|19915890|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
8077084|NCT03762668|19915889|P2|COMPLETED|Period 2, Second Week of Wear||29
8077085|NCT03762668|19915890|P1|COMPLETED|Period 2, Second Week of Wear||30
8077086|NCT03762668|19915889|P2|STARTED|Period 2, Second Week of Wear||29
8077087|NCT03762668|19915890|P1|STARTED|Period 2, Second Week of Wear||30
8077088|NCT03762668|19915889|P2|NOT COMPLETED|Period 1, First Week of Wear||1
8077089|NCT03762668|19915890|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8077090|NCT03762668|19915889|P2|COMPLETED|Period 1, First Week of Wear||29
8077091|NCT03762668|19915890|P1|COMPLETED|Period 1, First Week of Wear||30
8077092|NCT03762668|19915889|P2|STARTED|Period 1, First Week of Wear||30
8077093|NCT03762668|19915890|P1|STARTED|Period 1, First Week of Wear||30
8077094|NCT03762213|19915898|P2|NOT COMPLETED|Overall Study||0
8077095|NCT03762213|19915899|P1|NOT COMPLETED|Overall Study||0
8077096|NCT03762213|19915898|P2|COMPLETED|Overall Study||14
8077097|NCT03762213|19915899|P1|COMPLETED|Overall Study||16
8077098|NCT03762213|19915898|P2|STARTED|Overall Study||14
8077099|NCT03762213|19915899|P1|STARTED|Overall Study||16
8077100|NCT03762200|19915909|P1|NOT COMPLETED|Overall Study||0
8077101|NCT03762200|19915909|P1|COMPLETED|Overall Study|Completed Primary Endpoint|103
8077102|NCT03762200|19915909|P1|STARTED|Overall Study||103
8077103|NCT03761368|19915915|P2|NOT COMPLETED|Overall Study||0
8077104|NCT03761368|19915916|P1|NOT COMPLETED|Overall Study||0
8077105|NCT03761368|19915915|P2|COMPLETED|Overall Study||51
8077106|NCT03761368|19915916|P1|COMPLETED|Overall Study||50
8077107|NCT03761368|19915915|P2|STARTED|Overall Study||51
8077108|NCT03761368|19915916|P1|STARTED|Overall Study||50
8077109|NCT03760640|19915930|P2|NOT COMPLETED|Period 2||0
8077110|NCT03760640|19915931|P1|NOT COMPLETED|Period 2||0
8077111|NCT03760640|19915930|P2|COMPLETED|Period 2||22
8077112|NCT03760640|19915931|P1|COMPLETED|Period 2||20
8077113|NCT03760640|19915930|P2|STARTED|Period 2||22
8077114|NCT03760640|19915931|P1|STARTED|Period 2||20
8077115|NCT03760640|19915930|P2|NOT COMPLETED|Period 1||0
8077116|NCT03760640|19915931|P1|NOT COMPLETED|Period 1||0
8077117|NCT03760640|19915930|P2|COMPLETED|Period 1||22
8077118|NCT03760640|19915931|P1|COMPLETED|Period 1||20
8077119|NCT03760640|19915930|P2|Received at Least 1 Dose of Study Drug|Period 1||22
8077120|NCT03760640|19915931|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8077121|NCT03760640|19915930|P2|STARTED|Period 1||22
8077122|NCT03760640|19915931|P1|STARTED|Period 1||20
8077123|NCT03760510|19915949|P2|NOT COMPLETED|Overall Study||97
8077124|NCT03760510|19915950|P1|NOT COMPLETED|Overall Study||105
8077125|NCT03760510|19915949|P2|COMPLETED|Overall Study||153
8077126|NCT03760510|19915950|P1|COMPLETED|Overall Study||145
8077127|NCT03760510|19915949|P2|STARTED|Overall Study||250
8077128|NCT03760510|19915950|P1|STARTED|Overall Study||250
8077129|NCT03760250|19915962|P1|NOT COMPLETED|Overall Study||2
8077130|NCT03760250|19915962|P1|COMPLETED|Overall Study||4
8077131|NCT03760250|19915962|P1|STARTED|Overall Study||6
8077132|NCT03760146|19915973|P6|NOT COMPLETED|Overall Study||8
8077133|NCT03760146|19915974|P5|NOT COMPLETED|Overall Study||17
8077134|NCT03760146|19915975|P4|NOT COMPLETED|Overall Study||2
8077135|NCT03760146|19915976|P3|NOT COMPLETED|Overall Study||11
8077136|NCT03760146|19915977|P2|NOT COMPLETED|Overall Study||78
8077137|NCT03760146|19915978|P1|NOT COMPLETED|Overall Study||96
8077138|NCT03760146|19915973|P6|COMPLETED|Overall Study||104
8077139|NCT03760146|19915974|P5|COMPLETED|Overall Study||319
8077140|NCT03760146|19915975|P4|COMPLETED|Overall Study||109
8077141|NCT03760146|19915976|P3|COMPLETED|Overall Study||323
8077142|NCT03760146|19915977|P2|COMPLETED|Overall Study||1417
8077143|NCT03760146|19915978|P1|COMPLETED|Overall Study||1418
8077144|NCT03760146|19915973|P6|Evaluable-20 Immunogenicity Population|Overall Study||0
8077145|NCT03760146|19915974|P5|Evaluable-20 Immunogenicity Population|Overall Study||317
8077146|NCT03760146|19915975|P4|Evaluable-20 Immunogenicity Population|Overall Study||0
8077147|NCT03760146|19915976|P3|Evaluable-20 Immunogenicity Population|Overall Study||321
8077148|NCT03760146|19915977|P2|Evaluable-20 Immunogenicity Population|Overall Study||0
8077149|NCT03760146|19915978|P1|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
8077150|NCT03760146|19915973|P6|Safety Population|Overall Study||112
8077151|NCT03760146|19915974|P5|Safety Population|Overall Study||335
8077152|NCT03760146|19915975|P4|Safety Population|Overall Study||111
8077153|NCT03760146|19915976|P3|Safety Population|Overall Study||334
8077154|NCT03760146|19915977|P2|Safety Population|Overall Study||1490
8077155|NCT03760146|19915978|P1|Safety Population|Overall Study||1507
8077156|NCT03760146|19915973|P6|Vaccination 2|Overall Study||0
8077157|NCT03760146|19915974|P5|Vaccination 2|Overall Study||0
8077158|NCT03760146|19915975|P4|Vaccination 2|Overall Study||0
8077159|NCT03760146|19915976|P3|Vaccination 2|Overall Study||0
8077160|NCT03760146|19915977|P2|Vaccination 2|Overall Study||1446
8077161|NCT03760146|19915978|P1|Vaccination 2|Overall Study||1461
8077162|NCT03760146|19915973|P6|Vaccination 1|Overall Study||112
8077163|NCT03760146|19915974|P5|Vaccination 1|Overall Study||335
8077164|NCT03760146|19915975|P4|Vaccination 1|Overall Study||111
8077165|NCT03760146|19915976|P3|Vaccination 1|Overall Study||334
8077166|NCT03760146|19915977|P2|Vaccination 1|Overall Study||1490
8077167|NCT03760146|19915978|P1|Vaccination 1|Overall Study||1507
8077168|NCT03760146|19915973|P6|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077169|NCT03760146|19915974|P5|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077170|NCT03760146|19915975|P4|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077171|NCT03760146|19915976|P3|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077172|NCT03760146|19915977|P2|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
8077173|NCT03760146|19915978|P1|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
8077174|NCT03760146|19915973|P6|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077175|NCT03760146|19915974|P5|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077176|NCT03760146|19915975|P4|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077177|NCT03760146|19915976|P3|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077178|NCT03760146|19915977|P2|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
8077179|NCT03760146|19915978|P1|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
8077180|NCT03760146|19915973|P6|STARTED|Overall Study||112
8077181|NCT03760146|19915974|P5|STARTED|Overall Study||336
8077182|NCT03760146|19915975|P4|STARTED|Overall Study||111
8077183|NCT03760146|19915976|P3|STARTED|Overall Study||334
8077184|NCT03760146|19915977|P2|STARTED|Overall Study||1495
8077185|NCT03760146|19915978|P1|STARTED|Overall Study||1514
8077192|NCT03759600|19916063|P1|NOT COMPLETED|Overall Study||20
8077193|NCT03759600|19916063|P1|COMPLETED|Overall Study||0
8077194|NCT03759600|19916063|P1|STARTED|Overall Study||20
8077195|NCT03759587|19916077|P1|NOT COMPLETED|Overall Study||19
8077196|NCT03759587|19916077|P1|COMPLETED|Overall Study||0
8077197|NCT03759587|19916077|P1|STARTED|Overall Study||19
8077198|NCT03759340|19916090|P1|NOT COMPLETED|Overall Study||56
8077199|NCT03759340|19916090|P1|COMPLETED|Overall Study||0
8077200|NCT03759340|19916090|P1|STARTED|Overall Study||56
8077201|NCT03758365|19916099|P1|NOT COMPLETED|Overall Study||0
8077202|NCT03758365|19916099|P1|COMPLETED|Overall Study||36
8077203|NCT03758365|19916099|P1|Vehicle Cream|Overall Study||36
8077204|NCT03758365|19916099|P1|Desonide 0.05% Cream|Overall Study||36
8077205|NCT03758365|19916099|P1|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
8077206|NCT03758365|19916099|P1|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
8077207|NCT03758365|19916099|P1|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
8077208|NCT03758365|19916099|P1|Clobetasol Propionate 0.05% Lotion|Overall Study||36
8077209|NCT03758365|19916099|P1|MC2-01 Cream|Overall Study||36
8077210|NCT03758365|19916099|P1|STARTED|Overall Study||36
8077211|NCT03757988|19916110|P1|NOT COMPLETED|Overall Study||1
8077212|NCT03757988|19916110|P1|COMPLETED|Overall Study||16
8077213|NCT03757988|19916110|P1|STARTED|Overall Study||17
8077214|NCT03757234|19916133|P5|NOT COMPLETED|Overall Study||4
8077215|NCT03757234|19916134|P4|NOT COMPLETED|Overall Study||1
8077216|NCT03757234|19916135|P3|NOT COMPLETED|Overall Study||0
8077217|NCT03757234|19916136|P2|NOT COMPLETED|Overall Study||2
8077218|NCT03757234|19916137|P1|NOT COMPLETED|Overall Study||3
8077219|NCT03757234|19916133|P5|COMPLETED|Overall Study||70
8077220|NCT03757234|19916134|P4|COMPLETED|Overall Study||16
8077221|NCT03757234|19916135|P3|COMPLETED|Overall Study||17
8077222|NCT03757234|19916136|P2|COMPLETED|Overall Study||16
8077223|NCT03757234|19916137|P1|COMPLETED|Overall Study||72
8077224|NCT03757234|19916133|P5|Completed PTE Visit|Overall Study||71
8077225|NCT03757234|19916134|P4|Completed PTE Visit|Overall Study||16
8077226|NCT03757234|19916135|P3|Completed PTE Visit|Overall Study||17
8077227|NCT03757234|19916136|P2|Completed PTE Visit|Overall Study||16
8077228|NCT03757234|19916137|P1|Completed PTE Visit|Overall Study||72
8077229|NCT03757234|19916133|P5|STARTED|Overall Study||74
8077230|NCT03757234|19916134|P4|STARTED|Overall Study||17
8077231|NCT03757234|19916135|P3|STARTED|Overall Study||17
8077232|NCT03757234|19916136|P2|STARTED|Overall Study||18
8077233|NCT03757234|19916137|P1|STARTED|Overall Study||75
8077234|NCT03757039|19916173|P2|NOT COMPLETED|Overall Study||0
8077235|NCT03757039|19916174|P1|NOT COMPLETED|Overall Study||0
8077236|NCT03757039|19916173|P2|COMPLETED|Overall Study||9
8077237|NCT03757039|19916174|P1|COMPLETED|Overall Study||32
8077238|NCT03757039|19916173|P2|DACP MF|Overall Study||0
8077239|NCT03757039|19916174|P1|DACP MF|Overall Study||10
8077240|NCT03757039|19916173|P2|DT1 MF|Overall Study||0
8077241|NCT03757039|19916174|P1|DT1 MF|Overall Study||11
8077242|NCT03757039|19916173|P2|AOHG MF|Overall Study||0
8077243|NCT03757039|19916174|P1|AOHG MF|Overall Study||11
8077244|NCT03757039|19916173|P2|STARTED|Overall Study||9
8077245|NCT03757039|19916174|P1|STARTED|Overall Study||32
8077246|NCT03756506|19916184|P2|NOT COMPLETED|Overall Study||0
8077247|NCT03756506|19916185|P1|NOT COMPLETED|Overall Study||1
8077248|NCT03756506|19916184|P2|COMPLETED|Overall Study||6
8077249|NCT03756506|19916185|P1|COMPLETED|Overall Study||6
8077250|NCT03756506|19916184|P2|STARTED|Overall Study||6
8077251|NCT03756506|19916185|P1|STARTED|Overall Study||7
8077252|NCT03756038|19916195|P2|NOT COMPLETED|Overall Study||0
8077253|NCT03756038|19916196|P1|NOT COMPLETED|Overall Study||0
8077254|NCT03756038|19916195|P2|COMPLETED|Overall Study||0
8077255|NCT03756038|19916196|P1|COMPLETED|Overall Study||1
8077256|NCT03756038|19916195|P2|STARTED|Overall Study||0
8077257|NCT03756038|19916196|P1|STARTED|Overall Study||1
8077258|NCT03755882|19916204|P2|NOT COMPLETED|Period 2||0
8077259|NCT03755882|19916205|P1|NOT COMPLETED|Period 2||0
8077260|NCT03755882|19916204|P2|COMPLETED|Period 2||22
8077261|NCT03755882|19916205|P1|COMPLETED|Period 2||19
8077262|NCT03755882|19916204|P2|STARTED|Period 2||22
8077263|NCT03755882|19916205|P1|STARTED|Period 2||19
8077264|NCT03755882|19916204|P2|NOT COMPLETED|Period 1||0
8077265|NCT03755882|19916205|P1|NOT COMPLETED|Period 1||4
8077266|NCT03755882|19916204|P2|COMPLETED|Period 1||22
8077267|NCT03755882|19916205|P1|COMPLETED|Period 1||19
8077268|NCT03755882|19916204|P2|STARTED|Period 1||22
8077269|NCT03755882|19916205|P1|STARTED|Period 1||23
8077270|NCT03754582|19916211|P3|NOT COMPLETED|Follow-up Phase||1
8077271|NCT03754582|19916212|P2|NOT COMPLETED|Follow-up Phase||0
8077272|NCT03754582|19916213|P1|NOT COMPLETED|Follow-up Phase||0
8077273|NCT03754582|19916211|P3|COMPLETED|Follow-up Phase||20
8077274|NCT03754582|19916212|P2|COMPLETED|Follow-up Phase||0
8077275|NCT03754582|19916213|P1|COMPLETED|Follow-up Phase||0
8077276|NCT03754582|19916211|P3|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
8077277|NCT03754582|19916212|P2|STARTED|Follow-up Phase||0
8077278|NCT03754582|19916213|P1|STARTED|Follow-up Phase||0
8077279|NCT03754582|19916211|P3|NOT COMPLETED|Treatment Phase||0
8077280|NCT03754582|19916212|P2|NOT COMPLETED|Treatment Phase||1
8077281|NCT03754582|19916213|P1|NOT COMPLETED|Treatment Phase||0
8077282|NCT03754582|19916211|P3|COMPLETED|Treatment Phase||0
8077283|NCT03754582|19916212|P2|COMPLETED|Treatment Phase||20
8077284|NCT03754582|19916213|P1|COMPLETED|Treatment Phase||0
8077285|NCT03754582|19916211|P3|STARTED|Treatment Phase||0
8077286|NCT03754582|19916212|P2|STARTED|Treatment Phase||21
8077287|NCT03754582|19916213|P1|STARTED|Treatment Phase||0
8077288|NCT03754582|19916211|P3|NOT COMPLETED|Pretreatment Phase||0
8077289|NCT03754582|19916212|P2|NOT COMPLETED|Pretreatment Phase||0
8077290|NCT03754582|19916213|P1|NOT COMPLETED|Pretreatment Phase||0
8077291|NCT03754582|19916211|P3|COMPLETED|Pretreatment Phase||0
8077292|NCT03754582|19916212|P2|COMPLETED|Pretreatment Phase||0
8077293|NCT03754582|19916213|P1|COMPLETED|Pretreatment Phase||21
8077294|NCT03754582|19916211|P3|STARTED|Pretreatment Phase||0
8077295|NCT03754582|19916212|P2|STARTED|Pretreatment Phase||0
8077296|NCT03754582|19916213|P1|STARTED|Pretreatment Phase||21
8077297|NCT03754556|19916241|P1|NOT COMPLETED|Overall Study||0
8077298|NCT03754556|19916241|P1|COMPLETED|Overall Study||326658
8077299|NCT03754556|19916241|P1|STARTED|Overall Study||326658
8077300|NCT03753113|19916285|P2|NOT COMPLETED|Overall Study||0
8077301|NCT03753113|19916286|P1|NOT COMPLETED|Overall Study||0
8077302|NCT03753113|19916285|P2|COMPLETED|Overall Study||12
8077303|NCT03753113|19916286|P1|COMPLETED|Overall Study||12
8077304|NCT03753113|19916285|P2|STARTED|Overall Study||12
8077305|NCT03753113|19916286|P1|STARTED|Overall Study||12
8077306|NCT03752567|19916296|P1|NOT COMPLETED|Overall Study||0
8077307|NCT03752567|19916296|P1|COMPLETED|Overall Study||40
8077308|NCT03752567|19916296|P1|STARTED|Overall Study||40
8077309|NCT03752528|19916305|P1|NOT COMPLETED|Part B||4
8077310|NCT03752528|19916305|P1|COMPLETED|Part B||20
8077311|NCT03752528|19916305|P1|STARTED|Part B||24
8077312|NCT03752528|19916305|P1|NOT COMPLETED|Part A||2
8077313|NCT03752528|19916305|P1|COMPLETED|Part A||51
8077314|NCT03752528|19916305|P1|STARTED|Part A||53
8077315|NCT03752151|19916324|P1|NOT COMPLETED|Overall Study||2
8077316|NCT03752151|19916324|P1|COMPLETED|Overall Study||75
8077317|NCT03752151|19916324|P1|STARTED|Overall Study||77
8077318|NCT03751280|19916332|P2|NOT COMPLETED|Overall Study||12
8077319|NCT03751280|19916333|P1|NOT COMPLETED|Overall Study||8
8077320|NCT03751280|19916332|P2|COMPLETED|Overall Study||44
8077321|NCT03751280|19916333|P1|COMPLETED|Overall Study||48
8077322|NCT03751280|19916332|P2|Safety Set (SAF)|Overall Study||55
8077323|NCT03751280|19916333|P1|Safety Set (SAF)|Overall Study||55
8077324|NCT03751280|19916332|P2|Full Analysis Set (FAS)|Overall Study||55
8077325|NCT03751280|19916333|P1|Full Analysis Set (FAS)|Overall Study||54
8077326|NCT03751280|19916332|P2|STARTED|Overall Study||56
8077327|NCT03751280|19916333|P1|STARTED|Overall Study||56
8077328|NCT03751020|19916369|P3|NOT COMPLETED|Overall Study||10
8077329|NCT03751020|19916370|P2|NOT COMPLETED|Overall Study||4
8077330|NCT03751020|19916371|P1|NOT COMPLETED|Overall Study||9
8077331|NCT03751020|19916369|P3|COMPLETED|Overall Study||26
8077332|NCT03751020|19916370|P2|COMPLETED|Overall Study||32
8077333|NCT03751020|19916371|P1|COMPLETED|Overall Study||27
8077334|NCT03751020|19916369|P3|3 Month Follow Up|Overall Study||26
8077335|NCT03751020|19916370|P2|3 Month Follow Up|Overall Study||32
8077336|NCT03751020|19916371|P1|3 Month Follow Up|Overall Study||27
8077337|NCT03751020|19916369|P3|Post Intervention|Overall Study||30
8077338|NCT03751020|19916370|P2|Post Intervention|Overall Study||33
8077339|NCT03751020|19916371|P1|Post Intervention|Overall Study||33
8077340|NCT03751020|19916369|P3|STARTED|Overall Study||36
8077341|NCT03751020|19916370|P2|STARTED|Overall Study||36
8077342|NCT03751020|19916371|P1|STARTED|Overall Study||36
8077343|NCT03748979|19916477|P11|NOT COMPLETED|Overall Study||0
8077344|NCT03748979|19916478|P10|NOT COMPLETED|Overall Study||0
8077345|NCT03748979|19916479|P9|NOT COMPLETED|Overall Study||0
8077346|NCT03748979|19916480|P8|NOT COMPLETED|Overall Study||0
8077347|NCT03748979|19916481|P7|NOT COMPLETED|Overall Study||0
8077348|NCT03748979|19916482|P6|NOT COMPLETED|Overall Study||0
8077349|NCT03748979|19916483|P5|NOT COMPLETED|Overall Study||0
8077350|NCT03748979|19916484|P4|NOT COMPLETED|Overall Study||0
8077351|NCT03748979|19916485|P3|NOT COMPLETED|Overall Study||0
8077352|NCT03748979|19916486|P2|NOT COMPLETED|Overall Study||0
8077353|NCT03748979|19916487|P1|NOT COMPLETED|Overall Study||0
8077354|NCT03748979|19916477|P11|COMPLETED|Overall Study||6
8077355|NCT03748979|19916478|P10|COMPLETED|Overall Study||5
8077356|NCT03748979|19916479|P9|COMPLETED|Overall Study||4
8077357|NCT03748979|19916480|P8|COMPLETED|Overall Study||5
8077358|NCT03748979|19916481|P7|COMPLETED|Overall Study||5
8077359|NCT03748979|19916482|P6|COMPLETED|Overall Study||4
8077360|NCT03748979|19916483|P5|COMPLETED|Overall Study||4
8077361|NCT03748979|19916484|P4|COMPLETED|Overall Study||6
8077362|NCT03748979|19916485|P3|COMPLETED|Overall Study||6
8077363|NCT03748979|19916486|P2|COMPLETED|Overall Study||6
8077364|NCT03748979|19916487|P1|COMPLETED|Overall Study||6
8077365|NCT03748979|19916477|P11|STARTED|Overall Study||6
8077366|NCT03748979|19916478|P10|STARTED|Overall Study||5
8077367|NCT03748979|19916479|P9|STARTED|Overall Study||4
8077368|NCT03748979|19916480|P8|STARTED|Overall Study||5
8077369|NCT03748979|19916481|P7|STARTED|Overall Study||5
8077370|NCT03748979|19916482|P6|STARTED|Overall Study||4
8077371|NCT03748979|19916483|P5|STARTED|Overall Study||4
8077372|NCT03748979|19916484|P4|STARTED|Overall Study||6
8077373|NCT03748979|19916485|P3|STARTED|Overall Study||6
8077374|NCT03748979|19916486|P2|STARTED|Overall Study||6
8077375|NCT03748979|19916487|P1|STARTED|Overall Study||6
8077376|NCT03748758|19916541|P3|NOT COMPLETED|Overall Study||1
8077377|NCT03748758|19916542|P2|NOT COMPLETED|Overall Study||0
8077378|NCT03748758|19916543|P1|NOT COMPLETED|Overall Study||0
8077379|NCT03748758|19916541|P3|COMPLETED|Overall Study||5
8077380|NCT03748758|19916542|P2|COMPLETED|Overall Study||12
8077381|NCT03748758|19916543|P1|COMPLETED|Overall Study||12
8077382|NCT03748758|19916541|P3|STARTED|Overall Study||6
8077383|NCT03748758|19916542|P2|STARTED|Overall Study||12
8077384|NCT03748758|19916543|P1|STARTED|Overall Study||12
8077385|NCT03746405|19916597|P2|NOT COMPLETED|Overall Study||2
8077386|NCT03746405|19916598|P1|NOT COMPLETED|Overall Study||3
8077387|NCT03746405|19916597|P2|COMPLETED|Overall Study||6
8077388|NCT03746405|19916598|P1|COMPLETED|Overall Study||7
8077389|NCT03746405|19916597|P2|STARTED|Overall Study||8
8077390|NCT03746405|19916598|P1|STARTED|Overall Study||10
8077391|NCT03745937|19916608|P4|NOT COMPLETED|Overall Study||2
8077392|NCT03745937|19916609|P3|NOT COMPLETED|Overall Study||0
8077393|NCT03745937|19916610|P2|NOT COMPLETED|Overall Study||1
8077394|NCT03745937|19916611|P1|NOT COMPLETED|Overall Study||0
8077395|NCT03745937|19916608|P4|COMPLETED|Overall Study||7
8077396|NCT03745937|19916609|P3|COMPLETED|Overall Study||3
8077397|NCT03745937|19916610|P2|COMPLETED|Overall Study||5
8077398|NCT03745937|19916611|P1|COMPLETED|Overall Study||2
8077399|NCT03745937|19916608|P4|STARTED|Overall Study||9
8077400|NCT03745937|19916609|P3|STARTED|Overall Study||3
8077401|NCT03745937|19916610|P2|STARTED|Overall Study||6
8077402|NCT03745937|19916611|P1|STARTED|Overall Study||2
8077403|NCT03745222|19916725|P3|NOT COMPLETED|Overall Study||0
8077404|NCT03745222|19916726|P2|NOT COMPLETED|Overall Study||1
8077405|NCT03745222|19916727|P1|NOT COMPLETED|Overall Study||0
8077406|NCT03745222|19916725|P3|COMPLETED|Overall Study||0
8077407|NCT03745222|19916726|P2|COMPLETED|Overall Study||0
8077408|NCT03745222|19916727|P1|COMPLETED|Overall Study||0
8077409|NCT03745222|19916725|P3|STARTED|Overall Study||0
8077410|NCT03745222|19916726|P2|STARTED|Overall Study||1
8077411|NCT03745222|19916727|P1|STARTED|Overall Study||0
8077412|NCT03745092|19916767|P2|NOT COMPLETED|Overall Study||0
8077413|NCT03745092|19916768|P1|NOT COMPLETED|Overall Study||0
8077414|NCT03745092|19916767|P2|COMPLETED|Overall Study||23
8077415|NCT03745092|19916768|P1|COMPLETED|Overall Study||26
8077416|NCT03745092|19916767|P2|STARTED|Overall Study||23
8077417|NCT03745092|19916768|P1|STARTED|Overall Study||26
8077418|NCT03744780|19916784|P1|NOT COMPLETED|Overall Study||0
8077419|NCT03744780|19916784|P1|COMPLETED|Overall Study||32
8077420|NCT03744780|19916784|P1|STARTED|Overall Study||32
8077421|NCT03742973|19916804|P2|NOT COMPLETED|Overall Study||0
8077422|NCT03742973|19916805|P1|NOT COMPLETED|Overall Study||0
8077423|NCT03742973|19916804|P2|COMPLETED|Overall Study||0
8077424|NCT03742973|19916805|P1|COMPLETED|Overall Study||0
8077425|NCT03742973|19916804|P2|STARTED|Overall Study||0
8077426|NCT03742973|19916805|P1|STARTED|Overall Study||0
8077427|NCT03742440|19916816|P1|NOT COMPLETED|Overall Study||0
8077428|NCT03742440|19916816|P1|COMPLETED|Overall Study||40
8077429|NCT03742440|19916816|P1|STARTED|Overall Study||40
8077430|NCT03742271|19916822|P1|NOT COMPLETED|Overall Study||12
8077431|NCT03742271|19916822|P1|COMPLETED|Overall Study||115
8077432|NCT03742271|19916822|P1|STARTED|Overall Study||127
8077433|NCT03742154|19916828|P2|NOT COMPLETED|Overall Study||0
8077434|NCT03742154|19916829|P1|NOT COMPLETED|Overall Study||0
8077435|NCT03742154|19916828|P2|COMPLETED|Overall Study||49
8077436|NCT03742154|19916829|P1|COMPLETED|Overall Study||50
8077437|NCT03742154|19916828|P2|STARTED|Overall Study||49
8077438|NCT03742154|19916829|P1|STARTED|Overall Study||50
8077439|NCT03741725|19916839|P3|NOT COMPLETED|Overall Study||0
8077440|NCT03741725|19916840|P2|NOT COMPLETED|Overall Study||0
8077441|NCT03741725|19916841|P1|NOT COMPLETED|Overall Study||0
8077442|NCT03741725|19916839|P3|COMPLETED|Overall Study||100
8077443|NCT03741725|19916840|P2|COMPLETED|Overall Study||100
8077444|NCT03741725|19916841|P1|COMPLETED|Overall Study||101
8077445|NCT03741725|19916839|P3|STARTED|Overall Study||100
8077446|NCT03741725|19916840|P2|STARTED|Overall Study||100
8077447|NCT03741725|19916841|P1|STARTED|Overall Study||101
8077448|NCT03741062|19916872|P2|NOT COMPLETED|Overall Study||0
8077449|NCT03741062|19916873|P1|NOT COMPLETED|Overall Study||1
8077450|NCT03741062|19916872|P2|COMPLETED|Overall Study||6
8077451|NCT03741062|19916873|P1|COMPLETED|Overall Study||4
8077452|NCT03741062|19916872|P2|STARTED|Overall Study||6
8077453|NCT03741062|19916873|P1|STARTED|Overall Study||5
8077454|NCT03740659|19916886|P3|NOT COMPLETED|Overall Study||0
8077455|NCT03740659|19916887|P2|NOT COMPLETED|Overall Study||0
8077456|NCT03740659|19916888|P1|NOT COMPLETED|Overall Study||0
8077457|NCT03740659|19916886|P3|COMPLETED|Overall Study||41
8077458|NCT03740659|19916887|P2|COMPLETED|Overall Study||42
8077459|NCT03740659|19916888|P1|COMPLETED|Overall Study||42
8077460|NCT03740659|19916886|P3|STARTED|Overall Study||41
8077461|NCT03740659|19916887|P2|STARTED|Overall Study||42
8077462|NCT03740659|19916888|P1|STARTED|Overall Study||42
8077463|NCT03740152|19916902|P1|NOT COMPLETED|Overall Study||0
8077464|NCT03740152|19916902|P1|COMPLETED|Overall Study||10
8077465|NCT03740152|19916902|P1|STARTED|Overall Study||10
8077466|NCT03739866|19916916|P8|NOT COMPLETED|Overall Study||0
8077467|NCT03739866|19916917|P7|NOT COMPLETED|Overall Study||0
8077468|NCT03739866|19916918|P6|NOT COMPLETED|Overall Study||0
8077469|NCT03739866|19916919|P5|NOT COMPLETED|Overall Study||1
8077470|NCT03739866|19916920|P4|NOT COMPLETED|Overall Study||1
8077471|NCT03739866|19916921|P3|NOT COMPLETED|Overall Study||1
8077472|NCT03739866|19916922|P2|NOT COMPLETED|Overall Study||0
8077473|NCT03739866|19916923|P1|NOT COMPLETED|Overall Study||0
8077474|NCT03739866|19916916|P8|COMPLETED|Overall Study||5
8077475|NCT03739866|19916917|P7|COMPLETED|Overall Study||7
8077476|NCT03739866|19916918|P6|COMPLETED|Overall Study||10
8077477|NCT03739866|19916919|P5|COMPLETED|Overall Study||5
8077478|NCT03739866|19916920|P4|COMPLETED|Overall Study||5
8077479|NCT03739866|19916921|P3|COMPLETED|Overall Study||6
8077480|NCT03739866|19916922|P2|COMPLETED|Overall Study||6
8077481|NCT03739866|19916923|P1|COMPLETED|Overall Study||6
8077482|NCT03739866|19916916|P8|STARTED|Overall Study||5
8077483|NCT03739866|19916917|P7|STARTED|Overall Study||7
8077484|NCT03739866|19916918|P6|STARTED|Overall Study||10
8077485|NCT03739866|19916919|P5|STARTED|Overall Study||6
8077486|NCT03739866|19916920|P4|STARTED|Overall Study||6
8077487|NCT03739866|19916921|P3|STARTED|Overall Study||7
8077488|NCT03739866|19916922|P2|STARTED|Overall Study||6
8077489|NCT03739866|19916923|P1|STARTED|Overall Study||6
8077490|NCT03739528|19916992|P2|NOT COMPLETED|Overall Study||17
8077491|NCT03739528|19916993|P1|NOT COMPLETED|Overall Study||15
8077492|NCT03739528|19916992|P2|COMPLETED|Overall Study||388
8077493|NCT03739528|19916993|P1|COMPLETED|Overall Study||388
8077494|NCT03739528|19916992|P2|Received at Least One Treatment|Overall Study||393
8077495|NCT03739528|19916993|P1|Received at Least One Treatment|Overall Study||395
8077496|NCT03739528|19916992|P2|STARTED|Overall Study||405
8077497|NCT03739528|19916993|P1|STARTED|Overall Study||403
8077498|NCT03739242|19917025|P2|NOT COMPLETED|Overall Study||2
8077499|NCT03739242|19917026|P1|NOT COMPLETED|Overall Study||1
8077500|NCT03739242|19917025|P2|COMPLETED|Overall Study||42
8077501|NCT03739242|19917026|P1|COMPLETED|Overall Study||43
8077502|NCT03739242|19917025|P2|STARTED|Overall Study||44
8077503|NCT03739242|19917026|P1|STARTED|Overall Study||44
8077504|NCT03738865|19917064|P2|NOT COMPLETED|Overall Study||4
8077505|NCT03738865|19917065|P1|NOT COMPLETED|Overall Study||5
8077506|NCT03738865|19917064|P2|COMPLETED|Overall Study||62
8077507|NCT03738865|19917065|P1|COMPLETED|Overall Study||61
8077508|NCT03738865|19917064|P2|STARTED|Overall Study||66
8077509|NCT03738865|19917065|P1|STARTED|Overall Study||66
8077510|NCT03738475|19917081|P2|NOT COMPLETED|Overall Study||0
8077511|NCT03738475|19917082|P1|NOT COMPLETED|Overall Study||1
8077512|NCT03738475|19917081|P2|COMPLETED|Overall Study||18
8077513|NCT03738475|19917082|P1|COMPLETED|Overall Study||15
8077514|NCT03738475|19917081|P2|STARTED|Overall Study||18
8077515|NCT03738475|19917082|P1|STARTED|Overall Study||16
8077516|NCT03738020|19917119|P1|NOT COMPLETED|Overall Study||1
8077517|NCT03738020|19917119|P1|COMPLETED|Overall Study||57
8077518|NCT03738020|19917119|P1|STARTED|Overall Study||58
8077519|NCT03736031|19917128|P2|NOT COMPLETED|Overall Study||6
8077520|NCT03736031|19917129|P1|NOT COMPLETED|Overall Study||32
8077521|NCT03736031|19917128|P2|COMPLETED|Overall Study||40
8077522|NCT03736031|19917129|P1|COMPLETED|Overall Study||24
8077523|NCT03736031|19917128|P2|STARTED|Overall Study||46
8077524|NCT03736031|19917129|P1|STARTED|Overall Study||56
8077525|NCT03735862|19917141|P1|NOT COMPLETED|Overall Study||0
8077526|NCT03735862|19917141|P1|COMPLETED|Overall Study||73
8077527|NCT03735862|19917141|P1|STARTED|Overall Study||73
8077528|NCT03734822|19917149|P1|NOT COMPLETED|Overall Study||0
8077529|NCT03734822|19917149|P1|COMPLETED|Overall Study||47
8077530|NCT03734822|19917149|P1|STARTED|Overall Study||47
8077531|NCT03733899|19917153|P6|NOT COMPLETED|Period 3||0
8077532|NCT03733899|19917154|P5|NOT COMPLETED|Period 3||0
8077533|NCT03733899|19917155|P4|NOT COMPLETED|Period 3||0
8077534|NCT03733899|19917156|P3|NOT COMPLETED|Period 3||0
8077535|NCT03733899|19917157|P2|NOT COMPLETED|Period 3||0
8077536|NCT03733899|19917158|P1|NOT COMPLETED|Period 3||1
8077537|NCT03733899|19917153|P6|COMPLETED|Period 3||2
8077538|NCT03733899|19917154|P5|COMPLETED|Period 3||4
8077539|NCT03733899|19917155|P4|COMPLETED|Period 3||4
8077540|NCT03733899|19917156|P3|COMPLETED|Period 3||3
8077541|NCT03733899|19917157|P2|COMPLETED|Period 3||2
8077542|NCT03733899|19917158|P1|COMPLETED|Period 3||2
8077543|NCT03733899|19917153|P6|STARTED|Period 3||2
8077544|NCT03733899|19917154|P5|STARTED|Period 3||4
8077545|NCT03733899|19917155|P4|STARTED|Period 3||4
8077546|NCT03733899|19917156|P3|STARTED|Period 3||3
8077547|NCT03733899|19917157|P2|STARTED|Period 3||2
8077548|NCT03733899|19917158|P1|STARTED|Period 3||3
8077549|NCT03733899|19917153|P6|NOT COMPLETED|Period 2||0
8077550|NCT03733899|19917154|P5|NOT COMPLETED|Period 2||0
8077551|NCT03733899|19917155|P4|NOT COMPLETED|Period 2||0
8077552|NCT03733899|19917156|P3|NOT COMPLETED|Period 2||0
8077553|NCT03733899|19917157|P2|NOT COMPLETED|Period 2||1
8077554|NCT03733899|19917158|P1|NOT COMPLETED|Period 2||0
8077555|NCT03733899|19917153|P6|COMPLETED|Period 2||2
8077556|NCT03733899|19917154|P5|COMPLETED|Period 2||4
8077557|NCT03733899|19917155|P4|COMPLETED|Period 2||4
8077558|NCT03733899|19917156|P3|COMPLETED|Period 2||3
8077559|NCT03733899|19917157|P2|COMPLETED|Period 2||2
8077560|NCT03733899|19917158|P1|COMPLETED|Period 2||3
8077561|NCT03733899|19917153|P6|STARTED|Period 2||2
8077562|NCT03733899|19917154|P5|STARTED|Period 2||4
8077563|NCT03733899|19917155|P4|STARTED|Period 2||4
8077564|NCT03733899|19917156|P3|STARTED|Period 2||3
8077565|NCT03733899|19917157|P2|STARTED|Period 2||3
8077566|NCT03733899|19917158|P1|STARTED|Period 2||3
8077567|NCT03733899|19917153|P6|NOT COMPLETED|Period 1||1
8077568|NCT03733899|19917154|P5|NOT COMPLETED|Period 1||0
8077569|NCT03733899|19917155|P4|NOT COMPLETED|Period 1||0
8077570|NCT03733899|19917156|P3|NOT COMPLETED|Period 1||0
8077571|NCT03733899|19917157|P2|NOT COMPLETED|Period 1||0
8077572|NCT03733899|19917158|P1|NOT COMPLETED|Period 1||0
8077573|NCT03733899|19917153|P6|COMPLETED|Period 1||2
8077574|NCT03733899|19917154|P5|COMPLETED|Period 1||4
8077575|NCT03733899|19917155|P4|COMPLETED|Period 1||4
8077576|NCT03733899|19917156|P3|COMPLETED|Period 1||3
8077577|NCT03733899|19917157|P2|COMPLETED|Period 1||3
8077578|NCT03733899|19917158|P1|COMPLETED|Period 1||3
8077579|NCT03733899|19917153|P6|STARTED|Period 1||3
8077580|NCT03733899|19917154|P5|STARTED|Period 1||4
8077581|NCT03733899|19917155|P4|STARTED|Period 1||4
8077582|NCT03733899|19917156|P3|STARTED|Period 1||3
8077583|NCT03733899|19917157|P2|STARTED|Period 1||3
8077584|NCT03733899|19917158|P1|STARTED|Period 1||3
8077585|NCT03733470|19917186|P2|NOT COMPLETED|Overall Study||1
8077586|NCT03733470|19917187|P1|NOT COMPLETED|Overall Study||1
8077587|NCT03733470|19917186|P2|COMPLETED|Overall Study||10
8077588|NCT03733470|19917187|P1|COMPLETED|Overall Study||7
8077589|NCT03733470|19917186|P2|STARTED|Overall Study||11
8077590|NCT03733470|19917187|P1|STARTED|Overall Study||8
8077591|NCT03733301|19917196|P3|NOT COMPLETED|Overall Study||4
8077592|NCT03733301|19917197|P2|NOT COMPLETED|Overall Study||9
8077593|NCT03733301|19917198|P1|NOT COMPLETED|Overall Study||7
8077594|NCT03733301|19917196|P3|COMPLETED|Overall Study||107
8077595|NCT03733301|19917197|P2|COMPLETED|Overall Study||100
8077596|NCT03733301|19917198|P1|COMPLETED|Overall Study||102
8077597|NCT03733301|19917196|P3|Received One Dose of Study Drug|Overall Study||111
8077598|NCT03733301|19917197|P2|Received One Dose of Study Drug|Overall Study||109
8077599|NCT03733301|19917198|P1|Received One Dose of Study Drug|Overall Study||108
8077600|NCT03733301|19917196|P3|STARTED|Overall Study||111
8077601|NCT03733301|19917197|P2|STARTED|Overall Study||109
8077602|NCT03733301|19917198|P1|STARTED|Overall Study||109
8077603|NCT03732248|19917280|P2|NOT COMPLETED|Overall Study||0
8077604|NCT03732248|19917281|P1|NOT COMPLETED|Overall Study||1
8077605|NCT03732248|19917280|P2|COMPLETED|Overall Study||10
8077606|NCT03732248|19917281|P1|COMPLETED|Overall Study||10
8077607|NCT03732248|19917280|P2|STARTED|Overall Study||10
8077608|NCT03732248|19917281|P1|STARTED|Overall Study||11
8077619|NCT03730116|19917336|P1|NOT COMPLETED|3 Month After Inclusion||17
8077620|NCT03730116|19917336|P1|COMPLETED|3 Month After Inclusion||1892
8077621|NCT03730116|19917336|P1|3 Month After Inclusion|3 Month After Inclusion||1909
8077622|NCT03730116|19917336|P1|STARTED|3 Month After Inclusion||1909
8077623|NCT03730116|19917336|P1|NOT COMPLETED|1 Month After Inclusion||0
8077624|NCT03730116|19917336|P1|COMPLETED|1 Month After Inclusion||1909
8077625|NCT03730116|19917336|P1|1 Month After Inclusion|1 Month After Inclusion||1909
8077626|NCT03730116|19917336|P1|STARTED|1 Month After Inclusion||1909
8077627|NCT03730116|19917336|P1|NOT COMPLETED|Inclusion||0
8077628|NCT03730116|19917336|P1|COMPLETED|Inclusion||1909
8077629|NCT03730116|19917336|P1|FVFP|Inclusion||1909
8077630|NCT03730116|19917336|P1|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
8077631|NCT03730103|19917347|P2|NOT COMPLETED|Overall Study||5
8077632|NCT03730103|19917348|P1|NOT COMPLETED|Overall Study||0
8077633|NCT03730103|19917347|P2|COMPLETED|Overall Study||47
8077634|NCT03730103|19917348|P1|COMPLETED|Overall Study||61
8077635|NCT03730103|19917347|P2|STARTED|Overall Study||52
8077636|NCT03730103|19917348|P1|STARTED|Overall Study||61
8077637|NCT03729960|19917360|P1|NOT COMPLETED|Overall Study||0
8077638|NCT03729960|19917360|P1|COMPLETED|Overall Study||20
8077639|NCT03729960|19917360|P1|STARTED|Overall Study||20
8077640|NCT03728790|19917371|P2|NOT COMPLETED|Overall Study||0
8077641|NCT03728790|19917372|P1|NOT COMPLETED|Overall Study||0
8077642|NCT03728790|19917371|P2|COMPLETED|Overall Study||101
8077643|NCT03728790|19917372|P1|COMPLETED|Overall Study||112
8077644|NCT03728790|19917371|P2|STARTED|Overall Study||101
8077645|NCT03728790|19917372|P1|STARTED|Overall Study||112
8077646|NCT03728140|19917396|P2|NOT COMPLETED|Overall Study||7
8077647|NCT03728140|19917397|P1|NOT COMPLETED|Overall Study||10
8077648|NCT03728140|19917396|P2|COMPLETED|Overall Study||168
8077649|NCT03728140|19917397|P1|COMPLETED|Overall Study||150
8077650|NCT03728140|19917396|P2|STARTED|Overall Study|embryo transfer with new culture medium|175
8077651|NCT03728140|19917397|P1|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
8077652|NCT03727854|19917407|P2|NOT COMPLETED|Overall Study||0
8077653|NCT03727854|19917408|P1|NOT COMPLETED|Overall Study||0
8077654|NCT03727854|19917407|P2|COMPLETED|Overall Study||20
8077655|NCT03727854|19917408|P1|COMPLETED|Overall Study||20
8077656|NCT03727854|19917407|P2|STARTED|Overall Study||20
8077657|NCT03727854|19917408|P1|STARTED|Overall Study||20
8077658|NCT03727425|19917430|P1|NOT COMPLETED|Overall Study||0
8077659|NCT03727425|19917430|P1|COMPLETED|Overall Study||55
8077660|NCT03727425|19917430|P1|STARTED|Overall Study||55
8077661|NCT03727373|19917439|P1|NOT COMPLETED|Overall Study||0
8077662|NCT03727373|19917439|P1|COMPLETED|Overall Study||8
8077663|NCT03727373|19917439|P1|STARTED|Overall Study||8
8077664|NCT03726996|19917450|P1|NOT COMPLETED|Overall Study||4
8077665|NCT03726996|19917450|P1|COMPLETED|Overall Study||0
8077666|NCT03726996|19917450|P1|STARTED|Overall Study||4
8077667|NCT03726164|19917460|P2|NOT COMPLETED|Overall Study||197
8077668|NCT03726164|19917461|P1|NOT COMPLETED|Overall Study||211
8077669|NCT03726164|19917460|P2|COMPLETED|Overall Study||119
8077670|NCT03726164|19917461|P1|COMPLETED|Overall Study||99
8077671|NCT03726164|19917460|P2|STARTED|Overall Study||316
8077672|NCT03726164|19917461|P1|STARTED|Overall Study||310
8077673|NCT03725982|19917469|P2|NOT COMPLETED|Second Intervention||0
8077674|NCT03725982|19917470|P1|NOT COMPLETED|Second Intervention||0
8077675|NCT03725982|19917469|P2|COMPLETED|Second Intervention||17
8077676|NCT03725982|19917470|P1|COMPLETED|Second Intervention||19
8077677|NCT03725982|19917469|P2|STARTED|Second Intervention||17
8077678|NCT03725982|19917470|P1|STARTED|Second Intervention||19
8077679|NCT03725982|19917469|P2|NOT COMPLETED|First Intervention||2
8077680|NCT03725982|19917470|P1|NOT COMPLETED|First Intervention||1
8077681|NCT03725982|19917469|P2|COMPLETED|First Intervention||17
8077682|NCT03725982|19917470|P1|COMPLETED|First Intervention||19
8077683|NCT03725982|19917469|P2|STARTED|First Intervention||19
8077684|NCT03725982|19917470|P1|STARTED|First Intervention||20
8077685|NCT03725098|19917494|P2|NOT COMPLETED|Overall Study||0
8077686|NCT03725098|19917495|P1|NOT COMPLETED|Overall Study||0
8077687|NCT03725098|19917494|P2|COMPLETED|Overall Study||52
8077688|NCT03725098|19917495|P1|COMPLETED|Overall Study||53
8077689|NCT03725098|19917494|P2|STARTED|Overall Study||52
8077690|NCT03725098|19917495|P1|STARTED|Overall Study||53
8077691|NCT03725085|19917503|P1|NOT COMPLETED|Overall Study||2
8077692|NCT03725085|19917503|P1|COMPLETED|Overall Study||550
8077693|NCT03725085|19917503|P1|STARTED|Overall Study||552
8077700|NCT03724981|19917526|P2|NOT COMPLETED|Second Device||0
8077701|NCT03724981|19917527|P1|NOT COMPLETED|Second Device||0
8077702|NCT03724981|19917526|P2|COMPLETED|Second Device||155
8077703|NCT03724981|19917527|P1|COMPLETED|Second Device||155
8077704|NCT03724981|19917526|P2|STARTED|Second Device||155
8077705|NCT03724981|19917527|P1|STARTED|Second Device||155
8077706|NCT03724981|19917526|P2|NOT COMPLETED|First Device||1
8077707|NCT03724981|19917527|P1|NOT COMPLETED|First Device||1
8077708|NCT03724981|19917526|P2|COMPLETED|First Device||155
8077709|NCT03724981|19917527|P1|COMPLETED|First Device||155
8077710|NCT03724981|19917526|P2|STARTED|First Device||156
8077711|NCT03724981|19917527|P1|STARTED|First Device||156
8077712|NCT03724877|19917537|P2|NOT COMPLETED|Overall Study||0
8077713|NCT03724877|19917538|P1|NOT COMPLETED|Overall Study||0
8077714|NCT03724877|19917537|P2|COMPLETED|Overall Study||1932
8077715|NCT03724877|19917538|P1|COMPLETED|Overall Study||6921
8077716|NCT03724877|19917537|P2|STARTED|Overall Study||1932
8077717|NCT03724877|19917538|P1|STARTED|Overall Study||6921
8077718|NCT03724253|19917555|P5|NOT COMPLETED|Overall Study||0
8077719|NCT03724253|19917556|P4|NOT COMPLETED|Overall Study||0
8077720|NCT03724253|19917557|P3|NOT COMPLETED|Overall Study||0
8077721|NCT03724253|19917558|P2|NOT COMPLETED|Overall Study||0
8077722|NCT03724253|19917559|P1|NOT COMPLETED|Overall Study||0
8077723|NCT03724253|19917555|P5|COMPLETED|Overall Study||1
8077724|NCT03724253|19917556|P4|COMPLETED|Overall Study||3
8077725|NCT03724253|19917557|P3|COMPLETED|Overall Study||5
8077726|NCT03724253|19917558|P2|COMPLETED|Overall Study||5
8077727|NCT03724253|19917559|P1|COMPLETED|Overall Study||5
8077728|NCT03724253|19917555|P5|STARTED|Overall Study||1
8077729|NCT03724253|19917556|P4|STARTED|Overall Study||3
8077730|NCT03724253|19917557|P3|STARTED|Overall Study||5
8077731|NCT03724253|19917558|P2|STARTED|Overall Study||5
8077732|NCT03724253|19917559|P1|STARTED|Overall Study||5
8077733|NCT03723980|19917632|P2|NOT COMPLETED|Overall Study||5
8077734|NCT03723980|19917633|P1|NOT COMPLETED|Overall Study||7
8077735|NCT03723980|19917632|P2|COMPLETED|Overall Study||35
8077736|NCT03723980|19917633|P1|COMPLETED|Overall Study||33
8077737|NCT03723980|19917632|P2|STARTED|Overall Study||40
8077738|NCT03723980|19917633|P1|STARTED|Overall Study||40
8077739|NCT03723915|19917649|P1|NOT COMPLETED|Survival Follow-up||2
8077740|NCT03723915|19917649|P1|COMPLETED|Survival Follow-up||11
8077741|NCT03723915|19917649|P1|STARTED|Survival Follow-up||13
8077742|NCT03723915|19917649|P1|NOT COMPLETED|On Treatment||2
8077743|NCT03723915|19917649|P1|COMPLETED|On Treatment||13
8077744|NCT03723915|19917649|P1|Received First Dose of Study Drugs|On Treatment||13
8077745|NCT03723915|19917649|P1|Registered on Study|On Treatment||15
8077746|NCT03723915|19917649|P1|STARTED|On Treatment||15
8077747|NCT03723915|19917649|P1|NOT COMPLETED|Screening||2
8077748|NCT03723915|19917649|P1|COMPLETED|Screening||15
8077749|NCT03723915|19917649|P1|STARTED|Screening||17
8077750|NCT03723603|19917653|P1|NOT COMPLETED|Overall Study||3
8077751|NCT03723603|19917653|P1|COMPLETED|Overall Study||5
8077752|NCT03723603|19917653|P1|STARTED|Overall Study||8
8077753|NCT03722810|19917661|P2|NOT COMPLETED|Overall Study||4
8077754|NCT03722810|19917662|P1|NOT COMPLETED|Overall Study||7
8077755|NCT03722810|19917661|P2|COMPLETED|Overall Study||156
8077756|NCT03722810|19917662|P1|COMPLETED|Overall Study||150
8077757|NCT03722810|19917661|P2|STARTED|Overall Study||160
8077758|NCT03722810|19917662|P1|STARTED|Overall Study||157
8077759|NCT03722784|19917677|P2|NOT COMPLETED|Overall Study||2
8077760|NCT03722784|19917678|P1|NOT COMPLETED|Overall Study||2
8077761|NCT03722784|19917677|P2|COMPLETED|Overall Study||28
8077762|NCT03722784|19917678|P1|COMPLETED|Overall Study||56
8077763|NCT03722784|19917677|P2|STARTED|Overall Study||30
8077764|NCT03722784|19917678|P1|STARTED|Overall Study||58
8077765|NCT03722446|19917722|P2|NOT COMPLETED|Overall Study||2
8077766|NCT03722446|19917723|P1|NOT COMPLETED|Overall Study||15
8077767|NCT03722446|19917722|P2|COMPLETED|Overall Study||120
8077768|NCT03722446|19917723|P1|COMPLETED|Overall Study||120
8077769|NCT03722446|19917722|P2|STARTED|Overall Study||122
8077770|NCT03722446|19917723|P1|STARTED|Overall Study||135
8077771|NCT03722264|19917739|P1|NOT COMPLETED|Overall Study||3
8077772|NCT03722264|19917739|P1|COMPLETED|Overall Study||9
8077773|NCT03722264|19917739|P1|STARTED|Overall Study||12
8077774|NCT03722030|19917751|P2|NOT COMPLETED|Overall Study||0
8077775|NCT03722030|19917752|P1|NOT COMPLETED|Overall Study||1
8077776|NCT03722030|19917751|P2|COMPLETED|Overall Study||20
8077777|NCT03722030|19917752|P1|COMPLETED|Overall Study||19
8077778|NCT03722030|19917751|P2|STARTED|Overall Study||20
8077779|NCT03722030|19917752|P1|STARTED|Overall Study||20
8077780|NCT03721549|19917766|P2|NOT COMPLETED|Overall Study||0
8077781|NCT03721549|19917767|P1|NOT COMPLETED|Overall Study||1
8077782|NCT03721549|19917766|P2|COMPLETED|Overall Study||8
8077783|NCT03721549|19917767|P1|COMPLETED|Overall Study||7
8077784|NCT03721549|19917766|P2|STARTED|Overall Study||8
8077785|NCT03721549|19917767|P1|STARTED|Overall Study||8
8077786|NCT03720938|19917777|P2|NOT COMPLETED|Overall Study||623
8077787|NCT03720938|19917778|P1|NOT COMPLETED|Overall Study||189
8077788|NCT03720938|19917777|P2|COMPLETED|Overall Study||53
8077789|NCT03720938|19917778|P1|COMPLETED|Overall Study||53
8077790|NCT03720938|19917777|P2|STARTED|Overall Study||676
8077791|NCT03720938|19917778|P1|STARTED|Overall Study||242
8077792|NCT03720847|19917822|P2|NOT COMPLETED|Condition 2||0
8077793|NCT03720847|19917823|P1|NOT COMPLETED|Condition 2||0
8077794|NCT03720847|19917822|P2|COMPLETED|Condition 2||13
8077795|NCT03720847|19917823|P1|COMPLETED|Condition 2||14
8077796|NCT03720847|19917822|P2|STARTED|Condition 2||13
8077797|NCT03720847|19917823|P1|STARTED|Condition 2||14
8077798|NCT03720847|19917822|P2|NOT COMPLETED|Washout||2
8077799|NCT03720847|19917823|P1|NOT COMPLETED|Washout||1
8077800|NCT03720847|19917822|P2|COMPLETED|Washout||13
8077801|NCT03720847|19917823|P1|COMPLETED|Washout||14
8077802|NCT03720847|19917822|P2|STARTED|Washout||15
8077803|NCT03720847|19917823|P1|STARTED|Washout||15
8077804|NCT03720847|19917822|P2|NOT COMPLETED|Condition 1||0
8077805|NCT03720847|19917823|P1|NOT COMPLETED|Condition 1||0
8077806|NCT03720847|19917822|P2|COMPLETED|Condition 1||15
8077807|NCT03720847|19917823|P1|COMPLETED|Condition 1||15
8077808|NCT03720847|19917822|P2|STARTED|Condition 1||15
8077809|NCT03720847|19917823|P1|STARTED|Condition 1||15
8077810|NCT03720470|19917845|P6|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
8077811|NCT03720470|19917846|P5|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
8077812|NCT03720470|19917847|P4|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
8077813|NCT03720470|19917848|P3|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
8077814|NCT03720470|19917849|P2|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
8077815|NCT03720470|19917850|P1|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
8077816|NCT03720470|19917845|P6|COMPLETED|Treatment Period: Final 4 Weeks||218
8077817|NCT03720470|19917846|P5|COMPLETED|Treatment Period: Final 4 Weeks||204
8077818|NCT03720470|19917847|P4|COMPLETED|Treatment Period: Final 4 Weeks||210
8077819|NCT03720470|19917848|P3|COMPLETED|Treatment Period: Final 4 Weeks||55
8077820|NCT03720470|19917849|P2|COMPLETED|Treatment Period: Final 4 Weeks||58
8077821|NCT03720470|19917850|P1|COMPLETED|Treatment Period: Final 4 Weeks||0
8077822|NCT03720470|19917845|P6|Full Analysis Set|Treatment Period: Final 4 Weeks||223
8077823|NCT03720470|19917846|P5|Full Analysis Set|Treatment Period: Final 4 Weeks||208
8077824|NCT03720470|19917847|P4|Full Analysis Set|Treatment Period: Final 4 Weeks||217
8077825|NCT03720470|19917848|P3|Full Analysis Set|Treatment Period: Final 4 Weeks||57
8077826|NCT03720470|19917849|P2|Full Analysis Set|Treatment Period: Final 4 Weeks||60
8077827|NCT03720470|19917850|P1|Full Analysis Set|Treatment Period: Final 4 Weeks||0
8077828|NCT03720470|19917845|P6|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
8077829|NCT03720470|19917846|P5|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
8077830|NCT03720470|19917847|P4|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
8077831|NCT03720470|19917848|P3|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
8077832|NCT03720470|19917849|P2|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
8077833|NCT03720470|19917850|P1|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
8077834|NCT03720470|19917845|P6|STARTED|Treatment Period: Final 4 Weeks||223
8077835|NCT03720470|19917846|P5|STARTED|Treatment Period: Final 4 Weeks||208
8077836|NCT03720470|19917847|P4|STARTED|Treatment Period: Final 4 Weeks||217
8077837|NCT03720470|19917848|P3|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
8077838|NCT03720470|19917849|P2|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
8077839|NCT03720470|19917850|P1|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
8077840|NCT03720470|19917845|P6|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
8077841|NCT03720470|19917846|P5|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
8077842|NCT03720470|19917847|P4|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
8077843|NCT03720470|19917848|P3|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
8077844|NCT03720470|19917849|P2|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
8077845|NCT03720470|19917850|P1|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
8077846|NCT03720470|19917845|P6|COMPLETED|Treatment Period: First Part 16 Weeks||223
8077847|NCT03720470|19917846|P5|COMPLETED|Treatment Period: First Part 16 Weeks||208
8077848|NCT03720470|19917847|P4|COMPLETED|Treatment Period: First Part 16 Weeks||217
8077849|NCT03720470|19917848|P3|COMPLETED|Treatment Period: First Part 16 Weeks||0
8077850|NCT03720470|19917849|P2|COMPLETED|Treatment Period: First Part 16 Weeks||0
8077851|NCT03720470|19917850|P1|COMPLETED|Treatment Period: First Part 16 Weeks||117
8077852|NCT03720470|19917845|P6|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
8077853|NCT03720470|19917846|P5|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
8077854|NCT03720470|19917847|P4|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
8077855|NCT03720470|19917848|P3|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
8077856|NCT03720470|19917849|P2|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
8077857|NCT03720470|19917850|P1|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
8077858|NCT03720470|19917845|P6|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
8077859|NCT03720470|19917846|P5|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
8077860|NCT03720470|19917847|P4|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
8077861|NCT03720470|19917848|P3|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
8077862|NCT03720470|19917849|P2|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
8077863|NCT03720470|19917850|P1|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
8077864|NCT03720470|19917845|P6|STARTED|Treatment Period: First Part 16 Weeks||243
8077865|NCT03720470|19917846|P5|STARTED|Treatment Period: First Part 16 Weeks||226
8077866|NCT03720470|19917847|P4|STARTED|Treatment Period: First Part 16 Weeks||238
8077867|NCT03720470|19917848|P3|STARTED|Treatment Period: First Part 16 Weeks||0
8077868|NCT03720470|19917849|P2|STARTED|Treatment Period: First Part 16 Weeks||0
8077869|NCT03720470|19917850|P1|STARTED|Treatment Period: First Part 16 Weeks||131
8077870|NCT03720119|19917994|P1|NOT COMPLETED|Overall Study||9
8077871|NCT03720119|19917994|P1|COMPLETED|Overall Study||69
8077872|NCT03720119|19917994|P1|STARTED|Overall Study||78
8077873|NCT03719885|19918000|P1|NOT COMPLETED|Overall Study||20
8077874|NCT03719885|19918000|P1|COMPLETED|Overall Study||35
8077875|NCT03719885|19918000|P1|STARTED|Overall Study||55
8077876|NCT03719677|19918007|P1|NOT COMPLETED|Overall Study||0
8077877|NCT03719677|19918007|P1|COMPLETED|Overall Study||7
8077878|NCT03719677|19918007|P1|STARTED|Overall Study||7
8077879|NCT03719300|19918011|P1|NOT COMPLETED|Overall Study||0
8077880|NCT03719300|19918011|P1|COMPLETED|Overall Study||32
8077881|NCT03719300|19918011|P1|STARTED|Overall Study||32
8077882|NCT03718455|19918022|P1|NOT COMPLETED|Overall Study||0
8077883|NCT03718455|19918022|P1|COMPLETED|Overall Study||1
8077884|NCT03718455|19918022|P1|STARTED|Overall Study||1
8077885|NCT03718143|19918028|P3|NOT COMPLETED|Overall Study||1
8077886|NCT03718143|19918029|P2|NOT COMPLETED|Overall Study||2
8077887|NCT03718143|19918030|P1|NOT COMPLETED|Overall Study||3
8077888|NCT03718143|19918028|P3|COMPLETED|Overall Study||0
8077889|NCT03718143|19918029|P2|COMPLETED|Overall Study||0
8077890|NCT03718143|19918030|P1|COMPLETED|Overall Study||0
8077891|NCT03718143|19918028|P3|STARTED|Overall Study||1
8077892|NCT03718143|19918029|P2|STARTED|Overall Study||2
8077893|NCT03718143|19918030|P1|STARTED|Overall Study||3
8077894|NCT03718000|19918046|P2|NOT COMPLETED|Overall Study||5
8077895|NCT03718000|19918047|P1|NOT COMPLETED|Overall Study||2
8077896|NCT03718000|19918046|P2|COMPLETED|Overall Study||51
8077897|NCT03718000|19918047|P1|COMPLETED|Overall Study||53
8077898|NCT03718000|19918046|P2|STARTED|Overall Study||56
8077899|NCT03718000|19918047|P1|STARTED|Overall Study||55
8077900|NCT03717064|19918069|P1|NOT COMPLETED|Period 2||1
8077901|NCT03717064|19918069|P1|COMPLETED|Period 2||17
8077902|NCT03717064|19918069|P1|STARTED|Period 2||18
8077903|NCT03717064|19918069|P1|NOT COMPLETED|Period 1||0
8077904|NCT03717064|19918069|P1|COMPLETED|Period 1||18
8077905|NCT03717064|19918069|P1|STARTED|Period 1||18
8077906|NCT03716050|19918101|P8|NOT COMPLETED|Overall Study||2
8077907|NCT03716050|19918102|P7|NOT COMPLETED|Overall Study||0
8077908|NCT03716050|19918103|P6|NOT COMPLETED|Overall Study||0
8077909|NCT03716050|19918104|P5|NOT COMPLETED|Overall Study||0
8077910|NCT03716050|19918105|P4|NOT COMPLETED|Overall Study||2
8077911|NCT03716050|19918106|P3|NOT COMPLETED|Overall Study||1
8077912|NCT03716050|19918107|P2|NOT COMPLETED|Overall Study||0
8077913|NCT03716050|19918108|P1|NOT COMPLETED|Overall Study||0
8077914|NCT03716050|19918101|P8|COMPLETED|Overall Study||0
8077915|NCT03716050|19918102|P7|COMPLETED|Overall Study||4
8077916|NCT03716050|19918103|P6|COMPLETED|Overall Study||0
8077917|NCT03716050|19918104|P5|COMPLETED|Overall Study||1
8077918|NCT03716050|19918105|P4|COMPLETED|Overall Study||1
8077919|NCT03716050|19918106|P3|COMPLETED|Overall Study||0
8077920|NCT03716050|19918107|P2|COMPLETED|Overall Study||4
8077921|NCT03716050|19918108|P1|COMPLETED|Overall Study||2
8077922|NCT03716050|19918101|P8|STARTED|Overall Study||2
8077923|NCT03716050|19918102|P7|STARTED|Overall Study||4
8077924|NCT03716050|19918103|P6|STARTED|Overall Study||0
8077925|NCT03716050|19918104|P5|STARTED|Overall Study||1
8077926|NCT03716050|19918105|P4|STARTED|Overall Study||3
8077927|NCT03716050|19918106|P3|STARTED|Overall Study||1
8077928|NCT03716050|19918107|P2|STARTED|Overall Study||4
8077929|NCT03716050|19918108|P1|STARTED|Overall Study||2
8077930|NCT03716024|19918162|P2|NOT COMPLETED|Overall Study||18
8077931|NCT03716024|19918163|P1|NOT COMPLETED|Overall Study||11
8077932|NCT03716024|19918162|P2|COMPLETED|Overall Study||98
8077933|NCT03716024|19918163|P1|COMPLETED|Overall Study||107
8077934|NCT03716024|19918162|P2|STARTED|Overall Study||116
8077935|NCT03716024|19918163|P1|STARTED|Overall Study||118
8077936|NCT03715803|19918177|P2|NOT COMPLETED|Overall Study||0
8077937|NCT03715803|19918178|P1|NOT COMPLETED|Overall Study||0
8077938|NCT03715803|19918177|P2|COMPLETED|Overall Study||126
8077939|NCT03715803|19918178|P1|COMPLETED|Overall Study||91
8077940|NCT03715803|19918177|P2|STARTED|Overall Study||126
8077941|NCT03715803|19918178|P1|STARTED|Overall Study||91
8077942|NCT03715530|19918197|P3|NOT COMPLETED|Overall Study||2
8077943|NCT03715530|19918198|P2|NOT COMPLETED|Overall Study||1
8077944|NCT03715530|19918199|P1|NOT COMPLETED|Overall Study||3
8077945|NCT03715530|19918197|P3|COMPLETED|Overall Study||85
8077946|NCT03715530|19918198|P2|COMPLETED|Overall Study||41
8077947|NCT03715530|19918199|P1|COMPLETED|Overall Study||30
8077948|NCT03715530|19918197|P3|STARTED|Overall Study||87
8077949|NCT03715530|19918198|P2|STARTED|Overall Study||42
8077950|NCT03715530|19918199|P1|STARTED|Overall Study||33
8077951|NCT03715452|19918207|P1|NOT COMPLETED|Overall Study||0
8077952|NCT03715452|19918207|P1|COMPLETED|Overall Study||114
8077953|NCT03715452|19918207|P1|STARTED|Overall Study||114
8077954|NCT03715426|19918214|P2|NOT COMPLETED|Overall Study||25
8077955|NCT03715426|19918215|P1|NOT COMPLETED|Overall Study||21
8077956|NCT03715426|19918214|P2|COMPLETED|Overall Study||92
8077957|NCT03715426|19918215|P1|COMPLETED|Overall Study||112
8077958|NCT03715426|19918214|P2|4-Month Follow-Up Survey|Overall Study||92
8077959|NCT03715426|19918215|P1|4-Month Follow-Up Survey|Overall Study||112
8077960|NCT03715426|19918214|P2|1-Month Follow-Up Survey|Overall Study||97
8077961|NCT03715426|19918215|P1|1-Month Follow-Up Survey|Overall Study||113
8077962|NCT03715426|19918214|P2|STARTED|Overall Study||117
8077963|NCT03715426|19918215|P1|STARTED|Overall Study||133
8077964|NCT03714672|19918259|P4|NOT COMPLETED|Overall Study||1
8077965|NCT03714672|19918260|P3|NOT COMPLETED|Overall Study||4
8077966|NCT03714672|19918261|P2|NOT COMPLETED|Overall Study||4
8077967|NCT03714672|19918262|P1|NOT COMPLETED|Overall Study||2
8077968|NCT03714672|19918259|P4|COMPLETED|Overall Study||207
8077969|NCT03714672|19918260|P3|COMPLETED|Overall Study||202
8077970|NCT03714672|19918261|P2|COMPLETED|Overall Study||202
8077971|NCT03714672|19918262|P1|COMPLETED|Overall Study||207
8077972|NCT03714672|19918259|P4|Safety Set|Overall Study||207
8077973|NCT03714672|19918260|P3|Safety Set|Overall Study||206
8077974|NCT03714672|19918261|P2|Safety Set|Overall Study||205
8077975|NCT03714672|19918262|P1|Safety Set|Overall Study||208
8077976|NCT03714672|19918259|P4|STARTED|Overall Study||208
8077977|NCT03714672|19918260|P3|STARTED|Overall Study||206
8077978|NCT03714672|19918261|P2|STARTED|Overall Study||206
8077979|NCT03714672|19918262|P1|STARTED|Overall Study||209
8077980|NCT03714659|19918308|P1|NOT COMPLETED|Overall Study||1
8077981|NCT03714659|19918308|P1|COMPLETED|Overall Study||19
8077982|NCT03714659|19918308|P1|STARTED|Overall Study||20
8077983|NCT03714256|19918315|P2|NOT COMPLETED|Overall Study||0
8077984|NCT03714256|19918316|P1|NOT COMPLETED|Overall Study||0
8077985|NCT03714256|19918315|P2|COMPLETED|Overall Study||19
8077986|NCT03714256|19918316|P1|COMPLETED|Overall Study||14
8077987|NCT03714256|19918315|P2|STARTED|Overall Study||19
8077988|NCT03714256|19918316|P1|STARTED|Overall Study||14
8077989|NCT03714022|19918324|P2|NOT COMPLETED|Overall Study||3
8077990|NCT03714022|19918325|P1|NOT COMPLETED|Overall Study||4
8077991|NCT03714022|19918324|P2|COMPLETED|Overall Study||67
8077992|NCT03714022|19918325|P1|COMPLETED|Overall Study||66
8077993|NCT03714022|19918324|P2|STARTED|Overall Study||70
8077994|NCT03714022|19918325|P1|STARTED|Overall Study||70
8077995|NCT03712917|19918378|P3|NOT COMPLETED|Overall Study||9
8077996|NCT03712917|19918379|P2|NOT COMPLETED|Overall Study||8
8077997|NCT03712917|19918380|P1|NOT COMPLETED|Overall Study||9
8077998|NCT03712917|19918378|P3|COMPLETED|Overall Study||31
8077999|NCT03712917|19918379|P2|COMPLETED|Overall Study||32
8078000|NCT03712917|19918380|P1|COMPLETED|Overall Study||31
8078001|NCT03712917|19918378|P3|STARTED|Overall Study||40
8078002|NCT03712917|19918379|P2|STARTED|Overall Study||40
8078003|NCT03712917|19918380|P1|STARTED|Overall Study||40
8078004|NCT03710577|19918393|P2|NOT COMPLETED|Second Intervention||0
8078005|NCT03710577|19918394|P1|NOT COMPLETED|Second Intervention||0
8078006|NCT03710577|19918393|P2|COMPLETED|Second Intervention||4
8078007|NCT03710577|19918394|P1|COMPLETED|Second Intervention||8
8078008|NCT03710577|19918393|P2|STARTED|Second Intervention||4
8078009|NCT03710577|19918394|P1|STARTED|Second Intervention||8
8078010|NCT03710577|19918393|P2|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
8078011|NCT03710577|19918394|P1|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
8078012|NCT03710577|19918393|P2|COMPLETED|Time Between Sessions (2-5 Days)||4
8078013|NCT03710577|19918394|P1|COMPLETED|Time Between Sessions (2-5 Days)||8
8078014|NCT03710577|19918393|P2|STARTED|Time Between Sessions (2-5 Days)||4
8078015|NCT03710577|19918394|P1|STARTED|Time Between Sessions (2-5 Days)||8
8078016|NCT03710577|19918393|P2|NOT COMPLETED|First Intervention||0
8078017|NCT03710577|19918394|P1|NOT COMPLETED|First Intervention||0
8078018|NCT03710577|19918393|P2|COMPLETED|First Intervention||4
8078019|NCT03710577|19918394|P1|COMPLETED|First Intervention||8
8078020|NCT03710577|19918393|P2|STARTED|First Intervention||4
8078021|NCT03710577|19918394|P1|STARTED|First Intervention||8
8078022|NCT03710083|19918408|P1|NOT COMPLETED|Overall Study||3
8078023|NCT03710083|19918408|P1|COMPLETED|Overall Study||63
8078024|NCT03710083|19918408|P1|STARTED|Overall Study||66
8078025|NCT03709823|19918421|P6|NOT COMPLETED|Overall Study||0
8078026|NCT03709823|19918422|P5|NOT COMPLETED|Overall Study||1
8078027|NCT03709823|19918423|P4|NOT COMPLETED|Overall Study||2
8078028|NCT03709823|19918424|P3|NOT COMPLETED|Overall Study||3
8078029|NCT03709823|19918425|P2|NOT COMPLETED|Overall Study||5
8078030|NCT03709823|19918426|P1|NOT COMPLETED|Overall Study||3
8078031|NCT03709823|19918421|P6|COMPLETED|Overall Study||26
8078032|NCT03709823|19918422|P5|COMPLETED|Overall Study||49
8078033|NCT03709823|19918423|P4|COMPLETED|Overall Study||50
8078034|NCT03709823|19918424|P3|COMPLETED|Overall Study||22
8078035|NCT03709823|19918425|P2|COMPLETED|Overall Study||45
8078036|NCT03709823|19918426|P1|COMPLETED|Overall Study||48
8078037|NCT03709823|19918421|P6|STARTED|Overall Study||26
8078038|NCT03709823|19918422|P5|STARTED|Overall Study||50
8078039|NCT03709823|19918423|P4|STARTED|Overall Study||52
8078040|NCT03709823|19918424|P3|STARTED|Overall Study||25
8078041|NCT03709823|19918425|P2|STARTED|Overall Study||50
8078042|NCT03709823|19918426|P1|STARTED|Overall Study||51
8078043|NCT03709810|19918446|P2|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
8078044|NCT03709810|19918447|P1|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
8078045|NCT03709810|19918446|P2|COMPLETED|Treatment Period 2 (Visit 3)||24
8078046|NCT03709810|19918447|P1|COMPLETED|Treatment Period 2 (Visit 3)||24
8078047|NCT03709810|19918446|P2|STARTED|Treatment Period 2 (Visit 3)||24
8078048|NCT03709810|19918447|P1|STARTED|Treatment Period 2 (Visit 3)||24
8078049|NCT03709810|19918446|P2|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
8078050|NCT03709810|19918447|P1|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
8078051|NCT03709810|19918446|P2|COMPLETED|Treatment Period 1 (Visit 2)||24
8078052|NCT03709810|19918447|P1|COMPLETED|Treatment Period 1 (Visit 2)||24
8078053|NCT03709810|19918446|P2|STARTED|Treatment Period 1 (Visit 2)||24
8078054|NCT03709810|19918447|P1|STARTED|Treatment Period 1 (Visit 2)||24
8078055|NCT03709654|19918463|P2|NOT COMPLETED|Overall Study||2
8078056|NCT03709654|19918464|P1|NOT COMPLETED|Overall Study||3
8078057|NCT03709654|19918463|P2|COMPLETED|Overall Study||11
8078058|NCT03709654|19918464|P1|COMPLETED|Overall Study||20
8078059|NCT03709654|19918463|P2|STARTED|Overall Study||13
8078060|NCT03709654|19918464|P1|STARTED|Overall Study||23
8078061|NCT03709602|19918493|P3|NOT COMPLETED|Overall Study||0
8078062|NCT03709602|19918494|P2|NOT COMPLETED|Overall Study||0
8078063|NCT03709602|19918495|P1|NOT COMPLETED|Overall Study||0
8078064|NCT03709602|19918493|P3|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
8078065|NCT03709602|19918494|P2|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
8078066|NCT03709602|19918495|P1|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
8078067|NCT03709602|19918493|P3|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
8078068|NCT03709602|19918494|P2|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
8078069|NCT03709602|19918495|P1|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
8078070|NCT03709576|19918501|P1|NOT COMPLETED|Overall Study||1
8078071|NCT03709576|19918501|P1|COMPLETED|Overall Study||2
8078072|NCT03709576|19918501|P1|STARTED|Overall Study||3
8078073|NCT03708770|19918513|P1|NOT COMPLETED|Overall Study||10
8078074|NCT03708770|19918513|P1|COMPLETED|Overall Study||22
8078075|NCT03708770|19918513|P1|STARTED|Overall Study||32
8078076|NCT03708744|19918524|P4|NOT COMPLETED|Overall Study||0
8078077|NCT03708744|19918525|P3|NOT COMPLETED|Overall Study||1
8078078|NCT03708744|19918526|P2|NOT COMPLETED|Overall Study||0
8078079|NCT03708744|19918527|P1|NOT COMPLETED|Overall Study||0
8078080|NCT03708744|19918524|P4|COMPLETED|Overall Study||6
8078081|NCT03708744|19918525|P3|COMPLETED|Overall Study||4
8078082|NCT03708744|19918526|P2|COMPLETED|Overall Study||6
8078083|NCT03708744|19918527|P1|COMPLETED|Overall Study||7
8078084|NCT03708744|19918524|P4|STARTED|Overall Study||6
8078085|NCT03708744|19918525|P3|STARTED|Overall Study||5
8078086|NCT03708744|19918526|P2|STARTED|Overall Study||6
8078087|NCT03708744|19918527|P1|STARTED|Overall Study||7
8078088|NCT03708562|19918545|P1|NOT COMPLETED|Overall Study||12
8078089|NCT03708562|19918545|P1|COMPLETED|Overall Study||12
8078090|NCT03708562|19918545|P1|STARTED|Overall Study||24
8078091|NCT03708211|19918561|P2|NOT COMPLETED|Overall Study||8
8078092|NCT03708211|19918562|P1|NOT COMPLETED|Overall Study||12
8078093|NCT03708211|19918561|P2|COMPLETED|Overall Study||0
8078094|NCT03708211|19918562|P1|COMPLETED|Overall Study||0
8078095|NCT03708211|19918561|P2|STARTED|Overall Study||8
8078096|NCT03708211|19918562|P1|STARTED|Overall Study||12
8078097|NCT03707912|19918594|P2|NOT COMPLETED|Overall Study||0
8078098|NCT03707912|19918595|P1|NOT COMPLETED|Overall Study||1
8078099|NCT03707912|19918594|P2|COMPLETED|Overall Study||100
8078100|NCT03707912|19918595|P1|COMPLETED|Overall Study||103
8078101|NCT03707912|19918594|P2|STARTED|Overall Study||100
8078102|NCT03707912|19918595|P1|STARTED|Overall Study||104
8078103|NCT03707821|19918615|P2|NOT COMPLETED|Overall Study||1
8078104|NCT03707821|19918616|P1|NOT COMPLETED|Overall Study||2
8078105|NCT03707821|19918615|P2|COMPLETED|Overall Study||125
8078106|NCT03707821|19918616|P1|COMPLETED|Overall Study||123
8078107|NCT03707821|19918615|P2|STARTED|Overall Study||126
8078108|NCT03707821|19918616|P1|STARTED|Overall Study||125
8078109|NCT03707587|19918636|P2|NOT COMPLETED|Overall Study||1
8078110|NCT03707587|19918637|P1|NOT COMPLETED|Overall Study||0
8078111|NCT03707587|19918636|P2|COMPLETED|Overall Study||1
8078112|NCT03707587|19918637|P1|COMPLETED|Overall Study||7
8078113|NCT03707587|19918636|P2|STARTED|Overall Study||2
8078114|NCT03707587|19918637|P1|STARTED|Overall Study||7
8078115|NCT03707522|19918653|P4|NOT COMPLETED|Overall Study||36
8078116|NCT03707522|19918654|P3|NOT COMPLETED|Overall Study||41
8078117|NCT03707522|19918655|P2|NOT COMPLETED|Overall Study||27
8078118|NCT03707522|19918656|P1|NOT COMPLETED|Overall Study||24
8078119|NCT03707522|19918653|P4|COMPLETED|Overall Study||7
8078120|NCT03707522|19918654|P3|COMPLETED|Overall Study||11
8078121|NCT03707522|19918655|P2|COMPLETED|Overall Study||9
8078122|NCT03707522|19918656|P1|COMPLETED|Overall Study||7
8078123|NCT03707522|19918653|P4|STARTED|Overall Study||43
8078124|NCT03707522|19918654|P3|STARTED|Overall Study||52
8078125|NCT03707522|19918655|P2|STARTED|Overall Study||36
8078126|NCT03707522|19918656|P1|STARTED|Overall Study||31
8078127|NCT03706469|19918686|P4|NOT COMPLETED|Overall Study||0
8078128|NCT03706469|19918687|P3|NOT COMPLETED|Overall Study||0
8078129|NCT03706469|19918688|P2|NOT COMPLETED|Overall Study||0
8078130|NCT03706469|19918689|P1|NOT COMPLETED|Overall Study||0
8078131|NCT03706469|19918686|P4|COMPLETED|Overall Study||4
8078132|NCT03706469|19918687|P3|COMPLETED|Overall Study||4
8078133|NCT03706469|19918688|P2|COMPLETED|Overall Study||4
8078134|NCT03706469|19918689|P1|COMPLETED|Overall Study||4
8078135|NCT03706469|19918686|P4|STARTED|Overall Study||4
8078136|NCT03706469|19918687|P3|STARTED|Overall Study||4
8078137|NCT03706469|19918688|P2|STARTED|Overall Study||4
8078138|NCT03706469|19918689|P1|STARTED|Overall Study||4
8078139|NCT03706313|19918718|P2|NOT COMPLETED|Overall Study||0
8078140|NCT03706313|19918719|P1|NOT COMPLETED|Overall Study||0
8078141|NCT03706313|19918718|P2|COMPLETED|Overall Study||20
8078142|NCT03706313|19918719|P1|COMPLETED|Overall Study||20
8078143|NCT03706313|19918718|P2|STARTED|Overall Study||20
8078144|NCT03706313|19918719|P1|STARTED|Overall Study||20
8078145|NCT03705793|19918745|P2|NOT COMPLETED|Overall Study||5
8078146|NCT03705793|19918746|P1|NOT COMPLETED|Overall Study||5
8078147|NCT03705793|19918745|P2|COMPLETED|Overall Study||21
8078148|NCT03705793|19918746|P1|COMPLETED|Overall Study||22
8078149|NCT03705793|19918745|P2|STARTED|Overall Study||26
8078150|NCT03705793|19918746|P1|STARTED|Overall Study||27
8078151|NCT03705494|19918758|P2|NOT COMPLETED|Overall Study||3
8078152|NCT03705494|19918759|P1|NOT COMPLETED|Overall Study||7
8078153|NCT03705494|19918758|P2|COMPLETED|Overall Study||7
8078154|NCT03705494|19918759|P1|COMPLETED|Overall Study||3
8078155|NCT03705494|19918758|P2|STARTED|Overall Study||10
8078156|NCT03705494|19918759|P1|STARTED|Overall Study||10
8078157|NCT03705481|19918773|P1|NOT COMPLETED|Overall Study||0
8078158|NCT03705481|19918773|P1|COMPLETED|Overall Study||5
8078159|NCT03705481|19918773|P1|STARTED|Overall Study||5
8078160|NCT03704467|19918780|P1|NOT COMPLETED|Overall Study||0
8078161|NCT03704467|19918780|P1|COMPLETED|Overall Study||3
8078162|NCT03704467|19918780|P1|STARTED|Overall Study||3
8078163|NCT03704376|19918800|P2|NOT COMPLETED|Overall Study||4
8078164|NCT03704376|19918801|P1|NOT COMPLETED|Overall Study||4
8078165|NCT03704376|19918800|P2|COMPLETED|Overall Study||40
8078166|NCT03704376|19918801|P1|COMPLETED|Overall Study||38
8078167|NCT03704376|19918800|P2|STARTED|Overall Study||44
8078168|NCT03704376|19918801|P1|STARTED|Overall Study||42
8078169|NCT03704194|19918845|P2|NOT COMPLETED|Overall Study||1
8078170|NCT03704194|19918846|P1|NOT COMPLETED|Overall Study||0
8078171|NCT03704194|19918845|P2|COMPLETED|Overall Study||8
8078172|NCT03704194|19918846|P1|COMPLETED|Overall Study||8
8078173|NCT03704194|19918845|P2|STARTED|Overall Study||9
8078174|NCT03704194|19918846|P1|STARTED|Overall Study||8
8078175|NCT03703466|19918874|P3|NOT COMPLETED|Overall Study||2
8078176|NCT03703466|19918875|P2|NOT COMPLETED|Overall Study||6
8078177|NCT03703466|19918876|P1|NOT COMPLETED|Overall Study||4
8078178|NCT03703466|19918874|P3|COMPLETED|Overall Study||22
8078179|NCT03703466|19918875|P2|COMPLETED|Overall Study||18
8078180|NCT03703466|19918876|P1|COMPLETED|Overall Study||20
8078181|NCT03703466|19918874|P3|Received at Least One Dose of Study Drug|Overall Study||24
8078182|NCT03703466|19918875|P2|Received at Least One Dose of Study Drug|Overall Study||23
8078183|NCT03703466|19918876|P1|Received at Least One Dose of Study Drug|Overall Study||24
8078184|NCT03703466|19918874|P3|STARTED|Overall Study||24
8078185|NCT03703466|19918875|P2|STARTED|Overall Study||24
8078186|NCT03703466|19918876|P1|STARTED|Overall Study||24
8078187|NCT03703336|19918910|P2|NOT COMPLETED|Overall Study||14
8078188|NCT03703336|19918911|P1|NOT COMPLETED|Overall Study||38
8078189|NCT03703336|19918910|P2|COMPLETED|Overall Study||259
8078190|NCT03703336|19918911|P1|COMPLETED|Overall Study||514
8078191|NCT03703336|19918910|P2|Safety Population|Overall Study||274
8078192|NCT03703336|19918911|P1|Safety Population|Overall Study||551
8078193|NCT03703336|19918910|P2|Received Dose 2|Overall Study||263
8078194|NCT03703336|19918911|P1|Received Dose 2|Overall Study||518
8078195|NCT03703336|19918910|P2|Received Dose 1|Overall Study||273
8078196|NCT03703336|19918911|P1|Received Dose 1|Overall Study||552
8078197|NCT03703336|19918910|P2|STARTED|Overall Study||273
8078198|NCT03703336|19918911|P1|STARTED|Overall Study||552
8078199|NCT03702608|19918929|P1|NOT COMPLETED|Overall Study||0
8078200|NCT03702608|19918929|P1|COMPLETED|Overall Study||50
8078201|NCT03702608|19918929|P1|STARTED|Overall Study||50
8078202|NCT03702166|19918934|P1|NOT COMPLETED|Overall Study||2
8078203|NCT03702166|19918934|P1|COMPLETED|Overall Study||8
8078204|NCT03702166|19918934|P1|STARTED|Overall Study||10
8078205|NCT03701061|19918945|P2|NOT COMPLETED|Overall Study||0
8078206|NCT03701061|19918946|P1|NOT COMPLETED|Overall Study||0
8078207|NCT03701061|19918945|P2|COMPLETED|Overall Study||3
8078208|NCT03701061|19918946|P1|COMPLETED|Overall Study||9
8078209|NCT03701061|19918945|P2|STARTED|Overall Study||3
8078210|NCT03701061|19918946|P1|STARTED|Overall Study||9
8078211|NCT03700671|19918960|P2|NOT COMPLETED|Overall Study||2
8078212|NCT03700671|19918961|P1|NOT COMPLETED|Overall Study||1
8078213|NCT03700671|19918960|P2|COMPLETED|Overall Study||19
8078214|NCT03700671|19918961|P1|COMPLETED|Overall Study||20
8078215|NCT03700671|19918960|P2|STARTED|Overall Study||21
8078216|NCT03700671|19918961|P1|STARTED|Overall Study||21
8078217|NCT03700385|19918973|P1|NOT COMPLETED|Overall Study||1
8078218|NCT03700385|19918973|P1|COMPLETED|Overall Study||39
8078219|NCT03700385|19918973|P1|STARTED|Overall Study||40
8078220|NCT03698591|19918980|P2|NOT COMPLETED|Overall Study||5
8078221|NCT03698591|19918981|P1|NOT COMPLETED|Overall Study||5
8078222|NCT03698591|19918980|P2|COMPLETED|Overall Study||15
8078223|NCT03698591|19918981|P1|COMPLETED|Overall Study||15
8078224|NCT03698591|19918980|P2|STARTED|Overall Study||20
8078225|NCT03698591|19918981|P1|STARTED|Overall Study||20
8078226|NCT03698331|19918995|P2|NOT COMPLETED|Overall Study||6
8078227|NCT03698331|19918996|P1|NOT COMPLETED|Overall Study||4
8078228|NCT03698331|19918995|P2|COMPLETED|Overall Study||39
8078229|NCT03698331|19918996|P1|COMPLETED|Overall Study||40
8078230|NCT03698331|19918995|P2|Entered Withdrawal Period|Overall Study||39
8078231|NCT03698331|19918996|P1|Entered Withdrawal Period|Overall Study||42
8078232|NCT03698331|19918995|P2|STARTED|Overall Study||45
8078233|NCT03698331|19918996|P1|STARTED|Overall Study||44
8078234|NCT03698279|19919018|P6|NOT COMPLETED|Overall Study||0
8078235|NCT03698279|19919019|P5|NOT COMPLETED|Overall Study||0
8078236|NCT03698279|19919020|P4|NOT COMPLETED|Overall Study||6
8078237|NCT03698279|19919021|P3|NOT COMPLETED|Overall Study||7
8078238|NCT03698279|19919022|P2|NOT COMPLETED|Overall Study||2
8078239|NCT03698279|19919023|P1|NOT COMPLETED|Overall Study||5
8078240|NCT03698279|19919018|P6|COMPLETED|Overall Study||13
8078241|NCT03698279|19919019|P5|COMPLETED|Overall Study||13
8078242|NCT03698279|19919020|P4|COMPLETED|Overall Study||228
8078243|NCT03698279|19919021|P3|COMPLETED|Overall Study||152
8078244|NCT03698279|19919022|P2|COMPLETED|Overall Study||120
8078245|NCT03698279|19919023|P1|COMPLETED|Overall Study||119
8078246|NCT03698279|19919018|P6|Safety Analysis Set Population (SafAS)|Overall Study||13
8078247|NCT03698279|19919019|P5|Safety Analysis Set Population (SafAS)|Overall Study||13
8078248|NCT03698279|19919020|P4|Safety Analysis Set Population (SafAS)|Overall Study||234
8078249|NCT03698279|19919021|P3|Safety Analysis Set Population (SafAS)|Overall Study||158
8078250|NCT03698279|19919022|P2|Safety Analysis Set Population (SafAS)|Overall Study||121
8078251|NCT03698279|19919023|P1|Safety Analysis Set Population (SafAS)|Overall Study||122
8078252|NCT03698279|19919018|P6|STARTED|Overall Study||13
8078253|NCT03698279|19919019|P5|STARTED|Overall Study||13
8078254|NCT03698279|19919020|P4|STARTED|Overall Study||234
8078255|NCT03698279|19919021|P3|STARTED|Overall Study||159
8078256|NCT03698279|19919022|P2|STARTED|Overall Study||122
8078257|NCT03698279|19919023|P1|STARTED|Overall Study||124
8078258|NCT03697993|19919119|P2|NOT COMPLETED|Overall Study||5
8078259|NCT03697993|19919120|P1|NOT COMPLETED|Overall Study||10
8078260|NCT03697993|19919119|P2|COMPLETED|Overall Study||25
8078261|NCT03697993|19919120|P1|COMPLETED|Overall Study||22
8078262|NCT03697993|19919119|P2|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
8078263|NCT03697993|19919120|P1|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
8078264|NCT03697993|19919119|P2|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
8078265|NCT03697993|19919120|P1|Switched Treatment|Overall Study||0
8078266|NCT03697993|19919119|P2|Initiated Treatment|Overall Study||28
8078267|NCT03697993|19919120|P1|Initiated Treatment|Overall Study||30
8078268|NCT03697993|19919119|P2|STARTED|Overall Study||30
8078269|NCT03697993|19919120|P1|STARTED|Overall Study||32
8078270|NCT03697551|19919139|P1|NOT COMPLETED|Overall Study||0
8078271|NCT03697551|19919139|P1|COMPLETED|Overall Study||4
8078272|NCT03697551|19919139|P1|STARTED|Overall Study||4
8078273|NCT03697252|19919146|P2|NOT COMPLETED|Overall Study||19
8078274|NCT03697252|19919147|P1|NOT COMPLETED|Overall Study||18
8078275|NCT03697252|19919146|P2|COMPLETED|Overall Study||73
8078276|NCT03697252|19919147|P1|COMPLETED|Overall Study||72
8078277|NCT03697252|19919146|P2|STARTED|Overall Study||92
8078278|NCT03697252|19919147|P1|STARTED|Overall Study||90
8078279|NCT03697122|19919163|P1|NOT COMPLETED|Overall Study||0
8078280|NCT03697122|19919163|P1|COMPLETED|Overall Study||14
8078281|NCT03697122|19919163|P1|STARTED|Overall Study||14
8078282|NCT03697083|19919178|P3|NOT COMPLETED|Overall Study||0
8078283|NCT03697083|19919179|P2|NOT COMPLETED|Overall Study||10
8078284|NCT03697083|19919180|P1|NOT COMPLETED|Overall Study||0
8078285|NCT03697083|19919178|P3|COMPLETED|Overall Study||255
8078286|NCT03697083|19919179|P2|COMPLETED|Overall Study||250
8078287|NCT03697083|19919180|P1|COMPLETED|Overall Study||262
8078288|NCT03697083|19919178|P3|STARTED|Overall Study||255
8078289|NCT03697083|19919179|P2|STARTED|Overall Study||260
8078290|NCT03697083|19919180|P1|STARTED|Overall Study||262
8078291|NCT03696589|19919188|P1|NOT COMPLETED|Overall Study||1
8078292|NCT03696589|19919188|P1|COMPLETED|Overall Study||12
8078293|NCT03696589|19919188|P1|STARTED|Overall Study||13
8078294|NCT03695913|19919211|P1|NOT COMPLETED|Overall Study||0
8078295|NCT03695913|19919211|P1|COMPLETED|Overall Study||15
8078296|NCT03695913|19919211|P1|STARTED|Overall Study||15
8078297|NCT03695094|19919228|P2|NOT COMPLETED|Overall Study||1
8078298|NCT03695094|19919229|P1|NOT COMPLETED|Overall Study||2
8078299|NCT03695094|19919228|P2|COMPLETED|Overall Study||14
8078300|NCT03695094|19919229|P1|COMPLETED|Overall Study||14
8078301|NCT03695094|19919228|P2|STARTED|Overall Study||15
8078302|NCT03695094|19919229|P1|STARTED|Overall Study||16
8078303|NCT03694925|19919265|P3|NOT COMPLETED|Overall Study||0
8078304|NCT03694925|19919266|P2|NOT COMPLETED|Overall Study||3
8078305|NCT03694925|19919267|P1|NOT COMPLETED|Overall Study||0
8078306|NCT03694925|19919265|P3|COMPLETED|Overall Study||53
8078307|NCT03694925|19919266|P2|COMPLETED|Overall Study||70
8078308|NCT03694925|19919267|P1|COMPLETED|Overall Study||30
8078309|NCT03694925|19919265|P3|STARTED|Overall Study||53
8078310|NCT03694925|19919266|P2|STARTED|Overall Study||73
8078311|NCT03694925|19919267|P1|STARTED|Overall Study||30
8078312|NCT03694821|19919283|P3|NOT COMPLETED|Overall Study||4
8078313|NCT03694821|19919284|P2|NOT COMPLETED|Overall Study||8
8078314|NCT03694821|19919285|P1|NOT COMPLETED|Overall Study||4
8078315|NCT03694821|19919283|P3|COMPLETED|Overall Study||2
8078316|NCT03694821|19919284|P2|COMPLETED|Overall Study||0
8078317|NCT03694821|19919285|P1|COMPLETED|Overall Study||0
8078318|NCT03694821|19919283|P3|STARTED|Overall Study||6
8078319|NCT03694821|19919284|P2|STARTED|Overall Study||8
8078320|NCT03694821|19919285|P1|STARTED|Overall Study||4
8078321|NCT03693989|19919316|P2|NOT COMPLETED|Overall Study||4
8078322|NCT03693989|19919317|P1|NOT COMPLETED|Overall Study||3
8078323|NCT03693989|19919316|P2|COMPLETED|Overall Study||86
8078324|NCT03693989|19919317|P1|COMPLETED|Overall Study||85
8078325|NCT03693989|19919316|P2|STARTED|Overall Study||90
8078326|NCT03693989|19919317|P1|STARTED|Overall Study||88
8078327|NCT03693950|19919341|P2|NOT COMPLETED|Overall Study||0
8078328|NCT03693950|19919342|P1|NOT COMPLETED|Overall Study||1
8078329|NCT03693950|19919341|P2|COMPLETED|Overall Study||28
8078330|NCT03693950|19919342|P1|COMPLETED|Overall Study||28
8078331|NCT03693950|19919341|P2|STARTED|Overall Study||28
8078332|NCT03693950|19919342|P1|STARTED|Overall Study||29
8078333|NCT03693937|19919360|P1|NOT COMPLETED|Overall Study||0
8078334|NCT03693937|19919360|P1|COMPLETED|Overall Study||776
8078335|NCT03693937|19919360|P1|STARTED|Overall Study||776
8078336|NCT03693625|19919366|P2|NOT COMPLETED|Overall Study||8
8078337|NCT03693625|19919367|P1|NOT COMPLETED|Overall Study||23
8078338|NCT03693625|19919366|P2|COMPLETED|Overall Study||0
8078339|NCT03693625|19919367|P1|COMPLETED|Overall Study||0
8078340|NCT03693625|19919366|P2|STARTED|Overall Study||8
8078341|NCT03693625|19919367|P1|STARTED|Overall Study||23
8078342|NCT03692676|19919379|P4|NOT COMPLETED|Overall Study||3586
8078343|NCT03692676|19919380|P3|NOT COMPLETED|Overall Study||38344
8078344|NCT03692676|19919381|P2|NOT COMPLETED|Overall Study||47438
8078345|NCT03692676|19919382|P1|NOT COMPLETED|Overall Study||9425
8078346|NCT03692676|19919379|P4|COMPLETED|Overall Study||1561
8078347|NCT03692676|19919380|P3|COMPLETED|Overall Study||11135
8078348|NCT03692676|19919381|P2|COMPLETED|Overall Study||3704
8078349|NCT03692676|19919382|P1|COMPLETED|Overall Study||940
8078350|NCT03692676|19919379|P4|STARTED|Overall Study||5147
8078351|NCT03692676|19919380|P3|STARTED|Overall Study||49479
8078352|NCT03692676|19919381|P2|STARTED|Overall Study||51142
8078353|NCT03692676|19919382|P1|STARTED|Overall Study||10365
8078354|NCT03691948|19919398|P2|NOT COMPLETED|Overall Study||3
8078355|NCT03691948|19919399|P1|NOT COMPLETED|Overall Study||1
8078356|NCT03691948|19919398|P2|COMPLETED|Overall Study||30
8078357|NCT03691948|19919399|P1|COMPLETED|Overall Study||26
8078358|NCT03691948|19919398|P2|STARTED|Overall Study||33
8078359|NCT03691948|19919399|P1|STARTED|Overall Study||27
8078360|NCT03691844|19919418|P4|NOT COMPLETED|Overall Study||11
8078361|NCT03691844|19919419|P3|NOT COMPLETED|Overall Study||13
8078362|NCT03691844|19919420|P2|NOT COMPLETED|Overall Study||12
8078363|NCT03691844|19919421|P1|NOT COMPLETED|Overall Study||7
8078364|NCT03691844|19919418|P4|COMPLETED|Overall Study||70
8078365|NCT03691844|19919419|P3|COMPLETED|Overall Study||108
8078366|NCT03691844|19919420|P2|COMPLETED|Overall Study||109
8078367|NCT03691844|19919421|P1|COMPLETED|Overall Study||114
8078368|NCT03691844|19919418|P4|STARTED|Overall Study||81
8078369|NCT03691844|19919419|P3|STARTED|Overall Study||121
8078370|NCT03691844|19919420|P2|STARTED|Overall Study||121
8078371|NCT03691844|19919421|P1|STARTED|Overall Study||121
8078372|NCT03691831|19919486|P2|NOT COMPLETED|Overall Study||31
8078373|NCT03691831|19919487|P1|NOT COMPLETED|Overall Study||27
8078374|NCT03691831|19919486|P2|COMPLETED|Overall Study||220
8078375|NCT03691831|19919487|P1|COMPLETED|Overall Study||224
8078376|NCT03691831|19919486|P2|STARTED|Overall Study||251
8078377|NCT03691831|19919487|P1|STARTED|Overall Study||251
8078378|NCT03689920|19919503|P2|NOT COMPLETED|Overall Study||4
8078379|NCT03689920|19919504|P1|NOT COMPLETED|Overall Study||6
8078380|NCT03689920|19919503|P2|COMPLETED|Overall Study||48
8078381|NCT03689920|19919504|P1|COMPLETED|Overall Study||41
8078382|NCT03689920|19919503|P2|STARTED|Overall Study||52
8078383|NCT03689920|19919504|P1|STARTED|Overall Study||47
8078384|NCT03689452|19919512|P2|NOT COMPLETED|Overall Study||1
8078385|NCT03689452|19919513|P1|NOT COMPLETED|Overall Study||1
8078386|NCT03689452|19919512|P2|COMPLETED|Overall Study||14
8078387|NCT03689452|19919513|P1|COMPLETED|Overall Study||14
8078388|NCT03689452|19919512|P2|STARTED|Overall Study||15
8078389|NCT03689452|19919513|P1|STARTED|Overall Study||15
8078390|NCT03688880|19919531|P2|NOT COMPLETED|Overall Study||31
8078391|NCT03688880|19919532|P1|NOT COMPLETED|Overall Study||14
8078392|NCT03688880|19919531|P2|COMPLETED|Overall Study||29
8078393|NCT03688880|19919532|P1|COMPLETED|Overall Study||15
8078394|NCT03688880|19919531|P2|STARTED|Overall Study||60
8078395|NCT03688880|19919532|P1|STARTED|Overall Study||29
8078396|NCT03688620|19919559|P3|NOT COMPLETED|Overall Study||8
8078397|NCT03688620|19919560|P2|NOT COMPLETED|Overall Study||1
8078398|NCT03688620|19919561|P1|NOT COMPLETED|Overall Study||16
8078399|NCT03688620|19919559|P3|COMPLETED|Overall Study||445
8078400|NCT03688620|19919560|P2|COMPLETED|Overall Study||277
8078401|NCT03688620|19919561|P1|COMPLETED|Overall Study||313
8078402|NCT03688620|19919559|P3|STARTED|Overall Study||453
8078403|NCT03688620|19919560|P2|STARTED|Overall Study||278
8078404|NCT03688620|19919561|P1|STARTED|Overall Study||329
8078405|NCT03687970|19920044|P2|NOT COMPLETED|Overall Study||0
8078406|NCT03687970|19920045|P1|NOT COMPLETED|Overall Study||2
8078407|NCT03687970|19920044|P2|COMPLETED|Overall Study||20
8078408|NCT03687970|19920045|P1|COMPLETED|Overall Study||20
8078409|NCT03687970|19920044|P2|STARTED|Overall Study||20
8078410|NCT03687970|19920045|P1|STARTED|Overall Study||22
8078411|NCT03687827|19920055|P2|NOT COMPLETED|Treatment Period 2||3
8078412|NCT03687827|19920056|P1|NOT COMPLETED|Treatment Period 2||5
8078413|NCT03687827|19920055|P2|COMPLETED|Treatment Period 2||238
8078414|NCT03687827|19920056|P1|COMPLETED|Treatment Period 2||230
8078415|NCT03687827|19920055|P2|STARTED|Treatment Period 2||241
8078416|NCT03687827|19920056|P1|STARTED|Treatment Period 2||235
8078417|NCT03687827|19920055|P2|NOT COMPLETED|Treatment Period 1||8
8078418|NCT03687827|19920056|P1|NOT COMPLETED|Treatment Period 1||14
8078419|NCT03687827|19920055|P2|COMPLETED|Treatment Period 1||241
8078420|NCT03687827|19920056|P1|COMPLETED|Treatment Period 1||235
8078421|NCT03687827|19920055|P2|Per Protocol Set|Treatment Period 1||229
8078422|NCT03687827|19920056|P1|Per Protocol Set|Treatment Period 1||219
8078423|NCT03687827|19920055|P2|Safety Analysis Set (SAS)|Treatment Period 1||249
8078424|NCT03687827|19920056|P1|Safety Analysis Set (SAS)|Treatment Period 1||249
8078425|NCT03687827|19920055|P2|Full Analysis Set (FAS)|Treatment Period 1||249
8078426|NCT03687827|19920056|P1|Full Analysis Set (FAS)|Treatment Period 1||249
8078427|NCT03687827|19920055|P2|STARTED|Treatment Period 1||249
8078428|NCT03687827|19920056|P1|STARTED|Treatment Period 1||249
8078429|NCT03687736|19920072|P1|NOT COMPLETED|Overall Study||10
8078430|NCT03687736|19920072|P1|COMPLETED|Overall Study||110
8078431|NCT03687736|19920072|P1|STARTED|Overall Study||120
8078432|NCT03687684|19920091|P9|NOT COMPLETED|Overall Study||0
8078433|NCT03687684|19920092|P8|NOT COMPLETED|Overall Study||0
8078434|NCT03687684|19920093|P7|NOT COMPLETED|Overall Study||0
8078435|NCT03687684|19920094|P6|NOT COMPLETED|Overall Study||0
8078436|NCT03687684|19920095|P5|NOT COMPLETED|Overall Study||0
8078437|NCT03687684|19920096|P4|NOT COMPLETED|Overall Study||0
8078438|NCT03687684|19920097|P3|NOT COMPLETED|Overall Study||0
8078439|NCT03687684|19920098|P2|NOT COMPLETED|Overall Study||0
8078440|NCT03687684|19920099|P1|NOT COMPLETED|Overall Study||0
8078441|NCT03687684|19920091|P9|COMPLETED|Overall Study||6
8078442|NCT03687684|19920092|P8|COMPLETED|Overall Study||2
8078443|NCT03687684|19920093|P7|COMPLETED|Overall Study||6
8078444|NCT03687684|19920094|P6|COMPLETED|Overall Study||6
8078445|NCT03687684|19920095|P5|COMPLETED|Overall Study||6
8078446|NCT03687684|19920096|P4|COMPLETED|Overall Study||6
8078447|NCT03687684|19920097|P3|COMPLETED|Overall Study||2
8078448|NCT03687684|19920098|P2|COMPLETED|Overall Study||2
8078449|NCT03687684|19920099|P1|COMPLETED|Overall Study||4
8078450|NCT03687684|19920091|P9|STARTED|Overall Study||6
8078451|NCT03687684|19920092|P8|STARTED|Overall Study||2
8078452|NCT03687684|19920093|P7|STARTED|Overall Study||6
8078453|NCT03687684|19920094|P6|STARTED|Overall Study||6
8078454|NCT03687684|19920095|P5|STARTED|Overall Study||6
8078455|NCT03687684|19920096|P4|STARTED|Overall Study||6
8078456|NCT03687684|19920097|P3|STARTED|Overall Study||2
8078457|NCT03687684|19920098|P2|STARTED|Overall Study||2
8078458|NCT03687684|19920099|P1|STARTED|Overall Study||4
8078459|NCT03687450|19920189|P2|NOT COMPLETED|Overall Study||2
8078460|NCT03687450|19920190|P1|NOT COMPLETED|Overall Study||12
8078461|NCT03687450|19920189|P2|COMPLETED|Overall Study||16
8078462|NCT03687450|19920190|P1|COMPLETED|Overall Study||26
8078463|NCT03687450|19920189|P2|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
8078464|NCT03687450|19920190|P1|Two-month Follow-up|Overall Study|2 lost to follow-up|26
8078465|NCT03687450|19920189|P2|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
8078466|NCT03687450|19920190|P1|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
8078467|NCT03687450|19920189|P2|STARTED|Overall Study||18
8078468|NCT03687450|19920190|P1|STARTED|Overall Study||38
8078469|NCT03687372|19920218|P2|NOT COMPLETED|Overall Study||39
8078470|NCT03687372|19920219|P1|NOT COMPLETED|Overall Study||17
8078471|NCT03687372|19920218|P2|COMPLETED|Overall Study||210
8078472|NCT03687372|19920219|P1|COMPLETED|Overall Study||237
8078473|NCT03687372|19920218|P2|STARTED|Overall Study||249
8078474|NCT03687372|19920219|P1|STARTED|Overall Study||254
8078475|NCT03686176|19920236|P3|NOT COMPLETED|Overall Study||0
8078476|NCT03686176|19920237|P2|NOT COMPLETED|Overall Study||0
8078477|NCT03686176|19920238|P1|NOT COMPLETED|Overall Study||2
8078478|NCT03686176|19920236|P3|COMPLETED|Overall Study||20
8078479|NCT03686176|19920237|P2|COMPLETED|Overall Study||25
8078480|NCT03686176|19920238|P1|COMPLETED|Overall Study||17
8078481|NCT03686176|19920236|P3|STARTED|Overall Study||20
8078482|NCT03686176|19920237|P2|STARTED|Overall Study||25
8078483|NCT03686176|19920238|P1|STARTED|Overall Study||19
8078484|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078485|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078486|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078487|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078488|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078489|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078490|NCT03686033|19920277|P6|COMPLETED|Treatment Period 4 (1 Day)||0
8078491|NCT03686033|19920278|P5|COMPLETED|Treatment Period 4 (1 Day)||0
8078492|NCT03686033|19920279|P4|COMPLETED|Treatment Period 4 (1 Day)||1
8078493|NCT03686033|19920280|P3|COMPLETED|Treatment Period 4 (1 Day)||1
8078494|NCT03686033|19920281|P2|COMPLETED|Treatment Period 4 (1 Day)||1
8078495|NCT03686033|19920282|P1|COMPLETED|Treatment Period 4 (1 Day)||1
8078496|NCT03686033|19920277|P6|STARTED|Treatment Period 4 (1 Day)||0
8078497|NCT03686033|19920278|P5|STARTED|Treatment Period 4 (1 Day)||0
8078498|NCT03686033|19920279|P4|STARTED|Treatment Period 4 (1 Day)||1
8078499|NCT03686033|19920280|P3|STARTED|Treatment Period 4 (1 Day)||1
8078500|NCT03686033|19920281|P2|STARTED|Treatment Period 4 (1 Day)||1
8078501|NCT03686033|19920282|P1|STARTED|Treatment Period 4 (1 Day)||1
8078502|NCT03686033|19920277|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078503|NCT03686033|19920278|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078504|NCT03686033|19920279|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078505|NCT03686033|19920280|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078506|NCT03686033|19920281|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078507|NCT03686033|19920282|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078508|NCT03686033|19920277|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078509|NCT03686033|19920278|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078510|NCT03686033|19920279|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078511|NCT03686033|19920280|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078512|NCT03686033|19920281|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078513|NCT03686033|19920282|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078514|NCT03686033|19920277|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
8078515|NCT03686033|19920278|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
8078516|NCT03686033|19920279|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
8078517|NCT03686033|19920280|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
8078518|NCT03686033|19920281|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
8078519|NCT03686033|19920282|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
8078520|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078521|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078522|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078523|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078524|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078525|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078526|NCT03686033|19920277|P6|COMPLETED|Treatment Period 3 (1 Day)||0
8078527|NCT03686033|19920278|P5|COMPLETED|Treatment Period 3 (1 Day)||0
8078528|NCT03686033|19920279|P4|COMPLETED|Treatment Period 3 (1 Day)||1
8078529|NCT03686033|19920280|P3|COMPLETED|Treatment Period 3 (1 Day)||1
8078530|NCT03686033|19920281|P2|COMPLETED|Treatment Period 3 (1 Day)||1
8078531|NCT03686033|19920282|P1|COMPLETED|Treatment Period 3 (1 Day)||1
8078532|NCT03686033|19920277|P6|STARTED|Treatment Period 3 (1 Day)||0
8078533|NCT03686033|19920278|P5|STARTED|Treatment Period 3 (1 Day)||0
8078534|NCT03686033|19920279|P4|STARTED|Treatment Period 3 (1 Day)||1
8078535|NCT03686033|19920280|P3|STARTED|Treatment Period 3 (1 Day)||1
8078536|NCT03686033|19920281|P2|STARTED|Treatment Period 3 (1 Day)||1
8078537|NCT03686033|19920282|P1|STARTED|Treatment Period 3 (1 Day)||1
8078538|NCT03686033|19920277|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078539|NCT03686033|19920278|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078540|NCT03686033|19920279|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078541|NCT03686033|19920280|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078542|NCT03686033|19920281|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078543|NCT03686033|19920282|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078544|NCT03686033|19920277|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078545|NCT03686033|19920278|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078546|NCT03686033|19920279|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078547|NCT03686033|19920280|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078548|NCT03686033|19920281|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078549|NCT03686033|19920282|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078550|NCT03686033|19920277|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
8078551|NCT03686033|19920278|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
8078552|NCT03686033|19920279|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
8078553|NCT03686033|19920280|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
8078554|NCT03686033|19920281|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
8078555|NCT03686033|19920282|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
8078556|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078557|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||1
8078558|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078559|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078560|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078561|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078562|NCT03686033|19920277|P6|COMPLETED|Treatment Period 2 (1 Day)||0
8078563|NCT03686033|19920278|P5|COMPLETED|Treatment Period 2 (1 Day)||0
8078564|NCT03686033|19920279|P4|COMPLETED|Treatment Period 2 (1 Day)||1
8078565|NCT03686033|19920280|P3|COMPLETED|Treatment Period 2 (1 Day)||1
8078566|NCT03686033|19920281|P2|COMPLETED|Treatment Period 2 (1 Day)||1
8078567|NCT03686033|19920282|P1|COMPLETED|Treatment Period 2 (1 Day)||1
8078568|NCT03686033|19920277|P6|STARTED|Treatment Period 2 (1 Day)||0
8078569|NCT03686033|19920278|P5|STARTED|Treatment Period 2 (1 Day)||1
8078570|NCT03686033|19920279|P4|STARTED|Treatment Period 2 (1 Day)||1
8078571|NCT03686033|19920280|P3|STARTED|Treatment Period 2 (1 Day)||1
8078572|NCT03686033|19920281|P2|STARTED|Treatment Period 2 (1 Day)||1
8078573|NCT03686033|19920282|P1|STARTED|Treatment Period 2 (1 Day)||1
8078574|NCT03686033|19920277|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078575|NCT03686033|19920278|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078576|NCT03686033|19920279|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078577|NCT03686033|19920280|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078578|NCT03686033|19920281|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078579|NCT03686033|19920282|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078580|NCT03686033|19920277|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078581|NCT03686033|19920278|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078582|NCT03686033|19920279|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078583|NCT03686033|19920280|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078584|NCT03686033|19920281|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078585|NCT03686033|19920282|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078586|NCT03686033|19920277|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
8078587|NCT03686033|19920278|P5|STARTED|Washout Phase (at Least 2 Weeks)||1
8078588|NCT03686033|19920279|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
8078589|NCT03686033|19920280|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
8078590|NCT03686033|19920281|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
8078591|NCT03686033|19920282|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
8078592|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078593|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078594|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078595|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078596|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078597|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078598|NCT03686033|19920277|P6|COMPLETED|Treatment Period 1 (1 Day)||0
8078599|NCT03686033|19920278|P5|COMPLETED|Treatment Period 1 (1 Day)||1
8078600|NCT03686033|19920279|P4|COMPLETED|Treatment Period 1 (1 Day)||1
8078601|NCT03686033|19920280|P3|COMPLETED|Treatment Period 1 (1 Day)||1
8078602|NCT03686033|19920281|P2|COMPLETED|Treatment Period 1 (1 Day)||1
8078603|NCT03686033|19920282|P1|COMPLETED|Treatment Period 1 (1 Day)||1
8078604|NCT03686033|19920277|P6|STARTED|Treatment Period 1 (1 Day)||0
8078605|NCT03686033|19920278|P5|STARTED|Treatment Period 1 (1 Day)||1
8078606|NCT03686033|19920279|P4|STARTED|Treatment Period 1 (1 Day)||1
8078607|NCT03686033|19920280|P3|STARTED|Treatment Period 1 (1 Day)||1
8078608|NCT03686033|19920281|P2|STARTED|Treatment Period 1 (1 Day)||1
8078609|NCT03686033|19920282|P1|STARTED|Treatment Period 1 (1 Day)||1
8078610|NCT03685968|19920340|P3|NOT COMPLETED|Overall Study||0
8078611|NCT03685968|19920341|P2|NOT COMPLETED|Overall Study||0
8078612|NCT03685968|19920342|P1|NOT COMPLETED|Overall Study||0
8078613|NCT03685968|19920340|P3|COMPLETED|Overall Study||75
8078614|NCT03685968|19920341|P2|COMPLETED|Overall Study||75
8078615|NCT03685968|19920342|P1|COMPLETED|Overall Study||75
8078616|NCT03685968|19920340|P3|STARTED|Overall Study||75
8078617|NCT03685968|19920341|P2|STARTED|Overall Study||75
8078618|NCT03685968|19920342|P1|STARTED|Overall Study||75
8078619|NCT03685643|19920358|P2|NOT COMPLETED|Overall Study||22
8078620|NCT03685643|19920359|P1|NOT COMPLETED|Overall Study||14
8078621|NCT03685643|19920358|P2|COMPLETED|Overall Study||266
8078622|NCT03685643|19920359|P1|COMPLETED|Overall Study||276
8078623|NCT03685643|19920358|P2|STARTED|Overall Study||288
8078624|NCT03685643|19920359|P1|STARTED|Overall Study||290
8078625|NCT03685396|19920371|P2|NOT COMPLETED|Overall Study||0
8078626|NCT03685396|19920372|P1|NOT COMPLETED|Overall Study||0
8078627|NCT03685396|19920371|P2|COMPLETED|Overall Study||21
8078628|NCT03685396|19920372|P1|COMPLETED|Overall Study||21
8078629|NCT03685396|19920371|P2|STARTED|Overall Study||21
8078630|NCT03685396|19920372|P1|STARTED|Overall Study||21
8078631|NCT03684928|19920384|P2|NOT COMPLETED|Second Intervention||0
8078632|NCT03684928|19920385|P1|NOT COMPLETED|Second Intervention||1
8078633|NCT03684928|19920384|P2|COMPLETED|Second Intervention||19
8078634|NCT03684928|19920385|P1|COMPLETED|Second Intervention||20
8078635|NCT03684928|19920384|P2|STARTED|Second Intervention||19
8078636|NCT03684928|19920385|P1|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
8078637|NCT03684928|19920384|P2|NOT COMPLETED|First Intervention||3
8078638|NCT03684928|19920385|P1|NOT COMPLETED|First Intervention||0
8078639|NCT03684928|19920384|P2|COMPLETED|First Intervention||19
8078640|NCT03684928|19920385|P1|COMPLETED|First Intervention||23
8078641|NCT03684928|19920384|P2|STARTED|First Intervention||22
8078642|NCT03684928|19920385|P1|STARTED|First Intervention||23
8078643|NCT03684265|19920401|P2|NOT COMPLETED|Treatment Period 2||0
8078644|NCT03684265|19920402|P1|NOT COMPLETED|Treatment Period 2||0
8078645|NCT03684265|19920401|P2|COMPLETED|Treatment Period 2||13
8078646|NCT03684265|19920402|P1|COMPLETED|Treatment Period 2||13
8078647|NCT03684265|19920401|P2|STARTED|Treatment Period 2||13
8078648|NCT03684265|19920402|P1|STARTED|Treatment Period 2||13
8078649|NCT03684265|19920401|P2|NOT COMPLETED|Washout Period of 1 Week||0
8078650|NCT03684265|19920402|P1|NOT COMPLETED|Washout Period of 1 Week||0
8078651|NCT03684265|19920401|P2|COMPLETED|Washout Period of 1 Week||13
8078652|NCT03684265|19920402|P1|COMPLETED|Washout Period of 1 Week||13
8078653|NCT03684265|19920401|P2|STARTED|Washout Period of 1 Week||13
8078654|NCT03684265|19920402|P1|STARTED|Washout Period of 1 Week||13
8078655|NCT03684265|19920401|P2|NOT COMPLETED|Treatment Period 1||0
8078656|NCT03684265|19920402|P1|NOT COMPLETED|Treatment Period 1||0
8078657|NCT03684265|19920401|P2|COMPLETED|Treatment Period 1||13
8078658|NCT03684265|19920402|P1|COMPLETED|Treatment Period 1||13
8078659|NCT03684265|19920401|P2|STARTED|Treatment Period 1||13
8078660|NCT03684265|19920402|P1|STARTED|Treatment Period 1||13
8078661|NCT03684044|19920414|P2|NOT COMPLETED|Overall Study||20
8078662|NCT03684044|19920415|P1|NOT COMPLETED|Overall Study||22
8078663|NCT03684044|19920414|P2|COMPLETED|Overall Study||104
8078664|NCT03684044|19920415|P1|COMPLETED|Overall Study||217
8078665|NCT03684044|19920414|P2|STARTED|Overall Study||124
8078666|NCT03684044|19920415|P1|STARTED|Overall Study||239
8078667|NCT03683901|19920472|P1|NOT COMPLETED|Overall Study||0
8078668|NCT03683901|19920472|P1|COMPLETED|Overall Study||10
8078669|NCT03683901|19920472|P1|STARTED|Overall Study||10
8078670|NCT03683758|19920483|P2|NOT COMPLETED|Overall Study||3
8078671|NCT03683758|19920484|P1|NOT COMPLETED|Overall Study||3
8078672|NCT03683758|19920483|P2|COMPLETED|Overall Study||7
8078673|NCT03683758|19920484|P1|COMPLETED|Overall Study||8
8078674|NCT03683758|19920483|P2|STARTED|Overall Study||10
8078675|NCT03683758|19920484|P1|STARTED|Overall Study||11
8078676|NCT03682809|19920498|P2|NOT COMPLETED|Overall Study||0
8078677|NCT03682809|19920499|P1|NOT COMPLETED|Overall Study||0
8078678|NCT03682809|19920498|P2|COMPLETED|Overall Study||24
8078679|NCT03682809|19920499|P1|COMPLETED|Overall Study||22
8078680|NCT03682809|19920498|P2|STARTED|Overall Study||24
8078681|NCT03682809|19920499|P1|STARTED|Overall Study||22
8078682|NCT03682302|19920517|P4|NOT COMPLETED|Overall Study||2
8078683|NCT03682302|19920518|P3|NOT COMPLETED|Overall Study||1
8078684|NCT03682302|19920519|P2|NOT COMPLETED|Overall Study||2
8078685|NCT03682302|19920520|P1|NOT COMPLETED|Overall Study||1
8078686|NCT03682302|19920517|P4|COMPLETED|Overall Study||28
8078687|NCT03682302|19920518|P3|COMPLETED|Overall Study||5
8078688|NCT03682302|19920519|P2|COMPLETED|Overall Study||28
8078689|NCT03682302|19920520|P1|COMPLETED|Overall Study||30
8078690|NCT03682302|19920517|P4|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
8078691|NCT03682302|19920518|P3|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
8078692|NCT03682302|19920519|P2|STARTED|Overall Study||30
8078693|NCT03682302|19920520|P1|STARTED|Overall Study||31
8078694|NCT03681951|19920558|P8|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078695|NCT03681951|19920559|P7|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078696|NCT03681951|19920560|P6|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078697|NCT03681951|19920561|P5|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078698|NCT03681951|19920562|P4|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078699|NCT03681951|19920563|P3|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078700|NCT03681951|19920564|P2|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078701|NCT03681951|19920565|P1|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078702|NCT03681951|19920558|P8|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078703|NCT03681951|19920559|P7|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078704|NCT03681951|19920560|P6|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078705|NCT03681951|19920561|P5|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078706|NCT03681951|19920562|P4|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078707|NCT03681951|19920563|P3|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078708|NCT03681951|19920564|P2|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078709|NCT03681951|19920565|P1|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078710|NCT03681951|19920558|P8|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078711|NCT03681951|19920559|P7|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078712|NCT03681951|19920560|P6|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078713|NCT03681951|19920561|P5|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078714|NCT03681951|19920562|P4|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078715|NCT03681951|19920563|P3|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078716|NCT03681951|19920564|P2|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078717|NCT03681951|19920565|P1|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078718|NCT03681951|19920558|P8|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078719|NCT03681951|19920559|P7|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078720|NCT03681951|19920560|P6|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078721|NCT03681951|19920561|P5|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078722|NCT03681951|19920562|P4|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078723|NCT03681951|19920563|P3|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078724|NCT03681951|19920564|P2|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078725|NCT03681951|19920565|P1|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078726|NCT03681951|19920558|P8|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078727|NCT03681951|19920559|P7|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078728|NCT03681951|19920560|P6|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078729|NCT03681951|19920561|P5|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078730|NCT03681951|19920562|P4|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078731|NCT03681951|19920563|P3|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078732|NCT03681951|19920564|P2|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078733|NCT03681951|19920565|P1|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078734|NCT03681951|19920558|P8|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078735|NCT03681951|19920559|P7|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078736|NCT03681951|19920560|P6|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078737|NCT03681951|19920561|P5|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078738|NCT03681951|19920562|P4|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078739|NCT03681951|19920563|P3|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078740|NCT03681951|19920564|P2|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078741|NCT03681951|19920565|P1|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078742|NCT03681951|19920558|P8|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078743|NCT03681951|19920559|P7|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078744|NCT03681951|19920560|P6|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078745|NCT03681951|19920561|P5|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078746|NCT03681951|19920562|P4|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078747|NCT03681951|19920563|P3|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078748|NCT03681951|19920564|P2|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078749|NCT03681951|19920565|P1|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078750|NCT03681951|19920558|P8|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078751|NCT03681951|19920559|P7|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078752|NCT03681951|19920560|P6|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078753|NCT03681951|19920561|P5|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078754|NCT03681951|19920562|P4|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078755|NCT03681951|19920563|P3|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078756|NCT03681951|19920564|P2|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078757|NCT03681951|19920565|P1|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078758|NCT03681951|19920558|P8|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078759|NCT03681951|19920559|P7|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078760|NCT03681951|19920560|P6|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078761|NCT03681951|19920561|P5|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078762|NCT03681951|19920562|P4|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078763|NCT03681951|19920563|P3|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078764|NCT03681951|19920564|P2|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078765|NCT03681951|19920565|P1|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078766|NCT03681951|19920558|P8|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078767|NCT03681951|19920559|P7|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078768|NCT03681951|19920560|P6|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078769|NCT03681951|19920561|P5|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078770|NCT03681951|19920562|P4|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078771|NCT03681951|19920563|P3|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078772|NCT03681951|19920564|P2|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078773|NCT03681951|19920565|P1|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
8078774|NCT03681951|19920558|P8|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078775|NCT03681951|19920559|P7|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078776|NCT03681951|19920560|P6|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078777|NCT03681951|19920561|P5|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078778|NCT03681951|19920562|P4|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078779|NCT03681951|19920563|P3|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078780|NCT03681951|19920564|P2|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078781|NCT03681951|19920565|P1|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078782|NCT03681951|19920558|P8|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
8078783|NCT03681951|19920559|P7|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
8078784|NCT03681951|19920560|P6|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
8078785|NCT03681951|19920561|P5|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
8078786|NCT03681951|19920562|P4|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
8078787|NCT03681951|19920563|P3|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
8078788|NCT03681951|19920564|P2|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
8078789|NCT03681951|19920565|P1|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
8078790|NCT03681886|19920756|P1|NOT COMPLETED|Overall Study||2
8078791|NCT03681886|19920756|P1|COMPLETED|Overall Study||76
8078792|NCT03681886|19920756|P1|Underwent Optic Exchange|Overall Study||4
8078793|NCT03681886|19920756|P1|Failed Implantation|Overall Study||2
8078794|NCT03681886|19920756|P1|Successful Implantation|Overall Study||76
8078795|NCT03681886|19920756|P1|STARTED|Overall Study||78
8078796|NCT03681808|19920797|P2|NOT COMPLETED|Overall Study||17
8078797|NCT03681808|19920798|P1|NOT COMPLETED|Overall Study||14
8078798|NCT03681808|19920797|P2|COMPLETED|Overall Study||102
8078799|NCT03681808|19920798|P1|COMPLETED|Overall Study||109
8078800|NCT03681808|19920797|P2|STARTED|Overall Study||119
8078801|NCT03681808|19920798|P1|STARTED|Overall Study||123
8078820|NCT03681119|19920833|P2|NOT COMPLETED|Overall Study||0
8078821|NCT03681119|19920834|P1|NOT COMPLETED|Overall Study||6
8078822|NCT03681119|19920833|P2|COMPLETED|Overall Study||11
8078823|NCT03681119|19920834|P1|COMPLETED|Overall Study||66
8078824|NCT03681119|19920833|P2|STARTED|Overall Study||11
8078825|NCT03681119|19920834|P1|STARTED|Overall Study||72
8078826|NCT03681093|19920841|P3|NOT COMPLETED|Overall Study||1
8078827|NCT03681093|19920842|P2|NOT COMPLETED|Overall Study||2
8078828|NCT03681093|19920843|P1|NOT COMPLETED|Overall Study||0
8078829|NCT03681093|19920841|P3|COMPLETED|Overall Study||31
8078830|NCT03681093|19920842|P2|COMPLETED|Overall Study||32
8078831|NCT03681093|19920843|P1|COMPLETED|Overall Study||32
8078832|NCT03681093|19920841|P3|Safety Analysis Set (SAF)|Overall Study||32
8078833|NCT03681093|19920842|P2|Safety Analysis Set (SAF)|Overall Study||34
8078834|NCT03681093|19920843|P1|Safety Analysis Set (SAF)|Overall Study||32
8078835|NCT03681093|19920841|P3|Full Analysis Set (FAS)|Overall Study||28
8078836|NCT03681093|19920842|P2|Full Analysis Set (FAS)|Overall Study||32
8078837|NCT03681093|19920843|P1|Full Analysis Set (FAS)|Overall Study||31
8078838|NCT03681093|19920841|P3|STARTED|Overall Study||32
8078839|NCT03681093|19920842|P2|STARTED|Overall Study||34
8078840|NCT03681093|19920843|P1|STARTED|Overall Study||32
8078841|NCT03680105|19920869|P9|NOT COMPLETED|Overall Study||0
8078842|NCT03680105|19920870|P8|NOT COMPLETED|Overall Study||0
8078843|NCT03680105|19920871|P7|NOT COMPLETED|Overall Study||0
8078844|NCT03680105|19920872|P6|NOT COMPLETED|Overall Study||0
8078845|NCT03680105|19920873|P5|NOT COMPLETED|Overall Study||0
8078846|NCT03680105|19920874|P4|NOT COMPLETED|Overall Study||0
8078847|NCT03680105|19920875|P3|NOT COMPLETED|Overall Study||0
8078848|NCT03680105|19920876|P2|NOT COMPLETED|Overall Study||0
8078849|NCT03680105|19920877|P1|NOT COMPLETED|Overall Study||0
8078850|NCT03680105|19920869|P9|COMPLETED|Overall Study||8
8078851|NCT03680105|19920870|P8|COMPLETED|Overall Study||8
8078852|NCT03680105|19920871|P7|COMPLETED|Overall Study||8
8078853|NCT03680105|19920872|P6|COMPLETED|Overall Study||12
8078854|NCT03680105|19920873|P5|COMPLETED|Overall Study||8
8078855|NCT03680105|19920874|P4|COMPLETED|Overall Study||8
8078856|NCT03680105|19920875|P3|COMPLETED|Overall Study||8
8078857|NCT03680105|19920876|P2|COMPLETED|Overall Study||8
8078858|NCT03680105|19920877|P1|COMPLETED|Overall Study||8
8078859|NCT03680105|19920869|P9|STARTED|Overall Study||8
8078860|NCT03680105|19920870|P8|STARTED|Overall Study||8
8078861|NCT03680105|19920871|P7|STARTED|Overall Study||8
8078862|NCT03680105|19920872|P6|STARTED|Overall Study||12
8078863|NCT03680105|19920873|P5|STARTED|Overall Study||8
8078864|NCT03680105|19920874|P4|STARTED|Overall Study||8
8078865|NCT03680105|19920875|P3|STARTED|Overall Study||8
8078866|NCT03680105|19920876|P2|STARTED|Overall Study||8
8078867|NCT03680105|19920877|P1|STARTED|Overall Study||8
8078868|NCT03679975|19920923|P1|NOT COMPLETED|Overall Study||0
8078869|NCT03679975|19920923|P1|COMPLETED|Overall Study||9
8078870|NCT03679975|19920923|P1|STARTED|Overall Study||9
8078871|NCT03679741|19920927|P2|NOT COMPLETED|Period 3||0
8078872|NCT03679741|19920928|P1|NOT COMPLETED|Period 3||0
8078873|NCT03679741|19920927|P2|COMPLETED|Period 3||56
8078874|NCT03679741|19920928|P1|COMPLETED|Period 3||54
8078875|NCT03679741|19920927|P2|STARTED|Period 3||56
8078876|NCT03679741|19920928|P1|STARTED|Period 3||54
8078877|NCT03679741|19920927|P2|NOT COMPLETED|Period 2||2
8078878|NCT03679741|19920928|P1|NOT COMPLETED|Period 2||3
8078879|NCT03679741|19920927|P2|COMPLETED|Period 2||56
8078880|NCT03679741|19920928|P1|COMPLETED|Period 2||54
8078881|NCT03679741|19920927|P2|STARTED|Period 2||58
8078882|NCT03679741|19920928|P1|STARTED|Period 2||57
8078883|NCT03679741|19920927|P2|NOT COMPLETED|Period 1||3
8078884|NCT03679741|19920928|P1|NOT COMPLETED|Period 1||2
8078885|NCT03679741|19920927|P2|COMPLETED|Period 1||58
8078886|NCT03679741|19920928|P1|COMPLETED|Period 1||57
8078887|NCT03679741|19920927|P2|STARTED|Period 1||61
8078888|NCT03679741|19920928|P1|STARTED|Period 1||59
8078889|NCT03679494|19920950|P2|NOT COMPLETED|Overall Study||0
8078890|NCT03679494|19920951|P1|NOT COMPLETED|Overall Study||0
8078891|NCT03679494|19920950|P2|COMPLETED|Overall Study||63
8078892|NCT03679494|19920951|P1|COMPLETED|Overall Study||67
8078893|NCT03679494|19920950|P2|STARTED|Overall Study||63
8078894|NCT03679494|19920951|P1|STARTED|Overall Study||67
8078895|NCT03678870|19920971|P2|NOT COMPLETED|Overall Study||8
8078896|NCT03678870|19920972|P1|NOT COMPLETED|Overall Study||13
8078897|NCT03678870|19920971|P2|COMPLETED|Overall Study||91
8078898|NCT03678870|19920972|P1|COMPLETED|Overall Study||84
8078899|NCT03678870|19920971|P2|STARTED|Overall Study||99
8078900|NCT03678870|19920972|P1|STARTED|Overall Study||97
8078901|NCT03678311|19920984|P1|NOT COMPLETED|Overall Study||0
8078902|NCT03678311|19920984|P1|COMPLETED|Overall Study||9
8078903|NCT03678311|19920984|P1|STARTED|Overall Study||9
8078904|NCT03677401|19920992|P2|NOT COMPLETED|Overall Study||18
8078905|NCT03677401|19920993|P1|NOT COMPLETED|Overall Study||10
8078906|NCT03677401|19920992|P2|COMPLETED|Overall Study||129
8078907|NCT03677401|19920993|P1|COMPLETED|Overall Study||138
8078908|NCT03677401|19920992|P2|STARTED|Overall Study||147
8078909|NCT03677401|19920993|P1|STARTED|Overall Study||148
8078910|NCT03677375|19921017|P1|NOT COMPLETED|Overall Study||12
8078911|NCT03677375|19921017|P1|COMPLETED|Overall Study||81
8078912|NCT03677375|19921017|P1|STARTED|Overall Study||93
8078913|NCT03677245|19921021|P1|NOT COMPLETED|Overall Study||0
8078914|NCT03677245|19921021|P1|COMPLETED|Overall Study||8
8078915|NCT03677245|19921021|P1|STARTED|Overall Study||8
8078916|NCT03677089|19921028|P1|NOT COMPLETED|Overall Study||34
8078917|NCT03677089|19921028|P1|COMPLETED|Overall Study||114
8078918|NCT03677089|19921028|P1|Follow-Up|Overall Study||114
8078919|NCT03677089|19921028|P1|Post-Intervention|Overall Study||117
8078920|NCT03677089|19921028|P1|Mid-Intervention|Overall Study||120
8078921|NCT03677089|19921028|P1|Baseline/Pre-Intervention|Overall Study||137
8078922|NCT03677089|19921028|P1|STARTED|Overall Study||148
8078923|NCT03676803|19921059|P2|NOT COMPLETED|Overall Study||0
8078924|NCT03676803|19921060|P1|NOT COMPLETED|Overall Study||0
8078925|NCT03676803|19921059|P2|COMPLETED|Overall Study||16
8078926|NCT03676803|19921060|P1|COMPLETED|Overall Study||15
8078927|NCT03676803|19921059|P2|STARTED|Overall Study||16
8078928|NCT03676803|19921060|P1|STARTED|Overall Study||15
8078929|NCT03676270|19921068|P1|NOT COMPLETED|Overall Study||0
8078930|NCT03676270|19921068|P1|COMPLETED|Overall Study||6915
8078931|NCT03676270|19921068|P1|STARTED|Overall Study||6915
8078932|NCT03675776|19921075|P3|NOT COMPLETED|Safety Follow-up Period||0
8078933|NCT03675776|19921076|P2|NOT COMPLETED|Safety Follow-up Period||0
8078934|NCT03675776|19921077|P1|NOT COMPLETED|Safety Follow-up Period||0
8078935|NCT03675776|19921075|P3|COMPLETED|Safety Follow-up Period||7
8078936|NCT03675776|19921076|P2|COMPLETED|Safety Follow-up Period||8
8078937|NCT03675776|19921077|P1|COMPLETED|Safety Follow-up Period||6
8078938|NCT03675776|19921075|P3|STARTED|Safety Follow-up Period||7
8078939|NCT03675776|19921076|P2|STARTED|Safety Follow-up Period||8
8078940|NCT03675776|19921077|P1|STARTED|Safety Follow-up Period||6
8078941|NCT03675776|19921075|P3|NOT COMPLETED|Double Blind Treatment Period||8
8078942|NCT03675776|19921076|P2|NOT COMPLETED|Double Blind Treatment Period||6
8078943|NCT03675776|19921077|P1|NOT COMPLETED|Double Blind Treatment Period||6
8078944|NCT03675776|19921075|P3|COMPLETED|Double Blind Treatment Period||10
8078945|NCT03675776|19921076|P2|COMPLETED|Double Blind Treatment Period||11
8078946|NCT03675776|19921077|P1|COMPLETED|Double Blind Treatment Period||9
8078947|NCT03675776|19921075|P3|STARTED|Double Blind Treatment Period||18
8078948|NCT03675776|19921076|P2|STARTED|Double Blind Treatment Period||17
8078949|NCT03675776|19921077|P1|STARTED|Double Blind Treatment Period||15
8078950|NCT03675685|19921088|P1|NOT COMPLETED|Overall Study||0
8078951|NCT03675685|19921088|P1|COMPLETED|Overall Study||12
8078952|NCT03675685|19921088|P1|STARTED|Overall Study||12
8078953|NCT03675581|19921104|P1|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
8078954|NCT03675581|19921104|P1|COMPLETED|Period 2: Microgynon + Nintedanib||17
8078955|NCT03675581|19921104|P1|STARTED|Period 2: Microgynon + Nintedanib||17
8078956|NCT03675581|19921104|P1|NOT COMPLETED|Period 1: Microgynon Alone||0
8078957|NCT03675581|19921104|P1|COMPLETED|Period 1: Microgynon Alone||17
8078958|NCT03675581|19921104|P1|STARTED|Period 1: Microgynon Alone||17
8078959|NCT03675451|19921122|P1|NOT COMPLETED|Overall Study||0
8078960|NCT03675451|19921122|P1|COMPLETED|Overall Study||20
8078961|NCT03675451|19921122|P1|STARTED|Overall Study||20
8078962|NCT03674970|19921142|P3|NOT COMPLETED|Overall Study||3
8078963|NCT03674970|19921143|P2|NOT COMPLETED|Overall Study||7
8078964|NCT03674970|19921144|P1|NOT COMPLETED|Overall Study||3
8078965|NCT03674970|19921142|P3|COMPLETED|Overall Study||12
8078966|NCT03674970|19921143|P2|COMPLETED|Overall Study||8
8078967|NCT03674970|19921144|P1|COMPLETED|Overall Study||12
8078968|NCT03674970|19921142|P3|STARTED|Overall Study||15
8078969|NCT03674970|19921143|P2|STARTED|Overall Study||15
8078970|NCT03674970|19921144|P1|STARTED|Overall Study||15
8078971|NCT03674281|19921170|P3|NOT COMPLETED|Overall Study||3
8078972|NCT03674281|19921171|P2|NOT COMPLETED|Overall Study||3
8078973|NCT03674281|19921172|P1|NOT COMPLETED|Overall Study||3
8078974|NCT03674281|19921170|P3|COMPLETED|Overall Study||13
8078975|NCT03674281|19921171|P2|COMPLETED|Overall Study||13
8078976|NCT03674281|19921172|P1|COMPLETED|Overall Study||15
8078977|NCT03674281|19921170|P3|STARTED|Overall Study||16
8078978|NCT03674281|19921171|P2|STARTED|Overall Study||16
8078979|NCT03674281|19921172|P1|STARTED|Overall Study||18
8078980|NCT03674177|19921196|P4|NOT COMPLETED|Overall Study||2
8078981|NCT03674177|19921197|P3|NOT COMPLETED|Overall Study||0
8078982|NCT03674177|19921198|P2|NOT COMPLETED|Overall Study||1
8078983|NCT03674177|19921199|P1|NOT COMPLETED|Overall Study||2
8078984|NCT03674177|19921196|P4|COMPLETED|Overall Study||124
8078985|NCT03674177|19921197|P3|COMPLETED|Overall Study||126
8078986|NCT03674177|19921198|P2|COMPLETED|Overall Study||125
8078987|NCT03674177|19921199|P1|COMPLETED|Overall Study||122
8078988|NCT03674177|19921196|P4|STARTED|Overall Study||126
8078989|NCT03674177|19921197|P3|STARTED|Overall Study||126
8078990|NCT03674177|19921198|P2|STARTED|Overall Study||126
8078991|NCT03674177|19921199|P1|STARTED|Overall Study||124
8078992|NCT03673670|19921271|P6|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078993|NCT03673670|19921272|P5|NOT COMPLETED|Treatment Period 3 (3 Days)||1
8078994|NCT03673670|19921273|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078995|NCT03673670|19921274|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078996|NCT03673670|19921275|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078997|NCT03673670|19921276|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078998|NCT03673670|19921271|P6|COMPLETED|Treatment Period 3 (3 Days)||11
8078999|NCT03673670|19921272|P5|COMPLETED|Treatment Period 3 (3 Days)||10
8079000|NCT03673670|19921273|P4|COMPLETED|Treatment Period 3 (3 Days)||12
8079001|NCT03673670|19921274|P3|COMPLETED|Treatment Period 3 (3 Days)||11
8079002|NCT03673670|19921275|P2|COMPLETED|Treatment Period 3 (3 Days)||14
8079003|NCT03673670|19921276|P1|COMPLETED|Treatment Period 3 (3 Days)||13
8079004|NCT03673670|19921271|P6|STARTED|Treatment Period 3 (3 Days)||11
8079005|NCT03673670|19921272|P5|STARTED|Treatment Period 3 (3 Days)||11
8079006|NCT03673670|19921273|P4|STARTED|Treatment Period 3 (3 Days)||12
8079007|NCT03673670|19921274|P3|STARTED|Treatment Period 3 (3 Days)||11
8079008|NCT03673670|19921275|P2|STARTED|Treatment Period 3 (3 Days)||14
8079009|NCT03673670|19921276|P1|STARTED|Treatment Period 3 (3 Days)||13
8079010|NCT03673670|19921271|P6|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079011|NCT03673670|19921272|P5|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
8079012|NCT03673670|19921273|P4|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079013|NCT03673670|19921274|P3|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079014|NCT03673670|19921275|P2|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079015|NCT03673670|19921276|P1|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079016|NCT03673670|19921271|P6|COMPLETED|Washout Period 2 (7-14 Days)||11
8079017|NCT03673670|19921272|P5|COMPLETED|Washout Period 2 (7-14 Days)||11
8079018|NCT03673670|19921273|P4|COMPLETED|Washout Period 2 (7-14 Days)||12
8079019|NCT03673670|19921274|P3|COMPLETED|Washout Period 2 (7-14 Days)||11
8079020|NCT03673670|19921275|P2|COMPLETED|Washout Period 2 (7-14 Days)||14
8079021|NCT03673670|19921276|P1|COMPLETED|Washout Period 2 (7-14 Days)||13
8079022|NCT03673670|19921271|P6|STARTED|Washout Period 2 (7-14 Days)||11
8079023|NCT03673670|19921272|P5|STARTED|Washout Period 2 (7-14 Days)||12
8079024|NCT03673670|19921273|P4|STARTED|Washout Period 2 (7-14 Days)||12
8079025|NCT03673670|19921274|P3|STARTED|Washout Period 2 (7-14 Days)||11
8079026|NCT03673670|19921275|P2|STARTED|Washout Period 2 (7-14 Days)||14
8079027|NCT03673670|19921276|P1|STARTED|Washout Period 2 (7-14 Days)||13
8079028|NCT03673670|19921271|P6|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079029|NCT03673670|19921272|P5|NOT COMPLETED|Treatment Period 2 (3 Days)||1
8079030|NCT03673670|19921273|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079031|NCT03673670|19921274|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||1
8079032|NCT03673670|19921275|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079033|NCT03673670|19921276|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079034|NCT03673670|19921271|P6|COMPLETED|Treatment Period 2 (3 Days)||11
8079035|NCT03673670|19921272|P5|COMPLETED|Treatment Period 2 (3 Days)||12
8079036|NCT03673670|19921273|P4|COMPLETED|Treatment Period 2 (3 Days)||12
8079037|NCT03673670|19921274|P3|COMPLETED|Treatment Period 2 (3 Days)||11
8079038|NCT03673670|19921275|P2|COMPLETED|Treatment Period 2 (3 Days)||14
8079039|NCT03673670|19921276|P1|COMPLETED|Treatment Period 2 (3 Days)||13
8079040|NCT03673670|19921271|P6|STARTED|Treatment Period 2 (3 Days)||11
8079041|NCT03673670|19921272|P5|STARTED|Treatment Period 2 (3 Days)||13
8079042|NCT03673670|19921273|P4|STARTED|Treatment Period 2 (3 Days)||12
8079043|NCT03673670|19921274|P3|STARTED|Treatment Period 2 (3 Days)||12
8079044|NCT03673670|19921275|P2|STARTED|Treatment Period 2 (3 Days)||14
8079045|NCT03673670|19921276|P1|STARTED|Treatment Period 2 (3 Days)||13
8079046|NCT03673670|19921271|P6|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079047|NCT03673670|19921272|P5|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079048|NCT03673670|19921273|P4|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079049|NCT03673670|19921274|P3|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079050|NCT03673670|19921275|P2|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079051|NCT03673670|19921276|P1|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079052|NCT03673670|19921271|P6|COMPLETED|Washout Period 1 (7-14 Days)||11
8079053|NCT03673670|19921272|P5|COMPLETED|Washout Period 1 (7-14 Days)||13
8079054|NCT03673670|19921273|P4|COMPLETED|Washout Period 1 (7-14 Days)||12
8079055|NCT03673670|19921274|P3|COMPLETED|Washout Period 1 (7-14 Days)||12
8079056|NCT03673670|19921275|P2|COMPLETED|Washout Period 1 (7-14 Days)||14
8079057|NCT03673670|19921276|P1|COMPLETED|Washout Period 1 (7-14 Days)||13
8079058|NCT03673670|19921271|P6|STARTED|Washout Period 1 (7-14 Days)||11
8079059|NCT03673670|19921272|P5|STARTED|Washout Period 1 (7-14 Days)||13
8079060|NCT03673670|19921273|P4|STARTED|Washout Period 1 (7-14 Days)||12
8079061|NCT03673670|19921274|P3|STARTED|Washout Period 1 (7-14 Days)||12
8079062|NCT03673670|19921275|P2|STARTED|Washout Period 1 (7-14 Days)||14
8079063|NCT03673670|19921276|P1|STARTED|Washout Period 1 (7-14 Days)||13
8079064|NCT03673670|19921271|P6|NOT COMPLETED|Treatment Period 1 (3 Days)||2
8079065|NCT03673670|19921272|P5|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8079066|NCT03673670|19921273|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8079067|NCT03673670|19921274|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||1
8079068|NCT03673670|19921275|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8079069|NCT03673670|19921276|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||1
8079070|NCT03673670|19921271|P6|COMPLETED|Treatment Period 1 (3 Days)||11
8079071|NCT03673670|19921272|P5|COMPLETED|Treatment Period 1 (3 Days)||13
8079072|NCT03673670|19921273|P4|COMPLETED|Treatment Period 1 (3 Days)||12
8079073|NCT03673670|19921274|P3|COMPLETED|Treatment Period 1 (3 Days)||12
8079074|NCT03673670|19921275|P2|COMPLETED|Treatment Period 1 (3 Days)||14
8079075|NCT03673670|19921276|P1|COMPLETED|Treatment Period 1 (3 Days)||13
8079076|NCT03673670|19921271|P6|STARTED|Treatment Period 1 (3 Days)||13
8079077|NCT03673670|19921272|P5|STARTED|Treatment Period 1 (3 Days)||13
8079078|NCT03673670|19921273|P4|STARTED|Treatment Period 1 (3 Days)||12
8079079|NCT03673670|19921274|P3|STARTED|Treatment Period 1 (3 Days)||13
8079080|NCT03673670|19921275|P2|STARTED|Treatment Period 1 (3 Days)||14
8079081|NCT03673670|19921276|P1|STARTED|Treatment Period 1 (3 Days)||14
8079082|NCT03672396|19921323|P1|NOT COMPLETED|Overall Study||6
8079083|NCT03672396|19921323|P1|COMPLETED|Overall Study||16
8079084|NCT03672396|19921323|P1|STARTED|Overall Study||22
8079085|NCT03672370|19921346|P1|NOT COMPLETED|Overall Study||47
8079086|NCT03672370|19921346|P1|COMPLETED|Overall Study||42
8079087|NCT03672370|19921346|P1|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
8079088|NCT03670537|19921353|P1|NOT COMPLETED|Overall Study||1
8079089|NCT03670537|19921353|P1|COMPLETED|Overall Study||101
8079090|NCT03670537|19921353|P1|STARTED|Overall Study||102
8079091|NCT03669081|19921359|P2|NOT COMPLETED|Overall Study||1
8079092|NCT03669081|19921360|P1|NOT COMPLETED|Overall Study||1
8079093|NCT03669081|19921359|P2|COMPLETED|Overall Study||29
8079094|NCT03669081|19921360|P1|COMPLETED|Overall Study||33
8079095|NCT03669081|19921359|P2|STARTED|Overall Study||30
8079096|NCT03669081|19921360|P1|STARTED|Overall Study||34
8079097|NCT03668600|19921376|P1|NOT COMPLETED|Overall Study||230
8079098|NCT03668600|19921376|P1|COMPLETED|Overall Study||0
8079099|NCT03668600|19921376|P1|STARTED|Overall Study||230
8079100|NCT03667547|19921380|P1|NOT COMPLETED|Overall Study||0
8079101|NCT03667547|19921380|P1|COMPLETED|Overall Study||12
8079102|NCT03667547|19921380|P1|STARTED|Overall Study||12
8079103|NCT03664544|19921396|P2|NOT COMPLETED|Overall Study||0
8079104|NCT03664544|19921397|P1|NOT COMPLETED|Overall Study||0
8079105|NCT03664544|19921396|P2|COMPLETED|Overall Study||6
8079106|NCT03664544|19921397|P1|COMPLETED|Overall Study||6
8079107|NCT03664544|19921396|P2|STARTED|Overall Study||6
8079108|NCT03664544|19921397|P1|STARTED|Overall Study||6
8079109|NCT03664193|19921427|P1|NOT COMPLETED|Overall Study||0
8079110|NCT03664193|19921427|P1|COMPLETED|Overall Study||30
8079111|NCT03664193|19921427|P1|STARTED|Overall Study||30
8079112|NCT03663582|19921434|P1|NOT COMPLETED|Overall Study||1
8079113|NCT03663582|19921434|P1|COMPLETED|Overall Study||6
8079114|NCT03663582|19921434|P1|STARTED|Overall Study||7
8079115|NCT03663569|19921466|P1|NOT COMPLETED|Overall Study||63
8079116|NCT03663569|19921466|P1|COMPLETED|Overall Study||4756
8079117|NCT03663569|19921466|P1|STARTED|Overall Study||4819
8079118|NCT03663231|19921479|P2|NOT COMPLETED|Second Intervention||0
8079119|NCT03663231|19921480|P1|NOT COMPLETED|Second Intervention||0
8079120|NCT03663231|19921479|P2|COMPLETED|Second Intervention||12
8079121|NCT03663231|19921480|P1|COMPLETED|Second Intervention||14
8079122|NCT03663231|19921479|P2|STARTED|Second Intervention||12
8079123|NCT03663231|19921480|P1|STARTED|Second Intervention||14
8079124|NCT03663231|19921479|P2|NOT COMPLETED|Washout||0
8079125|NCT03663231|19921480|P1|NOT COMPLETED|Washout||0
8079126|NCT03663231|19921479|P2|COMPLETED|Washout||12
8079127|NCT03663231|19921480|P1|COMPLETED|Washout||14
8079128|NCT03663231|19921479|P2|STARTED|Washout||12
8079129|NCT03663231|19921480|P1|STARTED|Washout||14
8079130|NCT03663231|19921479|P2|NOT COMPLETED|First Intervention||1
8079131|NCT03663231|19921480|P1|NOT COMPLETED|First Intervention||2
8079132|NCT03663231|19921479|P2|COMPLETED|First Intervention||12
8079133|NCT03663231|19921480|P1|COMPLETED|First Intervention||14
8079134|NCT03663231|19921479|P2|STARTED|First Intervention||13
8079135|NCT03663231|19921480|P1|STARTED|First Intervention||16
8079136|NCT03663179|19921500|P2|NOT COMPLETED|Overall Study||1
8079137|NCT03663179|19921501|P1|NOT COMPLETED|Overall Study||4
8079138|NCT03663179|19921500|P2|COMPLETED|Overall Study||13
8079139|NCT03663179|19921501|P1|COMPLETED|Overall Study||14
8079140|NCT03663179|19921500|P2|STARTED|Overall Study||14
8079141|NCT03663179|19921501|P1|STARTED|Overall Study||18
8079142|NCT03663101|19921513|P4|NOT COMPLETED|Overall Study||0
8079143|NCT03663101|19921514|P3|NOT COMPLETED|Overall Study||0
8079144|NCT03663101|19921515|P2|NOT COMPLETED|Overall Study||0
8079145|NCT03663101|19921516|P1|NOT COMPLETED|Overall Study||0
8079146|NCT03663101|19921513|P4|COMPLETED|Overall Study||4
8079147|NCT03663101|19921514|P3|COMPLETED|Overall Study||5
8079148|NCT03663101|19921515|P2|COMPLETED|Overall Study||3
8079149|NCT03663101|19921516|P1|COMPLETED|Overall Study||4
8079150|NCT03663101|19921513|P4|STARTED|Overall Study||4
8079151|NCT03663101|19921514|P3|STARTED|Overall Study||5
8079152|NCT03663101|19921515|P2|STARTED|Overall Study||3
8079153|NCT03663101|19921516|P1|STARTED|Overall Study||4
8079154|NCT03662334|19921548|P2|NOT COMPLETED|Part 3: Treatment Period 2||0
8079155|NCT03662334|19921549|P1|NOT COMPLETED|Part 3: Treatment Period 2||0
8079156|NCT03662334|19921548|P2|COMPLETED|Part 3: Treatment Period 2||0
8079157|NCT03662334|19921549|P1|COMPLETED|Part 3: Treatment Period 2||0
8079158|NCT03662334|19921548|P2|STARTED|Part 3: Treatment Period 2||0
8079159|NCT03662334|19921549|P1|STARTED|Part 3: Treatment Period 2||0
8079160|NCT03662334|19921548|P2|NOT COMPLETED|Part 3: Treatment Period 1||0
8079161|NCT03662334|19921549|P1|NOT COMPLETED|Part 3: Treatment Period 1||0
8079162|NCT03662334|19921548|P2|COMPLETED|Part 3: Treatment Period 1||0
8079163|NCT03662334|19921549|P1|COMPLETED|Part 3: Treatment Period 1||0
8079164|NCT03662334|19921548|P2|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
8079165|NCT03662334|19921549|P1|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
8079166|NCT03662334|19921548|P2|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
8079167|NCT03662334|19921549|P1|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
8079168|NCT03662334|19921548|P2|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
8079169|NCT03662334|19921549|P1|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
8079170|NCT03662334|19921548|P2|STARTED|Part 2: Treatment Period 2 (2 Days)||7
8079171|NCT03662334|19921549|P1|STARTED|Part 2: Treatment Period 2 (2 Days)||7
8079172|NCT03662334|19921548|P2|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
8079173|NCT03662334|19921549|P1|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
8079174|NCT03662334|19921548|P2|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
8079175|NCT03662334|19921549|P1|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
8079176|NCT03662334|19921548|P2|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
8079177|NCT03662334|19921549|P1|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
8079178|NCT03662334|19921548|P2|NOT COMPLETED|Part 1: Treatment Period 2||0
8079179|NCT03662334|19921549|P1|NOT COMPLETED|Part 1: Treatment Period 2||0
8079180|NCT03662334|19921548|P2|COMPLETED|Part 1: Treatment Period 2||0
8079181|NCT03662334|19921549|P1|COMPLETED|Part 1: Treatment Period 2||0
8079182|NCT03662334|19921548|P2|STARTED|Part 1: Treatment Period 2||0
8079183|NCT03662334|19921549|P1|STARTED|Part 1: Treatment Period 2||0
8079184|NCT03662334|19921548|P2|NOT COMPLETED|Part 1: Treatment Period 1||0
8079185|NCT03662334|19921549|P1|NOT COMPLETED|Part 1: Treatment Period 1||0
8079186|NCT03662334|19921548|P2|COMPLETED|Part 1: Treatment Period 1||0
8079187|NCT03662334|19921549|P1|COMPLETED|Part 1: Treatment Period 1||0
8079188|NCT03662334|19921548|P2|STARTED|Part 1: Treatment Period 1||0
8079189|NCT03662334|19921549|P1|STARTED|Part 1: Treatment Period 1||0
8079190|NCT03662282|19921585|P1|NOT COMPLETED|Overall Study||0
8079191|NCT03662282|19921585|P1|COMPLETED|Overall Study||2
8079192|NCT03662282|19921585|P1|STARTED|Overall Study||2
8079193|NCT03662139|19921595|P2|NOT COMPLETED|Overall Study||0
8079194|NCT03662139|19921596|P1|NOT COMPLETED|Overall Study||0
8079195|NCT03662139|19921595|P2|COMPLETED|Overall Study||16
8079196|NCT03662139|19921596|P1|COMPLETED|Overall Study||16
8079197|NCT03662139|19921595|P2|STARTED|Overall Study||16
8079198|NCT03662139|19921596|P1|STARTED|Overall Study||16
8079199|NCT03661983|19921608|P4|NOT COMPLETED|Double-blind Randomized Phase||8
8079200|NCT03661983|19921609|P3|NOT COMPLETED|Double-blind Randomized Phase||1
8079201|NCT03661983|19921610|P2|NOT COMPLETED|Double-blind Randomized Phase||2
8079202|NCT03661983|19921611|P1|NOT COMPLETED|Double-blind Randomized Phase||0
8079203|NCT03661983|19921608|P4|COMPLETED|Double-blind Randomized Phase||0
8079204|NCT03661983|19921609|P3|COMPLETED|Double-blind Randomized Phase||7
8079205|NCT03661983|19921610|P2|COMPLETED|Double-blind Randomized Phase||7
8079206|NCT03661983|19921611|P1|COMPLETED|Double-blind Randomized Phase||0
8079207|NCT03661983|19921608|P4|STARTED|Double-blind Randomized Phase||8
8079208|NCT03661983|19921609|P3|STARTED|Double-blind Randomized Phase||8
8079209|NCT03661983|19921610|P2|STARTED|Double-blind Randomized Phase||9
8079210|NCT03661983|19921611|P1|STARTED|Double-blind Randomized Phase||0
8079211|NCT03661983|19921608|P4|NOT COMPLETED|Open Label Stabilization Phase||0
8079212|NCT03661983|19921609|P3|NOT COMPLETED|Open Label Stabilization Phase||0
8079213|NCT03661983|19921610|P2|NOT COMPLETED|Open Label Stabilization Phase||0
8079214|NCT03661983|19921611|P1|NOT COMPLETED|Open Label Stabilization Phase||11
8079215|NCT03661983|19921608|P4|COMPLETED|Open Label Stabilization Phase||0
8079216|NCT03661983|19921609|P3|COMPLETED|Open Label Stabilization Phase||0
8079217|NCT03661983|19921610|P2|COMPLETED|Open Label Stabilization Phase||0
8079218|NCT03661983|19921611|P1|COMPLETED|Open Label Stabilization Phase||25
8079219|NCT03661983|19921608|P4|STARTED|Open Label Stabilization Phase||0
8079220|NCT03661983|19921609|P3|STARTED|Open Label Stabilization Phase||0
8079221|NCT03661983|19921610|P2|STARTED|Open Label Stabilization Phase||0
8079222|NCT03661983|19921611|P1|STARTED|Open Label Stabilization Phase||36
8079223|NCT03661814|19921622|P2|NOT COMPLETED|Overall Study||0
8079224|NCT03661814|19921623|P1|NOT COMPLETED|Overall Study||0
8079225|NCT03661814|19921622|P2|COMPLETED|Overall Study||5
8079226|NCT03661814|19921623|P1|COMPLETED|Overall Study||2
8079227|NCT03661814|19921622|P2|STARTED|Overall Study||5
8079228|NCT03661814|19921623|P1|STARTED|Overall Study||2
8079229|NCT03661762|19921633|P1|NOT COMPLETED|Overall Study||8
8079230|NCT03661762|19921633|P1|COMPLETED|Overall Study||10
8079231|NCT03661762|19921633|P1|STARTED|Overall Study||18
8079232|NCT03661697|19921647|P2|NOT COMPLETED|Overall Study||0
8079233|NCT03661697|19921648|P1|NOT COMPLETED|Overall Study||0
8079234|NCT03661697|19921647|P2|COMPLETED|Overall Study||7
8079235|NCT03661697|19921648|P1|COMPLETED|Overall Study||7
8079236|NCT03661697|19921647|P2|STARTED|Overall Study||7
8079237|NCT03661697|19921648|P1|STARTED|Overall Study||7
8079238|NCT03660839|19921660|P4|NOT COMPLETED|Overall Study||0
8079239|NCT03660839|19921661|P3|NOT COMPLETED|Overall Study||0
8079240|NCT03660839|19921662|P2|NOT COMPLETED|Overall Study||0
8079241|NCT03660839|19921663|P1|NOT COMPLETED|Overall Study||0
8079242|NCT03660839|19921660|P4|COMPLETED|Overall Study||33
8079243|NCT03660839|19921661|P3|COMPLETED|Overall Study||36
8079244|NCT03660839|19921662|P2|COMPLETED|Overall Study||36
8079245|NCT03660839|19921663|P1|COMPLETED|Overall Study||35
8079246|NCT03660839|19921660|P4|STARTED|Overall Study||33
8079247|NCT03660839|19921661|P3|STARTED|Overall Study||36
8079248|NCT03660839|19921662|P2|STARTED|Overall Study||36
8079249|NCT03660839|19921663|P1|STARTED|Overall Study||35
8079250|NCT03660787|19921767|P4|NOT COMPLETED|Overall Study||0
8079251|NCT03660787|19921768|P3|NOT COMPLETED|Overall Study||1
8079252|NCT03660787|19921769|P2|NOT COMPLETED|Overall Study||1
8079253|NCT03660787|19921770|P1|NOT COMPLETED|Overall Study||1
8079254|NCT03660787|19921767|P4|COMPLETED|Overall Study||26
8079255|NCT03660787|19921768|P3|COMPLETED|Overall Study||25
8079256|NCT03660787|19921769|P2|COMPLETED|Overall Study||25
8079257|NCT03660787|19921770|P1|COMPLETED|Overall Study||25
8079258|NCT03660787|19921767|P4|STARTED|Overall Study||26
8079259|NCT03660787|19921768|P3|STARTED|Overall Study||26
8079260|NCT03660787|19921769|P2|STARTED|Overall Study||26
8079261|NCT03660787|19921770|P1|STARTED|Overall Study||26
8079262|NCT03660241|19921807|P3|NOT COMPLETED|Overall Study||0
8079263|NCT03660241|19921808|P2|NOT COMPLETED|Overall Study||0
8079264|NCT03660241|19921809|P1|NOT COMPLETED|Overall Study||0
8079265|NCT03660241|19921807|P3|COMPLETED|Overall Study||8
8079266|NCT03660241|19921808|P2|COMPLETED|Overall Study||7
8079267|NCT03660241|19921809|P1|COMPLETED|Overall Study||8
8079268|NCT03660241|19921807|P3|STARTED|Overall Study||8
8079269|NCT03660241|19921808|P2|STARTED|Overall Study||7
8079270|NCT03660241|19921809|P1|STARTED|Overall Study||8
8079271|NCT03658889|19921852|P2|NOT COMPLETED|Overall Study||0
8079272|NCT03658889|19921853|P1|NOT COMPLETED|Overall Study||2
8079273|NCT03658889|19921852|P2|COMPLETED|Overall Study||69
8079274|NCT03658889|19921853|P1|COMPLETED|Overall Study|Analysis population|306
8079275|NCT03658889|19921852|P2|STARTED|Overall Study||69
8079276|NCT03658889|19921853|P1|STARTED|Overall Study|Enrolled population|308
8079277|NCT03658876|19921884|P2|NOT COMPLETED|Overall Study||12
8079278|NCT03658876|19921885|P1|NOT COMPLETED|Overall Study||12
8079279|NCT03658876|19921884|P2|COMPLETED|Overall Study||84
8079280|NCT03658876|19921885|P1|COMPLETED|Overall Study||76
8079281|NCT03658876|19921884|P2|STARTED|Overall Study||96
8079282|NCT03658876|19921885|P1|STARTED|Overall Study||88
8079283|NCT03658811|19921891|P1|NOT COMPLETED|Overall Study||3
8079284|NCT03658811|19921891|P1|COMPLETED|Overall Study||16
8079285|NCT03658811|19921891|P1|STARTED|Overall Study||19
8079286|NCT03657407|19921900|P2|NOT COMPLETED|Overall Study||0
8079287|NCT03657407|19921901|P1|NOT COMPLETED|Overall Study||0
8079288|NCT03657407|19921900|P2|COMPLETED|Overall Study||27
8079289|NCT03657407|19921901|P1|COMPLETED|Overall Study||29
8079290|NCT03657407|19921900|P2|STARTED|Overall Study||27
8079291|NCT03657407|19921901|P1|STARTED|Overall Study||29
8079292|NCT03657264|19921917|P4|NOT COMPLETED|Overall Study||0
8079293|NCT03657264|19921918|P3|NOT COMPLETED|Overall Study||0
8079294|NCT03657264|19921919|P2|NOT COMPLETED|Overall Study||0
8079295|NCT03657264|19921920|P1|NOT COMPLETED|Overall Study||0
8079296|NCT03657264|19921917|P4|COMPLETED|Overall Study||12
8079297|NCT03657264|19921918|P3|COMPLETED|Overall Study||12
8079298|NCT03657264|19921919|P2|COMPLETED|Overall Study||12
8079299|NCT03657264|19921920|P1|COMPLETED|Overall Study||12
8079300|NCT03657264|19921917|P4|STARTED|Overall Study||12
8079301|NCT03657264|19921918|P3|STARTED|Overall Study||12
8079302|NCT03657264|19921919|P2|STARTED|Overall Study||12
8079303|NCT03657264|19921920|P1|STARTED|Overall Study||12
8079304|NCT03657095|19921935|P2|NOT COMPLETED|Overall Study||53
8079305|NCT03657095|19921936|P1|NOT COMPLETED|Overall Study||59
8079306|NCT03657095|19921935|P2|COMPLETED|Overall Study||0
8079307|NCT03657095|19921936|P1|COMPLETED|Overall Study||0
8079308|NCT03657095|19921935|P2|Received at Least 1 Dose of Study Drug|Overall Study||53
8079309|NCT03657095|19921936|P1|Received at Least 1 Dose of Study Drug|Overall Study||59
8079310|NCT03657095|19921935|P2|STARTED|Overall Study||53
8079311|NCT03657095|19921936|P1|STARTED|Overall Study||59
8079312|NCT03655951|19921952|P2|NOT COMPLETED|Overall Study||21
8079313|NCT03655951|19921953|P1|NOT COMPLETED|Overall Study||39
8079314|NCT03655951|19921952|P2|COMPLETED|Overall Study||351
8079315|NCT03655951|19921953|P1|COMPLETED|Overall Study||319
8079316|NCT03655951|19921952|P2|Completed Pretest|Overall Study||366
8079317|NCT03655951|19921953|P1|Completed Pretest|Overall Study||344
8079318|NCT03655951|19921952|P2|STARTED|Overall Study||372
8079319|NCT03655951|19921953|P1|STARTED|Overall Study||358
8079320|NCT03655444|19922115|P2|NOT COMPLETED|Overall Study||0
8079321|NCT03655444|19922116|P1|NOT COMPLETED|Overall Study||0
8079322|NCT03655444|19922115|P2|COMPLETED|Overall Study||3
8079323|NCT03655444|19922116|P1|COMPLETED|Overall Study||3
8079324|NCT03655444|19922115|P2|STARTED|Overall Study||3
8079325|NCT03655444|19922116|P1|STARTED|Overall Study||3
8079326|NCT03655301|19922130|P1|NOT COMPLETED|Overall Study||0
8079327|NCT03655301|19922130|P1|COMPLETED|Overall Study||13
8079328|NCT03655301|19922130|P1|STARTED|Overall Study||13
8079329|NCT03655106|19922142|P2|NOT COMPLETED|Overall Study||4
8079330|NCT03655106|19922143|P1|NOT COMPLETED|Overall Study||9
8079331|NCT03655106|19922142|P2|COMPLETED|Overall Study||131
8079332|NCT03655106|19922143|P1|COMPLETED|Overall Study||126
8079333|NCT03655106|19922142|P2|STARTED|Overall Study||135
8079334|NCT03655106|19922143|P1|STARTED|Overall Study||135
8079335|NCT03654560|19922155|P2|NOT COMPLETED|Overall Study||1
8079336|NCT03654560|19922156|P1|NOT COMPLETED|Overall Study||4
8079337|NCT03654560|19922155|P2|COMPLETED|Overall Study||117
8079338|NCT03654560|19922156|P1|COMPLETED|Overall Study||114
8079339|NCT03654560|19922155|P2|STARTED|Overall Study||118
8079340|NCT03654560|19922156|P1|STARTED|Overall Study||118
8079341|NCT03654417|19922172|P2|NOT COMPLETED|Overall Study||0
8079342|NCT03654417|19922173|P1|NOT COMPLETED|Overall Study||0
8079343|NCT03654417|19922172|P2|COMPLETED|Overall Study||18
8079344|NCT03654417|19922173|P1|COMPLETED|Overall Study||19
8079345|NCT03654417|19922172|P2|STARTED|Overall Study||18
8079346|NCT03654417|19922173|P1|STARTED|Overall Study||19
8079347|NCT03653429|19922197|P2|NOT COMPLETED|Overall Study||10
8079348|NCT03653429|19922198|P1|NOT COMPLETED|Overall Study||4
8079349|NCT03653429|19922197|P2|COMPLETED|Overall Study||41
8079350|NCT03653429|19922198|P1|COMPLETED|Overall Study||45
8079351|NCT03653429|19922197|P2|STARTED|Overall Study||51
8079352|NCT03653429|19922198|P1|STARTED|Overall Study||49
8079353|NCT03653416|19922212|P2|NOT COMPLETED|Overall Study||1
8079354|NCT03653416|19922213|P1|NOT COMPLETED|Overall Study||6
8079355|NCT03653416|19922212|P2|COMPLETED|Overall Study||46
8079356|NCT03653416|19922213|P1|COMPLETED|Overall Study||46
8079357|NCT03653416|19922212|P2|STARTED|Overall Study||47
8079358|NCT03653416|19922213|P1|STARTED|Overall Study||52
8079359|NCT03651856|19922231|P1|NOT COMPLETED|Overall Study||0
8079360|NCT03651856|19922231|P1|COMPLETED|Overall Study||10
8079361|NCT03651856|19922231|P1|STARTED|Overall Study||10
8079362|NCT03651479|19922237|P2|NOT COMPLETED|Overall Study||0
8079363|NCT03651479|19922238|P1|NOT COMPLETED|Overall Study||0
8079364|NCT03651479|19922237|P2|COMPLETED|Overall Study||20
8079365|NCT03651479|19922238|P1|COMPLETED|Overall Study||20
8079366|NCT03651479|19922237|P2|STARTED|Overall Study||20
8079367|NCT03651479|19922238|P1|STARTED|Overall Study||20
8079368|NCT03650842|19922254|P1|NOT COMPLETED|Overall Study||0
8079369|NCT03650842|19922254|P1|COMPLETED|Overall Study||25
8079370|NCT03650842|19922254|P1|STARTED|Overall Study||25
8079371|NCT03650400|19922263|P2|NOT COMPLETED|Overall Study||5
8079372|NCT03650400|19922264|P1|NOT COMPLETED|Overall Study||0
8079373|NCT03650400|19922263|P2|COMPLETED|Overall Study||0
8079374|NCT03650400|19922264|P1|COMPLETED|Overall Study||6
8079375|NCT03650400|19922263|P2|STARTED|Overall Study||5
8079376|NCT03650400|19922264|P1|STARTED|Overall Study||6
8079377|NCT03649867|19922292|P1|NOT COMPLETED|Overall Study||0
8079378|NCT03649867|19922292|P1|COMPLETED|Overall Study||13
8079379|NCT03649867|19922292|P1|STARTED|Overall Study||13
8079380|NCT03649815|19922296|P1|NOT COMPLETED|Overall Study||0
8079381|NCT03649815|19922296|P1|COMPLETED|Overall Study||38
8079382|NCT03649815|19922296|P1|STARTED|Overall Study||38
8079383|NCT03649750|19922302|P2|NOT COMPLETED|Period 2||0
8079384|NCT03649750|19922303|P1|NOT COMPLETED|Period 2||0
8079385|NCT03649750|19922302|P2|COMPLETED|Period 2||24
8079386|NCT03649750|19922303|P1|COMPLETED|Period 2||12
8079387|NCT03649750|19922302|P2|STARTED|Period 2||24
8079388|NCT03649750|19922303|P1|STARTED|Period 2||12
8079389|NCT03649750|19922302|P2|NOT COMPLETED|Washout: 7 Days||0
8079390|NCT03649750|19922303|P1|NOT COMPLETED|Washout: 7 Days||0
8079391|NCT03649750|19922302|P2|COMPLETED|Washout: 7 Days||24
8079392|NCT03649750|19922303|P1|COMPLETED|Washout: 7 Days||12
8079393|NCT03649750|19922302|P2|STARTED|Washout: 7 Days||24
8079394|NCT03649750|19922303|P1|STARTED|Washout: 7 Days||12
8079395|NCT03649750|19922302|P2|NOT COMPLETED|Period 1||0
8079396|NCT03649750|19922303|P1|NOT COMPLETED|Period 1||0
8079397|NCT03649750|19922302|P2|COMPLETED|Period 1||24
8079398|NCT03649750|19922303|P1|COMPLETED|Period 1||12
8079399|NCT03649750|19922302|P2|STARTED|Period 1||24
8079400|NCT03649750|19922303|P1|STARTED|Period 1||12
8079401|NCT03649646|19922322|P1|NOT COMPLETED|Overall Study||467
8079402|NCT03649646|19922322|P1|COMPLETED|Overall Study||4075
8079403|NCT03649646|19922322|P1|STARTED|Overall Study||4542
8079404|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 6 (4days)||0
8079405|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 6 (4days)||0
8079406|NCT03649412|19922331|P2|COMPLETED|Part B, Period 6 (4days)||14
8079407|NCT03649412|19922332|P1|COMPLETED|Part B, Period 6 (4days)||0
8079408|NCT03649412|19922331|P2|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
8079409|NCT03649412|19922332|P1|STARTED|Part B, Period 6 (4days)||0
8079410|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
8079411|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
8079412|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 5 (7 Days)||13
8079413|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 5 (7 Days)||0
8079414|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 5 (7 Days)||14
8079415|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 5 (7 Days)||0
8079416|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 5 (4 Days)||0
8079417|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 5 (4 Days)||0
8079418|NCT03649412|19922331|P2|COMPLETED|Part B, Period 5 (4 Days)||14
8079419|NCT03649412|19922332|P1|COMPLETED|Part B, Period 5 (4 Days)||0
8079420|NCT03649412|19922331|P2|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
8079421|NCT03649412|19922332|P1|STARTED|Part B, Period 5 (4 Days)||0
8079422|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
8079423|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
8079424|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 4 (7 Days)||15
8079425|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 4 (7 Days)||0
8079426|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 4 (7 Days)||15
8079427|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 4 (7 Days)||0
8079428|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 4 (4 Days)||0
8079429|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 4 (4 Days)||0
8079430|NCT03649412|19922331|P2|COMPLETED|Part B, Period 4 (4 Days)||15
8079431|NCT03649412|19922332|P1|COMPLETED|Part B, Period 4 (4 Days)||0
8079432|NCT03649412|19922331|P2|STARTED|Part B, Period 4 (4 Days)||15
8079433|NCT03649412|19922332|P1|STARTED|Part B, Period 4 (4 Days)||0
8079434|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
8079435|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
8079436|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 3 (7 Days)||15
8079437|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 3 (7 Days)||0
8079438|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 3 (7 Days)||15
8079439|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 3 (7 Days)||0
8079440|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 3 (4 Days)||0
8079441|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 3 (4 Days)||0
8079442|NCT03649412|19922331|P2|COMPLETED|Part B, Period 3 (4 Days)||15
8079443|NCT03649412|19922332|P1|COMPLETED|Part B, Period 3 (4 Days)||0
8079444|NCT03649412|19922331|P2|STARTED|Part B, Period 3 (4 Days)||15
8079445|NCT03649412|19922332|P1|STARTED|Part B, Period 3 (4 Days)||0
8079446|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
8079447|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
8079448|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 2 (7 Days)||15
8079449|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 2 (7 Days)||0
8079450|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 2 (7 Days)||15
8079451|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 2 (7 Days)||0
8079452|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 2 (4 Days)||0
8079453|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 2 (4 Days)||0
8079454|NCT03649412|19922331|P2|COMPLETED|Part B, Period 2 (4 Days)||15
8079455|NCT03649412|19922332|P1|COMPLETED|Part B, Period 2 (4 Days)||0
8079456|NCT03649412|19922331|P2|STARTED|Part B, Period 2 (4 Days)||15
8079457|NCT03649412|19922332|P1|STARTED|Part B, Period 2 (4 Days)||0
8079458|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
8079459|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
8079460|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 1 (7 Days)||15
8079461|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 1 (7 Days)||0
8079462|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 1 (7 Days)||16
8079463|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 1 (7 Days)||0
8079464|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 1 (4 Days)||0
8079465|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 1 (4 Days)||0
8079466|NCT03649412|19922331|P2|COMPLETED|Part B, Period 1 (4 Days)||16
8079467|NCT03649412|19922332|P1|COMPLETED|Part B, Period 1 (4 Days)||0
8079468|NCT03649412|19922331|P2|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
8079469|NCT03649412|19922332|P1|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
8079470|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 6 (4 Days)||0
8079471|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 6 (4 Days)||0
8079472|NCT03649412|19922331|P2|COMPLETED|Part A, Period 6 (4 Days)||0
8079473|NCT03649412|19922332|P1|COMPLETED|Part A, Period 6 (4 Days)||12
8079474|NCT03649412|19922331|P2|STARTED|Part A, Period 6 (4 Days)||0
8079475|NCT03649412|19922332|P1|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
8079476|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
8079477|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
8079478|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 5 (7 Days)||0
8079479|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 5 (7 Days)||11
8079480|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 5 (7 Days)||0
8079481|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 5 (7 Days)||12
8079482|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 5 (4 Days)||0
8079483|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 5 (4 Days)||0
8079484|NCT03649412|19922331|P2|COMPLETED|Part A, Period 5 (4 Days)||0
8079485|NCT03649412|19922332|P1|COMPLETED|Part A, Period 5 (4 Days)||12
8079486|NCT03649412|19922331|P2|STARTED|Part A, Period 5 (4 Days)||0
8079487|NCT03649412|19922332|P1|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
8079488|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
8079489|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
8079490|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 4 (7 Days)||0
8079491|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 4 (7 Days)||14
8079492|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 4 (7 Days)||0
8079493|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 4 (7 Days)||16
8079494|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 4 (4 Days)||0
8079495|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 4 (4 Days)||0
8079496|NCT03649412|19922331|P2|COMPLETED|Part A, Period 4 (4 Days)||0
8079497|NCT03649412|19922332|P1|COMPLETED|Part A, Period 4 (4 Days)||16
8079498|NCT03649412|19922331|P2|STARTED|Part A, Period 4 (4 Days)||0
8079499|NCT03649412|19922332|P1|STARTED|Part A, Period 4 (4 Days)||16
8079500|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
8079501|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
8079502|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 3 (7 Days)||0
8079503|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 3 (7 Days)||16
8079504|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 3 (7 Days)||0
8079505|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 3 (7 Days)||16
8079506|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 3 (4 Days)||0
8079507|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 3 (4 Days)||0
8079508|NCT03649412|19922331|P2|COMPLETED|Part A, Period 3 (4 Days)||0
8079509|NCT03649412|19922332|P1|COMPLETED|Part A, Period 3 (4 Days)||16
8079510|NCT03649412|19922331|P2|STARTED|Part A, Period 3 (4 Days)||0
8079511|NCT03649412|19922332|P1|STARTED|Part A, Period 3 (4 Days)||16
8079512|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
8079513|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
8079514|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 2 (7 Days)||0
8079515|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 2 (7 Days)||16
8079516|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 2 (7 Days)||0
8079517|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 2 (7 Days)||16
8079518|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 2 (3 Days)||0
8079519|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 2 (3 Days)||0
8079520|NCT03649412|19922331|P2|COMPLETED|Part A, Period 2 (3 Days)||0
8079521|NCT03649412|19922332|P1|COMPLETED|Part A, Period 2 (3 Days)||16
8079522|NCT03649412|19922331|P2|STARTED|Part A, Period 2 (3 Days)||0
8079523|NCT03649412|19922332|P1|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
8079524|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
8079525|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
8079526|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 1 (7 Days)||0
8079527|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 1 (7 Days)||15
8079528|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 1 (7 Days)||0
8079529|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 1 (7 Days)||16
8079530|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 1 (4 Days)||0
8079531|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 1 (4 Days)||0
8079532|NCT03649412|19922331|P2|COMPLETED|Part A, Period 1 (4 Days)||0
8079533|NCT03649412|19922332|P1|COMPLETED|Part A, Period 1 (4 Days)||16
8079534|NCT03649412|19922331|P2|STARTED|Part A, Period 1 (4 Days)||0
8079535|NCT03649412|19922332|P1|STARTED|Part A, Period 1 (4 Days)||16
8079536|NCT03648983|19922490|P1|NOT COMPLETED|Overall Study||95
8079537|NCT03648983|19922490|P1|COMPLETED|Overall Study||0
8079538|NCT03648983|19922490|P1|STARTED|Overall Study||95
8079539|NCT03648853|19922496|P1|NOT COMPLETED|Overall Study||0
8079540|NCT03648853|19922496|P1|COMPLETED|Overall Study||12
8079541|NCT03648853|19922496|P1|STARTED|Overall Study||12
8079542|NCT03647709|19922500|P1|NOT COMPLETED|Overall Study||14
8079543|NCT03647709|19922500|P1|COMPLETED|Overall Study||386
8079544|NCT03647709|19922500|P1|STARTED|Overall Study||400
8079545|NCT03647046|19922516|P1|NOT COMPLETED|Overall Study||4
8079546|NCT03647046|19922516|P1|COMPLETED|Overall Study||8
8079547|NCT03647046|19922516|P1|STARTED|Overall Study||12
8079548|NCT03647033|19922522|P2|NOT COMPLETED|Overall Study||0
8079549|NCT03647033|19922523|P1|NOT COMPLETED|Overall Study||0
8079550|NCT03647033|19922522|P2|COMPLETED|Overall Study||16
8079551|NCT03647033|19922523|P1|COMPLETED|Overall Study||16
8079552|NCT03647033|19922522|P2|STARTED|Overall Study||16
8079553|NCT03647033|19922523|P1|STARTED|Overall Study||16
8079554|NCT03646656|19922533|P2|NOT COMPLETED|Overall Study||0
8079555|NCT03646656|19922534|P1|NOT COMPLETED|Overall Study||3
8079556|NCT03646656|19922533|P2|COMPLETED|Overall Study||3
8079557|NCT03646656|19922534|P1|COMPLETED|Overall Study||9
8079558|NCT03646656|19922533|P2|Attended 1st Group Session|Overall Study||3
8079559|NCT03646656|19922534|P1|Attended 1st Group Session|Overall Study||10
8079560|NCT03646656|19922533|P2|STARTED|Overall Study||3
8079561|NCT03646656|19922534|P1|STARTED|Overall Study||12
8079568|NCT03645811|19922573|P3|NOT COMPLETED|Overall Study||2
8079569|NCT03645811|19922574|P2|NOT COMPLETED|Overall Study||2
8079570|NCT03645811|19922575|P1|NOT COMPLETED|Overall Study||2
8079571|NCT03645811|19922573|P3|COMPLETED|Overall Study||30
8079572|NCT03645811|19922574|P2|COMPLETED|Overall Study||30
8079573|NCT03645811|19922575|P1|COMPLETED|Overall Study||30
8079574|NCT03645811|19922573|P3|STARTED|Overall Study||32
8079575|NCT03645811|19922574|P2|STARTED|Overall Study||32
8079576|NCT03645811|19922575|P1|STARTED|Overall Study||32
8079577|NCT03645434|19922583|P6|NOT COMPLETED|Period 3||0
8079578|NCT03645434|19922584|P5|NOT COMPLETED|Period 3||0
8079579|NCT03645434|19922585|P4|NOT COMPLETED|Period 3||0
8079580|NCT03645434|19922586|P3|NOT COMPLETED|Period 3||0
8079581|NCT03645434|19922587|P2|NOT COMPLETED|Period 3||0
8079582|NCT03645434|19922588|P1|NOT COMPLETED|Period 3||0
8079583|NCT03645434|19922583|P6|COMPLETED|Period 3||11
8079584|NCT03645434|19922584|P5|COMPLETED|Period 3||11
8079585|NCT03645434|19922585|P4|COMPLETED|Period 3||10
8079586|NCT03645434|19922586|P3|COMPLETED|Period 3||11
8079587|NCT03645434|19922587|P2|COMPLETED|Period 3||13
8079588|NCT03645434|19922588|P1|COMPLETED|Period 3||10
8079589|NCT03645434|19922583|P6|STARTED|Period 3||11
8079590|NCT03645434|19922584|P5|STARTED|Period 3||11
8079591|NCT03645434|19922585|P4|STARTED|Period 3||10
8079592|NCT03645434|19922586|P3|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
8079593|NCT03645434|19922587|P2|STARTED|Period 3||13
8079594|NCT03645434|19922588|P1|STARTED|Period 3||10
8079595|NCT03645434|19922583|P6|NOT COMPLETED|Period 2||0
8079596|NCT03645434|19922584|P5|NOT COMPLETED|Period 2||0
8079597|NCT03645434|19922585|P4|NOT COMPLETED|Period 2||0
8079598|NCT03645434|19922586|P3|NOT COMPLETED|Period 2||0
8079599|NCT03645434|19922587|P2|NOT COMPLETED|Period 2||0
8079600|NCT03645434|19922588|P1|NOT COMPLETED|Period 2||0
8079601|NCT03645434|19922583|P6|COMPLETED|Period 2||11
8079602|NCT03645434|19922584|P5|COMPLETED|Period 2||11
8079603|NCT03645434|19922585|P4|COMPLETED|Period 2||10
8079604|NCT03645434|19922586|P3|COMPLETED|Period 2||13
8079605|NCT03645434|19922587|P2|COMPLETED|Period 2||13
8079606|NCT03645434|19922588|P1|COMPLETED|Period 2||10
8079607|NCT03645434|19922583|P6|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
8079608|NCT03645434|19922584|P5|STARTED|Period 2||11
8079609|NCT03645434|19922585|P4|STARTED|Period 2||10
8079610|NCT03645434|19922586|P3|STARTED|Period 2||13
8079611|NCT03645434|19922587|P2|STARTED|Period 2||13
8079612|NCT03645434|19922588|P1|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
8079613|NCT03645434|19922583|P6|NOT COMPLETED|Period 1||0
8079614|NCT03645434|19922584|P5|NOT COMPLETED|Period 1||1
8079615|NCT03645434|19922585|P4|NOT COMPLETED|Period 1||1
8079616|NCT03645434|19922586|P3|NOT COMPLETED|Period 1||0
8079617|NCT03645434|19922587|P2|NOT COMPLETED|Period 1||0
8079618|NCT03645434|19922588|P1|NOT COMPLETED|Period 1||0
8079619|NCT03645434|19922583|P6|COMPLETED|Period 1||12
8079620|NCT03645434|19922584|P5|COMPLETED|Period 1||11
8079621|NCT03645434|19922585|P4|COMPLETED|Period 1||10
8079622|NCT03645434|19922586|P3|COMPLETED|Period 1||13
8079623|NCT03645434|19922587|P2|COMPLETED|Period 1||13
8079624|NCT03645434|19922588|P1|COMPLETED|Period 1||12
8079625|NCT03645434|19922583|P6|STARTED|Period 1||12
8079626|NCT03645434|19922584|P5|STARTED|Period 1||12
8079627|NCT03645434|19922585|P4|STARTED|Period 1||11
8079628|NCT03645434|19922586|P3|STARTED|Period 1||13
8079629|NCT03645434|19922587|P2|STARTED|Period 1||13
8079630|NCT03645434|19922588|P1|STARTED|Period 1||12
8079631|NCT03645421|19922639|P4|NOT COMPLETED|Overall Study||4
8079632|NCT03645421|19922640|P3|NOT COMPLETED|Overall Study||5
8079633|NCT03645421|19922641|P2|NOT COMPLETED|Overall Study||0
8079634|NCT03645421|19922642|P1|NOT COMPLETED|Overall Study||0
8079635|NCT03645421|19922639|P4|COMPLETED|Overall Study||11
8079636|NCT03645421|19922640|P3|COMPLETED|Overall Study||10
8079637|NCT03645421|19922641|P2|COMPLETED|Overall Study||15
8079638|NCT03645421|19922642|P1|COMPLETED|Overall Study||16
8079639|NCT03645421|19922639|P4|Received Investigational Product (IP)|Overall Study||15
8079640|NCT03645421|19922640|P3|Received Investigational Product (IP)|Overall Study||15
8079641|NCT03645421|19922641|P2|Received Investigational Product (IP)|Overall Study||15
8079642|NCT03645421|19922642|P1|Received Investigational Product (IP)|Overall Study||16
8079643|NCT03645421|19922639|P4|STARTED|Overall Study||15
8079644|NCT03645421|19922640|P3|STARTED|Overall Study||15
8079645|NCT03645421|19922641|P2|STARTED|Overall Study||15
8079646|NCT03645421|19922642|P1|STARTED|Overall Study||16
8079647|NCT03644212|19922708|P2|NOT COMPLETED|Overall Study||0
8079648|NCT03644212|19922709|P1|NOT COMPLETED|Overall Study||0
8079649|NCT03644212|19922708|P2|COMPLETED|Overall Study||16
8079650|NCT03644212|19922709|P1|COMPLETED|Overall Study||63
8079651|NCT03644212|19922708|P2|STARTED|Overall Study||16
8079652|NCT03644212|19922709|P1|STARTED|Overall Study||63
8079653|NCT03644108|19922715|P1|NOT COMPLETED|Overall Study||0
8079654|NCT03644108|19922715|P1|COMPLETED|Overall Study||30
8079655|NCT03644108|19922715|P1|STARTED|Overall Study||30
8079656|NCT03644095|19922726|P2|NOT COMPLETED|Period 2||0
8079657|NCT03644095|19922727|P1|NOT COMPLETED|Period 2||0
8079658|NCT03644095|19922726|P2|COMPLETED|Period 2||15
8079659|NCT03644095|19922727|P1|COMPLETED|Period 2||15
8079660|NCT03644095|19922726|P2|STARTED|Period 2||15
8079661|NCT03644095|19922727|P1|STARTED|Period 2||15
8079662|NCT03644095|19922726|P2|NOT COMPLETED|Washout (7 Days)||0
8079663|NCT03644095|19922727|P1|NOT COMPLETED|Washout (7 Days)||0
8079664|NCT03644095|19922726|P2|COMPLETED|Washout (7 Days)||15
8079665|NCT03644095|19922727|P1|COMPLETED|Washout (7 Days)||15
8079666|NCT03644095|19922726|P2|STARTED|Washout (7 Days)||15
8079667|NCT03644095|19922727|P1|STARTED|Washout (7 Days)||15
8079668|NCT03644095|19922726|P2|NOT COMPLETED|Period 1||0
8079669|NCT03644095|19922727|P1|NOT COMPLETED|Period 1||0
8079670|NCT03644095|19922726|P2|COMPLETED|Period 1||15
8079671|NCT03644095|19922727|P1|COMPLETED|Period 1||15
8079672|NCT03644095|19922726|P2|STARTED|Period 1||15
8079673|NCT03644095|19922727|P1|STARTED|Period 1||15
8079674|NCT03643692|19922747|P1|NOT COMPLETED|Overall Study||0
8079675|NCT03643692|19922747|P1|COMPLETED|Overall Study||12
8079676|NCT03643692|19922747|P1|STARTED|Overall Study||12
8079677|NCT03643575|19922751|P6|NOT COMPLETED|Period 3||0
8079678|NCT03643575|19922752|P5|NOT COMPLETED|Period 3||0
8079679|NCT03643575|19922753|P4|NOT COMPLETED|Period 3||0
8079680|NCT03643575|19922754|P3|NOT COMPLETED|Period 3||0
8079681|NCT03643575|19922755|P2|NOT COMPLETED|Period 3||0
8079682|NCT03643575|19922756|P1|NOT COMPLETED|Period 3||0
8079683|NCT03643575|19922751|P6|COMPLETED|Period 3||5
8079684|NCT03643575|19922752|P5|COMPLETED|Period 3||5
8079685|NCT03643575|19922753|P4|COMPLETED|Period 3||4
8079686|NCT03643575|19922754|P3|COMPLETED|Period 3||5
8079687|NCT03643575|19922755|P2|COMPLETED|Period 3||4
8079688|NCT03643575|19922756|P1|COMPLETED|Period 3||4
8079689|NCT03643575|19922751|P6|STARTED|Period 3||5
8079690|NCT03643575|19922752|P5|STARTED|Period 3||5
8079691|NCT03643575|19922753|P4|STARTED|Period 3||4
8079692|NCT03643575|19922754|P3|STARTED|Period 3||5
8079693|NCT03643575|19922755|P2|STARTED|Period 3||4
8079694|NCT03643575|19922756|P1|STARTED|Period 3||4
8079695|NCT03643575|19922751|P6|NOT COMPLETED|Washout: 7 Days||0
8079696|NCT03643575|19922752|P5|NOT COMPLETED|Washout: 7 Days||0
8079697|NCT03643575|19922753|P4|NOT COMPLETED|Washout: 7 Days||0
8079698|NCT03643575|19922754|P3|NOT COMPLETED|Washout: 7 Days||0
8079699|NCT03643575|19922755|P2|NOT COMPLETED|Washout: 7 Days||1
8079700|NCT03643575|19922756|P1|NOT COMPLETED|Washout: 7 Days||0
8079701|NCT03643575|19922751|P6|COMPLETED|Washout: 7 Days||5
8079702|NCT03643575|19922752|P5|COMPLETED|Washout: 7 Days||5
8079703|NCT03643575|19922753|P4|COMPLETED|Washout: 7 Days||4
8079704|NCT03643575|19922754|P3|COMPLETED|Washout: 7 Days||5
8079705|NCT03643575|19922755|P2|COMPLETED|Washout: 7 Days||4
8079706|NCT03643575|19922756|P1|COMPLETED|Washout: 7 Days||4
8079707|NCT03643575|19922751|P6|STARTED|Washout: 7 Days||5
8079708|NCT03643575|19922752|P5|STARTED|Washout: 7 Days||5
8079709|NCT03643575|19922753|P4|STARTED|Washout: 7 Days||4
8079710|NCT03643575|19922754|P3|STARTED|Washout: 7 Days||5
8079711|NCT03643575|19922755|P2|STARTED|Washout: 7 Days||5
8079712|NCT03643575|19922756|P1|STARTED|Washout: 7 Days||4
8079713|NCT03643575|19922751|P6|NOT COMPLETED|Period 2||0
8079714|NCT03643575|19922752|P5|NOT COMPLETED|Period 2||0
8079715|NCT03643575|19922753|P4|NOT COMPLETED|Period 2||0
8079716|NCT03643575|19922754|P3|NOT COMPLETED|Period 2||0
8079717|NCT03643575|19922755|P2|NOT COMPLETED|Period 2||0
8079718|NCT03643575|19922756|P1|NOT COMPLETED|Period 2||0
8079719|NCT03643575|19922751|P6|COMPLETED|Period 2||5
8079720|NCT03643575|19922752|P5|COMPLETED|Period 2||5
8079721|NCT03643575|19922753|P4|COMPLETED|Period 2||4
8079722|NCT03643575|19922754|P3|COMPLETED|Period 2||5
8079723|NCT03643575|19922755|P2|COMPLETED|Period 2||5
8079724|NCT03643575|19922756|P1|COMPLETED|Period 2||4
8079725|NCT03643575|19922751|P6|STARTED|Period 2||5
8079726|NCT03643575|19922752|P5|STARTED|Period 2||5
8079727|NCT03643575|19922753|P4|STARTED|Period 2||4
8079728|NCT03643575|19922754|P3|STARTED|Period 2||5
8079729|NCT03643575|19922755|P2|STARTED|Period 2||5
8079730|NCT03643575|19922756|P1|STARTED|Period 2||4
8079731|NCT03643575|19922751|P6|NOT COMPLETED|Washout: 7 Days||0
8079732|NCT03643575|19922752|P5|NOT COMPLETED|Washout: 7 Days||0
8079733|NCT03643575|19922753|P4|NOT COMPLETED|Washout: 7 Days||1
8079734|NCT03643575|19922754|P3|NOT COMPLETED|Washout: 7 Days||0
8079735|NCT03643575|19922755|P2|NOT COMPLETED|Washout: 7 Days||0
8079736|NCT03643575|19922756|P1|NOT COMPLETED|Washout: 7 Days||1
8079737|NCT03643575|19922751|P6|COMPLETED|Washout: 7 Days||5
8079738|NCT03643575|19922752|P5|COMPLETED|Washout: 7 Days||5
8079739|NCT03643575|19922753|P4|COMPLETED|Washout: 7 Days||4
8079740|NCT03643575|19922754|P3|COMPLETED|Washout: 7 Days||5
8079741|NCT03643575|19922755|P2|COMPLETED|Washout: 7 Days||5
8079742|NCT03643575|19922756|P1|COMPLETED|Washout: 7 Days||4
8079743|NCT03643575|19922751|P6|STARTED|Washout: 7 Days||5
8079744|NCT03643575|19922752|P5|STARTED|Washout: 7 Days||5
8079745|NCT03643575|19922753|P4|STARTED|Washout: 7 Days||5
8079746|NCT03643575|19922754|P3|STARTED|Washout: 7 Days||5
8079747|NCT03643575|19922755|P2|STARTED|Washout: 7 Days||5
8079748|NCT03643575|19922756|P1|STARTED|Washout: 7 Days||5
8079749|NCT03643575|19922751|P6|NOT COMPLETED|Period 1||0
8079750|NCT03643575|19922752|P5|NOT COMPLETED|Period 1||0
8079751|NCT03643575|19922753|P4|NOT COMPLETED|Period 1||0
8079752|NCT03643575|19922754|P3|NOT COMPLETED|Period 1||0
8079753|NCT03643575|19922755|P2|NOT COMPLETED|Period 1||0
8079754|NCT03643575|19922756|P1|NOT COMPLETED|Period 1||0
8079755|NCT03643575|19922751|P6|COMPLETED|Period 1||5
8079756|NCT03643575|19922752|P5|COMPLETED|Period 1||5
8079757|NCT03643575|19922753|P4|COMPLETED|Period 1||5
8079758|NCT03643575|19922754|P3|COMPLETED|Period 1||5
8079759|NCT03643575|19922755|P2|COMPLETED|Period 1||5
8079760|NCT03643575|19922756|P1|COMPLETED|Period 1||5
8079761|NCT03643575|19922751|P6|STARTED|Period 1||5
8079762|NCT03643575|19922752|P5|STARTED|Period 1||5
8079763|NCT03643575|19922753|P4|STARTED|Period 1||5
8079764|NCT03643575|19922754|P3|STARTED|Period 1||5
8079765|NCT03643575|19922755|P2|STARTED|Period 1||5
8079766|NCT03643575|19922756|P1|STARTED|Period 1||5
8079767|NCT03643432|19922814|P2|NOT COMPLETED|Overall Study||0
8079768|NCT03643432|19922815|P1|NOT COMPLETED|Overall Study||1
8079769|NCT03643432|19922814|P2|COMPLETED|Overall Study||21
8079770|NCT03643432|19922815|P1|COMPLETED|Overall Study||26
8079771|NCT03643432|19922814|P2|STARTED|Overall Study||21
8079772|NCT03643432|19922815|P1|STARTED|Overall Study||27
8079773|NCT03643159|19922839|P1|NOT COMPLETED|Overall Study||2
8079774|NCT03643159|19922839|P1|COMPLETED|Overall Study||0
8079775|NCT03643159|19922839|P1|Received At Least 1 Dose Of Study Drug|Overall Study||2
8079776|NCT03643159|19922839|P1|STARTED|Overall Study||2
8079777|NCT03642873|19922846|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8079778|NCT03642873|19922847|P5|NOT COMPLETED|Third Intervention (1 Day)||1
8079779|NCT03642873|19922848|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8079780|NCT03642873|19922849|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8079781|NCT03642873|19922850|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8079782|NCT03642873|19922851|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8079783|NCT03642873|19922846|P6|COMPLETED|Third Intervention (1 Day)||4
8079784|NCT03642873|19922847|P5|COMPLETED|Third Intervention (1 Day)||3
8079785|NCT03642873|19922848|P4|COMPLETED|Third Intervention (1 Day)||4
8079786|NCT03642873|19922849|P3|COMPLETED|Third Intervention (1 Day)||4
8079787|NCT03642873|19922850|P2|COMPLETED|Third Intervention (1 Day)||4
8079788|NCT03642873|19922851|P1|COMPLETED|Third Intervention (1 Day)||4
8079789|NCT03642873|19922846|P6|STARTED|Third Intervention (1 Day)||4
8079790|NCT03642873|19922847|P5|STARTED|Third Intervention (1 Day)||4
8079791|NCT03642873|19922848|P4|STARTED|Third Intervention (1 Day)||4
8079792|NCT03642873|19922849|P3|STARTED|Third Intervention (1 Day)||4
8079793|NCT03642873|19922850|P2|STARTED|Third Intervention (1 Day)||4
8079794|NCT03642873|19922851|P1|STARTED|Third Intervention (1 Day)||4
8079795|NCT03642873|19922846|P6|NOT COMPLETED|Washout (7 Days)||0
8079796|NCT03642873|19922847|P5|NOT COMPLETED|Washout (7 Days)||0
8079797|NCT03642873|19922848|P4|NOT COMPLETED|Washout (7 Days)||0
8079798|NCT03642873|19922849|P3|NOT COMPLETED|Washout (7 Days)||0
8079799|NCT03642873|19922850|P2|NOT COMPLETED|Washout (7 Days)||0
8079800|NCT03642873|19922851|P1|NOT COMPLETED|Washout (7 Days)||0
8079801|NCT03642873|19922846|P6|COMPLETED|Washout (7 Days)||4
8079802|NCT03642873|19922847|P5|COMPLETED|Washout (7 Days)||4
8079803|NCT03642873|19922848|P4|COMPLETED|Washout (7 Days)||4
8079804|NCT03642873|19922849|P3|COMPLETED|Washout (7 Days)||4
8079805|NCT03642873|19922850|P2|COMPLETED|Washout (7 Days)||4
8079806|NCT03642873|19922851|P1|COMPLETED|Washout (7 Days)||4
8079807|NCT03642873|19922846|P6|STARTED|Washout (7 Days)||4
8079808|NCT03642873|19922847|P5|STARTED|Washout (7 Days)||4
8079809|NCT03642873|19922848|P4|STARTED|Washout (7 Days)||4
8079810|NCT03642873|19922849|P3|STARTED|Washout (7 Days)||4
8079811|NCT03642873|19922850|P2|STARTED|Washout (7 Days)||4
8079812|NCT03642873|19922851|P1|STARTED|Washout (7 Days)||4
8079813|NCT03642873|19922846|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8079814|NCT03642873|19922847|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8079815|NCT03642873|19922848|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8079816|NCT03642873|19922849|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8079817|NCT03642873|19922850|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8079818|NCT03642873|19922851|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8079819|NCT03642873|19922846|P6|COMPLETED|Second Intervention (1 Day)||4
8079820|NCT03642873|19922847|P5|COMPLETED|Second Intervention (1 Day)||4
8079821|NCT03642873|19922848|P4|COMPLETED|Second Intervention (1 Day)||4
8079822|NCT03642873|19922849|P3|COMPLETED|Second Intervention (1 Day)||4
8079823|NCT03642873|19922850|P2|COMPLETED|Second Intervention (1 Day)||4
8079824|NCT03642873|19922851|P1|COMPLETED|Second Intervention (1 Day)||4
8079825|NCT03642873|19922846|P6|STARTED|Second Intervention (1 Day)||4
8079826|NCT03642873|19922847|P5|STARTED|Second Intervention (1 Day)||4
8079827|NCT03642873|19922848|P4|STARTED|Second Intervention (1 Day)||4
8079828|NCT03642873|19922849|P3|STARTED|Second Intervention (1 Day)||4
8079829|NCT03642873|19922850|P2|STARTED|Second Intervention (1 Day)||4
8079830|NCT03642873|19922851|P1|STARTED|Second Intervention (1 Day)||4
8079831|NCT03642873|19922846|P6|NOT COMPLETED|Washout (7 Days)||0
8079832|NCT03642873|19922847|P5|NOT COMPLETED|Washout (7 Days)||0
8079833|NCT03642873|19922848|P4|NOT COMPLETED|Washout (7 Days)||0
8079834|NCT03642873|19922849|P3|NOT COMPLETED|Washout (7 Days)||0
8079835|NCT03642873|19922850|P2|NOT COMPLETED|Washout (7 Days)||0
8079836|NCT03642873|19922851|P1|NOT COMPLETED|Washout (7 Days)||0
8079837|NCT03642873|19922846|P6|COMPLETED|Washout (7 Days)||4
8079838|NCT03642873|19922847|P5|COMPLETED|Washout (7 Days)||4
8079839|NCT03642873|19922848|P4|COMPLETED|Washout (7 Days)||4
8079840|NCT03642873|19922849|P3|COMPLETED|Washout (7 Days)||4
8079841|NCT03642873|19922850|P2|COMPLETED|Washout (7 Days)||4
8079842|NCT03642873|19922851|P1|COMPLETED|Washout (7 Days)||4
8079843|NCT03642873|19922846|P6|STARTED|Washout (7 Days)||4
8079844|NCT03642873|19922847|P5|STARTED|Washout (7 Days)||4
8079845|NCT03642873|19922848|P4|STARTED|Washout (7 Days)||4
8079846|NCT03642873|19922849|P3|STARTED|Washout (7 Days)||4
8079847|NCT03642873|19922850|P2|STARTED|Washout (7 Days)||4
8079848|NCT03642873|19922851|P1|STARTED|Washout (7 Days)||4
8079849|NCT03642873|19922846|P6|NOT COMPLETED|First Intervention (1 Day)||0
8079850|NCT03642873|19922847|P5|NOT COMPLETED|First Intervention (1 Day)||0
8079851|NCT03642873|19922848|P4|NOT COMPLETED|First Intervention (1 Day)||0
8079852|NCT03642873|19922849|P3|NOT COMPLETED|First Intervention (1 Day)||0
8079853|NCT03642873|19922850|P2|NOT COMPLETED|First Intervention (1 Day)||0
8079854|NCT03642873|19922851|P1|NOT COMPLETED|First Intervention (1 Day)||0
8079855|NCT03642873|19922846|P6|COMPLETED|First Intervention (1 Day)||4
8079856|NCT03642873|19922847|P5|COMPLETED|First Intervention (1 Day)||4
8079857|NCT03642873|19922848|P4|COMPLETED|First Intervention (1 Day)||4
8079858|NCT03642873|19922849|P3|COMPLETED|First Intervention (1 Day)||4
8079859|NCT03642873|19922850|P2|COMPLETED|First Intervention (1 Day)||4
8079860|NCT03642873|19922851|P1|COMPLETED|First Intervention (1 Day)||4
8079861|NCT03642873|19922846|P6|STARTED|First Intervention (1 Day)||4
8079862|NCT03642873|19922847|P5|STARTED|First Intervention (1 Day)||4
8079863|NCT03642873|19922848|P4|STARTED|First Intervention (1 Day)||4
8079864|NCT03642873|19922849|P3|STARTED|First Intervention (1 Day)||4
8079865|NCT03642873|19922850|P2|STARTED|First Intervention (1 Day)||4
8079866|NCT03642873|19922851|P1|STARTED|First Intervention (1 Day)||4
8079867|NCT03642457|19922885|P2|NOT COMPLETED|Overall Study||0
8079868|NCT03642457|19922886|P1|NOT COMPLETED|Overall Study||0
8079869|NCT03642457|19922885|P2|COMPLETED|Overall Study||30
8079870|NCT03642457|19922886|P1|COMPLETED|Overall Study||35
8079871|NCT03642457|19922885|P2|STARTED|Overall Study||30
8079872|NCT03642457|19922886|P1|STARTED|Overall Study||35
8079873|NCT03642262|19922902|P2|NOT COMPLETED|Period 2||0
8079874|NCT03642262|19922903|P1|NOT COMPLETED|Period 2||0
8079875|NCT03642262|19922902|P2|COMPLETED|Period 2||16
8079876|NCT03642262|19922903|P1|COMPLETED|Period 2||11
8079877|NCT03642262|19922902|P2|STARTED|Period 2||16
8079878|NCT03642262|19922903|P1|STARTED|Period 2||11
8079879|NCT03642262|19922902|P2|NOT COMPLETED|Washout: 7 Days||0
8079880|NCT03642262|19922903|P1|NOT COMPLETED|Washout: 7 Days||0
8079881|NCT03642262|19922902|P2|COMPLETED|Washout: 7 Days||16
8079882|NCT03642262|19922903|P1|COMPLETED|Washout: 7 Days||11
8079883|NCT03642262|19922902|P2|STARTED|Washout: 7 Days||16
8079884|NCT03642262|19922903|P1|STARTED|Washout: 7 Days||11
8079885|NCT03642262|19922902|P2|NOT COMPLETED|Period 1||2
8079886|NCT03642262|19922903|P1|NOT COMPLETED|Period 1||1
8079887|NCT03642262|19922902|P2|COMPLETED|Period 1||16
8079888|NCT03642262|19922903|P1|COMPLETED|Period 1||11
8079889|NCT03642262|19922902|P2|STARTED|Period 1||18
8079890|NCT03642262|19922903|P1|STARTED|Period 1||12
8079891|NCT03641508|19922924|P2|NOT COMPLETED|Follow-up/Second Injection||0
8079892|NCT03641508|19922925|P1|NOT COMPLETED|Follow-up/Second Injection||0
8079893|NCT03641508|19922924|P2|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
8079894|NCT03641508|19922925|P1|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
8079895|NCT03641508|19922924|P2|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
8079896|NCT03641508|19922925|P1|STARTED|Follow-up/Second Injection||2
8079897|NCT03641508|19922924|P2|NOT COMPLETED|First Injection||0
8079898|NCT03641508|19922925|P1|NOT COMPLETED|First Injection||2
8079899|NCT03641508|19922924|P2|COMPLETED|First Injection||32
8079900|NCT03641508|19922925|P1|COMPLETED|First Injection||35
8079901|NCT03641508|19922924|P2|STARTED|First Injection||32
8079902|NCT03641508|19922925|P1|STARTED|First Injection||37
8079903|NCT03640832|19922937|P2|NOT COMPLETED|Overall Study||0
8079904|NCT03640832|19922938|P1|NOT COMPLETED|Overall Study||0
8079905|NCT03640832|19922937|P2|COMPLETED|Overall Study||46
8079906|NCT03640832|19922938|P1|COMPLETED|Overall Study||44
8079907|NCT03640832|19922937|P2|STARTED|Overall Study||46
8079908|NCT03640832|19922938|P1|STARTED|Overall Study||44
8079909|NCT03640559|19922952|P2|NOT COMPLETED|Overall Study||1
8079910|NCT03640559|19922953|P1|NOT COMPLETED|Overall Study||2
8079911|NCT03640559|19922952|P2|COMPLETED|Overall Study||24
8079912|NCT03640559|19922953|P1|COMPLETED|Overall Study||23
8079913|NCT03640559|19922952|P2|STARTED|Overall Study||25
8079914|NCT03640559|19922953|P1|STARTED|Overall Study||25
8079915|NCT03640507|19922962|P3|NOT COMPLETED|Overall Study||1
8079916|NCT03640507|19922963|P2|NOT COMPLETED|Overall Study||0
8079917|NCT03640507|19922964|P1|NOT COMPLETED|Overall Study||0
8079918|NCT03640507|19922962|P3|COMPLETED|Overall Study||10
8079919|NCT03640507|19922963|P2|COMPLETED|Overall Study||9
8079920|NCT03640507|19922964|P1|COMPLETED|Overall Study||10
8079921|NCT03640507|19922962|P3|STARTED|Overall Study||11
8079922|NCT03640507|19922963|P2|STARTED|Overall Study||9
8079923|NCT03640507|19922964|P1|STARTED|Overall Study||10
8079924|NCT03640052|19922984|P5|NOT COMPLETED|Overall Study||0
8079925|NCT03640052|19922985|P4|NOT COMPLETED|Overall Study||0
8079926|NCT03640052|19922986|P3|NOT COMPLETED|Overall Study||0
8079927|NCT03640052|19922987|P2|NOT COMPLETED|Overall Study||1
8079928|NCT03640052|19922988|P1|NOT COMPLETED|Overall Study||0
8079929|NCT03640052|19922984|P5|COMPLETED|Overall Study||1
8079930|NCT03640052|19922985|P4|COMPLETED|Overall Study||1
8079931|NCT03640052|19922986|P3|COMPLETED|Overall Study||1
8079932|NCT03640052|19922987|P2|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
8079933|NCT03640052|19922988|P1|COMPLETED|Overall Study||2
8079934|NCT03640052|19922984|P5|STARTED|Overall Study||1
8079935|NCT03640052|19922985|P4|STARTED|Overall Study||1
8079936|NCT03640052|19922986|P3|STARTED|Overall Study||1
8079937|NCT03640052|19922987|P2|STARTED|Overall Study||1
8079938|NCT03640052|19922988|P1|STARTED|Overall Study||2
8079939|NCT03639675|19923005|P1|NOT COMPLETED|Overall Study||1
8079940|NCT03639675|19923005|P1|COMPLETED|Overall Study||15
8079941|NCT03639675|19923005|P1|Received Treatment|Overall Study||16
8079942|NCT03639675|19923005|P1|STARTED|Overall Study||16
8079943|NCT03639311|19923012|P2|NOT COMPLETED|Overall Study||0
8079944|NCT03639311|19923013|P1|NOT COMPLETED|Overall Study||90
8079945|NCT03639311|19923012|P2|COMPLETED|Overall Study||7
8079946|NCT03639311|19923013|P1|COMPLETED|Overall Study||0
8079947|NCT03639311|19923012|P2|STARTED|Overall Study||7
8079948|NCT03639311|19923013|P1|STARTED|Overall Study||90
8079949|NCT03638908|19923095|P1|NOT COMPLETED|Overall Study||1
8079950|NCT03638908|19923095|P1|COMPLETED|Overall Study||7
8079951|NCT03638908|19923095|P1|STARTED|Overall Study||8
8079952|NCT03638635|19923112|P2|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
8079953|NCT03638635|19923113|P1|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
8079954|NCT03638635|19923112|P2|COMPLETED|Follow-Up (30 Days After Discharge)||0
8079955|NCT03638635|19923113|P1|COMPLETED|Follow-Up (30 Days After Discharge)||0
8079956|NCT03638635|19923112|P2|STARTED|Follow-Up (30 Days After Discharge)||22
8079957|NCT03638635|19923113|P1|STARTED|Follow-Up (30 Days After Discharge)||39
8079958|NCT03638635|19923112|P2|NOT COMPLETED|Initial Hospitalization||2
8079959|NCT03638635|19923113|P1|NOT COMPLETED|Initial Hospitalization||0
8079960|NCT03638635|19923112|P2|COMPLETED|Initial Hospitalization||22
8079961|NCT03638635|19923113|P1|COMPLETED|Initial Hospitalization||39
8079962|NCT03638635|19923112|P2|STARTED|Initial Hospitalization||24
8079963|NCT03638635|19923113|P1|STARTED|Initial Hospitalization||39
8079964|NCT03638323|19923143|P1|NOT COMPLETED|Overall Study||1
8079965|NCT03638323|19923143|P1|COMPLETED|Overall Study||37
8079966|NCT03638323|19923143|P1|STARTED|Overall Study||38
8079967|NCT03637517|19923167|P3|NOT COMPLETED|Overall Study||0
8079968|NCT03637517|19923168|P2|NOT COMPLETED|Overall Study||0
8079969|NCT03637517|19923169|P1|NOT COMPLETED|Overall Study||0
8079970|NCT03637517|19923167|P3|COMPLETED|Overall Study||14
8079971|NCT03637517|19923168|P2|COMPLETED|Overall Study||14
8079972|NCT03637517|19923169|P1|COMPLETED|Overall Study||14
8079973|NCT03637517|19923167|P3|STARTED|Overall Study||14
8079974|NCT03637517|19923168|P2|STARTED|Overall Study||14
8079975|NCT03637517|19923169|P1|STARTED|Overall Study||14
8079976|NCT03637348|19923195|P1|NOT COMPLETED|Overall Study||0
8079977|NCT03637348|19923195|P1|COMPLETED|Overall Study||45
8079978|NCT03637348|19923195|P1|STARTED|Overall Study||45
8079979|NCT03636893|19923202|P2|NOT COMPLETED|Overall Study||10
8079980|NCT03636893|19923203|P1|NOT COMPLETED|Overall Study||9
8079981|NCT03636893|19923202|P2|COMPLETED|Overall Study||24
8079982|NCT03636893|19923203|P1|COMPLETED|Overall Study||31
8079983|NCT03636893|19923202|P2|STARTED|Overall Study||34
8079984|NCT03636893|19923203|P1|STARTED|Overall Study||40
8079985|NCT03636386|19923211|P2|NOT COMPLETED|Overall Study||0
8079986|NCT03636386|19923212|P1|NOT COMPLETED|Overall Study||0
8079987|NCT03636386|19923211|P2|COMPLETED|Overall Study||24
8079988|NCT03636386|19923212|P1|COMPLETED|Overall Study||24
8079989|NCT03636386|19923211|P2|STARTED|Overall Study||24
8079990|NCT03636386|19923212|P1|STARTED|Overall Study||24
8079991|NCT03635957|19923220|P1|NOT COMPLETED|Pegloticase + IMM Period||3
8079992|NCT03635957|19923220|P1|COMPLETED|Pegloticase + IMM Period||11
8079993|NCT03635957|19923220|P1|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
8079994|NCT03635957|19923220|P1|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
8079995|NCT03635957|19923220|P1|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
8079996|NCT03635957|19923220|P1|STARTED|Pegloticase + IMM Period||14
8079997|NCT03635957|19923220|P1|NOT COMPLETED|Run-In Period||1
8079998|NCT03635957|19923220|P1|COMPLETED|Run-In Period||14
8079999|NCT03635957|19923220|P1|STARTED|Run-In Period||15
8080000|NCT03635424|19923231|P1|NOT COMPLETED|Overall Study||3
8080001|NCT03635424|19923231|P1|COMPLETED|Overall Study||147
8080002|NCT03635424|19923231|P1|STARTED|Overall Study||150
8080003|NCT03634579|19923252|P1|NOT COMPLETED|Overall Study||9
8080004|NCT03634579|19923252|P1|COMPLETED|Overall Study||0
8080005|NCT03634579|19923252|P1|STARTED|Overall Study||9
8080006|NCT03634306|19923263|P3|NOT COMPLETED|Overall Study||0
8080007|NCT03634306|19923264|P2|NOT COMPLETED|Overall Study||0
8080008|NCT03634306|19923265|P1|NOT COMPLETED|Overall Study||0
8080009|NCT03634306|19923263|P3|COMPLETED|Overall Study||5
8080010|NCT03634306|19923264|P2|COMPLETED|Overall Study||15
8080011|NCT03634306|19923265|P1|COMPLETED|Overall Study||15
8080012|NCT03634306|19923263|P3|STARTED|Overall Study||5
8080013|NCT03634306|19923264|P2|STARTED|Overall Study||15
8080014|NCT03634306|19923265|P1|STARTED|Overall Study||15
8080015|NCT03634085|19923350|P2|NOT COMPLETED|Overall Study||2
8080016|NCT03634085|19923351|P1|NOT COMPLETED|Overall Study||1
8080017|NCT03634085|19923350|P2|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency
~1 subject dropped out due to personal circumstances"|6
8080018|NCT03634085|19923351|P1|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
8080019|NCT03634085|19923350|P2|Period 4|Overall Study|this period is not applicable for Cohort B|0
8080020|NCT03634085|19923351|P1|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
8080021|NCT03634085|19923350|P2|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
8080022|NCT03634085|19923351|P1|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
8080023|NCT03634085|19923350|P2|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
8080024|NCT03634085|19923351|P1|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
8080025|NCT03634085|19923350|P2|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
8080026|NCT03634085|19923351|P1|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
8080027|NCT03634085|19923350|P2|STARTED|Overall Study||8
8080028|NCT03634085|19923351|P1|STARTED|Overall Study||8
8080029|NCT03633825|19923366|P2|NOT COMPLETED|Analysis||0
8080030|NCT03633825|19923367|P1|NOT COMPLETED|Analysis||0
8080031|NCT03633825|19923366|P2|COMPLETED|Analysis||325
8080032|NCT03633825|19923367|P1|COMPLETED|Analysis||327
8080033|NCT03633825|19923366|P2|STARTED|Analysis||325
8080034|NCT03633825|19923367|P1|STARTED|Analysis||327
8080035|NCT03633825|19923366|P2|NOT COMPLETED|Follow up||450
8080036|NCT03633825|19923367|P1|NOT COMPLETED|Follow up||478
8080037|NCT03633825|19923366|P2|COMPLETED|Follow up||325
8080038|NCT03633825|19923367|P1|COMPLETED|Follow up||327
8080039|NCT03633825|19923366|P2|STARTED|Follow up||775
8080040|NCT03633825|19923367|P1|STARTED|Follow up||805
8080041|NCT03633825|19923366|P2|NOT COMPLETED|Allocation||0
8080042|NCT03633825|19923367|P1|NOT COMPLETED|Allocation||0
8080043|NCT03633825|19923366|P2|COMPLETED|Allocation||775
8080044|NCT03633825|19923367|P1|COMPLETED|Allocation||805
8080045|NCT03633825|19923366|P2|STARTED|Allocation||775
8080046|NCT03633825|19923367|P1|STARTED|Allocation||805
8080047|NCT03633825|19923366|P2|NOT COMPLETED|Enrollment||18837
8080048|NCT03633825|19923367|P1|NOT COMPLETED|Enrollment||19033
8080049|NCT03633825|19923366|P2|COMPLETED|Enrollment||775
8080050|NCT03633825|19923367|P1|COMPLETED|Enrollment||805
8080051|NCT03633825|19923366|P2|STARTED|Enrollment||19612
8080052|NCT03633825|19923367|P1|STARTED|Enrollment||19838
8080053|NCT03633526|19923375|P1|NOT COMPLETED|Overall Study||0
8080054|NCT03633526|19923375|P1|COMPLETED|Overall Study||16
8080055|NCT03633526|19923375|P1|STARTED|Overall Study||16
8080056|NCT03633487|19923385|P1|NOT COMPLETED|Overall Study||0
8080057|NCT03633487|19923385|P1|COMPLETED|Overall Study||24
8080058|NCT03633487|19923385|P1|STARTED|Overall Study||24
8080059|NCT03633448|19923399|P2|NOT COMPLETED|Period 2 (1 Day)||0
8080060|NCT03633448|19923400|P1|NOT COMPLETED|Period 2 (1 Day)||0
8080061|NCT03633448|19923399|P2|COMPLETED|Period 2 (1 Day)||12
8080062|NCT03633448|19923400|P1|COMPLETED|Period 2 (1 Day)||12
8080063|NCT03633448|19923399|P2|STARTED|Period 2 (1 Day)||12
8080064|NCT03633448|19923400|P1|STARTED|Period 2 (1 Day)||12
8080065|NCT03633448|19923399|P2|NOT COMPLETED|Washout (7 Days)||0
8080066|NCT03633448|19923400|P1|NOT COMPLETED|Washout (7 Days)||0
8080067|NCT03633448|19923399|P2|COMPLETED|Washout (7 Days)||12
8080068|NCT03633448|19923400|P1|COMPLETED|Washout (7 Days)||12
8080069|NCT03633448|19923399|P2|STARTED|Washout (7 Days)||12
8080070|NCT03633448|19923400|P1|STARTED|Washout (7 Days)||12
8080071|NCT03633448|19923399|P2|NOT COMPLETED|Period 1 (1 Day)||0
8080072|NCT03633448|19923400|P1|NOT COMPLETED|Period 1 (1 Day)||0
8080073|NCT03633448|19923399|P2|COMPLETED|Period 1 (1 Day)||12
8080074|NCT03633448|19923400|P1|COMPLETED|Period 1 (1 Day)||12
8080075|NCT03633448|19923399|P2|STARTED|Period 1 (1 Day)||12
8080076|NCT03633448|19923400|P1|STARTED|Period 1 (1 Day)||12
8080077|NCT03633344|19923440|P2|NOT COMPLETED|Overall Study||0
8080078|NCT03633344|19923441|P1|NOT COMPLETED|Overall Study||0
8080079|NCT03633344|19923440|P2|COMPLETED|Overall Study||24
8080080|NCT03633344|19923441|P1|COMPLETED|Overall Study||120
8080081|NCT03633344|19923440|P2|STARTED|Overall Study||24
8080082|NCT03633344|19923441|P1|STARTED|Overall Study||120
8080083|NCT03633084|19923456|P3|NOT COMPLETED|Overall Study||0
8080084|NCT03633084|19923457|P2|NOT COMPLETED|Overall Study||0
8080085|NCT03633084|19923458|P1|NOT COMPLETED|Overall Study||0
8080086|NCT03633084|19923456|P3|COMPLETED|Overall Study||3
8080087|NCT03633084|19923457|P2|COMPLETED|Overall Study||3
8080088|NCT03633084|19923458|P1|COMPLETED|Overall Study||3
8080089|NCT03633084|19923456|P3|STARTED|Overall Study||3
8080090|NCT03633084|19923457|P2|STARTED|Overall Study||3
8080091|NCT03633084|19923458|P1|STARTED|Overall Study||3
8080092|NCT03632109|19923472|P1|NOT COMPLETED|Overall Study||0
8080093|NCT03632109|19923472|P1|COMPLETED|Overall Study||13
8080094|NCT03632109|19923472|P1|STARTED|Overall Study||13
8080095|NCT03632083|19923480|P8|NOT COMPLETED|Second Intervention||2
8080096|NCT03632083|19923481|P7|NOT COMPLETED|Second Intervention||0
8080097|NCT03632083|19923482|P6|NOT COMPLETED|Second Intervention||0
8080098|NCT03632083|19923483|P5|NOT COMPLETED|Second Intervention||0
8080099|NCT03632083|19923484|P4|NOT COMPLETED|Second Intervention||0
8080100|NCT03632083|19923485|P3|NOT COMPLETED|Second Intervention||0
8080101|NCT03632083|19923486|P2|NOT COMPLETED|Second Intervention||0
8080102|NCT03632083|19923487|P1|NOT COMPLETED|Second Intervention||0
8080103|NCT03632083|19923480|P8|COMPLETED|Second Intervention||5
8080104|NCT03632083|19923481|P7|COMPLETED|Second Intervention||7
8080105|NCT03632083|19923482|P6|COMPLETED|Second Intervention||9
8080106|NCT03632083|19923483|P5|COMPLETED|Second Intervention||9
8080107|NCT03632083|19923484|P4|COMPLETED|Second Intervention||7
8080108|NCT03632083|19923485|P3|COMPLETED|Second Intervention||7
8080109|NCT03632083|19923486|P2|COMPLETED|Second Intervention||5
8080110|NCT03632083|19923487|P1|COMPLETED|Second Intervention||5
8080111|NCT03632083|19923480|P8|STARTED|Second Intervention||7
8080112|NCT03632083|19923481|P7|STARTED|Second Intervention||7
8080113|NCT03632083|19923482|P6|STARTED|Second Intervention||9
8080114|NCT03632083|19923483|P5|STARTED|Second Intervention||9
8080115|NCT03632083|19923484|P4|STARTED|Second Intervention||7
8080116|NCT03632083|19923485|P3|STARTED|Second Intervention||7
8080117|NCT03632083|19923486|P2|STARTED|Second Intervention||5
8080118|NCT03632083|19923487|P1|STARTED|Second Intervention||5
8080119|NCT03632083|19923480|P8|NOT COMPLETED|First Intervention||0
8080120|NCT03632083|19923481|P7|NOT COMPLETED|First Intervention||0
8080121|NCT03632083|19923482|P6|NOT COMPLETED|First Intervention||0
8080122|NCT03632083|19923483|P5|NOT COMPLETED|First Intervention||0
8080123|NCT03632083|19923484|P4|NOT COMPLETED|First Intervention||0
8080124|NCT03632083|19923485|P3|NOT COMPLETED|First Intervention||0
8080125|NCT03632083|19923486|P2|NOT COMPLETED|First Intervention||0
8080126|NCT03632083|19923487|P1|NOT COMPLETED|First Intervention||0
8080127|NCT03632083|19923480|P8|COMPLETED|First Intervention||7
8080128|NCT03632083|19923481|P7|COMPLETED|First Intervention||7
8080129|NCT03632083|19923482|P6|COMPLETED|First Intervention||9
8080130|NCT03632083|19923483|P5|COMPLETED|First Intervention||9
8080131|NCT03632083|19923484|P4|COMPLETED|First Intervention||7
8080132|NCT03632083|19923485|P3|COMPLETED|First Intervention||7
8080133|NCT03632083|19923486|P2|COMPLETED|First Intervention||5
8080134|NCT03632083|19923487|P1|COMPLETED|First Intervention||5
8080135|NCT03632083|19923480|P8|STARTED|First Intervention||7
8080136|NCT03632083|19923481|P7|STARTED|First Intervention||7
8080137|NCT03632083|19923482|P6|STARTED|First Intervention||9
8080138|NCT03632083|19923483|P5|STARTED|First Intervention||9
8080139|NCT03632083|19923484|P4|STARTED|First Intervention||7
8080140|NCT03632083|19923485|P3|STARTED|First Intervention||7
8080141|NCT03632083|19923486|P2|STARTED|First Intervention||5
8080142|NCT03632083|19923487|P1|STARTED|First Intervention||5
8080143|NCT03631732|19923571|P2|NOT COMPLETED|Overall Study||153
8080144|NCT03631732|19923572|P1|NOT COMPLETED|Overall Study||300
8080145|NCT03631732|19923571|P2|COMPLETED|Overall Study||12
8080146|NCT03631732|19923572|P1|COMPLETED|Overall Study||31
8080147|NCT03631732|19923571|P2|STARTED|Overall Study||165
8080148|NCT03631732|19923572|P1|STARTED|Overall Study||331
8080149|NCT03630679|19923596|P2|NOT COMPLETED|Overall Study||12
8080150|NCT03630679|19923597|P1|NOT COMPLETED|Overall Study||7
8080151|NCT03630679|19923596|P2|COMPLETED|Overall Study||13
8080152|NCT03630679|19923597|P1|COMPLETED|Overall Study||13
8080153|NCT03630679|19923596|P2|STARTED|Overall Study||25
8080154|NCT03630679|19923597|P1|STARTED|Overall Study||20
8080155|NCT03630185|19923613|P2|NOT COMPLETED|Overall Study||4
8080156|NCT03630185|19923614|P1|NOT COMPLETED|Overall Study||4
8080157|NCT03630185|19923613|P2|COMPLETED|Overall Study||0
8080158|NCT03630185|19923614|P1|COMPLETED|Overall Study||0
8080159|NCT03630185|19923613|P2|6 Month Follow up|Overall Study||0
8080160|NCT03630185|19923614|P1|6 Month Follow up|Overall Study||0
8080161|NCT03630185|19923613|P2|90 Day Follow up|Overall Study||1
8080162|NCT03630185|19923614|P1|90 Day Follow up|Overall Study||0
8080163|NCT03630185|19923613|P2|30 Day Follow up|Overall Study||1
8080164|NCT03630185|19923614|P1|30 Day Follow up|Overall Study||1
8080165|NCT03630185|19923613|P2|STARTED|Overall Study||4
8080166|NCT03630185|19923614|P1|STARTED|Overall Study||4
8080179|NCT03630016|19923695|P1|NOT COMPLETED|Overall Study||1
8080180|NCT03630016|19923695|P1|COMPLETED|Overall Study||10
8080181|NCT03630016|19923695|P1|STARTED|Overall Study||11
8080182|NCT03629886|19923701|P2|NOT COMPLETED|Overall Study||180
8080183|NCT03629886|19923702|P1|NOT COMPLETED|Overall Study||0
8080184|NCT03629886|19923701|P2|COMPLETED|Overall Study||1686
8080185|NCT03629886|19923702|P1|COMPLETED|Overall Study||1671
8080186|NCT03629886|19923701|P2|STARTED|Overall Study||1866
8080187|NCT03629886|19923702|P1|STARTED|Overall Study||1671
8080188|NCT03629184|19923721|P2|NOT COMPLETED|Overall Study||1
8080189|NCT03629184|19923722|P1|NOT COMPLETED|Overall Study||3
8080190|NCT03629184|19923721|P2|COMPLETED|Overall Study||57
8080191|NCT03629184|19923722|P1|COMPLETED|Overall Study||112
8080192|NCT03629184|19923721|P2|STARTED|Overall Study||58
8080193|NCT03629184|19923722|P1|STARTED|Overall Study||115
8080194|NCT03629054|19923772|P2|NOT COMPLETED|Period 2 (4 Days)||1
8080195|NCT03629054|19923773|P1|NOT COMPLETED|Period 2 (4 Days)||0
8080196|NCT03629054|19923772|P2|COMPLETED|Period 2 (4 Days)||14
8080197|NCT03629054|19923773|P1|COMPLETED|Period 2 (4 Days)||15
8080198|NCT03629054|19923772|P2|Treated|Period 2 (4 Days)||14
8080199|NCT03629054|19923773|P1|Treated|Period 2 (4 Days)||15
8080200|NCT03629054|19923772|P2|STARTED|Period 2 (4 Days)|Started this period|15
8080201|NCT03629054|19923773|P1|STARTED|Period 2 (4 Days)|Started this period|15
8080202|NCT03629054|19923772|P2|NOT COMPLETED|Wasout Period (35 Days)||0
8080203|NCT03629054|19923773|P1|NOT COMPLETED|Wasout Period (35 Days)||0
8080204|NCT03629054|19923772|P2|COMPLETED|Wasout Period (35 Days)||15
8080205|NCT03629054|19923773|P1|COMPLETED|Wasout Period (35 Days)||15
8080206|NCT03629054|19923772|P2|STARTED|Wasout Period (35 Days)|Started this period|15
8080207|NCT03629054|19923773|P1|STARTED|Wasout Period (35 Days)|Started this period|15
8080208|NCT03629054|19923772|P2|NOT COMPLETED|Period 1 (4 Days)||0
8080209|NCT03629054|19923773|P1|NOT COMPLETED|Period 1 (4 Days)||0
8080210|NCT03629054|19923772|P2|COMPLETED|Period 1 (4 Days)||15
8080211|NCT03629054|19923773|P1|COMPLETED|Period 1 (4 Days)||15
8080212|NCT03629054|19923772|P2|STARTED|Period 1 (4 Days)|Started this period|15
8080213|NCT03629054|19923773|P1|STARTED|Period 1 (4 Days)|Started this period|15
8080214|NCT03629041|19923797|P4|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
8080215|NCT03629041|19923798|P3|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
8080216|NCT03629041|19923799|P2|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
8080217|NCT03629041|19923800|P1|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
8080218|NCT03629041|19923797|P4|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080219|NCT03629041|19923798|P3|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080220|NCT03629041|19923799|P2|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
8080221|NCT03629041|19923800|P1|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080222|NCT03629041|19923797|P4|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080223|NCT03629041|19923798|P3|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080224|NCT03629041|19923799|P2|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080225|NCT03629041|19923800|P1|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080226|NCT03629041|19923797|P4|NOT COMPLETED|Visit 1||0
8080227|NCT03629041|19923798|P3|NOT COMPLETED|Visit 1||0
8080228|NCT03629041|19923799|P2|NOT COMPLETED|Visit 1||0
8080229|NCT03629041|19923800|P1|NOT COMPLETED|Visit 1||0
8080230|NCT03629041|19923797|P4|COMPLETED|Visit 1||4
8080231|NCT03629041|19923798|P3|COMPLETED|Visit 1||4
8080232|NCT03629041|19923799|P2|COMPLETED|Visit 1||4
8080233|NCT03629041|19923800|P1|COMPLETED|Visit 1||4
8080234|NCT03629041|19923797|P4|STARTED|Visit 1||4
8080235|NCT03629041|19923798|P3|STARTED|Visit 1||4
8080236|NCT03629041|19923799|P2|STARTED|Visit 1||4
8080237|NCT03629041|19923800|P1|STARTED|Visit 1||4
8080238|NCT03629028|19923828|P2|NOT COMPLETED|Overall Study||25
8080239|NCT03629028|19923829|P1|NOT COMPLETED|Overall Study||32
8080240|NCT03629028|19923828|P2|COMPLETED|Overall Study||116
8080241|NCT03629028|19923829|P1|COMPLETED|Overall Study||109
8080242|NCT03629028|19923828|P2|STARTED|Overall Study||141
8080243|NCT03629028|19923829|P1|STARTED|Overall Study||141
8080244|NCT03628885|19923848|P3|NOT COMPLETED|Overall Study||60
8080245|NCT03628885|19923849|P2|NOT COMPLETED|Overall Study||47
8080246|NCT03628885|19923850|P1|NOT COMPLETED|Overall Study||39
8080247|NCT03628885|19923848|P3|COMPLETED|Overall Study||243
8080248|NCT03628885|19923849|P2|COMPLETED|Overall Study||252
8080249|NCT03628885|19923850|P1|COMPLETED|Overall Study||267
8080250|NCT03628885|19923848|P3|STARTED|Overall Study||303
8080251|NCT03628885|19923849|P2|STARTED|Overall Study||299
8080252|NCT03628885|19923850|P1|STARTED|Overall Study||306
8080253|NCT03628599|19923860|P2|NOT COMPLETED|Overall Study||1
8080254|NCT03628599|19923861|P1|NOT COMPLETED|Overall Study||0
8080255|NCT03628599|19923860|P2|COMPLETED|Overall Study||18
8080256|NCT03628599|19923861|P1|COMPLETED|Overall Study||18
8080257|NCT03628599|19923860|P2|STARTED|Overall Study||19
8080258|NCT03628599|19923861|P1|STARTED|Overall Study||18
8080259|NCT03628456|19923871|P1|NOT COMPLETED|Overall Study||0
8080260|NCT03628456|19923871|P1|COMPLETED|Overall Study||10
8080261|NCT03628456|19923871|P1|STARTED|Overall Study||10
8080262|NCT03628417|19923891|P2|NOT COMPLETED|Overall Study||1
8080263|NCT03628417|19923892|P1|NOT COMPLETED|Overall Study||1
8080264|NCT03628417|19923891|P2|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
8080265|NCT03628417|19923892|P1|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
8080266|NCT03628417|19923891|P2|Day 180|Overall Study||7
8080267|NCT03628417|19923892|P1|Day 180|Overall Study||7
8080268|NCT03628417|19923891|P2|Day 90|Overall Study||7
8080269|NCT03628417|19923892|P1|Day 90|Overall Study||7
8080270|NCT03628417|19923891|P2|Day 60|Overall Study||7
8080271|NCT03628417|19923892|P1|Day 60|Overall Study||7
8080272|NCT03628417|19923891|P2|Day 30|Overall Study||7
8080273|NCT03628417|19923892|P1|Day 30|Overall Study||7
8080274|NCT03628417|19923891|P2|Day 15|Overall Study||7
8080275|NCT03628417|19923892|P1|Day 15|Overall Study||7
8080276|NCT03628417|19923891|P2|Day 7|Overall Study||7
8080277|NCT03628417|19923892|P1|Day 7|Overall Study||7
8080278|NCT03628417|19923891|P2|Day 0|Overall Study||7
8080279|NCT03628417|19923892|P1|Day 0|Overall Study||7
8080280|NCT03628417|19923891|P2|STARTED|Overall Study||7
8080281|NCT03628417|19923892|P1|STARTED|Overall Study||7
8080282|NCT03627832|19923904|P2|NOT COMPLETED|Overall Study||1
8080283|NCT03627832|19923905|P1|NOT COMPLETED|Overall Study||10
8080284|NCT03627832|19923904|P2|COMPLETED|Overall Study||27
8080285|NCT03627832|19923905|P1|COMPLETED|Overall Study||18
8080286|NCT03627832|19923904|P2|STARTED|Overall Study||28
8080287|NCT03627832|19923905|P1|STARTED|Overall Study||28
8080288|NCT03627494|19923939|P12|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080289|NCT03627494|19923940|P11|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080290|NCT03627494|19923941|P10|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080291|NCT03627494|19923942|P9|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080292|NCT03627494|19923943|P8|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080293|NCT03627494|19923944|P7|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080294|NCT03627494|19923945|P6|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080295|NCT03627494|19923946|P5|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080296|NCT03627494|19923947|P4|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080297|NCT03627494|19923948|P3|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080298|NCT03627494|19923949|P2|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080299|NCT03627494|19923950|P1|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080300|NCT03627494|19923939|P12|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
8080301|NCT03627494|19923940|P11|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
8080302|NCT03627494|19923941|P10|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080303|NCT03627494|19923942|P9|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080304|NCT03627494|19923943|P8|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080305|NCT03627494|19923944|P7|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080306|NCT03627494|19923945|P6|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080307|NCT03627494|19923946|P5|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080308|NCT03627494|19923947|P4|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080309|NCT03627494|19923948|P3|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080310|NCT03627494|19923949|P2|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080311|NCT03627494|19923950|P1|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080312|NCT03627494|19923939|P12|STARTED|Part C Period2(4days)+Follow-up(14days)||5
8080313|NCT03627494|19923940|P11|STARTED|Part C Period2(4days)+Follow-up(14days)||5
8080314|NCT03627494|19923941|P10|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080315|NCT03627494|19923942|P9|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080316|NCT03627494|19923943|P8|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080317|NCT03627494|19923944|P7|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080318|NCT03627494|19923945|P6|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080319|NCT03627494|19923946|P5|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080320|NCT03627494|19923947|P4|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080321|NCT03627494|19923948|P3|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080322|NCT03627494|19923949|P2|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080323|NCT03627494|19923950|P1|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080324|NCT03627494|19923939|P12|NOT COMPLETED|Part C Washout 1 (7 Days)||1
8080325|NCT03627494|19923940|P11|NOT COMPLETED|Part C Washout 1 (7 Days)||1
8080326|NCT03627494|19923941|P10|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080327|NCT03627494|19923942|P9|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080328|NCT03627494|19923943|P8|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080329|NCT03627494|19923944|P7|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080330|NCT03627494|19923945|P6|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080331|NCT03627494|19923946|P5|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080332|NCT03627494|19923947|P4|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080333|NCT03627494|19923948|P3|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080334|NCT03627494|19923949|P2|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080335|NCT03627494|19923950|P1|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080336|NCT03627494|19923939|P12|COMPLETED|Part C Washout 1 (7 Days)||5
8080337|NCT03627494|19923940|P11|COMPLETED|Part C Washout 1 (7 Days)||5
8080338|NCT03627494|19923941|P10|COMPLETED|Part C Washout 1 (7 Days)||0
8080339|NCT03627494|19923942|P9|COMPLETED|Part C Washout 1 (7 Days)||0
8080340|NCT03627494|19923943|P8|COMPLETED|Part C Washout 1 (7 Days)||0
8080341|NCT03627494|19923944|P7|COMPLETED|Part C Washout 1 (7 Days)||0
8080342|NCT03627494|19923945|P6|COMPLETED|Part C Washout 1 (7 Days)||0
8080343|NCT03627494|19923946|P5|COMPLETED|Part C Washout 1 (7 Days)||0
8080344|NCT03627494|19923947|P4|COMPLETED|Part C Washout 1 (7 Days)||0
8080345|NCT03627494|19923948|P3|COMPLETED|Part C Washout 1 (7 Days)||0
8080346|NCT03627494|19923949|P2|COMPLETED|Part C Washout 1 (7 Days)||0
8080347|NCT03627494|19923950|P1|COMPLETED|Part C Washout 1 (7 Days)||0
8080348|NCT03627494|19923939|P12|STARTED|Part C Washout 1 (7 Days)||6
8080349|NCT03627494|19923940|P11|STARTED|Part C Washout 1 (7 Days)||6
8080350|NCT03627494|19923941|P10|STARTED|Part C Washout 1 (7 Days)||0
8080351|NCT03627494|19923942|P9|STARTED|Part C Washout 1 (7 Days)||0
8080352|NCT03627494|19923943|P8|STARTED|Part C Washout 1 (7 Days)||0
8080353|NCT03627494|19923944|P7|STARTED|Part C Washout 1 (7 Days)||0
8080354|NCT03627494|19923945|P6|STARTED|Part C Washout 1 (7 Days)||0
8080355|NCT03627494|19923946|P5|STARTED|Part C Washout 1 (7 Days)||0
8080356|NCT03627494|19923947|P4|STARTED|Part C Washout 1 (7 Days)||0
8080357|NCT03627494|19923948|P3|STARTED|Part C Washout 1 (7 Days)||0
8080358|NCT03627494|19923949|P2|STARTED|Part C Washout 1 (7 Days)||0
8080359|NCT03627494|19923950|P1|STARTED|Part C Washout 1 (7 Days)||0
8080360|NCT03627494|19923939|P12|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080361|NCT03627494|19923940|P11|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080362|NCT03627494|19923941|P10|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080363|NCT03627494|19923942|P9|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080364|NCT03627494|19923943|P8|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080365|NCT03627494|19923944|P7|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080366|NCT03627494|19923945|P6|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080367|NCT03627494|19923946|P5|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080368|NCT03627494|19923947|P4|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080369|NCT03627494|19923948|P3|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080370|NCT03627494|19923949|P2|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080371|NCT03627494|19923950|P1|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080372|NCT03627494|19923939|P12|COMPLETED|Part C Period 1 (4 Days)||6
8080373|NCT03627494|19923940|P11|COMPLETED|Part C Period 1 (4 Days)||6
8080374|NCT03627494|19923941|P10|COMPLETED|Part C Period 1 (4 Days)||0
8080375|NCT03627494|19923942|P9|COMPLETED|Part C Period 1 (4 Days)||0
8080376|NCT03627494|19923943|P8|COMPLETED|Part C Period 1 (4 Days)||0
8080377|NCT03627494|19923944|P7|COMPLETED|Part C Period 1 (4 Days)||0
8080378|NCT03627494|19923945|P6|COMPLETED|Part C Period 1 (4 Days)||0
8080379|NCT03627494|19923946|P5|COMPLETED|Part C Period 1 (4 Days)||0
8080380|NCT03627494|19923947|P4|COMPLETED|Part C Period 1 (4 Days)||0
8080381|NCT03627494|19923948|P3|COMPLETED|Part C Period 1 (4 Days)||0
8080382|NCT03627494|19923949|P2|COMPLETED|Part C Period 1 (4 Days)||0
8080383|NCT03627494|19923950|P1|COMPLETED|Part C Period 1 (4 Days)||0
8080384|NCT03627494|19923939|P12|STARTED|Part C Period 1 (4 Days)||6
8080385|NCT03627494|19923940|P11|STARTED|Part C Period 1 (4 Days)||6
8080386|NCT03627494|19923941|P10|STARTED|Part C Period 1 (4 Days)||0
8080387|NCT03627494|19923942|P9|STARTED|Part C Period 1 (4 Days)||0
8080388|NCT03627494|19923943|P8|STARTED|Part C Period 1 (4 Days)||0
8080389|NCT03627494|19923944|P7|STARTED|Part C Period 1 (4 Days)||0
8080390|NCT03627494|19923945|P6|STARTED|Part C Period 1 (4 Days)||0
8080391|NCT03627494|19923946|P5|STARTED|Part C Period 1 (4 Days)||0
8080392|NCT03627494|19923947|P4|STARTED|Part C Period 1 (4 Days)||0
8080393|NCT03627494|19923948|P3|STARTED|Part C Period 1 (4 Days)||0
8080394|NCT03627494|19923949|P2|STARTED|Part C Period 1 (4 Days)||0
8080395|NCT03627494|19923950|P1|STARTED|Part C Period 1 (4 Days)||0
8080396|NCT03627494|19923939|P12|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080397|NCT03627494|19923940|P11|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080398|NCT03627494|19923941|P10|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080399|NCT03627494|19923942|P9|NOT COMPLETED|Part B (Maximum of 34 Days)||2
8080400|NCT03627494|19923943|P8|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080401|NCT03627494|19923944|P7|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080402|NCT03627494|19923945|P6|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080403|NCT03627494|19923946|P5|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080404|NCT03627494|19923947|P4|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080405|NCT03627494|19923948|P3|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080406|NCT03627494|19923949|P2|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080407|NCT03627494|19923950|P1|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080408|NCT03627494|19923939|P12|COMPLETED|Part B (Maximum of 34 Days)||0
8080409|NCT03627494|19923940|P11|COMPLETED|Part B (Maximum of 34 Days)||0
8080410|NCT03627494|19923941|P10|COMPLETED|Part B (Maximum of 34 Days)||9
8080411|NCT03627494|19923942|P9|COMPLETED|Part B (Maximum of 34 Days)||7
8080412|NCT03627494|19923943|P8|COMPLETED|Part B (Maximum of 34 Days)||9
8080413|NCT03627494|19923944|P7|COMPLETED|Part B (Maximum of 34 Days)||9
8080414|NCT03627494|19923945|P6|COMPLETED|Part B (Maximum of 34 Days)||0
8080415|NCT03627494|19923946|P5|COMPLETED|Part B (Maximum of 34 Days)||0
8080416|NCT03627494|19923947|P4|COMPLETED|Part B (Maximum of 34 Days)||0
8080417|NCT03627494|19923948|P3|COMPLETED|Part B (Maximum of 34 Days)||0
8080418|NCT03627494|19923949|P2|COMPLETED|Part B (Maximum of 34 Days)||0
8080419|NCT03627494|19923950|P1|COMPLETED|Part B (Maximum of 34 Days)||0
8080420|NCT03627494|19923939|P12|STARTED|Part B (Maximum of 34 Days)||0
8080421|NCT03627494|19923940|P11|STARTED|Part B (Maximum of 34 Days)||0
8080422|NCT03627494|19923941|P10|STARTED|Part B (Maximum of 34 Days)||9
8080423|NCT03627494|19923942|P9|STARTED|Part B (Maximum of 34 Days)||9
8080424|NCT03627494|19923943|P8|STARTED|Part B (Maximum of 34 Days)||9
8080425|NCT03627494|19923944|P7|STARTED|Part B (Maximum of 34 Days)||9
8080426|NCT03627494|19923945|P6|STARTED|Part B (Maximum of 34 Days)||0
8080427|NCT03627494|19923946|P5|STARTED|Part B (Maximum of 34 Days)||0
8080428|NCT03627494|19923947|P4|STARTED|Part B (Maximum of 34 Days)||0
8080429|NCT03627494|19923948|P3|STARTED|Part B (Maximum of 34 Days)||0
8080430|NCT03627494|19923949|P2|STARTED|Part B (Maximum of 34 Days)||0
8080431|NCT03627494|19923950|P1|STARTED|Part B (Maximum of 34 Days)||0
8080432|NCT03627494|19923939|P12|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080433|NCT03627494|19923940|P11|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080434|NCT03627494|19923941|P10|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080435|NCT03627494|19923942|P9|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080436|NCT03627494|19923943|P8|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080437|NCT03627494|19923944|P7|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080438|NCT03627494|19923945|P6|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080439|NCT03627494|19923946|P5|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080440|NCT03627494|19923947|P4|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080441|NCT03627494|19923948|P3|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080442|NCT03627494|19923949|P2|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080443|NCT03627494|19923950|P1|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080444|NCT03627494|19923939|P12|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080445|NCT03627494|19923940|P11|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080446|NCT03627494|19923941|P10|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080447|NCT03627494|19923942|P9|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080448|NCT03627494|19923943|P8|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080449|NCT03627494|19923944|P7|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080450|NCT03627494|19923945|P6|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080451|NCT03627494|19923946|P5|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080452|NCT03627494|19923947|P4|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080453|NCT03627494|19923948|P3|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
8080454|NCT03627494|19923949|P2|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080455|NCT03627494|19923950|P1|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
8080456|NCT03627494|19923939|P12|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080457|NCT03627494|19923940|P11|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080458|NCT03627494|19923941|P10|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080459|NCT03627494|19923942|P9|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080460|NCT03627494|19923943|P8|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080461|NCT03627494|19923944|P7|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080462|NCT03627494|19923945|P6|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080463|NCT03627494|19923946|P5|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080464|NCT03627494|19923947|P4|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080465|NCT03627494|19923948|P3|STARTED|Part A Period3(4days)+Follow-up(14days)||2
8080466|NCT03627494|19923949|P2|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080467|NCT03627494|19923950|P1|STARTED|Part A Period3(4days)+Follow-up(14days)||2
8080468|NCT03627494|19923939|P12|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080469|NCT03627494|19923940|P11|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080470|NCT03627494|19923941|P10|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080471|NCT03627494|19923942|P9|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080472|NCT03627494|19923943|P8|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080473|NCT03627494|19923944|P7|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080474|NCT03627494|19923945|P6|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080475|NCT03627494|19923946|P5|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080476|NCT03627494|19923947|P4|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080477|NCT03627494|19923948|P3|NOT COMPLETED|Part A Washout 2 (7 Days)||1
8080478|NCT03627494|19923949|P2|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080479|NCT03627494|19923950|P1|NOT COMPLETED|Part A Washout 2 (7 Days)||1
8080480|NCT03627494|19923939|P12|COMPLETED|Part A Washout 2 (7 Days)||0
8080481|NCT03627494|19923940|P11|COMPLETED|Part A Washout 2 (7 Days)||0
8080482|NCT03627494|19923941|P10|COMPLETED|Part A Washout 2 (7 Days)||0
8080483|NCT03627494|19923942|P9|COMPLETED|Part A Washout 2 (7 Days)||0
8080484|NCT03627494|19923943|P8|COMPLETED|Part A Washout 2 (7 Days)||0
8080485|NCT03627494|19923944|P7|COMPLETED|Part A Washout 2 (7 Days)||0
8080486|NCT03627494|19923945|P6|COMPLETED|Part A Washout 2 (7 Days)||3
8080487|NCT03627494|19923946|P5|COMPLETED|Part A Washout 2 (7 Days)||3
8080488|NCT03627494|19923947|P4|COMPLETED|Part A Washout 2 (7 Days)||3
8080489|NCT03627494|19923948|P3|COMPLETED|Part A Washout 2 (7 Days)||2
8080490|NCT03627494|19923949|P2|COMPLETED|Part A Washout 2 (7 Days)||3
8080491|NCT03627494|19923950|P1|COMPLETED|Part A Washout 2 (7 Days)||2
8080492|NCT03627494|19923939|P12|STARTED|Part A Washout 2 (7 Days)||0
8080493|NCT03627494|19923940|P11|STARTED|Part A Washout 2 (7 Days)||0
8080494|NCT03627494|19923941|P10|STARTED|Part A Washout 2 (7 Days)||0
8080495|NCT03627494|19923942|P9|STARTED|Part A Washout 2 (7 Days)||0
8080496|NCT03627494|19923943|P8|STARTED|Part A Washout 2 (7 Days)||0
8080497|NCT03627494|19923944|P7|STARTED|Part A Washout 2 (7 Days)||0
8080498|NCT03627494|19923945|P6|STARTED|Part A Washout 2 (7 Days)||3
8080499|NCT03627494|19923946|P5|STARTED|Part A Washout 2 (7 Days)||3
8080500|NCT03627494|19923947|P4|STARTED|Part A Washout 2 (7 Days)||3
8080501|NCT03627494|19923948|P3|STARTED|Part A Washout 2 (7 Days)||3
8080502|NCT03627494|19923949|P2|STARTED|Part A Washout 2 (7 Days)||3
8080503|NCT03627494|19923950|P1|STARTED|Part A Washout 2 (7 Days)||3
8080504|NCT03627494|19923939|P12|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080505|NCT03627494|19923940|P11|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080506|NCT03627494|19923941|P10|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080507|NCT03627494|19923942|P9|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080508|NCT03627494|19923943|P8|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080509|NCT03627494|19923944|P7|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080510|NCT03627494|19923945|P6|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080511|NCT03627494|19923946|P5|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080512|NCT03627494|19923947|P4|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080513|NCT03627494|19923948|P3|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080514|NCT03627494|19923949|P2|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080515|NCT03627494|19923950|P1|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080516|NCT03627494|19923939|P12|COMPLETED|Part A Period 2 (4 Days)||0
8080517|NCT03627494|19923940|P11|COMPLETED|Part A Period 2 (4 Days)||0
8080518|NCT03627494|19923941|P10|COMPLETED|Part A Period 2 (4 Days)||0
8080519|NCT03627494|19923942|P9|COMPLETED|Part A Period 2 (4 Days)||0
8080520|NCT03627494|19923943|P8|COMPLETED|Part A Period 2 (4 Days)||0
8080521|NCT03627494|19923944|P7|COMPLETED|Part A Period 2 (4 Days)||0
8080522|NCT03627494|19923945|P6|COMPLETED|Part A Period 2 (4 Days)||3
8080523|NCT03627494|19923946|P5|COMPLETED|Part A Period 2 (4 Days)||3
8080524|NCT03627494|19923947|P4|COMPLETED|Part A Period 2 (4 Days)||3
8080525|NCT03627494|19923948|P3|COMPLETED|Part A Period 2 (4 Days)||3
8080526|NCT03627494|19923949|P2|COMPLETED|Part A Period 2 (4 Days)||3
8080527|NCT03627494|19923950|P1|COMPLETED|Part A Period 2 (4 Days)||3
8080528|NCT03627494|19923939|P12|STARTED|Part A Period 2 (4 Days)||0
8080529|NCT03627494|19923940|P11|STARTED|Part A Period 2 (4 Days)||0
8080530|NCT03627494|19923941|P10|STARTED|Part A Period 2 (4 Days)||0
8080531|NCT03627494|19923942|P9|STARTED|Part A Period 2 (4 Days)||0
8080532|NCT03627494|19923943|P8|STARTED|Part A Period 2 (4 Days)||0
8080533|NCT03627494|19923944|P7|STARTED|Part A Period 2 (4 Days)||0
8080534|NCT03627494|19923945|P6|STARTED|Part A Period 2 (4 Days)||3
8080535|NCT03627494|19923946|P5|STARTED|Part A Period 2 (4 Days)||3
8080536|NCT03627494|19923947|P4|STARTED|Part A Period 2 (4 Days)||3
8080537|NCT03627494|19923948|P3|STARTED|Part A Period 2 (4 Days)||3
8080538|NCT03627494|19923949|P2|STARTED|Part A Period 2 (4 Days)||3
8080539|NCT03627494|19923950|P1|STARTED|Part A Period 2 (4 Days)||3
8080540|NCT03627494|19923939|P12|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080541|NCT03627494|19923940|P11|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080542|NCT03627494|19923941|P10|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080543|NCT03627494|19923942|P9|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080544|NCT03627494|19923943|P8|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080545|NCT03627494|19923944|P7|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080546|NCT03627494|19923945|P6|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080547|NCT03627494|19923946|P5|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080548|NCT03627494|19923947|P4|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080549|NCT03627494|19923948|P3|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080550|NCT03627494|19923949|P2|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080551|NCT03627494|19923950|P1|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080552|NCT03627494|19923939|P12|COMPLETED|Part A Washout 1 (7 Days)||0
8080553|NCT03627494|19923940|P11|COMPLETED|Part A Washout 1 (7 Days)||0
8080554|NCT03627494|19923941|P10|COMPLETED|Part A Washout 1 (7 Days)||0
8080555|NCT03627494|19923942|P9|COMPLETED|Part A Washout 1 (7 Days)||0
8080556|NCT03627494|19923943|P8|COMPLETED|Part A Washout 1 (7 Days)||0
8080557|NCT03627494|19923944|P7|COMPLETED|Part A Washout 1 (7 Days)||0
8080558|NCT03627494|19923945|P6|COMPLETED|Part A Washout 1 (7 Days)||3
8080559|NCT03627494|19923946|P5|COMPLETED|Part A Washout 1 (7 Days)||3
8080560|NCT03627494|19923947|P4|COMPLETED|Part A Washout 1 (7 Days)||3
8080561|NCT03627494|19923948|P3|COMPLETED|Part A Washout 1 (7 Days)||3
8080562|NCT03627494|19923949|P2|COMPLETED|Part A Washout 1 (7 Days)||3
8080563|NCT03627494|19923950|P1|COMPLETED|Part A Washout 1 (7 Days)||3
8080564|NCT03627494|19923939|P12|STARTED|Part A Washout 1 (7 Days)||0
8080565|NCT03627494|19923940|P11|STARTED|Part A Washout 1 (7 Days)||0
8080566|NCT03627494|19923941|P10|STARTED|Part A Washout 1 (7 Days)||0
8080567|NCT03627494|19923942|P9|STARTED|Part A Washout 1 (7 Days)||0
8080568|NCT03627494|19923943|P8|STARTED|Part A Washout 1 (7 Days)||0
8080569|NCT03627494|19923944|P7|STARTED|Part A Washout 1 (7 Days)||0
8080570|NCT03627494|19923945|P6|STARTED|Part A Washout 1 (7 Days)||3
8080571|NCT03627494|19923946|P5|STARTED|Part A Washout 1 (7 Days)||3
8080572|NCT03627494|19923947|P4|STARTED|Part A Washout 1 (7 Days)||3
8080573|NCT03627494|19923948|P3|STARTED|Part A Washout 1 (7 Days)||3
8080574|NCT03627494|19923949|P2|STARTED|Part A Washout 1 (7 Days)||3
8080575|NCT03627494|19923950|P1|STARTED|Part A Washout 1 (7 Days)||3
8080576|NCT03627494|19923939|P12|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080577|NCT03627494|19923940|P11|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080578|NCT03627494|19923941|P10|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080579|NCT03627494|19923942|P9|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080580|NCT03627494|19923943|P8|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080581|NCT03627494|19923944|P7|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080582|NCT03627494|19923945|P6|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080583|NCT03627494|19923946|P5|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080584|NCT03627494|19923947|P4|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080585|NCT03627494|19923948|P3|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080586|NCT03627494|19923949|P2|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080587|NCT03627494|19923950|P1|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080588|NCT03627494|19923939|P12|COMPLETED|Part A Period 1 (4 Days)||0
8080589|NCT03627494|19923940|P11|COMPLETED|Part A Period 1 (4 Days)||0
8080590|NCT03627494|19923941|P10|COMPLETED|Part A Period 1 (4 Days)||0
8080591|NCT03627494|19923942|P9|COMPLETED|Part A Period 1 (4 Days)||0
8080592|NCT03627494|19923943|P8|COMPLETED|Part A Period 1 (4 Days)||0
8080593|NCT03627494|19923944|P7|COMPLETED|Part A Period 1 (4 Days)||0
8080594|NCT03627494|19923945|P6|COMPLETED|Part A Period 1 (4 Days)||3
8080595|NCT03627494|19923946|P5|COMPLETED|Part A Period 1 (4 Days)||3
8080596|NCT03627494|19923947|P4|COMPLETED|Part A Period 1 (4 Days)||3
8080597|NCT03627494|19923948|P3|COMPLETED|Part A Period 1 (4 Days)||3
8080598|NCT03627494|19923949|P2|COMPLETED|Part A Period 1 (4 Days)||3
8080599|NCT03627494|19923950|P1|COMPLETED|Part A Period 1 (4 Days)||3
8080600|NCT03627494|19923939|P12|STARTED|Part A Period 1 (4 Days)||0
8080601|NCT03627494|19923940|P11|STARTED|Part A Period 1 (4 Days)||0
8080602|NCT03627494|19923941|P10|STARTED|Part A Period 1 (4 Days)||0
8080603|NCT03627494|19923942|P9|STARTED|Part A Period 1 (4 Days)||0
8080604|NCT03627494|19923943|P8|STARTED|Part A Period 1 (4 Days)||0
8080605|NCT03627494|19923944|P7|STARTED|Part A Period 1 (4 Days)||0
8080606|NCT03627494|19923945|P6|STARTED|Part A Period 1 (4 Days)||3
8080607|NCT03627494|19923946|P5|STARTED|Part A Period 1 (4 Days)||3
8080608|NCT03627494|19923947|P4|STARTED|Part A Period 1 (4 Days)||3
8080609|NCT03627494|19923948|P3|STARTED|Part A Period 1 (4 Days)||3
8080610|NCT03627494|19923949|P2|STARTED|Part A Period 1 (4 Days)||3
8080611|NCT03627494|19923950|P1|STARTED|Part A Period 1 (4 Days)||3
8080612|NCT03627299|19924146|P1|NOT COMPLETED|Overall Study||0
8080613|NCT03627299|19924146|P1|COMPLETED|Overall Study||10
8080614|NCT03627299|19924146|P1|STARTED|Overall Study||10
8080615|NCT03627195|19924164|P6|NOT COMPLETED|Overall Study||0
8080616|NCT03627195|19924165|P5|NOT COMPLETED|Overall Study||0
8080617|NCT03627195|19924166|P4|NOT COMPLETED|Overall Study||0
8080618|NCT03627195|19924167|P3|NOT COMPLETED|Overall Study||0
8080619|NCT03627195|19924168|P2|NOT COMPLETED|Overall Study||0
8080620|NCT03627195|19924169|P1|NOT COMPLETED|Overall Study||1
8080621|NCT03627195|19924164|P6|COMPLETED|Overall Study||10
8080622|NCT03627195|19924165|P5|COMPLETED|Overall Study||6
8080623|NCT03627195|19924166|P4|COMPLETED|Overall Study||6
8080624|NCT03627195|19924167|P3|COMPLETED|Overall Study||6
8080625|NCT03627195|19924168|P2|COMPLETED|Overall Study||6
8080626|NCT03627195|19924169|P1|COMPLETED|Overall Study||5
8080627|NCT03627195|19924164|P6|STARTED|Overall Study||10
8080628|NCT03627195|19924165|P5|STARTED|Overall Study||6
8080629|NCT03627195|19924166|P4|STARTED|Overall Study||6
8080630|NCT03627195|19924167|P3|STARTED|Overall Study||6
8080631|NCT03627195|19924168|P2|STARTED|Overall Study||6
8080632|NCT03627195|19924169|P1|STARTED|Overall Study||6
8080633|NCT03626714|19924195|P1|NOT COMPLETED|Overall Study||0
8080634|NCT03626714|19924195|P1|COMPLETED|Overall Study||8
8080635|NCT03626714|19924195|P1|STARTED|Overall Study||8
8080636|NCT03626415|19924207|P3|NOT COMPLETED|Overall Study||0
8080637|NCT03626415|19924208|P2|NOT COMPLETED|Overall Study||0
8080638|NCT03626415|19924209|P1|NOT COMPLETED|Overall Study||0
8080639|NCT03626415|19924207|P3|COMPLETED|Overall Study||8
8080640|NCT03626415|19924208|P2|COMPLETED|Overall Study||8
8080641|NCT03626415|19924209|P1|COMPLETED|Overall Study||8
8080642|NCT03626415|19924207|P3|STARTED|Overall Study||8
8080643|NCT03626415|19924208|P2|STARTED|Overall Study||8
8080644|NCT03626415|19924209|P1|STARTED|Overall Study||8
8080645|NCT03624946|19924240|P2|NOT COMPLETED|Overall Study||1
8080646|NCT03624946|19924241|P1|NOT COMPLETED|Overall Study||0
8080647|NCT03624946|19924240|P2|COMPLETED|Overall Study||10
8080648|NCT03624946|19924241|P1|COMPLETED|Overall Study||19
8080649|NCT03624946|19924240|P2|STARTED|Overall Study||11
8080650|NCT03624946|19924241|P1|STARTED|Overall Study||19
8080651|NCT03624920|19924267|P6|NOT COMPLETED|Overall Study||1
8080652|NCT03624920|19924268|P5|NOT COMPLETED|Overall Study||4
8080653|NCT03624920|19924269|P4|NOT COMPLETED|Overall Study||1
8080654|NCT03624920|19924270|P3|NOT COMPLETED|Overall Study||1
8080655|NCT03624920|19924271|P2|NOT COMPLETED|Overall Study||2
8080656|NCT03624920|19924272|P1|NOT COMPLETED|Overall Study||1
8080657|NCT03624920|19924267|P6|COMPLETED|Overall Study||11
8080658|NCT03624920|19924268|P5|COMPLETED|Overall Study||7
8080659|NCT03624920|19924269|P4|COMPLETED|Overall Study||12
8080660|NCT03624920|19924270|P3|COMPLETED|Overall Study||12
8080661|NCT03624920|19924271|P2|COMPLETED|Overall Study||12
8080662|NCT03624920|19924272|P1|COMPLETED|Overall Study||13
8080663|NCT03624920|19924267|P6|STARTED|Overall Study||12
8080664|NCT03624920|19924268|P5|STARTED|Overall Study||11
8080665|NCT03624920|19924269|P4|STARTED|Overall Study||13
8080666|NCT03624920|19924270|P3|STARTED|Overall Study||13
8080667|NCT03624920|19924271|P2|STARTED|Overall Study||14
8080668|NCT03624920|19924272|P1|STARTED|Overall Study||14
8080669|NCT03624504|19924295|P1|NOT COMPLETED|Overall Study||1
8080670|NCT03624504|19924295|P1|COMPLETED|Overall Study||81
8080671|NCT03624504|19924295|P1|STARTED|Overall Study||82
8080672|NCT03623698|19924303|P1|NOT COMPLETED|Overall Study||0
8080673|NCT03623698|19924303|P1|COMPLETED|Overall Study||24
8080674|NCT03623698|19924303|P1|STARTED|Overall Study||24
8080675|NCT03623035|19924334|P1|NOT COMPLETED|Overall Study||0
8080676|NCT03623035|19924334|P1|COMPLETED|Overall Study||10
8080677|NCT03623035|19924334|P1|STARTED|Overall Study||10
8080678|NCT03622619|19924342|P2|NOT COMPLETED|Overall Study||2
8080679|NCT03622619|19924343|P1|NOT COMPLETED|Overall Study||2
8080680|NCT03622619|19924342|P2|COMPLETED|Overall Study||21
8080681|NCT03622619|19924343|P1|COMPLETED|Overall Study||21
8080682|NCT03622619|19924342|P2|STARTED|Overall Study||23
8080683|NCT03622619|19924343|P1|STARTED|Overall Study||23
8080684|NCT03622112|19924362|P7|NOT COMPLETED|Overall Study||9
8080685|NCT03622112|19924363|P6|NOT COMPLETED|Overall Study||42
8080686|NCT03622112|19924364|P5|NOT COMPLETED|Overall Study||10
8080687|NCT03622112|19924365|P4|NOT COMPLETED|Overall Study||22
8080688|NCT03622112|19924366|P3|NOT COMPLETED|Overall Study||16
8080689|NCT03622112|19924367|P2|NOT COMPLETED|Overall Study||20
8080690|NCT03622112|19924368|P1|NOT COMPLETED|Overall Study||25
8080691|NCT03622112|19924362|P7|COMPLETED|Overall Study||103
8080692|NCT03622112|19924363|P6|COMPLETED|Overall Study||71
8080693|NCT03622112|19924364|P5|COMPLETED|Overall Study||124
8080694|NCT03622112|19924365|P4|COMPLETED|Overall Study||91
8080695|NCT03622112|19924366|P3|COMPLETED|Overall Study||95
8080696|NCT03622112|19924367|P2|COMPLETED|Overall Study||92
8080697|NCT03622112|19924368|P1|COMPLETED|Overall Study||85
8080698|NCT03622112|19924362|P7|STARTED|Overall Study||112
8080699|NCT03622112|19924363|P6|STARTED|Overall Study||113
8080700|NCT03622112|19924364|P5|STARTED|Overall Study||134
8080701|NCT03622112|19924365|P4|STARTED|Overall Study||113
8080702|NCT03622112|19924366|P3|STARTED|Overall Study||111
8080703|NCT03622112|19924367|P2|STARTED|Overall Study||112
8080704|NCT03622112|19924368|P1|STARTED|Overall Study||110
8080705|NCT03621878|19924555|P3|NOT COMPLETED|Overall Study||0
8080706|NCT03621878|19924556|P2|NOT COMPLETED|Overall Study||0
8080707|NCT03621878|19924557|P1|NOT COMPLETED|Overall Study||0
8080708|NCT03621878|19924555|P3|COMPLETED|Overall Study||17
8080709|NCT03621878|19924556|P2|COMPLETED|Overall Study||17
8080710|NCT03621878|19924557|P1|COMPLETED|Overall Study||17
8080711|NCT03621878|19924555|P3|STARTED|Overall Study||17
8080712|NCT03621878|19924556|P2|STARTED|Overall Study||17
8080713|NCT03621878|19924557|P1|STARTED|Overall Study||17
8080714|NCT03621787|19924577|P1|NOT COMPLETED|Overall Study||0
8080715|NCT03621787|19924577|P1|COMPLETED|Overall Study||9
8080716|NCT03621787|19924577|P1|STARTED|Overall Study||9
8080717|NCT03621202|19924588|P1|NOT COMPLETED|Overall Study||6
8080718|NCT03621202|19924588|P1|COMPLETED|Overall Study||60
8080719|NCT03621202|19924588|P1|STARTED|Overall Study||66
8080720|NCT03620708|19924597|P3|NOT COMPLETED|Overall Study||3
8080721|NCT03620708|19924598|P2|NOT COMPLETED|Overall Study||1
8080722|NCT03620708|19924599|P1|NOT COMPLETED|Overall Study||1
8080723|NCT03620708|19924597|P3|COMPLETED|Overall Study||17
8080724|NCT03620708|19924598|P2|COMPLETED|Overall Study||18
8080725|NCT03620708|19924599|P1|COMPLETED|Overall Study||18
8080726|NCT03620708|19924597|P3|STARTED|Overall Study||20
8080727|NCT03620708|19924598|P2|STARTED|Overall Study||19
8080728|NCT03620708|19924599|P1|STARTED|Overall Study||19
8080729|NCT03620383|19924621|P2|NOT COMPLETED|Overall Study||0
8080730|NCT03620383|19924622|P1|NOT COMPLETED|Overall Study||0
8080731|NCT03620383|19924621|P2|COMPLETED|Overall Study||15
8080732|NCT03620383|19924622|P1|COMPLETED|Overall Study||30
8080733|NCT03620383|19924621|P2|STARTED|Overall Study||15
8080734|NCT03620383|19924622|P1|STARTED|Overall Study||30
8080735|NCT03619889|19924630|P2|NOT COMPLETED|Overall Study||0
8080736|NCT03619889|19924631|P1|NOT COMPLETED|Overall Study||2
8080737|NCT03619889|19924630|P2|COMPLETED|Overall Study||37
8080738|NCT03619889|19924631|P1|COMPLETED|Overall Study||35
8080739|NCT03619889|19924630|P2|STARTED|Overall Study||37
8080740|NCT03619889|19924631|P1|STARTED|Overall Study||37
8080741|NCT03619590|19924661|P1|NOT COMPLETED|Overall Study||0
8080742|NCT03619590|19924661|P1|COMPLETED|Overall Study||103
8080743|NCT03619590|19924661|P1|STARTED|Overall Study||103
8080744|NCT03619135|19924671|P2|NOT COMPLETED|Overall Study||0
8080745|NCT03619135|19924672|P1|NOT COMPLETED|Overall Study||0
8080746|NCT03619135|19924671|P2|COMPLETED|Overall Study||50
8080747|NCT03619135|19924672|P1|COMPLETED|Overall Study||50
8080748|NCT03619135|19924671|P2|STARTED|Overall Study||50
8080749|NCT03619135|19924672|P1|STARTED|Overall Study||50
8080750|NCT03618628|19924680|P1|NOT COMPLETED|Overall Study||2
8080751|NCT03618628|19924680|P1|COMPLETED|Overall Study||1
8080752|NCT03618628|19924680|P1|STARTED|Overall Study||3
8080753|NCT03618147|19924684|P1|NOT COMPLETED|Overall Study||0
8080754|NCT03618147|19924684|P1|COMPLETED|Overall Study||314
8080755|NCT03618147|19924684|P1|STARTED|Overall Study||314
8080756|NCT03618017|19924691|P2|NOT COMPLETED|Overall Study||5
8080757|NCT03618017|19924692|P1|NOT COMPLETED|Overall Study||7
8080758|NCT03618017|19924691|P2|COMPLETED|Overall Study||28
8080759|NCT03618017|19924692|P1|COMPLETED|Overall Study||26
8080760|NCT03618017|19924691|P2|STARTED|Overall Study||33
8080761|NCT03618017|19924692|P1|STARTED|Overall Study||33
8080762|NCT03617861|19924710|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8080763|NCT03617861|19924711|P3|NOT COMPLETED|Second Intervention (1 Day)||1
8080764|NCT03617861|19924712|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8080765|NCT03617861|19924713|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8080766|NCT03617861|19924710|P4|COMPLETED|Second Intervention (1 Day)||5
8080767|NCT03617861|19924711|P3|COMPLETED|Second Intervention (1 Day)||4
8080768|NCT03617861|19924712|P2|COMPLETED|Second Intervention (1 Day)||5
8080769|NCT03617861|19924713|P1|COMPLETED|Second Intervention (1 Day)||5
8080770|NCT03617861|19924710|P4|STARTED|Second Intervention (1 Day)||5
8080771|NCT03617861|19924711|P3|STARTED|Second Intervention (1 Day)||5
8080772|NCT03617861|19924712|P2|STARTED|Second Intervention (1 Day)||5
8080773|NCT03617861|19924713|P1|STARTED|Second Intervention (1 Day)||5
8080774|NCT03617861|19924710|P4|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080775|NCT03617861|19924711|P3|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080776|NCT03617861|19924712|P2|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080777|NCT03617861|19924713|P1|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080778|NCT03617861|19924710|P4|COMPLETED|Washout (1 to 4 Weeks)||5
8080779|NCT03617861|19924711|P3|COMPLETED|Washout (1 to 4 Weeks)||5
8080780|NCT03617861|19924712|P2|COMPLETED|Washout (1 to 4 Weeks)||5
8080781|NCT03617861|19924713|P1|COMPLETED|Washout (1 to 4 Weeks)||5
8080782|NCT03617861|19924710|P4|STARTED|Washout (1 to 4 Weeks)||5
8080783|NCT03617861|19924711|P3|STARTED|Washout (1 to 4 Weeks)||5
8080784|NCT03617861|19924712|P2|STARTED|Washout (1 to 4 Weeks)||5
8080785|NCT03617861|19924713|P1|STARTED|Washout (1 to 4 Weeks)||5
8080786|NCT03617861|19924710|P4|NOT COMPLETED|First Intervention (1 Day)||0
8080787|NCT03617861|19924711|P3|NOT COMPLETED|First Intervention (1 Day)||0
8080788|NCT03617861|19924712|P2|NOT COMPLETED|First Intervention (1 Day)||0
8080789|NCT03617861|19924713|P1|NOT COMPLETED|First Intervention (1 Day)||0
8080790|NCT03617861|19924710|P4|COMPLETED|First Intervention (1 Day)||5
8080791|NCT03617861|19924711|P3|COMPLETED|First Intervention (1 Day)||5
8080792|NCT03617861|19924712|P2|COMPLETED|First Intervention (1 Day)||5
8080793|NCT03617861|19924713|P1|COMPLETED|First Intervention (1 Day)||5
8080794|NCT03617861|19924710|P4|STARTED|First Intervention (1 Day)||5
8080795|NCT03617861|19924711|P3|STARTED|First Intervention (1 Day)||5
8080796|NCT03617861|19924712|P2|STARTED|First Intervention (1 Day)||5
8080797|NCT03617861|19924713|P1|STARTED|First Intervention (1 Day)||5
8080798|NCT03617588|19924745|P2|NOT COMPLETED|Overall Study||0
8080799|NCT03617588|19924746|P1|NOT COMPLETED|Overall Study||1
8080800|NCT03617588|19924745|P2|COMPLETED|Overall Study||29
8080801|NCT03617588|19924746|P1|COMPLETED|Overall Study||19
8080802|NCT03617588|19924745|P2|STARTED|Overall Study||29
8080803|NCT03617588|19924746|P1|STARTED|Overall Study||20
8080804|NCT03617523|19924763|P5|NOT COMPLETED|Overall Study||0
8080805|NCT03617523|19924764|P4|NOT COMPLETED|Overall Study||0
8080806|NCT03617523|19924765|P3|NOT COMPLETED|Overall Study||0
8080807|NCT03617523|19924766|P2|NOT COMPLETED|Overall Study||0
8080808|NCT03617523|19924767|P1|NOT COMPLETED|Overall Study||0
8080809|NCT03617523|19924763|P5|COMPLETED|Overall Study||60
8080810|NCT03617523|19924764|P4|COMPLETED|Overall Study||59
8080811|NCT03617523|19924765|P3|COMPLETED|Overall Study||61
8080812|NCT03617523|19924766|P2|COMPLETED|Overall Study||30
8080813|NCT03617523|19924767|P1|COMPLETED|Overall Study||30
8080814|NCT03617523|19924763|P5|STARTED|Overall Study||60
8080815|NCT03617523|19924764|P4|STARTED|Overall Study||59
8080816|NCT03617523|19924765|P3|STARTED|Overall Study||61
8080817|NCT03617523|19924766|P2|STARTED|Overall Study||30
8080818|NCT03617523|19924767|P1|STARTED|Overall Study||30
8080819|NCT03617419|19924799|P1|NOT COMPLETED|Part 2||0
8080820|NCT03617419|19924799|P1|COMPLETED|Part 2||14
8080821|NCT03617419|19924799|P1|STARTED|Part 2||14
8080822|NCT03617419|19924799|P1|NOT COMPLETED|Part 1||0
8080823|NCT03617419|19924799|P1|COMPLETED|Part 1||2
8080824|NCT03617419|19924799|P1|STARTED|Part 1||2
8080825|NCT03616977|19924807|P2|NOT COMPLETED|Period 4||0
8080826|NCT03616977|19924808|P1|NOT COMPLETED|Period 4||0
8080827|NCT03616977|19924807|P2|COMPLETED|Period 4||32
8080828|NCT03616977|19924808|P1|COMPLETED|Period 4||33
8080829|NCT03616977|19924807|P2|STARTED|Period 4||32
8080830|NCT03616977|19924808|P1|STARTED|Period 4||33
8080831|NCT03616977|19924807|P2|NOT COMPLETED|Period 3||1
8080832|NCT03616977|19924808|P1|NOT COMPLETED|Period 3||1
8080833|NCT03616977|19924807|P2|COMPLETED|Period 3||32
8080834|NCT03616977|19924808|P1|COMPLETED|Period 3||33
8080835|NCT03616977|19924807|P2|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
8080836|NCT03616977|19924808|P1|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
8080837|NCT03616977|19924807|P2|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
8080838|NCT03616977|19924808|P1|STARTED|Period 3||34
8080839|NCT03616977|19924807|P2|NOT COMPLETED|Period 2||0
8080840|NCT03616977|19924808|P1|NOT COMPLETED|Period 2||0
8080841|NCT03616977|19924807|P2|COMPLETED|Period 2||34
8080842|NCT03616977|19924808|P1|COMPLETED|Period 2||34
8080843|NCT03616977|19924807|P2|STARTED|Period 2||34
8080844|NCT03616977|19924808|P1|STARTED|Period 2||34
8080845|NCT03616977|19924807|P2|NOT COMPLETED|Period 1||1
8080846|NCT03616977|19924808|P1|NOT COMPLETED|Period 1||0
8080847|NCT03616977|19924807|P2|COMPLETED|Period 1||34
8080848|NCT03616977|19924808|P1|COMPLETED|Period 1||34
8080849|NCT03616977|19924807|P2|Received at Least One Dose of Study Drug|Period 1||34
8080850|NCT03616977|19924808|P1|Received at Least One Dose of Study Drug|Period 1||34
8080851|NCT03616977|19924807|P2|STARTED|Period 1||35
8080852|NCT03616977|19924808|P1|STARTED|Period 1||34
8080859|NCT03616171|19924837|P2|NOT COMPLETED|Overall Study||0
8080860|NCT03616171|19924838|P1|NOT COMPLETED|Overall Study||0
8080861|NCT03616171|19924837|P2|COMPLETED|Overall Study||2
8080862|NCT03616171|19924838|P1|COMPLETED|Overall Study||4
8080863|NCT03616171|19924837|P2|STARTED|Overall Study||2
8080864|NCT03616171|19924838|P1|STARTED|Overall Study||4
8080865|NCT03616106|19924853|P2|NOT COMPLETED|Overall Study||1
8080866|NCT03616106|19924854|P1|NOT COMPLETED|Overall Study||14
8080867|NCT03616106|19924853|P2|COMPLETED|Overall Study||2
8080868|NCT03616106|19924854|P1|COMPLETED|Overall Study||42
8080869|NCT03616106|19924853|P2|STARTED|Overall Study||3
8080870|NCT03616106|19924854|P1|STARTED|Overall Study||56
8080871|NCT03615911|19924891|P2|NOT COMPLETED|Overall Study||1
8080872|NCT03615911|19924892|P1|NOT COMPLETED|Overall Study||2
8080873|NCT03615911|19924891|P2|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
8080874|NCT03615911|19924892|P1|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
8080875|NCT03615911|19924891|P2|Received Late Booster Immunization|Overall Study||7
8080876|NCT03615911|19924892|P1|Received Late Booster Immunization|Overall Study||3
8080877|NCT03615911|19924891|P2|STARTED|Overall Study||12
8080878|NCT03615911|19924892|P1|STARTED|Overall Study||14
8080879|NCT03615807|19924910|P2|NOT COMPLETED|Overall Study||11
8080880|NCT03615807|19924911|P1|NOT COMPLETED|Overall Study||12
8080881|NCT03615807|19924910|P2|COMPLETED|Overall Study||80
8080882|NCT03615807|19924911|P1|COMPLETED|Overall Study||79
8080883|NCT03615807|19924910|P2|STARTED|Overall Study||91
8080884|NCT03615807|19924911|P1|STARTED|Overall Study||91
8080885|NCT03615534|19924923|P4|NOT COMPLETED|Overall Study||1
8080886|NCT03615534|19924924|P3|NOT COMPLETED|Overall Study||0
8080887|NCT03615534|19924925|P2|NOT COMPLETED|Overall Study||0
8080888|NCT03615534|19924926|P1|NOT COMPLETED|Overall Study||2
8080889|NCT03615534|19924923|P4|COMPLETED|Overall Study||13
8080890|NCT03615534|19924924|P3|COMPLETED|Overall Study||14
8080891|NCT03615534|19924925|P2|COMPLETED|Overall Study||15
8080892|NCT03615534|19924926|P1|COMPLETED|Overall Study||12
8080893|NCT03615534|19924923|P4|STARTED|Overall Study||14
8080894|NCT03615534|19924924|P3|STARTED|Overall Study||14
8080895|NCT03615534|19924925|P2|STARTED|Overall Study||15
8080896|NCT03615534|19924926|P1|STARTED|Overall Study||14
8080897|NCT03615508|19924968|P1|NOT COMPLETED|Overall Study||0
8080898|NCT03615508|19924968|P1|COMPLETED|Overall Study||1
8080899|NCT03615508|19924968|P1|STARTED|Overall Study||1
8080900|NCT03615482|19924974|P2|NOT COMPLETED|Overall Study||17
8080901|NCT03615482|19924975|P1|NOT COMPLETED|Overall Study||17
8080902|NCT03615482|19924974|P2|COMPLETED|Overall Study||583
8080903|NCT03615482|19924975|P1|COMPLETED|Overall Study||583
8080904|NCT03615482|19924974|P2|Vaccinated|Overall Study||598
8080905|NCT03615482|19924975|P1|Vaccinated|Overall Study||599
8080906|NCT03615482|19924974|P2|STARTED|Overall Study||600
8080907|NCT03615482|19924975|P1|STARTED|Overall Study||600
8080908|NCT03615183|19925010|P5|NOT COMPLETED|Overall Study||0
8080909|NCT03615183|19925011|P4|NOT COMPLETED|Overall Study||0
8080910|NCT03615183|19925012|P3|NOT COMPLETED|Overall Study||0
8080911|NCT03615183|19925013|P2|NOT COMPLETED|Overall Study||0
8080912|NCT03615183|19925014|P1|NOT COMPLETED|Overall Study||0
8080913|NCT03615183|19925010|P5|COMPLETED|Overall Study||0
8080914|NCT03615183|19925011|P4|COMPLETED|Overall Study||0
8080915|NCT03615183|19925012|P3|COMPLETED|Overall Study||5
8080916|NCT03615183|19925013|P2|COMPLETED|Overall Study||6
8080917|NCT03615183|19925014|P1|COMPLETED|Overall Study||6
8080918|NCT03615183|19925010|P5|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
8080919|NCT03615183|19925011|P4|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
8080920|NCT03615183|19925012|P3|STARTED|Overall Study||5
8080921|NCT03615183|19925013|P2|STARTED|Overall Study||6
8080922|NCT03615183|19925014|P1|STARTED|Overall Study||6
8080923|NCT03615066|19925073|P3|NOT COMPLETED|Overall Study||8
8080924|NCT03615066|19925074|P2|NOT COMPLETED|Overall Study||20
8080925|NCT03615066|19925075|P1|NOT COMPLETED|Overall Study||19
8080926|NCT03615066|19925073|P3|COMPLETED|Overall Study||5
8080927|NCT03615066|19925074|P2|COMPLETED|Overall Study||8
8080928|NCT03615066|19925075|P1|COMPLETED|Overall Study||7
8080929|NCT03615066|19925073|P3|STARTED|Overall Study||13
8080930|NCT03615066|19925074|P2|STARTED|Overall Study||28
8080931|NCT03615066|19925075|P1|STARTED|Overall Study||26
8080932|NCT03615001|19925125|P1|NOT COMPLETED|Overall Study||0
8080933|NCT03615001|19925125|P1|COMPLETED|Overall Study||20
8080934|NCT03615001|19925125|P1|STARTED|Overall Study||20
8080935|NCT03614975|19925132|P2|NOT COMPLETED|Overall Study||8
8080936|NCT03614975|19925133|P1|NOT COMPLETED|Overall Study||10
8080937|NCT03614975|19925132|P2|COMPLETED|Overall Study||73
8080938|NCT03614975|19925133|P1|COMPLETED|Overall Study||75
8080939|NCT03614975|19925132|P2|STARTED|Overall Study||81
8080940|NCT03614975|19925133|P1|STARTED|Overall Study||85
8080941|NCT03614416|19925143|P1|NOT COMPLETED|Overall Study||0
8080942|NCT03614416|19925143|P1|COMPLETED|Overall Study||13
8080943|NCT03614416|19925143|P1|STARTED|Overall Study||13
8080944|NCT03614156|19925155|P4|NOT COMPLETED|Safety Follow-Up Period||1
8080945|NCT03614156|19925156|P3|NOT COMPLETED|Safety Follow-Up Period||1
8080946|NCT03614156|19925157|P2|NOT COMPLETED|Safety Follow-Up Period||0
8080947|NCT03614156|19925158|P1|NOT COMPLETED|Safety Follow-Up Period||3
8080948|NCT03614156|19925155|P4|COMPLETED|Safety Follow-Up Period||34
8080949|NCT03614156|19925156|P3|COMPLETED|Safety Follow-Up Period||29
8080950|NCT03614156|19925157|P2|COMPLETED|Safety Follow-Up Period||26
8080951|NCT03614156|19925158|P1|COMPLETED|Safety Follow-Up Period||162
8080952|NCT03614156|19925155|P4|STARTED|Safety Follow-Up Period||35
8080953|NCT03614156|19925156|P3|STARTED|Safety Follow-Up Period||30
8080954|NCT03614156|19925157|P2|STARTED|Safety Follow-Up Period||26
8080955|NCT03614156|19925158|P1|STARTED|Safety Follow-Up Period||165
8080956|NCT03614156|19925155|P4|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
8080957|NCT03614156|19925156|P3|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
8080958|NCT03614156|19925157|P2|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
8080959|NCT03614156|19925158|P1|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
8080960|NCT03614156|19925155|P4|COMPLETED|Double-Blind Treatment Period (DBTP)||10
8080961|NCT03614156|19925156|P3|COMPLETED|Double-Blind Treatment Period (DBTP)||11
8080962|NCT03614156|19925157|P2|COMPLETED|Double-Blind Treatment Period (DBTP)||10
8080963|NCT03614156|19925158|P1|COMPLETED|Double-Blind Treatment Period (DBTP)||0
8080964|NCT03614156|19925155|P4|STARTED|Double-Blind Treatment Period (DBTP)||55
8080965|NCT03614156|19925156|P3|STARTED|Double-Blind Treatment Period (DBTP)||42
8080966|NCT03614156|19925157|P2|STARTED|Double-Blind Treatment Period (DBTP)||40
8080967|NCT03614156|19925158|P1|STARTED|Double-Blind Treatment Period (DBTP)||0
8080968|NCT03614156|19925155|P4|NOT COMPLETED|Open-Label Treatment Period||0
8080969|NCT03614156|19925156|P3|NOT COMPLETED|Open-Label Treatment Period||0
8080970|NCT03614156|19925157|P2|NOT COMPLETED|Open-Label Treatment Period||0
8080971|NCT03614156|19925158|P1|NOT COMPLETED|Open-Label Treatment Period||154
8080972|NCT03614156|19925155|P4|COMPLETED|Open-Label Treatment Period||0
8080973|NCT03614156|19925156|P3|COMPLETED|Open-Label Treatment Period||0
8080974|NCT03614156|19925157|P2|COMPLETED|Open-Label Treatment Period||0
8080975|NCT03614156|19925158|P1|COMPLETED|Open-Label Treatment Period||209
8080976|NCT03614156|19925155|P4|STARTED|Open-Label Treatment Period||0
8080977|NCT03614156|19925156|P3|STARTED|Open-Label Treatment Period||0
8080978|NCT03614156|19925157|P2|STARTED|Open-Label Treatment Period||0
8080979|NCT03614156|19925158|P1|STARTED|Open-Label Treatment Period||363
8080980|NCT03614078|19925170|P3|NOT COMPLETED|Overall Study||5
8080981|NCT03614078|19925171|P2|NOT COMPLETED|Overall Study||7
8080982|NCT03614078|19925172|P1|NOT COMPLETED|Overall Study||3
8080983|NCT03614078|19925170|P3|COMPLETED|Overall Study||26
8080984|NCT03614078|19925171|P2|COMPLETED|Overall Study||23
8080985|NCT03614078|19925172|P1|COMPLETED|Overall Study||28
8080986|NCT03614078|19925170|P3|STARTED|Overall Study||31
8080987|NCT03614078|19925171|P2|STARTED|Overall Study||30
8080988|NCT03614078|19925172|P1|STARTED|Overall Study||31
8080989|NCT03613649|19925201|P12|NOT COMPLETED|Fourth Treatment||0
8080990|NCT03613649|19925202|P11|NOT COMPLETED|Fourth Treatment||0
8080991|NCT03613649|19925203|P10|NOT COMPLETED|Fourth Treatment||0
8080992|NCT03613649|19925204|P9|NOT COMPLETED|Fourth Treatment||0
8080993|NCT03613649|19925205|P8|NOT COMPLETED|Fourth Treatment||0
8080994|NCT03613649|19925206|P7|NOT COMPLETED|Fourth Treatment||1
8080995|NCT03613649|19925207|P6|NOT COMPLETED|Fourth Treatment||0
8080996|NCT03613649|19925208|P5|NOT COMPLETED|Fourth Treatment||1
8080997|NCT03613649|19925209|P4|NOT COMPLETED|Fourth Treatment||0
8080998|NCT03613649|19925210|P3|NOT COMPLETED|Fourth Treatment||0
8080999|NCT03613649|19925211|P2|NOT COMPLETED|Fourth Treatment||0
8081000|NCT03613649|19925212|P1|NOT COMPLETED|Fourth Treatment||1
8081001|NCT03613649|19925201|P12|COMPLETED|Fourth Treatment||4
8081002|NCT03613649|19925202|P11|COMPLETED|Fourth Treatment||6
8081003|NCT03613649|19925203|P10|COMPLETED|Fourth Treatment||6
8081004|NCT03613649|19925204|P9|COMPLETED|Fourth Treatment||6
8081005|NCT03613649|19925205|P8|COMPLETED|Fourth Treatment||6
8081006|NCT03613649|19925206|P7|COMPLETED|Fourth Treatment||4
8081007|NCT03613649|19925207|P6|COMPLETED|Fourth Treatment||6
8081008|NCT03613649|19925208|P5|COMPLETED|Fourth Treatment||3
8081009|NCT03613649|19925209|P4|COMPLETED|Fourth Treatment||6
8081010|NCT03613649|19925210|P3|COMPLETED|Fourth Treatment||5
8081011|NCT03613649|19925211|P2|COMPLETED|Fourth Treatment||6
8081012|NCT03613649|19925212|P1|COMPLETED|Fourth Treatment||5
8081013|NCT03613649|19925201|P12|Received Treatment|Fourth Treatment||4
8081014|NCT03613649|19925202|P11|Received Treatment|Fourth Treatment||6
8081015|NCT03613649|19925203|P10|Received Treatment|Fourth Treatment||6
8081016|NCT03613649|19925204|P9|Received Treatment|Fourth Treatment||6
8081017|NCT03613649|19925205|P8|Received Treatment|Fourth Treatment||6
8081018|NCT03613649|19925206|P7|Received Treatment|Fourth Treatment||4
8081019|NCT03613649|19925207|P6|Received Treatment|Fourth Treatment||6
8081020|NCT03613649|19925208|P5|Received Treatment|Fourth Treatment||4
8081021|NCT03613649|19925209|P4|Received Treatment|Fourth Treatment||6
8081022|NCT03613649|19925210|P3|Received Treatment|Fourth Treatment||5
8081023|NCT03613649|19925211|P2|Received Treatment|Fourth Treatment||6
8081024|NCT03613649|19925212|P1|Received Treatment|Fourth Treatment||5
8081025|NCT03613649|19925201|P12|STARTED|Fourth Treatment||4
8081026|NCT03613649|19925202|P11|STARTED|Fourth Treatment||6
8081027|NCT03613649|19925203|P10|STARTED|Fourth Treatment||6
8081028|NCT03613649|19925204|P9|STARTED|Fourth Treatment||6
8081029|NCT03613649|19925205|P8|STARTED|Fourth Treatment||6
8081030|NCT03613649|19925206|P7|STARTED|Fourth Treatment||5
8081031|NCT03613649|19925207|P6|STARTED|Fourth Treatment||6
8081032|NCT03613649|19925208|P5|STARTED|Fourth Treatment||4
8081033|NCT03613649|19925209|P4|STARTED|Fourth Treatment||6
8081034|NCT03613649|19925210|P3|STARTED|Fourth Treatment||5
8081035|NCT03613649|19925211|P2|STARTED|Fourth Treatment||6
8081036|NCT03613649|19925212|P1|STARTED|Fourth Treatment||6
8081037|NCT03613649|19925201|P12|NOT COMPLETED|Third Treatment||2
8081038|NCT03613649|19925202|P11|NOT COMPLETED|Third Treatment||0
8081039|NCT03613649|19925203|P10|NOT COMPLETED|Third Treatment||0
8081040|NCT03613649|19925204|P9|NOT COMPLETED|Third Treatment||0
8081041|NCT03613649|19925205|P8|NOT COMPLETED|Third Treatment||0
8081042|NCT03613649|19925206|P7|NOT COMPLETED|Third Treatment||1
8081043|NCT03613649|19925207|P6|NOT COMPLETED|Third Treatment||0
8081044|NCT03613649|19925208|P5|NOT COMPLETED|Third Treatment||1
8081045|NCT03613649|19925209|P4|NOT COMPLETED|Third Treatment||0
8081046|NCT03613649|19925210|P3|NOT COMPLETED|Third Treatment||0
8081047|NCT03613649|19925211|P2|NOT COMPLETED|Third Treatment||0
8081048|NCT03613649|19925212|P1|NOT COMPLETED|Third Treatment||0
8081049|NCT03613649|19925201|P12|COMPLETED|Third Treatment||4
8081050|NCT03613649|19925202|P11|COMPLETED|Third Treatment||6
8081051|NCT03613649|19925203|P10|COMPLETED|Third Treatment||6
8081052|NCT03613649|19925204|P9|COMPLETED|Third Treatment||6
8081053|NCT03613649|19925205|P8|COMPLETED|Third Treatment||6
8081054|NCT03613649|19925206|P7|COMPLETED|Third Treatment||5
8081055|NCT03613649|19925207|P6|COMPLETED|Third Treatment||6
8081056|NCT03613649|19925208|P5|COMPLETED|Third Treatment||4
8081057|NCT03613649|19925209|P4|COMPLETED|Third Treatment||6
8081058|NCT03613649|19925210|P3|COMPLETED|Third Treatment||5
8081059|NCT03613649|19925211|P2|COMPLETED|Third Treatment||6
8081060|NCT03613649|19925212|P1|COMPLETED|Third Treatment||6
8081061|NCT03613649|19925201|P12|Received Treatment|Third Treatment||6
8081062|NCT03613649|19925202|P11|Received Treatment|Third Treatment||6
8081063|NCT03613649|19925203|P10|Received Treatment|Third Treatment||6
8081064|NCT03613649|19925204|P9|Received Treatment|Third Treatment||6
8081065|NCT03613649|19925205|P8|Received Treatment|Third Treatment||6
8081066|NCT03613649|19925206|P7|Received Treatment|Third Treatment||5
8081067|NCT03613649|19925207|P6|Received Treatment|Third Treatment||6
8081068|NCT03613649|19925208|P5|Received Treatment|Third Treatment||5
8081069|NCT03613649|19925209|P4|Received Treatment|Third Treatment||6
8081070|NCT03613649|19925210|P3|Received Treatment|Third Treatment||5
8081071|NCT03613649|19925211|P2|Received Treatment|Third Treatment||6
8081072|NCT03613649|19925212|P1|Received Treatment|Third Treatment||6
8081073|NCT03613649|19925201|P12|STARTED|Third Treatment||6
8081074|NCT03613649|19925202|P11|STARTED|Third Treatment||6
8081075|NCT03613649|19925203|P10|STARTED|Third Treatment||6
8081076|NCT03613649|19925204|P9|STARTED|Third Treatment||6
8081077|NCT03613649|19925205|P8|STARTED|Third Treatment||6
8081078|NCT03613649|19925206|P7|STARTED|Third Treatment||6
8081079|NCT03613649|19925207|P6|STARTED|Third Treatment||6
8081080|NCT03613649|19925208|P5|STARTED|Third Treatment||5
8081081|NCT03613649|19925209|P4|STARTED|Third Treatment||6
8081082|NCT03613649|19925210|P3|STARTED|Third Treatment||5
8081083|NCT03613649|19925211|P2|STARTED|Third Treatment||6
8081084|NCT03613649|19925212|P1|STARTED|Third Treatment||6
8081085|NCT03613649|19925201|P12|NOT COMPLETED|Second Treatment||0
8081086|NCT03613649|19925202|P11|NOT COMPLETED|Second Treatment||0
8081087|NCT03613649|19925203|P10|NOT COMPLETED|Second Treatment||0
8081088|NCT03613649|19925204|P9|NOT COMPLETED|Second Treatment||0
8081089|NCT03613649|19925205|P8|NOT COMPLETED|Second Treatment||0
8081090|NCT03613649|19925206|P7|NOT COMPLETED|Second Treatment||0
8081091|NCT03613649|19925207|P6|NOT COMPLETED|Second Treatment||0
8081092|NCT03613649|19925208|P5|NOT COMPLETED|Second Treatment||1
8081093|NCT03613649|19925209|P4|NOT COMPLETED|Second Treatment||0
8081094|NCT03613649|19925210|P3|NOT COMPLETED|Second Treatment||1
8081095|NCT03613649|19925211|P2|NOT COMPLETED|Second Treatment||0
8081096|NCT03613649|19925212|P1|NOT COMPLETED|Second Treatment||0
8081097|NCT03613649|19925201|P12|COMPLETED|Second Treatment||6
8081098|NCT03613649|19925202|P11|COMPLETED|Second Treatment||6
8081099|NCT03613649|19925203|P10|COMPLETED|Second Treatment||6
8081100|NCT03613649|19925204|P9|COMPLETED|Second Treatment||6
8081101|NCT03613649|19925205|P8|COMPLETED|Second Treatment||6
8081102|NCT03613649|19925206|P7|COMPLETED|Second Treatment||6
8081103|NCT03613649|19925207|P6|COMPLETED|Second Treatment||6
8081104|NCT03613649|19925208|P5|COMPLETED|Second Treatment||5
8081105|NCT03613649|19925209|P4|COMPLETED|Second Treatment||6
8081106|NCT03613649|19925210|P3|COMPLETED|Second Treatment||5
8081107|NCT03613649|19925211|P2|COMPLETED|Second Treatment||6
8081108|NCT03613649|19925212|P1|COMPLETED|Second Treatment||6
8081109|NCT03613649|19925201|P12|Received Treatment|Second Treatment||6
8081110|NCT03613649|19925202|P11|Received Treatment|Second Treatment||6
8081111|NCT03613649|19925203|P10|Received Treatment|Second Treatment||6
8081112|NCT03613649|19925204|P9|Received Treatment|Second Treatment||6
8081113|NCT03613649|19925205|P8|Received Treatment|Second Treatment||6
8081114|NCT03613649|19925206|P7|Received Treatment|Second Treatment||6
8081115|NCT03613649|19925207|P6|Received Treatment|Second Treatment||6
8081116|NCT03613649|19925208|P5|Received Treatment|Second Treatment||6
8081117|NCT03613649|19925209|P4|Received Treatment|Second Treatment||6
8081118|NCT03613649|19925210|P3|Received Treatment|Second Treatment||6
8081119|NCT03613649|19925211|P2|Received Treatment|Second Treatment||6
8081120|NCT03613649|19925212|P1|Received Treatment|Second Treatment||6
8081121|NCT03613649|19925201|P12|STARTED|Second Treatment||6
8081122|NCT03613649|19925202|P11|STARTED|Second Treatment||6
8081123|NCT03613649|19925203|P10|STARTED|Second Treatment||6
8081124|NCT03613649|19925204|P9|STARTED|Second Treatment||6
8081125|NCT03613649|19925205|P8|STARTED|Second Treatment||6
8081126|NCT03613649|19925206|P7|STARTED|Second Treatment||6
8081127|NCT03613649|19925207|P6|STARTED|Second Treatment||6
8081128|NCT03613649|19925208|P5|STARTED|Second Treatment||6
8081129|NCT03613649|19925209|P4|STARTED|Second Treatment||6
8081130|NCT03613649|19925210|P3|STARTED|Second Treatment||6
8081131|NCT03613649|19925211|P2|STARTED|Second Treatment||6
8081132|NCT03613649|19925212|P1|STARTED|Second Treatment||6
8081133|NCT03613649|19925201|P12|NOT COMPLETED|First Treatment||0
8081134|NCT03613649|19925202|P11|NOT COMPLETED|First Treatment||0
8081135|NCT03613649|19925203|P10|NOT COMPLETED|First Treatment||0
8081136|NCT03613649|19925204|P9|NOT COMPLETED|First Treatment||0
8081137|NCT03613649|19925205|P8|NOT COMPLETED|First Treatment||0
8081138|NCT03613649|19925206|P7|NOT COMPLETED|First Treatment||0
8081139|NCT03613649|19925207|P6|NOT COMPLETED|First Treatment||0
8081140|NCT03613649|19925208|P5|NOT COMPLETED|First Treatment||0
8081141|NCT03613649|19925209|P4|NOT COMPLETED|First Treatment||0
8081142|NCT03613649|19925210|P3|NOT COMPLETED|First Treatment||0
8081143|NCT03613649|19925211|P2|NOT COMPLETED|First Treatment||0
8081144|NCT03613649|19925212|P1|NOT COMPLETED|First Treatment||0
8081145|NCT03613649|19925201|P12|COMPLETED|First Treatment||6
8081146|NCT03613649|19925202|P11|COMPLETED|First Treatment||6
8081147|NCT03613649|19925203|P10|COMPLETED|First Treatment||6
8081148|NCT03613649|19925204|P9|COMPLETED|First Treatment||6
8081149|NCT03613649|19925205|P8|COMPLETED|First Treatment||6
8081150|NCT03613649|19925206|P7|COMPLETED|First Treatment||6
8081151|NCT03613649|19925207|P6|COMPLETED|First Treatment||6
8081152|NCT03613649|19925208|P5|COMPLETED|First Treatment||6
8081153|NCT03613649|19925209|P4|COMPLETED|First Treatment||6
8081154|NCT03613649|19925210|P3|COMPLETED|First Treatment||6
8081155|NCT03613649|19925211|P2|COMPLETED|First Treatment||6
8081156|NCT03613649|19925212|P1|COMPLETED|First Treatment||6
8081157|NCT03613649|19925201|P12|Received Treatment|First Treatment||6
8081158|NCT03613649|19925202|P11|Received Treatment|First Treatment||6
8081159|NCT03613649|19925203|P10|Received Treatment|First Treatment||6
8081160|NCT03613649|19925204|P9|Received Treatment|First Treatment||6
8081161|NCT03613649|19925205|P8|Received Treatment|First Treatment||6
8081162|NCT03613649|19925206|P7|Received Treatment|First Treatment||6
8081163|NCT03613649|19925207|P6|Received Treatment|First Treatment||6
8081164|NCT03613649|19925208|P5|Received Treatment|First Treatment||6
8081165|NCT03613649|19925209|P4|Received Treatment|First Treatment||6
8081166|NCT03613649|19925210|P3|Received Treatment|First Treatment||6
8081167|NCT03613649|19925211|P2|Received Treatment|First Treatment||6
8081168|NCT03613649|19925212|P1|Received Treatment|First Treatment||6
8081169|NCT03613649|19925201|P12|STARTED|First Treatment||6
8081170|NCT03613649|19925202|P11|STARTED|First Treatment||6
8081171|NCT03613649|19925203|P10|STARTED|First Treatment||6
8081172|NCT03613649|19925204|P9|STARTED|First Treatment||6
8081173|NCT03613649|19925205|P8|STARTED|First Treatment||6
8081174|NCT03613649|19925206|P7|STARTED|First Treatment||6
8081175|NCT03613649|19925207|P6|STARTED|First Treatment||6
8081176|NCT03613649|19925208|P5|STARTED|First Treatment||6
8081177|NCT03613649|19925209|P4|STARTED|First Treatment||6
8081178|NCT03613649|19925210|P3|STARTED|First Treatment||6
8081179|NCT03613649|19925211|P2|STARTED|First Treatment||6
8081180|NCT03613649|19925212|P1|STARTED|First Treatment||6
8081181|NCT03613493|19925341|P4|NOT COMPLETED|Overall Study||7
8081182|NCT03613493|19925342|P3|NOT COMPLETED|Overall Study||0
8081183|NCT03613493|19925343|P2|NOT COMPLETED|Overall Study||2
8081184|NCT03613493|19925344|P1|NOT COMPLETED|Overall Study||0
8081185|NCT03613493|19925341|P4|COMPLETED|Overall Study||83
8081186|NCT03613493|19925342|P3|COMPLETED|Overall Study||0
8081187|NCT03613493|19925343|P2|COMPLETED|Overall Study||73
8081188|NCT03613493|19925344|P1|COMPLETED|Overall Study||10
8081189|NCT03613493|19925341|P4|Enrollment Criteria Met|Overall Study||89
8081190|NCT03613493|19925342|P3|Enrollment Criteria Met|Overall Study||0
8081191|NCT03613493|19925343|P2|Enrollment Criteria Met|Overall Study||74
8081192|NCT03613493|19925344|P1|Enrollment Criteria Met|Overall Study||10
8081193|NCT03613493|19925341|P4|STARTED|Overall Study||90
8081194|NCT03613493|19925342|P3|STARTED|Overall Study||0
8081195|NCT03613493|19925343|P2|STARTED|Overall Study||75
8081196|NCT03613493|19925344|P1|STARTED|Overall Study||10
8081197|NCT03613129|19925357|P5|NOT COMPLETED|Post-treatment Assessment||0
8081198|NCT03613129|19925358|P4|NOT COMPLETED|Post-treatment Assessment||0
8081199|NCT03613129|19925359|P3|NOT COMPLETED|Post-treatment Assessment||0
8081200|NCT03613129|19925360|P2|NOT COMPLETED|Post-treatment Assessment||0
8081201|NCT03613129|19925361|P1|NOT COMPLETED|Post-treatment Assessment||0
8081202|NCT03613129|19925357|P5|COMPLETED|Post-treatment Assessment||2
8081203|NCT03613129|19925358|P4|COMPLETED|Post-treatment Assessment||2
8081204|NCT03613129|19925359|P3|COMPLETED|Post-treatment Assessment||7
8081205|NCT03613129|19925360|P2|COMPLETED|Post-treatment Assessment||3
8081206|NCT03613129|19925361|P1|COMPLETED|Post-treatment Assessment||0
8081207|NCT03613129|19925357|P5|STARTED|Post-treatment Assessment||2
8081208|NCT03613129|19925358|P4|STARTED|Post-treatment Assessment||2
8081209|NCT03613129|19925359|P3|STARTED|Post-treatment Assessment||7
8081210|NCT03613129|19925360|P2|STARTED|Post-treatment Assessment||3
8081211|NCT03613129|19925361|P1|STARTED|Post-treatment Assessment||0
8081212|NCT03613129|19925357|P5|NOT COMPLETED|Treatment||0
8081213|NCT03613129|19925358|P4|NOT COMPLETED|Treatment||0
8081214|NCT03613129|19925359|P3|NOT COMPLETED|Treatment||0
8081215|NCT03613129|19925360|P2|NOT COMPLETED|Treatment||0
8081216|NCT03613129|19925361|P1|NOT COMPLETED|Treatment||0
8081217|NCT03613129|19925357|P5|COMPLETED|Treatment||2
8081218|NCT03613129|19925358|P4|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
8081219|NCT03613129|19925359|P3|COMPLETED|Treatment||7
8081220|NCT03613129|19925360|P2|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
8081221|NCT03613129|19925361|P1|COMPLETED|Treatment||0
8081222|NCT03613129|19925357|P5|STARTED|Treatment||2
8081223|NCT03613129|19925358|P4|STARTED|Treatment||2
8081224|NCT03613129|19925359|P3|STARTED|Treatment||7
8081225|NCT03613129|19925360|P2|STARTED|Treatment||3
8081226|NCT03613129|19925361|P1|STARTED|Treatment||0
8081227|NCT03613129|19925357|P5|NOT COMPLETED|Pre-treatment Assessment||0
8081228|NCT03613129|19925358|P4|NOT COMPLETED|Pre-treatment Assessment||0
8081229|NCT03613129|19925359|P3|NOT COMPLETED|Pre-treatment Assessment||0
8081230|NCT03613129|19925360|P2|NOT COMPLETED|Pre-treatment Assessment||0
8081231|NCT03613129|19925361|P1|NOT COMPLETED|Pre-treatment Assessment||3
8081232|NCT03613129|19925357|P5|COMPLETED|Pre-treatment Assessment||2
8081233|NCT03613129|19925358|P4|COMPLETED|Pre-treatment Assessment||2
8081234|NCT03613129|19925359|P3|COMPLETED|Pre-treatment Assessment||7
8081235|NCT03613129|19925360|P2|COMPLETED|Pre-treatment Assessment||3
8081236|NCT03613129|19925361|P1|COMPLETED|Pre-treatment Assessment||0
8081237|NCT03613129|19925357|P5|STARTED|Pre-treatment Assessment||2
8081238|NCT03613129|19925358|P4|STARTED|Pre-treatment Assessment||2
8081239|NCT03613129|19925359|P3|STARTED|Pre-treatment Assessment||7
8081240|NCT03613129|19925360|P2|STARTED|Pre-treatment Assessment||3
8081241|NCT03613129|19925361|P1|STARTED|Pre-treatment Assessment||3
8081242|NCT03612856|19925386|P3|NOT COMPLETED|Post-dose Period||0
8081243|NCT03612856|19925387|P2|NOT COMPLETED|Post-dose Period||0
8081244|NCT03612856|19925388|P1|NOT COMPLETED|Post-dose Period||0
8081245|NCT03612856|19925386|P3|COMPLETED|Post-dose Period||8
8081246|NCT03612856|19925387|P2|COMPLETED|Post-dose Period||8
8081247|NCT03612856|19925388|P1|COMPLETED|Post-dose Period||8
8081248|NCT03612856|19925386|P3|STARTED|Post-dose Period||8
8081249|NCT03612856|19925387|P2|STARTED|Post-dose Period||8
8081250|NCT03612856|19925388|P1|STARTED|Post-dose Period||8
8081251|NCT03612856|19925386|P3|NOT COMPLETED|Pre-dose Period||1
8081252|NCT03612856|19925387|P2|NOT COMPLETED|Pre-dose Period||2
8081253|NCT03612856|19925388|P1|NOT COMPLETED|Pre-dose Period||0
8081254|NCT03612856|19925386|P3|COMPLETED|Pre-dose Period||8
8081255|NCT03612856|19925387|P2|COMPLETED|Pre-dose Period||8
8081256|NCT03612856|19925388|P1|COMPLETED|Pre-dose Period||8
8081257|NCT03612856|19925386|P3|STARTED|Pre-dose Period||9
8081258|NCT03612856|19925387|P2|STARTED|Pre-dose Period||10
8081259|NCT03612856|19925388|P1|STARTED|Pre-dose Period||8
8081260|NCT03611829|19925542|P2|NOT COMPLETED|Overall Study||25
8081261|NCT03611829|19925543|P1|NOT COMPLETED|Overall Study||22
8081262|NCT03611829|19925542|P2|COMPLETED|Overall Study||19
8081263|NCT03611829|19925543|P1|COMPLETED|Overall Study||21
8081264|NCT03611829|19925542|P2|STARTED|Overall Study||44
8081265|NCT03611829|19925543|P1|STARTED|Overall Study||43
8081266|NCT03610633|19925576|P2|NOT COMPLETED|Overall Study||1
8081267|NCT03610633|19925577|P1|NOT COMPLETED|Overall Study||0
8081268|NCT03610633|19925576|P2|COMPLETED|Overall Study||5
8081269|NCT03610633|19925577|P1|COMPLETED|Overall Study||5
8081270|NCT03610633|19925576|P2|STARTED|Overall Study||6
8081271|NCT03610633|19925577|P1|STARTED|Overall Study||5
8081272|NCT03610464|19925583|P1|NOT COMPLETED|Overall Study||0
8081273|NCT03610464|19925583|P1|COMPLETED|Overall Study||5
8081274|NCT03610464|19925583|P1|STARTED|Overall Study||5
8081275|NCT03610269|19925588|P1|NOT COMPLETED|Overall Study||16
8081276|NCT03610269|19925588|P1|COMPLETED|Overall Study||127
8081277|NCT03610269|19925588|P1|STARTED|Overall Study||143
8081278|NCT03609619|19925594|P2|NOT COMPLETED|Overall Study||6
8081279|NCT03609619|19925595|P1|NOT COMPLETED|Overall Study||10
8081280|NCT03609619|19925594|P2|COMPLETED|Overall Study||49
8081281|NCT03609619|19925595|P1|COMPLETED|Overall Study||44
8081282|NCT03609619|19925594|P2|STARTED|Overall Study||55
8081283|NCT03609619|19925595|P1|STARTED|Overall Study||54
8081284|NCT03608839|19925606|P3|NOT COMPLETED|Overall Study||0
8081285|NCT03608839|19925607|P2|NOT COMPLETED|Overall Study||0
8081286|NCT03608839|19925608|P1|NOT COMPLETED|Overall Study||0
8081287|NCT03608839|19925606|P3|COMPLETED|Overall Study||9
8081288|NCT03608839|19925607|P2|COMPLETED|Overall Study||9
8081289|NCT03608839|19925608|P1|COMPLETED|Overall Study||9
8081290|NCT03608839|19925606|P3|STARTED|Overall Study||9
8081291|NCT03608839|19925607|P2|STARTED|Overall Study||9
8081292|NCT03608839|19925608|P1|STARTED|Overall Study||9
8081293|NCT03608774|19925633|P2|NOT COMPLETED|Overall Study||7
8081294|NCT03608774|19925634|P1|NOT COMPLETED|Overall Study||7
8081295|NCT03608774|19925633|P2|COMPLETED|Overall Study||81
8081296|NCT03608774|19925634|P1|COMPLETED|Overall Study||82
8081297|NCT03608774|19925633|P2|STARTED|Overall Study||88
8081298|NCT03608774|19925634|P1|STARTED|Overall Study||89
8081299|NCT03608488|19925654|P4|NOT COMPLETED|Overall Study||5
8081300|NCT03608488|19925655|P3|NOT COMPLETED|Overall Study||2
8081301|NCT03608488|19925656|P2|NOT COMPLETED|Overall Study||3
8081302|NCT03608488|19925657|P1|NOT COMPLETED|Overall Study||1
8081303|NCT03608488|19925654|P4|COMPLETED|Overall Study||40
8081304|NCT03608488|19925655|P3|COMPLETED|Overall Study||20
8081305|NCT03608488|19925656|P2|COMPLETED|Overall Study||18
8081306|NCT03608488|19925657|P1|COMPLETED|Overall Study||21
8081307|NCT03608488|19925654|P4|STARTED|Overall Study||45
8081308|NCT03608488|19925655|P3|STARTED|Overall Study||22
8081309|NCT03608488|19925656|P2|STARTED|Overall Study||21
8081310|NCT03608488|19925657|P1|STARTED|Overall Study||22
8081311|NCT03607682|19925695|P1|NOT COMPLETED|Overall Study||2
8081312|NCT03607682|19925695|P1|COMPLETED|Overall Study||0
8081313|NCT03607682|19925695|P1|STARTED|Overall Study||2
8081314|NCT03607487|19925711|P4|NOT COMPLETED|Overall Study||1
8081315|NCT03607487|19925712|P3|NOT COMPLETED|Overall Study||0
8081316|NCT03607487|19925713|P2|NOT COMPLETED|Overall Study||0
8081317|NCT03607487|19925714|P1|NOT COMPLETED|Overall Study||2
8081318|NCT03607487|19925711|P4|COMPLETED|Overall Study||7
8081319|NCT03607487|19925712|P3|COMPLETED|Overall Study||9
8081320|NCT03607487|19925713|P2|COMPLETED|Overall Study||9
8081321|NCT03607487|19925714|P1|COMPLETED|Overall Study||7
8081322|NCT03607487|19925711|P4|STARTED|Overall Study||8
8081323|NCT03607487|19925712|P3|STARTED|Overall Study||9
8081324|NCT03607487|19925713|P2|STARTED|Overall Study||9
8081325|NCT03607487|19925714|P1|STARTED|Overall Study||9
8081326|NCT03606460|19925765|P2|NOT COMPLETED|Overall Study||8
8081327|NCT03606460|19925766|P1|NOT COMPLETED|Overall Study||1
8081328|NCT03606460|19925765|P2|COMPLETED|Overall Study||38
8081329|NCT03606460|19925766|P1|COMPLETED|Overall Study||94
8081330|NCT03606460|19925765|P2|STARTED|Overall Study||46
8081331|NCT03606460|19925766|P1|STARTED|Overall Study||95
8081332|NCT03606343|19925774|P1|NOT COMPLETED|Overall Study||0
8081333|NCT03606343|19925774|P1|COMPLETED|Overall Study||21
8081334|NCT03606343|19925774|P1|STARTED|Overall Study||21
8081335|NCT03605693|19925786|P2|NOT COMPLETED|Overall Study||0
8081336|NCT03605693|19925787|P1|NOT COMPLETED|Overall Study||5
8081337|NCT03605693|19925786|P2|COMPLETED|Overall Study||5
8081338|NCT03605693|19925787|P1|COMPLETED|Overall Study||0
8081339|NCT03605693|19925786|P2|STARTED|Overall Study||5
8081340|NCT03605693|19925787|P1|STARTED|Overall Study||5
8081341|NCT03605303|19925801|P2|NOT COMPLETED|Period 2||0
8081342|NCT03605303|19925802|P1|NOT COMPLETED|Period 2||0
8081343|NCT03605303|19925801|P2|COMPLETED|Period 2||0
8081344|NCT03605303|19925802|P1|COMPLETED|Period 2||0
8081345|NCT03605303|19925801|P2|STARTED|Period 2||0
8081346|NCT03605303|19925802|P1|STARTED|Period 2||0
8081347|NCT03605303|19925801|P2|NOT COMPLETED|Period 1||1
8081348|NCT03605303|19925802|P1|NOT COMPLETED|Period 1||2
8081349|NCT03605303|19925801|P2|COMPLETED|Period 1||0
8081350|NCT03605303|19925802|P1|COMPLETED|Period 1||0
8081351|NCT03605303|19925801|P2|STARTED|Period 1||1
8081352|NCT03605303|19925802|P1|STARTED|Period 1||2
8081353|NCT03604497|19925810|P1|NOT COMPLETED|Overall Study||52
8081354|NCT03604497|19925810|P1|COMPLETED|Overall Study||385
8081355|NCT03604497|19925810|P1|STARTED|Overall Study||437
8081356|NCT03604341|19925820|P2|NOT COMPLETED|Overall Study||2
8081357|NCT03604341|19925821|P1|NOT COMPLETED|Overall Study||2
8081358|NCT03604341|19925820|P2|COMPLETED|Overall Study||33
8081359|NCT03604341|19925821|P1|COMPLETED|Overall Study||33
8081360|NCT03604341|19925820|P2|STARTED|Overall Study||35
8081361|NCT03604341|19925821|P1|STARTED|Overall Study||35
8081362|NCT03604263|19925827|P1|NOT COMPLETED|Overall Study||2
8081363|NCT03604263|19925827|P1|COMPLETED|Overall Study||15
8081364|NCT03604263|19925827|P1|STARTED|Overall Study||17
8081365|NCT03603652|19925831|P1|NOT COMPLETED|Overall Study||2
8081366|NCT03603652|19925831|P1|COMPLETED|Overall Study||8
8081367|NCT03603652|19925831|P1|STARTED|Overall Study||10
8081368|NCT03603106|19925854|P11|NOT COMPLETED|Overall Study||0
8081369|NCT03603106|19925855|P10|NOT COMPLETED|Overall Study||0
8081370|NCT03603106|19925856|P9|NOT COMPLETED|Overall Study||0
8081371|NCT03603106|19925857|P8|NOT COMPLETED|Overall Study||0
8081372|NCT03603106|19925858|P7|NOT COMPLETED|Overall Study||0
8081373|NCT03603106|19925859|P6|NOT COMPLETED|Overall Study||0
8081374|NCT03603106|19925860|P5|NOT COMPLETED|Overall Study||0
8081375|NCT03603106|19925861|P4|NOT COMPLETED|Overall Study||0
8081376|NCT03603106|19925862|P3|NOT COMPLETED|Overall Study||0
8081377|NCT03603106|19925863|P2|NOT COMPLETED|Overall Study||0
8081378|NCT03603106|19925864|P1|NOT COMPLETED|Overall Study||0
8081379|NCT03603106|19925854|P11|COMPLETED|Overall Study||3
8081380|NCT03603106|19925855|P10|COMPLETED|Overall Study||3
8081381|NCT03603106|19925856|P9|COMPLETED|Overall Study||3
8081382|NCT03603106|19925857|P8|COMPLETED|Overall Study||3
8081383|NCT03603106|19925858|P7|COMPLETED|Overall Study||18
8081384|NCT03603106|19925859|P6|COMPLETED|Overall Study||6
8081385|NCT03603106|19925860|P5|COMPLETED|Overall Study||6
8081386|NCT03603106|19925861|P4|COMPLETED|Overall Study||6
8081387|NCT03603106|19925862|P3|COMPLETED|Overall Study||6
8081388|NCT03603106|19925863|P2|COMPLETED|Overall Study||6
8081389|NCT03603106|19925864|P1|COMPLETED|Overall Study||6
8081390|NCT03603106|19925854|P11|STARTED|Overall Study||3
8081391|NCT03603106|19925855|P10|STARTED|Overall Study||3
8081392|NCT03603106|19925856|P9|STARTED|Overall Study||3
8081393|NCT03603106|19925857|P8|STARTED|Overall Study||3
8081394|NCT03603106|19925858|P7|STARTED|Overall Study||18
8081395|NCT03603106|19925859|P6|STARTED|Overall Study||6
8081396|NCT03603106|19925860|P5|STARTED|Overall Study||6
8081397|NCT03603106|19925861|P4|STARTED|Overall Study||6
8081398|NCT03603106|19925862|P3|STARTED|Overall Study||6
8081399|NCT03603106|19925863|P2|STARTED|Overall Study||6
8081400|NCT03603106|19925864|P1|STARTED|Overall Study||6
8081401|NCT03603028|19925917|P1|NOT COMPLETED|Overall Study||1
8081402|NCT03603028|19925917|P1|COMPLETED|Overall Study||12
8081403|NCT03603028|19925917|P1|STARTED|Overall Study||13
8081404|NCT03602053|19925925|P3|NOT COMPLETED|Overall Study||11
8081405|NCT03602053|19925926|P2|NOT COMPLETED|Overall Study||18
8081406|NCT03602053|19925927|P1|NOT COMPLETED|Overall Study||19
8081407|NCT03602053|19925925|P3|COMPLETED|Overall Study||139
8081408|NCT03602053|19925926|P2|COMPLETED|Overall Study||132
8081409|NCT03602053|19925927|P1|COMPLETED|Overall Study||131
8081410|NCT03602053|19925925|P3|STARTED|Overall Study||150
8081411|NCT03602053|19925926|P2|STARTED|Overall Study||150
8081412|NCT03602053|19925927|P1|STARTED|Overall Study||150
8081413|NCT03601715|19925973|P3|NOT COMPLETED|Third Intervention||0
8081414|NCT03601715|19925974|P2|NOT COMPLETED|Third Intervention||0
8081415|NCT03601715|19925975|P1|NOT COMPLETED|Third Intervention||0
8081416|NCT03601715|19925973|P3|COMPLETED|Third Intervention||6
8081417|NCT03601715|19925974|P2|COMPLETED|Third Intervention||6
8081418|NCT03601715|19925975|P1|COMPLETED|Third Intervention||6
8081419|NCT03601715|19925973|P3|STARTED|Third Intervention||6
8081420|NCT03601715|19925974|P2|STARTED|Third Intervention||6
8081421|NCT03601715|19925975|P1|STARTED|Third Intervention||6
8081422|NCT03601715|19925973|P3|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
8081423|NCT03601715|19925974|P2|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
8081424|NCT03601715|19925975|P1|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
8081425|NCT03601715|19925973|P3|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
8081426|NCT03601715|19925974|P2|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
8081427|NCT03601715|19925975|P1|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
8081428|NCT03601715|19925973|P3|STARTED|Wash Out 2 (at Least 24 Hours)||6
8081429|NCT03601715|19925974|P2|STARTED|Wash Out 2 (at Least 24 Hours)||6
8081430|NCT03601715|19925975|P1|STARTED|Wash Out 2 (at Least 24 Hours)||6
8081431|NCT03601715|19925973|P3|NOT COMPLETED|Second Intervention||0
8081432|NCT03601715|19925974|P2|NOT COMPLETED|Second Intervention||1
8081433|NCT03601715|19925975|P1|NOT COMPLETED|Second Intervention||1
8081434|NCT03601715|19925973|P3|COMPLETED|Second Intervention||6
8081435|NCT03601715|19925974|P2|COMPLETED|Second Intervention||6
8081436|NCT03601715|19925975|P1|COMPLETED|Second Intervention||6
8081437|NCT03601715|19925973|P3|STARTED|Second Intervention||6
8081438|NCT03601715|19925974|P2|STARTED|Second Intervention||7
8081439|NCT03601715|19925975|P1|STARTED|Second Intervention||7
8081440|NCT03601715|19925973|P3|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
8081441|NCT03601715|19925974|P2|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
8081442|NCT03601715|19925975|P1|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
8081443|NCT03601715|19925973|P3|COMPLETED|Washout 1 (at Least 24 Hours)||6
8081444|NCT03601715|19925974|P2|COMPLETED|Washout 1 (at Least 24 Hours)||7
8081445|NCT03601715|19925975|P1|COMPLETED|Washout 1 (at Least 24 Hours)||7
8081446|NCT03601715|19925973|P3|STARTED|Washout 1 (at Least 24 Hours)||6
8081447|NCT03601715|19925974|P2|STARTED|Washout 1 (at Least 24 Hours)||7
8081448|NCT03601715|19925975|P1|STARTED|Washout 1 (at Least 24 Hours)||7
8081449|NCT03601715|19925973|P3|NOT COMPLETED|First Intervention||0
8081450|NCT03601715|19925974|P2|NOT COMPLETED|First Intervention||0
8081451|NCT03601715|19925975|P1|NOT COMPLETED|First Intervention||0
8081452|NCT03601715|19925973|P3|COMPLETED|First Intervention||6
8081453|NCT03601715|19925974|P2|COMPLETED|First Intervention||7
8081454|NCT03601715|19925975|P1|COMPLETED|First Intervention||7
8081455|NCT03601715|19925973|P3|STARTED|First Intervention||6
8081456|NCT03601715|19925974|P2|STARTED|First Intervention||7
8081457|NCT03601715|19925975|P1|STARTED|First Intervention||7
8081458|NCT03599986|19925989|P1|NOT COMPLETED|Overall Study||32
8081459|NCT03599986|19925989|P1|COMPLETED|Overall Study||366
8081460|NCT03599986|19925989|P1|STARTED|Overall Study||398
8081461|NCT03599687|19925997|P2|NOT COMPLETED|Overall Study||0
8081462|NCT03599687|19925998|P1|NOT COMPLETED|Overall Study||0
8081463|NCT03599687|19925997|P2|COMPLETED|Overall Study||82
8081464|NCT03599687|19925998|P1|COMPLETED|Overall Study||82
8081465|NCT03599687|19925997|P2|STARTED|Overall Study||82
8081466|NCT03599687|19925998|P1|STARTED|Overall Study||82
8081467|NCT03599349|19926008|P1|NOT COMPLETED|Overall Study||1
8081468|NCT03599349|19926008|P1|COMPLETED|Overall Study||19
8081469|NCT03599349|19926008|P1|Treated|Overall Study||20
8081470|NCT03599349|19926008|P1|STARTED|Overall Study||20
8081477|NCT03598140|19926037|P2|NOT COMPLETED|Overall Study||0
8081478|NCT03598140|19926038|P1|NOT COMPLETED|Overall Study||1
8081479|NCT03598140|19926037|P2|COMPLETED|Overall Study||11
8081480|NCT03598140|19926038|P1|COMPLETED|Overall Study||9
8081481|NCT03598140|19926037|P2|STARTED|Overall Study||11
8081482|NCT03598140|19926038|P1|STARTED|Overall Study||10
8081483|NCT03597178|19926050|P1|NOT COMPLETED|Overall Study||0
8081484|NCT03597178|19926050|P1|COMPLETED|Overall Study||14
8081485|NCT03597178|19926050|P1|STARTED|Overall Study||14
8081486|NCT03597022|19926057|P3|NOT COMPLETED|Overall Study||8
8081487|NCT03597022|19926058|P2|NOT COMPLETED|Overall Study||8
8081488|NCT03597022|19926059|P1|NOT COMPLETED|Overall Study||8
8081489|NCT03597022|19926057|P3|COMPLETED|Overall Study||0
8081490|NCT03597022|19926058|P2|COMPLETED|Overall Study||0
8081491|NCT03597022|19926059|P1|COMPLETED|Overall Study||0
8081492|NCT03597022|19926057|P3|STARTED|Overall Study||8
8081493|NCT03597022|19926058|P2|STARTED|Overall Study||8
8081494|NCT03597022|19926059|P1|STARTED|Overall Study||8
8081495|NCT03596723|19926078|P2|NOT COMPLETED|Overall Study||0
8081496|NCT03596723|19926079|P1|NOT COMPLETED|Overall Study||0
8081497|NCT03596723|19926078|P2|COMPLETED|Overall Study||1
8081498|NCT03596723|19926079|P1|COMPLETED|Overall Study||1
8081499|NCT03596723|19926078|P2|STARTED|Overall Study||1
8081500|NCT03596723|19926079|P1|STARTED|Overall Study||1
8081501|NCT03596177|19926089|P2|NOT COMPLETED|Double Blind Period||6
8081502|NCT03596177|19926090|P1|NOT COMPLETED|Double Blind Period||0
8081503|NCT03596177|19926089|P2|COMPLETED|Double Blind Period||12
8081504|NCT03596177|19926090|P1|COMPLETED|Double Blind Period||7
8081505|NCT03596177|19926089|P2|STARTED|Double Blind Period||18
8081506|NCT03596177|19926090|P1|STARTED|Double Blind Period||7
8081507|NCT03596177|19926089|P2|NOT COMPLETED|Single Blind Period||1
8081508|NCT03596177|19926090|P1|NOT COMPLETED|Single Blind Period||2
8081509|NCT03596177|19926089|P2|COMPLETED|Single Blind Period||18
8081510|NCT03596177|19926090|P1|COMPLETED|Single Blind Period||7
8081511|NCT03596177|19926089|P2|STARTED|Single Blind Period||19
8081512|NCT03596177|19926090|P1|STARTED|Single Blind Period||9
8081513|NCT03595215|19926140|P1|NOT COMPLETED|Overall Study||8
8081514|NCT03595215|19926140|P1|COMPLETED|Overall Study||10
8081515|NCT03595215|19926140|P1|STARTED|Overall Study||18
8081516|NCT03594227|19926148|P4|NOT COMPLETED|Overall Study||5
8081517|NCT03594227|19926149|P3|NOT COMPLETED|Overall Study||3
8081518|NCT03594227|19926150|P2|NOT COMPLETED|Overall Study||4
8081519|NCT03594227|19926151|P1|NOT COMPLETED|Overall Study||5
8081520|NCT03594227|19926148|P4|COMPLETED|Overall Study||14
8081521|NCT03594227|19926149|P3|COMPLETED|Overall Study||19
8081522|NCT03594227|19926150|P2|COMPLETED|Overall Study||19
8081523|NCT03594227|19926151|P1|COMPLETED|Overall Study||18
8081524|NCT03594227|19926148|P4|STARTED|Overall Study||19
8081525|NCT03594227|19926149|P3|STARTED|Overall Study||22
8081526|NCT03594227|19926150|P2|STARTED|Overall Study||23
8081527|NCT03594227|19926151|P1|STARTED|Overall Study||23
8081528|NCT03594045|19926287|P2|NOT COMPLETED|Overall Study||0
8081529|NCT03594045|19926288|P1|NOT COMPLETED|Overall Study||0
8081530|NCT03594045|19926287|P2|COMPLETED|Overall Study||5
8081531|NCT03594045|19926288|P1|COMPLETED|Overall Study||0
8081532|NCT03594045|19926287|P2|STARTED|Overall Study||5
8081533|NCT03594045|19926288|P1|STARTED|Overall Study||0
8081534|NCT03593902|19926308|P1|NOT COMPLETED|Overall Study||0
8081535|NCT03593902|19926308|P1|COMPLETED|Overall Study||9
8081536|NCT03593902|19926308|P1|STARTED|Overall Study||9
8081537|NCT03593681|19926313|P1|NOT COMPLETED|Overall Study||35
8081538|NCT03593681|19926313|P1|COMPLETED|Overall Study||115
8081539|NCT03593681|19926313|P1|STARTED|Overall Study||150
8081540|NCT03593200|19926336|P1|NOT COMPLETED|Overall Study||0
8081541|NCT03593200|19926336|P1|COMPLETED|Overall Study||4
8081542|NCT03593200|19926336|P1|STARTED|Overall Study||4
8081543|NCT03592186|19926353|P2|NOT COMPLETED|Overall Study||11
8081544|NCT03592186|19926354|P1|NOT COMPLETED|Overall Study||17
8081545|NCT03592186|19926353|P2|COMPLETED|Overall Study||51
8081546|NCT03592186|19926354|P1|COMPLETED|Overall Study||43
8081547|NCT03592186|19926353|P2|12-week Follow-up|Overall Study||51
8081548|NCT03592186|19926354|P1|12-week Follow-up|Overall Study||47
8081549|NCT03592186|19926353|P2|6-week Follow-up|Overall Study||56
8081550|NCT03592186|19926354|P1|6-week Follow-up|Overall Study||49
8081551|NCT03592186|19926353|P2|STARTED|Overall Study||62
8081552|NCT03592186|19926354|P1|STARTED|Overall Study||60
8081553|NCT03592121|19926362|P2|NOT COMPLETED|Overall Study||0
8081554|NCT03592121|19926363|P1|NOT COMPLETED|Overall Study||0
8081555|NCT03592121|19926362|P2|COMPLETED|Overall Study||0
8081556|NCT03592121|19926363|P1|COMPLETED|Overall Study||3
8081557|NCT03592121|19926362|P2|STARTED|Overall Study||0
8081558|NCT03592121|19926363|P1|STARTED|Overall Study||3
8081559|NCT03591458|19926371|P2|NOT COMPLETED|Overall Study||0
8081560|NCT03591458|19926372|P1|NOT COMPLETED|Overall Study||0
8081561|NCT03591458|19926371|P2|COMPLETED|Overall Study||1
8081562|NCT03591458|19926372|P1|COMPLETED|Overall Study||1
8081563|NCT03591458|19926371|P2|STARTED|Overall Study||1
8081564|NCT03591458|19926372|P1|STARTED|Overall Study||1
8081565|NCT03591406|19926402|P2|NOT COMPLETED|Overall Study||9
8081566|NCT03591406|19926403|P1|NOT COMPLETED|Overall Study||7
8081567|NCT03591406|19926402|P2|COMPLETED|Overall Study||174
8081568|NCT03591406|19926403|P1|COMPLETED|Overall Study||181
8081569|NCT03591406|19926402|P2|STARTED|Overall Study||183
8081570|NCT03591406|19926403|P1|STARTED|Overall Study||188
8081571|NCT03591068|19926431|P1|NOT COMPLETED|Overall Study||2
8081572|NCT03591068|19926431|P1|COMPLETED|Overall Study||9
8081573|NCT03591068|19926431|P1|STARTED|Overall Study||11
8081574|NCT03590743|19926449|P2|NOT COMPLETED|Overall Study||1
8081575|NCT03590743|19926450|P1|NOT COMPLETED|Overall Study||0
8081576|NCT03590743|19926449|P2|COMPLETED|Overall Study||2
8081577|NCT03590743|19926450|P1|COMPLETED|Overall Study||2
8081578|NCT03590743|19926449|P2|STARTED|Overall Study||3
8081579|NCT03590743|19926450|P1|STARTED|Overall Study||2
8081580|NCT03590613|19926462|P4|NOT COMPLETED|Period 4, 4 Days||0
8081581|NCT03590613|19926463|P3|NOT COMPLETED|Period 4, 4 Days||0
8081582|NCT03590613|19926464|P2|NOT COMPLETED|Period 4, 4 Days||0
8081583|NCT03590613|19926465|P1|NOT COMPLETED|Period 4, 4 Days||0
8081584|NCT03590613|19926462|P4|COMPLETED|Period 4, 4 Days||3
8081585|NCT03590613|19926463|P3|COMPLETED|Period 4, 4 Days||3
8081586|NCT03590613|19926464|P2|COMPLETED|Period 4, 4 Days||3
8081587|NCT03590613|19926465|P1|COMPLETED|Period 4, 4 Days||3
8081588|NCT03590613|19926462|P4|STARTED|Period 4, 4 Days||3
8081589|NCT03590613|19926463|P3|STARTED|Period 4, 4 Days||3
8081590|NCT03590613|19926464|P2|STARTED|Period 4, 4 Days||3
8081591|NCT03590613|19926465|P1|STARTED|Period 4, 4 Days||3
8081592|NCT03590613|19926462|P4|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081593|NCT03590613|19926463|P3|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081594|NCT03590613|19926464|P2|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081595|NCT03590613|19926465|P1|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081596|NCT03590613|19926462|P4|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081597|NCT03590613|19926463|P3|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081598|NCT03590613|19926464|P2|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081599|NCT03590613|19926465|P1|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081600|NCT03590613|19926462|P4|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081601|NCT03590613|19926463|P3|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081602|NCT03590613|19926464|P2|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081603|NCT03590613|19926465|P1|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081604|NCT03590613|19926462|P4|NOT COMPLETED|Period 3, 4 Days||0
8081605|NCT03590613|19926463|P3|NOT COMPLETED|Period 3, 4 Days||0
8081606|NCT03590613|19926464|P2|NOT COMPLETED|Period 3, 4 Days||0
8081607|NCT03590613|19926465|P1|NOT COMPLETED|Period 3, 4 Days||0
8081608|NCT03590613|19926462|P4|COMPLETED|Period 3, 4 Days||3
8081609|NCT03590613|19926463|P3|COMPLETED|Period 3, 4 Days||3
8081610|NCT03590613|19926464|P2|COMPLETED|Period 3, 4 Days||3
8081611|NCT03590613|19926465|P1|COMPLETED|Period 3, 4 Days||3
8081612|NCT03590613|19926462|P4|STARTED|Period 3, 4 Days||3
8081613|NCT03590613|19926463|P3|STARTED|Period 3, 4 Days||3
8081614|NCT03590613|19926464|P2|STARTED|Period 3, 4 Days||3
8081615|NCT03590613|19926465|P1|STARTED|Period 3, 4 Days||3
8081616|NCT03590613|19926462|P4|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081617|NCT03590613|19926463|P3|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081618|NCT03590613|19926464|P2|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081619|NCT03590613|19926465|P1|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081620|NCT03590613|19926462|P4|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081621|NCT03590613|19926463|P3|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081622|NCT03590613|19926464|P2|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081623|NCT03590613|19926465|P1|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081624|NCT03590613|19926462|P4|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081625|NCT03590613|19926463|P3|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081626|NCT03590613|19926464|P2|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081627|NCT03590613|19926465|P1|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081628|NCT03590613|19926462|P4|NOT COMPLETED|Period 2, 4 Days||1
8081629|NCT03590613|19926463|P3|NOT COMPLETED|Period 2, 4 Days||0
8081630|NCT03590613|19926464|P2|NOT COMPLETED|Period 2, 4 Days||0
8081631|NCT03590613|19926465|P1|NOT COMPLETED|Period 2, 4 Days||0
8081632|NCT03590613|19926462|P4|COMPLETED|Period 2, 4 Days||3
8081633|NCT03590613|19926463|P3|COMPLETED|Period 2, 4 Days||3
8081634|NCT03590613|19926464|P2|COMPLETED|Period 2, 4 Days||3
8081635|NCT03590613|19926465|P1|COMPLETED|Period 2, 4 Days||3
8081636|NCT03590613|19926462|P4|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
8081637|NCT03590613|19926463|P3|STARTED|Period 2, 4 Days||3
8081638|NCT03590613|19926464|P2|STARTED|Period 2, 4 Days||3
8081639|NCT03590613|19926465|P1|STARTED|Period 2, 4 Days||3
8081640|NCT03590613|19926462|P4|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081641|NCT03590613|19926463|P3|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081642|NCT03590613|19926464|P2|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081643|NCT03590613|19926465|P1|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081644|NCT03590613|19926462|P4|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081645|NCT03590613|19926463|P3|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081646|NCT03590613|19926464|P2|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081647|NCT03590613|19926465|P1|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081648|NCT03590613|19926462|P4|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081649|NCT03590613|19926463|P3|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081650|NCT03590613|19926464|P2|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081651|NCT03590613|19926465|P1|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081652|NCT03590613|19926462|P4|NOT COMPLETED|Period 1, 4 Days||0
8081653|NCT03590613|19926463|P3|NOT COMPLETED|Period 1, 4 Days||0
8081654|NCT03590613|19926464|P2|NOT COMPLETED|Period 1, 4 Days||0
8081655|NCT03590613|19926465|P1|NOT COMPLETED|Period 1, 4 Days||0
8081656|NCT03590613|19926462|P4|COMPLETED|Period 1, 4 Days||3
8081657|NCT03590613|19926463|P3|COMPLETED|Period 1, 4 Days||3
8081658|NCT03590613|19926464|P2|COMPLETED|Period 1, 4 Days||3
8081659|NCT03590613|19926465|P1|COMPLETED|Period 1, 4 Days||3
8081660|NCT03590613|19926462|P4|STARTED|Period 1, 4 Days||3
8081661|NCT03590613|19926463|P3|STARTED|Period 1, 4 Days||3
8081662|NCT03590613|19926464|P2|STARTED|Period 1, 4 Days||3
8081663|NCT03590613|19926465|P1|STARTED|Period 1, 4 Days||3
8081664|NCT03588806|19926583|P1|NOT COMPLETED|Overall Study||0
8081665|NCT03588806|19926583|P1|COMPLETED|Overall Study||11
8081666|NCT03588806|19926583|P1|STARTED|Overall Study||11
8081667|NCT03588741|19926594|P1|NOT COMPLETED|Overall Study||1
8081668|NCT03588741|19926594|P1|COMPLETED|Overall Study||0
8081669|NCT03588741|19926594|P1|STARTED|Overall Study||1
8081670|NCT03588572|19926601|P2|NOT COMPLETED|Visitation 3||2
8081671|NCT03588572|19926602|P1|NOT COMPLETED|Visitation 3||3
8081672|NCT03588572|19926601|P2|COMPLETED|Visitation 3||16
8081673|NCT03588572|19926602|P1|COMPLETED|Visitation 3||16
8081674|NCT03588572|19926601|P2|STARTED|Visitation 3||18
8081675|NCT03588572|19926602|P1|STARTED|Visitation 3||19
8081676|NCT03588572|19926601|P2|NOT COMPLETED|Visitation 2||2
8081677|NCT03588572|19926602|P1|NOT COMPLETED|Visitation 2||2
8081678|NCT03588572|19926601|P2|COMPLETED|Visitation 2||18
8081679|NCT03588572|19926602|P1|COMPLETED|Visitation 2||19
8081680|NCT03588572|19926601|P2|STARTED|Visitation 2||20
8081681|NCT03588572|19926602|P1|STARTED|Visitation 2||21
8081682|NCT03588572|19926601|P2|NOT COMPLETED|Visitation 1||1
8081683|NCT03588572|19926602|P1|NOT COMPLETED|Visitation 1||1
8081684|NCT03588572|19926601|P2|COMPLETED|Visitation 1||20
8081685|NCT03588572|19926602|P1|COMPLETED|Visitation 1||21
8081686|NCT03588572|19926601|P2|STARTED|Visitation 1||21
8081687|NCT03588572|19926602|P1|STARTED|Visitation 1||22
8081688|NCT03587974|19926620|P2|NOT COMPLETED|Overall Study||4
8081689|NCT03587974|19926621|P1|NOT COMPLETED|Overall Study||5
8081690|NCT03587974|19926620|P2|COMPLETED|Overall Study||26
8081691|NCT03587974|19926621|P1|COMPLETED|Overall Study||25
8081692|NCT03587974|19926620|P2|STARTED|Overall Study||30
8081693|NCT03587974|19926621|P1|STARTED|Overall Study||30
8081694|NCT03587428|19926631|P6|NOT COMPLETED|Period 3||0
8081695|NCT03587428|19926632|P5|NOT COMPLETED|Period 3||0
8081696|NCT03587428|19926633|P4|NOT COMPLETED|Period 3||0
8081697|NCT03587428|19926634|P3|NOT COMPLETED|Period 3||0
8081698|NCT03587428|19926635|P2|NOT COMPLETED|Period 3||0
8081699|NCT03587428|19926636|P1|NOT COMPLETED|Period 3||0
8081700|NCT03587428|19926631|P6|COMPLETED|Period 3||2
8081701|NCT03587428|19926632|P5|COMPLETED|Period 3||2
8081702|NCT03587428|19926633|P4|COMPLETED|Period 3||3
8081703|NCT03587428|19926634|P3|COMPLETED|Period 3||3
8081704|NCT03587428|19926635|P2|COMPLETED|Period 3||2
8081705|NCT03587428|19926636|P1|COMPLETED|Period 3||3
8081706|NCT03587428|19926631|P6|STARTED|Period 3||2
8081707|NCT03587428|19926632|P5|STARTED|Period 3||2
8081708|NCT03587428|19926633|P4|STARTED|Period 3||3
8081709|NCT03587428|19926634|P3|STARTED|Period 3||3
8081710|NCT03587428|19926635|P2|STARTED|Period 3||2
8081711|NCT03587428|19926636|P1|STARTED|Period 3||3
8081712|NCT03587428|19926631|P6|NOT COMPLETED|Period 2||0
8081713|NCT03587428|19926632|P5|NOT COMPLETED|Period 2||0
8081714|NCT03587428|19926633|P4|NOT COMPLETED|Period 2||0
8081715|NCT03587428|19926634|P3|NOT COMPLETED|Period 2||0
8081716|NCT03587428|19926635|P2|NOT COMPLETED|Period 2||0
8081717|NCT03587428|19926636|P1|NOT COMPLETED|Period 2||0
8081718|NCT03587428|19926631|P6|COMPLETED|Period 2||2
8081719|NCT03587428|19926632|P5|COMPLETED|Period 2||2
8081720|NCT03587428|19926633|P4|COMPLETED|Period 2||3
8081721|NCT03587428|19926634|P3|COMPLETED|Period 2||3
8081722|NCT03587428|19926635|P2|COMPLETED|Period 2||2
8081723|NCT03587428|19926636|P1|COMPLETED|Period 2||3
8081724|NCT03587428|19926631|P6|STARTED|Period 2||2
8081725|NCT03587428|19926632|P5|STARTED|Period 2||2
8081726|NCT03587428|19926633|P4|STARTED|Period 2||3
8081727|NCT03587428|19926634|P3|STARTED|Period 2||3
8081728|NCT03587428|19926635|P2|STARTED|Period 2||2
8081729|NCT03587428|19926636|P1|STARTED|Period 2||3
8081730|NCT03587428|19926631|P6|NOT COMPLETED|Period 1||0
8081731|NCT03587428|19926632|P5|NOT COMPLETED|Period 1||0
8081732|NCT03587428|19926633|P4|NOT COMPLETED|Period 1||0
8081733|NCT03587428|19926634|P3|NOT COMPLETED|Period 1||0
8081734|NCT03587428|19926635|P2|NOT COMPLETED|Period 1||0
8081735|NCT03587428|19926636|P1|NOT COMPLETED|Period 1||0
8081736|NCT03587428|19926631|P6|COMPLETED|Period 1||2
8081737|NCT03587428|19926632|P5|COMPLETED|Period 1||2
8081738|NCT03587428|19926633|P4|COMPLETED|Period 1||3
8081739|NCT03587428|19926634|P3|COMPLETED|Period 1||3
8081740|NCT03587428|19926635|P2|COMPLETED|Period 1||2
8081741|NCT03587428|19926636|P1|COMPLETED|Period 1||3
8081742|NCT03587428|19926631|P6|STARTED|Period 1||2
8081743|NCT03587428|19926632|P5|STARTED|Period 1||2
8081744|NCT03587428|19926633|P4|STARTED|Period 1||3
8081745|NCT03587428|19926634|P3|STARTED|Period 1||3
8081746|NCT03587428|19926635|P2|STARTED|Period 1||2
8081747|NCT03587428|19926636|P1|STARTED|Period 1||3
8081748|NCT03587207|19926658|P5|NOT COMPLETED|Overall Study||0
8081749|NCT03587207|19926659|P4|NOT COMPLETED|Overall Study||0
8081750|NCT03587207|19926660|P3|NOT COMPLETED|Overall Study||0
8081751|NCT03587207|19926661|P2|NOT COMPLETED|Overall Study||0
8081752|NCT03587207|19926662|P1|NOT COMPLETED|Overall Study||0
8081753|NCT03587207|19926658|P5|COMPLETED|Overall Study||102
8081754|NCT03587207|19926659|P4|COMPLETED|Overall Study||94
8081755|NCT03587207|19926660|P3|COMPLETED|Overall Study||100
8081756|NCT03587207|19926661|P2|COMPLETED|Overall Study||104
8081757|NCT03587207|19926662|P1|COMPLETED|Overall Study||100
8081758|NCT03587207|19926658|P5|STARTED|Overall Study||102
8081759|NCT03587207|19926659|P4|STARTED|Overall Study||94
8081760|NCT03587207|19926660|P3|STARTED|Overall Study||100
8081761|NCT03587207|19926661|P2|STARTED|Overall Study||104
8081762|NCT03587207|19926662|P1|STARTED|Overall Study||100
8081763|NCT03586830|19926737|P4|NOT COMPLETED|Overall Study||5
8081764|NCT03586830|19926738|P3|NOT COMPLETED|Overall Study||8
8081765|NCT03586830|19926739|P2|NOT COMPLETED|Overall Study||6
8081766|NCT03586830|19926740|P1|NOT COMPLETED|Overall Study||2
8081767|NCT03586830|19926737|P4|COMPLETED|Overall Study||44
8081768|NCT03586830|19926738|P3|COMPLETED|Overall Study||41
8081769|NCT03586830|19926739|P2|COMPLETED|Overall Study||42
8081770|NCT03586830|19926740|P1|COMPLETED|Overall Study||48
8081771|NCT03586830|19926737|P4|Treated|Overall Study||49
8081772|NCT03586830|19926738|P3|Treated|Overall Study||49
8081773|NCT03586830|19926739|P2|Treated|Overall Study||48
8081774|NCT03586830|19926740|P1|Treated|Overall Study||49
8081775|NCT03586830|19926737|P4|STARTED|Overall Study||49
8081776|NCT03586830|19926738|P3|STARTED|Overall Study||49
8081777|NCT03586830|19926739|P2|STARTED|Overall Study||48
8081778|NCT03586830|19926740|P1|STARTED|Overall Study||50
8081779|NCT03586726|19926762|P1|NOT COMPLETED|Overall Study||1
8081780|NCT03586726|19926762|P1|COMPLETED|Overall Study||15
8081781|NCT03586726|19926762|P1|STARTED|Overall Study||16
8081782|NCT03586648|19926779|P2|NOT COMPLETED|Period 2||0
8081783|NCT03586648|19926780|P1|NOT COMPLETED|Period 2||1
8081784|NCT03586648|19926779|P2|COMPLETED|Period 2||30
8081785|NCT03586648|19926780|P1|COMPLETED|Period 2||31
8081786|NCT03586648|19926779|P2|STARTED|Period 2||30
8081787|NCT03586648|19926780|P1|STARTED|Period 2||32
8081788|NCT03586648|19926779|P2|NOT COMPLETED|Period 1||4
8081789|NCT03586648|19926780|P1|NOT COMPLETED|Period 1||4
8081790|NCT03586648|19926779|P2|COMPLETED|Period 1||30
8081791|NCT03586648|19926780|P1|COMPLETED|Period 1||32
8081792|NCT03586648|19926779|P2|STARTED|Period 1||34
8081793|NCT03586648|19926780|P1|STARTED|Period 1||36
8081794|NCT03586583|19926788|P1|NOT COMPLETED|Overall Study||0
8081795|NCT03586583|19926788|P1|COMPLETED|Overall Study||600
8081796|NCT03586583|19926788|P1|STARTED|Overall Study||600
8081797|NCT03585959|19926793|P1|NOT COMPLETED|Overall Study||3
8081798|NCT03585959|19926793|P1|COMPLETED|Overall Study||47
8081799|NCT03585959|19926793|P1|STARTED|Overall Study||50
8081800|NCT03585790|19926815|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8081801|NCT03585790|19926816|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8081802|NCT03585790|19926815|P2|COMPLETED|Second Intervention (1 Week)||22
8081803|NCT03585790|19926816|P1|COMPLETED|Second Intervention (1 Week)||23
8081804|NCT03585790|19926815|P2|STARTED|Second Intervention (1 Week)||22
8081805|NCT03585790|19926816|P1|STARTED|Second Intervention (1 Week)||23
8081806|NCT03585790|19926815|P2|NOT COMPLETED|First Intervention (1 Week)||0
8081807|NCT03585790|19926816|P1|NOT COMPLETED|First Intervention (1 Week)||0
8081808|NCT03585790|19926815|P2|COMPLETED|First Intervention (1 Week)||22
8081809|NCT03585790|19926816|P1|COMPLETED|First Intervention (1 Week)||23
8081810|NCT03585790|19926815|P2|STARTED|First Intervention (1 Week)||22
8081811|NCT03585790|19926816|P1|STARTED|First Intervention (1 Week)||23
8081812|NCT03585543|19926823|P1|NOT COMPLETED|Overall Study||15
8081813|NCT03585543|19926823|P1|COMPLETED|Overall Study||15
8081814|NCT03585543|19926823|P1|3-month Post-intervention Follow-up (6 m|Overall Study||15
8081815|NCT03585543|19926823|P1|End-of-intervention Assessment (12 Weeks|Overall Study||22
8081816|NCT03585543|19926823|P1|Mid-intervention Assessment (6-weeks)|Overall Study||25
8081817|NCT03585543|19926823|P1|STARTED|Overall Study||30
8081818|NCT03585504|19926844|P2|NOT COMPLETED|Overall Study||29
8081819|NCT03585504|19926845|P1|NOT COMPLETED|Overall Study||26
8081820|NCT03585504|19926844|P2|COMPLETED|Overall Study||11
8081821|NCT03585504|19926845|P1|COMPLETED|Overall Study||15
8081822|NCT03585504|19926844|P2|STARTED|Overall Study||40
8081823|NCT03585504|19926845|P1|STARTED|Overall Study||41
8081824|NCT03585296|19926855|P1|NOT COMPLETED|Overall Study||5
8081825|NCT03585296|19926855|P1|COMPLETED|Overall Study||17
8081826|NCT03585296|19926855|P1|STARTED|Overall Study||22
8081827|NCT03585244|19926859|P1|NOT COMPLETED|Overall Study||15
8081828|NCT03585244|19926859|P1|COMPLETED|Overall Study||165
8081829|NCT03585244|19926859|P1|STARTED|Overall Study||180
8081830|NCT03583450|19926866|P2|NOT COMPLETED|Overall Study||0
8081831|NCT03583450|19926867|P1|NOT COMPLETED|Overall Study||1
8081832|NCT03583450|19926866|P2|COMPLETED|Overall Study||37
8081833|NCT03583450|19926867|P1|COMPLETED|Overall Study||33
8081834|NCT03583450|19926866|P2|STARTED|Overall Study||37
8081835|NCT03583450|19926867|P1|STARTED|Overall Study||34
8081836|NCT03583385|19926889|P2|NOT COMPLETED|Treatment Period 2||0
8081837|NCT03583385|19926890|P1|NOT COMPLETED|Treatment Period 2||1
8081838|NCT03583385|19926889|P2|COMPLETED|Treatment Period 2||23
8081839|NCT03583385|19926890|P1|COMPLETED|Treatment Period 2||21
8081840|NCT03583385|19926889|P2|STARTED|Treatment Period 2||23
8081841|NCT03583385|19926890|P1|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
8081842|NCT03583385|19926889|P2|NOT COMPLETED|Treatment Period 1||1
8081843|NCT03583385|19926890|P1|NOT COMPLETED|Treatment Period 1||1
8081844|NCT03583385|19926889|P2|COMPLETED|Treatment Period 1||23
8081845|NCT03583385|19926890|P1|COMPLETED|Treatment Period 1||23
8081846|NCT03583385|19926889|P2|STARTED|Treatment Period 1||24
8081847|NCT03583385|19926890|P1|STARTED|Treatment Period 1||24
8081848|NCT03582943|19926908|P2|NOT COMPLETED|Analyzed||1
8081849|NCT03582943|19926909|P1|NOT COMPLETED|Analyzed||4
8081850|NCT03582943|19926908|P2|COMPLETED|Analyzed||36
8081851|NCT03582943|19926909|P1|COMPLETED|Analyzed||33
8081852|NCT03582943|19926908|P2|STARTED|Analyzed||37
8081853|NCT03582943|19926909|P1|STARTED|Analyzed||37
8081854|NCT03582943|19926908|P2|NOT COMPLETED|Intervention and Follow up||2
8081855|NCT03582943|19926909|P1|NOT COMPLETED|Intervention and Follow up||4
8081856|NCT03582943|19926908|P2|COMPLETED|Intervention and Follow up||37
8081857|NCT03582943|19926909|P1|COMPLETED|Intervention and Follow up||37
8081858|NCT03582943|19926908|P2|STARTED|Intervention and Follow up||39
8081859|NCT03582943|19926909|P1|STARTED|Intervention and Follow up||41
8081860|NCT03582943|19926908|P2|NOT COMPLETED|Allocated to Groups||1
8081861|NCT03582943|19926909|P1|NOT COMPLETED|Allocated to Groups||1
8081862|NCT03582943|19926908|P2|COMPLETED|Allocated to Groups||39
8081863|NCT03582943|19926909|P1|COMPLETED|Allocated to Groups||41
8081864|NCT03582943|19926908|P2|STARTED|Allocated to Groups||40
8081865|NCT03582943|19926909|P1|STARTED|Allocated to Groups||42
8081866|NCT03582826|19926917|P2|NOT COMPLETED|Overall Study||0
8081867|NCT03582826|19926918|P1|NOT COMPLETED|Overall Study||41
8081868|NCT03582826|19926917|P2|COMPLETED|Overall Study||6
8081869|NCT03582826|19926918|P1|COMPLETED|Overall Study||78
8081870|NCT03582826|19926917|P2|STARTED|Overall Study||6
8081871|NCT03582826|19926918|P1|STARTED|Overall Study||119
8081872|NCT03582813|19926935|P2|NOT COMPLETED|Overall Study||21
8081873|NCT03582813|19926936|P1|NOT COMPLETED|Overall Study||19
8081874|NCT03582813|19926935|P2|COMPLETED|Overall Study||81
8081875|NCT03582813|19926936|P1|COMPLETED|Overall Study||95
8081876|NCT03582813|19926935|P2|STARTED|Overall Study||102
8081877|NCT03582813|19926936|P1|STARTED|Overall Study||114
8081878|NCT03582553|19926960|P6|NOT COMPLETED|Intervention 3/Visit 3||0
8081879|NCT03582553|19926961|P5|NOT COMPLETED|Intervention 3/Visit 3||0
8081880|NCT03582553|19926962|P4|NOT COMPLETED|Intervention 3/Visit 3||0
8081881|NCT03582553|19926963|P3|NOT COMPLETED|Intervention 3/Visit 3||0
8081882|NCT03582553|19926964|P2|NOT COMPLETED|Intervention 3/Visit 3||0
8081883|NCT03582553|19926965|P1|NOT COMPLETED|Intervention 3/Visit 3||0
8081884|NCT03582553|19926960|P6|COMPLETED|Intervention 3/Visit 3||3
8081885|NCT03582553|19926961|P5|COMPLETED|Intervention 3/Visit 3||3
8081886|NCT03582553|19926962|P4|COMPLETED|Intervention 3/Visit 3||3
8081887|NCT03582553|19926963|P3|COMPLETED|Intervention 3/Visit 3||3
8081888|NCT03582553|19926964|P2|COMPLETED|Intervention 3/Visit 3||3
8081889|NCT03582553|19926965|P1|COMPLETED|Intervention 3/Visit 3||3
8081890|NCT03582553|19926960|P6|STARTED|Intervention 3/Visit 3||3
8081891|NCT03582553|19926961|P5|STARTED|Intervention 3/Visit 3||3
8081892|NCT03582553|19926962|P4|STARTED|Intervention 3/Visit 3||3
8081893|NCT03582553|19926963|P3|STARTED|Intervention 3/Visit 3||3
8081894|NCT03582553|19926964|P2|STARTED|Intervention 3/Visit 3||3
8081895|NCT03582553|19926965|P1|STARTED|Intervention 3/Visit 3||3
8081896|NCT03582553|19926960|P6|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081897|NCT03582553|19926961|P5|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081898|NCT03582553|19926962|P4|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081899|NCT03582553|19926963|P3|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081900|NCT03582553|19926964|P2|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081901|NCT03582553|19926965|P1|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081902|NCT03582553|19926960|P6|COMPLETED|Washout Period (At Least 1 Week)||3
8081903|NCT03582553|19926961|P5|COMPLETED|Washout Period (At Least 1 Week)||3
8081904|NCT03582553|19926962|P4|COMPLETED|Washout Period (At Least 1 Week)||3
8081905|NCT03582553|19926963|P3|COMPLETED|Washout Period (At Least 1 Week)||3
8081906|NCT03582553|19926964|P2|COMPLETED|Washout Period (At Least 1 Week)||3
8081907|NCT03582553|19926965|P1|COMPLETED|Washout Period (At Least 1 Week)||3
8081908|NCT03582553|19926960|P6|STARTED|Washout Period (At Least 1 Week)||3
8081909|NCT03582553|19926961|P5|STARTED|Washout Period (At Least 1 Week)||3
8081910|NCT03582553|19926962|P4|STARTED|Washout Period (At Least 1 Week)||3
8081911|NCT03582553|19926963|P3|STARTED|Washout Period (At Least 1 Week)||3
8081912|NCT03582553|19926964|P2|STARTED|Washout Period (At Least 1 Week)||3
8081913|NCT03582553|19926965|P1|STARTED|Washout Period (At Least 1 Week)||3
8081914|NCT03582553|19926960|P6|NOT COMPLETED|Intervention 2/Visit 2||0
8081915|NCT03582553|19926961|P5|NOT COMPLETED|Intervention 2/Visit 2||0
8081916|NCT03582553|19926962|P4|NOT COMPLETED|Intervention 2/Visit 2||0
8081917|NCT03582553|19926963|P3|NOT COMPLETED|Intervention 2/Visit 2||0
8081918|NCT03582553|19926964|P2|NOT COMPLETED|Intervention 2/Visit 2||0
8081919|NCT03582553|19926965|P1|NOT COMPLETED|Intervention 2/Visit 2||0
8081920|NCT03582553|19926960|P6|COMPLETED|Intervention 2/Visit 2||3
8081921|NCT03582553|19926961|P5|COMPLETED|Intervention 2/Visit 2||3
8081922|NCT03582553|19926962|P4|COMPLETED|Intervention 2/Visit 2||3
8081923|NCT03582553|19926963|P3|COMPLETED|Intervention 2/Visit 2||3
8081924|NCT03582553|19926964|P2|COMPLETED|Intervention 2/Visit 2||3
8081925|NCT03582553|19926965|P1|COMPLETED|Intervention 2/Visit 2||3
8081926|NCT03582553|19926960|P6|STARTED|Intervention 2/Visit 2||3
8081927|NCT03582553|19926961|P5|STARTED|Intervention 2/Visit 2||3
8081928|NCT03582553|19926962|P4|STARTED|Intervention 2/Visit 2||3
8081929|NCT03582553|19926963|P3|STARTED|Intervention 2/Visit 2||3
8081930|NCT03582553|19926964|P2|STARTED|Intervention 2/Visit 2||3
8081931|NCT03582553|19926965|P1|STARTED|Intervention 2/Visit 2||3
8081932|NCT03582553|19926960|P6|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081933|NCT03582553|19926961|P5|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081934|NCT03582553|19926962|P4|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081935|NCT03582553|19926963|P3|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081936|NCT03582553|19926964|P2|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081937|NCT03582553|19926965|P1|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081938|NCT03582553|19926960|P6|COMPLETED|Washout Period ( At Least 1 Week)||3
8081939|NCT03582553|19926961|P5|COMPLETED|Washout Period ( At Least 1 Week)||3
8081940|NCT03582553|19926962|P4|COMPLETED|Washout Period ( At Least 1 Week)||3
8081941|NCT03582553|19926963|P3|COMPLETED|Washout Period ( At Least 1 Week)||3
8081942|NCT03582553|19926964|P2|COMPLETED|Washout Period ( At Least 1 Week)||3
8081943|NCT03582553|19926965|P1|COMPLETED|Washout Period ( At Least 1 Week)||3
8081944|NCT03582553|19926960|P6|STARTED|Washout Period ( At Least 1 Week)||3
8081945|NCT03582553|19926961|P5|STARTED|Washout Period ( At Least 1 Week)||3
8081946|NCT03582553|19926962|P4|STARTED|Washout Period ( At Least 1 Week)||3
8081947|NCT03582553|19926963|P3|STARTED|Washout Period ( At Least 1 Week)||3
8081948|NCT03582553|19926964|P2|STARTED|Washout Period ( At Least 1 Week)||3
8081949|NCT03582553|19926965|P1|STARTED|Washout Period ( At Least 1 Week)||3
8081950|NCT03582553|19926960|P6|NOT COMPLETED|Intervention 1/Visit 1||0
8081951|NCT03582553|19926961|P5|NOT COMPLETED|Intervention 1/Visit 1||0
8081952|NCT03582553|19926962|P4|NOT COMPLETED|Intervention 1/Visit 1||0
8081953|NCT03582553|19926963|P3|NOT COMPLETED|Intervention 1/Visit 1||0
8081954|NCT03582553|19926964|P2|NOT COMPLETED|Intervention 1/Visit 1||0
8081955|NCT03582553|19926965|P1|NOT COMPLETED|Intervention 1/Visit 1||0
8081956|NCT03582553|19926960|P6|COMPLETED|Intervention 1/Visit 1||3
8081957|NCT03582553|19926961|P5|COMPLETED|Intervention 1/Visit 1||3
8081958|NCT03582553|19926962|P4|COMPLETED|Intervention 1/Visit 1||3
8081959|NCT03582553|19926963|P3|COMPLETED|Intervention 1/Visit 1||3
8081960|NCT03582553|19926964|P2|COMPLETED|Intervention 1/Visit 1||3
8081961|NCT03582553|19926965|P1|COMPLETED|Intervention 1/Visit 1||3
8081962|NCT03582553|19926960|P6|STARTED|Intervention 1/Visit 1||3
8081963|NCT03582553|19926961|P5|STARTED|Intervention 1/Visit 1||3
8081964|NCT03582553|19926962|P4|STARTED|Intervention 1/Visit 1||3
8081965|NCT03582553|19926963|P3|STARTED|Intervention 1/Visit 1||3
8081966|NCT03582553|19926964|P2|STARTED|Intervention 1/Visit 1||3
8081967|NCT03582553|19926965|P1|STARTED|Intervention 1/Visit 1||3
8081968|NCT03582215|19927003|P8|NOT COMPLETED|Overall Study||2
8081969|NCT03582215|19927004|P7|NOT COMPLETED|Overall Study||2
8081970|NCT03582215|19927005|P6|NOT COMPLETED|Overall Study||0
8081971|NCT03582215|19927006|P5|NOT COMPLETED|Overall Study||0
8081972|NCT03582215|19927007|P4|NOT COMPLETED|Overall Study||0
8081973|NCT03582215|19927008|P3|NOT COMPLETED|Overall Study||0
8081974|NCT03582215|19927009|P2|NOT COMPLETED|Overall Study||0
8081975|NCT03582215|19927010|P1|NOT COMPLETED|Overall Study||1
8081976|NCT03582215|19927003|P8|COMPLETED|Overall Study||10
8081977|NCT03582215|19927004|P7|COMPLETED|Overall Study||10
8081978|NCT03582215|19927005|P6|COMPLETED|Overall Study||12
8081979|NCT03582215|19927006|P5|COMPLETED|Overall Study||12
8081980|NCT03582215|19927007|P4|COMPLETED|Overall Study||6
8081981|NCT03582215|19927008|P3|COMPLETED|Overall Study||6
8081982|NCT03582215|19927009|P2|COMPLETED|Overall Study||6
8081983|NCT03582215|19927010|P1|COMPLETED|Overall Study||5
8081984|NCT03582215|19927003|P8|STARTED|Overall Study||12
8081985|NCT03582215|19927004|P7|STARTED|Overall Study||12
8081986|NCT03582215|19927005|P6|STARTED|Overall Study||12
8081987|NCT03582215|19927006|P5|STARTED|Overall Study||12
8081988|NCT03582215|19927007|P4|STARTED|Overall Study||6
8081989|NCT03582215|19927008|P3|STARTED|Overall Study||6
8081990|NCT03582215|19927009|P2|STARTED|Overall Study||6
8081991|NCT03582215|19927010|P1|STARTED|Overall Study||6
8081992|NCT03581825|19927051|P2|NOT COMPLETED|Period 2||1
8081993|NCT03581825|19927052|P1|NOT COMPLETED|Period 2||0
8081994|NCT03581825|19927051|P2|COMPLETED|Period 2||30
8081995|NCT03581825|19927052|P1|COMPLETED|Period 2||30
8081996|NCT03581825|19927051|P2|STARTED|Period 2||31
8081997|NCT03581825|19927052|P1|STARTED|Period 2||30
8081998|NCT03581825|19927051|P2|NOT COMPLETED|Period 1||0
8081999|NCT03581825|19927052|P1|NOT COMPLETED|Period 1||1
8082000|NCT03581825|19927051|P2|COMPLETED|Period 1||31
8082001|NCT03581825|19927052|P1|COMPLETED|Period 1||30
8082002|NCT03581825|19927051|P2|STARTED|Period 1||31
8082003|NCT03581825|19927052|P1|STARTED|Period 1||31
8082004|NCT03581474|19927059|P1|NOT COMPLETED|Overall Study||0
8082005|NCT03581474|19927059|P1|COMPLETED|Overall Study||12
8082006|NCT03581474|19927059|P1|STARTED|Overall Study||12
8082007|NCT03581097|19927065|P2|NOT COMPLETED|Overall Study||0
8082008|NCT03581097|19927066|P1|NOT COMPLETED|Overall Study||0
8082009|NCT03581097|19927065|P2|COMPLETED|Overall Study||47
8082010|NCT03581097|19927066|P1|COMPLETED|Overall Study||46
8082011|NCT03581097|19927065|P2|STARTED|Overall Study||47
8082012|NCT03581097|19927066|P1|STARTED|Overall Study||46
8082013|NCT03580382|19927088|P2|NOT COMPLETED|Overall Study||3
8082014|NCT03580382|19927089|P1|NOT COMPLETED|Overall Study||0
8082015|NCT03580382|19927088|P2|COMPLETED|Overall Study||0
8082016|NCT03580382|19927089|P1|COMPLETED|Overall Study||0
8082017|NCT03580382|19927088|P2|STARTED|Overall Study||3
8082018|NCT03580382|19927089|P1|STARTED|Overall Study||0
8082019|NCT03579940|19927107|P11|NOT COMPLETED|Period 3||0
8082020|NCT03579940|19927108|P10|NOT COMPLETED|Period 3||0
8082021|NCT03579940|19927109|P9|NOT COMPLETED|Period 3||0
8082022|NCT03579940|19927110|P8|NOT COMPLETED|Period 3||0
8082023|NCT03579940|19927111|P7|NOT COMPLETED|Period 3||0
8082024|NCT03579940|19927112|P6|NOT COMPLETED|Period 3||0
8082025|NCT03579940|19927113|P5|NOT COMPLETED|Period 3||0
8082026|NCT03579940|19927114|P4|NOT COMPLETED|Period 3||0
8082027|NCT03579940|19927115|P3|NOT COMPLETED|Period 3||0
8082028|NCT03579940|19927116|P2|NOT COMPLETED|Period 3||0
8082029|NCT03579940|19927117|P1|NOT COMPLETED|Period 3||0
8082030|NCT03579940|19927107|P11|COMPLETED|Period 3||3
8082031|NCT03579940|19927108|P10|COMPLETED|Period 3||2
8082032|NCT03579940|19927109|P9|COMPLETED|Period 3||3
8082033|NCT03579940|19927110|P8|COMPLETED|Period 3||3
8082034|NCT03579940|19927111|P7|COMPLETED|Period 3||3
8082035|NCT03579940|19927112|P6|COMPLETED|Period 3||2
8082036|NCT03579940|19927113|P5|COMPLETED|Period 3||2
8082037|NCT03579940|19927114|P4|COMPLETED|Period 3||2
8082038|NCT03579940|19927115|P3|COMPLETED|Period 3||1
8082039|NCT03579940|19927116|P2|COMPLETED|Period 3||2
8082040|NCT03579940|19927117|P1|COMPLETED|Period 3||3
8082041|NCT03579940|19927107|P11|STARTED|Period 3||3
8082042|NCT03579940|19927108|P10|STARTED|Period 3||2
8082043|NCT03579940|19927109|P9|STARTED|Period 3||3
8082044|NCT03579940|19927110|P8|STARTED|Period 3||3
8082045|NCT03579940|19927111|P7|STARTED|Period 3||3
8082046|NCT03579940|19927112|P6|STARTED|Period 3||2
8082047|NCT03579940|19927113|P5|STARTED|Period 3||2
8082048|NCT03579940|19927114|P4|STARTED|Period 3||2
8082049|NCT03579940|19927115|P3|STARTED|Period 3||1
8082050|NCT03579940|19927116|P2|STARTED|Period 3||2
8082051|NCT03579940|19927117|P1|STARTED|Period 3||3
8082052|NCT03579940|19927107|P11|NOT COMPLETED|Period 2||0
8082053|NCT03579940|19927108|P10|NOT COMPLETED|Period 2||0
8082054|NCT03579940|19927109|P9|NOT COMPLETED|Period 2||0
8082055|NCT03579940|19927110|P8|NOT COMPLETED|Period 2||0
8082056|NCT03579940|19927111|P7|NOT COMPLETED|Period 2||0
8082057|NCT03579940|19927112|P6|NOT COMPLETED|Period 2||0
8082058|NCT03579940|19927113|P5|NOT COMPLETED|Period 2||0
8082059|NCT03579940|19927114|P4|NOT COMPLETED|Period 2||0
8082060|NCT03579940|19927115|P3|NOT COMPLETED|Period 2||1
8082061|NCT03579940|19927116|P2|NOT COMPLETED|Period 2||0
8082062|NCT03579940|19927117|P1|NOT COMPLETED|Period 2||0
8082063|NCT03579940|19927107|P11|COMPLETED|Period 2||3
8082064|NCT03579940|19927108|P10|COMPLETED|Period 2||2
8082065|NCT03579940|19927109|P9|COMPLETED|Period 2||3
8082066|NCT03579940|19927110|P8|COMPLETED|Period 2||3
8082067|NCT03579940|19927111|P7|COMPLETED|Period 2||3
8082068|NCT03579940|19927112|P6|COMPLETED|Period 2||2
8082069|NCT03579940|19927113|P5|COMPLETED|Period 2||2
8082070|NCT03579940|19927114|P4|COMPLETED|Period 2||2
8082071|NCT03579940|19927115|P3|COMPLETED|Period 2||1
8082072|NCT03579940|19927116|P2|COMPLETED|Period 2||2
8082073|NCT03579940|19927117|P1|COMPLETED|Period 2||3
8082074|NCT03579940|19927107|P11|STARTED|Period 2||3
8082075|NCT03579940|19927108|P10|STARTED|Period 2||2
8082076|NCT03579940|19927109|P9|STARTED|Period 2||3
8082077|NCT03579940|19927110|P8|STARTED|Period 2||3
8082078|NCT03579940|19927111|P7|STARTED|Period 2||3
8082079|NCT03579940|19927112|P6|STARTED|Period 2||2
8082080|NCT03579940|19927113|P5|STARTED|Period 2||2
8082081|NCT03579940|19927114|P4|STARTED|Period 2||2
8082082|NCT03579940|19927115|P3|STARTED|Period 2||2
8082083|NCT03579940|19927116|P2|STARTED|Period 2||2
8082084|NCT03579940|19927117|P1|STARTED|Period 2||3
8082085|NCT03579940|19927107|P11|NOT COMPLETED|Period 1||0
8082086|NCT03579940|19927108|P10|NOT COMPLETED|Period 1||0
8082087|NCT03579940|19927109|P9|NOT COMPLETED|Period 1||0
8082088|NCT03579940|19927110|P8|NOT COMPLETED|Period 1||0
8082089|NCT03579940|19927111|P7|NOT COMPLETED|Period 1||0
8082090|NCT03579940|19927112|P6|NOT COMPLETED|Period 1||0
8082091|NCT03579940|19927113|P5|NOT COMPLETED|Period 1||0
8082092|NCT03579940|19927114|P4|NOT COMPLETED|Period 1||0
8082093|NCT03579940|19927115|P3|NOT COMPLETED|Period 1||0
8082094|NCT03579940|19927116|P2|NOT COMPLETED|Period 1||0
8082095|NCT03579940|19927117|P1|NOT COMPLETED|Period 1||0
8082096|NCT03579940|19927107|P11|COMPLETED|Period 1||3
8082097|NCT03579940|19927108|P10|COMPLETED|Period 1||2
8082098|NCT03579940|19927109|P9|COMPLETED|Period 1||3
8082099|NCT03579940|19927110|P8|COMPLETED|Period 1||3
8082100|NCT03579940|19927111|P7|COMPLETED|Period 1||3
8082101|NCT03579940|19927112|P6|COMPLETED|Period 1||2
8082102|NCT03579940|19927113|P5|COMPLETED|Period 1||2
8082103|NCT03579940|19927114|P4|COMPLETED|Period 1||2
8082104|NCT03579940|19927115|P3|COMPLETED|Period 1||2
8082105|NCT03579940|19927116|P2|COMPLETED|Period 1||2
8082106|NCT03579940|19927117|P1|COMPLETED|Period 1||3
8082107|NCT03579940|19927107|P11|Received at Least 1 Dose of Study Drug|Period 1||3
8082108|NCT03579940|19927108|P10|Received at Least 1 Dose of Study Drug|Period 1||2
8082109|NCT03579940|19927109|P9|Received at Least 1 Dose of Study Drug|Period 1||3
8082110|NCT03579940|19927110|P8|Received at Least 1 Dose of Study Drug|Period 1||3
8082111|NCT03579940|19927111|P7|Received at Least 1 Dose of Study Drug|Period 1||3
8082112|NCT03579940|19927112|P6|Received at Least 1 Dose of Study Drug|Period 1||2
8082113|NCT03579940|19927113|P5|Received at Least 1 Dose of Study Drug|Period 1||2
8082114|NCT03579940|19927114|P4|Received at Least 1 Dose of Study Drug|Period 1||2
8082115|NCT03579940|19927115|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8082116|NCT03579940|19927116|P2|Received at Least 1 Dose of Study Drug|Period 1||2
8082117|NCT03579940|19927117|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8082118|NCT03579940|19927107|P11|STARTED|Period 1||3
8082119|NCT03579940|19927108|P10|STARTED|Period 1||2
8082120|NCT03579940|19927109|P9|STARTED|Period 1||3
8082121|NCT03579940|19927110|P8|STARTED|Period 1||3
8082122|NCT03579940|19927111|P7|STARTED|Period 1||3
8082123|NCT03579940|19927112|P6|STARTED|Period 1||2
8082124|NCT03579940|19927113|P5|STARTED|Period 1||2
8082125|NCT03579940|19927114|P4|STARTED|Period 1||2
8082126|NCT03579940|19927115|P3|STARTED|Period 1||2
8082127|NCT03579940|19927116|P2|STARTED|Period 1||2
8082128|NCT03579940|19927117|P1|STARTED|Period 1||3
8082129|NCT03579719|19927157|P1|NOT COMPLETED|Overall Study||1
8082130|NCT03579719|19927157|P1|COMPLETED|Overall Study||14
8082131|NCT03579719|19927157|P1|STARTED|Overall Study||15
8082132|NCT03579433|19927174|P1|NOT COMPLETED|Overall Study||6
8082133|NCT03579433|19927174|P1|COMPLETED|Overall Study||98
8082134|NCT03579433|19927174|P1|Barrett Calculator|Overall Study||102
8082135|NCT03579433|19927174|P1|ORA With VerifEye+|Overall Study||96
8082136|NCT03579433|19927174|P1|STARTED|Overall Study||104
8082137|NCT03578926|19927182|P2|NOT COMPLETED|Second Intervention||0
8082138|NCT03578926|19927183|P1|NOT COMPLETED|Second Intervention||0
8082139|NCT03578926|19927182|P2|COMPLETED|Second Intervention||21
8082140|NCT03578926|19927183|P1|COMPLETED|Second Intervention||23
8082141|NCT03578926|19927182|P2|STARTED|Second Intervention||21
8082142|NCT03578926|19927183|P1|STARTED|Second Intervention||23
8082143|NCT03578926|19927182|P2|NOT COMPLETED|First Intervention||0
8082144|NCT03578926|19927183|P1|NOT COMPLETED|First Intervention||0
8082145|NCT03578926|19927182|P2|COMPLETED|First Intervention||23
8082146|NCT03578926|19927183|P1|COMPLETED|First Intervention||21
8082147|NCT03578926|19927182|P2|STARTED|First Intervention||23
8082148|NCT03578926|19927183|P1|STARTED|First Intervention||21
8082149|NCT03578549|19927203|P1|NOT COMPLETED|Overall Study||1
8082150|NCT03578549|19927203|P1|COMPLETED|Overall Study||29
8082151|NCT03578549|19927203|P1|STARTED|Overall Study||30
8082152|NCT03578146|19927214|P6|NOT COMPLETED|Overall Study||3
8082153|NCT03578146|19927215|P5|NOT COMPLETED|Overall Study||0
8082154|NCT03578146|19927216|P4|NOT COMPLETED|Overall Study||0
8082155|NCT03578146|19927217|P3|NOT COMPLETED|Overall Study||1
8082156|NCT03578146|19927218|P2|NOT COMPLETED|Overall Study||1
8082157|NCT03578146|19927219|P1|NOT COMPLETED|Overall Study||1
8082158|NCT03578146|19927214|P6|COMPLETED|Overall Study||5
8082159|NCT03578146|19927215|P5|COMPLETED|Overall Study||6
8082160|NCT03578146|19927216|P4|COMPLETED|Overall Study||6
8082161|NCT03578146|19927217|P3|COMPLETED|Overall Study||5
8082162|NCT03578146|19927218|P2|COMPLETED|Overall Study||5
8082163|NCT03578146|19927219|P1|COMPLETED|Overall Study||15
8082164|NCT03578146|19927214|P6|STARTED|Overall Study||8
8082165|NCT03578146|19927215|P5|STARTED|Overall Study||6
8082166|NCT03578146|19927216|P4|STARTED|Overall Study||6
8082167|NCT03578146|19927217|P3|STARTED|Overall Study||6
8082168|NCT03578146|19927218|P2|STARTED|Overall Study||6
8082169|NCT03578146|19927219|P1|STARTED|Overall Study||16
8082170|NCT03577275|19927281|P1|NOT COMPLETED|Overall Study||0
8082171|NCT03577275|19927281|P1|COMPLETED|Overall Study||32
8082172|NCT03577275|19927281|P1|NST-4016 2000mg|Overall Study||32
8082173|NCT03577275|19927281|P1|NST-4016 600mg|Overall Study||32
8082174|NCT03577275|19927281|P1|Moxifloxacin 400mg|Overall Study||32
8082175|NCT03577275|19927281|P1|Placebo|Overall Study||32
8082176|NCT03577275|19927281|P1|STARTED|Overall Study|All participants received all of the 4 interventions|32
8082177|NCT03576118|19927309|P2|NOT COMPLETED|Overall Study||4
8082178|NCT03576118|19927310|P1|NOT COMPLETED|Overall Study||3
8082179|NCT03576118|19927309|P2|COMPLETED|Overall Study||33
8082180|NCT03576118|19927310|P1|COMPLETED|Overall Study||34
8082181|NCT03576118|19927309|P2|STARTED|Overall Study||37
8082182|NCT03576118|19927310|P1|STARTED|Overall Study||37
8082183|NCT03575962|19927316|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8082184|NCT03575962|19927317|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8082185|NCT03575962|19927316|P2|COMPLETED|Treatment Period 2 (4 Days)||7
8082186|NCT03575962|19927317|P1|COMPLETED|Treatment Period 2 (4 Days)||7
8082187|NCT03575962|19927316|P2|STARTED|Treatment Period 2 (4 Days)||7
8082188|NCT03575962|19927317|P1|STARTED|Treatment Period 2 (4 Days)||7
8082189|NCT03575962|19927316|P2|NOT COMPLETED|Washout Period (7 Days)||0
8082190|NCT03575962|19927317|P1|NOT COMPLETED|Washout Period (7 Days)||0
8082191|NCT03575962|19927316|P2|COMPLETED|Washout Period (7 Days)||7
8082192|NCT03575962|19927317|P1|COMPLETED|Washout Period (7 Days)||7
8082193|NCT03575962|19927316|P2|STARTED|Washout Period (7 Days)||7
8082194|NCT03575962|19927317|P1|STARTED|Washout Period (7 Days)||7
8082195|NCT03575962|19927316|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8082196|NCT03575962|19927317|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8082197|NCT03575962|19927316|P2|COMPLETED|Treatment Period 1 (4 Days)||7
8082198|NCT03575962|19927317|P1|COMPLETED|Treatment Period 1 (4 Days)||7
8082199|NCT03575962|19927316|P2|STARTED|Treatment Period 1 (4 Days)||7
8082200|NCT03575962|19927317|P1|STARTED|Treatment Period 1 (4 Days)||7
8082201|NCT03575871|19927360|P3|NOT COMPLETED|Overall Study||26
8082202|NCT03575871|19927361|P2|NOT COMPLETED|Overall Study||14
8082203|NCT03575871|19927362|P1|NOT COMPLETED|Overall Study||21
8082204|NCT03575871|19927360|P3|COMPLETED|Overall Study||52
8082205|NCT03575871|19927361|P2|COMPLETED|Overall Study||141
8082206|NCT03575871|19927362|P1|COMPLETED|Overall Study||137
8082207|NCT03575871|19927360|P3|STARTED|Overall Study||78
8082208|NCT03575871|19927361|P2|STARTED|Overall Study||155
8082209|NCT03575871|19927362|P1|STARTED|Overall Study||158
8082210|NCT03575806|19927426|P2|NOT COMPLETED|Overall Study||4
8082211|NCT03575806|19927427|P1|NOT COMPLETED|Overall Study||0
8082212|NCT03575806|19927426|P2|COMPLETED|Overall Study||23
8082213|NCT03575806|19927427|P1|COMPLETED|Overall Study||25
8082214|NCT03575806|19927426|P2|STARTED|Overall Study||27
8082215|NCT03575806|19927427|P1|STARTED|Overall Study||25
8082222|NCT03575702|19927452|P2|NOT COMPLETED|Overall Study||4
8082223|NCT03575702|19927453|P1|NOT COMPLETED|Overall Study||6
8082224|NCT03575702|19927452|P2|COMPLETED|Overall Study||146
8082225|NCT03575702|19927453|P1|COMPLETED|Overall Study||143
8082226|NCT03575702|19927452|P2|STARTED|Overall Study||150
8082227|NCT03575702|19927453|P1|STARTED|Overall Study||149
8082228|NCT03574818|19927487|P1|NOT COMPLETED|Overall Study||0
8082229|NCT03574818|19927487|P1|COMPLETED|Overall Study||1
8082230|NCT03574818|19927487|P1|STARTED|Overall Study||1
8082231|NCT03574441|19927494|P3|NOT COMPLETED|Overall Study||0
8082232|NCT03574441|19927495|P2|NOT COMPLETED|Overall Study||0
8082233|NCT03574441|19927496|P1|NOT COMPLETED|Overall Study||0
8082234|NCT03574441|19927494|P3|COMPLETED|Overall Study||30
8082235|NCT03574441|19927495|P2|COMPLETED|Overall Study||30
8082236|NCT03574441|19927496|P1|COMPLETED|Overall Study||31
8082237|NCT03574441|19927494|P3|STARTED|Overall Study||30
8082238|NCT03574441|19927495|P2|STARTED|Overall Study||30
8082239|NCT03574441|19927496|P1|STARTED|Overall Study||31
8082240|NCT03573908|19927509|P5|NOT COMPLETED|Randomized Withdrawal Period||2
8082241|NCT03573908|19927510|P4|NOT COMPLETED|Randomized Withdrawal Period||2
8082242|NCT03573908|19927511|P3|NOT COMPLETED|Randomized Withdrawal Period||8
8082243|NCT03573908|19927512|P2|NOT COMPLETED|Randomized Withdrawal Period||0
8082244|NCT03573908|19927513|P1|NOT COMPLETED|Randomized Withdrawal Period||0
8082245|NCT03573908|19927509|P5|COMPLETED|Randomized Withdrawal Period||137
8082246|NCT03573908|19927510|P4|COMPLETED|Randomized Withdrawal Period||136
8082247|NCT03573908|19927511|P3|COMPLETED|Randomized Withdrawal Period||272
8082248|NCT03573908|19927512|P2|COMPLETED|Randomized Withdrawal Period||0
8082249|NCT03573908|19927513|P1|COMPLETED|Randomized Withdrawal Period||0
8082250|NCT03573908|19927509|P5|STARTED|Randomized Withdrawal Period||139
8082251|NCT03573908|19927510|P4|STARTED|Randomized Withdrawal Period||138
8082252|NCT03573908|19927511|P3|STARTED|Randomized Withdrawal Period||280
8082253|NCT03573908|19927512|P2|STARTED|Randomized Withdrawal Period||0
8082254|NCT03573908|19927513|P1|STARTED|Randomized Withdrawal Period||0
8082255|NCT03573908|19927509|P5|NOT COMPLETED|Treatment Period||0
8082256|NCT03573908|19927510|P4|NOT COMPLETED|Treatment Period||0
8082257|NCT03573908|19927511|P3|NOT COMPLETED|Treatment Period||0
8082258|NCT03573908|19927512|P2|NOT COMPLETED|Treatment Period||26
8082259|NCT03573908|19927513|P1|NOT COMPLETED|Treatment Period||24
8082260|NCT03573908|19927509|P5|COMPLETED|Treatment Period||0
8082261|NCT03573908|19927510|P4|COMPLETED|Treatment Period||0
8082262|NCT03573908|19927511|P3|COMPLETED|Treatment Period||0
8082263|NCT03573908|19927512|P2|COMPLETED|Treatment Period||280
8082264|NCT03573908|19927513|P1|COMPLETED|Treatment Period||284
8082265|NCT03573908|19927509|P5|STARTED|Treatment Period||0
8082266|NCT03573908|19927510|P4|STARTED|Treatment Period||0
8082267|NCT03573908|19927511|P3|STARTED|Treatment Period||0
8082268|NCT03573908|19927512|P2|STARTED|Treatment Period||306
8082269|NCT03573908|19927513|P1|STARTED|Treatment Period||308
8082270|NCT03573830|19927530|P2|NOT COMPLETED|Overall Study||7
8082271|NCT03573830|19927531|P1|NOT COMPLETED|Overall Study||4
8082272|NCT03573830|19927530|P2|COMPLETED|Overall Study||360
8082273|NCT03573830|19927531|P1|COMPLETED|Overall Study||360
8082274|NCT03573830|19927530|P2|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
8082275|NCT03573830|19927531|P1|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
8082276|NCT03573830|19927530|P2|STARTED|Overall Study||367
8082277|NCT03573830|19927531|P1|STARTED|Overall Study||364
8082278|NCT03573817|19927554|P2|NOT COMPLETED|Overall Study||4
8082279|NCT03573817|19927555|P1|NOT COMPLETED|Overall Study||1
8082280|NCT03573817|19927554|P2|COMPLETED|Overall Study||55
8082281|NCT03573817|19927555|P1|COMPLETED|Overall Study||62
8082282|NCT03573817|19927554|P2|Randomized and Treated With Study Drug|Overall Study||59
8082283|NCT03573817|19927555|P1|Randomized and Treated With Study Drug|Overall Study||63
8082284|NCT03573817|19927554|P2|STARTED|Overall Study||59
8082285|NCT03573817|19927555|P1|STARTED|Overall Study||63
8082286|NCT03573505|19927583|P2|NOT COMPLETED|Overall Study||54
8082287|NCT03573505|19927584|P1|NOT COMPLETED|Overall Study||52
8082288|NCT03573505|19927583|P2|COMPLETED|Overall Study||0
8082289|NCT03573505|19927584|P1|COMPLETED|Overall Study||0
8082290|NCT03573505|19927583|P2|STARTED|Overall Study||54
8082291|NCT03573505|19927584|P1|STARTED|Overall Study||52
8082292|NCT03573336|19927630|P3|NOT COMPLETED|Overall Study||2
8082293|NCT03573336|19927631|P2|NOT COMPLETED|Overall Study||4
8082294|NCT03573336|19927632|P1|NOT COMPLETED|Overall Study||2
8082295|NCT03573336|19927630|P3|COMPLETED|Overall Study||0
8082296|NCT03573336|19927631|P2|COMPLETED|Overall Study||0
8082297|NCT03573336|19927632|P1|COMPLETED|Overall Study||0
8082298|NCT03573336|19927630|P3|Treated|Overall Study||2
8082299|NCT03573336|19927631|P2|Treated|Overall Study||4
8082300|NCT03573336|19927632|P1|Treated|Overall Study||2
8082301|NCT03573336|19927630|P3|STARTED|Overall Study||2
8082302|NCT03573336|19927631|P2|STARTED|Overall Study||4
8082303|NCT03573336|19927632|P1|STARTED|Overall Study||2
8082304|NCT03573323|19927651|P2|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
8082305|NCT03573323|19927652|P1|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
8082306|NCT03573323|19927651|P2|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
8082307|NCT03573323|19927652|P1|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
8082308|NCT03573323|19927651|P2|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
8082309|NCT03573323|19927652|P1|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
8082310|NCT03573323|19927651|P2|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
8082311|NCT03573323|19927652|P1|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
8082312|NCT03573323|19927651|P2|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
8082313|NCT03573323|19927652|P1|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
8082314|NCT03573323|19927651|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
8082315|NCT03573323|19927652|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
8082316|NCT03573323|19927651|P2|STARTED|Blinded Treatment Period (Weeks 0-24)||507
8082317|NCT03573323|19927652|P1|STARTED|Blinded Treatment Period (Weeks 0-24)||520
8082318|NCT03573206|19927676|P1|NOT COMPLETED|Overall Study||0
8082319|NCT03573206|19927676|P1|COMPLETED|Overall Study||168
8082320|NCT03573206|19927676|P1|STARTED|Overall Study||168
8082321|NCT03572972|19927691|P5|NOT COMPLETED|Overall Study||0
8082322|NCT03572972|19927692|P4|NOT COMPLETED|Overall Study||0
8082323|NCT03572972|19927693|P3|NOT COMPLETED|Overall Study||0
8082324|NCT03572972|19927694|P2|NOT COMPLETED|Overall Study||0
8082325|NCT03572972|19927695|P1|NOT COMPLETED|Overall Study||0
8082326|NCT03572972|19927691|P5|COMPLETED|Overall Study||16295
8082327|NCT03572972|19927692|P4|COMPLETED|Overall Study||8648
8082328|NCT03572972|19927693|P3|COMPLETED|Overall Study||17779
8082329|NCT03572972|19927694|P2|COMPLETED|Overall Study||11414
8082330|NCT03572972|19927695|P1|COMPLETED|Overall Study||10548
8082331|NCT03572972|19927691|P5|STARTED|Overall Study||16295
8082332|NCT03572972|19927692|P4|STARTED|Overall Study||8648
8082333|NCT03572972|19927693|P3|STARTED|Overall Study||17779
8082334|NCT03572972|19927694|P2|STARTED|Overall Study||11414
8082335|NCT03572972|19927695|P1|STARTED|Overall Study||10548
8082336|NCT03572218|19927800|P2|NOT COMPLETED|Overall Study||5
8082337|NCT03572218|19927801|P1|NOT COMPLETED|Overall Study||6
8082338|NCT03572218|19927800|P2|COMPLETED|Overall Study||31
8082339|NCT03572218|19927801|P1|COMPLETED|Overall Study||30
8082340|NCT03572218|19927800|P2|Week 26|Overall Study||31
8082341|NCT03572218|19927801|P1|Week 26|Overall Study||30
8082342|NCT03572218|19927800|P2|Week 12|Overall Study||31
8082343|NCT03572218|19927801|P1|Week 12|Overall Study||30
8082344|NCT03572218|19927800|P2|STARTED|Overall Study||36
8082345|NCT03572218|19927801|P1|STARTED|Overall Study||36
8082346|NCT03571724|19927919|P4|NOT COMPLETED|Week 1-6||0
8082347|NCT03571724|19927920|P3|NOT COMPLETED|Week 1-6||3
8082348|NCT03571724|19927921|P2|NOT COMPLETED|Week 1-6||8
8082349|NCT03571724|19927922|P1|NOT COMPLETED|Week 1-6||7
8082350|NCT03571724|19927919|P4|COMPLETED|Week 1-6||20
8082351|NCT03571724|19927920|P3|COMPLETED|Week 1-6||19
8082352|NCT03571724|19927921|P2|COMPLETED|Week 1-6||42
8082353|NCT03571724|19927922|P1|COMPLETED|Week 1-6||43
8082354|NCT03571724|19927919|P4|STARTED|Week 1-6||20
8082355|NCT03571724|19927920|P3|STARTED|Week 1-6||22
8082356|NCT03571724|19927921|P2|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
8082357|NCT03571724|19927922|P1|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
8082358|NCT03571724|19927919|P4|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082359|NCT03571724|19927920|P3|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082360|NCT03571724|19927921|P2|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082361|NCT03571724|19927922|P1|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082362|NCT03571724|19927919|P4|COMPLETED|Week -1 (Prior to Switching)||70
8082363|NCT03571724|19927920|P3|COMPLETED|Week -1 (Prior to Switching)||72
8082364|NCT03571724|19927921|P2|COMPLETED|Week -1 (Prior to Switching)||0
8082365|NCT03571724|19927922|P1|COMPLETED|Week -1 (Prior to Switching)||0
8082366|NCT03571724|19927919|P4|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
8082367|NCT03571724|19927920|P3|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
8082368|NCT03571724|19927921|P2|PK Nicotine|Week -1 (Prior to Switching)||0
8082369|NCT03571724|19927922|P1|PK Nicotine|Week -1 (Prior to Switching)||0
8082370|NCT03571724|19927919|P4|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
8082371|NCT03571724|19927920|P3|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
8082372|NCT03571724|19927921|P2|Topography|Week -1 (Prior to Switching)||0
8082373|NCT03571724|19927922|P1|Topography|Week -1 (Prior to Switching)||0
8082374|NCT03571724|19927919|P4|STARTED|Week -1 (Prior to Switching)||70
8082375|NCT03571724|19927920|P3|STARTED|Week -1 (Prior to Switching)||72
8082376|NCT03571724|19927921|P2|STARTED|Week -1 (Prior to Switching)||0
8082377|NCT03571724|19927922|P1|STARTED|Week -1 (Prior to Switching)||0
8082378|NCT03571672|19928031|P1|NOT COMPLETED|Overall Study||5
8082379|NCT03571672|19928031|P1|COMPLETED|Overall Study||148
8082380|NCT03571672|19928031|P1|STARTED|Overall Study||153
8082381|NCT03571607|19928054|P2|NOT COMPLETED|Overall Study||0
8082382|NCT03571607|19928055|P1|NOT COMPLETED|Overall Study||0
8082383|NCT03571607|19928054|P2|COMPLETED|Overall Study||153
8082384|NCT03571607|19928055|P1|COMPLETED|Overall Study||53
8082385|NCT03571607|19928054|P2|Vaccinated|Overall Study||153
8082386|NCT03571607|19928055|P1|Vaccinated|Overall Study||53
8082387|NCT03571607|19928054|P2|STARTED|Overall Study||153
8082388|NCT03571607|19928055|P1|STARTED|Overall Study||53
8082389|NCT03571256|19928072|P3|NOT COMPLETED|Overall Study||4
8082390|NCT03571256|19928073|P2|NOT COMPLETED|Overall Study||3
8082391|NCT03571256|19928074|P1|NOT COMPLETED|Overall Study||6
8082392|NCT03571256|19928072|P3|COMPLETED|Overall Study||48
8082393|NCT03571256|19928073|P2|COMPLETED|Overall Study||51
8082394|NCT03571256|19928074|P1|COMPLETED|Overall Study||46
8082395|NCT03571256|19928072|P3|Modified ITT (mITT) Analysis Set|Overall Study||51
8082396|NCT03571256|19928073|P2|Modified ITT (mITT) Analysis Set|Overall Study||53
8082397|NCT03571256|19928074|P1|Modified ITT (mITT) Analysis Set|Overall Study||49
8082398|NCT03571256|19928072|P3|Safety Analysis Set|Overall Study||51
8082399|NCT03571256|19928073|P2|Safety Analysis Set|Overall Study||54
8082400|NCT03571256|19928074|P1|Safety Analysis Set|Overall Study||52
8082401|NCT03571256|19928072|P3|STARTED|Overall Study||52
8082402|NCT03571256|19928073|P2|STARTED|Overall Study||54
8082403|NCT03571256|19928074|P1|STARTED|Overall Study||52
8082404|NCT03570658|19928105|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082405|NCT03570658|19928106|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082406|NCT03570658|19928107|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082407|NCT03570658|19928108|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082408|NCT03570658|19928105|P4|COMPLETED|Multiple Ascending Dose (MAD)||10
8082409|NCT03570658|19928106|P3|COMPLETED|Multiple Ascending Dose (MAD)||10
8082410|NCT03570658|19928107|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
8082411|NCT03570658|19928108|P1|COMPLETED|Multiple Ascending Dose (MAD)||4
8082412|NCT03570658|19928105|P4|STARTED|Multiple Ascending Dose (MAD)||10
8082413|NCT03570658|19928106|P3|STARTED|Multiple Ascending Dose (MAD)||10
8082414|NCT03570658|19928107|P2|STARTED|Multiple Ascending Dose (MAD)||0
8082415|NCT03570658|19928108|P1|STARTED|Multiple Ascending Dose (MAD)||4
8082416|NCT03570658|19928105|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082417|NCT03570658|19928106|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082418|NCT03570658|19928107|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082419|NCT03570658|19928108|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082420|NCT03570658|19928105|P4|COMPLETED|Single Ascending Dose (SAD)||10
8082421|NCT03570658|19928106|P3|COMPLETED|Single Ascending Dose (SAD)||10
8082422|NCT03570658|19928107|P2|COMPLETED|Single Ascending Dose (SAD)||2
8082423|NCT03570658|19928108|P1|COMPLETED|Single Ascending Dose (SAD)||6
8082424|NCT03570658|19928105|P4|STARTED|Single Ascending Dose (SAD)||10
8082425|NCT03570658|19928106|P3|STARTED|Single Ascending Dose (SAD)||10
8082426|NCT03570658|19928107|P2|STARTED|Single Ascending Dose (SAD)||2
8082427|NCT03570658|19928108|P1|STARTED|Single Ascending Dose (SAD)||6
8082428|NCT03570554|19928162|P4|NOT COMPLETED|Overall Study||1
8082429|NCT03570554|19928163|P3|NOT COMPLETED|Overall Study||1
8082430|NCT03570554|19928164|P2|NOT COMPLETED|Overall Study||0
8082431|NCT03570554|19928165|P1|NOT COMPLETED|Overall Study||0
8082432|NCT03570554|19928162|P4|COMPLETED|Overall Study||9
8082433|NCT03570554|19928163|P3|COMPLETED|Overall Study||10
8082434|NCT03570554|19928164|P2|COMPLETED|Overall Study||10
8082435|NCT03570554|19928165|P1|COMPLETED|Overall Study||10
8082436|NCT03570554|19928162|P4|STARTED|Overall Study||10
8082437|NCT03570554|19928163|P3|STARTED|Overall Study||11
8082438|NCT03570554|19928164|P2|STARTED|Overall Study||10
8082439|NCT03570554|19928165|P1|STARTED|Overall Study||10
8082440|NCT03570476|19928183|P1|NOT COMPLETED|Overall Study||0
8082441|NCT03570476|19928183|P1|COMPLETED|Overall Study||2
8082442|NCT03570476|19928183|P1|STARTED|Overall Study||2
8082443|NCT03570255|19928190|P1|NOT COMPLETED|Overall Study||0
8082444|NCT03570255|19928190|P1|COMPLETED|Overall Study||28
8082445|NCT03570255|19928190|P1|STARTED|Overall Study||28
8082446|NCT03570047|19928199|P5|NOT COMPLETED|Overall Study||0
8082447|NCT03570047|19928200|P4|NOT COMPLETED|Overall Study||0
8082448|NCT03570047|19928201|P3|NOT COMPLETED|Overall Study||0
8082449|NCT03570047|19928202|P2|NOT COMPLETED|Overall Study||0
8082450|NCT03570047|19928203|P1|NOT COMPLETED|Overall Study||0
8082451|NCT03570047|19928199|P5|COMPLETED|Overall Study||12262
8082452|NCT03570047|19928200|P4|COMPLETED|Overall Study||16564
8082453|NCT03570047|19928201|P3|COMPLETED|Overall Study||6925
8082454|NCT03570047|19928202|P2|COMPLETED|Overall Study||22336
8082455|NCT03570047|19928203|P1|COMPLETED|Overall Study||15902
8082456|NCT03570047|19928199|P5|STARTED|Overall Study||12262
8082457|NCT03570047|19928200|P4|STARTED|Overall Study||16564
8082458|NCT03570047|19928201|P3|STARTED|Overall Study||6925
8082459|NCT03570047|19928202|P2|STARTED|Overall Study||22336
8082460|NCT03570047|19928203|P1|STARTED|Overall Study||15902
8082461|NCT03569618|19928262|P2|NOT COMPLETED|Overall Study||1
8082462|NCT03569618|19928263|P1|NOT COMPLETED|Overall Study||3
8082463|NCT03569618|19928262|P2|COMPLETED|Overall Study||20
8082464|NCT03569618|19928263|P1|COMPLETED|Overall Study||20
8082465|NCT03569618|19928262|P2|STARTED|Overall Study||21
8082466|NCT03569618|19928263|P1|STARTED|Overall Study||23
8082467|NCT03569371|19928279|P1|NOT COMPLETED|Overall Study||3
8082468|NCT03569371|19928279|P1|COMPLETED|Overall Study||7
8082469|NCT03569371|19928279|P1|STARTED|Overall Study||10
8082470|NCT03569202|19928300|P2|NOT COMPLETED|Part 3||1
8082471|NCT03569202|19928301|P1|NOT COMPLETED|Part 3||2
8082472|NCT03569202|19928300|P2|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
8082473|NCT03569202|19928301|P1|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
8082474|NCT03569202|19928300|P2|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
8082475|NCT03569202|19928301|P1|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
8082476|NCT03569202|19928300|P2|NOT COMPLETED|Part 2||0
8082477|NCT03569202|19928301|P1|NOT COMPLETED|Part 2||0
8082478|NCT03569202|19928300|P2|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
8082479|NCT03569202|19928301|P1|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
8082480|NCT03569202|19928300|P2|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
8082481|NCT03569202|19928301|P1|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
8082482|NCT03569202|19928300|P2|NOT COMPLETED|Part 1||0
8082483|NCT03569202|19928301|P1|NOT COMPLETED|Part 1||0
8082484|NCT03569202|19928300|P2|COMPLETED|Part 1||0
8082485|NCT03569202|19928301|P1|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
8082486|NCT03569202|19928300|P2|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
8082487|NCT03569202|19928301|P1|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
8082488|NCT03569033|19928333|P2|NOT COMPLETED|Overall Study||0
8082489|NCT03569033|19928334|P1|NOT COMPLETED|Overall Study||0
8082490|NCT03569033|19928333|P2|COMPLETED|Overall Study||23
8082491|NCT03569033|19928334|P1|COMPLETED|Overall Study||23
8082492|NCT03569033|19928333|P2|STARTED|Overall Study||23
8082493|NCT03569033|19928334|P1|STARTED|Overall Study||23
8082494|NCT03568942|19928350|P1|NOT COMPLETED|Overall Study||2
8082495|NCT03568942|19928350|P1|COMPLETED|Overall Study||20
8082496|NCT03568942|19928350|P1|STARTED|Overall Study||22
8082497|NCT03568500|19928388|P3|NOT COMPLETED|Overall Study||4
8082498|NCT03568500|19928389|P2|NOT COMPLETED|Overall Study||6
8082499|NCT03568500|19928390|P1|NOT COMPLETED|Overall Study||10
8082500|NCT03568500|19928388|P3|COMPLETED|Overall Study||2
8082501|NCT03568500|19928389|P2|COMPLETED|Overall Study||14
8082502|NCT03568500|19928390|P1|COMPLETED|Overall Study||8
8082503|NCT03568500|19928388|P3|Received At Least 1 Dose of Study Drug|Overall Study||6
8082504|NCT03568500|19928389|P2|Received At Least 1 Dose of Study Drug|Overall Study||19
8082505|NCT03568500|19928390|P1|Received At Least 1 Dose of Study Drug|Overall Study||18
8082506|NCT03568500|19928388|P3|STARTED|Overall Study||6
8082507|NCT03568500|19928389|P2|STARTED|Overall Study||20
8082508|NCT03568500|19928390|P1|STARTED|Overall Study||18
8082509|NCT03567005|19928404|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8082510|NCT03567005|19928405|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8082511|NCT03567005|19928404|P2|COMPLETED|Period 2, Second 7 Days of Wear||31
8082512|NCT03567005|19928405|P1|COMPLETED|Period 2, Second 7 Days of Wear||29
8082513|NCT03567005|19928404|P2|STARTED|Period 2, Second 7 Days of Wear||31
8082514|NCT03567005|19928405|P1|STARTED|Period 2, Second 7 Days of Wear||29
8082515|NCT03567005|19928404|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8082516|NCT03567005|19928405|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8082517|NCT03567005|19928404|P2|COMPLETED|Period 1, First 7 Days of Wear||31
8082518|NCT03567005|19928405|P1|COMPLETED|Period 1, First 7 Days of Wear||29
8082519|NCT03567005|19928404|P2|STARTED|Period 1, First 7 Days of Wear||31
8082520|NCT03567005|19928405|P1|STARTED|Period 1, First 7 Days of Wear||29
8082521|NCT03566979|19928417|P4|NOT COMPLETED|Overall Study||6
8082522|NCT03566979|19928418|P3|NOT COMPLETED|Overall Study||10
8082523|NCT03566979|19928419|P2|NOT COMPLETED|Overall Study||7
8082524|NCT03566979|19928420|P1|NOT COMPLETED|Overall Study||5
8082525|NCT03566979|19928417|P4|COMPLETED|Overall Study||143
8082526|NCT03566979|19928418|P3|COMPLETED|Overall Study||132
8082527|NCT03566979|19928419|P2|COMPLETED|Overall Study||145
8082528|NCT03566979|19928420|P1|COMPLETED|Overall Study||53
8082529|NCT03566979|19928417|P4|STARTED|Overall Study||149
8082530|NCT03566979|19928418|P3|STARTED|Overall Study||142
8082531|NCT03566979|19928419|P2|STARTED|Overall Study||152
8082532|NCT03566979|19928420|P1|STARTED|Overall Study||58
8082533|NCT03566810|19928436|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082534|NCT03566810|19928437|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082535|NCT03566810|19928438|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082536|NCT03566810|19928439|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082537|NCT03566810|19928436|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
8082538|NCT03566810|19928437|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
8082539|NCT03566810|19928438|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
8082540|NCT03566810|19928439|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
8082541|NCT03566810|19928436|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||8
8082542|NCT03566810|19928437|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||8
8082543|NCT03566810|19928438|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||18
8082544|NCT03566810|19928439|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||19
8082545|NCT03566810|19928436|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8082546|NCT03566810|19928437|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8082547|NCT03566810|19928438|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
8082548|NCT03566810|19928439|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8082549|NCT03566810|19928436|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
8082550|NCT03566810|19928437|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
8082551|NCT03566810|19928438|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
8082552|NCT03566810|19928439|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
8082553|NCT03566810|19928436|P4|Treated|Treatment Period 1 (Day 1-Day 3)||8
8082554|NCT03566810|19928437|P3|Treated|Treatment Period 1 (Day 1-Day 3)||8
8082555|NCT03566810|19928438|P2|Treated|Treatment Period 1 (Day 1-Day 3)||18
8082556|NCT03566810|19928439|P1|Treated|Treatment Period 1 (Day 1-Day 3)||19
8082557|NCT03566810|19928436|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||8
8082558|NCT03566810|19928437|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||8
8082559|NCT03566810|19928438|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||19
8082560|NCT03566810|19928439|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||19
8082561|NCT03566680|19928501|P1|NOT COMPLETED|Overall Study||17
8082562|NCT03566680|19928501|P1|COMPLETED|Overall Study||29
8082563|NCT03566680|19928501|P1|STARTED|Overall Study||46
8082564|NCT03565887|19928512|P2|NOT COMPLETED|Overall Study||2
8082565|NCT03565887|19928513|P1|NOT COMPLETED|Overall Study||1
8082566|NCT03565887|19928512|P2|COMPLETED|Overall Study||53
8082567|NCT03565887|19928513|P1|COMPLETED|Overall Study||108
8082568|NCT03565887|19928512|P2|STARTED|Overall Study||55
8082569|NCT03565887|19928513|P1|STARTED|Overall Study||109
8082570|NCT03565874|19928521|P1|NOT COMPLETED|Overall Study||2
8082571|NCT03565874|19928521|P1|COMPLETED|Overall Study||4
8082572|NCT03565874|19928521|P1|STARTED|Overall Study||6
8082573|NCT03565679|19928534|P1|NOT COMPLETED|Overall Study||0
8082574|NCT03565679|19928534|P1|COMPLETED|Overall Study||10
8082575|NCT03565679|19928534|P1|STARTED|Overall Study||10
8082576|NCT03565666|19928541|P3|NOT COMPLETED|Overall Study||1
8082577|NCT03565666|19928542|P2|NOT COMPLETED|Overall Study||0
8082578|NCT03565666|19928543|P1|NOT COMPLETED|Overall Study||0
8082579|NCT03565666|19928541|P3|COMPLETED|Overall Study||11
8082580|NCT03565666|19928542|P2|COMPLETED|Overall Study||12
8082581|NCT03565666|19928543|P1|COMPLETED|Overall Study||12
8082582|NCT03565666|19928541|P3|STARTED|Overall Study||12
8082583|NCT03565666|19928542|P2|STARTED|Overall Study||12
8082584|NCT03565666|19928543|P1|STARTED|Overall Study||12
8082585|NCT03565328|19928580|P1|NOT COMPLETED|Overall Study||0
8082586|NCT03565328|19928580|P1|COMPLETED|Overall Study||1
8082587|NCT03565328|19928580|P1|STARTED|Overall Study||1
8082588|NCT03565315|19928592|P4|NOT COMPLETED|Overall Study||1
8082589|NCT03565315|19928593|P3|NOT COMPLETED|Overall Study||0
8082590|NCT03565315|19928594|P2|NOT COMPLETED|Overall Study||0
8082591|NCT03565315|19928595|P1|NOT COMPLETED|Overall Study||0
8082592|NCT03565315|19928592|P4|COMPLETED|Overall Study||1
8082593|NCT03565315|19928593|P3|COMPLETED|Overall Study||1
8082594|NCT03565315|19928594|P2|COMPLETED|Overall Study||3
8082595|NCT03565315|19928595|P1|COMPLETED|Overall Study||3
8082596|NCT03565315|19928592|P4|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
8082597|NCT03565315|19928593|P3|Discontinued Product Administrations|Overall Study||0
8082598|NCT03565315|19928594|P2|Discontinued Product Administrations|Overall Study||3
8082599|NCT03565315|19928595|P1|Discontinued Product Administrations|Overall Study||0
8082600|NCT03565315|19928592|P4|Product Administration Completed|Overall Study||0
8082601|NCT03565315|19928593|P3|Product Administration Completed|Overall Study||1
8082602|NCT03565315|19928594|P2|Product Administration Completed|Overall Study||0
8082603|NCT03565315|19928595|P1|Product Administration Completed|Overall Study||3
8082604|NCT03565315|19928592|P4|STARTED|Overall Study||2
8082605|NCT03565315|19928593|P3|STARTED|Overall Study||1
8082606|NCT03565315|19928594|P2|STARTED|Overall Study||3
8082607|NCT03565315|19928595|P1|STARTED|Overall Study||3
8082608|NCT03565211|19928632|P1|NOT COMPLETED|Overall Study||48
8082609|NCT03565211|19928632|P1|COMPLETED|Overall Study||206
8082610|NCT03565211|19928632|P1|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
8082611|NCT03565211|19928632|P1|STARTED|Overall Study||254
8082612|NCT03564886|19928657|P2|NOT COMPLETED|Overall Study||1
8082613|NCT03564886|19928658|P1|NOT COMPLETED|Overall Study||1
8082614|NCT03564886|19928657|P2|COMPLETED|Overall Study||23
8082615|NCT03564886|19928658|P1|COMPLETED|Overall Study||23
8082616|NCT03564886|19928657|P2|STARTED|Overall Study||24
8082617|NCT03564886|19928658|P1|STARTED|Overall Study||24
8082618|NCT03564444|19928670|P2|NOT COMPLETED|Overall Study||0
8082619|NCT03564444|19928671|P1|NOT COMPLETED|Overall Study||0
8082620|NCT03564444|19928670|P2|COMPLETED|Overall Study||240
8082621|NCT03564444|19928671|P1|COMPLETED|Overall Study||60
8082622|NCT03564444|19928670|P2|STARTED|Overall Study||240
8082623|NCT03564444|19928671|P1|STARTED|Overall Study||60
8082624|NCT03564353|19928691|P4|NOT COMPLETED|Overall Study||0
8082625|NCT03564353|19928692|P3|NOT COMPLETED|Overall Study||0
8082626|NCT03564353|19928693|P2|NOT COMPLETED|Overall Study||0
8082627|NCT03564353|19928694|P1|NOT COMPLETED|Overall Study||0
8082628|NCT03564353|19928691|P4|COMPLETED|Overall Study||10
8082629|NCT03564353|19928692|P3|COMPLETED|Overall Study||10
8082630|NCT03564353|19928693|P2|COMPLETED|Overall Study||10
8082631|NCT03564353|19928694|P1|COMPLETED|Overall Study||10
8082632|NCT03564353|19928691|P4|STARTED|Overall Study||10
8082633|NCT03564353|19928692|P3|STARTED|Overall Study||10
8082634|NCT03564353|19928693|P2|STARTED|Overall Study||10
8082635|NCT03564353|19928694|P1|STARTED|Overall Study||10
8082636|NCT03563716|19928706|P2|NOT COMPLETED|Overall Study||67
8082637|NCT03563716|19928707|P1|NOT COMPLETED|Overall Study||68
8082638|NCT03563716|19928706|P2|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
8082639|NCT03563716|19928707|P1|COMPLETED|Overall Study||0
8082640|NCT03563716|19928706|P2|STARTED|Overall Study||67
8082641|NCT03563716|19928707|P1|STARTED|Overall Study||68
8082642|NCT03563313|19928717|P2|NOT COMPLETED|Overall Study||0
8082643|NCT03563313|19928718|P1|NOT COMPLETED|Overall Study||0
8082644|NCT03563313|19928717|P2|COMPLETED|Overall Study||56
8082645|NCT03563313|19928718|P1|COMPLETED|Overall Study||112
8082646|NCT03563313|19928717|P2|STARTED|Overall Study||56
8082647|NCT03563313|19928718|P1|STARTED|Overall Study||112
8082648|NCT03563209|19928826|P1|NOT COMPLETED|Overall Study||0
8082649|NCT03563209|19928826|P1|COMPLETED|Overall Study||60
8082650|NCT03563209|19928826|P1|STARTED|Overall Study||60
8082651|NCT03563183|19928832|P1|NOT COMPLETED|Overall Study||0
8082652|NCT03563183|19928832|P1|COMPLETED|Overall Study||26976
8082653|NCT03563183|19928832|P1|STARTED|Overall Study||26976
8082654|NCT03562663|19928935|P2|NOT COMPLETED|Overall Study||6
8082655|NCT03562663|19928936|P1|NOT COMPLETED|Overall Study||7
8082656|NCT03562663|19928935|P2|COMPLETED|Overall Study||35
8082657|NCT03562663|19928936|P1|COMPLETED|Overall Study||34
8082658|NCT03562663|19928935|P2|STARTED|Overall Study||41
8082659|NCT03562663|19928936|P1|STARTED|Overall Study||41
8082660|NCT03562559|19928942|P1|NOT COMPLETED|Overall Study||0
8082661|NCT03562559|19928942|P1|COMPLETED|Overall Study||40
8082662|NCT03562559|19928942|P1|STARTED|Overall Study||40
8082663|NCT03562481|19928948|P2|NOT COMPLETED|Second Intervention||0
8082664|NCT03562481|19928949|P1|NOT COMPLETED|Second Intervention||0
8082665|NCT03562481|19928948|P2|COMPLETED|Second Intervention||14
8082666|NCT03562481|19928949|P1|COMPLETED|Second Intervention||11
8082667|NCT03562481|19928948|P2|STARTED|Second Intervention||14
8082668|NCT03562481|19928949|P1|STARTED|Second Intervention||11
8082669|NCT03562481|19928948|P2|NOT COMPLETED|Washout||0
8082670|NCT03562481|19928949|P1|NOT COMPLETED|Washout||0
8082671|NCT03562481|19928948|P2|COMPLETED|Washout||14
8082672|NCT03562481|19928949|P1|COMPLETED|Washout||11
8082673|NCT03562481|19928948|P2|STARTED|Washout||14
8082674|NCT03562481|19928949|P1|STARTED|Washout||11
8082675|NCT03562481|19928948|P2|NOT COMPLETED|First Intervention||0
8082676|NCT03562481|19928949|P1|NOT COMPLETED|First Intervention||1
8082677|NCT03562481|19928948|P2|COMPLETED|First Intervention||14
8082678|NCT03562481|19928949|P1|COMPLETED|First Intervention||11
8082679|NCT03562481|19928948|P2|STARTED|First Intervention||14
8082680|NCT03562481|19928949|P1|STARTED|First Intervention||12
8082681|NCT03562117|19928974|P3|NOT COMPLETED|Part 2, Up to 3 Days||0
8082682|NCT03562117|19928975|P2|NOT COMPLETED|Part 2, Up to 3 Days||0
8082683|NCT03562117|19928976|P1|NOT COMPLETED|Part 2, Up to 3 Days||0
8082684|NCT03562117|19928974|P3|COMPLETED|Part 2, Up to 3 Days||8
8082685|NCT03562117|19928975|P2|COMPLETED|Part 2, Up to 3 Days||0
8082686|NCT03562117|19928976|P1|COMPLETED|Part 2, Up to 3 Days||8
8082687|NCT03562117|19928974|P3|STARTED|Part 2, Up to 3 Days||8
8082688|NCT03562117|19928975|P2|STARTED|Part 2, Up to 3 Days||0
8082689|NCT03562117|19928976|P1|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
8082690|NCT03562117|19928974|P3|NOT COMPLETED|Part 1, Up to 3 Days||0
8082691|NCT03562117|19928975|P2|NOT COMPLETED|Part 1, Up to 3 Days||0
8082692|NCT03562117|19928976|P1|NOT COMPLETED|Part 1, Up to 3 Days||1
8082693|NCT03562117|19928974|P3|COMPLETED|Part 1, Up to 3 Days||0
8082694|NCT03562117|19928975|P2|COMPLETED|Part 1, Up to 3 Days||8
8082695|NCT03562117|19928976|P1|COMPLETED|Part 1, Up to 3 Days||7
8082696|NCT03562117|19928974|P3|STARTED|Part 1, Up to 3 Days||0
8082697|NCT03562117|19928975|P2|STARTED|Part 1, Up to 3 Days||8
8082698|NCT03562117|19928976|P1|STARTED|Part 1, Up to 3 Days||8
8082699|NCT03560986|19929064|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
8082700|NCT03560986|19929065|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
8082701|NCT03560986|19929064|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
8082702|NCT03560986|19929065|P1|COMPLETED|Treatment Period B/Follow-up Period 2||1
8082703|NCT03560986|19929064|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
8082704|NCT03560986|19929065|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
8082705|NCT03560986|19929064|P2|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
8082706|NCT03560986|19929065|P1|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
8082707|NCT03560986|19929064|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
8082708|NCT03560986|19929065|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
8082709|NCT03560986|19929064|P2|COMPLETED|Treatment Period A/Follow-up Period 1||13
8082710|NCT03560986|19929065|P1|COMPLETED|Treatment Period A/Follow-up Period 1||12
8082711|NCT03560986|19929064|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
8082712|NCT03560986|19929065|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
8082713|NCT03560986|19929064|P2|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
8082714|NCT03560986|19929065|P1|STARTED|Treatment Period A/Follow-up Period 1||48
8082715|NCT03560869|19929087|P2|NOT COMPLETED|Overall Study||9
8082716|NCT03560869|19929088|P1|NOT COMPLETED|Overall Study||7
8082717|NCT03560869|19929087|P2|COMPLETED|Overall Study||12
8082718|NCT03560869|19929088|P1|COMPLETED|Overall Study||7
8082719|NCT03560869|19929087|P2|STARTED|Overall Study||21
8082720|NCT03560869|19929088|P1|STARTED|Overall Study||14
8082721|NCT03560739|19929100|P4|NOT COMPLETED|Overall Study||0
8082722|NCT03560739|19929101|P3|NOT COMPLETED|Overall Study||0
8082723|NCT03560739|19929102|P2|NOT COMPLETED|Overall Study||1
8082724|NCT03560739|19929103|P1|NOT COMPLETED|Overall Study||0
8082725|NCT03560739|19929100|P4|COMPLETED|Overall Study||13
8082726|NCT03560739|19929101|P3|COMPLETED|Overall Study||13
8082727|NCT03560739|19929102|P2|COMPLETED|Overall Study||129
8082728|NCT03560739|19929103|P1|COMPLETED|Overall Study||128
8082729|NCT03560739|19929100|P4|STARTED|Overall Study||13
8082730|NCT03560739|19929101|P3|STARTED|Overall Study||13
8082731|NCT03560739|19929102|P2|STARTED|Overall Study||130
8082732|NCT03560739|19929103|P1|STARTED|Overall Study||128
8082733|NCT03560518|19929132|P3|NOT COMPLETED|Safety Follow-Up Period||0
8082734|NCT03560518|19929133|P2|NOT COMPLETED|Safety Follow-Up Period||0
8082735|NCT03560518|19929134|P1|NOT COMPLETED|Safety Follow-Up Period||0
8082736|NCT03560518|19929132|P3|COMPLETED|Safety Follow-Up Period||22
8082737|NCT03560518|19929133|P2|COMPLETED|Safety Follow-Up Period||17
8082738|NCT03560518|19929134|P1|COMPLETED|Safety Follow-Up Period||10
8082739|NCT03560518|19929132|P3|STARTED|Safety Follow-Up Period||22
8082740|NCT03560518|19929133|P2|STARTED|Safety Follow-Up Period||17
8082741|NCT03560518|19929134|P1|STARTED|Safety Follow-Up Period||10
8082742|NCT03560518|19929132|P3|NOT COMPLETED|Double Blind Treatment Period||23
8082743|NCT03560518|19929133|P2|NOT COMPLETED|Double Blind Treatment Period||29
8082744|NCT03560518|19929134|P1|NOT COMPLETED|Double Blind Treatment Period||25
8082745|NCT03560518|19929132|P3|COMPLETED|Double Blind Treatment Period||124
8082746|NCT03560518|19929133|P2|COMPLETED|Double Blind Treatment Period||116
8082747|NCT03560518|19929134|P1|COMPLETED|Double Blind Treatment Period||122
8082748|NCT03560518|19929132|P3|STARTED|Double Blind Treatment Period||147
8082749|NCT03560518|19929133|P2|STARTED|Double Blind Treatment Period||145
8082750|NCT03560518|19929134|P1|STARTED|Double Blind Treatment Period||147
8082751|NCT03560245|19929147|P2|NOT COMPLETED|Overall Study||7
8082752|NCT03560245|19929148|P1|NOT COMPLETED|Overall Study||5
8082753|NCT03560245|19929147|P2|COMPLETED|Overall Study||48
8082754|NCT03560245|19929148|P1|COMPLETED|Overall Study||48
8082755|NCT03560245|19929147|P2|STARTED|Overall Study||55
8082756|NCT03560245|19929148|P1|STARTED|Overall Study||53
8082757|NCT03560128|19929166|P2|NOT COMPLETED|Overall Study||8
8082758|NCT03560128|19929167|P1|NOT COMPLETED|Overall Study||12
8082759|NCT03560128|19929166|P2|COMPLETED|Overall Study||298
8082760|NCT03560128|19929167|P1|COMPLETED|Overall Study||294
8082761|NCT03560128|19929166|P2|STARTED|Overall Study||306
8082762|NCT03560128|19929167|P1|STARTED|Overall Study||306
8082763|NCT03559829|19929187|P1|NOT COMPLETED|Overall Study||0
8082764|NCT03559829|19929187|P1|COMPLETED|Overall Study||20
8082765|NCT03559829|19929187|P1|STARTED|Overall Study||20
8082766|NCT03559257|19929202|P2|NOT COMPLETED|Open-label Treatment Period||7
8082767|NCT03559257|19929203|P1|NOT COMPLETED|Open-label Treatment Period||10
8082768|NCT03559257|19929202|P2|COMPLETED|Open-label Treatment Period||217
8082769|NCT03559257|19929203|P1|COMPLETED|Open-label Treatment Period||215
8082770|NCT03559257|19929202|P2|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
8082771|NCT03559257|19929203|P1|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
8082772|NCT03559257|19929202|P2|NOT COMPLETED|Double Blind Treatment Period||8
8082773|NCT03559257|19929203|P1|NOT COMPLETED|Double Blind Treatment Period||4
8082774|NCT03559257|19929202|P2|COMPLETED|Double Blind Treatment Period||225
8082775|NCT03559257|19929203|P1|COMPLETED|Double Blind Treatment Period||226
8082776|NCT03559257|19929202|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
8082777|NCT03559257|19929203|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
8082778|NCT03559257|19929202|P2|STARTED|Double Blind Treatment Period||233
8082779|NCT03559257|19929203|P1|STARTED|Double Blind Treatment Period||230
8082780|NCT03559179|19929250|P3|NOT COMPLETED|Overall Study||0
8082781|NCT03559179|19929251|P2|NOT COMPLETED|Overall Study||1
8082782|NCT03559179|19929252|P1|NOT COMPLETED|Overall Study||0
8082783|NCT03559179|19929250|P3|COMPLETED|Overall Study||23
8082784|NCT03559179|19929251|P2|COMPLETED|Overall Study||23
8082785|NCT03559179|19929252|P1|COMPLETED|Overall Study||8
8082786|NCT03559179|19929250|P3|STARTED|Overall Study||23
8082787|NCT03559179|19929251|P2|STARTED|Overall Study||24
8082788|NCT03559179|19929252|P1|STARTED|Overall Study||8
8082789|NCT03559062|19929273|P3|NOT COMPLETED|Overall Study||0
8082790|NCT03559062|19929274|P2|NOT COMPLETED|Overall Study||1
8082791|NCT03559062|19929275|P1|NOT COMPLETED|Overall Study||0
8082792|NCT03559062|19929273|P3|COMPLETED|Overall Study||3
8082793|NCT03559062|19929274|P2|COMPLETED|Overall Study||53
8082794|NCT03559062|19929275|P1|COMPLETED|Overall Study||10
8082795|NCT03559062|19929273|P3|STARTED|Overall Study||3
8082796|NCT03559062|19929274|P2|STARTED|Overall Study||54
8082797|NCT03559062|19929275|P1|STARTED|Overall Study||10
8082798|NCT03558997|19929290|P4|NOT COMPLETED|Overall Study||2
8082799|NCT03558997|19929291|P3|NOT COMPLETED|Overall Study||8
8082800|NCT03558997|19929292|P2|NOT COMPLETED|Overall Study||2
8082801|NCT03558997|19929293|P1|NOT COMPLETED|Overall Study||1
8082802|NCT03558997|19929290|P4|COMPLETED|Overall Study||24
8082803|NCT03558997|19929291|P3|COMPLETED|Overall Study||18
8082804|NCT03558997|19929292|P2|COMPLETED|Overall Study||24
8082805|NCT03558997|19929293|P1|COMPLETED|Overall Study||24
8082806|NCT03558997|19929290|P4|STARTED|Overall Study||26
8082807|NCT03558997|19929291|P3|STARTED|Overall Study||26
8082808|NCT03558997|19929292|P2|STARTED|Overall Study||26
8082809|NCT03558997|19929293|P1|STARTED|Overall Study||25
8082810|NCT03558672|19929325|P1|NOT COMPLETED|Overall Study||10
8082811|NCT03558672|19929325|P1|COMPLETED|Overall Study||8
8082812|NCT03558672|19929325|P1|STARTED|Overall Study||18
8082813|NCT03558555|19929337|P2|NOT COMPLETED|Overall Study||1
8082814|NCT03558555|19929338|P1|NOT COMPLETED|Overall Study||2
8082815|NCT03558555|19929337|P2|COMPLETED|Overall Study||44
8082816|NCT03558555|19929338|P1|COMPLETED|Overall Study||56
8082817|NCT03558555|19929337|P2|STARTED|Overall Study||45
8082818|NCT03558555|19929338|P1|STARTED|Overall Study||58
8082819|NCT03558516|19929356|P2|NOT COMPLETED|Overall Study||2
8082820|NCT03558516|19929357|P1|NOT COMPLETED|Overall Study||2
8082821|NCT03558516|19929356|P2|COMPLETED|Overall Study||38
8082822|NCT03558516|19929357|P1|COMPLETED|Overall Study||38
8082823|NCT03558516|19929356|P2|STARTED|Overall Study||40
8082824|NCT03558516|19929357|P1|STARTED|Overall Study||40
8082825|NCT03558230|19929377|P2|NOT COMPLETED|Overall Study||0
8082826|NCT03558230|19929378|P1|NOT COMPLETED|Overall Study||0
8082827|NCT03558230|19929377|P2|COMPLETED|Overall Study||6
8082828|NCT03558230|19929378|P1|COMPLETED|Overall Study||7
8082829|NCT03558230|19929377|P2|STARTED|Overall Study||6
8082830|NCT03558230|19929378|P1|STARTED|Overall Study||7
8082831|NCT03558074|19929384|P1|NOT COMPLETED|Overall Study||2
8082832|NCT03558074|19929384|P1|COMPLETED|Overall Study||24
8082833|NCT03558074|19929384|P1|STARTED|Overall Study||26
8082834|NCT03558061|19929389|P1|NOT COMPLETED|Overall Study||1
8082835|NCT03558061|19929389|P1|COMPLETED|Overall Study||29
8082836|NCT03558061|19929389|P1|STARTED|Overall Study||30
8082837|NCT03557931|19929397|P3|NOT COMPLETED|Overall Study||13
8082838|NCT03557931|19929398|P2|NOT COMPLETED|Overall Study||19
8082839|NCT03557931|19929399|P1|NOT COMPLETED|Overall Study||31
8082840|NCT03557931|19929397|P3|COMPLETED|Overall Study||55
8082841|NCT03557931|19929398|P2|COMPLETED|Overall Study||46
8082842|NCT03557931|19929399|P1|COMPLETED|Overall Study||69
8082843|NCT03557931|19929397|P3|STARTED|Overall Study||68
8082844|NCT03557931|19929398|P2|STARTED|Overall Study||65
8082845|NCT03557931|19929399|P1|STARTED|Overall Study||100
8082846|NCT03557801|19929430|P3|NOT COMPLETED|Overall Study||3
8082847|NCT03557801|19929431|P2|NOT COMPLETED|Overall Study||1
8082848|NCT03557801|19929432|P1|NOT COMPLETED|Overall Study||2
8082849|NCT03557801|19929430|P3|COMPLETED|Overall Study||30
8082850|NCT03557801|19929431|P2|COMPLETED|Overall Study||32
8082851|NCT03557801|19929432|P1|COMPLETED|Overall Study||32
8082852|NCT03557801|19929430|P3|STARTED|Overall Study||33
8082853|NCT03557801|19929431|P2|STARTED|Overall Study||33
8082854|NCT03557801|19929432|P1|STARTED|Overall Study||34
8082855|NCT03557775|19929449|P3|NOT COMPLETED|Overall Study||4
8082856|NCT03557775|19929450|P2|NOT COMPLETED|Overall Study||3
8082857|NCT03557775|19929451|P1|NOT COMPLETED|Overall Study||1
8082858|NCT03557775|19929449|P3|COMPLETED|Overall Study||4
8082859|NCT03557775|19929450|P2|COMPLETED|Overall Study||4
8082860|NCT03557775|19929451|P1|COMPLETED|Overall Study||4
8082861|NCT03557775|19929449|P3|STARTED|Overall Study||8
8082862|NCT03557775|19929450|P2|STARTED|Overall Study||7
8082863|NCT03557775|19929451|P1|STARTED|Overall Study||5
8082864|NCT03557476|19929509|P2|NOT COMPLETED|Overall Study||0
8082865|NCT03557476|19929510|P1|NOT COMPLETED|Overall Study||0
8082866|NCT03557476|19929509|P2|COMPLETED|Overall Study||13
8082867|NCT03557476|19929510|P1|COMPLETED|Overall Study||13
8082868|NCT03557476|19929509|P2|STARTED|Overall Study||13
8082869|NCT03557476|19929510|P1|STARTED|Overall Study||13
8082870|NCT03556761|19929530|P2|NOT COMPLETED|Overall Study||29
8082871|NCT03556761|19929531|P1|NOT COMPLETED|Overall Study||24
8082872|NCT03556761|19929530|P2|COMPLETED|Overall Study||163
8082873|NCT03556761|19929531|P1|COMPLETED|Overall Study||168
8082874|NCT03556761|19929530|P2|STARTED|Overall Study||192
8082875|NCT03556761|19929531|P1|STARTED|Overall Study||192
8082876|NCT03556579|19929551|P4|NOT COMPLETED|Visit 2||0
8082877|NCT03556579|19929552|P3|NOT COMPLETED|Visit 2||0
8082878|NCT03556579|19929553|P2|NOT COMPLETED|Visit 2||0
8082879|NCT03556579|19929554|P1|NOT COMPLETED|Visit 2||0
8082880|NCT03556579|19929551|P4|COMPLETED|Visit 2||16
8082881|NCT03556579|19929552|P3|COMPLETED|Visit 2||14
8082882|NCT03556579|19929553|P2|COMPLETED|Visit 2||14
8082883|NCT03556579|19929554|P1|COMPLETED|Visit 2||16
8082884|NCT03556579|19929551|P4|STARTED|Visit 2||16
8082885|NCT03556579|19929552|P3|STARTED|Visit 2||14
8082886|NCT03556579|19929553|P2|STARTED|Visit 2||14
8082887|NCT03556579|19929554|P1|STARTED|Visit 2||16
8082888|NCT03556579|19929551|P4|NOT COMPLETED|Visit 1||0
8082889|NCT03556579|19929552|P3|NOT COMPLETED|Visit 1||0
8082890|NCT03556579|19929553|P2|NOT COMPLETED|Visit 1||0
8082891|NCT03556579|19929554|P1|NOT COMPLETED|Visit 1||0
8082892|NCT03556579|19929551|P4|COMPLETED|Visit 1||16
8082893|NCT03556579|19929552|P3|COMPLETED|Visit 1||14
8082894|NCT03556579|19929553|P2|COMPLETED|Visit 1||14
8082895|NCT03556579|19929554|P1|COMPLETED|Visit 1||16
8082896|NCT03556579|19929551|P4|STARTED|Visit 1||16
8082897|NCT03556579|19929552|P3|STARTED|Visit 1||14
8082898|NCT03556579|19929553|P2|STARTED|Visit 1||14
8082899|NCT03556579|19929554|P1|STARTED|Visit 1||16
8082900|NCT03555890|19929582|P4|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082901|NCT03555890|19929583|P3|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082902|NCT03555890|19929584|P2|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082903|NCT03555890|19929585|P1|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082904|NCT03555890|19929582|P4|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
8082905|NCT03555890|19929583|P3|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
8082906|NCT03555890|19929584|P2|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082907|NCT03555890|19929585|P1|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082908|NCT03555890|19929582|P4|STARTED|Part 2:Treatment Period 2 (10 Days)||23
8082909|NCT03555890|19929583|P3|STARTED|Part 2:Treatment Period 2 (10 Days)||24
8082910|NCT03555890|19929584|P2|STARTED|Part 2:Treatment Period 2 (10 Days)||0
8082911|NCT03555890|19929585|P1|STARTED|Part 2:Treatment Period 2 (10 Days)||0
8082912|NCT03555890|19929582|P4|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
8082913|NCT03555890|19929583|P3|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082914|NCT03555890|19929584|P2|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082915|NCT03555890|19929585|P1|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082916|NCT03555890|19929582|P4|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
8082917|NCT03555890|19929583|P3|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
8082918|NCT03555890|19929584|P2|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082919|NCT03555890|19929585|P1|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082920|NCT03555890|19929582|P4|STARTED|Part 2:Washout Period (at Least 5 Days)||24
8082921|NCT03555890|19929583|P3|STARTED|Part 2:Washout Period (at Least 5 Days)||24
8082922|NCT03555890|19929584|P2|STARTED|Part 2:Washout Period (at Least 5 Days)||0
8082923|NCT03555890|19929585|P1|STARTED|Part 2:Washout Period (at Least 5 Days)||0
8082924|NCT03555890|19929582|P4|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082925|NCT03555890|19929583|P3|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082926|NCT03555890|19929584|P2|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082927|NCT03555890|19929585|P1|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082928|NCT03555890|19929582|P4|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
8082929|NCT03555890|19929583|P3|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
8082930|NCT03555890|19929584|P2|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082931|NCT03555890|19929585|P1|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082932|NCT03555890|19929582|P4|STARTED|Part 2:Treatment Period 1 (3 Days)||24
8082933|NCT03555890|19929583|P3|STARTED|Part 2:Treatment Period 1 (3 Days)||24
8082934|NCT03555890|19929584|P2|STARTED|Part 2:Treatment Period 1 (3 Days)||0
8082935|NCT03555890|19929585|P1|STARTED|Part 2:Treatment Period 1 (3 Days)||0
8082936|NCT03555890|19929582|P4|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082937|NCT03555890|19929583|P3|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082938|NCT03555890|19929584|P2|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082939|NCT03555890|19929585|P1|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082940|NCT03555890|19929582|P4|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082941|NCT03555890|19929583|P3|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082942|NCT03555890|19929584|P2|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
8082943|NCT03555890|19929585|P1|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
8082944|NCT03555890|19929582|P4|STARTED|Part 1:Treatment Period 2 (10 Days)||0
8082945|NCT03555890|19929583|P3|STARTED|Part 1:Treatment Period 2 (10 Days)||0
8082946|NCT03555890|19929584|P2|STARTED|Part 1:Treatment Period 2 (10 Days)||12
8082947|NCT03555890|19929585|P1|STARTED|Part 1:Treatment Period 2 (10 Days)||12
8082948|NCT03555890|19929582|P4|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082949|NCT03555890|19929583|P3|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082950|NCT03555890|19929584|P2|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082951|NCT03555890|19929585|P1|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082952|NCT03555890|19929582|P4|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082953|NCT03555890|19929583|P3|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082954|NCT03555890|19929584|P2|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
8082955|NCT03555890|19929585|P1|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
8082956|NCT03555890|19929582|P4|STARTED|Part 1:Washout Period (at Least 5 Days)||0
8082957|NCT03555890|19929583|P3|STARTED|Part 1:Washout Period (at Least 5 Days)||0
8082958|NCT03555890|19929584|P2|STARTED|Part 1:Washout Period (at Least 5 Days)||12
8082959|NCT03555890|19929585|P1|STARTED|Part 1:Washout Period (at Least 5 Days)||12
8082960|NCT03555890|19929582|P4|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082961|NCT03555890|19929583|P3|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082962|NCT03555890|19929584|P2|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082963|NCT03555890|19929585|P1|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082964|NCT03555890|19929582|P4|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082965|NCT03555890|19929583|P3|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082966|NCT03555890|19929584|P2|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
8082967|NCT03555890|19929585|P1|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
8082968|NCT03555890|19929582|P4|STARTED|Part 1:Treatment Period 1 (3 Days)||0
8082969|NCT03555890|19929583|P3|STARTED|Part 1:Treatment Period 1 (3 Days)||0
8082970|NCT03555890|19929584|P2|STARTED|Part 1:Treatment Period 1 (3 Days)||12
8082971|NCT03555890|19929585|P1|STARTED|Part 1:Treatment Period 1 (3 Days)||12
8082972|NCT03555565|19929719|P1|NOT COMPLETED|Overall Study||15
8082973|NCT03555565|19929719|P1|COMPLETED|Overall Study||1011
8082974|NCT03555565|19929719|P1|STARTED|Overall Study||1026
8082975|NCT03555435|19929729|P3|NOT COMPLETED|Overall Study||8
8082976|NCT03555435|19929730|P2|NOT COMPLETED|Overall Study||19
8082977|NCT03555435|19929731|P1|NOT COMPLETED|Overall Study||17
8082978|NCT03555435|19929729|P3|COMPLETED|Overall Study||18
8082979|NCT03555435|19929730|P2|COMPLETED|Overall Study||8
8082980|NCT03555435|19929731|P1|COMPLETED|Overall Study||11
8082981|NCT03555435|19929729|P3|STARTED|Overall Study||26
8082982|NCT03555435|19929730|P2|STARTED|Overall Study||27
8082983|NCT03555435|19929731|P1|STARTED|Overall Study||28
8082984|NCT03555305|19929742|P2|NOT COMPLETED|Period 2||0
8082985|NCT03555305|19929743|P1|NOT COMPLETED|Period 2||0
8082986|NCT03555305|19929742|P2|COMPLETED|Period 2||27
8082987|NCT03555305|19929743|P1|COMPLETED|Period 2||29
8082988|NCT03555305|19929742|P2|STARTED|Period 2||27
8082989|NCT03555305|19929743|P1|STARTED|Period 2||29
8082990|NCT03555305|19929742|P2|NOT COMPLETED|Period 1||2
8082991|NCT03555305|19929743|P1|NOT COMPLETED|Period 1||0
8082992|NCT03555305|19929742|P2|COMPLETED|Period 1||27
8082993|NCT03555305|19929743|P1|COMPLETED|Period 1||29
8082994|NCT03555305|19929742|P2|Received at Least 1 Dose of Study Drug|Period 1||29
8082995|NCT03555305|19929743|P1|Received at Least 1 Dose of Study Drug|Period 1||29
8082996|NCT03555305|19929742|P2|STARTED|Period 1||29
8082997|NCT03555305|19929743|P1|STARTED|Period 1||29
8082998|NCT03554954|19929755|P1|NOT COMPLETED|Overall Study||0
8082999|NCT03554954|19929755|P1|COMPLETED|Overall Study||108
8083000|NCT03554954|19929755|P1|STARTED|Overall Study||108
8083001|NCT03554772|19929810|P4|NOT COMPLETED|Overall Study||2
8083002|NCT03554772|19929811|P3|NOT COMPLETED|Overall Study||0
8083003|NCT03554772|19929812|P2|NOT COMPLETED|Overall Study||0
8083004|NCT03554772|19929813|P1|NOT COMPLETED|Overall Study||0
8083005|NCT03554772|19929810|P4|COMPLETED|Overall Study||29
8083006|NCT03554772|19929811|P3|COMPLETED|Overall Study||29
8083007|NCT03554772|19929812|P2|COMPLETED|Overall Study||30
8083008|NCT03554772|19929813|P1|COMPLETED|Overall Study||30
8083009|NCT03554772|19929810|P4|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
8083010|NCT03554772|19929811|P3|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
8083011|NCT03554772|19929812|P2|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
8083012|NCT03554772|19929813|P1|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
8083013|NCT03554772|19929810|P4|STARTED|Overall Study||31
8083014|NCT03554772|19929811|P3|STARTED|Overall Study||29
8083015|NCT03554772|19929812|P2|STARTED|Overall Study||30
8083016|NCT03554772|19929813|P1|STARTED|Overall Study||30
8083017|NCT03554746|19929825|P2|NOT COMPLETED|Overall Study||0
8083018|NCT03554746|19929826|P1|NOT COMPLETED|Overall Study||0
8083019|NCT03554746|19929825|P2|COMPLETED|Overall Study||24
8083020|NCT03554746|19929826|P1|COMPLETED|Overall Study||24
8083021|NCT03554746|19929825|P2|STARTED|Overall Study||24
8083022|NCT03554746|19929826|P1|STARTED|Overall Study||24
8083023|NCT03554629|19929842|P1|NOT COMPLETED|Overall Study||6
8083024|NCT03554629|19929842|P1|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
8083025|NCT03554629|19929842|P1|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
8083026|NCT03554005|19929876|P6|NOT COMPLETED|Overall Study||11
8083027|NCT03554005|19929877|P5|NOT COMPLETED|Overall Study||6
8083028|NCT03554005|19929878|P4|NOT COMPLETED|Overall Study||1
8083029|NCT03554005|19929879|P3|NOT COMPLETED|Overall Study||1
8083030|NCT03554005|19929880|P2|NOT COMPLETED|Overall Study||1
8083031|NCT03554005|19929881|P1|NOT COMPLETED|Overall Study||1
8083032|NCT03554005|19929876|P6|COMPLETED|Overall Study||0
8083033|NCT03554005|19929877|P5|COMPLETED|Overall Study||5
8083034|NCT03554005|19929878|P4|COMPLETED|Overall Study||1
8083035|NCT03554005|19929879|P3|COMPLETED|Overall Study||1
8083036|NCT03554005|19929880|P2|COMPLETED|Overall Study||1
8083037|NCT03554005|19929881|P1|COMPLETED|Overall Study||0
8083038|NCT03554005|19929876|P6|STARTED|Overall Study||11
8083039|NCT03554005|19929877|P5|STARTED|Overall Study||11
8083040|NCT03554005|19929878|P4|STARTED|Overall Study||2
8083041|NCT03554005|19929879|P3|STARTED|Overall Study||2
8083042|NCT03554005|19929880|P2|STARTED|Overall Study||2
8083043|NCT03554005|19929881|P1|STARTED|Overall Study||1
8083044|NCT03553758|19929907|P1|NOT COMPLETED|Overall Study||1
8083045|NCT03553758|19929907|P1|COMPLETED|Overall Study||15
8083046|NCT03553758|19929907|P1|Completed Screening Visit|Overall Study||16
8083047|NCT03553758|19929907|P1|STARTED|Overall Study||16
8083048|NCT03552549|19929915|P2|NOT COMPLETED|Overall Study||52
8083049|NCT03552549|19929916|P1|NOT COMPLETED|Overall Study||53
8083050|NCT03552549|19929915|P2|COMPLETED|Overall Study||11
8083051|NCT03552549|19929916|P1|COMPLETED|Overall Study||10
8083052|NCT03552549|19929915|P2|Treated|Overall Study||62
8083053|NCT03552549|19929916|P1|Treated|Overall Study||62
8083054|NCT03552549|19929915|P2|STARTED|Overall Study||63
8083055|NCT03552549|19929916|P1|STARTED|Overall Study||63
8083056|NCT03552536|19929927|P3|NOT COMPLETED|Overall Study||0
8083057|NCT03552536|19929928|P2|NOT COMPLETED|Overall Study||0
8083058|NCT03552536|19929929|P1|NOT COMPLETED|Overall Study||0
8083059|NCT03552536|19929927|P3|COMPLETED|Overall Study||0
8083060|NCT03552536|19929928|P2|COMPLETED|Overall Study||0
8083061|NCT03552536|19929929|P1|COMPLETED|Overall Study||5
8083062|NCT03552536|19929927|P3|STARTED|Overall Study||0
8083063|NCT03552536|19929928|P2|STARTED|Overall Study||0
8083064|NCT03552536|19929929|P1|STARTED|Overall Study||5
8083065|NCT03552523|19929954|P2|NOT COMPLETED|Overall Study||1
8083066|NCT03552523|19929955|P1|NOT COMPLETED|Overall Study||1
8083067|NCT03552523|19929954|P2|COMPLETED|Overall Study||1
8083068|NCT03552523|19929955|P1|COMPLETED|Overall Study||4
8083069|NCT03552523|19929954|P2|STARTED|Overall Study||2
8083070|NCT03552523|19929955|P1|STARTED|Overall Study||5
8083071|NCT03552289|19929965|P2|NOT COMPLETED|Overall Study||3
8083072|NCT03552289|19929966|P1|NOT COMPLETED|Overall Study||1
8083073|NCT03552289|19929965|P2|COMPLETED|Overall Study||106
8083074|NCT03552289|19929966|P1|COMPLETED|Overall Study||101
8083075|NCT03552289|19929965|P2|STARTED|Overall Study||109
8083076|NCT03552289|19929966|P1|STARTED|Overall Study||102
8083077|NCT03551821|19929972|P1|NOT COMPLETED|Overall Study||0
8083078|NCT03551821|19929972|P1|COMPLETED|Overall Study||1
8083079|NCT03551821|19929972|P1|STARTED|Overall Study||1
8083080|NCT03551743|19929981|P4|NOT COMPLETED|Overall Study||0
8083081|NCT03551743|19929982|P3|NOT COMPLETED|Overall Study||0
8083082|NCT03551743|19929983|P2|NOT COMPLETED|Overall Study||0
8083083|NCT03551743|19929984|P1|NOT COMPLETED|Overall Study||2
8083084|NCT03551743|19929981|P4|COMPLETED|Overall Study||6
8083085|NCT03551743|19929982|P3|COMPLETED|Overall Study||6
8083086|NCT03551743|19929983|P2|COMPLETED|Overall Study||6
8083087|NCT03551743|19929984|P1|COMPLETED|Overall Study||8
8083088|NCT03551743|19929981|P4|STARTED|Overall Study||6
8083089|NCT03551743|19929982|P3|STARTED|Overall Study||6
8083090|NCT03551743|19929983|P2|STARTED|Overall Study||6
8083091|NCT03551743|19929984|P1|STARTED|Overall Study||10
8083092|NCT03551730|19930030|P4|NOT COMPLETED|Overall Study||0
8083093|NCT03551730|19930031|P3|NOT COMPLETED|Overall Study||0
8083094|NCT03551730|19930032|P2|NOT COMPLETED|Overall Study||0
8083095|NCT03551730|19930033|P1|NOT COMPLETED|Overall Study||1
8083096|NCT03551730|19930030|P4|COMPLETED|Overall Study||6
8083097|NCT03551730|19930031|P3|COMPLETED|Overall Study||6
8083098|NCT03551730|19930032|P2|COMPLETED|Overall Study||6
8083099|NCT03551730|19930033|P1|COMPLETED|Overall Study||8
8083100|NCT03551730|19930030|P4|STARTED|Overall Study||6
8083101|NCT03551730|19930031|P3|STARTED|Overall Study||6
8083102|NCT03551730|19930032|P2|STARTED|Overall Study||6
8083103|NCT03551730|19930033|P1|STARTED|Overall Study||9
8083104|NCT03550989|19930075|P4|NOT COMPLETED|Overall Study||0
8083105|NCT03550989|19930076|P3|NOT COMPLETED|Overall Study||1
8083106|NCT03550989|19930077|P2|NOT COMPLETED|Overall Study||1
8083107|NCT03550989|19930078|P1|NOT COMPLETED|Overall Study||2
8083108|NCT03550989|19930075|P4|COMPLETED|Overall Study||60
8083109|NCT03550989|19930076|P3|COMPLETED|Overall Study||76
8083110|NCT03550989|19930077|P2|COMPLETED|Overall Study||73
8083111|NCT03550989|19930078|P1|COMPLETED|Overall Study||188
8083112|NCT03550989|19930075|P4|STARTED|Overall Study||60
8083113|NCT03550989|19930076|P3|STARTED|Overall Study||77
8083114|NCT03550989|19930077|P2|STARTED|Overall Study||74
8083115|NCT03550989|19930078|P1|STARTED|Overall Study||190
8083116|NCT03550378|19930155|P2|NOT COMPLETED|Overall Study||1
8083117|NCT03550378|19930156|P1|NOT COMPLETED|Overall Study||0
8083118|NCT03550378|19930155|P2|COMPLETED|Overall Study||20
8083119|NCT03550378|19930156|P1|COMPLETED|Overall Study||20
8083120|NCT03550378|19930155|P2|STARTED|Overall Study||21
8083121|NCT03550378|19930156|P1|STARTED|Overall Study||20
8083122|NCT03550066|19930196|P2|NOT COMPLETED|Overall Study||0
8083123|NCT03550066|19930197|P1|NOT COMPLETED|Overall Study||0
8083124|NCT03550066|19930196|P2|COMPLETED|Overall Study||41
8083125|NCT03550066|19930197|P1|COMPLETED|Overall Study||49
8083126|NCT03550066|19930196|P2|STARTED|Overall Study||41
8083127|NCT03550066|19930197|P1|STARTED|Overall Study||49
8083128|NCT03549598|19930207|P1|NOT COMPLETED|Overall Study||0
8083129|NCT03549598|19930207|P1|COMPLETED|Overall Study||15
8083130|NCT03549598|19930207|P1|STARTED|Overall Study||15
8083131|NCT03549429|19930219|P2|NOT COMPLETED|Overall Study||3
8083132|NCT03549429|19930220|P1|NOT COMPLETED|Overall Study||5
8083133|NCT03549429|19930219|P2|COMPLETED|Overall Study||75
8083134|NCT03549429|19930220|P1|COMPLETED|Overall Study||76
8083135|NCT03549429|19930219|P2|STARTED|Overall Study||78
8083136|NCT03549429|19930220|P1|STARTED|Overall Study||81
8083137|NCT03549338|19930233|P3|NOT COMPLETED|Overall Study||0
8083138|NCT03549338|19930234|P2|NOT COMPLETED|Overall Study||1
8083139|NCT03549338|19930235|P1|NOT COMPLETED|Overall Study||1
8083140|NCT03549338|19930233|P3|COMPLETED|Overall Study||0
8083141|NCT03549338|19930234|P2|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
8083142|NCT03549338|19930235|P1|COMPLETED|Overall Study||0
8083143|NCT03549338|19930233|P3|STARTED|Overall Study||0
8083144|NCT03549338|19930234|P2|STARTED|Overall Study||1
8083145|NCT03549338|19930235|P1|STARTED|Overall Study||1
8083146|NCT03549234|19930243|P2|NOT COMPLETED|Overall Study||0
8083147|NCT03549234|19930244|P1|NOT COMPLETED|Overall Study||0
8083148|NCT03549234|19930243|P2|COMPLETED|Overall Study||50
8083149|NCT03549234|19930244|P1|COMPLETED|Overall Study||50
8083150|NCT03549234|19930243|P2|STARTED|Overall Study||50
8083151|NCT03549234|19930244|P1|STARTED|Overall Study||50
8083152|NCT03549130|19930262|P2|NOT COMPLETED|Overall Study||2
8083153|NCT03549130|19930263|P1|NOT COMPLETED|Overall Study||0
8083154|NCT03549130|19930262|P2|COMPLETED|Overall Study||64
8083155|NCT03549130|19930263|P1|COMPLETED|Overall Study||64
8083156|NCT03549130|19930262|P2|STARTED|Overall Study||66
8083157|NCT03549130|19930263|P1|STARTED|Overall Study||64
8083158|NCT03549117|19930281|P2|NOT COMPLETED|Overall Study||0
8083159|NCT03549117|19930282|P1|NOT COMPLETED|Overall Study||1
8083160|NCT03549117|19930281|P2|COMPLETED|Overall Study||70
8083161|NCT03549117|19930282|P1|COMPLETED|Overall Study||69
8083162|NCT03549117|19930281|P2|STARTED|Overall Study||70
8083163|NCT03549117|19930282|P1|STARTED|Overall Study||70
8083164|NCT03548337|19930310|P2|NOT COMPLETED|Toddler Dose||1
8083165|NCT03548337|19930311|P1|NOT COMPLETED|Toddler Dose||1
8083166|NCT03548337|19930310|P2|COMPLETED|Toddler Dose||138
8083167|NCT03548337|19930311|P1|COMPLETED|Toddler Dose||138
8083168|NCT03548337|19930310|P2|Vaccination 4|Toddler Dose||139
8083169|NCT03548337|19930311|P1|Vaccination 4|Toddler Dose||139
8083170|NCT03548337|19930310|P2|STARTED|Toddler Dose||139
8083171|NCT03548337|19930311|P1|STARTED|Toddler Dose||139
8083172|NCT03548337|19930310|P2|NOT COMPLETED|Infant Series||11
8083173|NCT03548337|19930311|P1|NOT COMPLETED|Infant Series||12
8083174|NCT03548337|19930310|P2|COMPLETED|Infant Series||139
8083175|NCT03548337|19930311|P1|COMPLETED|Infant Series||139
8083176|NCT03548337|19930310|P2|Vaccination 3|Infant Series||141
8083177|NCT03548337|19930311|P1|Vaccination 3|Infant Series||144
8083178|NCT03548337|19930310|P2|Vaccination 2|Infant Series||144
8083179|NCT03548337|19930311|P1|Vaccination 2|Infant Series||144
8083180|NCT03548337|19930310|P2|Vaccination 1|Infant Series||150
8083181|NCT03548337|19930311|P1|Vaccination 1|Infant Series||150
8083182|NCT03548337|19930310|P2|STARTED|Infant Series||150
8083183|NCT03548337|19930311|P1|STARTED|Infant Series||151
8083184|NCT03547635|19930362|P3|NOT COMPLETED|Overall Study||8
8083185|NCT03547635|19930363|P2|NOT COMPLETED|Overall Study||7
8083186|NCT03547635|19930364|P1|NOT COMPLETED|Overall Study||8
8083187|NCT03547635|19930362|P3|COMPLETED|Overall Study||29
8083188|NCT03547635|19930363|P2|COMPLETED|Overall Study||31
8083189|NCT03547635|19930364|P1|COMPLETED|Overall Study||33
8083190|NCT03547635|19930362|P3|STARTED|Overall Study||37
8083191|NCT03547635|19930363|P2|STARTED|Overall Study||38
8083192|NCT03547635|19930364|P1|STARTED|Overall Study||41
8083193|NCT03547583|19930375|P3|NOT COMPLETED|Overall Study||32
8083194|NCT03547583|19930376|P2|NOT COMPLETED|Overall Study||40
8083195|NCT03547583|19930377|P1|NOT COMPLETED|Overall Study||45
8083196|NCT03547583|19930375|P3|COMPLETED|Overall Study||230
8083197|NCT03547583|19930376|P2|COMPLETED|Overall Study||224
8083198|NCT03547583|19930377|P1|COMPLETED|Overall Study||218
8083199|NCT03547583|19930375|P3|Treated|Overall Study||262
8083200|NCT03547583|19930376|P2|Treated|Overall Study||264
8083201|NCT03547583|19930377|P1|Treated|Overall Study||262
8083202|NCT03547583|19930375|P3|STARTED|Overall Study||262
8083203|NCT03547583|19930376|P2|STARTED|Overall Study||264
8083204|NCT03547583|19930377|P1|STARTED|Overall Study||263
8083205|NCT03547531|19930393|P2|NOT COMPLETED|Overall Study||4
8083206|NCT03547531|19930394|P1|NOT COMPLETED|Overall Study||2
8083207|NCT03547531|19930393|P2|COMPLETED|Overall Study||58
8083208|NCT03547531|19930394|P1|COMPLETED|Overall Study||60
8083209|NCT03547531|19930393|P2|STARTED|Overall Study||62
8083210|NCT03547531|19930394|P1|STARTED|Overall Study||62
8083211|NCT03547167|19930408|P2|NOT COMPLETED|Overall Study||30
8083212|NCT03547167|19930409|P1|NOT COMPLETED|Overall Study||97
8083213|NCT03547167|19930408|P2|COMPLETED|Overall Study||350
8083214|NCT03547167|19930409|P1|COMPLETED|Overall Study||1038
8083215|NCT03547167|19930408|P2|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
8083216|NCT03547167|19930409|P1|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
8083217|NCT03547167|19930408|P2|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
8083218|NCT03547167|19930409|P1|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
8083219|NCT03547167|19930408|P2|STARTED|Overall Study||380
8083220|NCT03547167|19930409|P1|STARTED|Overall Study||1135
8083221|NCT03547154|19930461|P2|NOT COMPLETED|Overall Study||116
8083222|NCT03547154|19930462|P1|NOT COMPLETED|Overall Study||123
8083223|NCT03547154|19930461|P2|COMPLETED|Overall Study||55
8083224|NCT03547154|19930462|P1|COMPLETED|Overall Study||50
8083225|NCT03547154|19930461|P2|STARTED|Overall Study||171
8083226|NCT03547154|19930462|P1|STARTED|Overall Study||173
8083227|NCT03546842|19930474|P1|NOT COMPLETED|Overall Study||3
8083228|NCT03546842|19930474|P1|COMPLETED|Overall Study||198
8083229|NCT03546842|19930474|P1|Vaccination 3|Overall Study||198
8083230|NCT03546842|19930474|P1|Vaccination 2|Overall Study||200
8083231|NCT03546842|19930474|P1|Vaccination 1|Overall Study||200
8083232|NCT03546842|19930474|P1|STARTED|Overall Study||201
8083233|NCT03546816|19930485|P2|NOT COMPLETED|Overall Study||19
8083234|NCT03546816|19930486|P1|NOT COMPLETED|Overall Study||21
8083235|NCT03546816|19930485|P2|COMPLETED|Overall Study||124
8083236|NCT03546816|19930486|P1|COMPLETED|Overall Study||121
8083237|NCT03546816|19930485|P2|STARTED|Overall Study||143
8083238|NCT03546816|19930486|P1|STARTED|Overall Study||142
8083239|NCT03546621|19930514|P4|NOT COMPLETED|Overall Study||3
8083240|NCT03546621|19930515|P3|NOT COMPLETED|Overall Study||2
8083241|NCT03546621|19930516|P2|NOT COMPLETED|Overall Study||3
8083242|NCT03546621|19930517|P1|NOT COMPLETED|Overall Study||0
8083243|NCT03546621|19930514|P4|COMPLETED|Overall Study||25
8083244|NCT03546621|19930515|P3|COMPLETED|Overall Study||28
8083245|NCT03546621|19930516|P2|COMPLETED|Overall Study||29
8083246|NCT03546621|19930517|P1|COMPLETED|Overall Study||28
8083247|NCT03546621|19930514|P4|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
8083248|NCT03546621|19930515|P3|STARTED|Overall Study||30
8083249|NCT03546621|19930516|P2|STARTED|Overall Study||32
8083250|NCT03546621|19930517|P1|STARTED|Overall Study||28
8083251|NCT03546491|19930555|P1|NOT COMPLETED|Overall Study||2
8083252|NCT03546491|19930555|P1|COMPLETED|Overall Study||30
8083253|NCT03546491|19930555|P1|Received Test Product 2|Overall Study||32
8083254|NCT03546491|19930555|P1|Recieved Test Product 1|Overall Study||32
8083255|NCT03546491|19930555|P1|STARTED|Overall Study||32
8083256|NCT03546270|19930569|P2|NOT COMPLETED|Overall Study||0
8083257|NCT03546270|19930570|P1|NOT COMPLETED|Overall Study||0
8083258|NCT03546270|19930569|P2|COMPLETED|Overall Study||48
8083259|NCT03546270|19930570|P1|COMPLETED|Overall Study||52
8083260|NCT03546270|19930569|P2|STARTED|Overall Study||48
8083261|NCT03546270|19930570|P1|STARTED|Overall Study||52
8083262|NCT03546192|19930588|P2|NOT COMPLETED|Overall Study||0
8083263|NCT03546192|19930589|P1|NOT COMPLETED|Overall Study||0
8083264|NCT03546192|19930588|P2|COMPLETED|Overall Study||60
8083265|NCT03546192|19930589|P1|COMPLETED|Overall Study||60
8083266|NCT03546192|19930588|P2|STARTED|Overall Study||60
8083267|NCT03546192|19930589|P1|STARTED|Overall Study||60
8083268|NCT03545984|19930607|P2|NOT COMPLETED|Overall Study||9
8083269|NCT03545984|19930608|P1|NOT COMPLETED|Overall Study||11
8083270|NCT03545984|19930607|P2|COMPLETED|Overall Study||15
8083271|NCT03545984|19930608|P1|COMPLETED|Overall Study||13
8083272|NCT03545984|19930607|P2|STARTED|Overall Study||24
8083273|NCT03545984|19930608|P1|STARTED|Overall Study||24
8083274|NCT03545893|19930616|P2|NOT COMPLETED|Overall Study||0
8083275|NCT03545893|19930617|P1|NOT COMPLETED|Overall Study||0
8083276|NCT03545893|19930616|P2|COMPLETED|Overall Study||35
8083277|NCT03545893|19930617|P1|COMPLETED|Overall Study||35
8083278|NCT03545893|19930616|P2|STARTED|Overall Study||35
8083279|NCT03545893|19930617|P1|STARTED|Overall Study||35
8083280|NCT03545412|19930623|P1|NOT COMPLETED|Overall Study||0
8083281|NCT03545412|19930623|P1|COMPLETED|Overall Study||25
8083282|NCT03545412|19930623|P1|STARTED|Overall Study||25
8083283|NCT03544879|19930635|P2|NOT COMPLETED|Overall Study||1
8083284|NCT03544879|19930636|P1|NOT COMPLETED|Overall Study||0
8083285|NCT03544879|19930635|P2|COMPLETED|Overall Study||23
8083286|NCT03544879|19930636|P1|COMPLETED|Overall Study||22
8083287|NCT03544879|19930635|P2|Completed Follow-up Physical Assessment|Overall Study||21
8083288|NCT03544879|19930636|P1|Completed Follow-up Physical Assessment|Overall Study||20
8083289|NCT03544879|19930635|P2|STARTED|Overall Study||24
8083290|NCT03544879|19930636|P1|STARTED|Overall Study||22
8083291|NCT03544307|19930664|P2|NOT COMPLETED|Overall Study||0
8083292|NCT03544307|19930665|P1|NOT COMPLETED|Overall Study||0
8083293|NCT03544307|19930664|P2|COMPLETED|Overall Study||10
8083294|NCT03544307|19930665|P1|COMPLETED|Overall Study||10
8083295|NCT03544307|19930664|P2|STARTED|Overall Study||10
8083296|NCT03544307|19930665|P1|STARTED|Overall Study||10
8083297|NCT03544242|19930686|P3|NOT COMPLETED|Overall Study||0
8083298|NCT03544242|19930687|P2|NOT COMPLETED|Overall Study||0
8083299|NCT03544242|19930688|P1|NOT COMPLETED|Overall Study||0
8083300|NCT03544242|19930686|P3|COMPLETED|Overall Study||2
8083301|NCT03544242|19930687|P2|COMPLETED|Overall Study||1
8083302|NCT03544242|19930688|P1|COMPLETED|Overall Study||1
8083303|NCT03544242|19930686|P3|STARTED|Overall Study||2
8083304|NCT03544242|19930687|P2|STARTED|Overall Study||1
8083305|NCT03544242|19930688|P1|STARTED|Overall Study||1
8083306|NCT03544216|19930719|P2|NOT COMPLETED|Overall Study||0
8083307|NCT03544216|19930720|P1|NOT COMPLETED|Overall Study||0
8083308|NCT03544216|19930719|P2|COMPLETED|Overall Study||42
8083309|NCT03544216|19930720|P1|COMPLETED|Overall Study||42
8083310|NCT03544216|19930719|P2|STARTED|Overall Study||42
8083311|NCT03544216|19930720|P1|STARTED|Overall Study||42
8083312|NCT03543358|19930727|P2|NOT COMPLETED|Overall Study||0
8083313|NCT03543358|19930728|P1|NOT COMPLETED|Overall Study||3
8083314|NCT03543358|19930727|P2|COMPLETED|Overall Study||0
8083315|NCT03543358|19930728|P1|COMPLETED|Overall Study||0
8083316|NCT03543358|19930727|P2|Received Treatment or Retreatment|Overall Study||0
8083317|NCT03543358|19930728|P1|Received Treatment or Retreatment|Overall Study||0
8083318|NCT03543358|19930727|P2|STARTED|Overall Study||0
8083319|NCT03543358|19930728|P1|STARTED|Overall Study||3
8083320|NCT03543176|19930734|P2|NOT COMPLETED|Overall Study||0
8083321|NCT03543176|19930735|P1|NOT COMPLETED|Overall Study||0
8083322|NCT03543176|19930734|P2|COMPLETED|Overall Study||397
8083323|NCT03543176|19930735|P1|COMPLETED|Overall Study||392
8083324|NCT03543176|19930734|P2|STARTED|Overall Study||397
8083325|NCT03543176|19930735|P1|STARTED|Overall Study||392
8083326|NCT03543137|19930777|P2|NOT COMPLETED|Study Period 2: Up to Day 8||1
8083327|NCT03543137|19930778|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
8083328|NCT03543137|19930777|P2|COMPLETED|Study Period 2: Up to Day 8||18
8083329|NCT03543137|19930778|P1|COMPLETED|Study Period 2: Up to Day 8||16
8083330|NCT03543137|19930777|P2|Treated|Study Period 2: Up to Day 8||18
8083331|NCT03543137|19930778|P1|Treated|Study Period 2: Up to Day 8||16
8083332|NCT03543137|19930777|P2|STARTED|Study Period 2: Up to Day 8||19
8083333|NCT03543137|19930778|P1|STARTED|Study Period 2: Up to Day 8||18
8083334|NCT03543137|19930777|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083335|NCT03543137|19930778|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083336|NCT03543137|19930777|P2|COMPLETED|Washout Period: 5 to 7 Days||19
8083337|NCT03543137|19930778|P1|COMPLETED|Washout Period: 5 to 7 Days||18
8083338|NCT03543137|19930777|P2|STARTED|Washout Period: 5 to 7 Days||19
8083339|NCT03543137|19930778|P1|STARTED|Washout Period: 5 to 7 Days||18
8083340|NCT03543137|19930777|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083341|NCT03543137|19930778|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083342|NCT03543137|19930777|P2|COMPLETED|Study Period 1: Up to Day 1||19
8083343|NCT03543137|19930778|P1|COMPLETED|Study Period 1: Up to Day 1||18
8083344|NCT03543137|19930777|P2|STARTED|Study Period 1: Up to Day 1||19
8083345|NCT03543137|19930778|P1|STARTED|Study Period 1: Up to Day 1||18
8083346|NCT03542474|19930798|P1|NOT COMPLETED|Overall Study||0
8083347|NCT03542474|19930798|P1|COMPLETED|Overall Study||8
8083348|NCT03542474|19930798|P1|STARTED|Overall Study||8
8083349|NCT03541356|19930808|P5|NOT COMPLETED|Overall Study||0
8083350|NCT03541356|19930809|P4|NOT COMPLETED|Overall Study||0
8083351|NCT03541356|19930810|P3|NOT COMPLETED|Overall Study||0
8083352|NCT03541356|19930811|P2|NOT COMPLETED|Overall Study||0
8083353|NCT03541356|19930812|P1|NOT COMPLETED|Overall Study||0
8083354|NCT03541356|19930808|P5|COMPLETED|Overall Study||6
8083355|NCT03541356|19930809|P4|COMPLETED|Overall Study||6
8083356|NCT03541356|19930810|P3|COMPLETED|Overall Study||6
8083357|NCT03541356|19930811|P2|COMPLETED|Overall Study||6
8083358|NCT03541356|19930812|P1|COMPLETED|Overall Study||8
8083359|NCT03541356|19930808|P5|STARTED|Overall Study||6
8083360|NCT03541356|19930809|P4|STARTED|Overall Study||6
8083361|NCT03541356|19930810|P3|STARTED|Overall Study||6
8083362|NCT03541356|19930811|P2|STARTED|Overall Study||6
8083363|NCT03541356|19930812|P1|STARTED|Overall Study||8
8083364|NCT03541044|19930879|P2|NOT COMPLETED|Study Period 2: Up to Day 8||0
8083365|NCT03541044|19930880|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
8083366|NCT03541044|19930879|P2|COMPLETED|Study Period 2: Up to Day 8||23
8083367|NCT03541044|19930880|P1|COMPLETED|Study Period 2: Up to Day 8||21
8083368|NCT03541044|19930879|P2|STARTED|Study Period 2: Up to Day 8||23
8083369|NCT03541044|19930880|P1|STARTED|Study Period 2: Up to Day 8||23
8083370|NCT03541044|19930879|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083371|NCT03541044|19930880|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083372|NCT03541044|19930879|P2|COMPLETED|Washout Period: 5 to 7 Days||23
8083373|NCT03541044|19930880|P1|COMPLETED|Washout Period: 5 to 7 Days||23
8083374|NCT03541044|19930879|P2|STARTED|Washout Period: 5 to 7 Days||23
8083375|NCT03541044|19930880|P1|STARTED|Washout Period: 5 to 7 Days||23
8083376|NCT03541044|19930879|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083377|NCT03541044|19930880|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083378|NCT03541044|19930879|P2|COMPLETED|Study Period 1: Up to Day 1||23
8083379|NCT03541044|19930880|P1|COMPLETED|Study Period 1: Up to Day 1||23
8083380|NCT03541044|19930879|P2|STARTED|Study Period 1: Up to Day 1||23
8083381|NCT03541044|19930880|P1|STARTED|Study Period 1: Up to Day 1||23
8083382|NCT03540160|19930900|P1|NOT COMPLETED|Overall Study||379
8083383|NCT03540160|19930900|P1|COMPLETED|Overall Study||179
8083384|NCT03540160|19930900|P1|STARTED|Overall Study||558
8083385|NCT03540030|19930906|P2|NOT COMPLETED|Overall Study||3
8083386|NCT03540030|19930907|P1|NOT COMPLETED|Overall Study||18
8083387|NCT03540030|19930906|P2|COMPLETED|Overall Study||35
8083388|NCT03540030|19930907|P1|COMPLETED|Overall Study||30
8083389|NCT03540030|19930906|P2|STARTED|Overall Study||38
8083390|NCT03540030|19930907|P1|STARTED|Overall Study||48
8083391|NCT03539549|19930943|P1|NOT COMPLETED|Overall Study||17
8083392|NCT03539549|19930943|P1|COMPLETED|Overall Study||106
8083393|NCT03539549|19930943|P1|STARTED|Overall Study||123
8083394|NCT03539484|19930958|P7|NOT COMPLETED|Overall Study||2
8083395|NCT03539484|19930959|P6|NOT COMPLETED|Overall Study||5
8083396|NCT03539484|19930960|P5|NOT COMPLETED|Overall Study||13
8083397|NCT03539484|19930961|P4|NOT COMPLETED|Overall Study||3
8083398|NCT03539484|19930962|P3|NOT COMPLETED|Overall Study||1
8083399|NCT03539484|19930963|P2|NOT COMPLETED|Overall Study||1
8083400|NCT03539484|19930964|P1|NOT COMPLETED|Overall Study||1
8083401|NCT03539484|19930958|P7|COMPLETED|Overall Study||0
8083402|NCT03539484|19930959|P6|COMPLETED|Overall Study||0
8083403|NCT03539484|19930960|P5|COMPLETED|Overall Study||0
8083404|NCT03539484|19930961|P4|COMPLETED|Overall Study||0
8083405|NCT03539484|19930962|P3|COMPLETED|Overall Study||0
8083406|NCT03539484|19930963|P2|COMPLETED|Overall Study||0
8083407|NCT03539484|19930964|P1|COMPLETED|Overall Study||0
8083408|NCT03539484|19930958|P7|STARTED|Overall Study||2
8083409|NCT03539484|19930959|P6|STARTED|Overall Study||5
8083410|NCT03539484|19930960|P5|STARTED|Overall Study||13
8083411|NCT03539484|19930961|P4|STARTED|Overall Study||3
8083412|NCT03539484|19930962|P3|STARTED|Overall Study||1
8083413|NCT03539484|19930963|P2|STARTED|Overall Study||1
8083414|NCT03539484|19930964|P1|STARTED|Overall Study||1
8083415|NCT03539458|19931098|P1|NOT COMPLETED|Overall Study||1
8083416|NCT03539458|19931098|P1|COMPLETED|Overall Study||10
8083417|NCT03539458|19931098|P1|STARTED|Overall Study||11
8083418|NCT03539211|19931104|P2|NOT COMPLETED|Overall Study||0
8083419|NCT03539211|19931105|P1|NOT COMPLETED|Overall Study||0
8083420|NCT03539211|19931104|P2|COMPLETED|Overall Study||15
8083421|NCT03539211|19931105|P1|COMPLETED|Overall Study||16
8083422|NCT03539211|19931104|P2|STARTED|Overall Study||15
8083423|NCT03539211|19931105|P1|STARTED|Overall Study||16
8083424|NCT03538808|19931117|P4|NOT COMPLETED|Overall Study||2
8083425|NCT03538808|19931118|P3|NOT COMPLETED|Overall Study||4
8083426|NCT03538808|19931119|P2|NOT COMPLETED|Overall Study||0
8083427|NCT03538808|19931120|P1|NOT COMPLETED|Overall Study||2
8083428|NCT03538808|19931117|P4|COMPLETED|Overall Study||18
8083429|NCT03538808|19931118|P3|COMPLETED|Overall Study||16
8083430|NCT03538808|19931119|P2|COMPLETED|Overall Study||20
8083431|NCT03538808|19931120|P1|COMPLETED|Overall Study||18
8083432|NCT03538808|19931117|P4|STARTED|Overall Study||20
8083433|NCT03538808|19931118|P3|STARTED|Overall Study||20
8083434|NCT03538808|19931119|P2|STARTED|Overall Study||20
8083435|NCT03538808|19931120|P1|STARTED|Overall Study||20
8083436|NCT03538795|19931138|P1|NOT COMPLETED|Overall Study||0
8083437|NCT03538795|19931138|P1|COMPLETED|Overall Study||3
8083438|NCT03538795|19931138|P1|STARTED|Overall Study||3
8083439|NCT03538743|19931153|P9|NOT COMPLETED|Overall Study||3
8083440|NCT03538743|19931154|P8|NOT COMPLETED|Overall Study||0
8083441|NCT03538743|19931155|P7|NOT COMPLETED|Overall Study||0
8083442|NCT03538743|19931156|P6|NOT COMPLETED|Overall Study||0
8083443|NCT03538743|19931157|P5|NOT COMPLETED|Overall Study||0
8083444|NCT03538743|19931158|P4|NOT COMPLETED|Overall Study||2
8083445|NCT03538743|19931159|P3|NOT COMPLETED|Overall Study||1
8083446|NCT03538743|19931160|P2|NOT COMPLETED|Overall Study||0
8083447|NCT03538743|19931161|P1|NOT COMPLETED|Overall Study||0
8083448|NCT03538743|19931153|P9|COMPLETED|Overall Study||7
8083449|NCT03538743|19931154|P8|COMPLETED|Overall Study||8
8083450|NCT03538743|19931155|P7|COMPLETED|Overall Study||9
8083451|NCT03538743|19931156|P6|COMPLETED|Overall Study||9
8083452|NCT03538743|19931157|P5|COMPLETED|Overall Study||9
8083453|NCT03538743|19931158|P4|COMPLETED|Overall Study||8
8083454|NCT03538743|19931159|P3|COMPLETED|Overall Study||8
8083455|NCT03538743|19931160|P2|COMPLETED|Overall Study||9
8083456|NCT03538743|19931161|P1|COMPLETED|Overall Study||25
8083457|NCT03538743|19931153|P9|Received Treatment|Overall Study||10
8083458|NCT03538743|19931154|P8|Received Treatment|Overall Study||8
8083459|NCT03538743|19931155|P7|Received Treatment|Overall Study||9
8083460|NCT03538743|19931156|P6|Received Treatment|Overall Study||9
8083461|NCT03538743|19931157|P5|Received Treatment|Overall Study||9
8083462|NCT03538743|19931158|P4|Received Treatment|Overall Study||10
8083463|NCT03538743|19931159|P3|Received Treatment|Overall Study||9
8083464|NCT03538743|19931160|P2|Received Treatment|Overall Study||9
8083465|NCT03538743|19931161|P1|Received Treatment|Overall Study||25
8083466|NCT03538743|19931153|P9|STARTED|Overall Study||10
8083467|NCT03538743|19931154|P8|STARTED|Overall Study||8
8083468|NCT03538743|19931155|P7|STARTED|Overall Study||9
8083469|NCT03538743|19931156|P6|STARTED|Overall Study||9
8083470|NCT03538743|19931157|P5|STARTED|Overall Study||9
8083471|NCT03538743|19931158|P4|STARTED|Overall Study||10
8083472|NCT03538743|19931159|P3|STARTED|Overall Study||9
8083473|NCT03538743|19931160|P2|STARTED|Overall Study||9
8083474|NCT03538743|19931161|P1|STARTED|Overall Study||25
8083475|NCT03538717|19931264|P1|NOT COMPLETED|Overall Study||0
8083476|NCT03538717|19931264|P1|COMPLETED|Overall Study||157
8083477|NCT03538717|19931264|P1|STARTED|Overall Study||157
8083478|NCT03538015|19931325|P3|NOT COMPLETED|Overall Study||1
8083479|NCT03538015|19931326|P2|NOT COMPLETED|Overall Study||0
8083480|NCT03538015|19931327|P1|NOT COMPLETED|Overall Study||0
8083481|NCT03538015|19931325|P3|COMPLETED|Overall Study||0
8083482|NCT03538015|19931326|P2|COMPLETED|Overall Study||0
8083483|NCT03538015|19931327|P1|COMPLETED|Overall Study||0
8083484|NCT03538015|19931325|P3|STARTED|Overall Study||1
8083485|NCT03538015|19931326|P2|STARTED|Overall Study||0
8083486|NCT03538015|19931327|P1|STARTED|Overall Study||0
8083487|NCT03537664|19931353|P2|NOT COMPLETED|Overall Study||0
8083488|NCT03537664|19931354|P1|NOT COMPLETED|Overall Study||0
8083489|NCT03537664|19931353|P2|COMPLETED|Overall Study||25
8083490|NCT03537664|19931354|P1|COMPLETED|Overall Study||20
8083491|NCT03537664|19931353|P2|Endodontic Success|Overall Study||10
8083492|NCT03537664|19931354|P1|Endodontic Success|Overall Study||20
8083493|NCT03537664|19931353|P2|Bacterial Community Diversity|Overall Study||0
8083494|NCT03537664|19931354|P1|Bacterial Community Diversity|Overall Study||10
8083495|NCT03537664|19931353|P2|Bacterial Levels|Overall Study||25
8083496|NCT03537664|19931354|P1|Bacterial Levels|Overall Study||20
8083497|NCT03537664|19931353|P2|Metabolic Activity of Bacteria|Overall Study||25
8083498|NCT03537664|19931354|P1|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
8083499|NCT03537664|19931353|P2|STARTED|Overall Study||25
8083500|NCT03537664|19931354|P1|STARTED|Overall Study||20
8083501|NCT03537404|19931368|P2|NOT COMPLETED|Third Intervention (A or B or C)||0
8083502|NCT03537404|19931369|P1|NOT COMPLETED|Third Intervention (A or B or C)||0
8083503|NCT03537404|19931368|P2|COMPLETED|Third Intervention (A or B or C)||18
8083504|NCT03537404|19931369|P1|COMPLETED|Third Intervention (A or B or C)||18
8083505|NCT03537404|19931368|P2|STARTED|Third Intervention (A or B or C)||18
8083506|NCT03537404|19931369|P1|STARTED|Third Intervention (A or B or C)||18
8083507|NCT03537404|19931368|P2|NOT COMPLETED|Second Washout Period (8 Days)||0
8083508|NCT03537404|19931369|P1|NOT COMPLETED|Second Washout Period (8 Days)||0
8083509|NCT03537404|19931368|P2|COMPLETED|Second Washout Period (8 Days)||18
8083510|NCT03537404|19931369|P1|COMPLETED|Second Washout Period (8 Days)||18
8083511|NCT03537404|19931368|P2|STARTED|Second Washout Period (8 Days)||18
8083512|NCT03537404|19931369|P1|STARTED|Second Washout Period (8 Days)||18
8083513|NCT03537404|19931368|P2|NOT COMPLETED|Second Intervention (A or B or C)||0
8083514|NCT03537404|19931369|P1|NOT COMPLETED|Second Intervention (A or B or C)||0
8083515|NCT03537404|19931368|P2|COMPLETED|Second Intervention (A or B or C)||18
8083516|NCT03537404|19931369|P1|COMPLETED|Second Intervention (A or B or C)||18
8083517|NCT03537404|19931368|P2|STARTED|Second Intervention (A or B or C)||18
8083518|NCT03537404|19931369|P1|STARTED|Second Intervention (A or B or C)||18
8083519|NCT03537404|19931368|P2|NOT COMPLETED|First Washout Period (8 Days)||0
8083520|NCT03537404|19931369|P1|NOT COMPLETED|First Washout Period (8 Days)||0
8083521|NCT03537404|19931368|P2|COMPLETED|First Washout Period (8 Days)||18
8083522|NCT03537404|19931369|P1|COMPLETED|First Washout Period (8 Days)||18
8083523|NCT03537404|19931368|P2|STARTED|First Washout Period (8 Days)||18
8083524|NCT03537404|19931369|P1|STARTED|First Washout Period (8 Days)||18
8083525|NCT03537404|19931368|P2|NOT COMPLETED|First Intervention (A or B or C)||0
8083526|NCT03537404|19931369|P1|NOT COMPLETED|First Intervention (A or B or C)||0
8083527|NCT03537404|19931368|P2|COMPLETED|First Intervention (A or B or C)||18
8083528|NCT03537404|19931369|P1|COMPLETED|First Intervention (A or B or C)||18
8083529|NCT03537404|19931368|P2|STARTED|First Intervention (A or B or C)||18
8083530|NCT03537404|19931369|P1|STARTED|First Intervention (A or B or C)||18
8083531|NCT03537274|19931415|P4|NOT COMPLETED|Overall Study||76
8083532|NCT03537274|19931416|P3|NOT COMPLETED|Overall Study||76
8083533|NCT03537274|19931417|P2|NOT COMPLETED|Overall Study||69
8083534|NCT03537274|19931418|P1|NOT COMPLETED|Overall Study||60
8083535|NCT03537274|19931415|P4|COMPLETED|Overall Study||231
8083536|NCT03537274|19931416|P3|COMPLETED|Overall Study||228
8083537|NCT03537274|19931417|P2|COMPLETED|Overall Study||229
8083538|NCT03537274|19931418|P1|COMPLETED|Overall Study||255
8083539|NCT03537274|19931415|P4|Treated|Overall Study||303
8083540|NCT03537274|19931416|P3|Treated|Overall Study||304
8083541|NCT03537274|19931417|P2|Treated|Overall Study||297
8083542|NCT03537274|19931418|P1|Treated|Overall Study||315
8083543|NCT03537274|19931415|P4|STARTED|Overall Study||307
8083544|NCT03537274|19931416|P3|STARTED|Overall Study||304
8083545|NCT03537274|19931417|P2|STARTED|Overall Study||298
8083546|NCT03537274|19931418|P1|STARTED|Overall Study||315
8083547|NCT03537092|19931432|P1|NOT COMPLETED|Overall Study||0
8083548|NCT03537092|19931432|P1|COMPLETED|Overall Study||64
8083549|NCT03537092|19931432|P1|STARTED|Overall Study||64
8083550|NCT03536949|19931441|P2|NOT COMPLETED|Overall Study||2
8083551|NCT03536949|19931442|P1|NOT COMPLETED|Overall Study||14
8083552|NCT03536949|19931441|P2|COMPLETED|Overall Study||75
8083553|NCT03536949|19931442|P1|COMPLETED|Overall Study||143
8083554|NCT03536949|19931441|P2|STARTED|Overall Study||77
8083555|NCT03536949|19931442|P1|STARTED|Overall Study||157
8083556|NCT03536923|19931450|P1|NOT COMPLETED|Overall Study||0
8083557|NCT03536923|19931450|P1|COMPLETED|Overall Study||23
8083558|NCT03536923|19931450|P1|STARTED|Overall Study||23
8083559|NCT03536819|19931457|P1|NOT COMPLETED|Overall Study||5
8083560|NCT03536819|19931457|P1|COMPLETED|Overall Study||15
8083561|NCT03536819|19931457|P1|STARTED|Overall Study||20
8083562|NCT03536702|19931470|P2|NOT COMPLETED|Overall Study||12
8083563|NCT03536702|19931471|P1|NOT COMPLETED|Overall Study||14
8083564|NCT03536702|19931470|P2|COMPLETED|Overall Study||8
8083565|NCT03536702|19931471|P1|COMPLETED|Overall Study||26
8083566|NCT03536702|19931470|P2|STARTED|Overall Study||20
8083567|NCT03536702|19931471|P1|STARTED|Overall Study||40
8083568|NCT03536663|19931505|P1|NOT COMPLETED|Endexo||1
8083569|NCT03536663|19931505|P1|COMPLETED|Endexo||17
8083570|NCT03536663|19931505|P1|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
8083571|NCT03536663|19931505|P1|NOT COMPLETED|Optiflux||4
8083572|NCT03536663|19931505|P1|COMPLETED|Optiflux||19
8083573|NCT03536663|19931505|P1|STARTED|Optiflux||23
8083574|NCT03535974|19931523|P3|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
8083575|NCT03535974|19931524|P2|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
8083576|NCT03535974|19931525|P1|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
8083577|NCT03535974|19931523|P3|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
8083578|NCT03535974|19931524|P2|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
8083579|NCT03535974|19931525|P1|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
8083580|NCT03535974|19931523|P3|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
8083581|NCT03535974|19931524|P2|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
8083582|NCT03535974|19931525|P1|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
8083583|NCT03535974|19931523|P3|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
8083584|NCT03535974|19931524|P2|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
8083585|NCT03535974|19931525|P1|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
8083586|NCT03535974|19931523|P3|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
8083587|NCT03535974|19931524|P2|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
8083588|NCT03535974|19931525|P1|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
8083589|NCT03535974|19931523|P3|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
8083590|NCT03535974|19931524|P2|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
8083591|NCT03535974|19931525|P1|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
8083592|NCT03535844|19931535|P2|NOT COMPLETED|Overall Study||1
8083593|NCT03535844|19931536|P1|NOT COMPLETED|Overall Study||0
8083594|NCT03535844|19931535|P2|COMPLETED|Overall Study||18
8083595|NCT03535844|19931536|P1|COMPLETED|Overall Study||22
8083596|NCT03535844|19931535|P2|STARTED|Overall Study||19
8083597|NCT03535844|19931536|P1|STARTED|Overall Study||22
8083598|NCT03535649|19931572|P1|NOT COMPLETED|Overall Study||0
8083599|NCT03535649|19931572|P1|COMPLETED|Overall Study||105
8083600|NCT03535649|19931572|P1|STARTED|Overall Study||105
8083601|NCT03535571|19931581|P1|NOT COMPLETED|Overall Study||1
8083602|NCT03535571|19931581|P1|COMPLETED|Overall Study||19
8083603|NCT03535571|19931581|P1|STARTED|Overall Study||20
8083604|NCT03534986|19931613|P3|NOT COMPLETED|Overall Study||2
8083605|NCT03534986|19931614|P2|NOT COMPLETED|Overall Study||0
8083606|NCT03534986|19931615|P1|NOT COMPLETED|Overall Study||0
8083607|NCT03534986|19931613|P3|COMPLETED|Overall Study||10
8083608|NCT03534986|19931614|P2|COMPLETED|Overall Study||10
8083609|NCT03534986|19931615|P1|COMPLETED|Overall Study||10
8083610|NCT03534986|19931613|P3|STARTED|Overall Study||12
8083611|NCT03534986|19931614|P2|STARTED|Overall Study||10
8083612|NCT03534986|19931615|P1|STARTED|Overall Study||10
8083613|NCT03534427|19931637|P2|NOT COMPLETED|Overall Study||0
8083614|NCT03534427|19931638|P1|NOT COMPLETED|Overall Study||0
8083615|NCT03534427|19931637|P2|COMPLETED|Overall Study||20
8083616|NCT03534427|19931638|P1|COMPLETED|Overall Study||20
8083617|NCT03534427|19931637|P2|STARTED|Overall Study||20
8083618|NCT03534427|19931638|P1|STARTED|Overall Study||20
8083619|NCT03534362|19931666|P2|NOT COMPLETED|Overall Study||0
8083620|NCT03534362|19931667|P1|NOT COMPLETED|Overall Study||0
8083621|NCT03534362|19931666|P2|COMPLETED|Overall Study||1
8083622|NCT03534362|19931667|P1|COMPLETED|Overall Study||0
8083623|NCT03534362|19931666|P2|STARTED|Overall Study||1
8083624|NCT03534362|19931667|P1|STARTED|Overall Study||0
8083625|NCT03533829|19931680|P3|NOT COMPLETED|Overall Study||0
8083626|NCT03533829|19931681|P2|NOT COMPLETED|Overall Study||0
8083627|NCT03533829|19931682|P1|NOT COMPLETED|Overall Study||0
8083628|NCT03533829|19931680|P3|COMPLETED|Overall Study||10
8083629|NCT03533829|19931681|P2|COMPLETED|Overall Study||10
8083630|NCT03533829|19931682|P1|COMPLETED|Overall Study||10
8083631|NCT03533829|19931680|P3|STARTED|Overall Study||10
8083632|NCT03533829|19931681|P2|STARTED|Overall Study||10
8083633|NCT03533829|19931682|P1|STARTED|Overall Study||10
8083634|NCT03533374|19931782|P2|NOT COMPLETED|Overall Study||0
8083635|NCT03533374|19931783|P1|NOT COMPLETED|Overall Study||0
8083636|NCT03533374|19931782|P2|COMPLETED|Overall Study||46
8083637|NCT03533374|19931783|P1|COMPLETED|Overall Study||54
8083638|NCT03533374|19931782|P2|STARTED|Overall Study||46
8083639|NCT03533374|19931783|P1|STARTED|Overall Study||54
8083640|NCT03533244|19931796|P3|NOT COMPLETED|Overall Study||0
8083641|NCT03533244|19931797|P2|NOT COMPLETED|Overall Study||1
8083642|NCT03533244|19931798|P1|NOT COMPLETED|Overall Study||2
8083643|NCT03533244|19931796|P3|COMPLETED|Overall Study||22
8083644|NCT03533244|19931797|P2|COMPLETED|Overall Study||21
8083645|NCT03533244|19931798|P1|COMPLETED|Overall Study||18
8083646|NCT03533244|19931796|P3|STARTED|Overall Study||22
8083647|NCT03533244|19931797|P2|STARTED|Overall Study||22
8083648|NCT03533244|19931798|P1|STARTED|Overall Study||20
8083649|NCT03533036|19931814|P2|NOT COMPLETED|Overall Study||0
8083650|NCT03533036|19931815|P1|NOT COMPLETED|Overall Study||0
8083651|NCT03533036|19931814|P2|COMPLETED|Overall Study||15
8083652|NCT03533036|19931815|P1|COMPLETED|Overall Study||15
8083653|NCT03533036|19931814|P2|STARTED|Overall Study||15
8083654|NCT03533036|19931815|P1|STARTED|Overall Study||15
8083655|NCT03532048|19931824|P2|NOT COMPLETED|Overall Study||17
8083656|NCT03532048|19931825|P1|NOT COMPLETED|Overall Study||19
8083657|NCT03532048|19931824|P2|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
8083658|NCT03532048|19931825|P1|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
8083659|NCT03532048|19931824|P2|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
8083660|NCT03532048|19931825|P1|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
8083661|NCT03531905|19931842|P3|NOT COMPLETED|Overall Study||3
8083662|NCT03531905|19931843|P2|NOT COMPLETED|Overall Study||5
8083663|NCT03531905|19931844|P1|NOT COMPLETED|Overall Study||7
8083664|NCT03531905|19931842|P3|COMPLETED|Overall Study||77
8083665|NCT03531905|19931843|P2|COMPLETED|Overall Study||76
8083666|NCT03531905|19931844|P1|COMPLETED|Overall Study||74
8083667|NCT03531905|19931842|P3|STARTED|Overall Study||80
8083668|NCT03531905|19931843|P2|STARTED|Overall Study||81
8083669|NCT03531905|19931844|P1|STARTED|Overall Study||81
8083670|NCT03531710|19931902|P6|NOT COMPLETED|Overall Study||0
8083671|NCT03531710|19931903|P5|NOT COMPLETED|Overall Study||0
8083672|NCT03531710|19931904|P4|NOT COMPLETED|Overall Study||0
8083673|NCT03531710|19931905|P3|NOT COMPLETED|Overall Study||0
8083674|NCT03531710|19931906|P2|NOT COMPLETED|Overall Study||0
8083675|NCT03531710|19931907|P1|NOT COMPLETED|Overall Study||2
8083676|NCT03531710|19931902|P6|COMPLETED|Overall Study||2
8083677|NCT03531710|19931903|P5|COMPLETED|Overall Study||8
8083678|NCT03531710|19931904|P4|COMPLETED|Overall Study||5
8083679|NCT03531710|19931905|P3|COMPLETED|Overall Study||7
8083680|NCT03531710|19931906|P2|COMPLETED|Overall Study||2
8083681|NCT03531710|19931907|P1|COMPLETED|Overall Study||8
8083682|NCT03531710|19931902|P6|STARTED|Overall Study||2
8083683|NCT03531710|19931903|P5|STARTED|Overall Study||8
8083684|NCT03531710|19931904|P4|STARTED|Overall Study||5
8083685|NCT03531710|19931905|P3|STARTED|Overall Study||7
8083686|NCT03531710|19931906|P2|STARTED|Overall Study||2
8083687|NCT03531710|19931907|P1|STARTED|Overall Study||10
8083688|NCT03530917|19931953|P8|NOT COMPLETED|Overall Study||0
8083689|NCT03530917|19931954|P7|NOT COMPLETED|Overall Study||0
8083690|NCT03530917|19931955|P6|NOT COMPLETED|Overall Study||0
8083691|NCT03530917|19931956|P5|NOT COMPLETED|Overall Study||0
8083692|NCT03530917|19931957|P4|NOT COMPLETED|Overall Study||0
8083693|NCT03530917|19931958|P3|NOT COMPLETED|Overall Study||0
8083694|NCT03530917|19931959|P2|NOT COMPLETED|Overall Study||0
8083695|NCT03530917|19931960|P1|NOT COMPLETED|Overall Study||0
8083696|NCT03530917|19931953|P8|COMPLETED|Overall Study||16
8083697|NCT03530917|19931954|P7|COMPLETED|Overall Study||8
8083698|NCT03530917|19931955|P6|COMPLETED|Overall Study||6
8083699|NCT03530917|19931956|P5|COMPLETED|Overall Study||8
8083700|NCT03530917|19931957|P4|COMPLETED|Overall Study||8
8083701|NCT03530917|19931958|P3|COMPLETED|Overall Study||8
8083702|NCT03530917|19931959|P2|COMPLETED|Overall Study||8
8083703|NCT03530917|19931960|P1|COMPLETED|Overall Study||8
8083704|NCT03530917|19931953|P8|STARTED|Overall Study||16
8083705|NCT03530917|19931954|P7|STARTED|Overall Study||8
8083706|NCT03530917|19931955|P6|STARTED|Overall Study||6
8083707|NCT03530917|19931956|P5|STARTED|Overall Study||8
8083708|NCT03530917|19931957|P4|STARTED|Overall Study||8
8083709|NCT03530917|19931958|P3|STARTED|Overall Study||8
8083710|NCT03530917|19931959|P2|STARTED|Overall Study||8
8083711|NCT03530917|19931960|P1|STARTED|Overall Study||8
8083712|NCT03530631|19932044|P1|NOT COMPLETED|Placebo/Deception||0
8083713|NCT03530631|19932044|P1|COMPLETED|Placebo/Deception||4
8083714|NCT03530631|19932044|P1|STARTED|Placebo/Deception||4
8083715|NCT03530631|19932044|P1|NOT COMPLETED|Adderall/Deception||0
8083716|NCT03530631|19932044|P1|COMPLETED|Adderall/Deception||4
8083717|NCT03530631|19932044|P1|STARTED|Adderall/Deception||4
8083718|NCT03530631|19932044|P1|NOT COMPLETED|Placebo/Truth||0
8083719|NCT03530631|19932044|P1|COMPLETED|Placebo/Truth||4
8083720|NCT03530631|19932044|P1|STARTED|Placebo/Truth||4
8083721|NCT03530631|19932044|P1|NOT COMPLETED|Adderall/Truth||0
8083722|NCT03530631|19932044|P1|COMPLETED|Adderall/Truth||4
8083723|NCT03530631|19932044|P1|STARTED|Adderall/Truth||4
8083724|NCT03530345|19932056|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
8083725|NCT03530345|19932057|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
8083726|NCT03530345|19932056|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
8083727|NCT03530345|19932057|P1|COMPLETED|Treatment Period B/Follow-up Period 2||0
8083728|NCT03530345|19932056|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
8083729|NCT03530345|19932057|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
8083730|NCT03530345|19932056|P2|STARTED|Treatment Period B/Follow-up Period 2||7
8083731|NCT03530345|19932057|P1|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
8083732|NCT03530345|19932056|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
8083733|NCT03530345|19932057|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
8083734|NCT03530345|19932056|P2|COMPLETED|Treatment Period A/Follow-up Period 1||7
8083735|NCT03530345|19932057|P1|COMPLETED|Treatment Period A/Follow-up Period 1||7
8083736|NCT03530345|19932056|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
8083737|NCT03530345|19932057|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
8083738|NCT03530345|19932056|P2|STARTED|Treatment Period A/Follow-up Period 1||29
8083739|NCT03530345|19932057|P1|STARTED|Treatment Period A/Follow-up Period 1||28
8083740|NCT03530098|19932081|P2|NOT COMPLETED|Overall Study||0
8083741|NCT03530098|19932082|P1|NOT COMPLETED|Overall Study||0
8083742|NCT03530098|19932081|P2|COMPLETED|Overall Study||964
8083743|NCT03530098|19932082|P1|COMPLETED|Overall Study||939
8083744|NCT03530098|19932081|P2|Primary Analysis Set|Overall Study||792
8083745|NCT03530098|19932082|P1|Primary Analysis Set|Overall Study||739
8083746|NCT03530098|19932081|P2|Ground-truth Labeled|Overall Study||794
8083747|NCT03530098|19932082|P1|Ground-truth Labeled|Overall Study||741
8083748|NCT03530098|19932081|P2|STARTED|Overall Study||964
8083749|NCT03530098|19932082|P1|STARTED|Overall Study||939
8083750|NCT03529942|19932090|P1|NOT COMPLETED|Overall Study||23
8083751|NCT03529942|19932090|P1|COMPLETED|Overall Study||106
8083752|NCT03529942|19932090|P1|Reached Week 6 With Paired MRI|Overall Study||108
8083753|NCT03529942|19932090|P1|STARTED|Overall Study||129
8083754|NCT03529461|19932104|P2|NOT COMPLETED|Overall Study||0
8083755|NCT03529461|19932105|P1|NOT COMPLETED|Overall Study||0
8083756|NCT03529461|19932104|P2|COMPLETED|Overall Study||28
8083757|NCT03529461|19932105|P1|COMPLETED|Overall Study||28
8083758|NCT03529461|19932104|P2|STARTED|Overall Study||28
8083759|NCT03529461|19932105|P1|STARTED|Overall Study||28
8083760|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 4||3
8083761|NCT03528577|19932114|P1|COMPLETED|Sequence 4||125
8083762|NCT03528577|19932114|P1|STARTED|Sequence 4||128
8083763|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 3||1
8083764|NCT03528577|19932114|P1|COMPLETED|Sequence 3||127
8083765|NCT03528577|19932114|P1|STARTED|Sequence 3||128
8083766|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 2||3
8083767|NCT03528577|19932114|P1|COMPLETED|Sequence 2||125
8083768|NCT03528577|19932114|P1|STARTED|Sequence 2||128
8083769|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 1||2
8083770|NCT03528577|19932114|P1|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
8083771|NCT03528577|19932114|P1|STARTED|Sequence 1||128
8083772|NCT03528369|19932124|P3|NOT COMPLETED|Overall Study||0
8083773|NCT03528369|19932125|P2|NOT COMPLETED|Overall Study||1
8083774|NCT03528369|19932126|P1|NOT COMPLETED|Overall Study||3
8083775|NCT03528369|19932124|P3|COMPLETED|Overall Study||40
8083776|NCT03528369|19932125|P2|COMPLETED|Overall Study||41
8083777|NCT03528369|19932126|P1|COMPLETED|Overall Study||37
8083778|NCT03528369|19932124|P3|STARTED|Overall Study||40
8083779|NCT03528369|19932125|P2|STARTED|Overall Study||42
8083780|NCT03528369|19932126|P1|STARTED|Overall Study||40
8083781|NCT03528174|19932155|P1|NOT COMPLETED|Overall Study||2
8083782|NCT03528174|19932155|P1|COMPLETED|Overall Study||8
8083783|NCT03528174|19932155|P1|STARTED|Overall Study||10
8083784|NCT03527966|19932175|P2|NOT COMPLETED|Overall Study||0
8083785|NCT03527966|19932176|P1|NOT COMPLETED|Overall Study||3
8083786|NCT03527966|19932175|P2|COMPLETED|Overall Study||0
8083787|NCT03527966|19932176|P1|COMPLETED|Overall Study||0
8083788|NCT03527966|19932175|P2|STARTED|Overall Study||0
8083789|NCT03527966|19932176|P1|STARTED|Overall Study||3
8083790|NCT03527745|19932214|P26|NOT COMPLETED|Overall Study||3
8083791|NCT03527745|19932215|P25|NOT COMPLETED|Overall Study||1
8083792|NCT03527745|19932216|P24|NOT COMPLETED|Overall Study||8
8083793|NCT03527745|19932217|P23|NOT COMPLETED|Overall Study||6
8083794|NCT03527745|19932218|P22|NOT COMPLETED|Overall Study||5
8083795|NCT03527745|19932219|P21|NOT COMPLETED|Overall Study||1
8083796|NCT03527745|19932220|P20|NOT COMPLETED|Overall Study||1
8083797|NCT03527745|19932221|P19|NOT COMPLETED|Overall Study||0
8083798|NCT03527745|19932222|P18|NOT COMPLETED|Overall Study||0
8083799|NCT03527745|19932223|P17|NOT COMPLETED|Overall Study||1
8083800|NCT03527745|19932224|P16|NOT COMPLETED|Overall Study||0
8083801|NCT03527745|19932225|P15|NOT COMPLETED|Overall Study||0
8083802|NCT03527745|19932226|P14|NOT COMPLETED|Overall Study||0
8083803|NCT03527745|19932227|P13|NOT COMPLETED|Overall Study||0
8083804|NCT03527745|19932228|P12|NOT COMPLETED|Overall Study||1
8083805|NCT03527745|19932229|P11|NOT COMPLETED|Overall Study||1
8083806|NCT03527745|19932230|P10|NOT COMPLETED|Overall Study||2
8083807|NCT03527745|19932231|P9|NOT COMPLETED|Overall Study||3
8083808|NCT03527745|19932232|P8|NOT COMPLETED|Overall Study||2
8083809|NCT03527745|19932233|P7|NOT COMPLETED|Overall Study||3
8083810|NCT03527745|19932234|P6|NOT COMPLETED|Overall Study||2
8083811|NCT03527745|19932235|P5|NOT COMPLETED|Overall Study||0
8083812|NCT03527745|19932236|P4|NOT COMPLETED|Overall Study||9
8083813|NCT03527745|19932237|P3|NOT COMPLETED|Overall Study||7
8083814|NCT03527745|19932238|P2|NOT COMPLETED|Overall Study||6
8083815|NCT03527745|19932239|P1|NOT COMPLETED|Overall Study||3
8083816|NCT03527745|19932214|P26|COMPLETED|Overall Study||34
8083817|NCT03527745|19932215|P25|COMPLETED|Overall Study||39
8083818|NCT03527745|19932216|P24|COMPLETED|Overall Study||30
8083819|NCT03527745|19932217|P23|COMPLETED|Overall Study||35
8083820|NCT03527745|19932218|P22|COMPLETED|Overall Study||35
8083821|NCT03527745|19932219|P21|COMPLETED|Overall Study||25
8083822|NCT03527745|19932220|P20|COMPLETED|Overall Study||28
8083823|NCT03527745|19932221|P19|COMPLETED|Overall Study||27
8083824|NCT03527745|19932222|P18|COMPLETED|Overall Study||27
8083825|NCT03527745|19932223|P17|COMPLETED|Overall Study||23
8083826|NCT03527745|19932224|P16|COMPLETED|Overall Study||12
8083827|NCT03527745|19932225|P15|COMPLETED|Overall Study||13
8083828|NCT03527745|19932226|P14|COMPLETED|Overall Study||13
8083829|NCT03527745|19932227|P13|COMPLETED|Overall Study||0
8083830|NCT03527745|19932228|P12|COMPLETED|Overall Study||11
8083831|NCT03527745|19932229|P11|COMPLETED|Overall Study||8
8083832|NCT03527745|19932230|P10|COMPLETED|Overall Study||9
8083833|NCT03527745|19932231|P9|COMPLETED|Overall Study||7
8083834|NCT03527745|19932232|P8|COMPLETED|Overall Study||41
8083835|NCT03527745|19932233|P7|COMPLETED|Overall Study||43
8083836|NCT03527745|19932234|P6|COMPLETED|Overall Study||43
8083837|NCT03527745|19932235|P5|COMPLETED|Overall Study||46
8083838|NCT03527745|19932236|P4|COMPLETED|Overall Study||18
8083839|NCT03527745|19932237|P3|COMPLETED|Overall Study||23
8083840|NCT03527745|19932238|P2|COMPLETED|Overall Study||21
8083841|NCT03527745|19932239|P1|COMPLETED|Overall Study||24
8083842|NCT03527745|19932214|P26|STARTED|Overall Study||37
8083843|NCT03527745|19932215|P25|STARTED|Overall Study||40
8083844|NCT03527745|19932216|P24|STARTED|Overall Study||38
8083845|NCT03527745|19932217|P23|STARTED|Overall Study||41
8083846|NCT03527745|19932218|P22|STARTED|Overall Study||40
8083847|NCT03527745|19932219|P21|STARTED|Overall Study||26
8083848|NCT03527745|19932220|P20|STARTED|Overall Study||29
8083849|NCT03527745|19932221|P19|STARTED|Overall Study||27
8083850|NCT03527745|19932222|P18|STARTED|Overall Study||27
8083851|NCT03527745|19932223|P17|STARTED|Overall Study||24
8083852|NCT03527745|19932224|P16|STARTED|Overall Study||12
8083853|NCT03527745|19932225|P15|STARTED|Overall Study||13
8083854|NCT03527745|19932226|P14|STARTED|Overall Study||13
8083855|NCT03527745|19932227|P13|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
8083856|NCT03527745|19932228|P12|STARTED|Overall Study||12
8083857|NCT03527745|19932229|P11|STARTED|Overall Study||9
8083858|NCT03527745|19932230|P10|STARTED|Overall Study||11
8083859|NCT03527745|19932231|P9|STARTED|Overall Study||10
8083860|NCT03527745|19932232|P8|STARTED|Overall Study||43
8083861|NCT03527745|19932233|P7|STARTED|Overall Study||46
8083862|NCT03527745|19932234|P6|STARTED|Overall Study||45
8083863|NCT03527745|19932235|P5|STARTED|Overall Study||46
8083864|NCT03527745|19932236|P4|STARTED|Overall Study||27
8083865|NCT03527745|19932237|P3|STARTED|Overall Study||30
8083866|NCT03527745|19932238|P2|STARTED|Overall Study||27
8083867|NCT03527745|19932239|P1|STARTED|Overall Study||27
8083868|NCT03527173|19932321|P2|NOT COMPLETED|Overall Study||7
8083869|NCT03527173|19932322|P1|NOT COMPLETED|Overall Study||7
8083870|NCT03527173|19932321|P2|COMPLETED|Overall Study||28
8083871|NCT03527173|19932322|P1|COMPLETED|Overall Study||29
8083872|NCT03527173|19932321|P2|STARTED|Overall Study||35
8083873|NCT03527173|19932322|P1|STARTED|Overall Study||36
8083874|NCT03526055|19932364|P2|NOT COMPLETED|Second Program||0
8083875|NCT03526055|19932365|P1|NOT COMPLETED|Second Program||0
8083876|NCT03526055|19932364|P2|COMPLETED|Second Program||5
8083877|NCT03526055|19932365|P1|COMPLETED|Second Program||5
8083878|NCT03526055|19932364|P2|STARTED|Second Program||5
8083879|NCT03526055|19932365|P1|STARTED|Second Program||5
8083880|NCT03526055|19932364|P2|NOT COMPLETED|Initial Program||0
8083881|NCT03526055|19932365|P1|NOT COMPLETED|Initial Program||0
8083882|NCT03526055|19932364|P2|COMPLETED|Initial Program||5
8083883|NCT03526055|19932365|P1|COMPLETED|Initial Program||5
8083884|NCT03526055|19932364|P2|STARTED|Initial Program||5
8083885|NCT03526055|19932365|P1|STARTED|Initial Program||5
8083886|NCT03525678|19932382|P3|NOT COMPLETED|Overall Study||25
8083887|NCT03525678|19932383|P2|NOT COMPLETED|Overall Study||99
8083888|NCT03525678|19932384|P1|NOT COMPLETED|Overall Study||97
8083889|NCT03525678|19932382|P3|COMPLETED|Overall Study||0
8083890|NCT03525678|19932383|P2|COMPLETED|Overall Study||0
8083891|NCT03525678|19932384|P1|COMPLETED|Overall Study||0
8083892|NCT03525678|19932382|P3|Received Study Treatment|Overall Study||24
8083893|NCT03525678|19932383|P2|Received Study Treatment|Overall Study||99
8083894|NCT03525678|19932384|P1|Received Study Treatment|Overall Study||95
8083895|NCT03525678|19932382|P3|STARTED|Overall Study||25
8083896|NCT03525678|19932383|P2|STARTED|Overall Study||99
8083897|NCT03525678|19932384|P1|STARTED|Overall Study||97
8083898|NCT03525548|19932569|P2|NOT COMPLETED|Overall Study||0
8083899|NCT03525548|19932570|P1|NOT COMPLETED|Overall Study||0
8083900|NCT03525548|19932569|P2|COMPLETED|Overall Study||55
8083901|NCT03525548|19932570|P1|COMPLETED|Overall Study||52
8083902|NCT03525548|19932569|P2|STARTED|Overall Study||55
8083903|NCT03525548|19932570|P1|STARTED|Overall Study||52
8083904|NCT03525444|19932586|P2|NOT COMPLETED|Overall Study||3
8083905|NCT03525444|19932587|P1|NOT COMPLETED|Overall Study||0
8083906|NCT03525444|19932586|P2|COMPLETED|Overall Study||197
8083907|NCT03525444|19932587|P1|COMPLETED|Overall Study||203
8083908|NCT03525444|19932586|P2|Safety Set|Overall Study||202
8083909|NCT03525444|19932587|P1|Safety Set|Overall Study||201
8083910|NCT03525444|19932586|P2|STARTED|Overall Study||200
8083911|NCT03525444|19932587|P1|STARTED|Overall Study||203
8083912|NCT03525210|19932618|P2|NOT COMPLETED|Overall Study||2
8083913|NCT03525210|19932619|P1|NOT COMPLETED|Overall Study||4
8083914|NCT03525210|19932618|P2|COMPLETED|Overall Study||169
8083915|NCT03525210|19932619|P1|COMPLETED|Overall Study||96
8083916|NCT03525210|19932618|P2|STARTED|Overall Study||171
8083917|NCT03525210|19932619|P1|STARTED|Overall Study||100
8083918|NCT03525119|19932630|P3|NOT COMPLETED|Overall Study||43
8083919|NCT03525119|19932631|P2|NOT COMPLETED|Overall Study||39
8083920|NCT03525119|19932632|P1|NOT COMPLETED|Overall Study||40
8083921|NCT03525119|19932630|P3|COMPLETED|Overall Study||257
8083922|NCT03525119|19932631|P2|COMPLETED|Overall Study||261
8083923|NCT03525119|19932632|P1|COMPLETED|Overall Study||260
8083924|NCT03525119|19932630|P3|Safety Population|Overall Study||298
8083925|NCT03525119|19932631|P2|Safety Population|Overall Study||300
8083926|NCT03525119|19932632|P1|Safety Population|Overall Study||299
8083927|NCT03525119|19932630|P3|STARTED|Overall Study||300
8083928|NCT03525119|19932631|P2|STARTED|Overall Study||300
8083929|NCT03525119|19932632|P1|STARTED|Overall Study||300
8083930|NCT03524157|19932667|P3|NOT COMPLETED|Overall Study||1
8083931|NCT03524157|19932668|P2|NOT COMPLETED|Overall Study||0
8083932|NCT03524157|19932669|P1|NOT COMPLETED|Overall Study||0
8083933|NCT03524157|19932667|P3|COMPLETED|Overall Study||9
8083934|NCT03524157|19932668|P2|COMPLETED|Overall Study||10
8083935|NCT03524157|19932669|P1|COMPLETED|Overall Study||10
8083936|NCT03524157|19932667|P3|STARTED|Overall Study||10
8083937|NCT03524157|19932668|P2|STARTED|Overall Study||10
8083938|NCT03524157|19932669|P1|STARTED|Overall Study||10
8083939|NCT03523988|19932707|P3|NOT COMPLETED|Overall Study||18
8083940|NCT03523988|19932708|P2|NOT COMPLETED|Overall Study||16
8083941|NCT03523988|19932709|P1|NOT COMPLETED|Overall Study||17
8083942|NCT03523988|19932707|P3|COMPLETED|Overall Study||7
8083943|NCT03523988|19932708|P2|COMPLETED|Overall Study||8
8083944|NCT03523988|19932709|P1|COMPLETED|Overall Study||7
8083945|NCT03523988|19932707|P3|STARTED|Overall Study||25
8083946|NCT03523988|19932708|P2|STARTED|Overall Study||24
8083947|NCT03523988|19932709|P1|STARTED|Overall Study||24
8083948|NCT03522675|19932723|P1|NOT COMPLETED|Overall Study||2
8083949|NCT03522675|19932723|P1|COMPLETED|Overall Study||20
8083950|NCT03522675|19932723|P1|STARTED|Overall Study||22
8083951|NCT03522506|19932741|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8083952|NCT03522506|19932742|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8083953|NCT03522506|19932743|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8083954|NCT03522506|19932744|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8083955|NCT03522506|19932741|P4|COMPLETED|Treatment Period 4 (2 Days)||3
8083956|NCT03522506|19932742|P3|COMPLETED|Treatment Period 4 (2 Days)||5
8083957|NCT03522506|19932743|P2|COMPLETED|Treatment Period 4 (2 Days)||5
8083958|NCT03522506|19932744|P1|COMPLETED|Treatment Period 4 (2 Days)||5
8083959|NCT03522506|19932741|P4|STARTED|Treatment Period 4 (2 Days)||3
8083960|NCT03522506|19932742|P3|STARTED|Treatment Period 4 (2 Days)||5
8083961|NCT03522506|19932743|P2|STARTED|Treatment Period 4 (2 Days)||5
8083962|NCT03522506|19932744|P1|STARTED|Treatment Period 4 (2 Days)||5
8083963|NCT03522506|19932741|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8083964|NCT03522506|19932742|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8083965|NCT03522506|19932743|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8083966|NCT03522506|19932744|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8083967|NCT03522506|19932741|P4|COMPLETED|Washout Period 3 (7 Days)||3
8083968|NCT03522506|19932742|P3|COMPLETED|Washout Period 3 (7 Days)||5
8083969|NCT03522506|19932743|P2|COMPLETED|Washout Period 3 (7 Days)||5
8083970|NCT03522506|19932744|P1|COMPLETED|Washout Period 3 (7 Days)||5
8083971|NCT03522506|19932741|P4|STARTED|Washout Period 3 (7 Days)||3
8083972|NCT03522506|19932742|P3|STARTED|Washout Period 3 (7 Days)||5
8083973|NCT03522506|19932743|P2|STARTED|Washout Period 3 (7 Days)||5
8083974|NCT03522506|19932744|P1|STARTED|Washout Period 3 (7 Days)||5
8083975|NCT03522506|19932741|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8083976|NCT03522506|19932742|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8083977|NCT03522506|19932743|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8083978|NCT03522506|19932744|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8083979|NCT03522506|19932741|P4|COMPLETED|Treatment Period 3 (2 Days)||3
8083980|NCT03522506|19932742|P3|COMPLETED|Treatment Period 3 (2 Days)||5
8083981|NCT03522506|19932743|P2|COMPLETED|Treatment Period 3 (2 Days)||5
8083982|NCT03522506|19932744|P1|COMPLETED|Treatment Period 3 (2 Days)||5
8083983|NCT03522506|19932741|P4|STARTED|Treatment Period 3 (2 Days)||3
8083984|NCT03522506|19932742|P3|STARTED|Treatment Period 3 (2 Days)||5
8083985|NCT03522506|19932743|P2|STARTED|Treatment Period 3 (2 Days)||5
8083986|NCT03522506|19932744|P1|STARTED|Treatment Period 3 (2 Days)||5
8083987|NCT03522506|19932741|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
8083988|NCT03522506|19932742|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8083989|NCT03522506|19932743|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8083990|NCT03522506|19932744|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8083991|NCT03522506|19932741|P4|COMPLETED|Washout Period 2 (7 Days)||3
8083992|NCT03522506|19932742|P3|COMPLETED|Washout Period 2 (7 Days)||5
8083993|NCT03522506|19932743|P2|COMPLETED|Washout Period 2 (7 Days)||5
8083994|NCT03522506|19932744|P1|COMPLETED|Washout Period 2 (7 Days)||5
8083995|NCT03522506|19932741|P4|STARTED|Washout Period 2 (7 Days)||4
8083996|NCT03522506|19932742|P3|STARTED|Washout Period 2 (7 Days)||5
8083997|NCT03522506|19932743|P2|STARTED|Washout Period 2 (7 Days)||5
8083998|NCT03522506|19932744|P1|STARTED|Washout Period 2 (7 Days)||5
8083999|NCT03522506|19932741|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8084000|NCT03522506|19932742|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8084001|NCT03522506|19932743|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8084002|NCT03522506|19932744|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8084003|NCT03522506|19932741|P4|COMPLETED|Treatment Period 2 (2 Days)||4
8084004|NCT03522506|19932742|P3|COMPLETED|Treatment Period 2 (2 Days)||5
8084005|NCT03522506|19932743|P2|COMPLETED|Treatment Period 2 (2 Days)||5
8084006|NCT03522506|19932744|P1|COMPLETED|Treatment Period 2 (2 Days)||5
8084007|NCT03522506|19932741|P4|STARTED|Treatment Period 2 (2 Days)||4
8084008|NCT03522506|19932742|P3|STARTED|Treatment Period 2 (2 Days)||5
8084009|NCT03522506|19932743|P2|STARTED|Treatment Period 2 (2 Days)||5
8084010|NCT03522506|19932744|P1|STARTED|Treatment Period 2 (2 Days)||5
8084011|NCT03522506|19932741|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8084012|NCT03522506|19932742|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084013|NCT03522506|19932743|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084014|NCT03522506|19932744|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084015|NCT03522506|19932741|P4|COMPLETED|Washout Period 1 (7 Days)||4
8084016|NCT03522506|19932742|P3|COMPLETED|Washout Period 1 (7 Days)||5
8084017|NCT03522506|19932743|P2|COMPLETED|Washout Period 1 (7 Days)||5
8084018|NCT03522506|19932744|P1|COMPLETED|Washout Period 1 (7 Days)||5
8084019|NCT03522506|19932741|P4|STARTED|Washout Period 1 (7 Days)||5
8084020|NCT03522506|19932742|P3|STARTED|Washout Period 1 (7 Days)||5
8084021|NCT03522506|19932743|P2|STARTED|Washout Period 1 (7 Days)||5
8084022|NCT03522506|19932744|P1|STARTED|Washout Period 1 (7 Days)||5
8084023|NCT03522506|19932741|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8084024|NCT03522506|19932742|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8084025|NCT03522506|19932743|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8084026|NCT03522506|19932744|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8084027|NCT03522506|19932741|P4|COMPLETED|Treatment Period 1 (2 Days)||5
8084028|NCT03522506|19932742|P3|COMPLETED|Treatment Period 1 (2 Days)||5
8084029|NCT03522506|19932743|P2|COMPLETED|Treatment Period 1 (2 Days)||5
8084030|NCT03522506|19932744|P1|COMPLETED|Treatment Period 1 (2 Days)||5
8084031|NCT03522506|19932741|P4|STARTED|Treatment Period 1 (2 Days)||5
8084032|NCT03522506|19932742|P3|STARTED|Treatment Period 1 (2 Days)||5
8084033|NCT03522506|19932743|P2|STARTED|Treatment Period 1 (2 Days)||5
8084034|NCT03522506|19932744|P1|STARTED|Treatment Period 1 (2 Days)||5
8084035|NCT03522441|19932795|P3|NOT COMPLETED|Overall Study||11
8084036|NCT03522441|19932796|P2|NOT COMPLETED|Overall Study||19
8084037|NCT03522441|19932797|P1|NOT COMPLETED|Overall Study||26
8084038|NCT03522441|19932795|P3|COMPLETED|Overall Study||214
8084039|NCT03522441|19932796|P2|COMPLETED|Overall Study||431
8084040|NCT03522441|19932797|P1|COMPLETED|Overall Study||424
8084041|NCT03522441|19932795|P3|STARTED|Overall Study||225
8084042|NCT03522441|19932796|P2|STARTED|Overall Study||450
8084043|NCT03522441|19932797|P1|STARTED|Overall Study||450
8084044|NCT03522350|19932808|P2|NOT COMPLETED|Overall Study||0
8084045|NCT03522350|19932809|P1|NOT COMPLETED|Overall Study||0
8084046|NCT03522350|19932808|P2|COMPLETED|Overall Study||18
8084047|NCT03522350|19932809|P1|COMPLETED|Overall Study||18
8084048|NCT03522350|19932808|P2|STARTED|Overall Study||18
8084049|NCT03522350|19932809|P1|STARTED|Overall Study||18
8084050|NCT03521817|19932822|P2|NOT COMPLETED|Overall Study||1
8084051|NCT03521817|19932823|P1|NOT COMPLETED|Overall Study||0
8084052|NCT03521817|19932822|P2|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
8084053|NCT03521817|19932823|P1|COMPLETED|Overall Study||7
8084054|NCT03521817|19932822|P2|STARTED|Overall Study||5
8084055|NCT03521817|19932823|P1|STARTED|Overall Study||7
8084056|NCT03521791|19932831|P2|NOT COMPLETED|Overall Study||17
8084057|NCT03521791|19932832|P1|NOT COMPLETED|Overall Study||7
8084058|NCT03521791|19932831|P2|COMPLETED|Overall Study||73
8084059|NCT03521791|19932832|P1|COMPLETED|Overall Study||69
8084060|NCT03521791|19932831|P2|STARTED|Overall Study||90
8084061|NCT03521791|19932832|P1|STARTED|Overall Study||76
8084062|NCT03521141|19932859|P3|NOT COMPLETED|Overall Study||1
8084063|NCT03521141|19932860|P2|NOT COMPLETED|Overall Study||0
8084064|NCT03521141|19932861|P1|NOT COMPLETED|Overall Study||1
8084065|NCT03521141|19932859|P3|COMPLETED|Overall Study||19
8084066|NCT03521141|19932860|P2|COMPLETED|Overall Study||19
8084067|NCT03521141|19932861|P1|COMPLETED|Overall Study||18
8084068|NCT03521141|19932859|P3|STARTED|Overall Study||20
8084069|NCT03521141|19932860|P2|STARTED|Overall Study||19
8084070|NCT03521141|19932861|P1|STARTED|Overall Study||19
8084071|NCT03521089|19932886|P2|NOT COMPLETED|Overall Study||0
8084072|NCT03521089|19932887|P1|NOT COMPLETED|Overall Study||0
8084073|NCT03521089|19932886|P2|COMPLETED|Overall Study||8
8084074|NCT03521089|19932887|P1|COMPLETED|Overall Study||8
8084075|NCT03521089|19932886|P2|STARTED|Overall Study||8
8084076|NCT03521089|19932887|P1|STARTED|Overall Study||8
8084077|NCT03520959|19932907|P2|NOT COMPLETED|Overall Study||1
8084078|NCT03520959|19932908|P1|NOT COMPLETED|Overall Study||0
8084079|NCT03520959|19932907|P2|COMPLETED|Overall Study||0
8084080|NCT03520959|19932908|P1|COMPLETED|Overall Study||0
8084081|NCT03520959|19932907|P2|STARTED|Overall Study||1
8084082|NCT03520959|19932908|P1|STARTED|Overall Study||0
8084083|NCT03520348|19932930|P2|NOT COMPLETED|Overall Study||0
8084084|NCT03520348|19932931|P1|NOT COMPLETED|Overall Study||0
8084085|NCT03520348|19932930|P2|COMPLETED|Overall Study||12
8084086|NCT03520348|19932931|P1|COMPLETED|Overall Study||12
8084087|NCT03520348|19932930|P2|STARTED|Overall Study||12
8084088|NCT03520348|19932931|P1|STARTED|Overall Study||12
8084089|NCT03519932|19932955|P2|NOT COMPLETED|Second Intervention||0
8084090|NCT03519932|19932956|P1|NOT COMPLETED|Second Intervention||0
8084091|NCT03519932|19932955|P2|COMPLETED|Second Intervention||23
8084092|NCT03519932|19932956|P1|COMPLETED|Second Intervention||22
8084093|NCT03519932|19932955|P2|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
8084094|NCT03519932|19932956|P1|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
8084095|NCT03519932|19932955|P2|NOT COMPLETED|First Intervention||3
8084096|NCT03519932|19932956|P1|NOT COMPLETED|First Intervention||1
8084097|NCT03519932|19932955|P2|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
8084098|NCT03519932|19932956|P1|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
8084099|NCT03519932|19932955|P2|STARTED|First Intervention||25
8084100|NCT03519932|19932956|P1|STARTED|First Intervention||24
8084101|NCT03519919|19932982|P1|NOT COMPLETED|Overall Study||3
8084102|NCT03519919|19932982|P1|COMPLETED|Overall Study||48
8084103|NCT03519919|19932982|P1|STARTED|Overall Study||51
8084104|NCT03519867|19933034|P10|NOT COMPLETED|Overall Study||0
8084105|NCT03519867|19933035|P9|NOT COMPLETED|Overall Study||1
8084106|NCT03519867|19933036|P8|NOT COMPLETED|Overall Study||1
8084107|NCT03519867|19933037|P7|NOT COMPLETED|Overall Study||1
8084108|NCT03519867|19933038|P6|NOT COMPLETED|Overall Study||3
8084109|NCT03519867|19933039|P5|NOT COMPLETED|Overall Study||0
8084110|NCT03519867|19933040|P4|NOT COMPLETED|Overall Study||1
8084111|NCT03519867|19933041|P3|NOT COMPLETED|Overall Study||1
8084112|NCT03519867|19933042|P2|NOT COMPLETED|Overall Study||3
8084113|NCT03519867|19933043|P1|NOT COMPLETED|Overall Study||3
8084114|NCT03519867|19933034|P10|COMPLETED|Overall Study||4
8084115|NCT03519867|19933035|P9|COMPLETED|Overall Study||3
8084116|NCT03519867|19933036|P8|COMPLETED|Overall Study||4
8084117|NCT03519867|19933037|P7|COMPLETED|Overall Study||3
8084118|NCT03519867|19933038|P6|COMPLETED|Overall Study||2
8084119|NCT03519867|19933039|P5|COMPLETED|Overall Study||5
8084120|NCT03519867|19933040|P4|COMPLETED|Overall Study||3
8084121|NCT03519867|19933041|P3|COMPLETED|Overall Study||5
8084122|NCT03519867|19933042|P2|COMPLETED|Overall Study||4
8084123|NCT03519867|19933043|P1|COMPLETED|Overall Study||3
8084124|NCT03519867|19933034|P10|Treated|Overall Study||4
8084125|NCT03519867|19933035|P9|Treated|Overall Study||3
8084126|NCT03519867|19933036|P8|Treated|Overall Study||4
8084127|NCT03519867|19933037|P7|Treated|Overall Study||4
8084128|NCT03519867|19933038|P6|Treated|Overall Study||4
8084129|NCT03519867|19933039|P5|Treated|Overall Study||5
8084130|NCT03519867|19933040|P4|Treated|Overall Study||3
8084131|NCT03519867|19933041|P3|Treated|Overall Study||5
8084132|NCT03519867|19933042|P2|Treated|Overall Study||6
8084133|NCT03519867|19933043|P1|Treated|Overall Study||5
8084134|NCT03519867|19933034|P10|STARTED|Overall Study||4
8084135|NCT03519867|19933035|P9|STARTED|Overall Study||4
8084136|NCT03519867|19933036|P8|STARTED|Overall Study||5
8084137|NCT03519867|19933037|P7|STARTED|Overall Study||4
8084138|NCT03519867|19933038|P6|STARTED|Overall Study||5
8084139|NCT03519867|19933039|P5|STARTED|Overall Study||5
8084140|NCT03519867|19933040|P4|STARTED|Overall Study||4
8084141|NCT03519867|19933041|P3|STARTED|Overall Study||6
8084142|NCT03519867|19933042|P2|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
8084143|NCT03519867|19933043|P1|STARTED|Overall Study||6
8084144|NCT03519854|19933093|P18|NOT COMPLETED|Overall Study||0
8084145|NCT03519854|19933094|P17|NOT COMPLETED|Overall Study||0
8084146|NCT03519854|19933095|P16|NOT COMPLETED|Overall Study||0
8084147|NCT03519854|19933096|P15|NOT COMPLETED|Overall Study||0
8084148|NCT03519854|19933097|P14|NOT COMPLETED|Overall Study||0
8084149|NCT03519854|19933098|P13|NOT COMPLETED|Overall Study||0
8084150|NCT03519854|19933099|P12|NOT COMPLETED|Overall Study||0
8084151|NCT03519854|19933100|P11|NOT COMPLETED|Overall Study||0
8084152|NCT03519854|19933101|P10|NOT COMPLETED|Overall Study||0
8084153|NCT03519854|19933102|P9|NOT COMPLETED|Overall Study||0
8084154|NCT03519854|19933103|P8|NOT COMPLETED|Overall Study||0
8084155|NCT03519854|19933104|P7|NOT COMPLETED|Overall Study||0
8084156|NCT03519854|19933105|P6|NOT COMPLETED|Overall Study||0
8084157|NCT03519854|19933106|P5|NOT COMPLETED|Overall Study||0
8084158|NCT03519854|19933107|P4|NOT COMPLETED|Overall Study||0
8084159|NCT03519854|19933108|P3|NOT COMPLETED|Overall Study||1
8084160|NCT03519854|19933109|P2|NOT COMPLETED|Overall Study||0
8084161|NCT03519854|19933110|P1|NOT COMPLETED|Overall Study||0
8084162|NCT03519854|19933093|P18|COMPLETED|Overall Study||6
8084163|NCT03519854|19933094|P17|COMPLETED|Overall Study||6
8084164|NCT03519854|19933095|P16|COMPLETED|Overall Study||6
8084165|NCT03519854|19933096|P15|COMPLETED|Overall Study||6
8084166|NCT03519854|19933097|P14|COMPLETED|Overall Study||6
8084167|NCT03519854|19933098|P13|COMPLETED|Overall Study||3
8084168|NCT03519854|19933099|P12|COMPLETED|Overall Study||6
8084169|NCT03519854|19933100|P11|COMPLETED|Overall Study||6
8084170|NCT03519854|19933101|P10|COMPLETED|Overall Study||6
8084171|NCT03519854|19933102|P9|COMPLETED|Overall Study||6
8084172|NCT03519854|19933103|P8|COMPLETED|Overall Study||6
8084173|NCT03519854|19933104|P7|COMPLETED|Overall Study||3
8084174|NCT03519854|19933105|P6|COMPLETED|Overall Study||6
8084175|NCT03519854|19933106|P5|COMPLETED|Overall Study||6
8084176|NCT03519854|19933107|P4|COMPLETED|Overall Study||6
8084177|NCT03519854|19933108|P3|COMPLETED|Overall Study||4
8084178|NCT03519854|19933109|P2|COMPLETED|Overall Study||6
8084179|NCT03519854|19933110|P1|COMPLETED|Overall Study||4
8084180|NCT03519854|19933093|P18|Treated|Overall Study||6
8084181|NCT03519854|19933094|P17|Treated|Overall Study||6
8084182|NCT03519854|19933095|P16|Treated|Overall Study||6
8084183|NCT03519854|19933096|P15|Treated|Overall Study||6
8084184|NCT03519854|19933097|P14|Treated|Overall Study||6
8084185|NCT03519854|19933098|P13|Treated|Overall Study||3
8084186|NCT03519854|19933099|P12|Treated|Overall Study||6
8084187|NCT03519854|19933100|P11|Treated|Overall Study||6
8084188|NCT03519854|19933101|P10|Treated|Overall Study||6
8084189|NCT03519854|19933102|P9|Treated|Overall Study||6
8084190|NCT03519854|19933103|P8|Treated|Overall Study||6
8084191|NCT03519854|19933104|P7|Treated|Overall Study||3
8084192|NCT03519854|19933105|P6|Treated|Overall Study||6
8084193|NCT03519854|19933106|P5|Treated|Overall Study||6
8084194|NCT03519854|19933107|P4|Treated|Overall Study||6
8084195|NCT03519854|19933108|P3|Treated|Overall Study||4
8084196|NCT03519854|19933109|P2|Treated|Overall Study||6
8084197|NCT03519854|19933110|P1|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
8084198|NCT03519854|19933093|P18|STARTED|Overall Study||6
8084199|NCT03519854|19933094|P17|STARTED|Overall Study||6
8084200|NCT03519854|19933095|P16|STARTED|Overall Study||6
8084201|NCT03519854|19933096|P15|STARTED|Overall Study||6
8084202|NCT03519854|19933097|P14|STARTED|Overall Study||6
8084203|NCT03519854|19933098|P13|STARTED|Overall Study||3
8084204|NCT03519854|19933099|P12|STARTED|Overall Study||6
8084205|NCT03519854|19933100|P11|STARTED|Overall Study||6
8084206|NCT03519854|19933101|P10|STARTED|Overall Study||6
8084207|NCT03519854|19933102|P9|STARTED|Overall Study||6
8084208|NCT03519854|19933103|P8|STARTED|Overall Study||6
8084209|NCT03519854|19933104|P7|STARTED|Overall Study||3
8084210|NCT03519854|19933105|P6|STARTED|Overall Study||6
8084211|NCT03519854|19933106|P5|STARTED|Overall Study||6
8084212|NCT03519854|19933107|P4|STARTED|Overall Study||6
8084213|NCT03519854|19933108|P3|STARTED|Overall Study||5
8084214|NCT03519854|19933109|P2|STARTED|Overall Study||6
8084215|NCT03519854|19933110|P1|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
8084216|NCT03519516|19933276|P2|NOT COMPLETED|Overall Study||1
8084217|NCT03519516|19933277|P1|NOT COMPLETED|Overall Study||0
8084218|NCT03519516|19933276|P2|COMPLETED|Overall Study||14
8084219|NCT03519516|19933277|P1|COMPLETED|Overall Study||15
8084220|NCT03519516|19933276|P2|STARTED|Overall Study||15
8084221|NCT03519516|19933277|P1|STARTED|Overall Study||15
8084222|NCT03519282|19933301|P2|NOT COMPLETED|Second Intervention||0
8084223|NCT03519282|19933302|P1|NOT COMPLETED|Second Intervention||0
8084224|NCT03519282|19933301|P2|COMPLETED|Second Intervention||5
8084225|NCT03519282|19933302|P1|COMPLETED|Second Intervention||5
8084226|NCT03519282|19933301|P2|STARTED|Second Intervention||5
8084227|NCT03519282|19933302|P1|STARTED|Second Intervention||5
8084228|NCT03519282|19933301|P2|NOT COMPLETED|First Intervention||0
8084229|NCT03519282|19933302|P1|NOT COMPLETED|First Intervention||0
8084230|NCT03519282|19933301|P2|COMPLETED|First Intervention||5
8084231|NCT03519282|19933302|P1|COMPLETED|First Intervention||5
8084232|NCT03519282|19933301|P2|STARTED|First Intervention||5
8084233|NCT03519282|19933302|P1|STARTED|First Intervention||5
8084234|NCT03519243|19933317|P4|NOT COMPLETED|Overall Study||1
8084235|NCT03519243|19933318|P3|NOT COMPLETED|Overall Study||0
8084236|NCT03519243|19933319|P2|NOT COMPLETED|Overall Study||4
8084237|NCT03519243|19933320|P1|NOT COMPLETED|Overall Study||5
8084238|NCT03519243|19933317|P4|COMPLETED|Overall Study||24
8084239|NCT03519243|19933318|P3|COMPLETED|Overall Study||0
8084240|NCT03519243|19933319|P2|COMPLETED|Overall Study||21
8084241|NCT03519243|19933320|P1|COMPLETED|Overall Study||20
8084242|NCT03519243|19933317|P4|STARTED|Overall Study||25
8084243|NCT03519243|19933318|P3|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
8084244|NCT03519243|19933319|P2|STARTED|Overall Study||25
8084245|NCT03519243|19933320|P1|STARTED|Overall Study||25
8084246|NCT03519204|19933351|P2|NOT COMPLETED|Overall Study||15
8084247|NCT03519204|19933352|P1|NOT COMPLETED|Overall Study||13
8084248|NCT03519204|19933351|P2|COMPLETED|Overall Study||118
8084249|NCT03519204|19933352|P1|COMPLETED|Overall Study||30
8084250|NCT03519204|19933351|P2|Safety Population|Overall Study||136
8084251|NCT03519204|19933352|P1|Safety Population|Overall Study||40
8084252|NCT03519204|19933351|P2|mITT Population|Overall Study||130
8084253|NCT03519204|19933352|P1|mITT Population|Overall Study||33
8084254|NCT03519204|19933351|P2|STARTED|Overall Study||133
8084255|NCT03519204|19933352|P1|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
8084256|NCT03519087|19933371|P5|NOT COMPLETED|Laboratory Testing||6
8084257|NCT03519087|19933372|P4|NOT COMPLETED|Laboratory Testing||4
8084258|NCT03519087|19933373|P3|NOT COMPLETED|Laboratory Testing||2
8084259|NCT03519087|19933374|P2|NOT COMPLETED|Laboratory Testing||0
8084260|NCT03519087|19933375|P1|NOT COMPLETED|Laboratory Testing||0
8084261|NCT03519087|19933371|P5|COMPLETED|Laboratory Testing||1
8084262|NCT03519087|19933372|P4|COMPLETED|Laboratory Testing||2
8084263|NCT03519087|19933373|P3|COMPLETED|Laboratory Testing||4
8084264|NCT03519087|19933374|P2|COMPLETED|Laboratory Testing||0
8084265|NCT03519087|19933375|P1|COMPLETED|Laboratory Testing||0
8084266|NCT03519087|19933371|P5|Baseline Lab Testing|Laboratory Testing||3
8084267|NCT03519087|19933372|P4|Baseline Lab Testing|Laboratory Testing||4
8084268|NCT03519087|19933373|P3|Baseline Lab Testing|Laboratory Testing||5
8084269|NCT03519087|19933374|P2|Baseline Lab Testing|Laboratory Testing||0
8084270|NCT03519087|19933375|P1|Baseline Lab Testing|Laboratory Testing||0
8084271|NCT03519087|19933371|P5|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
8084272|NCT03519087|19933372|P4|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
8084273|NCT03519087|19933373|P3|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
8084274|NCT03519087|19933374|P2|STARTED|Laboratory Testing||0
8084275|NCT03519087|19933375|P1|STARTED|Laboratory Testing||0
8084276|NCT03519087|19933371|P5|NOT COMPLETED|Re-randomization for Treatment||0
8084277|NCT03519087|19933372|P4|NOT COMPLETED|Re-randomization for Treatment||0
8084278|NCT03519087|19933373|P3|NOT COMPLETED|Re-randomization for Treatment||0
8084279|NCT03519087|19933374|P2|NOT COMPLETED|Re-randomization for Treatment||32
8084280|NCT03519087|19933375|P1|NOT COMPLETED|Re-randomization for Treatment||27
8084281|NCT03519087|19933371|P5|COMPLETED|Re-randomization for Treatment||0
8084282|NCT03519087|19933372|P4|COMPLETED|Re-randomization for Treatment||0
8084283|NCT03519087|19933373|P3|COMPLETED|Re-randomization for Treatment||0
8084284|NCT03519087|19933374|P2|COMPLETED|Re-randomization for Treatment||7
8084285|NCT03519087|19933375|P1|COMPLETED|Re-randomization for Treatment||12
8084286|NCT03519087|19933371|P5|STARTED|Re-randomization for Treatment||0
8084287|NCT03519087|19933372|P4|STARTED|Re-randomization for Treatment||0
8084288|NCT03519087|19933373|P3|STARTED|Re-randomization for Treatment||0
8084289|NCT03519087|19933374|P2|STARTED|Re-randomization for Treatment||39
8084290|NCT03519087|19933375|P1|STARTED|Re-randomization for Treatment||39
8084291|NCT03519087|19933371|P5|NOT COMPLETED|Clinic Evaluation||0
8084292|NCT03519087|19933372|P4|NOT COMPLETED|Clinic Evaluation||0
8084293|NCT03519087|19933373|P3|NOT COMPLETED|Clinic Evaluation||0
8084294|NCT03519087|19933374|P2|NOT COMPLETED|Clinic Evaluation||18
8084295|NCT03519087|19933375|P1|NOT COMPLETED|Clinic Evaluation||16
8084296|NCT03519087|19933371|P5|COMPLETED|Clinic Evaluation||0
8084297|NCT03519087|19933372|P4|COMPLETED|Clinic Evaluation||0
8084298|NCT03519087|19933373|P3|COMPLETED|Clinic Evaluation||0
8084299|NCT03519087|19933374|P2|COMPLETED|Clinic Evaluation||39
8084300|NCT03519087|19933375|P1|COMPLETED|Clinic Evaluation||39
8084301|NCT03519087|19933371|P5|Confirmed Diagnosis by Physician|Clinic Evaluation||0
8084302|NCT03519087|19933372|P4|Confirmed Diagnosis by Physician|Clinic Evaluation||0
8084303|NCT03519087|19933373|P3|Confirmed Diagnosis by Physician|Clinic Evaluation||0
8084304|NCT03519087|19933374|P2|Confirmed Diagnosis by Physician|Clinic Evaluation||39
8084305|NCT03519087|19933375|P1|Confirmed Diagnosis by Physician|Clinic Evaluation||39
8084306|NCT03519087|19933371|P5|Received Assigned Intervention|Clinic Evaluation||0
8084307|NCT03519087|19933372|P4|Received Assigned Intervention|Clinic Evaluation||0
8084308|NCT03519087|19933373|P3|Received Assigned Intervention|Clinic Evaluation||0
8084309|NCT03519087|19933374|P2|Received Assigned Intervention|Clinic Evaluation||57
8084310|NCT03519087|19933375|P1|Received Assigned Intervention|Clinic Evaluation||54
8084311|NCT03519087|19933371|P5|STARTED|Clinic Evaluation||0
8084312|NCT03519087|19933372|P4|STARTED|Clinic Evaluation||0
8084313|NCT03519087|19933373|P3|STARTED|Clinic Evaluation||0
8084314|NCT03519087|19933374|P2|STARTED|Clinic Evaluation||57
8084315|NCT03519087|19933375|P1|STARTED|Clinic Evaluation||55
8084316|NCT03518840|19933411|P1|NOT COMPLETED|Overall Study||6
8084317|NCT03518840|19933411|P1|COMPLETED|Overall Study||57
8084318|NCT03518840|19933411|P1|STARTED|Overall Study||63
8084319|NCT03518125|19933424|P6|NOT COMPLETED|Overall Study||8
8084320|NCT03518125|19933425|P5|NOT COMPLETED|Overall Study||4
8084321|NCT03518125|19933426|P4|NOT COMPLETED|Overall Study||1
8084322|NCT03518125|19933427|P3|NOT COMPLETED|Overall Study||0
8084323|NCT03518125|19933428|P2|NOT COMPLETED|Overall Study||4
8084324|NCT03518125|19933429|P1|NOT COMPLETED|Overall Study||2
8084325|NCT03518125|19933424|P6|COMPLETED|Overall Study||44
8084326|NCT03518125|19933425|P5|COMPLETED|Overall Study||48
8084327|NCT03518125|19933426|P4|COMPLETED|Overall Study||51
8084328|NCT03518125|19933427|P3|COMPLETED|Overall Study||49
8084329|NCT03518125|19933428|P2|COMPLETED|Overall Study||46
8084330|NCT03518125|19933429|P1|COMPLETED|Overall Study||48
8084331|NCT03518125|19933424|P6|STARTED|Overall Study||52
8084332|NCT03518125|19933425|P5|STARTED|Overall Study||52
8084333|NCT03518125|19933426|P4|STARTED|Overall Study||52
8084334|NCT03518125|19933427|P3|STARTED|Overall Study||49
8084335|NCT03518125|19933428|P2|STARTED|Overall Study||50
8084336|NCT03518125|19933429|P1|STARTED|Overall Study||50
8084337|NCT03518008|19933527|P2|NOT COMPLETED|Period 2, Second Week of Wear||1
8084338|NCT03518008|19933528|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
8084339|NCT03518008|19933527|P2|COMPLETED|Period 2, Second Week of Wear||10
8084340|NCT03518008|19933528|P1|COMPLETED|Period 2, Second Week of Wear||11
8084341|NCT03518008|19933527|P2|STARTED|Period 2, Second Week of Wear||11
8084342|NCT03518008|19933528|P1|STARTED|Period 2, Second Week of Wear||11
8084343|NCT03518008|19933527|P2|NOT COMPLETED|Period 1, First Week of Wear||0
8084344|NCT03518008|19933528|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8084345|NCT03518008|19933527|P2|COMPLETED|Period 1, First Week of Wear||11
8084346|NCT03518008|19933528|P1|COMPLETED|Period 1, First Week of Wear||11
8084347|NCT03518008|19933527|P2|STARTED|Period 1, First Week of Wear||11
8084348|NCT03518008|19933528|P1|STARTED|Period 1, First Week of Wear||11
8084349|NCT03516227|19933536|P2|NOT COMPLETED|Overall Study||4
8084350|NCT03516227|19933537|P1|NOT COMPLETED|Overall Study||1
8084351|NCT03516227|19933536|P2|COMPLETED|Overall Study||16
8084352|NCT03516227|19933537|P1|COMPLETED|Overall Study||19
8084353|NCT03516227|19933536|P2|STARTED|Overall Study||20
8084354|NCT03516227|19933537|P1|STARTED|Overall Study||20
8084355|NCT03515941|19933553|P2|NOT COMPLETED|Overall Study||0
8084356|NCT03515941|19933554|P1|NOT COMPLETED|Overall Study||1
8084357|NCT03515941|19933553|P2|COMPLETED|Overall Study||2
8084358|NCT03515941|19933554|P1|COMPLETED|Overall Study||3
8084359|NCT03515941|19933553|P2|STARTED|Overall Study||2
8084360|NCT03515941|19933554|P1|STARTED|Overall Study||4
8084361|NCT03515681|19933564|P2|NOT COMPLETED|Overall Study||47
8084362|NCT03515681|19933565|P1|NOT COMPLETED|Overall Study||41
8084363|NCT03515681|19933564|P2|COMPLETED|Overall Study||25
8084364|NCT03515681|19933565|P1|COMPLETED|Overall Study||37
8084365|NCT03515681|19933564|P2|Completed at 6 Months|Overall Study||62
8084366|NCT03515681|19933565|P1|Completed at 6 Months|Overall Study||61
8084367|NCT03515681|19933564|P2|Randomized|Overall Study||70
8084368|NCT03515681|19933565|P1|Randomized|Overall Study||70
8084369|NCT03515681|19933564|P2|STARTED|Overall Study||72
8084370|NCT03515681|19933565|P1|STARTED|Overall Study||78
8084371|NCT03514966|19933585|P2|NOT COMPLETED|Overall Study||0
8084372|NCT03514966|19933586|P1|NOT COMPLETED|Overall Study||0
8084373|NCT03514966|19933585|P2|COMPLETED|Overall Study||43
8084374|NCT03514966|19933586|P1|COMPLETED|Overall Study||40
8084375|NCT03514966|19933585|P2|STARTED|Overall Study||43
8084376|NCT03514966|19933586|P1|STARTED|Overall Study||40
8084377|NCT03514277|19933599|P3|NOT COMPLETED|Overall Study||0
8084378|NCT03514277|19933600|P2|NOT COMPLETED|Overall Study||0
8084379|NCT03514277|19933601|P1|NOT COMPLETED|Overall Study||0
8084380|NCT03514277|19933599|P3|COMPLETED|Overall Study||4
8084381|NCT03514277|19933600|P2|COMPLETED|Overall Study||4
8084382|NCT03514277|19933601|P1|COMPLETED|Overall Study||11
8084383|NCT03514277|19933599|P3|STARTED|Overall Study||4
8084384|NCT03514277|19933600|P2|STARTED|Overall Study||4
8084385|NCT03514277|19933601|P1|STARTED|Overall Study||11
8084386|NCT03513848|19933620|P2|NOT COMPLETED|Overall Study||0
8084387|NCT03513848|19933621|P1|NOT COMPLETED|Overall Study||0
8084388|NCT03513848|19933620|P2|COMPLETED|Overall Study||6
8084389|NCT03513848|19933621|P1|COMPLETED|Overall Study||9
8084390|NCT03513848|19933620|P2|STARTED|Overall Study||6
8084391|NCT03513848|19933621|P1|STARTED|Overall Study||9
8084392|NCT03513757|19933631|P2|NOT COMPLETED|Overall Study||0
8084393|NCT03513757|19933632|P1|NOT COMPLETED|Overall Study||0
8084394|NCT03513757|19933631|P2|COMPLETED|Overall Study||18
8084395|NCT03513757|19933632|P1|COMPLETED|Overall Study||22
8084396|NCT03513757|19933631|P2|STARTED|Overall Study||18
8084397|NCT03513757|19933632|P1|STARTED|Overall Study||22
8084398|NCT03513588|19933665|P3|NOT COMPLETED|Overall Study||2
8084399|NCT03513588|19933666|P2|NOT COMPLETED|Overall Study||2
8084400|NCT03513588|19933667|P1|NOT COMPLETED|Overall Study||1
8084401|NCT03513588|19933665|P3|COMPLETED|Overall Study||13
8084402|NCT03513588|19933666|P2|COMPLETED|Overall Study||15
8084403|NCT03513588|19933667|P1|COMPLETED|Overall Study||15
8084404|NCT03513588|19933665|P3|STARTED|Overall Study||15
8084405|NCT03513588|19933666|P2|STARTED|Overall Study||17
8084406|NCT03513588|19933667|P1|STARTED|Overall Study||16
8084407|NCT03512457|19933701|P2|NOT COMPLETED|Overall Study||40
8084408|NCT03512457|19933702|P1|NOT COMPLETED|Overall Study||34
8084409|NCT03512457|19933701|P2|COMPLETED|Overall Study||185
8084410|NCT03512457|19933702|P1|COMPLETED|Overall Study||161
8084411|NCT03512457|19933701|P2|STARTED|Overall Study||225
8084412|NCT03512457|19933702|P1|STARTED|Overall Study||195
8084413|NCT03512353|19933710|P1|NOT COMPLETED|Overall Study||4
8084414|NCT03512353|19933710|P1|COMPLETED|Overall Study||3
8084415|NCT03512353|19933710|P1|Received Treatment|Overall Study||6
8084416|NCT03512353|19933710|P1|STARTED|Overall Study||7
8084417|NCT03512067|19933736|P1|NOT COMPLETED|Overall Study||0
8084418|NCT03512067|19933736|P1|COMPLETED|Overall Study||1
8084419|NCT03512067|19933736|P1|STARTED|Overall Study||1
8084420|NCT03512041|19933745|P4|NOT COMPLETED|Overall Study||0
8084421|NCT03512041|19933746|P3|NOT COMPLETED|Overall Study||0
8084422|NCT03512041|19933747|P2|NOT COMPLETED|Overall Study||0
8084423|NCT03512041|19933748|P1|NOT COMPLETED|Overall Study||0
8084424|NCT03512041|19933745|P4|COMPLETED|Overall Study||9
8084425|NCT03512041|19933746|P3|COMPLETED|Overall Study||11
8084426|NCT03512041|19933747|P2|COMPLETED|Overall Study||10
8084427|NCT03512041|19933748|P1|COMPLETED|Overall Study||10
8084428|NCT03512041|19933745|P4|STARTED|Overall Study||9
8084429|NCT03512041|19933746|P3|STARTED|Overall Study||11
8084430|NCT03512041|19933747|P2|STARTED|Overall Study||10
8084431|NCT03512041|19933748|P1|STARTED|Overall Study||10
8084432|NCT03512028|19933768|P2|NOT COMPLETED|Overall Study||0
8084433|NCT03512028|19933769|P1|NOT COMPLETED|Overall Study||4
8084434|NCT03512028|19933768|P2|COMPLETED|Overall Study||15
8084435|NCT03512028|19933769|P1|COMPLETED|Overall Study||15
8084436|NCT03512028|19933768|P2|STARTED|Overall Study||15
8084437|NCT03512028|19933769|P1|STARTED|Overall Study||19
8084438|NCT03511521|19933777|P2|NOT COMPLETED|Overall Study||0
8084439|NCT03511521|19933778|P1|NOT COMPLETED|Overall Study||0
8084440|NCT03511521|19933777|P2|COMPLETED|Overall Study||1
8084441|NCT03511521|19933778|P1|COMPLETED|Overall Study||2
8084442|NCT03511521|19933777|P2|STARTED|Overall Study||1
8084443|NCT03511521|19933778|P1|STARTED|Overall Study||2
8084447|NCT03511105|19933795|P2|NOT COMPLETED|Overall Study||0
8084448|NCT03511105|19933796|P1|NOT COMPLETED|Overall Study||2
8084449|NCT03511105|19933795|P2|COMPLETED|Overall Study||22
8084450|NCT03511105|19933796|P1|COMPLETED|Overall Study||23
8084451|NCT03511105|19933795|P2|STARTED|Overall Study||22
8084452|NCT03511105|19933796|P1|STARTED|Overall Study||25
8084453|NCT03510910|19933852|P2|NOT COMPLETED|Overall Study||3
8084454|NCT03510910|19933853|P1|NOT COMPLETED|Overall Study||2
8084455|NCT03510910|19933852|P2|COMPLETED|Overall Study||40
8084456|NCT03510910|19933853|P1|COMPLETED|Overall Study||40
8084457|NCT03510910|19933852|P2|STARTED|Overall Study||43
8084458|NCT03510910|19933853|P1|STARTED|Overall Study||42
8084459|NCT03510715|19933869|P2|NOT COMPLETED|Overall Study||0
8084460|NCT03510715|19933870|P1|NOT COMPLETED|Overall Study||1
8084461|NCT03510715|19933869|P2|COMPLETED|Overall Study||9
8084462|NCT03510715|19933870|P1|COMPLETED|Overall Study||8
8084463|NCT03510715|19933869|P2|STARTED|Overall Study||9
8084464|NCT03510715|19933870|P1|STARTED|Overall Study||9
8084465|NCT03510273|19933888|P1|NOT COMPLETED|Overall Study||9
8084466|NCT03510273|19933888|P1|COMPLETED|Overall Study||310
8084467|NCT03510273|19933888|P1|Completed All One-year Follow up Visits|Overall Study||118
8084468|NCT03510273|19933888|P1|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
8084469|NCT03510273|19933888|P1|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
8084470|NCT03510273|19933888|P1|Treated With Thermal Coagulation|Overall Study||319
8084471|NCT03510273|19933888|P1|STARTED|Overall Study||319
8084472|NCT03510195|19933897|P1|NOT COMPLETED|Overall Study||166
8084473|NCT03510195|19933897|P1|COMPLETED|Overall Study||101
8084474|NCT03510195|19933897|P1|STARTED|Overall Study||267
8084475|NCT03509948|19933911|P2|NOT COMPLETED|Overall Study||1
8084476|NCT03509948|19933912|P1|NOT COMPLETED|Overall Study||0
8084477|NCT03509948|19933911|P2|COMPLETED|Overall Study||6
8084478|NCT03509948|19933912|P1|COMPLETED|Overall Study||6
8084479|NCT03509948|19933911|P2|STARTED|Overall Study||7
8084480|NCT03509948|19933912|P1|STARTED|Overall Study||6
8084481|NCT03509883|19933936|P2|NOT COMPLETED|Cross-over and Treatment||0
8084482|NCT03509883|19933937|P1|NOT COMPLETED|Cross-over and Treatment||0
8084483|NCT03509883|19933936|P2|COMPLETED|Cross-over and Treatment||15
8084484|NCT03509883|19933937|P1|COMPLETED|Cross-over and Treatment||15
8084485|NCT03509883|19933936|P2|STARTED|Cross-over and Treatment||15
8084486|NCT03509883|19933937|P1|STARTED|Cross-over and Treatment||15
8084487|NCT03509883|19933936|P2|NOT COMPLETED|Initial Treatment Washout||0
8084488|NCT03509883|19933937|P1|NOT COMPLETED|Initial Treatment Washout||0
8084489|NCT03509883|19933936|P2|COMPLETED|Initial Treatment Washout||15
8084490|NCT03509883|19933937|P1|COMPLETED|Initial Treatment Washout||15
8084491|NCT03509883|19933936|P2|STARTED|Initial Treatment Washout||15
8084492|NCT03509883|19933937|P1|STARTED|Initial Treatment Washout||15
8084493|NCT03509883|19933936|P2|NOT COMPLETED|Initial Treatment||0
8084494|NCT03509883|19933937|P1|NOT COMPLETED|Initial Treatment||0
8084495|NCT03509883|19933936|P2|COMPLETED|Initial Treatment||15
8084496|NCT03509883|19933937|P1|COMPLETED|Initial Treatment||15
8084497|NCT03509883|19933936|P2|STARTED|Initial Treatment||15
8084498|NCT03509883|19933937|P1|STARTED|Initial Treatment||15
8084499|NCT03509766|19933972|P1|NOT COMPLETED|Overall Study||0
8084500|NCT03509766|19933972|P1|COMPLETED|Overall Study||24
8084501|NCT03509766|19933972|P1|STARTED|Overall Study||24
8084502|NCT03509675|19933980|P2|NOT COMPLETED|Second Intervention )7 Days)||0
8084503|NCT03509675|19933981|P1|NOT COMPLETED|Second Intervention )7 Days)||2
8084504|NCT03509675|19933980|P2|COMPLETED|Second Intervention )7 Days)||8
8084505|NCT03509675|19933981|P1|COMPLETED|Second Intervention )7 Days)||4
8084506|NCT03509675|19933980|P2|STARTED|Second Intervention )7 Days)||8
8084507|NCT03509675|19933981|P1|STARTED|Second Intervention )7 Days)||6
8084508|NCT03509675|19933980|P2|NOT COMPLETED|Washout Period (7 Days)||0
8084509|NCT03509675|19933981|P1|NOT COMPLETED|Washout Period (7 Days)||0
8084510|NCT03509675|19933980|P2|COMPLETED|Washout Period (7 Days)||8
8084511|NCT03509675|19933981|P1|COMPLETED|Washout Period (7 Days)||6
8084512|NCT03509675|19933980|P2|STARTED|Washout Period (7 Days)||8
8084513|NCT03509675|19933981|P1|STARTED|Washout Period (7 Days)||6
8084514|NCT03509675|19933980|P2|NOT COMPLETED|First Intervention (7 Days)||4
8084515|NCT03509675|19933981|P1|NOT COMPLETED|First Intervention (7 Days)||5
8084516|NCT03509675|19933980|P2|COMPLETED|First Intervention (7 Days)||8
8084517|NCT03509675|19933981|P1|COMPLETED|First Intervention (7 Days)||6
8084518|NCT03509675|19933980|P2|STARTED|First Intervention (7 Days)||12
8084519|NCT03509675|19933981|P1|STARTED|First Intervention (7 Days)||11
8084520|NCT03509350|19933989|P2|NOT COMPLETED|Overall Study||2
8084521|NCT03509350|19933990|P1|NOT COMPLETED|Overall Study||0
8084522|NCT03509350|19933989|P2|COMPLETED|Overall Study||247
8084523|NCT03509350|19933990|P1|COMPLETED|Overall Study||252
8084524|NCT03509350|19933989|P2|STARTED|Overall Study||249
8084525|NCT03509350|19933990|P1|STARTED|Overall Study||252
8084526|NCT03509207|19933996|P1|NOT COMPLETED|Overall Study||2
8084527|NCT03509207|19933996|P1|COMPLETED|Overall Study||1
8084528|NCT03509207|19933996|P1|STARTED|Overall Study||3
8084529|NCT03508843|19934001|P1|NOT COMPLETED|Overall Study||3
8084530|NCT03508843|19934001|P1|COMPLETED|Overall Study||147
8084531|NCT03508843|19934001|P1|STARTED|Overall Study||150
8084532|NCT03508687|19934009|P2|NOT COMPLETED|Overall Study||0
8084533|NCT03508687|19934010|P1|NOT COMPLETED|Overall Study||0
8084534|NCT03508687|19934009|P2|COMPLETED|Overall Study||3
8084535|NCT03508687|19934010|P1|COMPLETED|Overall Study||2
8084536|NCT03508687|19934009|P2|STARTED|Overall Study||3
8084537|NCT03508687|19934010|P1|STARTED|Overall Study||2
8084538|NCT03508661|19934052|P1|NOT COMPLETED|Overall Study||0
8084539|NCT03508661|19934052|P1|COMPLETED|Overall Study||10
8084540|NCT03508661|19934052|P1|STARTED|Overall Study||10
8084541|NCT03508609|19934066|P1|NOT COMPLETED|Overall Study||1
8084542|NCT03508609|19934066|P1|COMPLETED|Overall Study||19
8084543|NCT03508609|19934066|P1|STARTED|Overall Study||20
8084544|NCT03508050|19934078|P2|NOT COMPLETED|Overall Study||2
8084545|NCT03508050|19934079|P1|NOT COMPLETED|Overall Study||5
8084546|NCT03508050|19934078|P2|COMPLETED|Overall Study||15
8084547|NCT03508050|19934079|P1|COMPLETED|Overall Study||15
8084548|NCT03508050|19934078|P2|STARTED|Overall Study||17
8084549|NCT03508050|19934079|P1|STARTED|Overall Study||20
8084550|NCT03507569|19934113|P4|NOT COMPLETED|Overall Study||0
8084551|NCT03507569|19934114|P3|NOT COMPLETED|Overall Study||0
8084552|NCT03507569|19934115|P2|NOT COMPLETED|Overall Study||0
8084553|NCT03507569|19934116|P1|NOT COMPLETED|Overall Study||0
8084554|NCT03507569|19934113|P4|COMPLETED|Overall Study||1
8084555|NCT03507569|19934114|P3|COMPLETED|Overall Study||2
8084556|NCT03507569|19934115|P2|COMPLETED|Overall Study||1
8084557|NCT03507569|19934116|P1|COMPLETED|Overall Study||2
8084558|NCT03507569|19934113|P4|STARTED|Overall Study||1
8084559|NCT03507569|19934114|P3|STARTED|Overall Study||2
8084560|NCT03507569|19934115|P2|STARTED|Overall Study||1
8084561|NCT03507569|19934116|P1|STARTED|Overall Study||2
8084562|NCT03507036|19934134|P1|NOT COMPLETED|Overall Study||5
8084563|NCT03507036|19934134|P1|COMPLETED|Overall Study||15
8084564|NCT03507036|19934134|P1|STARTED|Overall Study||20
8084565|NCT03506477|19934154|P2|NOT COMPLETED|Overall Study||0
8084566|NCT03506477|19934155|P1|NOT COMPLETED|Overall Study||1
8084567|NCT03506477|19934154|P2|COMPLETED|Overall Study||5
8084568|NCT03506477|19934155|P1|COMPLETED|Overall Study||19
8084569|NCT03506477|19934154|P2|STARTED|Overall Study||5
8084570|NCT03506477|19934155|P1|STARTED|Overall Study||20
8084571|NCT03506425|19934184|P3|NOT COMPLETED|Overall Study||1
8084572|NCT03506425|19934185|P2|NOT COMPLETED|Overall Study||3
8084573|NCT03506425|19934186|P1|NOT COMPLETED|Overall Study||2
8084574|NCT03506425|19934184|P3|COMPLETED|Overall Study||4
8084575|NCT03506425|19934185|P2|COMPLETED|Overall Study||2
8084576|NCT03506425|19934186|P1|COMPLETED|Overall Study||3
8084577|NCT03506425|19934184|P3|STARTED|Overall Study||5
8084578|NCT03506425|19934185|P2|STARTED|Overall Study||5
8084579|NCT03506425|19934186|P1|STARTED|Overall Study||5
8084580|NCT03506347|19934199|P2|NOT COMPLETED|Overall Study||0
8084581|NCT03506347|19934200|P1|NOT COMPLETED|Overall Study||0
8084582|NCT03506347|19934199|P2|COMPLETED|Overall Study||12
8084583|NCT03506347|19934200|P1|COMPLETED|Overall Study||12
8084584|NCT03506347|19934199|P2|STARTED|Overall Study||12
8084585|NCT03506347|19934200|P1|STARTED|Overall Study||12
8084586|NCT03506295|19934208|P1|NOT COMPLETED|Overall Study||0
8084587|NCT03506295|19934208|P1|COMPLETED|Overall Study||10
8084588|NCT03506295|19934208|P1|STARTED|Overall Study||10
8084589|NCT03505593|19934221|P1|NOT COMPLETED|Overall Study||5
8084590|NCT03505593|19934221|P1|COMPLETED|Overall Study||43
8084591|NCT03505593|19934221|P1|STARTED|Overall Study||48
8084592|NCT03505372|19934227|P1|NOT COMPLETED|Overall Study||0
8084593|NCT03505372|19934227|P1|COMPLETED|Overall Study||5
8084594|NCT03505372|19934227|P1|STARTED|Overall Study||5
8084595|NCT03505190|19934237|P5|NOT COMPLETED|Overall Study||0
8084596|NCT03505190|19934238|P4|NOT COMPLETED|Overall Study||0
8084597|NCT03505190|19934239|P3|NOT COMPLETED|Overall Study||0
8084598|NCT03505190|19934240|P2|NOT COMPLETED|Overall Study||0
8084599|NCT03505190|19934241|P1|NOT COMPLETED|Overall Study||0
8084600|NCT03505190|19934237|P5|COMPLETED|Overall Study||8
8084601|NCT03505190|19934238|P4|COMPLETED|Overall Study||8
8084602|NCT03505190|19934239|P3|COMPLETED|Overall Study||8
8084603|NCT03505190|19934240|P2|COMPLETED|Overall Study||8
8084604|NCT03505190|19934241|P1|COMPLETED|Overall Study||9
8084605|NCT03505190|19934237|P5|STARTED|Overall Study||8
8084606|NCT03505190|19934238|P4|STARTED|Overall Study||8
8084607|NCT03505190|19934239|P3|STARTED|Overall Study||8
8084608|NCT03505190|19934240|P2|STARTED|Overall Study||8
8084609|NCT03505190|19934241|P1|STARTED|Overall Study||9
8084610|NCT03504189|19934318|P1|NOT COMPLETED|Overall Study||4
8084611|NCT03504189|19934318|P1|COMPLETED|Overall Study||147
8084612|NCT03504189|19934318|P1|STARTED|Overall Study||151
8084613|NCT03503578|19934327|P1|NOT COMPLETED|Overall Study||0
8084614|NCT03503578|19934327|P1|COMPLETED|Overall Study||12
8084615|NCT03503578|19934327|P1|STARTED|Overall Study||12
8084616|NCT03503292|19934333|P2|NOT COMPLETED|Overall Study||0
8084617|NCT03503292|19934334|P1|NOT COMPLETED|Overall Study||0
8084618|NCT03503292|19934333|P2|COMPLETED|Overall Study||90
8084619|NCT03503292|19934334|P1|COMPLETED|Overall Study||2
8084620|NCT03503292|19934333|P2|STARTED|Overall Study||90
8084621|NCT03503292|19934334|P1|STARTED|Overall Study||2
8084622|NCT03503188|19934344|P2|NOT COMPLETED|Overall Study||1
8084623|NCT03503188|19934345|P1|NOT COMPLETED|Overall Study||0
8084624|NCT03503188|19934344|P2|COMPLETED|Overall Study||145
8084625|NCT03503188|19934345|P1|COMPLETED|Overall Study||128
8084626|NCT03503188|19934344|P2|Sub-study|Overall Study||44
8084627|NCT03503188|19934345|P1|Sub-study|Overall Study||29
8084628|NCT03503188|19934344|P2|Main Study|Overall Study||101
8084629|NCT03503188|19934345|P1|Main Study|Overall Study||99
8084630|NCT03503188|19934344|P2|Entered in the Entire Study|Overall Study||145
8084631|NCT03503188|19934345|P1|Entered in the Entire Study|Overall Study||128
8084632|NCT03503188|19934344|P2|STARTED|Overall Study||146
8084633|NCT03503188|19934345|P1|STARTED|Overall Study||128
8084634|NCT03502915|19934363|P2|NOT COMPLETED|Overall Study||0
8084635|NCT03502915|19934364|P1|NOT COMPLETED|Overall Study||0
8084636|NCT03502915|19934363|P2|COMPLETED|Overall Study||24
8084637|NCT03502915|19934364|P1|COMPLETED|Overall Study||24
8084638|NCT03502915|19934363|P2|STARTED|Overall Study||24
8084639|NCT03502915|19934364|P1|STARTED|Overall Study||24
8084640|NCT03502681|19934380|P2|NOT COMPLETED|Overall Study||2
8084641|NCT03502681|19934381|P1|NOT COMPLETED|Overall Study||3
8084642|NCT03502681|19934380|P2|COMPLETED|Overall Study||1
8084643|NCT03502681|19934381|P1|COMPLETED|Overall Study||0
8084644|NCT03502681|19934380|P2|STARTED|Overall Study||3
8084645|NCT03502681|19934381|P1|STARTED|Overall Study||3
8084646|NCT03502616|19934402|P2|NOT COMPLETED|Week 16 to Week 48||3
8084647|NCT03502616|19934403|P1|NOT COMPLETED|Week 16 to Week 48||6
8084648|NCT03502616|19934402|P2|COMPLETED|Week 16 to Week 48||130
8084649|NCT03502616|19934403|P1|COMPLETED|Week 16 to Week 48||126
8084650|NCT03502616|19934402|P2|Treated|Week 16 to Week 48||133
8084651|NCT03502616|19934403|P1|Treated|Week 16 to Week 48||132
8084652|NCT03502616|19934402|P2|STARTED|Week 16 to Week 48||133
8084653|NCT03502616|19934403|P1|STARTED|Week 16 to Week 48||132
8084654|NCT03502616|19934402|P2|NOT COMPLETED|Up to Week 16||3
8084655|NCT03502616|19934403|P1|NOT COMPLETED|Up to Week 16||2
8084656|NCT03502616|19934402|P2|COMPLETED|Up to Week 16||133
8084657|NCT03502616|19934403|P1|COMPLETED|Up to Week 16||132
8084658|NCT03502616|19934402|P2|Treated|Up to Week 16||136
8084659|NCT03502616|19934403|P1|Treated|Up to Week 16||133
8084660|NCT03502616|19934402|P2|STARTED|Up to Week 16||136
8084661|NCT03502616|19934403|P1|STARTED|Up to Week 16||134
8084662|NCT03502070|19934497|P1|NOT COMPLETED|Overall Study||2
8084663|NCT03502070|19934497|P1|COMPLETED|Overall Study||45
8084664|NCT03502070|19934497|P1|STARTED|Overall Study||47
8084665|NCT03501693|19934501|P2|NOT COMPLETED|Second Reading Session||0
8084666|NCT03501693|19934502|P1|NOT COMPLETED|Second Reading Session||0
8084667|NCT03501693|19934501|P2|COMPLETED|Second Reading Session||75
8084668|NCT03501693|19934502|P1|COMPLETED|Second Reading Session||75
8084669|NCT03501693|19934501|P2|STARTED|Second Reading Session||75
8084670|NCT03501693|19934502|P1|STARTED|Second Reading Session||75
8084671|NCT03501693|19934501|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8084672|NCT03501693|19934502|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8084673|NCT03501693|19934501|P2|COMPLETED|4 Week Memory Washout Period||75
8084674|NCT03501693|19934502|P1|COMPLETED|4 Week Memory Washout Period||75
8084675|NCT03501693|19934501|P2|STARTED|4 Week Memory Washout Period||75
8084676|NCT03501693|19934502|P1|STARTED|4 Week Memory Washout Period||75
8084677|NCT03501693|19934501|P2|NOT COMPLETED|First Reading Session||0
8084678|NCT03501693|19934502|P1|NOT COMPLETED|First Reading Session||0
8084679|NCT03501693|19934501|P2|COMPLETED|First Reading Session||75
8084680|NCT03501693|19934502|P1|COMPLETED|First Reading Session||75
8084681|NCT03501693|19934501|P2|STARTED|First Reading Session||75
8084682|NCT03501693|19934502|P1|STARTED|First Reading Session||75
8084683|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084684|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084685|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084686|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084687|NCT03501277|19934518|P4|COMPLETED|Intervention Period 4 (4 Days)||15
8084688|NCT03501277|19934519|P3|COMPLETED|Intervention Period 4 (4 Days)||17
8084689|NCT03501277|19934520|P2|COMPLETED|Intervention Period 4 (4 Days)||18
8084690|NCT03501277|19934521|P1|COMPLETED|Intervention Period 4 (4 Days)||18
8084691|NCT03501277|19934518|P4|STARTED|Intervention Period 4 (4 Days)||15
8084692|NCT03501277|19934519|P3|STARTED|Intervention Period 4 (4 Days)||17
8084693|NCT03501277|19934520|P2|STARTED|Intervention Period 4 (4 Days)||18
8084694|NCT03501277|19934521|P1|STARTED|Intervention Period 4 (4 Days)||18
8084695|NCT03501277|19934518|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084696|NCT03501277|19934519|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084697|NCT03501277|19934520|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084698|NCT03501277|19934521|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084699|NCT03501277|19934518|P4|COMPLETED|Washout Period 3 (7 Days)||15
8084700|NCT03501277|19934519|P3|COMPLETED|Washout Period 3 (7 Days)||17
8084701|NCT03501277|19934520|P2|COMPLETED|Washout Period 3 (7 Days)||18
8084702|NCT03501277|19934521|P1|COMPLETED|Washout Period 3 (7 Days)||18
8084703|NCT03501277|19934518|P4|STARTED|Washout Period 3 (7 Days)||15
8084704|NCT03501277|19934519|P3|STARTED|Washout Period 3 (7 Days)||17
8084705|NCT03501277|19934520|P2|STARTED|Washout Period 3 (7 Days)||18
8084706|NCT03501277|19934521|P1|STARTED|Washout Period 3 (7 Days)||18
8084707|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 3 (4 Days)||1
8084708|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 3 (4 Days)||0
8084709|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 3 (4 Days)||0
8084710|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 3 (4 Days)||0
8084711|NCT03501277|19934518|P4|COMPLETED|Intervention Period 3 (4 Days)||15
8084712|NCT03501277|19934519|P3|COMPLETED|Intervention Period 3 (4 Days)||17
8084713|NCT03501277|19934520|P2|COMPLETED|Intervention Period 3 (4 Days)||18
8084714|NCT03501277|19934521|P1|COMPLETED|Intervention Period 3 (4 Days)||18
8084715|NCT03501277|19934518|P4|STARTED|Intervention Period 3 (4 Days)||16
8084716|NCT03501277|19934519|P3|STARTED|Intervention Period 3 (4 Days)||17
8084717|NCT03501277|19934520|P2|STARTED|Intervention Period 3 (4 Days)||18
8084718|NCT03501277|19934521|P1|STARTED|Intervention Period 3 (4 Days)||18
8084719|NCT03501277|19934518|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084720|NCT03501277|19934519|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084721|NCT03501277|19934520|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084722|NCT03501277|19934521|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084723|NCT03501277|19934518|P4|COMPLETED|Washout Period 2 (7 Days)||16
8084724|NCT03501277|19934519|P3|COMPLETED|Washout Period 2 (7 Days)||17
8084725|NCT03501277|19934520|P2|COMPLETED|Washout Period 2 (7 Days)||18
8084726|NCT03501277|19934521|P1|COMPLETED|Washout Period 2 (7 Days)||18
8084727|NCT03501277|19934518|P4|STARTED|Washout Period 2 (7 Days)||16
8084728|NCT03501277|19934519|P3|STARTED|Washout Period 2 (7 Days)||17
8084729|NCT03501277|19934520|P2|STARTED|Washout Period 2 (7 Days)||18
8084730|NCT03501277|19934521|P1|STARTED|Washout Period 2 (7 Days)||18
8084731|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 2 (4 Days)||1
8084732|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 2 (4 Days)||0
8084733|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 2 (4 Days)||0
8084734|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 2 (4 Days)||0
8084735|NCT03501277|19934518|P4|COMPLETED|Intervention Period 2 (4 Days)||16
8084736|NCT03501277|19934519|P3|COMPLETED|Intervention Period 2 (4 Days)||17
8084737|NCT03501277|19934520|P2|COMPLETED|Intervention Period 2 (4 Days)||18
8084738|NCT03501277|19934521|P1|COMPLETED|Intervention Period 2 (4 Days)||18
8084739|NCT03501277|19934518|P4|STARTED|Intervention Period 2 (4 Days)||17
8084740|NCT03501277|19934519|P3|STARTED|Intervention Period 2 (4 Days)||17
8084741|NCT03501277|19934520|P2|STARTED|Intervention Period 2 (4 Days)||18
8084742|NCT03501277|19934521|P1|STARTED|Intervention Period 2 (4 Days)||18
8084743|NCT03501277|19934518|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084744|NCT03501277|19934519|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084745|NCT03501277|19934520|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084746|NCT03501277|19934521|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084747|NCT03501277|19934518|P4|COMPLETED|Washout Period 1 (7 Days)||17
8084748|NCT03501277|19934519|P3|COMPLETED|Washout Period 1 (7 Days)||17
8084749|NCT03501277|19934520|P2|COMPLETED|Washout Period 1 (7 Days)||18
8084750|NCT03501277|19934521|P1|COMPLETED|Washout Period 1 (7 Days)||18
8084751|NCT03501277|19934518|P4|STARTED|Washout Period 1 (7 Days)||17
8084752|NCT03501277|19934519|P3|STARTED|Washout Period 1 (7 Days)||17
8084753|NCT03501277|19934520|P2|STARTED|Washout Period 1 (7 Days)||18
8084754|NCT03501277|19934521|P1|STARTED|Washout Period 1 (7 Days)||18
8084755|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 1 (4 Days)||1
8084756|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 1 (4 Days)||1
8084757|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 1 (4 Days)||0
8084758|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 1 (4 Days)||0
8084759|NCT03501277|19934518|P4|COMPLETED|Intervention Period 1 (4 Days)||17
8084760|NCT03501277|19934519|P3|COMPLETED|Intervention Period 1 (4 Days)||17
8084761|NCT03501277|19934520|P2|COMPLETED|Intervention Period 1 (4 Days)||18
8084762|NCT03501277|19934521|P1|COMPLETED|Intervention Period 1 (4 Days)||18
8084763|NCT03501277|19934518|P4|Safety Analysis Set|Intervention Period 1 (4 Days)||17
8084764|NCT03501277|19934519|P3|Safety Analysis Set|Intervention Period 1 (4 Days)||17
8084765|NCT03501277|19934520|P2|Safety Analysis Set|Intervention Period 1 (4 Days)||18
8084766|NCT03501277|19934521|P1|Safety Analysis Set|Intervention Period 1 (4 Days)||18
8084767|NCT03501277|19934518|P4|STARTED|Intervention Period 1 (4 Days)||18
8084768|NCT03501277|19934519|P3|STARTED|Intervention Period 1 (4 Days)||18
8084769|NCT03501277|19934520|P2|STARTED|Intervention Period 1 (4 Days)||18
8084770|NCT03501277|19934521|P1|STARTED|Intervention Period 1 (4 Days)||18
8084771|NCT03501264|19934537|P2|NOT COMPLETED|Overall Study||0
8084772|NCT03501264|19934538|P1|NOT COMPLETED|Overall Study||0
8084773|NCT03501264|19934537|P2|COMPLETED|Overall Study||120
8084774|NCT03501264|19934538|P1|COMPLETED|Overall Study||120
8084775|NCT03501264|19934537|P2|STARTED|Overall Study||120
8084776|NCT03501264|19934538|P1|STARTED|Overall Study||120
8084777|NCT03501069|19934553|P9|NOT COMPLETED|Period B||0
8084778|NCT03501069|19934554|P8|NOT COMPLETED|Period B||0
8084779|NCT03501069|19934555|P7|NOT COMPLETED|Period B||0
8084780|NCT03501069|19934556|P6|NOT COMPLETED|Period B||0
8084781|NCT03501069|19934557|P5|NOT COMPLETED|Period B||0
8084782|NCT03501069|19934558|P4|NOT COMPLETED|Period B||0
8084783|NCT03501069|19934559|P3|NOT COMPLETED|Period B||0
8084784|NCT03501069|19934560|P2|NOT COMPLETED|Period B||0
8084785|NCT03501069|19934561|P1|NOT COMPLETED|Period B||0
8084786|NCT03501069|19934553|P9|COMPLETED|Period B||0
8084787|NCT03501069|19934554|P8|COMPLETED|Period B||0
8084788|NCT03501069|19934555|P7|COMPLETED|Period B||0
8084789|NCT03501069|19934556|P6|COMPLETED|Period B||0
8084790|NCT03501069|19934557|P5|COMPLETED|Period B||0
8084791|NCT03501069|19934558|P4|COMPLETED|Period B||0
8084792|NCT03501069|19934559|P3|COMPLETED|Period B||2
8084793|NCT03501069|19934560|P2|COMPLETED|Period B||4
8084794|NCT03501069|19934561|P1|COMPLETED|Period B||2
8084795|NCT03501069|19934553|P9|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084796|NCT03501069|19934554|P8|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084797|NCT03501069|19934555|P7|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084798|NCT03501069|19934556|P6|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084799|NCT03501069|19934557|P5|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084800|NCT03501069|19934558|P4|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084801|NCT03501069|19934559|P3|STARTED|Period B||2
8084802|NCT03501069|19934560|P2|STARTED|Period B||4
8084803|NCT03501069|19934561|P1|STARTED|Period B||2
8084804|NCT03501069|19934553|P9|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084805|NCT03501069|19934554|P8|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084806|NCT03501069|19934555|P7|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084807|NCT03501069|19934556|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084808|NCT03501069|19934557|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084809|NCT03501069|19934558|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084810|NCT03501069|19934559|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084811|NCT03501069|19934560|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084812|NCT03501069|19934561|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084813|NCT03501069|19934553|P9|COMPLETED|Washout Period (at Least 14 Days)||0
8084814|NCT03501069|19934554|P8|COMPLETED|Washout Period (at Least 14 Days)||0
8084815|NCT03501069|19934555|P7|COMPLETED|Washout Period (at Least 14 Days)||0
8084816|NCT03501069|19934556|P6|COMPLETED|Washout Period (at Least 14 Days)||0
8084817|NCT03501069|19934557|P5|COMPLETED|Washout Period (at Least 14 Days)||0
8084818|NCT03501069|19934558|P4|COMPLETED|Washout Period (at Least 14 Days)||0
8084819|NCT03501069|19934559|P3|COMPLETED|Washout Period (at Least 14 Days)||2
8084820|NCT03501069|19934560|P2|COMPLETED|Washout Period (at Least 14 Days)||4
8084821|NCT03501069|19934561|P1|COMPLETED|Washout Period (at Least 14 Days)||2
8084822|NCT03501069|19934553|P9|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084823|NCT03501069|19934554|P8|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084824|NCT03501069|19934555|P7|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084825|NCT03501069|19934556|P6|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084826|NCT03501069|19934557|P5|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084827|NCT03501069|19934558|P4|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084828|NCT03501069|19934559|P3|STARTED|Washout Period (at Least 14 Days)||2
8084829|NCT03501069|19934560|P2|STARTED|Washout Period (at Least 14 Days)||4
8084830|NCT03501069|19934561|P1|STARTED|Washout Period (at Least 14 Days)||2
8084831|NCT03501069|19934553|P9|NOT COMPLETED|Period A||0
8084832|NCT03501069|19934554|P8|NOT COMPLETED|Period A||0
8084833|NCT03501069|19934555|P7|NOT COMPLETED|Period A||0
8084834|NCT03501069|19934556|P6|NOT COMPLETED|Period A||0
8084835|NCT03501069|19934557|P5|NOT COMPLETED|Period A||0
8084836|NCT03501069|19934558|P4|NOT COMPLETED|Period A||0
8084837|NCT03501069|19934559|P3|NOT COMPLETED|Period A||0
8084838|NCT03501069|19934560|P2|NOT COMPLETED|Period A||0
8084839|NCT03501069|19934561|P1|NOT COMPLETED|Period A||0
8084840|NCT03501069|19934553|P9|COMPLETED|Period A||3
8084841|NCT03501069|19934554|P8|COMPLETED|Period A||3
8084842|NCT03501069|19934555|P7|COMPLETED|Period A||6
8084843|NCT03501069|19934556|P6|COMPLETED|Period A||6
8084844|NCT03501069|19934557|P5|COMPLETED|Period A||1
8084845|NCT03501069|19934558|P4|COMPLETED|Period A||5
8084846|NCT03501069|19934559|P3|COMPLETED|Period A||2
8084847|NCT03501069|19934560|P2|COMPLETED|Period A||4
8084848|NCT03501069|19934561|P1|COMPLETED|Period A||2
8084849|NCT03501069|19934553|P9|STARTED|Period A||3
8084850|NCT03501069|19934554|P8|STARTED|Period A||3
8084851|NCT03501069|19934555|P7|STARTED|Period A||6
8084852|NCT03501069|19934556|P6|STARTED|Period A||6
8084853|NCT03501069|19934557|P5|STARTED|Period A||1
8084854|NCT03501069|19934558|P4|STARTED|Period A||5
8084855|NCT03501069|19934559|P3|STARTED|Period A||2
8084856|NCT03501069|19934560|P2|STARTED|Period A||4
8084857|NCT03501069|19934561|P1|STARTED|Period A||2
8084858|NCT03501043|19934631|P1|NOT COMPLETED|Overall Study||1
8084859|NCT03501043|19934631|P1|COMPLETED|Overall Study||10
8084860|NCT03501043|19934631|P1|STARTED|Overall Study||11
8084861|NCT03500679|19934648|P2|NOT COMPLETED|Overall Study||3
8084862|NCT03500679|19934649|P1|NOT COMPLETED|Overall Study||9
8084863|NCT03500679|19934648|P2|COMPLETED|Overall Study||22
8084864|NCT03500679|19934649|P1|COMPLETED|Overall Study||66
8084865|NCT03500679|19934648|P2|STARTED|Overall Study||25
8084866|NCT03500679|19934649|P1|STARTED|Overall Study||75
8084867|NCT03500406|19934697|P2|NOT COMPLETED|Overall Study||0
8084868|NCT03500406|19934698|P1|NOT COMPLETED|Overall Study||0
8084869|NCT03500406|19934697|P2|COMPLETED|Overall Study||20
8084870|NCT03500406|19934698|P1|COMPLETED|Overall Study||4
8084871|NCT03500406|19934697|P2|STARTED|Overall Study||20
8084872|NCT03500406|19934698|P1|STARTED|Overall Study||4
8084873|NCT03500302|19934716|P1|NOT COMPLETED|Overall Study||0
8084874|NCT03500302|19934716|P1|COMPLETED|Overall Study||19
8084875|NCT03500302|19934716|P1|STARTED|Overall Study||19
8084876|NCT03500289|19934723|P2|NOT COMPLETED|Overall Study||0
8084877|NCT03500289|19934724|P1|NOT COMPLETED|Overall Study||0
8084878|NCT03500289|19934723|P2|COMPLETED|Overall Study||6
8084879|NCT03500289|19934724|P1|COMPLETED|Overall Study||12
8084880|NCT03500289|19934723|P2|STARTED|Overall Study||6
8084881|NCT03500289|19934724|P1|STARTED|Overall Study||12
8084882|NCT03500224|19934740|P1|NOT COMPLETED|Overall Study||2
8084883|NCT03500224|19934740|P1|COMPLETED|Overall Study||4
8084884|NCT03500224|19934740|P1|STARTED|Overall Study||6
8084885|NCT03500211|19934779|P2|NOT COMPLETED|Overall Study||1
8084886|NCT03500211|19934780|P1|NOT COMPLETED|Overall Study||1
8084887|NCT03500211|19934779|P2|COMPLETED|Overall Study||24
8084888|NCT03500211|19934780|P1|COMPLETED|Overall Study||24
8084889|NCT03500211|19934779|P2|STARTED|Overall Study||25
8084890|NCT03500211|19934780|P1|STARTED|Overall Study||25
8084891|NCT03500198|19934796|P2|NOT COMPLETED|Overall Study||1
8084892|NCT03500198|19934797|P1|NOT COMPLETED|Overall Study||0
8084893|NCT03500198|19934796|P2|COMPLETED|Overall Study||107
8084894|NCT03500198|19934797|P1|COMPLETED|Overall Study||110
8084895|NCT03500198|19934796|P2|Second Eye|Overall Study||108
8084896|NCT03500198|19934797|P1|Second Eye|Overall Study||109
8084897|NCT03500198|19934796|P2|First Eye|Overall Study||108
8084898|NCT03500198|19934797|P1|First Eye|Overall Study||110
8084899|NCT03500198|19934796|P2|STARTED|Overall Study||108
8084900|NCT03500198|19934797|P1|STARTED|Overall Study||110
8084901|NCT03500159|19934813|P2|NOT COMPLETED|Overall Study||1
8084902|NCT03500159|19934814|P1|NOT COMPLETED|Overall Study||2
8084903|NCT03500159|19934813|P2|COMPLETED|Overall Study||0
8084904|NCT03500159|19934814|P1|COMPLETED|Overall Study||0
8084905|NCT03500159|19934813|P2|STARTED|Overall Study||1
8084906|NCT03500159|19934814|P1|STARTED|Overall Study||2
8084907|NCT03499067|19934820|P2|NOT COMPLETED|Second Intervention||0
8084908|NCT03499067|19934821|P1|NOT COMPLETED|Second Intervention||0
8084909|NCT03499067|19934820|P2|COMPLETED|Second Intervention||24
8084910|NCT03499067|19934821|P1|COMPLETED|Second Intervention||22
8084911|NCT03499067|19934820|P2|STARTED|Second Intervention||24
8084912|NCT03499067|19934821|P1|STARTED|Second Intervention||22
8084913|NCT03499067|19934820|P2|NOT COMPLETED|First Intervention||7
8084914|NCT03499067|19934821|P1|NOT COMPLETED|First Intervention||5
8084915|NCT03499067|19934820|P2|COMPLETED|First Intervention||24
8084916|NCT03499067|19934821|P1|COMPLETED|First Intervention||22
8084917|NCT03499067|19934820|P2|STARTED|First Intervention||31
8084918|NCT03499067|19934821|P1|STARTED|First Intervention||27
8084919|NCT03498560|19934861|P1|NOT COMPLETED|Overall Study||21
8084920|NCT03498560|19934861|P1|COMPLETED|Overall Study||17
8084921|NCT03498560|19934861|P1|Completed PSG|Overall Study||25
8084922|NCT03498560|19934861|P1|Completed Baseline Assessment|Overall Study||32
8084923|NCT03498560|19934861|P1|STARTED|Overall Study||38
8084924|NCT03498300|19934868|P2|NOT COMPLETED|Overall Study||8
8084925|NCT03498300|19934869|P1|NOT COMPLETED|Overall Study||3
8084926|NCT03498300|19934868|P2|COMPLETED|Overall Study||13
8084927|NCT03498300|19934869|P1|COMPLETED|Overall Study||18
8084928|NCT03498300|19934868|P2|STARTED|Overall Study||21
8084929|NCT03498300|19934869|P1|STARTED|Overall Study||21
8084930|NCT03498287|19934878|P2|NOT COMPLETED|Overall Study||5
8084931|NCT03498287|19934879|P1|NOT COMPLETED|Overall Study||3
8084932|NCT03498287|19934878|P2|COMPLETED|Overall Study||38
8084933|NCT03498287|19934879|P1|COMPLETED|Overall Study||42
8084934|NCT03498287|19934878|P2|STARTED|Overall Study||43
8084935|NCT03498287|19934879|P1|STARTED|Overall Study||45
8084936|NCT03498196|19934887|P1|NOT COMPLETED|Overall Study||0
8084937|NCT03498196|19934887|P1|COMPLETED|Overall Study||1
8084938|NCT03498196|19934887|P1|STARTED|Overall Study||1
8084939|NCT03497845|19934906|P12|NOT COMPLETED|Overall Study||22
8084940|NCT03497845|19934907|P11|NOT COMPLETED|Overall Study||15
8084941|NCT03497845|19934908|P10|NOT COMPLETED|Overall Study||6
8084942|NCT03497845|19934909|P9|NOT COMPLETED|Overall Study||14
8084943|NCT03497845|19934910|P8|NOT COMPLETED|Overall Study||10
8084944|NCT03497845|19934911|P7|NOT COMPLETED|Overall Study||8
8084945|NCT03497845|19934912|P6|NOT COMPLETED|Overall Study||18
8084946|NCT03497845|19934913|P5|NOT COMPLETED|Overall Study||21
8084947|NCT03497845|19934914|P4|NOT COMPLETED|Overall Study||10
8084948|NCT03497845|19934915|P3|NOT COMPLETED|Overall Study||11
8084949|NCT03497845|19934916|P2|NOT COMPLETED|Overall Study||13
8084950|NCT03497845|19934917|P1|NOT COMPLETED|Overall Study||5
8084951|NCT03497845|19934906|P12|COMPLETED|Overall Study|Day 262|38
8084952|NCT03497845|19934907|P11|COMPLETED|Overall Study|Day 262|46
8084953|NCT03497845|19934908|P10|COMPLETED|Overall Study|Day 142|53
8084954|NCT03497845|19934909|P9|COMPLETED|Overall Study|Day 142|47
8084955|NCT03497845|19934910|P8|COMPLETED|Overall Study|Day 142|50
8084956|NCT03497845|19934911|P7|COMPLETED|Overall Study|Day 142|51
8084957|NCT03497845|19934912|P6|COMPLETED|Overall Study|Day 262|44
8084958|NCT03497845|19934913|P5|COMPLETED|Overall Study|Day 262|38
8084959|NCT03497845|19934914|P4|COMPLETED|Overall Study|Day 142|50
8084960|NCT03497845|19934915|P3|COMPLETED|Overall Study|Day 142|50
8084961|NCT03497845|19934916|P2|COMPLETED|Overall Study|Day 142|45
8084962|NCT03497845|19934917|P1|COMPLETED|Overall Study|Day 142|55
8084963|NCT03497845|19934906|P12|STARTED|Overall Study||60
8084964|NCT03497845|19934907|P11|STARTED|Overall Study||61
8084965|NCT03497845|19934908|P10|STARTED|Overall Study||59
8084966|NCT03497845|19934909|P9|STARTED|Overall Study||61
8084967|NCT03497845|19934910|P8|STARTED|Overall Study||60
8084968|NCT03497845|19934911|P7|STARTED|Overall Study||59
8084969|NCT03497845|19934912|P6|STARTED|Overall Study||62
8084970|NCT03497845|19934913|P5|STARTED|Overall Study||59
8084971|NCT03497845|19934914|P4|STARTED|Overall Study||60
8084972|NCT03497845|19934915|P3|STARTED|Overall Study||61
8084973|NCT03497845|19934916|P2|STARTED|Overall Study||58
8084974|NCT03497845|19934917|P1|STARTED|Overall Study||60
8084975|NCT03497585|19934971|P1|NOT COMPLETED|Overall Study||55
8084976|NCT03497585|19934971|P1|COMPLETED|Overall Study||57
8084977|NCT03497585|19934971|P1|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
8084978|NCT03497130|19935004|P2|NOT COMPLETED|Overall Study||1
8084979|NCT03497130|19935005|P1|NOT COMPLETED|Overall Study||1
8084980|NCT03497130|19935004|P2|COMPLETED|Overall Study||13
8084981|NCT03497130|19935005|P1|COMPLETED|Overall Study||39
8084982|NCT03497130|19935004|P2|STARTED|Overall Study||14
8084983|NCT03497130|19935005|P1|STARTED|Overall Study||40
8084984|NCT03497039|19935017|P2|NOT COMPLETED|Overall Study||1
8084985|NCT03497039|19935018|P1|NOT COMPLETED|Overall Study||1
8084986|NCT03497039|19935017|P2|COMPLETED|Overall Study||16
8084987|NCT03497039|19935018|P1|COMPLETED|Overall Study||29
8084988|NCT03497039|19935017|P2|Treated|Overall Study||17
8084989|NCT03497039|19935018|P1|Treated|Overall Study||29
8084990|NCT03497039|19935017|P2|STARTED|Overall Study||17
8084991|NCT03497039|19935018|P1|STARTED|Overall Study||30
8084992|NCT03496987|19935032|P2|NOT COMPLETED|Overall Study||0
8084993|NCT03496987|19935033|P1|NOT COMPLETED|Overall Study||0
8084994|NCT03496987|19935032|P2|COMPLETED|Overall Study||51
8084995|NCT03496987|19935033|P1|COMPLETED|Overall Study||49
8084996|NCT03496987|19935032|P2|STARTED|Overall Study||51
8084997|NCT03496987|19935033|P1|STARTED|Overall Study||49
8084998|NCT03496974|19935053|P2|NOT COMPLETED|Overall Study||8
8084999|NCT03496974|19935054|P1|NOT COMPLETED|Overall Study||1
8085000|NCT03496974|19935053|P2|COMPLETED|Overall Study||20
8085001|NCT03496974|19935054|P1|COMPLETED|Overall Study||9
8085002|NCT03496974|19935053|P2|STARTED|Overall Study||28
8085003|NCT03496974|19935054|P1|STARTED|Overall Study||10
8085004|NCT03496428|19935088|P1|NOT COMPLETED|Overall Study||0
8085005|NCT03496428|19935088|P1|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
8085006|NCT03496428|19935088|P1|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
8085007|NCT03496324|19935093|P4|NOT COMPLETED|Period 7: Period 4||0
8085008|NCT03496324|19935094|P3|NOT COMPLETED|Period 7: Period 4||0
8085009|NCT03496324|19935095|P2|NOT COMPLETED|Period 7: Period 4||0
8085010|NCT03496324|19935096|P1|NOT COMPLETED|Period 7: Period 4||0
8085011|NCT03496324|19935093|P4|COMPLETED|Period 7: Period 4||6
8085012|NCT03496324|19935094|P3|COMPLETED|Period 7: Period 4||6
8085013|NCT03496324|19935095|P2|COMPLETED|Period 7: Period 4||6
8085014|NCT03496324|19935096|P1|COMPLETED|Period 7: Period 4||6
8085015|NCT03496324|19935093|P4|STARTED|Period 7: Period 4||6
8085016|NCT03496324|19935094|P3|STARTED|Period 7: Period 4||6
8085017|NCT03496324|19935095|P2|STARTED|Period 7: Period 4||6
8085018|NCT03496324|19935096|P1|STARTED|Period 7: Period 4||6
8085019|NCT03496324|19935093|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085020|NCT03496324|19935094|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085021|NCT03496324|19935095|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085022|NCT03496324|19935096|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085023|NCT03496324|19935093|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085024|NCT03496324|19935094|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085025|NCT03496324|19935095|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085026|NCT03496324|19935096|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085027|NCT03496324|19935093|P4|STARTED|Period 3: Washout (3 to 7 Days)||6
8085028|NCT03496324|19935094|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
8085029|NCT03496324|19935095|P2|STARTED|Period 3: Washout (3 to 7 Days)||6
8085030|NCT03496324|19935096|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
8085031|NCT03496324|19935093|P4|NOT COMPLETED|Period 3||0
8085032|NCT03496324|19935094|P3|NOT COMPLETED|Period 3||0
8085033|NCT03496324|19935095|P2|NOT COMPLETED|Period 3||0
8085034|NCT03496324|19935096|P1|NOT COMPLETED|Period 3||0
8085035|NCT03496324|19935093|P4|COMPLETED|Period 3||6
8085036|NCT03496324|19935094|P3|COMPLETED|Period 3||6
8085037|NCT03496324|19935095|P2|COMPLETED|Period 3||6
8085038|NCT03496324|19935096|P1|COMPLETED|Period 3||6
8085039|NCT03496324|19935093|P4|STARTED|Period 3||6
8085040|NCT03496324|19935094|P3|STARTED|Period 3||6
8085041|NCT03496324|19935095|P2|STARTED|Period 3||6
8085042|NCT03496324|19935096|P1|STARTED|Period 3||6
8085043|NCT03496324|19935093|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085044|NCT03496324|19935094|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085045|NCT03496324|19935095|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085046|NCT03496324|19935096|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085047|NCT03496324|19935093|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085048|NCT03496324|19935094|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085049|NCT03496324|19935095|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085050|NCT03496324|19935096|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085051|NCT03496324|19935093|P4|STARTED|Period 2: Washout (3 to 7 Days)||6
8085052|NCT03496324|19935094|P3|STARTED|Period 2: Washout (3 to 7 Days)||6
8085053|NCT03496324|19935095|P2|STARTED|Period 2: Washout (3 to 7 Days)||6
8085054|NCT03496324|19935096|P1|STARTED|Period 2: Washout (3 to 7 Days)||6
8085055|NCT03496324|19935093|P4|NOT COMPLETED|Period 2||0
8085056|NCT03496324|19935094|P3|NOT COMPLETED|Period 2||0
8085057|NCT03496324|19935095|P2|NOT COMPLETED|Period 2||0
8085058|NCT03496324|19935096|P1|NOT COMPLETED|Period 2||0
8085059|NCT03496324|19935093|P4|COMPLETED|Period 2||6
8085060|NCT03496324|19935094|P3|COMPLETED|Period 2||6
8085061|NCT03496324|19935095|P2|COMPLETED|Period 2||6
8085062|NCT03496324|19935096|P1|COMPLETED|Period 2||6
8085063|NCT03496324|19935093|P4|STARTED|Period 2||6
8085064|NCT03496324|19935094|P3|STARTED|Period 2||6
8085065|NCT03496324|19935095|P2|STARTED|Period 2||6
8085066|NCT03496324|19935096|P1|STARTED|Period 2||6
8085067|NCT03496324|19935093|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085068|NCT03496324|19935094|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085069|NCT03496324|19935095|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085070|NCT03496324|19935096|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085071|NCT03496324|19935093|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085072|NCT03496324|19935094|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085073|NCT03496324|19935095|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085074|NCT03496324|19935096|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085075|NCT03496324|19935093|P4|STARTED|Period 1: Washout (3 to 7 Days)||6
8085076|NCT03496324|19935094|P3|STARTED|Period 1: Washout (3 to 7 Days)||6
8085077|NCT03496324|19935095|P2|STARTED|Period 1: Washout (3 to 7 Days)||6
8085078|NCT03496324|19935096|P1|STARTED|Period 1: Washout (3 to 7 Days)||6
8085079|NCT03496324|19935093|P4|NOT COMPLETED|Period 1||0
8085080|NCT03496324|19935094|P3|NOT COMPLETED|Period 1||0
8085081|NCT03496324|19935095|P2|NOT COMPLETED|Period 1||0
8085082|NCT03496324|19935096|P1|NOT COMPLETED|Period 1||0
8085083|NCT03496324|19935093|P4|COMPLETED|Period 1||6
8085084|NCT03496324|19935094|P3|COMPLETED|Period 1||6
8085085|NCT03496324|19935095|P2|COMPLETED|Period 1||6
8085086|NCT03496324|19935096|P1|COMPLETED|Period 1||6
8085087|NCT03496324|19935093|P4|STARTED|Period 1||6
8085088|NCT03496324|19935094|P3|STARTED|Period 1||6
8085089|NCT03496324|19935095|P2|STARTED|Period 1||6
8085090|NCT03496324|19935096|P1|STARTED|Period 1||6
8085091|NCT03496220|19935136|P3|NOT COMPLETED|Third Intervention||0
8085092|NCT03496220|19935137|P2|NOT COMPLETED|Third Intervention||0
8085093|NCT03496220|19935138|P1|NOT COMPLETED|Third Intervention||0
8085094|NCT03496220|19935136|P3|COMPLETED|Third Intervention||5
8085095|NCT03496220|19935137|P2|COMPLETED|Third Intervention||8
8085096|NCT03496220|19935138|P1|COMPLETED|Third Intervention||11
8085097|NCT03496220|19935136|P3|STARTED|Third Intervention||5
8085098|NCT03496220|19935137|P2|STARTED|Third Intervention||8
8085099|NCT03496220|19935138|P1|STARTED|Third Intervention||11
8085100|NCT03496220|19935136|P3|NOT COMPLETED|Second Intervention||0
8085101|NCT03496220|19935137|P2|NOT COMPLETED|Second Intervention||0
8085102|NCT03496220|19935138|P1|NOT COMPLETED|Second Intervention||0
8085103|NCT03496220|19935136|P3|COMPLETED|Second Intervention||11
8085104|NCT03496220|19935137|P2|COMPLETED|Second Intervention||9
8085105|NCT03496220|19935138|P1|COMPLETED|Second Intervention||17
8085106|NCT03496220|19935136|P3|STARTED|Second Intervention||11
8085107|NCT03496220|19935137|P2|STARTED|Second Intervention||9
8085108|NCT03496220|19935138|P1|STARTED|Second Intervention||17
8085109|NCT03496220|19935136|P3|NOT COMPLETED|First Intervention||0
8085110|NCT03496220|19935137|P2|NOT COMPLETED|First Intervention||0
8085111|NCT03496220|19935138|P1|NOT COMPLETED|First Intervention||0
8085112|NCT03496220|19935136|P3|COMPLETED|First Intervention||10
8085113|NCT03496220|19935137|P2|COMPLETED|First Intervention||4
8085114|NCT03496220|19935138|P1|COMPLETED|First Intervention||15
8085115|NCT03496220|19935136|P3|STARTED|First Intervention||10
8085116|NCT03496220|19935137|P2|STARTED|First Intervention||4
8085117|NCT03496220|19935138|P1|STARTED|First Intervention||15
8085118|NCT03495908|19935146|P2|NOT COMPLETED|Overall Study||13
8085119|NCT03495908|19935147|P1|NOT COMPLETED|Overall Study||10
8085120|NCT03495908|19935146|P2|COMPLETED|Overall Study||54
8085121|NCT03495908|19935147|P1|COMPLETED|Overall Study||59
8085122|NCT03495908|19935146|P2|STARTED|Overall Study||67
8085123|NCT03495908|19935147|P1|STARTED|Overall Study||69
8085124|NCT03495856|19935165|P1|NOT COMPLETED|Overall Study||1
8085125|NCT03495856|19935165|P1|COMPLETED|Overall Study||22
8085126|NCT03495856|19935165|P1|STARTED|Overall Study||23
8085127|NCT03495817|19935183|P1|NOT COMPLETED|26 Week Extension||2
8085128|NCT03495817|19935183|P1|COMPLETED|26 Week Extension||17
8085129|NCT03495817|19935183|P1|STARTED|26 Week Extension||19
8085130|NCT03495817|19935183|P1|NOT COMPLETED|26 Week Open Label||8
8085131|NCT03495817|19935183|P1|COMPLETED|26 Week Open Label||23
8085132|NCT03495817|19935183|P1|STARTED|26 Week Open Label||31
8085133|NCT03495102|19935201|P3|NOT COMPLETED|Overall Study||54
8085134|NCT03495102|19935202|P2|NOT COMPLETED|Overall Study||67
8085135|NCT03495102|19935203|P1|NOT COMPLETED|Overall Study||56
8085136|NCT03495102|19935201|P3|COMPLETED|Overall Study||560
8085137|NCT03495102|19935202|P2|COMPLETED|Overall Study||549
8085138|NCT03495102|19935203|P1|COMPLETED|Overall Study||556
8085139|NCT03495102|19935201|P3|Received at Least One Dose of Study Drug|Overall Study||614
8085140|NCT03495102|19935202|P2|Received at Least One Dose of Study Drug|Overall Study||616
8085141|NCT03495102|19935203|P1|Received at Least One Dose of Study Drug|Overall Study||612
8085142|NCT03495102|19935201|P3|STARTED|Overall Study||614
8085143|NCT03495102|19935202|P2|STARTED|Overall Study||616
8085144|NCT03495102|19935203|P1|STARTED|Overall Study||612
8085145|NCT03494985|19935233|P4|NOT COMPLETED|Overall Study||5
8085146|NCT03494985|19935234|P3|NOT COMPLETED|Overall Study||6
8085147|NCT03494985|19935235|P2|NOT COMPLETED|Overall Study||6
8085148|NCT03494985|19935236|P1|NOT COMPLETED|Overall Study||5
8085149|NCT03494985|19935233|P4|COMPLETED|Overall Study||94
8085150|NCT03494985|19935234|P3|COMPLETED|Overall Study||92
8085151|NCT03494985|19935235|P2|COMPLETED|Overall Study||92
8085152|NCT03494985|19935236|P1|COMPLETED|Overall Study||96
8085153|NCT03494985|19935233|P4|STARTED|Overall Study||99
8085154|NCT03494985|19935234|P3|STARTED|Overall Study||98
8085155|NCT03494985|19935235|P2|STARTED|Overall Study||98
8085156|NCT03494985|19935236|P1|STARTED|Overall Study||101
8085157|NCT03493854|19935272|P2|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
8085158|NCT03493854|19935273|P1|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
8085159|NCT03493854|19935272|P2|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
8085160|NCT03493854|19935273|P1|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
8085161|NCT03493854|19935272|P2|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
8085162|NCT03493854|19935273|P1|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
8085163|NCT03493854|19935272|P2|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
8085164|NCT03493854|19935273|P1|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
8085165|NCT03493854|19935272|P2|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
8085166|NCT03493854|19935273|P1|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
8085167|NCT03493854|19935272|P2|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
8085168|NCT03493854|19935273|P1|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
8085169|NCT03493854|19935272|P2|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
8085170|NCT03493854|19935273|P1|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
8085171|NCT03493854|19935272|P2|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
8085172|NCT03493854|19935273|P1|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
8085173|NCT03493854|19935272|P2|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
8085174|NCT03493854|19935273|P1|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
8085175|NCT03493854|19935272|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
8085176|NCT03493854|19935273|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
8085177|NCT03493854|19935272|P2|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
8085178|NCT03493854|19935273|P1|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
8085179|NCT03493828|19935294|P3|NOT COMPLETED|Overall Study||0
8085180|NCT03493828|19935295|P2|NOT COMPLETED|Overall Study||0
8085181|NCT03493828|19935296|P1|NOT COMPLETED|Overall Study||0
8085182|NCT03493828|19935294|P3|COMPLETED|Overall Study||20
8085183|NCT03493828|19935295|P2|COMPLETED|Overall Study||20
8085184|NCT03493828|19935296|P1|COMPLETED|Overall Study||20
8085185|NCT03493828|19935294|P3|STARTED|Overall Study||20
8085186|NCT03493828|19935295|P2|STARTED|Overall Study||20
8085187|NCT03493828|19935296|P1|STARTED|Overall Study||20
8085188|NCT03493815|19935306|P2|NOT COMPLETED|Overall Study||11
8085189|NCT03493815|19935307|P1|NOT COMPLETED|Overall Study||9
8085190|NCT03493815|19935306|P2|COMPLETED|Overall Study||32
8085191|NCT03493815|19935307|P1|COMPLETED|Overall Study||33
8085192|NCT03493815|19935306|P2|STARTED|Overall Study||43
8085193|NCT03493815|19935307|P1|STARTED|Overall Study||42
8085194|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period D||0
8085195|NCT03493698|19935319|P1|COMPLETED|Treatment Period D||15
8085196|NCT03493698|19935319|P1|STARTED|Treatment Period D||15
8085197|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period C||2
8085198|NCT03493698|19935319|P1|COMPLETED|Treatment Period C||15
8085199|NCT03493698|19935319|P1|STARTED|Treatment Period C||17
8085200|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period B||0
8085201|NCT03493698|19935319|P1|COMPLETED|Treatment Period B||17
8085202|NCT03493698|19935319|P1|STARTED|Treatment Period B||17
8085203|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period A||0
8085204|NCT03493698|19935319|P1|COMPLETED|Treatment Period A||17
8085205|NCT03493698|19935319|P1|STARTED|Treatment Period A||17
8085206|NCT03493542|19935344|P2|NOT COMPLETED|Overall Study||9
8085207|NCT03493542|19935345|P1|NOT COMPLETED|Overall Study||7
8085208|NCT03493542|19935344|P2|COMPLETED|Overall Study||374
8085209|NCT03493542|19935345|P1|COMPLETED|Overall Study||376
8085210|NCT03493542|19935344|P2|Vaccination 3|Overall Study||374
8085211|NCT03493542|19935345|P1|Vaccination 3|Overall Study||376
8085212|NCT03493542|19935344|P2|Vaccination 2|Overall Study||378
8085213|NCT03493542|19935345|P1|Vaccination 2|Overall Study||379
8085214|NCT03493542|19935344|P2|Vaccination 1|Overall Study||383
8085215|NCT03493542|19935345|P1|Vaccination 1|Overall Study||383
8085216|NCT03493542|19935344|P2|STARTED|Overall Study||383
8085217|NCT03493542|19935345|P1|STARTED|Overall Study||383
8085218|NCT03493386|19935369|P4|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085219|NCT03493386|19935370|P3|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085220|NCT03493386|19935371|P2|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085221|NCT03493386|19935372|P1|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085222|NCT03493386|19935369|P4|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
8085223|NCT03493386|19935370|P3|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
8085224|NCT03493386|19935371|P2|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085225|NCT03493386|19935372|P1|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085226|NCT03493386|19935369|P4|STARTED|Part 2, Intervention Period 2 (2 Days)||6
8085227|NCT03493386|19935370|P3|STARTED|Part 2, Intervention Period 2 (2 Days)||6
8085228|NCT03493386|19935371|P2|STARTED|Part 2, Intervention Period 2 (2 Days)||0
8085229|NCT03493386|19935372|P1|STARTED|Part 2, Intervention Period 2 (2 Days)||0
8085230|NCT03493386|19935369|P4|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085231|NCT03493386|19935370|P3|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085232|NCT03493386|19935371|P2|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085233|NCT03493386|19935372|P1|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085234|NCT03493386|19935369|P4|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
8085235|NCT03493386|19935370|P3|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
8085236|NCT03493386|19935371|P2|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085237|NCT03493386|19935372|P1|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085238|NCT03493386|19935369|P4|STARTED|Part 2, Washout Period (at Least 5 Days)||6
8085239|NCT03493386|19935370|P3|STARTED|Part 2, Washout Period (at Least 5 Days)||6
8085240|NCT03493386|19935371|P2|STARTED|Part 2, Washout Period (at Least 5 Days)||0
8085241|NCT03493386|19935372|P1|STARTED|Part 2, Washout Period (at Least 5 Days)||0
8085242|NCT03493386|19935369|P4|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085243|NCT03493386|19935370|P3|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085244|NCT03493386|19935371|P2|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085245|NCT03493386|19935372|P1|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085246|NCT03493386|19935369|P4|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
8085247|NCT03493386|19935370|P3|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
8085248|NCT03493386|19935371|P2|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085249|NCT03493386|19935372|P1|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085250|NCT03493386|19935369|P4|STARTED|Part 2, Intervention Period 1 (2 Days)||6
8085251|NCT03493386|19935370|P3|STARTED|Part 2, Intervention Period 1 (2 Days)||6
8085252|NCT03493386|19935371|P2|STARTED|Part 2, Intervention Period 1 (2 Days)||0
8085253|NCT03493386|19935372|P1|STARTED|Part 2, Intervention Period 1 (2 Days)||0
8085254|NCT03493386|19935369|P4|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085255|NCT03493386|19935370|P3|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085256|NCT03493386|19935371|P2|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085257|NCT03493386|19935372|P1|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085258|NCT03493386|19935369|P4|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085259|NCT03493386|19935370|P3|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085260|NCT03493386|19935371|P2|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
8085261|NCT03493386|19935372|P1|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
8085262|NCT03493386|19935369|P4|STARTED|Part 1, Intervention Period 2 (2 Days)||0
8085263|NCT03493386|19935370|P3|STARTED|Part 1, Intervention Period 2 (2 Days)||0
8085264|NCT03493386|19935371|P2|STARTED|Part 1, Intervention Period 2 (2 Days)||25
8085265|NCT03493386|19935372|P1|STARTED|Part 1, Intervention Period 2 (2 Days)||26
8085266|NCT03493386|19935369|P4|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085267|NCT03493386|19935370|P3|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085268|NCT03493386|19935371|P2|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
8085269|NCT03493386|19935372|P1|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085270|NCT03493386|19935369|P4|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085271|NCT03493386|19935370|P3|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085272|NCT03493386|19935371|P2|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
8085273|NCT03493386|19935372|P1|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
8085274|NCT03493386|19935369|P4|STARTED|Part 1, Washout Period (at Least 5 Days)||0
8085275|NCT03493386|19935370|P3|STARTED|Part 1, Washout Period (at Least 5 Days)||0
8085276|NCT03493386|19935371|P2|STARTED|Part 1, Washout Period (at Least 5 Days)||26
8085277|NCT03493386|19935372|P1|STARTED|Part 1, Washout Period (at Least 5 Days)||26
8085278|NCT03493386|19935369|P4|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085279|NCT03493386|19935370|P3|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085280|NCT03493386|19935371|P2|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085281|NCT03493386|19935372|P1|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085282|NCT03493386|19935369|P4|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085283|NCT03493386|19935370|P3|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085284|NCT03493386|19935371|P2|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
8085285|NCT03493386|19935372|P1|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
8085286|NCT03493386|19935369|P4|STARTED|Part 1, Intervention Period 1 (2 Days)||0
8085287|NCT03493386|19935370|P3|STARTED|Part 1, Intervention Period 1 (2 Days)||0
8085288|NCT03493386|19935371|P2|STARTED|Part 1, Intervention Period 1 (2 Days)||26
8085289|NCT03493386|19935372|P1|STARTED|Part 1, Intervention Period 1 (2 Days)||26
8085290|NCT03492554|19935492|P2|NOT COMPLETED|Overall Study||14
8085291|NCT03492554|19935493|P1|NOT COMPLETED|Overall Study||0
8085292|NCT03492554|19935492|P2|COMPLETED|Overall Study||287
8085293|NCT03492554|19935493|P1|COMPLETED|Overall Study||301
8085294|NCT03492554|19935492|P2|STARTED|Overall Study||301
8085295|NCT03492554|19935493|P1|STARTED|Overall Study||301
8085296|NCT03492099|19935505|P1|NOT COMPLETED|Overall Study||9
8085297|NCT03492099|19935505|P1|COMPLETED|Overall Study||38
8085298|NCT03492099|19935505|P1|STARTED|Overall Study||47
8085299|NCT03491917|19935509|P2|NOT COMPLETED|Second Reading Session||0
8085300|NCT03491917|19935510|P1|NOT COMPLETED|Second Reading Session||0
8085301|NCT03491917|19935509|P2|COMPLETED|Second Reading Session||50
8085302|NCT03491917|19935510|P1|COMPLETED|Second Reading Session||50
8085303|NCT03491917|19935509|P2|STARTED|Second Reading Session||50
8085304|NCT03491917|19935510|P1|STARTED|Second Reading Session||50
8085305|NCT03491917|19935509|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8085306|NCT03491917|19935510|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8085307|NCT03491917|19935509|P2|COMPLETED|4 Week Memory Washout Period||50
8085308|NCT03491917|19935510|P1|COMPLETED|4 Week Memory Washout Period||50
8085309|NCT03491917|19935509|P2|STARTED|4 Week Memory Washout Period||50
8085310|NCT03491917|19935510|P1|STARTED|4 Week Memory Washout Period||50
8085311|NCT03491917|19935509|P2|NOT COMPLETED|First Reading Session||0
8085312|NCT03491917|19935510|P1|NOT COMPLETED|First Reading Session||0
8085313|NCT03491917|19935509|P2|COMPLETED|First Reading Session||50
8085314|NCT03491917|19935510|P1|COMPLETED|First Reading Session||50
8085315|NCT03491917|19935509|P2|STARTED|First Reading Session||50
8085316|NCT03491917|19935510|P1|STARTED|First Reading Session||50
8085317|NCT03491891|19935518|P2|NOT COMPLETED|Overall Study||380
8085318|NCT03491891|19935519|P1|NOT COMPLETED|Overall Study||853
8085319|NCT03491891|19935518|P2|COMPLETED|Overall Study||2058
8085320|NCT03491891|19935519|P1|COMPLETED|Overall Study||5185
8085321|NCT03491891|19935518|P2|STARTED|Overall Study||2438
8085322|NCT03491891|19935519|P1|STARTED|Overall Study||6038
8085323|NCT03491800|19935528|P3|NOT COMPLETED|Overall Study||0
8085324|NCT03491800|19935529|P2|NOT COMPLETED|Overall Study||0
8085325|NCT03491800|19935530|P1|NOT COMPLETED|Overall Study||0
8085326|NCT03491800|19935528|P3|COMPLETED|Overall Study||7
8085327|NCT03491800|19935529|P2|COMPLETED|Overall Study||23
8085328|NCT03491800|19935530|P1|COMPLETED|Overall Study||23
8085329|NCT03491800|19935528|P3|STARTED|Overall Study||7
8085330|NCT03491800|19935529|P2|STARTED|Overall Study||23
8085331|NCT03491800|19935530|P1|STARTED|Overall Study||23
8085332|NCT03491553|19935569|P6|NOT COMPLETED|Overall Study||0
8085333|NCT03491553|19935570|P5|NOT COMPLETED|Overall Study||0
8085334|NCT03491553|19935571|P4|NOT COMPLETED|Overall Study||1
8085335|NCT03491553|19935572|P3|NOT COMPLETED|Overall Study||0
8085336|NCT03491553|19935573|P2|NOT COMPLETED|Overall Study||1
8085337|NCT03491553|19935574|P1|NOT COMPLETED|Overall Study||1
8085338|NCT03491553|19935569|P6|COMPLETED|Overall Study||4
8085339|NCT03491553|19935570|P5|COMPLETED|Overall Study||5
8085340|NCT03491553|19935571|P4|COMPLETED|Overall Study||9
8085341|NCT03491553|19935572|P3|COMPLETED|Overall Study||10
8085342|NCT03491553|19935573|P2|COMPLETED|Overall Study||9
8085343|NCT03491553|19935574|P1|COMPLETED|Overall Study||8
8085344|NCT03491553|19935569|P6|STARTED|Overall Study||4
8085345|NCT03491553|19935570|P5|STARTED|Overall Study||5
8085346|NCT03491553|19935571|P4|STARTED|Overall Study||10
8085347|NCT03491553|19935572|P3|STARTED|Overall Study||10
8085348|NCT03491553|19935573|P2|STARTED|Overall Study||10
8085349|NCT03491553|19935574|P1|STARTED|Overall Study||9
8085350|NCT03491228|19935681|P1|NOT COMPLETED|Overall Study||0
8085351|NCT03491228|19935681|P1|COMPLETED|Overall Study||107
8085352|NCT03491228|19935681|P1|STARTED|Overall Study||107
8085353|NCT03491150|19935689|P2|NOT COMPLETED|Overall Study||73
8085354|NCT03491150|19935690|P1|NOT COMPLETED|Overall Study||76
8085355|NCT03491150|19935689|P2|COMPLETED|Overall Study||0
8085356|NCT03491150|19935690|P1|COMPLETED|Overall Study||0
8085357|NCT03491150|19935689|P2|STARTED|Overall Study||73
8085358|NCT03491150|19935690|P1|STARTED|Overall Study||76
8085359|NCT03490916|19935700|P2|NOT COMPLETED|Overall Study||0
8085360|NCT03490916|19935701|P1|NOT COMPLETED|Overall Study||0
8085361|NCT03490916|19935700|P2|COMPLETED|Overall Study||0
8085362|NCT03490916|19935701|P1|COMPLETED|Overall Study||0
8085363|NCT03490916|19935700|P2|STARTED|Overall Study||0
8085364|NCT03490916|19935701|P1|STARTED|Overall Study||0
8085365|NCT03490110|19935711|P2|NOT COMPLETED|Overall Study||3
8085366|NCT03490110|19935712|P1|NOT COMPLETED|Overall Study||3
8085367|NCT03490110|19935711|P2|COMPLETED|Overall Study||6
8085368|NCT03490110|19935712|P1|COMPLETED|Overall Study||6
8085369|NCT03490110|19935711|P2|STARTED|Overall Study||9
8085370|NCT03490110|19935712|P1|STARTED|Overall Study||9
8085371|NCT03490032|19935729|P3|NOT COMPLETED|Overall Study||0
8085372|NCT03490032|19935730|P2|NOT COMPLETED|Overall Study||0
8085373|NCT03490032|19935731|P1|NOT COMPLETED|Overall Study||1
8085374|NCT03490032|19935729|P3|COMPLETED|Overall Study||12
8085375|NCT03490032|19935730|P2|COMPLETED|Overall Study||12
8085376|NCT03490032|19935731|P1|COMPLETED|Overall Study||5
8085377|NCT03490032|19935729|P3|STARTED|Overall Study||12
8085378|NCT03490032|19935730|P2|STARTED|Overall Study||12
8085379|NCT03490032|19935731|P1|STARTED|Overall Study||6
8085380|NCT03489863|19935771|P2|NOT COMPLETED|Overall Study||1
8085381|NCT03489863|19935772|P1|NOT COMPLETED|Overall Study||0
8085382|NCT03489863|19935771|P2|COMPLETED|Overall Study||6
8085383|NCT03489863|19935772|P1|COMPLETED|Overall Study||7
8085384|NCT03489863|19935771|P2|STARTED|Overall Study||7
8085385|NCT03489863|19935772|P1|STARTED|Overall Study||7
8085386|NCT03489720|19935780|P2|NOT COMPLETED|Overall Study||0
8085387|NCT03489720|19935781|P1|NOT COMPLETED|Overall Study||2
8085388|NCT03489720|19935780|P2|COMPLETED|Overall Study||22
8085389|NCT03489720|19935781|P1|COMPLETED|Overall Study||22
8085390|NCT03489720|19935780|P2|STARTED|Overall Study||22
8085391|NCT03489720|19935781|P1|STARTED|Overall Study||24
8085392|NCT03489551|19935806|P1|NOT COMPLETED|Overall Study||2
8085393|NCT03489551|19935806|P1|COMPLETED|Overall Study||15
8085394|NCT03489551|19935806|P1|STARTED|Overall Study||17
8085395|NCT03489304|19935810|P1|NOT COMPLETED|Overall Study||4
8085396|NCT03489304|19935810|P1|COMPLETED|Overall Study||16
8085397|NCT03489304|19935810|P1|STARTED|Overall Study||20
8085398|NCT03488927|19935819|P3|NOT COMPLETED|Overall Study||217
8085399|NCT03488927|19935820|P2|NOT COMPLETED|Overall Study||118
8085400|NCT03488927|19935821|P1|NOT COMPLETED|Overall Study||44
8085401|NCT03488927|19935819|P3|COMPLETED|Overall Study||314
8085402|NCT03488927|19935820|P2|COMPLETED|Overall Study||314
8085403|NCT03488927|19935821|P1|COMPLETED|Overall Study||261
8085404|NCT03488927|19935819|P3|STARTED|Overall Study||531
8085405|NCT03488927|19935820|P2|STARTED|Overall Study||432
8085406|NCT03488927|19935821|P1|STARTED|Overall Study||305
8085407|NCT03488108|19935834|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8085408|NCT03488108|19935835|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
8085409|NCT03488108|19935834|P2|COMPLETED|Second Intervention (12 Weeks)||9
8085410|NCT03488108|19935835|P1|COMPLETED|Second Intervention (12 Weeks)||9
8085411|NCT03488108|19935834|P2|STARTED|Second Intervention (12 Weeks)||9
8085412|NCT03488108|19935835|P1|STARTED|Second Intervention (12 Weeks)||10
8085413|NCT03488108|19935834|P2|NOT COMPLETED|Washout (2 Months)||0
8085414|NCT03488108|19935835|P1|NOT COMPLETED|Washout (2 Months)||0
8085415|NCT03488108|19935834|P2|COMPLETED|Washout (2 Months)||9
8085416|NCT03488108|19935835|P1|COMPLETED|Washout (2 Months)||10
8085417|NCT03488108|19935834|P2|STARTED|Washout (2 Months)||9
8085418|NCT03488108|19935835|P1|STARTED|Washout (2 Months)||10
8085419|NCT03488108|19935834|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8085420|NCT03488108|19935835|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8085421|NCT03488108|19935834|P2|COMPLETED|First Intervention (12 Weeks)||9
8085422|NCT03488108|19935835|P1|COMPLETED|First Intervention (12 Weeks)||10
8085423|NCT03488108|19935834|P2|STARTED|First Intervention (12 Weeks)||10
8085424|NCT03488108|19935835|P1|STARTED|First Intervention (12 Weeks)||10
8085425|NCT03488030|19935853|P2|NOT COMPLETED|Overall Study||0
8085426|NCT03488030|19935854|P1|NOT COMPLETED|Overall Study||0
8085427|NCT03488030|19935853|P2|COMPLETED|Overall Study||145
8085428|NCT03488030|19935854|P1|COMPLETED|Overall Study||101
8085429|NCT03488030|19935853|P2|STARTED|Overall Study||145
8085430|NCT03488030|19935854|P1|STARTED|Overall Study||101
8085431|NCT03487588|19935902|P1|NOT COMPLETED|Overall Study||0
8085432|NCT03487588|19935902|P1|COMPLETED|Overall Study||41
8085433|NCT03487588|19935902|P1|STARTED|Overall Study||41
8085434|NCT03486990|19935917|P9|NOT COMPLETED|Overall Study||0
8085435|NCT03486990|19935918|P8|NOT COMPLETED|Overall Study||0
8085436|NCT03486990|19935919|P7|NOT COMPLETED|Overall Study||0
8085437|NCT03486990|19935920|P6|NOT COMPLETED|Overall Study||0
8085438|NCT03486990|19935921|P5|NOT COMPLETED|Overall Study||0
8085439|NCT03486990|19935922|P4|NOT COMPLETED|Overall Study||0
8085440|NCT03486990|19935923|P3|NOT COMPLETED|Overall Study||0
8085441|NCT03486990|19935924|P2|NOT COMPLETED|Overall Study||0
8085442|NCT03486990|19935925|P1|NOT COMPLETED|Overall Study||0
8085443|NCT03486990|19935917|P9|COMPLETED|Overall Study||2
8085444|NCT03486990|19935918|P8|COMPLETED|Overall Study||2
8085445|NCT03486990|19935919|P7|COMPLETED|Overall Study||2
8085446|NCT03486990|19935920|P6|COMPLETED|Overall Study||4
8085447|NCT03486990|19935921|P5|COMPLETED|Overall Study||3
8085448|NCT03486990|19935922|P4|COMPLETED|Overall Study||3
8085449|NCT03486990|19935923|P3|COMPLETED|Overall Study||3
8085450|NCT03486990|19935924|P2|COMPLETED|Overall Study||2
8085451|NCT03486990|19935925|P1|COMPLETED|Overall Study||2
8085452|NCT03486990|19935917|P9|STARTED|Overall Study||2
8085453|NCT03486990|19935918|P8|STARTED|Overall Study||2
8085454|NCT03486990|19935919|P7|STARTED|Overall Study||2
8085455|NCT03486990|19935920|P6|STARTED|Overall Study||4
8085456|NCT03486990|19935921|P5|STARTED|Overall Study||3
8085457|NCT03486990|19935922|P4|STARTED|Overall Study||3
8085458|NCT03486990|19935923|P3|STARTED|Overall Study||3
8085459|NCT03486990|19935924|P2|STARTED|Overall Study||2
8085460|NCT03486990|19935925|P1|STARTED|Overall Study||2
8085461|NCT03486392|19936104|P5|NOT COMPLETED|Overall Study||4
8085462|NCT03486392|19936105|P4|NOT COMPLETED|Overall Study||9
8085463|NCT03486392|19936106|P3|NOT COMPLETED|Overall Study||14
8085464|NCT03486392|19936107|P2|NOT COMPLETED|Overall Study||0
8085465|NCT03486392|19936108|P1|NOT COMPLETED|Overall Study||3
8085466|NCT03486392|19936104|P5|COMPLETED|Overall Study||115
8085467|NCT03486392|19936105|P4|COMPLETED|Overall Study||109
8085468|NCT03486392|19936106|P3|COMPLETED|Overall Study||104
8085469|NCT03486392|19936107|P2|COMPLETED|Overall Study||59
8085470|NCT03486392|19936108|P1|COMPLETED|Overall Study||57
8085471|NCT03486392|19936104|P5|STARTED|Overall Study||119
8085472|NCT03486392|19936105|P4|STARTED|Overall Study||118
8085473|NCT03486392|19936106|P3|STARTED|Overall Study||118
8085474|NCT03486392|19936107|P2|STARTED|Overall Study||59
8085475|NCT03486392|19936108|P1|STARTED|Overall Study||60
8085476|NCT03485976|19936140|P1|NOT COMPLETED|Overall Study||1
8085477|NCT03485976|19936140|P1|COMPLETED|Overall Study||11
8085478|NCT03485976|19936140|P1|STARTED|Overall Study||12
8085479|NCT03483896|19936148|P2|NOT COMPLETED|Overall Study||4
8085480|NCT03483896|19936149|P1|NOT COMPLETED|Overall Study||2
8085481|NCT03483896|19936148|P2|COMPLETED|Overall Study||46
8085482|NCT03483896|19936149|P1|COMPLETED|Overall Study||31
8085483|NCT03483896|19936148|P2|STARTED|Overall Study||50
8085484|NCT03483896|19936149|P1|STARTED|Overall Study||33
8085485|NCT03483623|19936157|P1|NOT COMPLETED|Overall Study||1
8085486|NCT03483623|19936157|P1|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085487|NCT03483623|19936157|P1|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085488|NCT03483623|19936157|P1|Started RAVEN FIS|Overall Study||44
8085489|NCT03483623|19936157|P1|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085490|NCT03483623|19936157|P1|Started RAVEN WELP|Overall Study||44
8085491|NCT03483623|19936157|P1|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085492|NCT03483623|19936157|P1|Started NATO FIS|Overall Study||44
8085493|NCT03483623|19936157|P1|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085494|NCT03483623|19936157|P1|Started NATO WELP|Overall Study||44
8085495|NCT03483623|19936157|P1|STARTED|Overall Study||44
8085496|NCT03483051|19936170|P2|NOT COMPLETED|Second Treatment, After Crossover||0
8085497|NCT03483051|19936171|P1|NOT COMPLETED|Second Treatment, After Crossover||0
8085498|NCT03483051|19936170|P2|COMPLETED|Second Treatment, After Crossover||1
8085499|NCT03483051|19936171|P1|COMPLETED|Second Treatment, After Crossover||2
8085500|NCT03483051|19936170|P2|STARTED|Second Treatment, After Crossover||1
8085501|NCT03483051|19936171|P1|STARTED|Second Treatment, After Crossover||2
8085502|NCT03483051|19936170|P2|NOT COMPLETED|First Treatment, Pre Crossover||0
8085503|NCT03483051|19936171|P1|NOT COMPLETED|First Treatment, Pre Crossover||0
8085504|NCT03483051|19936170|P2|COMPLETED|First Treatment, Pre Crossover||1
8085505|NCT03483051|19936171|P1|COMPLETED|First Treatment, Pre Crossover||2
8085506|NCT03483051|19936170|P2|STARTED|First Treatment, Pre Crossover||1
8085507|NCT03483051|19936171|P1|STARTED|First Treatment, Pre Crossover||2
8085508|NCT03482973|19936191|P2|NOT COMPLETED|Overall Study||0
8085509|NCT03482973|19936192|P1|NOT COMPLETED|Overall Study||0
8085510|NCT03482973|19936191|P2|COMPLETED|Overall Study||40
8085511|NCT03482973|19936192|P1|COMPLETED|Overall Study||40
8085512|NCT03482973|19936191|P2|STARTED|Overall Study||40
8085513|NCT03482973|19936192|P1|STARTED|Overall Study||40
8085514|NCT03482882|19936206|P1|NOT COMPLETED|Overall Study||7
8085515|NCT03482882|19936206|P1|COMPLETED|Overall Study||40
8085516|NCT03482882|19936206|P1|STARTED|Overall Study||47
8085517|NCT03482713|19936219|P2|NOT COMPLETED|Overall Study||0
8085518|NCT03482713|19936220|P1|NOT COMPLETED|Overall Study||0
8085519|NCT03482713|19936219|P2|COMPLETED|Overall Study||12
8085520|NCT03482713|19936220|P1|COMPLETED|Overall Study||11
8085521|NCT03482713|19936219|P2|STARTED|Overall Study||12
8085522|NCT03482713|19936220|P1|STARTED|Overall Study||11
8085523|NCT03482583|19936235|P3|NOT COMPLETED|Overall Study||21
8085524|NCT03482583|19936236|P2|NOT COMPLETED|Overall Study||9
8085525|NCT03482583|19936237|P1|NOT COMPLETED|Overall Study||25
8085526|NCT03482583|19936235|P3|COMPLETED|Overall Study||18
8085527|NCT03482583|19936236|P2|COMPLETED|Overall Study||5
8085528|NCT03482583|19936237|P1|COMPLETED|Overall Study||12
8085529|NCT03482583|19936235|P3|STARTED|Overall Study||39
8085530|NCT03482583|19936236|P2|STARTED|Overall Study||14
8085531|NCT03482583|19936237|P1|STARTED|Overall Study||37
8085532|NCT03482453|19936267|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085533|NCT03482453|19936268|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085534|NCT03482453|19936269|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085535|NCT03482453|19936270|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085536|NCT03482453|19936271|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085537|NCT03482453|19936272|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085538|NCT03482453|19936273|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085539|NCT03482453|19936274|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085540|NCT03482453|19936275|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085541|NCT03482453|19936276|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085542|NCT03482453|19936277|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085543|NCT03482453|19936278|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085544|NCT03482453|19936267|P12|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085545|NCT03482453|19936268|P11|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085546|NCT03482453|19936269|P10|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085547|NCT03482453|19936270|P9|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085548|NCT03482453|19936271|P8|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085549|NCT03482453|19936272|P7|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085550|NCT03482453|19936273|P6|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085551|NCT03482453|19936274|P5|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085552|NCT03482453|19936275|P4|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085553|NCT03482453|19936276|P3|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085554|NCT03482453|19936277|P2|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085555|NCT03482453|19936278|P1|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085556|NCT03482453|19936267|P12|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085557|NCT03482453|19936268|P11|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085558|NCT03482453|19936269|P10|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085559|NCT03482453|19936270|P9|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085560|NCT03482453|19936271|P8|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085561|NCT03482453|19936272|P7|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085562|NCT03482453|19936273|P6|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085563|NCT03482453|19936274|P5|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085564|NCT03482453|19936275|P4|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085565|NCT03482453|19936276|P3|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085566|NCT03482453|19936277|P2|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085567|NCT03482453|19936278|P1|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085568|NCT03482453|19936267|P12|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085569|NCT03482453|19936268|P11|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085570|NCT03482453|19936269|P10|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085571|NCT03482453|19936270|P9|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085572|NCT03482453|19936271|P8|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085573|NCT03482453|19936272|P7|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085574|NCT03482453|19936273|P6|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085575|NCT03482453|19936274|P5|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085576|NCT03482453|19936275|P4|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085577|NCT03482453|19936276|P3|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085578|NCT03482453|19936277|P2|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085579|NCT03482453|19936278|P1|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085580|NCT03482453|19936267|P12|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
8085581|NCT03482453|19936268|P11|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
8085582|NCT03482453|19936269|P10|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
8085583|NCT03482453|19936270|P9|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
8085584|NCT03482453|19936271|P8|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
8085585|NCT03482453|19936272|P7|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
8085586|NCT03482453|19936273|P6|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085587|NCT03482453|19936274|P5|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085588|NCT03482453|19936275|P4|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085589|NCT03482453|19936276|P3|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085590|NCT03482453|19936277|P2|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085591|NCT03482453|19936278|P1|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085592|NCT03482453|19936267|P12|STARTED|Parts 2, 3 Washout Period (7 Days)||6
8085593|NCT03482453|19936268|P11|STARTED|Parts 2, 3 Washout Period (7 Days)||6
8085594|NCT03482453|19936269|P10|STARTED|Parts 2, 3 Washout Period (7 Days)||5
8085595|NCT03482453|19936270|P9|STARTED|Parts 2, 3 Washout Period (7 Days)||5
8085596|NCT03482453|19936271|P8|STARTED|Parts 2, 3 Washout Period (7 Days)||3
8085597|NCT03482453|19936272|P7|STARTED|Parts 2, 3 Washout Period (7 Days)||3
8085598|NCT03482453|19936273|P6|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085599|NCT03482453|19936274|P5|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085600|NCT03482453|19936275|P4|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085601|NCT03482453|19936276|P3|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085602|NCT03482453|19936277|P2|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085603|NCT03482453|19936278|P1|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085604|NCT03482453|19936267|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085605|NCT03482453|19936268|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
8085606|NCT03482453|19936269|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085607|NCT03482453|19936270|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085608|NCT03482453|19936271|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085609|NCT03482453|19936272|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085610|NCT03482453|19936273|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085611|NCT03482453|19936274|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085612|NCT03482453|19936275|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085613|NCT03482453|19936276|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085614|NCT03482453|19936277|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085615|NCT03482453|19936278|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085616|NCT03482453|19936267|P12|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
8085617|NCT03482453|19936268|P11|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
8085618|NCT03482453|19936269|P10|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085619|NCT03482453|19936270|P9|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085620|NCT03482453|19936271|P8|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085621|NCT03482453|19936272|P7|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085622|NCT03482453|19936273|P6|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085623|NCT03482453|19936274|P5|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085624|NCT03482453|19936275|P4|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085625|NCT03482453|19936276|P3|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085626|NCT03482453|19936277|P2|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085627|NCT03482453|19936278|P1|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085628|NCT03482453|19936267|P12|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
8085629|NCT03482453|19936268|P11|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
8085630|NCT03482453|19936269|P10|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085631|NCT03482453|19936270|P9|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085632|NCT03482453|19936271|P8|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085633|NCT03482453|19936272|P7|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085634|NCT03482453|19936273|P6|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085635|NCT03482453|19936274|P5|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085636|NCT03482453|19936275|P4|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085637|NCT03482453|19936276|P3|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085638|NCT03482453|19936277|P2|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085639|NCT03482453|19936278|P1|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085640|NCT03482453|19936267|P12|NOT COMPLETED|Part 1 (1 Day)||0
8085641|NCT03482453|19936268|P11|NOT COMPLETED|Part 1 (1 Day)||0
8085642|NCT03482453|19936269|P10|NOT COMPLETED|Part 1 (1 Day)||0
8085643|NCT03482453|19936270|P9|NOT COMPLETED|Part 1 (1 Day)||0
8085644|NCT03482453|19936271|P8|NOT COMPLETED|Part 1 (1 Day)||0
8085645|NCT03482453|19936272|P7|NOT COMPLETED|Part 1 (1 Day)||0
8085646|NCT03482453|19936273|P6|NOT COMPLETED|Part 1 (1 Day)||0
8085647|NCT03482453|19936274|P5|NOT COMPLETED|Part 1 (1 Day)||0
8085648|NCT03482453|19936275|P4|NOT COMPLETED|Part 1 (1 Day)||0
8085649|NCT03482453|19936276|P3|NOT COMPLETED|Part 1 (1 Day)||0
8085650|NCT03482453|19936277|P2|NOT COMPLETED|Part 1 (1 Day)||0
8085651|NCT03482453|19936278|P1|NOT COMPLETED|Part 1 (1 Day)||0
8085652|NCT03482453|19936267|P12|COMPLETED|Part 1 (1 Day)||0
8085653|NCT03482453|19936268|P11|COMPLETED|Part 1 (1 Day)||0
8085654|NCT03482453|19936269|P10|COMPLETED|Part 1 (1 Day)||0
8085655|NCT03482453|19936270|P9|COMPLETED|Part 1 (1 Day)||0
8085656|NCT03482453|19936271|P8|COMPLETED|Part 1 (1 Day)||0
8085657|NCT03482453|19936272|P7|COMPLETED|Part 1 (1 Day)||0
8085658|NCT03482453|19936273|P6|COMPLETED|Part 1 (1 Day)||6
8085659|NCT03482453|19936274|P5|COMPLETED|Part 1 (1 Day)||6
8085660|NCT03482453|19936275|P4|COMPLETED|Part 1 (1 Day)||6
8085661|NCT03482453|19936276|P3|COMPLETED|Part 1 (1 Day)||6
8085662|NCT03482453|19936277|P2|COMPLETED|Part 1 (1 Day)||6
8085663|NCT03482453|19936278|P1|COMPLETED|Part 1 (1 Day)||10
8085664|NCT03482453|19936267|P12|STARTED|Part 1 (1 Day)||0
8085665|NCT03482453|19936268|P11|STARTED|Part 1 (1 Day)||0
8085666|NCT03482453|19936269|P10|STARTED|Part 1 (1 Day)||0
8085667|NCT03482453|19936270|P9|STARTED|Part 1 (1 Day)||0
8085668|NCT03482453|19936271|P8|STARTED|Part 1 (1 Day)||0
8085669|NCT03482453|19936272|P7|STARTED|Part 1 (1 Day)||0
8085670|NCT03482453|19936273|P6|STARTED|Part 1 (1 Day)||6
8085671|NCT03482453|19936274|P5|STARTED|Part 1 (1 Day)||6
8085672|NCT03482453|19936275|P4|STARTED|Part 1 (1 Day)||6
8085673|NCT03482453|19936276|P3|STARTED|Part 1 (1 Day)||6
8085674|NCT03482453|19936277|P2|STARTED|Part 1 (1 Day)||6
8085675|NCT03482453|19936278|P1|STARTED|Part 1 (1 Day)||10
8085676|NCT03482011|19936397|P8|NOT COMPLETED|Follow-up Period (12 Weeks)||17
8085677|NCT03482011|19936398|P7|NOT COMPLETED|Follow-up Period (12 Weeks)||2
8085678|NCT03482011|19936399|P6|NOT COMPLETED|Follow-up Period (12 Weeks)||1
8085679|NCT03482011|19936400|P5|NOT COMPLETED|Follow-up Period (12 Weeks)||0
8085680|NCT03482011|19936401|P4|NOT COMPLETED|Follow-up Period (12 Weeks)||5
8085681|NCT03482011|19936402|P3|NOT COMPLETED|Follow-up Period (12 Weeks)||1
8085682|NCT03482011|19936403|P2|NOT COMPLETED|Follow-up Period (12 Weeks)||0
8085683|NCT03482011|19936404|P1|NOT COMPLETED|Follow-up Period (12 Weeks)||0
8085684|NCT03482011|19936397|P8|COMPLETED|Follow-up Period (12 Weeks)||4
8085685|NCT03482011|19936398|P7|COMPLETED|Follow-up Period (12 Weeks)||2
8085686|NCT03482011|19936399|P6|COMPLETED|Follow-up Period (12 Weeks)||3
8085687|NCT03482011|19936400|P5|COMPLETED|Follow-up Period (12 Weeks)||2
8085688|NCT03482011|19936401|P4|COMPLETED|Follow-up Period (12 Weeks)||5
8085689|NCT03482011|19936402|P3|COMPLETED|Follow-up Period (12 Weeks)||0
8085690|NCT03482011|19936403|P2|COMPLETED|Follow-up Period (12 Weeks)||0
8085691|NCT03482011|19936404|P1|COMPLETED|Follow-up Period (12 Weeks)||0
8085692|NCT03482011|19936397|P8|STARTED|Follow-up Period (12 Weeks)||21
8085693|NCT03482011|19936398|P7|STARTED|Follow-up Period (12 Weeks)||4
8085694|NCT03482011|19936399|P6|STARTED|Follow-up Period (12 Weeks)||4
8085695|NCT03482011|19936400|P5|STARTED|Follow-up Period (12 Weeks)||2
8085696|NCT03482011|19936401|P4|STARTED|Follow-up Period (12 Weeks)||10
8085697|NCT03482011|19936402|P3|STARTED|Follow-up Period (12 Weeks)||1
8085698|NCT03482011|19936403|P2|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
8085699|NCT03482011|19936404|P1|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
8085700|NCT03482011|19936397|P8|NOT COMPLETED|Maintenance Period (36 Weeks)||17
8085701|NCT03482011|19936398|P7|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8085702|NCT03482011|19936399|P6|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8085703|NCT03482011|19936400|P5|NOT COMPLETED|Maintenance Period (36 Weeks)||5
8085704|NCT03482011|19936401|P4|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8085705|NCT03482011|19936402|P3|NOT COMPLETED|Maintenance Period (36 Weeks)||1
8085706|NCT03482011|19936403|P2|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8085707|NCT03482011|19936404|P1|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8085708|NCT03482011|19936397|P8|COMPLETED|Maintenance Period (36 Weeks)||123
8085709|NCT03482011|19936398|P7|COMPLETED|Maintenance Period (36 Weeks)||87
8085710|NCT03482011|19936399|P6|COMPLETED|Maintenance Period (36 Weeks)||86
8085711|NCT03482011|19936400|P5|COMPLETED|Maintenance Period (36 Weeks)||86
8085712|NCT03482011|19936401|P4|COMPLETED|Maintenance Period (36 Weeks)||90
8085713|NCT03482011|19936402|P3|COMPLETED|Maintenance Period (36 Weeks)||6
8085714|NCT03482011|19936403|P2|COMPLETED|Maintenance Period (36 Weeks)||0
8085715|NCT03482011|19936404|P1|COMPLETED|Maintenance Period (36 Weeks)||0
8085716|NCT03482011|19936397|P8|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
8085717|NCT03482011|19936398|P7|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
8085718|NCT03482011|19936399|P6|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
8085719|NCT03482011|19936400|P5|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
8085720|NCT03482011|19936401|P4|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
8085721|NCT03482011|19936402|P3|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
8085722|NCT03482011|19936403|P2|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
8085723|NCT03482011|19936404|P1|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
8085724|NCT03482011|19936397|P8|Relapse|Maintenance Period (36 Weeks)||0
8085725|NCT03482011|19936398|P7|Relapse|Maintenance Period (36 Weeks)||2
8085726|NCT03482011|19936399|P6|Relapse|Maintenance Period (36 Weeks)||3
8085727|NCT03482011|19936400|P5|Relapse|Maintenance Period (36 Weeks)||41
8085728|NCT03482011|19936401|P4|Relapse|Maintenance Period (36 Weeks)||0
8085729|NCT03482011|19936402|P3|Relapse|Maintenance Period (36 Weeks)||1
8085730|NCT03482011|19936403|P2|Relapse|Maintenance Period (36 Weeks)||0
8085731|NCT03482011|19936404|P1|Relapse|Maintenance Period (36 Weeks)||0
8085732|NCT03482011|19936397|P8|STARTED|Maintenance Period (36 Weeks)||140
8085733|NCT03482011|19936398|P7|STARTED|Maintenance Period (36 Weeks)||91
8085734|NCT03482011|19936399|P6|STARTED|Maintenance Period (36 Weeks)||90
8085735|NCT03482011|19936400|P5|STARTED|Maintenance Period (36 Weeks)||91
8085736|NCT03482011|19936401|P4|STARTED|Maintenance Period (36 Weeks)||94
8085737|NCT03482011|19936402|P3|STARTED|Maintenance Period (36 Weeks)||7
8085738|NCT03482011|19936403|P2|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8085739|NCT03482011|19936404|P1|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8085740|NCT03482011|19936397|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
8085741|NCT03482011|19936398|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
8085742|NCT03482011|19936399|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
8085743|NCT03482011|19936400|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
8085744|NCT03482011|19936401|P4|NOT COMPLETED|Induction Period (16 Weeks)||0
8085745|NCT03482011|19936402|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
8085746|NCT03482011|19936403|P2|NOT COMPLETED|Induction Period (16 Weeks)||11
8085747|NCT03482011|19936404|P1|NOT COMPLETED|Induction Period (16 Weeks)||6
8085748|NCT03482011|19936397|P8|COMPLETED|Induction Period (16 Weeks)||0
8085749|NCT03482011|19936398|P7|COMPLETED|Induction Period (16 Weeks)||0
8085750|NCT03482011|19936399|P6|COMPLETED|Induction Period (16 Weeks)||0
8085751|NCT03482011|19936400|P5|COMPLETED|Induction Period (16 Weeks)||0
8085752|NCT03482011|19936401|P4|COMPLETED|Induction Period (16 Weeks)||0
8085753|NCT03482011|19936402|P3|COMPLETED|Induction Period (16 Weeks)||0
8085754|NCT03482011|19936403|P2|COMPLETED|Induction Period (16 Weeks)||412
8085755|NCT03482011|19936404|P1|COMPLETED|Induction Period (16 Weeks)||101
8085756|NCT03482011|19936397|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085757|NCT03482011|19936398|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085758|NCT03482011|19936399|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085759|NCT03482011|19936400|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085760|NCT03482011|19936401|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085761|NCT03482011|19936402|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085762|NCT03482011|19936403|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
8085763|NCT03482011|19936404|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
8085764|NCT03482011|19936397|P8|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085765|NCT03482011|19936398|P7|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085766|NCT03482011|19936399|P6|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085767|NCT03482011|19936400|P5|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085768|NCT03482011|19936401|P4|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085769|NCT03482011|19936402|P3|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085770|NCT03482011|19936403|P2|STARTED|Induction Period (16 Weeks)||423
8085771|NCT03482011|19936404|P1|STARTED|Induction Period (16 Weeks)||107
8085772|NCT03481816|19936463|P2|NOT COMPLETED|Dose Expansion||12
8085773|NCT03481816|19936464|P1|NOT COMPLETED|Dose Expansion||0
8085774|NCT03481816|19936463|P2|COMPLETED|Dose Expansion||0
8085775|NCT03481816|19936464|P1|COMPLETED|Dose Expansion||0
8085776|NCT03481816|19936463|P2|STARTED|Dose Expansion||12
8085777|NCT03481816|19936464|P1|STARTED|Dose Expansion||0
8085778|NCT03481816|19936463|P2|NOT COMPLETED|Starting Dose||0
8085779|NCT03481816|19936464|P1|NOT COMPLETED|Starting Dose||1
8085780|NCT03481816|19936463|P2|COMPLETED|Starting Dose||0
8085781|NCT03481816|19936464|P1|COMPLETED|Starting Dose||5
8085782|NCT03481816|19936463|P2|STARTED|Starting Dose||0
8085783|NCT03481816|19936464|P1|STARTED|Starting Dose||6
8085784|NCT03481309|19936491|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8085785|NCT03481309|19936492|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8085786|NCT03481309|19936493|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8085787|NCT03481309|19936494|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8085788|NCT03481309|19936495|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8085789|NCT03481309|19936496|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8085790|NCT03481309|19936491|P6|COMPLETED|Third Intervention (1 Day)||3
8085791|NCT03481309|19936492|P5|COMPLETED|Third Intervention (1 Day)||3
8085792|NCT03481309|19936493|P4|COMPLETED|Third Intervention (1 Day)||3
8085793|NCT03481309|19936494|P3|COMPLETED|Third Intervention (1 Day)||3
8085794|NCT03481309|19936495|P2|COMPLETED|Third Intervention (1 Day)||3
8085795|NCT03481309|19936496|P1|COMPLETED|Third Intervention (1 Day)||3
8085796|NCT03481309|19936491|P6|STARTED|Third Intervention (1 Day)||3
8085797|NCT03481309|19936492|P5|STARTED|Third Intervention (1 Day)||3
8085798|NCT03481309|19936493|P4|STARTED|Third Intervention (1 Day)||3
8085799|NCT03481309|19936494|P3|STARTED|Third Intervention (1 Day)||3
8085800|NCT03481309|19936495|P2|STARTED|Third Intervention (1 Day)||3
8085801|NCT03481309|19936496|P1|STARTED|Third Intervention (1 Day)||3
8085802|NCT03481309|19936491|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
8085803|NCT03481309|19936492|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
8085804|NCT03481309|19936493|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
8085805|NCT03481309|19936494|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
8085806|NCT03481309|19936495|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
8085807|NCT03481309|19936496|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
8085808|NCT03481309|19936491|P6|COMPLETED|Washout (at Least 3 Days)||3
8085809|NCT03481309|19936492|P5|COMPLETED|Washout (at Least 3 Days)||3
8085810|NCT03481309|19936493|P4|COMPLETED|Washout (at Least 3 Days)||3
8085811|NCT03481309|19936494|P3|COMPLETED|Washout (at Least 3 Days)||3
8085812|NCT03481309|19936495|P2|COMPLETED|Washout (at Least 3 Days)||3
8085813|NCT03481309|19936496|P1|COMPLETED|Washout (at Least 3 Days)||3
8085814|NCT03481309|19936491|P6|STARTED|Washout (at Least 3 Days)||3
8085815|NCT03481309|19936492|P5|STARTED|Washout (at Least 3 Days)||3
8085816|NCT03481309|19936493|P4|STARTED|Washout (at Least 3 Days)||3
8085817|NCT03481309|19936494|P3|STARTED|Washout (at Least 3 Days)||3
8085818|NCT03481309|19936495|P2|STARTED|Washout (at Least 3 Days)||3
8085819|NCT03481309|19936496|P1|STARTED|Washout (at Least 3 Days)||3
8085820|NCT03481309|19936491|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8085821|NCT03481309|19936492|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8085822|NCT03481309|19936493|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8085823|NCT03481309|19936494|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8085824|NCT03481309|19936495|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8085825|NCT03481309|19936496|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8085826|NCT03481309|19936491|P6|COMPLETED|Second Intervention (1 Day)||3
8085827|NCT03481309|19936492|P5|COMPLETED|Second Intervention (1 Day)||3
8085828|NCT03481309|19936493|P4|COMPLETED|Second Intervention (1 Day)||3
8085829|NCT03481309|19936494|P3|COMPLETED|Second Intervention (1 Day)||3
8085830|NCT03481309|19936495|P2|COMPLETED|Second Intervention (1 Day)||3
8085831|NCT03481309|19936496|P1|COMPLETED|Second Intervention (1 Day)||3
8085832|NCT03481309|19936491|P6|STARTED|Second Intervention (1 Day)||3
8085833|NCT03481309|19936492|P5|STARTED|Second Intervention (1 Day)||3
8085834|NCT03481309|19936493|P4|STARTED|Second Intervention (1 Day)||3
8085835|NCT03481309|19936494|P3|STARTED|Second Intervention (1 Day)||3
8085836|NCT03481309|19936495|P2|STARTED|Second Intervention (1 Day)||3
8085837|NCT03481309|19936496|P1|STARTED|Second Intervention (1 Day)||3
8085838|NCT03481309|19936491|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
8085839|NCT03481309|19936492|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
8085840|NCT03481309|19936493|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
8085841|NCT03481309|19936494|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
8085842|NCT03481309|19936495|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
8085843|NCT03481309|19936496|P1|NOT COMPLETED|Washout (at Least 3 Days)||1
8085844|NCT03481309|19936491|P6|COMPLETED|Washout (at Least 3 Days)||3
8085845|NCT03481309|19936492|P5|COMPLETED|Washout (at Least 3 Days)||3
8085846|NCT03481309|19936493|P4|COMPLETED|Washout (at Least 3 Days)||3
8085847|NCT03481309|19936494|P3|COMPLETED|Washout (at Least 3 Days)||3
8085848|NCT03481309|19936495|P2|COMPLETED|Washout (at Least 3 Days)||3
8085849|NCT03481309|19936496|P1|COMPLETED|Washout (at Least 3 Days)||3
8085850|NCT03481309|19936491|P6|STARTED|Washout (at Least 3 Days)||3
8085851|NCT03481309|19936492|P5|STARTED|Washout (at Least 3 Days)||3
8085852|NCT03481309|19936493|P4|STARTED|Washout (at Least 3 Days)||3
8085853|NCT03481309|19936494|P3|STARTED|Washout (at Least 3 Days)||3
8085854|NCT03481309|19936495|P2|STARTED|Washout (at Least 3 Days)||3
8085855|NCT03481309|19936496|P1|STARTED|Washout (at Least 3 Days)||4
8085856|NCT03481309|19936491|P6|NOT COMPLETED|First Intervention (1 Day)||0
8085857|NCT03481309|19936492|P5|NOT COMPLETED|First Intervention (1 Day)||0
8085858|NCT03481309|19936493|P4|NOT COMPLETED|First Intervention (1 Day)||0
8085859|NCT03481309|19936494|P3|NOT COMPLETED|First Intervention (1 Day)||0
8085860|NCT03481309|19936495|P2|NOT COMPLETED|First Intervention (1 Day)||0
8085861|NCT03481309|19936496|P1|NOT COMPLETED|First Intervention (1 Day)||0
8085862|NCT03481309|19936491|P6|COMPLETED|First Intervention (1 Day)||3
8085863|NCT03481309|19936492|P5|COMPLETED|First Intervention (1 Day)||3
8085864|NCT03481309|19936493|P4|COMPLETED|First Intervention (1 Day)||3
8085865|NCT03481309|19936494|P3|COMPLETED|First Intervention (1 Day)||3
8085866|NCT03481309|19936495|P2|COMPLETED|First Intervention (1 Day)||3
8085867|NCT03481309|19936496|P1|COMPLETED|First Intervention (1 Day)||4
8085868|NCT03481309|19936491|P6|STARTED|First Intervention (1 Day)||3
8085869|NCT03481309|19936492|P5|STARTED|First Intervention (1 Day)||3
8085870|NCT03481309|19936493|P4|STARTED|First Intervention (1 Day)||3
8085871|NCT03481309|19936494|P3|STARTED|First Intervention (1 Day)||3
8085872|NCT03481309|19936495|P2|STARTED|First Intervention (1 Day)||3
8085873|NCT03481309|19936496|P1|STARTED|First Intervention (1 Day)||4
8085874|NCT03481270|19936512|P2|NOT COMPLETED|Overall Study||0
8085875|NCT03481270|19936513|P1|NOT COMPLETED|Overall Study||0
8085876|NCT03481270|19936512|P2|COMPLETED|Overall Study||313
8085877|NCT03481270|19936513|P1|COMPLETED|Overall Study||324
8085878|NCT03481270|19936512|P2|STARTED|Overall Study||313
8085879|NCT03481270|19936513|P1|STARTED|Overall Study||324
8085880|NCT03480919|19936522|P3|NOT COMPLETED|Overall Study||0
8085881|NCT03480919|19936523|P2|NOT COMPLETED|Overall Study||0
8085882|NCT03480919|19936524|P1|NOT COMPLETED|Overall Study||0
8085883|NCT03480919|19936522|P3|COMPLETED|Overall Study||1
8085884|NCT03480919|19936523|P2|COMPLETED|Overall Study||2
8085885|NCT03480919|19936524|P1|COMPLETED|Overall Study||1
8085886|NCT03480919|19936522|P3|STARTED|Overall Study||1
8085887|NCT03480919|19936523|P2|STARTED|Overall Study||2
8085888|NCT03480919|19936524|P1|STARTED|Overall Study||1
8085889|NCT03480841|19936538|P1|NOT COMPLETED|Overall Study||2
8085890|NCT03480841|19936538|P1|COMPLETED|Overall Study||8
8085891|NCT03480841|19936538|P1|Time 2 Data Collection (T2)|Overall Study||8
8085892|NCT03480841|19936538|P1|LENA Time 5|Overall Study||8
8085893|NCT03480841|19936538|P1|LENA Time 4|Overall Study||9
8085894|NCT03480841|19936538|P1|LENA Time 3|Overall Study||10
8085895|NCT03480841|19936538|P1|LENA Time 2|Overall Study||10
8085896|NCT03480841|19936538|P1|LENA Time 1|Overall Study||10
8085897|NCT03480841|19936538|P1|LENA Baseline|Overall Study||10
8085898|NCT03480841|19936538|P1|Time 1 Data Collection (T1)|Overall Study||10
8085899|NCT03480841|19936538|P1|STARTED|Overall Study||10
8085900|NCT03480802|19936549|P2|NOT COMPLETED|Overall Study||3
8085901|NCT03480802|19936550|P1|NOT COMPLETED|Overall Study||7
8085902|NCT03480802|19936549|P2|COMPLETED|Overall Study||147
8085903|NCT03480802|19936550|P1|COMPLETED|Overall Study||145
8085904|NCT03480802|19936549|P2|Week 8|Overall Study||148
8085905|NCT03480802|19936550|P1|Week 8|Overall Study||150
8085906|NCT03480802|19936549|P2|STARTED|Overall Study||150
8085907|NCT03480802|19936550|P1|STARTED|Overall Study||152
8085908|NCT03480763|19936578|P2|NOT COMPLETED|Overall Study||19
8085909|NCT03480763|19936579|P1|NOT COMPLETED|Overall Study||24
8085910|NCT03480763|19936578|P2|COMPLETED|Overall Study||306
8085911|NCT03480763|19936579|P1|COMPLETED|Overall Study||303
8085912|NCT03480763|19936578|P2|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
8085913|NCT03480763|19936579|P1|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
8085914|NCT03480763|19936578|P2|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
8085915|NCT03480763|19936579|P1|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
8085916|NCT03480763|19936578|P2|STARTED|Overall Study||325
8085917|NCT03480763|19936579|P1|STARTED|Overall Study||327
8085918|NCT03480750|19936647|P6|NOT COMPLETED|Overall Study||1
8085919|NCT03480750|19936648|P5|NOT COMPLETED|Overall Study||0
8085920|NCT03480750|19936649|P4|NOT COMPLETED|Overall Study||0
8085921|NCT03480750|19936650|P3|NOT COMPLETED|Overall Study||0
8085922|NCT03480750|19936651|P2|NOT COMPLETED|Overall Study||1
8085923|NCT03480750|19936652|P1|NOT COMPLETED|Overall Study||0
8085924|NCT03480750|19936647|P6|COMPLETED|Overall Study||1
8085925|NCT03480750|19936648|P5|COMPLETED|Overall Study||3
8085926|NCT03480750|19936649|P4|COMPLETED|Overall Study||3
8085927|NCT03480750|19936650|P3|COMPLETED|Overall Study||3
8085928|NCT03480750|19936651|P2|COMPLETED|Overall Study||3
8085929|NCT03480750|19936652|P1|COMPLETED|Overall Study||3
8085930|NCT03480750|19936647|P6|STARTED|Overall Study||2
8085931|NCT03480750|19936648|P5|STARTED|Overall Study||3
8085932|NCT03480750|19936649|P4|STARTED|Overall Study||3
8085933|NCT03480750|19936650|P3|STARTED|Overall Study||3
8085934|NCT03480750|19936651|P2|STARTED|Overall Study||4
8085935|NCT03480750|19936652|P1|STARTED|Overall Study||3
8085936|NCT03480425|19936676|P1|NOT COMPLETED|Overall Study||1
8085937|NCT03480425|19936676|P1|COMPLETED|Overall Study||10
8085938|NCT03480425|19936676|P1|STARTED|Overall Study||11
8085939|NCT03480152|19936682|P3|NOT COMPLETED|Phase II||0
8085940|NCT03480152|19936683|P2|NOT COMPLETED|Phase II||0
8085941|NCT03480152|19936684|P1|NOT COMPLETED|Phase II||0
8085942|NCT03480152|19936682|P3|COMPLETED|Phase II||0
8085943|NCT03480152|19936683|P2|COMPLETED|Phase II||0
8085944|NCT03480152|19936684|P1|COMPLETED|Phase II||0
8085945|NCT03480152|19936682|P3|STARTED|Phase II||0
8085946|NCT03480152|19936683|P2|STARTED|Phase II||0
8085947|NCT03480152|19936684|P1|STARTED|Phase II||0
8085948|NCT03480152|19936682|P3|NOT COMPLETED|Phase I||0
8085949|NCT03480152|19936683|P2|NOT COMPLETED|Phase I||0
8085950|NCT03480152|19936684|P1|NOT COMPLETED|Phase I||1
8085951|NCT03480152|19936682|P3|COMPLETED|Phase I||0
8085952|NCT03480152|19936683|P2|COMPLETED|Phase I||2
8085953|NCT03480152|19936684|P1|COMPLETED|Phase I||2
8085954|NCT03480152|19936682|P3|Received Intervention|Phase I||0
8085955|NCT03480152|19936683|P2|Received Intervention|Phase I||2
8085956|NCT03480152|19936684|P1|Received Intervention|Phase I||2
8085957|NCT03480152|19936682|P3|STARTED|Phase I||0
8085958|NCT03480152|19936683|P2|STARTED|Phase I||2
8085959|NCT03480152|19936684|P1|STARTED|Phase I||3
8085960|NCT03480048|19936701|P2|NOT COMPLETED|Overall Study||8
8085961|NCT03480048|19936702|P1|NOT COMPLETED|Overall Study||10
8085962|NCT03480048|19936701|P2|COMPLETED|Overall Study||17
8085963|NCT03480048|19936702|P1|COMPLETED|Overall Study||18
8085964|NCT03480048|19936701|P2|STARTED|Overall Study||25
8085965|NCT03480048|19936702|P1|STARTED|Overall Study||28
8085966|NCT03480009|19936714|P4|NOT COMPLETED|Overall Study||0
8085967|NCT03480009|19936715|P3|NOT COMPLETED|Overall Study||4
8085968|NCT03480009|19936716|P2|NOT COMPLETED|Overall Study||5
8085969|NCT03480009|19936717|P1|NOT COMPLETED|Overall Study||4
8085970|NCT03480009|19936714|P4|COMPLETED|Overall Study||16
8085971|NCT03480009|19936715|P3|COMPLETED|Overall Study||12
8085972|NCT03480009|19936716|P2|COMPLETED|Overall Study||57
8085973|NCT03480009|19936717|P1|COMPLETED|Overall Study||58
8085974|NCT03480009|19936714|P4|STARTED|Overall Study||16
8085975|NCT03480009|19936715|P3|STARTED|Overall Study||16
8085976|NCT03480009|19936716|P2|STARTED|Overall Study||62
8085977|NCT03480009|19936717|P1|STARTED|Overall Study||62
8085978|NCT03479944|19936739|P1|NOT COMPLETED|Overall Study||0
8085979|NCT03479944|19936739|P1|COMPLETED|Overall Study||55
8085980|NCT03479944|19936739|P1|Full Analysis Set|Overall Study||53
8085981|NCT03479944|19936739|P1|Conventional|Overall Study||55
8085982|NCT03479944|19936739|P1|FLACS|Overall Study||55
8085983|NCT03479944|19936739|P1|STARTED|Overall Study||55
8085984|NCT03479216|19936752|P2|NOT COMPLETED|Overall Study||5
8085985|NCT03479216|19936753|P1|NOT COMPLETED|Overall Study||5
8085986|NCT03479216|19936752|P2|COMPLETED|Overall Study||26
8085987|NCT03479216|19936753|P1|COMPLETED|Overall Study||26
8085988|NCT03479216|19936752|P2|STARTED|Overall Study||31
8085989|NCT03479216|19936753|P1|STARTED|Overall Study||31
8086006|NCT03478891|19936803|P3|NOT COMPLETED|Overall Study||3
8086007|NCT03478891|19936804|P2|NOT COMPLETED|Overall Study||0
8086008|NCT03478891|19936805|P1|NOT COMPLETED|Overall Study||1
8086009|NCT03478891|19936803|P3|COMPLETED|Overall Study||8
8086010|NCT03478891|19936804|P2|COMPLETED|Overall Study||5
8086011|NCT03478891|19936805|P1|COMPLETED|Overall Study||2
8086012|NCT03478891|19936803|P3|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
8086013|NCT03478891|19936804|P2|Received MAb114|Overall Study||5
8086014|NCT03478891|19936805|P1|Received MAb114|Overall Study||3
8086015|NCT03478891|19936803|P3|STARTED|Overall Study||11
8086016|NCT03478891|19936804|P2|STARTED|Overall Study||5
8086017|NCT03478891|19936805|P1|STARTED|Overall Study||3
8086018|NCT03478696|19936856|P2|NOT COMPLETED|Overall Study||12
8086019|NCT03478696|19936857|P1|NOT COMPLETED|Overall Study||17
8086020|NCT03478696|19936856|P2|COMPLETED|Overall Study||354
8086021|NCT03478696|19936857|P1|COMPLETED|Overall Study||349
8086022|NCT03478696|19936856|P2|STARTED|Overall Study||366
8086023|NCT03478696|19936857|P1|STARTED|Overall Study||366
8086024|NCT03478683|19936871|P2|NOT COMPLETED|Overall Study||18
8086025|NCT03478683|19936872|P1|NOT COMPLETED|Overall Study||13
8086026|NCT03478683|19936871|P2|COMPLETED|Overall Study||347
8086027|NCT03478683|19936872|P1|COMPLETED|Overall Study||350
8086028|NCT03478683|19936871|P2|STARTED|Overall Study||365
8086029|NCT03478683|19936872|P1|STARTED|Overall Study||363
8086030|NCT03478657|19936886|P2|NOT COMPLETED|Overall Study||1
8086031|NCT03478657|19936887|P1|NOT COMPLETED|Overall Study||0
8086032|NCT03478657|19936886|P2|COMPLETED|Overall Study||133
8086033|NCT03478657|19936887|P1|COMPLETED|Overall Study||88
8086034|NCT03478657|19936886|P2|STARTED|Overall Study||134
8086035|NCT03478657|19936887|P1|STARTED|Overall Study||88
8086036|NCT03478644|19936902|P2|NOT COMPLETED|Phase 2||1
8086037|NCT03478644|19936903|P1|NOT COMPLETED|Phase 2||3
8086038|NCT03478644|19936902|P2|COMPLETED|Phase 2||75
8086039|NCT03478644|19936903|P1|COMPLETED|Phase 2||73
8086040|NCT03478644|19936902|P2|STARTED|Phase 2||76
8086041|NCT03478644|19936903|P1|STARTED|Phase 2||76
8086042|NCT03478644|19936902|P2|NOT COMPLETED|Phase 1||0
8086043|NCT03478644|19936903|P1|NOT COMPLETED|Phase 1||0
8086044|NCT03478644|19936902|P2|COMPLETED|Phase 1||0
8086045|NCT03478644|19936903|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
8086046|NCT03478644|19936902|P2|STARTED|Phase 1||0
8086047|NCT03478644|19936903|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
8086048|NCT03478371|19936915|P1|NOT COMPLETED|Overall Study||5
8086049|NCT03478371|19936915|P1|COMPLETED|Overall Study||89
8086050|NCT03478371|19936915|P1|Received Tampon V|Overall Study||91
8086051|NCT03478371|19936915|P1|Recived Tampon T|Overall Study||90
8086052|NCT03478371|19936915|P1|Received Tampon M|Overall Study||92
8086053|NCT03478371|19936915|P1|Received Tampon D|Overall Study||91
8086054|NCT03478371|19936915|P1|STARTED|Overall Study||94
8086055|NCT03478254|19936937|P1|NOT COMPLETED|Overall Study||0
8086056|NCT03478254|19936937|P1|COMPLETED|Overall Study||300
8086057|NCT03478254|19936937|P1|STARTED|Overall Study||300
8086058|NCT03477903|19936943|P1|NOT COMPLETED|Overall Study||1
8086059|NCT03477903|19936943|P1|COMPLETED|Overall Study||0
8086060|NCT03477903|19936943|P1|STARTED|Overall Study||1
8086061|NCT03476850|19936956|P2|NOT COMPLETED|Overall Study||0
8086062|NCT03476850|19936957|P1|NOT COMPLETED|Overall Study||0
8086063|NCT03476850|19936956|P2|COMPLETED|Overall Study||24
8086064|NCT03476850|19936957|P1|COMPLETED|Overall Study||24
8086065|NCT03476850|19936956|P2|STARTED|Overall Study||24
8086066|NCT03476850|19936957|P1|STARTED|Overall Study||24
8086067|NCT03476278|19936973|P1|NOT COMPLETED|Overall Study||0
8086068|NCT03476278|19936973|P1|COMPLETED|Overall Study||300
8086069|NCT03476278|19936973|P1|STARTED|Overall Study||300
8086070|NCT03476239|19937019|P1|NOT COMPLETED|Overall Study||106
8086071|NCT03476239|19937019|P1|COMPLETED|Overall Study||0
8086072|NCT03476239|19937019|P1|Interim Analysis Set|Overall Study||90
8086073|NCT03476239|19937019|P1|Enrolled Before 21 February 2019|Overall Study||91
8086074|NCT03476239|19937019|P1|STARTED|Overall Study||106
8086075|NCT03476135|19937040|P2|NOT COMPLETED|Overall Study||0
8086076|NCT03476135|19937041|P1|NOT COMPLETED|Overall Study||0
8086077|NCT03476135|19937040|P2|COMPLETED|Overall Study||49
8086078|NCT03476135|19937041|P1|COMPLETED|Overall Study||42
8086079|NCT03476135|19937040|P2|STARTED|Overall Study||49
8086080|NCT03476135|19937041|P1|STARTED|Overall Study||42
8086081|NCT03475875|19937069|P2|NOT COMPLETED|Period 3||0
8086082|NCT03475875|19937070|P1|NOT COMPLETED|Period 3||0
8086083|NCT03475875|19937069|P2|COMPLETED|Period 3||43
8086084|NCT03475875|19937070|P1|COMPLETED|Period 3||40
8086085|NCT03475875|19937069|P2|STARTED|Period 3||43
8086086|NCT03475875|19937070|P1|STARTED|Period 3||40
8086087|NCT03475875|19937069|P2|NOT COMPLETED|Period 2||1
8086088|NCT03475875|19937070|P1|NOT COMPLETED|Period 2||3
8086089|NCT03475875|19937069|P2|COMPLETED|Period 2||43
8086090|NCT03475875|19937070|P1|COMPLETED|Period 2||40
8086091|NCT03475875|19937069|P2|STARTED|Period 2||44
8086092|NCT03475875|19937070|P1|STARTED|Period 2||43
8086093|NCT03475875|19937069|P2|NOT COMPLETED|Period 1||1
8086094|NCT03475875|19937070|P1|NOT COMPLETED|Period 1||3
8086095|NCT03475875|19937069|P2|COMPLETED|Period 1||44
8086096|NCT03475875|19937070|P1|COMPLETED|Period 1||43
8086097|NCT03475875|19937069|P2|STARTED|Period 1||45
8086098|NCT03475875|19937070|P1|STARTED|Period 1||46
8086107|NCT03474874|19937115|P1|NOT COMPLETED|Overall Study||14
8086108|NCT03474874|19937115|P1|COMPLETED|Overall Study||54
8086109|NCT03474874|19937115|P1|STARTED|Overall Study||68
8086110|NCT03474172|19937126|P2|NOT COMPLETED|Overall Study||0
8086111|NCT03474172|19937127|P1|NOT COMPLETED|Overall Study||0
8086112|NCT03474172|19937126|P2|COMPLETED|Overall Study||30
8086113|NCT03474172|19937127|P1|COMPLETED|Overall Study||30
8086114|NCT03474172|19937126|P2|STARTED|Overall Study||30
8086115|NCT03474172|19937127|P1|STARTED|Overall Study||30
8086116|NCT03474081|19937145|P2|NOT COMPLETED|Overall Study||13
8086117|NCT03474081|19937146|P1|NOT COMPLETED|Overall Study||17
8086118|NCT03474081|19937145|P2|COMPLETED|Overall Study||387
8086119|NCT03474081|19937146|P1|COMPLETED|Overall Study||383
8086120|NCT03474081|19937145|P2|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
8086121|NCT03474081|19937146|P1|Received Study Treatment|Overall Study||400
8086122|NCT03474081|19937145|P2|STARTED|Overall Study||400
8086123|NCT03474081|19937146|P1|STARTED|Overall Study||400
8086124|NCT03473886|19937162|P1|NOT COMPLETED|Overall Study||1
8086125|NCT03473886|19937162|P1|COMPLETED|Overall Study||7
8086126|NCT03473886|19937162|P1|STARTED|Overall Study||8
8086127|NCT03473808|19937187|P1|NOT COMPLETED|Overall Study||1
8086128|NCT03473808|19937187|P1|COMPLETED|Overall Study||4
8086129|NCT03473808|19937187|P1|STARTED|Overall Study||5
8086130|NCT03473665|19937194|P1|NOT COMPLETED|Overall Study||0
8086131|NCT03473665|19937194|P1|COMPLETED|Overall Study||9
8086132|NCT03473665|19937194|P1|STARTED|Overall Study||9
8086133|NCT03473236|19937219|P10|NOT COMPLETED|Overall Study||0
8086134|NCT03473236|19937220|P9|NOT COMPLETED|Overall Study||1
8086135|NCT03473236|19937221|P8|NOT COMPLETED|Overall Study||0
8086136|NCT03473236|19937222|P7|NOT COMPLETED|Overall Study||0
8086137|NCT03473236|19937223|P6|NOT COMPLETED|Overall Study||1
8086138|NCT03473236|19937224|P5|NOT COMPLETED|Overall Study||0
8086139|NCT03473236|19937225|P4|NOT COMPLETED|Overall Study||0
8086140|NCT03473236|19937226|P3|NOT COMPLETED|Overall Study||0
8086141|NCT03473236|19937227|P2|NOT COMPLETED|Overall Study||0
8086142|NCT03473236|19937228|P1|NOT COMPLETED|Overall Study||0
8086143|NCT03473236|19937219|P10|COMPLETED|Overall Study||6
8086144|NCT03473236|19937220|P9|COMPLETED|Overall Study||6
8086145|NCT03473236|19937221|P8|COMPLETED|Overall Study||6
8086146|NCT03473236|19937222|P7|COMPLETED|Overall Study||6
8086147|NCT03473236|19937223|P6|COMPLETED|Overall Study||6
8086148|NCT03473236|19937224|P5|COMPLETED|Overall Study||6
8086149|NCT03473236|19937225|P4|COMPLETED|Overall Study||6
8086150|NCT03473236|19937226|P3|COMPLETED|Overall Study||6
8086151|NCT03473236|19937227|P2|COMPLETED|Overall Study||6
8086152|NCT03473236|19937228|P1|COMPLETED|Overall Study||10
8086153|NCT03473236|19937219|P10|STARTED|Overall Study||6
8086154|NCT03473236|19937220|P9|STARTED|Overall Study||7
8086155|NCT03473236|19937221|P8|STARTED|Overall Study||6
8086156|NCT03473236|19937222|P7|STARTED|Overall Study||6
8086157|NCT03473236|19937223|P6|STARTED|Overall Study||7
8086158|NCT03473236|19937224|P5|STARTED|Overall Study||6
8086159|NCT03473236|19937225|P4|STARTED|Overall Study||6
8086160|NCT03473236|19937226|P3|STARTED|Overall Study||6
8086161|NCT03473236|19937227|P2|STARTED|Overall Study||6
8086162|NCT03473236|19937228|P1|STARTED|Overall Study||10
8086163|NCT03473197|19937395|P1|NOT COMPLETED|Overall Study||10
8086164|NCT03473197|19937395|P1|COMPLETED|Overall Study||51
8086165|NCT03473197|19937395|P1|Untreated Irradiated|Overall Study||51
8086166|NCT03473197|19937395|P1|Vehicle Ointment Non-irradiated|Overall Study||51
8086167|NCT03473197|19937395|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||51
8086168|NCT03473197|19937395|P1|Vehicle Ointment Irradiated|Overall Study||51
8086169|NCT03473197|19937395|P1|Diacerein 1% Ointment Irradiated|Overall Study||51
8086170|NCT03473197|19937395|P1|STARTED|Overall Study||61
8086171|NCT03473184|19937399|P1|NOT COMPLETED|Overall Study||0
8086172|NCT03473184|19937399|P1|COMPLETED|Overall Study||34
8086173|NCT03473184|19937399|P1|Untreated Irradiated|Overall Study||34
8086174|NCT03473184|19937399|P1|Vehicle Ointment Non-irradiated|Overall Study||34
8086175|NCT03473184|19937399|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||34
8086176|NCT03473184|19937399|P1|Vehicle Ointment Irradiated|Overall Study||34
8086177|NCT03473184|19937399|P1|Diacerein 1% Ointment Irradiated|Overall Study||34
8086178|NCT03473184|19937399|P1|STARTED|Overall Study||34
8086179|NCT03473171|19937403|P1|NOT COMPLETED|Overall Study||0
8086180|NCT03473171|19937403|P1|COMPLETED|Overall Study||5
8086181|NCT03473171|19937403|P1|STARTED|Overall Study||5
8086182|NCT03472547|19937407|P1|NOT COMPLETED|Overall Study||30
8086183|NCT03472547|19937407|P1|COMPLETED|Overall Study||204
8086184|NCT03472547|19937407|P1|STARTED|Overall Study||234
8086185|NCT03472534|19937411|P1|NOT COMPLETED|Overall Study||11
8086186|NCT03472534|19937411|P1|COMPLETED|Overall Study||35
8086187|NCT03472534|19937411|P1|0.9% Saline|Overall Study||46
8086188|NCT03472534|19937411|P1|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
8086189|NCT03472534|19937411|P1|Vehicle Ointment|Overall Study||46
8086190|NCT03472534|19937411|P1|Diacerein 1% Ointment|Overall Study||46
8086191|NCT03472534|19937411|P1|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
8086192|NCT03472326|19937417|P4|NOT COMPLETED|Part 2: Combination Therapy||3
8086193|NCT03472326|19937418|P3|NOT COMPLETED|Part 2: Combination Therapy||1
8086194|NCT03472326|19937419|P2|NOT COMPLETED|Part 2: Combination Therapy||0
8086195|NCT03472326|19937420|P1|NOT COMPLETED|Part 2: Combination Therapy||0
8086196|NCT03472326|19937417|P4|COMPLETED|Part 2: Combination Therapy||0
8086197|NCT03472326|19937418|P3|COMPLETED|Part 2: Combination Therapy||0
8086198|NCT03472326|19937419|P2|COMPLETED|Part 2: Combination Therapy||0
8086199|NCT03472326|19937420|P1|COMPLETED|Part 2: Combination Therapy||0
8086200|NCT03472326|19937417|P4|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
8086201|NCT03472326|19937418|P3|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
8086202|NCT03472326|19937419|P2|STARTED|Part 2: Combination Therapy||0
8086203|NCT03472326|19937420|P1|STARTED|Part 2: Combination Therapy||0
8086204|NCT03472326|19937417|P4|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086205|NCT03472326|19937418|P3|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086206|NCT03472326|19937419|P2|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086207|NCT03472326|19937420|P1|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086208|NCT03472326|19937417|P4|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086209|NCT03472326|19937418|P3|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086210|NCT03472326|19937419|P2|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
8086211|NCT03472326|19937420|P1|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
8086212|NCT03472326|19937417|P4|STARTED|Part 1: GS-9131 Functional Monotherapy||0
8086213|NCT03472326|19937418|P3|STARTED|Part 1: GS-9131 Functional Monotherapy||0
8086214|NCT03472326|19937419|P2|STARTED|Part 1: GS-9131 Functional Monotherapy||10
8086215|NCT03472326|19937420|P1|STARTED|Part 1: GS-9131 Functional Monotherapy||11
8086216|NCT03472287|19937442|P2|NOT COMPLETED|Overall Study||0
8086217|NCT03472287|19937443|P1|NOT COMPLETED|Overall Study||0
8086218|NCT03472287|19937442|P2|COMPLETED|Overall Study||3
8086219|NCT03472287|19937443|P1|COMPLETED|Overall Study||8
8086220|NCT03472287|19937442|P2|STARTED|Overall Study||3
8086221|NCT03472287|19937443|P1|STARTED|Overall Study||8
8086222|NCT03472014|19937449|P1|NOT COMPLETED|Overall Study||4
8086223|NCT03472014|19937449|P1|COMPLETED|Overall Study||18
8086224|NCT03472014|19937449|P1|STARTED|Overall Study||22
8086225|NCT03471975|19937460|P2|NOT COMPLETED|Overall Study||0
8086226|NCT03471975|19937461|P1|NOT COMPLETED|Overall Study||0
8086227|NCT03471975|19937460|P2|COMPLETED|Overall Study||20
8086228|NCT03471975|19937461|P1|COMPLETED|Overall Study||17
8086229|NCT03471975|19937460|P2|STARTED|Overall Study||20
8086230|NCT03471975|19937461|P1|STARTED|Overall Study||17
8086231|NCT03471871|19937471|P5|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
8086232|NCT03471871|19937472|P4|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
8086233|NCT03471871|19937473|P3|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
8086234|NCT03471871|19937474|P2|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
8086235|NCT03471871|19937475|P1|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
8086236|NCT03471871|19937471|P5|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
8086237|NCT03471871|19937472|P4|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
8086238|NCT03471871|19937473|P3|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
8086239|NCT03471871|19937474|P2|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
8086240|NCT03471871|19937475|P1|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
8086241|NCT03471871|19937471|P5|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
8086242|NCT03471871|19937472|P4|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
8086243|NCT03471871|19937473|P3|STARTED|Follow Up (14 Days for Both HV and OSA)||5
8086244|NCT03471871|19937474|P2|STARTED|Follow Up (14 Days for Both HV and OSA)||5
8086245|NCT03471871|19937475|P1|STARTED|Follow Up (14 Days for Both HV and OSA)||6
8086246|NCT03471871|19937471|P5|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086247|NCT03471871|19937472|P4|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086248|NCT03471871|19937473|P3|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086249|NCT03471871|19937474|P2|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086250|NCT03471871|19937475|P1|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086251|NCT03471871|19937471|P5|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086252|NCT03471871|19937472|P4|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086253|NCT03471871|19937473|P3|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
8086254|NCT03471871|19937474|P2|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
8086255|NCT03471871|19937475|P1|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
8086256|NCT03471871|19937471|P5|STARTED|Treatment Period 3: ( HV:1 Day)||0
8086257|NCT03471871|19937472|P4|STARTED|Treatment Period 3: ( HV:1 Day)||0
8086258|NCT03471871|19937473|P3|STARTED|Treatment Period 3: ( HV:1 Day)||5
8086259|NCT03471871|19937474|P2|STARTED|Treatment Period 3: ( HV:1 Day)||5
8086260|NCT03471871|19937475|P1|STARTED|Treatment Period 3: ( HV:1 Day)||6
8086261|NCT03471871|19937471|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086262|NCT03471871|19937472|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086263|NCT03471871|19937473|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086264|NCT03471871|19937474|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086265|NCT03471871|19937475|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086266|NCT03471871|19937471|P5|COMPLETED|Washout Period 2 (14 Days)||0
8086267|NCT03471871|19937472|P4|COMPLETED|Washout Period 2 (14 Days)||0
8086268|NCT03471871|19937473|P3|COMPLETED|Washout Period 2 (14 Days)||5
8086269|NCT03471871|19937474|P2|COMPLETED|Washout Period 2 (14 Days)||5
8086270|NCT03471871|19937475|P1|COMPLETED|Washout Period 2 (14 Days)||6
8086271|NCT03471871|19937471|P5|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
8086272|NCT03471871|19937472|P4|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
8086273|NCT03471871|19937473|P3|STARTED|Washout Period 2 (14 Days)||5
8086274|NCT03471871|19937474|P2|STARTED|Washout Period 2 (14 Days)||5
8086275|NCT03471871|19937475|P1|STARTED|Washout Period 2 (14 Days)||6
8086276|NCT03471871|19937471|P5|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
8086277|NCT03471871|19937472|P4|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086278|NCT03471871|19937473|P3|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086279|NCT03471871|19937474|P2|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086280|NCT03471871|19937475|P1|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086281|NCT03471871|19937471|P5|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
8086282|NCT03471871|19937472|P4|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
8086283|NCT03471871|19937473|P3|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086284|NCT03471871|19937474|P2|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086285|NCT03471871|19937475|P1|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
8086286|NCT03471871|19937471|P5|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
8086287|NCT03471871|19937472|P4|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
8086288|NCT03471871|19937473|P3|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086289|NCT03471871|19937474|P2|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086290|NCT03471871|19937475|P1|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
8086291|NCT03471871|19937471|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086292|NCT03471871|19937472|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086293|NCT03471871|19937473|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086294|NCT03471871|19937474|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086295|NCT03471871|19937475|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086296|NCT03471871|19937471|P5|COMPLETED|Washout Period 1 (14 Days)||19
8086297|NCT03471871|19937472|P4|COMPLETED|Washout Period 1 (14 Days)||18
8086298|NCT03471871|19937473|P3|COMPLETED|Washout Period 1 (14 Days)||5
8086299|NCT03471871|19937474|P2|COMPLETED|Washout Period 1 (14 Days)||5
8086300|NCT03471871|19937475|P1|COMPLETED|Washout Period 1 (14 Days)||6
8086301|NCT03471871|19937471|P5|STARTED|Washout Period 1 (14 Days)||19
8086302|NCT03471871|19937472|P4|STARTED|Washout Period 1 (14 Days)||18
8086303|NCT03471871|19937473|P3|STARTED|Washout Period 1 (14 Days)||5
8086304|NCT03471871|19937474|P2|STARTED|Washout Period 1 (14 Days)||5
8086305|NCT03471871|19937475|P1|STARTED|Washout Period 1 (14 Days)||6
8086306|NCT03471871|19937471|P5|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
8086307|NCT03471871|19937472|P4|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
8086308|NCT03471871|19937473|P3|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
8086309|NCT03471871|19937474|P2|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
8086310|NCT03471871|19937475|P1|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
8086311|NCT03471871|19937471|P5|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
8086312|NCT03471871|19937472|P4|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
8086313|NCT03471871|19937473|P3|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086314|NCT03471871|19937474|P2|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086315|NCT03471871|19937475|P1|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086316|NCT03471871|19937471|P5|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
8086317|NCT03471871|19937472|P4|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
8086318|NCT03471871|19937473|P3|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086319|NCT03471871|19937474|P2|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086320|NCT03471871|19937475|P1|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086321|NCT03471871|19937471|P5|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
8086322|NCT03471871|19937472|P4|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
8086323|NCT03471871|19937473|P3|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086324|NCT03471871|19937474|P2|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086325|NCT03471871|19937475|P1|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086326|NCT03471832|19937504|P2|NOT COMPLETED|Overall Study||0
8086327|NCT03471832|19937505|P1|NOT COMPLETED|Overall Study||0
8086328|NCT03471832|19937504|P2|COMPLETED|Overall Study||40
8086329|NCT03471832|19937505|P1|COMPLETED|Overall Study||40
8086330|NCT03471832|19937504|P2|STARTED|Overall Study||40
8086331|NCT03471832|19937505|P1|STARTED|Overall Study||40
8086332|NCT03471065|19937562|P1|NOT COMPLETED|Overall Study||0
8086333|NCT03471065|19937562|P1|COMPLETED|Overall Study||100
8086334|NCT03471065|19937562|P1|STARTED|Overall Study||100
8086335|NCT03470740|19937570|P2|NOT COMPLETED|Overall Study||6
8086336|NCT03470740|19937571|P1|NOT COMPLETED|Overall Study||4
8086337|NCT03470740|19937570|P2|COMPLETED|Overall Study||106
8086338|NCT03470740|19937571|P1|COMPLETED|Overall Study||108
8086339|NCT03470740|19937570|P2|STARTED|Overall Study||112
8086340|NCT03470740|19937571|P1|STARTED|Overall Study||112
8086341|NCT03470012|19937589|P1|NOT COMPLETED|Overall Study||0
8086342|NCT03470012|19937589|P1|COMPLETED|Overall Study||24
8086343|NCT03470012|19937589|P1|STARTED|Overall Study||24
8086344|NCT03469349|19937595|P2|NOT COMPLETED|Overall Study||10
8086345|NCT03469349|19937596|P1|NOT COMPLETED|Overall Study||5
8086346|NCT03469349|19937595|P2|COMPLETED|Overall Study||174
8086347|NCT03469349|19937596|P1|COMPLETED|Overall Study||177
8086348|NCT03469349|19937595|P2|STARTED|Overall Study||184
8086349|NCT03469349|19937596|P1|STARTED|Overall Study||182
8086350|NCT03469336|19937612|P1|NOT COMPLETED|Overall Study||1
8086351|NCT03469336|19937612|P1|COMPLETED|Overall Study||17
8086352|NCT03469336|19937612|P1|STARTED|Overall Study||18
8086353|NCT03469258|19937635|P1|NOT COMPLETED|Overall Study||4
8086354|NCT03469258|19937635|P1|COMPLETED|Overall Study||0
8086355|NCT03469258|19937635|P1|STARTED|Overall Study||4
8086356|NCT03468920|19937649|P2|NOT COMPLETED|Overall Study||0
8086357|NCT03468920|19937650|P1|NOT COMPLETED|Overall Study||0
8086358|NCT03468920|19937649|P2|COMPLETED|Overall Study||60
8086359|NCT03468920|19937650|P1|COMPLETED|Overall Study||60
8086360|NCT03468920|19937649|P2|STARTED|Overall Study||60
8086361|NCT03468920|19937650|P1|STARTED|Overall Study||60
8086362|NCT03468855|19937664|P1|NOT COMPLETED|Overall Study||11
8086363|NCT03468855|19937664|P1|COMPLETED|Overall Study||23
8086364|NCT03468855|19937664|P1|STARTED|Overall Study||34
8086365|NCT03468816|19937700|P2|NOT COMPLETED|Overall Study||0
8086366|NCT03468816|19937701|P1|NOT COMPLETED|Overall Study||0
8086367|NCT03468816|19937700|P2|COMPLETED|Overall Study||3
8086368|NCT03468816|19937701|P1|COMPLETED|Overall Study||2
8086369|NCT03468816|19937700|P2|STARTED|Overall Study||3
8086370|NCT03468816|19937701|P1|STARTED|Overall Study||2
8086371|NCT03468543|19937718|P1|NOT COMPLETED|Overall Study||3
8086372|NCT03468543|19937718|P1|COMPLETED|Overall Study||0
8086373|NCT03468543|19937718|P1|STARTED|Overall Study||3
8086374|NCT03468179|19937722|P1|NOT COMPLETED|Overall Study||0
8086375|NCT03468179|19937722|P1|COMPLETED|Overall Study||10
8086376|NCT03468179|19937722|P1|STARTED|Overall Study||10
8086377|NCT03468075|19937728|P1|NOT COMPLETED|Overall Study||0
8086378|NCT03468075|19937728|P1|COMPLETED|Overall Study||10
8086379|NCT03468075|19937728|P1|STARTED|Overall Study||10
8086380|NCT03467971|19937737|P2|NOT COMPLETED|Treatment Period 2||1
8086381|NCT03467971|19937738|P1|NOT COMPLETED|Treatment Period 2||0
8086382|NCT03467971|19937737|P2|COMPLETED|Treatment Period 2||10
8086383|NCT03467971|19937738|P1|COMPLETED|Treatment Period 2||10
8086384|NCT03467971|19937737|P2|STARTED|Treatment Period 2||11
8086385|NCT03467971|19937738|P1|STARTED|Treatment Period 2||10
8086386|NCT03467971|19937737|P2|NOT COMPLETED|Treatment Period 1||0
8086387|NCT03467971|19937738|P1|NOT COMPLETED|Treatment Period 1||0
8086388|NCT03467971|19937737|P2|COMPLETED|Treatment Period 1||11
8086389|NCT03467971|19937738|P1|COMPLETED|Treatment Period 1||10
8086390|NCT03467971|19937737|P2|STARTED|Treatment Period 1||11
8086391|NCT03467971|19937738|P1|STARTED|Treatment Period 1||10
8086392|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 4||0
8086393|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 4||0
8086394|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 4||0
8086395|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 4||0
8086396|NCT03467945|19937762|P4|COMPLETED|Treatment Period 4||9
8086397|NCT03467945|19937763|P3|COMPLETED|Treatment Period 4||8
8086398|NCT03467945|19937764|P2|COMPLETED|Treatment Period 4||9
8086399|NCT03467945|19937765|P1|COMPLETED|Treatment Period 4||9
8086400|NCT03467945|19937762|P4|STARTED|Treatment Period 4||9
8086401|NCT03467945|19937763|P3|STARTED|Treatment Period 4||8
8086402|NCT03467945|19937764|P2|STARTED|Treatment Period 4||9
8086403|NCT03467945|19937765|P1|STARTED|Treatment Period 4||9
8086404|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 3||1
8086405|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 3||2
8086406|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 3||0
8086407|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 3||1
8086408|NCT03467945|19937762|P4|COMPLETED|Treatment Period 3||9
8086409|NCT03467945|19937763|P3|COMPLETED|Treatment Period 3||8
8086410|NCT03467945|19937764|P2|COMPLETED|Treatment Period 3||9
8086411|NCT03467945|19937765|P1|COMPLETED|Treatment Period 3||9
8086412|NCT03467945|19937762|P4|STARTED|Treatment Period 3||10
8086413|NCT03467945|19937763|P3|STARTED|Treatment Period 3||10
8086414|NCT03467945|19937764|P2|STARTED|Treatment Period 3||9
8086415|NCT03467945|19937765|P1|STARTED|Treatment Period 3||10
8086416|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 2||0
8086417|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 2||0
8086418|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 2||1
8086419|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 2||0
8086420|NCT03467945|19937762|P4|COMPLETED|Treatment Period 2||10
8086421|NCT03467945|19937763|P3|COMPLETED|Treatment Period 2||10
8086422|NCT03467945|19937764|P2|COMPLETED|Treatment Period 2||9
8086423|NCT03467945|19937765|P1|COMPLETED|Treatment Period 2||10
8086424|NCT03467945|19937762|P4|STARTED|Treatment Period 2||10
8086425|NCT03467945|19937763|P3|STARTED|Treatment Period 2||10
8086426|NCT03467945|19937764|P2|STARTED|Treatment Period 2||10
8086427|NCT03467945|19937765|P1|STARTED|Treatment Period 2||10
8086428|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 1||0
8086429|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 1||0
8086430|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 1||0
8086431|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 1||0
8086432|NCT03467945|19937762|P4|COMPLETED|Treatment Period 1||10
8086433|NCT03467945|19937763|P3|COMPLETED|Treatment Period 1||10
8086434|NCT03467945|19937764|P2|COMPLETED|Treatment Period 1||10
8086435|NCT03467945|19937765|P1|COMPLETED|Treatment Period 1||10
8086436|NCT03467945|19937762|P4|STARTED|Treatment Period 1||10
8086437|NCT03467945|19937763|P3|STARTED|Treatment Period 1||10
8086438|NCT03467945|19937764|P2|STARTED|Treatment Period 1||10
8086439|NCT03467945|19937765|P1|STARTED|Treatment Period 1||10
8086440|NCT03467763|19937817|P1|NOT COMPLETED|Overall Study||3
8086441|NCT03467763|19937817|P1|COMPLETED|Overall Study||10
8086442|NCT03467763|19937817|P1|Weeks 15-16|Overall Study||2
8086443|NCT03467763|19937817|P1|Weeks 13-14|Overall Study||2
8086444|NCT03467763|19937817|P1|Week 11-12|Overall Study||6
8086445|NCT03467763|19937817|P1|Weeks 9 - 10|Overall Study||6
8086446|NCT03467763|19937817|P1|Weeks 7-8|Overall Study||7
8086447|NCT03467763|19937817|P1|Weeks 5-6|Overall Study||8
8086448|NCT03467763|19937817|P1|Weeks 3-4|Overall Study||10
8086449|NCT03467763|19937817|P1|Weeks 1-2|Overall Study||13
8086450|NCT03467763|19937817|P1|STARTED|Overall Study||13
8086451|NCT03467685|19937827|P2|NOT COMPLETED|Overall Study||0
8086452|NCT03467685|19937828|P1|NOT COMPLETED|Overall Study||0
8086453|NCT03467685|19937827|P2|COMPLETED|Overall Study||49
8086454|NCT03467685|19937828|P1|COMPLETED|Overall Study||52
8086455|NCT03467685|19937827|P2|STARTED|Overall Study||49
8086456|NCT03467685|19937828|P1|STARTED|Overall Study||52
8086457|NCT03467477|19937834|P1|NOT COMPLETED|Overall Study||0
8086458|NCT03467477|19937834|P1|COMPLETED|Overall Study||161
8086459|NCT03467477|19937834|P1|STARTED|Overall Study||161
8086460|NCT03467425|19937847|P2|NOT COMPLETED|Overall Study||54
8086461|NCT03467425|19937848|P1|NOT COMPLETED|Overall Study||47
8086462|NCT03467425|19937847|P2|COMPLETED|Overall Study||1493
8086463|NCT03467425|19937848|P1|COMPLETED|Overall Study||1498
8086464|NCT03467425|19937847|P2|WIP: Withdrawal by Participant|Overall Study||78
8086465|NCT03467425|19937848|P1|WIP: Withdrawal by Participant|Overall Study||91
8086466|NCT03467425|19937847|P2|WIP: Physician Decision|Overall Study||27
8086467|NCT03467425|19937848|P1|WIP: Physician Decision|Overall Study||14
8086468|NCT03467425|19937847|P2|WIP: Lack of Efficacy|Overall Study||28
8086469|NCT03467425|19937848|P1|WIP: Lack of Efficacy|Overall Study||56
8086470|NCT03467425|19937847|P2|WIP: Adverse Event|Overall Study||29
8086471|NCT03467425|19937848|P1|WIP: Adverse Event|Overall Study||112
8086472|NCT03467425|19937847|P2|WIP: Protocol Deviation|Overall Study||2
8086473|NCT03467425|19937848|P1|WIP: Protocol Deviation|Overall Study||0
8086474|NCT03467425|19937847|P2|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
8086475|NCT03467425|19937848|P1|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
8086476|NCT03467425|19937847|P2|Not Completed IP|Overall Study||188
8086477|NCT03467425|19937848|P1|Not Completed IP|Overall Study||288
8086478|NCT03467425|19937847|P2|Completed IP|Overall Study||1359
8086479|NCT03467425|19937848|P1|Completed IP|Overall Study||1256
8086480|NCT03467425|19937847|P2|Randomized But Did Not Start IP|Overall Study||0
8086481|NCT03467425|19937848|P1|Randomized But Did Not Start IP|Overall Study||1
8086482|NCT03467425|19937847|P2|STARTED|Overall Study||1547
8086483|NCT03467425|19937848|P1|STARTED|Overall Study||1545
8086484|NCT03467412|19937858|P5|NOT COMPLETED|Overall Study||3
8086485|NCT03467412|19937859|P4|NOT COMPLETED|Overall Study||2
8086486|NCT03467412|19937860|P3|NOT COMPLETED|Overall Study||5
8086487|NCT03467412|19937861|P2|NOT COMPLETED|Overall Study||1
8086488|NCT03467412|19937862|P1|NOT COMPLETED|Overall Study||3
8086489|NCT03467412|19937858|P5|COMPLETED|Overall Study||17
8086490|NCT03467412|19937859|P4|COMPLETED|Overall Study||23
8086491|NCT03467412|19937860|P3|COMPLETED|Overall Study||20
8086492|NCT03467412|19937861|P2|COMPLETED|Overall Study||24
8086493|NCT03467412|19937862|P1|COMPLETED|Overall Study||22
8086494|NCT03467412|19937858|P5|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
8086495|NCT03467412|19937859|P4|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086496|NCT03467412|19937860|P3|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086497|NCT03467412|19937861|P2|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086498|NCT03467412|19937862|P1|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086499|NCT03467048|19937897|P2|NOT COMPLETED|Overall Study||1
8086500|NCT03467048|19937898|P1|NOT COMPLETED|Overall Study||0
8086501|NCT03467048|19937897|P2|COMPLETED|Overall Study||63
8086502|NCT03467048|19937898|P1|COMPLETED|Overall Study||66
8086503|NCT03467048|19937897|P2|STARTED|Overall Study||64
8086504|NCT03467048|19937898|P1|STARTED|Overall Study||66
8086505|NCT03466918|19937908|P1|NOT COMPLETED|Overall Study||0
8086601|NCT03465904|19938022|P1|STARTED|Overall Study||298
8086506|NCT03466918|19937908|P1|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
8086507|NCT03466918|19937908|P1|Analysis Population|Overall Study||50
8086508|NCT03466918|19937908|P1|STARTED|Overall Study||58
8086509|NCT03466658|19937915|P1|NOT COMPLETED|Overall Study||3
8086510|NCT03466658|19937915|P1|COMPLETED|Overall Study||14
8086511|NCT03466658|19937915|P1|STARTED|Overall Study||17
8086512|NCT03466086|19937921|P2|NOT COMPLETED|Period 2||0
8086513|NCT03466086|19937922|P1|NOT COMPLETED|Period 2||0
8086514|NCT03466086|19937921|P2|COMPLETED|Period 2||27
8086515|NCT03466086|19937922|P1|COMPLETED|Period 2||26
8086516|NCT03466086|19937921|P2|STARTED|Period 2||27
8086517|NCT03466086|19937922|P1|STARTED|Period 2||26
8086518|NCT03466086|19937921|P2|NOT COMPLETED|Period 1||0
8086519|NCT03466086|19937922|P1|NOT COMPLETED|Period 1||2
8086520|NCT03466086|19937921|P2|COMPLETED|Period 1||27
8086521|NCT03466086|19937922|P1|COMPLETED|Period 1||26
8086522|NCT03466086|19937921|P2|STARTED|Period 1||27
8086523|NCT03466086|19937922|P1|STARTED|Period 1||28
8086524|NCT03466073|19937936|P6|NOT COMPLETED|Overall Study||1
8086525|NCT03466073|19937937|P5|NOT COMPLETED|Overall Study||0
8086526|NCT03466073|19937938|P4|NOT COMPLETED|Overall Study||0
8086527|NCT03466073|19937939|P3|NOT COMPLETED|Overall Study||0
8086528|NCT03466073|19937940|P2|NOT COMPLETED|Overall Study||0
8086529|NCT03466073|19937941|P1|NOT COMPLETED|Overall Study||1
8086530|NCT03466073|19937936|P6|COMPLETED|Overall Study||6
8086531|NCT03466073|19937937|P5|COMPLETED|Overall Study||6
8086532|NCT03466073|19937938|P4|COMPLETED|Overall Study||6
8086533|NCT03466073|19937939|P3|COMPLETED|Overall Study||6
8086534|NCT03466073|19937940|P2|COMPLETED|Overall Study||2
8086535|NCT03466073|19937941|P1|COMPLETED|Overall Study||5
8086536|NCT03466073|19937936|P6|STARTED|Overall Study||7
8086537|NCT03466073|19937937|P5|STARTED|Overall Study||6
8086538|NCT03466073|19937938|P4|STARTED|Overall Study||6
8086539|NCT03466073|19937939|P3|STARTED|Overall Study||6
8086540|NCT03466073|19937940|P2|STARTED|Overall Study||2
8086541|NCT03466073|19937941|P1|STARTED|Overall Study||6
8086542|NCT03466060|19937974|P6|NOT COMPLETED|Period 2||0
8086543|NCT03466060|19937975|P5|NOT COMPLETED|Period 2||0
8086544|NCT03466060|19937976|P4|NOT COMPLETED|Period 2||0
8086545|NCT03466060|19937977|P3|NOT COMPLETED|Period 2||1
8086546|NCT03466060|19937978|P2|NOT COMPLETED|Period 2||0
8086547|NCT03466060|19937979|P1|NOT COMPLETED|Period 2||0
8086548|NCT03466060|19937974|P6|COMPLETED|Period 2||18
8086549|NCT03466060|19937975|P5|COMPLETED|Period 2||20
8086550|NCT03466060|19937976|P4|COMPLETED|Period 2||17
8086551|NCT03466060|19937977|P3|COMPLETED|Period 2||16
8086552|NCT03466060|19937978|P2|COMPLETED|Period 2||16
8086553|NCT03466060|19937979|P1|COMPLETED|Period 2||19
8086554|NCT03466060|19937974|P6|STARTED|Period 2||18
8086555|NCT03466060|19937975|P5|STARTED|Period 2||20
8086556|NCT03466060|19937976|P4|STARTED|Period 2||17
8086557|NCT03466060|19937977|P3|STARTED|Period 2||17
8086558|NCT03466060|19937978|P2|STARTED|Period 2||16
8086559|NCT03466060|19937979|P1|STARTED|Period 2||19
8086560|NCT03466060|19937974|P6|NOT COMPLETED|Period 1||0
8086561|NCT03466060|19937975|P5|NOT COMPLETED|Period 1||0
8086562|NCT03466060|19937976|P4|NOT COMPLETED|Period 1||1
8086563|NCT03466060|19937977|P3|NOT COMPLETED|Period 1||3
8086564|NCT03466060|19937978|P2|NOT COMPLETED|Period 1||2
8086565|NCT03466060|19937979|P1|NOT COMPLETED|Period 1||0
8086566|NCT03466060|19937974|P6|COMPLETED|Period 1||18
8086567|NCT03466060|19937975|P5|COMPLETED|Period 1||20
8086568|NCT03466060|19937976|P4|COMPLETED|Period 1||17
8086569|NCT03466060|19937977|P3|COMPLETED|Period 1||17
8086570|NCT03466060|19937978|P2|COMPLETED|Period 1||16
8086571|NCT03466060|19937979|P1|COMPLETED|Period 1||19
8086572|NCT03466060|19937974|P6|STARTED|Period 1||18
8086573|NCT03466060|19937975|P5|STARTED|Period 1||20
8086574|NCT03466060|19937976|P4|STARTED|Period 1||18
8086575|NCT03466060|19937977|P3|STARTED|Period 1||20
8086576|NCT03466060|19937978|P2|STARTED|Period 1||18
8086577|NCT03466060|19937979|P1|STARTED|Period 1||19
8086578|NCT03466047|19937993|P1|NOT COMPLETED|Fat Small Intestine (1 Day)||0
8086579|NCT03466047|19937993|P1|COMPLETED|Fat Small Intestine (1 Day)||8
8086580|NCT03466047|19937993|P1|STARTED|Fat Small Intestine (1 Day)||8
8086581|NCT03466047|19937993|P1|NOT COMPLETED|Fat Stomach (1 Day)||0
8086582|NCT03466047|19937993|P1|COMPLETED|Fat Stomach (1 Day)||8
8086583|NCT03466047|19937993|P1|STARTED|Fat Stomach (1 Day)||8
8086584|NCT03466047|19937993|P1|NOT COMPLETED|CHO Small Intestine (1 Day)||0
8086585|NCT03466047|19937993|P1|COMPLETED|CHO Small Intestine (1 Day)||8
8086586|NCT03466047|19937993|P1|STARTED|CHO Small Intestine (1 Day)||8
8086587|NCT03466047|19937993|P1|NOT COMPLETED|CHO Stomach (1 Day)||0
8086588|NCT03466047|19937993|P1|COMPLETED|CHO Stomach (1 Day)||8
8086589|NCT03466047|19937993|P1|STARTED|CHO Stomach (1 Day)||8
8086590|NCT03466047|19937993|P1|NOT COMPLETED|Protein Small Intestine (1 Day)||0
8086591|NCT03466047|19937993|P1|COMPLETED|Protein Small Intestine (1 Day)||8
8086592|NCT03466047|19937993|P1|STARTED|Protein Small Intestine (1 Day)||8
8086593|NCT03466047|19937993|P1|NOT COMPLETED|Protein Stomach (1day)||0
8086594|NCT03466047|19937993|P1|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
8086595|NCT03466047|19937993|P1|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
8086596|NCT03465904|19938021|P2|NOT COMPLETED|Overall Study||66
8086597|NCT03465904|19938022|P1|NOT COMPLETED|Overall Study||89
8086598|NCT03465904|19938021|P2|COMPLETED|Overall Study||237
8086599|NCT03465904|19938022|P1|COMPLETED|Overall Study||209
8086600|NCT03465904|19938021|P2|STARTED|Overall Study||303
8086602|NCT03465891|19938042|P2|NOT COMPLETED|Overall Study||1
8086603|NCT03465891|19938043|P1|NOT COMPLETED|Overall Study||1
8086604|NCT03465891|19938042|P2|COMPLETED|Overall Study||0
8086605|NCT03465891|19938043|P1|COMPLETED|Overall Study||0
8086606|NCT03465891|19938042|P2|STARTED|Overall Study||1
8086607|NCT03465891|19938043|P1|STARTED|Overall Study||1
8086608|NCT03465878|19938051|P4|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086609|NCT03465878|19938052|P3|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086610|NCT03465878|19938053|P2|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086611|NCT03465878|19938054|P1|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086612|NCT03465878|19938051|P4|COMPLETED|Period2-Part B Second Intervention Day 1||17
8086613|NCT03465878|19938052|P3|COMPLETED|Period2-Part B Second Intervention Day 1||20
8086614|NCT03465878|19938053|P2|COMPLETED|Period2-Part B Second Intervention Day 1||0
8086615|NCT03465878|19938054|P1|COMPLETED|Period2-Part B Second Intervention Day 1||0
8086616|NCT03465878|19938051|P4|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
8086617|NCT03465878|19938052|P3|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
8086618|NCT03465878|19938053|P2|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
8086619|NCT03465878|19938054|P1|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
8086620|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
8086621|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
8086622|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
8086623|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
8086624|NCT03465878|19938051|P4|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
8086625|NCT03465878|19938052|P3|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
8086626|NCT03465878|19938053|P2|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
8086627|NCT03465878|19938054|P1|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
8086628|NCT03465878|19938051|P4|STARTED|Period2-Part B Second Intervention Day 1||17
8086629|NCT03465878|19938052|P3|STARTED|Period2-Part B Second Intervention Day 1||20
8086630|NCT03465878|19938053|P2|STARTED|Period2-Part B Second Intervention Day 1||0
8086631|NCT03465878|19938054|P1|STARTED|Period2-Part B Second Intervention Day 1||0
8086632|NCT03465878|19938051|P4|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
8086633|NCT03465878|19938052|P3|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
8086634|NCT03465878|19938053|P2|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
8086635|NCT03465878|19938054|P1|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
8086636|NCT03465878|19938051|P4|COMPLETED|Period 1-Part B First Intervention Day 1||17
8086637|NCT03465878|19938052|P3|COMPLETED|Period 1-Part B First Intervention Day 1||20
8086638|NCT03465878|19938053|P2|COMPLETED|Period 1-Part B First Intervention Day 1||0
8086639|NCT03465878|19938054|P1|COMPLETED|Period 1-Part B First Intervention Day 1||0
8086640|NCT03465878|19938051|P4|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
8086641|NCT03465878|19938052|P3|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
8086642|NCT03465878|19938053|P2|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
8086643|NCT03465878|19938054|P1|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
8086644|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
8086645|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
8086646|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
8086647|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
8086648|NCT03465878|19938051|P4|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
8086649|NCT03465878|19938052|P3|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
8086650|NCT03465878|19938053|P2|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
8086651|NCT03465878|19938054|P1|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
8086652|NCT03465878|19938051|P4|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
8086653|NCT03465878|19938052|P3|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
8086654|NCT03465878|19938053|P2|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
8086655|NCT03465878|19938054|P1|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
8086656|NCT03465878|19938051|P4|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
8086657|NCT03465878|19938052|P3|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
8086658|NCT03465878|19938053|P2|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
8086659|NCT03465878|19938054|P1|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
8086660|NCT03465878|19938051|P4|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086661|NCT03465878|19938052|P3|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086662|NCT03465878|19938053|P2|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086663|NCT03465878|19938054|P1|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086664|NCT03465878|19938051|P4|COMPLETED|Period2-Part A Second Intervention Day 1||0
8086665|NCT03465878|19938052|P3|COMPLETED|Period2-Part A Second Intervention Day 1||0
8086666|NCT03465878|19938053|P2|COMPLETED|Period2-Part A Second Intervention Day 1||20
8086667|NCT03465878|19938054|P1|COMPLETED|Period2-Part A Second Intervention Day 1||21
8086668|NCT03465878|19938051|P4|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
8086669|NCT03465878|19938052|P3|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
8086670|NCT03465878|19938053|P2|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
8086671|NCT03465878|19938054|P1|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
8086672|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
8086673|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
8086674|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
8086675|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
8086676|NCT03465878|19938051|P4|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
8086677|NCT03465878|19938052|P3|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
8086678|NCT03465878|19938053|P2|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
8086679|NCT03465878|19938054|P1|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
8086680|NCT03465878|19938051|P4|STARTED|Period2-Part A Second Intervention Day 1||0
8086681|NCT03465878|19938052|P3|STARTED|Period2-Part A Second Intervention Day 1||0
8086682|NCT03465878|19938053|P2|STARTED|Period2-Part A Second Intervention Day 1||20
8086683|NCT03465878|19938054|P1|STARTED|Period2-Part A Second Intervention Day 1||21
8086684|NCT03465878|19938051|P4|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
8086685|NCT03465878|19938052|P3|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
8086686|NCT03465878|19938053|P2|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
8086687|NCT03465878|19938054|P1|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
8086688|NCT03465878|19938051|P4|COMPLETED|Period 1-Part A First Intervention Day 1||0
8086689|NCT03465878|19938052|P3|COMPLETED|Period 1-Part A First Intervention Day 1||0
8086690|NCT03465878|19938053|P2|COMPLETED|Period 1-Part A First Intervention Day 1||20
8086691|NCT03465878|19938054|P1|COMPLETED|Period 1-Part A First Intervention Day 1||21
8086692|NCT03465878|19938051|P4|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
8086693|NCT03465878|19938052|P3|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
8086694|NCT03465878|19938053|P2|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
8086695|NCT03465878|19938054|P1|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
8086696|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
8086697|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
8086698|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
8086699|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
8086700|NCT03465878|19938051|P4|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
8086701|NCT03465878|19938052|P3|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
8086702|NCT03465878|19938053|P2|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
8086703|NCT03465878|19938054|P1|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
8086704|NCT03465878|19938051|P4|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
8086705|NCT03465878|19938052|P3|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
8086706|NCT03465878|19938053|P2|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
8086707|NCT03465878|19938054|P1|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
8086708|NCT03465878|19938051|P4|STARTED|Period 1-Part A First Intervention Day 1||0
8086709|NCT03465878|19938052|P3|STARTED|Period 1-Part A First Intervention Day 1||0
8086710|NCT03465878|19938053|P2|STARTED|Period 1-Part A First Intervention Day 1||21
8086711|NCT03465878|19938054|P1|STARTED|Period 1-Part A First Intervention Day 1||21
8086712|NCT03465735|19938094|P2|NOT COMPLETED|Overall Study||2
8086713|NCT03465735|19938095|P1|NOT COMPLETED|Overall Study||1
8086714|NCT03465735|19938094|P2|COMPLETED|Overall Study||5
8086715|NCT03465735|19938095|P1|COMPLETED|Overall Study||7
8086716|NCT03465735|19938094|P2|STARTED|Overall Study||7
8086717|NCT03465735|19938095|P1|STARTED|Overall Study||8
8086718|NCT03465709|19938101|P1|NOT COMPLETED|Overall Study||17
8086719|NCT03465709|19938101|P1|COMPLETED|Overall Study||0
8086720|NCT03465709|19938101|P1|STARTED|Overall Study||17
8086721|NCT03465436|19938113|P4|NOT COMPLETED|Period 4||0
8086722|NCT03465436|19938114|P3|NOT COMPLETED|Period 4||1
8086723|NCT03465436|19938115|P2|NOT COMPLETED|Period 4||0
8086724|NCT03465436|19938116|P1|NOT COMPLETED|Period 4||0
8086725|NCT03465436|19938113|P4|COMPLETED|Period 4||14
8086726|NCT03465436|19938114|P3|COMPLETED|Period 4||12
8086727|NCT03465436|19938115|P2|COMPLETED|Period 4||12
8086728|NCT03465436|19938116|P1|COMPLETED|Period 4||13
8086729|NCT03465436|19938113|P4|Received at Least 1 Dose of Study Drug|Period 4||14
8086730|NCT03465436|19938114|P3|Received at Least 1 Dose of Study Drug|Period 4||13
8086731|NCT03465436|19938115|P2|Received at Least 1 Dose of Study Drug|Period 4||12
8086732|NCT03465436|19938116|P1|Received at Least 1 Dose of Study Drug|Period 4||13
8086733|NCT03465436|19938113|P4|STARTED|Period 4||14
8086734|NCT03465436|19938114|P3|STARTED|Period 4||13
8086735|NCT03465436|19938115|P2|STARTED|Period 4||12
8086736|NCT03465436|19938116|P1|STARTED|Period 4||13
8086737|NCT03465436|19938113|P4|NOT COMPLETED|Period 3||0
8086738|NCT03465436|19938114|P3|NOT COMPLETED|Period 3||0
8086739|NCT03465436|19938115|P2|NOT COMPLETED|Period 3||1
8086740|NCT03465436|19938116|P1|NOT COMPLETED|Period 3||1
8086741|NCT03465436|19938113|P4|COMPLETED|Period 3||14
8086742|NCT03465436|19938114|P3|COMPLETED|Period 3||13
8086743|NCT03465436|19938115|P2|COMPLETED|Period 3||12
8086744|NCT03465436|19938116|P1|COMPLETED|Period 3||13
8086745|NCT03465436|19938113|P4|Received at Least One Dose of Study Drug|Period 3||14
8086746|NCT03465436|19938114|P3|Received at Least One Dose of Study Drug|Period 3||13
8086747|NCT03465436|19938115|P2|Received at Least One Dose of Study Drug|Period 3||12
8086748|NCT03465436|19938116|P1|Received at Least One Dose of Study Drug|Period 3||13
8086749|NCT03465436|19938113|P4|STARTED|Period 3||14
8086750|NCT03465436|19938114|P3|STARTED|Period 3||13
8086751|NCT03465436|19938115|P2|STARTED|Period 3||13
8086752|NCT03465436|19938116|P1|STARTED|Period 3||14
8086753|NCT03465436|19938113|P4|NOT COMPLETED|Period 2||0
8086754|NCT03465436|19938114|P3|NOT COMPLETED|Period 2||0
8086755|NCT03465436|19938115|P2|NOT COMPLETED|Period 2||1
8086756|NCT03465436|19938116|P1|NOT COMPLETED|Period 2||0
8086757|NCT03465436|19938113|P4|COMPLETED|Period 2||14
8086758|NCT03465436|19938114|P3|COMPLETED|Period 2||13
8086759|NCT03465436|19938115|P2|COMPLETED|Period 2||13
8086760|NCT03465436|19938116|P1|COMPLETED|Period 2||14
8086761|NCT03465436|19938113|P4|Received at Least 1 Dose of Study Drug|Period 2||14
8086762|NCT03465436|19938114|P3|Received at Least 1 Dose of Study Drug|Period 2||13
8086763|NCT03465436|19938115|P2|Received at Least 1 Dose of Study Drug|Period 2||13
8086764|NCT03465436|19938116|P1|Received at Least 1 Dose of Study Drug|Period 2||14
8086765|NCT03465436|19938113|P4|STARTED|Period 2||14
8086766|NCT03465436|19938114|P3|STARTED|Period 2||13
8086767|NCT03465436|19938115|P2|STARTED|Period 2||14
8086768|NCT03465436|19938116|P1|STARTED|Period 2||14
8086769|NCT03465436|19938113|P4|NOT COMPLETED|Period 1||0
8086770|NCT03465436|19938114|P3|NOT COMPLETED|Period 1||1
8086771|NCT03465436|19938115|P2|NOT COMPLETED|Period 1||0
8086772|NCT03465436|19938116|P1|NOT COMPLETED|Period 1||0
8086773|NCT03465436|19938113|P4|COMPLETED|Period 1||14
8086774|NCT03465436|19938114|P3|COMPLETED|Period 1||13
8086775|NCT03465436|19938115|P2|COMPLETED|Period 1||14
8086776|NCT03465436|19938116|P1|COMPLETED|Period 1||14
8086777|NCT03465436|19938113|P4|Received at Least 1 Dose of Study Drug|Period 1||14
8086778|NCT03465436|19938114|P3|Received at Least 1 Dose of Study Drug|Period 1||14
8086779|NCT03465436|19938115|P2|Received at Least 1 Dose of Study Drug|Period 1||14
8086780|NCT03465436|19938116|P1|Received at Least 1 Dose of Study Drug|Period 1||14
8086781|NCT03465436|19938113|P4|STARTED|Period 1||14
8086782|NCT03465436|19938114|P3|STARTED|Period 1||14
8086783|NCT03465436|19938115|P2|STARTED|Period 1||14
8086784|NCT03465436|19938116|P1|STARTED|Period 1||14
8086785|NCT03464383|19938153|P3|NOT COMPLETED|Overall Study||0
8086786|NCT03464383|19938154|P2|NOT COMPLETED|Overall Study||1
8086787|NCT03464383|19938155|P1|NOT COMPLETED|Overall Study||1
8086788|NCT03464383|19938153|P3|COMPLETED|Overall Study||63
8086789|NCT03464383|19938154|P2|COMPLETED|Overall Study||2
8086790|NCT03464383|19938155|P1|COMPLETED|Overall Study||2
8086791|NCT03464383|19938153|P3|STARTED|Overall Study||63
8086792|NCT03464383|19938154|P2|STARTED|Overall Study||3
8086793|NCT03464383|19938155|P1|STARTED|Overall Study||3
8086794|NCT03463941|19938180|P1|NOT COMPLETED|Overall Study||18
8086795|NCT03463941|19938180|P1|COMPLETED|Overall Study||62
8086796|NCT03463941|19938180|P1|STARTED|Overall Study||80
8086797|NCT03463512|19938192|P2|NOT COMPLETED|Overall Study||0
8086798|NCT03463512|19938193|P1|NOT COMPLETED|Overall Study||0
8086799|NCT03463512|19938192|P2|COMPLETED|Overall Study||62
8086800|NCT03463512|19938193|P1|COMPLETED|Overall Study||62
8086801|NCT03463512|19938192|P2|STARTED|Overall Study||62
8086802|NCT03463512|19938193|P1|STARTED|Overall Study||62
8086803|NCT03463161|19938203|P1|NOT COMPLETED|Overall Study||0
8086804|NCT03463161|19938203|P1|COMPLETED|Overall Study||2
8086805|NCT03463161|19938203|P1|STARTED|Overall Study||2
8086806|NCT03463031|19938212|P2|NOT COMPLETED|Overall Study||5
8086807|NCT03463031|19938213|P1|NOT COMPLETED|Overall Study||10
8086808|NCT03463031|19938212|P2|COMPLETED|Overall Study||216
8086809|NCT03463031|19938213|P1|COMPLETED|Overall Study||215
8086810|NCT03463031|19938212|P2|STARTED|Overall Study||221
8086811|NCT03463031|19938213|P1|STARTED|Overall Study||225
8086812|NCT03462927|19938227|P2|NOT COMPLETED|Overall Study||2
8086813|NCT03462927|19938228|P1|NOT COMPLETED|Overall Study||6
8086814|NCT03462927|19938227|P2|COMPLETED|Overall Study||29
8086815|NCT03462927|19938228|P1|COMPLETED|Overall Study||26
8086816|NCT03462927|19938227|P2|STARTED|Overall Study||31
8086817|NCT03462927|19938228|P1|STARTED|Overall Study||32
8086818|NCT03462745|19938254|P2|NOT COMPLETED|Overall Study||0
8086819|NCT03462745|19938255|P1|NOT COMPLETED|Overall Study||0
8086820|NCT03462745|19938254|P2|COMPLETED|Overall Study||92
8086821|NCT03462745|19938255|P1|COMPLETED|Overall Study||92
8086822|NCT03462745|19938254|P2|STARTED|Overall Study||92
8086823|NCT03462745|19938255|P1|STARTED|Overall Study||92
8086824|NCT03462082|19938261|P8|NOT COMPLETED|Open Label Phase||2
8086825|NCT03462082|19938262|P7|NOT COMPLETED|Open Label Phase||1
8086826|NCT03462082|19938263|P6|NOT COMPLETED|Open Label Phase||0
8086827|NCT03462082|19938264|P5|NOT COMPLETED|Open Label Phase||0
8086828|NCT03462082|19938265|P4|NOT COMPLETED|Open Label Phase||0
8086829|NCT03462082|19938266|P3|NOT COMPLETED|Open Label Phase||0
8086830|NCT03462082|19938267|P2|NOT COMPLETED|Open Label Phase||0
8086831|NCT03462082|19938268|P1|NOT COMPLETED|Open Label Phase||0
8086832|NCT03462082|19938261|P8|COMPLETED|Open Label Phase||8
8086833|NCT03462082|19938262|P7|COMPLETED|Open Label Phase||6
8086834|NCT03462082|19938263|P6|COMPLETED|Open Label Phase||0
8086835|NCT03462082|19938264|P5|COMPLETED|Open Label Phase||0
8086836|NCT03462082|19938265|P4|COMPLETED|Open Label Phase||0
8086837|NCT03462082|19938266|P3|COMPLETED|Open Label Phase||0
8086838|NCT03462082|19938267|P2|COMPLETED|Open Label Phase||0
8086839|NCT03462082|19938268|P1|COMPLETED|Open Label Phase||0
8086840|NCT03462082|19938261|P8|STARTED|Open Label Phase||10
8086841|NCT03462082|19938262|P7|STARTED|Open Label Phase||7
8086842|NCT03462082|19938263|P6|STARTED|Open Label Phase||0
8086843|NCT03462082|19938264|P5|STARTED|Open Label Phase||0
8086844|NCT03462082|19938265|P4|STARTED|Open Label Phase||0
8086845|NCT03462082|19938266|P3|STARTED|Open Label Phase||0
8086846|NCT03462082|19938267|P2|STARTED|Open Label Phase||0
8086847|NCT03462082|19938268|P1|STARTED|Open Label Phase||0
8086848|NCT03462082|19938261|P8|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086849|NCT03462082|19938262|P7|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086850|NCT03462082|19938263|P6|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086851|NCT03462082|19938264|P5|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086852|NCT03462082|19938265|P4|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086853|NCT03462082|19938266|P3|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086854|NCT03462082|19938267|P2|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086855|NCT03462082|19938268|P1|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086856|NCT03462082|19938261|P8|COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086857|NCT03462082|19938262|P7|COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086858|NCT03462082|19938263|P6|COMPLETED|Study Phase (Randomized, Blinded Period)||5
8086859|NCT03462082|19938264|P5|COMPLETED|Study Phase (Randomized, Blinded Period)||3
8086860|NCT03462082|19938265|P4|COMPLETED|Study Phase (Randomized, Blinded Period)||3
8086861|NCT03462082|19938266|P3|COMPLETED|Study Phase (Randomized, Blinded Period)||4
8086862|NCT03462082|19938267|P2|COMPLETED|Study Phase (Randomized, Blinded Period)||4
8086863|NCT03462082|19938268|P1|COMPLETED|Study Phase (Randomized, Blinded Period)||3
8086864|NCT03462082|19938261|P8|STARTED|Study Phase (Randomized, Blinded Period)||0
8086865|NCT03462082|19938262|P7|STARTED|Study Phase (Randomized, Blinded Period)||0
8086866|NCT03462082|19938263|P6|STARTED|Study Phase (Randomized, Blinded Period)||5
8086867|NCT03462082|19938264|P5|STARTED|Study Phase (Randomized, Blinded Period)||3
8086868|NCT03462082|19938265|P4|STARTED|Study Phase (Randomized, Blinded Period)||3
8086869|NCT03462082|19938266|P3|STARTED|Study Phase (Randomized, Blinded Period)||4
8086870|NCT03462082|19938267|P2|STARTED|Study Phase (Randomized, Blinded Period)||4
8086871|NCT03462082|19938268|P1|STARTED|Study Phase (Randomized, Blinded Period)||3
8086872|NCT03461757|19938319|P2|NOT COMPLETED|Overall Study||45
8086873|NCT03461757|19938320|P1|NOT COMPLETED|Overall Study||53
8086874|NCT03461757|19938319|P2|COMPLETED|Overall Study||689
8086875|NCT03461757|19938320|P1|COMPLETED|Overall Study||679
8086876|NCT03461757|19938319|P2|Treated|Overall Study||693
8086877|NCT03461757|19938320|P1|Treated|Overall Study||682
8086878|NCT03461757|19938319|P2|STARTED|Overall Study||734
8086879|NCT03461757|19938320|P1|STARTED|Overall Study||732
8086880|NCT03461705|19938370|P1|NOT COMPLETED|Overall Study||0
8086881|NCT03461705|19938370|P1|COMPLETED|Overall Study||5
8086882|NCT03461705|19938370|P1|STARTED|Overall Study||5
8086883|NCT03460990|19938383|P2|NOT COMPLETED|Overall Study||0
8086884|NCT03460990|19938384|P1|NOT COMPLETED|Overall Study||0
8086885|NCT03460990|19938383|P2|COMPLETED|Overall Study||54
8086886|NCT03460990|19938384|P1|COMPLETED|Overall Study||57
8086887|NCT03460990|19938383|P2|STARTED|Overall Study||54
8086888|NCT03460990|19938384|P1|STARTED|Overall Study||57
8086889|NCT03460899|19938398|P1|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
8086890|NCT03460899|19938398|P1|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
8086891|NCT03460899|19938398|P1|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
8086892|NCT03460899|19938398|P1|NOT COMPLETED|Euglycaemic Clamp||0
8086893|NCT03460899|19938398|P1|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
8086894|NCT03460899|19938398|P1|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
8086895|NCT03460587|19938405|P1|NOT COMPLETED|Overall Study||0
8086896|NCT03460587|19938405|P1|COMPLETED|Overall Study||13
8086897|NCT03460587|19938405|P1|STARTED|Overall Study||13
8086898|NCT03459794|19938412|P2|NOT COMPLETED|Overall Study||0
8086899|NCT03459794|19938413|P1|NOT COMPLETED|Overall Study||0
8086900|NCT03459794|19938412|P2|COMPLETED|Overall Study||4
8086901|NCT03459794|19938413|P1|COMPLETED|Overall Study||8
8086902|NCT03459794|19938412|P2|STARTED|Overall Study||4
8086903|NCT03459794|19938413|P1|STARTED|Overall Study||8
8086904|NCT03459612|19938433|P4|NOT COMPLETED|Period 4||0
8086905|NCT03459612|19938434|P3|NOT COMPLETED|Period 4||0
8086906|NCT03459612|19938435|P2|NOT COMPLETED|Period 4||0
8086907|NCT03459612|19938436|P1|NOT COMPLETED|Period 4||0
8086908|NCT03459612|19938433|P4|COMPLETED|Period 4||17
8086909|NCT03459612|19938434|P3|COMPLETED|Period 4||16
8086910|NCT03459612|19938435|P2|COMPLETED|Period 4||17
8086911|NCT03459612|19938436|P1|COMPLETED|Period 4||17
8086912|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 4||17
8086913|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 4||16
8086914|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 4||17
8086915|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 4||17
8086916|NCT03459612|19938433|P4|STARTED|Period 4||17
8086917|NCT03459612|19938434|P3|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
8086918|NCT03459612|19938435|P2|STARTED|Period 4||17
8086919|NCT03459612|19938436|P1|STARTED|Period 4||17
8086920|NCT03459612|19938433|P4|NOT COMPLETED|Period 3||0
8086921|NCT03459612|19938434|P3|NOT COMPLETED|Period 3||0
8086922|NCT03459612|19938435|P2|NOT COMPLETED|Period 3||0
8086923|NCT03459612|19938436|P1|NOT COMPLETED|Period 3||0
8086924|NCT03459612|19938433|P4|COMPLETED|Period 3||17
8086925|NCT03459612|19938434|P3|COMPLETED|Period 3||17
8086926|NCT03459612|19938435|P2|COMPLETED|Period 3||17
8086927|NCT03459612|19938436|P1|COMPLETED|Period 3||17
8086928|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 3||17
8086929|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 3||17
8086930|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 3||17
8086931|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 3||17
8086932|NCT03459612|19938433|P4|STARTED|Period 3||17
8086933|NCT03459612|19938434|P3|STARTED|Period 3||17
8086934|NCT03459612|19938435|P2|STARTED|Period 3||17
8086935|NCT03459612|19938436|P1|STARTED|Period 3||17
8086936|NCT03459612|19938433|P4|NOT COMPLETED|Period 2||0
8086937|NCT03459612|19938434|P3|NOT COMPLETED|Period 2||0
8086938|NCT03459612|19938435|P2|NOT COMPLETED|Period 2||0
8086939|NCT03459612|19938436|P1|NOT COMPLETED|Period 2||0
8086940|NCT03459612|19938433|P4|COMPLETED|Period 2||17
8086941|NCT03459612|19938434|P3|COMPLETED|Period 2||17
8086942|NCT03459612|19938435|P2|COMPLETED|Period 2||17
8086943|NCT03459612|19938436|P1|COMPLETED|Period 2||17
8086944|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 2||17
8086945|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 2||17
8086946|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 2||17
8086947|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 2||17
8086948|NCT03459612|19938433|P4|STARTED|Period 2||17
8086949|NCT03459612|19938434|P3|STARTED|Period 2||17
8086950|NCT03459612|19938435|P2|STARTED|Period 2||17
8086951|NCT03459612|19938436|P1|STARTED|Period 2||17
8086952|NCT03459612|19938433|P4|NOT COMPLETED|Period 1||0
8086953|NCT03459612|19938434|P3|NOT COMPLETED|Period 1||0
8086954|NCT03459612|19938435|P2|NOT COMPLETED|Period 1||0
8086955|NCT03459612|19938436|P1|NOT COMPLETED|Period 1||0
8086956|NCT03459612|19938433|P4|COMPLETED|Period 1||17
8086957|NCT03459612|19938434|P3|COMPLETED|Period 1||17
8086958|NCT03459612|19938435|P2|COMPLETED|Period 1||17
8086959|NCT03459612|19938436|P1|COMPLETED|Period 1||17
8086960|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 1||17
8086961|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 1||17
8086962|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 1||17
8086963|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 1||17
8086964|NCT03459612|19938433|P4|STARTED|Period 1||17
8086965|NCT03459612|19938434|P3|STARTED|Period 1||17
8086966|NCT03459612|19938435|P2|STARTED|Period 1||17
8086967|NCT03459612|19938436|P1|STARTED|Period 1||17
8086968|NCT03459196|19938494|P1|NOT COMPLETED|Overall Study||2
8086969|NCT03459196|19938494|P1|COMPLETED|Overall Study||52
8086970|NCT03459196|19938494|P1|STARTED|Overall Study||54
8086971|NCT03459131|19938499|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8086972|NCT03459131|19938500|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8086973|NCT03459131|19938499|P2|COMPLETED|Period 2, Second 7 Days of Wear||8
8086974|NCT03459131|19938500|P1|COMPLETED|Period 2, Second 7 Days of Wear||7
8086975|NCT03459131|19938499|P2|STARTED|Period 2, Second 7 Days of Wear||8
8086976|NCT03459131|19938500|P1|STARTED|Period 2, Second 7 Days of Wear||7
8086977|NCT03459131|19938499|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8086978|NCT03459131|19938500|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8086979|NCT03459131|19938499|P2|COMPLETED|Period 1, First 7 Days of Wear||8
8086980|NCT03459131|19938500|P1|COMPLETED|Period 1, First 7 Days of Wear||7
8086981|NCT03459131|19938499|P2|STARTED|Period 1, First 7 Days of Wear||8
8086982|NCT03459131|19938500|P1|STARTED|Period 1, First 7 Days of Wear||7
8086983|NCT03458871|19938508|P1|NOT COMPLETED|Overall Study||0
8086984|NCT03458871|19938508|P1|COMPLETED|Overall Study||16
8086985|NCT03458871|19938508|P1|STARTED|Overall Study||16
8086986|NCT03458702|19938538|P2|NOT COMPLETED|Picture Rating/Body Composition||0
8086987|NCT03458702|19938539|P1|NOT COMPLETED|Picture Rating/Body Composition||0
8086988|NCT03458702|19938538|P2|COMPLETED|Picture Rating/Body Composition||20
8086989|NCT03458702|19938539|P1|COMPLETED|Picture Rating/Body Composition||20
8086990|NCT03458702|19938538|P2|STARTED|Picture Rating/Body Composition||20
8086991|NCT03458702|19938539|P1|STARTED|Picture Rating/Body Composition||20
8086992|NCT03458702|19938538|P2|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
8086993|NCT03458702|19938539|P1|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
8086994|NCT03458702|19938538|P2|COMPLETED|Study Condition B (Yoga or Rest)||20
8086995|NCT03458702|19938539|P1|COMPLETED|Study Condition B (Yoga or Rest)||20
8086996|NCT03458702|19938538|P2|STARTED|Study Condition B (Yoga or Rest)||22
8086997|NCT03458702|19938539|P1|STARTED|Study Condition B (Yoga or Rest)||24
8086998|NCT03458702|19938538|P2|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
8086999|NCT03458702|19938539|P1|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
8087000|NCT03458702|19938538|P2|COMPLETED|Study Condition A (Yoga or Rest)||22
8087001|NCT03458702|19938539|P1|COMPLETED|Study Condition A (Yoga or Rest)||24
8087002|NCT03458702|19938538|P2|STARTED|Study Condition A (Yoga or Rest)||28
8087003|NCT03458702|19938539|P1|STARTED|Study Condition A (Yoga or Rest)||28
8087004|NCT03457909|19938555|P1|NOT COMPLETED|Overall Study||0
8087005|NCT03457909|19938555|P1|COMPLETED|Overall Study||25
8087006|NCT03457909|19938555|P1|STARTED|Overall Study||25
8087007|NCT03457727|19938568|P4|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8087008|NCT03457727|19938569|P3|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8087009|NCT03457727|19938570|P2|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8087010|NCT03457727|19938571|P1|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8087011|NCT03457727|19938568|P4|COMPLETED|Part 2, Period 4 (1 Day)||0
8087012|NCT03457727|19938569|P3|COMPLETED|Part 2, Period 4 (1 Day)||12
8087013|NCT03457727|19938570|P2|COMPLETED|Part 2, Period 4 (1 Day)||0
8087014|NCT03457727|19938571|P1|COMPLETED|Part 2, Period 4 (1 Day)||0
8087015|NCT03457727|19938568|P4|STARTED|Part 2, Period 4 (1 Day)||0
8087016|NCT03457727|19938569|P3|STARTED|Part 2, Period 4 (1 Day)||12
8087017|NCT03457727|19938570|P2|STARTED|Part 2, Period 4 (1 Day)||0
8087018|NCT03457727|19938571|P1|STARTED|Part 2, Period 4 (1 Day)||0
8087019|NCT03457727|19938568|P4|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8087020|NCT03457727|19938569|P3|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8087021|NCT03457727|19938570|P2|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8087022|NCT03457727|19938571|P1|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8087023|NCT03457727|19938568|P4|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
8087024|NCT03457727|19938569|P3|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
8087025|NCT03457727|19938570|P2|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8087026|NCT03457727|19938571|P1|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8087027|NCT03457727|19938568|P4|STARTED|Part 2, Washout Period 3 (5 Days)||11
8087028|NCT03457727|19938569|P3|STARTED|Part 2, Washout Period 3 (5 Days)||12
8087029|NCT03457727|19938570|P2|STARTED|Part 2, Washout Period 3 (5 Days)||0
8087030|NCT03457727|19938571|P1|STARTED|Part 2, Washout Period 3 (5 Days)||0
8087031|NCT03457727|19938568|P4|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8087032|NCT03457727|19938569|P3|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8087033|NCT03457727|19938570|P2|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8087034|NCT03457727|19938571|P1|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8087035|NCT03457727|19938568|P4|COMPLETED|Part 2, Period 3 (1 Day)||11
8087036|NCT03457727|19938569|P3|COMPLETED|Part 2, Period 3 (1 Day)||12
8087037|NCT03457727|19938570|P2|COMPLETED|Part 2, Period 3 (1 Day)||0
8087038|NCT03457727|19938571|P1|COMPLETED|Part 2, Period 3 (1 Day)||0
8087039|NCT03457727|19938568|P4|STARTED|Part 2, Period 3 (1 Day)||11
8087040|NCT03457727|19938569|P3|STARTED|Part 2, Period 3 (1 Day)||12
8087041|NCT03457727|19938570|P2|STARTED|Part 2, Period 3 (1 Day)||0
8087042|NCT03457727|19938571|P1|STARTED|Part 2, Period 3 (1 Day)||0
8087043|NCT03457727|19938568|P4|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8087044|NCT03457727|19938569|P3|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8087045|NCT03457727|19938570|P2|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8087046|NCT03457727|19938571|P1|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8087047|NCT03457727|19938568|P4|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
8087048|NCT03457727|19938569|P3|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
8087049|NCT03457727|19938570|P2|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8087050|NCT03457727|19938571|P1|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8087051|NCT03457727|19938568|P4|STARTED|Part 2, Washout Period 2 (5 Days)||11
8087052|NCT03457727|19938569|P3|STARTED|Part 2, Washout Period 2 (5 Days)||12
8087053|NCT03457727|19938570|P2|STARTED|Part 2, Washout Period 2 (5 Days)||0
8087054|NCT03457727|19938571|P1|STARTED|Part 2, Washout Period 2 (5 Days)||0
8087055|NCT03457727|19938568|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8087056|NCT03457727|19938569|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8087057|NCT03457727|19938570|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8087058|NCT03457727|19938571|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8087059|NCT03457727|19938568|P4|COMPLETED|Part 2, Period 2 (1 Day)||11
8087060|NCT03457727|19938569|P3|COMPLETED|Part 2, Period 2 (1 Day)||12
8087061|NCT03457727|19938570|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
8087062|NCT03457727|19938571|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
8087063|NCT03457727|19938568|P4|STARTED|Part 2, Period 2 (1 Day)||11
8087064|NCT03457727|19938569|P3|STARTED|Part 2, Period 2 (1 Day)||12
8087065|NCT03457727|19938570|P2|STARTED|Part 2, Period 2 (1 Day)||0
8087066|NCT03457727|19938571|P1|STARTED|Part 2, Period 2 (1 Day)||0
8087067|NCT03457727|19938568|P4|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
8087068|NCT03457727|19938569|P3|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8087069|NCT03457727|19938570|P2|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8087070|NCT03457727|19938571|P1|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8087071|NCT03457727|19938568|P4|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
8087072|NCT03457727|19938569|P3|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
8087073|NCT03457727|19938570|P2|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8087074|NCT03457727|19938571|P1|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8087075|NCT03457727|19938568|P4|STARTED|Part 2, Washout Period 1 (5 Days)||12
8087076|NCT03457727|19938569|P3|STARTED|Part 2, Washout Period 1 (5 Days)||12
8087077|NCT03457727|19938570|P2|STARTED|Part 2, Washout Period 1 (5 Days)||0
8087078|NCT03457727|19938571|P1|STARTED|Part 2, Washout Period 1 (5 Days)||0
8087079|NCT03457727|19938568|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8087080|NCT03457727|19938569|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8087081|NCT03457727|19938570|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8087082|NCT03457727|19938571|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8087083|NCT03457727|19938568|P4|COMPLETED|Part 2, Period 1 (1 Day)||12
8087084|NCT03457727|19938569|P3|COMPLETED|Part 2, Period 1 (1 Day)||12
8087085|NCT03457727|19938570|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
8087086|NCT03457727|19938571|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
8087087|NCT03457727|19938568|P4|STARTED|Part 2, Period 1 (1 Day)||12
8087088|NCT03457727|19938569|P3|STARTED|Part 2, Period 1 (1 Day)||12
8087089|NCT03457727|19938570|P2|STARTED|Part 2, Period 1 (1 Day)||0
8087090|NCT03457727|19938571|P1|STARTED|Part 2, Period 1 (1 Day)||0
8087091|NCT03457727|19938568|P4|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8087092|NCT03457727|19938569|P3|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8087093|NCT03457727|19938570|P2|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8087094|NCT03457727|19938571|P1|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8087095|NCT03457727|19938568|P4|COMPLETED|Part 1, Period 4 (1 Day)||0
8087096|NCT03457727|19938569|P3|COMPLETED|Part 1, Period 4 (1 Day)||0
8087097|NCT03457727|19938570|P2|COMPLETED|Part 1, Period 4 (1 Day)||8
8087098|NCT03457727|19938571|P1|COMPLETED|Part 1, Period 4 (1 Day)||8
8087099|NCT03457727|19938568|P4|STARTED|Part 1, Period 4 (1 Day)||0
8087100|NCT03457727|19938569|P3|STARTED|Part 1, Period 4 (1 Day)||0
8087101|NCT03457727|19938570|P2|STARTED|Part 1, Period 4 (1 Day)||8
8087102|NCT03457727|19938571|P1|STARTED|Part 1, Period 4 (1 Day)||8
8087103|NCT03457727|19938568|P4|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8087104|NCT03457727|19938569|P3|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8087105|NCT03457727|19938570|P2|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8087106|NCT03457727|19938571|P1|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8087107|NCT03457727|19938568|P4|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8087108|NCT03457727|19938569|P3|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8087109|NCT03457727|19938570|P2|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
8087110|NCT03457727|19938571|P1|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
8087111|NCT03457727|19938568|P4|STARTED|Part 1, Washout Period 3 (5 Days)||0
8087112|NCT03457727|19938569|P3|STARTED|Part 1, Washout Period 3 (5 Days)||0
8087113|NCT03457727|19938570|P2|STARTED|Part 1, Washout Period 3 (5 Days)||8
8087114|NCT03457727|19938571|P1|STARTED|Part 1, Washout Period 3 (5 Days)||8
8087115|NCT03457727|19938568|P4|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8087116|NCT03457727|19938569|P3|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8087117|NCT03457727|19938570|P2|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8087118|NCT03457727|19938571|P1|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8087119|NCT03457727|19938568|P4|COMPLETED|Part 1, Period 3 (1 Day)||0
8087120|NCT03457727|19938569|P3|COMPLETED|Part 1, Period 3 (1 Day)||0
8087121|NCT03457727|19938570|P2|COMPLETED|Part 1, Period 3 (1 Day)||8
8087122|NCT03457727|19938571|P1|COMPLETED|Part 1, Period 3 (1 Day)||8
8087123|NCT03457727|19938568|P4|STARTED|Part 1, Period 3 (1 Day)||0
8087124|NCT03457727|19938569|P3|STARTED|Part 1, Period 3 (1 Day)||0
8087125|NCT03457727|19938570|P2|STARTED|Part 1, Period 3 (1 Day)||8
8087126|NCT03457727|19938571|P1|STARTED|Part 1, Period 3 (1 Day)||8
8087127|NCT03457727|19938568|P4|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8087128|NCT03457727|19938569|P3|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8087129|NCT03457727|19938570|P2|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8087130|NCT03457727|19938571|P1|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8087131|NCT03457727|19938568|P4|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8087132|NCT03457727|19938569|P3|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8087133|NCT03457727|19938570|P2|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
8087134|NCT03457727|19938571|P1|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
8087135|NCT03457727|19938568|P4|STARTED|Part 1, Washout Period 2 (5 Days)||0
8087136|NCT03457727|19938569|P3|STARTED|Part 1, Washout Period 2 (5 Days)||0
8087137|NCT03457727|19938570|P2|STARTED|Part 1, Washout Period 2 (5 Days)||8
8087138|NCT03457727|19938571|P1|STARTED|Part 1, Washout Period 2 (5 Days)||8
8087139|NCT03457727|19938568|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8087140|NCT03457727|19938569|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8087141|NCT03457727|19938570|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8087142|NCT03457727|19938571|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8087143|NCT03457727|19938568|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
8087144|NCT03457727|19938569|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
8087145|NCT03457727|19938570|P2|COMPLETED|Part 1, Period 2 (1 Day)||8
8087146|NCT03457727|19938571|P1|COMPLETED|Part 1, Period 2 (1 Day)||8
8087147|NCT03457727|19938568|P4|STARTED|Part 1, Period 2 (1 Day)||0
8087148|NCT03457727|19938569|P3|STARTED|Part 1, Period 2 (1 Day)||0
8087149|NCT03457727|19938570|P2|STARTED|Part 1, Period 2 (1 Day)||8
8087150|NCT03457727|19938571|P1|STARTED|Part 1, Period 2 (1 Day)||8
8087151|NCT03457727|19938568|P4|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8087152|NCT03457727|19938569|P3|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8087153|NCT03457727|19938570|P2|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8087154|NCT03457727|19938571|P1|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8087155|NCT03457727|19938568|P4|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8087156|NCT03457727|19938569|P3|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8087157|NCT03457727|19938570|P2|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
8087158|NCT03457727|19938571|P1|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
8087159|NCT03457727|19938568|P4|STARTED|Part 1, Washout Period 1 (5 Days)||0
8087160|NCT03457727|19938569|P3|STARTED|Part 1, Washout Period 1 (5 Days)||0
8087161|NCT03457727|19938570|P2|STARTED|Part 1, Washout Period 1 (5 Days)||8
8087162|NCT03457727|19938571|P1|STARTED|Part 1, Washout Period 1 (5 Days)||8
8087163|NCT03457727|19938568|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8087164|NCT03457727|19938569|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8087165|NCT03457727|19938570|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8087166|NCT03457727|19938571|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8087167|NCT03457727|19938568|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
8087168|NCT03457727|19938569|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
8087169|NCT03457727|19938570|P2|COMPLETED|Part 1, Period 1 (1 Day)||8
8087170|NCT03457727|19938571|P1|COMPLETED|Part 1, Period 1 (1 Day)||8
8087171|NCT03457727|19938568|P4|STARTED|Part 1, Period 1 (1 Day)||0
8087172|NCT03457727|19938569|P3|STARTED|Part 1, Period 1 (1 Day)||0
8087173|NCT03457727|19938570|P2|STARTED|Part 1, Period 1 (1 Day)||8
8087174|NCT03457727|19938571|P1|STARTED|Part 1, Period 1 (1 Day)||8
8087175|NCT03457636|19938768|P1|NOT COMPLETED|Overall Study||2
8087176|NCT03457636|19938768|P1|COMPLETED|Overall Study||20
8087177|NCT03457636|19938768|P1|STARTED|Overall Study||22
8087178|NCT03456960|19938781|P6|NOT COMPLETED|Period 2 (1 Day)||0
8087179|NCT03456960|19938782|P5|NOT COMPLETED|Period 2 (1 Day)||0
8087180|NCT03456960|19938783|P4|NOT COMPLETED|Period 2 (1 Day)||1
8087181|NCT03456960|19938784|P3|NOT COMPLETED|Period 2 (1 Day)||0
8087182|NCT03456960|19938785|P2|NOT COMPLETED|Period 2 (1 Day)||0
8087183|NCT03456960|19938786|P1|NOT COMPLETED|Period 2 (1 Day)||1
8087184|NCT03456960|19938781|P6|COMPLETED|Period 2 (1 Day)||6
8087185|NCT03456960|19938782|P5|COMPLETED|Period 2 (1 Day)||6
8087186|NCT03456960|19938783|P4|COMPLETED|Period 2 (1 Day)||117
8087187|NCT03456960|19938784|P3|COMPLETED|Period 2 (1 Day)||119
8087188|NCT03456960|19938785|P2|COMPLETED|Period 2 (1 Day)||12
8087189|NCT03456960|19938786|P1|COMPLETED|Period 2 (1 Day)||11
8087190|NCT03456960|19938781|P6|STARTED|Period 2 (1 Day)||6
8087191|NCT03456960|19938782|P5|STARTED|Period 2 (1 Day)||6
8087192|NCT03456960|19938783|P4|STARTED|Period 2 (1 Day)||118
8087193|NCT03456960|19938784|P3|STARTED|Period 2 (1 Day)||119
8087194|NCT03456960|19938785|P2|STARTED|Period 2 (1 Day)||12
8087195|NCT03456960|19938786|P1|STARTED|Period 2 (1 Day)||12
8087196|NCT03456960|19938781|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087197|NCT03456960|19938782|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087198|NCT03456960|19938783|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||2
8087199|NCT03456960|19938784|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8087200|NCT03456960|19938785|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087201|NCT03456960|19938786|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087202|NCT03456960|19938781|P6|COMPLETED|Washout Period (at Least 14 Days)||6
8087203|NCT03456960|19938782|P5|COMPLETED|Washout Period (at Least 14 Days)||6
8087204|NCT03456960|19938783|P4|COMPLETED|Washout Period (at Least 14 Days)||118
8087205|NCT03456960|19938784|P3|COMPLETED|Washout Period (at Least 14 Days)||119
8087206|NCT03456960|19938785|P2|COMPLETED|Washout Period (at Least 14 Days)||12
8087207|NCT03456960|19938786|P1|COMPLETED|Washout Period (at Least 14 Days)||12
8087208|NCT03456960|19938781|P6|STARTED|Washout Period (at Least 14 Days)||6
8087209|NCT03456960|19938782|P5|STARTED|Washout Period (at Least 14 Days)||6
8087210|NCT03456960|19938783|P4|STARTED|Washout Period (at Least 14 Days)||120
8087211|NCT03456960|19938784|P3|STARTED|Washout Period (at Least 14 Days)||120
8087212|NCT03456960|19938785|P2|STARTED|Washout Period (at Least 14 Days)||12
8087213|NCT03456960|19938786|P1|STARTED|Washout Period (at Least 14 Days)||12
8087214|NCT03456960|19938781|P6|NOT COMPLETED|Period 1 (1 Day)||0
8087215|NCT03456960|19938782|P5|NOT COMPLETED|Period 1 (1 Day)||0
8087216|NCT03456960|19938783|P4|NOT COMPLETED|Period 1 (1 Day)||0
8087217|NCT03456960|19938784|P3|NOT COMPLETED|Period 1 (1 Day)||0
8087218|NCT03456960|19938785|P2|NOT COMPLETED|Period 1 (1 Day)||0
8087219|NCT03456960|19938786|P1|NOT COMPLETED|Period 1 (1 Day)||0
8087220|NCT03456960|19938781|P6|COMPLETED|Period 1 (1 Day)||6
8087221|NCT03456960|19938782|P5|COMPLETED|Period 1 (1 Day)||6
8087222|NCT03456960|19938783|P4|COMPLETED|Period 1 (1 Day)||120
8087223|NCT03456960|19938784|P3|COMPLETED|Period 1 (1 Day)||120
8087224|NCT03456960|19938785|P2|COMPLETED|Period 1 (1 Day)||12
8087225|NCT03456960|19938786|P1|COMPLETED|Period 1 (1 Day)||12
8087226|NCT03456960|19938781|P6|STARTED|Period 1 (1 Day)||6
8087227|NCT03456960|19938782|P5|STARTED|Period 1 (1 Day)||6
8087228|NCT03456960|19938783|P4|STARTED|Period 1 (1 Day)||120
8087229|NCT03456960|19938784|P3|STARTED|Period 1 (1 Day)||120
8087230|NCT03456960|19938785|P2|STARTED|Period 1 (1 Day)||12
8087231|NCT03456960|19938786|P1|STARTED|Period 1 (1 Day)||12
8087232|NCT03456856|19938878|P1|NOT COMPLETED|Overall Study||3
8087233|NCT03456856|19938878|P1|COMPLETED|Overall Study||27
8087234|NCT03456856|19938878|P1|STARTED|Overall Study||30
8087235|NCT03456700|19938882|P1|NOT COMPLETED|Overall Study||1
8087236|NCT03456700|19938882|P1|COMPLETED|Overall Study||21
8087237|NCT03456700|19938882|P1|STARTED|Overall Study||22
8087238|NCT03456427|19938890|P1|NOT COMPLETED|Overall Study||3
8087239|NCT03456427|19938890|P1|COMPLETED|Overall Study||33
8087240|NCT03456427|19938890|P1|STARTED|Overall Study||36
8087241|NCT03456245|19938899|P1|NOT COMPLETED|Overall Study||15
8087242|NCT03456245|19938899|P1|COMPLETED|Overall Study||190
8087243|NCT03456245|19938899|P1|STARTED|Overall Study||205
8087244|NCT03455556|19938903|P1|NOT COMPLETED|Overall Study||0
8087245|NCT03455556|19938903|P1|COMPLETED|Overall Study||1
8087246|NCT03455556|19938903|P1|STARTED|Overall Study||1
8087247|NCT03455543|19938914|P3|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
8087248|NCT03455543|19938915|P2|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087249|NCT03455543|19938916|P1|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087250|NCT03455543|19938914|P3|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
8087251|NCT03455543|19938915|P2|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087252|NCT03455543|19938916|P1|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087253|NCT03455543|19938914|P3|STARTED|Part B: Open-label Extension (24 Weeks)||152
8087254|NCT03455543|19938915|P2|STARTED|Part B: Open-label Extension (24 Weeks)||0
8087255|NCT03455543|19938916|P1|STARTED|Part B: Open-label Extension (24 Weeks)||0
8087256|NCT03455543|19938914|P3|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
8087257|NCT03455543|19938915|P2|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
8087258|NCT03455543|19938916|P1|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
8087259|NCT03455543|19938914|P3|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
8087260|NCT03455543|19938915|P2|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
8087261|NCT03455543|19938916|P1|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
8087262|NCT03455543|19938914|P3|STARTED|Part A: Randomized Treatment (17 Weeks)||0
8087263|NCT03455543|19938915|P2|STARTED|Part A: Randomized Treatment (17 Weeks)||90
8087264|NCT03455543|19938916|P1|STARTED|Part A: Randomized Treatment (17 Weeks)||92
8087265|NCT03455491|19938957|P3|NOT COMPLETED|Overall Study||0
8087266|NCT03455491|19938958|P2|NOT COMPLETED|Overall Study||0
8087267|NCT03455491|19938959|P1|NOT COMPLETED|Overall Study||0
8087268|NCT03455491|19938957|P3|COMPLETED|Overall Study||40
8087269|NCT03455491|19938958|P2|COMPLETED|Overall Study||40
8087270|NCT03455491|19938959|P1|COMPLETED|Overall Study||40
8087271|NCT03455491|19938957|P3|STARTED|Overall Study||40
8087272|NCT03455491|19938958|P2|STARTED|Overall Study||40
8087273|NCT03455491|19938959|P1|STARTED|Overall Study||40
8087274|NCT03455218|19938978|P2|NOT COMPLETED|Overall Study||0
8087275|NCT03455218|19938979|P1|NOT COMPLETED|Overall Study||0
8087276|NCT03455218|19938978|P2|COMPLETED|Overall Study||22
8087277|NCT03455218|19938979|P1|COMPLETED|Overall Study||18
8087278|NCT03455218|19938978|P2|STARTED|Overall Study||22
8087279|NCT03455218|19938979|P1|STARTED|Overall Study||18
8087280|NCT03454581|19939018|P3|NOT COMPLETED|Overall Study||3
8087281|NCT03454581|19939019|P2|NOT COMPLETED|Overall Study||3
8087282|NCT03454581|19939020|P1|NOT COMPLETED|Overall Study||4
8087283|NCT03454581|19939018|P3|COMPLETED|Overall Study||14
8087284|NCT03454581|19939019|P2|COMPLETED|Overall Study||13
8087285|NCT03454581|19939020|P1|COMPLETED|Overall Study||14
8087286|NCT03454581|19939018|P3|STARTED|Overall Study||17
8087287|NCT03454581|19939019|P2|STARTED|Overall Study||16
8087288|NCT03454581|19939020|P1|STARTED|Overall Study||18
8087289|NCT03454048|19939053|P4|NOT COMPLETED|Overall Study||0
8087290|NCT03454048|19939054|P3|NOT COMPLETED|Overall Study||0
8087291|NCT03454048|19939055|P2|NOT COMPLETED|Overall Study||0
8087292|NCT03454048|19939056|P1|NOT COMPLETED|Overall Study||0
8087293|NCT03454048|19939053|P4|COMPLETED|Overall Study||6
8087294|NCT03454048|19939054|P3|COMPLETED|Overall Study||6
8087295|NCT03454048|19939055|P2|COMPLETED|Overall Study||6
8087296|NCT03454048|19939056|P1|COMPLETED|Overall Study||6
8087297|NCT03454048|19939053|P4|STARTED|Overall Study||6
8087298|NCT03454048|19939054|P3|STARTED|Overall Study||6
8087299|NCT03454048|19939055|P2|STARTED|Overall Study||6
8087300|NCT03454048|19939056|P1|STARTED|Overall Study||6
8087301|NCT03453515|19939088|P2|NOT COMPLETED|Overall Study||13
8087302|NCT03453515|19939089|P1|NOT COMPLETED|Overall Study||6
8087303|NCT03453515|19939088|P2|COMPLETED|Overall Study||100
8087304|NCT03453515|19939089|P1|COMPLETED|Overall Study||107
8087305|NCT03453515|19939088|P2|STARTED|Overall Study||113
8087306|NCT03453515|19939089|P1|STARTED|Overall Study||113
8087307|NCT03453151|19939105|P1|NOT COMPLETED|Overall Study||4
8087308|NCT03453151|19939105|P1|COMPLETED|Overall Study||15
8087309|NCT03453151|19939105|P1|STARTED|Overall Study||19
8087310|NCT03453060|19939119|P5|NOT COMPLETED|Overall Study||0
8087311|NCT03453060|19939120|P4|NOT COMPLETED|Overall Study||0
8087312|NCT03453060|19939121|P3|NOT COMPLETED|Overall Study||0
8087313|NCT03453060|19939122|P2|NOT COMPLETED|Overall Study||0
8087314|NCT03453060|19939123|P1|NOT COMPLETED|Overall Study||0
8087315|NCT03453060|19939119|P5|COMPLETED|Overall Study||5
8087316|NCT03453060|19939120|P4|COMPLETED|Overall Study||4
8087317|NCT03453060|19939121|P3|COMPLETED|Overall Study||4
8087318|NCT03453060|19939122|P2|COMPLETED|Overall Study||4
8087319|NCT03453060|19939123|P1|COMPLETED|Overall Study||4
8087320|NCT03453060|19939119|P5|STARTED|Overall Study||5
8087321|NCT03453060|19939120|P4|STARTED|Overall Study||4
8087322|NCT03453060|19939121|P3|STARTED|Overall Study||4
8087323|NCT03453060|19939122|P2|STARTED|Overall Study||4
8087324|NCT03453060|19939123|P1|STARTED|Overall Study||4
8087325|NCT03452943|19939342|P2|NOT COMPLETED|Maintenance Period (5 Weeks)||0
8087326|NCT03452943|19939343|P1|NOT COMPLETED|Maintenance Period (5 Weeks)||3
8087327|NCT03452943|19939342|P2|COMPLETED|Maintenance Period (5 Weeks)||56
8087328|NCT03452943|19939343|P1|COMPLETED|Maintenance Period (5 Weeks)||51
8087329|NCT03452943|19939342|P2|STARTED|Maintenance Period (5 Weeks)||56
8087330|NCT03452943|19939343|P1|STARTED|Maintenance Period (5 Weeks)||54
8087331|NCT03452943|19939342|P2|NOT COMPLETED|Titration Period (7 Weeks)||4
8087332|NCT03452943|19939343|P1|NOT COMPLETED|Titration Period (7 Weeks)||5
8087333|NCT03452943|19939342|P2|COMPLETED|Titration Period (7 Weeks)||56
8087334|NCT03452943|19939343|P1|COMPLETED|Titration Period (7 Weeks)||54
8087335|NCT03452943|19939342|P2|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
8087336|NCT03452943|19939343|P1|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
8087337|NCT03452943|19939342|P2|Safety Analysis Set|Titration Period (7 Weeks)||59
8087338|NCT03452943|19939343|P1|Safety Analysis Set|Titration Period (7 Weeks)||58
8087339|NCT03452943|19939342|P2|STARTED|Titration Period (7 Weeks)||60
8087340|NCT03452943|19939343|P1|STARTED|Titration Period (7 Weeks)||59
8087341|NCT03452371|19939359|P2|NOT COMPLETED|Overall Study||0
8087342|NCT03452371|19939360|P1|NOT COMPLETED|Overall Study||0
8087343|NCT03452371|19939359|P2|COMPLETED|Overall Study||23
8087344|NCT03452371|19939360|P1|COMPLETED|Overall Study||21
8087345|NCT03452371|19939359|P2|STARTED|Overall Study||23
8087346|NCT03452371|19939360|P1|STARTED|Overall Study||21
8087347|NCT03452176|19939378|P2|NOT COMPLETED|Overall Study||0
8087348|NCT03452176|19939379|P1|NOT COMPLETED|Overall Study||0
8087349|NCT03452176|19939378|P2|COMPLETED|Overall Study||11
8087350|NCT03452176|19939379|P1|COMPLETED|Overall Study||11
8087351|NCT03452176|19939378|P2|STARTED|Overall Study||11
8087352|NCT03452176|19939379|P1|STARTED|Overall Study||11
8087353|NCT03451721|19939395|P1|NOT COMPLETED|Overall Study||1
8087354|NCT03451721|19939395|P1|COMPLETED|Overall Study||19
8087355|NCT03451721|19939395|P1|STARTED|Overall Study||20
8087356|NCT03450369|19939406|P2|NOT COMPLETED|Overall Study||0
8087357|NCT03450369|19939407|P1|NOT COMPLETED|Overall Study||0
8087358|NCT03450369|19939406|P2|COMPLETED|Overall Study||5
8087359|NCT03450369|19939407|P1|COMPLETED|Overall Study||5
8087360|NCT03450369|19939406|P2|STARTED|Overall Study||5
8087361|NCT03450369|19939407|P1|STARTED|Overall Study||5
8087368|NCT03450070|19939458|P1|NOT COMPLETED|Overall Study||8
8087369|NCT03450070|19939458|P1|COMPLETED|Overall Study||110
8087370|NCT03450070|19939458|P1|STARTED|Overall Study||118
8087371|NCT03449979|19939466|P4|NOT COMPLETED|Overall Study||1
8087372|NCT03449979|19939467|P3|NOT COMPLETED|Overall Study||0
8087373|NCT03449979|19939468|P2|NOT COMPLETED|Overall Study||0
8087374|NCT03449979|19939469|P1|NOT COMPLETED|Overall Study||0
8087375|NCT03449979|19939466|P4|COMPLETED|Overall Study||21
8087376|NCT03449979|19939467|P3|COMPLETED|Overall Study||21
8087377|NCT03449979|19939468|P2|COMPLETED|Overall Study||20
8087378|NCT03449979|19939469|P1|COMPLETED|Overall Study||21
8087379|NCT03449979|19939466|P4|STARTED|Overall Study||22
8087380|NCT03449979|19939467|P3|STARTED|Overall Study||21
8087381|NCT03449979|19939468|P2|STARTED|Overall Study||20
8087382|NCT03449979|19939469|P1|STARTED|Overall Study||21
8087383|NCT03449758|19939479|P1|NOT COMPLETED|Overall Study||19
8087384|NCT03449758|19939479|P1|COMPLETED|Overall Study||65
8087385|NCT03449758|19939479|P1|STARTED|Overall Study||84
8087386|NCT03449446|19939519|P7|NOT COMPLETED|Overall Study||1
8087387|NCT03449446|19939520|P6|NOT COMPLETED|Overall Study||9
8087388|NCT03449446|19939521|P5|NOT COMPLETED|Overall Study||12
8087389|NCT03449446|19939522|P4|NOT COMPLETED|Overall Study||9
8087390|NCT03449446|19939523|P3|NOT COMPLETED|Overall Study||7
8087391|NCT03449446|19939524|P2|NOT COMPLETED|Overall Study||7
8087392|NCT03449446|19939525|P1|NOT COMPLETED|Overall Study||36
8087393|NCT03449446|19939519|P7|COMPLETED|Overall Study||38
8087394|NCT03449446|19939520|P6|COMPLETED|Overall Study||69
8087395|NCT03449446|19939521|P5|COMPLETED|Overall Study||66
8087396|NCT03449446|19939522|P4|COMPLETED|Overall Study||71
8087397|NCT03449446|19939523|P3|COMPLETED|Overall Study||34
8087398|NCT03449446|19939524|P2|COMPLETED|Overall Study||33
8087399|NCT03449446|19939525|P1|COMPLETED|Overall Study||3
8087400|NCT03449446|19939519|P7|STARTED|Overall Study||39
8087401|NCT03449446|19939520|P6|STARTED|Overall Study||78
8087402|NCT03449446|19939521|P5|STARTED|Overall Study||78
8087403|NCT03449446|19939522|P4|STARTED|Overall Study||80
8087404|NCT03449446|19939523|P3|STARTED|Overall Study||41
8087405|NCT03449446|19939524|P2|STARTED|Overall Study||40
8087406|NCT03449446|19939525|P1|STARTED|Overall Study||39
8087407|NCT03449433|19939557|P5|NOT COMPLETED|Period 4||0
8087408|NCT03449433|19939558|P4|NOT COMPLETED|Period 4||0
8087409|NCT03449433|19939559|P3|NOT COMPLETED|Period 4||0
8087410|NCT03449433|19939560|P2|NOT COMPLETED|Period 4||0
8087411|NCT03449433|19939561|P1|NOT COMPLETED|Period 4||0
8087412|NCT03449433|19939557|P5|COMPLETED|Period 4||12
8087413|NCT03449433|19939558|P4|COMPLETED|Period 4||17
8087414|NCT03449433|19939559|P3|COMPLETED|Period 4||18
8087415|NCT03449433|19939560|P2|COMPLETED|Period 4||15
8087416|NCT03449433|19939561|P1|COMPLETED|Period 4||17
8087417|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 4||0
8087418|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 4||17
8087419|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 4||18
8087420|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 4||15
8087421|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 4||17
8087422|NCT03449433|19939557|P5|STARTED|Period 4||12
8087423|NCT03449433|19939558|P4|STARTED|Period 4||17
8087424|NCT03449433|19939559|P3|STARTED|Period 4||18
8087425|NCT03449433|19939560|P2|STARTED|Period 4||15
8087426|NCT03449433|19939561|P1|STARTED|Period 4||17
8087427|NCT03449433|19939557|P5|NOT COMPLETED|Period 3||0
8087428|NCT03449433|19939558|P4|NOT COMPLETED|Period 3||0
8087429|NCT03449433|19939559|P3|NOT COMPLETED|Period 3||0
8087430|NCT03449433|19939560|P2|NOT COMPLETED|Period 3||1
8087431|NCT03449433|19939561|P1|NOT COMPLETED|Period 3||0
8087432|NCT03449433|19939557|P5|COMPLETED|Period 3||12
8087433|NCT03449433|19939558|P4|COMPLETED|Period 3||17
8087434|NCT03449433|19939559|P3|COMPLETED|Period 3||18
8087435|NCT03449433|19939560|P2|COMPLETED|Period 3||15
8087436|NCT03449433|19939561|P1|COMPLETED|Period 3||17
8087437|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 3||0
8087438|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 3||17
8087439|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 3||18
8087440|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 3||15
8087441|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 3||17
8087442|NCT03449433|19939557|P5|STARTED|Period 3||12
8087443|NCT03449433|19939558|P4|STARTED|Period 3||17
8087444|NCT03449433|19939559|P3|STARTED|Period 3||18
8087445|NCT03449433|19939560|P2|STARTED|Period 3||16
8087446|NCT03449433|19939561|P1|STARTED|Period 3||17
8087447|NCT03449433|19939557|P5|NOT COMPLETED|Period 2||0
8087448|NCT03449433|19939558|P4|NOT COMPLETED|Period 2||0
8087449|NCT03449433|19939559|P3|NOT COMPLETED|Period 2||0
8087450|NCT03449433|19939560|P2|NOT COMPLETED|Period 2||0
8087451|NCT03449433|19939561|P1|NOT COMPLETED|Period 2||0
8087452|NCT03449433|19939557|P5|COMPLETED|Period 2||12
8087453|NCT03449433|19939558|P4|COMPLETED|Period 2||17
8087454|NCT03449433|19939559|P3|COMPLETED|Period 2||18
8087455|NCT03449433|19939560|P2|COMPLETED|Period 2||16
8087456|NCT03449433|19939561|P1|COMPLETED|Period 2||17
8087457|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 2||0
8087458|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 2||17
8087459|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 2||18
8087460|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 2||16
8087461|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 2||17
8087462|NCT03449433|19939557|P5|STARTED|Period 2||12
8087463|NCT03449433|19939558|P4|STARTED|Period 2||17
8087464|NCT03449433|19939559|P3|STARTED|Period 2||18
8087465|NCT03449433|19939560|P2|STARTED|Period 2||16
8087466|NCT03449433|19939561|P1|STARTED|Period 2||17
8087467|NCT03449433|19939557|P5|NOT COMPLETED|Period 1||0
8087468|NCT03449433|19939558|P4|NOT COMPLETED|Period 1||0
8087469|NCT03449433|19939559|P3|NOT COMPLETED|Period 1||0
8087470|NCT03449433|19939560|P2|NOT COMPLETED|Period 1||0
8087471|NCT03449433|19939561|P1|NOT COMPLETED|Period 1||0
8087472|NCT03449433|19939557|P5|COMPLETED|Period 1||12
8087473|NCT03449433|19939558|P4|COMPLETED|Period 1||17
8087474|NCT03449433|19939559|P3|COMPLETED|Period 1||18
8087475|NCT03449433|19939560|P2|COMPLETED|Period 1||16
8087476|NCT03449433|19939561|P1|COMPLETED|Period 1||17
8087477|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 1||0
8087478|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 1||17
8087479|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 1||18
8087480|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 1||16
8087481|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 1||17
8087482|NCT03449433|19939557|P5|STARTED|Period 1||12
8087483|NCT03449433|19939558|P4|STARTED|Period 1||17
8087484|NCT03449433|19939559|P3|STARTED|Period 1||18
8087485|NCT03449433|19939560|P2|STARTED|Period 1||16
8087486|NCT03449433|19939561|P1|STARTED|Period 1||17
8087487|NCT03449342|19939579|P2|NOT COMPLETED|Overall Study||0
8087488|NCT03449342|19939580|P1|NOT COMPLETED|Overall Study||0
8087489|NCT03449342|19939579|P2|COMPLETED|Overall Study||50
8087490|NCT03449342|19939580|P1|COMPLETED|Overall Study||10
8087491|NCT03449342|19939579|P2|STARTED|Overall Study||50
8087492|NCT03449342|19939580|P1|STARTED|Overall Study||10
8087493|NCT03448536|19939596|P2|NOT COMPLETED|Overall Study||4
8087494|NCT03448536|19939597|P1|NOT COMPLETED|Overall Study||12
8087495|NCT03448536|19939596|P2|COMPLETED|Overall Study||97
8087496|NCT03448536|19939597|P1|COMPLETED|Overall Study||88
8087497|NCT03448536|19939596|P2|Completed Second Intervention|Overall Study||87
8087498|NCT03448536|19939597|P1|Completed Second Intervention|Overall Study||82
8087499|NCT03448536|19939596|P2|Completed First Intervention|Overall Study||97
8087500|NCT03448536|19939597|P1|Completed First Intervention|Overall Study||95
8087501|NCT03448536|19939596|P2|Completed First Intervention|Overall Study||78
8087502|NCT03448536|19939597|P1|Completed First Intervention|Overall Study||83
8087503|NCT03448536|19939596|P2|STARTED|Overall Study||101
8087504|NCT03448536|19939597|P1|STARTED|Overall Study||100
8087505|NCT03448419|19939623|P2|NOT COMPLETED|Overall Study||16
8087506|NCT03448419|19939624|P1|NOT COMPLETED|Overall Study||13
8087507|NCT03448419|19939623|P2|COMPLETED|Overall Study||140
8087508|NCT03448419|19939624|P1|COMPLETED|Overall Study||143
8087509|NCT03448419|19939623|P2|Treated|Overall Study||155
8087510|NCT03448419|19939624|P1|Treated|Overall Study||156
8087511|NCT03448419|19939623|P2|STARTED|Overall Study||156
8087512|NCT03448419|19939624|P1|STARTED|Overall Study||156
8087513|NCT03448406|19939650|P2|NOT COMPLETED|Overall Study||13
8087514|NCT03448406|19939651|P1|NOT COMPLETED|Overall Study||11
8087515|NCT03448406|19939650|P2|COMPLETED|Overall Study||144
8087516|NCT03448406|19939651|P1|COMPLETED|Overall Study||147
8087517|NCT03448406|19939650|P2|STARTED|Overall Study||157
8087518|NCT03448406|19939651|P1|STARTED|Overall Study||158
8087519|NCT03448224|19939677|P2|NOT COMPLETED|Overall Study||0
8087520|NCT03448224|19939678|P1|NOT COMPLETED|Overall Study||1
8087521|NCT03448224|19939677|P2|COMPLETED|Overall Study||26
8087522|NCT03448224|19939678|P1|COMPLETED|Overall Study||27
8087523|NCT03448224|19939677|P2|STARTED|Overall Study||26
8087524|NCT03448224|19939678|P1|STARTED|Overall Study||28
8087525|NCT03447821|19939695|P3|NOT COMPLETED|Overall Study||1
8087526|NCT03447821|19939696|P2|NOT COMPLETED|Overall Study||1
8087527|NCT03447821|19939697|P1|NOT COMPLETED|Overall Study||1
8087528|NCT03447821|19939695|P3|COMPLETED|Overall Study||12
8087529|NCT03447821|19939696|P2|COMPLETED|Overall Study||12
8087530|NCT03447821|19939697|P1|COMPLETED|Overall Study||13
8087531|NCT03447821|19939695|P3|STARTED|Overall Study||13
8087532|NCT03447821|19939696|P2|STARTED|Overall Study||13
8087533|NCT03447821|19939697|P1|STARTED|Overall Study||14
8087534|NCT03447730|19939723|P3|NOT COMPLETED|Overall Study||0
8087535|NCT03447730|19939724|P2|NOT COMPLETED|Overall Study||2
8087536|NCT03447730|19939725|P1|NOT COMPLETED|Overall Study||0
8087537|NCT03447730|19939723|P3|COMPLETED|Overall Study||8
8087538|NCT03447730|19939724|P2|COMPLETED|Overall Study||7
8087539|NCT03447730|19939725|P1|COMPLETED|Overall Study||6
8087540|NCT03447730|19939723|P3|STARTED|Overall Study||8
8087541|NCT03447730|19939724|P2|STARTED|Overall Study||9
8087542|NCT03447730|19939725|P1|STARTED|Overall Study||6
8087543|NCT03447639|19939741|P2|NOT COMPLETED|Overall Study||2
8087544|NCT03447639|19939742|P1|NOT COMPLETED|Overall Study||0
8087545|NCT03447639|19939741|P2|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
8087546|NCT03447639|19939742|P1|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
8087547|NCT03447639|19939741|P2|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
8087548|NCT03447639|19939742|P1|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
8087549|NCT03447353|19939752|P1|NOT COMPLETED|Overall Study||10
8087550|NCT03447353|19939752|P1|COMPLETED|Overall Study||8
8087551|NCT03447353|19939752|P1|STARTED|Overall Study||18
8087552|NCT03447249|19939768|P2|NOT COMPLETED|Overall Study||0
8087553|NCT03447249|19939769|P1|NOT COMPLETED|Overall Study||5
8087554|NCT03447249|19939768|P2|COMPLETED|Overall Study||192
8087555|NCT03447249|19939769|P1|COMPLETED|Overall Study||185
8087556|NCT03447249|19939768|P2|Safety Set|Overall Study||193
8087557|NCT03447249|19939769|P1|Safety Set|Overall Study||189
8087558|NCT03447249|19939768|P2|STARTED|Overall Study||192
8087559|NCT03447249|19939769|P1|STARTED|Overall Study||190
8087560|NCT03447015|19939800|P2|NOT COMPLETED|Overall Study||44
8087561|NCT03447015|19939801|P1|NOT COMPLETED|Overall Study||45
8087562|NCT03447015|19939800|P2|COMPLETED|Overall Study||106
8087563|NCT03447015|19939801|P1|COMPLETED|Overall Study||95
8087564|NCT03447015|19939800|P2|STARTED|Overall Study||150
8087565|NCT03447015|19939801|P1|STARTED|Overall Study||140
8087566|NCT03446846|19939820|P3|NOT COMPLETED|Overall Study||16
8087567|NCT03446846|19939821|P2|NOT COMPLETED|Overall Study||5
8087568|NCT03446846|19939822|P1|NOT COMPLETED|Overall Study||7
8087569|NCT03446846|19939820|P3|COMPLETED|Overall Study||162
8087570|NCT03446846|19939821|P2|COMPLETED|Overall Study||87
8087571|NCT03446846|19939822|P1|COMPLETED|Overall Study||83
8087572|NCT03446846|19939820|P3|STARTED|Overall Study||178
8087573|NCT03446846|19939821|P2|STARTED|Overall Study||92
8087574|NCT03446846|19939822|P1|STARTED|Overall Study||90
8087575|NCT03446781|19939841|P2|NOT COMPLETED|Overall Study||17
8087576|NCT03446781|19939842|P1|NOT COMPLETED|Overall Study||28
8087577|NCT03446781|19939841|P2|COMPLETED|Overall Study||191
8087578|NCT03446781|19939842|P1|COMPLETED|Overall Study||186
8087579|NCT03446781|19939841|P2|STARTED|Overall Study||208
8087580|NCT03446781|19939842|P1|STARTED|Overall Study||214
8087581|NCT03446690|19939891|P2|NOT COMPLETED|Overall Study||0
8087582|NCT03446690|19939892|P1|NOT COMPLETED|Overall Study||7
8087583|NCT03446690|19939891|P2|COMPLETED|Overall Study||29
8087584|NCT03446690|19939892|P1|COMPLETED|Overall Study||26
8087585|NCT03446690|19939891|P2|STARTED|Overall Study||29
8087586|NCT03446690|19939892|P1|STARTED|Overall Study||33
8087587|NCT03446573|19939900|P2|NOT COMPLETED|Overall Study||372
8087588|NCT03446573|19939901|P1|NOT COMPLETED|Overall Study||369
8087589|NCT03446573|19939900|P2|COMPLETED|Overall Study||0
8087590|NCT03446573|19939901|P1|COMPLETED|Overall Study||0
8087591|NCT03446573|19939900|P2|STARTED|Overall Study||372
8087592|NCT03446573|19939901|P1|STARTED|Overall Study||369
8087593|NCT03445390|19939973|P2|NOT COMPLETED|Second Intervention||1
8087594|NCT03445390|19939974|P1|NOT COMPLETED|Second Intervention||2
8087595|NCT03445390|19939973|P2|COMPLETED|Second Intervention||10
8087596|NCT03445390|19939974|P1|COMPLETED|Second Intervention||10
8087597|NCT03445390|19939973|P2|STARTED|Second Intervention||11
8087598|NCT03445390|19939974|P1|STARTED|Second Intervention||12
8087599|NCT03445390|19939973|P2|NOT COMPLETED|First Intervention||2
8087600|NCT03445390|19939974|P1|NOT COMPLETED|First Intervention||2
8087601|NCT03445390|19939973|P2|COMPLETED|First Intervention||11
8087602|NCT03445390|19939974|P1|COMPLETED|First Intervention||12
8087603|NCT03445390|19939973|P2|STARTED|First Intervention||13
8087604|NCT03445390|19939974|P1|STARTED|First Intervention||14
8087605|NCT03445195|19939986|P2|NOT COMPLETED|Overall Study||0
8087606|NCT03445195|19939987|P1|NOT COMPLETED|Overall Study||2
8087607|NCT03445195|19939986|P2|COMPLETED|Overall Study||27
8087608|NCT03445195|19939987|P1|COMPLETED|Overall Study||51
8087609|NCT03445195|19939986|P2|STARTED|Overall Study||27
8087610|NCT03445195|19939987|P1|STARTED|Overall Study||53
8087611|NCT03445156|19940002|P3|NOT COMPLETED|Experiment Proper||0
8087612|NCT03445156|19940003|P2|NOT COMPLETED|Experiment Proper||0
8087613|NCT03445156|19940004|P1|NOT COMPLETED|Experiment Proper||0
8087614|NCT03445156|19940002|P3|COMPLETED|Experiment Proper||59
8087615|NCT03445156|19940003|P2|COMPLETED|Experiment Proper||115
8087616|NCT03445156|19940004|P1|COMPLETED|Experiment Proper||113
8087617|NCT03445156|19940002|P3|STARTED|Experiment Proper||59
8087618|NCT03445156|19940003|P2|STARTED|Experiment Proper||115
8087619|NCT03445156|19940004|P1|STARTED|Experiment Proper||113
8087620|NCT03445156|19940002|P3|NOT COMPLETED|Pilot Study||0
8087621|NCT03445156|19940003|P2|NOT COMPLETED|Pilot Study||0
8087622|NCT03445156|19940004|P1|NOT COMPLETED|Pilot Study||0
8087623|NCT03445156|19940002|P3|COMPLETED|Pilot Study||0
8087624|NCT03445156|19940003|P2|COMPLETED|Pilot Study||20
8087625|NCT03445156|19940004|P1|COMPLETED|Pilot Study||20
8087626|NCT03445156|19940002|P3|STARTED|Pilot Study||0
8087627|NCT03445156|19940003|P2|STARTED|Pilot Study||20
8087628|NCT03445156|19940004|P1|STARTED|Pilot Study||20
8087629|NCT03444766|19940021|P1|NOT COMPLETED|Overall Study||66
8087630|NCT03444766|19940021|P1|COMPLETED|Overall Study||34
8087631|NCT03444766|19940021|P1|STARTED|Overall Study||100
8087632|NCT03444584|19940030|P2|NOT COMPLETED|Overall Study||2
8087633|NCT03444584|19940031|P1|NOT COMPLETED|Overall Study||0
8087634|NCT03444584|19940030|P2|COMPLETED|Overall Study||23
8087635|NCT03444584|19940031|P1|COMPLETED|Overall Study||24
8087636|NCT03444584|19940030|P2|STARTED|Overall Study||25
8087637|NCT03444584|19940031|P1|STARTED|Overall Study||24
8087638|NCT03444090|19940089|P2|NOT COMPLETED|Overall Study||4
8087639|NCT03444090|19940090|P1|NOT COMPLETED|Overall Study||3
8087640|NCT03444090|19940089|P2|COMPLETED|Overall Study||210
8087641|NCT03444090|19940090|P1|COMPLETED|Overall Study||211
8087642|NCT03444090|19940089|P2|STARTED|Overall Study||214
8087643|NCT03444090|19940090|P1|STARTED|Overall Study||214
8087644|NCT03443713|19940101|P3|NOT COMPLETED|Close-out Visit (30 Minutes)||0
8087645|NCT03443713|19940102|P2|NOT COMPLETED|Close-out Visit (30 Minutes)||0
8087646|NCT03443713|19940103|P1|NOT COMPLETED|Close-out Visit (30 Minutes)||0
8087647|NCT03443713|19940101|P3|COMPLETED|Close-out Visit (30 Minutes)||8
8087648|NCT03443713|19940102|P2|COMPLETED|Close-out Visit (30 Minutes)||8
8087649|NCT03443713|19940103|P1|COMPLETED|Close-out Visit (30 Minutes)||8
8087650|NCT03443713|19940101|P3|STARTED|Close-out Visit (30 Minutes)||8
8087651|NCT03443713|19940102|P2|STARTED|Close-out Visit (30 Minutes)||8
8087652|NCT03443713|19940103|P1|STARTED|Close-out Visit (30 Minutes)||8
8087653|NCT03443713|19940101|P3|NOT COMPLETED|Third at Home Period (8-12 Days)||0
8087654|NCT03443713|19940102|P2|NOT COMPLETED|Third at Home Period (8-12 Days)||0
8087655|NCT03443713|19940103|P1|NOT COMPLETED|Third at Home Period (8-12 Days)||0
8087656|NCT03443713|19940101|P3|COMPLETED|Third at Home Period (8-12 Days)||8
8087657|NCT03443713|19940102|P2|COMPLETED|Third at Home Period (8-12 Days)||8
8087658|NCT03443713|19940103|P1|COMPLETED|Third at Home Period (8-12 Days)||8
8087659|NCT03443713|19940101|P3|STARTED|Third at Home Period (8-12 Days)||8
8087660|NCT03443713|19940102|P2|STARTED|Third at Home Period (8-12 Days)||8
8087661|NCT03443713|19940103|P1|STARTED|Third at Home Period (8-12 Days)||8
8087662|NCT03443713|19940101|P3|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
8087663|NCT03443713|19940102|P2|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
8087664|NCT03443713|19940103|P1|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
8087665|NCT03443713|19940101|P3|COMPLETED|Second Exercise Visit (1 Hour)||8
8087666|NCT03443713|19940102|P2|COMPLETED|Second Exercise Visit (1 Hour)||8
8087667|NCT03443713|19940103|P1|COMPLETED|Second Exercise Visit (1 Hour)||8
8087668|NCT03443713|19940101|P3|STARTED|Second Exercise Visit (1 Hour)||8
8087669|NCT03443713|19940102|P2|STARTED|Second Exercise Visit (1 Hour)||8
8087670|NCT03443713|19940103|P1|STARTED|Second Exercise Visit (1 Hour)||8
8087671|NCT03443713|19940101|P3|NOT COMPLETED|Second at Home Period (2-11 Days)||0
8087672|NCT03443713|19940102|P2|NOT COMPLETED|Second at Home Period (2-11 Days)||0
8087673|NCT03443713|19940103|P1|NOT COMPLETED|Second at Home Period (2-11 Days)||0
8087674|NCT03443713|19940101|P3|COMPLETED|Second at Home Period (2-11 Days)||8
8087675|NCT03443713|19940102|P2|COMPLETED|Second at Home Period (2-11 Days)||8
8087676|NCT03443713|19940103|P1|COMPLETED|Second at Home Period (2-11 Days)||8
8087677|NCT03443713|19940101|P3|STARTED|Second at Home Period (2-11 Days)||8
8087678|NCT03443713|19940102|P2|STARTED|Second at Home Period (2-11 Days)||8
8087679|NCT03443713|19940103|P1|STARTED|Second at Home Period (2-11 Days)||8
8087680|NCT03443713|19940101|P3|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
8087681|NCT03443713|19940102|P2|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
8087682|NCT03443713|19940103|P1|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
8087683|NCT03443713|19940101|P3|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
8087684|NCT03443713|19940102|P2|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
8087685|NCT03443713|19940103|P1|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
8087686|NCT03443713|19940101|P3|STARTED|Dexcom Insertion Visit (30 Minutes)||8
8087687|NCT03443713|19940102|P2|STARTED|Dexcom Insertion Visit (30 Minutes)||8
8087688|NCT03443713|19940103|P1|STARTED|Dexcom Insertion Visit (30 Minutes)||8
8087689|NCT03443713|19940101|P3|NOT COMPLETED|First Exercise Visit (1 Hour)||0
8087690|NCT03443713|19940102|P2|NOT COMPLETED|First Exercise Visit (1 Hour)||0
8087691|NCT03443713|19940103|P1|NOT COMPLETED|First Exercise Visit (1 Hour)||0
8087692|NCT03443713|19940101|P3|COMPLETED|First Exercise Visit (1 Hour)||8
8087693|NCT03443713|19940102|P2|COMPLETED|First Exercise Visit (1 Hour)||8
8087694|NCT03443713|19940103|P1|COMPLETED|First Exercise Visit (1 Hour)||8
8087695|NCT03443713|19940101|P3|STARTED|First Exercise Visit (1 Hour)||8
8087696|NCT03443713|19940102|P2|STARTED|First Exercise Visit (1 Hour)||8
8087697|NCT03443713|19940103|P1|STARTED|First Exercise Visit (1 Hour)||8
8087698|NCT03443713|19940101|P3|NOT COMPLETED|First at Home Period (9-14 Days)||1
8087699|NCT03443713|19940102|P2|NOT COMPLETED|First at Home Period (9-14 Days)||0
8087700|NCT03443713|19940103|P1|NOT COMPLETED|First at Home Period (9-14 Days)||0
8087701|NCT03443713|19940101|P3|COMPLETED|First at Home Period (9-14 Days)||8
8087702|NCT03443713|19940102|P2|COMPLETED|First at Home Period (9-14 Days)||8
8087703|NCT03443713|19940103|P1|COMPLETED|First at Home Period (9-14 Days)||8
8087704|NCT03443713|19940101|P3|STARTED|First at Home Period (9-14 Days)||9
8087705|NCT03443713|19940102|P2|STARTED|First at Home Period (9-14 Days)||8
8087706|NCT03443713|19940103|P1|STARTED|First at Home Period (9-14 Days)||8
8087707|NCT03443713|19940101|P3|NOT COMPLETED|Start up Visit (2 Hours)||0
8087708|NCT03443713|19940102|P2|NOT COMPLETED|Start up Visit (2 Hours)||0
8087709|NCT03443713|19940103|P1|NOT COMPLETED|Start up Visit (2 Hours)||0
8087710|NCT03443713|19940101|P3|COMPLETED|Start up Visit (2 Hours)||9
8087711|NCT03443713|19940102|P2|COMPLETED|Start up Visit (2 Hours)||8
8087712|NCT03443713|19940103|P1|COMPLETED|Start up Visit (2 Hours)||8
8087713|NCT03443713|19940101|P3|STARTED|Start up Visit (2 Hours)||9
8087714|NCT03443713|19940102|P2|STARTED|Start up Visit (2 Hours)||8
8087715|NCT03443713|19940103|P1|STARTED|Start up Visit (2 Hours)||8
8087716|NCT03443427|19940134|P2|NOT COMPLETED|Overall Study||5
8087717|NCT03443427|19940135|P1|NOT COMPLETED|Overall Study||8
8087718|NCT03443427|19940134|P2|COMPLETED|Overall Study||95
8087719|NCT03443427|19940135|P1|COMPLETED|Overall Study||92
8087720|NCT03443427|19940134|P2|STARTED|Overall Study||100
8087721|NCT03443427|19940135|P1|STARTED|Overall Study||100
8087722|NCT03443414|19940172|P5|NOT COMPLETED|Overall Study||5
8087723|NCT03443414|19940173|P4|NOT COMPLETED|Overall Study||5
8087724|NCT03443414|19940174|P3|NOT COMPLETED|Overall Study||6
8087725|NCT03443414|19940175|P2|NOT COMPLETED|Overall Study||3
8087726|NCT03443414|19940176|P1|NOT COMPLETED|Overall Study||11
8087727|NCT03443414|19940172|P5|COMPLETED|Overall Study||75
8087728|NCT03443414|19940173|P4|COMPLETED|Overall Study||75
8087729|NCT03443414|19940174|P3|COMPLETED|Overall Study||76
8087730|NCT03443414|19940175|P2|COMPLETED|Overall Study||78
8087731|NCT03443414|19940176|P1|COMPLETED|Overall Study||71
8087732|NCT03443414|19940172|P5|Received Treatment|Overall Study||79
8087733|NCT03443414|19940173|P4|Received Treatment|Overall Study||80
8087734|NCT03443414|19940174|P3|Received Treatment|Overall Study||82
8087735|NCT03443414|19940175|P2|Received Treatment|Overall Study||81
8087736|NCT03443414|19940176|P1|Received Treatment|Overall Study||81
8087737|NCT03443414|19940172|P5|STARTED|Overall Study||80
8087738|NCT03443414|19940173|P4|STARTED|Overall Study||80
8087739|NCT03443414|19940174|P3|STARTED|Overall Study||82
8087740|NCT03443414|19940175|P2|STARTED|Overall Study||81
8087741|NCT03443414|19940176|P1|STARTED|Overall Study||82
8087742|NCT03443063|19940215|P2|NOT COMPLETED|Overall Study||0
8087743|NCT03443063|19940216|P1|NOT COMPLETED|Overall Study||0
8087744|NCT03443063|19940215|P2|COMPLETED|Overall Study||8
8087745|NCT03443063|19940216|P1|COMPLETED|Overall Study||8
8087746|NCT03443063|19940215|P2|STARTED|Overall Study||8
8087747|NCT03443063|19940216|P1|STARTED|Overall Study||8
8087748|NCT03442933|19940266|P2|NOT COMPLETED|Overall Study||0
8087749|NCT03442933|19940267|P1|NOT COMPLETED|Overall Study||0
8087750|NCT03442933|19940266|P2|COMPLETED|Overall Study||20
8087751|NCT03442933|19940267|P1|COMPLETED|Overall Study||20
8087752|NCT03442933|19940266|P2|STARTED|Overall Study||20
8087753|NCT03442933|19940267|P1|STARTED|Overall Study||20
8087754|NCT03442868|19940278|P1|NOT COMPLETED|Overall Study||0
8087755|NCT03442868|19940278|P1|COMPLETED|Overall Study||15
8087756|NCT03442868|19940278|P1|STARTED|Overall Study||15
8087757|NCT03442829|19940287|P2|NOT COMPLETED|Overall Study||2
8087758|NCT03442829|19940288|P1|NOT COMPLETED|Overall Study||4
8087759|NCT03442829|19940287|P2|COMPLETED|Overall Study||25
8087760|NCT03442829|19940288|P1|COMPLETED|Overall Study||23
8087761|NCT03442829|19940287|P2|STARTED|Overall Study||27
8087762|NCT03442829|19940288|P1|STARTED|Overall Study||27
8087763|NCT03442725|19940304|P2|NOT COMPLETED|Overall Study||0
8087764|NCT03442725|19940305|P1|NOT COMPLETED|Overall Study||0
8087765|NCT03442725|19940304|P2|COMPLETED|Overall Study||8
8087766|NCT03442725|19940305|P1|COMPLETED|Overall Study||8
8087767|NCT03442725|19940304|P2|STARTED|Overall Study||8
8087768|NCT03442725|19940305|P1|STARTED|Overall Study||8
8087769|NCT03442699|19940337|P1|NOT COMPLETED|Overall Study||0
8087770|NCT03442699|19940337|P1|COMPLETED|Overall Study||6
8087771|NCT03442699|19940337|P1|STARTED|Overall Study||6
8087772|NCT03442595|19940347|P2|NOT COMPLETED|Overall Study||0
8087773|NCT03442595|19940348|P1|NOT COMPLETED|Overall Study||94
8087774|NCT03442595|19940347|P2|COMPLETED|Overall Study||366
8087775|NCT03442595|19940348|P1|COMPLETED|Overall Study||366
8087776|NCT03442595|19940347|P2|STARTED|Overall Study||366
8087777|NCT03442595|19940348|P1|STARTED|Overall Study||460
8087784|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087785|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087786|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087787|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087788|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087789|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087790|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087791|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087792|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087793|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087794|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087795|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087796|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087797|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087798|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087799|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087800|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087801|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087802|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087803|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087804|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087805|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087806|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087807|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087808|NCT03441984|19940380|P12|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087809|NCT03441984|19940381|P11|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087810|NCT03441984|19940382|P10|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087811|NCT03441984|19940383|P9|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087812|NCT03441984|19940384|P8|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087813|NCT03441984|19940385|P7|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087814|NCT03441984|19940386|P6|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087815|NCT03441984|19940387|P5|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087816|NCT03441984|19940388|P4|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087817|NCT03441984|19940389|P3|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087818|NCT03441984|19940390|P2|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087819|NCT03441984|19940391|P1|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087820|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087821|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087822|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087823|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087824|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087825|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087826|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087827|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087828|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087829|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087830|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087831|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087832|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087833|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087834|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087835|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087836|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087837|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087838|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087839|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087840|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087841|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087842|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087843|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087844|NCT03441984|19940380|P12|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087845|NCT03441984|19940381|P11|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087846|NCT03441984|19940382|P10|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087847|NCT03441984|19940383|P9|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087848|NCT03441984|19940384|P8|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087849|NCT03441984|19940385|P7|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087850|NCT03441984|19940386|P6|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087851|NCT03441984|19940387|P5|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087852|NCT03441984|19940388|P4|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087853|NCT03441984|19940389|P3|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087854|NCT03441984|19940390|P2|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087855|NCT03441984|19940391|P1|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087856|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087857|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087858|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087859|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087860|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087861|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087862|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087863|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087864|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087865|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087866|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087867|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087868|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087869|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087870|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087871|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087872|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087873|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087874|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087875|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087876|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087877|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087878|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087879|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087880|NCT03441984|19940380|P12|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087881|NCT03441984|19940381|P11|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087882|NCT03441984|19940382|P10|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087883|NCT03441984|19940383|P9|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087884|NCT03441984|19940384|P8|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087885|NCT03441984|19940385|P7|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087886|NCT03441984|19940386|P6|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087887|NCT03441984|19940387|P5|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087888|NCT03441984|19940388|P4|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087889|NCT03441984|19940389|P3|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087890|NCT03441984|19940390|P2|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087891|NCT03441984|19940391|P1|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087892|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087893|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087894|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087895|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087896|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087897|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087898|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087899|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087900|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087901|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087902|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087903|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087904|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087905|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087906|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087907|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087908|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087909|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087910|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087911|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087912|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087913|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087914|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087915|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087916|NCT03441984|19940380|P12|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087917|NCT03441984|19940381|P11|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087918|NCT03441984|19940382|P10|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087919|NCT03441984|19940383|P9|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087920|NCT03441984|19940384|P8|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087921|NCT03441984|19940385|P7|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087922|NCT03441984|19940386|P6|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087923|NCT03441984|19940387|P5|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087924|NCT03441984|19940388|P4|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087925|NCT03441984|19940389|P3|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087926|NCT03441984|19940390|P2|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087927|NCT03441984|19940391|P1|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087928|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087929|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087930|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087931|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087932|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087933|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087934|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087935|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087936|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087937|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087938|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087939|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087940|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087941|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087942|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087943|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087944|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087945|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087946|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087947|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087948|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087949|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087950|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087951|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087952|NCT03441984|19940380|P12|STARTED|Part 2: Period 1(Up to Day 4)||3
8087953|NCT03441984|19940381|P11|STARTED|Part 2: Period 1(Up to Day 4)||3
8087954|NCT03441984|19940382|P10|STARTED|Part 2: Period 1(Up to Day 4)||3
8087955|NCT03441984|19940383|P9|STARTED|Part 2: Period 1(Up to Day 4)||3
8087956|NCT03441984|19940384|P8|STARTED|Part 2: Period 1(Up to Day 4)||3
8087957|NCT03441984|19940385|P7|STARTED|Part 2: Period 1(Up to Day 4)||3
8087958|NCT03441984|19940386|P6|STARTED|Part 2: Period 1(Up to Day 4)||0
8087959|NCT03441984|19940387|P5|STARTED|Part 2: Period 1(Up to Day 4)||0
8087960|NCT03441984|19940388|P4|STARTED|Part 2: Period 1(Up to Day 4)||0
8087961|NCT03441984|19940389|P3|STARTED|Part 2: Period 1(Up to Day 4)||0
8087962|NCT03441984|19940390|P2|STARTED|Part 2: Period 1(Up to Day 4)||0
8087963|NCT03441984|19940391|P1|STARTED|Part 2: Period 1(Up to Day 4)||0
8087964|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087965|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087966|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087967|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087968|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087969|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087970|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087971|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087972|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087973|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087974|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087975|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087976|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087977|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087978|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087979|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087980|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087981|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087982|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087983|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087984|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087985|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
8087986|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087987|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087988|NCT03441984|19940380|P12|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087989|NCT03441984|19940381|P11|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087990|NCT03441984|19940382|P10|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087991|NCT03441984|19940383|P9|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087992|NCT03441984|19940384|P8|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087993|NCT03441984|19940385|P7|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087994|NCT03441984|19940386|P6|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087995|NCT03441984|19940387|P5|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087996|NCT03441984|19940388|P4|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087997|NCT03441984|19940389|P3|STARTED|Part 1: Period 3 (Up to Day 4 )||2
8087998|NCT03441984|19940390|P2|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087999|NCT03441984|19940391|P1|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8088000|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088001|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088002|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088003|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088004|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088005|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088006|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088007|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088008|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088009|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088010|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088011|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088012|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088013|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088014|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088015|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088016|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088017|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088018|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088019|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088020|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088021|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
8088022|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088023|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088024|NCT03441984|19940380|P12|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088025|NCT03441984|19940381|P11|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088026|NCT03441984|19940382|P10|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088027|NCT03441984|19940383|P9|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088028|NCT03441984|19940384|P8|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088029|NCT03441984|19940385|P7|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088030|NCT03441984|19940386|P6|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088031|NCT03441984|19940387|P5|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088032|NCT03441984|19940388|P4|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088033|NCT03441984|19940389|P3|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
8088034|NCT03441984|19940390|P2|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088035|NCT03441984|19940391|P1|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088036|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088037|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088038|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088039|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088040|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088041|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088042|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088043|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088044|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088045|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
8088046|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088047|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088048|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088049|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088050|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088051|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088052|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088053|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088054|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088055|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088056|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088057|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
8088058|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088059|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088060|NCT03441984|19940380|P12|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088061|NCT03441984|19940381|P11|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088062|NCT03441984|19940382|P10|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088063|NCT03441984|19940383|P9|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088064|NCT03441984|19940384|P8|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088065|NCT03441984|19940385|P7|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088066|NCT03441984|19940386|P6|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088067|NCT03441984|19940387|P5|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088068|NCT03441984|19940388|P4|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088069|NCT03441984|19940389|P3|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088070|NCT03441984|19940390|P2|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088071|NCT03441984|19940391|P1|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088072|NCT03441984|19940380|P12|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088073|NCT03441984|19940381|P11|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088074|NCT03441984|19940382|P10|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088075|NCT03441984|19940383|P9|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088076|NCT03441984|19940384|P8|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088077|NCT03441984|19940385|P7|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088078|NCT03441984|19940386|P6|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088079|NCT03441984|19940387|P5|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088080|NCT03441984|19940388|P4|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088081|NCT03441984|19940389|P3|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088082|NCT03441984|19940390|P2|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088083|NCT03441984|19940391|P1|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088084|NCT03441984|19940380|P12|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088085|NCT03441984|19940381|P11|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088086|NCT03441984|19940382|P10|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088087|NCT03441984|19940383|P9|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088088|NCT03441984|19940384|P8|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088089|NCT03441984|19940385|P7|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088090|NCT03441984|19940386|P6|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088091|NCT03441984|19940387|P5|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088092|NCT03441984|19940388|P4|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088093|NCT03441984|19940389|P3|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088094|NCT03441984|19940390|P2|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088095|NCT03441984|19940391|P1|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088096|NCT03441984|19940380|P12|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088097|NCT03441984|19940381|P11|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088098|NCT03441984|19940382|P10|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088099|NCT03441984|19940383|P9|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088100|NCT03441984|19940384|P8|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088101|NCT03441984|19940385|P7|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088102|NCT03441984|19940386|P6|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088103|NCT03441984|19940387|P5|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088104|NCT03441984|19940388|P4|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088105|NCT03441984|19940389|P3|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088106|NCT03441984|19940390|P2|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088107|NCT03441984|19940391|P1|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088108|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088109|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088110|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088111|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088112|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088113|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088114|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088115|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088116|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088117|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088118|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088119|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088120|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088121|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088122|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088123|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088124|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088125|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088126|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088127|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088128|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088129|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088130|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088131|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088132|NCT03441984|19940380|P12|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088133|NCT03441984|19940381|P11|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088134|NCT03441984|19940382|P10|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088135|NCT03441984|19940383|P9|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088136|NCT03441984|19940384|P8|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088137|NCT03441984|19940385|P7|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088138|NCT03441984|19940386|P6|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088139|NCT03441984|19940387|P5|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088140|NCT03441984|19940388|P4|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088141|NCT03441984|19940389|P3|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088142|NCT03441984|19940390|P2|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088143|NCT03441984|19940391|P1|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088144|NCT03441789|19940752|P2|NOT COMPLETED|Overall Study||4
8088145|NCT03441789|19940753|P1|NOT COMPLETED|Overall Study||1
8088146|NCT03441789|19940752|P2|COMPLETED|Overall Study||10
8088147|NCT03441789|19940753|P1|COMPLETED|Overall Study||13
8088148|NCT03441789|19940752|P2|STARTED|Overall Study||14
8088149|NCT03441789|19940753|P1|STARTED|Overall Study||14
8088150|NCT03441633|19940779|P10|NOT COMPLETED|Overall Study||0
8088151|NCT03441633|19940780|P9|NOT COMPLETED|Overall Study||0
8088152|NCT03441633|19940781|P8|NOT COMPLETED|Overall Study||0
8088153|NCT03441633|19940782|P7|NOT COMPLETED|Overall Study||0
8088154|NCT03441633|19940783|P6|NOT COMPLETED|Overall Study||0
8088155|NCT03441633|19940784|P5|NOT COMPLETED|Overall Study||0
8088156|NCT03441633|19940785|P4|NOT COMPLETED|Overall Study||0
8088157|NCT03441633|19940786|P3|NOT COMPLETED|Overall Study||0
8088158|NCT03441633|19940787|P2|NOT COMPLETED|Overall Study||0
8088159|NCT03441633|19940788|P1|NOT COMPLETED|Overall Study||0
8088160|NCT03441633|19940779|P10|COMPLETED|Overall Study||1562
8088161|NCT03441633|19940780|P9|COMPLETED|Overall Study||5132
8088162|NCT03441633|19940781|P8|COMPLETED|Overall Study||953
8088163|NCT03441633|19940782|P7|COMPLETED|Overall Study||2855
8088164|NCT03441633|19940783|P6|COMPLETED|Overall Study||363
8088165|NCT03441633|19940784|P5|COMPLETED|Overall Study||2286
8088166|NCT03441633|19940785|P4|COMPLETED|Overall Study||192
8088167|NCT03441633|19940786|P3|COMPLETED|Overall Study||32212
8088168|NCT03441633|19940787|P2|COMPLETED|Overall Study||1423
8088169|NCT03441633|19940788|P1|COMPLETED|Overall Study||4712
8088170|NCT03441633|19940779|P10|STARTED|Overall Study||1562
8088171|NCT03441633|19940780|P9|STARTED|Overall Study||5132
8088172|NCT03441633|19940781|P8|STARTED|Overall Study||953
8088173|NCT03441633|19940782|P7|STARTED|Overall Study||2855
8088174|NCT03441633|19940783|P6|STARTED|Overall Study||363
8088175|NCT03441633|19940784|P5|STARTED|Overall Study||2286
8088176|NCT03441633|19940785|P4|STARTED|Overall Study||192
8088177|NCT03441633|19940786|P3|STARTED|Overall Study||32212
8088178|NCT03441633|19940787|P2|STARTED|Overall Study||1423
8088179|NCT03441633|19940788|P1|STARTED|Overall Study||4712
8088180|NCT03441594|19940928|P1|NOT COMPLETED|Overall Study||0
8088181|NCT03441594|19940928|P1|COMPLETED|Overall Study||56
8088182|NCT03441594|19940928|P1|STARTED|Overall Study||56
8088183|NCT03441269|19940936|P3|NOT COMPLETED|Overall Study||1
8088184|NCT03441269|19940937|P2|NOT COMPLETED|Overall Study||1
8088185|NCT03441269|19940938|P1|NOT COMPLETED|Overall Study||0
8088186|NCT03441269|19940936|P3|COMPLETED|Overall Study||74
8088187|NCT03441269|19940937|P2|COMPLETED|Overall Study||74
8088188|NCT03441269|19940938|P1|COMPLETED|Overall Study||75
8088189|NCT03441269|19940936|P3|STARTED|Overall Study||75
8088190|NCT03441269|19940937|P2|STARTED|Overall Study||75
8088191|NCT03441269|19940938|P1|STARTED|Overall Study||75
8088192|NCT03441178|19940952|P3|NOT COMPLETED|Overall Study||1
8088193|NCT03441178|19940953|P2|NOT COMPLETED|Overall Study||1
8088194|NCT03441178|19940954|P1|NOT COMPLETED|Overall Study||0
8088195|NCT03441178|19940952|P3|COMPLETED|Overall Study||20
8088196|NCT03441178|19940953|P2|COMPLETED|Overall Study||43
8088197|NCT03441178|19940954|P1|COMPLETED|Overall Study||36
8088198|NCT03441178|19940952|P3|STARTED|Overall Study||21
8088199|NCT03441178|19940953|P2|STARTED|Overall Study||44
8088200|NCT03441178|19940954|P1|STARTED|Overall Study||36
8088201|NCT03440918|19940974|P2|NOT COMPLETED|Overall Study||16
8088202|NCT03440918|19940975|P1|NOT COMPLETED|Overall Study||0
8088203|NCT03440918|19940974|P2|COMPLETED|Overall Study||122
8088204|NCT03440918|19940975|P1|COMPLETED|Overall Study||133
8088205|NCT03440918|19940974|P2|STARTED|Overall Study||138
8088206|NCT03440918|19940975|P1|STARTED|Overall Study||133
8088207|NCT03440619|19941003|P1|NOT COMPLETED|Overall Study||0
8088208|NCT03440619|19941003|P1|COMPLETED|Overall Study||28
8088209|NCT03440619|19941003|P1|STARTED|Overall Study||28
8088210|NCT03440424|19941010|P3|NOT COMPLETED|Overall Study||0
8088211|NCT03440424|19941011|P2|NOT COMPLETED|Overall Study||0
8088212|NCT03440424|19941012|P1|NOT COMPLETED|Overall Study||0
8088213|NCT03440424|19941010|P3|COMPLETED|Overall Study||8
8088214|NCT03440424|19941011|P2|COMPLETED|Overall Study||8
8088215|NCT03440424|19941012|P1|COMPLETED|Overall Study||8
8088216|NCT03440424|19941010|P3|STARTED|Overall Study||8
8088217|NCT03440424|19941011|P2|STARTED|Overall Study||8
8088218|NCT03440424|19941012|P1|STARTED|Overall Study||8
8088219|NCT03439124|19941073|P2|NOT COMPLETED|Overall Study||0
8088220|NCT03439124|19941074|P1|NOT COMPLETED|Overall Study||4
8088221|NCT03439124|19941073|P2|COMPLETED|Overall Study||44
8088222|NCT03439124|19941074|P1|COMPLETED|Overall Study||90
8088223|NCT03439124|19941073|P2|STARTED|Overall Study||44
8088224|NCT03439124|19941074|P1|STARTED|Overall Study||94
8088225|NCT03439072|19941088|P2|NOT COMPLETED|Overall Study||4
8088226|NCT03439072|19941089|P1|NOT COMPLETED|Overall Study||2
8088227|NCT03439072|19941088|P2|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
8088228|NCT03439072|19941089|P1|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
8088229|NCT03439072|19941088|P2|STARTED|Overall Study||40
8088230|NCT03439072|19941089|P1|STARTED|Overall Study||41
8088231|NCT03438578|19941123|P2|NOT COMPLETED|Overall Study||4
8088232|NCT03438578|19941124|P1|NOT COMPLETED|Overall Study||1
8088233|NCT03438578|19941123|P2|COMPLETED|Overall Study||96
8088234|NCT03438578|19941124|P1|COMPLETED|Overall Study||99
8088235|NCT03438578|19941123|P2|STARTED|Overall Study||100
8088236|NCT03438578|19941124|P1|STARTED|Overall Study||100
8088237|NCT03438539|19941140|P6|NOT COMPLETED|Overall Study||8
8088238|NCT03438539|19941141|P5|NOT COMPLETED|Overall Study||3
8088239|NCT03438539|19941142|P4|NOT COMPLETED|Overall Study||9
8088240|NCT03438539|19941143|P3|NOT COMPLETED|Overall Study||10
8088241|NCT03438539|19941144|P2|NOT COMPLETED|Overall Study||4
8088242|NCT03438539|19941145|P1|NOT COMPLETED|Overall Study||8
8088243|NCT03438539|19941140|P6|COMPLETED|Overall Study||66
8088244|NCT03438539|19941141|P5|COMPLETED|Overall Study||70
8088245|NCT03438539|19941142|P4|COMPLETED|Overall Study||64
8088246|NCT03438539|19941143|P3|COMPLETED|Overall Study||66
8088247|NCT03438539|19941144|P2|COMPLETED|Overall Study||68
8088248|NCT03438539|19941145|P1|COMPLETED|Overall Study||68
8088249|NCT03438539|19941140|P6|STARTED|Overall Study||74
8088250|NCT03438539|19941141|P5|STARTED|Overall Study||73
8088251|NCT03438539|19941142|P4|STARTED|Overall Study||73
8088252|NCT03438539|19941143|P3|STARTED|Overall Study||76
8088253|NCT03438539|19941144|P2|STARTED|Overall Study||72
8088254|NCT03438539|19941145|P1|STARTED|Overall Study||76
8088255|NCT03438383|19941173|P2|NOT COMPLETED|Overall Study||3
8088256|NCT03438383|19941174|P1|NOT COMPLETED|Overall Study||9
8088257|NCT03438383|19941173|P2|COMPLETED|Overall Study||21
8088258|NCT03438383|19941174|P1|COMPLETED|Overall Study||14
8088259|NCT03438383|19941173|P2|STARTED|Overall Study||24
8088260|NCT03438383|19941174|P1|STARTED|Overall Study||23
8088261|NCT03438266|19941194|P1|NOT COMPLETED|Overall Study||0
8088262|NCT03438266|19941194|P1|COMPLETED|Overall Study||60
8088263|NCT03438266|19941194|P1|STARTED|Overall Study||60
8088264|NCT03437733|19941205|P2|NOT COMPLETED|Overall Study||3
8088265|NCT03437733|19941206|P1|NOT COMPLETED|Overall Study||0
8088266|NCT03437733|19941205|P2|COMPLETED|Overall Study||87
8088267|NCT03437733|19941206|P1|COMPLETED|Overall Study||8
8088268|NCT03437733|19941205|P2|Safety|Overall Study||87
8088269|NCT03437733|19941206|P1|Safety|Overall Study||8
8088270|NCT03437733|19941205|P2|STARTED|Overall Study||90
8088271|NCT03437733|19941206|P1|STARTED|Overall Study||8
8088272|NCT03437564|19941229|P2|NOT COMPLETED|Overall Study||0
8088273|NCT03437564|19941230|P1|NOT COMPLETED|Overall Study||0
8088274|NCT03437564|19941229|P2|COMPLETED|Overall Study||14
8088275|NCT03437564|19941230|P1|COMPLETED|Overall Study||14
8088276|NCT03437564|19941229|P2|STARTED|Overall Study||14
8088277|NCT03437564|19941230|P1|STARTED|Overall Study||14
8088278|NCT03437447|19941261|P3|NOT COMPLETED|Treatment Period 3||0
8088279|NCT03437447|19941262|P2|NOT COMPLETED|Treatment Period 3||0
8088280|NCT03437447|19941263|P1|NOT COMPLETED|Treatment Period 3||0
8088281|NCT03437447|19941261|P3|COMPLETED|Treatment Period 3||19
8088282|NCT03437447|19941262|P2|COMPLETED|Treatment Period 3||20
8088283|NCT03437447|19941263|P1|COMPLETED|Treatment Period 3||20
8088284|NCT03437447|19941261|P3|STARTED|Treatment Period 3||19
8088285|NCT03437447|19941262|P2|STARTED|Treatment Period 3||20
8088286|NCT03437447|19941263|P1|STARTED|Treatment Period 3||20
8088287|NCT03437447|19941261|P3|NOT COMPLETED|Treatment Period 2||0
8088288|NCT03437447|19941262|P2|NOT COMPLETED|Treatment Period 2||0
8088289|NCT03437447|19941263|P1|NOT COMPLETED|Treatment Period 2||0
8088290|NCT03437447|19941261|P3|COMPLETED|Treatment Period 2||19
8088291|NCT03437447|19941262|P2|COMPLETED|Treatment Period 2||20
8088292|NCT03437447|19941263|P1|COMPLETED|Treatment Period 2||20
8088293|NCT03437447|19941261|P3|STARTED|Treatment Period 2||19
8088294|NCT03437447|19941262|P2|STARTED|Treatment Period 2||20
8088295|NCT03437447|19941263|P1|STARTED|Treatment Period 2||20
8088296|NCT03437447|19941261|P3|NOT COMPLETED|Treatment Period 1||1
8088297|NCT03437447|19941262|P2|NOT COMPLETED|Treatment Period 1||0
8088298|NCT03437447|19941263|P1|NOT COMPLETED|Treatment Period 1||0
8088299|NCT03437447|19941261|P3|COMPLETED|Treatment Period 1||19
8088300|NCT03437447|19941262|P2|COMPLETED|Treatment Period 1||20
8088301|NCT03437447|19941263|P1|COMPLETED|Treatment Period 1||20
8088302|NCT03437447|19941261|P3|STARTED|Treatment Period 1||20
8088303|NCT03437447|19941262|P2|STARTED|Treatment Period 1||20
8088304|NCT03437447|19941263|P1|STARTED|Treatment Period 1||20
8088305|NCT03436732|19941318|P2|NOT COMPLETED|Overall Study||1
8088306|NCT03436732|19941319|P1|NOT COMPLETED|Overall Study||4
8088307|NCT03436732|19941318|P2|COMPLETED|Overall Study||0
8088308|NCT03436732|19941319|P1|COMPLETED|Overall Study||0
8088309|NCT03436732|19941318|P2|STARTED|Overall Study||1
8088310|NCT03436732|19941319|P1|STARTED|Overall Study||4
8088311|NCT03436420|19941332|P1|NOT COMPLETED|Overall Study||3
8088312|NCT03436420|19941332|P1|COMPLETED|Overall Study||3
8088313|NCT03436420|19941332|P1|STARTED|Overall Study||6
8088314|NCT03436147|19941375|P2|NOT COMPLETED|Overall Study||11
8088315|NCT03436147|19941376|P1|NOT COMPLETED|Overall Study||4
8088316|NCT03436147|19941375|P2|COMPLETED|Overall Study||19
8088317|NCT03436147|19941376|P1|COMPLETED|Overall Study||15
8088318|NCT03436147|19941375|P2|STARTED|Overall Study||30
8088319|NCT03436147|19941376|P1|STARTED|Overall Study||19
8088320|NCT03435783|19941388|P2|NOT COMPLETED|Overall Study||1
8088321|NCT03435783|19941389|P1|NOT COMPLETED|Overall Study||0
8088322|NCT03435783|19941388|P2|COMPLETED|Overall Study||19
8088323|NCT03435783|19941389|P1|COMPLETED|Overall Study||20
8088324|NCT03435783|19941388|P2|STARTED|Overall Study||20
8088325|NCT03435783|19941389|P1|STARTED|Overall Study||20
8088326|NCT03435562|19941403|P1|NOT COMPLETED|Overall Study||4
8088327|NCT03435562|19941403|P1|COMPLETED|Overall Study||18
8088328|NCT03435562|19941403|P1|STARTED|Overall Study||22
8088329|NCT03435497|19941485|P2|NOT COMPLETED|Overall Study||6
8088330|NCT03435497|19941486|P1|NOT COMPLETED|Overall Study||2
8088331|NCT03435497|19941485|P2|COMPLETED|Overall Study||41
8088332|NCT03435497|19941486|P1|COMPLETED|Overall Study||49
8088333|NCT03435497|19941485|P2|STARTED|Overall Study||47
8088334|NCT03435497|19941486|P1|STARTED|Overall Study||51
8088335|NCT03435185|19941502|P2|NOT COMPLETED|Overall Study||15
8088336|NCT03435185|19941503|P1|NOT COMPLETED|Overall Study||1
8088337|NCT03435185|19941502|P2|COMPLETED|Overall Study||28
8088338|NCT03435185|19941503|P1|COMPLETED|Overall Study||43
8088339|NCT03435185|19941502|P2|STARTED|Overall Study||43
8088340|NCT03435185|19941503|P1|STARTED|Overall Study||44
8088341|NCT03435081|19941514|P3|NOT COMPLETED|Overall Study||19
8088342|NCT03435081|19941515|P2|NOT COMPLETED|Overall Study||16
8088343|NCT03435081|19941516|P1|NOT COMPLETED|Overall Study||21
8088344|NCT03435081|19941514|P3|COMPLETED|Overall Study||127
8088345|NCT03435081|19941515|P2|COMPLETED|Overall Study||131
8088346|NCT03435081|19941516|P1|COMPLETED|Overall Study||126
8088347|NCT03435081|19941514|P3|Received at Least One Dose of Study Drug|Overall Study||146
8088348|NCT03435081|19941515|P2|Received at Least One Dose of Study Drug|Overall Study||147
8088349|NCT03435081|19941516|P1|Received at Least One Dose of Study Drug|Overall Study||147
8088350|NCT03435081|19941514|P3|STARTED|Overall Study||146
8088351|NCT03435081|19941515|P2|STARTED|Overall Study||147
8088352|NCT03435081|19941516|P1|STARTED|Overall Study||147
8088353|NCT03434977|19941593|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8088354|NCT03434977|19941594|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8088355|NCT03434977|19941593|P2|COMPLETED|Intervention Period 2 (6 Days)||5
8088356|NCT03434977|19941594|P1|COMPLETED|Intervention Period 2 (6 Days)||6
8088357|NCT03434977|19941593|P2|STARTED|Intervention Period 2 (6 Days)||5
8088358|NCT03434977|19941594|P1|STARTED|Intervention Period 2 (6 Days)||6
8088359|NCT03434977|19941593|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
8088360|NCT03434977|19941594|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
8088361|NCT03434977|19941593|P2|COMPLETED|Washout Period (at Least 6 Days)||5
8088362|NCT03434977|19941594|P1|COMPLETED|Washout Period (at Least 6 Days)||6
8088363|NCT03434977|19941593|P2|STARTED|Washout Period (at Least 6 Days)||6
8088364|NCT03434977|19941594|P1|STARTED|Washout Period (at Least 6 Days)||6
8088365|NCT03434977|19941593|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8088366|NCT03434977|19941594|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8088367|NCT03434977|19941593|P2|COMPLETED|Intervention Period 1 (6 Days)||6
8088368|NCT03434977|19941594|P1|COMPLETED|Intervention Period 1 (6 Days)||6
8088369|NCT03434977|19941593|P2|STARTED|Intervention Period 1 (6 Days)||6
8088370|NCT03434977|19941594|P1|STARTED|Intervention Period 1 (6 Days)||6
8088371|NCT03434457|19941628|P1|NOT COMPLETED|Overall Study||0
8088372|NCT03434457|19941628|P1|COMPLETED|Overall Study||630
8088373|NCT03434457|19941628|P1|STARTED|Overall Study||630
8088374|NCT03434249|19941661|P2|NOT COMPLETED|Overall Study||3
8088375|NCT03434249|19941662|P1|NOT COMPLETED|Overall Study||5
8088376|NCT03434249|19941661|P2|COMPLETED|Overall Study||37
8088377|NCT03434249|19941662|P1|COMPLETED|Overall Study||35
8088378|NCT03434249|19941661|P2|STARTED|Overall Study||40
8088379|NCT03434249|19941662|P1|STARTED|Overall Study||40
8088380|NCT03434119|19941696|P2|NOT COMPLETED|Overall Study||113
8088381|NCT03434119|19941697|P1|NOT COMPLETED|Overall Study||107
8088382|NCT03434119|19941696|P2|COMPLETED|Overall Study||12
8088383|NCT03434119|19941697|P1|COMPLETED|Overall Study||9
8088384|NCT03434119|19941696|P2|Treated|Overall Study||125
8088385|NCT03434119|19941697|P1|Treated|Overall Study||115
8088386|NCT03434119|19941696|P2|STARTED|Overall Study||125
8088387|NCT03434119|19941697|P1|STARTED|Overall Study||116
8088388|NCT03433794|19941718|P3|NOT COMPLETED|9-Month Assessment||142
8088389|NCT03433794|19941719|P2|NOT COMPLETED|9-Month Assessment||121
8088390|NCT03433794|19941720|P1|NOT COMPLETED|9-Month Assessment||134
8088391|NCT03433794|19941718|P3|COMPLETED|9-Month Assessment||39
8088392|NCT03433794|19941719|P2|COMPLETED|9-Month Assessment||52
8088393|NCT03433794|19941720|P1|COMPLETED|9-Month Assessment||49
8088394|NCT03433794|19941718|P3|STARTED|9-Month Assessment||181
8088395|NCT03433794|19941719|P2|STARTED|9-Month Assessment||173
8088396|NCT03433794|19941720|P1|STARTED|9-Month Assessment||183
8088397|NCT03433794|19941718|P3|NOT COMPLETED|6-Month Assessment||131
8088398|NCT03433794|19941719|P2|NOT COMPLETED|6-Month Assessment||115
8088399|NCT03433794|19941720|P1|NOT COMPLETED|6-Month Assessment||118
8088400|NCT03433794|19941718|P3|COMPLETED|6-Month Assessment||50
8088401|NCT03433794|19941719|P2|COMPLETED|6-Month Assessment||58
8088402|NCT03433794|19941720|P1|COMPLETED|6-Month Assessment||65
8088403|NCT03433794|19941718|P3|STARTED|6-Month Assessment||181
8088404|NCT03433794|19941719|P2|STARTED|6-Month Assessment||173
8088405|NCT03433794|19941720|P1|STARTED|6-Month Assessment||183
8088406|NCT03433794|19941718|P3|NOT COMPLETED|3-Month Assessment||110
8088407|NCT03433794|19941719|P2|NOT COMPLETED|3-Month Assessment||100
8088408|NCT03433794|19941720|P1|NOT COMPLETED|3-Month Assessment||114
8088409|NCT03433794|19941718|P3|COMPLETED|3-Month Assessment||71
8088410|NCT03433794|19941719|P2|COMPLETED|3-Month Assessment||73
8088411|NCT03433794|19941720|P1|COMPLETED|3-Month Assessment||69
8088412|NCT03433794|19941718|P3|STARTED|3-Month Assessment||181
8088413|NCT03433794|19941719|P2|STARTED|3-Month Assessment||173
8088414|NCT03433794|19941720|P1|STARTED|3-Month Assessment||183
8088415|NCT03433794|19941718|P3|NOT COMPLETED|6-Week Assessment||101
8088416|NCT03433794|19941719|P2|NOT COMPLETED|6-Week Assessment||88
8088417|NCT03433794|19941720|P1|NOT COMPLETED|6-Week Assessment||89
8088418|NCT03433794|19941718|P3|COMPLETED|6-Week Assessment||80
8088419|NCT03433794|19941719|P2|COMPLETED|6-Week Assessment||85
8088420|NCT03433794|19941720|P1|COMPLETED|6-Week Assessment||94
8088421|NCT03433794|19941718|P3|STARTED|6-Week Assessment||181
8088422|NCT03433794|19941719|P2|STARTED|6-Week Assessment||173
8088423|NCT03433794|19941720|P1|STARTED|6-Week Assessment||183
8088424|NCT03433794|19941718|P3|NOT COMPLETED|4-Week Assessment||90
8088425|NCT03433794|19941719|P2|NOT COMPLETED|4-Week Assessment||78
8088426|NCT03433794|19941720|P1|NOT COMPLETED|4-Week Assessment||85
8088427|NCT03433794|19941718|P3|COMPLETED|4-Week Assessment||91
8088428|NCT03433794|19941719|P2|COMPLETED|4-Week Assessment||95
8088429|NCT03433794|19941720|P1|COMPLETED|4-Week Assessment||98
8088430|NCT03433794|19941718|P3|STARTED|4-Week Assessment||181
8088431|NCT03433794|19941719|P2|STARTED|4-Week Assessment||173
8088432|NCT03433794|19941720|P1|STARTED|4-Week Assessment||183
8088433|NCT03433794|19941718|P3|NOT COMPLETED|2-Week Assessment||72
8088434|NCT03433794|19941719|P2|NOT COMPLETED|2-Week Assessment||61
8088435|NCT03433794|19941720|P1|NOT COMPLETED|2-Week Assessment||66
8088436|NCT03433794|19941718|P3|COMPLETED|2-Week Assessment||109
8088437|NCT03433794|19941719|P2|COMPLETED|2-Week Assessment||112
8088438|NCT03433794|19941720|P1|COMPLETED|2-Week Assessment||117
8088439|NCT03433794|19941718|P3|STARTED|2-Week Assessment||181
8088440|NCT03433794|19941719|P2|STARTED|2-Week Assessment||173
8088441|NCT03433794|19941720|P1|STARTED|2-Week Assessment||183
8088442|NCT03433794|19941718|P3|NOT COMPLETED|Baseline||0
8088443|NCT03433794|19941719|P2|NOT COMPLETED|Baseline||0
8088444|NCT03433794|19941720|P1|NOT COMPLETED|Baseline||0
8088445|NCT03433794|19941718|P3|COMPLETED|Baseline||181
8088446|NCT03433794|19941719|P2|COMPLETED|Baseline||173
8088447|NCT03433794|19941720|P1|COMPLETED|Baseline||183
8088448|NCT03433794|19941718|P3|STARTED|Baseline||181
8088449|NCT03433794|19941719|P2|STARTED|Baseline||173
8088450|NCT03433794|19941720|P1|STARTED|Baseline||183
8088451|NCT03433703|19941731|P1|NOT COMPLETED|Overall Study||2
8088452|NCT03433703|19941731|P1|COMPLETED|Overall Study||0
8088453|NCT03433703|19941731|P1|STARTED|Overall Study||2
8088454|NCT03433677|19941740|P2|NOT COMPLETED|Period 2||1
8088455|NCT03433677|19941741|P1|NOT COMPLETED|Period 2||1
8088456|NCT03433677|19941740|P2|COMPLETED|Period 2||24
8088457|NCT03433677|19941741|P1|COMPLETED|Period 2||22
8088458|NCT03433677|19941740|P2|Received at Least 1 Dose of Study Drug|Period 2||25
8088459|NCT03433677|19941741|P1|Received at Least 1 Dose of Study Drug|Period 2||23
8088460|NCT03433677|19941740|P2|STARTED|Period 2||25
8088461|NCT03433677|19941741|P1|STARTED|Period 2||23
8088462|NCT03433677|19941740|P2|NOT COMPLETED|Period 1||0
8088463|NCT03433677|19941741|P1|NOT COMPLETED|Period 1||1
8088464|NCT03433677|19941740|P2|COMPLETED|Period 1||25
8088465|NCT03433677|19941741|P1|COMPLETED|Period 1||23
8088466|NCT03433677|19941740|P2|Received at Least 1 Dose of Study Drug|Period 1||25
8088467|NCT03433677|19941741|P1|Received at Least 1 Dose of Study Drug|Period 1||24
8088468|NCT03433677|19941740|P2|STARTED|Period 1||25
8088469|NCT03433677|19941741|P1|STARTED|Period 1||24
8088470|NCT03432533|19941761|P2|NOT COMPLETED|Overall Study||11
8088471|NCT03432533|19941762|P1|NOT COMPLETED|Overall Study||15
8088472|NCT03432533|19941761|P2|COMPLETED|Overall Study||131
8088473|NCT03432533|19941762|P1|COMPLETED|Overall Study||126
8088474|NCT03432533|19941761|P2|Completed 6-Month Treatment Period|Overall Study||137
8088475|NCT03432533|19941762|P1|Completed 6-Month Treatment Period|Overall Study||136
8088476|NCT03432533|19941761|P2|STARTED|Overall Study||142
8088477|NCT03432533|19941762|P1|STARTED|Overall Study||141
8088478|NCT03432390|19941778|P2|NOT COMPLETED|Recovery Period||0
8088479|NCT03432390|19941779|P1|NOT COMPLETED|Recovery Period||0
8088480|NCT03432390|19941778|P2|COMPLETED|Recovery Period||34
8088481|NCT03432390|19941779|P1|COMPLETED|Recovery Period||34
8088482|NCT03432390|19941778|P2|STARTED|Recovery Period||34
8088483|NCT03432390|19941779|P1|STARTED|Recovery Period||34
8088484|NCT03432390|19941778|P2|NOT COMPLETED|Apnea Period||2
8088485|NCT03432390|19941779|P1|NOT COMPLETED|Apnea Period||2
8088486|NCT03432390|19941778|P2|COMPLETED|Apnea Period||34
8088487|NCT03432390|19941779|P1|COMPLETED|Apnea Period||34
8088488|NCT03432390|19941778|P2|STARTED|Apnea Period||36
8088489|NCT03432390|19941779|P1|STARTED|Apnea Period||36
8088490|NCT03431441|19941789|P1|NOT COMPLETED|Overall Study||5
8088491|NCT03431441|19941789|P1|COMPLETED|Overall Study||19
8088492|NCT03431441|19941789|P1|STARTED|Overall Study||24
8088493|NCT03431012|19941797|P4|NOT COMPLETED|Overall Study||0
8088494|NCT03431012|19941798|P3|NOT COMPLETED|Overall Study||0
8088495|NCT03431012|19941799|P2|NOT COMPLETED|Overall Study||0
8088496|NCT03431012|19941800|P1|NOT COMPLETED|Overall Study||0
8088497|NCT03431012|19941797|P4|COMPLETED|Overall Study||53
8088498|NCT03431012|19941798|P3|COMPLETED|Overall Study||56
8088499|NCT03431012|19941799|P2|COMPLETED|Overall Study||60
8088500|NCT03431012|19941800|P1|COMPLETED|Overall Study||47
8088501|NCT03431012|19941797|P4|STARTED|Overall Study||53
8088502|NCT03431012|19941798|P3|STARTED|Overall Study||56
8088503|NCT03431012|19941799|P2|STARTED|Overall Study||60
8088504|NCT03431012|19941800|P1|STARTED|Overall Study||47
8088505|NCT03430986|19941824|P2|NOT COMPLETED|24-week Post-Control Period||2
8088506|NCT03430986|19941825|P1|NOT COMPLETED|24-week Post-Control Period||1
8088507|NCT03430986|19941824|P2|COMPLETED|24-week Post-Control Period||116
8088508|NCT03430986|19941825|P1|COMPLETED|24-week Post-Control Period||30
8088509|NCT03430986|19941824|P2|STARTED|24-week Post-Control Period||118
8088510|NCT03430986|19941825|P1|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
8088511|NCT03430986|19941824|P2|NOT COMPLETED|24-week Control Period||4
8088512|NCT03430986|19941825|P1|NOT COMPLETED|24-week Control Period||8
8088513|NCT03430986|19941824|P2|COMPLETED|24-week Control Period||118
8088514|NCT03430986|19941825|P1|COMPLETED|24-week Control Period||34
8088515|NCT03430986|19941824|P2|Treated as Randomized|24-week Control Period||120
8088516|NCT03430986|19941825|P1|Treated as Randomized|24-week Control Period||42
8088517|NCT03430986|19941824|P2|STARTED|24-week Control Period||122
8088518|NCT03430986|19941825|P1|STARTED|24-week Control Period||42
8088519|NCT03430856|19941842|P3|NOT COMPLETED|Overall Study||1
8088520|NCT03430856|19941843|P2|NOT COMPLETED|Overall Study||3
8088521|NCT03430856|19941844|P1|NOT COMPLETED|Overall Study||2
8088522|NCT03430856|19941842|P3|COMPLETED|Overall Study||29
8088523|NCT03430856|19941843|P2|COMPLETED|Overall Study||27
8088524|NCT03430856|19941844|P1|COMPLETED|Overall Study||29
8088525|NCT03430856|19941842|P3|Exposed|Overall Study||30
8088526|NCT03430856|19941843|P2|Exposed|Overall Study||30
8088527|NCT03430856|19941844|P1|Exposed|Overall Study||31
8088528|NCT03430856|19941842|P3|STARTED|Overall Study||30
8088529|NCT03430856|19941843|P2|STARTED|Overall Study||30
8088530|NCT03430856|19941844|P1|STARTED|Overall Study||31
8088531|NCT03430245|19941882|P1|NOT COMPLETED|Overall Study||7
8088532|NCT03430245|19941882|P1|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
8088533|NCT03430245|19941882|P1|STARTED|Overall Study||16
8088534|NCT03430206|19941891|P2|NOT COMPLETED|Overall Study||17
8088535|NCT03430206|19941892|P1|NOT COMPLETED|Overall Study||22
8088536|NCT03430206|19941891|P2|COMPLETED|Overall Study||21
8088537|NCT03430206|19941892|P1|COMPLETED|Overall Study||18
8088538|NCT03430206|19941891|P2|STARTED|Overall Study||38
8088539|NCT03430206|19941892|P1|STARTED|Overall Study||40
8088540|NCT03430050|19941912|P2|NOT COMPLETED|Overall Study||0
8088541|NCT03430050|19941913|P1|NOT COMPLETED|Overall Study||0
8088542|NCT03430050|19941912|P2|COMPLETED|Overall Study||5
8088543|NCT03430050|19941913|P1|COMPLETED|Overall Study||3
8088544|NCT03430050|19941912|P2|STARTED|Overall Study||5
8088545|NCT03430050|19941913|P1|STARTED|Overall Study||3
8088546|NCT03429712|19941921|P1|NOT COMPLETED|Overall Study||9
8088547|NCT03429712|19941921|P1|COMPLETED|Overall Study||10
8088548|NCT03429712|19941921|P1|STARTED|Overall Study||19
8088549|NCT03429556|19941929|P4|NOT COMPLETED|Overall Study||0
8088550|NCT03429556|19941930|P3|NOT COMPLETED|Overall Study||0
8088551|NCT03429556|19941931|P2|NOT COMPLETED|Overall Study||1
8088552|NCT03429556|19941932|P1|NOT COMPLETED|Overall Study||0
8088553|NCT03429556|19941929|P4|COMPLETED|Overall Study||3
8088554|NCT03429556|19941930|P3|COMPLETED|Overall Study||4
8088555|NCT03429556|19941931|P2|COMPLETED|Overall Study||3
8088556|NCT03429556|19941932|P1|COMPLETED|Overall Study||12
8088557|NCT03429556|19941929|P4|STARTED|Overall Study||3
8088558|NCT03429556|19941930|P3|STARTED|Overall Study||4
8088559|NCT03429556|19941931|P2|STARTED|Overall Study||4
8088560|NCT03429556|19941932|P1|STARTED|Overall Study||12
8088561|NCT03429270|19941978|P1|NOT COMPLETED|Overall Study||0
8088562|NCT03429270|19941978|P1|COMPLETED|Overall Study||28
8088563|NCT03429270|19941978|P1|STARTED|Overall Study||28
8088564|NCT03428997|19941983|P1|NOT COMPLETED|Overall Study||8
8088565|NCT03428997|19941983|P1|COMPLETED|Overall Study||16
8088566|NCT03428997|19941983|P1|STARTED|Overall Study||24
8088567|NCT03428750|19941991|P2|NOT COMPLETED|Overall Study||21
8088568|NCT03428750|19941992|P1|NOT COMPLETED|Overall Study||24
8088569|NCT03428750|19941991|P2|COMPLETED|Overall Study||192
8088570|NCT03428750|19941992|P1|COMPLETED|Overall Study||186
8088571|NCT03428750|19941991|P2|STARTED|Overall Study||213
8088572|NCT03428750|19941992|P1|STARTED|Overall Study||210
8088573|NCT03428152|19942041|P2|NOT COMPLETED|Overall Study||11
8088574|NCT03428152|19942042|P1|NOT COMPLETED|Overall Study||7
8088575|NCT03428152|19942041|P2|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
8088576|NCT03428152|19942042|P1|COMPLETED|Overall Study||30
8088577|NCT03428152|19942041|P2|STARTED|Overall Study||41
8088578|NCT03428152|19942042|P1|STARTED|Overall Study||37
8088579|NCT03428100|19942062|P4|NOT COMPLETED|Overall Study||7
8088580|NCT03428100|19942063|P3|NOT COMPLETED|Overall Study||12
8088581|NCT03428100|19942064|P2|NOT COMPLETED|Overall Study||13
8088582|NCT03428100|19942065|P1|NOT COMPLETED|Overall Study||21
8088583|NCT03428100|19942062|P4|COMPLETED|Overall Study||85
8088584|NCT03428100|19942063|P3|COMPLETED|Overall Study||173
8088585|NCT03428100|19942064|P2|COMPLETED|Overall Study||80
8088586|NCT03428100|19942065|P1|COMPLETED|Overall Study||72
8088587|NCT03428100|19942062|P4|Received at Least One Dose of Study Drug|Overall Study||92
8088588|NCT03428100|19942063|P3|Received at Least One Dose of Study Drug|Overall Study||184
8088589|NCT03428100|19942064|P2|Received at Least One Dose of Study Drug|Overall Study||93
8088590|NCT03428100|19942065|P1|Received at Least One Dose of Study Drug|Overall Study||93
8088591|NCT03428100|19942062|P4|STARTED|Overall Study||92
8088592|NCT03428100|19942063|P3|STARTED|Overall Study||185
8088593|NCT03428100|19942064|P2|STARTED|Overall Study||93
8088594|NCT03428100|19942065|P1|STARTED|Overall Study||93
8088595|NCT03427931|19942180|P1|NOT COMPLETED|Overall Study||2
8088596|NCT03427931|19942180|P1|COMPLETED|Overall Study||5
8088597|NCT03427931|19942180|P1|STARTED|Overall Study||7
8088598|NCT03427892|19942185|P1|NOT COMPLETED|Overall Study||2
8088599|NCT03427892|19942185|P1|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
8088600|NCT03427892|19942185|P1|STARTED|Overall Study||21
8088601|NCT03427177|19942203|P2|NOT COMPLETED|Overall Study||27
8088602|NCT03427177|19942204|P1|NOT COMPLETED|Overall Study||33
8088603|NCT03427177|19942203|P2|COMPLETED|Overall Study||105
8088604|NCT03427177|19942204|P1|COMPLETED|Overall Study||92
8088605|NCT03427177|19942203|P2|STARTED|Overall Study||132
8088606|NCT03427177|19942204|P1|STARTED|Overall Study||125
8088607|NCT03427073|19942226|P8|NOT COMPLETED|Overall Study||4
8088608|NCT03427073|19942227|P7|NOT COMPLETED|Overall Study||3
8088609|NCT03427073|19942228|P6|NOT COMPLETED|Overall Study||4
8088610|NCT03427073|19942229|P5|NOT COMPLETED|Overall Study||3
8088611|NCT03427073|19942230|P4|NOT COMPLETED|Overall Study||3
8088612|NCT03427073|19942231|P3|NOT COMPLETED|Overall Study||1
8088613|NCT03427073|19942232|P2|NOT COMPLETED|Overall Study||1
8088614|NCT03427073|19942233|P1|NOT COMPLETED|Overall Study||1
8088615|NCT03427073|19942226|P8|COMPLETED|Overall Study||0
8088616|NCT03427073|19942227|P7|COMPLETED|Overall Study||0
8088617|NCT03427073|19942228|P6|COMPLETED|Overall Study||0
8088618|NCT03427073|19942229|P5|COMPLETED|Overall Study||0
8088619|NCT03427073|19942230|P4|COMPLETED|Overall Study||0
8088620|NCT03427073|19942231|P3|COMPLETED|Overall Study||0
8088621|NCT03427073|19942232|P2|COMPLETED|Overall Study||0
8088622|NCT03427073|19942233|P1|COMPLETED|Overall Study||0
8088623|NCT03427073|19942226|P8|STARTED|Overall Study||4
8088624|NCT03427073|19942227|P7|STARTED|Overall Study||3
8088625|NCT03427073|19942228|P6|STARTED|Overall Study||4
8088626|NCT03427073|19942229|P5|STARTED|Overall Study||3
8088627|NCT03427073|19942230|P4|STARTED|Overall Study||3
8088628|NCT03427073|19942231|P3|STARTED|Overall Study||1
8088629|NCT03427073|19942232|P2|STARTED|Overall Study||1
8088630|NCT03427073|19942233|P1|STARTED|Overall Study||1
8088631|NCT03426995|19942302|P19|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088632|NCT03426995|19942303|P18|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088633|NCT03426995|19942304|P17|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088634|NCT03426995|19942305|P16|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
8088635|NCT03426995|19942306|P15|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
8088636|NCT03426995|19942307|P14|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088637|NCT03426995|19942308|P13|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088638|NCT03426995|19942309|P12|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088639|NCT03426995|19942310|P11|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088640|NCT03426995|19942311|P10|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088641|NCT03426995|19942312|P9|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088642|NCT03426995|19942313|P8|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088643|NCT03426995|19942314|P7|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088644|NCT03426995|19942315|P6|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088645|NCT03426995|19942316|P5|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088646|NCT03426995|19942317|P4|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088647|NCT03426995|19942318|P3|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088648|NCT03426995|19942319|P2|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088649|NCT03426995|19942320|P1|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088650|NCT03426995|19942302|P19|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088651|NCT03426995|19942303|P18|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088652|NCT03426995|19942304|P17|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088653|NCT03426995|19942305|P16|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
8088654|NCT03426995|19942306|P15|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
8088655|NCT03426995|19942307|P14|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088656|NCT03426995|19942308|P13|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088657|NCT03426995|19942309|P12|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088658|NCT03426995|19942310|P11|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088659|NCT03426995|19942311|P10|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088660|NCT03426995|19942312|P9|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088661|NCT03426995|19942313|P8|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088662|NCT03426995|19942314|P7|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088663|NCT03426995|19942315|P6|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088740|NCT03426995|19942316|P5|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088664|NCT03426995|19942316|P5|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088665|NCT03426995|19942317|P4|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088666|NCT03426995|19942318|P3|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088667|NCT03426995|19942319|P2|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088668|NCT03426995|19942320|P1|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088669|NCT03426995|19942302|P19|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088670|NCT03426995|19942303|P18|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088671|NCT03426995|19942304|P17|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088672|NCT03426995|19942305|P16|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
8088673|NCT03426995|19942306|P15|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
8088674|NCT03426995|19942307|P14|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088675|NCT03426995|19942308|P13|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088676|NCT03426995|19942309|P12|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088677|NCT03426995|19942310|P11|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088678|NCT03426995|19942311|P10|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088679|NCT03426995|19942312|P9|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088680|NCT03426995|19942313|P8|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088681|NCT03426995|19942314|P7|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088682|NCT03426995|19942315|P6|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088683|NCT03426995|19942316|P5|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088684|NCT03426995|19942317|P4|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088685|NCT03426995|19942318|P3|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088686|NCT03426995|19942319|P2|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088687|NCT03426995|19942320|P1|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088688|NCT03426995|19942302|P19|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088689|NCT03426995|19942303|P18|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088690|NCT03426995|19942304|P17|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088691|NCT03426995|19942305|P16|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088692|NCT03426995|19942306|P15|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088693|NCT03426995|19942307|P14|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088694|NCT03426995|19942308|P13|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088695|NCT03426995|19942309|P12|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088696|NCT03426995|19942310|P11|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088697|NCT03426995|19942311|P10|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088698|NCT03426995|19942312|P9|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088699|NCT03426995|19942313|P8|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088700|NCT03426995|19942314|P7|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088701|NCT03426995|19942315|P6|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088702|NCT03426995|19942316|P5|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088703|NCT03426995|19942317|P4|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088704|NCT03426995|19942318|P3|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088705|NCT03426995|19942319|P2|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088706|NCT03426995|19942320|P1|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088707|NCT03426995|19942302|P19|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088708|NCT03426995|19942303|P18|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088709|NCT03426995|19942304|P17|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088710|NCT03426995|19942305|P16|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088711|NCT03426995|19942306|P15|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088712|NCT03426995|19942307|P14|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088713|NCT03426995|19942308|P13|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088714|NCT03426995|19942309|P12|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088715|NCT03426995|19942310|P11|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088716|NCT03426995|19942311|P10|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088717|NCT03426995|19942312|P9|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088718|NCT03426995|19942313|P8|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088719|NCT03426995|19942314|P7|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088720|NCT03426995|19942315|P6|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088721|NCT03426995|19942316|P5|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088722|NCT03426995|19942317|P4|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088723|NCT03426995|19942318|P3|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088724|NCT03426995|19942319|P2|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088725|NCT03426995|19942320|P1|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088726|NCT03426995|19942302|P19|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088727|NCT03426995|19942303|P18|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088728|NCT03426995|19942304|P17|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088729|NCT03426995|19942305|P16|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088730|NCT03426995|19942306|P15|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088731|NCT03426995|19942307|P14|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088732|NCT03426995|19942308|P13|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088733|NCT03426995|19942309|P12|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088734|NCT03426995|19942310|P11|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088735|NCT03426995|19942311|P10|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088736|NCT03426995|19942312|P9|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088737|NCT03426995|19942313|P8|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088738|NCT03426995|19942314|P7|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088739|NCT03426995|19942315|P6|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088741|NCT03426995|19942317|P4|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088742|NCT03426995|19942318|P3|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088743|NCT03426995|19942319|P2|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088744|NCT03426995|19942320|P1|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088745|NCT03426995|19942302|P19|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088746|NCT03426995|19942303|P18|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088747|NCT03426995|19942304|P17|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088748|NCT03426995|19942305|P16|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088749|NCT03426995|19942306|P15|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088750|NCT03426995|19942307|P14|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088751|NCT03426995|19942308|P13|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088752|NCT03426995|19942309|P12|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088753|NCT03426995|19942310|P11|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088754|NCT03426995|19942311|P10|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088755|NCT03426995|19942312|P9|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088756|NCT03426995|19942313|P8|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088757|NCT03426995|19942314|P7|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088758|NCT03426995|19942315|P6|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088759|NCT03426995|19942316|P5|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088760|NCT03426995|19942317|P4|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088761|NCT03426995|19942318|P3|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088762|NCT03426995|19942319|P2|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088763|NCT03426995|19942320|P1|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088764|NCT03426995|19942302|P19|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088765|NCT03426995|19942303|P18|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088766|NCT03426995|19942304|P17|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088767|NCT03426995|19942305|P16|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088768|NCT03426995|19942306|P15|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088769|NCT03426995|19942307|P14|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088770|NCT03426995|19942308|P13|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088771|NCT03426995|19942309|P12|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088772|NCT03426995|19942310|P11|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088773|NCT03426995|19942311|P10|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088774|NCT03426995|19942312|P9|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088775|NCT03426995|19942313|P8|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088776|NCT03426995|19942314|P7|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088777|NCT03426995|19942315|P6|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088778|NCT03426995|19942316|P5|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088779|NCT03426995|19942317|P4|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088780|NCT03426995|19942318|P3|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088781|NCT03426995|19942319|P2|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088782|NCT03426995|19942320|P1|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088783|NCT03426995|19942302|P19|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088784|NCT03426995|19942303|P18|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088785|NCT03426995|19942304|P17|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088786|NCT03426995|19942305|P16|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088787|NCT03426995|19942306|P15|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088788|NCT03426995|19942307|P14|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088789|NCT03426995|19942308|P13|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088790|NCT03426995|19942309|P12|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088791|NCT03426995|19942310|P11|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088792|NCT03426995|19942311|P10|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088793|NCT03426995|19942312|P9|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088794|NCT03426995|19942313|P8|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088795|NCT03426995|19942314|P7|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088796|NCT03426995|19942315|P6|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088797|NCT03426995|19942316|P5|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088798|NCT03426995|19942317|P4|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088799|NCT03426995|19942318|P3|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088800|NCT03426995|19942319|P2|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088801|NCT03426995|19942320|P1|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088802|NCT03426995|19942302|P19|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088803|NCT03426995|19942303|P18|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088804|NCT03426995|19942304|P17|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088805|NCT03426995|19942305|P16|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088806|NCT03426995|19942306|P15|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088807|NCT03426995|19942307|P14|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088808|NCT03426995|19942308|P13|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088809|NCT03426995|19942309|P12|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088810|NCT03426995|19942310|P11|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088811|NCT03426995|19942311|P10|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088812|NCT03426995|19942312|P9|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088813|NCT03426995|19942313|P8|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088814|NCT03426995|19942314|P7|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088815|NCT03426995|19942315|P6|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088816|NCT03426995|19942316|P5|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088817|NCT03426995|19942317|P4|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088818|NCT03426995|19942318|P3|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088819|NCT03426995|19942319|P2|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088820|NCT03426995|19942320|P1|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088821|NCT03426995|19942302|P19|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088822|NCT03426995|19942303|P18|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088823|NCT03426995|19942304|P17|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088824|NCT03426995|19942305|P16|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088825|NCT03426995|19942306|P15|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088826|NCT03426995|19942307|P14|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088827|NCT03426995|19942308|P13|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088828|NCT03426995|19942309|P12|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088829|NCT03426995|19942310|P11|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088830|NCT03426995|19942311|P10|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088831|NCT03426995|19942312|P9|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088832|NCT03426995|19942313|P8|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088833|NCT03426995|19942314|P7|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088834|NCT03426995|19942315|P6|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088835|NCT03426995|19942316|P5|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088836|NCT03426995|19942317|P4|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088837|NCT03426995|19942318|P3|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088838|NCT03426995|19942319|P2|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088839|NCT03426995|19942320|P1|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088840|NCT03426995|19942302|P19|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088841|NCT03426995|19942303|P18|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088842|NCT03426995|19942304|P17|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088843|NCT03426995|19942305|P16|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088844|NCT03426995|19942306|P15|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088845|NCT03426995|19942307|P14|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088846|NCT03426995|19942308|P13|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088847|NCT03426995|19942309|P12|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088848|NCT03426995|19942310|P11|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088849|NCT03426995|19942311|P10|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088850|NCT03426995|19942312|P9|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088851|NCT03426995|19942313|P8|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088852|NCT03426995|19942314|P7|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088853|NCT03426995|19942315|P6|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088854|NCT03426995|19942316|P5|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088855|NCT03426995|19942317|P4|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088856|NCT03426995|19942318|P3|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088857|NCT03426995|19942319|P2|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088858|NCT03426995|19942320|P1|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088859|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088860|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088861|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088862|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088863|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088864|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088865|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088866|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088867|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088868|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088869|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088870|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088871|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088872|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088873|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088874|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088875|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088876|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088877|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088878|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088879|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088880|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088881|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088882|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088883|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088884|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088885|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
8088886|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088887|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
8088888|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088889|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
8088890|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088891|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088892|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088893|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088894|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088895|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088896|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088897|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088898|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088899|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088900|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088901|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088902|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088903|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088904|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
8088905|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
8088906|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
8088907|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
8088908|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
8088909|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
8088910|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088911|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088912|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088913|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088914|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088915|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088916|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088917|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088918|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088919|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088920|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088921|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088922|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088923|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088924|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088925|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088926|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088927|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088928|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088929|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088930|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088931|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088932|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088933|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088934|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088935|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088936|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088937|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088938|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088939|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088940|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088941|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088942|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088943|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088944|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088945|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088946|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088947|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088948|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088949|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088950|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088951|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088952|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088953|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088954|NCT03426995|19942302|P19|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088955|NCT03426995|19942303|P18|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088956|NCT03426995|19942304|P17|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088957|NCT03426995|19942305|P16|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088958|NCT03426995|19942306|P15|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088959|NCT03426995|19942307|P14|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088960|NCT03426995|19942308|P13|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088961|NCT03426995|19942309|P12|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088962|NCT03426995|19942310|P11|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088963|NCT03426995|19942311|P10|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088964|NCT03426995|19942312|P9|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088965|NCT03426995|19942313|P8|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088966|NCT03426995|19942314|P7|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088967|NCT03426995|19942315|P6|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088968|NCT03426995|19942316|P5|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088969|NCT03426995|19942317|P4|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088970|NCT03426995|19942318|P3|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088971|NCT03426995|19942319|P2|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088972|NCT03426995|19942320|P1|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088973|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088974|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088975|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088976|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088977|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088978|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088979|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088980|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088981|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088982|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088983|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088984|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088985|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088986|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088987|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088988|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088989|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088990|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088991|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088992|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088993|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088994|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088995|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088996|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088997|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088998|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088999|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
8089000|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
8089001|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
8089002|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
8089003|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
8089004|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
8089005|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089006|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089007|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089008|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089009|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089010|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089011|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089012|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089013|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089014|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089015|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089016|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089017|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089018|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
8089019|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
8089020|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
8089021|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
8089022|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
8089023|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
8089024|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089025|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089026|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089027|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089028|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089029|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089030|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089031|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089032|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089033|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089034|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089035|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089036|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089037|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089038|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089039|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089040|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089041|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089042|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089043|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089044|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089045|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089046|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089047|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089048|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089049|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089050|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089051|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089052|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089053|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089054|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089055|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089056|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089057|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089058|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089059|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089060|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089061|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089062|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089063|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089064|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089065|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089066|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089067|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089068|NCT03426995|19942302|P19|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089069|NCT03426995|19942303|P18|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089070|NCT03426995|19942304|P17|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089071|NCT03426995|19942305|P16|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089072|NCT03426995|19942306|P15|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089073|NCT03426995|19942307|P14|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089074|NCT03426995|19942308|P13|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089075|NCT03426995|19942309|P12|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089076|NCT03426995|19942310|P11|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089077|NCT03426995|19942311|P10|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089078|NCT03426995|19942312|P9|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089079|NCT03426995|19942313|P8|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089080|NCT03426995|19942314|P7|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089081|NCT03426995|19942315|P6|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089082|NCT03426995|19942316|P5|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089083|NCT03426995|19942317|P4|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089084|NCT03426995|19942318|P3|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089085|NCT03426995|19942319|P2|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089086|NCT03426995|19942320|P1|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089087|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089088|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089089|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089090|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089091|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089092|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089093|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089094|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089095|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089096|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089097|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089098|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089099|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089100|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089101|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089102|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089103|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089104|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089105|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089106|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089107|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089108|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089109|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089110|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089111|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089112|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089113|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
8089114|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
8089115|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
8089116|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
8089117|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
8089118|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
8089119|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089120|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089121|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089122|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089123|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089124|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089125|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089126|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089127|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089128|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089129|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089130|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089131|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089132|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
8089133|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
8089134|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
8089135|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
8089136|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
8089137|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
8089138|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089139|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089140|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089141|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089142|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089143|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089144|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089145|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089146|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089147|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089148|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089149|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089150|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089151|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089152|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089153|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089154|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089155|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089156|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089157|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089158|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089159|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089160|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089161|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089162|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089163|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089164|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089165|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089166|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089167|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089168|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089169|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089170|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089171|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089172|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089173|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089174|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
8089175|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089176|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089177|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089178|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089179|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089180|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089181|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089182|NCT03426995|19942302|P19|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089183|NCT03426995|19942303|P18|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089184|NCT03426995|19942304|P17|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089185|NCT03426995|19942305|P16|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089186|NCT03426995|19942306|P15|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089187|NCT03426995|19942307|P14|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089188|NCT03426995|19942308|P13|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089189|NCT03426995|19942309|P12|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089190|NCT03426995|19942310|P11|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089191|NCT03426995|19942311|P10|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089192|NCT03426995|19942312|P9|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089193|NCT03426995|19942313|P8|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
8089194|NCT03426995|19942314|P7|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089195|NCT03426995|19942315|P6|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089196|NCT03426995|19942316|P5|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089197|NCT03426995|19942317|P4|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089198|NCT03426995|19942318|P3|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089199|NCT03426995|19942319|P2|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089200|NCT03426995|19942320|P1|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089201|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089202|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089203|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089204|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089205|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089206|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089207|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089208|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089209|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089210|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089211|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089212|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089213|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089214|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089215|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089216|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089217|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089218|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089219|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089220|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089221|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089222|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089223|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089224|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089225|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089226|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089227|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089228|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089229|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089230|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089231|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
8089232|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089233|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089234|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089235|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089236|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089237|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089238|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089239|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089240|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089241|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089242|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089243|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089244|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089245|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089246|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089247|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089248|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089249|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089250|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
8089251|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089252|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089253|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089254|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089255|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089256|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089257|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089258|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089259|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089260|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089261|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089262|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089263|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089264|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089265|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089266|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089267|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089268|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089269|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089270|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089271|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089272|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089273|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089274|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089275|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089276|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089277|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089278|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089279|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089280|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089281|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089282|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089283|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089284|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089285|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089286|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089287|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089288|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089289|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089290|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
8089291|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
8089292|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
8089293|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
8089294|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
8089295|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
8089296|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089297|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089298|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089299|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089300|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089301|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089302|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089303|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089304|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089305|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089306|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089307|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089308|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089309|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
8089310|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
8089311|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
8089312|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
8089313|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
8089314|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
8089315|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089316|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089317|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089318|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089319|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089320|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089321|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089322|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089323|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089324|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089325|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089326|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089327|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089328|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089329|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089330|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089331|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089332|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089333|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089334|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089335|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089336|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089337|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089338|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089339|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089340|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089341|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089342|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089343|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089344|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089345|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089346|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089347|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089348|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089349|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089350|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089351|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089352|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089353|NCT03426995|19942302|P19|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089354|NCT03426995|19942303|P18|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089355|NCT03426995|19942304|P17|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089356|NCT03426995|19942305|P16|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089357|NCT03426995|19942306|P15|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089358|NCT03426995|19942307|P14|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089359|NCT03426995|19942308|P13|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089360|NCT03426995|19942309|P12|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089361|NCT03426995|19942310|P11|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089362|NCT03426995|19942311|P10|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089363|NCT03426995|19942312|P9|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089364|NCT03426995|19942313|P8|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089365|NCT03426995|19942314|P7|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089366|NCT03426995|19942315|P6|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089367|NCT03426995|19942316|P5|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089368|NCT03426995|19942317|P4|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089369|NCT03426995|19942318|P3|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089370|NCT03426995|19942319|P2|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089371|NCT03426995|19942320|P1|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089372|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089373|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089374|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089375|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089376|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089377|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089378|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089379|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089380|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089381|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089382|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089383|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089384|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089385|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089386|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089387|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089388|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089389|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089390|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089391|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089392|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089393|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089394|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089395|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089396|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089397|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089398|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089399|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089400|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089401|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089402|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089403|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089404|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
8089405|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
8089406|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
8089407|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
8089408|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
8089409|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
8089410|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089411|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089412|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089413|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089414|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089415|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089416|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089417|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089418|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089419|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089420|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089421|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089422|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089423|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
8089424|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
8089425|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
8089426|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
8089427|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
8089428|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
8089429|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089430|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089431|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089432|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089433|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089434|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089435|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089436|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089437|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089438|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089439|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089440|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089441|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089442|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089443|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089444|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089445|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089446|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089447|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089448|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089449|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089450|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089451|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089452|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089453|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089454|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089455|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089456|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089457|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089458|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089459|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089460|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089461|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089462|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089463|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089464|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089465|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089466|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089467|NCT03426995|19942302|P19|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089468|NCT03426995|19942303|P18|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089469|NCT03426995|19942304|P17|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089470|NCT03426995|19942305|P16|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089471|NCT03426995|19942306|P15|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089472|NCT03426995|19942307|P14|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089473|NCT03426995|19942308|P13|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089474|NCT03426995|19942309|P12|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089475|NCT03426995|19942310|P11|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089476|NCT03426995|19942311|P10|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089477|NCT03426995|19942312|P9|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089478|NCT03426995|19942313|P8|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089479|NCT03426995|19942314|P7|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089480|NCT03426995|19942315|P6|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089481|NCT03426995|19942316|P5|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089482|NCT03426995|19942317|P4|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089483|NCT03426995|19942318|P3|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089484|NCT03426995|19942319|P2|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089485|NCT03426995|19942320|P1|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089486|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089487|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089488|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089489|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089490|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089491|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089492|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089493|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089494|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089495|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089496|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089497|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089498|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089499|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
8089500|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089501|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089502|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089503|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089504|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089505|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089506|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089507|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089508|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089509|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089510|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089511|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089512|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089513|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089514|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089515|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089516|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089517|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089518|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089519|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089520|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
8089521|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089522|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
8089523|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089524|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089525|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089526|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089527|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089528|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089529|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089530|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089531|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089532|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089533|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089534|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089535|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089536|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089537|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
8089538|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
8089539|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
8089540|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
8089541|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
8089542|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
8089543|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089544|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089545|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089546|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089547|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089548|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089549|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089550|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089551|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089552|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089553|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089554|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089555|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089556|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089557|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089558|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089559|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089560|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089561|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089562|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089563|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089564|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089565|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089566|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089567|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089568|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089569|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089570|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089571|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089572|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089573|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089574|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089575|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089576|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089655|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
8089577|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089578|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089579|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089580|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089581|NCT03426995|19942302|P19|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089582|NCT03426995|19942303|P18|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089583|NCT03426995|19942304|P17|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089584|NCT03426995|19942305|P16|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089585|NCT03426995|19942306|P15|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089586|NCT03426995|19942307|P14|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089587|NCT03426995|19942308|P13|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089588|NCT03426995|19942309|P12|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089589|NCT03426995|19942310|P11|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089590|NCT03426995|19942311|P10|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089591|NCT03426995|19942312|P9|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089592|NCT03426995|19942313|P8|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089593|NCT03426995|19942314|P7|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089594|NCT03426995|19942315|P6|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089595|NCT03426995|19942316|P5|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089596|NCT03426995|19942317|P4|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089597|NCT03426995|19942318|P3|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089598|NCT03426995|19942319|P2|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089599|NCT03426995|19942320|P1|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089600|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089601|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089602|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089603|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089604|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089605|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089606|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089607|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089608|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089609|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089610|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089611|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089612|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089613|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089614|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089615|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089616|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
8089617|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089618|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089619|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089620|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089621|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089622|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089623|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089624|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089625|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089626|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089627|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089628|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089629|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089630|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089631|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089632|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
8089633|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
8089634|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
8089635|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089636|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
8089637|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089638|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089639|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089640|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089641|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089642|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089643|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089644|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089645|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089646|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089647|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089648|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089649|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089650|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089651|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8089652|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8089653|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
8089654|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8089656|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089657|NCT03426787|19942667|P1|NOT COMPLETED|Overall Study||14
8089658|NCT03426787|19942667|P1|COMPLETED|Overall Study||56
8089659|NCT03426787|19942667|P1|STARTED|Overall Study||70
8089660|NCT03426631|19942677|P2|NOT COMPLETED|Overall Study||1
8089661|NCT03426631|19942678|P1|NOT COMPLETED|Overall Study||0
8089662|NCT03426631|19942677|P2|COMPLETED|Overall Study||5
8089663|NCT03426631|19942678|P1|COMPLETED|Overall Study||7
8089664|NCT03426631|19942677|P2|STARTED|Overall Study||6
8089665|NCT03426631|19942678|P1|STARTED|Overall Study||7
8089666|NCT03426566|19942684|P1|NOT COMPLETED|Overall Study||0
8089667|NCT03426566|19942684|P1|COMPLETED|Overall Study||974
8089668|NCT03426566|19942684|P1|STARTED|Overall Study||974
8089669|NCT03426436|19942690|P1|NOT COMPLETED|Overall Study||19
8089670|NCT03426436|19942690|P1|COMPLETED|Overall Study||295
8089671|NCT03426436|19942690|P1|STARTED|Overall Study||314
8089672|NCT03426137|19942698|P3|NOT COMPLETED|Overall Study||0
8089673|NCT03426137|19942699|P2|NOT COMPLETED|Overall Study||0
8089674|NCT03426137|19942700|P1|NOT COMPLETED|Overall Study||3
8089675|NCT03426137|19942698|P3|COMPLETED|Overall Study||0
8089676|NCT03426137|19942699|P2|COMPLETED|Overall Study||0
8089677|NCT03426137|19942700|P1|COMPLETED|Overall Study||0
8089678|NCT03426137|19942698|P3|STARTED|Overall Study||0
8089679|NCT03426137|19942699|P2|STARTED|Overall Study||0
8089680|NCT03426137|19942700|P1|STARTED|Overall Study||3
8089681|NCT03425396|19942713|P5|NOT COMPLETED|Overall Study||1
8089682|NCT03425396|19942714|P4|NOT COMPLETED|Overall Study||1
8089683|NCT03425396|19942715|P3|NOT COMPLETED|Overall Study||3
8089684|NCT03425396|19942716|P2|NOT COMPLETED|Overall Study||7
8089685|NCT03425396|19942717|P1|NOT COMPLETED|Overall Study||2
8089686|NCT03425396|19942713|P5|COMPLETED|Overall Study||53
8089687|NCT03425396|19942714|P4|COMPLETED|Overall Study||7
8089688|NCT03425396|19942715|P3|COMPLETED|Overall Study||51
8089689|NCT03425396|19942716|P2|COMPLETED|Overall Study||47
8089690|NCT03425396|19942717|P1|COMPLETED|Overall Study||53
8089691|NCT03425396|19942713|P5|Completed Final Follow-up Visit|Overall Study||53
8089692|NCT03425396|19942714|P4|Completed Final Follow-up Visit|Overall Study||7
8089693|NCT03425396|19942715|P3|Completed Final Follow-up Visit|Overall Study||51
8089694|NCT03425396|19942716|P2|Completed Final Follow-up Visit|Overall Study||47
8089695|NCT03425396|19942717|P1|Completed Final Follow-up Visit|Overall Study||53
8089696|NCT03425396|19942713|P5|Completed Post-therapy Evaluation Visit|Overall Study||54
8089697|NCT03425396|19942714|P4|Completed Post-therapy Evaluation Visit|Overall Study||7
8089698|NCT03425396|19942715|P3|Completed Post-therapy Evaluation Visit|Overall Study||51
8089699|NCT03425396|19942716|P2|Completed Post-therapy Evaluation Visit|Overall Study||49
8089700|NCT03425396|19942717|P1|Completed Post-therapy Evaluation Visit|Overall Study||53
8089701|NCT03425396|19942713|P5|Completed End of Treatment Visit|Overall Study||53
8089702|NCT03425396|19942714|P4|Completed End of Treatment Visit|Overall Study||7
8089703|NCT03425396|19942715|P3|Completed End of Treatment Visit|Overall Study||51
8089704|NCT03425396|19942716|P2|Completed End of Treatment Visit|Overall Study||52
8089705|NCT03425396|19942717|P1|Completed End of Treatment Visit|Overall Study||53
8089706|NCT03425396|19942713|P5|STARTED|Overall Study||54
8089707|NCT03425396|19942714|P4|STARTED|Overall Study||8
8089708|NCT03425396|19942715|P3|STARTED|Overall Study||54
8089709|NCT03425396|19942716|P2|STARTED|Overall Study||54
8089710|NCT03425396|19942717|P1|STARTED|Overall Study||55
8089711|NCT03425253|19942799|P1|NOT COMPLETED|Overall Study||16
8089712|NCT03425253|19942799|P1|COMPLETED|Overall Study||42
8089713|NCT03425253|19942799|P1|Evaluable Set (ES)|Overall Study||42
8089714|NCT03425253|19942799|P1|FAS|Overall Study||53
8089715|NCT03425253|19942799|P1|Safety Analysis Set|Overall Study||53
8089716|NCT03425253|19942799|P1|STARTED|Overall Study||58
8089717|NCT03424681|19942813|P2|NOT COMPLETED|Overall Study||1
8089718|NCT03424681|19942814|P1|NOT COMPLETED|Overall Study||0
8089719|NCT03424681|19942813|P2|COMPLETED|Overall Study||5
8089720|NCT03424681|19942814|P1|COMPLETED|Overall Study||6
8089721|NCT03424681|19942813|P2|STARTED|Overall Study||6
8089722|NCT03424681|19942814|P1|STARTED|Overall Study||6
8089723|NCT03424265|19942828|P2|NOT COMPLETED|Overall Study||2
8089724|NCT03424265|19942829|P1|NOT COMPLETED|Overall Study||1
8089725|NCT03424265|19942828|P2|COMPLETED|Overall Study||32
8089726|NCT03424265|19942829|P1|COMPLETED|Overall Study||28
8089727|NCT03424265|19942828|P2|STARTED|Overall Study||34
8089728|NCT03424265|19942829|P1|STARTED|Overall Study||29
8089729|NCT03424044|19942835|P9|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089730|NCT03424044|19942836|P8|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089731|NCT03424044|19942837|P7|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089732|NCT03424044|19942838|P6|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089733|NCT03424044|19942839|P5|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089734|NCT03424044|19942840|P4|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089735|NCT03424044|19942841|P3|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089736|NCT03424044|19942842|P2|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089737|NCT03424044|19942843|P1|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089738|NCT03424044|19942835|P9|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
8089739|NCT03424044|19942836|P8|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
8089740|NCT03424044|19942837|P7|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089741|NCT03424044|19942838|P6|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089742|NCT03424044|19942839|P5|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089743|NCT03424044|19942840|P4|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089744|NCT03424044|19942841|P3|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089745|NCT03424044|19942842|P2|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089746|NCT03424044|19942843|P1|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089747|NCT03424044|19942835|P9|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
8089748|NCT03424044|19942836|P8|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
8089749|NCT03424044|19942837|P7|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089750|NCT03424044|19942838|P6|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089751|NCT03424044|19942839|P5|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089752|NCT03424044|19942840|P4|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089753|NCT03424044|19942841|P3|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089754|NCT03424044|19942842|P2|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089755|NCT03424044|19942843|P1|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089756|NCT03424044|19942835|P9|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089757|NCT03424044|19942836|P8|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089758|NCT03424044|19942837|P7|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089759|NCT03424044|19942838|P6|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089760|NCT03424044|19942839|P5|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089761|NCT03424044|19942840|P4|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089762|NCT03424044|19942841|P3|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089763|NCT03424044|19942842|P2|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089764|NCT03424044|19942843|P1|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089765|NCT03424044|19942835|P9|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
8089766|NCT03424044|19942836|P8|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
8089767|NCT03424044|19942837|P7|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089768|NCT03424044|19942838|P6|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089769|NCT03424044|19942839|P5|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089770|NCT03424044|19942840|P4|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089771|NCT03424044|19942841|P3|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089772|NCT03424044|19942842|P2|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089773|NCT03424044|19942843|P1|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089774|NCT03424044|19942835|P9|STARTED|Optional Fourth Rest Period (7-45 Days)||1
8089775|NCT03424044|19942836|P8|STARTED|Optional Fourth Rest Period (7-45 Days)||1
8089776|NCT03424044|19942837|P7|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089777|NCT03424044|19942838|P6|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089778|NCT03424044|19942839|P5|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089779|NCT03424044|19942840|P4|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089780|NCT03424044|19942841|P3|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089781|NCT03424044|19942842|P2|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089782|NCT03424044|19942843|P1|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089783|NCT03424044|19942835|P9|NOT COMPLETED|Third Intervention (76 Hours)||0
8089784|NCT03424044|19942836|P8|NOT COMPLETED|Third Intervention (76 Hours)||0
8089785|NCT03424044|19942837|P7|NOT COMPLETED|Third Intervention (76 Hours)||1
8089786|NCT03424044|19942838|P6|NOT COMPLETED|Third Intervention (76 Hours)||0
8089787|NCT03424044|19942839|P5|NOT COMPLETED|Third Intervention (76 Hours)||0
8089788|NCT03424044|19942840|P4|NOT COMPLETED|Third Intervention (76 Hours)||1
8089789|NCT03424044|19942841|P3|NOT COMPLETED|Third Intervention (76 Hours)||0
8089790|NCT03424044|19942842|P2|NOT COMPLETED|Third Intervention (76 Hours)||0
8089791|NCT03424044|19942843|P1|NOT COMPLETED|Third Intervention (76 Hours)||1
8089792|NCT03424044|19942835|P9|COMPLETED|Third Intervention (76 Hours)||1
8089793|NCT03424044|19942836|P8|COMPLETED|Third Intervention (76 Hours)||1
8089794|NCT03424044|19942837|P7|COMPLETED|Third Intervention (76 Hours)||0
8089795|NCT03424044|19942838|P6|COMPLETED|Third Intervention (76 Hours)||4
8089796|NCT03424044|19942839|P5|COMPLETED|Third Intervention (76 Hours)||2
8089797|NCT03424044|19942840|P4|COMPLETED|Third Intervention (76 Hours)||2
8089798|NCT03424044|19942841|P3|COMPLETED|Third Intervention (76 Hours)||2
8089799|NCT03424044|19942842|P2|COMPLETED|Third Intervention (76 Hours)||3
8089800|NCT03424044|19942843|P1|COMPLETED|Third Intervention (76 Hours)||3
8089801|NCT03424044|19942835|P9|STARTED|Third Intervention (76 Hours)||1
8089802|NCT03424044|19942836|P8|STARTED|Third Intervention (76 Hours)||1
8089803|NCT03424044|19942837|P7|STARTED|Third Intervention (76 Hours)||1
8089804|NCT03424044|19942838|P6|STARTED|Third Intervention (76 Hours)||4
8089805|NCT03424044|19942839|P5|STARTED|Third Intervention (76 Hours)||2
8089806|NCT03424044|19942840|P4|STARTED|Third Intervention (76 Hours)||3
8089807|NCT03424044|19942841|P3|STARTED|Third Intervention (76 Hours)||2
8089808|NCT03424044|19942842|P2|STARTED|Third Intervention (76 Hours)||3
8089809|NCT03424044|19942843|P1|STARTED|Third Intervention (76 Hours)||4
8089810|NCT03424044|19942835|P9|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089811|NCT03424044|19942836|P8|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089812|NCT03424044|19942837|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089813|NCT03424044|19942838|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089814|NCT03424044|19942839|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089815|NCT03424044|19942840|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089816|NCT03424044|19942841|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089817|NCT03424044|19942842|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089818|NCT03424044|19942843|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089819|NCT03424044|19942835|P9|COMPLETED|Third Rest Period (7-45 Days)||1
8089820|NCT03424044|19942836|P8|COMPLETED|Third Rest Period (7-45 Days)||1
8089821|NCT03424044|19942837|P7|COMPLETED|Third Rest Period (7-45 Days)||1
8089822|NCT03424044|19942838|P6|COMPLETED|Third Rest Period (7-45 Days)||4
8089823|NCT03424044|19942839|P5|COMPLETED|Third Rest Period (7-45 Days)||2
8089824|NCT03424044|19942840|P4|COMPLETED|Third Rest Period (7-45 Days)||3
8089825|NCT03424044|19942841|P3|COMPLETED|Third Rest Period (7-45 Days)||2
8089826|NCT03424044|19942842|P2|COMPLETED|Third Rest Period (7-45 Days)||3
8089827|NCT03424044|19942843|P1|COMPLETED|Third Rest Period (7-45 Days)||4
8089828|NCT03424044|19942835|P9|STARTED|Third Rest Period (7-45 Days)||1
8089829|NCT03424044|19942836|P8|STARTED|Third Rest Period (7-45 Days)||1
8089830|NCT03424044|19942837|P7|STARTED|Third Rest Period (7-45 Days)||1
8089831|NCT03424044|19942838|P6|STARTED|Third Rest Period (7-45 Days)||4
8089832|NCT03424044|19942839|P5|STARTED|Third Rest Period (7-45 Days)||2
8089833|NCT03424044|19942840|P4|STARTED|Third Rest Period (7-45 Days)||3
8089834|NCT03424044|19942841|P3|STARTED|Third Rest Period (7-45 Days)||2
8089835|NCT03424044|19942842|P2|STARTED|Third Rest Period (7-45 Days)||3
8089836|NCT03424044|19942843|P1|STARTED|Third Rest Period (7-45 Days)||4
8089837|NCT03424044|19942835|P9|NOT COMPLETED|Second Intervention (76 Hours)||0
8089838|NCT03424044|19942836|P8|NOT COMPLETED|Second Intervention (76 Hours)||0
8089839|NCT03424044|19942837|P7|NOT COMPLETED|Second Intervention (76 Hours)||0
8089840|NCT03424044|19942838|P6|NOT COMPLETED|Second Intervention (76 Hours)||0
8089841|NCT03424044|19942839|P5|NOT COMPLETED|Second Intervention (76 Hours)||0
8089842|NCT03424044|19942840|P4|NOT COMPLETED|Second Intervention (76 Hours)||0
8089843|NCT03424044|19942841|P3|NOT COMPLETED|Second Intervention (76 Hours)||0
8089844|NCT03424044|19942842|P2|NOT COMPLETED|Second Intervention (76 Hours)||0
8089845|NCT03424044|19942843|P1|NOT COMPLETED|Second Intervention (76 Hours)||0
8089846|NCT03424044|19942835|P9|COMPLETED|Second Intervention (76 Hours)||1
8089847|NCT03424044|19942836|P8|COMPLETED|Second Intervention (76 Hours)||1
8089848|NCT03424044|19942837|P7|COMPLETED|Second Intervention (76 Hours)||1
8089849|NCT03424044|19942838|P6|COMPLETED|Second Intervention (76 Hours)||4
8089850|NCT03424044|19942839|P5|COMPLETED|Second Intervention (76 Hours)||2
8089851|NCT03424044|19942840|P4|COMPLETED|Second Intervention (76 Hours)||3
8089852|NCT03424044|19942841|P3|COMPLETED|Second Intervention (76 Hours)||2
8089853|NCT03424044|19942842|P2|COMPLETED|Second Intervention (76 Hours)||3
8089854|NCT03424044|19942843|P1|COMPLETED|Second Intervention (76 Hours)||4
8089855|NCT03424044|19942835|P9|STARTED|Second Intervention (76 Hours)||1
8089856|NCT03424044|19942836|P8|STARTED|Second Intervention (76 Hours)||1
8089857|NCT03424044|19942837|P7|STARTED|Second Intervention (76 Hours)||1
8089858|NCT03424044|19942838|P6|STARTED|Second Intervention (76 Hours)||4
8089859|NCT03424044|19942839|P5|STARTED|Second Intervention (76 Hours)||2
8089860|NCT03424044|19942840|P4|STARTED|Second Intervention (76 Hours)||3
8089861|NCT03424044|19942841|P3|STARTED|Second Intervention (76 Hours)||2
8089862|NCT03424044|19942842|P2|STARTED|Second Intervention (76 Hours)||3
8089863|NCT03424044|19942843|P1|STARTED|Second Intervention (76 Hours)||4
8089864|NCT03424044|19942835|P9|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089865|NCT03424044|19942836|P8|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089866|NCT03424044|19942837|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089867|NCT03424044|19942838|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089868|NCT03424044|19942839|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089869|NCT03424044|19942840|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089870|NCT03424044|19942841|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089871|NCT03424044|19942842|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089872|NCT03424044|19942843|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089873|NCT03424044|19942835|P9|COMPLETED|Second Rest Period (7-45 Days)||1
8089874|NCT03424044|19942836|P8|COMPLETED|Second Rest Period (7-45 Days)||1
8089875|NCT03424044|19942837|P7|COMPLETED|Second Rest Period (7-45 Days)||1
8089876|NCT03424044|19942838|P6|COMPLETED|Second Rest Period (7-45 Days)||4
8089877|NCT03424044|19942839|P5|COMPLETED|Second Rest Period (7-45 Days)||2
8089878|NCT03424044|19942840|P4|COMPLETED|Second Rest Period (7-45 Days)||3
8089879|NCT03424044|19942841|P3|COMPLETED|Second Rest Period (7-45 Days)||2
8089880|NCT03424044|19942842|P2|COMPLETED|Second Rest Period (7-45 Days)||3
8089881|NCT03424044|19942843|P1|COMPLETED|Second Rest Period (7-45 Days)||4
8089882|NCT03424044|19942835|P9|STARTED|Second Rest Period (7-45 Days)||1
8089883|NCT03424044|19942836|P8|STARTED|Second Rest Period (7-45 Days)||1
8089884|NCT03424044|19942837|P7|STARTED|Second Rest Period (7-45 Days)||1
8089885|NCT03424044|19942838|P6|STARTED|Second Rest Period (7-45 Days)||4
8089886|NCT03424044|19942839|P5|STARTED|Second Rest Period (7-45 Days)||2
8089887|NCT03424044|19942840|P4|STARTED|Second Rest Period (7-45 Days)||3
8089888|NCT03424044|19942841|P3|STARTED|Second Rest Period (7-45 Days)||2
8089889|NCT03424044|19942842|P2|STARTED|Second Rest Period (7-45 Days)||3
8089890|NCT03424044|19942843|P1|STARTED|Second Rest Period (7-45 Days)||4
8089891|NCT03424044|19942835|P9|NOT COMPLETED|First Intervention (76 Hours)||1
8089892|NCT03424044|19942836|P8|NOT COMPLETED|First Intervention (76 Hours)||1
8089893|NCT03424044|19942837|P7|NOT COMPLETED|First Intervention (76 Hours)||1
8089894|NCT03424044|19942838|P6|NOT COMPLETED|First Intervention (76 Hours)||0
8089895|NCT03424044|19942839|P5|NOT COMPLETED|First Intervention (76 Hours)||1
8089896|NCT03424044|19942840|P4|NOT COMPLETED|First Intervention (76 Hours)||0
8089897|NCT03424044|19942841|P3|NOT COMPLETED|First Intervention (76 Hours)||0
8089898|NCT03424044|19942842|P2|NOT COMPLETED|First Intervention (76 Hours)||0
8089899|NCT03424044|19942843|P1|NOT COMPLETED|First Intervention (76 Hours)||0
8089900|NCT03424044|19942835|P9|COMPLETED|First Intervention (76 Hours)||0
8089901|NCT03424044|19942836|P8|COMPLETED|First Intervention (76 Hours)||0
8089902|NCT03424044|19942837|P7|COMPLETED|First Intervention (76 Hours)||0
8089903|NCT03424044|19942838|P6|COMPLETED|First Intervention (76 Hours)||4
8089904|NCT03424044|19942839|P5|COMPLETED|First Intervention (76 Hours)||2
8089905|NCT03424044|19942840|P4|COMPLETED|First Intervention (76 Hours)||3
8089906|NCT03424044|19942841|P3|COMPLETED|First Intervention (76 Hours)||2
8089907|NCT03424044|19942842|P2|COMPLETED|First Intervention (76 Hours)||3
8089908|NCT03424044|19942843|P1|COMPLETED|First Intervention (76 Hours)||4
8089909|NCT03424044|19942835|P9|STARTED|First Intervention (76 Hours)||1
8089910|NCT03424044|19942836|P8|STARTED|First Intervention (76 Hours)||1
8089911|NCT03424044|19942837|P7|STARTED|First Intervention (76 Hours)||1
8089912|NCT03424044|19942838|P6|STARTED|First Intervention (76 Hours)||4
8089913|NCT03424044|19942839|P5|STARTED|First Intervention (76 Hours)||3
8089914|NCT03424044|19942840|P4|STARTED|First Intervention (76 Hours)||3
8089915|NCT03424044|19942841|P3|STARTED|First Intervention (76 Hours)||2
8089916|NCT03424044|19942842|P2|STARTED|First Intervention (76 Hours)||3
8089917|NCT03424044|19942843|P1|STARTED|First Intervention (76 Hours)||4
8089918|NCT03424044|19942835|P9|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089919|NCT03424044|19942836|P8|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089920|NCT03424044|19942837|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089921|NCT03424044|19942838|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089922|NCT03424044|19942839|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089923|NCT03424044|19942840|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089924|NCT03424044|19942841|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
8089925|NCT03424044|19942842|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089926|NCT03424044|19942843|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089927|NCT03424044|19942835|P9|COMPLETED|First Rest Period (1-12 Weeks)||1
8089928|NCT03424044|19942836|P8|COMPLETED|First Rest Period (1-12 Weeks)||1
8089929|NCT03424044|19942837|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
8089930|NCT03424044|19942838|P6|COMPLETED|First Rest Period (1-12 Weeks)||4
8089931|NCT03424044|19942839|P5|COMPLETED|First Rest Period (1-12 Weeks)||3
8089932|NCT03424044|19942840|P4|COMPLETED|First Rest Period (1-12 Weeks)||3
8089933|NCT03424044|19942841|P3|COMPLETED|First Rest Period (1-12 Weeks)||2
8089934|NCT03424044|19942842|P2|COMPLETED|First Rest Period (1-12 Weeks)||3
8089935|NCT03424044|19942843|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
8089936|NCT03424044|19942835|P9|STARTED|First Rest Period (1-12 Weeks)||1
8089937|NCT03424044|19942836|P8|STARTED|First Rest Period (1-12 Weeks)||1
8089938|NCT03424044|19942837|P7|STARTED|First Rest Period (1-12 Weeks)||1
8089939|NCT03424044|19942838|P6|STARTED|First Rest Period (1-12 Weeks)||4
8089940|NCT03424044|19942839|P5|STARTED|First Rest Period (1-12 Weeks)||3
8089941|NCT03424044|19942840|P4|STARTED|First Rest Period (1-12 Weeks)||3
8089942|NCT03424044|19942841|P3|STARTED|First Rest Period (1-12 Weeks)||3
8089943|NCT03424044|19942842|P2|STARTED|First Rest Period (1-12 Weeks)||3
8089944|NCT03424044|19942843|P1|STARTED|First Rest Period (1-12 Weeks)||4
8089945|NCT03424044|19942835|P9|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089946|NCT03424044|19942836|P8|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089947|NCT03424044|19942837|P7|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089948|NCT03424044|19942838|P6|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089949|NCT03424044|19942839|P5|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089950|NCT03424044|19942840|P4|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089951|NCT03424044|19942841|P3|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089952|NCT03424044|19942842|P2|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089953|NCT03424044|19942843|P1|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089954|NCT03424044|19942835|P9|COMPLETED|Dexcom Training Visit (1 Week)||1
8089955|NCT03424044|19942836|P8|COMPLETED|Dexcom Training Visit (1 Week)||1
8089956|NCT03424044|19942837|P7|COMPLETED|Dexcom Training Visit (1 Week)||1
8089957|NCT03424044|19942838|P6|COMPLETED|Dexcom Training Visit (1 Week)||4
8089958|NCT03424044|19942839|P5|COMPLETED|Dexcom Training Visit (1 Week)||3
8089959|NCT03424044|19942840|P4|COMPLETED|Dexcom Training Visit (1 Week)||3
8089960|NCT03424044|19942841|P3|COMPLETED|Dexcom Training Visit (1 Week)||3
8089961|NCT03424044|19942842|P2|COMPLETED|Dexcom Training Visit (1 Week)||3
8089962|NCT03424044|19942843|P1|COMPLETED|Dexcom Training Visit (1 Week)||4
8089963|NCT03424044|19942835|P9|STARTED|Dexcom Training Visit (1 Week)||1
8089964|NCT03424044|19942836|P8|STARTED|Dexcom Training Visit (1 Week)||1
8089965|NCT03424044|19942837|P7|STARTED|Dexcom Training Visit (1 Week)||1
8089966|NCT03424044|19942838|P6|STARTED|Dexcom Training Visit (1 Week)||4
8089967|NCT03424044|19942839|P5|STARTED|Dexcom Training Visit (1 Week)||3
8089968|NCT03424044|19942840|P4|STARTED|Dexcom Training Visit (1 Week)||3
8089969|NCT03424044|19942841|P3|STARTED|Dexcom Training Visit (1 Week)||3
8089970|NCT03424044|19942842|P2|STARTED|Dexcom Training Visit (1 Week)||3
8089971|NCT03424044|19942843|P1|STARTED|Dexcom Training Visit (1 Week)||4
8089972|NCT03423654|19942870|P2|NOT COMPLETED|Overall Study||0
8089973|NCT03423654|19942871|P1|NOT COMPLETED|Overall Study||0
8089974|NCT03423654|19942870|P2|COMPLETED|Overall Study||3
8089975|NCT03423654|19942871|P1|COMPLETED|Overall Study||3
8089976|NCT03423654|19942870|P2|STARTED|Overall Study||3
8089977|NCT03423654|19942871|P1|STARTED|Overall Study||3
8089978|NCT03423641|19942879|P2|NOT COMPLETED|Overall Study||8074
8089979|NCT03423641|19942880|P1|NOT COMPLETED|Overall Study||331
8089980|NCT03423641|19942879|P2|COMPLETED|Overall Study||10210
8089981|NCT03423641|19942880|P1|COMPLETED|Overall Study||15193
8089982|NCT03423641|19942879|P2|STARTED|Overall Study||18284
8089983|NCT03423641|19942880|P1|STARTED|Overall Study||15524
8089984|NCT03423173|19942915|P4|NOT COMPLETED|Overall Study||30
8089985|NCT03423173|19942916|P3|NOT COMPLETED|Overall Study||27
8089986|NCT03423173|19942917|P2|NOT COMPLETED|Overall Study||35
8089987|NCT03423173|19942918|P1|NOT COMPLETED|Overall Study||19
8089988|NCT03423173|19942915|P4|COMPLETED|Overall Study||234
8089989|NCT03423173|19942916|P3|COMPLETED|Overall Study||237
8089990|NCT03423173|19942917|P2|COMPLETED|Overall Study||228
8089991|NCT03423173|19942918|P1|COMPLETED|Overall Study||113
8089992|NCT03423173|19942915|P4|Received at Least 1 Dose of the IP|Overall Study||263
8089993|NCT03423173|19942916|P3|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
8089994|NCT03423173|19942917|P2|Received at Least 1 Dose of the IP|Overall Study||263
8089995|NCT03423173|19942918|P1|Received at Least 1 Dose of the IP|Overall Study||131
8089996|NCT03423173|19942915|P4|STARTED|Overall Study||264
8089997|NCT03423173|19942916|P3|STARTED|Overall Study||264
8089998|NCT03423173|19942917|P2|STARTED|Overall Study||263
8089999|NCT03423173|19942918|P1|STARTED|Overall Study||132
8090000|NCT03423082|19942956|P1|NOT COMPLETED|Overall Study||0
8090001|NCT03423082|19942956|P1|COMPLETED|Overall Study||1
8090002|NCT03423082|19942956|P1|STARTED|Overall Study||1
8090003|NCT03421886|19942965|P2|NOT COMPLETED|Overall Study||2
8090004|NCT03421886|19942966|P1|NOT COMPLETED|Overall Study||7
8090005|NCT03421886|19942965|P2|COMPLETED|Overall Study||13
8090006|NCT03421886|19942966|P1|COMPLETED|Overall Study||23
8090007|NCT03421886|19942965|P2|STARTED|Overall Study||15
8090008|NCT03421886|19942966|P1|STARTED|Overall Study||30
8090009|NCT03421730|19942972|P12|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090010|NCT03421730|19942973|P11|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090011|NCT03421730|19942974|P10|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090012|NCT03421730|19942975|P9|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090013|NCT03421730|19942976|P8|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090014|NCT03421730|19942977|P7|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090015|NCT03421730|19942978|P6|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090016|NCT03421730|19942979|P5|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090017|NCT03421730|19942980|P4|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090018|NCT03421730|19942981|P3|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090019|NCT03421730|19942982|P2|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090020|NCT03421730|19942983|P1|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090021|NCT03421730|19942972|P12|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090022|NCT03421730|19942973|P11|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090023|NCT03421730|19942974|P10|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
8090024|NCT03421730|19942975|P9|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090025|NCT03421730|19942976|P8|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090026|NCT03421730|19942977|P7|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090027|NCT03421730|19942978|P6|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090028|NCT03421730|19942979|P5|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090029|NCT03421730|19942980|P4|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090030|NCT03421730|19942981|P3|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090031|NCT03421730|19942982|P2|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090032|NCT03421730|19942983|P1|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090033|NCT03421730|19942972|P12|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090034|NCT03421730|19942973|P11|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090035|NCT03421730|19942974|P10|STARTED|Second Intervention (Day 8±3, Visit 3)||2
8090036|NCT03421730|19942975|P9|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090037|NCT03421730|19942976|P8|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090038|NCT03421730|19942977|P7|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090039|NCT03421730|19942978|P6|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090040|NCT03421730|19942979|P5|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090041|NCT03421730|19942980|P4|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090042|NCT03421730|19942981|P3|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090043|NCT03421730|19942982|P2|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090044|NCT03421730|19942983|P1|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090045|NCT03421730|19942972|P12|NOT COMPLETED|Washout (Days 4 to 10)||0
8090046|NCT03421730|19942973|P11|NOT COMPLETED|Washout (Days 4 to 10)||0
8090047|NCT03421730|19942974|P10|NOT COMPLETED|Washout (Days 4 to 10)||0
8090048|NCT03421730|19942975|P9|NOT COMPLETED|Washout (Days 4 to 10)||0
8090049|NCT03421730|19942976|P8|NOT COMPLETED|Washout (Days 4 to 10)||0
8090050|NCT03421730|19942977|P7|NOT COMPLETED|Washout (Days 4 to 10)||0
8090051|NCT03421730|19942978|P6|NOT COMPLETED|Washout (Days 4 to 10)||0
8090052|NCT03421730|19942979|P5|NOT COMPLETED|Washout (Days 4 to 10)||2
8090053|NCT03421730|19942980|P4|NOT COMPLETED|Washout (Days 4 to 10)||0
8090054|NCT03421730|19942981|P3|NOT COMPLETED|Washout (Days 4 to 10)||0
8090055|NCT03421730|19942982|P2|NOT COMPLETED|Washout (Days 4 to 10)||0
8090056|NCT03421730|19942983|P1|NOT COMPLETED|Washout (Days 4 to 10)||0
8090057|NCT03421730|19942972|P12|COMPLETED|Washout (Days 4 to 10)||1
8090058|NCT03421730|19942973|P11|COMPLETED|Washout (Days 4 to 10)||1
8090059|NCT03421730|19942974|P10|COMPLETED|Washout (Days 4 to 10)||2
8090060|NCT03421730|19942975|P9|COMPLETED|Washout (Days 4 to 10)||1
8090061|NCT03421730|19942976|P8|COMPLETED|Washout (Days 4 to 10)||1
8090062|NCT03421730|19942977|P7|COMPLETED|Washout (Days 4 to 10)||1
8090063|NCT03421730|19942978|P6|COMPLETED|Washout (Days 4 to 10)||1
8090064|NCT03421730|19942979|P5|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
8090065|NCT03421730|19942980|P4|COMPLETED|Washout (Days 4 to 10)||1
8090066|NCT03421730|19942981|P3|COMPLETED|Washout (Days 4 to 10)||1
8090067|NCT03421730|19942982|P2|COMPLETED|Washout (Days 4 to 10)||1
8090068|NCT03421730|19942983|P1|COMPLETED|Washout (Days 4 to 10)||1
8090069|NCT03421730|19942972|P12|STARTED|Washout (Days 4 to 10)||1
8090070|NCT03421730|19942973|P11|STARTED|Washout (Days 4 to 10)||1
8090071|NCT03421730|19942974|P10|STARTED|Washout (Days 4 to 10)||2
8090072|NCT03421730|19942975|P9|STARTED|Washout (Days 4 to 10)||1
8090073|NCT03421730|19942976|P8|STARTED|Washout (Days 4 to 10)||1
8090074|NCT03421730|19942977|P7|STARTED|Washout (Days 4 to 10)||1
8090075|NCT03421730|19942978|P6|STARTED|Washout (Days 4 to 10)||1
8090076|NCT03421730|19942979|P5|STARTED|Washout (Days 4 to 10)||3
8090077|NCT03421730|19942980|P4|STARTED|Washout (Days 4 to 10)||1
8090078|NCT03421730|19942981|P3|STARTED|Washout (Days 4 to 10)||1
8090079|NCT03421730|19942982|P2|STARTED|Washout (Days 4 to 10)||1
8090080|NCT03421730|19942983|P1|STARTED|Washout (Days 4 to 10)||1
8090081|NCT03421730|19942972|P12|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090082|NCT03421730|19942973|P11|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090083|NCT03421730|19942974|P10|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090084|NCT03421730|19942975|P9|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090085|NCT03421730|19942976|P8|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090086|NCT03421730|19942977|P7|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090087|NCT03421730|19942978|P6|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090088|NCT03421730|19942979|P5|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090089|NCT03421730|19942980|P4|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090090|NCT03421730|19942981|P3|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090091|NCT03421730|19942982|P2|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
8090092|NCT03421730|19942983|P1|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090093|NCT03421730|19942972|P12|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090094|NCT03421730|19942973|P11|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090095|NCT03421730|19942974|P10|COMPLETED|First Intervention (Day 1, Visit 2)||2
8090096|NCT03421730|19942975|P9|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090097|NCT03421730|19942976|P8|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090098|NCT03421730|19942977|P7|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090099|NCT03421730|19942978|P6|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090100|NCT03421730|19942979|P5|COMPLETED|First Intervention (Day 1, Visit 2)||3
8090101|NCT03421730|19942980|P4|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090102|NCT03421730|19942981|P3|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090103|NCT03421730|19942982|P2|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
8090104|NCT03421730|19942983|P1|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090105|NCT03421730|19942972|P12|STARTED|First Intervention (Day 1, Visit 2)||1
8090106|NCT03421730|19942973|P11|STARTED|First Intervention (Day 1, Visit 2)||1
8090107|NCT03421730|19942974|P10|STARTED|First Intervention (Day 1, Visit 2)||2
8090108|NCT03421730|19942975|P9|STARTED|First Intervention (Day 1, Visit 2)||1
8090109|NCT03421730|19942976|P8|STARTED|First Intervention (Day 1, Visit 2)||1
8090110|NCT03421730|19942977|P7|STARTED|First Intervention (Day 1, Visit 2)||1
8090111|NCT03421730|19942978|P6|STARTED|First Intervention (Day 1, Visit 2)||1
8090112|NCT03421730|19942979|P5|STARTED|First Intervention (Day 1, Visit 2)||3
8090113|NCT03421730|19942980|P4|STARTED|First Intervention (Day 1, Visit 2)||1
8090114|NCT03421730|19942981|P3|STARTED|First Intervention (Day 1, Visit 2)||1
8090115|NCT03421730|19942982|P2|STARTED|First Intervention (Day 1, Visit 2)||3
8090116|NCT03421730|19942983|P1|STARTED|First Intervention (Day 1, Visit 2)||1
8090117|NCT03421379|19943056|P2|NOT COMPLETED|Period 2||0
8090118|NCT03421379|19943057|P1|NOT COMPLETED|Period 2||0
8090119|NCT03421379|19943056|P2|COMPLETED|Period 2||37
8090120|NCT03421379|19943057|P1|COMPLETED|Period 2||32
8090121|NCT03421379|19943056|P2|STARTED|Period 2||37
8090122|NCT03421379|19943057|P1|STARTED|Period 2||32
8090123|NCT03421379|19943056|P2|NOT COMPLETED|Washout Period (3 to 14 Days)||0
8090124|NCT03421379|19943057|P1|NOT COMPLETED|Washout Period (3 to 14 Days)||0
8090125|NCT03421379|19943056|P2|COMPLETED|Washout Period (3 to 14 Days)||37
8090126|NCT03421379|19943057|P1|COMPLETED|Washout Period (3 to 14 Days)||32
8090127|NCT03421379|19943056|P2|STARTED|Washout Period (3 to 14 Days)||37
8090128|NCT03421379|19943057|P1|STARTED|Washout Period (3 to 14 Days)||32
8090129|NCT03421379|19943056|P2|NOT COMPLETED|Period 1||4
8090130|NCT03421379|19943057|P1|NOT COMPLETED|Period 1||2
8090131|NCT03421379|19943056|P2|COMPLETED|Period 1||37
8090132|NCT03421379|19943057|P1|COMPLETED|Period 1||32
8090133|NCT03421379|19943056|P2|Received at Least One Dose of Study Drug|Period 1||39
8090134|NCT03421379|19943057|P1|Received at Least One Dose of Study Drug|Period 1||33
8090135|NCT03421379|19943056|P2|STARTED|Period 1||41
8090136|NCT03421379|19943057|P1|STARTED|Period 1||34
8090137|NCT03421210|19943073|P1|NOT COMPLETED|Overall Study||53
8090138|NCT03421210|19943073|P1|COMPLETED|Overall Study||35
8090139|NCT03421210|19943073|P1|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
8090140|NCT03421210|19943073|P1|STARTED|Overall Study||88
8090141|NCT03420625|19943079|P1|NOT COMPLETED|Overall Study||0
8090142|NCT03420625|19943079|P1|COMPLETED|Overall Study||10
8090143|NCT03420625|19943079|P1|Calf NMES|Overall Study||10
8090144|NCT03420625|19943079|P1|Slow Calf IPC|Overall Study||10
8090145|NCT03420625|19943079|P1|Rapid Calf IPC|Overall Study||10
8090146|NCT03420625|19943079|P1|Foot IPC|Overall Study||10
8090147|NCT03420625|19943079|P1|Baseline|Overall Study||10
8090148|NCT03420625|19943079|P1|STARTED|Overall Study||10
8090149|NCT03420300|19943109|P1|NOT COMPLETED|Overall Study||2
8090150|NCT03420300|19943109|P1|COMPLETED|Overall Study||38
8090151|NCT03420300|19943109|P1|STARTED|Overall Study||40
8090152|NCT03419962|19943118|P1|NOT COMPLETED|Overall Study||37
8090153|NCT03419962|19943118|P1|COMPLETED|Overall Study||1322
8090154|NCT03419962|19943118|P1|STARTED|Overall Study||1359
8090155|NCT03419780|19943130|P2|NOT COMPLETED|Overall Study||0
8090156|NCT03419780|19943131|P1|NOT COMPLETED|Overall Study||0
8090157|NCT03419780|19943130|P2|COMPLETED|Overall Study||33
8090158|NCT03419780|19943131|P1|COMPLETED|Overall Study||33
8090159|NCT03419780|19943130|P2|STARTED|Overall Study||33
8090160|NCT03419780|19943131|P1|STARTED|Overall Study||33
8090161|NCT03419598|19943149|P1|NOT COMPLETED|Overall Study||2
8090162|NCT03419598|19943149|P1|COMPLETED|Overall Study||28
8090163|NCT03419598|19943149|P1|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
8090164|NCT03419598|19943149|P1|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
8090165|NCT03419598|19943149|P1|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
8090166|NCT03419598|19943149|P1|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
8090167|NCT03419598|19943149|P1|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
8090168|NCT03419598|19943149|P1|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
8090169|NCT03419598|19943149|P1|STARTED|Overall Study||30
8090170|NCT03419078|19943159|P3|NOT COMPLETED|Overall Study||0
8090171|NCT03419078|19943160|P2|NOT COMPLETED|Overall Study||0
8090172|NCT03419078|19943161|P1|NOT COMPLETED|Overall Study||0
8090173|NCT03419078|19943159|P3|COMPLETED|Overall Study||91
8090174|NCT03419078|19943160|P2|COMPLETED|Overall Study||148
8090175|NCT03419078|19943161|P1|COMPLETED|Overall Study||245
8090176|NCT03419078|19943159|P3|STARTED|Overall Study||91
8090177|NCT03419078|19943160|P2|STARTED|Overall Study||148
8090178|NCT03419078|19943161|P1|STARTED|Overall Study||245
8090179|NCT03418662|19943180|P2|NOT COMPLETED|Overall Study||4
8090180|NCT03418662|19943181|P1|NOT COMPLETED|Overall Study||3
8090181|NCT03418662|19943180|P2|COMPLETED|Overall Study||278
8090182|NCT03418662|19943181|P1|COMPLETED|Overall Study||284
8090183|NCT03418662|19943180|P2|STARTED|Overall Study||282
8090184|NCT03418662|19943181|P1|STARTED|Overall Study||287
8090185|NCT03418571|19943205|P2|NOT COMPLETED|Overall Study||0
8090186|NCT03418571|19943206|P1|NOT COMPLETED|Overall Study||1
8090187|NCT03418571|19943205|P2|COMPLETED|Overall Study||3
8090188|NCT03418571|19943206|P1|COMPLETED|Overall Study||11
8090189|NCT03418571|19943205|P2|STARTED|Overall Study||3
8090190|NCT03418571|19943206|P1|STARTED|Overall Study||12
8090191|NCT03418376|19943218|P4|NOT COMPLETED|Overall Study||1
8090192|NCT03418376|19943219|P3|NOT COMPLETED|Overall Study||3
8090193|NCT03418376|19943220|P2|NOT COMPLETED|Overall Study||5
8090194|NCT03418376|19943221|P1|NOT COMPLETED|Overall Study||1
8090195|NCT03418376|19943218|P4|COMPLETED|Overall Study||10
8090196|NCT03418376|19943219|P3|COMPLETED|Overall Study||8
8090197|NCT03418376|19943220|P2|COMPLETED|Overall Study||6
8090198|NCT03418376|19943221|P1|COMPLETED|Overall Study||11
8090199|NCT03418376|19943218|P4|STARTED|Overall Study||11
8090200|NCT03418376|19943219|P3|STARTED|Overall Study||11
8090201|NCT03418376|19943220|P2|STARTED|Overall Study||11
8090202|NCT03418376|19943221|P1|STARTED|Overall Study||12
8090203|NCT03418324|19943249|P2|NOT COMPLETED|Overall Study||2
8090204|NCT03418324|19943250|P1|NOT COMPLETED|Overall Study||1
8090205|NCT03418324|19943249|P2|COMPLETED|Overall Study||6
8090206|NCT03418324|19943250|P1|COMPLETED|Overall Study||2
8090207|NCT03418324|19943249|P2|STARTED|Overall Study||8
8090208|NCT03418324|19943250|P1|STARTED|Overall Study||3
8090209|NCT03418064|19943268|P2|NOT COMPLETED|Second Intervention (1 Month)||0
8090210|NCT03418064|19943269|P1|NOT COMPLETED|Second Intervention (1 Month)||0
8090211|NCT03418064|19943268|P2|COMPLETED|Second Intervention (1 Month)||21
8090212|NCT03418064|19943269|P1|COMPLETED|Second Intervention (1 Month)||21
8090213|NCT03418064|19943268|P2|STARTED|Second Intervention (1 Month)||21
8090214|NCT03418064|19943269|P1|STARTED|Second Intervention (1 Month)||21
8090215|NCT03418064|19943268|P2|NOT COMPLETED|First Intervention (1 Month)||0
8090216|NCT03418064|19943269|P1|NOT COMPLETED|First Intervention (1 Month)||0
8090217|NCT03418064|19943268|P2|COMPLETED|First Intervention (1 Month)||21
8090218|NCT03418064|19943269|P1|COMPLETED|First Intervention (1 Month)||21
8090219|NCT03418064|19943268|P2|STARTED|First Intervention (1 Month)||21
8090220|NCT03418064|19943269|P1|STARTED|First Intervention (1 Month)||21
8090221|NCT03417830|19943300|P2|NOT COMPLETED|Part B (up to 26 Days)||0
8090222|NCT03417830|19943301|P1|NOT COMPLETED|Part B (up to 26 Days)||0
8090223|NCT03417830|19943300|P2|COMPLETED|Part B (up to 26 Days)||0
8090224|NCT03417830|19943301|P1|COMPLETED|Part B (up to 26 Days)||0
8090225|NCT03417830|19943300|P2|STARTED|Part B (up to 26 Days)||0
8090226|NCT03417830|19943301|P1|STARTED|Part B (up to 26 Days)||0
8090227|NCT03417830|19943300|P2|NOT COMPLETED|Part A (up to 26 Days)||0
8090228|NCT03417830|19943301|P1|NOT COMPLETED|Part A (up to 26 Days)||1
8090229|NCT03417830|19943300|P2|COMPLETED|Part A (up to 26 Days)||0
8090230|NCT03417830|19943301|P1|COMPLETED|Part A (up to 26 Days)||1
8090231|NCT03417830|19943300|P2|STARTED|Part A (up to 26 Days)||0
8090232|NCT03417830|19943301|P1|STARTED|Part A (up to 26 Days)||2
8090233|NCT03417778|19943397|P2|NOT COMPLETED|Overall Study||0
8090234|NCT03417778|19943398|P1|NOT COMPLETED|Overall Study||0
8090235|NCT03417778|19943397|P2|COMPLETED|Overall Study||10
8090236|NCT03417778|19943398|P1|COMPLETED|Overall Study||10
8090237|NCT03417778|19943397|P2|STARTED|Overall Study||10
8090238|NCT03417778|19943398|P1|STARTED|Overall Study||10
8090239|NCT03417752|19943421|P3|NOT COMPLETED|Overall Study||40
8090240|NCT03417752|19943422|P2|NOT COMPLETED|Overall Study||42
8090241|NCT03417752|19943423|P1|NOT COMPLETED|Overall Study||34
8090242|NCT03417752|19943421|P3|COMPLETED|Overall Study||110
8090243|NCT03417752|19943422|P2|COMPLETED|Overall Study||133
8090244|NCT03417752|19943423|P1|COMPLETED|Overall Study||115
8090245|NCT03417752|19943421|P3|STARTED|Overall Study||150
8090246|NCT03417752|19943422|P2|STARTED|Overall Study||175
8090247|NCT03417752|19943423|P1|STARTED|Overall Study||149
8090248|NCT03417713|19943440|P1|NOT COMPLETED|Overall Study||3
8090249|NCT03417713|19943440|P1|COMPLETED|Overall Study||30
8090250|NCT03417713|19943440|P1|STARTED|Overall Study||33
8090251|NCT03417557|19943445|P2|NOT COMPLETED|2nd Intervention (3 Hours)||0
8090252|NCT03417557|19943446|P1|NOT COMPLETED|2nd Intervention (3 Hours)||0
8090253|NCT03417557|19943445|P2|COMPLETED|2nd Intervention (3 Hours)||8
8090254|NCT03417557|19943446|P1|COMPLETED|2nd Intervention (3 Hours)||9
8090255|NCT03417557|19943445|P2|STARTED|2nd Intervention (3 Hours)||8
8090256|NCT03417557|19943446|P1|STARTED|2nd Intervention (3 Hours)||9
8090257|NCT03417557|19943445|P2|NOT COMPLETED|1st Intervention (3 Hours)||0
8090258|NCT03417557|19943446|P1|NOT COMPLETED|1st Intervention (3 Hours)||0
8090259|NCT03417557|19943445|P2|COMPLETED|1st Intervention (3 Hours)||9
8090260|NCT03417557|19943446|P1|COMPLETED|1st Intervention (3 Hours)||8
8090261|NCT03417557|19943445|P2|STARTED|1st Intervention (3 Hours)||9
8090262|NCT03417557|19943446|P1|STARTED|1st Intervention (3 Hours)||8
8090263|NCT03417505|19943458|P2|NOT COMPLETED|Second Lens Type (30 Days)||0
8090264|NCT03417505|19943459|P1|NOT COMPLETED|Second Lens Type (30 Days)||0
8090265|NCT03417505|19943458|P2|COMPLETED|Second Lens Type (30 Days)||11
8090266|NCT03417505|19943459|P1|COMPLETED|Second Lens Type (30 Days)||8
8090267|NCT03417505|19943458|P2|STARTED|Second Lens Type (30 Days)||11
8090268|NCT03417505|19943459|P1|STARTED|Second Lens Type (30 Days)||8
8090269|NCT03417505|19943458|P2|NOT COMPLETED|Washout Period (7 Days)||0
8090270|NCT03417505|19943459|P1|NOT COMPLETED|Washout Period (7 Days)||0
8090271|NCT03417505|19943458|P2|COMPLETED|Washout Period (7 Days)||11
8090272|NCT03417505|19943459|P1|COMPLETED|Washout Period (7 Days)||8
8090273|NCT03417505|19943458|P2|STARTED|Washout Period (7 Days)||11
8090274|NCT03417505|19943459|P1|STARTED|Washout Period (7 Days)||8
8090275|NCT03417505|19943458|P2|NOT COMPLETED|First Lens Type (30 Days)||1
8090276|NCT03417505|19943459|P1|NOT COMPLETED|First Lens Type (30 Days)||1
8090277|NCT03417505|19943458|P2|COMPLETED|First Lens Type (30 Days)||11
8090278|NCT03417505|19943459|P1|COMPLETED|First Lens Type (30 Days)||8
8090279|NCT03417505|19943458|P2|STARTED|First Lens Type (30 Days)||12
8090280|NCT03417505|19943459|P1|STARTED|First Lens Type (30 Days)||9
8090281|NCT03417466|19943481|P1|NOT COMPLETED|Overall Study||0
8090282|NCT03417466|19943481|P1|COMPLETED|Overall Study||66
8090283|NCT03417466|19943481|P1|STARTED|Overall Study||66
8090284|NCT03417219|19943490|P2|NOT COMPLETED|Overall Study||3
8090285|NCT03417219|19943491|P1|NOT COMPLETED|Overall Study||0
8090286|NCT03417219|19943490|P2|COMPLETED|Overall Study||5
8090287|NCT03417219|19943491|P1|COMPLETED|Overall Study||8
8090288|NCT03417219|19943490|P2|STARTED|Overall Study||8
8090289|NCT03417219|19943491|P1|STARTED|Overall Study||8
8090290|NCT03417024|19943501|P1|NOT COMPLETED|Overall Study||13
8090291|NCT03417024|19943501|P1|COMPLETED|Overall Study||0
8090292|NCT03417024|19943501|P1|STARTED|Overall Study||13
8090293|NCT03416985|19943510|P3|NOT COMPLETED|Overall Study||6
8090294|NCT03416985|19943511|P2|NOT COMPLETED|Overall Study||0
8090295|NCT03416985|19943512|P1|NOT COMPLETED|Overall Study||2
8090296|NCT03416985|19943510|P3|COMPLETED|Overall Study||24
8090297|NCT03416985|19943511|P2|COMPLETED|Overall Study||30
8090298|NCT03416985|19943512|P1|COMPLETED|Overall Study||28
8090299|NCT03416985|19943510|P3|STARTED|Overall Study||30
8090300|NCT03416985|19943511|P2|STARTED|Overall Study||30
8090301|NCT03416985|19943512|P1|STARTED|Overall Study||30
8090302|NCT03416127|19943526|P3|NOT COMPLETED|Overall Study||1
8090303|NCT03416127|19943527|P2|NOT COMPLETED|Overall Study||1
8090304|NCT03416127|19943528|P1|NOT COMPLETED|Overall Study||0
8090305|NCT03416127|19943526|P3|COMPLETED|Overall Study||11
8090306|NCT03416127|19943527|P2|COMPLETED|Overall Study||11
8090307|NCT03416127|19943528|P1|COMPLETED|Overall Study||12
8090308|NCT03416127|19943526|P3|STARTED|Overall Study||12
8090309|NCT03416127|19943527|P2|STARTED|Overall Study||12
8090310|NCT03416127|19943528|P1|STARTED|Overall Study||12
8090311|NCT03415243|19943607|P2|NOT COMPLETED|Overall Study||0
8090312|NCT03415243|19943608|P1|NOT COMPLETED|Overall Study||0
8090313|NCT03415243|19943607|P2|COMPLETED|Overall Study||14
8090314|NCT03415243|19943608|P1|COMPLETED|Overall Study||14
8090315|NCT03415243|19943607|P2|STARTED|Overall Study||14
8090316|NCT03415243|19943608|P1|STARTED|Overall Study||14
8090317|NCT03415178|19943672|P2|NOT COMPLETED|Single Arm Period (up to Week 16)||1
8090318|NCT03415178|19943673|P1|NOT COMPLETED|Single Arm Period (up to Week 16)||0
8090319|NCT03415178|19943672|P2|COMPLETED|Single Arm Period (up to Week 16)||65
8090320|NCT03415178|19943673|P1|COMPLETED|Single Arm Period (up to Week 16)||0
8090321|NCT03415178|19943672|P2|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
8090322|NCT03415178|19943673|P1|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
8090323|NCT03415178|19943672|P2|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
8090324|NCT03415178|19943673|P1|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
8090325|NCT03415178|19943672|P2|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
8090326|NCT03415178|19943673|P1|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
8090327|NCT03415178|19943672|P2|Treated|Parallel-Arm Period (up to Week 4)||33
8090328|NCT03415178|19943673|P1|Treated|Parallel-Arm Period (up to Week 4)||34
8090329|NCT03415178|19943672|P2|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
8090330|NCT03415178|19943673|P1|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
8090331|NCT03415152|19943708|P1|NOT COMPLETED|Overall Study||1025
8090332|NCT03415152|19943708|P1|COMPLETED|Overall Study||1975
8090333|NCT03415152|19943708|P1|STARTED|Overall Study||3000
8090340|NCT03414359|19943738|P2|NOT COMPLETED|Overall Study||2
8090341|NCT03414359|19943739|P1|NOT COMPLETED|Overall Study||1
8090342|NCT03414359|19943738|P2|COMPLETED|Overall Study||33
8090343|NCT03414359|19943739|P1|COMPLETED|Overall Study||34
8090344|NCT03414359|19943738|P2|STARTED|Overall Study||35
8090345|NCT03414359|19943739|P1|STARTED|Overall Study||35
8090346|NCT03414047|19943751|P4|NOT COMPLETED|Overall Study||3
8090347|NCT03414047|19943752|P3|NOT COMPLETED|Overall Study||0
8090348|NCT03414047|19943753|P2|NOT COMPLETED|Overall Study||0
8090349|NCT03414047|19943754|P1|NOT COMPLETED|Overall Study||1
8090350|NCT03414047|19943751|P4|COMPLETED|Overall Study||28
8090351|NCT03414047|19943752|P3|COMPLETED|Overall Study||40
8090352|NCT03414047|19943753|P2|COMPLETED|Overall Study||44
8090353|NCT03414047|19943754|P1|COMPLETED|Overall Study||53
8090354|NCT03414047|19943751|P4|STARTED|Overall Study||31
8090355|NCT03414047|19943752|P3|STARTED|Overall Study||40
8090356|NCT03414047|19943753|P2|STARTED|Overall Study||44
8090357|NCT03414047|19943754|P1|STARTED|Overall Study||54
8090364|NCT03412929|19943814|P1|NOT COMPLETED|Overall Study||3
8090365|NCT03412929|19943814|P1|COMPLETED|Overall Study||5
8090366|NCT03412929|19943814|P1|STARTED|Overall Study||8
8090367|NCT03412734|19943825|P2|NOT COMPLETED|Overall Study||0
8090368|NCT03412734|19943826|P1|NOT COMPLETED|Overall Study||3
8090369|NCT03412734|19943825|P2|COMPLETED|Overall Study||41
8090370|NCT03412734|19943826|P1|COMPLETED|Overall Study||44
8090371|NCT03412734|19943825|P2|STARTED|Overall Study||41
8090372|NCT03412734|19943826|P1|STARTED|Overall Study||47
8090373|NCT03412084|19943834|P2|NOT COMPLETED|Overall Study||1
8090374|NCT03412084|19943835|P1|NOT COMPLETED|Overall Study||4
8090375|NCT03412084|19943834|P2|COMPLETED|Overall Study||35
8090376|NCT03412084|19943835|P1|COMPLETED|Overall Study||44
8090377|NCT03412084|19943834|P2|STARTED|Overall Study||36
8090378|NCT03412084|19943835|P1|STARTED|Overall Study||48
8090379|NCT03412019|19943845|P2|NOT COMPLETED|Overall Study||1
8090380|NCT03412019|19943846|P1|NOT COMPLETED|Overall Study||1
8090381|NCT03412019|19943845|P2|COMPLETED|Overall Study||10
8090382|NCT03412019|19943846|P1|COMPLETED|Overall Study||10
8090383|NCT03412019|19943845|P2|STARTED|Overall Study||11
8090384|NCT03412019|19943846|P1|STARTED|Overall Study||11
8090391|NCT03410862|19943879|P2|NOT COMPLETED|Overall Study||2
8090392|NCT03410862|19943880|P1|NOT COMPLETED|Overall Study||2
8090393|NCT03410862|19943879|P2|COMPLETED|Overall Study||42
8090394|NCT03410862|19943880|P1|COMPLETED|Overall Study||41
8090395|NCT03410862|19943879|P2|STARTED|Overall Study||44
8090396|NCT03410862|19943880|P1|STARTED|Overall Study||43
8090397|NCT03410797|19943888|P1|NOT COMPLETED|Overall Study||0
8090398|NCT03410797|19943888|P1|COMPLETED|Overall Study||11
8090399|NCT03410797|19943888|P1|STARTED|Overall Study||11
8090400|NCT03410628|19943897|P1|NOT COMPLETED|Overall Study||6
8090401|NCT03410628|19943897|P1|COMPLETED|Overall Study||15
8090402|NCT03410628|19943897|P1|STARTED|Overall Study||21
8090403|NCT03409796|19943904|P2|NOT COMPLETED|Overall Study||1
8090404|NCT03409796|19943905|P1|NOT COMPLETED|Overall Study||2
8090405|NCT03409796|19943904|P2|COMPLETED|Overall Study||6
8090406|NCT03409796|19943905|P1|COMPLETED|Overall Study||7
8090407|NCT03409796|19943904|P2|STARTED|Overall Study||7
8090408|NCT03409796|19943905|P1|STARTED|Overall Study||9
8090409|NCT03409731|19943917|P1|NOT COMPLETED|Overall Study||3
8090410|NCT03409731|19943917|P1|COMPLETED|Overall Study||132
8090411|NCT03409731|19943917|P1|STARTED|Overall Study||135
8090412|NCT03408730|19943991|P4|NOT COMPLETED|Overall Study||81
8090413|NCT03408730|19943992|P3|NOT COMPLETED|Overall Study||72
8090414|NCT03408730|19943993|P2|NOT COMPLETED|Overall Study||75
8090415|NCT03408730|19943994|P1|NOT COMPLETED|Overall Study||69
8090416|NCT03408730|19943991|P4|COMPLETED|Overall Study||625
8090417|NCT03408730|19943992|P3|COMPLETED|Overall Study||637
8090418|NCT03408730|19943993|P2|COMPLETED|Overall Study||636
8090419|NCT03408730|19943994|P1|COMPLETED|Overall Study||643
8090420|NCT03408730|19943991|P4|STARTED|Overall Study||706
8090421|NCT03408730|19943992|P3|STARTED|Overall Study||709
8090422|NCT03408730|19943993|P2|STARTED|Overall Study||711
8090423|NCT03408730|19943994|P1|STARTED|Overall Study||712
8090424|NCT03408639|19944011|P2|NOT COMPLETED|Overall Study||22
8090425|NCT03408639|19944012|P1|NOT COMPLETED|Overall Study||11
8090426|NCT03408639|19944011|P2|COMPLETED|Overall Study||56
8090427|NCT03408639|19944012|P1|COMPLETED|Overall Study||67
8090428|NCT03408639|19944011|P2|STARTED|Overall Study||78
8090429|NCT03408639|19944012|P1|STARTED|Overall Study||78
8090430|NCT03408483|19944042|P2|NOT COMPLETED|Overall Study||3
8090431|NCT03408483|19944043|P1|NOT COMPLETED|Overall Study||6
8090432|NCT03408483|19944042|P2|COMPLETED|Overall Study||35
8090433|NCT03408483|19944043|P1|COMPLETED|Overall Study||36
8090434|NCT03408483|19944042|P2|STARTED|Overall Study||38
8090435|NCT03408483|19944043|P1|STARTED|Overall Study||42
8090436|NCT03408392|19944069|P2|NOT COMPLETED|Treatment Period 2 (16 Days)||0
8090437|NCT03408392|19944070|P1|NOT COMPLETED|Treatment Period 2 (16 Days)||0
8090438|NCT03408392|19944069|P2|COMPLETED|Treatment Period 2 (16 Days)||14
8090439|NCT03408392|19944070|P1|COMPLETED|Treatment Period 2 (16 Days)||14
8090440|NCT03408392|19944069|P2|STARTED|Treatment Period 2 (16 Days)||14
8090441|NCT03408392|19944070|P1|STARTED|Treatment Period 2 (16 Days)||14
8090442|NCT03408392|19944069|P2|NOT COMPLETED|Wash-out Period (14 Days)||0
8090443|NCT03408392|19944070|P1|NOT COMPLETED|Wash-out Period (14 Days)||0
8090444|NCT03408392|19944069|P2|COMPLETED|Wash-out Period (14 Days)||14
8090445|NCT03408392|19944070|P1|COMPLETED|Wash-out Period (14 Days)||14
8090446|NCT03408392|19944069|P2|STARTED|Wash-out Period (14 Days)||14
8090447|NCT03408392|19944070|P1|STARTED|Wash-out Period (14 Days)||14
8090448|NCT03408392|19944069|P2|NOT COMPLETED|Treatment Period 1 (16 Days)||0
8090449|NCT03408392|19944070|P1|NOT COMPLETED|Treatment Period 1 (16 Days)||0
8090450|NCT03408392|19944069|P2|COMPLETED|Treatment Period 1 (16 Days)||14
8090451|NCT03408392|19944070|P1|COMPLETED|Treatment Period 1 (16 Days)||14
8090452|NCT03408392|19944069|P2|STARTED|Treatment Period 1 (16 Days)||14
8090453|NCT03408392|19944070|P1|STARTED|Treatment Period 1 (16 Days)||14
8090454|NCT03408171|19944124|P2|NOT COMPLETED|Overall Study||0
8090455|NCT03408171|19944125|P1|NOT COMPLETED|Overall Study||0
8090456|NCT03408171|19944124|P2|COMPLETED|Overall Study||20
8090457|NCT03408171|19944125|P1|COMPLETED|Overall Study||20
8090458|NCT03408171|19944124|P2|STARTED|Overall Study||20
8090459|NCT03408171|19944125|P1|STARTED|Overall Study||20
8090460|NCT03407625|19944153|P2|NOT COMPLETED|Overall Study||0
8090461|NCT03407625|19944154|P1|NOT COMPLETED|Overall Study||0
8090462|NCT03407625|19944153|P2|COMPLETED|Overall Study||1110
8090463|NCT03407625|19944154|P1|COMPLETED|Overall Study||1117
8090464|NCT03407625|19944153|P2|STARTED|Overall Study||1110
8090465|NCT03407625|19944154|P1|STARTED|Overall Study||1117
8090466|NCT03407612|19944208|P2|NOT COMPLETED|Overall Study||0
8090467|NCT03407612|19944209|P1|NOT COMPLETED|Overall Study||0
8090468|NCT03407612|19944208|P2|COMPLETED|Overall Study||23
8090469|NCT03407612|19944209|P1|COMPLETED|Overall Study||19
8090470|NCT03407612|19944208|P2|STARTED|Overall Study||23
8090471|NCT03407612|19944209|P1|STARTED|Overall Study||19
8090472|NCT03407482|19944219|P1|NOT COMPLETED|Overall Study||131
8090473|NCT03407482|19944219|P1|COMPLETED|Overall Study||29
8090474|NCT03407482|19944219|P1|STARTED|Overall Study||160
8090475|NCT03407430|19944230|P2|NOT COMPLETED|Second Intervention||0
8090476|NCT03407430|19944231|P1|NOT COMPLETED|Second Intervention||0
8090477|NCT03407430|19944230|P2|COMPLETED|Second Intervention||3
8090478|NCT03407430|19944231|P1|COMPLETED|Second Intervention||4
8090479|NCT03407430|19944230|P2|STARTED|Second Intervention||3
8090480|NCT03407430|19944231|P1|STARTED|Second Intervention||4
8090481|NCT03407430|19944230|P2|NOT COMPLETED|Washout||0
8090482|NCT03407430|19944231|P1|NOT COMPLETED|Washout||1
8090483|NCT03407430|19944230|P2|COMPLETED|Washout||3
8090484|NCT03407430|19944231|P1|COMPLETED|Washout||4
8090485|NCT03407430|19944230|P2|STARTED|Washout||3
8090486|NCT03407430|19944231|P1|STARTED|Washout||5
8090487|NCT03407430|19944230|P2|NOT COMPLETED|First Intervention||0
8090488|NCT03407430|19944231|P1|NOT COMPLETED|First Intervention||0
8090489|NCT03407430|19944230|P2|COMPLETED|First Intervention||3
8090490|NCT03407430|19944231|P1|COMPLETED|First Intervention||5
8090491|NCT03407430|19944230|P2|STARTED|First Intervention||3
8090492|NCT03407430|19944231|P1|STARTED|First Intervention||5
8090493|NCT03407170|19944263|P1|NOT COMPLETED|Overall Study||1
8090494|NCT03407170|19944263|P1|COMPLETED|Overall Study||0
8090495|NCT03407170|19944263|P1|STARTED|Overall Study||1
8090496|NCT03407118|19944276|P2|NOT COMPLETED|Period 2||0
8090497|NCT03407118|19944277|P1|NOT COMPLETED|Period 2||1
8090498|NCT03407118|19944276|P2|COMPLETED|Period 2||17
8090499|NCT03407118|19944277|P1|COMPLETED|Period 2||13
8090500|NCT03407118|19944276|P2|Received at Least 1 Dose of Study Drug|Period 2||17
8090501|NCT03407118|19944277|P1|Received at Least 1 Dose of Study Drug|Period 2||13
8090502|NCT03407118|19944276|P2|STARTED|Period 2||17
8090503|NCT03407118|19944277|P1|STARTED|Period 2||14
8090504|NCT03407118|19944276|P2|NOT COMPLETED|Period 1||0
8090505|NCT03407118|19944277|P1|NOT COMPLETED|Period 1||0
8090506|NCT03407118|19944276|P2|COMPLETED|Period 1||17
8090507|NCT03407118|19944277|P1|COMPLETED|Period 1||14
8090508|NCT03407118|19944276|P2|Received at Least 1 Dose of Study Drug|Period 1||17
8090509|NCT03407118|19944277|P1|Received at Least 1 Dose of Study Drug|Period 1||14
8090510|NCT03407118|19944276|P2|STARTED|Period 1||17
8090511|NCT03407118|19944277|P1|STARTED|Period 1||14
8090512|NCT03406325|19944293|P8|NOT COMPLETED|Overall Study||0
8090513|NCT03406325|19944294|P7|NOT COMPLETED|Overall Study||0
8090514|NCT03406325|19944295|P6|NOT COMPLETED|Overall Study||0
8090515|NCT03406325|19944296|P5|NOT COMPLETED|Overall Study||0
8090516|NCT03406325|19944297|P4|NOT COMPLETED|Overall Study||0
8090517|NCT03406325|19944298|P3|NOT COMPLETED|Overall Study||0
8090518|NCT03406325|19944299|P2|NOT COMPLETED|Overall Study||0
8090519|NCT03406325|19944300|P1|NOT COMPLETED|Overall Study||0
8090520|NCT03406325|19944293|P8|COMPLETED|Overall Study||1
8090521|NCT03406325|19944294|P7|COMPLETED|Overall Study||1
8090522|NCT03406325|19944295|P6|COMPLETED|Overall Study||1
8090523|NCT03406325|19944296|P5|COMPLETED|Overall Study||1
8090524|NCT03406325|19944297|P4|COMPLETED|Overall Study||1
8090525|NCT03406325|19944298|P3|COMPLETED|Overall Study||1
8090526|NCT03406325|19944299|P2|COMPLETED|Overall Study||1
8090527|NCT03406325|19944300|P1|COMPLETED|Overall Study||12
8090528|NCT03406325|19944293|P8|STARTED|Overall Study||1
8090529|NCT03406325|19944294|P7|STARTED|Overall Study||1
8090530|NCT03406325|19944295|P6|STARTED|Overall Study||1
8090531|NCT03406325|19944296|P5|STARTED|Overall Study||1
8090532|NCT03406325|19944297|P4|STARTED|Overall Study||1
8090533|NCT03406325|19944298|P3|STARTED|Overall Study||1
8090534|NCT03406325|19944299|P2|STARTED|Overall Study||1
8090535|NCT03406325|19944300|P1|STARTED|Overall Study||12
8090536|NCT03406260|19944354|P6|NOT COMPLETED|Period 3||0
8090537|NCT03406260|19944355|P5|NOT COMPLETED|Period 3||0
8090538|NCT03406260|19944356|P4|NOT COMPLETED|Period 3||0
8090539|NCT03406260|19944357|P3|NOT COMPLETED|Period 3||0
8090540|NCT03406260|19944358|P2|NOT COMPLETED|Period 3||0
8090541|NCT03406260|19944359|P1|NOT COMPLETED|Period 3||0
8090542|NCT03406260|19944354|P6|COMPLETED|Period 3||6
8090543|NCT03406260|19944355|P5|COMPLETED|Period 3||5
8090544|NCT03406260|19944356|P4|COMPLETED|Period 3||6
8090545|NCT03406260|19944357|P3|COMPLETED|Period 3||6
8090546|NCT03406260|19944358|P2|COMPLETED|Period 3||6
8090547|NCT03406260|19944359|P1|COMPLETED|Period 3||6
8090548|NCT03406260|19944354|P6|STARTED|Period 3||6
8090549|NCT03406260|19944355|P5|STARTED|Period 3||5
8090550|NCT03406260|19944356|P4|STARTED|Period 3||6
8090551|NCT03406260|19944357|P3|STARTED|Period 3||6
8090552|NCT03406260|19944358|P2|STARTED|Period 3||6
8090553|NCT03406260|19944359|P1|STARTED|Period 3||6
8090554|NCT03406260|19944354|P6|NOT COMPLETED|Period 2||0
8090555|NCT03406260|19944355|P5|NOT COMPLETED|Period 2||0
8090556|NCT03406260|19944356|P4|NOT COMPLETED|Period 2||0
8090557|NCT03406260|19944357|P3|NOT COMPLETED|Period 2||0
8090558|NCT03406260|19944358|P2|NOT COMPLETED|Period 2||0
8090559|NCT03406260|19944359|P1|NOT COMPLETED|Period 2||0
8090560|NCT03406260|19944354|P6|COMPLETED|Period 2||6
8090561|NCT03406260|19944355|P5|COMPLETED|Period 2||5
8090562|NCT03406260|19944356|P4|COMPLETED|Period 2||6
8090563|NCT03406260|19944357|P3|COMPLETED|Period 2||6
8090564|NCT03406260|19944358|P2|COMPLETED|Period 2||6
8090565|NCT03406260|19944359|P1|COMPLETED|Period 2||6
8090566|NCT03406260|19944354|P6|STARTED|Period 2||6
8090567|NCT03406260|19944355|P5|STARTED|Period 2||5
8090568|NCT03406260|19944356|P4|STARTED|Period 2||6
8090569|NCT03406260|19944357|P3|STARTED|Period 2||6
8090570|NCT03406260|19944358|P2|STARTED|Period 2||6
8090571|NCT03406260|19944359|P1|STARTED|Period 2||6
8090572|NCT03406260|19944354|P6|NOT COMPLETED|Period 1||0
8090573|NCT03406260|19944355|P5|NOT COMPLETED|Period 1||1
8090574|NCT03406260|19944356|P4|NOT COMPLETED|Period 1||0
8090575|NCT03406260|19944357|P3|NOT COMPLETED|Period 1||0
8090576|NCT03406260|19944358|P2|NOT COMPLETED|Period 1||0
8090577|NCT03406260|19944359|P1|NOT COMPLETED|Period 1||0
8090578|NCT03406260|19944354|P6|COMPLETED|Period 1||6
8090579|NCT03406260|19944355|P5|COMPLETED|Period 1||5
8090580|NCT03406260|19944356|P4|COMPLETED|Period 1||6
8090581|NCT03406260|19944357|P3|COMPLETED|Period 1||6
8090582|NCT03406260|19944358|P2|COMPLETED|Period 1||6
8090583|NCT03406260|19944359|P1|COMPLETED|Period 1||6
8090584|NCT03406260|19944354|P6|Received at Least 1 Dose of Study Drug|Period 1||6
8090585|NCT03406260|19944355|P5|Received at Least 1 Dose of Study Drug|Period 1||6
8090586|NCT03406260|19944356|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8090587|NCT03406260|19944357|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8090588|NCT03406260|19944358|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8090589|NCT03406260|19944359|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8090590|NCT03406260|19944354|P6|STARTED|Period 1||6
8090591|NCT03406260|19944355|P5|STARTED|Period 1||6
8090592|NCT03406260|19944356|P4|STARTED|Period 1||6
8090593|NCT03406260|19944357|P3|STARTED|Period 1||6
8090594|NCT03406260|19944358|P2|STARTED|Period 1||6
8090595|NCT03406260|19944359|P1|STARTED|Period 1||6
8090596|NCT03405935|19944371|P1|NOT COMPLETED|Overall Study||8
8090597|NCT03405935|19944371|P1|COMPLETED|Overall Study||78
8090598|NCT03405935|19944371|P1|STARTED|Overall Study||86
8090599|NCT03405818|19944398|P1|NOT COMPLETED|Overall Study||8
8090600|NCT03405818|19944398|P1|COMPLETED|Overall Study||47
8090601|NCT03405818|19944398|P1|STARTED|Overall Study||55
8090602|NCT03405259|19944441|P2|NOT COMPLETED|Overall Study||0
8090603|NCT03405259|19944442|P1|NOT COMPLETED|Overall Study||0
8090604|NCT03405259|19944441|P2|COMPLETED|Overall Study||11
8090605|NCT03405259|19944442|P1|COMPLETED|Overall Study||11
8090606|NCT03405259|19944441|P2|STARTED|Overall Study||11
8090607|NCT03405259|19944442|P1|STARTED|Overall Study||11
8090608|NCT03404843|19944452|P2|NOT COMPLETED|Overall Study||1
8090609|NCT03404843|19944453|P1|NOT COMPLETED|Overall Study||4
8090610|NCT03404843|19944452|P2|COMPLETED|Overall Study||13
8090611|NCT03404843|19944453|P1|COMPLETED|Overall Study||13
8090612|NCT03404843|19944452|P2|STARTED|Overall Study||14
8090613|NCT03404843|19944453|P1|STARTED|Overall Study||17
8090614|NCT03404674|19944485|P6|NOT COMPLETED|Overall Study||1
8090615|NCT03404674|19944486|P5|NOT COMPLETED|Overall Study||0
8090616|NCT03404674|19944487|P4|NOT COMPLETED|Overall Study||1
8090617|NCT03404674|19944488|P3|NOT COMPLETED|Overall Study||2
8090618|NCT03404674|19944489|P2|NOT COMPLETED|Overall Study||1
8090619|NCT03404674|19944490|P1|NOT COMPLETED|Overall Study||0
8090620|NCT03404674|19944485|P6|COMPLETED|Overall Study||9
8090621|NCT03404674|19944486|P5|COMPLETED|Overall Study||10
8090622|NCT03404674|19944487|P4|COMPLETED|Overall Study||9
8090623|NCT03404674|19944488|P3|COMPLETED|Overall Study||8
8090624|NCT03404674|19944489|P2|COMPLETED|Overall Study||4
8090625|NCT03404674|19944490|P1|COMPLETED|Overall Study||5
8090626|NCT03404674|19944485|P6|Received Dose 3|Overall Study||9
8090627|NCT03404674|19944486|P5|Received Dose 3|Overall Study||10
8090628|NCT03404674|19944487|P4|Received Dose 3|Overall Study||9
8090629|NCT03404674|19944488|P3|Received Dose 3|Overall Study||9
8090630|NCT03404674|19944489|P2|Received Dose 3|Overall Study||4
8090631|NCT03404674|19944490|P1|Received Dose 3|Overall Study||5
8090632|NCT03404674|19944485|P6|Received Dose 2|Overall Study||10
8090633|NCT03404674|19944486|P5|Received Dose 2|Overall Study||10
8090634|NCT03404674|19944487|P4|Received Dose 2|Overall Study||9
8090635|NCT03404674|19944488|P3|Received Dose 2|Overall Study||10
8090636|NCT03404674|19944489|P2|Received Dose 2|Overall Study||4
8090637|NCT03404674|19944490|P1|Received Dose 2|Overall Study||5
8090638|NCT03404674|19944485|P6|STARTED|Overall Study||10
8090639|NCT03404674|19944486|P5|STARTED|Overall Study||10
8090640|NCT03404674|19944487|P4|STARTED|Overall Study||10
8090641|NCT03404674|19944488|P3|STARTED|Overall Study||10
8090642|NCT03404674|19944489|P2|STARTED|Overall Study||5
8090643|NCT03404674|19944490|P1|STARTED|Overall Study||5
8090644|NCT03404206|19944585|P3|NOT COMPLETED|Overall Study||0
8090645|NCT03404206|19944586|P2|NOT COMPLETED|Overall Study||2
8090646|NCT03404206|19944587|P1|NOT COMPLETED|Overall Study||4
8090647|NCT03404206|19944585|P3|COMPLETED|Overall Study||55
8090648|NCT03404206|19944586|P2|COMPLETED|Overall Study||164
8090649|NCT03404206|19944587|P1|COMPLETED|Overall Study||162
8090650|NCT03404206|19944585|P3|STARTED|Overall Study||55
8090651|NCT03404206|19944586|P2|STARTED|Overall Study||166
8090652|NCT03404206|19944587|P1|STARTED|Overall Study||166
8090653|NCT03404167|19944601|P1|NOT COMPLETED|Overall Study||0
8090654|NCT03404167|19944601|P1|COMPLETED|Overall Study||8
8090655|NCT03404167|19944601|P1|STARTED|Overall Study||8
8090656|NCT03403712|19944638|P2|NOT COMPLETED|Overall Study||100
8090657|NCT03403712|19944639|P1|NOT COMPLETED|Overall Study||105
8090658|NCT03403712|19944638|P2|COMPLETED|Overall Study||102
8090659|NCT03403712|19944639|P1|COMPLETED|Overall Study||95
8090660|NCT03403712|19944638|P2|STARTED|Overall Study||202
8090661|NCT03403712|19944639|P1|STARTED|Overall Study||200
8090662|NCT03403517|19944661|P2|NOT COMPLETED|Overall Study||0
8090663|NCT03403517|19944662|P1|NOT COMPLETED|Overall Study||0
8090664|NCT03403517|19944661|P2|COMPLETED|Overall Study||86
8090665|NCT03403517|19944662|P1|COMPLETED|Overall Study||88
8090666|NCT03403517|19944661|P2|STARTED|Overall Study||86
8090667|NCT03403517|19944662|P1|STARTED|Overall Study||88
8090668|NCT03403504|19944678|P2|NOT COMPLETED|Period 2||0
8090669|NCT03403504|19944679|P1|NOT COMPLETED|Period 2||0
8090670|NCT03403504|19944678|P2|COMPLETED|Period 2||11
8090671|NCT03403504|19944679|P1|COMPLETED|Period 2||12
8090672|NCT03403504|19944678|P2|STARTED|Period 2||11
8090673|NCT03403504|19944679|P1|STARTED|Period 2||12
8090674|NCT03403504|19944678|P2|NOT COMPLETED|Period 1||1
8090675|NCT03403504|19944679|P1|NOT COMPLETED|Period 1||0
8090676|NCT03403504|19944678|P2|COMPLETED|Period 1||11
8090677|NCT03403504|19944679|P1|COMPLETED|Period 1||12
8090678|NCT03403504|19944678|P2|STARTED|Period 1||12
8090679|NCT03403504|19944679|P1|STARTED|Period 1||12
8090680|NCT03403491|19944699|P2|NOT COMPLETED|Overall Study||5
8090681|NCT03403491|19944700|P1|NOT COMPLETED|Overall Study||3
8090682|NCT03403491|19944699|P2|COMPLETED|Overall Study||18
8090683|NCT03403491|19944700|P1|COMPLETED|Overall Study||17
8090684|NCT03403491|19944699|P2|STARTED|Overall Study||23
8090685|NCT03403491|19944700|P1|STARTED|Overall Study||20
8090686|NCT03403426|19944732|P1|NOT COMPLETED|Overall Study||3
8090687|NCT03403426|19944732|P1|COMPLETED|Overall Study||82
8090688|NCT03403426|19944732|P1|STARTED|Overall Study||85
8090689|NCT03403413|19944745|P1|NOT COMPLETED|Overall Study||2
8090690|NCT03403413|19944745|P1|COMPLETED|Overall Study||3
8090691|NCT03403413|19944745|P1|STARTED|Overall Study||5
8090692|NCT03403400|19944763|P3|NOT COMPLETED|Overall Study||2
8090693|NCT03403400|19944764|P2|NOT COMPLETED|Overall Study||0
8090694|NCT03403400|19944765|P1|NOT COMPLETED|Overall Study||2
8090695|NCT03403400|19944763|P3|COMPLETED|Overall Study||4
8090696|NCT03403400|19944764|P2|COMPLETED|Overall Study||6
8090697|NCT03403400|19944765|P1|COMPLETED|Overall Study||3
8090698|NCT03403400|19944763|P3|STARTED|Overall Study||6
8090699|NCT03403400|19944764|P2|STARTED|Overall Study||6
8090700|NCT03403400|19944765|P1|STARTED|Overall Study||5
8090701|NCT03403374|19944797|P1|NOT COMPLETED|Overall Study||1
8090702|NCT03403374|19944797|P1|COMPLETED|Overall Study||29
8090703|NCT03403374|19944797|P1|STARTED|Overall Study||30
8090704|NCT03403036|19944804|P1|NOT COMPLETED|Overall Study||5
8090705|NCT03403036|19944804|P1|COMPLETED|Overall Study||34
8090706|NCT03403036|19944804|P1|STARTED|Overall Study||39
8090707|NCT03402932|19944814|P4|NOT COMPLETED|Overall Study||0
8090708|NCT03402932|19944815|P3|NOT COMPLETED|Overall Study||0
8090709|NCT03402932|19944816|P2|NOT COMPLETED|Overall Study||0
8090710|NCT03402932|19944817|P1|NOT COMPLETED|Overall Study||0
8090711|NCT03402932|19944814|P4|COMPLETED|Overall Study||8
8090712|NCT03402932|19944815|P3|COMPLETED|Overall Study||8
8090713|NCT03402932|19944816|P2|COMPLETED|Overall Study||8
8090714|NCT03402932|19944817|P1|COMPLETED|Overall Study||13
8090715|NCT03402932|19944814|P4|STARTED|Overall Study||8
8090716|NCT03402932|19944815|P3|STARTED|Overall Study||8
8090717|NCT03402932|19944816|P2|STARTED|Overall Study||8
8090718|NCT03402932|19944817|P1|STARTED|Overall Study||13
8090719|NCT03402893|19944831|P1|NOT COMPLETED|Overall Study||1
8090720|NCT03402893|19944831|P1|COMPLETED|Overall Study||20
8090721|NCT03402893|19944831|P1|STARTED|Overall Study||21
8090722|NCT03402750|19944842|P2|NOT COMPLETED|Overall Study||1
8090723|NCT03402750|19944843|P1|NOT COMPLETED|Overall Study||2
8090724|NCT03402750|19944842|P2|COMPLETED|Overall Study||19
8090725|NCT03402750|19944843|P1|COMPLETED|Overall Study||18
8090726|NCT03402750|19944842|P2|STARTED|Overall Study||20
8090727|NCT03402750|19944843|P1|STARTED|Overall Study||20
8090728|NCT03402555|19944857|P1|NOT COMPLETED|Overall Study||5
8090729|NCT03402555|19944857|P1|COMPLETED|Overall Study||91
8090730|NCT03402555|19944857|P1|STARTED|Overall Study||96
8090731|NCT03401671|19944865|P2|NOT COMPLETED|Overall Study||0
8090732|NCT03401671|19944866|P1|NOT COMPLETED|Overall Study||0
8090733|NCT03401671|19944865|P2|COMPLETED|Overall Study||16
8090734|NCT03401671|19944866|P1|COMPLETED|Overall Study||16
8090735|NCT03401671|19944865|P2|STARTED|Overall Study||16
8090736|NCT03401671|19944866|P1|STARTED|Overall Study||16
8090737|NCT03401450|19944908|P2|NOT COMPLETED|Overall Study||13
8090738|NCT03401450|19944909|P1|NOT COMPLETED|Overall Study||12
8090739|NCT03401450|19944908|P2|COMPLETED|Overall Study||23
8090740|NCT03401450|19944909|P1|COMPLETED|Overall Study||21
8090741|NCT03401450|19944908|P2|STARTED|Overall Study||36
8090742|NCT03401450|19944909|P1|STARTED|Overall Study||33
8090743|NCT03400800|19944921|P2|NOT COMPLETED|Overall Study||37
8090744|NCT03400800|19944922|P1|NOT COMPLETED|Overall Study||38
8090745|NCT03400800|19944921|P2|COMPLETED|Overall Study||770
8090746|NCT03400800|19944922|P1|COMPLETED|Overall Study||772
8090747|NCT03400800|19944921|P2|STARTED|Overall Study||807
8090748|NCT03400800|19944922|P1|STARTED|Overall Study||810
8090757|NCT03400579|19944951|P1|NOT COMPLETED|Overall Study||0
8090758|NCT03400579|19944951|P1|COMPLETED|Overall Study||10
8090759|NCT03400579|19944951|P1|STARTED|Overall Study||10
8090760|NCT03400475|19944963|P2|NOT COMPLETED|Overall Study||0
8090761|NCT03400475|19944964|P1|NOT COMPLETED|Overall Study||0
8090762|NCT03400475|19944963|P2|COMPLETED|Overall Study||22
8090763|NCT03400475|19944964|P1|COMPLETED|Overall Study||24
8090764|NCT03400475|19944963|P2|STARTED|Overall Study||22
8090765|NCT03400475|19944964|P1|STARTED|Overall Study||24
8090766|NCT03400449|19945006|P2|NOT COMPLETED|Overall Study||0
8090767|NCT03400449|19945007|P1|NOT COMPLETED|Overall Study||1
8090768|NCT03400449|19945006|P2|COMPLETED|Overall Study||119
8090769|NCT03400449|19945007|P1|COMPLETED|Overall Study||120
8090770|NCT03400449|19945006|P2|STARTED|Overall Study||119
8090771|NCT03400449|19945007|P1|STARTED|Overall Study||121
8090784|NCT03399370|19945054|P2|NOT COMPLETED|Overall Study||86
8090785|NCT03399370|19945055|P1|NOT COMPLETED|Overall Study||60
8090786|NCT03399370|19945054|P2|COMPLETED|Overall Study||694
8090787|NCT03399370|19945055|P1|COMPLETED|Overall Study||721
8090788|NCT03399370|19945054|P2|STARTED|Overall Study||780
8090789|NCT03399370|19945055|P1|STARTED|Overall Study||781
8090790|NCT03398928|19945077|P2|NOT COMPLETED|Overall Study||0
8090791|NCT03398928|19945078|P1|NOT COMPLETED|Overall Study||0
8090792|NCT03398928|19945077|P2|COMPLETED|Overall Study||31
8090793|NCT03398928|19945078|P1|COMPLETED|Overall Study||50
8090794|NCT03398928|19945077|P2|STARTED|Overall Study||31
8090795|NCT03398928|19945078|P1|STARTED|Overall Study||50
8090796|NCT03398798|19945106|P4|NOT COMPLETED|Overall Study||0
8090797|NCT03398798|19945107|P3|NOT COMPLETED|Overall Study||0
8090798|NCT03398798|19945108|P2|NOT COMPLETED|Overall Study||0
8090799|NCT03398798|19945109|P1|NOT COMPLETED|Overall Study||0
8090800|NCT03398798|19945106|P4|COMPLETED|Overall Study||9
8090801|NCT03398798|19945107|P3|COMPLETED|Overall Study||9
8090802|NCT03398798|19945108|P2|COMPLETED|Overall Study||9
8090803|NCT03398798|19945109|P1|COMPLETED|Overall Study||9
8090804|NCT03398798|19945106|P4|STARTED|Overall Study||9
8090805|NCT03398798|19945107|P3|STARTED|Overall Study||9
8090806|NCT03398798|19945108|P2|STARTED|Overall Study||9
8090807|NCT03398798|19945109|P1|STARTED|Overall Study||9
8090808|NCT03398421|19945143|P2|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
8090809|NCT03398421|19945144|P1|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
8090810|NCT03398421|19945143|P2|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
8090811|NCT03398421|19945144|P1|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
8090812|NCT03398421|19945143|P2|STARTED|Treatment Period 2 (Up to 11 Days)||20
8090813|NCT03398421|19945144|P1|STARTED|Treatment Period 2 (Up to 11 Days)||0
8090814|NCT03398421|19945143|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8090815|NCT03398421|19945144|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8090816|NCT03398421|19945143|P2|COMPLETED|Washout Period (Up to 14 Days)||0
8090817|NCT03398421|19945144|P1|COMPLETED|Washout Period (Up to 14 Days)||20
8090818|NCT03398421|19945143|P2|STARTED|Washout Period (Up to 14 Days)||0
8090819|NCT03398421|19945144|P1|STARTED|Washout Period (Up to 14 Days)||20
8090820|NCT03398421|19945143|P2|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
8090821|NCT03398421|19945144|P1|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
8090822|NCT03398421|19945143|P2|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
8090823|NCT03398421|19945144|P1|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
8090824|NCT03398421|19945143|P2|STARTED|Treatment Period 1 (Up to 6 Days)||0
8090825|NCT03398421|19945144|P1|STARTED|Treatment Period 1 (Up to 6 Days)||20
8090826|NCT03398356|19945208|P3|NOT COMPLETED|After 15 Weeks of Treatment||0
8090827|NCT03398356|19945209|P2|NOT COMPLETED|After 15 Weeks of Treatment||0
8090828|NCT03398356|19945210|P1|NOT COMPLETED|After 15 Weeks of Treatment||0
8090829|NCT03398356|19945208|P3|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090830|NCT03398356|19945209|P2|COMPLETED|After 15 Weeks of Treatment||11
8090831|NCT03398356|19945210|P1|COMPLETED|After 15 Weeks of Treatment||14
8090832|NCT03398356|19945208|P3|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090833|NCT03398356|19945209|P2|STARTED|After 15 Weeks of Treatment||11
8090834|NCT03398356|19945210|P1|STARTED|After 15 Weeks of Treatment||14
8090835|NCT03398356|19945208|P3|NOT COMPLETED|After 12 Weeks of Treatment||0
8090836|NCT03398356|19945209|P2|NOT COMPLETED|After 12 Weeks of Treatment||0
8090837|NCT03398356|19945210|P1|NOT COMPLETED|After 12 Weeks of Treatment||0
8090838|NCT03398356|19945208|P3|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090839|NCT03398356|19945209|P2|COMPLETED|After 12 Weeks of Treatment||11
8090840|NCT03398356|19945210|P1|COMPLETED|After 12 Weeks of Treatment||14
8090841|NCT03398356|19945208|P3|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090842|NCT03398356|19945209|P2|STARTED|After 12 Weeks of Treatment||11
8090843|NCT03398356|19945210|P1|STARTED|After 12 Weeks of Treatment||14
8090844|NCT03398356|19945208|P3|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8090845|NCT03398356|19945209|P2|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8090846|NCT03398356|19945210|P1|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8090847|NCT03398356|19945208|P3|COMPLETED|Post 6 Week Period Initial Evaluation||0
8090848|NCT03398356|19945209|P2|COMPLETED|Post 6 Week Period Initial Evaluation||11
8090849|NCT03398356|19945210|P1|COMPLETED|Post 6 Week Period Initial Evaluation||14
8090850|NCT03398356|19945208|P3|STARTED|Post 6 Week Period Initial Evaluation||0
8090851|NCT03398356|19945209|P2|STARTED|Post 6 Week Period Initial Evaluation||11
8090852|NCT03398356|19945210|P1|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
8090853|NCT03398356|19945208|P3|NOT COMPLETED|After 6 Weeks of Treatment||0
8090854|NCT03398356|19945209|P2|NOT COMPLETED|After 6 Weeks of Treatment||2
8090855|NCT03398356|19945210|P1|NOT COMPLETED|After 6 Weeks of Treatment||0
8090856|NCT03398356|19945208|P3|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090857|NCT03398356|19945209|P2|COMPLETED|After 6 Weeks of Treatment||11
8090858|NCT03398356|19945210|P1|COMPLETED|After 6 Weeks of Treatment||12
8090859|NCT03398356|19945208|P3|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090860|NCT03398356|19945209|P2|STARTED|After 6 Weeks of Treatment||13
8090861|NCT03398356|19945210|P1|STARTED|After 6 Weeks of Treatment||12
8090862|NCT03398356|19945208|P3|NOT COMPLETED|Before Treatment||11
8090863|NCT03398356|19945209|P2|NOT COMPLETED|Before Treatment||8
8090864|NCT03398356|19945210|P1|NOT COMPLETED|Before Treatment||3
8090865|NCT03398356|19945208|P3|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
8090866|NCT03398356|19945209|P2|COMPLETED|Before Treatment||13
8090867|NCT03398356|19945210|P1|COMPLETED|Before Treatment||12
8090868|NCT03398356|19945208|P3|STARTED|Before Treatment||11
8090869|NCT03398356|19945209|P2|STARTED|Before Treatment||21
8090870|NCT03398356|19945210|P1|STARTED|Before Treatment||15
8090871|NCT03398330|19945235|P2|NOT COMPLETED|Period 2||0
8090872|NCT03398330|19945236|P1|NOT COMPLETED|Period 2||1
8090873|NCT03398330|19945235|P2|COMPLETED|Period 2||17
8090874|NCT03398330|19945236|P1|COMPLETED|Period 2||19
8090875|NCT03398330|19945235|P2|STARTED|Period 2||17
8090876|NCT03398330|19945236|P1|STARTED|Period 2||20
8090877|NCT03398330|19945235|P2|NOT COMPLETED|Period 1||4
8090878|NCT03398330|19945236|P1|NOT COMPLETED|Period 1||1
8090879|NCT03398330|19945235|P2|COMPLETED|Period 1||17
8090880|NCT03398330|19945236|P1|COMPLETED|Period 1||20
8090881|NCT03398330|19945235|P2|STARTED|Period 1||21
8090882|NCT03398330|19945236|P1|STARTED|Period 1||21
8090883|NCT03398278|19945258|P2|NOT COMPLETED|Period 2||2
8090884|NCT03398278|19945259|P1|NOT COMPLETED|Period 2||2
8090885|NCT03398278|19945258|P2|COMPLETED|Period 2||17
8090886|NCT03398278|19945259|P1|COMPLETED|Period 2||16
8090887|NCT03398278|19945258|P2|STARTED|Period 2||19
8090888|NCT03398278|19945259|P1|STARTED|Period 2||18
8090889|NCT03398278|19945258|P2|NOT COMPLETED|Period 1||0
8090890|NCT03398278|19945259|P1|NOT COMPLETED|Period 1||1
8090891|NCT03398278|19945258|P2|COMPLETED|Period 1||19
8090892|NCT03398278|19945259|P1|COMPLETED|Period 1||18
8090893|NCT03398278|19945258|P2|STARTED|Period 1||19
8090894|NCT03398278|19945259|P1|STARTED|Period 1||19
8090895|NCT03398213|19945282|P3|NOT COMPLETED|Overall Study||0
8090896|NCT03398213|19945283|P2|NOT COMPLETED|Overall Study||0
8090897|NCT03398213|19945284|P1|NOT COMPLETED|Overall Study||0
8090898|NCT03398213|19945282|P3|COMPLETED|Overall Study||22
8090899|NCT03398213|19945283|P2|COMPLETED|Overall Study||24
8090900|NCT03398213|19945284|P1|COMPLETED|Overall Study||26
8090901|NCT03398213|19945282|P3|STARTED|Overall Study||22
8090902|NCT03398213|19945283|P2|STARTED|Overall Study||24
8090903|NCT03398213|19945284|P1|STARTED|Overall Study||26
8090904|NCT03397771|19945315|P2|NOT COMPLETED|Overall Study||7
8090905|NCT03397771|19945316|P1|NOT COMPLETED|Overall Study||8
8090906|NCT03397771|19945315|P2|COMPLETED|Overall Study||22
8090907|NCT03397771|19945316|P1|COMPLETED|Overall Study||45
8090908|NCT03397771|19945315|P2|STARTED|Overall Study||29
8090909|NCT03397771|19945316|P1|STARTED|Overall Study||53
8090910|NCT03397394|19945327|P3|NOT COMPLETED|Overall Study||0
8090911|NCT03397394|19945328|P2|NOT COMPLETED|Overall Study||0
8090912|NCT03397394|19945329|P1|NOT COMPLETED|Overall Study||0
8090913|NCT03397394|19945327|P3|COMPLETED|Overall Study||20
8090914|NCT03397394|19945328|P2|COMPLETED|Overall Study||30
8090915|NCT03397394|19945329|P1|COMPLETED|Overall Study||47
8090916|NCT03397394|19945327|P3|STARTED|Overall Study||20
8090917|NCT03397394|19945328|P2|STARTED|Overall Study||30
8090918|NCT03397394|19945329|P1|STARTED|Overall Study||47
8090919|NCT03397121|19945353|P2|NOT COMPLETED|Overall Study||9
8090920|NCT03397121|19945354|P1|NOT COMPLETED|Overall Study||7
8090921|NCT03397121|19945353|P2|COMPLETED|Overall Study||231
8090922|NCT03397121|19945354|P1|COMPLETED|Overall Study||235
8090923|NCT03397121|19945353|P2|STARTED|Overall Study||240
8090924|NCT03397121|19945354|P1|STARTED|Overall Study||242
8090925|NCT03396913|19945376|P2|NOT COMPLETED|Overall Study||6
8090926|NCT03396913|19945377|P1|NOT COMPLETED|Overall Study||0
8090927|NCT03396913|19945376|P2|COMPLETED|Overall Study||39
8090928|NCT03396913|19945377|P1|COMPLETED|Overall Study||43
8090929|NCT03396913|19945376|P2|STARTED|Overall Study||45
8090930|NCT03396913|19945377|P1|STARTED|Overall Study||43
8090931|NCT03396835|19945387|P1|NOT COMPLETED|Overall Study||2
8090932|NCT03396835|19945387|P1|COMPLETED|Overall Study||14
8090933|NCT03396835|19945387|P1|STARTED|Overall Study||16
8090940|NCT03395990|19945402|P2|NOT COMPLETED|Overall Study||0
8090941|NCT03395990|19945403|P1|NOT COMPLETED|Overall Study||0
8090942|NCT03395990|19945402|P2|COMPLETED|Overall Study||8
8090943|NCT03395990|19945403|P1|COMPLETED|Overall Study||8
8090944|NCT03395990|19945402|P2|STARTED|Overall Study||8
8090945|NCT03395990|19945403|P1|STARTED|Overall Study||8
8090946|NCT03395886|19945411|P2|NOT COMPLETED|Overall Study||38
8090947|NCT03395886|19945412|P1|NOT COMPLETED|Overall Study||52
8090948|NCT03395886|19945411|P2|COMPLETED|Overall Study||0
8090949|NCT03395886|19945412|P1|COMPLETED|Overall Study||0
8090950|NCT03395886|19945411|P2|STARTED|Overall Study||38
8090951|NCT03395886|19945412|P1|STARTED|Overall Study||52
8090952|NCT03394508|19945422|P2|NOT COMPLETED|Overall Study||3
8090953|NCT03394508|19945423|P1|NOT COMPLETED|Overall Study||1
8090954|NCT03394508|19945422|P2|COMPLETED|Overall Study||14
8090955|NCT03394508|19945423|P1|COMPLETED|Overall Study||12
8090956|NCT03394508|19945422|P2|STARTED|Overall Study||17
8090957|NCT03394508|19945423|P1|STARTED|Overall Study||13
8090958|NCT03394391|19945449|P2|NOT COMPLETED|Overall Study||2
8090959|NCT03394391|19945450|P1|NOT COMPLETED|Overall Study||1
8090960|NCT03394391|19945449|P2|COMPLETED|Overall Study||104
8090961|NCT03394391|19945450|P1|COMPLETED|Overall Study||105
8090962|NCT03394391|19945449|P2|STARTED|Overall Study||106
8090963|NCT03394391|19945450|P1|STARTED|Overall Study||106
8090964|NCT03393806|19945468|P2|NOT COMPLETED|Overall Study||0
8090965|NCT03393806|19945469|P1|NOT COMPLETED|Overall Study||1
8090966|NCT03393806|19945468|P2|COMPLETED|Overall Study||8
8090967|NCT03393806|19945469|P1|COMPLETED|Overall Study||8
8090968|NCT03393806|19945468|P2|STARTED|Overall Study||8
8090969|NCT03393806|19945469|P1|STARTED|Overall Study||9
8090970|NCT03393754|19945514|P2|NOT COMPLETED|Overall Study||38
8090971|NCT03393754|19945515|P1|NOT COMPLETED|Overall Study||26
8090972|NCT03393754|19945514|P2|COMPLETED|Overall Study||758
8090973|NCT03393754|19945515|P1|COMPLETED|Overall Study||785
8090974|NCT03393754|19945514|P2|STARTED|Overall Study||796
8090975|NCT03393754|19945515|P1|STARTED|Overall Study||811
8090976|NCT03393494|19945528|P3|NOT COMPLETED|Overall Study||25
8090977|NCT03393494|19945529|P2|NOT COMPLETED|Overall Study||75
8090978|NCT03393494|19945530|P1|NOT COMPLETED|Overall Study||68
8090979|NCT03393494|19945528|P3|COMPLETED|Overall Study||140
8090980|NCT03393494|19945529|P2|COMPLETED|Overall Study||256
8090981|NCT03393494|19945530|P1|COMPLETED|Overall Study||261
8090982|NCT03393494|19945528|P3|STARTED|Overall Study||165
8090983|NCT03393494|19945529|P2|STARTED|Overall Study||331
8090984|NCT03393494|19945530|P1|STARTED|Overall Study||329
8090985|NCT03393208|19945545|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090986|NCT03393208|19945546|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090987|NCT03393208|19945547|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090988|NCT03393208|19945548|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090989|NCT03393208|19945545|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
8090990|NCT03393208|19945546|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
8090991|NCT03393208|19945547|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
8090992|NCT03393208|19945548|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
8090993|NCT03393208|19945545|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||9
8090994|NCT03393208|19945546|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||9
8090995|NCT03393208|19945547|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||13
8090996|NCT03393208|19945548|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||13
8090997|NCT03393208|19945545|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8090998|NCT03393208|19945546|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8090999|NCT03393208|19945547|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8091000|NCT03393208|19945548|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8091001|NCT03393208|19945545|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
8091002|NCT03393208|19945546|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
8091003|NCT03393208|19945547|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
8091004|NCT03393208|19945548|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
8091005|NCT03393208|19945545|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||9
8091006|NCT03393208|19945546|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||9
8091007|NCT03393208|19945547|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||13
8091008|NCT03393208|19945548|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||13
8091009|NCT03392532|19945602|P2|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
8091010|NCT03392532|19945603|P1|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
8091011|NCT03392532|19945602|P2|COMPLETED|Period 2, Second 30 Minutes of Wear||18
8091012|NCT03392532|19945603|P1|COMPLETED|Period 2, Second 30 Minutes of Wear||18
8091013|NCT03392532|19945602|P2|STARTED|Period 2, Second 30 Minutes of Wear||18
8091014|NCT03392532|19945603|P1|STARTED|Period 2, Second 30 Minutes of Wear||18
8091015|NCT03392532|19945602|P2|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
8091016|NCT03392532|19945603|P1|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
8091017|NCT03392532|19945602|P2|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
8091018|NCT03392532|19945603|P1|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
8091019|NCT03392532|19945602|P2|STARTED|Period 1, FIrst 30 Minutes of Wear||18
8091020|NCT03392532|19945603|P1|STARTED|Period 1, FIrst 30 Minutes of Wear||18
8091021|NCT03392194|19945611|P2|NOT COMPLETED|Overall Study||2
8091022|NCT03392194|19945612|P1|NOT COMPLETED|Overall Study||2
8091023|NCT03392194|19945611|P2|COMPLETED|Overall Study||15
8091024|NCT03392194|19945612|P1|COMPLETED|Overall Study||14
8091025|NCT03392194|19945611|P2|STARTED|Overall Study||17
8091026|NCT03392194|19945612|P1|STARTED|Overall Study||16
8091027|NCT03391986|19945621|P3|NOT COMPLETED|Overall Study||0
8091028|NCT03391986|19945622|P2|NOT COMPLETED|Overall Study||0
8091029|NCT03391986|19945623|P1|NOT COMPLETED|Overall Study||0
8091030|NCT03391986|19945621|P3|COMPLETED|Overall Study||50
8091031|NCT03391986|19945622|P2|COMPLETED|Overall Study||50
8091032|NCT03391986|19945623|P1|COMPLETED|Overall Study||53
8091033|NCT03391986|19945621|P3|STARTED|Overall Study||50
8091034|NCT03391986|19945622|P2|STARTED|Overall Study||50
8091035|NCT03391986|19945623|P1|STARTED|Overall Study||53
8091042|NCT03390426|19945647|P2|NOT COMPLETED|Overall Study||1
8091043|NCT03390426|19945648|P1|NOT COMPLETED|Overall Study||0
8091044|NCT03390426|19945647|P2|COMPLETED|Overall Study||15
8091045|NCT03390426|19945648|P1|COMPLETED|Overall Study||15
8091046|NCT03390426|19945647|P2|STARTED|Overall Study||16
8091047|NCT03390426|19945648|P1|STARTED|Overall Study||15
8091048|NCT03390257|19945660|P1|NOT COMPLETED|Overall Study||0
8091049|NCT03390257|19945660|P1|COMPLETED|Overall Study||14
8091050|NCT03390257|19945660|P1|STARTED|Overall Study||14
8091051|NCT03390166|19945668|P2|NOT COMPLETED|Overall Study||10
8091052|NCT03390166|19945669|P1|NOT COMPLETED|Overall Study||12
8091053|NCT03390166|19945668|P2|COMPLETED|Overall Study||305
8091054|NCT03390166|19945669|P1|COMPLETED|Overall Study||618
8091055|NCT03390166|19945668|P2|STARTED|Overall Study||315
8091056|NCT03390166|19945669|P1|STARTED|Overall Study||630
8091057|NCT03389854|19945685|P4|NOT COMPLETED|Overall Study||8
8091058|NCT03389854|19945686|P3|NOT COMPLETED|Overall Study||5
8091059|NCT03389854|19945687|P2|NOT COMPLETED|Overall Study||6
8091060|NCT03389854|19945688|P1|NOT COMPLETED|Overall Study||1
8091061|NCT03389854|19945685|P4|COMPLETED|Overall Study||19
8091062|NCT03389854|19945686|P3|COMPLETED|Overall Study||23
8091063|NCT03389854|19945687|P2|COMPLETED|Overall Study||21
8091064|NCT03389854|19945688|P1|COMPLETED|Overall Study||27
8091065|NCT03389854|19945685|P4|STARTED|Overall Study||27
8091066|NCT03389854|19945686|P3|STARTED|Overall Study||28
8091067|NCT03389854|19945687|P2|STARTED|Overall Study||27
8091068|NCT03389854|19945688|P1|STARTED|Overall Study||28
8091069|NCT03389308|19945723|P1|NOT COMPLETED|Overall Study||12
8091070|NCT03389308|19945723|P1|COMPLETED|Overall Study||39
8091071|NCT03389308|19945723|P1|STARTED|Overall Study||51
8091072|NCT03388645|19945729|P2|NOT COMPLETED|High Dose RSV A2||1
8091073|NCT03388645|19945730|P1|NOT COMPLETED|High Dose RSV A2||0
8091074|NCT03388645|19945729|P2|COMPLETED|High Dose RSV A2||7
8091075|NCT03388645|19945730|P1|COMPLETED|High Dose RSV A2||0
8091076|NCT03388645|19945729|P2|STARTED|High Dose RSV A2||8
8091077|NCT03388645|19945730|P1|STARTED|High Dose RSV A2||0
8091078|NCT03388645|19945729|P2|NOT COMPLETED|Low Dose RSV A2||0
8091079|NCT03388645|19945730|P1|NOT COMPLETED|Low Dose RSV A2||0
8091080|NCT03388645|19945729|P2|COMPLETED|Low Dose RSV A2||0
8091081|NCT03388645|19945730|P1|COMPLETED|Low Dose RSV A2||4
8091082|NCT03388645|19945729|P2|STARTED|Low Dose RSV A2||0
8091083|NCT03388645|19945730|P1|STARTED|Low Dose RSV A2||4
8091084|NCT03387683|19945748|P2|NOT COMPLETED|Overall Study||0
8091085|NCT03387683|19945749|P1|NOT COMPLETED|Overall Study||2
8091086|NCT03387683|19945748|P2|COMPLETED|Overall Study||26
8091087|NCT03387683|19945749|P1|COMPLETED|Overall Study||25
8091088|NCT03387683|19945748|P2|STARTED|Overall Study||26
8091089|NCT03387683|19945749|P1|STARTED|Overall Study||27
8091090|NCT03387462|19945757|P1|NOT COMPLETED|Overall Study||1
8091091|NCT03387462|19945757|P1|COMPLETED|Overall Study||19
8091092|NCT03387462|19945757|P1|8 Weeks|Overall Study||19
8091093|NCT03387462|19945757|P1|4 Weeks|Overall Study||20
8091094|NCT03387462|19945757|P1|STARTED|Overall Study||20
8091095|NCT03387319|19945766|P2|NOT COMPLETED|Overall Study||0
8091096|NCT03387319|19945767|P1|NOT COMPLETED|Overall Study||0
8091097|NCT03387319|19945766|P2|COMPLETED|Overall Study||25
8091098|NCT03387319|19945767|P1|COMPLETED|Overall Study||25
8091099|NCT03387319|19945766|P2|STARTED|Overall Study||25
8091100|NCT03387319|19945767|P1|STARTED|Overall Study||25
8091101|NCT03387059|19945787|P2|NOT COMPLETED|Overall Study||4
8091102|NCT03387059|19945788|P1|NOT COMPLETED|Overall Study||5
8091103|NCT03387059|19945787|P2|COMPLETED|Overall Study||0
8091104|NCT03387059|19945788|P1|COMPLETED|Overall Study||0
8091105|NCT03387059|19945787|P2|STARTED|Overall Study||4
8091106|NCT03387059|19945788|P1|STARTED|Overall Study||5
8091107|NCT03387046|19945802|P2|NOT COMPLETED|Overall Study||1
8091108|NCT03387046|19945803|P1|NOT COMPLETED|Overall Study||1
8091109|NCT03387046|19945802|P2|COMPLETED|Overall Study||1
8091110|NCT03387046|19945803|P1|COMPLETED|Overall Study||4
8091111|NCT03387046|19945802|P2|STARTED|Overall Study||2
8091112|NCT03387046|19945803|P1|STARTED|Overall Study||5
8091113|NCT03386994|19945830|P1|NOT COMPLETED|Overall Study||38
8091114|NCT03386994|19945830|P1|COMPLETED|Overall Study||166
8091115|NCT03386994|19945830|P1|STARTED|Overall Study||204
8091116|NCT03386474|19945890|P2|NOT COMPLETED|Overall Study||1
8091117|NCT03386474|19945891|P1|NOT COMPLETED|Overall Study||1
8091118|NCT03386474|19945890|P2|COMPLETED|Overall Study||42
8091119|NCT03386474|19945891|P1|COMPLETED|Overall Study||106
8091120|NCT03386474|19945890|P2|STARTED|Overall Study||43
8091121|NCT03386474|19945891|P1|STARTED|Overall Study||107
8091122|NCT03386448|19945913|P2|NOT COMPLETED|Overall Study||2
8091123|NCT03386448|19945914|P1|NOT COMPLETED|Overall Study||0
8091124|NCT03386448|19945913|P2|COMPLETED|Overall Study||6
8091125|NCT03386448|19945914|P1|COMPLETED|Overall Study||6
8091126|NCT03386448|19945913|P2|STARTED|Overall Study||8
8091127|NCT03386448|19945914|P1|STARTED|Overall Study||6
8091128|NCT03386435|19945922|P2|NOT COMPLETED|Overall Study||7
8091129|NCT03386435|19945923|P1|NOT COMPLETED|Overall Study||5
8091130|NCT03386435|19945922|P2|COMPLETED|Overall Study||73
8091131|NCT03386435|19945923|P1|COMPLETED|Overall Study||75
8091132|NCT03386435|19945922|P2|STARTED|Overall Study||80
8091133|NCT03386435|19945923|P1|STARTED|Overall Study||80
8091134|NCT03386032|19945938|P3|NOT COMPLETED|Overall Study||0
8091135|NCT03386032|19945939|P2|NOT COMPLETED|Overall Study||7
8091136|NCT03386032|19945940|P1|NOT COMPLETED|Overall Study||18
8091137|NCT03386032|19945938|P3|COMPLETED|Overall Study||11
8091138|NCT03386032|19945939|P2|COMPLETED|Overall Study||11
8091139|NCT03386032|19945940|P1|COMPLETED|Overall Study||18
8091140|NCT03386032|19945938|P3|STARTED|Overall Study||11
8091141|NCT03386032|19945939|P2|STARTED|Overall Study||18
8091142|NCT03386032|19945940|P1|STARTED|Overall Study||36
8091143|NCT03384953|19945953|P2|NOT COMPLETED|Overall Study||8
8091144|NCT03384953|19945954|P1|NOT COMPLETED|Overall Study||40
8091145|NCT03384953|19945953|P2|COMPLETED|Overall Study||4
8091146|NCT03384953|19945954|P1|COMPLETED|Overall Study||51
8091147|NCT03384953|19945953|P2|Completed Treatment|Overall Study||6
8091148|NCT03384953|19945954|P1|Completed Treatment|Overall Study||68
8091149|NCT03384953|19945953|P2|STARTED|Overall Study||12
8091150|NCT03384953|19945954|P1|STARTED|Overall Study||91
8091151|NCT03384329|19945962|P2|NOT COMPLETED|Overall Study||0
8091152|NCT03384329|19945963|P1|NOT COMPLETED|Overall Study||0
8091153|NCT03384329|19945962|P2|COMPLETED|Overall Study||11
8091154|NCT03384329|19945963|P1|COMPLETED|Overall Study||11
8091155|NCT03384329|19945962|P2|STARTED|Overall Study||11
8091156|NCT03384329|19945963|P1|STARTED|Overall Study||11
8091157|NCT03384316|19945975|P2|NOT COMPLETED|Overall Study||1
8091158|NCT03384316|19945976|P1|NOT COMPLETED|Overall Study||0
8091159|NCT03384316|19945975|P2|COMPLETED|Overall Study||4
8091160|NCT03384316|19945976|P1|COMPLETED|Overall Study||6
8091161|NCT03384316|19945975|P2|STARTED|Overall Study||5
8091162|NCT03384316|19945976|P1|STARTED|Overall Study||6
8091163|NCT03384173|19946001|P1|NOT COMPLETED|Overall Study||0
8091164|NCT03384173|19946001|P1|COMPLETED|Overall Study||35
8091165|NCT03384173|19946001|P1|STARTED|Overall Study||35
8091166|NCT03383887|19946015|P2|NOT COMPLETED|Overall Study||1
8091167|NCT03383887|19946016|P1|NOT COMPLETED|Overall Study||0
8091168|NCT03383887|19946015|P2|COMPLETED|Overall Study||5
8091169|NCT03383887|19946016|P1|COMPLETED|Overall Study||5
8091170|NCT03383887|19946015|P2|STARTED|Overall Study||6
8091171|NCT03383887|19946016|P1|STARTED|Overall Study||5
8091172|NCT03383783|19946024|P1|NOT COMPLETED|Overall Study||2
8091173|NCT03383783|19946024|P1|COMPLETED|Overall Study||25
8091174|NCT03383783|19946024|P1|STARTED|Overall Study||27
8091175|NCT03383757|19946088|P1|NOT COMPLETED|Overall Study||39
8091176|NCT03383757|19946088|P1|COMPLETED|Overall Study||78
8091177|NCT03383757|19946088|P1|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
8091178|NCT03383757|19946088|P1|TruSignal AllFit Sensor Data Pairs|Overall Study||52
8091179|NCT03383757|19946088|P1|TruSignal Sensitive Sensor Subjects|Overall Study||59
8091180|NCT03383757|19946088|P1|TruSignal AllFit Sensor Subjects|Overall Study||56
8091181|NCT03383757|19946088|P1|STARTED|Overall Study||117
8091182|NCT03383627|19946094|P1|NOT COMPLETED|Overall Study||0
8091183|NCT03383627|19946094|P1|COMPLETED|Overall Study||80
8091184|NCT03383627|19946094|P1|STARTED|Overall Study||80
8091185|NCT03383614|19946108|P4|NOT COMPLETED|Overall Study||0
8091186|NCT03383614|19946109|P3|NOT COMPLETED|Overall Study||0
8091187|NCT03383614|19946110|P2|NOT COMPLETED|Overall Study||1
8091188|NCT03383614|19946111|P1|NOT COMPLETED|Overall Study||0
8091189|NCT03383614|19946108|P4|COMPLETED|Overall Study||6
8091190|NCT03383614|19946109|P3|COMPLETED|Overall Study||6
8091191|NCT03383614|19946110|P2|COMPLETED|Overall Study||5
8091192|NCT03383614|19946111|P1|COMPLETED|Overall Study||6
8091193|NCT03383614|19946108|P4|STARTED|Overall Study||6
8091194|NCT03383614|19946109|P3|STARTED|Overall Study||6
8091195|NCT03383614|19946110|P2|STARTED|Overall Study||6
8091196|NCT03383614|19946111|P1|STARTED|Overall Study||6
8091197|NCT03383588|19946278|P3|NOT COMPLETED|Overall Study||0
8091198|NCT03383588|19946279|P2|NOT COMPLETED|Overall Study||0
8091199|NCT03383588|19946280|P1|NOT COMPLETED|Overall Study||0
8091200|NCT03383588|19946278|P3|COMPLETED|Overall Study||9
8091201|NCT03383588|19946279|P2|COMPLETED|Overall Study||9
8091202|NCT03383588|19946280|P1|COMPLETED|Overall Study||8
8091203|NCT03383588|19946278|P3|STARTED|Overall Study||9
8091204|NCT03383588|19946279|P2|STARTED|Overall Study||9
8091205|NCT03383588|19946280|P1|STARTED|Overall Study||8
8091206|NCT03383523|19946295|P7|NOT COMPLETED|Overall Study||0
8091207|NCT03383523|19946296|P6|NOT COMPLETED|Overall Study||0
8091208|NCT03383523|19946297|P5|NOT COMPLETED|Overall Study||0
8091209|NCT03383523|19946298|P4|NOT COMPLETED|Overall Study||0
8091210|NCT03383523|19946299|P3|NOT COMPLETED|Overall Study||1
8091211|NCT03383523|19946300|P2|NOT COMPLETED|Overall Study||0
8091212|NCT03383523|19946301|P1|NOT COMPLETED|Overall Study||1
8091213|NCT03383523|19946295|P7|COMPLETED|Overall Study||10
8091214|NCT03383523|19946296|P6|COMPLETED|Overall Study||12
8091215|NCT03383523|19946297|P5|COMPLETED|Overall Study||11
8091216|NCT03383523|19946298|P4|COMPLETED|Overall Study||12
8091217|NCT03383523|19946299|P3|COMPLETED|Overall Study||9
8091218|NCT03383523|19946300|P2|COMPLETED|Overall Study||11
8091219|NCT03383523|19946301|P1|COMPLETED|Overall Study||10
8091220|NCT03383523|19946295|P7|STARTED|Overall Study||10
8091221|NCT03383523|19946296|P6|STARTED|Overall Study||12
8091222|NCT03383523|19946297|P5|STARTED|Overall Study||11
8091223|NCT03383523|19946298|P4|STARTED|Overall Study||12
8091224|NCT03383523|19946299|P3|STARTED|Overall Study||10
8091225|NCT03383523|19946300|P2|STARTED|Overall Study||11
8091226|NCT03383523|19946301|P1|STARTED|Overall Study||11
8091227|NCT03383198|19946368|P2|NOT COMPLETED|Overall Study||0
8091228|NCT03383198|19946369|P1|NOT COMPLETED|Overall Study||0
8091229|NCT03383198|19946368|P2|COMPLETED|Overall Study||1
8091230|NCT03383198|19946369|P1|COMPLETED|Overall Study||4
8091231|NCT03383198|19946368|P2|STARTED|Overall Study||1
8091232|NCT03383198|19946369|P1|STARTED|Overall Study||4
8091233|NCT03382912|19946379|P2|NOT COMPLETED|Overall Study||12
8091234|NCT03382912|19946380|P1|NOT COMPLETED|Overall Study||6
8091235|NCT03382912|19946379|P2|COMPLETED|Overall Study||13
8091236|NCT03382912|19946380|P1|COMPLETED|Overall Study||21
8091237|NCT03382912|19946379|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
8091238|NCT03382912|19946380|P1|Received at Least 1 Dose of Study Drug|Overall Study||27
8091239|NCT03382912|19946379|P2|STARTED|Overall Study||25
8091240|NCT03382912|19946380|P1|STARTED|Overall Study||27
8091241|NCT03382899|19946396|P2|NOT COMPLETED|Overall Study||35
8091242|NCT03382899|19946397|P1|NOT COMPLETED|Overall Study||31
8091243|NCT03382899|19946396|P2|COMPLETED|Overall Study||15
8091244|NCT03382899|19946397|P1|COMPLETED|Overall Study||20
8091245|NCT03382899|19946396|P2|Received at Least 1 Dose of Study Drug|Overall Study||48
8091246|NCT03382899|19946397|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
8091247|NCT03382899|19946396|P2|STARTED|Overall Study||50
8091248|NCT03382899|19946397|P1|STARTED|Overall Study||51
8091249|NCT03382834|19946413|P2|NOT COMPLETED|Overall Study||1
8091250|NCT03382834|19946414|P1|NOT COMPLETED|Overall Study||1
8091251|NCT03382834|19946413|P2|COMPLETED|Overall Study||9
8091252|NCT03382834|19946414|P1|COMPLETED|Overall Study||20
8091253|NCT03382834|19946413|P2|STARTED|Overall Study||10
8091254|NCT03382834|19946414|P1|STARTED|Overall Study||21
8091255|NCT03382665|19946426|P1|NOT COMPLETED|Overall Study||45
8091256|NCT03382665|19946426|P1|COMPLETED|Overall Study||25
8091257|NCT03382665|19946426|P1|5 Year Follow up|Overall Study||25
8091258|NCT03382665|19946426|P1|Actual Enrollment|Overall Study||59
8091259|NCT03382665|19946426|P1|STARTED|Overall Study||70
8091260|NCT03382262|19946438|P4|NOT COMPLETED|Overall Study||1
8091261|NCT03382262|19946439|P3|NOT COMPLETED|Overall Study||1
8091262|NCT03382262|19946440|P2|NOT COMPLETED|Overall Study||0
8091263|NCT03382262|19946441|P1|NOT COMPLETED|Overall Study||0
8091264|NCT03382262|19946438|P4|COMPLETED|Overall Study||14
8091265|NCT03382262|19946439|P3|COMPLETED|Overall Study||14
8091266|NCT03382262|19946440|P2|COMPLETED|Overall Study||13
8091267|NCT03382262|19946441|P1|COMPLETED|Overall Study||12
8091268|NCT03382262|19946438|P4|STARTED|Overall Study||15
8091269|NCT03382262|19946439|P3|STARTED|Overall Study||15
8091270|NCT03382262|19946440|P2|STARTED|Overall Study||13
8091271|NCT03382262|19946441|P1|STARTED|Overall Study||12
8091272|NCT03381989|19946455|P1|NOT COMPLETED|Overall Study||8
8091273|NCT03381989|19946455|P1|COMPLETED|Overall Study||22
8091274|NCT03381989|19946455|P1|STARTED|Overall Study||30
8091275|NCT03381742|19946464|P4|NOT COMPLETED|Overall Study||0
8091276|NCT03381742|19946465|P3|NOT COMPLETED|Overall Study||0
8091277|NCT03381742|19946466|P2|NOT COMPLETED|Overall Study||0
8091278|NCT03381742|19946467|P1|NOT COMPLETED|Overall Study||0
8091279|NCT03381742|19946464|P4|COMPLETED|Overall Study||506
8091280|NCT03381742|19946465|P3|COMPLETED|Overall Study||1511
8091281|NCT03381742|19946466|P2|COMPLETED|Overall Study||501
8091282|NCT03381742|19946467|P1|COMPLETED|Overall Study||525
8091283|NCT03381742|19946464|P4|STARTED|Overall Study||506
8091284|NCT03381742|19946465|P3|STARTED|Overall Study||1511
8091285|NCT03381742|19946466|P2|STARTED|Overall Study||501
8091286|NCT03381742|19946467|P1|STARTED|Overall Study||525
8091287|NCT03381248|19946499|P2|NOT COMPLETED|Overall Study||6
8091288|NCT03381248|19946500|P1|NOT COMPLETED|Overall Study||13
8091289|NCT03381248|19946499|P2|COMPLETED|Overall Study||82
8091290|NCT03381248|19946500|P1|COMPLETED|Overall Study||76
8091291|NCT03381248|19946499|P2|STARTED|Overall Study||88
8091292|NCT03381248|19946500|P1|STARTED|Overall Study||89
8091293|NCT03380845|19946514|P1|NOT COMPLETED|Overall Study||0
8091294|NCT03380845|19946514|P1|COMPLETED|Overall Study||4
8091295|NCT03380845|19946514|P1|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
8091296|NCT03380780|19946524|P1|NOT COMPLETED|Overall Study||0
8091297|NCT03380780|19946524|P1|COMPLETED|Overall Study||16
8091298|NCT03380780|19946524|P1|STARTED|Overall Study||16
8091299|NCT03380572|19946593|P2|NOT COMPLETED|Overall Study||0
8091300|NCT03380572|19946594|P1|NOT COMPLETED|Overall Study||0
8091301|NCT03380572|19946593|P2|COMPLETED|Overall Study||20
8091302|NCT03380572|19946594|P1|COMPLETED|Overall Study||20
8091303|NCT03380572|19946593|P2|STARTED|Overall Study||20
8091304|NCT03380572|19946594|P1|STARTED|Overall Study||20
8091305|NCT03380429|19946607|P5|NOT COMPLETED|Overall Study||5
8091306|NCT03380429|19946608|P4|NOT COMPLETED|Overall Study||10
8091307|NCT03380429|19946609|P3|NOT COMPLETED|Overall Study||11
8091308|NCT03380429|19946610|P2|NOT COMPLETED|Overall Study||7
8091309|NCT03380429|19946611|P1|NOT COMPLETED|Overall Study||5
8091310|NCT03380429|19946607|P5|COMPLETED|Overall Study||81
8091311|NCT03380429|19946608|P4|COMPLETED|Overall Study||78
8091312|NCT03380429|19946609|P3|COMPLETED|Overall Study||77
8091313|NCT03380429|19946610|P2|COMPLETED|Overall Study||81
8091314|NCT03380429|19946611|P1|COMPLETED|Overall Study||82
8091315|NCT03380429|19946607|P5|STARTED|Overall Study||86
8091316|NCT03380429|19946608|P4|STARTED|Overall Study||88
8091317|NCT03380429|19946609|P3|STARTED|Overall Study||88
8091318|NCT03380429|19946610|P2|STARTED|Overall Study||88
8091319|NCT03380429|19946611|P1|STARTED|Overall Study||87
8091320|NCT03380390|19946664|P1|NOT COMPLETED|Overall Study||3
8091321|NCT03380390|19946664|P1|COMPLETED|Overall Study||43
8091322|NCT03380390|19946664|P1|STARTED|Overall Study||46
8091323|NCT03379753|19946672|P2|NOT COMPLETED|Overall Study||25
8091324|NCT03379753|19946673|P1|NOT COMPLETED|Overall Study||15
8091325|NCT03379753|19946672|P2|COMPLETED|Overall Study||46
8091326|NCT03379753|19946673|P1|COMPLETED|Overall Study||46
8091327|NCT03379753|19946672|P2|STARTED|Overall Study||71
8091328|NCT03379753|19946673|P1|STARTED|Overall Study||61
8091329|NCT03379740|19946681|P2|NOT COMPLETED|Overall Study||0
8091330|NCT03379740|19946682|P1|NOT COMPLETED|Overall Study||0
8091331|NCT03379740|19946681|P2|COMPLETED|Overall Study||7
8091332|NCT03379740|19946682|P1|COMPLETED|Overall Study||8
8091333|NCT03379740|19946681|P2|STARTED|Overall Study||7
8091334|NCT03379740|19946682|P1|STARTED|Overall Study||8
8091335|NCT03379545|19946760|P1|NOT COMPLETED|Overall Study||0
8091336|NCT03379545|19946760|P1|COMPLETED|Overall Study||29
8091337|NCT03379545|19946760|P1|STARTED|Overall Study||29
8091338|NCT03379506|19946769|P4|NOT COMPLETED|Overall Study||11
8091339|NCT03379506|19946770|P3|NOT COMPLETED|Overall Study||0
8091340|NCT03379506|19946771|P2|NOT COMPLETED|Overall Study||9
8091341|NCT03379506|19946772|P1|NOT COMPLETED|Overall Study||0
8091342|NCT03379506|19946769|P4|COMPLETED|Overall Study||0
8091343|NCT03379506|19946770|P3|COMPLETED|Overall Study||7
8091344|NCT03379506|19946771|P2|COMPLETED|Overall Study||8
8091345|NCT03379506|19946772|P1|COMPLETED|Overall Study||22
8091346|NCT03379506|19946769|P4|STARTED|Overall Study||11
8091347|NCT03379506|19946770|P3|STARTED|Overall Study||7
8091348|NCT03379506|19946771|P2|STARTED|Overall Study||17
8091349|NCT03379506|19946772|P1|STARTED|Overall Study||22
8091350|NCT03379376|19946822|P1|NOT COMPLETED|Overall Study||5
8091351|NCT03379376|19946822|P1|COMPLETED|Overall Study||5
8091352|NCT03379376|19946822|P1|STARTED|Overall Study||10
8091353|NCT03379233|19946832|P2|NOT COMPLETED|Overall Study||6
8091354|NCT03379233|19946833|P1|NOT COMPLETED|Overall Study||1
8091355|NCT03379233|19946832|P2|COMPLETED|Overall Study||0
8091356|NCT03379233|19946833|P1|COMPLETED|Overall Study||0
8091357|NCT03379233|19946832|P2|STARTED|Overall Study||6
8091358|NCT03379233|19946833|P1|STARTED|Overall Study||1
8091359|NCT03378973|19946847|P2|NOT COMPLETED|Overall Study||0
8091360|NCT03378973|19946848|P1|NOT COMPLETED|Overall Study||0
8091361|NCT03378973|19946847|P2|COMPLETED|Overall Study||3
8091362|NCT03378973|19946848|P1|COMPLETED|Overall Study||4
8091363|NCT03378973|19946847|P2|STARTED|Overall Study||3
8091364|NCT03378973|19946848|P1|STARTED|Overall Study||4
8091365|NCT03378076|19946856|P2|NOT COMPLETED|Overall Study||0
8091366|NCT03378076|19946857|P1|NOT COMPLETED|Overall Study||0
8091367|NCT03378076|19946856|P2|COMPLETED|Overall Study||12
8091368|NCT03378076|19946857|P1|COMPLETED|Overall Study||12
8091369|NCT03378076|19946856|P2|STARTED|Overall Study||12
8091370|NCT03378076|19946857|P1|STARTED|Overall Study||12
8091371|NCT03377634|19946867|P2|NOT COMPLETED|Study Period||0
8091372|NCT03377634|19946868|P1|NOT COMPLETED|Study Period||2
8091373|NCT03377634|19946867|P2|COMPLETED|Study Period||13
8091374|NCT03377634|19946868|P1|COMPLETED|Study Period||13
8091375|NCT03377634|19946867|P2|STARTED|Study Period||13
8091376|NCT03377634|19946868|P1|STARTED|Study Period||15
8091377|NCT03377634|19946867|P2|NOT COMPLETED|Intervention Usability Testing Period||0
8091378|NCT03377634|19946868|P1|NOT COMPLETED|Intervention Usability Testing Period||0
8091379|NCT03377634|19946867|P2|COMPLETED|Intervention Usability Testing Period||0
8091380|NCT03377634|19946868|P1|COMPLETED|Intervention Usability Testing Period||5
8091381|NCT03377634|19946867|P2|STARTED|Intervention Usability Testing Period||0
8091382|NCT03377634|19946868|P1|STARTED|Intervention Usability Testing Period||5
8091383|NCT03376516|19946890|P1|NOT COMPLETED|Overall Study||2
8091384|NCT03376516|19946890|P1|COMPLETED|Overall Study||9
8091385|NCT03376516|19946890|P1|SURG Population|Overall Study||2
8091386|NCT03376516|19946890|P1|PP Population|Overall Study||9
8091387|NCT03376516|19946890|P1|PK Population|Overall Study||10
8091388|NCT03376516|19946890|P1|FAS Population|Overall Study||10
8091389|NCT03376516|19946890|P1|SAF Population|Overall Study||10
8091390|NCT03376516|19946890|P1|Received Treatment|Overall Study||10
8091391|NCT03376516|19946890|P1|STARTED|Overall Study||11
8091392|NCT03376295|19946922|P2|NOT COMPLETED|Overall Study||0
8091393|NCT03376295|19946923|P1|NOT COMPLETED|Overall Study||0
8091394|NCT03376295|19946922|P2|COMPLETED|Overall Study||1977
8091395|NCT03376295|19946923|P1|COMPLETED|Overall Study||1977
8091396|NCT03376295|19946922|P2|STARTED|Overall Study||1977
8091397|NCT03376295|19946923|P1|STARTED|Overall Study||1977
8091398|NCT03376256|19946935|P2|NOT COMPLETED|Overall Study||0
8091399|NCT03376256|19946936|P1|NOT COMPLETED|Overall Study||0
8091400|NCT03376256|19946935|P2|COMPLETED|Overall Study||0
8091401|NCT03376256|19946936|P1|COMPLETED|Overall Study||2
8091402|NCT03376256|19946935|P2|STARTED|Overall Study||0
8091403|NCT03376256|19946936|P1|STARTED|Overall Study||2
8091410|NCT03375294|19946965|P1|NOT COMPLETED|Overall Study||0
8091411|NCT03375294|19946965|P1|COMPLETED|Overall Study||3
8091412|NCT03375294|19946965|P1|STARTED|Overall Study||3
8091413|NCT03374995|19946971|P2|NOT COMPLETED|Overall Study||1
8091414|NCT03374995|19946972|P1|NOT COMPLETED|Overall Study||0
8091415|NCT03374995|19946971|P2|COMPLETED|Overall Study||11
8091416|NCT03374995|19946972|P1|COMPLETED|Overall Study||13
8091417|NCT03374995|19946971|P2|STARTED|Overall Study||12
8091418|NCT03374995|19946972|P1|STARTED|Overall Study||13
8091419|NCT03374488|19946986|P2|NOT COMPLETED|Overall Study||37
8091420|NCT03374488|19946987|P1|NOT COMPLETED|Overall Study||41
8091421|NCT03374488|19946986|P2|COMPLETED|Overall Study||5
8091422|NCT03374488|19946987|P1|COMPLETED|Overall Study||1
8091423|NCT03374488|19946986|P2|All Participants as Treated (APaT)|Overall Study||41
8091424|NCT03374488|19946987|P1|All Participants as Treated (APaT)|Overall Study||42
8091425|NCT03374488|19946986|P2|Intention-to-Treat (ITT)|Overall Study||42
8091426|NCT03374488|19946987|P1|Intention-to-Treat (ITT)|Overall Study||42
8091427|NCT03374488|19946986|P2|STARTED|Overall Study||42
8091428|NCT03374488|19946987|P1|STARTED|Overall Study||42
8091429|NCT03374189|19946999|P2|NOT COMPLETED|Overall Study||0
8091430|NCT03374189|19947000|P1|NOT COMPLETED|Overall Study||1
8091431|NCT03374189|19946999|P2|COMPLETED|Overall Study||39
8091432|NCT03374189|19947000|P1|COMPLETED|Overall Study||39
8091433|NCT03374189|19946999|P2|STARTED|Overall Study||39
8091434|NCT03374189|19947000|P1|STARTED|Overall Study||40
8091435|NCT03374176|19947020|P2|NOT COMPLETED|Overall Study||0
8091436|NCT03374176|19947021|P1|NOT COMPLETED|Overall Study||0
8091437|NCT03374176|19947020|P2|COMPLETED|Overall Study||21
8091438|NCT03374176|19947021|P1|COMPLETED|Overall Study||21
8091439|NCT03374176|19947020|P2|STARTED|Overall Study||21
8091440|NCT03374176|19947021|P1|STARTED|Overall Study||21
8091441|NCT03373890|19947035|P2|NOT COMPLETED|Overall Study||0
8091442|NCT03373890|19947036|P1|NOT COMPLETED|Overall Study||0
8091443|NCT03373890|19947035|P2|COMPLETED|Overall Study||6
8091444|NCT03373890|19947036|P1|COMPLETED|Overall Study||6
8091445|NCT03373890|19947035|P2|STARTED|Overall Study||6
8091446|NCT03373890|19947036|P1|STARTED|Overall Study||6
8091447|NCT03373591|19947059|P3|NOT COMPLETED|Overall Study||0
8091448|NCT03373591|19947060|P2|NOT COMPLETED|Overall Study||0
8091449|NCT03373591|19947061|P1|NOT COMPLETED|Overall Study||0
8091450|NCT03373591|19947059|P3|COMPLETED|Overall Study||73
8091451|NCT03373591|19947060|P2|COMPLETED|Overall Study||71
8091452|NCT03373591|19947061|P1|COMPLETED|Overall Study||75
8091453|NCT03373591|19947059|P3|STARTED|Overall Study||73
8091454|NCT03373591|19947060|P2|STARTED|Overall Study||71
8091455|NCT03373591|19947061|P1|STARTED|Overall Study||75
8091456|NCT03373240|19947092|P2|NOT COMPLETED|Overall Study||4
8091457|NCT03373240|19947093|P1|NOT COMPLETED|Overall Study||11
8091458|NCT03373240|19947092|P2|COMPLETED|Overall Study|This is the 1-month post follow-up|20
8091459|NCT03373240|19947093|P1|COMPLETED|Overall Study|This is the 1-month post follow-up|11
8091460|NCT03373240|19947092|P2|4-week Post Treatment|Overall Study||23
8091461|NCT03373240|19947093|P1|4-week Post Treatment|Overall Study||14
8091462|NCT03373240|19947092|P2|STARTED|Overall Study||24
8091463|NCT03373240|19947093|P1|STARTED|Overall Study||22
8091464|NCT03373162|19947117|P1|NOT COMPLETED|Overall Study||0
8091465|NCT03373162|19947117|P1|COMPLETED|Overall Study||10
8091466|NCT03373162|19947117|P1|STARTED|Overall Study||10
8091467|NCT03373006|19947123|P1|NOT COMPLETED|Overall Study||0
8091468|NCT03373006|19947123|P1|COMPLETED|Overall Study||20
8091469|NCT03373006|19947123|P1|STARTED|Overall Study||20
8091470|NCT03372928|19947127|P2|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
8091471|NCT03372928|19947128|P1|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
8091472|NCT03372928|19947127|P2|COMPLETED|Second Intervention (5 d Energy Deficit)||9
8091473|NCT03372928|19947128|P1|COMPLETED|Second Intervention (5 d Energy Deficit)||10
8091474|NCT03372928|19947127|P2|STARTED|Second Intervention (5 d Energy Deficit)||9
8091475|NCT03372928|19947128|P1|STARTED|Second Intervention (5 d Energy Deficit)||10
8091476|NCT03372928|19947127|P2|NOT COMPLETED|Washout (14 d)||1
8091477|NCT03372928|19947128|P1|NOT COMPLETED|Washout (14 d)||0
8091478|NCT03372928|19947127|P2|COMPLETED|Washout (14 d)||9
8091479|NCT03372928|19947128|P1|COMPLETED|Washout (14 d)||10
8091480|NCT03372928|19947127|P2|STARTED|Washout (14 d)||10
8091481|NCT03372928|19947128|P1|STARTED|Washout (14 d)||10
8091482|NCT03372928|19947127|P2|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
8091483|NCT03372928|19947128|P1|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
8091484|NCT03372928|19947127|P2|COMPLETED|First Intervention (5 d Energy Deficit)||10
8091485|NCT03372928|19947128|P1|COMPLETED|First Intervention (5 d Energy Deficit)||10
8091486|NCT03372928|19947127|P2|STARTED|First Intervention (5 d Energy Deficit)||10
8091487|NCT03372928|19947128|P1|STARTED|First Intervention (5 d Energy Deficit)||10
8091488|NCT03372603|19947140|P2|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
8091489|NCT03372603|19947141|P1|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
8091490|NCT03372603|19947140|P2|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
8091491|NCT03372603|19947141|P1|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
8091492|NCT03372603|19947140|P2|STARTED|Treatment Period 2 (Up to 7 Days)||8
8091493|NCT03372603|19947141|P1|STARTED|Treatment Period 2 (Up to 7 Days)||8
8091494|NCT03372603|19947140|P2|NOT COMPLETED|Wash-out Period (14-21 Days)||0
8091495|NCT03372603|19947141|P1|NOT COMPLETED|Wash-out Period (14-21 Days)||1
8091496|NCT03372603|19947140|P2|COMPLETED|Wash-out Period (14-21 Days)||8
8091497|NCT03372603|19947141|P1|COMPLETED|Wash-out Period (14-21 Days)||8
8091498|NCT03372603|19947140|P2|STARTED|Wash-out Period (14-21 Days)||8
8091499|NCT03372603|19947141|P1|STARTED|Wash-out Period (14-21 Days)||9
8091500|NCT03372603|19947140|P2|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
8091501|NCT03372603|19947141|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
8091502|NCT03372603|19947140|P2|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
8091503|NCT03372603|19947141|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
8091504|NCT03372603|19947140|P2|STARTED|Treatment Period 1 (Up to 7 Days)||8
8091505|NCT03372603|19947141|P1|STARTED|Treatment Period 1 (Up to 7 Days)||9
8091506|NCT03372551|19947183|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8091507|NCT03372551|19947184|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8091508|NCT03372551|19947183|P2|COMPLETED|Second Intervention (1 Week)||16
8091509|NCT03372551|19947184|P1|COMPLETED|Second Intervention (1 Week)||16
8091510|NCT03372551|19947183|P2|STARTED|Second Intervention (1 Week)||16
8091511|NCT03372551|19947184|P1|STARTED|Second Intervention (1 Week)||16
8091512|NCT03372551|19947183|P2|NOT COMPLETED|First Intervention (1 Week)||0
8091513|NCT03372551|19947184|P1|NOT COMPLETED|First Intervention (1 Week)||1
8091514|NCT03372551|19947183|P2|COMPLETED|First Intervention (1 Week)||16
8091515|NCT03372551|19947184|P1|COMPLETED|First Intervention (1 Week)||16
8091516|NCT03372551|19947183|P2|STARTED|First Intervention (1 Week)||16
8091517|NCT03372551|19947184|P1|STARTED|First Intervention (1 Week)||17
8091518|NCT03372382|19947203|P2|NOT COMPLETED|Overall Study||4
8091519|NCT03372382|19947204|P1|NOT COMPLETED|Overall Study||9
8091520|NCT03372382|19947203|P2|COMPLETED|Overall Study||81
8091521|NCT03372382|19947204|P1|COMPLETED|Overall Study||76
8091522|NCT03372382|19947203|P2|STARTED|Overall Study||85
8091523|NCT03372382|19947204|P1|STARTED|Overall Study||85
8091524|NCT03372369|19947214|P2|NOT COMPLETED|Intervention and Follow-Up Period||3
8091525|NCT03372369|19947215|P1|NOT COMPLETED|Intervention and Follow-Up Period||3
8091526|NCT03372369|19947214|P2|COMPLETED|Intervention and Follow-Up Period||470
8091527|NCT03372369|19947215|P1|COMPLETED|Intervention and Follow-Up Period||466
8091528|NCT03372369|19947214|P2|STARTED|Intervention and Follow-Up Period||473
8091529|NCT03372369|19947215|P1|STARTED|Intervention and Follow-Up Period||469
8091530|NCT03372369|19947214|P2|NOT COMPLETED|Qualification Period||22
8091531|NCT03372369|19947215|P1|NOT COMPLETED|Qualification Period||26
8091532|NCT03372369|19947214|P2|COMPLETED|Qualification Period||473
8091533|NCT03372369|19947215|P1|COMPLETED|Qualification Period||469
8091534|NCT03372369|19947214|P2|STARTED|Qualification Period||495
8091535|NCT03372369|19947215|P1|STARTED|Qualification Period||495
8091536|NCT03372083|19947227|P1|NOT COMPLETED|Overall Study||5
8091537|NCT03372083|19947227|P1|COMPLETED|Overall Study||39
8091538|NCT03372083|19947227|P1|STARTED|Overall Study||44
8091539|NCT03371459|19947259|P2|NOT COMPLETED|Period 2||0
8091540|NCT03371459|19947260|P1|NOT COMPLETED|Period 2||0
8091541|NCT03371459|19947259|P2|COMPLETED|Period 2||22
8091542|NCT03371459|19947260|P1|COMPLETED|Period 2||23
8091543|NCT03371459|19947259|P2|STARTED|Period 2||22
8091544|NCT03371459|19947260|P1|STARTED|Period 2||23
8091545|NCT03371459|19947259|P2|NOT COMPLETED|Washout||1
8091546|NCT03371459|19947260|P1|NOT COMPLETED|Washout||0
8091547|NCT03371459|19947259|P2|COMPLETED|Washout||22
8091548|NCT03371459|19947260|P1|COMPLETED|Washout||23
8091549|NCT03371459|19947259|P2|STARTED|Washout||23
8091550|NCT03371459|19947260|P1|STARTED|Washout||23
8091551|NCT03371459|19947259|P2|NOT COMPLETED|Period 1||0
8091552|NCT03371459|19947260|P1|NOT COMPLETED|Period 1||0
8091553|NCT03371459|19947259|P2|COMPLETED|Period 1||23
8091554|NCT03371459|19947260|P1|COMPLETED|Period 1||23
8091555|NCT03371459|19947259|P2|STARTED|Period 1||23
8091556|NCT03371459|19947260|P1|STARTED|Period 1||23
8091557|NCT03371381|19947268|P1|NOT COMPLETED|Overall Study||12
8091558|NCT03371381|19947268|P1|COMPLETED|Overall Study||0
8091559|NCT03371381|19947268|P1|STARTED|Overall Study||12
8091560|NCT03370770|19947280|P1|NOT COMPLETED|Overall Study||106
8091561|NCT03370770|19947280|P1|COMPLETED|Overall Study||98
8091562|NCT03370770|19947280|P1|STARTED|Overall Study||204
8091563|NCT03370536|19947285|P1|NOT COMPLETED|Overall Study||1
8091564|NCT03370536|19947285|P1|COMPLETED|Overall Study||0
8091565|NCT03370536|19947285|P1|STARTED|Overall Study||1
8091566|NCT03370419|19947294|P1|NOT COMPLETED|Overall Study||16
8091567|NCT03370419|19947294|P1|COMPLETED|Overall Study||24
8091568|NCT03370419|19947294|P1|STARTED|Overall Study||40
8091569|NCT03370302|19947304|P6|NOT COMPLETED|Dose Expansion Phase||0
8091570|NCT03370302|19947305|P5|NOT COMPLETED|Dose Expansion Phase||0
8091571|NCT03370302|19947306|P4|NOT COMPLETED|Dose Expansion Phase||6
8091572|NCT03370302|19947307|P3|NOT COMPLETED|Dose Expansion Phase||0
8091573|NCT03370302|19947308|P2|NOT COMPLETED|Dose Expansion Phase||0
8091574|NCT03370302|19947309|P1|NOT COMPLETED|Dose Expansion Phase||0
8091575|NCT03370302|19947304|P6|COMPLETED|Dose Expansion Phase||0
8091576|NCT03370302|19947305|P5|COMPLETED|Dose Expansion Phase||0
8091577|NCT03370302|19947306|P4|COMPLETED|Dose Expansion Phase||0
8091578|NCT03370302|19947307|P3|COMPLETED|Dose Expansion Phase||0
8091579|NCT03370302|19947308|P2|COMPLETED|Dose Expansion Phase||0
8091580|NCT03370302|19947309|P1|COMPLETED|Dose Expansion Phase||0
8091581|NCT03370302|19947304|P6|STARTED|Dose Expansion Phase||0
8091582|NCT03370302|19947305|P5|STARTED|Dose Expansion Phase||0
8091583|NCT03370302|19947306|P4|STARTED|Dose Expansion Phase||6
8091584|NCT03370302|19947307|P3|STARTED|Dose Expansion Phase||0
8091585|NCT03370302|19947308|P2|STARTED|Dose Expansion Phase||0
8091586|NCT03370302|19947309|P1|STARTED|Dose Expansion Phase||0
8091587|NCT03370302|19947304|P6|NOT COMPLETED|Dose Escalation Phase||3
8091588|NCT03370302|19947305|P5|NOT COMPLETED|Dose Escalation Phase||3
8091589|NCT03370302|19947306|P4|NOT COMPLETED|Dose Escalation Phase||0
8091590|NCT03370302|19947307|P3|NOT COMPLETED|Dose Escalation Phase||7
8091591|NCT03370302|19947308|P2|NOT COMPLETED|Dose Escalation Phase||6
8091592|NCT03370302|19947309|P1|NOT COMPLETED|Dose Escalation Phase||3
8091593|NCT03370302|19947304|P6|COMPLETED|Dose Escalation Phase||0
8091594|NCT03370302|19947305|P5|COMPLETED|Dose Escalation Phase||0
8091595|NCT03370302|19947306|P4|COMPLETED|Dose Escalation Phase||0
8091596|NCT03370302|19947307|P3|COMPLETED|Dose Escalation Phase||0
8091597|NCT03370302|19947308|P2|COMPLETED|Dose Escalation Phase||0
8091598|NCT03370302|19947309|P1|COMPLETED|Dose Escalation Phase||0
8091599|NCT03370302|19947304|P6|STARTED|Dose Escalation Phase||3
8091600|NCT03370302|19947305|P5|STARTED|Dose Escalation Phase||3
8091601|NCT03370302|19947306|P4|STARTED|Dose Escalation Phase||0
8091602|NCT03370302|19947307|P3|STARTED|Dose Escalation Phase||7
8091603|NCT03370302|19947308|P2|STARTED|Dose Escalation Phase||6
8091604|NCT03370302|19947309|P1|STARTED|Dose Escalation Phase||3
8091605|NCT03370289|19947406|P1|NOT COMPLETED|Overall Study||5
8091606|NCT03370289|19947406|P1|COMPLETED|Overall Study||50
8091607|NCT03370289|19947406|P1|STARTED|Overall Study||55
8091608|NCT03370042|19947425|P2|NOT COMPLETED|Overall Study||0
8091609|NCT03370042|19947426|P1|NOT COMPLETED|Overall Study||0
8091610|NCT03370042|19947425|P2|COMPLETED|Overall Study||10
8091611|NCT03370042|19947426|P1|COMPLETED|Overall Study||10
8091612|NCT03370042|19947425|P2|STARTED|Overall Study||10
8091613|NCT03370042|19947426|P1|STARTED|Overall Study||10
8091614|NCT03369951|19947440|P1|NOT COMPLETED|Overall Study||6
8091615|NCT03369951|19947440|P1|COMPLETED|Overall Study||52
8091616|NCT03369951|19947440|P1|Received Study Drug|Overall Study||57
8091617|NCT03369951|19947440|P1|STARTED|Overall Study||58
8091618|NCT03369756|19947465|P1|NOT COMPLETED|Overall Study||7
8091619|NCT03369756|19947465|P1|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
8091620|NCT03369756|19947465|P1|STARTED|Overall Study||43
8091621|NCT03369704|19947475|P2|NOT COMPLETED|Follow-up Epoch||0
8091622|NCT03369704|19947476|P1|NOT COMPLETED|Follow-up Epoch||1
8091623|NCT03369704|19947475|P2|COMPLETED|Follow-up Epoch||174
8091624|NCT03369704|19947476|P1|COMPLETED|Follow-up Epoch||160
8091625|NCT03369704|19947475|P2|STARTED|Follow-up Epoch||174
8091626|NCT03369704|19947476|P1|STARTED|Follow-up Epoch||161
8091627|NCT03369704|19947475|P2|NOT COMPLETED|Treatment Epoch||3
8091628|NCT03369704|19947476|P1|NOT COMPLETED|Treatment Epoch||4
8091629|NCT03369704|19947475|P2|COMPLETED|Treatment Epoch||172
8091630|NCT03369704|19947476|P1|COMPLETED|Treatment Epoch||158
8091631|NCT03369704|19947475|P2|STARTED|Treatment Epoch||175
8091632|NCT03369704|19947476|P1|STARTED|Treatment Epoch||162
8091633|NCT03369418|19947511|P2|NOT COMPLETED|Overall Study||3
8091634|NCT03369418|19947512|P1|NOT COMPLETED|Overall Study||3
8091635|NCT03369418|19947511|P2|COMPLETED|Overall Study||11
8091636|NCT03369418|19947512|P1|COMPLETED|Overall Study||13
8091637|NCT03369418|19947511|P2|STARTED|Overall Study||14
8091638|NCT03369418|19947512|P1|STARTED|Overall Study||16
8091639|NCT03369340|19947520|P6|NOT COMPLETED|Day 4||0
8091640|NCT03369340|19947521|P5|NOT COMPLETED|Day 4||0
8091641|NCT03369340|19947522|P4|NOT COMPLETED|Day 4||0
8091642|NCT03369340|19947523|P3|NOT COMPLETED|Day 4||0
8091643|NCT03369340|19947524|P2|NOT COMPLETED|Day 4||0
8091644|NCT03369340|19947525|P1|NOT COMPLETED|Day 4||0
8091645|NCT03369340|19947520|P6|COMPLETED|Day 4||3
8091646|NCT03369340|19947521|P5|COMPLETED|Day 4||3
8091647|NCT03369340|19947522|P4|COMPLETED|Day 4||3
8091648|NCT03369340|19947523|P3|COMPLETED|Day 4||3
8091649|NCT03369340|19947524|P2|COMPLETED|Day 4||3
8091650|NCT03369340|19947525|P1|COMPLETED|Day 4||3
8091651|NCT03369340|19947520|P6|STARTED|Day 4||3
8091652|NCT03369340|19947521|P5|STARTED|Day 4||3
8091653|NCT03369340|19947522|P4|STARTED|Day 4||3
8091654|NCT03369340|19947523|P3|STARTED|Day 4||3
8091655|NCT03369340|19947524|P2|STARTED|Day 4||3
8091656|NCT03369340|19947525|P1|STARTED|Day 4||3
8091657|NCT03369340|19947520|P6|NOT COMPLETED|Day 3||0
8091658|NCT03369340|19947521|P5|NOT COMPLETED|Day 3||0
8091659|NCT03369340|19947522|P4|NOT COMPLETED|Day 3||0
8091660|NCT03369340|19947523|P3|NOT COMPLETED|Day 3||0
8091661|NCT03369340|19947524|P2|NOT COMPLETED|Day 3||0
8091662|NCT03369340|19947525|P1|NOT COMPLETED|Day 3||0
8091663|NCT03369340|19947520|P6|COMPLETED|Day 3||3
8091664|NCT03369340|19947521|P5|COMPLETED|Day 3||3
8091665|NCT03369340|19947522|P4|COMPLETED|Day 3||3
8091666|NCT03369340|19947523|P3|COMPLETED|Day 3||3
8091667|NCT03369340|19947524|P2|COMPLETED|Day 3||3
8091668|NCT03369340|19947525|P1|COMPLETED|Day 3||3
8091669|NCT03369340|19947520|P6|STARTED|Day 3||3
8091670|NCT03369340|19947521|P5|STARTED|Day 3||3
8091671|NCT03369340|19947522|P4|STARTED|Day 3||3
8091672|NCT03369340|19947523|P3|STARTED|Day 3||3
8091673|NCT03369340|19947524|P2|STARTED|Day 3||3
8091674|NCT03369340|19947525|P1|STARTED|Day 3||3
8091675|NCT03369340|19947520|P6|NOT COMPLETED|Day 2||0
8091676|NCT03369340|19947521|P5|NOT COMPLETED|Day 2||0
8091677|NCT03369340|19947522|P4|NOT COMPLETED|Day 2||0
8091678|NCT03369340|19947523|P3|NOT COMPLETED|Day 2||0
8091679|NCT03369340|19947524|P2|NOT COMPLETED|Day 2||0
8091680|NCT03369340|19947525|P1|NOT COMPLETED|Day 2||0
8091681|NCT03369340|19947520|P6|COMPLETED|Day 2||3
8091682|NCT03369340|19947521|P5|COMPLETED|Day 2||3
8091683|NCT03369340|19947522|P4|COMPLETED|Day 2||3
8091684|NCT03369340|19947523|P3|COMPLETED|Day 2||3
8091685|NCT03369340|19947524|P2|COMPLETED|Day 2||3
8091686|NCT03369340|19947525|P1|COMPLETED|Day 2||3
8091687|NCT03369340|19947520|P6|STARTED|Day 2||3
8091688|NCT03369340|19947521|P5|STARTED|Day 2||3
8091689|NCT03369340|19947522|P4|STARTED|Day 2||3
8091690|NCT03369340|19947523|P3|STARTED|Day 2||3
8091691|NCT03369340|19947524|P2|STARTED|Day 2||3
8091692|NCT03369340|19947525|P1|STARTED|Day 2||3
8091693|NCT03369197|19947605|P2|NOT COMPLETED|Overall Study||0
8091694|NCT03369197|19947606|P1|NOT COMPLETED|Overall Study||0
8091695|NCT03369197|19947605|P2|COMPLETED|Overall Study||57
8091696|NCT03369197|19947606|P1|COMPLETED|Overall Study||53
8091697|NCT03369197|19947605|P2|STARTED|Overall Study||57
8091698|NCT03369197|19947606|P1|STARTED|Overall Study||53
8091699|NCT03369158|19947626|P2|NOT COMPLETED|Overall Study||0
8091700|NCT03369158|19947627|P1|NOT COMPLETED|Overall Study||0
8091701|NCT03369158|19947626|P2|COMPLETED|Overall Study||15
8091702|NCT03369158|19947627|P1|COMPLETED|Overall Study||14
8091703|NCT03369158|19947626|P2|STARTED|Overall Study||15
8091704|NCT03369158|19947627|P1|STARTED|Overall Study||14
8091705|NCT03368937|19947639|P1|NOT COMPLETED|Overall Study||0
8091706|NCT03368937|19947639|P1|COMPLETED|Overall Study||5
8091707|NCT03368937|19947639|P1|STARTED|Overall Study||5
8091708|NCT03368898|19947646|P3|NOT COMPLETED|Overall Study||0
8091709|NCT03368898|19947647|P2|NOT COMPLETED|Overall Study||0
8091710|NCT03368898|19947648|P1|NOT COMPLETED|Overall Study||0
8091711|NCT03368898|19947646|P3|COMPLETED|Overall Study||34
8091712|NCT03368898|19947647|P2|COMPLETED|Overall Study||33
8091713|NCT03368898|19947648|P1|COMPLETED|Overall Study||37
8091714|NCT03368898|19947646|P3|STARTED|Overall Study||34
8091715|NCT03368898|19947647|P2|STARTED|Overall Study||33
8091716|NCT03368898|19947648|P1|STARTED|Overall Study||37
8091717|NCT03368807|19947668|P1|NOT COMPLETED|Period 2 (Unblinded CGM)||0
8091718|NCT03368807|19947668|P1|COMPLETED|Period 2 (Unblinded CGM)||73
8091719|NCT03368807|19947668|P1|STARTED|Period 2 (Unblinded CGM)||73
8091720|NCT03368807|19947668|P1|NOT COMPLETED|Period 1 (Blinded CGM)||6
8091721|NCT03368807|19947668|P1|COMPLETED|Period 1 (Blinded CGM)||73
8091722|NCT03368807|19947668|P1|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
8091723|NCT03368807|19947668|P1|STARTED|Period 1 (Blinded CGM)||79
8091724|NCT03368235|19947684|P2|NOT COMPLETED|Overall Study||0
8091725|NCT03368235|19947685|P1|NOT COMPLETED|Overall Study||0
8091726|NCT03368235|19947684|P2|COMPLETED|Overall Study||10
8091727|NCT03368235|19947685|P1|COMPLETED|Overall Study||11
8091728|NCT03368235|19947684|P2|STARTED|Overall Study||10
8091729|NCT03368235|19947685|P1|STARTED|Overall Study||11
8091730|NCT03368170|19947718|P2|NOT COMPLETED|Overall Study||1
8091731|NCT03368170|19947719|P1|NOT COMPLETED|Overall Study||2
8091732|NCT03368170|19947718|P2|COMPLETED|Overall Study||35
8091733|NCT03368170|19947719|P1|COMPLETED|Overall Study||37
8091734|NCT03368170|19947718|P2|STARTED|Overall Study||36
8091735|NCT03368170|19947719|P1|STARTED|Overall Study||39
8091736|NCT03368053|19947731|P1|NOT COMPLETED|Overall Study||0
8091737|NCT03368053|19947731|P1|COMPLETED|Overall Study||36
8091738|NCT03368053|19947731|P1|STARTED|Overall Study||36
8091739|NCT03366207|19947746|P1|NOT COMPLETED|Overall Study||8
8091740|NCT03366207|19947746|P1|COMPLETED|Overall Study||242
8091741|NCT03366207|19947746|P1|STARTED|Overall Study||250
8091742|NCT03365934|19947751|P1|NOT COMPLETED|Overall Study||2
8091743|NCT03365934|19947751|P1|COMPLETED|Overall Study||33
8091744|NCT03365934|19947751|P1|STARTED|Overall Study||35
8091745|NCT03365778|19948027|P3|NOT COMPLETED|Overall Study||0
8091746|NCT03365778|19948028|P2|NOT COMPLETED|Overall Study||0
8091747|NCT03365778|19948029|P1|NOT COMPLETED|Overall Study||0
8091748|NCT03365778|19948027|P3|COMPLETED|Overall Study||53
8091749|NCT03365778|19948028|P2|COMPLETED|Overall Study||17
8091750|NCT03365778|19948029|P1|COMPLETED|Overall Study||16
8091751|NCT03365778|19948027|P3|STARTED|Overall Study||53
8091752|NCT03365778|19948028|P2|STARTED|Overall Study||17
8091753|NCT03365778|19948029|P1|STARTED|Overall Study||16
8091754|NCT03365011|19948041|P2|NOT COMPLETED|Overall Study||2
8091755|NCT03365011|19948042|P1|NOT COMPLETED|Overall Study||1
8091756|NCT03365011|19948041|P2|COMPLETED|Overall Study||18
8091757|NCT03365011|19948042|P1|COMPLETED|Overall Study||19
8091758|NCT03365011|19948041|P2|STARTED|Overall Study||20
8091759|NCT03365011|19948042|P1|STARTED|Overall Study||20
8091760|NCT03364608|19948052|P1|NOT COMPLETED|Overall Study||8
8091761|NCT03364608|19948052|P1|COMPLETED|Overall Study||78
8091762|NCT03364608|19948052|P1|Proventil 180 µg|Overall Study||79
8091763|NCT03364608|19948052|P1|Proventil 90 µg|Overall Study||82
8091764|NCT03364608|19948052|P1|AS MDI 180 µg|Overall Study||81
8091765|NCT03364608|19948052|P1|AS MDI 90 µg|Overall Study||81
8091766|NCT03364608|19948052|P1|Placebo MDI|Overall Study||82
8091767|NCT03364608|19948052|P1|STARTED|Overall Study||86
8091768|NCT03364335|19948079|P5|NOT COMPLETED|Overall Study||11
8091769|NCT03364335|19948080|P4|NOT COMPLETED|Overall Study||13
8091770|NCT03364335|19948081|P3|NOT COMPLETED|Overall Study||11
8091771|NCT03364335|19948082|P2|NOT COMPLETED|Overall Study||11
8091772|NCT03364335|19948083|P1|NOT COMPLETED|Overall Study||10
8091773|NCT03364335|19948079|P5|COMPLETED|Overall Study||41
8091774|NCT03364335|19948080|P4|COMPLETED|Overall Study||37
8091775|NCT03364335|19948081|P3|COMPLETED|Overall Study||42
8091776|NCT03364335|19948082|P2|COMPLETED|Overall Study||40
8091777|NCT03364335|19948083|P1|COMPLETED|Overall Study||42
8091778|NCT03364335|19948079|P5|STARTED|Overall Study||52
8091779|NCT03364335|19948080|P4|STARTED|Overall Study||50
8091780|NCT03364335|19948081|P3|STARTED|Overall Study||53
8091781|NCT03364335|19948082|P2|STARTED|Overall Study||51
8091782|NCT03364335|19948083|P1|STARTED|Overall Study||52
8091783|NCT03364192|19948155|P1|NOT COMPLETED|Overall Study||16
8091784|NCT03364192|19948155|P1|COMPLETED|Overall Study||12
8091785|NCT03364192|19948155|P1|STARTED|Overall Study||28
8091786|NCT03364023|19948162|P1|NOT COMPLETED|Overall Study||17
8091787|NCT03364023|19948162|P1|COMPLETED|Overall Study||166
8091788|NCT03364023|19948162|P1|STARTED|Overall Study||183
8091789|NCT03363906|19948169|P2|NOT COMPLETED|Period 2 (Test or Reference)||1
8091790|NCT03363906|19948170|P1|NOT COMPLETED|Period 2 (Test or Reference)||4
8091791|NCT03363906|19948169|P2|COMPLETED|Period 2 (Test or Reference)||9
8091792|NCT03363906|19948170|P1|COMPLETED|Period 2 (Test or Reference)||10
8091793|NCT03363906|19948169|P2|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
8091794|NCT03363906|19948170|P1|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
8091795|NCT03363906|19948169|P2|STARTED|Period 2 (Test or Reference)||10
8091796|NCT03363906|19948170|P1|STARTED|Period 2 (Test or Reference)||14
8091797|NCT03363906|19948169|P2|NOT COMPLETED|Period 1 (Reference or Test)||2
8091798|NCT03363906|19948170|P1|NOT COMPLETED|Period 1 (Reference or Test)||1
8091799|NCT03363906|19948169|P2|COMPLETED|Period 1 (Reference or Test)||10
8091800|NCT03363906|19948170|P1|COMPLETED|Period 1 (Reference or Test)||14
8091801|NCT03363906|19948169|P2|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
8091802|NCT03363906|19948170|P1|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
8091803|NCT03363906|19948169|P2|STARTED|Period 1 (Reference or Test)||12
8091804|NCT03363906|19948170|P1|STARTED|Period 1 (Reference or Test)||15
8091877|NCT03363776|19948243|P3|NOT COMPLETED|Overall Study||2
8091878|NCT03363776|19948244|P2|NOT COMPLETED|Overall Study||3
8091879|NCT03363776|19948245|P1|NOT COMPLETED|Overall Study||3
8091880|NCT03363776|19948243|P3|COMPLETED|Overall Study||1
8091881|NCT03363776|19948244|P2|COMPLETED|Overall Study||0
8091882|NCT03363776|19948245|P1|COMPLETED|Overall Study||1
8091883|NCT03363776|19948243|P3|STARTED|Overall Study||3
8091884|NCT03363776|19948244|P2|STARTED|Overall Study||3
8091885|NCT03363776|19948245|P1|STARTED|Overall Study||4
8091886|NCT03363633|19948337|P1|NOT COMPLETED|Overall Study||12
8091887|NCT03363633|19948337|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
8091888|NCT03363633|19948337|P1|STARTED|Overall Study||12
8091889|NCT03362944|19948345|P2|NOT COMPLETED|Second Intervention||0
8091890|NCT03362944|19948346|P1|NOT COMPLETED|Second Intervention||0
8091891|NCT03362944|19948345|P2|COMPLETED|Second Intervention||8
8091892|NCT03362944|19948346|P1|COMPLETED|Second Intervention||8
8091893|NCT03362944|19948345|P2|STARTED|Second Intervention||8
8091894|NCT03362944|19948346|P1|STARTED|Second Intervention||8
8091895|NCT03362944|19948345|P2|NOT COMPLETED|Single Week Washout Period||0
8091896|NCT03362944|19948346|P1|NOT COMPLETED|Single Week Washout Period||0
8091897|NCT03362944|19948345|P2|COMPLETED|Single Week Washout Period||8
8091898|NCT03362944|19948346|P1|COMPLETED|Single Week Washout Period||8
8091899|NCT03362944|19948345|P2|STARTED|Single Week Washout Period||8
8091900|NCT03362944|19948346|P1|STARTED|Single Week Washout Period||8
8091901|NCT03362944|19948345|P2|NOT COMPLETED|First Intervention||0
8091902|NCT03362944|19948346|P1|NOT COMPLETED|First Intervention||0
8091903|NCT03362944|19948345|P2|COMPLETED|First Intervention||8
8091904|NCT03362944|19948346|P1|COMPLETED|First Intervention||8
8091905|NCT03362944|19948345|P2|STARTED|First Intervention||8
8091906|NCT03362944|19948346|P1|STARTED|First Intervention||8
8091907|NCT03362879|19948362|P1|NOT COMPLETED|Overall Study||0
8091908|NCT03362879|19948362|P1|COMPLETED|Overall Study||409
8091909|NCT03362879|19948362|P1|STARTED|Overall Study||409
8091910|NCT03361917|19948380|P2|NOT COMPLETED|Overall Study||0
8091911|NCT03361917|19948381|P1|NOT COMPLETED|Overall Study||0
8091912|NCT03361917|19948380|P2|COMPLETED|Overall Study||101
8091913|NCT03361917|19948381|P1|COMPLETED|Overall Study||99
8091914|NCT03361917|19948380|P2|STARTED|Overall Study||101
8091915|NCT03361917|19948381|P1|STARTED|Overall Study||99
8091916|NCT03361865|19948399|P2|NOT COMPLETED|Overall Study||49
8091917|NCT03361865|19948400|P1|NOT COMPLETED|Overall Study||43
8091918|NCT03361865|19948399|P2|COMPLETED|Overall Study||0
8091919|NCT03361865|19948400|P1|COMPLETED|Overall Study||1
8091920|NCT03361865|19948399|P2|All Participants as Treated (APaT)|Overall Study||49
8091921|NCT03361865|19948400|P1|All Participants as Treated (APaT)|Overall Study||43
8091922|NCT03361865|19948399|P2|Intention-to-Treat (ITT)|Overall Study||49
8091923|NCT03361865|19948400|P1|Intention-to-Treat (ITT)|Overall Study||44
8091924|NCT03361865|19948399|P2|STARTED|Overall Study||49
8091925|NCT03361865|19948400|P1|STARTED|Overall Study||44
8091926|NCT03361605|19948410|P1|NOT COMPLETED|Overall Study||3
8091927|NCT03361605|19948410|P1|COMPLETED|Overall Study||26
8091928|NCT03361605|19948410|P1|STARTED|Overall Study||29
8091929|NCT03361228|19948417|P2|NOT COMPLETED|Overall Study||1
8091930|NCT03361228|19948418|P1|NOT COMPLETED|Overall Study||4
8091931|NCT03361228|19948417|P2|COMPLETED|Overall Study||0
8091932|NCT03361228|19948418|P1|COMPLETED|Overall Study||0
8091933|NCT03361228|19948417|P2|STARTED|Overall Study||1
8091934|NCT03361228|19948418|P1|STARTED|Overall Study||4
8091935|NCT03361176|19948440|P2|NOT COMPLETED|Overall Study||5
8091936|NCT03361176|19948441|P1|NOT COMPLETED|Overall Study||1
8091937|NCT03361176|19948440|P2|COMPLETED|Overall Study||15
8091938|NCT03361176|19948441|P1|COMPLETED|Overall Study||9
8091939|NCT03361176|19948440|P2|STARTED|Overall Study||20
8091940|NCT03361176|19948441|P1|STARTED|Overall Study||10
8091941|NCT03360903|19948453|P2|NOT COMPLETED|Second Intervention||0
8091942|NCT03360903|19948454|P1|NOT COMPLETED|Second Intervention||0
8091943|NCT03360903|19948453|P2|COMPLETED|Second Intervention||4
8091944|NCT03360903|19948454|P1|COMPLETED|Second Intervention||4
8091945|NCT03360903|19948453|P2|STARTED|Second Intervention||4
8091946|NCT03360903|19948454|P1|STARTED|Second Intervention||4
8091947|NCT03360903|19948453|P2|NOT COMPLETED|Washout (2 Weeks)||0
8091948|NCT03360903|19948454|P1|NOT COMPLETED|Washout (2 Weeks)||0
8091949|NCT03360903|19948453|P2|COMPLETED|Washout (2 Weeks)||4
8091950|NCT03360903|19948454|P1|COMPLETED|Washout (2 Weeks)||4
8091951|NCT03360903|19948453|P2|STARTED|Washout (2 Weeks)||4
8091952|NCT03360903|19948454|P1|STARTED|Washout (2 Weeks)||4
8091953|NCT03360903|19948453|P2|NOT COMPLETED|First Intervention||0
8091954|NCT03360903|19948454|P1|NOT COMPLETED|First Intervention||0
8091955|NCT03360903|19948453|P2|COMPLETED|First Intervention||4
8091956|NCT03360903|19948454|P1|COMPLETED|First Intervention||4
8091957|NCT03360903|19948453|P2|STARTED|First Intervention||4
8091958|NCT03360903|19948454|P1|STARTED|First Intervention||4
8091959|NCT03360747|19948472|P1|NOT COMPLETED|Overall Study||1
8091960|NCT03360747|19948472|P1|COMPLETED|Overall Study||2
8091961|NCT03360747|19948472|P1|STARTED|Overall Study||3
8091962|NCT03360344|19948488|P3|NOT COMPLETED|Overall Study||1
8091963|NCT03360344|19948489|P2|NOT COMPLETED|Overall Study||1
8091964|NCT03360344|19948490|P1|NOT COMPLETED|Overall Study||0
8091965|NCT03360344|19948488|P3|COMPLETED|Overall Study||12
8091966|NCT03360344|19948489|P2|COMPLETED|Overall Study||15
8091967|NCT03360344|19948490|P1|COMPLETED|Overall Study||15
8091968|NCT03360344|19948488|P3|STARTED|Overall Study||13
8091969|NCT03360344|19948489|P2|STARTED|Overall Study||16
8091970|NCT03360344|19948490|P1|STARTED|Overall Study||15
8091971|NCT03360110|19948510|P2|NOT COMPLETED|Second Intervention||0
8091972|NCT03360110|19948511|P1|NOT COMPLETED|Second Intervention||0
8091973|NCT03360110|19948510|P2|COMPLETED|Second Intervention||26
8091974|NCT03360110|19948511|P1|COMPLETED|Second Intervention||27
8091975|NCT03360110|19948510|P2|STARTED|Second Intervention||26
8091976|NCT03360110|19948511|P1|STARTED|Second Intervention||27
8091977|NCT03360110|19948510|P2|NOT COMPLETED|First Intervention||0
8091978|NCT03360110|19948511|P1|NOT COMPLETED|First Intervention||0
8091979|NCT03360110|19948510|P2|COMPLETED|First Intervention||26
8091980|NCT03360110|19948511|P1|COMPLETED|First Intervention||27
8091981|NCT03360110|19948510|P2|STARTED|First Intervention||26
8091982|NCT03360110|19948511|P1|STARTED|First Intervention||27
8091983|NCT03360071|19948553|P2|NOT COMPLETED|Overall Study||0
8091984|NCT03360071|19948554|P1|NOT COMPLETED|Overall Study||1
8091985|NCT03360071|19948553|P2|COMPLETED|Overall Study||14
8091986|NCT03360071|19948554|P1|COMPLETED|Overall Study||16
8091987|NCT03360071|19948553|P2|STARTED|Overall Study||14
8091988|NCT03360071|19948554|P1|STARTED|Overall Study||17
8091989|NCT03359850|19948568|P2|NOT COMPLETED|Extension Phase (Up to 18 Months)||7
8091990|NCT03359850|19948569|P1|NOT COMPLETED|Extension Phase (Up to 18 Months)||8
8091991|NCT03359850|19948568|P2|COMPLETED|Extension Phase (Up to 18 Months)||0
8091992|NCT03359850|19948569|P1|COMPLETED|Extension Phase (Up to 18 Months)||0
8091993|NCT03359850|19948568|P2|STARTED|Extension Phase (Up to 18 Months)||7
8091994|NCT03359850|19948569|P1|STARTED|Extension Phase (Up to 18 Months)||8
8091995|NCT03359850|19948568|P2|NOT COMPLETED|PK Phase (Up to Day 8)||1
8091996|NCT03359850|19948569|P1|NOT COMPLETED|PK Phase (Up to Day 8)||1
8091997|NCT03359850|19948568|P2|COMPLETED|PK Phase (Up to Day 8)||7
8091998|NCT03359850|19948569|P1|COMPLETED|PK Phase (Up to Day 8)||8
8091999|NCT03359850|19948568|P2|STARTED|PK Phase (Up to Day 8)||8
8092000|NCT03359850|19948569|P1|STARTED|PK Phase (Up to Day 8)||9
8092001|NCT03359629|19948641|P2|NOT COMPLETED|Overall Study||0
8092002|NCT03359629|19948642|P1|NOT COMPLETED|Overall Study||0
8092003|NCT03359629|19948641|P2|COMPLETED|Overall Study||10
8092004|NCT03359629|19948642|P1|COMPLETED|Overall Study||200
8092005|NCT03359629|19948641|P2|STARTED|Overall Study||10
8092006|NCT03359629|19948642|P1|STARTED|Overall Study||200
8092007|NCT03359473|19948652|P4|NOT COMPLETED|Overall Study||5
8092008|NCT03359473|19948653|P3|NOT COMPLETED|Overall Study||6
8092009|NCT03359473|19948654|P2|NOT COMPLETED|Overall Study||6
8092010|NCT03359473|19948655|P1|NOT COMPLETED|Overall Study||2
8092011|NCT03359473|19948652|P4|COMPLETED|Overall Study||20
8092012|NCT03359473|19948653|P3|COMPLETED|Overall Study||18
8092013|NCT03359473|19948654|P2|COMPLETED|Overall Study||18
8092014|NCT03359473|19948655|P1|COMPLETED|Overall Study||21
8092015|NCT03359473|19948652|P4|STARTED|Overall Study||25
8092016|NCT03359473|19948653|P3|STARTED|Overall Study||24
8092017|NCT03359473|19948654|P2|STARTED|Overall Study||24
8092018|NCT03359473|19948655|P1|STARTED|Overall Study||23
8092019|NCT03358576|19948867|P2|NOT COMPLETED|Overall Study||25
8092020|NCT03358576|19948868|P1|NOT COMPLETED|Overall Study||26
8092021|NCT03358576|19948867|P2|COMPLETED|Overall Study||311
8092022|NCT03358576|19948868|P1|COMPLETED|Overall Study||312
8092023|NCT03358576|19948867|P2|STARTED|Overall Study||336
8092024|NCT03358576|19948868|P1|STARTED|Overall Study||338
8092025|NCT03358472|19948879|P3|NOT COMPLETED|Overall Study||16
8092026|NCT03358472|19948880|P2|NOT COMPLETED|Overall Study||10
8092027|NCT03358472|19948881|P1|NOT COMPLETED|Overall Study||15
8092028|NCT03358472|19948879|P3|COMPLETED|Overall Study||19
8092029|NCT03358472|19948880|P2|COMPLETED|Overall Study||9
8092030|NCT03358472|19948881|P1|COMPLETED|Overall Study||20
8092031|NCT03358472|19948879|P3|All Participants as Treated (APaT)|Overall Study||34
8092032|NCT03358472|19948880|P2|All Participants as Treated (APaT)|Overall Study||19
8092033|NCT03358472|19948881|P1|All Participants as Treated (APaT)|Overall Study||34
8092034|NCT03358472|19948879|P3|Intention-to-Treat (ITT)|Overall Study||35
8092035|NCT03358472|19948880|P2|Intention-to-Treat (ITT)|Overall Study||19
8092036|NCT03358472|19948881|P1|Intention-to-Treat (ITT)|Overall Study||35
8092037|NCT03358472|19948879|P3|STARTED|Overall Study||35
8092038|NCT03358472|19948880|P2|STARTED|Overall Study||19
8092039|NCT03358472|19948881|P1|STARTED|Overall Study||35
8092040|NCT03358407|19948905|P10|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092041|NCT03358407|19948906|P9|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092042|NCT03358407|19948907|P8|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092043|NCT03358407|19948908|P7|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092044|NCT03358407|19948909|P6|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092045|NCT03358407|19948910|P5|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092046|NCT03358407|19948911|P4|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092047|NCT03358407|19948912|P3|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092048|NCT03358407|19948913|P2|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092049|NCT03358407|19948914|P1|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092050|NCT03358407|19948905|P10|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092051|NCT03358407|19948906|P9|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092052|NCT03358407|19948907|P8|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092053|NCT03358407|19948908|P7|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092054|NCT03358407|19948909|P6|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092055|NCT03358407|19948910|P5|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092056|NCT03358407|19948911|P4|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092057|NCT03358407|19948912|P3|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092058|NCT03358407|19948913|P2|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092059|NCT03358407|19948914|P1|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092060|NCT03358407|19948905|P10|STARTED|Part B: Overall Period (11 Weeks)||0
8092061|NCT03358407|19948906|P9|STARTED|Part B: Overall Period (11 Weeks)||0
8092062|NCT03358407|19948907|P8|STARTED|Part B: Overall Period (11 Weeks)||0
8092063|NCT03358407|19948908|P7|STARTED|Part B: Overall Period (11 Weeks)||0
8092064|NCT03358407|19948909|P6|STARTED|Part B: Overall Period (11 Weeks)||0
8092065|NCT03358407|19948910|P5|STARTED|Part B: Overall Period (11 Weeks)||0
8092066|NCT03358407|19948911|P4|STARTED|Part B: Overall Period (11 Weeks)||0
8092067|NCT03358407|19948912|P3|STARTED|Part B: Overall Period (11 Weeks)||0
8092068|NCT03358407|19948913|P2|STARTED|Part B: Overall Period (11 Weeks)||0
8092069|NCT03358407|19948914|P1|STARTED|Part B: Overall Period (11 Weeks)||0
8092070|NCT03358407|19948905|P10|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092071|NCT03358407|19948906|P9|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092072|NCT03358407|19948907|P8|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
8092073|NCT03358407|19948908|P7|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
8092074|NCT03358407|19948909|P6|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
8092075|NCT03358407|19948910|P5|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092076|NCT03358407|19948911|P4|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092077|NCT03358407|19948912|P3|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092078|NCT03358407|19948913|P2|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092079|NCT03358407|19948914|P1|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092080|NCT03358407|19948905|P10|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092081|NCT03358407|19948906|P9|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092082|NCT03358407|19948907|P8|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092083|NCT03358407|19948908|P7|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092084|NCT03358407|19948909|P6|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092085|NCT03358407|19948910|P5|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092086|NCT03358407|19948911|P4|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092087|NCT03358407|19948912|P3|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092088|NCT03358407|19948913|P2|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092089|NCT03358407|19948914|P1|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092090|NCT03358407|19948905|P10|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092091|NCT03358407|19948906|P9|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092092|NCT03358407|19948907|P8|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
8092093|NCT03358407|19948908|P7|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
8092094|NCT03358407|19948909|P6|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
8092095|NCT03358407|19948910|P5|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092096|NCT03358407|19948911|P4|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092097|NCT03358407|19948912|P3|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092098|NCT03358407|19948913|P2|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092099|NCT03358407|19948914|P1|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092100|NCT03358407|19948905|P10|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092101|NCT03358407|19948906|P9|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092102|NCT03358407|19948907|P8|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092103|NCT03358407|19948908|P7|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
8092104|NCT03358407|19948909|P6|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092105|NCT03358407|19948910|P5|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092106|NCT03358407|19948911|P4|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092107|NCT03358407|19948912|P3|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092108|NCT03358407|19948913|P2|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092109|NCT03358407|19948914|P1|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092110|NCT03358407|19948905|P10|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092111|NCT03358407|19948906|P9|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092112|NCT03358407|19948907|P8|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092113|NCT03358407|19948908|P7|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
8092114|NCT03358407|19948909|P6|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092115|NCT03358407|19948910|P5|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092116|NCT03358407|19948911|P4|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092117|NCT03358407|19948912|P3|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092118|NCT03358407|19948913|P2|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092119|NCT03358407|19948914|P1|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092120|NCT03358407|19948905|P10|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092121|NCT03358407|19948906|P9|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092122|NCT03358407|19948907|P8|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
8092123|NCT03358407|19948908|P7|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092124|NCT03358407|19948909|P6|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092125|NCT03358407|19948910|P5|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092126|NCT03358407|19948911|P4|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092127|NCT03358407|19948912|P3|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092128|NCT03358407|19948913|P2|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092129|NCT03358407|19948914|P1|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092130|NCT03358407|19948905|P10|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092131|NCT03358407|19948906|P9|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092132|NCT03358407|19948907|P8|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092133|NCT03358407|19948908|P7|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092134|NCT03358407|19948909|P6|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092135|NCT03358407|19948910|P5|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092136|NCT03358407|19948911|P4|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092137|NCT03358407|19948912|P3|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092138|NCT03358407|19948913|P2|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092139|NCT03358407|19948914|P1|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092140|NCT03358407|19948905|P10|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092141|NCT03358407|19948906|P9|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092142|NCT03358407|19948907|P8|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092143|NCT03358407|19948908|P7|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092144|NCT03358407|19948909|P6|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092145|NCT03358407|19948910|P5|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092146|NCT03358407|19948911|P4|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092147|NCT03358407|19948912|P3|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092148|NCT03358407|19948913|P2|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092149|NCT03358407|19948914|P1|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092150|NCT03358407|19948905|P10|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092151|NCT03358407|19948906|P9|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092152|NCT03358407|19948907|P8|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092153|NCT03358407|19948908|P7|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092154|NCT03358407|19948909|P6|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092155|NCT03358407|19948910|P5|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
8092156|NCT03358407|19948911|P4|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092157|NCT03358407|19948912|P3|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092158|NCT03358407|19948913|P2|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092159|NCT03358407|19948914|P1|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092160|NCT03358407|19948905|P10|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092161|NCT03358407|19948906|P9|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092162|NCT03358407|19948907|P8|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092163|NCT03358407|19948908|P7|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092164|NCT03358407|19948909|P6|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092165|NCT03358407|19948910|P5|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
8092166|NCT03358407|19948911|P4|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092167|NCT03358407|19948912|P3|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092168|NCT03358407|19948913|P2|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092169|NCT03358407|19948914|P1|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092170|NCT03358407|19948905|P10|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092171|NCT03358407|19948906|P9|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092172|NCT03358407|19948907|P8|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092173|NCT03358407|19948908|P7|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092174|NCT03358407|19948909|P6|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092175|NCT03358407|19948910|P5|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
8092176|NCT03358407|19948911|P4|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092177|NCT03358407|19948912|P3|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092178|NCT03358407|19948913|P2|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092179|NCT03358407|19948914|P1|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092180|NCT03358407|19948905|P10|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092181|NCT03358407|19948906|P9|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092182|NCT03358407|19948907|P8|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092183|NCT03358407|19948908|P7|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092184|NCT03358407|19948909|P6|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092185|NCT03358407|19948910|P5|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092186|NCT03358407|19948911|P4|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092187|NCT03358407|19948912|P3|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092188|NCT03358407|19948913|P2|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092189|NCT03358407|19948914|P1|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092190|NCT03358407|19948905|P10|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092191|NCT03358407|19948906|P9|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092192|NCT03358407|19948907|P8|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092193|NCT03358407|19948908|P7|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092194|NCT03358407|19948909|P6|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092195|NCT03358407|19948910|P5|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092196|NCT03358407|19948911|P4|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092197|NCT03358407|19948912|P3|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092198|NCT03358407|19948913|P2|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092199|NCT03358407|19948914|P1|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092200|NCT03358407|19948905|P10|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092201|NCT03358407|19948906|P9|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092202|NCT03358407|19948907|P8|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092203|NCT03358407|19948908|P7|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092204|NCT03358407|19948909|P6|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092205|NCT03358407|19948910|P5|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092206|NCT03358407|19948911|P4|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092207|NCT03358407|19948912|P3|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092208|NCT03358407|19948913|P2|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092209|NCT03358407|19948914|P1|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092210|NCT03358407|19948905|P10|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092211|NCT03358407|19948906|P9|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092212|NCT03358407|19948907|P8|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092213|NCT03358407|19948908|P7|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092214|NCT03358407|19948909|P6|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092215|NCT03358407|19948910|P5|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092216|NCT03358407|19948911|P4|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092217|NCT03358407|19948912|P3|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
8092218|NCT03358407|19948913|P2|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092219|NCT03358407|19948914|P1|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092220|NCT03358407|19948905|P10|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092221|NCT03358407|19948906|P9|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092222|NCT03358407|19948907|P8|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092223|NCT03358407|19948908|P7|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092224|NCT03358407|19948909|P6|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092225|NCT03358407|19948910|P5|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092226|NCT03358407|19948911|P4|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092227|NCT03358407|19948912|P3|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
8092228|NCT03358407|19948913|P2|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092229|NCT03358407|19948914|P1|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092230|NCT03358407|19948905|P10|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092231|NCT03358407|19948906|P9|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092232|NCT03358407|19948907|P8|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092233|NCT03358407|19948908|P7|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092234|NCT03358407|19948909|P6|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092235|NCT03358407|19948910|P5|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092236|NCT03358407|19948911|P4|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092237|NCT03358407|19948912|P3|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
8092238|NCT03358407|19948913|P2|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092239|NCT03358407|19948914|P1|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092240|NCT03358407|19948905|P10|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092241|NCT03358407|19948906|P9|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092242|NCT03358407|19948907|P8|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092243|NCT03358407|19948908|P7|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092244|NCT03358407|19948909|P6|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092245|NCT03358407|19948910|P5|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092246|NCT03358407|19948911|P4|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092247|NCT03358407|19948912|P3|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092248|NCT03358407|19948913|P2|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092249|NCT03358407|19948914|P1|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092250|NCT03358407|19948905|P10|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092251|NCT03358407|19948906|P9|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092252|NCT03358407|19948907|P8|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092253|NCT03358407|19948908|P7|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092254|NCT03358407|19948909|P6|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092255|NCT03358407|19948910|P5|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092256|NCT03358407|19948911|P4|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092257|NCT03358407|19948912|P3|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092258|NCT03358407|19948913|P2|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092259|NCT03358407|19948914|P1|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092260|NCT03358407|19948905|P10|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092261|NCT03358407|19948906|P9|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092262|NCT03358407|19948907|P8|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092263|NCT03358407|19948908|P7|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092264|NCT03358407|19948909|P6|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092265|NCT03358407|19948910|P5|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092266|NCT03358407|19948911|P4|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092267|NCT03358407|19948912|P3|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092268|NCT03358407|19948913|P2|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092269|NCT03358407|19948914|P1|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092270|NCT03358407|19948905|P10|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092271|NCT03358407|19948906|P9|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092272|NCT03358407|19948907|P8|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092273|NCT03358407|19948908|P7|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092274|NCT03358407|19948909|P6|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092275|NCT03358407|19948910|P5|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092276|NCT03358407|19948911|P4|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092277|NCT03358407|19948912|P3|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092278|NCT03358407|19948913|P2|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092279|NCT03358407|19948914|P1|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092280|NCT03358355|19949176|P1|NOT COMPLETED|Overall Study||0
8092281|NCT03358355|19949176|P1|COMPLETED|Overall Study||9
8092282|NCT03358355|19949176|P1|STARTED|Overall Study||9
8092283|NCT03358329|19949191|P1|NOT COMPLETED|Overall Study||4
8092284|NCT03358329|19949191|P1|COMPLETED|Overall Study||46
8092285|NCT03358329|19949191|P1|STARTED|Overall Study||50
8092286|NCT03358251|19949197|P1|NOT COMPLETED|Overall Study||0
8092287|NCT03358251|19949197|P1|COMPLETED|Overall Study||34
8092288|NCT03358251|19949197|P1|STARTED|Overall Study||34
8092289|NCT03358238|19949222|P2|NOT COMPLETED|Overall Study||1
8092290|NCT03358238|19949223|P1|NOT COMPLETED|Overall Study||0
8092291|NCT03358238|19949222|P2|COMPLETED|Overall Study||24
8092292|NCT03358238|19949223|P1|COMPLETED|Overall Study||23
8092293|NCT03358238|19949222|P2|STARTED|Overall Study||25
8092294|NCT03358238|19949223|P1|STARTED|Overall Study||23
8092295|NCT03358147|19949243|P5|NOT COMPLETED|Overall Study||14
8092296|NCT03358147|19949244|P4|NOT COMPLETED|Overall Study||36
8092297|NCT03358147|19949245|P3|NOT COMPLETED|Overall Study||34
8092298|NCT03358147|19949246|P2|NOT COMPLETED|Overall Study||39
8092299|NCT03358147|19949247|P1|NOT COMPLETED|Overall Study||34
8092300|NCT03358147|19949243|P5|COMPLETED|Overall Study||105
8092301|NCT03358147|19949244|P4|COMPLETED|Overall Study||201
8092302|NCT03358147|19949245|P3|COMPLETED|Overall Study||206
8092303|NCT03358147|19949246|P2|COMPLETED|Overall Study||201
8092304|NCT03358147|19949247|P1|COMPLETED|Overall Study||201
8092305|NCT03358147|19949243|P5|STARTED|Overall Study||119
8092306|NCT03358147|19949244|P4|STARTED|Overall Study||237
8092307|NCT03358147|19949245|P3|STARTED|Overall Study||240
8092308|NCT03358147|19949246|P2|STARTED|Overall Study||240
8092309|NCT03358147|19949247|P1|STARTED|Overall Study||235
8092310|NCT03357731|19949284|P6|NOT COMPLETED|Overall Study||1
8092311|NCT03357731|19949285|P5|NOT COMPLETED|Overall Study||1
8092312|NCT03357731|19949286|P4|NOT COMPLETED|Overall Study||3
8092313|NCT03357731|19949287|P3|NOT COMPLETED|Overall Study||1
8092314|NCT03357731|19949288|P2|NOT COMPLETED|Overall Study||0
8092315|NCT03357731|19949289|P1|NOT COMPLETED|Overall Study||0
8092316|NCT03357731|19949284|P6|COMPLETED|Overall Study||7
8092317|NCT03357731|19949285|P5|COMPLETED|Overall Study||7
8092318|NCT03357731|19949286|P4|COMPLETED|Overall Study||4
8092319|NCT03357731|19949287|P3|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
8092320|NCT03357731|19949288|P2|COMPLETED|Overall Study||7
8092321|NCT03357731|19949289|P1|COMPLETED|Overall Study||8
8092322|NCT03357731|19949284|P6|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
8092323|NCT03357731|19949285|P5|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
8092324|NCT03357731|19949286|P4|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);
~1 discontinued P2 due to hypotension"|4
8092325|NCT03357731|19949287|P3|Completed Period 2 (P2)|Overall Study||7
8092326|NCT03357731|19949288|P2|Completed Period 2 (P2)|Overall Study||7
8092327|NCT03357731|19949289|P1|Completed Period 2 (P2)|Overall Study||8
8092328|NCT03357731|19949284|P6|Completed Period 1 (P1)|Overall Study||8
8092329|NCT03357731|19949285|P5|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
8092330|NCT03357731|19949286|P4|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
8092331|NCT03357731|19949287|P3|Completed Period 1 (P1)|Overall Study||7
8092332|NCT03357731|19949288|P2|Completed Period 1 (P1)|Overall Study||7
8092333|NCT03357731|19949289|P1|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
8092334|NCT03357731|19949284|P6|STARTED|Overall Study||8
8092335|NCT03357731|19949285|P5|STARTED|Overall Study||8
8092336|NCT03357731|19949286|P4|STARTED|Overall Study||7
8092337|NCT03357731|19949287|P3|STARTED|Overall Study||7
8092338|NCT03357731|19949288|P2|STARTED|Overall Study||7
8092339|NCT03357731|19949289|P1|STARTED|Overall Study||8
8092340|NCT03357614|19949317|P2|NOT COMPLETED|Overall Study||28
8092341|NCT03357614|19949318|P1|NOT COMPLETED|Overall Study||25
8092342|NCT03357614|19949317|P2|COMPLETED|Overall Study||670
8092343|NCT03357614|19949318|P1|COMPLETED|Overall Study||672
8092344|NCT03357614|19949317|P2|STARTED|Overall Study||698
8092345|NCT03357614|19949318|P1|STARTED|Overall Study||697
8092346|NCT03357471|19949328|P2|NOT COMPLETED|Overall Study||0
8092347|NCT03357471|19949329|P1|NOT COMPLETED|Overall Study||2
8092348|NCT03357471|19949328|P2|COMPLETED|Overall Study||32
8092349|NCT03357471|19949329|P1|COMPLETED|Overall Study||33
8092350|NCT03357471|19949328|P2|STARTED|Overall Study||32
8092351|NCT03357471|19949329|P1|STARTED|Overall Study||35
8092352|NCT03357393|19949356|P3|NOT COMPLETED|Overall Study||0
8092353|NCT03357393|19949357|P2|NOT COMPLETED|Overall Study||0
8092354|NCT03357393|19949358|P1|NOT COMPLETED|Overall Study||0
8092355|NCT03357393|19949356|P3|COMPLETED|Overall Study||50
8092356|NCT03357393|19949357|P2|COMPLETED|Overall Study||50
8092357|NCT03357393|19949358|P1|COMPLETED|Overall Study||50
8092358|NCT03357393|19949356|P3|STARTED|Overall Study||50
8092359|NCT03357393|19949357|P2|STARTED|Overall Study||50
8092360|NCT03357393|19949358|P1|STARTED|Overall Study||50
8092361|NCT03357341|19949386|P2|NOT COMPLETED|Overall Study||12
8092362|NCT03357341|19949387|P1|NOT COMPLETED|Overall Study||7
8092363|NCT03357341|19949386|P2|COMPLETED|Overall Study||86
8092364|NCT03357341|19949387|P1|COMPLETED|Overall Study||89
8092365|NCT03357341|19949386|P2|STARTED|Overall Study||98
8092366|NCT03357341|19949387|P1|STARTED|Overall Study||96
8092367|NCT03356977|19949427|P1|NOT COMPLETED|Overall Study||5
8092368|NCT03356977|19949427|P1|COMPLETED|Overall Study||132
8092369|NCT03356977|19949427|P1|STARTED|Overall Study||137
8092370|NCT03355820|19949439|P1|NOT COMPLETED|Overall Study||0
8092371|NCT03355820|19949439|P1|COMPLETED|Overall Study||227
8092372|NCT03355820|19949439|P1|STARTED|Overall Study||227
8092373|NCT03354754|19949452|P2|NOT COMPLETED|Overall Study||0
8092374|NCT03354754|19949453|P1|NOT COMPLETED|Overall Study||0
8092375|NCT03354754|19949452|P2|COMPLETED|Overall Study||1
8092376|NCT03354754|19949453|P1|COMPLETED|Overall Study||2
8092377|NCT03354754|19949452|P2|STARTED|Overall Study||1
8092378|NCT03354754|19949453|P1|STARTED|Overall Study||2
8092379|NCT03354663|19949475|P1|NOT COMPLETED|Completed 30-day Visit||2
8092380|NCT03354663|19949475|P1|COMPLETED|Completed 30-day Visit||149
8092381|NCT03354663|19949475|P1|STARTED|Completed 30-day Visit||151
8092382|NCT03354663|19949475|P1|NOT COMPLETED|Enrollment to Catheter Insertion||5
8092383|NCT03354663|19949475|P1|COMPLETED|Enrollment to Catheter Insertion||151
8092384|NCT03354663|19949475|P1|STARTED|Enrollment to Catheter Insertion||156
8092385|NCT03354637|19949502|P3|NOT COMPLETED|Open Label Extension||28
8092386|NCT03354637|19949503|P2|NOT COMPLETED|Open Label Extension||0
8092387|NCT03354637|19949504|P1|NOT COMPLETED|Open Label Extension||0
8092388|NCT03354637|19949502|P3|COMPLETED|Open Label Extension||33
8092389|NCT03354637|19949503|P2|COMPLETED|Open Label Extension||0
8092390|NCT03354637|19949504|P1|COMPLETED|Open Label Extension||0
8092391|NCT03354637|19949502|P3|STARTED|Open Label Extension||61
8092392|NCT03354637|19949503|P2|STARTED|Open Label Extension||0
8092393|NCT03354637|19949504|P1|STARTED|Open Label Extension||0
8092394|NCT03354637|19949502|P3|NOT COMPLETED|Double-blind Period||7
8092395|NCT03354637|19949503|P2|NOT COMPLETED|Double-blind Period||13
8092396|NCT03354637|19949504|P1|NOT COMPLETED|Double-blind Period||17
8092397|NCT03354637|19949502|P3|COMPLETED|Double-blind Period||35
8092398|NCT03354637|19949503|P2|COMPLETED|Double-blind Period||31
8092399|NCT03354637|19949504|P1|COMPLETED|Double-blind Period||26
8092400|NCT03354637|19949502|P3|STARTED|Double-blind Period||42
8092401|NCT03354637|19949503|P2|STARTED|Double-blind Period||44
8092402|NCT03354637|19949504|P1|STARTED|Double-blind Period||43
8092403|NCT03354598|19949563|P2|NOT COMPLETED|Overall Study||75
8092404|NCT03354598|19949564|P1|NOT COMPLETED|Overall Study||80
8092405|NCT03354598|19949563|P2|COMPLETED|Overall Study||761
8092406|NCT03354598|19949564|P1|COMPLETED|Overall Study||755
8092407|NCT03354598|19949563|P2|Safety Participants|Overall Study||827
8092408|NCT03354598|19949564|P1|Safety Participants|Overall Study||833
8092409|NCT03354598|19949563|P2|Intent to Treat (ITT) Participants|Overall Study||803
8092410|NCT03354598|19949564|P1|Intent to Treat (ITT) Participants|Overall Study||787
8092411|NCT03354598|19949563|P2|Modified Intent to Treat (MITT) Participants|Overall Study||794
8092412|NCT03354598|19949564|P1|Modified Intent to Treat (MITT) Participants|Overall Study||785
8092413|NCT03354598|19949563|P2|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
8092414|NCT03354598|19949564|P1|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
8092415|NCT03354598|19949563|P2|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
8092416|NCT03354598|19949564|P1|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
8092417|NCT03354598|19949563|P2|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
8092418|NCT03354598|19949564|P1|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
8092419|NCT03354598|19949563|P2|STARTED|Overall Study||836
8092420|NCT03354598|19949564|P1|STARTED|Overall Study||835
8092421|NCT03354429|19949578|P2|NOT COMPLETED|Overall Study||7
8092422|NCT03354429|19949579|P1|NOT COMPLETED|Overall Study||9
8092423|NCT03354429|19949578|P2|COMPLETED|Overall Study||5486
8092424|NCT03354429|19949579|P1|COMPLETED|Overall Study||5514
8092425|NCT03354429|19949578|P2|STARTED|Overall Study||5493
8092426|NCT03354429|19949579|P1|STARTED|Overall Study||5523
8092427|NCT03354325|19949599|P2|NOT COMPLETED|Overall Study||15
8092428|NCT03354325|19949600|P1|NOT COMPLETED|Overall Study||20
8092429|NCT03354325|19949599|P2|COMPLETED|Overall Study||138
8092430|NCT03354325|19949600|P1|COMPLETED|Overall Study||131
8092431|NCT03354325|19949599|P2|STARTED|Overall Study||153
8092432|NCT03354325|19949600|P1|STARTED|Overall Study||151
8092433|NCT03353922|19949630|P6|NOT COMPLETED|Overall Study||0
8092434|NCT03353922|19949631|P5|NOT COMPLETED|Overall Study||0
8092435|NCT03353922|19949632|P4|NOT COMPLETED|Overall Study||1
8092436|NCT03353922|19949633|P3|NOT COMPLETED|Overall Study||1
8092437|NCT03353922|19949634|P2|NOT COMPLETED|Overall Study||1
8092438|NCT03353922|19949635|P1|NOT COMPLETED|Overall Study||1
8092439|NCT03353922|19949630|P6|COMPLETED|Overall Study||6
8092440|NCT03353922|19949631|P5|COMPLETED|Overall Study||5
8092441|NCT03353922|19949632|P4|COMPLETED|Overall Study||5
8092442|NCT03353922|19949633|P3|COMPLETED|Overall Study||5
8092443|NCT03353922|19949634|P2|COMPLETED|Overall Study||5
8092444|NCT03353922|19949635|P1|COMPLETED|Overall Study||5
8092445|NCT03353922|19949630|P6|STARTED|Overall Study||6
8092446|NCT03353922|19949631|P5|STARTED|Overall Study||5
8092447|NCT03353922|19949632|P4|STARTED|Overall Study||6
8092448|NCT03353922|19949633|P3|STARTED|Overall Study||6
8092449|NCT03353922|19949634|P2|STARTED|Overall Study||6
8092450|NCT03353922|19949635|P1|STARTED|Overall Study||6
8092451|NCT03353246|19949652|P1|NOT COMPLETED|Overall Study||0
8092452|NCT03353246|19949652|P1|COMPLETED|Overall Study||500
8092453|NCT03353246|19949652|P1|STARTED|Overall Study||500
8092454|NCT03352882|19949669|P1|NOT COMPLETED|Overall Study||0
8092455|NCT03352882|19949669|P1|COMPLETED|Overall Study||1
8092456|NCT03352882|19949669|P1|STARTED|Overall Study||1
8092457|NCT03352713|19949677|P1|NOT COMPLETED|Overall Study||26
8092458|NCT03352713|19949677|P1|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
8092459|NCT03352713|19949677|P1|STARTED|Overall Study||185
8092460|NCT03352609|19949685|P2|NOT COMPLETED|Overall Study||0
8092461|NCT03352609|19949686|P1|NOT COMPLETED|Overall Study||0
8092462|NCT03352609|19949685|P2|COMPLETED|Overall Study||3
8092463|NCT03352609|19949686|P1|COMPLETED|Overall Study||2
8092464|NCT03352609|19949685|P2|STARTED|Overall Study||3
8092465|NCT03352609|19949686|P1|STARTED|Overall Study||2
8092466|NCT03352453|19949698|P2|NOT COMPLETED|Overall Study||32
8092467|NCT03352453|19949699|P1|NOT COMPLETED|Overall Study||22
8092468|NCT03352453|19949698|P2|COMPLETED|Overall Study||40
8092469|NCT03352453|19949699|P1|COMPLETED|Overall Study||44
8092470|NCT03352453|19949698|P2|STARTED|Overall Study||72
8092471|NCT03352453|19949699|P1|STARTED|Overall Study||66
8092472|NCT03352323|19949711|P1|NOT COMPLETED|Overall Study||1
8092473|NCT03352323|19949711|P1|COMPLETED|Overall Study||49
8092474|NCT03352323|19949711|P1|STARTED|Overall Study||50
8092475|NCT03351933|19949715|P1|NOT COMPLETED|Overall Study||2
8092476|NCT03351933|19949715|P1|COMPLETED|Overall Study||26
8092477|NCT03351933|19949715|P1|STARTED|Overall Study||28
8092478|NCT03351738|19949725|P6|NOT COMPLETED|Overall Study||0
8092479|NCT03351738|19949726|P5|NOT COMPLETED|Overall Study||0
8092480|NCT03351738|19949727|P4|NOT COMPLETED|Overall Study||1
8092481|NCT03351738|19949728|P3|NOT COMPLETED|Overall Study||0
8092482|NCT03351738|19949729|P2|NOT COMPLETED|Overall Study||1
8092483|NCT03351738|19949730|P1|NOT COMPLETED|Overall Study||0
8092484|NCT03351738|19949725|P6|COMPLETED|Overall Study||22
8092485|NCT03351738|19949726|P5|COMPLETED|Overall Study||21
8092486|NCT03351738|19949727|P4|COMPLETED|Overall Study||21
8092487|NCT03351738|19949728|P3|COMPLETED|Overall Study||24
8092488|NCT03351738|19949729|P2|COMPLETED|Overall Study||19
8092489|NCT03351738|19949730|P1|COMPLETED|Overall Study||23
8092490|NCT03351738|19949725|P6|STARTED|Overall Study||22
8092491|NCT03351738|19949726|P5|STARTED|Overall Study||21
8092492|NCT03351738|19949727|P4|STARTED|Overall Study||22
8092493|NCT03351738|19949728|P3|STARTED|Overall Study||24
8092494|NCT03351738|19949729|P2|STARTED|Overall Study||20
8092495|NCT03351738|19949730|P1|STARTED|Overall Study||23
8092496|NCT03351699|19949806|P5|NOT COMPLETED|Overall Study||0
8092497|NCT03351699|19949807|P4|NOT COMPLETED|Overall Study||0
8092498|NCT03351699|19949808|P3|NOT COMPLETED|Overall Study||0
8092499|NCT03351699|19949809|P2|NOT COMPLETED|Overall Study||0
8092500|NCT03351699|19949810|P1|NOT COMPLETED|Overall Study||0
8092501|NCT03351699|19949806|P5|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
8092502|NCT03351699|19949807|P4|COMPLETED|Overall Study||6
8092503|NCT03351699|19949808|P3|COMPLETED|Overall Study||6
8092504|NCT03351699|19949809|P2|COMPLETED|Overall Study||6
8092505|NCT03351699|19949810|P1|COMPLETED|Overall Study||6
8092506|NCT03351699|19949806|P5|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
8092507|NCT03351699|19949807|P4|STARTED|Overall Study||6
8092508|NCT03351699|19949808|P3|STARTED|Overall Study||6
8092509|NCT03351699|19949809|P2|STARTED|Overall Study||6
8092510|NCT03351699|19949810|P1|STARTED|Overall Study||6
8092511|NCT03351335|19949882|P3|NOT COMPLETED|Overall Study||4
8092512|NCT03351335|19949883|P2|NOT COMPLETED|Overall Study||0
8092513|NCT03351335|19949884|P1|NOT COMPLETED|Overall Study||0
8092514|NCT03351335|19949882|P3|COMPLETED|Overall Study||16
8092515|NCT03351335|19949883|P2|COMPLETED|Overall Study||19
8092516|NCT03351335|19949884|P1|COMPLETED|Overall Study||21
8092517|NCT03351335|19949882|P3|STARTED|Overall Study||20
8092518|NCT03351335|19949883|P2|STARTED|Overall Study||19
8092519|NCT03351335|19949884|P1|STARTED|Overall Study||21
8092520|NCT03351231|19949904|P1|NOT COMPLETED|Safety Follow-Up Period||3
8092521|NCT03351231|19949904|P1|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
8092522|NCT03351231|19949904|P1|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
8092523|NCT03351231|19949904|P1|NOT COMPLETED|Combination Therapy Period||5
8092524|NCT03351231|19949904|P1|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
8092525|NCT03351231|19949904|P1|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
8092526|NCT03351101|19949928|P2|NOT COMPLETED|Overall Study||3
8092527|NCT03351101|19949929|P1|NOT COMPLETED|Overall Study||1
8092528|NCT03351101|19949928|P2|COMPLETED|Overall Study||129
8092529|NCT03351101|19949929|P1|COMPLETED|Overall Study||135
8092530|NCT03351101|19949928|P2|STARTED|Overall Study||132
8092531|NCT03351101|19949929|P1|STARTED|Overall Study||136
8092532|NCT03350984|19949939|P2|NOT COMPLETED|Overall Study||8
8092533|NCT03350984|19949940|P1|NOT COMPLETED|Overall Study||8
8092534|NCT03350984|19949939|P2|COMPLETED|Overall Study||28
8092535|NCT03350984|19949940|P1|COMPLETED|Overall Study||31
8092536|NCT03350984|19949939|P2|STARTED|Overall Study||36
8092537|NCT03350984|19949940|P1|STARTED|Overall Study||39
8092538|NCT03350919|19949952|P2|NOT COMPLETED|Overall Study||0
8092539|NCT03350919|19949953|P1|NOT COMPLETED|Overall Study||2
8092540|NCT03350919|19949952|P2|COMPLETED|Overall Study||23
8092541|NCT03350919|19949953|P1|COMPLETED|Overall Study||23
8092542|NCT03350919|19949952|P2|STARTED|Overall Study||23
8092543|NCT03350919|19949953|P1|STARTED|Overall Study||25
8092544|NCT03350724|19949963|P2|NOT COMPLETED|Overall Study||0
8092545|NCT03350724|19949964|P1|NOT COMPLETED|Overall Study||0
8092546|NCT03350724|19949963|P2|COMPLETED|Overall Study||17
8092547|NCT03350724|19949964|P1|COMPLETED|Overall Study||17
8092548|NCT03350724|19949963|P2|STARTED|Overall Study||17
8092549|NCT03350724|19949964|P1|STARTED|Overall Study||17
8092550|NCT03350503|19950018|P1|NOT COMPLETED|Overall Study||5
8092551|NCT03350503|19950018|P1|COMPLETED|Overall Study||116
8092552|NCT03350503|19950018|P1|STARTED|Overall Study||121
8092553|NCT03350256|19950022|P1|NOT COMPLETED|Overall Study||36
8092554|NCT03350256|19950022|P1|COMPLETED|Overall Study||24
8092555|NCT03350256|19950022|P1|6 Month Follow up|Overall Study||24
8092556|NCT03350256|19950022|P1|3 Month Follow up|Overall Study||27
8092557|NCT03350256|19950022|P1|1 Month Follow up|Overall Study||30
8092558|NCT03350256|19950022|P1|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
8092559|NCT03350256|19950022|P1|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
8092560|NCT03350256|19950022|P1|STARTED|Overall Study||60
8092561|NCT03350217|19950044|P2|NOT COMPLETED|Overall Study||0
8092562|NCT03350217|19950045|P1|NOT COMPLETED|Overall Study||2
8092563|NCT03350217|19950044|P2|COMPLETED|Overall Study||81
8092564|NCT03350217|19950045|P1|COMPLETED|Overall Study||77
8092565|NCT03350217|19950044|P2|STARTED|Overall Study||81
8092566|NCT03350217|19950045|P1|STARTED|Overall Study||79
8092567|NCT03349632|19950075|P6|NOT COMPLETED|Period 2, Second Week of Wear||0
8092568|NCT03349632|19950076|P5|NOT COMPLETED|Period 2, Second Week of Wear||0
8092569|NCT03349632|19950077|P4|NOT COMPLETED|Period 2, Second Week of Wear||0
8092570|NCT03349632|19950078|P3|NOT COMPLETED|Period 2, Second Week of Wear||0
8092571|NCT03349632|19950079|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
8092572|NCT03349632|19950080|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
8092573|NCT03349632|19950075|P6|COMPLETED|Period 2, Second Week of Wear||11
8092574|NCT03349632|19950076|P5|COMPLETED|Period 2, Second Week of Wear||11
8092575|NCT03349632|19950077|P4|COMPLETED|Period 2, Second Week of Wear||11
8092576|NCT03349632|19950078|P3|COMPLETED|Period 2, Second Week of Wear||11
8092577|NCT03349632|19950079|P2|COMPLETED|Period 2, Second Week of Wear||11
8092578|NCT03349632|19950080|P1|COMPLETED|Period 2, Second Week of Wear||11
8092579|NCT03349632|19950075|P6|STARTED|Period 2, Second Week of Wear||11
8092580|NCT03349632|19950076|P5|STARTED|Period 2, Second Week of Wear||11
8092581|NCT03349632|19950077|P4|STARTED|Period 2, Second Week of Wear||11
8092582|NCT03349632|19950078|P3|STARTED|Period 2, Second Week of Wear||11
8092583|NCT03349632|19950079|P2|STARTED|Period 2, Second Week of Wear||11
8092584|NCT03349632|19950080|P1|STARTED|Period 2, Second Week of Wear||11
8092585|NCT03349632|19950075|P6|NOT COMPLETED|Period 1, First Week of Wear||0
8092586|NCT03349632|19950076|P5|NOT COMPLETED|Period 1, First Week of Wear||0
8092587|NCT03349632|19950077|P4|NOT COMPLETED|Period 1, First Week of Wear||0
8092588|NCT03349632|19950078|P3|NOT COMPLETED|Period 1, First Week of Wear||0
8092589|NCT03349632|19950079|P2|NOT COMPLETED|Period 1, First Week of Wear||0
8092590|NCT03349632|19950080|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8092591|NCT03349632|19950075|P6|COMPLETED|Period 1, First Week of Wear||11
8092592|NCT03349632|19950076|P5|COMPLETED|Period 1, First Week of Wear||11
8092593|NCT03349632|19950077|P4|COMPLETED|Period 1, First Week of Wear||11
8092594|NCT03349632|19950078|P3|COMPLETED|Period 1, First Week of Wear||11
8092595|NCT03349632|19950079|P2|COMPLETED|Period 1, First Week of Wear||11
8092596|NCT03349632|19950080|P1|COMPLETED|Period 1, First Week of Wear||11
8092597|NCT03349632|19950075|P6|STARTED|Period 1, First Week of Wear||11
8092598|NCT03349632|19950076|P5|STARTED|Period 1, First Week of Wear||11
8092599|NCT03349632|19950077|P4|STARTED|Period 1, First Week of Wear||11
8092600|NCT03349632|19950078|P3|STARTED|Period 1, First Week of Wear||11
8092601|NCT03349632|19950079|P2|STARTED|Period 1, First Week of Wear||11
8092602|NCT03349632|19950080|P1|STARTED|Period 1, First Week of Wear||11
8092603|NCT03349515|19950096|P2|NOT COMPLETED|Overall Study||1
8092604|NCT03349515|19950097|P1|NOT COMPLETED|Overall Study||5
8092605|NCT03349515|19950096|P2|COMPLETED|Overall Study||50
8092606|NCT03349515|19950097|P1|COMPLETED|Overall Study||50
8092607|NCT03349515|19950096|P2|STARTED|Overall Study||51
8092608|NCT03349515|19950097|P1|STARTED|Overall Study||55
8092609|NCT03349437|19950103|P3|NOT COMPLETED|Intervention||0
8092610|NCT03349437|19950104|P2|NOT COMPLETED|Intervention||0
8092611|NCT03349437|19950105|P1|NOT COMPLETED|Intervention||0
8092612|NCT03349437|19950103|P3|COMPLETED|Intervention||10
8092613|NCT03349437|19950104|P2|COMPLETED|Intervention||10
8092614|NCT03349437|19950105|P1|COMPLETED|Intervention||0
8092615|NCT03349437|19950103|P3|STARTED|Intervention||10
8092616|NCT03349437|19950104|P2|STARTED|Intervention||10
8092617|NCT03349437|19950105|P1|STARTED|Intervention||0
8092618|NCT03349437|19950103|P3|NOT COMPLETED|Screening||0
8092619|NCT03349437|19950104|P2|NOT COMPLETED|Screening||0
8092620|NCT03349437|19950105|P1|NOT COMPLETED|Screening||5
8092621|NCT03349437|19950103|P3|COMPLETED|Screening||0
8092622|NCT03349437|19950104|P2|COMPLETED|Screening||0
8092623|NCT03349437|19950105|P1|COMPLETED|Screening||20
8092624|NCT03349437|19950103|P3|STARTED|Screening||0
8092625|NCT03349437|19950104|P2|STARTED|Screening||0
8092626|NCT03349437|19950105|P1|STARTED|Screening||25
8092627|NCT03349333|19950112|P1|NOT COMPLETED|Overall Study||71
8092628|NCT03349333|19950112|P1|COMPLETED|Overall Study||0
8092629|NCT03349333|19950112|P1|STARTED|Overall Study||71
8092630|NCT03349099|19950135|P2|NOT COMPLETED|Overall Study||4
8092631|NCT03349099|19950136|P1|NOT COMPLETED|Overall Study||4
8092632|NCT03349099|19950135|P2|COMPLETED|Overall Study||43
8092633|NCT03349099|19950136|P1|COMPLETED|Overall Study||44
8092634|NCT03349099|19950135|P2|STARTED|Overall Study||47
8092635|NCT03349099|19950136|P1|STARTED|Overall Study||48
8092636|NCT03349060|19950149|P3|NOT COMPLETED|Overall Study||16
8092637|NCT03349060|19950150|P2|NOT COMPLETED|Overall Study||17
8092638|NCT03349060|19950151|P1|NOT COMPLETED|Overall Study||21
8092639|NCT03349060|19950149|P3|COMPLETED|Overall Study||61
8092640|NCT03349060|19950150|P2|COMPLETED|Overall Study||137
8092641|NCT03349060|19950151|P1|COMPLETED|Overall Study||135
8092642|NCT03349060|19950149|P3|STARTED|Overall Study||77
8092643|NCT03349060|19950150|P2|STARTED|Overall Study||154
8092644|NCT03349060|19950151|P1|STARTED|Overall Study||156
8092645|NCT03349034|19950292|P2|NOT COMPLETED|Overall Study||2
8092646|NCT03349034|19950293|P1|NOT COMPLETED|Overall Study||4
8092647|NCT03349034|19950292|P2|COMPLETED|Overall Study||10
8092648|NCT03349034|19950293|P1|COMPLETED|Overall Study||8
8092649|NCT03349034|19950292|P2|STARTED|Overall Study||12
8092650|NCT03349034|19950293|P1|STARTED|Overall Study||12
8092651|NCT03348904|19950314|P3|NOT COMPLETED|Overall Study||0
8092652|NCT03348904|19950315|P2|NOT COMPLETED|Overall Study||1
8092653|NCT03348904|19950316|P1|NOT COMPLETED|Overall Study||0
8092654|NCT03348904|19950314|P3|COMPLETED|Overall Study||0
8092655|NCT03348904|19950315|P2|COMPLETED|Overall Study||1
8092656|NCT03348904|19950316|P1|COMPLETED|Overall Study||0
8092657|NCT03348904|19950314|P3|STARTED|Overall Study||0
8092658|NCT03348904|19950315|P2|STARTED|Overall Study||2
8092659|NCT03348904|19950316|P1|STARTED|Overall Study||0
8092660|NCT03348683|19950335|P2|NOT COMPLETED|Overall Study||0
8092661|NCT03348683|19950336|P1|NOT COMPLETED|Overall Study||0
8092662|NCT03348683|19950335|P2|COMPLETED|Overall Study||119
8092663|NCT03348683|19950336|P1|COMPLETED|Overall Study||121
8092664|NCT03348683|19950335|P2|STARTED|Overall Study||119
8092665|NCT03348683|19950336|P1|STARTED|Overall Study||121
8092666|NCT03346902|19950360|P2|NOT COMPLETED|Overall Study||0
8092667|NCT03346902|19950361|P1|NOT COMPLETED|Overall Study||0
8092668|NCT03346902|19950360|P2|COMPLETED|Overall Study||8
8092669|NCT03346902|19950361|P1|COMPLETED|Overall Study||4
8092670|NCT03346902|19950360|P2|STARTED|Overall Study||8
8092671|NCT03346902|19950361|P1|STARTED|Overall Study||4
8092672|NCT03346850|19950369|P2|NOT COMPLETED|Overall Study||3
8092673|NCT03346850|19950370|P1|NOT COMPLETED|Overall Study||2
8092674|NCT03346850|19950369|P2|COMPLETED|Overall Study||17
8092675|NCT03346850|19950370|P1|COMPLETED|Overall Study||18
8092676|NCT03346850|19950369|P2|STARTED|Overall Study||20
8092677|NCT03346850|19950370|P1|STARTED|Overall Study||20
8092678|NCT03346759|19950392|P2|NOT COMPLETED|Third Menstrual Cycle||0
8092679|NCT03346759|19950393|P1|NOT COMPLETED|Third Menstrual Cycle||0
8092680|NCT03346759|19950392|P2|COMPLETED|Third Menstrual Cycle||10
8092681|NCT03346759|19950393|P1|COMPLETED|Third Menstrual Cycle||11
8092682|NCT03346759|19950392|P2|STARTED|Third Menstrual Cycle||10
8092683|NCT03346759|19950393|P1|STARTED|Third Menstrual Cycle||11
8092684|NCT03346759|19950392|P2|NOT COMPLETED|Second Menstrual Cycle||0
8092685|NCT03346759|19950393|P1|NOT COMPLETED|Second Menstrual Cycle||1
8092686|NCT03346759|19950392|P2|COMPLETED|Second Menstrual Cycle||10
8092687|NCT03346759|19950393|P1|COMPLETED|Second Menstrual Cycle||11
8092688|NCT03346759|19950392|P2|STARTED|Second Menstrual Cycle||10
8092689|NCT03346759|19950393|P1|STARTED|Second Menstrual Cycle||12
8092690|NCT03346759|19950392|P2|NOT COMPLETED|First Menstrual Cycle||0
8092691|NCT03346759|19950393|P1|NOT COMPLETED|First Menstrual Cycle||1
8092692|NCT03346759|19950392|P2|COMPLETED|First Menstrual Cycle||10
8092693|NCT03346759|19950393|P1|COMPLETED|First Menstrual Cycle||12
8092694|NCT03346759|19950392|P2|STARTED|First Menstrual Cycle||10
8092695|NCT03346759|19950393|P1|STARTED|First Menstrual Cycle||13
8092696|NCT03346759|19950392|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
8092697|NCT03346759|19950393|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
8092698|NCT03346759|19950392|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
8092699|NCT03346759|19950393|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
8092700|NCT03346759|19950392|P2|STARTED|Enrollment to Baseline Data Collected||13
8092701|NCT03346759|19950393|P1|STARTED|Enrollment to Baseline Data Collected||15
8092702|NCT03346161|19950404|P2|NOT COMPLETED|Overall Study||0
8092703|NCT03346161|19950405|P1|NOT COMPLETED|Overall Study||0
8092704|NCT03346161|19950404|P2|COMPLETED|Overall Study||60
8092705|NCT03346161|19950405|P1|COMPLETED|Overall Study||60
8092706|NCT03346161|19950404|P2|STARTED|Overall Study||60
8092707|NCT03346161|19950405|P1|STARTED|Overall Study||60
8092708|NCT03346057|19950437|P4|NOT COMPLETED|Overall Study||2
8092709|NCT03346057|19950438|P3|NOT COMPLETED|Overall Study||1
8092710|NCT03346057|19950439|P2|NOT COMPLETED|Overall Study||8
8092711|NCT03346057|19950440|P1|NOT COMPLETED|Overall Study||7
8092712|NCT03346057|19950437|P4|COMPLETED|Overall Study||51
8092713|NCT03346057|19950438|P3|COMPLETED|Overall Study||67
8092714|NCT03346057|19950439|P2|COMPLETED|Overall Study||104
8092715|NCT03346057|19950440|P1|COMPLETED|Overall Study||104
8092716|NCT03346057|19950437|P4|Treated|Overall Study||51
8092717|NCT03346057|19950438|P3|Treated|Overall Study||68
8092718|NCT03346057|19950439|P2|Treated|Overall Study||107
8092719|NCT03346057|19950440|P1|Treated|Overall Study||105
8092720|NCT03346057|19950437|P4|STARTED|Overall Study||53
8092721|NCT03346057|19950438|P3|STARTED|Overall Study||68
8092722|NCT03346057|19950439|P2|STARTED|Overall Study||112
8092723|NCT03346057|19950440|P1|STARTED|Overall Study||111
8092724|NCT03345979|19950472|P2|NOT COMPLETED|Overall Study||58
8092725|NCT03345979|19950473|P1|NOT COMPLETED|Overall Study||43
8092726|NCT03345979|19950472|P2|COMPLETED|Overall Study||43
8092727|NCT03345979|19950473|P1|COMPLETED|Overall Study||56
8092728|NCT03345979|19950472|P2|STARTED|Overall Study||101
8092729|NCT03345979|19950473|P1|STARTED|Overall Study||99
8092730|NCT03345914|19950494|P3|NOT COMPLETED|Overall Study||122
8092731|NCT03345914|19950495|P2|NOT COMPLETED|Overall Study||122
8092732|NCT03345914|19950496|P1|NOT COMPLETED|Overall Study||123
8092733|NCT03345914|19950494|P3|COMPLETED|Overall Study||0
8092734|NCT03345914|19950495|P2|COMPLETED|Overall Study||0
8092735|NCT03345914|19950496|P1|COMPLETED|Overall Study||0
8092736|NCT03345914|19950494|P3|Completed Week 28 End of Study|Overall Study||0
8092737|NCT03345914|19950495|P2|Completed Week 28 End of Study|Overall Study||0
8092738|NCT03345914|19950496|P1|Completed Week 28 End of Study|Overall Study||0
8092739|NCT03345914|19950494|P3|Completed Week 16 Study Treatment|Overall Study||119
8092740|NCT03345914|19950495|P2|Completed Week 16 Study Treatment|Overall Study||118
8092741|NCT03345914|19950496|P1|Completed Week 16 Study Treatment|Overall Study||114
8092742|NCT03345914|19950494|P3|STARTED|Overall Study||122
8092743|NCT03345914|19950495|P2|STARTED|Overall Study||122
8092744|NCT03345914|19950496|P1|STARTED|Overall Study||123
8092745|NCT03345901|19950567|P1|NOT COMPLETED|Overall Study||18
8092746|NCT03345901|19950567|P1|COMPLETED|Overall Study||0
8092747|NCT03345901|19950567|P1|STARTED|Overall Study||18
8092748|NCT03345472|19950572|P1|NOT COMPLETED|3 Months to 12 Months||8
8092749|NCT03345472|19950572|P1|COMPLETED|3 Months to 12 Months||91
8092750|NCT03345472|19950572|P1|STARTED|3 Months to 12 Months||99
8092751|NCT03345472|19950572|P1|NOT COMPLETED|Implant to 3 Months||4
8092752|NCT03345472|19950572|P1|COMPLETED|Implant to 3 Months||99
8092753|NCT03345472|19950572|P1|STARTED|Implant to 3 Months||103
8092754|NCT03345407|19950586|P7|NOT COMPLETED|Overall Study||45
8092755|NCT03345407|19950587|P6|NOT COMPLETED|Overall Study||16
8092756|NCT03345407|19950588|P5|NOT COMPLETED|Overall Study||15
8092757|NCT03345407|19950589|P4|NOT COMPLETED|Overall Study||11
8092758|NCT03345407|19950590|P3|NOT COMPLETED|Overall Study||12
8092759|NCT03345407|19950591|P2|NOT COMPLETED|Overall Study||3
8092760|NCT03345407|19950592|P1|NOT COMPLETED|Overall Study||32
8092761|NCT03345407|19950586|P7|COMPLETED|Overall Study||233
8092762|NCT03345407|19950587|P6|COMPLETED|Overall Study||73
8092763|NCT03345407|19950588|P5|COMPLETED|Overall Study||75
8092764|NCT03345407|19950589|P4|COMPLETED|Overall Study||81
8092765|NCT03345407|19950590|P3|COMPLETED|Overall Study||79
8092766|NCT03345407|19950591|P2|COMPLETED|Overall Study||19
8092767|NCT03345407|19950592|P1|COMPLETED|Overall Study||244
8092768|NCT03345407|19950586|P7|STARTED|Overall Study||278
8092769|NCT03345407|19950587|P6|STARTED|Overall Study||89
8092770|NCT03345407|19950588|P5|STARTED|Overall Study||90
8092771|NCT03345407|19950589|P4|STARTED|Overall Study||92
8092772|NCT03345407|19950590|P3|STARTED|Overall Study||91
8092773|NCT03345407|19950591|P2|STARTED|Overall Study||22
8092774|NCT03345407|19950592|P1|STARTED|Overall Study||276
8092775|NCT03345108|19950777|P6|NOT COMPLETED|Period-3||0
8092776|NCT03345108|19950778|P5|NOT COMPLETED|Period-3||0
8092777|NCT03345108|19950779|P4|NOT COMPLETED|Period-3||0
8092778|NCT03345108|19950780|P3|NOT COMPLETED|Period-3||0
8092779|NCT03345108|19950781|P2|NOT COMPLETED|Period-3||0
8092780|NCT03345108|19950782|P1|NOT COMPLETED|Period-3||0
8092781|NCT03345108|19950777|P6|COMPLETED|Period-3||8
8092782|NCT03345108|19950778|P5|COMPLETED|Period-3||8
8092783|NCT03345108|19950779|P4|COMPLETED|Period-3||8
8092784|NCT03345108|19950780|P3|COMPLETED|Period-3||8
8092785|NCT03345108|19950781|P2|COMPLETED|Period-3||8
8092786|NCT03345108|19950782|P1|COMPLETED|Period-3||7
8092787|NCT03345108|19950777|P6|STARTED|Period-3||8
8092788|NCT03345108|19950778|P5|STARTED|Period-3||8
8092789|NCT03345108|19950779|P4|STARTED|Period-3||8
8092790|NCT03345108|19950780|P3|STARTED|Period-3||8
8092791|NCT03345108|19950781|P2|STARTED|Period-3||8
8092792|NCT03345108|19950782|P1|STARTED|Period-3||7
8092793|NCT03345108|19950777|P6|NOT COMPLETED|Period-2||0
8092794|NCT03345108|19950778|P5|NOT COMPLETED|Period-2||0
8092795|NCT03345108|19950779|P4|NOT COMPLETED|Period-2||0
8092796|NCT03345108|19950780|P3|NOT COMPLETED|Period-2||0
8092797|NCT03345108|19950781|P2|NOT COMPLETED|Period-2||0
8092798|NCT03345108|19950782|P1|NOT COMPLETED|Period-2||0
8092799|NCT03345108|19950777|P6|COMPLETED|Period-2||8
8092800|NCT03345108|19950778|P5|COMPLETED|Period-2||8
8092801|NCT03345108|19950779|P4|COMPLETED|Period-2||8
8092802|NCT03345108|19950780|P3|COMPLETED|Period-2||8
8092803|NCT03345108|19950781|P2|COMPLETED|Period-2||8
8092804|NCT03345108|19950782|P1|COMPLETED|Period-2||8
8092805|NCT03345108|19950777|P6|STARTED|Period-2||8
8092806|NCT03345108|19950778|P5|STARTED|Period-2||8
8092807|NCT03345108|19950779|P4|STARTED|Period-2||8
8092808|NCT03345108|19950780|P3|STARTED|Period-2||8
8092809|NCT03345108|19950781|P2|STARTED|Period-2||8
8092810|NCT03345108|19950782|P1|STARTED|Period-2||8
8092811|NCT03345108|19950777|P6|NOT COMPLETED|Period-1||0
8092812|NCT03345108|19950778|P5|NOT COMPLETED|Period-1||0
8092813|NCT03345108|19950779|P4|NOT COMPLETED|Period-1||0
8092814|NCT03345108|19950780|P3|NOT COMPLETED|Period-1||0
8092815|NCT03345108|19950781|P2|NOT COMPLETED|Period-1||0
8092816|NCT03345108|19950782|P1|NOT COMPLETED|Period-1||0
8092817|NCT03345108|19950777|P6|COMPLETED|Period-1||8
8092818|NCT03345108|19950778|P5|COMPLETED|Period-1||8
8092819|NCT03345108|19950779|P4|COMPLETED|Period-1||8
8092820|NCT03345108|19950780|P3|COMPLETED|Period-1||8
8092821|NCT03345108|19950781|P2|COMPLETED|Period-1||8
8092822|NCT03345108|19950782|P1|COMPLETED|Period-1||8
8092823|NCT03345108|19950777|P6|STARTED|Period-1||8
8092824|NCT03345108|19950778|P5|STARTED|Period-1||8
8092825|NCT03345108|19950779|P4|STARTED|Period-1||8
8092826|NCT03345108|19950780|P3|STARTED|Period-1||8
8092827|NCT03345108|19950781|P2|STARTED|Period-1||8
8092828|NCT03345108|19950782|P1|STARTED|Period-1||8
8092829|NCT03344861|19950790|P1|NOT COMPLETED|Overall Study||0
8092830|NCT03344861|19950790|P1|COMPLETED|Overall Study||10
8092831|NCT03344861|19950790|P1|STARTED|Overall Study||10
8092832|NCT03344640|19950821|P2|NOT COMPLETED|Follow-up Epoch||2
8092833|NCT03344640|19950822|P1|NOT COMPLETED|Follow-up Epoch||0
8092834|NCT03344640|19950821|P2|COMPLETED|Follow-up Epoch||42
8092835|NCT03344640|19950822|P1|COMPLETED|Follow-up Epoch||46
8092836|NCT03344640|19950821|P2|STARTED|Follow-up Epoch||44
8092837|NCT03344640|19950822|P1|STARTED|Follow-up Epoch||46
8092838|NCT03344640|19950821|P2|NOT COMPLETED|Overall Study||3
8092839|NCT03344640|19950822|P1|NOT COMPLETED|Overall Study||3
8092840|NCT03344640|19950821|P2|COMPLETED|Overall Study||44
8092841|NCT03344640|19950822|P1|COMPLETED|Overall Study||46
8092842|NCT03344640|19950821|P2|STARTED|Overall Study||47
8092843|NCT03344640|19950822|P1|STARTED|Overall Study||49
8092844|NCT03344562|19950851|P2|NOT COMPLETED|Overall Study||0
8092845|NCT03344562|19950852|P1|NOT COMPLETED|Overall Study||2
8092846|NCT03344562|19950851|P2|COMPLETED|Overall Study||9
8092847|NCT03344562|19950852|P1|COMPLETED|Overall Study||8
8092848|NCT03344562|19950851|P2|STARTED|Overall Study||9
8092849|NCT03344562|19950852|P1|STARTED|Overall Study||10
8092850|NCT03344510|19950862|P2|NOT COMPLETED|Second Injection (5 Minutes)||0
8092851|NCT03344510|19950863|P1|NOT COMPLETED|Second Injection (5 Minutes)||0
8092852|NCT03344510|19950862|P2|COMPLETED|Second Injection (5 Minutes)||26
8092853|NCT03344510|19950863|P1|COMPLETED|Second Injection (5 Minutes)||21
8092854|NCT03344510|19950862|P2|Received Injection|Second Injection (5 Minutes)||26
8092855|NCT03344510|19950863|P1|Received Injection|Second Injection (5 Minutes)||21
8092856|NCT03344510|19950862|P2|STARTED|Second Injection (5 Minutes)||26
8092857|NCT03344510|19950863|P1|STARTED|Second Injection (5 Minutes)||21
8092858|NCT03344510|19950862|P2|NOT COMPLETED|Wash Out (10 Minutes||0
8092859|NCT03344510|19950863|P1|NOT COMPLETED|Wash Out (10 Minutes||0
8092860|NCT03344510|19950862|P2|COMPLETED|Wash Out (10 Minutes||26
8092861|NCT03344510|19950863|P1|COMPLETED|Wash Out (10 Minutes||21
8092862|NCT03344510|19950862|P2|STARTED|Wash Out (10 Minutes||26
8092863|NCT03344510|19950863|P1|STARTED|Wash Out (10 Minutes||21
8092864|NCT03344510|19950862|P2|NOT COMPLETED|First Injection (5 Minutes)||0
8092865|NCT03344510|19950863|P1|NOT COMPLETED|First Injection (5 Minutes)||0
8092866|NCT03344510|19950862|P2|COMPLETED|First Injection (5 Minutes)||26
8092867|NCT03344510|19950863|P1|COMPLETED|First Injection (5 Minutes)||21
8092868|NCT03344510|19950862|P2|Received Injection|First Injection (5 Minutes)||26
8092869|NCT03344510|19950863|P1|Received Injection|First Injection (5 Minutes)||21
8092870|NCT03344510|19950862|P2|STARTED|First Injection (5 Minutes)||26
8092871|NCT03344510|19950863|P1|STARTED|First Injection (5 Minutes)||21
8092872|NCT03344172|19950872|P2|NOT COMPLETED|Overall Study||0
8092873|NCT03344172|19950873|P1|NOT COMPLETED|Overall Study||1
8092874|NCT03344172|19950872|P2|COMPLETED|Overall Study||16
8092875|NCT03344172|19950873|P1|COMPLETED|Overall Study||15
8092876|NCT03344172|19950872|P2|STARTED|Overall Study||16
8092877|NCT03344172|19950873|P1|STARTED|Overall Study||16
8092878|NCT03343639|19950891|P2|NOT COMPLETED|Overall Study||12
8092879|NCT03343639|19950892|P1|NOT COMPLETED|Overall Study||14
8092880|NCT03343639|19950891|P2|COMPLETED|Overall Study||90
8092881|NCT03343639|19950892|P1|COMPLETED|Overall Study||88
8092882|NCT03343639|19950891|P2|STARTED|Overall Study||102
8092883|NCT03343639|19950892|P1|STARTED|Overall Study||102
8092884|NCT03343080|19950906|P2|NOT COMPLETED|Overall Study||0
8092885|NCT03343080|19950907|P1|NOT COMPLETED|Overall Study||0
8092886|NCT03343080|19950906|P2|COMPLETED|Overall Study||18
8092887|NCT03343080|19950907|P1|COMPLETED|Overall Study||14
8092888|NCT03343080|19950906|P2|STARTED|Overall Study||18
8092889|NCT03343080|19950907|P1|STARTED|Overall Study||14
8092890|NCT03343067|19950920|P3|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
8092891|NCT03343067|19950921|P2|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
8092892|NCT03343067|19950922|P1|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092893|NCT03343067|19950920|P3|COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092894|NCT03343067|19950921|P2|COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092895|NCT03343067|19950922|P1|COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092896|NCT03343067|19950920|P3|STARTED|Double Blind Period: Month 3 to Month 6||1
8092897|NCT03343067|19950921|P2|STARTED|Double Blind Period: Month 3 to Month 6||3
8092898|NCT03343067|19950922|P1|STARTED|Double Blind Period: Month 3 to Month 6||0
8092899|NCT03343067|19950920|P3|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
8092900|NCT03343067|19950921|P2|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
8092901|NCT03343067|19950922|P1|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
8092902|NCT03343067|19950920|P3|COMPLETED|Open Label Period: Day 1 to Month 3||1
8092903|NCT03343067|19950921|P2|COMPLETED|Open Label Period: Day 1 to Month 3||3
8092904|NCT03343067|19950922|P1|COMPLETED|Open Label Period: Day 1 to Month 3||0
8092905|NCT03343067|19950920|P3|STARTED|Open Label Period: Day 1 to Month 3||1
8092906|NCT03343067|19950921|P2|STARTED|Open Label Period: Day 1 to Month 3||3
8092907|NCT03343067|19950922|P1|STARTED|Open Label Period: Day 1 to Month 3||7
8092908|NCT03342898|19951050|P3|NOT COMPLETED|Overall Study||54
8092909|NCT03342898|19951051|P2|NOT COMPLETED|Overall Study||53
8092910|NCT03342898|19951052|P1|NOT COMPLETED|Overall Study||54
8092911|NCT03342898|19951050|P3|COMPLETED|Overall Study||246
8092912|NCT03342898|19951051|P2|COMPLETED|Overall Study||247
8092913|NCT03342898|19951052|P1|COMPLETED|Overall Study||246
8092914|NCT03342898|19951050|P3|STARTED|Overall Study||300
8092915|NCT03342898|19951051|P2|STARTED|Overall Study||300
8092916|NCT03342898|19951052|P1|STARTED|Overall Study||300
8092917|NCT03342638|19951095|P2|NOT COMPLETED|Overall Study||1
8092918|NCT03342638|19951096|P1|NOT COMPLETED|Overall Study||1
8092919|NCT03342638|19951095|P2|COMPLETED|Overall Study||31
8092920|NCT03342638|19951096|P1|COMPLETED|Overall Study||33
8092921|NCT03342638|19951095|P2|STARTED|Overall Study||32
8092922|NCT03342638|19951096|P1|STARTED|Overall Study||34
8092923|NCT03342560|19951102|P1|NOT COMPLETED|Overall Study||2
8092924|NCT03342560|19951102|P1|COMPLETED|Overall Study||28
8092925|NCT03342560|19951102|P1|STARTED|Overall Study||30
8092926|NCT03342469|19951112|P4|NOT COMPLETED|Overall Study||0
8092927|NCT03342469|19951113|P3|NOT COMPLETED|Overall Study||0
8092928|NCT03342469|19951114|P2|NOT COMPLETED|Overall Study||1
8092929|NCT03342469|19951115|P1|NOT COMPLETED|Overall Study||0
8092930|NCT03342469|19951112|P4|COMPLETED|Overall Study||8
8092931|NCT03342469|19951113|P3|COMPLETED|Overall Study||3
8092932|NCT03342469|19951114|P2|COMPLETED|Overall Study||8
8092933|NCT03342469|19951115|P1|COMPLETED|Overall Study||9
8092934|NCT03342469|19951112|P4|STARTED|Overall Study||8
8092935|NCT03342469|19951113|P3|STARTED|Overall Study||3
8092936|NCT03342469|19951114|P2|STARTED|Overall Study||9
8092937|NCT03342469|19951115|P1|STARTED|Overall Study||9
8092938|NCT03342157|19951133|P2|NOT COMPLETED|Overall Study||0
8092939|NCT03342157|19951134|P1|NOT COMPLETED|Overall Study||0
8092940|NCT03342157|19951133|P2|COMPLETED|Overall Study||1
8092941|NCT03342157|19951134|P1|COMPLETED|Overall Study||1
8092942|NCT03342157|19951133|P2|STARTED|Overall Study||1
8092943|NCT03342157|19951134|P1|STARTED|Overall Study||1
8092944|NCT03342053|19951146|P2|NOT COMPLETED|Overall Study||1
8092945|NCT03342053|19951147|P1|NOT COMPLETED|Overall Study||2
8092946|NCT03342053|19951146|P2|COMPLETED|Overall Study||22
8092947|NCT03342053|19951147|P1|COMPLETED|Overall Study||21
8092948|NCT03342053|19951146|P2|STARTED|Overall Study||23
8092949|NCT03342053|19951147|P1|STARTED|Overall Study||23
8092950|NCT03341923|19951165|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
8092951|NCT03341923|19951166|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8092952|NCT03341923|19951165|P2|COMPLETED|Period 2, Second 14 Days of Wear||65
8092953|NCT03341923|19951166|P1|COMPLETED|Period 2, Second 14 Days of Wear||67
8092954|NCT03341923|19951165|P2|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
8092955|NCT03341923|19951166|P1|STARTED|Period 2, Second 14 Days of Wear||67
8092956|NCT03341923|19951165|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||0
8092957|NCT03341923|19951166|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
8092958|NCT03341923|19951165|P2|COMPLETED|Period 1, First 14 Days of Wear||67
8092959|NCT03341923|19951166|P1|COMPLETED|Period 1, First 14 Days of Wear||67
8092960|NCT03341923|19951165|P2|STARTED|Period 1, First 14 Days of Wear||67
8092961|NCT03341923|19951166|P1|STARTED|Period 1, First 14 Days of Wear||67
8092962|NCT03341910|19951178|P4|NOT COMPLETED|Overall Study||0
8092963|NCT03341910|19951179|P3|NOT COMPLETED|Overall Study||0
8092964|NCT03341910|19951180|P2|NOT COMPLETED|Overall Study||0
8092965|NCT03341910|19951181|P1|NOT COMPLETED|Overall Study||0
8092966|NCT03341910|19951178|P4|COMPLETED|Overall Study||26
8092967|NCT03341910|19951179|P3|COMPLETED|Overall Study||26
8092968|NCT03341910|19951180|P2|COMPLETED|Overall Study||49
8092969|NCT03341910|19951181|P1|COMPLETED|Overall Study||54
8092970|NCT03341910|19951178|P4|STARTED|Overall Study||26
8092971|NCT03341910|19951179|P3|STARTED|Overall Study||26
8092972|NCT03341910|19951180|P2|STARTED|Overall Study||49
8092973|NCT03341910|19951181|P1|STARTED|Overall Study||54
8092974|NCT03341728|19951191|P2|NOT COMPLETED|Session 2||0
8092975|NCT03341728|19951192|P1|NOT COMPLETED|Session 2||0
8092976|NCT03341728|19951191|P2|COMPLETED|Session 2||7
8092977|NCT03341728|19951192|P1|COMPLETED|Session 2||7
8092978|NCT03341728|19951191|P2|STARTED|Session 2||7
8092979|NCT03341728|19951192|P1|STARTED|Session 2||7
8092980|NCT03341728|19951191|P2|NOT COMPLETED|Washout (1 Week)||0
8092981|NCT03341728|19951192|P1|NOT COMPLETED|Washout (1 Week)||0
8092982|NCT03341728|19951191|P2|COMPLETED|Washout (1 Week)||7
8092983|NCT03341728|19951192|P1|COMPLETED|Washout (1 Week)||7
8092984|NCT03341728|19951191|P2|STARTED|Washout (1 Week)||7
8092985|NCT03341728|19951192|P1|STARTED|Washout (1 Week)||7
8092986|NCT03341728|19951191|P2|NOT COMPLETED|Session 1||0
8092987|NCT03341728|19951192|P1|NOT COMPLETED|Session 1||0
8092988|NCT03341728|19951191|P2|COMPLETED|Session 1||7
8092989|NCT03341728|19951192|P1|COMPLETED|Session 1||7
8092990|NCT03341728|19951191|P2|STARTED|Session 1||7
8092991|NCT03341728|19951192|P1|STARTED|Session 1||7
8092992|NCT03341637|19951210|P2|NOT COMPLETED|Overall Study||4
8092993|NCT03341637|19951211|P1|NOT COMPLETED|Overall Study||5
8092994|NCT03341637|19951210|P2|COMPLETED|Overall Study||296
8092995|NCT03341637|19951211|P1|COMPLETED|Overall Study||95
8092996|NCT03341637|19951210|P2|STARTED|Overall Study||300
8092997|NCT03341637|19951211|P1|STARTED|Overall Study||100
8092998|NCT03341546|19951233|P1|NOT COMPLETED|Overall Study||0
8092999|NCT03341546|19951233|P1|COMPLETED|Overall Study||20
8093000|NCT03341546|19951233|P1|STARTED|Overall Study||20
8093001|NCT03341533|19951239|P2|NOT COMPLETED|Overall Study||2
8093002|NCT03341533|19951240|P1|NOT COMPLETED|Overall Study||3
8093003|NCT03341533|19951239|P2|COMPLETED|Overall Study||68
8093004|NCT03341533|19951240|P1|COMPLETED|Overall Study||69
8093005|NCT03341533|19951239|P2|STARTED|Overall Study||70
8093006|NCT03341533|19951240|P1|STARTED|Overall Study||72
8093007|NCT03341312|19951252|P4|NOT COMPLETED|Period 4||0
8093008|NCT03341312|19951253|P3|NOT COMPLETED|Period 4||0
8093009|NCT03341312|19951254|P2|NOT COMPLETED|Period 4||0
8093010|NCT03341312|19951255|P1|NOT COMPLETED|Period 4||0
8093011|NCT03341312|19951252|P4|COMPLETED|Period 4||8
8093012|NCT03341312|19951253|P3|COMPLETED|Period 4||9
8093013|NCT03341312|19951254|P2|COMPLETED|Period 4||9
8093014|NCT03341312|19951255|P1|COMPLETED|Period 4||9
8093015|NCT03341312|19951252|P4|STARTED|Period 4||8
8093016|NCT03341312|19951253|P3|STARTED|Period 4||9
8093017|NCT03341312|19951254|P2|STARTED|Period 4||9
8093018|NCT03341312|19951255|P1|STARTED|Period 4||9
8093019|NCT03341312|19951252|P4|NOT COMPLETED|Period 3||0
8093020|NCT03341312|19951253|P3|NOT COMPLETED|Period 3||0
8093021|NCT03341312|19951254|P2|NOT COMPLETED|Period 3||0
8093022|NCT03341312|19951255|P1|NOT COMPLETED|Period 3||0
8093023|NCT03341312|19951252|P4|COMPLETED|Period 3||8
8093024|NCT03341312|19951253|P3|COMPLETED|Period 3||9
8093025|NCT03341312|19951254|P2|COMPLETED|Period 3||9
8093026|NCT03341312|19951255|P1|COMPLETED|Period 3||9
8093027|NCT03341312|19951252|P4|STARTED|Period 3||8
8093028|NCT03341312|19951253|P3|STARTED|Period 3||9
8093029|NCT03341312|19951254|P2|STARTED|Period 3||9
8093030|NCT03341312|19951255|P1|STARTED|Period 3||9
8093031|NCT03341312|19951252|P4|NOT COMPLETED|Period 2||0
8093032|NCT03341312|19951253|P3|NOT COMPLETED|Period 2||0
8093033|NCT03341312|19951254|P2|NOT COMPLETED|Period 2||0
8093034|NCT03341312|19951255|P1|NOT COMPLETED|Period 2||0
8093035|NCT03341312|19951252|P4|COMPLETED|Period 2||8
8093036|NCT03341312|19951253|P3|COMPLETED|Period 2||9
8093037|NCT03341312|19951254|P2|COMPLETED|Period 2||9
8093038|NCT03341312|19951255|P1|COMPLETED|Period 2||9
8093039|NCT03341312|19951252|P4|STARTED|Period 2||8
8093040|NCT03341312|19951253|P3|STARTED|Period 2||9
8093041|NCT03341312|19951254|P2|STARTED|Period 2||9
8093042|NCT03341312|19951255|P1|STARTED|Period 2||9
8093043|NCT03341312|19951252|P4|NOT COMPLETED|Period 1||0
8093044|NCT03341312|19951253|P3|NOT COMPLETED|Period 1||0
8093045|NCT03341312|19951254|P2|NOT COMPLETED|Period 1||1
8093046|NCT03341312|19951255|P1|NOT COMPLETED|Period 1||0
8093047|NCT03341312|19951252|P4|COMPLETED|Period 1||8
8093048|NCT03341312|19951253|P3|COMPLETED|Period 1||9
8093049|NCT03341312|19951254|P2|COMPLETED|Period 1||9
8093050|NCT03341312|19951255|P1|COMPLETED|Period 1||9
8093051|NCT03341312|19951252|P4|Received at Least One Dose of Study Drug|Period 1||8
8093052|NCT03341312|19951253|P3|Received at Least One Dose of Study Drug|Period 1||9
8093053|NCT03341312|19951254|P2|Received at Least One Dose of Study Drug|Period 1||10
8093054|NCT03341312|19951255|P1|Received at Least One Dose of Study Drug|Period 1||9
8093055|NCT03341312|19951252|P4|STARTED|Period 1||8
8093056|NCT03341312|19951253|P3|STARTED|Period 1||9
8093057|NCT03341312|19951254|P2|STARTED|Period 1||10
8093058|NCT03341312|19951255|P1|STARTED|Period 1||9
8093059|NCT03341299|19951267|P4|NOT COMPLETED|Period 4||0
8093060|NCT03341299|19951268|P3|NOT COMPLETED|Period 4||0
8093061|NCT03341299|19951269|P2|NOT COMPLETED|Period 4||0
8093062|NCT03341299|19951270|P1|NOT COMPLETED|Period 4||0
8093063|NCT03341299|19951267|P4|COMPLETED|Period 4||9
8093064|NCT03341299|19951268|P3|COMPLETED|Period 4||8
8093065|NCT03341299|19951269|P2|COMPLETED|Period 4||9
8093066|NCT03341299|19951270|P1|COMPLETED|Period 4||9
8093067|NCT03341299|19951267|P4|STARTED|Period 4||9
8093068|NCT03341299|19951268|P3|STARTED|Period 4||8
8093069|NCT03341299|19951269|P2|STARTED|Period 4||9
8093070|NCT03341299|19951270|P1|STARTED|Period 4||9
8093071|NCT03341299|19951267|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093072|NCT03341299|19951268|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093073|NCT03341299|19951269|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093074|NCT03341299|19951270|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093075|NCT03341299|19951267|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093076|NCT03341299|19951268|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
8093077|NCT03341299|19951269|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093078|NCT03341299|19951270|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093079|NCT03341299|19951267|P4|STARTED|Washout (A Minimum of 21 Hours)||9
8093080|NCT03341299|19951268|P3|STARTED|Washout (A Minimum of 21 Hours)||8
8093081|NCT03341299|19951269|P2|STARTED|Washout (A Minimum of 21 Hours)||9
8093082|NCT03341299|19951270|P1|STARTED|Washout (A Minimum of 21 Hours)||9
8093083|NCT03341299|19951267|P4|NOT COMPLETED|Period 3||0
8093084|NCT03341299|19951268|P3|NOT COMPLETED|Period 3||0
8093085|NCT03341299|19951269|P2|NOT COMPLETED|Period 3||0
8093086|NCT03341299|19951270|P1|NOT COMPLETED|Period 3||0
8093087|NCT03341299|19951267|P4|COMPLETED|Period 3||9
8093088|NCT03341299|19951268|P3|COMPLETED|Period 3||8
8093089|NCT03341299|19951269|P2|COMPLETED|Period 3||9
8093090|NCT03341299|19951270|P1|COMPLETED|Period 3||9
8093091|NCT03341299|19951267|P4|STARTED|Period 3||9
8093092|NCT03341299|19951268|P3|STARTED|Period 3||8
8093093|NCT03341299|19951269|P2|STARTED|Period 3||9
8093094|NCT03341299|19951270|P1|STARTED|Period 3||9
8093095|NCT03341299|19951267|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093096|NCT03341299|19951268|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093097|NCT03341299|19951269|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093098|NCT03341299|19951270|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093099|NCT03341299|19951267|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093100|NCT03341299|19951268|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
8093101|NCT03341299|19951269|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093102|NCT03341299|19951270|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093103|NCT03341299|19951267|P4|STARTED|Washout (A Minimum of 21 Hours)||9
8093104|NCT03341299|19951268|P3|STARTED|Washout (A Minimum of 21 Hours)||8
8093105|NCT03341299|19951269|P2|STARTED|Washout (A Minimum of 21 Hours)||9
8093106|NCT03341299|19951270|P1|STARTED|Washout (A Minimum of 21 Hours)||9
8093107|NCT03341299|19951267|P4|NOT COMPLETED|Period 2||0
8093108|NCT03341299|19951268|P3|NOT COMPLETED|Period 2||0
8093109|NCT03341299|19951269|P2|NOT COMPLETED|Period 2||0
8093110|NCT03341299|19951270|P1|NOT COMPLETED|Period 2||0
8093111|NCT03341299|19951267|P4|COMPLETED|Period 2||9
8093112|NCT03341299|19951268|P3|COMPLETED|Period 2||8
8093113|NCT03341299|19951269|P2|COMPLETED|Period 2||9
8093114|NCT03341299|19951270|P1|COMPLETED|Period 2||9
8093115|NCT03341299|19951267|P4|STARTED|Period 2||9
8093116|NCT03341299|19951268|P3|STARTED|Period 2||8
8093117|NCT03341299|19951269|P2|STARTED|Period 2||9
8093118|NCT03341299|19951270|P1|STARTED|Period 2||9
8093119|NCT03341299|19951267|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093120|NCT03341299|19951268|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
8093121|NCT03341299|19951269|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093122|NCT03341299|19951270|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093123|NCT03341299|19951267|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093124|NCT03341299|19951268|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
8093125|NCT03341299|19951269|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093126|NCT03341299|19951270|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093127|NCT03341299|19951267|P4|STARTED|Washout (A Minimum of 21 Hours)||9
8093128|NCT03341299|19951268|P3|STARTED|Washout (A Minimum of 21 Hours)||9
8093129|NCT03341299|19951269|P2|STARTED|Washout (A Minimum of 21 Hours)||9
8093130|NCT03341299|19951270|P1|STARTED|Washout (A Minimum of 21 Hours)||9
8093131|NCT03341299|19951267|P4|NOT COMPLETED|Period 1||0
8093132|NCT03341299|19951268|P3|NOT COMPLETED|Period 1||0
8093133|NCT03341299|19951269|P2|NOT COMPLETED|Period 1||0
8093134|NCT03341299|19951270|P1|NOT COMPLETED|Period 1||0
8093135|NCT03341299|19951267|P4|COMPLETED|Period 1||9
8093136|NCT03341299|19951268|P3|COMPLETED|Period 1||9
8093137|NCT03341299|19951269|P2|COMPLETED|Period 1||9
8093138|NCT03341299|19951270|P1|COMPLETED|Period 1||9
8093139|NCT03341299|19951267|P4|STARTED|Period 1||9
8093140|NCT03341299|19951268|P3|STARTED|Period 1||9
8093141|NCT03341299|19951269|P2|STARTED|Period 1||9
8093142|NCT03341299|19951270|P1|STARTED|Period 1||9
8093155|NCT03340883|19951307|P6|NOT COMPLETED|Overall Study||0
8093156|NCT03340883|19951308|P5|NOT COMPLETED|Overall Study||0
8093157|NCT03340883|19951309|P4|NOT COMPLETED|Overall Study||0
8093158|NCT03340883|19951310|P3|NOT COMPLETED|Overall Study||0
8093159|NCT03340883|19951311|P2|NOT COMPLETED|Overall Study||0
8093160|NCT03340883|19951312|P1|NOT COMPLETED|Overall Study||0
8093161|NCT03340883|19951307|P6|COMPLETED|Overall Study||3
8093162|NCT03340883|19951308|P5|COMPLETED|Overall Study||3
8093163|NCT03340883|19951309|P4|COMPLETED|Overall Study||4
8093164|NCT03340883|19951310|P3|COMPLETED|Overall Study||4
8093165|NCT03340883|19951311|P2|COMPLETED|Overall Study||3
8093166|NCT03340883|19951312|P1|COMPLETED|Overall Study||4
8093167|NCT03340883|19951307|P6|STARTED|Overall Study||3
8093168|NCT03340883|19951308|P5|STARTED|Overall Study||3
8093169|NCT03340883|19951309|P4|STARTED|Overall Study||4
8093170|NCT03340883|19951310|P3|STARTED|Overall Study||4
8093171|NCT03340883|19951311|P2|STARTED|Overall Study||3
8093172|NCT03340883|19951312|P1|STARTED|Overall Study||4
8093173|NCT03340805|19951370|P2|NOT COMPLETED|Overall Study||0
8093174|NCT03340805|19951371|P1|NOT COMPLETED|Overall Study||0
8093175|NCT03340805|19951370|P2|COMPLETED|Overall Study||26
8093176|NCT03340805|19951371|P1|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
8093177|NCT03340805|19951370|P2|STARTED|Overall Study||26
8093178|NCT03340805|19951371|P1|STARTED|Overall Study||24
8093179|NCT03340610|19951391|P1|NOT COMPLETED|Overall Study||3
8093180|NCT03340610|19951391|P1|COMPLETED|Overall Study||27
8093181|NCT03340610|19951391|P1|STARTED|Overall Study||30
8093182|NCT03340350|19951395|P1|NOT COMPLETED|Overall Study||6
8093183|NCT03340350|19951395|P1|COMPLETED|Overall Study||4
8093184|NCT03340350|19951395|P1|STARTED|Overall Study||10
8093185|NCT03339726|19951410|P3|NOT COMPLETED|Overall Study||0
8093186|NCT03339726|19951411|P2|NOT COMPLETED|Overall Study||1
8093187|NCT03339726|19951412|P1|NOT COMPLETED|Overall Study||1
8093188|NCT03339726|19951410|P3|COMPLETED|Overall Study||63
8093189|NCT03339726|19951411|P2|COMPLETED|Overall Study||65
8093190|NCT03339726|19951412|P1|COMPLETED|Overall Study||63
8093191|NCT03339726|19951410|P3|STARTED|Overall Study||63
8093192|NCT03339726|19951411|P2|STARTED|Overall Study||66
8093193|NCT03339726|19951412|P1|STARTED|Overall Study||64
8093194|NCT03339583|19951470|P2|NOT COMPLETED|Follow-up (14 Days)||3
8093195|NCT03339583|19951471|P1|NOT COMPLETED|Follow-up (14 Days)||6
8093196|NCT03339583|19951470|P2|COMPLETED|Follow-up (14 Days)||18
8093197|NCT03339583|19951471|P1|COMPLETED|Follow-up (14 Days)||12
8093198|NCT03339583|19951470|P2|STARTED|Follow-up (14 Days)||21
8093199|NCT03339583|19951471|P1|STARTED|Follow-up (14 Days)||18
8093200|NCT03339583|19951470|P2|NOT COMPLETED|Second Intervention (14 Days)||2
8093201|NCT03339583|19951471|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8093202|NCT03339583|19951470|P2|COMPLETED|Second Intervention (14 Days)||21
8093203|NCT03339583|19951471|P1|COMPLETED|Second Intervention (14 Days)||18
8093204|NCT03339583|19951470|P2|STARTED|Second Intervention (14 Days)||23
8093205|NCT03339583|19951471|P1|STARTED|Second Intervention (14 Days)||18
8093206|NCT03339583|19951470|P2|NOT COMPLETED|Washout (14 Days)||0
8093207|NCT03339583|19951471|P1|NOT COMPLETED|Washout (14 Days)||0
8093208|NCT03339583|19951470|P2|COMPLETED|Washout (14 Days)||23
8093209|NCT03339583|19951471|P1|COMPLETED|Washout (14 Days)||18
8093210|NCT03339583|19951470|P2|STARTED|Washout (14 Days)||23
8093211|NCT03339583|19951471|P1|STARTED|Washout (14 Days)||18
8093212|NCT03339583|19951470|P2|NOT COMPLETED|First Intervention (14 Days)||0
8093213|NCT03339583|19951471|P1|NOT COMPLETED|First Intervention (14 Days)||1
8093214|NCT03339583|19951470|P2|COMPLETED|First Intervention (14 Days)||23
8093215|NCT03339583|19951471|P1|COMPLETED|First Intervention (14 Days)||18
8093216|NCT03339583|19951470|P2|STARTED|First Intervention (14 Days)||23
8093217|NCT03339583|19951471|P1|STARTED|First Intervention (14 Days)||19
8093218|NCT03339453|19951509|P2|NOT COMPLETED|Second Visit for Alternate Glucagon||0
8093219|NCT03339453|19951510|P1|NOT COMPLETED|Second Visit for Alternate Glucagon||0
8093220|NCT03339453|19951509|P2|COMPLETED|Second Visit for Alternate Glucagon||34
8093221|NCT03339453|19951510|P1|COMPLETED|Second Visit for Alternate Glucagon||35
8093222|NCT03339453|19951509|P2|STARTED|Second Visit for Alternate Glucagon||34
8093223|NCT03339453|19951510|P1|STARTED|Second Visit for Alternate Glucagon||35
8093224|NCT03339453|19951509|P2|NOT COMPLETED|First Visit of Glucagon Treatment||1
8093225|NCT03339453|19951510|P1|NOT COMPLETED|First Visit of Glucagon Treatment||0
8093226|NCT03339453|19951509|P2|COMPLETED|First Visit of Glucagon Treatment||34
8093227|NCT03339453|19951510|P1|COMPLETED|First Visit of Glucagon Treatment||35
8093228|NCT03339453|19951509|P2|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
8093229|NCT03339453|19951510|P1|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
8093230|NCT03339453|19951509|P2|STARTED|First Visit of Glucagon Treatment||35
8093231|NCT03339453|19951510|P1|STARTED|First Visit of Glucagon Treatment||35
8093232|NCT03339401|19951528|P2|NOT COMPLETED|Overall Study||4
8093233|NCT03339401|19951529|P1|NOT COMPLETED|Overall Study||9
8093234|NCT03339401|19951528|P2|COMPLETED|Overall Study||5
8093235|NCT03339401|19951529|P1|COMPLETED|Overall Study||11
8093236|NCT03339401|19951528|P2|STARTED|Overall Study||9
8093237|NCT03339401|19951529|P1|STARTED|Overall Study||20
8093238|NCT03339206|19951538|P3|NOT COMPLETED|Overall Study||0
8093239|NCT03339206|19951539|P2|NOT COMPLETED|Overall Study||0
8093240|NCT03339206|19951540|P1|NOT COMPLETED|Overall Study||0
8093241|NCT03339206|19951538|P3|COMPLETED|Overall Study||264
8093242|NCT03339206|19951539|P2|COMPLETED|Overall Study||263
8093243|NCT03339206|19951540|P1|COMPLETED|Overall Study||262
8093244|NCT03339206|19951538|P3|STARTED|Overall Study||264
8093245|NCT03339206|19951539|P2|STARTED|Overall Study||263
8093246|NCT03339206|19951540|P1|STARTED|Overall Study||262
8093247|NCT03338855|19951583|P2|NOT COMPLETED|Overall Study||0
8093248|NCT03338855|19951584|P1|NOT COMPLETED|Overall Study||1
8093249|NCT03338855|19951583|P2|COMPLETED|Overall Study||14
8093250|NCT03338855|19951584|P1|COMPLETED|Overall Study||11
8093251|NCT03338855|19951583|P2|Received Treatment in Period 2|Overall Study||14
8093252|NCT03338855|19951584|P1|Received Treatment in Period 2|Overall Study||11
8093253|NCT03338855|19951583|P2|Received Treatment in Period 1|Overall Study||14
8093254|NCT03338855|19951584|P1|Received Treatment in Period 1|Overall Study||12
8093255|NCT03338855|19951583|P2|STARTED|Overall Study||14
8093256|NCT03338855|19951584|P1|STARTED|Overall Study||12
8093269|NCT03338803|19951635|P1|NOT COMPLETED|Overall Study||0
8093270|NCT03338803|19951635|P1|COMPLETED|Overall Study||11001
8093271|NCT03338803|19951635|P1|STARTED|Overall Study||11001
8093272|NCT03338673|19951644|P2|NOT COMPLETED|Overall Study||1
8093273|NCT03338673|19951645|P1|NOT COMPLETED|Overall Study||1
8093274|NCT03338673|19951644|P2|COMPLETED|Overall Study||5
8093275|NCT03338673|19951645|P1|COMPLETED|Overall Study||5
8093276|NCT03338673|19951644|P2|STARTED|Overall Study||6
8093277|NCT03338673|19951645|P1|STARTED|Overall Study||6
8093278|NCT03338556|19951657|P4|NOT COMPLETED|Overall Study||2
8093279|NCT03338556|19951658|P3|NOT COMPLETED|Overall Study||2
8093280|NCT03338556|19951659|P2|NOT COMPLETED|Overall Study||4
8093281|NCT03338556|19951660|P1|NOT COMPLETED|Overall Study||2
8093282|NCT03338556|19951657|P4|COMPLETED|Overall Study||24
8093283|NCT03338556|19951658|P3|COMPLETED|Overall Study||22
8093284|NCT03338556|19951659|P2|COMPLETED|Overall Study||23
8093285|NCT03338556|19951660|P1|COMPLETED|Overall Study||23
8093286|NCT03338556|19951657|P4|STARTED|Overall Study||26
8093287|NCT03338556|19951658|P3|STARTED|Overall Study||24
8093288|NCT03338556|19951659|P2|STARTED|Overall Study||27
8093289|NCT03338556|19951660|P1|STARTED|Overall Study||25
8093290|NCT03338400|19951680|P2|NOT COMPLETED|Overall Study||2
8093291|NCT03338400|19951681|P1|NOT COMPLETED|Overall Study||1
8093292|NCT03338400|19951680|P2|COMPLETED|Overall Study||24
8093293|NCT03338400|19951681|P1|COMPLETED|Overall Study||24
8093294|NCT03338400|19951680|P2|STARTED|Overall Study||26
8093295|NCT03338400|19951681|P1|STARTED|Overall Study||25
8093296|NCT03338036|19951691|P4|NOT COMPLETED|Overall Study||0
8093297|NCT03338036|19951692|P3|NOT COMPLETED|Overall Study||3
8093298|NCT03338036|19951693|P2|NOT COMPLETED|Overall Study||4
8093299|NCT03338036|19951694|P1|NOT COMPLETED|Overall Study||0
8093300|NCT03338036|19951691|P4|COMPLETED|Overall Study||8
8093301|NCT03338036|19951692|P3|COMPLETED|Overall Study||9
8093302|NCT03338036|19951693|P2|COMPLETED|Overall Study||7
8093303|NCT03338036|19951694|P1|COMPLETED|Overall Study||0
8093304|NCT03338036|19951691|P4|STARTED|Overall Study||8
8093305|NCT03338036|19951692|P3|STARTED|Overall Study||12
8093306|NCT03338036|19951693|P2|STARTED|Overall Study||11
8093307|NCT03338036|19951694|P1|STARTED|Overall Study||0
8093308|NCT03337490|19951717|P3|NOT COMPLETED|Overall Study||35
8093309|NCT03337490|19951718|P2|NOT COMPLETED|Overall Study||14
8093310|NCT03337490|19951719|P1|NOT COMPLETED|Overall Study||11
8093311|NCT03337490|19951717|P3|COMPLETED|Overall Study||7
8093312|NCT03337490|19951718|P2|COMPLETED|Overall Study||112
8093313|NCT03337490|19951719|P1|COMPLETED|Overall Study||117
8093314|NCT03337490|19951717|P3|STARTED|Overall Study||42
8093315|NCT03337490|19951718|P2|STARTED|Overall Study||126
8093316|NCT03337490|19951719|P1|STARTED|Overall Study||128
8093317|NCT03337477|19951732|P2|NOT COMPLETED|Overall Study||13
8093318|NCT03337477|19951733|P1|NOT COMPLETED|Overall Study||11
8093319|NCT03337477|19951732|P2|COMPLETED|Overall Study||24
8093320|NCT03337477|19951733|P1|COMPLETED|Overall Study||22
8093321|NCT03337477|19951732|P2|STARTED|Overall Study||37
8093322|NCT03337477|19951733|P1|STARTED|Overall Study||33
8093323|NCT03337308|19951757|P4|NOT COMPLETED|Overall Study||2
8093324|NCT03337308|19951758|P3|NOT COMPLETED|Overall Study||5
8093325|NCT03337308|19951759|P2|NOT COMPLETED|Overall Study||7
8093326|NCT03337308|19951760|P1|NOT COMPLETED|Overall Study||5
8093327|NCT03337308|19951757|P4|COMPLETED|Overall Study||53
8093328|NCT03337308|19951758|P3|COMPLETED|Overall Study||104
8093329|NCT03337308|19951759|P2|COMPLETED|Overall Study||103
8093330|NCT03337308|19951760|P1|COMPLETED|Overall Study||103
8093331|NCT03337308|19951757|P4|STARTED|Overall Study||55
8093332|NCT03337308|19951758|P3|STARTED|Overall Study||109
8093333|NCT03337308|19951759|P2|STARTED|Overall Study||110
8093334|NCT03337308|19951760|P1|STARTED|Overall Study||108
8093335|NCT03337139|19951796|P2|NOT COMPLETED|Phase II||3
8093336|NCT03337139|19951797|P1|NOT COMPLETED|Phase II||5
8093337|NCT03337139|19951796|P2|COMPLETED|Phase II||36
8093338|NCT03337139|19951797|P1|COMPLETED|Phase II||33
8093339|NCT03337139|19951796|P2|26 Week Assessment|Phase II||37
8093340|NCT03337139|19951797|P1|26 Week Assessment|Phase II||34
8093341|NCT03337139|19951796|P2|STARTED|Phase II||39
8093342|NCT03337139|19951797|P1|STARTED|Phase II||38
8093343|NCT03337139|19951796|P2|NOT COMPLETED|Phase I||0
8093344|NCT03337139|19951797|P1|NOT COMPLETED|Phase I||10
8093345|NCT03337139|19951796|P2|COMPLETED|Phase I||0
8093346|NCT03337139|19951797|P1|COMPLETED|Phase I||77
8093347|NCT03337139|19951796|P2|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
8093348|NCT03337139|19951797|P1|STARTED|Phase I||87
8093349|NCT03336853|19951817|P2|NOT COMPLETED|Overall Study||0
8093350|NCT03336853|19951818|P1|NOT COMPLETED|Overall Study||0
8093351|NCT03336853|19951817|P2|COMPLETED|Overall Study||30
8093352|NCT03336853|19951818|P1|COMPLETED|Overall Study||30
8093353|NCT03336853|19951817|P2|STARTED|Overall Study||30
8093354|NCT03336853|19951818|P1|STARTED|Overall Study||30
8093355|NCT03336645|19951824|P1|NOT COMPLETED|Overall Study||0
8093356|NCT03336645|19951824|P1|COMPLETED|Overall Study||25
8093357|NCT03336645|19951824|P1|STARTED|Overall Study||25
8093358|NCT03336502|19951848|P2|NOT COMPLETED|Overall Study||9
8093359|NCT03336502|19951849|P1|NOT COMPLETED|Overall Study||4
8093360|NCT03336502|19951848|P2|COMPLETED|Overall Study||31
8093361|NCT03336502|19951849|P1|COMPLETED|Overall Study||26
8093362|NCT03336502|19951848|P2|STARTED|Overall Study||40
8093363|NCT03336502|19951849|P1|STARTED|Overall Study||30
8093364|NCT03335800|19951876|P1|NOT COMPLETED|Overall Study||419531
8093365|NCT03335800|19951876|P1|COMPLETED|Overall Study||396
8093366|NCT03335800|19951876|P1|Attended Second Study Visit|Overall Study||396
8093367|NCT03335800|19951876|P1|ECG Patch Returned for Analysis|Overall Study||450
8093368|NCT03335800|19951876|P1|ECG Patch Shipped|Overall Study||658
8093369|NCT03335800|19951876|P1|Attended First Study Visit|Overall Study||945
8093370|NCT03335800|19951876|P1|Received Irregular Pulse Notification|Overall Study||2161
8093371|NCT03335800|19951876|P1|STARTED|Overall Study||419927
8093372|NCT03335761|19951886|P3|NOT COMPLETED|Overall Study||2
8093373|NCT03335761|19951887|P2|NOT COMPLETED|Overall Study||1
8093374|NCT03335761|19951888|P1|NOT COMPLETED|Overall Study||2
8093375|NCT03335761|19951886|P3|COMPLETED|Overall Study||13
8093376|NCT03335761|19951887|P2|COMPLETED|Overall Study||13
8093377|NCT03335761|19951888|P1|COMPLETED|Overall Study||17
8093378|NCT03335761|19951886|P3|Implanted With a Neurostimulator Device|Overall Study||14
8093379|NCT03335761|19951887|P2|Implanted With a Neurostimulator Device|Overall Study||14
8093380|NCT03335761|19951888|P1|Implanted With a Neurostimulator Device|Overall Study||18
8093381|NCT03335761|19951886|P3|STARTED|Overall Study||15
8093382|NCT03335761|19951887|P2|STARTED|Overall Study||14
8093383|NCT03335761|19951888|P1|STARTED|Overall Study||19
8093384|NCT03335566|19951901|P2|NOT COMPLETED|Overall Study||3
8093385|NCT03335566|19951902|P1|NOT COMPLETED|Overall Study||4
8093386|NCT03335566|19951901|P2|COMPLETED|Overall Study||203
8093387|NCT03335566|19951902|P1|COMPLETED|Overall Study||214
8093388|NCT03335566|19951901|P2|STARTED|Overall Study||206
8093389|NCT03335566|19951902|P1|STARTED|Overall Study||218
8093390|NCT03335254|19951934|P20|NOT COMPLETED|Period 3, Day 26-30||0
8093391|NCT03335254|19951935|P19|NOT COMPLETED|Period 3, Day 26-30||0
8093392|NCT03335254|19951936|P18|NOT COMPLETED|Period 3, Day 26-30||0
8093393|NCT03335254|19951937|P17|NOT COMPLETED|Period 3, Day 26-30||0
8093394|NCT03335254|19951938|P16|NOT COMPLETED|Period 3, Day 26-30||0
8093395|NCT03335254|19951939|P15|NOT COMPLETED|Period 3, Day 26-30||0
8093396|NCT03335254|19951940|P14|NOT COMPLETED|Period 3, Day 26-30||0
8093397|NCT03335254|19951941|P13|NOT COMPLETED|Period 3, Day 26-30||0
8093398|NCT03335254|19951942|P12|NOT COMPLETED|Period 3, Day 26-30||0
8093399|NCT03335254|19951943|P11|NOT COMPLETED|Period 3, Day 26-30||0
8093400|NCT03335254|19951944|P10|NOT COMPLETED|Period 3, Day 26-30||0
8093401|NCT03335254|19951945|P9|NOT COMPLETED|Period 3, Day 26-30||0
8093402|NCT03335254|19951946|P8|NOT COMPLETED|Period 3, Day 26-30||0
8093403|NCT03335254|19951947|P7|NOT COMPLETED|Period 3, Day 26-30||0
8093404|NCT03335254|19951948|P6|NOT COMPLETED|Period 3, Day 26-30||0
8093405|NCT03335254|19951949|P5|NOT COMPLETED|Period 3, Day 26-30||0
8093406|NCT03335254|19951950|P4|NOT COMPLETED|Period 3, Day 26-30||0
8093407|NCT03335254|19951951|P3|NOT COMPLETED|Period 3, Day 26-30||0
8093408|NCT03335254|19951952|P2|NOT COMPLETED|Period 3, Day 26-30||0
8093409|NCT03335254|19951953|P1|NOT COMPLETED|Period 3, Day 26-30||0
8093410|NCT03335254|19951934|P20|COMPLETED|Period 3, Day 26-30||0
8093411|NCT03335254|19951935|P19|COMPLETED|Period 3, Day 26-30||0
8093412|NCT03335254|19951936|P18|COMPLETED|Period 3, Day 26-30||0
8093413|NCT03335254|19951937|P17|COMPLETED|Period 3, Day 26-30||0
8093414|NCT03335254|19951938|P16|COMPLETED|Period 3, Day 26-30||0
8093415|NCT03335254|19951939|P15|COMPLETED|Period 3, Day 26-30||0
8093416|NCT03335254|19951940|P14|COMPLETED|Period 3, Day 26-30||0
8093417|NCT03335254|19951941|P13|COMPLETED|Period 3, Day 26-30||0
8093418|NCT03335254|19951942|P12|COMPLETED|Period 3, Day 26-30||0
8093419|NCT03335254|19951943|P11|COMPLETED|Period 3, Day 26-30||0
8093420|NCT03335254|19951944|P10|COMPLETED|Period 3, Day 26-30||0
8093421|NCT03335254|19951945|P9|COMPLETED|Period 3, Day 26-30||0
8093422|NCT03335254|19951946|P8|COMPLETED|Period 3, Day 26-30||0
8093423|NCT03335254|19951947|P7|COMPLETED|Period 3, Day 26-30||0
8093424|NCT03335254|19951948|P6|COMPLETED|Period 3, Day 26-30||0
8093425|NCT03335254|19951949|P5|COMPLETED|Period 3, Day 26-30||0
8093426|NCT03335254|19951950|P4|COMPLETED|Period 3, Day 26-30||0
8093427|NCT03335254|19951951|P3|COMPLETED|Period 3, Day 26-30||0
8093428|NCT03335254|19951952|P2|COMPLETED|Period 3, Day 26-30||0
8093429|NCT03335254|19951953|P1|COMPLETED|Period 3, Day 26-30||9
8093430|NCT03335254|19951934|P20|STARTED|Period 3, Day 26-30||0
8093431|NCT03335254|19951935|P19|STARTED|Period 3, Day 26-30||0
8093432|NCT03335254|19951936|P18|STARTED|Period 3, Day 26-30||0
8093433|NCT03335254|19951937|P17|STARTED|Period 3, Day 26-30||0
8093434|NCT03335254|19951938|P16|STARTED|Period 3, Day 26-30||0
8093435|NCT03335254|19951939|P15|STARTED|Period 3, Day 26-30||0
8093436|NCT03335254|19951940|P14|STARTED|Period 3, Day 26-30||0
8093437|NCT03335254|19951941|P13|STARTED|Period 3, Day 26-30||0
8093438|NCT03335254|19951942|P12|STARTED|Period 3, Day 26-30||0
8093439|NCT03335254|19951943|P11|STARTED|Period 3, Day 26-30||0
8093440|NCT03335254|19951944|P10|STARTED|Period 3, Day 26-30||0
8093441|NCT03335254|19951945|P9|STARTED|Period 3, Day 26-30||0
8093442|NCT03335254|19951946|P8|STARTED|Period 3, Day 26-30||0
8093443|NCT03335254|19951947|P7|STARTED|Period 3, Day 26-30||0
8093444|NCT03335254|19951948|P6|STARTED|Period 3, Day 26-30||0
8093445|NCT03335254|19951949|P5|STARTED|Period 3, Day 26-30||0
8093446|NCT03335254|19951950|P4|STARTED|Period 3, Day 26-30||0
8093447|NCT03335254|19951951|P3|STARTED|Period 3, Day 26-30||0
8093448|NCT03335254|19951952|P2|STARTED|Period 3, Day 26-30||0
8093449|NCT03335254|19951953|P1|STARTED|Period 3, Day 26-30||9
8093450|NCT03335254|19951934|P20|NOT COMPLETED|Period 3, Day 16-25||0
8093451|NCT03335254|19951935|P19|NOT COMPLETED|Period 3, Day 16-25||0
8093452|NCT03335254|19951936|P18|NOT COMPLETED|Period 3, Day 16-25||0
8093453|NCT03335254|19951937|P17|NOT COMPLETED|Period 3, Day 16-25||0
8093454|NCT03335254|19951938|P16|NOT COMPLETED|Period 3, Day 16-25||0
8093455|NCT03335254|19951939|P15|NOT COMPLETED|Period 3, Day 16-25||0
8093456|NCT03335254|19951940|P14|NOT COMPLETED|Period 3, Day 16-25||0
8093457|NCT03335254|19951941|P13|NOT COMPLETED|Period 3, Day 16-25||0
8093458|NCT03335254|19951942|P12|NOT COMPLETED|Period 3, Day 16-25||0
8093459|NCT03335254|19951943|P11|NOT COMPLETED|Period 3, Day 16-25||0
8093460|NCT03335254|19951944|P10|NOT COMPLETED|Period 3, Day 16-25||0
8093461|NCT03335254|19951945|P9|NOT COMPLETED|Period 3, Day 16-25||0
8093462|NCT03335254|19951946|P8|NOT COMPLETED|Period 3, Day 16-25||0
8093463|NCT03335254|19951947|P7|NOT COMPLETED|Period 3, Day 16-25||0
8093464|NCT03335254|19951948|P6|NOT COMPLETED|Period 3, Day 16-25||0
8093465|NCT03335254|19951949|P5|NOT COMPLETED|Period 3, Day 16-25||0
8093466|NCT03335254|19951950|P4|NOT COMPLETED|Period 3, Day 16-25||0
8093467|NCT03335254|19951951|P3|NOT COMPLETED|Period 3, Day 16-25||0
8093468|NCT03335254|19951952|P2|NOT COMPLETED|Period 3, Day 16-25||0
8093469|NCT03335254|19951953|P1|NOT COMPLETED|Period 3, Day 16-25||0
8093470|NCT03335254|19951934|P20|COMPLETED|Period 3, Day 16-25||0
8093471|NCT03335254|19951935|P19|COMPLETED|Period 3, Day 16-25||0
8093472|NCT03335254|19951936|P18|COMPLETED|Period 3, Day 16-25||0
8093473|NCT03335254|19951937|P17|COMPLETED|Period 3, Day 16-25||0
8093474|NCT03335254|19951938|P16|COMPLETED|Period 3, Day 16-25||0
8093475|NCT03335254|19951939|P15|COMPLETED|Period 3, Day 16-25||0
8093476|NCT03335254|19951940|P14|COMPLETED|Period 3, Day 16-25||0
8093477|NCT03335254|19951941|P13|COMPLETED|Period 3, Day 16-25||0
8093478|NCT03335254|19951942|P12|COMPLETED|Period 3, Day 16-25||0
8093479|NCT03335254|19951943|P11|COMPLETED|Period 3, Day 16-25||0
8093480|NCT03335254|19951944|P10|COMPLETED|Period 3, Day 16-25||0
8093481|NCT03335254|19951945|P9|COMPLETED|Period 3, Day 16-25||0
8093482|NCT03335254|19951946|P8|COMPLETED|Period 3, Day 16-25||0
8093483|NCT03335254|19951947|P7|COMPLETED|Period 3, Day 16-25||0
8093484|NCT03335254|19951948|P6|COMPLETED|Period 3, Day 16-25||0
8093485|NCT03335254|19951949|P5|COMPLETED|Period 3, Day 16-25||0
8093486|NCT03335254|19951950|P4|COMPLETED|Period 3, Day 16-25||0
8093487|NCT03335254|19951951|P3|COMPLETED|Period 3, Day 16-25||0
8093488|NCT03335254|19951952|P2|COMPLETED|Period 3, Day 16-25||0
8093489|NCT03335254|19951953|P1|COMPLETED|Period 3, Day 16-25||9
8093490|NCT03335254|19951934|P20|STARTED|Period 3, Day 16-25||0
8093491|NCT03335254|19951935|P19|STARTED|Period 3, Day 16-25||0
8093492|NCT03335254|19951936|P18|STARTED|Period 3, Day 16-25||0
8093493|NCT03335254|19951937|P17|STARTED|Period 3, Day 16-25||0
8093494|NCT03335254|19951938|P16|STARTED|Period 3, Day 16-25||0
8093495|NCT03335254|19951939|P15|STARTED|Period 3, Day 16-25||0
8093496|NCT03335254|19951940|P14|STARTED|Period 3, Day 16-25||0
8093497|NCT03335254|19951941|P13|STARTED|Period 3, Day 16-25||0
8093498|NCT03335254|19951942|P12|STARTED|Period 3, Day 16-25||0
8093499|NCT03335254|19951943|P11|STARTED|Period 3, Day 16-25||0
8093500|NCT03335254|19951944|P10|STARTED|Period 3, Day 16-25||0
8093501|NCT03335254|19951945|P9|STARTED|Period 3, Day 16-25||0
8093502|NCT03335254|19951946|P8|STARTED|Period 3, Day 16-25||0
8093503|NCT03335254|19951947|P7|STARTED|Period 3, Day 16-25||0
8093504|NCT03335254|19951948|P6|STARTED|Period 3, Day 16-25||0
8093505|NCT03335254|19951949|P5|STARTED|Period 3, Day 16-25||0
8093506|NCT03335254|19951950|P4|STARTED|Period 3, Day 16-25||0
8093507|NCT03335254|19951951|P3|STARTED|Period 3, Day 16-25||0
8093508|NCT03335254|19951952|P2|STARTED|Period 3, Day 16-25||0
8093509|NCT03335254|19951953|P1|STARTED|Period 3, Day 16-25||9
8093510|NCT03335254|19951934|P20|NOT COMPLETED|Period 2, Day 1-15||0
8093511|NCT03335254|19951935|P19|NOT COMPLETED|Period 2, Day 1-15||0
8093512|NCT03335254|19951936|P18|NOT COMPLETED|Period 2, Day 1-15||0
8093513|NCT03335254|19951937|P17|NOT COMPLETED|Period 2, Day 1-15||0
8093514|NCT03335254|19951938|P16|NOT COMPLETED|Period 2, Day 1-15||0
8093515|NCT03335254|19951939|P15|NOT COMPLETED|Period 2, Day 1-15||0
8093516|NCT03335254|19951940|P14|NOT COMPLETED|Period 2, Day 1-15||0
8093517|NCT03335254|19951941|P13|NOT COMPLETED|Period 2, Day 1-15||0
8093518|NCT03335254|19951942|P12|NOT COMPLETED|Period 2, Day 1-15||0
8093519|NCT03335254|19951943|P11|NOT COMPLETED|Period 2, Day 1-15||0
8093520|NCT03335254|19951944|P10|NOT COMPLETED|Period 2, Day 1-15||0
8093521|NCT03335254|19951945|P9|NOT COMPLETED|Period 2, Day 1-15||0
8093522|NCT03335254|19951946|P8|NOT COMPLETED|Period 2, Day 1-15||0
8093523|NCT03335254|19951947|P7|NOT COMPLETED|Period 2, Day 1-15||0
8093524|NCT03335254|19951948|P6|NOT COMPLETED|Period 2, Day 1-15||0
8093525|NCT03335254|19951949|P5|NOT COMPLETED|Period 2, Day 1-15||0
8093526|NCT03335254|19951950|P4|NOT COMPLETED|Period 2, Day 1-15||0
8093527|NCT03335254|19951951|P3|NOT COMPLETED|Period 2, Day 1-15||0
8093528|NCT03335254|19951952|P2|NOT COMPLETED|Period 2, Day 1-15||0
8093529|NCT03335254|19951953|P1|NOT COMPLETED|Period 2, Day 1-15||0
8093530|NCT03335254|19951934|P20|COMPLETED|Period 2, Day 1-15||0
8093531|NCT03335254|19951935|P19|COMPLETED|Period 2, Day 1-15||0
8093532|NCT03335254|19951936|P18|COMPLETED|Period 2, Day 1-15||0
8093533|NCT03335254|19951937|P17|COMPLETED|Period 2, Day 1-15||0
8093534|NCT03335254|19951938|P16|COMPLETED|Period 2, Day 1-15||0
8093535|NCT03335254|19951939|P15|COMPLETED|Period 2, Day 1-15||0
8093536|NCT03335254|19951940|P14|COMPLETED|Period 2, Day 1-15||0
8093537|NCT03335254|19951941|P13|COMPLETED|Period 2, Day 1-15||0
8093538|NCT03335254|19951942|P12|COMPLETED|Period 2, Day 1-15||0
8093539|NCT03335254|19951943|P11|COMPLETED|Period 2, Day 1-15||0
8093540|NCT03335254|19951944|P10|COMPLETED|Period 2, Day 1-15||0
8093541|NCT03335254|19951945|P9|COMPLETED|Period 2, Day 1-15||0
8093542|NCT03335254|19951946|P8|COMPLETED|Period 2, Day 1-15||0
8093543|NCT03335254|19951947|P7|COMPLETED|Period 2, Day 1-15||0
8093544|NCT03335254|19951948|P6|COMPLETED|Period 2, Day 1-15||0
8093545|NCT03335254|19951949|P5|COMPLETED|Period 2, Day 1-15||0
8093546|NCT03335254|19951950|P4|COMPLETED|Period 2, Day 1-15||0
8093547|NCT03335254|19951951|P3|COMPLETED|Period 2, Day 1-15||0
8093548|NCT03335254|19951952|P2|COMPLETED|Period 2, Day 1-15||0
8093549|NCT03335254|19951953|P1|COMPLETED|Period 2, Day 1-15||9
8093550|NCT03335254|19951934|P20|STARTED|Period 2, Day 1-15||0
8093551|NCT03335254|19951935|P19|STARTED|Period 2, Day 1-15||0
8093552|NCT03335254|19951936|P18|STARTED|Period 2, Day 1-15||0
8093553|NCT03335254|19951937|P17|STARTED|Period 2, Day 1-15||0
8093554|NCT03335254|19951938|P16|STARTED|Period 2, Day 1-15||0
8093555|NCT03335254|19951939|P15|STARTED|Period 2, Day 1-15||0
8093556|NCT03335254|19951940|P14|STARTED|Period 2, Day 1-15||0
8093557|NCT03335254|19951941|P13|STARTED|Period 2, Day 1-15||0
8093558|NCT03335254|19951942|P12|STARTED|Period 2, Day 1-15||0
8093559|NCT03335254|19951943|P11|STARTED|Period 2, Day 1-15||0
8093560|NCT03335254|19951944|P10|STARTED|Period 2, Day 1-15||0
8093561|NCT03335254|19951945|P9|STARTED|Period 2, Day 1-15||0
8093562|NCT03335254|19951946|P8|STARTED|Period 2, Day 1-15||0
8093563|NCT03335254|19951947|P7|STARTED|Period 2, Day 1-15||0
8093564|NCT03335254|19951948|P6|STARTED|Period 2, Day 1-15||0
8093565|NCT03335254|19951949|P5|STARTED|Period 2, Day 1-15||0
8093566|NCT03335254|19951950|P4|STARTED|Period 2, Day 1-15||0
8093567|NCT03335254|19951951|P3|STARTED|Period 2, Day 1-15||0
8093568|NCT03335254|19951952|P2|STARTED|Period 2, Day 1-15||0
8093569|NCT03335254|19951953|P1|STARTED|Period 2, Day 1-15||9
8093570|NCT03335254|19951934|P20|NOT COMPLETED|Period 1||0
8093571|NCT03335254|19951935|P19|NOT COMPLETED|Period 1||0
8093572|NCT03335254|19951936|P18|NOT COMPLETED|Period 1||0
8093573|NCT03335254|19951937|P17|NOT COMPLETED|Period 1||0
8093574|NCT03335254|19951938|P16|NOT COMPLETED|Period 1||0
8093575|NCT03335254|19951939|P15|NOT COMPLETED|Period 1||0
8093576|NCT03335254|19951940|P14|NOT COMPLETED|Period 1||0
8093577|NCT03335254|19951941|P13|NOT COMPLETED|Period 1||0
8093578|NCT03335254|19951942|P12|NOT COMPLETED|Period 1||0
8093579|NCT03335254|19951943|P11|NOT COMPLETED|Period 1||0
8093580|NCT03335254|19951944|P10|NOT COMPLETED|Period 1||0
8093581|NCT03335254|19951945|P9|NOT COMPLETED|Period 1||0
8093582|NCT03335254|19951946|P8|NOT COMPLETED|Period 1||0
8093583|NCT03335254|19951947|P7|NOT COMPLETED|Period 1||0
8093584|NCT03335254|19951948|P6|NOT COMPLETED|Period 1||0
8093585|NCT03335254|19951949|P5|NOT COMPLETED|Period 1||0
8093586|NCT03335254|19951950|P4|NOT COMPLETED|Period 1||0
8093587|NCT03335254|19951951|P3|NOT COMPLETED|Period 1||0
8093588|NCT03335254|19951952|P2|NOT COMPLETED|Period 1||0
8093589|NCT03335254|19951953|P1|NOT COMPLETED|Period 1||0
8093590|NCT03335254|19951934|P20|COMPLETED|Period 1||0
8093591|NCT03335254|19951935|P19|COMPLETED|Period 1||0
8093592|NCT03335254|19951936|P18|COMPLETED|Period 1||0
8093593|NCT03335254|19951937|P17|COMPLETED|Period 1||0
8093594|NCT03335254|19951938|P16|COMPLETED|Period 1||0
8093595|NCT03335254|19951939|P15|COMPLETED|Period 1||0
8093596|NCT03335254|19951940|P14|COMPLETED|Period 1||0
8093597|NCT03335254|19951941|P13|COMPLETED|Period 1||0
8093598|NCT03335254|19951942|P12|COMPLETED|Period 1||0
8093599|NCT03335254|19951943|P11|COMPLETED|Period 1||0
8093600|NCT03335254|19951944|P10|COMPLETED|Period 1||0
8093601|NCT03335254|19951945|P9|COMPLETED|Period 1||0
8093602|NCT03335254|19951946|P8|COMPLETED|Period 1||0
8093603|NCT03335254|19951947|P7|COMPLETED|Period 1||0
8093604|NCT03335254|19951948|P6|COMPLETED|Period 1||0
8093605|NCT03335254|19951949|P5|COMPLETED|Period 1||0
8093606|NCT03335254|19951950|P4|COMPLETED|Period 1||0
8093607|NCT03335254|19951951|P3|COMPLETED|Period 1||0
8093608|NCT03335254|19951952|P2|COMPLETED|Period 1||0
8093609|NCT03335254|19951953|P1|COMPLETED|Period 1||9
8093610|NCT03335254|19951934|P20|STARTED|Period 1||0
8093611|NCT03335254|19951935|P19|STARTED|Period 1||0
8093612|NCT03335254|19951936|P18|STARTED|Period 1||0
8093613|NCT03335254|19951937|P17|STARTED|Period 1||0
8093614|NCT03335254|19951938|P16|STARTED|Period 1||0
8093615|NCT03335254|19951939|P15|STARTED|Period 1||0
8093616|NCT03335254|19951940|P14|STARTED|Period 1||0
8093617|NCT03335254|19951941|P13|STARTED|Period 1||0
8093618|NCT03335254|19951942|P12|STARTED|Period 1||0
8093619|NCT03335254|19951943|P11|STARTED|Period 1||0
8093620|NCT03335254|19951944|P10|STARTED|Period 1||0
8093621|NCT03335254|19951945|P9|STARTED|Period 1||0
8093622|NCT03335254|19951946|P8|STARTED|Period 1||0
8093623|NCT03335254|19951947|P7|STARTED|Period 1||0
8093624|NCT03335254|19951948|P6|STARTED|Period 1||0
8093625|NCT03335254|19951949|P5|STARTED|Period 1||0
8093626|NCT03335254|19951950|P4|STARTED|Period 1||0
8093627|NCT03335254|19951951|P3|STARTED|Period 1||0
8093628|NCT03335254|19951952|P2|STARTED|Period 1||0
8093629|NCT03335254|19951953|P1|STARTED|Period 1||9
8093630|NCT03334825|19951984|P2|NOT COMPLETED|Overall Study||4
8093631|NCT03334825|19951985|P1|NOT COMPLETED|Overall Study||7
8093632|NCT03334825|19951984|P2|COMPLETED|Overall Study||113
8093633|NCT03334825|19951985|P1|COMPLETED|Overall Study||112
8093634|NCT03334825|19951984|P2|STARTED|Overall Study||117
8093635|NCT03334825|19951985|P1|STARTED|Overall Study||119
8093636|NCT03334812|19951997|P4|NOT COMPLETED|Overall Study||0
8093637|NCT03334812|19951998|P3|NOT COMPLETED|Overall Study||0
8093638|NCT03334812|19951999|P2|NOT COMPLETED|Overall Study||0
8093639|NCT03334812|19952000|P1|NOT COMPLETED|Overall Study||0
8093640|NCT03334812|19951997|P4|COMPLETED|Overall Study||0
8093641|NCT03334812|19951998|P3|COMPLETED|Overall Study||0
8093642|NCT03334812|19951999|P2|COMPLETED|Overall Study||5
8093643|NCT03334812|19952000|P1|COMPLETED|Overall Study||9
8093644|NCT03334812|19951997|P4|STARTED|Overall Study||0
8093645|NCT03334812|19951998|P3|STARTED|Overall Study||0
8093646|NCT03334812|19951999|P2|STARTED|Overall Study||5
8093647|NCT03334812|19952000|P1|STARTED|Overall Study||9
8093648|NCT03334747|19952031|P9|NOT COMPLETED|Follow-Up Phase||1
8093649|NCT03334747|19952032|P8|NOT COMPLETED|Follow-Up Phase||0
8093650|NCT03334747|19952033|P7|NOT COMPLETED|Follow-Up Phase||1
8093651|NCT03334747|19952034|P6|NOT COMPLETED|Follow-Up Phase||0
8093652|NCT03334747|19952035|P5|NOT COMPLETED|Follow-Up Phase||0
8093653|NCT03334747|19952036|P4|NOT COMPLETED|Follow-Up Phase||0
8093654|NCT03334747|19952037|P3|NOT COMPLETED|Follow-Up Phase||0
8093655|NCT03334747|19952038|P2|NOT COMPLETED|Follow-Up Phase||0
8093656|NCT03334747|19952039|P1|NOT COMPLETED|Follow-Up Phase||0
8093657|NCT03334747|19952031|P9|COMPLETED|Follow-Up Phase||50
8093658|NCT03334747|19952032|P8|COMPLETED|Follow-Up Phase||22
8093659|NCT03334747|19952033|P7|COMPLETED|Follow-Up Phase||20
8093660|NCT03334747|19952034|P6|COMPLETED|Follow-Up Phase||19
8093661|NCT03334747|19952035|P5|COMPLETED|Follow-Up Phase||21
8093662|NCT03334747|19952036|P4|COMPLETED|Follow-Up Phase||20
8093663|NCT03334747|19952037|P3|COMPLETED|Follow-Up Phase||12
8093664|NCT03334747|19952038|P2|COMPLETED|Follow-Up Phase||10
8093665|NCT03334747|19952039|P1|COMPLETED|Follow-Up Phase||9
8093666|NCT03334747|19952031|P9|STARTED|Follow-Up Phase||51
8093667|NCT03334747|19952032|P8|STARTED|Follow-Up Phase||22
8093668|NCT03334747|19952033|P7|STARTED|Follow-Up Phase||21
8093669|NCT03334747|19952034|P6|STARTED|Follow-Up Phase||19
8093670|NCT03334747|19952035|P5|STARTED|Follow-Up Phase||21
8093671|NCT03334747|19952036|P4|STARTED|Follow-Up Phase||20
8093672|NCT03334747|19952037|P3|STARTED|Follow-Up Phase||12
8093673|NCT03334747|19952038|P2|STARTED|Follow-Up Phase||10
8093674|NCT03334747|19952039|P1|STARTED|Follow-Up Phase||9
8093675|NCT03334747|19952031|P9|NOT COMPLETED|Treatment Phase||0
8093676|NCT03334747|19952032|P8|NOT COMPLETED|Treatment Phase||0
8093677|NCT03334747|19952033|P7|NOT COMPLETED|Treatment Phase||0
8093678|NCT03334747|19952034|P6|NOT COMPLETED|Treatment Phase||1
8093679|NCT03334747|19952035|P5|NOT COMPLETED|Treatment Phase||1
8093680|NCT03334747|19952036|P4|NOT COMPLETED|Treatment Phase||0
8093681|NCT03334747|19952037|P3|NOT COMPLETED|Treatment Phase||0
8093682|NCT03334747|19952038|P2|NOT COMPLETED|Treatment Phase||0
8093683|NCT03334747|19952039|P1|NOT COMPLETED|Treatment Phase||1
8093684|NCT03334747|19952031|P9|COMPLETED|Treatment Phase||51
8093685|NCT03334747|19952032|P8|COMPLETED|Treatment Phase||22
8093686|NCT03334747|19952033|P7|COMPLETED|Treatment Phase||21
8093687|NCT03334747|19952034|P6|COMPLETED|Treatment Phase||19
8093688|NCT03334747|19952035|P5|COMPLETED|Treatment Phase||21
8093689|NCT03334747|19952036|P4|COMPLETED|Treatment Phase||20
8093690|NCT03334747|19952037|P3|COMPLETED|Treatment Phase||12
8093691|NCT03334747|19952038|P2|COMPLETED|Treatment Phase||10
8093692|NCT03334747|19952039|P1|COMPLETED|Treatment Phase||9
8093693|NCT03334747|19952031|P9|STARTED|Treatment Phase||51
8093694|NCT03334747|19952032|P8|STARTED|Treatment Phase||22
8093695|NCT03334747|19952033|P7|STARTED|Treatment Phase||21
8093696|NCT03334747|19952034|P6|STARTED|Treatment Phase||20
8093697|NCT03334747|19952035|P5|STARTED|Treatment Phase||22
8093698|NCT03334747|19952036|P4|STARTED|Treatment Phase||20
8093699|NCT03334747|19952037|P3|STARTED|Treatment Phase||12
8093700|NCT03334747|19952038|P2|STARTED|Treatment Phase||10
8093701|NCT03334747|19952039|P1|STARTED|Treatment Phase||10
8093702|NCT03334734|19952131|P4|NOT COMPLETED|Overall Study||0
8093703|NCT03334734|19952132|P3|NOT COMPLETED|Overall Study||2
8093704|NCT03334734|19952133|P2|NOT COMPLETED|Overall Study||0
8093705|NCT03334734|19952134|P1|NOT COMPLETED|Overall Study||0
8093706|NCT03334734|19952131|P4|COMPLETED|Overall Study||1
8093707|NCT03334734|19952132|P3|COMPLETED|Overall Study||5
8093708|NCT03334734|19952133|P2|COMPLETED|Overall Study||4
8093709|NCT03334734|19952134|P1|COMPLETED|Overall Study||4
8093710|NCT03334734|19952131|P4|STARTED|Overall Study||1
8093711|NCT03334734|19952132|P3|STARTED|Overall Study||7
8093712|NCT03334734|19952133|P2|STARTED|Overall Study||4
8093713|NCT03334734|19952134|P1|STARTED|Overall Study||4
8093714|NCT03334721|19952229|P2|NOT COMPLETED|Overall Study||0
8093715|NCT03334721|19952230|P1|NOT COMPLETED|Overall Study||2
8093716|NCT03334721|19952229|P2|COMPLETED|Overall Study||11
8093717|NCT03334721|19952230|P1|COMPLETED|Overall Study||10
8093718|NCT03334721|19952229|P2|STARTED|Overall Study||11
8093719|NCT03334721|19952230|P1|STARTED|Overall Study||12
8093726|NCT03334448|19952281|P4|NOT COMPLETED|Period 4||0
8093727|NCT03334448|19952282|P3|NOT COMPLETED|Period 4||0
8093728|NCT03334448|19952283|P2|NOT COMPLETED|Period 4||0
8093729|NCT03334448|19952284|P1|NOT COMPLETED|Period 4||0
8093730|NCT03334448|19952281|P4|COMPLETED|Period 4||11
8093731|NCT03334448|19952282|P3|COMPLETED|Period 4||13
8093732|NCT03334448|19952283|P2|COMPLETED|Period 4||11
8093733|NCT03334448|19952284|P1|COMPLETED|Period 4||12
8093734|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 4||11
8093735|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 4||13
8093736|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 4||11
8093737|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 4||12
8093738|NCT03334448|19952281|P4|STARTED|Period 4||11
8093739|NCT03334448|19952282|P3|STARTED|Period 4||13
8093740|NCT03334448|19952283|P2|STARTED|Period 4||11
8093741|NCT03334448|19952284|P1|STARTED|Period 4||12
8093742|NCT03334448|19952281|P4|NOT COMPLETED|Washout||1
8093743|NCT03334448|19952282|P3|NOT COMPLETED|Washout||0
8093744|NCT03334448|19952283|P2|NOT COMPLETED|Washout||0
8093745|NCT03334448|19952284|P1|NOT COMPLETED|Washout||0
8093746|NCT03334448|19952281|P4|COMPLETED|Washout||11
8093747|NCT03334448|19952282|P3|COMPLETED|Washout||13
8093748|NCT03334448|19952283|P2|COMPLETED|Washout||11
8093749|NCT03334448|19952284|P1|COMPLETED|Washout||12
8093750|NCT03334448|19952281|P4|STARTED|Washout||12
8093751|NCT03334448|19952282|P3|STARTED|Washout||13
8093752|NCT03334448|19952283|P2|STARTED|Washout||11
8093753|NCT03334448|19952284|P1|STARTED|Washout||12
8093754|NCT03334448|19952281|P4|NOT COMPLETED|Period 3||0
8093755|NCT03334448|19952282|P3|NOT COMPLETED|Period 3||0
8093756|NCT03334448|19952283|P2|NOT COMPLETED|Period 3||0
8093757|NCT03334448|19952284|P1|NOT COMPLETED|Period 3||0
8093758|NCT03334448|19952281|P4|COMPLETED|Period 3||12
8093759|NCT03334448|19952282|P3|COMPLETED|Period 3||13
8093760|NCT03334448|19952283|P2|COMPLETED|Period 3||11
8093761|NCT03334448|19952284|P1|COMPLETED|Period 3||12
8093762|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 3||12
8093763|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 3||13
8093764|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 3||11
8093765|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 3||12
8093766|NCT03334448|19952281|P4|STARTED|Period 3||12
8093767|NCT03334448|19952282|P3|STARTED|Period 3||13
8093768|NCT03334448|19952283|P2|STARTED|Period 3||11
8093769|NCT03334448|19952284|P1|STARTED|Period 3||12
8093770|NCT03334448|19952281|P4|NOT COMPLETED|Washout||0
8093771|NCT03334448|19952282|P3|NOT COMPLETED|Washout||0
8093772|NCT03334448|19952283|P2|NOT COMPLETED|Washout||1
8093773|NCT03334448|19952284|P1|NOT COMPLETED|Washout||0
8093774|NCT03334448|19952281|P4|COMPLETED|Washout||12
8093775|NCT03334448|19952282|P3|COMPLETED|Washout||13
8093776|NCT03334448|19952283|P2|COMPLETED|Washout||11
8093777|NCT03334448|19952284|P1|COMPLETED|Washout||12
8093778|NCT03334448|19952281|P4|STARTED|Washout||12
8093779|NCT03334448|19952282|P3|STARTED|Washout||13
8093780|NCT03334448|19952283|P2|STARTED|Washout||12
8093781|NCT03334448|19952284|P1|STARTED|Washout||12
8093782|NCT03334448|19952281|P4|NOT COMPLETED|Period 2||0
8093783|NCT03334448|19952282|P3|NOT COMPLETED|Period 2||0
8093784|NCT03334448|19952283|P2|NOT COMPLETED|Period 2||0
8093785|NCT03334448|19952284|P1|NOT COMPLETED|Period 2||0
8093786|NCT03334448|19952281|P4|COMPLETED|Period 2||12
8093787|NCT03334448|19952282|P3|COMPLETED|Period 2||13
8093788|NCT03334448|19952283|P2|COMPLETED|Period 2||12
8093789|NCT03334448|19952284|P1|COMPLETED|Period 2||12
8093790|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 2||12
8093791|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 2||13
8093792|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 2||12
8093793|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 2||12
8093794|NCT03334448|19952281|P4|STARTED|Period 2||12
8093795|NCT03334448|19952282|P3|STARTED|Period 2||13
8093796|NCT03334448|19952283|P2|STARTED|Period 2||12
8093797|NCT03334448|19952284|P1|STARTED|Period 2||12
8093798|NCT03334448|19952281|P4|NOT COMPLETED|Washout||0
8093799|NCT03334448|19952282|P3|NOT COMPLETED|Washout||0
8093800|NCT03334448|19952283|P2|NOT COMPLETED|Washout||0
8093801|NCT03334448|19952284|P1|NOT COMPLETED|Washout||0
8093802|NCT03334448|19952281|P4|COMPLETED|Washout||12
8093803|NCT03334448|19952282|P3|COMPLETED|Washout||13
8093804|NCT03334448|19952283|P2|COMPLETED|Washout||12
8093805|NCT03334448|19952284|P1|COMPLETED|Washout||12
8093806|NCT03334448|19952281|P4|STARTED|Washout||12
8093807|NCT03334448|19952282|P3|STARTED|Washout||13
8093808|NCT03334448|19952283|P2|STARTED|Washout||12
8093809|NCT03334448|19952284|P1|STARTED|Washout||12
8093810|NCT03334448|19952281|P4|NOT COMPLETED|Period 1||0
8093811|NCT03334448|19952282|P3|NOT COMPLETED|Period 1||0
8093812|NCT03334448|19952283|P2|NOT COMPLETED|Period 1||0
8093813|NCT03334448|19952284|P1|NOT COMPLETED|Period 1||0
8093814|NCT03334448|19952281|P4|COMPLETED|Period 1||12
8093815|NCT03334448|19952282|P3|COMPLETED|Period 1||13
8093816|NCT03334448|19952283|P2|COMPLETED|Period 1||12
8093817|NCT03334448|19952284|P1|COMPLETED|Period 1||12
8093818|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 1||12
8093819|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 1||13
8093820|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 1||12
8093821|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 1||12
8093822|NCT03334448|19952281|P4|STARTED|Period 1||12
8093823|NCT03334448|19952282|P3|STARTED|Period 1||13
8093824|NCT03334448|19952283|P2|STARTED|Period 1||12
8093825|NCT03334448|19952284|P1|STARTED|Period 1||12
8093826|NCT03334422|19952296|P4|NOT COMPLETED|Overall Study||6
8093827|NCT03334422|19952297|P3|NOT COMPLETED|Overall Study||10
8093828|NCT03334422|19952298|P2|NOT COMPLETED|Overall Study||10
8093829|NCT03334422|19952299|P1|NOT COMPLETED|Overall Study||19
8093830|NCT03334422|19952296|P4|COMPLETED|Overall Study||117
8093831|NCT03334422|19952297|P3|COMPLETED|Overall Study||113
8093832|NCT03334422|19952298|P2|COMPLETED|Overall Study||115
8093833|NCT03334422|19952299|P1|COMPLETED|Overall Study||225
8093834|NCT03334422|19952296|P4|Received at Least One Dose of Study Drug|Overall Study||123
8093835|NCT03334422|19952297|P3|Received at Least One Dose of Study Drug|Overall Study||123
8093836|NCT03334422|19952298|P2|Received at Least One Dose of Study Drug|Overall Study||124
8093837|NCT03334422|19952299|P1|Received at Least One Dose of Study Drug|Overall Study||244
8093838|NCT03334422|19952296|P4|STARTED|Overall Study||123
8093839|NCT03334422|19952297|P3|STARTED|Overall Study||123
8093840|NCT03334422|19952298|P2|STARTED|Overall Study||125
8093841|NCT03334422|19952299|P1|STARTED|Overall Study||244
8093842|NCT03334396|19952406|P8|NOT COMPLETED|Overall Study||1
8093843|NCT03334396|19952407|P7|NOT COMPLETED|Overall Study||3
8093844|NCT03334396|19952408|P6|NOT COMPLETED|Overall Study||1
8093845|NCT03334396|19952409|P5|NOT COMPLETED|Overall Study||3
8093846|NCT03334396|19952410|P4|NOT COMPLETED|Overall Study||5
8093847|NCT03334396|19952411|P3|NOT COMPLETED|Overall Study||10
8093848|NCT03334396|19952412|P2|NOT COMPLETED|Overall Study||11
8093849|NCT03334396|19952413|P1|NOT COMPLETED|Overall Study||23
8093850|NCT03334396|19952406|P8|COMPLETED|Overall Study||7
8093851|NCT03334396|19952407|P7|COMPLETED|Overall Study||5
8093852|NCT03334396|19952408|P6|COMPLETED|Overall Study||4
8093853|NCT03334396|19952409|P5|COMPLETED|Overall Study||12
8093854|NCT03334396|19952410|P4|COMPLETED|Overall Study||120
8093855|NCT03334396|19952411|P3|COMPLETED|Overall Study||113
8093856|NCT03334396|19952412|P2|COMPLETED|Overall Study||116
8093857|NCT03334396|19952413|P1|COMPLETED|Overall Study||226
8093858|NCT03334396|19952406|P8|Received at Least One Dose of Study Drug|Overall Study||8
8093859|NCT03334396|19952407|P7|Received at Least One Dose of Study Drug|Overall Study||8
8093860|NCT03334396|19952408|P6|Received at Least One Dose of Study Drug|Overall Study||5
8093861|NCT03334396|19952409|P5|Received at Least One Dose of Study Drug|Overall Study||15
8093862|NCT03334396|19952410|P4|Received at Least One Dose of Study Drug|Overall Study||125
8093863|NCT03334396|19952411|P3|Received at Least One Dose of Study Drug|Overall Study||123
8093864|NCT03334396|19952412|P2|Received at Least One Dose of Study Drug|Overall Study||127
8093865|NCT03334396|19952413|P1|Received at Least One Dose of Study Drug|Overall Study||249
8093866|NCT03334396|19952406|P8|STARTED|Overall Study||8
8093867|NCT03334396|19952407|P7|STARTED|Overall Study||8
8093868|NCT03334396|19952408|P6|STARTED|Overall Study||5
8093869|NCT03334396|19952409|P5|STARTED|Overall Study||15
8093870|NCT03334396|19952410|P4|STARTED|Overall Study||125
8093871|NCT03334396|19952411|P3|STARTED|Overall Study||123
8093872|NCT03334396|19952412|P2|STARTED|Overall Study||127
8093873|NCT03334396|19952413|P1|STARTED|Overall Study||249
8093874|NCT03334214|19952518|P2|NOT COMPLETED|Overall Study||2
8093875|NCT03334214|19952519|P1|NOT COMPLETED|Overall Study||1
8093876|NCT03334214|19952518|P2|COMPLETED|Overall Study||27
8093877|NCT03334214|19952519|P1|COMPLETED|Overall Study||14
8093878|NCT03334214|19952518|P2|STARTED|Overall Study||29
8093879|NCT03334214|19952519|P1|STARTED|Overall Study||15
8093880|NCT03334175|19952545|P2|NOT COMPLETED|Overall Study||1
8093881|NCT03334175|19952546|P1|NOT COMPLETED|Overall Study||0
8093882|NCT03334175|19952545|P2|COMPLETED|Overall Study||9
8093883|NCT03334175|19952546|P1|COMPLETED|Overall Study||8
8093884|NCT03334175|19952545|P2|STARTED|Overall Study||10
8093885|NCT03334175|19952546|P1|STARTED|Overall Study||8
8093886|NCT03333876|19952568|P1|NOT COMPLETED|Positional Therapy||0
8093887|NCT03333876|19952568|P1|COMPLETED|Positional Therapy||54
8093888|NCT03333876|19952568|P1|STARTED|Positional Therapy||54
8093889|NCT03333876|19952568|P1|NOT COMPLETED|Mandibular Advancement||4
8093890|NCT03333876|19952568|P1|COMPLETED|Mandibular Advancement||50
8093891|NCT03333876|19952568|P1|STARTED|Mandibular Advancement||54
8093892|NCT03333876|19952568|P1|NOT COMPLETED|Nasal Dilator||6
8093893|NCT03333876|19952568|P1|COMPLETED|Nasal Dilator||48
8093894|NCT03333876|19952568|P1|STARTED|Nasal Dilator||54
8093895|NCT03333876|19952568|P1|NOT COMPLETED|Screening Period||4
8093896|NCT03333876|19952568|P1|COMPLETED|Screening Period||54
8093897|NCT03333876|19952568|P1|STARTED|Screening Period||58
8093898|NCT03333746|19952589|P1|NOT COMPLETED|Overall Study||1
8093899|NCT03333746|19952589|P1|COMPLETED|Overall Study||0
8093900|NCT03333746|19952589|P1|STARTED|Overall Study||1
8093901|NCT03333577|19952600|P1|NOT COMPLETED|Overall Study||7
8093902|NCT03333577|19952600|P1|COMPLETED|Overall Study||25
8093903|NCT03333577|19952600|P1|STARTED|Overall Study||32
8093904|NCT03333317|19952608|P3|NOT COMPLETED|Overall Study||0
8093905|NCT03333317|19952609|P2|NOT COMPLETED|Overall Study||0
8093906|NCT03333317|19952610|P1|NOT COMPLETED|Overall Study||0
8093907|NCT03333317|19952608|P3|COMPLETED|Overall Study||3
8093908|NCT03333317|19952609|P2|COMPLETED|Overall Study||1
8093909|NCT03333317|19952610|P1|COMPLETED|Overall Study||3
8093910|NCT03333317|19952608|P3|STARTED|Overall Study||3
8093911|NCT03333317|19952609|P2|STARTED|Overall Study||1
8093912|NCT03333317|19952610|P1|STARTED|Overall Study||3
8093913|NCT03332979|19952728|P1|NOT COMPLETED|Overall Study||0
8093914|NCT03332979|19952728|P1|COMPLETED|Overall Study||150
8093915|NCT03332979|19952728|P1|STARTED|Overall Study||150
8093916|NCT03332784|19952759|P20|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093917|NCT03332784|19952760|P19|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093918|NCT03332784|19952761|P18|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093919|NCT03332784|19952762|P17|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093920|NCT03332784|19952763|P16|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093921|NCT03332784|19952764|P15|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093922|NCT03332784|19952765|P14|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093923|NCT03332784|19952766|P13|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093924|NCT03332784|19952767|P12|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093925|NCT03332784|19952768|P11|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093926|NCT03332784|19952769|P10|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093927|NCT03332784|19952770|P9|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093928|NCT03332784|19952771|P8|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093929|NCT03332784|19952772|P7|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093930|NCT03332784|19952773|P6|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093931|NCT03332784|19952774|P5|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093932|NCT03332784|19952775|P4|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093933|NCT03332784|19952776|P3|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093934|NCT03332784|19952777|P2|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093935|NCT03332784|19952778|P1|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8093936|NCT03332784|19952759|P20|COMPLETED|Part 1- Period 3 (1 Day)||0
8093937|NCT03332784|19952760|P19|COMPLETED|Part 1- Period 3 (1 Day)||0
8093938|NCT03332784|19952761|P18|COMPLETED|Part 1- Period 3 (1 Day)||0
8093939|NCT03332784|19952762|P17|COMPLETED|Part 1- Period 3 (1 Day)||0
8093940|NCT03332784|19952763|P16|COMPLETED|Part 1- Period 3 (1 Day)||0
8093941|NCT03332784|19952764|P15|COMPLETED|Part 1- Period 3 (1 Day)||0
8093942|NCT03332784|19952765|P14|COMPLETED|Part 1- Period 3 (1 Day)||0
8093943|NCT03332784|19952766|P13|COMPLETED|Part 1- Period 3 (1 Day)||0
8093944|NCT03332784|19952767|P12|COMPLETED|Part 1- Period 3 (1 Day)||0
8093945|NCT03332784|19952768|P11|COMPLETED|Part 1- Period 3 (1 Day)||0
8093946|NCT03332784|19952769|P10|COMPLETED|Part 1- Period 3 (1 Day)||0
8093947|NCT03332784|19952770|P9|COMPLETED|Part 1- Period 3 (1 Day)||0
8093948|NCT03332784|19952771|P8|COMPLETED|Part 1- Period 3 (1 Day)||2
8093949|NCT03332784|19952772|P7|COMPLETED|Part 1- Period 3 (1 Day)||2
8093950|NCT03332784|19952773|P6|COMPLETED|Part 1- Period 3 (1 Day)||2
8093951|NCT03332784|19952774|P5|COMPLETED|Part 1- Period 3 (1 Day)||2
8093952|NCT03332784|19952775|P4|COMPLETED|Part 1- Period 3 (1 Day)||2
8093953|NCT03332784|19952776|P3|COMPLETED|Part 1- Period 3 (1 Day)||2
8093954|NCT03332784|19952777|P2|COMPLETED|Part 1- Period 3 (1 Day)||1
8093955|NCT03332784|19952778|P1|COMPLETED|Part 1- Period 3 (1 Day)||2
8093956|NCT03332784|19952759|P20|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8093957|NCT03332784|19952760|P19|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8093958|NCT03332784|19952761|P18|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8093959|NCT03332784|19952762|P17|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8093960|NCT03332784|19952763|P16|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8093961|NCT03332784|19952764|P15|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8093962|NCT03332784|19952765|P14|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8093963|NCT03332784|19952766|P13|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8093964|NCT03332784|19952767|P12|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8093965|NCT03332784|19952768|P11|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8093966|NCT03332784|19952769|P10|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8093967|NCT03332784|19952770|P9|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8093968|NCT03332784|19952771|P8|STARTED|Part 1- Period 3 (1 Day)||2
8093969|NCT03332784|19952772|P7|STARTED|Part 1- Period 3 (1 Day)||2
8093970|NCT03332784|19952773|P6|STARTED|Part 1- Period 3 (1 Day)||2
8093971|NCT03332784|19952774|P5|STARTED|Part 1- Period 3 (1 Day)||2
8093972|NCT03332784|19952775|P4|STARTED|Part 1- Period 3 (1 Day)||2
8093973|NCT03332784|19952776|P3|STARTED|Part 1- Period 3 (1 Day)||2
8093974|NCT03332784|19952777|P2|STARTED|Part 1- Period 3 (1 Day)||1
8093975|NCT03332784|19952778|P1|STARTED|Part 1- Period 3 (1 Day)||2
8093976|NCT03332784|19952759|P20|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093977|NCT03332784|19952760|P19|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093978|NCT03332784|19952761|P18|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093979|NCT03332784|19952762|P17|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093980|NCT03332784|19952763|P16|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093981|NCT03332784|19952764|P15|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093982|NCT03332784|19952765|P14|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093983|NCT03332784|19952766|P13|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093984|NCT03332784|19952767|P12|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093985|NCT03332784|19952768|P11|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093986|NCT03332784|19952769|P10|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093987|NCT03332784|19952770|P9|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093988|NCT03332784|19952771|P8|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093989|NCT03332784|19952772|P7|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093990|NCT03332784|19952773|P6|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093991|NCT03332784|19952774|P5|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093992|NCT03332784|19952775|P4|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093993|NCT03332784|19952776|P3|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093994|NCT03332784|19952777|P2|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093995|NCT03332784|19952778|P1|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8093996|NCT03332784|19952759|P20|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
8093997|NCT03332784|19952760|P19|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
8093998|NCT03332784|19952761|P18|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8093999|NCT03332784|19952762|P17|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094000|NCT03332784|19952763|P16|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094001|NCT03332784|19952764|P15|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
8094002|NCT03332784|19952765|P14|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8094003|NCT03332784|19952766|P13|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8094004|NCT03332784|19952767|P12|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8094005|NCT03332784|19952768|P11|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8094006|NCT03332784|19952769|P10|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8094007|NCT03332784|19952770|P9|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8094008|NCT03332784|19952771|P8|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094009|NCT03332784|19952772|P7|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094010|NCT03332784|19952773|P6|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094011|NCT03332784|19952774|P5|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094012|NCT03332784|19952775|P4|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094013|NCT03332784|19952776|P3|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094014|NCT03332784|19952777|P2|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
8094015|NCT03332784|19952778|P1|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8094016|NCT03332784|19952759|P20|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
8094017|NCT03332784|19952760|P19|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
8094018|NCT03332784|19952761|P18|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094019|NCT03332784|19952762|P17|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094020|NCT03332784|19952763|P16|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094021|NCT03332784|19952764|P15|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
8094022|NCT03332784|19952765|P14|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8094023|NCT03332784|19952766|P13|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8094024|NCT03332784|19952767|P12|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8094025|NCT03332784|19952768|P11|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8094026|NCT03332784|19952769|P10|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8094027|NCT03332784|19952770|P9|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8094028|NCT03332784|19952771|P8|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094029|NCT03332784|19952772|P7|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094030|NCT03332784|19952773|P6|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094031|NCT03332784|19952774|P5|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094032|NCT03332784|19952775|P4|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094033|NCT03332784|19952776|P3|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094034|NCT03332784|19952777|P2|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
8094035|NCT03332784|19952778|P1|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8094036|NCT03332784|19952759|P20|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094037|NCT03332784|19952760|P19|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094038|NCT03332784|19952761|P18|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094039|NCT03332784|19952762|P17|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094040|NCT03332784|19952763|P16|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094041|NCT03332784|19952764|P15|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8094042|NCT03332784|19952765|P14|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094043|NCT03332784|19952766|P13|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094044|NCT03332784|19952767|P12|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094045|NCT03332784|19952768|P11|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094046|NCT03332784|19952769|P10|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094047|NCT03332784|19952770|P9|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094048|NCT03332784|19952771|P8|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094049|NCT03332784|19952772|P7|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094050|NCT03332784|19952773|P6|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094051|NCT03332784|19952774|P5|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094052|NCT03332784|19952775|P4|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094053|NCT03332784|19952776|P3|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094054|NCT03332784|19952777|P2|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8094055|NCT03332784|19952778|P1|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8094056|NCT03332784|19952759|P20|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
8094057|NCT03332784|19952760|P19|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
8094058|NCT03332784|19952761|P18|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094059|NCT03332784|19952762|P17|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094060|NCT03332784|19952763|P16|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094061|NCT03332784|19952764|P15|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8094062|NCT03332784|19952765|P14|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
8094063|NCT03332784|19952766|P13|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
8094064|NCT03332784|19952767|P12|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094065|NCT03332784|19952768|P11|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
8094066|NCT03332784|19952769|P10|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
8094067|NCT03332784|19952770|P9|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
8094068|NCT03332784|19952771|P8|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094069|NCT03332784|19952772|P7|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094070|NCT03332784|19952773|P6|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094071|NCT03332784|19952774|P5|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094072|NCT03332784|19952775|P4|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094073|NCT03332784|19952776|P3|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094074|NCT03332784|19952777|P2|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8094075|NCT03332784|19952778|P1|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8094076|NCT03332784|19952759|P20|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
8094077|NCT03332784|19952760|P19|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
8094078|NCT03332784|19952761|P18|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8094079|NCT03332784|19952762|P17|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8094080|NCT03332784|19952763|P16|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8094081|NCT03332784|19952764|P15|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8094082|NCT03332784|19952765|P14|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
8094083|NCT03332784|19952766|P13|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
8094084|NCT03332784|19952767|P12|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094085|NCT03332784|19952768|P11|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
8094086|NCT03332784|19952769|P10|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
8094087|NCT03332784|19952770|P9|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
8094088|NCT03332784|19952771|P8|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094089|NCT03332784|19952772|P7|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094090|NCT03332784|19952773|P6|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094091|NCT03332784|19952774|P5|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094092|NCT03332784|19952775|P4|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094093|NCT03332784|19952776|P3|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094094|NCT03332784|19952777|P2|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094095|NCT03332784|19952778|P1|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8094105|NCT03332160|19953048|P2|NOT COMPLETED|Overall Study||5
8094106|NCT03332160|19953049|P1|NOT COMPLETED|Overall Study||1
8094107|NCT03332160|19953048|P2|COMPLETED|Overall Study||19
8094108|NCT03332160|19953049|P1|COMPLETED|Overall Study||24
8094109|NCT03332160|19953048|P2|STARTED|Overall Study||24
8094110|NCT03332160|19953049|P1|STARTED|Overall Study||25
8094111|NCT03331965|19953081|P2|NOT COMPLETED|Overall Study||4
8094112|NCT03331965|19953082|P1|NOT COMPLETED|Overall Study||10
8094113|NCT03331965|19953081|P2|COMPLETED|Overall Study||51
8094114|NCT03331965|19953082|P1|COMPLETED|Overall Study||45
8094115|NCT03331965|19953081|P2|STARTED|Overall Study||55
8094116|NCT03331965|19953082|P1|STARTED|Overall Study||55
8094117|NCT03331835|19953098|P2|NOT COMPLETED|Overall Study||47
8094118|NCT03331835|19953099|P1|NOT COMPLETED|Overall Study||14
8094119|NCT03331835|19953098|P2|COMPLETED|Overall Study||58
8094120|NCT03331835|19953099|P1|COMPLETED|Overall Study||91
8094121|NCT03331835|19953098|P2|STARTED|Overall Study||105
8094122|NCT03331835|19953099|P1|STARTED|Overall Study||105
8094123|NCT03331315|19953133|P2|NOT COMPLETED|Overall Study||14
8094124|NCT03331315|19953134|P1|NOT COMPLETED|Overall Study||18
8094125|NCT03331315|19953133|P2|COMPLETED|Overall Study||68
8094126|NCT03331315|19953134|P1|COMPLETED|Overall Study||70
8094127|NCT03331315|19953133|P2|STARTED|Overall Study||82
8094128|NCT03331315|19953134|P1|STARTED|Overall Study||88
8094129|NCT03331185|19953156|P2|NOT COMPLETED|Overall Study||0
8094130|NCT03331185|19953157|P1|NOT COMPLETED|Overall Study||0
8094131|NCT03331185|19953156|P2|COMPLETED|Overall Study||12
8094132|NCT03331185|19953157|P1|COMPLETED|Overall Study||14
8094133|NCT03331185|19953156|P2|STARTED|Overall Study||12
8094134|NCT03331185|19953157|P1|STARTED|Overall Study||14
8094135|NCT03331042|19953171|P4|NOT COMPLETED|Overall Study||1
8094136|NCT03331042|19953172|P3|NOT COMPLETED|Overall Study||1
8094137|NCT03331042|19953173|P2|NOT COMPLETED|Overall Study||0
8094138|NCT03331042|19953174|P1|NOT COMPLETED|Overall Study||1
8094139|NCT03331042|19953171|P4|COMPLETED|Overall Study||20
8094140|NCT03331042|19953172|P3|COMPLETED|Overall Study||20
8094141|NCT03331042|19953173|P2|COMPLETED|Overall Study||21
8094142|NCT03331042|19953174|P1|COMPLETED|Overall Study||21
8094143|NCT03331042|19953171|P4|STARTED|Overall Study||21
8094144|NCT03331042|19953172|P3|STARTED|Overall Study||21
8094145|NCT03331042|19953173|P2|STARTED|Overall Study||21
8094146|NCT03331042|19953174|P1|STARTED|Overall Study||22
8094147|NCT03330834|19953220|P1|NOT COMPLETED|Overall Study||0
8094148|NCT03330834|19953220|P1|COMPLETED|Overall Study||1
8094149|NCT03330834|19953220|P1|STARTED|Overall Study||1
8094150|NCT03330457|19953230|P4|NOT COMPLETED|Overall Study||0
8094151|NCT03330457|19953231|P3|NOT COMPLETED|Overall Study||0
8094152|NCT03330457|19953232|P2|NOT COMPLETED|Overall Study||0
8094153|NCT03330457|19953233|P1|NOT COMPLETED|Overall Study||0
8094154|NCT03330457|19953230|P4|COMPLETED|Overall Study||3
8094155|NCT03330457|19953231|P3|COMPLETED|Overall Study||6
8094156|NCT03330457|19953232|P2|COMPLETED|Overall Study||3
8094157|NCT03330457|19953233|P1|COMPLETED|Overall Study||6
8094158|NCT03330457|19953230|P4|STARTED|Overall Study||3
8094159|NCT03330457|19953231|P3|STARTED|Overall Study||6
8094160|NCT03330457|19953232|P2|STARTED|Overall Study||3
8094161|NCT03330457|19953233|P1|STARTED|Overall Study||6
8094162|NCT03330275|19953247|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094163|NCT03330275|19953248|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094164|NCT03330275|19953249|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094165|NCT03330275|19953250|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094166|NCT03330275|19953251|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094167|NCT03330275|19953252|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094168|NCT03330275|19953253|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094169|NCT03330275|19953254|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094170|NCT03330275|19953255|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094171|NCT03330275|19953256|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094172|NCT03330275|19953247|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094173|NCT03330275|19953248|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094174|NCT03330275|19953249|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094175|NCT03330275|19953250|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094176|NCT03330275|19953251|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094177|NCT03330275|19953252|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094178|NCT03330275|19953253|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094179|NCT03330275|19953254|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094180|NCT03330275|19953255|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094181|NCT03330275|19953256|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094182|NCT03330275|19953247|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
8094183|NCT03330275|19953248|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
8094184|NCT03330275|19953249|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
8094185|NCT03330275|19953250|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
8094186|NCT03330275|19953251|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
8094187|NCT03330275|19953252|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
8094188|NCT03330275|19953253|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
8094189|NCT03330275|19953254|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
8094190|NCT03330275|19953255|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
8094191|NCT03330275|19953256|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
8094192|NCT03330275|19953247|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094193|NCT03330275|19953248|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094194|NCT03330275|19953249|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094195|NCT03330275|19953250|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094196|NCT03330275|19953251|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094197|NCT03330275|19953252|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094198|NCT03330275|19953253|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094199|NCT03330275|19953254|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094200|NCT03330275|19953255|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094201|NCT03330275|19953256|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094202|NCT03330275|19953247|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094203|NCT03330275|19953248|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094204|NCT03330275|19953249|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094205|NCT03330275|19953250|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094206|NCT03330275|19953251|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094207|NCT03330275|19953252|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094208|NCT03330275|19953253|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094209|NCT03330275|19953254|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094210|NCT03330275|19953255|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094211|NCT03330275|19953256|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094212|NCT03330275|19953247|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
8094213|NCT03330275|19953248|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
8094214|NCT03330275|19953249|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
8094215|NCT03330275|19953250|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
8094216|NCT03330275|19953251|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
8094217|NCT03330275|19953252|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
8094218|NCT03330275|19953253|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
8094219|NCT03330275|19953254|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
8094220|NCT03330275|19953255|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
8094221|NCT03330275|19953256|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
8094222|NCT03330275|19953247|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094223|NCT03330275|19953248|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094224|NCT03330275|19953249|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094225|NCT03330275|19953250|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094226|NCT03330275|19953251|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094227|NCT03330275|19953252|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094228|NCT03330275|19953253|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094229|NCT03330275|19953254|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094230|NCT03330275|19953255|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094231|NCT03330275|19953256|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094232|NCT03330275|19953247|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094233|NCT03330275|19953248|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094234|NCT03330275|19953249|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094235|NCT03330275|19953250|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094236|NCT03330275|19953251|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094237|NCT03330275|19953252|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094238|NCT03330275|19953253|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094239|NCT03330275|19953254|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094240|NCT03330275|19953255|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094241|NCT03330275|19953256|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094242|NCT03330275|19953247|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
8094243|NCT03330275|19953248|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
8094244|NCT03330275|19953249|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
8094245|NCT03330275|19953250|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
8094246|NCT03330275|19953251|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
8094247|NCT03330275|19953252|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
8094248|NCT03330275|19953253|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
8094249|NCT03330275|19953254|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
8094250|NCT03330275|19953255|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
8094251|NCT03330275|19953256|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
8094252|NCT03330275|19953247|P10|NOT COMPLETED|Visit 1 - Period 2||0
8094253|NCT03330275|19953248|P9|NOT COMPLETED|Visit 1 - Period 2||0
8094254|NCT03330275|19953249|P8|NOT COMPLETED|Visit 1 - Period 2||0
8094255|NCT03330275|19953250|P7|NOT COMPLETED|Visit 1 - Period 2||0
8094256|NCT03330275|19953251|P6|NOT COMPLETED|Visit 1 - Period 2||0
8094257|NCT03330275|19953252|P5|NOT COMPLETED|Visit 1 - Period 2||0
8094258|NCT03330275|19953253|P4|NOT COMPLETED|Visit 1 - Period 2||0
8094259|NCT03330275|19953254|P3|NOT COMPLETED|Visit 1 - Period 2||0
8094260|NCT03330275|19953255|P2|NOT COMPLETED|Visit 1 - Period 2||0
8094261|NCT03330275|19953256|P1|NOT COMPLETED|Visit 1 - Period 2||0
8094262|NCT03330275|19953247|P10|COMPLETED|Visit 1 - Period 2||0
8094263|NCT03330275|19953248|P9|COMPLETED|Visit 1 - Period 2||0
8094264|NCT03330275|19953249|P8|COMPLETED|Visit 1 - Period 2||0
8094265|NCT03330275|19953250|P7|COMPLETED|Visit 1 - Period 2||0
8094266|NCT03330275|19953251|P6|COMPLETED|Visit 1 - Period 2||0
8094267|NCT03330275|19953252|P5|COMPLETED|Visit 1 - Period 2||0
8094268|NCT03330275|19953253|P4|COMPLETED|Visit 1 - Period 2||6
8094269|NCT03330275|19953254|P3|COMPLETED|Visit 1 - Period 2||6
8094270|NCT03330275|19953255|P2|COMPLETED|Visit 1 - Period 2||6
8094271|NCT03330275|19953256|P1|COMPLETED|Visit 1 - Period 2||6
8094272|NCT03330275|19953247|P10|STARTED|Visit 1 - Period 2||0
8094273|NCT03330275|19953248|P9|STARTED|Visit 1 - Period 2||0
8094274|NCT03330275|19953249|P8|STARTED|Visit 1 - Period 2||0
8094275|NCT03330275|19953250|P7|STARTED|Visit 1 - Period 2||0
8094276|NCT03330275|19953251|P6|STARTED|Visit 1 - Period 2||0
8094277|NCT03330275|19953252|P5|STARTED|Visit 1 - Period 2||0
8094278|NCT03330275|19953253|P4|STARTED|Visit 1 - Period 2||6
8094279|NCT03330275|19953254|P3|STARTED|Visit 1 - Period 2||6
8094280|NCT03330275|19953255|P2|STARTED|Visit 1 - Period 2||6
8094281|NCT03330275|19953256|P1|STARTED|Visit 1 - Period 2||6
8094282|NCT03330275|19953247|P10|NOT COMPLETED|Visit 1 - Period 1||0
8094283|NCT03330275|19953248|P9|NOT COMPLETED|Visit 1 - Period 1||0
8094284|NCT03330275|19953249|P8|NOT COMPLETED|Visit 1 - Period 1||0
8094285|NCT03330275|19953250|P7|NOT COMPLETED|Visit 1 - Period 1||0
8094286|NCT03330275|19953251|P6|NOT COMPLETED|Visit 1 - Period 1||0
8094287|NCT03330275|19953252|P5|NOT COMPLETED|Visit 1 - Period 1||0
8094288|NCT03330275|19953253|P4|NOT COMPLETED|Visit 1 - Period 1||0
8094289|NCT03330275|19953254|P3|NOT COMPLETED|Visit 1 - Period 1||0
8094290|NCT03330275|19953255|P2|NOT COMPLETED|Visit 1 - Period 1||0
8094291|NCT03330275|19953256|P1|NOT COMPLETED|Visit 1 - Period 1||0
8094292|NCT03330275|19953247|P10|COMPLETED|Visit 1 - Period 1||0
8094293|NCT03330275|19953248|P9|COMPLETED|Visit 1 - Period 1||0
8094294|NCT03330275|19953249|P8|COMPLETED|Visit 1 - Period 1||0
8094295|NCT03330275|19953250|P7|COMPLETED|Visit 1 - Period 1||0
8094296|NCT03330275|19953251|P6|COMPLETED|Visit 1 - Period 1||0
8094297|NCT03330275|19953252|P5|COMPLETED|Visit 1 - Period 1||0
8094298|NCT03330275|19953253|P4|COMPLETED|Visit 1 - Period 1||6
8094299|NCT03330275|19953254|P3|COMPLETED|Visit 1 - Period 1||6
8094300|NCT03330275|19953255|P2|COMPLETED|Visit 1 - Period 1||6
8094301|NCT03330275|19953256|P1|COMPLETED|Visit 1 - Period 1||6
8094302|NCT03330275|19953247|P10|STARTED|Visit 1 - Period 1||0
8094303|NCT03330275|19953248|P9|STARTED|Visit 1 - Period 1||0
8094304|NCT03330275|19953249|P8|STARTED|Visit 1 - Period 1||0
8094305|NCT03330275|19953250|P7|STARTED|Visit 1 - Period 1||0
8094306|NCT03330275|19953251|P6|STARTED|Visit 1 - Period 1||0
8094307|NCT03330275|19953252|P5|STARTED|Visit 1 - Period 1||0
8094308|NCT03330275|19953253|P4|STARTED|Visit 1 - Period 1||6
8094309|NCT03330275|19953254|P3|STARTED|Visit 1 - Period 1||6
8094310|NCT03330275|19953255|P2|STARTED|Visit 1 - Period 1||6
8094311|NCT03330275|19953256|P1|STARTED|Visit 1 - Period 1||6
8094312|NCT03330236|19953284|P2|NOT COMPLETED|Overall Study||84
8094313|NCT03330236|19953285|P1|NOT COMPLETED|Overall Study||100
8094314|NCT03330236|19953284|P2|COMPLETED|Overall Study||697
8094315|NCT03330236|19953285|P1|COMPLETED|Overall Study||679
8094316|NCT03330236|19953284|P2|Modified ITT|Overall Study||774
8094317|NCT03330236|19953285|P1|Modified ITT|Overall Study||773
8094318|NCT03330236|19953284|P2|Received Surgery|Overall Study||781
8094319|NCT03330236|19953285|P1|Received Surgery|Overall Study||779
8094320|NCT03330236|19953284|P2|STARTED|Overall Study||781
8094321|NCT03330236|19953285|P1|STARTED|Overall Study||779
8094322|NCT03330041|19953309|P1|NOT COMPLETED|Overall Study||2
8094323|NCT03330041|19953309|P1|COMPLETED|Overall Study||48
8094324|NCT03330041|19953309|P1|STARTED|Overall Study||50
8094325|NCT03329989|19953319|P1|NOT COMPLETED|Overall Study||23
8094326|NCT03329989|19953319|P1|COMPLETED|Overall Study||135
8094327|NCT03329989|19953319|P1|STARTED|Overall Study||158
8094328|NCT03329937|19953331|P1|NOT COMPLETED|Overall Study||0
8094329|NCT03329937|19953331|P1|COMPLETED|Overall Study||21
8094330|NCT03329937|19953331|P1|STARTED|Overall Study||21
8094331|NCT03329885|19953346|P9|NOT COMPLETED|Overall Study||0
8094332|NCT03329885|19953347|P8|NOT COMPLETED|Overall Study||1
8094333|NCT03329885|19953348|P7|NOT COMPLETED|Overall Study||1
8094334|NCT03329885|19953349|P6|NOT COMPLETED|Overall Study||0
8094335|NCT03329885|19953350|P5|NOT COMPLETED|Overall Study||0
8094336|NCT03329885|19953351|P4|NOT COMPLETED|Overall Study||0
8094337|NCT03329885|19953352|P3|NOT COMPLETED|Overall Study||0
8094338|NCT03329885|19953353|P2|NOT COMPLETED|Overall Study||0
8094339|NCT03329885|19953354|P1|NOT COMPLETED|Overall Study||0
8094340|NCT03329885|19953346|P9|COMPLETED|Overall Study||0
8094341|NCT03329885|19953347|P8|COMPLETED|Overall Study||0
8094342|NCT03329885|19953348|P7|COMPLETED|Overall Study||0
8094343|NCT03329885|19953349|P6|COMPLETED|Overall Study||3
8094344|NCT03329885|19953350|P5|COMPLETED|Overall Study||6
8094345|NCT03329885|19953351|P4|COMPLETED|Overall Study||6
8094346|NCT03329885|19953352|P3|COMPLETED|Overall Study||6
8094347|NCT03329885|19953353|P2|COMPLETED|Overall Study||6
8094348|NCT03329885|19953354|P1|COMPLETED|Overall Study||9
8094349|NCT03329885|19953346|P9|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
8094350|NCT03329885|19953347|P8|STARTED|Overall Study||1
8094351|NCT03329885|19953348|P7|STARTED|Overall Study||1
8094352|NCT03329885|19953349|P6|STARTED|Overall Study||3
8094353|NCT03329885|19953350|P5|STARTED|Overall Study||6
8094354|NCT03329885|19953351|P4|STARTED|Overall Study||6
8094355|NCT03329885|19953352|P3|STARTED|Overall Study||6
8094356|NCT03329885|19953353|P2|STARTED|Overall Study||6
8094357|NCT03329885|19953354|P1|STARTED|Overall Study||9
8094378|NCT03329573|19953609|P4|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
8094379|NCT03329573|19953610|P3|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
8094380|NCT03329573|19953611|P2|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
8094381|NCT03329573|19953612|P1|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
8094382|NCT03329573|19953609|P4|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
8094383|NCT03329573|19953610|P3|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
8094384|NCT03329573|19953611|P2|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
8094385|NCT03329573|19953612|P1|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
8094386|NCT03329573|19953609|P4|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
8094387|NCT03329573|19953610|P3|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
8094388|NCT03329573|19953611|P2|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
8094389|NCT03329573|19953612|P1|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
8094390|NCT03329573|19953609|P4|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094391|NCT03329573|19953610|P3|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094392|NCT03329573|19953611|P2|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094393|NCT03329573|19953612|P1|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094394|NCT03329573|19953609|P4|COMPLETED|Washout Period (Day 6 to Day 11)||19
8094395|NCT03329573|19953610|P3|COMPLETED|Washout Period (Day 6 to Day 11)||19
8094396|NCT03329573|19953611|P2|COMPLETED|Washout Period (Day 6 to Day 11)||21
8094397|NCT03329573|19953612|P1|COMPLETED|Washout Period (Day 6 to Day 11)||22
8094398|NCT03329573|19953609|P4|STARTED|Washout Period (Day 6 to Day 11)||19
8094399|NCT03329573|19953610|P3|STARTED|Washout Period (Day 6 to Day 11)||19
8094400|NCT03329573|19953611|P2|STARTED|Washout Period (Day 6 to Day 11)||21
8094401|NCT03329573|19953612|P1|STARTED|Washout Period (Day 6 to Day 11)||22
8094402|NCT03329573|19953609|P4|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
8094403|NCT03329573|19953610|P3|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
8094404|NCT03329573|19953611|P2|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
8094405|NCT03329573|19953612|P1|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
8094406|NCT03329573|19953609|P4|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
8094407|NCT03329573|19953610|P3|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
8094408|NCT03329573|19953611|P2|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
8094409|NCT03329573|19953612|P1|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
8094410|NCT03329573|19953609|P4|STARTED|Treatment Period 1 (Up to 5 Days)||19
8094411|NCT03329573|19953610|P3|STARTED|Treatment Period 1 (Up to 5 Days)||19
8094412|NCT03329573|19953611|P2|STARTED|Treatment Period 1 (Up to 5 Days)||24
8094413|NCT03329573|19953612|P1|STARTED|Treatment Period 1 (Up to 5 Days)||23
8094414|NCT03329209|19953678|P1|NOT COMPLETED|Overall Study||0
8094415|NCT03329209|19953678|P1|COMPLETED|Overall Study||16
8094416|NCT03329209|19953678|P1|STARTED|Overall Study||16
8094417|NCT03328949|19953686|P1|NOT COMPLETED|Overall Study||0
8094418|NCT03328949|19953686|P1|COMPLETED|Overall Study||120
8094419|NCT03328949|19953686|P1|STARTED|Overall Study||120
8094420|NCT03328897|19953696|P3|NOT COMPLETED|Follow-up Epoch||2
8094421|NCT03328897|19953697|P2|NOT COMPLETED|Follow-up Epoch||3
8094422|NCT03328897|19953698|P1|NOT COMPLETED|Follow-up Epoch||8
8094423|NCT03328897|19953696|P3|COMPLETED|Follow-up Epoch||79
8094424|NCT03328897|19953697|P2|COMPLETED|Follow-up Epoch||160
8094425|NCT03328897|19953698|P1|COMPLETED|Follow-up Epoch||153
8094426|NCT03328897|19953696|P3|STARTED|Follow-up Epoch||81
8094427|NCT03328897|19953697|P2|STARTED|Follow-up Epoch||163
8094428|NCT03328897|19953698|P1|STARTED|Follow-up Epoch||161
8094429|NCT03328897|19953696|P3|NOT COMPLETED|Randomized-treatment Epoch||2
8094430|NCT03328897|19953697|P2|NOT COMPLETED|Randomized-treatment Epoch||5
8094431|NCT03328897|19953698|P1|NOT COMPLETED|Randomized-treatment Epoch||16
8094432|NCT03328897|19953696|P3|COMPLETED|Randomized-treatment Epoch||81
8094433|NCT03328897|19953697|P2|COMPLETED|Randomized-treatment Epoch||162
8094434|NCT03328897|19953698|P1|COMPLETED|Randomized-treatment Epoch||152
8094435|NCT03328897|19953696|P3|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
8094436|NCT03328897|19953697|P2|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
8094437|NCT03328897|19953698|P1|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
8094438|NCT03328897|19953696|P3|STARTED|Randomized-treatment Epoch||83
8094439|NCT03328897|19953697|P2|STARTED|Randomized-treatment Epoch||167
8094440|NCT03328897|19953698|P1|STARTED|Randomized-treatment Epoch||168
8094441|NCT03328624|19953727|P1|NOT COMPLETED|Overall Study||0
8094442|NCT03328624|19953727|P1|COMPLETED|Overall Study||36
8094443|NCT03328624|19953727|P1|STARTED|Overall Study||36
8094444|NCT03328208|19953733|P2|NOT COMPLETED|Overall Study||0
8094445|NCT03328208|19953734|P1|NOT COMPLETED|Overall Study||0
8094446|NCT03328208|19953733|P2|COMPLETED|Overall Study||35
8094447|NCT03328208|19953734|P1|COMPLETED|Overall Study||37
8094448|NCT03328208|19953733|P2|STARTED|Overall Study||35
8094449|NCT03328208|19953734|P1|STARTED|Overall Study||37
8094450|NCT03328182|19953760|P1|NOT COMPLETED|Overall Study||4
8094451|NCT03328182|19953760|P1|COMPLETED|Overall Study||30
8094452|NCT03328182|19953760|P1|STARTED|Overall Study||34
8094453|NCT03327402|19953765|P1|NOT COMPLETED|Overall Study||2
8094454|NCT03327402|19953765|P1|COMPLETED|Overall Study||22
8094455|NCT03327402|19953765|P1|Sparse PK Sampling Group|Overall Study||12
8094456|NCT03327402|19953765|P1|Rich PK Sampling Group|Overall Study||12
8094457|NCT03327402|19953765|P1|STARTED|Overall Study||24
8094458|NCT03327051|19953800|P2|NOT COMPLETED|Overall Study||5
8094459|NCT03327051|19953801|P1|NOT COMPLETED|Overall Study||5
8094460|NCT03327051|19953800|P2|COMPLETED|Overall Study||15
8094461|NCT03327051|19953801|P1|COMPLETED|Overall Study||14
8094462|NCT03327051|19953800|P2|Attended Visit 2 (Week 0)|Overall Study||15
8094463|NCT03327051|19953801|P1|Attended Visit 2 (Week 0)|Overall Study||15
8094464|NCT03327051|19953800|P2|Received Treatment|Overall Study||16
8094465|NCT03327051|19953801|P1|Received Treatment|Overall Study||16
8094466|NCT03327051|19953800|P2|STARTED|Overall Study||20
8094467|NCT03327051|19953801|P1|STARTED|Overall Study||19
8094468|NCT03326999|19953815|P2|NOT COMPLETED|Overall Study||0
8094469|NCT03326999|19953816|P1|NOT COMPLETED|Overall Study||0
8094470|NCT03326999|19953815|P2|COMPLETED|Overall Study||30
8094471|NCT03326999|19953816|P1|COMPLETED|Overall Study||30
8094472|NCT03326999|19953815|P2|STARTED|Overall Study||30
8094473|NCT03326999|19953816|P1|STARTED|Overall Study||30
8094474|NCT03326986|19953835|P3|NOT COMPLETED|Overall Study||0
8094475|NCT03326986|19953836|P2|NOT COMPLETED|Overall Study||0
8094476|NCT03326986|19953837|P1|NOT COMPLETED|Overall Study||0
8094477|NCT03326986|19953835|P3|COMPLETED|Overall Study||8
8094478|NCT03326986|19953836|P2|COMPLETED|Overall Study||8
8094479|NCT03326986|19953837|P1|COMPLETED|Overall Study||8
8094480|NCT03326986|19953835|P3|STARTED|Overall Study||8
8094481|NCT03326986|19953836|P2|STARTED|Overall Study||8
8094482|NCT03326986|19953837|P1|STARTED|Overall Study||8
8094483|NCT03326895|19954077|P1|NOT COMPLETED|Overall Study||0
8094484|NCT03326895|19954077|P1|COMPLETED|Overall Study||168
8094485|NCT03326895|19954077|P1|STARTED|Overall Study||168
8094486|NCT03326869|19954084|P2|NOT COMPLETED|Overall Study||1
8094487|NCT03326869|19954085|P1|NOT COMPLETED|Overall Study||1
8094488|NCT03326869|19954084|P2|COMPLETED|Overall Study||0
8094489|NCT03326869|19954085|P1|COMPLETED|Overall Study||0
8094490|NCT03326869|19954084|P2|STARTED|Overall Study||1
8094491|NCT03326869|19954085|P1|STARTED|Overall Study||1
8094492|NCT03326843|19954093|P1|NOT COMPLETED|Overall Study||0
8094493|NCT03326843|19954093|P1|COMPLETED|Overall Study||4
8094494|NCT03326843|19954093|P1|STARTED|Overall Study||4
8094495|NCT03326518|19954101|P3|NOT COMPLETED|Overall Study||1
8094496|NCT03326518|19954102|P2|NOT COMPLETED|Overall Study||0
8094497|NCT03326518|19954103|P1|NOT COMPLETED|Overall Study||3
8094498|NCT03326518|19954101|P3|COMPLETED|Overall Study||13
8094499|NCT03326518|19954102|P2|COMPLETED|Overall Study||12
8094500|NCT03326518|19954103|P1|COMPLETED|Overall Study||16
8094501|NCT03326518|19954101|P3|STARTED|Overall Study||14
8094502|NCT03326518|19954102|P2|STARTED|Overall Study||12
8094503|NCT03326518|19954103|P1|STARTED|Overall Study||19
8094504|NCT03326323|19954138|P1|NOT COMPLETED|Overall Study||3
8094505|NCT03326323|19954138|P1|COMPLETED|Overall Study||40
8094506|NCT03326323|19954138|P1|STARTED|Overall Study||43
8094507|NCT03325894|19954145|P2|NOT COMPLETED|Overall Study||77
8094508|NCT03325894|19954146|P1|NOT COMPLETED|Overall Study||64
8094509|NCT03325894|19954145|P2|COMPLETED|Overall Study||0
8094510|NCT03325894|19954146|P1|COMPLETED|Overall Study||0
8094511|NCT03325894|19954145|P2|STARTED|Overall Study||77
8094512|NCT03325894|19954146|P1|STARTED|Overall Study||64
8094513|NCT03325881|19954214|P2|NOT COMPLETED|Overall Study||3
8094514|NCT03325881|19954215|P1|NOT COMPLETED|Overall Study||3
8094515|NCT03325881|19954214|P2|COMPLETED|Overall Study||42
8094516|NCT03325881|19954215|P1|COMPLETED|Overall Study||41
8094517|NCT03325881|19954214|P2|Treated|Overall Study||45
8094518|NCT03325881|19954215|P1|Treated|Overall Study||43
8094519|NCT03325881|19954214|P2|STARTED|Overall Study||45
8094520|NCT03325881|19954215|P1|STARTED|Overall Study||44
8094521|NCT03325673|19954243|P2|NOT COMPLETED|Overall Study||0
8094522|NCT03325673|19954244|P1|NOT COMPLETED|Overall Study||4
8094523|NCT03325673|19954243|P2|COMPLETED|Overall Study||42
8094524|NCT03325673|19954244|P1|COMPLETED|Overall Study||38
8094525|NCT03325673|19954243|P2|STARTED|Overall Study||42
8094526|NCT03325673|19954244|P1|STARTED|Overall Study||42
8094527|NCT03325114|19954256|P1|NOT COMPLETED|Overall Study||1
8094528|NCT03325114|19954256|P1|COMPLETED|Overall Study||0
8094529|NCT03325114|19954256|P1|STARTED|Overall Study||1
8094530|NCT03324607|19954263|P1|NOT COMPLETED|Overall Study||0
8094531|NCT03324607|19954263|P1|COMPLETED|Overall Study||20
8094532|NCT03324607|19954263|P1|STARTED|Overall Study||20
8094533|NCT03324451|19954280|P2|NOT COMPLETED|Overall Study||13
8094534|NCT03324451|19954281|P1|NOT COMPLETED|Overall Study||32
8094535|NCT03324451|19954280|P2|COMPLETED|Overall Study||41
8094536|NCT03324451|19954281|P1|COMPLETED|Overall Study||65
8094537|NCT03324451|19954280|P2|STARTED|Overall Study||54
8094538|NCT03324451|19954281|P1|STARTED|Overall Study||97
8094539|NCT03323736|19954298|P3|NOT COMPLETED|Overall Study||2
8094540|NCT03323736|19954299|P2|NOT COMPLETED|Overall Study||12
8094541|NCT03323736|19954300|P1|NOT COMPLETED|Overall Study||19
8094542|NCT03323736|19954298|P3|COMPLETED|Overall Study||68
8094543|NCT03323736|19954299|P2|COMPLETED|Overall Study||47
8094544|NCT03323736|19954300|P1|COMPLETED|Overall Study||222
8094545|NCT03323736|19954298|P3|Treated|Overall Study||68
8094546|NCT03323736|19954299|P2|Treated|Overall Study||47
8094547|NCT03323736|19954300|P1|Treated|Overall Study||222
8094548|NCT03323736|19954298|P3|STARTED|Overall Study||70
8094549|NCT03323736|19954299|P2|STARTED|Overall Study||59
8094550|NCT03323736|19954300|P1|STARTED|Overall Study||241
8094551|NCT03323723|19954311|P1|NOT COMPLETED|Treatment Phase||9
8094552|NCT03323723|19954311|P1|COMPLETED|Treatment Phase||51
8094553|NCT03323723|19954311|P1|STARTED|Treatment Phase||60
8094554|NCT03323723|19954311|P1|NOT COMPLETED|Baseline Phase||4
8094555|NCT03323723|19954311|P1|COMPLETED|Baseline Phase||60
8094556|NCT03323723|19954311|P1|STARTED|Baseline Phase||64
8094557|NCT03323723|19954311|P1|NOT COMPLETED|Screening||9
8094558|NCT03323723|19954311|P1|COMPLETED|Screening||64
8094559|NCT03323723|19954311|P1|STARTED|Screening||73
8094560|NCT03323307|19954318|P1|NOT COMPLETED|Overall Study||0
8094561|NCT03323307|19954318|P1|COMPLETED|Overall Study||70
8094562|NCT03323307|19954318|P1|STARTED|Overall Study||70
8094563|NCT03323164|19954327|P2|NOT COMPLETED|Overall Study||2
8094564|NCT03323164|19954328|P1|NOT COMPLETED|Overall Study||2
8094565|NCT03323164|19954327|P2|COMPLETED|Overall Study||15
8094566|NCT03323164|19954328|P1|COMPLETED|Overall Study||16
8094567|NCT03323164|19954327|P2|STARTED|Overall Study||17
8094568|NCT03323164|19954328|P1|STARTED|Overall Study||18
8094569|NCT03323086|19954354|P2|NOT COMPLETED|Overall Study||2
8094570|NCT03323086|19954355|P1|NOT COMPLETED|Overall Study||3
8094571|NCT03323086|19954354|P2|COMPLETED|Overall Study||20
8094572|NCT03323086|19954355|P1|COMPLETED|Overall Study||23
8094573|NCT03323086|19954354|P2|STARTED|Overall Study||22
8094574|NCT03323086|19954355|P1|STARTED|Overall Study||26
8094575|NCT03322930|19954373|P2|NOT COMPLETED|Overall Study||0
8094576|NCT03322930|19954374|P1|NOT COMPLETED|Overall Study||0
8094577|NCT03322930|19954373|P2|COMPLETED|Overall Study||20
8094578|NCT03322930|19954374|P1|COMPLETED|Overall Study||20
8094579|NCT03322930|19954373|P2|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
8094580|NCT03322930|19954374|P1|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
8094581|NCT03322566|19954383|P3|NOT COMPLETED|Overall Study||55
8094582|NCT03322566|19954384|P2|NOT COMPLETED|Overall Study||87
8094583|NCT03322566|19954385|P1|NOT COMPLETED|Overall Study||91
8094584|NCT03322566|19954383|P3|COMPLETED|Overall Study||0
8094585|NCT03322566|19954384|P2|COMPLETED|Overall Study||0
8094586|NCT03322566|19954385|P1|COMPLETED|Overall Study||0
8094587|NCT03322566|19954383|P3|STARTED|Overall Study||55
8094588|NCT03322566|19954384|P2|STARTED|Overall Study||87
8094589|NCT03322566|19954385|P1|STARTED|Overall Study||91
8094590|NCT03322540|19954404|P2|NOT COMPLETED|Overall Study||77
8094591|NCT03322540|19954405|P1|NOT COMPLETED|Overall Study||77
8094592|NCT03322540|19954404|P2|COMPLETED|Overall Study||0
8094593|NCT03322540|19954405|P1|COMPLETED|Overall Study||0
8094594|NCT03322540|19954404|P2|STARTED|Overall Study||77
8094595|NCT03322540|19954405|P1|STARTED|Overall Study||77
8094596|NCT03322514|19954413|P2|NOT COMPLETED|Overall Study||1
8094597|NCT03322514|19954414|P1|NOT COMPLETED|Overall Study||1
8094598|NCT03322514|19954413|P2|COMPLETED|Overall Study||5
8094599|NCT03322514|19954414|P1|COMPLETED|Overall Study||5
8094600|NCT03322514|19954413|P2|STARTED|Overall Study||6
8094601|NCT03322514|19954414|P1|STARTED|Overall Study||6
8094602|NCT03322462|19954424|P1|NOT COMPLETED|Overall Study||3
8094603|NCT03322462|19954424|P1|COMPLETED|Overall Study||152
8094604|NCT03322462|19954424|P1|Flortaucipir PET Scan|Overall Study||155
8094605|NCT03322462|19954424|P1|STARTED|Overall Study||155
8094606|NCT03322423|19954433|P2|NOT COMPLETED|Period 2||2
8094607|NCT03322423|19954434|P1|NOT COMPLETED|Period 2||1
8094608|NCT03322423|19954433|P2|COMPLETED|Period 2||36
8094609|NCT03322423|19954434|P1|COMPLETED|Period 2||35
8094610|NCT03322423|19954433|P2|STARTED|Period 2||38
8094611|NCT03322423|19954434|P1|STARTED|Period 2||36
8094612|NCT03322423|19954433|P2|NOT COMPLETED|Period 1||2
8094613|NCT03322423|19954434|P1|NOT COMPLETED|Period 1||2
8094614|NCT03322423|19954433|P2|COMPLETED|Period 1||38
8094615|NCT03322423|19954434|P1|COMPLETED|Period 1||36
8094616|NCT03322423|19954433|P2|STARTED|Period 1||40
8094617|NCT03322423|19954434|P1|STARTED|Period 1||38
8094618|NCT03322293|19954447|P3|NOT COMPLETED|Overall Study||1
8094619|NCT03322293|19954448|P2|NOT COMPLETED|Overall Study||0
8094620|NCT03322293|19954449|P1|NOT COMPLETED|Overall Study||0
8094621|NCT03322293|19954447|P3|COMPLETED|Overall Study||7
8094622|NCT03322293|19954448|P2|COMPLETED|Overall Study||8
8094623|NCT03322293|19954449|P1|COMPLETED|Overall Study||8
8094624|NCT03322293|19954447|P3|STARTED|Overall Study||8
8094625|NCT03322293|19954448|P2|STARTED|Overall Study||8
8094626|NCT03322293|19954449|P1|STARTED|Overall Study||8
8094627|NCT03321721|19954472|P3|NOT COMPLETED|Overall Study||11
8094628|NCT03321721|19954473|P2|NOT COMPLETED|Overall Study||8
8094629|NCT03321721|19954474|P1|NOT COMPLETED|Overall Study||4
8094630|NCT03321721|19954472|P3|COMPLETED|Overall Study||1
8094631|NCT03321721|19954473|P2|COMPLETED|Overall Study||2
8094632|NCT03321721|19954474|P1|COMPLETED|Overall Study||0
8094633|NCT03321721|19954472|P3|STARTED|Overall Study||12
8094634|NCT03321721|19954473|P2|STARTED|Overall Study||10
8094635|NCT03321721|19954474|P1|STARTED|Overall Study||4
8094636|NCT03321396|19954491|P1|NOT COMPLETED|Overall Study||1
8094637|NCT03321396|19954491|P1|COMPLETED|Overall Study||12
8094638|NCT03321396|19954491|P1|STARTED|Overall Study||13
8094639|NCT03321253|19954497|P1|NOT COMPLETED|Overall Study||0
8094640|NCT03321253|19954497|P1|COMPLETED|Overall Study||38
8094641|NCT03321253|19954497|P1|STARTED|Overall Study||38
8094642|NCT03321097|19954507|P2|NOT COMPLETED|Overall Study||0
8094643|NCT03321097|19954508|P1|NOT COMPLETED|Overall Study||0
8094644|NCT03321097|19954507|P2|COMPLETED|Overall Study||18
8094645|NCT03321097|19954508|P1|COMPLETED|Overall Study||18
8094646|NCT03321097|19954507|P2|STARTED|Overall Study||18
8094647|NCT03321097|19954508|P1|STARTED|Overall Study||18
8094648|NCT03320941|19954529|P5|NOT COMPLETED|Overall Study||0
8094649|NCT03320941|19954530|P4|NOT COMPLETED|Overall Study||1
8094650|NCT03320941|19954531|P3|NOT COMPLETED|Overall Study||0
8094651|NCT03320941|19954532|P2|NOT COMPLETED|Overall Study||0
8094652|NCT03320941|19954533|P1|NOT COMPLETED|Overall Study||0
8094653|NCT03320941|19954529|P5|COMPLETED|Overall Study||29
8094654|NCT03320941|19954530|P4|COMPLETED|Overall Study||30
8094655|NCT03320941|19954531|P3|COMPLETED|Overall Study||28
8094656|NCT03320941|19954532|P2|COMPLETED|Overall Study||19
8094657|NCT03320941|19954533|P1|COMPLETED|Overall Study||19
8094658|NCT03320941|19954529|P5|STARTED|Overall Study||29
8094659|NCT03320941|19954530|P4|STARTED|Overall Study||31
8094660|NCT03320941|19954531|P3|STARTED|Overall Study||28
8094661|NCT03320941|19954532|P2|STARTED|Overall Study||19
8094662|NCT03320941|19954533|P1|STARTED|Overall Study||19
8094663|NCT03320824|19954636|P2|NOT COMPLETED|Overall Study||4
8094664|NCT03320824|19954637|P1|NOT COMPLETED|Overall Study||18
8094665|NCT03320824|19954636|P2|COMPLETED|Overall Study||85
8094666|NCT03320824|19954637|P1|COMPLETED|Overall Study||166
8094667|NCT03320824|19954636|P2|STARTED|Overall Study||89
8094668|NCT03320824|19954637|P1|STARTED|Overall Study||184
8094669|NCT03320564|19954653|P1|NOT COMPLETED|Overall Study||1
8094670|NCT03320564|19954653|P1|COMPLETED|Overall Study||1
8094671|NCT03320564|19954653|P1|STARTED|Overall Study||2
8094672|NCT03320369|19954657|P1|NOT COMPLETED|Overall Study||3
8094673|NCT03320369|19954657|P1|COMPLETED|Overall Study||15
8094674|NCT03320369|19954657|P1|STARTED|Overall Study||18
8094675|NCT03320096|19954666|P1|NOT COMPLETED|Overall Study||0
8094676|NCT03320096|19954666|P1|COMPLETED|Overall Study||20
8094677|NCT03320096|19954666|P1|STARTED|Overall Study||20
8094678|NCT03319810|19954673|P1|NOT COMPLETED|Overall Study||0
8094679|NCT03319810|19954673|P1|COMPLETED|Overall Study||5
8094680|NCT03319810|19954673|P1|STARTED|Overall Study||5
8094681|NCT03319719|19954678|P1|NOT COMPLETED|Overall Study||1
8094682|NCT03319719|19954678|P1|COMPLETED|Overall Study||51
8094683|NCT03319719|19954678|P1|STARTED|Overall Study||52
8094684|NCT03319407|19954692|P1|NOT COMPLETED|Overall Study||21
8094685|NCT03319407|19954692|P1|COMPLETED|Overall Study||0
8094686|NCT03319407|19954692|P1|STARTED|Overall Study||21
8094687|NCT03319277|19954698|P2|NOT COMPLETED|Overall Study||0
8094688|NCT03319277|19954699|P1|NOT COMPLETED|Overall Study||0
8094689|NCT03319277|19954698|P2|COMPLETED|Overall Study||59
8094690|NCT03319277|19954699|P1|COMPLETED|Overall Study||59
8094691|NCT03319277|19954698|P2|STARTED|Overall Study||59
8094692|NCT03319277|19954699|P1|STARTED|Overall Study||59
8094693|NCT03319212|19954711|P2|NOT COMPLETED|Overall Study||5
8094694|NCT03319212|19954712|P1|NOT COMPLETED|Overall Study||3
8094695|NCT03319212|19954711|P2|COMPLETED|Overall Study||47
8094696|NCT03319212|19954712|P1|COMPLETED|Overall Study||26
8094697|NCT03319212|19954711|P2|STARTED|Overall Study||52
8094698|NCT03319212|19954712|P1|STARTED|Overall Study||29
8094699|NCT03319173|19954739|P2|NOT COMPLETED|Overall Study||0
8094700|NCT03319173|19954740|P1|NOT COMPLETED|Overall Study||0
8094701|NCT03319173|19954739|P2|COMPLETED|Overall Study||50
8094702|NCT03319173|19954740|P1|COMPLETED|Overall Study||48
8094703|NCT03319173|19954739|P2|STARTED|Overall Study||50
8094704|NCT03319173|19954740|P1|STARTED|Overall Study||48
8094705|NCT03319134|19954779|P3|NOT COMPLETED|Overall Study||0
8094706|NCT03319134|19954780|P2|NOT COMPLETED|Overall Study||0
8094707|NCT03319134|19954781|P1|NOT COMPLETED|Overall Study||0
8094708|NCT03319134|19954779|P3|COMPLETED|Overall Study||15
8094709|NCT03319134|19954780|P2|COMPLETED|Overall Study||15
8094710|NCT03319134|19954781|P1|COMPLETED|Overall Study||15
8094711|NCT03319134|19954779|P3|STARTED|Overall Study||15
8094712|NCT03319134|19954780|P2|STARTED|Overall Study||15
8094713|NCT03319134|19954781|P1|STARTED|Overall Study||15
8094714|NCT03318861|19954794|P5|NOT COMPLETED|Overall Study||3
8094715|NCT03318861|19954795|P4|NOT COMPLETED|Overall Study||4
8094716|NCT03318861|19954796|P3|NOT COMPLETED|Overall Study||3
8094717|NCT03318861|19954797|P2|NOT COMPLETED|Overall Study||4
8094718|NCT03318861|19954798|P1|NOT COMPLETED|Overall Study||3
8094719|NCT03318861|19954794|P5|COMPLETED|Overall Study||0
8094720|NCT03318861|19954795|P4|COMPLETED|Overall Study||0
8094721|NCT03318861|19954796|P3|COMPLETED|Overall Study||0
8094722|NCT03318861|19954797|P2|COMPLETED|Overall Study||0
8094723|NCT03318861|19954798|P1|COMPLETED|Overall Study||0
8094724|NCT03318861|19954794|P5|STARTED|Overall Study||3
8094725|NCT03318861|19954795|P4|STARTED|Overall Study||4
8094726|NCT03318861|19954796|P3|STARTED|Overall Study||3
8094727|NCT03318861|19954797|P2|STARTED|Overall Study||4
8094728|NCT03318861|19954798|P1|STARTED|Overall Study||3
8094729|NCT03318809|19954846|P2|NOT COMPLETED|Overall Study||0
8094730|NCT03318809|19954847|P1|NOT COMPLETED|Overall Study||0
8094731|NCT03318809|19954846|P2|COMPLETED|Overall Study||6
8094732|NCT03318809|19954847|P1|COMPLETED|Overall Study||6
8094733|NCT03318809|19954846|P2|STARTED|Overall Study||6
8094734|NCT03318809|19954847|P1|STARTED|Overall Study||6
8094735|NCT03318783|19954865|P2|NOT COMPLETED|Overall Study||2
8094736|NCT03318783|19954866|P1|NOT COMPLETED|Overall Study||0
8094737|NCT03318783|19954865|P2|COMPLETED|Overall Study||8
8094738|NCT03318783|19954866|P1|COMPLETED|Overall Study||10
8094739|NCT03318783|19954865|P2|STARTED|Overall Study||10
8094740|NCT03318783|19954866|P1|STARTED|Overall Study||10
8094741|NCT03318341|19954892|P2|NOT COMPLETED|Month 2||0
8094742|NCT03318341|19954893|P1|NOT COMPLETED|Month 2||0
8094743|NCT03318341|19954892|P2|COMPLETED|Month 2||12
8094744|NCT03318341|19954893|P1|COMPLETED|Month 2||13
8094745|NCT03318341|19954892|P2|STARTED|Month 2||12
8094746|NCT03318341|19954893|P1|STARTED|Month 2||13
8094747|NCT03318341|19954892|P2|NOT COMPLETED|Month 1||1
8094748|NCT03318341|19954893|P1|NOT COMPLETED|Month 1||0
8094749|NCT03318341|19954892|P2|COMPLETED|Month 1||12
8094750|NCT03318341|19954893|P1|COMPLETED|Month 1||13
8094751|NCT03318341|19954892|P2|STARTED|Month 1||13
8094752|NCT03318341|19954893|P1|STARTED|Month 1||13
8094753|NCT03318315|19954906|P3|NOT COMPLETED|Overall Study||4
8094754|NCT03318315|19954907|P2|NOT COMPLETED|Overall Study||3
8094755|NCT03318315|19954908|P1|NOT COMPLETED|Overall Study||4
8094756|NCT03318315|19954906|P3|COMPLETED|Overall Study||30
8094757|NCT03318315|19954907|P2|COMPLETED|Overall Study||50
8094758|NCT03318315|19954908|P1|COMPLETED|Overall Study||58
8094759|NCT03318315|19954906|P3|Received Third Vaccination|Overall Study||0
8094760|NCT03318315|19954907|P2|Received Third Vaccination|Overall Study||46
8094761|NCT03318315|19954908|P1|Received Third Vaccination|Overall Study||0
8094762|NCT03318315|19954906|P3|Received Second Vaccination|Overall Study||0
8094763|NCT03318315|19954907|P2|Received Second Vaccination|Overall Study||48
8094764|NCT03318315|19954908|P1|Received Second Vaccination|Overall Study||59
8094765|NCT03318315|19954906|P3|Received First Vaccination|Overall Study||34
8094766|NCT03318315|19954907|P2|Received First Vaccination|Overall Study||53
8094767|NCT03318315|19954908|P1|Received First Vaccination|Overall Study||62
8094768|NCT03318315|19954906|P3|STARTED|Overall Study||34
8094769|NCT03318315|19954907|P2|STARTED|Overall Study||53
8094770|NCT03318315|19954908|P1|STARTED|Overall Study||62
8094771|NCT03317431|19954999|P1|NOT COMPLETED|Overall Study||0
8094772|NCT03317431|19954999|P1|COMPLETED|Overall Study||46
8094773|NCT03317431|19954999|P1|STARTED|Overall Study||46
8094774|NCT03316976|19955009|P2|NOT COMPLETED|Overall Study||0
8094775|NCT03316976|19955010|P1|NOT COMPLETED|Overall Study||0
8094776|NCT03316976|19955009|P2|COMPLETED|Overall Study||20
8094777|NCT03316976|19955010|P1|COMPLETED|Overall Study||20
8094778|NCT03316976|19955009|P2|STARTED|Overall Study||20
8094779|NCT03316976|19955010|P1|STARTED|Overall Study||20
8094780|NCT03316911|19955022|P2|NOT COMPLETED|Overall Study||29
8094781|NCT03316911|19955023|P1|NOT COMPLETED|Overall Study||33
8094782|NCT03316911|19955022|P2|COMPLETED|Overall Study||110
8094783|NCT03316911|19955023|P1|COMPLETED|Overall Study||89
8094784|NCT03316911|19955022|P2|5-Month Follow-up Survey|Overall Study||110
8094785|NCT03316911|19955023|P1|5-Month Follow-up Survey|Overall Study||89
8094786|NCT03316911|19955022|P2|3-Month Follow-up Survey|Overall Study||112
8094787|NCT03316911|19955023|P1|3-Month Follow-up Survey|Overall Study||93
8094788|NCT03316911|19955022|P2|STARTED|Overall Study|3 did not complete baseline survey|139
8094789|NCT03316911|19955023|P1|STARTED|Overall Study|2 did not complete baseline survey|122
8094790|NCT03316807|19955057|P2|NOT COMPLETED|Overall Study||26
8094791|NCT03316807|19955058|P1|NOT COMPLETED|Overall Study||31
8094792|NCT03316807|19955057|P2|COMPLETED|Overall Study||65
8094793|NCT03316807|19955058|P1|COMPLETED|Overall Study||60
8094794|NCT03316807|19955057|P2|STARTED|Overall Study||91
8094795|NCT03316807|19955058|P1|STARTED|Overall Study||91
8094796|NCT03316378|19955090|P2|NOT COMPLETED|Overall Study||0
8094797|NCT03316378|19955091|P1|NOT COMPLETED|Overall Study||0
8094798|NCT03316378|19955090|P2|COMPLETED|Overall Study||23
8094799|NCT03316378|19955091|P1|COMPLETED|Overall Study||23
8094800|NCT03316378|19955090|P2|STARTED|Overall Study||23
8094801|NCT03316378|19955091|P1|STARTED|Overall Study||23
8094802|NCT03316131|19955101|P2|NOT COMPLETED|Treatment Period 2||0
8094803|NCT03316131|19955102|P1|NOT COMPLETED|Treatment Period 2||1
8094804|NCT03316131|19955101|P2|COMPLETED|Treatment Period 2||18
8094805|NCT03316131|19955102|P1|COMPLETED|Treatment Period 2||17
8094806|NCT03316131|19955101|P2|STARTED|Treatment Period 2||18
8094807|NCT03316131|19955102|P1|STARTED|Treatment Period 2||18
8094808|NCT03316131|19955101|P2|NOT COMPLETED|Treatment Period 1||0
8094809|NCT03316131|19955102|P1|NOT COMPLETED|Treatment Period 1||0
8094810|NCT03316131|19955101|P2|COMPLETED|Treatment Period 1||18
8094811|NCT03316131|19955102|P1|COMPLETED|Treatment Period 1||18
8094812|NCT03316131|19955101|P2|STARTED|Treatment Period 1||18
8094813|NCT03316131|19955102|P1|STARTED|Treatment Period 1||18
8094814|NCT03316105|19955122|P2|NOT COMPLETED|Overall Study||0
8094815|NCT03316105|19955123|P1|NOT COMPLETED|Overall Study||0
8094816|NCT03316105|19955122|P2|COMPLETED|Overall Study||7
8094817|NCT03316105|19955123|P1|COMPLETED|Overall Study||9
8094818|NCT03316105|19955122|P2|STARTED|Overall Study||7
8094819|NCT03316105|19955123|P1|STARTED|Overall Study||9
8094820|NCT03315949|19955131|P2|NOT COMPLETED|Overall Study||10
8094821|NCT03315949|19955132|P1|NOT COMPLETED|Overall Study||5
8094822|NCT03315949|19955131|P2|COMPLETED|Overall Study||166
8094823|NCT03315949|19955132|P1|COMPLETED|Overall Study||171
8094824|NCT03315949|19955131|P2|STARTED|Overall Study||176
8094825|NCT03315949|19955132|P1|STARTED|Overall Study||176
8094826|NCT03315793|19955140|P2|NOT COMPLETED|Overall Study||3
8094827|NCT03315793|19955141|P1|NOT COMPLETED|Overall Study||5
8094828|NCT03315793|19955140|P2|COMPLETED|Overall Study||71
8094829|NCT03315793|19955141|P1|COMPLETED|Overall Study||70
8094830|NCT03315793|19955140|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
8094831|NCT03315793|19955141|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
8094832|NCT03315793|19955140|P2|STARTED|Overall Study||74
8094833|NCT03315793|19955141|P1|STARTED|Overall Study||75
8094834|NCT03315780|19955155|P2|NOT COMPLETED|Period 2||0
8094835|NCT03315780|19955156|P1|NOT COMPLETED|Period 2||0
8094836|NCT03315780|19955155|P2|COMPLETED|Period 2||6
8094837|NCT03315780|19955156|P1|COMPLETED|Period 2||6
8094838|NCT03315780|19955155|P2|STARTED|Period 2||6
8094839|NCT03315780|19955156|P1|STARTED|Period 2||6
8094840|NCT03315780|19955155|P2|NOT COMPLETED|Period 1||0
8094841|NCT03315780|19955156|P1|NOT COMPLETED|Period 1||0
8094842|NCT03315780|19955155|P2|COMPLETED|Period 1||6
8094843|NCT03315780|19955156|P1|COMPLETED|Period 1||6
8094844|NCT03315780|19955155|P2|Received One Dose of Study Drug|Period 1||6
8094845|NCT03315780|19955156|P1|Received One Dose of Study Drug|Period 1||6
8094846|NCT03315780|19955155|P2|STARTED|Period 1||6
8094847|NCT03315780|19955156|P1|STARTED|Period 1||6
8094848|NCT03315702|19955176|P1|NOT COMPLETED|Overall Study||0
8094849|NCT03315702|19955176|P1|COMPLETED|Overall Study||52
8094850|NCT03315702|19955176|P1|STARTED|Overall Study||52
8094851|NCT03315689|19955185|P2|NOT COMPLETED|Open Label Extension = 52 Weeks||3
8094852|NCT03315689|19955186|P1|NOT COMPLETED|Open Label Extension = 52 Weeks||0
8094853|NCT03315689|19955185|P2|COMPLETED|Open Label Extension = 52 Weeks||7
8094854|NCT03315689|19955186|P1|COMPLETED|Open Label Extension = 52 Weeks||0
8094855|NCT03315689|19955185|P2|STARTED|Open Label Extension = 52 Weeks||10
8094856|NCT03315689|19955186|P1|STARTED|Open Label Extension = 52 Weeks||0
8094857|NCT03315689|19955185|P2|NOT COMPLETED|Double-blind Period = 28 Days||0
8094858|NCT03315689|19955186|P1|NOT COMPLETED|Double-blind Period = 28 Days||1
8094859|NCT03315689|19955185|P2|COMPLETED|Double-blind Period = 28 Days||7
8094860|NCT03315689|19955186|P1|COMPLETED|Double-blind Period = 28 Days||3
8094861|NCT03315689|19955185|P2|STARTED|Double-blind Period = 28 Days||7
8094862|NCT03315689|19955186|P1|STARTED|Double-blind Period = 28 Days||4
8094863|NCT03315572|19955216|P2|NOT COMPLETED|Overall Study||0
8094864|NCT03315572|19955217|P1|NOT COMPLETED|Overall Study||0
8094865|NCT03315572|19955216|P2|COMPLETED|Overall Study||14
8094866|NCT03315572|19955217|P1|COMPLETED|Overall Study||14
8094867|NCT03315572|19955216|P2|STARTED|Overall Study||14
8094868|NCT03315572|19955217|P1|STARTED|Overall Study||14
8094869|NCT03315559|19955240|P1|NOT COMPLETED|Treatment Period 2 (15 Days)||0
8094870|NCT03315559|19955240|P1|COMPLETED|Treatment Period 2 (15 Days)||6
8094871|NCT03315559|19955240|P1|STARTED|Treatment Period 2 (15 Days)||6
8094872|NCT03315559|19955240|P1|NOT COMPLETED|Washout Period (14 Days)||0
8094873|NCT03315559|19955240|P1|COMPLETED|Washout Period (14 Days)||6
8094874|NCT03315559|19955240|P1|STARTED|Washout Period (14 Days)||6
8094875|NCT03315559|19955240|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8094876|NCT03315559|19955240|P1|COMPLETED|Treatment Period 1 (8 Days)||6
8094877|NCT03315559|19955240|P1|STARTED|Treatment Period 1 (8 Days)||6
8094878|NCT03315286|19955280|P2|NOT COMPLETED|Overall Study||4
8094879|NCT03315286|19955281|P1|NOT COMPLETED|Overall Study||1
8094880|NCT03315286|19955280|P2|COMPLETED|Overall Study||43
8094881|NCT03315286|19955281|P1|COMPLETED|Overall Study||49
8094882|NCT03315286|19955280|P2|STARTED|Overall Study||47
8094883|NCT03315286|19955281|P1|STARTED|Overall Study||50
8094884|NCT03315104|19955300|P3|NOT COMPLETED|Overall Study||5
8094885|NCT03315104|19955301|P2|NOT COMPLETED|Overall Study||4
8094886|NCT03315104|19955302|P1|NOT COMPLETED|Overall Study||3
8094887|NCT03315104|19955300|P3|COMPLETED|Overall Study||19
8094888|NCT03315104|19955301|P2|COMPLETED|Overall Study||16
8094889|NCT03315104|19955302|P1|COMPLETED|Overall Study||18
8094890|NCT03315104|19955300|P3|Dosed (Safety Population)|Overall Study||22
8094891|NCT03315104|19955301|P2|Dosed (Safety Population)|Overall Study||19
8094892|NCT03315104|19955302|P1|Dosed (Safety Population)|Overall Study||19
8094893|NCT03315104|19955300|P3|STARTED|Overall Study||24
8094894|NCT03315104|19955301|P2|STARTED|Overall Study||20
8094895|NCT03315104|19955302|P1|STARTED|Overall Study||21
8094896|NCT03314857|19955322|P1|NOT COMPLETED|Overall Study||5
8094897|NCT03314857|19955322|P1|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
8094898|NCT03314857|19955322|P1|Analysis Population|Overall Study||61
8094899|NCT03314857|19955322|P1|STARTED|Overall Study||67
8094900|NCT03314753|19955330|P2|NOT COMPLETED|Overall Study||0
8094901|NCT03314753|19955331|P1|NOT COMPLETED|Overall Study||0
8094902|NCT03314753|19955330|P2|COMPLETED|Overall Study||36
8094903|NCT03314753|19955331|P1|COMPLETED|Overall Study||53
8094904|NCT03314753|19955330|P2|STARTED|Overall Study||36
8094905|NCT03314753|19955331|P1|STARTED|Overall Study||53
8094906|NCT03314662|19955356|P3|NOT COMPLETED|Overall Study||5
8094907|NCT03314662|19955357|P2|NOT COMPLETED|Overall Study||5
8094908|NCT03314662|19955358|P1|NOT COMPLETED|Overall Study||8
8094909|NCT03314662|19955356|P3|COMPLETED|Overall Study||439
8094910|NCT03314662|19955357|P2|COMPLETED|Overall Study||440
8094911|NCT03314662|19955358|P1|COMPLETED|Overall Study||881
8094912|NCT03314662|19955356|P3|Treated|Overall Study||444
8094913|NCT03314662|19955357|P2|Treated|Overall Study||444
8094914|NCT03314662|19955358|P1|Treated|Overall Study||888
8094915|NCT03314662|19955356|P3|STARTED|Overall Study||444
8094916|NCT03314662|19955357|P2|STARTED|Overall Study||445
8094917|NCT03314662|19955358|P1|STARTED|Overall Study||889
8094918|NCT03314519|19955403|P2|NOT COMPLETED|Overall Study||2
8094919|NCT03314519|19955404|P1|NOT COMPLETED|Overall Study||3
8094920|NCT03314519|19955403|P2|COMPLETED|Overall Study||98
8094921|NCT03314519|19955404|P1|COMPLETED|Overall Study||97
8094922|NCT03314519|19955403|P2|STARTED|Overall Study||100
8094923|NCT03314519|19955404|P1|STARTED|Overall Study||100
8094924|NCT03314233|19955414|P1|NOT COMPLETED|Overall Study||1
8094925|NCT03314233|19955414|P1|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
8094926|NCT03314233|19955414|P1|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
8094927|NCT03313310|19955427|P2|NOT COMPLETED|Phase 3||1
8094928|NCT03313310|19955428|P1|NOT COMPLETED|Phase 3||0
8094929|NCT03313310|19955427|P2|COMPLETED|Phase 3||40
8094930|NCT03313310|19955428|P1|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
8094931|NCT03313310|19955427|P2|STARTED|Phase 3||41
8094932|NCT03313310|19955428|P1|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
8094933|NCT03313310|19955427|P2|NOT COMPLETED|Phase 2||0
8094934|NCT03313310|19955428|P1|NOT COMPLETED|Phase 2||4
8094935|NCT03313310|19955427|P2|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
8094936|NCT03313310|19955428|P1|COMPLETED|Phase 2||47
8094937|NCT03313310|19955427|P2|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
8094938|NCT03313310|19955428|P1|STARTED|Phase 2||51
8094939|NCT03313050|19955470|P4|NOT COMPLETED|Stage 2: 12 Months||20
8094940|NCT03313050|19955471|P3|NOT COMPLETED|Stage 2: 12 Months||11
8094941|NCT03313050|19955472|P2|NOT COMPLETED|Stage 2: 12 Months||0
8094942|NCT03313050|19955473|P1|NOT COMPLETED|Stage 2: 12 Months||0
8094943|NCT03313050|19955470|P4|COMPLETED|Stage 2: 12 Months||204
8094944|NCT03313050|19955471|P3|COMPLETED|Stage 2: 12 Months||210
8094945|NCT03313050|19955472|P2|COMPLETED|Stage 2: 12 Months||0
8094946|NCT03313050|19955473|P1|COMPLETED|Stage 2: 12 Months||0
8094947|NCT03313050|19955470|P4|Vaccinated|Stage 2: 12 Months||223
8094948|NCT03313050|19955471|P3|Vaccinated|Stage 2: 12 Months||221
8094949|NCT03313050|19955472|P2|Vaccinated|Stage 2: 12 Months||0
8094950|NCT03313050|19955473|P1|Vaccinated|Stage 2: 12 Months||0
8094951|NCT03313050|19955470|P4|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
8094952|NCT03313050|19955471|P3|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
8094953|NCT03313050|19955472|P2|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
8094954|NCT03313050|19955473|P1|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
8094955|NCT03313050|19955470|P4|NOT COMPLETED|Stage 1: 6 Months||0
8094956|NCT03313050|19955471|P3|NOT COMPLETED|Stage 1: 6 Months||0
8094957|NCT03313050|19955472|P2|NOT COMPLETED|Stage 1: 6 Months||0
8094958|NCT03313050|19955473|P1|NOT COMPLETED|Stage 1: 6 Months||0
8094959|NCT03313050|19955470|P4|COMPLETED|Stage 1: 6 Months||0
8094960|NCT03313050|19955471|P3|COMPLETED|Stage 1: 6 Months||0
8094961|NCT03313050|19955472|P2|COMPLETED|Stage 1: 6 Months||32
8094962|NCT03313050|19955473|P1|COMPLETED|Stage 1: 6 Months||34
8094963|NCT03313050|19955470|P4|Vaccinated|Stage 1: 6 Months||0
8094964|NCT03313050|19955471|P3|Vaccinated|Stage 1: 6 Months||0
8094965|NCT03313050|19955472|P2|Vaccinated|Stage 1: 6 Months||32
8094966|NCT03313050|19955473|P1|Vaccinated|Stage 1: 6 Months||34
8094967|NCT03313050|19955470|P4|STARTED|Stage 1: 6 Months||0
8094968|NCT03313050|19955471|P3|STARTED|Stage 1: 6 Months||0
8094969|NCT03313050|19955472|P2|STARTED|Stage 1: 6 Months||32
8094970|NCT03313050|19955473|P1|STARTED|Stage 1: 6 Months||34
8094971|NCT03313037|19955513|P2|NOT COMPLETED|Overall Study||20
8094972|NCT03313037|19955514|P1|NOT COMPLETED|Overall Study||20
8094973|NCT03313037|19955513|P2|COMPLETED|Overall Study||202
8094974|NCT03313037|19955514|P1|COMPLETED|Overall Study||202
8094975|NCT03313037|19955513|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||208
8094976|NCT03313037|19955514|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||210
8094977|NCT03313037|19955513|P2|Safety Population|Overall Study||222
8094978|NCT03313037|19955514|P1|Safety Population|Overall Study||221
8094979|NCT03313037|19955513|P2|STARTED|Overall Study||222
8094980|NCT03313037|19955514|P1|STARTED|Overall Study||222
8094981|NCT03312933|19955536|P1|NOT COMPLETED|Overall Study||54
8094982|NCT03312933|19955536|P1|COMPLETED|Overall Study||46
8094983|NCT03312933|19955536|P1|STARTED|Overall Study||100
8094984|NCT03312543|19955542|P2|NOT COMPLETED|Regression (Week 12 to Week 24)||2
8094985|NCT03312543|19955543|P1|NOT COMPLETED|Regression (Week 12 to Week 24)||1
8094986|NCT03312543|19955542|P2|COMPLETED|Regression (Week 12 to Week 24)||52
8094987|NCT03312543|19955543|P1|COMPLETED|Regression (Week 12 to Week 24)||55
8094988|NCT03312543|19955542|P2|STARTED|Regression (Week 12 to Week 24)||54
8094989|NCT03312543|19955543|P1|STARTED|Regression (Week 12 to Week 24)||56
8094990|NCT03312543|19955542|P2|NOT COMPLETED|Treatment (Baseline to Week 12)||5
8094991|NCT03312543|19955543|P1|NOT COMPLETED|Treatment (Baseline to Week 12)||4
8094992|NCT03312543|19955542|P2|COMPLETED|Treatment (Baseline to Week 12)||54
8094993|NCT03312543|19955543|P1|COMPLETED|Treatment (Baseline to Week 12)||56
8094994|NCT03312543|19955542|P2|STARTED|Treatment (Baseline to Week 12)||59
8094995|NCT03312543|19955543|P1|STARTED|Treatment (Baseline to Week 12)||60
8094996|NCT03312543|19955542|P2|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
8094997|NCT03312543|19955543|P1|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
8094998|NCT03312543|19955542|P2|COMPLETED|Before Treatment (Screening to Baseline)||59
8094999|NCT03312543|19955543|P1|COMPLETED|Before Treatment (Screening to Baseline)||60
8095000|NCT03312543|19955542|P2|STARTED|Before Treatment (Screening to Baseline)||63
8095001|NCT03312543|19955543|P1|STARTED|Before Treatment (Screening to Baseline)||61
8095002|NCT03312517|19955617|P6|NOT COMPLETED|Overall Study||0
8095003|NCT03312517|19955618|P5|NOT COMPLETED|Overall Study||0
8095004|NCT03312517|19955619|P4|NOT COMPLETED|Overall Study||0
8095005|NCT03312517|19955620|P3|NOT COMPLETED|Overall Study||0
8095006|NCT03312517|19955621|P2|NOT COMPLETED|Overall Study||0
8095007|NCT03312517|19955622|P1|NOT COMPLETED|Overall Study||0
8095008|NCT03312517|19955617|P6|COMPLETED|Overall Study||2
8095009|NCT03312517|19955618|P5|COMPLETED|Overall Study||2
8095010|NCT03312517|19955619|P4|COMPLETED|Overall Study||2
8095011|NCT03312517|19955620|P3|COMPLETED|Overall Study||2
8095012|NCT03312517|19955621|P2|COMPLETED|Overall Study||2
8095013|NCT03312517|19955622|P1|COMPLETED|Overall Study||2
8095014|NCT03312517|19955617|P6|STARTED|Overall Study||2
8095015|NCT03312517|19955618|P5|STARTED|Overall Study||2
8095016|NCT03312517|19955619|P4|STARTED|Overall Study||2
8095017|NCT03312517|19955620|P3|STARTED|Overall Study||2
8095018|NCT03312517|19955621|P2|STARTED|Overall Study||2
8095019|NCT03312517|19955622|P1|STARTED|Overall Study||2
8095020|NCT03312348|19955630|P1|NOT COMPLETED|Overall Study||0
8095021|NCT03312348|19955630|P1|COMPLETED|Overall Study||30
8095022|NCT03312348|19955630|P1|STARTED|Overall Study||30
8095023|NCT03312231|19955639|P5|NOT COMPLETED|Overall Study||1
8095024|NCT03312231|19955640|P4|NOT COMPLETED|Overall Study||3
8095025|NCT03312231|19955641|P3|NOT COMPLETED|Overall Study||4
8095026|NCT03312231|19955642|P2|NOT COMPLETED|Overall Study||11
8095027|NCT03312231|19955643|P1|NOT COMPLETED|Overall Study||3
8095028|NCT03312231|19955639|P5|COMPLETED|Overall Study||89
8095029|NCT03312231|19955640|P4|COMPLETED|Overall Study||86
8095030|NCT03312231|19955641|P3|COMPLETED|Overall Study||177
8095031|NCT03312231|19955642|P2|COMPLETED|Overall Study||165
8095032|NCT03312231|19955643|P1|COMPLETED|Overall Study||181
8095033|NCT03312231|19955639|P5|STARTED|Overall Study||90
8095034|NCT03312231|19955640|P4|STARTED|Overall Study||89
8095035|NCT03312231|19955641|P3|STARTED|Overall Study||181
8095036|NCT03312231|19955642|P2|STARTED|Overall Study||176
8095037|NCT03312231|19955643|P1|STARTED|Overall Study||184
8095038|NCT03312114|19955845|P1|NOT COMPLETED|Overall Study||5
8095039|NCT03312114|19955845|P1|COMPLETED|Overall Study||0
8095040|NCT03312114|19955845|P1|STARTED|Overall Study||5
8095041|NCT03311841|19955855|P5|NOT COMPLETED|Period 2||0
8095042|NCT03311841|19955856|P4|NOT COMPLETED|Period 2||0
8095043|NCT03311841|19955857|P3|NOT COMPLETED|Period 2||0
8095044|NCT03311841|19955858|P2|NOT COMPLETED|Period 2||0
8095045|NCT03311841|19955859|P1|NOT COMPLETED|Period 2||0
8095046|NCT03311841|19955855|P5|COMPLETED|Period 2||6
8095047|NCT03311841|19955856|P4|COMPLETED|Period 2||6
8095048|NCT03311841|19955857|P3|COMPLETED|Period 2||6
8095049|NCT03311841|19955858|P2|COMPLETED|Period 2||6
8095050|NCT03311841|19955859|P1|COMPLETED|Period 2||6
8095051|NCT03311841|19955855|P5|STARTED|Period 2||6
8095052|NCT03311841|19955856|P4|STARTED|Period 2||6
8095053|NCT03311841|19955857|P3|STARTED|Period 2||6
8095054|NCT03311841|19955858|P2|STARTED|Period 2||6
8095055|NCT03311841|19955859|P1|STARTED|Period 2||6
8095056|NCT03311841|19955855|P5|NOT COMPLETED|14-day Wash-out||0
8095057|NCT03311841|19955856|P4|NOT COMPLETED|14-day Wash-out||1
8095058|NCT03311841|19955857|P3|NOT COMPLETED|14-day Wash-out||0
8095059|NCT03311841|19955858|P2|NOT COMPLETED|14-day Wash-out||1
8095060|NCT03311841|19955859|P1|NOT COMPLETED|14-day Wash-out||0
8095061|NCT03311841|19955855|P5|COMPLETED|14-day Wash-out||6
8095062|NCT03311841|19955856|P4|COMPLETED|14-day Wash-out||6
8095063|NCT03311841|19955857|P3|COMPLETED|14-day Wash-out||6
8095064|NCT03311841|19955858|P2|COMPLETED|14-day Wash-out||6
8095065|NCT03311841|19955859|P1|COMPLETED|14-day Wash-out||6
8095066|NCT03311841|19955855|P5|STARTED|14-day Wash-out||6
8095067|NCT03311841|19955856|P4|STARTED|14-day Wash-out||7
8095068|NCT03311841|19955857|P3|STARTED|14-day Wash-out||6
8095069|NCT03311841|19955858|P2|STARTED|14-day Wash-out||7
8095070|NCT03311841|19955859|P1|STARTED|14-day Wash-out||6
8095071|NCT03311841|19955855|P5|NOT COMPLETED|Period 1||0
8095072|NCT03311841|19955856|P4|NOT COMPLETED|Period 1||0
8095073|NCT03311841|19955857|P3|NOT COMPLETED|Period 1||0
8095074|NCT03311841|19955858|P2|NOT COMPLETED|Period 1||0
8095075|NCT03311841|19955859|P1|NOT COMPLETED|Period 1||0
8095076|NCT03311841|19955855|P5|COMPLETED|Period 1||6
8095077|NCT03311841|19955856|P4|COMPLETED|Period 1||7
8095078|NCT03311841|19955857|P3|COMPLETED|Period 1||6
8095079|NCT03311841|19955858|P2|COMPLETED|Period 1||7
8095080|NCT03311841|19955859|P1|COMPLETED|Period 1||6
8095081|NCT03311841|19955855|P5|STARTED|Period 1||6
8095082|NCT03311841|19955856|P4|STARTED|Period 1||7
8095083|NCT03311841|19955857|P3|STARTED|Period 1||6
8095084|NCT03311841|19955858|P2|STARTED|Period 1||7
8095085|NCT03311841|19955859|P1|STARTED|Period 1||6
8095086|NCT03311659|19955960|P1|NOT COMPLETED|Overall Study||1
8095087|NCT03311659|19955960|P1|COMPLETED|Overall Study||446
8095088|NCT03311659|19955960|P1|STARTED|Overall Study||447
8095089|NCT03311646|19955975|P1|NOT COMPLETED|Overall Study||15
8095090|NCT03311646|19955975|P1|COMPLETED|Overall Study|Completed VLNC Condition|16
8095091|NCT03311646|19955975|P1|STARTED|Overall Study|Number who were eligible and consented.|31
8095092|NCT03311373|19955982|P1|NOT COMPLETED|Overall Study||9
8095093|NCT03311373|19955982|P1|COMPLETED|Overall Study||47
8095094|NCT03311373|19955982|P1|STARTED|Overall Study||56
8095095|NCT03311230|19956040|P4|NOT COMPLETED|Overall Study||7
8095096|NCT03311230|19956041|P3|NOT COMPLETED|Overall Study||2
8095097|NCT03311230|19956042|P2|NOT COMPLETED|Overall Study||5
8095098|NCT03311230|19956043|P1|NOT COMPLETED|Overall Study||1
8095099|NCT03311230|19956040|P4|COMPLETED|Overall Study||143
8095100|NCT03311230|19956041|P3|COMPLETED|Overall Study||148
8095101|NCT03311230|19956042|P2|COMPLETED|Overall Study||146
8095102|NCT03311230|19956043|P1|COMPLETED|Overall Study||150
8095103|NCT03311230|19956040|P4|STARTED|Overall Study||150
8095104|NCT03311230|19956041|P3|STARTED|Overall Study||150
8095105|NCT03311230|19956042|P2|STARTED|Overall Study||151
8095106|NCT03311230|19956043|P1|STARTED|Overall Study||151
8095107|NCT03310775|19956067|P2|NOT COMPLETED|Overall Study||4
8095108|NCT03310775|19956068|P1|NOT COMPLETED|Overall Study||2
8095109|NCT03310775|19956067|P2|COMPLETED|Overall Study||14
8095110|NCT03310775|19956068|P1|COMPLETED|Overall Study||17
8095111|NCT03310775|19956067|P2|STARTED|Overall Study||18
8095112|NCT03310775|19956068|P1|STARTED|Overall Study||19
8095113|NCT03310723|19956086|P2|NOT COMPLETED|Overall Study||3
8095114|NCT03310723|19956087|P1|NOT COMPLETED|Overall Study||0
8095115|NCT03310723|19956086|P2|COMPLETED|Overall Study||17
8095116|NCT03310723|19956087|P1|COMPLETED|Overall Study||20
8095117|NCT03310723|19956086|P2|STARTED|Overall Study||20
8095118|NCT03310723|19956087|P1|STARTED|Overall Study||20
8095119|NCT03310580|19956098|P3|NOT COMPLETED|Overall Study||0
8095120|NCT03310580|19956099|P2|NOT COMPLETED|Overall Study||1
8095121|NCT03310580|19956100|P1|NOT COMPLETED|Overall Study||0
8095122|NCT03310580|19956098|P3|COMPLETED|Overall Study||12
8095123|NCT03310580|19956099|P2|COMPLETED|Overall Study||14
8095124|NCT03310580|19956100|P1|COMPLETED|Overall Study||15
8095125|NCT03310580|19956098|P3|STARTED|Overall Study||12
8095126|NCT03310580|19956099|P2|STARTED|Overall Study||15
8095127|NCT03310580|19956100|P1|STARTED|Overall Study||15
8095128|NCT03310450|19956114|P3|NOT COMPLETED|Overall Study||0
8095129|NCT03310450|19956115|P2|NOT COMPLETED|Overall Study||4
8095130|NCT03310450|19956116|P1|NOT COMPLETED|Overall Study||2
8095131|NCT03310450|19956114|P3|COMPLETED|Overall Study||28
8095132|NCT03310450|19956115|P2|COMPLETED|Overall Study||30
8095133|NCT03310450|19956116|P1|COMPLETED|Overall Study||30
8095134|NCT03310450|19956114|P3|STARTED|Overall Study||28
8095135|NCT03310450|19956115|P2|STARTED|Overall Study||34
8095136|NCT03310450|19956116|P1|STARTED|Overall Study||32
8095137|NCT03310411|19956133|P4|NOT COMPLETED|Period Title: Period 4||0
8095138|NCT03310411|19956134|P3|NOT COMPLETED|Period Title: Period 4||0
8095139|NCT03310411|19956135|P2|NOT COMPLETED|Period Title: Period 4||0
8095140|NCT03310411|19956136|P1|NOT COMPLETED|Period Title: Period 4||0
8095141|NCT03310411|19956133|P4|COMPLETED|Period Title: Period 4||9
8095142|NCT03310411|19956134|P3|COMPLETED|Period Title: Period 4||10
8095143|NCT03310411|19956135|P2|COMPLETED|Period Title: Period 4||10
8095144|NCT03310411|19956136|P1|COMPLETED|Period Title: Period 4||10
8095145|NCT03310411|19956133|P4|STARTED|Period Title: Period 4||9
8095146|NCT03310411|19956134|P3|STARTED|Period Title: Period 4||10
8095147|NCT03310411|19956135|P2|STARTED|Period Title: Period 4||10
8095148|NCT03310411|19956136|P1|STARTED|Period Title: Period 4||10
8095149|NCT03310411|19956133|P4|NOT COMPLETED|Period 3||0
8095150|NCT03310411|19956134|P3|NOT COMPLETED|Period 3||0
8095151|NCT03310411|19956135|P2|NOT COMPLETED|Period 3||0
8095152|NCT03310411|19956136|P1|NOT COMPLETED|Period 3||0
8095153|NCT03310411|19956133|P4|COMPLETED|Period 3||9
8095154|NCT03310411|19956134|P3|COMPLETED|Period 3||10
8095155|NCT03310411|19956135|P2|COMPLETED|Period 3||10
8095156|NCT03310411|19956136|P1|COMPLETED|Period 3||10
8095157|NCT03310411|19956133|P4|STARTED|Period 3||9
8095158|NCT03310411|19956134|P3|STARTED|Period 3||10
8095159|NCT03310411|19956135|P2|STARTED|Period 3||10
8095160|NCT03310411|19956136|P1|STARTED|Period 3||10
8095161|NCT03310411|19956133|P4|NOT COMPLETED|Period 2||0
8095162|NCT03310411|19956134|P3|NOT COMPLETED|Period 2||0
8095163|NCT03310411|19956135|P2|NOT COMPLETED|Period 2||0
8095164|NCT03310411|19956136|P1|NOT COMPLETED|Period 2||0
8095165|NCT03310411|19956133|P4|COMPLETED|Period 2||9
8095166|NCT03310411|19956134|P3|COMPLETED|Period 2||10
8095167|NCT03310411|19956135|P2|COMPLETED|Period 2||10
8095168|NCT03310411|19956136|P1|COMPLETED|Period 2||10
8095169|NCT03310411|19956133|P4|STARTED|Period 2||9
8095170|NCT03310411|19956134|P3|STARTED|Period 2||10
8095171|NCT03310411|19956135|P2|STARTED|Period 2||10
8095172|NCT03310411|19956136|P1|STARTED|Period 2||10
8095173|NCT03310411|19956133|P4|NOT COMPLETED|Period 1||1
8095174|NCT03310411|19956134|P3|NOT COMPLETED|Period 1||0
8095175|NCT03310411|19956135|P2|NOT COMPLETED|Period 1||0
8095176|NCT03310411|19956136|P1|NOT COMPLETED|Period 1||0
8095177|NCT03310411|19956133|P4|COMPLETED|Period 1||9
8095178|NCT03310411|19956134|P3|COMPLETED|Period 1||10
8095179|NCT03310411|19956135|P2|COMPLETED|Period 1||10
8095180|NCT03310411|19956136|P1|COMPLETED|Period 1||10
8095181|NCT03310411|19956133|P4|Received at Least 1 Dose of Study Drug|Period 1||10
8095182|NCT03310411|19956134|P3|Received at Least 1 Dose of Study Drug|Period 1||10
8095183|NCT03310411|19956135|P2|Received at Least 1 Dose of Study Drug|Period 1||10
8095184|NCT03310411|19956136|P1|Received at Least 1 Dose of Study Drug|Period 1||10
8095185|NCT03310411|19956133|P4|STARTED|Period 1||10
8095186|NCT03310411|19956134|P3|STARTED|Period 1||10
8095187|NCT03310411|19956135|P2|STARTED|Period 1||10
8095188|NCT03310411|19956136|P1|STARTED|Period 1||10
8095189|NCT03310268|19956157|P3|NOT COMPLETED|Overall Study||0
8095190|NCT03310268|19956158|P2|NOT COMPLETED|Overall Study||5
8095191|NCT03310268|19956159|P1|NOT COMPLETED|Overall Study||1
8095192|NCT03310268|19956157|P3|COMPLETED|Overall Study||61
8095193|NCT03310268|19956158|P2|COMPLETED|Overall Study||57
8095194|NCT03310268|19956159|P1|COMPLETED|Overall Study||61
8095195|NCT03310268|19956157|P3|STARTED|Overall Study||61
8095196|NCT03310268|19956158|P2|STARTED|Overall Study||62
8095197|NCT03310268|19956159|P1|STARTED|Overall Study||62
8095198|NCT03310021|19956190|P20|NOT COMPLETED|Overall Study||0
8095199|NCT03310021|19956191|P19|NOT COMPLETED|Overall Study||0
8095200|NCT03310021|19956192|P18|NOT COMPLETED|Overall Study||0
8095201|NCT03310021|19956193|P17|NOT COMPLETED|Overall Study||0
8095202|NCT03310021|19956194|P16|NOT COMPLETED|Overall Study||0
8095203|NCT03310021|19956195|P15|NOT COMPLETED|Overall Study||0
8095204|NCT03310021|19956196|P14|NOT COMPLETED|Overall Study||0
8095205|NCT03310021|19956197|P13|NOT COMPLETED|Overall Study||0
8095206|NCT03310021|19956198|P12|NOT COMPLETED|Overall Study||0
8095207|NCT03310021|19956199|P11|NOT COMPLETED|Overall Study||1
8095208|NCT03310021|19956200|P10|NOT COMPLETED|Overall Study||0
8095209|NCT03310021|19956201|P9|NOT COMPLETED|Overall Study||0
8095210|NCT03310021|19956202|P8|NOT COMPLETED|Overall Study||0
8095211|NCT03310021|19956203|P7|NOT COMPLETED|Overall Study||1
8095212|NCT03310021|19956204|P6|NOT COMPLETED|Overall Study||0
8095213|NCT03310021|19956205|P5|NOT COMPLETED|Overall Study||0
8095214|NCT03310021|19956206|P4|NOT COMPLETED|Overall Study||0
8095215|NCT03310021|19956207|P3|NOT COMPLETED|Overall Study||0
8095216|NCT03310021|19956208|P2|NOT COMPLETED|Overall Study||0
8095217|NCT03310021|19956209|P1|NOT COMPLETED|Overall Study||0
8095218|NCT03310021|19956190|P20|COMPLETED|Overall Study||3
8095219|NCT03310021|19956191|P19|COMPLETED|Overall Study||8
8095220|NCT03310021|19956192|P18|COMPLETED|Overall Study||5
8095221|NCT03310021|19956193|P17|COMPLETED|Overall Study||10
8095222|NCT03310021|19956194|P16|COMPLETED|Overall Study||3
8095223|NCT03310021|19956195|P15|COMPLETED|Overall Study||6
8095224|NCT03310021|19956196|P14|COMPLETED|Overall Study||4
8095225|NCT03310021|19956197|P13|COMPLETED|Overall Study||8
8095226|NCT03310021|19956198|P12|COMPLETED|Overall Study||3
8095227|NCT03310021|19956199|P11|COMPLETED|Overall Study||5
8095228|NCT03310021|19956200|P10|COMPLETED|Overall Study||3
8095229|NCT03310021|19956201|P9|COMPLETED|Overall Study||6
8095230|NCT03310021|19956202|P8|COMPLETED|Overall Study||4
8095231|NCT03310021|19956203|P7|COMPLETED|Overall Study||7
8095232|NCT03310021|19956204|P6|COMPLETED|Overall Study||4
8095233|NCT03310021|19956205|P5|COMPLETED|Overall Study||8
8095234|NCT03310021|19956206|P4|COMPLETED|Overall Study||3
8095235|NCT03310021|19956207|P3|COMPLETED|Overall Study||6
8095236|NCT03310021|19956208|P2|COMPLETED|Overall Study||3
8095237|NCT03310021|19956209|P1|COMPLETED|Overall Study||6
8095238|NCT03310021|19956190|P20|STARTED|Overall Study||3
8095239|NCT03310021|19956191|P19|STARTED|Overall Study||8
8095240|NCT03310021|19956192|P18|STARTED|Overall Study||5
8095241|NCT03310021|19956193|P17|STARTED|Overall Study||10
8095242|NCT03310021|19956194|P16|STARTED|Overall Study||3
8095243|NCT03310021|19956195|P15|STARTED|Overall Study||6
8095244|NCT03310021|19956196|P14|STARTED|Overall Study||4
8095245|NCT03310021|19956197|P13|STARTED|Overall Study||8
8095246|NCT03310021|19956198|P12|STARTED|Overall Study||3
8095247|NCT03310021|19956199|P11|STARTED|Overall Study||6
8095248|NCT03310021|19956200|P10|STARTED|Overall Study||3
8095249|NCT03310021|19956201|P9|STARTED|Overall Study||6
8095250|NCT03310021|19956202|P8|STARTED|Overall Study||4
8095251|NCT03310021|19956203|P7|STARTED|Overall Study||8
8095252|NCT03310021|19956204|P6|STARTED|Overall Study||4
8095253|NCT03310021|19956205|P5|STARTED|Overall Study||8
8095254|NCT03310021|19956206|P4|STARTED|Overall Study||3
8095255|NCT03310021|19956207|P3|STARTED|Overall Study||6
8095256|NCT03310021|19956208|P2|STARTED|Overall Study||3
8095257|NCT03310021|19956209|P1|STARTED|Overall Study||6
8095258|NCT03309943|19956353|P2|NOT COMPLETED|Overall Study||2
8095259|NCT03309943|19956354|P1|NOT COMPLETED|Overall Study||0
8095260|NCT03309943|19956353|P2|COMPLETED|Overall Study||20
8095261|NCT03309943|19956354|P1|COMPLETED|Overall Study||22
8095262|NCT03309943|19956353|P2|STARTED|Overall Study||22
8095263|NCT03309943|19956354|P1|STARTED|Overall Study||22
8095264|NCT03309787|19956383|P3|NOT COMPLETED|Overall Study||2
8095265|NCT03309787|19956384|P2|NOT COMPLETED|Overall Study||6
8095266|NCT03309787|19956385|P1|NOT COMPLETED|Overall Study||2
8095267|NCT03309787|19956383|P3|COMPLETED|Overall Study||7
8095268|NCT03309787|19956384|P2|COMPLETED|Overall Study||14
8095269|NCT03309787|19956385|P1|COMPLETED|Overall Study||6
8095270|NCT03309787|19956383|P3|STARTED|Overall Study||9
8095271|NCT03309787|19956384|P2|STARTED|Overall Study||20
8095272|NCT03309787|19956385|P1|STARTED|Overall Study||8
8095273|NCT03309696|19956417|P4|NOT COMPLETED|Overall Study||0
8095274|NCT03309696|19956418|P3|NOT COMPLETED|Overall Study||0
8095275|NCT03309696|19956419|P2|NOT COMPLETED|Overall Study||5
8095276|NCT03309696|19956420|P1|NOT COMPLETED|Overall Study||0
8095277|NCT03309696|19956417|P4|COMPLETED|Overall Study||0
8095278|NCT03309696|19956418|P3|COMPLETED|Overall Study||0
8095279|NCT03309696|19956419|P2|COMPLETED|Overall Study||0
8095280|NCT03309696|19956420|P1|COMPLETED|Overall Study||5
8095281|NCT03309696|19956417|P4|STARTED|Overall Study||0
8095282|NCT03309696|19956418|P3|STARTED|Overall Study||0
8095283|NCT03309696|19956419|P2|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
8095284|NCT03309696|19956420|P1|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
8095285|NCT03309657|19956428|P1|NOT COMPLETED|Overall Study||0
8095286|NCT03309657|19956428|P1|COMPLETED|Overall Study||10
8095287|NCT03309657|19956428|P1|STARTED|Overall Study||10
8095288|NCT03309202|19956439|P4|NOT COMPLETED|Overall Study||0
8095289|NCT03309202|19956440|P3|NOT COMPLETED|Overall Study||0
8095290|NCT03309202|19956441|P2|NOT COMPLETED|Overall Study||0
8095291|NCT03309202|19956442|P1|NOT COMPLETED|Overall Study||1
8095292|NCT03309202|19956439|P4|COMPLETED|Overall Study||6
8095293|NCT03309202|19956440|P3|COMPLETED|Overall Study||6
8095294|NCT03309202|19956441|P2|COMPLETED|Overall Study||6
8095295|NCT03309202|19956442|P1|COMPLETED|Overall Study||5
8095296|NCT03309202|19956439|P4|STARTED|Overall Study||6
8095297|NCT03309202|19956440|P3|STARTED|Overall Study||6
8095298|NCT03309202|19956441|P2|STARTED|Overall Study||6
8095299|NCT03309202|19956442|P1|STARTED|Overall Study||6
8095300|NCT03309072|19956526|P2|NOT COMPLETED|Overall Study||0
8095301|NCT03309072|19956527|P1|NOT COMPLETED|Overall Study||0
8095302|NCT03309072|19956526|P2|COMPLETED|Overall Study||15
8095303|NCT03309072|19956527|P1|COMPLETED|Overall Study||15
8095304|NCT03309072|19956526|P2|STARTED|Overall Study||15
8095305|NCT03309072|19956527|P1|STARTED|Overall Study||15
8095306|NCT03308968|19956536|P3|NOT COMPLETED|Open-Label Period (12 Weeks)||12
8095307|NCT03308968|19956537|P2|NOT COMPLETED|Open-Label Period (12 Weeks)||12
8095308|NCT03308968|19956538|P1|NOT COMPLETED|Open-Label Period (12 Weeks)||11
8095309|NCT03308968|19956536|P3|COMPLETED|Open-Label Period (12 Weeks)||260
8095310|NCT03308968|19956537|P2|COMPLETED|Open-Label Period (12 Weeks)||259
8095311|NCT03308968|19956538|P1|COMPLETED|Open-Label Period (12 Weeks)||253
8095312|NCT03308968|19956536|P3|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
8095313|NCT03308968|19956537|P2|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
8095314|NCT03308968|19956538|P1|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
8095315|NCT03308968|19956536|P3|STARTED|Open-Label Period (12 Weeks)||272
8095316|NCT03308968|19956537|P2|STARTED|Open-Label Period (12 Weeks)||271
8095317|NCT03308968|19956538|P1|STARTED|Open-Label Period (12 Weeks)||264
8095318|NCT03308968|19956536|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
8095319|NCT03308968|19956537|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
8095320|NCT03308968|19956538|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
8095321|NCT03308968|19956536|P3|COMPLETED|Double-Blind Period (12 Weeks)||272
8095322|NCT03308968|19956537|P2|COMPLETED|Double-Blind Period (12 Weeks)||271
8095323|NCT03308968|19956538|P1|COMPLETED|Double-Blind Period (12 Weeks)||264
8095324|NCT03308968|19956536|P3|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
8095325|NCT03308968|19956537|P2|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
8095326|NCT03308968|19956538|P1|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
8095327|NCT03308968|19956536|P3|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
8095328|NCT03308968|19956537|P2|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
8095329|NCT03308968|19956538|P1|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
8095330|NCT03308968|19956536|P3|STARTED|Double-Blind Period (12 Weeks)||283
8095331|NCT03308968|19956537|P2|STARTED|Double-Blind Period (12 Weeks)||276
8095332|NCT03308968|19956538|P1|STARTED|Double-Blind Period (12 Weeks)||279
8095333|NCT03308825|19956616|P4|NOT COMPLETED|Overall Study||0
8095334|NCT03308825|19956617|P3|NOT COMPLETED|Overall Study||1
8095335|NCT03308825|19956618|P2|NOT COMPLETED|Overall Study||4
8095336|NCT03308825|19956619|P1|NOT COMPLETED|Overall Study||2
8095337|NCT03308825|19956616|P4|COMPLETED|Overall Study||60
8095338|NCT03308825|19956617|P3|COMPLETED|Overall Study||59
8095339|NCT03308825|19956618|P2|COMPLETED|Overall Study||57
8095340|NCT03308825|19956619|P1|COMPLETED|Overall Study||57
8095341|NCT03308825|19956616|P4|STARTED|Overall Study||60
8095342|NCT03308825|19956617|P3|STARTED|Overall Study||60
8095343|NCT03308825|19956618|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
8095344|NCT03308825|19956619|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
8095345|NCT03308799|19956648|P3|NOT COMPLETED|Overall Study||21
8095346|NCT03308799|19956649|P2|NOT COMPLETED|Overall Study||28
8095347|NCT03308799|19956650|P1|NOT COMPLETED|Overall Study||22
8095348|NCT03308799|19956648|P3|COMPLETED|Overall Study||94
8095349|NCT03308799|19956649|P2|COMPLETED|Overall Study||309
8095350|NCT03308799|19956650|P1|COMPLETED|Overall Study||320
8095351|NCT03308799|19956648|P3|STARTED|Overall Study||115
8095352|NCT03308799|19956649|P2|STARTED|Overall Study||337
8095353|NCT03308799|19956650|P1|STARTED|Overall Study||342
8095354|NCT03308669|19956666|P2|NOT COMPLETED|Overall Study||0
8095355|NCT03308669|19956667|P1|NOT COMPLETED|Overall Study||0
8095356|NCT03308669|19956666|P2|COMPLETED|Overall Study||20
8095357|NCT03308669|19956667|P1|COMPLETED|Overall Study||10
8095358|NCT03308669|19956666|P2|Received at Least One Dose of Study Drug|Overall Study||20
8095359|NCT03308669|19956667|P1|Received at Least One Dose of Study Drug|Overall Study||10
8095360|NCT03308669|19956666|P2|STARTED|Overall Study||20
8095361|NCT03308669|19956667|P1|STARTED|Overall Study||10
8095362|NCT03308058|19956689|P2|NOT COMPLETED|Overall Study||0
8095363|NCT03308058|19956690|P1|NOT COMPLETED|Overall Study||0
8095364|NCT03308058|19956689|P2|COMPLETED|Overall Study||23
8095365|NCT03308058|19956690|P1|COMPLETED|Overall Study||23
8095366|NCT03308058|19956689|P2|STARTED|Overall Study||23
8095367|NCT03308058|19956690|P1|STARTED|Overall Study||23
8095368|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 4||0
8095369|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 4||0
8095370|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 4||0
8095371|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 4||0
8095372|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 4||0
8095373|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 4||0
8095374|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 4||0
8095375|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 4||0
8095376|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 4||0
8095377|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 4||0
8095378|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 4||0
8095379|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 4||3
8095380|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 4||4
8095381|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 4||4
8095382|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 4||4
8095383|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 4||0
8095384|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 4||0
8095385|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 4||0
8095386|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 4||0
8095387|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 4||0
8095388|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 4||0
8095389|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 4||0
8095390|NCT03307252|19956707|P11|STARTED|Part 3, Period 4||3
8095391|NCT03307252|19956708|P10|STARTED|Part 3, Period 4||4
8095392|NCT03307252|19956709|P9|STARTED|Part 3, Period 4||4
8095393|NCT03307252|19956710|P8|STARTED|Part 3, Period 4||4
8095394|NCT03307252|19956711|P7|STARTED|Part 3, Period 4||0
8095395|NCT03307252|19956712|P6|STARTED|Part 3, Period 4||0
8095396|NCT03307252|19956713|P5|STARTED|Part 3, Period 4||0
8095397|NCT03307252|19956714|P4|STARTED|Part 3, Period 4||0
8095398|NCT03307252|19956715|P3|STARTED|Part 3, Period 4||0
8095399|NCT03307252|19956716|P2|STARTED|Part 3, Period 4||0
8095400|NCT03307252|19956717|P1|STARTED|Part 3, Period 4||0
8095401|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
8095402|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095403|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095404|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095405|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095406|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095407|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095408|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095409|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095410|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095411|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095412|NCT03307252|19956707|P11|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
8095413|NCT03307252|19956708|P10|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
8095414|NCT03307252|19956709|P9|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
8095415|NCT03307252|19956710|P8|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
8095416|NCT03307252|19956711|P7|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095417|NCT03307252|19956712|P6|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095418|NCT03307252|19956713|P5|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095419|NCT03307252|19956714|P4|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095420|NCT03307252|19956715|P3|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095421|NCT03307252|19956716|P2|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095422|NCT03307252|19956717|P1|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095423|NCT03307252|19956707|P11|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095424|NCT03307252|19956708|P10|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095425|NCT03307252|19956709|P9|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095426|NCT03307252|19956710|P8|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095427|NCT03307252|19956711|P7|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095428|NCT03307252|19956712|P6|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095429|NCT03307252|19956713|P5|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095430|NCT03307252|19956714|P4|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095431|NCT03307252|19956715|P3|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095432|NCT03307252|19956716|P2|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095433|NCT03307252|19956717|P1|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095434|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 3||0
8095435|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 3||0
8095436|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 3||0
8095437|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 3||0
8095438|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 3||0
8095439|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 3||0
8095440|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 3||0
8095441|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 3||0
8095442|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 3||0
8095443|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 3||0
8095444|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 3||0
8095445|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 3||4
8095446|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 3||4
8095447|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 3||4
8095448|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 3||4
8095449|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 3||0
8095450|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 3||0
8095451|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 3||0
8095452|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 3||0
8095453|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 3||0
8095454|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 3||0
8095455|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 3||0
8095456|NCT03307252|19956707|P11|STARTED|Part 3, Period 3||4
8095457|NCT03307252|19956708|P10|STARTED|Part 3, Period 3||4
8095458|NCT03307252|19956709|P9|STARTED|Part 3, Period 3||4
8095459|NCT03307252|19956710|P8|STARTED|Part 3, Period 3||4
8095460|NCT03307252|19956711|P7|STARTED|Part 3, Period 3||0
8095461|NCT03307252|19956712|P6|STARTED|Part 3, Period 3||0
8095462|NCT03307252|19956713|P5|STARTED|Part 3, Period 3||0
8095463|NCT03307252|19956714|P4|STARTED|Part 3, Period 3||0
8095464|NCT03307252|19956715|P3|STARTED|Part 3, Period 3||0
8095465|NCT03307252|19956716|P2|STARTED|Part 3, Period 3||0
8095466|NCT03307252|19956717|P1|STARTED|Part 3, Period 3||0
8095467|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095468|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095469|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095470|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095471|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095472|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095473|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095474|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095475|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095476|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095477|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095478|NCT03307252|19956707|P11|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095479|NCT03307252|19956708|P10|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095480|NCT03307252|19956709|P9|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095481|NCT03307252|19956710|P8|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095482|NCT03307252|19956711|P7|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095483|NCT03307252|19956712|P6|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095484|NCT03307252|19956713|P5|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095485|NCT03307252|19956714|P4|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095486|NCT03307252|19956715|P3|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095487|NCT03307252|19956716|P2|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095488|NCT03307252|19956717|P1|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095489|NCT03307252|19956707|P11|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095490|NCT03307252|19956708|P10|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095491|NCT03307252|19956709|P9|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095492|NCT03307252|19956710|P8|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095493|NCT03307252|19956711|P7|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095494|NCT03307252|19956712|P6|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095495|NCT03307252|19956713|P5|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095496|NCT03307252|19956714|P4|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095497|NCT03307252|19956715|P3|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095498|NCT03307252|19956716|P2|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095499|NCT03307252|19956717|P1|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095500|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 2||0
8095501|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 2||0
8095502|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 2||0
8095503|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 2||0
8095504|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 2||0
8095505|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 2||0
8095506|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 2||0
8095507|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 2||0
8095508|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 2||0
8095509|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 2||0
8095510|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 2||0
8095511|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 2||4
8095512|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 2||4
8095513|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 2||4
8095514|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 2||4
8095515|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 2||0
8095516|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 2||0
8095517|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 2||0
8095518|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 2||0
8095519|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 2||0
8095520|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 2||0
8095521|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 2||0
8095522|NCT03307252|19956707|P11|STARTED|Part 3, Period 2||4
8095523|NCT03307252|19956708|P10|STARTED|Part 3, Period 2||4
8095524|NCT03307252|19956709|P9|STARTED|Part 3, Period 2||4
8095525|NCT03307252|19956710|P8|STARTED|Part 3, Period 2||4
8095526|NCT03307252|19956711|P7|STARTED|Part 3, Period 2||0
8095527|NCT03307252|19956712|P6|STARTED|Part 3, Period 2||0
8095528|NCT03307252|19956713|P5|STARTED|Part 3, Period 2||0
8095529|NCT03307252|19956714|P4|STARTED|Part 3, Period 2||0
8095530|NCT03307252|19956715|P3|STARTED|Part 3, Period 2||0
8095531|NCT03307252|19956716|P2|STARTED|Part 3, Period 2||0
8095532|NCT03307252|19956717|P1|STARTED|Part 3, Period 2||0
8095533|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095534|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095535|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095536|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095537|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095538|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095539|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095540|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095541|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095542|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095543|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095544|NCT03307252|19956707|P11|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095545|NCT03307252|19956708|P10|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095546|NCT03307252|19956709|P9|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095547|NCT03307252|19956710|P8|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095548|NCT03307252|19956711|P7|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095549|NCT03307252|19956712|P6|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095550|NCT03307252|19956713|P5|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095551|NCT03307252|19956714|P4|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095552|NCT03307252|19956715|P3|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095553|NCT03307252|19956716|P2|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095554|NCT03307252|19956717|P1|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095555|NCT03307252|19956707|P11|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095556|NCT03307252|19956708|P10|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095557|NCT03307252|19956709|P9|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095558|NCT03307252|19956710|P8|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095559|NCT03307252|19956711|P7|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095560|NCT03307252|19956712|P6|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095561|NCT03307252|19956713|P5|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095562|NCT03307252|19956714|P4|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095563|NCT03307252|19956715|P3|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095564|NCT03307252|19956716|P2|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095565|NCT03307252|19956717|P1|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095566|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 1||0
8095567|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 1||0
8095568|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 1||0
8095569|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 1||0
8095570|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 1||0
8095571|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 1||0
8095572|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 1||0
8095573|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 1||0
8095574|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 1||0
8095575|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 1||0
8095576|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 1||0
8095577|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095578|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095579|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095580|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095581|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 1||0
8095582|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 1||0
8095583|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 1||0
8095584|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 1||0
8095585|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 1||0
8095586|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 1||0
8095587|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 1||0
8095588|NCT03307252|19956707|P11|STARTED|Part 3, Period 1||4
8095589|NCT03307252|19956708|P10|STARTED|Part 3, Period 1||4
8095590|NCT03307252|19956709|P9|STARTED|Part 3, Period 1||4
8095591|NCT03307252|19956710|P8|STARTED|Part 3, Period 1||4
8095592|NCT03307252|19956711|P7|STARTED|Part 3, Period 1||0
8095593|NCT03307252|19956712|P6|STARTED|Part 3, Period 1||0
8095594|NCT03307252|19956713|P5|STARTED|Part 3, Period 1||0
8095595|NCT03307252|19956714|P4|STARTED|Part 3, Period 1||0
8095596|NCT03307252|19956715|P3|STARTED|Part 3, Period 1||0
8095597|NCT03307252|19956716|P2|STARTED|Part 3, Period 1||0
8095598|NCT03307252|19956717|P1|STARTED|Part 3, Period 1||0
8095599|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 4||0
8095600|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 4||0
8095601|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 4||0
8095602|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 4||0
8095603|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 4||1
8095604|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 4||0
8095605|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 4||0
8095606|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 4||0
8095607|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 4||0
8095608|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 4||0
8095609|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 4||0
8095610|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 4||0
8095611|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 4||0
8095612|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 4||0
8095613|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 4||0
8095614|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 4||4
8095615|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 4||3
8095616|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 4||3
8095617|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 4||4
8095618|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 4||0
8095619|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 4||0
8095620|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 4||0
8095621|NCT03307252|19956707|P11|STARTED|Part 2, Period 4||0
8095622|NCT03307252|19956708|P10|STARTED|Part 2, Period 4||0
8095623|NCT03307252|19956709|P9|STARTED|Part 2, Period 4||0
8095624|NCT03307252|19956710|P8|STARTED|Part 2, Period 4||0
8095625|NCT03307252|19956711|P7|STARTED|Part 2, Period 4||5
8095626|NCT03307252|19956712|P6|STARTED|Part 2, Period 4||3
8095627|NCT03307252|19956713|P5|STARTED|Part 2, Period 4||3
8095628|NCT03307252|19956714|P4|STARTED|Part 2, Period 4||4
8095629|NCT03307252|19956715|P3|STARTED|Part 2, Period 4||0
8095630|NCT03307252|19956716|P2|STARTED|Part 2, Period 4||0
8095631|NCT03307252|19956717|P1|STARTED|Part 2, Period 4||0
8095632|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095633|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095634|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095635|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095636|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
8095637|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095638|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095639|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095640|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095641|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095642|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095643|NCT03307252|19956707|P11|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095644|NCT03307252|19956708|P10|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095645|NCT03307252|19956709|P9|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095646|NCT03307252|19956710|P8|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095647|NCT03307252|19956711|P7|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
8095648|NCT03307252|19956712|P6|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
8095649|NCT03307252|19956713|P5|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
8095650|NCT03307252|19956714|P4|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
8095651|NCT03307252|19956715|P3|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095652|NCT03307252|19956716|P2|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095653|NCT03307252|19956717|P1|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095654|NCT03307252|19956707|P11|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095655|NCT03307252|19956708|P10|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095656|NCT03307252|19956709|P9|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095657|NCT03307252|19956710|P8|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095658|NCT03307252|19956711|P7|STARTED|Part 2, Washout Period 3 (7 Days)||5
8095659|NCT03307252|19956712|P6|STARTED|Part 2, Washout Period 3 (7 Days)||3
8095660|NCT03307252|19956713|P5|STARTED|Part 2, Washout Period 3 (7 Days)||3
8095661|NCT03307252|19956714|P4|STARTED|Part 2, Washout Period 3 (7 Days)||4
8095662|NCT03307252|19956715|P3|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095663|NCT03307252|19956716|P2|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095664|NCT03307252|19956717|P1|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095665|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 3||0
8095666|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 3||0
8095667|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 3||0
8095668|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 3||0
8095669|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 3||0
8095670|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 3||0
8095671|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 3||1
8095672|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 3||0
8095673|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 3||0
8095674|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 3||0
8095675|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 3||0
8095676|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 3||0
8095677|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 3||0
8095678|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 3||0
8095679|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 3||0
8095680|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 3||5
8095681|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 3||3
8095682|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 3||3
8095683|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 3||4
8095684|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 3||0
8095685|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 3||0
8095686|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 3||0
8095687|NCT03307252|19956707|P11|STARTED|Part 2, Period 3||0
8095688|NCT03307252|19956708|P10|STARTED|Part 2, Period 3||0
8095689|NCT03307252|19956709|P9|STARTED|Part 2, Period 3||0
8095690|NCT03307252|19956710|P8|STARTED|Part 2, Period 3||0
8095691|NCT03307252|19956711|P7|STARTED|Part 2, Period 3||5
8095692|NCT03307252|19956712|P6|STARTED|Part 2, Period 3||3
8095693|NCT03307252|19956713|P5|STARTED|Part 2, Period 3||4
8095694|NCT03307252|19956714|P4|STARTED|Part 2, Period 3||4
8095695|NCT03307252|19956715|P3|STARTED|Part 2, Period 3||0
8095696|NCT03307252|19956716|P2|STARTED|Part 2, Period 3||0
8095697|NCT03307252|19956717|P1|STARTED|Part 2, Period 3||0
8095698|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095699|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095700|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095701|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095702|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095703|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095704|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095705|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095706|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095707|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095708|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095709|NCT03307252|19956707|P11|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095710|NCT03307252|19956708|P10|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095711|NCT03307252|19956709|P9|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095712|NCT03307252|19956710|P8|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095713|NCT03307252|19956711|P7|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
8095714|NCT03307252|19956712|P6|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
8095715|NCT03307252|19956713|P5|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
8095716|NCT03307252|19956714|P4|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
8095717|NCT03307252|19956715|P3|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095718|NCT03307252|19956716|P2|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095719|NCT03307252|19956717|P1|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095720|NCT03307252|19956707|P11|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095721|NCT03307252|19956708|P10|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095722|NCT03307252|19956709|P9|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095723|NCT03307252|19956710|P8|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095724|NCT03307252|19956711|P7|STARTED|Part 2, Washout Period 2 (7 Days)||5
8095725|NCT03307252|19956712|P6|STARTED|Part 2, Washout Period 2 (7 Days)||3
8095726|NCT03307252|19956713|P5|STARTED|Part 2, Washout Period 2 (7 Days)||4
8095727|NCT03307252|19956714|P4|STARTED|Part 2, Washout Period 2 (7 Days)||4
8095728|NCT03307252|19956715|P3|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095729|NCT03307252|19956716|P2|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095730|NCT03307252|19956717|P1|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095731|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 2||0
8095732|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 2||0
8095733|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 2||0
8095734|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 2||0
8095735|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 2||0
8095736|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 2||0
8095737|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 2||0
8095738|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 2||0
8095739|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 2||0
8095740|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 2||0
8095741|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 2||0
8095742|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 2||0
8095743|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 2||0
8095744|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 2||0
8095745|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 2||0
8095746|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 2||5
8095747|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 2||3
8095748|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 2||4
8095749|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 2||4
8095750|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 2||0
8095751|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 2||0
8095752|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 2||0
8095753|NCT03307252|19956707|P11|STARTED|Part 2, Period 2||0
8095754|NCT03307252|19956708|P10|STARTED|Part 2, Period 2||0
8095755|NCT03307252|19956709|P9|STARTED|Part 2, Period 2||0
8095756|NCT03307252|19956710|P8|STARTED|Part 2, Period 2||0
8095757|NCT03307252|19956711|P7|STARTED|Part 2, Period 2||5
8095758|NCT03307252|19956712|P6|STARTED|Part 2, Period 2||3
8095759|NCT03307252|19956713|P5|STARTED|Part 2, Period 2||4
8095760|NCT03307252|19956714|P4|STARTED|Part 2, Period 2||4
8095761|NCT03307252|19956715|P3|STARTED|Part 2, Period 2||0
8095762|NCT03307252|19956716|P2|STARTED|Part 2, Period 2||0
8095763|NCT03307252|19956717|P1|STARTED|Part 2, Period 2||0
8095764|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095765|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095766|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095767|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095768|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095769|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095770|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095771|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095772|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095773|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095774|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095775|NCT03307252|19956707|P11|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095776|NCT03307252|19956708|P10|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095777|NCT03307252|19956709|P9|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095778|NCT03307252|19956710|P8|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095779|NCT03307252|19956711|P7|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
8095780|NCT03307252|19956712|P6|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
8095781|NCT03307252|19956713|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
8095782|NCT03307252|19956714|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
8095783|NCT03307252|19956715|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095784|NCT03307252|19956716|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095785|NCT03307252|19956717|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095786|NCT03307252|19956707|P11|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095787|NCT03307252|19956708|P10|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095788|NCT03307252|19956709|P9|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095789|NCT03307252|19956710|P8|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095790|NCT03307252|19956711|P7|STARTED|Part 2, Washout Period 1 (7 Days)||5
8095791|NCT03307252|19956712|P6|STARTED|Part 2, Washout Period 1 (7 Days)||3
8095792|NCT03307252|19956713|P5|STARTED|Part 2, Washout Period 1 (7 Days)||4
8095793|NCT03307252|19956714|P4|STARTED|Part 2, Washout Period 1 (7 Days)||4
8095794|NCT03307252|19956715|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095795|NCT03307252|19956716|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095796|NCT03307252|19956717|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095797|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 1||0
8095798|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 1||0
8095799|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 1||0
8095800|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 1||0
8095801|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 1||0
8095802|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 1||1
8095803|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 1||0
8095804|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 1||0
8095805|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 1||0
8095806|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 1||0
8095807|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 1||0
8095808|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 1||0
8095809|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 1||0
8095810|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 1||0
8095811|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 1||0
8095812|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 1||5
8095813|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 1||3
8095814|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 1||4
8095815|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 1||4
8095816|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 1||0
8095817|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 1||0
8095818|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 1||0
8095819|NCT03307252|19956707|P11|STARTED|Part 2, Period 1||0
8095820|NCT03307252|19956708|P10|STARTED|Part 2, Period 1||0
8095821|NCT03307252|19956709|P9|STARTED|Part 2, Period 1||0
8095822|NCT03307252|19956710|P8|STARTED|Part 2, Period 1||0
8095823|NCT03307252|19956711|P7|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
8095824|NCT03307252|19956712|P6|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
8095825|NCT03307252|19956713|P5|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
8095826|NCT03307252|19956714|P4|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
8095827|NCT03307252|19956715|P3|STARTED|Part 2, Period 1||0
8095828|NCT03307252|19956716|P2|STARTED|Part 2, Period 1||0
8095829|NCT03307252|19956717|P1|STARTED|Part 2, Period 1||0
8095830|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Period 3||0
8095831|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Period 3||0
8095832|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Period 3||0
8095833|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Period 3||0
8095834|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Period 3||0
8095835|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Period 3||0
8095836|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Period 3||0
8095837|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Period 3||0
8095838|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Period 3||0
8095839|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Period 3||0
8095840|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Period 3||0
8095841|NCT03307252|19956707|P11|COMPLETED|Part 1, Period 3||0
8095842|NCT03307252|19956708|P10|COMPLETED|Part 1, Period 3||0
8095843|NCT03307252|19956709|P9|COMPLETED|Part 1, Period 3||0
8095844|NCT03307252|19956710|P8|COMPLETED|Part 1, Period 3||0
8095845|NCT03307252|19956711|P7|COMPLETED|Part 1, Period 3||0
8095846|NCT03307252|19956712|P6|COMPLETED|Part 1, Period 3||0
8095847|NCT03307252|19956713|P5|COMPLETED|Part 1, Period 3||0
8095848|NCT03307252|19956714|P4|COMPLETED|Part 1, Period 3||0
8095849|NCT03307252|19956715|P3|COMPLETED|Part 1, Period 3||4
8095850|NCT03307252|19956716|P2|COMPLETED|Part 1, Period 3||4
8095851|NCT03307252|19956717|P1|COMPLETED|Part 1, Period 3||4
8095852|NCT03307252|19956707|P11|STARTED|Part 1, Period 3||0
8095853|NCT03307252|19956708|P10|STARTED|Part 1, Period 3||0
8095854|NCT03307252|19956709|P9|STARTED|Part 1, Period 3||0
8095855|NCT03307252|19956710|P8|STARTED|Part 1, Period 3||0
8095856|NCT03307252|19956711|P7|STARTED|Part 1, Period 3||0
8095857|NCT03307252|19956712|P6|STARTED|Part 1, Period 3||0
8095858|NCT03307252|19956713|P5|STARTED|Part 1, Period 3||0
8095859|NCT03307252|19956714|P4|STARTED|Part 1, Period 3||0
8095860|NCT03307252|19956715|P3|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
8095861|NCT03307252|19956716|P2|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
8095862|NCT03307252|19956717|P1|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
8095863|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095864|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095865|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095866|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095867|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095868|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095869|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095870|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095871|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095872|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095873|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095874|NCT03307252|19956707|P11|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095875|NCT03307252|19956708|P10|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095876|NCT03307252|19956709|P9|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095877|NCT03307252|19956710|P8|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095878|NCT03307252|19956711|P7|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095879|NCT03307252|19956712|P6|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095880|NCT03307252|19956713|P5|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095881|NCT03307252|19956714|P4|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095882|NCT03307252|19956715|P3|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
8095883|NCT03307252|19956716|P2|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
8095884|NCT03307252|19956717|P1|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
8095885|NCT03307252|19956707|P11|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095886|NCT03307252|19956708|P10|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095887|NCT03307252|19956709|P9|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095888|NCT03307252|19956710|P8|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095889|NCT03307252|19956711|P7|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095890|NCT03307252|19956712|P6|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095891|NCT03307252|19956713|P5|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095892|NCT03307252|19956714|P4|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095893|NCT03307252|19956715|P3|STARTED|Part 1, Washout Period 2 (13 Days)||4
8095894|NCT03307252|19956716|P2|STARTED|Part 1, Washout Period 2 (13 Days)||4
8095895|NCT03307252|19956717|P1|STARTED|Part 1, Washout Period 2 (13 Days)||4
8095896|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Period 2||0
8095897|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Period 2||0
8095898|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Period 2||0
8095899|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Period 2||0
8095900|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Period 2||0
8095901|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Period 2||0
8095902|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Period 2||0
8095903|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Period 2||0
8095904|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Period 2||0
8095905|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Period 2||0
8095906|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Period 2||0
8095907|NCT03307252|19956707|P11|COMPLETED|Part 1, Period 2||0
8095908|NCT03307252|19956708|P10|COMPLETED|Part 1, Period 2||0
8095909|NCT03307252|19956709|P9|COMPLETED|Part 1, Period 2||0
8095910|NCT03307252|19956710|P8|COMPLETED|Part 1, Period 2||0
8095911|NCT03307252|19956711|P7|COMPLETED|Part 1, Period 2||0
8095912|NCT03307252|19956712|P6|COMPLETED|Part 1, Period 2||0
8095913|NCT03307252|19956713|P5|COMPLETED|Part 1, Period 2||0
8095914|NCT03307252|19956714|P4|COMPLETED|Part 1, Period 2||0
8095915|NCT03307252|19956715|P3|COMPLETED|Part 1, Period 2||4
8095916|NCT03307252|19956716|P2|COMPLETED|Part 1, Period 2||4
8095917|NCT03307252|19956717|P1|COMPLETED|Part 1, Period 2||4
8095918|NCT03307252|19956707|P11|STARTED|Part 1, Period 2||0
8095919|NCT03307252|19956708|P10|STARTED|Part 1, Period 2||0
8095920|NCT03307252|19956709|P9|STARTED|Part 1, Period 2||0
8095921|NCT03307252|19956710|P8|STARTED|Part 1, Period 2||0
8095922|NCT03307252|19956711|P7|STARTED|Part 1, Period 2||0
8095923|NCT03307252|19956712|P6|STARTED|Part 1, Period 2||0
8095924|NCT03307252|19956713|P5|STARTED|Part 1, Period 2||0
8095925|NCT03307252|19956714|P4|STARTED|Part 1, Period 2||0
8095926|NCT03307252|19956715|P3|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
8095927|NCT03307252|19956716|P2|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
8095928|NCT03307252|19956717|P1|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
8095929|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095930|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095931|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095932|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095933|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095934|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095935|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095936|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095937|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095938|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095939|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095940|NCT03307252|19956707|P11|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095941|NCT03307252|19956708|P10|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095942|NCT03307252|19956709|P9|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095943|NCT03307252|19956710|P8|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095944|NCT03307252|19956711|P7|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095945|NCT03307252|19956712|P6|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095946|NCT03307252|19956713|P5|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095947|NCT03307252|19956714|P4|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095948|NCT03307252|19956715|P3|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
8095949|NCT03307252|19956716|P2|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
8095950|NCT03307252|19956717|P1|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
8095951|NCT03307252|19956707|P11|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095952|NCT03307252|19956708|P10|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095953|NCT03307252|19956709|P9|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095954|NCT03307252|19956710|P8|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095955|NCT03307252|19956711|P7|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095956|NCT03307252|19956712|P6|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095957|NCT03307252|19956713|P5|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095958|NCT03307252|19956714|P4|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095959|NCT03307252|19956715|P3|STARTED|Part 1, Washout Period 1 (13 Days)||4
8095960|NCT03307252|19956716|P2|STARTED|Part 1, Washout Period 1 (13 Days)||4
8095961|NCT03307252|19956717|P1|STARTED|Part 1, Washout Period 1 (13 Days)||4
8095962|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Period 1||0
8095963|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Period 1||0
8095964|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Period 1||0
8095965|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Period 1||0
8095966|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Period 1||0
8095967|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Period 1||0
8095968|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Period 1||0
8095969|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Period 1||0
8095970|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Period 1||0
8095971|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Period 1||0
8095972|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Period 1||0
8095973|NCT03307252|19956707|P11|COMPLETED|Part 1, Period 1||0
8095974|NCT03307252|19956708|P10|COMPLETED|Part 1, Period 1||0
8095975|NCT03307252|19956709|P9|COMPLETED|Part 1, Period 1||0
8095976|NCT03307252|19956710|P8|COMPLETED|Part 1, Period 1||0
8095977|NCT03307252|19956711|P7|COMPLETED|Part 1, Period 1||0
8095978|NCT03307252|19956712|P6|COMPLETED|Part 1, Period 1||0
8095979|NCT03307252|19956713|P5|COMPLETED|Part 1, Period 1||0
8095980|NCT03307252|19956714|P4|COMPLETED|Part 1, Period 1||0
8095981|NCT03307252|19956715|P3|COMPLETED|Part 1, Period 1||4
8095982|NCT03307252|19956716|P2|COMPLETED|Part 1, Period 1||4
8095983|NCT03307252|19956717|P1|COMPLETED|Part 1, Period 1||4
8095984|NCT03307252|19956707|P11|STARTED|Part 1, Period 1||0
8095985|NCT03307252|19956708|P10|STARTED|Part 1, Period 1||0
8095986|NCT03307252|19956709|P9|STARTED|Part 1, Period 1||0
8095987|NCT03307252|19956710|P8|STARTED|Part 1, Period 1||0
8095988|NCT03307252|19956711|P7|STARTED|Part 1, Period 1||0
8095989|NCT03307252|19956712|P6|STARTED|Part 1, Period 1||0
8095990|NCT03307252|19956713|P5|STARTED|Part 1, Period 1||0
8095991|NCT03307252|19956714|P4|STARTED|Part 1, Period 1||0
8095992|NCT03307252|19956715|P3|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
8095993|NCT03307252|19956716|P2|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
8095994|NCT03307252|19956717|P1|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
8095995|NCT03307174|19956754|P2|NOT COMPLETED|Overall Study||7
8095996|NCT03307174|19956755|P1|NOT COMPLETED|Overall Study||14
8095997|NCT03307174|19956754|P2|COMPLETED|Overall Study||53
8095998|NCT03307174|19956755|P1|COMPLETED|Overall Study||46
8095999|NCT03307174|19956754|P2|STARTED|Overall Study||60
8096000|NCT03307174|19956755|P1|STARTED|Overall Study||60
8096001|NCT03307005|19956775|P2|NOT COMPLETED|Overall Study||0
8096002|NCT03307005|19956776|P1|NOT COMPLETED|Overall Study||0
8096003|NCT03307005|19956775|P2|COMPLETED|Overall Study||2
8096004|NCT03307005|19956776|P1|COMPLETED|Overall Study||3
8096005|NCT03307005|19956775|P2|STARTED|Overall Study||2
8096006|NCT03307005|19956776|P1|STARTED|Overall Study||3
8096007|NCT03306641|19956794|P2|NOT COMPLETED|Second Intervention||0
8096008|NCT03306641|19956795|P1|NOT COMPLETED|Second Intervention||0
8096009|NCT03306641|19956794|P2|COMPLETED|Second Intervention||22
8096010|NCT03306641|19956795|P1|COMPLETED|Second Intervention||23
8096011|NCT03306641|19956794|P2|STARTED|Second Intervention||22
8096012|NCT03306641|19956795|P1|STARTED|Second Intervention||23
8096013|NCT03306641|19956794|P2|NOT COMPLETED|First Intervention||0
8096014|NCT03306641|19956795|P1|NOT COMPLETED|First Intervention||0
8096015|NCT03306641|19956794|P2|COMPLETED|First Intervention||22
8096016|NCT03306641|19956795|P1|COMPLETED|First Intervention||23
8096017|NCT03306641|19956794|P2|STARTED|First Intervention||22
8096018|NCT03306641|19956795|P1|STARTED|First Intervention||23
8096019|NCT03306589|19956809|P6|NOT COMPLETED|Part 2 (69 Days)||0
8096020|NCT03306589|19956810|P5|NOT COMPLETED|Part 2 (69 Days)||0
8096021|NCT03306589|19956811|P4|NOT COMPLETED|Part 2 (69 Days)||0
8096022|NCT03306589|19956812|P3|NOT COMPLETED|Part 2 (69 Days)||0
8096023|NCT03306589|19956813|P2|NOT COMPLETED|Part 2 (69 Days)||0
8096024|NCT03306589|19956814|P1|NOT COMPLETED|Part 2 (69 Days)||0
8096025|NCT03306589|19956809|P6|COMPLETED|Part 2 (69 Days)||0
8096026|NCT03306589|19956810|P5|COMPLETED|Part 2 (69 Days)||0
8096027|NCT03306589|19956811|P4|COMPLETED|Part 2 (69 Days)||0
8096028|NCT03306589|19956812|P3|COMPLETED|Part 2 (69 Days)||0
8096029|NCT03306589|19956813|P2|COMPLETED|Part 2 (69 Days)||0
8096030|NCT03306589|19956814|P1|COMPLETED|Part 2 (69 Days)||0
8096031|NCT03306589|19956809|P6|STARTED|Part 2 (69 Days)||0
8096032|NCT03306589|19956810|P5|STARTED|Part 2 (69 Days)||0
8096033|NCT03306589|19956811|P4|STARTED|Part 2 (69 Days)||0
8096034|NCT03306589|19956812|P3|STARTED|Part 2 (69 Days)||0
8096035|NCT03306589|19956813|P2|STARTED|Part 2 (69 Days)||0
8096036|NCT03306589|19956814|P1|STARTED|Part 2 (69 Days)||0
8096037|NCT03306589|19956809|P6|NOT COMPLETED|Part 1 (69 Days)||0
8096038|NCT03306589|19956810|P5|NOT COMPLETED|Part 1 (69 Days)||0
8096039|NCT03306589|19956811|P4|NOT COMPLETED|Part 1 (69 Days)||0
8096040|NCT03306589|19956812|P3|NOT COMPLETED|Part 1 (69 Days)||0
8096041|NCT03306589|19956813|P2|NOT COMPLETED|Part 1 (69 Days)||0
8096042|NCT03306589|19956814|P1|NOT COMPLETED|Part 1 (69 Days)||0
8096043|NCT03306589|19956809|P6|COMPLETED|Part 1 (69 Days)||0
8096044|NCT03306589|19956810|P5|COMPLETED|Part 1 (69 Days)||0
8096045|NCT03306589|19956811|P4|COMPLETED|Part 1 (69 Days)||4
8096046|NCT03306589|19956812|P3|COMPLETED|Part 1 (69 Days)||2
8096047|NCT03306589|19956813|P2|COMPLETED|Part 1 (69 Days)||4
8096048|NCT03306589|19956814|P1|COMPLETED|Part 1 (69 Days)||2
8096049|NCT03306589|19956809|P6|STARTED|Part 1 (69 Days)||0
8096050|NCT03306589|19956810|P5|STARTED|Part 1 (69 Days)||0
8096051|NCT03306589|19956811|P4|STARTED|Part 1 (69 Days)||4
8096052|NCT03306589|19956812|P3|STARTED|Part 1 (69 Days)||2
8096053|NCT03306589|19956813|P2|STARTED|Part 1 (69 Days)||4
8096054|NCT03306589|19956814|P1|STARTED|Part 1 (69 Days)||2
8096055|NCT03306420|19956920|P5|NOT COMPLETED|Overall Study||0
8096056|NCT03306420|19956921|P4|NOT COMPLETED|Overall Study||0
8096057|NCT03306420|19956922|P3|NOT COMPLETED|Overall Study||0
8096058|NCT03306420|19956923|P2|NOT COMPLETED|Overall Study||0
8096059|NCT03306420|19956924|P1|NOT COMPLETED|Overall Study||0
8096060|NCT03306420|19956920|P5|COMPLETED|Overall Study||3
8096061|NCT03306420|19956921|P4|COMPLETED|Overall Study||3
8096062|NCT03306420|19956922|P3|COMPLETED|Overall Study||3
8096063|NCT03306420|19956923|P2|COMPLETED|Overall Study||3
8096064|NCT03306420|19956924|P1|COMPLETED|Overall Study||3
8096065|NCT03306420|19956920|P5|STARTED|Overall Study||3
8096066|NCT03306420|19956921|P4|STARTED|Overall Study||3
8096067|NCT03306420|19956922|P3|STARTED|Overall Study||3
8096068|NCT03306420|19956923|P2|STARTED|Overall Study||3
8096069|NCT03306420|19956924|P1|STARTED|Overall Study||3
8096070|NCT03306277|19957036|P1|NOT COMPLETED|Overall Study||3
8096071|NCT03306277|19957036|P1|COMPLETED|Overall Study||19
8096072|NCT03306277|19957036|P1|STARTED|Overall Study||22
8096073|NCT03306199|19957043|P1|NOT COMPLETED|Overall Study||15
8096074|NCT03306199|19957043|P1|COMPLETED|Overall Study||67
8096075|NCT03306199|19957043|P1|STARTED|Overall Study||82
8096076|NCT03306043|19957047|P1|NOT COMPLETED|Overall Study||4
8096077|NCT03306043|19957047|P1|COMPLETED|Overall Study||98
8096078|NCT03306043|19957047|P1|STARTED|Overall Study||102
8096079|NCT03305887|19957055|P2|NOT COMPLETED|Overall Study||10
8096080|NCT03305887|19957056|P1|NOT COMPLETED|Overall Study||11
8096081|NCT03305887|19957055|P2|COMPLETED|Overall Study||83
8096082|NCT03305887|19957056|P1|COMPLETED|Overall Study||80
8096083|NCT03305887|19957055|P2|STARTED|Overall Study||93
8096084|NCT03305887|19957056|P1|STARTED|Overall Study||91
8096085|NCT03305822|19957062|P2|NOT COMPLETED|Period 2||0
8096086|NCT03305822|19957063|P1|NOT COMPLETED|Period 2||0
8096087|NCT03305822|19957062|P2|COMPLETED|Period 2||18
8096088|NCT03305822|19957063|P1|COMPLETED|Period 2||20
8096089|NCT03305822|19957062|P2|Received at Least 1 Dose of Study Drug|Period 2||18
8096090|NCT03305822|19957063|P1|Received at Least 1 Dose of Study Drug|Period 2||20
8096091|NCT03305822|19957062|P2|STARTED|Period 2||18
8096092|NCT03305822|19957063|P1|STARTED|Period 2||20
8096093|NCT03305822|19957062|P2|NOT COMPLETED|Washout||0
8096094|NCT03305822|19957063|P1|NOT COMPLETED|Washout||0
8096095|NCT03305822|19957062|P2|COMPLETED|Washout||18
8096096|NCT03305822|19957063|P1|COMPLETED|Washout||20
8096097|NCT03305822|19957062|P2|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
8096098|NCT03305822|19957063|P1|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
8096099|NCT03305822|19957062|P2|NOT COMPLETED|Period 1||0
8096100|NCT03305822|19957063|P1|NOT COMPLETED|Period 1||0
8096101|NCT03305822|19957062|P2|COMPLETED|Period 1||18
8096102|NCT03305822|19957063|P1|COMPLETED|Period 1||20
8096103|NCT03305822|19957062|P2|Received at Least 1 Dose of Study Drug|Period 1||18
8096104|NCT03305822|19957063|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8096105|NCT03305822|19957062|P2|STARTED|Period 1||18
8096106|NCT03305822|19957063|P1|STARTED|Period 1||20
8096107|NCT03305770|19957073|P2|NOT COMPLETED|Overall Study||1
8096108|NCT03305770|19957074|P1|NOT COMPLETED|Overall Study||1
8096109|NCT03305770|19957073|P2|COMPLETED|Overall Study||36
8096110|NCT03305770|19957074|P1|COMPLETED|Overall Study||69
8096111|NCT03305770|19957073|P2|Completed Analysis Set|Overall Study||36
8096112|NCT03305770|19957074|P1|Completed Analysis Set|Overall Study||69
8096113|NCT03305770|19957073|P2|Enrolled Dispensed Analysis Set|Overall Study||36
8096114|NCT03305770|19957074|P1|Enrolled Dispensed Analysis Set|Overall Study||70
8096115|NCT03305770|19957073|P2|STARTED|Overall Study||37
8096116|NCT03305770|19957074|P1|STARTED|Overall Study||70
8096117|NCT03305731|19957082|P1|NOT COMPLETED|Overall Study||1
8096118|NCT03305731|19957082|P1|COMPLETED|Overall Study||20
8096119|NCT03305731|19957082|P1|Week 11|Overall Study||20
8096120|NCT03305731|19957082|P1|Week 6|Overall Study||20
8096121|NCT03305731|19957082|P1|STARTED|Overall Study||21
8096122|NCT03305575|19957093|P2|NOT COMPLETED|Overall Study||0
8096123|NCT03305575|19957094|P1|NOT COMPLETED|Overall Study||1
8096124|NCT03305575|19957093|P2|COMPLETED|Overall Study||5
8096125|NCT03305575|19957094|P1|COMPLETED|Overall Study||4
8096126|NCT03305575|19957093|P2|STARTED|Overall Study||5
8096127|NCT03305575|19957094|P1|STARTED|Overall Study||5
8096128|NCT03305419|19957114|P8|NOT COMPLETED|Part B (14 Days)||0
8096129|NCT03305419|19957115|P7|NOT COMPLETED|Part B (14 Days)||5
8096130|NCT03305419|19957116|P6|NOT COMPLETED|Part B (14 Days)||10
8096131|NCT03305419|19957117|P5|NOT COMPLETED|Part B (14 Days)||3
8096132|NCT03305419|19957118|P4|NOT COMPLETED|Part B (14 Days)||0
8096133|NCT03305419|19957119|P3|NOT COMPLETED|Part B (14 Days)||0
8096134|NCT03305419|19957120|P2|NOT COMPLETED|Part B (14 Days)||0
8096135|NCT03305419|19957121|P1|NOT COMPLETED|Part B (14 Days)||0
8096136|NCT03305419|19957114|P8|COMPLETED|Part B (14 Days)||0
8096137|NCT03305419|19957115|P7|COMPLETED|Part B (14 Days)||8
8096138|NCT03305419|19957116|P6|COMPLETED|Part B (14 Days)||10
8096139|NCT03305419|19957117|P5|COMPLETED|Part B (14 Days)||11
8096140|NCT03305419|19957118|P4|COMPLETED|Part B (14 Days)||0
8096141|NCT03305419|19957119|P3|COMPLETED|Part B (14 Days)||0
8096142|NCT03305419|19957120|P2|COMPLETED|Part B (14 Days)||0
8096143|NCT03305419|19957121|P1|COMPLETED|Part B (14 Days)||0
8096144|NCT03305419|19957114|P8|STARTED|Part B (14 Days)||0
8096145|NCT03305419|19957115|P7|STARTED|Part B (14 Days)||13
8096146|NCT03305419|19957116|P6|STARTED|Part B (14 Days)||20
8096147|NCT03305419|19957117|P5|STARTED|Part B (14 Days)||14
8096148|NCT03305419|19957118|P4|STARTED|Part B (14 Days)||0
8096149|NCT03305419|19957119|P3|STARTED|Part B (14 Days)||0
8096150|NCT03305419|19957120|P2|STARTED|Part B (14 Days)||0
8096151|NCT03305419|19957121|P1|STARTED|Part B (14 Days)||0
8096152|NCT03305419|19957114|P8|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096153|NCT03305419|19957115|P7|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096154|NCT03305419|19957116|P6|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096155|NCT03305419|19957117|P5|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096156|NCT03305419|19957118|P4|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096157|NCT03305419|19957119|P3|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096158|NCT03305419|19957120|P2|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096159|NCT03305419|19957121|P1|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096160|NCT03305419|19957114|P8|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096161|NCT03305419|19957115|P7|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096162|NCT03305419|19957116|P6|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096163|NCT03305419|19957117|P5|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096164|NCT03305419|19957118|P4|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096165|NCT03305419|19957119|P3|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096166|NCT03305419|19957120|P2|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096167|NCT03305419|19957121|P1|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096168|NCT03305419|19957114|P8|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096169|NCT03305419|19957115|P7|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096170|NCT03305419|19957116|P6|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096171|NCT03305419|19957117|P5|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096172|NCT03305419|19957118|P4|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
8096173|NCT03305419|19957119|P3|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
8096174|NCT03305419|19957120|P2|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
8096175|NCT03305419|19957121|P1|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
8096176|NCT03305419|19957114|P8|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096177|NCT03305419|19957115|P7|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096178|NCT03305419|19957116|P6|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096179|NCT03305419|19957117|P5|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096180|NCT03305419|19957118|P4|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096181|NCT03305419|19957119|P3|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096182|NCT03305419|19957120|P2|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096183|NCT03305419|19957121|P1|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
8096184|NCT03305419|19957114|P8|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096185|NCT03305419|19957115|P7|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096186|NCT03305419|19957116|P6|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096187|NCT03305419|19957117|P5|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096188|NCT03305419|19957118|P4|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
8096189|NCT03305419|19957119|P3|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
8096190|NCT03305419|19957120|P2|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
8096191|NCT03305419|19957121|P1|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
8096192|NCT03305419|19957114|P8|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096193|NCT03305419|19957115|P7|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096194|NCT03305419|19957116|P6|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096195|NCT03305419|19957117|P5|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096196|NCT03305419|19957118|P4|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
8096197|NCT03305419|19957119|P3|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
8096198|NCT03305419|19957120|P2|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
8096199|NCT03305419|19957121|P1|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
8096200|NCT03305419|19957114|P8|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096201|NCT03305419|19957115|P7|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096202|NCT03305419|19957116|P6|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096203|NCT03305419|19957117|P5|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096204|NCT03305419|19957118|P4|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096205|NCT03305419|19957119|P3|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096206|NCT03305419|19957120|P2|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
8096207|NCT03305419|19957121|P1|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096208|NCT03305419|19957114|P8|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096209|NCT03305419|19957115|P7|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096210|NCT03305419|19957116|P6|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096211|NCT03305419|19957117|P5|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096212|NCT03305419|19957118|P4|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
8096213|NCT03305419|19957119|P3|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
8096214|NCT03305419|19957120|P2|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
8096215|NCT03305419|19957121|P1|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
8096216|NCT03305419|19957114|P8|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096217|NCT03305419|19957115|P7|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096218|NCT03305419|19957116|P6|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096219|NCT03305419|19957117|P5|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096220|NCT03305419|19957118|P4|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096221|NCT03305419|19957119|P3|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096222|NCT03305419|19957120|P2|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096223|NCT03305419|19957121|P1|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096224|NCT03305159|19957253|P2|NOT COMPLETED|Overall Study||8
8096225|NCT03305159|19957254|P1|NOT COMPLETED|Overall Study||3
8096226|NCT03305159|19957253|P2|COMPLETED|Overall Study||60
8096227|NCT03305159|19957254|P1|COMPLETED|Overall Study||63
8096228|NCT03305159|19957253|P2|STARTED|Overall Study||68
8096229|NCT03305159|19957254|P1|STARTED|Overall Study||66
8096230|NCT03305081|19957262|P2|NOT COMPLETED|Overall Study||15
8096231|NCT03305081|19957263|P1|NOT COMPLETED|Overall Study||10
8096232|NCT03305081|19957262|P2|COMPLETED|Overall Study||5
8096233|NCT03305081|19957263|P1|COMPLETED|Overall Study||15
8096234|NCT03305081|19957262|P2|STARTED|Overall Study||20
8096235|NCT03305081|19957263|P1|STARTED|Overall Study||25
8096236|NCT03305055|19957273|P2|NOT COMPLETED|Overall Study||2
8096237|NCT03305055|19957274|P1|NOT COMPLETED|Overall Study||1
8096238|NCT03305055|19957273|P2|COMPLETED|Overall Study||0
8096239|NCT03305055|19957274|P1|COMPLETED|Overall Study||1
8096240|NCT03305055|19957273|P2|STARTED|Overall Study||2
8096241|NCT03305055|19957274|P1|STARTED|Overall Study||2
8096242|NCT03304873|19957292|P2|NOT COMPLETED|Overall Study||8
8096243|NCT03304873|19957293|P1|NOT COMPLETED|Overall Study||1
8096244|NCT03304873|19957292|P2|COMPLETED|Overall Study||16
8096245|NCT03304873|19957293|P1|COMPLETED|Overall Study||22
8096246|NCT03304873|19957292|P2|STARTED|Overall Study||24
8096247|NCT03304873|19957293|P1|STARTED|Overall Study||23
8096248|NCT03304119|19957303|P2|NOT COMPLETED|Overall Study||0
8096249|NCT03304119|19957304|P1|NOT COMPLETED|Overall Study||0
8096250|NCT03304119|19957303|P2|COMPLETED|Overall Study||55
8096251|NCT03304119|19957304|P1|COMPLETED|Overall Study||37
8096252|NCT03304119|19957303|P2|STARTED|Overall Study||55
8096253|NCT03304119|19957304|P1|STARTED|Overall Study||37
8096254|NCT03304106|19957316|P2|NOT COMPLETED|Overall Study||2
8096255|NCT03304106|19957317|P1|NOT COMPLETED|Overall Study||13
8096256|NCT03304106|19957316|P2|COMPLETED|Overall Study||56
8096257|NCT03304106|19957317|P1|COMPLETED|Overall Study||31
8096258|NCT03304106|19957316|P2|STARTED|Overall Study||58
8096259|NCT03304106|19957317|P1|STARTED|Overall Study||44
8096260|NCT03303950|19957323|P1|NOT COMPLETED|Overall Study||0
8096261|NCT03303950|19957323|P1|COMPLETED|Overall Study||6
8096262|NCT03303950|19957323|P1|STARTED|Overall Study||6
8096263|NCT03303911|19957329|P2|NOT COMPLETED|Overall Study||0
8096264|NCT03303911|19957330|P1|NOT COMPLETED|Overall Study||0
8096265|NCT03303911|19957329|P2|COMPLETED|Overall Study||13
8096266|NCT03303911|19957330|P1|COMPLETED|Overall Study||13
8096267|NCT03303911|19957329|P2|STARTED|Overall Study||13
8096268|NCT03303911|19957330|P1|STARTED|Overall Study||13
8096269|NCT03303794|19957386|P2|NOT COMPLETED|Overall Study||0
8096270|NCT03303794|19957387|P1|NOT COMPLETED|Overall Study||0
8096271|NCT03303794|19957386|P2|COMPLETED|Overall Study||12
8096272|NCT03303794|19957387|P1|COMPLETED|Overall Study||13
8096273|NCT03303794|19957386|P2|STARTED|Overall Study||12
8096274|NCT03303794|19957387|P1|STARTED|Overall Study||13
8096275|NCT03303521|19957399|P2|NOT COMPLETED|Overall Study||3
8096276|NCT03303521|19957400|P1|NOT COMPLETED|Overall Study||5
8096277|NCT03303521|19957399|P2|COMPLETED|Overall Study||96
8096278|NCT03303521|19957400|P1|COMPLETED|Overall Study||92
8096279|NCT03303521|19957399|P2|STARTED|Overall Study||99
8096280|NCT03303521|19957400|P1|STARTED|Overall Study||97
8096281|NCT03303417|19957410|P2|NOT COMPLETED|Overall Study||1
8096282|NCT03303417|19957411|P1|NOT COMPLETED|Overall Study||1
8096283|NCT03303417|19957410|P2|COMPLETED|Overall Study||7
8096284|NCT03303417|19957411|P1|COMPLETED|Overall Study||7
8096285|NCT03303417|19957410|P2|STARTED|Overall Study||8
8096286|NCT03303417|19957411|P1|STARTED|Overall Study||8
8096287|NCT03303404|19957425|P1|NOT COMPLETED|Overall Study||0
8096288|NCT03303404|19957425|P1|COMPLETED|Overall Study||22
8096289|NCT03303404|19957425|P1|STARTED|Overall Study||22
8096290|NCT03303196|19957429|P2|NOT COMPLETED|Overall Study||0
8096291|NCT03303196|19957430|P1|NOT COMPLETED|Overall Study||0
8096292|NCT03303196|19957429|P2|COMPLETED|Overall Study||5
8096293|NCT03303196|19957430|P1|COMPLETED|Overall Study||5
8096294|NCT03303196|19957429|P2|Washout|Overall Study||5
8096295|NCT03303196|19957430|P1|Washout|Overall Study||5
8096296|NCT03303196|19957429|P2|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
8096297|NCT03303196|19957430|P1|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
8096298|NCT03303144|19957435|P3|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
8096299|NCT03303144|19957436|P2|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096300|NCT03303144|19957437|P1|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096301|NCT03303144|19957435|P3|COMPLETED|Triferic Via IV Infusion (Day 10)||25
8096302|NCT03303144|19957436|P2|COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096303|NCT03303144|19957437|P1|COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096304|NCT03303144|19957435|P3|STARTED|Triferic Via IV Infusion (Day 10)||26
8096305|NCT03303144|19957436|P2|STARTED|Triferic Via IV Infusion (Day 10)||0
8096306|NCT03303144|19957437|P1|STARTED|Triferic Via IV Infusion (Day 10)||0
8096307|NCT03303144|19957435|P3|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096308|NCT03303144|19957436|P2|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
8096309|NCT03303144|19957437|P1|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096310|NCT03303144|19957435|P3|COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096311|NCT03303144|19957436|P2|COMPLETED|Triferic Via IV Infusion (Day 8)||25
8096312|NCT03303144|19957437|P1|COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096313|NCT03303144|19957435|P3|STARTED|Triferic Via IV Infusion (Day 8)||0
8096314|NCT03303144|19957436|P2|STARTED|Triferic Via IV Infusion (Day 8)||26
8096315|NCT03303144|19957437|P1|STARTED|Triferic Via IV Infusion (Day 8)||0
8096316|NCT03303144|19957435|P3|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096317|NCT03303144|19957436|P2|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096318|NCT03303144|19957437|P1|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096319|NCT03303144|19957435|P3|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096320|NCT03303144|19957436|P2|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096321|NCT03303144|19957437|P1|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
8096322|NCT03303144|19957435|P3|STARTED|Triferic Via Hemodialysate (Day 3)||0
8096323|NCT03303144|19957436|P2|STARTED|Triferic Via Hemodialysate (Day 3)||0
8096324|NCT03303144|19957437|P1|STARTED|Triferic Via Hemodialysate (Day 3)||26
8096325|NCT03302975|19957452|P1|NOT COMPLETED|Overall Study||4
8096326|NCT03302975|19957452|P1|COMPLETED|Overall Study||12
8096327|NCT03302975|19957452|P1|STARTED|Overall Study||16
8096328|NCT03302936|19957460|P2|NOT COMPLETED|Overall Study||4
8096329|NCT03302936|19957461|P1|NOT COMPLETED|Overall Study||3
8096330|NCT03302936|19957460|P2|COMPLETED|Overall Study||45
8096331|NCT03302936|19957461|P1|COMPLETED|Overall Study||46
8096332|NCT03302936|19957460|P2|STARTED|Overall Study||49
8096333|NCT03302936|19957461|P1|STARTED|Overall Study||49
8096334|NCT03302793|19957471|P2|NOT COMPLETED|Overall Study||2
8096335|NCT03302793|19957472|P1|NOT COMPLETED|Overall Study||0
8096336|NCT03302793|19957471|P2|COMPLETED|Overall Study||4
8096337|NCT03302793|19957472|P1|COMPLETED|Overall Study||6
8096338|NCT03302793|19957471|P2|STARTED|Overall Study||6
8096339|NCT03302793|19957472|P1|STARTED|Overall Study||6
8096340|NCT03302780|19957482|P2|NOT COMPLETED|Overall Study||0
8096341|NCT03302780|19957483|P1|NOT COMPLETED|Overall Study||0
8096342|NCT03302780|19957482|P2|COMPLETED|Overall Study||3
8096343|NCT03302780|19957483|P1|COMPLETED|Overall Study||3
8096344|NCT03302780|19957482|P2|STARTED|Overall Study||3
8096345|NCT03302780|19957483|P1|STARTED|Overall Study||3
8096346|NCT03302741|19957493|P2|NOT COMPLETED|Overall Study||1
8096347|NCT03302741|19957494|P1|NOT COMPLETED|Overall Study||1
8096348|NCT03302741|19957493|P2|COMPLETED|Overall Study||8
8096349|NCT03302741|19957494|P1|COMPLETED|Overall Study||7
8096350|NCT03302741|19957493|P2|STARTED|Overall Study||9
8096351|NCT03302741|19957494|P1|STARTED|Overall Study||8
8096352|NCT03302559|19957510|P1|NOT COMPLETED|Overall Study||6
8096353|NCT03302559|19957510|P1|COMPLETED|Overall Study||23
8096354|NCT03302559|19957510|P1|STARTED|Overall Study||29
8096355|NCT03302416|19957524|P1|NOT COMPLETED|Overall Study||0
8096356|NCT03302416|19957524|P1|COMPLETED|Overall Study||19
8096357|NCT03302416|19957524|P1|STARTED|Overall Study||19
8096358|NCT03302247|19957528|P1|NOT COMPLETED|Overall Study||3
8096359|NCT03302247|19957528|P1|COMPLETED|Overall Study||0
8096360|NCT03302247|19957528|P1|STARTED|Overall Study||3
8096361|NCT03301844|19957535|P2|NOT COMPLETED|Overall Study||1
8096362|NCT03301844|19957536|P1|NOT COMPLETED|Overall Study||1
8096363|NCT03301844|19957535|P2|COMPLETED|Overall Study||18
8096364|NCT03301844|19957536|P1|COMPLETED|Overall Study||18
8096365|NCT03301844|19957535|P2|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
8096366|NCT03301844|19957536|P1|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
8096367|NCT03301779|19957550|P2|NOT COMPLETED|Overall Study||7
8096368|NCT03301779|19957551|P1|NOT COMPLETED|Overall Study||8
8096369|NCT03301779|19957550|P2|COMPLETED|Overall Study||45
8096370|NCT03301779|19957551|P1|COMPLETED|Overall Study||40
8096371|NCT03301779|19957550|P2|STARTED|Overall Study||52
8096372|NCT03301779|19957551|P1|STARTED|Overall Study||48
8096373|NCT03301740|19957563|P2|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
8096374|NCT03301740|19957564|P1|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
8096375|NCT03301740|19957563|P2|COMPLETED|Phase 4 Intervention (3 Weeks)||16
8096376|NCT03301740|19957564|P1|COMPLETED|Phase 4 Intervention (3 Weeks)||16
8096377|NCT03301740|19957563|P2|STARTED|Phase 4 Intervention (3 Weeks)||16
8096378|NCT03301740|19957564|P1|STARTED|Phase 4 Intervention (3 Weeks)||17
8096379|NCT03301740|19957563|P2|NOT COMPLETED|Third Washout (1 Week)||0
8096380|NCT03301740|19957564|P1|NOT COMPLETED|Third Washout (1 Week)||0
8096381|NCT03301740|19957563|P2|COMPLETED|Third Washout (1 Week)||16
8096382|NCT03301740|19957564|P1|COMPLETED|Third Washout (1 Week)||17
8096383|NCT03301740|19957563|P2|STARTED|Third Washout (1 Week)||16
8096384|NCT03301740|19957564|P1|STARTED|Third Washout (1 Week)||17
8096385|NCT03301740|19957563|P2|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
8096386|NCT03301740|19957564|P1|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
8096387|NCT03301740|19957563|P2|COMPLETED|Phase 3 Intervention (3 Weeks)||16
8096388|NCT03301740|19957564|P1|COMPLETED|Phase 3 Intervention (3 Weeks)||17
8096389|NCT03301740|19957563|P2|STARTED|Phase 3 Intervention (3 Weeks)||16
8096390|NCT03301740|19957564|P1|STARTED|Phase 3 Intervention (3 Weeks)||17
8096391|NCT03301740|19957563|P2|NOT COMPLETED|Second Washout (1 Week)||0
8096392|NCT03301740|19957564|P1|NOT COMPLETED|Second Washout (1 Week)||0
8096393|NCT03301740|19957563|P2|COMPLETED|Second Washout (1 Week)||16
8096394|NCT03301740|19957564|P1|COMPLETED|Second Washout (1 Week)||17
8096395|NCT03301740|19957563|P2|STARTED|Second Washout (1 Week)||16
8096396|NCT03301740|19957564|P1|STARTED|Second Washout (1 Week)||17
8096397|NCT03301740|19957563|P2|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
8096398|NCT03301740|19957564|P1|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
8096399|NCT03301740|19957563|P2|COMPLETED|Phase 2 Intervention (3 Weeks)||16
8096400|NCT03301740|19957564|P1|COMPLETED|Phase 2 Intervention (3 Weeks)||17
8096401|NCT03301740|19957563|P2|STARTED|Phase 2 Intervention (3 Weeks)||16
8096402|NCT03301740|19957564|P1|STARTED|Phase 2 Intervention (3 Weeks)||18
8096403|NCT03301740|19957563|P2|NOT COMPLETED|First Washout (1 Week)||0
8096404|NCT03301740|19957564|P1|NOT COMPLETED|First Washout (1 Week)||0
8096405|NCT03301740|19957563|P2|COMPLETED|First Washout (1 Week)||16
8096406|NCT03301740|19957564|P1|COMPLETED|First Washout (1 Week)||18
8096407|NCT03301740|19957563|P2|STARTED|First Washout (1 Week)||16
8096408|NCT03301740|19957564|P1|STARTED|First Washout (1 Week)||18
8096409|NCT03301740|19957563|P2|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
8096410|NCT03301740|19957564|P1|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
8096411|NCT03301740|19957563|P2|COMPLETED|Phase 1 Intervention (3 Weeks)||16
8096412|NCT03301740|19957564|P1|COMPLETED|Phase 1 Intervention (3 Weeks)||18
8096413|NCT03301740|19957563|P2|STARTED|Phase 1 Intervention (3 Weeks)||16
8096414|NCT03301740|19957564|P1|STARTED|Phase 1 Intervention (3 Weeks)||18
8096415|NCT03301714|19957607|P3|NOT COMPLETED|Overall Study||7
8096416|NCT03301714|19957608|P2|NOT COMPLETED|Overall Study||6
8096417|NCT03301714|19957609|P1|NOT COMPLETED|Overall Study||10
8096418|NCT03301714|19957607|P3|COMPLETED|Overall Study||53
8096419|NCT03301714|19957608|P2|COMPLETED|Overall Study||54
8096420|NCT03301714|19957609|P1|COMPLETED|Overall Study||50
8096421|NCT03301714|19957607|P3|STARTED|Overall Study||60
8096422|NCT03301714|19957608|P2|STARTED|Overall Study||60
8096423|NCT03301714|19957609|P1|STARTED|Overall Study||60
8096424|NCT03301649|19957626|P3|NOT COMPLETED|Overall Study||85
8096425|NCT03301649|19957627|P2|NOT COMPLETED|Overall Study||44
8096426|NCT03301649|19957628|P1|NOT COMPLETED|Overall Study||43
8096427|NCT03301649|19957626|P3|COMPLETED|Overall Study||27
8096428|NCT03301649|19957627|P2|COMPLETED|Overall Study||356
8096429|NCT03301649|19957628|P1|COMPLETED|Overall Study||356
8096430|NCT03301649|19957626|P3|Per-protocol (PP) Population|Overall Study||103
8096431|NCT03301649|19957627|P2|Per-protocol (PP) Population|Overall Study||354
8096432|NCT03301649|19957628|P1|Per-protocol (PP) Population|Overall Study||345
8096433|NCT03301649|19957626|P3|Modified Intent-to-treat(mITT)Population|Overall Study||111
8096434|NCT03301649|19957627|P2|Modified Intent-to-treat(mITT)Population|Overall Study||380
8096435|NCT03301649|19957628|P1|Modified Intent-to-treat(mITT)Population|Overall Study||372
8096436|NCT03301649|19957626|P3|Safety Population|Overall Study||112
8096437|NCT03301649|19957627|P2|Safety Population|Overall Study||400
8096438|NCT03301649|19957628|P1|Safety Population|Overall Study||399
8096439|NCT03301649|19957626|P3|STARTED|Overall Study||112
8096440|NCT03301649|19957627|P2|STARTED|Overall Study||400
8096441|NCT03301649|19957628|P1|STARTED|Overall Study||399
8096442|NCT03301298|19957650|P7|NOT COMPLETED|Fed Conditions||0
8096443|NCT03301298|19957651|P6|NOT COMPLETED|Fed Conditions||0
8096444|NCT03301298|19957652|P5|NOT COMPLETED|Fed Conditions||0
8096445|NCT03301298|19957653|P4|NOT COMPLETED|Fed Conditions||0
8096446|NCT03301298|19957654|P3|NOT COMPLETED|Fed Conditions||0
8096447|NCT03301298|19957655|P2|NOT COMPLETED|Fed Conditions||0
8096448|NCT03301298|19957656|P1|NOT COMPLETED|Fed Conditions||0
8096449|NCT03301298|19957650|P7|COMPLETED|Fed Conditions||2
8096450|NCT03301298|19957651|P6|COMPLETED|Fed Conditions||0
8096451|NCT03301298|19957652|P5|COMPLETED|Fed Conditions||5
8096452|NCT03301298|19957653|P4|COMPLETED|Fed Conditions||0
8096453|NCT03301298|19957654|P3|COMPLETED|Fed Conditions||0
8096454|NCT03301298|19957655|P2|COMPLETED|Fed Conditions||0
8096455|NCT03301298|19957656|P1|COMPLETED|Fed Conditions||0
8096456|NCT03301298|19957650|P7|STARTED|Fed Conditions||2
8096457|NCT03301298|19957651|P6|STARTED|Fed Conditions||0
8096458|NCT03301298|19957652|P5|STARTED|Fed Conditions||5
8096459|NCT03301298|19957653|P4|STARTED|Fed Conditions||0
8096460|NCT03301298|19957654|P3|STARTED|Fed Conditions||0
8096461|NCT03301298|19957655|P2|STARTED|Fed Conditions||0
8096462|NCT03301298|19957656|P1|STARTED|Fed Conditions||0
8096463|NCT03301298|19957650|P7|NOT COMPLETED|Unfed Conditions||0
8096464|NCT03301298|19957651|P6|NOT COMPLETED|Unfed Conditions||0
8096465|NCT03301298|19957652|P5|NOT COMPLETED|Unfed Conditions||0
8096466|NCT03301298|19957653|P4|NOT COMPLETED|Unfed Conditions||0
8096467|NCT03301298|19957654|P3|NOT COMPLETED|Unfed Conditions||0
8096468|NCT03301298|19957655|P2|NOT COMPLETED|Unfed Conditions||0
8096469|NCT03301298|19957656|P1|NOT COMPLETED|Unfed Conditions||0
8096470|NCT03301298|19957650|P7|COMPLETED|Unfed Conditions||12
8096471|NCT03301298|19957651|P6|COMPLETED|Unfed Conditions||6
8096472|NCT03301298|19957652|P5|COMPLETED|Unfed Conditions||6
8096473|NCT03301298|19957653|P4|COMPLETED|Unfed Conditions||6
8096474|NCT03301298|19957654|P3|COMPLETED|Unfed Conditions||6
8096475|NCT03301298|19957655|P2|COMPLETED|Unfed Conditions||6
8096476|NCT03301298|19957656|P1|COMPLETED|Unfed Conditions||6
8096477|NCT03301298|19957650|P7|STARTED|Unfed Conditions||12
8096478|NCT03301298|19957651|P6|STARTED|Unfed Conditions||6
8096479|NCT03301298|19957652|P5|STARTED|Unfed Conditions||6
8096480|NCT03301298|19957653|P4|STARTED|Unfed Conditions||6
8096481|NCT03301298|19957654|P3|STARTED|Unfed Conditions||6
8096482|NCT03301298|19957655|P2|STARTED|Unfed Conditions||6
8096483|NCT03301298|19957656|P1|STARTED|Unfed Conditions||6
8096484|NCT03301272|19957694|P2|NOT COMPLETED|Second Intervention (30 Days)||0
8096485|NCT03301272|19957695|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8096486|NCT03301272|19957694|P2|COMPLETED|Second Intervention (30 Days)||9
8096487|NCT03301272|19957695|P1|COMPLETED|Second Intervention (30 Days)||7
8096488|NCT03301272|19957694|P2|STARTED|Second Intervention (30 Days)||9
8096489|NCT03301272|19957695|P1|STARTED|Second Intervention (30 Days)||7
8096490|NCT03301272|19957694|P2|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
8096491|NCT03301272|19957695|P1|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
8096492|NCT03301272|19957694|P2|COMPLETED|Washout (90 Days From 1st Intervention)||9
8096493|NCT03301272|19957695|P1|COMPLETED|Washout (90 Days From 1st Intervention)||7
8096494|NCT03301272|19957694|P2|STARTED|Washout (90 Days From 1st Intervention)||9
8096495|NCT03301272|19957695|P1|STARTED|Washout (90 Days From 1st Intervention)||7
8096496|NCT03301272|19957694|P2|NOT COMPLETED|First Intervention (30 Days)||0
8096497|NCT03301272|19957695|P1|NOT COMPLETED|First Intervention (30 Days)||0
8096498|NCT03301272|19957694|P2|COMPLETED|First Intervention (30 Days)||9
8096499|NCT03301272|19957695|P1|COMPLETED|First Intervention (30 Days)||7
8096500|NCT03301272|19957694|P2|STARTED|First Intervention (30 Days)||9
8096501|NCT03301272|19957695|P1|STARTED|First Intervention (30 Days)||7
8096502|NCT03301155|19957711|P2|NOT COMPLETED|Overall Study||7
8096503|NCT03301155|19957712|P1|NOT COMPLETED|Overall Study||8
8096504|NCT03301155|19957711|P2|COMPLETED|Overall Study||501
8096505|NCT03301155|19957712|P1|COMPLETED|Overall Study||520
8096506|NCT03301155|19957711|P2|STARTED|Overall Study||508
8096507|NCT03301155|19957712|P1|STARTED|Overall Study||528
8096508|NCT03300843|19957726|P1|NOT COMPLETED|Overall Study||0
8096509|NCT03300843|19957726|P1|COMPLETED|Overall Study||1
8096510|NCT03300843|19957726|P1|STARTED|Overall Study||1
8096511|NCT03300674|19957734|P2|NOT COMPLETED|Overall Study||0
8096512|NCT03300674|19957735|P1|NOT COMPLETED|Overall Study||0
8096513|NCT03300674|19957734|P2|COMPLETED|Overall Study||77
8096514|NCT03300674|19957735|P1|COMPLETED|Overall Study||77
8096515|NCT03300674|19957734|P2|STARTED|Overall Study||77
8096516|NCT03300674|19957735|P1|STARTED|Overall Study||77
8096523|NCT03300466|19957760|P2|NOT COMPLETED|Overall Study||0
8096524|NCT03300466|19957761|P1|NOT COMPLETED|Overall Study||1
8096525|NCT03300466|19957760|P2|COMPLETED|Overall Study||10
8096526|NCT03300466|19957761|P1|COMPLETED|Overall Study||9
8096527|NCT03300466|19957760|P2|STARTED|Overall Study||10
8096528|NCT03300466|19957761|P1|STARTED|Overall Study||10
8096529|NCT03300024|19957771|P2|NOT COMPLETED|Overall Study||6
8096530|NCT03300024|19957772|P1|NOT COMPLETED|Overall Study||4
8096531|NCT03300024|19957771|P2|COMPLETED|Overall Study||0
8096532|NCT03300024|19957772|P1|COMPLETED|Overall Study||0
8096533|NCT03300024|19957771|P2|STARTED|Overall Study||6
8096534|NCT03300024|19957772|P1|STARTED|Overall Study||4
8096535|NCT03299686|19957826|P2|NOT COMPLETED|Follow-up Epoch||1
8096536|NCT03299686|19957827|P1|NOT COMPLETED|Follow-up Epoch||0
8096537|NCT03299686|19957826|P2|COMPLETED|Follow-up Epoch||43
8096538|NCT03299686|19957827|P1|COMPLETED|Follow-up Epoch||59
8096539|NCT03299686|19957826|P2|STARTED|Follow-up Epoch||44
8096540|NCT03299686|19957827|P1|STARTED|Follow-up Epoch||59
8096541|NCT03299686|19957826|P2|NOT COMPLETED|Treatment Epoch||4
8096542|NCT03299686|19957827|P1|NOT COMPLETED|Treatment Epoch||11
8096543|NCT03299686|19957826|P2|COMPLETED|Treatment Epoch||44
8096544|NCT03299686|19957827|P1|COMPLETED|Treatment Epoch||59
8096545|NCT03299686|19957826|P2|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
8096546|NCT03299686|19957827|P1|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
8096547|NCT03299686|19957826|P2|STARTED|Treatment Epoch||48
8096548|NCT03299686|19957827|P1|STARTED|Treatment Epoch||70
8096549|NCT03299101|19957843|P1|NOT COMPLETED|Overall Study||10
8096550|NCT03299101|19957843|P1|COMPLETED|Overall Study||25
8096551|NCT03299101|19957843|P1|STARTED|Overall Study||35
8096552|NCT03299049|19957866|P2|NOT COMPLETED|Overall Study||523
8096553|NCT03299049|19957867|P1|NOT COMPLETED|Overall Study||522
8096554|NCT03299049|19957866|P2|COMPLETED|Overall Study||0
8096555|NCT03299049|19957867|P1|COMPLETED|Overall Study||0
8096556|NCT03299049|19957866|P2|STARTED|Overall Study||523
8096557|NCT03299049|19957867|P1|STARTED|Overall Study||522
8096558|NCT03298867|19957966|P2|NOT COMPLETED|Overall Study||2
8096559|NCT03298867|19957967|P1|NOT COMPLETED|Overall Study||2
8096560|NCT03298867|19957966|P2|COMPLETED|Overall Study||39
8096561|NCT03298867|19957967|P1|COMPLETED|Overall Study||40
8096562|NCT03298867|19957966|P2|STARTED|Overall Study||41
8096563|NCT03298867|19957967|P1|STARTED|Overall Study||42
8096564|NCT03298412|19957983|P1|NOT COMPLETED|Treatment Period||0
8096565|NCT03298412|19957983|P1|COMPLETED|Treatment Period||1
8096566|NCT03298412|19957983|P1|STARTED|Treatment Period||1
8096567|NCT03298412|19957983|P1|NOT COMPLETED|Run-in Period||9
8096568|NCT03298412|19957983|P1|COMPLETED|Run-in Period||1
8096569|NCT03298412|19957983|P1|STARTED|Run-in Period||10
8096570|NCT03298113|19957993|P2|NOT COMPLETED|Overall Study||0
8096571|NCT03298113|19957994|P1|NOT COMPLETED|Overall Study||0
8096572|NCT03298113|19957993|P2|COMPLETED|Overall Study||10
8096573|NCT03298113|19957994|P1|COMPLETED|Overall Study||10
8096574|NCT03298113|19957993|P2|IAD 2A|Overall Study||6
8096575|NCT03298113|19957994|P1|IAD 2A|Overall Study||7
8096576|NCT03298113|19957993|P2|IAD 1A|Overall Study||4
8096577|NCT03298113|19957994|P1|IAD 1A|Overall Study||3
8096578|NCT03298113|19957993|P2|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
8096579|NCT03298113|19957994|P1|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
8096580|NCT03298048|19958033|P3|NOT COMPLETED|Overall Study||0
8096581|NCT03298048|19958034|P2|NOT COMPLETED|Overall Study||0
8096582|NCT03298048|19958035|P1|NOT COMPLETED|Overall Study||0
8096583|NCT03298048|19958033|P3|COMPLETED|Overall Study||8
8096584|NCT03298048|19958034|P2|COMPLETED|Overall Study||3
8096585|NCT03298048|19958035|P1|COMPLETED|Overall Study||4
8096586|NCT03298048|19958033|P3|STARTED|Overall Study||8
8096587|NCT03298048|19958034|P2|STARTED|Overall Study||3
8096588|NCT03298048|19958035|P1|STARTED|Overall Study||4
8096589|NCT03298035|19958060|P2|NOT COMPLETED|Overall Study||2
8096590|NCT03298035|19958061|P1|NOT COMPLETED|Overall Study||1
8096591|NCT03298035|19958060|P2|COMPLETED|Overall Study||7
8096592|NCT03298035|19958061|P1|COMPLETED|Overall Study||9
8096593|NCT03298035|19958060|P2|Received Intervention|Overall Study||7
8096594|NCT03298035|19958061|P1|Received Intervention|Overall Study||9
8096595|NCT03298035|19958060|P2|STARTED|Overall Study||9
8096596|NCT03298035|19958061|P1|STARTED|Overall Study||10
8096597|NCT03297944|19958083|P1|NOT COMPLETED|Overall Study||0
8096598|NCT03297944|19958083|P1|COMPLETED|Overall Study||15
8096599|NCT03297944|19958083|P1|PLC/ALP|Overall Study||15
8096600|NCT03297944|19958083|P1|PLC/PLC|Overall Study||15
8096601|NCT03297944|19958083|P1|ZOL/PLC|Overall Study||15
8096602|NCT03297944|19958083|P1|0.5ALP/PLC|Overall Study||15
8096603|NCT03297944|19958083|P1|1ALP/PLC|Overall Study||15
8096604|NCT03297944|19958083|P1|2ALP/PLC|Overall Study||15
8096605|NCT03297944|19958083|P1|STARTED|Overall Study||15
8096606|NCT03297294|19958094|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096607|NCT03297294|19958095|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
8096608|NCT03297294|19958096|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096609|NCT03297294|19958097|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096610|NCT03297294|19958098|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096611|NCT03297294|19958094|P5|COMPLETED|Treatment Withdrawal Period (TW)||27
8096612|NCT03297294|19958095|P4|COMPLETED|Treatment Withdrawal Period (TW)||11
8096613|NCT03297294|19958096|P3|COMPLETED|Treatment Withdrawal Period (TW)||14
8096614|NCT03297294|19958097|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
8096615|NCT03297294|19958098|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
8096616|NCT03297294|19958094|P5|STARTED|Treatment Withdrawal Period (TW)||27
8096617|NCT03297294|19958095|P4|STARTED|Treatment Withdrawal Period (TW)||12
8096618|NCT03297294|19958096|P3|STARTED|Treatment Withdrawal Period (TW)||14
8096619|NCT03297294|19958097|P2|STARTED|Treatment Withdrawal Period (TW)||0
8096620|NCT03297294|19958098|P1|STARTED|Treatment Withdrawal Period (TW)||0
8096621|NCT03297294|19958094|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8096622|NCT03297294|19958095|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8096623|NCT03297294|19958096|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8096624|NCT03297294|19958097|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
8096625|NCT03297294|19958098|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
8096626|NCT03297294|19958094|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
8096627|NCT03297294|19958095|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
8096628|NCT03297294|19958096|P3|COMPLETED|Double-Blind Treatment Period (DB)||0
8096629|NCT03297294|19958097|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
8096630|NCT03297294|19958098|P1|COMPLETED|Double-Blind Treatment Period (DB)||32
8096631|NCT03297294|19958094|P5|STARTED|Double-Blind Treatment Period (DB)||0
8096632|NCT03297294|19958095|P4|STARTED|Double-Blind Treatment Period (DB)||0
8096633|NCT03297294|19958096|P3|STARTED|Double-Blind Treatment Period (DB)||0
8096634|NCT03297294|19958097|P2|STARTED|Double-Blind Treatment Period (DB)||67
8096635|NCT03297294|19958098|P1|STARTED|Double-Blind Treatment Period (DB)||70
8096636|NCT03297112|19958132|P1|NOT COMPLETED|Overall Study||0
8096637|NCT03297112|19958132|P1|COMPLETED|Overall Study||12
8096638|NCT03297112|19958132|P1|STARTED|Overall Study||12
8096639|NCT03297021|19958140|P3|NOT COMPLETED|Overall Study||4
8096640|NCT03297021|19958141|P2|NOT COMPLETED|Overall Study||4
8096641|NCT03297021|19958142|P1|NOT COMPLETED|Overall Study||5
8096642|NCT03297021|19958140|P3|COMPLETED|Overall Study||43
8096643|NCT03297021|19958141|P2|COMPLETED|Overall Study||42
8096644|NCT03297021|19958142|P1|COMPLETED|Overall Study||43
8096645|NCT03297021|19958140|P3|STARTED|Overall Study||47
8096646|NCT03297021|19958141|P2|STARTED|Overall Study||46
8096647|NCT03297021|19958142|P1|STARTED|Overall Study||48
8096648|NCT03296787|19958166|P4|NOT COMPLETED|Overall Study||0
8096649|NCT03296787|19958167|P3|NOT COMPLETED|Overall Study||0
8096650|NCT03296787|19958168|P2|NOT COMPLETED|Overall Study||0
8096651|NCT03296787|19958169|P1|NOT COMPLETED|Overall Study||0
8096652|NCT03296787|19958166|P4|COMPLETED|Overall Study||7
8096653|NCT03296787|19958167|P3|COMPLETED|Overall Study||9
8096654|NCT03296787|19958168|P2|COMPLETED|Overall Study||8
8096655|NCT03296787|19958169|P1|COMPLETED|Overall Study||8
8096656|NCT03296787|19958166|P4|STARTED|Overall Study||7
8096657|NCT03296787|19958167|P3|STARTED|Overall Study||9
8096658|NCT03296787|19958168|P2|STARTED|Overall Study||8
8096659|NCT03296787|19958169|P1|STARTED|Overall Study||8
8096660|NCT03296566|19958206|P2|NOT COMPLETED|Overall Study||49
8096661|NCT03296566|19958207|P1|NOT COMPLETED|Overall Study||19
8096662|NCT03296566|19958206|P2|COMPLETED|Overall Study||103
8096663|NCT03296566|19958207|P1|COMPLETED|Overall Study||126
8096664|NCT03296566|19958206|P2|STARTED|Overall Study||152
8096665|NCT03296566|19958207|P1|STARTED|Overall Study||145
8096666|NCT03296280|19958223|P2|NOT COMPLETED|Overall Study||7
8096667|NCT03296280|19958224|P1|NOT COMPLETED|Overall Study||6
8096668|NCT03296280|19958223|P2|COMPLETED|Overall Study||36
8096669|NCT03296280|19958224|P1|COMPLETED|Overall Study||67
8096670|NCT03296280|19958223|P2|STARTED|Overall Study||43
8096671|NCT03296280|19958224|P1|STARTED|Overall Study||73
8096672|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 3||0
8096673|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 3||0
8096674|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 3||0
8096675|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 3||0
8096676|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 3||0
8096677|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 3||0
8096678|NCT03296072|19958244|P6|COMPLETED|Treament Period 3||11
8096679|NCT03296072|19958245|P5|COMPLETED|Treament Period 3||10
8096680|NCT03296072|19958246|P4|COMPLETED|Treament Period 3||10
8096681|NCT03296072|19958247|P3|COMPLETED|Treament Period 3||10
8096682|NCT03296072|19958248|P2|COMPLETED|Treament Period 3||11
8096683|NCT03296072|19958249|P1|COMPLETED|Treament Period 3||10
8096684|NCT03296072|19958244|P6|STARTED|Treament Period 3||11
8096685|NCT03296072|19958245|P5|STARTED|Treament Period 3||10
8096686|NCT03296072|19958246|P4|STARTED|Treament Period 3||10
8096687|NCT03296072|19958247|P3|STARTED|Treament Period 3||10
8096688|NCT03296072|19958248|P2|STARTED|Treament Period 3||11
8096689|NCT03296072|19958249|P1|STARTED|Treament Period 3||10
8096690|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096691|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096692|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096693|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096694|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096695|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096696|NCT03296072|19958244|P6|COMPLETED|Treament Period 2: Wash Out Period||11
8096697|NCT03296072|19958245|P5|COMPLETED|Treament Period 2: Wash Out Period||10
8096698|NCT03296072|19958246|P4|COMPLETED|Treament Period 2: Wash Out Period||10
8096699|NCT03296072|19958247|P3|COMPLETED|Treament Period 2: Wash Out Period||10
8096700|NCT03296072|19958248|P2|COMPLETED|Treament Period 2: Wash Out Period||11
8096701|NCT03296072|19958249|P1|COMPLETED|Treament Period 2: Wash Out Period||10
8096702|NCT03296072|19958244|P6|STARTED|Treament Period 2: Wash Out Period||11
8096703|NCT03296072|19958245|P5|STARTED|Treament Period 2: Wash Out Period||10
8096704|NCT03296072|19958246|P4|STARTED|Treament Period 2: Wash Out Period||10
8096705|NCT03296072|19958247|P3|STARTED|Treament Period 2: Wash Out Period||10
8096706|NCT03296072|19958248|P2|STARTED|Treament Period 2: Wash Out Period||11
8096707|NCT03296072|19958249|P1|STARTED|Treament Period 2: Wash Out Period||10
8096708|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 2||0
8096709|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 2||0
8096710|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 2||0
8096711|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 2||0
8096712|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 2||0
8096713|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 2||0
8096714|NCT03296072|19958244|P6|COMPLETED|Treament Period 2||11
8096715|NCT03296072|19958245|P5|COMPLETED|Treament Period 2||10
8096716|NCT03296072|19958246|P4|COMPLETED|Treament Period 2||10
8096717|NCT03296072|19958247|P3|COMPLETED|Treament Period 2||10
8096718|NCT03296072|19958248|P2|COMPLETED|Treament Period 2||11
8096719|NCT03296072|19958249|P1|COMPLETED|Treament Period 2||10
8096720|NCT03296072|19958244|P6|STARTED|Treament Period 2||11
8096721|NCT03296072|19958245|P5|STARTED|Treament Period 2||10
8096722|NCT03296072|19958246|P4|STARTED|Treament Period 2||10
8096723|NCT03296072|19958247|P3|STARTED|Treament Period 2||10
8096724|NCT03296072|19958248|P2|STARTED|Treament Period 2||11
8096725|NCT03296072|19958249|P1|STARTED|Treament Period 2||10
8096726|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096727|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096728|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096729|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096730|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096731|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096732|NCT03296072|19958244|P6|COMPLETED|Treament Period 1: Wash Out Period||11
8096733|NCT03296072|19958245|P5|COMPLETED|Treament Period 1: Wash Out Period||10
8096734|NCT03296072|19958246|P4|COMPLETED|Treament Period 1: Wash Out Period||10
8096735|NCT03296072|19958247|P3|COMPLETED|Treament Period 1: Wash Out Period||10
8096736|NCT03296072|19958248|P2|COMPLETED|Treament Period 1: Wash Out Period||11
8096737|NCT03296072|19958249|P1|COMPLETED|Treament Period 1: Wash Out Period||10
8096738|NCT03296072|19958244|P6|STARTED|Treament Period 1: Wash Out Period||11
8096739|NCT03296072|19958245|P5|STARTED|Treament Period 1: Wash Out Period||10
8096740|NCT03296072|19958246|P4|STARTED|Treament Period 1: Wash Out Period||10
8096741|NCT03296072|19958247|P3|STARTED|Treament Period 1: Wash Out Period||10
8096742|NCT03296072|19958248|P2|STARTED|Treament Period 1: Wash Out Period||11
8096743|NCT03296072|19958249|P1|STARTED|Treament Period 1: Wash Out Period||10
8096744|NCT03296072|19958244|P6|NOT COMPLETED|Treatment Period 1||0
8096745|NCT03296072|19958245|P5|NOT COMPLETED|Treatment Period 1||0
8096746|NCT03296072|19958246|P4|NOT COMPLETED|Treatment Period 1||0
8096747|NCT03296072|19958247|P3|NOT COMPLETED|Treatment Period 1||0
8096748|NCT03296072|19958248|P2|NOT COMPLETED|Treatment Period 1||0
8096749|NCT03296072|19958249|P1|NOT COMPLETED|Treatment Period 1||0
8096750|NCT03296072|19958244|P6|COMPLETED|Treatment Period 1||11
8096751|NCT03296072|19958245|P5|COMPLETED|Treatment Period 1||10
8096752|NCT03296072|19958246|P4|COMPLETED|Treatment Period 1||10
8096753|NCT03296072|19958247|P3|COMPLETED|Treatment Period 1||10
8096754|NCT03296072|19958248|P2|COMPLETED|Treatment Period 1||11
8096755|NCT03296072|19958249|P1|COMPLETED|Treatment Period 1||10
8096756|NCT03296072|19958244|P6|STARTED|Treatment Period 1||11
8096757|NCT03296072|19958245|P5|STARTED|Treatment Period 1||10
8096758|NCT03296072|19958246|P4|STARTED|Treatment Period 1||10
8096759|NCT03296072|19958247|P3|STARTED|Treatment Period 1||10
8096760|NCT03296072|19958248|P2|STARTED|Treatment Period 1||11
8096761|NCT03296072|19958249|P1|STARTED|Treatment Period 1||10
8096762|NCT03295630|19958266|P1|NOT COMPLETED|Overall Study||0
8096763|NCT03295630|19958266|P1|COMPLETED|Overall Study||20
8096764|NCT03295630|19958266|P1|STARTED|Overall Study||20
8096765|NCT03295266|19958273|P2|NOT COMPLETED|Overall Study||0
8096766|NCT03295266|19958274|P1|NOT COMPLETED|Overall Study||0
8096767|NCT03295266|19958273|P2|COMPLETED|Overall Study||4
8096768|NCT03295266|19958274|P1|COMPLETED|Overall Study||5
8096769|NCT03295266|19958273|P2|STARTED|Overall Study||4
8096770|NCT03295266|19958274|P1|STARTED|Overall Study||5
8096771|NCT03295201|19958304|P2|NOT COMPLETED|Overall Study||2
8096772|NCT03295201|19958305|P1|NOT COMPLETED|Overall Study||1
8096773|NCT03295201|19958304|P2|COMPLETED|Overall Study||9
8096774|NCT03295201|19958305|P1|COMPLETED|Overall Study||10
8096775|NCT03295201|19958304|P2|STARTED|Overall Study||11
8096776|NCT03295201|19958305|P1|STARTED|Overall Study||11
8096777|NCT03294681|19958357|P1|NOT COMPLETED|Overall Study||1
8096778|NCT03294681|19958357|P1|COMPLETED|Overall Study||152
8096779|NCT03294681|19958357|P1|STARTED|Overall Study||153
8096780|NCT03294629|19958363|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
8096781|NCT03294629|19958364|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
8096782|NCT03294629|19958363|P2|COMPLETED|Second Intervention (2 Weeks)||13
8096783|NCT03294629|19958364|P1|COMPLETED|Second Intervention (2 Weeks)||12
8096784|NCT03294629|19958363|P2|STARTED|Second Intervention (2 Weeks)||15
8096785|NCT03294629|19958364|P1|STARTED|Second Intervention (2 Weeks)||14
8096786|NCT03294629|19958363|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
8096787|NCT03294629|19958364|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
8096788|NCT03294629|19958363|P2|COMPLETED|First Intervention (2 Weeks)||15
8096789|NCT03294629|19958364|P1|COMPLETED|First Intervention (2 Weeks)||14
8096790|NCT03294629|19958363|P2|STARTED|First Intervention (2 Weeks)||19
8096791|NCT03294629|19958364|P1|STARTED|First Intervention (2 Weeks)||16
8096792|NCT03294538|19958395|P3|NOT COMPLETED|Overall Study||2
8096793|NCT03294538|19958396|P2|NOT COMPLETED|Overall Study||5
8096794|NCT03294538|19958397|P1|NOT COMPLETED|Overall Study||5
8096795|NCT03294538|19958395|P3|COMPLETED|Overall Study||131
8096796|NCT03294538|19958396|P2|COMPLETED|Overall Study||257
8096797|NCT03294538|19958397|P1|COMPLETED|Overall Study||263
8096798|NCT03294538|19958395|P3|PP Population|Overall Study||126
8096799|NCT03294538|19958396|P2|PP Population|Overall Study||227
8096800|NCT03294538|19958397|P1|PP Population|Overall Study||244
8096801|NCT03294538|19958395|P3|mITT Population|Overall Study||132
8096802|NCT03294538|19958396|P2|mITT Population|Overall Study||262
8096803|NCT03294538|19958397|P1|mITT Population|Overall Study||267
8096804|NCT03294538|19958395|P3|Safety Population|Overall Study||132
8096805|NCT03294538|19958396|P2|Safety Population|Overall Study||262
8096806|NCT03294538|19958397|P1|Safety Population|Overall Study||267
8096807|NCT03294538|19958395|P3|STARTED|Overall Study||133
8096808|NCT03294538|19958396|P2|STARTED|Overall Study||262
8096809|NCT03294538|19958397|P1|STARTED|Overall Study||268
8096810|NCT03293654|19958415|P3|NOT COMPLETED|Overall Study||0
8096811|NCT03293654|19958416|P2|NOT COMPLETED|Overall Study||1
8096812|NCT03293654|19958417|P1|NOT COMPLETED|Overall Study||0
8096813|NCT03293654|19958415|P3|COMPLETED|Overall Study||38
8096814|NCT03293654|19958416|P2|COMPLETED|Overall Study||37
8096815|NCT03293654|19958417|P1|COMPLETED|Overall Study||38
8096816|NCT03293654|19958415|P3|STARTED|Overall Study||38
8096817|NCT03293654|19958416|P2|STARTED|Overall Study||38
8096818|NCT03293654|19958417|P1|STARTED|Overall Study||38
8096823|NCT03293394|19958466|P2|NOT COMPLETED|Follow-up (6 Months)||2
8096824|NCT03293394|19958467|P1|NOT COMPLETED|Follow-up (6 Months)||4
8096825|NCT03293394|19958466|P2|COMPLETED|Follow-up (6 Months)||8
8096826|NCT03293394|19958467|P1|COMPLETED|Follow-up (6 Months)||16
8096827|NCT03293394|19958466|P2|STARTED|Follow-up (6 Months)||10
8096828|NCT03293394|19958467|P1|STARTED|Follow-up (6 Months)||20
8096829|NCT03293394|19958466|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8096830|NCT03293394|19958467|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8096831|NCT03293394|19958466|P2|COMPLETED|First Intervention (2 Weeks)||10
8096832|NCT03293394|19958467|P1|COMPLETED|First Intervention (2 Weeks)||20
8096833|NCT03293394|19958466|P2|STARTED|First Intervention (2 Weeks)||10
8096834|NCT03293394|19958467|P1|STARTED|First Intervention (2 Weeks)||20
8096835|NCT03293238|19958491|P4|NOT COMPLETED|Overall Study||0
8096836|NCT03293238|19958492|P3|NOT COMPLETED|Overall Study||0
8096837|NCT03293238|19958493|P2|NOT COMPLETED|Overall Study||0
8096838|NCT03293238|19958494|P1|NOT COMPLETED|Overall Study||0
8096839|NCT03293238|19958491|P4|COMPLETED|Overall Study||14
8096840|NCT03293238|19958492|P3|COMPLETED|Overall Study||14
8096841|NCT03293238|19958493|P2|COMPLETED|Overall Study||16
8096842|NCT03293238|19958494|P1|COMPLETED|Overall Study||19
8096843|NCT03293238|19958491|P4|STARTED|Overall Study||14
8096844|NCT03293238|19958492|P3|STARTED|Overall Study||14
8096845|NCT03293238|19958493|P2|STARTED|Overall Study||16
8096846|NCT03293238|19958494|P1|STARTED|Overall Study||19
8096847|NCT03292692|19958514|P2|NOT COMPLETED|Overall Study||38
8096848|NCT03292692|19958515|P1|NOT COMPLETED|Overall Study||38
8096849|NCT03292692|19958514|P2|COMPLETED|Overall Study||260
8096850|NCT03292692|19958515|P1|COMPLETED|Overall Study||264
8096851|NCT03292692|19958514|P2|STARTED|Overall Study||298
8096852|NCT03292692|19958515|P1|STARTED|Overall Study||302
8096859|NCT03292614|19958540|P1|NOT COMPLETED|Overall Study||0
8096860|NCT03292614|19958540|P1|COMPLETED|Overall Study||25
8096861|NCT03292614|19958540|P1|STARTED|Overall Study||25
8096862|NCT03292562|19958546|P2|NOT COMPLETED|Overall Study||1
8096863|NCT03292562|19958547|P1|NOT COMPLETED|Overall Study||6
8096864|NCT03292562|19958546|P2|COMPLETED|Overall Study||30
8096865|NCT03292562|19958547|P1|COMPLETED|Overall Study||29
8096866|NCT03292562|19958546|P2|STARTED|Overall Study||31
8096867|NCT03292562|19958547|P1|STARTED|Overall Study||35
8096868|NCT03292432|19958569|P2|NOT COMPLETED|Overall Study||21
8096869|NCT03292432|19958570|P1|NOT COMPLETED|Overall Study||29
8096870|NCT03292432|19958569|P2|COMPLETED|Overall Study||22
8096871|NCT03292432|19958570|P1|COMPLETED|Overall Study||17
8096872|NCT03292432|19958569|P2|Started Study Intervention|Overall Study||43
8096873|NCT03292432|19958570|P1|Started Study Intervention|Overall Study||45
8096874|NCT03292432|19958569|P2|STARTED|Overall Study||43
8096875|NCT03292432|19958570|P1|STARTED|Overall Study||46
8096876|NCT03292016|19958596|P6|NOT COMPLETED|Third Intervention||0
8096877|NCT03292016|19958597|P5|NOT COMPLETED|Third Intervention||0
8096878|NCT03292016|19958598|P4|NOT COMPLETED|Third Intervention||0
8096879|NCT03292016|19958599|P3|NOT COMPLETED|Third Intervention||0
8096880|NCT03292016|19958600|P2|NOT COMPLETED|Third Intervention||0
8096881|NCT03292016|19958601|P1|NOT COMPLETED|Third Intervention||0
8096882|NCT03292016|19958596|P6|COMPLETED|Third Intervention||2
8096883|NCT03292016|19958597|P5|COMPLETED|Third Intervention||1
8096884|NCT03292016|19958598|P4|COMPLETED|Third Intervention||1
8096885|NCT03292016|19958599|P3|COMPLETED|Third Intervention||2
8096886|NCT03292016|19958600|P2|COMPLETED|Third Intervention||0
8096887|NCT03292016|19958601|P1|COMPLETED|Third Intervention||1
8096888|NCT03292016|19958596|P6|STARTED|Third Intervention||2
8096889|NCT03292016|19958597|P5|STARTED|Third Intervention||1
8096890|NCT03292016|19958598|P4|STARTED|Third Intervention||1
8096891|NCT03292016|19958599|P3|STARTED|Third Intervention||2
8096892|NCT03292016|19958600|P2|STARTED|Third Intervention||0
8096893|NCT03292016|19958601|P1|STARTED|Third Intervention||1
8096894|NCT03292016|19958596|P6|NOT COMPLETED|Second Washout||0
8096895|NCT03292016|19958597|P5|NOT COMPLETED|Second Washout||0
8096896|NCT03292016|19958598|P4|NOT COMPLETED|Second Washout||0
8096897|NCT03292016|19958599|P3|NOT COMPLETED|Second Washout||0
8096898|NCT03292016|19958600|P2|NOT COMPLETED|Second Washout||1
8096899|NCT03292016|19958601|P1|NOT COMPLETED|Second Washout||0
8096900|NCT03292016|19958596|P6|COMPLETED|Second Washout||2
8096901|NCT03292016|19958597|P5|COMPLETED|Second Washout||1
8096902|NCT03292016|19958598|P4|COMPLETED|Second Washout||1
8096903|NCT03292016|19958599|P3|COMPLETED|Second Washout||2
8096904|NCT03292016|19958600|P2|COMPLETED|Second Washout||0
8096905|NCT03292016|19958601|P1|COMPLETED|Second Washout||1
8096906|NCT03292016|19958596|P6|STARTED|Second Washout||2
8096907|NCT03292016|19958597|P5|STARTED|Second Washout||1
8096908|NCT03292016|19958598|P4|STARTED|Second Washout||1
8096909|NCT03292016|19958599|P3|STARTED|Second Washout||2
8096910|NCT03292016|19958600|P2|STARTED|Second Washout||1
8096911|NCT03292016|19958601|P1|STARTED|Second Washout||1
8096912|NCT03292016|19958596|P6|NOT COMPLETED|Second Intervention||0
8096913|NCT03292016|19958597|P5|NOT COMPLETED|Second Intervention||0
8096914|NCT03292016|19958598|P4|NOT COMPLETED|Second Intervention||0
8096915|NCT03292016|19958599|P3|NOT COMPLETED|Second Intervention||0
8096916|NCT03292016|19958600|P2|NOT COMPLETED|Second Intervention||0
8096917|NCT03292016|19958601|P1|NOT COMPLETED|Second Intervention||0
8096918|NCT03292016|19958596|P6|COMPLETED|Second Intervention||2
8096919|NCT03292016|19958597|P5|COMPLETED|Second Intervention||1
8096920|NCT03292016|19958598|P4|COMPLETED|Second Intervention||1
8096921|NCT03292016|19958599|P3|COMPLETED|Second Intervention||2
8096922|NCT03292016|19958600|P2|COMPLETED|Second Intervention||1
8096923|NCT03292016|19958601|P1|COMPLETED|Second Intervention||1
8096924|NCT03292016|19958596|P6|STARTED|Second Intervention||2
8096925|NCT03292016|19958597|P5|STARTED|Second Intervention||1
8096926|NCT03292016|19958598|P4|STARTED|Second Intervention||1
8096927|NCT03292016|19958599|P3|STARTED|Second Intervention||2
8096928|NCT03292016|19958600|P2|STARTED|Second Intervention||1
8096929|NCT03292016|19958601|P1|STARTED|Second Intervention||1
8096930|NCT03292016|19958596|P6|NOT COMPLETED|First Washout||0
8096931|NCT03292016|19958597|P5|NOT COMPLETED|First Washout||0
8096932|NCT03292016|19958598|P4|NOT COMPLETED|First Washout||0
8096933|NCT03292016|19958599|P3|NOT COMPLETED|First Washout||0
8096934|NCT03292016|19958600|P2|NOT COMPLETED|First Washout||0
8096935|NCT03292016|19958601|P1|NOT COMPLETED|First Washout||0
8096936|NCT03292016|19958596|P6|COMPLETED|First Washout||2
8096937|NCT03292016|19958597|P5|COMPLETED|First Washout||1
8096938|NCT03292016|19958598|P4|COMPLETED|First Washout||1
8096939|NCT03292016|19958599|P3|COMPLETED|First Washout||2
8096940|NCT03292016|19958600|P2|COMPLETED|First Washout||1
8096941|NCT03292016|19958601|P1|COMPLETED|First Washout||1
8096942|NCT03292016|19958596|P6|STARTED|First Washout||2
8096943|NCT03292016|19958597|P5|STARTED|First Washout||1
8096944|NCT03292016|19958598|P4|STARTED|First Washout||1
8096945|NCT03292016|19958599|P3|STARTED|First Washout||2
8096946|NCT03292016|19958600|P2|STARTED|First Washout||1
8096947|NCT03292016|19958601|P1|STARTED|First Washout||1
8096948|NCT03292016|19958596|P6|NOT COMPLETED|First Intervention||0
8096949|NCT03292016|19958597|P5|NOT COMPLETED|First Intervention||0
8096950|NCT03292016|19958598|P4|NOT COMPLETED|First Intervention||0
8096951|NCT03292016|19958599|P3|NOT COMPLETED|First Intervention||0
8096952|NCT03292016|19958600|P2|NOT COMPLETED|First Intervention||0
8096953|NCT03292016|19958601|P1|NOT COMPLETED|First Intervention||0
8096954|NCT03292016|19958596|P6|COMPLETED|First Intervention||2
8096955|NCT03292016|19958597|P5|COMPLETED|First Intervention||1
8096956|NCT03292016|19958598|P4|COMPLETED|First Intervention||1
8096957|NCT03292016|19958599|P3|COMPLETED|First Intervention||2
8096958|NCT03292016|19958600|P2|COMPLETED|First Intervention||1
8096959|NCT03292016|19958601|P1|COMPLETED|First Intervention||1
8096960|NCT03292016|19958596|P6|STARTED|First Intervention||2
8096961|NCT03292016|19958597|P5|STARTED|First Intervention||1
8096962|NCT03292016|19958598|P4|STARTED|First Intervention||1
8096963|NCT03292016|19958599|P3|STARTED|First Intervention||2
8096964|NCT03292016|19958600|P2|STARTED|First Intervention||1
8096965|NCT03292016|19958601|P1|STARTED|First Intervention||1
8096966|NCT03291613|19958639|P1|NOT COMPLETED|Overall Study||1
8096967|NCT03291613|19958639|P1|COMPLETED|Overall Study||12
8096968|NCT03291613|19958639|P1|STARTED|Overall Study||13
8096969|NCT03291288|19958643|P2|NOT COMPLETED|Pexidartinib Only||25
8096970|NCT03291288|19958644|P1|NOT COMPLETED|Pexidartinib Only||0
8096971|NCT03291288|19958643|P2|COMPLETED|Pexidartinib Only||0
8096972|NCT03291288|19958644|P1|COMPLETED|Pexidartinib Only||0
8096973|NCT03291288|19958643|P2|STARTED|Pexidartinib Only|1 participant completed Part 1 but did not enter Part 2.|25
8096974|NCT03291288|19958644|P1|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
8096975|NCT03291288|19958643|P2|NOT COMPLETED|Drug-drug Interaction Phase||0
8096976|NCT03291288|19958644|P1|NOT COMPLETED|Drug-drug Interaction Phase||7
8096977|NCT03291288|19958643|P2|COMPLETED|Drug-drug Interaction Phase||0
8096978|NCT03291288|19958644|P1|COMPLETED|Drug-drug Interaction Phase||25
8096979|NCT03291288|19958643|P2|Ongoing|Drug-drug Interaction Phase||0
8096980|NCT03291288|19958644|P1|Ongoing|Drug-drug Interaction Phase||1
8096981|NCT03291288|19958643|P2|STARTED|Drug-drug Interaction Phase||0
8096982|NCT03291288|19958644|P1|STARTED|Drug-drug Interaction Phase||32
8096983|NCT03291197|19958686|P1|NOT COMPLETED|Overall Study||0
8096984|NCT03291197|19958686|P1|COMPLETED|Overall Study||5
8096985|NCT03291197|19958686|P1|STARTED|Overall Study||5
8096986|NCT03290768|19958694|P1|NOT COMPLETED|Overall Study||165
8096987|NCT03290768|19958694|P1|COMPLETED|Overall Study||193
8096988|NCT03290768|19958694|P1|STARTED|Overall Study||358
8096989|NCT03290378|19958708|P3|NOT COMPLETED|Overall Study||16
8096990|NCT03290378|19958709|P2|NOT COMPLETED|Overall Study||10
8096991|NCT03290378|19958710|P1|NOT COMPLETED|Overall Study||3
8096992|NCT03290378|19958708|P3|COMPLETED|Overall Study||120
8096993|NCT03290378|19958709|P2|COMPLETED|Overall Study||123
8096994|NCT03290378|19958710|P1|COMPLETED|Overall Study||137
8096995|NCT03290378|19958708|P3|STARTED|Overall Study||136
8096996|NCT03290378|19958709|P2|STARTED|Overall Study||133
8096997|NCT03290378|19958710|P1|STARTED|Overall Study||140
8096998|NCT03290300|19958718|P1|NOT COMPLETED|Overall Study||3
8096999|NCT03290300|19958718|P1|COMPLETED|Overall Study||36
8097000|NCT03290300|19958718|P1|STARTED|Overall Study||39
8097007|NCT03289858|19958742|P2|NOT COMPLETED|Overall Study||0
8097008|NCT03289858|19958743|P1|NOT COMPLETED|Overall Study||2
8097009|NCT03289858|19958742|P2|COMPLETED|Overall Study||28
8097010|NCT03289858|19958743|P1|COMPLETED|Overall Study||25
8097011|NCT03289858|19958742|P2|STARTED|Overall Study||28
8097012|NCT03289858|19958743|P1|STARTED|Overall Study||27
8097013|NCT03289676|19958751|P2|NOT COMPLETED|Overall Study||1
8097014|NCT03289676|19958752|P1|NOT COMPLETED|Overall Study||4
8097015|NCT03289676|19958751|P2|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
8097016|NCT03289676|19958752|P1|COMPLETED|Overall Study||23
8097017|NCT03289676|19958751|P2|STARTED|Overall Study||26
8097018|NCT03289676|19958752|P1|STARTED|Overall Study||27
8097019|NCT03289533|19958762|P1|NOT COMPLETED|Overall Study||22
8097020|NCT03289533|19958762|P1|COMPLETED|Overall Study||0
8097021|NCT03289533|19958762|P1|STARTED|Overall Study||22
8097022|NCT03289481|19958785|P2|NOT COMPLETED|Overall Study||2
8097023|NCT03289481|19958786|P1|NOT COMPLETED|Overall Study||2
8097024|NCT03289481|19958785|P2|COMPLETED|Overall Study||5
8097025|NCT03289481|19958786|P1|COMPLETED|Overall Study||4
8097026|NCT03289481|19958785|P2|STARTED|Overall Study||7
8097027|NCT03289481|19958786|P1|STARTED|Overall Study||6
8097028|NCT03289234|19958801|P3|NOT COMPLETED|Overall Study||0
8097029|NCT03289234|19958802|P2|NOT COMPLETED|Overall Study||0
8097030|NCT03289234|19958803|P1|NOT COMPLETED|Overall Study||0
8097031|NCT03289234|19958801|P3|COMPLETED|Overall Study||8
8097032|NCT03289234|19958802|P2|COMPLETED|Overall Study||6
8097033|NCT03289234|19958803|P1|COMPLETED|Overall Study||8
8097034|NCT03289234|19958801|P3|STARTED|Overall Study||8
8097035|NCT03289234|19958802|P2|STARTED|Overall Study||6
8097036|NCT03289234|19958803|P1|STARTED|Overall Study||8
8097037|NCT03289208|19958823|P3|NOT COMPLETED|Overall Study||0
8097038|NCT03289208|19958824|P2|NOT COMPLETED|Overall Study||0
8097039|NCT03289208|19958825|P1|NOT COMPLETED|Overall Study||1
8097040|NCT03289208|19958823|P3|COMPLETED|Overall Study||11
8097041|NCT03289208|19958824|P2|COMPLETED|Overall Study||8
8097042|NCT03289208|19958825|P1|COMPLETED|Overall Study||10
8097043|NCT03289208|19958823|P3|STARTED|Overall Study||11
8097044|NCT03289208|19958824|P2|STARTED|Overall Study||8
8097045|NCT03289208|19958825|P1|STARTED|Overall Study||11
8097046|NCT03288987|19958844|P2|NOT COMPLETED|Overall Study||4
8097047|NCT03288987|19958845|P1|NOT COMPLETED|Overall Study||10
8097048|NCT03288987|19958844|P2|COMPLETED|Overall Study|Per protocol population|40
8097049|NCT03288987|19958845|P1|COMPLETED|Overall Study|Per protocol population|72
8097050|NCT03288987|19958844|P2|Patients Receiving Medication|Overall Study||44
8097051|NCT03288987|19958845|P1|Patients Receiving Medication|Overall Study||80
8097052|NCT03288987|19958844|P2|STARTED|Overall Study||44
8097053|NCT03288987|19958845|P1|STARTED|Overall Study||82
8097054|NCT03288779|19958861|P1|NOT COMPLETED|Overall Study||3
8097055|NCT03288779|19958861|P1|COMPLETED|Overall Study||3
8097056|NCT03288779|19958861|P1|STARTED|Overall Study||6
8097057|NCT03287869|19958868|P2|NOT COMPLETED|Overall Study||93
8097058|NCT03287869|19958869|P1|NOT COMPLETED|Overall Study||83
8097059|NCT03287869|19958868|P2|COMPLETED|Overall Study||100
8097060|NCT03287869|19958869|P1|COMPLETED|Overall Study||105
8097061|NCT03287869|19958868|P2|Analyzed For Safety (Safety Sample)|Overall Study||184
8097062|NCT03287869|19958869|P1|Analyzed For Safety (Safety Sample)|Overall Study||184
8097063|NCT03287869|19958868|P2|STARTED|Overall Study||193
8097064|NCT03287869|19958869|P1|STARTED|Overall Study||188
8097075|NCT03287804|19958890|P1|NOT COMPLETED|Overall Study||11
8097076|NCT03287804|19958890|P1|COMPLETED|Overall Study||1
8097077|NCT03287804|19958890|P1|Received Study Treatment|Overall Study||11
8097078|NCT03287804|19958890|P1|Started Pre-conditioning Therapy|Overall Study||11
8097079|NCT03287804|19958890|P1|Leukaperesed|Overall Study||12
8097080|NCT03287804|19958890|P1|STARTED|Overall Study||12
8097081|NCT03287791|19958906|P3|NOT COMPLETED|Overall Study||36
8097082|NCT03287791|19958907|P2|NOT COMPLETED|Overall Study||36
8097083|NCT03287791|19958908|P1|NOT COMPLETED|Overall Study||32
8097084|NCT03287791|19958906|P3|COMPLETED|Overall Study||264
8097085|NCT03287791|19958907|P2|COMPLETED|Overall Study||276
8097086|NCT03287791|19958908|P1|COMPLETED|Overall Study||280
8097087|NCT03287791|19958906|P3|PP Population|Overall Study||245
8097088|NCT03287791|19958907|P2|PP Population|Overall Study||259
8097089|NCT03287791|19958908|P1|PP Population|Overall Study||262
8097090|NCT03287791|19958906|P3|mITT Population|Overall Study||283
8097091|NCT03287791|19958907|P2|mITT Population|Overall Study||291
8097092|NCT03287791|19958908|P1|mITT Population|Overall Study||291
8097093|NCT03287791|19958906|P3|Safety Population|Overall Study||291
8097094|NCT03287791|19958907|P2|Safety Population|Overall Study||297
8097095|NCT03287791|19958908|P1|Safety Population|Overall Study||306
8097096|NCT03287791|19958906|P3|STARTED|Overall Study||300
8097097|NCT03287791|19958907|P2|STARTED|Overall Study||312
8097098|NCT03287791|19958908|P1|STARTED|Overall Study||312
8097099|NCT03287622|19958921|P2|NOT COMPLETED|Overall Study||48
8097100|NCT03287622|19958922|P1|NOT COMPLETED|Overall Study||58
8097101|NCT03287622|19958921|P2|COMPLETED|Overall Study||308
8097102|NCT03287622|19958922|P1|COMPLETED|Overall Study||298
8097103|NCT03287622|19958921|P2|Sub-randomized to Nudge/NoNudge|Overall Study||266
8097104|NCT03287622|19958922|P1|Sub-randomized to Nudge/NoNudge|Overall Study||253
8097105|NCT03287622|19958921|P2|STARTED|Overall Study||356
8097106|NCT03287622|19958922|P1|STARTED|Overall Study||356
8097107|NCT03287089|19958944|P2|NOT COMPLETED|Overall Study||6
8097108|NCT03287089|19958945|P1|NOT COMPLETED|Overall Study||0
8097109|NCT03287089|19958944|P2|COMPLETED|Overall Study||76
8097110|NCT03287089|19958945|P1|COMPLETED|Overall Study||82
8097111|NCT03287089|19958944|P2|STARTED|Overall Study||82
8097112|NCT03287089|19958945|P1|STARTED|Overall Study||82
8097113|NCT03286829|19958959|P4|NOT COMPLETED|Overall Study||0
8097114|NCT03286829|19958960|P3|NOT COMPLETED|Overall Study||0
8097115|NCT03286829|19958961|P2|NOT COMPLETED|Overall Study||0
8097116|NCT03286829|19958962|P1|NOT COMPLETED|Overall Study||0
8097117|NCT03286829|19958959|P4|COMPLETED|Overall Study||15
8097118|NCT03286829|19958960|P3|COMPLETED|Overall Study||15
8097119|NCT03286829|19958961|P2|COMPLETED|Overall Study||15
8097120|NCT03286829|19958962|P1|COMPLETED|Overall Study||15
8097121|NCT03286829|19958959|P4|STARTED|Overall Study||15
8097122|NCT03286829|19958960|P3|STARTED|Overall Study||15
8097123|NCT03286829|19958961|P2|STARTED|Overall Study||15
8097124|NCT03286829|19958962|P1|STARTED|Overall Study||15
8097125|NCT03286751|19958980|P6|NOT COMPLETED|Period 6||0
8097126|NCT03286751|19958981|P5|NOT COMPLETED|Period 6||0
8097127|NCT03286751|19958982|P4|NOT COMPLETED|Period 6||0
8097128|NCT03286751|19958983|P3|NOT COMPLETED|Period 6||0
8097129|NCT03286751|19958984|P2|NOT COMPLETED|Period 6||0
8097130|NCT03286751|19958985|P1|NOT COMPLETED|Period 6||0
8097131|NCT03286751|19958980|P6|COMPLETED|Period 6||7
8097132|NCT03286751|19958981|P5|COMPLETED|Period 6||5
8097133|NCT03286751|19958982|P4|COMPLETED|Period 6||7
8097134|NCT03286751|19958983|P3|COMPLETED|Period 6||7
8097135|NCT03286751|19958984|P2|COMPLETED|Period 6||6
8097136|NCT03286751|19958985|P1|COMPLETED|Period 6||7
8097137|NCT03286751|19958980|P6|STARTED|Period 6||7
8097138|NCT03286751|19958981|P5|STARTED|Period 6||5
8097139|NCT03286751|19958982|P4|STARTED|Period 6||7
8097140|NCT03286751|19958983|P3|STARTED|Period 6||7
8097141|NCT03286751|19958984|P2|STARTED|Period 6||6
8097142|NCT03286751|19958985|P1|STARTED|Period 6||7
8097143|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 5||0
8097144|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 5||1
8097145|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 5||0
8097146|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 5||0
8097147|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 5||0
8097148|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 5||0
8097149|NCT03286751|19958980|P6|COMPLETED|Washout Period 5||7
8097150|NCT03286751|19958981|P5|COMPLETED|Washout Period 5||5
8097151|NCT03286751|19958982|P4|COMPLETED|Washout Period 5||7
8097152|NCT03286751|19958983|P3|COMPLETED|Washout Period 5||7
8097153|NCT03286751|19958984|P2|COMPLETED|Washout Period 5||6
8097154|NCT03286751|19958985|P1|COMPLETED|Washout Period 5||7
8097155|NCT03286751|19958980|P6|STARTED|Washout Period 5||7
8097156|NCT03286751|19958981|P5|STARTED|Washout Period 5||6
8097157|NCT03286751|19958982|P4|STARTED|Washout Period 5||7
8097158|NCT03286751|19958983|P3|STARTED|Washout Period 5||7
8097159|NCT03286751|19958984|P2|STARTED|Washout Period 5||6
8097160|NCT03286751|19958985|P1|STARTED|Washout Period 5||7
8097161|NCT03286751|19958980|P6|NOT COMPLETED|Period 5||0
8097162|NCT03286751|19958981|P5|NOT COMPLETED|Period 5||0
8097163|NCT03286751|19958982|P4|NOT COMPLETED|Period 5||0
8097164|NCT03286751|19958983|P3|NOT COMPLETED|Period 5||0
8097165|NCT03286751|19958984|P2|NOT COMPLETED|Period 5||0
8097166|NCT03286751|19958985|P1|NOT COMPLETED|Period 5||0
8097167|NCT03286751|19958980|P6|COMPLETED|Period 5||7
8097168|NCT03286751|19958981|P5|COMPLETED|Period 5||6
8097169|NCT03286751|19958982|P4|COMPLETED|Period 5||7
8097170|NCT03286751|19958983|P3|COMPLETED|Period 5||7
8097171|NCT03286751|19958984|P2|COMPLETED|Period 5||6
8097172|NCT03286751|19958985|P1|COMPLETED|Period 5||7
8097173|NCT03286751|19958980|P6|STARTED|Period 5||7
8097174|NCT03286751|19958981|P5|STARTED|Period 5||6
8097175|NCT03286751|19958982|P4|STARTED|Period 5||7
8097176|NCT03286751|19958983|P3|STARTED|Period 5||7
8097177|NCT03286751|19958984|P2|STARTED|Period 5||6
8097178|NCT03286751|19958985|P1|STARTED|Period 5||7
8097179|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 4||0
8097180|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 4||0
8097181|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 4||0
8097182|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 4||0
8097183|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 4||0
8097184|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 4||0
8097185|NCT03286751|19958980|P6|COMPLETED|Washout Period 4||7
8097186|NCT03286751|19958981|P5|COMPLETED|Washout Period 4||6
8097187|NCT03286751|19958982|P4|COMPLETED|Washout Period 4||7
8097188|NCT03286751|19958983|P3|COMPLETED|Washout Period 4||7
8097189|NCT03286751|19958984|P2|COMPLETED|Washout Period 4||6
8097190|NCT03286751|19958985|P1|COMPLETED|Washout Period 4||7
8097191|NCT03286751|19958980|P6|STARTED|Washout Period 4||7
8097192|NCT03286751|19958981|P5|STARTED|Washout Period 4||6
8097193|NCT03286751|19958982|P4|STARTED|Washout Period 4||7
8097194|NCT03286751|19958983|P3|STARTED|Washout Period 4||7
8097195|NCT03286751|19958984|P2|STARTED|Washout Period 4||6
8097196|NCT03286751|19958985|P1|STARTED|Washout Period 4||7
8097197|NCT03286751|19958980|P6|NOT COMPLETED|Period 4||0
8097198|NCT03286751|19958981|P5|NOT COMPLETED|Period 4||0
8097199|NCT03286751|19958982|P4|NOT COMPLETED|Period 4||0
8097200|NCT03286751|19958983|P3|NOT COMPLETED|Period 4||0
8097201|NCT03286751|19958984|P2|NOT COMPLETED|Period 4||0
8097202|NCT03286751|19958985|P1|NOT COMPLETED|Period 4||0
8097203|NCT03286751|19958980|P6|COMPLETED|Period 4||7
8097204|NCT03286751|19958981|P5|COMPLETED|Period 4||6
8097205|NCT03286751|19958982|P4|COMPLETED|Period 4||7
8097206|NCT03286751|19958983|P3|COMPLETED|Period 4||7
8097207|NCT03286751|19958984|P2|COMPLETED|Period 4||6
8097208|NCT03286751|19958985|P1|COMPLETED|Period 4||7
8097209|NCT03286751|19958980|P6|STARTED|Period 4||7
8097210|NCT03286751|19958981|P5|STARTED|Period 4||6
8097211|NCT03286751|19958982|P4|STARTED|Period 4||7
8097212|NCT03286751|19958983|P3|STARTED|Period 4||7
8097213|NCT03286751|19958984|P2|STARTED|Period 4||6
8097214|NCT03286751|19958985|P1|STARTED|Period 4||7
8097215|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 3||0
8097216|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 3||0
8097217|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 3||0
8097218|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 3||0
8097219|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 3||0
8097220|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 3||0
8097221|NCT03286751|19958980|P6|COMPLETED|Washout Period 3||7
8097222|NCT03286751|19958981|P5|COMPLETED|Washout Period 3||6
8097223|NCT03286751|19958982|P4|COMPLETED|Washout Period 3||7
8097224|NCT03286751|19958983|P3|COMPLETED|Washout Period 3||7
8097225|NCT03286751|19958984|P2|COMPLETED|Washout Period 3||6
8097226|NCT03286751|19958985|P1|COMPLETED|Washout Period 3||7
8097227|NCT03286751|19958980|P6|STARTED|Washout Period 3||7
8097228|NCT03286751|19958981|P5|STARTED|Washout Period 3||6
8097229|NCT03286751|19958982|P4|STARTED|Washout Period 3||7
8097230|NCT03286751|19958983|P3|STARTED|Washout Period 3||7
8097231|NCT03286751|19958984|P2|STARTED|Washout Period 3||6
8097232|NCT03286751|19958985|P1|STARTED|Washout Period 3||7
8097233|NCT03286751|19958980|P6|NOT COMPLETED|Period 3||0
8097234|NCT03286751|19958981|P5|NOT COMPLETED|Period 3||0
8097235|NCT03286751|19958982|P4|NOT COMPLETED|Period 3||0
8097236|NCT03286751|19958983|P3|NOT COMPLETED|Period 3||0
8097237|NCT03286751|19958984|P2|NOT COMPLETED|Period 3||0
8097238|NCT03286751|19958985|P1|NOT COMPLETED|Period 3||0
8097239|NCT03286751|19958980|P6|COMPLETED|Period 3||7
8097240|NCT03286751|19958981|P5|COMPLETED|Period 3||6
8097241|NCT03286751|19958982|P4|COMPLETED|Period 3||7
8097242|NCT03286751|19958983|P3|COMPLETED|Period 3||7
8097243|NCT03286751|19958984|P2|COMPLETED|Period 3||6
8097244|NCT03286751|19958985|P1|COMPLETED|Period 3||7
8097245|NCT03286751|19958980|P6|STARTED|Period 3||7
8097246|NCT03286751|19958981|P5|STARTED|Period 3||6
8097247|NCT03286751|19958982|P4|STARTED|Period 3||7
8097248|NCT03286751|19958983|P3|STARTED|Period 3||7
8097249|NCT03286751|19958984|P2|STARTED|Period 3||6
8097250|NCT03286751|19958985|P1|STARTED|Period 3||7
8097251|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 2||0
8097252|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 2||0
8097253|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 2||0
8097254|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 2||0
8097255|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 2||1
8097256|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 2||0
8097257|NCT03286751|19958980|P6|COMPLETED|Washout Period 2||7
8097258|NCT03286751|19958981|P5|COMPLETED|Washout Period 2||6
8097259|NCT03286751|19958982|P4|COMPLETED|Washout Period 2||7
8097260|NCT03286751|19958983|P3|COMPLETED|Washout Period 2||7
8097261|NCT03286751|19958984|P2|COMPLETED|Washout Period 2||6
8097262|NCT03286751|19958985|P1|COMPLETED|Washout Period 2||7
8097263|NCT03286751|19958980|P6|STARTED|Washout Period 2||7
8097264|NCT03286751|19958981|P5|STARTED|Washout Period 2||6
8097265|NCT03286751|19958982|P4|STARTED|Washout Period 2||7
8097266|NCT03286751|19958983|P3|STARTED|Washout Period 2||7
8097267|NCT03286751|19958984|P2|STARTED|Washout Period 2||7
8097268|NCT03286751|19958985|P1|STARTED|Washout Period 2||7
8097269|NCT03286751|19958980|P6|NOT COMPLETED|Period 2||0
8097270|NCT03286751|19958981|P5|NOT COMPLETED|Period 2||0
8097271|NCT03286751|19958982|P4|NOT COMPLETED|Period 2||0
8097272|NCT03286751|19958983|P3|NOT COMPLETED|Period 2||0
8097273|NCT03286751|19958984|P2|NOT COMPLETED|Period 2||0
8097274|NCT03286751|19958985|P1|NOT COMPLETED|Period 2||0
8097275|NCT03286751|19958980|P6|COMPLETED|Period 2||7
8097276|NCT03286751|19958981|P5|COMPLETED|Period 2||6
8097277|NCT03286751|19958982|P4|COMPLETED|Period 2||7
8097278|NCT03286751|19958983|P3|COMPLETED|Period 2||7
8097279|NCT03286751|19958984|P2|COMPLETED|Period 2||7
8097280|NCT03286751|19958985|P1|COMPLETED|Period 2||7
8097281|NCT03286751|19958980|P6|STARTED|Period 2||7
8097282|NCT03286751|19958981|P5|STARTED|Period 2||6
8097283|NCT03286751|19958982|P4|STARTED|Period 2||7
8097284|NCT03286751|19958983|P3|STARTED|Period 2||7
8097285|NCT03286751|19958984|P2|STARTED|Period 2||7
8097286|NCT03286751|19958985|P1|STARTED|Period 2||7
8097287|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 1||0
8097288|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 1||1
8097289|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 1||0
8097290|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 1||0
8097291|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 1||0
8097292|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 1||0
8097293|NCT03286751|19958980|P6|COMPLETED|Washout Period 1||7
8097294|NCT03286751|19958981|P5|COMPLETED|Washout Period 1||6
8097295|NCT03286751|19958982|P4|COMPLETED|Washout Period 1||7
8097296|NCT03286751|19958983|P3|COMPLETED|Washout Period 1||7
8097297|NCT03286751|19958984|P2|COMPLETED|Washout Period 1||7
8097298|NCT03286751|19958985|P1|COMPLETED|Washout Period 1||7
8097299|NCT03286751|19958980|P6|STARTED|Washout Period 1||7
8097300|NCT03286751|19958981|P5|STARTED|Washout Period 1||7
8097301|NCT03286751|19958982|P4|STARTED|Washout Period 1||7
8097302|NCT03286751|19958983|P3|STARTED|Washout Period 1||7
8097303|NCT03286751|19958984|P2|STARTED|Washout Period 1||7
8097304|NCT03286751|19958985|P1|STARTED|Washout Period 1||7
8097305|NCT03286751|19958980|P6|NOT COMPLETED|Period 1||0
8097306|NCT03286751|19958981|P5|NOT COMPLETED|Period 1||0
8097307|NCT03286751|19958982|P4|NOT COMPLETED|Period 1||0
8097308|NCT03286751|19958983|P3|NOT COMPLETED|Period 1||0
8097309|NCT03286751|19958984|P2|NOT COMPLETED|Period 1||0
8097310|NCT03286751|19958985|P1|NOT COMPLETED|Period 1||0
8097311|NCT03286751|19958980|P6|COMPLETED|Period 1||7
8097312|NCT03286751|19958981|P5|COMPLETED|Period 1||7
8097313|NCT03286751|19958982|P4|COMPLETED|Period 1||7
8097314|NCT03286751|19958983|P3|COMPLETED|Period 1||7
8097315|NCT03286751|19958984|P2|COMPLETED|Period 1||7
8097316|NCT03286751|19958985|P1|COMPLETED|Period 1||7
8097317|NCT03286751|19958980|P6|Received at Least One Dose of Study Drug|Period 1||7
8097318|NCT03286751|19958981|P5|Received at Least One Dose of Study Drug|Period 1||7
8097319|NCT03286751|19958982|P4|Received at Least One Dose of Study Drug|Period 1||7
8097320|NCT03286751|19958983|P3|Received at Least One Dose of Study Drug|Period 1||7
8097321|NCT03286751|19958984|P2|Received at Least One Dose of Study Drug|Period 1||7
8097322|NCT03286751|19958985|P1|Received at Least One Dose of Study Drug|Period 1||7
8097323|NCT03286751|19958980|P6|STARTED|Period 1||7
8097324|NCT03286751|19958981|P5|STARTED|Period 1||7
8097325|NCT03286751|19958982|P4|STARTED|Period 1||7
8097326|NCT03286751|19958983|P3|STARTED|Period 1||7
8097327|NCT03286751|19958984|P2|STARTED|Period 1||7
8097328|NCT03286751|19958985|P1|STARTED|Period 1||7
8097329|NCT03286400|19959005|P1|NOT COMPLETED|Overall Study||25
8097330|NCT03286400|19959005|P1|COMPLETED|Overall Study||102
8097331|NCT03286400|19959005|P1|STARTED|Overall Study||127
8097332|NCT03286283|19959018|P1|NOT COMPLETED|Overall Study||0
8097333|NCT03286283|19959018|P1|COMPLETED|Overall Study||55
8097334|NCT03286283|19959018|P1|STARTED|Overall Study||55
8097335|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 5||0
8097336|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 5||0
8097337|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 5||0
8097338|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 5||0
8097339|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 5||0
8097340|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 5||0
8097341|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 5||0
8097342|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 5||0
8097343|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 5||0
8097344|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 5||0
8097345|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 5||0
8097346|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 5||0
8097347|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 5||4
8097348|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 5||5
8097349|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 5||6
8097350|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 5||6
8097351|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 5||6
8097352|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 5||6
8097353|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 5||5
8097354|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 5||5
8097355|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 5||5
8097356|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 5||5
8097357|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 5||0
8097358|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 5||0
8097359|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 5||4
8097360|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 5||5
8097361|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 5||6
8097362|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 5||6
8097363|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 5||6
8097364|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 5||6
8097365|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 5||5
8097366|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 5||5
8097367|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 5||5
8097368|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 5||5
8097369|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 5||0
8097370|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 5||0
8097371|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 4||1
8097372|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 4||0
8097373|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 4||0
8097374|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 4||0
8097375|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 4||0
8097376|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 4||0
8097377|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 4||0
8097378|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 4||0
8097379|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 4||0
8097380|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 4||0
8097381|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 4||0
8097382|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 4||0
8097383|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 4||4
8097384|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 4||5
8097385|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 4||6
8097386|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 4||6
8097387|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 4||6
8097388|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 4||6
8097389|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 4||5
8097390|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 4||5
8097391|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 4||5
8097392|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 4||5
8097393|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 4||0
8097394|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 4||0
8097395|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 4||5
8097396|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 4||5
8097397|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 4||6
8097398|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 4||6
8097399|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 4||6
8097400|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 4||6
8097401|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 4||5
8097402|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 4||5
8097403|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 4||5
8097404|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 4||5
8097405|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 4||0
8097406|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 4||0
8097407|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 3||0
8097408|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 3||0
8097409|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 3||0
8097410|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 3||0
8097411|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 3||0
8097412|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 3||0
8097413|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 3||0
8097414|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 3||0
8097415|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 3||0
8097416|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 3||0
8097417|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 3||0
8097418|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 3||0
8097419|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 3||5
8097420|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 3||5
8097421|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 3||6
8097422|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 3||6
8097423|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 3||6
8097424|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 3||6
8097425|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 3||5
8097426|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 3||5
8097427|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 3||5
8097428|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 3||5
8097429|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 3||0
8097430|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 3||0
8097431|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 3||5
8097432|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 3||5
8097433|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 3||6
8097434|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 3||6
8097435|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 3||6
8097436|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 3||6
8097437|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 3||5
8097438|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 3||5
8097439|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 3||5
8097440|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 3||5
8097441|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 3||0
8097442|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 3||0
8097443|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 2||0
8097444|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 2||0
8097445|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 2||0
8097446|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 2||0
8097447|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 2||0
8097448|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 2||0
8097449|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 2||0
8097450|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 2||0
8097451|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 2||0
8097452|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 2||0
8097453|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 2||0
8097454|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 2||0
8097455|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 2||5
8097456|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 2||5
8097457|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 2||6
8097458|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 2||6
8097459|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 2||6
8097460|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 2||6
8097461|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 2||5
8097462|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 2||5
8097463|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 2||5
8097464|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 2||5
8097465|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 2||0
8097466|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 2||0
8097467|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 2||5
8097468|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 2||5
8097469|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 2||6
8097470|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 2||6
8097471|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 2||6
8097472|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 2||6
8097473|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 2||5
8097474|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 2||5
8097475|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 2||5
8097476|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 2||5
8097477|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 2||0
8097478|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 2||0
8097479|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 1||1
8097480|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 1||0
8097481|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 1||0
8097482|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 1||0
8097483|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 1||0
8097484|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 1||0
8097485|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 1||1
8097486|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 1||0
8097487|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 1||1
8097488|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 1||1
8097489|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 1||0
8097490|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 1||0
8097491|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 1||5
8097492|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 1||5
8097493|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 1||6
8097494|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 1||6
8097495|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 1||6
8097496|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 1||6
8097497|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 1||5
8097498|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 1||5
8097499|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 1||5
8097500|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 1||5
8097501|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 1||0
8097502|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 1||0
8097503|NCT03286218|19959034|P12|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097504|NCT03286218|19959035|P11|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
8097505|NCT03286218|19959036|P10|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097506|NCT03286218|19959037|P9|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097507|NCT03286218|19959038|P8|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097508|NCT03286218|19959039|P7|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097509|NCT03286218|19959040|P6|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097510|NCT03286218|19959041|P5|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
8097511|NCT03286218|19959042|P4|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097512|NCT03286218|19959043|P3|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097513|NCT03286218|19959044|P2|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
8097514|NCT03286218|19959045|P1|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
8097515|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097516|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
8097517|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097518|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097519|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097520|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097521|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097522|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
8097523|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097524|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097525|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
8097526|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
8097527|NCT03286218|19959034|P12|NOT COMPLETED|Qualification Phase Period 2||0
8097528|NCT03286218|19959035|P11|NOT COMPLETED|Qualification Phase Period 2||0
8097529|NCT03286218|19959036|P10|NOT COMPLETED|Qualification Phase Period 2||0
8097530|NCT03286218|19959037|P9|NOT COMPLETED|Qualification Phase Period 2||0
8097531|NCT03286218|19959038|P8|NOT COMPLETED|Qualification Phase Period 2||0
8097532|NCT03286218|19959039|P7|NOT COMPLETED|Qualification Phase Period 2||0
8097533|NCT03286218|19959040|P6|NOT COMPLETED|Qualification Phase Period 2||0
8097534|NCT03286218|19959041|P5|NOT COMPLETED|Qualification Phase Period 2||0
8097535|NCT03286218|19959042|P4|NOT COMPLETED|Qualification Phase Period 2||0
8097536|NCT03286218|19959043|P3|NOT COMPLETED|Qualification Phase Period 2||0
8097537|NCT03286218|19959044|P2|NOT COMPLETED|Qualification Phase Period 2||19
8097538|NCT03286218|19959045|P1|NOT COMPLETED|Qualification Phase Period 2||17
8097539|NCT03286218|19959034|P12|COMPLETED|Qualification Phase Period 2||0
8097540|NCT03286218|19959035|P11|COMPLETED|Qualification Phase Period 2||0
8097541|NCT03286218|19959036|P10|COMPLETED|Qualification Phase Period 2||0
8097542|NCT03286218|19959037|P9|COMPLETED|Qualification Phase Period 2||0
8097543|NCT03286218|19959038|P8|COMPLETED|Qualification Phase Period 2||0
8097544|NCT03286218|19959039|P7|COMPLETED|Qualification Phase Period 2||0
8097545|NCT03286218|19959040|P6|COMPLETED|Qualification Phase Period 2||0
8097546|NCT03286218|19959041|P5|COMPLETED|Qualification Phase Period 2||0
8097547|NCT03286218|19959042|P4|COMPLETED|Qualification Phase Period 2||0
8097548|NCT03286218|19959043|P3|COMPLETED|Qualification Phase Period 2||0
8097549|NCT03286218|19959044|P2|COMPLETED|Qualification Phase Period 2||28
8097550|NCT03286218|19959045|P1|COMPLETED|Qualification Phase Period 2||30
8097551|NCT03286218|19959034|P12|STARTED|Qualification Phase Period 2||0
8097552|NCT03286218|19959035|P11|STARTED|Qualification Phase Period 2||0
8097553|NCT03286218|19959036|P10|STARTED|Qualification Phase Period 2||0
8097554|NCT03286218|19959037|P9|STARTED|Qualification Phase Period 2||0
8097555|NCT03286218|19959038|P8|STARTED|Qualification Phase Period 2||0
8097556|NCT03286218|19959039|P7|STARTED|Qualification Phase Period 2||0
8097557|NCT03286218|19959040|P6|STARTED|Qualification Phase Period 2||0
8097558|NCT03286218|19959041|P5|STARTED|Qualification Phase Period 2||0
8097559|NCT03286218|19959042|P4|STARTED|Qualification Phase Period 2||0
8097560|NCT03286218|19959043|P3|STARTED|Qualification Phase Period 2||0
8097561|NCT03286218|19959044|P2|STARTED|Qualification Phase Period 2||47
8097562|NCT03286218|19959045|P1|STARTED|Qualification Phase Period 2||47
8097563|NCT03286218|19959034|P12|NOT COMPLETED|Qualification Phase Period 1||0
8097564|NCT03286218|19959035|P11|NOT COMPLETED|Qualification Phase Period 1||0
8097565|NCT03286218|19959036|P10|NOT COMPLETED|Qualification Phase Period 1||0
8097566|NCT03286218|19959037|P9|NOT COMPLETED|Qualification Phase Period 1||0
8097567|NCT03286218|19959038|P8|NOT COMPLETED|Qualification Phase Period 1||0
8097568|NCT03286218|19959039|P7|NOT COMPLETED|Qualification Phase Period 1||0
8097569|NCT03286218|19959040|P6|NOT COMPLETED|Qualification Phase Period 1||0
8097570|NCT03286218|19959041|P5|NOT COMPLETED|Qualification Phase Period 1||0
8097571|NCT03286218|19959042|P4|NOT COMPLETED|Qualification Phase Period 1||0
8097572|NCT03286218|19959043|P3|NOT COMPLETED|Qualification Phase Period 1||0
8097573|NCT03286218|19959044|P2|NOT COMPLETED|Qualification Phase Period 1||1
8097574|NCT03286218|19959045|P1|NOT COMPLETED|Qualification Phase Period 1||1
8097575|NCT03286218|19959034|P12|COMPLETED|Qualification Phase Period 1||0
8097576|NCT03286218|19959035|P11|COMPLETED|Qualification Phase Period 1||0
8097577|NCT03286218|19959036|P10|COMPLETED|Qualification Phase Period 1||0
8097578|NCT03286218|19959037|P9|COMPLETED|Qualification Phase Period 1||0
8097579|NCT03286218|19959038|P8|COMPLETED|Qualification Phase Period 1||0
8097580|NCT03286218|19959039|P7|COMPLETED|Qualification Phase Period 1||0
8097581|NCT03286218|19959040|P6|COMPLETED|Qualification Phase Period 1||0
8097582|NCT03286218|19959041|P5|COMPLETED|Qualification Phase Period 1||0
8097583|NCT03286218|19959042|P4|COMPLETED|Qualification Phase Period 1||0
8097584|NCT03286218|19959043|P3|COMPLETED|Qualification Phase Period 1||0
8097585|NCT03286218|19959044|P2|COMPLETED|Qualification Phase Period 1||47
8097586|NCT03286218|19959045|P1|COMPLETED|Qualification Phase Period 1||47
8097587|NCT03286218|19959034|P12|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097588|NCT03286218|19959035|P11|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097589|NCT03286218|19959036|P10|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097590|NCT03286218|19959037|P9|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097591|NCT03286218|19959038|P8|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097592|NCT03286218|19959039|P7|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097593|NCT03286218|19959040|P6|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097594|NCT03286218|19959041|P5|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097595|NCT03286218|19959042|P4|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097596|NCT03286218|19959043|P3|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097597|NCT03286218|19959044|P2|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
8097598|NCT03286218|19959045|P1|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
8097599|NCT03286218|19959034|P12|STARTED|Qualification Phase Period 1||0
8097600|NCT03286218|19959035|P11|STARTED|Qualification Phase Period 1||0
8097601|NCT03286218|19959036|P10|STARTED|Qualification Phase Period 1||0
8097602|NCT03286218|19959037|P9|STARTED|Qualification Phase Period 1||0
8097603|NCT03286218|19959038|P8|STARTED|Qualification Phase Period 1||0
8097604|NCT03286218|19959039|P7|STARTED|Qualification Phase Period 1||0
8097605|NCT03286218|19959040|P6|STARTED|Qualification Phase Period 1||0
8097606|NCT03286218|19959041|P5|STARTED|Qualification Phase Period 1||0
8097607|NCT03286218|19959042|P4|STARTED|Qualification Phase Period 1||0
8097608|NCT03286218|19959043|P3|STARTED|Qualification Phase Period 1||0
8097609|NCT03286218|19959044|P2|STARTED|Qualification Phase Period 1||48
8097610|NCT03286218|19959045|P1|STARTED|Qualification Phase Period 1||48
8097611|NCT03285984|19959087|P1|NOT COMPLETED|Overall Study||0
8097612|NCT03285984|19959087|P1|COMPLETED|Overall Study||56
8097613|NCT03285984|19959087|P1|Received Test Product 4|Overall Study||56
8097614|NCT03285984|19959087|P1|Received Test Product 3|Overall Study||56
8097615|NCT03285984|19959087|P1|Received Test Product 2|Overall Study||56
8097616|NCT03285984|19959087|P1|Received Test Product 1|Overall Study||56
8097617|NCT03285984|19959087|P1|STARTED|Overall Study||56
8097618|NCT03285724|19959099|P1|NOT COMPLETED|Overall Study||0
8097619|NCT03285724|19959099|P1|COMPLETED|Overall Study||1
8097620|NCT03285724|19959099|P1|STARTED|Overall Study||1
8097621|NCT03285711|19959108|P4|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097622|NCT03285711|19959109|P3|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097623|NCT03285711|19959110|P2|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
8097624|NCT03285711|19959111|P1|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097625|NCT03285711|19959108|P4|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
8097626|NCT03285711|19959109|P3|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097627|NCT03285711|19959110|P2|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
8097628|NCT03285711|19959111|P1|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097629|NCT03285711|19959108|P4|STARTED|Extended Blinded Phase (Week 32 to 52)||1
8097630|NCT03285711|19959109|P3|STARTED|Extended Blinded Phase (Week 32 to 52)||0
8097631|NCT03285711|19959110|P2|STARTED|Extended Blinded Phase (Week 32 to 52)||3
8097632|NCT03285711|19959111|P1|STARTED|Extended Blinded Phase (Week 32 to 52)||0
8097633|NCT03285711|19959108|P4|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
8097634|NCT03285711|19959109|P3|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
8097635|NCT03285711|19959110|P2|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
8097636|NCT03285711|19959111|P1|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
8097637|NCT03285711|19959108|P4|COMPLETED|Blinded Phase (Week 16 to 32)||1
8097638|NCT03285711|19959109|P3|COMPLETED|Blinded Phase (Week 16 to 32)||0
8097639|NCT03285711|19959110|P2|COMPLETED|Blinded Phase (Week 16 to 32)||3
8097640|NCT03285711|19959111|P1|COMPLETED|Blinded Phase (Week 16 to 32)||0
8097641|NCT03285711|19959108|P4|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
8097642|NCT03285711|19959109|P3|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
8097643|NCT03285711|19959110|P2|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
8097644|NCT03285711|19959111|P1|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
8097645|NCT03285711|19959108|P4|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
8097646|NCT03285711|19959109|P3|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
8097647|NCT03285711|19959110|P2|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
8097648|NCT03285711|19959111|P1|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
8097649|NCT03285711|19959108|P4|COMPLETED|Blinded Phase (Up to Week 16)||0
8097650|NCT03285711|19959109|P3|COMPLETED|Blinded Phase (Up to Week 16)||0
8097651|NCT03285711|19959110|P2|COMPLETED|Blinded Phase (Up to Week 16)||4
8097652|NCT03285711|19959111|P1|COMPLETED|Blinded Phase (Up to Week 16)||1
8097653|NCT03285711|19959108|P4|STARTED|Blinded Phase (Up to Week 16)||0
8097654|NCT03285711|19959109|P3|STARTED|Blinded Phase (Up to Week 16)||0
8097655|NCT03285711|19959110|P2|STARTED|Blinded Phase (Up to Week 16)||5
8097656|NCT03285711|19959111|P1|STARTED|Blinded Phase (Up to Week 16)||4
8097657|NCT03285555|19959133|P2|NOT COMPLETED|Overall Study||0
8097658|NCT03285555|19959134|P1|NOT COMPLETED|Overall Study||0
8097659|NCT03285555|19959133|P2|COMPLETED|Overall Study||30
8097660|NCT03285555|19959134|P1|COMPLETED|Overall Study||30
8097661|NCT03285555|19959133|P2|STARTED|Overall Study||30
8097662|NCT03285555|19959134|P1|STARTED|Overall Study||30
8097663|NCT03285542|19959144|P2|NOT COMPLETED|Overall Study||0
8097664|NCT03285542|19959145|P1|NOT COMPLETED|Overall Study||0
8097665|NCT03285542|19959144|P2|COMPLETED|Overall Study||30
8097666|NCT03285542|19959145|P1|COMPLETED|Overall Study||30
8097667|NCT03285542|19959144|P2|STARTED|Overall Study||30
8097668|NCT03285542|19959145|P1|STARTED|Overall Study||30
8097669|NCT03285529|19959157|P2|NOT COMPLETED|Overall Study||0
8097670|NCT03285529|19959158|P1|NOT COMPLETED|Overall Study||0
8097671|NCT03285529|19959157|P2|COMPLETED|Overall Study||30
8097672|NCT03285529|19959158|P1|COMPLETED|Overall Study||30
8097673|NCT03285529|19959157|P2|STARTED|Overall Study||30
8097674|NCT03285529|19959158|P1|STARTED|Overall Study||30
8097675|NCT03285373|19959166|P4|NOT COMPLETED|Overall Study||0
8097676|NCT03285373|19959167|P3|NOT COMPLETED|Overall Study||0
8097677|NCT03285373|19959168|P2|NOT COMPLETED|Overall Study||0
8097678|NCT03285373|19959169|P1|NOT COMPLETED|Overall Study||0
8097679|NCT03285373|19959166|P4|COMPLETED|Overall Study||130
8097680|NCT03285373|19959167|P3|COMPLETED|Overall Study||266
8097681|NCT03285373|19959168|P2|COMPLETED|Overall Study||253
8097682|NCT03285373|19959169|P1|COMPLETED|Overall Study||314
8097683|NCT03285373|19959166|P4|STARTED|Overall Study||130
8097684|NCT03285373|19959167|P3|STARTED|Overall Study||266
8097685|NCT03285373|19959168|P2|STARTED|Overall Study||253
8097686|NCT03285373|19959169|P1|STARTED|Overall Study||314
8097687|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097688|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097689|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097690|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097691|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Chagas Follow-Up||13
8097692|NCT03285295|19959219|P5|COMPLETED|Alinity s Chagas Follow-Up||0
8097693|NCT03285295|19959220|P4|COMPLETED|Alinity s Chagas Follow-Up||0
8097694|NCT03285295|19959221|P3|COMPLETED|Alinity s Chagas Follow-Up||0
8097695|NCT03285295|19959222|P2|COMPLETED|Alinity s Chagas Follow-Up||0
8097696|NCT03285295|19959223|P1|COMPLETED|Alinity s Chagas Follow-Up||1
8097697|NCT03285295|19959219|P5|STARTED|Alinity s Chagas Follow-Up||0
8097698|NCT03285295|19959220|P4|STARTED|Alinity s Chagas Follow-Up||0
8097699|NCT03285295|19959221|P3|STARTED|Alinity s Chagas Follow-Up||0
8097700|NCT03285295|19959222|P2|STARTED|Alinity s Chagas Follow-Up||0
8097701|NCT03285295|19959223|P1|STARTED|Alinity s Chagas Follow-Up||14
8097702|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Chagas||0
8097703|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Chagas||0
8097704|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Chagas||0
8097705|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Chagas||0
8097706|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Chagas||219
8097707|NCT03285295|19959219|P5|COMPLETED|Alinity s Chagas||0
8097708|NCT03285295|19959220|P4|COMPLETED|Alinity s Chagas||615
8097709|NCT03285295|19959221|P3|COMPLETED|Alinity s Chagas||0
8097710|NCT03285295|19959222|P2|COMPLETED|Alinity s Chagas||320
8097711|NCT03285295|19959223|P1|COMPLETED|Alinity s Chagas||15804
8097712|NCT03285295|19959219|P5|STARTED|Alinity s Chagas||0
8097713|NCT03285295|19959220|P4|STARTED|Alinity s Chagas||615
8097714|NCT03285295|19959221|P3|STARTED|Alinity s Chagas||0
8097715|NCT03285295|19959222|P2|STARTED|Alinity s Chagas||320
8097716|NCT03285295|19959223|P1|STARTED|Alinity s Chagas||16023
8097717|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097718|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097719|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097720|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097721|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
8097722|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097723|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097724|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097725|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097726|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HBc Follow-Up||2
8097727|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HBc Follow-Up||0
8097728|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HBc Follow-Up||0
8097729|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HBc Follow-Up||0
8097730|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HBc Follow-Up||0
8097731|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HBc Follow-Up||16
8097732|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HBc||0
8097733|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HBc||0
8097734|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HBc||0
8097735|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HBc||1
8097736|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HBc||91
8097737|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HBc||0
8097738|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HBc||0
8097739|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HBc||403
8097740|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HBc||404
8097741|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HBc||15877
8097742|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HBc||0
8097743|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HBc||0
8097744|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HBc||403
8097745|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HBc||405
8097746|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HBc||15968
8097747|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097748|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097749|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097750|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097751|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
8097752|NCT03285295|19959219|P5|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097753|NCT03285295|19959220|P4|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097754|NCT03285295|19959221|P3|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097755|NCT03285295|19959222|P2|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097756|NCT03285295|19959223|P1|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
8097757|NCT03285295|19959219|P5|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097758|NCT03285295|19959220|P4|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097759|NCT03285295|19959221|P3|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097760|NCT03285295|19959222|P2|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097761|NCT03285295|19959223|P1|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
8097762|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097763|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097764|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097765|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097766|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
8097767|NCT03285295|19959219|P5|COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097768|NCT03285295|19959220|P4|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
8097769|NCT03285295|19959221|P3|COMPLETED|Alinity s HIV Ag/Ab Combo||605
8097770|NCT03285295|19959222|P2|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
8097771|NCT03285295|19959223|P1|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
8097772|NCT03285295|19959219|P5|STARTED|Alinity s HIV Ag/Ab Combo||0
8097773|NCT03285295|19959220|P4|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
8097774|NCT03285295|19959221|P3|STARTED|Alinity s HIV Ag/Ab Combo||605
8097775|NCT03285295|19959222|P2|STARTED|Alinity s HIV Ag/Ab Combo||1336
8097776|NCT03285295|19959223|P1|STARTED|Alinity s HIV Ag/Ab Combo||17095
8097777|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097778|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097779|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097780|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097781|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
8097782|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097783|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097784|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097785|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097786|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HCV Follow-Up||2
8097787|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HCV Follow-Up||0
8097788|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HCV Follow-Up||0
8097789|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HCV Follow-Up||0
8097790|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HCV Follow-Up||0
8097791|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HCV Follow-Up||20
8097792|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HCV||0
8097793|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HCV||0
8097794|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HCV||0
8097795|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HCV||0
8097796|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HCV||96
8097797|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HCV||0
8097798|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HCV||0
8097799|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HCV||407
8097800|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HCV||402
8097801|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HCV||16999
8097802|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HCV||0
8097803|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HCV||0
8097804|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HCV||407
8097805|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HCV||402
8097806|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HCV||17095
8097807|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097808|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097809|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097810|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097811|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
8097812|NCT03285295|19959219|P5|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097813|NCT03285295|19959220|P4|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097814|NCT03285295|19959221|P3|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097815|NCT03285295|19959222|P2|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097816|NCT03285295|19959223|P1|COMPLETED|Alinity s HTLV I/II Follow-Up||8
8097817|NCT03285295|19959219|P5|STARTED|Alinity s HTLV I/II Follow-Up||0
8097818|NCT03285295|19959220|P4|STARTED|Alinity s HTLV I/II Follow-Up||0
8097819|NCT03285295|19959221|P3|STARTED|Alinity s HTLV I/II Follow-Up||0
8097820|NCT03285295|19959222|P2|STARTED|Alinity s HTLV I/II Follow-Up||0
8097821|NCT03285295|19959223|P1|STARTED|Alinity s HTLV I/II Follow-Up||12
8097822|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HTLV I/II||0
8097823|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HTLV I/II||0
8097824|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HTLV I/II||0
8097825|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HTLV I/II||0
8097826|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HTLV I/II||91
8097827|NCT03285295|19959219|P5|COMPLETED|Alinity s HTLV I/II||0
8097828|NCT03285295|19959220|P4|COMPLETED|Alinity s HTLV I/II||509
8097829|NCT03285295|19959221|P3|COMPLETED|Alinity s HTLV I/II||502
8097830|NCT03285295|19959222|P2|COMPLETED|Alinity s HTLV I/II||706
8097831|NCT03285295|19959223|P1|COMPLETED|Alinity s HTLV I/II||15877
8097832|NCT03285295|19959219|P5|STARTED|Alinity s HTLV I/II||0
8097833|NCT03285295|19959220|P4|STARTED|Alinity s HTLV I/II||509
8097834|NCT03285295|19959221|P3|STARTED|Alinity s HTLV I/II||502
8097835|NCT03285295|19959222|P2|STARTED|Alinity s HTLV I/II||706
8097836|NCT03285295|19959223|P1|STARTED|Alinity s HTLV I/II||15968
8097837|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097838|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097839|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097840|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097841|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097842|NCT03285295|19959219|P5|COMPLETED|Alinity s HBsAg Follow-Up||0
8097843|NCT03285295|19959220|P4|COMPLETED|Alinity s HBsAg Follow-Up||0
8097844|NCT03285295|19959221|P3|COMPLETED|Alinity s HBsAg Follow-Up||0
8097845|NCT03285295|19959222|P2|COMPLETED|Alinity s HBsAg Follow-Up||0
8097846|NCT03285295|19959223|P1|COMPLETED|Alinity s HBsAg Follow-Up||0
8097847|NCT03285295|19959219|P5|STARTED|Alinity s HBsAg Follow-Up||0
8097848|NCT03285295|19959220|P4|STARTED|Alinity s HBsAg Follow-Up||0
8097849|NCT03285295|19959221|P3|STARTED|Alinity s HBsAg Follow-Up||0
8097850|NCT03285295|19959222|P2|STARTED|Alinity s HBsAg Follow-Up||0
8097851|NCT03285295|19959223|P1|STARTED|Alinity s HBsAg Follow-Up||0
8097852|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097853|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097854|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097855|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097856|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097857|NCT03285295|19959219|P5|COMPLETED|Alinity s HBsAg Confirmatory||0
8097858|NCT03285295|19959220|P4|COMPLETED|Alinity s HBsAg Confirmatory||0
8097859|NCT03285295|19959221|P3|COMPLETED|Alinity s HBsAg Confirmatory||3
8097860|NCT03285295|19959222|P2|COMPLETED|Alinity s HBsAg Confirmatory||432
8097861|NCT03285295|19959223|P1|COMPLETED|Alinity s HBsAg Confirmatory||8
8097862|NCT03285295|19959219|P5|STARTED|Alinity s HBsAg Confirmatory||0
8097863|NCT03285295|19959220|P4|STARTED|Alinity s HBsAg Confirmatory||0
8097864|NCT03285295|19959221|P3|STARTED|Alinity s HBsAg Confirmatory||3
8097865|NCT03285295|19959222|P2|STARTED|Alinity s HBsAg Confirmatory||432
8097866|NCT03285295|19959223|P1|STARTED|Alinity s HBsAg Confirmatory||8
8097867|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HBsAg||0
8097868|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HBsAg||0
8097869|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HBsAg||0
8097870|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HBsAg||6
8097871|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HBsAg||102
8097872|NCT03285295|19959219|P5|COMPLETED|Alinity s HBsAg||51
8097873|NCT03285295|19959220|P4|COMPLETED|Alinity s HBsAg||0
8097874|NCT03285295|19959221|P3|COMPLETED|Alinity s HBsAg||403
8097875|NCT03285295|19959222|P2|COMPLETED|Alinity s HBsAg||432
8097876|NCT03285295|19959223|P1|COMPLETED|Alinity s HBsAg||16993
8097877|NCT03285295|19959219|P5|STARTED|Alinity s HBsAg||51
8097878|NCT03285295|19959220|P4|STARTED|Alinity s HBsAg||0
8097879|NCT03285295|19959221|P3|STARTED|Alinity s HBsAg||403
8097880|NCT03285295|19959222|P2|STARTED|Alinity s HBsAg||438
8097881|NCT03285295|19959223|P1|STARTED|Alinity s HBsAg||17095
8097882|NCT03285113|19959252|P1|NOT COMPLETED|Overall Study||2
8097883|NCT03285113|19959252|P1|COMPLETED|Overall Study||8
8097884|NCT03285113|19959252|P1|STARTED|Overall Study||10
8097885|NCT03285061|19959261|P2|NOT COMPLETED|Overall Study||2
8097886|NCT03285061|19959262|P1|NOT COMPLETED|Overall Study||1
8097887|NCT03285061|19959261|P2|COMPLETED|Overall Study||36
8097888|NCT03285061|19959262|P1|COMPLETED|Overall Study||36
8097889|NCT03285061|19959261|P2|STARTED|Overall Study||38
8097890|NCT03285061|19959262|P1|STARTED|Overall Study||37
8097891|NCT03284411|19959268|P1|NOT COMPLETED|Overall Study||0
8097892|NCT03284411|19959268|P1|COMPLETED|Overall Study||30
8097893|NCT03284411|19959268|P1|STARTED|Overall Study||30
8097894|NCT03284229|19959273|P1|NOT COMPLETED|Overall Study||3
8097895|NCT03284229|19959273|P1|COMPLETED|Overall Study||25
8097896|NCT03284229|19959273|P1|STARTED|Overall Study||28
8097897|NCT03283787|19959289|P3|NOT COMPLETED|Overall Study||7
8097898|NCT03283787|19959290|P2|NOT COMPLETED|Overall Study||7
8097899|NCT03283787|19959291|P1|NOT COMPLETED|Overall Study||3
8097900|NCT03283787|19959289|P3|COMPLETED|Overall Study||13
8097901|NCT03283787|19959290|P2|COMPLETED|Overall Study||13
8097902|NCT03283787|19959291|P1|COMPLETED|Overall Study||17
8097903|NCT03283787|19959289|P3|STARTED|Overall Study||20
8097904|NCT03283787|19959290|P2|STARTED|Overall Study||20
8097905|NCT03283787|19959291|P1|STARTED|Overall Study||20
8097906|NCT03283709|19959307|P2|NOT COMPLETED|Overall Study||1
8097907|NCT03283709|19959308|P1|NOT COMPLETED|Overall Study||0
8097908|NCT03283709|19959307|P2|COMPLETED|Overall Study||0
8097909|NCT03283709|19959308|P1|COMPLETED|Overall Study||0
8097910|NCT03283709|19959307|P2|STARTED|Overall Study||1
8097911|NCT03283709|19959308|P1|STARTED|Overall Study||0
8097912|NCT03283696|19959340|P2|NOT COMPLETED|Overall Study||6
8097913|NCT03283696|19959341|P1|NOT COMPLETED|Overall Study||7
8097914|NCT03283696|19959340|P2|COMPLETED|Overall Study||2
8097915|NCT03283696|19959341|P1|COMPLETED|Overall Study||9
8097916|NCT03283696|19959340|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8097917|NCT03283696|19959341|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
8097918|NCT03283696|19959340|P2|STARTED|Overall Study||8
8097919|NCT03283696|19959341|P1|STARTED|Overall Study||16
8097920|NCT03283436|19959369|P2|NOT COMPLETED|Overall Study||0
8097921|NCT03283436|19959370|P1|NOT COMPLETED|Overall Study||6
8097922|NCT03283436|19959369|P2|COMPLETED|Overall Study||50
8097923|NCT03283436|19959370|P1|COMPLETED|Overall Study||44
8097924|NCT03283436|19959369|P2|STARTED|Overall Study||50
8097925|NCT03283436|19959370|P1|STARTED|Overall Study||50
8097926|NCT03283319|19959386|P6|NOT COMPLETED|Overall Study||4
8097927|NCT03283319|19959387|P5|NOT COMPLETED|Overall Study||4
8097928|NCT03283319|19959388|P4|NOT COMPLETED|Overall Study||7
8097929|NCT03283319|19959389|P3|NOT COMPLETED|Overall Study||7
8097930|NCT03283319|19959390|P2|NOT COMPLETED|Overall Study||6
8097931|NCT03283319|19959391|P1|NOT COMPLETED|Overall Study||7
8097932|NCT03283319|19959386|P6|COMPLETED|Overall Study||57
8097933|NCT03283319|19959387|P5|COMPLETED|Overall Study||56
8097934|NCT03283319|19959388|P4|COMPLETED|Overall Study||54
8097935|NCT03283319|19959389|P3|COMPLETED|Overall Study||55
8097936|NCT03283319|19959390|P2|COMPLETED|Overall Study||54
8097937|NCT03283319|19959391|P1|COMPLETED|Overall Study||55
8097938|NCT03283319|19959386|P6|STARTED|Overall Study||61
8097939|NCT03283319|19959387|P5|STARTED|Overall Study||60
8097940|NCT03283319|19959388|P4|STARTED|Overall Study||61
8097941|NCT03283319|19959389|P3|STARTED|Overall Study||62
8097942|NCT03283319|19959390|P2|STARTED|Overall Study||60
8097943|NCT03283319|19959391|P1|STARTED|Overall Study||62
8097944|NCT03283098|19959533|P2|NOT COMPLETED|Overall Study||1
8097945|NCT03283098|19959534|P1|NOT COMPLETED|Overall Study||0
8097946|NCT03283098|19959533|P2|COMPLETED|Overall Study||24
8097947|NCT03283098|19959534|P1|COMPLETED|Overall Study||8
8097948|NCT03283098|19959533|P2|STARTED|Overall Study||25
8097949|NCT03283098|19959534|P1|STARTED|Overall Study||8
8097950|NCT03282682|19959573|P3|NOT COMPLETED|Overall Study||0
8097951|NCT03282682|19959574|P2|NOT COMPLETED|Overall Study||0
8097952|NCT03282682|19959575|P1|NOT COMPLETED|Overall Study||0
8097953|NCT03282682|19959573|P3|COMPLETED|Overall Study||8
8097954|NCT03282682|19959574|P2|COMPLETED|Overall Study||8
8097955|NCT03282682|19959575|P1|COMPLETED|Overall Study||6
8097956|NCT03282682|19959573|P3|STARTED|Overall Study||8
8097957|NCT03282682|19959574|P2|STARTED|Overall Study||8
8097958|NCT03282682|19959575|P1|STARTED|Overall Study||6
8097959|NCT03282591|19959636|P2|NOT COMPLETED|Overall Study||4
8097960|NCT03282591|19959637|P1|NOT COMPLETED|Overall Study||4
8097961|NCT03282591|19959636|P2|COMPLETED|Overall Study||89
8097962|NCT03282591|19959637|P1|COMPLETED|Overall Study||88
8097963|NCT03282591|19959636|P2|STARTED|Overall Study||93
8097964|NCT03282591|19959637|P1|STARTED|Overall Study||92
8097965|NCT03282240|19959654|P3|NOT COMPLETED|Overall Study||3
8097966|NCT03282240|19959655|P2|NOT COMPLETED|Overall Study||3
8097967|NCT03282240|19959656|P1|NOT COMPLETED|Overall Study||10
8097968|NCT03282240|19959654|P3|COMPLETED|Overall Study||447
8097969|NCT03282240|19959655|P2|COMPLETED|Overall Study||440
8097970|NCT03282240|19959656|P1|COMPLETED|Overall Study||1767
8097971|NCT03282240|19959654|P3|STARTED|Overall Study||450
8097972|NCT03282240|19959655|P2|STARTED|Overall Study||443
8097973|NCT03282240|19959656|P1|STARTED|Overall Study||1777
8097974|NCT03282227|19959708|P1|NOT COMPLETED|Overall Study||215
8097975|NCT03282227|19959708|P1|COMPLETED|Overall Study||127
8097976|NCT03282227|19959708|P1|Completed at Least 6 Months|Overall Study||257
8097977|NCT03282227|19959708|P1|STARTED|Overall Study||342
8097978|NCT03282071|19959720|P2|NOT COMPLETED|Overall Study||9
8097979|NCT03282071|19959721|P1|NOT COMPLETED|Overall Study||10
8097980|NCT03282071|19959720|P2|COMPLETED|Overall Study||60
8097981|NCT03282071|19959721|P1|COMPLETED|Overall Study||65
8097982|NCT03282071|19959720|P2|STARTED|Overall Study||69
8097983|NCT03282071|19959721|P1|STARTED|Overall Study||75
8097984|NCT03281876|19959744|P2|NOT COMPLETED|Overall Study||39
8097985|NCT03281876|19959745|P1|NOT COMPLETED|Overall Study||23
8097986|NCT03281876|19959744|P2|COMPLETED|Overall Study||263
8097987|NCT03281876|19959745|P1|COMPLETED|Overall Study||281
8097988|NCT03281876|19959744|P2|STARTED|Overall Study||302
8097989|NCT03281876|19959745|P1|STARTED|Overall Study||304
8097990|NCT03281668|19959815|P1|NOT COMPLETED|Overall Study||8
8097991|NCT03281668|19959815|P1|COMPLETED|Overall Study||21
8097992|NCT03281668|19959815|P1|STARTED|Overall Study||29
8097993|NCT03281577|19959843|P4|NOT COMPLETED|Overall Study||1
8097994|NCT03281577|19959844|P3|NOT COMPLETED|Overall Study||0
8097995|NCT03281577|19959845|P2|NOT COMPLETED|Overall Study||0
8097996|NCT03281577|19959846|P1|NOT COMPLETED|Overall Study||1
8097997|NCT03281577|19959843|P4|COMPLETED|Overall Study||6
8097998|NCT03281577|19959844|P3|COMPLETED|Overall Study||9
8097999|NCT03281577|19959845|P2|COMPLETED|Overall Study||10
8098000|NCT03281577|19959846|P1|COMPLETED|Overall Study||9
8098001|NCT03281577|19959843|P4|STARTED|Overall Study||7
8098002|NCT03281577|19959844|P3|STARTED|Overall Study||9
8098003|NCT03281577|19959845|P2|STARTED|Overall Study||10
8098004|NCT03281577|19959846|P1|STARTED|Overall Study||10
8098005|NCT03281200|19959877|P1|NOT COMPLETED|Overall Study||0
8098006|NCT03281200|19959877|P1|COMPLETED|Overall Study||172
8098007|NCT03281200|19959877|P1|STARTED|Overall Study||172
8098008|NCT03280615|19959901|P2|NOT COMPLETED|Overall Study||5
8098009|NCT03280615|19959902|P1|NOT COMPLETED|Overall Study||4
8098010|NCT03280615|19959901|P2|COMPLETED|Overall Study||45
8098011|NCT03280615|19959902|P1|COMPLETED|Overall Study||46
8098012|NCT03280615|19959901|P2|STARTED|Overall Study||50
8098013|NCT03280615|19959902|P1|STARTED|Overall Study||50
8098014|NCT03280550|19959914|P2|NOT COMPLETED|Overall Study||3
8098015|NCT03280550|19959915|P1|NOT COMPLETED|Overall Study||2
8098016|NCT03280550|19959914|P2|COMPLETED|Overall Study||69
8098017|NCT03280550|19959915|P1|COMPLETED|Overall Study||64
8098018|NCT03280550|19959914|P2|STARTED|Overall Study||72
8098019|NCT03280550|19959915|P1|STARTED|Overall Study||66
8098020|NCT03280537|19959967|P2|NOT COMPLETED|Overall Study||4
8098021|NCT03280537|19959968|P1|NOT COMPLETED|Overall Study||2
8098022|NCT03280537|19959967|P2|COMPLETED|Overall Study||58
8098023|NCT03280537|19959968|P1|COMPLETED|Overall Study||63
8098024|NCT03280537|19959967|P2|STARTED|Overall Study||62
8098025|NCT03280537|19959968|P1|STARTED|Overall Study||65
8098026|NCT03280381|19960020|P2|NOT COMPLETED|Overall Study||2
8098027|NCT03280381|19960021|P1|NOT COMPLETED|Overall Study||0
8098028|NCT03280381|19960020|P2|COMPLETED|Overall Study||97
8098029|NCT03280381|19960021|P1|COMPLETED|Overall Study||101
8098030|NCT03280381|19960020|P2|STARTED|Overall Study||99
8098031|NCT03280381|19960021|P1|STARTED|Overall Study||101
8098035|NCT03280108|19960037|P2|NOT COMPLETED|Overall Study||0
8098036|NCT03280108|19960038|P1|NOT COMPLETED|Overall Study||2
8098037|NCT03280108|19960037|P2|COMPLETED|Overall Study||114
8098038|NCT03280108|19960038|P1|COMPLETED|Overall Study||127
8098039|NCT03280108|19960037|P2|STARTED|Overall Study||114
8098040|NCT03280108|19960038|P1|STARTED|Overall Study||129
8098041|NCT03279731|19960071|P2|NOT COMPLETED|Overall Study||3
8098042|NCT03279731|19960072|P1|NOT COMPLETED|Overall Study||6
8098043|NCT03279731|19960071|P2|COMPLETED|Overall Study||14
8098044|NCT03279731|19960072|P1|COMPLETED|Overall Study||13
8098045|NCT03279731|19960071|P2|STARTED|Overall Study||17
8098046|NCT03279731|19960072|P1|STARTED|Overall Study||19
8098047|NCT03279458|19960084|P1|NOT COMPLETED|Overall Study||0
8098048|NCT03279458|19960084|P1|COMPLETED|Overall Study||40
8098049|NCT03279458|19960084|P1|STARTED|Overall Study||40
8098050|NCT03279237|19960090|P1|NOT COMPLETED|Overall Study||5
8098051|NCT03279237|19960090|P1|COMPLETED|Overall Study||20
8098052|NCT03279237|19960090|P1|Surgical Resection|Overall Study||20
8098053|NCT03279237|19960090|P1|Chemo-radiation|Overall Study||23
8098054|NCT03279237|19960090|P1|STARTED|Overall Study||25
8098055|NCT03278886|19960099|P2|NOT COMPLETED|Overall Study||1
8098056|NCT03278886|19960100|P1|NOT COMPLETED|Overall Study||0
8098057|NCT03278886|19960099|P2|COMPLETED|Overall Study||2
8098058|NCT03278886|19960100|P1|COMPLETED|Overall Study||8
8098059|NCT03278886|19960099|P2|STARTED|Overall Study||3
8098060|NCT03278886|19960100|P1|STARTED|Overall Study||8
8098061|NCT03278106|19960120|P1|NOT COMPLETED|Overall Study||1
8098062|NCT03278106|19960120|P1|COMPLETED|Overall Study||27
8098063|NCT03278106|19960120|P1|STARTED|Overall Study||28
8098064|NCT03278067|19960131|P3|NOT COMPLETED|Overall Study||0
8098065|NCT03278067|19960132|P2|NOT COMPLETED|Overall Study||0
8098066|NCT03278067|19960133|P1|NOT COMPLETED|Overall Study||0
8098067|NCT03278067|19960131|P3|COMPLETED|Overall Study||4196
8098068|NCT03278067|19960132|P2|COMPLETED|Overall Study||3310
8098069|NCT03278067|19960133|P1|COMPLETED|Overall Study||16433
8098070|NCT03278067|19960131|P3|STARTED|Overall Study||4196
8098071|NCT03278067|19960132|P2|STARTED|Overall Study||3310
8098072|NCT03278067|19960133|P1|STARTED|Overall Study||16433
8098073|NCT03278028|19960536|P2|NOT COMPLETED|Overall Study||2
8098074|NCT03278028|19960537|P1|NOT COMPLETED|Overall Study||4
8098075|NCT03278028|19960536|P2|COMPLETED|Overall Study||76
8098076|NCT03278028|19960537|P1|COMPLETED|Overall Study||77
8098077|NCT03278028|19960536|P2|STARTED|Overall Study||78
8098078|NCT03278028|19960537|P1|STARTED|Overall Study||81
8098079|NCT03277846|19960545|P2|NOT COMPLETED|Overall Study||11
8098080|NCT03277846|19960546|P1|NOT COMPLETED|Overall Study||12
8098081|NCT03277846|19960545|P2|COMPLETED|Overall Study||40
8098082|NCT03277846|19960546|P1|COMPLETED|Overall Study||38
8098083|NCT03277846|19960545|P2|STARTED|Overall Study||51
8098084|NCT03277846|19960546|P1|STARTED|Overall Study||50
8098085|NCT03277378|19960554|P2|NOT COMPLETED|Overall Study||34
8098086|NCT03277378|19960555|P1|NOT COMPLETED|Overall Study||24
8098087|NCT03277378|19960554|P2|COMPLETED|Overall Study||101
8098088|NCT03277378|19960555|P1|COMPLETED|Overall Study||111
8098089|NCT03277378|19960554|P2|Exit Study|Overall Study||8
8098090|NCT03277378|19960555|P1|Exit Study|Overall Study||11
8098091|NCT03277378|19960554|P2|Completed Extended Trial With Tonic Stim|Overall Study||12
8098092|NCT03277378|19960555|P1|Completed Extended Trial With Tonic Stim|Overall Study||8
8098093|NCT03277378|19960554|P2|Not Qualified for Permanent Implant|Overall Study||20
8098094|NCT03277378|19960555|P1|Not Qualified for Permanent Implant|Overall Study||19
8098095|NCT03277378|19960554|P2|Qualified for Permanent Implant|Overall Study||93
8098096|NCT03277378|19960555|P1|Qualified for Permanent Implant|Overall Study||103
8098097|NCT03277378|19960554|P2|Completed Initial Trial|Overall Study||122
8098098|NCT03277378|19960555|P1|Completed Initial Trial|Overall Study||126
8098099|NCT03277378|19960554|P2|Received Lead Implant|Overall Study||123
8098100|NCT03277378|19960555|P1|Received Lead Implant|Overall Study||129
8098101|NCT03277378|19960554|P2|STARTED|Overall Study||135
8098102|NCT03277378|19960555|P1|STARTED|Overall Study||135
8098103|NCT03277274|19960606|P3|NOT COMPLETED|Overall Study||0
8098104|NCT03277274|19960607|P2|NOT COMPLETED|Overall Study||0
8098105|NCT03277274|19960608|P1|NOT COMPLETED|Overall Study||0
8098106|NCT03277274|19960606|P3|COMPLETED|Overall Study||7
8098107|NCT03277274|19960607|P2|COMPLETED|Overall Study||10
8098108|NCT03277274|19960608|P1|COMPLETED|Overall Study||8
8098109|NCT03277274|19960606|P3|STARTED|Overall Study||7
8098110|NCT03277274|19960607|P2|STARTED|Overall Study||10
8098111|NCT03277274|19960608|P1|STARTED|Overall Study||8
8098112|NCT03277183|19960639|P2|NOT COMPLETED|Overall Study||2
8098113|NCT03277183|19960640|P1|NOT COMPLETED|Overall Study||3
8098114|NCT03277183|19960639|P2|COMPLETED|Overall Study||0
8098115|NCT03277183|19960640|P1|COMPLETED|Overall Study||0
8098116|NCT03277183|19960639|P2|STARTED|Overall Study||2
8098117|NCT03277183|19960640|P1|STARTED|Overall Study||3
8098126|NCT03276936|19960687|P2|NOT COMPLETED|Overall Study||38
8098127|NCT03276936|19960688|P1|NOT COMPLETED|Overall Study||56
8098128|NCT03276936|19960687|P2|COMPLETED|Overall Study||134
8098129|NCT03276936|19960688|P1|COMPLETED|Overall Study||276
8098130|NCT03276936|19960687|P2|STARTED|Overall Study||172
8098131|NCT03276936|19960688|P1|STARTED|Overall Study||332
8098132|NCT03276871|19960708|P2|NOT COMPLETED|Overall Study||0
8098133|NCT03276871|19960709|P1|NOT COMPLETED|Overall Study||0
8098134|NCT03276871|19960708|P2|COMPLETED|Overall Study||19
8098135|NCT03276871|19960709|P1|COMPLETED|Overall Study||21
8098136|NCT03276871|19960708|P2|STARTED|Overall Study||19
8098137|NCT03276871|19960709|P1|STARTED|Overall Study||21
8098138|NCT03276494|19960721|P1|NOT COMPLETED|Overall Study||1
8098139|NCT03276494|19960721|P1|COMPLETED|Overall Study||5
8098140|NCT03276494|19960721|P1|STARTED|Overall Study||6
8098141|NCT03276078|19960726|P1|NOT COMPLETED|Overall Study||1
8098142|NCT03276078|19960726|P1|COMPLETED|Overall Study||19
8098143|NCT03276078|19960726|P1|STARTED|Overall Study||20
8098144|NCT03276026|19960755|P2|NOT COMPLETED|Overall Study||0
8098145|NCT03276026|19960756|P1|NOT COMPLETED|Overall Study||1
8098146|NCT03276026|19960755|P2|COMPLETED|Overall Study||33
8098147|NCT03276026|19960756|P1|COMPLETED|Overall Study||34
8098148|NCT03276026|19960755|P2|STARTED|Overall Study||33
8098149|NCT03276026|19960756|P1|STARTED|Overall Study||35
8098150|NCT03275870|19960766|P1|NOT COMPLETED|Overall Study||14
8098151|NCT03275870|19960766|P1|COMPLETED|Overall Study||3
8098152|NCT03275870|19960766|P1|STARTED|Overall Study||17
8098153|NCT03275623|19960773|P2|NOT COMPLETED|Overall Study||2
8098154|NCT03275623|19960774|P1|NOT COMPLETED|Overall Study||5
8098155|NCT03275623|19960773|P2|COMPLETED|Overall Study||28
8098156|NCT03275623|19960774|P1|COMPLETED|Overall Study||25
8098157|NCT03275623|19960773|P2|STARTED|Overall Study||30
8098158|NCT03275623|19960774|P1|STARTED|Overall Study||30
8098159|NCT03274986|19960784|P2|NOT COMPLETED|Overall Study||2
8098160|NCT03274986|19960785|P1|NOT COMPLETED|Overall Study||0
8098161|NCT03274986|19960784|P2|COMPLETED|Overall Study||111
8098162|NCT03274986|19960785|P1|COMPLETED|Overall Study||107
8098163|NCT03274986|19960784|P2|Successful Implantation, as Treated|Overall Study||113
8098164|NCT03274986|19960785|P1|Successful Implantation, as Treated|Overall Study||107
8098165|NCT03274986|19960784|P2|STARTED|Overall Study||113
8098166|NCT03274986|19960785|P1|STARTED|Overall Study||107
8098167|NCT03274856|19960818|P2|NOT COMPLETED|Overall Study||0
8098168|NCT03274856|19960819|P1|NOT COMPLETED|Overall Study||0
8098169|NCT03274856|19960818|P2|COMPLETED|Overall Study||9
8098170|NCT03274856|19960819|P1|COMPLETED|Overall Study||10
8098171|NCT03274856|19960818|P2|STARTED|Overall Study||9
8098172|NCT03274856|19960819|P1|STARTED|Overall Study||10
8098173|NCT03274518|19960835|P2|NOT COMPLETED|Second Intervention||0
8098174|NCT03274518|19960836|P1|NOT COMPLETED|Second Intervention||0
8098175|NCT03274518|19960835|P2|COMPLETED|Second Intervention||8
8098176|NCT03274518|19960836|P1|COMPLETED|Second Intervention||8
8098177|NCT03274518|19960835|P2|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
8098178|NCT03274518|19960836|P1|STARTED|Second Intervention||8
8098179|NCT03274518|19960835|P2|NOT COMPLETED|Washout Period||0
8098180|NCT03274518|19960836|P1|NOT COMPLETED|Washout Period||0
8098181|NCT03274518|19960835|P2|COMPLETED|Washout Period||8
8098182|NCT03274518|19960836|P1|COMPLETED|Washout Period||8
8098183|NCT03274518|19960835|P2|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
8098184|NCT03274518|19960836|P1|STARTED|Washout Period||8
8098185|NCT03274518|19960835|P2|NOT COMPLETED|First Intervention||0
8098186|NCT03274518|19960836|P1|NOT COMPLETED|First Intervention||0
8098187|NCT03274518|19960835|P2|COMPLETED|First Intervention||8
8098188|NCT03274518|19960836|P1|COMPLETED|First Intervention||8
8098189|NCT03274518|19960835|P2|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
8098190|NCT03274518|19960836|P1|STARTED|First Intervention||8
8098191|NCT03274453|19960852|P4|NOT COMPLETED|Overall Study||4
8098192|NCT03274453|19960853|P3|NOT COMPLETED|Overall Study||4
8098193|NCT03274453|19960854|P2|NOT COMPLETED|Overall Study||6
8098194|NCT03274453|19960855|P1|NOT COMPLETED|Overall Study||4
8098195|NCT03274453|19960852|P4|COMPLETED|Overall Study||25
8098196|NCT03274453|19960853|P3|COMPLETED|Overall Study||28
8098197|NCT03274453|19960854|P2|COMPLETED|Overall Study||24
8098198|NCT03274453|19960855|P1|COMPLETED|Overall Study||34
8098199|NCT03274453|19960852|P4|STARTED|Overall Study||29
8098200|NCT03274453|19960853|P3|STARTED|Overall Study||32
8098201|NCT03274453|19960854|P2|STARTED|Overall Study||30
8098202|NCT03274453|19960855|P1|STARTED|Overall Study||38
8098203|NCT03274440|19960865|P6|NOT COMPLETED|Overall Study||0
8098204|NCT03274440|19960866|P5|NOT COMPLETED|Overall Study||0
8098205|NCT03274440|19960867|P4|NOT COMPLETED|Overall Study||1
8098206|NCT03274440|19960868|P3|NOT COMPLETED|Overall Study||0
8098207|NCT03274440|19960869|P2|NOT COMPLETED|Overall Study||0
8098208|NCT03274440|19960870|P1|NOT COMPLETED|Overall Study||1
8098209|NCT03274440|19960865|P6|COMPLETED|Overall Study||3
8098210|NCT03274440|19960866|P5|COMPLETED|Overall Study||1
8098211|NCT03274440|19960867|P4|COMPLETED|Overall Study||0
8098212|NCT03274440|19960868|P3|COMPLETED|Overall Study||4
8098213|NCT03274440|19960869|P2|COMPLETED|Overall Study||2
8098214|NCT03274440|19960870|P1|COMPLETED|Overall Study||2
8098215|NCT03274440|19960865|P6|STARTED|Overall Study||3
8098216|NCT03274440|19960866|P5|STARTED|Overall Study||1
8098217|NCT03274440|19960867|P4|STARTED|Overall Study||1
8098218|NCT03274440|19960868|P3|STARTED|Overall Study||4
8098219|NCT03274440|19960869|P2|STARTED|Overall Study||2
8098220|NCT03274440|19960870|P1|STARTED|Overall Study||3
8098221|NCT03274076|19960883|P4|NOT COMPLETED|24 Weeks Open Label||1
8098222|NCT03274076|19960884|P3|NOT COMPLETED|24 Weeks Open Label||2
8098223|NCT03274076|19960885|P2|NOT COMPLETED|24 Weeks Open Label||0
8098224|NCT03274076|19960886|P1|NOT COMPLETED|24 Weeks Open Label||0
8098225|NCT03274076|19960883|P4|COMPLETED|24 Weeks Open Label||3
8098226|NCT03274076|19960884|P3|COMPLETED|24 Weeks Open Label||8
8098227|NCT03274076|19960885|P2|COMPLETED|24 Weeks Open Label||0
8098228|NCT03274076|19960886|P1|COMPLETED|24 Weeks Open Label||0
8098229|NCT03274076|19960883|P4|STARTED|24 Weeks Open Label||4
8098230|NCT03274076|19960884|P3|STARTED|24 Weeks Open Label||10
8098231|NCT03274076|19960885|P2|STARTED|24 Weeks Open Label||0
8098232|NCT03274076|19960886|P1|STARTED|24 Weeks Open Label||0
8098233|NCT03274076|19960883|P4|NOT COMPLETED|24 Weeks Double Blind||0
8098234|NCT03274076|19960884|P3|NOT COMPLETED|24 Weeks Double Blind||0
8098235|NCT03274076|19960885|P2|NOT COMPLETED|24 Weeks Double Blind||1
8098236|NCT03274076|19960886|P1|NOT COMPLETED|24 Weeks Double Blind||0
8098237|NCT03274076|19960883|P4|COMPLETED|24 Weeks Double Blind||0
8098238|NCT03274076|19960884|P3|COMPLETED|24 Weeks Double Blind||0
8098239|NCT03274076|19960885|P2|COMPLETED|24 Weeks Double Blind||4
8098240|NCT03274076|19960886|P1|COMPLETED|24 Weeks Double Blind||10
8098241|NCT03274076|19960883|P4|STARTED|24 Weeks Double Blind||0
8098242|NCT03274076|19960884|P3|STARTED|24 Weeks Double Blind||0
8098243|NCT03274076|19960885|P2|STARTED|24 Weeks Double Blind||5
8098244|NCT03274076|19960886|P1|STARTED|24 Weeks Double Blind||10
8098245|NCT03273946|19960914|P1|NOT COMPLETED|Overall Study||9
8098246|NCT03273946|19960914|P1|COMPLETED|Overall Study||149
8098247|NCT03273946|19960914|P1|STARTED|Overall Study||158
8098248|NCT03273673|19960922|P2|NOT COMPLETED|Overall Study||0
8098249|NCT03273673|19960923|P1|NOT COMPLETED|Overall Study||4
8098250|NCT03273673|19960922|P2|COMPLETED|Overall Study||22
8098251|NCT03273673|19960923|P1|COMPLETED|Overall Study||14
8098252|NCT03273673|19960922|P2|STARTED|Overall Study||22
8098253|NCT03273673|19960923|P1|STARTED|Overall Study||18
8098254|NCT03273543|19960941|P2|NOT COMPLETED|Overall Study||0
8098255|NCT03273543|19960942|P1|NOT COMPLETED|Overall Study||0
8098256|NCT03273543|19960941|P2|COMPLETED|Overall Study||10
8098257|NCT03273543|19960942|P1|COMPLETED|Overall Study||10
8098258|NCT03273543|19960941|P2|STARTED|Overall Study||10
8098259|NCT03273543|19960942|P1|STARTED|Overall Study||10
8098260|NCT03273426|19960950|P2|NOT COMPLETED|Overall Study||0
8098261|NCT03273426|19960951|P1|NOT COMPLETED|Overall Study||0
8098262|NCT03273426|19960950|P2|COMPLETED|Overall Study||20
8098263|NCT03273426|19960951|P1|COMPLETED|Overall Study||20
8098264|NCT03273426|19960950|P2|STARTED|Overall Study||20
8098265|NCT03273426|19960951|P1|STARTED|Overall Study||20
8098266|NCT03273387|19960962|P2|NOT COMPLETED|Overall Study||3
8098267|NCT03273387|19960963|P1|NOT COMPLETED|Overall Study||3
8098268|NCT03273387|19960962|P2|COMPLETED|Overall Study||10
8098269|NCT03273387|19960963|P1|COMPLETED|Overall Study||10
8098270|NCT03273387|19960962|P2|STARTED|Overall Study||13
8098271|NCT03273387|19960963|P1|STARTED|Overall Study||13
8098272|NCT03273283|19960975|P2|NOT COMPLETED|Overall Study||20
8098273|NCT03273283|19960976|P1|NOT COMPLETED|Overall Study||27
8098274|NCT03273283|19960975|P2|COMPLETED|Overall Study||81
8098275|NCT03273283|19960976|P1|COMPLETED|Overall Study||72
8098276|NCT03273283|19960975|P2|STARTED|Overall Study||101
8098277|NCT03273283|19960976|P1|STARTED|Overall Study||99
8098278|NCT03273166|19960984|P1|NOT COMPLETED|Overall Study||31
8098279|NCT03273166|19960984|P1|COMPLETED|Overall Study||51
8098280|NCT03273166|19960984|P1|STARTED|Overall Study||82
8098287|NCT03272711|19961014|P2|NOT COMPLETED|Overall Study||8
8098288|NCT03272711|19961015|P1|NOT COMPLETED|Overall Study||7
8098289|NCT03272711|19961014|P2|COMPLETED|Overall Study||41
8098290|NCT03272711|19961015|P1|COMPLETED|Overall Study||44
8098291|NCT03272711|19961014|P2|STARTED|Overall Study||49
8098292|NCT03272711|19961015|P1|STARTED|Overall Study||51
8098293|NCT03272139|19961027|P2|NOT COMPLETED|Overall Study||0
8098294|NCT03272139|19961028|P1|NOT COMPLETED|Overall Study||0
8098295|NCT03272139|19961027|P2|COMPLETED|Overall Study||63
8098296|NCT03272139|19961028|P1|COMPLETED|Overall Study||63
8098297|NCT03272139|19961027|P2|STARTED|Overall Study||63
8098298|NCT03272139|19961028|P1|STARTED|Overall Study||63
8098299|NCT03271424|19961041|P3|NOT COMPLETED|April-May 2016||0
8098300|NCT03271424|19961042|P2|NOT COMPLETED|April-May 2016||0
8098301|NCT03271424|19961043|P1|NOT COMPLETED|April-May 2016||0
8098302|NCT03271424|19961041|P3|COMPLETED|April-May 2016||40
8098303|NCT03271424|19961042|P2|COMPLETED|April-May 2016||0
8098304|NCT03271424|19961043|P1|COMPLETED|April-May 2016||0
8098305|NCT03271424|19961041|P3|STARTED|April-May 2016||40
8098306|NCT03271424|19961042|P2|STARTED|April-May 2016||0
8098307|NCT03271424|19961043|P1|STARTED|April-May 2016||0
8098308|NCT03271424|19961041|P3|NOT COMPLETED|December 2015||0
8098309|NCT03271424|19961042|P2|NOT COMPLETED|December 2015||0
8098310|NCT03271424|19961043|P1|NOT COMPLETED|December 2015||0
8098311|NCT03271424|19961041|P3|COMPLETED|December 2015||0
8098312|NCT03271424|19961042|P2|COMPLETED|December 2015||35
8098313|NCT03271424|19961043|P1|COMPLETED|December 2015||0
8098314|NCT03271424|19961041|P3|STARTED|December 2015||0
8098315|NCT03271424|19961042|P2|STARTED|December 2015||35
8098316|NCT03271424|19961043|P1|STARTED|December 2015||0
8098317|NCT03271424|19961041|P3|NOT COMPLETED|November 2015||0
8098318|NCT03271424|19961042|P2|NOT COMPLETED|November 2015||0
8098319|NCT03271424|19961043|P1|NOT COMPLETED|November 2015||0
8098320|NCT03271424|19961041|P3|COMPLETED|November 2015||0
8098321|NCT03271424|19961042|P2|COMPLETED|November 2015||0
8098322|NCT03271424|19961043|P1|COMPLETED|November 2015||20
8098323|NCT03271424|19961041|P3|STARTED|November 2015||0
8098324|NCT03271424|19961042|P2|STARTED|November 2015||0
8098325|NCT03271424|19961043|P1|STARTED|November 2015||20
8098326|NCT03271307|19961058|P5|NOT COMPLETED|Overall Study||91
8098327|NCT03271307|19961059|P4|NOT COMPLETED|Overall Study||28
8098328|NCT03271307|19961060|P3|NOT COMPLETED|Overall Study||0
8098329|NCT03271307|19961061|P2|NOT COMPLETED|Overall Study||0
8098330|NCT03271307|19961062|P1|NOT COMPLETED|Overall Study||0
8098331|NCT03271307|19961058|P5|COMPLETED|Overall Study||258
8098332|NCT03271307|19961059|P4|COMPLETED|Overall Study||107
8098333|NCT03271307|19961060|P3|COMPLETED|Overall Study||2097
8098334|NCT03271307|19961061|P2|COMPLETED|Overall Study||1837
8098335|NCT03271307|19961062|P1|COMPLETED|Overall Study||1951
8098336|NCT03271307|19961058|P5|STARTED|Overall Study||349
8098337|NCT03271307|19961059|P4|STARTED|Overall Study||135
8098338|NCT03271307|19961060|P3|STARTED|Overall Study||2097
8098339|NCT03271307|19961061|P2|STARTED|Overall Study||1837
8098340|NCT03271307|19961062|P1|STARTED|Overall Study||1951
8098341|NCT03271021|19961118|P2|NOT COMPLETED|Overall Study||106
8098342|NCT03271021|19961119|P1|NOT COMPLETED|Overall Study||89
8098343|NCT03271021|19961118|P2|COMPLETED|Overall Study||644
8098344|NCT03271021|19961119|P1|COMPLETED|Overall Study||649
8098345|NCT03271021|19961118|P2|STARTED|Overall Study||750
8098346|NCT03271021|19961119|P1|STARTED|Overall Study||738
8098347|NCT03270657|19961137|P1|NOT COMPLETED|Overall Study||1
8098348|NCT03270657|19961137|P1|COMPLETED|Overall Study||4
8098349|NCT03270657|19961137|P1|STARTED|Overall Study||5
8098350|NCT03270644|19961143|P1|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
8098351|NCT03270644|19961143|P1|COMPLETED|Day 4 - 10 Propranolol Reference||42
8098352|NCT03270644|19961143|P1|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
8098353|NCT03270644|19961143|P1|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
8098354|NCT03270644|19961143|P1|STARTED|Day 4 - 10 Propranolol Reference||43
8098355|NCT03270644|19961143|P1|NOT COMPLETED|Day 1 Lasmiditan Reference||1
8098356|NCT03270644|19961143|P1|COMPLETED|Day 1 Lasmiditan Reference||43
8098357|NCT03270644|19961143|P1|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
8098358|NCT03270644|19961143|P1|STARTED|Day 1 Lasmiditan Reference||44
8098359|NCT03270436|19961166|P2|NOT COMPLETED|6 Months Post-Intervention||51
8098360|NCT03270436|19961167|P1|NOT COMPLETED|6 Months Post-Intervention||40
8098361|NCT03270436|19961166|P2|COMPLETED|6 Months Post-Intervention||116
8098362|NCT03270436|19961167|P1|COMPLETED|6 Months Post-Intervention||173
8098363|NCT03270436|19961166|P2|STARTED|6 Months Post-Intervention||167
8098364|NCT03270436|19961167|P1|STARTED|6 Months Post-Intervention||213
8098365|NCT03270436|19961166|P2|NOT COMPLETED|Immediate Post-Intervention||56
8098366|NCT03270436|19961167|P1|NOT COMPLETED|Immediate Post-Intervention||41
8098367|NCT03270436|19961166|P2|COMPLETED|Immediate Post-Intervention||111
8098368|NCT03270436|19961167|P1|COMPLETED|Immediate Post-Intervention||172
8098369|NCT03270436|19961166|P2|STARTED|Immediate Post-Intervention||167
8098370|NCT03270436|19961167|P1|STARTED|Immediate Post-Intervention||213
8098371|NCT03270436|19961166|P2|NOT COMPLETED|Baseline||1
8098372|NCT03270436|19961167|P1|NOT COMPLETED|Baseline||1
8098373|NCT03270436|19961166|P2|COMPLETED|Baseline||166
8098374|NCT03270436|19961167|P1|COMPLETED|Baseline||212
8098375|NCT03270436|19961166|P2|STARTED|Baseline||167
8098376|NCT03270436|19961167|P1|STARTED|Baseline||213
8098377|NCT03270085|19961193|P2|NOT COMPLETED|Overall Study||0
8098378|NCT03270085|19961194|P1|NOT COMPLETED|Overall Study||1
8098379|NCT03270085|19961193|P2|COMPLETED|Overall Study||15
8098380|NCT03270085|19961194|P1|COMPLETED|Overall Study||14
8098381|NCT03270085|19961193|P2|STARTED|Overall Study||15
8098382|NCT03270085|19961194|P1|STARTED|Overall Study||15
8098383|NCT03269968|19961206|P2|NOT COMPLETED|Overall Study||0
8098384|NCT03269968|19961207|P1|NOT COMPLETED|Overall Study||0
8098385|NCT03269968|19961206|P2|COMPLETED|Overall Study||0
8098386|NCT03269968|19961207|P1|COMPLETED|Overall Study||0
8098387|NCT03269968|19961206|P2|STARTED|Overall Study||0
8098388|NCT03269968|19961207|P1|STARTED|Overall Study||0
8098389|NCT03269552|19961215|P1|NOT COMPLETED|Overall Study||2
8098390|NCT03269552|19961215|P1|COMPLETED|Overall Study||2
8098391|NCT03269552|19961215|P1|STARTED|Overall Study||4
8098392|NCT03268941|19961226|P7|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098393|NCT03268941|19961227|P6|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098394|NCT03268941|19961228|P5|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098395|NCT03268941|19961229|P4|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098396|NCT03268941|19961230|P3|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098397|NCT03268941|19961231|P2|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098398|NCT03268941|19961232|P1|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098399|NCT03268941|19961226|P7|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098400|NCT03268941|19961227|P6|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
8098401|NCT03268941|19961228|P5|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098402|NCT03268941|19961229|P4|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098403|NCT03268941|19961230|P3|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098404|NCT03268941|19961231|P2|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098405|NCT03268941|19961232|P1|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098406|NCT03268941|19961226|P7|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098407|NCT03268941|19961227|P6|STARTED|Part 2: Period 2: Fasted (Day 25)||6
8098408|NCT03268941|19961228|P5|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098409|NCT03268941|19961229|P4|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098410|NCT03268941|19961230|P3|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098411|NCT03268941|19961231|P2|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098412|NCT03268941|19961232|P1|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098413|NCT03268941|19961226|P7|NOT COMPLETED|Part 2: Days 17 to 25||2
8098414|NCT03268941|19961227|P6|NOT COMPLETED|Part 2: Days 17 to 25||0
8098415|NCT03268941|19961228|P5|NOT COMPLETED|Part 2: Days 17 to 25||0
8098416|NCT03268941|19961229|P4|NOT COMPLETED|Part 2: Days 17 to 25||0
8098417|NCT03268941|19961230|P3|NOT COMPLETED|Part 2: Days 17 to 25||0
8098418|NCT03268941|19961231|P2|NOT COMPLETED|Part 2: Days 17 to 25||0
8098419|NCT03268941|19961232|P1|NOT COMPLETED|Part 2: Days 17 to 25||0
8098420|NCT03268941|19961226|P7|COMPLETED|Part 2: Days 17 to 25||13
8098421|NCT03268941|19961227|P6|COMPLETED|Part 2: Days 17 to 25||0
8098422|NCT03268941|19961228|P5|COMPLETED|Part 2: Days 17 to 25||6
8098423|NCT03268941|19961229|P4|COMPLETED|Part 2: Days 17 to 25||0
8098424|NCT03268941|19961230|P3|COMPLETED|Part 2: Days 17 to 25||0
8098425|NCT03268941|19961231|P2|COMPLETED|Part 2: Days 17 to 25||0
8098426|NCT03268941|19961232|P1|COMPLETED|Part 2: Days 17 to 25||0
8098427|NCT03268941|19961226|P7|Treated|Part 2: Days 17 to 25||13
8098428|NCT03268941|19961227|P6|Treated|Part 2: Days 17 to 25||0
8098429|NCT03268941|19961228|P5|Treated|Part 2: Days 17 to 25||6
8098430|NCT03268941|19961229|P4|Treated|Part 2: Days 17 to 25||0
8098431|NCT03268941|19961230|P3|Treated|Part 2: Days 17 to 25||0
8098432|NCT03268941|19961231|P2|Treated|Part 2: Days 17 to 25||0
8098433|NCT03268941|19961232|P1|Treated|Part 2: Days 17 to 25||0
8098434|NCT03268941|19961226|P7|STARTED|Part 2: Days 17 to 25||15
8098435|NCT03268941|19961227|P6|STARTED|Part 2: Days 17 to 25||0
8098436|NCT03268941|19961228|P5|STARTED|Part 2: Days 17 to 25||6
8098437|NCT03268941|19961229|P4|STARTED|Part 2: Days 17 to 25||0
8098438|NCT03268941|19961230|P3|STARTED|Part 2: Days 17 to 25||0
8098439|NCT03268941|19961231|P2|STARTED|Part 2: Days 17 to 25||0
8098440|NCT03268941|19961232|P1|STARTED|Part 2: Days 17 to 25||0
8098441|NCT03268941|19961226|P7|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098442|NCT03268941|19961227|P6|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098443|NCT03268941|19961228|P5|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098444|NCT03268941|19961229|P4|NOT COMPLETED|Part 1 (Days 1 to 9)||2
8098445|NCT03268941|19961230|P3|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098446|NCT03268941|19961231|P2|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098447|NCT03268941|19961232|P1|NOT COMPLETED|Part 1 (Days 1 to 9)||1
8098448|NCT03268941|19961226|P7|COMPLETED|Part 1 (Days 1 to 9)||0
8098449|NCT03268941|19961227|P6|COMPLETED|Part 1 (Days 1 to 9)||0
8098450|NCT03268941|19961228|P5|COMPLETED|Part 1 (Days 1 to 9)||0
8098451|NCT03268941|19961229|P4|COMPLETED|Part 1 (Days 1 to 9)||11
8098452|NCT03268941|19961230|P3|COMPLETED|Part 1 (Days 1 to 9)||12
8098453|NCT03268941|19961231|P2|COMPLETED|Part 1 (Days 1 to 9)||14
8098454|NCT03268941|19961232|P1|COMPLETED|Part 1 (Days 1 to 9)||11
8098455|NCT03268941|19961226|P7|STARTED|Part 1 (Days 1 to 9)||0
8098456|NCT03268941|19961227|P6|STARTED|Part 1 (Days 1 to 9)||0
8098457|NCT03268941|19961228|P5|STARTED|Part 1 (Days 1 to 9)||0
8098458|NCT03268941|19961229|P4|STARTED|Part 1 (Days 1 to 9)||13
8098459|NCT03268941|19961230|P3|STARTED|Part 1 (Days 1 to 9)||12
8098460|NCT03268941|19961231|P2|STARTED|Part 1 (Days 1 to 9)||14
8098461|NCT03268941|19961232|P1|STARTED|Part 1 (Days 1 to 9)||12
8098462|NCT03268746|19961294|P1|NOT COMPLETED|Overall Study||1
8098463|NCT03268746|19961294|P1|COMPLETED|Overall Study||44
8098464|NCT03268746|19961294|P1|STARTED|Overall Study||45
8098465|NCT03268590|19961316|P1|NOT COMPLETED|Overall Study||1
8098466|NCT03268590|19961316|P1|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
8098467|NCT03268590|19961316|P1|STARTED|Overall Study||33
8098468|NCT03268343|19961323|P2|NOT COMPLETED|Overall Study||0
8098469|NCT03268343|19961324|P1|NOT COMPLETED|Overall Study||0
8098470|NCT03268343|19961323|P2|COMPLETED|Overall Study||12
8098471|NCT03268343|19961324|P1|COMPLETED|Overall Study||12
8098472|NCT03268343|19961323|P2|STARTED|Overall Study||12
8098473|NCT03268343|19961324|P1|STARTED|Overall Study||12
8098474|NCT03268005|19961351|P2|NOT COMPLETED|Overall Study||14
8098475|NCT03268005|19961352|P1|NOT COMPLETED|Overall Study||15
8098476|NCT03268005|19961351|P2|COMPLETED|Overall Study||531
8098477|NCT03268005|19961352|P1|COMPLETED|Overall Study||531
8098478|NCT03268005|19961351|P2|Safety Analysis Set|Overall Study||544
8098479|NCT03268005|19961352|P1|Safety Analysis Set|Overall Study||544
8098480|NCT03268005|19961351|P2|Full Analysis Set|Overall Study||545
8098481|NCT03268005|19961352|P1|Full Analysis Set|Overall Study||546
8098482|NCT03268005|19961351|P2|STARTED|Overall Study||545
8098483|NCT03268005|19961352|P1|STARTED|Overall Study||546
8098484|NCT03267940|19961466|P6|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
8098485|NCT03267940|19961467|P5|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
8098486|NCT03267940|19961468|P4|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
8098487|NCT03267940|19961469|P3|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
8098488|NCT03267940|19961470|P2|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098489|NCT03267940|19961471|P1|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098490|NCT03267940|19961466|P6|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098491|NCT03267940|19961467|P5|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
8098492|NCT03267940|19961468|P4|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098493|NCT03267940|19961469|P3|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
8098494|NCT03267940|19961470|P2|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098495|NCT03267940|19961471|P1|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098496|NCT03267940|19961466|P6|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
8098497|NCT03267940|19961467|P5|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
8098498|NCT03267940|19961468|P4|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
8098499|NCT03267940|19961469|P3|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
8098500|NCT03267940|19961470|P2|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
8098501|NCT03267940|19961471|P1|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
8098502|NCT03267940|19961466|P6|STARTED|Expansion (Maximum Exposure: 421 Days)||10
8098503|NCT03267940|19961467|P5|STARTED|Expansion (Maximum Exposure: 421 Days)||11
8098504|NCT03267940|19961468|P4|STARTED|Expansion (Maximum Exposure: 421 Days)||22
8098505|NCT03267940|19961469|P3|STARTED|Expansion (Maximum Exposure: 421 Days)||24
8098506|NCT03267940|19961470|P2|STARTED|Expansion (Maximum Exposure: 421 Days)||0
8098507|NCT03267940|19961471|P1|STARTED|Expansion (Maximum Exposure: 421 Days)||0
8098508|NCT03267940|19961466|P6|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098509|NCT03267940|19961467|P5|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098510|NCT03267940|19961468|P4|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098511|NCT03267940|19961469|P3|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098512|NCT03267940|19961470|P2|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
8098513|NCT03267940|19961471|P1|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
8098514|NCT03267940|19961466|P6|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098515|NCT03267940|19961467|P5|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098516|NCT03267940|19961468|P4|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098517|NCT03267940|19961469|P3|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098518|NCT03267940|19961470|P2|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
8098519|NCT03267940|19961471|P1|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
8098520|NCT03267940|19961466|P6|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098521|NCT03267940|19961467|P5|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098522|NCT03267940|19961468|P4|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098523|NCT03267940|19961469|P3|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098524|NCT03267940|19961470|P2|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
8098525|NCT03267940|19961471|P1|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
8098526|NCT03267940|19961466|P6|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098527|NCT03267940|19961467|P5|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098528|NCT03267940|19961468|P4|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098529|NCT03267940|19961469|P3|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098530|NCT03267940|19961470|P2|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
8098531|NCT03267940|19961471|P1|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
8098532|NCT03267576|19961573|P2|NOT COMPLETED|Period 2: Day 44 to 71||2
8098533|NCT03267576|19961574|P1|NOT COMPLETED|Period 2: Day 44 to 71||1
8098534|NCT03267576|19961573|P2|COMPLETED|Period 2: Day 44 to 71||30
8098535|NCT03267576|19961574|P1|COMPLETED|Period 2: Day 44 to 71||30
8098536|NCT03267576|19961573|P2|STARTED|Period 2: Day 44 to 71||32
8098537|NCT03267576|19961574|P1|STARTED|Period 2: Day 44 to 71||31
8098538|NCT03267576|19961573|P2|NOT COMPLETED|Washout Period: 16 Days||0
8098539|NCT03267576|19961574|P1|NOT COMPLETED|Washout Period: 16 Days||0
8098540|NCT03267576|19961573|P2|COMPLETED|Washout Period: 16 Days||32
8098541|NCT03267576|19961574|P1|COMPLETED|Washout Period: 16 Days||31
8098542|NCT03267576|19961573|P2|STARTED|Washout Period: 16 Days||32
8098543|NCT03267576|19961574|P1|STARTED|Washout Period: 16 Days||31
8098544|NCT03267576|19961573|P2|NOT COMPLETED|Period 1: Day 0 to 27||0
8098545|NCT03267576|19961574|P1|NOT COMPLETED|Period 1: Day 0 to 27||0
8098546|NCT03267576|19961573|P2|COMPLETED|Period 1: Day 0 to 27||32
8098547|NCT03267576|19961574|P1|COMPLETED|Period 1: Day 0 to 27||31
8098548|NCT03267576|19961573|P2|STARTED|Period 1: Day 0 to 27||32
8098549|NCT03267576|19961574|P1|STARTED|Period 1: Day 0 to 27||31
8098550|NCT03267511|19961612|P4|NOT COMPLETED|Overall Study||1
8098551|NCT03267511|19961613|P3|NOT COMPLETED|Overall Study||0
8098552|NCT03267511|19961614|P2|NOT COMPLETED|Overall Study||0
8098553|NCT03267511|19961615|P1|NOT COMPLETED|Overall Study||0
8098554|NCT03267511|19961612|P4|COMPLETED|Overall Study||30
8098555|NCT03267511|19961613|P3|COMPLETED|Overall Study||30
8098556|NCT03267511|19961614|P2|COMPLETED|Overall Study||31
8098557|NCT03267511|19961615|P1|COMPLETED|Overall Study||31
8098558|NCT03267511|19961612|P4|STARTED|Overall Study||31
8098559|NCT03267511|19961613|P3|STARTED|Overall Study||30
8098560|NCT03267511|19961614|P2|STARTED|Overall Study||31
8098561|NCT03267511|19961615|P1|STARTED|Overall Study||31
8098562|NCT03267264|19961631|P4|NOT COMPLETED|Overall Study||4
8098563|NCT03267264|19961632|P3|NOT COMPLETED|Overall Study||2
8098564|NCT03267264|19961633|P2|NOT COMPLETED|Overall Study||0
8098565|NCT03267264|19961634|P1|NOT COMPLETED|Overall Study||1
8098566|NCT03267264|19961631|P4|COMPLETED|Overall Study||61
8098567|NCT03267264|19961632|P3|COMPLETED|Overall Study||66
8098568|NCT03267264|19961633|P2|COMPLETED|Overall Study||49
8098569|NCT03267264|19961634|P1|COMPLETED|Overall Study||65
8098570|NCT03267264|19961631|P4|Sequence B(Comparator)|Overall Study||32
8098571|NCT03267264|19961632|P3|Sequence B(Comparator)|Overall Study||33
8098572|NCT03267264|19961633|P2|Sequence B(Comparator)|Overall Study||24
8098573|NCT03267264|19961634|P1|Sequence B(Comparator)|Overall Study||32
8098574|NCT03267264|19961631|P4|Sequence A(Nucleus)|Overall Study||33
8098575|NCT03267264|19961632|P3|Sequence A(Nucleus)|Overall Study||33
8098576|NCT03267264|19961633|P2|Sequence A(Nucleus)|Overall Study||25
8098577|NCT03267264|19961634|P1|Sequence A(Nucleus)|Overall Study||34
8098578|NCT03267264|19961631|P4|STARTED|Overall Study||65
8098579|NCT03267264|19961632|P3|STARTED|Overall Study||68
8098580|NCT03267264|19961633|P2|STARTED|Overall Study||49
8098581|NCT03267264|19961634|P1|STARTED|Overall Study||66
8098582|NCT03267212|19961651|P2|NOT COMPLETED|Second Intervention||0
8098583|NCT03267212|19961652|P1|NOT COMPLETED|Second Intervention||0
8098584|NCT03267212|19961651|P2|COMPLETED|Second Intervention||6
8098585|NCT03267212|19961652|P1|COMPLETED|Second Intervention||4
8098586|NCT03267212|19961651|P2|STARTED|Second Intervention||6
8098587|NCT03267212|19961652|P1|STARTED|Second Intervention||4
8098588|NCT03267212|19961651|P2|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
8098589|NCT03267212|19961652|P1|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
8098590|NCT03267212|19961651|P2|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
8098591|NCT03267212|19961652|P1|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
8098592|NCT03267212|19961651|P2|STARTED|Washout (Min 2 Days / Max 7 Days)||6
8098593|NCT03267212|19961652|P1|STARTED|Washout (Min 2 Days / Max 7 Days)||5
8098594|NCT03267212|19961651|P2|NOT COMPLETED|First Intervention||3
8098595|NCT03267212|19961652|P1|NOT COMPLETED|First Intervention||1
8098596|NCT03267212|19961651|P2|COMPLETED|First Intervention||6
8098597|NCT03267212|19961652|P1|COMPLETED|First Intervention||5
8098598|NCT03267212|19961651|P2|Low SCI|First Intervention||4
8098599|NCT03267212|19961652|P1|Low SCI|First Intervention||4
8098600|NCT03267212|19961651|P2|High SCI|First Intervention||5
8098601|NCT03267212|19961652|P1|High SCI|First Intervention||2
8098602|NCT03267212|19961651|P2|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
8098603|NCT03267212|19961652|P1|STARTED|First Intervention|Non-invasive ventilation|6
8098604|NCT03266588|19961667|P3|NOT COMPLETED|Long-term Treatment Period||65
8098605|NCT03266588|19961668|P2|NOT COMPLETED|Long-term Treatment Period||240
8098606|NCT03266588|19961669|P1|NOT COMPLETED|Long-term Treatment Period||406
8098607|NCT03266588|19961667|P3|COMPLETED|Long-term Treatment Period||243
8098608|NCT03266588|19961668|P2|COMPLETED|Long-term Treatment Period||271
8098609|NCT03266588|19961669|P1|COMPLETED|Long-term Treatment Period||683
8098610|NCT03266588|19961667|P3|Treated|Long-term Treatment Period||286
8098611|NCT03266588|19961668|P2|Treated|Long-term Treatment Period||481
8098612|NCT03266588|19961669|P1|Treated|Long-term Treatment Period||1033
8098613|NCT03266588|19961667|P3|STARTED|Long-term Treatment Period||308
8098614|NCT03266588|19961668|P2|STARTED|Long-term Treatment Period||511
8098615|NCT03266588|19961669|P1|STARTED|Long-term Treatment Period||1089
8098616|NCT03266588|19961667|P3|NOT COMPLETED|Observational Period||168
8098617|NCT03266588|19961668|P2|NOT COMPLETED|Observational Period||275
8098618|NCT03266588|19961669|P1|NOT COMPLETED|Observational Period||516
8098619|NCT03266588|19961667|P3|COMPLETED|Observational Period||308
8098620|NCT03266588|19961668|P2|COMPLETED|Observational Period||511
8098621|NCT03266588|19961669|P1|COMPLETED|Observational Period||1089
8098622|NCT03266588|19961667|P3|STARTED|Observational Period||476
8098623|NCT03266588|19961668|P2|STARTED|Observational Period||786
8098624|NCT03266588|19961669|P1|STARTED|Observational Period||1605
8098625|NCT03266419|19961688|P2|NOT COMPLETED|Overall Study||0
8098626|NCT03266419|19961689|P1|NOT COMPLETED|Overall Study||0
8098627|NCT03266419|19961688|P2|COMPLETED|Overall Study||49
8098628|NCT03266419|19961689|P1|COMPLETED|Overall Study||51
8098629|NCT03266419|19961688|P2|STARTED|Overall Study||49
8098630|NCT03266419|19961689|P1|STARTED|Overall Study||51
8098631|NCT03266172|19961700|P3|NOT COMPLETED|Part C Period 6(2 Days)||0
8098632|NCT03266172|19961701|P2|NOT COMPLETED|Part C Period 6(2 Days)||0
8098633|NCT03266172|19961702|P1|NOT COMPLETED|Part C Period 6(2 Days)||0
8098634|NCT03266172|19961700|P3|COMPLETED|Part C Period 6(2 Days)||14
8098635|NCT03266172|19961701|P2|COMPLETED|Part C Period 6(2 Days)||0
8098636|NCT03266172|19961702|P1|COMPLETED|Part C Period 6(2 Days)||0
8098637|NCT03266172|19961700|P3|STARTED|Part C Period 6(2 Days)||14
8098638|NCT03266172|19961701|P2|STARTED|Part C Period 6(2 Days)||0
8098639|NCT03266172|19961702|P1|STARTED|Part C Period 6(2 Days)||0
8098640|NCT03266172|19961700|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
8098641|NCT03266172|19961701|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098642|NCT03266172|19961702|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098643|NCT03266172|19961700|P3|COMPLETED|Part C Washout Period (7 Days)||14
8098644|NCT03266172|19961701|P2|COMPLETED|Part C Washout Period (7 Days)||0
8098645|NCT03266172|19961702|P1|COMPLETED|Part C Washout Period (7 Days)||0
8098646|NCT03266172|19961700|P3|STARTED|Part C Washout Period (7 Days)||15
8098647|NCT03266172|19961701|P2|STARTED|Part C Washout Period (7 Days)||0
8098648|NCT03266172|19961702|P1|STARTED|Part C Washout Period (7 Days)||0
8098649|NCT03266172|19961700|P3|NOT COMPLETED|Part C Period 5(2 Days)||0
8098650|NCT03266172|19961701|P2|NOT COMPLETED|Part C Period 5(2 Days)||0
8098651|NCT03266172|19961702|P1|NOT COMPLETED|Part C Period 5(2 Days)||0
8098652|NCT03266172|19961700|P3|COMPLETED|Part C Period 5(2 Days)||15
8098653|NCT03266172|19961701|P2|COMPLETED|Part C Period 5(2 Days)||0
8098654|NCT03266172|19961702|P1|COMPLETED|Part C Period 5(2 Days)||0
8098655|NCT03266172|19961700|P3|STARTED|Part C Period 5(2 Days)||15
8098656|NCT03266172|19961701|P2|STARTED|Part C Period 5(2 Days)||0
8098657|NCT03266172|19961702|P1|STARTED|Part C Period 5(2 Days)||0
8098658|NCT03266172|19961700|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
8098659|NCT03266172|19961701|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098660|NCT03266172|19961702|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098661|NCT03266172|19961700|P3|COMPLETED|Part C Washout Period (7 Days)||15
8098662|NCT03266172|19961701|P2|COMPLETED|Part C Washout Period (7 Days)||0
8098663|NCT03266172|19961702|P1|COMPLETED|Part C Washout Period (7 Days)||0
8098664|NCT03266172|19961700|P3|STARTED|Part C Washout Period (7 Days)||16
8098665|NCT03266172|19961701|P2|STARTED|Part C Washout Period (7 Days)||0
8098666|NCT03266172|19961702|P1|STARTED|Part C Washout Period (7 Days)||0
8098667|NCT03266172|19961700|P3|NOT COMPLETED|Part C Period 4(2 Days)||0
8098668|NCT03266172|19961701|P2|NOT COMPLETED|Part C Period 4(2 Days)||0
8098669|NCT03266172|19961702|P1|NOT COMPLETED|Part C Period 4(2 Days)||0
8098670|NCT03266172|19961700|P3|COMPLETED|Part C Period 4(2 Days)||16
8098671|NCT03266172|19961701|P2|COMPLETED|Part C Period 4(2 Days)||0
8098672|NCT03266172|19961702|P1|COMPLETED|Part C Period 4(2 Days)||0
8098673|NCT03266172|19961700|P3|STARTED|Part C Period 4(2 Days)||16
8098674|NCT03266172|19961701|P2|STARTED|Part C Period 4(2 Days)||0
8098675|NCT03266172|19961702|P1|STARTED|Part C Period 4(2 Days)||0
8098676|NCT03266172|19961700|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098677|NCT03266172|19961701|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098678|NCT03266172|19961702|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098679|NCT03266172|19961700|P3|COMPLETED|Part C Washout Period (7 Days)||16
8098680|NCT03266172|19961701|P2|COMPLETED|Part C Washout Period (7 Days)||0
8098681|NCT03266172|19961702|P1|COMPLETED|Part C Washout Period (7 Days)||0
8098682|NCT03266172|19961700|P3|STARTED|Part C Washout Period (7 Days)||16
8098683|NCT03266172|19961701|P2|STARTED|Part C Washout Period (7 Days)||0
8098684|NCT03266172|19961702|P1|STARTED|Part C Washout Period (7 Days)||0
8098685|NCT03266172|19961700|P3|NOT COMPLETED|Part C Period 3(2 Days)||0
8098686|NCT03266172|19961701|P2|NOT COMPLETED|Part C Period 3(2 Days)||0
8098687|NCT03266172|19961702|P1|NOT COMPLETED|Part C Period 3(2 Days)||0
8098688|NCT03266172|19961700|P3|COMPLETED|Part C Period 3(2 Days)||16
8098689|NCT03266172|19961701|P2|COMPLETED|Part C Period 3(2 Days)||0
8098690|NCT03266172|19961702|P1|COMPLETED|Part C Period 3(2 Days)||0
8098691|NCT03266172|19961700|P3|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
8098692|NCT03266172|19961701|P2|STARTED|Part C Period 3(2 Days)||0
8098693|NCT03266172|19961702|P1|STARTED|Part C Period 3(2 Days)||0
8098694|NCT03266172|19961700|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098695|NCT03266172|19961701|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098696|NCT03266172|19961702|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098697|NCT03266172|19961700|P3|COMPLETED|Part C Washout Period (7 Days)||15
8098698|NCT03266172|19961701|P2|COMPLETED|Part C Washout Period (7 Days)||0
8098699|NCT03266172|19961702|P1|COMPLETED|Part C Washout Period (7 Days)||0
8098700|NCT03266172|19961700|P3|STARTED|Part C Washout Period (7 Days)||15
8098701|NCT03266172|19961701|P2|STARTED|Part C Washout Period (7 Days)||0
8098702|NCT03266172|19961702|P1|STARTED|Part C Washout Period (7 Days)||0
8098703|NCT03266172|19961700|P3|NOT COMPLETED|Part C Period 2(2 Days)||0
8098704|NCT03266172|19961701|P2|NOT COMPLETED|Part C Period 2(2 Days)||0
8098705|NCT03266172|19961702|P1|NOT COMPLETED|Part C Period 2(2 Days)||0
8098706|NCT03266172|19961700|P3|COMPLETED|Part C Period 2(2 Days)||15
8098707|NCT03266172|19961701|P2|COMPLETED|Part C Period 2(2 Days)||0
8098708|NCT03266172|19961702|P1|COMPLETED|Part C Period 2(2 Days)||0
8098709|NCT03266172|19961700|P3|STARTED|Part C Period 2(2 Days)||15
8098710|NCT03266172|19961701|P2|STARTED|Part C Period 2(2 Days)||0
8098711|NCT03266172|19961702|P1|STARTED|Part C Period 2(2 Days)||0
8098712|NCT03266172|19961700|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098713|NCT03266172|19961701|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098714|NCT03266172|19961702|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8098715|NCT03266172|19961700|P3|COMPLETED|Part C Washout Period (7 Days)||15
8098716|NCT03266172|19961701|P2|COMPLETED|Part C Washout Period (7 Days)||0
8098717|NCT03266172|19961702|P1|COMPLETED|Part C Washout Period (7 Days)||0
8098718|NCT03266172|19961700|P3|STARTED|Part C Washout Period (7 Days)||15
8098719|NCT03266172|19961701|P2|STARTED|Part C Washout Period (7 Days)||0
8098720|NCT03266172|19961702|P1|STARTED|Part C Washout Period (7 Days)||0
8098721|NCT03266172|19961700|P3|NOT COMPLETED|Part C: Period 1(2 Days)||0
8098722|NCT03266172|19961701|P2|NOT COMPLETED|Part C: Period 1(2 Days)||0
8098723|NCT03266172|19961702|P1|NOT COMPLETED|Part C: Period 1(2 Days)||0
8098724|NCT03266172|19961700|P3|COMPLETED|Part C: Period 1(2 Days)||15
8098725|NCT03266172|19961701|P2|COMPLETED|Part C: Period 1(2 Days)||0
8098726|NCT03266172|19961702|P1|COMPLETED|Part C: Period 1(2 Days)||0
8098727|NCT03266172|19961700|P3|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
8098728|NCT03266172|19961701|P2|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
8098729|NCT03266172|19961702|P1|STARTED|Part C: Period 1(2 Days)||0
8098730|NCT03266172|19961700|P3|NOT COMPLETED|Part B: Period 3 (4 Days)||0
8098731|NCT03266172|19961701|P2|NOT COMPLETED|Part B: Period 3 (4 Days)||0
8098732|NCT03266172|19961702|P1|NOT COMPLETED|Part B: Period 3 (4 Days)||0
8098733|NCT03266172|19961700|P3|COMPLETED|Part B: Period 3 (4 Days)||0
8098734|NCT03266172|19961701|P2|COMPLETED|Part B: Period 3 (4 Days)||6
8098735|NCT03266172|19961702|P1|COMPLETED|Part B: Period 3 (4 Days)||0
8098736|NCT03266172|19961700|P3|STARTED|Part B: Period 3 (4 Days)||0
8098737|NCT03266172|19961701|P2|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
8098738|NCT03266172|19961702|P1|STARTED|Part B: Period 3 (4 Days)||0
8098739|NCT03266172|19961700|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
8098740|NCT03266172|19961701|P2|NOT COMPLETED|Part B: Washout (7 Days)||2
8098741|NCT03266172|19961702|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
8098742|NCT03266172|19961700|P3|COMPLETED|Part B: Washout (7 Days)||0
8098743|NCT03266172|19961701|P2|COMPLETED|Part B: Washout (7 Days)||8
8098744|NCT03266172|19961702|P1|COMPLETED|Part B: Washout (7 Days)||0
8098745|NCT03266172|19961700|P3|STARTED|Part B: Washout (7 Days)||0
8098746|NCT03266172|19961701|P2|STARTED|Part B: Washout (7 Days)||10
8098747|NCT03266172|19961702|P1|STARTED|Part B: Washout (7 Days)||0
8098748|NCT03266172|19961700|P3|NOT COMPLETED|Part B: Period 2 (4 Days)||0
8098749|NCT03266172|19961701|P2|NOT COMPLETED|Part B: Period 2 (4 Days)||0
8098750|NCT03266172|19961702|P1|NOT COMPLETED|Part B: Period 2 (4 Days)||0
8098751|NCT03266172|19961700|P3|COMPLETED|Part B: Period 2 (4 Days)||0
8098752|NCT03266172|19961701|P2|COMPLETED|Part B: Period 2 (4 Days)||10
8098753|NCT03266172|19961702|P1|COMPLETED|Part B: Period 2 (4 Days)||0
8098754|NCT03266172|19961700|P3|STARTED|Part B: Period 2 (4 Days)||0
8098755|NCT03266172|19961701|P2|STARTED|Part B: Period 2 (4 Days)||10
8098756|NCT03266172|19961702|P1|STARTED|Part B: Period 2 (4 Days)||0
8098757|NCT03266172|19961700|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
8098758|NCT03266172|19961701|P2|NOT COMPLETED|Part B: Washout (7 Days)||0
8098759|NCT03266172|19961702|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
8098760|NCT03266172|19961700|P3|COMPLETED|Part B: Washout (7 Days)||0
8098761|NCT03266172|19961701|P2|COMPLETED|Part B: Washout (7 Days)||10
8098762|NCT03266172|19961702|P1|COMPLETED|Part B: Washout (7 Days)||0
8098763|NCT03266172|19961700|P3|STARTED|Part B: Washout (7 Days)||0
8098764|NCT03266172|19961701|P2|STARTED|Part B: Washout (7 Days)||10
8098765|NCT03266172|19961702|P1|STARTED|Part B: Washout (7 Days)||0
8098766|NCT03266172|19961700|P3|NOT COMPLETED|Part B: Period 1 (4 Days)||0
8098767|NCT03266172|19961701|P2|NOT COMPLETED|Part B: Period 1 (4 Days)||0
8098768|NCT03266172|19961702|P1|NOT COMPLETED|Part B: Period 1 (4 Days)||0
8098769|NCT03266172|19961700|P3|COMPLETED|Part B: Period 1 (4 Days)||0
8098770|NCT03266172|19961701|P2|COMPLETED|Part B: Period 1 (4 Days)||10
8098771|NCT03266172|19961702|P1|COMPLETED|Part B: Period 1 (4 Days)||0
8098772|NCT03266172|19961700|P3|STARTED|Part B: Period 1 (4 Days)||0
8098773|NCT03266172|19961701|P2|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
8098774|NCT03266172|19961702|P1|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
8098775|NCT03266172|19961700|P3|NOT COMPLETED|Part A: Period 4 (2 Days)||0
8098776|NCT03266172|19961701|P2|NOT COMPLETED|Part A: Period 4 (2 Days)||0
8098777|NCT03266172|19961702|P1|NOT COMPLETED|Part A: Period 4 (2 Days)||0
8098778|NCT03266172|19961700|P3|COMPLETED|Part A: Period 4 (2 Days)||0
8098779|NCT03266172|19961701|P2|COMPLETED|Part A: Period 4 (2 Days)||0
8098780|NCT03266172|19961702|P1|COMPLETED|Part A: Period 4 (2 Days)||16
8098781|NCT03266172|19961700|P3|STARTED|Part A: Period 4 (2 Days)||0
8098782|NCT03266172|19961701|P2|STARTED|Part A: Period 4 (2 Days)||0
8098783|NCT03266172|19961702|P1|STARTED|Part A: Period 4 (2 Days)||16
8098784|NCT03266172|19961700|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
8098785|NCT03266172|19961701|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
8098786|NCT03266172|19961702|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
8098787|NCT03266172|19961700|P3|COMPLETED|Part A: Washout (7 Days)||0
8098788|NCT03266172|19961701|P2|COMPLETED|Part A: Washout (7 Days)||0
8098789|NCT03266172|19961702|P1|COMPLETED|Part A: Washout (7 Days)||16
8098790|NCT03266172|19961700|P3|STARTED|Part A: Washout (7 Days)||0
8098791|NCT03266172|19961701|P2|STARTED|Part A: Washout (7 Days)||0
8098792|NCT03266172|19961702|P1|STARTED|Part A: Washout (7 Days)||16
8098793|NCT03266172|19961700|P3|NOT COMPLETED|Part A: Period 3 (2 Days)||0
8098794|NCT03266172|19961701|P2|NOT COMPLETED|Part A: Period 3 (2 Days)||0
8098795|NCT03266172|19961702|P1|NOT COMPLETED|Part A: Period 3 (2 Days)||0
8098796|NCT03266172|19961700|P3|COMPLETED|Part A: Period 3 (2 Days)||0
8098797|NCT03266172|19961701|P2|COMPLETED|Part A: Period 3 (2 Days)||0
8098798|NCT03266172|19961702|P1|COMPLETED|Part A: Period 3 (2 Days)||16
8098799|NCT03266172|19961700|P3|STARTED|Part A: Period 3 (2 Days)||0
8098800|NCT03266172|19961701|P2|STARTED|Part A: Period 3 (2 Days)||0
8098801|NCT03266172|19961702|P1|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
8098802|NCT03266172|19961700|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
8098803|NCT03266172|19961701|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
8098804|NCT03266172|19961702|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
8098805|NCT03266172|19961700|P3|COMPLETED|Part A: Washout (7 Days)||0
8098806|NCT03266172|19961701|P2|COMPLETED|Part A: Washout (7 Days)||0
8098807|NCT03266172|19961702|P1|COMPLETED|Part A: Washout (7 Days)||13
8098808|NCT03266172|19961700|P3|STARTED|Part A: Washout (7 Days)||0
8098809|NCT03266172|19961701|P2|STARTED|Part A: Washout (7 Days)||0
8098810|NCT03266172|19961702|P1|STARTED|Part A: Washout (7 Days)||13
8098811|NCT03266172|19961700|P3|NOT COMPLETED|Part A: Period 2 (2 Days)||0
8098812|NCT03266172|19961701|P2|NOT COMPLETED|Part A: Period 2 (2 Days)||0
8098813|NCT03266172|19961702|P1|NOT COMPLETED|Part A: Period 2 (2 Days)||0
8098814|NCT03266172|19961700|P3|COMPLETED|Part A: Period 2 (2 Days)||0
8098815|NCT03266172|19961701|P2|COMPLETED|Part A: Period 2 (2 Days)||0
8098816|NCT03266172|19961702|P1|COMPLETED|Part A: Period 2 (2 Days)||13
8098817|NCT03266172|19961700|P3|STARTED|Part A: Period 2 (2 Days)||0
8098818|NCT03266172|19961701|P2|STARTED|Part A: Period 2 (2 Days)||0
8098819|NCT03266172|19961702|P1|STARTED|Part A: Period 2 (2 Days)||13
8098820|NCT03266172|19961700|P3|NOT COMPLETED|Part A: Washout Period (7 Days)||0
8098821|NCT03266172|19961701|P2|NOT COMPLETED|Part A: Washout Period (7 Days)||0
8098822|NCT03266172|19961702|P1|NOT COMPLETED|Part A: Washout Period (7 Days)||2
8098823|NCT03266172|19961700|P3|COMPLETED|Part A: Washout Period (7 Days)||0
8098824|NCT03266172|19961701|P2|COMPLETED|Part A: Washout Period (7 Days)||0
8098825|NCT03266172|19961702|P1|COMPLETED|Part A: Washout Period (7 Days)||13
8098826|NCT03266172|19961700|P3|STARTED|Part A: Washout Period (7 Days)||0
8098827|NCT03266172|19961701|P2|STARTED|Part A: Washout Period (7 Days)||0
8098828|NCT03266172|19961702|P1|STARTED|Part A: Washout Period (7 Days)||15
8098829|NCT03266172|19961700|P3|NOT COMPLETED|Part A: Period 1(2 Days)||0
8098830|NCT03266172|19961701|P2|NOT COMPLETED|Part A: Period 1(2 Days)||0
8098831|NCT03266172|19961702|P1|NOT COMPLETED|Part A: Period 1(2 Days)||1
8098832|NCT03266172|19961700|P3|COMPLETED|Part A: Period 1(2 Days)||0
8098833|NCT03266172|19961701|P2|COMPLETED|Part A: Period 1(2 Days)||0
8098834|NCT03266172|19961702|P1|COMPLETED|Part A: Period 1(2 Days)||15
8098835|NCT03266172|19961700|P3|STARTED|Part A: Period 1(2 Days)||0
8098836|NCT03266172|19961701|P2|STARTED|Part A: Period 1(2 Days)||0
8098837|NCT03266172|19961702|P1|STARTED|Part A: Period 1(2 Days)||16
8098838|NCT03266107|19961947|P1|NOT COMPLETED|12-Month Follow-up Visit||1
8098839|NCT03266107|19961947|P1|COMPLETED|12-Month Follow-up Visit||45
8098840|NCT03266107|19961947|P1|STARTED|12-Month Follow-up Visit||46
8098841|NCT03266107|19961947|P1|NOT COMPLETED|3-Month Follow-up Visit||1
8098842|NCT03266107|19961947|P1|COMPLETED|3-Month Follow-up Visit||46
8098843|NCT03266107|19961947|P1|STARTED|3-Month Follow-up Visit||47
8098844|NCT03266107|19961947|P1|NOT COMPLETED|Enrollment to Procedure||3
8098845|NCT03266107|19961947|P1|COMPLETED|Enrollment to Procedure||47
8098846|NCT03266107|19961947|P1|STARTED|Enrollment to Procedure||50
8098847|NCT03266094|19961959|P1|NOT COMPLETED|Overall Study||2
8098848|NCT03266094|19961959|P1|COMPLETED|Overall Study||58
8098849|NCT03266094|19961959|P1|STARTED|Overall Study||60
8098850|NCT03265938|19961977|P1|NOT COMPLETED|Overall Study||8
8098851|NCT03265938|19961977|P1|COMPLETED|Overall Study||92
8098852|NCT03265938|19961977|P1|STARTED|Overall Study||100
8098853|NCT03265600|19961990|P2|NOT COMPLETED|Overall Study||12
8098854|NCT03265600|19961991|P1|NOT COMPLETED|Overall Study||24
8098855|NCT03265600|19961990|P2|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
8098856|NCT03265600|19961991|P1|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
8098857|NCT03265600|19961990|P2|STARTED|Overall Study||44
8098858|NCT03265600|19961991|P1|STARTED|Overall Study||92
8098859|NCT03265132|19962017|P2|NOT COMPLETED|Overall Study||6
8098860|NCT03265132|19962018|P1|NOT COMPLETED|Overall Study||0
8098861|NCT03265132|19962017|P2|COMPLETED|Overall Study||0
8098862|NCT03265132|19962018|P1|COMPLETED|Overall Study||6
8098863|NCT03265132|19962017|P2|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
8098864|NCT03265132|19962018|P1|STARTED|Overall Study||6
8098865|NCT03265119|19962116|P2|NOT COMPLETED|Overall Study||7
8098866|NCT03265119|19962117|P1|NOT COMPLETED|Overall Study||10
8098867|NCT03265119|19962116|P2|COMPLETED|Overall Study||28
8098868|NCT03265119|19962117|P1|COMPLETED|Overall Study||24
8098869|NCT03265119|19962116|P2|STARTED|Overall Study||35
8098870|NCT03265119|19962117|P1|STARTED|Overall Study||34
8098871|NCT03264456|19962125|P1|NOT COMPLETED|Overall Study||4
8098872|NCT03264456|19962125|P1|COMPLETED|Overall Study||14
8098873|NCT03264456|19962125|P1|STARTED|Overall Study||18
8098874|NCT03264248|19962132|P1|NOT COMPLETED|Overall Study||0
8098875|NCT03264248|19962132|P1|COMPLETED|Overall Study||9
8098876|NCT03264248|19962132|P1|STARTED|Overall Study||9
8098877|NCT03264157|19962141|P2|NOT COMPLETED|Overall Study||7
8098878|NCT03264157|19962142|P1|NOT COMPLETED|Overall Study||13
8098879|NCT03264157|19962141|P2|COMPLETED|Overall Study||74
8098880|NCT03264157|19962142|P1|COMPLETED|Overall Study||68
8098881|NCT03264157|19962141|P2|STARTED|Overall Study||81
8098882|NCT03264157|19962142|P1|STARTED|Overall Study||81
8098883|NCT03263806|19962160|P2|NOT COMPLETED|Overall Study||7
8098884|NCT03263806|19962161|P1|NOT COMPLETED|Overall Study||6
8098885|NCT03263806|19962160|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
8098886|NCT03263806|19962161|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
8098887|NCT03263806|19962160|P2|STARTED|Overall Study||7
8098888|NCT03263806|19962161|P1|STARTED|Overall Study||6
8098889|NCT03263702|19962175|P2|NOT COMPLETED|Overall Study||4
8098890|NCT03263702|19962176|P1|NOT COMPLETED|Overall Study||3
8098891|NCT03263702|19962175|P2|COMPLETED|Overall Study||22
8098892|NCT03263702|19962176|P1|COMPLETED|Overall Study||35
8098893|NCT03263702|19962175|P2|STARTED|Overall Study||26
8098894|NCT03263702|19962176|P1|STARTED|Overall Study||38
8098895|NCT03262441|19962202|P1|NOT COMPLETED|Overall Study||1
8098896|NCT03262441|19962202|P1|COMPLETED|Overall Study||4
8098897|NCT03262441|19962202|P1|STARTED|Overall Study||5
8098898|NCT03262233|19962214|P4|NOT COMPLETED|Overall Study||29
8098899|NCT03262233|19962215|P3|NOT COMPLETED|Overall Study||25
8098900|NCT03262233|19962216|P2|NOT COMPLETED|Overall Study||21
8098901|NCT03262233|19962217|P1|NOT COMPLETED|Overall Study||18
8098902|NCT03262233|19962214|P4|COMPLETED|Overall Study||32
8098903|NCT03262233|19962215|P3|COMPLETED|Overall Study||34
8098904|NCT03262233|19962216|P2|COMPLETED|Overall Study||32
8098905|NCT03262233|19962217|P1|COMPLETED|Overall Study||35
8098906|NCT03262233|19962214|P4|STARTED|Overall Study||61
8098907|NCT03262233|19962215|P3|STARTED|Overall Study||59
8098908|NCT03262233|19962216|P2|STARTED|Overall Study||53
8098909|NCT03262233|19962217|P1|STARTED|Overall Study||53
8098910|NCT03262038|19962241|P2|NOT COMPLETED|Overall Study||1
8098911|NCT03262038|19962242|P1|NOT COMPLETED|Overall Study||0
8098912|NCT03262038|19962241|P2|COMPLETED|Overall Study||27
8098913|NCT03262038|19962242|P1|COMPLETED|Overall Study||18
8098914|NCT03262038|19962241|P2|STARTED|Overall Study||28
8098915|NCT03262038|19962242|P1|STARTED|Overall Study||18
8098916|NCT03262012|19962258|P4|NOT COMPLETED|Overall Study||15
8098917|NCT03262012|19962259|P3|NOT COMPLETED|Overall Study||14
8098918|NCT03262012|19962260|P2|NOT COMPLETED|Overall Study||36
8098919|NCT03262012|19962261|P1|NOT COMPLETED|Overall Study||27
8098920|NCT03262012|19962258|P4|COMPLETED|Overall Study||54
8098921|NCT03262012|19962259|P3|COMPLETED|Overall Study||56
8098922|NCT03262012|19962260|P2|COMPLETED|Overall Study||102
8098923|NCT03262012|19962261|P1|COMPLETED|Overall Study||112
8098924|NCT03262012|19962258|P4|STARTED|Overall Study||69
8098925|NCT03262012|19962259|P3|STARTED|Overall Study||70
8098926|NCT03262012|19962260|P2|STARTED|Overall Study||138
8098927|NCT03262012|19962261|P1|STARTED|Overall Study||139
8098928|NCT03261999|19962279|P1|NOT COMPLETED|Overall Study||15
8098929|NCT03261999|19962279|P1|COMPLETED|Overall Study||129
8098930|NCT03261999|19962279|P1|PP|Overall Study||132
8098931|NCT03261999|19962279|P1|ITT|Overall Study||144
8098932|NCT03261999|19962279|P1|STARTED|Overall Study||144
8098933|NCT03261531|19962284|P1|NOT COMPLETED|Overall Study||4
8098934|NCT03261531|19962284|P1|COMPLETED|Overall Study||3
8098935|NCT03261531|19962284|P1|STARTED|Overall Study||7
8098936|NCT03261167|19962302|P2|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
8098937|NCT03261167|19962303|P1|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
8098938|NCT03261167|19962302|P2|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
8098939|NCT03261167|19962303|P1|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
8098940|NCT03261167|19962302|P2|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
8098941|NCT03261167|19962303|P1|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
8098942|NCT03261167|19962302|P2|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
8098943|NCT03261167|19962303|P1|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
8098944|NCT03261167|19962302|P2|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
8098945|NCT03261167|19962303|P1|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
8098946|NCT03261167|19962302|P2|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
8098947|NCT03261167|19962303|P1|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
8098948|NCT03261167|19962302|P2|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
8098949|NCT03261167|19962303|P1|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
8098950|NCT03261167|19962302|P2|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
8098951|NCT03261167|19962303|P1|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
8098952|NCT03261167|19962302|P2|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
8098953|NCT03261167|19962303|P1|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
8098954|NCT03261167|19962302|P2|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
8098955|NCT03261167|19962303|P1|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
8098956|NCT03261167|19962302|P2|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
8098957|NCT03261167|19962303|P1|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
8098958|NCT03261167|19962302|P2|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
8098959|NCT03261167|19962303|P1|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
8098960|NCT03260894|19962341|P2|NOT COMPLETED|Overall Study||50
8098961|NCT03260894|19962342|P1|NOT COMPLETED|Overall Study||46
8098962|NCT03260894|19962341|P2|COMPLETED|Overall Study||15
8098963|NCT03260894|19962342|P1|COMPLETED|Overall Study||18
8098964|NCT03260894|19962341|P2|All Subjects as Treated (ASaT)|Overall Study||63
8098965|NCT03260894|19962342|P1|All Subjects as Treated (ASaT)|Overall Study||64
8098966|NCT03260894|19962341|P2|Intention-to-Treat (ITT)|Overall Study||65
8098967|NCT03260894|19962342|P1|Intention-to-Treat (ITT)|Overall Study||64
8098968|NCT03260894|19962341|P2|STARTED|Overall Study||65
8098969|NCT03260894|19962342|P1|STARTED|Overall Study||64
8098970|NCT03260868|19962354|P2|NOT COMPLETED|Overall Study||3
8098971|NCT03260868|19962355|P1|NOT COMPLETED|Overall Study||3
8098972|NCT03260868|19962354|P2|COMPLETED|Overall Study||4
8098973|NCT03260868|19962355|P1|COMPLETED|Overall Study||5
8098974|NCT03260868|19962354|P2|Safety Population|Overall Study||6
8098975|NCT03260868|19962355|P1|Safety Population|Overall Study||8
8098976|NCT03260868|19962354|P2|STARTED|Overall Study||7
8098977|NCT03260868|19962355|P1|STARTED|Overall Study||8
8098978|NCT03260699|19962395|P2|NOT COMPLETED|Overall Study||2
8098979|NCT03260699|19962396|P1|NOT COMPLETED|Overall Study||0
8098980|NCT03260699|19962395|P2|COMPLETED|Overall Study||2
8098981|NCT03260699|19962396|P1|COMPLETED|Overall Study||5
8098982|NCT03260699|19962395|P2|STARTED|Overall Study||4
8098983|NCT03260699|19962396|P1|STARTED|Overall Study||5
8098984|NCT03260595|19962425|P3|NOT COMPLETED|Overall Study||0
8098985|NCT03260595|19962426|P2|NOT COMPLETED|Overall Study||0
8098986|NCT03260595|19962427|P1|NOT COMPLETED|Overall Study||0
8098987|NCT03260595|19962425|P3|COMPLETED|Overall Study||2
8098988|NCT03260595|19962426|P2|COMPLETED|Overall Study||10
8098989|NCT03260595|19962427|P1|COMPLETED|Overall Study||20
8098990|NCT03260595|19962425|P3|STARTED|Overall Study||2
8098991|NCT03260595|19962426|P2|STARTED|Overall Study||10
8098992|NCT03260595|19962427|P1|STARTED|Overall Study||20
8098993|NCT03260426|19962451|P2|NOT COMPLETED|Overall Study||0
8098994|NCT03260426|19962452|P1|NOT COMPLETED|Overall Study||0
8098995|NCT03260426|19962451|P2|COMPLETED|Overall Study||50
8098996|NCT03260426|19962452|P1|COMPLETED|Overall Study||50
8098997|NCT03260426|19962451|P2|STARTED|Overall Study||50
8098998|NCT03260426|19962452|P1|STARTED|Overall Study||50
8098999|NCT03260205|19962477|P5|NOT COMPLETED|Overall Study||14
8099000|NCT03260205|19962478|P4|NOT COMPLETED|Overall Study||7
8099001|NCT03260205|19962479|P3|NOT COMPLETED|Overall Study||11
8099002|NCT03260205|19962480|P2|NOT COMPLETED|Overall Study||8
8099003|NCT03260205|19962481|P1|NOT COMPLETED|Overall Study||9
8099004|NCT03260205|19962477|P5|COMPLETED|Overall Study||25
8099005|NCT03260205|19962478|P4|COMPLETED|Overall Study||30
8099006|NCT03260205|19962479|P3|COMPLETED|Overall Study||26
8099007|NCT03260205|19962480|P2|COMPLETED|Overall Study||32
8099008|NCT03260205|19962481|P1|COMPLETED|Overall Study||37
8099009|NCT03260205|19962477|P5|Received Treatment|Overall Study||38
8099010|NCT03260205|19962478|P4|Received Treatment|Overall Study||34
8099011|NCT03260205|19962479|P3|Received Treatment|Overall Study||35
8099012|NCT03260205|19962480|P2|Received Treatment|Overall Study||39
8099013|NCT03260205|19962481|P1|Received Treatment|Overall Study||45
8099014|NCT03260205|19962477|P5|STARTED|Overall Study||39
8099015|NCT03260205|19962478|P4|STARTED|Overall Study||37
8099016|NCT03260205|19962479|P3|STARTED|Overall Study||37
8099017|NCT03260205|19962480|P2|STARTED|Overall Study||40
8099018|NCT03260205|19962481|P1|STARTED|Overall Study||46
8099019|NCT03259555|19962544|P2|NOT COMPLETED|Overall Study||30
8099020|NCT03259555|19962545|P1|NOT COMPLETED|Overall Study||34
8099021|NCT03259555|19962544|P2|COMPLETED|Overall Study||134
8099022|NCT03259555|19962545|P1|COMPLETED|Overall Study||124
8099023|NCT03259555|19962544|P2|Received At Least 1 Dose of Study Drug|Overall Study||163
8099024|NCT03259555|19962545|P1|Received At Least 1 Dose of Study Drug|Overall Study||158
8099025|NCT03259555|19962544|P2|STARTED|Overall Study||164
8099026|NCT03259555|19962545|P1|STARTED|Overall Study||158
8099027|NCT03259490|19962555|P2|NOT COMPLETED|Period 2||0
8099028|NCT03259490|19962556|P1|NOT COMPLETED|Period 2||1
8099029|NCT03259490|19962555|P2|COMPLETED|Period 2||14
8099030|NCT03259490|19962556|P1|COMPLETED|Period 2||14
8099031|NCT03259490|19962555|P2|STARTED|Period 2||14
8099032|NCT03259490|19962556|P1|STARTED|Period 2||15
8099033|NCT03259490|19962555|P2|NOT COMPLETED|Period 1||1
8099034|NCT03259490|19962556|P1|NOT COMPLETED|Period 1||0
8099035|NCT03259490|19962555|P2|COMPLETED|Period 1||14
8099036|NCT03259490|19962556|P1|COMPLETED|Period 1||15
8099037|NCT03259490|19962555|P2|STARTED|Period 1||15
8099038|NCT03259490|19962556|P1|STARTED|Period 1||15
8099039|NCT03259425|19962578|P1|NOT COMPLETED|Overall Study||1
8099040|NCT03259425|19962578|P1|COMPLETED|Overall Study||6
8099041|NCT03259425|19962578|P1|Surgery|Overall Study||6
8099042|NCT03259425|19962578|P1|STARTED|Overall Study||7
8099043|NCT03259139|19962588|P6|NOT COMPLETED|Overall Study||6
8099044|NCT03259139|19962589|P5|NOT COMPLETED|Overall Study||6
8099045|NCT03259139|19962590|P4|NOT COMPLETED|Overall Study||5
8099046|NCT03259139|19962591|P3|NOT COMPLETED|Overall Study||5
8099047|NCT03259139|19962592|P2|NOT COMPLETED|Overall Study||4
8099048|NCT03259139|19962593|P1|NOT COMPLETED|Overall Study||4
8099049|NCT03259139|19962588|P6|COMPLETED|Overall Study||35
8099050|NCT03259139|19962589|P5|COMPLETED|Overall Study||35
8099051|NCT03259139|19962590|P4|COMPLETED|Overall Study||37
8099052|NCT03259139|19962591|P3|COMPLETED|Overall Study||37
8099053|NCT03259139|19962592|P2|COMPLETED|Overall Study||38
8099054|NCT03259139|19962593|P1|COMPLETED|Overall Study||38
8099055|NCT03259139|19962588|P6|Found Handgun|Overall Study||35
8099056|NCT03259139|19962589|P5|Found Handgun|Overall Study||35
8099057|NCT03259139|19962590|P4|Found Handgun|Overall Study||37
8099058|NCT03259139|19962591|P3|Found Handgun|Overall Study||37
8099059|NCT03259139|19962592|P2|Found Handgun|Overall Study||38
8099060|NCT03259139|19962593|P1|Found Handgun|Overall Study||38
8099061|NCT03259139|19962588|P6|Outlier Elimination|Overall Study||39
8099062|NCT03259139|19962589|P5|Outlier Elimination|Overall Study||39
8099063|NCT03259139|19962590|P4|Outlier Elimination|Overall Study||41
8099064|NCT03259139|19962591|P3|Outlier Elimination|Overall Study||41
8099065|NCT03259139|19962592|P2|Outlier Elimination|Overall Study||41
8099066|NCT03259139|19962593|P1|Outlier Elimination|Overall Study||41
8099067|NCT03259139|19962588|P6|Eligible|Overall Study||41
8099068|NCT03259139|19962589|P5|Eligible|Overall Study||41
8099069|NCT03259139|19962590|P4|Eligible|Overall Study||41
8099070|NCT03259139|19962591|P3|Eligible|Overall Study||41
8099071|NCT03259139|19962592|P2|Eligible|Overall Study||41
8099072|NCT03259139|19962593|P1|Eligible|Overall Study||41
8099073|NCT03259139|19962588|P6|STARTED|Overall Study||41
8099074|NCT03259139|19962589|P5|STARTED|Overall Study||41
8099075|NCT03259139|19962590|P4|STARTED|Overall Study||42
8099076|NCT03259139|19962591|P3|STARTED|Overall Study||42
8099077|NCT03259139|19962592|P2|STARTED|Overall Study||42
8099078|NCT03259139|19962593|P1|STARTED|Overall Study||42
8099079|NCT03259087|19962624|P5|NOT COMPLETED|Period 2 of Part 2||1
8099080|NCT03259087|19962625|P4|NOT COMPLETED|Period 2 of Part 2||0
8099081|NCT03259087|19962626|P3|NOT COMPLETED|Period 2 of Part 2||0
8099082|NCT03259087|19962627|P2|NOT COMPLETED|Period 2 of Part 2||0
8099083|NCT03259087|19962628|P1|NOT COMPLETED|Period 2 of Part 2||0
8099084|NCT03259087|19962624|P5|COMPLETED|Period 2 of Part 2||6
8099085|NCT03259087|19962625|P4|COMPLETED|Period 2 of Part 2||0
8099086|NCT03259087|19962626|P3|COMPLETED|Period 2 of Part 2||0
8099087|NCT03259087|19962627|P2|COMPLETED|Period 2 of Part 2||0
8099088|NCT03259087|19962628|P1|COMPLETED|Period 2 of Part 2||0
8099089|NCT03259087|19962624|P5|STARTED|Period 2 of Part 2||7
8099090|NCT03259087|19962625|P4|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099091|NCT03259087|19962626|P3|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099092|NCT03259087|19962627|P2|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099093|NCT03259087|19962628|P1|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099094|NCT03259087|19962624|P5|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
8099095|NCT03259087|19962625|P4|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099096|NCT03259087|19962626|P3|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099097|NCT03259087|19962627|P2|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099098|NCT03259087|19962628|P1|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099099|NCT03259087|19962624|P5|COMPLETED|Part 1 and Period 1 of Part 2||7
8099100|NCT03259087|19962625|P4|COMPLETED|Part 1 and Period 1 of Part 2||10
8099101|NCT03259087|19962626|P3|COMPLETED|Part 1 and Period 1 of Part 2||8
8099102|NCT03259087|19962627|P2|COMPLETED|Part 1 and Period 1 of Part 2||8
8099103|NCT03259087|19962628|P1|COMPLETED|Part 1 and Period 1 of Part 2||8
8099104|NCT03259087|19962624|P5|STARTED|Part 1 and Period 1 of Part 2||8
8099105|NCT03259087|19962625|P4|STARTED|Part 1 and Period 1 of Part 2||10
8099106|NCT03259087|19962626|P3|STARTED|Part 1 and Period 1 of Part 2||8
8099107|NCT03259087|19962627|P2|STARTED|Part 1 and Period 1 of Part 2||8
8099108|NCT03259087|19962628|P1|STARTED|Part 1 and Period 1 of Part 2||8
8099109|NCT03258814|19962756|P3|NOT COMPLETED|Overall Study||10
8099110|NCT03258814|19962757|P2|NOT COMPLETED|Overall Study||3
8099111|NCT03258814|19962758|P1|NOT COMPLETED|Overall Study||4
8099112|NCT03258814|19962756|P3|COMPLETED|Overall Study||0
8099113|NCT03258814|19962757|P2|COMPLETED|Overall Study||0
8099114|NCT03258814|19962758|P1|COMPLETED|Overall Study||0
8099115|NCT03258814|19962756|P3|STARTED|Overall Study||10
8099116|NCT03258814|19962757|P2|STARTED|Overall Study||3
8099117|NCT03258814|19962758|P1|STARTED|Overall Study||4
8099118|NCT03258762|19962813|P2|NOT COMPLETED|Overall Study||1
8099119|NCT03258762|19962814|P1|NOT COMPLETED|Overall Study||0
8099120|NCT03258762|19962813|P2|COMPLETED|Overall Study||6
8099121|NCT03258762|19962814|P1|COMPLETED|Overall Study||7
8099122|NCT03258762|19962813|P2|STARTED|Overall Study||7
8099123|NCT03258762|19962814|P1|STARTED|Overall Study||7
8099124|NCT03258710|19962874|P1|NOT COMPLETED|Overall Study||3
8099125|NCT03258710|19962874|P1|COMPLETED|Overall Study||72
8099126|NCT03258710|19962874|P1|STARTED|Overall Study||75
8099127|NCT03258645|19962913|P1|NOT COMPLETED|Overall Study||0
8099128|NCT03258645|19962913|P1|COMPLETED|Overall Study||1489
8099129|NCT03258645|19962913|P1|STARTED|Overall Study||1489
8099130|NCT03257995|19962968|P6|NOT COMPLETED|Overall Study||2
8099131|NCT03257995|19962969|P5|NOT COMPLETED|Overall Study||0
8099132|NCT03257995|19962970|P4|NOT COMPLETED|Overall Study||0
8099133|NCT03257995|19962971|P3|NOT COMPLETED|Overall Study||0
8099134|NCT03257995|19962972|P2|NOT COMPLETED|Overall Study||1
8099135|NCT03257995|19962973|P1|NOT COMPLETED|Overall Study||0
8099136|NCT03257995|19962968|P6|COMPLETED|Overall Study||7
8099137|NCT03257995|19962969|P5|COMPLETED|Overall Study||9
8099138|NCT03257995|19962970|P4|COMPLETED|Overall Study||9
8099139|NCT03257995|19962971|P3|COMPLETED|Overall Study||9
8099140|NCT03257995|19962972|P2|COMPLETED|Overall Study||8
8099141|NCT03257995|19962973|P1|COMPLETED|Overall Study||9
8099142|NCT03257995|19962968|P6|STARTED|Overall Study||9
8099143|NCT03257995|19962969|P5|STARTED|Overall Study||9
8099144|NCT03257995|19962970|P4|STARTED|Overall Study||9
8099145|NCT03257995|19962971|P3|STARTED|Overall Study||9
8099146|NCT03257995|19962972|P2|STARTED|Overall Study||9
8099147|NCT03257995|19962973|P1|STARTED|Overall Study||9
8099148|NCT03257865|19963023|P2|NOT COMPLETED|Overall Study||35
8099149|NCT03257865|19963024|P1|NOT COMPLETED|Overall Study||35
8099150|NCT03257865|19963023|P2|COMPLETED|Overall Study||135
8099151|NCT03257865|19963024|P1|COMPLETED|Overall Study||128
8099152|NCT03257865|19963023|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
8099153|NCT03257865|19963024|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
8099154|NCT03257865|19963023|P2|STARTED|Overall Study||170
8099155|NCT03257865|19963024|P1|STARTED|Overall Study||163
8099156|NCT03257813|19963034|P2|NOT COMPLETED|Overall Study||3
8099157|NCT03257813|19963035|P1|NOT COMPLETED|Overall Study||6
8099158|NCT03257813|19963034|P2|COMPLETED|Overall Study||27
8099159|NCT03257813|19963035|P1|COMPLETED|Overall Study||24
8099160|NCT03257813|19963034|P2|STARTED|Overall Study||30
8099161|NCT03257813|19963035|P1|STARTED|Overall Study||30
8099162|NCT03257657|19963057|P2|NOT COMPLETED|Overall Study||5
8099163|NCT03257657|19963058|P1|NOT COMPLETED|Overall Study||0
8099164|NCT03257657|19963057|P2|COMPLETED|Overall Study||15
8099165|NCT03257657|19963058|P1|COMPLETED|Overall Study||22
8099166|NCT03257657|19963057|P2|STARTED|Overall Study||20
8099167|NCT03257657|19963058|P1|STARTED|Overall Study||22
8099168|NCT03257631|19963089|P4|NOT COMPLETED|Overall Study||10
8099169|NCT03257631|19963090|P3|NOT COMPLETED|Overall Study||23
8099170|NCT03257631|19963091|P2|NOT COMPLETED|Overall Study||9
8099171|NCT03257631|19963092|P1|NOT COMPLETED|Overall Study||11
8099172|NCT03257631|19963089|P4|COMPLETED|Overall Study||0
8099173|NCT03257631|19963090|P3|COMPLETED|Overall Study||0
8099174|NCT03257631|19963091|P2|COMPLETED|Overall Study||0
8099175|NCT03257631|19963092|P1|COMPLETED|Overall Study||0
8099176|NCT03257631|19963089|P4|Received Study Drug|Overall Study||10
8099177|NCT03257631|19963090|P3|Received Study Drug|Overall Study||22
8099178|NCT03257631|19963091|P2|Received Study Drug|Overall Study||9
8099179|NCT03257631|19963092|P1|Received Study Drug|Overall Study||11
8099180|NCT03257631|19963089|P4|STARTED|Overall Study||10
8099181|NCT03257631|19963090|P3|STARTED|Overall Study||23
8099182|NCT03257631|19963091|P2|STARTED|Overall Study||9
8099183|NCT03257631|19963092|P1|STARTED|Overall Study||11
8099184|NCT03257410|19963128|P2|NOT COMPLETED|Overall Study||21
8099185|NCT03257410|19963129|P1|NOT COMPLETED|Overall Study||21
8099186|NCT03257410|19963128|P2|COMPLETED|Overall Study||65
8099187|NCT03257410|19963129|P1|COMPLETED|Overall Study||65
8099188|NCT03257410|19963128|P2|STARTED|Overall Study||86
8099189|NCT03257410|19963129|P1|STARTED|Overall Study||86
8099190|NCT03257371|19963269|P1|NOT COMPLETED|Overall Study||1
8099191|NCT03257371|19963269|P1|COMPLETED|Overall Study||9
8099192|NCT03257371|19963269|P1|STARTED|Overall Study||10
8099193|NCT03257358|19963278|P2|NOT COMPLETED|Overall Study||34
8099194|NCT03257358|19963279|P1|NOT COMPLETED|Overall Study||71
8099195|NCT03257358|19963278|P2|COMPLETED|Overall Study||183
8099196|NCT03257358|19963279|P1|COMPLETED|Overall Study||94
8099197|NCT03257358|19963278|P2|Never Received Treatment|Overall Study||0
8099198|NCT03257358|19963279|P1|Never Received Treatment|Overall Study||2
8099199|NCT03257358|19963278|P2|STARTED|Overall Study||217
8099200|NCT03257358|19963279|P1|STARTED|Overall Study||165
8099201|NCT03257202|19963379|P1|NOT COMPLETED|Overall Study||0
8099202|NCT03257202|19963379|P1|COMPLETED|Overall Study||12
8099203|NCT03257202|19963379|P1|STARTED|Overall Study||12
8099204|NCT03257189|19963389|P1|NOT COMPLETED|Overall Study||0
8099205|NCT03257189|19963389|P1|COMPLETED|Overall Study||30
8099206|NCT03257189|19963389|P1|STARTED|Overall Study||30
8099207|NCT03256968|19963401|P1|NOT COMPLETED|Overall Study||0
8099208|NCT03256968|19963401|P1|COMPLETED|Overall Study||1
8099209|NCT03256968|19963401|P1|STARTED|Overall Study||1
8099210|NCT03256851|19963407|P2|NOT COMPLETED|Overall Study||0
8099211|NCT03256851|19963408|P1|NOT COMPLETED|Overall Study||1
8099212|NCT03256851|19963407|P2|COMPLETED|Overall Study||10
8099213|NCT03256851|19963408|P1|COMPLETED|Overall Study||9
8099214|NCT03256851|19963407|P2|STARTED|Overall Study||10
8099215|NCT03256851|19963408|P1|STARTED|Overall Study||10
8099216|NCT03256799|19963416|P1|NOT COMPLETED|Overall Study||0
8099217|NCT03256799|19963416|P1|COMPLETED|Overall Study||1
8099218|NCT03256799|19963416|P1|STARTED|Overall Study||1
8099219|NCT03256695|19963420|P1|NOT COMPLETED|Overall Study||39
8099220|NCT03256695|19963420|P1|COMPLETED|Overall Study||366
8099221|NCT03256695|19963420|P1|Used ABS eMDPI at Least Once|Overall Study||390
8099222|NCT03256695|19963420|P1|STARTED|Overall Study||405
8099223|NCT03256578|19963430|P2|NOT COMPLETED|Overall Study||56
8099224|NCT03256578|19963431|P1|NOT COMPLETED|Overall Study||66
8099225|NCT03256578|19963430|P2|COMPLETED|Overall Study||150
8099226|NCT03256578|19963431|P1|COMPLETED|Overall Study||138
8099227|NCT03256578|19963430|P2|STARTED|Overall Study||206
8099228|NCT03256578|19963431|P1|STARTED|Overall Study||204
8099229|NCT03256552|19963481|P1|NOT COMPLETED|Overall Study||5
8099230|NCT03256552|19963481|P1|COMPLETED|Overall Study||61
8099231|NCT03256552|19963481|P1|Placebo MDI|Overall Study||65
8099232|NCT03256552|19963481|P1|GP MDI 7.2 µg|Overall Study||62
8099233|NCT03256552|19963481|P1|GP MDI 14.4 µg|Overall Study||63
8099234|NCT03256552|19963481|P1|GP MDI 28.8 µg|Overall Study||61
8099235|NCT03256552|19963481|P1|STARTED|Overall Study||66
8099236|NCT03256526|19963506|P3|NOT COMPLETED|Overall Study||3
8099237|NCT03256526|19963507|P2|NOT COMPLETED|Overall Study||0
8099238|NCT03256526|19963508|P1|NOT COMPLETED|Overall Study||2
8099239|NCT03256526|19963506|P3|COMPLETED|Overall Study||14
8099240|NCT03256526|19963507|P2|COMPLETED|Overall Study||17
8099241|NCT03256526|19963508|P1|COMPLETED|Overall Study||17
8099242|NCT03256526|19963506|P3|STARTED|Overall Study||17
8099243|NCT03256526|19963507|P2|STARTED|Overall Study||17
8099244|NCT03256526|19963508|P1|STARTED|Overall Study||19
8099245|NCT03256253|19963528|P1|NOT COMPLETED|Overall Study||12
8099246|NCT03256253|19963528|P1|COMPLETED|Overall Study||6
8099247|NCT03256253|19963528|P1|STARTED|Overall Study||18
8099248|NCT03256162|19963534|P2|NOT COMPLETED|Overall Study||4
8099249|NCT03256162|19963535|P1|NOT COMPLETED|Overall Study||5
8099250|NCT03256162|19963534|P2|COMPLETED|Overall Study||8
8099251|NCT03256162|19963535|P1|COMPLETED|Overall Study||8
8099252|NCT03256162|19963534|P2|STARTED|Overall Study||12
8099253|NCT03256162|19963535|P1|STARTED|Overall Study||13
8099254|NCT03256136|19963557|P4|NOT COMPLETED|Overall Study||0
8099255|NCT03256136|19963558|P3|NOT COMPLETED|Overall Study||0
8099256|NCT03256136|19963559|P2|NOT COMPLETED|Overall Study||0
8099257|NCT03256136|19963560|P1|NOT COMPLETED|Overall Study||0
8099258|NCT03256136|19963557|P4|COMPLETED|Overall Study||1
8099259|NCT03256136|19963558|P3|COMPLETED|Overall Study||4
8099260|NCT03256136|19963559|P2|COMPLETED|Overall Study||1
8099261|NCT03256136|19963560|P1|COMPLETED|Overall Study||3
8099262|NCT03256136|19963557|P4|STARTED|Overall Study||1
8099263|NCT03256136|19963558|P3|STARTED|Overall Study||4
8099264|NCT03256136|19963559|P2|STARTED|Overall Study||1
8099265|NCT03256136|19963560|P1|STARTED|Overall Study||3
8099266|NCT03255980|19963590|P4|NOT COMPLETED|Overall Study||12
8099267|NCT03255980|19963591|P3|NOT COMPLETED|Overall Study||6
8099268|NCT03255980|19963592|P2|NOT COMPLETED|Overall Study||8
8099269|NCT03255980|19963593|P1|NOT COMPLETED|Overall Study||3
8099270|NCT03255980|19963590|P4|COMPLETED|Overall Study||8
8099271|NCT03255980|19963591|P3|COMPLETED|Overall Study||14
8099272|NCT03255980|19963592|P2|COMPLETED|Overall Study||12
8099273|NCT03255980|19963593|P1|COMPLETED|Overall Study||17
8099274|NCT03255980|19963590|P4|STARTED|Overall Study||20
8099275|NCT03255980|19963591|P3|STARTED|Overall Study||20
8099276|NCT03255980|19963592|P2|STARTED|Overall Study||20
8099277|NCT03255980|19963593|P1|STARTED|Overall Study||20
8099278|NCT03255902|19963603|P1|NOT COMPLETED|Overall Study||2
8099279|NCT03255902|19963603|P1|COMPLETED|Overall Study||5
8099280|NCT03255902|19963603|P1|STARTED|Overall Study||7
8099281|NCT03255824|19963610|P2|NOT COMPLETED|Overall Study||1
8099282|NCT03255824|19963611|P1|NOT COMPLETED|Overall Study||2
8099283|NCT03255824|19963610|P2|COMPLETED|Overall Study||74
8099284|NCT03255824|19963611|P1|COMPLETED|Overall Study||67
8099285|NCT03255824|19963610|P2|STARTED|Overall Study||75
8099286|NCT03255824|19963611|P1|STARTED|Overall Study||69
8099287|NCT03255733|19963639|P1|NOT COMPLETED|Overall Study||4
8099288|NCT03255733|19963639|P1|COMPLETED|Overall Study||25
8099289|NCT03255733|19963639|P1|STARTED|Overall Study||29
8099290|NCT03255655|19963646|P2|NOT COMPLETED|Overall Study||4
8099291|NCT03255655|19963647|P1|NOT COMPLETED|Overall Study||7
8099292|NCT03255655|19963646|P2|COMPLETED|Overall Study||8
8099293|NCT03255655|19963647|P1|COMPLETED|Overall Study||22
8099294|NCT03255655|19963646|P2|STARTED|Overall Study||12
8099295|NCT03255655|19963647|P1|STARTED|Overall Study||29
8099296|NCT03255382|19963657|P2|NOT COMPLETED|Overall Study||0
8099297|NCT03255382|19963658|P1|NOT COMPLETED|Overall Study||13
8099298|NCT03255382|19963657|P2|COMPLETED|Overall Study||60
8099299|NCT03255382|19963658|P1|COMPLETED|Overall Study||47
8099300|NCT03255382|19963657|P2|STARTED|Overall Study||60
8099301|NCT03255382|19963658|P1|STARTED|Overall Study||60
8099302|NCT03255291|19963832|P6|NOT COMPLETED|Overall Study||10
8099303|NCT03255291|19963833|P5|NOT COMPLETED|Overall Study||7
8099304|NCT03255291|19963834|P4|NOT COMPLETED|Overall Study||6
8099305|NCT03255291|19963835|P3|NOT COMPLETED|Overall Study||6
8099306|NCT03255291|19963836|P2|NOT COMPLETED|Overall Study||12
8099307|NCT03255291|19963837|P1|NOT COMPLETED|Overall Study||13
8099308|NCT03255291|19963832|P6|COMPLETED|Overall Study||85
8099309|NCT03255291|19963833|P5|COMPLETED|Overall Study||88
8099310|NCT03255291|19963834|P4|COMPLETED|Overall Study||84
8099311|NCT03255291|19963835|P3|COMPLETED|Overall Study||85
8099312|NCT03255291|19963836|P2|COMPLETED|Overall Study||78
8099313|NCT03255291|19963837|P1|COMPLETED|Overall Study||80
8099314|NCT03255291|19963832|P6|STARTED|Overall Study||95
8099315|NCT03255291|19963833|P5|STARTED|Overall Study||95
8099316|NCT03255291|19963834|P4|STARTED|Overall Study||90
8099317|NCT03255291|19963835|P3|STARTED|Overall Study||91
8099318|NCT03255291|19963836|P2|STARTED|Overall Study||90
8099319|NCT03255291|19963837|P1|STARTED|Overall Study||93
8099320|NCT03255187|19963870|P2|NOT COMPLETED|Period at Fourth Follow-up||0
8099321|NCT03255187|19963871|P1|NOT COMPLETED|Period at Fourth Follow-up||0
8099322|NCT03255187|19963870|P2|COMPLETED|Period at Fourth Follow-up||31
8099323|NCT03255187|19963871|P1|COMPLETED|Period at Fourth Follow-up||34
8099324|NCT03255187|19963870|P2|STARTED|Period at Fourth Follow-up||31
8099325|NCT03255187|19963871|P1|STARTED|Period at Fourth Follow-up||34
8099326|NCT03255187|19963870|P2|NOT COMPLETED|Period From Third to Fourth Follow-up||0
8099327|NCT03255187|19963871|P1|NOT COMPLETED|Period From Third to Fourth Follow-up||0
8099328|NCT03255187|19963870|P2|COMPLETED|Period From Third to Fourth Follow-up||31
8099329|NCT03255187|19963871|P1|COMPLETED|Period From Third to Fourth Follow-up||34
8099330|NCT03255187|19963870|P2|STARTED|Period From Third to Fourth Follow-up||31
8099331|NCT03255187|19963871|P1|STARTED|Period From Third to Fourth Follow-up||34
8099332|NCT03255187|19963870|P2|NOT COMPLETED|Period From Second to Third Follow-up||0
8099333|NCT03255187|19963871|P1|NOT COMPLETED|Period From Second to Third Follow-up||0
8099334|NCT03255187|19963870|P2|COMPLETED|Period From Second to Third Follow-up||31
8099335|NCT03255187|19963871|P1|COMPLETED|Period From Second to Third Follow-up||34
8099336|NCT03255187|19963870|P2|STARTED|Period From Second to Third Follow-up||31
8099337|NCT03255187|19963871|P1|STARTED|Period From Second to Third Follow-up||34
8099338|NCT03255187|19963870|P2|NOT COMPLETED|Period From First to Second Follow-up||1
8099339|NCT03255187|19963871|P1|NOT COMPLETED|Period From First to Second Follow-up||0
8099340|NCT03255187|19963870|P2|COMPLETED|Period From First to Second Follow-up||31
8099341|NCT03255187|19963871|P1|COMPLETED|Period From First to Second Follow-up||34
8099342|NCT03255187|19963870|P2|STARTED|Period From First to Second Follow-up||32
8099343|NCT03255187|19963871|P1|STARTED|Period From First to Second Follow-up||34
8099344|NCT03255187|19963870|P2|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
8099345|NCT03255187|19963871|P1|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
8099346|NCT03255187|19963870|P2|COMPLETED|Periodfrom Enrollment to First Follow-up||32
8099347|NCT03255187|19963871|P1|COMPLETED|Periodfrom Enrollment to First Follow-up||34
8099348|NCT03255187|19963870|P2|STARTED|Periodfrom Enrollment to First Follow-up||35
8099349|NCT03255187|19963871|P1|STARTED|Periodfrom Enrollment to First Follow-up||35
8099350|NCT03254719|19963911|P1|NOT COMPLETED|Overall Study||0
8099351|NCT03254719|19963911|P1|COMPLETED|Overall Study||40
8099352|NCT03254719|19963911|P1|STARTED|Overall Study||40
8099353|NCT03254602|19963930|P1|NOT COMPLETED|Overall Study||4
8099354|NCT03254602|19963930|P1|COMPLETED|Overall Study||29
8099355|NCT03254602|19963930|P1|STARTED|Overall Study||33
8099356|NCT03254459|19963938|P2|NOT COMPLETED|Overall Study||23
8099357|NCT03254459|19963939|P1|NOT COMPLETED|Overall Study||10
8099358|NCT03254459|19963938|P2|COMPLETED|Overall Study||27
8099359|NCT03254459|19963939|P1|COMPLETED|Overall Study||40
8099360|NCT03254459|19963938|P2|STARTED|Overall Study||50
8099361|NCT03254459|19963939|P1|STARTED|Overall Study||50
8099362|NCT03254147|19963957|P1|NOT COMPLETED|Overall Study||0
8099363|NCT03254147|19963957|P1|COMPLETED|Overall Study||53969
8099364|NCT03254147|19963957|P1|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
8099365|NCT03254134|19963964|P2|NOT COMPLETED|Overall Study||3630
8099366|NCT03254134|19963965|P1|NOT COMPLETED|Overall Study||599
8099367|NCT03254134|19963964|P2|COMPLETED|Overall Study||13115
8099368|NCT03254134|19963965|P1|COMPLETED|Overall Study||5146
8099369|NCT03254134|19963964|P2|STARTED|Overall Study||16745
8099370|NCT03254134|19963965|P1|STARTED|Overall Study||5745
8099371|NCT03252964|19963973|P1|NOT COMPLETED|Overall Study||32
8099372|NCT03252964|19963973|P1|COMPLETED|Overall Study||20
8099373|NCT03252964|19963973|P1|STARTED|Overall Study||52
8099374|NCT03252353|19963989|P2|NOT COMPLETED|Overall Study||0
8099375|NCT03252353|19963990|P1|NOT COMPLETED|Overall Study||0
8099376|NCT03252353|19963989|P2|COMPLETED|Overall Study||28
8099377|NCT03252353|19963990|P1|COMPLETED|Overall Study||28
8099378|NCT03252353|19963989|P2|STARTED|Overall Study||28
8099379|NCT03252353|19963990|P1|STARTED|Overall Study||28
8099380|NCT03252145|19964002|P2|NOT COMPLETED|Overall Study||2
8099381|NCT03252145|19964003|P1|NOT COMPLETED|Overall Study||2
8099382|NCT03252145|19964002|P2|COMPLETED|Overall Study||13
8099383|NCT03252145|19964003|P1|COMPLETED|Overall Study||11
8099384|NCT03252145|19964002|P2|STARTED|Overall Study||15
8099385|NCT03252145|19964003|P1|STARTED|Overall Study||13
8099386|NCT03252015|19964071|P4|NOT COMPLETED|Overall Study||1
8099387|NCT03252015|19964072|P3|NOT COMPLETED|Overall Study||1
8099388|NCT03252015|19964073|P2|NOT COMPLETED|Overall Study||1
8099389|NCT03252015|19964074|P1|NOT COMPLETED|Overall Study||1
8099390|NCT03252015|19964071|P4|COMPLETED|Overall Study||14
8099391|NCT03252015|19964072|P3|COMPLETED|Overall Study||14
8099392|NCT03252015|19964073|P2|COMPLETED|Overall Study||27
8099393|NCT03252015|19964074|P1|COMPLETED|Overall Study||11
8099394|NCT03252015|19964071|P4|Received at Least 1 Dose of Study Drug|Overall Study||15
8099395|NCT03252015|19964072|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
8099396|NCT03252015|19964073|P2|Received at Least 1 Dose of Study Drug|Overall Study||28
8099397|NCT03252015|19964074|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8099398|NCT03252015|19964071|P4|STARTED|Overall Study||15
8099399|NCT03252015|19964072|P3|STARTED|Overall Study||15
8099400|NCT03252015|19964073|P2|STARTED|Overall Study||28
8099401|NCT03252015|19964074|P1|STARTED|Overall Study||12
8099402|NCT03251963|19964112|P2|NOT COMPLETED|Overall Study||5
8099403|NCT03251963|19964113|P1|NOT COMPLETED|Overall Study||9
8099404|NCT03251963|19964112|P2|COMPLETED|Overall Study||61
8099405|NCT03251963|19964113|P1|COMPLETED|Overall Study||56
8099406|NCT03251963|19964112|P2|STARTED|Overall Study||66
8099407|NCT03251963|19964113|P1|STARTED|Overall Study||65
8099408|NCT03251937|19964123|P1|NOT COMPLETED|Overall Study||3
8099409|NCT03251937|19964123|P1|COMPLETED|Overall Study||37
8099410|NCT03251937|19964123|P1|STARTED|Overall Study||40
8099411|NCT03251482|19964132|P5|NOT COMPLETED|Overall Study||0
8099412|NCT03251482|19964133|P4|NOT COMPLETED|Overall Study||0
8099413|NCT03251482|19964134|P3|NOT COMPLETED|Overall Study||0
8099414|NCT03251482|19964135|P2|NOT COMPLETED|Overall Study||1
8099415|NCT03251482|19964136|P1|NOT COMPLETED|Overall Study||0
8099416|NCT03251482|19964132|P5|COMPLETED|Overall Study||63
8099417|NCT03251482|19964133|P4|COMPLETED|Overall Study||122
8099418|NCT03251482|19964134|P3|COMPLETED|Overall Study||43
8099419|NCT03251482|19964135|P2|COMPLETED|Overall Study||40
8099420|NCT03251482|19964136|P1|COMPLETED|Overall Study||39
8099421|NCT03251482|19964132|P5|Treated|Overall Study||63
8099422|NCT03251482|19964133|P4|Treated|Overall Study||122
8099423|NCT03251482|19964134|P3|Treated|Overall Study||42
8099424|NCT03251482|19964135|P2|Treated|Overall Study||40
8099425|NCT03251482|19964136|P1|Treated|Overall Study||38
8099426|NCT03251482|19964132|P5|STARTED|Overall Study||63
8099427|NCT03251482|19964133|P4|STARTED|Overall Study||122
8099428|NCT03251482|19964134|P3|STARTED|Overall Study||43
8099429|NCT03251482|19964135|P2|STARTED|Overall Study||41
8099430|NCT03251482|19964136|P1|STARTED|Overall Study||39
8099431|NCT03251326|19964208|P4|NOT COMPLETED|Overall Study||0
8099432|NCT03251326|19964209|P3|NOT COMPLETED|Overall Study||0
8099433|NCT03251326|19964210|P2|NOT COMPLETED|Overall Study||0
8099434|NCT03251326|19964211|P1|NOT COMPLETED|Overall Study||0
8099435|NCT03251326|19964208|P4|COMPLETED|Overall Study||0
8099436|NCT03251326|19964209|P3|COMPLETED|Overall Study||0
8099437|NCT03251326|19964210|P2|COMPLETED|Overall Study||0
8099438|NCT03251326|19964211|P1|COMPLETED|Overall Study||0
8099439|NCT03251326|19964208|P4|STARTED|Overall Study||0
8099440|NCT03251326|19964209|P3|STARTED|Overall Study||0
8099441|NCT03251326|19964210|P2|STARTED|Overall Study||0
8099442|NCT03251326|19964211|P1|STARTED|Overall Study||0
8099443|NCT03250845|19964221|P1|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
8099444|NCT03250845|19964221|P1|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
8099445|NCT03250845|19964221|P1|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
8099446|NCT03250845|19964221|P1|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
8099447|NCT03250845|19964221|P1|COMPLETED|Multigam 5% Infusion (Baseline)||30
8099448|NCT03250845|19964221|P1|STARTED|Multigam 5% Infusion (Baseline)||30
8099449|NCT03250689|19964232|P2|NOT COMPLETED|Overall Study||0
8099450|NCT03250689|19964233|P1|NOT COMPLETED|Overall Study||0
8099451|NCT03250689|19964232|P2|COMPLETED|Overall Study||14
8099452|NCT03250689|19964233|P1|COMPLETED|Overall Study||5
8099453|NCT03250689|19964232|P2|STARTED|Overall Study||14
8099454|NCT03250689|19964233|P1|STARTED|Overall Study||5
8099455|NCT03249935|19964293|P1|NOT COMPLETED|Overall Study||45
8099456|NCT03249935|19964293|P1|COMPLETED|Overall Study||55
8099457|NCT03249935|19964293|P1|STARTED|Overall Study||100
8099458|NCT03249909|19964302|P3|NOT COMPLETED|Overall Study||0
8099459|NCT03249909|19964303|P2|NOT COMPLETED|Overall Study||1
8099460|NCT03249909|19964304|P1|NOT COMPLETED|Overall Study||6
8099461|NCT03249909|19964302|P3|COMPLETED|Overall Study||16
8099462|NCT03249909|19964303|P2|COMPLETED|Overall Study||14
8099463|NCT03249909|19964304|P1|COMPLETED|Overall Study||72
8099464|NCT03249909|19964302|P3|STARTED|Overall Study||16
8099465|NCT03249909|19964303|P2|STARTED|Overall Study||15
8099466|NCT03249909|19964304|P1|STARTED|Overall Study||78
8099467|NCT03249779|19964339|P1|NOT COMPLETED|Overall Study||0
8099468|NCT03249779|19964339|P1|COMPLETED|Overall Study||8
8099469|NCT03249779|19964339|P1|STARTED|Overall Study||8
8099470|NCT03249584|19964344|P1|NOT COMPLETED|Overall Study||98
8099471|NCT03249584|19964344|P1|COMPLETED|Overall Study||2
8099472|NCT03249584|19964344|P1|Month 3 Primary Objective|Overall Study|Included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3|42
8099473|NCT03249584|19964344|P1|Month 3|Overall Study||46
8099474|NCT03249584|19964344|P1|STARTED|Overall Study|87 subjects in the Thoracic/Lumbar and 13 subjects in the Periacetabulum, Iliac Crest, and/or Sacrum|100
8099475|NCT03249454|19964348|P11|NOT COMPLETED|Overall Study||1
8099476|NCT03249454|19964349|P10|NOT COMPLETED|Overall Study||1
8099477|NCT03249454|19964350|P9|NOT COMPLETED|Overall Study||0
8099478|NCT03249454|19964351|P8|NOT COMPLETED|Overall Study||0
8099479|NCT03249454|19964352|P7|NOT COMPLETED|Overall Study||0
8099480|NCT03249454|19964353|P6|NOT COMPLETED|Overall Study||0
8099481|NCT03249454|19964354|P5|NOT COMPLETED|Overall Study||0
8099482|NCT03249454|19964355|P4|NOT COMPLETED|Overall Study||0
8099483|NCT03249454|19964356|P3|NOT COMPLETED|Overall Study||0
8099484|NCT03249454|19964357|P2|NOT COMPLETED|Overall Study||0
8099485|NCT03249454|19964358|P1|NOT COMPLETED|Overall Study||0
8099486|NCT03249454|19964348|P11|COMPLETED|Overall Study||0
8099487|NCT03249454|19964349|P10|COMPLETED|Overall Study||0
8099488|NCT03249454|19964350|P9|COMPLETED|Overall Study||1
8099489|NCT03249454|19964351|P8|COMPLETED|Overall Study||1
8099490|NCT03249454|19964352|P7|COMPLETED|Overall Study||1
8099491|NCT03249454|19964353|P6|COMPLETED|Overall Study||2
8099492|NCT03249454|19964354|P5|COMPLETED|Overall Study||1
8099493|NCT03249454|19964355|P4|COMPLETED|Overall Study||1
8099494|NCT03249454|19964356|P3|COMPLETED|Overall Study||2
8099495|NCT03249454|19964357|P2|COMPLETED|Overall Study||1
8099496|NCT03249454|19964358|P1|COMPLETED|Overall Study||1
8099497|NCT03249454|19964348|P11|Fifth Intervention (1 Day)|Overall Study||0
8099498|NCT03249454|19964349|P10|Fifth Intervention (1 Day)|Overall Study||0
8099499|NCT03249454|19964350|P9|Fifth Intervention (1 Day)|Overall Study||1
8099500|NCT03249454|19964351|P8|Fifth Intervention (1 Day)|Overall Study||1
8099501|NCT03249454|19964352|P7|Fifth Intervention (1 Day)|Overall Study||1
8099502|NCT03249454|19964353|P6|Fifth Intervention (1 Day)|Overall Study||2
8099503|NCT03249454|19964354|P5|Fifth Intervention (1 Day)|Overall Study||1
8099504|NCT03249454|19964355|P4|Fifth Intervention (1 Day)|Overall Study||1
8099505|NCT03249454|19964356|P3|Fifth Intervention (1 Day)|Overall Study||2
8099506|NCT03249454|19964357|P2|Fifth Intervention (1 Day)|Overall Study||1
8099507|NCT03249454|19964358|P1|Fifth Intervention (1 Day)|Overall Study||1
8099508|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099509|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099510|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099511|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099512|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099513|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099514|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099515|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099516|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099517|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099518|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099519|NCT03249454|19964348|P11|Fourth Intervention (1 Day)|Overall Study||0
8099520|NCT03249454|19964349|P10|Fourth Intervention (1 Day)|Overall Study||0
8099521|NCT03249454|19964350|P9|Fourth Intervention (1 Day)|Overall Study||1
8099522|NCT03249454|19964351|P8|Fourth Intervention (1 Day)|Overall Study||1
8099523|NCT03249454|19964352|P7|Fourth Intervention (1 Day)|Overall Study||1
8099524|NCT03249454|19964353|P6|Fourth Intervention (1 Day)|Overall Study||2
8099525|NCT03249454|19964354|P5|Fourth Intervention (1 Day)|Overall Study||1
8099526|NCT03249454|19964355|P4|Fourth Intervention (1 Day)|Overall Study||1
8099527|NCT03249454|19964356|P3|Fourth Intervention (1 Day)|Overall Study||2
8099528|NCT03249454|19964357|P2|Fourth Intervention (1 Day)|Overall Study||1
8099529|NCT03249454|19964358|P1|Fourth Intervention (1 Day)|Overall Study||1
8099530|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099531|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099532|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099533|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099534|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099535|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099536|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099537|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099538|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099539|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099540|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099541|NCT03249454|19964348|P11|Third Intervention (1 Day)|Overall Study||0
8099542|NCT03249454|19964349|P10|Third Intervention (1 Day)|Overall Study||0
8099543|NCT03249454|19964350|P9|Third Intervention (1 Day)|Overall Study||1
8099544|NCT03249454|19964351|P8|Third Intervention (1 Day)|Overall Study||1
8099545|NCT03249454|19964352|P7|Third Intervention (1 Day)|Overall Study||1
8099546|NCT03249454|19964353|P6|Third Intervention (1 Day)|Overall Study||2
8099547|NCT03249454|19964354|P5|Third Intervention (1 Day)|Overall Study||1
8099548|NCT03249454|19964355|P4|Third Intervention (1 Day)|Overall Study||1
8099549|NCT03249454|19964356|P3|Third Intervention (1 Day)|Overall Study||2
8099550|NCT03249454|19964357|P2|Third Intervention (1 Day)|Overall Study||1
8099551|NCT03249454|19964358|P1|Third Intervention (1 Day)|Overall Study||1
8099552|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099553|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099554|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099555|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099556|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099557|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099558|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099559|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099560|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099561|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099562|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099563|NCT03249454|19964348|P11|Second Intervention (1 Day)|Overall Study||0
8099564|NCT03249454|19964349|P10|Second Intervention (1 Day)|Overall Study||0
8099565|NCT03249454|19964350|P9|Second Intervention (1 Day)|Overall Study||1
8099566|NCT03249454|19964351|P8|Second Intervention (1 Day)|Overall Study||1
8099567|NCT03249454|19964352|P7|Second Intervention (1 Day)|Overall Study||1
8099568|NCT03249454|19964353|P6|Second Intervention (1 Day)|Overall Study||2
8099569|NCT03249454|19964354|P5|Second Intervention (1 Day)|Overall Study||1
8099570|NCT03249454|19964355|P4|Second Intervention (1 Day)|Overall Study||1
8099571|NCT03249454|19964356|P3|Second Intervention (1 Day)|Overall Study||2
8099572|NCT03249454|19964357|P2|Second Intervention (1 Day)|Overall Study||1
8099573|NCT03249454|19964358|P1|Second Intervention (1 Day)|Overall Study||1
8099574|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099575|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099576|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099577|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099578|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099579|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099580|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099581|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099582|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099583|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099584|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099585|NCT03249454|19964348|P11|First Intervention (1 Day)|Overall Study||0
8099586|NCT03249454|19964349|P10|First Intervention (1 Day)|Overall Study||0
8099587|NCT03249454|19964350|P9|First Intervention (1 Day)|Overall Study||1
8099588|NCT03249454|19964351|P8|First Intervention (1 Day)|Overall Study||1
8099589|NCT03249454|19964352|P7|First Intervention (1 Day)|Overall Study||1
8099590|NCT03249454|19964353|P6|First Intervention (1 Day)|Overall Study||2
8099591|NCT03249454|19964354|P5|First Intervention (1 Day)|Overall Study||1
8099592|NCT03249454|19964355|P4|First Intervention (1 Day)|Overall Study||1
8099593|NCT03249454|19964356|P3|First Intervention (1 Day)|Overall Study||2
8099594|NCT03249454|19964357|P2|First Intervention (1 Day)|Overall Study||1
8099595|NCT03249454|19964358|P1|First Intervention (1 Day)|Overall Study||1
8099596|NCT03249454|19964348|P11|STARTED|Overall Study||1
8099597|NCT03249454|19964349|P10|STARTED|Overall Study||1
8099598|NCT03249454|19964350|P9|STARTED|Overall Study||1
8099599|NCT03249454|19964351|P8|STARTED|Overall Study||1
8099600|NCT03249454|19964352|P7|STARTED|Overall Study||1
8099601|NCT03249454|19964353|P6|STARTED|Overall Study||2
8099602|NCT03249454|19964354|P5|STARTED|Overall Study||1
8099603|NCT03249454|19964355|P4|STARTED|Overall Study||1
8099604|NCT03249454|19964356|P3|STARTED|Overall Study||2
8099605|NCT03249454|19964357|P2|STARTED|Overall Study||1
8099606|NCT03249454|19964358|P1|STARTED|Overall Study||1
8099607|NCT03249272|19964381|P3|NOT COMPLETED|Overall Study||0
8099608|NCT03249272|19964382|P2|NOT COMPLETED|Overall Study||0
8099609|NCT03249272|19964383|P1|NOT COMPLETED|Overall Study||0
8099610|NCT03249272|19964381|P3|COMPLETED|Overall Study||6
8099611|NCT03249272|19964382|P2|COMPLETED|Overall Study||6
8099612|NCT03249272|19964383|P1|COMPLETED|Overall Study||19
8099613|NCT03249272|19964381|P3|STARTED|Overall Study||6
8099614|NCT03249272|19964382|P2|STARTED|Overall Study||6
8099615|NCT03249272|19964383|P1|STARTED|Overall Study||19
8099616|NCT03249116|19964406|P3|NOT COMPLETED|Overall Study||0
8099617|NCT03249116|19964407|P2|NOT COMPLETED|Overall Study||0
8099618|NCT03249116|19964408|P1|NOT COMPLETED|Overall Study||0
8099619|NCT03249116|19964406|P3|COMPLETED|Overall Study||25
8099620|NCT03249116|19964407|P2|COMPLETED|Overall Study||25
8099621|NCT03249116|19964408|P1|COMPLETED|Overall Study||25
8099622|NCT03249116|19964406|P3|STARTED|Overall Study||25
8099623|NCT03249116|19964407|P2|STARTED|Overall Study||25
8099624|NCT03249116|19964408|P1|STARTED|Overall Study||25
8099625|NCT03248947|19964428|P1|NOT COMPLETED|Overall Study||8
8099626|NCT03248947|19964428|P1|COMPLETED|Overall Study||63
8099627|NCT03248947|19964428|P1|STARTED|Overall Study||71
8099628|NCT03248882|19964446|P5|NOT COMPLETED|Overall Study||13
8099629|NCT03248882|19964447|P4|NOT COMPLETED|Overall Study||10
8099630|NCT03248882|19964448|P3|NOT COMPLETED|Overall Study||7
8099631|NCT03248882|19964449|P2|NOT COMPLETED|Overall Study||5
8099632|NCT03248882|19964450|P1|NOT COMPLETED|Overall Study||7
8099633|NCT03248882|19964446|P5|COMPLETED|Overall Study||48
8099634|NCT03248882|19964447|P4|COMPLETED|Overall Study||48
8099635|NCT03248882|19964448|P3|COMPLETED|Overall Study||55
8099636|NCT03248882|19964449|P2|COMPLETED|Overall Study||58
8099637|NCT03248882|19964450|P1|COMPLETED|Overall Study||54
8099638|NCT03248882|19964446|P5|Received Treatment|Overall Study||61
8099639|NCT03248882|19964447|P4|Received Treatment|Overall Study||58
8099640|NCT03248882|19964448|P3|Received Treatment|Overall Study||62
8099641|NCT03248882|19964449|P2|Received Treatment|Overall Study||63
8099642|NCT03248882|19964450|P1|Received Treatment|Overall Study||61
8099643|NCT03248882|19964446|P5|STARTED|Overall Study||61
8099644|NCT03248882|19964447|P4|STARTED|Overall Study||58
8099645|NCT03248882|19964448|P3|STARTED|Overall Study||62
8099646|NCT03248882|19964449|P2|STARTED|Overall Study||63
8099647|NCT03248882|19964450|P1|STARTED|Overall Study||61
8099648|NCT03248492|19964492|P5|NOT COMPLETED|Overall Study||4
8099649|NCT03248492|19964493|P4|NOT COMPLETED|Overall Study||130
8099650|NCT03248492|19964494|P3|NOT COMPLETED|Overall Study||21
8099651|NCT03248492|19964495|P2|NOT COMPLETED|Overall Study||48
8099652|NCT03248492|19964496|P1|NOT COMPLETED|Overall Study||50
8099653|NCT03248492|19964492|P5|COMPLETED|Overall Study||0
8099654|NCT03248492|19964493|P4|COMPLETED|Overall Study||0
8099655|NCT03248492|19964494|P3|COMPLETED|Overall Study||0
8099656|NCT03248492|19964495|P2|COMPLETED|Overall Study||0
8099657|NCT03248492|19964496|P1|COMPLETED|Overall Study||0
8099658|NCT03248492|19964492|P5|STARTED|Overall Study||4
8099659|NCT03248492|19964493|P4|STARTED|Overall Study||130
8099660|NCT03248492|19964494|P3|STARTED|Overall Study||21
8099661|NCT03248492|19964495|P2|STARTED|Overall Study||48
8099662|NCT03248492|19964496|P1|STARTED|Overall Study||50
8099663|NCT03248141|19964536|P2|NOT COMPLETED|Overall Study||0
8099664|NCT03248141|19964537|P1|NOT COMPLETED|Overall Study||0
8099665|NCT03248141|19964536|P2|COMPLETED|Overall Study||0
8099666|NCT03248141|19964537|P1|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
8099667|NCT03248141|19964536|P2|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
8099668|NCT03248141|19964537|P1|STARTED|Overall Study||11
8099669|NCT03247985|19964547|P2|NOT COMPLETED|Overall Study||0
8099670|NCT03247985|19964548|P1|NOT COMPLETED|Overall Study||0
8099671|NCT03247985|19964547|P2|COMPLETED|Overall Study||19
8099672|NCT03247985|19964548|P1|COMPLETED|Overall Study||19
8099673|NCT03247985|19964547|P2|STARTED|Overall Study||19
8099674|NCT03247985|19964548|P1|STARTED|Overall Study||19
8099675|NCT03247816|19964562|P1|NOT COMPLETED|Overall Study||29
8099676|NCT03247816|19964562|P1|COMPLETED|Overall Study||30
8099677|NCT03247816|19964562|P1|STARTED|Overall Study||59
8099678|NCT03247790|19964592|P1|NOT COMPLETED|Period 2: Inter-ictal Period||0
8099679|NCT03247790|19964592|P1|COMPLETED|Period 2: Inter-ictal Period||16
8099680|NCT03247790|19964592|P1|STARTED|Period 2: Inter-ictal Period||16
8099681|NCT03247790|19964592|P1|NOT COMPLETED|Period 1: Migraine Attack||0
8099682|NCT03247790|19964592|P1|COMPLETED|Period 1: Migraine Attack||16
8099683|NCT03247790|19964592|P1|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
8099684|NCT03247790|19964592|P1|STARTED|Period 1: Migraine Attack||16
8099685|NCT03247738|19964606|P2|NOT COMPLETED|Overall Study||0
8099686|NCT03247738|19964607|P1|NOT COMPLETED|Overall Study||0
8099687|NCT03247738|19964606|P2|COMPLETED|Overall Study||25
8099688|NCT03247738|19964607|P1|COMPLETED|Overall Study||25
8099689|NCT03247738|19964606|P2|STARTED|Overall Study||25
8099690|NCT03247738|19964607|P1|STARTED|Overall Study||25
8099691|NCT03247673|19964618|P3|NOT COMPLETED|Overall Study||4
8099692|NCT03247673|19964619|P2|NOT COMPLETED|Overall Study||0
8099693|NCT03247673|19964620|P1|NOT COMPLETED|Overall Study||1
8099694|NCT03247673|19964618|P3|COMPLETED|Overall Study||44
8099695|NCT03247673|19964619|P2|COMPLETED|Overall Study||47
8099696|NCT03247673|19964620|P1|COMPLETED|Overall Study||45
8099697|NCT03247673|19964618|P3|STARTED|Overall Study||48
8099698|NCT03247673|19964619|P2|STARTED|Overall Study||47
8099699|NCT03247673|19964620|P1|STARTED|Overall Study||46
8099700|NCT03246724|19964644|P4|NOT COMPLETED|Overall Study||8
8099701|NCT03246724|19964645|P3|NOT COMPLETED|Overall Study||15
8099702|NCT03246724|19964646|P2|NOT COMPLETED|Overall Study||7
8099703|NCT03246724|19964647|P1|NOT COMPLETED|Overall Study||14
8099704|NCT03246724|19964644|P4|COMPLETED|Overall Study||44
8099705|NCT03246724|19964645|P3|COMPLETED|Overall Study||70
8099706|NCT03246724|19964646|P2|COMPLETED|Overall Study||84
8099707|NCT03246724|19964647|P1|COMPLETED|Overall Study||85
8099708|NCT03246724|19964644|P4|STARTED|Overall Study||52
8099709|NCT03246724|19964645|P3|STARTED|Overall Study||85
8099710|NCT03246724|19964646|P2|STARTED|Overall Study||91
8099711|NCT03246724|19964647|P1|STARTED|Overall Study||99
8099712|NCT03246672|19964673|P1|NOT COMPLETED|Overall Study||2
8099713|NCT03246672|19964673|P1|COMPLETED|Overall Study||28
8099714|NCT03246672|19964673|P1|Completed First Phone Call|Overall Study||29
8099715|NCT03246672|19964673|P1|STARTED|Overall Study||30
8099716|NCT03246152|19964679|P1|NOT COMPLETED|Overall Study||3
8099717|NCT03246152|19964679|P1|COMPLETED|Overall Study||28
8099718|NCT03246152|19964679|P1|STARTED|Overall Study||31
8099719|NCT03246061|19964687|P2|NOT COMPLETED|Overall Study||21
8099720|NCT03246061|19964688|P1|NOT COMPLETED|Overall Study||15
8099721|NCT03246061|19964687|P2|COMPLETED|Overall Study||53
8099722|NCT03246061|19964688|P1|COMPLETED|Overall Study||51
8099723|NCT03246061|19964687|P2|Interim Analysis|Overall Study||53
8099724|NCT03246061|19964688|P1|Interim Analysis|Overall Study||51
8099725|NCT03246061|19964687|P2|STARTED|Overall Study||74
8099726|NCT03246061|19964688|P1|STARTED|Overall Study||66
8099727|NCT03245762|19964698|P2|NOT COMPLETED|Overall Study||0
8099728|NCT03245762|19964699|P1|NOT COMPLETED|Overall Study||0
8099729|NCT03245762|19964698|P2|COMPLETED|Overall Study||5
8099730|NCT03245762|19964699|P1|COMPLETED|Overall Study||10
8099731|NCT03245762|19964698|P2|STARTED|Overall Study||5
8099732|NCT03245762|19964699|P1|STARTED|Overall Study||10
8099733|NCT03245619|19964722|P17|NOT COMPLETED|Part C (Up to 34 Days)||0
8099734|NCT03245619|19964723|P16|NOT COMPLETED|Part C (Up to 34 Days)||0
8099735|NCT03245619|19964724|P15|NOT COMPLETED|Part C (Up to 34 Days)||0
8099736|NCT03245619|19964725|P14|NOT COMPLETED|Part C (Up to 34 Days)||0
8099737|NCT03245619|19964726|P13|NOT COMPLETED|Part C (Up to 34 Days)||0
8099738|NCT03245619|19964727|P12|NOT COMPLETED|Part C (Up to 34 Days)||0
8099739|NCT03245619|19964728|P11|NOT COMPLETED|Part C (Up to 34 Days)||0
8099740|NCT03245619|19964729|P10|NOT COMPLETED|Part C (Up to 34 Days)||0
8099741|NCT03245619|19964730|P9|NOT COMPLETED|Part C (Up to 34 Days)||0
8099742|NCT03245619|19964731|P8|NOT COMPLETED|Part C (Up to 34 Days)||0
8099743|NCT03245619|19964732|P7|NOT COMPLETED|Part C (Up to 34 Days)||0
8099744|NCT03245619|19964733|P6|NOT COMPLETED|Part C (Up to 34 Days)||0
8099745|NCT03245619|19964734|P5|NOT COMPLETED|Part C (Up to 34 Days)||0
8099746|NCT03245619|19964735|P4|NOT COMPLETED|Part C (Up to 34 Days)||0
8099747|NCT03245619|19964736|P3|NOT COMPLETED|Part C (Up to 34 Days)||0
8099748|NCT03245619|19964737|P2|NOT COMPLETED|Part C (Up to 34 Days)||0
8099749|NCT03245619|19964738|P1|NOT COMPLETED|Part C (Up to 34 Days)||0
8099750|NCT03245619|19964722|P17|COMPLETED|Part C (Up to 34 Days)||0
8099751|NCT03245619|19964723|P16|COMPLETED|Part C (Up to 34 Days)||0
8099752|NCT03245619|19964724|P15|COMPLETED|Part C (Up to 34 Days)||0
8099753|NCT03245619|19964725|P14|COMPLETED|Part C (Up to 34 Days)||0
8099754|NCT03245619|19964726|P13|COMPLETED|Part C (Up to 34 Days)||0
8099755|NCT03245619|19964727|P12|COMPLETED|Part C (Up to 34 Days)||0
8099756|NCT03245619|19964728|P11|COMPLETED|Part C (Up to 34 Days)||0
8099757|NCT03245619|19964729|P10|COMPLETED|Part C (Up to 34 Days)||0
8099758|NCT03245619|19964730|P9|COMPLETED|Part C (Up to 34 Days)||0
8099759|NCT03245619|19964731|P8|COMPLETED|Part C (Up to 34 Days)||0
8099760|NCT03245619|19964732|P7|COMPLETED|Part C (Up to 34 Days)||0
8099761|NCT03245619|19964733|P6|COMPLETED|Part C (Up to 34 Days)||0
8099762|NCT03245619|19964734|P5|COMPLETED|Part C (Up to 34 Days)||0
8099763|NCT03245619|19964735|P4|COMPLETED|Part C (Up to 34 Days)||0
8099764|NCT03245619|19964736|P3|COMPLETED|Part C (Up to 34 Days)||0
8099765|NCT03245619|19964737|P2|COMPLETED|Part C (Up to 34 Days)||0
8099766|NCT03245619|19964738|P1|COMPLETED|Part C (Up to 34 Days)||0
8099767|NCT03245619|19964722|P17|STARTED|Part C (Up to 34 Days)||0
8099768|NCT03245619|19964723|P16|STARTED|Part C (Up to 34 Days)||0
8099769|NCT03245619|19964724|P15|STARTED|Part C (Up to 34 Days)||0
8099770|NCT03245619|19964725|P14|STARTED|Part C (Up to 34 Days)||0
8099771|NCT03245619|19964726|P13|STARTED|Part C (Up to 34 Days)||0
8099772|NCT03245619|19964727|P12|STARTED|Part C (Up to 34 Days)||0
8099773|NCT03245619|19964728|P11|STARTED|Part C (Up to 34 Days)||0
8099774|NCT03245619|19964729|P10|STARTED|Part C (Up to 34 Days)||0
8099775|NCT03245619|19964730|P9|STARTED|Part C (Up to 34 Days)||0
8099776|NCT03245619|19964731|P8|STARTED|Part C (Up to 34 Days)||0
8099777|NCT03245619|19964732|P7|STARTED|Part C (Up to 34 Days)||0
8099778|NCT03245619|19964733|P6|STARTED|Part C (Up to 34 Days)||0
8099779|NCT03245619|19964734|P5|STARTED|Part C (Up to 34 Days)||0
8099780|NCT03245619|19964735|P4|STARTED|Part C (Up to 34 Days)||0
8099781|NCT03245619|19964736|P3|STARTED|Part C (Up to 34 Days)||0
8099782|NCT03245619|19964737|P2|STARTED|Part C (Up to 34 Days)||0
8099783|NCT03245619|19964738|P1|STARTED|Part C (Up to 34 Days)||0
8099784|NCT03245619|19964722|P17|NOT COMPLETED|Part B (Up to 34 Days)||0
8099785|NCT03245619|19964723|P16|NOT COMPLETED|Part B (Up to 34 Days)||0
8099786|NCT03245619|19964724|P15|NOT COMPLETED|Part B (Up to 34 Days)||0
8099787|NCT03245619|19964725|P14|NOT COMPLETED|Part B (Up to 34 Days)||0
8099788|NCT03245619|19964726|P13|NOT COMPLETED|Part B (Up to 34 Days)||0
8099789|NCT03245619|19964727|P12|NOT COMPLETED|Part B (Up to 34 Days)||0
8099790|NCT03245619|19964728|P11|NOT COMPLETED|Part B (Up to 34 Days)||0
8099791|NCT03245619|19964729|P10|NOT COMPLETED|Part B (Up to 34 Days)||0
8099792|NCT03245619|19964730|P9|NOT COMPLETED|Part B (Up to 34 Days)||0
8099793|NCT03245619|19964731|P8|NOT COMPLETED|Part B (Up to 34 Days)||0
8099794|NCT03245619|19964732|P7|NOT COMPLETED|Part B (Up to 34 Days)||0
8099795|NCT03245619|19964733|P6|NOT COMPLETED|Part B (Up to 34 Days)||0
8099796|NCT03245619|19964734|P5|NOT COMPLETED|Part B (Up to 34 Days)||0
8099797|NCT03245619|19964735|P4|NOT COMPLETED|Part B (Up to 34 Days)||0
8099798|NCT03245619|19964736|P3|NOT COMPLETED|Part B (Up to 34 Days)||0
8099799|NCT03245619|19964737|P2|NOT COMPLETED|Part B (Up to 34 Days)||0
8099800|NCT03245619|19964738|P1|NOT COMPLETED|Part B (Up to 34 Days)||0
8099801|NCT03245619|19964722|P17|COMPLETED|Part B (Up to 34 Days)||0
8099802|NCT03245619|19964723|P16|COMPLETED|Part B (Up to 34 Days)||0
8099803|NCT03245619|19964724|P15|COMPLETED|Part B (Up to 34 Days)||0
8099804|NCT03245619|19964725|P14|COMPLETED|Part B (Up to 34 Days)||0
8099805|NCT03245619|19964726|P13|COMPLETED|Part B (Up to 34 Days)||0
8099806|NCT03245619|19964727|P12|COMPLETED|Part B (Up to 34 Days)||0
8099807|NCT03245619|19964728|P11|COMPLETED|Part B (Up to 34 Days)||0
8099808|NCT03245619|19964729|P10|COMPLETED|Part B (Up to 34 Days)||0
8099809|NCT03245619|19964730|P9|COMPLETED|Part B (Up to 34 Days)||0
8099810|NCT03245619|19964731|P8|COMPLETED|Part B (Up to 34 Days)||0
8099811|NCT03245619|19964732|P7|COMPLETED|Part B (Up to 34 Days)||0
8099812|NCT03245619|19964733|P6|COMPLETED|Part B (Up to 34 Days)||0
8099813|NCT03245619|19964734|P5|COMPLETED|Part B (Up to 34 Days)||0
8099814|NCT03245619|19964735|P4|COMPLETED|Part B (Up to 34 Days)||0
8099815|NCT03245619|19964736|P3|COMPLETED|Part B (Up to 34 Days)||0
8099816|NCT03245619|19964737|P2|COMPLETED|Part B (Up to 34 Days)||0
8099817|NCT03245619|19964738|P1|COMPLETED|Part B (Up to 34 Days)||0
8099818|NCT03245619|19964722|P17|STARTED|Part B (Up to 34 Days)||0
8099819|NCT03245619|19964723|P16|STARTED|Part B (Up to 34 Days)||0
8099820|NCT03245619|19964724|P15|STARTED|Part B (Up to 34 Days)||0
8099821|NCT03245619|19964725|P14|STARTED|Part B (Up to 34 Days)||0
8099822|NCT03245619|19964726|P13|STARTED|Part B (Up to 34 Days)||0
8099823|NCT03245619|19964727|P12|STARTED|Part B (Up to 34 Days)||0
8099824|NCT03245619|19964728|P11|STARTED|Part B (Up to 34 Days)||0
8099825|NCT03245619|19964729|P10|STARTED|Part B (Up to 34 Days)||0
8099826|NCT03245619|19964730|P9|STARTED|Part B (Up to 34 Days)||0
8099827|NCT03245619|19964731|P8|STARTED|Part B (Up to 34 Days)||0
8099828|NCT03245619|19964732|P7|STARTED|Part B (Up to 34 Days)||0
8099829|NCT03245619|19964733|P6|STARTED|Part B (Up to 34 Days)||0
8099830|NCT03245619|19964734|P5|STARTED|Part B (Up to 34 Days)||0
8099831|NCT03245619|19964735|P4|STARTED|Part B (Up to 34 Days)||0
8099832|NCT03245619|19964736|P3|STARTED|Part B (Up to 34 Days)||0
8099833|NCT03245619|19964737|P2|STARTED|Part B (Up to 34 Days)||0
8099834|NCT03245619|19964738|P1|STARTED|Part B (Up to 34 Days)||0
8099835|NCT03245619|19964722|P17|NOT COMPLETED|Part A (Up to Day 22)||0
8099836|NCT03245619|19964723|P16|NOT COMPLETED|Part A (Up to Day 22)||0
8099837|NCT03245619|19964724|P15|NOT COMPLETED|Part A (Up to Day 22)||0
8099838|NCT03245619|19964725|P14|NOT COMPLETED|Part A (Up to Day 22)||0
8099839|NCT03245619|19964726|P13|NOT COMPLETED|Part A (Up to Day 22)||0
8099840|NCT03245619|19964727|P12|NOT COMPLETED|Part A (Up to Day 22)||0
8099841|NCT03245619|19964728|P11|NOT COMPLETED|Part A (Up to Day 22)||0
8099842|NCT03245619|19964729|P10|NOT COMPLETED|Part A (Up to Day 22)||0
8099843|NCT03245619|19964730|P9|NOT COMPLETED|Part A (Up to Day 22)||0
8099844|NCT03245619|19964731|P8|NOT COMPLETED|Part A (Up to Day 22)||0
8099845|NCT03245619|19964732|P7|NOT COMPLETED|Part A (Up to Day 22)||0
8099846|NCT03245619|19964733|P6|NOT COMPLETED|Part A (Up to Day 22)||0
8099847|NCT03245619|19964734|P5|NOT COMPLETED|Part A (Up to Day 22)||0
8099848|NCT03245619|19964735|P4|NOT COMPLETED|Part A (Up to Day 22)||0
8099849|NCT03245619|19964736|P3|NOT COMPLETED|Part A (Up to Day 22)||6
8099850|NCT03245619|19964737|P2|NOT COMPLETED|Part A (Up to Day 22)||6
8099851|NCT03245619|19964738|P1|NOT COMPLETED|Part A (Up to Day 22)||4
8099852|NCT03245619|19964722|P17|COMPLETED|Part A (Up to Day 22)||0
8099853|NCT03245619|19964723|P16|COMPLETED|Part A (Up to Day 22)||0
8099854|NCT03245619|19964724|P15|COMPLETED|Part A (Up to Day 22)||0
8099855|NCT03245619|19964725|P14|COMPLETED|Part A (Up to Day 22)||0
8099856|NCT03245619|19964726|P13|COMPLETED|Part A (Up to Day 22)||0
8099857|NCT03245619|19964727|P12|COMPLETED|Part A (Up to Day 22)||0
8099858|NCT03245619|19964728|P11|COMPLETED|Part A (Up to Day 22)||0
8099859|NCT03245619|19964729|P10|COMPLETED|Part A (Up to Day 22)||0
8099860|NCT03245619|19964730|P9|COMPLETED|Part A (Up to Day 22)||0
8099861|NCT03245619|19964731|P8|COMPLETED|Part A (Up to Day 22)||0
8099862|NCT03245619|19964732|P7|COMPLETED|Part A (Up to Day 22)||0
8099863|NCT03245619|19964733|P6|COMPLETED|Part A (Up to Day 22)||0
8099864|NCT03245619|19964734|P5|COMPLETED|Part A (Up to Day 22)||0
8099865|NCT03245619|19964735|P4|COMPLETED|Part A (Up to Day 22)||1
8099866|NCT03245619|19964736|P3|COMPLETED|Part A (Up to Day 22)||0
8099867|NCT03245619|19964737|P2|COMPLETED|Part A (Up to Day 22)||0
8099868|NCT03245619|19964738|P1|COMPLETED|Part A (Up to Day 22)||1
8099869|NCT03245619|19964722|P17|STARTED|Part A (Up to Day 22)||0
8099870|NCT03245619|19964723|P16|STARTED|Part A (Up to Day 22)||0
8099871|NCT03245619|19964724|P15|STARTED|Part A (Up to Day 22)||0
8099872|NCT03245619|19964725|P14|STARTED|Part A (Up to Day 22)||0
8099873|NCT03245619|19964726|P13|STARTED|Part A (Up to Day 22)||0
8099874|NCT03245619|19964727|P12|STARTED|Part A (Up to Day 22)||0
8099875|NCT03245619|19964728|P11|STARTED|Part A (Up to Day 22)||0
8099876|NCT03245619|19964729|P10|STARTED|Part A (Up to Day 22)||0
8099877|NCT03245619|19964730|P9|STARTED|Part A (Up to Day 22)||0
8099878|NCT03245619|19964731|P8|STARTED|Part A (Up to Day 22)||0
8099879|NCT03245619|19964732|P7|STARTED|Part A (Up to Day 22)||0
8099880|NCT03245619|19964733|P6|STARTED|Part A (Up to Day 22)||0
8099881|NCT03245619|19964734|P5|STARTED|Part A (Up to Day 22)||0
8099882|NCT03245619|19964735|P4|STARTED|Part A (Up to Day 22)||1
8099883|NCT03245619|19964736|P3|STARTED|Part A (Up to Day 22)||6
8099884|NCT03245619|19964737|P2|STARTED|Part A (Up to Day 22)||6
8099885|NCT03245619|19964738|P1|STARTED|Part A (Up to Day 22)||5
8099886|NCT03245463|19964993|P2|NOT COMPLETED|Overall Study||0
8099887|NCT03245463|19964994|P1|NOT COMPLETED|Overall Study||0
8099888|NCT03245463|19964993|P2|COMPLETED|Overall Study||12
8099889|NCT03245463|19964994|P1|COMPLETED|Overall Study||12
8099890|NCT03245463|19964993|P2|STARTED|Overall Study||12
8099891|NCT03245463|19964994|P1|STARTED|Overall Study||12
8099892|NCT03245398|19965012|P2|NOT COMPLETED|Overall Study||0
8099893|NCT03245398|19965013|P1|NOT COMPLETED|Overall Study||1
8099894|NCT03245398|19965012|P2|COMPLETED|Overall Study||93
8099895|NCT03245398|19965013|P1|COMPLETED|Overall Study||92
8099896|NCT03245398|19965012|P2|STARTED|Overall Study||93
8099897|NCT03245398|19965013|P1|STARTED|Overall Study||93
8099898|NCT03244865|19965035|P1|NOT COMPLETED|Overall Study||0
8099899|NCT03244865|19965035|P1|COMPLETED|Overall Study||35
8099900|NCT03244865|19965035|P1|STARTED|Overall Study||35
8099901|NCT03244800|19965043|P4|NOT COMPLETED|Overall Study||2
8099902|NCT03244800|19965044|P3|NOT COMPLETED|Overall Study||0
8099903|NCT03244800|19965045|P2|NOT COMPLETED|Overall Study||1
8099904|NCT03244800|19965046|P1|NOT COMPLETED|Overall Study||0
8099905|NCT03244800|19965043|P4|COMPLETED|Overall Study||18
8099906|NCT03244800|19965044|P3|COMPLETED|Overall Study||6
8099907|NCT03244800|19965045|P2|COMPLETED|Overall Study||25
8099908|NCT03244800|19965046|P1|COMPLETED|Overall Study||13
8099909|NCT03244800|19965043|P4|STARTED|Overall Study||20
8099910|NCT03244800|19965044|P3|STARTED|Overall Study||6
8099911|NCT03244800|19965045|P2|STARTED|Overall Study||26
8099912|NCT03244800|19965046|P1|STARTED|Overall Study||13
8099913|NCT03244618|19965106|P2|NOT COMPLETED|Overall Study||9
8099914|NCT03244618|19965107|P1|NOT COMPLETED|Overall Study||7
8099915|NCT03244618|19965106|P2|COMPLETED|Overall Study||122
8099916|NCT03244618|19965107|P1|COMPLETED|Overall Study||125
8099917|NCT03244618|19965106|P2|Week 2|Overall Study||125
8099918|NCT03244618|19965107|P1|Week 2|Overall Study||128
8099919|NCT03244618|19965106|P2|STARTED|Overall Study||131
8099920|NCT03244618|19965107|P1|STARTED|Overall Study||132
8099921|NCT03243981|19965123|P1|NOT COMPLETED|Overall Study||0
8099922|NCT03243981|19965123|P1|COMPLETED|Overall Study||5
8099923|NCT03243981|19965123|P1|STARTED|Overall Study||5
8099924|NCT03243630|19965142|P1|NOT COMPLETED|Overall Study||2
8099925|NCT03243630|19965142|P1|COMPLETED|Overall Study||22
8099926|NCT03243630|19965142|P1|Green Apple and Menthol E-liquid Lower|Overall Study||21
8099927|NCT03243630|19965142|P1|Green Apple and Menthol E-liquid Higher|Overall Study||21
8099928|NCT03243630|19965142|P1|Green Apple and Menthol E-liquid Saline|Overall Study||21
8099929|NCT03243630|19965142|P1|Green Apple E-liquid Lower|Overall Study||20
8099930|NCT03243630|19965142|P1|Green Apple E-liquid Higher|Overall Study||20
8099931|NCT03243630|19965142|P1|Green Apple E-liquid Saline|Overall Study||20
8099932|NCT03243630|19965142|P1|Menthol E-liquid Lower|Overall Study||22
8099933|NCT03243630|19965142|P1|Menthol E-liquid Higher|Overall Study||22
8099934|NCT03243630|19965142|P1|Menthol E-liquid Saline|Overall Study||22
8099935|NCT03243630|19965142|P1|STARTED|Overall Study||24
8099936|NCT03243305|19965150|P1|NOT COMPLETED|Overall Study||935
8099937|NCT03243305|19965150|P1|COMPLETED|Overall Study||449
8099938|NCT03243305|19965150|P1|STARTED|Overall Study||1384
8099939|NCT03243084|19965157|P2|NOT COMPLETED|Session 2||0
8099940|NCT03243084|19965158|P1|NOT COMPLETED|Session 2||0
8099941|NCT03243084|19965157|P2|COMPLETED|Session 2||10
8099942|NCT03243084|19965158|P1|COMPLETED|Session 2||10
8099943|NCT03243084|19965157|P2|STARTED|Session 2||10
8099944|NCT03243084|19965158|P1|STARTED|Session 2||10
8099945|NCT03243084|19965157|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
8099946|NCT03243084|19965158|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
8099947|NCT03243084|19965157|P2|COMPLETED|Washout (1-3 Weeks)||10
8099948|NCT03243084|19965158|P1|COMPLETED|Washout (1-3 Weeks)||10
8099949|NCT03243084|19965157|P2|STARTED|Washout (1-3 Weeks)||10
8099950|NCT03243084|19965158|P1|STARTED|Washout (1-3 Weeks)||11
8099951|NCT03243084|19965157|P2|NOT COMPLETED|Session 1||0
8099952|NCT03243084|19965158|P1|NOT COMPLETED|Session 1||0
8099953|NCT03243084|19965157|P2|COMPLETED|Session 1||10
8099954|NCT03243084|19965158|P1|COMPLETED|Session 1||11
8099955|NCT03243084|19965157|P2|STARTED|Session 1||10
8099956|NCT03243084|19965158|P1|STARTED|Session 1||11
8099957|NCT03242941|19965168|P1|NOT COMPLETED|Overall Study||2
8099958|NCT03242941|19965168|P1|COMPLETED|Overall Study||14
8099959|NCT03242941|19965168|P1|STARTED|Overall Study||16
8099960|NCT03242863|19965174|P6|NOT COMPLETED|Study Week 3||0
8099961|NCT03242863|19965175|P5|NOT COMPLETED|Study Week 3||0
8099962|NCT03242863|19965176|P4|NOT COMPLETED|Study Week 3||0
8099963|NCT03242863|19965177|P3|NOT COMPLETED|Study Week 3||0
8099964|NCT03242863|19965178|P2|NOT COMPLETED|Study Week 3||0
8099965|NCT03242863|19965179|P1|NOT COMPLETED|Study Week 3||0
8099966|NCT03242863|19965174|P6|COMPLETED|Study Week 3||5
8099967|NCT03242863|19965175|P5|COMPLETED|Study Week 3||12
8099968|NCT03242863|19965176|P4|COMPLETED|Study Week 3||4
8099969|NCT03242863|19965177|P3|COMPLETED|Study Week 3||4
8099970|NCT03242863|19965178|P2|COMPLETED|Study Week 3||15
8099971|NCT03242863|19965179|P1|COMPLETED|Study Week 3||13
8099972|NCT03242863|19965174|P6|STARTED|Study Week 3||5
8099973|NCT03242863|19965175|P5|STARTED|Study Week 3||12
8099974|NCT03242863|19965176|P4|STARTED|Study Week 3||4
8099975|NCT03242863|19965177|P3|STARTED|Study Week 3||4
8099976|NCT03242863|19965178|P2|STARTED|Study Week 3||15
8099977|NCT03242863|19965179|P1|STARTED|Study Week 3||13
8099978|NCT03242863|19965174|P6|NOT COMPLETED|Study Week 2||0
8099979|NCT03242863|19965175|P5|NOT COMPLETED|Study Week 2||0
8099980|NCT03242863|19965176|P4|NOT COMPLETED|Study Week 2||0
8099981|NCT03242863|19965177|P3|NOT COMPLETED|Study Week 2||0
8099982|NCT03242863|19965178|P2|NOT COMPLETED|Study Week 2||0
8099983|NCT03242863|19965179|P1|NOT COMPLETED|Study Week 2||0
8099984|NCT03242863|19965174|P6|COMPLETED|Study Week 2||5
8099985|NCT03242863|19965175|P5|COMPLETED|Study Week 2||12
8099986|NCT03242863|19965176|P4|COMPLETED|Study Week 2||4
8099987|NCT03242863|19965177|P3|COMPLETED|Study Week 2||4
8099988|NCT03242863|19965178|P2|COMPLETED|Study Week 2||15
8099989|NCT03242863|19965179|P1|COMPLETED|Study Week 2||13
8099990|NCT03242863|19965174|P6|STARTED|Study Week 2||5
8099991|NCT03242863|19965175|P5|STARTED|Study Week 2||12
8099992|NCT03242863|19965176|P4|STARTED|Study Week 2||4
8099993|NCT03242863|19965177|P3|STARTED|Study Week 2||4
8099994|NCT03242863|19965178|P2|STARTED|Study Week 2||15
8099995|NCT03242863|19965179|P1|STARTED|Study Week 2||13
8099996|NCT03242863|19965174|P6|NOT COMPLETED|Study Week 1||0
8099997|NCT03242863|19965175|P5|NOT COMPLETED|Study Week 1||3
8099998|NCT03242863|19965176|P4|NOT COMPLETED|Study Week 1||0
8099999|NCT03242863|19965177|P3|NOT COMPLETED|Study Week 1||0
8100000|NCT03242863|19965178|P2|NOT COMPLETED|Study Week 1||1
8100001|NCT03242863|19965179|P1|NOT COMPLETED|Study Week 1||0
8100002|NCT03242863|19965174|P6|COMPLETED|Study Week 1||5
8100003|NCT03242863|19965175|P5|COMPLETED|Study Week 1||12
8100004|NCT03242863|19965176|P4|COMPLETED|Study Week 1||4
8100005|NCT03242863|19965177|P3|COMPLETED|Study Week 1||4
8100006|NCT03242863|19965178|P2|COMPLETED|Study Week 1||15
8100007|NCT03242863|19965179|P1|COMPLETED|Study Week 1||13
8100008|NCT03242863|19965174|P6|STARTED|Study Week 1||5
8100009|NCT03242863|19965175|P5|STARTED|Study Week 1||15
8100010|NCT03242863|19965176|P4|STARTED|Study Week 1||4
8100011|NCT03242863|19965177|P3|STARTED|Study Week 1||4
8100012|NCT03242863|19965178|P2|STARTED|Study Week 1||16
8100013|NCT03242863|19965179|P1|STARTED|Study Week 1||13
8100014|NCT03242590|19965196|P1|NOT COMPLETED|Overall Study||0
8100015|NCT03242590|19965196|P1|COMPLETED|Overall Study||95
8100016|NCT03242590|19965196|P1|STARTED|Overall Study||95
8100017|NCT03242434|19965202|P2|NOT COMPLETED|Overall Study||2
8100018|NCT03242434|19965203|P1|NOT COMPLETED|Overall Study||0
8100019|NCT03242434|19965202|P2|COMPLETED|Overall Study||1
8100020|NCT03242434|19965203|P1|COMPLETED|Overall Study||15
8100021|NCT03242434|19965202|P2|STARTED|Overall Study||3
8100022|NCT03242434|19965203|P1|STARTED|Overall Study||15
8100023|NCT03242408|19965211|P1|NOT COMPLETED|Overall Study||2
8100024|NCT03242408|19965211|P1|COMPLETED|Overall Study||98
8100025|NCT03242408|19965211|P1|STARTED|Overall Study||100
8100026|NCT03241927|19965215|P2|NOT COMPLETED|Overall Study||0
8100027|NCT03241927|19965216|P1|NOT COMPLETED|Overall Study||1
8100028|NCT03241927|19965215|P2|COMPLETED|Overall Study||0
8100029|NCT03241927|19965216|P1|COMPLETED|Overall Study||0
8100030|NCT03241927|19965215|P2|STARTED|Overall Study||0
8100031|NCT03241927|19965216|P1|STARTED|Overall Study||1
8100032|NCT03241862|19965236|P1|NOT COMPLETED|Overall Study||0
8100033|NCT03241862|19965236|P1|COMPLETED|Overall Study||20
8100034|NCT03241862|19965236|P1|STARTED|Overall Study||20
8100035|NCT03241810|19965243|P2|NOT COMPLETED|Overall Study||0
8100036|NCT03241810|19965244|P1|NOT COMPLETED|Overall Study||0
8100037|NCT03241810|19965243|P2|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
8100038|NCT03241810|19965244|P1|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
8100039|NCT03241810|19965243|P2|STARTED|Overall Study||11
8100040|NCT03241810|19965244|P1|STARTED|Overall Study||11
8100041|NCT03241368|19965262|P1|NOT COMPLETED|Overall Study||39
8100042|NCT03241368|19965262|P1|COMPLETED|Overall Study||119
8100043|NCT03241368|19965262|P1|STARTED|Overall Study||158
8100053|NCT03240575|19965286|P4|NOT COMPLETED|Overall Study||2
8100054|NCT03240575|19965287|P3|NOT COMPLETED|Overall Study||0
8100055|NCT03240575|19965288|P2|NOT COMPLETED|Overall Study||14
8100056|NCT03240575|19965289|P1|NOT COMPLETED|Overall Study||2
8100057|NCT03240575|19965286|P4|COMPLETED|Overall Study||3
8100058|NCT03240575|19965287|P3|COMPLETED|Overall Study||6
8100059|NCT03240575|19965288|P2|COMPLETED|Overall Study||131
8100060|NCT03240575|19965289|P1|COMPLETED|Overall Study||144
8100061|NCT03240575|19965286|P4|STARTED|Overall Study||5
8100062|NCT03240575|19965287|P3|STARTED|Overall Study||6
8100063|NCT03240575|19965288|P2|STARTED|Overall Study||145
8100064|NCT03240575|19965289|P1|STARTED|Overall Study||146
8100065|NCT03240081|19965311|P2|NOT COMPLETED|Overall Study||3
8100066|NCT03240081|19965312|P1|NOT COMPLETED|Overall Study||0
8100067|NCT03240081|19965311|P2|COMPLETED|Overall Study||22
8100068|NCT03240081|19965312|P1|COMPLETED|Overall Study||25
8100069|NCT03240081|19965311|P2|STARTED|Overall Study||25
8100070|NCT03240081|19965312|P1|STARTED|Overall Study||25
8100071|NCT03239873|19965322|P2|NOT COMPLETED|Overall Study||27
8100072|NCT03239873|19965323|P1|NOT COMPLETED|Overall Study||32
8100073|NCT03239873|19965322|P2|COMPLETED|Overall Study||273
8100074|NCT03239873|19965323|P1|COMPLETED|Overall Study||268
8100075|NCT03239873|19965322|P2|Vaccination 2|Overall Study||282
8100076|NCT03239873|19965323|P1|Vaccination 2|Overall Study||276
8100077|NCT03239873|19965322|P2|Vaccination 1|Overall Study||300
8100078|NCT03239873|19965323|P1|Vaccination 1|Overall Study||299
8100079|NCT03239873|19965322|P2|STARTED|Overall Study||300
8100080|NCT03239873|19965323|P1|STARTED|Overall Study||300
8100081|NCT03239665|19965369|P2|NOT COMPLETED|Overall Study||20
8100082|NCT03239665|19965370|P1|NOT COMPLETED|Overall Study||28
8100083|NCT03239665|19965369|P2|COMPLETED|Overall Study||140
8100084|NCT03239665|19965370|P1|COMPLETED|Overall Study||147
8100085|NCT03239665|19965369|P2|Submitted Survey Data|Overall Study||140
8100086|NCT03239665|19965370|P1|Submitted Survey Data|Overall Study||147
8100087|NCT03239665|19965369|P2|Met Inclusion Criteria|Overall Study||144
8100088|NCT03239665|19965370|P1|Met Inclusion Criteria|Overall Study||150
8100089|NCT03239665|19965369|P2|STARTED|Overall Study||160
8100090|NCT03239665|19965370|P1|STARTED|Overall Study||175
8100091|NCT03239522|19965390|P1|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
8100092|NCT03239522|19965390|P1|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
8100093|NCT03239522|19965390|P1|STARTED|Treatment Period 2 (Up to 15 Days)||6
8100094|NCT03239522|19965390|P1|NOT COMPLETED|Washout Period (Up to 7 Days)||0
8100095|NCT03239522|19965390|P1|COMPLETED|Washout Period (Up to 7 Days)||6
8100096|NCT03239522|19965390|P1|STARTED|Washout Period (Up to 7 Days)||6
8100097|NCT03239522|19965390|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
8100098|NCT03239522|19965390|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
8100099|NCT03239522|19965390|P1|STARTED|Treatment Period 1 (Up to 7 Days)||6
8100100|NCT03239496|19965484|P4|NOT COMPLETED|Overall Study||14
8100101|NCT03239496|19965485|P3|NOT COMPLETED|Overall Study||12
8100102|NCT03239496|19965486|P2|NOT COMPLETED|Overall Study||10
8100103|NCT03239496|19965487|P1|NOT COMPLETED|Overall Study||14
8100104|NCT03239496|19965484|P4|COMPLETED|Overall Study||203
8100105|NCT03239496|19965485|P3|COMPLETED|Overall Study||166
8100106|NCT03239496|19965486|P2|COMPLETED|Overall Study||168
8100107|NCT03239496|19965487|P1|COMPLETED|Overall Study||186
8100108|NCT03239496|19965484|P4|STARTED|Overall Study||217
8100109|NCT03239496|19965485|P3|STARTED|Overall Study||178
8100110|NCT03239496|19965486|P2|STARTED|Overall Study||178
8100111|NCT03239496|19965487|P1|STARTED|Overall Study||200
8100112|NCT03239483|19965515|P2|NOT COMPLETED|Overall Study||0
8100113|NCT03239483|19965516|P1|NOT COMPLETED|Overall Study||2
8100114|NCT03239483|19965515|P2|COMPLETED|Overall Study||9
8100115|NCT03239483|19965516|P1|COMPLETED|Overall Study||17
8100116|NCT03239483|19965515|P2|STARTED|Overall Study||9
8100117|NCT03239483|19965516|P1|STARTED|Overall Study||19
8100118|NCT03239106|19965530|P1|NOT COMPLETED|Overall Study||7
8100119|NCT03239106|19965530|P1|COMPLETED|Overall Study||3
8100120|NCT03239106|19965530|P1|STARTED|Overall Study||10
8100121|NCT03238924|19965537|P2|NOT COMPLETED|Overall Study||2
8100122|NCT03238924|19965538|P1|NOT COMPLETED|Overall Study||2
8100123|NCT03238924|19965537|P2|COMPLETED|Overall Study||7
8100124|NCT03238924|19965538|P1|COMPLETED|Overall Study||6
8100125|NCT03238924|19965537|P2|STARTED|Overall Study||9
8100126|NCT03238924|19965538|P1|STARTED|Overall Study||8
8100127|NCT03238911|19965550|P2|NOT COMPLETED|Overall Study||3
8100128|NCT03238911|19965551|P1|NOT COMPLETED|Overall Study||3
8100129|NCT03238911|19965550|P2|COMPLETED|Overall Study||58
8100130|NCT03238911|19965551|P1|COMPLETED|Overall Study||59
8100131|NCT03238911|19965550|P2|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
8100132|NCT03238911|19965551|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
8100133|NCT03238911|19965550|P2|STARTED|Overall Study||61
8100134|NCT03238911|19965551|P1|STARTED|Overall Study||62
8100135|NCT03238781|19965594|P3|NOT COMPLETED|Overall Study||20
8100136|NCT03238781|19965595|P2|NOT COMPLETED|Overall Study||17
8100137|NCT03238781|19965596|P1|NOT COMPLETED|Overall Study||26
8100138|NCT03238781|19965594|P3|COMPLETED|Overall Study||82
8100139|NCT03238781|19965595|P2|COMPLETED|Overall Study||87
8100140|NCT03238781|19965596|P1|COMPLETED|Overall Study||111
8100141|NCT03238781|19965594|P3|STARTED|Overall Study||102
8100142|NCT03238781|19965595|P2|STARTED|Overall Study||104
8100143|NCT03238781|19965596|P1|STARTED|Overall Study||137
8100144|NCT03238352|19965646|P3|NOT COMPLETED|Overall Study||1
8100145|NCT03238352|19965647|P2|NOT COMPLETED|Overall Study||3
8100146|NCT03238352|19965648|P1|NOT COMPLETED|Overall Study||0
8100147|NCT03238352|19965646|P3|COMPLETED|Overall Study||22
8100148|NCT03238352|19965647|P2|COMPLETED|Overall Study||20
8100149|NCT03238352|19965648|P1|COMPLETED|Overall Study||43
8100150|NCT03238352|19965646|P3|STARTED|Overall Study||23
8100151|NCT03238352|19965647|P2|STARTED|Overall Study||23
8100152|NCT03238352|19965648|P1|STARTED|Overall Study||43
8100153|NCT03238001|19965659|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
8100154|NCT03238001|19965659|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
8100155|NCT03238001|19965659|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
8100156|NCT03238001|19965659|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
8100157|NCT03238001|19965659|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
8100158|NCT03238001|19965659|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
8100159|NCT03237871|19965682|P1|NOT COMPLETED|Overall Study||6
8100160|NCT03237871|19965682|P1|COMPLETED|Overall Study||11
8100161|NCT03237871|19965682|P1|STARTED|Overall Study||17
8100162|NCT03237845|19965690|P2|NOT COMPLETED|Overall Study||50
8100163|NCT03237845|19965691|P1|NOT COMPLETED|Overall Study||56
8100164|NCT03237845|19965690|P2|COMPLETED|Overall Study||542
8100165|NCT03237845|19965691|P1|COMPLETED|Overall Study||538
8100166|NCT03237845|19965690|P2|Treated|Overall Study||543
8100167|NCT03237845|19965691|P1|Treated|Overall Study||543
8100168|NCT03237845|19965690|P2|STARTED|Overall Study||592
8100169|NCT03237845|19965691|P1|STARTED|Overall Study||594
8100170|NCT03237156|19965725|P4|NOT COMPLETED|Overall Study||0
8100171|NCT03237156|19965726|P3|NOT COMPLETED|Overall Study||0
8100172|NCT03237156|19965727|P2|NOT COMPLETED|Overall Study||0
8100173|NCT03237156|19965728|P1|NOT COMPLETED|Overall Study||0
8100174|NCT03237156|19965725|P4|COMPLETED|Overall Study||6
8100175|NCT03237156|19965726|P3|COMPLETED|Overall Study||6
8100176|NCT03237156|19965727|P2|COMPLETED|Overall Study||6
8100177|NCT03237156|19965728|P1|COMPLETED|Overall Study||6
8100178|NCT03237156|19965725|P4|STARTED|Overall Study||6
8100179|NCT03237156|19965726|P3|STARTED|Overall Study||6
8100180|NCT03237156|19965727|P2|STARTED|Overall Study||6
8100181|NCT03237156|19965728|P1|STARTED|Overall Study||6
8100182|NCT03237065|19965821|P2|NOT COMPLETED|Overall Study||4
8100183|NCT03237065|19965822|P1|NOT COMPLETED|Overall Study||4
8100184|NCT03237065|19965821|P2|COMPLETED|Overall Study||57
8100185|NCT03237065|19965822|P1|COMPLETED|Overall Study||57
8100186|NCT03237065|19965821|P2|Safety Analysis Set|Overall Study||57
8100187|NCT03237065|19965822|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
8100188|NCT03237065|19965821|P2|STARTED|Overall Study||61
8100189|NCT03237065|19965822|P1|STARTED|Overall Study||61
8100190|NCT03237013|19965865|P3|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
8100191|NCT03237013|19965866|P2|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
8100192|NCT03237013|19965867|P1|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
8100193|NCT03237013|19965865|P3|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
8100194|NCT03237013|19965866|P2|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
8100195|NCT03237013|19965867|P1|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
8100196|NCT03237013|19965865|P3|STARTED|Immediate Post-treatment to 1-mo F/u||73
8100197|NCT03237013|19965866|P2|STARTED|Immediate Post-treatment to 1-mo F/u||73
8100198|NCT03237013|19965867|P1|STARTED|Immediate Post-treatment to 1-mo F/u||73
8100199|NCT03237013|19965865|P3|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8100200|NCT03237013|19965866|P2|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8100201|NCT03237013|19965867|P1|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8100202|NCT03237013|19965865|P3|COMPLETED|Baseline to Immediate Post-treatment||73
8100203|NCT03237013|19965866|P2|COMPLETED|Baseline to Immediate Post-treatment||73
8100204|NCT03237013|19965867|P1|COMPLETED|Baseline to Immediate Post-treatment||73
8100205|NCT03237013|19965865|P3|STARTED|Baseline to Immediate Post-treatment||73
8100206|NCT03237013|19965866|P2|STARTED|Baseline to Immediate Post-treatment||73
8100207|NCT03237013|19965867|P1|STARTED|Baseline to Immediate Post-treatment||73
8100208|NCT03236779|19965916|P2|NOT COMPLETED|Overall Study||21
8100209|NCT03236779|19965917|P1|NOT COMPLETED|Overall Study||13
8100210|NCT03236779|19965916|P2|COMPLETED|Overall Study||30
8100211|NCT03236779|19965917|P1|COMPLETED|Overall Study||38
8100212|NCT03236779|19965916|P2|STARTED|Overall Study||51
8100213|NCT03236779|19965917|P1|STARTED|Overall Study||51
8100214|NCT03236311|19965931|P2|NOT COMPLETED|Overall Study||3
8100215|NCT03236311|19965932|P1|NOT COMPLETED|Overall Study||0
8100216|NCT03236311|19965931|P2|COMPLETED|Overall Study||2
8100217|NCT03236311|19965932|P1|COMPLETED|Overall Study||5
8100218|NCT03236311|19965931|P2|STARTED|Overall Study||5
8100219|NCT03236311|19965932|P1|STARTED|Overall Study||5
8100220|NCT03236168|19965942|P1|NOT COMPLETED|Overall Study||11
8100221|NCT03236168|19965942|P1|COMPLETED|Overall Study||107
8100222|NCT03236168|19965942|P1|STARTED|Overall Study||118
8100223|NCT03235817|19965949|P3|NOT COMPLETED|Overall Study||2
8100224|NCT03235817|19965950|P2|NOT COMPLETED|Overall Study||1
8100225|NCT03235817|19965951|P1|NOT COMPLETED|Overall Study||3
8100226|NCT03235817|19965949|P3|COMPLETED|Overall Study||11
8100227|NCT03235817|19965950|P2|COMPLETED|Overall Study||12
8100228|NCT03235817|19965951|P1|COMPLETED|Overall Study||10
8100229|NCT03235817|19965949|P3|STARTED|Overall Study||13
8100230|NCT03235817|19965950|P2|STARTED|Overall Study||13
8100231|NCT03235817|19965951|P1|STARTED|Overall Study||13
8100232|NCT03235726|19965976|P10|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100233|NCT03235726|19965977|P9|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100234|NCT03235726|19965978|P8|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100235|NCT03235726|19965979|P7|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100236|NCT03235726|19965980|P6|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100237|NCT03235726|19965981|P5|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100238|NCT03235726|19965982|P4|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100239|NCT03235726|19965983|P3|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100240|NCT03235726|19965984|P2|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100241|NCT03235726|19965985|P1|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100242|NCT03235726|19965976|P10|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
8100243|NCT03235726|19965977|P9|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100244|NCT03235726|19965978|P8|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100245|NCT03235726|19965979|P7|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100246|NCT03235726|19965980|P6|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100247|NCT03235726|19965981|P5|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100248|NCT03235726|19965982|P4|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100249|NCT03235726|19965983|P3|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100250|NCT03235726|19965984|P2|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100251|NCT03235726|19965985|P1|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100252|NCT03235726|19965976|P10|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
8100253|NCT03235726|19965977|P9|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100254|NCT03235726|19965978|P8|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100255|NCT03235726|19965979|P7|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100256|NCT03235726|19965980|P6|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100257|NCT03235726|19965981|P5|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100258|NCT03235726|19965982|P4|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100259|NCT03235726|19965983|P3|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100260|NCT03235726|19965984|P2|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100261|NCT03235726|19965985|P1|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100262|NCT03235726|19965976|P10|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100263|NCT03235726|19965977|P9|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100264|NCT03235726|19965978|P8|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100265|NCT03235726|19965979|P7|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100266|NCT03235726|19965980|P6|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100267|NCT03235726|19965981|P5|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100268|NCT03235726|19965982|P4|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100269|NCT03235726|19965983|P3|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100270|NCT03235726|19965984|P2|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100271|NCT03235726|19965985|P1|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100272|NCT03235726|19965976|P10|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100273|NCT03235726|19965977|P9|COMPLETED|Part 2 (Cohort A - Day 1)||2
8100274|NCT03235726|19965978|P8|COMPLETED|Part 2 (Cohort A - Day 1)||6
8100275|NCT03235726|19965979|P7|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100276|NCT03235726|19965980|P6|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100277|NCT03235726|19965981|P5|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100278|NCT03235726|19965982|P4|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100279|NCT03235726|19965983|P3|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100280|NCT03235726|19965984|P2|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100281|NCT03235726|19965985|P1|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100282|NCT03235726|19965976|P10|STARTED|Part 2 (Cohort A - Day 1)||0
8100283|NCT03235726|19965977|P9|STARTED|Part 2 (Cohort A - Day 1)||2
8100284|NCT03235726|19965978|P8|STARTED|Part 2 (Cohort A - Day 1)||6
8100285|NCT03235726|19965979|P7|STARTED|Part 2 (Cohort A - Day 1)||0
8100286|NCT03235726|19965980|P6|STARTED|Part 2 (Cohort A - Day 1)||0
8100287|NCT03235726|19965981|P5|STARTED|Part 2 (Cohort A - Day 1)||0
8100288|NCT03235726|19965982|P4|STARTED|Part 2 (Cohort A - Day 1)||0
8100289|NCT03235726|19965983|P3|STARTED|Part 2 (Cohort A - Day 1)||0
8100290|NCT03235726|19965984|P2|STARTED|Part 2 (Cohort A - Day 1)||0
8100291|NCT03235726|19965985|P1|STARTED|Part 2 (Cohort A - Day 1)||0
8100292|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100293|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100294|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100295|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100296|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100297|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
8100298|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100299|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100300|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100301|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100302|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100303|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100304|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100305|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
8100306|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
8100307|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
8100308|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100309|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100310|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100311|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100312|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100313|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100314|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100315|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
8100316|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
8100317|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
8100318|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100319|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100320|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100321|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100322|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100323|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100324|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100325|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100326|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100327|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100328|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100329|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100330|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100331|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100332|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100333|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100334|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100335|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100336|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100337|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100338|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
8100339|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
8100340|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100341|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100342|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100343|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100344|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100345|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100346|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100347|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100348|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
8100349|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
8100350|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100351|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100352|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100353|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100354|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100355|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100356|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100357|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100358|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100359|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100360|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100361|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100362|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100363|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100364|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100365|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100366|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100367|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100368|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
8100369|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100370|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
8100371|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100372|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100373|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100374|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100375|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100376|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100377|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100378|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
8100379|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100380|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
8100381|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100382|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100383|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100384|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100385|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100386|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100387|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100388|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100389|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100390|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100391|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100392|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100393|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100394|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100395|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100396|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100397|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100398|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
8100399|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100400|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100401|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
8100402|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100403|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100404|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100405|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100406|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100407|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100408|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
8100409|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100410|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100411|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
8100412|NCT03235479|19966139|P2|NOT COMPLETED|Overall Study||40
8100413|NCT03235479|19966140|P1|NOT COMPLETED|Overall Study||41
8100414|NCT03235479|19966139|P2|COMPLETED|Overall Study||540
8100415|NCT03235479|19966140|P1|COMPLETED|Overall Study||541
8100416|NCT03235479|19966139|P2|Treated|Overall Study||549
8100417|NCT03235479|19966140|P1|Treated|Overall Study||546
8100418|NCT03235479|19966139|P2|STARTED|Overall Study||580
8100419|NCT03235479|19966140|P1|STARTED|Overall Study||582
8100420|NCT03235414|19966170|P1|NOT COMPLETED|Overall Study||0
8100421|NCT03235414|19966170|P1|COMPLETED|Overall Study||101
8100422|NCT03235414|19966170|P1|STARTED|Overall Study||101
8100423|NCT03235349|19966177|P1|NOT COMPLETED|Overall Study||2
8100424|NCT03235349|19966177|P1|COMPLETED|Overall Study||158
8100425|NCT03235349|19966177|P1|STARTED|Overall Study||160
8100426|NCT03235284|19966187|P3|NOT COMPLETED|Overall Study||1
8100427|NCT03235284|19966188|P2|NOT COMPLETED|Overall Study||2
8100428|NCT03235284|19966189|P1|NOT COMPLETED|Overall Study||1
8100429|NCT03235284|19966187|P3|COMPLETED|Overall Study||14
8100430|NCT03235284|19966188|P2|COMPLETED|Overall Study||13
8100431|NCT03235284|19966189|P1|COMPLETED|Overall Study||14
8100432|NCT03235284|19966187|P3|STARTED|Overall Study||15
8100433|NCT03235284|19966188|P2|STARTED|Overall Study||15
8100434|NCT03235284|19966189|P1|STARTED|Overall Study||15
8100435|NCT03235115|19966206|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100436|NCT03235115|19966207|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100437|NCT03235115|19966208|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100438|NCT03235115|19966209|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100439|NCT03235115|19966210|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100440|NCT03235115|19966211|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100441|NCT03235115|19966206|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
8100442|NCT03235115|19966207|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8100443|NCT03235115|19966208|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8100444|NCT03235115|19966209|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
8100445|NCT03235115|19966210|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8100446|NCT03235115|19966211|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
8100447|NCT03235115|19966206|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
8100448|NCT03235115|19966207|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8100449|NCT03235115|19966208|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8100450|NCT03235115|19966209|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
8100451|NCT03235115|19966210|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8100452|NCT03235115|19966211|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
8100453|NCT03235115|19966206|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100454|NCT03235115|19966207|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100455|NCT03235115|19966208|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100456|NCT03235115|19966209|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100457|NCT03235115|19966210|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100458|NCT03235115|19966211|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100459|NCT03235115|19966206|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
8100460|NCT03235115|19966207|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8100461|NCT03235115|19966208|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8100462|NCT03235115|19966209|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
8100463|NCT03235115|19966210|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8100464|NCT03235115|19966211|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
8100465|NCT03235115|19966206|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
8100466|NCT03235115|19966207|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
8100467|NCT03235115|19966208|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
8100468|NCT03235115|19966209|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
8100469|NCT03235115|19966210|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
8100470|NCT03235115|19966211|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
8100471|NCT03235115|19966206|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
8100472|NCT03235115|19966207|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100473|NCT03235115|19966208|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100474|NCT03235115|19966209|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100475|NCT03235115|19966210|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100476|NCT03235115|19966211|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100477|NCT03235115|19966206|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
8100478|NCT03235115|19966207|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8100479|NCT03235115|19966208|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8100480|NCT03235115|19966209|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
8100481|NCT03235115|19966210|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8100482|NCT03235115|19966211|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
8100483|NCT03235115|19966206|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
8100484|NCT03235115|19966207|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
8100485|NCT03235115|19966208|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
8100486|NCT03235115|19966209|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
8100487|NCT03235115|19966210|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
8100488|NCT03235115|19966211|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
8100489|NCT03235089|19966231|P2|NOT COMPLETED|Overall Study||3
8100490|NCT03235089|19966232|P1|NOT COMPLETED|Overall Study||3
8100491|NCT03235089|19966231|P2|COMPLETED|Overall Study||28
8100492|NCT03235089|19966232|P1|COMPLETED|Overall Study||28
8100493|NCT03235089|19966231|P2|STARTED|Overall Study||31
8100494|NCT03235089|19966232|P1|STARTED|Overall Study||31
8100495|NCT03235050|19966273|P5|NOT COMPLETED|Overall Study||11
8100496|NCT03235050|19966274|P4|NOT COMPLETED|Overall Study||14
8100497|NCT03235050|19966275|P3|NOT COMPLETED|Overall Study||4
8100498|NCT03235050|19966276|P2|NOT COMPLETED|Overall Study||5
8100499|NCT03235050|19966277|P1|NOT COMPLETED|Overall Study||4
8100500|NCT03235050|19966273|P5|COMPLETED|Overall Study||245
8100501|NCT03235050|19966274|P4|COMPLETED|Overall Study||242
8100502|NCT03235050|19966275|P3|COMPLETED|Overall Study||96
8100503|NCT03235050|19966276|P2|COMPLETED|Overall Study||105
8100504|NCT03235050|19966277|P1|COMPLETED|Overall Study||108
8100505|NCT03235050|19966273|P5|STARTED|Overall Study||256
8100506|NCT03235050|19966274|P4|STARTED|Overall Study||256
8100507|NCT03235050|19966275|P3|STARTED|Overall Study||100
8100508|NCT03235050|19966276|P2|STARTED|Overall Study||110
8100509|NCT03235050|19966277|P1|STARTED|Overall Study||112
8100510|NCT03234465|19966338|P2|NOT COMPLETED|Overall Study||40
8100511|NCT03234465|19966339|P1|NOT COMPLETED|Overall Study||33
8100512|NCT03234465|19966338|P2|COMPLETED|Overall Study||60
8100513|NCT03234465|19966339|P1|COMPLETED|Overall Study||67
8100514|NCT03234465|19966338|P2|STARTED|Overall Study||100
8100515|NCT03234465|19966339|P1|STARTED|Overall Study||100
8100516|NCT03234374|19966347|P2|NOT COMPLETED|Overall Study||1
8100517|NCT03234374|19966348|P1|NOT COMPLETED|Overall Study||1
8100518|NCT03234374|19966347|P2|COMPLETED|Overall Study||16
8100519|NCT03234374|19966348|P1|COMPLETED|Overall Study||34
8100520|NCT03234374|19966347|P2|STARTED|Overall Study||17
8100521|NCT03234374|19966348|P1|STARTED|Overall Study||35
8100522|NCT03234036|19966369|P4|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100523|NCT03234036|19966370|P3|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100524|NCT03234036|19966371|P2|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100525|NCT03234036|19966372|P1|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100526|NCT03234036|19966369|P4|COMPLETED|Part 2 (Up to 25 Days)||7
8100527|NCT03234036|19966370|P3|COMPLETED|Part 2 (Up to 25 Days)||3
8100528|NCT03234036|19966371|P2|COMPLETED|Part 2 (Up to 25 Days)||0
8100529|NCT03234036|19966372|P1|COMPLETED|Part 2 (Up to 25 Days)||0
8100530|NCT03234036|19966369|P4|STARTED|Part 2 (Up to 25 Days)||7
8100531|NCT03234036|19966370|P3|STARTED|Part 2 (Up to 25 Days)||3
8100532|NCT03234036|19966371|P2|STARTED|Part 2 (Up to 25 Days)||0
8100533|NCT03234036|19966372|P1|STARTED|Part 2 (Up to 25 Days)||0
8100534|NCT03234036|19966369|P4|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100535|NCT03234036|19966370|P3|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100536|NCT03234036|19966371|P2|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100537|NCT03234036|19966372|P1|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100538|NCT03234036|19966369|P4|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100539|NCT03234036|19966370|P3|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100540|NCT03234036|19966371|P2|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100541|NCT03234036|19966372|P1|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100542|NCT03234036|19966369|P4|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100543|NCT03234036|19966370|P3|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100544|NCT03234036|19966371|P2|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100545|NCT03234036|19966372|P1|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100546|NCT03234036|19966369|P4|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100547|NCT03234036|19966370|P3|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100548|NCT03234036|19966371|P2|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100549|NCT03234036|19966372|P1|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100550|NCT03234036|19966369|P4|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100551|NCT03234036|19966370|P3|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100552|NCT03234036|19966371|P2|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100553|NCT03234036|19966372|P1|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100554|NCT03234036|19966369|P4|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100555|NCT03234036|19966370|P3|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100556|NCT03234036|19966371|P2|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100557|NCT03234036|19966372|P1|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100558|NCT03234036|19966369|P4|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100559|NCT03234036|19966370|P3|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100560|NCT03234036|19966371|P2|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100561|NCT03234036|19966372|P1|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100562|NCT03234036|19966369|P4|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100563|NCT03234036|19966370|P3|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100564|NCT03234036|19966371|P2|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100565|NCT03234036|19966372|P1|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100566|NCT03234036|19966369|P4|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100567|NCT03234036|19966370|P3|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100568|NCT03234036|19966371|P2|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100569|NCT03234036|19966372|P1|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100570|NCT03234036|19966369|P4|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100571|NCT03234036|19966370|P3|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100572|NCT03234036|19966371|P2|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
8100573|NCT03234036|19966372|P1|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
8100574|NCT03234036|19966369|P4|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100575|NCT03234036|19966370|P3|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100576|NCT03234036|19966371|P2|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
8100577|NCT03234036|19966372|P1|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
8100578|NCT03234036|19966369|P4|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100579|NCT03234036|19966370|P3|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100580|NCT03234036|19966371|P2|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
8100581|NCT03234036|19966372|P1|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
8100582|NCT03234036|19966369|P4|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100583|NCT03234036|19966370|P3|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100584|NCT03234036|19966371|P2|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100585|NCT03234036|19966372|P1|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100586|NCT03234036|19966369|P4|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100587|NCT03234036|19966370|P3|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100588|NCT03234036|19966371|P2|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100589|NCT03234036|19966372|P1|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100590|NCT03234036|19966369|P4|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100591|NCT03234036|19966370|P3|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100592|NCT03234036|19966371|P2|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100593|NCT03234036|19966372|P1|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100594|NCT03233737|19966479|P5|NOT COMPLETED|Overall Study||0
8100595|NCT03233737|19966480|P4|NOT COMPLETED|Overall Study||0
8100596|NCT03233737|19966481|P3|NOT COMPLETED|Overall Study||0
8100597|NCT03233737|19966482|P2|NOT COMPLETED|Overall Study||0
8100598|NCT03233737|19966483|P1|NOT COMPLETED|Overall Study||0
8100599|NCT03233737|19966479|P5|COMPLETED|Overall Study||26
8100600|NCT03233737|19966480|P4|COMPLETED|Overall Study||24
8100601|NCT03233737|19966481|P3|COMPLETED|Overall Study||5
8100602|NCT03233737|19966482|P2|COMPLETED|Overall Study||10
8100603|NCT03233737|19966483|P1|COMPLETED|Overall Study||10
8100604|NCT03233737|19966479|P5|STARTED|Overall Study||26
8100605|NCT03233737|19966480|P4|STARTED|Overall Study||24
8100606|NCT03233737|19966481|P3|STARTED|Overall Study||5
8100607|NCT03233737|19966482|P2|STARTED|Overall Study||10
8100608|NCT03233737|19966483|P1|STARTED|Overall Study||10
8100609|NCT03233529|19966543|P1|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
8100610|NCT03233529|19966543|P1|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
8100611|NCT03233529|19966543|P1|STARTED|Open-Label Period (Day 15 to Day 71)||39
8100612|NCT03233529|19966543|P1|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
8100613|NCT03233529|19966543|P1|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
8100614|NCT03233529|19966543|P1|STARTED|Double-Blind Period (Day 1 to Day 15)||40
8100615|NCT03233438|19966587|P2|NOT COMPLETED|Overall Study||11
8100616|NCT03233438|19966588|P1|NOT COMPLETED|Overall Study||6
8100617|NCT03233438|19966587|P2|COMPLETED|Overall Study||32
8100618|NCT03233438|19966588|P1|COMPLETED|Overall Study||42
8100619|NCT03233438|19966587|P2|STARTED|Overall Study||43
8100620|NCT03233438|19966588|P1|STARTED|Overall Study||48
8100621|NCT03233308|19966654|P1|NOT COMPLETED|Overall Study||2
8100622|NCT03233308|19966654|P1|COMPLETED|Overall Study||18
8100623|NCT03233308|19966654|P1|STARTED|Overall Study||20
8100624|NCT03233230|19966670|P4|NOT COMPLETED|Overall Study||8
8100625|NCT03233230|19966671|P3|NOT COMPLETED|Overall Study||12
8100626|NCT03233230|19966672|P2|NOT COMPLETED|Overall Study||15
8100627|NCT03233230|19966673|P1|NOT COMPLETED|Overall Study||15
8100628|NCT03233230|19966670|P4|COMPLETED|Overall Study||91
8100629|NCT03233230|19966671|P3|COMPLETED|Overall Study||84
8100630|NCT03233230|19966672|P2|COMPLETED|Overall Study||83
8100631|NCT03233230|19966673|P1|COMPLETED|Overall Study||82
8100632|NCT03233230|19966670|P4|STARTED|Overall Study||99
8100633|NCT03233230|19966671|P3|STARTED|Overall Study||96
8100634|NCT03233230|19966672|P2|STARTED|Overall Study||98
8100635|NCT03233230|19966673|P1|STARTED|Overall Study||97
8100636|NCT03233217|19966832|P5|NOT COMPLETED|Overall Study||0
8100637|NCT03233217|19966833|P4|NOT COMPLETED|Overall Study||0
8100638|NCT03233217|19966834|P3|NOT COMPLETED|Overall Study||0
8100639|NCT03233217|19966835|P2|NOT COMPLETED|Overall Study||0
8100640|NCT03233217|19966836|P1|NOT COMPLETED|Overall Study||0
8100641|NCT03233217|19966832|P5|COMPLETED|Overall Study||55
8100642|NCT03233217|19966833|P4|COMPLETED|Overall Study||55
8100643|NCT03233217|19966834|P3|COMPLETED|Overall Study||55
8100644|NCT03233217|19966835|P2|COMPLETED|Overall Study||5
8100645|NCT03233217|19966836|P1|COMPLETED|Overall Study||5
8100646|NCT03233217|19966832|P5|Per-protocol Analysis Set (PPAS)|Overall Study||54
8100647|NCT03233217|19966833|P4|Per-protocol Analysis Set (PPAS)|Overall Study||55
8100648|NCT03233217|19966834|P3|Per-protocol Analysis Set (PPAS)|Overall Study||55
8100649|NCT03233217|19966835|P2|Per-protocol Analysis Set (PPAS)|Overall Study||5
8100650|NCT03233217|19966836|P1|Per-protocol Analysis Set (PPAS)|Overall Study||5
8100651|NCT03233217|19966832|P5|Safety Analysis Set (SafAS)|Overall Study||55
8100652|NCT03233217|19966833|P4|Safety Analysis Set (SafAS)|Overall Study||55
8100653|NCT03233217|19966834|P3|Safety Analysis Set (SafAS)|Overall Study||55
8100654|NCT03233217|19966835|P2|Safety Analysis Set (SafAS)|Overall Study||5
8100655|NCT03233217|19966836|P1|Safety Analysis Set (SafAS)|Overall Study||5
8100656|NCT03233217|19966832|P5|STARTED|Overall Study||55
8100657|NCT03233217|19966833|P4|STARTED|Overall Study||55
8100658|NCT03233217|19966834|P3|STARTED|Overall Study||55
8100659|NCT03233217|19966835|P2|STARTED|Overall Study||5
8100660|NCT03233217|19966836|P1|STARTED|Overall Study||5
8100661|NCT03233009|19966865|P1|NOT COMPLETED|Overall Study||1
8100662|NCT03233009|19966865|P1|COMPLETED|Overall Study||39
8100663|NCT03233009|19966865|P1|Reference Product|Overall Study||39
8100664|NCT03233009|19966865|P1|Test Product 4|Overall Study||39
8100665|NCT03233009|19966865|P1|Test Product 3|Overall Study||39
8100666|NCT03233009|19966865|P1|Test Product 2|Overall Study||39
8100667|NCT03233009|19966865|P1|Test Product 1|Overall Study||39
8100668|NCT03233009|19966865|P1|STARTED|Overall Study||40
8100669|NCT03232983|19966908|P4|NOT COMPLETED|Period 4||0
8100670|NCT03232983|19966909|P3|NOT COMPLETED|Period 4||0
8100671|NCT03232983|19966910|P2|NOT COMPLETED|Period 4||0
8100672|NCT03232983|19966911|P1|NOT COMPLETED|Period 4||1
8100673|NCT03232983|19966908|P4|COMPLETED|Period 4||6
8100674|NCT03232983|19966909|P3|COMPLETED|Period 4||5
8100675|NCT03232983|19966910|P2|COMPLETED|Period 4||7
8100676|NCT03232983|19966911|P1|COMPLETED|Period 4||6
8100677|NCT03232983|19966908|P4|STARTED|Period 4||6
8100678|NCT03232983|19966909|P3|STARTED|Period 4||5
8100679|NCT03232983|19966910|P2|STARTED|Period 4||7
8100680|NCT03232983|19966911|P1|STARTED|Period 4||7
8100681|NCT03232983|19966908|P4|NOT COMPLETED|Washout Period 3||0
8100682|NCT03232983|19966909|P3|NOT COMPLETED|Washout Period 3||0
8100683|NCT03232983|19966910|P2|NOT COMPLETED|Washout Period 3||0
8100684|NCT03232983|19966911|P1|NOT COMPLETED|Washout Period 3||0
8100685|NCT03232983|19966908|P4|COMPLETED|Washout Period 3||6
8100686|NCT03232983|19966909|P3|COMPLETED|Washout Period 3||5
8100687|NCT03232983|19966910|P2|COMPLETED|Washout Period 3||7
8100688|NCT03232983|19966911|P1|COMPLETED|Washout Period 3||7
8100689|NCT03232983|19966908|P4|STARTED|Washout Period 3||6
8100690|NCT03232983|19966909|P3|STARTED|Washout Period 3||5
8100691|NCT03232983|19966910|P2|STARTED|Washout Period 3||7
8100692|NCT03232983|19966911|P1|STARTED|Washout Period 3||7
8100693|NCT03232983|19966908|P4|NOT COMPLETED|Period 3||0
8100694|NCT03232983|19966909|P3|NOT COMPLETED|Period 3||0
8100695|NCT03232983|19966910|P2|NOT COMPLETED|Period 3||0
8100696|NCT03232983|19966911|P1|NOT COMPLETED|Period 3||0
8100697|NCT03232983|19966908|P4|COMPLETED|Period 3||6
8100698|NCT03232983|19966909|P3|COMPLETED|Period 3||5
8100699|NCT03232983|19966910|P2|COMPLETED|Period 3||7
8100700|NCT03232983|19966911|P1|COMPLETED|Period 3||7
8100701|NCT03232983|19966908|P4|STARTED|Period 3||6
8100702|NCT03232983|19966909|P3|STARTED|Period 3||5
8100703|NCT03232983|19966910|P2|STARTED|Period 3||7
8100704|NCT03232983|19966911|P1|STARTED|Period 3||7
8100705|NCT03232983|19966908|P4|NOT COMPLETED|Washout Period 2||1
8100706|NCT03232983|19966909|P3|NOT COMPLETED|Washout Period 2||1
8100707|NCT03232983|19966910|P2|NOT COMPLETED|Washout Period 2||0
8100708|NCT03232983|19966911|P1|NOT COMPLETED|Washout Period 2||0
8100709|NCT03232983|19966908|P4|COMPLETED|Washout Period 2||6
8100710|NCT03232983|19966909|P3|COMPLETED|Washout Period 2||5
8100711|NCT03232983|19966910|P2|COMPLETED|Washout Period 2||7
8100712|NCT03232983|19966911|P1|COMPLETED|Washout Period 2||7
8100713|NCT03232983|19966908|P4|STARTED|Washout Period 2||7
8100714|NCT03232983|19966909|P3|STARTED|Washout Period 2||6
8100715|NCT03232983|19966910|P2|STARTED|Washout Period 2||7
8100716|NCT03232983|19966911|P1|STARTED|Washout Period 2||7
8100717|NCT03232983|19966908|P4|NOT COMPLETED|Period 2||0
8100718|NCT03232983|19966909|P3|NOT COMPLETED|Period 2||0
8100719|NCT03232983|19966910|P2|NOT COMPLETED|Period 2||0
8100720|NCT03232983|19966911|P1|NOT COMPLETED|Period 2||0
8100721|NCT03232983|19966908|P4|COMPLETED|Period 2||7
8100722|NCT03232983|19966909|P3|COMPLETED|Period 2||6
8100723|NCT03232983|19966910|P2|COMPLETED|Period 2||7
8100724|NCT03232983|19966911|P1|COMPLETED|Period 2||7
8100725|NCT03232983|19966908|P4|STARTED|Period 2||7
8100726|NCT03232983|19966909|P3|STARTED|Period 2||6
8100727|NCT03232983|19966910|P2|STARTED|Period 2||7
8100728|NCT03232983|19966911|P1|STARTED|Period 2||7
8100729|NCT03232983|19966908|P4|NOT COMPLETED|Washout Period 1||0
8100730|NCT03232983|19966909|P3|NOT COMPLETED|Washout Period 1||0
8100731|NCT03232983|19966910|P2|NOT COMPLETED|Washout Period 1||0
8100732|NCT03232983|19966911|P1|NOT COMPLETED|Washout Period 1||0
8100733|NCT03232983|19966908|P4|COMPLETED|Washout Period 1||7
8100734|NCT03232983|19966909|P3|COMPLETED|Washout Period 1||6
8100735|NCT03232983|19966910|P2|COMPLETED|Washout Period 1||7
8100736|NCT03232983|19966911|P1|COMPLETED|Washout Period 1||7
8100737|NCT03232983|19966908|P4|STARTED|Washout Period 1||7
8100738|NCT03232983|19966909|P3|STARTED|Washout Period 1||6
8100739|NCT03232983|19966910|P2|STARTED|Washout Period 1||7
8100740|NCT03232983|19966911|P1|STARTED|Washout Period 1||7
8100741|NCT03232983|19966908|P4|NOT COMPLETED|Period 1||0
8100742|NCT03232983|19966909|P3|NOT COMPLETED|Period 1||1
8100743|NCT03232983|19966910|P2|NOT COMPLETED|Period 1||0
8100744|NCT03232983|19966911|P1|NOT COMPLETED|Period 1||0
8100745|NCT03232983|19966908|P4|COMPLETED|Period 1||7
8100746|NCT03232983|19966909|P3|COMPLETED|Period 1||6
8100747|NCT03232983|19966910|P2|COMPLETED|Period 1||7
8100748|NCT03232983|19966911|P1|COMPLETED|Period 1||7
8100749|NCT03232983|19966908|P4|Received at Least One Dose of Study Drug|Period 1||7
8100750|NCT03232983|19966909|P3|Received at Least One Dose of Study Drug|Period 1||7
8100751|NCT03232983|19966910|P2|Received at Least One Dose of Study Drug|Period 1||7
8100752|NCT03232983|19966911|P1|Received at Least One Dose of Study Drug|Period 1||7
8100753|NCT03232983|19966908|P4|STARTED|Period 1||7
8100754|NCT03232983|19966909|P3|STARTED|Period 1||7
8100755|NCT03232983|19966910|P2|STARTED|Period 1||7
8100756|NCT03232983|19966911|P1|STARTED|Period 1||7
8100757|NCT03232892|19966924|P1|NOT COMPLETED|Overall Study||0
8100758|NCT03232892|19966924|P1|COMPLETED|Overall Study||1
8100759|NCT03232892|19966924|P1|STARTED|Overall Study||1
8100760|NCT03232827|19966932|P1|NOT COMPLETED|Flavored-very Low Sweetened||0
8100761|NCT03232827|19966932|P1|COMPLETED|Flavored-very Low Sweetened||66
8100762|NCT03232827|19966932|P1|STARTED|Flavored-very Low Sweetened||66
8100763|NCT03232827|19966932|P1|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
8100764|NCT03232827|19966932|P1|COMPLETED|Unflavored-very Low Sweetened (UU)||66
8100765|NCT03232827|19966932|P1|STARTED|Unflavored-very Low Sweetened (UU)||66
8100766|NCT03232827|19966932|P1|NOT COMPLETED|Unflavored-sweetened (US)||0
8100767|NCT03232827|19966932|P1|COMPLETED|Unflavored-sweetened (US)||86
8100768|NCT03232827|19966932|P1|STARTED|Unflavored-sweetened (US)||86
8100769|NCT03232827|19966932|P1|NOT COMPLETED|Flavored-sweetened (FS)||0
8100770|NCT03232827|19966932|P1|COMPLETED|Flavored-sweetened (FS)||80
8100771|NCT03232827|19966932|P1|STARTED|Flavored-sweetened (FS)||80
8100772|NCT03232580|19966946|P1|NOT COMPLETED|Overall Study||0
8100773|NCT03232580|19966946|P1|COMPLETED|Overall Study||5
8100774|NCT03232580|19966946|P1|STARTED|Overall Study||5
8100775|NCT03232567|19966955|P4|NOT COMPLETED|Overall Study||0
8100776|NCT03232567|19966956|P3|NOT COMPLETED|Overall Study||0
8100777|NCT03232567|19966957|P2|NOT COMPLETED|Overall Study||1
8100778|NCT03232567|19966958|P1|NOT COMPLETED|Overall Study||0
8100779|NCT03232567|19966955|P4|COMPLETED|Overall Study||15
8100780|NCT03232567|19966956|P3|COMPLETED|Overall Study||15
8100781|NCT03232567|19966957|P2|COMPLETED|Overall Study||14
8100782|NCT03232567|19966958|P1|COMPLETED|Overall Study||15
8100783|NCT03232567|19966955|P4|STARTED|Overall Study||15
8100784|NCT03232567|19966956|P3|STARTED|Overall Study||15
8100785|NCT03232567|19966957|P2|STARTED|Overall Study||15
8100786|NCT03232567|19966958|P1|STARTED|Overall Study||15
8100787|NCT03232333|19966980|P1|NOT COMPLETED|Overall Study||15
8100788|NCT03232333|19966980|P1|COMPLETED|Overall Study||38
8100789|NCT03232333|19966980|P1|STARTED|Overall Study||53
8100790|NCT03231943|19966997|P13|NOT COMPLETED|Part 2||0
8100791|NCT03231943|19966998|P12|NOT COMPLETED|Part 2||1
8100792|NCT03231943|19966999|P11|NOT COMPLETED|Part 2||1
8100793|NCT03231943|19967000|P10|NOT COMPLETED|Part 2||0
8100794|NCT03231943|19967001|P9|NOT COMPLETED|Part 2||0
8100795|NCT03231943|19967002|P8|NOT COMPLETED|Part 2||0
8100796|NCT03231943|19967003|P7|NOT COMPLETED|Part 2||0
8100797|NCT03231943|19967004|P6|NOT COMPLETED|Part 2||0
8100798|NCT03231943|19967005|P5|NOT COMPLETED|Part 2||0
8100799|NCT03231943|19967006|P4|NOT COMPLETED|Part 2||0
8100800|NCT03231943|19967007|P3|NOT COMPLETED|Part 2||0
8100801|NCT03231943|19967008|P2|NOT COMPLETED|Part 2||0
8100802|NCT03231943|19967009|P1|NOT COMPLETED|Part 2||0
8100803|NCT03231943|19966997|P13|COMPLETED|Part 2||14
8100804|NCT03231943|19966998|P12|COMPLETED|Part 2||6
8100805|NCT03231943|19966999|P11|COMPLETED|Part 2||24
8100806|NCT03231943|19967000|P10|COMPLETED|Part 2||6
8100807|NCT03231943|19967001|P9|COMPLETED|Part 2||6
8100808|NCT03231943|19967002|P8|COMPLETED|Part 2||0
8100809|NCT03231943|19967003|P7|COMPLETED|Part 2||0
8100810|NCT03231943|19967004|P6|COMPLETED|Part 2||0
8100811|NCT03231943|19967005|P5|COMPLETED|Part 2||0
8100812|NCT03231943|19967006|P4|COMPLETED|Part 2||0
8100813|NCT03231943|19967007|P3|COMPLETED|Part 2||0
8100814|NCT03231943|19967008|P2|COMPLETED|Part 2||0
8100815|NCT03231943|19967009|P1|COMPLETED|Part 2||0
8100816|NCT03231943|19966997|P13|STARTED|Part 2||14
8100817|NCT03231943|19966998|P12|STARTED|Part 2||7
8100818|NCT03231943|19966999|P11|STARTED|Part 2||25
8100819|NCT03231943|19967000|P10|STARTED|Part 2||6
8100820|NCT03231943|19967001|P9|STARTED|Part 2||6
8100821|NCT03231943|19967002|P8|STARTED|Part 2||0
8100822|NCT03231943|19967003|P7|STARTED|Part 2||0
8100823|NCT03231943|19967004|P6|STARTED|Part 2||0
8100824|NCT03231943|19967005|P5|STARTED|Part 2||0
8100825|NCT03231943|19967006|P4|STARTED|Part 2||0
8100826|NCT03231943|19967007|P3|STARTED|Part 2||0
8100827|NCT03231943|19967008|P2|STARTED|Part 2||0
8100828|NCT03231943|19967009|P1|STARTED|Part 2||0
8100829|NCT03231943|19966997|P13|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100830|NCT03231943|19966998|P12|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100831|NCT03231943|19966999|P11|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100832|NCT03231943|19967000|P10|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100833|NCT03231943|19967001|P9|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100834|NCT03231943|19967002|P8|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100835|NCT03231943|19967003|P7|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100836|NCT03231943|19967004|P6|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100837|NCT03231943|19967005|P5|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100838|NCT03231943|19967006|P4|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100839|NCT03231943|19967007|P3|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100840|NCT03231943|19967008|P2|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100841|NCT03231943|19967009|P1|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100842|NCT03231943|19966997|P13|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100843|NCT03231943|19966998|P12|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100844|NCT03231943|19966999|P11|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100845|NCT03231943|19967000|P10|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100846|NCT03231943|19967001|P9|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8100847|NCT03231943|19967002|P8|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100848|NCT03231943|19967003|P7|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100849|NCT03231943|19967004|P6|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100850|NCT03231943|19967005|P5|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100851|NCT03231943|19967006|P4|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100852|NCT03231943|19967007|P3|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100853|NCT03231943|19967008|P2|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100854|NCT03231943|19967009|P1|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8100855|NCT03231943|19966997|P13|STARTED|Part 1 Period 4 (up to Day 60)||0
8100856|NCT03231943|19966998|P12|STARTED|Part 1 Period 4 (up to Day 60)||0
8100857|NCT03231943|19966999|P11|STARTED|Part 1 Period 4 (up to Day 60)||0
8100858|NCT03231943|19967000|P10|STARTED|Part 1 Period 4 (up to Day 60)||0
8100859|NCT03231943|19967001|P9|STARTED|Part 1 Period 4 (up to Day 60)||0
8100860|NCT03231943|19967002|P8|STARTED|Part 1 Period 4 (up to Day 60)||2
8100861|NCT03231943|19967003|P7|STARTED|Part 1 Period 4 (up to Day 60)||2
8100862|NCT03231943|19967004|P6|STARTED|Part 1 Period 4 (up to Day 60)||2
8100863|NCT03231943|19967005|P5|STARTED|Part 1 Period 4 (up to Day 60)||2
8100864|NCT03231943|19967006|P4|STARTED|Part 1 Period 4 (up to Day 60)||2
8100865|NCT03231943|19967007|P3|STARTED|Part 1 Period 4 (up to Day 60)||2
8100866|NCT03231943|19967008|P2|STARTED|Part 1 Period 4 (up to Day 60)||2
8100867|NCT03231943|19967009|P1|STARTED|Part 1 Period 4 (up to Day 60)||2
8100868|NCT03231943|19966997|P13|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100869|NCT03231943|19966998|P12|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100870|NCT03231943|19966999|P11|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100871|NCT03231943|19967000|P10|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100872|NCT03231943|19967001|P9|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100873|NCT03231943|19967002|P8|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100874|NCT03231943|19967003|P7|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100875|NCT03231943|19967004|P6|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100876|NCT03231943|19967005|P5|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100877|NCT03231943|19967006|P4|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100878|NCT03231943|19967007|P3|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100879|NCT03231943|19967008|P2|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100880|NCT03231943|19967009|P1|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
8100881|NCT03231943|19966997|P13|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100882|NCT03231943|19966998|P12|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100883|NCT03231943|19966999|P11|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100884|NCT03231943|19967000|P10|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100885|NCT03231943|19967001|P9|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8100886|NCT03231943|19967002|P8|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8100887|NCT03231943|19967003|P7|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8100888|NCT03231943|19967004|P6|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8100889|NCT03231943|19967005|P5|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8100890|NCT03231943|19967006|P4|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8100891|NCT03231943|19967007|P3|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8100892|NCT03231943|19967008|P2|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8100893|NCT03231943|19967009|P1|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
8100894|NCT03231943|19966997|P13|STARTED|Part 1, Period 3 (up to Day 45)||0
8100895|NCT03231943|19966998|P12|STARTED|Part 1, Period 3 (up to Day 45)||0
8100896|NCT03231943|19966999|P11|STARTED|Part 1, Period 3 (up to Day 45)||0
8100897|NCT03231943|19967000|P10|STARTED|Part 1, Period 3 (up to Day 45)||0
8100898|NCT03231943|19967001|P9|STARTED|Part 1, Period 3 (up to Day 45)||0
8100899|NCT03231943|19967002|P8|STARTED|Part 1, Period 3 (up to Day 45)||2
8100900|NCT03231943|19967003|P7|STARTED|Part 1, Period 3 (up to Day 45)||2
8100901|NCT03231943|19967004|P6|STARTED|Part 1, Period 3 (up to Day 45)||2
8100902|NCT03231943|19967005|P5|STARTED|Part 1, Period 3 (up to Day 45)||2
8100903|NCT03231943|19967006|P4|STARTED|Part 1, Period 3 (up to Day 45)||2
8100904|NCT03231943|19967007|P3|STARTED|Part 1, Period 3 (up to Day 45)||2
8100905|NCT03231943|19967008|P2|STARTED|Part 1, Period 3 (up to Day 45)||2
8100906|NCT03231943|19967009|P1|STARTED|Part 1, Period 3 (up to Day 45)||2
8100907|NCT03231943|19966997|P13|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100908|NCT03231943|19966998|P12|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100909|NCT03231943|19966999|P11|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100910|NCT03231943|19967000|P10|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100911|NCT03231943|19967001|P9|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100912|NCT03231943|19967002|P8|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100913|NCT03231943|19967003|P7|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100914|NCT03231943|19967004|P6|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100915|NCT03231943|19967005|P5|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100916|NCT03231943|19967006|P4|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100917|NCT03231943|19967007|P3|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
8100918|NCT03231943|19967008|P2|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
8100919|NCT03231943|19967009|P1|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100920|NCT03231943|19966997|P13|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100921|NCT03231943|19966998|P12|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100922|NCT03231943|19966999|P11|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100923|NCT03231943|19967000|P10|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100924|NCT03231943|19967001|P9|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8100925|NCT03231943|19967002|P8|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8100926|NCT03231943|19967003|P7|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8100927|NCT03231943|19967004|P6|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8100928|NCT03231943|19967005|P5|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8100929|NCT03231943|19967006|P4|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8100930|NCT03231943|19967007|P3|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
8100931|NCT03231943|19967008|P2|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
8100932|NCT03231943|19967009|P1|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8100933|NCT03231943|19966997|P13|STARTED|Part 1, Period 2 (up to Day 30)||0
8100934|NCT03231943|19966998|P12|STARTED|Part 1, Period 2 (up to Day 30)||0
8100935|NCT03231943|19966999|P11|STARTED|Part 1, Period 2 (up to Day 30)||0
8100936|NCT03231943|19967000|P10|STARTED|Part 1, Period 2 (up to Day 30)||0
8100937|NCT03231943|19967001|P9|STARTED|Part 1, Period 2 (up to Day 30)||0
8100938|NCT03231943|19967002|P8|STARTED|Part 1, Period 2 (up to Day 30)||2
8100939|NCT03231943|19967003|P7|STARTED|Part 1, Period 2 (up to Day 30)||2
8100940|NCT03231943|19967004|P6|STARTED|Part 1, Period 2 (up to Day 30)||2
8100941|NCT03231943|19967005|P5|STARTED|Part 1, Period 2 (up to Day 30)||2
8100942|NCT03231943|19967006|P4|STARTED|Part 1, Period 2 (up to Day 30)||2
8100943|NCT03231943|19967007|P3|STARTED|Part 1, Period 2 (up to Day 30)||2
8100944|NCT03231943|19967008|P2|STARTED|Part 1, Period 2 (up to Day 30)||2
8100945|NCT03231943|19967009|P1|STARTED|Part 1, Period 2 (up to Day 30)||2
8100946|NCT03231943|19966997|P13|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100947|NCT03231943|19966998|P12|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100948|NCT03231943|19966999|P11|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100949|NCT03231943|19967000|P10|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100950|NCT03231943|19967001|P9|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100951|NCT03231943|19967002|P8|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100952|NCT03231943|19967003|P7|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100953|NCT03231943|19967004|P6|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100954|NCT03231943|19967005|P5|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100955|NCT03231943|19967006|P4|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100956|NCT03231943|19967007|P3|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100957|NCT03231943|19967008|P2|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100958|NCT03231943|19967009|P1|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100959|NCT03231943|19966997|P13|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100960|NCT03231943|19966998|P12|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100961|NCT03231943|19966999|P11|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100962|NCT03231943|19967000|P10|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100963|NCT03231943|19967001|P9|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8100964|NCT03231943|19967002|P8|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100965|NCT03231943|19967003|P7|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100966|NCT03231943|19967004|P6|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100967|NCT03231943|19967005|P5|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100968|NCT03231943|19967006|P4|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100969|NCT03231943|19967007|P3|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100970|NCT03231943|19967008|P2|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100971|NCT03231943|19967009|P1|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8100972|NCT03231943|19966997|P13|STARTED|Part 1, Period 1 (up to Day 15)||0
8100973|NCT03231943|19966998|P12|STARTED|Part 1, Period 1 (up to Day 15)||0
8100974|NCT03231943|19966999|P11|STARTED|Part 1, Period 1 (up to Day 15)||0
8100975|NCT03231943|19967000|P10|STARTED|Part 1, Period 1 (up to Day 15)||0
8100976|NCT03231943|19967001|P9|STARTED|Part 1, Period 1 (up to Day 15)||0
8100977|NCT03231943|19967002|P8|STARTED|Part 1, Period 1 (up to Day 15)||2
8100978|NCT03231943|19967003|P7|STARTED|Part 1, Period 1 (up to Day 15)||2
8100979|NCT03231943|19967004|P6|STARTED|Part 1, Period 1 (up to Day 15)||2
8100980|NCT03231943|19967005|P5|STARTED|Part 1, Period 1 (up to Day 15)||2
8100981|NCT03231943|19967006|P4|STARTED|Part 1, Period 1 (up to Day 15)||2
8100982|NCT03231943|19967007|P3|STARTED|Part 1, Period 1 (up to Day 15)||2
8100983|NCT03231943|19967008|P2|STARTED|Part 1, Period 1 (up to Day 15)||2
8100984|NCT03231943|19967009|P1|STARTED|Part 1, Period 1 (up to Day 15)||2
8100985|NCT03231917|19967459|P2|NOT COMPLETED|Overall Study||0
8100986|NCT03231917|19967460|P1|NOT COMPLETED|Overall Study||0
8100987|NCT03231917|19967459|P2|COMPLETED|Overall Study||61
8100988|NCT03231917|19967460|P1|COMPLETED|Overall Study||60
8100989|NCT03231917|19967459|P2|STARTED|Overall Study||61
8100990|NCT03231917|19967460|P1|STARTED|Overall Study||60
8100991|NCT03231800|19967472|P2|NOT COMPLETED|Overall Study||3
8100992|NCT03231800|19967473|P1|NOT COMPLETED|Overall Study||3
8100993|NCT03231800|19967472|P2|COMPLETED|Overall Study||44
8100994|NCT03231800|19967473|P1|COMPLETED|Overall Study||45
8100995|NCT03231800|19967472|P2|Safety Population|Overall Study||47
8100996|NCT03231800|19967473|P1|Safety Population|Overall Study||47
8100997|NCT03231800|19967472|P2|STARTED|Overall Study||47
8100998|NCT03231800|19967473|P1|STARTED|Overall Study||48
8100999|NCT03231709|19967489|P2|NOT COMPLETED|Treatment Period 2||1
8101000|NCT03231709|19967490|P1|NOT COMPLETED|Treatment Period 2||0
8101001|NCT03231709|19967489|P2|COMPLETED|Treatment Period 2||28
8101002|NCT03231709|19967490|P1|COMPLETED|Treatment Period 2||30
8101003|NCT03231709|19967489|P2|STARTED|Treatment Period 2||29
8101004|NCT03231709|19967490|P1|STARTED|Treatment Period 2||30
8101005|NCT03231709|19967489|P2|NOT COMPLETED|Treatment Period 1||1
8101006|NCT03231709|19967490|P1|NOT COMPLETED|Treatment Period 1||0
8101007|NCT03231709|19967489|P2|COMPLETED|Treatment Period 1||29
8101008|NCT03231709|19967490|P1|COMPLETED|Treatment Period 1||30
8101009|NCT03231709|19967489|P2|STARTED|Treatment Period 1||30
8101010|NCT03231709|19967490|P1|STARTED|Treatment Period 1||30
8101011|NCT03231371|19967508|P1|NOT COMPLETED|Overall Study||13
8101012|NCT03231371|19967508|P1|COMPLETED|Overall Study||9
8101013|NCT03231371|19967508|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
8101014|NCT03231371|19967508|P1|STARTED|Overall Study||22
8101015|NCT03231345|19967513|P1|NOT COMPLETED|Overall Study||0
8101016|NCT03231345|19967513|P1|COMPLETED|Overall Study||35
8101017|NCT03231345|19967513|P1|STARTED|Overall Study||35
8101018|NCT03231228|19967521|P2|NOT COMPLETED|Overall Study||0
8101019|NCT03231228|19967522|P1|NOT COMPLETED|Overall Study||3
8101020|NCT03231228|19967521|P2|COMPLETED|Overall Study||28
8101021|NCT03231228|19967522|P1|COMPLETED|Overall Study||30
8101022|NCT03231228|19967521|P2|STARTED|Overall Study||28
8101023|NCT03231228|19967522|P1|STARTED|Overall Study||33
8101024|NCT03230864|19967533|P4|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
8101025|NCT03230864|19967534|P3|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
8101026|NCT03230864|19967535|P2|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
8101027|NCT03230864|19967536|P1|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
8101028|NCT03230864|19967533|P4|COMPLETED|Double Blind Treatment (DBT) Period||31
8101029|NCT03230864|19967534|P3|COMPLETED|Double Blind Treatment (DBT) Period||27
8101030|NCT03230864|19967535|P2|COMPLETED|Double Blind Treatment (DBT) Period||0
8101031|NCT03230864|19967536|P1|COMPLETED|Double Blind Treatment (DBT) Period||0
8101032|NCT03230864|19967533|P4|STARTED|Double Blind Treatment (DBT) Period||33
8101033|NCT03230864|19967534|P3|STARTED|Double Blind Treatment (DBT) Period||35
8101034|NCT03230864|19967535|P2|STARTED|Double Blind Treatment (DBT) Period||0
8101035|NCT03230864|19967536|P1|STARTED|Double Blind Treatment (DBT) Period||0
8101036|NCT03230864|19967533|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8101037|NCT03230864|19967534|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8101038|NCT03230864|19967535|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||19
8101039|NCT03230864|19967536|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||32
8101040|NCT03230864|19967533|P4|COMPLETED|Prospective Confirmation (PC) Period||0
8101041|NCT03230864|19967534|P3|COMPLETED|Prospective Confirmation (PC) Period||0
8101042|NCT03230864|19967535|P2|COMPLETED|Prospective Confirmation (PC) Period||32
8101043|NCT03230864|19967536|P1|COMPLETED|Prospective Confirmation (PC) Period||36
8101044|NCT03230864|19967533|P4|STARTED|Prospective Confirmation (PC) Period||0
8101045|NCT03230864|19967534|P3|STARTED|Prospective Confirmation (PC) Period||0
8101046|NCT03230864|19967535|P2|STARTED|Prospective Confirmation (PC) Period||51
8101047|NCT03230864|19967536|P1|STARTED|Prospective Confirmation (PC) Period||68
8101048|NCT03229486|19967554|P2|NOT COMPLETED|Overall Study||1
8101049|NCT03229486|19967555|P1|NOT COMPLETED|Overall Study||0
8101050|NCT03229486|19967554|P2|COMPLETED|Overall Study||19
8101051|NCT03229486|19967555|P1|COMPLETED|Overall Study||20
8101052|NCT03229486|19967554|P2|STARTED|Overall Study||20
8101053|NCT03229486|19967555|P1|STARTED|Overall Study||20
8101054|NCT03229252|19967576|P3|NOT COMPLETED|Overall Study||6
8101055|NCT03229252|19967577|P2|NOT COMPLETED|Overall Study||0
8101056|NCT03229252|19967578|P1|NOT COMPLETED|Overall Study||2
8101057|NCT03229252|19967576|P3|COMPLETED|Overall Study||39
8101058|NCT03229252|19967577|P2|COMPLETED|Overall Study||15
8101059|NCT03229252|19967578|P1|COMPLETED|Overall Study||29
8101060|NCT03229252|19967576|P3|STARTED|Overall Study||45
8101061|NCT03229252|19967577|P2|STARTED|Overall Study||15
8101062|NCT03229252|19967578|P1|STARTED|Overall Study||31
8101063|NCT03229109|19967596|P4|NOT COMPLETED|Overall Study||1
8101064|NCT03229109|19967597|P3|NOT COMPLETED|Overall Study||0
8101065|NCT03229109|19967598|P2|NOT COMPLETED|Overall Study||0
8101066|NCT03229109|19967599|P1|NOT COMPLETED|Overall Study||0
8101067|NCT03229109|19967596|P4|COMPLETED|Overall Study||50
8101068|NCT03229109|19967597|P3|COMPLETED|Overall Study||50
8101069|NCT03229109|19967598|P2|COMPLETED|Overall Study||50
8101070|NCT03229109|19967599|P1|COMPLETED|Overall Study||50
8101071|NCT03229109|19967596|P4|STARTED|Overall Study||51
8101072|NCT03229109|19967597|P3|STARTED|Overall Study||50
8101073|NCT03229109|19967598|P2|STARTED|Overall Study||50
8101074|NCT03229109|19967599|P1|STARTED|Overall Study||50
8101075|NCT03228914|19967609|P2|NOT COMPLETED|Overall Study||0
8101076|NCT03228914|19967610|P1|NOT COMPLETED|Overall Study||0
8101077|NCT03228914|19967609|P2|COMPLETED|Overall Study||20
8101078|NCT03228914|19967610|P1|COMPLETED|Overall Study||20
8101079|NCT03228914|19967609|P2|STARTED|Overall Study||20
8101080|NCT03228914|19967610|P1|STARTED|Overall Study||20
8101081|NCT03228836|19967618|P1|NOT COMPLETED|Overall Study||17
8101082|NCT03228836|19967618|P1|COMPLETED|Overall Study||11
8101083|NCT03228836|19967618|P1|Treated|Overall Study||28
8101084|NCT03228836|19967618|P1|STARTED|Overall Study||28
8101085|NCT03228433|19967630|P6|NOT COMPLETED|Overall Study||0
8101086|NCT03228433|19967631|P5|NOT COMPLETED|Overall Study||0
8101087|NCT03228433|19967632|P4|NOT COMPLETED|Overall Study||1
8101088|NCT03228433|19967633|P3|NOT COMPLETED|Overall Study||0
8101089|NCT03228433|19967634|P2|NOT COMPLETED|Overall Study||0
8101090|NCT03228433|19967635|P1|NOT COMPLETED|Overall Study||1
8101091|NCT03228433|19967630|P6|COMPLETED|Overall Study||6
8101092|NCT03228433|19967631|P5|COMPLETED|Overall Study||6
8101093|NCT03228433|19967632|P4|COMPLETED|Overall Study||5
8101094|NCT03228433|19967633|P3|COMPLETED|Overall Study||6
8101095|NCT03228433|19967634|P2|COMPLETED|Overall Study||6
8101096|NCT03228433|19967635|P1|COMPLETED|Overall Study||9
8101097|NCT03228433|19967630|P6|STARTED|Overall Study||6
8101098|NCT03228433|19967631|P5|STARTED|Overall Study||6
8101099|NCT03228433|19967632|P4|STARTED|Overall Study||6
8101100|NCT03228433|19967633|P3|STARTED|Overall Study||6
8101101|NCT03228433|19967634|P2|STARTED|Overall Study||6
8101102|NCT03228433|19967635|P1|STARTED|Overall Study||10
8101103|NCT03228212|19967710|P2|NOT COMPLETED|Period 3||0
8101104|NCT03228212|19967711|P1|NOT COMPLETED|Period 3||0
8101105|NCT03228212|19967710|P2|COMPLETED|Period 3||64
8101106|NCT03228212|19967711|P1|COMPLETED|Period 3||63
8101107|NCT03228212|19967710|P2|STARTED|Period 3||64
8101108|NCT03228212|19967711|P1|STARTED|Period 3||63
8101109|NCT03228212|19967710|P2|NOT COMPLETED|Period 2||0
8101110|NCT03228212|19967711|P1|NOT COMPLETED|Period 2||1
8101111|NCT03228212|19967710|P2|COMPLETED|Period 2||64
8101112|NCT03228212|19967711|P1|COMPLETED|Period 2||63
8101113|NCT03228212|19967710|P2|STARTED|Period 2||64
8101114|NCT03228212|19967711|P1|STARTED|Period 2||64
8101115|NCT03228212|19967710|P2|NOT COMPLETED|Period 1||1
8101116|NCT03228212|19967711|P1|NOT COMPLETED|Period 1||1
8101117|NCT03228212|19967710|P2|COMPLETED|Period 1||64
8101118|NCT03228212|19967711|P1|COMPLETED|Period 1||64
8101119|NCT03228212|19967710|P2|STARTED|Period 1||65
8101120|NCT03228212|19967711|P1|STARTED|Period 1||65
8101121|NCT03227861|19967727|P1|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
8101122|NCT03227861|19967727|P1|COMPLETED|Extension Period (Week 48 to Week 96)||0
8101123|NCT03227861|19967727|P1|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
8101124|NCT03227861|19967727|P1|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
8101125|NCT03227861|19967727|P1|COMPLETED|Main Study Period (Week 0 to Week 48)||97
8101126|NCT03227861|19967727|P1|STARTED|Main Study Period (Week 0 to Week 48)||109
8101127|NCT03227692|19967759|P2|NOT COMPLETED|Overall Study||5
8101128|NCT03227692|19967760|P1|NOT COMPLETED|Overall Study||5
8101129|NCT03227692|19967759|P2|COMPLETED|Overall Study||41
8101130|NCT03227692|19967760|P1|COMPLETED|Overall Study||42
8101131|NCT03227692|19967759|P2|STARTED|Overall Study||46
8101132|NCT03227692|19967760|P1|STARTED|Overall Study||47
8101133|NCT03227445|19967788|P4|NOT COMPLETED|Period 2 (28 Days)||3
8101134|NCT03227445|19967789|P3|NOT COMPLETED|Period 2 (28 Days)||2
8101135|NCT03227445|19967790|P2|NOT COMPLETED|Period 2 (28 Days)||1
8101136|NCT03227445|19967791|P1|NOT COMPLETED|Period 2 (28 Days)||1
8101137|NCT03227445|19967788|P4|COMPLETED|Period 2 (28 Days)||55
8101138|NCT03227445|19967789|P3|COMPLETED|Period 2 (28 Days)||57
8101139|NCT03227445|19967790|P2|COMPLETED|Period 2 (28 Days)||56
8101140|NCT03227445|19967791|P1|COMPLETED|Period 2 (28 Days)||57
8101141|NCT03227445|19967788|P4|STARTED|Period 2 (28 Days)||58
8101142|NCT03227445|19967789|P3|STARTED|Period 2 (28 Days)||59
8101143|NCT03227445|19967790|P2|STARTED|Period 2 (28 Days)||57
8101144|NCT03227445|19967791|P1|STARTED|Period 2 (28 Days)||58
8101145|NCT03227445|19967788|P4|NOT COMPLETED|Period 1 (28 Days)||2
8101146|NCT03227445|19967789|P3|NOT COMPLETED|Period 1 (28 Days)||1
8101147|NCT03227445|19967790|P2|NOT COMPLETED|Period 1 (28 Days)||2
8101148|NCT03227445|19967791|P1|NOT COMPLETED|Period 1 (28 Days)||2
8101149|NCT03227445|19967788|P4|COMPLETED|Period 1 (28 Days)||58
8101150|NCT03227445|19967789|P3|COMPLETED|Period 1 (28 Days)||59
8101151|NCT03227445|19967790|P2|COMPLETED|Period 1 (28 Days)||57
8101152|NCT03227445|19967791|P1|COMPLETED|Period 1 (28 Days)||58
8101153|NCT03227445|19967788|P4|STARTED|Period 1 (28 Days)||60
8101154|NCT03227445|19967789|P3|STARTED|Period 1 (28 Days)||60
8101155|NCT03227445|19967790|P2|STARTED|Period 1 (28 Days)||59
8101156|NCT03227445|19967791|P1|STARTED|Period 1 (28 Days)||60
8101169|NCT03226769|19967863|P2|NOT COMPLETED|Overall Study||1
8101170|NCT03226769|19967864|P1|NOT COMPLETED|Overall Study||0
8101171|NCT03226769|19967863|P2|COMPLETED|Overall Study||27
8101172|NCT03226769|19967864|P1|COMPLETED|Overall Study||29
8101173|NCT03226769|19967863|P2|STARTED|Overall Study||28
8101174|NCT03226769|19967864|P1|STARTED|Overall Study||29
8101175|NCT03226691|19967872|P1|NOT COMPLETED|Overall Study||0
8101176|NCT03226691|19967872|P1|COMPLETED|Overall Study||15
8101177|NCT03226691|19967872|P1|STARTED|Overall Study||15
8101178|NCT03226392|19967878|P2|NOT COMPLETED|Overall Study||8
8101179|NCT03226392|19967879|P1|NOT COMPLETED|Overall Study||11
8101180|NCT03226392|19967878|P2|COMPLETED|Overall Study||344
8101181|NCT03226392|19967879|P1|COMPLETED|Overall Study||341
8101182|NCT03226392|19967878|P2|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
8101183|NCT03226392|19967879|P1|FAS|Overall Study||352
8101184|NCT03226392|19967878|P2|STARTED|Overall Study||352
8101185|NCT03226392|19967879|P1|STARTED|Overall Study||352
8101186|NCT03226366|19967895|P4|NOT COMPLETED|Overall Study||0
8101187|NCT03226366|19967896|P3|NOT COMPLETED|Overall Study||0
8101188|NCT03226366|19967897|P2|NOT COMPLETED|Overall Study||0
8101189|NCT03226366|19967898|P1|NOT COMPLETED|Overall Study||0
8101190|NCT03226366|19967895|P4|COMPLETED|Overall Study||641
8101191|NCT03226366|19967896|P3|COMPLETED|Overall Study||1183
8101192|NCT03226366|19967897|P2|COMPLETED|Overall Study||495
8101193|NCT03226366|19967898|P1|COMPLETED|Overall Study||911
8101194|NCT03226366|19967895|P4|STARTED|Overall Study||641
8101195|NCT03226366|19967896|P3|STARTED|Overall Study||1183
8101196|NCT03226366|19967897|P2|STARTED|Overall Study||495
8101197|NCT03226366|19967898|P1|STARTED|Overall Study||911
8101198|NCT03226353|19967920|P1|NOT COMPLETED|Overall Study||6
8101199|NCT03226353|19967920|P1|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
8101200|NCT03226353|19967920|P1|Other Habitual Lens Types|Overall Study||75
8101201|NCT03226353|19967920|P1|Habitual Wearers of Proclear 1 Day|Overall Study||2
8101202|NCT03226353|19967920|P1|STARTED|Overall Study||77
8101203|NCT03226275|19967944|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101204|NCT03226275|19967945|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101205|NCT03226275|19967946|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101206|NCT03226275|19967947|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101207|NCT03226275|19967944|P4|COMPLETED|Treatment Period 2 (8 Days)||7
8101208|NCT03226275|19967945|P3|COMPLETED|Treatment Period 2 (8 Days)||7
8101209|NCT03226275|19967946|P2|COMPLETED|Treatment Period 2 (8 Days)||8
8101210|NCT03226275|19967947|P1|COMPLETED|Treatment Period 2 (8 Days)||8
8101211|NCT03226275|19967944|P4|STARTED|Treatment Period 2 (8 Days)||7
8101212|NCT03226275|19967945|P3|STARTED|Treatment Period 2 (8 Days)||7
8101213|NCT03226275|19967946|P2|STARTED|Treatment Period 2 (8 Days)||8
8101214|NCT03226275|19967947|P1|STARTED|Treatment Period 2 (8 Days)||8
8101215|NCT03226275|19967944|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||1
8101216|NCT03226275|19967945|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||1
8101217|NCT03226275|19967946|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8101218|NCT03226275|19967947|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8101219|NCT03226275|19967944|P4|COMPLETED|Treatment Period 1 (8 Days)||7
8101220|NCT03226275|19967945|P3|COMPLETED|Treatment Period 1 (8 Days)||7
8101221|NCT03226275|19967946|P2|COMPLETED|Treatment Period 1 (8 Days)||8
8101222|NCT03226275|19967947|P1|COMPLETED|Treatment Period 1 (8 Days)||8
8101223|NCT03226275|19967944|P4|STARTED|Treatment Period 1 (8 Days)||8
8101224|NCT03226275|19967945|P3|STARTED|Treatment Period 1 (8 Days)||8
8101225|NCT03226275|19967946|P2|STARTED|Treatment Period 1 (8 Days)||8
8101226|NCT03226275|19967947|P1|STARTED|Treatment Period 1 (8 Days)||8
8101227|NCT03226249|19967993|P1|NOT COMPLETED|Survival Follow-up||30
8101228|NCT03226249|19967993|P1|COMPLETED|Survival Follow-up||0
8101229|NCT03226249|19967993|P1|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
8101230|NCT03226249|19967993|P1|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
8101231|NCT03226249|19967993|P1|COMPLETED|PEM Consolidation (1-2 Years)||0
8101232|NCT03226249|19967993|P1|STARTED|PEM Consolidation (1-2 Years)||29
8101233|NCT03226249|19967993|P1|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
8101234|NCT03226249|19967993|P1|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
8101235|NCT03226249|19967993|P1|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
8101236|NCT03226249|19967993|P1|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
8101237|NCT03226249|19967993|P1|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
8101238|NCT03226249|19967993|P1|NOT COMPLETED|2 Cycles of AVD + PET#3||0
8101239|NCT03226249|19967993|P1|COMPLETED|2 Cycles of AVD + PET#3||30
8101240|NCT03226249|19967993|P1|PET#3|2 Cycles of AVD + PET#3||30
8101241|NCT03226249|19967993|P1|AVD Cycle 2|2 Cycles of AVD + PET#3||30
8101242|NCT03226249|19967993|P1|AVD Cycle 1|2 Cycles of AVD + PET#3||30
8101243|NCT03226249|19967993|P1|STARTED|2 Cycles of AVD + PET#3||30
8101244|NCT03226249|19967993|P1|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
8101245|NCT03226249|19967993|P1|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
8101246|NCT03226249|19967993|P1|PET#2|PEM Induction Cycles 1-3, and PET#2||30
8101247|NCT03226249|19967993|P1|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
8101248|NCT03226249|19967993|P1|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
8101249|NCT03226249|19967993|P1|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
8101250|NCT03226249|19967993|P1|STARTED|PEM Induction Cycles 1-3, and PET#2||30
8101251|NCT03226223|19968001|P2|NOT COMPLETED|Overall Study||2
8101252|NCT03226223|19968002|P1|NOT COMPLETED|Overall Study||2
8101253|NCT03226223|19968001|P2|COMPLETED|Overall Study||6
8101254|NCT03226223|19968002|P1|COMPLETED|Overall Study||8
8101255|NCT03226223|19968001|P2|STARTED|Overall Study||8
8101256|NCT03226223|19968002|P1|STARTED|Overall Study||10
8101257|NCT03225599|19968010|P1|NOT COMPLETED|Overall Study||2
8101258|NCT03225599|19968010|P1|COMPLETED|Overall Study||7
8101259|NCT03225599|19968010|P1|STARTED|Overall Study||9
8101260|NCT03225573|19968014|P1|NOT COMPLETED|Overall Study||0
8101261|NCT03225573|19968014|P1|COMPLETED|Overall Study||60
8101262|NCT03225573|19968014|P1|STARTED|Overall Study||60
8101263|NCT03225313|19968021|P3|NOT COMPLETED|Overall Study||0
8101264|NCT03225313|19968022|P2|NOT COMPLETED|Overall Study||0
8101265|NCT03225313|19968023|P1|NOT COMPLETED|Overall Study||0
8101266|NCT03225313|19968021|P3|COMPLETED|Overall Study|25 Patients|25
8101267|NCT03225313|19968022|P2|COMPLETED|Overall Study|25 Patients|25
8101268|NCT03225313|19968023|P1|COMPLETED|Overall Study|25 Patients|25
8101269|NCT03225313|19968021|P3|STARTED|Overall Study|25 Patients|25
8101270|NCT03225313|19968022|P2|STARTED|Overall Study|25 Patients|25
8101271|NCT03225313|19968023|P1|STARTED|Overall Study|25 Patients|25
8101272|NCT03225001|19968055|P1|NOT COMPLETED|Overall Study||9
8101273|NCT03225001|19968055|P1|COMPLETED|Overall Study||188
8101274|NCT03225001|19968055|P1|Valve-Implanted|Overall Study||195
8101275|NCT03225001|19968055|P1|STARTED|Overall Study||197
8101276|NCT03224598|19968063|P3|NOT COMPLETED|Overall Study||0
8101277|NCT03224598|19968064|P2|NOT COMPLETED|Overall Study||3
8101278|NCT03224598|19968065|P1|NOT COMPLETED|Overall Study||0
8101279|NCT03224598|19968063|P3|COMPLETED|Overall Study||13
8101280|NCT03224598|19968064|P2|COMPLETED|Overall Study||14
8101281|NCT03224598|19968065|P1|COMPLETED|Overall Study||9
8101282|NCT03224598|19968063|P3|STARTED|Overall Study||13
8101283|NCT03224598|19968064|P2|STARTED|Overall Study||17
8101284|NCT03224598|19968065|P1|STARTED|Overall Study||9
8101285|NCT03224390|19968075|P2|NOT COMPLETED|Overall Study||35
8101286|NCT03224390|19968076|P1|NOT COMPLETED|Overall Study||27
8101287|NCT03224390|19968075|P2|COMPLETED|Overall Study||21
8101288|NCT03224390|19968076|P1|COMPLETED|Overall Study||29
8101289|NCT03224390|19968075|P2|STARTED|Overall Study||56
8101290|NCT03224390|19968076|P1|STARTED|Overall Study||56
8101291|NCT03224325|19968091|P7|NOT COMPLETED|Overall Study||1
8101292|NCT03224325|19968092|P6|NOT COMPLETED|Overall Study||0
8101293|NCT03224325|19968093|P5|NOT COMPLETED|Overall Study||0
8101294|NCT03224325|19968094|P4|NOT COMPLETED|Overall Study||1
8101295|NCT03224325|19968095|P3|NOT COMPLETED|Overall Study||0
8101296|NCT03224325|19968096|P2|NOT COMPLETED|Overall Study||0
8101297|NCT03224325|19968097|P1|NOT COMPLETED|Overall Study||1
8101298|NCT03224325|19968091|P7|COMPLETED|Overall Study||6
8101299|NCT03224325|19968092|P6|COMPLETED|Overall Study||6
8101300|NCT03224325|19968093|P5|COMPLETED|Overall Study||6
8101301|NCT03224325|19968094|P4|COMPLETED|Overall Study||5
8101302|NCT03224325|19968095|P3|COMPLETED|Overall Study||6
8101303|NCT03224325|19968096|P2|COMPLETED|Overall Study||6
8101304|NCT03224325|19968097|P1|COMPLETED|Overall Study||12
8101305|NCT03224325|19968091|P7|STARTED|Overall Study||7
8101306|NCT03224325|19968092|P6|STARTED|Overall Study||6
8101307|NCT03224325|19968093|P5|STARTED|Overall Study||6
8101308|NCT03224325|19968094|P4|STARTED|Overall Study||6
8101309|NCT03224325|19968095|P3|STARTED|Overall Study||6
8101310|NCT03224325|19968096|P2|STARTED|Overall Study||6
8101311|NCT03224325|19968097|P1|STARTED|Overall Study||13
8101312|NCT03224234|19968162|P2|NOT COMPLETED|Pilot||0
8101313|NCT03224234|19968163|P1|NOT COMPLETED|Pilot||0
8101314|NCT03224234|19968162|P2|COMPLETED|Pilot||7
8101315|NCT03224234|19968163|P1|COMPLETED|Pilot||11
8101316|NCT03224234|19968162|P2|STARTED|Pilot||7
8101317|NCT03224234|19968163|P1|STARTED|Pilot||11
8101318|NCT03224234|19968162|P2|NOT COMPLETED|Main Study||5
8101319|NCT03224234|19968163|P1|NOT COMPLETED|Main Study||5
8101320|NCT03224234|19968162|P2|COMPLETED|Main Study||35
8101321|NCT03224234|19968163|P1|COMPLETED|Main Study||35
8101322|NCT03224234|19968162|P2|STARTED|Main Study||40
8101323|NCT03224234|19968163|P1|STARTED|Main Study||40
8101324|NCT03224130|19968211|P2|NOT COMPLETED|Overall Study||1
8101325|NCT03224130|19968212|P1|NOT COMPLETED|Overall Study||0
8101326|NCT03224130|19968211|P2|COMPLETED|Overall Study||482
8101327|NCT03224130|19968212|P1|COMPLETED|Overall Study||483
8101328|NCT03224130|19968211|P2|STARTED|Overall Study||483
8101329|NCT03224130|19968212|P1|STARTED|Overall Study||483
8101330|NCT03223909|19968233|P3|NOT COMPLETED|Overall Study||16
8101331|NCT03223909|19968234|P2|NOT COMPLETED|Overall Study||45
8101332|NCT03223909|19968235|P1|NOT COMPLETED|Overall Study||48
8101333|NCT03223909|19968233|P3|COMPLETED|Overall Study||81
8101334|NCT03223909|19968234|P2|COMPLETED|Overall Study||64
8101335|NCT03223909|19968235|P1|COMPLETED|Overall Study||72
8101336|NCT03223909|19968233|P3|STARTED|Overall Study||97
8101337|NCT03223909|19968234|P2|STARTED|Overall Study||109
8101338|NCT03223909|19968235|P1|STARTED|Overall Study||120
8101339|NCT03223662|19968264|P1|NOT COMPLETED|Overall Study||2
8101340|NCT03223662|19968264|P1|COMPLETED|Overall Study||0
8101341|NCT03223662|19968264|P1|STARTED|Overall Study||2
8101342|NCT03223337|19968278|P4|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101343|NCT03223337|19968279|P3|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101344|NCT03223337|19968280|P2|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101345|NCT03223337|19968281|P1|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101346|NCT03223337|19968278|P4|COMPLETED|Part 2 (Up to 16 Days)||9
8101347|NCT03223337|19968279|P3|COMPLETED|Part 2 (Up to 16 Days)||12
8101348|NCT03223337|19968280|P2|COMPLETED|Part 2 (Up to 16 Days)||0
8101349|NCT03223337|19968281|P1|COMPLETED|Part 2 (Up to 16 Days)||0
8101350|NCT03223337|19968278|P4|STARTED|Part 2 (Up to 16 Days)||9
8101351|NCT03223337|19968279|P3|STARTED|Part 2 (Up to 16 Days)||12
8101352|NCT03223337|19968280|P2|STARTED|Part 2 (Up to 16 Days)||0
8101353|NCT03223337|19968281|P1|STARTED|Part 2 (Up to 16 Days)||0
8101354|NCT03223337|19968278|P4|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101355|NCT03223337|19968279|P3|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101356|NCT03223337|19968280|P2|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101357|NCT03223337|19968281|P1|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101358|NCT03223337|19968278|P4|COMPLETED|Part 1 (Up to 16 Days)||0
8101359|NCT03223337|19968279|P3|COMPLETED|Part 1 (Up to 16 Days)||0
8101360|NCT03223337|19968280|P2|COMPLETED|Part 1 (Up to 16 Days)||8
8101361|NCT03223337|19968281|P1|COMPLETED|Part 1 (Up to 16 Days)||8
8101362|NCT03223337|19968278|P4|STARTED|Part 1 (Up to 16 Days)||0
8101363|NCT03223337|19968279|P3|STARTED|Part 1 (Up to 16 Days)||0
8101364|NCT03223337|19968280|P2|STARTED|Part 1 (Up to 16 Days)||8
8101365|NCT03223337|19968281|P1|STARTED|Part 1 (Up to 16 Days)||8
8101366|NCT03223246|19968349|P2|NOT COMPLETED|5-7 Days||31
8101367|NCT03223246|19968350|P1|NOT COMPLETED|5-7 Days||42
8101368|NCT03223246|19968349|P2|COMPLETED|5-7 Days||35
8101369|NCT03223246|19968350|P1|COMPLETED|5-7 Days||41
8101370|NCT03223246|19968349|P2|STARTED|5-7 Days||66
8101371|NCT03223246|19968350|P1|STARTED|5-7 Days||83
8101372|NCT03223246|19968349|P2|NOT COMPLETED|48-72 Hours||31
8101373|NCT03223246|19968350|P1|NOT COMPLETED|48-72 Hours||21
8101374|NCT03223246|19968349|P2|COMPLETED|48-72 Hours||35
8101375|NCT03223246|19968350|P1|COMPLETED|48-72 Hours||62
8101376|NCT03223246|19968349|P2|STARTED|48-72 Hours||66
8101377|NCT03223246|19968350|P1|STARTED|48-72 Hours||83
8101378|NCT03222583|19968368|P2|NOT COMPLETED|Overall Study||6
8101379|NCT03222583|19968369|P1|NOT COMPLETED|Overall Study||5
8101380|NCT03222583|19968368|P2|COMPLETED|Overall Study||177
8101381|NCT03222583|19968369|P1|COMPLETED|Overall Study||358
8101382|NCT03222583|19968368|P2|Completed Open-label Period|Overall Study||181
8101383|NCT03222583|19968369|P1|Completed Open-label Period|Overall Study||0
8101384|NCT03222583|19968368|P2|Entered Open-label Period|Overall Study||182
8101385|NCT03222583|19968369|P1|Entered Open-label Period|Overall Study||0
8101386|NCT03222583|19968368|P2|Completed Double-blind Period|Overall Study||183
8101387|NCT03222583|19968369|P1|Completed Double-blind Period|Overall Study||360
8101388|NCT03222583|19968368|P2|Received Double-blind Treatment|Overall Study||183
8101389|NCT03222583|19968369|P1|Received Double-blind Treatment|Overall Study||362
8101390|NCT03222583|19968368|P2|STARTED|Overall Study||183
8101391|NCT03222583|19968369|P1|STARTED|Overall Study||363
8101392|NCT03222505|19968382|P2|NOT COMPLETED|Overall Study||0
8101393|NCT03222505|19968383|P1|NOT COMPLETED|Overall Study||0
8101394|NCT03222505|19968382|P2|COMPLETED|Overall Study||7
8101395|NCT03222505|19968383|P1|COMPLETED|Overall Study||5
8101396|NCT03222505|19968382|P2|STARTED|Overall Study||7
8101397|NCT03222505|19968383|P1|STARTED|Overall Study||5
8101398|NCT03222427|19968393|P1|NOT COMPLETED|Overall Study||0
8101399|NCT03222427|19968393|P1|COMPLETED|Overall Study||8
8101400|NCT03222427|19968393|P1|Received One Dose of Study Drug|Overall Study||8
8101401|NCT03222427|19968393|P1|STARTED|Overall Study||8
8101402|NCT03222414|19968402|P2|NOT COMPLETED|Overall Study||0
8101403|NCT03222414|19968403|P1|NOT COMPLETED|Overall Study||0
8101404|NCT03222414|19968402|P2|COMPLETED|Overall Study||1
8101405|NCT03222414|19968403|P1|COMPLETED|Overall Study||0
8101406|NCT03222414|19968402|P2|STARTED|Overall Study||1
8101407|NCT03222414|19968403|P1|STARTED|Overall Study||0
8101408|NCT03222141|19968419|P1|NOT COMPLETED|Overall Study||18
8101409|NCT03222141|19968419|P1|COMPLETED|Overall Study||565
8101410|NCT03222141|19968419|P1|STARTED|Overall Study||583
8101411|NCT03222128|19968425|P1|NOT COMPLETED|Overall Study||106
8101412|NCT03222128|19968425|P1|COMPLETED|Overall Study||968
8101413|NCT03222128|19968425|P1|Valve-Implanted|Overall Study||1069
8101414|NCT03222128|19968425|P1|STARTED|Overall Study||1074
8101415|NCT03222037|19968430|P2|NOT COMPLETED|Period 2||0
8101416|NCT03222037|19968431|P1|NOT COMPLETED|Period 2||0
8101417|NCT03222037|19968430|P2|COMPLETED|Period 2||22
8101418|NCT03222037|19968431|P1|COMPLETED|Period 2||21
8101419|NCT03222037|19968430|P2|STARTED|Period 2||22
8101420|NCT03222037|19968431|P1|STARTED|Period 2||21
8101421|NCT03222037|19968430|P2|NOT COMPLETED|Period 1||0
8101422|NCT03222037|19968431|P1|NOT COMPLETED|Period 1||0
8101423|NCT03222037|19968430|P2|COMPLETED|Period 1||22
8101424|NCT03222037|19968431|P1|COMPLETED|Period 1||21
8101425|NCT03222037|19968430|P2|STARTED|Period 1||22
8101426|NCT03222037|19968431|P1|STARTED|Period 1||21
8101427|NCT03221764|19968439|P1|NOT COMPLETED|Overall Study||0
8101428|NCT03221764|19968439|P1|COMPLETED|Overall Study||20
8101429|NCT03221764|19968439|P1|STARTED|Overall Study||20
8101430|NCT03221738|19968445|P1|NOT COMPLETED|Overall Study||0
8101431|NCT03221738|19968445|P1|COMPLETED|Overall Study||10
8101432|NCT03221738|19968445|P1|STARTED|Overall Study||10
8101433|NCT03221660|19968451|P1|NOT COMPLETED|Overall Study||0
8101434|NCT03221660|19968451|P1|COMPLETED|Overall Study||50
8101435|NCT03221660|19968451|P1|STARTED|Overall Study||50
8101436|NCT03221192|19968456|P1|NOT COMPLETED|Overall Study||0
8101437|NCT03221192|19968456|P1|COMPLETED|Overall Study||27
8101438|NCT03221192|19968456|P1|STARTED|Overall Study||27
8101439|NCT03220854|19968498|P3|NOT COMPLETED|Overall Study||0
8101440|NCT03220854|19968499|P2|NOT COMPLETED|Overall Study||0
8101441|NCT03220854|19968500|P1|NOT COMPLETED|Overall Study||0
8101442|NCT03220854|19968498|P3|COMPLETED|Overall Study||1
8101443|NCT03220854|19968499|P2|COMPLETED|Overall Study||0
8101444|NCT03220854|19968500|P1|COMPLETED|Overall Study||4
8101445|NCT03220854|19968498|P3|STARTED|Overall Study||1
8101446|NCT03220854|19968499|P2|STARTED|Overall Study||0
8101447|NCT03220854|19968500|P1|STARTED|Overall Study||4
8101448|NCT03220737|19968533|P7|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101449|NCT03220737|19968534|P6|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101450|NCT03220737|19968535|P5|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101451|NCT03220737|19968536|P4|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101452|NCT03220737|19968537|P3|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101453|NCT03220737|19968538|P2|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101454|NCT03220737|19968539|P1|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
8101455|NCT03220737|19968533|P7|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101456|NCT03220737|19968534|P6|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101457|NCT03220737|19968535|P5|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101458|NCT03220737|19968536|P4|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101459|NCT03220737|19968537|P3|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101460|NCT03220737|19968538|P2|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101461|NCT03220737|19968539|P1|COMPLETED|Long-term Follow-up (Day 365-730)||62
8101462|NCT03220737|19968533|P7|STARTED|Long-term Follow-up (Day 365-730)||0
8101463|NCT03220737|19968534|P6|STARTED|Long-term Follow-up (Day 365-730)||0
8101464|NCT03220737|19968535|P5|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
8101465|NCT03220737|19968536|P4|STARTED|Long-term Follow-up (Day 365-730)||0
8101466|NCT03220737|19968537|P3|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
8101467|NCT03220737|19968538|P2|STARTED|Long-term Follow-up (Day 365-730)||0
8101468|NCT03220737|19968539|P1|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
8101469|NCT03220737|19968533|P7|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101470|NCT03220737|19968534|P6|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101471|NCT03220737|19968535|P5|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
8101472|NCT03220737|19968536|P4|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101473|NCT03220737|19968537|P3|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101474|NCT03220737|19968538|P2|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101475|NCT03220737|19968539|P1|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101476|NCT03220737|19968533|P7|COMPLETED|Placebo Crossover (Day 181-365)||0
8101477|NCT03220737|19968534|P6|COMPLETED|Placebo Crossover (Day 181-365)||0
8101478|NCT03220737|19968535|P5|COMPLETED|Placebo Crossover (Day 181-365)||5
8101479|NCT03220737|19968536|P4|COMPLETED|Placebo Crossover (Day 181-365)||0
8101480|NCT03220737|19968537|P3|COMPLETED|Placebo Crossover (Day 181-365)||11
8101481|NCT03220737|19968538|P2|COMPLETED|Placebo Crossover (Day 181-365)||0
8101482|NCT03220737|19968539|P1|COMPLETED|Placebo Crossover (Day 181-365)||13
8101483|NCT03220737|19968533|P7|STARTED|Placebo Crossover (Day 181-365)||0
8101484|NCT03220737|19968534|P6|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
8101485|NCT03220737|19968535|P5|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
8101486|NCT03220737|19968536|P4|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
8101487|NCT03220737|19968537|P3|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
8101488|NCT03220737|19968538|P2|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
8101489|NCT03220737|19968539|P1|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
8101490|NCT03220737|19968533|P7|NOT COMPLETED|Main Study (Day 1 - 181)||1
8101491|NCT03220737|19968534|P6|NOT COMPLETED|Main Study (Day 1 - 181)||1
8101492|NCT03220737|19968535|P5|NOT COMPLETED|Main Study (Day 1 - 181)||20
8101493|NCT03220737|19968536|P4|NOT COMPLETED|Main Study (Day 1 - 181)||3
8101494|NCT03220737|19968537|P3|NOT COMPLETED|Main Study (Day 1 - 181)||12
8101495|NCT03220737|19968538|P2|NOT COMPLETED|Main Study (Day 1 - 181)||2
8101496|NCT03220737|19968539|P1|NOT COMPLETED|Main Study (Day 1 - 181)||6
8101497|NCT03220737|19968533|P7|COMPLETED|Main Study (Day 1 - 181)||2687
8101498|NCT03220737|19968534|P6|COMPLETED|Main Study (Day 1 - 181)||25
8101499|NCT03220737|19968535|P5|COMPLETED|Main Study (Day 1 - 181)||130
8101500|NCT03220737|19968536|P4|COMPLETED|Main Study (Day 1 - 181)||24
8101501|NCT03220737|19968537|P3|COMPLETED|Main Study (Day 1 - 181)||146
8101502|NCT03220737|19968538|P2|COMPLETED|Main Study (Day 1 - 181)||24
8101503|NCT03220737|19968539|P1|COMPLETED|Main Study (Day 1 - 181)||157
8101504|NCT03220737|19968533|P7|STARTED|Main Study (Day 1 - 181)||2688
8101505|NCT03220737|19968534|P6|STARTED|Main Study (Day 1 - 181)||26
8101506|NCT03220737|19968535|P5|STARTED|Main Study (Day 1 - 181)||150
8101507|NCT03220737|19968536|P4|STARTED|Main Study (Day 1 - 181)||27
8101508|NCT03220737|19968537|P3|STARTED|Main Study (Day 1 - 181)||158
8101509|NCT03220737|19968538|P2|STARTED|Main Study (Day 1 - 181)||26
8101510|NCT03220737|19968539|P1|STARTED|Main Study (Day 1 - 181)||163
8101511|NCT03220412|19968580|P2|NOT COMPLETED|Overall Study||0
8101512|NCT03220412|19968581|P1|NOT COMPLETED|Overall Study||0
8101513|NCT03220412|19968580|P2|COMPLETED|Overall Study||50
8101514|NCT03220412|19968581|P1|COMPLETED|Overall Study||54
8101515|NCT03220412|19968580|P2|STARTED|Overall Study||50
8101516|NCT03220412|19968581|P1|STARTED|Overall Study||54
8101517|NCT03220230|19968589|P1|NOT COMPLETED|Overall Study||0
8101518|NCT03220230|19968589|P1|COMPLETED|Overall Study||4240
8101519|NCT03220230|19968589|P1|STARTED|Overall Study||4240
8101520|NCT03220217|19968602|P3|NOT COMPLETED|Overall Study||1
8101521|NCT03220217|19968603|P2|NOT COMPLETED|Overall Study||1
8101522|NCT03220217|19968604|P1|NOT COMPLETED|Overall Study||0
8101523|NCT03220217|19968602|P3|COMPLETED|Overall Study||10
8101524|NCT03220217|19968603|P2|COMPLETED|Overall Study||9
8101525|NCT03220217|19968604|P1|COMPLETED|Overall Study||8
8101526|NCT03220217|19968602|P3|STARTED|Overall Study||11
8101527|NCT03220217|19968603|P2|STARTED|Overall Study||10
8101528|NCT03220217|19968604|P1|STARTED|Overall Study||8
8101529|NCT03220204|19968674|P3|NOT COMPLETED|Overall Study||3
8101530|NCT03220204|19968675|P2|NOT COMPLETED|Overall Study||2
8101531|NCT03220204|19968676|P1|NOT COMPLETED|Overall Study||1
8101532|NCT03220204|19968674|P3|COMPLETED|Overall Study||12
8101533|NCT03220204|19968675|P2|COMPLETED|Overall Study||13
8101534|NCT03220204|19968676|P1|COMPLETED|Overall Study||14
8101535|NCT03220204|19968674|P3|STARTED|Overall Study||15
8101536|NCT03220204|19968675|P2|STARTED|Overall Study||15
8101537|NCT03220204|19968676|P1|STARTED|Overall Study||15
8101538|NCT03220048|19968726|P3|NOT COMPLETED|Overall Study||1
8101539|NCT03220048|19968727|P2|NOT COMPLETED|Overall Study||2
8101540|NCT03220048|19968728|P1|NOT COMPLETED|Overall Study||0
8101541|NCT03220048|19968726|P3|COMPLETED|Overall Study||27
8101542|NCT03220048|19968727|P2|COMPLETED|Overall Study||25
8101543|NCT03220048|19968728|P1|COMPLETED|Overall Study||11
8101544|NCT03220048|19968726|P3|STARTED|Overall Study||28
8101545|NCT03220048|19968727|P2|STARTED|Overall Study||27
8101546|NCT03220048|19968728|P1|STARTED|Overall Study||11
8101547|NCT03219723|19968751|P1|NOT COMPLETED|Overall Study||10
8101548|NCT03219723|19968751|P1|COMPLETED|Overall Study||550
8101549|NCT03219723|19968751|P1|STARTED|Overall Study||560
8101550|NCT03219372|19968758|P2|NOT COMPLETED|Overall Study||0
8101551|NCT03219372|19968759|P1|NOT COMPLETED|Overall Study||1
8101552|NCT03219372|19968758|P2|COMPLETED|Overall Study||0
8101553|NCT03219372|19968759|P1|COMPLETED|Overall Study||0
8101554|NCT03219372|19968758|P2|STARTED|Overall Study||0
8101555|NCT03219372|19968759|P1|STARTED|Overall Study||1
8101556|NCT03219320|19968783|P4|NOT COMPLETED|Overall Study||3
8101557|NCT03219320|19968784|P3|NOT COMPLETED|Overall Study||5
8101558|NCT03219320|19968785|P2|NOT COMPLETED|Overall Study||3
8101559|NCT03219320|19968786|P1|NOT COMPLETED|Overall Study||2
8101560|NCT03219320|19968783|P4|COMPLETED|Overall Study||69
8101561|NCT03219320|19968784|P3|COMPLETED|Overall Study||72
8101562|NCT03219320|19968785|P2|COMPLETED|Overall Study||74
8101563|NCT03219320|19968786|P1|COMPLETED|Overall Study||73
8101564|NCT03219320|19968783|P4|STARTED|Overall Study||72
8101565|NCT03219320|19968784|P3|STARTED|Overall Study||77
8101566|NCT03219320|19968785|P2|STARTED|Overall Study||77
8101567|NCT03219320|19968786|P1|STARTED|Overall Study||75
8101568|NCT03219294|19968806|P2|NOT COMPLETED|Overall Study||0
8101569|NCT03219294|19968807|P1|NOT COMPLETED|Overall Study||0
8101570|NCT03219294|19968806|P2|COMPLETED|Overall Study||58
8101571|NCT03219294|19968807|P1|COMPLETED|Overall Study||58
8101572|NCT03219294|19968806|P2|STARTED|Overall Study||58
8101573|NCT03219294|19968807|P1|STARTED|Overall Study||58
8101574|NCT03219216|19968817|P2|NOT COMPLETED|Overall Study||1
8101575|NCT03219216|19968818|P1|NOT COMPLETED|Overall Study||0
8101576|NCT03219216|19968817|P2|COMPLETED|Overall Study||24
8101577|NCT03219216|19968818|P1|COMPLETED|Overall Study||75
8101578|NCT03219216|19968817|P2|STARTED|Overall Study||25
8101579|NCT03219216|19968818|P1|STARTED|Overall Study||75
8101580|NCT03218592|19968827|P3|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
8101581|NCT03218592|19968828|P2|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
8101582|NCT03218592|19968829|P1|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
8101583|NCT03218592|19968827|P3|COMPLETED|Phase 3: 3 Doses Per Week||4
8101584|NCT03218592|19968828|P2|COMPLETED|Phase 3: 3 Doses Per Week||4
8101585|NCT03218592|19968829|P1|COMPLETED|Phase 3: 3 Doses Per Week||4
8101586|NCT03218592|19968827|P3|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
8101587|NCT03218592|19968828|P2|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
8101588|NCT03218592|19968829|P1|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
8101589|NCT03218592|19968827|P3|STARTED|Phase 3: 3 Doses Per Week||4
8101590|NCT03218592|19968828|P2|STARTED|Phase 3: 3 Doses Per Week||4
8101591|NCT03218592|19968829|P1|STARTED|Phase 3: 3 Doses Per Week||4
8101592|NCT03218592|19968827|P3|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
8101593|NCT03218592|19968828|P2|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
8101594|NCT03218592|19968829|P1|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
8101595|NCT03218592|19968827|P3|COMPLETED|Phase 3: 1 Dose Per Period||4
8101596|NCT03218592|19968828|P2|COMPLETED|Phase 3: 1 Dose Per Period||4
8101597|NCT03218592|19968829|P1|COMPLETED|Phase 3: 1 Dose Per Period||4
8101598|NCT03218592|19968827|P3|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
8101599|NCT03218592|19968828|P2|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
8101600|NCT03218592|19968829|P1|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
8101601|NCT03218592|19968827|P3|STARTED|Phase 3: 1 Dose Per Period||4
8101602|NCT03218592|19968828|P2|STARTED|Phase 3: 1 Dose Per Period||4
8101603|NCT03218592|19968829|P1|STARTED|Phase 3: 1 Dose Per Period||4
8101604|NCT03218592|19968827|P3|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
8101605|NCT03218592|19968828|P2|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
8101606|NCT03218592|19968829|P1|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
8101607|NCT03218592|19968827|P3|COMPLETED|Phase 3: 0 Doses Per Week||4
8101608|NCT03218592|19968828|P2|COMPLETED|Phase 3: 0 Doses Per Week||4
8101609|NCT03218592|19968829|P1|COMPLETED|Phase 3: 0 Doses Per Week||4
8101610|NCT03218592|19968827|P3|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
8101611|NCT03218592|19968828|P2|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
8101612|NCT03218592|19968829|P1|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
8101613|NCT03218592|19968827|P3|STARTED|Phase 3: 0 Doses Per Week||4
8101614|NCT03218592|19968828|P2|STARTED|Phase 3: 0 Doses Per Week||4
8101615|NCT03218592|19968829|P1|STARTED|Phase 3: 0 Doses Per Week||4
8101616|NCT03218592|19968827|P3|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
8101617|NCT03218592|19968828|P2|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
8101618|NCT03218592|19968829|P1|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
8101619|NCT03218592|19968827|P3|COMPLETED|Phase 2: Daily Doses x 28 Days||12
8101620|NCT03218592|19968828|P2|COMPLETED|Phase 2: Daily Doses x 28 Days||12
8101621|NCT03218592|19968829|P1|COMPLETED|Phase 2: Daily Doses x 28 Days||12
8101622|NCT03218592|19968827|P3|STARTED|Phase 2: Daily Doses x 28 Days||12
8101623|NCT03218592|19968828|P2|STARTED|Phase 2: Daily Doses x 28 Days||12
8101624|NCT03218592|19968829|P1|STARTED|Phase 2: Daily Doses x 28 Days||12
8101625|NCT03218592|19968827|P3|NOT COMPLETED|Phase 1: 1 Dose||0
8101626|NCT03218592|19968828|P2|NOT COMPLETED|Phase 1: 1 Dose||0
8101627|NCT03218592|19968829|P1|NOT COMPLETED|Phase 1: 1 Dose||0
8101628|NCT03218592|19968827|P3|COMPLETED|Phase 1: 1 Dose||12
8101629|NCT03218592|19968828|P2|COMPLETED|Phase 1: 1 Dose||12
8101630|NCT03218592|19968829|P1|COMPLETED|Phase 1: 1 Dose||12
8101631|NCT03218592|19968827|P3|STARTED|Phase 1: 1 Dose||12
8101632|NCT03218592|19968828|P2|STARTED|Phase 1: 1 Dose||12
8101633|NCT03218592|19968829|P1|STARTED|Phase 1: 1 Dose||12
8101634|NCT03218566|19968849|P1|NOT COMPLETED|Overall Study||9
8101635|NCT03218566|19968849|P1|COMPLETED|Overall Study||110
8101636|NCT03218566|19968849|P1|STARTED|Overall Study||119
8101637|NCT03218397|19968864|P2|NOT COMPLETED|Overall Study||29
8101638|NCT03218397|19968865|P1|NOT COMPLETED|Overall Study||23
8101639|NCT03218397|19968864|P2|COMPLETED|Overall Study||222
8101640|NCT03218397|19968865|P1|COMPLETED|Overall Study||226
8101641|NCT03218397|19968864|P2|STARTED|Overall Study||251
8101642|NCT03218397|19968865|P1|STARTED|Overall Study||249
8101643|NCT03218163|19968893|P1|NOT COMPLETED|Overall Study||0
8101644|NCT03218163|19968893|P1|COMPLETED|Overall Study||0
8101645|NCT03218163|19968893|P1|STARTED|Overall Study||0
8101646|NCT03217968|19968897|P1|NOT COMPLETED|Overall Study||11
8101647|NCT03217968|19968897|P1|COMPLETED|Overall Study||48
8101648|NCT03217968|19968897|P1|STARTED|Overall Study||59
8101649|NCT03217175|19968906|P2|NOT COMPLETED|Overall Study||1
8101650|NCT03217175|19968907|P1|NOT COMPLETED|Overall Study||4
8101651|NCT03217175|19968906|P2|COMPLETED|Overall Study||0
8101652|NCT03217175|19968907|P1|COMPLETED|Overall Study||0
8101653|NCT03217175|19968906|P2|STARTED|Overall Study||1
8101654|NCT03217175|19968907|P1|STARTED|Overall Study||4
8101655|NCT03216954|19968921|P5|NOT COMPLETED|Overall Study||1
8101656|NCT03216954|19968922|P4|NOT COMPLETED|Overall Study||0
8101657|NCT03216954|19968923|P3|NOT COMPLETED|Overall Study||1
8101658|NCT03216954|19968924|P2|NOT COMPLETED|Overall Study||1
8101659|NCT03216954|19968925|P1|NOT COMPLETED|Overall Study||2
8101660|NCT03216954|19968921|P5|COMPLETED|Overall Study||0
8101661|NCT03216954|19968922|P4|COMPLETED|Overall Study||3
8101662|NCT03216954|19968923|P3|COMPLETED|Overall Study||2
8101663|NCT03216954|19968924|P2|COMPLETED|Overall Study||2
8101664|NCT03216954|19968925|P1|COMPLETED|Overall Study||2
8101665|NCT03216954|19968921|P5|STARTED|Overall Study||1
8101666|NCT03216954|19968922|P4|STARTED|Overall Study||3
8101667|NCT03216954|19968923|P3|STARTED|Overall Study||3
8101668|NCT03216954|19968924|P2|STARTED|Overall Study||3
8101669|NCT03216954|19968925|P1|STARTED|Overall Study||4
8101670|NCT03216902|19968939|P6|NOT COMPLETED|Overall Study||3
8101671|NCT03216902|19968940|P5|NOT COMPLETED|Overall Study||1
8101672|NCT03216902|19968941|P4|NOT COMPLETED|Overall Study||0
8101673|NCT03216902|19968942|P3|NOT COMPLETED|Overall Study||1
8101674|NCT03216902|19968943|P2|NOT COMPLETED|Overall Study||1
8101675|NCT03216902|19968944|P1|NOT COMPLETED|Overall Study||2
8101676|NCT03216902|19968939|P6|COMPLETED|Overall Study||42
8101677|NCT03216902|19968940|P5|COMPLETED|Overall Study||43
8101678|NCT03216902|19968941|P4|COMPLETED|Overall Study||43
8101679|NCT03216902|19968942|P3|COMPLETED|Overall Study||42
8101680|NCT03216902|19968943|P2|COMPLETED|Overall Study||43
8101681|NCT03216902|19968944|P1|COMPLETED|Overall Study||20
8101682|NCT03216902|19968939|P6|STARTED|Overall Study||45
8101683|NCT03216902|19968940|P5|STARTED|Overall Study||44
8101684|NCT03216902|19968941|P4|STARTED|Overall Study||43
8101685|NCT03216902|19968942|P3|STARTED|Overall Study||43
8101686|NCT03216902|19968943|P2|STARTED|Overall Study||44
8101687|NCT03216902|19968944|P1|STARTED|Overall Study||22
8101688|NCT03216850|19969014|P1|NOT COMPLETED|Overall Study||6
8101689|NCT03216850|19969014|P1|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
8101690|NCT03216850|19969014|P1|STARTED|Overall Study||15
8101691|NCT03216746|19969022|P4|NOT COMPLETED|Overall Study||6
8101692|NCT03216746|19969023|P3|NOT COMPLETED|Overall Study||5
8101693|NCT03216746|19969024|P2|NOT COMPLETED|Overall Study||8
8101694|NCT03216746|19969025|P1|NOT COMPLETED|Overall Study||6
8101695|NCT03216746|19969022|P4|COMPLETED|Overall Study||63
8101696|NCT03216746|19969023|P3|COMPLETED|Overall Study||63
8101697|NCT03216746|19969024|P2|COMPLETED|Overall Study||71
8101698|NCT03216746|19969025|P1|COMPLETED|Overall Study||66
8101699|NCT03216746|19969022|P4|STARTED|Overall Study||69
8101700|NCT03216746|19969023|P3|STARTED|Overall Study||68
8101701|NCT03216746|19969024|P2|STARTED|Overall Study||79
8101702|NCT03216746|19969025|P1|STARTED|Overall Study||72
8101703|NCT03216512|19969037|P2|NOT COMPLETED|Overall Study||1
8101704|NCT03216512|19969038|P1|NOT COMPLETED|Overall Study||0
8101705|NCT03216512|19969037|P2|COMPLETED|Overall Study||13
8101706|NCT03216512|19969038|P1|COMPLETED|Overall Study||17
8101707|NCT03216512|19969037|P2|STARTED|Overall Study||14
8101708|NCT03216512|19969038|P1|STARTED|Overall Study||17
8101709|NCT03216499|19969056|P1|NOT COMPLETED|Overall Study||0
8101710|NCT03216499|19969056|P1|COMPLETED|Overall Study||24
8101711|NCT03216499|19969056|P1|STARTED|Overall Study||24
8101712|NCT03216265|19969066|P3|NOT COMPLETED|Overall Study||3
8101713|NCT03216265|19969067|P2|NOT COMPLETED|Overall Study||1
8101714|NCT03216265|19969068|P1|NOT COMPLETED|Overall Study||2
8101715|NCT03216265|19969066|P3|COMPLETED|Overall Study||19
8101716|NCT03216265|19969067|P2|COMPLETED|Overall Study||21
8101717|NCT03216265|19969068|P1|COMPLETED|Overall Study||20
8101718|NCT03216265|19969066|P3|STARTED|Overall Study||22
8101719|NCT03216265|19969067|P2|STARTED|Overall Study||22
8101720|NCT03216265|19969068|P1|STARTED|Overall Study||22
8101721|NCT03216200|19969118|P1|NOT COMPLETED|Overall Study||0
8101722|NCT03216200|19969118|P1|COMPLETED|Overall Study||5
8101723|NCT03216200|19969118|P1|STARTED|Overall Study||5
8101724|NCT03215901|19969126|P3|NOT COMPLETED|Overall Study||0
8101725|NCT03215901|19969127|P2|NOT COMPLETED|Overall Study||0
8101726|NCT03215901|19969128|P1|NOT COMPLETED|Overall Study||0
8101727|NCT03215901|19969126|P3|COMPLETED|Overall Study||116
8101728|NCT03215901|19969127|P2|COMPLETED|Overall Study||112
8101729|NCT03215901|19969128|P1|COMPLETED|Overall Study||199
8101730|NCT03215901|19969126|P3|STARTED|Overall Study||116
8101731|NCT03215901|19969127|P2|STARTED|Overall Study||112
8101732|NCT03215901|19969128|P1|STARTED|Overall Study||199
8101733|NCT03215758|19969159|P2|NOT COMPLETED|Overall Study||8
8101734|NCT03215758|19969160|P1|NOT COMPLETED|Overall Study||5
8101735|NCT03215758|19969159|P2|COMPLETED|Overall Study||328
8101736|NCT03215758|19969160|P1|COMPLETED|Overall Study||334
8101737|NCT03215758|19969159|P2|STARTED|Overall Study||336
8101738|NCT03215758|19969160|P1|STARTED|Overall Study||339
8101739|NCT03215706|19969174|P2|NOT COMPLETED|Treatment Period||246
8101740|NCT03215706|19969175|P1|NOT COMPLETED|Treatment Period||342
8101741|NCT03215706|19969174|P2|COMPLETED|Treatment Period||103
8101742|NCT03215706|19969175|P1|COMPLETED|Treatment Period||16
8101743|NCT03215706|19969174|P2|STARTED|Treatment Period||349
8101744|NCT03215706|19969175|P1|STARTED|Treatment Period||358
8101745|NCT03215706|19969174|P2|NOT COMPLETED|Randomization||9
8101746|NCT03215706|19969175|P1|NOT COMPLETED|Randomization||3
8101747|NCT03215706|19969174|P2|COMPLETED|Randomization||349
8101748|NCT03215706|19969175|P1|COMPLETED|Randomization||358
8101749|NCT03215706|19969174|P2|STARTED|Randomization||358
8101750|NCT03215706|19969175|P1|STARTED|Randomization||361
8101751|NCT03215667|19969195|P1|NOT COMPLETED|Overall Study||4
8101752|NCT03215667|19969195|P1|COMPLETED|Overall Study||5
8101753|NCT03215667|19969195|P1|STARTED|Overall Study||9
8101754|NCT03214952|19969200|P1|NOT COMPLETED|Overall Study||58
8101755|NCT03214952|19969200|P1|COMPLETED|Overall Study||3125
8101756|NCT03214952|19969200|P1|STARTED|Overall Study||3183
8101757|NCT03214588|19969215|P3|NOT COMPLETED|Overall Study||2
8101758|NCT03214588|19969216|P2|NOT COMPLETED|Overall Study||1
8101759|NCT03214588|19969217|P1|NOT COMPLETED|Overall Study||1
8101760|NCT03214588|19969215|P3|COMPLETED|Overall Study||24
8101761|NCT03214588|19969216|P2|COMPLETED|Overall Study||13
8101762|NCT03214588|19969217|P1|COMPLETED|Overall Study||26
8101763|NCT03214588|19969215|P3|STARTED|Overall Study||26
8101764|NCT03214588|19969216|P2|STARTED|Overall Study||14
8101765|NCT03214588|19969217|P1|STARTED|Overall Study||27
8101766|NCT03214406|19969284|P2|NOT COMPLETED|Overall Study||15
8101767|NCT03214406|19969285|P1|NOT COMPLETED|Overall Study||10
8101768|NCT03214406|19969284|P2|COMPLETED|Overall Study||78
8101769|NCT03214406|19969285|P1|COMPLETED|Overall Study||78
8101770|NCT03214406|19969284|P2|STARTED|Overall Study||93
8101771|NCT03214406|19969285|P1|STARTED|Overall Study||88
8101772|NCT03214380|19969299|P6|NOT COMPLETED|Treatment Period||11
8101773|NCT03214380|19969300|P5|NOT COMPLETED|Treatment Period||9
8101774|NCT03214380|19969301|P4|NOT COMPLETED|Treatment Period||0
8101775|NCT03214380|19969302|P3|NOT COMPLETED|Treatment Period||16
8101776|NCT03214380|19969303|P2|NOT COMPLETED|Treatment Period||18
8101777|NCT03214380|19969304|P1|NOT COMPLETED|Treatment Period||0
8101778|NCT03214380|19969299|P6|COMPLETED|Treatment Period||71
8101779|NCT03214380|19969300|P5|COMPLETED|Treatment Period||73
8101780|NCT03214380|19969301|P4|COMPLETED|Treatment Period||0
8101781|NCT03214380|19969302|P3|COMPLETED|Treatment Period||320
8101782|NCT03214380|19969303|P2|COMPLETED|Treatment Period||319
8101783|NCT03214380|19969304|P1|COMPLETED|Treatment Period||0
8101784|NCT03214380|19969299|P6|Received at Least 1 Dose of Study Drug|Treatment Period||82
8101785|NCT03214380|19969300|P5|Received at Least 1 Dose of Study Drug|Treatment Period||82
8101786|NCT03214380|19969301|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
8101787|NCT03214380|19969302|P3|Received at Least 1 Dose of Study Drug|Treatment Period||336
8101788|NCT03214380|19969303|P2|Received at Least 1 Dose of Study Drug|Treatment Period||337
8101789|NCT03214380|19969304|P1|Received at Least 1 Dose of Study Drug|Treatment Period||0
8101790|NCT03214380|19969299|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
8101791|NCT03214380|19969300|P5|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
8101792|NCT03214380|19969301|P4|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101793|NCT03214380|19969302|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
8101794|NCT03214380|19969303|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
8101795|NCT03214380|19969304|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101796|NCT03214380|19969299|P6|NOT COMPLETED|Lead-in||0
8101797|NCT03214380|19969300|P5|NOT COMPLETED|Lead-in||0
8101798|NCT03214380|19969301|P4|NOT COMPLETED|Lead-in||19
8101799|NCT03214380|19969302|P3|NOT COMPLETED|Lead-in||0
8101800|NCT03214380|19969303|P2|NOT COMPLETED|Lead-in||0
8101801|NCT03214380|19969304|P1|NOT COMPLETED|Lead-in||77
8101802|NCT03214380|19969299|P6|COMPLETED|Lead-in||0
8101803|NCT03214380|19969300|P5|COMPLETED|Lead-in||0
8101804|NCT03214380|19969301|P4|COMPLETED|Lead-in||164
8101805|NCT03214380|19969302|P3|COMPLETED|Lead-in||0
8101806|NCT03214380|19969303|P2|COMPLETED|Lead-in||0
8101807|NCT03214380|19969304|P1|COMPLETED|Lead-in||673
8101808|NCT03214380|19969299|P6|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101809|NCT03214380|19969300|P5|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101810|NCT03214380|19969301|P4|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
8101811|NCT03214380|19969302|P3|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101812|NCT03214380|19969303|P2|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101813|NCT03214380|19969304|P1|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
8101814|NCT03214380|19969299|P6|STARTED|Lead-in||0
8101815|NCT03214380|19969300|P5|STARTED|Lead-in||0
8101816|NCT03214380|19969301|P4|STARTED|Lead-in||183
8101817|NCT03214380|19969302|P3|STARTED|Lead-in||0
8101818|NCT03214380|19969303|P2|STARTED|Lead-in||0
8101819|NCT03214380|19969304|P1|STARTED|Lead-in||750
8101820|NCT03214367|19969340|P8|NOT COMPLETED|Treatment Period||1
8101821|NCT03214367|19969341|P7|NOT COMPLETED|Treatment Period||2
8101822|NCT03214367|19969342|P6|NOT COMPLETED|Treatment Period||3
8101823|NCT03214367|19969343|P5|NOT COMPLETED|Treatment Period||0
8101824|NCT03214367|19969344|P4|NOT COMPLETED|Treatment Period||19
8101825|NCT03214367|19969345|P3|NOT COMPLETED|Treatment Period||33
8101826|NCT03214367|19969346|P2|NOT COMPLETED|Treatment Period||34
8101827|NCT03214367|19969347|P1|NOT COMPLETED|Treatment Period||0
8101828|NCT03214367|19969340|P8|COMPLETED|Treatment Period||21
8101829|NCT03214367|19969341|P7|COMPLETED|Treatment Period||19
8101830|NCT03214367|19969342|P6|COMPLETED|Treatment Period||28
8101831|NCT03214367|19969343|P5|COMPLETED|Treatment Period||0
8101832|NCT03214367|19969344|P4|COMPLETED|Treatment Period||310
8101833|NCT03214367|19969345|P3|COMPLETED|Treatment Period||418
8101834|NCT03214367|19969346|P2|COMPLETED|Treatment Period||408
8101835|NCT03214367|19969347|P1|COMPLETED|Treatment Period||0
8101836|NCT03214367|19969340|P8|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
8101837|NCT03214367|19969341|P7|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
8101838|NCT03214367|19969342|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
8101839|NCT03214367|19969343|P5|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101840|NCT03214367|19969344|P4|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
8101841|NCT03214367|19969345|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
8101842|NCT03214367|19969346|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
8101843|NCT03214367|19969347|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101844|NCT03214367|19969340|P8|NOT COMPLETED|Lead-in Period||0
8101845|NCT03214367|19969341|P7|NOT COMPLETED|Lead-in Period||0
8101846|NCT03214367|19969342|P6|NOT COMPLETED|Lead-in Period||0
8101847|NCT03214367|19969343|P5|NOT COMPLETED|Lead-in Period||2
8101848|NCT03214367|19969344|P4|NOT COMPLETED|Lead-in Period||0
8101849|NCT03214367|19969345|P3|NOT COMPLETED|Lead-in Period||0
8101850|NCT03214367|19969346|P2|NOT COMPLETED|Lead-in Period||0
8101851|NCT03214367|19969347|P1|NOT COMPLETED|Lead-in Period||94
8101852|NCT03214367|19969340|P8|COMPLETED|Lead-in Period||0
8101853|NCT03214367|19969341|P7|COMPLETED|Lead-in Period||0
8101854|NCT03214367|19969342|P6|COMPLETED|Lead-in Period||0
8101855|NCT03214367|19969343|P5|COMPLETED|Lead-in Period||74
8101856|NCT03214367|19969344|P4|COMPLETED|Lead-in Period||0
8101857|NCT03214367|19969345|P3|COMPLETED|Lead-in Period||0
8101858|NCT03214367|19969346|P2|COMPLETED|Lead-in Period||0
8101859|NCT03214367|19969347|P1|COMPLETED|Lead-in Period||1222
8101860|NCT03214367|19969340|P8|STARTED|Lead-in Period||0
8101861|NCT03214367|19969341|P7|STARTED|Lead-in Period||0
8101862|NCT03214367|19969342|P6|STARTED|Lead-in Period||0
8101863|NCT03214367|19969343|P5|STARTED|Lead-in Period||76
8101864|NCT03214367|19969344|P4|STARTED|Lead-in Period||0
8101865|NCT03214367|19969345|P3|STARTED|Lead-in Period||0
8101866|NCT03214367|19969346|P2|STARTED|Lead-in Period||0
8101867|NCT03214367|19969347|P1|STARTED|Lead-in Period||1316
8101868|NCT03214224|19969392|P1|NOT COMPLETED|Overall Study||9
8101869|NCT03214224|19969392|P1|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
8101870|NCT03214224|19969392|P1|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
8101871|NCT03214094|19969401|P1|NOT COMPLETED|Overall Study||60
8101872|NCT03214094|19969401|P1|COMPLETED|Overall Study||1059
8101873|NCT03214094|19969401|P1|STARTED|Overall Study||1119
8101874|NCT03214081|19969409|P1|NOT COMPLETED|Overall Study||63
8101875|NCT03214081|19969409|P1|COMPLETED|Overall Study||1174
8101876|NCT03214081|19969409|P1|STARTED|Overall Study||1237
8101877|NCT03213626|19969424|P1|NOT COMPLETED|Overall Study||7
8101878|NCT03213626|19969424|P1|COMPLETED|Overall Study||0
8101879|NCT03213626|19969424|P1|STARTED|Overall Study||7
8101880|NCT03213509|19969434|P2|NOT COMPLETED|Overall Study||5
8101881|NCT03213509|19969435|P1|NOT COMPLETED|Overall Study||4
8101882|NCT03213509|19969434|P2|COMPLETED|Overall Study||85
8101883|NCT03213509|19969435|P1|COMPLETED|Overall Study||76
8101884|NCT03213509|19969434|P2|STARTED|Overall Study||90
8101885|NCT03213509|19969435|P1|STARTED|Overall Study||80
8101886|NCT03213405|19969450|P4|NOT COMPLETED|Overall Study||0
8101887|NCT03213405|19969451|P3|NOT COMPLETED|Overall Study||0
8101888|NCT03213405|19969452|P2|NOT COMPLETED|Overall Study||0
8101889|NCT03213405|19969453|P1|NOT COMPLETED|Overall Study||0
8101890|NCT03213405|19969450|P4|COMPLETED|Overall Study||6
8101891|NCT03213405|19969451|P3|COMPLETED|Overall Study||6
8101892|NCT03213405|19969452|P2|COMPLETED|Overall Study||6
8101893|NCT03213405|19969453|P1|COMPLETED|Overall Study||6
8101894|NCT03213405|19969450|P4|STARTED|Overall Study||6
8101895|NCT03213405|19969451|P3|STARTED|Overall Study||6
8101896|NCT03213405|19969452|P2|STARTED|Overall Study||6
8101897|NCT03213405|19969453|P1|STARTED|Overall Study||6
8101898|NCT03213366|19969465|P2|NOT COMPLETED|Overall Study||4
8101899|NCT03213366|19969466|P1|NOT COMPLETED|Overall Study||9
8101900|NCT03213366|19969465|P2|COMPLETED|Overall Study||67
8101901|NCT03213366|19969466|P1|COMPLETED|Overall Study||72
8101902|NCT03213366|19969465|P2|STARTED|Overall Study||71
8101903|NCT03213366|19969466|P1|STARTED|Overall Study||81
8101904|NCT03212690|19969492|P1|NOT COMPLETED|Overall Study||1
8101905|NCT03212690|19969492|P1|COMPLETED|Overall Study||56
8101906|NCT03212690|19969492|P1|STARTED|Overall Study||57
8101907|NCT03212638|19969514|P5|NOT COMPLETED|Period 5||0
8101908|NCT03212638|19969515|P4|NOT COMPLETED|Period 5||0
8101909|NCT03212638|19969516|P3|NOT COMPLETED|Period 5||0
8101910|NCT03212638|19969517|P2|NOT COMPLETED|Period 5||0
8101911|NCT03212638|19969518|P1|NOT COMPLETED|Period 5||0
8101912|NCT03212638|19969514|P5|COMPLETED|Period 5||9
8101913|NCT03212638|19969515|P4|COMPLETED|Period 5||9
8101914|NCT03212638|19969516|P3|COMPLETED|Period 5||0
8101915|NCT03212638|19969517|P2|COMPLETED|Period 5||0
8101916|NCT03212638|19969518|P1|COMPLETED|Period 5||0
8101917|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 5||9
8101918|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 5||9
8101919|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 5||0
8101920|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 5||0
8101921|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 5||0
8101922|NCT03212638|19969514|P5|STARTED|Period 5||9
8101923|NCT03212638|19969515|P4|STARTED|Period 5||9
8101924|NCT03212638|19969516|P3|STARTED|Period 5||0
8101925|NCT03212638|19969517|P2|STARTED|Period 5||0
8101926|NCT03212638|19969518|P1|STARTED|Period 5||0
8101927|NCT03212638|19969514|P5|NOT COMPLETED|Period 4||0
8101928|NCT03212638|19969515|P4|NOT COMPLETED|Period 4||0
8101929|NCT03212638|19969516|P3|NOT COMPLETED|Period 4||0
8101930|NCT03212638|19969517|P2|NOT COMPLETED|Period 4||0
8101931|NCT03212638|19969518|P1|NOT COMPLETED|Period 4||0
8101932|NCT03212638|19969514|P5|COMPLETED|Period 4||9
8101933|NCT03212638|19969515|P4|COMPLETED|Period 4||9
8101934|NCT03212638|19969516|P3|COMPLETED|Period 4||0
8101935|NCT03212638|19969517|P2|COMPLETED|Period 4||0
8101936|NCT03212638|19969518|P1|COMPLETED|Period 4||0
8101937|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 4||9
8101938|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 4||9
8101939|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 4||0
8101940|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 4||0
8101941|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 4||0
8101942|NCT03212638|19969514|P5|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
8101943|NCT03212638|19969515|P4|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
8101944|NCT03212638|19969516|P3|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
8101945|NCT03212638|19969517|P2|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
8101946|NCT03212638|19969518|P1|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
8101947|NCT03212638|19969514|P5|NOT COMPLETED|Period 3||0
8101948|NCT03212638|19969515|P4|NOT COMPLETED|Period 3||0
8101949|NCT03212638|19969516|P3|NOT COMPLETED|Period 3||0
8101950|NCT03212638|19969517|P2|NOT COMPLETED|Period 3||0
8101951|NCT03212638|19969518|P1|NOT COMPLETED|Period 3||0
8101952|NCT03212638|19969514|P5|COMPLETED|Period 3||0
8101953|NCT03212638|19969515|P4|COMPLETED|Period 3||0
8101954|NCT03212638|19969516|P3|COMPLETED|Period 3||8
8101955|NCT03212638|19969517|P2|COMPLETED|Period 3||8
8101956|NCT03212638|19969518|P1|COMPLETED|Period 3||8
8101957|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 3||0
8101958|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 3||0
8101959|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 3||8
8101960|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 3||8
8101961|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 3||8
8101962|NCT03212638|19969514|P5|STARTED|Period 3||0
8101963|NCT03212638|19969515|P4|STARTED|Period 3||0
8101964|NCT03212638|19969516|P3|STARTED|Period 3||8
8101965|NCT03212638|19969517|P2|STARTED|Period 3||8
8101966|NCT03212638|19969518|P1|STARTED|Period 3||8
8101967|NCT03212638|19969514|P5|NOT COMPLETED|Period 2||0
8101968|NCT03212638|19969515|P4|NOT COMPLETED|Period 2||0
8101969|NCT03212638|19969516|P3|NOT COMPLETED|Period 2||0
8101970|NCT03212638|19969517|P2|NOT COMPLETED|Period 2||0
8101971|NCT03212638|19969518|P1|NOT COMPLETED|Period 2||0
8101972|NCT03212638|19969514|P5|COMPLETED|Period 2||0
8101973|NCT03212638|19969515|P4|COMPLETED|Period 2||0
8101974|NCT03212638|19969516|P3|COMPLETED|Period 2||8
8101975|NCT03212638|19969517|P2|COMPLETED|Period 2||8
8101976|NCT03212638|19969518|P1|COMPLETED|Period 2||8
8101977|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 2||0
8101978|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 2||0
8101979|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 2||8
8101980|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 2||8
8101981|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 2||8
8101982|NCT03212638|19969514|P5|STARTED|Period 2||0
8101983|NCT03212638|19969515|P4|STARTED|Period 2||0
8101984|NCT03212638|19969516|P3|STARTED|Period 2||8
8101985|NCT03212638|19969517|P2|STARTED|Period 2||8
8101986|NCT03212638|19969518|P1|STARTED|Period 2||8
8101987|NCT03212638|19969514|P5|NOT COMPLETED|Period 1||0
8101988|NCT03212638|19969515|P4|NOT COMPLETED|Period 1||0
8101989|NCT03212638|19969516|P3|NOT COMPLETED|Period 1||0
8101990|NCT03212638|19969517|P2|NOT COMPLETED|Period 1||0
8101991|NCT03212638|19969518|P1|NOT COMPLETED|Period 1||0
8101992|NCT03212638|19969514|P5|COMPLETED|Period 1||0
8101993|NCT03212638|19969515|P4|COMPLETED|Period 1||0
8101994|NCT03212638|19969516|P3|COMPLETED|Period 1||8
8101995|NCT03212638|19969517|P2|COMPLETED|Period 1||8
8101996|NCT03212638|19969518|P1|COMPLETED|Period 1||8
8101997|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 1||0
8101998|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 1||0
8101999|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 1||8
8102000|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 1||8
8102001|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 1||8
8102002|NCT03212638|19969514|P5|STARTED|Period 1||0
8102003|NCT03212638|19969515|P4|STARTED|Period 1||0
8102004|NCT03212638|19969516|P3|STARTED|Period 1||8
8102005|NCT03212638|19969517|P2|STARTED|Period 1||8
8102006|NCT03212638|19969518|P1|STARTED|Period 1||8
8102007|NCT03212521|19969540|P1|NOT COMPLETED|Overall Study||7
8102008|NCT03212521|19969540|P1|COMPLETED|Overall Study||223
8102009|NCT03212521|19969540|P1|STARTED|Overall Study||230
8102010|NCT03212365|19969549|P2|NOT COMPLETED|Overall Study||14
8102011|NCT03212365|19969550|P1|NOT COMPLETED|Overall Study||23
8102012|NCT03212365|19969549|P2|COMPLETED|Overall Study||130
8102013|NCT03212365|19969550|P1|COMPLETED|Overall Study||128
8102014|NCT03212365|19969549|P2|STARTED|Overall Study||144
8102015|NCT03212365|19969550|P1|STARTED|Overall Study||151
8102016|NCT03212326|19969562|P1|NOT COMPLETED|Overall Study||4
8102017|NCT03212326|19969562|P1|COMPLETED|Overall Study||20
8102018|NCT03212326|19969562|P1|STARTED|Overall Study||24
8102019|NCT03212261|19969567|P1|NOT COMPLETED|Overall Study||16
8102020|NCT03212261|19969567|P1|COMPLETED|Overall Study||21
8102021|NCT03212261|19969567|P1|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
8102022|NCT03212261|19969567|P1|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
8102023|NCT03212261|19969567|P1|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
8102024|NCT03212261|19969567|P1|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
8102025|NCT03212261|19969567|P1|Remained Eligible|Overall Study||35
8102026|NCT03212261|19969567|P1|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
8102027|NCT03212144|19969575|P2|NOT COMPLETED|Second Sequence (4 Weeks)||1
8102028|NCT03212144|19969576|P1|NOT COMPLETED|Second Sequence (4 Weeks)||1
8102029|NCT03212144|19969575|P2|COMPLETED|Second Sequence (4 Weeks)||0
8102030|NCT03212144|19969576|P1|COMPLETED|Second Sequence (4 Weeks)||0
8102031|NCT03212144|19969575|P2|STARTED|Second Sequence (4 Weeks)||1
8102032|NCT03212144|19969576|P1|STARTED|Second Sequence (4 Weeks)||1
8102033|NCT03212144|19969575|P2|NOT COMPLETED|Washout (4 Weeks)||0
8102034|NCT03212144|19969576|P1|NOT COMPLETED|Washout (4 Weeks)||0
8102035|NCT03212144|19969575|P2|COMPLETED|Washout (4 Weeks)||1
8102036|NCT03212144|19969576|P1|COMPLETED|Washout (4 Weeks)||1
8102037|NCT03212144|19969575|P2|STARTED|Washout (4 Weeks)||1
8102038|NCT03212144|19969576|P1|STARTED|Washout (4 Weeks)||1
8102039|NCT03212144|19969575|P2|NOT COMPLETED|First Sequence (4 Weeks)||0
8102040|NCT03212144|19969576|P1|NOT COMPLETED|First Sequence (4 Weeks)||1
8102041|NCT03212144|19969575|P2|COMPLETED|First Sequence (4 Weeks)||1
8102042|NCT03212144|19969576|P1|COMPLETED|First Sequence (4 Weeks)||1
8102043|NCT03212144|19969575|P2|STARTED|First Sequence (4 Weeks)||1
8102044|NCT03212144|19969576|P1|STARTED|First Sequence (4 Weeks)||2
8102045|NCT03211858|19969584|P2|NOT COMPLETED|Overall Study||33
8102046|NCT03211858|19969585|P1|NOT COMPLETED|Overall Study||37
8102047|NCT03211858|19969584|P2|COMPLETED|Overall Study||263
8102048|NCT03211858|19969585|P1|COMPLETED|Overall Study||264
8102049|NCT03211858|19969584|P2|Treated|Overall Study||296
8102050|NCT03211858|19969585|P1|Treated|Overall Study||301
8102051|NCT03211858|19969584|P2|STARTED|Overall Study||296
8102052|NCT03211858|19969585|P1|STARTED|Overall Study||301
8102053|NCT03211156|19969637|P2|NOT COMPLETED|Overall Study||3
8102054|NCT03211156|19969638|P1|NOT COMPLETED|Overall Study||2
8102055|NCT03211156|19969637|P2|COMPLETED|Overall Study||45
8102056|NCT03211156|19969638|P1|COMPLETED|Overall Study||47
8102057|NCT03211156|19969637|P2|Received Study Drug|Overall Study||45
8102058|NCT03211156|19969638|P1|Received Study Drug|Overall Study||47
8102059|NCT03211156|19969637|P2|STARTED|Overall Study||48
8102060|NCT03211156|19969638|P1|STARTED|Overall Study||49
8102061|NCT03211117|19969646|P2|NOT COMPLETED|Overall Study||0
8102062|NCT03211117|19969647|P1|NOT COMPLETED|Overall Study||0
8102063|NCT03211117|19969646|P2|COMPLETED|Overall Study||3
8102064|NCT03211117|19969647|P1|COMPLETED|Overall Study||0
8102065|NCT03211117|19969646|P2|STARTED|Overall Study||3
8102066|NCT03211117|19969647|P1|STARTED|Overall Study||0
8102067|NCT03210961|19969669|P15|NOT COMPLETED|Overall Study||2
8102068|NCT03210961|19969670|P14|NOT COMPLETED|Overall Study||4
8102069|NCT03210961|19969671|P13|NOT COMPLETED|Overall Study||2
8102070|NCT03210961|19969672|P12|NOT COMPLETED|Overall Study||0
8102071|NCT03210961|19969673|P11|NOT COMPLETED|Overall Study||1
8102072|NCT03210961|19969674|P10|NOT COMPLETED|Overall Study||0
8102073|NCT03210961|19969675|P9|NOT COMPLETED|Overall Study||0
8102074|NCT03210961|19969676|P8|NOT COMPLETED|Overall Study||0
8102075|NCT03210961|19969677|P7|NOT COMPLETED|Overall Study||1
8102076|NCT03210961|19969678|P6|NOT COMPLETED|Overall Study||0
8102077|NCT03210961|19969679|P5|NOT COMPLETED|Overall Study||0
8102078|NCT03210961|19969680|P4|NOT COMPLETED|Overall Study||1
8102079|NCT03210961|19969681|P3|NOT COMPLETED|Overall Study||0
8102080|NCT03210961|19969682|P2|NOT COMPLETED|Overall Study||0
8102081|NCT03210961|19969683|P1|NOT COMPLETED|Overall Study||0
8102082|NCT03210961|19969669|P15|COMPLETED|Overall Study||9
8102083|NCT03210961|19969670|P14|COMPLETED|Overall Study||11
8102084|NCT03210961|19969671|P13|COMPLETED|Overall Study||12
8102085|NCT03210961|19969672|P12|COMPLETED|Overall Study||5
8102086|NCT03210961|19969673|P11|COMPLETED|Overall Study||6
8102087|NCT03210961|19969674|P10|COMPLETED|Overall Study||6
8102088|NCT03210961|19969675|P9|COMPLETED|Overall Study||8
8102089|NCT03210961|19969676|P8|COMPLETED|Overall Study||7
8102090|NCT03210961|19969677|P7|COMPLETED|Overall Study||7
8102091|NCT03210961|19969678|P6|COMPLETED|Overall Study||6
8102092|NCT03210961|19969679|P5|COMPLETED|Overall Study||6
8102093|NCT03210961|19969680|P4|COMPLETED|Overall Study||1
8102094|NCT03210961|19969681|P3|COMPLETED|Overall Study||1
8102095|NCT03210961|19969682|P2|COMPLETED|Overall Study||9
8102096|NCT03210961|19969683|P1|COMPLETED|Overall Study||4
8102097|NCT03210961|19969669|P15|STARTED|Overall Study||11
8102098|NCT03210961|19969670|P14|STARTED|Overall Study||15
8102099|NCT03210961|19969671|P13|STARTED|Overall Study||14
8102100|NCT03210961|19969672|P12|STARTED|Overall Study||5
8102101|NCT03210961|19969673|P11|STARTED|Overall Study||7
8102102|NCT03210961|19969674|P10|STARTED|Overall Study||6
8102103|NCT03210961|19969675|P9|STARTED|Overall Study||8
8102104|NCT03210961|19969676|P8|STARTED|Overall Study||7
8102105|NCT03210961|19969677|P7|STARTED|Overall Study||8
8102106|NCT03210961|19969678|P6|STARTED|Overall Study||6
8102107|NCT03210961|19969679|P5|STARTED|Overall Study||6
8102108|NCT03210961|19969680|P4|STARTED|Overall Study||2
8102109|NCT03210961|19969681|P3|STARTED|Overall Study||1
8102110|NCT03210961|19969682|P2|STARTED|Overall Study||9
8102111|NCT03210961|19969683|P1|STARTED|Overall Study||4
8102112|NCT03210701|19970032|P1|NOT COMPLETED|Overall Study||0
8102113|NCT03210701|19970032|P1|COMPLETED|Overall Study||123
8102114|NCT03210701|19970032|P1|STARTED|Overall Study||123
8102115|NCT03210519|19970042|P2|NOT COMPLETED|Overall Study||0
8102116|NCT03210519|19970043|P1|NOT COMPLETED|Overall Study||2
8102117|NCT03210519|19970042|P2|COMPLETED|Overall Study||10
8102118|NCT03210519|19970043|P1|COMPLETED|Overall Study||9
8102119|NCT03210519|19970042|P2|STARTED|Overall Study||10
8102120|NCT03210519|19970043|P1|STARTED|Overall Study||11
8102121|NCT03210376|19970069|P2|NOT COMPLETED|Overall Study||0
8102122|NCT03210376|19970070|P1|NOT COMPLETED|Overall Study||0
8102123|NCT03210376|19970069|P2|COMPLETED|Overall Study||50
8102124|NCT03210376|19970070|P1|COMPLETED|Overall Study||50
8102125|NCT03210376|19970069|P2|STARTED|Overall Study||50
8102126|NCT03210376|19970070|P1|STARTED|Overall Study||50
8102127|NCT03210337|19970090|P2|NOT COMPLETED|Overall Study||5
8102128|NCT03210337|19970091|P1|NOT COMPLETED|Overall Study||8
8102129|NCT03210337|19970090|P2|COMPLETED|Overall Study||74
8102130|NCT03210337|19970091|P1|COMPLETED|Overall Study||70
8102131|NCT03210337|19970090|P2|STARTED|Overall Study||79
8102132|NCT03210337|19970091|P1|STARTED|Overall Study||78
8102133|NCT03210220|19970099|P2|NOT COMPLETED|Overall Study||0
8102134|NCT03210220|19970100|P1|NOT COMPLETED|Overall Study||1
8102135|NCT03210220|19970099|P2|COMPLETED|Overall Study||20
8102136|NCT03210220|19970100|P1|COMPLETED|Overall Study||19
8102137|NCT03210220|19970099|P2|STARTED|Overall Study||20
8102138|NCT03210220|19970100|P1|STARTED|Overall Study||20
8102139|NCT03210155|19970108|P2|NOT COMPLETED|Overall Study||0
8102140|NCT03210155|19970109|P1|NOT COMPLETED|Overall Study||0
8102141|NCT03210155|19970108|P2|COMPLETED|Overall Study||1
8102142|NCT03210155|19970109|P1|COMPLETED|Overall Study||0
8102143|NCT03210155|19970108|P2|STARTED|Overall Study||1
8102144|NCT03210155|19970109|P1|STARTED|Overall Study||0
8102145|NCT03209973|19970123|P1|NOT COMPLETED|Overall Study||4
8102146|NCT03209973|19970123|P1|COMPLETED|Overall Study||66
8102147|NCT03209973|19970123|P1|STARTED|Overall Study||70
8102148|NCT03209570|19970129|P2|NOT COMPLETED|Overall Study||13
8102149|NCT03209570|19970130|P1|NOT COMPLETED|Overall Study||10
8102150|NCT03209570|19970129|P2|COMPLETED|Overall Study||12
8102151|NCT03209570|19970130|P1|COMPLETED|Overall Study||14
8102152|NCT03209570|19970129|P2|STARTED|Overall Study||25
8102153|NCT03209570|19970130|P1|STARTED|Overall Study||24
8102154|NCT03209518|19970140|P1|NOT COMPLETED|Overall Study||2
8102155|NCT03209518|19970140|P1|COMPLETED|Overall Study||310
8102156|NCT03209518|19970140|P1|STARTED|Overall Study||312
8102157|NCT03209492|19970145|P1|NOT COMPLETED|Overall Study||5
8102158|NCT03209492|19970145|P1|COMPLETED|Overall Study||328
8102159|NCT03209492|19970145|P1|STARTED|Overall Study||333
8102160|NCT03208933|19970150|P1|NOT COMPLETED|Overall Study||13
8102161|NCT03208933|19970150|P1|COMPLETED|Overall Study||47
8102162|NCT03208933|19970150|P1|STARTED|Overall Study||60
8102163|NCT03208673|19970159|P1|NOT COMPLETED|Overall Study||0
8102164|NCT03208673|19970159|P1|COMPLETED|Overall Study||32
8102165|NCT03208673|19970159|P1|STARTED|Overall Study||32
8102166|NCT03208192|19970167|P2|NOT COMPLETED|Overall Study||0
8102167|NCT03208192|19970168|P1|NOT COMPLETED|Overall Study||0
8102168|NCT03208192|19970167|P2|COMPLETED|Overall Study||36
8102169|NCT03208192|19970168|P1|COMPLETED|Overall Study||32
8102170|NCT03208192|19970167|P2|STARTED|Overall Study||36
8102171|NCT03208192|19970168|P1|STARTED|Overall Study||32
8102172|NCT03208166|19970188|P2|NOT COMPLETED|Overall Study||0
8102173|NCT03208166|19970189|P1|NOT COMPLETED|Overall Study||0
8102174|NCT03208166|19970188|P2|COMPLETED|Overall Study||1
8102175|NCT03208166|19970189|P1|COMPLETED|Overall Study||1
8102176|NCT03208166|19970188|P2|STARTED|Overall Study||1
8102177|NCT03208166|19970189|P1|STARTED|Overall Study||1
8102178|NCT03208088|19970197|P10|NOT COMPLETED|Period 5||0
8102179|NCT03208088|19970198|P9|NOT COMPLETED|Period 5||0
8102180|NCT03208088|19970199|P8|NOT COMPLETED|Period 5||0
8102181|NCT03208088|19970200|P7|NOT COMPLETED|Period 5||0
8102182|NCT03208088|19970201|P6|NOT COMPLETED|Period 5||0
8102183|NCT03208088|19970202|P5|NOT COMPLETED|Period 5||0
8102184|NCT03208088|19970203|P4|NOT COMPLETED|Period 5||0
8102185|NCT03208088|19970204|P3|NOT COMPLETED|Period 5||0
8102186|NCT03208088|19970205|P2|NOT COMPLETED|Period 5||0
8102187|NCT03208088|19970206|P1|NOT COMPLETED|Period 5||0
8102188|NCT03208088|19970197|P10|COMPLETED|Period 5||9
8102189|NCT03208088|19970198|P9|COMPLETED|Period 5||7
8102190|NCT03208088|19970199|P8|COMPLETED|Period 5||10
8102191|NCT03208088|19970200|P7|COMPLETED|Period 5||8
8102192|NCT03208088|19970201|P6|COMPLETED|Period 5||9
8102193|NCT03208088|19970202|P5|COMPLETED|Period 5||9
8102194|NCT03208088|19970203|P4|COMPLETED|Period 5||7
8102195|NCT03208088|19970204|P3|COMPLETED|Period 5||10
8102196|NCT03208088|19970205|P2|COMPLETED|Period 5||9
8102197|NCT03208088|19970206|P1|COMPLETED|Period 5||10
8102198|NCT03208088|19970197|P10|STARTED|Period 5||9
8102199|NCT03208088|19970198|P9|STARTED|Period 5||7
8102200|NCT03208088|19970199|P8|STARTED|Period 5||10
8102201|NCT03208088|19970200|P7|STARTED|Period 5||8
8102202|NCT03208088|19970201|P6|STARTED|Period 5||9
8102203|NCT03208088|19970202|P5|STARTED|Period 5||9
8102204|NCT03208088|19970203|P4|STARTED|Period 5||7
8102205|NCT03208088|19970204|P3|STARTED|Period 5||10
8102206|NCT03208088|19970205|P2|STARTED|Period 5||9
8102207|NCT03208088|19970206|P1|STARTED|Period 5||10
8102208|NCT03208088|19970197|P10|NOT COMPLETED|Period 4||0
8102209|NCT03208088|19970198|P9|NOT COMPLETED|Period 4||0
8102210|NCT03208088|19970199|P8|NOT COMPLETED|Period 4||0
8102211|NCT03208088|19970200|P7|NOT COMPLETED|Period 4||0
8102212|NCT03208088|19970201|P6|NOT COMPLETED|Period 4||0
8102213|NCT03208088|19970202|P5|NOT COMPLETED|Period 4||0
8102214|NCT03208088|19970203|P4|NOT COMPLETED|Period 4||1
8102215|NCT03208088|19970204|P3|NOT COMPLETED|Period 4||0
8102216|NCT03208088|19970205|P2|NOT COMPLETED|Period 4||0
8102217|NCT03208088|19970206|P1|NOT COMPLETED|Period 4||0
8102218|NCT03208088|19970197|P10|COMPLETED|Period 4||9
8102219|NCT03208088|19970198|P9|COMPLETED|Period 4||7
8102220|NCT03208088|19970199|P8|COMPLETED|Period 4||10
8102221|NCT03208088|19970200|P7|COMPLETED|Period 4||8
8102222|NCT03208088|19970201|P6|COMPLETED|Period 4||9
8102223|NCT03208088|19970202|P5|COMPLETED|Period 4||9
8102224|NCT03208088|19970203|P4|COMPLETED|Period 4||7
8102225|NCT03208088|19970204|P3|COMPLETED|Period 4||10
8102226|NCT03208088|19970205|P2|COMPLETED|Period 4||9
8102227|NCT03208088|19970206|P1|COMPLETED|Period 4||10
8102228|NCT03208088|19970197|P10|STARTED|Period 4||9
8102229|NCT03208088|19970198|P9|STARTED|Period 4||7
8102230|NCT03208088|19970199|P8|STARTED|Period 4||10
8102231|NCT03208088|19970200|P7|STARTED|Period 4||8
8102232|NCT03208088|19970201|P6|STARTED|Period 4||9
8102233|NCT03208088|19970202|P5|STARTED|Period 4||9
8102234|NCT03208088|19970203|P4|STARTED|Period 4||8
8102235|NCT03208088|19970204|P3|STARTED|Period 4||10
8102236|NCT03208088|19970205|P2|STARTED|Period 4||9
8102237|NCT03208088|19970206|P1|STARTED|Period 4||10
8102238|NCT03208088|19970197|P10|NOT COMPLETED|Period 3||0
8102239|NCT03208088|19970198|P9|NOT COMPLETED|Period 3||0
8102240|NCT03208088|19970199|P8|NOT COMPLETED|Period 3||0
8102241|NCT03208088|19970200|P7|NOT COMPLETED|Period 3||0
8102242|NCT03208088|19970201|P6|NOT COMPLETED|Period 3||0
8102243|NCT03208088|19970202|P5|NOT COMPLETED|Period 3||0
8102244|NCT03208088|19970203|P4|NOT COMPLETED|Period 3||1
8102245|NCT03208088|19970204|P3|NOT COMPLETED|Period 3||0
8102246|NCT03208088|19970205|P2|NOT COMPLETED|Period 3||0
8102247|NCT03208088|19970206|P1|NOT COMPLETED|Period 3||0
8102248|NCT03208088|19970197|P10|COMPLETED|Period 3||9
8102249|NCT03208088|19970198|P9|COMPLETED|Period 3||7
8102250|NCT03208088|19970199|P8|COMPLETED|Period 3||10
8102251|NCT03208088|19970200|P7|COMPLETED|Period 3||8
8102252|NCT03208088|19970201|P6|COMPLETED|Period 3||9
8102253|NCT03208088|19970202|P5|COMPLETED|Period 3||9
8102254|NCT03208088|19970203|P4|COMPLETED|Period 3||8
8102255|NCT03208088|19970204|P3|COMPLETED|Period 3||10
8102256|NCT03208088|19970205|P2|COMPLETED|Period 3||9
8102257|NCT03208088|19970206|P1|COMPLETED|Period 3||10
8102258|NCT03208088|19970197|P10|STARTED|Period 3||9
8102259|NCT03208088|19970198|P9|STARTED|Period 3||7
8102260|NCT03208088|19970199|P8|STARTED|Period 3||10
8102261|NCT03208088|19970200|P7|STARTED|Period 3||8
8102262|NCT03208088|19970201|P6|STARTED|Period 3||9
8102263|NCT03208088|19970202|P5|STARTED|Period 3||9
8102264|NCT03208088|19970203|P4|STARTED|Period 3||9
8102265|NCT03208088|19970204|P3|STARTED|Period 3||10
8102266|NCT03208088|19970205|P2|STARTED|Period 3||9
8102267|NCT03208088|19970206|P1|STARTED|Period 3||10
8102268|NCT03208088|19970197|P10|NOT COMPLETED|Period 2||0
8102269|NCT03208088|19970198|P9|NOT COMPLETED|Period 2||1
8102270|NCT03208088|19970199|P8|NOT COMPLETED|Period 2||0
8102271|NCT03208088|19970200|P7|NOT COMPLETED|Period 2||0
8102272|NCT03208088|19970201|P6|NOT COMPLETED|Period 2||0
8102273|NCT03208088|19970202|P5|NOT COMPLETED|Period 2||0
8102274|NCT03208088|19970203|P4|NOT COMPLETED|Period 2||0
8102275|NCT03208088|19970204|P3|NOT COMPLETED|Period 2||0
8102276|NCT03208088|19970205|P2|NOT COMPLETED|Period 2||0
8102277|NCT03208088|19970206|P1|NOT COMPLETED|Period 2||0
8102278|NCT03208088|19970197|P10|COMPLETED|Period 2||9
8102279|NCT03208088|19970198|P9|COMPLETED|Period 2||7
8102280|NCT03208088|19970199|P8|COMPLETED|Period 2||10
8102281|NCT03208088|19970200|P7|COMPLETED|Period 2||8
8102282|NCT03208088|19970201|P6|COMPLETED|Period 2||9
8102283|NCT03208088|19970202|P5|COMPLETED|Period 2||9
8102284|NCT03208088|19970203|P4|COMPLETED|Period 2||9
8102285|NCT03208088|19970204|P3|COMPLETED|Period 2||10
8102286|NCT03208088|19970205|P2|COMPLETED|Period 2||9
8102287|NCT03208088|19970206|P1|COMPLETED|Period 2||10
8102288|NCT03208088|19970197|P10|STARTED|Period 2||9
8102289|NCT03208088|19970198|P9|STARTED|Period 2||8
8102290|NCT03208088|19970199|P8|STARTED|Period 2||10
8102291|NCT03208088|19970200|P7|STARTED|Period 2||8
8102292|NCT03208088|19970201|P6|STARTED|Period 2||9
8102293|NCT03208088|19970202|P5|STARTED|Period 2||9
8102294|NCT03208088|19970203|P4|STARTED|Period 2||9
8102295|NCT03208088|19970204|P3|STARTED|Period 2||10
8102296|NCT03208088|19970205|P2|STARTED|Period 2||9
8102297|NCT03208088|19970206|P1|STARTED|Period 2||10
8102298|NCT03208088|19970197|P10|NOT COMPLETED|Period 1||0
8102299|NCT03208088|19970198|P9|NOT COMPLETED|Period 1||0
8102300|NCT03208088|19970199|P8|NOT COMPLETED|Period 1||0
8102301|NCT03208088|19970200|P7|NOT COMPLETED|Period 1||0
8102302|NCT03208088|19970201|P6|NOT COMPLETED|Period 1||0
8102303|NCT03208088|19970202|P5|NOT COMPLETED|Period 1||0
8102304|NCT03208088|19970203|P4|NOT COMPLETED|Period 1||0
8102305|NCT03208088|19970204|P3|NOT COMPLETED|Period 1||0
8102306|NCT03208088|19970205|P2|NOT COMPLETED|Period 1||0
8102307|NCT03208088|19970206|P1|NOT COMPLETED|Period 1||0
8102308|NCT03208088|19970197|P10|COMPLETED|Period 1||9
8102309|NCT03208088|19970198|P9|COMPLETED|Period 1||8
8102310|NCT03208088|19970199|P8|COMPLETED|Period 1||10
8102311|NCT03208088|19970200|P7|COMPLETED|Period 1||8
8102312|NCT03208088|19970201|P6|COMPLETED|Period 1||9
8102313|NCT03208088|19970202|P5|COMPLETED|Period 1||9
8102314|NCT03208088|19970203|P4|COMPLETED|Period 1||9
8102315|NCT03208088|19970204|P3|COMPLETED|Period 1||10
8102316|NCT03208088|19970205|P2|COMPLETED|Period 1||9
8102317|NCT03208088|19970206|P1|COMPLETED|Period 1||10
8102318|NCT03208088|19970197|P10|STARTED|Period 1||9
8102319|NCT03208088|19970198|P9|STARTED|Period 1||8
8102320|NCT03208088|19970199|P8|STARTED|Period 1||10
8102321|NCT03208088|19970200|P7|STARTED|Period 1||8
8102322|NCT03208088|19970201|P6|STARTED|Period 1||9
8102323|NCT03208088|19970202|P5|STARTED|Period 1||9
8102324|NCT03208088|19970203|P4|STARTED|Period 1||9
8102325|NCT03208088|19970204|P3|STARTED|Period 1||10
8102326|NCT03208088|19970205|P2|STARTED|Period 1||9
8102327|NCT03208088|19970206|P1|STARTED|Period 1||10
8102328|NCT03207776|19970221|P2|NOT COMPLETED|Overall Study||0
8102329|NCT03207776|19970222|P1|NOT COMPLETED|Overall Study||0
8102330|NCT03207776|19970221|P2|COMPLETED|Overall Study||2353
8102331|NCT03207776|19970222|P1|COMPLETED|Overall Study||2479
8102332|NCT03207776|19970221|P2|STARTED|Overall Study||2353
8102333|NCT03207776|19970222|P1|STARTED|Overall Study||2479
8102334|NCT03207763|19970236|P2|NOT COMPLETED|Overall Study||0
8102335|NCT03207763|19970237|P1|NOT COMPLETED|Overall Study||1
8102336|NCT03207763|19970236|P2|COMPLETED|Overall Study||25
8102337|NCT03207763|19970237|P1|COMPLETED|Overall Study||7
8102338|NCT03207763|19970236|P2|Completed Patches 2 and 3 Study|Overall Study||23
8102339|NCT03207763|19970237|P1|Completed Patches 2 and 3 Study|Overall Study||5
8102340|NCT03207763|19970236|P2|Eligible and Opted for Patches 2 and 3|Overall Study||23
8102341|NCT03207763|19970237|P1|Eligible and Opted for Patches 2 and 3|Overall Study||5
8102342|NCT03207763|19970236|P2|STARTED|Overall Study||25
8102343|NCT03207763|19970237|P1|STARTED|Overall Study||8
8102344|NCT03207750|19970263|P2|NOT COMPLETED|Overall Study||66
8102345|NCT03207750|19970264|P1|NOT COMPLETED|Overall Study||58
8102346|NCT03207750|19970263|P2|COMPLETED|Overall Study||574
8102347|NCT03207750|19970264|P1|COMPLETED|Overall Study||574
8102348|NCT03207750|19970263|P2|STARTED|Overall Study||640
8102349|NCT03207750|19970264|P1|STARTED|Overall Study||632
8102350|NCT03207438|19970310|P4|NOT COMPLETED|Overall Study||112
8102351|NCT03207438|19970311|P3|NOT COMPLETED|Overall Study||232
8102352|NCT03207438|19970312|P2|NOT COMPLETED|Overall Study||21
8102353|NCT03207438|19970313|P1|NOT COMPLETED|Overall Study||19
8102354|NCT03207438|19970310|P4|COMPLETED|Overall Study||470
8102355|NCT03207438|19970311|P3|COMPLETED|Overall Study||643
8102356|NCT03207438|19970312|P2|COMPLETED|Overall Study||145
8102357|NCT03207438|19970313|P1|COMPLETED|Overall Study||148
8102358|NCT03207438|19970310|P4|STARTED|Overall Study||582
8102359|NCT03207438|19970311|P3|STARTED|Overall Study||875
8102360|NCT03207438|19970312|P2|STARTED|Overall Study||166
8102361|NCT03207438|19970313|P1|STARTED|Overall Study||167
8102362|NCT03207399|19970330|P1|NOT COMPLETED|Overall Study||0
8102363|NCT03207399|19970330|P1|COMPLETED|Overall Study||1
8102364|NCT03207399|19970330|P1|STARTED|Overall Study||1
8102365|NCT03207243|19970344|P2|NOT COMPLETED|Overall Study||44
8102366|NCT03207243|19970345|P1|NOT COMPLETED|Overall Study||59
8102367|NCT03207243|19970344|P2|COMPLETED|Overall Study||39
8102368|NCT03207243|19970345|P1|COMPLETED|Overall Study||23
8102369|NCT03207243|19970344|P2|STARTED|Overall Study||83
8102370|NCT03207243|19970345|P1|STARTED|Overall Study||82
8102371|NCT03207074|19970452|P1|NOT COMPLETED|Overall Study||0
8102372|NCT03207074|19970452|P1|COMPLETED|Overall Study||150
8102373|NCT03207074|19970452|P1|STARTED|Overall Study||150
8102374|NCT03206970|19970456|P1|NOT COMPLETED|Overall Study||26
8102375|NCT03206970|19970456|P1|COMPLETED|Overall Study||60
8102376|NCT03206970|19970456|P1|STARTED|Overall Study||86
8102377|NCT03206918|19970460|P1|NOT COMPLETED|Overall Study||6
8102378|NCT03206918|19970460|P1|COMPLETED|Overall Study||85
8102379|NCT03206918|19970460|P1|STARTED|Overall Study||91
8102380|NCT03206788|19970466|P2|NOT COMPLETED|Overall Study||3
8102381|NCT03206788|19970467|P1|NOT COMPLETED|Overall Study||0
8102382|NCT03206788|19970466|P2|COMPLETED|Overall Study||2
8102383|NCT03206788|19970467|P1|COMPLETED|Overall Study||2
8102384|NCT03206788|19970466|P2|STARTED|Overall Study||5
8102385|NCT03206788|19970467|P1|STARTED|Overall Study||2
8102386|NCT03206216|19970505|P2|NOT COMPLETED|Overall Study||1
8102387|NCT03206216|19970506|P1|NOT COMPLETED|Overall Study||0
8102388|NCT03206216|19970505|P2|COMPLETED|Overall Study||0
8102389|NCT03206216|19970506|P1|COMPLETED|Overall Study||0
8102390|NCT03206216|19970505|P2|STARTED|Overall Study||1
8102391|NCT03206216|19970506|P1|STARTED|Overall Study||0
8102392|NCT03205488|19970517|P3|NOT COMPLETED|Overall Study||5
8102393|NCT03205488|19970518|P2|NOT COMPLETED|Overall Study||2
8102394|NCT03205488|19970519|P1|NOT COMPLETED|Overall Study||1
8102395|NCT03205488|19970517|P3|COMPLETED|Overall Study||21
8102396|NCT03205488|19970518|P2|COMPLETED|Overall Study||23
8102397|NCT03205488|19970519|P1|COMPLETED|Overall Study||24
8102398|NCT03205488|19970517|P3|STARTED|Overall Study||26
8102399|NCT03205488|19970518|P2|STARTED|Overall Study||25
8102400|NCT03205488|19970519|P1|STARTED|Overall Study||25
8102401|NCT03205371|19970545|P12|NOT COMPLETED|Overall Study||1
8102402|NCT03205371|19970546|P11|NOT COMPLETED|Overall Study||0
8102403|NCT03205371|19970547|P10|NOT COMPLETED|Overall Study||0
8102404|NCT03205371|19970548|P9|NOT COMPLETED|Overall Study||5
8102405|NCT03205371|19970549|P8|NOT COMPLETED|Overall Study||3
8102406|NCT03205371|19970550|P7|NOT COMPLETED|Overall Study||10
8102407|NCT03205371|19970551|P6|NOT COMPLETED|Overall Study||0
8102408|NCT03205371|19970552|P5|NOT COMPLETED|Overall Study||0
8102409|NCT03205371|19970553|P4|NOT COMPLETED|Overall Study||0
8102410|NCT03205371|19970554|P3|NOT COMPLETED|Overall Study||0
8102411|NCT03205371|19970555|P2|NOT COMPLETED|Overall Study||1
8102412|NCT03205371|19970556|P1|NOT COMPLETED|Overall Study||4
8102413|NCT03205371|19970545|P12|COMPLETED|Overall Study||99
8102414|NCT03205371|19970546|P11|COMPLETED|Overall Study||100
8102415|NCT03205371|19970547|P10|COMPLETED|Overall Study||200
8102416|NCT03205371|19970548|P9|COMPLETED|Overall Study||95
8102417|NCT03205371|19970549|P8|COMPLETED|Overall Study||97
8102418|NCT03205371|19970550|P7|COMPLETED|Overall Study||190
8102419|NCT03205371|19970551|P6|COMPLETED|Overall Study||42
8102420|NCT03205371|19970552|P5|COMPLETED|Overall Study||42
8102421|NCT03205371|19970553|P4|COMPLETED|Overall Study||86
8102422|NCT03205371|19970554|P3|COMPLETED|Overall Study||53
8102423|NCT03205371|19970555|P2|COMPLETED|Overall Study||52
8102424|NCT03205371|19970556|P1|COMPLETED|Overall Study||103
8102425|NCT03205371|19970545|P12|Per-protocol Analysis Set (PPAS)|Overall Study||92
8102426|NCT03205371|19970546|P11|Per-protocol Analysis Set (PPAS)|Overall Study||96
8102427|NCT03205371|19970547|P10|Per-protocol Analysis Set (PPAS)|Overall Study||196
8102428|NCT03205371|19970548|P9|Per-protocol Analysis Set (PPAS)|Overall Study||68
8102429|NCT03205371|19970549|P8|Per-protocol Analysis Set (PPAS)|Overall Study||79
8102430|NCT03205371|19970550|P7|Per-protocol Analysis Set (PPAS)|Overall Study||155
8102431|NCT03205371|19970551|P6|Per-protocol Analysis Set (PPAS)|Overall Study||42
8102432|NCT03205371|19970552|P5|Per-protocol Analysis Set (PPAS)|Overall Study||42
8102433|NCT03205371|19970553|P4|Per-protocol Analysis Set (PPAS)|Overall Study||85
8102434|NCT03205371|19970554|P3|Per-protocol Analysis Set (PPAS)|Overall Study||50
8102435|NCT03205371|19970555|P2|Per-protocol Analysis Set (PPAS)|Overall Study||45
8102436|NCT03205371|19970556|P1|Per-protocol Analysis Set (PPAS)|Overall Study||92
8102437|NCT03205371|19970545|P12|Safety Analysis Set (SafAS)|Overall Study||99
8102438|NCT03205371|19970546|P11|Safety Analysis Set (SafAS)|Overall Study||100
8102439|NCT03205371|19970547|P10|Safety Analysis Set (SafAS)|Overall Study||200
8102440|NCT03205371|19970548|P9|Safety Analysis Set (SafAS)|Overall Study||100
8102441|NCT03205371|19970549|P8|Safety Analysis Set (SafAS)|Overall Study||100
8102442|NCT03205371|19970550|P7|Safety Analysis Set (SafAS)|Overall Study||200
8102443|NCT03205371|19970551|P6|Safety Analysis Set (SafAS)|Overall Study||42
8102444|NCT03205371|19970552|P5|Safety Analysis Set (SafAS)|Overall Study||42
8102445|NCT03205371|19970553|P4|Safety Analysis Set (SafAS)|Overall Study||86
8102446|NCT03205371|19970554|P3|Safety Analysis Set (SafAS)|Overall Study||53
8102447|NCT03205371|19970555|P2|Safety Analysis Set (SafAS)|Overall Study||52
8102448|NCT03205371|19970556|P1|Safety Analysis Set (SafAS)|Overall Study||103
8102449|NCT03205371|19970545|P12|STARTED|Overall Study||100
8102450|NCT03205371|19970546|P11|STARTED|Overall Study||100
8102451|NCT03205371|19970547|P10|STARTED|Overall Study||200
8102452|NCT03205371|19970548|P9|STARTED|Overall Study||100
8102453|NCT03205371|19970549|P8|STARTED|Overall Study||100
8102454|NCT03205371|19970550|P7|STARTED|Overall Study||200
8102455|NCT03205371|19970551|P6|STARTED|Overall Study||42
8102456|NCT03205371|19970552|P5|STARTED|Overall Study||42
8102457|NCT03205371|19970553|P4|STARTED|Overall Study||86
8102458|NCT03205371|19970554|P3|STARTED|Overall Study||53
8102459|NCT03205371|19970555|P2|STARTED|Overall Study||53
8102460|NCT03205371|19970556|P1|STARTED|Overall Study||107
8102461|NCT03205358|19970636|P2|NOT COMPLETED|Overall Study||0
8102462|NCT03205358|19970637|P1|NOT COMPLETED|Overall Study||0
8102463|NCT03205358|19970636|P2|COMPLETED|Overall Study||94
8102464|NCT03205358|19970637|P1|COMPLETED|Overall Study||94
8102465|NCT03205358|19970636|P2|STARTED|Overall Study||94
8102466|NCT03205358|19970637|P1|STARTED|Overall Study||94
8102467|NCT03205163|19970645|P2|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
8102468|NCT03205163|19970646|P1|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
8102469|NCT03205163|19970645|P2|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
8102470|NCT03205163|19970646|P1|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
8102471|NCT03205163|19970645|P2|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
8102472|NCT03205163|19970646|P1|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
8102473|NCT03205163|19970645|P2|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
8102474|NCT03205163|19970646|P1|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
8102475|NCT03205163|19970645|P2|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
8102476|NCT03205163|19970646|P1|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
8102477|NCT03205163|19970645|P2|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
8102478|NCT03205163|19970646|P1|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
8102479|NCT03205163|19970645|P2|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
8102480|NCT03205163|19970646|P1|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
8102481|NCT03205163|19970645|P2|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
8102482|NCT03205163|19970646|P1|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
8102483|NCT03205150|19970697|P3|NOT COMPLETED|Overall Study||2
8102484|NCT03205150|19970698|P2|NOT COMPLETED|Overall Study||7
8102485|NCT03205150|19970699|P1|NOT COMPLETED|Overall Study||2
8102486|NCT03205150|19970697|P3|COMPLETED|Overall Study||19
8102487|NCT03205150|19970698|P2|COMPLETED|Overall Study||36
8102488|NCT03205150|19970699|P1|COMPLETED|Overall Study||41
8102489|NCT03205150|19970697|P3|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
8102490|NCT03205150|19970698|P2|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
8102491|NCT03205150|19970699|P1|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
8102492|NCT03205150|19970697|P3|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
8102493|NCT03205150|19970698|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
8102494|NCT03205150|19970699|P1|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
8102495|NCT03205150|19970697|P3|Safety Analysis Set|Overall Study||21
8102496|NCT03205150|19970698|P2|Safety Analysis Set|Overall Study||43
8102497|NCT03205150|19970699|P1|Safety Analysis Set|Overall Study||43
8102498|NCT03205150|19970697|P3|STARTED|Overall Study||21
8102499|NCT03205150|19970698|P2|STARTED|Overall Study||43
8102500|NCT03205150|19970699|P1|STARTED|Overall Study||43
8102501|NCT03205046|19970737|P2|NOT COMPLETED|Overall Study||10
8102502|NCT03205046|19970738|P1|NOT COMPLETED|Overall Study||13
8102503|NCT03205046|19970737|P2|COMPLETED|Overall Study||2
8102504|NCT03205046|19970738|P1|COMPLETED|Overall Study||0
8102505|NCT03205046|19970737|P2|STARTED|Overall Study||12
8102506|NCT03205046|19970738|P1|STARTED|Overall Study||13
8102507|NCT03204942|19970747|P3|NOT COMPLETED|Overall Study||0
8102508|NCT03204942|19970748|P2|NOT COMPLETED|Overall Study||0
8102509|NCT03204942|19970749|P1|NOT COMPLETED|Overall Study||0
8102510|NCT03204942|19970747|P3|COMPLETED|Overall Study||23
8102511|NCT03204942|19970748|P2|COMPLETED|Overall Study||23
8102512|NCT03204942|19970749|P1|COMPLETED|Overall Study||23
8102513|NCT03204942|19970747|P3|STARTED|Overall Study||23
8102514|NCT03204942|19970748|P2|STARTED|Overall Study||23
8102515|NCT03204942|19970749|P1|STARTED|Overall Study||23
8102516|NCT03204643|19970777|P2|NOT COMPLETED|Overall Study||0
8102517|NCT03204643|19970778|P1|NOT COMPLETED|Overall Study||0
8102518|NCT03204643|19970777|P2|COMPLETED|Overall Study||314
8102519|NCT03204643|19970778|P1|COMPLETED|Overall Study||323
8102520|NCT03204643|19970777|P2|STARTED|Overall Study||314
8102521|NCT03204643|19970778|P1|STARTED|Overall Study||323
8102522|NCT03204539|19970792|P2|NOT COMPLETED|Overall Study||1
8102523|NCT03204539|19970793|P1|NOT COMPLETED|Overall Study||0
8102524|NCT03204539|19970792|P2|COMPLETED|Overall Study||0
8102525|NCT03204539|19970793|P1|COMPLETED|Overall Study||0
8102526|NCT03204539|19970792|P2|STARTED|Overall Study||1
8102527|NCT03204539|19970793|P1|STARTED|Overall Study||0
8102528|NCT03204279|19970817|P2|NOT COMPLETED|Overall Study||1
8102529|NCT03204279|19970818|P1|NOT COMPLETED|Overall Study||0
8102530|NCT03204279|19970817|P2|COMPLETED|Overall Study||32
8102531|NCT03204279|19970818|P1|COMPLETED|Overall Study||34
8102532|NCT03204279|19970817|P2|STARTED|Overall Study||33
8102533|NCT03204279|19970818|P1|STARTED|Overall Study||34
8102534|NCT03203564|19970833|P4|NOT COMPLETED|Overall Study||0
8102535|NCT03203564|19970834|P3|NOT COMPLETED|Overall Study||0
8102536|NCT03203564|19970835|P2|NOT COMPLETED|Overall Study||0
8102537|NCT03203564|19970836|P1|NOT COMPLETED|Overall Study||0
8102538|NCT03203564|19970833|P4|COMPLETED|Overall Study||9
8102539|NCT03203564|19970834|P3|COMPLETED|Overall Study||8
8102540|NCT03203564|19970835|P2|COMPLETED|Overall Study||8
8102541|NCT03203564|19970836|P1|COMPLETED|Overall Study||8
8102542|NCT03203564|19970833|P4|STARTED|Overall Study||9
8102543|NCT03203564|19970834|P3|STARTED|Overall Study||8
8102544|NCT03203564|19970835|P2|STARTED|Overall Study||8
8102545|NCT03203564|19970836|P1|STARTED|Overall Study||8
8102546|NCT03203291|19970945|P1|NOT COMPLETED|Overall Study||1
8102547|NCT03203291|19970945|P1|COMPLETED|Overall Study||11
8102548|NCT03203291|19970945|P1|STARTED|Overall Study||12
8102549|NCT03202550|19970957|P2|NOT COMPLETED|Overall Study||0
8102550|NCT03202550|19970958|P1|NOT COMPLETED|Overall Study||0
8102551|NCT03202550|19970957|P2|COMPLETED|Overall Study||11
8102552|NCT03202550|19970958|P1|COMPLETED|Overall Study||13
8102553|NCT03202550|19970957|P2|STARTED|Overall Study||11
8102554|NCT03202550|19970958|P1|STARTED|Overall Study||13
8102555|NCT03202472|19970980|P1|NOT COMPLETED|Overall Study||0
8102556|NCT03202472|19970980|P1|COMPLETED|Overall Study||50
8102557|NCT03202472|19970980|P1|STARTED|Overall Study||50
8102558|NCT03201900|19970993|P1|NOT COMPLETED|Extension Phase (Up to 124 Weeks)||46
8102559|NCT03201900|19970993|P1|COMPLETED|Extension Phase (Up to 124 Weeks)||0
8102560|NCT03201900|19970993|P1|STARTED|Extension Phase (Up to 124 Weeks)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
8102561|NCT03201900|19970993|P1|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
8102562|NCT03201900|19970993|P1|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
8102563|NCT03201900|19970993|P1|Treated|Treatment Phase (Up to 62 Weeks)||89
8102564|NCT03201900|19970993|P1|STARTED|Treatment Phase (Up to 62 Weeks)||91
8102565|NCT03201419|19971008|P9|NOT COMPLETED|Overall Study||2
8102566|NCT03201419|19971009|P8|NOT COMPLETED|Overall Study||1
8102567|NCT03201419|19971010|P7|NOT COMPLETED|Overall Study||6
8102568|NCT03201419|19971011|P6|NOT COMPLETED|Overall Study||1
8102569|NCT03201419|19971012|P5|NOT COMPLETED|Overall Study||1
8102570|NCT03201419|19971013|P4|NOT COMPLETED|Overall Study||0
8102571|NCT03201419|19971014|P3|NOT COMPLETED|Overall Study||2
8102572|NCT03201419|19971015|P2|NOT COMPLETED|Overall Study||3
8102573|NCT03201419|19971016|P1|NOT COMPLETED|Overall Study||8
8102574|NCT03201419|19971008|P9|COMPLETED|Overall Study||15
8102575|NCT03201419|19971009|P8|COMPLETED|Overall Study||25
8102576|NCT03201419|19971010|P7|COMPLETED|Overall Study||81
8102577|NCT03201419|19971011|P6|COMPLETED|Overall Study||33
8102578|NCT03201419|19971012|P5|COMPLETED|Overall Study||12
8102579|NCT03201419|19971013|P4|COMPLETED|Overall Study||14
8102580|NCT03201419|19971014|P3|COMPLETED|Overall Study||22
8102581|NCT03201419|19971015|P2|COMPLETED|Overall Study||24
8102582|NCT03201419|19971016|P1|COMPLETED|Overall Study||52
8102583|NCT03201419|19971008|P9|STARTED|Overall Study||17
8102584|NCT03201419|19971009|P8|STARTED|Overall Study||26
8102585|NCT03201419|19971010|P7|STARTED|Overall Study||87
8102586|NCT03201419|19971011|P6|STARTED|Overall Study||34
8102587|NCT03201419|19971012|P5|STARTED|Overall Study||13
8102588|NCT03201419|19971013|P4|STARTED|Overall Study||14
8102589|NCT03201419|19971014|P3|STARTED|Overall Study||24
8102590|NCT03201419|19971015|P2|STARTED|Overall Study||27
8102591|NCT03201419|19971016|P1|STARTED|Overall Study||60
8102592|NCT03200925|19971352|P2|NOT COMPLETED|Overall Study||0
8102593|NCT03200925|19971353|P1|NOT COMPLETED|Overall Study||0
8102594|NCT03200925|19971352|P2|COMPLETED|Overall Study||120
8102595|NCT03200925|19971353|P1|COMPLETED|Overall Study||120
8102596|NCT03200925|19971352|P2|STARTED|Overall Study||120
8102597|NCT03200925|19971353|P1|STARTED|Overall Study||120
8102598|NCT03200912|19971366|P3|NOT COMPLETED|Overall Study||4
8102599|NCT03200912|19971367|P2|NOT COMPLETED|Overall Study||3
8102600|NCT03200912|19971368|P1|NOT COMPLETED|Overall Study||4
8102601|NCT03200912|19971366|P3|COMPLETED|Overall Study||164
8102602|NCT03200912|19971367|P2|COMPLETED|Overall Study||166
8102603|NCT03200912|19971368|P1|COMPLETED|Overall Study||166
8102604|NCT03200912|19971366|P3|STARTED|Overall Study||168
8102605|NCT03200912|19971367|P2|STARTED|Overall Study||169
8102606|NCT03200912|19971368|P1|STARTED|Overall Study||170
8102607|NCT03200860|19971378|P2|NOT COMPLETED|Overall Study||0
8102608|NCT03200860|19971379|P1|NOT COMPLETED|Overall Study||1
8102609|NCT03200860|19971378|P2|COMPLETED|Overall Study||39
8102610|NCT03200860|19971379|P1|COMPLETED|Overall Study||40
8102611|NCT03200860|19971378|P2|STARTED|Overall Study||39
8102612|NCT03200860|19971379|P1|STARTED|Overall Study||41
8102613|NCT03200535|19971403|P4|NOT COMPLETED|Overall Study||0
8102614|NCT03200535|19971404|P3|NOT COMPLETED|Overall Study||0
8102615|NCT03200535|19971405|P2|NOT COMPLETED|Overall Study||0
8102616|NCT03200535|19971406|P1|NOT COMPLETED|Overall Study||0
8102617|NCT03200535|19971403|P4|COMPLETED|Overall Study||1000
8102618|NCT03200535|19971404|P3|COMPLETED|Overall Study||1862
8102619|NCT03200535|19971405|P2|COMPLETED|Overall Study||1863
8102620|NCT03200535|19971406|P1|COMPLETED|Overall Study||1863
8102621|NCT03200535|19971403|P4|STARTED|Overall Study||1000
8102622|NCT03200535|19971404|P3|STARTED|Overall Study||1862
8102623|NCT03200535|19971405|P2|STARTED|Overall Study||1863
8102624|NCT03200535|19971406|P1|STARTED|Overall Study||1863
8102625|NCT03199911|19971422|P2|NOT COMPLETED|Overall Study||6
8102626|NCT03199911|19971423|P1|NOT COMPLETED|Overall Study||7
8102627|NCT03199911|19971422|P2|COMPLETED|Overall Study||187
8102628|NCT03199911|19971423|P1|COMPLETED|Overall Study||201
8102629|NCT03199911|19971422|P2|Primary Outcome Analyzed|Overall Study||187
8102630|NCT03199911|19971423|P1|Primary Outcome Analyzed|Overall Study||201
8102631|NCT03199911|19971422|P2|Lost to Follow-up|Overall Study||5
8102632|NCT03199911|19971423|P1|Lost to Follow-up|Overall Study||5
8102633|NCT03199911|19971422|P2|Received Allocated Treatment|Overall Study||192
8102634|NCT03199911|19971423|P1|Received Allocated Treatment|Overall Study||206
8102635|NCT03199911|19971422|P2|Did Not Proceed With Surgery|Overall Study||1
8102636|NCT03199911|19971423|P1|Did Not Proceed With Surgery|Overall Study||2
8102637|NCT03199911|19971422|P2|STARTED|Overall Study||193
8102638|NCT03199911|19971423|P1|STARTED|Overall Study||208
8102639|NCT03199872|19971435|P1|NOT COMPLETED|Overall Study||0
8102640|NCT03199872|19971435|P1|COMPLETED|Overall Study||22
8102641|NCT03199872|19971435|P1|STARTED|Overall Study||22
8102642|NCT03199079|19971442|P2|NOT COMPLETED|Overall Study||0
8102643|NCT03199079|19971443|P1|NOT COMPLETED|Overall Study||0
8102644|NCT03199079|19971442|P2|COMPLETED|Overall Study||10
8102645|NCT03199079|19971443|P1|COMPLETED|Overall Study||10
8102646|NCT03199079|19971442|P2|STARTED|Overall Study||10
8102647|NCT03199079|19971443|P1|STARTED|Overall Study||10
8102648|NCT03198884|19971451|P1|NOT COMPLETED|Overall Study||0
8102649|NCT03198884|19971451|P1|COMPLETED|Overall Study||20
8102650|NCT03198884|19971451|P1|STARTED|Overall Study||20
8102651|NCT03198767|19971474|P7|NOT COMPLETED|Overall Study||0
8102652|NCT03198767|19971475|P6|NOT COMPLETED|Overall Study||0
8102653|NCT03198767|19971476|P5|NOT COMPLETED|Overall Study||0
8102654|NCT03198767|19971477|P4|NOT COMPLETED|Overall Study||6
8102655|NCT03198767|19971478|P3|NOT COMPLETED|Overall Study||0
8102656|NCT03198767|19971479|P2|NOT COMPLETED|Overall Study||0
8102657|NCT03198767|19971480|P1|NOT COMPLETED|Overall Study||0
8102658|NCT03198767|19971474|P7|COMPLETED|Overall Study||8
8102659|NCT03198767|19971475|P6|COMPLETED|Overall Study||8
8102660|NCT03198767|19971476|P5|COMPLETED|Overall Study||8
8102661|NCT03198767|19971477|P4|COMPLETED|Overall Study||0
8102662|NCT03198767|19971478|P3|COMPLETED|Overall Study||8
8102663|NCT03198767|19971479|P2|COMPLETED|Overall Study||8
8102664|NCT03198767|19971480|P1|COMPLETED|Overall Study||8
8102665|NCT03198767|19971474|P7|STARTED|Overall Study||8
8102666|NCT03198767|19971475|P6|STARTED|Overall Study||8
8102667|NCT03198767|19971476|P5|STARTED|Overall Study||8
8102668|NCT03198767|19971477|P4|STARTED|Overall Study||6
8102669|NCT03198767|19971478|P3|STARTED|Overall Study||8
8102670|NCT03198767|19971479|P2|STARTED|Overall Study||8
8102671|NCT03198767|19971480|P1|STARTED|Overall Study||8
8102672|NCT03198754|19971521|P2|NOT COMPLETED|Overall Study||8
8102673|NCT03198754|19971522|P1|NOT COMPLETED|Overall Study||11
8102674|NCT03198754|19971521|P2|COMPLETED|Overall Study||27
8102675|NCT03198754|19971522|P1|COMPLETED|Overall Study||27
8102676|NCT03198754|19971521|P2|STARTED|Overall Study||35
8102677|NCT03198754|19971522|P1|STARTED|Overall Study||38
8102678|NCT03198520|19971560|P1|NOT COMPLETED|Overall Study||6
8102679|NCT03198520|19971560|P1|COMPLETED|Overall Study||40
8102680|NCT03198520|19971560|P1|STARTED|Overall Study||46
8102681|NCT03198507|19971583|P2|NOT COMPLETED|Overall Study||0
8102682|NCT03198507|19971584|P1|NOT COMPLETED|Overall Study||1
8102683|NCT03198507|19971583|P2|COMPLETED|Overall Study||227
8102684|NCT03198507|19971584|P1|COMPLETED|Overall Study||227
8102685|NCT03198507|19971583|P2|STARTED|Overall Study||227
8102686|NCT03198507|19971584|P1|STARTED|Overall Study||228
8102687|NCT03198000|19971599|P3|NOT COMPLETED|Overall Study||0
8102688|NCT03198000|19971600|P2|NOT COMPLETED|Overall Study||0
8102689|NCT03198000|19971601|P1|NOT COMPLETED|Overall Study||0
8102690|NCT03198000|19971599|P3|COMPLETED|Overall Study||41
8102691|NCT03198000|19971600|P2|COMPLETED|Overall Study||38
8102692|NCT03198000|19971601|P1|COMPLETED|Overall Study||41
8102693|NCT03198000|19971599|P3|STARTED|Overall Study||41
8102694|NCT03198000|19971600|P2|STARTED|Overall Study||38
8102695|NCT03198000|19971601|P1|STARTED|Overall Study||41
8102696|NCT03197883|19971710|P2|NOT COMPLETED|Overall Study||6
8102697|NCT03197883|19971711|P1|NOT COMPLETED|Overall Study||3
8102698|NCT03197883|19971710|P2|COMPLETED|Overall Study||44
8102699|NCT03197883|19971711|P1|COMPLETED|Overall Study||47
8102700|NCT03197883|19971710|P2|STARTED|Overall Study||50
8102701|NCT03197883|19971711|P1|STARTED|Overall Study||50
8102702|NCT03197558|19971741|P1|NOT COMPLETED|Overall Study||1
8102703|NCT03197558|19971741|P1|COMPLETED|Overall Study||29
8102704|NCT03197558|19971741|P1|STARTED|Overall Study||30
8102705|NCT03197376|19971749|P4|NOT COMPLETED|Immune Persistence Phase||5
8102706|NCT03197376|19971750|P3|NOT COMPLETED|Immune Persistence Phase||5
8102707|NCT03197376|19971751|P2|NOT COMPLETED|Immune Persistence Phase||4
8102708|NCT03197376|19971752|P1|NOT COMPLETED|Immune Persistence Phase||5
8102709|NCT03197376|19971749|P4|COMPLETED|Immune Persistence Phase||190
8102710|NCT03197376|19971750|P3|COMPLETED|Immune Persistence Phase||123
8102711|NCT03197376|19971751|P2|COMPLETED|Immune Persistence Phase||129
8102712|NCT03197376|19971752|P1|COMPLETED|Immune Persistence Phase||127
8102713|NCT03197376|19971749|P4|STARTED|Immune Persistence Phase||195
8102714|NCT03197376|19971750|P3|STARTED|Immune Persistence Phase||128
8102715|NCT03197376|19971751|P2|STARTED|Immune Persistence Phase||133
8102716|NCT03197376|19971752|P1|STARTED|Immune Persistence Phase||132
8102717|NCT03197376|19971749|P4|NOT COMPLETED|Primary and Booster Phase||25
8102718|NCT03197376|19971750|P3|NOT COMPLETED|Primary and Booster Phase||20
8102719|NCT03197376|19971751|P2|NOT COMPLETED|Primary and Booster Phase||13
8102720|NCT03197376|19971752|P1|NOT COMPLETED|Primary and Booster Phase||15
8102721|NCT03197376|19971749|P4|COMPLETED|Primary and Booster Phase||722
8102722|NCT03197376|19971750|P3|COMPLETED|Primary and Booster Phase||480
8102723|NCT03197376|19971751|P2|COMPLETED|Primary and Booster Phase||488
8102724|NCT03197376|19971752|P1|COMPLETED|Primary and Booster Phase||487
8102725|NCT03197376|19971749|P4|Received Booster Vaccine|Primary and Booster Phase||213
8102726|NCT03197376|19971750|P3|Received Booster Vaccine|Primary and Booster Phase||139
8102727|NCT03197376|19971751|P2|Received Booster Vaccine|Primary and Booster Phase||144
8102728|NCT03197376|19971752|P1|Received Booster Vaccine|Primary and Booster Phase||145
8102729|NCT03197376|19971749|P4|Booster Cohort|Primary and Booster Phase||224
8102730|NCT03197376|19971750|P3|Booster Cohort|Primary and Booster Phase||150
8102731|NCT03197376|19971751|P2|Booster Cohort|Primary and Booster Phase||151
8102732|NCT03197376|19971752|P1|Booster Cohort|Primary and Booster Phase||150
8102733|NCT03197376|19971749|P4|Primary Reactogenicity Cohort|Primary and Booster Phase||364
8102734|NCT03197376|19971750|P3|Primary Reactogenicity Cohort|Primary and Booster Phase||257
8102735|NCT03197376|19971751|P2|Primary Reactogenicity Cohort|Primary and Booster Phase||243
8102736|NCT03197376|19971752|P1|Primary Reactogenicity Cohort|Primary and Booster Phase||251
8102737|NCT03197376|19971749|P4|Vaccinated-Dose 3|Primary and Booster Phase||731
8102738|NCT03197376|19971750|P3|Vaccinated-Dose 3|Primary and Booster Phase||490
8102739|NCT03197376|19971751|P2|Vaccinated-Dose 3|Primary and Booster Phase||493
8102740|NCT03197376|19971752|P1|Vaccinated-Dose 3|Primary and Booster Phase||492
8102741|NCT03197376|19971749|P4|Vaccinated-Dose 2|Primary and Booster Phase||738
8102742|NCT03197376|19971750|P3|Vaccinated-Dose 2|Primary and Booster Phase||491
8102743|NCT03197376|19971751|P2|Vaccinated-Dose 2|Primary and Booster Phase||495
8102744|NCT03197376|19971752|P1|Vaccinated-Dose 2|Primary and Booster Phase||495
8102745|NCT03197376|19971749|P4|Vaccinated-Dose 1|Primary and Booster Phase||747
8102746|NCT03197376|19971750|P3|Vaccinated-Dose 1|Primary and Booster Phase||500
8102747|NCT03197376|19971751|P2|Vaccinated-Dose 1|Primary and Booster Phase||501
8102748|NCT03197376|19971752|P1|Vaccinated-Dose 1|Primary and Booster Phase||502
8102749|NCT03197376|19971749|P4|STARTED|Primary and Booster Phase||747
8102750|NCT03197376|19971750|P3|STARTED|Primary and Booster Phase||500
8102751|NCT03197376|19971751|P2|STARTED|Primary and Booster Phase||501
8102752|NCT03197376|19971752|P1|STARTED|Primary and Booster Phase||502
8102756|NCT03196635|19971826|P1|NOT COMPLETED|Overall Study||1
8102757|NCT03196635|19971826|P1|COMPLETED|Overall Study||30
8102758|NCT03196635|19971826|P1|STARTED|Overall Study||31
8102759|NCT03196505|19971846|P2|NOT COMPLETED|Overall Study||26
8102760|NCT03196505|19971847|P1|NOT COMPLETED|Overall Study||26
8102761|NCT03196505|19971846|P2|COMPLETED|Overall Study||90
8102762|NCT03196505|19971847|P1|COMPLETED|Overall Study||89
8102763|NCT03196505|19971846|P2|STARTED|Overall Study||116
8102764|NCT03196505|19971847|P1|STARTED|Overall Study||115
8102765|NCT03196349|19971858|P3|NOT COMPLETED|Overall Study||13
8102766|NCT03196349|19971859|P2|NOT COMPLETED|Overall Study||14
8102767|NCT03196349|19971860|P1|NOT COMPLETED|Overall Study||17
8102768|NCT03196349|19971858|P3|COMPLETED|Overall Study||0
8102769|NCT03196349|19971859|P2|COMPLETED|Overall Study||0
8102770|NCT03196349|19971860|P1|COMPLETED|Overall Study||0
8102771|NCT03196349|19971858|P3|STARTED|Overall Study||13
8102772|NCT03196349|19971859|P2|STARTED|Overall Study||14
8102773|NCT03196349|19971860|P1|STARTED|Overall Study||17
8102774|NCT03196232|19971886|P1|NOT COMPLETED|Overall Study||0
8102775|NCT03196232|19971886|P1|COMPLETED|Overall Study||3
8102776|NCT03196232|19971886|P1|STARTED|Overall Study||3
8102777|NCT03196193|19971897|P2|NOT COMPLETED|Overall Study||0
8102778|NCT03196193|19971898|P1|NOT COMPLETED|Overall Study||3
8102779|NCT03196193|19971897|P2|COMPLETED|Overall Study||119
8102780|NCT03196193|19971898|P1|COMPLETED|Overall Study||118
8102781|NCT03196193|19971897|P2|STARTED|Overall Study||119
8102782|NCT03196193|19971898|P1|STARTED|Overall Study||121
8102783|NCT03195517|19971910|P1|NOT COMPLETED|Overall Study||0
8102784|NCT03195517|19971910|P1|COMPLETED|Overall Study||33
8102785|NCT03195517|19971910|P1|STARTED|Overall Study||33
8102786|NCT03195010|19971925|P2|NOT COMPLETED|Overall Study||0
8102787|NCT03195010|19971926|P1|NOT COMPLETED|Overall Study||0
8102788|NCT03195010|19971925|P2|COMPLETED|Overall Study||2
8102789|NCT03195010|19971926|P1|COMPLETED|Overall Study||2
8102790|NCT03195010|19971925|P2|STARTED|Overall Study||2
8102791|NCT03195010|19971926|P1|STARTED|Overall Study||2
8102792|NCT03194776|19971953|P2|NOT COMPLETED|Overall Study||0
8102793|NCT03194776|19971954|P1|NOT COMPLETED|Overall Study||0
8102794|NCT03194776|19971953|P2|COMPLETED|Overall Study||23
8102795|NCT03194776|19971954|P1|COMPLETED|Overall Study||23
8102796|NCT03194776|19971953|P2|STARTED|Overall Study||23
8102797|NCT03194776|19971954|P1|STARTED|Overall Study||23
8102798|NCT03194698|19971972|P2|NOT COMPLETED|Overall Study||0
8102799|NCT03194698|19971973|P1|NOT COMPLETED|Overall Study||0
8102800|NCT03194698|19971972|P2|COMPLETED|Overall Study||10
8102801|NCT03194698|19971973|P1|COMPLETED|Overall Study||10
8102802|NCT03194698|19971972|P2|STARTED|Overall Study||10
8102803|NCT03194698|19971973|P1|STARTED|Overall Study||10
8102804|NCT03194503|19971985|P2|NOT COMPLETED|Overall Study||0
8102805|NCT03194503|19971986|P1|NOT COMPLETED|Overall Study||0
8102806|NCT03194503|19971985|P2|COMPLETED|Overall Study||1054
8102807|NCT03194503|19971986|P1|COMPLETED|Overall Study||458
8102808|NCT03194503|19971985|P2|STARTED|Overall Study||1054
8102809|NCT03194503|19971986|P1|STARTED|Overall Study||458
8102810|NCT03194490|19971996|P2|NOT COMPLETED|Overall Study||3
8102811|NCT03194490|19971997|P1|NOT COMPLETED|Overall Study||2
8102812|NCT03194490|19971996|P2|COMPLETED|Overall Study||20
8102813|NCT03194490|19971997|P1|COMPLETED|Overall Study||18
8102814|NCT03194490|19971996|P2|STARTED|Overall Study||23
8102815|NCT03194490|19971997|P1|STARTED|Overall Study||20
8102816|NCT03194464|19972039|P1|NOT COMPLETED|Overall Study||2
8102817|NCT03194464|19972039|P1|COMPLETED|Overall Study||13
8102818|NCT03194464|19972039|P1|STARTED|Overall Study||15
8102819|NCT03194373|19972046|P1|NOT COMPLETED|Overall Study||2
8102820|NCT03194373|19972046|P1|COMPLETED|Overall Study||18
8102821|NCT03194373|19972046|P1|STARTED|Overall Study||20
8102822|NCT03194334|19972053|P3|NOT COMPLETED|3-6 Months||0
8102823|NCT03194334|19972054|P2|NOT COMPLETED|3-6 Months||0
8102824|NCT03194334|19972055|P1|NOT COMPLETED|3-6 Months||0
8102825|NCT03194334|19972053|P3|COMPLETED|3-6 Months||14
8102826|NCT03194334|19972054|P2|COMPLETED|3-6 Months||15
8102827|NCT03194334|19972055|P1|COMPLETED|3-6 Months||10
8102828|NCT03194334|19972053|P3|STARTED|3-6 Months||14
8102829|NCT03194334|19972054|P2|STARTED|3-6 Months||15
8102830|NCT03194334|19972055|P1|STARTED|3-6 Months||10
8102831|NCT03194334|19972053|P3|NOT COMPLETED|0-3 Months||1
8102832|NCT03194334|19972054|P2|NOT COMPLETED|0-3 Months||0
8102833|NCT03194334|19972055|P1|NOT COMPLETED|0-3 Months||0
8102834|NCT03194334|19972053|P3|COMPLETED|0-3 Months||14
8102835|NCT03194334|19972054|P2|COMPLETED|0-3 Months||15
8102836|NCT03194334|19972055|P1|COMPLETED|0-3 Months||10
8102837|NCT03194334|19972053|P3|STARTED|0-3 Months||15
8102838|NCT03194334|19972054|P2|STARTED|0-3 Months||15
8102839|NCT03194334|19972055|P1|STARTED|0-3 Months||10
8102840|NCT03194217|19972130|P4|NOT COMPLETED|Overall Study||4
8102841|NCT03194217|19972131|P3|NOT COMPLETED|Overall Study||4
8102842|NCT03194217|19972132|P2|NOT COMPLETED|Overall Study||3
8102843|NCT03194217|19972133|P1|NOT COMPLETED|Overall Study||0
8102844|NCT03194217|19972130|P4|COMPLETED|Overall Study||60
8102845|NCT03194217|19972131|P3|COMPLETED|Overall Study||56
8102846|NCT03194217|19972132|P2|COMPLETED|Overall Study||57
8102847|NCT03194217|19972133|P1|COMPLETED|Overall Study||60
8102848|NCT03194217|19972130|P4|STARTED|Overall Study||64
8102849|NCT03194217|19972131|P3|STARTED|Overall Study||60
8102850|NCT03194217|19972132|P2|STARTED|Overall Study||60
8102851|NCT03194217|19972133|P1|STARTED|Overall Study||60
8102852|NCT03193593|19972150|P7|NOT COMPLETED|Overall Study||4
8102853|NCT03193593|19972151|P6|NOT COMPLETED|Overall Study||3
8102854|NCT03193593|19972152|P5|NOT COMPLETED|Overall Study||1
8102855|NCT03193593|19972153|P4|NOT COMPLETED|Overall Study||0
8102856|NCT03193593|19972154|P3|NOT COMPLETED|Overall Study||1
8102857|NCT03193593|19972155|P2|NOT COMPLETED|Overall Study||1
8102858|NCT03193593|19972156|P1|NOT COMPLETED|Overall Study||4
8102859|NCT03193593|19972150|P7|COMPLETED|Overall Study||8
8102860|NCT03193593|19972151|P6|COMPLETED|Overall Study||13
8102861|NCT03193593|19972152|P5|COMPLETED|Overall Study||7
8102862|NCT03193593|19972153|P4|COMPLETED|Overall Study||4
8102863|NCT03193593|19972154|P3|COMPLETED|Overall Study||3
8102864|NCT03193593|19972155|P2|COMPLETED|Overall Study||3
8102865|NCT03193593|19972156|P1|COMPLETED|Overall Study||14
8102866|NCT03193593|19972150|P7|STARTED|Overall Study||12
8102867|NCT03193593|19972151|P6|STARTED|Overall Study||16
8102868|NCT03193593|19972152|P5|STARTED|Overall Study||8
8102869|NCT03193593|19972153|P4|STARTED|Overall Study||4
8102870|NCT03193593|19972154|P3|STARTED|Overall Study||4
8102871|NCT03193593|19972155|P2|STARTED|Overall Study||4
8102872|NCT03193593|19972156|P1|STARTED|Overall Study||18
8102873|NCT03193047|19972174|P2|NOT COMPLETED|Overall Study||0
8102874|NCT03193047|19972175|P1|NOT COMPLETED|Overall Study||2
8102875|NCT03193047|19972174|P2|COMPLETED|Overall Study||28
8102876|NCT03193047|19972175|P1|COMPLETED|Overall Study||29
8102877|NCT03193047|19972174|P2|STARTED|Overall Study||28
8102878|NCT03193047|19972175|P1|STARTED|Overall Study||31
8102879|NCT03193021|19972195|P2|NOT COMPLETED|Overall Study||1
8102880|NCT03193021|19972196|P1|NOT COMPLETED|Overall Study||1
8102881|NCT03193021|19972195|P2|COMPLETED|Overall Study||103
8102882|NCT03193021|19972196|P1|COMPLETED|Overall Study||99
8102883|NCT03193021|19972195|P2|STARTED|Overall Study||104
8102884|NCT03193021|19972196|P1|STARTED|Overall Study||100
8102885|NCT03192904|19972221|P2|NOT COMPLETED|Overall Study||2
8102886|NCT03192904|19972222|P1|NOT COMPLETED|Overall Study||3
8102887|NCT03192904|19972221|P2|COMPLETED|Overall Study||33
8102888|NCT03192904|19972222|P1|COMPLETED|Overall Study||32
8102889|NCT03192904|19972221|P2|STARTED|Overall Study||35
8102890|NCT03192904|19972222|P1|STARTED|Overall Study||35
8102891|NCT03192826|19972259|P3|NOT COMPLETED|Overall Study||0
8102892|NCT03192826|19972260|P2|NOT COMPLETED|Overall Study||0
8102893|NCT03192826|19972261|P1|NOT COMPLETED|Overall Study||0
8102894|NCT03192826|19972259|P3|COMPLETED|Overall Study||25
8102895|NCT03192826|19972260|P2|COMPLETED|Overall Study||27
8102896|NCT03192826|19972261|P1|COMPLETED|Overall Study||27
8102897|NCT03192826|19972259|P3|STARTED|Overall Study||25
8102898|NCT03192826|19972260|P2|STARTED|Overall Study||27
8102899|NCT03192826|19972261|P1|STARTED|Overall Study||27
8102900|NCT03192488|19972278|P6|NOT COMPLETED|Third Intervention (d1)||0
8102901|NCT03192488|19972279|P5|NOT COMPLETED|Third Intervention (d1)||1
8102902|NCT03192488|19972280|P4|NOT COMPLETED|Third Intervention (d1)||0
8102903|NCT03192488|19972281|P3|NOT COMPLETED|Third Intervention (d1)||0
8102904|NCT03192488|19972282|P2|NOT COMPLETED|Third Intervention (d1)||0
8102905|NCT03192488|19972283|P1|NOT COMPLETED|Third Intervention (d1)||0
8102906|NCT03192488|19972278|P6|COMPLETED|Third Intervention (d1)||0
8102907|NCT03192488|19972279|P5|COMPLETED|Third Intervention (d1)||0
8102908|NCT03192488|19972280|P4|COMPLETED|Third Intervention (d1)||1
8102909|NCT03192488|19972281|P3|COMPLETED|Third Intervention (d1)||1
8102910|NCT03192488|19972282|P2|COMPLETED|Third Intervention (d1)||5
8102911|NCT03192488|19972283|P1|COMPLETED|Third Intervention (d1)||1
8102912|NCT03192488|19972278|P6|STARTED|Third Intervention (d1)||0
8102913|NCT03192488|19972279|P5|STARTED|Third Intervention (d1)||1
8102914|NCT03192488|19972280|P4|STARTED|Third Intervention (d1)||1
8102915|NCT03192488|19972281|P3|STARTED|Third Intervention (d1)||1
8102916|NCT03192488|19972282|P2|STARTED|Third Intervention (d1)||5
8102917|NCT03192488|19972283|P1|STARTED|Third Intervention (d1)||1
8102918|NCT03192488|19972278|P6|NOT COMPLETED|Second Washout (>6d)||0
8102919|NCT03192488|19972279|P5|NOT COMPLETED|Second Washout (>6d)||0
8102920|NCT03192488|19972280|P4|NOT COMPLETED|Second Washout (>6d)||0
8102921|NCT03192488|19972281|P3|NOT COMPLETED|Second Washout (>6d)||0
8102922|NCT03192488|19972282|P2|NOT COMPLETED|Second Washout (>6d)||0
8102923|NCT03192488|19972283|P1|NOT COMPLETED|Second Washout (>6d)||0
8102924|NCT03192488|19972278|P6|COMPLETED|Second Washout (>6d)||0
8102925|NCT03192488|19972279|P5|COMPLETED|Second Washout (>6d)||1
8102926|NCT03192488|19972280|P4|COMPLETED|Second Washout (>6d)||1
8102927|NCT03192488|19972281|P3|COMPLETED|Second Washout (>6d)||1
8102928|NCT03192488|19972282|P2|COMPLETED|Second Washout (>6d)||5
8102929|NCT03192488|19972283|P1|COMPLETED|Second Washout (>6d)||1
8102930|NCT03192488|19972278|P6|STARTED|Second Washout (>6d)||0
8102931|NCT03192488|19972279|P5|STARTED|Second Washout (>6d)||1
8102932|NCT03192488|19972280|P4|STARTED|Second Washout (>6d)||1
8102933|NCT03192488|19972281|P3|STARTED|Second Washout (>6d)||1
8102934|NCT03192488|19972282|P2|STARTED|Second Washout (>6d)||5
8102935|NCT03192488|19972283|P1|STARTED|Second Washout (>6d)||1
8102936|NCT03192488|19972278|P6|NOT COMPLETED|Second Intervention (d1)||0
8102937|NCT03192488|19972279|P5|NOT COMPLETED|Second Intervention (d1)||0
8102938|NCT03192488|19972280|P4|NOT COMPLETED|Second Intervention (d1)||0
8102939|NCT03192488|19972281|P3|NOT COMPLETED|Second Intervention (d1)||0
8102940|NCT03192488|19972282|P2|NOT COMPLETED|Second Intervention (d1)||0
8102941|NCT03192488|19972283|P1|NOT COMPLETED|Second Intervention (d1)||0
8102942|NCT03192488|19972278|P6|COMPLETED|Second Intervention (d1)||0
8102943|NCT03192488|19972279|P5|COMPLETED|Second Intervention (d1)||1
8102944|NCT03192488|19972280|P4|COMPLETED|Second Intervention (d1)||1
8102945|NCT03192488|19972281|P3|COMPLETED|Second Intervention (d1)||1
8102946|NCT03192488|19972282|P2|COMPLETED|Second Intervention (d1)||5
8102947|NCT03192488|19972283|P1|COMPLETED|Second Intervention (d1)||1
8102948|NCT03192488|19972278|P6|STARTED|Second Intervention (d1)||0
8102949|NCT03192488|19972279|P5|STARTED|Second Intervention (d1)||1
8102950|NCT03192488|19972280|P4|STARTED|Second Intervention (d1)||1
8102951|NCT03192488|19972281|P3|STARTED|Second Intervention (d1)||1
8102952|NCT03192488|19972282|P2|STARTED|Second Intervention (d1)||5
8102953|NCT03192488|19972283|P1|STARTED|Second Intervention (d1)||1
8102954|NCT03192488|19972278|P6|NOT COMPLETED|First Washout (>6d)||1
8102955|NCT03192488|19972279|P5|NOT COMPLETED|First Washout (>6d)||0
8102956|NCT03192488|19972280|P4|NOT COMPLETED|First Washout (>6d)||0
8102957|NCT03192488|19972281|P3|NOT COMPLETED|First Washout (>6d)||1
8102958|NCT03192488|19972282|P2|NOT COMPLETED|First Washout (>6d)||0
8102959|NCT03192488|19972283|P1|NOT COMPLETED|First Washout (>6d)||0
8102960|NCT03192488|19972278|P6|COMPLETED|First Washout (>6d)||0
8102961|NCT03192488|19972279|P5|COMPLETED|First Washout (>6d)||1
8102962|NCT03192488|19972280|P4|COMPLETED|First Washout (>6d)||1
8102963|NCT03192488|19972281|P3|COMPLETED|First Washout (>6d)||1
8102964|NCT03192488|19972282|P2|COMPLETED|First Washout (>6d)||5
8102965|NCT03192488|19972283|P1|COMPLETED|First Washout (>6d)||1
8102966|NCT03192488|19972278|P6|STARTED|First Washout (>6d)||1
8102967|NCT03192488|19972279|P5|STARTED|First Washout (>6d)||1
8102968|NCT03192488|19972280|P4|STARTED|First Washout (>6d)||1
8102969|NCT03192488|19972281|P3|STARTED|First Washout (>6d)||2
8102970|NCT03192488|19972282|P2|STARTED|First Washout (>6d)||5
8102971|NCT03192488|19972283|P1|STARTED|First Washout (>6d)||1
8102972|NCT03192488|19972278|P6|NOT COMPLETED|First Intervention (d1)||0
8102973|NCT03192488|19972279|P5|NOT COMPLETED|First Intervention (d1)||0
8102974|NCT03192488|19972280|P4|NOT COMPLETED|First Intervention (d1)||0
8102975|NCT03192488|19972281|P3|NOT COMPLETED|First Intervention (d1)||0
8102976|NCT03192488|19972282|P2|NOT COMPLETED|First Intervention (d1)||0
8102977|NCT03192488|19972283|P1|NOT COMPLETED|First Intervention (d1)||0
8102978|NCT03192488|19972278|P6|COMPLETED|First Intervention (d1)||1
8102979|NCT03192488|19972279|P5|COMPLETED|First Intervention (d1)||1
8102980|NCT03192488|19972280|P4|COMPLETED|First Intervention (d1)||1
8102981|NCT03192488|19972281|P3|COMPLETED|First Intervention (d1)||2
8102982|NCT03192488|19972282|P2|COMPLETED|First Intervention (d1)||5
8102983|NCT03192488|19972283|P1|COMPLETED|First Intervention (d1)||1
8102984|NCT03192488|19972278|P6|STARTED|First Intervention (d1)||1
8102985|NCT03192488|19972279|P5|STARTED|First Intervention (d1)||1
8102986|NCT03192488|19972280|P4|STARTED|First Intervention (d1)||1
8102987|NCT03192488|19972281|P3|STARTED|First Intervention (d1)||2
8102988|NCT03192488|19972282|P2|STARTED|First Intervention (d1)||5
8102989|NCT03192488|19972283|P1|STARTED|First Intervention (d1)||1
8102990|NCT03192475|19972299|P2|NOT COMPLETED|Overall Study||9
8102991|NCT03192475|19972300|P1|NOT COMPLETED|Overall Study||13
8102992|NCT03192475|19972299|P2|COMPLETED|Overall Study||151
8102993|NCT03192475|19972300|P1|COMPLETED|Overall Study||149
8102994|NCT03192475|19972299|P2|STARTED|Overall Study||160
8102995|NCT03192475|19972300|P1|STARTED|Overall Study||162
8102996|NCT03192306|19972336|P2|NOT COMPLETED|Overall Study||145
8102997|NCT03192306|19972337|P1|NOT COMPLETED|Overall Study||152
8102998|NCT03192306|19972336|P2|COMPLETED|Overall Study||79
8102999|NCT03192306|19972337|P1|COMPLETED|Overall Study||75
8103000|NCT03192306|19972336|P2|Modified Intent to Treat (MITT)|Overall Study||80
8103001|NCT03192306|19972337|P1|Modified Intent to Treat (MITT)|Overall Study||76
8103002|NCT03192306|19972336|P2|STARTED|Overall Study||224
8103003|NCT03192306|19972337|P1|STARTED|Overall Study||227
8103004|NCT03192150|19972357|P2|NOT COMPLETED|Overall Study||54
8103005|NCT03192150|19972358|P1|NOT COMPLETED|Overall Study||55
8103006|NCT03192150|19972357|P2|COMPLETED|Overall Study||29
8103007|NCT03192150|19972358|P1|COMPLETED|Overall Study||108
8103008|NCT03192150|19972357|P2|STARTED|Overall Study||83
8103009|NCT03192150|19972358|P1|STARTED|Overall Study||163
8103010|NCT03192137|19972368|P2|NOT COMPLETED|Overall Study||58
8103011|NCT03192137|19972369|P1|NOT COMPLETED|Overall Study||50
8103012|NCT03192137|19972368|P2|COMPLETED|Overall Study||29
8103013|NCT03192137|19972369|P1|COMPLETED|Overall Study||123
8103014|NCT03192137|19972368|P2|STARTED|Overall Study||87
8103015|NCT03192137|19972369|P1|STARTED|Overall Study||173
8103016|NCT03191552|19972380|P3|NOT COMPLETED|Overall Study||0
8103017|NCT03191552|19972381|P2|NOT COMPLETED|Overall Study||1
8103018|NCT03191552|19972382|P1|NOT COMPLETED|Overall Study||1
8103019|NCT03191552|19972380|P3|COMPLETED|Overall Study||8
8103020|NCT03191552|19972381|P2|COMPLETED|Overall Study||8
8103021|NCT03191552|19972382|P1|COMPLETED|Overall Study||8
8103022|NCT03191552|19972380|P3|STARTED|Overall Study||8
8103023|NCT03191552|19972381|P2|STARTED|Overall Study||9
8103024|NCT03191552|19972382|P1|STARTED|Overall Study||9
8103025|NCT03191396|19972435|P2|NOT COMPLETED|Overall Study||5
8103026|NCT03191396|19972436|P1|NOT COMPLETED|Overall Study||3
8103027|NCT03191396|19972435|P2|COMPLETED|Overall Study||282
8103028|NCT03191396|19972436|P1|COMPLETED|Overall Study||287
8103029|NCT03191396|19972435|P2|STARTED|Overall Study||287
8103030|NCT03191396|19972436|P1|STARTED|Overall Study||290
8103031|NCT03190993|19972524|P2|NOT COMPLETED|Overall Study||0
8103032|NCT03190993|19972525|P1|NOT COMPLETED|Overall Study||0
8103033|NCT03190993|19972524|P2|COMPLETED|Overall Study||10
8103034|NCT03190993|19972525|P1|COMPLETED|Overall Study||10
8103035|NCT03190993|19972524|P2|STARTED|Overall Study||10
8103036|NCT03190993|19972525|P1|STARTED|Overall Study||10
8103037|NCT03190460|19972533|P2|NOT COMPLETED|Overall Study||18
8103038|NCT03190460|19972534|P1|NOT COMPLETED|Overall Study||37
8103039|NCT03190460|19972533|P2|COMPLETED|Overall Study||2
8103040|NCT03190460|19972534|P1|COMPLETED|Overall Study||3
8103041|NCT03190460|19972533|P2|STARTED|Overall Study||20
8103042|NCT03190460|19972534|P1|STARTED|Overall Study||40
8103043|NCT03190369|19972542|P2|NOT COMPLETED|Overall Study||8
8103044|NCT03190369|19972543|P1|NOT COMPLETED|Overall Study||1
8103045|NCT03190369|19972542|P2|COMPLETED|Overall Study||212
8103046|NCT03190369|19972543|P1|COMPLETED|Overall Study||219
8103047|NCT03190369|19972542|P2|Treated|Overall Study||218
8103048|NCT03190369|19972543|P1|Treated|Overall Study||220
8103049|NCT03190369|19972542|P2|STARTED|Overall Study||220
8103050|NCT03190369|19972543|P1|STARTED|Overall Study||220
8103051|NCT03190213|19972561|P1|NOT COMPLETED|Overall Study||0
8103052|NCT03190213|19972561|P1|COMPLETED|Overall Study||6
8103053|NCT03190213|19972561|P1|STARTED|Overall Study||6
8103054|NCT03190083|19972569|P1|NOT COMPLETED|Overall Study||0
8103055|NCT03190083|19972569|P1|COMPLETED|Overall Study||16
8103056|NCT03190083|19972569|P1|STARTED|Overall Study||16
8103057|NCT03190005|19972580|P7|NOT COMPLETED|Overall Study||0
8103058|NCT03190005|19972581|P6|NOT COMPLETED|Overall Study||0
8103059|NCT03190005|19972582|P5|NOT COMPLETED|Overall Study||0
8103060|NCT03190005|19972583|P4|NOT COMPLETED|Overall Study||0
8103061|NCT03190005|19972584|P3|NOT COMPLETED|Overall Study||0
8103062|NCT03190005|19972585|P2|NOT COMPLETED|Overall Study||0
8103063|NCT03190005|19972586|P1|NOT COMPLETED|Overall Study||0
8103064|NCT03190005|19972580|P7|COMPLETED|Overall Study||5
8103065|NCT03190005|19972581|P6|COMPLETED|Overall Study||5
8103066|NCT03190005|19972582|P5|COMPLETED|Overall Study||5
8103067|NCT03190005|19972583|P4|COMPLETED|Overall Study||5
8103068|NCT03190005|19972584|P3|COMPLETED|Overall Study||5
8103069|NCT03190005|19972585|P2|COMPLETED|Overall Study||5
8103070|NCT03190005|19972586|P1|COMPLETED|Overall Study||5
8103071|NCT03190005|19972580|P7|STARTED|Overall Study||5
8103072|NCT03190005|19972581|P6|STARTED|Overall Study||5
8103073|NCT03190005|19972582|P5|STARTED|Overall Study||5
8103074|NCT03190005|19972583|P4|STARTED|Overall Study||5
8103075|NCT03190005|19972584|P3|STARTED|Overall Study||5
8103076|NCT03190005|19972585|P2|STARTED|Overall Study||5
8103077|NCT03190005|19972586|P1|STARTED|Overall Study||5
8103078|NCT03189745|19972604|P2|NOT COMPLETED|Overall Study||1
8103079|NCT03189745|19972605|P1|NOT COMPLETED|Overall Study||1
8103080|NCT03189745|19972604|P2|COMPLETED|Overall Study||58
8103081|NCT03189745|19972605|P1|COMPLETED|Overall Study||169
8103082|NCT03189745|19972604|P2|STARTED|Overall Study||59
8103083|NCT03189745|19972605|P1|STARTED|Overall Study||170
8103084|NCT03189589|19972633|P2|NOT COMPLETED|Overall Study||0
8103085|NCT03189589|19972634|P1|NOT COMPLETED|Overall Study||0
8103086|NCT03189589|19972633|P2|COMPLETED|Overall Study||6
8103087|NCT03189589|19972634|P1|COMPLETED|Overall Study||6
8103088|NCT03189589|19972633|P2|STARTED|Overall Study||6
8103089|NCT03189589|19972634|P1|STARTED|Overall Study||6
8103090|NCT03189446|19972658|P1|NOT COMPLETED|Overall Study||5
8103091|NCT03189446|19972658|P1|COMPLETED|Overall Study||27
8103092|NCT03189446|19972658|P1|STARTED|Overall Study||32
8103093|NCT03189134|19972663|P1|NOT COMPLETED|Overall Study||0
8103094|NCT03189134|19972663|P1|COMPLETED|Overall Study||6
8103095|NCT03189134|19972663|P1|STARTED|Overall Study||6
8103096|NCT03188536|19972669|P1|NOT COMPLETED|Overall Study||6
8103097|NCT03188536|19972669|P1|COMPLETED|Overall Study||276
8103098|NCT03188536|19972669|P1|STARTED|Overall Study||282
8103099|NCT03188523|19972683|P4|NOT COMPLETED|Overall Study||0
8103100|NCT03188523|19972684|P3|NOT COMPLETED|Overall Study||0
8103101|NCT03188523|19972685|P2|NOT COMPLETED|Overall Study||0
8103102|NCT03188523|19972686|P1|NOT COMPLETED|Overall Study||0
8103103|NCT03188523|19972683|P4|COMPLETED|Overall Study||0
8103104|NCT03188523|19972684|P3|COMPLETED|Overall Study||0
8103105|NCT03188523|19972685|P2|COMPLETED|Overall Study||6
8103106|NCT03188523|19972686|P1|COMPLETED|Overall Study||6
8103107|NCT03188523|19972683|P4|STARTED|Overall Study||0
8103108|NCT03188523|19972684|P3|STARTED|Overall Study||0
8103109|NCT03188523|19972685|P2|STARTED|Overall Study||6
8103110|NCT03188523|19972686|P1|STARTED|Overall Study||6
8103111|NCT03188263|19972738|P2|NOT COMPLETED|Overall Study||0
8103112|NCT03188263|19972739|P1|NOT COMPLETED|Overall Study||4
8103113|NCT03188263|19972738|P2|COMPLETED|Overall Study||0
8103114|NCT03188263|19972739|P1|COMPLETED|Overall Study||6
8103115|NCT03188263|19972738|P2|STARTED|Overall Study||0
8103116|NCT03188263|19972739|P1|STARTED|Overall Study||10
8103117|NCT03188120|19972747|P1|NOT COMPLETED|Overall Study||47
8103118|NCT03188120|19972747|P1|COMPLETED|Overall Study||146
8103119|NCT03188120|19972747|P1|STARTED|Overall Study||193
8103120|NCT03188055|19972754|P6|NOT COMPLETED|Overall Study||0
8103121|NCT03188055|19972755|P5|NOT COMPLETED|Overall Study||0
8103122|NCT03188055|19972756|P4|NOT COMPLETED|Overall Study||12
8103123|NCT03188055|19972757|P3|NOT COMPLETED|Overall Study||19
8103124|NCT03188055|19972758|P2|NOT COMPLETED|Overall Study||19
8103125|NCT03188055|19972759|P1|NOT COMPLETED|Overall Study||0
8103126|NCT03188055|19972754|P6|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|0
8103127|NCT03188055|19972755|P5|COMPLETED|Overall Study||59
8103128|NCT03188055|19972756|P4|COMPLETED|Overall Study||26
8103129|NCT03188055|19972757|P3|COMPLETED|Overall Study||43
8103130|NCT03188055|19972758|P2|COMPLETED|Overall Study||29
8103131|NCT03188055|19972759|P1|COMPLETED|Overall Study||48
8103132|NCT03188055|19972754|P6|Family Survey 3|Overall Study||0
8103133|NCT03188055|19972755|P5|Family Survey 3|Overall Study||0
8103134|NCT03188055|19972756|P4|Family Survey 3|Overall Study||26
8103135|NCT03188055|19972757|P3|Family Survey 3|Overall Study||0
8103136|NCT03188055|19972758|P2|Family Survey 3|Overall Study||29
8103137|NCT03188055|19972759|P1|Family Survey 3|Overall Study||0
8103138|NCT03188055|19972754|P6|Family Survey 2|Overall Study||0
8103139|NCT03188055|19972755|P5|Family Survey 2|Overall Study||0
8103140|NCT03188055|19972756|P4|Family Survey 2|Overall Study||35
8103141|NCT03188055|19972757|P3|Family Survey 2|Overall Study||0
8103142|NCT03188055|19972758|P2|Family Survey 2|Overall Study||34
8103143|NCT03188055|19972759|P1|Family Survey 2|Overall Study||0
8103144|NCT03188055|19972754|P6|Family Survey 1|Overall Study||0
8103145|NCT03188055|19972755|P5|Family Survey 1|Overall Study||0
8103146|NCT03188055|19972756|P4|Family Survey 1|Overall Study||38
8103147|NCT03188055|19972757|P3|Family Survey 1|Overall Study||0
8103148|NCT03188055|19972758|P2|Family Survey 1|Overall Study||37
8103149|NCT03188055|19972759|P1|Family Survey 1|Overall Study||0
8103150|NCT03188055|19972754|P6|Nurse Survey 1|Overall Study||0
8103151|NCT03188055|19972755|P5|Nurse Survey 1|Overall Study||0
8103152|NCT03188055|19972756|P4|Nurse Survey 1|Overall Study||27
8103153|NCT03188055|19972757|P3|Nurse Survey 1|Overall Study||0
8103154|NCT03188055|19972758|P2|Nurse Survey 1|Overall Study||32
8103155|NCT03188055|19972759|P1|Nurse Survey 1|Overall Study||0
8103156|NCT03188055|19972754|P6|Patient Survey 1|Overall Study||0
8103157|NCT03188055|19972755|P5|Patient Survey 1|Overall Study||0
8103158|NCT03188055|19972756|P4|Patient Survey 1|Overall Study||13
8103159|NCT03188055|19972757|P3|Patient Survey 1|Overall Study||0
8103160|NCT03188055|19972758|P2|Patient Survey 1|Overall Study||16
8103161|NCT03188055|19972759|P1|Patient Survey 1|Overall Study||0
8103162|NCT03188055|19972754|P6|MDS Post-Intervention Survey Responses|Overall Study||134
8103163|NCT03188055|19972755|P5|MDS Post-Intervention Survey Responses|Overall Study||0
8103164|NCT03188055|19972756|P4|MDS Post-Intervention Survey Responses|Overall Study||0
8103165|NCT03188055|19972757|P3|MDS Post-Intervention Survey Responses|Overall Study||0
8103166|NCT03188055|19972758|P2|MDS Post-Intervention Survey Responses|Overall Study||0
8103167|NCT03188055|19972759|P1|MDS Post-Intervention Survey Responses|Overall Study||0
8103168|NCT03188055|19972754|P6|MDS Pre-Intervention Survey Responses|Overall Study||99
8103169|NCT03188055|19972755|P5|MDS Pre-Intervention Survey Responses|Overall Study||0
8103170|NCT03188055|19972756|P4|MDS Pre-Intervention Survey Responses|Overall Study||0
8103171|NCT03188055|19972757|P3|MDS Pre-Intervention Survey Responses|Overall Study||0
8103172|NCT03188055|19972758|P2|MDS Pre-Intervention Survey Responses|Overall Study||0
8103173|NCT03188055|19972759|P1|MDS Pre-Intervention Survey Responses|Overall Study||0
8103174|NCT03188055|19972754|P6|Patients Who Provided Self-Consent|Overall Study||0
8103175|NCT03188055|19972755|P5|Patients Who Provided Self-Consent|Overall Study||0
8103176|NCT03188055|19972756|P4|Patients Who Provided Self-Consent|Overall Study||19
8103177|NCT03188055|19972757|P3|Patients Who Provided Self-Consent|Overall Study||0
8103178|NCT03188055|19972758|P2|Patients Who Provided Self-Consent|Overall Study||24
8103179|NCT03188055|19972759|P1|Patients Who Provided Self-Consent|Overall Study||0
8103180|NCT03188055|19972754|P6|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|0
8103181|NCT03188055|19972755|P5|STARTED|Overall Study||59
8103182|NCT03188055|19972756|P4|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
8103183|NCT03188055|19972757|P3|STARTED|Overall Study||62
8103184|NCT03188055|19972758|P2|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
8103185|NCT03188055|19972759|P1|STARTED|Overall Study||48
8103186|NCT03187756|19972785|P1|NOT COMPLETED|Overall Study||4
8103187|NCT03187756|19972785|P1|COMPLETED|Overall Study||2
8103188|NCT03187756|19972785|P1|STARTED|Overall Study||6
8103189|NCT03187678|19972795|P1|NOT COMPLETED|Period 3 (Oral Selexipag)||0
8103190|NCT03187678|19972795|P1|COMPLETED|Period 3 (Oral Selexipag)||20
8103191|NCT03187678|19972795|P1|STARTED|Period 3 (Oral Selexipag)||20
8103192|NCT03187678|19972795|P1|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
8103193|NCT03187678|19972795|P1|COMPLETED|Period 2 (Intravenous Selexipag)||20
8103194|NCT03187678|19972795|P1|STARTED|Period 2 (Intravenous Selexipag)||20
8103195|NCT03187678|19972795|P1|NOT COMPLETED|Period 1 (Oral Selexipag)||0
8103196|NCT03187678|19972795|P1|COMPLETED|Period 1 (Oral Selexipag)||20
8103197|NCT03187678|19972795|P1|STARTED|Period 1 (Oral Selexipag)||20
8103198|NCT03187301|19972803|P7|NOT COMPLETED|Third Intervention||0
8103199|NCT03187301|19972804|P6|NOT COMPLETED|Third Intervention||0
8103200|NCT03187301|19972805|P5|NOT COMPLETED|Third Intervention||0
8103201|NCT03187301|19972806|P4|NOT COMPLETED|Third Intervention||0
8103202|NCT03187301|19972807|P3|NOT COMPLETED|Third Intervention||0
8103203|NCT03187301|19972808|P2|NOT COMPLETED|Third Intervention||0
8103204|NCT03187301|19972809|P1|NOT COMPLETED|Third Intervention||0
8103205|NCT03187301|19972803|P7|COMPLETED|Third Intervention||0
8103206|NCT03187301|19972804|P6|COMPLETED|Third Intervention||7
8103207|NCT03187301|19972805|P5|COMPLETED|Third Intervention||7
8103208|NCT03187301|19972806|P4|COMPLETED|Third Intervention||6
8103209|NCT03187301|19972807|P3|COMPLETED|Third Intervention||7
8103210|NCT03187301|19972808|P2|COMPLETED|Third Intervention||7
8103211|NCT03187301|19972809|P1|COMPLETED|Third Intervention||6
8103212|NCT03187301|19972803|P7|STARTED|Third Intervention||0
8103213|NCT03187301|19972804|P6|STARTED|Third Intervention||7
8103214|NCT03187301|19972805|P5|STARTED|Third Intervention||7
8103215|NCT03187301|19972806|P4|STARTED|Third Intervention||6
8103216|NCT03187301|19972807|P3|STARTED|Third Intervention||7
8103217|NCT03187301|19972808|P2|STARTED|Third Intervention||7
8103218|NCT03187301|19972809|P1|STARTED|Third Intervention||6
8103219|NCT03187301|19972803|P7|NOT COMPLETED|Second Washout||0
8103220|NCT03187301|19972804|P6|NOT COMPLETED|Second Washout||0
8103221|NCT03187301|19972805|P5|NOT COMPLETED|Second Washout||0
8103222|NCT03187301|19972806|P4|NOT COMPLETED|Second Washout||0
8103223|NCT03187301|19972807|P3|NOT COMPLETED|Second Washout||0
8103224|NCT03187301|19972808|P2|NOT COMPLETED|Second Washout||0
8103225|NCT03187301|19972809|P1|NOT COMPLETED|Second Washout||0
8103226|NCT03187301|19972803|P7|COMPLETED|Second Washout||0
8103227|NCT03187301|19972804|P6|COMPLETED|Second Washout||7
8103228|NCT03187301|19972805|P5|COMPLETED|Second Washout||7
8103229|NCT03187301|19972806|P4|COMPLETED|Second Washout||6
8103230|NCT03187301|19972807|P3|COMPLETED|Second Washout||7
8103231|NCT03187301|19972808|P2|COMPLETED|Second Washout||7
8103232|NCT03187301|19972809|P1|COMPLETED|Second Washout||6
8103233|NCT03187301|19972803|P7|STARTED|Second Washout||0
8103234|NCT03187301|19972804|P6|STARTED|Second Washout||7
8103235|NCT03187301|19972805|P5|STARTED|Second Washout||7
8103236|NCT03187301|19972806|P4|STARTED|Second Washout||6
8103237|NCT03187301|19972807|P3|STARTED|Second Washout||7
8103238|NCT03187301|19972808|P2|STARTED|Second Washout||7
8103239|NCT03187301|19972809|P1|STARTED|Second Washout||6
8103240|NCT03187301|19972803|P7|NOT COMPLETED|Second Intervention||0
8103241|NCT03187301|19972804|P6|NOT COMPLETED|Second Intervention||0
8103242|NCT03187301|19972805|P5|NOT COMPLETED|Second Intervention||0
8103243|NCT03187301|19972806|P4|NOT COMPLETED|Second Intervention||0
8103244|NCT03187301|19972807|P3|NOT COMPLETED|Second Intervention||0
8103245|NCT03187301|19972808|P2|NOT COMPLETED|Second Intervention||0
8103246|NCT03187301|19972809|P1|NOT COMPLETED|Second Intervention||0
8103247|NCT03187301|19972803|P7|COMPLETED|Second Intervention||0
8103248|NCT03187301|19972804|P6|COMPLETED|Second Intervention||7
8103249|NCT03187301|19972805|P5|COMPLETED|Second Intervention||7
8103250|NCT03187301|19972806|P4|COMPLETED|Second Intervention||6
8103251|NCT03187301|19972807|P3|COMPLETED|Second Intervention||7
8103252|NCT03187301|19972808|P2|COMPLETED|Second Intervention||7
8103253|NCT03187301|19972809|P1|COMPLETED|Second Intervention||6
8103254|NCT03187301|19972803|P7|STARTED|Second Intervention||0
8103255|NCT03187301|19972804|P6|STARTED|Second Intervention||7
8103256|NCT03187301|19972805|P5|STARTED|Second Intervention||7
8103257|NCT03187301|19972806|P4|STARTED|Second Intervention||6
8103258|NCT03187301|19972807|P3|STARTED|Second Intervention||7
8103259|NCT03187301|19972808|P2|STARTED|Second Intervention||7
8103260|NCT03187301|19972809|P1|STARTED|Second Intervention||6
8103261|NCT03187301|19972803|P7|NOT COMPLETED|First Washout||0
8103262|NCT03187301|19972804|P6|NOT COMPLETED|First Washout||0
8103263|NCT03187301|19972805|P5|NOT COMPLETED|First Washout||0
8103264|NCT03187301|19972806|P4|NOT COMPLETED|First Washout||0
8103265|NCT03187301|19972807|P3|NOT COMPLETED|First Washout||0
8103266|NCT03187301|19972808|P2|NOT COMPLETED|First Washout||0
8103267|NCT03187301|19972809|P1|NOT COMPLETED|First Washout||0
8103268|NCT03187301|19972803|P7|COMPLETED|First Washout||0
8103269|NCT03187301|19972804|P6|COMPLETED|First Washout||7
8103270|NCT03187301|19972805|P5|COMPLETED|First Washout||7
8103271|NCT03187301|19972806|P4|COMPLETED|First Washout||6
8103272|NCT03187301|19972807|P3|COMPLETED|First Washout||7
8103273|NCT03187301|19972808|P2|COMPLETED|First Washout||7
8103274|NCT03187301|19972809|P1|COMPLETED|First Washout||6
8103275|NCT03187301|19972803|P7|STARTED|First Washout||0
8103276|NCT03187301|19972804|P6|STARTED|First Washout||7
8103277|NCT03187301|19972805|P5|STARTED|First Washout||7
8103278|NCT03187301|19972806|P4|STARTED|First Washout||6
8103279|NCT03187301|19972807|P3|STARTED|First Washout||7
8103280|NCT03187301|19972808|P2|STARTED|First Washout||7
8103281|NCT03187301|19972809|P1|STARTED|First Washout||6
8103282|NCT03187301|19972803|P7|NOT COMPLETED|First Intervention||0
8103283|NCT03187301|19972804|P6|NOT COMPLETED|First Intervention||0
8103284|NCT03187301|19972805|P5|NOT COMPLETED|First Intervention||0
8103285|NCT03187301|19972806|P4|NOT COMPLETED|First Intervention||0
8103286|NCT03187301|19972807|P3|NOT COMPLETED|First Intervention||0
8103287|NCT03187301|19972808|P2|NOT COMPLETED|First Intervention||0
8103288|NCT03187301|19972809|P1|NOT COMPLETED|First Intervention||0
8103289|NCT03187301|19972803|P7|COMPLETED|First Intervention||0
8103290|NCT03187301|19972804|P6|COMPLETED|First Intervention||7
8103291|NCT03187301|19972805|P5|COMPLETED|First Intervention||7
8103292|NCT03187301|19972806|P4|COMPLETED|First Intervention||6
8103293|NCT03187301|19972807|P3|COMPLETED|First Intervention||7
8103294|NCT03187301|19972808|P2|COMPLETED|First Intervention||7
8103295|NCT03187301|19972809|P1|COMPLETED|First Intervention||6
8103296|NCT03187301|19972803|P7|STARTED|First Intervention||0
8103297|NCT03187301|19972804|P6|STARTED|First Intervention||7
8103298|NCT03187301|19972805|P5|STARTED|First Intervention||7
8103299|NCT03187301|19972806|P4|STARTED|First Intervention||6
8103300|NCT03187301|19972807|P3|STARTED|First Intervention||7
8103301|NCT03187301|19972808|P2|STARTED|First Intervention||7
8103302|NCT03187301|19972809|P1|STARTED|First Intervention||6
8103303|NCT03187301|19972803|P7|NOT COMPLETED|Pre-Intervention||0
8103304|NCT03187301|19972804|P6|NOT COMPLETED|Pre-Intervention||0
8103305|NCT03187301|19972805|P5|NOT COMPLETED|Pre-Intervention||0
8103306|NCT03187301|19972806|P4|NOT COMPLETED|Pre-Intervention||0
8103307|NCT03187301|19972807|P3|NOT COMPLETED|Pre-Intervention||0
8103308|NCT03187301|19972808|P2|NOT COMPLETED|Pre-Intervention||0
8103309|NCT03187301|19972809|P1|NOT COMPLETED|Pre-Intervention||1
8103310|NCT03187301|19972803|P7|COMPLETED|Pre-Intervention||0
8103311|NCT03187301|19972804|P6|COMPLETED|Pre-Intervention||7
8103312|NCT03187301|19972805|P5|COMPLETED|Pre-Intervention||7
8103313|NCT03187301|19972806|P4|COMPLETED|Pre-Intervention||6
8103314|NCT03187301|19972807|P3|COMPLETED|Pre-Intervention||7
8103315|NCT03187301|19972808|P2|COMPLETED|Pre-Intervention||7
8103316|NCT03187301|19972809|P1|COMPLETED|Pre-Intervention||6
8103317|NCT03187301|19972803|P7|STARTED|Pre-Intervention||0
8103318|NCT03187301|19972804|P6|STARTED|Pre-Intervention||7
8103319|NCT03187301|19972805|P5|STARTED|Pre-Intervention||7
8103320|NCT03187301|19972806|P4|STARTED|Pre-Intervention||6
8103321|NCT03187301|19972807|P3|STARTED|Pre-Intervention||7
8103322|NCT03187301|19972808|P2|STARTED|Pre-Intervention||7
8103323|NCT03187301|19972809|P1|STARTED|Pre-Intervention||7
8103324|NCT03187301|19972803|P7|NOT COMPLETED|Titration Period||7
8103325|NCT03187301|19972804|P6|NOT COMPLETED|Titration Period||0
8103326|NCT03187301|19972805|P5|NOT COMPLETED|Titration Period||0
8103327|NCT03187301|19972806|P4|NOT COMPLETED|Titration Period||0
8103328|NCT03187301|19972807|P3|NOT COMPLETED|Titration Period||0
8103329|NCT03187301|19972808|P2|NOT COMPLETED|Titration Period||0
8103330|NCT03187301|19972809|P1|NOT COMPLETED|Titration Period||0
8103331|NCT03187301|19972803|P7|COMPLETED|Titration Period||0
8103332|NCT03187301|19972804|P6|COMPLETED|Titration Period||7
8103333|NCT03187301|19972805|P5|COMPLETED|Titration Period||7
8103334|NCT03187301|19972806|P4|COMPLETED|Titration Period||6
8103335|NCT03187301|19972807|P3|COMPLETED|Titration Period||7
8103336|NCT03187301|19972808|P2|COMPLETED|Titration Period||7
8103337|NCT03187301|19972809|P1|COMPLETED|Titration Period||7
8103338|NCT03187301|19972803|P7|STARTED|Titration Period||7
8103339|NCT03187301|19972804|P6|STARTED|Titration Period||7
8103340|NCT03187301|19972805|P5|STARTED|Titration Period||7
8103341|NCT03187301|19972806|P4|STARTED|Titration Period||6
8103342|NCT03187301|19972807|P3|STARTED|Titration Period||7
8103343|NCT03187301|19972808|P2|STARTED|Titration Period||7
8103344|NCT03187301|19972809|P1|STARTED|Titration Period||7
8103345|NCT03187197|19972861|P3|NOT COMPLETED|Overall Study||23
8103346|NCT03187197|19972862|P2|NOT COMPLETED|Overall Study||393
8103347|NCT03187197|19972863|P1|NOT COMPLETED|Overall Study||46
8103348|NCT03187197|19972861|P3|COMPLETED|Overall Study||32
8103349|NCT03187197|19972862|P2|COMPLETED|Overall Study||704
8103350|NCT03187197|19972863|P1|COMPLETED|Overall Study||107
8103351|NCT03187197|19972861|P3|Started (Eligible Participants as FAS)|Overall Study||54
8103352|NCT03187197|19972862|P2|Started (Eligible Participants as FAS)|Overall Study||1052
8103353|NCT03187197|19972863|P1|Started (Eligible Participants as FAS)|Overall Study||139
8103354|NCT03187197|19972861|P3|STARTED|Overall Study||55
8103355|NCT03187197|19972862|P2|STARTED|Overall Study||1097
8103356|NCT03187197|19972863|P1|STARTED|Overall Study||153
8103357|NCT03187002|19972876|P2|NOT COMPLETED|Overall Study||0
8103358|NCT03187002|19972877|P1|NOT COMPLETED|Overall Study||0
8103359|NCT03187002|19972876|P2|COMPLETED|Overall Study||54
8103360|NCT03187002|19972877|P1|COMPLETED|Overall Study||55
8103361|NCT03187002|19972876|P2|STARTED|Overall Study||54
8103362|NCT03187002|19972877|P1|STARTED|Overall Study||55
8103363|NCT03186781|19972901|P6|NOT COMPLETED|Overall Study||0
8103364|NCT03186781|19972902|P5|NOT COMPLETED|Overall Study||3
8103365|NCT03186781|19972903|P4|NOT COMPLETED|Overall Study||0
8103366|NCT03186781|19972904|P3|NOT COMPLETED|Overall Study||1
8103367|NCT03186781|19972905|P2|NOT COMPLETED|Overall Study||0
8103368|NCT03186781|19972906|P1|NOT COMPLETED|Overall Study||0
8103369|NCT03186781|19972901|P6|COMPLETED|Overall Study||10
8103370|NCT03186781|19972902|P5|COMPLETED|Overall Study||7
8103371|NCT03186781|19972903|P4|COMPLETED|Overall Study||10
8103372|NCT03186781|19972904|P3|COMPLETED|Overall Study||9
8103373|NCT03186781|19972905|P2|COMPLETED|Overall Study||5
8103374|NCT03186781|19972906|P1|COMPLETED|Overall Study||5
8103375|NCT03186781|19972901|P6|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
8103376|NCT03186781|19972902|P5|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=1) and lost to follow up (n=1)|8
8103377|NCT03186781|19972903|P4|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
8103378|NCT03186781|19972904|P3|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
8103379|NCT03186781|19972905|P2|Received All Product Administrations|Overall Study||5
8103380|NCT03186781|19972906|P1|Received All Product Administrations|Overall Study||5
8103381|NCT03186781|19972901|P6|Received First Product Administration|Overall Study||10
8103382|NCT03186781|19972902|P5|Received First Product Administration|Overall Study||10
8103383|NCT03186781|19972903|P4|Received First Product Administration|Overall Study||10
8103384|NCT03186781|19972904|P3|Received First Product Administration|Overall Study||10
8103385|NCT03186781|19972905|P2|Received First Product Administration|Overall Study||5
8103386|NCT03186781|19972906|P1|Received First Product Administration|Overall Study||5
8103387|NCT03186781|19972901|P6|STARTED|Overall Study||10
8103388|NCT03186781|19972902|P5|STARTED|Overall Study||10
8103389|NCT03186781|19972903|P4|STARTED|Overall Study||10
8103390|NCT03186781|19972904|P3|STARTED|Overall Study||10
8103391|NCT03186781|19972905|P2|STARTED|Overall Study||5
8103392|NCT03186781|19972906|P1|STARTED|Overall Study||5
8103393|NCT03186677|19972977|P5|NOT COMPLETED|Period 2||0
8103394|NCT03186677|19972978|P4|NOT COMPLETED|Period 2||0
8103395|NCT03186677|19972979|P3|NOT COMPLETED|Period 2||0
8103396|NCT03186677|19972980|P2|NOT COMPLETED|Period 2||0
8103397|NCT03186677|19972981|P1|NOT COMPLETED|Period 2||0
8103398|NCT03186677|19972977|P5|COMPLETED|Period 2||2
8103399|NCT03186677|19972978|P4|COMPLETED|Period 2||5
8103400|NCT03186677|19972979|P3|COMPLETED|Period 2||0
8103401|NCT03186677|19972980|P2|COMPLETED|Period 2||0
8103402|NCT03186677|19972981|P1|COMPLETED|Period 2||0
8103403|NCT03186677|19972977|P5|STARTED|Period 2||2
8103404|NCT03186677|19972978|P4|STARTED|Period 2||5
8103405|NCT03186677|19972979|P3|STARTED|Period 2||0
8103406|NCT03186677|19972980|P2|STARTED|Period 2||0
8103407|NCT03186677|19972981|P1|STARTED|Period 2||0
8103408|NCT03186677|19972977|P5|NOT COMPLETED|Period 1||0
8103409|NCT03186677|19972978|P4|NOT COMPLETED|Period 1||0
8103410|NCT03186677|19972979|P3|NOT COMPLETED|Period 1||0
8103411|NCT03186677|19972980|P2|NOT COMPLETED|Period 1||0
8103412|NCT03186677|19972981|P1|NOT COMPLETED|Period 1||0
8103413|NCT03186677|19972977|P5|COMPLETED|Period 1||0
8103414|NCT03186677|19972978|P4|COMPLETED|Period 1||0
8103415|NCT03186677|19972979|P3|COMPLETED|Period 1||3
8103416|NCT03186677|19972980|P2|COMPLETED|Period 1||3
8103417|NCT03186677|19972981|P1|COMPLETED|Period 1||3
8103418|NCT03186677|19972977|P5|STARTED|Period 1||0
8103419|NCT03186677|19972978|P4|STARTED|Period 1||0
8103420|NCT03186677|19972979|P3|STARTED|Period 1||3
8103421|NCT03186677|19972980|P2|STARTED|Period 1||3
8103422|NCT03186677|19972981|P1|STARTED|Period 1||3
8103423|NCT03185481|19973003|P1|NOT COMPLETED|Overall Study||5
8103424|NCT03185481|19973003|P1|COMPLETED|Overall Study||0
8103425|NCT03185481|19973003|P1|STARTED|Overall Study||5
8103426|NCT03185455|19973022|P2|NOT COMPLETED|Overall Study||0
8103427|NCT03185455|19973023|P1|NOT COMPLETED|Overall Study||0
8103428|NCT03185455|19973022|P2|COMPLETED|Overall Study||103
8103429|NCT03185455|19973023|P1|COMPLETED|Overall Study||103
8103430|NCT03185455|19973022|P2|STARTED|Overall Study||103
8103431|NCT03185455|19973023|P1|STARTED|Overall Study||103
8103432|NCT03185182|19973037|P1|NOT COMPLETED|Overall Study||0
8103433|NCT03185182|19973037|P1|COMPLETED|Overall Study||5
8103434|NCT03185182|19973037|P1|STARTED|Overall Study||5
8103435|NCT03185065|19973046|P4|NOT COMPLETED|Period 4 (6 Weeks)||1
8103436|NCT03185065|19973047|P3|NOT COMPLETED|Period 4 (6 Weeks)||1
8103437|NCT03185065|19973048|P2|NOT COMPLETED|Period 4 (6 Weeks)||1
8103438|NCT03185065|19973049|P1|NOT COMPLETED|Period 4 (6 Weeks)||0
8103439|NCT03185065|19973046|P4|COMPLETED|Period 4 (6 Weeks)||31
8103440|NCT03185065|19973047|P3|COMPLETED|Period 4 (6 Weeks)||26
8103441|NCT03185065|19973048|P2|COMPLETED|Period 4 (6 Weeks)||27
8103442|NCT03185065|19973049|P1|COMPLETED|Period 4 (6 Weeks)||31
8103443|NCT03185065|19973046|P4|STARTED|Period 4 (6 Weeks)||32
8103444|NCT03185065|19973047|P3|STARTED|Period 4 (6 Weeks)||27
8103445|NCT03185065|19973048|P2|STARTED|Period 4 (6 Weeks)||28
8103446|NCT03185065|19973049|P1|STARTED|Period 4 (6 Weeks)||31
8103447|NCT03185065|19973046|P4|NOT COMPLETED|Washout (2 Weeks)||0
8103448|NCT03185065|19973047|P3|NOT COMPLETED|Washout (2 Weeks)||2
8103449|NCT03185065|19973048|P2|NOT COMPLETED|Washout (2 Weeks)||1
8103450|NCT03185065|19973049|P1|NOT COMPLETED|Washout (2 Weeks)||0
8103451|NCT03185065|19973046|P4|COMPLETED|Washout (2 Weeks)||32
8103452|NCT03185065|19973047|P3|COMPLETED|Washout (2 Weeks)||27
8103453|NCT03185065|19973048|P2|COMPLETED|Washout (2 Weeks)||28
8103454|NCT03185065|19973049|P1|COMPLETED|Washout (2 Weeks)||31
8103455|NCT03185065|19973046|P4|STARTED|Washout (2 Weeks)||32
8103456|NCT03185065|19973047|P3|STARTED|Washout (2 Weeks)||29
8103457|NCT03185065|19973048|P2|STARTED|Washout (2 Weeks)||29
8103458|NCT03185065|19973049|P1|STARTED|Washout (2 Weeks)||31
8103459|NCT03185065|19973046|P4|NOT COMPLETED|Period 3 (6 Weeks)||0
8103460|NCT03185065|19973047|P3|NOT COMPLETED|Period 3 (6 Weeks)||2
8103461|NCT03185065|19973048|P2|NOT COMPLETED|Period 3 (6 Weeks)||0
8103462|NCT03185065|19973049|P1|NOT COMPLETED|Period 3 (6 Weeks)||0
8103463|NCT03185065|19973046|P4|COMPLETED|Period 3 (6 Weeks)||32
8103464|NCT03185065|19973047|P3|COMPLETED|Period 3 (6 Weeks)||29
8103465|NCT03185065|19973048|P2|COMPLETED|Period 3 (6 Weeks)||29
8103466|NCT03185065|19973049|P1|COMPLETED|Period 3 (6 Weeks)||31
8103467|NCT03185065|19973046|P4|STARTED|Period 3 (6 Weeks)||32
8103468|NCT03185065|19973047|P3|STARTED|Period 3 (6 Weeks)||31
8103469|NCT03185065|19973048|P2|STARTED|Period 3 (6 Weeks)||29
8103470|NCT03185065|19973049|P1|STARTED|Period 3 (6 Weeks)||31
8103471|NCT03185065|19973046|P4|NOT COMPLETED|Washout (2 Weeks)||2
8103472|NCT03185065|19973047|P3|NOT COMPLETED|Washout (2 Weeks)||1
8103473|NCT03185065|19973048|P2|NOT COMPLETED|Washout (2 Weeks)||2
8103474|NCT03185065|19973049|P1|NOT COMPLETED|Washout (2 Weeks)||1
8103475|NCT03185065|19973046|P4|COMPLETED|Washout (2 Weeks)||32
8103476|NCT03185065|19973047|P3|COMPLETED|Washout (2 Weeks)||31
8103477|NCT03185065|19973048|P2|COMPLETED|Washout (2 Weeks)||29
8103478|NCT03185065|19973049|P1|COMPLETED|Washout (2 Weeks)||31
8103479|NCT03185065|19973046|P4|STARTED|Washout (2 Weeks)||34
8103480|NCT03185065|19973047|P3|STARTED|Washout (2 Weeks)||32
8103481|NCT03185065|19973048|P2|STARTED|Washout (2 Weeks)||31
8103482|NCT03185065|19973049|P1|STARTED|Washout (2 Weeks)||32
8103483|NCT03185065|19973046|P4|NOT COMPLETED|Period 2 (6 Weeks)||1
8103484|NCT03185065|19973047|P3|NOT COMPLETED|Period 2 (6 Weeks)||0
8103485|NCT03185065|19973048|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
8103486|NCT03185065|19973049|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
8103487|NCT03185065|19973046|P4|COMPLETED|Period 2 (6 Weeks)||34
8103488|NCT03185065|19973047|P3|COMPLETED|Period 2 (6 Weeks)||32
8103489|NCT03185065|19973048|P2|COMPLETED|Period 2 (6 Weeks)||31
8103490|NCT03185065|19973049|P1|COMPLETED|Period 2 (6 Weeks)||32
8103491|NCT03185065|19973046|P4|STARTED|Period 2 (6 Weeks)||35
8103492|NCT03185065|19973047|P3|STARTED|Period 2 (6 Weeks)||32
8103493|NCT03185065|19973048|P2|STARTED|Period 2 (6 Weeks)||31
8103494|NCT03185065|19973049|P1|STARTED|Period 2 (6 Weeks)||32
8103495|NCT03185065|19973046|P4|NOT COMPLETED|Washout (2 Weeks)||1
8103496|NCT03185065|19973047|P3|NOT COMPLETED|Washout (2 Weeks)||0
8103497|NCT03185065|19973048|P2|NOT COMPLETED|Washout (2 Weeks)||2
8103498|NCT03185065|19973049|P1|NOT COMPLETED|Washout (2 Weeks)||0
8103499|NCT03185065|19973046|P4|COMPLETED|Washout (2 Weeks)||35
8103500|NCT03185065|19973047|P3|COMPLETED|Washout (2 Weeks)||32
8103501|NCT03185065|19973048|P2|COMPLETED|Washout (2 Weeks)||31
8103502|NCT03185065|19973049|P1|COMPLETED|Washout (2 Weeks)||32
8103503|NCT03185065|19973046|P4|STARTED|Washout (2 Weeks)||36
8103504|NCT03185065|19973047|P3|STARTED|Washout (2 Weeks)||32
8103505|NCT03185065|19973048|P2|STARTED|Washout (2 Weeks)||33
8103506|NCT03185065|19973049|P1|STARTED|Washout (2 Weeks)||32
8103507|NCT03185065|19973046|P4|NOT COMPLETED|Period 1 (6 Weeks)||1
8103508|NCT03185065|19973047|P3|NOT COMPLETED|Period 1 (6 Weeks)||3
8103509|NCT03185065|19973048|P2|NOT COMPLETED|Period 1 (6 Weeks)||1
8103510|NCT03185065|19973049|P1|NOT COMPLETED|Period 1 (6 Weeks)||3
8103511|NCT03185065|19973046|P4|COMPLETED|Period 1 (6 Weeks)||36
8103512|NCT03185065|19973047|P3|COMPLETED|Period 1 (6 Weeks)||32
8103513|NCT03185065|19973048|P2|COMPLETED|Period 1 (6 Weeks)||33
8103514|NCT03185065|19973049|P1|COMPLETED|Period 1 (6 Weeks)||32
8103515|NCT03185065|19973046|P4|STARTED|Period 1 (6 Weeks)||37
8103516|NCT03185065|19973047|P3|STARTED|Period 1 (6 Weeks)||35
8103517|NCT03185065|19973048|P2|STARTED|Period 1 (6 Weeks)||34
8103518|NCT03185065|19973049|P1|STARTED|Period 1 (6 Weeks)||35
8103519|NCT03184987|19973074|P3|NOT COMPLETED|Overall Study||4
8103520|NCT03184987|19973075|P2|NOT COMPLETED|Overall Study||1
8103521|NCT03184987|19973076|P1|NOT COMPLETED|Overall Study||1
8103522|NCT03184987|19973074|P3|COMPLETED|Overall Study||51
8103523|NCT03184987|19973075|P2|COMPLETED|Overall Study||8
8103524|NCT03184987|19973076|P1|COMPLETED|Overall Study||46
8103525|NCT03184987|19973074|P3|STARTED|Overall Study||55
8103526|NCT03184987|19973075|P2|STARTED|Overall Study||9
8103527|NCT03184987|19973076|P1|STARTED|Overall Study||47
8103528|NCT03184701|19973141|P1|NOT COMPLETED|Overall Study||17
8103529|NCT03184701|19973141|P1|COMPLETED|Overall Study||28
8103530|NCT03184701|19973141|P1|STARTED|Overall Study||45
8103531|NCT03184519|19973145|P1|NOT COMPLETED|Overall Study||27
8103532|NCT03184519|19973145|P1|COMPLETED|Overall Study||129
8103533|NCT03184519|19973145|P1|STARTED|Overall Study||156
8103534|NCT03184441|19973149|P1|NOT COMPLETED|Overall Study||1
8103535|NCT03184441|19973149|P1|COMPLETED|Overall Study|Last subject completed study|10
8103536|NCT03184441|19973149|P1|STARTED|Overall Study||11
8103537|NCT03184428|19973157|P1|NOT COMPLETED|Overall Study||822
8103538|NCT03184428|19973157|P1|COMPLETED|Overall Study||2963
8103539|NCT03184428|19973157|P1|STARTED|Overall Study||3785
8103540|NCT03184077|19973175|P2|NOT COMPLETED|Overall Study||21
8103541|NCT03184077|19973176|P1|NOT COMPLETED|Overall Study||21
8103542|NCT03184077|19973175|P2|COMPLETED|Overall Study||131
8103543|NCT03184077|19973176|P1|COMPLETED|Overall Study||145
8103544|NCT03184077|19973175|P2|STARTED|Overall Study||152
8103545|NCT03184077|19973176|P1|STARTED|Overall Study||166
8103546|NCT03183869|19973188|P2|NOT COMPLETED|Overall Study||5
8103547|NCT03183869|19973189|P1|NOT COMPLETED|Overall Study||4
8103548|NCT03183869|19973188|P2|COMPLETED|Overall Study||2
8103549|NCT03183869|19973189|P1|COMPLETED|Overall Study||0
8103550|NCT03183869|19973188|P2|STARTED|Overall Study||7
8103551|NCT03183869|19973189|P1|STARTED|Overall Study||4
8103552|NCT03183518|19973195|P1|NOT COMPLETED|Overall Study||3
8103553|NCT03183518|19973195|P1|COMPLETED|Overall Study||33
8103554|NCT03183518|19973195|P1|Negative Control|Overall Study||36
8103555|NCT03183518|19973195|P1|Test Product|Overall Study||36
8103556|NCT03183518|19973195|P1|STARTED|Overall Study||36
8103557|NCT03183063|19973229|P3|NOT COMPLETED|Overall Study||4
8103558|NCT03183063|19973230|P2|NOT COMPLETED|Overall Study||4
8103559|NCT03183063|19973231|P1|NOT COMPLETED|Overall Study||5
8103560|NCT03183063|19973229|P3|COMPLETED|Overall Study||111
8103561|NCT03183063|19973230|P2|COMPLETED|Overall Study||0
8103562|NCT03183063|19973231|P1|COMPLETED|Overall Study||15
8103563|NCT03183063|19973229|P3|STARTED|Overall Study||115
8103564|NCT03183063|19973230|P2|STARTED|Overall Study||4
8103565|NCT03183063|19973231|P1|STARTED|Overall Study||20
8103566|NCT03182933|19973256|P2|NOT COMPLETED|Overall Study||0
8103567|NCT03182933|19973257|P1|NOT COMPLETED|Overall Study||1
8103568|NCT03182933|19973256|P2|COMPLETED|Overall Study||32
8103569|NCT03182933|19973257|P1|COMPLETED|Overall Study||31
8103570|NCT03182933|19973256|P2|STARTED|Overall Study||32
8103571|NCT03182933|19973257|P1|STARTED|Overall Study||32
8103572|NCT03182920|19973273|P3|NOT COMPLETED|Period 2||0
8103573|NCT03182920|19973274|P2|NOT COMPLETED|Period 2||0
8103574|NCT03182920|19973275|P1|NOT COMPLETED|Period 2||0
8103575|NCT03182920|19973273|P3|COMPLETED|Period 2||0
8103576|NCT03182920|19973274|P2|COMPLETED|Period 2||9
8103577|NCT03182920|19973275|P1|COMPLETED|Period 2||9
8103578|NCT03182920|19973273|P3|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
8103579|NCT03182920|19973274|P2|STARTED|Period 2||9
8103580|NCT03182920|19973275|P1|STARTED|Period 2||9
8103581|NCT03182920|19973273|P3|NOT COMPLETED|Washout Period||0
8103582|NCT03182920|19973274|P2|NOT COMPLETED|Washout Period||0
8103583|NCT03182920|19973275|P1|NOT COMPLETED|Washout Period||0
8103584|NCT03182920|19973273|P3|COMPLETED|Washout Period||0
8103585|NCT03182920|19973274|P2|COMPLETED|Washout Period||9
8103586|NCT03182920|19973275|P1|COMPLETED|Washout Period||9
8103587|NCT03182920|19973273|P3|STARTED|Washout Period||0
8103588|NCT03182920|19973274|P2|STARTED|Washout Period||9
8103589|NCT03182920|19973275|P1|STARTED|Washout Period||9
8103590|NCT03182920|19973273|P3|NOT COMPLETED|Period 1||0
8103591|NCT03182920|19973274|P2|NOT COMPLETED|Period 1||0
8103592|NCT03182920|19973275|P1|NOT COMPLETED|Period 1||0
8103593|NCT03182920|19973273|P3|COMPLETED|Period 1||17
8103594|NCT03182920|19973274|P2|COMPLETED|Period 1||9
8103595|NCT03182920|19973275|P1|COMPLETED|Period 1||9
8103596|NCT03182920|19973273|P3|STARTED|Period 1||17
8103597|NCT03182920|19973274|P2|STARTED|Period 1||9
8103598|NCT03182920|19973275|P1|STARTED|Period 1||9
8103599|NCT03182738|19973286|P2|NOT COMPLETED|Overall Study||5
8103600|NCT03182738|19973287|P1|NOT COMPLETED|Overall Study||9
8103601|NCT03182738|19973286|P2|COMPLETED|Overall Study||45
8103602|NCT03182738|19973287|P1|COMPLETED|Overall Study||41
8103603|NCT03182738|19973286|P2|STARTED|Overall Study||50
8103604|NCT03182738|19973287|P1|STARTED|Overall Study||50
8103605|NCT03182582|19973301|P2|NOT COMPLETED|Treatment 2||0
8103606|NCT03182582|19973302|P1|NOT COMPLETED|Treatment 2||0
8103607|NCT03182582|19973301|P2|COMPLETED|Treatment 2||10
8103608|NCT03182582|19973302|P1|COMPLETED|Treatment 2||12
8103609|NCT03182582|19973301|P2|STARTED|Treatment 2||10
8103610|NCT03182582|19973302|P1|STARTED|Treatment 2||12
8103611|NCT03182582|19973301|P2|NOT COMPLETED|Treatment 1||0
8103612|NCT03182582|19973302|P1|NOT COMPLETED|Treatment 1||0
8103613|NCT03182582|19973301|P2|COMPLETED|Treatment 1||10
8103614|NCT03182582|19973302|P1|COMPLETED|Treatment 1||12
8103615|NCT03182582|19973301|P2|STARTED|Treatment 1||10
8103616|NCT03182582|19973302|P1|STARTED|Treatment 1||12
8103617|NCT03181724|19973319|P2|NOT COMPLETED|Overall Study||0
8103618|NCT03181724|19973320|P1|NOT COMPLETED|Overall Study||0
8103619|NCT03181724|19973319|P2|COMPLETED|Overall Study||45
8103620|NCT03181724|19973320|P1|COMPLETED|Overall Study||45
8103621|NCT03181724|19973319|P2|STARTED|Overall Study||45
8103622|NCT03181724|19973320|P1|STARTED|Overall Study||45
8103623|NCT03181594|19973336|P1|NOT COMPLETED|Overall Study||2
8103624|NCT03181594|19973336|P1|COMPLETED|Overall Study||98
8103625|NCT03181594|19973336|P1|90-day Follow-up|Overall Study||98
8103626|NCT03181594|19973336|P1|30-day Follow-up|Overall Study||99
8103627|NCT03181594|19973336|P1|STARTED|Overall Study||100
8103628|NCT03181503|19973344|P2|NOT COMPLETED|Overall Study||3
8103629|NCT03181503|19973345|P1|NOT COMPLETED|Overall Study||7
8103630|NCT03181503|19973344|P2|COMPLETED|Overall Study||31
8103631|NCT03181503|19973345|P1|COMPLETED|Overall Study||29
8103632|NCT03181503|19973344|P2|Treated|Overall Study||34
8103633|NCT03181503|19973345|P1|Treated|Overall Study||36
8103634|NCT03181503|19973344|P2|STARTED|Overall Study||34
8103635|NCT03181503|19973345|P1|STARTED|Overall Study||36
8103636|NCT03181451|19973384|P3|NOT COMPLETED|Overall Study||0
8103637|NCT03181451|19973385|P2|NOT COMPLETED|Overall Study||2
8103638|NCT03181451|19973386|P1|NOT COMPLETED|Overall Study||0
8103639|NCT03181451|19973384|P3|COMPLETED|Overall Study||12
8103640|NCT03181451|19973385|P2|COMPLETED|Overall Study||11
8103641|NCT03181451|19973386|P1|COMPLETED|Overall Study||12
8103642|NCT03181451|19973384|P3|STARTED|Overall Study||12
8103643|NCT03181451|19973385|P2|STARTED|Overall Study||13
8103644|NCT03181451|19973386|P1|STARTED|Overall Study||12
8103645|NCT03181308|19973546|P2|NOT COMPLETED|Overall Study||0
8103646|NCT03181308|19973547|P1|NOT COMPLETED|Overall Study||0
8103647|NCT03181308|19973546|P2|COMPLETED|Overall Study||8
8103648|NCT03181308|19973547|P1|COMPLETED|Overall Study||3
8103649|NCT03181308|19973546|P2|STARTED|Overall Study||8
8103650|NCT03181308|19973547|P1|STARTED|Overall Study||3
8103651|NCT03181009|19973563|P2|NOT COMPLETED|Overall Study||2
8103652|NCT03181009|19973564|P1|NOT COMPLETED|Overall Study||0
8103653|NCT03181009|19973563|P2|COMPLETED|Overall Study||28
8103654|NCT03181009|19973564|P1|COMPLETED|Overall Study||30
8103655|NCT03181009|19973563|P2|STARTED|Overall Study||30
8103656|NCT03181009|19973564|P1|STARTED|Overall Study||30
8103657|NCT03180801|19973573|P3|NOT COMPLETED|Overall Study||10
8103658|NCT03180801|19973574|P2|NOT COMPLETED|Overall Study||12
8103659|NCT03180801|19973575|P1|NOT COMPLETED|Overall Study||8
8103660|NCT03180801|19973573|P3|COMPLETED|Overall Study||41
8103661|NCT03180801|19973574|P2|COMPLETED|Overall Study||40
8103662|NCT03180801|19973575|P1|COMPLETED|Overall Study||42
8103663|NCT03180801|19973573|P3|Intention to Treat|Overall Study||41
8103664|NCT03180801|19973574|P2|Intention to Treat|Overall Study||40
8103665|NCT03180801|19973575|P1|Intention to Treat|Overall Study||42
8103666|NCT03180801|19973573|P3|Safety Population|Overall Study||51
8103667|NCT03180801|19973574|P2|Safety Population|Overall Study||52
8103668|NCT03180801|19973575|P1|Safety Population|Overall Study||50
8103669|NCT03180801|19973573|P3|STARTED|Overall Study||51
8103670|NCT03180801|19973574|P2|STARTED|Overall Study||52
8103671|NCT03180801|19973575|P1|STARTED|Overall Study||50
8103672|NCT03180645|19973619|P3|NOT COMPLETED|Overall Study||2
8103673|NCT03180645|19973620|P2|NOT COMPLETED|Overall Study||1
8103674|NCT03180645|19973621|P1|NOT COMPLETED|Overall Study||0
8103675|NCT03180645|19973619|P3|COMPLETED|Overall Study||22
8103676|NCT03180645|19973620|P2|COMPLETED|Overall Study||23
8103677|NCT03180645|19973621|P1|COMPLETED|Overall Study||24
8103678|NCT03180645|19973619|P3|STARTED|Overall Study||24
8103679|NCT03180645|19973620|P2|STARTED|Overall Study||24
8103680|NCT03180645|19973621|P1|STARTED|Overall Study||24
8103681|NCT03180619|19973663|P3|NOT COMPLETED|Overall Study||28
8103682|NCT03180619|19973664|P2|NOT COMPLETED|Overall Study||15
8103683|NCT03180619|19973665|P1|NOT COMPLETED|Overall Study||73
8103684|NCT03180619|19973663|P3|COMPLETED|Overall Study||3
8103685|NCT03180619|19973664|P2|COMPLETED|Overall Study||0
8103686|NCT03180619|19973665|P1|COMPLETED|Overall Study||5
8103687|NCT03180619|19973663|P3|STARTED|Overall Study||31
8103688|NCT03180619|19973664|P2|STARTED|Overall Study||15
8103689|NCT03180619|19973665|P1|STARTED|Overall Study||78
8103690|NCT03180528|19973762|P1|NOT COMPLETED|Overall Study||3
8103691|NCT03180528|19973762|P1|COMPLETED|Overall Study||27
8103692|NCT03180528|19973762|P1|STARTED|Overall Study||30
8103693|NCT03180515|19973766|P1|NOT COMPLETED|Aim 3||0
8103694|NCT03180515|19973766|P1|COMPLETED|Aim 3||1
8103695|NCT03180515|19973766|P1|STARTED|Aim 3||1
8103696|NCT03180515|19973766|P1|NOT COMPLETED|Aim 2||0
8103697|NCT03180515|19973766|P1|COMPLETED|Aim 2||12
8103698|NCT03180515|19973766|P1|STARTED|Aim 2||12
8103699|NCT03180515|19973766|P1|NOT COMPLETED|Aim 1||0
8103700|NCT03180515|19973766|P1|COMPLETED|Aim 1||12
8103701|NCT03180515|19973766|P1|STARTED|Aim 1||12
8103702|NCT03180489|19973811|P2|NOT COMPLETED|Overall Study||4
8103703|NCT03180489|19973812|P1|NOT COMPLETED|Overall Study||8
8103704|NCT03180489|19973811|P2|COMPLETED|Overall Study||25
8103705|NCT03180489|19973812|P1|COMPLETED|Overall Study||25
8103706|NCT03180489|19973811|P2|STARTED|Overall Study||29
8103707|NCT03180489|19973812|P1|STARTED|Overall Study||33
8103708|NCT03180385|19973844|P2|NOT COMPLETED|Overall Study||0
8103709|NCT03180385|19973845|P1|NOT COMPLETED|Overall Study||0
8103710|NCT03180385|19973844|P2|COMPLETED|Overall Study||2
8103711|NCT03180385|19973845|P1|COMPLETED|Overall Study||0
8103712|NCT03180385|19973844|P2|STARTED|Overall Study||2
8103713|NCT03180385|19973845|P1|STARTED|Overall Study||0
8103714|NCT03180138|19973872|P3|NOT COMPLETED|Overall Study||24
8103715|NCT03180138|19973873|P2|NOT COMPLETED|Overall Study||13
8103716|NCT03180138|19973874|P1|NOT COMPLETED|Overall Study||22
8103717|NCT03180138|19973872|P3|COMPLETED|Overall Study||179
8103718|NCT03180138|19973873|P2|COMPLETED|Overall Study||188
8103719|NCT03180138|19973874|P1|COMPLETED|Overall Study||182
8103720|NCT03180138|19973872|P3|STARTED|Overall Study||203
8103721|NCT03180138|19973873|P2|STARTED|Overall Study||201
8103722|NCT03180138|19973874|P1|STARTED|Overall Study||204
8103723|NCT03179891|19973885|P2|NOT COMPLETED|Second Intervention (After 14 Days)||0
8103724|NCT03179891|19973886|P1|NOT COMPLETED|Second Intervention (After 14 Days)||0
8103725|NCT03179891|19973885|P2|COMPLETED|Second Intervention (After 14 Days)||20
8103726|NCT03179891|19973886|P1|COMPLETED|Second Intervention (After 14 Days)||11
8103727|NCT03179891|19973885|P2|STARTED|Second Intervention (After 14 Days)||20
8103728|NCT03179891|19973886|P1|STARTED|Second Intervention (After 14 Days)||11
8103729|NCT03179891|19973885|P2|NOT COMPLETED|First Intervention||2
8103730|NCT03179891|19973886|P1|NOT COMPLETED|First Intervention||2
8103731|NCT03179891|19973885|P2|COMPLETED|First Intervention||20
8103732|NCT03179891|19973886|P1|COMPLETED|First Intervention||11
8103733|NCT03179891|19973885|P2|STARTED|First Intervention||22
8103734|NCT03179891|19973886|P1|STARTED|First Intervention||13
8103735|NCT03179345|19973910|P4|NOT COMPLETED|Overall Study||2
8103736|NCT03179345|19973911|P3|NOT COMPLETED|Overall Study||1
8103737|NCT03179345|19973912|P2|NOT COMPLETED|Overall Study||1
8103738|NCT03179345|19973913|P1|NOT COMPLETED|Overall Study||0
8103739|NCT03179345|19973910|P4|COMPLETED|Overall Study||6
8103740|NCT03179345|19973911|P3|COMPLETED|Overall Study||7
8103741|NCT03179345|19973912|P2|COMPLETED|Overall Study||7
8103742|NCT03179345|19973913|P1|COMPLETED|Overall Study||8
8103743|NCT03179345|19973910|P4|Received Placebo|Overall Study||8
8103744|NCT03179345|19973911|P3|Received Placebo|Overall Study||7
8103745|NCT03179345|19973912|P2|Received Placebo|Overall Study||7
8103746|NCT03179345|19973913|P1|Received Placebo|Overall Study||8
8103747|NCT03179345|19973910|P4|Received Lyrica®|Overall Study||8
8103748|NCT03179345|19973911|P3|Received Lyrica®|Overall Study||8
8103749|NCT03179345|19973912|P2|Received Lyrica®|Overall Study||7
8103750|NCT03179345|19973913|P1|Received Lyrica®|Overall Study||8
8103751|NCT03179345|19973910|P4|Received Neurontin®|Overall Study||8
8103752|NCT03179345|19973911|P3|Received Neurontin®|Overall Study||7
8103753|NCT03179345|19973912|P2|Received Neurontin®|Overall Study||8
8103754|NCT03179345|19973913|P1|Received Neurontin®|Overall Study||8
8103755|NCT03179345|19973910|P4|Received Gralise®|Overall Study||6
8103756|NCT03179345|19973911|P3|Received Gralise®|Overall Study||7
8103757|NCT03179345|19973912|P2|Received Gralise®|Overall Study||7
8103758|NCT03179345|19973913|P1|Received Gralise®|Overall Study||8
8103759|NCT03179345|19973910|P4|STARTED|Overall Study||8
8103760|NCT03179345|19973911|P3|STARTED|Overall Study||8
8103761|NCT03179345|19973912|P2|STARTED|Overall Study||8
8103762|NCT03179345|19973913|P1|STARTED|Overall Study||8
8103763|NCT03179319|19973965|P2|NOT COMPLETED|Overall Study||0
8103764|NCT03179319|19973966|P1|NOT COMPLETED|Overall Study||6
8103765|NCT03179319|19973965|P2|COMPLETED|Overall Study||20
8103766|NCT03179319|19973966|P1|COMPLETED|Overall Study||34
8103767|NCT03179319|19973965|P2|3 Month Visit|Overall Study||20
8103768|NCT03179319|19973966|P1|3 Month Visit|Overall Study||37
8103769|NCT03179319|19973965|P2|STARTED|Overall Study||20
8103770|NCT03179319|19973966|P1|STARTED|Overall Study||40
8103771|NCT03178942|19973981|P2|NOT COMPLETED|Overall Study||2
8103772|NCT03178942|19973982|P1|NOT COMPLETED|Overall Study||3
8103773|NCT03178942|19973981|P2|COMPLETED|Overall Study||123
8103774|NCT03178942|19973982|P1|COMPLETED|Overall Study||126
8103775|NCT03178942|19973981|P2|STARTED|Overall Study||125
8103776|NCT03178942|19973982|P1|STARTED|Overall Study||129
8103777|NCT03178851|19973997|P3|NOT COMPLETED|Overall Study||52
8103778|NCT03178851|19973998|P2|NOT COMPLETED|Overall Study||11
8103779|NCT03178851|19973999|P1|NOT COMPLETED|Overall Study||92
8103780|NCT03178851|19973997|P3|COMPLETED|Overall Study||0
8103781|NCT03178851|19973998|P2|COMPLETED|Overall Study||0
8103782|NCT03178851|19973999|P1|COMPLETED|Overall Study||0
8103783|NCT03178851|19973997|P3|STARTED|Overall Study||52
8103784|NCT03178851|19973998|P2|STARTED|Overall Study||11
8103785|NCT03178851|19973999|P1|STARTED|Overall Study||92
8103786|NCT03178344|19974029|P2|NOT COMPLETED|Second Session||0
8103787|NCT03178344|19974030|P1|NOT COMPLETED|Second Session||0
8103788|NCT03178344|19974029|P2|COMPLETED|Second Session||10
8103789|NCT03178344|19974030|P1|COMPLETED|Second Session||10
8103790|NCT03178344|19974029|P2|STARTED|Second Session||10
8103791|NCT03178344|19974030|P1|STARTED|Second Session||10
8103792|NCT03178344|19974029|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
8103793|NCT03178344|19974030|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
8103794|NCT03178344|19974029|P2|COMPLETED|Washout Period (5-9 Days)||10
8103795|NCT03178344|19974030|P1|COMPLETED|Washout Period (5-9 Days)||10
8103796|NCT03178344|19974029|P2|STARTED|Washout Period (5-9 Days)||10
8103797|NCT03178344|19974030|P1|STARTED|Washout Period (5-9 Days)||10
8103798|NCT03178344|19974029|P2|NOT COMPLETED|First Session||0
8103799|NCT03178344|19974030|P1|NOT COMPLETED|First Session||0
8103800|NCT03178344|19974029|P2|COMPLETED|First Session||10
8103801|NCT03178344|19974030|P1|COMPLETED|First Session||10
8103802|NCT03178344|19974029|P2|STARTED|First Session||10
8103803|NCT03178344|19974030|P1|STARTED|First Session||10
8103804|NCT03178266|19974046|P2|NOT COMPLETED|Overall Study||4
8103805|NCT03178266|19974047|P1|NOT COMPLETED|Overall Study||0
8103806|NCT03178266|19974046|P2|COMPLETED|Overall Study||16
8103807|NCT03178266|19974047|P1|COMPLETED|Overall Study||21
8103808|NCT03178266|19974046|P2|STARTED|Overall Study||20
8103809|NCT03178266|19974047|P1|STARTED|Overall Study||21
8103810|NCT03178045|19974057|P2|NOT COMPLETED|Overall Study||83
8103811|NCT03178045|19974058|P1|NOT COMPLETED|Overall Study||86
8103812|NCT03178045|19974057|P2|COMPLETED|Overall Study||1314
8103813|NCT03178045|19974058|P1|COMPLETED|Overall Study||1310
8103814|NCT03178045|19974057|P2|STARTED|Overall Study||1397
8103815|NCT03178045|19974058|P1|STARTED|Overall Study||1396
8103816|NCT03177798|19974085|P2|NOT COMPLETED|Overall Study||0
8103817|NCT03177798|19974086|P1|NOT COMPLETED|Overall Study||0
8103818|NCT03177798|19974085|P2|COMPLETED|Overall Study||6
8103819|NCT03177798|19974086|P1|COMPLETED|Overall Study||5
8103820|NCT03177798|19974085|P2|Intervention 2|Overall Study||6
8103821|NCT03177798|19974086|P1|Intervention 2|Overall Study||5
8103822|NCT03177798|19974085|P2|Washout|Overall Study||6
8103823|NCT03177798|19974086|P1|Washout|Overall Study||5
8103824|NCT03177798|19974085|P2|Intervention 1|Overall Study||6
8103825|NCT03177798|19974086|P1|Intervention 1|Overall Study||5
8103826|NCT03177798|19974085|P2|STARTED|Overall Study||6
8103827|NCT03177798|19974086|P1|STARTED|Overall Study||5
8103828|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103829|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103830|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103831|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103832|NCT03177603|19974098|P4|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
8103833|NCT03177603|19974099|P3|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103834|NCT03177603|19974100|P2|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103835|NCT03177603|19974101|P1|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103836|NCT03177603|19974098|P4|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
8103837|NCT03177603|19974099|P3|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103838|NCT03177603|19974100|P2|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103839|NCT03177603|19974101|P1|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103840|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103841|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103842|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103843|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103844|NCT03177603|19974098|P4|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103845|NCT03177603|19974099|P3|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
8103846|NCT03177603|19974100|P2|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103847|NCT03177603|19974101|P1|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103848|NCT03177603|19974098|P4|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103849|NCT03177603|19974099|P3|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
8103850|NCT03177603|19974100|P2|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103851|NCT03177603|19974101|P1|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103852|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103853|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103854|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103855|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103856|NCT03177603|19974098|P4|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103857|NCT03177603|19974099|P3|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103858|NCT03177603|19974100|P2|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
8103859|NCT03177603|19974101|P1|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103860|NCT03177603|19974098|P4|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103861|NCT03177603|19974099|P3|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103862|NCT03177603|19974100|P2|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
8103863|NCT03177603|19974101|P1|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103864|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103865|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103866|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103867|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103868|NCT03177603|19974098|P4|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103869|NCT03177603|19974099|P3|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103870|NCT03177603|19974100|P2|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103871|NCT03177603|19974101|P1|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
8103872|NCT03177603|19974098|P4|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103873|NCT03177603|19974099|P3|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103874|NCT03177603|19974100|P2|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103875|NCT03177603|19974101|P1|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
8103876|NCT03177395|19974271|P4|NOT COMPLETED|Overall Study||0
8103877|NCT03177395|19974272|P3|NOT COMPLETED|Overall Study||0
8103878|NCT03177395|19974273|P2|NOT COMPLETED|Overall Study||0
8103879|NCT03177395|19974274|P1|NOT COMPLETED|Overall Study||0
8103880|NCT03177395|19974271|P4|COMPLETED|Overall Study||6
8103881|NCT03177395|19974272|P3|COMPLETED|Overall Study||6
8103882|NCT03177395|19974273|P2|COMPLETED|Overall Study||6
8103883|NCT03177395|19974274|P1|COMPLETED|Overall Study||6
8103884|NCT03177395|19974271|P4|STARTED|Overall Study||6
8103885|NCT03177395|19974272|P3|STARTED|Overall Study||6
8103886|NCT03177395|19974273|P2|STARTED|Overall Study||6
8103887|NCT03177395|19974274|P1|STARTED|Overall Study||6
8103888|NCT03176654|19974378|P2|NOT COMPLETED|Overall Study||0
8103889|NCT03176654|19974379|P1|NOT COMPLETED|Overall Study||0
8103890|NCT03176654|19974378|P2|COMPLETED|Overall Study||15
8103891|NCT03176654|19974379|P1|COMPLETED|Overall Study||13
8103892|NCT03176654|19974378|P2|STARTED|Overall Study||15
8103893|NCT03176654|19974379|P1|STARTED|Overall Study||13
8103894|NCT03176459|19974401|P2|NOT COMPLETED|Overall Study||7
8103895|NCT03176459|19974402|P1|NOT COMPLETED|Overall Study||5
8103896|NCT03176459|19974401|P2|COMPLETED|Overall Study||83
8103897|NCT03176459|19974402|P1|COMPLETED|Overall Study||91
8103898|NCT03176459|19974401|P2|STARTED|Overall Study||90
8103899|NCT03176459|19974402|P1|STARTED|Overall Study||96
8103900|NCT03176407|19974424|P1|NOT COMPLETED|Overall Study||3
8103901|NCT03176407|19974424|P1|COMPLETED|Overall Study||27
8103902|NCT03176407|19974424|P1|STARTED|Overall Study||30
8103903|NCT03176238|19974434|P2|NOT COMPLETED|Overall Study||36
8103904|NCT03176238|19974435|P1|NOT COMPLETED|Overall Study||199
8103905|NCT03176238|19974434|P2|COMPLETED|Overall Study||0
8103906|NCT03176238|19974435|P1|COMPLETED|Overall Study||0
8103907|NCT03176238|19974434|P2|STARTED|Overall Study||36
8103908|NCT03176238|19974435|P1|STARTED|Overall Study||199
8103909|NCT03175562|19974454|P1|NOT COMPLETED|Overall Study||16
8103910|NCT03175562|19974454|P1|COMPLETED|Overall Study||224
8103911|NCT03175562|19974454|P1|Negative Control|Overall Study||240
8103912|NCT03175562|19974454|P1|Test Product|Overall Study||240
8103913|NCT03175562|19974454|P1|STARTED|Overall Study||240
8103914|NCT03175172|19974479|P1|NOT COMPLETED|Overall Study||10
8103915|NCT03175172|19974479|P1|COMPLETED|Overall Study||0
8103916|NCT03175172|19974479|P1|STARTED|Overall Study||10
8103917|NCT03175120|19974489|P2|NOT COMPLETED|Overall Study||12
8103918|NCT03175120|19974490|P1|NOT COMPLETED|Overall Study||12
8103919|NCT03175120|19974489|P2|COMPLETED|Overall Study||139
8103920|NCT03175120|19974490|P1|COMPLETED|Overall Study||290
8103921|NCT03175120|19974489|P2|Safety Analysis Set (SAS)|Overall Study||151
8103922|NCT03175120|19974490|P1|Safety Analysis Set (SAS)|Overall Study||301
8103923|NCT03175120|19974489|P2|Full Analysis Set (FAS)|Overall Study||151
8103924|NCT03175120|19974490|P1|Full Analysis Set (FAS)|Overall Study||302
8103925|NCT03175120|19974489|P2|Treated|Overall Study||151
8103926|NCT03175120|19974490|P1|Treated|Overall Study||301
8103927|NCT03175120|19974489|P2|STARTED|Overall Study||151
8103928|NCT03175120|19974490|P1|STARTED|Overall Study||302
8103929|NCT03174366|19974612|P1|NOT COMPLETED|Overall Study||0
8103930|NCT03174366|19974612|P1|COMPLETED|Overall Study||7
8103931|NCT03174366|19974612|P1|STARTED|Overall Study||7
8103932|NCT03174158|19974621|P4|NOT COMPLETED|Overall Study||1
8103933|NCT03174158|19974622|P3|NOT COMPLETED|Overall Study||2
8103934|NCT03174158|19974623|P2|NOT COMPLETED|Overall Study||2
8103935|NCT03174158|19974624|P1|NOT COMPLETED|Overall Study||4
8103936|NCT03174158|19974621|P4|COMPLETED|Overall Study||38
8103937|NCT03174158|19974622|P3|COMPLETED|Overall Study||34
8103938|NCT03174158|19974623|P2|COMPLETED|Overall Study||37
8103939|NCT03174158|19974624|P1|COMPLETED|Overall Study||35
8103940|NCT03174158|19974621|P4|STARTED|Overall Study||39
8103941|NCT03174158|19974622|P3|STARTED|Overall Study||36
8103942|NCT03174158|19974623|P2|STARTED|Overall Study||39
8103943|NCT03174158|19974624|P1|STARTED|Overall Study||39
8103944|NCT03174132|19974660|P1|NOT COMPLETED|Overall Study||0
8103945|NCT03174132|19974660|P1|COMPLETED|Overall Study||70
8103946|NCT03174132|19974660|P1|STARTED|Overall Study||70
8103947|NCT03173170|19974665|P1|NOT COMPLETED|Intervention Period 2 (9 Days)||0
8103948|NCT03173170|19974665|P1|COMPLETED|Intervention Period 2 (9 Days)||10
8103949|NCT03173170|19974665|P1|STARTED|Intervention Period 2 (9 Days)||10
8103950|NCT03173170|19974665|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8103951|NCT03173170|19974665|P1|COMPLETED|Washout Period (at Least 7 Days)||10
8103952|NCT03173170|19974665|P1|STARTED|Washout Period (at Least 7 Days)||10
8103953|NCT03173170|19974665|P1|NOT COMPLETED|First Intervention Period (6 Days)||0
8103954|NCT03173170|19974665|P1|COMPLETED|First Intervention Period (6 Days)||10
8103955|NCT03173170|19974665|P1|STARTED|First Intervention Period (6 Days)||10
8103956|NCT03172702|19974674|P1|NOT COMPLETED|Overall Study||28
8103957|NCT03172702|19974674|P1|COMPLETED|Overall Study||122
8103958|NCT03172702|19974674|P1|Received Treatment in MP|Overall Study||150
8103959|NCT03172702|19974674|P1|Received Treatment in CP|Overall Study||150
8103960|NCT03172702|19974674|P1|STARTED|Overall Study||150
8103961|NCT03172520|19974695|P1|NOT COMPLETED|Overall Study||10
8103962|NCT03172520|19974695|P1|COMPLETED|Overall Study||0
8103963|NCT03172520|19974695|P1|STARTED|Overall Study||10
8103964|NCT03172494|19974702|P3|NOT COMPLETED|Overall Study||29
8103965|NCT03172494|19974703|P2|NOT COMPLETED|Overall Study||12
8103966|NCT03172494|19974704|P1|NOT COMPLETED|Overall Study||20
8103967|NCT03172494|19974702|P3|COMPLETED|Overall Study||151
8103968|NCT03172494|19974703|P2|COMPLETED|Overall Study||167
8103969|NCT03172494|19974704|P1|COMPLETED|Overall Study||341
8103970|NCT03172494|19974702|P3|Exposed|Overall Study||180
8103971|NCT03172494|19974703|P2|Exposed|Overall Study||175
8103972|NCT03172494|19974704|P1|Exposed|Overall Study||358
8103973|NCT03172494|19974702|P3|Safety Analysis Set (SAS)|Overall Study||180
8103974|NCT03172494|19974703|P2|Safety Analysis Set (SAS)|Overall Study||175
8103975|NCT03172494|19974704|P1|Safety Analysis Set (SAS)|Overall Study||358
8103976|NCT03172494|19974702|P3|Full Analysis Set (FAS)|Overall Study||180
8103977|NCT03172494|19974703|P2|Full Analysis Set (FAS)|Overall Study||179
8103978|NCT03172494|19974704|P1|Full Analysis Set (FAS)|Overall Study||361
8103979|NCT03172494|19974702|P3|STARTED|Overall Study||180
8103980|NCT03172494|19974703|P2|STARTED|Overall Study||179
8103981|NCT03172494|19974704|P1|STARTED|Overall Study||361
8103982|NCT03172481|19974887|P2|NOT COMPLETED|Double-blind||0
8103983|NCT03172481|19974888|P1|NOT COMPLETED|Double-blind||1
8103984|NCT03172481|19974887|P2|COMPLETED|Double-blind||73
8103985|NCT03172481|19974888|P1|COMPLETED|Double-blind||74
8103986|NCT03172481|19974887|P2|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
8103987|NCT03172481|19974888|P1|STARTED|Double-blind||75
8103988|NCT03172481|19974887|P2|NOT COMPLETED|Open-label||0
8103989|NCT03172481|19974888|P1|NOT COMPLETED|Open-label||8
8103990|NCT03172481|19974887|P2|COMPLETED|Open-label||0
8103991|NCT03172481|19974888|P1|COMPLETED|Open-label||148
8103992|NCT03172481|19974887|P2|STARTED|Open-label||0
8103993|NCT03172481|19974888|P1|STARTED|Open-label||156
8103994|NCT03172364|19974896|P2|NOT COMPLETED|Overall Study||1
8103995|NCT03172364|19974897|P1|NOT COMPLETED|Overall Study||2
8103996|NCT03172364|19974896|P2|COMPLETED|Overall Study||57
8103997|NCT03172364|19974897|P1|COMPLETED|Overall Study||53
8103998|NCT03172364|19974896|P2|STARTED|Overall Study||58
8103999|NCT03172364|19974897|P1|STARTED|Overall Study||55
8104000|NCT03172130|19974915|P2|NOT COMPLETED|Overall Study||1
8104001|NCT03172130|19974916|P1|NOT COMPLETED|Overall Study||3
8104002|NCT03172130|19974915|P2|COMPLETED|Overall Study||9
8104003|NCT03172130|19974916|P1|COMPLETED|Overall Study||9
8104004|NCT03172130|19974915|P2|STARTED|Overall Study||10
8104005|NCT03172130|19974916|P1|STARTED|Overall Study||12
8104006|NCT03171415|19974941|P5|NOT COMPLETED|Overall Study||2
8104007|NCT03171415|19974942|P4|NOT COMPLETED|Overall Study||0
8104008|NCT03171415|19974943|P3|NOT COMPLETED|Overall Study||0
8104009|NCT03171415|19974944|P2|NOT COMPLETED|Overall Study||0
8104010|NCT03171415|19974945|P1|NOT COMPLETED|Overall Study||0
8104011|NCT03171415|19974941|P5|COMPLETED|Overall Study||7
8104012|NCT03171415|19974942|P4|COMPLETED|Overall Study||6
8104013|NCT03171415|19974943|P3|COMPLETED|Overall Study||6
8104014|NCT03171415|19974944|P2|COMPLETED|Overall Study||6
8104015|NCT03171415|19974945|P1|COMPLETED|Overall Study||6
8104016|NCT03171415|19974941|P5|STARTED|Overall Study||9
8104017|NCT03171415|19974942|P4|STARTED|Overall Study||6
8104018|NCT03171415|19974943|P3|STARTED|Overall Study||6
8104019|NCT03171415|19974944|P2|STARTED|Overall Study||6
8104020|NCT03171415|19974945|P1|STARTED|Overall Study||6
8104021|NCT03171051|19975006|P1|NOT COMPLETED|Overall Study||0
8104022|NCT03171051|19975006|P1|COMPLETED|Overall Study||10
8104023|NCT03171051|19975006|P1|STARTED|Overall Study||10
8104024|NCT03170609|19975018|P7|NOT COMPLETED|Overall Study||1
8104025|NCT03170609|19975019|P6|NOT COMPLETED|Overall Study||2
8104026|NCT03170609|19975020|P5|NOT COMPLETED|Overall Study||1
8104027|NCT03170609|19975021|P4|NOT COMPLETED|Overall Study||2
8104028|NCT03170609|19975022|P3|NOT COMPLETED|Overall Study||6
8104029|NCT03170609|19975023|P2|NOT COMPLETED|Overall Study||2
8104030|NCT03170609|19975024|P1|NOT COMPLETED|Overall Study||3
8104031|NCT03170609|19975018|P7|COMPLETED|Overall Study||51
8104032|NCT03170609|19975019|P6|COMPLETED|Overall Study||50
8104033|NCT03170609|19975020|P5|COMPLETED|Overall Study||51
8104034|NCT03170609|19975021|P4|COMPLETED|Overall Study||50
8104035|NCT03170609|19975022|P3|COMPLETED|Overall Study||46
8104036|NCT03170609|19975023|P2|COMPLETED|Overall Study||50
8104037|NCT03170609|19975024|P1|COMPLETED|Overall Study||50
8104038|NCT03170609|19975018|P7|Vaccinated|Overall Study||52
8104039|NCT03170609|19975019|P6|Vaccinated|Overall Study||52
8104040|NCT03170609|19975020|P5|Vaccinated|Overall Study||52
8104041|NCT03170609|19975021|P4|Vaccinated|Overall Study||52
8104042|NCT03170609|19975022|P3|Vaccinated|Overall Study||52
8104043|NCT03170609|19975023|P2|Vaccinated|Overall Study||52
8104044|NCT03170609|19975024|P1|Vaccinated|Overall Study||52
8104045|NCT03170609|19975018|P7|STARTED|Overall Study||52
8104046|NCT03170609|19975019|P6|STARTED|Overall Study||52
8104047|NCT03170609|19975020|P5|STARTED|Overall Study||52
8104048|NCT03170609|19975021|P4|STARTED|Overall Study||52
8104049|NCT03170609|19975022|P3|STARTED|Overall Study||52
8104050|NCT03170609|19975023|P2|STARTED|Overall Study||52
8104051|NCT03170609|19975024|P1|STARTED|Overall Study||53
8104052|NCT03170544|19975094|P12|NOT COMPLETED|Part 4||0
8104053|NCT03170544|19975095|P11|NOT COMPLETED|Part 4||0
8104054|NCT03170544|19975096|P10|NOT COMPLETED|Part 4||0
8104055|NCT03170544|19975097|P9|NOT COMPLETED|Part 4||0
8104056|NCT03170544|19975098|P8|NOT COMPLETED|Part 4||0
8104057|NCT03170544|19975099|P7|NOT COMPLETED|Part 4||0
8104058|NCT03170544|19975100|P6|NOT COMPLETED|Part 4||0
8104059|NCT03170544|19975101|P5|NOT COMPLETED|Part 4||0
8104060|NCT03170544|19975102|P4|NOT COMPLETED|Part 4||0
8104061|NCT03170544|19975103|P3|NOT COMPLETED|Part 4||0
8104062|NCT03170544|19975104|P2|NOT COMPLETED|Part 4||0
8104063|NCT03170544|19975105|P1|NOT COMPLETED|Part 4||0
8104064|NCT03170544|19975094|P12|COMPLETED|Part 4||6
8104065|NCT03170544|19975095|P11|COMPLETED|Part 4||3
8104066|NCT03170544|19975096|P10|COMPLETED|Part 4||0
8104067|NCT03170544|19975097|P9|COMPLETED|Part 4||0
8104068|NCT03170544|19975098|P8|COMPLETED|Part 4||0
8104069|NCT03170544|19975099|P7|COMPLETED|Part 4||0
8104070|NCT03170544|19975100|P6|COMPLETED|Part 4||0
8104071|NCT03170544|19975101|P5|COMPLETED|Part 4||0
8104072|NCT03170544|19975102|P4|COMPLETED|Part 4||0
8104073|NCT03170544|19975103|P3|COMPLETED|Part 4||0
8104074|NCT03170544|19975104|P2|COMPLETED|Part 4||0
8104075|NCT03170544|19975105|P1|COMPLETED|Part 4||0
8104076|NCT03170544|19975094|P12|STARTED|Part 4||6
8104077|NCT03170544|19975095|P11|STARTED|Part 4||3
8104078|NCT03170544|19975096|P10|STARTED|Part 4||0
8104079|NCT03170544|19975097|P9|STARTED|Part 4||0
8104080|NCT03170544|19975098|P8|STARTED|Part 4||0
8104081|NCT03170544|19975099|P7|STARTED|Part 4||0
8104082|NCT03170544|19975100|P6|STARTED|Part 4||0
8104083|NCT03170544|19975101|P5|STARTED|Part 4||0
8104084|NCT03170544|19975102|P4|STARTED|Part 4||0
8104085|NCT03170544|19975103|P3|STARTED|Part 4||0
8104086|NCT03170544|19975104|P2|STARTED|Part 4||0
8104087|NCT03170544|19975105|P1|STARTED|Part 4||0
8104088|NCT03170544|19975094|P12|NOT COMPLETED|Part 3||0
8104089|NCT03170544|19975095|P11|NOT COMPLETED|Part 3||0
8104090|NCT03170544|19975096|P10|NOT COMPLETED|Part 3||0
8104091|NCT03170544|19975097|P9|NOT COMPLETED|Part 3||0
8104092|NCT03170544|19975098|P8|NOT COMPLETED|Part 3||0
8104093|NCT03170544|19975099|P7|NOT COMPLETED|Part 3||0
8104094|NCT03170544|19975100|P6|NOT COMPLETED|Part 3||0
8104095|NCT03170544|19975101|P5|NOT COMPLETED|Part 3||0
8104096|NCT03170544|19975102|P4|NOT COMPLETED|Part 3||0
8104097|NCT03170544|19975103|P3|NOT COMPLETED|Part 3||0
8104098|NCT03170544|19975104|P2|NOT COMPLETED|Part 3||0
8104099|NCT03170544|19975105|P1|NOT COMPLETED|Part 3||0
8104100|NCT03170544|19975094|P12|COMPLETED|Part 3||0
8104101|NCT03170544|19975095|P11|COMPLETED|Part 3||0
8104102|NCT03170544|19975096|P10|COMPLETED|Part 3||6
8104103|NCT03170544|19975097|P9|COMPLETED|Part 3||6
8104104|NCT03170544|19975098|P8|COMPLETED|Part 3||4
8104105|NCT03170544|19975099|P7|COMPLETED|Part 3||0
8104106|NCT03170544|19975100|P6|COMPLETED|Part 3||0
8104107|NCT03170544|19975101|P5|COMPLETED|Part 3||0
8104108|NCT03170544|19975102|P4|COMPLETED|Part 3||0
8104109|NCT03170544|19975103|P3|COMPLETED|Part 3||0
8104110|NCT03170544|19975104|P2|COMPLETED|Part 3||0
8104111|NCT03170544|19975105|P1|COMPLETED|Part 3||0
8104112|NCT03170544|19975094|P12|STARTED|Part 3||0
8104113|NCT03170544|19975095|P11|STARTED|Part 3||0
8104114|NCT03170544|19975096|P10|STARTED|Part 3||6
8104115|NCT03170544|19975097|P9|STARTED|Part 3||6
8104116|NCT03170544|19975098|P8|STARTED|Part 3||4
8104117|NCT03170544|19975099|P7|STARTED|Part 3||0
8104118|NCT03170544|19975100|P6|STARTED|Part 3||0
8104119|NCT03170544|19975101|P5|STARTED|Part 3||0
8104120|NCT03170544|19975102|P4|STARTED|Part 3||0
8104121|NCT03170544|19975103|P3|STARTED|Part 3||0
8104122|NCT03170544|19975104|P2|STARTED|Part 3||0
8104123|NCT03170544|19975105|P1|STARTED|Part 3||0
8104124|NCT03170544|19975094|P12|NOT COMPLETED|Part 2||0
8104125|NCT03170544|19975095|P11|NOT COMPLETED|Part 2||0
8104126|NCT03170544|19975096|P10|NOT COMPLETED|Part 2||0
8104127|NCT03170544|19975097|P9|NOT COMPLETED|Part 2||0
8104128|NCT03170544|19975098|P8|NOT COMPLETED|Part 2||0
8104129|NCT03170544|19975099|P7|NOT COMPLETED|Part 2||0
8104130|NCT03170544|19975100|P6|NOT COMPLETED|Part 2||0
8104131|NCT03170544|19975101|P5|NOT COMPLETED|Part 2||0
8104132|NCT03170544|19975102|P4|NOT COMPLETED|Part 2||0
8104133|NCT03170544|19975103|P3|NOT COMPLETED|Part 2||0
8104134|NCT03170544|19975104|P2|NOT COMPLETED|Part 2||0
8104135|NCT03170544|19975105|P1|NOT COMPLETED|Part 2||0
8104136|NCT03170544|19975094|P12|COMPLETED|Part 2||0
8104137|NCT03170544|19975095|P11|COMPLETED|Part 2||0
8104138|NCT03170544|19975096|P10|COMPLETED|Part 2||0
8104139|NCT03170544|19975097|P9|COMPLETED|Part 2||0
8104140|NCT03170544|19975098|P8|COMPLETED|Part 2||0
8104141|NCT03170544|19975099|P7|COMPLETED|Part 2||4
8104142|NCT03170544|19975100|P6|COMPLETED|Part 2||0
8104143|NCT03170544|19975101|P5|COMPLETED|Part 2||0
8104144|NCT03170544|19975102|P4|COMPLETED|Part 2||0
8104145|NCT03170544|19975103|P3|COMPLETED|Part 2||0
8104146|NCT03170544|19975104|P2|COMPLETED|Part 2||0
8104147|NCT03170544|19975105|P1|COMPLETED|Part 2||0
8104148|NCT03170544|19975094|P12|STARTED|Part 2||0
8104149|NCT03170544|19975095|P11|STARTED|Part 2||0
8104150|NCT03170544|19975096|P10|STARTED|Part 2||0
8104151|NCT03170544|19975097|P9|STARTED|Part 2||0
8104152|NCT03170544|19975098|P8|STARTED|Part 2||0
8104153|NCT03170544|19975099|P7|STARTED|Part 2||4
8104154|NCT03170544|19975100|P6|STARTED|Part 2||0
8104155|NCT03170544|19975101|P5|STARTED|Part 2||0
8104156|NCT03170544|19975102|P4|STARTED|Part 2||0
8104157|NCT03170544|19975103|P3|STARTED|Part 2||0
8104158|NCT03170544|19975104|P2|STARTED|Part 2||0
8104159|NCT03170544|19975105|P1|STARTED|Part 2||0
8104160|NCT03170544|19975094|P12|NOT COMPLETED|Part 1||0
8104161|NCT03170544|19975095|P11|NOT COMPLETED|Part 1||0
8104162|NCT03170544|19975096|P10|NOT COMPLETED|Part 1||0
8104163|NCT03170544|19975097|P9|NOT COMPLETED|Part 1||0
8104164|NCT03170544|19975098|P8|NOT COMPLETED|Part 1||0
8104165|NCT03170544|19975099|P7|NOT COMPLETED|Part 1||0
8104166|NCT03170544|19975100|P6|NOT COMPLETED|Part 1||0
8104167|NCT03170544|19975101|P5|NOT COMPLETED|Part 1||0
8104168|NCT03170544|19975102|P4|NOT COMPLETED|Part 1||1
8104169|NCT03170544|19975103|P3|NOT COMPLETED|Part 1||0
8104170|NCT03170544|19975104|P2|NOT COMPLETED|Part 1||0
8104171|NCT03170544|19975105|P1|NOT COMPLETED|Part 1||1
8104172|NCT03170544|19975094|P12|COMPLETED|Part 1||0
8104173|NCT03170544|19975095|P11|COMPLETED|Part 1||0
8104174|NCT03170544|19975096|P10|COMPLETED|Part 1||0
8104175|NCT03170544|19975097|P9|COMPLETED|Part 1||0
8104176|NCT03170544|19975098|P8|COMPLETED|Part 1||0
8104177|NCT03170544|19975099|P7|COMPLETED|Part 1||0
8104178|NCT03170544|19975100|P6|COMPLETED|Part 1||6
8104179|NCT03170544|19975101|P5|COMPLETED|Part 1||6
8104180|NCT03170544|19975102|P4|COMPLETED|Part 1||6
8104181|NCT03170544|19975103|P3|COMPLETED|Part 1||6
8104182|NCT03170544|19975104|P2|COMPLETED|Part 1||6
8104183|NCT03170544|19975105|P1|COMPLETED|Part 1||9
8104184|NCT03170544|19975094|P12|STARTED|Part 1||0
8104185|NCT03170544|19975095|P11|STARTED|Part 1||0
8104186|NCT03170544|19975096|P10|STARTED|Part 1||0
8104187|NCT03170544|19975097|P9|STARTED|Part 1||0
8104188|NCT03170544|19975098|P8|STARTED|Part 1||0
8104189|NCT03170544|19975099|P7|STARTED|Part 1||0
8104190|NCT03170544|19975100|P6|STARTED|Part 1||6
8104191|NCT03170544|19975101|P5|STARTED|Part 1||6
8104192|NCT03170544|19975102|P4|STARTED|Part 1||7
8104193|NCT03170544|19975103|P3|STARTED|Part 1||6
8104194|NCT03170544|19975104|P2|STARTED|Part 1||6
8104195|NCT03170544|19975105|P1|STARTED|Part 1||10
8104196|NCT03170271|19975269|P2|NOT COMPLETED|Overall Study||11
8104197|NCT03170271|19975270|P1|NOT COMPLETED|Overall Study||33
8104198|NCT03170271|19975269|P2|COMPLETED|Overall Study||218
8104199|NCT03170271|19975270|P1|COMPLETED|Overall Study||398
8104200|NCT03170271|19975269|P2|Received Treatment|Overall Study||229
8104201|NCT03170271|19975270|P1|Received Treatment|Overall Study||427
8104202|NCT03170271|19975269|P2|STARTED|Overall Study||229
8104203|NCT03170271|19975270|P1|STARTED|Overall Study||431
8104204|NCT03170232|19975298|P2|NOT COMPLETED|Overall Study||27
8104205|NCT03170232|19975299|P1|NOT COMPLETED|Overall Study||27
8104206|NCT03170232|19975298|P2|COMPLETED|Overall Study||0
8104207|NCT03170232|19975299|P1|COMPLETED|Overall Study||0
8104208|NCT03170232|19975298|P2|STARTED|Overall Study||27
8104209|NCT03170232|19975299|P1|STARTED|Overall Study||27
8104210|NCT03170219|19975345|P2|NOT COMPLETED|Overall Study||0
8104211|NCT03170219|19975346|P1|NOT COMPLETED|Overall Study||0
8104212|NCT03170219|19975345|P2|COMPLETED|Overall Study||4
8104213|NCT03170219|19975346|P1|COMPLETED|Overall Study||7
8104214|NCT03170219|19975345|P2|STARTED|Overall Study||4
8104215|NCT03170219|19975346|P1|STARTED|Overall Study||7
8104216|NCT03170193|19975377|P7|NOT COMPLETED|Overall Study||0
8104217|NCT03170193|19975378|P6|NOT COMPLETED|Overall Study||0
8104218|NCT03170193|19975379|P5|NOT COMPLETED|Overall Study||0
8104219|NCT03170193|19975380|P4|NOT COMPLETED|Overall Study||1
8104220|NCT03170193|19975381|P3|NOT COMPLETED|Overall Study||0
8104221|NCT03170193|19975382|P2|NOT COMPLETED|Overall Study||1
8104222|NCT03170193|19975383|P1|NOT COMPLETED|Overall Study||1
8104223|NCT03170193|19975377|P7|COMPLETED|Overall Study||6
8104224|NCT03170193|19975378|P6|COMPLETED|Overall Study||6
8104225|NCT03170193|19975379|P5|COMPLETED|Overall Study||6
8104226|NCT03170193|19975380|P4|COMPLETED|Overall Study||5
8104227|NCT03170193|19975381|P3|COMPLETED|Overall Study||6
8104228|NCT03170193|19975382|P2|COMPLETED|Overall Study||5
8104229|NCT03170193|19975383|P1|COMPLETED|Overall Study||11
8104230|NCT03170193|19975377|P7|STARTED|Overall Study||6
8104231|NCT03170193|19975378|P6|STARTED|Overall Study||6
8104232|NCT03170193|19975379|P5|STARTED|Overall Study||6
8104233|NCT03170193|19975380|P4|STARTED|Overall Study||6
8104234|NCT03170193|19975381|P3|STARTED|Overall Study||6
8104235|NCT03170193|19975382|P2|STARTED|Overall Study||6
8104236|NCT03170193|19975383|P1|STARTED|Overall Study||12
8104237|NCT03170154|19975452|P1|NOT COMPLETED|Overall Study||8
8104238|NCT03170154|19975452|P1|COMPLETED|Overall Study||342
8104239|NCT03170154|19975452|P1|Rotational Stability Sub-study|Overall Study||141
8104240|NCT03170154|19975452|P1|STARTED|Overall Study||350
8104241|NCT03169816|19975467|P2|NOT COMPLETED|Overall Study||13
8104242|NCT03169816|19975468|P1|NOT COMPLETED|Overall Study||27
8104243|NCT03169816|19975467|P2|COMPLETED|Overall Study||3
8104244|NCT03169816|19975468|P1|COMPLETED|Overall Study||6
8104245|NCT03169816|19975467|P2|STARTED|Overall Study||16
8104246|NCT03169816|19975468|P1|STARTED|Overall Study||33
8104247|NCT03169530|19975476|P2|NOT COMPLETED|Overall Study||17
8104248|NCT03169530|19975477|P1|NOT COMPLETED|Overall Study||15
8104249|NCT03169530|19975476|P2|COMPLETED|Overall Study||0
8104250|NCT03169530|19975477|P1|COMPLETED|Overall Study||0
8104251|NCT03169530|19975476|P2|STARTED|Overall Study||17
8104252|NCT03169530|19975477|P1|STARTED|Overall Study||15
8104253|NCT03169244|19975497|P2|NOT COMPLETED|Overall Study||4
8104254|NCT03169244|19975498|P1|NOT COMPLETED|Overall Study||5
8104255|NCT03169244|19975497|P2|COMPLETED|Overall Study||16
8104256|NCT03169244|19975498|P1|COMPLETED|Overall Study||17
8104257|NCT03169244|19975497|P2|Received Intervention|Overall Study||18
8104258|NCT03169244|19975498|P1|Received Intervention|Overall Study||22
8104259|NCT03169244|19975497|P2|Randomly Assigned|Overall Study||20
8104260|NCT03169244|19975498|P1|Randomly Assigned|Overall Study||22
8104261|NCT03169244|19975497|P2|STARTED|Overall Study||20
8104262|NCT03169244|19975498|P1|STARTED|Overall Study||22
8104263|NCT03169153|19975508|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
8104264|NCT03169153|19975509|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
8104265|NCT03169153|19975508|P2|COMPLETED|Period 2, Second 30 Days of Wear||32
8104266|NCT03169153|19975509|P1|COMPLETED|Period 2, Second 30 Days of Wear||37
8104267|NCT03169153|19975508|P2|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
8104268|NCT03169153|19975509|P1|STARTED|Period 2, Second 30 Days of Wear||39
8104269|NCT03169153|19975508|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||4
8104270|NCT03169153|19975509|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
8104271|NCT03169153|19975508|P2|COMPLETED|Period 1, First 30 Days of Wear||35
8104272|NCT03169153|19975509|P1|COMPLETED|Period 1, First 30 Days of Wear||39
8104273|NCT03169153|19975508|P2|STARTED|Period 1, First 30 Days of Wear||39
8104274|NCT03169153|19975509|P1|STARTED|Period 1, First 30 Days of Wear||42
8104275|NCT03169062|19975515|P1|NOT COMPLETED|Overall Study||0
8104276|NCT03169062|19975515|P1|COMPLETED|Overall Study||10
8104277|NCT03169062|19975515|P1|STARTED|Overall Study||10
8104278|NCT03168919|19975520|P1|NOT COMPLETED|Overall Study||2
8104279|NCT03168919|19975520|P1|COMPLETED|Overall Study||3
8104280|NCT03168919|19975520|P1|STARTED|Overall Study||5
8104281|NCT03168906|19975530|P2|NOT COMPLETED|Overall Study||6
8104282|NCT03168906|19975531|P1|NOT COMPLETED|Overall Study||6
8104283|NCT03168906|19975530|P2|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
8104284|NCT03168906|19975531|P1|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
8104285|NCT03168906|19975530|P2|STARTED|Overall Study||6
8104286|NCT03168906|19975531|P1|STARTED|Overall Study||6
8104287|NCT03168841|19975551|P1|NOT COMPLETED|Overall Study||4
8104288|NCT03168841|19975551|P1|COMPLETED|Overall Study||36
8104289|NCT03168841|19975551|P1|STARTED|Overall Study||40
8104290|NCT03168542|19975558|P3|NOT COMPLETED|Overall Study||0
8104291|NCT03168542|19975559|P2|NOT COMPLETED|Overall Study||0
8104292|NCT03168542|19975560|P1|NOT COMPLETED|Overall Study||0
8104293|NCT03168542|19975558|P3|COMPLETED|Overall Study||9
8104294|NCT03168542|19975559|P2|COMPLETED|Overall Study||5
8104295|NCT03168542|19975560|P1|COMPLETED|Overall Study||7
8104296|NCT03168542|19975558|P3|STARTED|Overall Study||9
8104297|NCT03168542|19975559|P2|STARTED|Overall Study||5
8104298|NCT03168542|19975560|P1|STARTED|Overall Study||7
8104299|NCT03168425|19975577|P2|NOT COMPLETED|Overall Study||11
8104300|NCT03168425|19975578|P1|NOT COMPLETED|Overall Study||7
8104301|NCT03168425|19975577|P2|COMPLETED|Overall Study||85
8104302|NCT03168425|19975578|P1|COMPLETED|Overall Study||87
8104303|NCT03168425|19975577|P2|STARTED|Overall Study||96
8104304|NCT03168425|19975578|P1|STARTED|Overall Study||94
8104305|NCT03168308|19975588|P2|NOT COMPLETED|Overall Study||0
8104306|NCT03168308|19975589|P1|NOT COMPLETED|Overall Study||0
8104307|NCT03168308|19975588|P2|COMPLETED|Overall Study||44
8104308|NCT03168308|19975589|P1|COMPLETED|Overall Study||48
8104309|NCT03168308|19975588|P2|STARTED|Overall Study||44
8104310|NCT03168308|19975589|P1|STARTED|Overall Study||48
8104311|NCT03168295|19975602|P5|NOT COMPLETED|Overall Study||0
8104312|NCT03168295|19975603|P4|NOT COMPLETED|Overall Study||0
8104313|NCT03168295|19975604|P3|NOT COMPLETED|Overall Study||0
8104314|NCT03168295|19975605|P2|NOT COMPLETED|Overall Study||0
8104315|NCT03168295|19975606|P1|NOT COMPLETED|Overall Study||0
8104316|NCT03168295|19975602|P5|COMPLETED|Overall Study||20
8104317|NCT03168295|19975603|P4|COMPLETED|Overall Study||4
8104318|NCT03168295|19975604|P3|COMPLETED|Overall Study||4
8104319|NCT03168295|19975605|P2|COMPLETED|Overall Study||3
8104320|NCT03168295|19975606|P1|COMPLETED|Overall Study||3
8104321|NCT03168295|19975602|P5|STARTED|Overall Study||20
8104322|NCT03168295|19975603|P4|STARTED|Overall Study||4
8104323|NCT03168295|19975604|P3|STARTED|Overall Study||4
8104324|NCT03168295|19975605|P2|STARTED|Overall Study||3
8104325|NCT03168295|19975606|P1|STARTED|Overall Study||3
8104326|NCT03168022|19975620|P2|NOT COMPLETED|Overall Study||1
8104327|NCT03168022|19975621|P1|NOT COMPLETED|Overall Study||0
8104328|NCT03168022|19975620|P2|COMPLETED|Overall Study||21
8104329|NCT03168022|19975621|P1|COMPLETED|Overall Study||21
8104330|NCT03168022|19975620|P2|STARTED|Overall Study||22
8104331|NCT03168022|19975621|P1|STARTED|Overall Study||21
8104332|NCT03167541|19975629|P2|NOT COMPLETED|Second Intervention||0
8104333|NCT03167541|19975630|P1|NOT COMPLETED|Second Intervention||0
8104334|NCT03167541|19975629|P2|COMPLETED|Second Intervention||9
8104335|NCT03167541|19975630|P1|COMPLETED|Second Intervention||9
8104336|NCT03167541|19975629|P2|STARTED|Second Intervention||9
8104337|NCT03167541|19975630|P1|STARTED|Second Intervention||9
8104338|NCT03167541|19975629|P2|NOT COMPLETED|Washout: 5-8 Days||0
8104339|NCT03167541|19975630|P1|NOT COMPLETED|Washout: 5-8 Days||0
8104340|NCT03167541|19975629|P2|COMPLETED|Washout: 5-8 Days||9
8104341|NCT03167541|19975630|P1|COMPLETED|Washout: 5-8 Days||9
8104342|NCT03167541|19975629|P2|STARTED|Washout: 5-8 Days||9
8104343|NCT03167541|19975630|P1|STARTED|Washout: 5-8 Days||9
8104344|NCT03167541|19975629|P2|NOT COMPLETED|First Intervention||0
8104345|NCT03167541|19975630|P1|NOT COMPLETED|First Intervention||0
8104346|NCT03167541|19975629|P2|COMPLETED|First Intervention||9
8104347|NCT03167541|19975630|P1|COMPLETED|First Intervention||9
8104348|NCT03167541|19975629|P2|STARTED|First Intervention||9
8104349|NCT03167541|19975630|P1|STARTED|First Intervention||9
8104350|NCT03167151|19975655|P3|NOT COMPLETED|Overall Study||1
8104351|NCT03167151|19975656|P2|NOT COMPLETED|Overall Study||1
8104352|NCT03167151|19975657|P1|NOT COMPLETED|Overall Study||1
8104353|NCT03167151|19975655|P3|COMPLETED|Overall Study||2
8104354|NCT03167151|19975656|P2|COMPLETED|Overall Study||2
8104355|NCT03167151|19975657|P1|COMPLETED|Overall Study||2
8104356|NCT03167151|19975655|P3|STARTED|Overall Study||3
8104357|NCT03167151|19975656|P2|STARTED|Overall Study||3
8104358|NCT03167151|19975657|P1|STARTED|Overall Study||3
8104359|NCT03166735|19975670|P5|NOT COMPLETED|Overall Study||4
8104360|NCT03166735|19975671|P4|NOT COMPLETED|Overall Study||1
8104361|NCT03166735|19975672|P3|NOT COMPLETED|Overall Study||3
8104362|NCT03166735|19975673|P2|NOT COMPLETED|Overall Study||3
8104363|NCT03166735|19975674|P1|NOT COMPLETED|Overall Study||1
8104364|NCT03166735|19975670|P5|COMPLETED|Overall Study||28
8104365|NCT03166735|19975671|P4|COMPLETED|Overall Study||16
8104366|NCT03166735|19975672|P3|COMPLETED|Overall Study||13
8104367|NCT03166735|19975673|P2|COMPLETED|Overall Study||13
8104368|NCT03166735|19975674|P1|COMPLETED|Overall Study||32
8104369|NCT03166735|19975670|P5|Treated|Overall Study||32
8104370|NCT03166735|19975671|P4|Treated|Overall Study||17
8104371|NCT03166735|19975672|P3|Treated|Overall Study||16
8104372|NCT03166735|19975673|P2|Treated|Overall Study||16
8104373|NCT03166735|19975674|P1|Treated|Overall Study||32
8104374|NCT03166735|19975670|P5|STARTED|Overall Study||32
8104375|NCT03166735|19975671|P4|STARTED|Overall Study||17
8104376|NCT03166735|19975672|P3|STARTED|Overall Study||16
8104377|NCT03166735|19975673|P2|STARTED|Overall Study||16
8104378|NCT03166735|19975674|P1|STARTED|Overall Study||33
8104379|NCT03166618|19975724|P2|NOT COMPLETED|Overall Study||1
8104380|NCT03166618|19975725|P1|NOT COMPLETED|Overall Study||0
8104381|NCT03166618|19975724|P2|COMPLETED|Overall Study||0
8104382|NCT03166618|19975725|P1|COMPLETED|Overall Study||0
8104383|NCT03166618|19975724|P2|STARTED|Overall Study||1
8104384|NCT03166618|19975725|P1|STARTED|Overall Study||0
8104385|NCT03166215|19975737|P3|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
8104386|NCT03166215|19975738|P2|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104387|NCT03166215|19975739|P1|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104388|NCT03166215|19975737|P3|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
8104389|NCT03166215|19975738|P2|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104390|NCT03166215|19975739|P1|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104391|NCT03166215|19975737|P3|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
8104392|NCT03166215|19975738|P2|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104393|NCT03166215|19975739|P1|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104394|NCT03166215|19975737|P3|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104395|NCT03166215|19975738|P2|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
8104396|NCT03166215|19975739|P1|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104397|NCT03166215|19975737|P3|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104398|NCT03166215|19975738|P2|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
8104399|NCT03166215|19975739|P1|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
8104400|NCT03166215|19975737|P3|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104401|NCT03166215|19975738|P2|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
8104402|NCT03166215|19975739|P1|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
8104403|NCT03166124|19975779|P4|NOT COMPLETED|Treatment Period 2||0
8104404|NCT03166124|19975780|P3|NOT COMPLETED|Treatment Period 2||0
8104405|NCT03166124|19975781|P2|NOT COMPLETED|Treatment Period 2||0
8104406|NCT03166124|19975782|P1|NOT COMPLETED|Treatment Period 2||0
8104407|NCT03166124|19975779|P4|COMPLETED|Treatment Period 2||20
8104408|NCT03166124|19975780|P3|COMPLETED|Treatment Period 2||17
8104409|NCT03166124|19975781|P2|COMPLETED|Treatment Period 2||18
8104410|NCT03166124|19975782|P1|COMPLETED|Treatment Period 2||20
8104411|NCT03166124|19975779|P4|STARTED|Treatment Period 2||20
8104412|NCT03166124|19975780|P3|STARTED|Treatment Period 2||17
8104413|NCT03166124|19975781|P2|STARTED|Treatment Period 2||18
8104414|NCT03166124|19975782|P1|STARTED|Treatment Period 2||20
8104415|NCT03166124|19975779|P4|NOT COMPLETED|Wash-out Period||1
8104416|NCT03166124|19975780|P3|NOT COMPLETED|Wash-out Period||1
8104417|NCT03166124|19975781|P2|NOT COMPLETED|Wash-out Period||2
8104418|NCT03166124|19975782|P1|NOT COMPLETED|Wash-out Period||0
8104419|NCT03166124|19975779|P4|COMPLETED|Wash-out Period||20
8104420|NCT03166124|19975780|P3|COMPLETED|Wash-out Period||17
8104421|NCT03166124|19975781|P2|COMPLETED|Wash-out Period||18
8104422|NCT03166124|19975782|P1|COMPLETED|Wash-out Period||20
8104423|NCT03166124|19975779|P4|STARTED|Wash-out Period||21
8104424|NCT03166124|19975780|P3|STARTED|Wash-out Period||18
8104425|NCT03166124|19975781|P2|STARTED|Wash-out Period||20
8104426|NCT03166124|19975782|P1|STARTED|Wash-out Period||20
8104427|NCT03166124|19975779|P4|NOT COMPLETED|Treatment Period 1||0
8104428|NCT03166124|19975780|P3|NOT COMPLETED|Treatment Period 1||1
8104429|NCT03166124|19975781|P2|NOT COMPLETED|Treatment Period 1||0
8104430|NCT03166124|19975782|P1|NOT COMPLETED|Treatment Period 1||0
8104431|NCT03166124|19975779|P4|COMPLETED|Treatment Period 1||21
8104432|NCT03166124|19975780|P3|COMPLETED|Treatment Period 1||18
8104433|NCT03166124|19975781|P2|COMPLETED|Treatment Period 1||20
8104434|NCT03166124|19975782|P1|COMPLETED|Treatment Period 1||20
8104435|NCT03166124|19975779|P4|Received at Least One Dose of Study Drug|Treatment Period 1||21
8104436|NCT03166124|19975780|P3|Received at Least One Dose of Study Drug|Treatment Period 1||18
8104437|NCT03166124|19975781|P2|Received at Least One Dose of Study Drug|Treatment Period 1||20
8104438|NCT03166124|19975782|P1|Received at Least One Dose of Study Drug|Treatment Period 1||20
8104439|NCT03166124|19975779|P4|STARTED|Treatment Period 1||21
8104440|NCT03166124|19975780|P3|STARTED|Treatment Period 1||19
8104441|NCT03166124|19975781|P2|STARTED|Treatment Period 1||20
8104442|NCT03166124|19975782|P1|STARTED|Treatment Period 1||20
8104443|NCT03165981|19975798|P2|NOT COMPLETED|Overall Study||4
8104444|NCT03165981|19975799|P1|NOT COMPLETED|Overall Study||11
8104445|NCT03165981|19975798|P2|COMPLETED|Overall Study||107
8104446|NCT03165981|19975799|P1|COMPLETED|Overall Study||99
8104447|NCT03165981|19975798|P2|Per Protocol Population|Overall Study||107
8104448|NCT03165981|19975799|P1|Per Protocol Population|Overall Study||99
8104449|NCT03165981|19975798|P2|STARTED|Overall Study||111
8104450|NCT03165981|19975799|P1|STARTED|Overall Study||110
8104451|NCT03165955|19975827|P1|NOT COMPLETED|Treatment||8
8104452|NCT03165955|19975827|P1|COMPLETED|Treatment||20
8104453|NCT03165955|19975827|P1|STARTED|Treatment||28
8104454|NCT03165955|19975827|P1|NOT COMPLETED|Screening/Baseline||3
8104455|NCT03165955|19975827|P1|COMPLETED|Screening/Baseline||28
8104456|NCT03165955|19975827|P1|STARTED|Screening/Baseline||31
8104457|NCT03165916|19975846|P2|NOT COMPLETED|Overall Study||0
8104458|NCT03165916|19975847|P1|NOT COMPLETED|Overall Study||0
8104459|NCT03165916|19975846|P2|COMPLETED|Overall Study||57
8104460|NCT03165916|19975847|P1|COMPLETED|Overall Study||58
8104461|NCT03165916|19975846|P2|Reconstruction Interventions|Overall Study||57
8104462|NCT03165916|19975847|P1|Reconstruction Interventions|Overall Study||59
8104463|NCT03165916|19975846|P2|STARTED|Overall Study||57
8104464|NCT03165916|19975847|P1|STARTED|Overall Study||58
8104465|NCT03165747|19975857|P2|NOT COMPLETED|Overall Study||0
8104466|NCT03165747|19975858|P1|NOT COMPLETED|Overall Study||0
8104467|NCT03165747|19975857|P2|COMPLETED|Overall Study||0
8104468|NCT03165747|19975858|P1|COMPLETED|Overall Study||0
8104469|NCT03165747|19975857|P2|STARTED|Overall Study||0
8104470|NCT03165747|19975858|P1|STARTED|Overall Study||0
8104471|NCT03165617|19975886|P2|NOT COMPLETED|Overall Study||9
8104472|NCT03165617|19975887|P1|NOT COMPLETED|Overall Study||9
8104473|NCT03165617|19975886|P2|COMPLETED|Overall Study||2247
8104474|NCT03165617|19975887|P1|COMPLETED|Overall Study||2249
8104475|NCT03165617|19975886|P2|STARTED|Overall Study||2256
8104476|NCT03165617|19975887|P1|STARTED|Overall Study||2258
8104477|NCT03165175|19975951|P2|NOT COMPLETED|Baseline to 3-month||0
8104478|NCT03165175|19975952|P1|NOT COMPLETED|Baseline to 3-month||4
8104479|NCT03165175|19975951|P2|COMPLETED|Baseline to 3-month||39
8104480|NCT03165175|19975952|P1|COMPLETED|Baseline to 3-month||31
8104481|NCT03165175|19975951|P2|STARTED|Baseline to 3-month||39
8104482|NCT03165175|19975952|P1|STARTED|Baseline to 3-month||35
8104483|NCT03165175|19975951|P2|NOT COMPLETED|1-month to 3-month||0
8104484|NCT03165175|19975952|P1|NOT COMPLETED|1-month to 3-month||6
8104485|NCT03165175|19975951|P2|COMPLETED|1-month to 3-month||39
8104486|NCT03165175|19975952|P1|COMPLETED|1-month to 3-month||35
8104487|NCT03165175|19975951|P2|STARTED|1-month to 3-month||39
8104488|NCT03165175|19975952|P1|STARTED|1-month to 3-month||41
8104489|NCT03165110|19975966|P1|NOT COMPLETED|Overall Study||1
8104490|NCT03165110|19975966|P1|COMPLETED|Overall Study||46
8104491|NCT03165110|19975966|P1|STARTED|Overall Study||47
8104492|NCT03165058|19975980|P2|NOT COMPLETED|Overall Study||0
8104493|NCT03165058|19975981|P1|NOT COMPLETED|Overall Study||0
8104494|NCT03165058|19975980|P2|COMPLETED|Overall Study||11
8104495|NCT03165058|19975981|P1|COMPLETED|Overall Study||21
8104496|NCT03165058|19975980|P2|STARTED|Overall Study||11
8104497|NCT03165058|19975981|P1|STARTED|Overall Study||21
8104498|NCT03165045|19975988|P1|NOT COMPLETED|Visit 2||182
8104499|NCT03165045|19975988|P1|COMPLETED|Visit 2||1140
8104500|NCT03165045|19975988|P1|STARTED|Visit 2||1322
8104501|NCT03165045|19975988|P1|NOT COMPLETED|Visit 1||29
8104502|NCT03165045|19975988|P1|COMPLETED|Visit 1||1322
8104503|NCT03165045|19975988|P1|STARTED|Visit 1||1351
8104504|NCT03164629|19975999|P2|NOT COMPLETED|Overall Study||0
8104505|NCT03164629|19976000|P1|NOT COMPLETED|Overall Study||0
8104506|NCT03164629|19975999|P2|COMPLETED|Overall Study||25
8104507|NCT03164629|19976000|P1|COMPLETED|Overall Study||25
8104508|NCT03164629|19975999|P2|STARTED|Overall Study||25
8104509|NCT03164629|19976000|P1|STARTED|Overall Study||25
8104510|NCT03164551|19976008|P2|NOT COMPLETED|Overall Study||16
8104511|NCT03164551|19976009|P1|NOT COMPLETED|Overall Study||29
8104512|NCT03164551|19976008|P2|COMPLETED|Overall Study||192
8104513|NCT03164551|19976009|P1|COMPLETED|Overall Study||171
8104514|NCT03164551|19976008|P2|STARTED|Overall Study||208
8104515|NCT03164551|19976009|P1|STARTED|Overall Study||200
8104516|NCT03163758|19976035|P2|NOT COMPLETED|Overall Study||7
8104517|NCT03163758|19976036|P1|NOT COMPLETED|Overall Study||8
8104518|NCT03163758|19976035|P2|COMPLETED|Overall Study||14
8104519|NCT03163758|19976036|P1|COMPLETED|Overall Study||13
8104520|NCT03163758|19976035|P2|STARTED|Overall Study||21
8104521|NCT03163758|19976036|P1|STARTED|Overall Study||21
8104522|NCT03163342|19976048|P1|NOT COMPLETED|Overall Study||0
8104523|NCT03163342|19976048|P1|COMPLETED|Overall Study||20
8104524|NCT03163342|19976048|P1|STARTED|Overall Study||20
8104525|NCT03163303|19976057|P2|NOT COMPLETED|Overall Study||0
8104526|NCT03163303|19976058|P1|NOT COMPLETED|Overall Study||0
8104527|NCT03163303|19976057|P2|COMPLETED|Overall Study||94
8104528|NCT03163303|19976058|P1|COMPLETED|Overall Study||85
8104529|NCT03163303|19976057|P2|STARTED|Overall Study||94
8104530|NCT03163303|19976058|P1|STARTED|Overall Study||85
8104531|NCT03163134|19976092|P2|NOT COMPLETED|Overall Study||0
8104532|NCT03163134|19976093|P1|NOT COMPLETED|Overall Study||0
8104533|NCT03163134|19976092|P2|COMPLETED|Overall Study||85
8104534|NCT03163134|19976093|P1|COMPLETED|Overall Study||85
8104535|NCT03163134|19976092|P2|STARTED|Overall Study||85
8104536|NCT03163134|19976093|P1|STARTED|Overall Study||85
8104537|NCT03163017|19976101|P1|NOT COMPLETED|Overall Study||0
8104538|NCT03163017|19976101|P1|COMPLETED|Overall Study||30
8104539|NCT03163017|19976101|P1|STARTED|Overall Study||30
8104567|NCT03162614|19976432|P6|NOT COMPLETED|Overall Study||0
8104568|NCT03162614|19976433|P5|NOT COMPLETED|Overall Study||5
8104569|NCT03162614|19976434|P4|NOT COMPLETED|Overall Study||7
8104570|NCT03162614|19976435|P3|NOT COMPLETED|Overall Study||4
8104571|NCT03162614|19976436|P2|NOT COMPLETED|Overall Study||5
8104572|NCT03162614|19976437|P1|NOT COMPLETED|Overall Study||6
8104573|NCT03162614|19976432|P6|COMPLETED|Overall Study||24
8104574|NCT03162614|19976433|P5|COMPLETED|Overall Study||21
8104575|NCT03162614|19976434|P4|COMPLETED|Overall Study||19
8104576|NCT03162614|19976435|P3|COMPLETED|Overall Study||22
8104577|NCT03162614|19976436|P2|COMPLETED|Overall Study||21
8104578|NCT03162614|19976437|P1|COMPLETED|Overall Study||20
8104579|NCT03162614|19976432|P6|STARTED|Overall Study||24
8104580|NCT03162614|19976433|P5|STARTED|Overall Study||26
8104581|NCT03162614|19976434|P4|STARTED|Overall Study||26
8104582|NCT03162614|19976435|P3|STARTED|Overall Study||26
8104583|NCT03162614|19976436|P2|STARTED|Overall Study||26
8104584|NCT03162614|19976437|P1|STARTED|Overall Study||26
8104585|NCT03162458|19976531|P2|NOT COMPLETED|Overall Study||0
8104586|NCT03162458|19976532|P1|NOT COMPLETED|Overall Study||0
8104587|NCT03162458|19976531|P2|COMPLETED|Overall Study||71
8104588|NCT03162458|19976532|P1|COMPLETED|Overall Study||71
8104589|NCT03162458|19976531|P2|STARTED|Overall Study||71
8104590|NCT03162458|19976532|P1|STARTED|Overall Study||71
8104591|NCT03162354|19976558|P2|NOT COMPLETED|Overall Study||0
8104592|NCT03162354|19976559|P1|NOT COMPLETED|Overall Study||0
8104593|NCT03162354|19976558|P2|COMPLETED|Overall Study||237
8104594|NCT03162354|19976559|P1|COMPLETED|Overall Study||183
8104595|NCT03162354|19976558|P2|STARTED|Overall Study||237
8104596|NCT03162354|19976559|P1|STARTED|Overall Study||183
8104597|NCT03162328|19976590|P3|NOT COMPLETED|Study Period||1
8104598|NCT03162328|19976591|P2|NOT COMPLETED|Study Period||0
8104599|NCT03162328|19976592|P1|NOT COMPLETED|Study Period||0
8104600|NCT03162328|19976590|P3|COMPLETED|Study Period||31
8104601|NCT03162328|19976591|P2|COMPLETED|Study Period||30
8104602|NCT03162328|19976592|P1|COMPLETED|Study Period||0
8104603|NCT03162328|19976590|P3|STARTED|Study Period||32
8104604|NCT03162328|19976591|P2|STARTED|Study Period||30
8104605|NCT03162328|19976592|P1|STARTED|Study Period||0
8104606|NCT03162328|19976590|P3|NOT COMPLETED|Screening Period||0
8104607|NCT03162328|19976591|P2|NOT COMPLETED|Screening Period||0
8104608|NCT03162328|19976592|P1|NOT COMPLETED|Screening Period||22
8104609|NCT03162328|19976590|P3|COMPLETED|Screening Period||0
8104610|NCT03162328|19976591|P2|COMPLETED|Screening Period||0
8104611|NCT03162328|19976592|P1|COMPLETED|Screening Period||62
8104612|NCT03162328|19976590|P3|STARTED|Screening Period||0
8104613|NCT03162328|19976591|P2|STARTED|Screening Period||0
8104614|NCT03162328|19976592|P1|STARTED|Screening Period||84
8104615|NCT03162055|19976621|P2|NOT COMPLETED|Overall Study||43
8104616|NCT03162055|19976622|P1|NOT COMPLETED|Overall Study||62
8104617|NCT03162055|19976621|P2|COMPLETED|Overall Study||517
8104618|NCT03162055|19976622|P1|COMPLETED|Overall Study||497
8104619|NCT03162055|19976621|P2|Per Protocol (PP) Analysis Set|Overall Study||510
8104620|NCT03162055|19976622|P1|Per Protocol (PP) Analysis Set|Overall Study||506
8104621|NCT03162055|19976621|P2|Full Analysis Set (FAS)|Overall Study||552
8104622|NCT03162055|19976622|P1|Full Analysis Set (FAS)|Overall Study||552
8104623|NCT03162055|19976621|P2|Safety Analysis Set|Overall Study||552
8104624|NCT03162055|19976622|P1|Safety Analysis Set|Overall Study||552
8104625|NCT03162055|19976621|P2|Received Treatment|Overall Study||560
8104626|NCT03162055|19976622|P1|Received Treatment|Overall Study||557
8104627|NCT03162055|19976621|P2|STARTED|Overall Study||560
8104628|NCT03162055|19976622|P1|STARTED|Overall Study||559
8104629|NCT03161964|19976648|P2|NOT COMPLETED|Overall Study||1
8104630|NCT03161964|19976649|P1|NOT COMPLETED|Overall Study||0
8104631|NCT03161964|19976648|P2|COMPLETED|Overall Study||0
8104632|NCT03161964|19976649|P1|COMPLETED|Overall Study||1
8104633|NCT03161964|19976648|P2|STARTED|Overall Study||1
8104634|NCT03161964|19976649|P1|STARTED|Overall Study||1
8104635|NCT03161938|19976687|P2|NOT COMPLETED|Overall Study||0
8104636|NCT03161938|19976688|P1|NOT COMPLETED|Overall Study||0
8104637|NCT03161938|19976687|P2|COMPLETED|Overall Study||32
8104638|NCT03161938|19976688|P1|COMPLETED|Overall Study||32
8104639|NCT03161938|19976687|P2|STARTED|Overall Study||32
8104640|NCT03161938|19976688|P1|STARTED|Overall Study||32
8104641|NCT03161405|19976714|P1|NOT COMPLETED|Second Intervention Period (6 Days)||1
8104642|NCT03161405|19976714|P1|COMPLETED|Second Intervention Period (6 Days)||11
8104643|NCT03161405|19976714|P1|STARTED|Second Intervention Period (6 Days)||12
8104644|NCT03161405|19976714|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
8104645|NCT03161405|19976714|P1|COMPLETED|Washout Period (at Least 4 Days)||12
8104646|NCT03161405|19976714|P1|STARTED|Washout Period (at Least 4 Days)||12
8104647|NCT03161405|19976714|P1|NOT COMPLETED|First Intervention Period (3 Days)||0
8104648|NCT03161405|19976714|P1|COMPLETED|First Intervention Period (3 Days)||12
8104649|NCT03161405|19976714|P1|STARTED|First Intervention Period (3 Days)||12
8104650|NCT03161327|19976725|P1|NOT COMPLETED|Overall Study||0
8104651|NCT03161327|19976725|P1|COMPLETED|Overall Study||238
8104652|NCT03161327|19976725|P1|STARTED|Overall Study||238
8104653|NCT03160898|19976734|P4|NOT COMPLETED|Overall Study||19
8104654|NCT03160898|19976735|P3|NOT COMPLETED|Overall Study||16
8104655|NCT03160898|19976736|P2|NOT COMPLETED|Overall Study||13
8104656|NCT03160898|19976737|P1|NOT COMPLETED|Overall Study||20
8104657|NCT03160898|19976734|P4|COMPLETED|Overall Study||98
8104658|NCT03160898|19976735|P3|COMPLETED|Overall Study||97
8104659|NCT03160898|19976736|P2|COMPLETED|Overall Study||100
8104660|NCT03160898|19976737|P1|COMPLETED|Overall Study||95
8104661|NCT03160898|19976734|P4|STARTED|Overall Study||117
8104662|NCT03160898|19976735|P3|STARTED|Overall Study||113
8104663|NCT03160898|19976736|P2|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
8104664|NCT03160898|19976737|P1|STARTED|Overall Study||115
8104665|NCT03160885|19976760|P7|NOT COMPLETED|Maintenance Treatment Period||0
8104666|NCT03160885|19976761|P6|NOT COMPLETED|Maintenance Treatment Period||15
8104667|NCT03160885|19976762|P5|NOT COMPLETED|Maintenance Treatment Period||31
8104668|NCT03160885|19976763|P4|NOT COMPLETED|Maintenance Treatment Period||40
8104669|NCT03160885|19976764|P3|NOT COMPLETED|Maintenance Treatment Period||39
8104670|NCT03160885|19976765|P2|NOT COMPLETED|Maintenance Treatment Period||0
8104671|NCT03160885|19976766|P1|NOT COMPLETED|Maintenance Treatment Period||0
8104672|NCT03160885|19976760|P7|COMPLETED|Maintenance Treatment Period||0
8104673|NCT03160885|19976761|P6|COMPLETED|Maintenance Treatment Period||16
8104674|NCT03160885|19976762|P5|COMPLETED|Maintenance Treatment Period||15
8104675|NCT03160885|19976763|P4|COMPLETED|Maintenance Treatment Period||50
8104676|NCT03160885|19976764|P3|COMPLETED|Maintenance Treatment Period||52
8104677|NCT03160885|19976765|P2|COMPLETED|Maintenance Treatment Period||0
8104678|NCT03160885|19976766|P1|COMPLETED|Maintenance Treatment Period||0
8104679|NCT03160885|19976760|P7|STARTED|Maintenance Treatment Period||0
8104680|NCT03160885|19976761|P6|STARTED|Maintenance Treatment Period||31
8104681|NCT03160885|19976762|P5|STARTED|Maintenance Treatment Period||46
8104682|NCT03160885|19976763|P4|STARTED|Maintenance Treatment Period||90
8104683|NCT03160885|19976764|P3|STARTED|Maintenance Treatment Period||91
8104684|NCT03160885|19976765|P2|STARTED|Maintenance Treatment Period||0
8104685|NCT03160885|19976766|P1|STARTED|Maintenance Treatment Period||0
8104686|NCT03160885|19976760|P7|NOT COMPLETED|Open-label Treatment||137
8104687|NCT03160885|19976761|P6|NOT COMPLETED|Open-label Treatment||0
8104688|NCT03160885|19976762|P5|NOT COMPLETED|Open-label Treatment||0
8104689|NCT03160885|19976763|P4|NOT COMPLETED|Open-label Treatment||0
8104690|NCT03160885|19976764|P3|NOT COMPLETED|Open-label Treatment||0
8104691|NCT03160885|19976765|P2|NOT COMPLETED|Open-label Treatment||0
8104692|NCT03160885|19976766|P1|NOT COMPLETED|Open-label Treatment||0
8104693|NCT03160885|19976760|P7|COMPLETED|Open-label Treatment||423
8104694|NCT03160885|19976761|P6|COMPLETED|Open-label Treatment||0
8104695|NCT03160885|19976762|P5|COMPLETED|Open-label Treatment||0
8104696|NCT03160885|19976763|P4|COMPLETED|Open-label Treatment||0
8104697|NCT03160885|19976764|P3|COMPLETED|Open-label Treatment||0
8104698|NCT03160885|19976765|P2|COMPLETED|Open-label Treatment||0
8104699|NCT03160885|19976766|P1|COMPLETED|Open-label Treatment||0
8104700|NCT03160885|19976760|P7|STARTED|Open-label Treatment||560
8104701|NCT03160885|19976761|P6|STARTED|Open-label Treatment||0
8104702|NCT03160885|19976762|P5|STARTED|Open-label Treatment||0
8104703|NCT03160885|19976763|P4|STARTED|Open-label Treatment||0
8104704|NCT03160885|19976764|P3|STARTED|Open-label Treatment||0
8104705|NCT03160885|19976765|P2|STARTED|Open-label Treatment||0
8104706|NCT03160885|19976766|P1|STARTED|Open-label Treatment||0
8104707|NCT03160885|19976760|P7|NOT COMPLETED|Initial Treatment Period||0
8104708|NCT03160885|19976761|P6|NOT COMPLETED|Initial Treatment Period||0
8104709|NCT03160885|19976762|P5|NOT COMPLETED|Initial Treatment Period||0
8104710|NCT03160885|19976763|P4|NOT COMPLETED|Initial Treatment Period||0
8104711|NCT03160885|19976764|P3|NOT COMPLETED|Initial Treatment Period||0
8104712|NCT03160885|19976765|P2|NOT COMPLETED|Initial Treatment Period||22
8104713|NCT03160885|19976766|P1|NOT COMPLETED|Initial Treatment Period||35
8104714|NCT03160885|19976760|P7|COMPLETED|Initial Treatment Period||0
8104715|NCT03160885|19976761|P6|COMPLETED|Initial Treatment Period||0
8104716|NCT03160885|19976762|P5|COMPLETED|Initial Treatment Period||0
8104717|NCT03160885|19976763|P4|COMPLETED|Initial Treatment Period||0
8104718|NCT03160885|19976764|P3|COMPLETED|Initial Treatment Period||0
8104719|NCT03160885|19976765|P2|COMPLETED|Initial Treatment Period||179
8104720|NCT03160885|19976766|P1|COMPLETED|Initial Treatment Period||558
8104721|NCT03160885|19976760|P7|STARTED|Initial Treatment Period||0
8104722|NCT03160885|19976761|P6|STARTED|Initial Treatment Period||0
8104723|NCT03160885|19976762|P5|STARTED|Initial Treatment Period||0
8104724|NCT03160885|19976763|P4|STARTED|Initial Treatment Period||0
8104725|NCT03160885|19976764|P3|STARTED|Initial Treatment Period||0
8104726|NCT03160885|19976765|P2|STARTED|Initial Treatment Period||201
8104727|NCT03160885|19976766|P1|STARTED|Initial Treatment Period||593
8104728|NCT03160716|19976812|P1|NOT COMPLETED|Overall Study||1
8104729|NCT03160716|19976812|P1|COMPLETED|Overall Study||59
8104730|NCT03160716|19976812|P1|STARTED|Overall Study||60
8104731|NCT03160703|19976823|P4|NOT COMPLETED|Overall Study||1
8104732|NCT03160703|19976824|P3|NOT COMPLETED|Overall Study||0
8104733|NCT03160703|19976825|P2|NOT COMPLETED|Overall Study||0
8104734|NCT03160703|19976826|P1|NOT COMPLETED|Overall Study||0
8104735|NCT03160703|19976823|P4|COMPLETED|Overall Study||54
8104736|NCT03160703|19976824|P3|COMPLETED|Overall Study||55
8104737|NCT03160703|19976825|P2|COMPLETED|Overall Study||55
8104738|NCT03160703|19976826|P1|COMPLETED|Overall Study||55
8104739|NCT03160703|19976823|P4|STARTED|Overall Study||55
8104740|NCT03160703|19976824|P3|STARTED|Overall Study||55
8104741|NCT03160703|19976825|P2|STARTED|Overall Study||55
8104742|NCT03160703|19976826|P1|STARTED|Overall Study||55
8104743|NCT03160573|19976840|P4|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104744|NCT03160573|19976841|P3|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104745|NCT03160573|19976842|P2|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104746|NCT03160573|19976843|P1|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104747|NCT03160573|19976840|P4|COMPLETED|Second Sequence (3 Weeks)||23
8104748|NCT03160573|19976841|P3|COMPLETED|Second Sequence (3 Weeks)||23
8104749|NCT03160573|19976842|P2|COMPLETED|Second Sequence (3 Weeks)||23
8104750|NCT03160573|19976843|P1|COMPLETED|Second Sequence (3 Weeks)||22
8104751|NCT03160573|19976840|P4|STARTED|Second Sequence (3 Weeks)||23
8104752|NCT03160573|19976841|P3|STARTED|Second Sequence (3 Weeks)||23
8104753|NCT03160573|19976842|P2|STARTED|Second Sequence (3 Weeks)||23
8104754|NCT03160573|19976843|P1|STARTED|Second Sequence (3 Weeks)||22
8104755|NCT03160573|19976840|P4|NOT COMPLETED|Washout (2 Weeks)||0
8104756|NCT03160573|19976841|P3|NOT COMPLETED|Washout (2 Weeks)||0
8104757|NCT03160573|19976842|P2|NOT COMPLETED|Washout (2 Weeks)||0
8104758|NCT03160573|19976843|P1|NOT COMPLETED|Washout (2 Weeks)||0
8104759|NCT03160573|19976840|P4|COMPLETED|Washout (2 Weeks)||23
8104760|NCT03160573|19976841|P3|COMPLETED|Washout (2 Weeks)||23
8104761|NCT03160573|19976842|P2|COMPLETED|Washout (2 Weeks)||23
8104762|NCT03160573|19976843|P1|COMPLETED|Washout (2 Weeks)||22
8104763|NCT03160573|19976840|P4|STARTED|Washout (2 Weeks)||23
8104764|NCT03160573|19976841|P3|STARTED|Washout (2 Weeks)||23
8104765|NCT03160573|19976842|P2|STARTED|Washout (2 Weeks)||23
8104766|NCT03160573|19976843|P1|STARTED|Washout (2 Weeks)||22
8104767|NCT03160573|19976840|P4|NOT COMPLETED|First Sequence (3 Weeks)||2
8104768|NCT03160573|19976841|P3|NOT COMPLETED|First Sequence (3 Weeks)||2
8104769|NCT03160573|19976842|P2|NOT COMPLETED|First Sequence (3 Weeks)||3
8104770|NCT03160573|19976843|P1|NOT COMPLETED|First Sequence (3 Weeks)||1
8104771|NCT03160573|19976840|P4|COMPLETED|First Sequence (3 Weeks)||23
8104772|NCT03160573|19976841|P3|COMPLETED|First Sequence (3 Weeks)||23
8104773|NCT03160573|19976842|P2|COMPLETED|First Sequence (3 Weeks)||23
8104774|NCT03160573|19976843|P1|COMPLETED|First Sequence (3 Weeks)||22
8104775|NCT03160573|19976840|P4|STARTED|First Sequence (3 Weeks)||25
8104776|NCT03160573|19976841|P3|STARTED|First Sequence (3 Weeks)||25
8104777|NCT03160573|19976842|P2|STARTED|First Sequence (3 Weeks)||26
8104778|NCT03160573|19976843|P1|STARTED|First Sequence (3 Weeks)||23
8104779|NCT03160560|19976857|P4|NOT COMPLETED|Second Intervention (3 Weeks)||0
8104780|NCT03160560|19976858|P3|NOT COMPLETED|Second Intervention (3 Weeks)||0
8104781|NCT03160560|19976859|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8104782|NCT03160560|19976860|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
8104783|NCT03160560|19976857|P4|COMPLETED|Second Intervention (3 Weeks)||25
8104784|NCT03160560|19976858|P3|COMPLETED|Second Intervention (3 Weeks)||24
8104785|NCT03160560|19976859|P2|COMPLETED|Second Intervention (3 Weeks)||24
8104786|NCT03160560|19976860|P1|COMPLETED|Second Intervention (3 Weeks)||22
8104787|NCT03160560|19976857|P4|STARTED|Second Intervention (3 Weeks)||25
8104788|NCT03160560|19976858|P3|STARTED|Second Intervention (3 Weeks)||24
8104789|NCT03160560|19976859|P2|STARTED|Second Intervention (3 Weeks)||24
8104790|NCT03160560|19976860|P1|STARTED|Second Intervention (3 Weeks)||23
8104791|NCT03160560|19976857|P4|NOT COMPLETED|Washout (2 Weeks)||0
8104792|NCT03160560|19976858|P3|NOT COMPLETED|Washout (2 Weeks)||0
8104793|NCT03160560|19976859|P2|NOT COMPLETED|Washout (2 Weeks)||0
8104794|NCT03160560|19976860|P1|NOT COMPLETED|Washout (2 Weeks)||0
8104795|NCT03160560|19976857|P4|COMPLETED|Washout (2 Weeks)||25
8104796|NCT03160560|19976858|P3|COMPLETED|Washout (2 Weeks)||24
8104797|NCT03160560|19976859|P2|COMPLETED|Washout (2 Weeks)||24
8104798|NCT03160560|19976860|P1|COMPLETED|Washout (2 Weeks)||23
8104799|NCT03160560|19976857|P4|STARTED|Washout (2 Weeks)||25
8104800|NCT03160560|19976858|P3|STARTED|Washout (2 Weeks)||24
8104801|NCT03160560|19976859|P2|STARTED|Washout (2 Weeks)||24
8104802|NCT03160560|19976860|P1|STARTED|Washout (2 Weeks)||23
8104803|NCT03160560|19976857|P4|NOT COMPLETED|First Intervention (3 Weeks)||0
8104804|NCT03160560|19976858|P3|NOT COMPLETED|First Intervention (3 Weeks)||1
8104805|NCT03160560|19976859|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
8104806|NCT03160560|19976860|P1|NOT COMPLETED|First Intervention (3 Weeks)||2
8104807|NCT03160560|19976857|P4|COMPLETED|First Intervention (3 Weeks)||25
8104808|NCT03160560|19976858|P3|COMPLETED|First Intervention (3 Weeks)||24
8104809|NCT03160560|19976859|P2|COMPLETED|First Intervention (3 Weeks)||24
8104810|NCT03160560|19976860|P1|COMPLETED|First Intervention (3 Weeks)||23
8104811|NCT03160560|19976857|P4|STARTED|First Intervention (3 Weeks)||25
8104812|NCT03160560|19976858|P3|STARTED|First Intervention (3 Weeks)||25
8104813|NCT03160560|19976859|P2|STARTED|First Intervention (3 Weeks)||25
8104814|NCT03160560|19976860|P1|STARTED|First Intervention (3 Weeks)||25
8104815|NCT03160170|19976872|P2|NOT COMPLETED|Overall Study||0
8104816|NCT03160170|19976873|P1|NOT COMPLETED|Overall Study||0
8104817|NCT03160170|19976872|P2|COMPLETED|Overall Study||10
8104818|NCT03160170|19976873|P1|COMPLETED|Overall Study||10
8104819|NCT03160170|19976872|P2|STARTED|Overall Study||10
8104820|NCT03160170|19976873|P1|STARTED|Overall Study||10
8104821|NCT03160027|19976887|P4|NOT COMPLETED|Overall Study||0
8104822|NCT03160027|19976888|P3|NOT COMPLETED|Overall Study||0
8104823|NCT03160027|19976889|P2|NOT COMPLETED|Overall Study||0
8104824|NCT03160027|19976890|P1|NOT COMPLETED|Overall Study||0
8104825|NCT03160027|19976887|P4|COMPLETED|Overall Study||4
8104826|NCT03160027|19976888|P3|COMPLETED|Overall Study||6
8104827|NCT03160027|19976889|P2|COMPLETED|Overall Study||4
8104828|NCT03160027|19976890|P1|COMPLETED|Overall Study||6
8104829|NCT03160027|19976887|P4|STARTED|Overall Study||4
8104830|NCT03160027|19976888|P3|STARTED|Overall Study||6
8104831|NCT03160027|19976889|P2|STARTED|Overall Study||4
8104832|NCT03160027|19976890|P1|STARTED|Overall Study||6
8104833|NCT03159624|19976925|P2|NOT COMPLETED|Overall Study||1
8104834|NCT03159624|19976926|P1|NOT COMPLETED|Overall Study||0
8104835|NCT03159624|19976925|P2|COMPLETED|Overall Study||25
8104836|NCT03159624|19976926|P1|COMPLETED|Overall Study||21
8104837|NCT03159624|19976925|P2|STARTED|Overall Study||26
8104838|NCT03159624|19976926|P1|STARTED|Overall Study||21
8104839|NCT03159611|19976938|P2|NOT COMPLETED|Overall Study||15
8104840|NCT03159611|19976939|P1|NOT COMPLETED|Overall Study||23
8104841|NCT03159611|19976938|P2|COMPLETED|Overall Study||72
8104842|NCT03159611|19976939|P1|COMPLETED|Overall Study||72
8104843|NCT03159611|19976938|P2|STARTED|Overall Study||87
8104844|NCT03159611|19976939|P1|STARTED|Overall Study||95
8104845|NCT03159468|19976959|P6|NOT COMPLETED|Overall Study||0
8104846|NCT03159468|19976960|P5|NOT COMPLETED|Overall Study||0
8104847|NCT03159468|19976961|P4|NOT COMPLETED|Overall Study||0
8104848|NCT03159468|19976962|P3|NOT COMPLETED|Overall Study||3
8104849|NCT03159468|19976963|P2|NOT COMPLETED|Overall Study||0
8104850|NCT03159468|19976964|P1|NOT COMPLETED|Overall Study||0
8104851|NCT03159468|19976959|P6|COMPLETED|Overall Study||34
8104852|NCT03159468|19976960|P5|COMPLETED|Overall Study||34
8104853|NCT03159468|19976961|P4|COMPLETED|Overall Study||34
8104854|NCT03159468|19976962|P3|COMPLETED|Overall Study||34
8104855|NCT03159468|19976963|P2|COMPLETED|Overall Study||35
8104856|NCT03159468|19976964|P1|COMPLETED|Overall Study||35
8104857|NCT03159468|19976959|P6|STARTED|Overall Study||34
8104858|NCT03159468|19976960|P5|STARTED|Overall Study||34
8104859|NCT03159468|19976961|P4|STARTED|Overall Study||34
8104860|NCT03159468|19976962|P3|STARTED|Overall Study||37
8104861|NCT03159468|19976963|P2|STARTED|Overall Study||35
8104862|NCT03159468|19976964|P1|STARTED|Overall Study||35
8104863|NCT03159299|19976980|P2|NOT COMPLETED|Overall Study||1
8104864|NCT03159299|19976981|P1|NOT COMPLETED|Overall Study||2
8104865|NCT03159299|19976980|P2|COMPLETED|Overall Study||20
8104866|NCT03159299|19976981|P1|COMPLETED|Overall Study||24
8104867|NCT03159299|19976980|P2|STARTED|Overall Study||21
8104868|NCT03159299|19976981|P1|STARTED|Overall Study||26
8104869|NCT03159260|19976989|P2|NOT COMPLETED|Overall Study||4
8104870|NCT03159260|19976990|P1|NOT COMPLETED|Overall Study||3
8104871|NCT03159260|19976989|P2|COMPLETED|Overall Study||25
8104872|NCT03159260|19976990|P1|COMPLETED|Overall Study||25
8104873|NCT03159260|19976989|P2|STARTED|Overall Study||29
8104874|NCT03159260|19976990|P1|STARTED|Overall Study||28
8104875|NCT03159143|19977004|P1|NOT COMPLETED|Overall Study||0
8104876|NCT03159143|19977004|P1|COMPLETED|Overall Study||22
8104877|NCT03159143|19977004|P1|STARTED|Overall Study||22
8104878|NCT03159091|19977013|P2|NOT COMPLETED|Overall Study||4
8104879|NCT03159091|19977014|P1|NOT COMPLETED|Overall Study||5
8104880|NCT03159091|19977013|P2|COMPLETED|Overall Study||113
8104881|NCT03159091|19977014|P1|COMPLETED|Overall Study||116
8104882|NCT03159091|19977013|P2|STARTED|Overall Study||117
8104883|NCT03159091|19977014|P1|STARTED|Overall Study||121
8104884|NCT03158688|19977030|P2|NOT COMPLETED|Overall Study||312
8104885|NCT03158688|19977031|P1|NOT COMPLETED|Overall Study||154
8104886|NCT03158688|19977030|P2|COMPLETED|Overall Study||0
8104887|NCT03158688|19977031|P1|COMPLETED|Overall Study||0
8104888|NCT03158688|19977030|P2|Treated|Overall Study||308
8104889|NCT03158688|19977031|P1|Treated|Overall Study||153
8104890|NCT03158688|19977030|P2|STARTED|Overall Study||312
8104891|NCT03158688|19977031|P1|STARTED|Overall Study||154
8104892|NCT03158311|19977064|P3|NOT COMPLETED|Overall Study||28
8104893|NCT03158311|19977065|P2|NOT COMPLETED|Overall Study||16
8104894|NCT03158311|19977066|P1|NOT COMPLETED|Overall Study||22
8104895|NCT03158311|19977064|P3|COMPLETED|Overall Study||448
8104896|NCT03158311|19977065|P2|COMPLETED|Overall Study||460
8104897|NCT03158311|19977066|P1|COMPLETED|Overall Study||452
8104898|NCT03158311|19977064|P3|Safety Set (SAF)|Overall Study||475
8104899|NCT03158311|19977065|P2|Safety Set (SAF)|Overall Study||476
8104900|NCT03158311|19977066|P1|Safety Set (SAF)|Overall Study||474
8104901|NCT03158311|19977064|P3|Full Analysis Set (FAS)|Overall Study||475
8104902|NCT03158311|19977065|P2|Full Analysis Set (FAS)|Overall Study||476
8104903|NCT03158311|19977066|P1|Full Analysis Set (FAS)|Overall Study||474
8104904|NCT03158311|19977064|P3|STARTED|Overall Study||476
8104905|NCT03158311|19977065|P2|STARTED|Overall Study||476
8104906|NCT03158311|19977066|P1|STARTED|Overall Study||474
8104907|NCT03158285|19977098|P3|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8104908|NCT03158285|19977099|P2|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
8104909|NCT03158285|19977100|P1|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
8104910|NCT03158285|19977098|P3|COMPLETED|Active Treatment Period: Week 24 - 52||227
8104911|NCT03158285|19977099|P2|COMPLETED|Active Treatment Period: Week 24 - 52||234
8104912|NCT03158285|19977100|P1|COMPLETED|Active Treatment Period: Week 24 - 52||228
8104913|NCT03158285|19977098|P3|STARTED|Active Treatment Period: Week 24 - 52|2 participants who discontinued without receiving study agent at and post Week 24 were not included.|234
8104914|NCT03158285|19977099|P2|STARTED|Active Treatment Period: Week 24 - 52||240
8104915|NCT03158285|19977100|P1|STARTED|Active Treatment Period: Week 24 - 52|2 participants who discontinued without receiving study agent at and post Week 24 were not included.|238
8104916|NCT03158285|19977098|P3|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
8104917|NCT03158285|19977099|P2|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
8104918|NCT03158285|19977100|P1|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
8104919|NCT03158285|19977098|P3|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
8104920|NCT03158285|19977099|P2|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
8104921|NCT03158285|19977100|P1|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
8104922|NCT03158285|19977098|P3|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
8104923|NCT03158285|19977099|P2|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
8104924|NCT03158285|19977100|P1|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
8104925|NCT03158285|19977098|P3|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
8104926|NCT03158285|19977099|P2|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
8104927|NCT03158285|19977100|P1|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
8104928|NCT03158285|19977098|P3|STARTED|Placebo-controlled Period: Week 0 - 24||245
8104929|NCT03158285|19977099|P2|STARTED|Placebo-controlled Period: Week 0 - 24||248
8104930|NCT03158285|19977100|P1|STARTED|Placebo-controlled Period: Week 0 - 24||246
8104931|NCT03158272|19977316|P4|NOT COMPLETED|Overall Study||6
8104932|NCT03158272|19977317|P3|NOT COMPLETED|Overall Study||6
8104933|NCT03158272|19977318|P2|NOT COMPLETED|Overall Study||4
8104934|NCT03158272|19977319|P1|NOT COMPLETED|Overall Study||3
8104935|NCT03158272|19977316|P4|COMPLETED|Overall Study||0
8104936|NCT03158272|19977317|P3|COMPLETED|Overall Study||0
8104937|NCT03158272|19977318|P2|COMPLETED|Overall Study||0
8104938|NCT03158272|19977319|P1|COMPLETED|Overall Study||0
8104939|NCT03158272|19977316|P4|STARTED|Overall Study||6
8104940|NCT03158272|19977317|P3|STARTED|Overall Study||6
8104941|NCT03158272|19977318|P2|STARTED|Overall Study||4
8104942|NCT03158272|19977319|P1|STARTED|Overall Study||3
8104943|NCT03158220|19977389|P2|NOT COMPLETED|Overall Study||16
8104944|NCT03158220|19977390|P1|NOT COMPLETED|Overall Study||17
8104945|NCT03158220|19977389|P2|COMPLETED|Overall Study||626
8104946|NCT03158220|19977390|P1|COMPLETED|Overall Study||553
8104947|NCT03158220|19977389|P2|Vaccination 3|Overall Study||629
8104948|NCT03158220|19977390|P1|Vaccination 3|Overall Study||556
8104949|NCT03158220|19977389|P2|Vaccination 2|Overall Study||635
8104950|NCT03158220|19977390|P1|Vaccination 2|Overall Study||563
8104951|NCT03158220|19977389|P2|Vaccination 1|Overall Study||640
8104952|NCT03158220|19977390|P1|Vaccination 1|Overall Study||570
8104953|NCT03158220|19977389|P2|STARTED|Overall Study||642
8104954|NCT03158220|19977390|P1|STARTED|Overall Study||570
8104955|NCT03158038|19977410|P2|NOT COMPLETED|Overall Study||0
8104956|NCT03158038|19977411|P1|NOT COMPLETED|Overall Study||0
8104957|NCT03158038|19977410|P2|COMPLETED|Overall Study||60
8104958|NCT03158038|19977411|P1|COMPLETED|Overall Study||240
8104959|NCT03158038|19977410|P2|STARTED|Overall Study||60
8104960|NCT03158038|19977411|P1|STARTED|Overall Study||240
8104961|NCT03158012|19977427|P2|NOT COMPLETED|Overall Study||1
8104962|NCT03158012|19977428|P1|NOT COMPLETED|Overall Study||0
8104963|NCT03158012|19977427|P2|COMPLETED|Overall Study||6
8104964|NCT03158012|19977428|P1|COMPLETED|Overall Study||8
8104965|NCT03158012|19977427|P2|STARTED|Overall Study||7
8104966|NCT03158012|19977428|P1|STARTED|Overall Study||8
8104967|NCT03157583|19977434|P1|NOT COMPLETED|Overall Study||1
8104968|NCT03157583|19977434|P1|COMPLETED|Overall Study||7
8104969|NCT03157583|19977434|P1|STARTED|Overall Study||8
8104970|NCT03157531|19977452|P1|NOT COMPLETED|Overall Study||6
8104971|NCT03157531|19977452|P1|COMPLETED|Overall Study||91
8104972|NCT03157531|19977452|P1|Analyzed at 30 Days For MAEs|Overall Study||93
8104973|NCT03157531|19977452|P1|STARTED|Overall Study||97
8104974|NCT03157232|19977467|P1|NOT COMPLETED|Overall Study||0
8104975|NCT03157232|19977467|P1|COMPLETED|Overall Study||18
8104976|NCT03157232|19977467|P1|STARTED|Overall Study||18
8104977|NCT03156543|19977473|P2|NOT COMPLETED|Overall Study||0
8104978|NCT03156543|19977474|P1|NOT COMPLETED|Overall Study||1
8104979|NCT03156543|19977473|P2|COMPLETED|Overall Study||23
8104980|NCT03156543|19977474|P1|COMPLETED|Overall Study||8
8104981|NCT03156543|19977473|P2|STARTED|Overall Study||23
8104982|NCT03156543|19977474|P1|STARTED|Overall Study||9
8104983|NCT03155269|19977484|P2|NOT COMPLETED|Overall Study||7
8104984|NCT03155269|19977485|P1|NOT COMPLETED|Overall Study||5
8104985|NCT03155269|19977484|P2|COMPLETED|Overall Study||50
8104986|NCT03155269|19977485|P1|COMPLETED|Overall Study||52
8104987|NCT03155269|19977484|P2|STARTED|Overall Study||57
8104988|NCT03155269|19977485|P1|STARTED|Overall Study||57
8104989|NCT03155178|19977531|P4|NOT COMPLETED|Overall Study||7
8104990|NCT03155178|19977532|P3|NOT COMPLETED|Overall Study||7
8104991|NCT03155178|19977533|P2|NOT COMPLETED|Overall Study||7
8104992|NCT03155178|19977534|P1|NOT COMPLETED|Overall Study||7
8104993|NCT03155178|19977531|P4|COMPLETED|Overall Study||62
8104994|NCT03155178|19977532|P3|COMPLETED|Overall Study||62
8104995|NCT03155178|19977533|P2|COMPLETED|Overall Study||62
8104996|NCT03155178|19977534|P1|COMPLETED|Overall Study||62
8104997|NCT03155178|19977531|P4|STARTED|Overall Study||69
8104998|NCT03155178|19977532|P3|STARTED|Overall Study||69
8104999|NCT03155178|19977533|P2|STARTED|Overall Study||69
8105000|NCT03155178|19977534|P1|STARTED|Overall Study||69
8105001|NCT03154333|19977554|P2|NOT COMPLETED|Overall Study||5
8105002|NCT03154333|19977555|P1|NOT COMPLETED|Overall Study||7
8105003|NCT03154333|19977554|P2|COMPLETED|Overall Study||21
8105004|NCT03154333|19977555|P1|COMPLETED|Overall Study||21
8105005|NCT03154333|19977554|P2|STARTED|Overall Study||26
8105006|NCT03154333|19977555|P1|STARTED|Overall Study||28
8105007|NCT03154086|19977578|P15|NOT COMPLETED|Part B (Up to 25 Days)||0
8105008|NCT03154086|19977579|P14|NOT COMPLETED|Part B (Up to 25 Days)||0
8105009|NCT03154086|19977580|P13|NOT COMPLETED|Part B (Up to 25 Days)||0
8105010|NCT03154086|19977581|P12|NOT COMPLETED|Part B (Up to 25 Days)||0
8105011|NCT03154086|19977582|P11|NOT COMPLETED|Part B (Up to 25 Days)||1
8105012|NCT03154086|19977583|P10|NOT COMPLETED|Part B (Up to 25 Days)||0
8105013|NCT03154086|19977584|P9|NOT COMPLETED|Part B (Up to 25 Days)||0
8105014|NCT03154086|19977585|P8|NOT COMPLETED|Part B (Up to 25 Days)||0
8105015|NCT03154086|19977586|P7|NOT COMPLETED|Part B (Up to 25 Days)||0
8105016|NCT03154086|19977587|P6|NOT COMPLETED|Part B (Up to 25 Days)||0
8105017|NCT03154086|19977588|P5|NOT COMPLETED|Part B (Up to 25 Days)||0
8105018|NCT03154086|19977589|P4|NOT COMPLETED|Part B (Up to 25 Days)||0
8105019|NCT03154086|19977590|P3|NOT COMPLETED|Part B (Up to 25 Days)||0
8105020|NCT03154086|19977591|P2|NOT COMPLETED|Part B (Up to 25 Days)||0
8105021|NCT03154086|19977592|P1|NOT COMPLETED|Part B (Up to 25 Days)||0
8105022|NCT03154086|19977578|P15|COMPLETED|Part B (Up to 25 Days)||6
8105023|NCT03154086|19977579|P14|COMPLETED|Part B (Up to 25 Days)||6
8105024|NCT03154086|19977580|P13|COMPLETED|Part B (Up to 25 Days)||6
8105025|NCT03154086|19977581|P12|COMPLETED|Part B (Up to 25 Days)||6
8105026|NCT03154086|19977582|P11|COMPLETED|Part B (Up to 25 Days)||5
8105027|NCT03154086|19977583|P10|COMPLETED|Part B (Up to 25 Days)||10
8105028|NCT03154086|19977584|P9|COMPLETED|Part B (Up to 25 Days)||0
8105029|NCT03154086|19977585|P8|COMPLETED|Part B (Up to 25 Days)||0
8105030|NCT03154086|19977586|P7|COMPLETED|Part B (Up to 25 Days)||0
8105031|NCT03154086|19977587|P6|COMPLETED|Part B (Up to 25 Days)||0
8105032|NCT03154086|19977588|P5|COMPLETED|Part B (Up to 25 Days)||0
8105033|NCT03154086|19977589|P4|COMPLETED|Part B (Up to 25 Days)||0
8105034|NCT03154086|19977590|P3|COMPLETED|Part B (Up to 25 Days)||0
8105035|NCT03154086|19977591|P2|COMPLETED|Part B (Up to 25 Days)||0
8105036|NCT03154086|19977592|P1|COMPLETED|Part B (Up to 25 Days)||0
8105037|NCT03154086|19977578|P15|STARTED|Part B (Up to 25 Days)||6
8105038|NCT03154086|19977579|P14|STARTED|Part B (Up to 25 Days)||6
8105039|NCT03154086|19977580|P13|STARTED|Part B (Up to 25 Days)||6
8105040|NCT03154086|19977581|P12|STARTED|Part B (Up to 25 Days)||6
8105041|NCT03154086|19977582|P11|STARTED|Part B (Up to 25 Days)||6
8105042|NCT03154086|19977583|P10|STARTED|Part B (Up to 25 Days)||10
8105043|NCT03154086|19977584|P9|STARTED|Part B (Up to 25 Days)||0
8105044|NCT03154086|19977585|P8|STARTED|Part B (Up to 25 Days)||0
8105045|NCT03154086|19977586|P7|STARTED|Part B (Up to 25 Days)||0
8105046|NCT03154086|19977587|P6|STARTED|Part B (Up to 25 Days)||0
8105047|NCT03154086|19977588|P5|STARTED|Part B (Up to 25 Days)||0
8105048|NCT03154086|19977589|P4|STARTED|Part B (Up to 25 Days)||0
8105049|NCT03154086|19977590|P3|STARTED|Part B (Up to 25 Days)||0
8105050|NCT03154086|19977591|P2|STARTED|Part B (Up to 25 Days)||0
8105051|NCT03154086|19977592|P1|STARTED|Part B (Up to 25 Days)||0
8105052|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105053|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105054|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105055|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105056|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105057|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105058|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
8105059|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
8105060|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105061|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105062|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105063|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105064|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105065|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105066|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105067|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105068|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105069|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105070|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105071|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105072|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105073|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
8105074|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
8105075|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
8105076|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105077|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105078|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105079|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105080|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105081|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105082|NCT03154086|19977578|P15|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105083|NCT03154086|19977579|P14|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105084|NCT03154086|19977580|P13|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105085|NCT03154086|19977581|P12|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105086|NCT03154086|19977582|P11|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105087|NCT03154086|19977583|P10|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105088|NCT03154086|19977584|P9|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
8105089|NCT03154086|19977585|P8|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
8105090|NCT03154086|19977586|P7|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
8105091|NCT03154086|19977587|P6|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105092|NCT03154086|19977588|P5|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105093|NCT03154086|19977589|P4|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105094|NCT03154086|19977590|P3|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105095|NCT03154086|19977591|P2|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105096|NCT03154086|19977592|P1|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105097|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105098|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105099|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105100|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105101|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105102|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105103|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105104|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105105|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105106|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105107|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105108|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105109|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105110|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105111|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105112|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105113|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105114|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105115|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105116|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105117|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105118|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
8105119|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105120|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105121|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105122|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105123|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105124|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105125|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105126|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105127|NCT03154086|19977578|P15|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105128|NCT03154086|19977579|P14|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105129|NCT03154086|19977580|P13|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105130|NCT03154086|19977581|P12|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105131|NCT03154086|19977582|P11|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105132|NCT03154086|19977583|P10|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105133|NCT03154086|19977584|P9|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
8105134|NCT03154086|19977585|P8|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105135|NCT03154086|19977586|P7|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105136|NCT03154086|19977587|P6|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105137|NCT03154086|19977588|P5|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105138|NCT03154086|19977589|P4|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105139|NCT03154086|19977590|P3|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105140|NCT03154086|19977591|P2|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105141|NCT03154086|19977592|P1|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105142|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105143|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105144|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105145|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105146|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105147|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105148|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105149|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105150|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105151|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105152|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105153|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105154|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105155|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105156|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105157|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105158|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105159|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105160|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105161|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105162|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105163|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
8105164|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105165|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105166|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105167|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105168|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105169|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105170|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105171|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105172|NCT03154086|19977578|P15|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105173|NCT03154086|19977579|P14|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105174|NCT03154086|19977580|P13|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105175|NCT03154086|19977581|P12|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105176|NCT03154086|19977582|P11|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105177|NCT03154086|19977583|P10|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105178|NCT03154086|19977584|P9|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
8105179|NCT03154086|19977585|P8|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105180|NCT03154086|19977586|P7|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105181|NCT03154086|19977587|P6|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105182|NCT03154086|19977588|P5|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105183|NCT03154086|19977589|P4|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105184|NCT03154086|19977590|P3|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105185|NCT03154086|19977591|P2|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105186|NCT03154086|19977592|P1|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105187|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105188|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105189|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105190|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105191|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105192|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105193|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105194|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105195|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105196|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105197|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105198|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105199|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105200|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105201|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105202|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105203|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105204|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105205|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105206|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105207|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105208|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105209|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105210|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105211|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
8105212|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
8105213|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105214|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105215|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105216|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105217|NCT03154086|19977578|P15|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105218|NCT03154086|19977579|P14|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105219|NCT03154086|19977580|P13|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105220|NCT03154086|19977581|P12|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105221|NCT03154086|19977582|P11|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105222|NCT03154086|19977583|P10|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105223|NCT03154086|19977584|P9|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105224|NCT03154086|19977585|P8|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105225|NCT03154086|19977586|P7|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105226|NCT03154086|19977587|P6|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
8105227|NCT03154086|19977588|P5|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
8105228|NCT03154086|19977589|P4|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105229|NCT03154086|19977590|P3|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105230|NCT03154086|19977591|P2|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105231|NCT03154086|19977592|P1|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105232|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105233|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105234|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105235|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105236|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105237|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105238|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105239|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105240|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105241|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105242|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105243|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105244|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105245|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105246|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105247|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105248|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105249|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105250|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105251|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105252|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105253|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105254|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105255|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105256|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
8105257|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
8105258|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105259|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105260|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105261|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105262|NCT03154086|19977578|P15|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105263|NCT03154086|19977579|P14|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105264|NCT03154086|19977580|P13|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105265|NCT03154086|19977581|P12|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105266|NCT03154086|19977582|P11|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105267|NCT03154086|19977583|P10|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105268|NCT03154086|19977584|P9|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105269|NCT03154086|19977585|P8|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105270|NCT03154086|19977586|P7|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105271|NCT03154086|19977587|P6|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
8105272|NCT03154086|19977588|P5|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
8105273|NCT03154086|19977589|P4|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105274|NCT03154086|19977590|P3|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105275|NCT03154086|19977591|P2|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105276|NCT03154086|19977592|P1|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105277|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105278|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105279|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105280|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105281|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105282|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105283|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105284|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105285|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105286|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105287|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105288|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105289|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105290|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105291|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105292|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105293|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105294|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105295|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105296|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105297|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105298|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105299|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105300|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105301|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
8105302|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
8105303|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105304|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105305|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105306|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105307|NCT03154086|19977578|P15|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105308|NCT03154086|19977579|P14|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105309|NCT03154086|19977580|P13|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105310|NCT03154086|19977581|P12|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105311|NCT03154086|19977582|P11|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105312|NCT03154086|19977583|P10|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105313|NCT03154086|19977584|P9|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105314|NCT03154086|19977585|P8|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105315|NCT03154086|19977586|P7|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105316|NCT03154086|19977587|P6|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
8105317|NCT03154086|19977588|P5|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
8105318|NCT03154086|19977589|P4|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105319|NCT03154086|19977590|P3|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105320|NCT03154086|19977591|P2|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105321|NCT03154086|19977592|P1|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105322|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105323|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105324|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105325|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105326|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105327|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105328|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105329|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105330|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105331|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105332|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105333|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105334|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105335|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105336|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
8105337|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105338|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105339|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105340|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105341|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105342|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105343|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105344|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105345|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105346|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105347|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105348|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105349|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
8105350|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105351|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105352|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105353|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105354|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105355|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105356|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105357|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105358|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105359|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105360|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105361|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105362|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105363|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105364|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
8105365|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105366|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
8105367|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105368|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105369|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105370|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105371|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105372|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105373|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105374|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105375|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105376|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105377|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105378|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105379|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
8105380|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105381|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105382|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105383|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105384|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105385|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105386|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105387|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105388|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105389|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105390|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105391|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105392|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105393|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105394|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
8105395|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105396|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105397|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105398|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105399|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105400|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105401|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105402|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105403|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105404|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105405|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105406|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105407|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105408|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105409|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105410|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105411|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105412|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105413|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105414|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105415|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105416|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105417|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105418|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105419|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105420|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105421|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105422|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105423|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105424|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105425|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105426|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105427|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105428|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105429|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105430|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105431|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105432|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105433|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105434|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105435|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105436|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105437|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105438|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105439|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105440|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105441|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105442|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105443|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105444|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105445|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105446|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105447|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105448|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105449|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105450|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105451|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105452|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105453|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105454|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105455|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
8105456|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105457|NCT03154086|19977578|P15|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105458|NCT03154086|19977579|P14|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105459|NCT03154086|19977580|P13|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105460|NCT03154086|19977581|P12|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105461|NCT03154086|19977582|P11|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105462|NCT03154086|19977583|P10|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105463|NCT03154086|19977584|P9|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105464|NCT03154086|19977585|P8|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105465|NCT03154086|19977586|P7|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105466|NCT03154086|19977587|P6|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105467|NCT03154086|19977588|P5|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105468|NCT03154086|19977589|P4|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105469|NCT03154086|19977590|P3|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105470|NCT03154086|19977591|P2|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
8105471|NCT03154086|19977592|P1|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105472|NCT03154086|19977578|P15|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105473|NCT03154086|19977579|P14|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105474|NCT03154086|19977580|P13|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105475|NCT03154086|19977581|P12|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105476|NCT03154086|19977582|P11|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105477|NCT03154086|19977583|P10|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105478|NCT03154086|19977584|P9|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105479|NCT03154086|19977585|P8|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105480|NCT03154086|19977586|P7|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105481|NCT03154086|19977587|P6|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105482|NCT03154086|19977588|P5|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105483|NCT03154086|19977589|P4|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105484|NCT03154086|19977590|P3|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105485|NCT03154086|19977591|P2|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
8105486|NCT03154086|19977592|P1|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105487|NCT03154086|19977578|P15|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105488|NCT03154086|19977579|P14|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105489|NCT03154086|19977580|P13|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105490|NCT03154086|19977581|P12|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105491|NCT03154086|19977582|P11|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105492|NCT03154086|19977583|P10|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105493|NCT03154086|19977584|P9|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105494|NCT03154086|19977585|P8|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105495|NCT03154086|19977586|P7|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105496|NCT03154086|19977587|P6|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105497|NCT03154086|19977588|P5|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105498|NCT03154086|19977589|P4|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105499|NCT03154086|19977590|P3|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105500|NCT03154086|19977591|P2|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105501|NCT03154086|19977592|P1|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105502|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105503|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105504|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105505|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105506|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105507|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105508|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105509|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105510|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105511|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105512|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105513|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105514|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105515|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105516|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105517|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105518|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105519|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105520|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105521|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105522|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105523|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105524|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105525|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105526|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105527|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105528|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105529|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105530|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105531|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105532|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105533|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105534|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105535|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105536|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105537|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105538|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105539|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105540|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105541|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105542|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105543|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
8105544|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105545|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105546|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105547|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105548|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105549|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105550|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105551|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105552|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105553|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105554|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105555|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105556|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105557|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105558|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
8105559|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105560|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105561|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105562|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105563|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105564|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105565|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105566|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105567|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105568|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105569|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105570|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105571|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105572|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105573|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
8105574|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105575|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105576|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105577|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105578|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105579|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105580|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105581|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105582|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105583|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105584|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105585|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105586|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105587|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105588|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105589|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105590|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105591|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105592|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105593|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105594|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105595|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105596|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105597|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105598|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105599|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105600|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105601|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105602|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105603|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105604|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105605|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105606|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105607|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105608|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105609|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105610|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105611|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105612|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105613|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105614|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105615|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105616|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105617|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105618|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105619|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105620|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105621|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105622|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105623|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105624|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105625|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105626|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105627|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105628|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105629|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105630|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105631|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105632|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105633|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105634|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105635|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105636|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105637|NCT03154047|19977992|P1|NOT COMPLETED|Overall Study||80
8105638|NCT03154047|19977992|P1|COMPLETED|Overall Study||0
8105639|NCT03154047|19977992|P1|Number of Patients Dosed|Overall Study||80
8105640|NCT03154047|19977992|P1|STARTED|Overall Study||80
8105641|NCT03153956|19977998|P2|NOT COMPLETED|Overall Study||0
8105642|NCT03153956|19977999|P1|NOT COMPLETED|Overall Study||0
8105643|NCT03153956|19977998|P2|COMPLETED|Overall Study||38
8105644|NCT03153956|19977999|P1|COMPLETED|Overall Study||39
8105645|NCT03153956|19977998|P2|STARTED|Overall Study||38
8105646|NCT03153956|19977999|P1|STARTED|Overall Study||39
8105647|NCT03152591|19978011|P2|NOT COMPLETED|Overall Study||0
8105648|NCT03152591|19978012|P1|NOT COMPLETED|Overall Study||0
8105649|NCT03152591|19978011|P2|COMPLETED|Overall Study||14
8105650|NCT03152591|19978012|P1|COMPLETED|Overall Study||15
8105651|NCT03152591|19978011|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||14
8105652|NCT03152591|19978012|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||15
8105653|NCT03152591|19978011|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8105654|NCT03152591|19978012|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||14
8105655|NCT03152591|19978011|P2|STARTED|Overall Study||14
8105656|NCT03152591|19978012|P1|STARTED|Overall Study||15
8105657|NCT03152552|19978039|P5|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
8105658|NCT03152552|19978040|P4|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
8105659|NCT03152552|19978041|P3|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
8105660|NCT03152552|19978042|P2|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
8105661|NCT03152552|19978043|P1|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
8105662|NCT03152552|19978039|P5|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105663|NCT03152552|19978040|P4|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105664|NCT03152552|19978041|P3|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105665|NCT03152552|19978042|P2|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105666|NCT03152552|19978043|P1|COMPLETED|Treatment Period 2 (24 Weeks)||1
8105667|NCT03152552|19978039|P5|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
8105668|NCT03152552|19978040|P4|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
8105669|NCT03152552|19978041|P3|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
8105670|NCT03152552|19978042|P2|STARTED|Treatment Period 2 (24 Weeks)||5
8105671|NCT03152552|19978043|P1|STARTED|Treatment Period 2 (24 Weeks)||7
8105672|NCT03152552|19978039|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
8105673|NCT03152552|19978040|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
8105674|NCT03152552|19978041|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
8105675|NCT03152552|19978042|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
8105676|NCT03152552|19978043|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
8105677|NCT03152552|19978039|P5|COMPLETED|Treatment Period 1 (12 Weeks)||12
8105678|NCT03152552|19978040|P4|COMPLETED|Treatment Period 1 (12 Weeks)||10
8105679|NCT03152552|19978041|P3|COMPLETED|Treatment Period 1 (12 Weeks)||10
8105680|NCT03152552|19978042|P2|COMPLETED|Treatment Period 1 (12 Weeks)||5
8105681|NCT03152552|19978043|P1|COMPLETED|Treatment Period 1 (12 Weeks)||7
8105682|NCT03152552|19978039|P5|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
8105683|NCT03152552|19978040|P4|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
8105684|NCT03152552|19978041|P3|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
8105685|NCT03152552|19978042|P2|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
8105686|NCT03152552|19978043|P1|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
8105687|NCT03152552|19978039|P5|STARTED|Treatment Period 1 (12 Weeks)||33
8105688|NCT03152552|19978040|P4|STARTED|Treatment Period 1 (12 Weeks)||30
8105689|NCT03152552|19978041|P3|STARTED|Treatment Period 1 (12 Weeks)||31
8105690|NCT03152552|19978042|P2|STARTED|Treatment Period 1 (12 Weeks)||16
8105691|NCT03152552|19978043|P1|STARTED|Treatment Period 1 (12 Weeks)||15
8105692|NCT03152526|19978176|P2|NOT COMPLETED|Overall Study||1
8105693|NCT03152526|19978177|P1|NOT COMPLETED|Overall Study||0
8105694|NCT03152526|19978176|P2|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
8105695|NCT03152526|19978177|P1|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
8105696|NCT03152526|19978176|P2|STARTED|Overall Study|One participant was enrolled on this arm.|1
8105697|NCT03152526|19978177|P1|STARTED|Overall Study|No participants were enrolled on this arm.|0
8105698|NCT03152136|19978188|P3|NOT COMPLETED|Overall Study||1
8105699|NCT03152136|19978189|P2|NOT COMPLETED|Overall Study||0
8105700|NCT03152136|19978190|P1|NOT COMPLETED|Overall Study||3
8105701|NCT03152136|19978188|P3|COMPLETED|Overall Study||14
8105702|NCT03152136|19978189|P2|COMPLETED|Overall Study||15
8105703|NCT03152136|19978190|P1|COMPLETED|Overall Study||29
8105704|NCT03152136|19978188|P3|STARTED|Overall Study||15
8105705|NCT03152136|19978189|P2|STARTED|Overall Study||15
8105706|NCT03152136|19978190|P1|STARTED|Overall Study||32
8105707|NCT03152110|19978197|P1|NOT COMPLETED|Overall Study||3
8105708|NCT03152110|19978197|P1|COMPLETED|Overall Study||7
8105709|NCT03152110|19978197|P1|STARTED|Overall Study||10
8105710|NCT03152019|19978212|P2|NOT COMPLETED|Overall Study||1
8105711|NCT03152019|19978213|P1|NOT COMPLETED|Overall Study||0
8105712|NCT03152019|19978212|P2|COMPLETED|Overall Study||24
8105713|NCT03152019|19978213|P1|COMPLETED|Overall Study||25
8105714|NCT03152019|19978212|P2|STARTED|Overall Study||25
8105715|NCT03152019|19978213|P1|STARTED|Overall Study||25
8105716|NCT03151551|19978221|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||28
8105717|NCT03151551|19978222|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||25
8105718|NCT03151551|19978221|P2|COMPLETED|Post-Treatment Follow-Up Period||230
8105719|NCT03151551|19978222|P1|COMPLETED|Post-Treatment Follow-Up Period||240
8105720|NCT03151551|19978221|P2|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
8105721|NCT03151551|19978222|P1|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
8105722|NCT03151551|19978221|P2|NOT COMPLETED|Open-Label Treatment Period||24
8105723|NCT03151551|19978222|P1|NOT COMPLETED|Open-Label Treatment Period||18
8105724|NCT03151551|19978221|P2|COMPLETED|Open-Label Treatment Period||259
8105725|NCT03151551|19978222|P1|COMPLETED|Open-Label Treatment Period||265
8105726|NCT03151551|19978221|P2|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
8105727|NCT03151551|19978222|P1|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
8105728|NCT03151551|19978221|P2|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
8105729|NCT03151551|19978222|P1|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
8105730|NCT03151551|19978221|P2|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
8105731|NCT03151551|19978222|P1|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
8105732|NCT03151551|19978221|P2|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
8105733|NCT03151551|19978222|P1|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
8105734|NCT03151551|19978221|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
8105735|NCT03151551|19978222|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
8105736|NCT03151551|19978221|P2|STARTED|Open-Label Treatment Period||283
8105737|NCT03151551|19978222|P1|STARTED|Open-Label Treatment Period||283
8105738|NCT03151434|19978289|P3|NOT COMPLETED|Overall Study||7
8105739|NCT03151434|19978290|P2|NOT COMPLETED|Overall Study||7
8105740|NCT03151434|19978291|P1|NOT COMPLETED|Overall Study||13
8105741|NCT03151434|19978289|P3|COMPLETED|Overall Study||40
8105742|NCT03151434|19978290|P2|COMPLETED|Overall Study||40
8105743|NCT03151434|19978291|P1|COMPLETED|Overall Study||40
8105744|NCT03151434|19978289|P3|STARTED|Overall Study||47
8105745|NCT03151434|19978290|P2|STARTED|Overall Study||47
8105746|NCT03151434|19978291|P1|STARTED|Overall Study||53
8105747|NCT03151265|19978319|P2|NOT COMPLETED|Overall Study||0
8105748|NCT03151265|19978320|P1|NOT COMPLETED|Overall Study||0
8105749|NCT03151265|19978319|P2|COMPLETED|Overall Study||20
8105750|NCT03151265|19978320|P1|COMPLETED|Overall Study||20
8105751|NCT03151265|19978319|P2|STARTED|Overall Study||20
8105752|NCT03151265|19978320|P1|STARTED|Overall Study||20
8105753|NCT03151226|19978342|P1|NOT COMPLETED|Overall Study||3
8105754|NCT03151226|19978342|P1|COMPLETED|Overall Study||0
8105755|NCT03151226|19978342|P1|STARTED|Overall Study||3
8105756|NCT03151148|19978348|P2|NOT COMPLETED|Overall Study||0
8105757|NCT03151148|19978349|P1|NOT COMPLETED|Overall Study||2
8105758|NCT03151148|19978348|P2|COMPLETED|Overall Study||18
8105759|NCT03151148|19978349|P1|COMPLETED|Overall Study||34
8105760|NCT03151148|19978348|P2|STARTED|Overall Study||18
8105761|NCT03151148|19978349|P1|STARTED|Overall Study||36
8105762|NCT03151083|19978400|P3|NOT COMPLETED|Overall Study||4
8105763|NCT03151083|19978401|P2|NOT COMPLETED|Overall Study||1
8105764|NCT03151083|19978402|P1|NOT COMPLETED|Overall Study||2
8105765|NCT03151083|19978400|P3|COMPLETED|Overall Study||26
8105766|NCT03151083|19978401|P2|COMPLETED|Overall Study||19
8105767|NCT03151083|19978402|P1|COMPLETED|Overall Study||25
8105768|NCT03151083|19978400|P3|STARTED|Overall Study||30
8105769|NCT03151083|19978401|P2|STARTED|Overall Study||20
8105770|NCT03151083|19978402|P1|STARTED|Overall Study||27
8105771|NCT03150758|19978417|P1|NOT COMPLETED|Overall Study||0
8105772|NCT03150758|19978417|P1|COMPLETED|Overall Study||6
8105773|NCT03150758|19978417|P1|STARTED|Overall Study||6
8105774|NCT03150719|19978423|P2|NOT COMPLETED|Overall Study||2
8105775|NCT03150719|19978424|P1|NOT COMPLETED|Overall Study||1
8105776|NCT03150719|19978423|P2|COMPLETED|Overall Study||48
8105777|NCT03150719|19978424|P1|COMPLETED|Overall Study||46
8105778|NCT03150719|19978423|P2|STARTED|Overall Study||50
8105779|NCT03150719|19978424|P1|STARTED|Overall Study||47
8105780|NCT03150485|19978440|P6|NOT COMPLETED|Overall Study||0
8105781|NCT03150485|19978441|P5|NOT COMPLETED|Overall Study||0
8105782|NCT03150485|19978442|P4|NOT COMPLETED|Overall Study||0
8105783|NCT03150485|19978443|P3|NOT COMPLETED|Overall Study||0
8105784|NCT03150485|19978444|P2|NOT COMPLETED|Overall Study||1
8105785|NCT03150485|19978445|P1|NOT COMPLETED|Overall Study||0
8105786|NCT03150485|19978440|P6|COMPLETED|Overall Study||1
8105787|NCT03150485|19978441|P5|COMPLETED|Overall Study||2
8105788|NCT03150485|19978442|P4|COMPLETED|Overall Study||5
8105789|NCT03150485|19978443|P3|COMPLETED|Overall Study||4
8105790|NCT03150485|19978444|P2|COMPLETED|Overall Study||8
8105791|NCT03150485|19978445|P1|COMPLETED|Overall Study||2
8105792|NCT03150485|19978440|P6|STARTED|Overall Study||1
8105793|NCT03150485|19978441|P5|STARTED|Overall Study||2
8105794|NCT03150485|19978442|P4|STARTED|Overall Study||5
8105795|NCT03150485|19978443|P3|STARTED|Overall Study||4
8105796|NCT03150485|19978444|P2|STARTED|Overall Study||9
8105797|NCT03150485|19978445|P1|STARTED|Overall Study||2
8105798|NCT03150199|19978462|P2|NOT COMPLETED|Overall Study||0
8105799|NCT03150199|19978463|P1|NOT COMPLETED|Overall Study||0
8105800|NCT03150199|19978462|P2|COMPLETED|Overall Study||30
8105801|NCT03150199|19978463|P1|COMPLETED|Overall Study||30
8105802|NCT03150199|19978462|P2|STARTED|Overall Study||30
8105803|NCT03150199|19978463|P1|STARTED|Overall Study||30
8105804|NCT03150160|19978514|P2|NOT COMPLETED|Overall Study||0
8105805|NCT03150160|19978515|P1|NOT COMPLETED|Overall Study||0
8105806|NCT03150160|19978514|P2|COMPLETED|Overall Study||1
8105807|NCT03150160|19978515|P1|COMPLETED|Overall Study||0
8105808|NCT03150160|19978514|P2|STARTED|Overall Study||1
8105809|NCT03150160|19978515|P1|STARTED|Overall Study||0
8105810|NCT03150108|19978531|P2|NOT COMPLETED|Overall Study||0
8105811|NCT03150108|19978532|P1|NOT COMPLETED|Overall Study||0
8105812|NCT03150108|19978531|P2|COMPLETED|Overall Study||12
8105813|NCT03150108|19978532|P1|COMPLETED|Overall Study||12
8105814|NCT03150108|19978531|P2|STARTED|Overall Study||12
8105815|NCT03150108|19978532|P1|STARTED|Overall Study||12
8105816|NCT03150082|19978622|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
8105817|NCT03150082|19978623|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
8105818|NCT03150082|19978622|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
8105819|NCT03150082|19978623|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
8105820|NCT03150082|19978622|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
8105821|NCT03150082|19978623|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
8105822|NCT03150082|19978622|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8105823|NCT03150082|19978623|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8105824|NCT03150082|19978622|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
8105825|NCT03150082|19978623|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
8105826|NCT03150082|19978622|P2|STARTED|Washout Period (Up to 4 Weeks)||13
8105827|NCT03150082|19978623|P1|STARTED|Washout Period (Up to 4 Weeks)||12
8105828|NCT03150082|19978622|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
8105829|NCT03150082|19978623|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
8105830|NCT03150082|19978622|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
8105831|NCT03150082|19978623|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
8105832|NCT03150082|19978622|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
8105833|NCT03150082|19978623|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
8105834|NCT03149991|19978679|P2|NOT COMPLETED|Overall Study||2
8105835|NCT03149991|19978680|P1|NOT COMPLETED|Overall Study||4
8105836|NCT03149991|19978679|P2|COMPLETED|Overall Study||24
8105837|NCT03149991|19978680|P1|COMPLETED|Overall Study||21
8105838|NCT03149991|19978679|P2|Exited|Overall Study||2
8105839|NCT03149991|19978680|P1|Exited|Overall Study||4
8105840|NCT03149991|19978679|P2|Completed Primary Endpoint (Day 14)|Overall Study||24
8105841|NCT03149991|19978680|P1|Completed Primary Endpoint (Day 14)|Overall Study||25
8105842|NCT03149991|19978679|P2|STARTED|Overall Study||26
8105843|NCT03149991|19978680|P1|STARTED|Overall Study||25
8105844|NCT03149887|19978708|P2|NOT COMPLETED|Overall Study||0
8105845|NCT03149887|19978709|P1|NOT COMPLETED|Overall Study||0
8105846|NCT03149887|19978708|P2|COMPLETED|Overall Study||27
8105847|NCT03149887|19978709|P1|COMPLETED|Overall Study||27
8105848|NCT03149887|19978708|P2|STARTED|Overall Study||27
8105849|NCT03149887|19978709|P1|STARTED|Overall Study||27
8105850|NCT03149848|19978729|P1|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
8105851|NCT03149848|19978729|P1|COMPLETED|Period 2 (Day 15 to Day 28)||12
8105852|NCT03149848|19978729|P1|STARTED|Period 2 (Day 15 to Day 28)||14
8105853|NCT03149848|19978729|P1|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
8105854|NCT03149848|19978729|P1|COMPLETED|Period 1 (Day 1 to Day 14)||14
8105855|NCT03149848|19978729|P1|STARTED|Period 1 (Day 1 to Day 14)||15
8105856|NCT03149172|19978769|P3|NOT COMPLETED|Overall Study||2
8105857|NCT03149172|19978770|P2|NOT COMPLETED|Overall Study||1
8105858|NCT03149172|19978771|P1|NOT COMPLETED|Overall Study||2
8105859|NCT03149172|19978769|P3|COMPLETED|Overall Study||5
8105860|NCT03149172|19978770|P2|COMPLETED|Overall Study||5
8105861|NCT03149172|19978771|P1|COMPLETED|Overall Study||6
8105862|NCT03149172|19978769|P3|STARTED|Overall Study||7
8105863|NCT03149172|19978770|P2|STARTED|Overall Study||6
8105864|NCT03149172|19978771|P1|STARTED|Overall Study||8
8105865|NCT03149055|19978782|P1|NOT COMPLETED|Overall Study||4
8105866|NCT03149055|19978782|P1|COMPLETED|Overall Study||95
8105867|NCT03149055|19978782|P1|STARTED|Overall Study||99
8105868|NCT03149042|19978787|P1|NOT COMPLETED|Overall Study||23
8105869|NCT03149042|19978787|P1|COMPLETED|Overall Study||52
8105870|NCT03149042|19978787|P1|STARTED|Overall Study||75
8105871|NCT03148756|19978801|P2|NOT COMPLETED|Overall Study||1
8105872|NCT03148756|19978802|P1|NOT COMPLETED|Overall Study||0
8105873|NCT03148756|19978801|P2|COMPLETED|Overall Study||1
8105874|NCT03148756|19978802|P1|COMPLETED|Overall Study||0
8105875|NCT03148756|19978801|P2|STARTED|Overall Study||2
8105876|NCT03148756|19978802|P1|STARTED|Overall Study||0
8105877|NCT03148691|19978835|P3|NOT COMPLETED|Overall Study||8
8105878|NCT03148691|19978836|P2|NOT COMPLETED|Overall Study||2
8105879|NCT03148691|19978837|P1|NOT COMPLETED|Overall Study||3
8105880|NCT03148691|19978835|P3|COMPLETED|Overall Study||92
8105881|NCT03148691|19978836|P2|COMPLETED|Overall Study||101
8105882|NCT03148691|19978837|P1|COMPLETED|Overall Study||47
8105883|NCT03148691|19978835|P3|STARTED|Overall Study||100
8105884|NCT03148691|19978836|P2|STARTED|Overall Study||103
8105885|NCT03148691|19978837|P1|STARTED|Overall Study||50
8105886|NCT03148470|19978847|P2|NOT COMPLETED|Overall Study||0
8105887|NCT03148470|19978848|P1|NOT COMPLETED|Overall Study||1
8105888|NCT03148470|19978847|P2|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
8105889|NCT03148470|19978848|P1|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
8105890|NCT03148470|19978847|P2|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
8105891|NCT03148470|19978848|P1|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
8105892|NCT03148262|19978864|P2|NOT COMPLETED|Overall Study||1
8105893|NCT03148262|19978865|P1|NOT COMPLETED|Overall Study||3
8105894|NCT03148262|19978864|P2|COMPLETED|Overall Study||31
8105895|NCT03148262|19978865|P1|COMPLETED|Overall Study||28
8105896|NCT03148262|19978864|P2|STARTED|Overall Study||32
8105897|NCT03148262|19978865|P1|STARTED|Overall Study||31
8105898|NCT03148236|19978873|P2|NOT COMPLETED|Overall Study||0
8105899|NCT03148236|19978874|P1|NOT COMPLETED|Overall Study||0
8105900|NCT03148236|19978873|P2|COMPLETED|Overall Study||10
8105901|NCT03148236|19978874|P1|COMPLETED|Overall Study||10
8105902|NCT03148236|19978873|P2|STARTED|Overall Study||10
8105903|NCT03148236|19978874|P1|STARTED|Overall Study||10
8105904|NCT03148067|19978900|P1|NOT COMPLETED|Overall Study||4
8105905|NCT03148067|19978900|P1|COMPLETED|Overall Study||221
8105906|NCT03148067|19978900|P1|STARTED|Overall Study||225
8105907|NCT03147690|19978905|P1|NOT COMPLETED|Overall Study||3
8105908|NCT03147690|19978905|P1|COMPLETED|Overall Study||71
8105909|NCT03147690|19978905|P1|STARTED|Overall Study||74
8105910|NCT03147495|19978929|P2|NOT COMPLETED|Overall Study||6
8105911|NCT03147495|19978930|P1|NOT COMPLETED|Overall Study||0
8105912|NCT03147495|19978929|P2|COMPLETED|Overall Study||40
8105913|NCT03147495|19978930|P1|COMPLETED|Overall Study||40
8105914|NCT03147495|19978929|P2|STARTED|Overall Study||46
8105915|NCT03147495|19978930|P1|STARTED|Overall Study||40
8105916|NCT03147248|19978952|P6|NOT COMPLETED|Overall Study||31
8105917|NCT03147248|19978953|P5|NOT COMPLETED|Overall Study||26
8105918|NCT03147248|19978954|P4|NOT COMPLETED|Overall Study||2
8105919|NCT03147248|19978955|P3|NOT COMPLETED|Overall Study||2
8105920|NCT03147248|19978956|P2|NOT COMPLETED|Overall Study||2
8105921|NCT03147248|19978957|P1|NOT COMPLETED|Overall Study||1
8105922|NCT03147248|19978952|P6|COMPLETED|Overall Study||145
8105923|NCT03147248|19978953|P5|COMPLETED|Overall Study||141
8105924|NCT03147248|19978954|P4|COMPLETED|Overall Study||10
8105925|NCT03147248|19978955|P3|COMPLETED|Overall Study||10
8105926|NCT03147248|19978956|P2|COMPLETED|Overall Study||9
8105927|NCT03147248|19978957|P1|COMPLETED|Overall Study||12
8105928|NCT03147248|19978952|P6|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
8105929|NCT03147248|19978953|P5|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
8105930|NCT03147248|19978954|P4|STARTED|Overall Study|This cohort is only for Part 1.|12
8105931|NCT03147248|19978955|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
8105932|NCT03147248|19978956|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
8105933|NCT03147248|19978957|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
8105934|NCT03146741|19978979|P1|NOT COMPLETED|Overall Study||10
8105935|NCT03146741|19978979|P1|COMPLETED|Overall Study||10
8105936|NCT03146741|19978979|P1|STARTED|Overall Study||20
8105937|NCT03146585|19978987|P3|NOT COMPLETED|Overall Study||0
8105938|NCT03146585|19978988|P2|NOT COMPLETED|Overall Study||0
8105939|NCT03146585|19978989|P1|NOT COMPLETED|Overall Study||0
8105940|NCT03146585|19978987|P3|COMPLETED|Overall Study||5
8105941|NCT03146585|19978988|P2|COMPLETED|Overall Study||10
8105942|NCT03146585|19978989|P1|COMPLETED|Overall Study||25
8105943|NCT03146585|19978987|P3|STARTED|Overall Study||5
8105944|NCT03146585|19978988|P2|STARTED|Overall Study||10
8105945|NCT03146585|19978989|P1|STARTED|Overall Study||25
8105946|NCT03146403|19978999|P2|NOT COMPLETED|Overall Study||3
8105947|NCT03146403|19979000|P1|NOT COMPLETED|Overall Study||2
8105948|NCT03146403|19978999|P2|COMPLETED|Overall Study||14
8105949|NCT03146403|19979000|P1|COMPLETED|Overall Study||14
8105950|NCT03146403|19978999|P2|STARTED|Overall Study||17
8105951|NCT03146403|19979000|P1|STARTED|Overall Study||16
8105952|NCT03145818|19979018|P4|NOT COMPLETED|Overall Study||0
8105953|NCT03145818|19979019|P3|NOT COMPLETED|Overall Study||0
8105954|NCT03145818|19979020|P2|NOT COMPLETED|Overall Study||8
8105955|NCT03145818|19979021|P1|NOT COMPLETED|Overall Study||91
8105956|NCT03145818|19979018|P4|COMPLETED|Overall Study||9
8105957|NCT03145818|19979019|P3|COMPLETED|Overall Study||10
8105958|NCT03145818|19979020|P2|COMPLETED|Overall Study||0
8105959|NCT03145818|19979021|P1|COMPLETED|Overall Study||8
8105960|NCT03145818|19979018|P4|STARTED|Overall Study||9
8105961|NCT03145818|19979019|P3|STARTED|Overall Study||10
8105962|NCT03145818|19979020|P2|STARTED|Overall Study||8
8105963|NCT03145818|19979021|P1|STARTED|Overall Study||99
8105964|NCT03145259|19979029|P1|NOT COMPLETED|Overall Study||0
8105965|NCT03145259|19979029|P1|COMPLETED|Overall Study||12
8105966|NCT03145259|19979029|P1|STARTED|Overall Study||12
8105967|NCT03145207|19979036|P1|NOT COMPLETED|Overall Study||2
8105968|NCT03145207|19979036|P1|COMPLETED|Overall Study||12
8105969|NCT03145207|19979036|P1|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
8105970|NCT03144635|19979051|P1|NOT COMPLETED|Overall Study||80
8105971|NCT03144635|19979051|P1|COMPLETED|Overall Study||0
8105972|NCT03144635|19979051|P1|STARTED|Overall Study||80
8105973|NCT03144518|19979063|P2|NOT COMPLETED|16 Week Post-Vaccination||2
8105974|NCT03144518|19979064|P1|NOT COMPLETED|16 Week Post-Vaccination||3
8105975|NCT03144518|19979063|P2|COMPLETED|16 Week Post-Vaccination||49
8105976|NCT03144518|19979064|P1|COMPLETED|16 Week Post-Vaccination||49
8105977|NCT03144518|19979063|P2|STARTED|16 Week Post-Vaccination||51
8105978|NCT03144518|19979064|P1|STARTED|16 Week Post-Vaccination||52
8105979|NCT03144518|19979063|P2|NOT COMPLETED|4 Weeks Post-Vaccination||0
8105980|NCT03144518|19979064|P1|NOT COMPLETED|4 Weeks Post-Vaccination||1
8105981|NCT03144518|19979063|P2|COMPLETED|4 Weeks Post-Vaccination||51
8105982|NCT03144518|19979064|P1|COMPLETED|4 Weeks Post-Vaccination||51
8105983|NCT03144518|19979063|P2|STARTED|4 Weeks Post-Vaccination||51
8105984|NCT03144518|19979064|P1|STARTED|4 Weeks Post-Vaccination||52
8105985|NCT03144518|19979063|P2|NOT COMPLETED|Primary Outcome (Mood)||0
8105986|NCT03144518|19979064|P1|NOT COMPLETED|Primary Outcome (Mood)||0
8105987|NCT03144518|19979063|P2|COMPLETED|Primary Outcome (Mood)||51
8105988|NCT03144518|19979064|P1|COMPLETED|Primary Outcome (Mood)||52
8105989|NCT03144518|19979063|P2|STARTED|Primary Outcome (Mood)||51
8105990|NCT03144518|19979064|P1|STARTED|Primary Outcome (Mood)||52
8105991|NCT03144180|19979081|P2|NOT COMPLETED|Overall Study||6
8105992|NCT03144180|19979082|P1|NOT COMPLETED|Overall Study||2
8105993|NCT03144180|19979081|P2|COMPLETED|Overall Study||10
8105994|NCT03144180|19979082|P1|COMPLETED|Overall Study||14
8105995|NCT03144180|19979081|P2|STARTED|Overall Study||16
8105996|NCT03144180|19979082|P1|STARTED|Overall Study||16
8105997|NCT03143855|19979094|P2|NOT COMPLETED|Overall Study||4
8105998|NCT03143855|19979095|P1|NOT COMPLETED|Overall Study||5
8105999|NCT03143855|19979094|P2|COMPLETED|Overall Study||6
8106000|NCT03143855|19979095|P1|COMPLETED|Overall Study||12
8106001|NCT03143855|19979094|P2|STARTED|Overall Study||10
8106002|NCT03143855|19979095|P1|STARTED|Overall Study||17
8106003|NCT03143569|19979103|P2|NOT COMPLETED|Overall Study||2
8106004|NCT03143569|19979104|P1|NOT COMPLETED|Overall Study||0
8106005|NCT03143569|19979103|P2|COMPLETED|Overall Study||8
8106006|NCT03143569|19979104|P1|COMPLETED|Overall Study||10
8106007|NCT03143569|19979103|P2|STARTED|Overall Study||10
8106008|NCT03143569|19979104|P1|STARTED|Overall Study||10
8106009|NCT03143166|19979126|P1|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
8106010|NCT03143166|19979126|P1|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
8106011|NCT03143166|19979126|P1|STARTED|Period 2 (Washout of at Least 4 Days)||36
8106012|NCT03143166|19979126|P1|NOT COMPLETED|Period 1||0
8106013|NCT03143166|19979126|P1|COMPLETED|Period 1||36
8106014|NCT03143166|19979126|P1|STARTED|Period 1||36
8106015|NCT03143101|19979145|P3|NOT COMPLETED|Overall Study||0
8106016|NCT03143101|19979146|P2|NOT COMPLETED|Overall Study||3
8106017|NCT03143101|19979147|P1|NOT COMPLETED|Overall Study||2
8106018|NCT03143101|19979145|P3|COMPLETED|Overall Study||67
8106019|NCT03143101|19979146|P2|COMPLETED|Overall Study||63
8106020|NCT03143101|19979147|P1|COMPLETED|Overall Study||65
8106021|NCT03143101|19979145|P3|STARTED|Overall Study||67
8106022|NCT03143101|19979146|P2|STARTED|Overall Study||66
8106023|NCT03143101|19979147|P1|STARTED|Overall Study||67
8106024|NCT03142932|19979202|P2|NOT COMPLETED|Overall Study||11
8106025|NCT03142932|19979203|P1|NOT COMPLETED|Overall Study||2
8106026|NCT03142932|19979202|P2|COMPLETED|Overall Study||39
8106027|NCT03142932|19979203|P1|COMPLETED|Overall Study||50
8106028|NCT03142932|19979202|P2|STARTED|Overall Study||50
8106029|NCT03142932|19979203|P1|STARTED|Overall Study||52
8106030|NCT03142750|19979219|P2|NOT COMPLETED|Overall Study||1
8106031|NCT03142750|19979220|P1|NOT COMPLETED|Overall Study||4
8106032|NCT03142750|19979219|P2|COMPLETED|Overall Study||9
8106033|NCT03142750|19979220|P1|COMPLETED|Overall Study||10
8106034|NCT03142750|19979219|P2|STARTED|Overall Study||10
8106035|NCT03142750|19979220|P1|STARTED|Overall Study||14
8106036|NCT03141931|19979233|P2|NOT COMPLETED|Overall Study||6
8106037|NCT03141931|19979234|P1|NOT COMPLETED|Overall Study||12
8106038|NCT03141931|19979233|P2|COMPLETED|Overall Study||52
8106039|NCT03141931|19979234|P1|COMPLETED|Overall Study||49
8106040|NCT03141931|19979233|P2|STARTED|Overall Study||58
8106041|NCT03141931|19979234|P1|STARTED|Overall Study||61
8106042|NCT03141788|19979254|P1|NOT COMPLETED|Overall Study||8
8106043|NCT03141788|19979254|P1|COMPLETED|Overall Study||44
8106044|NCT03141788|19979254|P1|STARTED|Overall Study||52
8106045|NCT03141528|19979271|P2|NOT COMPLETED|Overall Study||41
8106046|NCT03141528|19979272|P1|NOT COMPLETED|Overall Study||47
8106047|NCT03141528|19979271|P2|COMPLETED|Overall Study||77
8106048|NCT03141528|19979272|P1|COMPLETED|Overall Study||75
8106049|NCT03141528|19979271|P2|STARTED|Overall Study||118
8106050|NCT03141528|19979272|P1|STARTED|Overall Study||122
8106051|NCT03141372|19979314|P2|NOT COMPLETED|Overall Study||2
8106052|NCT03141372|19979315|P1|NOT COMPLETED|Overall Study||0
8106053|NCT03141372|19979314|P2|COMPLETED|Overall Study||40
8106054|NCT03141372|19979315|P1|COMPLETED|Overall Study||42
8106055|NCT03141372|19979314|P2|STARTED|Overall Study||42
8106056|NCT03141372|19979315|P1|STARTED|Overall Study||42
8106057|NCT03141307|19979335|P2|NOT COMPLETED|Follow-Up||54
8106058|NCT03141307|19979336|P1|NOT COMPLETED|Follow-Up||97
8106059|NCT03141307|19979335|P2|COMPLETED|Follow-Up||184
8106060|NCT03141307|19979336|P1|COMPLETED|Follow-Up||370
8106061|NCT03141307|19979335|P2|STARTED|Follow-Up||238
8106062|NCT03141307|19979336|P1|STARTED|Follow-Up||467
8106063|NCT03141307|19979335|P2|NOT COMPLETED|In-Hospital||2
8106064|NCT03141307|19979336|P1|NOT COMPLETED|In-Hospital||4
8106065|NCT03141307|19979335|P2|COMPLETED|In-Hospital||238
8106066|NCT03141307|19979336|P1|COMPLETED|In-Hospital||467
8106067|NCT03141307|19979335|P2|STARTED|In-Hospital||240
8106068|NCT03141307|19979336|P1|STARTED|In-Hospital||471
8106069|NCT03141151|19979354|P2|NOT COMPLETED|Overall Study||4
8106070|NCT03141151|19979355|P1|NOT COMPLETED|Overall Study||6
8106071|NCT03141151|19979354|P2|COMPLETED|Overall Study||54
8106072|NCT03141151|19979355|P1|COMPLETED|Overall Study||53
8106073|NCT03141151|19979354|P2|STARTED|Overall Study||58
8106074|NCT03141151|19979355|P1|STARTED|Overall Study||59
8106075|NCT03141086|19979373|P2|NOT COMPLETED|Overall Study||5
8106076|NCT03141086|19979374|P1|NOT COMPLETED|Overall Study||1
8106077|NCT03141086|19979373|P2|COMPLETED|Overall Study||12
8106078|NCT03141086|19979374|P1|COMPLETED|Overall Study||6
8106079|NCT03141086|19979373|P2|STARTED|Overall Study||17
8106080|NCT03141086|19979374|P1|STARTED|Overall Study||7
8106081|NCT03140631|19979403|P2|NOT COMPLETED|Overall Study||0
8106082|NCT03140631|19979404|P1|NOT COMPLETED|Overall Study||0
8106083|NCT03140631|19979403|P2|COMPLETED|Overall Study||77
8106084|NCT03140631|19979404|P1|COMPLETED|Overall Study||73
8106085|NCT03140631|19979403|P2|STARTED|Overall Study||77
8106086|NCT03140631|19979404|P1|STARTED|Overall Study||73
8106087|NCT03139604|19979414|P2|NOT COMPLETED|Overall Study||220
8106088|NCT03139604|19979415|P1|NOT COMPLETED|Overall Study||219
8106089|NCT03139604|19979414|P2|COMPLETED|Overall Study||0
8106090|NCT03139604|19979415|P1|COMPLETED|Overall Study||0
8106091|NCT03139604|19979414|P2|STARTED|Overall Study||220
8106092|NCT03139604|19979415|P1|STARTED|Overall Study||219
8106093|NCT03139578|19979427|P4|NOT COMPLETED|Period 2||0
8106094|NCT03139578|19979428|P3|NOT COMPLETED|Period 2||0
8106095|NCT03139578|19979429|P2|NOT COMPLETED|Period 2||0
8106096|NCT03139578|19979430|P1|NOT COMPLETED|Period 2||0
8106097|NCT03139578|19979427|P4|COMPLETED|Period 2||13
8106098|NCT03139578|19979428|P3|COMPLETED|Period 2||12
8106099|NCT03139578|19979429|P2|COMPLETED|Period 2||13
8106100|NCT03139578|19979430|P1|COMPLETED|Period 2||12
8106101|NCT03139578|19979427|P4|Discontinued|Period 2||0
8106102|NCT03139578|19979428|P3|Discontinued|Period 2||0
8106103|NCT03139578|19979429|P2|Discontinued|Period 2||0
8106104|NCT03139578|19979430|P1|Discontinued|Period 2||0
8106105|NCT03139578|19979427|P4|STARTED|Period 2||13
8106106|NCT03139578|19979428|P3|STARTED|Period 2||12
8106107|NCT03139578|19979429|P2|STARTED|Period 2||13
8106108|NCT03139578|19979430|P1|STARTED|Period 2||12
8106109|NCT03139578|19979427|P4|NOT COMPLETED|Period 1||0
8106110|NCT03139578|19979428|P3|NOT COMPLETED|Period 1||0
8106111|NCT03139578|19979429|P2|NOT COMPLETED|Period 1||0
8106112|NCT03139578|19979430|P1|NOT COMPLETED|Period 1||0
8106113|NCT03139578|19979427|P4|COMPLETED|Period 1||13
8106114|NCT03139578|19979428|P3|COMPLETED|Period 1||12
8106115|NCT03139578|19979429|P2|COMPLETED|Period 1||13
8106116|NCT03139578|19979430|P1|COMPLETED|Period 1||12
8106117|NCT03139578|19979427|P4|Discontinued|Period 1||0
8106118|NCT03139578|19979428|P3|Discontinued|Period 1||0
8106119|NCT03139578|19979429|P2|Discontinued|Period 1||0
8106120|NCT03139578|19979430|P1|Discontinued|Period 1||0
8106121|NCT03139578|19979427|P4|STARTED|Period 1||13
8106122|NCT03139578|19979428|P3|STARTED|Period 1||12
8106123|NCT03139578|19979429|P2|STARTED|Period 1||13
8106124|NCT03139578|19979430|P1|STARTED|Period 1||12
8106125|NCT03139552|19979464|P1|NOT COMPLETED|Overall Study||3
8106126|NCT03139552|19979464|P1|COMPLETED|Overall Study||147
8106127|NCT03139552|19979464|P1|STARTED|Overall Study||150
8106128|NCT03139448|19979507|P2|NOT COMPLETED|Overall Study||26
8106129|NCT03139448|19979508|P1|NOT COMPLETED|Overall Study||12
8106130|NCT03139448|19979507|P2|COMPLETED|Overall Study||63
8106131|NCT03139448|19979508|P1|COMPLETED|Overall Study||73
8106132|NCT03139448|19979507|P2|Intervention Started|Overall Study||70
8106133|NCT03139448|19979508|P1|Intervention Started|Overall Study||79
8106134|NCT03139448|19979507|P2|STARTED|Overall Study||89
8106135|NCT03139448|19979508|P1|STARTED|Overall Study||85
8106136|NCT03139279|19979532|P2|NOT COMPLETED|Overall Study||6
8106137|NCT03139279|19979533|P1|NOT COMPLETED|Overall Study||7
8106138|NCT03139279|19979532|P2|COMPLETED|Overall Study||50
8106139|NCT03139279|19979533|P1|COMPLETED|Overall Study||51
8106140|NCT03139279|19979532|P2|STARTED|Overall Study||56
8106141|NCT03139279|19979533|P1|STARTED|Overall Study||58
8106142|NCT03139240|19979551|P4|NOT COMPLETED|Overall Study||0
8106143|NCT03139240|19979552|P3|NOT COMPLETED|Overall Study||1
8106144|NCT03139240|19979553|P2|NOT COMPLETED|Overall Study||1
8106145|NCT03139240|19979554|P1|NOT COMPLETED|Overall Study||0
8106146|NCT03139240|19979551|P4|COMPLETED|Overall Study||38
8106147|NCT03139240|19979552|P3|COMPLETED|Overall Study||37
8106148|NCT03139240|19979553|P2|COMPLETED|Overall Study||47
8106149|NCT03139240|19979554|P1|COMPLETED|Overall Study||48
8106150|NCT03139240|19979551|P4|STARTED|Overall Study||38
8106151|NCT03139240|19979552|P3|STARTED|Overall Study||38
8106152|NCT03139240|19979553|P2|STARTED|Overall Study||48
8106153|NCT03139240|19979554|P1|STARTED|Overall Study||48
8106154|NCT03139032|19979564|P1|NOT COMPLETED|Overall Study||0
8106155|NCT03139032|19979564|P1|COMPLETED|Overall Study||1
8106156|NCT03139032|19979564|P1|STARTED|Overall Study||1
8106157|NCT03138967|19979586|P2|NOT COMPLETED|Overall Study||4
8106158|NCT03138967|19979587|P1|NOT COMPLETED|Overall Study||1
8106159|NCT03138967|19979586|P2|COMPLETED|Overall Study||24
8106160|NCT03138967|19979587|P1|COMPLETED|Overall Study||25
8106161|NCT03138967|19979586|P2|Post-operative Day(POD) 7 Follow-up|Overall Study||24
8106162|NCT03138967|19979587|P1|Post-operative Day(POD) 7 Follow-up|Overall Study||25
8106163|NCT03138967|19979586|P2|Post-operative Day(POD) 1 Follow-up|Overall Study||25
8106164|NCT03138967|19979587|P1|Post-operative Day(POD) 1 Follow-up|Overall Study||25
8106165|NCT03138967|19979586|P2|STARTED|Overall Study||28
8106166|NCT03138967|19979587|P1|STARTED|Overall Study||26
8106167|NCT03138876|19979597|P1|NOT COMPLETED|Overall Study||0
8106168|NCT03138876|19979597|P1|COMPLETED|Overall Study||20
8106169|NCT03138876|19979597|P1|STARTED|Overall Study||20
8106170|NCT03138798|19979606|P2|NOT COMPLETED|Overall Study||4
8106171|NCT03138798|19979607|P1|NOT COMPLETED|Overall Study||6
8106172|NCT03138798|19979606|P2|COMPLETED|Overall Study||171
8106173|NCT03138798|19979607|P1|COMPLETED|Overall Study||167
8106174|NCT03138798|19979606|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
8106175|NCT03138798|19979607|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
8106176|NCT03138798|19979606|P2|STARTED|Overall Study||175
8106177|NCT03138798|19979607|P1|STARTED|Overall Study||173
8106178|NCT03138655|19979638|P8|NOT COMPLETED|Overall Study||2
8106179|NCT03138655|19979639|P7|NOT COMPLETED|Overall Study||3
8106180|NCT03138655|19979640|P6|NOT COMPLETED|Overall Study||5
8106181|NCT03138655|19979641|P5|NOT COMPLETED|Overall Study||2
8106182|NCT03138655|19979642|P4|NOT COMPLETED|Overall Study||3
8106183|NCT03138655|19979643|P3|NOT COMPLETED|Overall Study||2
8106184|NCT03138655|19979644|P2|NOT COMPLETED|Overall Study||2
8106185|NCT03138655|19979645|P1|NOT COMPLETED|Overall Study||3
8106186|NCT03138655|19979638|P8|COMPLETED|Overall Study||10
8106187|NCT03138655|19979639|P7|COMPLETED|Overall Study||9
8106188|NCT03138655|19979640|P6|COMPLETED|Overall Study||7
8106189|NCT03138655|19979641|P5|COMPLETED|Overall Study||11
8106190|NCT03138655|19979642|P4|COMPLETED|Overall Study||7
8106191|NCT03138655|19979643|P3|COMPLETED|Overall Study||9
8106192|NCT03138655|19979644|P2|COMPLETED|Overall Study||7
8106193|NCT03138655|19979645|P1|COMPLETED|Overall Study||7
8106194|NCT03138655|19979638|P8|STARTED|Overall Study||12
8106195|NCT03138655|19979639|P7|STARTED|Overall Study||12
8106196|NCT03138655|19979640|P6|STARTED|Overall Study||12
8106197|NCT03138655|19979641|P5|STARTED|Overall Study||13
8106198|NCT03138655|19979642|P4|STARTED|Overall Study||10
8106199|NCT03138655|19979643|P3|STARTED|Overall Study||11
8106200|NCT03138655|19979644|P2|STARTED|Overall Study||9
8106201|NCT03138655|19979645|P1|STARTED|Overall Study||10
8106202|NCT03138590|19979687|P2|NOT COMPLETED|Overall Study||0
8106203|NCT03138590|19979688|P1|NOT COMPLETED|Overall Study||0
8106204|NCT03138590|19979687|P2|COMPLETED|Overall Study||10
8106205|NCT03138590|19979688|P1|COMPLETED|Overall Study||10
8106206|NCT03138590|19979687|P2|STARTED|Overall Study||10
8106207|NCT03138590|19979688|P1|STARTED|Overall Study||10
8106208|NCT03138577|19979701|P7|NOT COMPLETED|Overall Study||0
8106209|NCT03138577|19979702|P6|NOT COMPLETED|Overall Study||0
8106210|NCT03138577|19979703|P5|NOT COMPLETED|Overall Study||0
8106211|NCT03138577|19979704|P4|NOT COMPLETED|Overall Study||0
8106212|NCT03138577|19979705|P3|NOT COMPLETED|Overall Study||0
8106213|NCT03138577|19979706|P2|NOT COMPLETED|Overall Study||0
8106214|NCT03138577|19979707|P1|NOT COMPLETED|Overall Study||0
8106215|NCT03138577|19979701|P7|COMPLETED|Overall Study||3
8106216|NCT03138577|19979702|P6|COMPLETED|Overall Study||3
8106217|NCT03138577|19979703|P5|COMPLETED|Overall Study||3
8106218|NCT03138577|19979704|P4|COMPLETED|Overall Study||3
8106219|NCT03138577|19979705|P3|COMPLETED|Overall Study||3
8106220|NCT03138577|19979706|P2|COMPLETED|Overall Study||3
8106221|NCT03138577|19979707|P1|COMPLETED|Overall Study||3
8106222|NCT03138577|19979701|P7|STARTED|Overall Study||3
8106223|NCT03138577|19979702|P6|STARTED|Overall Study||3
8106224|NCT03138577|19979703|P5|STARTED|Overall Study||3
8106225|NCT03138577|19979704|P4|STARTED|Overall Study||3
8106226|NCT03138577|19979705|P3|STARTED|Overall Study||3
8106227|NCT03138577|19979706|P2|STARTED|Overall Study||3
8106228|NCT03138577|19979707|P1|STARTED|Overall Study||3
8106229|NCT03138382|19979752|P2|NOT COMPLETED|Overall Study||0
8106230|NCT03138382|19979753|P1|NOT COMPLETED|Overall Study||0
8106231|NCT03138382|19979752|P2|COMPLETED|Overall Study||10
8106232|NCT03138382|19979753|P1|COMPLETED|Overall Study||10
8106233|NCT03138382|19979752|P2|STARTED|Overall Study||10
8106234|NCT03138382|19979753|P1|STARTED|Overall Study||10
8106235|NCT03138330|19979761|P1|NOT COMPLETED|Overall Study||4
8106236|NCT03138330|19979761|P1|COMPLETED|Overall Study||91
8106237|NCT03138330|19979761|P1|STARTED|Overall Study||95
8106238|NCT03137784|19979766|P6|NOT COMPLETED|Overall Study||0
8106239|NCT03137784|19979767|P5|NOT COMPLETED|Overall Study||1
8106240|NCT03137784|19979768|P4|NOT COMPLETED|Overall Study||0
8106241|NCT03137784|19979769|P3|NOT COMPLETED|Overall Study||0
8106242|NCT03137784|19979770|P2|NOT COMPLETED|Overall Study||1
8106243|NCT03137784|19979771|P1|NOT COMPLETED|Overall Study||2
8106244|NCT03137784|19979766|P6|COMPLETED|Overall Study||25
8106245|NCT03137784|19979767|P5|COMPLETED|Overall Study||24
8106246|NCT03137784|19979768|P4|COMPLETED|Overall Study||24
8106247|NCT03137784|19979769|P3|COMPLETED|Overall Study||25
8106248|NCT03137784|19979770|P2|COMPLETED|Overall Study||24
8106249|NCT03137784|19979771|P1|COMPLETED|Overall Study||22
8106250|NCT03137784|19979766|P6|STARTED|Overall Study||25
8106251|NCT03137784|19979767|P5|STARTED|Overall Study||25
8106252|NCT03137784|19979768|P4|STARTED|Overall Study||24
8106253|NCT03137784|19979769|P3|STARTED|Overall Study||25
8106254|NCT03137784|19979770|P2|STARTED|Overall Study||25
8106255|NCT03137784|19979771|P1|STARTED|Overall Study||24
8106259|NCT03137225|19979812|P2|NOT COMPLETED|Second 4 Hour Measurement Period||0
8106260|NCT03137225|19979813|P1|NOT COMPLETED|Second 4 Hour Measurement Period||0
8106261|NCT03137225|19979812|P2|COMPLETED|Second 4 Hour Measurement Period||0
8106262|NCT03137225|19979813|P1|COMPLETED|Second 4 Hour Measurement Period||1
8106263|NCT03137225|19979812|P2|STARTED|Second 4 Hour Measurement Period||0
8106264|NCT03137225|19979813|P1|STARTED|Second 4 Hour Measurement Period||1
8106265|NCT03137225|19979812|P2|NOT COMPLETED|First 4 Hour Measurement Period||0
8106266|NCT03137225|19979813|P1|NOT COMPLETED|First 4 Hour Measurement Period||0
8106267|NCT03137225|19979812|P2|COMPLETED|First 4 Hour Measurement Period||0
8106268|NCT03137225|19979813|P1|COMPLETED|First 4 Hour Measurement Period||1
8106269|NCT03137225|19979812|P2|STARTED|First 4 Hour Measurement Period||0
8106270|NCT03137225|19979813|P1|STARTED|First 4 Hour Measurement Period||1
8106271|NCT03137173|19979827|P2|NOT COMPLETED|Overall Study||36
8106272|NCT03137173|19979828|P1|NOT COMPLETED|Overall Study||26
8106273|NCT03137173|19979827|P2|COMPLETED|Overall Study||308
8106274|NCT03137173|19979828|P1|COMPLETED|Overall Study||309
8106275|NCT03137173|19979827|P2|STARTED|Overall Study||344
8106276|NCT03137173|19979828|P1|STARTED|Overall Study||335
8106277|NCT03137069|19979844|P6|NOT COMPLETED|Overall Study||2
8106278|NCT03137069|19979845|P5|NOT COMPLETED|Overall Study||2
8106279|NCT03137069|19979846|P4|NOT COMPLETED|Overall Study||6
8106280|NCT03137069|19979847|P3|NOT COMPLETED|Overall Study||3
8106281|NCT03137069|19979848|P2|NOT COMPLETED|Overall Study||6
8106282|NCT03137069|19979849|P1|NOT COMPLETED|Overall Study||1
8106283|NCT03137069|19979844|P6|COMPLETED|Overall Study||21
8106284|NCT03137069|19979845|P5|COMPLETED|Overall Study||22
8106285|NCT03137069|19979846|P4|COMPLETED|Overall Study||17
8106286|NCT03137069|19979847|P3|COMPLETED|Overall Study||20
8106287|NCT03137069|19979848|P2|COMPLETED|Overall Study||22
8106288|NCT03137069|19979849|P1|COMPLETED|Overall Study||12
8106289|NCT03137069|19979844|P6|STARTED|Overall Study||23
8106290|NCT03137069|19979845|P5|STARTED|Overall Study||24
8106291|NCT03137069|19979846|P4|STARTED|Overall Study||23
8106292|NCT03137069|19979847|P3|STARTED|Overall Study||23
8106293|NCT03137069|19979848|P2|STARTED|Overall Study||28
8106294|NCT03137069|19979849|P1|STARTED|Overall Study||13
8106295|NCT03136861|19979892|P7|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
8106296|NCT03136861|19979893|P6|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106297|NCT03136861|19979894|P5|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
8106298|NCT03136861|19979895|P4|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
8106299|NCT03136861|19979896|P3|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
8106300|NCT03136861|19979897|P2|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106301|NCT03136861|19979898|P1|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106302|NCT03136861|19979892|P7|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
8106303|NCT03136861|19979893|P6|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
8106304|NCT03136861|19979894|P5|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
8106305|NCT03136861|19979895|P4|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
8106306|NCT03136861|19979896|P3|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
8106307|NCT03136861|19979897|P2|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106308|NCT03136861|19979898|P1|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106309|NCT03136861|19979892|P7|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
8106310|NCT03136861|19979893|P6|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
8106311|NCT03136861|19979894|P5|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
8106312|NCT03136861|19979895|P4|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
8106313|NCT03136861|19979896|P3|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
8106314|NCT03136861|19979897|P2|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106315|NCT03136861|19979898|P1|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106316|NCT03136861|19979892|P7|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106317|NCT03136861|19979893|P6|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106318|NCT03136861|19979894|P5|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106319|NCT03136861|19979895|P4|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106320|NCT03136861|19979896|P3|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106321|NCT03136861|19979897|P2|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
8106322|NCT03136861|19979898|P1|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
8106323|NCT03136861|19979892|P7|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106324|NCT03136861|19979893|P6|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106325|NCT03136861|19979894|P5|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106326|NCT03136861|19979895|P4|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106327|NCT03136861|19979896|P3|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106328|NCT03136861|19979897|P2|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
8106329|NCT03136861|19979898|P1|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
8106330|NCT03136861|19979892|P7|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106331|NCT03136861|19979893|P6|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106332|NCT03136861|19979894|P5|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106333|NCT03136861|19979895|P4|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106334|NCT03136861|19979896|P3|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106335|NCT03136861|19979897|P2|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
8106336|NCT03136861|19979898|P1|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
8106337|NCT03136484|19979913|P2|NOT COMPLETED|Overall Study||22
8106338|NCT03136484|19979914|P1|NOT COMPLETED|Overall Study||27
8106339|NCT03136484|19979913|P2|COMPLETED|Overall Study||372
8106340|NCT03136484|19979914|P1|COMPLETED|Overall Study||367
8106341|NCT03136484|19979913|P2|Exposed|Overall Study||394
8106342|NCT03136484|19979914|P1|Exposed|Overall Study||392
8106343|NCT03136484|19979913|P2|STARTED|Overall Study||394
8106344|NCT03136484|19979914|P1|STARTED|Overall Study||394
8106345|NCT03136380|19980042|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106346|NCT03136380|19980043|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106347|NCT03136380|19980044|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106348|NCT03136380|19980045|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106349|NCT03136380|19980046|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106350|NCT03136380|19980042|P5|COMPLETED|Part 2, Period 2 (3 Days)||8
8106351|NCT03136380|19980043|P4|COMPLETED|Part 2, Period 2 (3 Days)||8
8106352|NCT03136380|19980044|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
8106353|NCT03136380|19980045|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
8106354|NCT03136380|19980046|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
8106355|NCT03136380|19980042|P5|STARTED|Part 2, Period 2 (3 Days)||8
8106356|NCT03136380|19980043|P4|STARTED|Part 2, Period 2 (3 Days)||8
8106357|NCT03136380|19980044|P3|STARTED|Part 2, Period 2 (3 Days)||0
8106358|NCT03136380|19980045|P2|STARTED|Part 2, Period 2 (3 Days)||0
8106359|NCT03136380|19980046|P1|STARTED|Part 2, Period 2 (3 Days)||0
8106360|NCT03136380|19980042|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106361|NCT03136380|19980043|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106362|NCT03136380|19980044|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106363|NCT03136380|19980045|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106364|NCT03136380|19980046|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106365|NCT03136380|19980042|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
8106366|NCT03136380|19980043|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
8106367|NCT03136380|19980044|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106368|NCT03136380|19980045|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106369|NCT03136380|19980046|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106370|NCT03136380|19980042|P5|STARTED|Part 2, Washout Period 1 (7 Days)||8
8106371|NCT03136380|19980043|P4|STARTED|Part 2, Washout Period 1 (7 Days)||8
8106372|NCT03136380|19980044|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
8106373|NCT03136380|19980045|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
8106374|NCT03136380|19980046|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
8106375|NCT03136380|19980042|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106376|NCT03136380|19980043|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106377|NCT03136380|19980044|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106378|NCT03136380|19980045|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106379|NCT03136380|19980046|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106380|NCT03136380|19980042|P5|COMPLETED|Part 2, Period 1 (3 Days)||8
8106381|NCT03136380|19980043|P4|COMPLETED|Part 2, Period 1 (3 Days)||8
8106382|NCT03136380|19980044|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
8106383|NCT03136380|19980045|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
8106384|NCT03136380|19980046|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
8106385|NCT03136380|19980042|P5|STARTED|Part 2, Period 1 (3 Days)||8
8106386|NCT03136380|19980043|P4|STARTED|Part 2, Period 1 (3 Days)||8
8106387|NCT03136380|19980044|P3|STARTED|Part 2, Period 1 (3 Days)||0
8106388|NCT03136380|19980045|P2|STARTED|Part 2, Period 1 (3 Days)||0
8106389|NCT03136380|19980046|P1|STARTED|Part 2, Period 1 (3 Days)||0
8106390|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106391|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106392|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106393|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106394|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106395|NCT03136380|19980042|P5|COMPLETED|Part 1, Period 3 (4 Days)||0
8106396|NCT03136380|19980043|P4|COMPLETED|Part 1, Period 3 (4 Days)||0
8106397|NCT03136380|19980044|P3|COMPLETED|Part 1, Period 3 (4 Days)||6
8106398|NCT03136380|19980045|P2|COMPLETED|Part 1, Period 3 (4 Days)||5
8106399|NCT03136380|19980046|P1|COMPLETED|Part 1, Period 3 (4 Days)||6
8106400|NCT03136380|19980042|P5|STARTED|Part 1, Period 3 (4 Days)||0
8106401|NCT03136380|19980043|P4|STARTED|Part 1, Period 3 (4 Days)||0
8106402|NCT03136380|19980044|P3|STARTED|Part 1, Period 3 (4 Days)||6
8106403|NCT03136380|19980045|P2|STARTED|Part 1, Period 3 (4 Days)||5
8106404|NCT03136380|19980046|P1|STARTED|Part 1, Period 3 (4 Days)||6
8106405|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106406|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106407|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106408|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
8106409|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106410|NCT03136380|19980042|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106411|NCT03136380|19980043|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106412|NCT03136380|19980044|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
8106413|NCT03136380|19980045|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
8106414|NCT03136380|19980046|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
8106415|NCT03136380|19980042|P5|STARTED|Part 1, Washout Period 2 (7 Days)||0
8106416|NCT03136380|19980043|P4|STARTED|Part 1, Washout Period 2 (7 Days)||0
8106417|NCT03136380|19980044|P3|STARTED|Part 1, Washout Period 2 (7 Days)||6
8106418|NCT03136380|19980045|P2|STARTED|Part 1, Washout Period 2 (7 Days)||6
8106419|NCT03136380|19980046|P1|STARTED|Part 1, Washout Period 2 (7 Days)||6
8106420|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106421|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106422|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106423|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106424|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106425|NCT03136380|19980042|P5|COMPLETED|Part 1, Period 2 (3 Days)||0
8106426|NCT03136380|19980043|P4|COMPLETED|Part 1, Period 2 (3 Days)||0
8106427|NCT03136380|19980044|P3|COMPLETED|Part 1, Period 2 (3 Days)||6
8106428|NCT03136380|19980045|P2|COMPLETED|Part 1, Period 2 (3 Days)||6
8106429|NCT03136380|19980046|P1|COMPLETED|Part 1, Period 2 (3 Days)||6
8106430|NCT03136380|19980042|P5|STARTED|Part 1, Period 2 (3 Days)||0
8106431|NCT03136380|19980043|P4|STARTED|Part 1, Period 2 (3 Days)||0
8106432|NCT03136380|19980044|P3|STARTED|Part 1, Period 2 (3 Days)||6
8106433|NCT03136380|19980045|P2|STARTED|Part 1, Period 2 (3 Days)||6
8106434|NCT03136380|19980046|P1|STARTED|Part 1, Period 2 (3 Days)||6
8106435|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106436|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106437|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106438|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106439|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106440|NCT03136380|19980042|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106441|NCT03136380|19980043|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106442|NCT03136380|19980044|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
8106443|NCT03136380|19980045|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
8106444|NCT03136380|19980046|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
8106445|NCT03136380|19980042|P5|STARTED|Part 1, Washout Period 1 (7 Days)||0
8106446|NCT03136380|19980043|P4|STARTED|Part 1, Washout Period 1 (7 Days)||0
8106447|NCT03136380|19980044|P3|STARTED|Part 1, Washout Period 1 (7 Days)||6
8106448|NCT03136380|19980045|P2|STARTED|Part 1, Washout Period 1 (7 Days)||6
8106449|NCT03136380|19980046|P1|STARTED|Part 1, Washout Period 1 (7 Days)||6
8106450|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106451|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106452|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106453|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106454|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106455|NCT03136380|19980042|P5|COMPLETED|Part 1, Period 1 (3 Days)||0
8106456|NCT03136380|19980043|P4|COMPLETED|Part 1, Period 1 (3 Days)||0
8106457|NCT03136380|19980044|P3|COMPLETED|Part 1, Period 1 (3 Days)||6
8106458|NCT03136380|19980045|P2|COMPLETED|Part 1, Period 1 (3 Days)||6
8106459|NCT03136380|19980046|P1|COMPLETED|Part 1, Period 1 (3 Days)||6
8106460|NCT03136380|19980042|P5|STARTED|Part 1, Period 1 (3 Days)||0
8106461|NCT03136380|19980043|P4|STARTED|Part 1, Period 1 (3 Days)||0
8106462|NCT03136380|19980044|P3|STARTED|Part 1, Period 1 (3 Days)||6
8106463|NCT03136380|19980045|P2|STARTED|Part 1, Period 1 (3 Days)||6
8106464|NCT03136380|19980046|P1|STARTED|Part 1, Period 1 (3 Days)||6
8106465|NCT03136367|19980222|P3|NOT COMPLETED|T5 1 Year After Surgery||129
8106466|NCT03136367|19980223|P2|NOT COMPLETED|T5 1 Year After Surgery||136
8106467|NCT03136367|19980224|P1|NOT COMPLETED|T5 1 Year After Surgery||36
8106468|NCT03136367|19980222|P3|COMPLETED|T5 1 Year After Surgery||56
8106469|NCT03136367|19980223|P2|COMPLETED|T5 1 Year After Surgery||62
8106470|NCT03136367|19980224|P1|COMPLETED|T5 1 Year After Surgery||13
8106471|NCT03136367|19980222|P3|STARTED|T5 1 Year After Surgery||185
8106472|NCT03136367|19980223|P2|STARTED|T5 1 Year After Surgery||198
8106473|NCT03136367|19980224|P1|STARTED|T5 1 Year After Surgery||49
8106474|NCT03136367|19980222|P3|NOT COMPLETED|T4 12 Weeks After Surgery||9
8106475|NCT03136367|19980223|P2|NOT COMPLETED|T4 12 Weeks After Surgery||5
8106476|NCT03136367|19980224|P1|NOT COMPLETED|T4 12 Weeks After Surgery||2
8106477|NCT03136367|19980222|P3|COMPLETED|T4 12 Weeks After Surgery||185
8106478|NCT03136367|19980223|P2|COMPLETED|T4 12 Weeks After Surgery||198
8106479|NCT03136367|19980224|P1|COMPLETED|T4 12 Weeks After Surgery||49
8106480|NCT03136367|19980222|P3|STARTED|T4 12 Weeks After Surgery||194
8106481|NCT03136367|19980223|P2|STARTED|T4 12 Weeks After Surgery||203
8106482|NCT03136367|19980224|P1|STARTED|T4 12 Weeks After Surgery||51
8106483|NCT03136367|19980222|P3|NOT COMPLETED|T3 1 Week After Surgery||31
8106484|NCT03136367|19980223|P2|NOT COMPLETED|T3 1 Week After Surgery||32
8106485|NCT03136367|19980224|P1|NOT COMPLETED|T3 1 Week After Surgery||10
8106486|NCT03136367|19980222|P3|COMPLETED|T3 1 Week After Surgery||194
8106487|NCT03136367|19980223|P2|COMPLETED|T3 1 Week After Surgery||203
8106488|NCT03136367|19980224|P1|COMPLETED|T3 1 Week After Surgery||51
8106489|NCT03136367|19980222|P3|STARTED|T3 1 Week After Surgery||225
8106490|NCT03136367|19980223|P2|STARTED|T3 1 Week After Surgery||235
8106491|NCT03136367|19980224|P1|STARTED|T3 1 Week After Surgery||61
8106492|NCT03136367|19980222|P3|NOT COMPLETED|T2 Post-consultation||31
8106493|NCT03136367|19980223|P2|NOT COMPLETED|T2 Post-consultation||6
8106494|NCT03136367|19980224|P1|NOT COMPLETED|T2 Post-consultation||3
8106495|NCT03136367|19980222|P3|COMPLETED|T2 Post-consultation||225
8106496|NCT03136367|19980223|P2|COMPLETED|T2 Post-consultation||235
8106497|NCT03136367|19980224|P1|COMPLETED|T2 Post-consultation||61
8106498|NCT03136367|19980222|P3|STARTED|T2 Post-consultation||256
8106499|NCT03136367|19980223|P2|STARTED|T2 Post-consultation||241
8106500|NCT03136367|19980224|P1|STARTED|T2 Post-consultation||64
8106501|NCT03136367|19980222|P3|NOT COMPLETED|T1 Consultation||1
8106502|NCT03136367|19980223|P2|NOT COMPLETED|T1 Consultation||7
8106503|NCT03136367|19980224|P1|NOT COMPLETED|T1 Consultation||2
8106504|NCT03136367|19980222|P3|COMPLETED|T1 Consultation||256
8106505|NCT03136367|19980223|P2|COMPLETED|T1 Consultation||241
8106506|NCT03136367|19980224|P1|COMPLETED|T1 Consultation|received the intervention|64
8106507|NCT03136367|19980222|P3|STARTED|T1 Consultation||257
8106508|NCT03136367|19980223|P2|STARTED|T1 Consultation||248
8106509|NCT03136367|19980224|P1|STARTED|T1 Consultation||66
8106510|NCT03136328|19980261|P1|NOT COMPLETED|Overall Study||0
8106511|NCT03136328|19980261|P1|COMPLETED|Overall Study||11
8106512|NCT03136328|19980261|P1|STARTED|Overall Study||11
8106513|NCT03136198|19980269|P2|NOT COMPLETED|Overall Study||1
8106514|NCT03136198|19980270|P1|NOT COMPLETED|Overall Study||0
8106515|NCT03136198|19980269|P2|COMPLETED|Overall Study||63
8106516|NCT03136198|19980270|P1|COMPLETED|Overall Study||66
8106517|NCT03136198|19980269|P2|STARTED|Overall Study||64
8106518|NCT03136198|19980270|P1|STARTED|Overall Study||66
8106519|NCT03136159|19980278|P2|NOT COMPLETED|Overall Study||0
8106520|NCT03136159|19980279|P1|NOT COMPLETED|Overall Study||5
8106521|NCT03136159|19980278|P2|COMPLETED|Overall Study||190
8106522|NCT03136159|19980279|P1|COMPLETED|Overall Study||185
8106523|NCT03136159|19980278|P2|STARTED|Overall Study||190
8106524|NCT03136159|19980279|P1|STARTED|Overall Study||190
8106525|NCT03136107|19980285|P1|NOT COMPLETED|Overall Study||1
8106526|NCT03136107|19980285|P1|COMPLETED|Overall Study||25
8106527|NCT03136107|19980285|P1|Negative Control|Overall Study||26
8106528|NCT03136107|19980285|P1|Reference Product|Overall Study||26
8106529|NCT03136107|19980285|P1|Test Product|Overall Study||26
8106530|NCT03136107|19980285|P1|STARTED|Overall Study||26
8106531|NCT03136068|19980295|P2|NOT COMPLETED|Overall Study||1
8106532|NCT03136068|19980296|P1|NOT COMPLETED|Overall Study||2
8106533|NCT03136068|19980295|P2|COMPLETED|Overall Study||89
8106534|NCT03136068|19980296|P1|COMPLETED|Overall Study||86
8106535|NCT03136068|19980295|P2|STARTED|Overall Study||90
8106536|NCT03136068|19980296|P1|STARTED|Overall Study||88
8106537|NCT03135899|19980318|P8|NOT COMPLETED|Overall Study||0
8106538|NCT03135899|19980319|P7|NOT COMPLETED|Overall Study||1
8106539|NCT03135899|19980320|P6|NOT COMPLETED|Overall Study||2
8106540|NCT03135899|19980321|P5|NOT COMPLETED|Overall Study||0
8106541|NCT03135899|19980322|P4|NOT COMPLETED|Overall Study||0
8106542|NCT03135899|19980323|P3|NOT COMPLETED|Overall Study||0
8106543|NCT03135899|19980324|P2|NOT COMPLETED|Overall Study||0
8106544|NCT03135899|19980325|P1|NOT COMPLETED|Overall Study||0
8106545|NCT03135899|19980318|P8|COMPLETED|Overall Study||8
8106546|NCT03135899|19980319|P7|COMPLETED|Overall Study||7
8106547|NCT03135899|19980320|P6|COMPLETED|Overall Study||7
8106548|NCT03135899|19980321|P5|COMPLETED|Overall Study||8
8106549|NCT03135899|19980322|P4|COMPLETED|Overall Study||1
8106550|NCT03135899|19980323|P3|COMPLETED|Overall Study||1
8106551|NCT03135899|19980324|P2|COMPLETED|Overall Study||1
8106552|NCT03135899|19980325|P1|COMPLETED|Overall Study||1
8106553|NCT03135899|19980318|P8|STARTED|Overall Study||8
8106554|NCT03135899|19980319|P7|STARTED|Overall Study||8
8106555|NCT03135899|19980320|P6|STARTED|Overall Study||9
8106556|NCT03135899|19980321|P5|STARTED|Overall Study||8
8106557|NCT03135899|19980322|P4|STARTED|Overall Study||1
8106558|NCT03135899|19980323|P3|STARTED|Overall Study||1
8106559|NCT03135899|19980324|P2|STARTED|Overall Study||1
8106560|NCT03135899|19980325|P1|STARTED|Overall Study||1
8106561|NCT03135548|19980358|P3|NOT COMPLETED|Overall Study||3
8106562|NCT03135548|19980359|P2|NOT COMPLETED|Overall Study||4
8106563|NCT03135548|19980360|P1|NOT COMPLETED|Overall Study||5
8106564|NCT03135548|19980358|P3|COMPLETED|Overall Study||18
8106565|NCT03135548|19980359|P2|COMPLETED|Overall Study||15
8106566|NCT03135548|19980360|P1|COMPLETED|Overall Study||14
8106567|NCT03135548|19980358|P3|STARTED|Overall Study||21
8106568|NCT03135548|19980359|P2|STARTED|Overall Study||19
8106569|NCT03135548|19980360|P1|STARTED|Overall Study||19
8106570|NCT03135535|19980380|P1|NOT COMPLETED|Overall Study||0
8106571|NCT03135535|19980380|P1|COMPLETED|Overall Study||30
8106572|NCT03135535|19980380|P1|STARTED|Overall Study||30
8106573|NCT03135522|19980390|P2|NOT COMPLETED|Overall Study||0
8106574|NCT03135522|19980391|P1|NOT COMPLETED|Overall Study||1
8106575|NCT03135522|19980390|P2|COMPLETED|Overall Study||17
8106576|NCT03135522|19980391|P1|COMPLETED|Overall Study||16
8106577|NCT03135522|19980390|P2|STARTED|Overall Study||17
8106578|NCT03135522|19980391|P1|STARTED|Overall Study||17
8106579|NCT03135431|19980405|P2|NOT COMPLETED|Overall Study||0
8106580|NCT03135431|19980406|P1|NOT COMPLETED|Overall Study||2
8106581|NCT03135431|19980405|P2|COMPLETED|Overall Study||20
8106582|NCT03135431|19980406|P1|COMPLETED|Overall Study||18
8106583|NCT03135431|19980405|P2|STARTED|Overall Study||20
8106584|NCT03135431|19980406|P1|STARTED|Overall Study||20
8106585|NCT03135379|19980418|P2|NOT COMPLETED|Overall Study||3
8106586|NCT03135379|19980419|P1|NOT COMPLETED|Overall Study||1
8106587|NCT03135379|19980418|P2|COMPLETED|Overall Study||59
8106588|NCT03135379|19980419|P1|COMPLETED|Overall Study||61
8106589|NCT03135379|19980418|P2|STARTED|Overall Study||62
8106590|NCT03135379|19980419|P1|STARTED|Overall Study||62
8106591|NCT03135028|19980427|P1|NOT COMPLETED|Overall Study||9
8106592|NCT03135028|19980427|P1|COMPLETED|Overall Study||0
8106593|NCT03135028|19980427|P1|STARTED|Overall Study||9
8106594|NCT03135015|19980435|P2|NOT COMPLETED|Overall Study||0
8106595|NCT03135015|19980436|P1|NOT COMPLETED|Overall Study||2
8106596|NCT03135015|19980435|P2|COMPLETED|Overall Study||11
8106597|NCT03135015|19980436|P1|COMPLETED|Overall Study||9
8106598|NCT03135015|19980435|P2|4g Tablets|Overall Study||11
8106599|NCT03135015|19980436|P1|4g Tablets|Overall Study||9
8106600|NCT03135015|19980435|P2|2g Tablets|Overall Study||11
8106601|NCT03135015|19980436|P1|2g Tablets|Overall Study||9
8106602|NCT03135015|19980435|P2|4g Capsules|Overall Study||11
8106603|NCT03135015|19980436|P1|4g Capsules|Overall Study||9
8106604|NCT03135015|19980435|P2|2g Capsules|Overall Study||11
8106605|NCT03135015|19980436|P1|2g Capsules|Overall Study||9
8106606|NCT03135015|19980435|P2|Placebo Capsules|Overall Study||11
8106607|NCT03135015|19980436|P1|Placebo Capsules|Overall Study||9
8106608|NCT03135015|19980435|P2|Water Control|Overall Study||11
8106609|NCT03135015|19980436|P1|Water Control|Overall Study||9
8106610|NCT03135015|19980435|P2|STARTED|Overall Study||11
8106611|NCT03135015|19980436|P1|STARTED|Overall Study||11
8106612|NCT03134963|19980546|P4|NOT COMPLETED|Overall Study||0
8106613|NCT03134963|19980547|P3|NOT COMPLETED|Overall Study||0
8106614|NCT03134963|19980548|P2|NOT COMPLETED|Overall Study||0
8106615|NCT03134963|19980549|P1|NOT COMPLETED|Overall Study||0
8106616|NCT03134963|19980546|P4|COMPLETED|Overall Study||14
8106617|NCT03134963|19980547|P3|COMPLETED|Overall Study||3
8106618|NCT03134963|19980548|P2|COMPLETED|Overall Study||13
8106619|NCT03134963|19980549|P1|COMPLETED|Overall Study||12
8106620|NCT03134963|19980546|P4|STARTED|Overall Study||14
8106621|NCT03134963|19980547|P3|STARTED|Overall Study||3
8106622|NCT03134963|19980548|P2|STARTED|Overall Study||13
8106623|NCT03134963|19980549|P1|STARTED|Overall Study||12
8106624|NCT03134911|19980573|P1|NOT COMPLETED|Overall Study||34
8106625|NCT03134911|19980573|P1|COMPLETED|Overall Study||501
8106626|NCT03134911|19980573|P1|STARTED|Overall Study||535
8106627|NCT03134768|19980600|P1|NOT COMPLETED|Overall Study||0
8106628|NCT03134768|19980600|P1|COMPLETED|Overall Study||50
8106629|NCT03134768|19980600|P1|STARTED|Overall Study||50
8106630|NCT03134703|19980608|P2|NOT COMPLETED|Overall Study||2
8106631|NCT03134703|19980609|P1|NOT COMPLETED|Overall Study||6
8106632|NCT03134703|19980608|P2|COMPLETED|Overall Study||3
8106633|NCT03134703|19980609|P1|COMPLETED|Overall Study||0
8106634|NCT03134703|19980608|P2|STARTED|Overall Study||5
8106635|NCT03134703|19980609|P1|STARTED|Overall Study||6
8106636|NCT03134599|19980635|P6|NOT COMPLETED|Week 3||1
8106637|NCT03134599|19980636|P5|NOT COMPLETED|Week 3||0
8106638|NCT03134599|19980637|P4|NOT COMPLETED|Week 3||1
8106639|NCT03134599|19980638|P3|NOT COMPLETED|Week 3||0
8106640|NCT03134599|19980639|P2|NOT COMPLETED|Week 3||0
8106641|NCT03134599|19980640|P1|NOT COMPLETED|Week 3||0
8106642|NCT03134599|19980635|P6|COMPLETED|Week 3||8
8106643|NCT03134599|19980636|P5|COMPLETED|Week 3||8
8106644|NCT03134599|19980637|P4|COMPLETED|Week 3||9
8106645|NCT03134599|19980638|P3|COMPLETED|Week 3||10
8106646|NCT03134599|19980639|P2|COMPLETED|Week 3||10
8106647|NCT03134599|19980640|P1|COMPLETED|Week 3||9
8106648|NCT03134599|19980635|P6|STARTED|Week 3||9
8106649|NCT03134599|19980636|P5|STARTED|Week 3||8
8106650|NCT03134599|19980637|P4|STARTED|Week 3||10
8106651|NCT03134599|19980638|P3|STARTED|Week 3||10
8106652|NCT03134599|19980639|P2|STARTED|Week 3||10
8106653|NCT03134599|19980640|P1|STARTED|Week 3||9
8106654|NCT03134599|19980635|P6|NOT COMPLETED|Week 2||0
8106655|NCT03134599|19980636|P5|NOT COMPLETED|Week 2||1
8106656|NCT03134599|19980637|P4|NOT COMPLETED|Week 2||1
8106657|NCT03134599|19980638|P3|NOT COMPLETED|Week 2||0
8106658|NCT03134599|19980639|P2|NOT COMPLETED|Week 2||0
8106659|NCT03134599|19980640|P1|NOT COMPLETED|Week 2||1
8106660|NCT03134599|19980635|P6|COMPLETED|Week 2||9
8106661|NCT03134599|19980636|P5|COMPLETED|Week 2||8
8106662|NCT03134599|19980637|P4|COMPLETED|Week 2||10
8106663|NCT03134599|19980638|P3|COMPLETED|Week 2||10
8106664|NCT03134599|19980639|P2|COMPLETED|Week 2||10
8106665|NCT03134599|19980640|P1|COMPLETED|Week 2||9
8106666|NCT03134599|19980635|P6|STARTED|Week 2||9
8106667|NCT03134599|19980636|P5|STARTED|Week 2||9
8106668|NCT03134599|19980637|P4|STARTED|Week 2||11
8106669|NCT03134599|19980638|P3|STARTED|Week 2||10
8106670|NCT03134599|19980639|P2|STARTED|Week 2||10
8106671|NCT03134599|19980640|P1|STARTED|Week 2||10
8106672|NCT03134599|19980635|P6|NOT COMPLETED|Week 1||0
8106673|NCT03134599|19980636|P5|NOT COMPLETED|Week 1||1
8106674|NCT03134599|19980637|P4|NOT COMPLETED|Week 1||0
8106675|NCT03134599|19980638|P3|NOT COMPLETED|Week 1||0
8106676|NCT03134599|19980639|P2|NOT COMPLETED|Week 1||0
8106677|NCT03134599|19980640|P1|NOT COMPLETED|Week 1||0
8106678|NCT03134599|19980635|P6|COMPLETED|Week 1||9
8106679|NCT03134599|19980636|P5|COMPLETED|Week 1||9
8106680|NCT03134599|19980637|P4|COMPLETED|Week 1||11
8106681|NCT03134599|19980638|P3|COMPLETED|Week 1||10
8106682|NCT03134599|19980639|P2|COMPLETED|Week 1||10
8106683|NCT03134599|19980640|P1|COMPLETED|Week 1||10
8106684|NCT03134599|19980635|P6|STARTED|Week 1||9
8106685|NCT03134599|19980636|P5|STARTED|Week 1||10
8106686|NCT03134599|19980637|P4|STARTED|Week 1||11
8106687|NCT03134599|19980638|P3|STARTED|Week 1||10
8106688|NCT03134599|19980639|P2|STARTED|Week 1||10
8106689|NCT03134599|19980640|P1|STARTED|Week 1||10
8106690|NCT03134326|19980648|P1|NOT COMPLETED|Overall Study||0
8106691|NCT03134326|19980648|P1|COMPLETED|Overall Study||21
8106692|NCT03134326|19980648|P1|STARTED|Overall Study||21
8106693|NCT03134313|19980652|P1|NOT COMPLETED|Overall Study||0
8106694|NCT03134313|19980652|P1|COMPLETED|Overall Study||25
8106695|NCT03134313|19980652|P1|STARTED|Overall Study||25
8106696|NCT03134248|19980656|P6|NOT COMPLETED|Week 3||0
8106697|NCT03134248|19980657|P5|NOT COMPLETED|Week 3||0
8106698|NCT03134248|19980658|P4|NOT COMPLETED|Week 3||0
8106699|NCT03134248|19980659|P3|NOT COMPLETED|Week 3||0
8106700|NCT03134248|19980660|P2|NOT COMPLETED|Week 3||0
8106701|NCT03134248|19980661|P1|NOT COMPLETED|Week 3||0
8106702|NCT03134248|19980656|P6|COMPLETED|Week 3||9
8106703|NCT03134248|19980657|P5|COMPLETED|Week 3||9
8106704|NCT03134248|19980658|P4|COMPLETED|Week 3||7
8106705|NCT03134248|19980659|P3|COMPLETED|Week 3||9
8106706|NCT03134248|19980660|P2|COMPLETED|Week 3||8
8106707|NCT03134248|19980661|P1|COMPLETED|Week 3||7
8106708|NCT03134248|19980656|P6|STARTED|Week 3||9
8106709|NCT03134248|19980657|P5|STARTED|Week 3||9
8106710|NCT03134248|19980658|P4|STARTED|Week 3||7
8106711|NCT03134248|19980659|P3|STARTED|Week 3||9
8106712|NCT03134248|19980660|P2|STARTED|Week 3||8
8106713|NCT03134248|19980661|P1|STARTED|Week 3||7
8106714|NCT03134248|19980656|P6|NOT COMPLETED|Week 2||0
8106715|NCT03134248|19980657|P5|NOT COMPLETED|Week 2||0
8106716|NCT03134248|19980658|P4|NOT COMPLETED|Week 2||0
8106717|NCT03134248|19980659|P3|NOT COMPLETED|Week 2||0
8106718|NCT03134248|19980660|P2|NOT COMPLETED|Week 2||0
8106719|NCT03134248|19980661|P1|NOT COMPLETED|Week 2||0
8106720|NCT03134248|19980656|P6|COMPLETED|Week 2||9
8106721|NCT03134248|19980657|P5|COMPLETED|Week 2||9
8106722|NCT03134248|19980658|P4|COMPLETED|Week 2||7
8106723|NCT03134248|19980659|P3|COMPLETED|Week 2||9
8106724|NCT03134248|19980660|P2|COMPLETED|Week 2||8
8106725|NCT03134248|19980661|P1|COMPLETED|Week 2||7
8106726|NCT03134248|19980656|P6|STARTED|Week 2||9
8106727|NCT03134248|19980657|P5|STARTED|Week 2||9
8106728|NCT03134248|19980658|P4|STARTED|Week 2||7
8106729|NCT03134248|19980659|P3|STARTED|Week 2||9
8106730|NCT03134248|19980660|P2|STARTED|Week 2||8
8106731|NCT03134248|19980661|P1|STARTED|Week 2||7
8106732|NCT03134248|19980656|P6|NOT COMPLETED|Week 1||0
8106733|NCT03134248|19980657|P5|NOT COMPLETED|Week 1||0
8106734|NCT03134248|19980658|P4|NOT COMPLETED|Week 1||0
8106735|NCT03134248|19980659|P3|NOT COMPLETED|Week 1||0
8106736|NCT03134248|19980660|P2|NOT COMPLETED|Week 1||0
8106737|NCT03134248|19980661|P1|NOT COMPLETED|Week 1||0
8106738|NCT03134248|19980656|P6|COMPLETED|Week 1||9
8106739|NCT03134248|19980657|P5|COMPLETED|Week 1||9
8106740|NCT03134248|19980658|P4|COMPLETED|Week 1||7
8106741|NCT03134248|19980659|P3|COMPLETED|Week 1||9
8106742|NCT03134248|19980660|P2|COMPLETED|Week 1||8
8106743|NCT03134248|19980661|P1|COMPLETED|Week 1||7
8106744|NCT03134248|19980656|P6|STARTED|Week 1||9
8106745|NCT03134248|19980657|P5|STARTED|Week 1||9
8106746|NCT03134248|19980658|P4|STARTED|Week 1||7
8106747|NCT03134248|19980659|P3|STARTED|Week 1||9
8106748|NCT03134248|19980660|P2|STARTED|Week 1||8
8106749|NCT03134248|19980661|P1|STARTED|Week 1||7
8106750|NCT03134222|19980680|P5|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
8106751|NCT03134222|19980681|P4|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
8106752|NCT03134222|19980682|P3|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
8106753|NCT03134222|19980683|P2|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
8106754|NCT03134222|19980684|P1|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
8106755|NCT03134222|19980680|P5|COMPLETED|Treatment Period (Week 12 to 48)||3
8106756|NCT03134222|19980681|P4|COMPLETED|Treatment Period (Week 12 to 48)||3
8106757|NCT03134222|19980682|P3|COMPLETED|Treatment Period (Week 12 to 48)||0
8106758|NCT03134222|19980683|P2|COMPLETED|Treatment Period (Week 12 to 48)||11
8106759|NCT03134222|19980684|P1|COMPLETED|Treatment Period (Week 12 to 48)||12
8106760|NCT03134222|19980680|P5|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
8106761|NCT03134222|19980681|P4|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
8106762|NCT03134222|19980682|P3|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
8106763|NCT03134222|19980683|P2|STARTED|Treatment Period (Week 12 to 48)||14
8106764|NCT03134222|19980684|P1|STARTED|Treatment Period (Week 12 to 48)||14
8106765|NCT03134222|19980680|P5|NOT COMPLETED|Treatment Period (Up to Week 12)||0
8106766|NCT03134222|19980681|P4|NOT COMPLETED|Treatment Period (Up to Week 12)||0
8106767|NCT03134222|19980682|P3|NOT COMPLETED|Treatment Period (Up to Week 12)||2
8106768|NCT03134222|19980683|P2|NOT COMPLETED|Treatment Period (Up to Week 12)||4
8106769|NCT03134222|19980684|P1|NOT COMPLETED|Treatment Period (Up to Week 12)||5
8106770|NCT03134222|19980680|P5|COMPLETED|Treatment Period (Up to Week 12)||0
8106771|NCT03134222|19980681|P4|COMPLETED|Treatment Period (Up to Week 12)||0
8106772|NCT03134222|19980682|P3|COMPLETED|Treatment Period (Up to Week 12)||8
8106773|NCT03134222|19980683|P2|COMPLETED|Treatment Period (Up to Week 12)||14
8106774|NCT03134222|19980684|P1|COMPLETED|Treatment Period (Up to Week 12)||14
8106775|NCT03134222|19980680|P5|STARTED|Treatment Period (Up to Week 12)||0
8106776|NCT03134222|19980681|P4|STARTED|Treatment Period (Up to Week 12)||0
8106777|NCT03134222|19980682|P3|STARTED|Treatment Period (Up to Week 12)||10
8106778|NCT03134222|19980683|P2|STARTED|Treatment Period (Up to Week 12)||18
8106779|NCT03134222|19980684|P1|STARTED|Treatment Period (Up to Week 12)||19
8106780|NCT03134183|19980706|P2|NOT COMPLETED|Overall Study||1
8106781|NCT03134183|19980707|P1|NOT COMPLETED|Overall Study||1
8106782|NCT03134183|19980706|P2|COMPLETED|Overall Study||33
8106783|NCT03134183|19980707|P1|COMPLETED|Overall Study||35
8106784|NCT03134183|19980706|P2|STARTED|Overall Study||34
8106785|NCT03134183|19980707|P1|STARTED|Overall Study||36
8106786|NCT03134144|19980717|P2|NOT COMPLETED|Overall Study||0
8106787|NCT03134144|19980718|P1|NOT COMPLETED|Overall Study||0
8106788|NCT03134144|19980717|P2|COMPLETED|Overall Study||30
8106789|NCT03134144|19980718|P1|COMPLETED|Overall Study||15
8106790|NCT03134144|19980717|P2|STARTED|Overall Study||30
8106791|NCT03134144|19980718|P1|STARTED|Overall Study||15
8106792|NCT03134092|19980735|P3|NOT COMPLETED|Overall Study||0
8106793|NCT03134092|19980736|P2|NOT COMPLETED|Overall Study||0
8106794|NCT03134092|19980737|P1|NOT COMPLETED|Overall Study||0
8106795|NCT03134092|19980735|P3|COMPLETED|Overall Study||433
8106796|NCT03134092|19980736|P2|COMPLETED|Overall Study||435
8106797|NCT03134092|19980737|P1|COMPLETED|Overall Study||434
8106798|NCT03134092|19980735|P3|STARTED|Overall Study||433
8106799|NCT03134092|19980736|P2|STARTED|Overall Study||435
8106800|NCT03134092|19980737|P1|STARTED|Overall Study||434
8106801|NCT03133767|19980758|P2|NOT COMPLETED|Overall Study||25
8106802|NCT03133767|19980759|P1|NOT COMPLETED|Overall Study||38
8106803|NCT03133767|19980758|P2|COMPLETED|Overall Study||53
8106804|NCT03133767|19980759|P1|COMPLETED|Overall Study||41
8106805|NCT03133767|19980758|P2|STARTED|Overall Study||78
8106806|NCT03133767|19980759|P1|STARTED|Overall Study||79
8106807|NCT03133481|19980775|P2|NOT COMPLETED|Overall Study||4
8106808|NCT03133481|19980776|P1|NOT COMPLETED|Overall Study||0
8106809|NCT03133481|19980775|P2|COMPLETED|Overall Study||45
8106810|NCT03133481|19980776|P1|COMPLETED|Overall Study||45
8106811|NCT03133481|19980775|P2|STARTED|Overall Study||49
8106812|NCT03133481|19980776|P1|STARTED|Overall Study||45
8106813|NCT03132753|19980806|P2|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
8106814|NCT03132753|19980807|P1|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
8106815|NCT03132753|19980806|P2|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
8106816|NCT03132753|19980807|P1|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
8106817|NCT03132753|19980806|P2|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
8106818|NCT03132753|19980807|P1|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
8106819|NCT03132753|19980806|P2|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
8106820|NCT03132753|19980807|P1|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
8106821|NCT03132753|19980806|P2|COMPLETED|Baseline - 6 Month Follow-Up||22
8106822|NCT03132753|19980807|P1|COMPLETED|Baseline - 6 Month Follow-Up||19
8106823|NCT03132753|19980806|P2|STARTED|Baseline - 6 Month Follow-Up||54
8106824|NCT03132753|19980807|P1|STARTED|Baseline - 6 Month Follow-Up||46
8106825|NCT03132571|19980895|P2|NOT COMPLETED|Overall Study||0
8106826|NCT03132571|19980896|P1|NOT COMPLETED|Overall Study||0
8106827|NCT03132571|19980895|P2|COMPLETED|Overall Study||2
8106828|NCT03132571|19980896|P1|COMPLETED|Overall Study||3
8106829|NCT03132571|19980895|P2|STARTED|Overall Study||2
8106830|NCT03132571|19980896|P1|STARTED|Overall Study||3
8106831|NCT03132298|19980910|P2|NOT COMPLETED|Overall Study||13
8106832|NCT03132298|19980911|P1|NOT COMPLETED|Overall Study||12
8106833|NCT03132298|19980910|P2|COMPLETED|Overall Study||35
8106834|NCT03132298|19980911|P1|COMPLETED|Overall Study||36
8106835|NCT03132298|19980910|P2|STARTED|Overall Study||48
8106836|NCT03132298|19980911|P1|STARTED|Overall Study||48
8106837|NCT03132246|19980941|P1|NOT COMPLETED|Overall Study||104
8106838|NCT03132246|19980941|P1|COMPLETED|Overall Study||156
8106839|NCT03132246|19980941|P1|STARTED|Overall Study||260
8106840|NCT03132220|19980952|P2|NOT COMPLETED|Overall Study||12
8106841|NCT03132220|19980953|P1|NOT COMPLETED|Overall Study||18
8106842|NCT03132220|19980952|P2|COMPLETED|Overall Study||54
8106843|NCT03132220|19980953|P1|COMPLETED|Overall Study||47
8106844|NCT03132220|19980952|P2|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
8106845|NCT03132220|19980953|P1|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
8106846|NCT03132220|19980952|P2|STARTED|Overall Study||66
8106847|NCT03132220|19980953|P1|STARTED|Overall Study||65
8106848|NCT03131999|19980981|P2|NOT COMPLETED|Overall Study||1
8106849|NCT03131999|19980982|P1|NOT COMPLETED|Overall Study||0
8106850|NCT03131999|19980981|P2|COMPLETED|Overall Study||7
8106851|NCT03131999|19980982|P1|COMPLETED|Overall Study||8
8106852|NCT03131999|19980981|P2|STARTED|Overall Study||8
8106853|NCT03131999|19980982|P1|STARTED|Overall Study||8
8106854|NCT03131895|19980994|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8106855|NCT03131895|19980995|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8106856|NCT03131895|19980996|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||1
8106857|NCT03131895|19980997|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
8106858|NCT03131895|19980994|P4|COMPLETED|Intervention Period 2 (2 Days)||25
8106859|NCT03131895|19980995|P3|COMPLETED|Intervention Period 2 (2 Days)||26
8106860|NCT03131895|19980996|P2|COMPLETED|Intervention Period 2 (2 Days)||22
8106861|NCT03131895|19980997|P1|COMPLETED|Intervention Period 2 (2 Days)||26
8106862|NCT03131895|19980994|P4|STARTED|Intervention Period 2 (2 Days)||25
8106863|NCT03131895|19980995|P3|STARTED|Intervention Period 2 (2 Days)||26
8106864|NCT03131895|19980996|P2|STARTED|Intervention Period 2 (2 Days)||23
8106865|NCT03131895|19980997|P1|STARTED|Intervention Period 2 (2 Days)||27
8106866|NCT03131895|19980994|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||5
8106867|NCT03131895|19980995|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||4
8106868|NCT03131895|19980996|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||5
8106869|NCT03131895|19980997|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||1
8106870|NCT03131895|19980994|P4|COMPLETED|Washout Period (at Least 5 Days)||25
8106871|NCT03131895|19980995|P3|COMPLETED|Washout Period (at Least 5 Days)||26
8106872|NCT03131895|19980996|P2|COMPLETED|Washout Period (at Least 5 Days)||23
8106873|NCT03131895|19980997|P1|COMPLETED|Washout Period (at Least 5 Days)||27
8106874|NCT03131895|19980994|P4|STARTED|Washout Period (at Least 5 Days)||30
8106875|NCT03131895|19980995|P3|STARTED|Washout Period (at Least 5 Days)||30
8106876|NCT03131895|19980996|P2|STARTED|Washout Period (at Least 5 Days)||28
8106877|NCT03131895|19980997|P1|STARTED|Washout Period (at Least 5 Days)||28
8106878|NCT03131895|19980994|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106879|NCT03131895|19980995|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106880|NCT03131895|19980996|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106881|NCT03131895|19980997|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106882|NCT03131895|19980994|P4|COMPLETED|Intervention Period 1 (2 Days)||30
8106883|NCT03131895|19980995|P3|COMPLETED|Intervention Period 1 (2 Days)||30
8106884|NCT03131895|19980996|P2|COMPLETED|Intervention Period 1 (2 Days)||28
8106885|NCT03131895|19980997|P1|COMPLETED|Intervention Period 1 (2 Days)||28
8106886|NCT03131895|19980994|P4|STARTED|Intervention Period 1 (2 Days)||30
8106887|NCT03131895|19980995|P3|STARTED|Intervention Period 1 (2 Days)||30
8106888|NCT03131895|19980996|P2|STARTED|Intervention Period 1 (2 Days)||28
8106889|NCT03131895|19980997|P1|STARTED|Intervention Period 1 (2 Days)||28
8106890|NCT03131713|19981017|P2|NOT COMPLETED|Overall Study||0
8106891|NCT03131713|19981018|P1|NOT COMPLETED|Overall Study||5
8106892|NCT03131713|19981017|P2|COMPLETED|Overall Study||51
8106893|NCT03131713|19981018|P1|COMPLETED|Overall Study||45
8106894|NCT03131713|19981017|P2|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
8106895|NCT03131713|19981018|P1|STARTED|Overall Study||50
8106896|NCT03131687|19981042|P6|NOT COMPLETED|Overall Study||5
8106897|NCT03131687|19981043|P5|NOT COMPLETED|Overall Study||8
8106898|NCT03131687|19981044|P4|NOT COMPLETED|Overall Study||4
8106899|NCT03131687|19981045|P3|NOT COMPLETED|Overall Study||3
8106900|NCT03131687|19981046|P2|NOT COMPLETED|Overall Study||9
8106901|NCT03131687|19981047|P1|NOT COMPLETED|Overall Study||6
8106902|NCT03131687|19981042|P6|COMPLETED|Overall Study||49
8106903|NCT03131687|19981043|P5|COMPLETED|Overall Study||45
8106904|NCT03131687|19981044|P4|COMPLETED|Overall Study||48
8106905|NCT03131687|19981045|P3|COMPLETED|Overall Study||52
8106906|NCT03131687|19981046|P2|COMPLETED|Overall Study||44
8106907|NCT03131687|19981047|P1|COMPLETED|Overall Study||45
8106908|NCT03131687|19981042|P6|Received at Least One Dose of Study Drug|Overall Study||54
8106909|NCT03131687|19981043|P5|Received at Least One Dose of Study Drug|Overall Study||53
8106910|NCT03131687|19981044|P4|Received at Least One Dose of Study Drug|Overall Study||51
8106911|NCT03131687|19981045|P3|Received at Least One Dose of Study Drug|Overall Study||55
8106912|NCT03131687|19981046|P2|Received at Least One Dose of Study Drug|Overall Study||52
8106913|NCT03131687|19981047|P1|Received at Least One Dose of Study Drug|Overall Study||51
8106914|NCT03131687|19981042|P6|STARTED|Overall Study||54
8106915|NCT03131687|19981043|P5|STARTED|Overall Study||53
8106916|NCT03131687|19981044|P4|STARTED|Overall Study||52
8106917|NCT03131687|19981045|P3|STARTED|Overall Study||55
8106918|NCT03131687|19981046|P2|STARTED|Overall Study||53
8106919|NCT03131687|19981047|P1|STARTED|Overall Study||51
8106920|NCT03131648|19981157|P8|NOT COMPLETED|Open-label (Short Term Extension)||3
8106921|NCT03131648|19981158|P7|NOT COMPLETED|Open-label (Short Term Extension)||0
8106922|NCT03131648|19981159|P6|NOT COMPLETED|Open-label (Short Term Extension)||0
8106923|NCT03131648|19981160|P5|NOT COMPLETED|Open-label (Short Term Extension)||0
8106924|NCT03131648|19981161|P4|NOT COMPLETED|Open-label (Short Term Extension)||0
8106925|NCT03131648|19981162|P3|NOT COMPLETED|Open-label (Short Term Extension)||0
8106926|NCT03131648|19981163|P2|NOT COMPLETED|Open-label (Short Term Extension)||0
8106927|NCT03131648|19981164|P1|NOT COMPLETED|Open-label (Short Term Extension)||0
8106928|NCT03131648|19981157|P8|COMPLETED|Open-label (Short Term Extension)||62
8106929|NCT03131648|19981158|P7|COMPLETED|Open-label (Short Term Extension)||0
8106930|NCT03131648|19981159|P6|COMPLETED|Open-label (Short Term Extension)||0
8106931|NCT03131648|19981160|P5|COMPLETED|Open-label (Short Term Extension)||0
8106932|NCT03131648|19981161|P4|COMPLETED|Open-label (Short Term Extension)||0
8106933|NCT03131648|19981162|P3|COMPLETED|Open-label (Short Term Extension)||0
8106934|NCT03131648|19981163|P2|COMPLETED|Open-label (Short Term Extension)||0
8106935|NCT03131648|19981164|P1|COMPLETED|Open-label (Short Term Extension)||0
8106936|NCT03131648|19981157|P8|STARTED|Open-label (Short Term Extension)||65
8106937|NCT03131648|19981158|P7|STARTED|Open-label (Short Term Extension)||0
8106938|NCT03131648|19981159|P6|STARTED|Open-label (Short Term Extension)||0
8106939|NCT03131648|19981160|P5|STARTED|Open-label (Short Term Extension)||0
8106940|NCT03131648|19981161|P4|STARTED|Open-label (Short Term Extension)||0
8106941|NCT03131648|19981162|P3|STARTED|Open-label (Short Term Extension)||0
8106942|NCT03131648|19981163|P2|STARTED|Open-label (Short Term Extension)||0
8106943|NCT03131648|19981164|P1|STARTED|Open-label (Short Term Extension)||0
8106944|NCT03131648|19981157|P8|NOT COMPLETED|Maintenance Treatment Period||0
8106945|NCT03131648|19981158|P7|NOT COMPLETED|Maintenance Treatment Period||0
8106946|NCT03131648|19981159|P6|NOT COMPLETED|Maintenance Treatment Period||14
8106947|NCT03131648|19981160|P5|NOT COMPLETED|Maintenance Treatment Period||15
8106948|NCT03131648|19981161|P4|NOT COMPLETED|Maintenance Treatment Period||25
8106949|NCT03131648|19981162|P3|NOT COMPLETED|Maintenance Treatment Period||27
8106950|NCT03131648|19981163|P2|NOT COMPLETED|Maintenance Treatment Period||0
8106951|NCT03131648|19981164|P1|NOT COMPLETED|Maintenance Treatment Period||0
8106952|NCT03131648|19981157|P8|COMPLETED|Maintenance Treatment Period||0
8106953|NCT03131648|19981158|P7|COMPLETED|Maintenance Treatment Period||0
8106954|NCT03131648|19981159|P6|COMPLETED|Maintenance Treatment Period||15
8106955|NCT03131648|19981160|P5|COMPLETED|Maintenance Treatment Period||21
8106956|NCT03131648|19981161|P4|COMPLETED|Maintenance Treatment Period||53
8106957|NCT03131648|19981162|P3|COMPLETED|Maintenance Treatment Period||44
8106958|NCT03131648|19981163|P2|COMPLETED|Maintenance Treatment Period||0
8106959|NCT03131648|19981164|P1|COMPLETED|Maintenance Treatment Period||0
8106960|NCT03131648|19981157|P8|STARTED|Maintenance Treatment Period||0
8106961|NCT03131648|19981158|P7|STARTED|Maintenance Treatment Period||0
8106962|NCT03131648|19981159|P6|STARTED|Maintenance Treatment Period||29
8106963|NCT03131648|19981160|P5|STARTED|Maintenance Treatment Period||36
8106964|NCT03131648|19981161|P4|STARTED|Maintenance Treatment Period||78
8106965|NCT03131648|19981162|P3|STARTED|Maintenance Treatment Period||71
8106966|NCT03131648|19981163|P2|STARTED|Maintenance Treatment Period||0
8106967|NCT03131648|19981164|P1|STARTED|Maintenance Treatment Period||0
8106968|NCT03131648|19981157|P8|NOT COMPLETED|Open-label Treatment||0
8106969|NCT03131648|19981158|P7|NOT COMPLETED|Open-label Treatment||118
8106970|NCT03131648|19981159|P6|NOT COMPLETED|Open-label Treatment||0
8106971|NCT03131648|19981160|P5|NOT COMPLETED|Open-label Treatment||0
8106972|NCT03131648|19981161|P4|NOT COMPLETED|Open-label Treatment||0
8106973|NCT03131648|19981162|P3|NOT COMPLETED|Open-label Treatment||0
8106974|NCT03131648|19981163|P2|NOT COMPLETED|Open-label Treatment||0
8106975|NCT03131648|19981164|P1|NOT COMPLETED|Open-label Treatment||0
8106976|NCT03131648|19981157|P8|COMPLETED|Open-label Treatment||0
8106977|NCT03131648|19981158|P7|COMPLETED|Open-label Treatment||446
8106978|NCT03131648|19981159|P6|COMPLETED|Open-label Treatment||0
8106979|NCT03131648|19981160|P5|COMPLETED|Open-label Treatment||0
8106980|NCT03131648|19981161|P4|COMPLETED|Open-label Treatment||0
8106981|NCT03131648|19981162|P3|COMPLETED|Open-label Treatment||0
8106982|NCT03131648|19981163|P2|COMPLETED|Open-label Treatment||0
8106983|NCT03131648|19981164|P1|COMPLETED|Open-label Treatment||0
8106984|NCT03131648|19981157|P8|STARTED|Open-label Treatment||0
8106985|NCT03131648|19981158|P7|STARTED|Open-label Treatment||564
8106986|NCT03131648|19981159|P6|STARTED|Open-label Treatment||0
8106987|NCT03131648|19981160|P5|STARTED|Open-label Treatment||0
8106988|NCT03131648|19981161|P4|STARTED|Open-label Treatment||0
8106989|NCT03131648|19981162|P3|STARTED|Open-label Treatment||0
8106990|NCT03131648|19981163|P2|STARTED|Open-label Treatment||0
8106991|NCT03131648|19981164|P1|STARTED|Open-label Treatment||0
8106992|NCT03131648|19981157|P8|NOT COMPLETED|Initial Treatment Period||0
8106993|NCT03131648|19981158|P7|NOT COMPLETED|Initial Treatment Period||0
8106994|NCT03131648|19981159|P6|NOT COMPLETED|Initial Treatment Period||0
8106995|NCT03131648|19981160|P5|NOT COMPLETED|Initial Treatment Period||0
8106996|NCT03131648|19981161|P4|NOT COMPLETED|Initial Treatment Period||0
8106997|NCT03131648|19981162|P3|NOT COMPLETED|Initial Treatment Period||0
8106998|NCT03131648|19981163|P2|NOT COMPLETED|Initial Treatment Period||20
8106999|NCT03131648|19981164|P1|NOT COMPLETED|Initial Treatment Period||53
8107000|NCT03131648|19981157|P8|COMPLETED|Initial Treatment Period||0
8107001|NCT03131648|19981158|P7|COMPLETED|Initial Treatment Period||0
8107002|NCT03131648|19981159|P6|COMPLETED|Initial Treatment Period||0
8107003|NCT03131648|19981160|P5|COMPLETED|Initial Treatment Period||0
8107004|NCT03131648|19981161|P4|COMPLETED|Initial Treatment Period||0
8107005|NCT03131648|19981162|P3|COMPLETED|Initial Treatment Period||0
8107006|NCT03131648|19981163|P2|COMPLETED|Initial Treatment Period||179
8107007|NCT03131648|19981164|P1|COMPLETED|Initial Treatment Period||550
8107008|NCT03131648|19981157|P8|STARTED|Initial Treatment Period||0
8107009|NCT03131648|19981158|P7|STARTED|Initial Treatment Period||0
8107010|NCT03131648|19981159|P6|STARTED|Initial Treatment Period||0
8107011|NCT03131648|19981160|P5|STARTED|Initial Treatment Period||0
8107012|NCT03131648|19981161|P4|STARTED|Initial Treatment Period||0
8107013|NCT03131648|19981162|P3|STARTED|Initial Treatment Period||0
8107014|NCT03131648|19981163|P2|STARTED|Initial Treatment Period||199
8107015|NCT03131648|19981164|P1|STARTED|Initial Treatment Period||603
8107016|NCT03131596|19981212|P2|NOT COMPLETED|Overall Study||3
8107017|NCT03131596|19981213|P1|NOT COMPLETED|Overall Study||6
8107018|NCT03131596|19981212|P2|COMPLETED|Overall Study||97
8107019|NCT03131596|19981213|P1|COMPLETED|Overall Study||94
8107020|NCT03131596|19981212|P2|STARTED|Overall Study||100
8107021|NCT03131596|19981213|P1|STARTED|Overall Study||100
8107022|NCT03131479|19981230|P5|NOT COMPLETED|Overall Study||0
8107023|NCT03131479|19981231|P4|NOT COMPLETED|Overall Study||2
8107024|NCT03131479|19981232|P3|NOT COMPLETED|Overall Study||1
8107025|NCT03131479|19981233|P2|NOT COMPLETED|Overall Study||0
8107026|NCT03131479|19981234|P1|NOT COMPLETED|Overall Study||0
8107027|NCT03131479|19981230|P5|COMPLETED|Overall Study||10
8107028|NCT03131479|19981231|P4|COMPLETED|Overall Study||10
8107029|NCT03131479|19981232|P3|COMPLETED|Overall Study||10
8107030|NCT03131479|19981233|P2|COMPLETED|Overall Study||10
8107031|NCT03131479|19981234|P1|COMPLETED|Overall Study||10
8107032|NCT03131479|19981230|P5|Pharcodynamic Analysis Set (PD)|Overall Study||10
8107033|NCT03131479|19981231|P4|Pharcodynamic Analysis Set (PD)|Overall Study||12
8107034|NCT03131479|19981232|P3|Pharcodynamic Analysis Set (PD)|Overall Study||11
8107035|NCT03131479|19981233|P2|Pharcodynamic Analysis Set (PD)|Overall Study||10
8107036|NCT03131479|19981234|P1|Pharcodynamic Analysis Set (PD)|Overall Study||10
8107037|NCT03131479|19981230|P5|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
8107038|NCT03131479|19981231|P4|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
8107039|NCT03131479|19981232|P3|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
8107040|NCT03131479|19981233|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
8107041|NCT03131479|19981234|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
8107042|NCT03131479|19981230|P5|Safety Analysis Set (SS)|Overall Study||10
8107043|NCT03131479|19981231|P4|Safety Analysis Set (SS)|Overall Study||12
8107044|NCT03131479|19981232|P3|Safety Analysis Set (SS)|Overall Study||11
8107045|NCT03131479|19981233|P2|Safety Analysis Set (SS)|Overall Study||10
8107046|NCT03131479|19981234|P1|Safety Analysis Set (SS)|Overall Study||10
8107047|NCT03131479|19981230|P5|STARTED|Overall Study||10
8107048|NCT03131479|19981231|P4|STARTED|Overall Study||12
8107049|NCT03131479|19981232|P3|STARTED|Overall Study||11
8107050|NCT03131479|19981233|P2|STARTED|Overall Study||10
8107051|NCT03131479|19981234|P1|STARTED|Overall Study||10
8107052|NCT03131219|19981293|P2|NOT COMPLETED|Extension Period||10
8107053|NCT03131219|19981294|P1|NOT COMPLETED|Extension Period||17
8107054|NCT03131219|19981293|P2|COMPLETED|Extension Period||0
8107055|NCT03131219|19981294|P1|COMPLETED|Extension Period||0
8107056|NCT03131219|19981293|P2|Ongoing|Extension Period||10
8107057|NCT03131219|19981294|P1|Ongoing|Extension Period||16
8107058|NCT03131219|19981293|P2|Received At Least 1 Dose of Study Drug|Extension Period||10
8107059|NCT03131219|19981294|P1|Received At Least 1 Dose of Study Drug|Extension Period||17
8107060|NCT03131219|19981293|P2|STARTED|Extension Period||10
8107061|NCT03131219|19981294|P1|STARTED|Extension Period||17
8107062|NCT03131219|19981293|P2|NOT COMPLETED|Initial Evaluation Period||0
8107063|NCT03131219|19981294|P1|NOT COMPLETED|Initial Evaluation Period||4
8107064|NCT03131219|19981293|P2|COMPLETED|Initial Evaluation Period||10
8107065|NCT03131219|19981294|P1|COMPLETED|Initial Evaluation Period||17
8107066|NCT03131219|19981293|P2|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
8107067|NCT03131219|19981294|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
8107068|NCT03131219|19981293|P2|STARTED|Initial Evaluation Period||10
8107069|NCT03131219|19981294|P1|STARTED|Initial Evaluation Period||21
8107070|NCT03131206|19981320|P4|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107071|NCT03131206|19981321|P3|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107072|NCT03131206|19981322|P2|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107073|NCT03131206|19981323|P1|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107074|NCT03131206|19981320|P4|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107075|NCT03131206|19981321|P3|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107076|NCT03131206|19981322|P2|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107077|NCT03131206|19981323|P1|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107078|NCT03131206|19981320|P4|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107079|NCT03131206|19981321|P3|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107080|NCT03131206|19981322|P2|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107081|NCT03131206|19981323|P1|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107082|NCT03131206|19981320|P4|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107083|NCT03131206|19981321|P3|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107084|NCT03131206|19981322|P2|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107085|NCT03131206|19981323|P1|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107086|NCT03131206|19981320|P4|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107087|NCT03131206|19981321|P3|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107088|NCT03131206|19981322|P2|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107089|NCT03131206|19981323|P1|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
8107090|NCT03131206|19981320|P4|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107091|NCT03131206|19981321|P3|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107092|NCT03131206|19981322|P2|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107093|NCT03131206|19981323|P1|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
8107094|NCT03131167|19981354|P13|NOT COMPLETED|Overall Study||0
8107095|NCT03131167|19981355|P12|NOT COMPLETED|Overall Study||0
8107096|NCT03131167|19981356|P11|NOT COMPLETED|Overall Study||0
8107097|NCT03131167|19981357|P10|NOT COMPLETED|Overall Study||0
8107098|NCT03131167|19981358|P9|NOT COMPLETED|Overall Study||0
8107099|NCT03131167|19981359|P8|NOT COMPLETED|Overall Study||0
8107100|NCT03131167|19981360|P7|NOT COMPLETED|Overall Study||0
8107101|NCT03131167|19981361|P6|NOT COMPLETED|Overall Study||1
8107102|NCT03131167|19981362|P5|NOT COMPLETED|Overall Study||0
8107103|NCT03131167|19981363|P4|NOT COMPLETED|Overall Study||0
8107104|NCT03131167|19981364|P3|NOT COMPLETED|Overall Study||0
8107105|NCT03131167|19981365|P2|NOT COMPLETED|Overall Study||0
8107106|NCT03131167|19981366|P1|NOT COMPLETED|Overall Study||0
8107107|NCT03131167|19981354|P13|COMPLETED|Overall Study||5
8107108|NCT03131167|19981355|P12|COMPLETED|Overall Study||5
8107109|NCT03131167|19981356|P11|COMPLETED|Overall Study||4
8107110|NCT03131167|19981357|P10|COMPLETED|Overall Study||5
8107111|NCT03131167|19981358|P9|COMPLETED|Overall Study||2
8107112|NCT03131167|19981359|P8|COMPLETED|Overall Study||5
8107113|NCT03131167|19981360|P7|COMPLETED|Overall Study||5
8107114|NCT03131167|19981361|P6|COMPLETED|Overall Study||4
8107115|NCT03131167|19981362|P5|COMPLETED|Overall Study||6
8107116|NCT03131167|19981363|P4|COMPLETED|Overall Study||5
8107117|NCT03131167|19981364|P3|COMPLETED|Overall Study||5
8107118|NCT03131167|19981365|P2|COMPLETED|Overall Study||5
8107119|NCT03131167|19981366|P1|COMPLETED|Overall Study||6
8107120|NCT03131167|19981354|P13|STARTED|Overall Study||5
8107121|NCT03131167|19981355|P12|STARTED|Overall Study||5
8107122|NCT03131167|19981356|P11|STARTED|Overall Study||4
8107123|NCT03131167|19981357|P10|STARTED|Overall Study||5
8107124|NCT03131167|19981358|P9|STARTED|Overall Study||2
8107125|NCT03131167|19981359|P8|STARTED|Overall Study||5
8107126|NCT03131167|19981360|P7|STARTED|Overall Study||5
8107127|NCT03131167|19981361|P6|STARTED|Overall Study||5
8107128|NCT03131167|19981362|P5|STARTED|Overall Study||6
8107129|NCT03131167|19981363|P4|STARTED|Overall Study||5
8107130|NCT03131167|19981364|P3|STARTED|Overall Study||5
8107131|NCT03131167|19981365|P2|STARTED|Overall Study||5
8107132|NCT03131167|19981366|P1|STARTED|Overall Study||6
8107133|NCT03130738|19981410|P3|NOT COMPLETED|Overall Study||6
8107134|NCT03130738|19981411|P2|NOT COMPLETED|Overall Study||2
8107135|NCT03130738|19981412|P1|NOT COMPLETED|Overall Study||3
8107136|NCT03130738|19981410|P3|COMPLETED|Overall Study||14
8107137|NCT03130738|19981411|P2|COMPLETED|Overall Study||20
8107138|NCT03130738|19981412|P1|COMPLETED|Overall Study||20
8107139|NCT03130738|19981410|P3|STARTED|Overall Study||20
8107140|NCT03130738|19981411|P2|STARTED|Overall Study||22
8107141|NCT03130738|19981412|P1|STARTED|Overall Study||23
8107142|NCT03130257|19981426|P3|NOT COMPLETED|Overall Study||2
8107143|NCT03130257|19981427|P2|NOT COMPLETED|Overall Study||0
8107144|NCT03130257|19981428|P1|NOT COMPLETED|Overall Study||1
8107145|NCT03130257|19981426|P3|COMPLETED|Overall Study||166
8107146|NCT03130257|19981427|P2|COMPLETED|Overall Study||170
8107147|NCT03130257|19981428|P1|COMPLETED|Overall Study||171
8107148|NCT03130257|19981426|P3|STARTED|Overall Study||168
8107149|NCT03130257|19981427|P2|STARTED|Overall Study||170
8107150|NCT03130257|19981428|P1|STARTED|Overall Study||172
8107151|NCT03129321|19981439|P3|NOT COMPLETED|Overall Study||55
8107152|NCT03129321|19981440|P2|NOT COMPLETED|Overall Study||109
8107153|NCT03129321|19981441|P1|NOT COMPLETED|Overall Study||98
8107154|NCT03129321|19981439|P3|COMPLETED|Overall Study||120
8107155|NCT03129321|19981440|P2|COMPLETED|Overall Study||241
8107156|NCT03129321|19981441|P1|COMPLETED|Overall Study||253
8107157|NCT03129321|19981439|P3|STARTED|Overall Study||175
8107158|NCT03129321|19981440|P2|STARTED|Overall Study||350
8107159|NCT03129321|19981441|P1|STARTED|Overall Study||351
8107160|NCT03129178|19981463|P2|NOT COMPLETED|Overall Study||2
8107161|NCT03129178|19981464|P1|NOT COMPLETED|Overall Study||1
8107162|NCT03129178|19981463|P2|COMPLETED|Overall Study||11
8107163|NCT03129178|19981464|P1|COMPLETED|Overall Study||12
8107164|NCT03129178|19981463|P2|STARTED|Overall Study||13
8107165|NCT03129178|19981464|P1|STARTED|Overall Study||13
8107166|NCT03128931|19981482|P1|NOT COMPLETED|Overall Study||4
8107167|NCT03128931|19981482|P1|COMPLETED|Overall Study||41
8107168|NCT03128931|19981482|P1|STARTED|Overall Study||45
8107172|NCT03128723|19981492|P1|NOT COMPLETED|Overall Study||2
8107173|NCT03128723|19981492|P1|COMPLETED|Overall Study||43
8107174|NCT03128723|19981492|P1|STARTED|Overall Study||45
8107175|NCT03128411|19981507|P1|NOT COMPLETED|Long Term Follow-up Phase||19
8107176|NCT03128411|19981507|P1|COMPLETED|Long Term Follow-up Phase||0
8107267|NCT03126539|19981683|P2|NOT COMPLETED|Overall Study||1
8107177|NCT03128411|19981507|P1|STARTED|Long Term Follow-up Phase|"Participants who discontinued treatment phase, entered this phase, except those were Ongoing."|19
8107178|NCT03128411|19981507|P1|NOT COMPLETED|Treatment Phase||60
8107179|NCT03128411|19981507|P1|COMPLETED|Treatment Phase||0
8107180|NCT03128411|19981507|P1|Received Treatment|Treatment Phase||60
8107181|NCT03128411|19981507|P1|STARTED|Treatment Phase||60
8107182|NCT03128372|19981546|P1|NOT COMPLETED|Overall Study||0
8107183|NCT03128372|19981546|P1|COMPLETED|Overall Study||32
8107184|NCT03128372|19981546|P1|STARTED|Overall Study||32
8107185|NCT03128307|19981550|P1|NOT COMPLETED|Overall Study||34
8107186|NCT03128307|19981550|P1|COMPLETED|Overall Study||570
8107187|NCT03128307|19981550|P1|STARTED|Overall Study||604
8107188|NCT03128099|19981558|P3|NOT COMPLETED|Overall Study||1
8107189|NCT03128099|19981559|P2|NOT COMPLETED|Overall Study||4
8107190|NCT03128099|19981560|P1|NOT COMPLETED|Overall Study||2
8107191|NCT03128099|19981558|P3|COMPLETED|Overall Study||21
8107192|NCT03128099|19981559|P2|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
8107193|NCT03128099|19981560|P1|COMPLETED|Overall Study||19
8107194|NCT03128099|19981558|P3|Hour 2 (High Dose) Completed|Overall Study||0
8107195|NCT03128099|19981559|P2|Hour 2 (High Dose) Completed|Overall Study||0
8107196|NCT03128099|19981560|P1|Hour 2 (High Dose) Completed|Overall Study||0
8107197|NCT03128099|19981558|P3|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
8107198|NCT03128099|19981559|P2|Hour 2 (High Dose)Started|Overall Study||4
8107199|NCT03128099|19981560|P1|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
8107200|NCT03128099|19981558|P3|Hour 1 (Low Dose) Completed|Overall Study||21
8107201|NCT03128099|19981559|P2|Hour 1 (Low Dose) Completed|Overall Study||4
8107202|NCT03128099|19981560|P1|Hour 1 (Low Dose) Completed|Overall Study||19
8107203|NCT03128099|19981558|P3|Hour 1 (Low Dose) Started|Overall Study||22
8107204|NCT03128099|19981559|P2|Hour 1 (Low Dose) Started|Overall Study||4
8107205|NCT03128099|19981560|P1|Hour 1 (Low Dose) Started|Overall Study||21
8107206|NCT03128099|19981558|P3|STARTED|Overall Study||22
8107207|NCT03128099|19981559|P2|STARTED|Overall Study||4
8107208|NCT03128099|19981560|P1|STARTED|Overall Study||21
8107209|NCT03128086|19981568|P2|NOT COMPLETED|Overall Study||0
8107210|NCT03128086|19981569|P1|NOT COMPLETED|Overall Study||0
8107211|NCT03128086|19981568|P2|COMPLETED|Overall Study||44
8107212|NCT03128086|19981569|P1|COMPLETED|Overall Study||50
8107213|NCT03128086|19981568|P2|STARTED|Overall Study||44
8107214|NCT03128086|19981569|P1|STARTED|Overall Study||50
8107215|NCT03128008|19981589|P1|NOT COMPLETED|Overall Study||9
8107216|NCT03128008|19981589|P1|COMPLETED|Overall Study|9 participants are in follow up|1
8107217|NCT03128008|19981589|P1|STARTED|Overall Study||10
8107218|NCT03127956|19981594|P1|NOT COMPLETED|Overall Study||317
8107219|NCT03127956|19981594|P1|COMPLETED|Overall Study||431
8107220|NCT03127956|19981594|P1|STARTED|Overall Study||748
8107221|NCT03127943|19981598|P2|NOT COMPLETED|Second Intervention||0
8107222|NCT03127943|19981599|P1|NOT COMPLETED|Second Intervention||0
8107223|NCT03127943|19981598|P2|COMPLETED|Second Intervention||12
8107224|NCT03127943|19981599|P1|COMPLETED|Second Intervention||12
8107225|NCT03127943|19981598|P2|STARTED|Second Intervention||12
8107226|NCT03127943|19981599|P1|STARTED|Second Intervention||12
8107227|NCT03127943|19981598|P2|NOT COMPLETED|Washout (1 Week)||0
8107228|NCT03127943|19981599|P1|NOT COMPLETED|Washout (1 Week)||0
8107229|NCT03127943|19981598|P2|COMPLETED|Washout (1 Week)||12
8107230|NCT03127943|19981599|P1|COMPLETED|Washout (1 Week)||12
8107231|NCT03127943|19981598|P2|STARTED|Washout (1 Week)||12
8107232|NCT03127943|19981599|P1|STARTED|Washout (1 Week)||12
8107233|NCT03127943|19981598|P2|NOT COMPLETED|First Intervention||0
8107234|NCT03127943|19981599|P1|NOT COMPLETED|First Intervention||0
8107235|NCT03127943|19981598|P2|COMPLETED|First Intervention||12
8107236|NCT03127943|19981599|P1|COMPLETED|First Intervention||12
8107237|NCT03127943|19981598|P2|STARTED|First Intervention||12
8107238|NCT03127943|19981599|P1|STARTED|First Intervention||12
8107239|NCT03127644|19981610|P3|NOT COMPLETED|Overall Study||2
8107240|NCT03127644|19981611|P2|NOT COMPLETED|Overall Study||0
8107241|NCT03127644|19981612|P1|NOT COMPLETED|Overall Study||0
8107242|NCT03127644|19981610|P3|COMPLETED|Overall Study||31
8107243|NCT03127644|19981611|P2|COMPLETED|Overall Study||36
8107244|NCT03127644|19981612|P1|COMPLETED|Overall Study||34
8107245|NCT03127644|19981610|P3|STARTED|Overall Study||33
8107246|NCT03127644|19981611|P2|STARTED|Overall Study||36
8107247|NCT03127644|19981612|P1|STARTED|Overall Study||34
8107248|NCT03127384|19981644|P1|NOT COMPLETED|Overall Study||6
8107249|NCT03127384|19981644|P1|COMPLETED|Overall Study||43
8107250|NCT03127384|19981644|P1|Completed 3 Month Visit|Overall Study||47
8107251|NCT03127384|19981644|P1|STARTED|Overall Study||49
8107252|NCT03127228|19981652|P2|NOT COMPLETED|Overall Study||0
8107253|NCT03127228|19981653|P1|NOT COMPLETED|Overall Study||0
8107254|NCT03127228|19981652|P2|COMPLETED|Overall Study||12
8107255|NCT03127228|19981653|P1|COMPLETED|Overall Study||12
8107256|NCT03127228|19981652|P2|STARTED|Overall Study||12
8107257|NCT03127228|19981653|P1|STARTED|Overall Study||12
8107258|NCT03126682|19981667|P2|NOT COMPLETED|Overall Study||0
8107259|NCT03126682|19981668|P1|NOT COMPLETED|Overall Study||0
8107260|NCT03126682|19981667|P2|COMPLETED|Overall Study||5
8107261|NCT03126682|19981668|P1|COMPLETED|Overall Study||5
8107262|NCT03126682|19981667|P2|STARTED|Overall Study||5
8107263|NCT03126682|19981668|P1|STARTED|Overall Study||5
8107264|NCT03126539|19981680|P5|NOT COMPLETED|Overall Study||0
8107265|NCT03126539|19981681|P4|NOT COMPLETED|Overall Study||0
8107266|NCT03126539|19981682|P3|NOT COMPLETED|Overall Study||1
8107268|NCT03126539|19981684|P1|NOT COMPLETED|Overall Study||1
8107269|NCT03126539|19981680|P5|COMPLETED|Overall Study||0
8107270|NCT03126539|19981681|P4|COMPLETED|Overall Study||0
8107271|NCT03126539|19981682|P3|COMPLETED|Overall Study||8
8107272|NCT03126539|19981683|P2|COMPLETED|Overall Study||8
8107273|NCT03126539|19981684|P1|COMPLETED|Overall Study||8
8107274|NCT03126539|19981680|P5|STARTED|Overall Study||0
8107275|NCT03126539|19981681|P4|STARTED|Overall Study|Group B was not done|0
8107276|NCT03126539|19981682|P3|STARTED|Overall Study||9
8107277|NCT03126539|19981683|P2|STARTED|Overall Study||9
8107278|NCT03126539|19981684|P1|STARTED|Overall Study||9
8107279|NCT03126448|19981700|P3|NOT COMPLETED|Overall Study||10
8107280|NCT03126448|19981701|P2|NOT COMPLETED|Overall Study||8
8107281|NCT03126448|19981702|P1|NOT COMPLETED|Overall Study||13
8107282|NCT03126448|19981700|P3|COMPLETED|Overall Study||27
8107283|NCT03126448|19981701|P2|COMPLETED|Overall Study||41
8107284|NCT03126448|19981702|P1|COMPLETED|Overall Study||43
8107285|NCT03126448|19981700|P3|STARTED|Overall Study||37
8107286|NCT03126448|19981701|P2|STARTED|Overall Study||49
8107287|NCT03126448|19981702|P1|STARTED|Overall Study||56
8107288|NCT03126344|19981713|P3|NOT COMPLETED|Overall Study||5
8107289|NCT03126344|19981714|P2|NOT COMPLETED|Overall Study||0
8107290|NCT03126344|19981715|P1|NOT COMPLETED|Overall Study||0
8107291|NCT03126344|19981713|P3|COMPLETED|Overall Study||28
8107292|NCT03126344|19981714|P2|COMPLETED|Overall Study||33
8107293|NCT03126344|19981715|P1|COMPLETED|Overall Study||33
8107294|NCT03126344|19981713|P3|STARTED|Overall Study||33
8107295|NCT03126344|19981714|P2|STARTED|Overall Study||33
8107296|NCT03126344|19981715|P1|STARTED|Overall Study||33
8107297|NCT03125941|19981731|P2|NOT COMPLETED|Overall Study||2
8107298|NCT03125941|19981732|P1|NOT COMPLETED|Overall Study||1
8107299|NCT03125941|19981731|P2|COMPLETED|Overall Study||63
8107300|NCT03125941|19981732|P1|COMPLETED|Overall Study||64
8107301|NCT03125941|19981731|P2|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
8107302|NCT03125941|19981732|P1|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
8107303|NCT03125941|19981731|P2|STARTED|Overall Study||65
8107304|NCT03125941|19981732|P1|STARTED|Overall Study||65
8107305|NCT03125915|19981768|P4|NOT COMPLETED|6 Month Follow-up||3
8107306|NCT03125915|19981769|P3|NOT COMPLETED|6 Month Follow-up||6
8107307|NCT03125915|19981770|P2|NOT COMPLETED|6 Month Follow-up||3
8107308|NCT03125915|19981771|P1|NOT COMPLETED|6 Month Follow-up||7
8107309|NCT03125915|19981768|P4|COMPLETED|6 Month Follow-up||31
8107310|NCT03125915|19981769|P3|COMPLETED|6 Month Follow-up||28
8107311|NCT03125915|19981770|P2|COMPLETED|6 Month Follow-up||37
8107312|NCT03125915|19981771|P1|COMPLETED|6 Month Follow-up||25
8107313|NCT03125915|19981768|P4|STARTED|6 Month Follow-up||34
8107314|NCT03125915|19981769|P3|STARTED|6 Month Follow-up||34
8107315|NCT03125915|19981770|P2|STARTED|6 Month Follow-up||40
8107316|NCT03125915|19981771|P1|STARTED|6 Month Follow-up||32
8107317|NCT03125915|19981768|P4|NOT COMPLETED|3 Month Follow-up||2
8107318|NCT03125915|19981769|P3|NOT COMPLETED|3 Month Follow-up||4
8107319|NCT03125915|19981770|P2|NOT COMPLETED|3 Month Follow-up||4
8107320|NCT03125915|19981771|P1|NOT COMPLETED|3 Month Follow-up||6
8107321|NCT03125915|19981768|P4|COMPLETED|3 Month Follow-up||32
8107322|NCT03125915|19981769|P3|COMPLETED|3 Month Follow-up||30
8107323|NCT03125915|19981770|P2|COMPLETED|3 Month Follow-up||36
8107324|NCT03125915|19981771|P1|COMPLETED|3 Month Follow-up||26
8107325|NCT03125915|19981768|P4|STARTED|3 Month Follow-up||34
8107326|NCT03125915|19981769|P3|STARTED|3 Month Follow-up||34
8107327|NCT03125915|19981770|P2|STARTED|3 Month Follow-up||40
8107328|NCT03125915|19981771|P1|STARTED|3 Month Follow-up||32
8107329|NCT03125915|19981768|P4|NOT COMPLETED|1 Month Follow up||3
8107330|NCT03125915|19981769|P3|NOT COMPLETED|1 Month Follow up||2
8107331|NCT03125915|19981770|P2|NOT COMPLETED|1 Month Follow up||3
8107332|NCT03125915|19981771|P1|NOT COMPLETED|1 Month Follow up||3
8107333|NCT03125915|19981768|P4|COMPLETED|1 Month Follow up||31
8107334|NCT03125915|19981769|P3|COMPLETED|1 Month Follow up||32
8107335|NCT03125915|19981770|P2|COMPLETED|1 Month Follow up||37
8107336|NCT03125915|19981771|P1|COMPLETED|1 Month Follow up||29
8107337|NCT03125915|19981768|P4|STARTED|1 Month Follow up||34
8107338|NCT03125915|19981769|P3|STARTED|1 Month Follow up||34
8107339|NCT03125915|19981770|P2|STARTED|1 Month Follow up||40
8107340|NCT03125915|19981771|P1|STARTED|1 Month Follow up||32
8107341|NCT03125915|19981768|P4|NOT COMPLETED|Baseline and Intervention||0
8107342|NCT03125915|19981769|P3|NOT COMPLETED|Baseline and Intervention||0
8107343|NCT03125915|19981770|P2|NOT COMPLETED|Baseline and Intervention||0
8107344|NCT03125915|19981771|P1|NOT COMPLETED|Baseline and Intervention||0
8107345|NCT03125915|19981768|P4|COMPLETED|Baseline and Intervention||34
8107346|NCT03125915|19981769|P3|COMPLETED|Baseline and Intervention||34
8107347|NCT03125915|19981770|P2|COMPLETED|Baseline and Intervention||40
8107348|NCT03125915|19981771|P1|COMPLETED|Baseline and Intervention||32
8107349|NCT03125915|19981768|P4|STARTED|Baseline and Intervention||34
8107350|NCT03125915|19981769|P3|STARTED|Baseline and Intervention||34
8107351|NCT03125915|19981770|P2|STARTED|Baseline and Intervention||40
8107352|NCT03125915|19981771|P1|STARTED|Baseline and Intervention||32
8107359|NCT03125395|19981837|P1|NOT COMPLETED|Overall Study||10
8107360|NCT03125395|19981837|P1|COMPLETED|Overall Study||47
8107361|NCT03125395|19981837|P1|Study 116 LCI Substudy Set|Overall Study||31
8107362|NCT03125395|19981837|P1|Study 116 FAS|Overall Study||57
8107363|NCT03125395|19981837|P1|Study 115B FAS|Overall Study||60
8107364|NCT03125395|19981837|P1|STARTED|Overall Study||57
8107386|NCT03125031|19982067|P2|NOT COMPLETED|Overall Study||0
8107387|NCT03125031|19982068|P1|NOT COMPLETED|Overall Study||0
8107388|NCT03125031|19982067|P2|COMPLETED|Overall Study||44
8107389|NCT03125031|19982068|P1|COMPLETED|Overall Study||44
8107390|NCT03125031|19982067|P2|STARTED|Overall Study||44
8107391|NCT03125031|19982068|P1|STARTED|Overall Study||44
8107392|NCT03125018|19982073|P1|NOT COMPLETED|Overall Study||0
8107393|NCT03125018|19982073|P1|COMPLETED|Overall Study||13
8107394|NCT03125018|19982073|P1|STARTED|Overall Study||13
8107395|NCT03125005|19982077|P1|NOT COMPLETED|Overall Study||0
8107396|NCT03125005|19982077|P1|COMPLETED|Overall Study||51
8107397|NCT03125005|19982077|P1|STARTED|Overall Study||51
8107398|NCT03124979|19982081|P1|NOT COMPLETED|Overall Study||0
8107399|NCT03124979|19982081|P1|COMPLETED|Overall Study||13
8107400|NCT03124979|19982081|P1|STARTED|Overall Study||13
8107401|NCT03124966|19982085|P1|NOT COMPLETED|Overall Study||0
8107402|NCT03124966|19982085|P1|COMPLETED|Overall Study||118
8107403|NCT03124966|19982085|P1|STARTED|Overall Study||118
8107404|NCT03124927|19982089|P1|NOT COMPLETED|Overall Study||0
8107405|NCT03124927|19982089|P1|COMPLETED|Overall Study||25
8107406|NCT03124927|19982089|P1|STARTED|Overall Study||25
8107407|NCT03124901|19982093|P1|NOT COMPLETED|Overall Study||0
8107408|NCT03124901|19982093|P1|COMPLETED|Overall Study||147
8107409|NCT03124901|19982093|P1|STARTED|Overall Study||147
8107410|NCT03124836|19982097|P1|NOT COMPLETED|Overall Study||0
8107411|NCT03124836|19982097|P1|COMPLETED|Overall Study||28
8107412|NCT03124836|19982097|P1|STARTED|Overall Study||28
8107413|NCT03124823|19982101|P1|NOT COMPLETED|Overall Study||0
8107414|NCT03124823|19982101|P1|COMPLETED|Overall Study||11
8107415|NCT03124823|19982101|P1|STARTED|Overall Study||11
8107416|NCT03124797|19982105|P1|NOT COMPLETED|Overall Study||0
8107417|NCT03124797|19982105|P1|COMPLETED|Overall Study||18
8107418|NCT03124797|19982105|P1|STARTED|Overall Study||18
8107419|NCT03124784|19982109|P1|NOT COMPLETED|Overall Study||2
8107420|NCT03124784|19982109|P1|COMPLETED|Overall Study||25
8107421|NCT03124784|19982109|P1|STARTED|Overall Study||27
8107422|NCT03124771|19982113|P1|NOT COMPLETED|Overall Study||0
8107423|NCT03124771|19982113|P1|COMPLETED|Overall Study||132
8107424|NCT03124771|19982113|P1|STARTED|Overall Study||132
8107425|NCT03124758|19982117|P1|NOT COMPLETED|Overall Study||0
8107426|NCT03124758|19982117|P1|COMPLETED|Overall Study||354
8107427|NCT03124758|19982117|P1|STARTED|Overall Study||354
8107428|NCT03124693|19982121|P1|NOT COMPLETED|Overall Study||0
8107429|NCT03124693|19982121|P1|COMPLETED|Overall Study||90
8107430|NCT03124693|19982121|P1|STARTED|Overall Study||90
8107431|NCT03124602|19982125|P1|NOT COMPLETED|Overall Study||10
8107432|NCT03124602|19982125|P1|COMPLETED|Overall Study||25
8107433|NCT03124602|19982125|P1|STARTED|Overall Study||35
8107434|NCT03124563|19982131|P2|NOT COMPLETED|Overall Study||2
8107435|NCT03124563|19982132|P1|NOT COMPLETED|Overall Study||2
8107436|NCT03124563|19982131|P2|COMPLETED|Overall Study||29
8107437|NCT03124563|19982132|P1|COMPLETED|Overall Study||30
8107438|NCT03124563|19982131|P2|Pre-test|Overall Study||30
8107439|NCT03124563|19982132|P1|Pre-test|Overall Study||30
8107440|NCT03124563|19982131|P2|STARTED|Overall Study||31
8107441|NCT03124563|19982132|P1|STARTED|Overall Study||32
8107442|NCT03124550|19982148|P1|NOT COMPLETED|Overall Study||0
8107443|NCT03124550|19982148|P1|COMPLETED|Overall Study||18
8107444|NCT03124550|19982148|P1|STARTED|Overall Study||18
8107445|NCT03124537|19982157|P2|NOT COMPLETED|Overall Study||13
8107446|NCT03124537|19982158|P1|NOT COMPLETED|Overall Study||10
8107447|NCT03124537|19982157|P2|COMPLETED|Overall Study||32
8107448|NCT03124537|19982158|P1|COMPLETED|Overall Study||31
8107449|NCT03124537|19982157|P2|STARTED|Overall Study||45
8107450|NCT03124537|19982158|P1|STARTED|Overall Study||41
8107451|NCT03124407|19982182|P4|NOT COMPLETED|Overall Study||0
8107452|NCT03124407|19982183|P3|NOT COMPLETED|Overall Study||1
8107453|NCT03124407|19982184|P2|NOT COMPLETED|Overall Study||0
8107454|NCT03124407|19982185|P1|NOT COMPLETED|Overall Study||1
8107455|NCT03124407|19982182|P4|COMPLETED|Overall Study||20
8107456|NCT03124407|19982183|P3|COMPLETED|Overall Study||39
8107457|NCT03124407|19982184|P2|COMPLETED|Overall Study||20
8107458|NCT03124407|19982185|P1|COMPLETED|Overall Study||39
8107459|NCT03124407|19982182|P4|STARTED|Overall Study||20
8107460|NCT03124407|19982183|P3|STARTED|Overall Study||40
8107461|NCT03124407|19982184|P2|STARTED|Overall Study||20
8107462|NCT03124407|19982185|P1|STARTED|Overall Study||40
8107463|NCT03124381|19982205|P2|NOT COMPLETED|Overall Study||6
8107464|NCT03124381|19982206|P1|NOT COMPLETED|Overall Study||9
8107465|NCT03124381|19982205|P2|COMPLETED|Overall Study||55
8107466|NCT03124381|19982206|P1|COMPLETED|Overall Study||56
8107467|NCT03124381|19982205|P2|STARTED|Overall Study||61
8107468|NCT03124381|19982206|P1|STARTED|Overall Study||65
8107469|NCT03124342|19982298|P2|NOT COMPLETED|Overall Study||0
8107470|NCT03124342|19982299|P1|NOT COMPLETED|Overall Study||0
8107471|NCT03124342|19982298|P2|COMPLETED|Overall Study||121
8107472|NCT03124342|19982299|P1|COMPLETED|Overall Study||111
8107473|NCT03124342|19982298|P2|STARTED|Overall Study||121
8107474|NCT03124342|19982299|P1|STARTED|Overall Study||111
8107475|NCT03124199|19982313|P1|NOT COMPLETED|Overall Study||4
8107476|NCT03124199|19982313|P1|COMPLETED|Overall Study||36
8107477|NCT03124199|19982313|P1|STARTED|Overall Study||40
8107478|NCT03124108|19982322|P3|NOT COMPLETED|Overall Study||0
8107479|NCT03124108|19982323|P2|NOT COMPLETED|Overall Study||1
8107480|NCT03124108|19982324|P1|NOT COMPLETED|Overall Study||0
8107481|NCT03124108|19982322|P3|COMPLETED|Overall Study||15
8107482|NCT03124108|19982323|P2|COMPLETED|Overall Study||14
8107483|NCT03124108|19982324|P1|COMPLETED|Overall Study||15
8107484|NCT03124108|19982322|P3|STARTED|Overall Study||15
8107485|NCT03124108|19982323|P2|STARTED|Overall Study||15
8107486|NCT03124108|19982324|P1|STARTED|Overall Study||15
8107487|NCT03123874|19982457|P2|NOT COMPLETED|Overall Study||0
8107488|NCT03123874|19982458|P1|NOT COMPLETED|Overall Study||0
8107489|NCT03123874|19982457|P2|COMPLETED|Overall Study||25
8107490|NCT03123874|19982458|P1|COMPLETED|Overall Study||27
8107491|NCT03123874|19982457|P2|STARTED|Overall Study||25
8107492|NCT03123874|19982458|P1|STARTED|Overall Study||27
8107493|NCT03123861|19982470|P2|NOT COMPLETED|Overall Study||3
8107494|NCT03123861|19982471|P1|NOT COMPLETED|Overall Study||3
8107495|NCT03123861|19982470|P2|COMPLETED|Overall Study||20
8107496|NCT03123861|19982471|P1|COMPLETED|Overall Study||19
8107497|NCT03123861|19982470|P2|Received Intervention|Overall Study||22
8107498|NCT03123861|19982471|P1|Received Intervention|Overall Study||21
8107499|NCT03123861|19982470|P2|STARTED|Overall Study||23
8107500|NCT03123861|19982471|P1|STARTED|Overall Study||22
8107501|NCT03123848|19982483|P1|NOT COMPLETED|Overall Study||0
8107502|NCT03123848|19982483|P1|COMPLETED|Overall Study||8
8107503|NCT03123848|19982483|P1|STARTED|Overall Study||8
8107504|NCT03123614|19982507|P2|NOT COMPLETED|Overall Study||0
8107505|NCT03123614|19982508|P1|NOT COMPLETED|Overall Study||0
8107506|NCT03123614|19982507|P2|COMPLETED|Overall Study||74
8107507|NCT03123614|19982508|P1|COMPLETED|Overall Study||57
8107508|NCT03123614|19982507|P2|STARTED|Overall Study||74
8107509|NCT03123614|19982508|P1|STARTED|Overall Study||57
8107510|NCT03123471|19982522|P2|NOT COMPLETED|Apremilast Extension Phase||25
8107511|NCT03123471|19982523|P1|NOT COMPLETED|Apremilast Extension Phase||8
8107512|NCT03123471|19982522|P2|COMPLETED|Apremilast Extension Phase||140
8107513|NCT03123471|19982523|P1|COMPLETED|Apremilast Extension Phase||76
8107514|NCT03123471|19982522|P2|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
8107515|NCT03123471|19982523|P1|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
8107516|NCT03123471|19982522|P2|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
8107517|NCT03123471|19982523|P1|STARTED|Apremilast Extension Phase||84
8107518|NCT03123471|19982522|P2|NOT COMPLETED|Placebo-controlled Phase||33
8107519|NCT03123471|19982523|P1|NOT COMPLETED|Placebo-controlled Phase||18
8107520|NCT03123471|19982522|P2|COMPLETED|Placebo-controlled Phase||168
8107521|NCT03123471|19982523|P1|COMPLETED|Placebo-controlled Phase||84
8107522|NCT03123471|19982522|P2|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
8107523|NCT03123471|19982523|P1|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
8107524|NCT03123471|19982522|P2|STARTED|Placebo-controlled Phase||201
8107525|NCT03123471|19982523|P1|STARTED|Placebo-controlled Phase||102
8107526|NCT03123393|19982550|P2|NOT COMPLETED|Overall Study||23
8107527|NCT03123393|19982551|P1|NOT COMPLETED|Overall Study||21
8107528|NCT03123393|19982550|P2|COMPLETED|Overall Study||2
8107529|NCT03123393|19982551|P1|COMPLETED|Overall Study||3
8107530|NCT03123393|19982550|P2|STARTED|Overall Study||25
8107531|NCT03123393|19982551|P1|STARTED|Overall Study||24
8107532|NCT03123354|19982579|P1|NOT COMPLETED|Overall Study||6
8107533|NCT03123354|19982579|P1|COMPLETED|Overall Study||38
8107534|NCT03123354|19982579|P1|STARTED|Overall Study||44
8107535|NCT03123263|19982583|P1|NOT COMPLETED|Overall Study||0
8107536|NCT03123263|19982583|P1|COMPLETED|Overall Study||60
8107537|NCT03123263|19982583|P1|STARTED|Overall Study||60
8107538|NCT03123055|19982590|P1|NOT COMPLETED|Overall Study||0
8107539|NCT03123055|19982590|P1|COMPLETED|Overall Study||28
8107540|NCT03123055|19982590|P1|STARTED|Overall Study||28
8107541|NCT03122886|19982604|P2|NOT COMPLETED|Overall Study||2
8107542|NCT03122886|19982605|P1|NOT COMPLETED|Overall Study||1
8107543|NCT03122886|19982604|P2|COMPLETED|Overall Study||7
8107544|NCT03122886|19982605|P1|COMPLETED|Overall Study||9
8107545|NCT03122886|19982604|P2|STARTED|Overall Study||9
8107546|NCT03122886|19982605|P1|STARTED|Overall Study||10
8107547|NCT03122587|19982614|P3|NOT COMPLETED|Overall Study||1
8107548|NCT03122587|19982615|P2|NOT COMPLETED|Overall Study||2
8107549|NCT03122587|19982616|P1|NOT COMPLETED|Overall Study||2
8107550|NCT03122587|19982614|P3|COMPLETED|Overall Study||12
8107551|NCT03122587|19982615|P2|COMPLETED|Overall Study||10
8107552|NCT03122587|19982616|P1|COMPLETED|Overall Study||11
8107553|NCT03122587|19982614|P3|STARTED|Overall Study||13
8107554|NCT03122587|19982615|P2|STARTED|Overall Study||12
8107555|NCT03122587|19982616|P1|STARTED|Overall Study||13
8107556|NCT03122548|19982627|P1|NOT COMPLETED|Overall Study||5
8107557|NCT03122548|19982627|P1|COMPLETED|Overall Study||0
8107558|NCT03122548|19982627|P1|STARTED|Overall Study||5
8107559|NCT03122457|19982635|P1|NOT COMPLETED|Overall Study||6
8107560|NCT03122457|19982635|P1|COMPLETED|Overall Study||16
8107561|NCT03122457|19982635|P1|STARTED|Overall Study||22
8107562|NCT03122223|19982644|P4|NOT COMPLETED|Overall Study||0
8107563|NCT03122223|19982645|P3|NOT COMPLETED|Overall Study||4
8107564|NCT03122223|19982646|P2|NOT COMPLETED|Overall Study||5
8107565|NCT03122223|19982647|P1|NOT COMPLETED|Overall Study||3
8107566|NCT03122223|19982644|P4|COMPLETED|Overall Study||10
8107567|NCT03122223|19982645|P3|COMPLETED|Overall Study||46
8107568|NCT03122223|19982646|P2|COMPLETED|Overall Study||45
8107569|NCT03122223|19982647|P1|COMPLETED|Overall Study||47
8107570|NCT03122223|19982644|P4|Month 12 Immunogenicity Cohort|Overall Study||10
8107571|NCT03122223|19982645|P3|Month 12 Immunogenicity Cohort|Overall Study||46
8107572|NCT03122223|19982646|P2|Month 12 Immunogenicity Cohort|Overall Study||45
8107573|NCT03122223|19982647|P1|Month 12 Immunogenicity Cohort|Overall Study||47
8107574|NCT03122223|19982644|P4|Month 6.5 Immunogenicity Cohort|Overall Study||8
8107575|NCT03122223|19982645|P3|Month 6.5 Immunogenicity Cohort|Overall Study||47
8107576|NCT03122223|19982646|P2|Month 6.5 Immunogenicity Cohort|Overall Study||48
8107577|NCT03122223|19982647|P1|Month 6.5 Immunogenicity Cohort|Overall Study||49
8107578|NCT03122223|19982644|P4|STARTED|Overall Study||10
8107579|NCT03122223|19982645|P3|STARTED|Overall Study||50
8107580|NCT03122223|19982646|P2|STARTED|Overall Study||50
8107581|NCT03122223|19982647|P1|STARTED|Overall Study||50
8107582|NCT03122184|19982703|P2|NOT COMPLETED|Overall Study||6
8107583|NCT03122184|19982704|P1|NOT COMPLETED|Overall Study||8
8107584|NCT03122184|19982703|P2|COMPLETED|Overall Study||17
8107585|NCT03122184|19982704|P1|COMPLETED|Overall Study||16
8107586|NCT03122184|19982703|P2|STARTED|Overall Study||23
8107587|NCT03122184|19982704|P1|STARTED|Overall Study||24
8107588|NCT03122171|19982741|P1|NOT COMPLETED|Overall Study||1
8107589|NCT03122171|19982741|P1|COMPLETED|Overall Study||5
8107590|NCT03122171|19982741|P1|STARTED|Overall Study||6
8107591|NCT03122145|19982750|P2|NOT COMPLETED|Overall Study||0
8107592|NCT03122145|19982751|P1|NOT COMPLETED|Overall Study||3
8107593|NCT03122145|19982750|P2|COMPLETED|Overall Study||12
8107594|NCT03122145|19982751|P1|COMPLETED|Overall Study||34
8107595|NCT03122145|19982750|P2|STARTED|Overall Study||12
8107596|NCT03122145|19982751|P1|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
8107597|NCT03121950|19982761|P2|NOT COMPLETED|Overall Study||2
8107598|NCT03121950|19982762|P1|NOT COMPLETED|Overall Study||11
8107599|NCT03121950|19982761|P2|COMPLETED|Overall Study||1
8107600|NCT03121950|19982762|P1|COMPLETED|Overall Study||6
8107601|NCT03121950|19982761|P2|STARTED|Overall Study||3
8107602|NCT03121950|19982762|P1|STARTED|Overall Study||17
8107603|NCT03121820|19982774|P2|NOT COMPLETED|Second Period (After Washout)||0
8107604|NCT03121820|19982775|P1|NOT COMPLETED|Second Period (After Washout)||0
8107605|NCT03121820|19982774|P2|COMPLETED|Second Period (After Washout)||9
8107606|NCT03121820|19982775|P1|COMPLETED|Second Period (After Washout)||9
8107607|NCT03121820|19982774|P2|STARTED|Second Period (After Washout)||9
8107608|NCT03121820|19982775|P1|STARTED|Second Period (After Washout)||9
8107609|NCT03121820|19982774|P2|NOT COMPLETED|First Period||0
8107610|NCT03121820|19982775|P1|NOT COMPLETED|First Period||0
8107611|NCT03121820|19982774|P2|COMPLETED|First Period||9
8107612|NCT03121820|19982775|P1|COMPLETED|First Period||9
8107613|NCT03121820|19982774|P2|STARTED|First Period||9
8107614|NCT03121820|19982775|P1|STARTED|First Period||9
8107615|NCT03121612|19982785|P2|NOT COMPLETED|Overall Study||0
8107616|NCT03121612|19982786|P1|NOT COMPLETED|Overall Study||0
8107617|NCT03121612|19982785|P2|COMPLETED|Overall Study||25
8107618|NCT03121612|19982786|P1|COMPLETED|Overall Study||26
8107619|NCT03121612|19982785|P2|STARTED|Overall Study||25
8107620|NCT03121612|19982786|P1|STARTED|Overall Study||26
8107621|NCT03121365|19982830|P2|NOT COMPLETED|7 Months||8
8107622|NCT03121365|19982831|P1|NOT COMPLETED|7 Months||10
8107623|NCT03121365|19982830|P2|COMPLETED|7 Months||37
8107624|NCT03121365|19982831|P1|COMPLETED|7 Months||44
8107625|NCT03121365|19982830|P2|STARTED|7 Months||45
8107626|NCT03121365|19982831|P1|STARTED|7 Months||54
8107627|NCT03121365|19982830|P2|NOT COMPLETED|4 Months||1
8107628|NCT03121365|19982831|P1|NOT COMPLETED|4 Months||3
8107629|NCT03121365|19982830|P2|COMPLETED|4 Months||44
8107630|NCT03121365|19982831|P1|COMPLETED|4 Months||51
8107631|NCT03121365|19982830|P2|STARTED|4 Months||45
8107632|NCT03121365|19982831|P1|STARTED|4 Months||54
8107633|NCT03121365|19982830|P2|NOT COMPLETED|1 Months||3
8107634|NCT03121365|19982831|P1|NOT COMPLETED|1 Months||2
8107635|NCT03121365|19982830|P2|COMPLETED|1 Months||45
8107636|NCT03121365|19982831|P1|COMPLETED|1 Months||52
8107637|NCT03121365|19982830|P2|STARTED|1 Months||48
8107638|NCT03121365|19982831|P1|STARTED|1 Months||54
8107639|NCT03121365|19982830|P2|NOT COMPLETED|Baseline||1
8107640|NCT03121365|19982831|P1|NOT COMPLETED|Baseline||1
8107641|NCT03121365|19982830|P2|COMPLETED|Baseline||48
8107642|NCT03121365|19982831|P1|COMPLETED|Baseline||54
8107643|NCT03121365|19982830|P2|STARTED|Baseline||49
8107644|NCT03121365|19982831|P1|STARTED|Baseline||55
8107645|NCT03121144|19982859|P1|NOT COMPLETED|Overall Study||0
8107646|NCT03121144|19982859|P1|COMPLETED|Overall Study||34
8107647|NCT03121144|19982859|P1|STARTED|Overall Study||34
8107648|NCT03120676|19982863|P1|NOT COMPLETED|Overall Study||1
8107649|NCT03120676|19982863|P1|COMPLETED|Overall Study||2
8107650|NCT03120676|19982863|P1|STARTED|Overall Study||3
8107651|NCT03120520|19982871|P4|NOT COMPLETED|Overall Study||3
8107652|NCT03120520|19982872|P3|NOT COMPLETED|Overall Study||4
8107653|NCT03120520|19982873|P2|NOT COMPLETED|Overall Study||4
8107654|NCT03120520|19982874|P1|NOT COMPLETED|Overall Study||4
8107655|NCT03120520|19982871|P4|COMPLETED|Overall Study||29
8107656|NCT03120520|19982872|P3|COMPLETED|Overall Study||26
8107657|NCT03120520|19982873|P2|COMPLETED|Overall Study||27
8107658|NCT03120520|19982874|P1|COMPLETED|Overall Study||27
8107659|NCT03120520|19982871|P4|STARTED|Overall Study||32
8107660|NCT03120520|19982872|P3|STARTED|Overall Study||30
8107661|NCT03120520|19982873|P2|STARTED|Overall Study||31
8107662|NCT03120520|19982874|P1|STARTED|Overall Study||31
8107663|NCT03120351|19982898|P2|NOT COMPLETED|Overall Study||1
8107664|NCT03120351|19982899|P1|NOT COMPLETED|Overall Study||1
8107665|NCT03120351|19982898|P2|COMPLETED|Overall Study||39
8107666|NCT03120351|19982899|P1|COMPLETED|Overall Study||39
8107667|NCT03120351|19982898|P2|STARTED|Overall Study||40
8107668|NCT03120351|19982899|P1|STARTED|Overall Study||40
8107669|NCT03120013|19982905|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8107670|NCT03120013|19982906|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8107671|NCT03120013|19982905|P2|COMPLETED|Second Intervention (2 Weeks)||10
8107672|NCT03120013|19982906|P1|COMPLETED|Second Intervention (2 Weeks)||10
8107673|NCT03120013|19982905|P2|STARTED|Second Intervention (2 Weeks)||10
8107674|NCT03120013|19982906|P1|STARTED|Second Intervention (2 Weeks)||10
8107675|NCT03120013|19982905|P2|NOT COMPLETED|Washout (6 Months)||0
8107676|NCT03120013|19982906|P1|NOT COMPLETED|Washout (6 Months)||0
8107677|NCT03120013|19982905|P2|COMPLETED|Washout (6 Months)||10
8107678|NCT03120013|19982906|P1|COMPLETED|Washout (6 Months)||10
8107679|NCT03120013|19982905|P2|STARTED|Washout (6 Months)||10
8107680|NCT03120013|19982906|P1|STARTED|Washout (6 Months)||10
8107681|NCT03120013|19982905|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
8107682|NCT03120013|19982906|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8107683|NCT03120013|19982905|P2|COMPLETED|First Intervention (2 Weeks)||10
8107684|NCT03120013|19982906|P1|COMPLETED|First Intervention (2 Weeks)||10
8107685|NCT03120013|19982905|P2|Received Intervention|First Intervention (2 Weeks)||11
8107686|NCT03120013|19982906|P1|Received Intervention|First Intervention (2 Weeks)||10
8107687|NCT03120013|19982905|P2|STARTED|First Intervention (2 Weeks)||11
8107688|NCT03120013|19982906|P1|STARTED|First Intervention (2 Weeks)||10
8107689|NCT03119831|19982929|P3|NOT COMPLETED|Overall Study||0
8107690|NCT03119831|19982930|P2|NOT COMPLETED|Overall Study||0
8107691|NCT03119831|19982931|P1|NOT COMPLETED|Overall Study||0
8107692|NCT03119831|19982929|P3|COMPLETED|Overall Study||14
8107693|NCT03119831|19982930|P2|COMPLETED|Overall Study||14
8107694|NCT03119831|19982931|P1|COMPLETED|Overall Study||14
8107695|NCT03119831|19982929|P3|STARTED|Overall Study||14
8107696|NCT03119831|19982930|P2|STARTED|Overall Study||14
8107697|NCT03119831|19982931|P1|STARTED|Overall Study||14
8107698|NCT03119701|19982950|P2|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
8107699|NCT03119701|19982951|P1|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
8107700|NCT03119701|19982950|P2|COMPLETED|Mid-term (Final) Follow-up at D90||9
8107701|NCT03119701|19982951|P1|COMPLETED|Mid-term (Final) Follow-up at D90||22
8107702|NCT03119701|19982950|P2|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
8107703|NCT03119701|19982951|P1|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
8107704|NCT03119701|19982950|P2|NOT COMPLETED|6-day Dosing||3
8107705|NCT03119701|19982951|P1|NOT COMPLETED|6-day Dosing||7
8107706|NCT03119701|19982950|P2|COMPLETED|6-day Dosing||8
8107707|NCT03119701|19982951|P1|COMPLETED|6-day Dosing||22
8107708|NCT03119701|19982950|P2|STARTED|6-day Dosing||11
8107709|NCT03119701|19982951|P1|STARTED|6-day Dosing||29
8107710|NCT03119688|19982983|P1|NOT COMPLETED|Overall Study||4
8107711|NCT03119688|19982983|P1|COMPLETED|Overall Study||44
8107712|NCT03119688|19982983|P1|STARTED|Overall Study||48
8107713|NCT03119662|19983016|P2|NOT COMPLETED|Overall Study||1
8107714|NCT03119662|19983017|P1|NOT COMPLETED|Overall Study||0
8107715|NCT03119662|19983016|P2|COMPLETED|Overall Study||1
8107716|NCT03119662|19983017|P1|COMPLETED|Overall Study||2
8107717|NCT03119662|19983016|P2|STARTED|Overall Study||2
8107718|NCT03119662|19983017|P1|STARTED|Overall Study||2
8107719|NCT03119649|19983038|P5|NOT COMPLETED|Overall Study||0
8107720|NCT03119649|19983039|P4|NOT COMPLETED|Overall Study||0
8107721|NCT03119649|19983040|P3|NOT COMPLETED|Overall Study||0
8107722|NCT03119649|19983041|P2|NOT COMPLETED|Overall Study||0
8107723|NCT03119649|19983042|P1|NOT COMPLETED|Overall Study||0
8107724|NCT03119649|19983038|P5|COMPLETED|Overall Study||14
8107725|NCT03119649|19983039|P4|COMPLETED|Overall Study||14
8107726|NCT03119649|19983040|P3|COMPLETED|Overall Study||10
8107727|NCT03119649|19983041|P2|COMPLETED|Overall Study||10
8107728|NCT03119649|19983042|P1|COMPLETED|Overall Study||11
8107729|NCT03119649|19983038|P5|STARTED|Overall Study||14
8107730|NCT03119649|19983039|P4|STARTED|Overall Study||14
8107731|NCT03119649|19983040|P3|STARTED|Overall Study||10
8107732|NCT03119649|19983041|P2|STARTED|Overall Study||10
8107733|NCT03119649|19983042|P1|STARTED|Overall Study||11
8107734|NCT03119610|19983087|P2|NOT COMPLETED|Overall Study||1
8107735|NCT03119610|19983088|P1|NOT COMPLETED|Overall Study||1
8107736|NCT03119610|19983087|P2|COMPLETED|Overall Study||9
8107737|NCT03119610|19983088|P1|COMPLETED|Overall Study||12
8107738|NCT03119610|19983087|P2|STARTED|Overall Study||10
8107739|NCT03119610|19983088|P1|STARTED|Overall Study||13
8107740|NCT03119571|19983120|P2|NOT COMPLETED|Overall Study||0
8107741|NCT03119571|19983121|P1|NOT COMPLETED|Overall Study||0
8107742|NCT03119571|19983120|P2|COMPLETED|Overall Study||34
8107743|NCT03119571|19983121|P1|COMPLETED|Overall Study||31
8107744|NCT03119571|19983120|P2|STARTED|Overall Study||34
8107745|NCT03119571|19983121|P1|STARTED|Overall Study||31
8107746|NCT03119389|19983129|P2|NOT COMPLETED|Overall Study||0
8107747|NCT03119389|19983130|P1|NOT COMPLETED|Overall Study||0
8107748|NCT03119389|19983129|P2|COMPLETED|Overall Study||7627
8107749|NCT03119389|19983130|P1|COMPLETED|Overall Study||6791
8107750|NCT03119389|19983129|P2|STARTED|Overall Study||7627
8107751|NCT03119389|19983130|P1|STARTED|Overall Study||6791
8107752|NCT03119181|19983146|P2|NOT COMPLETED|Overall Study||0
8107753|NCT03119181|19983147|P1|NOT COMPLETED|Overall Study||0
8107754|NCT03119181|19983146|P2|COMPLETED|Overall Study||21
8107755|NCT03119181|19983147|P1|COMPLETED|Overall Study||19
8107756|NCT03119181|19983146|P2|STARTED|Overall Study||21
8107757|NCT03119181|19983147|P1|STARTED|Overall Study||19
8107758|NCT03119168|19983155|P2|NOT COMPLETED|Overall Study||0
8107759|NCT03119168|19983156|P1|NOT COMPLETED|Overall Study||0
8107760|NCT03119168|19983155|P2|COMPLETED|Overall Study||139
8107761|NCT03119168|19983156|P1|COMPLETED|Overall Study||129
8107762|NCT03119168|19983155|P2|STARTED|Overall Study||139
8107763|NCT03119168|19983156|P1|STARTED|Overall Study||129
8107764|NCT03119025|19983168|P1|NOT COMPLETED|Overall Study||0
8107765|NCT03119025|19983168|P1|COMPLETED|Overall Study||10
8107766|NCT03119025|19983168|P1|STARTED|Overall Study||10
8107767|NCT03118947|19983175|P1|NOT COMPLETED|Overall Study||29
8107768|NCT03118947|19983175|P1|COMPLETED|Overall Study||49
8107769|NCT03118947|19983175|P1|STARTED|Overall Study||78
8107770|NCT03118934|19983182|P6|NOT COMPLETED|Overall Study||2
8107771|NCT03118934|19983183|P5|NOT COMPLETED|Overall Study||2
8107772|NCT03118934|19983184|P4|NOT COMPLETED|Overall Study||1
8107773|NCT03118934|19983185|P3|NOT COMPLETED|Overall Study||1
8107774|NCT03118934|19983186|P2|NOT COMPLETED|Overall Study||1
8107775|NCT03118934|19983187|P1|NOT COMPLETED|Overall Study||0
8107776|NCT03118934|19983182|P6|COMPLETED|Overall Study||23
8107777|NCT03118934|19983183|P5|COMPLETED|Overall Study||27
8107778|NCT03118934|19983184|P4|COMPLETED|Overall Study||28
8107779|NCT03118934|19983185|P3|COMPLETED|Overall Study||33
8107780|NCT03118934|19983186|P2|COMPLETED|Overall Study||30
8107781|NCT03118934|19983187|P1|COMPLETED|Overall Study||34
8107782|NCT03118934|19983182|P6|Safety Analysis Set|Overall Study||25
8107783|NCT03118934|19983183|P5|Safety Analysis Set|Overall Study||26
8107784|NCT03118934|19983184|P4|Safety Analysis Set|Overall Study||29
8107785|NCT03118934|19983185|P3|Safety Analysis Set|Overall Study||34
8107786|NCT03118934|19983186|P2|Safety Analysis Set|Overall Study||29
8107787|NCT03118934|19983187|P1|Safety Analysis Set|Overall Study||34
8107788|NCT03118934|19983182|P6|STARTED|Overall Study||25
8107789|NCT03118934|19983183|P5|STARTED|Overall Study||29
8107790|NCT03118934|19983184|P4|STARTED|Overall Study||29
8107791|NCT03118934|19983185|P3|STARTED|Overall Study||34
8107792|NCT03118934|19983186|P2|STARTED|Overall Study||31
8107793|NCT03118934|19983187|P1|STARTED|Overall Study||34
8107794|NCT03118843|19983197|P1|NOT COMPLETED|Overall Study||0
8107795|NCT03118843|19983197|P1|COMPLETED|Overall Study||31
8107796|NCT03118843|19983197|P1|STARTED|Overall Study||31
8107797|NCT03118765|19983211|P5|NOT COMPLETED|Overall Study||2
8107798|NCT03118765|19983212|P4|NOT COMPLETED|Overall Study||3
8107799|NCT03118765|19983213|P3|NOT COMPLETED|Overall Study||5
8107800|NCT03118765|19983214|P2|NOT COMPLETED|Overall Study||2
8107801|NCT03118765|19983215|P1|NOT COMPLETED|Overall Study||4
8107802|NCT03118765|19983211|P5|COMPLETED|Overall Study||28
8107803|NCT03118765|19983212|P4|COMPLETED|Overall Study||29
8107804|NCT03118765|19983213|P3|COMPLETED|Overall Study||26
8107805|NCT03118765|19983214|P2|COMPLETED|Overall Study||30
8107806|NCT03118765|19983215|P1|COMPLETED|Overall Study||26
8107807|NCT03118765|19983211|P5|STARTED|Overall Study||30
8107808|NCT03118765|19983212|P4|STARTED|Overall Study||32
8107809|NCT03118765|19983213|P3|STARTED|Overall Study||31
8107810|NCT03118765|19983214|P2|STARTED|Overall Study||32
8107811|NCT03118765|19983215|P1|STARTED|Overall Study||30
8107812|NCT03118739|19983311|P2|NOT COMPLETED|Overall Study||4
8107813|NCT03118739|19983312|P1|NOT COMPLETED|Overall Study||7
8107814|NCT03118739|19983311|P2|COMPLETED|Overall Study||24
8107815|NCT03118739|19983312|P1|COMPLETED|Overall Study||25
8107816|NCT03118739|19983311|P2|Completed 24 Weeks of Treatment|Overall Study||25
8107817|NCT03118739|19983312|P1|Completed 24 Weeks of Treatment|Overall Study||24
8107818|NCT03118739|19983311|P2|Completed 12 Weeks of Treatment|Overall Study||25
8107819|NCT03118739|19983312|P1|Completed 12 Weeks of Treatment|Overall Study||26
8107820|NCT03118739|19983311|P2|STARTED|Overall Study||28
8107821|NCT03118739|19983312|P1|STARTED|Overall Study||32
8107822|NCT03118596|19983404|P2|NOT COMPLETED|Overall Study||4
8107823|NCT03118596|19983405|P1|NOT COMPLETED|Overall Study||0
8107824|NCT03118596|19983404|P2|COMPLETED|Overall Study||86
8107825|NCT03118596|19983405|P1|COMPLETED|Overall Study||90
8107826|NCT03118596|19983404|P2|Failed|Overall Study||4
8107827|NCT03118596|19983405|P1|Failed|Overall Study||0
8107828|NCT03118596|19983404|P2|Treated|Overall Study||0
8107829|NCT03118596|19983405|P1|Treated|Overall Study||2
8107830|NCT03118596|19983404|P2|STARTED|Overall Study||90
8107831|NCT03118596|19983405|P1|STARTED|Overall Study||90
8107832|NCT03118297|19983425|P2|NOT COMPLETED|Overall Study||2
8107833|NCT03118297|19983426|P1|NOT COMPLETED|Overall Study||0
8107834|NCT03118297|19983425|P2|COMPLETED|Overall Study||31
8107835|NCT03118297|19983426|P1|COMPLETED|Overall Study||32
8107836|NCT03118297|19983425|P2|STARTED|Overall Study||33
8107837|NCT03118297|19983426|P1|STARTED|Overall Study||32
8107838|NCT03117569|19983442|P2|NOT COMPLETED|Overall Study||12
8107839|NCT03117569|19983443|P1|NOT COMPLETED|Overall Study||4
8107840|NCT03117569|19983442|P2|COMPLETED|Overall Study||241
8107841|NCT03117569|19983443|P1|COMPLETED|Overall Study||123
8107842|NCT03117569|19983442|P2|STARTED|Overall Study||253
8107843|NCT03117569|19983443|P1|STARTED|Overall Study||127
8107844|NCT03117517|19983467|P2|NOT COMPLETED|Overall Study||4
8107845|NCT03117517|19983468|P1|NOT COMPLETED|Overall Study||5
8107846|NCT03117517|19983467|P2|COMPLETED|Overall Study||49
8107847|NCT03117517|19983468|P1|COMPLETED|Overall Study||48
8107848|NCT03117517|19983467|P2|STARTED|Overall Study||53
8107849|NCT03117517|19983468|P1|STARTED|Overall Study||53
8107850|NCT03117361|19983478|P1|NOT COMPLETED|Overall Study||10
8107851|NCT03117361|19983478|P1|COMPLETED|Overall Study||0
8107852|NCT03117361|19983478|P1|STARTED|Overall Study||10
8107853|NCT03117140|19983505|P4|NOT COMPLETED|Overall Study||0
8107854|NCT03117140|19983506|P3|NOT COMPLETED|Overall Study||0
8107855|NCT03117140|19983507|P2|NOT COMPLETED|Overall Study||0
8107856|NCT03117140|19983508|P1|NOT COMPLETED|Overall Study||0
8107857|NCT03117140|19983505|P4|COMPLETED|Overall Study||40
8107858|NCT03117140|19983506|P3|COMPLETED|Overall Study||40
8107859|NCT03117140|19983507|P2|COMPLETED|Overall Study||40
8107860|NCT03117140|19983508|P1|COMPLETED|Overall Study||40
8107861|NCT03117140|19983505|P4|STARTED|Overall Study||40
8107862|NCT03117140|19983506|P3|STARTED|Overall Study||40
8107863|NCT03117140|19983507|P2|STARTED|Overall Study||40
8107864|NCT03117140|19983508|P1|STARTED|Overall Study||40
8107865|NCT03116841|19983574|P1|NOT COMPLETED|Overall Study||0
8107866|NCT03116841|19983574|P1|COMPLETED|Overall Study||3
8107867|NCT03116841|19983574|P1|STARTED|Overall Study||3
8107868|NCT03116828|19983593|P2|NOT COMPLETED|Overall Study||21
8107869|NCT03116828|19983594|P1|NOT COMPLETED|Overall Study||8
8107870|NCT03116828|19983593|P2|COMPLETED|Overall Study||37
8107871|NCT03116828|19983594|P1|COMPLETED|Overall Study||36
8107872|NCT03116828|19983593|P2|STARTED|Overall Study||58
8107873|NCT03116828|19983594|P1|STARTED|Overall Study||44
8107874|NCT03116698|19983604|P4|NOT COMPLETED|Overall Study||2
8107875|NCT03116698|19983605|P3|NOT COMPLETED|Overall Study||8
8107876|NCT03116698|19983606|P2|NOT COMPLETED|Overall Study||6
8107877|NCT03116698|19983607|P1|NOT COMPLETED|Overall Study||6
8107878|NCT03116698|19983604|P4|COMPLETED|Overall Study||55
8107879|NCT03116698|19983605|P3|COMPLETED|Overall Study||54
8107880|NCT03116698|19983606|P2|COMPLETED|Overall Study||51
8107881|NCT03116698|19983607|P1|COMPLETED|Overall Study||56
8107882|NCT03116698|19983604|P4|STARTED|Overall Study||57
8107883|NCT03116698|19983605|P3|STARTED|Overall Study||62
8107884|NCT03116698|19983606|P2|STARTED|Overall Study||57
8107885|NCT03116698|19983607|P1|STARTED|Overall Study||62
8107894|NCT03115853|19983636|P1|NOT COMPLETED|Overall Study||0
8107895|NCT03115853|19983636|P1|COMPLETED|Overall Study||31
8107896|NCT03115853|19983636|P1|STARTED|Overall Study||31
8107897|NCT03115827|19983654|P1|NOT COMPLETED|Overall Study||3
8107898|NCT03115827|19983654|P1|COMPLETED|Overall Study||12
8107899|NCT03115827|19983654|P1|STARTED|Overall Study||15
8107900|NCT03115580|19983664|P2|NOT COMPLETED|Overall Study||0
8107901|NCT03115580|19983665|P1|NOT COMPLETED|Overall Study||0
8107902|NCT03115580|19983664|P2|COMPLETED|Overall Study||36
8107903|NCT03115580|19983665|P1|COMPLETED|Overall Study||35
8107904|NCT03115580|19983664|P2|STARTED|Overall Study||36
8107905|NCT03115580|19983665|P1|STARTED|Overall Study||35
8107906|NCT03115476|19983684|P3|NOT COMPLETED|LP0084-1369||162
8107907|NCT03115476|19983685|P2|NOT COMPLETED|LP0084-1369||210
8107908|NCT03115476|19983686|P1|NOT COMPLETED|LP0084-1369||191
8107909|NCT03115476|19983684|P3|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
8107910|NCT03115476|19983685|P2|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
8107911|NCT03115476|19983686|P1|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
8107912|NCT03115476|19983684|P3|STARTED|LP0084-1369||162
8107913|NCT03115476|19983685|P2|STARTED|LP0084-1369||210
8107914|NCT03115476|19983686|P1|STARTED|LP0084-1369||191
8107915|NCT03115476|19983684|P3|NOT COMPLETED|Main Trials (LP0084-119x)||0
8107916|NCT03115476|19983685|P2|NOT COMPLETED|Main Trials (LP0084-119x)||0
8107917|NCT03115476|19983686|P1|NOT COMPLETED|Main Trials (LP0084-119x)||0
8107918|NCT03115476|19983684|P3|COMPLETED|Main Trials (LP0084-119x)||409
8107919|NCT03115476|19983685|P2|COMPLETED|Main Trials (LP0084-119x)||418
8107920|NCT03115476|19983686|P1|COMPLETED|Main Trials (LP0084-119x)||407
8107921|NCT03115476|19983684|P3|STARTED|Main Trials (LP0084-119x)||409
8107922|NCT03115476|19983685|P2|STARTED|Main Trials (LP0084-119x)||418
8107923|NCT03115476|19983686|P1|STARTED|Main Trials (LP0084-119x)||407
8107924|NCT03115411|19983697|P1|NOT COMPLETED|Overall Study||0
8107925|NCT03115411|19983697|P1|COMPLETED|Overall Study||23
8107926|NCT03115411|19983697|P1|STARTED|Overall Study||23
8107927|NCT03115177|19983703|P2|NOT COMPLETED|Overall Study||0
8107928|NCT03115177|19983704|P1|NOT COMPLETED|Overall Study||0
8107929|NCT03115177|19983703|P2|COMPLETED|Overall Study||29
8107930|NCT03115177|19983704|P1|COMPLETED|Overall Study||27
8107931|NCT03115177|19983703|P2|STARTED|Overall Study||29
8107932|NCT03115177|19983704|P1|STARTED|Overall Study||27
8107933|NCT03114995|19983713|P3|NOT COMPLETED|Overall Study||0
8107934|NCT03114995|19983714|P2|NOT COMPLETED|Overall Study||1
8107935|NCT03114995|19983715|P1|NOT COMPLETED|Overall Study||1
8107936|NCT03114995|19983713|P3|COMPLETED|Overall Study||78
8107937|NCT03114995|19983714|P2|COMPLETED|Overall Study||30
8107938|NCT03114995|19983715|P1|COMPLETED|Overall Study||30
8107939|NCT03114995|19983713|P3|STARTED|Overall Study||78
8107940|NCT03114995|19983714|P2|STARTED|Overall Study||31
8107941|NCT03114995|19983715|P1|STARTED|Overall Study||31
8107942|NCT03114969|19983735|P9|NOT COMPLETED|Overall Study||2
8107943|NCT03114969|19983736|P8|NOT COMPLETED|Overall Study||0
8107944|NCT03114969|19983737|P7|NOT COMPLETED|Overall Study||1
8107945|NCT03114969|19983738|P6|NOT COMPLETED|Overall Study||1
8107946|NCT03114969|19983739|P5|NOT COMPLETED|Overall Study||0
8107947|NCT03114969|19983740|P4|NOT COMPLETED|Overall Study||2
8107948|NCT03114969|19983741|P3|NOT COMPLETED|Overall Study||4
8107949|NCT03114969|19983742|P2|NOT COMPLETED|Overall Study||0
8107950|NCT03114969|19983743|P1|NOT COMPLETED|Overall Study||0
8107951|NCT03114969|19983735|P9|COMPLETED|Overall Study||48
8107952|NCT03114969|19983736|P8|COMPLETED|Overall Study||50
8107953|NCT03114969|19983737|P7|COMPLETED|Overall Study||49
8107954|NCT03114969|19983738|P6|COMPLETED|Overall Study||48
8107955|NCT03114969|19983739|P5|COMPLETED|Overall Study||51
8107956|NCT03114969|19983740|P4|COMPLETED|Overall Study||48
8107957|NCT03114969|19983741|P3|COMPLETED|Overall Study||46
8107958|NCT03114969|19983742|P2|COMPLETED|Overall Study||50
8107959|NCT03114969|19983743|P1|COMPLETED|Overall Study||50
8107960|NCT03114969|19983735|P9|STARTED|Overall Study||50
8107961|NCT03114969|19983736|P8|STARTED|Overall Study||50
8107962|NCT03114969|19983737|P7|STARTED|Overall Study||50
8107963|NCT03114969|19983738|P6|STARTED|Overall Study||49
8107964|NCT03114969|19983739|P5|STARTED|Overall Study||51
8107965|NCT03114969|19983740|P4|STARTED|Overall Study||50
8107966|NCT03114969|19983741|P3|STARTED|Overall Study||50
8107967|NCT03114969|19983742|P2|STARTED|Overall Study||50
8107968|NCT03114969|19983743|P1|STARTED|Overall Study||50
8107969|NCT03114683|19983838|P1|NOT COMPLETED|Overall Study||44
8107970|NCT03114683|19983838|P1|COMPLETED|Overall Study||52
8107971|NCT03114683|19983838|P1|STARTED|Overall Study||96
8107972|NCT03114657|19983844|P2|NOT COMPLETED|Overall Study||407
8107973|NCT03114657|19983845|P1|NOT COMPLETED|Overall Study||399
8107974|NCT03114657|19983844|P2|COMPLETED|Overall Study||0
8107975|NCT03114657|19983845|P1|COMPLETED|Overall Study||0
8107976|NCT03114657|19983844|P2|STARTED|Overall Study||407
8107977|NCT03114657|19983845|P1|STARTED|Overall Study||399
8107978|NCT03114488|19983890|P2|NOT COMPLETED|Time Period 2||3
8107979|NCT03114488|19983891|P1|NOT COMPLETED|Time Period 2||1
8107980|NCT03114488|19983890|P2|COMPLETED|Time Period 2||19
8107981|NCT03114488|19983891|P1|COMPLETED|Time Period 2||18
8107982|NCT03114488|19983890|P2|STARTED|Time Period 2||22
8107983|NCT03114488|19983891|P1|STARTED|Time Period 2||19
8107984|NCT03114488|19983890|P2|NOT COMPLETED|Time Period 1||0
8107985|NCT03114488|19983891|P1|NOT COMPLETED|Time Period 1||0
8107986|NCT03114488|19983890|P2|COMPLETED|Time Period 1||22
8107987|NCT03114488|19983891|P1|COMPLETED|Time Period 1||19
8107988|NCT03114488|19983890|P2|STARTED|Time Period 1||22
8107989|NCT03114488|19983891|P1|STARTED|Time Period 1||19
8107990|NCT03113916|19983903|P2|NOT COMPLETED|Overall Study||12
8107991|NCT03113916|19983904|P1|NOT COMPLETED|Overall Study||11
8107992|NCT03113916|19983903|P2|COMPLETED|Overall Study||84
8107993|NCT03113916|19983904|P1|COMPLETED|Overall Study||88
8107994|NCT03113916|19983903|P2|STARTED|Overall Study||96
8107995|NCT03113916|19983904|P1|STARTED|Overall Study||99
8107996|NCT03113656|19983935|P2|NOT COMPLETED|Overall Study||0
8107997|NCT03113656|19983936|P1|NOT COMPLETED|Overall Study||0
8107998|NCT03113656|19983935|P2|COMPLETED|Overall Study||7
8107999|NCT03113656|19983936|P1|COMPLETED|Overall Study||9
8108000|NCT03113656|19983935|P2|STARTED|Overall Study||7
8108001|NCT03113656|19983936|P1|STARTED|Overall Study||9
8108002|NCT03112993|19983944|P2|NOT COMPLETED|Overall Study||0
8108003|NCT03112993|19983945|P1|NOT COMPLETED|Overall Study||0
8108004|NCT03112993|19983944|P2|COMPLETED|Overall Study||21
8108005|NCT03112993|19983945|P1|COMPLETED|Overall Study||19
8108006|NCT03112993|19983944|P2|STARTED|Overall Study||21
8108007|NCT03112993|19983945|P1|STARTED|Overall Study||19
8108008|NCT03111550|19983962|P3|NOT COMPLETED|Overall Study||3
8108009|NCT03111550|19983963|P2|NOT COMPLETED|Overall Study||2
8108010|NCT03111550|19983964|P1|NOT COMPLETED|Overall Study||4
8108011|NCT03111550|19983962|P3|COMPLETED|Overall Study||76
8108012|NCT03111550|19983963|P2|COMPLETED|Overall Study||71
8108013|NCT03111550|19983964|P1|COMPLETED|Overall Study||73
8108014|NCT03111550|19983962|P3|STARTED|Overall Study|First eye|79
8108015|NCT03111550|19983963|P2|STARTED|Overall Study|First eye|73
8108016|NCT03111550|19983964|P1|STARTED|Overall Study|First eye|77
8108017|NCT03111316|19983982|P4|NOT COMPLETED|Overall Study||0
8108018|NCT03111316|19983983|P3|NOT COMPLETED|Overall Study||0
8108019|NCT03111316|19983984|P2|NOT COMPLETED|Overall Study||0
8108020|NCT03111316|19983985|P1|NOT COMPLETED|Overall Study||0
8108021|NCT03111316|19983982|P4|COMPLETED|Overall Study||25
8108022|NCT03111316|19983983|P3|COMPLETED|Overall Study||25
8108023|NCT03111316|19983984|P2|COMPLETED|Overall Study||24
8108024|NCT03111316|19983985|P1|COMPLETED|Overall Study||26
8108025|NCT03111316|19983982|P4|STARTED|Overall Study||25
8108026|NCT03111316|19983983|P3|STARTED|Overall Study||25
8108027|NCT03111316|19983984|P2|STARTED|Overall Study||24
8108028|NCT03111316|19983985|P1|STARTED|Overall Study||26
8108029|NCT03111108|19984001|P2|NOT COMPLETED|Overall Study||1
8108030|NCT03111108|19984002|P1|NOT COMPLETED|Overall Study||1
8108031|NCT03111108|19984001|P2|COMPLETED|Overall Study||63
8108032|NCT03111108|19984002|P1|COMPLETED|Overall Study||52
8108033|NCT03111108|19984001|P2|STARTED|Overall Study||64
8108034|NCT03111108|19984002|P1|STARTED|Overall Study||53
8108035|NCT03110900|19984020|P2|NOT COMPLETED|Overall Study||1
8108036|NCT03110900|19984021|P1|NOT COMPLETED|Overall Study||1
8108037|NCT03110900|19984020|P2|COMPLETED|Overall Study||0
8108038|NCT03110900|19984021|P1|COMPLETED|Overall Study||0
8108039|NCT03110900|19984020|P2|STARTED|Overall Study||1
8108040|NCT03110900|19984021|P1|STARTED|Overall Study||1
8108041|NCT03110770|19984032|P5|NOT COMPLETED|Overall Study||123
8108042|NCT03110770|19984033|P4|NOT COMPLETED|Overall Study||133
8108043|NCT03110770|19984034|P3|NOT COMPLETED|Overall Study||2
8108044|NCT03110770|19984035|P2|NOT COMPLETED|Overall Study||0
8108045|NCT03110770|19984036|P1|NOT COMPLETED|Overall Study||6
8108046|NCT03110770|19984032|P5|COMPLETED|Overall Study||1045
8108047|NCT03110770|19984033|P4|COMPLETED|Overall Study||1037
8108048|NCT03110770|19984034|P3|COMPLETED|Overall Study||28
8108049|NCT03110770|19984035|P2|COMPLETED|Overall Study||30
8108050|NCT03110770|19984036|P1|COMPLETED|Overall Study||24
8108051|NCT03110770|19984032|P5|Received Third Product Administration|Overall Study||1107
8108052|NCT03110770|19984033|P4|Received Third Product Administration|Overall Study||1107
8108053|NCT03110770|19984034|P3|Received Third Product Administration|Overall Study||28
8108054|NCT03110770|19984035|P2|Received Third Product Administration|Overall Study||27
8108055|NCT03110770|19984036|P1|Received Third Product Administration|Overall Study||29
8108056|NCT03110770|19984032|P5|Received Second Product Administration|Overall Study||1127
8108057|NCT03110770|19984033|P4|Received Second Product Administration|Overall Study||1126
8108058|NCT03110770|19984034|P3|Received Second Product Administration|Overall Study||29
8108059|NCT03110770|19984035|P2|Received Second Product Administration|Overall Study||29
8108060|NCT03110770|19984036|P1|Received Second Product Administration|Overall Study||30
8108061|NCT03110770|19984032|P5|Received First Product Administration|Overall Study||1161
8108062|NCT03110770|19984033|P4|Received First Product Administration|Overall Study||1162
8108063|NCT03110770|19984034|P3|Received First Product Administration|Overall Study||30
8108064|NCT03110770|19984035|P2|Received First Product Administration|Overall Study||30
8108065|NCT03110770|19984036|P1|Received First Product Administration|Overall Study||30
8108066|NCT03110770|19984032|P5|STARTED|Overall Study||1168
8108067|NCT03110770|19984033|P4|STARTED|Overall Study||1170
8108068|NCT03110770|19984034|P3|STARTED|Overall Study||30
8108069|NCT03110770|19984035|P2|STARTED|Overall Study||30
8108070|NCT03110770|19984036|P1|STARTED|Overall Study||30
8108071|NCT03110692|19984081|P2|NOT COMPLETED|Overall Study||0
8108072|NCT03110692|19984082|P1|NOT COMPLETED|Overall Study||0
8108073|NCT03110692|19984081|P2|COMPLETED|Overall Study||509
8108074|NCT03110692|19984082|P1|COMPLETED|Overall Study||679
8108075|NCT03110692|19984081|P2|STARTED|Overall Study||509
8108076|NCT03110692|19984082|P1|STARTED|Overall Study||679
8108077|NCT03110601|19984088|P1|NOT COMPLETED|Stimgenics SCS Parameters||3
8108078|NCT03110601|19984088|P1|COMPLETED|Stimgenics SCS Parameters||20
8108079|NCT03110601|19984088|P1|STARTED|Stimgenics SCS Parameters||23
8108080|NCT03110601|19984088|P1|NOT COMPLETED|Washout Period||1
8108081|NCT03110601|19984088|P1|COMPLETED|Washout Period||23
8108082|NCT03110601|19984088|P1|STARTED|Washout Period||24
8108083|NCT03110601|19984088|P1|NOT COMPLETED|Conventional SCS Parameters||1
8108084|NCT03110601|19984088|P1|COMPLETED|Conventional SCS Parameters||24
8108085|NCT03110601|19984088|P1|STARTED|Conventional SCS Parameters||25
8108086|NCT03110471|19984097|P2|NOT COMPLETED|Overall Study||0
8108087|NCT03110471|19984098|P1|NOT COMPLETED|Overall Study||0
8108088|NCT03110471|19984097|P2|COMPLETED|Overall Study||30
8108089|NCT03110471|19984098|P1|COMPLETED|Overall Study||30
8108090|NCT03110471|19984097|P2|STARTED|Overall Study||30
8108091|NCT03110471|19984098|P1|STARTED|Overall Study||30
8108092|NCT03110458|19984110|P3|NOT COMPLETED|Overall Study||3
8108093|NCT03110458|19984111|P2|NOT COMPLETED|Overall Study||4
8108094|NCT03110458|19984112|P1|NOT COMPLETED|Overall Study||6
8108095|NCT03110458|19984110|P3|COMPLETED|Overall Study||31
8108096|NCT03110458|19984111|P2|COMPLETED|Overall Study||32
8108097|NCT03110458|19984112|P1|COMPLETED|Overall Study||31
8108098|NCT03110458|19984110|P3|STARTED|Overall Study||34
8108099|NCT03110458|19984111|P2|STARTED|Overall Study||36
8108100|NCT03110458|19984112|P1|STARTED|Overall Study||37
8108101|NCT03110380|19984140|P2|NOT COMPLETED|Overall Study||283
8108102|NCT03110380|19984141|P1|NOT COMPLETED|Overall Study||284
8108103|NCT03110380|19984140|P2|COMPLETED|Overall Study||0
8108104|NCT03110380|19984141|P1|COMPLETED|Overall Study||0
8108105|NCT03110380|19984140|P2|STARTED|Overall Study||283
8108106|NCT03110380|19984141|P1|STARTED|Overall Study||284
8108107|NCT03110185|19984153|P2|NOT COMPLETED|Overall Study||31
8108108|NCT03110185|19984154|P1|NOT COMPLETED|Overall Study||10
8108109|NCT03110185|19984153|P2|COMPLETED|Overall Study||33
8108110|NCT03110185|19984154|P1|COMPLETED|Overall Study||17
8108111|NCT03110185|19984153|P2|STARTED|Overall Study||64
8108112|NCT03110185|19984154|P1|STARTED|Overall Study||27
8108113|NCT03110159|19984164|P1|NOT COMPLETED|Overall Study||1
8108114|NCT03110159|19984164|P1|COMPLETED|Overall Study||0
8108115|NCT03110159|19984164|P1|STARTED|Overall Study||1
8108116|NCT03110029|19984175|P2|NOT COMPLETED|Overall Study||1
8108117|NCT03110029|19984176|P1|NOT COMPLETED|Overall Study||1
8108118|NCT03110029|19984175|P2|COMPLETED|Overall Study||5
8108119|NCT03110029|19984176|P1|COMPLETED|Overall Study||6
8108120|NCT03110029|19984175|P2|STARTED|Overall Study||6
8108121|NCT03110029|19984176|P1|STARTED|Overall Study||7
8108122|NCT03110003|19984186|P2|NOT COMPLETED|Overall Study||0
8108123|NCT03110003|19984187|P1|NOT COMPLETED|Overall Study||0
8108124|NCT03110003|19984186|P2|COMPLETED|Overall Study||24
8108125|NCT03110003|19984187|P1|COMPLETED|Overall Study||21
8108126|NCT03110003|19984186|P2|STARTED|Overall Study||24
8108127|NCT03110003|19984187|P1|STARTED|Overall Study||21
8108128|NCT03109951|19984203|P1|NOT COMPLETED|Overall Study||0
8108129|NCT03109951|19984203|P1|COMPLETED|Overall Study||187
8108130|NCT03109951|19984203|P1|STARTED|Overall Study||187
8108131|NCT03109873|19984211|P2|NOT COMPLETED|Overall Study||0
8108132|NCT03109873|19984212|P1|NOT COMPLETED|Overall Study||0
8108133|NCT03109873|19984211|P2|COMPLETED|Overall Study||4
8108134|NCT03109873|19984212|P1|COMPLETED|Overall Study||5
8108135|NCT03109873|19984211|P2|STARTED|Overall Study||4
8108136|NCT03109873|19984212|P1|STARTED|Overall Study||5
8108137|NCT03109769|19984228|P2|NOT COMPLETED|Overall Study||0
8108138|NCT03109769|19984229|P1|NOT COMPLETED|Overall Study||0
8108139|NCT03109769|19984228|P2|COMPLETED|Overall Study||22
8108140|NCT03109769|19984229|P1|COMPLETED|Overall Study||22
8108141|NCT03109769|19984228|P2|STARTED|Overall Study||22
8108142|NCT03109769|19984229|P1|STARTED|Overall Study||22
8108143|NCT03109418|19984239|P2|NOT COMPLETED|Overall Study||1
8108144|NCT03109418|19984240|P1|NOT COMPLETED|Overall Study||0
8108145|NCT03109418|19984239|P2|COMPLETED|Overall Study||3
8108146|NCT03109418|19984240|P1|COMPLETED|Overall Study||2
8108147|NCT03109418|19984239|P2|STARTED|Overall Study||4
8108148|NCT03109418|19984240|P1|STARTED|Overall Study||2
8108149|NCT03109184|19984250|P2|NOT COMPLETED|Overall Study||7
8108150|NCT03109184|19984251|P1|NOT COMPLETED|Overall Study||7
8108151|NCT03109184|19984250|P2|COMPLETED|Overall Study||52
8108152|NCT03109184|19984251|P1|COMPLETED|Overall Study||53
8108153|NCT03109184|19984250|P2|STARTED|Overall Study||59
8108154|NCT03109184|19984251|P1|STARTED|Overall Study||60
8108155|NCT03109015|19984271|P2|NOT COMPLETED|Overall Study||0
8108156|NCT03109015|19984272|P1|NOT COMPLETED|Overall Study||0
8108157|NCT03109015|19984271|P2|COMPLETED|Overall Study||3
8108158|NCT03109015|19984272|P1|COMPLETED|Overall Study||4
8108159|NCT03109015|19984271|P2|STARTED|Overall Study||3
8108160|NCT03109015|19984272|P1|STARTED|Overall Study||4
8108161|NCT03108924|19984306|P4|NOT COMPLETED|Overall Study||0
8108162|NCT03108924|19984307|P3|NOT COMPLETED|Overall Study||0
8108163|NCT03108924|19984308|P2|NOT COMPLETED|Overall Study||0
8108164|NCT03108924|19984309|P1|NOT COMPLETED|Overall Study||0
8108165|NCT03108924|19984306|P4|COMPLETED|Overall Study||6
8108166|NCT03108924|19984307|P3|COMPLETED|Overall Study||6
8108167|NCT03108924|19984308|P2|COMPLETED|Overall Study||6
8108168|NCT03108924|19984309|P1|COMPLETED|Overall Study||6
8108169|NCT03108924|19984306|P4|STARTED|Overall Study||6
8108170|NCT03108924|19984307|P3|STARTED|Overall Study||6
8108171|NCT03108924|19984308|P2|STARTED|Overall Study||6
8108172|NCT03108924|19984309|P1|STARTED|Overall Study||6
8108173|NCT03108521|19984405|P2|NOT COMPLETED|Overall Study||0
8108174|NCT03108521|19984406|P1|NOT COMPLETED|Overall Study||12
8108175|NCT03108521|19984405|P2|COMPLETED|Overall Study||36
8108176|NCT03108521|19984406|P1|COMPLETED|Overall Study||71
8108177|NCT03108521|19984405|P2|STARTED|Overall Study||36
8108178|NCT03108521|19984406|P1|STARTED|Overall Study||83
8108179|NCT03108482|19984420|P4|NOT COMPLETED|Overall Study||3
8108180|NCT03108482|19984421|P3|NOT COMPLETED|Overall Study||2
8108181|NCT03108482|19984422|P2|NOT COMPLETED|Overall Study||4
8108182|NCT03108482|19984423|P1|NOT COMPLETED|Overall Study||0
8108183|NCT03108482|19984420|P4|COMPLETED|Overall Study||86
8108184|NCT03108482|19984421|P3|COMPLETED|Overall Study||180
8108185|NCT03108482|19984422|P2|COMPLETED|Overall Study||179
8108186|NCT03108482|19984423|P1|COMPLETED|Overall Study||183
8108187|NCT03108482|19984420|P4|STARTED|Overall Study||89
8108188|NCT03108482|19984421|P3|STARTED|Overall Study||182
8108189|NCT03108482|19984422|P2|STARTED|Overall Study||183
8108190|NCT03108482|19984423|P1|STARTED|Overall Study||183
8108191|NCT03108469|19984435|P2|NOT COMPLETED|Overall Study||4
8108192|NCT03108469|19984436|P1|NOT COMPLETED|Overall Study||4
8108193|NCT03108469|19984435|P2|COMPLETED|Overall Study||11
8108194|NCT03108469|19984436|P1|COMPLETED|Overall Study||11
8108195|NCT03108469|19984435|P2|STARTED|Overall Study||15
8108196|NCT03108469|19984436|P1|STARTED|Overall Study||15
8108197|NCT03108157|19984458|P2|NOT COMPLETED|Overall Study||4
8108198|NCT03108157|19984459|P1|NOT COMPLETED|Overall Study||15
8108199|NCT03108157|19984458|P2|COMPLETED|Overall Study||172
8108200|NCT03108157|19984459|P1|COMPLETED|Overall Study||161
8108201|NCT03108157|19984458|P2|STARTED|Overall Study||176
8108202|NCT03108157|19984459|P1|STARTED|Overall Study||176
8108203|NCT03108027|19984469|P6|NOT COMPLETED|Period 3||0
8108204|NCT03108027|19984470|P5|NOT COMPLETED|Period 3||0
8108205|NCT03108027|19984471|P4|NOT COMPLETED|Period 3||0
8108206|NCT03108027|19984472|P3|NOT COMPLETED|Period 3||0
8108207|NCT03108027|19984473|P2|NOT COMPLETED|Period 3||1
8108208|NCT03108027|19984474|P1|NOT COMPLETED|Period 3||0
8108209|NCT03108027|19984469|P6|COMPLETED|Period 3||6
8108210|NCT03108027|19984470|P5|COMPLETED|Period 3||6
8108211|NCT03108027|19984471|P4|COMPLETED|Period 3||4
8108212|NCT03108027|19984472|P3|COMPLETED|Period 3||6
8108213|NCT03108027|19984473|P2|COMPLETED|Period 3||5
8108214|NCT03108027|19984474|P1|COMPLETED|Period 3||7
8108215|NCT03108027|19984469|P6|STARTED|Period 3||6
8108216|NCT03108027|19984470|P5|STARTED|Period 3||6
8108217|NCT03108027|19984471|P4|STARTED|Period 3||4
8108218|NCT03108027|19984472|P3|STARTED|Period 3||6
8108219|NCT03108027|19984473|P2|STARTED|Period 3||6
8108220|NCT03108027|19984474|P1|STARTED|Period 3||7
8108221|NCT03108027|19984469|P6|NOT COMPLETED|Period 2||0
8108222|NCT03108027|19984470|P5|NOT COMPLETED|Period 2||0
8108223|NCT03108027|19984471|P4|NOT COMPLETED|Period 2||0
8108224|NCT03108027|19984472|P3|NOT COMPLETED|Period 2||0
8108225|NCT03108027|19984473|P2|NOT COMPLETED|Period 2||0
8108226|NCT03108027|19984474|P1|NOT COMPLETED|Period 2||0
8108227|NCT03108027|19984469|P6|COMPLETED|Period 2||6
8108228|NCT03108027|19984470|P5|COMPLETED|Period 2||6
8108229|NCT03108027|19984471|P4|COMPLETED|Period 2||4
8108230|NCT03108027|19984472|P3|COMPLETED|Period 2||6
8108231|NCT03108027|19984473|P2|COMPLETED|Period 2||6
8108232|NCT03108027|19984474|P1|COMPLETED|Period 2||7
8108233|NCT03108027|19984469|P6|STARTED|Period 2||6
8108234|NCT03108027|19984470|P5|STARTED|Period 2||6
8108235|NCT03108027|19984471|P4|STARTED|Period 2||4
8108236|NCT03108027|19984472|P3|STARTED|Period 2||6
8108237|NCT03108027|19984473|P2|STARTED|Period 2||6
8108238|NCT03108027|19984474|P1|STARTED|Period 2||7
8108239|NCT03108027|19984469|P6|NOT COMPLETED|Period 1||0
8108240|NCT03108027|19984470|P5|NOT COMPLETED|Period 1||0
8108241|NCT03108027|19984471|P4|NOT COMPLETED|Period 1||2
8108242|NCT03108027|19984472|P3|NOT COMPLETED|Period 1||0
8108243|NCT03108027|19984473|P2|NOT COMPLETED|Period 1||0
8108244|NCT03108027|19984474|P1|NOT COMPLETED|Period 1||0
8108245|NCT03108027|19984469|P6|COMPLETED|Period 1||6
8108246|NCT03108027|19984470|P5|COMPLETED|Period 1||6
8108247|NCT03108027|19984471|P4|COMPLETED|Period 1||4
8108248|NCT03108027|19984472|P3|COMPLETED|Period 1||6
8108249|NCT03108027|19984473|P2|COMPLETED|Period 1||6
8108250|NCT03108027|19984474|P1|COMPLETED|Period 1||7
8108251|NCT03108027|19984469|P6|STARTED|Period 1||6
8108252|NCT03108027|19984470|P5|STARTED|Period 1||6
8108253|NCT03108027|19984471|P4|STARTED|Period 1||6
8108254|NCT03108027|19984472|P3|STARTED|Period 1||6
8108255|NCT03108027|19984473|P2|STARTED|Period 1||6
8108256|NCT03108027|19984474|P1|STARTED|Period 1||7
8108257|NCT03107754|19984490|P2|NOT COMPLETED|Overall Study||0
8108258|NCT03107754|19984491|P1|NOT COMPLETED|Overall Study||0
8108259|NCT03107754|19984490|P2|COMPLETED|Overall Study||50
8108260|NCT03107754|19984491|P1|COMPLETED|Overall Study||48
8108261|NCT03107754|19984490|P2|STARTED|Overall Study||50
8108262|NCT03107754|19984491|P1|STARTED|Overall Study||48
8108263|NCT03107715|19984501|P2|NOT COMPLETED|Overall Study||7
8108264|NCT03107715|19984502|P1|NOT COMPLETED|Overall Study||4
8108265|NCT03107715|19984501|P2|COMPLETED|Overall Study||104
8108266|NCT03107715|19984502|P1|COMPLETED|Overall Study||128
8108267|NCT03107715|19984501|P2|STARTED|Overall Study||111
8108268|NCT03107715|19984502|P1|STARTED|Overall Study||132
8108269|NCT03107611|19984517|P3|NOT COMPLETED|Overall Study||9
8108270|NCT03107611|19984518|P2|NOT COMPLETED|Overall Study||4
8108271|NCT03107611|19984519|P1|NOT COMPLETED|Overall Study||7
8108272|NCT03107611|19984517|P3|COMPLETED|Overall Study||212
8108273|NCT03107611|19984518|P2|COMPLETED|Overall Study||212
8108274|NCT03107611|19984519|P1|COMPLETED|Overall Study||210
8108275|NCT03107611|19984517|P3|Dosed|Overall Study||220
8108276|NCT03107611|19984518|P2|Dosed|Overall Study||214
8108277|NCT03107611|19984519|P1|Dosed|Overall Study||215
8108278|NCT03107611|19984517|P3|STARTED|Overall Study||221
8108279|NCT03107611|19984518|P2|STARTED|Overall Study||216
8108280|NCT03107611|19984519|P1|STARTED|Overall Study||217
8108281|NCT03107377|19984538|P2|NOT COMPLETED|Overall Study||99
8108282|NCT03107377|19984539|P1|NOT COMPLETED|Overall Study||91
8108283|NCT03107377|19984538|P2|COMPLETED|Overall Study||335
8108284|NCT03107377|19984539|P1|COMPLETED|Overall Study||335
8108285|NCT03107377|19984538|P2|STARTED|Overall Study||434
8108286|NCT03107377|19984539|P1|STARTED|Overall Study||426
8108287|NCT03107052|19984564|P3|NOT COMPLETED|Overall Study||41
8108288|NCT03107052|19984565|P2|NOT COMPLETED|Overall Study||46
8108289|NCT03107052|19984566|P1|NOT COMPLETED|Overall Study||119
8108290|NCT03107052|19984564|P3|COMPLETED|Overall Study||29
8108291|NCT03107052|19984565|P2|COMPLETED|Overall Study||14
8108292|NCT03107052|19984566|P1|COMPLETED|Overall Study||26
8108293|NCT03107052|19984564|P3|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
8108294|NCT03107052|19984565|P2|Safety Analysis Set|Overall Study||60
8108295|NCT03107052|19984566|P1|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
8108296|NCT03107052|19984564|P3|STARTED|Overall Study||70
8108297|NCT03107052|19984565|P2|STARTED|Overall Study||60
8108298|NCT03107052|19984566|P1|STARTED|Overall Study||145
8108299|NCT03107026|19984610|P3|NOT COMPLETED|Overall Study||56
8108300|NCT03107026|19984611|P2|NOT COMPLETED|Overall Study||38
8108301|NCT03107026|19984612|P1|NOT COMPLETED|Overall Study||32
8108302|NCT03107026|19984610|P3|COMPLETED|Overall Study||106
8108303|NCT03107026|19984611|P2|COMPLETED|Overall Study||123
8108304|NCT03107026|19984612|P1|COMPLETED|Overall Study||131
8108305|NCT03107026|19984610|P3|STARTED|Overall Study||162
8108306|NCT03107026|19984611|P2|STARTED|Overall Study||161
8108307|NCT03107026|19984612|P1|STARTED|Overall Study||163
8108308|NCT03106870|19984661|P2|NOT COMPLETED|Overall Study||0
8108309|NCT03106870|19984662|P1|NOT COMPLETED|Overall Study||0
8108310|NCT03106870|19984661|P2|COMPLETED|Overall Study||31
8108311|NCT03106870|19984662|P1|COMPLETED|Overall Study||31
8108312|NCT03106870|19984661|P2|STARTED|Overall Study||31
8108313|NCT03106870|19984662|P1|STARTED|Overall Study||31
8108317|NCT03106753|19984679|P2|NOT COMPLETED|Overall Study||1
8108318|NCT03106753|19984680|P1|NOT COMPLETED|Overall Study||0
8108319|NCT03106753|19984679|P2|COMPLETED|Overall Study||16
8108320|NCT03106753|19984680|P1|COMPLETED|Overall Study||17
8108321|NCT03106753|19984679|P2|STARTED|Overall Study||17
8108322|NCT03106753|19984680|P1|STARTED|Overall Study||17
8108323|NCT03106636|19984704|P2|NOT COMPLETED|Overall Study||26
8108324|NCT03106636|19984705|P1|NOT COMPLETED|Overall Study||44
8108325|NCT03106636|19984704|P2|COMPLETED|Overall Study||164
8108326|NCT03106636|19984705|P1|COMPLETED|Overall Study||182
8108327|NCT03106636|19984704|P2|STARTED|Overall Study||190
8108328|NCT03106636|19984705|P1|STARTED|Overall Study||226
8108329|NCT03106337|19984741|P1|NOT COMPLETED|Overall Study||0
8108330|NCT03106337|19984741|P1|COMPLETED|Overall Study||35
8108331|NCT03106337|19984741|P1|STARTED|Overall Study||35
8108332|NCT03106077|19984746|P2|NOT COMPLETED|Overall Study||0
8108333|NCT03106077|19984747|P1|NOT COMPLETED|Overall Study||94
8108334|NCT03106077|19984746|P2|COMPLETED|Overall Study||0
8108335|NCT03106077|19984747|P1|COMPLETED|Overall Study||2
8108336|NCT03106077|19984746|P2|STARTED|Overall Study||0
8108337|NCT03106077|19984747|P1|STARTED|Overall Study||96
8108338|NCT03105518|19984757|P1|NOT COMPLETED|Overall Study||0
8108339|NCT03105518|19984757|P1|COMPLETED|Overall Study||100
8108340|NCT03105518|19984757|P1|STARTED|Overall Study||100
8108341|NCT03105479|19984762|P7|NOT COMPLETED|Overall Study||0
8108342|NCT03105479|19984763|P6|NOT COMPLETED|Overall Study||0
8108343|NCT03105479|19984764|P5|NOT COMPLETED|Overall Study||0
8108344|NCT03105479|19984765|P4|NOT COMPLETED|Overall Study||0
8108345|NCT03105479|19984766|P3|NOT COMPLETED|Overall Study||0
8108346|NCT03105479|19984767|P2|NOT COMPLETED|Overall Study||0
8108347|NCT03105479|19984768|P1|NOT COMPLETED|Overall Study||0
8108348|NCT03105479|19984762|P7|COMPLETED|Overall Study||0
8108349|NCT03105479|19984763|P6|COMPLETED|Overall Study||0
8108350|NCT03105479|19984764|P5|COMPLETED|Overall Study||0
8108351|NCT03105479|19984765|P4|COMPLETED|Overall Study||0
8108352|NCT03105479|19984766|P3|COMPLETED|Overall Study||0
8108353|NCT03105479|19984767|P2|COMPLETED|Overall Study||0
8108354|NCT03105479|19984768|P1|COMPLETED|Overall Study||1
8108355|NCT03105479|19984762|P7|STARTED|Overall Study||0
8108356|NCT03105479|19984763|P6|STARTED|Overall Study||0
8108357|NCT03105479|19984764|P5|STARTED|Overall Study||0
8108358|NCT03105479|19984765|P4|STARTED|Overall Study||0
8108359|NCT03105479|19984766|P3|STARTED|Overall Study||0
8108360|NCT03105479|19984767|P2|STARTED|Overall Study||0
8108361|NCT03105479|19984768|P1|STARTED|Overall Study||1
8108362|NCT03105362|19984791|P1|NOT COMPLETED|Overall Study||2
8108363|NCT03105362|19984791|P1|COMPLETED|Overall Study||2
8108364|NCT03105362|19984791|P1|Completed 2 Week Questionaire|Overall Study||2
8108365|NCT03105362|19984791|P1|Completed 2 Weeks of Study|Overall Study||3
8108366|NCT03105362|19984791|P1|Completed 1 Week of Study|Overall Study||4
8108367|NCT03105362|19984791|P1|STARTED|Overall Study||4
8108368|NCT03105297|19984798|P1|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
8108369|NCT03105297|19984798|P1|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
8108370|NCT03105297|19984798|P1|Treated|Nasal Resistance Phase (Day 30, 31)||55
8108371|NCT03105297|19984798|P1|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
8108372|NCT03105297|19984798|P1|NOT COMPLETED|Active Phase (Day 2-29)||0
8108373|NCT03105297|19984798|P1|COMPLETED|Active Phase (Day 2-29)||70
8108374|NCT03105297|19984798|P1|STARTED|Active Phase (Day 2-29)||70
8108375|NCT03105297|19984798|P1|NOT COMPLETED|Baseline Phase (Day 1)||21
8108376|NCT03105297|19984798|P1|COMPLETED|Baseline Phase (Day 1)||70
8108377|NCT03105297|19984798|P1|STARTED|Baseline Phase (Day 1)||91
8108378|NCT03104985|19984832|P2|NOT COMPLETED|Overall Study||0
8108379|NCT03104985|19984833|P1|NOT COMPLETED|Overall Study||0
8108380|NCT03104985|19984832|P2|COMPLETED|Overall Study||34
8108381|NCT03104985|19984833|P1|COMPLETED|Overall Study||34
8108382|NCT03104985|19984832|P2|STARTED|Overall Study||34
8108383|NCT03104985|19984833|P1|STARTED|Overall Study||34
8108384|NCT03104816|19984842|P3|NOT COMPLETED|Overall Study||2
8108385|NCT03104816|19984843|P2|NOT COMPLETED|Overall Study||2
8108386|NCT03104816|19984844|P1|NOT COMPLETED|Overall Study||2
8108387|NCT03104816|19984842|P3|COMPLETED|Overall Study||4
8108388|NCT03104816|19984843|P2|COMPLETED|Overall Study||9
8108389|NCT03104816|19984844|P1|COMPLETED|Overall Study||9
8108390|NCT03104816|19984842|P3|STARTED|Overall Study||6
8108391|NCT03104816|19984843|P2|STARTED|Overall Study||11
8108392|NCT03104816|19984844|P1|STARTED|Overall Study||11
8108393|NCT03104738|19984854|P2|NOT COMPLETED|Overall Study||0
8108394|NCT03104738|19984855|P1|NOT COMPLETED|Overall Study||0
8108395|NCT03104738|19984854|P2|COMPLETED|Overall Study||20
8108396|NCT03104738|19984855|P1|COMPLETED|Overall Study||20
8108397|NCT03104738|19984854|P2|STARTED|Overall Study||20
8108398|NCT03104738|19984855|P1|STARTED|Overall Study||20
8108399|NCT03104647|19984881|P1|NOT COMPLETED|Overall Study||0
8108400|NCT03104647|19984881|P1|COMPLETED|Overall Study||20
8108401|NCT03104647|19984881|P1|STARTED|Overall Study||20
8108402|NCT03104322|19984886|P1|NOT COMPLETED|Overall Study||1
8108403|NCT03104322|19984886|P1|COMPLETED|Overall Study||6
8108404|NCT03104322|19984886|P1|STARTED|Overall Study||7
8108405|NCT03104192|19984898|P4|NOT COMPLETED|Overall Study||3
8108406|NCT03104192|19984899|P3|NOT COMPLETED|Overall Study||2
8108407|NCT03104192|19984900|P2|NOT COMPLETED|Overall Study||4
8108408|NCT03104192|19984901|P1|NOT COMPLETED|Overall Study||0
8108409|NCT03104192|19984898|P4|COMPLETED|Overall Study||14
8108410|NCT03104192|19984899|P3|COMPLETED|Overall Study||14
8108411|NCT03104192|19984900|P2|COMPLETED|Overall Study||23
8108412|NCT03104192|19984901|P1|COMPLETED|Overall Study||9
8108413|NCT03104192|19984898|P4|STARTED|Overall Study||17
8108414|NCT03104192|19984899|P3|STARTED|Overall Study||16
8108415|NCT03104192|19984900|P2|STARTED|Overall Study||27
8108416|NCT03104192|19984901|P1|STARTED|Overall Study||9
8108417|NCT03103919|19984952|P2|NOT COMPLETED|Overall Study||2
8108418|NCT03103919|19984953|P1|NOT COMPLETED|Overall Study||2
8108419|NCT03103919|19984952|P2|COMPLETED|Overall Study||17
8108420|NCT03103919|19984953|P1|COMPLETED|Overall Study||18
8108421|NCT03103919|19984952|P2|STARTED|Overall Study||19
8108422|NCT03103919|19984953|P1|STARTED|Overall Study||20
8108423|NCT03103906|19984989|P2|NOT COMPLETED|Overall Study||3
8108424|NCT03103906|19984990|P1|NOT COMPLETED|Overall Study||4
8108425|NCT03103906|19984989|P2|COMPLETED|Overall Study||39
8108426|NCT03103906|19984990|P1|COMPLETED|Overall Study||36
8108427|NCT03103906|19984989|P2|STARTED|Overall Study||42
8108428|NCT03103906|19984990|P1|STARTED|Overall Study||40
8108429|NCT03103763|19985013|P3|NOT COMPLETED|Overall Study||7
8108430|NCT03103763|19985014|P2|NOT COMPLETED|Overall Study||8
8108431|NCT03103763|19985015|P1|NOT COMPLETED|Overall Study||15
8108432|NCT03103763|19985013|P3|COMPLETED|Overall Study||37
8108433|NCT03103763|19985014|P2|COMPLETED|Overall Study||36
8108434|NCT03103763|19985015|P1|COMPLETED|Overall Study||29
8108435|NCT03103763|19985013|P3|STARTED|Overall Study||44
8108436|NCT03103763|19985014|P2|STARTED|Overall Study||44
8108437|NCT03103763|19985015|P1|STARTED|Overall Study||44
8108438|NCT03103503|19985044|P1|NOT COMPLETED|Overall Study||901
8108439|NCT03103503|19985044|P1|COMPLETED|Overall Study||0
8108440|NCT03103503|19985044|P1|STARTED|Overall Study||901
8108441|NCT03103282|19985054|P1|NOT COMPLETED|Overall Study||0
8108442|NCT03103282|19985054|P1|COMPLETED|Overall Study||65
8108443|NCT03103282|19985054|P1|STARTED|Overall Study||65
8108444|NCT03103100|19985069|P3|NOT COMPLETED|Overall Study||2
8108445|NCT03103100|19985070|P2|NOT COMPLETED|Overall Study||0
8108446|NCT03103100|19985071|P1|NOT COMPLETED|Overall Study||2
8108447|NCT03103100|19985069|P3|COMPLETED|Overall Study||23
8108448|NCT03103100|19985070|P2|COMPLETED|Overall Study||25
8108449|NCT03103100|19985071|P1|COMPLETED|Overall Study||23
8108450|NCT03103100|19985069|P3|STARTED|Overall Study||25
8108451|NCT03103100|19985070|P2|STARTED|Overall Study||25
8108452|NCT03103100|19985071|P1|STARTED|Overall Study||25
8108453|NCT03103061|19985088|P1|NOT COMPLETED|Overall Study||0
8108454|NCT03103061|19985088|P1|COMPLETED|Overall Study||24
8108455|NCT03103061|19985088|P1|STARTED|Overall Study||24
8108456|NCT03102918|19985095|P2|NOT COMPLETED|Overall Study||0
8108457|NCT03102918|19985096|P1|NOT COMPLETED|Overall Study||1
8108458|NCT03102918|19985095|P2|COMPLETED|Overall Study||5
8108459|NCT03102918|19985096|P1|COMPLETED|Overall Study||4
8108460|NCT03102918|19985095|P2|STARTED|Overall Study||5
8108461|NCT03102918|19985096|P1|STARTED|Overall Study||5
8108462|NCT03102879|19985104|P2|NOT COMPLETED|Overall Study||0
8108463|NCT03102879|19985105|P1|NOT COMPLETED|Overall Study||0
8108464|NCT03102879|19985104|P2|COMPLETED|Overall Study||18
8108465|NCT03102879|19985105|P1|COMPLETED|Overall Study||18
8108466|NCT03102879|19985104|P2|STARTED|Overall Study||18
8108467|NCT03102879|19985105|P1|STARTED|Overall Study||18
8108468|NCT03102762|19985122|P2|NOT COMPLETED|Overall Study||0
8108469|NCT03102762|19985123|P1|NOT COMPLETED|Overall Study||1
8108470|NCT03102762|19985122|P2|COMPLETED|Overall Study||35
8108471|NCT03102762|19985123|P1|COMPLETED|Overall Study||34
8108472|NCT03102762|19985122|P2|STARTED|Overall Study||35
8108473|NCT03102762|19985123|P1|STARTED|Overall Study||35
8108474|NCT03102736|19985151|P2|NOT COMPLETED|Overall Study||0
8108475|NCT03102736|19985152|P1|NOT COMPLETED|Overall Study||0
8108476|NCT03102736|19985151|P2|COMPLETED|Overall Study||9
8108477|NCT03102736|19985152|P1|COMPLETED|Overall Study||7
8108478|NCT03102736|19985151|P2|STARTED|Overall Study||9
8108479|NCT03102736|19985152|P1|STARTED|Overall Study||7
8108480|NCT03102710|19985167|P3|NOT COMPLETED|Overall Study||0
8108481|NCT03102710|19985168|P2|NOT COMPLETED|Overall Study||3
8108482|NCT03102710|19985169|P1|NOT COMPLETED|Overall Study||1
8108483|NCT03102710|19985167|P3|COMPLETED|Overall Study||27
8108484|NCT03102710|19985168|P2|COMPLETED|Overall Study||27
8108485|NCT03102710|19985169|P1|COMPLETED|Overall Study||27
8108486|NCT03102710|19985167|P3|STARTED|Overall Study||27
8108487|NCT03102710|19985168|P2|STARTED|Overall Study||30
8108488|NCT03102710|19985169|P1|STARTED|Overall Study||28
8108489|NCT03102411|19985183|P1|NOT COMPLETED|Overall Study||163
8108490|NCT03102411|19985183|P1|COMPLETED|Overall Study||1718
8108491|NCT03102411|19985183|P1|STARTED|Overall Study||1881
8108492|NCT03102190|19985188|P1|NOT COMPLETED|Overall Study||0
8108493|NCT03102190|19985188|P1|COMPLETED|Overall Study||6
8108494|NCT03102190|19985188|P1|STARTED|Overall Study||6
8108495|NCT03102034|19985194|P2|NOT COMPLETED|Overall Study||0
8108496|NCT03102034|19985195|P1|NOT COMPLETED|Overall Study||1
8108497|NCT03102034|19985194|P2|COMPLETED|Overall Study||11
8108498|NCT03102034|19985195|P1|COMPLETED|Overall Study||20
8108499|NCT03102034|19985194|P2|STARTED|Overall Study||11
8108500|NCT03102034|19985195|P1|STARTED|Overall Study||21
8108501|NCT03101592|19985224|P3|NOT COMPLETED|Overall Study||118
8108502|NCT03101592|19985225|P2|NOT COMPLETED|Overall Study||170
8108503|NCT03101592|19985226|P1|NOT COMPLETED|Overall Study||111
8108504|NCT03101592|19985224|P3|COMPLETED|Overall Study||2981
8108505|NCT03101592|19985225|P2|COMPLETED|Overall Study||2726
8108506|NCT03101592|19985226|P1|COMPLETED|Overall Study||3012
8108507|NCT03101592|19985224|P3|STARTED|Overall Study||3099
8108508|NCT03101592|19985225|P2|STARTED|Overall Study||2896
8108509|NCT03101592|19985226|P1|STARTED|Overall Study||3123
8108510|NCT03101462|19985245|P2|NOT COMPLETED|Overall Study||1
8108511|NCT03101462|19985246|P1|NOT COMPLETED|Overall Study||1
8108512|NCT03101462|19985245|P2|COMPLETED|Overall Study||18
8108513|NCT03101462|19985246|P1|COMPLETED|Overall Study||18
8108514|NCT03101462|19985245|P2|STARTED|Overall Study||19
8108515|NCT03101462|19985246|P1|STARTED|Overall Study||19
8108516|NCT03101371|19985262|P2|NOT COMPLETED|Overall Study||6
8108517|NCT03101371|19985263|P1|NOT COMPLETED|Overall Study||3
8108518|NCT03101371|19985262|P2|COMPLETED|Overall Study||45
8108519|NCT03101371|19985263|P1|COMPLETED|Overall Study||45
8108520|NCT03101371|19985262|P2|STARTED|Overall Study||51
8108521|NCT03101371|19985263|P1|STARTED|Overall Study||48
8108522|NCT03101293|19985283|P2|NOT COMPLETED|Intervention Period 2||0
8108523|NCT03101293|19985284|P1|NOT COMPLETED|Intervention Period 2||0
8108524|NCT03101293|19985283|P2|COMPLETED|Intervention Period 2||8
8108525|NCT03101293|19985284|P1|COMPLETED|Intervention Period 2||6
8108526|NCT03101293|19985283|P2|STARTED|Intervention Period 2||8
8108527|NCT03101293|19985284|P1|STARTED|Intervention Period 2||6
8108528|NCT03101293|19985283|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8108529|NCT03101293|19985284|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||1
8108530|NCT03101293|19985283|P2|COMPLETED|Washout Period (at Least 7 Days)||8
8108531|NCT03101293|19985284|P1|COMPLETED|Washout Period (at Least 7 Days)||6
8108532|NCT03101293|19985283|P2|STARTED|Washout Period (at Least 7 Days)||8
8108533|NCT03101293|19985284|P1|STARTED|Washout Period (at Least 7 Days)||7
8108534|NCT03101293|19985283|P2|NOT COMPLETED|Intervention Period 1||0
8108535|NCT03101293|19985284|P1|NOT COMPLETED|Intervention Period 1||0
8108536|NCT03101293|19985283|P2|COMPLETED|Intervention Period 1||8
8108537|NCT03101293|19985284|P1|COMPLETED|Intervention Period 1||7
8108538|NCT03101293|19985283|P2|STARTED|Intervention Period 1||8
8108539|NCT03101293|19985284|P1|STARTED|Intervention Period 1||7
8108540|NCT03101267|19985299|P3|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
8108541|NCT03101267|19985300|P2|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
8108542|NCT03101267|19985301|P1|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
8108543|NCT03101267|19985299|P3|COMPLETED|Pollinosis Symptoms Survey Period||47
8108544|NCT03101267|19985300|P2|COMPLETED|Pollinosis Symptoms Survey Period||48
8108545|NCT03101267|19985301|P1|COMPLETED|Pollinosis Symptoms Survey Period||47
8108546|NCT03101267|19985299|P3|STARTED|Pollinosis Symptoms Survey Period||47
8108547|NCT03101267|19985300|P2|STARTED|Pollinosis Symptoms Survey Period||48
8108548|NCT03101267|19985301|P1|STARTED|Pollinosis Symptoms Survey Period||47
8108549|NCT03101267|19985299|P3|NOT COMPLETED|Primary Study Period||3
8108550|NCT03101267|19985300|P2|NOT COMPLETED|Primary Study Period||2
8108551|NCT03101267|19985301|P1|NOT COMPLETED|Primary Study Period||3
8108552|NCT03101267|19985299|P3|COMPLETED|Primary Study Period||47
8108553|NCT03101267|19985300|P2|COMPLETED|Primary Study Period||48
8108554|NCT03101267|19985301|P1|COMPLETED|Primary Study Period||47
8108555|NCT03101267|19985299|P3|STARTED|Primary Study Period||50
8108556|NCT03101267|19985300|P2|STARTED|Primary Study Period||50
8108557|NCT03101267|19985301|P1|STARTED|Primary Study Period||50
8108558|NCT03101150|19985356|P2|NOT COMPLETED|Overall Study||10
8108559|NCT03101150|19985357|P1|NOT COMPLETED|Overall Study||5
8108560|NCT03101150|19985356|P2|COMPLETED|Overall Study||83
8108561|NCT03101150|19985357|P1|COMPLETED|Overall Study||81
8108562|NCT03101150|19985356|P2|STARTED|Overall Study||93
8108563|NCT03101150|19985357|P1|STARTED|Overall Study||86
8108564|NCT03101033|19985369|P2|NOT COMPLETED|Overall Study||9
8108565|NCT03101033|19985370|P1|NOT COMPLETED|Overall Study||5
8108566|NCT03101033|19985369|P2|COMPLETED|Overall Study||51
8108567|NCT03101033|19985370|P1|COMPLETED|Overall Study||27
8108568|NCT03101033|19985369|P2|STARTED|Overall Study||60
8108569|NCT03101033|19985370|P1|STARTED|Overall Study||32
8108570|NCT03101020|19985392|P2|NOT COMPLETED|Overall Study||3
8108571|NCT03101020|19985393|P1|NOT COMPLETED|Overall Study||1
8108572|NCT03101020|19985392|P2|COMPLETED|Overall Study||7
8108573|NCT03101020|19985393|P1|COMPLETED|Overall Study||9
8108574|NCT03101020|19985392|P2|STARTED|Overall Study||10
8108575|NCT03101020|19985393|P1|STARTED|Overall Study||10
8108576|NCT03100968|19985407|P2|NOT COMPLETED|Overall Study||0
8108577|NCT03100968|19985408|P1|NOT COMPLETED|Overall Study||0
8108578|NCT03100968|19985407|P2|COMPLETED|Overall Study||75
8108579|NCT03100968|19985408|P1|COMPLETED|Overall Study||75
8108580|NCT03100968|19985407|P2|STARTED|Overall Study||75
8108581|NCT03100968|19985408|P1|STARTED|Overall Study||75
8108582|NCT03100942|19985428|P7|NOT COMPLETED|Placebo Arm Re-Randomized||1
8108583|NCT03100942|19985429|P6|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108584|NCT03100942|19985430|P5|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108585|NCT03100942|19985431|P4|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108586|NCT03100942|19985432|P3|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108587|NCT03100942|19985433|P2|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108588|NCT03100942|19985434|P1|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108589|NCT03100942|19985428|P7|COMPLETED|Placebo Arm Re-Randomized||9
8108590|NCT03100942|19985429|P6|COMPLETED|Placebo Arm Re-Randomized||12
8108591|NCT03100942|19985430|P5|COMPLETED|Placebo Arm Re-Randomized||10
8108592|NCT03100942|19985431|P4|COMPLETED|Placebo Arm Re-Randomized||0
8108593|NCT03100942|19985432|P3|COMPLETED|Placebo Arm Re-Randomized||0
8108594|NCT03100942|19985433|P2|COMPLETED|Placebo Arm Re-Randomized||0
8108595|NCT03100942|19985434|P1|COMPLETED|Placebo Arm Re-Randomized||0
8108596|NCT03100942|19985428|P7|STARTED|Placebo Arm Re-Randomized||10
8108597|NCT03100942|19985429|P6|STARTED|Placebo Arm Re-Randomized||12
8108598|NCT03100942|19985430|P5|STARTED|Placebo Arm Re-Randomized||10
8108599|NCT03100942|19985431|P4|STARTED|Placebo Arm Re-Randomized||0
8108600|NCT03100942|19985432|P3|STARTED|Placebo Arm Re-Randomized||0
8108601|NCT03100942|19985433|P2|STARTED|Placebo Arm Re-Randomized||0
8108602|NCT03100942|19985434|P1|STARTED|Placebo Arm Re-Randomized||0
8108603|NCT03100942|19985428|P7|NOT COMPLETED|Randomized Treatment Period||0
8108604|NCT03100942|19985429|P6|NOT COMPLETED|Randomized Treatment Period||0
8108605|NCT03100942|19985430|P5|NOT COMPLETED|Randomized Treatment Period||0
8108606|NCT03100942|19985431|P4|NOT COMPLETED|Randomized Treatment Period||5
8108607|NCT03100942|19985432|P3|NOT COMPLETED|Randomized Treatment Period||6
8108608|NCT03100942|19985433|P2|NOT COMPLETED|Randomized Treatment Period||9
8108609|NCT03100942|19985434|P1|NOT COMPLETED|Randomized Treatment Period||12
8108610|NCT03100942|19985428|P7|COMPLETED|Randomized Treatment Period||0
8108611|NCT03100942|19985429|P6|COMPLETED|Randomized Treatment Period||0
8108612|NCT03100942|19985430|P5|COMPLETED|Randomized Treatment Period||0
8108613|NCT03100942|19985431|P4|COMPLETED|Randomized Treatment Period||32
8108614|NCT03100942|19985432|P3|COMPLETED|Randomized Treatment Period||33
8108615|NCT03100942|19985433|P2|COMPLETED|Randomized Treatment Period||29
8108616|NCT03100942|19985434|P1|COMPLETED|Randomized Treatment Period||26
8108617|NCT03100942|19985428|P7|STARTED|Randomized Treatment Period||0
8108618|NCT03100942|19985429|P6|STARTED|Randomized Treatment Period||0
8108619|NCT03100942|19985430|P5|STARTED|Randomized Treatment Period||0
8108620|NCT03100942|19985431|P4|STARTED|Randomized Treatment Period||37
8108621|NCT03100942|19985432|P3|STARTED|Randomized Treatment Period||39
8108622|NCT03100942|19985433|P2|STARTED|Randomized Treatment Period||38
8108623|NCT03100942|19985434|P1|STARTED|Randomized Treatment Period||38
8108624|NCT03100864|19985463|P1|NOT COMPLETED|Overall Study||0
8108625|NCT03100864|19985463|P1|COMPLETED|Overall Study||8
8108626|NCT03100864|19985463|P1|STARTED|Overall Study||8
8108627|NCT03100838|19985472|P4|NOT COMPLETED|Overall Study||1
8108628|NCT03100838|19985473|P3|NOT COMPLETED|Overall Study||2
8108629|NCT03100838|19985474|P2|NOT COMPLETED|Overall Study||2
8108630|NCT03100838|19985475|P1|NOT COMPLETED|Overall Study||2
8108631|NCT03100838|19985472|P4|COMPLETED|Overall Study||15
8108632|NCT03100838|19985473|P3|COMPLETED|Overall Study||14
8108633|NCT03100838|19985474|P2|COMPLETED|Overall Study||14
8108634|NCT03100838|19985475|P1|COMPLETED|Overall Study||14
8108635|NCT03100838|19985472|P4|STARTED|Overall Study||16
8108636|NCT03100838|19985473|P3|STARTED|Overall Study||16
8108637|NCT03100838|19985474|P2|STARTED|Overall Study||16
8108638|NCT03100838|19985475|P1|STARTED|Overall Study||16
8108639|NCT03100825|19985501|P1|NOT COMPLETED|Overall Study||8
8108640|NCT03100825|19985501|P1|COMPLETED|Overall Study||86
8108641|NCT03100825|19985501|P1|STARTED|Overall Study||94
8108642|NCT03100617|19985511|P1|NOT COMPLETED|Overall Study||0
8108643|NCT03100617|19985511|P1|COMPLETED|Overall Study||6
8108644|NCT03100617|19985511|P1|STARTED|Overall Study||6
8108645|NCT03100500|19985515|P1|NOT COMPLETED|Overall Study||0
8108646|NCT03100500|19985515|P1|COMPLETED|Overall Study||51
8108647|NCT03100500|19985515|P1|STARTED|Overall Study||51
8108648|NCT03100344|19985528|P4|NOT COMPLETED|Overall Study||12
8108649|NCT03100344|19985529|P3|NOT COMPLETED|Overall Study||7
8108650|NCT03100344|19985530|P2|NOT COMPLETED|Overall Study||11
8108651|NCT03100344|19985531|P1|NOT COMPLETED|Overall Study||14
8108652|NCT03100344|19985528|P4|COMPLETED|Overall Study||45
8108653|NCT03100344|19985529|P3|COMPLETED|Overall Study||50
8108654|NCT03100344|19985530|P2|COMPLETED|Overall Study||44
8108655|NCT03100344|19985531|P1|COMPLETED|Overall Study||43
8108656|NCT03100344|19985528|P4|STARTED|Overall Study||57
8108657|NCT03100344|19985529|P3|STARTED|Overall Study||57
8108658|NCT03100344|19985530|P2|STARTED|Overall Study||55
8108659|NCT03100344|19985531|P1|STARTED|Overall Study||57
8108660|NCT03100123|19985611|P2|NOT COMPLETED|Overall Study||0
8108661|NCT03100123|19985612|P1|NOT COMPLETED|Overall Study||0
8108662|NCT03100123|19985611|P2|COMPLETED|Overall Study||1
8108663|NCT03100123|19985612|P1|COMPLETED|Overall Study||0
8108664|NCT03100123|19985611|P2|STARTED|Overall Study||1
8108665|NCT03100123|19985612|P1|STARTED|Overall Study||0
8108666|NCT03100058|19985634|P13|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
8108667|NCT03100058|19985635|P12|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
8108668|NCT03100058|19985636|P11|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
8108669|NCT03100058|19985637|P10|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
8108670|NCT03100058|19985638|P9|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108671|NCT03100058|19985639|P8|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108672|NCT03100058|19985640|P7|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108673|NCT03100058|19985641|P6|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108674|NCT03100058|19985642|P5|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108675|NCT03100058|19985643|P4|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108676|NCT03100058|19985644|P3|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108677|NCT03100058|19985645|P2|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108678|NCT03100058|19985646|P1|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108679|NCT03100058|19985634|P13|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
8108680|NCT03100058|19985635|P12|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
8108681|NCT03100058|19985636|P11|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
8108682|NCT03100058|19985637|P10|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
8108683|NCT03100058|19985638|P9|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108684|NCT03100058|19985639|P8|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108685|NCT03100058|19985640|P7|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108686|NCT03100058|19985641|P6|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108687|NCT03100058|19985642|P5|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108688|NCT03100058|19985643|P4|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108689|NCT03100058|19985644|P3|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108690|NCT03100058|19985645|P2|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108691|NCT03100058|19985646|P1|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108692|NCT03100058|19985634|P13|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
8108693|NCT03100058|19985635|P12|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
8108694|NCT03100058|19985636|P11|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
8108695|NCT03100058|19985637|P10|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
8108696|NCT03100058|19985638|P9|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108697|NCT03100058|19985639|P8|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108698|NCT03100058|19985640|P7|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108699|NCT03100058|19985641|P6|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108700|NCT03100058|19985642|P5|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108701|NCT03100058|19985643|P4|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108702|NCT03100058|19985644|P3|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108703|NCT03100058|19985645|P2|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108704|NCT03100058|19985646|P1|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108705|NCT03100058|19985634|P13|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108706|NCT03100058|19985635|P12|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108707|NCT03100058|19985636|P11|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108708|NCT03100058|19985637|P10|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108709|NCT03100058|19985638|P9|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
8108710|NCT03100058|19985639|P8|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
8108711|NCT03100058|19985640|P7|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
8108712|NCT03100058|19985641|P6|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
8108713|NCT03100058|19985642|P5|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
8108714|NCT03100058|19985643|P4|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
8108715|NCT03100058|19985644|P3|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
8108716|NCT03100058|19985645|P2|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
8108717|NCT03100058|19985646|P1|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
8108718|NCT03100058|19985634|P13|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108719|NCT03100058|19985635|P12|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108720|NCT03100058|19985636|P11|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108721|NCT03100058|19985637|P10|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108722|NCT03100058|19985638|P9|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
8108723|NCT03100058|19985639|P8|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
8108724|NCT03100058|19985640|P7|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
8108725|NCT03100058|19985641|P6|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
8108726|NCT03100058|19985642|P5|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
8108727|NCT03100058|19985643|P4|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
8108728|NCT03100058|19985644|P3|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
8108729|NCT03100058|19985645|P2|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
8108730|NCT03100058|19985646|P1|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
8108731|NCT03100058|19985634|P13|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108732|NCT03100058|19985635|P12|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108733|NCT03100058|19985636|P11|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108734|NCT03100058|19985637|P10|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108735|NCT03100058|19985638|P9|STARTED|Epoch 3 (24 Weeks of Treatment)||78
8108736|NCT03100058|19985639|P8|STARTED|Epoch 3 (24 Weeks of Treatment)||76
8108737|NCT03100058|19985640|P7|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108738|NCT03100058|19985641|P6|STARTED|Epoch 3 (24 Weeks of Treatment)||39
8108739|NCT03100058|19985642|P5|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108740|NCT03100058|19985643|P4|STARTED|Epoch 3 (24 Weeks of Treatment)||77
8108741|NCT03100058|19985644|P3|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108742|NCT03100058|19985645|P2|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108743|NCT03100058|19985646|P1|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108744|NCT03099694|19985853|P2|NOT COMPLETED|Overall Study||18
8108745|NCT03099694|19985854|P1|NOT COMPLETED|Overall Study||20
8108746|NCT03099694|19985853|P2|COMPLETED|Overall Study||152
8108747|NCT03099694|19985854|P1|COMPLETED|Overall Study||150
8108748|NCT03099694|19985853|P2|STARTED|Overall Study||170
8108749|NCT03099694|19985854|P1|STARTED|Overall Study||170
8108750|NCT03099655|19985882|P1|NOT COMPLETED|Overall Study||61
8108751|NCT03099655|19985882|P1|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
8108752|NCT03099655|19985882|P1|STARTED|Overall Study||440
8108753|NCT03099538|19985893|P1|NOT COMPLETED|Overall Study||3
8108754|NCT03099538|19985893|P1|COMPLETED|Overall Study||1
8108755|NCT03099538|19985893|P1|STARTED|Overall Study||4
8108756|NCT03099369|19985905|P2|NOT COMPLETED|Overall Study||4
8108757|NCT03099369|19985906|P1|NOT COMPLETED|Overall Study||6
8108758|NCT03099369|19985905|P2|COMPLETED|Overall Study||5
8108759|NCT03099369|19985906|P1|COMPLETED|Overall Study||5
8108760|NCT03099369|19985905|P2|STARTED|Overall Study||9
8108761|NCT03099369|19985906|P1|STARTED|Overall Study||11
8108762|NCT03099187|19985918|P4|NOT COMPLETED|12-month Safety Follow-up||26
8108763|NCT03099187|19985919|P3|NOT COMPLETED|12-month Safety Follow-up||19
8108764|NCT03099187|19985920|P2|NOT COMPLETED|12-month Safety Follow-up||0
8108765|NCT03099187|19985921|P1|NOT COMPLETED|12-month Safety Follow-up||0
8108766|NCT03099187|19985918|P4|COMPLETED|12-month Safety Follow-up||84
8108767|NCT03099187|19985919|P3|COMPLETED|12-month Safety Follow-up||75
8108768|NCT03099187|19985920|P2|COMPLETED|12-month Safety Follow-up||0
8108769|NCT03099187|19985921|P1|COMPLETED|12-month Safety Follow-up||0
8108770|NCT03099187|19985918|P4|STARTED|12-month Safety Follow-up||110
8108771|NCT03099187|19985919|P3|STARTED|12-month Safety Follow-up||94
8108772|NCT03099187|19985920|P2|STARTED|12-month Safety Follow-up||0
8108773|NCT03099187|19985921|P1|STARTED|12-month Safety Follow-up||0
8108774|NCT03099187|19985918|P4|NOT COMPLETED|Double-blind Treatment||0
8108775|NCT03099187|19985919|P3|NOT COMPLETED|Double-blind Treatment||0
8108776|NCT03099187|19985920|P2|NOT COMPLETED|Double-blind Treatment||16
8108777|NCT03099187|19985921|P1|NOT COMPLETED|Double-blind Treatment||33
8108778|NCT03099187|19985918|P4|COMPLETED|Double-blind Treatment||0
8108779|NCT03099187|19985919|P3|COMPLETED|Double-blind Treatment||0
8108780|NCT03099187|19985920|P2|COMPLETED|Double-blind Treatment||110
8108781|NCT03099187|19985921|P1|COMPLETED|Double-blind Treatment||94
8108782|NCT03099187|19985918|P4|STARTED|Double-blind Treatment||0
8108783|NCT03099187|19985919|P3|STARTED|Double-blind Treatment||0
8108784|NCT03099187|19985920|P2|STARTED|Double-blind Treatment||126
8108785|NCT03099187|19985921|P1|STARTED|Double-blind Treatment||127
8108786|NCT03099161|19985976|P3|NOT COMPLETED|Overall Study||3
8108787|NCT03099161|19985977|P2|NOT COMPLETED|Overall Study||4
8108788|NCT03099161|19985978|P1|NOT COMPLETED|Overall Study||3
8108789|NCT03099161|19985976|P3|COMPLETED|Overall Study||0
8108790|NCT03099161|19985977|P2|COMPLETED|Overall Study||0
8108791|NCT03099161|19985978|P1|COMPLETED|Overall Study||0
8108792|NCT03099161|19985976|P3|STARTED|Overall Study||3
8108793|NCT03099161|19985977|P2|STARTED|Overall Study||4
8108794|NCT03099161|19985978|P1|STARTED|Overall Study||3
8108795|NCT03099096|19985995|P1|NOT COMPLETED|Overall Study||2
8108796|NCT03099096|19985995|P1|COMPLETED|Overall Study||157
8108797|NCT03099096|19985995|P1|STARTED|Overall Study||159
8108798|NCT03098979|19986008|P6|NOT COMPLETED|Overall Study||4
8108799|NCT03098979|19986009|P5|NOT COMPLETED|Overall Study||9
8108800|NCT03098979|19986010|P4|NOT COMPLETED|Overall Study||5
8108801|NCT03098979|19986011|P3|NOT COMPLETED|Overall Study||4
8108802|NCT03098979|19986012|P2|NOT COMPLETED|Overall Study||2
8108803|NCT03098979|19986013|P1|NOT COMPLETED|Overall Study||6
8108804|NCT03098979|19986008|P6|COMPLETED|Overall Study||47
8108805|NCT03098979|19986009|P5|COMPLETED|Overall Study||41
8108806|NCT03098979|19986010|P4|COMPLETED|Overall Study||46
8108807|NCT03098979|19986011|P3|COMPLETED|Overall Study||46
8108808|NCT03098979|19986012|P2|COMPLETED|Overall Study||25
8108809|NCT03098979|19986013|P1|COMPLETED|Overall Study||70
8108810|NCT03098979|19986008|P6|STARTED|Overall Study||51
8108811|NCT03098979|19986009|P5|STARTED|Overall Study||50
8108812|NCT03098979|19986010|P4|STARTED|Overall Study||51
8108813|NCT03098979|19986011|P3|STARTED|Overall Study||50
8108814|NCT03098979|19986012|P2|STARTED|Overall Study||27
8108815|NCT03098979|19986013|P1|STARTED|Overall Study||76
8108816|NCT03098966|19986051|P1|NOT COMPLETED|Overall Study||0
8108817|NCT03098966|19986051|P1|COMPLETED|Overall Study||368
8108818|NCT03098966|19986051|P1|STARTED|Overall Study||368
8108819|NCT03098745|19986057|P6|NOT COMPLETED|Day 3||0
8108820|NCT03098745|19986058|P5|NOT COMPLETED|Day 3||0
8108821|NCT03098745|19986059|P4|NOT COMPLETED|Day 3||0
8108822|NCT03098745|19986060|P3|NOT COMPLETED|Day 3||0
8108823|NCT03098745|19986061|P2|NOT COMPLETED|Day 3||0
8108824|NCT03098745|19986062|P1|NOT COMPLETED|Day 3||0
8108825|NCT03098745|19986057|P6|COMPLETED|Day 3||4
8108826|NCT03098745|19986058|P5|COMPLETED|Day 3||10
8108827|NCT03098745|19986059|P4|COMPLETED|Day 3||8
8108828|NCT03098745|19986060|P3|COMPLETED|Day 3||8
8108829|NCT03098745|19986061|P2|COMPLETED|Day 3||3
8108830|NCT03098745|19986062|P1|COMPLETED|Day 3||7
8108831|NCT03098745|19986057|P6|STARTED|Day 3||4
8108832|NCT03098745|19986058|P5|STARTED|Day 3||10
8108833|NCT03098745|19986059|P4|STARTED|Day 3||8
8108834|NCT03098745|19986060|P3|STARTED|Day 3||8
8108835|NCT03098745|19986061|P2|STARTED|Day 3||3
8108836|NCT03098745|19986062|P1|STARTED|Day 3||7
8108837|NCT03098745|19986057|P6|NOT COMPLETED|Day 2||0
8108838|NCT03098745|19986058|P5|NOT COMPLETED|Day 2||0
8108839|NCT03098745|19986059|P4|NOT COMPLETED|Day 2||0
8108840|NCT03098745|19986060|P3|NOT COMPLETED|Day 2||0
8108841|NCT03098745|19986061|P2|NOT COMPLETED|Day 2||0
8108842|NCT03098745|19986062|P1|NOT COMPLETED|Day 2||0
8108843|NCT03098745|19986057|P6|COMPLETED|Day 2||4
8108844|NCT03098745|19986058|P5|COMPLETED|Day 2||10
8108845|NCT03098745|19986059|P4|COMPLETED|Day 2||8
8108846|NCT03098745|19986060|P3|COMPLETED|Day 2||8
8108847|NCT03098745|19986061|P2|COMPLETED|Day 2||3
8108848|NCT03098745|19986062|P1|COMPLETED|Day 2||7
8108849|NCT03098745|19986057|P6|STARTED|Day 2||4
8108850|NCT03098745|19986058|P5|STARTED|Day 2||10
8108851|NCT03098745|19986059|P4|STARTED|Day 2||8
8108852|NCT03098745|19986060|P3|STARTED|Day 2||8
8108853|NCT03098745|19986061|P2|STARTED|Day 2||3
8108854|NCT03098745|19986062|P1|STARTED|Day 2||7
8108855|NCT03098745|19986057|P6|NOT COMPLETED|Day 1||0
8108856|NCT03098745|19986058|P5|NOT COMPLETED|Day 1||0
8108857|NCT03098745|19986059|P4|NOT COMPLETED|Day 1||0
8108858|NCT03098745|19986060|P3|NOT COMPLETED|Day 1||0
8108859|NCT03098745|19986061|P2|NOT COMPLETED|Day 1||0
8108860|NCT03098745|19986062|P1|NOT COMPLETED|Day 1||0
8108861|NCT03098745|19986057|P6|COMPLETED|Day 1||4
8108862|NCT03098745|19986058|P5|COMPLETED|Day 1||10
8108863|NCT03098745|19986059|P4|COMPLETED|Day 1||8
8108864|NCT03098745|19986060|P3|COMPLETED|Day 1||8
8108865|NCT03098745|19986061|P2|COMPLETED|Day 1||3
8108866|NCT03098745|19986062|P1|COMPLETED|Day 1||7
8108867|NCT03098745|19986057|P6|STARTED|Day 1||4
8108868|NCT03098745|19986058|P5|STARTED|Day 1||10
8108869|NCT03098745|19986059|P4|STARTED|Day 1||8
8108870|NCT03098745|19986060|P3|STARTED|Day 1||8
8108871|NCT03098745|19986061|P2|STARTED|Day 1||3
8108872|NCT03098745|19986062|P1|STARTED|Day 1||7
8108873|NCT03098641|19986098|P1|NOT COMPLETED|Overall Study||52
8108874|NCT03098641|19986098|P1|COMPLETED|Overall Study||220
8108875|NCT03098641|19986098|P1|STARTED|Overall Study||272
8108876|NCT03098615|19986116|P1|NOT COMPLETED|Overall Study||2
8108877|NCT03098615|19986116|P1|COMPLETED|Overall Study||17
8108878|NCT03098615|19986116|P1|STARTED|Overall Study||19
8108879|NCT03098173|19986123|P2|NOT COMPLETED|Overall Study||2
8108880|NCT03098173|19986124|P1|NOT COMPLETED|Overall Study||1
8108881|NCT03098173|19986123|P2|COMPLETED|Overall Study||79
8108882|NCT03098173|19986124|P1|COMPLETED|Overall Study||80
8108883|NCT03098173|19986123|P2|STARTED|Overall Study||81
8108884|NCT03098173|19986124|P1|STARTED|Overall Study||81
8108885|NCT03098030|19986156|P4|NOT COMPLETED|Overall Study||85
8108886|NCT03098030|19986157|P3|NOT COMPLETED|Overall Study||166
8108887|NCT03098030|19986158|P2|NOT COMPLETED|Overall Study||163
8108888|NCT03098030|19986159|P1|NOT COMPLETED|Overall Study||10
8108889|NCT03098030|19986156|P4|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
8108890|NCT03098030|19986157|P3|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
8108891|NCT03098030|19986158|P2|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
8108892|NCT03098030|19986159|P1|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
8108893|NCT03098030|19986156|P4|STARTED|Overall Study||94
8108894|NCT03098030|19986157|P3|STARTED|Overall Study||190
8108895|NCT03098030|19986158|P2|STARTED|Overall Study||187
8108896|NCT03098030|19986159|P1|STARTED|Overall Study||12
8108897|NCT03097861|19986180|P3|NOT COMPLETED|Overall Study||9
8108898|NCT03097861|19986181|P2|NOT COMPLETED|Overall Study||22
8108899|NCT03097861|19986182|P1|NOT COMPLETED|Overall Study||7
8108900|NCT03097861|19986180|P3|COMPLETED|Overall Study||122
8108901|NCT03097861|19986181|P2|COMPLETED|Overall Study||254
8108902|NCT03097861|19986182|P1|COMPLETED|Overall Study||138
8108903|NCT03097861|19986180|P3|Per-protocol Population (PP)|Overall Study||113
8108904|NCT03097861|19986181|P2|Per-protocol Population (PP)|Overall Study||234
8108905|NCT03097861|19986182|P1|Per-protocol Population (PP)|Overall Study||126
8108906|NCT03097861|19986180|P3|Completers|Overall Study||121
8108907|NCT03097861|19986181|P2|Completers|Overall Study||255
8108908|NCT03097861|19986182|P1|Completers|Overall Study||129
8108909|NCT03097861|19986180|P3|Modified Intent to Treat|Overall Study||130
8108910|NCT03097861|19986181|P2|Modified Intent to Treat|Overall Study||275
8108911|NCT03097861|19986182|P1|Modified Intent to Treat|Overall Study||143
8108912|NCT03097861|19986180|P3|Safety Population|Overall Study||130
8108913|NCT03097861|19986181|P2|Safety Population|Overall Study||275
8108914|NCT03097861|19986182|P1|Safety Population|Overall Study||143
8108915|NCT03097861|19986180|P3|STARTED|Overall Study||131
8108916|NCT03097861|19986181|P2|STARTED|Overall Study||276
8108917|NCT03097861|19986182|P1|STARTED|Overall Study||145
8108918|NCT03097614|19986199|P1|NOT COMPLETED|Overall Study||3
8108919|NCT03097614|19986199|P1|COMPLETED|Overall Study||54
8108920|NCT03097614|19986199|P1|STARTED|Overall Study||57
8108921|NCT03097484|19986205|P2|NOT COMPLETED|Overall Study||0
8108922|NCT03097484|19986206|P1|NOT COMPLETED|Overall Study||0
8108923|NCT03097484|19986205|P2|COMPLETED|Overall Study||19
8108924|NCT03097484|19986206|P1|COMPLETED|Overall Study||19
8108925|NCT03097484|19986205|P2|STARTED|Overall Study||19
8108926|NCT03097484|19986206|P1|STARTED|Overall Study||19
8108927|NCT03097341|19986219|P5|NOT COMPLETED|Overall Study||0
8108928|NCT03097341|19986220|P4|NOT COMPLETED|Overall Study||0
8108929|NCT03097341|19986221|P3|NOT COMPLETED|Overall Study||0
8108930|NCT03097341|19986222|P2|NOT COMPLETED|Overall Study||0
8108931|NCT03097341|19986223|P1|NOT COMPLETED|Overall Study||0
8108932|NCT03097341|19986219|P5|COMPLETED|Overall Study||5
8108933|NCT03097341|19986220|P4|COMPLETED|Overall Study||4
8108934|NCT03097341|19986221|P3|COMPLETED|Overall Study||4
8108935|NCT03097341|19986222|P2|COMPLETED|Overall Study||4
8108936|NCT03097341|19986223|P1|COMPLETED|Overall Study||4
8108937|NCT03097341|19986219|P5|STARTED|Overall Study||5
8108938|NCT03097341|19986220|P4|STARTED|Overall Study||4
8108939|NCT03097341|19986221|P3|STARTED|Overall Study||4
8108940|NCT03097341|19986222|P2|STARTED|Overall Study||4
8108941|NCT03097341|19986223|P1|STARTED|Overall Study||4
8108942|NCT03097289|19986301|P1|NOT COMPLETED|Overall Study||6
8108943|NCT03097289|19986301|P1|COMPLETED|Overall Study||26
8108944|NCT03097289|19986301|P1|STARTED|Overall Study||32
8108945|NCT03097133|19986310|P2|NOT COMPLETED|Overall Study||34
8108946|NCT03097133|19986311|P1|NOT COMPLETED|Overall Study||30
8108947|NCT03097133|19986310|P2|COMPLETED|Overall Study||81
8108948|NCT03097133|19986311|P1|COMPLETED|Overall Study||85
8108949|NCT03097133|19986310|P2|Treated|Overall Study||114
8108950|NCT03097133|19986311|P1|Treated|Overall Study||113
8108951|NCT03097133|19986310|P2|STARTED|Overall Study||115
8108952|NCT03097133|19986311|P1|STARTED|Overall Study||115
8108953|NCT03097029|19986361|P1|NOT COMPLETED|Overall Study||1
8108954|NCT03097029|19986361|P1|COMPLETED|Overall Study||14
8108955|NCT03097029|19986361|P1|STARTED|Overall Study||15
8108956|NCT03096873|19986368|P2|NOT COMPLETED|Overall Study||0
8108957|NCT03096873|19986369|P1|NOT COMPLETED|Overall Study||0
8108958|NCT03096873|19986368|P2|COMPLETED|Overall Study||20
8108959|NCT03096873|19986369|P1|COMPLETED|Overall Study||20
8108960|NCT03096873|19986368|P2|STARTED|Overall Study||20
8108961|NCT03096873|19986369|P1|STARTED|Overall Study||20
8108962|NCT03096483|19986405|P1|NOT COMPLETED|Overall Study||1
8108963|NCT03096483|19986405|P1|COMPLETED|Overall Study||11
8108964|NCT03096483|19986405|P1|STARTED|Overall Study||12
8108965|NCT03096444|19986410|P1|NOT COMPLETED|Overall Study||0
8108966|NCT03096444|19986410|P1|COMPLETED|Overall Study||13
8108967|NCT03096444|19986410|P1|STARTED|Overall Study||13
8108968|NCT03096314|19986434|P2|NOT COMPLETED|Confirmed Vitamin D Deficient||12
8108969|NCT03096314|19986435|P1|NOT COMPLETED|Confirmed Vitamin D Deficient||7
8108970|NCT03096314|19986434|P2|COMPLETED|Confirmed Vitamin D Deficient||528
8108971|NCT03096314|19986435|P1|COMPLETED|Confirmed Vitamin D Deficient||531
8108972|NCT03096314|19986434|P2|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
8108973|NCT03096314|19986435|P1|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
8108974|NCT03096314|19986434|P2|NOT COMPLETED|Screened Vitamin D Deficient||12
8108975|NCT03096314|19986435|P1|NOT COMPLETED|Screened Vitamin D Deficient||9
8108976|NCT03096314|19986434|P2|COMPLETED|Screened Vitamin D Deficient||656
8108977|NCT03096314|19986435|P1|COMPLETED|Screened Vitamin D Deficient||681
8108978|NCT03096314|19986434|P2|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
8108979|NCT03096314|19986435|P1|STARTED|Screened Vitamin D Deficient||690
8108980|NCT03095885|19986483|P1|NOT COMPLETED|Overall Study||0
8108981|NCT03095885|19986483|P1|COMPLETED|Overall Study||22
8108982|NCT03095885|19986483|P1|STARTED|Overall Study||22
8108983|NCT03095651|19986497|P8|NOT COMPLETED|Overall Study||0
8108984|NCT03095651|19986498|P7|NOT COMPLETED|Overall Study||0
8108985|NCT03095651|19986499|P6|NOT COMPLETED|Overall Study||1
8108986|NCT03095651|19986500|P5|NOT COMPLETED|Overall Study||0
8108987|NCT03095651|19986501|P4|NOT COMPLETED|Overall Study||1
8108988|NCT03095651|19986502|P3|NOT COMPLETED|Overall Study||0
8108989|NCT03095651|19986503|P2|NOT COMPLETED|Overall Study||1
8108990|NCT03095651|19986504|P1|NOT COMPLETED|Overall Study||1
8108991|NCT03095651|19986497|P8|COMPLETED|Overall Study||4
8108992|NCT03095651|19986498|P7|COMPLETED|Overall Study||6
8108993|NCT03095651|19986499|P6|COMPLETED|Overall Study||6
8108994|NCT03095651|19986500|P5|COMPLETED|Overall Study||0
8108995|NCT03095651|19986501|P4|COMPLETED|Overall Study||3
8108996|NCT03095651|19986502|P3|COMPLETED|Overall Study||0
8108997|NCT03095651|19986503|P2|COMPLETED|Overall Study||5
8108998|NCT03095651|19986504|P1|COMPLETED|Overall Study||5
8108999|NCT03095651|19986497|P8|STARTED|Overall Study||4
8109000|NCT03095651|19986498|P7|STARTED|Overall Study||6
8109001|NCT03095651|19986499|P6|STARTED|Overall Study||7
8109002|NCT03095651|19986500|P5|STARTED|Overall Study||0
8109003|NCT03095651|19986501|P4|STARTED|Overall Study||4
8109004|NCT03095651|19986502|P3|STARTED|Overall Study||0
8109005|NCT03095651|19986503|P2|STARTED|Overall Study||6
8109006|NCT03095651|19986504|P1|STARTED|Overall Study||6
8109007|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109008|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109009|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109010|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109011|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109012|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109013|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109014|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109015|NCT03095638|19986628|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109016|NCT03095638|19986629|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109017|NCT03095638|19986630|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109018|NCT03095638|19986631|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109019|NCT03095638|19986632|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109020|NCT03095638|19986633|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109021|NCT03095638|19986634|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109022|NCT03095638|19986635|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109023|NCT03095638|19986628|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109024|NCT03095638|19986629|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109025|NCT03095638|19986630|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109026|NCT03095638|19986631|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109027|NCT03095638|19986632|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109028|NCT03095638|19986633|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109029|NCT03095638|19986634|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
8109030|NCT03095638|19986635|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
8109031|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109032|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109033|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109034|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109035|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109036|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109037|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109038|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109039|NCT03095638|19986628|P8|COMPLETED|P2: Period 3 (4 Days)||4
8109040|NCT03095638|19986629|P7|COMPLETED|P2: Period 3 (4 Days)||4
8109041|NCT03095638|19986630|P6|COMPLETED|P2: Period 3 (4 Days)||4
8109042|NCT03095638|19986631|P5|COMPLETED|P2: Period 3 (4 Days)||4
8109043|NCT03095638|19986632|P4|COMPLETED|P2: Period 3 (4 Days)||4
8109044|NCT03095638|19986633|P3|COMPLETED|P2: Period 3 (4 Days)||4
8109045|NCT03095638|19986634|P2|COMPLETED|P2: Period 3 (4 Days)||0
8109046|NCT03095638|19986635|P1|COMPLETED|P2: Period 3 (4 Days)||0
8109047|NCT03095638|19986628|P8|STARTED|P2: Period 3 (4 Days)||4
8109048|NCT03095638|19986629|P7|STARTED|P2: Period 3 (4 Days)||4
8109049|NCT03095638|19986630|P6|STARTED|P2: Period 3 (4 Days)||4
8109050|NCT03095638|19986631|P5|STARTED|P2: Period 3 (4 Days)||4
8109051|NCT03095638|19986632|P4|STARTED|P2: Period 3 (4 Days)||4
8109052|NCT03095638|19986633|P3|STARTED|P2: Period 3 (4 Days)||4
8109053|NCT03095638|19986634|P2|STARTED|P2: Period 3 (4 Days)||0
8109054|NCT03095638|19986635|P1|STARTED|P2: Period 3 (4 Days)||0
8109055|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109056|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109057|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109058|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109059|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109060|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109061|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109062|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109063|NCT03095638|19986628|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109064|NCT03095638|19986629|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109065|NCT03095638|19986630|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109066|NCT03095638|19986631|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109067|NCT03095638|19986632|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109068|NCT03095638|19986633|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109069|NCT03095638|19986634|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109070|NCT03095638|19986635|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109071|NCT03095638|19986628|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109072|NCT03095638|19986629|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109073|NCT03095638|19986630|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109074|NCT03095638|19986631|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109075|NCT03095638|19986632|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109076|NCT03095638|19986633|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109077|NCT03095638|19986634|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
8109078|NCT03095638|19986635|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
8109079|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109080|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109081|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109082|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109083|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109084|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109085|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109086|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109087|NCT03095638|19986628|P8|COMPLETED|P2: Period 2 (4 Days)||4
8109088|NCT03095638|19986629|P7|COMPLETED|P2: Period 2 (4 Days)||4
8109089|NCT03095638|19986630|P6|COMPLETED|P2: Period 2 (4 Days)||4
8109090|NCT03095638|19986631|P5|COMPLETED|P2: Period 2 (4 Days)||4
8109091|NCT03095638|19986632|P4|COMPLETED|P2: Period 2 (4 Days)||4
8109092|NCT03095638|19986633|P3|COMPLETED|P2: Period 2 (4 Days)||4
8109093|NCT03095638|19986634|P2|COMPLETED|P2: Period 2 (4 Days)||0
8109094|NCT03095638|19986635|P1|COMPLETED|P2: Period 2 (4 Days)||0
8109095|NCT03095638|19986628|P8|STARTED|P2: Period 2 (4 Days)||4
8109096|NCT03095638|19986629|P7|STARTED|P2: Period 2 (4 Days)||4
8109097|NCT03095638|19986630|P6|STARTED|P2: Period 2 (4 Days)||4
8109098|NCT03095638|19986631|P5|STARTED|P2: Period 2 (4 Days)||4
8109099|NCT03095638|19986632|P4|STARTED|P2: Period 2 (4 Days)||4
8109100|NCT03095638|19986633|P3|STARTED|P2: Period 2 (4 Days)||4
8109101|NCT03095638|19986634|P2|STARTED|P2: Period 2 (4 Days)||0
8109102|NCT03095638|19986635|P1|STARTED|P2: Period 2 (4 Days)||0
8109103|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109104|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109105|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109106|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109107|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109108|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109109|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109110|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109111|NCT03095638|19986628|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109112|NCT03095638|19986629|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109113|NCT03095638|19986630|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109114|NCT03095638|19986631|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109115|NCT03095638|19986632|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109116|NCT03095638|19986633|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109117|NCT03095638|19986634|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109118|NCT03095638|19986635|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109119|NCT03095638|19986628|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109120|NCT03095638|19986629|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109121|NCT03095638|19986630|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109122|NCT03095638|19986631|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109123|NCT03095638|19986632|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109124|NCT03095638|19986633|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109125|NCT03095638|19986634|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
8109126|NCT03095638|19986635|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
8109127|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109128|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109129|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109130|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109131|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109132|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109133|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109134|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109135|NCT03095638|19986628|P8|COMPLETED|P2: Period 1 (4 Days)||4
8109136|NCT03095638|19986629|P7|COMPLETED|P2: Period 1 (4 Days)||4
8109137|NCT03095638|19986630|P6|COMPLETED|P2: Period 1 (4 Days)||4
8109138|NCT03095638|19986631|P5|COMPLETED|P2: Period 1 (4 Days)||4
8109139|NCT03095638|19986632|P4|COMPLETED|P2: Period 1 (4 Days)||4
8109140|NCT03095638|19986633|P3|COMPLETED|P2: Period 1 (4 Days)||4
8109141|NCT03095638|19986634|P2|COMPLETED|P2: Period 1 (4 Days)||0
8109142|NCT03095638|19986635|P1|COMPLETED|P2: Period 1 (4 Days)||0
8109143|NCT03095638|19986628|P8|STARTED|P2: Period 1 (4 Days)||4
8109144|NCT03095638|19986629|P7|STARTED|P2: Period 1 (4 Days)||4
8109145|NCT03095638|19986630|P6|STARTED|P2: Period 1 (4 Days)||4
8109146|NCT03095638|19986631|P5|STARTED|P2: Period 1 (4 Days)||4
8109147|NCT03095638|19986632|P4|STARTED|P2: Period 1 (4 Days)||4
8109148|NCT03095638|19986633|P3|STARTED|P2: Period 1 (4 Days)||4
8109149|NCT03095638|19986634|P2|STARTED|P2: Period 1 (4 Days)||0
8109150|NCT03095638|19986635|P1|STARTED|P2: Period 1 (4 Days)||0
8109151|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109152|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109153|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109154|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109155|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109156|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109157|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109158|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109159|NCT03095638|19986628|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109160|NCT03095638|19986629|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109161|NCT03095638|19986630|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109162|NCT03095638|19986631|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109163|NCT03095638|19986632|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109164|NCT03095638|19986633|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109165|NCT03095638|19986634|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
8109166|NCT03095638|19986635|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
8109167|NCT03095638|19986628|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109168|NCT03095638|19986629|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109169|NCT03095638|19986630|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109170|NCT03095638|19986631|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109171|NCT03095638|19986632|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109172|NCT03095638|19986633|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109173|NCT03095638|19986634|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
8109174|NCT03095638|19986635|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
8109175|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109176|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109177|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109178|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109179|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109180|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109181|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109182|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109183|NCT03095638|19986628|P8|COMPLETED|P1: Period 2 (4 Days)||0
8109184|NCT03095638|19986629|P7|COMPLETED|P1: Period 2 (4 Days)||0
8109185|NCT03095638|19986630|P6|COMPLETED|P1: Period 2 (4 Days)||0
8109186|NCT03095638|19986631|P5|COMPLETED|P1: Period 2 (4 Days)||0
8109187|NCT03095638|19986632|P4|COMPLETED|P1: Period 2 (4 Days)||0
8109188|NCT03095638|19986633|P3|COMPLETED|P1: Period 2 (4 Days)||0
8109189|NCT03095638|19986634|P2|COMPLETED|P1: Period 2 (4 Days)||7
8109190|NCT03095638|19986635|P1|COMPLETED|P1: Period 2 (4 Days)||7
8109191|NCT03095638|19986628|P8|STARTED|P1: Period 2 (4 Days)||0
8109192|NCT03095638|19986629|P7|STARTED|P1: Period 2 (4 Days)||0
8109193|NCT03095638|19986630|P6|STARTED|P1: Period 2 (4 Days)||0
8109194|NCT03095638|19986631|P5|STARTED|P1: Period 2 (4 Days)||0
8109195|NCT03095638|19986632|P4|STARTED|P1: Period 2 (4 Days)||0
8109196|NCT03095638|19986633|P3|STARTED|P1: Period 2 (4 Days)||0
8109197|NCT03095638|19986634|P2|STARTED|P1: Period 2 (4 Days)||7
8109198|NCT03095638|19986635|P1|STARTED|P1: Period 2 (4 Days)||7
8109199|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109200|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109201|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109202|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109203|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109204|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109205|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109206|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109207|NCT03095638|19986628|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109208|NCT03095638|19986629|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109209|NCT03095638|19986630|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109210|NCT03095638|19986631|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109211|NCT03095638|19986632|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109212|NCT03095638|19986633|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109213|NCT03095638|19986634|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
8109214|NCT03095638|19986635|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
8109215|NCT03095638|19986628|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109216|NCT03095638|19986629|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109217|NCT03095638|19986630|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109218|NCT03095638|19986631|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109219|NCT03095638|19986632|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109220|NCT03095638|19986633|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109221|NCT03095638|19986634|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
8109222|NCT03095638|19986635|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
8109223|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109224|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109225|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109226|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109227|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109228|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109229|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109230|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109231|NCT03095638|19986628|P8|COMPLETED|P1: Period 1 (4 Days)||0
8109232|NCT03095638|19986629|P7|COMPLETED|P1: Period 1 (4 Days)||0
8109233|NCT03095638|19986630|P6|COMPLETED|P1: Period 1 (4 Days)||0
8109234|NCT03095638|19986631|P5|COMPLETED|P1: Period 1 (4 Days)||0
8109235|NCT03095638|19986632|P4|COMPLETED|P1: Period 1 (4 Days)||0
8109236|NCT03095638|19986633|P3|COMPLETED|P1: Period 1 (4 Days)||0
8109237|NCT03095638|19986634|P2|COMPLETED|P1: Period 1 (4 Days)||7
8109238|NCT03095638|19986635|P1|COMPLETED|P1: Period 1 (4 Days)||7
8109239|NCT03095638|19986628|P8|STARTED|P1: Period 1 (4 Days)||0
8109240|NCT03095638|19986629|P7|STARTED|P1: Period 1 (4 Days)||0
8109241|NCT03095638|19986630|P6|STARTED|P1: Period 1 (4 Days)||0
8109242|NCT03095638|19986631|P5|STARTED|P1: Period 1 (4 Days)||0
8109243|NCT03095638|19986632|P4|STARTED|P1: Period 1 (4 Days)||0
8109244|NCT03095638|19986633|P3|STARTED|P1: Period 1 (4 Days)||0
8109245|NCT03095638|19986634|P2|STARTED|P1: Period 1 (4 Days)||7
8109246|NCT03095638|19986635|P1|STARTED|P1: Period 1 (4 Days)||7
8109247|NCT03095599|19986783|P2|NOT COMPLETED|Overall Study||0
8109248|NCT03095599|19986784|P1|NOT COMPLETED|Overall Study||3
8109249|NCT03095599|19986783|P2|COMPLETED|Overall Study||148
8109250|NCT03095599|19986784|P1|COMPLETED|Overall Study||738
8109251|NCT03095599|19986783|P2|Vaccinated|Overall Study||148
8109252|NCT03095599|19986784|P1|Vaccinated|Overall Study||740
8109253|NCT03095599|19986783|P2|Withdrawal Before Vaccination|Overall Study||0
8109254|NCT03095599|19986784|P1|Withdrawal Before Vaccination|Overall Study||1
8109255|NCT03095599|19986783|P2|STARTED|Overall Study||148
8109256|NCT03095599|19986784|P1|STARTED|Overall Study||741
8109257|NCT03095521|19986820|P2|NOT COMPLETED|Overall Study||2
8109258|NCT03095521|19986821|P1|NOT COMPLETED|Overall Study||0
8109259|NCT03095521|19986820|P2|COMPLETED|Overall Study||111
8109260|NCT03095521|19986821|P1|COMPLETED|Overall Study||115
8109261|NCT03095521|19986820|P2|Safety Population|Overall Study||113
8109262|NCT03095521|19986821|P1|Safety Population|Overall Study||115
8109263|NCT03095521|19986820|P2|Per Protocol Population PP|Overall Study||107
8109264|NCT03095521|19986821|P1|Per Protocol Population PP|Overall Study||113
8109265|NCT03095521|19986820|P2|Intent to Treat Population ITT|Overall Study||113
8109266|NCT03095521|19986821|P1|Intent to Treat Population ITT|Overall Study||115
8109267|NCT03095521|19986820|P2|STARTED|Overall Study||113
8109268|NCT03095521|19986821|P1|STARTED|Overall Study||115
8109269|NCT03095508|19986839|P2|NOT COMPLETED|Overall Study||1
8109270|NCT03095508|19986840|P1|NOT COMPLETED|Overall Study||0
8109271|NCT03095508|19986839|P2|COMPLETED|Overall Study||114
8109272|NCT03095508|19986840|P1|COMPLETED|Overall Study||114
8109273|NCT03095508|19986839|P2|ITT Population|Overall Study||115
8109274|NCT03095508|19986840|P1|ITT Population|Overall Study||114
8109275|NCT03095508|19986839|P2|Safety Population|Overall Study||115
8109276|NCT03095508|19986840|P1|Safety Population|Overall Study||114
8109277|NCT03095508|19986839|P2|Per Protocol Population|Overall Study||111
8109278|NCT03095508|19986840|P1|Per Protocol Population|Overall Study||112
8109279|NCT03095508|19986839|P2|STARTED|Overall Study||115
8109280|NCT03095508|19986840|P1|STARTED|Overall Study||114
8109281|NCT03095456|19986858|P2|NOT COMPLETED|Overall Study||8
8109282|NCT03095456|19986859|P1|NOT COMPLETED|Overall Study||4
8109283|NCT03095456|19986858|P2|COMPLETED|Overall Study||96
8109284|NCT03095456|19986859|P1|COMPLETED|Overall Study||99
8109285|NCT03095456|19986858|P2|STARTED|Overall Study||104
8109286|NCT03095456|19986859|P1|STARTED|Overall Study||103
8109287|NCT03095053|19986877|P2|NOT COMPLETED|Overall Study||0
8109288|NCT03095053|19986878|P1|NOT COMPLETED|Overall Study||29
8109289|NCT03095053|19986877|P2|COMPLETED|Overall Study||111
8109290|NCT03095053|19986878|P1|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
8109291|NCT03095053|19986877|P2|STARTED|Overall Study|All blastocysts scored morphologically|111
8109292|NCT03095053|19986878|P1|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
8109293|NCT03095027|19986888|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
8109294|NCT03095027|19986889|P1|NOT COMPLETED|Period 2, Second Week of Wear||1
8109295|NCT03095027|19986888|P2|COMPLETED|Period 2, Second Week of Wear||24
8109296|NCT03095027|19986889|P1|COMPLETED|Period 2, Second Week of Wear||26
8109297|NCT03095027|19986888|P2|STARTED|Period 2, Second Week of Wear||24
8109298|NCT03095027|19986889|P1|STARTED|Period 2, Second Week of Wear||27
8109299|NCT03095027|19986888|P2|NOT COMPLETED|Period 1, First Week of Wear||0
8109300|NCT03095027|19986889|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8109301|NCT03095027|19986888|P2|COMPLETED|Period 1, First Week of Wear||24
8109302|NCT03095027|19986889|P1|COMPLETED|Period 1, First Week of Wear||27
8109303|NCT03095027|19986888|P2|STARTED|Period 1, First Week of Wear||24
8109304|NCT03095027|19986889|P1|STARTED|Period 1, First Week of Wear||27
8109305|NCT03094806|19986897|P2|NOT COMPLETED|Overall Study||0
8109306|NCT03094806|19986898|P1|NOT COMPLETED|Overall Study||0
8109307|NCT03094806|19986897|P2|COMPLETED|Overall Study||47
8109308|NCT03094806|19986898|P1|COMPLETED|Overall Study||44
8109309|NCT03094806|19986897|P2|STARTED|Overall Study||47
8109310|NCT03094806|19986898|P1|STARTED|Overall Study||44
8109311|NCT03094325|19986916|P1|NOT COMPLETED|Overall Study||0
8109312|NCT03094325|19986916|P1|COMPLETED|Overall Study||10
8109313|NCT03094325|19986916|P1|OPIE After Cardiopulmonary Bypass|Overall Study||10
8109314|NCT03094325|19986916|P1|TEE After Cardiopulmonary Bypass|Overall Study||10
8109315|NCT03094325|19986916|P1|OPIE Before Cardiopulmonary Bypass|Overall Study||10
8109316|NCT03094325|19986916|P1|TEE Before Cardiopulmonary Bypass|Overall Study||10
8109317|NCT03094325|19986916|P1|STARTED|Overall Study||10
8109318|NCT03094195|19986925|P8|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109319|NCT03094195|19986926|P7|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109320|NCT03094195|19986927|P6|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109321|NCT03094195|19986928|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109322|NCT03094195|19986929|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109323|NCT03094195|19986930|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109324|NCT03094195|19986931|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109325|NCT03094195|19986932|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109326|NCT03094195|19986925|P8|COMPLETED|Treatment Withdrawal Period (TW)||26
8109327|NCT03094195|19986926|P7|COMPLETED|Treatment Withdrawal Period (TW)||13
8109328|NCT03094195|19986927|P6|COMPLETED|Treatment Withdrawal Period (TW)||15
8109329|NCT03094195|19986928|P5|COMPLETED|Treatment Withdrawal Period (TW)||13
8109330|NCT03094195|19986929|P4|COMPLETED|Treatment Withdrawal Period (TW)||13
8109331|NCT03094195|19986930|P3|COMPLETED|Treatment Withdrawal Period (TW)||0
8109332|NCT03094195|19986931|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
8109333|NCT03094195|19986932|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
8109334|NCT03094195|19986925|P8|STARTED|Treatment Withdrawal Period (TW)||26
8109335|NCT03094195|19986926|P7|STARTED|Treatment Withdrawal Period (TW)||13
8109336|NCT03094195|19986927|P6|STARTED|Treatment Withdrawal Period (TW)||15
8109337|NCT03094195|19986928|P5|STARTED|Treatment Withdrawal Period (TW)||13
8109338|NCT03094195|19986929|P4|STARTED|Treatment Withdrawal Period (TW)||13
8109339|NCT03094195|19986930|P3|STARTED|Treatment Withdrawal Period (TW)||0
8109340|NCT03094195|19986931|P2|STARTED|Treatment Withdrawal Period (TW)||0
8109341|NCT03094195|19986932|P1|STARTED|Treatment Withdrawal Period (TW)||0
8109342|NCT03094195|19986925|P8|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109343|NCT03094195|19986926|P7|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109344|NCT03094195|19986927|P6|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109345|NCT03094195|19986928|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109346|NCT03094195|19986929|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109347|NCT03094195|19986930|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
8109348|NCT03094195|19986931|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
8109349|NCT03094195|19986932|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
8109350|NCT03094195|19986925|P8|COMPLETED|Double-Blind Treatment Period (DB)||0
8109351|NCT03094195|19986926|P7|COMPLETED|Double-Blind Treatment Period (DB)||0
8109352|NCT03094195|19986927|P6|COMPLETED|Double-Blind Treatment Period (DB)||0
8109353|NCT03094195|19986928|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
8109354|NCT03094195|19986929|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
8109355|NCT03094195|19986930|P3|COMPLETED|Double-Blind Treatment Period (DB)||29
8109356|NCT03094195|19986931|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
8109357|NCT03094195|19986932|P1|COMPLETED|Double-Blind Treatment Period (DB)||28
8109358|NCT03094195|19986925|P8|STARTED|Double-Blind Treatment Period (DB)||0
8109359|NCT03094195|19986926|P7|STARTED|Double-Blind Treatment Period (DB)||0
8109360|NCT03094195|19986927|P6|STARTED|Double-Blind Treatment Period (DB)||0
8109361|NCT03094195|19986928|P5|STARTED|Double-Blind Treatment Period (DB)||0
8109362|NCT03094195|19986929|P4|STARTED|Double-Blind Treatment Period (DB)||0
8109363|NCT03094195|19986930|P3|STARTED|Double-Blind Treatment Period (DB)||43
8109364|NCT03094195|19986931|P2|STARTED|Double-Blind Treatment Period (DB)||43
8109365|NCT03094195|19986932|P1|STARTED|Double-Blind Treatment Period (DB)||43
8109384|NCT03093415|19986990|P3|NOT COMPLETED|Enrollment to SVR12 Results||3
8109385|NCT03093415|19986991|P2|NOT COMPLETED|Enrollment to SVR12 Results||8
8109386|NCT03093415|19986992|P1|NOT COMPLETED|Enrollment to SVR12 Results||1
8109387|NCT03093415|19986990|P3|COMPLETED|Enrollment to SVR12 Results||47
8109388|NCT03093415|19986991|P2|COMPLETED|Enrollment to SVR12 Results||17
8109389|NCT03093415|19986992|P1|COMPLETED|Enrollment to SVR12 Results||24
8109390|NCT03093415|19986990|P3|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
8109391|NCT03093415|19986991|P2|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
8109392|NCT03093415|19986992|P1|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
8109393|NCT03093415|19986990|P3|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
8109394|NCT03093415|19986991|P2|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
8109395|NCT03093415|19986992|P1|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
8109396|NCT03093415|19986990|P3|COMPLETED|Assessed for Eligibility --> Enrollment||50
8109397|NCT03093415|19986991|P2|COMPLETED|Assessed for Eligibility --> Enrollment||25
8109398|NCT03093415|19986992|P1|COMPLETED|Assessed for Eligibility --> Enrollment||25
8109399|NCT03093415|19986990|P3|STARTED|Assessed for Eligibility --> Enrollment||50
8109400|NCT03093415|19986991|P2|STARTED|Assessed for Eligibility --> Enrollment||135
8109401|NCT03093415|19986992|P1|STARTED|Assessed for Eligibility --> Enrollment||165
8109402|NCT03093350|19987015|P1|NOT COMPLETED|Overall Study||2
8109403|NCT03093350|19987015|P1|COMPLETED|Overall Study||10
8109404|NCT03093350|19987015|P1|Started Treatment|Overall Study||10
8109405|NCT03093350|19987015|P1|STARTED|Overall Study||12
8109406|NCT03093324|19987023|P2|NOT COMPLETED|Overall Study||19
8109407|NCT03093324|19987024|P1|NOT COMPLETED|Overall Study||9
8109408|NCT03093324|19987023|P2|COMPLETED|Overall Study||233
8109409|NCT03093324|19987024|P1|COMPLETED|Overall Study||245
8109410|NCT03093324|19987023|P2|Safety Population|Overall Study||251
8109411|NCT03093324|19987024|P1|Safety Population|Overall Study||253
8109412|NCT03093324|19987023|P2|STARTED|Overall Study||252
8109413|NCT03093324|19987024|P1|STARTED|Overall Study||254
8109414|NCT03093272|19987046|P1|NOT COMPLETED|Overall Study||0
8109415|NCT03093272|19987046|P1|COMPLETED|Overall Study||9
8109416|NCT03093272|19987046|P1|STARTED|Overall Study||9
8109417|NCT03093207|19987057|P2|NOT COMPLETED|Overall Study||0
8109418|NCT03093207|19987058|P1|NOT COMPLETED|Overall Study||0
8109419|NCT03093207|19987057|P2|COMPLETED|Overall Study||17
8109420|NCT03093207|19987058|P1|COMPLETED|Overall Study||17
8109421|NCT03093207|19987057|P2|STARTED|Overall Study||17
8109422|NCT03093207|19987058|P1|STARTED|Overall Study||17
8109423|NCT03093181|19987071|P3|NOT COMPLETED|Overall Study||3
8109424|NCT03093181|19987072|P2|NOT COMPLETED|Overall Study||2
8109425|NCT03093181|19987073|P1|NOT COMPLETED|Overall Study||3
8109426|NCT03093181|19987071|P3|COMPLETED|Overall Study||41
8109427|NCT03093181|19987072|P2|COMPLETED|Overall Study||42
8109428|NCT03093181|19987073|P1|COMPLETED|Overall Study||41
8109429|NCT03093181|19987071|P3|STARTED|Overall Study||44
8109430|NCT03093181|19987072|P2|STARTED|Overall Study||44
8109431|NCT03093181|19987073|P1|STARTED|Overall Study||44
8109432|NCT03093025|19987102|P3|NOT COMPLETED|Overall Study||2
8109433|NCT03093025|19987103|P2|NOT COMPLETED|Overall Study||2
8109434|NCT03093025|19987104|P1|NOT COMPLETED|Overall Study||4
8109435|NCT03093025|19987102|P3|COMPLETED|Overall Study||16
8109436|NCT03093025|19987103|P2|COMPLETED|Overall Study||15
8109437|NCT03093025|19987104|P1|COMPLETED|Overall Study||12
8109438|NCT03093025|19987102|P3|STARTED|Overall Study||18
8109439|NCT03093025|19987103|P2|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
8109440|NCT03093025|19987104|P1|STARTED|Overall Study||16
8109441|NCT03092791|19987135|P8|NOT COMPLETED|Overall Study||60
8109442|NCT03092791|19987136|P7|NOT COMPLETED|Overall Study||60
8109443|NCT03092791|19987137|P6|NOT COMPLETED|Overall Study||60
8109444|NCT03092791|19987138|P5|NOT COMPLETED|Overall Study||60
8109445|NCT03092791|19987139|P4|NOT COMPLETED|Overall Study||0
8109446|NCT03092791|19987140|P3|NOT COMPLETED|Overall Study||0
8109447|NCT03092791|19987141|P2|NOT COMPLETED|Overall Study||0
8109448|NCT03092791|19987142|P1|NOT COMPLETED|Overall Study||0
8109449|NCT03092791|19987135|P8|COMPLETED|Overall Study||0
8109450|NCT03092791|19987136|P7|COMPLETED|Overall Study||0
8109451|NCT03092791|19987137|P6|COMPLETED|Overall Study||0
8109452|NCT03092791|19987138|P5|COMPLETED|Overall Study||0
8109453|NCT03092791|19987139|P4|COMPLETED|Overall Study||30
8109454|NCT03092791|19987140|P3|COMPLETED|Overall Study||30
8109455|NCT03092791|19987141|P2|COMPLETED|Overall Study||20
8109456|NCT03092791|19987142|P1|COMPLETED|Overall Study||20
8109457|NCT03092791|19987135|P8|STARTED|Overall Study||60
8109458|NCT03092791|19987136|P7|STARTED|Overall Study||60
8109459|NCT03092791|19987137|P6|STARTED|Overall Study||60
8109460|NCT03092791|19987138|P5|STARTED|Overall Study||60
8109461|NCT03092791|19987139|P4|STARTED|Overall Study||30
8109462|NCT03092791|19987140|P3|STARTED|Overall Study||30
8109463|NCT03092791|19987141|P2|STARTED|Overall Study||20
8109464|NCT03092791|19987142|P1|STARTED|Overall Study||20
8109465|NCT03092752|19987257|P1|NOT COMPLETED|Overall Study||361469
8109466|NCT03092752|19987257|P1|COMPLETED|Overall Study||162116
8109467|NCT03092752|19987257|P1|STARTED|Overall Study||523585
8109468|NCT03092726|19987322|P2|NOT COMPLETED|Overall Study||14
8109469|NCT03092726|19987323|P1|NOT COMPLETED|Overall Study||9
8109470|NCT03092726|19987322|P2|COMPLETED|Overall Study||81
8109471|NCT03092726|19987323|P1|COMPLETED|Overall Study||79
8109472|NCT03092726|19987322|P2|Treated|Overall Study||95
8109473|NCT03092726|19987323|P1|Treated|Overall Study||88
8109474|NCT03092726|19987322|P2|STARTED|Overall Study||95
8109475|NCT03092726|19987323|P1|STARTED|Overall Study||88
8109476|NCT03092479|19987349|P2|NOT COMPLETED|Overall Study||2
8109477|NCT03092479|19987350|P1|NOT COMPLETED|Overall Study||7
8109478|NCT03092479|19987349|P2|COMPLETED|Overall Study||24
8109479|NCT03092479|19987350|P1|COMPLETED|Overall Study||17
8109480|NCT03092479|19987349|P2|STARTED|Overall Study||26
8109481|NCT03092479|19987350|P1|STARTED|Overall Study||24
8109482|NCT03092375|19987372|P4|NOT COMPLETED|Overall Study||0
8109483|NCT03092375|19987373|P3|NOT COMPLETED|Overall Study||1
8109484|NCT03092375|19987374|P2|NOT COMPLETED|Overall Study||1
8109485|NCT03092375|19987375|P1|NOT COMPLETED|Overall Study||0
8109486|NCT03092375|19987372|P4|COMPLETED|Overall Study||29
8109487|NCT03092375|19987373|P3|COMPLETED|Overall Study||20
8109488|NCT03092375|19987374|P2|COMPLETED|Overall Study||48
8109489|NCT03092375|19987375|P1|COMPLETED|Overall Study||78
8109490|NCT03092375|19987372|P4|STARTED|Overall Study||29
8109491|NCT03092375|19987373|P3|STARTED|Overall Study||21
8109492|NCT03092375|19987374|P2|STARTED|Overall Study||49
8109493|NCT03092375|19987375|P1|STARTED|Overall Study||78
8109494|NCT03092219|19987403|P2|NOT COMPLETED|Overall Study||4
8109495|NCT03092219|19987404|P1|NOT COMPLETED|Overall Study||7
8109496|NCT03092219|19987403|P2|COMPLETED|Overall Study||48
8109497|NCT03092219|19987404|P1|COMPLETED|Overall Study||143
8109498|NCT03092219|19987403|P2|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
8109499|NCT03092219|19987404|P1|Pooled SAFT Population|Overall Study||150
8109500|NCT03092219|19987403|P2|Primary Analysis Endpoint|Overall Study||51
8109501|NCT03092219|19987404|P1|Primary Analysis Endpoint|Overall Study||150
8109502|NCT03092219|19987403|P2|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
8109503|NCT03092219|19987404|P1|Baseline / ITT Population|Overall Study||150
8109504|NCT03092219|19987403|P2|STARTED|Overall Study||52
8109505|NCT03092219|19987404|P1|STARTED|Overall Study||150
8109506|NCT03091920|19987448|P3|NOT COMPLETED|Overall Study||0
8109507|NCT03091920|19987449|P2|NOT COMPLETED|Overall Study||1
8109508|NCT03091920|19987450|P1|NOT COMPLETED|Overall Study||0
8109509|NCT03091920|19987448|P3|COMPLETED|Overall Study||10
8109510|NCT03091920|19987449|P2|COMPLETED|Overall Study||9
8109511|NCT03091920|19987450|P1|COMPLETED|Overall Study||6
8109512|NCT03091920|19987448|P3|STARTED|Overall Study||10
8109513|NCT03091920|19987449|P2|STARTED|Overall Study||10
8109514|NCT03091920|19987450|P1|STARTED|Overall Study||6
8109515|NCT03091777|19987597|P3|NOT COMPLETED|Overall Study||37
8109516|NCT03091777|19987598|P2|NOT COMPLETED|Overall Study||33
8109517|NCT03091777|19987599|P1|NOT COMPLETED|Overall Study||32
8109518|NCT03091777|19987597|P3|COMPLETED|Overall Study||257
8109519|NCT03091777|19987598|P2|COMPLETED|Overall Study||255
8109520|NCT03091777|19987599|P1|COMPLETED|Overall Study||257
8109521|NCT03091777|19987597|P3|STARTED|Overall Study||294
8109522|NCT03091777|19987598|P2|STARTED|Overall Study||288
8109523|NCT03091777|19987599|P1|STARTED|Overall Study||289
8109524|NCT03091751|19987607|P1|NOT COMPLETED|Overall Study||0
8109525|NCT03091751|19987607|P1|COMPLETED|Overall Study||22
8109526|NCT03091751|19987607|P1|STARTED|Overall Study||22
8109527|NCT03091673|19987618|P2|NOT COMPLETED|Second Dose||0
8109528|NCT03091673|19987619|P1|NOT COMPLETED|Second Dose||0
8109529|NCT03091673|19987618|P2|COMPLETED|Second Dose||11
8109530|NCT03091673|19987619|P1|COMPLETED|Second Dose||0
8109531|NCT03091673|19987618|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
8109532|NCT03091673|19987619|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
8109533|NCT03091673|19987618|P2|NOT COMPLETED|First Dose||0
8109534|NCT03091673|19987619|P1|NOT COMPLETED|First Dose||0
8109535|NCT03091673|19987618|P2|COMPLETED|First Dose||0
8109536|NCT03091673|19987619|P1|COMPLETED|First Dose||31
8109537|NCT03091673|19987618|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
8109538|NCT03091673|19987619|P1|STARTED|First Dose||31
8109539|NCT03091478|19987639|P1|NOT COMPLETED|Overall Study||0
8109540|NCT03091478|19987639|P1|COMPLETED|Overall Study||13
8109541|NCT03091478|19987639|P1|STARTED|Overall Study||13
8109542|NCT03091439|19987647|P2|NOT COMPLETED|Overall Study||0
8109543|NCT03091439|19987648|P1|NOT COMPLETED|Overall Study||1
8109544|NCT03091439|19987647|P2|COMPLETED|Overall Study||0
8109545|NCT03091439|19987648|P1|COMPLETED|Overall Study||0
8109546|NCT03091439|19987647|P2|STARTED|Overall Study||0
8109547|NCT03091439|19987648|P1|STARTED|Overall Study||1
8109548|NCT03091400|19987672|P2|NOT COMPLETED|Phase 2 - 6 Weeks||0
8109549|NCT03091400|19987673|P1|NOT COMPLETED|Phase 2 - 6 Weeks||0
8109550|NCT03091400|19987672|P2|COMPLETED|Phase 2 - 6 Weeks||6
8109551|NCT03091400|19987673|P1|COMPLETED|Phase 2 - 6 Weeks||4
8109552|NCT03091400|19987672|P2|STARTED|Phase 2 - 6 Weeks||6
8109553|NCT03091400|19987673|P1|STARTED|Phase 2 - 6 Weeks||4
8109554|NCT03091400|19987672|P2|NOT COMPLETED|Washout - 2 Weeks||0
8109555|NCT03091400|19987673|P1|NOT COMPLETED|Washout - 2 Weeks||1
8109556|NCT03091400|19987672|P2|COMPLETED|Washout - 2 Weeks||6
8109557|NCT03091400|19987673|P1|COMPLETED|Washout - 2 Weeks||4
8109558|NCT03091400|19987672|P2|STARTED|Washout - 2 Weeks||6
8109559|NCT03091400|19987673|P1|STARTED|Washout - 2 Weeks||5
8109560|NCT03091400|19987672|P2|NOT COMPLETED|Phase 1 - 6 Weeks||0
8109561|NCT03091400|19987673|P1|NOT COMPLETED|Phase 1 - 6 Weeks||0
8109562|NCT03091400|19987672|P2|COMPLETED|Phase 1 - 6 Weeks||6
8109563|NCT03091400|19987673|P1|COMPLETED|Phase 1 - 6 Weeks||5
8109564|NCT03091400|19987672|P2|STARTED|Phase 1 - 6 Weeks||6
8109565|NCT03091400|19987673|P1|STARTED|Phase 1 - 6 Weeks||5
8109566|NCT03091361|19987689|P1|NOT COMPLETED|Overall Study||0
8109567|NCT03091361|19987689|P1|COMPLETED|Overall Study||30
8109568|NCT03091361|19987689|P1|STARTED|Overall Study||30
8109569|NCT03091348|19987695|P2|NOT COMPLETED|Overall Study||1
8109570|NCT03091348|19987696|P1|NOT COMPLETED|Overall Study||2
8109571|NCT03091348|19987695|P2|COMPLETED|Overall Study||1
8109572|NCT03091348|19987696|P1|COMPLETED|Overall Study||0
8109573|NCT03091348|19987695|P2|STARTED|Overall Study||2
8109574|NCT03091348|19987696|P1|STARTED|Overall Study||2
8109575|NCT03091192|19987722|P2|NOT COMPLETED|Overall Study||27
8109576|NCT03091192|19987723|P1|NOT COMPLETED|Overall Study||33
8109577|NCT03091192|19987722|P2|COMPLETED|Overall Study||0
8109578|NCT03091192|19987723|P1|COMPLETED|Overall Study||0
8109579|NCT03091192|19987722|P2|STARTED|Overall Study||27
8109580|NCT03091192|19987723|P1|STARTED|Overall Study||33
8109581|NCT03091179|19987741|P2|NOT COMPLETED|Overall Study||0
8109582|NCT03091179|19987742|P1|NOT COMPLETED|Overall Study||0
8109583|NCT03091179|19987741|P2|COMPLETED|Overall Study||10
8109584|NCT03091179|19987742|P1|COMPLETED|Overall Study||10
8109585|NCT03091179|19987741|P2|STARTED|Overall Study||10
8109586|NCT03091179|19987742|P1|STARTED|Overall Study||10
8109587|NCT03090958|19987768|P1|NOT COMPLETED|Overall Study||0
8109588|NCT03090958|19987768|P1|COMPLETED|Overall Study||20
8109589|NCT03090958|19987768|P1|STARTED|Overall Study||20
8109590|NCT03090256|19987780|P1|NOT COMPLETED|Overall Study||0
8109591|NCT03090256|19987780|P1|COMPLETED|Overall Study||68
8109592|NCT03090256|19987780|P1|STARTED|Overall Study||68
8109593|NCT03090100|19987791|P2|NOT COMPLETED|Overall Study||48
8109594|NCT03090100|19987792|P1|NOT COMPLETED|Overall Study||27
8109595|NCT03090100|19987791|P2|COMPLETED|Overall Study||466
8109596|NCT03090100|19987792|P1|COMPLETED|Overall Study||507
8109597|NCT03090100|19987791|P2|Treated|Overall Study||511
8109598|NCT03090100|19987792|P1|Treated|Overall Study||534
8109599|NCT03090100|19987791|P2|STARTED|Overall Study||514
8109600|NCT03090100|19987792|P1|STARTED|Overall Study||534
8109601|NCT03089944|19987832|P1|NOT COMPLETED|Overall Study||12
8109602|NCT03089944|19987832|P1|COMPLETED|Overall Study||331
8109603|NCT03089944|19987832|P1|STARTED|Overall Study||343
8109604|NCT03089879|19987846|P3|NOT COMPLETED|Overall Study||0
8109605|NCT03089879|19987847|P2|NOT COMPLETED|Overall Study||0
8109606|NCT03089879|19987848|P1|NOT COMPLETED|Overall Study||0
8109607|NCT03089879|19987846|P3|COMPLETED|Overall Study||26
8109608|NCT03089879|19987847|P2|COMPLETED|Overall Study||2
8109609|NCT03089879|19987848|P1|COMPLETED|Overall Study||7
8109610|NCT03089879|19987846|P3|STARTED|Overall Study||26
8109611|NCT03089879|19987847|P2|STARTED|Overall Study||2
8109612|NCT03089879|19987848|P1|STARTED|Overall Study||7
8109613|NCT03089853|19987879|P2|NOT COMPLETED|Overall Study||1
8109614|NCT03089853|19987880|P1|NOT COMPLETED|Overall Study||2
8109615|NCT03089853|19987879|P2|COMPLETED|Overall Study||2
8109616|NCT03089853|19987880|P1|COMPLETED|Overall Study||2
8109617|NCT03089853|19987879|P2|STARTED|Overall Study||3
8109618|NCT03089853|19987880|P1|STARTED|Overall Study||4
8109619|NCT03089580|19987902|P1|NOT COMPLETED|Overall Study||2
8109620|NCT03089580|19987902|P1|COMPLETED|Overall Study||12
8109621|NCT03089580|19987902|P1|STARTED|Overall Study||14
8109622|NCT03089216|19987913|P4|NOT COMPLETED|Overall Study||1
8109623|NCT03089216|19987914|P3|NOT COMPLETED|Overall Study||0
8109624|NCT03089216|19987915|P2|NOT COMPLETED|Overall Study||0
8109625|NCT03089216|19987916|P1|NOT COMPLETED|Overall Study||0
8109626|NCT03089216|19987913|P4|COMPLETED|Overall Study||26
8109627|NCT03089216|19987914|P3|COMPLETED|Overall Study||27
8109628|NCT03089216|19987915|P2|COMPLETED|Overall Study||27
8109629|NCT03089216|19987916|P1|COMPLETED|Overall Study||27
8109630|NCT03089216|19987913|P4|STARTED|Overall Study||27
8109631|NCT03089216|19987914|P3|STARTED|Overall Study||27
8109632|NCT03089216|19987915|P2|STARTED|Overall Study||27
8109633|NCT03089216|19987916|P1|STARTED|Overall Study||27
8109634|NCT03089047|19987932|P2|NOT COMPLETED|Overall Study||0
8109635|NCT03089047|19987933|P1|NOT COMPLETED|Overall Study||1
8109636|NCT03089047|19987932|P2|COMPLETED|Overall Study||2
8109637|NCT03089047|19987933|P1|COMPLETED|Overall Study||1
8109638|NCT03089047|19987932|P2|STARTED|Overall Study||2
8109639|NCT03089047|19987933|P1|STARTED|Overall Study||2
8109640|NCT03088917|19987943|P1|NOT COMPLETED|Overall Study||96
8109641|NCT03088917|19987943|P1|COMPLETED|Overall Study||10
8109642|NCT03088917|19987943|P1|STARTED|Overall Study||106
8109643|NCT03088345|19987953|P2|NOT COMPLETED|Overall Study||0
8109644|NCT03088345|19987954|P1|NOT COMPLETED|Overall Study||0
8109645|NCT03088345|19987953|P2|COMPLETED|Overall Study||10
8109646|NCT03088345|19987954|P1|COMPLETED|Overall Study||10
8109647|NCT03088345|19987953|P2|STARTED|Overall Study||10
8109648|NCT03088345|19987954|P1|STARTED|Overall Study||10
8109649|NCT03088267|19987970|P2|NOT COMPLETED|Overall Study||0
8109650|NCT03088267|19987971|P1|NOT COMPLETED|Overall Study||0
8109651|NCT03088267|19987970|P2|COMPLETED|Overall Study||9
8109652|NCT03088267|19987971|P1|COMPLETED|Overall Study||9
8109653|NCT03088267|19987970|P2|STARTED|Overall Study||9
8109654|NCT03088267|19987971|P1|STARTED|Overall Study||9
8109655|NCT03088137|19987982|P2|NOT COMPLETED|Overall Study||0
8109656|NCT03088137|19987983|P1|NOT COMPLETED|Overall Study||0
8109657|NCT03088137|19987982|P2|COMPLETED|Overall Study||55
8109658|NCT03088137|19987983|P1|COMPLETED|Overall Study||55
8109659|NCT03088137|19987982|P2|STARTED|Overall Study||55
8109660|NCT03088137|19987983|P1|STARTED|Overall Study||55
8109670|NCT03087786|19988026|P2|NOT COMPLETED|Overall Study||0
8109671|NCT03087786|19988027|P1|NOT COMPLETED|Overall Study||2
8109672|NCT03087786|19988026|P2|COMPLETED|Overall Study||50
8109673|NCT03087786|19988027|P1|COMPLETED|Overall Study||48
8109674|NCT03087786|19988026|P2|STARTED|Overall Study||50
8109675|NCT03087786|19988027|P1|STARTED|Overall Study||50
8109676|NCT03087643|19988063|P2|NOT COMPLETED|Overall Study||6
8109677|NCT03087643|19988064|P1|NOT COMPLETED|Overall Study||4
8109678|NCT03087643|19988063|P2|COMPLETED|Overall Study||19
8109679|NCT03087643|19988064|P1|COMPLETED|Overall Study||22
8109680|NCT03087643|19988063|P2|STARTED|Overall Study||25
8109681|NCT03087643|19988064|P1|STARTED|Overall Study||26
8109682|NCT03087604|19988080|P2|NOT COMPLETED|Overall Study||0
8109683|NCT03087604|19988081|P1|NOT COMPLETED|Overall Study||0
8109684|NCT03087604|19988080|P2|COMPLETED|Overall Study||50
8109685|NCT03087604|19988081|P1|COMPLETED|Overall Study||50
8109686|NCT03087604|19988080|P2|STARTED|Overall Study||50
8109687|NCT03087604|19988081|P1|STARTED|Overall Study||50
8109688|NCT03087513|19988091|P1|NOT COMPLETED|Second Intervention After 3 hr Washout||2
8109689|NCT03087513|19988091|P1|COMPLETED|Second Intervention After 3 hr Washout||38
8109690|NCT03087513|19988091|P1|STARTED|Second Intervention After 3 hr Washout||40
8109691|NCT03087513|19988091|P1|NOT COMPLETED|First Intervention||0
8109692|NCT03087513|19988091|P1|COMPLETED|First Intervention||40
8109693|NCT03087513|19988091|P1|STARTED|First Intervention||40
8109694|NCT03086707|19988107|P2|NOT COMPLETED|Overall Study||0
8109695|NCT03086707|19988108|P1|NOT COMPLETED|Overall Study||0
8109696|NCT03086707|19988107|P2|COMPLETED|Overall Study||7
8109697|NCT03086707|19988108|P1|COMPLETED|Overall Study||7
8109698|NCT03086707|19988107|P2|STARTED|Overall Study||7
8109699|NCT03086707|19988108|P1|STARTED|Overall Study||7
8109700|NCT03086551|19988138|P2|NOT COMPLETED|Second Intervention||0
8109701|NCT03086551|19988139|P1|NOT COMPLETED|Second Intervention||0
8109702|NCT03086551|19988138|P2|COMPLETED|Second Intervention||1
8109703|NCT03086551|19988139|P1|COMPLETED|Second Intervention||1
8109704|NCT03086551|19988138|P2|STARTED|Second Intervention||1
8109705|NCT03086551|19988139|P1|STARTED|Second Intervention||1
8109706|NCT03086551|19988138|P2|NOT COMPLETED|Washout||3
8109707|NCT03086551|19988139|P1|NOT COMPLETED|Washout||3
8109708|NCT03086551|19988138|P2|COMPLETED|Washout||1
8109709|NCT03086551|19988139|P1|COMPLETED|Washout||1
8109710|NCT03086551|19988138|P2|STARTED|Washout||4
8109711|NCT03086551|19988139|P1|STARTED|Washout||4
8109712|NCT03086551|19988138|P2|NOT COMPLETED|First Intervention||1
8109713|NCT03086551|19988139|P1|NOT COMPLETED|First Intervention||1
8109714|NCT03086551|19988138|P2|COMPLETED|First Intervention||4
8109715|NCT03086551|19988139|P1|COMPLETED|First Intervention||4
8109716|NCT03086551|19988138|P2|STARTED|First Intervention||5
8109717|NCT03086551|19988139|P1|STARTED|First Intervention||5
8109718|NCT03086447|19988155|P2|NOT COMPLETED|Overall Study||20
8109719|NCT03086447|19988156|P1|NOT COMPLETED|Overall Study||11
8109720|NCT03086447|19988155|P2|COMPLETED|Overall Study||110
8109721|NCT03086447|19988156|P1|COMPLETED|Overall Study||121
8109722|NCT03086447|19988155|P2|STARTED|Overall Study||130
8109723|NCT03086447|19988156|P1|STARTED|Overall Study||132
8109724|NCT03086408|19988178|P2|NOT COMPLETED|Overall Study||0
8109725|NCT03086408|19988179|P1|NOT COMPLETED|Overall Study||0
8109726|NCT03086408|19988178|P2|COMPLETED|Overall Study||10
8109727|NCT03086408|19988179|P1|COMPLETED|Overall Study||10
8109728|NCT03086408|19988178|P2|STARTED|Overall Study||10
8109729|NCT03086408|19988179|P1|STARTED|Overall Study||10
8109730|NCT03086356|19988203|P1|NOT COMPLETED|Overall Study||0
8109731|NCT03086356|19988203|P1|COMPLETED|Overall Study||12
8109732|NCT03086356|19988203|P1|STARTED|Overall Study||12
8109733|NCT03086343|19988214|P2|NOT COMPLETED|Overall Study||25
8109734|NCT03086343|19988215|P1|NOT COMPLETED|Overall Study||32
8109735|NCT03086343|19988214|P2|COMPLETED|Overall Study||278
8109736|NCT03086343|19988215|P1|COMPLETED|Overall Study||277
8109737|NCT03086343|19988214|P2|STARTED|Overall Study||303
8109738|NCT03086343|19988215|P1|STARTED|Overall Study||309
8109739|NCT03086330|19988227|P2|NOT COMPLETED|Overall Study||4
8109740|NCT03086330|19988228|P1|NOT COMPLETED|Overall Study||4
8109741|NCT03086330|19988227|P2|COMPLETED|Overall Study||147
8109742|NCT03086330|19988228|P1|COMPLETED|Overall Study||147
8109743|NCT03086330|19988227|P2|Exposed|Overall Study||151
8109744|NCT03086330|19988228|P1|Exposed|Overall Study||150
8109745|NCT03086330|19988227|P2|STARTED|Overall Study||151
8109746|NCT03086330|19988228|P1|STARTED|Overall Study||151
8109747|NCT03086265|19988350|P2|NOT COMPLETED|Overall Study||0
8109748|NCT03086265|19988351|P1|NOT COMPLETED|Overall Study||0
8109749|NCT03086265|19988350|P2|COMPLETED|Overall Study||10
8109750|NCT03086265|19988351|P1|COMPLETED|Overall Study||10
8109751|NCT03086265|19988350|P2|STARTED|Overall Study||10
8109752|NCT03086265|19988351|P1|STARTED|Overall Study||10
8109753|NCT03086213|19988408|P2|NOT COMPLETED|Overall Study||0
8109754|NCT03086213|19988409|P1|NOT COMPLETED|Overall Study||0
8109755|NCT03086213|19988408|P2|COMPLETED|Overall Study||24
8109756|NCT03086213|19988409|P1|COMPLETED|Overall Study||24
8109757|NCT03086213|19988408|P2|STARTED|Overall Study||24
8109758|NCT03086213|19988409|P1|STARTED|Overall Study||24
8109759|NCT03086135|19988425|P1|NOT COMPLETED|Overall Study||3
8109760|NCT03086135|19988425|P1|COMPLETED|Overall Study||48
8109761|NCT03086135|19988425|P1|STARTED|Overall Study||51
8109762|NCT03086018|19988452|P1|NOT COMPLETED|Final Testing for End of Trial||2
8109763|NCT03086018|19988452|P1|COMPLETED|Final Testing for End of Trial||28
8109764|NCT03086018|19988452|P1|STARTED|Final Testing for End of Trial||30
8109765|NCT03086018|19988452|P1|NOT COMPLETED|Field Testing||0
8109766|NCT03086018|19988452|P1|COMPLETED|Field Testing||30
8109767|NCT03086018|19988452|P1|STARTED|Field Testing||30
8109768|NCT03085914|19988467|P7|NOT COMPLETED|Overall Study||11
8109769|NCT03085914|19988468|P6|NOT COMPLETED|Overall Study||8
8109770|NCT03085914|19988469|P5|NOT COMPLETED|Overall Study||13
8109771|NCT03085914|19988470|P4|NOT COMPLETED|Overall Study||9
8109772|NCT03085914|19988471|P3|NOT COMPLETED|Overall Study||11
8109773|NCT03085914|19988472|P2|NOT COMPLETED|Overall Study||9
8109774|NCT03085914|19988473|P1|NOT COMPLETED|Overall Study||9
8109775|NCT03085914|19988467|P7|COMPLETED|Overall Study||0
8109776|NCT03085914|19988468|P6|COMPLETED|Overall Study||0
8109777|NCT03085914|19988469|P5|COMPLETED|Overall Study||0
8109778|NCT03085914|19988470|P4|COMPLETED|Overall Study||0
8109779|NCT03085914|19988471|P3|COMPLETED|Overall Study||0
8109780|NCT03085914|19988472|P2|COMPLETED|Overall Study||0
8109781|NCT03085914|19988473|P1|COMPLETED|Overall Study||0
8109782|NCT03085914|19988467|P7|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
8109783|NCT03085914|19988468|P6|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
8109784|NCT03085914|19988469|P5|Phase 2 Mandatory Biopsy Cohort|Overall Study||6
8109785|NCT03085914|19988470|P4|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
8109786|NCT03085914|19988471|P3|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
8109787|NCT03085914|19988472|P2|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
8109788|NCT03085914|19988473|P1|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
8109789|NCT03085914|19988467|P7|STARTED|Overall Study||11
8109790|NCT03085914|19988468|P6|STARTED|Overall Study||8
8109791|NCT03085914|19988469|P5|STARTED|Overall Study||13
8109792|NCT03085914|19988470|P4|STARTED|Overall Study||9
8109793|NCT03085914|19988471|P3|STARTED|Overall Study||11
8109794|NCT03085914|19988472|P2|STARTED|Overall Study||9
8109795|NCT03085914|19988473|P1|STARTED|Overall Study||9
8109796|NCT03085836|19988506|P3|NOT COMPLETED|Overall Study||0
8109797|NCT03085836|19988507|P2|NOT COMPLETED|Overall Study||0
8109798|NCT03085836|19988508|P1|NOT COMPLETED|Overall Study||0
8109799|NCT03085836|19988506|P3|COMPLETED|Overall Study||10
8109800|NCT03085836|19988507|P2|COMPLETED|Overall Study||11
8109801|NCT03085836|19988508|P1|COMPLETED|Overall Study||12
8109802|NCT03085836|19988506|P3|STARTED|Overall Study||10
8109803|NCT03085836|19988507|P2|STARTED|Overall Study||11
8109804|NCT03085836|19988508|P1|STARTED|Overall Study||12
8109805|NCT03085797|19988557|P2|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
8109806|NCT03085797|19988558|P1|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
8109807|NCT03085797|19988557|P2|COMPLETED|No-treatment Follow-up Period (6 Months)||68
8109808|NCT03085797|19988558|P1|COMPLETED|No-treatment Follow-up Period (6 Months)||65
8109809|NCT03085797|19988557|P2|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
8109810|NCT03085797|19988558|P1|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
8109811|NCT03085797|19988557|P2|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
8109812|NCT03085797|19988558|P1|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
8109813|NCT03085797|19988557|P2|COMPLETED|Treatment Period (TP) (52 Weeks)||189
8109814|NCT03085797|19988558|P1|COMPLETED|Treatment Period (TP) (52 Weeks)||184
8109815|NCT03085797|19988557|P2|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
8109816|NCT03085797|19988558|P1|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
8109817|NCT03085797|19988557|P2|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
8109818|NCT03085797|19988558|P1|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
8109819|NCT03085797|19988557|P2|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
8109820|NCT03085797|19988558|P1|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
8109821|NCT03085797|19988557|P2|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
8109822|NCT03085797|19988558|P1|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
8109823|NCT03085797|19988557|P2|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
8109824|NCT03085797|19988558|P1|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
8109825|NCT03085797|19988557|P2|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
8109826|NCT03085797|19988558|P1|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
8109827|NCT03085797|19988557|P2|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
8109828|NCT03085797|19988558|P1|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
8109829|NCT03085797|19988557|P2|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
8109830|NCT03085797|19988558|P1|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
8109831|NCT03085797|19988557|P2|STARTED|Treatment Period (TP) (52 Weeks)||206
8109832|NCT03085797|19988558|P1|STARTED|Treatment Period (TP) (52 Weeks)||201
8109833|NCT03085238|19988580|P1|NOT COMPLETED|Overall Study||4
8109834|NCT03085238|19988580|P1|COMPLETED|Overall Study||19
8109835|NCT03085238|19988580|P1|18 Months|Overall Study||7
8109836|NCT03085238|19988580|P1|15 Months|Overall Study||11
8109837|NCT03085238|19988580|P1|12 Months|Overall Study||14
8109838|NCT03085238|19988580|P1|9 Months|Overall Study||16
8109839|NCT03085238|19988580|P1|6 Months|Overall Study||19
8109840|NCT03085238|19988580|P1|3 Months|Overall Study||22
8109841|NCT03085238|19988580|P1|1 Month|Overall Study||23
8109842|NCT03085238|19988580|P1|STARTED|Overall Study||23
8109843|NCT03085017|19988607|P2|NOT COMPLETED|Overall Study||3
8109844|NCT03085017|19988608|P1|NOT COMPLETED|Overall Study||0
8109845|NCT03085017|19988607|P2|COMPLETED|Overall Study||24
8109846|NCT03085017|19988608|P1|COMPLETED|Overall Study||30
8109847|NCT03085017|19988607|P2|STARTED|Overall Study||27
8109848|NCT03085017|19988608|P1|STARTED|Overall Study||30
8109849|NCT03084315|19988634|P2|NOT COMPLETED|Overall Study||9
8109850|NCT03084315|19988635|P1|NOT COMPLETED|Overall Study||10
8109851|NCT03084315|19988634|P2|COMPLETED|Overall Study||109
8109852|NCT03084315|19988635|P1|COMPLETED|Overall Study||106
8109853|NCT03084315|19988634|P2|STARTED|Overall Study||118
8109854|NCT03084315|19988635|P1|STARTED|Overall Study||116
8109855|NCT03083990|19988645|P2|NOT COMPLETED|Overall Study||0
8109856|NCT03083990|19988646|P1|NOT COMPLETED|Overall Study||1
8109857|NCT03083990|19988645|P2|COMPLETED|Overall Study||50
8109858|NCT03083990|19988646|P1|COMPLETED|Overall Study||49
8109859|NCT03083990|19988645|P2|STARTED|Overall Study||50
8109860|NCT03083990|19988646|P1|STARTED|Overall Study||50
8109861|NCT03083847|19988684|P10|NOT COMPLETED|Overall Study||0
8109862|NCT03083847|19988685|P9|NOT COMPLETED|Overall Study||0
8109863|NCT03083847|19988686|P8|NOT COMPLETED|Overall Study||0
8109864|NCT03083847|19988687|P7|NOT COMPLETED|Overall Study||0
8109865|NCT03083847|19988688|P6|NOT COMPLETED|Overall Study||0
8109866|NCT03083847|19988689|P5|NOT COMPLETED|Overall Study||0
8109867|NCT03083847|19988690|P4|NOT COMPLETED|Overall Study||0
8109868|NCT03083847|19988691|P3|NOT COMPLETED|Overall Study||4
8109869|NCT03083847|19988692|P2|NOT COMPLETED|Overall Study||1
8109870|NCT03083847|19988693|P1|NOT COMPLETED|Overall Study||1
8109871|NCT03083847|19988684|P10|COMPLETED|Overall Study||4
8109872|NCT03083847|19988685|P9|COMPLETED|Overall Study||2
8109873|NCT03083847|19988686|P8|COMPLETED|Overall Study||4
8109874|NCT03083847|19988687|P7|COMPLETED|Overall Study||2
8109875|NCT03083847|19988688|P6|COMPLETED|Overall Study||2
8109876|NCT03083847|19988689|P5|COMPLETED|Overall Study||8
8109877|NCT03083847|19988690|P4|COMPLETED|Overall Study||4
8109878|NCT03083847|19988691|P3|COMPLETED|Overall Study||6
8109879|NCT03083847|19988692|P2|COMPLETED|Overall Study||9
8109880|NCT03083847|19988693|P1|COMPLETED|Overall Study||8
8109881|NCT03083847|19988684|P10|STARTED|Overall Study||4
8109882|NCT03083847|19988685|P9|STARTED|Overall Study||2
8109883|NCT03083847|19988686|P8|STARTED|Overall Study||4
8109884|NCT03083847|19988687|P7|STARTED|Overall Study||2
8109885|NCT03083847|19988688|P6|STARTED|Overall Study||2
8109886|NCT03083847|19988689|P5|STARTED|Overall Study||8
8109887|NCT03083847|19988690|P4|STARTED|Overall Study||4
8109888|NCT03083847|19988691|P3|STARTED|Overall Study||10
8109889|NCT03083847|19988692|P2|STARTED|Overall Study||10
8109890|NCT03083847|19988693|P1|STARTED|Overall Study||9
8109891|NCT03083769|19988715|P2|NOT COMPLETED|Overall Study||32
8109892|NCT03083769|19988716|P1|NOT COMPLETED|Overall Study||20
8109893|NCT03083769|19988715|P2|COMPLETED|Overall Study||631
8109894|NCT03083769|19988716|P1|COMPLETED|Overall Study||819
8109895|NCT03083769|19988715|P2|STARTED|Overall Study||663
8109896|NCT03083769|19988716|P1|STARTED|Overall Study||839
8109897|NCT03083639|19988728|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8109898|NCT03083639|19988729|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8109899|NCT03083639|19988728|P2|COMPLETED|Intervention Period 2 (1 Day)||25
8109900|NCT03083639|19988729|P1|COMPLETED|Intervention Period 2 (1 Day)||25
8109901|NCT03083639|19988728|P2|STARTED|Intervention Period 2 (1 Day)||25
8109902|NCT03083639|19988729|P1|STARTED|Intervention Period 2 (1 Day)||25
8109903|NCT03083639|19988728|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
8109904|NCT03083639|19988729|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||1
8109905|NCT03083639|19988728|P2|COMPLETED|Washout Period (at Least 6 Days)||25
8109906|NCT03083639|19988729|P1|COMPLETED|Washout Period (at Least 6 Days)||25
8109907|NCT03083639|19988728|P2|STARTED|Washout Period (at Least 6 Days)||26
8109908|NCT03083639|19988729|P1|STARTED|Washout Period (at Least 6 Days)||26
8109909|NCT03083639|19988728|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8109910|NCT03083639|19988729|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8109911|NCT03083639|19988728|P2|COMPLETED|Intervention Period 1 (1 Day)||26
8109912|NCT03083639|19988729|P1|COMPLETED|Intervention Period 1 (1 Day)||26
8109913|NCT03083639|19988728|P2|STARTED|Intervention Period 1 (1 Day)||26
8109914|NCT03083639|19988729|P1|STARTED|Intervention Period 1 (1 Day)||26
8109915|NCT03083483|19988742|P3|NOT COMPLETED|Overall Study||3
8109916|NCT03083483|19988743|P2|NOT COMPLETED|Overall Study||2
8109917|NCT03083483|19988744|P1|NOT COMPLETED|Overall Study||4
8109918|NCT03083483|19988742|P3|COMPLETED|Overall Study||20
8109919|NCT03083483|19988743|P2|COMPLETED|Overall Study||20
8109920|NCT03083483|19988744|P1|COMPLETED|Overall Study||20
8109921|NCT03083483|19988742|P3|STARTED|Overall Study||23
8109922|NCT03083483|19988743|P2|STARTED|Overall Study||22
8109923|NCT03083483|19988744|P1|STARTED|Overall Study||24
8109924|NCT03083470|19988763|P5|NOT COMPLETED|Overall Study||2
8109925|NCT03083470|19988764|P4|NOT COMPLETED|Overall Study||0
8109926|NCT03083470|19988765|P3|NOT COMPLETED|Overall Study||0
8109927|NCT03083470|19988766|P2|NOT COMPLETED|Overall Study||0
8109928|NCT03083470|19988767|P1|NOT COMPLETED|Overall Study||0
8109929|NCT03083470|19988763|P5|COMPLETED|Overall Study||7
8109930|NCT03083470|19988764|P4|COMPLETED|Overall Study||6
8109931|NCT03083470|19988765|P3|COMPLETED|Overall Study||6
8109932|NCT03083470|19988766|P2|COMPLETED|Overall Study||6
8109933|NCT03083470|19988767|P1|COMPLETED|Overall Study||6
8109934|NCT03083470|19988763|P5|STARTED|Overall Study||9
8109935|NCT03083470|19988764|P4|STARTED|Overall Study||6
8109936|NCT03083470|19988765|P3|STARTED|Overall Study||6
8109937|NCT03083470|19988766|P2|STARTED|Overall Study||6
8109938|NCT03083470|19988767|P1|STARTED|Overall Study||6
8109939|NCT03083379|19988806|P2|NOT COMPLETED|Overall Study||0
8109940|NCT03083379|19988807|P1|NOT COMPLETED|Overall Study||0
8109941|NCT03083379|19988806|P2|COMPLETED|Overall Study||15
8109942|NCT03083379|19988807|P1|COMPLETED|Overall Study||15
8109943|NCT03083379|19988806|P2|STARTED|Overall Study||15
8109944|NCT03083379|19988807|P1|STARTED|Overall Study||15
8109945|NCT03082599|19988815|P2|NOT COMPLETED|Overall Study||0
8109946|NCT03082599|19988816|P1|NOT COMPLETED|Overall Study||1
8109947|NCT03082599|19988815|P2|COMPLETED|Overall Study||39
8109948|NCT03082599|19988816|P1|COMPLETED|Overall Study||39
8109949|NCT03082599|19988815|P2|STARTED|Overall Study||39
8109950|NCT03082599|19988816|P1|STARTED|Overall Study||40
8109951|NCT03082586|19988848|P6|NOT COMPLETED|Overall Study||0
8109952|NCT03082586|19988849|P5|NOT COMPLETED|Overall Study||0
8109953|NCT03082586|19988850|P4|NOT COMPLETED|Overall Study||0
8109954|NCT03082586|19988851|P3|NOT COMPLETED|Overall Study||0
8109955|NCT03082586|19988852|P2|NOT COMPLETED|Overall Study||0
8109956|NCT03082586|19988853|P1|NOT COMPLETED|Overall Study||0
8109957|NCT03082586|19988848|P6|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
8109958|NCT03082586|19988849|P5|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
8109959|NCT03082586|19988850|P4|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
8109960|NCT03082586|19988851|P3|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
8109961|NCT03082586|19988852|P2|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
8109962|NCT03082586|19988853|P1|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
8109963|NCT03082586|19988848|P6|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
8109964|NCT03082586|19988849|P5|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
8109965|NCT03082586|19988850|P4|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
8109966|NCT03082586|19988851|P3|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
8109967|NCT03082586|19988852|P2|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
8109968|NCT03082586|19988853|P1|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
8109969|NCT03082196|19988875|P2|NOT COMPLETED|Overall Study||13
8109970|NCT03082196|19988876|P1|NOT COMPLETED|Overall Study||9
8109971|NCT03082196|19988875|P2|COMPLETED|Overall Study||129
8109972|NCT03082196|19988876|P1|COMPLETED|Overall Study||133
8109973|NCT03082196|19988875|P2|STARTED|Overall Study||142
8109974|NCT03082196|19988876|P1|STARTED|Overall Study||142
8109975|NCT03081884|19988888|P1|NOT COMPLETED|Overall Study||4
8109976|NCT03081884|19988888|P1|COMPLETED|Overall Study||57
8109977|NCT03081884|19988888|P1|STARTED|Overall Study||61
8109978|NCT03080961|19988894|P1|NOT COMPLETED|Overall Study||3
8109979|NCT03080961|19988894|P1|COMPLETED|Overall Study||43
8109980|NCT03080961|19988894|P1|STARTED|Overall Study||46
8109981|NCT03080493|19988905|P2|NOT COMPLETED|Overall Study||2
8109982|NCT03080493|19988906|P1|NOT COMPLETED|Overall Study||1
8109983|NCT03080493|19988905|P2|COMPLETED|Overall Study||58
8109984|NCT03080493|19988906|P1|COMPLETED|Overall Study||60
8109985|NCT03080493|19988905|P2|STARTED|Overall Study||60
8109986|NCT03080493|19988906|P1|STARTED|Overall Study||61
8109987|NCT03080454|19988922|P1|NOT COMPLETED|Anodal FU (7 Days)||4
8109988|NCT03080454|19988922|P1|COMPLETED|Anodal FU (7 Days)||19
8109989|NCT03080454|19988922|P1|STARTED|Anodal FU (7 Days)||23
8109990|NCT03080454|19988922|P1|NOT COMPLETED|Anodal Doublestim (5 Days)||1
8109991|NCT03080454|19988922|P1|COMPLETED|Anodal Doublestim (5 Days)||23
8109992|NCT03080454|19988922|P1|STARTED|Anodal Doublestim (5 Days)||24
8109993|NCT03080454|19988922|P1|NOT COMPLETED|Sham FU (7days)||0
8109994|NCT03080454|19988922|P1|COMPLETED|Sham FU (7days)||24
8109995|NCT03080454|19988922|P1|STARTED|Sham FU (7days)||24
8109996|NCT03080454|19988922|P1|NOT COMPLETED|Sham Doublestim (5days)||0
8109997|NCT03080454|19988922|P1|COMPLETED|Sham Doublestim (5days)||24
8109998|NCT03080454|19988922|P1|STARTED|Sham Doublestim (5days)||24
8109999|NCT03080454|19988922|P1|NOT COMPLETED|Baseline||2
8110000|NCT03080454|19988922|P1|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
8110001|NCT03080454|19988922|P1|STARTED|Baseline||26
8110002|NCT03079531|19988931|P1|NOT COMPLETED|Overall Study||7
8110003|NCT03079531|19988931|P1|COMPLETED|Overall Study||17
8110004|NCT03079531|19988931|P1|Attended ≥1 Post-baseline Visit|Overall Study||23
8110005|NCT03079531|19988931|P1|STARTED|Overall Study||24
8110006|NCT03079375|19988944|P3|NOT COMPLETED|Overall Study||21
8110007|NCT03079375|19988945|P2|NOT COMPLETED|Overall Study||6
8110008|NCT03079375|19988946|P1|NOT COMPLETED|Overall Study||5
8110009|NCT03079375|19988944|P3|COMPLETED|Overall Study||476
8110010|NCT03079375|19988945|P2|COMPLETED|Overall Study||493
8110011|NCT03079375|19988946|P1|COMPLETED|Overall Study||498
8110012|NCT03079375|19988944|P3|STARTED|Overall Study||497
8110013|NCT03079375|19988945|P2|STARTED|Overall Study||499
8110014|NCT03079375|19988946|P1|STARTED|Overall Study||503
8110015|NCT03078946|19988980|P2|NOT COMPLETED|Overall Study||0
8110016|NCT03078946|19988981|P1|NOT COMPLETED|Overall Study||0
8110017|NCT03078946|19988980|P2|COMPLETED|Overall Study||30
8110018|NCT03078946|19988981|P1|COMPLETED|Overall Study||30
8110019|NCT03078946|19988980|P2|STARTED|Overall Study||30
8110020|NCT03078946|19988981|P1|STARTED|Overall Study||30
8110021|NCT03078816|19988989|P1|NOT COMPLETED|Overall Study||1
8110022|NCT03078816|19988989|P1|COMPLETED|Overall Study||4
8110023|NCT03078816|19988989|P1|STARTED|Overall Study||5
8110034|NCT03078647|19989018|P3|NOT COMPLETED|Overall Study||0
8110035|NCT03078647|19989019|P2|NOT COMPLETED|Overall Study||1
8110036|NCT03078647|19989020|P1|NOT COMPLETED|Overall Study||0
8110037|NCT03078647|19989018|P3|COMPLETED|Overall Study||3
8110038|NCT03078647|19989019|P2|COMPLETED|Overall Study||10
8110039|NCT03078647|19989020|P1|COMPLETED|Overall Study||17
8110040|NCT03078647|19989018|P3|STARTED|Overall Study||3
8110041|NCT03078647|19989019|P2|STARTED|Overall Study||11
8110042|NCT03078647|19989020|P1|STARTED|Overall Study||17
8110043|NCT03078595|19989039|P2|NOT COMPLETED|Overall Study||0
8110044|NCT03078595|19989040|P1|NOT COMPLETED|Overall Study||0
8110045|NCT03078595|19989039|P2|COMPLETED|Overall Study||24
8110046|NCT03078595|19989040|P1|COMPLETED|Overall Study||24
8110047|NCT03078595|19989039|P2|STARTED|Overall Study||24
8110048|NCT03078595|19989040|P1|STARTED|Overall Study||24
8110049|NCT03078582|19989050|P2|NOT COMPLETED|Overall Study||8
8110050|NCT03078582|19989051|P1|NOT COMPLETED|Overall Study||0
8110051|NCT03078582|19989050|P2|COMPLETED|Overall Study||8
8110052|NCT03078582|19989051|P1|COMPLETED|Overall Study||10
8110053|NCT03078582|19989050|P2|STARTED|Overall Study||16
8110054|NCT03078582|19989051|P1|STARTED|Overall Study||10
8110055|NCT03078556|19989071|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110056|NCT03078556|19989072|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110057|NCT03078556|19989073|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110058|NCT03078556|19989074|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110059|NCT03078556|19989071|P4|COMPLETED|Treatment Period 3 (4 Days)||9
8110060|NCT03078556|19989072|P3|COMPLETED|Treatment Period 3 (4 Days)||7
8110061|NCT03078556|19989073|P2|COMPLETED|Treatment Period 3 (4 Days)||7
8110062|NCT03078556|19989074|P1|COMPLETED|Treatment Period 3 (4 Days)||9
8110063|NCT03078556|19989071|P4|STARTED|Treatment Period 3 (4 Days)||9
8110064|NCT03078556|19989072|P3|STARTED|Treatment Period 3 (4 Days)||7
8110065|NCT03078556|19989073|P2|STARTED|Treatment Period 3 (4 Days)||7
8110066|NCT03078556|19989074|P1|STARTED|Treatment Period 3 (4 Days)||9
8110067|NCT03078556|19989071|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110068|NCT03078556|19989072|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110069|NCT03078556|19989073|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110070|NCT03078556|19989074|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110071|NCT03078556|19989071|P4|COMPLETED|Washout Period 2 (7 Days)||9
8110072|NCT03078556|19989072|P3|COMPLETED|Washout Period 2 (7 Days)||7
8110073|NCT03078556|19989073|P2|COMPLETED|Washout Period 2 (7 Days)||7
8110074|NCT03078556|19989074|P1|COMPLETED|Washout Period 2 (7 Days)||9
8110075|NCT03078556|19989071|P4|STARTED|Washout Period 2 (7 Days)||9
8110076|NCT03078556|19989072|P3|STARTED|Washout Period 2 (7 Days)||7
8110077|NCT03078556|19989073|P2|STARTED|Washout Period 2 (7 Days)||7
8110078|NCT03078556|19989074|P1|STARTED|Washout Period 2 (7 Days)||9
8110079|NCT03078556|19989071|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110080|NCT03078556|19989072|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110081|NCT03078556|19989073|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110082|NCT03078556|19989074|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110083|NCT03078556|19989071|P4|COMPLETED|Treatment Period 2 (4 Days)||37
8110084|NCT03078556|19989072|P3|COMPLETED|Treatment Period 2 (4 Days)||37
8110085|NCT03078556|19989073|P2|COMPLETED|Treatment Period 2 (4 Days)||36
8110086|NCT03078556|19989074|P1|COMPLETED|Treatment Period 2 (4 Days)||37
8110087|NCT03078556|19989071|P4|STARTED|Treatment Period 2 (4 Days)||37
8110088|NCT03078556|19989072|P3|STARTED|Treatment Period 2 (4 Days)||37
8110089|NCT03078556|19989073|P2|STARTED|Treatment Period 2 (4 Days)||36
8110090|NCT03078556|19989074|P1|STARTED|Treatment Period 2 (4 Days)||37
8110091|NCT03078556|19989071|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8110092|NCT03078556|19989072|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
8110093|NCT03078556|19989073|P2|NOT COMPLETED|Washout Period 1 (7 Days)||2
8110094|NCT03078556|19989074|P1|NOT COMPLETED|Washout Period 1 (7 Days)||2
8110095|NCT03078556|19989071|P4|COMPLETED|Washout Period 1 (7 Days)||37
8110096|NCT03078556|19989072|P3|COMPLETED|Washout Period 1 (7 Days)||37
8110097|NCT03078556|19989073|P2|COMPLETED|Washout Period 1 (7 Days)||36
8110098|NCT03078556|19989074|P1|COMPLETED|Washout Period 1 (7 Days)||37
8110099|NCT03078556|19989071|P4|STARTED|Washout Period 1 (7 Days)||38
8110100|NCT03078556|19989072|P3|STARTED|Washout Period 1 (7 Days)||38
8110101|NCT03078556|19989073|P2|STARTED|Washout Period 1 (7 Days)||38
8110102|NCT03078556|19989074|P1|STARTED|Washout Period 1 (7 Days)||39
8110103|NCT03078556|19989071|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8110104|NCT03078556|19989072|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8110105|NCT03078556|19989073|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8110106|NCT03078556|19989074|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8110107|NCT03078556|19989071|P4|COMPLETED|Treatment Period 1 (4 Days)||38
8110108|NCT03078556|19989072|P3|COMPLETED|Treatment Period 1 (4 Days)||38
8110109|NCT03078556|19989073|P2|COMPLETED|Treatment Period 1 (4 Days)||38
8110110|NCT03078556|19989074|P1|COMPLETED|Treatment Period 1 (4 Days)||39
8110111|NCT03078556|19989071|P4|STARTED|Treatment Period 1 (4 Days)||38
8110112|NCT03078556|19989072|P3|STARTED|Treatment Period 1 (4 Days)||38
8110113|NCT03078556|19989073|P2|STARTED|Treatment Period 1 (4 Days)||39
8110114|NCT03078556|19989074|P1|STARTED|Treatment Period 1 (4 Days)||39
8110115|NCT03078504|19989212|P1|NOT COMPLETED|Overall Study||0
8110116|NCT03078504|19989212|P1|COMPLETED|Overall Study||6
8110117|NCT03078504|19989212|P1|STARTED|Overall Study||6
8110118|NCT03078478|19989218|P2|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
8110119|NCT03078478|19989219|P1|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
8110120|NCT03078478|19989218|P2|COMPLETED|Maintencance Period 2 (36 Weeks)||734
8110121|NCT03078478|19989219|P1|COMPLETED|Maintencance Period 2 (36 Weeks)||733
8110122|NCT03078478|19989218|P2|STARTED|Maintencance Period 2 (36 Weeks)||761
8110123|NCT03078478|19989219|P1|STARTED|Maintencance Period 2 (36 Weeks)||758
8110124|NCT03078478|19989218|P2|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
8110125|NCT03078478|19989219|P1|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
8110126|NCT03078478|19989218|P2|COMPLETED|Maintenance Period 1 (36 Weeks)||761
8110127|NCT03078478|19989219|P1|COMPLETED|Maintenance Period 1 (36 Weeks)||758
8110128|NCT03078478|19989218|P2|STARTED|Maintenance Period 1 (36 Weeks)||804
8110129|NCT03078478|19989219|P1|STARTED|Maintenance Period 1 (36 Weeks)||805
8110130|NCT03078478|19989218|P2|NOT COMPLETED|Titration Period (16 Weeks)||0
8110131|NCT03078478|19989219|P1|NOT COMPLETED|Titration Period (16 Weeks)||0
8110132|NCT03078478|19989218|P2|COMPLETED|Titration Period (16 Weeks)||804
8110133|NCT03078478|19989219|P1|COMPLETED|Titration Period (16 Weeks)||805
8110134|NCT03078478|19989218|P2|Safety Analysis Set|Titration Period (16 Weeks)||798
8110135|NCT03078478|19989219|P1|Safety Analysis Set|Titration Period (16 Weeks)||802
8110136|NCT03078478|19989218|P2|Full Analysis Set|Titration Period (16 Weeks)||804
8110137|NCT03078478|19989219|P1|Full Analysis Set|Titration Period (16 Weeks)||805
8110138|NCT03078478|19989218|P2|STARTED|Titration Period (16 Weeks)||804
8110139|NCT03078478|19989219|P1|STARTED|Titration Period (16 Weeks)||805
8110140|NCT03078270|19989257|P2|NOT COMPLETED|Overall Study||0
8110141|NCT03078270|19989258|P1|NOT COMPLETED|Overall Study||4
8110142|NCT03078270|19989257|P2|COMPLETED|Overall Study||0
8110143|NCT03078270|19989258|P1|COMPLETED|Overall Study||0
8110144|NCT03078270|19989257|P2|STARTED|Overall Study||0
8110145|NCT03078270|19989258|P1|STARTED|Overall Study||4
8110146|NCT03078127|19989267|P3|NOT COMPLETED|Third Intervention||0
8110147|NCT03078127|19989268|P2|NOT COMPLETED|Third Intervention||0
8110148|NCT03078127|19989269|P1|NOT COMPLETED|Third Intervention||0
8110149|NCT03078127|19989267|P3|COMPLETED|Third Intervention||3
8110150|NCT03078127|19989268|P2|COMPLETED|Third Intervention||3
8110151|NCT03078127|19989269|P1|COMPLETED|Third Intervention||4
8110152|NCT03078127|19989267|P3|STARTED|Third Intervention||3
8110153|NCT03078127|19989268|P2|STARTED|Third Intervention||3
8110154|NCT03078127|19989269|P1|STARTED|Third Intervention||4
8110155|NCT03078127|19989267|P3|NOT COMPLETED|Washout (3-21 Days)||0
8110156|NCT03078127|19989268|P2|NOT COMPLETED|Washout (3-21 Days)||0
8110157|NCT03078127|19989269|P1|NOT COMPLETED|Washout (3-21 Days)||0
8110158|NCT03078127|19989267|P3|COMPLETED|Washout (3-21 Days)||3
8110159|NCT03078127|19989268|P2|COMPLETED|Washout (3-21 Days)||3
8110160|NCT03078127|19989269|P1|COMPLETED|Washout (3-21 Days)||4
8110161|NCT03078127|19989267|P3|STARTED|Washout (3-21 Days)||3
8110162|NCT03078127|19989268|P2|STARTED|Washout (3-21 Days)||3
8110163|NCT03078127|19989269|P1|STARTED|Washout (3-21 Days)||4
8110164|NCT03078127|19989267|P3|NOT COMPLETED|Second Intervention||0
8110165|NCT03078127|19989268|P2|NOT COMPLETED|Second Intervention||0
8110166|NCT03078127|19989269|P1|NOT COMPLETED|Second Intervention||0
8110167|NCT03078127|19989267|P3|COMPLETED|Second Intervention||3
8110168|NCT03078127|19989268|P2|COMPLETED|Second Intervention||3
8110169|NCT03078127|19989269|P1|COMPLETED|Second Intervention||4
8110170|NCT03078127|19989267|P3|STARTED|Second Intervention||3
8110171|NCT03078127|19989268|P2|STARTED|Second Intervention||3
8110172|NCT03078127|19989269|P1|STARTED|Second Intervention||4
8110173|NCT03078127|19989267|P3|NOT COMPLETED|Washout (3-21 Days)||0
8110174|NCT03078127|19989268|P2|NOT COMPLETED|Washout (3-21 Days)||0
8110175|NCT03078127|19989269|P1|NOT COMPLETED|Washout (3-21 Days)||0
8110176|NCT03078127|19989267|P3|COMPLETED|Washout (3-21 Days)||3
8110177|NCT03078127|19989268|P2|COMPLETED|Washout (3-21 Days)||3
8110178|NCT03078127|19989269|P1|COMPLETED|Washout (3-21 Days)||4
8110179|NCT03078127|19989267|P3|STARTED|Washout (3-21 Days)||3
8110180|NCT03078127|19989268|P2|STARTED|Washout (3-21 Days)||3
8110181|NCT03078127|19989269|P1|STARTED|Washout (3-21 Days)||4
8110182|NCT03078127|19989267|P3|NOT COMPLETED|First Intervention||0
8110183|NCT03078127|19989268|P2|NOT COMPLETED|First Intervention||0
8110184|NCT03078127|19989269|P1|NOT COMPLETED|First Intervention||0
8110185|NCT03078127|19989267|P3|COMPLETED|First Intervention||3
8110186|NCT03078127|19989268|P2|COMPLETED|First Intervention||3
8110187|NCT03078127|19989269|P1|COMPLETED|First Intervention||4
8110188|NCT03078127|19989267|P3|STARTED|First Intervention||3
8110189|NCT03078127|19989268|P2|STARTED|First Intervention||3
8110190|NCT03078127|19989269|P1|STARTED|First Intervention||4
8110191|NCT03077919|19989305|P2|NOT COMPLETED|Overall Study||1
8110192|NCT03077919|19989306|P1|NOT COMPLETED|Overall Study||4
8110193|NCT03077919|19989305|P2|COMPLETED|Overall Study||38
8110194|NCT03077919|19989306|P1|COMPLETED|Overall Study||70
8110195|NCT03077919|19989305|P2|Final CAPS|Overall Study||38
8110196|NCT03077919|19989306|P1|Final CAPS|Overall Study||70
8110197|NCT03077919|19989305|P2|Week 8 Visit|Overall Study||38
8110198|NCT03077919|19989306|P1|Week 8 Visit|Overall Study||71
8110199|NCT03077919|19989305|P2|Week 6 Visit|Overall Study||38
8110200|NCT03077919|19989306|P1|Week 6 Visit|Overall Study||73
8110201|NCT03077919|19989305|P2|Week 4 Visit|Overall Study||38
8110202|NCT03077919|19989306|P1|Week 4 Visit|Overall Study||73
8110203|NCT03077919|19989305|P2|Week 2 Visit|Overall Study||39
8110204|NCT03077919|19989306|P1|Week 2 Visit|Overall Study||74
8110205|NCT03077919|19989305|P2|STARTED|Overall Study||39
8110206|NCT03077919|19989306|P1|STARTED|Overall Study||74
8110207|NCT03077893|19989336|P2|NOT COMPLETED|Overall Study||3
8110208|NCT03077893|19989337|P1|NOT COMPLETED|Overall Study||4
8110209|NCT03077893|19989336|P2|COMPLETED|Overall Study||16
8110210|NCT03077893|19989337|P1|COMPLETED|Overall Study||14
8110211|NCT03077893|19989336|P2|STARTED|Overall Study||19
8110212|NCT03077893|19989337|P1|STARTED|Overall Study||18
8110213|NCT03077724|19989366|P2|NOT COMPLETED|Overall Study||2
8110214|NCT03077724|19989367|P1|NOT COMPLETED|Overall Study||8
8110215|NCT03077724|19989366|P2|COMPLETED|Overall Study||12
8110216|NCT03077724|19989367|P1|COMPLETED|Overall Study||6
8110217|NCT03077724|19989366|P2|STARTED|Overall Study||14
8110218|NCT03077724|19989367|P1|STARTED|Overall Study||14
8110219|NCT03077711|19989379|P2|NOT COMPLETED|Overall Study||2
8110220|NCT03077711|19989380|P1|NOT COMPLETED|Overall Study||4
8110221|NCT03077711|19989379|P2|COMPLETED|Overall Study||43
8110222|NCT03077711|19989380|P1|COMPLETED|Overall Study||43
8110223|NCT03077711|19989379|P2|STARTED|Overall Study||45
8110224|NCT03077711|19989380|P1|STARTED|Overall Study||47
8110225|NCT03077659|19989399|P3|NOT COMPLETED|Overall Study||1
8110226|NCT03077659|19989400|P2|NOT COMPLETED|Overall Study||0
8110227|NCT03077659|19989401|P1|NOT COMPLETED|Overall Study||0
8110228|NCT03077659|19989399|P3|COMPLETED|Overall Study||9
8110229|NCT03077659|19989400|P2|COMPLETED|Overall Study||3
8110230|NCT03077659|19989401|P1|COMPLETED|Overall Study||3
8110231|NCT03077659|19989399|P3|STARTED|Overall Study||10
8110232|NCT03077659|19989400|P2|STARTED|Overall Study||3
8110233|NCT03077659|19989401|P1|STARTED|Overall Study||3
8110234|NCT03077607|19989432|P2|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
8110235|NCT03077607|19989433|P1|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
8110236|NCT03077607|19989432|P2|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
8110237|NCT03077607|19989433|P1|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
8110238|NCT03077607|19989432|P2|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
8110239|NCT03077607|19989433|P1|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
8110240|NCT03077607|19989432|P2|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8110241|NCT03077607|19989433|P1|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8110242|NCT03077607|19989432|P2|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8110243|NCT03077607|19989433|P1|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8110244|NCT03077607|19989432|P2|NOT COMPLETED|Period 1 (15 Days)||0
8110245|NCT03077607|19989433|P1|NOT COMPLETED|Period 1 (15 Days)||2
8110246|NCT03077607|19989432|P2|COMPLETED|Period 1 (15 Days)||17
8110247|NCT03077607|19989433|P1|COMPLETED|Period 1 (15 Days)||17
8110248|NCT03077607|19989432|P2|Received Talazoparib|Period 1 (15 Days)||17
8110249|NCT03077607|19989433|P1|Received Talazoparib|Period 1 (15 Days)||19
8110250|NCT03077607|19989432|P2|Treated (With Any Study Drug)|Period 1 (15 Days)||17
8110251|NCT03077607|19989433|P1|Treated (With Any Study Drug)|Period 1 (15 Days)||19
8110252|NCT03077607|19989432|P2|STARTED|Period 1 (15 Days)||17
8110253|NCT03077607|19989433|P1|STARTED|Period 1 (15 Days)||19
8110254|NCT03077438|19989501|P2|NOT COMPLETED|Overall Study||14
8110255|NCT03077438|19989502|P1|NOT COMPLETED|Overall Study||12
8110256|NCT03077438|19989501|P2|COMPLETED|Overall Study||487
8110257|NCT03077438|19989502|P1|COMPLETED|Overall Study||487
8110258|NCT03077438|19989501|P2|Safety Analysis Set (SafAS)|Overall Study||494
8110259|NCT03077438|19989502|P1|Safety Analysis Set (SafAS)|Overall Study||498
8110260|NCT03077438|19989501|P2|STARTED|Overall Study||501
8110261|NCT03077438|19989502|P1|STARTED|Overall Study||499
8110262|NCT03077165|19989524|P6|NOT COMPLETED|Overall Study||0
8110263|NCT03077165|19989525|P5|NOT COMPLETED|Overall Study||3
8110264|NCT03077165|19989526|P4|NOT COMPLETED|Overall Study||0
8110265|NCT03077165|19989527|P3|NOT COMPLETED|Overall Study||0
8110266|NCT03077165|19989528|P2|NOT COMPLETED|Overall Study||0
8110267|NCT03077165|19989529|P1|NOT COMPLETED|Overall Study||1
8110268|NCT03077165|19989524|P6|COMPLETED|Overall Study||20
8110269|NCT03077165|19989525|P5|COMPLETED|Overall Study||16
8110270|NCT03077165|19989526|P4|COMPLETED|Overall Study||19
8110271|NCT03077165|19989527|P3|COMPLETED|Overall Study||20
8110272|NCT03077165|19989528|P2|COMPLETED|Overall Study||22
8110273|NCT03077165|19989529|P1|COMPLETED|Overall Study||20
8110274|NCT03077165|19989524|P6|STARTED|Overall Study||20
8110275|NCT03077165|19989525|P5|STARTED|Overall Study||19
8110276|NCT03077165|19989526|P4|STARTED|Overall Study||19
8110277|NCT03077165|19989527|P3|STARTED|Overall Study||20
8110278|NCT03077165|19989528|P2|STARTED|Overall Study||22
8110279|NCT03077165|19989529|P1|STARTED|Overall Study||21
8110280|NCT03076996|19989543|P1|NOT COMPLETED|Overall Study||6
8110281|NCT03076996|19989543|P1|COMPLETED|Overall Study||35
8110282|NCT03076996|19989543|P1|STARTED|Overall Study||41
8110283|NCT03076983|19989552|P2|NOT COMPLETED|Overall Study||0
8110284|NCT03076983|19989553|P1|NOT COMPLETED|Overall Study||0
8110285|NCT03076983|19989552|P2|COMPLETED|Overall Study||25
8110286|NCT03076983|19989553|P1|COMPLETED|Overall Study||55
8110287|NCT03076983|19989552|P2|STARTED|Overall Study||25
8110288|NCT03076983|19989553|P1|STARTED|Overall Study||55
8110289|NCT03076970|19989569|P6|NOT COMPLETED|Washout Period 3||0
8110290|NCT03076970|19989570|P5|NOT COMPLETED|Washout Period 3||0
8110291|NCT03076970|19989571|P4|NOT COMPLETED|Washout Period 3||0
8110292|NCT03076970|19989572|P3|NOT COMPLETED|Washout Period 3||0
8110293|NCT03076970|19989573|P2|NOT COMPLETED|Washout Period 3||0
8110294|NCT03076970|19989574|P1|NOT COMPLETED|Washout Period 3||0
8110295|NCT03076970|19989569|P6|COMPLETED|Washout Period 3||6
8110296|NCT03076970|19989570|P5|COMPLETED|Washout Period 3||5
8110297|NCT03076970|19989571|P4|COMPLETED|Washout Period 3||7
8110298|NCT03076970|19989572|P3|COMPLETED|Washout Period 3||7
8110299|NCT03076970|19989573|P2|COMPLETED|Washout Period 3||7
8110300|NCT03076970|19989574|P1|COMPLETED|Washout Period 3||7
8110301|NCT03076970|19989569|P6|STARTED|Washout Period 3||6
8110302|NCT03076970|19989570|P5|STARTED|Washout Period 3||5
8110303|NCT03076970|19989571|P4|STARTED|Washout Period 3||7
8110304|NCT03076970|19989572|P3|STARTED|Washout Period 3||7
8110305|NCT03076970|19989573|P2|STARTED|Washout Period 3||7
8110306|NCT03076970|19989574|P1|STARTED|Washout Period 3||7
8110307|NCT03076970|19989569|P6|NOT COMPLETED|Period 3||1
8110308|NCT03076970|19989570|P5|NOT COMPLETED|Period 3||1
8110309|NCT03076970|19989571|P4|NOT COMPLETED|Period 3||0
8110310|NCT03076970|19989572|P3|NOT COMPLETED|Period 3||0
8110311|NCT03076970|19989573|P2|NOT COMPLETED|Period 3||0
8110312|NCT03076970|19989574|P1|NOT COMPLETED|Period 3||0
8110313|NCT03076970|19989569|P6|COMPLETED|Period 3||6
8110314|NCT03076970|19989570|P5|COMPLETED|Period 3||5
8110315|NCT03076970|19989571|P4|COMPLETED|Period 3||7
8110316|NCT03076970|19989572|P3|COMPLETED|Period 3||7
8110317|NCT03076970|19989573|P2|COMPLETED|Period 3||7
8110318|NCT03076970|19989574|P1|COMPLETED|Period 3||7
8110319|NCT03076970|19989569|P6|STARTED|Period 3||7
8110320|NCT03076970|19989570|P5|STARTED|Period 3||6
8110321|NCT03076970|19989571|P4|STARTED|Period 3||7
8110322|NCT03076970|19989572|P3|STARTED|Period 3||7
8110323|NCT03076970|19989573|P2|STARTED|Period 3||7
8110324|NCT03076970|19989574|P1|STARTED|Period 3||7
8110325|NCT03076970|19989569|P6|NOT COMPLETED|Washout Period 2||0
8110326|NCT03076970|19989570|P5|NOT COMPLETED|Washout Period 2||1
8110327|NCT03076970|19989571|P4|NOT COMPLETED|Washout Period 2||0
8110328|NCT03076970|19989572|P3|NOT COMPLETED|Washout Period 2||0
8110329|NCT03076970|19989573|P2|NOT COMPLETED|Washout Period 2||0
8110330|NCT03076970|19989574|P1|NOT COMPLETED|Washout Period 2||0
8110331|NCT03076970|19989569|P6|COMPLETED|Washout Period 2||7
8110332|NCT03076970|19989570|P5|COMPLETED|Washout Period 2||6
8110333|NCT03076970|19989571|P4|COMPLETED|Washout Period 2||7
8110334|NCT03076970|19989572|P3|COMPLETED|Washout Period 2||7
8110335|NCT03076970|19989573|P2|COMPLETED|Washout Period 2||7
8110336|NCT03076970|19989574|P1|COMPLETED|Washout Period 2||7
8110337|NCT03076970|19989569|P6|STARTED|Washout Period 2||7
8110338|NCT03076970|19989570|P5|STARTED|Washout Period 2||7
8110339|NCT03076970|19989571|P4|STARTED|Washout Period 2||7
8110340|NCT03076970|19989572|P3|STARTED|Washout Period 2||7
8110341|NCT03076970|19989573|P2|STARTED|Washout Period 2||7
8110342|NCT03076970|19989574|P1|STARTED|Washout Period 2||7
8110343|NCT03076970|19989569|P6|NOT COMPLETED|Period 2||0
8110344|NCT03076970|19989570|P5|NOT COMPLETED|Period 2||0
8110345|NCT03076970|19989571|P4|NOT COMPLETED|Period 2||0
8110346|NCT03076970|19989572|P3|NOT COMPLETED|Period 2||0
8110347|NCT03076970|19989573|P2|NOT COMPLETED|Period 2||0
8110348|NCT03076970|19989574|P1|NOT COMPLETED|Period 2||0
8110349|NCT03076970|19989569|P6|COMPLETED|Period 2||7
8110350|NCT03076970|19989570|P5|COMPLETED|Period 2||7
8110351|NCT03076970|19989571|P4|COMPLETED|Period 2||7
8110352|NCT03076970|19989572|P3|COMPLETED|Period 2||7
8110353|NCT03076970|19989573|P2|COMPLETED|Period 2||7
8110354|NCT03076970|19989574|P1|COMPLETED|Period 2||7
8110355|NCT03076970|19989569|P6|STARTED|Period 2||7
8110356|NCT03076970|19989570|P5|STARTED|Period 2||7
8110357|NCT03076970|19989571|P4|STARTED|Period 2||7
8110358|NCT03076970|19989572|P3|STARTED|Period 2||7
8110359|NCT03076970|19989573|P2|STARTED|Period 2||7
8110360|NCT03076970|19989574|P1|STARTED|Period 2||7
8110361|NCT03076970|19989569|P6|NOT COMPLETED|Washout Period 1||0
8110362|NCT03076970|19989570|P5|NOT COMPLETED|Washout Period 1||0
8110363|NCT03076970|19989571|P4|NOT COMPLETED|Washout Period 1||0
8110364|NCT03076970|19989572|P3|NOT COMPLETED|Washout Period 1||0
8110365|NCT03076970|19989573|P2|NOT COMPLETED|Washout Period 1||0
8110366|NCT03076970|19989574|P1|NOT COMPLETED|Washout Period 1||0
8110367|NCT03076970|19989569|P6|COMPLETED|Washout Period 1||7
8110368|NCT03076970|19989570|P5|COMPLETED|Washout Period 1||7
8110369|NCT03076970|19989571|P4|COMPLETED|Washout Period 1||7
8110370|NCT03076970|19989572|P3|COMPLETED|Washout Period 1||7
8110371|NCT03076970|19989573|P2|COMPLETED|Washout Period 1||7
8110372|NCT03076970|19989574|P1|COMPLETED|Washout Period 1||7
8110373|NCT03076970|19989569|P6|STARTED|Washout Period 1||7
8110374|NCT03076970|19989570|P5|STARTED|Washout Period 1||7
8110375|NCT03076970|19989571|P4|STARTED|Washout Period 1||7
8110376|NCT03076970|19989572|P3|STARTED|Washout Period 1||7
8110377|NCT03076970|19989573|P2|STARTED|Washout Period 1||7
8110378|NCT03076970|19989574|P1|STARTED|Washout Period 1||7
8110379|NCT03076970|19989569|P6|NOT COMPLETED|Period 1||0
8110380|NCT03076970|19989570|P5|NOT COMPLETED|Period 1||0
8110381|NCT03076970|19989571|P4|NOT COMPLETED|Period 1||0
8110382|NCT03076970|19989572|P3|NOT COMPLETED|Period 1||0
8110383|NCT03076970|19989573|P2|NOT COMPLETED|Period 1||0
8110384|NCT03076970|19989574|P1|NOT COMPLETED|Period 1||0
8110385|NCT03076970|19989569|P6|COMPLETED|Period 1||7
8110386|NCT03076970|19989570|P5|COMPLETED|Period 1||7
8110387|NCT03076970|19989571|P4|COMPLETED|Period 1||7
8110388|NCT03076970|19989572|P3|COMPLETED|Period 1||7
8110389|NCT03076970|19989573|P2|COMPLETED|Period 1||7
8110390|NCT03076970|19989574|P1|COMPLETED|Period 1||7
8110391|NCT03076970|19989569|P6|Received at Least 1 Dose of Study Drug|Period 1||7
8110392|NCT03076970|19989570|P5|Received at Least 1 Dose of Study Drug|Period 1||7
8110393|NCT03076970|19989571|P4|Received at Least 1 Dose of Study Drug|Period 1||7
8110394|NCT03076970|19989572|P3|Received at Least 1 Dose of Study Drug|Period 1||7
8110395|NCT03076970|19989573|P2|Received at Least 1 Dose of Study Drug|Period 1||7
8110396|NCT03076970|19989574|P1|Received at Least 1 Dose of Study Drug|Period 1||7
8110397|NCT03076970|19989569|P6|STARTED|Period 1||7
8110398|NCT03076970|19989570|P5|STARTED|Period 1||7
8110399|NCT03076970|19989571|P4|STARTED|Period 1||7
8110400|NCT03076970|19989572|P3|STARTED|Period 1||7
8110401|NCT03076970|19989573|P2|STARTED|Period 1||7
8110402|NCT03076970|19989574|P1|STARTED|Period 1||7
8110403|NCT03076515|19989626|P2|NOT COMPLETED|Overall Study||29
8110404|NCT03076515|19989627|P1|NOT COMPLETED|Overall Study||25
8110405|NCT03076515|19989626|P2|COMPLETED|Overall Study||33
8110406|NCT03076515|19989627|P1|COMPLETED|Overall Study||33
8110407|NCT03076515|19989626|P2|STARTED|Overall Study||62
8110408|NCT03076515|19989627|P1|STARTED|Overall Study||58
8110409|NCT03076359|19989635|P2|NOT COMPLETED|Overall Study||0
8110410|NCT03076359|19989636|P1|NOT COMPLETED|Overall Study||0
8110411|NCT03076359|19989635|P2|COMPLETED|Overall Study||150
8110412|NCT03076359|19989636|P1|COMPLETED|Overall Study||170
8110413|NCT03076359|19989635|P2|STARTED|Overall Study||150
8110414|NCT03076359|19989636|P1|STARTED|Overall Study||170
8110415|NCT03076190|19989646|P2|NOT COMPLETED|Overall Study||41
8110416|NCT03076190|19989647|P1|NOT COMPLETED|Overall Study||18
8110417|NCT03076190|19989646|P2|COMPLETED|Overall Study||36
8110418|NCT03076190|19989647|P1|COMPLETED|Overall Study||32
8110419|NCT03076190|19989646|P2|STARTED|Overall Study||77
8110420|NCT03076190|19989647|P1|STARTED|Overall Study||50
8110421|NCT03075904|19989660|P1|NOT COMPLETED|Overall Study||4
8110422|NCT03075904|19989660|P1|COMPLETED|Overall Study||4
8110423|NCT03075904|19989660|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8110424|NCT03075904|19989660|P1|STARTED|Overall Study||8
8110425|NCT03075891|19989670|P2|NOT COMPLETED|Overall Study||13
8110426|NCT03075891|19989671|P1|NOT COMPLETED|Overall Study||9
8110427|NCT03075891|19989670|P2|COMPLETED|Overall Study||125
8110428|NCT03075891|19989671|P1|COMPLETED|Overall Study||126
8110429|NCT03075891|19989670|P2|STARTED|Overall Study||138
8110430|NCT03075891|19989671|P1|STARTED|Overall Study||135
8110431|NCT03075878|19989677|P1|NOT COMPLETED|Overall Study||1
8110432|NCT03075878|19989677|P1|COMPLETED|Overall Study||7
8110433|NCT03075878|19989677|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8110434|NCT03075878|19989677|P1|STARTED|Overall Study||8
8110435|NCT03075839|19989685|P1|NOT COMPLETED|Overall Study||4
8110436|NCT03075839|19989685|P1|COMPLETED|Overall Study||29
8110437|NCT03075839|19989685|P1|STARTED|Overall Study||33
8110438|NCT03075644|19989693|P2|NOT COMPLETED|Overall Study||1
8110439|NCT03075644|19989694|P1|NOT COMPLETED|Overall Study||1
8110440|NCT03075644|19989693|P2|COMPLETED|Overall Study||45
8110441|NCT03075644|19989694|P1|COMPLETED|Overall Study||15
8110442|NCT03075644|19989693|P2|Safety Analysis Set (SAS)|Overall Study||46
8110443|NCT03075644|19989694|P1|Safety Analysis Set (SAS)|Overall Study||16
8110444|NCT03075644|19989693|P2|Full Analysis Set (FAS)|Overall Study||46
8110445|NCT03075644|19989694|P1|Full Analysis Set (FAS)|Overall Study||16
8110446|NCT03075644|19989693|P2|STARTED|Overall Study||46
8110447|NCT03075644|19989694|P1|STARTED|Overall Study||16
8110448|NCT03075553|19989755|P1|NOT COMPLETED|Overall Study||0
8110449|NCT03075553|19989755|P1|COMPLETED|Overall Study||12
8110450|NCT03075553|19989755|P1|STARTED|Overall Study||12
8110451|NCT03075527|19989764|P1|NOT COMPLETED|Overall Study||2
8110452|NCT03075527|19989764|P1|COMPLETED|Overall Study||17
8110453|NCT03075527|19989764|P1|STARTED|Overall Study||19
8110454|NCT03075449|19989768|P1|NOT COMPLETED|Overall Study||0
8110455|NCT03075449|19989768|P1|COMPLETED|Overall Study||170
8110456|NCT03075449|19989768|P1|STARTED|Overall Study||170
8110457|NCT03075410|19989788|P9|NOT COMPLETED|Part B (up to 28 Days)||0
8110458|NCT03075410|19989789|P8|NOT COMPLETED|Part B (up to 28 Days)||0
8110459|NCT03075410|19989790|P7|NOT COMPLETED|Part B (up to 28 Days)||0
8110460|NCT03075410|19989791|P6|NOT COMPLETED|Part B (up to 28 Days)||0
8110461|NCT03075410|19989792|P5|NOT COMPLETED|Part B (up to 28 Days)||0
8110462|NCT03075410|19989793|P4|NOT COMPLETED|Part B (up to 28 Days)||0
8110463|NCT03075410|19989794|P3|NOT COMPLETED|Part B (up to 28 Days)||0
8110464|NCT03075410|19989795|P2|NOT COMPLETED|Part B (up to 28 Days)||0
8110465|NCT03075410|19989796|P1|NOT COMPLETED|Part B (up to 28 Days)||0
8110466|NCT03075410|19989788|P9|COMPLETED|Part B (up to 28 Days)||8
8110467|NCT03075410|19989789|P8|COMPLETED|Part B (up to 28 Days)||7
8110468|NCT03075410|19989790|P7|COMPLETED|Part B (up to 28 Days)||4
8110469|NCT03075410|19989791|P6|COMPLETED|Part B (up to 28 Days)||0
8110470|NCT03075410|19989792|P5|COMPLETED|Part B (up to 28 Days)||0
8110471|NCT03075410|19989793|P4|COMPLETED|Part B (up to 28 Days)||0
8110472|NCT03075410|19989794|P3|COMPLETED|Part B (up to 28 Days)||0
8110473|NCT03075410|19989795|P2|COMPLETED|Part B (up to 28 Days)||0
8110474|NCT03075410|19989796|P1|COMPLETED|Part B (up to 28 Days)||0
8110475|NCT03075410|19989788|P9|STARTED|Part B (up to 28 Days)||8
8110476|NCT03075410|19989789|P8|STARTED|Part B (up to 28 Days)||7
8110477|NCT03075410|19989790|P7|STARTED|Part B (up to 28 Days)||4
8110478|NCT03075410|19989791|P6|STARTED|Part B (up to 28 Days)||0
8110479|NCT03075410|19989792|P5|STARTED|Part B (up to 28 Days)||0
8110480|NCT03075410|19989793|P4|STARTED|Part B (up to 28 Days)||0
8110481|NCT03075410|19989794|P3|STARTED|Part B (up to 28 Days)||0
8110482|NCT03075410|19989795|P2|STARTED|Part B (up to 28 Days)||0
8110483|NCT03075410|19989796|P1|STARTED|Part B (up to 28 Days)||0
8110484|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110485|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110486|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110487|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110488|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110489|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110490|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110491|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110492|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110493|NCT03075410|19989788|P9|COMPLETED|Part A-Period 4 (14 Days)||0
8110494|NCT03075410|19989789|P8|COMPLETED|Part A-Period 4 (14 Days)||0
8110495|NCT03075410|19989790|P7|COMPLETED|Part A-Period 4 (14 Days)||0
8110496|NCT03075410|19989791|P6|COMPLETED|Part A-Period 4 (14 Days)||1
8110497|NCT03075410|19989792|P5|COMPLETED|Part A-Period 4 (14 Days)||2
8110498|NCT03075410|19989793|P4|COMPLETED|Part A-Period 4 (14 Days)||1
8110499|NCT03075410|19989794|P3|COMPLETED|Part A-Period 4 (14 Days)||2
8110500|NCT03075410|19989795|P2|COMPLETED|Part A-Period 4 (14 Days)||1
8110501|NCT03075410|19989796|P1|COMPLETED|Part A-Period 4 (14 Days)||1
8110502|NCT03075410|19989788|P9|STARTED|Part A-Period 4 (14 Days)||0
8110503|NCT03075410|19989789|P8|STARTED|Part A-Period 4 (14 Days)||0
8110504|NCT03075410|19989790|P7|STARTED|Part A-Period 4 (14 Days)||0
8110505|NCT03075410|19989791|P6|STARTED|Part A-Period 4 (14 Days)||1
8110506|NCT03075410|19989792|P5|STARTED|Part A-Period 4 (14 Days)||2
8110507|NCT03075410|19989793|P4|STARTED|Part A-Period 4 (14 Days)||1
8110508|NCT03075410|19989794|P3|STARTED|Part A-Period 4 (14 Days)||2
8110509|NCT03075410|19989795|P2|STARTED|Part A-Period 4 (14 Days)||1
8110510|NCT03075410|19989796|P1|STARTED|Part A-Period 4 (14 Days)||1
8110511|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110512|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110513|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110514|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110515|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110516|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110517|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110518|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110519|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110520|NCT03075410|19989788|P9|COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110521|NCT03075410|19989789|P8|COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110522|NCT03075410|19989790|P7|COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110523|NCT03075410|19989791|P6|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110524|NCT03075410|19989792|P5|COMPLETED|Part A-Washout Period 3 (14 Days)||2
8110525|NCT03075410|19989793|P4|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110526|NCT03075410|19989794|P3|COMPLETED|Part A-Washout Period 3 (14 Days)||2
8110527|NCT03075410|19989795|P2|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110528|NCT03075410|19989796|P1|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110529|NCT03075410|19989788|P9|STARTED|Part A-Washout Period 3 (14 Days)||0
8110530|NCT03075410|19989789|P8|STARTED|Part A-Washout Period 3 (14 Days)||0
8110531|NCT03075410|19989790|P7|STARTED|Part A-Washout Period 3 (14 Days)||0
8110532|NCT03075410|19989791|P6|STARTED|Part A-Washout Period 3 (14 Days)||1
8110533|NCT03075410|19989792|P5|STARTED|Part A-Washout Period 3 (14 Days)||2
8110534|NCT03075410|19989793|P4|STARTED|Part A-Washout Period 3 (14 Days)||1
8110535|NCT03075410|19989794|P3|STARTED|Part A-Washout Period 3 (14 Days)||2
8110536|NCT03075410|19989795|P2|STARTED|Part A-Washout Period 3 (14 Days)||1
8110537|NCT03075410|19989796|P1|STARTED|Part A-Washout Period 3 (14 Days)||1
8110538|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110539|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110540|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110541|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110542|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110543|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110544|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110545|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110546|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 3 (14 Days)||1
8110547|NCT03075410|19989788|P9|COMPLETED|Part A-Period 3 (14 Days)||0
8110548|NCT03075410|19989789|P8|COMPLETED|Part A-Period 3 (14 Days)||0
8110549|NCT03075410|19989790|P7|COMPLETED|Part A-Period 3 (14 Days)||0
8110550|NCT03075410|19989791|P6|COMPLETED|Part A-Period 3 (14 Days)||1
8110551|NCT03075410|19989792|P5|COMPLETED|Part A-Period 3 (14 Days)||2
8110552|NCT03075410|19989793|P4|COMPLETED|Part A-Period 3 (14 Days)||1
8110553|NCT03075410|19989794|P3|COMPLETED|Part A-Period 3 (14 Days)||2
8110554|NCT03075410|19989795|P2|COMPLETED|Part A-Period 3 (14 Days)||1
8110555|NCT03075410|19989796|P1|COMPLETED|Part A-Period 3 (14 Days)||1
8110556|NCT03075410|19989788|P9|STARTED|Part A-Period 3 (14 Days)||0
8110557|NCT03075410|19989789|P8|STARTED|Part A-Period 3 (14 Days)||0
8110558|NCT03075410|19989790|P7|STARTED|Part A-Period 3 (14 Days)||0
8110559|NCT03075410|19989791|P6|STARTED|Part A-Period 3 (14 Days)||1
8110560|NCT03075410|19989792|P5|STARTED|Part A-Period 3 (14 Days)||2
8110561|NCT03075410|19989793|P4|STARTED|Part A-Period 3 (14 Days)||1
8110562|NCT03075410|19989794|P3|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
8110563|NCT03075410|19989795|P2|STARTED|Part A-Period 3 (14 Days)||1
8110564|NCT03075410|19989796|P1|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
8110565|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110566|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110567|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110568|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110569|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110570|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110571|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110572|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110573|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110574|NCT03075410|19989788|P9|COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110575|NCT03075410|19989789|P8|COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110576|NCT03075410|19989790|P7|COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110577|NCT03075410|19989791|P6|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110578|NCT03075410|19989792|P5|COMPLETED|Part A-Washout Period 2 (14 Days)||2
8110579|NCT03075410|19989793|P4|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110580|NCT03075410|19989794|P3|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110581|NCT03075410|19989795|P2|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110582|NCT03075410|19989796|P1|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110583|NCT03075410|19989788|P9|STARTED|Part A-Washout Period 2 (14 Days)||0
8110584|NCT03075410|19989789|P8|STARTED|Part A-Washout Period 2 (14 Days)||0
8110585|NCT03075410|19989790|P7|STARTED|Part A-Washout Period 2 (14 Days)||0
8110586|NCT03075410|19989791|P6|STARTED|Part A-Washout Period 2 (14 Days)||1
8110587|NCT03075410|19989792|P5|STARTED|Part A-Washout Period 2 (14 Days)||2
8110588|NCT03075410|19989793|P4|STARTED|Part A-Washout Period 2 (14 Days)||1
8110589|NCT03075410|19989794|P3|STARTED|Part A-Washout Period 2 (14 Days)||1
8110590|NCT03075410|19989795|P2|STARTED|Part A-Washout Period 2 (14 Days)||1
8110591|NCT03075410|19989796|P1|STARTED|Part A-Washout Period 2 (14 Days)||1
8110592|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110593|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110594|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110595|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110596|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110597|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110598|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 2 (14 Days)||1
8110599|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110600|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 2 (14 Days)||1
8110601|NCT03075410|19989788|P9|COMPLETED|Part A-Period 2 (14 Days)||0
8110602|NCT03075410|19989789|P8|COMPLETED|Part A-Period 2 (14 Days)||0
8110603|NCT03075410|19989790|P7|COMPLETED|Part A-Period 2 (14 Days)||0
8110604|NCT03075410|19989791|P6|COMPLETED|Part A-Period 2 (14 Days)||1
8110605|NCT03075410|19989792|P5|COMPLETED|Part A-Period 2 (14 Days)||2
8110606|NCT03075410|19989793|P4|COMPLETED|Part A-Period 2 (14 Days)||1
8110607|NCT03075410|19989794|P3|COMPLETED|Part A-Period 2 (14 Days)||1
8110608|NCT03075410|19989795|P2|COMPLETED|Part A-Period 2 (14 Days)||1
8110609|NCT03075410|19989796|P1|COMPLETED|Part A-Period 2 (14 Days)||1
8110610|NCT03075410|19989788|P9|STARTED|Part A-Period 2 (14 Days)||0
8110611|NCT03075410|19989789|P8|STARTED|Part A-Period 2 (14 Days)||0
8110612|NCT03075410|19989790|P7|STARTED|Part A-Period 2 (14 Days)||0
8110613|NCT03075410|19989791|P6|STARTED|Part A-Period 2 (14 Days)||1
8110614|NCT03075410|19989792|P5|STARTED|Part A-Period 2 (14 Days)||2
8110615|NCT03075410|19989793|P4|STARTED|Part A-Period 2 (14 Days)||1
8110616|NCT03075410|19989794|P3|STARTED|Part A-Period 2 (14 Days)||2
8110617|NCT03075410|19989795|P2|STARTED|Part A-Period 2 (14 Days)||1
8110618|NCT03075410|19989796|P1|STARTED|Part A-Period 2 (14 Days)||2
8110619|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110620|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110621|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110622|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110623|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110624|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110625|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110626|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110627|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110628|NCT03075410|19989788|P9|COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110629|NCT03075410|19989789|P8|COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110630|NCT03075410|19989790|P7|COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110631|NCT03075410|19989791|P6|COMPLETED|Part A-Washout Period 1 (14 Days)||1
8110632|NCT03075410|19989792|P5|COMPLETED|Part A-Washout Period 1 (14 Days)||2
8110633|NCT03075410|19989793|P4|COMPLETED|Part A-Washout Period 1 (14 Days)||1
8110634|NCT03075410|19989794|P3|COMPLETED|Part A-Washout Period 1 (14 Days)||2
8110635|NCT03075410|19989795|P2|COMPLETED|Part A-Washout Period 1 (14 Days)||1
8110636|NCT03075410|19989796|P1|COMPLETED|Part A-Washout Period 1 (14 Days)||2
8110637|NCT03075410|19989788|P9|STARTED|Part A-Washout Period 1 (14 Days)||0
8110638|NCT03075410|19989789|P8|STARTED|Part A-Washout Period 1 (14 Days)||0
8110639|NCT03075410|19989790|P7|STARTED|Part A-Washout Period 1 (14 Days)||0
8110640|NCT03075410|19989791|P6|STARTED|Part A-Washout Period 1 (14 Days)||1
8110641|NCT03075410|19989792|P5|STARTED|Part A-Washout Period 1 (14 Days)||2
8110642|NCT03075410|19989793|P4|STARTED|Part A-Washout Period 1 (14 Days)||1
8110643|NCT03075410|19989794|P3|STARTED|Part A-Washout Period 1 (14 Days)||2
8110644|NCT03075410|19989795|P2|STARTED|Part A-Washout Period 1 (14 Days)||1
8110645|NCT03075410|19989796|P1|STARTED|Part A-Washout Period 1 (14 Days)||2
8110646|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110647|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110648|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110649|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110650|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110651|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110652|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110653|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110654|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110655|NCT03075410|19989788|P9|COMPLETED|Part A-Period 1 (14 Days)||0
8110656|NCT03075410|19989789|P8|COMPLETED|Part A-Period 1 (14 Days)||0
8110657|NCT03075410|19989790|P7|COMPLETED|Part A-Period 1 (14 Days)||0
8110658|NCT03075410|19989791|P6|COMPLETED|Part A-Period 1 (14 Days)||1
8110659|NCT03075410|19989792|P5|COMPLETED|Part A-Period 1 (14 Days)||2
8110660|NCT03075410|19989793|P4|COMPLETED|Part A-Period 1 (14 Days)||1
8110661|NCT03075410|19989794|P3|COMPLETED|Part A-Period 1 (14 Days)||2
8110662|NCT03075410|19989795|P2|COMPLETED|Part A-Period 1 (14 Days)||1
8110663|NCT03075410|19989796|P1|COMPLETED|Part A-Period 1 (14 Days)||2
8110664|NCT03075410|19989788|P9|STARTED|Part A-Period 1 (14 Days)||0
8110665|NCT03075410|19989789|P8|STARTED|Part A-Period 1 (14 Days)||0
8110666|NCT03075410|19989790|P7|STARTED|Part A-Period 1 (14 Days)||0
8110667|NCT03075410|19989791|P6|STARTED|Part A-Period 1 (14 Days)||1
8110668|NCT03075410|19989792|P5|STARTED|Part A-Period 1 (14 Days)||2
8110669|NCT03075410|19989793|P4|STARTED|Part A-Period 1 (14 Days)||1
8110670|NCT03075410|19989794|P3|STARTED|Part A-Period 1 (14 Days)||2
8110671|NCT03075410|19989795|P2|STARTED|Part A-Period 1 (14 Days)||1
8110672|NCT03075410|19989796|P1|STARTED|Part A-Period 1 (14 Days)||2
8110673|NCT03075267|19989963|P3|NOT COMPLETED|Overall Study||0
8110674|NCT03075267|19989964|P2|NOT COMPLETED|Overall Study||0
8110675|NCT03075267|19989965|P1|NOT COMPLETED|Overall Study||1
8110676|NCT03075267|19989963|P3|COMPLETED|Overall Study||32
8110677|NCT03075267|19989964|P2|COMPLETED|Overall Study||32
8110678|NCT03075267|19989965|P1|COMPLETED|Overall Study||31
8110679|NCT03075267|19989963|P3|STARTED|Overall Study||32
8110680|NCT03075267|19989964|P2|STARTED|Overall Study||32
8110681|NCT03075267|19989965|P1|STARTED|Overall Study||32
8110682|NCT03075163|19990099|P2|NOT COMPLETED|Overall Study||138
8110683|NCT03075163|19990100|P1|NOT COMPLETED|Overall Study||138
8110684|NCT03075163|19990099|P2|COMPLETED|Overall Study||12
8110685|NCT03075163|19990100|P1|COMPLETED|Overall Study||12
8110686|NCT03075163|19990099|P2|STARTED|Overall Study||150
8110687|NCT03075163|19990100|P1|STARTED|Overall Study||150
8110688|NCT03074682|19990109|P3|NOT COMPLETED|Overall Study||0
8110689|NCT03074682|19990110|P2|NOT COMPLETED|Overall Study||0
8110690|NCT03074682|19990111|P1|NOT COMPLETED|Overall Study||0
8110691|NCT03074682|19990109|P3|COMPLETED|Overall Study||18
8110692|NCT03074682|19990110|P2|COMPLETED|Overall Study||18
8110693|NCT03074682|19990111|P1|COMPLETED|Overall Study||18
8110694|NCT03074682|19990109|P3|STARTED|Overall Study||18
8110695|NCT03074682|19990110|P2|STARTED|Overall Study||18
8110696|NCT03074682|19990111|P1|STARTED|Overall Study||18
8110697|NCT03074630|19990128|P1|NOT COMPLETED|Overall Study||1
8110698|NCT03074630|19990128|P1|COMPLETED|Overall Study||11
8110699|NCT03074630|19990128|P1|STARTED|Overall Study||12
8110700|NCT03074500|19990147|P3|NOT COMPLETED|Overall Study||1
8110701|NCT03074500|19990148|P2|NOT COMPLETED|Overall Study||1
8110702|NCT03074500|19990149|P1|NOT COMPLETED|Overall Study||1
8110703|NCT03074500|19990147|P3|COMPLETED|Overall Study||10
8110704|NCT03074500|19990148|P2|COMPLETED|Overall Study||10
8110705|NCT03074500|19990149|P1|COMPLETED|Overall Study||10
8110706|NCT03074500|19990147|P3|STARTED|Overall Study||11
8110707|NCT03074500|19990148|P2|STARTED|Overall Study||11
8110708|NCT03074500|19990149|P1|STARTED|Overall Study||11
8110709|NCT03074409|19990177|P2|NOT COMPLETED|Overall Study||4
8110710|NCT03074409|19990178|P1|NOT COMPLETED|Overall Study||4
8110711|NCT03074409|19990177|P2|COMPLETED|Overall Study||38
8110712|NCT03074409|19990178|P1|COMPLETED|Overall Study||37
8110713|NCT03074409|19990177|P2|STARTED|Overall Study||42
8110714|NCT03074409|19990178|P1|STARTED|Overall Study||41
8110715|NCT03074331|19990186|P1|NOT COMPLETED|Overall Study||7
8110716|NCT03074331|19990186|P1|COMPLETED|Overall Study||123
8110717|NCT03074331|19990186|P1|STARTED|Overall Study||130
8110718|NCT03074162|19990198|P6|NOT COMPLETED|Period 3||0
8110719|NCT03074162|19990199|P5|NOT COMPLETED|Period 3||1
8110720|NCT03074162|19990200|P4|NOT COMPLETED|Period 3||0
8110721|NCT03074162|19990201|P3|NOT COMPLETED|Period 3||0
8110722|NCT03074162|19990202|P2|NOT COMPLETED|Period 3||0
8110723|NCT03074162|19990203|P1|NOT COMPLETED|Period 3||1
8110724|NCT03074162|19990198|P6|COMPLETED|Period 3||7
8110725|NCT03074162|19990199|P5|COMPLETED|Period 3||7
8110726|NCT03074162|19990200|P4|COMPLETED|Period 3||8
8110727|NCT03074162|19990201|P3|COMPLETED|Period 3||6
8110728|NCT03074162|19990202|P2|COMPLETED|Period 3||8
8110729|NCT03074162|19990203|P1|COMPLETED|Period 3||7
8110730|NCT03074162|19990198|P6|STARTED|Period 3||7
8110731|NCT03074162|19990199|P5|STARTED|Period 3||8
8110732|NCT03074162|19990200|P4|STARTED|Period 3||8
8110733|NCT03074162|19990201|P3|STARTED|Period 3||6
8110734|NCT03074162|19990202|P2|STARTED|Period 3||8
8110735|NCT03074162|19990203|P1|STARTED|Period 3||8
8110736|NCT03074162|19990198|P6|NOT COMPLETED|Period 2 Including Washout 2||1
8110737|NCT03074162|19990199|P5|NOT COMPLETED|Period 2 Including Washout 2||0
8110738|NCT03074162|19990200|P4|NOT COMPLETED|Period 2 Including Washout 2||0
8110739|NCT03074162|19990201|P3|NOT COMPLETED|Period 2 Including Washout 2||1
8110740|NCT03074162|19990202|P2|NOT COMPLETED|Period 2 Including Washout 2||0
8110741|NCT03074162|19990203|P1|NOT COMPLETED|Period 2 Including Washout 2||0
8110742|NCT03074162|19990198|P6|COMPLETED|Period 2 Including Washout 2||7
8110743|NCT03074162|19990199|P5|COMPLETED|Period 2 Including Washout 2||8
8110744|NCT03074162|19990200|P4|COMPLETED|Period 2 Including Washout 2||8
8110745|NCT03074162|19990201|P3|COMPLETED|Period 2 Including Washout 2||6
8110746|NCT03074162|19990202|P2|COMPLETED|Period 2 Including Washout 2||8
8110747|NCT03074162|19990203|P1|COMPLETED|Period 2 Including Washout 2||8
8110748|NCT03074162|19990198|P6|STARTED|Period 2 Including Washout 2||8
8110749|NCT03074162|19990199|P5|STARTED|Period 2 Including Washout 2||8
8110750|NCT03074162|19990200|P4|STARTED|Period 2 Including Washout 2||8
8110751|NCT03074162|19990201|P3|STARTED|Period 2 Including Washout 2||7
8110752|NCT03074162|19990202|P2|STARTED|Period 2 Including Washout 2||8
8110753|NCT03074162|19990203|P1|STARTED|Period 2 Including Washout 2||8
8110754|NCT03074162|19990198|P6|NOT COMPLETED|Period 1 Including Washout 1||0
8110755|NCT03074162|19990199|P5|NOT COMPLETED|Period 1 Including Washout 1||0
8110756|NCT03074162|19990200|P4|NOT COMPLETED|Period 1 Including Washout 1||0
8110757|NCT03074162|19990201|P3|NOT COMPLETED|Period 1 Including Washout 1||1
8110758|NCT03074162|19990202|P2|NOT COMPLETED|Period 1 Including Washout 1||0
8110759|NCT03074162|19990203|P1|NOT COMPLETED|Period 1 Including Washout 1||0
8110760|NCT03074162|19990198|P6|COMPLETED|Period 1 Including Washout 1||8
8110761|NCT03074162|19990199|P5|COMPLETED|Period 1 Including Washout 1||8
8110762|NCT03074162|19990200|P4|COMPLETED|Period 1 Including Washout 1||8
8110763|NCT03074162|19990201|P3|COMPLETED|Period 1 Including Washout 1||7
8110764|NCT03074162|19990202|P2|COMPLETED|Period 1 Including Washout 1||8
8110765|NCT03074162|19990203|P1|COMPLETED|Period 1 Including Washout 1||8
8110766|NCT03074162|19990198|P6|STARTED|Period 1 Including Washout 1||8
8110767|NCT03074162|19990199|P5|STARTED|Period 1 Including Washout 1||8
8110768|NCT03074162|19990200|P4|STARTED|Period 1 Including Washout 1||8
8110769|NCT03074162|19990201|P3|STARTED|Period 1 Including Washout 1||8
8110770|NCT03074162|19990202|P2|STARTED|Period 1 Including Washout 1||8
8110771|NCT03074162|19990203|P1|STARTED|Period 1 Including Washout 1||8
8110778|NCT03073798|19990265|P1|NOT COMPLETED|Overall Study||2
8110779|NCT03073798|19990265|P1|COMPLETED|Overall Study||10
8110780|NCT03073798|19990265|P1|STARTED|Overall Study||12
8110781|NCT03073759|19990278|P2|NOT COMPLETED|Overall Study||0
8110782|NCT03073759|19990279|P1|NOT COMPLETED|Overall Study||0
8110783|NCT03073759|19990278|P2|COMPLETED|Overall Study||2
8110784|NCT03073759|19990279|P1|COMPLETED|Overall Study||2
8110785|NCT03073759|19990278|P2|STARTED|Overall Study||2
8110786|NCT03073759|19990279|P1|STARTED|Overall Study||2
8110787|NCT03073486|19990289|P2|NOT COMPLETED|Overall Study||44
8110788|NCT03073486|19990290|P1|NOT COMPLETED|Overall Study||88
8110789|NCT03073486|19990289|P2|COMPLETED|Overall Study||207
8110790|NCT03073486|19990290|P1|COMPLETED|Overall Study||405
8110791|NCT03073486|19990289|P2|STARTED|Overall Study||251
8110792|NCT03073486|19990290|P1|STARTED|Overall Study||493
8110793|NCT03073213|19990303|P3|NOT COMPLETED|Multiple Dose Period||1
8110794|NCT03073213|19990304|P2|NOT COMPLETED|Multiple Dose Period||0
8110795|NCT03073213|19990305|P1|NOT COMPLETED|Multiple Dose Period||0
8110796|NCT03073213|19990303|P3|COMPLETED|Multiple Dose Period||14
8110797|NCT03073213|19990304|P2|COMPLETED|Multiple Dose Period||14
8110798|NCT03073213|19990305|P1|COMPLETED|Multiple Dose Period||0
8110799|NCT03073213|19990303|P3|Participants Enrolled From Single Dose|Multiple Dose Period||2
8110800|NCT03073213|19990304|P2|Participants Enrolled From Single Dose|Multiple Dose Period||7
8110801|NCT03073213|19990305|P1|Participants Enrolled From Single Dose|Multiple Dose Period||0
8110802|NCT03073213|19990303|P3|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
8110803|NCT03073213|19990304|P2|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
8110804|NCT03073213|19990305|P1|STARTED|Multiple Dose Period||0
8110805|NCT03073213|19990303|P3|NOT COMPLETED|Single Dose Period||0
8110806|NCT03073213|19990304|P2|NOT COMPLETED|Single Dose Period||0
8110807|NCT03073213|19990305|P1|NOT COMPLETED|Single Dose Period||0
8110808|NCT03073213|19990303|P3|COMPLETED|Single Dose Period||0
8110809|NCT03073213|19990304|P2|COMPLETED|Single Dose Period||0
8110810|NCT03073213|19990305|P1|COMPLETED|Single Dose Period||12
8110811|NCT03073213|19990303|P3|STARTED|Single Dose Period||0
8110812|NCT03073213|19990304|P2|STARTED|Single Dose Period||0
8110813|NCT03073213|19990305|P1|STARTED|Single Dose Period||12
8110814|NCT03073200|19990320|P3|NOT COMPLETED|Overall Study||30
8110815|NCT03073200|19990321|P2|NOT COMPLETED|Overall Study||115
8110816|NCT03073200|19990322|P1|NOT COMPLETED|Overall Study||55
8110817|NCT03073200|19990320|P3|COMPLETED|Overall Study||0
8110818|NCT03073200|19990321|P2|COMPLETED|Overall Study||0
8110819|NCT03073200|19990322|P1|COMPLETED|Overall Study||1
8110820|NCT03073200|19990320|P3|Pts in Etanercept Approved Countries|Overall Study||30
8110821|NCT03073200|19990321|P2|Pts in Etanercept Approved Countries|Overall Study||38
8110822|NCT03073200|19990322|P1|Pts in Etanercept Approved Countries|Overall Study||19
8110823|NCT03073200|19990320|P3|STARTED|Overall Study||30
8110824|NCT03073200|19990321|P2|STARTED|Overall Study||115
8110825|NCT03073200|19990322|P1|STARTED|Overall Study||56
8110826|NCT03073148|19990360|P3|NOT COMPLETED|Overall Study||4
8110827|NCT03073148|19990361|P2|NOT COMPLETED|Overall Study||0
8110828|NCT03073148|19990362|P1|NOT COMPLETED|Overall Study||0
8110829|NCT03073148|19990360|P3|COMPLETED|Overall Study||0
8110830|NCT03073148|19990361|P2|COMPLETED|Overall Study||10
8110831|NCT03073148|19990362|P1|COMPLETED|Overall Study||21
8110832|NCT03073148|19990360|P3|STARTED|Overall Study||4
8110833|NCT03073148|19990361|P2|STARTED|Overall Study||10
8110834|NCT03073148|19990362|P1|STARTED|Overall Study||21
8110835|NCT03073109|19990384|P2|NOT COMPLETED|Overall Study||2
8110836|NCT03073109|19990385|P1|NOT COMPLETED|Overall Study||10
8110837|NCT03073109|19990384|P2|COMPLETED|Overall Study||68
8110838|NCT03073109|19990385|P1|COMPLETED|Overall Study||90
8110839|NCT03073109|19990384|P2|STARTED|Overall Study||70
8110840|NCT03073109|19990385|P1|STARTED|Overall Study||100
8110841|NCT03072875|19990413|P1|NOT COMPLETED|Overall Study||1
8110842|NCT03072875|19990413|P1|COMPLETED|Overall Study||25
8110843|NCT03072875|19990413|P1|STARTED|Overall Study||26
8110844|NCT03072732|19990420|P2|NOT COMPLETED|Overall Study||0
8110845|NCT03072732|19990421|P1|NOT COMPLETED|Overall Study||0
8110846|NCT03072732|19990420|P2|COMPLETED|Overall Study||20
8110847|NCT03072732|19990421|P1|COMPLETED|Overall Study||20
8110848|NCT03072732|19990420|P2|STARTED|Overall Study||20
8110849|NCT03072732|19990421|P1|STARTED|Overall Study||20
8110850|NCT03072719|19990429|P2|NOT COMPLETED|Overall Study||1
8110851|NCT03072719|19990430|P1|NOT COMPLETED|Overall Study||1
8110852|NCT03072719|19990429|P2|COMPLETED|Overall Study||59
8110853|NCT03072719|19990430|P1|COMPLETED|Overall Study||59
8110854|NCT03072719|19990429|P2|STARTED|Overall Study||60
8110855|NCT03072719|19990430|P1|STARTED|Overall Study||60
8110856|NCT03072550|19990440|P1|NOT COMPLETED|Overall Study||2
8110857|NCT03072550|19990440|P1|COMPLETED|Overall Study||24
8110858|NCT03072550|19990440|P1|STARTED|Overall Study||26
8110859|NCT03071887|19990444|P1|NOT COMPLETED|Overall Study||6
8110860|NCT03071887|19990444|P1|COMPLETED|Overall Study||7
8110861|NCT03071887|19990444|P1|STARTED|Overall Study||13
8110862|NCT03071744|19990449|P1|NOT COMPLETED|Overall Study||2
8110863|NCT03071744|19990449|P1|COMPLETED|Overall Study||4
8110864|NCT03071744|19990449|P1|STARTED|Overall Study||6
8110865|NCT03071276|19990455|P1|NOT COMPLETED|Overall Study||15
8110866|NCT03071276|19990455|P1|COMPLETED|Overall Study||22
8110867|NCT03071276|19990455|P1|STARTED|Overall Study||37
8110868|NCT03071263|19990463|P2|NOT COMPLETED|Overall Study||7
8110869|NCT03071263|19990464|P1|NOT COMPLETED|Overall Study||3
8110870|NCT03071263|19990463|P2|COMPLETED|Overall Study||141
8110871|NCT03071263|19990464|P1|COMPLETED|Overall Study||144
8110872|NCT03071263|19990463|P2|STARTED|Overall Study||148
8110873|NCT03071263|19990464|P1|STARTED|Overall Study||147
8110874|NCT03070964|19990488|P1|NOT COMPLETED|Overall Study||14
8110875|NCT03070964|19990488|P1|COMPLETED|Overall Study||0
8110876|NCT03070964|19990488|P1|STARTED|Overall Study||14
8110877|NCT03070782|19990499|P6|NOT COMPLETED|Overall Study||7
8110878|NCT03070782|19990500|P5|NOT COMPLETED|Overall Study||12
8110879|NCT03070782|19990501|P4|NOT COMPLETED|Overall Study||5
8110880|NCT03070782|19990502|P3|NOT COMPLETED|Overall Study||4
8110881|NCT03070782|19990503|P2|NOT COMPLETED|Overall Study||1
8110882|NCT03070782|19990504|P1|NOT COMPLETED|Overall Study||7
8110883|NCT03070782|19990499|P6|COMPLETED|Overall Study||40
8110884|NCT03070782|19990500|P5|COMPLETED|Overall Study||36
8110885|NCT03070782|19990501|P4|COMPLETED|Overall Study||43
8110886|NCT03070782|19990502|P3|COMPLETED|Overall Study||43
8110887|NCT03070782|19990503|P2|COMPLETED|Overall Study||47
8110888|NCT03070782|19990504|P1|COMPLETED|Overall Study||41
8110889|NCT03070782|19990499|P6|STARTED|Overall Study||47
8110890|NCT03070782|19990500|P5|STARTED|Overall Study||48
8110891|NCT03070782|19990501|P4|STARTED|Overall Study||48
8110892|NCT03070782|19990502|P3|STARTED|Overall Study||47
8110893|NCT03070782|19990503|P2|STARTED|Overall Study||48
8110894|NCT03070782|19990504|P1|STARTED|Overall Study||48
8110895|NCT03070730|19990575|P3|NOT COMPLETED|Overall Study||0
8110896|NCT03070730|19990576|P2|NOT COMPLETED|Overall Study||0
8110897|NCT03070730|19990577|P1|NOT COMPLETED|Overall Study||0
8110898|NCT03070730|19990575|P3|COMPLETED|Overall Study||0
8110899|NCT03070730|19990576|P2|COMPLETED|Overall Study||0
8110900|NCT03070730|19990577|P1|COMPLETED|Overall Study||0
8110901|NCT03070730|19990575|P3|STARTED|Overall Study||0
8110902|NCT03070730|19990576|P2|STARTED|Overall Study||0
8110903|NCT03070730|19990577|P1|STARTED|Overall Study||0
8110904|NCT03070548|19990708|P1|NOT COMPLETED|Overall Study||0
8110905|NCT03070548|19990708|P1|COMPLETED|Overall Study||6
8110906|NCT03070548|19990708|P1|STARTED|Overall Study||6
8110907|NCT03070483|19990744|P1|NOT COMPLETED|Overall Study||2
8110908|NCT03070483|19990744|P1|COMPLETED|Overall Study||3
8110909|NCT03070483|19990744|P1|STARTED|Overall Study||5
8110910|NCT03070470|19990759|P6|NOT COMPLETED|Overall Study||2
8110911|NCT03070470|19990760|P5|NOT COMPLETED|Overall Study||0
8110912|NCT03070470|19990761|P4|NOT COMPLETED|Overall Study||0
8110913|NCT03070470|19990762|P3|NOT COMPLETED|Overall Study||0
8110914|NCT03070470|19990763|P2|NOT COMPLETED|Overall Study||1
8110915|NCT03070470|19990764|P1|NOT COMPLETED|Overall Study||0
8110916|NCT03070470|19990759|P6|COMPLETED|Overall Study||8
8110917|NCT03070470|19990760|P5|COMPLETED|Overall Study||10
8110918|NCT03070470|19990761|P4|COMPLETED|Overall Study||10
8110919|NCT03070470|19990762|P3|COMPLETED|Overall Study||10
8110920|NCT03070470|19990763|P2|COMPLETED|Overall Study||9
8110921|NCT03070470|19990764|P1|COMPLETED|Overall Study||10
8110922|NCT03070470|19990759|P6|STARTED|Overall Study||10
8110923|NCT03070470|19990760|P5|STARTED|Overall Study||10
8110924|NCT03070470|19990761|P4|STARTED|Overall Study||10
8110925|NCT03070470|19990762|P3|STARTED|Overall Study||10
8110926|NCT03070470|19990763|P2|STARTED|Overall Study||10
8110927|NCT03070470|19990764|P1|STARTED|Overall Study||10
8110928|NCT03070431|19990791|P1|NOT COMPLETED|Overall Study||4
8110929|NCT03070431|19990791|P1|COMPLETED|Overall Study||40
8110930|NCT03070431|19990791|P1|STARTED|Overall Study||44
8110931|NCT03070236|19990806|P1|NOT COMPLETED|Overall Study||0
8110932|NCT03070236|19990806|P1|COMPLETED|Overall Study||912
8110933|NCT03070236|19990806|P1|Active Surveillance (AS) Arm|Overall Study||374
8110934|NCT03070236|19990806|P1|Guideline Concordant Care (GCC) Arm|Overall Study||538
8110935|NCT03070236|19990806|P1|STARTED|Overall Study||912
8110936|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 4 + Washout||1
8110937|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 4 + Washout||0
8110938|NCT03070171|19990813|P2|COMPLETED|Treatment Period 4 + Washout||78
8110939|NCT03070171|19990814|P1|COMPLETED|Treatment Period 4 + Washout||80
8110940|NCT03070171|19990813|P2|STARTED|Treatment Period 4 + Washout||79
8110941|NCT03070171|19990814|P1|STARTED|Treatment Period 4 + Washout||80
8110942|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 3 + Washout||0
8110943|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 3 + Washout||0
8110944|NCT03070171|19990813|P2|COMPLETED|Treatment Period 3 + Washout||79
8110945|NCT03070171|19990814|P1|COMPLETED|Treatment Period 3 + Washout||80
8110946|NCT03070171|19990813|P2|STARTED|Treatment Period 3 + Washout||79
8110947|NCT03070171|19990814|P1|STARTED|Treatment Period 3 + Washout||80
8110948|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 2 + Washout||1
8110949|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 2 + Washout||0
8110950|NCT03070171|19990813|P2|COMPLETED|Treatment Period 2 + Washout||79
8110951|NCT03070171|19990814|P1|COMPLETED|Treatment Period 2 + Washout||80
8110952|NCT03070171|19990813|P2|STARTED|Treatment Period 2 + Washout||80
8110953|NCT03070171|19990814|P1|STARTED|Treatment Period 2 + Washout||80
8110954|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
8110955|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
8110956|NCT03070171|19990813|P2|COMPLETED|Treatment Period 1 + Washout||80
8110957|NCT03070171|19990814|P1|COMPLETED|Treatment Period 1 + Washout||80
8110958|NCT03070171|19990813|P2|STARTED|Treatment Period 1 + Washout||80
8110959|NCT03070171|19990814|P1|STARTED|Treatment Period 1 + Washout||80
8110960|NCT03070002|19990830|P1|NOT COMPLETED|Follow up for 2 Years||1
8110961|NCT03070002|19990830|P1|COMPLETED|Follow up for 2 Years||0
8110962|NCT03070002|19990830|P1|STARTED|Follow up for 2 Years||1
8110963|NCT03070002|19990830|P1|NOT COMPLETED|3 Cycles of Treatment||0
8110964|NCT03070002|19990830|P1|COMPLETED|3 Cycles of Treatment||1
8110965|NCT03070002|19990830|P1|STARTED|3 Cycles of Treatment||1
8110966|NCT03069989|19990838|P2|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
8110967|NCT03069989|19990839|P1|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
8110968|NCT03069989|19990838|P2|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
8110969|NCT03069989|19990839|P1|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
8110970|NCT03069989|19990838|P2|STARTED|Dosing Period 2 (Up to 16 Days)||5
8110971|NCT03069989|19990839|P1|STARTED|Dosing Period 2 (Up to 16 Days)||3
8110972|NCT03069989|19990838|P2|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
8110973|NCT03069989|19990839|P1|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
8110974|NCT03069989|19990838|P2|COMPLETED|Wash Out Period (Up to 28 Days))||5
8110975|NCT03069989|19990839|P1|COMPLETED|Wash Out Period (Up to 28 Days))||3
8110976|NCT03069989|19990838|P2|STARTED|Wash Out Period (Up to 28 Days))||5
8110977|NCT03069989|19990839|P1|STARTED|Wash Out Period (Up to 28 Days))||3
8110978|NCT03069989|19990838|P2|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
8110979|NCT03069989|19990839|P1|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
8110980|NCT03069989|19990838|P2|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
8110981|NCT03069989|19990839|P1|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
8110982|NCT03069989|19990838|P2|STARTED|Dosing Period 1 (Up to 2 Days)||5
8110983|NCT03069989|19990839|P1|STARTED|Dosing Period 1 (Up to 2 Days)||3
8110984|NCT03069677|19990927|P2|NOT COMPLETED|Overall Study||3
8110985|NCT03069677|19990928|P1|NOT COMPLETED|Overall Study||3
8110986|NCT03069677|19990927|P2|COMPLETED|Overall Study||77
8110987|NCT03069677|19990928|P1|COMPLETED|Overall Study||77
8110988|NCT03069677|19990927|P2|STARTED|Overall Study||80
8110989|NCT03069677|19990928|P1|STARTED|Overall Study||80
8110990|NCT03069482|19990946|P2|NOT COMPLETED|Overall Study||1
8110991|NCT03069482|19990947|P1|NOT COMPLETED|Overall Study||1
8110992|NCT03069482|19990946|P2|COMPLETED|Overall Study||28
8110993|NCT03069482|19990947|P1|COMPLETED|Overall Study||33
8110994|NCT03069482|19990946|P2|STARTED|Overall Study||29
8110995|NCT03069482|19990947|P1|STARTED|Overall Study||34
8110996|NCT03069365|19991057|P1|NOT COMPLETED|Overall Study||1
8110997|NCT03069365|19991057|P1|COMPLETED|Overall Study||100
8110998|NCT03069365|19991057|P1|STARTED|Overall Study||101
8110999|NCT03069352|19991065|P2|NOT COMPLETED|Overall Study||40
8111000|NCT03069352|19991066|P1|NOT COMPLETED|Overall Study||12
8111001|NCT03069352|19991065|P2|COMPLETED|Overall Study||103
8111002|NCT03069352|19991066|P1|COMPLETED|Overall Study||56
8111003|NCT03069352|19991065|P2|Received Treatment|Overall Study||142
8111004|NCT03069352|19991066|P1|Received Treatment|Overall Study||68
8111005|NCT03069352|19991065|P2|STARTED|Overall Study||143
8111006|NCT03069352|19991066|P1|STARTED|Overall Study||68
8111007|NCT03069313|19991108|P1|NOT COMPLETED|Overall Study||5
8111008|NCT03069313|19991108|P1|COMPLETED|Overall Study||36
8111009|NCT03069313|19991108|P1|STARTED|Overall Study||41
8111010|NCT03068897|19991119|P4|NOT COMPLETED|Overall Study||6
8111011|NCT03068897|19991120|P3|NOT COMPLETED|Overall Study||1
8111012|NCT03068897|19991121|P2|NOT COMPLETED|Overall Study||4
8111013|NCT03068897|19991122|P1|NOT COMPLETED|Overall Study||4
8111014|NCT03068897|19991119|P4|COMPLETED|Overall Study||74
8111015|NCT03068897|19991120|P3|COMPLETED|Overall Study||79
8111016|NCT03068897|19991121|P2|COMPLETED|Overall Study||76
8111017|NCT03068897|19991122|P1|COMPLETED|Overall Study||76
8111018|NCT03068897|19991119|P4|STARTED|Overall Study||80
8111019|NCT03068897|19991120|P3|STARTED|Overall Study||80
8111020|NCT03068897|19991121|P2|STARTED|Overall Study||80
8111021|NCT03068897|19991122|P1|STARTED|Overall Study||80
8111022|NCT03068767|19991146|P2|NOT COMPLETED|Overall Study||3
8111023|NCT03068767|19991147|P1|NOT COMPLETED|Overall Study||10
8111024|NCT03068767|19991146|P2|COMPLETED|Overall Study|December 2018|71
8111025|NCT03068767|19991147|P1|COMPLETED|Overall Study|December 2018|65
8111026|NCT03068767|19991146|P2|STARTED|Overall Study|from August 2017 to September 2018|74
8111027|NCT03068767|19991147|P1|STARTED|Overall Study|from August 2017 to September 2018|75
8111028|NCT03068754|19991157|P4|NOT COMPLETED|Open Label Extension Period (OLE)||6
8111029|NCT03068754|19991158|P3|NOT COMPLETED|Open Label Extension Period (OLE)||21
8111030|NCT03068754|19991159|P2|NOT COMPLETED|Open Label Extension Period (OLE)||0
8111031|NCT03068754|19991160|P1|NOT COMPLETED|Open Label Extension Period (OLE)||0
8111032|NCT03068754|19991157|P4|COMPLETED|Open Label Extension Period (OLE)||2
8111033|NCT03068754|19991158|P3|COMPLETED|Open Label Extension Period (OLE)||4
8111034|NCT03068754|19991159|P2|COMPLETED|Open Label Extension Period (OLE)||0
8111035|NCT03068754|19991160|P1|COMPLETED|Open Label Extension Period (OLE)||0
8111036|NCT03068754|19991157|P4|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
8111037|NCT03068754|19991158|P3|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
8111038|NCT03068754|19991159|P2|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
8111039|NCT03068754|19991160|P1|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
8111040|NCT03068754|19991157|P4|Completed OLE Period|Open Label Extension Period (OLE)||2
8111041|NCT03068754|19991158|P3|Completed OLE Period|Open Label Extension Period (OLE)||3
8111042|NCT03068754|19991159|P2|Completed OLE Period|Open Label Extension Period (OLE)||0
8111043|NCT03068754|19991160|P1|Completed OLE Period|Open Label Extension Period (OLE)||0
8111044|NCT03068754|19991157|P4|Completed Taper|Open Label Extension Period (OLE)||7
8111045|NCT03068754|19991158|P3|Completed Taper|Open Label Extension Period (OLE)||19
8111046|NCT03068754|19991159|P2|Completed Taper|Open Label Extension Period (OLE)||0
8111047|NCT03068754|19991160|P1|Completed Taper|Open Label Extension Period (OLE)||0
8111048|NCT03068754|19991157|P4|STARTED|Open Label Extension Period (OLE)||8
8111049|NCT03068754|19991158|P3|STARTED|Open Label Extension Period (OLE)||25
8111050|NCT03068754|19991159|P2|STARTED|Open Label Extension Period (OLE)||0
8111051|NCT03068754|19991160|P1|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
8111052|NCT03068754|19991157|P4|NOT COMPLETED|Randomized Treatment Period (RTP)||0
8111053|NCT03068754|19991158|P3|NOT COMPLETED|Randomized Treatment Period (RTP)||0
8111054|NCT03068754|19991159|P2|NOT COMPLETED|Randomized Treatment Period (RTP)||39
8111055|NCT03068754|19991160|P1|NOT COMPLETED|Randomized Treatment Period (RTP)||67
8111056|NCT03068754|19991157|P4|COMPLETED|Randomized Treatment Period (RTP)||0
8111057|NCT03068754|19991158|P3|COMPLETED|Randomized Treatment Period (RTP)||0
8111058|NCT03068754|19991159|P2|COMPLETED|Randomized Treatment Period (RTP)||9
8111059|NCT03068754|19991160|P1|COMPLETED|Randomized Treatment Period (RTP)||28
8111060|NCT03068754|19991157|P4|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
8111061|NCT03068754|19991158|P3|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
8111062|NCT03068754|19991159|P2|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
8111063|NCT03068754|19991160|P1|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
8111064|NCT03068754|19991157|P4|Completed RTP|Randomized Treatment Period (RTP)||0
8111065|NCT03068754|19991158|P3|Completed RTP|Randomized Treatment Period (RTP)||0
8111066|NCT03068754|19991159|P2|Completed RTP|Randomized Treatment Period (RTP)||9
8111067|NCT03068754|19991160|P1|Completed RTP|Randomized Treatment Period (RTP)||27
8111068|NCT03068754|19991157|P4|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
8111069|NCT03068754|19991158|P3|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
8111070|NCT03068754|19991159|P2|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
8111071|NCT03068754|19991160|P1|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
8111072|NCT03068754|19991157|P4|Completed Taper|Randomized Treatment Period (RTP)||0
8111073|NCT03068754|19991158|P3|Completed Taper|Randomized Treatment Period (RTP)||0
8111074|NCT03068754|19991159|P2|Completed Taper|Randomized Treatment Period (RTP)||28
8111075|NCT03068754|19991160|P1|Completed Taper|Randomized Treatment Period (RTP)||58
8111076|NCT03068754|19991157|P4|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
8111077|NCT03068754|19991158|P3|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
8111078|NCT03068754|19991159|P2|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
8111079|NCT03068754|19991160|P1|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
8111080|NCT03068754|19991157|P4|Safety Population|Randomized Treatment Period (RTP)||0
8111081|NCT03068754|19991158|P3|Safety Population|Randomized Treatment Period (RTP)||0
8111082|NCT03068754|19991159|P2|Safety Population|Randomized Treatment Period (RTP)||47
8111083|NCT03068754|19991160|P1|Safety Population|Randomized Treatment Period (RTP)||95
8111084|NCT03068754|19991157|P4|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
8111085|NCT03068754|19991158|P3|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
8111086|NCT03068754|19991159|P2|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
8111087|NCT03068754|19991160|P1|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
8111088|NCT03068754|19991157|P4|STARTED|Randomized Treatment Period (RTP)||0
8111089|NCT03068754|19991158|P3|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
8111090|NCT03068754|19991159|P2|STARTED|Randomized Treatment Period (RTP)||48
8111091|NCT03068754|19991160|P1|STARTED|Randomized Treatment Period (RTP)||95
8111092|NCT03068611|19991180|P2|NOT COMPLETED|Overall Study||25
8111093|NCT03068611|19991181|P1|NOT COMPLETED|Overall Study||31
8111094|NCT03068611|19991180|P2|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
8111095|NCT03068611|19991181|P1|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
8111096|NCT03068611|19991180|P2|STARTED|Overall Study||58
8111097|NCT03068611|19991181|P1|STARTED|Overall Study||61
8111098|NCT03068468|19991195|P4|NOT COMPLETED|Open-Label Extension Period||276
8111099|NCT03068468|19991196|P3|NOT COMPLETED|Open-Label Extension Period||140
8111100|NCT03068468|19991197|P2|NOT COMPLETED|Open-Label Extension Period||0
8111101|NCT03068468|19991198|P1|NOT COMPLETED|Open-Label Extension Period||0
8111102|NCT03068468|19991195|P4|COMPLETED|Open-Label Extension Period||0
8111103|NCT03068468|19991196|P3|COMPLETED|Open-Label Extension Period||0
8111104|NCT03068468|19991197|P2|COMPLETED|Open-Label Extension Period||0
8111105|NCT03068468|19991198|P1|COMPLETED|Open-Label Extension Period||0
8111106|NCT03068468|19991195|P4|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
8111107|NCT03068468|19991196|P3|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
8111108|NCT03068468|19991197|P2|STARTED|Open-Label Extension Period||0
8111109|NCT03068468|19991198|P1|STARTED|Open-Label Extension Period||0
8111110|NCT03068468|19991195|P4|NOT COMPLETED|Placebo-Controlled Period||0
8111111|NCT03068468|19991196|P3|NOT COMPLETED|Placebo-Controlled Period||0
8111112|NCT03068468|19991197|P2|NOT COMPLETED|Placebo-Controlled Period||45
8111113|NCT03068468|19991198|P1|NOT COMPLETED|Placebo-Controlled Period||22
8111114|NCT03068468|19991195|P4|COMPLETED|Placebo-Controlled Period||0
8111115|NCT03068468|19991196|P3|COMPLETED|Placebo-Controlled Period||0
8111116|NCT03068468|19991197|P2|COMPLETED|Placebo-Controlled Period||279
8111117|NCT03068468|19991198|P1|COMPLETED|Placebo-Controlled Period||144
8111118|NCT03068468|19991195|P4|Treated|Placebo-Controlled Period||0
8111119|NCT03068468|19991196|P3|Treated|Placebo-Controlled Period||0
8111120|NCT03068468|19991197|P2|Treated|Placebo-Controlled Period||321
8111121|NCT03068468|19991198|P1|Treated|Placebo-Controlled Period||165
8111122|NCT03068468|19991195|P4|STARTED|Placebo-Controlled Period||0
8111123|NCT03068468|19991196|P3|STARTED|Placebo-Controlled Period||0
8111124|NCT03068468|19991197|P2|STARTED|Placebo-Controlled Period||324
8111125|NCT03068468|19991198|P1|STARTED|Placebo-Controlled Period||166
8111126|NCT03068312|19991236|P2|NOT COMPLETED|Overall Study||0
8111127|NCT03068312|19991237|P1|NOT COMPLETED|Overall Study||0
8111128|NCT03068312|19991236|P2|COMPLETED|Overall Study||19
8111129|NCT03068312|19991237|P1|COMPLETED|Overall Study||19
8111130|NCT03068312|19991236|P2|STARTED|Overall Study||19
8111131|NCT03068312|19991237|P1|STARTED|Overall Study||19
8111132|NCT03068091|19991243|P1|NOT COMPLETED|Overall Study||1
8111133|NCT03068091|19991243|P1|COMPLETED|Overall Study||24
8111134|NCT03068091|19991243|P1|STARTED|Overall Study||25
8111135|NCT03067987|19991250|P2|NOT COMPLETED|Overall Study||13
8111136|NCT03067987|19991251|P1|NOT COMPLETED|Overall Study||10
8111137|NCT03067987|19991250|P2|COMPLETED|Overall Study||40
8111138|NCT03067987|19991251|P1|COMPLETED|Overall Study||40
8111139|NCT03067987|19991250|P2|STARTED|Overall Study||53
8111140|NCT03067987|19991251|P1|STARTED|Overall Study||50
8111141|NCT03067948|19991263|P1|NOT COMPLETED|Overall Study||0
8111142|NCT03067948|19991263|P1|COMPLETED|Overall Study||32
8111143|NCT03067948|19991263|P1|STARTED|Overall Study||32
8111144|NCT03067506|19991268|P1|NOT COMPLETED|Overall Study||0
8111145|NCT03067506|19991268|P1|COMPLETED|Overall Study||30
8111146|NCT03067506|19991268|P1|STARTED|Overall Study||30
8111153|NCT03066999|19991336|P2|NOT COMPLETED|Overall Study||2
8111154|NCT03066999|19991337|P1|NOT COMPLETED|Overall Study||0
8111155|NCT03066999|19991336|P2|COMPLETED|Overall Study||1
8111156|NCT03066999|19991337|P1|COMPLETED|Overall Study||2
8111157|NCT03066999|19991336|P2|STARTED|Overall Study||3
8111158|NCT03066999|19991337|P1|STARTED|Overall Study||2
8111159|NCT03066778|19991357|P2|NOT COMPLETED|Overall Study||225
8111160|NCT03066778|19991358|P1|NOT COMPLETED|Overall Study||228
8111161|NCT03066778|19991357|P2|COMPLETED|Overall Study||0
8111162|NCT03066778|19991358|P1|COMPLETED|Overall Study||0
8111163|NCT03066778|19991357|P2|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
8111164|NCT03066778|19991358|P1|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
8111165|NCT03066778|19991357|P2|STARTED|Overall Study||225
8111166|NCT03066778|19991358|P1|STARTED|Overall Study||228
8111167|NCT03066622|19991386|P2|NOT COMPLETED|Overall Study||26
8111168|NCT03066622|19991387|P1|NOT COMPLETED|Overall Study||26
8111169|NCT03066622|19991386|P2|COMPLETED|Overall Study||35
8111170|NCT03066622|19991387|P1|COMPLETED|Overall Study||35
8111171|NCT03066622|19991386|P2|STARTED|Overall Study||61
8111172|NCT03066622|19991387|P1|STARTED|Overall Study||61
8111173|NCT03066609|19991400|P4|NOT COMPLETED|OVERALL STUDY||5
8111174|NCT03066609|19991401|P3|NOT COMPLETED|OVERALL STUDY||4
8111175|NCT03066609|19991402|P2|NOT COMPLETED|OVERALL STUDY||8
8111176|NCT03066609|19991403|P1|NOT COMPLETED|OVERALL STUDY||10
8111177|NCT03066609|19991400|P4|COMPLETED|OVERALL STUDY||124
8111178|NCT03066609|19991401|P3|COMPLETED|OVERALL STUDY||2
8111179|NCT03066609|19991402|P2|COMPLETED|OVERALL STUDY||264
8111180|NCT03066609|19991403|P1|COMPLETED|OVERALL STUDY||126
8111181|NCT03066609|19991400|P4|STARTED|OVERALL STUDY||129
8111182|NCT03066609|19991401|P3|STARTED|OVERALL STUDY||6
8111183|NCT03066609|19991402|P2|STARTED|OVERALL STUDY||272
8111184|NCT03066609|19991403|P1|STARTED|OVERALL STUDY||136
8111185|NCT03066609|19991400|P4|NOT COMPLETED|MAINTENANCE||3
8111186|NCT03066609|19991401|P3|NOT COMPLETED|MAINTENANCE||2
8111187|NCT03066609|19991402|P2|NOT COMPLETED|MAINTENANCE||4
8111188|NCT03066609|19991403|P1|NOT COMPLETED|MAINTENANCE||7
8111189|NCT03066609|19991400|P4|COMPLETED|MAINTENANCE||126
8111190|NCT03066609|19991401|P3|COMPLETED|MAINTENANCE||2
8111191|NCT03066609|19991402|P2|COMPLETED|MAINTENANCE||266
8111192|NCT03066609|19991403|P1|COMPLETED|MAINTENANCE||127
8111193|NCT03066609|19991400|P4|STARTED|MAINTENANCE||129
8111194|NCT03066609|19991401|P3|STARTED|MAINTENANCE||4
8111195|NCT03066609|19991402|P2|STARTED|MAINTENANCE||270
8111196|NCT03066609|19991403|P1|STARTED|MAINTENANCE||134
8111197|NCT03066609|19991400|P4|NOT COMPLETED|INDUCTION||0
8111198|NCT03066609|19991401|P3|NOT COMPLETED|INDUCTION||2
8111199|NCT03066609|19991402|P2|NOT COMPLETED|INDUCTION||2
8111200|NCT03066609|19991403|P1|NOT COMPLETED|INDUCTION||2
8111201|NCT03066609|19991400|P4|COMPLETED|INDUCTION||0
8111202|NCT03066609|19991401|P3|COMPLETED|INDUCTION||133
8111203|NCT03066609|19991402|P2|COMPLETED|INDUCTION||270
8111204|NCT03066609|19991403|P1|COMPLETED|INDUCTION||134
8111205|NCT03066609|19991400|P4|STARTED|INDUCTION||0
8111206|NCT03066609|19991401|P3|STARTED|INDUCTION||135
8111207|NCT03066609|19991402|P2|STARTED|INDUCTION||272
8111208|NCT03066609|19991403|P1|STARTED|INDUCTION||136
8111209|NCT03066193|19991433|P1|NOT COMPLETED|Overall Study||1
8111210|NCT03066193|19991433|P1|COMPLETED|Overall Study||16
8111211|NCT03066193|19991433|P1|STARTED|Overall Study||17
8111212|NCT03066102|19991437|P1|NOT COMPLETED|Overall Study||0
8111213|NCT03066102|19991437|P1|COMPLETED|Overall Study||30
8111214|NCT03066102|19991437|P1|STARTED|Overall Study||30
8111215|NCT03065933|19991446|P1|NOT COMPLETED|Overall Study||5
8111216|NCT03065933|19991446|P1|COMPLETED|Overall Study||0
8111217|NCT03065933|19991446|P1|STARTED|Overall Study||5
8111218|NCT03065530|19991454|P4|NOT COMPLETED|Overall Study||2
8111219|NCT03065530|19991455|P3|NOT COMPLETED|Overall Study||1
8111220|NCT03065530|19991456|P2|NOT COMPLETED|Overall Study||1
8111221|NCT03065530|19991457|P1|NOT COMPLETED|Overall Study||2
8111222|NCT03065530|19991454|P4|COMPLETED|Overall Study||28
8111223|NCT03065530|19991455|P3|COMPLETED|Overall Study||29
8111224|NCT03065530|19991456|P2|COMPLETED|Overall Study||29
8111225|NCT03065530|19991457|P1|COMPLETED|Overall Study||28
8111226|NCT03065530|19991454|P4|STARTED|Overall Study||30
8111227|NCT03065530|19991455|P3|STARTED|Overall Study||30
8111228|NCT03065530|19991456|P2|STARTED|Overall Study||30
8111229|NCT03065530|19991457|P1|STARTED|Overall Study||30
8111230|NCT03065283|19991536|P2|NOT COMPLETED|Overall Study||0
8111231|NCT03065283|19991537|P1|NOT COMPLETED|Overall Study||0
8111232|NCT03065283|19991536|P2|COMPLETED|Overall Study||25
8111233|NCT03065283|19991537|P1|COMPLETED|Overall Study||50
8111234|NCT03065283|19991536|P2|STARTED|Overall Study||25
8111235|NCT03065283|19991537|P1|STARTED|Overall Study||50
8111236|NCT03065205|19991543|P1|NOT COMPLETED|Overall Study||12
8111237|NCT03065205|19991543|P1|COMPLETED|Overall Study||53
8111238|NCT03065205|19991543|P1|STARTED|Overall Study||65
8111239|NCT03065075|19991552|P2|NOT COMPLETED|Overall Study||0
8111240|NCT03065075|19991553|P1|NOT COMPLETED|Overall Study||0
8111241|NCT03065075|19991552|P2|COMPLETED|Overall Study||76
8111242|NCT03065075|19991553|P1|COMPLETED|Overall Study||76
8111243|NCT03065075|19991552|P2|As-treated Analysis|Overall Study||77
8111244|NCT03065075|19991553|P1|As-treated Analysis|Overall Study||69
8111245|NCT03065075|19991552|P2|Intent-to-treat Analysis|Overall Study||74
8111246|NCT03065075|19991553|P1|Intent-to-treat Analysis|Overall Study||72
8111247|NCT03065075|19991552|P2|STARTED|Overall Study||76
8111248|NCT03065075|19991553|P1|STARTED|Overall Study||76
8111249|NCT03065023|19991565|P5|NOT COMPLETED|Overall Study||0
8111250|NCT03065023|19991566|P4|NOT COMPLETED|Overall Study||3
8111251|NCT03065023|19991567|P3|NOT COMPLETED|Overall Study||1
8111252|NCT03065023|19991568|P2|NOT COMPLETED|Overall Study||2
8111253|NCT03065023|19991569|P1|NOT COMPLETED|Overall Study||2
8111254|NCT03065023|19991565|P5|COMPLETED|Overall Study||0
8111255|NCT03065023|19991566|P4|COMPLETED|Overall Study||3
8111256|NCT03065023|19991567|P3|COMPLETED|Overall Study||2
8111257|NCT03065023|19991568|P2|COMPLETED|Overall Study||1
8111258|NCT03065023|19991569|P1|COMPLETED|Overall Study||1
8111259|NCT03065023|19991565|P5|STARTED|Overall Study|Group B not started for business reasons.|0
8111260|NCT03065023|19991566|P4|STARTED|Overall Study||6
8111261|NCT03065023|19991567|P3|STARTED|Overall Study||3
8111262|NCT03065023|19991568|P2|STARTED|Overall Study||3
8111263|NCT03065023|19991569|P1|STARTED|Overall Study||3
8111264|NCT03064841|19991635|P1|NOT COMPLETED|Overall Study||17
8111265|NCT03064841|19991635|P1|COMPLETED|Overall Study||1520
8111266|NCT03064841|19991635|P1|STARTED|Overall Study||1537
8111267|NCT03064451|19991650|P1|NOT COMPLETED|Overall Study||14
8111268|NCT03064451|19991650|P1|COMPLETED|Overall Study||46
8111269|NCT03064451|19991650|P1|Safety Population|Overall Study||52
8111270|NCT03064451|19991650|P1|STARTED|Overall Study||60
8111271|NCT03064126|19991668|P4|NOT COMPLETED|Overall Study||1
8111272|NCT03064126|19991669|P3|NOT COMPLETED|Overall Study||3
8111273|NCT03064126|19991670|P2|NOT COMPLETED|Overall Study||7
8111274|NCT03064126|19991671|P1|NOT COMPLETED|Overall Study||26
8111275|NCT03064126|19991668|P4|COMPLETED|Overall Study||11
8111276|NCT03064126|19991669|P3|COMPLETED|Overall Study||49
8111277|NCT03064126|19991670|P2|COMPLETED|Overall Study||91
8111278|NCT03064126|19991671|P1|COMPLETED|Overall Study||252
8111279|NCT03064126|19991668|P4|STARTED|Overall Study||12
8111280|NCT03064126|19991669|P3|STARTED|Overall Study||52
8111281|NCT03064126|19991670|P2|STARTED|Overall Study||98
8111282|NCT03064126|19991671|P1|STARTED|Overall Study||278
8111283|NCT03064113|19991720|P4|NOT COMPLETED|Washout (7 Days)||0
8111284|NCT03064113|19991721|P3|NOT COMPLETED|Washout (7 Days)||0
8111285|NCT03064113|19991722|P2|NOT COMPLETED|Washout (7 Days)||0
8111286|NCT03064113|19991723|P1|NOT COMPLETED|Washout (7 Days)||0
8111287|NCT03064113|19991720|P4|COMPLETED|Washout (7 Days)||8
8111288|NCT03064113|19991721|P3|COMPLETED|Washout (7 Days)||8
8111289|NCT03064113|19991722|P2|COMPLETED|Washout (7 Days)||8
8111290|NCT03064113|19991723|P1|COMPLETED|Washout (7 Days)||8
8111291|NCT03064113|19991720|P4|STARTED|Washout (7 Days)||8
8111292|NCT03064113|19991721|P3|STARTED|Washout (7 Days)||8
8111293|NCT03064113|19991722|P2|STARTED|Washout (7 Days)||8
8111294|NCT03064113|19991723|P1|STARTED|Washout (7 Days)||8
8111295|NCT03064113|19991720|P4|NOT COMPLETED|Intervention 4 (2 Days)||0
8111296|NCT03064113|19991721|P3|NOT COMPLETED|Intervention 4 (2 Days)||0
8111297|NCT03064113|19991722|P2|NOT COMPLETED|Intervention 4 (2 Days)||0
8111298|NCT03064113|19991723|P1|NOT COMPLETED|Intervention 4 (2 Days)||0
8111299|NCT03064113|19991720|P4|COMPLETED|Intervention 4 (2 Days)||8
8111300|NCT03064113|19991721|P3|COMPLETED|Intervention 4 (2 Days)||8
8111301|NCT03064113|19991722|P2|COMPLETED|Intervention 4 (2 Days)||8
8111302|NCT03064113|19991723|P1|COMPLETED|Intervention 4 (2 Days)||8
8111303|NCT03064113|19991720|P4|STARTED|Intervention 4 (2 Days)||8
8111304|NCT03064113|19991721|P3|STARTED|Intervention 4 (2 Days)||8
8111305|NCT03064113|19991722|P2|STARTED|Intervention 4 (2 Days)||8
8111306|NCT03064113|19991723|P1|STARTED|Intervention 4 (2 Days)||8
8111307|NCT03064113|19991720|P4|NOT COMPLETED|Washout (7 Days)||0
8111308|NCT03064113|19991721|P3|NOT COMPLETED|Washout (7 Days)||0
8111309|NCT03064113|19991722|P2|NOT COMPLETED|Washout (7 Days)||0
8111310|NCT03064113|19991723|P1|NOT COMPLETED|Washout (7 Days)||0
8111311|NCT03064113|19991720|P4|COMPLETED|Washout (7 Days)||8
8111312|NCT03064113|19991721|P3|COMPLETED|Washout (7 Days)||8
8111313|NCT03064113|19991722|P2|COMPLETED|Washout (7 Days)||8
8111314|NCT03064113|19991723|P1|COMPLETED|Washout (7 Days)||8
8111315|NCT03064113|19991720|P4|STARTED|Washout (7 Days)||8
8111316|NCT03064113|19991721|P3|STARTED|Washout (7 Days)||8
8111317|NCT03064113|19991722|P2|STARTED|Washout (7 Days)||8
8111318|NCT03064113|19991723|P1|STARTED|Washout (7 Days)||8
8111319|NCT03064113|19991720|P4|NOT COMPLETED|Intervention 3 (2 Days)||0
8111320|NCT03064113|19991721|P3|NOT COMPLETED|Intervention 3 (2 Days)||0
8111321|NCT03064113|19991722|P2|NOT COMPLETED|Intervention 3 (2 Days)||0
8111322|NCT03064113|19991723|P1|NOT COMPLETED|Intervention 3 (2 Days)||0
8111323|NCT03064113|19991720|P4|COMPLETED|Intervention 3 (2 Days)||8
8111324|NCT03064113|19991721|P3|COMPLETED|Intervention 3 (2 Days)||8
8111325|NCT03064113|19991722|P2|COMPLETED|Intervention 3 (2 Days)||8
8111326|NCT03064113|19991723|P1|COMPLETED|Intervention 3 (2 Days)||8
8111327|NCT03064113|19991720|P4|STARTED|Intervention 3 (2 Days)||8
8111328|NCT03064113|19991721|P3|STARTED|Intervention 3 (2 Days)||8
8111329|NCT03064113|19991722|P2|STARTED|Intervention 3 (2 Days)||8
8111330|NCT03064113|19991723|P1|STARTED|Intervention 3 (2 Days)||8
8111331|NCT03064113|19991720|P4|NOT COMPLETED|Washout (7 Days)||0
8111332|NCT03064113|19991721|P3|NOT COMPLETED|Washout (7 Days)||0
8111333|NCT03064113|19991722|P2|NOT COMPLETED|Washout (7 Days)||0
8111334|NCT03064113|19991723|P1|NOT COMPLETED|Washout (7 Days)||0
8111335|NCT03064113|19991720|P4|COMPLETED|Washout (7 Days)||8
8111336|NCT03064113|19991721|P3|COMPLETED|Washout (7 Days)||8
8111337|NCT03064113|19991722|P2|COMPLETED|Washout (7 Days)||8
8111338|NCT03064113|19991723|P1|COMPLETED|Washout (7 Days)||8
8111339|NCT03064113|19991720|P4|STARTED|Washout (7 Days)||8
8111340|NCT03064113|19991721|P3|STARTED|Washout (7 Days)||8
8111341|NCT03064113|19991722|P2|STARTED|Washout (7 Days)||8
8111342|NCT03064113|19991723|P1|STARTED|Washout (7 Days)||8
8111343|NCT03064113|19991720|P4|NOT COMPLETED|Intervention 2 (2 Days)||0
8111344|NCT03064113|19991721|P3|NOT COMPLETED|Intervention 2 (2 Days)||0
8111345|NCT03064113|19991722|P2|NOT COMPLETED|Intervention 2 (2 Days)||0
8111346|NCT03064113|19991723|P1|NOT COMPLETED|Intervention 2 (2 Days)||0
8111347|NCT03064113|19991720|P4|COMPLETED|Intervention 2 (2 Days)||8
8111348|NCT03064113|19991721|P3|COMPLETED|Intervention 2 (2 Days)||8
8111349|NCT03064113|19991722|P2|COMPLETED|Intervention 2 (2 Days)||8
8111350|NCT03064113|19991723|P1|COMPLETED|Intervention 2 (2 Days)||8
8111351|NCT03064113|19991720|P4|STARTED|Intervention 2 (2 Days)||8
8111352|NCT03064113|19991721|P3|STARTED|Intervention 2 (2 Days)||8
8111353|NCT03064113|19991722|P2|STARTED|Intervention 2 (2 Days)||8
8111354|NCT03064113|19991723|P1|STARTED|Intervention 2 (2 Days)||8
8111355|NCT03064113|19991720|P4|NOT COMPLETED|Washout (7 Days)||0
8111356|NCT03064113|19991721|P3|NOT COMPLETED|Washout (7 Days)||0
8111357|NCT03064113|19991722|P2|NOT COMPLETED|Washout (7 Days)||0
8111358|NCT03064113|19991723|P1|NOT COMPLETED|Washout (7 Days)||0
8111359|NCT03064113|19991720|P4|COMPLETED|Washout (7 Days)||8
8111360|NCT03064113|19991721|P3|COMPLETED|Washout (7 Days)||8
8111361|NCT03064113|19991722|P2|COMPLETED|Washout (7 Days)||8
8111362|NCT03064113|19991723|P1|COMPLETED|Washout (7 Days)||8
8111363|NCT03064113|19991720|P4|STARTED|Washout (7 Days)||8
8111364|NCT03064113|19991721|P3|STARTED|Washout (7 Days)||8
8111365|NCT03064113|19991722|P2|STARTED|Washout (7 Days)||8
8111366|NCT03064113|19991723|P1|STARTED|Washout (7 Days)||8
8111367|NCT03064113|19991720|P4|NOT COMPLETED|Intervention 1 (2 Days)||0
8111368|NCT03064113|19991721|P3|NOT COMPLETED|Intervention 1 (2 Days)||0
8111369|NCT03064113|19991722|P2|NOT COMPLETED|Intervention 1 (2 Days)||0
8111370|NCT03064113|19991723|P1|NOT COMPLETED|Intervention 1 (2 Days)||0
8111371|NCT03064113|19991720|P4|COMPLETED|Intervention 1 (2 Days)||8
8111372|NCT03064113|19991721|P3|COMPLETED|Intervention 1 (2 Days)||8
8111373|NCT03064113|19991722|P2|COMPLETED|Intervention 1 (2 Days)||8
8111374|NCT03064113|19991723|P1|COMPLETED|Intervention 1 (2 Days)||8
8111375|NCT03064113|19991720|P4|STARTED|Intervention 1 (2 Days)||8
8111376|NCT03064113|19991721|P3|STARTED|Intervention 1 (2 Days)||8
8111377|NCT03064113|19991722|P2|STARTED|Intervention 1 (2 Days)||8
8111378|NCT03064113|19991723|P1|STARTED|Intervention 1 (2 Days)||8
8111379|NCT03063476|19991757|P1|NOT COMPLETED|Overall Study||0
8111380|NCT03063476|19991757|P1|COMPLETED|Overall Study||2
8111381|NCT03063476|19991757|P1|STARTED|Overall Study||2
8111382|NCT03063437|19991764|P2|NOT COMPLETED|Overall Study||0
8111383|NCT03063437|19991765|P1|NOT COMPLETED|Overall Study||0
8111384|NCT03063437|19991764|P2|COMPLETED|Overall Study||5
8111385|NCT03063437|19991765|P1|COMPLETED|Overall Study||4
8111386|NCT03063437|19991764|P2|STARTED|Overall Study||5
8111387|NCT03063437|19991765|P1|STARTED|Overall Study||4
8111388|NCT03063385|19991793|P2|NOT COMPLETED|Overall Study||76
8111389|NCT03063385|19991794|P1|NOT COMPLETED|Overall Study||87
8111390|NCT03063385|19991793|P2|COMPLETED|Overall Study||254
8111391|NCT03063385|19991794|P1|COMPLETED|Overall Study||243
8111392|NCT03063385|19991793|P2|12-month Follow-up|Overall Study||254
8111393|NCT03063385|19991794|P1|12-month Follow-up|Overall Study||243
8111394|NCT03063385|19991793|P2|6-month Follow-up|Overall Study||259
8111395|NCT03063385|19991794|P1|6-month Follow-up|Overall Study||265
8111396|NCT03063385|19991793|P2|3-month Follow-up|Overall Study||259
8111397|NCT03063385|19991794|P1|3-month Follow-up|Overall Study||257
8111398|NCT03063385|19991793|P2|STARTED|Overall Study||330
8111399|NCT03063385|19991794|P1|STARTED|Overall Study||330
8111400|NCT03063294|19991806|P2|NOT COMPLETED|Overall Study||0
8111401|NCT03063294|19991807|P1|NOT COMPLETED|Overall Study||0
8111402|NCT03063294|19991806|P2|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
8111403|NCT03063294|19991807|P1|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
8111404|NCT03063294|19991806|P2|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
8111405|NCT03063294|19991807|P1|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
8111406|NCT03063086|19991813|P6|NOT COMPLETED|Overall Study||1
8111407|NCT03063086|19991814|P5|NOT COMPLETED|Overall Study||0
8111408|NCT03063086|19991815|P4|NOT COMPLETED|Overall Study||3
8111409|NCT03063086|19991816|P3|NOT COMPLETED|Overall Study||1
8111410|NCT03063086|19991817|P2|NOT COMPLETED|Overall Study||1
8111411|NCT03063086|19991818|P1|NOT COMPLETED|Overall Study||3
8111412|NCT03063086|19991813|P6|COMPLETED|Overall Study||18
8111413|NCT03063086|19991814|P5|COMPLETED|Overall Study||20
8111414|NCT03063086|19991815|P4|COMPLETED|Overall Study||17
8111415|NCT03063086|19991816|P3|COMPLETED|Overall Study||17
8111416|NCT03063086|19991817|P2|COMPLETED|Overall Study||19
8111417|NCT03063086|19991818|P1|COMPLETED|Overall Study||16
8111418|NCT03063086|19991813|P6|STARTED|Overall Study||19
8111419|NCT03063086|19991814|P5|STARTED|Overall Study||20
8111420|NCT03063086|19991815|P4|STARTED|Overall Study||20
8111421|NCT03063086|19991816|P3|STARTED|Overall Study||18
8111422|NCT03063086|19991817|P2|STARTED|Overall Study||20
8111423|NCT03063086|19991818|P1|STARTED|Overall Study||19
8111424|NCT03062917|19991846|P5|NOT COMPLETED|Overall Study||0
8111425|NCT03062917|19991847|P4|NOT COMPLETED|Overall Study||0
8111426|NCT03062917|19991848|P3|NOT COMPLETED|Overall Study||0
8111427|NCT03062917|19991849|P2|NOT COMPLETED|Overall Study||0
8111428|NCT03062917|19991850|P1|NOT COMPLETED|Overall Study||0
8111429|NCT03062917|19991846|P5|COMPLETED|Overall Study||0
8111430|NCT03062917|19991847|P4|COMPLETED|Overall Study||20
8111431|NCT03062917|19991848|P3|COMPLETED|Overall Study||49
8111432|NCT03062917|19991849|P2|COMPLETED|Overall Study||51
8111433|NCT03062917|19991850|P1|COMPLETED|Overall Study||32
8111434|NCT03062917|19991846|P5|STARTED|Overall Study||0
8111435|NCT03062917|19991847|P4|STARTED|Overall Study||20
8111436|NCT03062917|19991848|P3|STARTED|Overall Study||49
8111437|NCT03062917|19991849|P2|STARTED|Overall Study||51
8111438|NCT03062917|19991850|P1|STARTED|Overall Study||32
8111439|NCT03062891|19991864|P2|NOT COMPLETED|Overall Study||38
8111440|NCT03062891|19991865|P1|NOT COMPLETED|Overall Study||52
8111441|NCT03062891|19991864|P2|COMPLETED|Overall Study||62
8111442|NCT03062891|19991865|P1|COMPLETED|Overall Study||47
8111443|NCT03062891|19991864|P2|Followup|Overall Study||62
8111444|NCT03062891|19991865|P1|Followup|Overall Study||47
8111445|NCT03062891|19991864|P2|End of Intervention|Overall Study||78
8111446|NCT03062891|19991865|P1|End of Intervention|Overall Study||67
8111447|NCT03062891|19991864|P2|Mid-intervention|Overall Study||74
8111448|NCT03062891|19991865|P1|Mid-intervention|Overall Study||68
8111449|NCT03062891|19991864|P2|STARTED|Overall Study||100
8111450|NCT03062891|19991865|P1|STARTED|Overall Study||99
8111451|NCT03062605|19991910|P2|NOT COMPLETED|Overall Study||10
8111452|NCT03062605|19991911|P1|NOT COMPLETED|Overall Study||11
8111453|NCT03062605|19991910|P2|COMPLETED|Overall Study||13
8111454|NCT03062605|19991911|P1|COMPLETED|Overall Study||14
8111455|NCT03062605|19991910|P2|STARTED|Overall Study||23
8111456|NCT03062605|19991911|P1|STARTED|Overall Study||25
8111457|NCT03062488|19991920|P3|NOT COMPLETED|Overall Study||0
8111458|NCT03062488|19991921|P2|NOT COMPLETED|Overall Study||0
8111459|NCT03062488|19991922|P1|NOT COMPLETED|Overall Study||0
8111460|NCT03062488|19991920|P3|COMPLETED|Overall Study||41
8111461|NCT03062488|19991921|P2|COMPLETED|Overall Study||51
8111462|NCT03062488|19991922|P1|COMPLETED|Overall Study||51
8111463|NCT03062488|19991920|P3|STARTED|Overall Study||41
8111464|NCT03062488|19991921|P2|STARTED|Overall Study||51
8111465|NCT03062488|19991922|P1|STARTED|Overall Study||51
8111466|NCT03062267|19991938|P2|NOT COMPLETED|Overall Study||5
8111467|NCT03062267|19991939|P1|NOT COMPLETED|Overall Study||2
8111468|NCT03062267|19991938|P2|COMPLETED|Overall Study||32
8111469|NCT03062267|19991939|P1|COMPLETED|Overall Study||10
8111470|NCT03062267|19991938|P2|STARTED|Overall Study||37
8111471|NCT03062267|19991939|P1|STARTED|Overall Study||12
8111472|NCT03062228|19991951|P1|NOT COMPLETED|Overall Study||0
8111473|NCT03062228|19991951|P1|COMPLETED|Overall Study||162
8111474|NCT03062228|19991951|P1|STARTED|Overall Study||162
8111475|NCT03061513|19991964|P2|NOT COMPLETED|Overall Study||1
8111476|NCT03061513|19991965|P1|NOT COMPLETED|Overall Study||0
8111477|NCT03061513|19991964|P2|COMPLETED|Overall Study||4
8111478|NCT03061513|19991965|P1|COMPLETED|Overall Study||6
8111479|NCT03061513|19991964|P2|STARTED|Overall Study||5
8111480|NCT03061513|19991965|P1|STARTED|Overall Study||6
8111481|NCT03061331|19991975|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8111482|NCT03061331|19991976|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8111483|NCT03061331|19991975|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
8111484|NCT03061331|19991976|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
8111485|NCT03061331|19991975|P2|STARTED|Treatment Period 2 (8 Weeks)||9
8111486|NCT03061331|19991976|P1|STARTED|Treatment Period 2 (8 Weeks)||8
8111487|NCT03061331|19991975|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
8111488|NCT03061331|19991976|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
8111489|NCT03061331|19991975|P2|COMPLETED|Washout Period (8 Weeks)||9
8111490|NCT03061331|19991976|P1|COMPLETED|Washout Period (8 Weeks)||8
8111491|NCT03061331|19991975|P2|STARTED|Washout Period (8 Weeks)||10
8111492|NCT03061331|19991976|P1|STARTED|Washout Period (8 Weeks)||10
8111493|NCT03061331|19991975|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
8111494|NCT03061331|19991976|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
8111495|NCT03061331|19991975|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
8111496|NCT03061331|19991976|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
8111497|NCT03061331|19991975|P2|STARTED|Treatment Period 1 (8 Weeks)||10
8111498|NCT03061331|19991976|P1|STARTED|Treatment Period 1 (8 Weeks)||10
8111499|NCT03061279|19991984|P2|NOT COMPLETED|Overall Study||1
8111500|NCT03061279|19991985|P1|NOT COMPLETED|Overall Study||0
8111501|NCT03061279|19991984|P2|COMPLETED|Overall Study||0
8111502|NCT03061279|19991985|P1|COMPLETED|Overall Study||0
8111503|NCT03061279|19991984|P2|STARTED|Overall Study||1
8111504|NCT03061279|19991985|P1|STARTED|Overall Study||0
8111505|NCT03061214|19992006|P3|NOT COMPLETED|Overall Study||10
8111506|NCT03061214|19992007|P2|NOT COMPLETED|Overall Study||28
8111507|NCT03061214|19992008|P1|NOT COMPLETED|Overall Study||25
8111508|NCT03061214|19992006|P3|COMPLETED|Overall Study||280
8111509|NCT03061214|19992007|P2|COMPLETED|Overall Study||262
8111510|NCT03061214|19992008|P1|COMPLETED|Overall Study||263
8111511|NCT03061214|19992006|P3|Safety Analysis Set (SAS)|Overall Study||290
8111512|NCT03061214|19992007|P2|Safety Analysis Set (SAS)|Overall Study||290
8111513|NCT03061214|19992008|P1|Safety Analysis Set (SAS)|Overall Study||287
8111514|NCT03061214|19992006|P3|Full Analysis Set (FAS)|Overall Study||290
8111515|NCT03061214|19992007|P2|Full Analysis Set (FAS)|Overall Study||290
8111516|NCT03061214|19992008|P1|Full Analysis Set (FAS)|Overall Study||288
8111517|NCT03061214|19992006|P3|Exposed|Overall Study||290
8111518|NCT03061214|19992007|P2|Exposed|Overall Study||290
8111519|NCT03061214|19992008|P1|Exposed|Overall Study||287
8111520|NCT03061214|19992006|P3|STARTED|Overall Study||290
8111521|NCT03061214|19992007|P2|STARTED|Overall Study||290
8111522|NCT03061214|19992008|P1|STARTED|Overall Study||288
8111523|NCT03061188|19992234|P4|NOT COMPLETED|On Follow-up for 3 Years||5
8111524|NCT03061188|19992235|P3|NOT COMPLETED|On Follow-up for 3 Years||5
8111525|NCT03061188|19992236|P2|NOT COMPLETED|On Follow-up for 3 Years||3
8111526|NCT03061188|19992237|P1|NOT COMPLETED|On Follow-up for 3 Years||0
8111527|NCT03061188|19992234|P4|COMPLETED|On Follow-up for 3 Years||1
8111528|NCT03061188|19992235|P3|COMPLETED|On Follow-up for 3 Years||1
8111529|NCT03061188|19992236|P2|COMPLETED|On Follow-up for 3 Years||0
8111530|NCT03061188|19992237|P1|COMPLETED|On Follow-up for 3 Years||0
8111531|NCT03061188|19992234|P4|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
8111532|NCT03061188|19992235|P3|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
8111533|NCT03061188|19992236|P2|STARTED|On Follow-up for 3 Years||3
8111534|NCT03061188|19992237|P1|STARTED|On Follow-up for 3 Years||0
8111535|NCT03061188|19992234|P4|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
8111536|NCT03061188|19992235|P3|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
8111537|NCT03061188|19992236|P2|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
8111538|NCT03061188|19992237|P1|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
8111539|NCT03061188|19992234|P4|COMPLETED|Went on to Cycle 2 and Beyond||5
8111540|NCT03061188|19992235|P3|COMPLETED|Went on to Cycle 2 and Beyond||5
8111541|NCT03061188|19992236|P2|COMPLETED|Went on to Cycle 2 and Beyond||3
8111542|NCT03061188|19992237|P1|COMPLETED|Went on to Cycle 2 and Beyond||0
8111543|NCT03061188|19992234|P4|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
8111544|NCT03061188|19992235|P3|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
8111545|NCT03061188|19992236|P2|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
8111546|NCT03061188|19992237|P1|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
8111547|NCT03061188|19992234|P4|STARTED|Went on to Cycle 2 and Beyond||6
8111548|NCT03061188|19992235|P3|STARTED|Went on to Cycle 2 and Beyond||6
8111549|NCT03061188|19992236|P2|STARTED|Went on to Cycle 2 and Beyond||3
8111550|NCT03061188|19992237|P1|STARTED|Went on to Cycle 2 and Beyond||0
8111551|NCT03061188|19992234|P4|NOT COMPLETED|Completed 1st Cycle||0
8111552|NCT03061188|19992235|P3|NOT COMPLETED|Completed 1st Cycle||0
8111553|NCT03061188|19992236|P2|NOT COMPLETED|Completed 1st Cycle||0
8111554|NCT03061188|19992237|P1|NOT COMPLETED|Completed 1st Cycle||0
8111555|NCT03061188|19992234|P4|COMPLETED|Completed 1st Cycle||6
8111556|NCT03061188|19992235|P3|COMPLETED|Completed 1st Cycle||6
8111557|NCT03061188|19992236|P2|COMPLETED|Completed 1st Cycle||3
8111558|NCT03061188|19992237|P1|COMPLETED|Completed 1st Cycle||0
8111559|NCT03061188|19992234|P4|STARTED|Completed 1st Cycle||6
8111560|NCT03061188|19992235|P3|STARTED|Completed 1st Cycle||6
8111561|NCT03061188|19992236|P2|STARTED|Completed 1st Cycle||3
8111562|NCT03061188|19992237|P1|STARTED|Completed 1st Cycle||0
8111563|NCT03061175|19992259|P2|NOT COMPLETED|Followup 2 at 6 Months||7
8111564|NCT03061175|19992260|P1|NOT COMPLETED|Followup 2 at 6 Months||4
8111565|NCT03061175|19992259|P2|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
8111566|NCT03061175|19992260|P1|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
8111567|NCT03061175|19992259|P2|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
8111568|NCT03061175|19992260|P1|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
8111569|NCT03061175|19992259|P2|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
8111570|NCT03061175|19992260|P1|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
8111571|NCT03061175|19992259|P2|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
8111572|NCT03061175|19992260|P1|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
8111573|NCT03061175|19992259|P2|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
8111574|NCT03061175|19992260|P1|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
8111575|NCT03061175|19992259|P2|NOT COMPLETED|Baseline||0
8111576|NCT03061175|19992260|P1|NOT COMPLETED|Baseline||1
8111577|NCT03061175|19992259|P2|COMPLETED|Baseline||47
8111578|NCT03061175|19992260|P1|COMPLETED|Baseline||46
8111579|NCT03061175|19992259|P2|STARTED|Baseline||47
8111580|NCT03061175|19992260|P1|STARTED|Baseline||47
8111581|NCT03061097|19992284|P2|NOT COMPLETED|Overall Study||3
8111582|NCT03061097|19992285|P1|NOT COMPLETED|Overall Study||0
8111583|NCT03061097|19992284|P2|COMPLETED|Overall Study||0
8111584|NCT03061097|19992285|P1|COMPLETED|Overall Study||4
8111585|NCT03061097|19992284|P2|STARTED|Overall Study||3
8111586|NCT03061097|19992285|P1|STARTED|Overall Study||4
8111587|NCT03060759|19992299|P2|NOT COMPLETED|Overall Study||3
8111588|NCT03060759|19992300|P1|NOT COMPLETED|Overall Study||5
8111589|NCT03060759|19992299|P2|COMPLETED|Overall Study||12
8111590|NCT03060759|19992300|P1|COMPLETED|Overall Study||15
8111591|NCT03060759|19992299|P2|STARTED|Overall Study||15
8111592|NCT03060759|19992300|P1|STARTED|Overall Study||20
8111593|NCT03060551|19992306|P1|NOT COMPLETED|Overall Study||2
8111594|NCT03060551|19992306|P1|COMPLETED|Overall Study||18
8111595|NCT03060551|19992306|P1|STARTED|Overall Study||20
8111596|NCT03060512|19992327|P2|NOT COMPLETED|Overall Study||9
8111597|NCT03060512|19992328|P1|NOT COMPLETED|Overall Study||7
8111598|NCT03060512|19992327|P2|COMPLETED|Overall Study||130
8111599|NCT03060512|19992328|P1|COMPLETED|Overall Study||130
8111600|NCT03060512|19992327|P2|Treated With PEG 3350|Overall Study||138
8111601|NCT03060512|19992328|P1|Treated With PEG 3350|Overall Study||130
8111602|NCT03060512|19992327|P2|Treated With Movantik|Overall Study||135
8111603|NCT03060512|19992328|P1|Treated With Movantik|Overall Study||136
8111604|NCT03060512|19992327|P2|STARTED|Overall Study||139
8111605|NCT03060512|19992328|P1|STARTED|Overall Study||137
8111606|NCT03060486|19992345|P1|NOT COMPLETED|Overall Study||0
8111607|NCT03060486|19992345|P1|COMPLETED|Overall Study||15
8111608|NCT03060486|19992345|P1|STARTED|Overall Study||15
8111609|NCT03059901|19992351|P2|NOT COMPLETED|Overall Study||2
8111610|NCT03059901|19992352|P1|NOT COMPLETED|Overall Study||4
8111611|NCT03059901|19992351|P2|COMPLETED|Overall Study||28
8111612|NCT03059901|19992352|P1|COMPLETED|Overall Study||26
8111613|NCT03059901|19992351|P2|STARTED|Overall Study||30
8111614|NCT03059901|19992352|P1|STARTED|Overall Study||30
8111615|NCT03059810|19992358|P1|NOT COMPLETED|Overall Study||0
8111616|NCT03059810|19992358|P1|COMPLETED|Overall Study||63
8111617|NCT03059810|19992358|P1|STARTED|Overall Study||63
8111618|NCT03058991|19992365|P3|NOT COMPLETED|Overall Study||12
8111619|NCT03058991|19992366|P2|NOT COMPLETED|Overall Study||12
8111620|NCT03058991|19992367|P1|NOT COMPLETED|Overall Study||18
8111621|NCT03058991|19992365|P3|COMPLETED|Overall Study||25
8111622|NCT03058991|19992366|P2|COMPLETED|Overall Study||20
8111623|NCT03058991|19992367|P1|COMPLETED|Overall Study||21
8111624|NCT03058991|19992365|P3|1-Week Follow Up|Overall Study||28
8111625|NCT03058991|19992366|P2|1-Week Follow Up|Overall Study||27
8111626|NCT03058991|19992367|P1|1-Week Follow Up|Overall Study||23
8111627|NCT03058991|19992365|P3|STARTED|Overall Study||37
8111628|NCT03058991|19992366|P2|STARTED|Overall Study||32
8111629|NCT03058991|19992367|P1|STARTED|Overall Study||39
8111630|NCT03058705|19992393|P1|NOT COMPLETED|Overall Study||4
8111631|NCT03058705|19992393|P1|COMPLETED|Overall Study||6
8111632|NCT03058705|19992393|P1|STARTED|Overall Study||10
8111633|NCT03058692|19992399|P2|NOT COMPLETED|Overall Study||2
8111634|NCT03058692|19992400|P1|NOT COMPLETED|Overall Study||3
8111635|NCT03058692|19992399|P2|COMPLETED|Overall Study||57
8111636|NCT03058692|19992400|P1|COMPLETED|Overall Study||58
8111637|NCT03058692|19992399|P2|STARTED|Overall Study||59
8111638|NCT03058692|19992400|P1|STARTED|Overall Study||61
8111639|NCT03057704|19992514|P2|NOT COMPLETED|Overall Study||0
8111640|NCT03057704|19992515|P1|NOT COMPLETED|Overall Study||0
8111641|NCT03057704|19992514|P2|COMPLETED|Overall Study||25
8111642|NCT03057704|19992515|P1|COMPLETED|Overall Study||25
8111643|NCT03057704|19992514|P2|STARTED|Overall Study||25
8111644|NCT03057704|19992515|P1|STARTED|Overall Study||25
8111645|NCT03057613|19992525|P1|NOT COMPLETED|Overall Study||0
8111646|NCT03057613|19992525|P1|COMPLETED|Overall Study||18
8111647|NCT03057613|19992525|P1|STARTED|Overall Study||18
8111652|NCT03057366|19992537|P3|NOT COMPLETED|Part B||0
8111653|NCT03057366|19992538|P2|NOT COMPLETED|Part B||0
8111654|NCT03057366|19992539|P1|NOT COMPLETED|Part B||0
8111655|NCT03057366|19992537|P3|COMPLETED|Part B||2
8111656|NCT03057366|19992538|P2|COMPLETED|Part B||5
8111657|NCT03057366|19992539|P1|COMPLETED|Part B||0
8111658|NCT03057366|19992537|P3|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
8111659|NCT03057366|19992538|P2|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
8111660|NCT03057366|19992539|P1|STARTED|Part B||0
8111661|NCT03057366|19992537|P3|NOT COMPLETED|Part A||0
8111662|NCT03057366|19992538|P2|NOT COMPLETED|Part A||0
8111663|NCT03057366|19992539|P1|NOT COMPLETED|Part A||0
8111664|NCT03057366|19992537|P3|COMPLETED|Part A||0
8111665|NCT03057366|19992538|P2|COMPLETED|Part A||0
8111666|NCT03057366|19992539|P1|COMPLETED|Part A||8
8111667|NCT03057366|19992537|P3|STARTED|Part A||0
8111668|NCT03057366|19992538|P2|STARTED|Part A||0
8111669|NCT03057366|19992539|P1|STARTED|Part A||8
8111670|NCT03057132|19992562|P1|NOT COMPLETED|Overall Study||0
8111671|NCT03057132|19992562|P1|COMPLETED|Overall Study||1
8111672|NCT03057132|19992562|P1|STARTED|Overall Study||1
8111673|NCT03056573|19992569|P2|NOT COMPLETED|Overall Study||5
8111674|NCT03056573|19992570|P1|NOT COMPLETED|Overall Study||5
8111675|NCT03056573|19992569|P2|COMPLETED|Overall Study||14
8111676|NCT03056573|19992570|P1|COMPLETED|Overall Study||40
8111677|NCT03056573|19992569|P2|STARTED|Overall Study||19
8111678|NCT03056573|19992570|P1|STARTED|Overall Study||45
8111679|NCT03056456|19992614|P4|NOT COMPLETED|Period 4||0
8111680|NCT03056456|19992615|P3|NOT COMPLETED|Period 4||0
8111681|NCT03056456|19992616|P2|NOT COMPLETED|Period 4||0
8111682|NCT03056456|19992617|P1|NOT COMPLETED|Period 4||0
8111683|NCT03056456|19992614|P4|COMPLETED|Period 4||5
8111684|NCT03056456|19992615|P3|COMPLETED|Period 4||6
8111685|NCT03056456|19992616|P2|COMPLETED|Period 4||6
8111686|NCT03056456|19992617|P1|COMPLETED|Period 4||6
8111687|NCT03056456|19992614|P4|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
8111688|NCT03056456|19992615|P3|STARTED|Period 4||6
8111689|NCT03056456|19992616|P2|STARTED|Period 4||6
8111690|NCT03056456|19992617|P1|STARTED|Period 4||6
8111691|NCT03056456|19992614|P4|NOT COMPLETED|Period 3||0
8111692|NCT03056456|19992615|P3|NOT COMPLETED|Period 3||0
8111693|NCT03056456|19992616|P2|NOT COMPLETED|Period 3||0
8111694|NCT03056456|19992617|P1|NOT COMPLETED|Period 3||0
8111695|NCT03056456|19992614|P4|COMPLETED|Period 3||6
8111696|NCT03056456|19992615|P3|COMPLETED|Period 3||6
8111697|NCT03056456|19992616|P2|COMPLETED|Period 3||6
8111698|NCT03056456|19992617|P1|COMPLETED|Period 3||6
8111699|NCT03056456|19992614|P4|STARTED|Period 3||6
8111700|NCT03056456|19992615|P3|STARTED|Period 3||6
8111701|NCT03056456|19992616|P2|STARTED|Period 3||6
8111702|NCT03056456|19992617|P1|STARTED|Period 3||6
8111703|NCT03056456|19992614|P4|NOT COMPLETED|Period 2||0
8111704|NCT03056456|19992615|P3|NOT COMPLETED|Period 2||0
8111705|NCT03056456|19992616|P2|NOT COMPLETED|Period 2||0
8111706|NCT03056456|19992617|P1|NOT COMPLETED|Period 2||0
8111707|NCT03056456|19992614|P4|COMPLETED|Period 2||6
8111708|NCT03056456|19992615|P3|COMPLETED|Period 2||6
8111709|NCT03056456|19992616|P2|COMPLETED|Period 2||6
8111710|NCT03056456|19992617|P1|COMPLETED|Period 2||6
8111711|NCT03056456|19992614|P4|STARTED|Period 2||6
8111712|NCT03056456|19992615|P3|STARTED|Period 2||6
8111713|NCT03056456|19992616|P2|STARTED|Period 2||6
8111714|NCT03056456|19992617|P1|STARTED|Period 2||6
8111715|NCT03056456|19992614|P4|NOT COMPLETED|Period 1||0
8111716|NCT03056456|19992615|P3|NOT COMPLETED|Period 1||0
8111717|NCT03056456|19992616|P2|NOT COMPLETED|Period 1||0
8111718|NCT03056456|19992617|P1|NOT COMPLETED|Period 1||0
8111719|NCT03056456|19992614|P4|COMPLETED|Period 1||6
8111720|NCT03056456|19992615|P3|COMPLETED|Period 1||6
8111721|NCT03056456|19992616|P2|COMPLETED|Period 1||6
8111722|NCT03056456|19992617|P1|COMPLETED|Period 1||6
8111723|NCT03056456|19992614|P4|Received One Dose of Study Drug|Period 1||6
8111724|NCT03056456|19992615|P3|Received One Dose of Study Drug|Period 1||6
8111725|NCT03056456|19992616|P2|Received One Dose of Study Drug|Period 1||6
8111726|NCT03056456|19992617|P1|Received One Dose of Study Drug|Period 1||6
8111727|NCT03056456|19992614|P4|STARTED|Period 1||6
8111728|NCT03056456|19992615|P3|STARTED|Period 1||6
8111729|NCT03056456|19992616|P2|STARTED|Period 1||6
8111730|NCT03056456|19992617|P1|STARTED|Period 1||6
8111731|NCT03056352|19992630|P1|NOT COMPLETED|Overall Study||1
8111732|NCT03056352|19992630|P1|COMPLETED|Overall Study||20
8111733|NCT03056352|19992630|P1|STARTED|Overall Study||21
8111734|NCT03056300|19992636|P1|NOT COMPLETED|Overall Study||3
8111735|NCT03056300|19992636|P1|COMPLETED|Overall Study||47
8111736|NCT03056300|19992636|P1|STARTED|Overall Study||50
8111737|NCT03056144|19992641|P1|NOT COMPLETED|Overall Study||0
8111738|NCT03056144|19992641|P1|COMPLETED|Overall Study||1
8111739|NCT03056144|19992641|P1|STARTED|Overall Study||1
8111740|NCT03056040|19992653|P2|NOT COMPLETED|Extension Period||95
8111741|NCT03056040|19992654|P1|NOT COMPLETED|Extension Period||96
8111742|NCT03056040|19992653|P2|COMPLETED|Extension Period||0
8111743|NCT03056040|19992654|P1|COMPLETED|Extension Period||0
8111744|NCT03056040|19992653|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||95
8111745|NCT03056040|19992654|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||96
8111746|NCT03056040|19992653|P2|STARTED|Extension Period||95
8111747|NCT03056040|19992654|P1|STARTED|Extension Period||96
8111748|NCT03056040|19992653|P2|NOT COMPLETED|Primary Evaluation Period||3
8111749|NCT03056040|19992654|P1|NOT COMPLETED|Primary Evaluation Period||1
8111750|NCT03056040|19992653|P2|COMPLETED|Primary Evaluation Period||95
8111751|NCT03056040|19992654|P1|COMPLETED|Primary Evaluation Period||96
8111752|NCT03056040|19992653|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
8111753|NCT03056040|19992654|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
8111754|NCT03056040|19992653|P2|STARTED|Primary Evaluation Period||98
8111755|NCT03056040|19992654|P1|STARTED|Primary Evaluation Period||97
8111756|NCT03055988|19992668|P2|NOT COMPLETED|Period 2||2
8111757|NCT03055988|19992669|P1|NOT COMPLETED|Period 2||1
8111758|NCT03055988|19992668|P2|COMPLETED|Period 2||31
8111759|NCT03055988|19992669|P1|COMPLETED|Period 2||36
8111760|NCT03055988|19992668|P2|STARTED|Period 2||33
8111761|NCT03055988|19992669|P1|STARTED|Period 2||37
8111762|NCT03055988|19992668|P2|NOT COMPLETED|Period 1||5
8111763|NCT03055988|19992669|P1|NOT COMPLETED|Period 1||1
8111764|NCT03055988|19992668|P2|COMPLETED|Period 1||33
8111765|NCT03055988|19992669|P1|COMPLETED|Period 1||37
8111766|NCT03055988|19992668|P2|STARTED|Period 1||38
8111767|NCT03055988|19992669|P1|STARTED|Period 1||38
8111768|NCT03055897|19992691|P1|NOT COMPLETED|Overall Study||0
8111769|NCT03055897|19992691|P1|COMPLETED|Overall Study||15
8111770|NCT03055897|19992691|P1|STARTED|Overall Study||15
8111771|NCT03055858|19992695|P1|NOT COMPLETED|Overall Study||6
8111772|NCT03055858|19992695|P1|COMPLETED|Overall Study||194
8111773|NCT03055858|19992695|P1|CAP Cohort|Overall Study||150
8111774|NCT03055858|19992695|P1|IDE Cohort|Overall Study||50
8111775|NCT03055858|19992695|P1|STARTED|Overall Study||200
8111776|NCT03055832|19992703|P2|NOT COMPLETED|Week 4||0
8111777|NCT03055832|19992704|P1|NOT COMPLETED|Week 4||0
8111778|NCT03055832|19992703|P2|COMPLETED|Week 4||71
8111779|NCT03055832|19992704|P1|COMPLETED|Week 4||70
8111780|NCT03055832|19992703|P2|STARTED|Week 4||71
8111781|NCT03055832|19992704|P1|STARTED|Week 4||70
8111782|NCT03055832|19992703|P2|NOT COMPLETED|Week 2||0
8111783|NCT03055832|19992704|P1|NOT COMPLETED|Week 2||1
8111784|NCT03055832|19992703|P2|COMPLETED|Week 2||71
8111785|NCT03055832|19992704|P1|COMPLETED|Week 2||70
8111786|NCT03055832|19992703|P2|STARTED|Week 2||71
8111787|NCT03055832|19992704|P1|STARTED|Week 2||71
8111788|NCT03055832|19992703|P2|NOT COMPLETED|Day 1||0
8111789|NCT03055832|19992704|P1|NOT COMPLETED|Day 1||0
8111790|NCT03055832|19992703|P2|COMPLETED|Day 1||71
8111791|NCT03055832|19992704|P1|COMPLETED|Day 1||71
8111792|NCT03055832|19992703|P2|STARTED|Day 1||71
8111793|NCT03055832|19992704|P1|STARTED|Day 1||71
8111794|NCT03055832|19992703|P2|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
8111795|NCT03055832|19992704|P1|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
8111796|NCT03055832|19992703|P2|COMPLETED|Immediately Post-Procedure (Hour 1)||71
8111797|NCT03055832|19992704|P1|COMPLETED|Immediately Post-Procedure (Hour 1)||71
8111798|NCT03055832|19992703|P2|STARTED|Immediately Post-Procedure (Hour 1)||71
8111799|NCT03055832|19992704|P1|STARTED|Immediately Post-Procedure (Hour 1)||71
8111800|NCT03055832|19992703|P2|NOT COMPLETED|Baseline||0
8111801|NCT03055832|19992704|P1|NOT COMPLETED|Baseline||0
8111802|NCT03055832|19992703|P2|COMPLETED|Baseline||71
8111803|NCT03055832|19992704|P1|COMPLETED|Baseline||71
8111804|NCT03055832|19992703|P2|STARTED|Baseline||71
8111805|NCT03055832|19992704|P1|STARTED|Baseline||71
8111806|NCT03055806|19992764|P4|NOT COMPLETED|Overall Study||15
8111807|NCT03055806|19992765|P3|NOT COMPLETED|Overall Study||13
8111808|NCT03055806|19992766|P2|NOT COMPLETED|Overall Study||7
8111809|NCT03055806|19992767|P1|NOT COMPLETED|Overall Study||6
8111810|NCT03055806|19992764|P4|COMPLETED|Overall Study||57
8111811|NCT03055806|19992765|P3|COMPLETED|Overall Study||58
8111812|NCT03055806|19992766|P2|COMPLETED|Overall Study||41
8111813|NCT03055806|19992767|P1|COMPLETED|Overall Study||42
8111814|NCT03055806|19992764|P4|STARTED|Overall Study||72
8111815|NCT03055806|19992765|P3|STARTED|Overall Study||71
8111816|NCT03055806|19992766|P2|STARTED|Overall Study||48
8111817|NCT03055806|19992767|P1|STARTED|Overall Study||48
8111818|NCT03055650|19992809|P1|NOT COMPLETED|Overall Study||0
8111819|NCT03055650|19992809|P1|COMPLETED|Overall Study||30
8111820|NCT03055650|19992809|P1|STARTED|Overall Study||30
8111821|NCT03055624|19992816|P1|NOT COMPLETED|Overall Study||9
8111822|NCT03055624|19992816|P1|COMPLETED|Overall Study||0
8111823|NCT03055624|19992816|P1|STARTED|Overall Study||9
8111824|NCT03055494|19992827|P2|NOT COMPLETED|Overall Study||1
8111825|NCT03055494|19992828|P1|NOT COMPLETED|Overall Study||10
8111826|NCT03055494|19992827|P2|COMPLETED|Overall Study||27
8111827|NCT03055494|19992828|P1|COMPLETED|Overall Study||44
8111828|NCT03055494|19992827|P2|STARTED|Overall Study||28
8111829|NCT03055494|19992828|P1|STARTED|Overall Study||54
8111830|NCT03055338|19992859|P3|NOT COMPLETED|Overall Study||12
8111831|NCT03055338|19992860|P2|NOT COMPLETED|Overall Study||11
8111832|NCT03055338|19992861|P1|NOT COMPLETED|Overall Study||18
8111833|NCT03055338|19992859|P3|COMPLETED|Overall Study||77
8111834|NCT03055338|19992860|P2|COMPLETED|Overall Study||34
8111835|NCT03055338|19992861|P1|COMPLETED|Overall Study||72
8111836|NCT03055338|19992859|P3|STARTED|Overall Study||89
8111837|NCT03055338|19992860|P2|STARTED|Overall Study||45
8111838|NCT03055338|19992861|P1|STARTED|Overall Study||90
8111839|NCT03055260|19992880|P2|NOT COMPLETED|Overall Study||0
8111840|NCT03055260|19992881|P1|NOT COMPLETED|Overall Study||1
8111841|NCT03055260|19992880|P2|COMPLETED|Overall Study||0
8111842|NCT03055260|19992881|P1|COMPLETED|Overall Study||7
8111843|NCT03055260|19992880|P2|STARTED|Overall Study||0
8111844|NCT03055260|19992881|P1|STARTED|Overall Study||8
8111845|NCT03055221|19992889|P1|NOT COMPLETED|Overall Study||16
8111846|NCT03055221|19992889|P1|COMPLETED|Overall Study||0
8111847|NCT03055221|19992889|P1|STARTED|Overall Study||16
8111848|NCT03055195|19992896|P2|NOT COMPLETED|Overall Study||14
8111849|NCT03055195|19992897|P1|NOT COMPLETED|Overall Study||12
8111850|NCT03055195|19992896|P2|COMPLETED|Overall Study||4
8111851|NCT03055195|19992897|P1|COMPLETED|Overall Study||4
8111852|NCT03055195|19992896|P2|STARTED|Overall Study||18
8111853|NCT03055195|19992897|P1|STARTED|Overall Study||16
8111854|NCT03055156|19992951|P2|NOT COMPLETED|Overall Study||0
8111855|NCT03055156|19992952|P1|NOT COMPLETED|Overall Study||0
8111856|NCT03055156|19992951|P2|COMPLETED|Overall Study||273
8111857|NCT03055156|19992952|P1|COMPLETED|Overall Study||281
8111858|NCT03055156|19992951|P2|STARTED|Overall Study||273
8111859|NCT03055156|19992952|P1|STARTED|Overall Study||281
8111860|NCT03055000|19992989|P3|NOT COMPLETED|Overall Study||0
8111861|NCT03055000|19992990|P2|NOT COMPLETED|Overall Study||0
8111862|NCT03055000|19992991|P1|NOT COMPLETED|Overall Study||0
8111863|NCT03055000|19992989|P3|COMPLETED|Overall Study||16
8111864|NCT03055000|19992990|P2|COMPLETED|Overall Study||17
8111865|NCT03055000|19992991|P1|COMPLETED|Overall Study||16
8111866|NCT03055000|19992989|P3|STARTED|Overall Study||16
8111867|NCT03055000|19992990|P2|STARTED|Overall Study||17
8111868|NCT03055000|19992991|P1|STARTED|Overall Study||16
8111869|NCT03054922|19993077|P3|NOT COMPLETED|Overall Study||0
8111870|NCT03054922|19993078|P2|NOT COMPLETED|Overall Study||0
8111871|NCT03054922|19993079|P1|NOT COMPLETED|Overall Study||0
8111872|NCT03054922|19993077|P3|COMPLETED|Overall Study||20
8111873|NCT03054922|19993078|P2|COMPLETED|Overall Study||19
8111874|NCT03054922|19993079|P1|COMPLETED|Overall Study||20
8111875|NCT03054922|19993077|P3|STARTED|Overall Study||20
8111876|NCT03054922|19993078|P2|STARTED|Overall Study||19
8111877|NCT03054922|19993079|P1|STARTED|Overall Study||20
8111878|NCT03054857|19993101|P2|NOT COMPLETED|Overall Study||0
8111879|NCT03054857|19993102|P1|NOT COMPLETED|Overall Study||1
8111880|NCT03054857|19993101|P2|COMPLETED|Overall Study||50
8111881|NCT03054857|19993102|P1|COMPLETED|Overall Study||49
8111882|NCT03054857|19993101|P2|STARTED|Overall Study||50
8111883|NCT03054857|19993102|P1|STARTED|Overall Study||50
8111884|NCT03054844|19993118|P2|NOT COMPLETED|Overall Study||1
8111885|NCT03054844|19993119|P1|NOT COMPLETED|Overall Study||3
8111886|NCT03054844|19993118|P2|COMPLETED|Overall Study||26
8111887|NCT03054844|19993119|P1|COMPLETED|Overall Study||25
8111888|NCT03054844|19993118|P2|STARTED|Overall Study||27
8111889|NCT03054844|19993119|P1|STARTED|Overall Study||28
8111890|NCT03054805|19993138|P3|NOT COMPLETED|Overall Study||2
8111891|NCT03054805|19993139|P2|NOT COMPLETED|Overall Study||10
8111892|NCT03054805|19993140|P1|NOT COMPLETED|Overall Study||16
8111893|NCT03054805|19993138|P3|COMPLETED|Overall Study||42
8111894|NCT03054805|19993139|P2|COMPLETED|Overall Study||41
8111895|NCT03054805|19993140|P1|COMPLETED|Overall Study||42
8111896|NCT03054805|19993138|P3|STARTED|Overall Study||44
8111897|NCT03054805|19993139|P2|STARTED|Overall Study||51
8111898|NCT03054805|19993140|P1|STARTED|Overall Study||58
8111899|NCT03054740|19993150|P2|NOT COMPLETED|Overall Study||0
8111900|NCT03054740|19993151|P1|NOT COMPLETED|Overall Study||0
8111901|NCT03054740|19993150|P2|COMPLETED|Overall Study||15
8111902|NCT03054740|19993151|P1|COMPLETED|Overall Study||15
8111903|NCT03054740|19993150|P2|STARTED|Overall Study||15
8111904|NCT03054740|19993151|P1|STARTED|Overall Study||15
8111905|NCT03054649|19993165|P2|NOT COMPLETED|Overall Study||0
8111906|NCT03054649|19993166|P1|NOT COMPLETED|Overall Study||0
8111907|NCT03054649|19993165|P2|COMPLETED|Overall Study||27
8111908|NCT03054649|19993166|P1|COMPLETED|Overall Study||27
8111909|NCT03054649|19993165|P2|STARTED|Overall Study||27
8111910|NCT03054649|19993166|P1|STARTED|Overall Study||27
8111911|NCT03054506|19993223|P3|NOT COMPLETED|Overall Study||0
8111912|NCT03054506|19993224|P2|NOT COMPLETED|Overall Study||0
8111913|NCT03054506|19993225|P1|NOT COMPLETED|Overall Study||1
8111914|NCT03054506|19993223|P3|COMPLETED|Overall Study||9
8111915|NCT03054506|19993224|P2|COMPLETED|Overall Study||11
8111916|NCT03054506|19993225|P1|COMPLETED|Overall Study||19
8111917|NCT03054506|19993223|P3|STARTED|Overall Study||9
8111918|NCT03054506|19993224|P2|STARTED|Overall Study||11
8111919|NCT03054506|19993225|P1|STARTED|Overall Study||20
8111920|NCT03054428|19993269|P3|NOT COMPLETED|Overall Study||79
8111921|NCT03054428|19993270|P2|NOT COMPLETED|Overall Study||80
8111922|NCT03054428|19993271|P1|NOT COMPLETED|Overall Study||83
8111923|NCT03054428|19993269|P3|COMPLETED|Overall Study||3
8111924|NCT03054428|19993270|P2|COMPLETED|Overall Study||4
8111925|NCT03054428|19993271|P1|COMPLETED|Overall Study||2
8111926|NCT03054428|19993269|P3|Completed Week 28 (End of Study)|Overall Study||3
8111927|NCT03054428|19993270|P2|Completed Week 28 (End of Study)|Overall Study||4
8111928|NCT03054428|19993271|P1|Completed Week 28 (End of Study)|Overall Study||2
8111929|NCT03054428|19993269|P3|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
8111930|NCT03054428|19993270|P2|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
8111931|NCT03054428|19993271|P1|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
8111932|NCT03054428|19993269|P3|STARTED|Overall Study||82
8111933|NCT03054428|19993270|P2|STARTED|Overall Study||84
8111934|NCT03054428|19993271|P1|STARTED|Overall Study||85
8111935|NCT03054103|19993339|P3|NOT COMPLETED|Overall Study||0
8111936|NCT03054103|19993340|P2|NOT COMPLETED|Overall Study||0
8111937|NCT03054103|19993341|P1|NOT COMPLETED|Overall Study||0
8111938|NCT03054103|19993339|P3|COMPLETED|Overall Study||35
8111939|NCT03054103|19993340|P2|COMPLETED|Overall Study||29
8111940|NCT03054103|19993341|P1|COMPLETED|Overall Study||41
8111941|NCT03054103|19993339|P3|STARTED|Overall Study||35
8111942|NCT03054103|19993340|P2|STARTED|Overall Study||29
8111943|NCT03054103|19993341|P1|STARTED|Overall Study||41
8111944|NCT03054077|19993360|P2|NOT COMPLETED|Overall Study||0
8111945|NCT03054077|19993361|P1|NOT COMPLETED|Overall Study||0
8111946|NCT03054077|19993360|P2|COMPLETED|Overall Study||12
8111947|NCT03054077|19993361|P1|COMPLETED|Overall Study||12
8111948|NCT03054077|19993360|P2|STARTED|Overall Study||12
8111949|NCT03054077|19993361|P1|STARTED|Overall Study||12
8111950|NCT03054064|19993367|P1|NOT COMPLETED|Overall Study||6
8111951|NCT03054064|19993367|P1|COMPLETED|Overall Study||42
8111952|NCT03054064|19993367|P1|Screen Failure|Overall Study||2
8111953|NCT03054064|19993367|P1|STARTED|Overall Study||48
8111954|NCT03054051|19993377|P2|NOT COMPLETED|Overall Study||0
8111955|NCT03054051|19993378|P1|NOT COMPLETED|Overall Study||0
8111956|NCT03054051|19993377|P2|COMPLETED|Overall Study||30
8111957|NCT03054051|19993378|P1|COMPLETED|Overall Study||30
8111958|NCT03054051|19993377|P2|STARTED|Overall Study||30
8111959|NCT03054051|19993378|P1|STARTED|Overall Study||30
8111960|NCT03053960|19993407|P1|NOT COMPLETED|Overall Study||0
8111961|NCT03053960|19993407|P1|COMPLETED|Overall Study||8
8111962|NCT03053960|19993407|P1|STARTED|Overall Study||8
8111963|NCT03053518|19993412|P1|NOT COMPLETED|Overall Study||10
8111964|NCT03053518|19993412|P1|COMPLETED|Overall Study||12
8111965|NCT03053518|19993412|P1|STARTED|Overall Study||22
8111966|NCT03053492|19993418|P2|NOT COMPLETED|Overall Study||6
8111967|NCT03053492|19993419|P1|NOT COMPLETED|Overall Study||8
8111968|NCT03053492|19993418|P2|COMPLETED|Overall Study||27
8111969|NCT03053492|19993419|P1|COMPLETED|Overall Study||25
8111970|NCT03053492|19993418|P2|STARTED|Overall Study||33
8111971|NCT03053492|19993419|P1|STARTED|Overall Study||33
8111972|NCT03053427|19993433|P2|NOT COMPLETED|Overall Study||16
8111973|NCT03053427|19993434|P1|NOT COMPLETED|Overall Study||13
8111974|NCT03053427|19993433|P2|COMPLETED|Overall Study||173
8111975|NCT03053427|19993434|P1|COMPLETED|Overall Study||173
8111976|NCT03053427|19993433|P2|STARTED|Overall Study||189
8111977|NCT03053427|19993434|P1|STARTED|Overall Study||186
8111978|NCT03053401|19993458|P2|NOT COMPLETED|Overall Study||0
8111979|NCT03053401|19993459|P1|NOT COMPLETED|Overall Study||0
8111980|NCT03053401|19993458|P2|COMPLETED|Overall Study||26
8111981|NCT03053401|19993459|P1|COMPLETED|Overall Study||26
8111982|NCT03053401|19993458|P2|STARTED|Overall Study||26
8111983|NCT03053401|19993459|P1|STARTED|Overall Study||26
8111984|NCT03053180|19993469|P1|NOT COMPLETED|Overall Study||1
8111985|NCT03053180|19993469|P1|COMPLETED|Overall Study||59
8111986|NCT03053180|19993469|P1|STARTED|Overall Study||60
8111987|NCT03053063|19993481|P4|NOT COMPLETED|Open-Label Phase||23
8111988|NCT03053063|19993482|P3|NOT COMPLETED|Open-Label Phase||0
8111989|NCT03053063|19993483|P2|NOT COMPLETED|Open-Label Phase||0
8111990|NCT03053063|19993484|P1|NOT COMPLETED|Open-Label Phase||0
8111991|NCT03053063|19993481|P4|COMPLETED|Open-Label Phase||0
8111992|NCT03053063|19993482|P3|COMPLETED|Open-Label Phase||0
8111993|NCT03053063|19993483|P2|COMPLETED|Open-Label Phase||0
8111994|NCT03053063|19993484|P1|COMPLETED|Open-Label Phase||0
8111995|NCT03053063|19993481|P4|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
8111996|NCT03053063|19993482|P3|STARTED|Open-Label Phase||0
8111997|NCT03053063|19993483|P2|STARTED|Open-Label Phase||0
8111998|NCT03053063|19993484|P1|STARTED|Open-Label Phase||0
8111999|NCT03053063|19993481|P4|NOT COMPLETED|Randomized Phase||0
8112000|NCT03053063|19993482|P3|NOT COMPLETED|Randomized Phase||174
8112001|NCT03053063|19993483|P2|NOT COMPLETED|Randomized Phase||354
8112002|NCT03053063|19993484|P1|NOT COMPLETED|Randomized Phase||355
8112003|NCT03053063|19993481|P4|COMPLETED|Randomized Phase||0
8112004|NCT03053063|19993482|P3|COMPLETED|Randomized Phase||0
8112005|NCT03053063|19993483|P2|COMPLETED|Randomized Phase||0
8112006|NCT03053063|19993484|P1|COMPLETED|Randomized Phase||0
8112007|NCT03053063|19993481|P4|STARTED|Randomized Phase||0
8112008|NCT03053063|19993482|P3|STARTED|Randomized Phase||174
8112009|NCT03053063|19993483|P2|STARTED|Randomized Phase||354
8112010|NCT03053063|19993484|P1|STARTED|Randomized Phase||355
8112011|NCT03053050|19993514|P4|NOT COMPLETED|Open-label Phase||99
8112012|NCT03053050|19993515|P3|NOT COMPLETED|Open-label Phase||0
8112013|NCT03053050|19993516|P2|NOT COMPLETED|Open-label Phase||0
8112014|NCT03053050|19993517|P1|NOT COMPLETED|Open-label Phase||0
8112015|NCT03053050|19993514|P4|COMPLETED|Open-label Phase||0
8112016|NCT03053050|19993515|P3|COMPLETED|Open-label Phase||0
8112017|NCT03053050|19993516|P2|COMPLETED|Open-label Phase||0
8112018|NCT03053050|19993517|P1|COMPLETED|Open-label Phase||0
8112019|NCT03053050|19993514|P4|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
8112020|NCT03053050|19993515|P3|STARTED|Open-label Phase||0
8112021|NCT03053050|19993516|P2|STARTED|Open-label Phase||0
8112022|NCT03053050|19993517|P1|STARTED|Open-label Phase||0
8112023|NCT03053050|19993514|P4|NOT COMPLETED|Randomized Phase||0
8112024|NCT03053050|19993515|P3|NOT COMPLETED|Randomized Phase||161
8112025|NCT03053050|19993516|P2|NOT COMPLETED|Randomized Phase||323
8112026|NCT03053050|19993517|P1|NOT COMPLETED|Randomized Phase||324
8112027|NCT03053050|19993514|P4|COMPLETED|Randomized Phase||0
8112028|NCT03053050|19993515|P3|COMPLETED|Randomized Phase||0
8112029|NCT03053050|19993516|P2|COMPLETED|Randomized Phase||0
8112030|NCT03053050|19993517|P1|COMPLETED|Randomized Phase||0
8112031|NCT03053050|19993514|P4|STARTED|Randomized Phase||0
8112032|NCT03053050|19993515|P3|STARTED|Randomized Phase||161
8112033|NCT03053050|19993516|P2|STARTED|Randomized Phase||323
8112034|NCT03053050|19993517|P1|STARTED|Randomized Phase||324
8112035|NCT03052972|19993549|P2|NOT COMPLETED|Overall Study||0
8112036|NCT03052972|19993550|P1|NOT COMPLETED|Overall Study||0
8112037|NCT03052972|19993549|P2|COMPLETED|Overall Study||5
8112038|NCT03052972|19993550|P1|COMPLETED|Overall Study||18
8112039|NCT03052972|19993549|P2|STARTED|Overall Study||5
8112040|NCT03052972|19993550|P1|STARTED|Overall Study||18
8112041|NCT03052764|19993561|P2|NOT COMPLETED|Open-Label Re-Treatment Period||0
8112042|NCT03052764|19993562|P1|NOT COMPLETED|Open-Label Re-Treatment Period||0
8112043|NCT03052764|19993561|P2|COMPLETED|Open-Label Re-Treatment Period||33
8112044|NCT03052764|19993562|P1|COMPLETED|Open-Label Re-Treatment Period||58
8112045|NCT03052764|19993561|P2|STARTED|Open-Label Re-Treatment Period||33
8112046|NCT03052764|19993562|P1|STARTED|Open-Label Re-Treatment Period||58
8112047|NCT03052764|19993561|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8112048|NCT03052764|19993562|P1|NOT COMPLETED|Double-Blind Treatment Period||10
8112049|NCT03052764|19993561|P2|COMPLETED|Double-Blind Treatment Period||37
8112050|NCT03052764|19993562|P1|COMPLETED|Double-Blind Treatment Period||70
8112051|NCT03052764|19993561|P2|mITT|Double-Blind Treatment Period||39
8112052|NCT03052764|19993562|P1|mITT|Double-Blind Treatment Period||78
8112053|NCT03052764|19993561|P2|STARTED|Double-Blind Treatment Period||40
8112054|NCT03052764|19993562|P1|STARTED|Double-Blind Treatment Period||80
8112055|NCT03052725|19993582|P2|NOT COMPLETED|Overall Study||150
8112056|NCT03052725|19993583|P1|NOT COMPLETED|Overall Study||148
8112057|NCT03052725|19993582|P2|COMPLETED|Overall Study||47
8112058|NCT03052725|19993583|P1|COMPLETED|Overall Study||46
8112059|NCT03052725|19993582|P2|Safety Analysis Set|Overall Study||196
8112060|NCT03052725|19993583|P1|Safety Analysis Set|Overall Study||194
8112061|NCT03052725|19993582|P2|STARTED|Overall Study||197
8112062|NCT03052725|19993583|P1|STARTED|Overall Study||194
8112063|NCT03052530|19993620|P1|NOT COMPLETED|Overall Study||0
8112064|NCT03052530|19993620|P1|COMPLETED|Overall Study||61
8112065|NCT03052530|19993620|P1|STARTED|Overall Study||61
8112066|NCT03052517|19993630|P3|NOT COMPLETED|Overall Study||328
8112067|NCT03052517|19993631|P2|NOT COMPLETED|Overall Study||1014
8112068|NCT03052517|19993632|P1|NOT COMPLETED|Overall Study||1017
8112069|NCT03052517|19993630|P3|COMPLETED|Overall Study||32
8112070|NCT03052517|19993631|P2|COMPLETED|Overall Study||71
8112071|NCT03052517|19993632|P1|COMPLETED|Overall Study||76
8112072|NCT03052517|19993630|P3|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
8112073|NCT03052517|19993631|P2|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
8112074|NCT03052517|19993632|P1|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
8112075|NCT03052517|19993630|P3|STARTED|Overall Study||360
8112076|NCT03052517|19993631|P2|STARTED|Overall Study||1085
8112077|NCT03052517|19993632|P1|STARTED|Overall Study||1093
8112078|NCT03052426|19993676|P3|NOT COMPLETED|Overall Study||1
8112079|NCT03052426|19993677|P2|NOT COMPLETED|Overall Study||1
8112080|NCT03052426|19993678|P1|NOT COMPLETED|Overall Study||2
8112081|NCT03052426|19993676|P3|COMPLETED|Overall Study||5
8112082|NCT03052426|19993677|P2|COMPLETED|Overall Study||5
8112083|NCT03052426|19993678|P1|COMPLETED|Overall Study||4
8112084|NCT03052426|19993676|P3|STARTED|Overall Study||6
8112085|NCT03052426|19993677|P2|STARTED|Overall Study||6
8112086|NCT03052426|19993678|P1|STARTED|Overall Study||6
8112087|NCT03052322|19993693|P2|NOT COMPLETED|Overall Study||32
8112088|NCT03052322|19993694|P1|NOT COMPLETED|Overall Study||21
8112089|NCT03052322|19993693|P2|COMPLETED|Overall Study||113
8112090|NCT03052322|19993694|P1|COMPLETED|Overall Study||122
8112091|NCT03052322|19993693|P2|STARTED|Overall Study||145
8112092|NCT03052322|19993694|P1|STARTED|Overall Study||143
8112093|NCT03052257|19993746|P2|NOT COMPLETED|Overall Study||3
8112094|NCT03052257|19993747|P1|NOT COMPLETED|Overall Study||5
8112095|NCT03052257|19993746|P2|COMPLETED|Overall Study||97
8112096|NCT03052257|19993747|P1|COMPLETED|Overall Study||95
8112097|NCT03052257|19993746|P2|STARTED|Overall Study||100
8112098|NCT03052257|19993747|P1|STARTED|Overall Study||100
8112099|NCT03051646|19993755|P2|NOT COMPLETED|Overall Study||0
8112100|NCT03051646|19993756|P1|NOT COMPLETED|Overall Study||0
8112101|NCT03051646|19993755|P2|COMPLETED|Overall Study||6
8112102|NCT03051646|19993756|P1|COMPLETED|Overall Study||6
8112103|NCT03051646|19993755|P2|STARTED|Overall Study||6
8112104|NCT03051646|19993756|P1|STARTED|Overall Study||6
8112105|NCT03051633|19993766|P2|NOT COMPLETED|Overall Study||7
8112106|NCT03051633|19993767|P1|NOT COMPLETED|Overall Study||93
8112107|NCT03051633|19993766|P2|COMPLETED|Overall Study||179
8112108|NCT03051633|19993767|P1|COMPLETED|Overall Study||249
8112109|NCT03051633|19993766|P2|STARTED|Overall Study||186
8112110|NCT03051633|19993767|P1|STARTED|Overall Study||342
8112111|NCT03051607|19993777|P1|NOT COMPLETED|Overall Study||66
8112112|NCT03051607|19993777|P1|COMPLETED|Overall Study||0
8112113|NCT03051607|19993777|P1|STARTED|Overall Study||66
8112114|NCT03051217|19993787|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
8112115|NCT03051217|19993788|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
8112116|NCT03051217|19993789|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
8112117|NCT03051217|19993790|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
8112118|NCT03051217|19993791|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112119|NCT03051217|19993792|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112120|NCT03051217|19993793|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112121|NCT03051217|19993787|P7|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
8112122|NCT03051217|19993788|P6|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
8112123|NCT03051217|19993789|P5|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
8112124|NCT03051217|19993790|P4|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
8112125|NCT03051217|19993791|P3|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112126|NCT03051217|19993792|P2|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112127|NCT03051217|19993793|P1|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112128|NCT03051217|19993787|P7|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
8112129|NCT03051217|19993788|P6|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
8112130|NCT03051217|19993789|P5|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
8112131|NCT03051217|19993790|P4|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
8112132|NCT03051217|19993791|P3|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8112133|NCT03051217|19993792|P2|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8112134|NCT03051217|19993793|P1|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8112135|NCT03051217|19993787|P7|STARTED|Maintenance Period (Week 16 to Week 52)||20
8112136|NCT03051217|19993788|P6|STARTED|Maintenance Period (Week 16 to Week 52)||26
8112137|NCT03051217|19993789|P5|STARTED|Maintenance Period (Week 16 to Week 52)||51
8112138|NCT03051217|19993790|P4|STARTED|Maintenance Period (Week 16 to Week 52)||23
8112139|NCT03051217|19993791|P3|STARTED|Maintenance Period (Week 16 to Week 52)||0
8112140|NCT03051217|19993792|P2|STARTED|Maintenance Period (Week 16 to Week 52)||0
8112141|NCT03051217|19993793|P1|STARTED|Maintenance Period (Week 16 to Week 52)||0
8112142|NCT03051217|19993787|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112143|NCT03051217|19993788|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112144|NCT03051217|19993789|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112145|NCT03051217|19993790|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112146|NCT03051217|19993791|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
8112147|NCT03051217|19993792|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
8112148|NCT03051217|19993793|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8112149|NCT03051217|19993787|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112150|NCT03051217|19993788|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112151|NCT03051217|19993789|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112152|NCT03051217|19993790|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112153|NCT03051217|19993791|P3|COMPLETED|Initial Period (Week 0 to Week 16)||51
8112154|NCT03051217|19993792|P2|COMPLETED|Initial Period (Week 0 to Week 16)||46
8112155|NCT03051217|19993793|P1|COMPLETED|Initial Period (Week 0 to Week 16)||23
8112156|NCT03051217|19993787|P7|STARTED|Initial Period (Week 0 to Week 16)||0
8112157|NCT03051217|19993788|P6|STARTED|Initial Period (Week 0 to Week 16)||0
8112158|NCT03051217|19993789|P5|STARTED|Initial Period (Week 0 to Week 16)||0
8112159|NCT03051217|19993790|P4|STARTED|Initial Period (Week 0 to Week 16)||0
8112160|NCT03051217|19993791|P3|STARTED|Initial Period (Week 0 to Week 16)||53
8112161|NCT03051217|19993792|P2|STARTED|Initial Period (Week 0 to Week 16)||48
8112162|NCT03051217|19993793|P1|STARTED|Initial Period (Week 0 to Week 16)||26
8112163|NCT03051165|19993822|P1|NOT COMPLETED|Overall Study||13
8112164|NCT03051165|19993822|P1|COMPLETED|Overall Study||0
8112165|NCT03051165|19993822|P1|Completed Some Day 137 Assessments|Overall Study||0
8112166|NCT03051165|19993822|P1|Began HGNS Treatment Withdrawal|Overall Study||0
8112167|NCT03051165|19993822|P1|Completed Some Day 105 Assessments|Overall Study||1
8112168|NCT03051165|19993822|P1|Completed Some Baseline Assessments|Overall Study||1
8112169|NCT03051165|19993822|P1|STARTED|Overall Study||13
8112170|NCT03051100|19993836|P2|NOT COMPLETED|Overall Study||0
8112171|NCT03051100|19993837|P1|NOT COMPLETED|Overall Study||1
8112172|NCT03051100|19993836|P2|COMPLETED|Overall Study||43
8112173|NCT03051100|19993837|P1|COMPLETED|Overall Study||19
8112174|NCT03051100|19993836|P2|STARTED|Overall Study||43
8112175|NCT03051100|19993837|P1|STARTED|Overall Study||20
8112176|NCT03050918|19993853|P2|NOT COMPLETED|Overall Study||0
8112177|NCT03050918|19993854|P1|NOT COMPLETED|Overall Study||0
8112178|NCT03050918|19993853|P2|COMPLETED|Overall Study||1520
8112179|NCT03050918|19993854|P1|COMPLETED|Overall Study||1534
8112180|NCT03050918|19993853|P2|STARTED|Overall Study||1520
8112181|NCT03050918|19993854|P1|STARTED|Overall Study||1534
8112182|NCT03050775|19993876|P2|NOT COMPLETED|Overall Study||0
8112183|NCT03050775|19993877|P1|NOT COMPLETED|Overall Study||0
8112184|NCT03050775|19993876|P2|COMPLETED|Overall Study||35
8112185|NCT03050775|19993877|P1|COMPLETED|Overall Study||35
8112186|NCT03050775|19993876|P2|STARTED|Overall Study||35
8112187|NCT03050775|19993877|P1|STARTED|Overall Study||35
8112188|NCT03050697|19993895|P1|NOT COMPLETED|Overall Study||0
8112189|NCT03050697|19993895|P1|COMPLETED|Overall Study||12
8112190|NCT03050697|19993895|P1|STARTED|Overall Study||12
8112191|NCT03050619|19993932|P6|NOT COMPLETED|Overall Study||0
8112192|NCT03050619|19993933|P5|NOT COMPLETED|Overall Study||0
8112193|NCT03050619|19993934|P4|NOT COMPLETED|Overall Study||0
8112194|NCT03050619|19993935|P3|NOT COMPLETED|Overall Study||0
8112195|NCT03050619|19993936|P2|NOT COMPLETED|Overall Study||0
8112196|NCT03050619|19993937|P1|NOT COMPLETED|Overall Study||0
8112197|NCT03050619|19993932|P6|COMPLETED|Overall Study||1351
8112198|NCT03050619|19993933|P5|COMPLETED|Overall Study||6079
8112199|NCT03050619|19993934|P4|COMPLETED|Overall Study||14007
8112200|NCT03050619|19993935|P3|COMPLETED|Overall Study||6416
8112201|NCT03050619|19993936|P2|COMPLETED|Overall Study||3926
8112202|NCT03050619|19993937|P1|COMPLETED|Overall Study||129
8112203|NCT03050619|19993932|P6|STARTED|Overall Study||1351
8112204|NCT03050619|19993933|P5|STARTED|Overall Study||6079
8112205|NCT03050619|19993934|P4|STARTED|Overall Study||14007
8112206|NCT03050619|19993935|P3|STARTED|Overall Study||6416
8112207|NCT03050619|19993936|P2|STARTED|Overall Study||3926
8112208|NCT03050619|19993937|P1|STARTED|Overall Study||129
8112209|NCT03050541|19994074|P3|NOT COMPLETED|Overall Study||8
8112210|NCT03050541|19994075|P2|NOT COMPLETED|Overall Study||8
8112211|NCT03050541|19994076|P1|NOT COMPLETED|Overall Study||8
8112212|NCT03050541|19994074|P3|COMPLETED|Overall Study||20
8112213|NCT03050541|19994075|P2|COMPLETED|Overall Study||20
8112214|NCT03050541|19994076|P1|COMPLETED|Overall Study||20
8112215|NCT03050541|19994074|P3|STARTED|Overall Study||28
8112216|NCT03050541|19994075|P2|STARTED|Overall Study||28
8112217|NCT03050541|19994076|P1|STARTED|Overall Study||28
8112218|NCT03050398|19994087|P1|NOT COMPLETED|Overall Study||8
8112219|NCT03050398|19994087|P1|COMPLETED|Overall Study||0
8112220|NCT03050398|19994087|P1|STARTED|Overall Study||8
8112221|NCT03050372|19994092|P2|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
8112222|NCT03050372|19994093|P1|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
8112223|NCT03050372|19994092|P2|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
8112224|NCT03050372|19994093|P1|COMPLETED|Second Intervention (Nights #4 and #5)||5
8112225|NCT03050372|19994092|P2|STARTED|Second Intervention (Nights #4 and #5)||6
8112226|NCT03050372|19994093|P1|STARTED|Second Intervention (Nights #4 and #5)||5
8112227|NCT03050372|19994092|P2|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
8112228|NCT03050372|19994093|P1|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
8112229|NCT03050372|19994092|P2|COMPLETED|First Intervention (Nights #2 and #3)||6
8112230|NCT03050372|19994093|P1|COMPLETED|First Intervention (Nights #2 and #3)||5
8112231|NCT03050372|19994092|P2|STARTED|First Intervention (Nights #2 and #3)||6
8112232|NCT03050372|19994093|P1|STARTED|First Intervention (Nights #2 and #3)||5
8112233|NCT03050372|19994092|P2|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
8112234|NCT03050372|19994093|P1|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
8112235|NCT03050372|19994092|P2|COMPLETED|Adaptation Night (Night #1 PSG)||6
8112236|NCT03050372|19994093|P1|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
8112237|NCT03050372|19994092|P2|STARTED|Adaptation Night (Night #1 PSG)||6
8112238|NCT03050372|19994093|P1|STARTED|Adaptation Night (Night #1 PSG)||6
8112239|NCT03050359|19994116|P2|NOT COMPLETED|Overall Study||20
8112240|NCT03050359|19994117|P1|NOT COMPLETED|Overall Study||17
8112241|NCT03050359|19994116|P2|COMPLETED|Overall Study||248
8112242|NCT03050359|19994117|P1|COMPLETED|Overall Study||248
8112243|NCT03050359|19994116|P2|STARTED|Overall Study||268
8112244|NCT03050359|19994117|P1|STARTED|Overall Study||265
8112245|NCT03050320|19994131|P2|NOT COMPLETED|Overall Study||1
8112246|NCT03050320|19994132|P1|NOT COMPLETED|Overall Study||1
8112247|NCT03050320|19994131|P2|COMPLETED|Overall Study||21
8112248|NCT03050320|19994132|P1|COMPLETED|Overall Study||20
8112249|NCT03050320|19994131|P2|STARTED|Overall Study||22
8112250|NCT03050320|19994132|P1|STARTED|Overall Study||21
8112251|NCT03050294|19994166|P4|NOT COMPLETED|Overall Study||0
8112252|NCT03050294|19994167|P3|NOT COMPLETED|Overall Study||0
8112253|NCT03050294|19994168|P2|NOT COMPLETED|Overall Study||0
8112254|NCT03050294|19994169|P1|NOT COMPLETED|Overall Study||0
8112255|NCT03050294|19994166|P4|COMPLETED|Overall Study||6
8112256|NCT03050294|19994167|P3|COMPLETED|Overall Study||6
8112257|NCT03050294|19994168|P2|COMPLETED|Overall Study||6
8112258|NCT03050294|19994169|P1|COMPLETED|Overall Study||6
8112259|NCT03050294|19994166|P4|STARTED|Overall Study||6
8112260|NCT03050294|19994167|P3|STARTED|Overall Study||6
8112261|NCT03050294|19994168|P2|STARTED|Overall Study||6
8112262|NCT03050294|19994169|P1|STARTED|Overall Study||6
8112263|NCT03050216|19994191|P1|NOT COMPLETED|Overall Study||0
8112264|NCT03050216|19994191|P1|COMPLETED|Overall Study||8
8112265|NCT03050216|19994191|P1|STARTED|Overall Study||8
8112266|NCT03050203|19994203|P2|NOT COMPLETED|Overall Study||0
8112267|NCT03050203|19994204|P1|NOT COMPLETED|Overall Study||0
8112268|NCT03050203|19994203|P2|COMPLETED|Overall Study||18
8112269|NCT03050203|19994204|P1|COMPLETED|Overall Study||19
8112270|NCT03050203|19994203|P2|STARTED|Overall Study||18
8112271|NCT03050203|19994204|P1|STARTED|Overall Study||19
8112272|NCT03049852|19994213|P3|NOT COMPLETED|Overall Study||0
8112273|NCT03049852|19994214|P2|NOT COMPLETED|Overall Study||1
8112274|NCT03049852|19994215|P1|NOT COMPLETED|Overall Study||0
8112275|NCT03049852|19994213|P3|COMPLETED|Overall Study||26
8112276|NCT03049852|19994214|P2|COMPLETED|Overall Study||24
8112277|NCT03049852|19994215|P1|COMPLETED|Overall Study||24
8112278|NCT03049852|19994213|P3|STARTED|Overall Study||26
8112279|NCT03049852|19994214|P2|STARTED|Overall Study||25
8112280|NCT03049852|19994215|P1|STARTED|Overall Study||24
8112281|NCT03049748|19994227|P2|NOT COMPLETED|Overall Study||6
8112282|NCT03049748|19994228|P1|NOT COMPLETED|Overall Study||4
8112283|NCT03049748|19994227|P2|COMPLETED|Overall Study||14
8112284|NCT03049748|19994228|P1|COMPLETED|Overall Study||16
8112285|NCT03049748|19994227|P2|STARTED|Overall Study||20
8112286|NCT03049748|19994228|P1|STARTED|Overall Study||20
8112287|NCT03049501|19994246|P2|NOT COMPLETED|Overall Study||29
8112288|NCT03049501|19994247|P1|NOT COMPLETED|Overall Study||22
8112289|NCT03049501|19994246|P2|COMPLETED|Overall Study||92
8112290|NCT03049501|19994247|P1|COMPLETED|Overall Study||101
8112291|NCT03049501|19994246|P2|12 Month Follow up|Overall Study||92
8112292|NCT03049501|19994247|P1|12 Month Follow up|Overall Study||101
8112293|NCT03049501|19994246|P2|6 Month Follow up|Overall Study||91
8112294|NCT03049501|19994247|P1|6 Month Follow up|Overall Study||107
8112295|NCT03049501|19994246|P2|STARTED|Overall Study||121
8112296|NCT03049501|19994247|P1|STARTED|Overall Study||123
8112297|NCT03049488|19994269|P6|NOT COMPLETED|Overall Study||0
8112298|NCT03049488|19994270|P5|NOT COMPLETED|Overall Study||2
8112299|NCT03049488|19994271|P4|NOT COMPLETED|Overall Study||2
8112300|NCT03049488|19994272|P3|NOT COMPLETED|Overall Study||0
8112301|NCT03049488|19994273|P2|NOT COMPLETED|Overall Study||2
8112302|NCT03049488|19994274|P1|NOT COMPLETED|Overall Study||2
8112303|NCT03049488|19994269|P6|COMPLETED|Overall Study||15
8112304|NCT03049488|19994270|P5|COMPLETED|Overall Study||13
8112305|NCT03049488|19994271|P4|COMPLETED|Overall Study||13
8112306|NCT03049488|19994272|P3|COMPLETED|Overall Study||20
8112307|NCT03049488|19994273|P2|COMPLETED|Overall Study||13
8112308|NCT03049488|19994274|P1|COMPLETED|Overall Study||13
8112309|NCT03049488|19994269|P6|Received Optional Second Dose|Overall Study||10
8112310|NCT03049488|19994270|P5|Received Optional Second Dose|Overall Study||11
8112311|NCT03049488|19994271|P4|Received Optional Second Dose|Overall Study||9
8112312|NCT03049488|19994272|P3|Received Optional Second Dose|Overall Study||11
8112313|NCT03049488|19994273|P2|Received Optional Second Dose|Overall Study||11
8112314|NCT03049488|19994274|P1|Received Optional Second Dose|Overall Study||10
8112315|NCT03049488|19994269|P6|Received First Product Administration|Overall Study||15
8112316|NCT03049488|19994270|P5|Received First Product Administration|Overall Study||15
8112317|NCT03049488|19994271|P4|Received First Product Administration|Overall Study||15
8112318|NCT03049488|19994272|P3|Received First Product Administration|Overall Study||20
8112319|NCT03049488|19994273|P2|Received First Product Administration|Overall Study||15
8112320|NCT03049488|19994274|P1|Received First Product Administration|Overall Study||15
8112321|NCT03049488|19994269|P6|STARTED|Overall Study||15
8112322|NCT03049488|19994270|P5|STARTED|Overall Study||15
8112323|NCT03049488|19994271|P4|STARTED|Overall Study||15
8112324|NCT03049488|19994272|P3|STARTED|Overall Study||20
8112325|NCT03049488|19994273|P2|STARTED|Overall Study||15
8112326|NCT03049488|19994274|P1|STARTED|Overall Study||15
8112327|NCT03049280|19994357|P1|NOT COMPLETED|Overall Study||1
8112328|NCT03049280|19994357|P1|COMPLETED|Overall Study||32
8112329|NCT03049280|19994357|P1|STARTED|Overall Study||33
8112330|NCT03048747|19994363|P1|NOT COMPLETED|Overall Study||5
8112331|NCT03048747|19994363|P1|COMPLETED|Overall Study||11
8112332|NCT03048747|19994363|P1|STARTED|Overall Study||16
8112333|NCT03048500|19994368|P1|NOT COMPLETED|Follow up for 3 Years||16
8112334|NCT03048500|19994368|P1|COMPLETED|Follow up for 3 Years||0
8112335|NCT03048500|19994368|P1|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
8112336|NCT03048500|19994368|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
8112337|NCT03048500|19994368|P1|COMPLETED|Reached 1st Response/Continued Treatment||9
8112338|NCT03048500|19994368|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
8112339|NCT03048500|19994368|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||16
8112340|NCT03048500|19994368|P1|STARTED|Reached 1st Response/Continued Treatment||16
8112341|NCT03048500|19994368|P1|NOT COMPLETED|2 Cycles of Treatment||1
8112342|NCT03048500|19994368|P1|COMPLETED|2 Cycles of Treatment||16
8112343|NCT03048500|19994368|P1|Attempted 2nd Cycle|2 Cycles of Treatment||16
8112344|NCT03048500|19994368|P1|Attempted 1st Cycle|2 Cycles of Treatment||17
8112345|NCT03048500|19994368|P1|STARTED|2 Cycles of Treatment||17
8112346|NCT03048383|19994376|P3|NOT COMPLETED|Overall Study||12
8112347|NCT03048383|19994377|P2|NOT COMPLETED|Overall Study||8
8112348|NCT03048383|19994378|P1|NOT COMPLETED|Overall Study||13
8112349|NCT03048383|19994376|P3|COMPLETED|Overall Study||10
8112350|NCT03048383|19994377|P2|COMPLETED|Overall Study||13
8112351|NCT03048383|19994378|P1|COMPLETED|Overall Study||15
8112352|NCT03048383|19994376|P3|STARTED|Overall Study||22
8112353|NCT03048383|19994377|P2|STARTED|Overall Study||21
8112354|NCT03048383|19994378|P1|STARTED|Overall Study||28
8112355|NCT03048058|19994391|P2|NOT COMPLETED|Overall Study||4
8112356|NCT03048058|19994392|P1|NOT COMPLETED|Overall Study||4
8112357|NCT03048058|19994391|P2|COMPLETED|Overall Study||6
8112358|NCT03048058|19994392|P1|COMPLETED|Overall Study||6
8112359|NCT03048058|19994391|P2|STARTED|Overall Study||10
8112360|NCT03048058|19994392|P1|STARTED|Overall Study||10
8112361|NCT03048006|19994410|P1|NOT COMPLETED|Overall Study||0
8112362|NCT03048006|19994410|P1|COMPLETED|Overall Study||44456
8112363|NCT03048006|19994410|P1|STARTED|Overall Study||44456
8112364|NCT03047720|19994418|P2|NOT COMPLETED|Second Intervention (6weeks)||0
8112365|NCT03047720|19994419|P1|NOT COMPLETED|Second Intervention (6weeks)||0
8112366|NCT03047720|19994418|P2|COMPLETED|Second Intervention (6weeks)||0
8112367|NCT03047720|19994419|P1|COMPLETED|Second Intervention (6weeks)||0
8112368|NCT03047720|19994418|P2|STARTED|Second Intervention (6weeks)||0
8112369|NCT03047720|19994419|P1|STARTED|Second Intervention (6weeks)||0
8112370|NCT03047720|19994418|P2|NOT COMPLETED|First Intervention (6weeks)||0
8112371|NCT03047720|19994419|P1|NOT COMPLETED|First Intervention (6weeks)||7
8112372|NCT03047720|19994418|P2|COMPLETED|First Intervention (6weeks)||0
8112373|NCT03047720|19994419|P1|COMPLETED|First Intervention (6weeks)||5
8112374|NCT03047720|19994418|P2|STARTED|First Intervention (6weeks)||0
8112375|NCT03047720|19994419|P1|STARTED|First Intervention (6weeks)||12
8112376|NCT03047551|19994433|P2|NOT COMPLETED|Overall Study||3
8112377|NCT03047551|19994434|P1|NOT COMPLETED|Overall Study||2
8112378|NCT03047551|19994433|P2|COMPLETED|Overall Study||312
8112379|NCT03047551|19994434|P1|COMPLETED|Overall Study||317
8112380|NCT03047551|19994433|P2|STARTED|Overall Study||315
8112381|NCT03047551|19994434|P1|STARTED|Overall Study||319
8112382|NCT03047447|19994445|P3|NOT COMPLETED|Overall Study||0
8112383|NCT03047447|19994446|P2|NOT COMPLETED|Overall Study||0
8112384|NCT03047447|19994447|P1|NOT COMPLETED|Overall Study||0
8112385|NCT03047447|19994445|P3|COMPLETED|Overall Study||10
8112386|NCT03047447|19994446|P2|COMPLETED|Overall Study||10
8112387|NCT03047447|19994447|P1|COMPLETED|Overall Study||10
8112388|NCT03047447|19994445|P3|STARTED|Overall Study||10
8112389|NCT03047447|19994446|P2|STARTED|Overall Study||10
8112390|NCT03047447|19994447|P1|STARTED|Overall Study||10
8112391|NCT03047174|19994469|P2|NOT COMPLETED|Overall Study||2
8112392|NCT03047174|19994470|P1|NOT COMPLETED|Overall Study||19
8112393|NCT03047174|19994469|P2|COMPLETED|Overall Study||27
8112394|NCT03047174|19994470|P1|COMPLETED|Overall Study||9
8112395|NCT03047174|19994469|P2|STARTED|Overall Study||29
8112396|NCT03047174|19994470|P1|STARTED|Overall Study||28
8112397|NCT03046472|19994500|P2|NOT COMPLETED|Overall Study||0
8112398|NCT03046472|19994501|P1|NOT COMPLETED|Overall Study||0
8112399|NCT03046472|19994500|P2|COMPLETED|Overall Study||17
8112400|NCT03046472|19994501|P1|COMPLETED|Overall Study||33
8112401|NCT03046472|19994500|P2|STARTED|Overall Study||17
8112402|NCT03046472|19994501|P1|STARTED|Overall Study||33
8112403|NCT03046446|19994511|P1|NOT COMPLETED|Overall Study||59
8112404|NCT03046446|19994511|P1|COMPLETED|Overall Study||149
8112405|NCT03046446|19994511|P1|Completed at Week 52|Overall Study||133
8112406|NCT03046446|19994511|P1|Completed at Week 24|Overall Study||6
8112407|NCT03046446|19994511|P1|Completed at Week 12|Overall Study||10
8112408|NCT03046446|19994511|P1|Second Injection|Overall Study||179
8112409|NCT03046446|19994511|P1|STARTED|Overall Study||208
8112410|NCT03046225|19994521|P2|NOT COMPLETED|Overall Study||0
8112411|NCT03046225|19994522|P1|NOT COMPLETED|Overall Study||0
8112412|NCT03046225|19994521|P2|COMPLETED|Overall Study||13
8112413|NCT03046225|19994522|P1|COMPLETED|Overall Study||13
8112414|NCT03046225|19994521|P2|STARTED|Overall Study||13
8112415|NCT03046225|19994522|P1|STARTED|Overall Study||13
8112416|NCT03046212|19994534|P2|NOT COMPLETED|Overall Study||0
8112417|NCT03046212|19994535|P1|NOT COMPLETED|Overall Study||0
8112418|NCT03046212|19994534|P2|COMPLETED|Overall Study||15
8112419|NCT03046212|19994535|P1|COMPLETED|Overall Study||15
8112420|NCT03046212|19994534|P2|STARTED|Overall Study||15
8112421|NCT03046212|19994535|P1|STARTED|Overall Study||15
8112422|NCT03045926|19994545|P1|NOT COMPLETED|Overall Study||0
8112423|NCT03045926|19994545|P1|COMPLETED|Overall Study||35
8112424|NCT03045926|19994545|P1|STARTED|Overall Study||35
8112425|NCT03045887|19994574|P10|NOT COMPLETED|Part B (14 Days)||0
8112426|NCT03045887|19994575|P9|NOT COMPLETED|Part B (14 Days)||0
8112427|NCT03045887|19994576|P8|NOT COMPLETED|Part B (14 Days)||0
8112428|NCT03045887|19994577|P7|NOT COMPLETED|Part B (14 Days)||0
8112429|NCT03045887|19994578|P6|NOT COMPLETED|Part B (14 Days)||0
8112430|NCT03045887|19994579|P5|NOT COMPLETED|Part B (14 Days)||0
8112431|NCT03045887|19994580|P4|NOT COMPLETED|Part B (14 Days)||0
8112432|NCT03045887|19994581|P3|NOT COMPLETED|Part B (14 Days)||0
8112433|NCT03045887|19994582|P2|NOT COMPLETED|Part B (14 Days)||0
8112434|NCT03045887|19994583|P1|NOT COMPLETED|Part B (14 Days)||0
8112435|NCT03045887|19994574|P10|COMPLETED|Part B (14 Days)||9
8112436|NCT03045887|19994575|P9|COMPLETED|Part B (14 Days)||3
8112437|NCT03045887|19994576|P8|COMPLETED|Part B (14 Days)||0
8112438|NCT03045887|19994577|P7|COMPLETED|Part B (14 Days)||0
8112439|NCT03045887|19994578|P6|COMPLETED|Part B (14 Days)||0
8112440|NCT03045887|19994579|P5|COMPLETED|Part B (14 Days)||0
8112441|NCT03045887|19994580|P4|COMPLETED|Part B (14 Days)||0
8112442|NCT03045887|19994581|P3|COMPLETED|Part B (14 Days)||0
8112443|NCT03045887|19994582|P2|COMPLETED|Part B (14 Days)||0
8112444|NCT03045887|19994583|P1|COMPLETED|Part B (14 Days)||0
8112445|NCT03045887|19994574|P10|STARTED|Part B (14 Days)||9
8112446|NCT03045887|19994575|P9|STARTED|Part B (14 Days)||3
8112447|NCT03045887|19994576|P8|STARTED|Part B (14 Days)||0
8112448|NCT03045887|19994577|P7|STARTED|Part B (14 Days)||0
8112449|NCT03045887|19994578|P6|STARTED|Part B (14 Days)||0
8112450|NCT03045887|19994579|P5|STARTED|Part B (14 Days)||0
8112451|NCT03045887|19994580|P4|STARTED|Part B (14 Days)||0
8112452|NCT03045887|19994581|P3|STARTED|Part B (14 Days)||0
8112453|NCT03045887|19994582|P2|STARTED|Part B (14 Days)||0
8112454|NCT03045887|19994583|P1|STARTED|Part B (14 Days)||0
8112455|NCT03045887|19994574|P10|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112456|NCT03045887|19994575|P9|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112457|NCT03045887|19994576|P8|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112458|NCT03045887|19994577|P7|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112459|NCT03045887|19994578|P6|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112460|NCT03045887|19994579|P5|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112461|NCT03045887|19994580|P4|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112462|NCT03045887|19994581|P3|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112463|NCT03045887|19994582|P2|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112464|NCT03045887|19994583|P1|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112465|NCT03045887|19994574|P10|COMPLETED|Part A, Period 3 (1 Day)||0
8112466|NCT03045887|19994575|P9|COMPLETED|Part A, Period 3 (1 Day)||0
8112467|NCT03045887|19994576|P8|COMPLETED|Part A, Period 3 (1 Day)||4
8112468|NCT03045887|19994577|P7|COMPLETED|Part A, Period 3 (1 Day)||4
8112469|NCT03045887|19994578|P6|COMPLETED|Part A, Period 3 (1 Day)||4
8112470|NCT03045887|19994579|P5|COMPLETED|Part A, Period 3 (1 Day)||4
8112471|NCT03045887|19994580|P4|COMPLETED|Part A, Period 3 (1 Day)||2
8112472|NCT03045887|19994581|P3|COMPLETED|Part A, Period 3 (1 Day)||4
8112473|NCT03045887|19994582|P2|COMPLETED|Part A, Period 3 (1 Day)||4
8112474|NCT03045887|19994583|P1|COMPLETED|Part A, Period 3 (1 Day)||3
8112475|NCT03045887|19994574|P10|STARTED|Part A, Period 3 (1 Day)||0
8112476|NCT03045887|19994575|P9|STARTED|Part A, Period 3 (1 Day)||0
8112477|NCT03045887|19994576|P8|STARTED|Part A, Period 3 (1 Day)||4
8112478|NCT03045887|19994577|P7|STARTED|Part A, Period 3 (1 Day)||4
8112479|NCT03045887|19994578|P6|STARTED|Part A, Period 3 (1 Day)||4
8112480|NCT03045887|19994579|P5|STARTED|Part A, Period 3 (1 Day)||4
8112481|NCT03045887|19994580|P4|STARTED|Part A, Period 3 (1 Day)||2
8112482|NCT03045887|19994581|P3|STARTED|Part A, Period 3 (1 Day)||4
8112483|NCT03045887|19994582|P2|STARTED|Part A, Period 3 (1 Day)||4
8112484|NCT03045887|19994583|P1|STARTED|Part A, Period 3 (1 Day)||3
8112485|NCT03045887|19994574|P10|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112486|NCT03045887|19994575|P9|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112487|NCT03045887|19994576|P8|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112488|NCT03045887|19994577|P7|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112489|NCT03045887|19994578|P6|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112490|NCT03045887|19994579|P5|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112491|NCT03045887|19994580|P4|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
8112492|NCT03045887|19994581|P3|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
8112493|NCT03045887|19994582|P2|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112494|NCT03045887|19994583|P1|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112495|NCT03045887|19994574|P10|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112496|NCT03045887|19994575|P9|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112497|NCT03045887|19994576|P8|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112498|NCT03045887|19994577|P7|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112499|NCT03045887|19994578|P6|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112500|NCT03045887|19994579|P5|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112501|NCT03045887|19994580|P4|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
8112502|NCT03045887|19994581|P3|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112503|NCT03045887|19994582|P2|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112504|NCT03045887|19994583|P1|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
8112505|NCT03045887|19994574|P10|STARTED|Part A,Washout Period 2 (4 Weeks)||0
8112506|NCT03045887|19994575|P9|STARTED|Part A,Washout Period 2 (4 Weeks)||0
8112507|NCT03045887|19994576|P8|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112508|NCT03045887|19994577|P7|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112509|NCT03045887|19994578|P6|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112510|NCT03045887|19994579|P5|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112511|NCT03045887|19994580|P4|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112512|NCT03045887|19994581|P3|STARTED|Part A,Washout Period 2 (4 Weeks)||5
8112513|NCT03045887|19994582|P2|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112514|NCT03045887|19994583|P1|STARTED|Part A,Washout Period 2 (4 Weeks)||3
8112515|NCT03045887|19994574|P10|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112516|NCT03045887|19994575|P9|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112517|NCT03045887|19994576|P8|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112518|NCT03045887|19994577|P7|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112519|NCT03045887|19994578|P6|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112520|NCT03045887|19994579|P5|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112521|NCT03045887|19994580|P4|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112522|NCT03045887|19994581|P3|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112523|NCT03045887|19994582|P2|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112524|NCT03045887|19994583|P1|NOT COMPLETED|Part A, Period 2 (1 Day)||1
8112525|NCT03045887|19994574|P10|COMPLETED|Part A, Period 2 (1 Day)||0
8112526|NCT03045887|19994575|P9|COMPLETED|Part A, Period 2 (1 Day)||0
8112527|NCT03045887|19994576|P8|COMPLETED|Part A, Period 2 (1 Day)||4
8112528|NCT03045887|19994577|P7|COMPLETED|Part A, Period 2 (1 Day)||4
8112529|NCT03045887|19994578|P6|COMPLETED|Part A, Period 2 (1 Day)||4
8112530|NCT03045887|19994579|P5|COMPLETED|Part A, Period 2 (1 Day)||4
8112531|NCT03045887|19994580|P4|COMPLETED|Part A, Period 2 (1 Day)||4
8112532|NCT03045887|19994581|P3|COMPLETED|Part A, Period 2 (1 Day)||5
8112533|NCT03045887|19994582|P2|COMPLETED|Part A, Period 2 (1 Day)||4
8112534|NCT03045887|19994583|P1|COMPLETED|Part A, Period 2 (1 Day)||3
8112535|NCT03045887|19994574|P10|STARTED|Part A, Period 2 (1 Day)||0
8112536|NCT03045887|19994575|P9|STARTED|Part A, Period 2 (1 Day)||0
8112537|NCT03045887|19994576|P8|STARTED|Part A, Period 2 (1 Day)||4
8112538|NCT03045887|19994577|P7|STARTED|Part A, Period 2 (1 Day)||4
8112539|NCT03045887|19994578|P6|STARTED|Part A, Period 2 (1 Day)||4
8112540|NCT03045887|19994579|P5|STARTED|Part A, Period 2 (1 Day)||4
8112541|NCT03045887|19994580|P4|STARTED|Part A, Period 2 (1 Day)||4
8112542|NCT03045887|19994581|P3|STARTED|Part A, Period 2 (1 Day)||5
8112543|NCT03045887|19994582|P2|STARTED|Part A, Period 2 (1 Day)||4
8112544|NCT03045887|19994583|P1|STARTED|Part A, Period 2 (1 Day)||4
8112545|NCT03045887|19994574|P10|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112546|NCT03045887|19994575|P9|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112547|NCT03045887|19994576|P8|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112548|NCT03045887|19994577|P7|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112549|NCT03045887|19994578|P6|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112550|NCT03045887|19994579|P5|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112551|NCT03045887|19994580|P4|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
8112552|NCT03045887|19994581|P3|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112553|NCT03045887|19994582|P2|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112554|NCT03045887|19994583|P1|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
8112555|NCT03045887|19994574|P10|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112556|NCT03045887|19994575|P9|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112557|NCT03045887|19994576|P8|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112558|NCT03045887|19994577|P7|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112559|NCT03045887|19994578|P6|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112560|NCT03045887|19994579|P5|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112561|NCT03045887|19994580|P4|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112562|NCT03045887|19994581|P3|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
8112563|NCT03045887|19994582|P2|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112564|NCT03045887|19994583|P1|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112565|NCT03045887|19994574|P10|STARTED|Part A,Washout Period 1(4 Weeks)||0
8112566|NCT03045887|19994575|P9|STARTED|Part A,Washout Period 1(4 Weeks)||0
8112567|NCT03045887|19994576|P8|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112568|NCT03045887|19994577|P7|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112569|NCT03045887|19994578|P6|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112570|NCT03045887|19994579|P5|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112571|NCT03045887|19994580|P4|STARTED|Part A,Washout Period 1(4 Weeks)||5
8112572|NCT03045887|19994581|P3|STARTED|Part A,Washout Period 1(4 Weeks)||5
8112573|NCT03045887|19994582|P2|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112574|NCT03045887|19994583|P1|STARTED|Part A,Washout Period 1(4 Weeks)||7
8112575|NCT03045887|19994574|P10|NOT COMPLETED|Part A, Period (1 Day)||0
8112576|NCT03045887|19994575|P9|NOT COMPLETED|Part A, Period (1 Day)||0
8112577|NCT03045887|19994576|P8|NOT COMPLETED|Part A, Period (1 Day)||0
8112578|NCT03045887|19994577|P7|NOT COMPLETED|Part A, Period (1 Day)||0
8112579|NCT03045887|19994578|P6|NOT COMPLETED|Part A, Period (1 Day)||0
8112580|NCT03045887|19994579|P5|NOT COMPLETED|Part A, Period (1 Day)||0
8112581|NCT03045887|19994580|P4|NOT COMPLETED|Part A, Period (1 Day)||0
8112582|NCT03045887|19994581|P3|NOT COMPLETED|Part A, Period (1 Day)||0
8112583|NCT03045887|19994582|P2|NOT COMPLETED|Part A, Period (1 Day)||0
8112584|NCT03045887|19994583|P1|NOT COMPLETED|Part A, Period (1 Day)||0
8112585|NCT03045887|19994574|P10|COMPLETED|Part A, Period (1 Day)||0
8112586|NCT03045887|19994575|P9|COMPLETED|Part A, Period (1 Day)||0
8112587|NCT03045887|19994576|P8|COMPLETED|Part A, Period (1 Day)||4
8112588|NCT03045887|19994577|P7|COMPLETED|Part A, Period (1 Day)||4
8112589|NCT03045887|19994578|P6|COMPLETED|Part A, Period (1 Day)||4
8112590|NCT03045887|19994579|P5|COMPLETED|Part A, Period (1 Day)||4
8112591|NCT03045887|19994580|P4|COMPLETED|Part A, Period (1 Day)||5
8112592|NCT03045887|19994581|P3|COMPLETED|Part A, Period (1 Day)||5
8112593|NCT03045887|19994582|P2|COMPLETED|Part A, Period (1 Day)||4
8112594|NCT03045887|19994583|P1|COMPLETED|Part A, Period (1 Day)||7
8112595|NCT03045887|19994574|P10|STARTED|Part A, Period (1 Day)||0
8112596|NCT03045887|19994575|P9|STARTED|Part A, Period (1 Day)||0
8112597|NCT03045887|19994576|P8|STARTED|Part A, Period (1 Day)||4
8112598|NCT03045887|19994577|P7|STARTED|Part A, Period (1 Day)||4
8112599|NCT03045887|19994578|P6|STARTED|Part A, Period (1 Day)||4
8112600|NCT03045887|19994579|P5|STARTED|Part A, Period (1 Day)||4
8112601|NCT03045887|19994580|P4|STARTED|Part A, Period (1 Day)||5
8112602|NCT03045887|19994581|P3|STARTED|Part A, Period (1 Day)||5
8112603|NCT03045887|19994582|P2|STARTED|Part A, Period (1 Day)||4
8112604|NCT03045887|19994583|P1|STARTED|Part A, Period (1 Day)||7
8112605|NCT03045861|19994725|P4|NOT COMPLETED|Part B (Up to 10 Days)||0
8112606|NCT03045861|19994726|P3|NOT COMPLETED|Part B (Up to 10 Days)||0
8112607|NCT03045861|19994727|P2|NOT COMPLETED|Part B (Up to 10 Days)||0
8112608|NCT03045861|19994728|P1|NOT COMPLETED|Part B (Up to 10 Days)||0
8112609|NCT03045861|19994725|P4|COMPLETED|Part B (Up to 10 Days)||8
8112610|NCT03045861|19994726|P3|COMPLETED|Part B (Up to 10 Days)||0
8112611|NCT03045861|19994727|P2|COMPLETED|Part B (Up to 10 Days)||8
8112612|NCT03045861|19994728|P1|COMPLETED|Part B (Up to 10 Days)||7
8112613|NCT03045861|19994725|P4|STARTED|Part B (Up to 10 Days)||8
8112614|NCT03045861|19994726|P3|STARTED|Part B (Up to 10 Days)||0
8112615|NCT03045861|19994727|P2|STARTED|Part B (Up to 10 Days)||8
8112616|NCT03045861|19994728|P1|STARTED|Part B (Up to 10 Days)||7
8112617|NCT03045861|19994725|P4|NOT COMPLETED|Part A (Up to 10 Days)||0
8112618|NCT03045861|19994726|P3|NOT COMPLETED|Part A (Up to 10 Days)||0
8112619|NCT03045861|19994727|P2|NOT COMPLETED|Part A (Up to 10 Days)||0
8112620|NCT03045861|19994728|P1|NOT COMPLETED|Part A (Up to 10 Days)||0
8112621|NCT03045861|19994725|P4|COMPLETED|Part A (Up to 10 Days)||0
8112622|NCT03045861|19994726|P3|COMPLETED|Part A (Up to 10 Days)||10
8112623|NCT03045861|19994727|P2|COMPLETED|Part A (Up to 10 Days)||0
8112624|NCT03045861|19994728|P1|COMPLETED|Part A (Up to 10 Days)||0
8112625|NCT03045861|19994725|P4|STARTED|Part A (Up to 10 Days)||0
8112626|NCT03045861|19994726|P3|STARTED|Part A (Up to 10 Days)||10
8112627|NCT03045861|19994727|P2|STARTED|Part A (Up to 10 Days)||0
8112628|NCT03045861|19994728|P1|STARTED|Part A (Up to 10 Days)||0
8112629|NCT03045809|19994854|P1|NOT COMPLETED|Overall Study||0
8112630|NCT03045809|19994854|P1|COMPLETED|Overall Study||705
8112631|NCT03045809|19994854|P1|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
8112632|NCT03045809|19994854|P1|STARTED|Overall Study||705
8112636|NCT03045302|19994865|P1|NOT COMPLETED|Overall Study||1
8112637|NCT03045302|19994865|P1|COMPLETED|Overall Study||3
8112638|NCT03045302|19994865|P1|STARTED|Overall Study||4
8112639|NCT03045081|19994871|P2|NOT COMPLETED|Overall Study||11
8112640|NCT03045081|19994872|P1|NOT COMPLETED|Overall Study||6
8112641|NCT03045081|19994871|P2|COMPLETED|Overall Study||37
8112642|NCT03045081|19994872|P1|COMPLETED|Overall Study||45
8112643|NCT03045081|19994871|P2|STARTED|Overall Study||48
8112644|NCT03045081|19994872|P1|STARTED|Overall Study||51
8112645|NCT03044886|19994891|P3|NOT COMPLETED|Overall Study||12
8112646|NCT03044886|19994892|P2|NOT COMPLETED|Overall Study||10
8112647|NCT03044886|19994893|P1|NOT COMPLETED|Overall Study||15
8112648|NCT03044886|19994891|P3|COMPLETED|Overall Study||108
8112649|NCT03044886|19994892|P2|COMPLETED|Overall Study||110
8112650|NCT03044886|19994893|P1|COMPLETED|Overall Study||105
8112651|NCT03044886|19994891|P3|STARTED|Overall Study||120
8112652|NCT03044886|19994892|P2|STARTED|Overall Study||120
8112653|NCT03044886|19994893|P1|STARTED|Overall Study||120
8112654|NCT03044730|19994934|P1|NOT COMPLETED|On Follow-up for 2 Years||25
8112655|NCT03044730|19994934|P1|COMPLETED|On Follow-up for 2 Years||4
8112656|NCT03044730|19994934|P1|STARTED|On Follow-up for 2 Years||29
8112657|NCT03044730|19994934|P1|NOT COMPLETED|Cycles 4 and Beyond||10
8112658|NCT03044730|19994934|P1|COMPLETED|Cycles 4 and Beyond||16
8112659|NCT03044730|19994934|P1|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
8112660|NCT03044730|19994934|P1|Started Cycle 4|Cycles 4 and Beyond||20
8112661|NCT03044730|19994934|P1|Assessed for Cycle 4|Cycles 4 and Beyond||26
8112662|NCT03044730|19994934|P1|STARTED|Cycles 4 and Beyond||26
8112663|NCT03044730|19994934|P1|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
8112664|NCT03044730|19994934|P1|COMPLETED|3 Cycles of Pembro + Capecitab||26
8112665|NCT03044730|19994934|P1|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
8112666|NCT03044730|19994934|P1|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
8112667|NCT03044730|19994934|P1|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
8112668|NCT03044730|19994934|P1|STARTED|3 Cycles of Pembro + Capecitab||30
8112669|NCT03044691|19994945|P2|NOT COMPLETED|Overall Study||0
8112670|NCT03044691|19994946|P1|NOT COMPLETED|Overall Study||0
8112671|NCT03044691|19994945|P2|COMPLETED|Overall Study||84
8112672|NCT03044691|19994946|P1|COMPLETED|Overall Study||0
8112673|NCT03044691|19994945|P2|STARTED|Overall Study||84
8112674|NCT03044691|19994946|P1|STARTED|Overall Study||0
8112687|NCT03044431|19994981|P1|NOT COMPLETED|Overall Study||59
8112688|NCT03044431|19994981|P1|COMPLETED|Overall Study||148
8112689|NCT03044431|19994981|P1|STARTED|Overall Study||207
8112690|NCT03044353|19994994|P3|NOT COMPLETED|Overall Study||0
8112691|NCT03044353|19994995|P2|NOT COMPLETED|Overall Study||1
8112692|NCT03044353|19994996|P1|NOT COMPLETED|Overall Study||0
8112693|NCT03044353|19994994|P3|COMPLETED|Overall Study||0
8112694|NCT03044353|19994995|P2|COMPLETED|Overall Study||0
8112695|NCT03044353|19994996|P1|COMPLETED|Overall Study||6
8112696|NCT03044353|19994994|P3|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
8112697|NCT03044353|19994995|P2|STARTED|Overall Study||1
8112698|NCT03044353|19994996|P1|STARTED|Overall Study||6
8112699|NCT03044197|19995079|P2|NOT COMPLETED|Overall Study||1
8112700|NCT03044197|19995080|P1|NOT COMPLETED|Overall Study||3
8112701|NCT03044197|19995079|P2|COMPLETED|Overall Study||11
8112702|NCT03044197|19995080|P1|COMPLETED|Overall Study||9
8112703|NCT03044197|19995079|P2|STARTED|Overall Study||12
8112704|NCT03044197|19995080|P1|STARTED|Overall Study||12
8112705|NCT03044106|19995090|P2|NOT COMPLETED|Visit 2||0
8112706|NCT03044106|19995091|P1|NOT COMPLETED|Visit 2||0
8112707|NCT03044106|19995090|P2|COMPLETED|Visit 2||20
8112708|NCT03044106|19995091|P1|COMPLETED|Visit 2||22
8112709|NCT03044106|19995090|P2|STARTED|Visit 2||20
8112710|NCT03044106|19995091|P1|STARTED|Visit 2||22
8112711|NCT03044106|19995090|P2|NOT COMPLETED|Washout (1 Week)||2
8112712|NCT03044106|19995091|P1|NOT COMPLETED|Washout (1 Week)||0
8112713|NCT03044106|19995090|P2|COMPLETED|Washout (1 Week)||20
8112714|NCT03044106|19995091|P1|COMPLETED|Washout (1 Week)||22
8112715|NCT03044106|19995090|P2|STARTED|Washout (1 Week)||22
8112716|NCT03044106|19995091|P1|STARTED|Washout (1 Week)||22
8112717|NCT03044106|19995090|P2|NOT COMPLETED|Visit 1||0
8112718|NCT03044106|19995091|P1|NOT COMPLETED|Visit 1||0
8112719|NCT03044106|19995090|P2|COMPLETED|Visit 1||22
8112720|NCT03044106|19995091|P1|COMPLETED|Visit 1||22
8112721|NCT03044106|19995090|P2|STARTED|Visit 1||22
8112722|NCT03044106|19995091|P1|STARTED|Visit 1||22
8112723|NCT03044028|19995108|P3|NOT COMPLETED|Overall Study||0
8112724|NCT03044028|19995109|P2|NOT COMPLETED|Overall Study||10
8112725|NCT03044028|19995110|P1|NOT COMPLETED|Overall Study||10
8112726|NCT03044028|19995108|P3|COMPLETED|Overall Study||22
8112727|NCT03044028|19995109|P2|COMPLETED|Overall Study||12
8112728|NCT03044028|19995110|P1|COMPLETED|Overall Study||12
8112729|NCT03044028|19995108|P3|STARTED|Overall Study||22
8112730|NCT03044028|19995109|P2|STARTED|Overall Study||22
8112731|NCT03044028|19995110|P1|STARTED|Overall Study||22
8112732|NCT03043885|19995146|P4|NOT COMPLETED|Overall Study||0
8112733|NCT03043885|19995147|P3|NOT COMPLETED|Overall Study||0
8112734|NCT03043885|19995148|P2|NOT COMPLETED|Overall Study||0
8112735|NCT03043885|19995149|P1|NOT COMPLETED|Overall Study||0
8112736|NCT03043885|19995146|P4|COMPLETED|Overall Study||10
8112737|NCT03043885|19995147|P3|COMPLETED|Overall Study||10
8112738|NCT03043885|19995148|P2|COMPLETED|Overall Study||10
8112739|NCT03043885|19995149|P1|COMPLETED|Overall Study||10
8112740|NCT03043885|19995146|P4|STARTED|Overall Study||10
8112741|NCT03043885|19995147|P3|STARTED|Overall Study||10
8112742|NCT03043885|19995148|P2|STARTED|Overall Study||10
8112743|NCT03043885|19995149|P1|STARTED|Overall Study||10
8112744|NCT03043651|19995163|P1|NOT COMPLETED|Overall Study||48
8112745|NCT03043651|19995163|P1|COMPLETED|Overall Study||0
8112746|NCT03043651|19995163|P1|STARTED|Overall Study||48
8112747|NCT03043599|19995167|P1|NOT COMPLETED|Overall Study||0
8112748|NCT03043599|19995167|P1|COMPLETED|Overall Study||21
8112749|NCT03043599|19995167|P1|STARTED|Overall Study||21
8112750|NCT03043560|19995175|P2|NOT COMPLETED|Overall Study||3
8112751|NCT03043560|19995176|P1|NOT COMPLETED|Overall Study||1
8112752|NCT03043560|19995175|P2|COMPLETED|Overall Study||21
8112753|NCT03043560|19995176|P1|COMPLETED|Overall Study||20
8112754|NCT03043560|19995175|P2|STARTED|Overall Study||24
8112755|NCT03043560|19995176|P1|STARTED|Overall Study||21
8112756|NCT03043534|19995200|P2|NOT COMPLETED|Overall Study||0
8112757|NCT03043534|19995201|P1|NOT COMPLETED|Overall Study||0
8112758|NCT03043534|19995200|P2|COMPLETED|Overall Study||14
8112759|NCT03043534|19995201|P1|COMPLETED|Overall Study||15
8112760|NCT03043534|19995200|P2|STARTED|Overall Study||14
8112761|NCT03043534|19995201|P1|STARTED|Overall Study||15
8112762|NCT03043365|19995217|P2|NOT COMPLETED|Week 16 to Week 24||0
8112763|NCT03043365|19995218|P1|NOT COMPLETED|Week 16 to Week 24||0
8112764|NCT03043365|19995217|P2|COMPLETED|Week 16 to Week 24||14
8112765|NCT03043365|19995218|P1|COMPLETED|Week 16 to Week 24||16
8112766|NCT03043365|19995217|P2|STARTED|Week 16 to Week 24||14
8112767|NCT03043365|19995218|P1|STARTED|Week 16 to Week 24||16
8112768|NCT03043365|19995217|P2|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
8112769|NCT03043365|19995218|P1|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
8112770|NCT03043365|19995217|P2|COMPLETED|Week 8 to Week 16 - Washout Period||14
8112771|NCT03043365|19995218|P1|COMPLETED|Week 8 to Week 16 - Washout Period||16
8112772|NCT03043365|19995217|P2|STARTED|Week 8 to Week 16 - Washout Period||14
8112773|NCT03043365|19995218|P1|STARTED|Week 8 to Week 16 - Washout Period||17
8112774|NCT03043365|19995217|P2|NOT COMPLETED|Weeks 0 to Week 8||3
8112775|NCT03043365|19995218|P1|NOT COMPLETED|Weeks 0 to Week 8||3
8112776|NCT03043365|19995217|P2|COMPLETED|Weeks 0 to Week 8||14
8112777|NCT03043365|19995218|P1|COMPLETED|Weeks 0 to Week 8||17
8112778|NCT03043365|19995217|P2|STARTED|Weeks 0 to Week 8||17
8112779|NCT03043365|19995218|P1|STARTED|Weeks 0 to Week 8||20
8112780|NCT03043274|19995231|P2|NOT COMPLETED|Overall Study||1
8112781|NCT03043274|19995232|P1|NOT COMPLETED|Overall Study||0
8112782|NCT03043274|19995231|P2|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
8112783|NCT03043274|19995232|P1|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
8112784|NCT03043274|19995231|P2|STARTED|Overall Study||10
8112785|NCT03043274|19995232|P1|STARTED|Overall Study||13
8112786|NCT03043105|19995248|P1|NOT COMPLETED|Overall Study||0
8112787|NCT03043105|19995248|P1|COMPLETED|Overall Study||25
8112788|NCT03043105|19995248|P1|STARTED|Overall Study||25
8112789|NCT03043079|19995260|P3|NOT COMPLETED|Overall Study||0
8112790|NCT03043079|19995261|P2|NOT COMPLETED|Overall Study||0
8112791|NCT03043079|19995262|P1|NOT COMPLETED|Overall Study||0
8112792|NCT03043079|19995260|P3|COMPLETED|Overall Study||10
8112793|NCT03043079|19995261|P2|COMPLETED|Overall Study||14
8112794|NCT03043079|19995262|P1|COMPLETED|Overall Study||21
8112795|NCT03043079|19995260|P3|STARTED|Overall Study||10
8112796|NCT03043079|19995261|P2|STARTED|Overall Study||14
8112797|NCT03043079|19995262|P1|STARTED|Overall Study||21
8112798|NCT03042910|19995272|P1|NOT COMPLETED|Overall Study||7
8112799|NCT03042910|19995272|P1|COMPLETED|Overall Study||31
8112800|NCT03042910|19995272|P1|Treated|Overall Study||37
8112801|NCT03042910|19995272|P1|STARTED|Overall Study||38
8112802|NCT03042780|19995295|P1|NOT COMPLETED|Overall Study||0
8112803|NCT03042780|19995295|P1|COMPLETED|Overall Study||2
8112804|NCT03042780|19995295|P1|STARTED|Overall Study||2
8112805|NCT03042767|19995303|P2|NOT COMPLETED|Overall Study||2
8112806|NCT03042767|19995304|P1|NOT COMPLETED|Overall Study||1
8112807|NCT03042767|19995303|P2|COMPLETED|Overall Study||11
8112808|NCT03042767|19995304|P1|COMPLETED|Overall Study||11
8112809|NCT03042767|19995303|P2|STARTED|Overall Study||13
8112810|NCT03042767|19995304|P1|STARTED|Overall Study||12
8112811|NCT03042715|19995330|P1|NOT COMPLETED|Overall Study||1
8112812|NCT03042715|19995330|P1|COMPLETED|Overall Study||5
8112813|NCT03042715|19995330|P1|STARTED|Overall Study||6
8112814|NCT03042702|19995334|P1|NOT COMPLETED|Overall Study||0
8112815|NCT03042702|19995334|P1|COMPLETED|Overall Study||2
8112816|NCT03042702|19995334|P1|STARTED|Overall Study||2
8112817|NCT03042559|19995345|P2|NOT COMPLETED|Overall Study||1
8112818|NCT03042559|19995346|P1|NOT COMPLETED|Overall Study||1
8112819|NCT03042559|19995345|P2|COMPLETED|Overall Study||20
8112820|NCT03042559|19995346|P1|COMPLETED|Overall Study||21
8112821|NCT03042559|19995345|P2|STARTED|Overall Study||21
8112822|NCT03042559|19995346|P1|STARTED|Overall Study||22
8112823|NCT03042299|19995408|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8112824|NCT03042299|19995409|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8112825|NCT03042299|19995408|P2|COMPLETED|Intervention Period 2 (6 Days)||7
8112826|NCT03042299|19995409|P1|COMPLETED|Intervention Period 2 (6 Days)||7
8112827|NCT03042299|19995408|P2|STARTED|Intervention Period 2 (6 Days)||7
8112828|NCT03042299|19995409|P1|STARTED|Intervention Period 2 (6 Days)||7
8112829|NCT03042299|19995408|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
8112830|NCT03042299|19995409|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
8112831|NCT03042299|19995408|P2|COMPLETED|Washout Period (at Least 6 Days)||7
8112832|NCT03042299|19995409|P1|COMPLETED|Washout Period (at Least 6 Days)||7
8112833|NCT03042299|19995408|P2|STARTED|Washout Period (at Least 6 Days)||7
8112834|NCT03042299|19995409|P1|STARTED|Washout Period (at Least 6 Days)||7
8112835|NCT03042299|19995408|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8112836|NCT03042299|19995409|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8112837|NCT03042299|19995408|P2|COMPLETED|Intervention Period 1 (6 Days)||7
8112838|NCT03042299|19995409|P1|COMPLETED|Intervention Period 1 (6 Days)||7
8112839|NCT03042299|19995408|P2|STARTED|Intervention Period 1 (6 Days)||7
8112840|NCT03042299|19995409|P1|STARTED|Intervention Period 1 (6 Days)||7
8112841|NCT03041909|19995438|P3|NOT COMPLETED|Overall Study||0
8112842|NCT03041909|19995439|P2|NOT COMPLETED|Overall Study||0
8112843|NCT03041909|19995440|P1|NOT COMPLETED|Overall Study||0
8112844|NCT03041909|19995438|P3|COMPLETED|Overall Study||1
8112845|NCT03041909|19995439|P2|COMPLETED|Overall Study||1
8112846|NCT03041909|19995440|P1|COMPLETED|Overall Study||3
8112847|NCT03041909|19995438|P3|STARTED|Overall Study||1
8112848|NCT03041909|19995439|P2|STARTED|Overall Study||1
8112849|NCT03041909|19995440|P1|STARTED|Overall Study||3
8112850|NCT03041896|19995461|P4|NOT COMPLETED|Overall Study||3
8112851|NCT03041896|19995462|P3|NOT COMPLETED|Overall Study||63
8112852|NCT03041896|19995463|P2|NOT COMPLETED|Overall Study||0
8112853|NCT03041896|19995464|P1|NOT COMPLETED|Overall Study||0
8112854|NCT03041896|19995461|P4|COMPLETED|Overall Study||253
8112855|NCT03041896|19995462|P3|COMPLETED|Overall Study||2236
8112856|NCT03041896|19995463|P2|COMPLETED|Overall Study||1009
8112857|NCT03041896|19995464|P1|COMPLETED|Overall Study||1486
8112858|NCT03041896|19995461|P4|STARTED|Overall Study||256
8112859|NCT03041896|19995462|P3|STARTED|Overall Study||2299
8112860|NCT03041896|19995463|P2|STARTED|Overall Study||1009
8112861|NCT03041896|19995464|P1|STARTED|Overall Study||1486
8112862|NCT03041792|19995481|P2|NOT COMPLETED|Overall Study||3
8112863|NCT03041792|19995482|P1|NOT COMPLETED|Overall Study||4
8112864|NCT03041792|19995481|P2|COMPLETED|Overall Study||26
8112865|NCT03041792|19995482|P1|COMPLETED|Overall Study||28
8112866|NCT03041792|19995481|P2|Received Treatment|Overall Study||28
8112867|NCT03041792|19995482|P1|Received Treatment|Overall Study||32
8112868|NCT03041792|19995481|P2|STARTED|Overall Study||29
8112869|NCT03041792|19995482|P1|STARTED|Overall Study||32
8112870|NCT03041467|19995506|P2|NOT COMPLETED|Overall Study||160
8112871|NCT03041467|19995507|P1|NOT COMPLETED|Overall Study||170
8112872|NCT03041467|19995506|P2|COMPLETED|Overall Study||0
8112873|NCT03041467|19995507|P1|COMPLETED|Overall Study||0
8112874|NCT03041467|19995506|P2|STARTED|Overall Study||160
8112875|NCT03041467|19995507|P1|STARTED|Overall Study||170
8112876|NCT03041441|19995537|P1|NOT COMPLETED|Overall Study||2
8112877|NCT03041441|19995537|P1|COMPLETED|Overall Study||3
8112878|NCT03041441|19995537|P1|STARTED|Overall Study||5
8112879|NCT03041298|19995545|P1|NOT COMPLETED|Overall Study||0
8112880|NCT03041298|19995545|P1|COMPLETED|Overall Study||1537
8112881|NCT03041298|19995545|P1|STARTED|Overall Study||1537
8112882|NCT03041181|19995555|P2|NOT COMPLETED|Overall Study||2
8112883|NCT03041181|19995556|P1|NOT COMPLETED|Overall Study||1
8112884|NCT03041181|19995555|P2|COMPLETED|Overall Study||0
8112885|NCT03041181|19995556|P1|COMPLETED|Overall Study||0
8112886|NCT03041181|19995555|P2|STARTED|Overall Study||2
8112887|NCT03041181|19995556|P1|STARTED|Overall Study||1
8112888|NCT03041116|19995572|P2|NOT COMPLETED|Open-label||37
8112889|NCT03041116|19995573|P1|NOT COMPLETED|Open-label||41
8112890|NCT03041116|19995572|P2|COMPLETED|Open-label||0
8112891|NCT03041116|19995573|P1|COMPLETED|Open-label||0
8112892|NCT03041116|19995572|P2|Received At Least 1 Dose of Study Drug|Open-label||37
8112893|NCT03041116|19995573|P1|Received At Least 1 Dose of Study Drug|Open-label||41
8112894|NCT03041116|19995572|P2|STARTED|Open-label||37
8112895|NCT03041116|19995573|P1|STARTED|Open-label||41
8112896|NCT03041116|19995572|P2|NOT COMPLETED|Double-blind||6
8112897|NCT03041116|19995573|P1|NOT COMPLETED|Double-blind||0
8112898|NCT03041116|19995572|P2|COMPLETED|Double-blind||37
8112899|NCT03041116|19995573|P1|COMPLETED|Double-blind||41
8112900|NCT03041116|19995572|P2|Received at Least 1 Dose of Study Drug|Double-blind||43
8112901|NCT03041116|19995573|P1|Received at Least 1 Dose of Study Drug|Double-blind||41
8112902|NCT03041116|19995572|P2|STARTED|Double-blind||43
8112903|NCT03041116|19995573|P1|STARTED|Double-blind||41
8112904|NCT03041090|19995589|P2|NOT COMPLETED|Overall Study||3
8112905|NCT03041090|19995590|P1|NOT COMPLETED|Overall Study||0
8112906|NCT03041090|19995589|P2|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
8112907|NCT03041090|19995590|P1|COMPLETED|Overall Study||109
8112908|NCT03041090|19995589|P2|STARTED|Overall Study||24
8112909|NCT03041090|19995590|P1|STARTED|Overall Study||109
8112916|NCT03040713|19995642|P1|NOT COMPLETED|Overall Study||3
8112917|NCT03040713|19995642|P1|COMPLETED|Overall Study||13
8112918|NCT03040713|19995642|P1|STARTED|Overall Study||16
8112919|NCT03040687|19995650|P3|NOT COMPLETED|Overall Study||0
8112920|NCT03040687|19995651|P2|NOT COMPLETED|Overall Study||0
8112921|NCT03040687|19995652|P1|NOT COMPLETED|Overall Study||1
8112922|NCT03040687|19995650|P3|COMPLETED|Overall Study||20
8112923|NCT03040687|19995651|P2|COMPLETED|Overall Study||20
8112924|NCT03040687|19995652|P1|COMPLETED|Overall Study||19
8112925|NCT03040687|19995650|P3|STARTED|Overall Study||20
8112926|NCT03040687|19995651|P2|STARTED|Overall Study||20
8112927|NCT03040687|19995652|P1|STARTED|Overall Study||20
8112928|NCT03040479|19995666|P3|NOT COMPLETED|Overall Study||0
8112929|NCT03040479|19995667|P2|NOT COMPLETED|Overall Study||0
8112930|NCT03040479|19995668|P1|NOT COMPLETED|Overall Study||0
8112931|NCT03040479|19995666|P3|COMPLETED|Overall Study||8
8112932|NCT03040479|19995667|P2|COMPLETED|Overall Study||8
8112933|NCT03040479|19995668|P1|COMPLETED|Overall Study||8
8112934|NCT03040479|19995666|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8112935|NCT03040479|19995667|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8112936|NCT03040479|19995668|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8112937|NCT03040479|19995666|P3|STARTED|Overall Study||8
8112938|NCT03040479|19995667|P2|STARTED|Overall Study||8
8112939|NCT03040479|19995668|P1|STARTED|Overall Study||8
8112940|NCT03040466|19995696|P2|NOT COMPLETED|Overall Study||0
8112941|NCT03040466|19995697|P1|NOT COMPLETED|Overall Study||0
8112942|NCT03040466|19995696|P2|COMPLETED|Overall Study||115
8112943|NCT03040466|19995697|P1|COMPLETED|Overall Study||65
8112944|NCT03040466|19995696|P2|STARTED|Overall Study||115
8112945|NCT03040466|19995697|P1|STARTED|Overall Study||65
8112946|NCT03040362|19995707|P1|NOT COMPLETED|Overall Study||0
8112947|NCT03040362|19995707|P1|COMPLETED|Overall Study||8
8112948|NCT03040362|19995707|P1|Received at Least 1dose of Study Drug|Overall Study||8
8112949|NCT03040362|19995707|P1|STARTED|Overall Study||8
8112950|NCT03040336|19995721|P2|NOT COMPLETED|Overall Study||3
8112951|NCT03040336|19995722|P1|NOT COMPLETED|Overall Study||3
8112952|NCT03040336|19995721|P2|COMPLETED|Overall Study||4
8112953|NCT03040336|19995722|P1|COMPLETED|Overall Study||7
8112954|NCT03040336|19995721|P2|STARTED|Overall Study||7
8112955|NCT03040336|19995722|P1|STARTED|Overall Study||10
8112956|NCT03040323|19995754|P2|NOT COMPLETED|Overall Study||0
8112957|NCT03040323|19995755|P1|NOT COMPLETED|Overall Study||0
8112958|NCT03040323|19995754|P2|COMPLETED|Overall Study||0
8112959|NCT03040323|19995755|P1|COMPLETED|Overall Study||0
8112960|NCT03040323|19995754|P2|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
8112961|NCT03040323|19995755|P1|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
8112962|NCT03040011|19995766|P3|NOT COMPLETED|Primary Outcome Follow Up||1
8112963|NCT03040011|19995767|P2|NOT COMPLETED|Primary Outcome Follow Up||1
8112964|NCT03040011|19995768|P1|NOT COMPLETED|Primary Outcome Follow Up||4
8112965|NCT03040011|19995766|P3|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
8112966|NCT03040011|19995767|P2|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
8112967|NCT03040011|19995768|P1|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
8112968|NCT03040011|19995766|P3|STARTED|Primary Outcome Follow Up||25
8112969|NCT03040011|19995767|P2|STARTED|Primary Outcome Follow Up||25
8112970|NCT03040011|19995768|P1|STARTED|Primary Outcome Follow Up||25
8112971|NCT03040011|19995766|P3|NOT COMPLETED|Received Randomized Study Intervention||0
8112972|NCT03040011|19995767|P2|NOT COMPLETED|Received Randomized Study Intervention||0
8112973|NCT03040011|19995768|P1|NOT COMPLETED|Received Randomized Study Intervention||0
8112974|NCT03040011|19995766|P3|COMPLETED|Received Randomized Study Intervention||25
8112975|NCT03040011|19995767|P2|COMPLETED|Received Randomized Study Intervention||25
8112976|NCT03040011|19995768|P1|COMPLETED|Received Randomized Study Intervention||25
8112977|NCT03040011|19995766|P3|STARTED|Received Randomized Study Intervention||25
8112978|NCT03040011|19995767|P2|STARTED|Received Randomized Study Intervention||25
8112979|NCT03040011|19995768|P1|STARTED|Received Randomized Study Intervention||25
8112980|NCT03039738|19995835|P2|NOT COMPLETED|Overall Study||0
8112981|NCT03039738|19995836|P1|NOT COMPLETED|Overall Study||54
8112982|NCT03039738|19995835|P2|COMPLETED|Overall Study||0
8112983|NCT03039738|19995836|P1|COMPLETED|Overall Study||152
8112984|NCT03039738|19995835|P2|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
8112985|NCT03039738|19995836|P1|STARTED|Overall Study||206
8112986|NCT03039699|19995858|P2|NOT COMPLETED|Overall Study||35
8112987|NCT03039699|19995859|P1|NOT COMPLETED|Overall Study||22
8112988|NCT03039699|19995858|P2|COMPLETED|Overall Study||97
8112989|NCT03039699|19995859|P1|COMPLETED|Overall Study||105
8112990|NCT03039699|19995858|P2|STARTED|Overall Study||132
8112991|NCT03039699|19995859|P1|STARTED|Overall Study||127
8112992|NCT03039686|19995882|P3|NOT COMPLETED|Open Label Period||42
8112993|NCT03039686|19995883|P2|NOT COMPLETED|Open Label Period||38
8112994|NCT03039686|19995884|P1|NOT COMPLETED|Open Label Period||0
8112995|NCT03039686|19995882|P3|COMPLETED|Open Label Period||0
8112996|NCT03039686|19995883|P2|COMPLETED|Open Label Period||0
8112997|NCT03039686|19995884|P1|COMPLETED|Open Label Period||0
8112998|NCT03039686|19995882|P3|Completed DB, Did Not Start OL|Open Label Period||3
8112999|NCT03039686|19995883|P2|Completed DB, Did Not Start OL|Open Label Period||2
8113000|NCT03039686|19995884|P1|Completed DB, Did Not Start OL|Open Label Period||2
8113001|NCT03039686|19995882|P3|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
8113002|NCT03039686|19995883|P2|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
8113003|NCT03039686|19995884|P1|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
8113004|NCT03039686|19995882|P3|NOT COMPLETED|Double-blind Period||23
8113005|NCT03039686|19995883|P2|NOT COMPLETED|Double-blind Period||29
8113006|NCT03039686|19995884|P1|NOT COMPLETED|Double-blind Period||27
8113007|NCT03039686|19995882|P3|COMPLETED|Double-blind Period||32
8113008|NCT03039686|19995883|P2|COMPLETED|Double-blind Period||26
8113009|NCT03039686|19995884|P1|COMPLETED|Double-blind Period||29
8113010|NCT03039686|19995882|P3|STARTED|Double-blind Period||55
8113011|NCT03039686|19995883|P2|STARTED|Double-blind Period||55
8113012|NCT03039686|19995884|P1|STARTED|Double-blind Period||56
8113013|NCT03039621|19995950|P2|NOT COMPLETED|Overall Study||16
8113014|NCT03039621|19995951|P1|NOT COMPLETED|Overall Study||12
8113015|NCT03039621|19995950|P2|COMPLETED|Overall Study||128
8113016|NCT03039621|19995951|P1|COMPLETED|Overall Study||131
8113017|NCT03039621|19995950|P2|STARTED|Overall Study||144
8113018|NCT03039621|19995951|P1|STARTED|Overall Study||143
8113019|NCT03039569|19995975|P2|NOT COMPLETED|Overall Study||4
8113020|NCT03039569|19995976|P1|NOT COMPLETED|Overall Study||5
8113021|NCT03039569|19995975|P2|COMPLETED|Overall Study||35
8113022|NCT03039569|19995976|P1|COMPLETED|Overall Study||35
8113023|NCT03039569|19995975|P2|STARTED|Overall Study||39
8113024|NCT03039569|19995976|P1|STARTED|Overall Study||40
8113025|NCT03039543|19996006|P2|NOT COMPLETED|Overall Study||3
8113026|NCT03039543|19996007|P1|NOT COMPLETED|Overall Study||1
8113027|NCT03039543|19996006|P2|COMPLETED|Overall Study||51
8113028|NCT03039543|19996007|P1|COMPLETED|Overall Study||53
8113029|NCT03039543|19996006|P2|STARTED|Overall Study||54
8113030|NCT03039543|19996007|P1|STARTED|Overall Study||54
8113031|NCT03039283|19996021|P1|NOT COMPLETED|Overall Study||2
8113032|NCT03039283|19996021|P1|COMPLETED|Overall Study||160
8113033|NCT03039283|19996021|P1|STARTED|Overall Study||162
8113034|NCT03039192|19996032|P2|NOT COMPLETED|Overall Study||30
8113035|NCT03039192|19996033|P1|NOT COMPLETED|Overall Study||32
8113036|NCT03039192|19996032|P2|COMPLETED|Overall Study||84
8113037|NCT03039192|19996033|P1|COMPLETED|Overall Study||80
8113038|NCT03039192|19996032|P2|Treated|Overall Study||113
8113039|NCT03039192|19996033|P1|Treated|Overall Study||112
8113040|NCT03039192|19996032|P2|STARTED|Overall Study||114
8113041|NCT03039192|19996033|P1|STARTED|Overall Study||112
8113042|NCT03039179|19996085|P2|NOT COMPLETED|Overall Study||0
8113043|NCT03039179|19996086|P1|NOT COMPLETED|Overall Study||0
8113044|NCT03039179|19996085|P2|COMPLETED|Overall Study||42
8113045|NCT03039179|19996086|P1|COMPLETED|Overall Study||38
8113046|NCT03039179|19996085|P2|STARTED|Overall Study||42
8113047|NCT03039179|19996086|P1|STARTED|Overall Study||38
8113048|NCT03039088|19996096|P2|NOT COMPLETED|Overall Study||0
8113049|NCT03039088|19996097|P1|NOT COMPLETED|Overall Study||0
8113050|NCT03039088|19996096|P2|COMPLETED|Overall Study||316
8113051|NCT03039088|19996097|P1|COMPLETED|Overall Study||192
8113052|NCT03039088|19996096|P2|STARTED|Overall Study||316
8113053|NCT03039088|19996097|P1|STARTED|Overall Study||192
8113054|NCT03038880|19996106|P3|NOT COMPLETED|Overall Study||0
8113055|NCT03038880|19996107|P2|NOT COMPLETED|Overall Study||3
8113056|NCT03038880|19996108|P1|NOT COMPLETED|Overall Study||3
8113057|NCT03038880|19996106|P3|COMPLETED|Overall Study||16
8113058|NCT03038880|19996107|P2|COMPLETED|Overall Study||28
8113059|NCT03038880|19996108|P1|COMPLETED|Overall Study||21
8113060|NCT03038880|19996106|P3|STARTED|Overall Study||16
8113061|NCT03038880|19996107|P2|STARTED|Overall Study||31
8113062|NCT03038880|19996108|P1|STARTED|Overall Study||24
8113063|NCT03038867|19996171|P2|NOT COMPLETED|Overall Study||0
8113064|NCT03038867|19996172|P1|NOT COMPLETED|Overall Study||0
8113065|NCT03038867|19996171|P2|COMPLETED|Overall Study||32
8113066|NCT03038867|19996172|P1|COMPLETED|Overall Study||37
8113067|NCT03038867|19996171|P2|STARTED|Overall Study||32
8113068|NCT03038867|19996172|P1|STARTED|Overall Study||37
8113069|NCT03038815|19996288|P2|NOT COMPLETED|Intervention 2, 1 Hour||0
8113070|NCT03038815|19996289|P1|NOT COMPLETED|Intervention 2, 1 Hour||0
8113071|NCT03038815|19996288|P2|COMPLETED|Intervention 2, 1 Hour||10
8113072|NCT03038815|19996289|P1|COMPLETED|Intervention 2, 1 Hour||10
8113073|NCT03038815|19996288|P2|STARTED|Intervention 2, 1 Hour||10
8113074|NCT03038815|19996289|P1|STARTED|Intervention 2, 1 Hour||10
8113075|NCT03038815|19996288|P2|NOT COMPLETED|Intervention 1, 1 Hour||0
8113076|NCT03038815|19996289|P1|NOT COMPLETED|Intervention 1, 1 Hour||0
8113077|NCT03038815|19996288|P2|COMPLETED|Intervention 1, 1 Hour||10
8113078|NCT03038815|19996289|P1|COMPLETED|Intervention 1, 1 Hour||10
8113079|NCT03038815|19996288|P2|STARTED|Intervention 1, 1 Hour||10
8113080|NCT03038815|19996289|P1|STARTED|Intervention 1, 1 Hour||10
8113081|NCT03038815|19996288|P2|NOT COMPLETED|Controll Condition, 1 Hour||0
8113082|NCT03038815|19996289|P1|NOT COMPLETED|Controll Condition, 1 Hour||0
8113083|NCT03038815|19996288|P2|COMPLETED|Controll Condition, 1 Hour||10
8113084|NCT03038815|19996289|P1|COMPLETED|Controll Condition, 1 Hour||10
8113085|NCT03038815|19996288|P2|STARTED|Controll Condition, 1 Hour||10
8113086|NCT03038815|19996289|P1|STARTED|Controll Condition, 1 Hour||10
8113087|NCT03038126|19996301|P2|NOT COMPLETED|Overall Study||4
8113088|NCT03038126|19996302|P1|NOT COMPLETED|Overall Study||9
8113089|NCT03038126|19996301|P2|COMPLETED|Overall Study||51
8113090|NCT03038126|19996302|P1|COMPLETED|Overall Study||54
8113091|NCT03038126|19996301|P2|STARTED|Overall Study||55
8113092|NCT03038126|19996302|P1|STARTED|Overall Study||63
8113093|NCT03038113|19996326|P14|NOT COMPLETED|Overall Study||1
8113094|NCT03038113|19996327|P13|NOT COMPLETED|Overall Study||0
8113095|NCT03038113|19996328|P12|NOT COMPLETED|Overall Study||0
8113096|NCT03038113|19996329|P11|NOT COMPLETED|Overall Study||0
8113097|NCT03038113|19996330|P10|NOT COMPLETED|Overall Study||0
8113098|NCT03038113|19996331|P9|NOT COMPLETED|Overall Study||0
8113099|NCT03038113|19996332|P8|NOT COMPLETED|Overall Study||0
8113100|NCT03038113|19996333|P7|NOT COMPLETED|Overall Study||1
8113101|NCT03038113|19996334|P6|NOT COMPLETED|Overall Study||0
8113102|NCT03038113|19996335|P5|NOT COMPLETED|Overall Study||0
8113103|NCT03038113|19996336|P4|NOT COMPLETED|Overall Study||0
8113104|NCT03038113|19996337|P3|NOT COMPLETED|Overall Study||1
8113105|NCT03038113|19996338|P2|NOT COMPLETED|Overall Study||0
8113106|NCT03038113|19996339|P1|NOT COMPLETED|Overall Study||0
8113107|NCT03038113|19996326|P14|COMPLETED|Overall Study||14
8113108|NCT03038113|19996327|P13|COMPLETED|Overall Study||4
8113109|NCT03038113|19996328|P12|COMPLETED|Overall Study||7
8113110|NCT03038113|19996329|P11|COMPLETED|Overall Study||14
8113111|NCT03038113|19996330|P10|COMPLETED|Overall Study||6
8113112|NCT03038113|19996331|P9|COMPLETED|Overall Study||7
8113113|NCT03038113|19996332|P8|COMPLETED|Overall Study||6
8113114|NCT03038113|19996333|P7|COMPLETED|Overall Study||11
8113115|NCT03038113|19996334|P6|COMPLETED|Overall Study||8
8113116|NCT03038113|19996335|P5|COMPLETED|Overall Study||8
8113117|NCT03038113|19996336|P4|COMPLETED|Overall Study||8
8113118|NCT03038113|19996337|P3|COMPLETED|Overall Study||7
8113119|NCT03038113|19996338|P2|COMPLETED|Overall Study||8
8113120|NCT03038113|19996339|P1|COMPLETED|Overall Study||8
8113121|NCT03038113|19996326|P14|STARTED|Overall Study||15
8113122|NCT03038113|19996327|P13|STARTED|Overall Study||4
8113123|NCT03038113|19996328|P12|STARTED|Overall Study||7
8113124|NCT03038113|19996329|P11|STARTED|Overall Study||14
8113125|NCT03038113|19996330|P10|STARTED|Overall Study||6
8113126|NCT03038113|19996331|P9|STARTED|Overall Study||7
8113127|NCT03038113|19996332|P8|STARTED|Overall Study||6
8113128|NCT03038113|19996333|P7|STARTED|Overall Study||12
8113129|NCT03038113|19996334|P6|STARTED|Overall Study||8
8113130|NCT03038113|19996335|P5|STARTED|Overall Study||8
8113131|NCT03038113|19996336|P4|STARTED|Overall Study||8
8113132|NCT03038113|19996337|P3|STARTED|Overall Study||8
8113133|NCT03038113|19996338|P2|STARTED|Overall Study||8
8113134|NCT03038113|19996339|P1|STARTED|Overall Study||8
8113135|NCT03037983|19996550|P2|NOT COMPLETED|Overall Study||0
8113136|NCT03037983|19996551|P1|NOT COMPLETED|Overall Study||0
8113137|NCT03037983|19996550|P2|COMPLETED|Overall Study||4
8113138|NCT03037983|19996551|P1|COMPLETED|Overall Study||5
8113139|NCT03037983|19996550|P2|STARTED|Overall Study||4
8113140|NCT03037983|19996551|P1|STARTED|Overall Study||5
8113141|NCT03037905|19996565|P2|NOT COMPLETED|Overall Study||0
8113142|NCT03037905|19996566|P1|NOT COMPLETED|Overall Study||0
8113143|NCT03037905|19996565|P2|COMPLETED|Overall Study||50
8113144|NCT03037905|19996566|P1|COMPLETED|Overall Study||50
8113145|NCT03037905|19996565|P2|STARTED|Overall Study||50
8113146|NCT03037905|19996566|P1|STARTED|Overall Study||50
8113147|NCT03037619|19996580|P2|NOT COMPLETED|Overall Study||1
8113148|NCT03037619|19996581|P1|NOT COMPLETED|Overall Study||0
8113149|NCT03037619|19996580|P2|COMPLETED|Overall Study|7 participants and 7 buddies|14
8113150|NCT03037619|19996581|P1|COMPLETED|Overall Study||8
8113151|NCT03037619|19996580|P2|STARTED|Overall Study|8 participants and 7 buddies|15
8113152|NCT03037619|19996581|P1|STARTED|Overall Study||8
8113153|NCT03037580|19996595|P2|NOT COMPLETED|Overall Study||16
8113154|NCT03037580|19996596|P1|NOT COMPLETED|Overall Study||16
8113155|NCT03037580|19996595|P2|COMPLETED|Overall Study||27
8113156|NCT03037580|19996596|P1|COMPLETED|Overall Study||25
8113157|NCT03037580|19996595|P2|STARTED|Overall Study||43
8113158|NCT03037580|19996596|P1|STARTED|Overall Study||41
8113159|NCT03037541|19996610|P2|NOT COMPLETED|Overall Study||0
8113160|NCT03037541|19996611|P1|NOT COMPLETED|Overall Study||0
8113161|NCT03037541|19996610|P2|COMPLETED|Overall Study||30
8113162|NCT03037541|19996611|P1|COMPLETED|Overall Study||30
8113163|NCT03037541|19996610|P2|STARTED|Overall Study||30
8113164|NCT03037541|19996611|P1|STARTED|Overall Study||30
8113165|NCT03037489|19996621|P2|NOT COMPLETED|Overall Study||0
8113166|NCT03037489|19996622|P1|NOT COMPLETED|Overall Study||7
8113167|NCT03037489|19996621|P2|COMPLETED|Overall Study||4
8113168|NCT03037489|19996622|P1|COMPLETED|Overall Study||39
8113169|NCT03037489|19996621|P2|STARTED|Overall Study||4
8113170|NCT03037489|19996622|P1|STARTED|Overall Study||46
8113171|NCT03037307|19996628|P6|NOT COMPLETED|Period 3||0
8113172|NCT03037307|19996629|P5|NOT COMPLETED|Period 3||0
8113173|NCT03037307|19996630|P4|NOT COMPLETED|Period 3||0
8113174|NCT03037307|19996631|P3|NOT COMPLETED|Period 3||0
8113175|NCT03037307|19996632|P2|NOT COMPLETED|Period 3||0
8113176|NCT03037307|19996633|P1|NOT COMPLETED|Period 3||0
8113177|NCT03037307|19996628|P6|COMPLETED|Period 3||8
8113178|NCT03037307|19996629|P5|COMPLETED|Period 3||7
8113179|NCT03037307|19996630|P4|COMPLETED|Period 3||6
8113180|NCT03037307|19996631|P3|COMPLETED|Period 3||8
8113181|NCT03037307|19996632|P2|COMPLETED|Period 3||7
8113182|NCT03037307|19996633|P1|COMPLETED|Period 3||7
8113183|NCT03037307|19996628|P6|STARTED|Period 3||8
8113184|NCT03037307|19996629|P5|STARTED|Period 3||7
8113185|NCT03037307|19996630|P4|STARTED|Period 3||6
8113186|NCT03037307|19996631|P3|STARTED|Period 3||8
8113187|NCT03037307|19996632|P2|STARTED|Period 3||7
8113188|NCT03037307|19996633|P1|STARTED|Period 3||7
8113189|NCT03037307|19996628|P6|NOT COMPLETED|Wash Out Period 2||0
8113190|NCT03037307|19996629|P5|NOT COMPLETED|Wash Out Period 2||0
8113191|NCT03037307|19996630|P4|NOT COMPLETED|Wash Out Period 2||0
8113192|NCT03037307|19996631|P3|NOT COMPLETED|Wash Out Period 2||0
8113193|NCT03037307|19996632|P2|NOT COMPLETED|Wash Out Period 2||0
8113194|NCT03037307|19996633|P1|NOT COMPLETED|Wash Out Period 2||0
8113195|NCT03037307|19996628|P6|COMPLETED|Wash Out Period 2||8
8113196|NCT03037307|19996629|P5|COMPLETED|Wash Out Period 2||7
8113197|NCT03037307|19996630|P4|COMPLETED|Wash Out Period 2||6
8113198|NCT03037307|19996631|P3|COMPLETED|Wash Out Period 2||8
8113199|NCT03037307|19996632|P2|COMPLETED|Wash Out Period 2||7
8113200|NCT03037307|19996633|P1|COMPLETED|Wash Out Period 2||7
8113201|NCT03037307|19996628|P6|STARTED|Wash Out Period 2||8
8113202|NCT03037307|19996629|P5|STARTED|Wash Out Period 2||7
8113203|NCT03037307|19996630|P4|STARTED|Wash Out Period 2||6
8113204|NCT03037307|19996631|P3|STARTED|Wash Out Period 2||8
8113205|NCT03037307|19996632|P2|STARTED|Wash Out Period 2||7
8113206|NCT03037307|19996633|P1|STARTED|Wash Out Period 2||7
8113207|NCT03037307|19996628|P6|NOT COMPLETED|Period 2||0
8113208|NCT03037307|19996629|P5|NOT COMPLETED|Period 2||0
8113209|NCT03037307|19996630|P4|NOT COMPLETED|Period 2||0
8113210|NCT03037307|19996631|P3|NOT COMPLETED|Period 2||0
8113211|NCT03037307|19996632|P2|NOT COMPLETED|Period 2||0
8113212|NCT03037307|19996633|P1|NOT COMPLETED|Period 2||0
8113213|NCT03037307|19996628|P6|COMPLETED|Period 2||8
8113214|NCT03037307|19996629|P5|COMPLETED|Period 2||7
8113215|NCT03037307|19996630|P4|COMPLETED|Period 2||6
8113216|NCT03037307|19996631|P3|COMPLETED|Period 2||8
8113217|NCT03037307|19996632|P2|COMPLETED|Period 2||7
8113218|NCT03037307|19996633|P1|COMPLETED|Period 2||7
8113219|NCT03037307|19996628|P6|STARTED|Period 2||8
8113220|NCT03037307|19996629|P5|STARTED|Period 2||7
8113221|NCT03037307|19996630|P4|STARTED|Period 2||6
8113222|NCT03037307|19996631|P3|STARTED|Period 2||8
8113223|NCT03037307|19996632|P2|STARTED|Period 2||7
8113224|NCT03037307|19996633|P1|STARTED|Period 2||7
8113225|NCT03037307|19996628|P6|NOT COMPLETED|Wash Out Period 1||0
8113226|NCT03037307|19996629|P5|NOT COMPLETED|Wash Out Period 1||0
8113227|NCT03037307|19996630|P4|NOT COMPLETED|Wash Out Period 1||0
8113228|NCT03037307|19996631|P3|NOT COMPLETED|Wash Out Period 1||0
8113229|NCT03037307|19996632|P2|NOT COMPLETED|Wash Out Period 1||0
8113230|NCT03037307|19996633|P1|NOT COMPLETED|Wash Out Period 1||0
8113231|NCT03037307|19996628|P6|COMPLETED|Wash Out Period 1||8
8113232|NCT03037307|19996629|P5|COMPLETED|Wash Out Period 1||7
8113233|NCT03037307|19996630|P4|COMPLETED|Wash Out Period 1||6
8113234|NCT03037307|19996631|P3|COMPLETED|Wash Out Period 1||8
8113235|NCT03037307|19996632|P2|COMPLETED|Wash Out Period 1||7
8113236|NCT03037307|19996633|P1|COMPLETED|Wash Out Period 1||7
8113237|NCT03037307|19996628|P6|STARTED|Wash Out Period 1||8
8113238|NCT03037307|19996629|P5|STARTED|Wash Out Period 1||7
8113239|NCT03037307|19996630|P4|STARTED|Wash Out Period 1||6
8113240|NCT03037307|19996631|P3|STARTED|Wash Out Period 1||8
8113241|NCT03037307|19996632|P2|STARTED|Wash Out Period 1||7
8113242|NCT03037307|19996633|P1|STARTED|Wash Out Period 1||7
8113243|NCT03037307|19996628|P6|NOT COMPLETED|Period 1||0
8113244|NCT03037307|19996629|P5|NOT COMPLETED|Period 1||0
8113245|NCT03037307|19996630|P4|NOT COMPLETED|Period 1||1
8113246|NCT03037307|19996631|P3|NOT COMPLETED|Period 1||0
8113247|NCT03037307|19996632|P2|NOT COMPLETED|Period 1||0
8113248|NCT03037307|19996633|P1|NOT COMPLETED|Period 1||0
8113249|NCT03037307|19996628|P6|COMPLETED|Period 1||8
8113250|NCT03037307|19996629|P5|COMPLETED|Period 1||7
8113251|NCT03037307|19996630|P4|COMPLETED|Period 1||6
8113252|NCT03037307|19996631|P3|COMPLETED|Period 1||8
8113253|NCT03037307|19996632|P2|COMPLETED|Period 1||7
8113254|NCT03037307|19996633|P1|COMPLETED|Period 1||7
8113255|NCT03037307|19996628|P6|STARTED|Period 1||8
8113256|NCT03037307|19996629|P5|STARTED|Period 1||7
8113257|NCT03037307|19996630|P4|STARTED|Period 1||7
8113258|NCT03037307|19996631|P3|STARTED|Period 1||8
8113259|NCT03037307|19996632|P2|STARTED|Period 1||7
8113260|NCT03037307|19996633|P1|STARTED|Period 1||7
8113261|NCT03037281|19996645|P2|NOT COMPLETED|Overall Study||0
8113262|NCT03037281|19996646|P1|NOT COMPLETED|Overall Study||0
8113263|NCT03037281|19996645|P2|COMPLETED|Overall Study||8
8113264|NCT03037281|19996646|P1|COMPLETED|Overall Study||6
8113265|NCT03037281|19996645|P2|STARTED|Overall Study||8
8113266|NCT03037281|19996646|P1|STARTED|Overall Study||6
8113267|NCT03037203|19996667|P3|NOT COMPLETED|Overall Study||1
8113268|NCT03037203|19996668|P2|NOT COMPLETED|Overall Study||2
8113269|NCT03037203|19996669|P1|NOT COMPLETED|Overall Study||1
8113270|NCT03037203|19996667|P3|COMPLETED|Overall Study||9
8113271|NCT03037203|19996668|P2|COMPLETED|Overall Study||26
8113272|NCT03037203|19996669|P1|COMPLETED|Overall Study||27
8113273|NCT03037203|19996667|P3|STARTED|Overall Study||10
8113274|NCT03037203|19996668|P2|STARTED|Overall Study||28
8113275|NCT03037203|19996669|P1|STARTED|Overall Study||28
8113276|NCT03036852|19996693|P1|NOT COMPLETED|Overall Study||6
8113277|NCT03036852|19996693|P1|COMPLETED|Overall Study||53
8113278|NCT03036852|19996693|P1|STARTED|Overall Study||59
8113279|NCT03036839|19996750|P3|NOT COMPLETED|Overall Study||5
8113280|NCT03036839|19996751|P2|NOT COMPLETED|Overall Study||0
8113281|NCT03036839|19996752|P1|NOT COMPLETED|Overall Study||3
8113282|NCT03036839|19996750|P3|COMPLETED|Overall Study||14
8113283|NCT03036839|19996751|P2|COMPLETED|Overall Study||31
8113284|NCT03036839|19996752|P1|COMPLETED|Overall Study||42
8113285|NCT03036839|19996750|P3|STARTED|Overall Study||19
8113286|NCT03036839|19996751|P2|STARTED|Overall Study||31
8113287|NCT03036839|19996752|P1|STARTED|Overall Study||45
8113288|NCT03036813|19996805|P3|NOT COMPLETED|Overall Study||26
8113289|NCT03036813|19996806|P2|NOT COMPLETED|Overall Study||27
8113290|NCT03036813|19996807|P1|NOT COMPLETED|Overall Study||22
8113291|NCT03036813|19996805|P3|COMPLETED|Overall Study||66
8113292|NCT03036813|19996806|P2|COMPLETED|Overall Study||63
8113293|NCT03036813|19996807|P1|COMPLETED|Overall Study||70
8113294|NCT03036813|19996805|P3|STARTED|Overall Study||92
8113295|NCT03036813|19996806|P2|STARTED|Overall Study||90
8113296|NCT03036813|19996807|P1|STARTED|Overall Study||92
8113297|NCT03036735|19996830|P1|NOT COMPLETED|Overall Study||10
8113298|NCT03036735|19996830|P1|COMPLETED|Overall Study||0
8113299|NCT03036735|19996830|P1|STARTED|Overall Study||10
8113300|NCT03036384|19996838|P10|NOT COMPLETED|Overall Study||0
8113301|NCT03036384|19996839|P9|NOT COMPLETED|Overall Study||0
8113302|NCT03036384|19996840|P8|NOT COMPLETED|Overall Study||0
8113303|NCT03036384|19996841|P7|NOT COMPLETED|Overall Study||0
8113304|NCT03036384|19996842|P6|NOT COMPLETED|Overall Study||0
8113305|NCT03036384|19996843|P5|NOT COMPLETED|Overall Study||0
8113306|NCT03036384|19996844|P4|NOT COMPLETED|Overall Study||0
8113307|NCT03036384|19996845|P3|NOT COMPLETED|Overall Study||0
8113308|NCT03036384|19996846|P2|NOT COMPLETED|Overall Study||0
8113309|NCT03036384|19996847|P1|NOT COMPLETED|Overall Study||0
8113310|NCT03036384|19996838|P10|COMPLETED|Overall Study||4
8113311|NCT03036384|19996839|P9|COMPLETED|Overall Study||4
8113312|NCT03036384|19996840|P8|COMPLETED|Overall Study||4
8113313|NCT03036384|19996841|P7|COMPLETED|Overall Study||4
8113314|NCT03036384|19996842|P6|COMPLETED|Overall Study||4
8113315|NCT03036384|19996843|P5|COMPLETED|Overall Study||4
8113316|NCT03036384|19996844|P4|COMPLETED|Overall Study||4
8113317|NCT03036384|19996845|P3|COMPLETED|Overall Study||4
8113318|NCT03036384|19996846|P2|COMPLETED|Overall Study||4
8113319|NCT03036384|19996847|P1|COMPLETED|Overall Study||4
8113320|NCT03036384|19996838|P10|STARTED|Overall Study||4
8113321|NCT03036384|19996839|P9|STARTED|Overall Study||4
8113322|NCT03036384|19996840|P8|STARTED|Overall Study||4
8113323|NCT03036384|19996841|P7|STARTED|Overall Study||4
8113324|NCT03036384|19996842|P6|STARTED|Overall Study||4
8113325|NCT03036384|19996843|P5|STARTED|Overall Study||4
8113326|NCT03036384|19996844|P4|STARTED|Overall Study||4
8113327|NCT03036384|19996845|P3|STARTED|Overall Study||4
8113328|NCT03036384|19996846|P2|STARTED|Overall Study||4
8113329|NCT03036384|19996847|P1|STARTED|Overall Study||4
8113330|NCT03036293|19996893|P4|NOT COMPLETED|Overall Study||1
8113331|NCT03036293|19996894|P3|NOT COMPLETED|Overall Study||1
8113332|NCT03036293|19996895|P2|NOT COMPLETED|Overall Study||3
8113333|NCT03036293|19996896|P1|NOT COMPLETED|Overall Study||1
8113334|NCT03036293|19996893|P4|COMPLETED|Overall Study||64
8113335|NCT03036293|19996894|P3|COMPLETED|Overall Study||130
8113336|NCT03036293|19996895|P2|COMPLETED|Overall Study||64
8113337|NCT03036293|19996896|P1|COMPLETED|Overall Study||126
8113338|NCT03036293|19996893|P4|STARTED|Overall Study||65
8113339|NCT03036293|19996894|P3|STARTED|Overall Study||131
8113340|NCT03036293|19996895|P2|STARTED|Overall Study||67
8113341|NCT03036293|19996896|P1|STARTED|Overall Study||127
8113342|NCT03036215|19996924|P2|NOT COMPLETED|Overall Study||3
8113343|NCT03036215|19996925|P1|NOT COMPLETED|Overall Study||2
8113344|NCT03036215|19996924|P2|COMPLETED|Overall Study||36
8113345|NCT03036215|19996925|P1|COMPLETED|Overall Study||39
8113346|NCT03036215|19996924|P2|STARTED|Overall Study||39
8113347|NCT03036215|19996925|P1|STARTED|Overall Study||41
8113348|NCT03036163|19996942|P7|NOT COMPLETED|Overall Study||0
8113349|NCT03036163|19996943|P6|NOT COMPLETED|Overall Study||0
8113350|NCT03036163|19996944|P5|NOT COMPLETED|Overall Study||0
8113351|NCT03036163|19996945|P4|NOT COMPLETED|Overall Study||0
8113352|NCT03036163|19996946|P3|NOT COMPLETED|Overall Study||0
8113353|NCT03036163|19996947|P2|NOT COMPLETED|Overall Study||0
8113354|NCT03036163|19996948|P1|NOT COMPLETED|Overall Study||0
8113355|NCT03036163|19996942|P7|COMPLETED|Overall Study||5
8113356|NCT03036163|19996943|P6|COMPLETED|Overall Study||5
8113357|NCT03036163|19996944|P5|COMPLETED|Overall Study||6
8113358|NCT03036163|19996945|P4|COMPLETED|Overall Study||6
8113359|NCT03036163|19996946|P3|COMPLETED|Overall Study||6
8113360|NCT03036163|19996947|P2|COMPLETED|Overall Study||6
8113361|NCT03036163|19996948|P1|COMPLETED|Overall Study||6
8113362|NCT03036163|19996942|P7|STARTED|Overall Study||5
8113363|NCT03036163|19996943|P6|STARTED|Overall Study||5
8113364|NCT03036163|19996944|P5|STARTED|Overall Study||6
8113365|NCT03036163|19996945|P4|STARTED|Overall Study||6
8113366|NCT03036163|19996946|P3|STARTED|Overall Study||6
8113367|NCT03036163|19996947|P2|STARTED|Overall Study||6
8113368|NCT03036163|19996948|P1|STARTED|Overall Study||6
8113369|NCT03036124|19997039|P2|NOT COMPLETED|Overall Study||6
8113370|NCT03036124|19997040|P1|NOT COMPLETED|Overall Study||5
8113371|NCT03036124|19997039|P2|COMPLETED|Overall Study||2365
8113372|NCT03036124|19997040|P1|COMPLETED|Overall Study||2368
8113373|NCT03036124|19997039|P2|STARTED|Overall Study||2371
8113374|NCT03036124|19997040|P1|STARTED|Overall Study||2373
8113375|NCT03036072|19997058|P2|NOT COMPLETED|Overall Study||3
8113376|NCT03036072|19997059|P1|NOT COMPLETED|Overall Study||0
8113377|NCT03036072|19997058|P2|COMPLETED|Overall Study||10
8113378|NCT03036072|19997059|P1|COMPLETED|Overall Study||12
8113379|NCT03036072|19997058|P2|STARTED|Overall Study||13
8113380|NCT03036072|19997059|P1|STARTED|Overall Study||12
8113381|NCT03035955|19997069|P2|NOT COMPLETED|Overall Study||1
8113382|NCT03035955|19997070|P1|NOT COMPLETED|Overall Study||1
8113383|NCT03035955|19997069|P2|COMPLETED|Overall Study||9
8113384|NCT03035955|19997070|P1|COMPLETED|Overall Study||9
8113385|NCT03035955|19997069|P2|STARTED|Overall Study||10
8113386|NCT03035955|19997070|P1|STARTED|Overall Study||10
8113387|NCT03035942|19997079|P3|NOT COMPLETED|Overall Study||5
8113388|NCT03035942|19997080|P2|NOT COMPLETED|Overall Study||4
8113389|NCT03035942|19997081|P1|NOT COMPLETED|Overall Study||8
8113390|NCT03035942|19997079|P3|COMPLETED|Overall Study||40
8113391|NCT03035942|19997080|P2|COMPLETED|Overall Study||41
8113392|NCT03035942|19997081|P1|COMPLETED|Overall Study||37
8113393|NCT03035942|19997079|P3|STARTED|Overall Study||45
8113394|NCT03035942|19997080|P2|STARTED|Overall Study||45
8113395|NCT03035942|19997081|P1|STARTED|Overall Study||45
8113396|NCT03035929|19997098|P1|NOT COMPLETED|Overall Study||0
8113397|NCT03035929|19997098|P1|COMPLETED|Overall Study||10
8113398|NCT03035929|19997098|P1|STARTED|Overall Study||10
8113399|NCT03035916|19997110|P3|NOT COMPLETED|Overall Study||0
8113400|NCT03035916|19997111|P2|NOT COMPLETED|Overall Study||2
8113401|NCT03035916|19997112|P1|NOT COMPLETED|Overall Study||0
8113402|NCT03035916|19997110|P3|COMPLETED|Overall Study||31
8113403|NCT03035916|19997111|P2|COMPLETED|Overall Study||28
8113404|NCT03035916|19997112|P1|COMPLETED|Overall Study||30
8113405|NCT03035916|19997110|P3|STARTED|Overall Study||31
8113406|NCT03035916|19997111|P2|STARTED|Overall Study||30
8113407|NCT03035916|19997112|P1|STARTED|Overall Study||30
8113408|NCT03035864|19997161|P2|NOT COMPLETED|Follow-up Period||4
8113409|NCT03035864|19997162|P1|NOT COMPLETED|Follow-up Period||11
8113410|NCT03035864|19997161|P2|COMPLETED|Follow-up Period||55
8113411|NCT03035864|19997162|P1|COMPLETED|Follow-up Period||105
8113412|NCT03035864|19997161|P2|STARTED|Follow-up Period||59
8113413|NCT03035864|19997162|P1|STARTED|Follow-up Period||116
8113414|NCT03035864|19997161|P2|NOT COMPLETED|Treatment Period||1
8113415|NCT03035864|19997162|P1|NOT COMPLETED|Treatment Period||4
8113416|NCT03035864|19997161|P2|COMPLETED|Treatment Period||59
8113417|NCT03035864|19997162|P1|COMPLETED|Treatment Period||116
8113418|NCT03035864|19997161|P2|STARTED|Treatment Period||60
8113419|NCT03035864|19997162|P1|STARTED|Treatment Period||120
8113420|NCT03035760|19997183|P5|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113421|NCT03035760|19997184|P4|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113422|NCT03035760|19997185|P3|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113423|NCT03035760|19997186|P2|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113424|NCT03035760|19997187|P1|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113425|NCT03035760|19997183|P5|COMPLETED|Second Intervention - 7 Days Follow-up||6
8113426|NCT03035760|19997184|P4|COMPLETED|Second Intervention - 7 Days Follow-up||6
8113427|NCT03035760|19997185|P3|COMPLETED|Second Intervention - 7 Days Follow-up||0
8113428|NCT03035760|19997186|P2|COMPLETED|Second Intervention - 7 Days Follow-up||0
8113429|NCT03035760|19997187|P1|COMPLETED|Second Intervention - 7 Days Follow-up||0
8113430|NCT03035760|19997183|P5|STARTED|Second Intervention - 7 Days Follow-up||6
8113431|NCT03035760|19997184|P4|STARTED|Second Intervention - 7 Days Follow-up||6
8113432|NCT03035760|19997185|P3|STARTED|Second Intervention - 7 Days Follow-up||0
8113433|NCT03035760|19997186|P2|STARTED|Second Intervention - 7 Days Follow-up||0
8113434|NCT03035760|19997187|P1|STARTED|Second Intervention - 7 Days Follow-up||0
8113435|NCT03035760|19997183|P5|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113436|NCT03035760|19997184|P4|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113437|NCT03035760|19997185|P3|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113438|NCT03035760|19997186|P2|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113439|NCT03035760|19997187|P1|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113440|NCT03035760|19997183|P5|COMPLETED|First Intervention - 10/7 Days Follow-up||6
8113441|NCT03035760|19997184|P4|COMPLETED|First Intervention - 10/7 Days Follow-up||6
8113442|NCT03035760|19997185|P3|COMPLETED|First Intervention - 10/7 Days Follow-up||8
8113443|NCT03035760|19997186|P2|COMPLETED|First Intervention - 10/7 Days Follow-up||8
8113444|NCT03035760|19997187|P1|COMPLETED|First Intervention - 10/7 Days Follow-up||8
8113445|NCT03035760|19997183|P5|STARTED|First Intervention - 10/7 Days Follow-up||6
8113446|NCT03035760|19997184|P4|STARTED|First Intervention - 10/7 Days Follow-up||6
8113447|NCT03035760|19997185|P3|STARTED|First Intervention - 10/7 Days Follow-up||8
8113448|NCT03035760|19997186|P2|STARTED|First Intervention - 10/7 Days Follow-up||8
8113449|NCT03035760|19997187|P1|STARTED|First Intervention - 10/7 Days Follow-up||8
8113450|NCT03035708|19997217|P2|NOT COMPLETED|Overall Study||11
8113451|NCT03035708|19997218|P1|NOT COMPLETED|Overall Study||4
8113452|NCT03035708|19997217|P2|COMPLETED|Overall Study||13
8113453|NCT03035708|19997218|P1|COMPLETED|Overall Study||19
8113454|NCT03035708|19997217|P2|STARTED|Overall Study||24
8113455|NCT03035708|19997218|P1|STARTED|Overall Study||23
8113456|NCT03035487|19997232|P1|NOT COMPLETED|Overall Study||0
8113457|NCT03035487|19997232|P1|COMPLETED|Overall Study||9
8113458|NCT03035487|19997232|P1|STARTED|Overall Study||9
8113459|NCT03035032|19997236|P1|NOT COMPLETED|Overall Study||43
8113460|NCT03035032|19997236|P1|COMPLETED|Overall Study||64
8113461|NCT03035032|19997236|P1|STARTED|Overall Study||107
8113462|NCT03034967|19997257|P6|NOT COMPLETED|Overall Study||15
8113463|NCT03034967|19997258|P5|NOT COMPLETED|Overall Study||14
8113464|NCT03034967|19997259|P4|NOT COMPLETED|Overall Study||11
8113465|NCT03034967|19997260|P3|NOT COMPLETED|Overall Study||13
8113466|NCT03034967|19997261|P2|NOT COMPLETED|Overall Study||5
8113467|NCT03034967|19997262|P1|NOT COMPLETED|Overall Study||14
8113468|NCT03034967|19997257|P6|COMPLETED|Overall Study||87
8113469|NCT03034967|19997258|P5|COMPLETED|Overall Study||88
8113470|NCT03034967|19997259|P4|COMPLETED|Overall Study||92
8113471|NCT03034967|19997260|P3|COMPLETED|Overall Study||90
8113472|NCT03034967|19997261|P2|COMPLETED|Overall Study||97
8113473|NCT03034967|19997262|P1|COMPLETED|Overall Study||88
8113474|NCT03034967|19997257|P6|STARTED|Overall Study||102
8113475|NCT03034967|19997258|P5|STARTED|Overall Study||102
8113476|NCT03034967|19997259|P4|STARTED|Overall Study||103
8113477|NCT03034967|19997260|P3|STARTED|Overall Study||103
8113478|NCT03034967|19997261|P2|STARTED|Overall Study||102
8113479|NCT03034967|19997262|P1|STARTED|Overall Study||102
8113480|NCT03034954|19997460|P2|NOT COMPLETED|Overall Study||0
8113481|NCT03034954|19997461|P1|NOT COMPLETED|Overall Study||1
8113482|NCT03034954|19997460|P2|COMPLETED|Overall Study||21
8113483|NCT03034954|19997461|P1|COMPLETED|Overall Study||20
8113484|NCT03034954|19997460|P2|STARTED|Overall Study||21
8113485|NCT03034954|19997461|P1|STARTED|Overall Study||21
8113486|NCT03034928|19997513|P4|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113487|NCT03034928|19997514|P3|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113488|NCT03034928|19997515|P2|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113489|NCT03034928|19997516|P1|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113490|NCT03034928|19997513|P4|COMPLETED|Period 2, Second 2 Hours of Wear||8
8113491|NCT03034928|19997514|P3|COMPLETED|Period 2, Second 2 Hours of Wear||9
8113492|NCT03034928|19997515|P2|COMPLETED|Period 2, Second 2 Hours of Wear||8
8113493|NCT03034928|19997516|P1|COMPLETED|Period 2, Second 2 Hours of Wear||8
8113494|NCT03034928|19997513|P4|STARTED|Period 2, Second 2 Hours of Wear||8
8113495|NCT03034928|19997514|P3|STARTED|Period 2, Second 2 Hours of Wear||9
8113496|NCT03034928|19997515|P2|STARTED|Period 2, Second 2 Hours of Wear||8
8113497|NCT03034928|19997516|P1|STARTED|Period 2, Second 2 Hours of Wear||8
8113498|NCT03034928|19997513|P4|NOT COMPLETED|Washout Period Between Lens Wear||0
8113499|NCT03034928|19997514|P3|NOT COMPLETED|Washout Period Between Lens Wear||0
8113500|NCT03034928|19997515|P2|NOT COMPLETED|Washout Period Between Lens Wear||0
8113501|NCT03034928|19997516|P1|NOT COMPLETED|Washout Period Between Lens Wear||0
8113502|NCT03034928|19997513|P4|COMPLETED|Washout Period Between Lens Wear||8
8113503|NCT03034928|19997514|P3|COMPLETED|Washout Period Between Lens Wear||9
8113504|NCT03034928|19997515|P2|COMPLETED|Washout Period Between Lens Wear||8
8113505|NCT03034928|19997516|P1|COMPLETED|Washout Period Between Lens Wear||8
8113506|NCT03034928|19997513|P4|STARTED|Washout Period Between Lens Wear||8
8113507|NCT03034928|19997514|P3|STARTED|Washout Period Between Lens Wear||9
8113508|NCT03034928|19997515|P2|STARTED|Washout Period Between Lens Wear||8
8113509|NCT03034928|19997516|P1|STARTED|Washout Period Between Lens Wear||8
8113510|NCT03034928|19997513|P4|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113511|NCT03034928|19997514|P3|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113512|NCT03034928|19997515|P2|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113513|NCT03034928|19997516|P1|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113514|NCT03034928|19997513|P4|COMPLETED|Period 1, First 2 Hours of Wear||8
8113515|NCT03034928|19997514|P3|COMPLETED|Period 1, First 2 Hours of Wear||9
8113516|NCT03034928|19997515|P2|COMPLETED|Period 1, First 2 Hours of Wear||8
8113517|NCT03034928|19997516|P1|COMPLETED|Period 1, First 2 Hours of Wear||8
8113518|NCT03034928|19997513|P4|STARTED|Period 1, First 2 Hours of Wear||8
8113519|NCT03034928|19997514|P3|STARTED|Period 1, First 2 Hours of Wear||9
8113520|NCT03034928|19997515|P2|STARTED|Period 1, First 2 Hours of Wear||8
8113521|NCT03034928|19997516|P1|STARTED|Period 1, First 2 Hours of Wear||8
8113522|NCT03034915|19997528|P3|NOT COMPLETED|Overall Study||126
8113523|NCT03034915|19997529|P2|NOT COMPLETED|Overall Study||154
8113524|NCT03034915|19997530|P1|NOT COMPLETED|Overall Study||95
8113525|NCT03034915|19997528|P3|COMPLETED|Overall Study||683
8113526|NCT03034915|19997529|P2|COMPLETED|Overall Study||650
8113527|NCT03034915|19997530|P1|COMPLETED|Overall Study||717
8113528|NCT03034915|19997528|P3|STARTED|Overall Study||809
8113529|NCT03034915|19997529|P2|STARTED|Overall Study||804
8113530|NCT03034915|19997530|P1|STARTED|Overall Study||812
8113531|NCT03034772|19997570|P2|NOT COMPLETED|Overall Study||2
8113532|NCT03034772|19997571|P1|NOT COMPLETED|Overall Study||0
8113533|NCT03034772|19997570|P2|COMPLETED|Overall Study||23
8113534|NCT03034772|19997571|P1|COMPLETED|Overall Study||27
8113535|NCT03034772|19997570|P2|STARTED|Overall Study||25
8113536|NCT03034772|19997571|P1|STARTED|Overall Study||27
8113537|NCT03034577|19997587|P2|NOT COMPLETED|Overall Study||35
8113538|NCT03034577|19997588|P1|NOT COMPLETED|Overall Study||31
8113539|NCT03034577|19997587|P2|COMPLETED|Overall Study||140
8113540|NCT03034577|19997588|P1|COMPLETED|Overall Study||144
8113541|NCT03034577|19997587|P2|STARTED|Overall Study||175
8113542|NCT03034577|19997588|P1|STARTED|Overall Study||175
8113543|NCT03034460|19997606|P2|NOT COMPLETED|Overall Study||3
8113544|NCT03034460|19997607|P1|NOT COMPLETED|Overall Study||3
8113545|NCT03034460|19997606|P2|COMPLETED|Overall Study||19
8113546|NCT03034460|19997607|P1|COMPLETED|Overall Study||45
8113547|NCT03034460|19997606|P2|STARTED|Overall Study||22
8113548|NCT03034460|19997607|P1|STARTED|Overall Study||48
8113549|NCT03034057|19997649|P1|NOT COMPLETED|Overall Study||55
8113550|NCT03034057|19997649|P1|COMPLETED|Overall Study||114
8113551|NCT03034057|19997649|P1|STARTED|Overall Study||169
8113552|NCT03034044|19997655|P1|NOT COMPLETED|Overall Study||1
8113553|NCT03034044|19997655|P1|COMPLETED|Overall Study||105
8113554|NCT03034044|19997655|P1|Received Xyntha|Overall Study||105
8113555|NCT03034044|19997655|P1|STARTED|Overall Study||106
8113556|NCT03033784|19997677|P13|NOT COMPLETED|Overall Study||2
8113557|NCT03033784|19997678|P12|NOT COMPLETED|Overall Study||0
8113558|NCT03033784|19997679|P11|NOT COMPLETED|Overall Study||0
8113559|NCT03033784|19997680|P10|NOT COMPLETED|Overall Study||0
8113560|NCT03033784|19997681|P9|NOT COMPLETED|Overall Study||0
8113561|NCT03033784|19997682|P8|NOT COMPLETED|Overall Study||0
8113562|NCT03033784|19997683|P7|NOT COMPLETED|Overall Study||0
8113563|NCT03033784|19997684|P6|NOT COMPLETED|Overall Study||0
8113564|NCT03033784|19997685|P5|NOT COMPLETED|Overall Study||0
8113565|NCT03033784|19997686|P4|NOT COMPLETED|Overall Study||0
8113566|NCT03033784|19997687|P3|NOT COMPLETED|Overall Study||0
8113567|NCT03033784|19997688|P2|NOT COMPLETED|Overall Study||1
8113568|NCT03033784|19997689|P1|NOT COMPLETED|Overall Study||0
8113569|NCT03033784|19997677|P13|COMPLETED|Overall Study||17
8113570|NCT03033784|19997678|P12|COMPLETED|Overall Study||1
8113571|NCT03033784|19997679|P11|COMPLETED|Overall Study||1
8113572|NCT03033784|19997680|P10|COMPLETED|Overall Study||1
8113573|NCT03033784|19997681|P9|COMPLETED|Overall Study||1
8113574|NCT03033784|19997682|P8|COMPLETED|Overall Study||2
8113575|NCT03033784|19997683|P7|COMPLETED|Overall Study||2
8113576|NCT03033784|19997684|P6|COMPLETED|Overall Study||2
8113577|NCT03033784|19997685|P5|COMPLETED|Overall Study||3
8113578|NCT03033784|19997686|P4|COMPLETED|Overall Study||4
8113579|NCT03033784|19997687|P3|COMPLETED|Overall Study||4
8113580|NCT03033784|19997688|P2|COMPLETED|Overall Study||1
8113581|NCT03033784|19997689|P1|COMPLETED|Overall Study||9
8113582|NCT03033784|19997677|P13|Clinical Visit 4|Overall Study||0
8113583|NCT03033784|19997678|P12|Clinical Visit 4|Overall Study||1
8113584|NCT03033784|19997679|P11|Clinical Visit 4|Overall Study||1
8113585|NCT03033784|19997680|P10|Clinical Visit 4|Overall Study||1
8113586|NCT03033784|19997681|P9|Clinical Visit 4|Overall Study||1
8113587|NCT03033784|19997682|P8|Clinical Visit 4|Overall Study||2
8113588|NCT03033784|19997683|P7|Clinical Visit 4|Overall Study||2
8113589|NCT03033784|19997684|P6|Clinical Visit 4|Overall Study||2
8113590|NCT03033784|19997685|P5|Clinical Visit 4|Overall Study||3
8113591|NCT03033784|19997686|P4|Clinical Visit 4|Overall Study||4
8113592|NCT03033784|19997687|P3|Clinical Visit 4|Overall Study||4
8113593|NCT03033784|19997688|P2|Clinical Visit 4|Overall Study||1
8113594|NCT03033784|19997689|P1|Clinical Visit 4|Overall Study||9
8113595|NCT03033784|19997677|P13|Clinical Visit 3|Overall Study||0
8113596|NCT03033784|19997678|P12|Clinical Visit 3|Overall Study||1
8113597|NCT03033784|19997679|P11|Clinical Visit 3|Overall Study||1
8113598|NCT03033784|19997680|P10|Clinical Visit 3|Overall Study||1
8113599|NCT03033784|19997681|P9|Clinical Visit 3|Overall Study||1
8113600|NCT03033784|19997682|P8|Clinical Visit 3|Overall Study||2
8113601|NCT03033784|19997683|P7|Clinical Visit 3|Overall Study||2
8113602|NCT03033784|19997684|P6|Clinical Visit 3|Overall Study||2
8113603|NCT03033784|19997685|P5|Clinical Visit 3|Overall Study||3
8113604|NCT03033784|19997686|P4|Clinical Visit 3|Overall Study||4
8113605|NCT03033784|19997687|P3|Clinical Visit 3|Overall Study||4
8113606|NCT03033784|19997688|P2|Clinical Visit 3|Overall Study||1
8113607|NCT03033784|19997689|P1|Clinical Visit 3|Overall Study||9
8113608|NCT03033784|19997677|P13|Clinical Visit 2|Overall Study||17
8113609|NCT03033784|19997678|P12|Clinical Visit 2|Overall Study||1
8113610|NCT03033784|19997679|P11|Clinical Visit 2|Overall Study||1
8113611|NCT03033784|19997680|P10|Clinical Visit 2|Overall Study||1
8113612|NCT03033784|19997681|P9|Clinical Visit 2|Overall Study||1
8113613|NCT03033784|19997682|P8|Clinical Visit 2|Overall Study||2
8113614|NCT03033784|19997683|P7|Clinical Visit 2|Overall Study||2
8113615|NCT03033784|19997684|P6|Clinical Visit 2|Overall Study||2
8113616|NCT03033784|19997685|P5|Clinical Visit 2|Overall Study||3
8113617|NCT03033784|19997686|P4|Clinical Visit 2|Overall Study||4
8113618|NCT03033784|19997687|P3|Clinical Visit 2|Overall Study||4
8113619|NCT03033784|19997688|P2|Clinical Visit 2|Overall Study||2
8113620|NCT03033784|19997689|P1|Clinical Visit 2|Overall Study||9
8113621|NCT03033784|19997677|P13|STARTED|Overall Study||19
8113622|NCT03033784|19997678|P12|STARTED|Overall Study||1
8113623|NCT03033784|19997679|P11|STARTED|Overall Study||1
8113624|NCT03033784|19997680|P10|STARTED|Overall Study||1
8113625|NCT03033784|19997681|P9|STARTED|Overall Study||1
8113626|NCT03033784|19997682|P8|STARTED|Overall Study||2
8113627|NCT03033784|19997683|P7|STARTED|Overall Study||2
8113628|NCT03033784|19997684|P6|STARTED|Overall Study||2
8113629|NCT03033784|19997685|P5|STARTED|Overall Study||3
8113630|NCT03033784|19997686|P4|STARTED|Overall Study||4
8113631|NCT03033784|19997687|P3|STARTED|Overall Study||4
8113632|NCT03033784|19997688|P2|STARTED|Overall Study||2
8113633|NCT03033784|19997689|P1|STARTED|Overall Study||9
8113634|NCT03033745|19997730|P3|NOT COMPLETED|Overall Study||2
8113635|NCT03033745|19997731|P2|NOT COMPLETED|Overall Study||1
8113636|NCT03033745|19997732|P1|NOT COMPLETED|Overall Study||1
8113637|NCT03033745|19997730|P3|COMPLETED|Overall Study||14
8113638|NCT03033745|19997731|P2|COMPLETED|Overall Study||17
8113639|NCT03033745|19997732|P1|COMPLETED|Overall Study||14
8113640|NCT03033745|19997730|P3|STARTED|Overall Study||16
8113641|NCT03033745|19997731|P2|STARTED|Overall Study||18
8113642|NCT03033745|19997732|P1|STARTED|Overall Study||15
8113643|NCT03033511|19997767|P2|NOT COMPLETED|Overall Study||0
8113644|NCT03033511|19997768|P1|NOT COMPLETED|Overall Study||0
8113645|NCT03033511|19997767|P2|COMPLETED|Overall Study||372
8113646|NCT03033511|19997768|P1|COMPLETED|Overall Study||376
8113647|NCT03033511|19997767|P2|STARTED|Overall Study||372
8113648|NCT03033511|19997768|P1|STARTED|Overall Study||376
8113649|NCT03033134|19997780|P2|NOT COMPLETED|Overall Study||12
8113650|NCT03033134|19997781|P1|NOT COMPLETED|Overall Study||42
8113651|NCT03033134|19997780|P2|COMPLETED|Overall Study||0
8113652|NCT03033134|19997781|P1|COMPLETED|Overall Study||0
8113653|NCT03033134|19997780|P2|6-month Primary Endpoints|Overall Study||12
8113654|NCT03033134|19997781|P1|6-month Primary Endpoints|Overall Study||42
8113655|NCT03033134|19997780|P2|STARTED|Overall Study||12
8113656|NCT03033134|19997781|P1|STARTED|Overall Study||42
8113657|NCT03032965|19997803|P2|NOT COMPLETED|Overall Study||0
8113658|NCT03032965|19997804|P1|NOT COMPLETED|Overall Study||0
8113659|NCT03032965|19997803|P2|COMPLETED|Overall Study||68
8113660|NCT03032965|19997804|P1|COMPLETED|Overall Study||61
8113661|NCT03032965|19997803|P2|STARTED|Overall Study||68
8113662|NCT03032965|19997804|P1|STARTED|Overall Study||61
8113663|NCT03032523|19997828|P2|NOT COMPLETED|Overall Study||2
8113664|NCT03032523|19997829|P1|NOT COMPLETED|Overall Study||3
8113665|NCT03032523|19997828|P2|COMPLETED|Overall Study||4
8113666|NCT03032523|19997829|P1|COMPLETED|Overall Study||12
8113667|NCT03032523|19997828|P2|STARTED|Overall Study||6
8113668|NCT03032523|19997829|P1|STARTED|Overall Study||15
8113669|NCT03032510|19997841|P2|NOT COMPLETED|Overall Study||18
8113670|NCT03032510|19997842|P1|NOT COMPLETED|Overall Study||27
8113671|NCT03032510|19997841|P2|COMPLETED|Overall Study||584
8113672|NCT03032510|19997842|P1|COMPLETED|Overall Study||576
8113673|NCT03032510|19997841|P2|STARTED|Overall Study||602
8113674|NCT03032510|19997842|P1|STARTED|Overall Study||603
8113675|NCT03032393|19997854|P2|NOT COMPLETED|Overall Study||0
8113676|NCT03032393|19997855|P1|NOT COMPLETED|Overall Study||0
8113677|NCT03032393|19997854|P2|COMPLETED|Overall Study||15
8113678|NCT03032393|19997855|P1|COMPLETED|Overall Study||15
8113679|NCT03032393|19997854|P2|STARTED|Overall Study||15
8113680|NCT03032393|19997855|P1|STARTED|Overall Study||15
8113681|NCT03032380|19997863|P2|NOT COMPLETED|Overall Study||40
8113682|NCT03032380|19997864|P1|NOT COMPLETED|Overall Study||42
8113683|NCT03032380|19997863|P2|COMPLETED|Overall Study||112
8113684|NCT03032380|19997864|P1|COMPLETED|Overall Study||106
8113685|NCT03032380|19997863|P2|Received Treatment|Overall Study||150
8113686|NCT03032380|19997864|P1|Received Treatment|Overall Study||148
8113687|NCT03032380|19997863|P2|STARTED|Overall Study||152
8113688|NCT03032380|19997864|P1|STARTED|Overall Study||148
8113689|NCT03032263|19997896|P2|NOT COMPLETED|Overall Study||0
8113690|NCT03032263|19997897|P1|NOT COMPLETED|Overall Study||0
8113691|NCT03032263|19997896|P2|COMPLETED|Overall Study||6
8113692|NCT03032263|19997897|P1|COMPLETED|Overall Study||6
8113693|NCT03032263|19997896|P2|STARTED|Overall Study||6
8113694|NCT03032263|19997897|P1|STARTED|Overall Study||6
8113695|NCT03031899|19997911|P1|NOT COMPLETED|Overall Study||2
8113696|NCT03031899|19997911|P1|COMPLETED|Overall Study||25
8113697|NCT03031899|19997911|P1|STARTED|Overall Study||27
8113698|NCT03031795|19997921|P2|NOT COMPLETED|Overall Study||1
8113699|NCT03031795|19997922|P1|NOT COMPLETED|Overall Study||0
8113700|NCT03031795|19997921|P2|COMPLETED|Overall Study||35
8113701|NCT03031795|19997922|P1|COMPLETED|Overall Study||35
8113702|NCT03031795|19997921|P2|STARTED|Overall Study||36
8113703|NCT03031795|19997922|P1|STARTED|Overall Study||35
8113704|NCT03031678|19997928|P1|NOT COMPLETED|Overall Study||1
8113705|NCT03031678|19997928|P1|COMPLETED|Overall Study||49
8113706|NCT03031678|19997928|P1|CI Alone Test Condition Complete|Overall Study||10
8113707|NCT03031678|19997928|P1|EAS Test Condition Complete|Overall Study||39
8113708|NCT03031678|19997928|P1|STARTED|Overall Study||50
8113709|NCT03031496|19997937|P2|NOT COMPLETED|Period 2||0
8113710|NCT03031496|19997938|P1|NOT COMPLETED|Period 2||0
8113711|NCT03031496|19997937|P2|COMPLETED|Period 2||19
8113712|NCT03031496|19997938|P1|COMPLETED|Period 2||19
8113713|NCT03031496|19997937|P2|STARTED|Period 2||19
8113714|NCT03031496|19997938|P1|STARTED|Period 2||19
8113715|NCT03031496|19997937|P2|NOT COMPLETED|Period 1||2
8113716|NCT03031496|19997938|P1|NOT COMPLETED|Period 1||2
8113717|NCT03031496|19997937|P2|COMPLETED|Period 1||19
8113718|NCT03031496|19997938|P1|COMPLETED|Period 1||19
8113719|NCT03031496|19997937|P2|STARTED|Period 1||21
8113720|NCT03031496|19997938|P1|STARTED|Period 1||21
8113721|NCT03031431|19997974|P1|NOT COMPLETED|Overall Study||1
8113722|NCT03031431|19997974|P1|COMPLETED|Overall Study||129
8113723|NCT03031431|19997974|P1|STARTED|Overall Study||130
8113724|NCT03031340|19997983|P2|NOT COMPLETED|Overall Study||1
8113725|NCT03031340|19997984|P1|NOT COMPLETED|Overall Study||2
8113726|NCT03031340|19997983|P2|COMPLETED|Overall Study||0
8113727|NCT03031340|19997984|P1|COMPLETED|Overall Study||0
8113728|NCT03031340|19997983|P2|STARTED|Overall Study||1
8113729|NCT03031340|19997984|P1|STARTED|Overall Study||2
8113730|NCT03030989|19998002|P2|NOT COMPLETED|Overall Study||14
8113731|NCT03030989|19998003|P1|NOT COMPLETED|Overall Study||12
8113732|NCT03030989|19998002|P2|COMPLETED|Overall Study||15
8113733|NCT03030989|19998003|P1|COMPLETED|Overall Study||9
8113734|NCT03030989|19998002|P2|STARTED|Overall Study||29
8113735|NCT03030989|19998003|P1|STARTED|Overall Study||21
8113736|NCT03030638|19998019|P8|NOT COMPLETED|Overall Study||0
8113737|NCT03030638|19998020|P7|NOT COMPLETED|Overall Study||0
8113738|NCT03030638|19998021|P6|NOT COMPLETED|Overall Study||0
8113739|NCT03030638|19998022|P5|NOT COMPLETED|Overall Study||0
8113740|NCT03030638|19998023|P4|NOT COMPLETED|Overall Study||0
8113741|NCT03030638|19998024|P3|NOT COMPLETED|Overall Study||0
8113742|NCT03030638|19998025|P2|NOT COMPLETED|Overall Study||0
8113743|NCT03030638|19998026|P1|NOT COMPLETED|Overall Study||0
8113744|NCT03030638|19998019|P8|COMPLETED|Overall Study||127
8113745|NCT03030638|19998020|P7|COMPLETED|Overall Study||364
8113746|NCT03030638|19998021|P6|COMPLETED|Overall Study||1592
8113747|NCT03030638|19998022|P5|COMPLETED|Overall Study||696
8113748|NCT03030638|19998023|P4|COMPLETED|Overall Study||6406
8113749|NCT03030638|19998024|P3|COMPLETED|Overall Study||1712
8113750|NCT03030638|19998025|P2|COMPLETED|Overall Study||1841
8113751|NCT03030638|19998026|P1|COMPLETED|Overall Study||1386
8113752|NCT03030638|19998019|P8|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113753|NCT03030638|19998020|P7|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113754|NCT03030638|19998021|P6|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113755|NCT03030638|19998022|P5|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113756|NCT03030638|19998023|P4|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113757|NCT03030638|19998024|P3|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113758|NCT03030638|19998025|P2|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
8113759|NCT03030638|19998026|P1|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
8113760|NCT03030638|19998019|P8|STARTED|Overall Study||127
8113761|NCT03030638|19998020|P7|STARTED|Overall Study||364
8113762|NCT03030638|19998021|P6|STARTED|Overall Study||1592
8113763|NCT03030638|19998022|P5|STARTED|Overall Study||696
8113764|NCT03030638|19998023|P4|STARTED|Overall Study||6406
8113765|NCT03030638|19998024|P3|STARTED|Overall Study||1712
8113766|NCT03030638|19998025|P2|STARTED|Overall Study||1841
8113767|NCT03030638|19998026|P1|STARTED|Overall Study||1386
8113768|NCT03030599|19998056|P3|NOT COMPLETED|Open-label Extension||0
8113769|NCT03030599|19998057|P2|NOT COMPLETED|Open-label Extension||0
8113770|NCT03030599|19998058|P1|NOT COMPLETED|Open-label Extension||7
8113771|NCT03030599|19998056|P3|COMPLETED|Open-label Extension||0
8113772|NCT03030599|19998057|P2|COMPLETED|Open-label Extension||0
8113773|NCT03030599|19998058|P1|COMPLETED|Open-label Extension||67
8113774|NCT03030599|19998056|P3|STARTED|Open-label Extension||0
8113775|NCT03030599|19998057|P2|STARTED|Open-label Extension||0
8113776|NCT03030599|19998058|P1|STARTED|Open-label Extension||74
8113777|NCT03030599|19998056|P3|NOT COMPLETED|Double Blind Randomized Withdrawal||8
8113778|NCT03030599|19998057|P2|NOT COMPLETED|Double Blind Randomized Withdrawal||0
8113779|NCT03030599|19998058|P1|NOT COMPLETED|Double Blind Randomized Withdrawal||0
8113780|NCT03030599|19998056|P3|COMPLETED|Double Blind Randomized Withdrawal||59
8113781|NCT03030599|19998057|P2|COMPLETED|Double Blind Randomized Withdrawal||69
8113782|NCT03030599|19998058|P1|COMPLETED|Double Blind Randomized Withdrawal||0
8113783|NCT03030599|19998056|P3|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
8113784|NCT03030599|19998057|P2|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
8113785|NCT03030599|19998058|P1|STARTED|Double Blind Randomized Withdrawal||0
8113786|NCT03030599|19998056|P3|NOT COMPLETED|Stable Dose||0
8113787|NCT03030599|19998057|P2|NOT COMPLETED|Stable Dose||0
8113788|NCT03030599|19998058|P1|NOT COMPLETED|Stable Dose||5
8113789|NCT03030599|19998056|P3|COMPLETED|Stable Dose||0
8113790|NCT03030599|19998057|P2|COMPLETED|Stable Dose||0
8113791|NCT03030599|19998058|P1|COMPLETED|Stable Dose||144
8113792|NCT03030599|19998056|P3|STARTED|Stable Dose||0
8113793|NCT03030599|19998057|P2|STARTED|Stable Dose||0
8113794|NCT03030599|19998058|P1|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
8113795|NCT03030599|19998056|P3|NOT COMPLETED|Open Label Treatment and Titration||0
8113796|NCT03030599|19998057|P2|NOT COMPLETED|Open Label Treatment and Titration||0
8113797|NCT03030599|19998058|P1|NOT COMPLETED|Open Label Treatment and Titration||46
8113798|NCT03030599|19998056|P3|COMPLETED|Open Label Treatment and Titration||0
8113799|NCT03030599|19998057|P2|COMPLETED|Open Label Treatment and Titration||0
8113800|NCT03030599|19998058|P1|COMPLETED|Open Label Treatment and Titration||155
8113801|NCT03030599|19998056|P3|STARTED|Open Label Treatment and Titration||0
8113802|NCT03030599|19998057|P2|STARTED|Open Label Treatment and Titration||0
8113803|NCT03030599|19998058|P1|STARTED|Open Label Treatment and Titration||201
8113804|NCT03030183|19998074|P1|NOT COMPLETED|Overall Study||0
8113805|NCT03030183|19998074|P1|COMPLETED|Overall Study||3
8113806|NCT03030183|19998074|P1|STARTED|Overall Study||3
8113807|NCT03029988|19998084|P1|NOT COMPLETED|Overall Study||0
8113808|NCT03029988|19998084|P1|COMPLETED|Overall Study||3
8113809|NCT03029988|19998084|P1|STARTED|Overall Study||3
8113810|NCT03029832|19998091|P2|NOT COMPLETED|Overall Study||1
8113811|NCT03029832|19998092|P1|NOT COMPLETED|Overall Study||4
8113812|NCT03029832|19998091|P2|COMPLETED|Overall Study||0
8113813|NCT03029832|19998092|P1|COMPLETED|Overall Study||0
8113814|NCT03029832|19998091|P2|STARTED|Overall Study||1
8113815|NCT03029832|19998092|P1|STARTED|Overall Study||4
8113816|NCT03029819|19998122|P2|NOT COMPLETED|Overall Study||6
8113817|NCT03029819|19998123|P1|NOT COMPLETED|Overall Study||3
8113818|NCT03029819|19998122|P2|COMPLETED|Overall Study||33
8113819|NCT03029819|19998123|P1|COMPLETED|Overall Study||30
8113820|NCT03029819|19998122|P2|STARTED|Overall Study||39
8113821|NCT03029819|19998123|P1|STARTED|Overall Study||33
8113822|NCT03029780|19998137|P2|NOT COMPLETED|Overall Study||11
8113823|NCT03029780|19998138|P1|NOT COMPLETED|Overall Study||6
8113824|NCT03029780|19998137|P2|COMPLETED|Overall Study||41
8113825|NCT03029780|19998138|P1|COMPLETED|Overall Study||46
8113826|NCT03029780|19998137|P2|STARTED|Overall Study||52
8113827|NCT03029780|19998138|P1|STARTED|Overall Study||52
8113828|NCT03029715|19998152|P2|NOT COMPLETED|Overall Study||0
8113829|NCT03029715|19998153|P1|NOT COMPLETED|Overall Study||0
8113830|NCT03029715|19998152|P2|COMPLETED|Overall Study||50
8113831|NCT03029715|19998153|P1|COMPLETED|Overall Study||50
8113832|NCT03029715|19998152|P2|STARTED|Overall Study||50
8113833|NCT03029715|19998153|P1|STARTED|Overall Study||50
8113834|NCT03029650|19998161|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
8113835|NCT03029650|19998162|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
8113836|NCT03029650|19998161|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
8113837|NCT03029650|19998162|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
8113838|NCT03029650|19998161|P2|STARTED|2nd Intervention (3 - 6 Days)||10
8113839|NCT03029650|19998162|P1|STARTED|2nd Intervention (3 - 6 Days)||13
8113840|NCT03029650|19998161|P2|NOT COMPLETED|Washout (1 Week)||2
8113841|NCT03029650|19998162|P1|NOT COMPLETED|Washout (1 Week)||1
8113842|NCT03029650|19998161|P2|COMPLETED|Washout (1 Week)||10
8113843|NCT03029650|19998162|P1|COMPLETED|Washout (1 Week)||13
8113844|NCT03029650|19998161|P2|STARTED|Washout (1 Week)||12
8113845|NCT03029650|19998162|P1|STARTED|Washout (1 Week)||14
8113846|NCT03029650|19998161|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
8113847|NCT03029650|19998162|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
8113848|NCT03029650|19998161|P2|COMPLETED|First Intervention (3 - 6 Days)||12
8113849|NCT03029650|19998162|P1|COMPLETED|First Intervention (3 - 6 Days)||14
8113850|NCT03029650|19998161|P2|STARTED|First Intervention (3 - 6 Days)||12
8113851|NCT03029650|19998162|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
8113852|NCT03029624|19998177|P1|NOT COMPLETED|Overall Study||5
8113853|NCT03029624|19998177|P1|COMPLETED|Overall Study||41
8113854|NCT03029624|19998177|P1|Primary Endpoint (3 Months)|Overall Study||44
8113855|NCT03029624|19998177|P1|STARTED|Overall Study||46
8113856|NCT03029234|19998184|P1|NOT COMPLETED|Overall Study||67
8113857|NCT03029234|19998184|P1|COMPLETED|Overall Study||59
8113858|NCT03029234|19998184|P1|Received Carfilzomib|Overall Study||123
8113859|NCT03029234|19998184|P1|STARTED|Overall Study||126
8113860|NCT03029091|19998211|P2|NOT COMPLETED|Overall Study||0
8113861|NCT03029091|19998212|P1|NOT COMPLETED|Overall Study||0
8113862|NCT03029091|19998211|P2|COMPLETED|Overall Study||7
8113863|NCT03029091|19998212|P1|COMPLETED|Overall Study||8
8113864|NCT03029091|19998211|P2|STARTED|Overall Study||7
8113865|NCT03029091|19998212|P1|STARTED|Overall Study||8
8113866|NCT03029000|19998238|P1|NOT COMPLETED|Overall Study||0
8113867|NCT03029000|19998238|P1|COMPLETED|Overall Study||1
8113868|NCT03029000|19998238|P1|STARTED|Overall Study||1
8113869|NCT03028987|19998251|P2|NOT COMPLETED|Overall Study||0
8113870|NCT03028987|19998252|P1|NOT COMPLETED|Overall Study||0
8113871|NCT03028987|19998251|P2|COMPLETED|Overall Study||5
8113872|NCT03028987|19998252|P1|COMPLETED|Overall Study||5
8113873|NCT03028987|19998251|P2|STARTED|Overall Study||5
8113874|NCT03028987|19998252|P1|STARTED|Overall Study||5
8113875|NCT03028974|19998265|P7|NOT COMPLETED|2017-2018||0
8113876|NCT03028974|19998266|P6|NOT COMPLETED|2017-2018||0
8113877|NCT03028974|19998267|P5|NOT COMPLETED|2017-2018||0
8113878|NCT03028974|19998268|P4|NOT COMPLETED|2017-2018||0
8113879|NCT03028974|19998269|P3|NOT COMPLETED|2017-2018||0
8113880|NCT03028974|19998270|P2|NOT COMPLETED|2017-2018||0
8113881|NCT03028974|19998271|P1|NOT COMPLETED|2017-2018||0
8113882|NCT03028974|19998265|P7|COMPLETED|2017-2018||5
8113883|NCT03028974|19998266|P6|COMPLETED|2017-2018||0
8113884|NCT03028974|19998267|P5|COMPLETED|2017-2018||0
8113885|NCT03028974|19998268|P4|COMPLETED|2017-2018||5
8113886|NCT03028974|19998269|P3|COMPLETED|2017-2018||0
8113887|NCT03028974|19998270|P2|COMPLETED|2017-2018||0
8113888|NCT03028974|19998271|P1|COMPLETED|2017-2018||0
8113889|NCT03028974|19998265|P7|STARTED|2017-2018|5 new participants were enrolled.|5
8113890|NCT03028974|19998266|P6|STARTED|2017-2018||0
8113891|NCT03028974|19998267|P5|STARTED|2017-2018||0
8113892|NCT03028974|19998268|P4|STARTED|2017-2018||5
8113893|NCT03028974|19998269|P3|STARTED|2017-2018||0
8113894|NCT03028974|19998270|P2|STARTED|2017-2018||0
8113895|NCT03028974|19998271|P1|STARTED|2017-2018||0
8113896|NCT03028974|19998265|P7|NOT COMPLETED|2016-2017||0
8113897|NCT03028974|19998266|P6|NOT COMPLETED|2016-2017||0
8113898|NCT03028974|19998267|P5|NOT COMPLETED|2016-2017||0
8113899|NCT03028974|19998268|P4|NOT COMPLETED|2016-2017||0
8113900|NCT03028974|19998269|P3|NOT COMPLETED|2016-2017||0
8113901|NCT03028974|19998270|P2|NOT COMPLETED|2016-2017||0
8113902|NCT03028974|19998271|P1|NOT COMPLETED|2016-2017||0
8113903|NCT03028974|19998265|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
8113904|NCT03028974|19998266|P6|COMPLETED|2016-2017||0
8113905|NCT03028974|19998267|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
8113906|NCT03028974|19998268|P4|COMPLETED|2016-2017||4
8113907|NCT03028974|19998269|P3|COMPLETED|2016-2017||0
8113908|NCT03028974|19998270|P2|COMPLETED|2016-2017||0
8113909|NCT03028974|19998271|P1|COMPLETED|2016-2017||0
8113910|NCT03028974|19998265|P7|STARTED|2016-2017|18 new participants were enrolled.|18
8113911|NCT03028974|19998266|P6|STARTED|2016-2017||0
8113912|NCT03028974|19998267|P5|STARTED|2016-2017|2 new participants were enrolled.|2
8113913|NCT03028974|19998268|P4|STARTED|2016-2017|1 new participant was enrolled.|4
8113914|NCT03028974|19998269|P3|STARTED|2016-2017||0
8113915|NCT03028974|19998270|P2|STARTED|2016-2017||0
8113916|NCT03028974|19998271|P1|STARTED|2016-2017||0
8113917|NCT03028974|19998265|P7|NOT COMPLETED|2015-2016||0
8113918|NCT03028974|19998266|P6|NOT COMPLETED|2015-2016||0
8113919|NCT03028974|19998267|P5|NOT COMPLETED|2015-2016||0
8113920|NCT03028974|19998268|P4|NOT COMPLETED|2015-2016||0
8113921|NCT03028974|19998269|P3|NOT COMPLETED|2015-2016||0
8113922|NCT03028974|19998270|P2|NOT COMPLETED|2015-2016||0
8113923|NCT03028974|19998271|P1|NOT COMPLETED|2015-2016||0
8113924|NCT03028974|19998265|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
8113925|NCT03028974|19998266|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
8113926|NCT03028974|19998267|P5|COMPLETED|2015-2016||0
8113927|NCT03028974|19998268|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
8113928|NCT03028974|19998269|P3|COMPLETED|2015-2016||0
8113929|NCT03028974|19998270|P2|COMPLETED|2015-2016||0
8113930|NCT03028974|19998271|P1|COMPLETED|2015-2016||0
8113931|NCT03028974|19998265|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
8113932|NCT03028974|19998266|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
8113933|NCT03028974|19998267|P5|STARTED|2015-2016||0
8113934|NCT03028974|19998268|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
8113935|NCT03028974|19998269|P3|STARTED|2015-2016||0
8113936|NCT03028974|19998270|P2|STARTED|2015-2016||0
8113937|NCT03028974|19998271|P1|STARTED|2015-2016||0
8113938|NCT03028974|19998265|P7|NOT COMPLETED|2014-2015||0
8113939|NCT03028974|19998266|P6|NOT COMPLETED|2014-2015||0
8113940|NCT03028974|19998267|P5|NOT COMPLETED|2014-2015||0
8113941|NCT03028974|19998268|P4|NOT COMPLETED|2014-2015||0
8113942|NCT03028974|19998269|P3|NOT COMPLETED|2014-2015||0
8113943|NCT03028974|19998270|P2|NOT COMPLETED|2014-2015||0
8113944|NCT03028974|19998271|P1|NOT COMPLETED|2014-2015||0
8113945|NCT03028974|19998265|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
8113946|NCT03028974|19998266|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
8113947|NCT03028974|19998267|P5|COMPLETED|2014-2015||0
8113948|NCT03028974|19998268|P4|COMPLETED|2014-2015||3
8113949|NCT03028974|19998269|P3|COMPLETED|2014-2015||0
8113950|NCT03028974|19998270|P2|COMPLETED|2014-2015||0
8113951|NCT03028974|19998271|P1|COMPLETED|2014-2015||1
8113952|NCT03028974|19998265|P7|STARTED|2014-2015||13
8113953|NCT03028974|19998266|P6|STARTED|2014-2015||11
8113954|NCT03028974|19998267|P5|STARTED|2014-2015||0
8113955|NCT03028974|19998268|P4|STARTED|2014-2015||3
8113956|NCT03028974|19998269|P3|STARTED|2014-2015||0
8113957|NCT03028974|19998270|P2|STARTED|2014-2015||0
8113958|NCT03028974|19998271|P1|STARTED|2014-2015||1
8113965|NCT03028870|19998307|P4|NOT COMPLETED|Overall Study||9
8113966|NCT03028870|19998308|P3|NOT COMPLETED|Overall Study||16
8113967|NCT03028870|19998309|P2|NOT COMPLETED|Overall Study||10
8113968|NCT03028870|19998310|P1|NOT COMPLETED|Overall Study||17
8113969|NCT03028870|19998307|P4|COMPLETED|Overall Study||65
8113970|NCT03028870|19998308|P3|COMPLETED|Overall Study||60
8113971|NCT03028870|19998309|P2|COMPLETED|Overall Study||57
8113972|NCT03028870|19998310|P1|COMPLETED|Overall Study||57
8113973|NCT03028870|19998307|P4|STARTED|Overall Study||74
8113974|NCT03028870|19998308|P3|STARTED|Overall Study||76
8113975|NCT03028870|19998309|P2|STARTED|Overall Study||67
8113976|NCT03028870|19998310|P1|STARTED|Overall Study||74
8113977|NCT03028636|19998388|P1|NOT COMPLETED|Overall Study||6
8113978|NCT03028636|19998388|P1|COMPLETED|Overall Study||11
8113979|NCT03028636|19998388|P1|STARTED|Overall Study||17
8113980|NCT03028467|19998401|P4|NOT COMPLETED|Overall Study||0
8113981|NCT03028467|19998402|P3|NOT COMPLETED|Overall Study||0
8113982|NCT03028467|19998403|P2|NOT COMPLETED|Overall Study||0
8113983|NCT03028467|19998404|P1|NOT COMPLETED|Overall Study||0
8113984|NCT03028467|19998401|P4|COMPLETED|Overall Study||4
8113985|NCT03028467|19998402|P3|COMPLETED|Overall Study||4
8113986|NCT03028467|19998403|P2|COMPLETED|Overall Study||3
8113987|NCT03028467|19998404|P1|COMPLETED|Overall Study||4
8113988|NCT03028467|19998401|P4|STARTED|Overall Study||4
8113989|NCT03028467|19998402|P3|STARTED|Overall Study||4
8113990|NCT03028467|19998403|P2|STARTED|Overall Study||3
8113991|NCT03028467|19998404|P1|STARTED|Overall Study||4
8113992|NCT03028363|19998468|P2|NOT COMPLETED|Overall Study||33
8113993|NCT03028363|19998469|P1|NOT COMPLETED|Overall Study||78
8113994|NCT03028363|19998468|P2|COMPLETED|Overall Study||228
8113995|NCT03028363|19998469|P1|COMPLETED|Overall Study||420
8113996|NCT03028363|19998468|P2|STARTED|Overall Study||261
8113997|NCT03028363|19998469|P1|STARTED|Overall Study||498
8113998|NCT03028324|19998479|P1|NOT COMPLETED|Overall Study||0
8113999|NCT03028324|19998479|P1|COMPLETED|Overall Study||4
8114000|NCT03028324|19998479|P1|STARTED|Overall Study||4
8114001|NCT03028220|19998486|P2|NOT COMPLETED|Overall Study||0
8114002|NCT03028220|19998487|P1|NOT COMPLETED|Overall Study||0
8114003|NCT03028220|19998486|P2|COMPLETED|Overall Study||20
8114004|NCT03028220|19998487|P1|COMPLETED|Overall Study||20
8114005|NCT03028220|19998486|P2|STARTED|Overall Study||20
8114006|NCT03028220|19998487|P1|STARTED|Overall Study||20
8114007|NCT03028142|19998515|P6|NOT COMPLETED|Overall Study||1
8114008|NCT03028142|19998516|P5|NOT COMPLETED|Overall Study||1
8114009|NCT03028142|19998517|P4|NOT COMPLETED|Overall Study||0
8114010|NCT03028142|19998518|P3|NOT COMPLETED|Overall Study||0
8114011|NCT03028142|19998519|P2|NOT COMPLETED|Overall Study||1
8114012|NCT03028142|19998520|P1|NOT COMPLETED|Overall Study||1
8114013|NCT03028142|19998515|P6|COMPLETED|Overall Study||3
8114014|NCT03028142|19998516|P5|COMPLETED|Overall Study||5
8114015|NCT03028142|19998517|P4|COMPLETED|Overall Study||4
8114016|NCT03028142|19998518|P3|COMPLETED|Overall Study||6
8114017|NCT03028142|19998519|P2|COMPLETED|Overall Study||4
8114018|NCT03028142|19998520|P1|COMPLETED|Overall Study||4
8114019|NCT03028142|19998515|P6|STARTED|Overall Study||4
8114020|NCT03028142|19998516|P5|STARTED|Overall Study||6
8114021|NCT03028142|19998517|P4|STARTED|Overall Study||4
8114022|NCT03028142|19998518|P3|STARTED|Overall Study||6
8114023|NCT03028142|19998519|P2|STARTED|Overall Study||5
8114024|NCT03028142|19998520|P1|STARTED|Overall Study||5
8114025|NCT03028129|19998539|P2|NOT COMPLETED|Overall Study||87
8114026|NCT03028129|19998540|P1|NOT COMPLETED|Overall Study||126
8114027|NCT03028129|19998539|P2|COMPLETED|Overall Study||122
8114028|NCT03028129|19998540|P1|COMPLETED|Overall Study||132
8114029|NCT03028129|19998539|P2|STARTED|Overall Study||209
8114030|NCT03028129|19998540|P1|STARTED|Overall Study||258
8114031|NCT03028025|19998548|P2|NOT COMPLETED|Overall Study||1
8114032|NCT03028025|19998549|P1|NOT COMPLETED|Overall Study||3
8114033|NCT03028025|19998548|P2|COMPLETED|Overall Study||93
8114034|NCT03028025|19998549|P1|COMPLETED|Overall Study||87
8114035|NCT03028025|19998548|P2|STARTED|Overall Study||94
8114036|NCT03028025|19998549|P1|STARTED|Overall Study||90
8114037|NCT03028012|19998560|P3|NOT COMPLETED|Overall Study||3
8114038|NCT03028012|19998561|P2|NOT COMPLETED|Overall Study||3
8114039|NCT03028012|19998562|P1|NOT COMPLETED|Overall Study||2
8114040|NCT03028012|19998560|P3|COMPLETED|Overall Study||0
8114041|NCT03028012|19998561|P2|COMPLETED|Overall Study||0
8114042|NCT03028012|19998562|P1|COMPLETED|Overall Study||2
8114043|NCT03028012|19998560|P3|STARTED|Overall Study||3
8114044|NCT03028012|19998561|P2|STARTED|Overall Study||3
8114045|NCT03028012|19998562|P1|STARTED|Overall Study||4
8114046|NCT03027661|19998578|P2|NOT COMPLETED|Overall Study||0
8114047|NCT03027661|19998579|P1|NOT COMPLETED|Overall Study||0
8114048|NCT03027661|19998578|P2|COMPLETED|Overall Study||21
8114049|NCT03027661|19998579|P1|COMPLETED|Overall Study||20
8114050|NCT03027661|19998578|P2|STARTED|Overall Study||21
8114051|NCT03027661|19998579|P1|STARTED|Overall Study||20
8114052|NCT03026803|19998587|P1|NOT COMPLETED|Overall Study||0
8114053|NCT03026803|19998587|P1|COMPLETED|Overall Study||4
8114054|NCT03026803|19998587|P1|STARTED|Overall Study||4
8114055|NCT03026777|19998593|P2|NOT COMPLETED|Overall Study||0
8114056|NCT03026777|19998594|P1|NOT COMPLETED|Overall Study||0
8114057|NCT03026777|19998593|P2|COMPLETED|Overall Study||169
8114058|NCT03026777|19998594|P1|COMPLETED|Overall Study||168
8114059|NCT03026777|19998593|P2|STARTED|Overall Study||169
8114060|NCT03026777|19998594|P1|STARTED|Overall Study||168
8114061|NCT03026556|19998615|P3|NOT COMPLETED|Overall Study||0
8114062|NCT03026556|19998616|P2|NOT COMPLETED|Overall Study||0
8114063|NCT03026556|19998617|P1|NOT COMPLETED|Overall Study||0
8114064|NCT03026556|19998615|P3|COMPLETED|Overall Study||12594
8114065|NCT03026556|19998616|P2|COMPLETED|Overall Study||17177
8114066|NCT03026556|19998617|P1|COMPLETED|Overall Study||12763
8114067|NCT03026556|19998615|P3|STARTED|Overall Study||12594
8114068|NCT03026556|19998616|P2|STARTED|Overall Study||17177
8114069|NCT03026556|19998617|P1|STARTED|Overall Study||12763
8114070|NCT03026530|19998676|P2|NOT COMPLETED|Overall Study||29
8114071|NCT03026530|19998677|P1|NOT COMPLETED|Overall Study||21
8114072|NCT03026530|19998676|P2|COMPLETED|Overall Study||71
8114073|NCT03026530|19998677|P1|COMPLETED|Overall Study||79
8114074|NCT03026530|19998676|P2|STARTED|Overall Study||100
8114075|NCT03026530|19998677|P1|STARTED|Overall Study||100
8114076|NCT03026283|19998685|P8|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114077|NCT03026283|19998686|P7|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114078|NCT03026283|19998687|P6|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114079|NCT03026283|19998688|P5|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114080|NCT03026283|19998689|P4|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114081|NCT03026283|19998690|P3|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114082|NCT03026283|19998691|P2|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114083|NCT03026283|19998692|P1|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114084|NCT03026283|19998685|P8|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114085|NCT03026283|19998686|P7|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
8114086|NCT03026283|19998687|P6|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114087|NCT03026283|19998688|P5|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114088|NCT03026283|19998689|P4|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114089|NCT03026283|19998690|P3|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114090|NCT03026283|19998691|P2|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114091|NCT03026283|19998692|P1|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8114092|NCT03026283|19998685|P8|STARTED|Optimal Care/ICA Diagnostic Cath||0
8114093|NCT03026283|19998686|P7|STARTED|Optimal Care/ICA Diagnostic Cath||21
8114094|NCT03026283|19998687|P6|STARTED|Optimal Care/ICA Diagnostic Cath||0
8114095|NCT03026283|19998688|P5|STARTED|Optimal Care/ICA Diagnostic Cath||0
8114096|NCT03026283|19998689|P4|STARTED|Optimal Care/ICA Diagnostic Cath||0
8114097|NCT03026283|19998690|P3|STARTED|Optimal Care/ICA Diagnostic Cath||0
8114098|NCT03026283|19998691|P2|STARTED|Optimal Care/ICA Diagnostic Cath||0
8114099|NCT03026283|19998692|P1|STARTED|Optimal Care/ICA Diagnostic Cath||0
8114100|NCT03026283|19998685|P8|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8114101|NCT03026283|19998686|P7|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8114102|NCT03026283|19998687|P6|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
8114103|NCT03026283|19998688|P5|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
8114104|NCT03026283|19998689|P4|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
8114105|NCT03026283|19998690|P3|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8114106|NCT03026283|19998691|P2|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8114107|NCT03026283|19998692|P1|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8114108|NCT03026283|19998685|P8|COMPLETED|Optimal Care/Stress Test/ICA||0
8114109|NCT03026283|19998686|P7|COMPLETED|Optimal Care/Stress Test/ICA||0
8114110|NCT03026283|19998687|P6|COMPLETED|Optimal Care/Stress Test/ICA||73
8114111|NCT03026283|19998688|P5|COMPLETED|Optimal Care/Stress Test/ICA||14
8114112|NCT03026283|19998689|P4|COMPLETED|Optimal Care/Stress Test/ICA||108
8114113|NCT03026283|19998690|P3|COMPLETED|Optimal Care/Stress Test/ICA||0
8114114|NCT03026283|19998691|P2|COMPLETED|Optimal Care/Stress Test/ICA||0
8114115|NCT03026283|19998692|P1|COMPLETED|Optimal Care/Stress Test/ICA||0
8114116|NCT03026283|19998685|P8|STARTED|Optimal Care/Stress Test/ICA||0
8114117|NCT03026283|19998686|P7|STARTED|Optimal Care/Stress Test/ICA||0
8114118|NCT03026283|19998687|P6|STARTED|Optimal Care/Stress Test/ICA||101
8114119|NCT03026283|19998688|P5|STARTED|Optimal Care/Stress Test/ICA||52
8114120|NCT03026283|19998689|P4|STARTED|Optimal Care/Stress Test/ICA||128
8114121|NCT03026283|19998690|P3|STARTED|Optimal Care/Stress Test/ICA||0
8114122|NCT03026283|19998691|P2|STARTED|Optimal Care/Stress Test/ICA||0
8114123|NCT03026283|19998692|P1|STARTED|Optimal Care/Stress Test/ICA||0
8114124|NCT03026283|19998685|P8|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114125|NCT03026283|19998686|P7|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114126|NCT03026283|19998687|P6|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114127|NCT03026283|19998688|P5|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114128|NCT03026283|19998689|P4|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114129|NCT03026283|19998690|P3|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
8114130|NCT03026283|19998691|P2|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
8114131|NCT03026283|19998692|P1|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114132|NCT03026283|19998685|P8|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114133|NCT03026283|19998686|P7|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114134|NCT03026283|19998687|P6|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114135|NCT03026283|19998688|P5|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114136|NCT03026283|19998689|P4|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114137|NCT03026283|19998690|P3|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
8114138|NCT03026283|19998691|P2|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
8114139|NCT03026283|19998692|P1|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8114140|NCT03026283|19998685|P8|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8114141|NCT03026283|19998686|P7|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8114142|NCT03026283|19998687|P6|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8114143|NCT03026283|19998688|P5|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8114144|NCT03026283|19998689|P4|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8114145|NCT03026283|19998690|P3|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
8114146|NCT03026283|19998691|P2|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
8114147|NCT03026283|19998692|P1|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8114148|NCT03026283|19998685|P8|NOT COMPLETED|CCTA Diagnosis||0
8114149|NCT03026283|19998686|P7|NOT COMPLETED|CCTA Diagnosis||0
8114150|NCT03026283|19998687|P6|NOT COMPLETED|CCTA Diagnosis||0
8114151|NCT03026283|19998688|P5|NOT COMPLETED|CCTA Diagnosis||0
8114152|NCT03026283|19998689|P4|NOT COMPLETED|CCTA Diagnosis||0
8114153|NCT03026283|19998690|P3|NOT COMPLETED|CCTA Diagnosis||0
8114154|NCT03026283|19998691|P2|NOT COMPLETED|CCTA Diagnosis||0
8114155|NCT03026283|19998692|P1|NOT COMPLETED|CCTA Diagnosis||14
8114156|NCT03026283|19998685|P8|COMPLETED|CCTA Diagnosis||0
8114157|NCT03026283|19998686|P7|COMPLETED|CCTA Diagnosis||0
8114158|NCT03026283|19998687|P6|COMPLETED|CCTA Diagnosis||0
8114159|NCT03026283|19998688|P5|COMPLETED|CCTA Diagnosis||0
8114160|NCT03026283|19998689|P4|COMPLETED|CCTA Diagnosis||0
8114161|NCT03026283|19998690|P3|COMPLETED|CCTA Diagnosis||0
8114162|NCT03026283|19998691|P2|COMPLETED|CCTA Diagnosis||0
8114163|NCT03026283|19998692|P1|COMPLETED|CCTA Diagnosis||572
8114164|NCT03026283|19998685|P8|STARTED|CCTA Diagnosis||0
8114165|NCT03026283|19998686|P7|STARTED|CCTA Diagnosis||0
8114166|NCT03026283|19998687|P6|STARTED|CCTA Diagnosis||0
8114167|NCT03026283|19998688|P5|STARTED|CCTA Diagnosis||0
8114168|NCT03026283|19998689|P4|STARTED|CCTA Diagnosis||0
8114169|NCT03026283|19998690|P3|STARTED|CCTA Diagnosis||0
8114170|NCT03026283|19998691|P2|STARTED|CCTA Diagnosis||0
8114171|NCT03026283|19998692|P1|STARTED|CCTA Diagnosis||586
8114172|NCT03026257|19998713|P6|NOT COMPLETED|Overall Study||0
8114173|NCT03026257|19998714|P5|NOT COMPLETED|Overall Study||1
8114174|NCT03026257|19998715|P4|NOT COMPLETED|Overall Study||1
8114175|NCT03026257|19998716|P3|NOT COMPLETED|Overall Study||0
8114176|NCT03026257|19998717|P2|NOT COMPLETED|Overall Study||1
8114177|NCT03026257|19998718|P1|NOT COMPLETED|Overall Study||6
8114178|NCT03026257|19998713|P6|COMPLETED|Overall Study||46
8114179|NCT03026257|19998714|P5|COMPLETED|Overall Study||22
8114180|NCT03026257|19998715|P4|COMPLETED|Overall Study||24
8114181|NCT03026257|19998716|P3|COMPLETED|Overall Study||34
8114182|NCT03026257|19998717|P2|COMPLETED|Overall Study||63
8114183|NCT03026257|19998718|P1|COMPLETED|Overall Study||54
8114184|NCT03026257|19998713|P6|Treated|Overall Study||47
8114185|NCT03026257|19998714|P5|Treated|Overall Study||23
8114186|NCT03026257|19998715|P4|Treated|Overall Study||24
8114187|NCT03026257|19998716|P3|Treated|Overall Study||35
8114188|NCT03026257|19998717|P2|Treated|Overall Study||65
8114189|NCT03026257|19998718|P1|Treated|Overall Study||58
8114190|NCT03026257|19998713|P6|STARTED|Overall Study||46
8114191|NCT03026257|19998714|P5|STARTED|Overall Study||23
8114192|NCT03026257|19998715|P4|STARTED|Overall Study||25
8114193|NCT03026257|19998716|P3|STARTED|Overall Study||34
8114194|NCT03026257|19998717|P2|STARTED|Overall Study||64
8114195|NCT03026257|19998718|P1|STARTED|Overall Study||60
8114196|NCT03026166|19998734|P2|NOT COMPLETED|Overall Study||12
8114197|NCT03026166|19998735|P1|NOT COMPLETED|Overall Study||30
8114198|NCT03026166|19998734|P2|COMPLETED|Overall Study||0
8114199|NCT03026166|19998735|P1|COMPLETED|Overall Study||0
8114200|NCT03026166|19998734|P2|STARTED|Overall Study||12
8114201|NCT03026166|19998735|P1|STARTED|Overall Study||30
8114202|NCT03026088|19998751|P1|NOT COMPLETED|Overall Study||20
8114203|NCT03026088|19998751|P1|COMPLETED|Overall Study||0
8114204|NCT03026088|19998751|P1|STARTED|Overall Study||20
8114205|NCT03026075|19998775|P1|NOT COMPLETED|Overall Study||1
8114206|NCT03026075|19998775|P1|COMPLETED|Overall Study||46
8114207|NCT03026075|19998775|P1|STARTED|Overall Study||47
8114208|NCT03025945|19998781|P2|NOT COMPLETED|Overall Study||0
8114209|NCT03025945|19998782|P1|NOT COMPLETED|Overall Study||0
8114210|NCT03025945|19998781|P2|COMPLETED|Overall Study||331
8114211|NCT03025945|19998782|P1|COMPLETED|Overall Study||331
8114212|NCT03025945|19998781|P2|STARTED|Overall Study||331
8114213|NCT03025945|19998782|P1|STARTED|Overall Study||331
8114214|NCT03025542|19998790|P2|NOT COMPLETED|Overall Study||2
8114215|NCT03025542|19998791|P1|NOT COMPLETED|Overall Study||2
8114216|NCT03025542|19998790|P2|COMPLETED|Overall Study||15
8114217|NCT03025542|19998791|P1|COMPLETED|Overall Study||30
8114218|NCT03025542|19998790|P2|STARTED|Overall Study||17
8114219|NCT03025542|19998791|P1|STARTED|Overall Study||32
8114220|NCT03025217|19998831|P1|NOT COMPLETED|Overall Study||4
8114221|NCT03025217|19998831|P1|COMPLETED|Overall Study||27
8114222|NCT03025217|19998831|P1|STARTED|Overall Study||31
8114223|NCT03024970|19998836|P2|NOT COMPLETED|Second Intervention||0
8114224|NCT03024970|19998837|P1|NOT COMPLETED|Second Intervention||1
8114225|NCT03024970|19998836|P2|COMPLETED|Second Intervention||38
8114226|NCT03024970|19998837|P1|COMPLETED|Second Intervention||32
8114227|NCT03024970|19998836|P2|STARTED|Second Intervention||38
8114228|NCT03024970|19998837|P1|STARTED|Second Intervention||33
8114229|NCT03024970|19998836|P2|NOT COMPLETED|First Intervention||0
8114230|NCT03024970|19998837|P1|NOT COMPLETED|First Intervention||1
8114231|NCT03024970|19998836|P2|COMPLETED|First Intervention||38
8114232|NCT03024970|19998837|P1|COMPLETED|First Intervention||33
8114233|NCT03024970|19998836|P2|STARTED|First Intervention||38
8114234|NCT03024970|19998837|P1|STARTED|First Intervention||34
8114235|NCT03024606|19998915|P2|NOT COMPLETED|Overall Study||10
8114236|NCT03024606|19998916|P1|NOT COMPLETED|Overall Study||9
8114237|NCT03024606|19998915|P2|COMPLETED|Overall Study||16
8114238|NCT03024606|19998916|P1|COMPLETED|Overall Study||14
8114239|NCT03024606|19998915|P2|STARTED|Overall Study||26
8114240|NCT03024606|19998916|P1|STARTED|Overall Study||23
8114241|NCT03024112|19998924|P2|NOT COMPLETED|Overall Study||0
8114242|NCT03024112|19998925|P1|NOT COMPLETED|Overall Study||7
8114243|NCT03024112|19998924|P2|COMPLETED|Overall Study||26
8114244|NCT03024112|19998925|P1|COMPLETED|Overall Study||18
8114245|NCT03024112|19998924|P2|STARTED|Overall Study||26
8114246|NCT03024112|19998925|P1|STARTED|Overall Study||25
8114247|NCT03023891|19998937|P1|NOT COMPLETED|Overall Study||0
8114248|NCT03023891|19998937|P1|COMPLETED|Overall Study||18
8114249|NCT03023891|19998937|P1|STARTED|Overall Study||18
8114250|NCT03023878|19998944|P1|NOT COMPLETED|Long Term Follow-Up Period||2
8114251|NCT03023878|19998944|P1|COMPLETED|Long Term Follow-Up Period||26
8114252|NCT03023878|19998944|P1|STARTED|Long Term Follow-Up Period||28
8114253|NCT03023878|19998944|P1|NOT COMPLETED|Treatment Period||3
8114254|NCT03023878|19998944|P1|COMPLETED|Treatment Period||25
8114255|NCT03023878|19998944|P1|Started Cycle 2|Treatment Period||11
8114256|NCT03023878|19998944|P1|Started Cycle 1|Treatment Period||28
8114257|NCT03023878|19998944|P1|STARTED|Treatment Period||28
8114258|NCT03023878|19998944|P1|NOT COMPLETED|Between Run-In and Treatment Periods||2
8114259|NCT03023878|19998944|P1|COMPLETED|Between Run-In and Treatment Periods||28
8114260|NCT03023878|19998944|P1|STARTED|Between Run-In and Treatment Periods||30
8114261|NCT03023878|19998944|P1|NOT COMPLETED|Pre-Study Run-In Period||17
8114262|NCT03023878|19998944|P1|COMPLETED|Pre-Study Run-In Period||30
8114263|NCT03023878|19998944|P1|STARTED|Pre-Study Run-In Period||47
8114264|NCT03023722|19998957|P1|NOT COMPLETED|Overall Study||4
8114265|NCT03023722|19998957|P1|COMPLETED|Overall Study||14
8114266|NCT03023722|19998957|P1|STARTED|Overall Study||18
8114267|NCT03023709|19998965|P2|NOT COMPLETED|Overall Study||0
8114268|NCT03023709|19998966|P1|NOT COMPLETED|Overall Study||0
8114269|NCT03023709|19998965|P2|COMPLETED|Overall Study||0
8114270|NCT03023709|19998966|P1|COMPLETED|Overall Study||3
8114271|NCT03023709|19998965|P2|STARTED|Overall Study||0
8114272|NCT03023709|19998966|P1|STARTED|Overall Study||3
8114273|NCT03023683|19998976|P2|NOT COMPLETED|Overall Study||1
8114274|NCT03023683|19998977|P1|NOT COMPLETED|Overall Study||0
8114275|NCT03023683|19998976|P2|COMPLETED|Overall Study||17
8114276|NCT03023683|19998977|P1|COMPLETED|Overall Study||0
8114277|NCT03023683|19998976|P2|STARTED|Overall Study||18
8114278|NCT03023683|19998977|P1|STARTED|Overall Study||0
8114279|NCT03023553|19998987|P2|NOT COMPLETED|Overall Study||1
8114280|NCT03023553|19998988|P1|NOT COMPLETED|Overall Study||0
8114281|NCT03023553|19998987|P2|COMPLETED|Overall Study||8
8114282|NCT03023553|19998988|P1|COMPLETED|Overall Study||4
8114283|NCT03023553|19998987|P2|STARTED|Overall Study||9
8114284|NCT03023553|19998988|P1|STARTED|Overall Study||4
8114285|NCT03023488|19998996|P1|NOT COMPLETED|Overall Study||0
8114286|NCT03023488|19998996|P1|COMPLETED|Overall Study||46
8114287|NCT03023488|19998996|P1|STARTED|Overall Study||46
8114288|NCT03023423|19999012|P3|NOT COMPLETED|Overall Study||46
8114289|NCT03023423|19999013|P2|NOT COMPLETED|Overall Study||46
8114290|NCT03023423|19999014|P1|NOT COMPLETED|Overall Study||7
8114291|NCT03023423|19999012|P3|COMPLETED|Overall Study||0
8114292|NCT03023423|19999013|P2|COMPLETED|Overall Study||0
8114293|NCT03023423|19999014|P1|COMPLETED|Overall Study||0
8114294|NCT03023423|19999012|P3|Crossover From Atezo to Dara + Atezo|Overall Study||0
8114295|NCT03023423|19999013|P2|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
8114296|NCT03023423|19999014|P1|Crossover From Atezo to Dara + Atezo|Overall Study||0
8114297|NCT03023423|19999012|P3|Treated|Overall Study||44
8114298|NCT03023423|19999013|P2|Treated|Overall Study||44
8114299|NCT03023423|19999014|P1|Treated|Overall Study||7
8114300|NCT03023423|19999012|P3|STARTED|Overall Study||46
8114301|NCT03023423|19999013|P2|STARTED|Overall Study||46
8114302|NCT03023423|19999014|P1|STARTED|Overall Study||7
8114303|NCT03023176|19999044|P1|NOT COMPLETED|Overall Study||0
8114304|NCT03023176|19999044|P1|COMPLETED|Overall Study||20
8114305|NCT03023176|19999044|P1|STARTED|Overall Study||20
8114306|NCT03023137|19999051|P2|NOT COMPLETED|Overall Study||9
8114307|NCT03023137|19999052|P1|NOT COMPLETED|Overall Study||4
8114308|NCT03023137|19999051|P2|COMPLETED|Overall Study||162
8114309|NCT03023137|19999052|P1|COMPLETED|Overall Study||174
8114310|NCT03023137|19999051|P2|STARTED|Overall Study||171
8114311|NCT03023137|19999052|P1|STARTED|Overall Study||178
8114312|NCT03022981|19999081|P3|NOT COMPLETED|Overall Study||6
8114313|NCT03022981|19999082|P2|NOT COMPLETED|Overall Study||4
8114314|NCT03022981|19999083|P1|NOT COMPLETED|Overall Study||6
8114315|NCT03022981|19999081|P3|COMPLETED|Overall Study||35
8114316|NCT03022981|19999082|P2|COMPLETED|Overall Study||69
8114317|NCT03022981|19999083|P1|COMPLETED|Overall Study||96
8114318|NCT03022981|19999081|P3|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
8114319|NCT03022981|19999082|P2|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
8114320|NCT03022981|19999083|P1|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
8114321|NCT03022981|19999081|P3|STARTED|Overall Study||41
8114322|NCT03022981|19999082|P2|STARTED|Overall Study||73
8114323|NCT03022981|19999083|P1|STARTED|Overall Study||102
8114324|NCT03022916|19999159|P4|NOT COMPLETED|Overall Study||0
8114325|NCT03022916|19999160|P3|NOT COMPLETED|Overall Study||0
8114326|NCT03022916|19999161|P2|NOT COMPLETED|Overall Study||0
8114327|NCT03022916|19999162|P1|NOT COMPLETED|Overall Study||0
8114328|NCT03022916|19999159|P4|COMPLETED|Overall Study||5
8114329|NCT03022916|19999160|P3|COMPLETED|Overall Study||5
8114330|NCT03022916|19999161|P2|COMPLETED|Overall Study||5
8114331|NCT03022916|19999162|P1|COMPLETED|Overall Study||5
8114332|NCT03022916|19999159|P4|Nail Polish, Top Coat|Overall Study||5
8114333|NCT03022916|19999160|P3|Nail Polish, Top Coat|Overall Study||5
8114334|NCT03022916|19999161|P2|Nail Polish, Top Coat|Overall Study||5
8114335|NCT03022916|19999162|P1|Nail Polish, Top Coat|Overall Study||5
8114336|NCT03022916|19999159|P4|Nail Polish, Base Coat|Overall Study||5
8114337|NCT03022916|19999160|P3|Nail Polish, Base Coat|Overall Study||5
8114338|NCT03022916|19999161|P2|Nail Polish, Base Coat|Overall Study||5
8114339|NCT03022916|19999162|P1|Nail Polish, Base Coat|Overall Study||5
8114340|NCT03022916|19999159|P4|Nail Polish|Overall Study||5
8114341|NCT03022916|19999160|P3|Nail Polish|Overall Study||5
8114342|NCT03022916|19999161|P2|Nail Polish|Overall Study||5
8114343|NCT03022916|19999162|P1|Nail Polish|Overall Study||5
8114344|NCT03022916|19999159|P4|STARTED|Overall Study||5
8114345|NCT03022916|19999160|P3|STARTED|Overall Study||5
8114346|NCT03022916|19999161|P2|STARTED|Overall Study||5
8114347|NCT03022916|19999162|P1|STARTED|Overall Study||5
8114348|NCT03022799|19999182|P13|NOT COMPLETED|Overall Study||0
8114349|NCT03022799|19999183|P12|NOT COMPLETED|Overall Study||0
8114350|NCT03022799|19999184|P11|NOT COMPLETED|Overall Study||1
8114351|NCT03022799|19999185|P10|NOT COMPLETED|Overall Study||1
8114352|NCT03022799|19999186|P9|NOT COMPLETED|Overall Study||0
8114353|NCT03022799|19999187|P8|NOT COMPLETED|Overall Study||0
8114354|NCT03022799|19999188|P7|NOT COMPLETED|Overall Study||0
8114355|NCT03022799|19999189|P6|NOT COMPLETED|Overall Study||0
8114356|NCT03022799|19999190|P5|NOT COMPLETED|Overall Study||0
8114357|NCT03022799|19999191|P4|NOT COMPLETED|Overall Study||0
8114358|NCT03022799|19999192|P3|NOT COMPLETED|Overall Study||0
8114359|NCT03022799|19999193|P2|NOT COMPLETED|Overall Study||0
8114360|NCT03022799|19999194|P1|NOT COMPLETED|Overall Study||0
8114361|NCT03022799|19999182|P13|COMPLETED|Overall Study||10
8114362|NCT03022799|19999183|P12|COMPLETED|Overall Study||6
8114363|NCT03022799|19999184|P11|COMPLETED|Overall Study||5
8114364|NCT03022799|19999185|P10|COMPLETED|Overall Study||5
8114365|NCT03022799|19999186|P9|COMPLETED|Overall Study||6
8114366|NCT03022799|19999187|P8|COMPLETED|Overall Study||6
8114367|NCT03022799|19999188|P7|COMPLETED|Overall Study||12
8114368|NCT03022799|19999189|P6|COMPLETED|Overall Study||6
8114369|NCT03022799|19999190|P5|COMPLETED|Overall Study||6
8114370|NCT03022799|19999191|P4|COMPLETED|Overall Study||6
8114371|NCT03022799|19999192|P3|COMPLETED|Overall Study||6
8114372|NCT03022799|19999193|P2|COMPLETED|Overall Study||6
8114373|NCT03022799|19999194|P1|COMPLETED|Overall Study||6
8114374|NCT03022799|19999182|P13|STARTED|Overall Study||10
8114375|NCT03022799|19999183|P12|STARTED|Overall Study||6
8114376|NCT03022799|19999184|P11|STARTED|Overall Study||6
8114377|NCT03022799|19999185|P10|STARTED|Overall Study||6
8114378|NCT03022799|19999186|P9|STARTED|Overall Study||6
8114379|NCT03022799|19999187|P8|STARTED|Overall Study||6
8114380|NCT03022799|19999188|P7|STARTED|Overall Study||12
8114381|NCT03022799|19999189|P6|STARTED|Overall Study||6
8114382|NCT03022799|19999190|P5|STARTED|Overall Study||6
8114383|NCT03022799|19999191|P4|STARTED|Overall Study||6
8114384|NCT03022799|19999192|P3|STARTED|Overall Study||6
8114385|NCT03022799|19999193|P2|STARTED|Overall Study||6
8114386|NCT03022799|19999194|P1|STARTED|Overall Study||6
8114387|NCT03022630|19999391|P2|NOT COMPLETED|Overall Study||12
8114388|NCT03022630|19999392|P1|NOT COMPLETED|Overall Study||9
8114389|NCT03022630|19999391|P2|COMPLETED|Overall Study||20
8114390|NCT03022630|19999392|P1|COMPLETED|Overall Study||22
8114391|NCT03022630|19999391|P2|STARTED|Overall Study||32
8114392|NCT03022630|19999392|P1|STARTED|Overall Study||31
8114393|NCT03022526|19999442|P2|NOT COMPLETED|Overall Study||5
8114394|NCT03022526|19999443|P1|NOT COMPLETED|Overall Study||10
8114395|NCT03022526|19999442|P2|COMPLETED|Overall Study||25
8114396|NCT03022526|19999443|P1|COMPLETED|Overall Study||21
8114397|NCT03022526|19999442|P2|STARTED|Overall Study||30
8114398|NCT03022526|19999443|P1|STARTED|Overall Study||31
8114399|NCT03022435|19999482|P5|NOT COMPLETED|Overall Study||0
8114400|NCT03022435|19999483|P4|NOT COMPLETED|Overall Study||0
8114401|NCT03022435|19999484|P3|NOT COMPLETED|Overall Study||0
8114402|NCT03022435|19999485|P2|NOT COMPLETED|Overall Study||0
8114403|NCT03022435|19999486|P1|NOT COMPLETED|Overall Study||0
8114404|NCT03022435|19999482|P5|COMPLETED|Overall Study||3
8114405|NCT03022435|19999483|P4|COMPLETED|Overall Study||3
8114406|NCT03022435|19999484|P3|COMPLETED|Overall Study||6
8114407|NCT03022435|19999485|P2|COMPLETED|Overall Study||5
8114408|NCT03022435|19999486|P1|COMPLETED|Overall Study||5
8114409|NCT03022435|19999482|P5|STARTED|Overall Study||3
8114410|NCT03022435|19999483|P4|STARTED|Overall Study||3
8114411|NCT03022435|19999484|P3|STARTED|Overall Study||6
8114412|NCT03022435|19999485|P2|STARTED|Overall Study||5
8114413|NCT03022435|19999486|P1|STARTED|Overall Study||5
8114414|NCT03022422|19999509|P6|NOT COMPLETED|Overall Study||0
8114415|NCT03022422|19999510|P5|NOT COMPLETED|Overall Study||0
8114416|NCT03022422|19999511|P4|NOT COMPLETED|Overall Study||0
8114417|NCT03022422|19999512|P3|NOT COMPLETED|Overall Study||3
8114418|NCT03022422|19999513|P2|NOT COMPLETED|Overall Study||0
8114419|NCT03022422|19999514|P1|NOT COMPLETED|Overall Study||0
8114420|NCT03022422|19999509|P6|COMPLETED|Overall Study||5
8114421|NCT03022422|19999510|P5|COMPLETED|Overall Study||5
8114422|NCT03022422|19999511|P4|COMPLETED|Overall Study||12
8114423|NCT03022422|19999512|P3|COMPLETED|Overall Study||20
8114424|NCT03022422|19999513|P2|COMPLETED|Overall Study||10
8114425|NCT03022422|19999514|P1|COMPLETED|Overall Study||8
8114426|NCT03022422|19999509|P6|STARTED|Overall Study||5
8114427|NCT03022422|19999510|P5|STARTED|Overall Study||5
8114428|NCT03022422|19999511|P4|STARTED|Overall Study||12
8114429|NCT03022422|19999512|P3|STARTED|Overall Study||23
8114430|NCT03022422|19999513|P2|STARTED|Overall Study||10
8114431|NCT03022422|19999514|P1|STARTED|Overall Study||8
8114432|NCT03022396|19999540|P6|NOT COMPLETED|Overall Study||0
8114433|NCT03022396|19999541|P5|NOT COMPLETED|Overall Study||0
8114434|NCT03022396|19999542|P4|NOT COMPLETED|Overall Study||0
8114435|NCT03022396|19999543|P3|NOT COMPLETED|Overall Study||0
8114436|NCT03022396|19999544|P2|NOT COMPLETED|Overall Study||0
8114437|NCT03022396|19999545|P1|NOT COMPLETED|Overall Study||0
8114438|NCT03022396|19999540|P6|COMPLETED|Overall Study||8
8114439|NCT03022396|19999541|P5|COMPLETED|Overall Study||14
8114440|NCT03022396|19999542|P4|COMPLETED|Overall Study||20
8114441|NCT03022396|19999543|P3|COMPLETED|Overall Study||10
8114442|NCT03022396|19999544|P2|COMPLETED|Overall Study||14
8114443|NCT03022396|19999545|P1|COMPLETED|Overall Study||16
8114444|NCT03022396|19999540|P6|STARTED|Overall Study||8
8114445|NCT03022396|19999541|P5|STARTED|Overall Study||14
8114446|NCT03022396|19999542|P4|STARTED|Overall Study||20
8114447|NCT03022396|19999543|P3|STARTED|Overall Study||10
8114448|NCT03022396|19999544|P2|STARTED|Overall Study||14
8114449|NCT03022396|19999545|P1|STARTED|Overall Study||16
8114450|NCT03022370|19999569|P2|NOT COMPLETED|Overall Study||121
8114451|NCT03022370|19999570|P1|NOT COMPLETED|Overall Study||180
8114452|NCT03022370|19999569|P2|COMPLETED|Overall Study||553
8114453|NCT03022370|19999570|P1|COMPLETED|Overall Study||497
8114454|NCT03022370|19999569|P2|STARTED|Overall Study||674
8114455|NCT03022370|19999570|P1|STARTED|Overall Study||677
8114456|NCT03022084|19999646|P2|NOT COMPLETED|Overall Study||3
8114457|NCT03022084|19999647|P1|NOT COMPLETED|Overall Study||2
8114458|NCT03022084|19999646|P2|COMPLETED|Overall Study||29
8114459|NCT03022084|19999647|P1|COMPLETED|Overall Study||27
8114460|NCT03022084|19999646|P2|STARTED|Overall Study||32
8114461|NCT03022084|19999647|P1|STARTED|Overall Study||29
8114462|NCT03022045|19999655|P2|NOT COMPLETED|Overall Study||2
8114463|NCT03022045|19999656|P1|NOT COMPLETED|Overall Study||1
8114464|NCT03022045|19999655|P2|COMPLETED|Overall Study||6
8114465|NCT03022045|19999656|P1|COMPLETED|Overall Study||8
8114466|NCT03022045|19999655|P2|STARTED|Overall Study||8
8114467|NCT03022045|19999656|P1|STARTED|Overall Study||9
8114468|NCT03021759|19999673|P3|NOT COMPLETED|Overall Study||0
8114469|NCT03021759|19999674|P2|NOT COMPLETED|Overall Study||0
8114470|NCT03021759|19999675|P1|NOT COMPLETED|Overall Study||0
8114471|NCT03021759|19999673|P3|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
8114472|NCT03021759|19999674|P2|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
8114473|NCT03021759|19999675|P1|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
8114474|NCT03021759|19999673|P3|STARTED|Overall Study||1465
8114475|NCT03021759|19999674|P2|STARTED|Overall Study||1743
8114476|NCT03021759|19999675|P1|STARTED|Overall Study||1566
8114477|NCT03021668|19999685|P2|NOT COMPLETED|Overall Study||1
8114478|NCT03021668|19999686|P1|NOT COMPLETED|Overall Study||0
8114479|NCT03021668|19999685|P2|COMPLETED|Overall Study||61
8114480|NCT03021668|19999686|P1|COMPLETED|Overall Study||62
8114481|NCT03021668|19999685|P2|STARTED|Overall Study||62
8114482|NCT03021668|19999686|P1|STARTED|Overall Study||62
8114483|NCT03021642|19999698|P2|NOT COMPLETED|Treatment Period 2 (Day 22)||0
8114484|NCT03021642|19999699|P1|NOT COMPLETED|Treatment Period 2 (Day 22)||0
8114485|NCT03021642|19999698|P2|COMPLETED|Treatment Period 2 (Day 22)||11
8114486|NCT03021642|19999699|P1|COMPLETED|Treatment Period 2 (Day 22)||11
8114487|NCT03021642|19999698|P2|STARTED|Treatment Period 2 (Day 22)||11
8114488|NCT03021642|19999699|P1|STARTED|Treatment Period 2 (Day 22)||11
8114489|NCT03021642|19999698|P2|NOT COMPLETED|Washout Period (21 Days)||1
8114490|NCT03021642|19999699|P1|NOT COMPLETED|Washout Period (21 Days)||1
8114491|NCT03021642|19999698|P2|COMPLETED|Washout Period (21 Days)||11
8114492|NCT03021642|19999699|P1|COMPLETED|Washout Period (21 Days)||11
8114493|NCT03021642|19999698|P2|STARTED|Washout Period (21 Days)||12
8114494|NCT03021642|19999699|P1|STARTED|Washout Period (21 Days)||12
8114495|NCT03021642|19999698|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8114496|NCT03021642|19999699|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8114497|NCT03021642|19999698|P2|COMPLETED|Treatment Period 1 (Day 1)||12
8114498|NCT03021642|19999699|P1|COMPLETED|Treatment Period 1 (Day 1)||12
8114499|NCT03021642|19999698|P2|STARTED|Treatment Period 1 (Day 1)||12
8114500|NCT03021642|19999699|P1|STARTED|Treatment Period 1 (Day 1)||12
8114501|NCT03021564|19999739|P2|NOT COMPLETED|Overall Study||468
8114502|NCT03021564|19999740|P1|NOT COMPLETED|Overall Study||84
8114503|NCT03021564|19999739|P2|COMPLETED|Overall Study||89
8114504|NCT03021564|19999740|P1|COMPLETED|Overall Study||36
8114505|NCT03021564|19999739|P2|STARTED|Overall Study||557
8114506|NCT03021564|19999740|P1|STARTED|Overall Study||120
8114507|NCT03021538|19999766|P2|NOT COMPLETED|Overall Study||0
8114508|NCT03021538|19999767|P1|NOT COMPLETED|Overall Study||0
8114509|NCT03021538|19999766|P2|COMPLETED|Overall Study||7
8114510|NCT03021538|19999767|P1|COMPLETED|Overall Study||6
8114511|NCT03021538|19999766|P2|STARTED|Overall Study||7
8114512|NCT03021538|19999767|P1|STARTED|Overall Study||6
8114513|NCT03021343|19999775|P2|NOT COMPLETED|Overall Study||7
8114514|NCT03021343|19999776|P1|NOT COMPLETED|Overall Study||5
8114515|NCT03021343|19999775|P2|COMPLETED|Overall Study||174
8114516|NCT03021343|19999776|P1|COMPLETED|Overall Study||174
8114517|NCT03021343|19999775|P2|STARTED|Overall Study||181
8114518|NCT03021343|19999776|P1|STARTED|Overall Study||179
8114519|NCT03021304|19999784|P1|NOT COMPLETED|Overall Study||1
8114520|NCT03021304|19999784|P1|COMPLETED|Overall Study||55
8114521|NCT03021304|19999784|P1|STARTED|Overall Study||56
8114522|NCT03021265|19999789|P1|NOT COMPLETED|Overall Study||122
8114523|NCT03021265|19999789|P1|COMPLETED|Overall Study||554
8114524|NCT03021265|19999789|P1|STARTED|Overall Study||676
8114525|NCT03021187|19999799|P4|NOT COMPLETED|Overall Study||9
8114526|NCT03021187|19999800|P3|NOT COMPLETED|Overall Study||6
8114527|NCT03021187|19999801|P2|NOT COMPLETED|Overall Study||9
8114528|NCT03021187|19999802|P1|NOT COMPLETED|Overall Study||10
8114529|NCT03021187|19999799|P4|COMPLETED|Overall Study||175
8114530|NCT03021187|19999800|P3|COMPLETED|Overall Study||175
8114531|NCT03021187|19999801|P2|COMPLETED|Overall Study||173
8114532|NCT03021187|19999802|P1|COMPLETED|Overall Study||174
8114533|NCT03021187|19999799|P4|Safety Analysis Set (SAS)|Overall Study||184
8114534|NCT03021187|19999800|P3|Safety Analysis Set (SAS)|Overall Study||181
8114535|NCT03021187|19999801|P2|Safety Analysis Set (SAS)|Overall Study||181
8114536|NCT03021187|19999802|P1|Safety Analysis Set (SAS)|Overall Study||184
8114537|NCT03021187|19999799|P4|Full Analysis Set (FAS)|Overall Study||184
8114538|NCT03021187|19999800|P3|Full Analysis Set (FAS)|Overall Study||181
8114539|NCT03021187|19999801|P2|Full Analysis Set (FAS)|Overall Study||182
8114540|NCT03021187|19999802|P1|Full Analysis Set (FAS)|Overall Study||184
8114541|NCT03021187|19999799|P4|Exposed|Overall Study||184
8114542|NCT03021187|19999800|P3|Exposed|Overall Study||181
8114543|NCT03021187|19999801|P2|Exposed|Overall Study||181
8114544|NCT03021187|19999802|P1|Exposed|Overall Study||184
8114545|NCT03021187|19999799|P4|STARTED|Overall Study||184
8114546|NCT03021187|19999800|P3|STARTED|Overall Study||181
8114547|NCT03021187|19999801|P2|STARTED|Overall Study||182
8114548|NCT03021187|19999802|P1|STARTED|Overall Study||184
8114549|NCT03021018|19999958|P3|NOT COMPLETED|Overall Study||0
8114550|NCT03021018|19999959|P2|NOT COMPLETED|Overall Study||0
8114551|NCT03021018|19999960|P1|NOT COMPLETED|Overall Study||2
8114552|NCT03021018|19999958|P3|COMPLETED|Overall Study||15
8114553|NCT03021018|19999959|P2|COMPLETED|Overall Study||15
8114554|NCT03021018|19999960|P1|COMPLETED|Overall Study||14
8114555|NCT03021018|19999958|P3|STARTED|Overall Study||15
8114556|NCT03021018|19999959|P2|STARTED|Overall Study||15
8114557|NCT03021018|19999960|P1|STARTED|Overall Study||16
8114558|NCT03021005|19999991|P2|NOT COMPLETED|Overall Study||26
8114559|NCT03021005|19999992|P1|NOT COMPLETED|Overall Study||39
8114560|NCT03021005|19999991|P2|COMPLETED|Overall Study||72
8114561|NCT03021005|19999992|P1|COMPLETED|Overall Study||63
8114562|NCT03021005|19999991|P2|STARTED|Overall Study||98
8114563|NCT03021005|19999992|P1|STARTED|Overall Study||102
8114570|NCT03020745|20000052|P10|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114571|NCT03020745|20000053|P9|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
8114572|NCT03020745|20000054|P8|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114573|NCT03020745|20000055|P7|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114574|NCT03020745|20000056|P6|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
8114575|NCT03020745|20000057|P5|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114576|NCT03020745|20000058|P4|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114577|NCT03020745|20000059|P3|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114578|NCT03020745|20000060|P2|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114579|NCT03020745|20000061|P1|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114580|NCT03020745|20000052|P10|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
8114581|NCT03020745|20000053|P9|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
8114582|NCT03020745|20000054|P8|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
8114583|NCT03020745|20000055|P7|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
8114584|NCT03020745|20000056|P6|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
8114585|NCT03020745|20000057|P5|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114586|NCT03020745|20000058|P4|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114587|NCT03020745|20000059|P3|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114588|NCT03020745|20000060|P2|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114589|NCT03020745|20000061|P1|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114590|NCT03020745|20000052|P10|STARTED|Part 2:Optional FU (Up to 450 Days)||15
8114591|NCT03020745|20000053|P9|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
8114592|NCT03020745|20000054|P8|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
8114593|NCT03020745|20000055|P7|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
8114594|NCT03020745|20000056|P6|STARTED|Part 2:Optional FU (Up to 450 Days)||10
8114595|NCT03020745|20000057|P5|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114596|NCT03020745|20000058|P4|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114597|NCT03020745|20000059|P3|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114598|NCT03020745|20000060|P2|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114599|NCT03020745|20000061|P1|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114600|NCT03020745|20000052|P10|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114601|NCT03020745|20000053|P9|NOT COMPLETED|Part 2 (Up to 169 Days)||1
8114602|NCT03020745|20000054|P8|NOT COMPLETED|Part 2 (Up to 169 Days)||1
8114603|NCT03020745|20000055|P7|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114604|NCT03020745|20000056|P6|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114605|NCT03020745|20000057|P5|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114606|NCT03020745|20000058|P4|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114607|NCT03020745|20000059|P3|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114608|NCT03020745|20000060|P2|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114609|NCT03020745|20000061|P1|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114610|NCT03020745|20000052|P10|COMPLETED|Part 2 (Up to 169 Days)||15
8114611|NCT03020745|20000053|P9|COMPLETED|Part 2 (Up to 169 Days)||14
8114612|NCT03020745|20000054|P8|COMPLETED|Part 2 (Up to 169 Days)||19
8114613|NCT03020745|20000055|P7|COMPLETED|Part 2 (Up to 169 Days)||6
8114614|NCT03020745|20000056|P6|COMPLETED|Part 2 (Up to 169 Days)||10
8114615|NCT03020745|20000057|P5|COMPLETED|Part 2 (Up to 169 Days)||0
8114616|NCT03020745|20000058|P4|COMPLETED|Part 2 (Up to 169 Days)||0
8114617|NCT03020745|20000059|P3|COMPLETED|Part 2 (Up to 169 Days)||0
8114618|NCT03020745|20000060|P2|COMPLETED|Part 2 (Up to 169 Days)||0
8114619|NCT03020745|20000061|P1|COMPLETED|Part 2 (Up to 169 Days)||0
8114620|NCT03020745|20000052|P10|STARTED|Part 2 (Up to 169 Days)||15
8114621|NCT03020745|20000053|P9|STARTED|Part 2 (Up to 169 Days)||15
8114622|NCT03020745|20000054|P8|STARTED|Part 2 (Up to 169 Days)||20
8114623|NCT03020745|20000055|P7|STARTED|Part 2 (Up to 169 Days)||6
8114624|NCT03020745|20000056|P6|STARTED|Part 2 (Up to 169 Days)||10
8114625|NCT03020745|20000057|P5|STARTED|Part 2 (Up to 169 Days)||0
8114626|NCT03020745|20000058|P4|STARTED|Part 2 (Up to 169 Days)||0
8114627|NCT03020745|20000059|P3|STARTED|Part 2 (Up to 169 Days)||0
8114628|NCT03020745|20000060|P2|STARTED|Part 2 (Up to 169 Days)||0
8114629|NCT03020745|20000061|P1|STARTED|Part 2 (Up to 169 Days)||0
8114630|NCT03020745|20000052|P10|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114631|NCT03020745|20000053|P9|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114632|NCT03020745|20000054|P8|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114633|NCT03020745|20000055|P7|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114634|NCT03020745|20000056|P6|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114635|NCT03020745|20000057|P5|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114636|NCT03020745|20000058|P4|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114637|NCT03020745|20000059|P3|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114638|NCT03020745|20000060|P2|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114639|NCT03020745|20000061|P1|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114640|NCT03020745|20000052|P10|COMPLETED|Part 1 (Up to 60 Days)||0
8114641|NCT03020745|20000053|P9|COMPLETED|Part 1 (Up to 60 Days)||0
8114642|NCT03020745|20000054|P8|COMPLETED|Part 1 (Up to 60 Days)||0
8114643|NCT03020745|20000055|P7|COMPLETED|Part 1 (Up to 60 Days)||0
8114644|NCT03020745|20000056|P6|COMPLETED|Part 1 (Up to 60 Days)||0
8114645|NCT03020745|20000057|P5|COMPLETED|Part 1 (Up to 60 Days)||0
8114646|NCT03020745|20000058|P4|COMPLETED|Part 1 (Up to 60 Days)||6
8114647|NCT03020745|20000059|P3|COMPLETED|Part 1 (Up to 60 Days)||0
8114648|NCT03020745|20000060|P2|COMPLETED|Part 1 (Up to 60 Days)||3
8114649|NCT03020745|20000061|P1|COMPLETED|Part 1 (Up to 60 Days)||3
8114650|NCT03020745|20000052|P10|STARTED|Part 1 (Up to 60 Days)||0
8114651|NCT03020745|20000053|P9|STARTED|Part 1 (Up to 60 Days)||0
8114652|NCT03020745|20000054|P8|STARTED|Part 1 (Up to 60 Days)||0
8114653|NCT03020745|20000055|P7|STARTED|Part 1 (Up to 60 Days)||0
8114654|NCT03020745|20000056|P6|STARTED|Part 1 (Up to 60 Days)||0
8114655|NCT03020745|20000057|P5|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
8114656|NCT03020745|20000058|P4|STARTED|Part 1 (Up to 60 Days)||6
8114657|NCT03020745|20000059|P3|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
8114658|NCT03020745|20000060|P2|STARTED|Part 1 (Up to 60 Days)||3
8114659|NCT03020745|20000061|P1|STARTED|Part 1 (Up to 60 Days)||3
8114660|NCT03020719|20000401|P2|NOT COMPLETED|Overall Study||2
8114661|NCT03020719|20000402|P1|NOT COMPLETED|Overall Study||0
8114662|NCT03020719|20000401|P2|COMPLETED|Overall Study||28
8114663|NCT03020719|20000402|P1|COMPLETED|Overall Study||30
8114664|NCT03020719|20000401|P2|STARTED|Overall Study||30
8114665|NCT03020719|20000402|P1|STARTED|Overall Study||30
8114666|NCT03020576|20000422|P2|NOT COMPLETED|Overall Study||2
8114667|NCT03020576|20000423|P1|NOT COMPLETED|Overall Study||1
8114668|NCT03020576|20000422|P2|COMPLETED|Overall Study||14
8114669|NCT03020576|20000423|P1|COMPLETED|Overall Study||14
8114670|NCT03020576|20000422|P2|STARTED|Overall Study||16
8114671|NCT03020576|20000423|P1|STARTED|Overall Study||15
8114672|NCT03020550|20000445|P2|NOT COMPLETED|Overall Study||0
8114673|NCT03020550|20000446|P1|NOT COMPLETED|Overall Study||0
8114674|NCT03020550|20000445|P2|COMPLETED|Overall Study||16
8114675|NCT03020550|20000446|P1|COMPLETED|Overall Study||8
8114676|NCT03020550|20000445|P2|STARTED|Overall Study||16
8114677|NCT03020550|20000446|P1|STARTED|Overall Study||8
8114678|NCT03020537|20000462|P2|NOT COMPLETED|Overall Study||0
8114679|NCT03020537|20000463|P1|NOT COMPLETED|Overall Study||0
8114680|NCT03020537|20000462|P2|COMPLETED|Overall Study||7
8114681|NCT03020537|20000463|P1|COMPLETED|Overall Study||1
8114682|NCT03020537|20000462|P2|STARTED|Overall Study||7
8114683|NCT03020537|20000463|P1|STARTED|Overall Study||1
8114684|NCT03020524|20000474|P3|NOT COMPLETED|Overall Study||0
8114685|NCT03020524|20000475|P2|NOT COMPLETED|Overall Study||0
8114686|NCT03020524|20000476|P1|NOT COMPLETED|Overall Study||0
8114687|NCT03020524|20000474|P3|COMPLETED|Overall Study||3
8114688|NCT03020524|20000475|P2|COMPLETED|Overall Study||3
8114689|NCT03020524|20000476|P1|COMPLETED|Overall Study||3
8114690|NCT03020524|20000474|P3|STARTED|Overall Study||3
8114691|NCT03020524|20000475|P2|STARTED|Overall Study||3
8114692|NCT03020524|20000476|P1|STARTED|Overall Study||3
8114693|NCT03020498|20000487|P3|NOT COMPLETED|Overall Study||0
8114694|NCT03020498|20000488|P2|NOT COMPLETED|Overall Study||3
8114695|NCT03020498|20000489|P1|NOT COMPLETED|Overall Study||0
8114696|NCT03020498|20000487|P3|COMPLETED|Overall Study||36
8114697|NCT03020498|20000488|P2|COMPLETED|Overall Study||38
8114698|NCT03020498|20000489|P1|COMPLETED|Overall Study||14
8114699|NCT03020498|20000487|P3|STARTED|Overall Study||36
8114700|NCT03020498|20000488|P2|STARTED|Overall Study||41
8114701|NCT03020498|20000489|P1|STARTED|Overall Study||14
8114702|NCT03020472|20000500|P1|NOT COMPLETED|Overall Study||0
8114703|NCT03020472|20000500|P1|COMPLETED|Overall Study||6
8114704|NCT03020472|20000500|P1|STARTED|Overall Study||6
8114705|NCT03020446|20000506|P1|NOT COMPLETED|Overall Study||3
8114706|NCT03020446|20000506|P1|COMPLETED|Overall Study||0
8114707|NCT03020446|20000506|P1|STARTED|Overall Study||3
8114708|NCT03020160|20000514|P2|NOT COMPLETED|Overall Study||41
8114709|NCT03020160|20000515|P1|NOT COMPLETED|Overall Study||7
8114710|NCT03020160|20000514|P2|COMPLETED|Overall Study||0
8114711|NCT03020160|20000515|P1|COMPLETED|Overall Study||0
8114712|NCT03020160|20000514|P2|Completed 24 Weeks in the Study|Overall Study||41
8114713|NCT03020160|20000515|P1|Completed 24 Weeks in the Study|Overall Study||7
8114714|NCT03020160|20000514|P2|STARTED|Overall Study||41
8114715|NCT03020160|20000515|P1|STARTED|Overall Study||7
8114716|NCT03020095|20000568|P1|NOT COMPLETED|Overall Study||1
8114717|NCT03020095|20000568|P1|COMPLETED|Overall Study||37
8114718|NCT03020095|20000568|P1|STARTED|Overall Study||38
8114719|NCT03020069|20000574|P2|NOT COMPLETED|Overall Study||1
8114720|NCT03020069|20000575|P1|NOT COMPLETED|Overall Study||0
8114721|NCT03020069|20000574|P2|COMPLETED|Overall Study||3
8114722|NCT03020069|20000575|P1|COMPLETED|Overall Study||9
8114723|NCT03020069|20000574|P2|STARTED|Overall Study||4
8114724|NCT03020069|20000575|P1|STARTED|Overall Study||9
8114725|NCT03020004|20000587|P1|NOT COMPLETED|Overall Study||1
8114726|NCT03020004|20000587|P1|COMPLETED|Overall Study||69
8114727|NCT03020004|20000587|P1|STARTED|Overall Study||70
8114728|NCT03019783|20000593|P2|NOT COMPLETED|Overall Study||0
8114729|NCT03019783|20000594|P1|NOT COMPLETED|Overall Study||0
8114730|NCT03019783|20000593|P2|COMPLETED|Overall Study||31
8114731|NCT03019783|20000594|P1|COMPLETED|Overall Study||29
8114732|NCT03019783|20000593|P2|STARTED|Overall Study||31
8114733|NCT03019783|20000594|P1|STARTED|Overall Study||29
8114734|NCT03019744|20000604|P2|NOT COMPLETED|Overall Study||8
8114735|NCT03019744|20000605|P1|NOT COMPLETED|Overall Study||6
8114736|NCT03019744|20000604|P2|COMPLETED|Overall Study||36
8114737|NCT03019744|20000605|P1|COMPLETED|Overall Study||32
8114738|NCT03019744|20000604|P2|STARTED|Overall Study||44
8114739|NCT03019744|20000605|P1|STARTED|Overall Study||38
8114740|NCT03019627|20000621|P2|NOT COMPLETED|Overall Study||8
8114741|NCT03019627|20000622|P1|NOT COMPLETED|Overall Study||15
8114742|NCT03019627|20000621|P2|COMPLETED|Overall Study||42
8114743|NCT03019627|20000622|P1|COMPLETED|Overall Study||85
8114744|NCT03019627|20000621|P2|STARTED|Overall Study||50
8114745|NCT03019627|20000622|P1|STARTED|Overall Study||100
8114746|NCT03019549|20000638|P1|NOT COMPLETED|Period 2||5
8114747|NCT03019549|20000638|P1|COMPLETED|Period 2||26
8114748|NCT03019549|20000638|P1|Received at Least 1 Dose of Study Drug|Period 2||29
8114749|NCT03019549|20000638|P1|STARTED|Period 2||31
8114750|NCT03019549|20000638|P1|NOT COMPLETED|Washout||11
8114751|NCT03019549|20000638|P1|COMPLETED|Washout||31
8114752|NCT03019549|20000638|P1|STARTED|Washout||42
8114753|NCT03019549|20000638|P1|NOT COMPLETED|Period 1||0
8114754|NCT03019549|20000638|P1|COMPLETED|Period 1||42
8114755|NCT03019549|20000638|P1|Received 1 Dose of Study Drug|Period 1||42
8114756|NCT03019549|20000638|P1|STARTED|Period 1||42
8114757|NCT03019458|20000651|P2|NOT COMPLETED|Overall Study||1
8114758|NCT03019458|20000652|P1|NOT COMPLETED|Overall Study||0
8114759|NCT03019458|20000651|P2|COMPLETED|Overall Study||25
8114760|NCT03019458|20000652|P1|COMPLETED|Overall Study||24
8114761|NCT03019458|20000651|P2|STARTED|Overall Study||26
8114762|NCT03019458|20000652|P1|STARTED|Overall Study||24
8114763|NCT03018938|20000666|P2|NOT COMPLETED|Overall Study||85
8114764|NCT03018938|20000667|P1|NOT COMPLETED|Overall Study||66
8114765|NCT03018938|20000666|P2|COMPLETED|Overall Study||325
8114766|NCT03018938|20000667|P1|COMPLETED|Overall Study||338
8114767|NCT03018938|20000666|P2|Received at Least 1 Dose of Study Drug|Overall Study||410
8114768|NCT03018938|20000667|P1|Received at Least 1 Dose of Study Drug|Overall Study||404
8114769|NCT03018938|20000666|P2|STARTED|Overall Study||410
8114770|NCT03018938|20000667|P1|STARTED|Overall Study||404
8114771|NCT03018691|20000706|P3|NOT COMPLETED|Overall Study||7
8114772|NCT03018691|20000707|P2|NOT COMPLETED|Overall Study||1
8114773|NCT03018691|20000708|P1|NOT COMPLETED|Overall Study||2
8114774|NCT03018691|20000706|P3|COMPLETED|Overall Study||17
8114775|NCT03018691|20000707|P2|COMPLETED|Overall Study||24
8114776|NCT03018691|20000708|P1|COMPLETED|Overall Study||22
8114777|NCT03018691|20000706|P3|STARTED|Overall Study||24
8114778|NCT03018691|20000707|P2|STARTED|Overall Study||25
8114779|NCT03018691|20000708|P1|STARTED|Overall Study||24
8114780|NCT03018340|20000744|P2|NOT COMPLETED|Overall Study||30
8114781|NCT03018340|20000745|P1|NOT COMPLETED|Overall Study||8
8114782|NCT03018340|20000744|P2|COMPLETED|Overall Study||125
8114783|NCT03018340|20000745|P1|COMPLETED|Overall Study||44
8114784|NCT03018340|20000744|P2|STARTED|Overall Study||155
8114785|NCT03018340|20000745|P1|STARTED|Overall Study||52
8114789|NCT03018106|20000804|P2|NOT COMPLETED|Overall Study||1
8114790|NCT03018106|20000805|P1|NOT COMPLETED|Overall Study||0
8114791|NCT03018106|20000804|P2|COMPLETED|Overall Study||0
8114792|NCT03018106|20000805|P1|COMPLETED|Overall Study||0
8114793|NCT03018106|20000804|P2|STARTED|Overall Study||1
8114794|NCT03018106|20000805|P1|STARTED|Overall Study||0
8114795|NCT03018028|20000818|P5|NOT COMPLETED|Overall Study||0
8114796|NCT03018028|20000819|P4|NOT COMPLETED|Overall Study||2
8114797|NCT03018028|20000820|P3|NOT COMPLETED|Overall Study||1
8114798|NCT03018028|20000821|P2|NOT COMPLETED|Overall Study||0
8114799|NCT03018028|20000822|P1|NOT COMPLETED|Overall Study||3
8114800|NCT03018028|20000818|P5|COMPLETED|Overall Study||49
8114801|NCT03018028|20000819|P4|COMPLETED|Overall Study||46
8114802|NCT03018028|20000820|P3|COMPLETED|Overall Study||47
8114803|NCT03018028|20000821|P2|COMPLETED|Overall Study||49
8114804|NCT03018028|20000822|P1|COMPLETED|Overall Study||46
8114805|NCT03018028|20000818|P5|Safety Analysis Set (SAS)|Overall Study||49
8114806|NCT03018028|20000819|P4|Safety Analysis Set (SAS)|Overall Study||48
8114807|NCT03018028|20000820|P3|Safety Analysis Set (SAS)|Overall Study||48
8114808|NCT03018028|20000821|P2|Safety Analysis Set (SAS)|Overall Study||49
8114809|NCT03018028|20000822|P1|Safety Analysis Set (SAS)|Overall Study||49
8114810|NCT03018028|20000818|P5|Full Analysis Set (FAS)|Overall Study||49
8114811|NCT03018028|20000819|P4|Full Analysis Set (FAS)|Overall Study||48
8114812|NCT03018028|20000820|P3|Full Analysis Set (FAS)|Overall Study||48
8114813|NCT03018028|20000821|P2|Full Analysis Set (FAS)|Overall Study||49
8114814|NCT03018028|20000822|P1|Full Analysis Set (FAS)|Overall Study||49
8114815|NCT03018028|20000818|P5|STARTED|Overall Study||49
8114816|NCT03018028|20000819|P4|STARTED|Overall Study||48
8114817|NCT03018028|20000820|P3|STARTED|Overall Study||48
8114818|NCT03018028|20000821|P2|STARTED|Overall Study||49
8114819|NCT03018028|20000822|P1|STARTED|Overall Study||49
8114820|NCT03017937|20001067|P1|NOT COMPLETED|Overall Study||0
8114821|NCT03017937|20001067|P1|COMPLETED|Overall Study||155
8114822|NCT03017937|20001067|P1|STARTED|Overall Study||155
8114823|NCT03017846|20001072|P1|NOT COMPLETED|Overall Study||5
8114824|NCT03017846|20001072|P1|COMPLETED|Overall Study||25
8114825|NCT03017846|20001072|P1|STARTED|Overall Study||30
8114826|NCT03017612|20001080|P1|NOT COMPLETED|Overall Study||2
8114827|NCT03017612|20001080|P1|COMPLETED|Overall Study||11
8114828|NCT03017612|20001080|P1|STARTED|Overall Study||13
8114829|NCT03017261|20001088|P1|NOT COMPLETED|12 Month Follow up||47
8114830|NCT03017261|20001088|P1|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
8114831|NCT03017261|20001088|P1|STARTED|12 Month Follow up||106
8114832|NCT03017261|20001088|P1|NOT COMPLETED|6 Month Follow up||9
8114833|NCT03017261|20001088|P1|COMPLETED|6 Month Follow up||106
8114834|NCT03017261|20001088|P1|STARTED|6 Month Follow up||115
8114835|NCT03017261|20001088|P1|NOT COMPLETED|3 Month Follow up||0
8114836|NCT03017261|20001088|P1|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
8114837|NCT03017261|20001088|P1|STARTED|3 Month Follow up||115
8114838|NCT03017261|20001088|P1|NOT COMPLETED|6 Week Follow up||0
8114839|NCT03017261|20001088|P1|COMPLETED|6 Week Follow up||115
8114840|NCT03017261|20001088|P1|STARTED|6 Week Follow up||115
8114841|NCT03017235|20001125|P2|NOT COMPLETED|Overall Study||14
8114842|NCT03017235|20001126|P1|NOT COMPLETED|Overall Study||12
8114843|NCT03017235|20001125|P2|COMPLETED|Overall Study||447
8114844|NCT03017235|20001126|P1|COMPLETED|Overall Study||444
8114845|NCT03017235|20001125|P2|STARTED|Overall Study||461
8114846|NCT03017235|20001126|P1|STARTED|Overall Study||456
8114847|NCT03017040|20001176|P2|NOT COMPLETED|Overall Study||1
8114848|NCT03017040|20001177|P1|NOT COMPLETED|Overall Study||1
8114849|NCT03017040|20001176|P2|COMPLETED|Overall Study||0
8114850|NCT03017040|20001177|P1|COMPLETED|Overall Study||0
8114851|NCT03017040|20001176|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
8114940|NCT03015220|20001445|P3|Safety Analysis Set (SAS)|Overall Study||130
8114852|NCT03017040|20001177|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
8114853|NCT03016325|20001195|P8|NOT COMPLETED|182-Day Follow-Up Period||5
8114854|NCT03016325|20001196|P7|NOT COMPLETED|182-Day Follow-Up Period||4
8114855|NCT03016325|20001197|P6|NOT COMPLETED|182-Day Follow-Up Period||5
8114856|NCT03016325|20001198|P5|NOT COMPLETED|182-Day Follow-Up Period||12
8114857|NCT03016325|20001199|P4|NOT COMPLETED|182-Day Follow-Up Period||13
8114858|NCT03016325|20001200|P3|NOT COMPLETED|182-Day Follow-Up Period||11
8114859|NCT03016325|20001201|P2|NOT COMPLETED|182-Day Follow-Up Period||4
8114860|NCT03016325|20001202|P1|NOT COMPLETED|182-Day Follow-Up Period||4
8114861|NCT03016325|20001195|P8|COMPLETED|182-Day Follow-Up Period||1
8114862|NCT03016325|20001196|P7|COMPLETED|182-Day Follow-Up Period||2
8114863|NCT03016325|20001197|P6|COMPLETED|182-Day Follow-Up Period||1
8114864|NCT03016325|20001198|P5|COMPLETED|182-Day Follow-Up Period||60
8114865|NCT03016325|20001199|P4|COMPLETED|182-Day Follow-Up Period||58
8114866|NCT03016325|20001200|P3|COMPLETED|182-Day Follow-Up Period||60
8114867|NCT03016325|20001201|P2|COMPLETED|182-Day Follow-Up Period||45
8114868|NCT03016325|20001202|P1|COMPLETED|182-Day Follow-Up Period||44
8114869|NCT03016325|20001195|P8|STARTED|182-Day Follow-Up Period||6
8114870|NCT03016325|20001196|P7|STARTED|182-Day Follow-Up Period||6
8114871|NCT03016325|20001197|P6|STARTED|182-Day Follow-Up Period||6
8114872|NCT03016325|20001198|P5|STARTED|182-Day Follow-Up Period||72
8114873|NCT03016325|20001199|P4|STARTED|182-Day Follow-Up Period||71
8114874|NCT03016325|20001200|P3|STARTED|182-Day Follow-Up Period||71
8114875|NCT03016325|20001201|P2|STARTED|182-Day Follow-Up Period||49
8114876|NCT03016325|20001202|P1|STARTED|182-Day Follow-Up Period||48
8114877|NCT03016325|20001195|P8|NOT COMPLETED|32-Day Follow-Up Period||0
8114878|NCT03016325|20001196|P7|NOT COMPLETED|32-Day Follow-Up Period||1
8114879|NCT03016325|20001197|P6|NOT COMPLETED|32-Day Follow-Up Period||0
8114880|NCT03016325|20001198|P5|NOT COMPLETED|32-Day Follow-Up Period||8
8114881|NCT03016325|20001199|P4|NOT COMPLETED|32-Day Follow-Up Period||8
8114882|NCT03016325|20001200|P3|NOT COMPLETED|32-Day Follow-Up Period||9
8114883|NCT03016325|20001201|P2|NOT COMPLETED|32-Day Follow-Up Period||2
8114884|NCT03016325|20001202|P1|NOT COMPLETED|32-Day Follow-Up Period||4
8114885|NCT03016325|20001195|P8|COMPLETED|32-Day Follow-Up Period||6
8114886|NCT03016325|20001196|P7|COMPLETED|32-Day Follow-Up Period||5
8114887|NCT03016325|20001197|P6|COMPLETED|32-Day Follow-Up Period||6
8114888|NCT03016325|20001198|P5|COMPLETED|32-Day Follow-Up Period||64
8114889|NCT03016325|20001199|P4|COMPLETED|32-Day Follow-Up Period||63
8114890|NCT03016325|20001200|P3|COMPLETED|32-Day Follow-Up Period||62
8114891|NCT03016325|20001201|P2|COMPLETED|32-Day Follow-Up Period||47
8114892|NCT03016325|20001202|P1|COMPLETED|32-Day Follow-Up Period||44
8114893|NCT03016325|20001195|P8|STARTED|32-Day Follow-Up Period||6
8114894|NCT03016325|20001196|P7|STARTED|32-Day Follow-Up Period||6
8114895|NCT03016325|20001197|P6|STARTED|32-Day Follow-Up Period||6
8114896|NCT03016325|20001198|P5|STARTED|32-Day Follow-Up Period||72
8114897|NCT03016325|20001199|P4|STARTED|32-Day Follow-Up Period||71
8114898|NCT03016325|20001200|P3|STARTED|32-Day Follow-Up Period||71
8114899|NCT03016325|20001201|P2|STARTED|32-Day Follow-Up Period||49
8114900|NCT03016325|20001202|P1|STARTED|32-Day Follow-Up Period||48
8114901|NCT03016325|20001195|P8|NOT COMPLETED|Treatment Period||0
8114902|NCT03016325|20001196|P7|NOT COMPLETED|Treatment Period||0
8114903|NCT03016325|20001197|P6|NOT COMPLETED|Treatment Period||0
8114904|NCT03016325|20001198|P5|NOT COMPLETED|Treatment Period||2
8114905|NCT03016325|20001199|P4|NOT COMPLETED|Treatment Period||0
8114906|NCT03016325|20001200|P3|NOT COMPLETED|Treatment Period||1
8114907|NCT03016325|20001201|P2|NOT COMPLETED|Treatment Period||1
8114908|NCT03016325|20001202|P1|NOT COMPLETED|Treatment Period||0
8114909|NCT03016325|20001195|P8|COMPLETED|Treatment Period||6
8114910|NCT03016325|20001196|P7|COMPLETED|Treatment Period||6
8114911|NCT03016325|20001197|P6|COMPLETED|Treatment Period||6
8114912|NCT03016325|20001198|P5|COMPLETED|Treatment Period||70
8114913|NCT03016325|20001199|P4|COMPLETED|Treatment Period||71
8114914|NCT03016325|20001200|P3|COMPLETED|Treatment Period||70
8114915|NCT03016325|20001201|P2|COMPLETED|Treatment Period||48
8114916|NCT03016325|20001202|P1|COMPLETED|Treatment Period||48
8114917|NCT03016325|20001195|P8|STARTED|Treatment Period||6
8114918|NCT03016325|20001196|P7|STARTED|Treatment Period||6
8114919|NCT03016325|20001197|P6|STARTED|Treatment Period||6
8114920|NCT03016325|20001198|P5|STARTED|Treatment Period||72
8114921|NCT03016325|20001199|P4|STARTED|Treatment Period||71
8114922|NCT03016325|20001200|P3|STARTED|Treatment Period||71
8114923|NCT03016325|20001201|P2|STARTED|Treatment Period||49
8114924|NCT03016325|20001202|P1|STARTED|Treatment Period||48
8114925|NCT03016078|20001425|P1|NOT COMPLETED|Overall Study||2
8114926|NCT03016078|20001425|P1|COMPLETED|Overall Study||19
8114927|NCT03016078|20001425|P1|STARTED|Overall Study||21
8114928|NCT03015649|20001436|P1|NOT COMPLETED|Overall Study||0
8114929|NCT03015649|20001436|P1|COMPLETED|Overall Study||34
8114930|NCT03015649|20001436|P1|STARTED|Overall Study||34
8114931|NCT03015220|20001444|P4|NOT COMPLETED|Overall Study||2
8114932|NCT03015220|20001445|P3|NOT COMPLETED|Overall Study||3
8114933|NCT03015220|20001446|P2|NOT COMPLETED|Overall Study||2
8114934|NCT03015220|20001447|P1|NOT COMPLETED|Overall Study||3
8114935|NCT03015220|20001444|P4|COMPLETED|Overall Study||63
8114936|NCT03015220|20001445|P3|COMPLETED|Overall Study||127
8114937|NCT03015220|20001446|P2|COMPLETED|Overall Study||130
8114938|NCT03015220|20001447|P1|COMPLETED|Overall Study||128
8114939|NCT03015220|20001444|P4|Safety Analysis Set (SAS)|Overall Study||65
8114941|NCT03015220|20001446|P2|Safety Analysis Set (SAS)|Overall Study||132
8114942|NCT03015220|20001447|P1|Safety Analysis Set (SAS)|Overall Study||131
8114943|NCT03015220|20001444|P4|Full Analysis Set (FAS)|Overall Study||65
8114944|NCT03015220|20001445|P3|Full Analysis Set (FAS)|Overall Study||130
8114945|NCT03015220|20001446|P2|Full Analysis Set (FAS)|Overall Study||132
8114946|NCT03015220|20001447|P1|Full Analysis Set (FAS)|Overall Study||131
8114947|NCT03015220|20001444|P4|STARTED|Overall Study||65
8114948|NCT03015220|20001445|P3|STARTED|Overall Study||130
8114949|NCT03015220|20001446|P2|STARTED|Overall Study||132
8114950|NCT03015220|20001447|P1|STARTED|Overall Study||131
8114951|NCT03015181|20001592|P7|NOT COMPLETED|Overall Study||1
8114952|NCT03015181|20001593|P6|NOT COMPLETED|Overall Study||1
8114953|NCT03015181|20001594|P5|NOT COMPLETED|Overall Study||0
8114954|NCT03015181|20001595|P4|NOT COMPLETED|Overall Study||0
8114955|NCT03015181|20001596|P3|NOT COMPLETED|Overall Study||0
8114956|NCT03015181|20001597|P2|NOT COMPLETED|Overall Study||0
8114957|NCT03015181|20001598|P1|NOT COMPLETED|Overall Study||1
8114958|NCT03015181|20001592|P7|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
8114959|NCT03015181|20001593|P6|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
8114960|NCT03015181|20001594|P5|COMPLETED|Overall Study||3
8114961|NCT03015181|20001595|P4|COMPLETED|Overall Study||3
8114962|NCT03015181|20001596|P3|COMPLETED|Overall Study||3
8114963|NCT03015181|20001597|P2|COMPLETED|Overall Study||3
8114964|NCT03015181|20001598|P1|COMPLETED|Overall Study||3
8114965|NCT03015181|20001592|P7|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
8114966|NCT03015181|20001593|P6|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
8114967|NCT03015181|20001594|P5|Discontinued VRC07-523LS Administrations|Overall Study||0
8114968|NCT03015181|20001595|P4|Discontinued VRC07-523LS Administrations|Overall Study||0
8114969|NCT03015181|20001596|P3|Discontinued VRC07-523LS Administrations|Overall Study||0
8114970|NCT03015181|20001597|P2|Discontinued VRC07-523LS Administrations|Overall Study||0
8114971|NCT03015181|20001598|P1|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
8114972|NCT03015181|20001592|P7|Received VRC07-523LS Per Protocol|Overall Study||4
8114973|NCT03015181|20001593|P6|Received VRC07-523LS Per Protocol|Overall Study||4
8114974|NCT03015181|20001594|P5|Received VRC07-523LS Per Protocol|Overall Study||3
8114975|NCT03015181|20001595|P4|Received VRC07-523LS Per Protocol|Overall Study||3
8114976|NCT03015181|20001596|P3|Received VRC07-523LS Per Protocol|Overall Study||3
8114977|NCT03015181|20001597|P2|Received VRC07-523LS Per Protocol|Overall Study||3
8114978|NCT03015181|20001598|P1|Received VRC07-523LS Per Protocol|Overall Study||3
8114979|NCT03015181|20001592|P7|STARTED|Overall Study||5
8114980|NCT03015181|20001593|P6|STARTED|Overall Study||5
8114981|NCT03015181|20001594|P5|STARTED|Overall Study||3
8114982|NCT03015181|20001595|P4|STARTED|Overall Study||3
8114983|NCT03015181|20001596|P3|STARTED|Overall Study||3
8114984|NCT03015181|20001597|P2|STARTED|Overall Study||3
8114985|NCT03015181|20001598|P1|STARTED|Overall Study||4
8114986|NCT03015142|20001709|P1|NOT COMPLETED|Overall Study||1
8114987|NCT03015142|20001709|P1|COMPLETED|Overall Study||20
8114988|NCT03015142|20001709|P1|STARTED|Overall Study||21
8114989|NCT03014700|20001724|P2|NOT COMPLETED|Overall Study||1
8114990|NCT03014700|20001725|P1|NOT COMPLETED|Overall Study||5
8114991|NCT03014700|20001724|P2|COMPLETED|Overall Study||29
8114992|NCT03014700|20001725|P1|COMPLETED|Overall Study||25
8114993|NCT03014700|20001724|P2|STARTED|Overall Study||30
8114994|NCT03014700|20001725|P1|STARTED|Overall Study||30
8114995|NCT03014674|20001744|P3|NOT COMPLETED|Overall Study||0
8114996|NCT03014674|20001745|P2|NOT COMPLETED|Overall Study||0
8114997|NCT03014674|20001746|P1|NOT COMPLETED|Overall Study||1
8114998|NCT03014674|20001744|P3|COMPLETED|Overall Study||80
8114999|NCT03014674|20001745|P2|COMPLETED|Overall Study||79
8115000|NCT03014674|20001746|P1|COMPLETED|Overall Study||84
8115001|NCT03014674|20001744|P3|STARTED|Overall Study||80
8115002|NCT03014674|20001745|P2|STARTED|Overall Study||79
8115003|NCT03014674|20001746|P1|STARTED|Overall Study||85
8115004|NCT03014492|20001810|P2|NOT COMPLETED|Overall Study||0
8115005|NCT03014492|20001811|P1|NOT COMPLETED|Overall Study||0
8115006|NCT03014492|20001810|P2|COMPLETED|Overall Study||28
8115007|NCT03014492|20001811|P1|COMPLETED|Overall Study||44
8115008|NCT03014492|20001810|P2|STARTED|Overall Study||28
8115009|NCT03014492|20001811|P1|STARTED|Overall Study||44
8115010|NCT03014479|20001821|P2|NOT COMPLETED|Overall Study||4
8115011|NCT03014479|20001822|P1|NOT COMPLETED|Overall Study||0
8115012|NCT03014479|20001821|P2|COMPLETED|Overall Study||105
8115013|NCT03014479|20001822|P1|COMPLETED|Overall Study||110
8115014|NCT03014479|20001821|P2|STARTED|Overall Study||109
8115015|NCT03014479|20001822|P1|STARTED|Overall Study||110
8115016|NCT03014453|20001868|P1|NOT COMPLETED|Overall Study||71
8115017|NCT03014453|20001868|P1|COMPLETED|Overall Study||116
8115018|NCT03014453|20001868|P1|STARTED|Overall Study||187
8115019|NCT03014206|20001872|P1|NOT COMPLETED|Overall Study||12
8115020|NCT03014206|20001872|P1|COMPLETED|Overall Study||684
8115021|NCT03014206|20001872|P1|STARTED|Overall Study||696
8115022|NCT03014180|20001876|P1|NOT COMPLETED|Overall Study||2
8115023|NCT03014180|20001876|P1|COMPLETED|Overall Study||58
8115024|NCT03014180|20001876|P1|STARTED|Overall Study||60
8115025|NCT03014011|20001885|P2|NOT COMPLETED|Second Intervention||0
8115026|NCT03014011|20001886|P1|NOT COMPLETED|Second Intervention||0
8115027|NCT03014011|20001885|P2|COMPLETED|Second Intervention||13
8115028|NCT03014011|20001886|P1|COMPLETED|Second Intervention||12
8115029|NCT03014011|20001885|P2|STARTED|Second Intervention||13
8115030|NCT03014011|20001886|P1|STARTED|Second Intervention||12
8115031|NCT03014011|20001885|P2|NOT COMPLETED|Washout||0
8115032|NCT03014011|20001886|P1|NOT COMPLETED|Washout||1
8115033|NCT03014011|20001885|P2|COMPLETED|Washout||13
8115034|NCT03014011|20001886|P1|COMPLETED|Washout||12
8115035|NCT03014011|20001885|P2|STARTED|Washout||13
8115036|NCT03014011|20001886|P1|STARTED|Washout||13
8115037|NCT03014011|20001885|P2|NOT COMPLETED|First Intervention||0
8115038|NCT03014011|20001886|P1|NOT COMPLETED|First Intervention||1
8115039|NCT03014011|20001885|P2|COMPLETED|First Intervention||13
8115040|NCT03014011|20001886|P1|COMPLETED|First Intervention||13
8115041|NCT03014011|20001885|P2|STARTED|First Intervention||13
8115042|NCT03014011|20001886|P1|STARTED|First Intervention||14
8115043|NCT03013985|20001894|P2|NOT COMPLETED|Overall Study||19
8115044|NCT03013985|20001895|P1|NOT COMPLETED|Overall Study||16
8115045|NCT03013985|20001894|P2|COMPLETED|Overall Study||84
8115046|NCT03013985|20001895|P1|COMPLETED|Overall Study||92
8115047|NCT03013985|20001894|P2|STARTED|Overall Study||103
8115048|NCT03013985|20001895|P1|STARTED|Overall Study||108
8115049|NCT03012841|20001927|P2|NOT COMPLETED|Overall Study||21
8115050|NCT03012841|20001928|P1|NOT COMPLETED|Overall Study||20
8115051|NCT03012841|20001927|P2|COMPLETED|Overall Study||0
8115052|NCT03012841|20001928|P1|COMPLETED|Overall Study||145
8115053|NCT03012841|20001927|P2|STARTED|Overall Study||21
8115054|NCT03012841|20001928|P1|STARTED|Overall Study||165
8115055|NCT03012828|20001942|P6|NOT COMPLETED|Overall Study||2
8115056|NCT03012828|20001943|P5|NOT COMPLETED|Overall Study||2
8115057|NCT03012828|20001944|P4|NOT COMPLETED|Overall Study||0
8115058|NCT03012828|20001945|P3|NOT COMPLETED|Overall Study||2
8115059|NCT03012828|20001946|P2|NOT COMPLETED|Overall Study||0
8115060|NCT03012828|20001947|P1|NOT COMPLETED|Overall Study||1
8115061|NCT03012828|20001942|P6|COMPLETED|Overall Study||8
8115062|NCT03012828|20001943|P5|COMPLETED|Overall Study||8
8115063|NCT03012828|20001944|P4|COMPLETED|Overall Study||10
8115064|NCT03012828|20001945|P3|COMPLETED|Overall Study||8
8115065|NCT03012828|20001946|P2|COMPLETED|Overall Study||10
8115066|NCT03012828|20001947|P1|COMPLETED|Overall Study||9
8115067|NCT03012828|20001942|P6|STARTED|Overall Study||10
8115068|NCT03012828|20001943|P5|STARTED|Overall Study||10
8115069|NCT03012828|20001944|P4|STARTED|Overall Study||10
8115070|NCT03012828|20001945|P3|STARTED|Overall Study||10
8115071|NCT03012828|20001946|P2|STARTED|Overall Study||10
8115072|NCT03012828|20001947|P1|STARTED|Overall Study||10
8115073|NCT03012594|20001980|P1|NOT COMPLETED|Overall Study||3
8115074|NCT03012594|20001980|P1|COMPLETED|Overall Study||9
8115075|NCT03012594|20001980|P1|STARTED|Overall Study||12
8115076|NCT03012334|20001995|P10|NOT COMPLETED|Period 5||0
8115077|NCT03012334|20001996|P9|NOT COMPLETED|Period 5||0
8115078|NCT03012334|20001997|P8|NOT COMPLETED|Period 5||0
8115079|NCT03012334|20001998|P7|NOT COMPLETED|Period 5||0
8115080|NCT03012334|20001999|P6|NOT COMPLETED|Period 5||0
8115081|NCT03012334|20002000|P5|NOT COMPLETED|Period 5||0
8115082|NCT03012334|20002001|P4|NOT COMPLETED|Period 5||0
8115083|NCT03012334|20002002|P3|NOT COMPLETED|Period 5||0
8115084|NCT03012334|20002003|P2|NOT COMPLETED|Period 5||0
8115085|NCT03012334|20002004|P1|NOT COMPLETED|Period 5||0
8115086|NCT03012334|20001995|P10|COMPLETED|Period 5||8
8115087|NCT03012334|20001996|P9|COMPLETED|Period 5||8
8115088|NCT03012334|20001997|P8|COMPLETED|Period 5||8
8115089|NCT03012334|20001998|P7|COMPLETED|Period 5||8
8115090|NCT03012334|20001999|P6|COMPLETED|Period 5||9
8115091|NCT03012334|20002000|P5|COMPLETED|Period 5||9
8115092|NCT03012334|20002001|P4|COMPLETED|Period 5||9
8115093|NCT03012334|20002002|P3|COMPLETED|Period 5||8
8115094|NCT03012334|20002003|P2|COMPLETED|Period 5||8
8115095|NCT03012334|20002004|P1|COMPLETED|Period 5||9
8115096|NCT03012334|20001995|P10|STARTED|Period 5||8
8115097|NCT03012334|20001996|P9|STARTED|Period 5||8
8115098|NCT03012334|20001997|P8|STARTED|Period 5||8
8115099|NCT03012334|20001998|P7|STARTED|Period 5||8
8115100|NCT03012334|20001999|P6|STARTED|Period 5||9
8115101|NCT03012334|20002000|P5|STARTED|Period 5||9
8115102|NCT03012334|20002001|P4|STARTED|Period 5||9
8115103|NCT03012334|20002002|P3|STARTED|Period 5||8
8115104|NCT03012334|20002003|P2|STARTED|Period 5||8
8115105|NCT03012334|20002004|P1|STARTED|Period 5||9
8115106|NCT03012334|20001995|P10|NOT COMPLETED|Period 4||0
8115107|NCT03012334|20001996|P9|NOT COMPLETED|Period 4||1
8115108|NCT03012334|20001997|P8|NOT COMPLETED|Period 4||0
8115109|NCT03012334|20001998|P7|NOT COMPLETED|Period 4||1
8115110|NCT03012334|20001999|P6|NOT COMPLETED|Period 4||0
8115111|NCT03012334|20002000|P5|NOT COMPLETED|Period 4||0
8115112|NCT03012334|20002001|P4|NOT COMPLETED|Period 4||0
8115113|NCT03012334|20002002|P3|NOT COMPLETED|Period 4||0
8115114|NCT03012334|20002003|P2|NOT COMPLETED|Period 4||0
8115115|NCT03012334|20002004|P1|NOT COMPLETED|Period 4||0
8115116|NCT03012334|20001995|P10|COMPLETED|Period 4||8
8115117|NCT03012334|20001996|P9|COMPLETED|Period 4||8
8115118|NCT03012334|20001997|P8|COMPLETED|Period 4||8
8115119|NCT03012334|20001998|P7|COMPLETED|Period 4||8
8115120|NCT03012334|20001999|P6|COMPLETED|Period 4||9
8115121|NCT03012334|20002000|P5|COMPLETED|Period 4||9
8115122|NCT03012334|20002001|P4|COMPLETED|Period 4||9
8115123|NCT03012334|20002002|P3|COMPLETED|Period 4||8
8115124|NCT03012334|20002003|P2|COMPLETED|Period 4||8
8115125|NCT03012334|20002004|P1|COMPLETED|Period 4||9
8115126|NCT03012334|20001995|P10|STARTED|Period 4||8
8115127|NCT03012334|20001996|P9|STARTED|Period 4||9
8115128|NCT03012334|20001997|P8|STARTED|Period 4||8
8115129|NCT03012334|20001998|P7|STARTED|Period 4||9
8115130|NCT03012334|20001999|P6|STARTED|Period 4||9
8115131|NCT03012334|20002000|P5|STARTED|Period 4||9
8115132|NCT03012334|20002001|P4|STARTED|Period 4||9
8115133|NCT03012334|20002002|P3|STARTED|Period 4||8
8115134|NCT03012334|20002003|P2|STARTED|Period 4||8
8115135|NCT03012334|20002004|P1|STARTED|Period 4||9
8115136|NCT03012334|20001995|P10|NOT COMPLETED|Period 3||0
8115137|NCT03012334|20001996|P9|NOT COMPLETED|Period 3||0
8115138|NCT03012334|20001997|P8|NOT COMPLETED|Period 3||0
8115139|NCT03012334|20001998|P7|NOT COMPLETED|Period 3||0
8115140|NCT03012334|20001999|P6|NOT COMPLETED|Period 3||0
8115141|NCT03012334|20002000|P5|NOT COMPLETED|Period 3||0
8115142|NCT03012334|20002001|P4|NOT COMPLETED|Period 3||0
8115143|NCT03012334|20002002|P3|NOT COMPLETED|Period 3||0
8115144|NCT03012334|20002003|P2|NOT COMPLETED|Period 3||0
8115145|NCT03012334|20002004|P1|NOT COMPLETED|Period 3||0
8115146|NCT03012334|20001995|P10|COMPLETED|Period 3||8
8115147|NCT03012334|20001996|P9|COMPLETED|Period 3||9
8115148|NCT03012334|20001997|P8|COMPLETED|Period 3||8
8115149|NCT03012334|20001998|P7|COMPLETED|Period 3||9
8115150|NCT03012334|20001999|P6|COMPLETED|Period 3||9
8115151|NCT03012334|20002000|P5|COMPLETED|Period 3||9
8115152|NCT03012334|20002001|P4|COMPLETED|Period 3||9
8115153|NCT03012334|20002002|P3|COMPLETED|Period 3||8
8115154|NCT03012334|20002003|P2|COMPLETED|Period 3||8
8115155|NCT03012334|20002004|P1|COMPLETED|Period 3||9
8115156|NCT03012334|20001995|P10|STARTED|Period 3||8
8115157|NCT03012334|20001996|P9|STARTED|Period 3||9
8115158|NCT03012334|20001997|P8|STARTED|Period 3||8
8115159|NCT03012334|20001998|P7|STARTED|Period 3||9
8115160|NCT03012334|20001999|P6|STARTED|Period 3||9
8115161|NCT03012334|20002000|P5|STARTED|Period 3||9
8115162|NCT03012334|20002001|P4|STARTED|Period 3||9
8115163|NCT03012334|20002002|P3|STARTED|Period 3||8
8115164|NCT03012334|20002003|P2|STARTED|Period 3||8
8115165|NCT03012334|20002004|P1|STARTED|Period 3||9
8115166|NCT03012334|20001995|P10|NOT COMPLETED|Period 2||0
8115167|NCT03012334|20001996|P9|NOT COMPLETED|Period 2||0
8115168|NCT03012334|20001997|P8|NOT COMPLETED|Period 2||1
8115169|NCT03012334|20001998|P7|NOT COMPLETED|Period 2||0
8115170|NCT03012334|20001999|P6|NOT COMPLETED|Period 2||0
8115171|NCT03012334|20002000|P5|NOT COMPLETED|Period 2||0
8115172|NCT03012334|20002001|P4|NOT COMPLETED|Period 2||0
8115173|NCT03012334|20002002|P3|NOT COMPLETED|Period 2||1
8115174|NCT03012334|20002003|P2|NOT COMPLETED|Period 2||1
8115175|NCT03012334|20002004|P1|NOT COMPLETED|Period 2||0
8115176|NCT03012334|20001995|P10|COMPLETED|Period 2||8
8115177|NCT03012334|20001996|P9|COMPLETED|Period 2||9
8115178|NCT03012334|20001997|P8|COMPLETED|Period 2||8
8115179|NCT03012334|20001998|P7|COMPLETED|Period 2||9
8115180|NCT03012334|20001999|P6|COMPLETED|Period 2||9
8115181|NCT03012334|20002000|P5|COMPLETED|Period 2||9
8115182|NCT03012334|20002001|P4|COMPLETED|Period 2||9
8115183|NCT03012334|20002002|P3|COMPLETED|Period 2||8
8115184|NCT03012334|20002003|P2|COMPLETED|Period 2||8
8115185|NCT03012334|20002004|P1|COMPLETED|Period 2||9
8115186|NCT03012334|20001995|P10|STARTED|Period 2||8
8115187|NCT03012334|20001996|P9|STARTED|Period 2||9
8115188|NCT03012334|20001997|P8|STARTED|Period 2||9
8115189|NCT03012334|20001998|P7|STARTED|Period 2||9
8115190|NCT03012334|20001999|P6|STARTED|Period 2||9
8115191|NCT03012334|20002000|P5|STARTED|Period 2||9
8115192|NCT03012334|20002001|P4|STARTED|Period 2||9
8115193|NCT03012334|20002002|P3|STARTED|Period 2||9
8115194|NCT03012334|20002003|P2|STARTED|Period 2||9
8115195|NCT03012334|20002004|P1|STARTED|Period 2||9
8115196|NCT03012334|20001995|P10|NOT COMPLETED|Period 1||1
8115197|NCT03012334|20001996|P9|NOT COMPLETED|Period 1||0
8115198|NCT03012334|20001997|P8|NOT COMPLETED|Period 1||0
8115199|NCT03012334|20001998|P7|NOT COMPLETED|Period 1||0
8115200|NCT03012334|20001999|P6|NOT COMPLETED|Period 1||0
8115201|NCT03012334|20002000|P5|NOT COMPLETED|Period 1||0
8115202|NCT03012334|20002001|P4|NOT COMPLETED|Period 1||0
8115203|NCT03012334|20002002|P3|NOT COMPLETED|Period 1||0
8115204|NCT03012334|20002003|P2|NOT COMPLETED|Period 1||0
8115205|NCT03012334|20002004|P1|NOT COMPLETED|Period 1||0
8115206|NCT03012334|20001995|P10|COMPLETED|Period 1||8
8115207|NCT03012334|20001996|P9|COMPLETED|Period 1||9
8115208|NCT03012334|20001997|P8|COMPLETED|Period 1||9
8115209|NCT03012334|20001998|P7|COMPLETED|Period 1||9
8115210|NCT03012334|20001999|P6|COMPLETED|Period 1||9
8115211|NCT03012334|20002000|P5|COMPLETED|Period 1||9
8115212|NCT03012334|20002001|P4|COMPLETED|Period 1||9
8115213|NCT03012334|20002002|P3|COMPLETED|Period 1||9
8115214|NCT03012334|20002003|P2|COMPLETED|Period 1||9
8115215|NCT03012334|20002004|P1|COMPLETED|Period 1||9
8115216|NCT03012334|20001995|P10|STARTED|Period 1||9
8115217|NCT03012334|20001996|P9|STARTED|Period 1||9
8115218|NCT03012334|20001997|P8|STARTED|Period 1||9
8115219|NCT03012334|20001998|P7|STARTED|Period 1||9
8115220|NCT03012334|20001999|P6|STARTED|Period 1||9
8115221|NCT03012334|20002000|P5|STARTED|Period 1||9
8115222|NCT03012334|20002001|P4|STARTED|Period 1||9
8115223|NCT03012334|20002002|P3|STARTED|Period 1||9
8115224|NCT03012334|20002003|P2|STARTED|Period 1||9
8115225|NCT03012334|20002004|P1|STARTED|Period 1||9
8115226|NCT03012191|20002054|P3|NOT COMPLETED|Overall Study||0
8115227|NCT03012191|20002055|P2|NOT COMPLETED|Overall Study||0
8115228|NCT03012191|20002056|P1|NOT COMPLETED|Overall Study||0
8115229|NCT03012191|20002054|P3|COMPLETED|Overall Study||2
8115230|NCT03012191|20002055|P2|COMPLETED|Overall Study||2
8115231|NCT03012191|20002056|P1|COMPLETED|Overall Study||2
8115232|NCT03012191|20002054|P3|STARTED|Overall Study||2
8115233|NCT03012191|20002055|P2|STARTED|Overall Study||2
8115234|NCT03012191|20002056|P1|STARTED|Overall Study||2
8115235|NCT03012061|20002074|P3|NOT COMPLETED|Overall Study||8
8115236|NCT03012061|20002075|P2|NOT COMPLETED|Overall Study||9
8115237|NCT03012061|20002076|P1|NOT COMPLETED|Overall Study||6
8115238|NCT03012061|20002074|P3|COMPLETED|Overall Study||131
8115239|NCT03012061|20002075|P2|COMPLETED|Overall Study||130
8115240|NCT03012061|20002076|P1|COMPLETED|Overall Study||137
8115241|NCT03012061|20002074|P3|STARTED|Overall Study||139
8115242|NCT03012061|20002075|P2|STARTED|Overall Study||139
8115243|NCT03012061|20002076|P1|STARTED|Overall Study||143
8115244|NCT03011840|20002101|P2|NOT COMPLETED|Overall Study||21
8115245|NCT03011840|20002102|P1|NOT COMPLETED|Overall Study||0
8115246|NCT03011840|20002101|P2|COMPLETED|Overall Study||196
8115247|NCT03011840|20002102|P1|COMPLETED|Overall Study||232
8115248|NCT03011840|20002101|P2|STARTED|Overall Study||217
8115249|NCT03011840|20002102|P1|STARTED|Overall Study||232
8115250|NCT03011099|20002112|P2|NOT COMPLETED|Overall Study||2
8115251|NCT03011099|20002113|P1|NOT COMPLETED|Overall Study||0
8115252|NCT03011099|20002112|P2|COMPLETED|Overall Study||3
8115253|NCT03011099|20002113|P1|COMPLETED|Overall Study||6
8115254|NCT03011099|20002112|P2|STARTED|Overall Study||5
8115255|NCT03011099|20002113|P1|STARTED|Overall Study||6
8115256|NCT03011034|20002139|P2|NOT COMPLETED|Overall Study||0
8115257|NCT03011034|20002140|P1|NOT COMPLETED|Overall Study||1
8115258|NCT03011034|20002139|P2|COMPLETED|Overall Study||33
8115259|NCT03011034|20002140|P1|COMPLETED|Overall Study||0
8115260|NCT03011034|20002139|P2|STARTED|Overall Study||33
8115261|NCT03011034|20002140|P1|STARTED|Overall Study||1
8115262|NCT03010800|20002170|P2|NOT COMPLETED|Cross Over||0
8115263|NCT03010800|20002171|P1|NOT COMPLETED|Cross Over||0
8115264|NCT03010800|20002170|P2|COMPLETED|Cross Over||4
8115265|NCT03010800|20002171|P1|COMPLETED|Cross Over||4
8115266|NCT03010800|20002170|P2|STARTED|Cross Over||4
8115267|NCT03010800|20002171|P1|STARTED|Cross Over||4
8115268|NCT03010800|20002170|P2|NOT COMPLETED|Initial Assignment||0
8115269|NCT03010800|20002171|P1|NOT COMPLETED|Initial Assignment||0
8115270|NCT03010800|20002170|P2|COMPLETED|Initial Assignment||4
8115271|NCT03010800|20002171|P1|COMPLETED|Initial Assignment||4
8115272|NCT03010800|20002170|P2|STARTED|Initial Assignment||4
8115273|NCT03010800|20002171|P1|STARTED|Initial Assignment||4
8115274|NCT03010631|20002181|P4|NOT COMPLETED|Cohort 2||0
8115275|NCT03010631|20002182|P3|NOT COMPLETED|Cohort 2||0
8115276|NCT03010631|20002183|P2|NOT COMPLETED|Cohort 2||0
8115277|NCT03010631|20002184|P1|NOT COMPLETED|Cohort 2||0
8115278|NCT03010631|20002181|P4|COMPLETED|Cohort 2||7
8115279|NCT03010631|20002182|P3|COMPLETED|Cohort 2||7
8115280|NCT03010631|20002183|P2|COMPLETED|Cohort 2||0
8115281|NCT03010631|20002184|P1|COMPLETED|Cohort 2||0
8115282|NCT03010631|20002181|P4|STARTED|Cohort 2||7
8115283|NCT03010631|20002182|P3|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
8115284|NCT03010631|20002183|P2|STARTED|Cohort 2||0
8115285|NCT03010631|20002184|P1|STARTED|Cohort 2||0
8115286|NCT03010631|20002181|P4|NOT COMPLETED|Cohort 1||0
8115287|NCT03010631|20002182|P3|NOT COMPLETED|Cohort 1||0
8115288|NCT03010631|20002183|P2|NOT COMPLETED|Cohort 1||0
8115289|NCT03010631|20002184|P1|NOT COMPLETED|Cohort 1||4
8115290|NCT03010631|20002181|P4|COMPLETED|Cohort 1||0
8115291|NCT03010631|20002182|P3|COMPLETED|Cohort 1||0
8115292|NCT03010631|20002183|P2|COMPLETED|Cohort 1||17
8115293|NCT03010631|20002184|P1|COMPLETED|Cohort 1||14
8115294|NCT03010631|20002181|P4|STARTED|Cohort 1||0
8115295|NCT03010631|20002182|P3|STARTED|Cohort 1||0
8115296|NCT03010631|20002183|P2|STARTED|Cohort 1||17
8115297|NCT03010631|20002184|P1|STARTED|Cohort 1||18
8115298|NCT03010501|20002202|P6|NOT COMPLETED|Study Week 3||0
8115299|NCT03010501|20002203|P5|NOT COMPLETED|Study Week 3||0
8115300|NCT03010501|20002204|P4|NOT COMPLETED|Study Week 3||1
8115301|NCT03010501|20002205|P3|NOT COMPLETED|Study Week 3||0
8115302|NCT03010501|20002206|P2|NOT COMPLETED|Study Week 3||0
8115303|NCT03010501|20002207|P1|NOT COMPLETED|Study Week 3||0
8115304|NCT03010501|20002202|P6|COMPLETED|Study Week 3||11
8115305|NCT03010501|20002203|P5|COMPLETED|Study Week 3||7
8115306|NCT03010501|20002204|P4|COMPLETED|Study Week 3||4
8115307|NCT03010501|20002205|P3|COMPLETED|Study Week 3||7
8115308|NCT03010501|20002206|P2|COMPLETED|Study Week 3||14
8115309|NCT03010501|20002207|P1|COMPLETED|Study Week 3||7
8115310|NCT03010501|20002202|P6|STARTED|Study Week 3||11
8115311|NCT03010501|20002203|P5|STARTED|Study Week 3||7
8115312|NCT03010501|20002204|P4|STARTED|Study Week 3||5
8115313|NCT03010501|20002205|P3|STARTED|Study Week 3||7
8115314|NCT03010501|20002206|P2|STARTED|Study Week 3||14
8115315|NCT03010501|20002207|P1|STARTED|Study Week 3||7
8115316|NCT03010501|20002202|P6|NOT COMPLETED|Study Week 2||0
8115317|NCT03010501|20002203|P5|NOT COMPLETED|Study Week 2||0
8115318|NCT03010501|20002204|P4|NOT COMPLETED|Study Week 2||0
8115319|NCT03010501|20002205|P3|NOT COMPLETED|Study Week 2||0
8115320|NCT03010501|20002206|P2|NOT COMPLETED|Study Week 2||0
8115321|NCT03010501|20002207|P1|NOT COMPLETED|Study Week 2||0
8115322|NCT03010501|20002202|P6|COMPLETED|Study Week 2||11
8115323|NCT03010501|20002203|P5|COMPLETED|Study Week 2||7
8115324|NCT03010501|20002204|P4|COMPLETED|Study Week 2||5
8115325|NCT03010501|20002205|P3|COMPLETED|Study Week 2||7
8115326|NCT03010501|20002206|P2|COMPLETED|Study Week 2||14
8115327|NCT03010501|20002207|P1|COMPLETED|Study Week 2||7
8115328|NCT03010501|20002202|P6|STARTED|Study Week 2||11
8115329|NCT03010501|20002203|P5|STARTED|Study Week 2||7
8115330|NCT03010501|20002204|P4|STARTED|Study Week 2||5
8115331|NCT03010501|20002205|P3|STARTED|Study Week 2||7
8115332|NCT03010501|20002206|P2|STARTED|Study Week 2||14
8115333|NCT03010501|20002207|P1|STARTED|Study Week 2||7
8115334|NCT03010501|20002202|P6|NOT COMPLETED|Study Week 1||0
8115335|NCT03010501|20002203|P5|NOT COMPLETED|Study Week 1||0
8115336|NCT03010501|20002204|P4|NOT COMPLETED|Study Week 1||2
8115337|NCT03010501|20002205|P3|NOT COMPLETED|Study Week 1||0
8115338|NCT03010501|20002206|P2|NOT COMPLETED|Study Week 1||1
8115339|NCT03010501|20002207|P1|NOT COMPLETED|Study Week 1||2
8115340|NCT03010501|20002202|P6|COMPLETED|Study Week 1||11
8115341|NCT03010501|20002203|P5|COMPLETED|Study Week 1||7
8115342|NCT03010501|20002204|P4|COMPLETED|Study Week 1||5
8115343|NCT03010501|20002205|P3|COMPLETED|Study Week 1||7
8115344|NCT03010501|20002206|P2|COMPLETED|Study Week 1||14
8115345|NCT03010501|20002207|P1|COMPLETED|Study Week 1||7
8115346|NCT03010501|20002202|P6|STARTED|Study Week 1||11
8115347|NCT03010501|20002203|P5|STARTED|Study Week 1||7
8115348|NCT03010501|20002204|P4|STARTED|Study Week 1||7
8115349|NCT03010501|20002205|P3|STARTED|Study Week 1||7
8115350|NCT03010501|20002206|P2|STARTED|Study Week 1||15
8115351|NCT03010501|20002207|P1|STARTED|Study Week 1||9
8115352|NCT03010423|20002221|P1|NOT COMPLETED|Overall Study||8
8115353|NCT03010423|20002221|P1|COMPLETED|Overall Study||0
8115354|NCT03010423|20002221|P1|STARTED|Overall Study||8
8115355|NCT03010254|20002234|P2|NOT COMPLETED|Overall Study||5
8115356|NCT03010254|20002235|P1|NOT COMPLETED|Overall Study||7
8115357|NCT03010254|20002234|P2|COMPLETED|Overall Study||118
8115358|NCT03010254|20002235|P1|COMPLETED|Overall Study||152
8115359|NCT03010254|20002234|P2|Successful Implantation|Overall Study||120
8115360|NCT03010254|20002235|P1|Successful Implantation|Overall Study||156
8115361|NCT03010254|20002234|P2|Attempted Implantation|Overall Study||120
8115362|NCT03010254|20002235|P1|Attempted Implantation|Overall Study||156
8115363|NCT03010254|20002234|P2|STARTED|Overall Study||123
8115364|NCT03010254|20002235|P1|STARTED|Overall Study||159
8115365|NCT03010137|20002262|P2|NOT COMPLETED|Overall Study||0
8115366|NCT03010137|20002263|P1|NOT COMPLETED|Overall Study||0
8115367|NCT03010137|20002262|P2|COMPLETED|Overall Study||15
8115368|NCT03010137|20002263|P1|COMPLETED|Overall Study||15
8115369|NCT03010137|20002262|P2|STARTED|Overall Study||15
8115370|NCT03010137|20002263|P1|STARTED|Overall Study||15
8115371|NCT03009162|20002279|P2|NOT COMPLETED|Overall Study||0
8115372|NCT03009162|20002280|P1|NOT COMPLETED|Overall Study||0
8115373|NCT03009162|20002279|P2|COMPLETED|Overall Study||8
8115374|NCT03009162|20002280|P1|COMPLETED|Overall Study||8
8115375|NCT03009162|20002279|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8115376|NCT03009162|20002280|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8115377|NCT03009162|20002279|P2|STARTED|Overall Study||8
8115378|NCT03009162|20002280|P1|STARTED|Overall Study||8
8115379|NCT03008889|20002302|P2|NOT COMPLETED|Overall Study||0
8115380|NCT03008889|20002303|P1|NOT COMPLETED|Overall Study||0
8115381|NCT03008889|20002302|P2|COMPLETED|Overall Study||1
8115382|NCT03008889|20002303|P1|COMPLETED|Overall Study||1
8115383|NCT03008889|20002302|P2|STARTED|Overall Study||1
8115384|NCT03008889|20002303|P1|STARTED|Overall Study||1
8115385|NCT03008837|20002328|P2|NOT COMPLETED|Overall Study||4
8115386|NCT03008837|20002329|P1|NOT COMPLETED|Overall Study||3
8115387|NCT03008837|20002328|P2|COMPLETED|Overall Study||5
8115388|NCT03008837|20002329|P1|COMPLETED|Overall Study||9
8115389|NCT03008837|20002328|P2|STARTED|Overall Study||9
8115390|NCT03008837|20002329|P1|STARTED|Overall Study||12
8115391|NCT03008707|20002347|P2|NOT COMPLETED|Overall Study||0
8115392|NCT03008707|20002348|P1|NOT COMPLETED|Overall Study||0
8115393|NCT03008707|20002347|P2|COMPLETED|Overall Study||38
8115394|NCT03008707|20002348|P1|COMPLETED|Overall Study||28
8115395|NCT03008707|20002347|P2|STARTED|Overall Study||38
8115396|NCT03008707|20002348|P1|STARTED|Overall Study||28
8115397|NCT03008213|20002368|P1|NOT COMPLETED|Overall Study||0
8115398|NCT03008213|20002368|P1|COMPLETED|Overall Study||1
8115399|NCT03008213|20002368|P1|STARTED|Overall Study||1
8115400|NCT03008174|20002374|P2|NOT COMPLETED|Overall Study||4
8115401|NCT03008174|20002375|P1|NOT COMPLETED|Overall Study||3
8115402|NCT03008174|20002374|P2|COMPLETED|Overall Study||6
8115403|NCT03008174|20002375|P1|COMPLETED|Overall Study||7
8115404|NCT03008174|20002374|P2|STARTED|Overall Study||10
8115405|NCT03008174|20002375|P1|STARTED|Overall Study||10
8115406|NCT03007966|20002403|P2|NOT COMPLETED|Overall Study||0
8115407|NCT03007966|20002404|P1|NOT COMPLETED|Overall Study||1
8115408|NCT03007966|20002403|P2|COMPLETED|Overall Study||30
8115409|NCT03007966|20002404|P1|COMPLETED|Overall Study||29
8115410|NCT03007966|20002403|P2|STARTED|Overall Study||30
8115411|NCT03007966|20002404|P1|STARTED|Overall Study||30
8115412|NCT03007719|20002436|P2|NOT COMPLETED|Overall Study||0
8115413|NCT03007719|20002437|P1|NOT COMPLETED|Overall Study||0
8115414|NCT03007719|20002436|P2|COMPLETED|Overall Study||4
8115415|NCT03007719|20002437|P1|COMPLETED|Overall Study||0
8115416|NCT03007719|20002436|P2|STARTED|Overall Study||4
8115417|NCT03007719|20002437|P1|STARTED|Overall Study||0
8115418|NCT03007472|20002445|P1|NOT COMPLETED|Overall Study||5
8115419|NCT03007472|20002445|P1|COMPLETED|Overall Study||91
8115420|NCT03007472|20002445|P1|STARTED|Overall Study||96
8115421|NCT03007394|20002453|P2|NOT COMPLETED|Overall Study||63
8115422|NCT03007394|20002454|P1|NOT COMPLETED|Overall Study||27
8115423|NCT03007394|20002453|P2|COMPLETED|Overall Study||91
8115424|NCT03007394|20002454|P1|COMPLETED|Overall Study||91
8115425|NCT03007394|20002453|P2|STARTED|Overall Study||154
8115426|NCT03007394|20002454|P1|STARTED|Overall Study||118
8115427|NCT03007225|20002464|P2|NOT COMPLETED|Overall Study||0
8115428|NCT03007225|20002465|P1|NOT COMPLETED|Overall Study||0
8115429|NCT03007225|20002464|P2|COMPLETED|Overall Study||25
8115430|NCT03007225|20002465|P1|COMPLETED|Overall Study||25
8115431|NCT03007225|20002464|P2|STARTED|Overall Study|followed up for at least 6 months after TACE|25
8115432|NCT03007225|20002465|P1|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
8115433|NCT03006926|20002473|P2|NOT COMPLETED|Overall Study||98
8115434|NCT03006926|20002474|P1|NOT COMPLETED|Overall Study||0
8115435|NCT03006926|20002473|P2|COMPLETED|Overall Study||0
8115436|NCT03006926|20002474|P1|COMPLETED|Overall Study||6
8115437|NCT03006926|20002473|P2|STARTED|Overall Study||98
8115438|NCT03006926|20002474|P1|STARTED|Overall Study||6
8115439|NCT03006562|20002494|P2|NOT COMPLETED|Overall Study||1
8115440|NCT03006562|20002495|P1|NOT COMPLETED|Overall Study||0
8115441|NCT03006562|20002494|P2|COMPLETED|Overall Study||249
8115442|NCT03006562|20002495|P1|COMPLETED|Overall Study||251
8115443|NCT03006562|20002494|P2|Voluntary Ultrasound at 30 Days|Overall Study||137
8115444|NCT03006562|20002495|P1|Voluntary Ultrasound at 30 Days|Overall Study||141
8115445|NCT03006562|20002494|P2|STARTED|Overall Study||250
8115446|NCT03006562|20002495|P1|STARTED|Overall Study||251
8115447|NCT03006471|20002515|P2|NOT COMPLETED|Overall Study||2
8115448|NCT03006471|20002516|P1|NOT COMPLETED|Overall Study||2
8115449|NCT03006471|20002515|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
8115450|NCT03006471|20002516|P1|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
8115451|NCT03006471|20002515|P2|STARTED|Overall Study||15
8115452|NCT03006471|20002516|P1|STARTED|Overall Study||15
8115453|NCT03006458|20002586|P2|NOT COMPLETED|Second Intervention||0
8115454|NCT03006458|20002587|P1|NOT COMPLETED|Second Intervention||0
8115455|NCT03006458|20002586|P2|COMPLETED|Second Intervention||10
8115456|NCT03006458|20002587|P1|COMPLETED|Second Intervention||14
8115457|NCT03006458|20002586|P2|STARTED|Second Intervention||10
8115458|NCT03006458|20002587|P1|STARTED|Second Intervention||14
8115459|NCT03006458|20002586|P2|NOT COMPLETED|First Intervention||3
8115460|NCT03006458|20002587|P1|NOT COMPLETED|First Intervention||0
8115461|NCT03006458|20002586|P2|COMPLETED|First Intervention||7
8115462|NCT03006458|20002587|P1|COMPLETED|First Intervention||14
8115463|NCT03006458|20002586|P2|STARTED|First Intervention||10
8115464|NCT03006458|20002587|P1|STARTED|First Intervention||14
8115465|NCT03006341|20002629|P4|NOT COMPLETED|Overall Study||10685
8115466|NCT03006341|20002630|P3|NOT COMPLETED|Overall Study||30993
8115467|NCT03006341|20002631|P2|NOT COMPLETED|Overall Study||67505
8115468|NCT03006341|20002632|P1|NOT COMPLETED|Overall Study||25069
8115469|NCT03006341|20002629|P4|COMPLETED|Overall Study||637
8115470|NCT03006341|20002630|P3|COMPLETED|Overall Study||1602
8115471|NCT03006341|20002631|P2|COMPLETED|Overall Study||2566
8115472|NCT03006341|20002632|P1|COMPLETED|Overall Study||1130
8115473|NCT03006341|20002629|P4|STARTED|Overall Study||11322
8115474|NCT03006341|20002630|P3|STARTED|Overall Study||32595
8115475|NCT03006341|20002631|P2|STARTED|Overall Study||70071
8115476|NCT03006341|20002632|P1|STARTED|Overall Study||26199
8115477|NCT03005288|20002676|P2|NOT COMPLETED|Overall Study||8
8115478|NCT03005288|20002677|P1|NOT COMPLETED|Overall Study||12
8115479|NCT03005288|20002676|P2|COMPLETED|Overall Study||31
8115480|NCT03005288|20002677|P1|COMPLETED|Overall Study||27
8115481|NCT03005288|20002676|P2|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
8115482|NCT03005288|20002677|P1|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
8115483|NCT03005288|20002676|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
8115484|NCT03005288|20002677|P1|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
8115485|NCT03005288|20002676|P2|Safety Analysis Set|Overall Study||38
8115486|NCT03005288|20002677|P1|Safety Analysis Set|Overall Study||37
8115487|NCT03005288|20002676|P2|STARTED|Overall Study||39
8115488|NCT03005288|20002677|P1|STARTED|Overall Study||39
8115489|NCT03005067|20002709|P2|NOT COMPLETED|Overall Study||7
8115490|NCT03005067|20002710|P1|NOT COMPLETED|Overall Study||10
8115491|NCT03005067|20002709|P2|COMPLETED|Overall Study||74
8115492|NCT03005067|20002710|P1|COMPLETED|Overall Study||80
8115493|NCT03005067|20002709|P2|STARTED|Overall Study||81
8115494|NCT03005067|20002710|P1|STARTED|Overall Study||90
8115495|NCT03005041|20002722|P2|NOT COMPLETED|Period 2||0
8115496|NCT03005041|20002723|P1|NOT COMPLETED|Period 2||0
8115497|NCT03005041|20002722|P2|COMPLETED|Period 2||27
8115498|NCT03005041|20002723|P1|COMPLETED|Period 2||28
8115499|NCT03005041|20002722|P2|STARTED|Period 2||27
8115500|NCT03005041|20002723|P1|STARTED|Period 2||28
8115501|NCT03005041|20002722|P2|NOT COMPLETED|Washout Period 1||0
8115502|NCT03005041|20002723|P1|NOT COMPLETED|Washout Period 1||0
8115503|NCT03005041|20002722|P2|COMPLETED|Washout Period 1||27
8115504|NCT03005041|20002723|P1|COMPLETED|Washout Period 1||28
8115505|NCT03005041|20002722|P2|STARTED|Washout Period 1||27
8115506|NCT03005041|20002723|P1|STARTED|Washout Period 1||28
8115507|NCT03005041|20002722|P2|NOT COMPLETED|Period 1||0
8115508|NCT03005041|20002723|P1|NOT COMPLETED|Period 1||0
8115509|NCT03005041|20002722|P2|COMPLETED|Period 1||27
8115510|NCT03005041|20002723|P1|COMPLETED|Period 1||28
8115511|NCT03005041|20002722|P2|STARTED|Period 1||27
8115512|NCT03005041|20002723|P1|STARTED|Period 1||28
8115513|NCT03004924|20002738|P3|NOT COMPLETED|Overall Study||28
8115514|NCT03004924|20002739|P2|NOT COMPLETED|Overall Study||14
8115515|NCT03004924|20002740|P1|NOT COMPLETED|Overall Study||27
8115516|NCT03004924|20002738|P3|COMPLETED|Overall Study||293
8115517|NCT03004924|20002739|P2|COMPLETED|Overall Study||94
8115518|NCT03004924|20002740|P1|COMPLETED|Overall Study||297
8115519|NCT03004924|20002738|P3|STARTED|Overall Study||321
8115520|NCT03004924|20002739|P2|STARTED|Overall Study||108
8115521|NCT03004924|20002740|P1|STARTED|Overall Study||324
8115522|NCT03004911|20002792|P2|NOT COMPLETED|Overall Study||3
8115523|NCT03004911|20002793|P1|NOT COMPLETED|Overall Study||1
8115524|NCT03004911|20002792|P2|COMPLETED|Overall Study||17
8115525|NCT03004911|20002793|P1|COMPLETED|Overall Study||19
8115526|NCT03004911|20002792|P2|STARTED|Overall Study||20
8115527|NCT03004911|20002793|P1|STARTED|Overall Study||20
8115528|NCT03004846|20002811|P3|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8115529|NCT03004846|20002812|P2|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8115530|NCT03004846|20002813|P1|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8115531|NCT03004846|20002811|P3|COMPLETED|Part B (Up to 14 Weeks)||0
8115532|NCT03004846|20002812|P2|COMPLETED|Part B (Up to 14 Weeks)||0
8115533|NCT03004846|20002813|P1|COMPLETED|Part B (Up to 14 Weeks)||0
8115534|NCT03004846|20002811|P3|STARTED|Part B (Up to 14 Weeks)||0
8115535|NCT03004846|20002812|P2|STARTED|Part B (Up to 14 Weeks)||0
8115536|NCT03004846|20002813|P1|STARTED|Part B (Up to 14 Weeks)||0
8115537|NCT03004846|20002811|P3|NOT COMPLETED|Part A (Up to 14 Weeks)||0
8115538|NCT03004846|20002812|P2|NOT COMPLETED|Part A (Up to 14 Weeks)||0
8115539|NCT03004846|20002813|P1|NOT COMPLETED|Part A (Up to 14 Weeks)||0
8115540|NCT03004846|20002811|P3|COMPLETED|Part A (Up to 14 Weeks)||0
8115541|NCT03004846|20002812|P2|COMPLETED|Part A (Up to 14 Weeks)||0
8115542|NCT03004846|20002813|P1|COMPLETED|Part A (Up to 14 Weeks)||8
8115543|NCT03004846|20002811|P3|STARTED|Part A (Up to 14 Weeks)||0
8115544|NCT03004846|20002812|P2|STARTED|Part A (Up to 14 Weeks)||0
8115545|NCT03004846|20002813|P1|STARTED|Part A (Up to 14 Weeks)||8
8115546|NCT03004638|20002865|P6|NOT COMPLETED|Overall Study||0
8115547|NCT03004638|20002866|P5|NOT COMPLETED|Overall Study||0
8115548|NCT03004638|20002867|P4|NOT COMPLETED|Overall Study||0
8115549|NCT03004638|20002868|P3|NOT COMPLETED|Overall Study||0
8115550|NCT03004638|20002869|P2|NOT COMPLETED|Overall Study||0
8115551|NCT03004638|20002870|P1|NOT COMPLETED|Overall Study||0
8115552|NCT03004638|20002865|P6|COMPLETED|Overall Study||7
8115553|NCT03004638|20002866|P5|COMPLETED|Overall Study||1
8115554|NCT03004638|20002867|P4|COMPLETED|Overall Study||6
8115555|NCT03004638|20002868|P3|COMPLETED|Overall Study||6
8115556|NCT03004638|20002869|P2|COMPLETED|Overall Study||6
8115557|NCT03004638|20002870|P1|COMPLETED|Overall Study||6
8115558|NCT03004638|20002865|P6|STARTED|Overall Study||7
8115559|NCT03004638|20002866|P5|STARTED|Overall Study||1
8115560|NCT03004638|20002867|P4|STARTED|Overall Study||6
8115561|NCT03004638|20002868|P3|STARTED|Overall Study||6
8115562|NCT03004638|20002869|P2|STARTED|Overall Study||6
8115563|NCT03004638|20002870|P1|STARTED|Overall Study||6
8115564|NCT03004534|20002976|P1|NOT COMPLETED|Overall Study||0
8115565|NCT03004534|20002976|P1|COMPLETED|Overall Study||36
8115566|NCT03004534|20002976|P1|STARTED|Overall Study||36
8115567|NCT03004469|20002984|P3|NOT COMPLETED|Overall Study||25
8115568|NCT03004469|20002985|P2|NOT COMPLETED|Overall Study||49
8115569|NCT03004469|20002986|P1|NOT COMPLETED|Overall Study||61
8115570|NCT03004469|20002984|P3|COMPLETED|Overall Study||60
8115571|NCT03004469|20002985|P2|COMPLETED|Overall Study||135
8115572|NCT03004469|20002986|P1|COMPLETED|Overall Study||128
8115573|NCT03004469|20002984|P3|STARTED|Overall Study||85
8115574|NCT03004469|20002985|P2|STARTED|Overall Study||184
8115575|NCT03004469|20002986|P1|STARTED|Overall Study||189
8115576|NCT03003793|20003020|P2|NOT COMPLETED|Overall Study||0
8115577|NCT03003793|20003021|P1|NOT COMPLETED|Overall Study||0
8115578|NCT03003793|20003020|P2|COMPLETED|Overall Study||16
8115579|NCT03003793|20003021|P1|COMPLETED|Overall Study||16
8115580|NCT03003793|20003020|P2|STARTED|Overall Study||16
8115581|NCT03003793|20003021|P1|STARTED|Overall Study||16
8115582|NCT03003520|20003029|P2|NOT COMPLETED|Follow-up||3
8115583|NCT03003520|20003030|P1|NOT COMPLETED|Follow-up||14
8115584|NCT03003520|20003029|P2|COMPLETED|Follow-up||0
8115585|NCT03003520|20003030|P1|COMPLETED|Follow-up||0
8115586|NCT03003520|20003029|P2|STARTED|Follow-up||3
8115587|NCT03003520|20003030|P1|STARTED|Follow-up||14
8115588|NCT03003520|20003029|P2|NOT COMPLETED|Consolidation||1
8115589|NCT03003520|20003030|P1|NOT COMPLETED|Consolidation||24
8115590|NCT03003520|20003029|P2|COMPLETED|Consolidation||2
8115591|NCT03003520|20003030|P1|COMPLETED|Consolidation||1
8115592|NCT03003520|20003029|P2|STARTED|Consolidation||3
8115593|NCT03003520|20003030|P1|STARTED|Consolidation||25
8115594|NCT03003520|20003029|P2|NOT COMPLETED|Induction||0
8115595|NCT03003520|20003030|P1|NOT COMPLETED|Induction||13
8115596|NCT03003520|20003029|P2|COMPLETED|Induction||3
8115597|NCT03003520|20003030|P1|COMPLETED|Induction||30
8115598|NCT03003520|20003029|P2|Efficacy Evaluable Population|Induction||3
8115599|NCT03003520|20003030|P1|Efficacy Evaluable Population|Induction||37
8115600|NCT03003520|20003029|P2|Safety Population|Induction||3
8115601|NCT03003520|20003030|P1|Safety Population|Induction||43
8115602|NCT03003520|20003029|P2|STARTED|Induction||3
8115603|NCT03003520|20003030|P1|STARTED|Induction||43
8115604|NCT03003494|20003048|P1|NOT COMPLETED|Overall Study||28
8115605|NCT03003494|20003048|P1|COMPLETED|Overall Study||278
8115606|NCT03003494|20003048|P1|STARTED|Overall Study||306
8115607|NCT03003390|20003059|P2|NOT COMPLETED|Overall Study||0
8115608|NCT03003390|20003060|P1|NOT COMPLETED|Overall Study||4
8115609|NCT03003390|20003059|P2|COMPLETED|Overall Study||24
8115610|NCT03003390|20003060|P1|COMPLETED|Overall Study||23
8115611|NCT03003390|20003059|P2|STARTED|Overall Study||24
8115612|NCT03003390|20003060|P1|STARTED|Overall Study||27
8115613|NCT03003000|20003088|P3|NOT COMPLETED|Overall Study||5
8115614|NCT03003000|20003089|P2|NOT COMPLETED|Overall Study||4
8115615|NCT03003000|20003090|P1|NOT COMPLETED|Overall Study||5
8115616|NCT03003000|20003088|P3|COMPLETED|Overall Study||251
8115617|NCT03003000|20003089|P2|COMPLETED|Overall Study||249
8115618|NCT03003000|20003090|P1|COMPLETED|Overall Study||121
8115619|NCT03003000|20003088|P3|STARTED|Overall Study||256
8115620|NCT03003000|20003089|P2|STARTED|Overall Study||253
8115621|NCT03003000|20003090|P1|STARTED|Overall Study||126
8115622|NCT03002974|20003119|P3|NOT COMPLETED|Overall Study||18
8115623|NCT03002974|20003120|P2|NOT COMPLETED|Overall Study||16
8115624|NCT03002974|20003121|P1|NOT COMPLETED|Overall Study||20
8115625|NCT03002974|20003119|P3|COMPLETED|Overall Study||36
8115626|NCT03002974|20003120|P2|COMPLETED|Overall Study||40
8115627|NCT03002974|20003121|P1|COMPLETED|Overall Study||35
8115628|NCT03002974|20003119|P3|Safety Population|Overall Study||52
8115629|NCT03002974|20003120|P2|Safety Population|Overall Study||55
8115630|NCT03002974|20003121|P1|Safety Population|Overall Study||54
8115631|NCT03002974|20003119|P3|Intention To Treat Populatio|Overall Study||54
8115632|NCT03002974|20003120|P2|Intention To Treat Populatio|Overall Study||56
8115633|NCT03002974|20003121|P1|Intention To Treat Populatio|Overall Study||55
8115634|NCT03002974|20003119|P3|STARTED|Overall Study||54
8115635|NCT03002974|20003120|P2|STARTED|Overall Study||56
8115636|NCT03002974|20003121|P1|STARTED|Overall Study||55
8115637|NCT03002818|20003192|P1|NOT COMPLETED|Overall Study||1
8115638|NCT03002818|20003192|P1|COMPLETED|Overall Study||40
8115639|NCT03002818|20003192|P1|STARTED|Overall Study||41
8115640|NCT03002753|20003206|P3|NOT COMPLETED|Second Randomization (Re-randomization)||0
8115641|NCT03002753|20003207|P2|NOT COMPLETED|Second Randomization (Re-randomization)||1
8115642|NCT03002753|20003208|P1|NOT COMPLETED|Second Randomization (Re-randomization)||0
8115643|NCT03002753|20003206|P3|COMPLETED|Second Randomization (Re-randomization)||0
8115644|NCT03002753|20003207|P2|COMPLETED|Second Randomization (Re-randomization)||9
8115645|NCT03002753|20003208|P1|COMPLETED|Second Randomization (Re-randomization)||11
8115646|NCT03002753|20003206|P3|STARTED|Second Randomization (Re-randomization)||0
8115647|NCT03002753|20003207|P2|STARTED|Second Randomization (Re-randomization)||10
8115648|NCT03002753|20003208|P1|STARTED|Second Randomization (Re-randomization)||11
8115649|NCT03002753|20003206|P3|NOT COMPLETED|First Randomization||0
8115650|NCT03002753|20003207|P2|NOT COMPLETED|First Randomization||1
8115651|NCT03002753|20003208|P1|NOT COMPLETED|First Randomization||1
8115652|NCT03002753|20003206|P3|COMPLETED|First Randomization||21
8115653|NCT03002753|20003207|P2|COMPLETED|First Randomization||11
8115654|NCT03002753|20003208|P1|COMPLETED|First Randomization||9
8115655|NCT03002753|20003206|P3|STARTED|First Randomization||21
8115656|NCT03002753|20003207|P2|STARTED|First Randomization||12
8115657|NCT03002753|20003208|P1|STARTED|First Randomization||10
8115658|NCT03002623|20003218|P2|NOT COMPLETED|Overall Study||1
8115659|NCT03002623|20003219|P1|NOT COMPLETED|Overall Study||2
8115660|NCT03002623|20003218|P2|COMPLETED|Overall Study||2
8115661|NCT03002623|20003219|P1|COMPLETED|Overall Study||2
8115662|NCT03002623|20003218|P2|STARTED|Overall Study||3
8115663|NCT03002623|20003219|P1|STARTED|Overall Study||4
8115664|NCT03002610|20003236|P3|NOT COMPLETED|Overall Study||13
8115665|NCT03002610|20003237|P2|NOT COMPLETED|Overall Study||25
8115666|NCT03002610|20003238|P1|NOT COMPLETED|Overall Study||6
8115667|NCT03002610|20003236|P3|COMPLETED|Overall Study||21
8115668|NCT03002610|20003237|P2|COMPLETED|Overall Study||25
8115669|NCT03002610|20003238|P1|COMPLETED|Overall Study||18
8115670|NCT03002610|20003236|P3|STARTED|Overall Study||34
8115671|NCT03002610|20003237|P2|STARTED|Overall Study||50
8115672|NCT03002610|20003238|P1|STARTED|Overall Study||24
8115673|NCT03002454|20003255|P1|NOT COMPLETED|Overall Study||0
8115674|NCT03002454|20003255|P1|COMPLETED|Overall Study||4
8115675|NCT03002454|20003255|P1|STARTED|Overall Study||4
8115676|NCT03002311|20003262|P2|NOT COMPLETED|Overall Study||30
8115677|NCT03002311|20003263|P1|NOT COMPLETED|Overall Study||19
8115678|NCT03002311|20003262|P2|COMPLETED|Overall Study||150
8115679|NCT03002311|20003263|P1|COMPLETED|Overall Study||128
8115680|NCT03002311|20003262|P2|STARTED|Overall Study||180
8115681|NCT03002311|20003263|P1|STARTED|Overall Study||147
8115682|NCT03002194|20003271|P1|NOT COMPLETED|Overall Study||10
8115683|NCT03002194|20003271|P1|COMPLETED|Overall Study||38
8115684|NCT03002194|20003271|P1|STARTED|Overall Study||48
8115685|NCT03002077|20003277|P1|NOT COMPLETED|Overall Study||438
8115686|NCT03002077|20003277|P1|COMPLETED|Overall Study||179
8115687|NCT03002077|20003277|P1|STARTED|Overall Study||617
8115688|NCT03002038|20003285|P2|NOT COMPLETED|Overall Study||7
8115689|NCT03002038|20003286|P1|NOT COMPLETED|Overall Study||11
8115690|NCT03002038|20003285|P2|COMPLETED|Overall Study||33
8115691|NCT03002038|20003286|P1|COMPLETED|Overall Study||35
8115692|NCT03002038|20003285|P2|STARTED|Overall Study||40
8115693|NCT03002038|20003286|P1|STARTED|Overall Study||46
8115694|NCT03002012|20003298|P2|NOT COMPLETED|Overall Study||0
8115695|NCT03002012|20003299|P1|NOT COMPLETED|Overall Study||0
8115696|NCT03002012|20003298|P2|COMPLETED|Overall Study||11
8115697|NCT03002012|20003299|P1|COMPLETED|Overall Study||11
8115698|NCT03002012|20003298|P2|STARTED|Overall Study||11
8115699|NCT03002012|20003299|P1|STARTED|Overall Study||11
8115700|NCT03001778|20003321|P2|NOT COMPLETED|Overall Study||0
8115701|NCT03001778|20003322|P1|NOT COMPLETED|Overall Study||0
8115702|NCT03001778|20003321|P2|COMPLETED|Overall Study||46
8115703|NCT03001778|20003322|P1|COMPLETED|Overall Study||21
8115704|NCT03001778|20003321|P2|STARTED|Overall Study||46
8115705|NCT03001778|20003322|P1|STARTED|Overall Study||21
8115706|NCT03001674|20003330|P2|NOT COMPLETED|Overall Study||0
8115707|NCT03001674|20003331|P1|NOT COMPLETED|Overall Study||0
8115708|NCT03001674|20003330|P2|COMPLETED|Overall Study||5
8115709|NCT03001674|20003331|P1|COMPLETED|Overall Study||10
8115710|NCT03001674|20003330|P2|STARTED|Overall Study||5
8115711|NCT03001674|20003331|P1|STARTED|Overall Study||10
8115712|NCT03001557|20003342|P5|NOT COMPLETED|Overall Study||0
8115713|NCT03001557|20003343|P4|NOT COMPLETED|Overall Study||0
8115714|NCT03001557|20003344|P3|NOT COMPLETED|Overall Study||1
8115715|NCT03001557|20003345|P2|NOT COMPLETED|Overall Study||0
8115716|NCT03001557|20003346|P1|NOT COMPLETED|Overall Study||0
8115717|NCT03001557|20003342|P5|COMPLETED|Overall Study||12
8115718|NCT03001557|20003343|P4|COMPLETED|Overall Study||13
8115719|NCT03001557|20003344|P3|COMPLETED|Overall Study||13
8115720|NCT03001557|20003345|P2|COMPLETED|Overall Study||12
8115721|NCT03001557|20003346|P1|COMPLETED|Overall Study||12
8115722|NCT03001557|20003342|P5|Treated|Overall Study||12
8115723|NCT03001557|20003343|P4|Treated|Overall Study||13
8115724|NCT03001557|20003344|P3|Treated|Overall Study||13
8115725|NCT03001557|20003345|P2|Treated|Overall Study||12
8115726|NCT03001557|20003346|P1|Treated|Overall Study||12
8115727|NCT03001557|20003342|P5|STARTED|Overall Study||12
8115728|NCT03001557|20003343|P4|STARTED|Overall Study||13
8115729|NCT03001557|20003344|P3|STARTED|Overall Study||14
8115730|NCT03001557|20003345|P2|STARTED|Overall Study||12
8115731|NCT03001557|20003346|P1|STARTED|Overall Study||12
8115732|NCT03001453|20003615|P2|NOT COMPLETED|Overall Study||0
8115733|NCT03001453|20003616|P1|NOT COMPLETED|Overall Study||0
8115734|NCT03001453|20003615|P2|COMPLETED|Overall Study||57
8115735|NCT03001453|20003616|P1|COMPLETED|Overall Study||50
8115736|NCT03001453|20003615|P2|STARTED|Overall Study||57
8115737|NCT03001453|20003616|P1|STARTED|Overall Study||50
8115738|NCT03001258|20003633|P3|NOT COMPLETED|Overall Study||0
8115739|NCT03001258|20003634|P2|NOT COMPLETED|Overall Study||0
8115740|NCT03001258|20003635|P1|NOT COMPLETED|Overall Study||0
8115741|NCT03001258|20003633|P3|COMPLETED|Overall Study||485
8115742|NCT03001258|20003634|P2|COMPLETED|Overall Study||751
8115743|NCT03001258|20003635|P1|COMPLETED|Overall Study||765
8115744|NCT03001258|20003633|P3|STARTED|Overall Study||485
8115745|NCT03001258|20003634|P2|STARTED|Overall Study||751
8115746|NCT03001258|20003635|P1|STARTED|Overall Study||765
8115747|NCT03001219|20003645|P2|NOT COMPLETED|Extension Period Analysis||45
8115748|NCT03001219|20003646|P1|NOT COMPLETED|Extension Period Analysis||5
8115749|NCT03001219|20003645|P2|COMPLETED|Extension Period Analysis||52
8115750|NCT03001219|20003646|P1|COMPLETED|Extension Period Analysis||4
8115751|NCT03001219|20003645|P2|STARTED|Extension Period Analysis||97
8115752|NCT03001219|20003646|P1|STARTED|Extension Period Analysis||9
8115753|NCT03001219|20003645|P2|NOT COMPLETED|Proof of Concept||7
8115754|NCT03001219|20003646|P1|NOT COMPLETED|Proof of Concept||2
8115755|NCT03001219|20003645|P2|COMPLETED|Proof of Concept||65
8115756|NCT03001219|20003646|P1|COMPLETED|Proof of Concept||35
8115757|NCT03001219|20003645|P2|STARTED|Proof of Concept||72
8115758|NCT03001219|20003646|P1|STARTED|Proof of Concept||37
8115759|NCT03001076|20003707|P2|NOT COMPLETED|Overall Study||5
8115760|NCT03001076|20003708|P1|NOT COMPLETED|Overall Study||7
8115761|NCT03001076|20003707|P2|COMPLETED|Overall Study||176
8115762|NCT03001076|20003708|P1|COMPLETED|Overall Study||81
8115763|NCT03001076|20003707|P2|STARTED|Overall Study||181
8115764|NCT03001076|20003708|P1|STARTED|Overall Study||88
8115765|NCT03001011|20003742|P2|NOT COMPLETED|Overall Study||21
8115766|NCT03001011|20003743|P1|NOT COMPLETED|Overall Study||27
8115767|NCT03001011|20003742|P2|COMPLETED|Overall Study||80
8115768|NCT03001011|20003743|P1|COMPLETED|Overall Study||74
8115769|NCT03001011|20003742|P2|STARTED|Overall Study||101
8115770|NCT03001011|20003743|P1|STARTED|Overall Study||101
8115771|NCT03000686|20003777|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115772|NCT03000686|20003778|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115773|NCT03000686|20003779|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115774|NCT03000686|20003780|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115775|NCT03000686|20003777|P4|COMPLETED|Part 2, Period 2 (1 Day)||3
8115776|NCT03000686|20003778|P3|COMPLETED|Part 2, Period 2 (1 Day)||3
8115777|NCT03000686|20003779|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
8115778|NCT03000686|20003780|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
8115779|NCT03000686|20003777|P4|STARTED|Part 2, Period 2 (1 Day)||3
8115780|NCT03000686|20003778|P3|STARTED|Part 2, Period 2 (1 Day)||3
8115781|NCT03000686|20003779|P2|STARTED|Part 2, Period 2 (1 Day)||0
8115782|NCT03000686|20003780|P1|STARTED|Part 2, Period 2 (1 Day)||0
8115783|NCT03000686|20003777|P4|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115784|NCT03000686|20003778|P3|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115785|NCT03000686|20003779|P2|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115786|NCT03000686|20003780|P1|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115787|NCT03000686|20003777|P4|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
8115788|NCT03000686|20003778|P3|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
8115789|NCT03000686|20003779|P2|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115790|NCT03000686|20003780|P1|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115791|NCT03000686|20003777|P4|STARTED|Part 2, Wash-out (Up to 14 Days)||3
8115792|NCT03000686|20003778|P3|STARTED|Part 2, Wash-out (Up to 14 Days)||3
8115793|NCT03000686|20003779|P2|STARTED|Part 2, Wash-out (Up to 14 Days)||0
8115794|NCT03000686|20003780|P1|STARTED|Part 2, Wash-out (Up to 14 Days)||0
8115795|NCT03000686|20003777|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115796|NCT03000686|20003778|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115797|NCT03000686|20003779|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115798|NCT03000686|20003780|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115799|NCT03000686|20003777|P4|COMPLETED|Part 2, Period 1 (1 Day)||3
8115800|NCT03000686|20003778|P3|COMPLETED|Part 2, Period 1 (1 Day)||3
8115801|NCT03000686|20003779|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
8115802|NCT03000686|20003780|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
8115803|NCT03000686|20003777|P4|STARTED|Part 2, Period 1 (1 Day)||3
8115804|NCT03000686|20003778|P3|STARTED|Part 2, Period 1 (1 Day)||3
8115805|NCT03000686|20003779|P2|STARTED|Part 2, Period 1 (1 Day)||0
8115806|NCT03000686|20003780|P1|STARTED|Part 2, Period 1 (1 Day)||0
8115807|NCT03000686|20003777|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115808|NCT03000686|20003778|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115809|NCT03000686|20003779|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115810|NCT03000686|20003780|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115811|NCT03000686|20003777|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
8115812|NCT03000686|20003778|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
8115813|NCT03000686|20003779|P2|COMPLETED|Part 1, Period 2 (1 Day)||5
8115814|NCT03000686|20003780|P1|COMPLETED|Part 1, Period 2 (1 Day)||5
8115815|NCT03000686|20003777|P4|STARTED|Part 1, Period 2 (1 Day)||0
8115816|NCT03000686|20003778|P3|STARTED|Part 1, Period 2 (1 Day)||0
8115817|NCT03000686|20003779|P2|STARTED|Part 1, Period 2 (1 Day)||5
8115818|NCT03000686|20003780|P1|STARTED|Part 1, Period 2 (1 Day)||5
8115819|NCT03000686|20003777|P4|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115820|NCT03000686|20003778|P3|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115821|NCT03000686|20003779|P2|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115822|NCT03000686|20003780|P1|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115823|NCT03000686|20003777|P4|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115824|NCT03000686|20003778|P3|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115825|NCT03000686|20003779|P2|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
8115826|NCT03000686|20003780|P1|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
8115827|NCT03000686|20003777|P4|STARTED|Part 1, Wash-out (Up to 14 Days)||0
8115828|NCT03000686|20003778|P3|STARTED|Part 1, Wash-out (Up to 14 Days)||0
8115829|NCT03000686|20003779|P2|STARTED|Part 1, Wash-out (Up to 14 Days)||5
8115830|NCT03000686|20003780|P1|STARTED|Part 1, Wash-out (Up to 14 Days)||5
8115831|NCT03000686|20003777|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8115832|NCT03000686|20003778|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8115833|NCT03000686|20003779|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
8115834|NCT03000686|20003780|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8115835|NCT03000686|20003777|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
8115836|NCT03000686|20003778|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
8115837|NCT03000686|20003779|P2|COMPLETED|Part 1, Period 1 (1 Day)||5
8115838|NCT03000686|20003780|P1|COMPLETED|Part 1, Period 1 (1 Day)||5
8115839|NCT03000686|20003777|P4|STARTED|Part 1, Period 1 (1 Day)||0
8115840|NCT03000686|20003778|P3|STARTED|Part 1, Period 1 (1 Day)||0
8115841|NCT03000686|20003779|P2|STARTED|Part 1, Period 1 (1 Day)||6
8115842|NCT03000686|20003780|P1|STARTED|Part 1, Period 1 (1 Day)||5
8115843|NCT03000673|20003850|P4|NOT COMPLETED|Overall Study||0
8115844|NCT03000673|20003851|P3|NOT COMPLETED|Overall Study||0
8115845|NCT03000673|20003852|P2|NOT COMPLETED|Overall Study||0
8115846|NCT03000673|20003853|P1|NOT COMPLETED|Overall Study||1
8115847|NCT03000673|20003850|P4|COMPLETED|Overall Study||9
8115848|NCT03000673|20003851|P3|COMPLETED|Overall Study||7
8115849|NCT03000673|20003852|P2|COMPLETED|Overall Study||9
8115850|NCT03000673|20003853|P1|COMPLETED|Overall Study||6
8115851|NCT03000673|20003850|P4|STARTED|Overall Study||9
8115852|NCT03000673|20003851|P3|STARTED|Overall Study||7
8115853|NCT03000673|20003852|P2|STARTED|Overall Study||9
8115854|NCT03000673|20003853|P1|STARTED|Overall Study||7
8115855|NCT03000608|20003935|P2|NOT COMPLETED|Overall Study||4
8115856|NCT03000608|20003936|P1|NOT COMPLETED|Overall Study||6
8115857|NCT03000608|20003935|P2|COMPLETED|Overall Study||19
8115858|NCT03000608|20003936|P1|COMPLETED|Overall Study||40
8115859|NCT03000608|20003935|P2|STARTED|Overall Study||23
8115860|NCT03000608|20003936|P1|STARTED|Overall Study||46
8115861|NCT03000569|20003946|P2|NOT COMPLETED|Overall Study||0
8115862|NCT03000569|20003947|P1|NOT COMPLETED|Overall Study||1
8115863|NCT03000569|20003946|P2|COMPLETED|Overall Study||14
8115864|NCT03000569|20003947|P1|COMPLETED|Overall Study||14
8115865|NCT03000569|20003946|P2|STARTED|Overall Study||14
8115866|NCT03000569|20003947|P1|STARTED|Overall Study||15
8115867|NCT03000530|20004082|P3|NOT COMPLETED|Overall Study||4
8115868|NCT03000530|20004083|P2|NOT COMPLETED|Overall Study||5
8115869|NCT03000530|20004084|P1|NOT COMPLETED|Overall Study||0
8115870|NCT03000530|20004082|P3|COMPLETED|Overall Study||41
8115871|NCT03000530|20004083|P2|COMPLETED|Overall Study||39
8115872|NCT03000530|20004084|P1|COMPLETED|Overall Study||13
8115873|NCT03000530|20004082|P3|STARTED|Overall Study||45
8115874|NCT03000530|20004083|P2|STARTED|Overall Study||44
8115875|NCT03000530|20004084|P1|STARTED|Overall Study||13
8115876|NCT03000452|20004282|P1|NOT COMPLETED|Follow-Up Period||7
8115877|NCT03000452|20004282|P1|COMPLETED|Follow-Up Period||10
8115878|NCT03000452|20004282|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
8115879|NCT03000452|20004282|P1|NOT COMPLETED|Treatment Period||18
8115880|NCT03000452|20004282|P1|COMPLETED|Treatment Period||0
8115881|NCT03000452|20004282|P1|STARTED|Treatment Period||18
8115882|NCT03000309|20004298|P1|NOT COMPLETED|Overall Study||1
8115883|NCT03000309|20004298|P1|COMPLETED|Overall Study||19
8115884|NCT03000309|20004298|P1|STARTED|Overall Study||20
8115885|NCT03000283|20004318|P1|NOT COMPLETED|Overall Study||0
8115886|NCT03000283|20004318|P1|COMPLETED|Overall Study||7
8115887|NCT03000283|20004318|P1|STARTED|Overall Study||7
8115888|NCT03000088|20004329|P2|NOT COMPLETED|Overall Study||0
8115889|NCT03000088|20004330|P1|NOT COMPLETED|Overall Study||0
8115890|NCT03000088|20004329|P2|COMPLETED|Overall Study||70
8115891|NCT03000088|20004330|P1|COMPLETED|Overall Study||70
8115892|NCT03000088|20004329|P2|STARTED|Overall Study||70
8115893|NCT03000088|20004330|P1|STARTED|Overall Study||70
8115894|NCT03000075|20004339|P7|NOT COMPLETED|Part B||1
8115895|NCT03000075|20004340|P6|NOT COMPLETED|Part B||2
8115896|NCT03000075|20004341|P5|NOT COMPLETED|Part B||1
8115897|NCT03000075|20004342|P4|NOT COMPLETED|Part B||0
8115898|NCT03000075|20004343|P3|NOT COMPLETED|Part B||0
8115899|NCT03000075|20004344|P2|NOT COMPLETED|Part B||0
8115900|NCT03000075|20004345|P1|NOT COMPLETED|Part B||0
8115901|NCT03000075|20004339|P7|COMPLETED|Part B||54
8115902|NCT03000075|20004340|P6|COMPLETED|Part B||56
8115903|NCT03000075|20004341|P5|COMPLETED|Part B||26
8115904|NCT03000075|20004342|P4|COMPLETED|Part B||27
8115905|NCT03000075|20004343|P3|COMPLETED|Part B||0
8115906|NCT03000075|20004344|P2|COMPLETED|Part B||0
8115907|NCT03000075|20004345|P1|COMPLETED|Part B||0
8115908|NCT03000075|20004339|P7|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
8115909|NCT03000075|20004340|P6|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
8115910|NCT03000075|20004341|P5|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
8115911|NCT03000075|20004342|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
8115912|NCT03000075|20004343|P3|STARTED|Part B||0
8115913|NCT03000075|20004344|P2|STARTED|Part B||0
8115914|NCT03000075|20004345|P1|STARTED|Part B||0
8115915|NCT03000075|20004339|P7|NOT COMPLETED|Part A||0
8115916|NCT03000075|20004340|P6|NOT COMPLETED|Part A||0
8115917|NCT03000075|20004341|P5|NOT COMPLETED|Part A||0
8115918|NCT03000075|20004342|P4|NOT COMPLETED|Part A||0
8115919|NCT03000075|20004343|P3|NOT COMPLETED|Part A||0
8115920|NCT03000075|20004344|P2|NOT COMPLETED|Part A||0
8115921|NCT03000075|20004345|P1|NOT COMPLETED|Part A||4
8115922|NCT03000075|20004339|P7|COMPLETED|Part A||0
8115923|NCT03000075|20004340|P6|COMPLETED|Part A||0
8115924|NCT03000075|20004341|P5|COMPLETED|Part A||0
8115925|NCT03000075|20004342|P4|COMPLETED|Part A||0
8115926|NCT03000075|20004343|P3|COMPLETED|Part A||55
8115927|NCT03000075|20004344|P2|COMPLETED|Part A||58
8115928|NCT03000075|20004345|P1|COMPLETED|Part A||54
8115929|NCT03000075|20004339|P7|STARTED|Part A||0
8115930|NCT03000075|20004340|P6|STARTED|Part A||0
8115931|NCT03000075|20004341|P5|STARTED|Part A||0
8115932|NCT03000075|20004342|P4|STARTED|Part A||0
8115933|NCT03000075|20004343|P3|STARTED|Part A||55
8115934|NCT03000075|20004344|P2|STARTED|Part A||58
8115935|NCT03000075|20004345|P1|STARTED|Part A||58
8115936|NCT02999763|20004389|P1|NOT COMPLETED|Overall Study||12
8115937|NCT02999763|20004389|P1|COMPLETED|Overall Study||58
8115938|NCT02999763|20004389|P1|STARTED|Overall Study||70
8115939|NCT02999672|20004398|P2|NOT COMPLETED|Overall Study||7
8115940|NCT02999672|20004399|P1|NOT COMPLETED|Overall Study||13
8115941|NCT02999672|20004398|P2|COMPLETED|Overall Study||0
8115942|NCT02999672|20004399|P1|COMPLETED|Overall Study||0
8115943|NCT02999672|20004398|P2|STARTED|Overall Study||7
8115944|NCT02999672|20004399|P1|STARTED|Overall Study||13
8115945|NCT02999633|20004415|P1|NOT COMPLETED|Overall Study||14
8115946|NCT02999633|20004415|P1|COMPLETED|Overall Study||0
8115947|NCT02999633|20004415|P1|STARTED|Overall Study||14
8115948|NCT02999178|20004425|P2|NOT COMPLETED|Overall Study||100
8115949|NCT02999178|20004426|P1|NOT COMPLETED|Overall Study||114
8115950|NCT02999178|20004425|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
8115951|NCT02999178|20004426|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
8115952|NCT02999178|20004425|P2|STARTED|Overall Study||331
8115953|NCT02999178|20004426|P1|STARTED|Overall Study||332
8115954|NCT02999100|20004476|P6|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115955|NCT02999100|20004477|P5|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115956|NCT02999100|20004478|P4|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115957|NCT02999100|20004479|P3|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115958|NCT02999100|20004480|P2|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115959|NCT02999100|20004481|P1|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115960|NCT02999100|20004476|P6|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
8115961|NCT02999100|20004477|P5|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
8115962|NCT02999100|20004478|P4|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
8115963|NCT02999100|20004479|P3|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
8115964|NCT02999100|20004480|P2|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115965|NCT02999100|20004481|P1|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115966|NCT02999100|20004476|P6|STARTED|Part 2 (Day 14): Dosing Session 2||2
8115967|NCT02999100|20004477|P5|STARTED|Part 2 (Day 14): Dosing Session 2||3
8115968|NCT02999100|20004478|P4|STARTED|Part 2 (Day 14): Dosing Session 2||3
8115969|NCT02999100|20004479|P3|STARTED|Part 2 (Day 14): Dosing Session 2||4
8115970|NCT02999100|20004480|P2|STARTED|Part 2 (Day 14): Dosing Session 2||0
8115971|NCT02999100|20004481|P1|STARTED|Part 2 (Day 14): Dosing Session 2||0
8115972|NCT02999100|20004476|P6|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
8115973|NCT02999100|20004477|P5|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115974|NCT02999100|20004478|P4|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115975|NCT02999100|20004479|P3|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
8115976|NCT02999100|20004480|P2|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115977|NCT02999100|20004481|P1|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115978|NCT02999100|20004476|P6|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
8115979|NCT02999100|20004477|P5|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
8115980|NCT02999100|20004478|P4|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
8115981|NCT02999100|20004479|P3|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
8115982|NCT02999100|20004480|P2|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115983|NCT02999100|20004481|P1|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115984|NCT02999100|20004476|P6|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
8115985|NCT02999100|20004477|P5|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
8115986|NCT02999100|20004478|P4|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
8115987|NCT02999100|20004479|P3|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
8115988|NCT02999100|20004480|P2|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
8115989|NCT02999100|20004481|P1|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
8115990|NCT02999100|20004476|P6|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115991|NCT02999100|20004477|P5|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115992|NCT02999100|20004478|P4|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115993|NCT02999100|20004479|P3|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115994|NCT02999100|20004480|P2|NOT COMPLETED|Part 1 (up to 15 Days)||1
8115995|NCT02999100|20004481|P1|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115996|NCT02999100|20004476|P6|COMPLETED|Part 1 (up to 15 Days)||0
8115997|NCT02999100|20004477|P5|COMPLETED|Part 1 (up to 15 Days)||0
8115998|NCT02999100|20004478|P4|COMPLETED|Part 1 (up to 15 Days)||0
8115999|NCT02999100|20004479|P3|COMPLETED|Part 1 (up to 15 Days)||0
8116000|NCT02999100|20004480|P2|COMPLETED|Part 1 (up to 15 Days)||7
8116001|NCT02999100|20004481|P1|COMPLETED|Part 1 (up to 15 Days)||9
8116002|NCT02999100|20004476|P6|STARTED|Part 1 (up to 15 Days)||0
8116003|NCT02999100|20004477|P5|STARTED|Part 1 (up to 15 Days)||0
8116004|NCT02999100|20004478|P4|STARTED|Part 1 (up to 15 Days)||0
8116005|NCT02999100|20004479|P3|STARTED|Part 1 (up to 15 Days)||0
8116006|NCT02999100|20004480|P2|STARTED|Part 1 (up to 15 Days)||8
8116007|NCT02999100|20004481|P1|STARTED|Part 1 (up to 15 Days)||9
8116008|NCT02998996|20004649|P6|NOT COMPLETED|Overall Study||0
8116009|NCT02998996|20004650|P5|NOT COMPLETED|Overall Study||1
8116010|NCT02998996|20004651|P4|NOT COMPLETED|Overall Study||0
8116011|NCT02998996|20004652|P3|NOT COMPLETED|Overall Study||1
8116012|NCT02998996|20004653|P2|NOT COMPLETED|Overall Study||1
8116013|NCT02998996|20004654|P1|NOT COMPLETED|Overall Study||0
8116014|NCT02998996|20004649|P6|COMPLETED|Overall Study||19
8116015|NCT02998996|20004650|P5|COMPLETED|Overall Study||17
8116016|NCT02998996|20004651|P4|COMPLETED|Overall Study||18
8116017|NCT02998996|20004652|P3|COMPLETED|Overall Study||35
8116018|NCT02998996|20004653|P2|COMPLETED|Overall Study||34
8116019|NCT02998996|20004654|P1|COMPLETED|Overall Study||36
8116020|NCT02998996|20004649|P6|STARTED|Overall Study||19
8116021|NCT02998996|20004650|P5|STARTED|Overall Study||18
8116022|NCT02998996|20004651|P4|STARTED|Overall Study||18
8116023|NCT02998996|20004652|P3|STARTED|Overall Study||36
8116024|NCT02998996|20004653|P2|STARTED|Overall Study||35
8116025|NCT02998996|20004654|P1|STARTED|Overall Study||36
8116026|NCT02998684|20004674|P2|NOT COMPLETED|Overall Study||1
8116027|NCT02998684|20004675|P1|NOT COMPLETED|Overall Study||3
8116028|NCT02998684|20004674|P2|COMPLETED|Overall Study||6
8116029|NCT02998684|20004675|P1|COMPLETED|Overall Study||4
8116030|NCT02998684|20004674|P2|STARTED|Overall Study||7
8116031|NCT02998684|20004675|P1|STARTED|Overall Study||7
8116032|NCT02998671|20004688|P5|NOT COMPLETED|Period 2||0
8116033|NCT02998671|20004689|P4|NOT COMPLETED|Period 2||4
8116034|NCT02998671|20004690|P3|NOT COMPLETED|Period 2||1
8116035|NCT02998671|20004691|P2|NOT COMPLETED|Period 2||7
8116036|NCT02998671|20004692|P1|NOT COMPLETED|Period 2||3
8116037|NCT02998671|20004688|P5|COMPLETED|Period 2||0
8116038|NCT02998671|20004689|P4|COMPLETED|Period 2||4
8116039|NCT02998671|20004690|P3|COMPLETED|Period 2||5
8116040|NCT02998671|20004691|P2|COMPLETED|Period 2||3
8116041|NCT02998671|20004692|P1|COMPLETED|Period 2||14
8116042|NCT02998671|20004688|P5|STARTED|Period 2||0
8116043|NCT02998671|20004689|P4|STARTED|Period 2||8
8116044|NCT02998671|20004690|P3|STARTED|Period 2||6
8116045|NCT02998671|20004691|P2|STARTED|Period 2||10
8116046|NCT02998671|20004692|P1|STARTED|Period 2||17
8116047|NCT02998671|20004688|P5|NOT COMPLETED|Period 1||4
8116048|NCT02998671|20004689|P4|NOT COMPLETED|Period 1||0
8116049|NCT02998671|20004690|P3|NOT COMPLETED|Period 1||0
8116050|NCT02998671|20004691|P2|NOT COMPLETED|Period 1||3
8116051|NCT02998671|20004692|P1|NOT COMPLETED|Period 1||4
8116052|NCT02998671|20004688|P5|COMPLETED|Period 1||0
8116053|NCT02998671|20004689|P4|COMPLETED|Period 1||8
8116054|NCT02998671|20004690|P3|COMPLETED|Period 1||6
8116055|NCT02998671|20004691|P2|COMPLETED|Period 1||10
8116056|NCT02998671|20004692|P1|COMPLETED|Period 1||17
8116057|NCT02998671|20004688|P5|STARTED|Period 1||4
8116058|NCT02998671|20004689|P4|STARTED|Period 1||8
8116059|NCT02998671|20004690|P3|STARTED|Period 1||6
8116060|NCT02998671|20004691|P2|STARTED|Period 1||13
8116061|NCT02998671|20004692|P1|STARTED|Period 1||21
8116062|NCT02998554|20004737|P2|NOT COMPLETED|Overall Study||11
8116063|NCT02998554|20004738|P1|NOT COMPLETED|Overall Study||11
8116064|NCT02998554|20004737|P2|COMPLETED|Overall Study||66
8116065|NCT02998554|20004738|P1|COMPLETED|Overall Study||68
8116066|NCT02998554|20004737|P2|STARTED|Overall Study||77
8116067|NCT02998554|20004738|P1|STARTED|Overall Study||79
8116068|NCT02998541|20004769|P3|NOT COMPLETED|Overall Study||6
8116069|NCT02998541|20004770|P2|NOT COMPLETED|Overall Study||9
8116070|NCT02998541|20004771|P1|NOT COMPLETED|Overall Study||8
8116071|NCT02998541|20004769|P3|COMPLETED|Overall Study||37
8116072|NCT02998541|20004770|P2|COMPLETED|Overall Study||81
8116073|NCT02998541|20004771|P1|COMPLETED|Overall Study||78
8116074|NCT02998541|20004769|P3|STARTED|Overall Study||43
8116075|NCT02998541|20004770|P2|STARTED|Overall Study||90
8116076|NCT02998541|20004771|P1|STARTED|Overall Study||86
8116077|NCT02998476|20004826|P2|NOT COMPLETED|Overall Study||5
8116078|NCT02998476|20004827|P1|NOT COMPLETED|Overall Study||55
8116079|NCT02998476|20004826|P2|COMPLETED|Overall Study||0
8116080|NCT02998476|20004827|P1|COMPLETED|Overall Study||0
8116081|NCT02998476|20004826|P2|STARTED|Overall Study||5
8116082|NCT02998476|20004827|P1|STARTED|Overall Study||55
8116083|NCT02998021|20004837|P2|NOT COMPLETED|Overall Study||2
8116084|NCT02998021|20004838|P1|NOT COMPLETED|Overall Study||3
8116085|NCT02998021|20004837|P2|COMPLETED|Overall Study||0
8116086|NCT02998021|20004838|P1|COMPLETED|Overall Study||5
8116087|NCT02998021|20004837|P2|STARTED|Overall Study||2
8116088|NCT02998021|20004838|P1|STARTED|Overall Study||8
8116089|NCT02997904|20004864|P2|NOT COMPLETED|Overall Study||0
8116090|NCT02997904|20004865|P1|NOT COMPLETED|Overall Study||0
8116091|NCT02997904|20004864|P2|COMPLETED|Overall Study||49
8116092|NCT02997904|20004865|P1|COMPLETED|Overall Study||51
8116093|NCT02997904|20004864|P2|STARTED|Overall Study||49
8116094|NCT02997904|20004865|P1|STARTED|Overall Study||51
8116095|NCT02997735|20004877|P2|NOT COMPLETED|Overall Study||0
8116096|NCT02997735|20004878|P1|NOT COMPLETED|Overall Study||0
8116097|NCT02997735|20004877|P2|COMPLETED|Overall Study||251
8116098|NCT02997735|20004878|P1|COMPLETED|Overall Study||233
8116099|NCT02997735|20004877|P2|STARTED|Overall Study||251
8116100|NCT02997735|20004878|P1|STARTED|Overall Study||233
8116101|NCT02997722|20004902|P2|NOT COMPLETED|Overall Study||0
8116102|NCT02997722|20004903|P1|NOT COMPLETED|Overall Study||0
8116103|NCT02997722|20004902|P2|COMPLETED|Overall Study||1
8116104|NCT02997722|20004903|P1|COMPLETED|Overall Study||3
8116105|NCT02997722|20004902|P2|STARTED|Overall Study||1
8116106|NCT02997722|20004903|P1|STARTED|Overall Study||3
8116107|NCT02997163|20004913|P4|NOT COMPLETED|Overall Study||1
8116108|NCT02997163|20004914|P3|NOT COMPLETED|Overall Study||0
8116109|NCT02997163|20004915|P2|NOT COMPLETED|Overall Study||0
8116110|NCT02997163|20004916|P1|NOT COMPLETED|Overall Study||1
8116111|NCT02997163|20004913|P4|COMPLETED|Overall Study||7
8116112|NCT02997163|20004914|P3|COMPLETED|Overall Study||8
8116113|NCT02997163|20004915|P2|COMPLETED|Overall Study||9
8116114|NCT02997163|20004916|P1|COMPLETED|Overall Study||8
8116115|NCT02997163|20004913|P4|STARTED|Overall Study||8
8116116|NCT02997163|20004914|P3|STARTED|Overall Study||8
8116117|NCT02997163|20004915|P2|STARTED|Overall Study||9
8116118|NCT02997163|20004916|P1|STARTED|Overall Study||9
8116119|NCT02996968|20005048|P2|NOT COMPLETED|Overall Study||0
8116120|NCT02996968|20005049|P1|NOT COMPLETED|Overall Study||1
8116121|NCT02996968|20005048|P2|COMPLETED|Overall Study||79
8116122|NCT02996968|20005049|P1|COMPLETED|Overall Study||78
8116123|NCT02996968|20005048|P2|STARTED|Overall Study||79
8116124|NCT02996968|20005049|P1|STARTED|Overall Study||79
8116125|NCT02996682|20005057|P2|NOT COMPLETED|Overall Study||3
8116126|NCT02996682|20005058|P1|NOT COMPLETED|Overall Study||0
8116127|NCT02996682|20005057|P2|COMPLETED|Overall Study||48
8116128|NCT02996682|20005058|P1|COMPLETED|Overall Study||51
8116129|NCT02996682|20005057|P2|STARTED|Overall Study||51
8116130|NCT02996682|20005058|P1|STARTED|Overall Study||51
8116131|NCT02996591|20005082|P2|NOT COMPLETED|Overall Study||0
8116132|NCT02996591|20005083|P1|NOT COMPLETED|Overall Study||0
8116133|NCT02996591|20005082|P2|COMPLETED|Overall Study||18
8116134|NCT02996591|20005083|P1|COMPLETED|Overall Study||18
8116135|NCT02996591|20005082|P2|STARTED|Overall Study||18
8116136|NCT02996591|20005083|P1|STARTED|Overall Study||18
8116137|NCT02996500|20005137|P6|NOT COMPLETED|Overall Study||4
8116138|NCT02996500|20005138|P5|NOT COMPLETED|Overall Study||5
8116139|NCT02996500|20005139|P4|NOT COMPLETED|Overall Study||4
8116140|NCT02996500|20005140|P3|NOT COMPLETED|Overall Study||10
8116141|NCT02996500|20005141|P2|NOT COMPLETED|Overall Study||1
8116142|NCT02996500|20005142|P1|NOT COMPLETED|Overall Study||8
8116143|NCT02996500|20005137|P6|COMPLETED|Overall Study||44
8116144|NCT02996500|20005138|P5|COMPLETED|Overall Study||45
8116145|NCT02996500|20005139|P4|COMPLETED|Overall Study||46
8116146|NCT02996500|20005140|P3|COMPLETED|Overall Study||29
8116147|NCT02996500|20005141|P2|COMPLETED|Overall Study||42
8116148|NCT02996500|20005142|P1|COMPLETED|Overall Study||31
8116149|NCT02996500|20005137|P6|STARTED|Overall Study||48
8116150|NCT02996500|20005138|P5|STARTED|Overall Study||50
8116151|NCT02996500|20005139|P4|STARTED|Overall Study||50
8116152|NCT02996500|20005140|P3|STARTED|Overall Study||39
8116153|NCT02996500|20005141|P2|STARTED|Overall Study||43
8116154|NCT02996500|20005142|P1|STARTED|Overall Study||39
8116155|NCT02996474|20005325|P1|NOT COMPLETED|Overall Study||5
8116156|NCT02996474|20005325|P1|COMPLETED|Overall Study||5
8116157|NCT02996474|20005325|P1|STARTED|Overall Study||10
8116158|NCT02996448|20005329|P1|NOT COMPLETED|Overall Study||3
8116159|NCT02996448|20005329|P1|COMPLETED|Overall Study||0
8116160|NCT02996448|20005329|P1|STARTED|Overall Study||3
8116161|NCT02996097|20005335|P2|NOT COMPLETED|Overall Study||11
8116162|NCT02996097|20005336|P1|NOT COMPLETED|Overall Study||11
8116163|NCT02996097|20005335|P2|COMPLETED|Overall Study||19
8116164|NCT02996097|20005336|P1|COMPLETED|Overall Study||19
8116165|NCT02996097|20005335|P2|Per Protocol Population|Overall Study||22
8116166|NCT02996097|20005336|P1|Per Protocol Population|Overall Study||22
8116167|NCT02996097|20005335|P2|STARTED|Overall Study||30
8116168|NCT02996097|20005336|P1|STARTED|Overall Study||30
8116169|NCT02995980|20005343|P1|NOT COMPLETED|Overall Study||14
8116170|NCT02995980|20005343|P1|COMPLETED|Overall Study||114
8116171|NCT02995980|20005343|P1|STARTED|Overall Study||128
8116172|NCT02995967|20005354|P2|NOT COMPLETED|Overall Study||0
8116173|NCT02995967|20005355|P1|NOT COMPLETED|Overall Study||0
8116174|NCT02995967|20005354|P2|COMPLETED|Overall Study||2
8116175|NCT02995967|20005355|P1|COMPLETED|Overall Study||1
8116176|NCT02995967|20005354|P2|STARTED|Overall Study||2
8116177|NCT02995967|20005355|P1|STARTED|Overall Study||1
8116178|NCT02994979|20005381|P2|NOT COMPLETED|Overall Study||0
8116179|NCT02994979|20005382|P1|NOT COMPLETED|Overall Study||0
8116180|NCT02994979|20005381|P2|COMPLETED|Overall Study||105
8116181|NCT02994979|20005382|P1|COMPLETED|Overall Study||114
8116182|NCT02994979|20005381|P2|STARTED|Overall Study||105
8116183|NCT02994979|20005382|P1|STARTED|Overall Study||114
8116184|NCT02994732|20005394|P1|NOT COMPLETED|Overall Study||0
8116185|NCT02994732|20005394|P1|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
8116186|NCT02994732|20005394|P1|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
8116187|NCT02994251|20005408|P1|NOT COMPLETED|Overall Study||0
8116188|NCT02994251|20005408|P1|COMPLETED|Overall Study||0
8116189|NCT02994251|20005408|P1|STARTED|Overall Study||0
8116190|NCT02994108|20005420|P2|NOT COMPLETED|Phase 2 Assessment||7
8116191|NCT02994108|20005421|P1|NOT COMPLETED|Phase 2 Assessment||9
8116192|NCT02994108|20005420|P2|COMPLETED|Phase 2 Assessment||69
8116193|NCT02994108|20005421|P1|COMPLETED|Phase 2 Assessment||63
8116194|NCT02994108|20005420|P2|STARTED|Phase 2 Assessment||76
8116195|NCT02994108|20005421|P1|STARTED|Phase 2 Assessment||72
8116196|NCT02994108|20005420|P2|NOT COMPLETED|Phase 1 Assessment||3
8116197|NCT02994108|20005421|P1|NOT COMPLETED|Phase 1 Assessment||5
8116198|NCT02994108|20005420|P2|COMPLETED|Phase 1 Assessment||73
8116199|NCT02994108|20005421|P1|COMPLETED|Phase 1 Assessment||67
8116200|NCT02994108|20005420|P2|STARTED|Phase 1 Assessment||76
8116201|NCT02994108|20005421|P1|STARTED|Phase 1 Assessment||72
8116202|NCT02994108|20005420|P2|NOT COMPLETED|Intervention Messages||0
8116203|NCT02994108|20005421|P1|NOT COMPLETED|Intervention Messages||2
8116204|NCT02994108|20005420|P2|COMPLETED|Intervention Messages||76
8116205|NCT02994108|20005421|P1|COMPLETED|Intervention Messages||72
8116206|NCT02994108|20005420|P2|STARTED|Intervention Messages||76
8116207|NCT02994108|20005421|P1|STARTED|Intervention Messages||74
8116208|NCT02994056|20005453|P1|NOT COMPLETED|Overall Study||9
8116209|NCT02994056|20005453|P1|COMPLETED|Overall Study||23
8116210|NCT02994056|20005453|P1|STARTED|Overall Study||32
8116211|NCT02993926|20005487|P3|NOT COMPLETED|Follow-Up Phase||0
8116212|NCT02993926|20005488|P2|NOT COMPLETED|Follow-Up Phase||0
8116213|NCT02993926|20005489|P1|NOT COMPLETED|Follow-Up Phase||0
8116214|NCT02993926|20005487|P3|COMPLETED|Follow-Up Phase||26
8116215|NCT02993926|20005488|P2|COMPLETED|Follow-Up Phase||44
8116216|NCT02993926|20005489|P1|COMPLETED|Follow-Up Phase||0
8116217|NCT02993926|20005487|P3|STARTED|Follow-Up Phase||26
8116218|NCT02993926|20005488|P2|STARTED|Follow-Up Phase||44
8116219|NCT02993926|20005489|P1|STARTED|Follow-Up Phase||0
8116220|NCT02993926|20005487|P3|NOT COMPLETED|Enantone Treatment Phase||0
8116221|NCT02993926|20005488|P2|NOT COMPLETED|Enantone Treatment Phase||0
8116222|NCT02993926|20005489|P1|NOT COMPLETED|Enantone Treatment Phase||32
8116223|NCT02993926|20005487|P3|COMPLETED|Enantone Treatment Phase||0
8116224|NCT02993926|20005488|P2|COMPLETED|Enantone Treatment Phase||0
8116225|NCT02993926|20005489|P1|COMPLETED|Enantone Treatment Phase||76
8116226|NCT02993926|20005487|P3|STARTED|Enantone Treatment Phase||0
8116227|NCT02993926|20005488|P2|STARTED|Enantone Treatment Phase||0
8116228|NCT02993926|20005489|P1|STARTED|Enantone Treatment Phase||108
8116229|NCT02993783|20005521|P2|NOT COMPLETED|Overall Study||9
8116230|NCT02993783|20005522|P1|NOT COMPLETED|Overall Study||6
8116231|NCT02993783|20005521|P2|COMPLETED|Overall Study||0
8116232|NCT02993783|20005522|P1|COMPLETED|Overall Study||2
8116233|NCT02993783|20005521|P2|STARTED|Overall Study||9
8116234|NCT02993783|20005522|P1|STARTED|Overall Study||8
8116235|NCT02993757|20005554|P2|NOT COMPLETED|Overall Study||178
8116236|NCT02993757|20005555|P1|NOT COMPLETED|Overall Study||164
8116237|NCT02993757|20005554|P2|COMPLETED|Overall Study||84
8116238|NCT02993757|20005555|P1|COMPLETED|Overall Study||102
8116239|NCT02993757|20005554|P2|Safety Analysis Set (SafAS)|Overall Study||260
8116240|NCT02993757|20005555|P1|Safety Analysis Set (SafAS)|Overall Study||263
8116241|NCT02993757|20005554|P2|STARTED|Overall Study||262
8116242|NCT02993757|20005555|P1|STARTED|Overall Study||266
8116243|NCT02993471|20005587|P1|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
8116244|NCT02993471|20005587|P1|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
8116245|NCT02993471|20005587|P1|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
8116246|NCT02993471|20005587|P1|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
8116247|NCT02993471|20005587|P1|NOT COMPLETED|Period 1 (Drug Cocktail)||0
8116248|NCT02993471|20005587|P1|COMPLETED|Period 1 (Drug Cocktail)||28
8116249|NCT02993471|20005587|P1|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
8116250|NCT02993471|20005587|P1|STARTED|Period 1 (Drug Cocktail)||28
8116251|NCT02993445|20005623|P2|NOT COMPLETED|Second Intervention (5 Mins)||0
8116252|NCT02993445|20005624|P1|NOT COMPLETED|Second Intervention (5 Mins)||0
8116253|NCT02993445|20005623|P2|COMPLETED|Second Intervention (5 Mins)||5
8116254|NCT02993445|20005624|P1|COMPLETED|Second Intervention (5 Mins)||6
8116255|NCT02993445|20005623|P2|STARTED|Second Intervention (5 Mins)||5
8116256|NCT02993445|20005624|P1|STARTED|Second Intervention (5 Mins)||6
8116257|NCT02993445|20005623|P2|NOT COMPLETED|Washout (2 Weeks)||0
8116258|NCT02993445|20005624|P1|NOT COMPLETED|Washout (2 Weeks)||0
8116259|NCT02993445|20005623|P2|COMPLETED|Washout (2 Weeks)||5
8116260|NCT02993445|20005624|P1|COMPLETED|Washout (2 Weeks)||6
8116261|NCT02993445|20005623|P2|STARTED|Washout (2 Weeks)||5
8116262|NCT02993445|20005624|P1|STARTED|Washout (2 Weeks)||6
8116263|NCT02993445|20005623|P2|NOT COMPLETED|First Intervention (5 Minutes)||0
8116264|NCT02993445|20005624|P1|NOT COMPLETED|First Intervention (5 Minutes)||0
8116265|NCT02993445|20005623|P2|COMPLETED|First Intervention (5 Minutes)||5
8116266|NCT02993445|20005624|P1|COMPLETED|First Intervention (5 Minutes)||6
8116267|NCT02993445|20005623|P2|STARTED|First Intervention (5 Minutes)||5
8116268|NCT02993445|20005624|P1|STARTED|First Intervention (5 Minutes)||6
8116269|NCT02993302|20005634|P2|NOT COMPLETED|Overall Study||0
8116270|NCT02993302|20005635|P1|NOT COMPLETED|Overall Study||0
8116271|NCT02993302|20005634|P2|COMPLETED|Overall Study||12
8116272|NCT02993302|20005635|P1|COMPLETED|Overall Study||13
8116273|NCT02993302|20005634|P2|STARTED|Overall Study||12
8116274|NCT02993302|20005635|P1|STARTED|Overall Study||13
8116275|NCT02993250|20005649|P2|NOT COMPLETED|Overall Study||1
8116276|NCT02993250|20005650|P1|NOT COMPLETED|Overall Study||0
8116277|NCT02993250|20005649|P2|COMPLETED|Overall Study||10
8116278|NCT02993250|20005650|P1|COMPLETED|Overall Study||22
8116279|NCT02993250|20005649|P2|STARTED|Overall Study||11
8116280|NCT02993250|20005650|P1|STARTED|Overall Study||22
8116281|NCT02992691|20005670|P1|NOT COMPLETED|Overall Study||3
8116282|NCT02992691|20005670|P1|COMPLETED|Overall Study||53
8116283|NCT02992691|20005670|P1|Received Negative Control|Overall Study||55
8116284|NCT02992691|20005670|P1|Received Positive Control|Overall Study||55
8116285|NCT02992691|20005670|P1|Received Test Product 3|Overall Study||52
8116286|NCT02992691|20005670|P1|Received Test Product 2|Overall Study||55
8116287|NCT02992691|20005670|P1|Received Test Product 1|Overall Study||55
8116288|NCT02992691|20005670|P1|STARTED|Overall Study||56
8116289|NCT02992418|20005689|P2|NOT COMPLETED|Overall Study||342
8116290|NCT02992418|20005690|P1|NOT COMPLETED|Overall Study||346
8116291|NCT02992418|20005689|P2|COMPLETED|Overall Study||0
8116292|NCT02992418|20005690|P1|COMPLETED|Overall Study||0
8116293|NCT02992418|20005689|P2|Safety Analysis Set (SafAS)|Overall Study||342
8116294|NCT02992418|20005690|P1|Safety Analysis Set (SafAS)|Overall Study||338
8116295|NCT02992418|20005689|P2|STARTED|Overall Study||342
8116296|NCT02992418|20005690|P1|STARTED|Overall Study||346
8116297|NCT02992288|20005730|P6|NOT COMPLETED|Overall Study||13
8116298|NCT02992288|20005731|P5|NOT COMPLETED|Overall Study||8
8116299|NCT02992288|20005732|P4|NOT COMPLETED|Overall Study||9
8116300|NCT02992288|20005733|P3|NOT COMPLETED|Overall Study||7
8116301|NCT02992288|20005734|P2|NOT COMPLETED|Overall Study||5
8116302|NCT02992288|20005735|P1|NOT COMPLETED|Overall Study||17
8116303|NCT02992288|20005730|P6|COMPLETED|Overall Study||59
8116304|NCT02992288|20005731|P5|COMPLETED|Overall Study||61
8116305|NCT02992288|20005732|P4|COMPLETED|Overall Study||64
8116306|NCT02992288|20005733|P3|COMPLETED|Overall Study||63
8116307|NCT02992288|20005734|P2|COMPLETED|Overall Study||32
8116308|NCT02992288|20005735|P1|COMPLETED|Overall Study||89
8116309|NCT02992288|20005730|P6|Treated|Overall Study||72
8116310|NCT02992288|20005731|P5|Treated|Overall Study||69
8116311|NCT02992288|20005732|P4|Treated|Overall Study||72
8116312|NCT02992288|20005733|P3|Treated|Overall Study||70
8116313|NCT02992288|20005734|P2|Treated|Overall Study||37
8116314|NCT02992288|20005735|P1|Treated|Overall Study||106
8116315|NCT02992288|20005730|P6|STARTED|Overall Study||72
8116316|NCT02992288|20005731|P5|STARTED|Overall Study||69
8116317|NCT02992288|20005732|P4|STARTED|Overall Study||73
8116318|NCT02992288|20005733|P3|STARTED|Overall Study||70
8116319|NCT02992288|20005734|P2|STARTED|Overall Study||37
8116320|NCT02992288|20005735|P1|STARTED|Overall Study||106
8116321|NCT02992236|20005793|P2|NOT COMPLETED|Overall Study||0
8116322|NCT02992236|20005794|P1|NOT COMPLETED|Overall Study||0
8116323|NCT02992236|20005793|P2|COMPLETED|Overall Study||8
8116324|NCT02992236|20005794|P1|COMPLETED|Overall Study||8
8116325|NCT02992236|20005793|P2|STARTED|Overall Study||8
8116326|NCT02992236|20005794|P1|STARTED|Overall Study||8
8116327|NCT02992197|20005806|P2|NOT COMPLETED|Overall Study||7
8116328|NCT02992197|20005807|P1|NOT COMPLETED|Overall Study||11
8116329|NCT02992197|20005806|P2|COMPLETED|Overall Study||103
8116330|NCT02992197|20005807|P1|COMPLETED|Overall Study||99
8116331|NCT02992197|20005806|P2|STARTED|Overall Study||110
8116332|NCT02992197|20005807|P1|STARTED|Overall Study||110
8116333|NCT02992132|20005820|P3|NOT COMPLETED|Overall Study||7
8116334|NCT02992132|20005821|P2|NOT COMPLETED|Overall Study||8
8116335|NCT02992132|20005822|P1|NOT COMPLETED|Overall Study||13
8116336|NCT02992132|20005820|P3|COMPLETED|Overall Study||29
8116337|NCT02992132|20005821|P2|COMPLETED|Overall Study||27
8116338|NCT02992132|20005822|P1|COMPLETED|Overall Study||27
8116339|NCT02992132|20005820|P3|STARTED|Overall Study||36
8116340|NCT02992132|20005821|P2|STARTED|Overall Study||35
8116341|NCT02992132|20005822|P1|STARTED|Overall Study||40
8116342|NCT02992119|20005840|P7|NOT COMPLETED|Overall Study||3
8116343|NCT02992119|20005841|P6|NOT COMPLETED|Overall Study||0
8116344|NCT02992119|20005842|P5|NOT COMPLETED|Overall Study||0
8116345|NCT02992119|20005843|P4|NOT COMPLETED|Overall Study||0
8116346|NCT02992119|20005844|P3|NOT COMPLETED|Overall Study||1
8116347|NCT02992119|20005845|P2|NOT COMPLETED|Overall Study||1
8116348|NCT02992119|20005846|P1|NOT COMPLETED|Overall Study||2
8116349|NCT02992119|20005840|P7|COMPLETED|Overall Study||28
8116350|NCT02992119|20005841|P6|COMPLETED|Overall Study||30
8116351|NCT02992119|20005842|P5|COMPLETED|Overall Study||30
8116352|NCT02992119|20005843|P4|COMPLETED|Overall Study||30
8116353|NCT02992119|20005844|P3|COMPLETED|Overall Study||29
8116354|NCT02992119|20005845|P2|COMPLETED|Overall Study||20
8116355|NCT02992119|20005846|P1|COMPLETED|Overall Study||19
8116356|NCT02992119|20005840|P7|STARTED|Overall Study||31
8116357|NCT02992119|20005841|P6|STARTED|Overall Study||30
8116358|NCT02992119|20005842|P5|STARTED|Overall Study||30
8116359|NCT02992119|20005843|P4|STARTED|Overall Study||30
8116360|NCT02992119|20005844|P3|STARTED|Overall Study||30
8116361|NCT02992119|20005845|P2|STARTED|Overall Study||21
8116362|NCT02992119|20005846|P1|STARTED|Overall Study||21
8116363|NCT02992067|20005897|P1|NOT COMPLETED|Overall Study||0
8116364|NCT02992067|20005897|P1|COMPLETED|Overall Study||359
8116365|NCT02992067|20005897|P1|STARTED|Overall Study||359
8116366|NCT02991898|20005901|P1|NOT COMPLETED|Overall Study||0
8116367|NCT02991898|20005901|P1|COMPLETED|Overall Study||3
8116368|NCT02991898|20005901|P1|STARTED|Overall Study||3
8116369|NCT02991859|20005935|P17|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116370|NCT02991859|20005936|P16|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116371|NCT02991859|20005937|P15|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116372|NCT02991859|20005938|P14|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116373|NCT02991859|20005939|P13|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116374|NCT02991859|20005940|P12|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116375|NCT02991859|20005941|P11|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116376|NCT02991859|20005942|P10|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116377|NCT02991859|20005943|P9|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116378|NCT02991859|20005944|P8|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116379|NCT02991859|20005945|P7|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116380|NCT02991859|20005946|P6|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116381|NCT02991859|20005947|P5|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116382|NCT02991859|20005948|P4|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116383|NCT02991859|20005949|P3|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116384|NCT02991859|20005950|P2|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116385|NCT02991859|20005951|P1|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116386|NCT02991859|20005935|P17|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116387|NCT02991859|20005936|P16|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116388|NCT02991859|20005937|P15|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116389|NCT02991859|20005938|P14|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116390|NCT02991859|20005939|P13|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116391|NCT02991859|20005940|P12|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116392|NCT02991859|20005941|P11|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116393|NCT02991859|20005942|P10|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116394|NCT02991859|20005943|P9|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
8116395|NCT02991859|20005944|P8|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116396|NCT02991859|20005945|P7|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116397|NCT02991859|20005946|P6|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
8116398|NCT02991859|20005947|P5|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116399|NCT02991859|20005948|P4|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116400|NCT02991859|20005949|P3|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116401|NCT02991859|20005950|P2|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116402|NCT02991859|20005951|P1|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116403|NCT02991859|20005935|P17|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116404|NCT02991859|20005936|P16|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116405|NCT02991859|20005937|P15|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116406|NCT02991859|20005938|P14|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116407|NCT02991859|20005939|P13|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116408|NCT02991859|20005940|P12|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116409|NCT02991859|20005941|P11|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116410|NCT02991859|20005942|P10|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116411|NCT02991859|20005943|P9|STARTED|Period2,Escalation Phase5,Upto Day 112||1
8116412|NCT02991859|20005944|P8|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116413|NCT02991859|20005945|P7|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116414|NCT02991859|20005946|P6|STARTED|Period2,Escalation Phase5,Upto Day 112||1
8116415|NCT02991859|20005947|P5|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116416|NCT02991859|20005948|P4|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116417|NCT02991859|20005949|P3|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116418|NCT02991859|20005950|P2|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116419|NCT02991859|20005951|P1|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116420|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116421|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116422|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116423|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116424|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116425|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116426|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116427|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116428|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
8116429|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116430|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116431|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116432|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116433|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116434|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116435|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116436|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116437|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116438|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116439|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116440|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116441|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116442|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116443|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116444|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116445|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
8116446|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116447|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116448|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
8116449|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116450|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116451|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116452|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116453|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116454|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116455|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116456|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116457|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116458|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116459|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116460|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116461|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116462|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116463|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116464|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116465|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase4, Upto Day 105||1
8116466|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116467|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116468|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116469|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116470|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116471|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116472|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116473|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116474|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116475|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116476|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116477|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116478|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116479|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116480|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116481|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116482|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116483|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116484|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116485|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116486|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116487|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116488|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116489|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116490|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116491|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116492|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116493|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116494|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116495|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116496|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116497|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116498|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116499|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
8116500|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116501|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116502|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116503|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116504|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116505|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116506|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116507|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116508|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116509|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116510|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116511|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116512|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116513|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116514|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116515|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116516|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase3, Upto Day 98||1
8116517|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116518|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116519|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116520|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116521|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116522|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116523|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116524|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116525|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116526|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116527|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116528|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116529|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116530|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116531|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116532|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116533|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116534|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116535|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116536|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116537|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116538|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116539|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116540|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116541|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116542|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116543|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116544|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116545|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116546|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116547|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116548|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116549|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116550|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
8116551|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116552|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116553|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116554|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116555|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116556|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116557|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116558|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116559|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116560|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116561|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116562|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116563|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116564|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116565|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116566|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116567|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase2, Upto Day 91||1
8116568|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116569|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116570|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116571|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116572|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116573|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116574|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116575|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116576|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116577|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116578|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116579|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116580|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116581|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116582|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116583|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116584|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116585|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116586|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116587|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116588|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116589|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116590|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116591|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116592|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116593|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116594|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116595|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116596|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116597|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116598|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116599|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116600|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116601|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
8116602|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116603|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116604|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116605|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116606|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116607|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116608|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116609|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116610|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116611|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116612|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116613|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
8116614|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
8116615|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116616|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116617|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116618|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase1, Upto Day 84||1
8116619|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116620|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116621|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116622|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116623|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116624|NCT02991859|20005935|P17|NOT COMPLETED|Wash Out, Up to Day 77||0
8116625|NCT02991859|20005936|P16|NOT COMPLETED|Wash Out, Up to Day 77||0
8116626|NCT02991859|20005937|P15|NOT COMPLETED|Wash Out, Up to Day 77||0
8116627|NCT02991859|20005938|P14|NOT COMPLETED|Wash Out, Up to Day 77||0
8116628|NCT02991859|20005939|P13|NOT COMPLETED|Wash Out, Up to Day 77||0
8116629|NCT02991859|20005940|P12|NOT COMPLETED|Wash Out, Up to Day 77||0
8116630|NCT02991859|20005941|P11|NOT COMPLETED|Wash Out, Up to Day 77||0
8116631|NCT02991859|20005942|P10|NOT COMPLETED|Wash Out, Up to Day 77||1
8116632|NCT02991859|20005943|P9|NOT COMPLETED|Wash Out, Up to Day 77||0
8116633|NCT02991859|20005944|P8|NOT COMPLETED|Wash Out, Up to Day 77||0
8116634|NCT02991859|20005945|P7|NOT COMPLETED|Wash Out, Up to Day 77||0
8116635|NCT02991859|20005946|P6|NOT COMPLETED|Wash Out, Up to Day 77||1
8116636|NCT02991859|20005947|P5|NOT COMPLETED|Wash Out, Up to Day 77||0
8116637|NCT02991859|20005948|P4|NOT COMPLETED|Wash Out, Up to Day 77||0
8116638|NCT02991859|20005949|P3|NOT COMPLETED|Wash Out, Up to Day 77||0
8116639|NCT02991859|20005950|P2|NOT COMPLETED|Wash Out, Up to Day 77||0
8116640|NCT02991859|20005951|P1|NOT COMPLETED|Wash Out, Up to Day 77||0
8116641|NCT02991859|20005935|P17|COMPLETED|Wash Out, Up to Day 77||0
8116642|NCT02991859|20005936|P16|COMPLETED|Wash Out, Up to Day 77||0
8116643|NCT02991859|20005937|P15|COMPLETED|Wash Out, Up to Day 77||0
8116644|NCT02991859|20005938|P14|COMPLETED|Wash Out, Up to Day 77||0
8116645|NCT02991859|20005939|P13|COMPLETED|Wash Out, Up to Day 77||0
8116646|NCT02991859|20005940|P12|COMPLETED|Wash Out, Up to Day 77||2
8116647|NCT02991859|20005941|P11|COMPLETED|Wash Out, Up to Day 77||1
8116648|NCT02991859|20005942|P10|COMPLETED|Wash Out, Up to Day 77||1
8116649|NCT02991859|20005943|P9|COMPLETED|Wash Out, Up to Day 77||2
8116650|NCT02991859|20005944|P8|COMPLETED|Wash Out, Up to Day 77||2
8116651|NCT02991859|20005945|P7|COMPLETED|Wash Out, Up to Day 77||2
8116652|NCT02991859|20005946|P6|COMPLETED|Wash Out, Up to Day 77||1
8116653|NCT02991859|20005947|P5|COMPLETED|Wash Out, Up to Day 77||2
8116654|NCT02991859|20005948|P4|COMPLETED|Wash Out, Up to Day 77||2
8116655|NCT02991859|20005949|P3|COMPLETED|Wash Out, Up to Day 77||2
8116656|NCT02991859|20005950|P2|COMPLETED|Wash Out, Up to Day 77||2
8116657|NCT02991859|20005951|P1|COMPLETED|Wash Out, Up to Day 77||2
8116658|NCT02991859|20005935|P17|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116659|NCT02991859|20005936|P16|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116660|NCT02991859|20005937|P15|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116661|NCT02991859|20005938|P14|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116662|NCT02991859|20005939|P13|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116663|NCT02991859|20005940|P12|STARTED|Wash Out, Up to Day 77||2
8116664|NCT02991859|20005941|P11|STARTED|Wash Out, Up to Day 77||1
8116665|NCT02991859|20005942|P10|STARTED|Wash Out, Up to Day 77||2
8116666|NCT02991859|20005943|P9|STARTED|Wash Out, Up to Day 77||2
8116667|NCT02991859|20005944|P8|STARTED|Wash Out, Up to Day 77||2
8116668|NCT02991859|20005945|P7|STARTED|Wash Out, Up to Day 77||2
8116669|NCT02991859|20005946|P6|STARTED|Wash Out, Up to Day 77||2
8116670|NCT02991859|20005947|P5|STARTED|Wash Out, Up to Day 77||2
8116671|NCT02991859|20005948|P4|STARTED|Wash Out, Up to Day 77||2
8116672|NCT02991859|20005949|P3|STARTED|Wash Out, Up to Day 77||2
8116673|NCT02991859|20005950|P2|STARTED|Wash Out, Up to Day 77||2
8116674|NCT02991859|20005951|P1|STARTED|Wash Out, Up to Day 77||2
8116675|NCT02991859|20005935|P17|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116676|NCT02991859|20005936|P16|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116677|NCT02991859|20005937|P15|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116678|NCT02991859|20005938|P14|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116679|NCT02991859|20005939|P13|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116680|NCT02991859|20005940|P12|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116681|NCT02991859|20005941|P11|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116682|NCT02991859|20005942|P10|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116683|NCT02991859|20005943|P9|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116684|NCT02991859|20005944|P8|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116685|NCT02991859|20005945|P7|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116686|NCT02991859|20005946|P6|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116687|NCT02991859|20005947|P5|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116688|NCT02991859|20005948|P4|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116689|NCT02991859|20005949|P3|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116690|NCT02991859|20005950|P2|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116691|NCT02991859|20005951|P1|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116692|NCT02991859|20005935|P17|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
8116693|NCT02991859|20005936|P16|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
8116694|NCT02991859|20005937|P15|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
8116695|NCT02991859|20005938|P14|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
8116696|NCT02991859|20005939|P13|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
8116697|NCT02991859|20005940|P12|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116698|NCT02991859|20005941|P11|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
8116699|NCT02991859|20005942|P10|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116700|NCT02991859|20005943|P9|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116701|NCT02991859|20005944|P8|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116702|NCT02991859|20005945|P7|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116703|NCT02991859|20005946|P6|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116704|NCT02991859|20005947|P5|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116705|NCT02991859|20005948|P4|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116706|NCT02991859|20005949|P3|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116707|NCT02991859|20005950|P2|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116708|NCT02991859|20005951|P1|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116709|NCT02991859|20005935|P17|STARTED|Period1, Escalation Phase5, Upto Day35||3
8116710|NCT02991859|20005936|P16|STARTED|Period1, Escalation Phase5, Upto Day35||3
8116711|NCT02991859|20005937|P15|STARTED|Period1, Escalation Phase5, Upto Day35||6
8116712|NCT02991859|20005938|P14|STARTED|Period1, Escalation Phase5, Upto Day35||6
8116713|NCT02991859|20005939|P13|STARTED|Period1, Escalation Phase5, Upto Day35||6
8116714|NCT02991859|20005940|P12|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116715|NCT02991859|20005941|P11|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
8116716|NCT02991859|20005942|P10|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116717|NCT02991859|20005943|P9|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116718|NCT02991859|20005944|P8|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116719|NCT02991859|20005945|P7|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116720|NCT02991859|20005946|P6|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116721|NCT02991859|20005947|P5|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116722|NCT02991859|20005948|P4|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116723|NCT02991859|20005949|P3|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116724|NCT02991859|20005950|P2|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116725|NCT02991859|20005951|P1|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116726|NCT02991859|20005935|P17|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116727|NCT02991859|20005936|P16|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116728|NCT02991859|20005937|P15|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116729|NCT02991859|20005938|P14|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116730|NCT02991859|20005939|P13|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116731|NCT02991859|20005940|P12|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116732|NCT02991859|20005941|P11|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116733|NCT02991859|20005942|P10|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116734|NCT02991859|20005943|P9|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116735|NCT02991859|20005944|P8|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116736|NCT02991859|20005945|P7|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116737|NCT02991859|20005946|P6|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116738|NCT02991859|20005947|P5|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116739|NCT02991859|20005948|P4|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116740|NCT02991859|20005949|P3|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116741|NCT02991859|20005950|P2|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116742|NCT02991859|20005951|P1|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116743|NCT02991859|20005935|P17|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
8116744|NCT02991859|20005936|P16|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
8116745|NCT02991859|20005937|P15|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
8116746|NCT02991859|20005938|P14|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
8116747|NCT02991859|20005939|P13|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
8116748|NCT02991859|20005940|P12|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116749|NCT02991859|20005941|P11|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116750|NCT02991859|20005942|P10|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116751|NCT02991859|20005943|P9|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116752|NCT02991859|20005944|P8|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116753|NCT02991859|20005945|P7|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116754|NCT02991859|20005946|P6|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116755|NCT02991859|20005947|P5|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116756|NCT02991859|20005948|P4|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116757|NCT02991859|20005949|P3|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116758|NCT02991859|20005950|P2|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116759|NCT02991859|20005951|P1|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116760|NCT02991859|20005935|P17|STARTED|Period1, Escalation Phase4, Upto Day28||3
8116761|NCT02991859|20005936|P16|STARTED|Period1, Escalation Phase4, Upto Day28||3
8116762|NCT02991859|20005937|P15|STARTED|Period1, Escalation Phase4, Upto Day28||6
8116763|NCT02991859|20005938|P14|STARTED|Period1, Escalation Phase4, Upto Day28||6
8116764|NCT02991859|20005939|P13|STARTED|Period1, Escalation Phase4, Upto Day28||6
8116765|NCT02991859|20005940|P12|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116766|NCT02991859|20005941|P11|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116767|NCT02991859|20005942|P10|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116768|NCT02991859|20005943|P9|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116769|NCT02991859|20005944|P8|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116770|NCT02991859|20005945|P7|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116771|NCT02991859|20005946|P6|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
8116772|NCT02991859|20005947|P5|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116773|NCT02991859|20005948|P4|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116774|NCT02991859|20005949|P3|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116775|NCT02991859|20005950|P2|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116776|NCT02991859|20005951|P1|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116777|NCT02991859|20005935|P17|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116778|NCT02991859|20005936|P16|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116779|NCT02991859|20005937|P15|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116780|NCT02991859|20005938|P14|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
8116781|NCT02991859|20005939|P13|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
8116782|NCT02991859|20005940|P12|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116783|NCT02991859|20005941|P11|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116784|NCT02991859|20005942|P10|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116785|NCT02991859|20005943|P9|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116786|NCT02991859|20005944|P8|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116787|NCT02991859|20005945|P7|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116788|NCT02991859|20005946|P6|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116789|NCT02991859|20005947|P5|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116790|NCT02991859|20005948|P4|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116791|NCT02991859|20005949|P3|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116792|NCT02991859|20005950|P2|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116793|NCT02991859|20005951|P1|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116794|NCT02991859|20005935|P17|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
8116795|NCT02991859|20005936|P16|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
8116796|NCT02991859|20005937|P15|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
8116797|NCT02991859|20005938|P14|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
8116798|NCT02991859|20005939|P13|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
8116799|NCT02991859|20005940|P12|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116800|NCT02991859|20005941|P11|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116801|NCT02991859|20005942|P10|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116802|NCT02991859|20005943|P9|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116803|NCT02991859|20005944|P8|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116804|NCT02991859|20005945|P7|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116805|NCT02991859|20005946|P6|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
8116806|NCT02991859|20005947|P5|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116807|NCT02991859|20005948|P4|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116808|NCT02991859|20005949|P3|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116809|NCT02991859|20005950|P2|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116810|NCT02991859|20005951|P1|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116811|NCT02991859|20005935|P17|STARTED|Period1, Escalation Phase3, Upto Day21||3
8116812|NCT02991859|20005936|P16|STARTED|Period1, Escalation Phase3, Upto Day21||3
8116813|NCT02991859|20005937|P15|STARTED|Period1, Escalation Phase3, Upto Day21||6
8116814|NCT02991859|20005938|P14|STARTED|Period1, Escalation Phase3, Upto Day21||7
8116815|NCT02991859|20005939|P13|STARTED|Period1, Escalation Phase3, Upto Day21||7
8116816|NCT02991859|20005940|P12|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116817|NCT02991859|20005941|P11|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116818|NCT02991859|20005942|P10|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116819|NCT02991859|20005943|P9|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116820|NCT02991859|20005944|P8|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116821|NCT02991859|20005945|P7|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116822|NCT02991859|20005946|P6|STARTED|Period1, Escalation Phase3, Upto Day21||3
8116823|NCT02991859|20005947|P5|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116824|NCT02991859|20005948|P4|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116825|NCT02991859|20005949|P3|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116826|NCT02991859|20005950|P2|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116827|NCT02991859|20005951|P1|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116828|NCT02991859|20005935|P17|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116829|NCT02991859|20005936|P16|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116830|NCT02991859|20005937|P15|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116831|NCT02991859|20005938|P14|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116832|NCT02991859|20005939|P13|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116833|NCT02991859|20005940|P12|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116834|NCT02991859|20005941|P11|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116835|NCT02991859|20005942|P10|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116836|NCT02991859|20005943|P9|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116837|NCT02991859|20005944|P8|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116838|NCT02991859|20005945|P7|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116839|NCT02991859|20005946|P6|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116840|NCT02991859|20005947|P5|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116841|NCT02991859|20005948|P4|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116842|NCT02991859|20005949|P3|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116843|NCT02991859|20005950|P2|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116844|NCT02991859|20005951|P1|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116845|NCT02991859|20005935|P17|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
8116846|NCT02991859|20005936|P16|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
8116847|NCT02991859|20005937|P15|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
8116848|NCT02991859|20005938|P14|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
8116849|NCT02991859|20005939|P13|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
8116850|NCT02991859|20005940|P12|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116851|NCT02991859|20005941|P11|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116852|NCT02991859|20005942|P10|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116853|NCT02991859|20005943|P9|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116854|NCT02991859|20005944|P8|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116855|NCT02991859|20005945|P7|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116856|NCT02991859|20005946|P6|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
8116857|NCT02991859|20005947|P5|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116858|NCT02991859|20005948|P4|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116859|NCT02991859|20005949|P3|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116860|NCT02991859|20005950|P2|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116861|NCT02991859|20005951|P1|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116862|NCT02991859|20005935|P17|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
8116863|NCT02991859|20005936|P16|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
8116864|NCT02991859|20005937|P15|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
8116865|NCT02991859|20005938|P14|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
8116866|NCT02991859|20005939|P13|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
8116867|NCT02991859|20005940|P12|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116868|NCT02991859|20005941|P11|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116869|NCT02991859|20005942|P10|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116870|NCT02991859|20005943|P9|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116871|NCT02991859|20005944|P8|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116872|NCT02991859|20005945|P7|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116873|NCT02991859|20005946|P6|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
8116874|NCT02991859|20005947|P5|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116875|NCT02991859|20005948|P4|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116876|NCT02991859|20005949|P3|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116877|NCT02991859|20005950|P2|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116878|NCT02991859|20005951|P1|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116879|NCT02991859|20005935|P17|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116880|NCT02991859|20005936|P16|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116881|NCT02991859|20005937|P15|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116882|NCT02991859|20005938|P14|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116883|NCT02991859|20005939|P13|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116884|NCT02991859|20005940|P12|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116885|NCT02991859|20005941|P11|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116886|NCT02991859|20005942|P10|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116887|NCT02991859|20005943|P9|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116888|NCT02991859|20005944|P8|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116889|NCT02991859|20005945|P7|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116890|NCT02991859|20005946|P6|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116891|NCT02991859|20005947|P5|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
8116892|NCT02991859|20005948|P4|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116893|NCT02991859|20005949|P3|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116894|NCT02991859|20005950|P2|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
8116895|NCT02991859|20005951|P1|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116896|NCT02991859|20005935|P17|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
8116897|NCT02991859|20005936|P16|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
8116898|NCT02991859|20005937|P15|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
8116899|NCT02991859|20005938|P14|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
8116900|NCT02991859|20005939|P13|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
8116901|NCT02991859|20005940|P12|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116902|NCT02991859|20005941|P11|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116903|NCT02991859|20005942|P10|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116904|NCT02991859|20005943|P9|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116905|NCT02991859|20005944|P8|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116906|NCT02991859|20005945|P7|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116907|NCT02991859|20005946|P6|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
8116908|NCT02991859|20005947|P5|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116909|NCT02991859|20005948|P4|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116910|NCT02991859|20005949|P3|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116911|NCT02991859|20005950|P2|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116912|NCT02991859|20005951|P1|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116913|NCT02991859|20005935|P17|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116914|NCT02991859|20005936|P16|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116915|NCT02991859|20005937|P15|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
8116916|NCT02991859|20005938|P14|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
8116917|NCT02991859|20005939|P13|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
8116918|NCT02991859|20005940|P12|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116919|NCT02991859|20005941|P11|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116920|NCT02991859|20005942|P10|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116921|NCT02991859|20005943|P9|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116922|NCT02991859|20005944|P8|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116923|NCT02991859|20005945|P7|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116924|NCT02991859|20005946|P6|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116925|NCT02991859|20005947|P5|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116926|NCT02991859|20005948|P4|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116927|NCT02991859|20005949|P3|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116928|NCT02991859|20005950|P2|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116929|NCT02991859|20005951|P1|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116930|NCT02991820|20006196|P2|NOT COMPLETED|Overall Study||0
8116931|NCT02991820|20006197|P1|NOT COMPLETED|Overall Study||0
8116932|NCT02991820|20006196|P2|COMPLETED|Overall Study||31
8116933|NCT02991820|20006197|P1|COMPLETED|Overall Study||12
8116934|NCT02991820|20006196|P2|STARTED|Overall Study||31
8116935|NCT02991820|20006197|P1|STARTED|Overall Study||12
8116936|NCT02991729|20006207|P2|NOT COMPLETED|Overall Study||0
8116937|NCT02991729|20006208|P1|NOT COMPLETED|Overall Study||0
8116938|NCT02991729|20006207|P2|COMPLETED|Overall Study||92
8116939|NCT02991729|20006208|P1|COMPLETED|Overall Study||105
8116940|NCT02991729|20006207|P2|STARTED|Overall Study||92
8116941|NCT02991729|20006208|P1|STARTED|Overall Study||105
8116942|NCT02991599|20006222|P2|NOT COMPLETED|Overall Study||37
8116943|NCT02991599|20006223|P1|NOT COMPLETED|Overall Study||38
8116944|NCT02991599|20006222|P2|COMPLETED|Overall Study||61
8116945|NCT02991599|20006223|P1|COMPLETED|Overall Study||60
8116946|NCT02991599|20006222|P2|STARTED|Overall Study||98
8116947|NCT02991599|20006223|P1|STARTED|Overall Study||98
8116948|NCT02991430|20006246|P3|NOT COMPLETED|Post-treatment Observation Period||5
8116949|NCT02991430|20006247|P2|NOT COMPLETED|Post-treatment Observation Period||6
8116950|NCT02991430|20006248|P1|NOT COMPLETED|Post-treatment Observation Period||3
8116951|NCT02991430|20006246|P3|COMPLETED|Post-treatment Observation Period||5
8116952|NCT02991430|20006247|P2|COMPLETED|Post-treatment Observation Period||2
8116953|NCT02991430|20006248|P1|COMPLETED|Post-treatment Observation Period||4
8116954|NCT02991430|20006246|P3|STARTED|Post-treatment Observation Period||10
8116955|NCT02991430|20006247|P2|STARTED|Post-treatment Observation Period||8
8116956|NCT02991430|20006248|P1|STARTED|Post-treatment Observation Period||7
8116957|NCT02991430|20006246|P3|NOT COMPLETED|Treatment Period 2||4
8116958|NCT02991430|20006247|P2|NOT COMPLETED|Treatment Period 2||3
8116959|NCT02991430|20006248|P1|NOT COMPLETED|Treatment Period 2||6
8116960|NCT02991430|20006246|P3|COMPLETED|Treatment Period 2||10
8116961|NCT02991430|20006247|P2|COMPLETED|Treatment Period 2||8
8116962|NCT02991430|20006248|P1|COMPLETED|Treatment Period 2||7
8116963|NCT02991430|20006246|P3|STARTED|Treatment Period 2||14
8116964|NCT02991430|20006247|P2|STARTED|Treatment Period 2||11
8116965|NCT02991430|20006248|P1|STARTED|Treatment Period 2||13
8116966|NCT02991430|20006246|P3|NOT COMPLETED|Treatment Period 1||2
8116967|NCT02991430|20006247|P2|NOT COMPLETED|Treatment Period 1||4
8116968|NCT02991430|20006248|P1|NOT COMPLETED|Treatment Period 1||1
8116969|NCT02991430|20006246|P3|COMPLETED|Treatment Period 1||14
8116970|NCT02991430|20006247|P2|COMPLETED|Treatment Period 1||11
8116971|NCT02991430|20006248|P1|COMPLETED|Treatment Period 1||13
8116972|NCT02991430|20006246|P3|STARTED|Treatment Period 1||16
8116973|NCT02991430|20006247|P2|STARTED|Treatment Period 1||15
8116974|NCT02991430|20006248|P1|STARTED|Treatment Period 1||14
8116975|NCT02991118|20006285|P2|NOT COMPLETED|Overall Study||32
8116976|NCT02991118|20006286|P1|NOT COMPLETED|Overall Study||7
8116977|NCT02991118|20006285|P2|COMPLETED|Overall Study||490
8116978|NCT02991118|20006286|P1|COMPLETED|Overall Study||250
8116979|NCT02991118|20006285|P2|STARTED|Overall Study||522
8116980|NCT02991118|20006286|P1|STARTED|Overall Study||257
8116981|NCT02991040|20006330|P1|NOT COMPLETED|Overall Study||4
8116982|NCT02991040|20006330|P1|COMPLETED|Overall Study||96
8116983|NCT02991040|20006330|P1|STARTED|Overall Study||100
8116984|NCT02990910|20006345|P2|NOT COMPLETED|Overall Study||10
8116985|NCT02990910|20006346|P1|NOT COMPLETED|Overall Study||6
8116986|NCT02990910|20006345|P2|COMPLETED|Overall Study||130
8116987|NCT02990910|20006346|P1|COMPLETED|Overall Study||134
8116988|NCT02990910|20006345|P2|STARTED|Overall Study||140
8116989|NCT02990910|20006346|P1|STARTED|Overall Study||140
8117000|NCT02990000|20006405|P2|NOT COMPLETED|Overall Study||34
8117001|NCT02990000|20006406|P1|NOT COMPLETED|Overall Study||36
8117002|NCT02990000|20006405|P2|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
8117003|NCT02990000|20006406|P1|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
8117004|NCT02990000|20006405|P2|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
8117005|NCT02990000|20006406|P1|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
8117006|NCT02990000|20006405|P2|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
8117007|NCT02990000|20006406|P1|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
8117008|NCT02989805|20006426|P2|NOT COMPLETED|Overall Study||4
8117009|NCT02989805|20006427|P1|NOT COMPLETED|Overall Study||6
8117010|NCT02989805|20006426|P2|COMPLETED|Overall Study||162
8117011|NCT02989805|20006427|P1|COMPLETED|Overall Study||154
8117012|NCT02989805|20006426|P2|STARTED|Overall Study||166
8117013|NCT02989805|20006427|P1|STARTED|Overall Study||160
8117014|NCT02989727|20006443|P4|NOT COMPLETED|Overall Study||0
8117015|NCT02989727|20006444|P3|NOT COMPLETED|Overall Study||0
8117016|NCT02989727|20006445|P2|NOT COMPLETED|Overall Study||0
8117017|NCT02989727|20006446|P1|NOT COMPLETED|Overall Study||0
8117018|NCT02989727|20006443|P4|COMPLETED|Overall Study||30
8117019|NCT02989727|20006444|P3|COMPLETED|Overall Study||30
8117020|NCT02989727|20006445|P2|COMPLETED|Overall Study||44
8117021|NCT02989727|20006446|P1|COMPLETED|Overall Study||46
8117022|NCT02989727|20006443|P4|STARTED|Overall Study||30
8117023|NCT02989727|20006444|P3|STARTED|Overall Study||30
8117024|NCT02989727|20006445|P2|STARTED|Overall Study||44
8117025|NCT02989727|20006446|P1|STARTED|Overall Study||46
8117026|NCT02989714|20006522|P1|NOT COMPLETED|Overall Study||1
8117027|NCT02989714|20006522|P1|COMPLETED|Overall Study||12
8117028|NCT02989714|20006522|P1|Started Nivolumab|Overall Study||12
8117029|NCT02989714|20006522|P1|STARTED|Overall Study||13
8117030|NCT02989649|20006528|P1|NOT COMPLETED|Overall Study||420
8117031|NCT02989649|20006528|P1|COMPLETED|Overall Study||173
8117032|NCT02989649|20006528|P1|Eligible to Enter Into Treatment Period|Overall Study||509
8117033|NCT02989649|20006528|P1|Started But Not Treated|Overall Study||84
8117034|NCT02989649|20006528|P1|STARTED|Overall Study||593
8117035|NCT02989610|20006540|P1|NOT COMPLETED|Overall Study||39
8117036|NCT02989610|20006540|P1|COMPLETED|Overall Study||195
8117037|NCT02989610|20006540|P1|STARTED|Overall Study||234
8117038|NCT02989545|20006546|P1|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
8117039|NCT02989545|20006546|P1|COMPLETED|Treatment Period - Anal Tape Provided||20
8117040|NCT02989545|20006546|P1|STARTED|Treatment Period - Anal Tape Provided||20
8117041|NCT02989545|20006546|P1|NOT COMPLETED|Control Period - no Intervention||0
8117042|NCT02989545|20006546|P1|COMPLETED|Control Period - no Intervention||20
8117043|NCT02989545|20006546|P1|STARTED|Control Period - no Intervention||20
8117044|NCT02989389|20006570|P10|NOT COMPLETED|Period 3||0
8117045|NCT02989389|20006571|P9|NOT COMPLETED|Period 3||0
8117046|NCT02989389|20006572|P8|NOT COMPLETED|Period 3||0
8117047|NCT02989389|20006573|P7|NOT COMPLETED|Period 3||0
8117048|NCT02989389|20006574|P6|NOT COMPLETED|Period 3||0
8117049|NCT02989389|20006575|P5|NOT COMPLETED|Period 3||0
8117050|NCT02989389|20006576|P4|NOT COMPLETED|Period 3||0
8117051|NCT02989389|20006577|P3|NOT COMPLETED|Period 3||0
8117052|NCT02989389|20006578|P2|NOT COMPLETED|Period 3||0
8117053|NCT02989389|20006579|P1|NOT COMPLETED|Period 3||0
8117054|NCT02989389|20006570|P10|COMPLETED|Period 3||0
8117055|NCT02989389|20006571|P9|COMPLETED|Period 3||0
8117056|NCT02989389|20006572|P8|COMPLETED|Period 3||0
8117057|NCT02989389|20006573|P7|COMPLETED|Period 3||0
8117058|NCT02989389|20006574|P6|COMPLETED|Period 3||3
8117059|NCT02989389|20006575|P5|COMPLETED|Period 3||3
8117060|NCT02989389|20006576|P4|COMPLETED|Period 3||3
8117061|NCT02989389|20006577|P3|COMPLETED|Period 3||3
8117062|NCT02989389|20006578|P2|COMPLETED|Period 3||3
8117063|NCT02989389|20006579|P1|COMPLETED|Period 3||3
8117064|NCT02989389|20006570|P10|STARTED|Period 3||0
8117065|NCT02989389|20006571|P9|STARTED|Period 3||0
8117066|NCT02989389|20006572|P8|STARTED|Period 3||0
8117067|NCT02989389|20006573|P7|STARTED|Period 3||0
8117068|NCT02989389|20006574|P6|STARTED|Period 3||3
8117069|NCT02989389|20006575|P5|STARTED|Period 3||3
8117070|NCT02989389|20006576|P4|STARTED|Period 3||3
8117071|NCT02989389|20006577|P3|STARTED|Period 3||3
8117072|NCT02989389|20006578|P2|STARTED|Period 3||3
8117073|NCT02989389|20006579|P1|STARTED|Period 3||3
8117074|NCT02989389|20006570|P10|NOT COMPLETED|Period 2||0
8117075|NCT02989389|20006571|P9|NOT COMPLETED|Period 2||0
8117076|NCT02989389|20006572|P8|NOT COMPLETED|Period 2||0
8117077|NCT02989389|20006573|P7|NOT COMPLETED|Period 2||0
8117078|NCT02989389|20006574|P6|NOT COMPLETED|Period 2||0
8117079|NCT02989389|20006575|P5|NOT COMPLETED|Period 2||0
8117080|NCT02989389|20006576|P4|NOT COMPLETED|Period 2||0
8117081|NCT02989389|20006577|P3|NOT COMPLETED|Period 2||0
8117082|NCT02989389|20006578|P2|NOT COMPLETED|Period 2||0
8117083|NCT02989389|20006579|P1|NOT COMPLETED|Period 2||0
8117084|NCT02989389|20006570|P10|COMPLETED|Period 2||0
8117085|NCT02989389|20006571|P9|COMPLETED|Period 2||0
8117086|NCT02989389|20006572|P8|COMPLETED|Period 2||0
8117087|NCT02989389|20006573|P7|COMPLETED|Period 2||0
8117088|NCT02989389|20006574|P6|COMPLETED|Period 2||3
8117089|NCT02989389|20006575|P5|COMPLETED|Period 2||3
8117090|NCT02989389|20006576|P4|COMPLETED|Period 2||3
8117091|NCT02989389|20006577|P3|COMPLETED|Period 2||3
8117092|NCT02989389|20006578|P2|COMPLETED|Period 2||3
8117093|NCT02989389|20006579|P1|COMPLETED|Period 2||3
8117094|NCT02989389|20006570|P10|STARTED|Period 2|Part B was planned as a single period study.|0
8117095|NCT02989389|20006571|P9|STARTED|Period 2|Part B was planned as a single period study.|0
8117096|NCT02989389|20006572|P8|STARTED|Period 2|Part B was planned as a single period study.|0
8117097|NCT02989389|20006573|P7|STARTED|Period 2|Part B was planned as a single period study.|0
8117098|NCT02989389|20006574|P6|STARTED|Period 2||3
8117099|NCT02989389|20006575|P5|STARTED|Period 2||3
8117100|NCT02989389|20006576|P4|STARTED|Period 2||3
8117101|NCT02989389|20006577|P3|STARTED|Period 2||3
8117102|NCT02989389|20006578|P2|STARTED|Period 2||3
8117103|NCT02989389|20006579|P1|STARTED|Period 2||3
8117104|NCT02989389|20006570|P10|NOT COMPLETED|Period 1||0
8117105|NCT02989389|20006571|P9|NOT COMPLETED|Period 1||1
8117106|NCT02989389|20006572|P8|NOT COMPLETED|Period 1||0
8117107|NCT02989389|20006573|P7|NOT COMPLETED|Period 1||0
8117108|NCT02989389|20006574|P6|NOT COMPLETED|Period 1||0
8117109|NCT02989389|20006575|P5|NOT COMPLETED|Period 1||0
8117110|NCT02989389|20006576|P4|NOT COMPLETED|Period 1||0
8117111|NCT02989389|20006577|P3|NOT COMPLETED|Period 1||0
8117112|NCT02989389|20006578|P2|NOT COMPLETED|Period 1||1
8117113|NCT02989389|20006579|P1|NOT COMPLETED|Period 1||0
8117114|NCT02989389|20006570|P10|COMPLETED|Period 1||6
8117115|NCT02989389|20006571|P9|COMPLETED|Period 1||5
8117116|NCT02989389|20006572|P8|COMPLETED|Period 1||5
8117117|NCT02989389|20006573|P7|COMPLETED|Period 1||6
8117118|NCT02989389|20006574|P6|COMPLETED|Period 1||3
8117119|NCT02989389|20006575|P5|COMPLETED|Period 1||3
8117120|NCT02989389|20006576|P4|COMPLETED|Period 1||3
8117121|NCT02989389|20006577|P3|COMPLETED|Period 1||3
8117122|NCT02989389|20006578|P2|COMPLETED|Period 1||3
8117123|NCT02989389|20006579|P1|COMPLETED|Period 1||3
8117124|NCT02989389|20006570|P10|Received at Least 1 Dose of Study Drug|Period 1||6
8117125|NCT02989389|20006571|P9|Received at Least 1 Dose of Study Drug|Period 1||6
8117126|NCT02989389|20006572|P8|Received at Least 1 Dose of Study Drug|Period 1||5
8117127|NCT02989389|20006573|P7|Received at Least 1 Dose of Study Drug|Period 1||6
8117128|NCT02989389|20006574|P6|Received at Least 1 Dose of Study Drug|Period 1||3
8117129|NCT02989389|20006575|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8117130|NCT02989389|20006576|P4|Received at Least 1 Dose of Study Drug|Period 1||3
8117131|NCT02989389|20006577|P3|Received at Least 1 Dose of Study Drug|Period 1||3
8117132|NCT02989389|20006578|P2|Received at Least 1 Dose of Study Drug|Period 1||4
8117133|NCT02989389|20006579|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8117134|NCT02989389|20006570|P10|STARTED|Period 1||6
8117135|NCT02989389|20006571|P9|STARTED|Period 1||6
8117136|NCT02989389|20006572|P8|STARTED|Period 1||5
8117137|NCT02989389|20006573|P7|STARTED|Period 1||6
8117138|NCT02989389|20006574|P6|STARTED|Period 1||3
8117139|NCT02989389|20006575|P5|STARTED|Period 1||3
8117140|NCT02989389|20006576|P4|STARTED|Period 1||3
8117141|NCT02989389|20006577|P3|STARTED|Period 1||3
8117142|NCT02989389|20006578|P2|STARTED|Period 1||4
8117143|NCT02989389|20006579|P1|STARTED|Period 1||3
8117144|NCT02989168|20006645|P2|NOT COMPLETED|Overall Study||3
8117145|NCT02989168|20006646|P1|NOT COMPLETED|Overall Study||4
8117146|NCT02989168|20006645|P2|COMPLETED|Overall Study||0
8117147|NCT02989168|20006646|P1|COMPLETED|Overall Study||7
8117148|NCT02989168|20006645|P2|STARTED|Overall Study||3
8117149|NCT02989168|20006646|P1|STARTED|Overall Study||11
8117150|NCT02988882|20006668|P2|NOT COMPLETED|Overall Study||2
8117151|NCT02988882|20006669|P1|NOT COMPLETED|Overall Study||3
8117152|NCT02988882|20006668|P2|COMPLETED|Overall Study||40
8117153|NCT02988882|20006669|P1|COMPLETED|Overall Study||41
8117154|NCT02988882|20006668|P2|STARTED|Overall Study||42
8117155|NCT02988882|20006669|P1|STARTED|Overall Study||44
8117156|NCT02988856|20006679|P1|NOT COMPLETED|Overall Study||3
8117157|NCT02988856|20006679|P1|COMPLETED|Overall Study||8
8117158|NCT02988856|20006679|P1|STARTED|Overall Study||11
8117159|NCT02988843|20006685|P1|NOT COMPLETED|Overall Study||0
8117160|NCT02988843|20006685|P1|COMPLETED|Overall Study||1
8117161|NCT02988843|20006685|P1|STARTED|Overall Study||1
8117162|NCT02988622|20006692|P1|NOT COMPLETED|Overall Study||17
8117163|NCT02988622|20006692|P1|COMPLETED|Overall Study||83
8117164|NCT02988622|20006692|P1|STARTED|Overall Study||100
8117165|NCT02988349|20006716|P2|NOT COMPLETED|Overall Study||0
8117166|NCT02988349|20006717|P1|NOT COMPLETED|Overall Study||0
8117167|NCT02988349|20006716|P2|COMPLETED|Overall Study||21
8117168|NCT02988349|20006717|P1|COMPLETED|Overall Study||21
8117169|NCT02988349|20006716|P2|STARTED|Overall Study||21
8117170|NCT02988349|20006717|P1|STARTED|Overall Study||21
8117171|NCT02988219|20006727|P2|NOT COMPLETED|Overall Study||3
8117172|NCT02988219|20006728|P1|NOT COMPLETED|Overall Study||1
8117173|NCT02988219|20006727|P2|COMPLETED|Overall Study||22
8117174|NCT02988219|20006728|P1|COMPLETED|Overall Study||24
8117175|NCT02988219|20006727|P2|STARTED|Overall Study||25
8117176|NCT02988219|20006728|P1|STARTED|Overall Study||25
8117177|NCT02988193|20006738|P2|NOT COMPLETED|Overall Study||0
8117178|NCT02988193|20006739|P1|NOT COMPLETED|Overall Study||0
8117179|NCT02988193|20006738|P2|COMPLETED|Overall Study||16
8117180|NCT02988193|20006739|P1|COMPLETED|Overall Study||12
8117181|NCT02988193|20006738|P2|STARTED|Overall Study||16
8117182|NCT02988193|20006739|P1|STARTED|Overall Study||12
8117183|NCT02988115|20006747|P2|NOT COMPLETED|Overall Study||4
8117184|NCT02988115|20006748|P1|NOT COMPLETED|Overall Study||14
8117185|NCT02988115|20006747|P2|COMPLETED|Overall Study||107
8117186|NCT02988115|20006748|P1|COMPLETED|Overall Study||220
8117187|NCT02988115|20006747|P2|STARTED|Overall Study||111
8117188|NCT02988115|20006748|P1|STARTED|Overall Study||234
8117189|NCT02988050|20006764|P2|NOT COMPLETED|Overall Study||0
8117190|NCT02988050|20006765|P1|NOT COMPLETED|Overall Study||0
8117191|NCT02988050|20006764|P2|COMPLETED|Overall Study||30
8117192|NCT02988050|20006765|P1|COMPLETED|Overall Study||30
8117193|NCT02988050|20006764|P2|STARTED|Overall Study||30
8117194|NCT02988050|20006765|P1|STARTED|Overall Study||30
8117195|NCT02987972|20006774|P3|NOT COMPLETED|Overall Study||42
8117196|NCT02987972|20006775|P2|NOT COMPLETED|Overall Study||45
8117197|NCT02987972|20006776|P1|NOT COMPLETED|Overall Study||43
8117198|NCT02987972|20006774|P3|COMPLETED|Overall Study||308
8117199|NCT02987972|20006775|P2|COMPLETED|Overall Study||305
8117200|NCT02987972|20006776|P1|COMPLETED|Overall Study||308
8117201|NCT02987972|20006774|P3|Vaccination 4|Overall Study||311
8117202|NCT02987972|20006775|P2|Vaccination 4|Overall Study||306
8117203|NCT02987972|20006776|P1|Vaccination 4|Overall Study||310
8117204|NCT02987972|20006774|P3|Vaccination 3|Overall Study||332
8117205|NCT02987972|20006775|P2|Vaccination 3|Overall Study||331
8117206|NCT02987972|20006776|P1|Vaccination 3|Overall Study||330
8117207|NCT02987972|20006774|P3|Vaccination 2|Overall Study||335
8117208|NCT02987972|20006775|P2|Vaccination 2|Overall Study||335
8117209|NCT02987972|20006776|P1|Vaccination 2|Overall Study||333
8117210|NCT02987972|20006774|P3|Vaccination 1|Overall Study||347
8117211|NCT02987972|20006775|P2|Vaccination 1|Overall Study||347
8117212|NCT02987972|20006776|P1|Vaccination 1|Overall Study||350
8117213|NCT02987972|20006774|P3|STARTED|Overall Study||350
8117214|NCT02987972|20006775|P2|STARTED|Overall Study||350
8117215|NCT02987972|20006776|P1|STARTED|Overall Study||351
8117216|NCT02987868|20006805|P2|NOT COMPLETED|Second Intervention||0
8117217|NCT02987868|20006806|P1|NOT COMPLETED|Second Intervention||0
8117218|NCT02987868|20006805|P2|COMPLETED|Second Intervention||8
8117219|NCT02987868|20006806|P1|COMPLETED|Second Intervention||8
8117220|NCT02987868|20006805|P2|STARTED|Second Intervention||8
8117221|NCT02987868|20006806|P1|STARTED|Second Intervention||8
8117222|NCT02987868|20006805|P2|NOT COMPLETED|Wash Out Period 1 Week||0
8117223|NCT02987868|20006806|P1|NOT COMPLETED|Wash Out Period 1 Week||0
8117224|NCT02987868|20006805|P2|COMPLETED|Wash Out Period 1 Week||8
8117225|NCT02987868|20006806|P1|COMPLETED|Wash Out Period 1 Week||8
8117226|NCT02987868|20006805|P2|STARTED|Wash Out Period 1 Week||8
8117227|NCT02987868|20006806|P1|STARTED|Wash Out Period 1 Week||8
8117228|NCT02987868|20006805|P2|NOT COMPLETED|First Intervention||0
8117229|NCT02987868|20006806|P1|NOT COMPLETED|First Intervention||0
8117230|NCT02987868|20006805|P2|COMPLETED|First Intervention||8
8117231|NCT02987868|20006806|P1|COMPLETED|First Intervention||8
8117232|NCT02987868|20006805|P2|STARTED|First Intervention||8
8117233|NCT02987868|20006806|P1|STARTED|First Intervention||8
8117234|NCT02987660|20006814|P2|NOT COMPLETED|Overall Study||10
8117235|NCT02987660|20006815|P1|NOT COMPLETED|Overall Study||10
8117236|NCT02987660|20006814|P2|COMPLETED|Overall Study||0
8117237|NCT02987660|20006815|P1|COMPLETED|Overall Study||0
8117238|NCT02987660|20006814|P2|STARTED|Overall Study||10
8117239|NCT02987660|20006815|P1|STARTED|Overall Study||10
8117240|NCT02987621|20006825|P2|NOT COMPLETED|Overall Study||0
8117241|NCT02987621|20006826|P1|NOT COMPLETED|Overall Study||0
8117242|NCT02987621|20006825|P2|COMPLETED|Overall Study||7
8117243|NCT02987621|20006826|P1|COMPLETED|Overall Study||7
8117244|NCT02987621|20006825|P2|STARTED|Overall Study||7
8117245|NCT02987621|20006826|P1|STARTED|Overall Study||7
8117258|NCT02987374|20006856|P1|NOT COMPLETED|Overall Study||0
8117259|NCT02987374|20006856|P1|COMPLETED|Overall Study||10
8117260|NCT02987374|20006856|P1|STARTED|Overall Study||10
8117261|NCT02987231|20006863|P2|NOT COMPLETED|Overall Study||0
8117262|NCT02987231|20006864|P1|NOT COMPLETED|Overall Study||0
8117263|NCT02987231|20006863|P2|COMPLETED|Overall Study||30
8117264|NCT02987231|20006864|P1|COMPLETED|Overall Study||30
8117265|NCT02987231|20006863|P2|STARTED|Overall Study||30
8117266|NCT02987231|20006864|P1|STARTED|Overall Study||30
8117267|NCT02987205|20006872|P1|NOT COMPLETED|Overall Study||4
8117268|NCT02987205|20006872|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
8117269|NCT02987205|20006872|P1|Treated - Bilateral NLF Injection|Overall Study||163
8117270|NCT02987205|20006872|P1|STARTED|Overall Study||163
8117271|NCT02986958|20006882|P2|NOT COMPLETED|Overall Study||0
8117272|NCT02986958|20006883|P1|NOT COMPLETED|Overall Study||0
8117273|NCT02986958|20006882|P2|COMPLETED|Overall Study||44
8117274|NCT02986958|20006883|P1|COMPLETED|Overall Study||49
8117275|NCT02986958|20006882|P2|STARTED|Overall Study||44
8117276|NCT02986958|20006883|P1|STARTED|Overall Study||49
8117277|NCT02986854|20006906|P3|NOT COMPLETED|Overall Study||3
8117278|NCT02986854|20006907|P2|NOT COMPLETED|Overall Study||12
8117279|NCT02986854|20006908|P1|NOT COMPLETED|Overall Study||3
8117280|NCT02986854|20006906|P3|COMPLETED|Overall Study||97
8117281|NCT02986854|20006907|P2|COMPLETED|Overall Study||288
8117282|NCT02986854|20006908|P1|COMPLETED|Overall Study||298
8117283|NCT02986854|20006906|P3|STARTED|Overall Study||100
8117284|NCT02986854|20006907|P2|STARTED|Overall Study||300
8117285|NCT02986854|20006908|P1|STARTED|Overall Study||301
8117286|NCT02986711|20006983|P2|NOT COMPLETED|Overall Study||10
8117287|NCT02986711|20006984|P1|NOT COMPLETED|Overall Study||8
8117288|NCT02986711|20006983|P2|COMPLETED|Overall Study||70
8117289|NCT02986711|20006984|P1|COMPLETED|Overall Study||70
8117290|NCT02986711|20006983|P2|STARTED|Overall Study||80
8117291|NCT02986711|20006984|P1|STARTED|Overall Study||78
8117292|NCT02986373|20006992|P1|NOT COMPLETED|Overall Study||39
8117293|NCT02986373|20006992|P1|COMPLETED|Overall Study||106
8117294|NCT02986373|20006992|P1|STARTED|Overall Study||145
8117295|NCT02986282|20007027|P1|NOT COMPLETED|Overall Study||16
8117296|NCT02986282|20007027|P1|COMPLETED|Overall Study||99
8117297|NCT02986282|20007027|P1|STARTED|Overall Study||115
8117298|NCT02986139|20007034|P2|NOT COMPLETED|Overall Study||4
8117299|NCT02986139|20007035|P1|NOT COMPLETED|Overall Study||1
8117300|NCT02986139|20007034|P2|COMPLETED|Overall Study||51
8117301|NCT02986139|20007035|P1|COMPLETED|Overall Study||55
8117302|NCT02986139|20007034|P2|Received Etanercept|Overall Study||53
8117303|NCT02986139|20007035|P1|Received Etanercept|Overall Study||56
8117304|NCT02986139|20007034|P2|STARTED|Overall Study||55
8117305|NCT02986139|20007035|P1|STARTED|Overall Study||56
8117306|NCT02985996|20007052|P5|NOT COMPLETED|Overall Study||0
8117307|NCT02985996|20007053|P4|NOT COMPLETED|Overall Study||0
8117308|NCT02985996|20007054|P3|NOT COMPLETED|Overall Study||1
8117309|NCT02985996|20007055|P2|NOT COMPLETED|Overall Study||1
8117310|NCT02985996|20007056|P1|NOT COMPLETED|Overall Study||0
8117311|NCT02985996|20007052|P5|COMPLETED|Overall Study||9
8117312|NCT02985996|20007053|P4|COMPLETED|Overall Study||7
8117313|NCT02985996|20007054|P3|COMPLETED|Overall Study||9
8117314|NCT02985996|20007055|P2|COMPLETED|Overall Study||7
8117315|NCT02985996|20007056|P1|COMPLETED|Overall Study||5
8117316|NCT02985996|20007052|P5|STARTED|Overall Study||9
8117317|NCT02985996|20007053|P4|STARTED|Overall Study||7
8117318|NCT02985996|20007054|P3|STARTED|Overall Study||10
8117319|NCT02985996|20007055|P2|STARTED|Overall Study||8
8117320|NCT02985996|20007056|P1|STARTED|Overall Study||5
8117321|NCT02985840|20007170|P2|NOT COMPLETED|Overall Study||0
8117322|NCT02985840|20007171|P1|NOT COMPLETED|Overall Study||0
8117323|NCT02985840|20007170|P2|COMPLETED|Overall Study||63
8117324|NCT02985840|20007171|P1|COMPLETED|Overall Study||64
8117325|NCT02985840|20007170|P2|STARTED|Overall Study||63
8117326|NCT02985840|20007171|P1|STARTED|Overall Study||64
8117327|NCT02985827|20007181|P2|NOT COMPLETED|Overall Study||0
8117328|NCT02985827|20007182|P1|NOT COMPLETED|Overall Study||0
8117329|NCT02985827|20007181|P2|COMPLETED|Overall Study||15
8117330|NCT02985827|20007182|P1|COMPLETED|Overall Study||33
8117331|NCT02985827|20007181|P2|STARTED|Overall Study||15
8117332|NCT02985827|20007182|P1|STARTED|Overall Study||33
8117333|NCT02985684|20007190|P1|NOT COMPLETED|6-Month Closure Success Evaluation||8
8117334|NCT02985684|20007190|P1|COMPLETED|6-Month Closure Success Evaluation||112
8117335|NCT02985684|20007190|P1|STARTED|6-Month Closure Success Evaluation||120
8117336|NCT02985684|20007190|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||5
8117337|NCT02985684|20007190|P1|COMPLETED|6-Month Clinical Success Evaluation||120
8117338|NCT02985684|20007190|P1|STARTED|6-Month Clinical Success Evaluation||125
8117339|NCT02985398|20007201|P1|NOT COMPLETED|Overall Study||22
8117340|NCT02985398|20007201|P1|COMPLETED|Overall Study||106
8117341|NCT02985398|20007201|P1|Participants Treated|Overall Study||128
8117342|NCT02985398|20007201|P1|STARTED|Overall Study||128
8117343|NCT02984995|20007219|P2|NOT COMPLETED|Overall Study||3
8117344|NCT02984995|20007220|P1|NOT COMPLETED|Overall Study||25
8117345|NCT02984995|20007219|P2|COMPLETED|Overall Study||0
8117346|NCT02984995|20007220|P1|COMPLETED|Overall Study||9
8117347|NCT02984995|20007219|P2|STARTED|Overall Study||3
8117348|NCT02984995|20007220|P1|STARTED|Overall Study||34
8117349|NCT02984982|20007267|P2|NOT COMPLETED|Overall Study||10
8117350|NCT02984982|20007268|P1|NOT COMPLETED|Overall Study||8
8117351|NCT02984982|20007267|P2|COMPLETED|Overall Study||94
8117352|NCT02984982|20007268|P1|COMPLETED|Overall Study||94
8117353|NCT02984982|20007267|P2|Treated|Overall Study||103
8117354|NCT02984982|20007268|P1|Treated|Overall Study||102
8117355|NCT02984982|20007267|P2|STARTED|Overall Study||104
8117356|NCT02984982|20007268|P1|STARTED|Overall Study||102
8117357|NCT02984943|20007320|P1|NOT COMPLETED|Overall Study||4
8117358|NCT02984943|20007320|P1|COMPLETED|Overall Study||10
8117359|NCT02984943|20007320|P1|STARTED|Overall Study||14
8117360|NCT02984878|20007365|P2|NOT COMPLETED|Overall Study||0
8117361|NCT02984878|20007366|P1|NOT COMPLETED|Overall Study||0
8117362|NCT02984878|20007365|P2|COMPLETED|Overall Study||41
8117363|NCT02984878|20007366|P1|COMPLETED|Overall Study||30
8117364|NCT02984878|20007365|P2|STARTED|Overall Study||41
8117365|NCT02984878|20007366|P1|STARTED|Overall Study||30
8117366|NCT02984709|20007378|P2|NOT COMPLETED|Overall Study||0
8117367|NCT02984709|20007379|P1|NOT COMPLETED|Overall Study||0
8117368|NCT02984709|20007378|P2|COMPLETED|Overall Study||24
8117369|NCT02984709|20007379|P1|COMPLETED|Overall Study||24
8117370|NCT02984709|20007378|P2|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
8117371|NCT02984709|20007379|P1|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
8117372|NCT02984644|20007403|P2|NOT COMPLETED|Overall Study||0
8117373|NCT02984644|20007404|P1|NOT COMPLETED|Overall Study||0
8117374|NCT02984644|20007403|P2|COMPLETED|Overall Study||10
8117375|NCT02984644|20007404|P1|COMPLETED|Overall Study||20
8117376|NCT02984644|20007403|P2|STARTED|Overall Study||10
8117377|NCT02984644|20007404|P1|STARTED|Overall Study||20
8117378|NCT02984267|20007434|P2|NOT COMPLETED|Overall Study||1
8117379|NCT02984267|20007435|P1|NOT COMPLETED|Overall Study||1
8117380|NCT02984267|20007434|P2|COMPLETED|Overall Study||9
8117381|NCT02984267|20007435|P1|COMPLETED|Overall Study||7
8117382|NCT02984267|20007434|P2|STARTED|Overall Study||10
8117383|NCT02984267|20007435|P1|STARTED|Overall Study||8
8117384|NCT02983981|20007459|P1|NOT COMPLETED|Overall Study||0
8117385|NCT02983981|20007459|P1|COMPLETED|Overall Study||20
8117386|NCT02983981|20007459|P1|STARTED|Overall Study||20
8117387|NCT02983877|20007466|P1|NOT COMPLETED|Overall Study||0
8117388|NCT02983877|20007466|P1|COMPLETED|Overall Study||38
8117389|NCT02983877|20007466|P1|STARTED|Overall Study||38
8117390|NCT02983825|20007473|P1|NOT COMPLETED|Overall Study||3
8117391|NCT02983825|20007473|P1|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
8117392|NCT02983825|20007473|P1|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
8117393|NCT02983617|20007480|P2|NOT COMPLETED|Overall Study||30
8117394|NCT02983617|20007481|P1|NOT COMPLETED|Overall Study||6
8117395|NCT02983617|20007480|P2|COMPLETED|Overall Study||0
8117396|NCT02983617|20007481|P1|COMPLETED|Overall Study||0
8117397|NCT02983617|20007480|P2|STARTED|Overall Study||30
8117398|NCT02983617|20007481|P1|STARTED|Overall Study||6
8117399|NCT02983604|20007499|P4|NOT COMPLETED|Overall Study||0
8117400|NCT02983604|20007500|P3|NOT COMPLETED|Overall Study||1
8117401|NCT02983604|20007501|P2|NOT COMPLETED|Overall Study||0
8117402|NCT02983604|20007502|P1|NOT COMPLETED|Overall Study||0
8117403|NCT02983604|20007499|P4|COMPLETED|Overall Study||3
8117404|NCT02983604|20007500|P3|COMPLETED|Overall Study||3
8117405|NCT02983604|20007501|P2|COMPLETED|Overall Study||3
8117406|NCT02983604|20007502|P1|COMPLETED|Overall Study||4
8117407|NCT02983604|20007499|P4|STARTED|Overall Study||3
8117408|NCT02983604|20007500|P3|STARTED|Overall Study||4
8117409|NCT02983604|20007501|P2|STARTED|Overall Study||3
8117410|NCT02983604|20007502|P1|STARTED|Overall Study||4
8117411|NCT02983448|20007540|P2|NOT COMPLETED|Overall Study||0
8117412|NCT02983448|20007541|P1|NOT COMPLETED|Overall Study||0
8117413|NCT02983448|20007540|P2|COMPLETED|Overall Study||12
8117414|NCT02983448|20007541|P1|COMPLETED|Overall Study||12
8117415|NCT02983448|20007540|P2|STARTED|Overall Study||12
8117416|NCT02983448|20007541|P1|STARTED|Overall Study||12
8117417|NCT02983305|20007551|P2|NOT COMPLETED|Overall Study||0
8117418|NCT02983305|20007552|P1|NOT COMPLETED|Overall Study||2
8117419|NCT02983305|20007551|P2|COMPLETED|Overall Study||10
8117420|NCT02983305|20007552|P1|COMPLETED|Overall Study||10
8117421|NCT02983305|20007551|P2|STARTED|Overall Study||10
8117422|NCT02983305|20007552|P1|STARTED|Overall Study||12
8117423|NCT02983227|20007562|P2|NOT COMPLETED|Overall Study||14
8117424|NCT02983227|20007563|P1|NOT COMPLETED|Overall Study||59
8117425|NCT02983227|20007562|P2|COMPLETED|Overall Study||72
8117426|NCT02983227|20007563|P1|COMPLETED|Overall Study||351
8117427|NCT02983227|20007562|P2|STARTED|Overall Study||86
8117428|NCT02983227|20007563|P1|STARTED|Overall Study||410
8117429|NCT02983058|20007623|P2|NOT COMPLETED|Overall Study||3
8117430|NCT02983058|20007624|P1|NOT COMPLETED|Overall Study||5
8117431|NCT02983058|20007623|P2|COMPLETED|Overall Study||2
8117432|NCT02983058|20007624|P1|COMPLETED|Overall Study||2
8117433|NCT02983058|20007623|P2|STARTED|Overall Study||5
8117434|NCT02983058|20007624|P1|STARTED|Overall Study||7
8117435|NCT02982928|20007634|P1|NOT COMPLETED|Overall Study||0
8117436|NCT02982928|20007634|P1|COMPLETED|Overall Study||11
8117437|NCT02982928|20007634|P1|STARTED|Overall Study||11
8117438|NCT02982863|20007643|P5|NOT COMPLETED|Overall Study||492
8117439|NCT02982863|20007644|P4|NOT COMPLETED|Overall Study||1400
8117440|NCT02982863|20007645|P3|NOT COMPLETED|Overall Study||1852
8117441|NCT02982863|20007646|P2|NOT COMPLETED|Overall Study||4261
8117442|NCT02982863|20007647|P1|NOT COMPLETED|Overall Study||809
8117443|NCT02982863|20007643|P5|COMPLETED|Overall Study||2268
8117444|NCT02982863|20007644|P4|COMPLETED|Overall Study||8758
8117445|NCT02982863|20007645|P3|COMPLETED|Overall Study||11386
8117446|NCT02982863|20007646|P2|COMPLETED|Overall Study||12484
8117447|NCT02982863|20007647|P1|COMPLETED|Overall Study||4936
8117448|NCT02982863|20007643|P5|STARTED|Overall Study||2760
8117449|NCT02982863|20007644|P4|STARTED|Overall Study||10158
8117450|NCT02982863|20007645|P3|STARTED|Overall Study||13238
8117451|NCT02982863|20007646|P2|STARTED|Overall Study||16745
8117452|NCT02982863|20007647|P1|STARTED|Overall Study||5745
8117453|NCT02982720|20007704|P1|NOT COMPLETED|Overall Study||4
8117454|NCT02982720|20007704|P1|COMPLETED|Overall Study||0
8117455|NCT02982720|20007704|P1|STARTED|Overall Study||4
8117456|NCT02982239|20007714|P2|NOT COMPLETED|Overall Study||2
8117457|NCT02982239|20007715|P1|NOT COMPLETED|Overall Study||3
8117458|NCT02982239|20007714|P2|COMPLETED|Overall Study||18
8117459|NCT02982239|20007715|P1|COMPLETED|Overall Study||17
8117460|NCT02982239|20007714|P2|STARTED|Overall Study||20
8117461|NCT02982239|20007715|P1|STARTED|Overall Study||20
8117462|NCT02982213|20007731|P2|NOT COMPLETED|Overall Study||1
8117463|NCT02982213|20007732|P1|NOT COMPLETED|Overall Study||5
8117464|NCT02982213|20007731|P2|COMPLETED|Overall Study||74
8117465|NCT02982213|20007732|P1|COMPLETED|Overall Study||70
8117466|NCT02982213|20007731|P2|STARTED|Overall Study||75
8117467|NCT02982213|20007732|P1|STARTED|Overall Study||75
8117468|NCT02982187|20007748|P8|NOT COMPLETED|Overall Study||0
8117469|NCT02982187|20007749|P7|NOT COMPLETED|Overall Study||1
8117470|NCT02982187|20007750|P6|NOT COMPLETED|Overall Study||0
8117471|NCT02982187|20007751|P5|NOT COMPLETED|Overall Study||0
8117472|NCT02982187|20007752|P4|NOT COMPLETED|Overall Study||0
8117473|NCT02982187|20007753|P3|NOT COMPLETED|Overall Study||0
8117474|NCT02982187|20007754|P2|NOT COMPLETED|Overall Study||0
8117475|NCT02982187|20007755|P1|NOT COMPLETED|Overall Study||0
8117476|NCT02982187|20007748|P8|COMPLETED|Overall Study||20
8117477|NCT02982187|20007749|P7|COMPLETED|Overall Study||19
8117478|NCT02982187|20007750|P6|COMPLETED|Overall Study||20
8117479|NCT02982187|20007751|P5|COMPLETED|Overall Study||20
8117480|NCT02982187|20007752|P4|COMPLETED|Overall Study||20
8117481|NCT02982187|20007753|P3|COMPLETED|Overall Study||20
8117482|NCT02982187|20007754|P2|COMPLETED|Overall Study||20
8117483|NCT02982187|20007755|P1|COMPLETED|Overall Study||20
8117484|NCT02982187|20007748|P8|STARTED|Overall Study||20
8117485|NCT02982187|20007749|P7|STARTED|Overall Study||20
8117486|NCT02982187|20007750|P6|STARTED|Overall Study||20
8117487|NCT02982187|20007751|P5|STARTED|Overall Study||20
8117488|NCT02982187|20007752|P4|STARTED|Overall Study||20
8117489|NCT02982187|20007753|P3|STARTED|Overall Study||20
8117490|NCT02982187|20007754|P2|STARTED|Overall Study||20
8117491|NCT02982187|20007755|P1|STARTED|Overall Study||20
8117492|NCT02982018|20007805|P2|NOT COMPLETED|Overall Study||3
8117493|NCT02982018|20007806|P1|NOT COMPLETED|Overall Study||5
8117494|NCT02982018|20007805|P2|COMPLETED|Overall Study||61
8117495|NCT02982018|20007806|P1|COMPLETED|Overall Study||62
8117496|NCT02982018|20007805|P2|STARTED|Overall Study||64
8117497|NCT02982018|20007806|P1|STARTED|Overall Study||67
8117498|NCT02981602|20007825|P5|NOT COMPLETED|Overall Study||0
8117499|NCT02981602|20007826|P4|NOT COMPLETED|Overall Study||1
8117500|NCT02981602|20007827|P3|NOT COMPLETED|Overall Study||0
8117501|NCT02981602|20007828|P2|NOT COMPLETED|Overall Study||0
8117502|NCT02981602|20007829|P1|NOT COMPLETED|Overall Study||0
8117503|NCT02981602|20007825|P5|COMPLETED|Overall Study||2
8117504|NCT02981602|20007826|P4|COMPLETED|Overall Study||4
8117505|NCT02981602|20007827|P3|COMPLETED|Overall Study||6
8117506|NCT02981602|20007828|P2|COMPLETED|Overall Study||12
8117507|NCT02981602|20007829|P1|COMPLETED|Overall Study||6
8117508|NCT02981602|20007825|P5|STARTED|Overall Study||2
8117509|NCT02981602|20007826|P4|STARTED|Overall Study||5
8117510|NCT02981602|20007827|P3|STARTED|Overall Study||6
8117511|NCT02981602|20007828|P2|STARTED|Overall Study||12
8117512|NCT02981602|20007829|P1|STARTED|Overall Study||6
8117516|NCT02981342|20008021|P4|NOT COMPLETED|Overall Study||14
8117517|NCT02981342|20008022|P3|NOT COMPLETED|Overall Study||13
8117518|NCT02981342|20008023|P2|NOT COMPLETED|Overall Study||11
8117519|NCT02981342|20008024|P1|NOT COMPLETED|Overall Study||0
8117520|NCT02981342|20008021|P4|COMPLETED|Overall Study||19
8117521|NCT02981342|20008022|P3|COMPLETED|Overall Study||20
8117522|NCT02981342|20008023|P2|COMPLETED|Overall Study||22
8117523|NCT02981342|20008024|P1|COMPLETED|Overall Study||7
8117524|NCT02981342|20008021|P4|Received at Least One Dose of Study Drug|Overall Study||26
8117525|NCT02981342|20008022|P3|Received at Least One Dose of Study Drug|Overall Study||33
8117526|NCT02981342|20008023|P2|Received at Least One Dose of Study Drug|Overall Study||32
8117527|NCT02981342|20008024|P1|Received at Least One Dose of Study Drug|Overall Study||7
8117528|NCT02981342|20008021|P4|STARTED|Overall Study||33
8117529|NCT02981342|20008022|P3|STARTED|Overall Study||33
8117530|NCT02981342|20008023|P2|STARTED|Overall Study||33
8117531|NCT02981342|20008024|P1|STARTED|Overall Study||7
8117532|NCT02980978|20008067|P2|NOT COMPLETED|Overall Study||8
8117533|NCT02980978|20008068|P1|NOT COMPLETED|Overall Study||6
8117534|NCT02980978|20008067|P2|COMPLETED|Overall Study||50
8117535|NCT02980978|20008068|P1|COMPLETED|Overall Study||54
8117536|NCT02980978|20008067|P2|STARTED|Overall Study||58
8117537|NCT02980978|20008068|P1|STARTED|Overall Study||60
8117538|NCT02980783|20008082|P1|NOT COMPLETED|Overall Study||1
8117539|NCT02980783|20008082|P1|COMPLETED|Overall Study||52
8117540|NCT02980783|20008082|P1|STARTED|Overall Study||53
8117541|NCT02980601|20008095|P2|NOT COMPLETED|Overall Study||3
8117542|NCT02980601|20008096|P1|NOT COMPLETED|Overall Study||5
8117543|NCT02980601|20008095|P2|COMPLETED|Overall Study||1
8117544|NCT02980601|20008096|P1|COMPLETED|Overall Study||1
8117545|NCT02980601|20008095|P2|STARTED|Overall Study||4
8117546|NCT02980601|20008096|P1|STARTED|Overall Study||6
8117547|NCT02980523|20008189|P5|NOT COMPLETED|Overall Study||10
8117548|NCT02980523|20008190|P4|NOT COMPLETED|Overall Study||9
8117549|NCT02980523|20008191|P3|NOT COMPLETED|Overall Study||6
8117550|NCT02980523|20008192|P2|NOT COMPLETED|Overall Study||11
8117551|NCT02980523|20008193|P1|NOT COMPLETED|Overall Study||3
8117552|NCT02980523|20008189|P5|COMPLETED|Overall Study||20
8117553|NCT02980523|20008190|P4|COMPLETED|Overall Study||21
8117554|NCT02980523|20008191|P3|COMPLETED|Overall Study||24
8117555|NCT02980523|20008192|P2|COMPLETED|Overall Study||19
8117556|NCT02980523|20008193|P1|COMPLETED|Overall Study||27
8117557|NCT02980523|20008189|P5|STARTED|Overall Study||30
8117558|NCT02980523|20008190|P4|STARTED|Overall Study||30
8117559|NCT02980523|20008191|P3|STARTED|Overall Study||30
8117560|NCT02980523|20008192|P2|STARTED|Overall Study||30
8117561|NCT02980523|20008193|P1|STARTED|Overall Study||30
8117562|NCT02980224|20008237|P2|NOT COMPLETED|Overall Study||3
8117563|NCT02980224|20008238|P1|NOT COMPLETED|Overall Study||4
8117564|NCT02980224|20008237|P2|COMPLETED|Overall Study||88
8117565|NCT02980224|20008238|P1|COMPLETED|Overall Study||85
8117566|NCT02980224|20008237|P2|STARTED|Overall Study||91
8117567|NCT02980224|20008238|P1|STARTED|Overall Study||89
8117568|NCT02980211|20008248|P1|NOT COMPLETED|Overall Study||0
8117569|NCT02980211|20008248|P1|COMPLETED|Overall Study||17
8117570|NCT02980211|20008248|P1|STARTED|Overall Study||17
8117571|NCT02980133|20008256|P4|NOT COMPLETED|Overall Study||6
8117572|NCT02980133|20008257|P3|NOT COMPLETED|Overall Study||7
8117573|NCT02980133|20008258|P2|NOT COMPLETED|Overall Study||5
8117574|NCT02980133|20008259|P1|NOT COMPLETED|Overall Study||7
8117575|NCT02980133|20008256|P4|COMPLETED|Overall Study||205
8117576|NCT02980133|20008257|P3|COMPLETED|Overall Study||203
8117577|NCT02980133|20008258|P2|COMPLETED|Overall Study||206
8117578|NCT02980133|20008259|P1|COMPLETED|Overall Study||202
8117579|NCT02980133|20008256|P4|Received at Least 1 Dose of Study Drug|Overall Study||211
8117580|NCT02980133|20008257|P3|Received at Least 1 Dose of Study Drug|Overall Study||208
8117581|NCT02980133|20008258|P2|Received at Least 1 Dose of Study Drug|Overall Study||211
8117582|NCT02980133|20008259|P1|Received at Least 1 Dose of Study Drug|Overall Study||209
8117583|NCT02980133|20008256|P4|STARTED|Overall Study||211
8117584|NCT02980133|20008257|P3|STARTED|Overall Study||210
8117585|NCT02980133|20008258|P2|STARTED|Overall Study||211
8117586|NCT02980133|20008259|P1|STARTED|Overall Study||209
8117587|NCT02980107|20008297|P2|NOT COMPLETED|Overall Study||62
8117588|NCT02980107|20008298|P1|NOT COMPLETED|Overall Study||51
8117589|NCT02980107|20008297|P2|COMPLETED|Overall Study||45
8117590|NCT02980107|20008298|P1|COMPLETED|Overall Study||54
8117591|NCT02980107|20008297|P2|STARTED|Overall Study||107
8117592|NCT02980107|20008298|P1|STARTED|Overall Study||105
8117593|NCT02980042|20008312|P2|NOT COMPLETED|Overall Study||0
8117594|NCT02980042|20008313|P1|NOT COMPLETED|Overall Study||7
8117595|NCT02980042|20008312|P2|COMPLETED|Overall Study||100
8117596|NCT02980042|20008313|P1|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
8117597|NCT02980042|20008312|P2|STARTED|Overall Study||100
8117598|NCT02980042|20008313|P1|STARTED|Overall Study||100
8117599|NCT02979899|20008332|P2|NOT COMPLETED|Overall Study||0
8117600|NCT02979899|20008333|P1|NOT COMPLETED|Overall Study||0
8117601|NCT02979899|20008332|P2|COMPLETED|Overall Study||64
8117602|NCT02979899|20008333|P1|COMPLETED|Overall Study||64
8117603|NCT02979899|20008332|P2|STARTED|Overall Study||64
8117604|NCT02979899|20008333|P1|STARTED|Overall Study||64
8117605|NCT02979639|20008345|P1|NOT COMPLETED|Overall Study||14
8117606|NCT02979639|20008345|P1|COMPLETED|Overall Study||387
8117607|NCT02979639|20008345|P1|STARTED|Overall Study||401
8117608|NCT02979613|20008377|P2|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
8117609|NCT02979613|20008378|P1|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
8117610|NCT02979613|20008377|P2|COMPLETED|Open-Label Extension (OLE) Phase||231
8117611|NCT02979613|20008378|P1|COMPLETED|Open-Label Extension (OLE) Phase||232
8117612|NCT02979613|20008377|P2|STARTED|Open-Label Extension (OLE) Phase||237
8117613|NCT02979613|20008378|P1|STARTED|Open-Label Extension (OLE) Phase||235
8117614|NCT02979613|20008377|P2|NOT COMPLETED|Double-Blind Phase||8
8117615|NCT02979613|20008378|P1|NOT COMPLETED|Double-Blind Phase||10
8117616|NCT02979613|20008377|P2|COMPLETED|Double-Blind Phase||237
8117617|NCT02979613|20008378|P1|COMPLETED|Double-Blind Phase||235
8117618|NCT02979613|20008377|P2|STARTED|Double-Blind Phase||245
8117619|NCT02979613|20008378|P1|STARTED|Double-Blind Phase||245
8117620|NCT02979535|20008438|P2|NOT COMPLETED|Overall Study||101
8117621|NCT02979535|20008439|P1|NOT COMPLETED|Overall Study||95
8117622|NCT02979535|20008438|P2|COMPLETED|Overall Study||140
8117623|NCT02979535|20008439|P1|COMPLETED|Overall Study||144
8117624|NCT02979535|20008438|P2|Safety Analysis Set|Overall Study||241
8117625|NCT02979535|20008439|P1|Safety Analysis Set|Overall Study||237
8117626|NCT02979535|20008438|P2|STARTED|Overall Study||241
8117627|NCT02979535|20008439|P1|STARTED|Overall Study||239
8117628|NCT02979444|20008476|P3|NOT COMPLETED|Overall Study||10
8117629|NCT02979444|20008477|P2|NOT COMPLETED|Overall Study||17
8117630|NCT02979444|20008478|P1|NOT COMPLETED|Overall Study||23
8117631|NCT02979444|20008476|P3|COMPLETED|Overall Study||149
8117632|NCT02979444|20008477|P2|COMPLETED|Overall Study||293
8117633|NCT02979444|20008478|P1|COMPLETED|Overall Study||382
8117634|NCT02979444|20008476|P3|STARTED|Overall Study||159
8117635|NCT02979444|20008477|P2|STARTED|Overall Study||310
8117636|NCT02979444|20008478|P1|STARTED|Overall Study||405
8117637|NCT02979431|20008502|P4|NOT COMPLETED|Overall Study||1
8117638|NCT02979431|20008503|P3|NOT COMPLETED|Overall Study||2
8117639|NCT02979431|20008504|P2|NOT COMPLETED|Overall Study||2
8117640|NCT02979431|20008505|P1|NOT COMPLETED|Overall Study||4
8117641|NCT02979431|20008502|P4|COMPLETED|Overall Study||44
8117642|NCT02979431|20008503|P3|COMPLETED|Overall Study||43
8117643|NCT02979431|20008504|P2|COMPLETED|Overall Study||44
8117644|NCT02979431|20008505|P1|COMPLETED|Overall Study||40
8117645|NCT02979431|20008502|P4|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
8117646|NCT02979431|20008503|P3|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
8117647|NCT02979431|20008504|P2|Included in the Safety Population|Overall Study||45
8117648|NCT02979431|20008505|P1|Included in the Safety Population|Overall Study||40
8117649|NCT02979431|20008502|P4|Included in the mITT Population|Overall Study||45
8117650|NCT02979431|20008503|P3|Included in the mITT Population|Overall Study||43
8117651|NCT02979431|20008504|P2|Included in the mITT Population|Overall Study||45
8117652|NCT02979431|20008505|P1|Included in the mITT Population|Overall Study||42
8117653|NCT02979431|20008502|P4|STARTED|Overall Study||45
8117654|NCT02979431|20008503|P3|STARTED|Overall Study||45
8117655|NCT02979431|20008504|P2|STARTED|Overall Study||46
8117656|NCT02979431|20008505|P1|STARTED|Overall Study||44
8117657|NCT02979301|20008557|P2|NOT COMPLETED|Overall Study||0
8117658|NCT02979301|20008558|P1|NOT COMPLETED|Overall Study||1
8117659|NCT02979301|20008557|P2|COMPLETED|Overall Study||11
8117660|NCT02979301|20008558|P1|COMPLETED|Overall Study||10
8117661|NCT02979301|20008557|P2|STARTED|Overall Study||11
8117662|NCT02979301|20008558|P1|STARTED|Overall Study||11
8117663|NCT02979262|20008566|P2|NOT COMPLETED|Overall Study||9
8117664|NCT02979262|20008567|P1|NOT COMPLETED|Overall Study||12
8117665|NCT02979262|20008566|P2|COMPLETED|Overall Study||20
8117666|NCT02979262|20008567|P1|COMPLETED|Overall Study||21
8117667|NCT02979262|20008566|P2|Received Allocated Intervention|Overall Study||27
8117668|NCT02979262|20008567|P1|Received Allocated Intervention|Overall Study||30
8117669|NCT02979262|20008566|P2|STARTED|Overall Study||29
8117670|NCT02979262|20008567|P1|STARTED|Overall Study||33
8117671|NCT02979249|20008583|P1|NOT COMPLETED|Overall Study||6
8117672|NCT02979249|20008583|P1|COMPLETED|Overall Study||10
8117673|NCT02979249|20008583|P1|STARTED|Overall Study||16
8117674|NCT02979197|20008591|P3|NOT COMPLETED|Overall Study||0
8117675|NCT02979197|20008592|P2|NOT COMPLETED|Overall Study||4
8117676|NCT02979197|20008593|P1|NOT COMPLETED|Overall Study||4
8117677|NCT02979197|20008591|P3|COMPLETED|Overall Study||8
8117678|NCT02979197|20008592|P2|COMPLETED|Overall Study||45
8117679|NCT02979197|20008593|P1|COMPLETED|Overall Study||44
8117680|NCT02979197|20008591|P3|STARTED|Overall Study||8
8117681|NCT02979197|20008592|P2|STARTED|Overall Study||49
8117682|NCT02979197|20008593|P1|STARTED|Overall Study||48
8117683|NCT02979054|20008621|P2|NOT COMPLETED|Overall Study||0
8117684|NCT02979054|20008622|P1|NOT COMPLETED|Overall Study||0
8117685|NCT02979054|20008621|P2|COMPLETED|Overall Study||64
8117686|NCT02979054|20008622|P1|COMPLETED|Overall Study||71
8117687|NCT02979054|20008621|P2|STARTED|Overall Study||64
8117688|NCT02979054|20008622|P1|STARTED|Overall Study||71
8117689|NCT02978833|20008636|P2|NOT COMPLETED|Overall Study||1
8117690|NCT02978833|20008637|P1|NOT COMPLETED|Overall Study||1
8117691|NCT02978833|20008636|P2|COMPLETED|Overall Study||0
8117692|NCT02978833|20008637|P1|COMPLETED|Overall Study||0
8117693|NCT02978833|20008636|P2|STARTED|Overall Study||1
8117694|NCT02978833|20008637|P1|STARTED|Overall Study||1
8117695|NCT02978508|20008655|P2|NOT COMPLETED|Overall Study||0
8117696|NCT02978508|20008656|P1|NOT COMPLETED|Overall Study||0
8117697|NCT02978508|20008655|P2|COMPLETED|Overall Study||70
8117698|NCT02978508|20008656|P1|COMPLETED|Overall Study||70
8117699|NCT02978508|20008655|P2|STARTED|Overall Study||70
8117700|NCT02978508|20008656|P1|STARTED|Overall Study||70
8117701|NCT02978417|20008666|P2|NOT COMPLETED|Overall Study||2
8117702|NCT02978417|20008667|P1|NOT COMPLETED|Overall Study||2
8117703|NCT02978417|20008666|P2|COMPLETED|Overall Study||3
8117704|NCT02978417|20008667|P1|COMPLETED|Overall Study||3
8117705|NCT02978417|20008666|P2|STARTED|Overall Study||5
8117706|NCT02978417|20008667|P1|STARTED|Overall Study||5
8117707|NCT02978339|20008701|P1|NOT COMPLETED|Overall Study||0
8117708|NCT02978339|20008701|P1|COMPLETED|Overall Study||15
8117709|NCT02978339|20008701|P1|STARTED|Overall Study||15
8117710|NCT02978157|20008713|P2|NOT COMPLETED|Overall Study||0
8117711|NCT02978157|20008714|P1|NOT COMPLETED|Overall Study||0
8117712|NCT02978157|20008713|P2|COMPLETED|Overall Study||50
8117713|NCT02978157|20008714|P1|COMPLETED|Overall Study||52
8117714|NCT02978157|20008713|P2|STARTED|Overall Study||50
8117715|NCT02978157|20008714|P1|STARTED|Overall Study||52
8117716|NCT02977572|20008722|P2|NOT COMPLETED|Overall Study||2
8117717|NCT02977572|20008723|P1|NOT COMPLETED|Overall Study||2
8117718|NCT02977572|20008722|P2|COMPLETED|Overall Study||54
8117719|NCT02977572|20008723|P1|COMPLETED|Overall Study||56
8117720|NCT02977572|20008722|P2|STARTED|Overall Study||56
8117721|NCT02977572|20008723|P1|STARTED|Overall Study||58
8117722|NCT02977507|20008745|P2|NOT COMPLETED|Overall Study||0
8117723|NCT02977507|20008746|P1|NOT COMPLETED|Overall Study||2
8117724|NCT02977507|20008745|P2|COMPLETED|Overall Study||10
8117725|NCT02977507|20008746|P1|COMPLETED|Overall Study||6
8117726|NCT02977507|20008745|P2|STARTED|Overall Study||10
8117727|NCT02977507|20008746|P1|STARTED|Overall Study||8
8117728|NCT02976519|20008776|P7|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
8117729|NCT02976519|20008777|P6|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117730|NCT02976519|20008778|P5|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117731|NCT02976519|20008779|P4|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117732|NCT02976519|20008780|P3|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117733|NCT02976519|20008781|P2|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117734|NCT02976519|20008782|P1|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117735|NCT02976519|20008776|P7|COMPLETED|Treatment Period 2 (Part 2 Only)||9
8117736|NCT02976519|20008777|P6|COMPLETED|Treatment Period 2 (Part 2 Only)||12
8117737|NCT02976519|20008778|P5|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117738|NCT02976519|20008779|P4|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117739|NCT02976519|20008780|P3|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117740|NCT02976519|20008781|P2|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117741|NCT02976519|20008782|P1|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117742|NCT02976519|20008776|P7|STARTED|Treatment Period 2 (Part 2 Only)||10
8117743|NCT02976519|20008777|P6|STARTED|Treatment Period 2 (Part 2 Only)||12
8117744|NCT02976519|20008778|P5|STARTED|Treatment Period 2 (Part 2 Only)||0
8117745|NCT02976519|20008779|P4|STARTED|Treatment Period 2 (Part 2 Only)||0
8117746|NCT02976519|20008780|P3|STARTED|Treatment Period 2 (Part 2 Only)||0
8117747|NCT02976519|20008781|P2|STARTED|Treatment Period 2 (Part 2 Only)||0
8117748|NCT02976519|20008782|P1|STARTED|Treatment Period 2 (Part 2 Only)||0
8117749|NCT02976519|20008776|P7|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
8117750|NCT02976519|20008777|P6|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117751|NCT02976519|20008778|P5|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117752|NCT02976519|20008779|P4|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117753|NCT02976519|20008780|P3|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117754|NCT02976519|20008781|P2|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117755|NCT02976519|20008782|P1|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117756|NCT02976519|20008776|P7|COMPLETED|Wash-out Period (Part 2 Only)||10
8117757|NCT02976519|20008777|P6|COMPLETED|Wash-out Period (Part 2 Only)||12
8117758|NCT02976519|20008778|P5|COMPLETED|Wash-out Period (Part 2 Only)||0
8117759|NCT02976519|20008779|P4|COMPLETED|Wash-out Period (Part 2 Only)||0
8117760|NCT02976519|20008780|P3|COMPLETED|Wash-out Period (Part 2 Only)||0
8117761|NCT02976519|20008781|P2|COMPLETED|Wash-out Period (Part 2 Only)||0
8117762|NCT02976519|20008782|P1|COMPLETED|Wash-out Period (Part 2 Only)||0
8117763|NCT02976519|20008776|P7|STARTED|Wash-out Period (Part 2 Only)||12
8117764|NCT02976519|20008777|P6|STARTED|Wash-out Period (Part 2 Only)||12
8117765|NCT02976519|20008778|P5|STARTED|Wash-out Period (Part 2 Only)||0
8117766|NCT02976519|20008779|P4|STARTED|Wash-out Period (Part 2 Only)||0
8117767|NCT02976519|20008780|P3|STARTED|Wash-out Period (Part 2 Only)||0
8117768|NCT02976519|20008781|P2|STARTED|Wash-out Period (Part 2 Only)||0
8117769|NCT02976519|20008782|P1|STARTED|Wash-out Period (Part 2 Only)||0
8117770|NCT02976519|20008776|P7|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117771|NCT02976519|20008777|P6|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117772|NCT02976519|20008778|P5|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117773|NCT02976519|20008779|P4|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
8117774|NCT02976519|20008780|P3|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117775|NCT02976519|20008781|P2|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
8117776|NCT02976519|20008782|P1|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117777|NCT02976519|20008776|P7|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
8117778|NCT02976519|20008777|P6|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
8117779|NCT02976519|20008778|P5|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
8117780|NCT02976519|20008779|P4|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
8117781|NCT02976519|20008780|P3|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
8117782|NCT02976519|20008781|P2|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
8117783|NCT02976519|20008782|P1|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
8117784|NCT02976519|20008776|P7|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
8117785|NCT02976519|20008777|P6|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
8117786|NCT02976519|20008778|P5|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117787|NCT02976519|20008779|P4|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117788|NCT02976519|20008780|P3|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117789|NCT02976519|20008781|P2|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117790|NCT02976519|20008782|P1|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117791|NCT02976181|20008806|P1|NOT COMPLETED|Overall Study||1
8117792|NCT02976181|20008806|P1|COMPLETED|Overall Study||112
8117793|NCT02976181|20008806|P1|STARTED|Overall Study||113
8117794|NCT02976103|20008813|P2|NOT COMPLETED|Overall Study||8
8117795|NCT02976103|20008814|P1|NOT COMPLETED|Overall Study||13
8117796|NCT02976103|20008813|P2|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
8117797|NCT02976103|20008814|P1|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
8117798|NCT02976103|20008813|P2|STARTED|Overall Study||72
8117799|NCT02976103|20008814|P1|STARTED|Overall Study||67
8117800|NCT02975973|20008869|P4|NOT COMPLETED|Overall Study||0
8117801|NCT02975973|20008870|P3|NOT COMPLETED|Overall Study||1
8117802|NCT02975973|20008871|P2|NOT COMPLETED|Overall Study||1
8117803|NCT02975973|20008872|P1|NOT COMPLETED|Overall Study||1
8117804|NCT02975973|20008869|P4|COMPLETED|Overall Study||4
8117805|NCT02975973|20008870|P3|COMPLETED|Overall Study||0
8117806|NCT02975973|20008871|P2|COMPLETED|Overall Study||1
8117807|NCT02975973|20008872|P1|COMPLETED|Overall Study||0
8117808|NCT02975973|20008869|P4|STARTED|Overall Study||4
8117809|NCT02975973|20008870|P3|STARTED|Overall Study||1
8117810|NCT02975973|20008871|P2|STARTED|Overall Study||2
8117811|NCT02975973|20008872|P1|STARTED|Overall Study||1
8117812|NCT02975804|20008896|P2|NOT COMPLETED|Overall Study||0
8117813|NCT02975804|20008897|P1|NOT COMPLETED|Overall Study||0
8117814|NCT02975804|20008896|P2|COMPLETED|Overall Study||9
8117815|NCT02975804|20008897|P1|COMPLETED|Overall Study||9
8117816|NCT02975804|20008896|P2|STARTED|Overall Study||9
8117817|NCT02975804|20008897|P1|STARTED|Overall Study||9
8117821|NCT02975557|20008956|P3|NOT COMPLETED|Overall Study||1
8117822|NCT02975557|20008957|P2|NOT COMPLETED|Overall Study||3
8117823|NCT02975557|20008958|P1|NOT COMPLETED|Overall Study||1
8117824|NCT02975557|20008956|P3|COMPLETED|Overall Study||5
8117825|NCT02975557|20008957|P2|COMPLETED|Overall Study||2
8117826|NCT02975557|20008958|P1|COMPLETED|Overall Study||3
8117827|NCT02975557|20008956|P3|STARTED|Overall Study||6
8117828|NCT02975557|20008957|P2|STARTED|Overall Study||5
8117829|NCT02975557|20008958|P1|STARTED|Overall Study||4
8117830|NCT02975336|20008970|P4|NOT COMPLETED|Overall Study||33
8117831|NCT02975336|20008971|P3|NOT COMPLETED|Overall Study||27
8117832|NCT02975336|20008972|P2|NOT COMPLETED|Overall Study||29
8117833|NCT02975336|20008973|P1|NOT COMPLETED|Overall Study||32
8117834|NCT02975336|20008970|P4|COMPLETED|Overall Study||84
8117835|NCT02975336|20008971|P3|COMPLETED|Overall Study||90
8117836|NCT02975336|20008972|P2|COMPLETED|Overall Study||89
8117837|NCT02975336|20008973|P1|COMPLETED|Overall Study||85
8117838|NCT02975336|20008970|P4|STARTED|Overall Study||117
8117839|NCT02975336|20008971|P3|STARTED|Overall Study||117
8117840|NCT02975336|20008972|P2|STARTED|Overall Study||118
8117841|NCT02975336|20008973|P1|STARTED|Overall Study||117
8117842|NCT02975206|20009206|P3|NOT COMPLETED|Overall Study||17
8117843|NCT02975206|20009207|P2|NOT COMPLETED|Overall Study||17
8117844|NCT02975206|20009208|P1|NOT COMPLETED|Overall Study||27
8117845|NCT02975206|20009206|P3|COMPLETED|Overall Study||145
8117846|NCT02975206|20009207|P2|COMPLETED|Overall Study||144
8117847|NCT02975206|20009208|P1|COMPLETED|Overall Study||134
8117848|NCT02975206|20009206|P3|STARTED|Overall Study||162
8117849|NCT02975206|20009207|P2|STARTED|Overall Study||161
8117850|NCT02975206|20009208|P1|STARTED|Overall Study||161
8117851|NCT02974868|20009225|P4|NOT COMPLETED|Cross-Over Extension (COE) Period||0
8117852|NCT02974868|20009226|P3|NOT COMPLETED|Cross-Over Extension (COE) Period||3
8117853|NCT02974868|20009227|P2|NOT COMPLETED|Cross-Over Extension (COE) Period||1
8117854|NCT02974868|20009228|P1|NOT COMPLETED|Cross-Over Extension (COE) Period||2
8117855|NCT02974868|20009225|P4|COMPLETED|Cross-Over Extension (COE) Period||3
8117856|NCT02974868|20009226|P3|COMPLETED|Cross-Over Extension (COE) Period||8
8117857|NCT02974868|20009227|P2|COMPLETED|Cross-Over Extension (COE) Period||1
8117858|NCT02974868|20009228|P1|COMPLETED|Cross-Over Extension (COE) Period||5
8117859|NCT02974868|20009225|P4|STARTED|Cross-Over Extension (COE) Period||3
8117860|NCT02974868|20009226|P3|STARTED|Cross-Over Extension (COE) Period||11
8117861|NCT02974868|20009227|P2|STARTED|Cross-Over Extension (COE) Period||2
8117862|NCT02974868|20009228|P1|STARTED|Cross-Over Extension (COE) Period||7
8117863|NCT02974868|20009225|P4|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
8117864|NCT02974868|20009226|P3|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
8117865|NCT02974868|20009227|P2|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
8117866|NCT02974868|20009228|P1|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
8117867|NCT02974868|20009225|P4|COMPLETED|Single-Blind Extension (SBE) Period||23
8117868|NCT02974868|20009226|P3|COMPLETED|Single-Blind Extension (SBE) Period||27
8117869|NCT02974868|20009227|P2|COMPLETED|Single-Blind Extension (SBE) Period||11
8117870|NCT02974868|20009228|P1|COMPLETED|Single-Blind Extension (SBE) Period||15
8117871|NCT02974868|20009225|P4|STARTED|Single-Blind Extension (SBE) Period||29
8117872|NCT02974868|20009226|P3|STARTED|Single-Blind Extension (SBE) Period||38
8117873|NCT02974868|20009227|P2|STARTED|Single-Blind Extension (SBE) Period||12
8117874|NCT02974868|20009228|P1|STARTED|Single-Blind Extension (SBE) Period||17
8117875|NCT02974868|20009225|P4|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
8117876|NCT02974868|20009226|P3|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
8117877|NCT02974868|20009227|P2|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
8117878|NCT02974868|20009228|P1|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
8117879|NCT02974868|20009225|P4|COMPLETED|Initial 24-Week Treatment Period (TP)||35
8117880|NCT02974868|20009226|P3|COMPLETED|Initial 24-Week Treatment Period (TP)||45
8117881|NCT02974868|20009227|P2|COMPLETED|Initial 24-Week Treatment Period (TP)||14
8117882|NCT02974868|20009228|P1|COMPLETED|Initial 24-Week Treatment Period (TP)||20
8117883|NCT02974868|20009225|P4|STARTED|Initial 24-Week Treatment Period (TP)||47
8117884|NCT02974868|20009226|P3|STARTED|Initial 24-Week Treatment Period (TP)||48
8117885|NCT02974868|20009227|P2|STARTED|Initial 24-Week Treatment Period (TP)||23
8117886|NCT02974868|20009228|P1|STARTED|Initial 24-Week Treatment Period (TP)||24
8117887|NCT02974855|20009350|P4|NOT COMPLETED|Overall Study||1
8117888|NCT02974855|20009351|P3|NOT COMPLETED|Overall Study||0
8117889|NCT02974855|20009352|P2|NOT COMPLETED|Overall Study||1
8117890|NCT02974855|20009353|P1|NOT COMPLETED|Overall Study||0
8117891|NCT02974855|20009350|P4|COMPLETED|Overall Study||6
8117892|NCT02974855|20009351|P3|COMPLETED|Overall Study||6
8117893|NCT02974855|20009352|P2|COMPLETED|Overall Study||5
8117894|NCT02974855|20009353|P1|COMPLETED|Overall Study||7
8117895|NCT02974855|20009350|P4|STARTED|Overall Study||7
8117896|NCT02974855|20009351|P3|STARTED|Overall Study||6
8117897|NCT02974855|20009352|P2|STARTED|Overall Study||6
8117898|NCT02974855|20009353|P1|STARTED|Overall Study||7
8117899|NCT02974842|20009539|P1|NOT COMPLETED|Overall Study||8
8117900|NCT02974842|20009539|P1|COMPLETED|Overall Study||42
8117901|NCT02974842|20009539|P1|STARTED|Overall Study|Participants|50
8117902|NCT02974686|20009545|P2|NOT COMPLETED|Overall Study||0
8117903|NCT02974686|20009546|P1|NOT COMPLETED|Overall Study||0
8117904|NCT02974686|20009545|P2|COMPLETED|Overall Study||0
8117905|NCT02974686|20009546|P1|COMPLETED|Overall Study||0
8117906|NCT02974686|20009545|P2|STARTED|Overall Study||0
8117907|NCT02974686|20009546|P1|STARTED|Overall Study||0
8117908|NCT02974634|20009558|P2|NOT COMPLETED|Overall Study||21
8117909|NCT02974634|20009559|P1|NOT COMPLETED|Overall Study||28
8117910|NCT02974634|20009558|P2|COMPLETED|Overall Study||89
8117911|NCT02974634|20009559|P1|COMPLETED|Overall Study||78
8117912|NCT02974634|20009558|P2|STARTED|Overall Study||110
8117913|NCT02974634|20009559|P1|STARTED|Overall Study||106
8117914|NCT02974543|20009569|P2|NOT COMPLETED|Overall Study||0
8117915|NCT02974543|20009570|P1|NOT COMPLETED|Overall Study||1
8117916|NCT02974543|20009569|P2|COMPLETED|Overall Study||10
8117917|NCT02974543|20009570|P1|COMPLETED|Overall Study||10
8117918|NCT02974543|20009569|P2|Began Crossover Assignment|Overall Study||10
8117919|NCT02974543|20009570|P1|Began Crossover Assignment|Overall Study||10
8117920|NCT02974543|20009569|P2|Began Washout Period|Overall Study||10
8117921|NCT02974543|20009570|P1|Began Washout Period|Overall Study||10
8117922|NCT02974543|20009569|P2|STARTED|Overall Study||10
8117923|NCT02974543|20009570|P1|STARTED|Overall Study||11
8117924|NCT02974296|20009592|P2|NOT COMPLETED|Overall Study||1
8117925|NCT02974296|20009593|P1|NOT COMPLETED|Overall Study||0
8117926|NCT02974296|20009592|P2|COMPLETED|Overall Study||22
8117927|NCT02974296|20009593|P1|COMPLETED|Overall Study||10
8117928|NCT02974296|20009592|P2|STARTED|Overall Study||23
8117929|NCT02974296|20009593|P1|STARTED|Overall Study||10
8117930|NCT02974153|20009604|P3|NOT COMPLETED|Overall Study||50
8117931|NCT02974153|20009605|P2|NOT COMPLETED|Overall Study||48
8117932|NCT02974153|20009606|P1|NOT COMPLETED|Overall Study||52
8117933|NCT02974153|20009604|P3|COMPLETED|Overall Study||325
8117934|NCT02974153|20009605|P2|COMPLETED|Overall Study||324
8117935|NCT02974153|20009606|P1|COMPLETED|Overall Study||322
8117936|NCT02974153|20009604|P3|Participants Treated|Overall Study||366
8117937|NCT02974153|20009605|P2|Participants Treated|Overall Study||356
8117938|NCT02974153|20009606|P1|Participants Treated|Overall Study||350
8117939|NCT02974153|20009604|P3|STARTED|Overall Study||375
8117940|NCT02974153|20009605|P2|STARTED|Overall Study||372
8117941|NCT02974153|20009606|P1|STARTED|Overall Study||374
8117942|NCT02974140|20009692|P1|NOT COMPLETED|Overall Study||39
8117943|NCT02974140|20009692|P1|COMPLETED|Overall Study||0
8117944|NCT02974140|20009692|P1|Manual (Fellow Eye)|Overall Study||38
8117945|NCT02974140|20009692|P1|CRS (Left or Right Eye)|Overall Study||38
8117946|NCT02974140|20009692|P1|STARTED|Overall Study||39
8117947|NCT02974114|20009708|P3|NOT COMPLETED|Overall Study||2
8117948|NCT02974114|20009709|P2|NOT COMPLETED|Overall Study||1
8117949|NCT02974114|20009710|P1|NOT COMPLETED|Overall Study||0
8117950|NCT02974114|20009708|P3|COMPLETED|Overall Study||6
8117951|NCT02974114|20009709|P2|COMPLETED|Overall Study||6
8117952|NCT02974114|20009710|P1|COMPLETED|Overall Study||6
8117953|NCT02974114|20009708|P3|STARTED|Overall Study||8
8117954|NCT02974114|20009709|P2|STARTED|Overall Study||7
8117955|NCT02974114|20009710|P1|STARTED|Overall Study||6
8117956|NCT02974088|20009753|P2|NOT COMPLETED|Overall Study||3
8117957|NCT02974088|20009754|P1|NOT COMPLETED|Overall Study||0
8117958|NCT02974088|20009753|P2|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
8117959|NCT02974088|20009754|P1|COMPLETED|Overall Study||23
8117960|NCT02974088|20009753|P2|STARTED|Overall Study||24
8117961|NCT02974088|20009754|P1|STARTED|Overall Study||23
8117962|NCT02973802|20009760|P1|NOT COMPLETED|Overall Study||2
8117963|NCT02973802|20009760|P1|COMPLETED|Overall Study||10
8117964|NCT02973802|20009760|P1|STARTED|Overall Study||12
8117965|NCT02973503|20009774|P1|NOT COMPLETED|Overall Study||0
8117966|NCT02973503|20009774|P1|COMPLETED|Overall Study||117
8117967|NCT02973503|20009774|P1|STARTED|Overall Study||117
8117968|NCT02973477|20009787|P2|NOT COMPLETED|Second Intervention||0
8117969|NCT02973477|20009788|P1|NOT COMPLETED|Second Intervention||1
8117970|NCT02973477|20009787|P2|COMPLETED|Second Intervention||24
8117971|NCT02973477|20009788|P1|COMPLETED|Second Intervention||17
8117972|NCT02973477|20009787|P2|STARTED|Second Intervention||24
8117973|NCT02973477|20009788|P1|STARTED|Second Intervention||18
8117974|NCT02973477|20009787|P2|NOT COMPLETED|Washout||0
8117975|NCT02973477|20009788|P1|NOT COMPLETED|Washout||1
8117976|NCT02973477|20009787|P2|COMPLETED|Washout||24
8117977|NCT02973477|20009788|P1|COMPLETED|Washout||18
8117978|NCT02973477|20009787|P2|STARTED|Washout||24
8117979|NCT02973477|20009788|P1|STARTED|Washout||19
8117980|NCT02973477|20009787|P2|NOT COMPLETED|First Intervention||2
8117981|NCT02973477|20009788|P1|NOT COMPLETED|First Intervention||0
8117982|NCT02973477|20009787|P2|COMPLETED|First Intervention||24
8117983|NCT02973477|20009788|P1|COMPLETED|First Intervention||19
8117984|NCT02973477|20009787|P2|STARTED|First Intervention||26
8117985|NCT02973477|20009788|P1|STARTED|First Intervention||19
8117986|NCT02973438|20009805|P4|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117987|NCT02973438|20009806|P3|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117988|NCT02973438|20009807|P2|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117989|NCT02973438|20009808|P1|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117990|NCT02973438|20009805|P4|COMPLETED|Second Treatment Session (4 Days)||1
8117991|NCT02973438|20009806|P3|COMPLETED|Second Treatment Session (4 Days)||2
8117992|NCT02973438|20009807|P2|COMPLETED|Second Treatment Session (4 Days)||1
8117993|NCT02973438|20009808|P1|COMPLETED|Second Treatment Session (4 Days)||2
8117994|NCT02973438|20009805|P4|STARTED|Second Treatment Session (4 Days)||1
8117995|NCT02973438|20009806|P3|STARTED|Second Treatment Session (4 Days)||2
8117996|NCT02973438|20009807|P2|STARTED|Second Treatment Session (4 Days)||1
8117997|NCT02973438|20009808|P1|STARTED|Second Treatment Session (4 Days)||2
8117998|NCT02973438|20009805|P4|NOT COMPLETED|Washout (Three Weeks)||0
8117999|NCT02973438|20009806|P3|NOT COMPLETED|Washout (Three Weeks)||0
8118000|NCT02973438|20009807|P2|NOT COMPLETED|Washout (Three Weeks)||0
8118001|NCT02973438|20009808|P1|NOT COMPLETED|Washout (Three Weeks)||0
8118002|NCT02973438|20009805|P4|COMPLETED|Washout (Three Weeks)||1
8118003|NCT02973438|20009806|P3|COMPLETED|Washout (Three Weeks)||2
8118004|NCT02973438|20009807|P2|COMPLETED|Washout (Three Weeks)||1
8118005|NCT02973438|20009808|P1|COMPLETED|Washout (Three Weeks)||2
8118006|NCT02973438|20009805|P4|STARTED|Washout (Three Weeks)||1
8118007|NCT02973438|20009806|P3|STARTED|Washout (Three Weeks)||2
8118008|NCT02973438|20009807|P2|STARTED|Washout (Three Weeks)||1
8118009|NCT02973438|20009808|P1|STARTED|Washout (Three Weeks)||2
8118010|NCT02973438|20009805|P4|NOT COMPLETED|First Treatment Session (4 Days)||0
8118011|NCT02973438|20009806|P3|NOT COMPLETED|First Treatment Session (4 Days)||0
8118012|NCT02973438|20009807|P2|NOT COMPLETED|First Treatment Session (4 Days)||0
8118013|NCT02973438|20009808|P1|NOT COMPLETED|First Treatment Session (4 Days)||0
8118014|NCT02973438|20009805|P4|COMPLETED|First Treatment Session (4 Days)||1
8118015|NCT02973438|20009806|P3|COMPLETED|First Treatment Session (4 Days)||2
8118016|NCT02973438|20009807|P2|COMPLETED|First Treatment Session (4 Days)||1
8118017|NCT02973438|20009808|P1|COMPLETED|First Treatment Session (4 Days)||2
8118018|NCT02973438|20009805|P4|STARTED|First Treatment Session (4 Days)||1
8118019|NCT02973438|20009806|P3|STARTED|First Treatment Session (4 Days)||2
8118020|NCT02973438|20009807|P2|STARTED|First Treatment Session (4 Days)||1
8118021|NCT02973438|20009808|P1|STARTED|First Treatment Session (4 Days)||2
8118022|NCT02973100|20009826|P4|NOT COMPLETED|Overall Study||7
8118023|NCT02973100|20009827|P3|NOT COMPLETED|Overall Study||4
8118024|NCT02973100|20009828|P2|NOT COMPLETED|Overall Study||8
8118025|NCT02973100|20009829|P1|NOT COMPLETED|Overall Study||7
8118026|NCT02973100|20009826|P4|COMPLETED|Overall Study||69
8118027|NCT02973100|20009827|P3|COMPLETED|Overall Study||75
8118028|NCT02973100|20009828|P2|COMPLETED|Overall Study||73
8118029|NCT02973100|20009829|P1|COMPLETED|Overall Study||75
8118030|NCT02973100|20009826|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
8118031|NCT02973100|20009827|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
8118032|NCT02973100|20009828|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
8118033|NCT02973100|20009829|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
8118034|NCT02973100|20009826|P4|STARTED|Overall Study||76
8118035|NCT02973100|20009827|P3|STARTED|Overall Study||79
8118036|NCT02973100|20009828|P2|STARTED|Overall Study||81
8118037|NCT02973100|20009829|P1|STARTED|Overall Study||82
8118038|NCT02973048|20009867|P2|NOT COMPLETED|Overall Study||3
8118039|NCT02973048|20009868|P1|NOT COMPLETED|Overall Study||1
8118040|NCT02973048|20009867|P2|COMPLETED|Overall Study||17
8118041|NCT02973048|20009868|P1|COMPLETED|Overall Study||19
8118042|NCT02973048|20009867|P2|STARTED|Overall Study||20
8118043|NCT02973048|20009868|P1|STARTED|Overall Study||20
8118044|NCT02972658|20009920|P4|NOT COMPLETED|Overall Study||131
8118045|NCT02972658|20009921|P3|NOT COMPLETED|Overall Study||75
8118046|NCT02972658|20009922|P2|NOT COMPLETED|Overall Study||138
8118047|NCT02972658|20009923|P1|NOT COMPLETED|Overall Study||76
8118048|NCT02972658|20009920|P4|COMPLETED|Overall Study||0
8118049|NCT02972658|20009921|P3|COMPLETED|Overall Study||0
8118050|NCT02972658|20009922|P2|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
8118051|NCT02972658|20009923|P1|COMPLETED|Overall Study||0
8118052|NCT02972658|20009920|P4|Received at Least 1 Dose of Study Drug|Overall Study||131
8118053|NCT02972658|20009921|P3|Received at Least 1 Dose of Study Drug|Overall Study||74
8118054|NCT02972658|20009922|P2|Received at Least 1 Dose of Study Drug|Overall Study||139
8118055|NCT02972658|20009923|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
8118056|NCT02972658|20009920|P4|STARTED|Overall Study||131
8118057|NCT02972658|20009921|P3|STARTED|Overall Study||75
8118058|NCT02972658|20009922|P2|STARTED|Overall Study||139
8118059|NCT02972658|20009923|P1|STARTED|Overall Study||76
8118060|NCT02972632|20009953|P1|NOT COMPLETED|Overall Study||17
8118061|NCT02972632|20009953|P1|COMPLETED|Overall Study||106
8118062|NCT02972632|20009953|P1|Safety Analysis Set|Overall Study||122
8118063|NCT02972632|20009953|P1|STARTED|Overall Study||123
8118064|NCT02972554|20009966|P2|NOT COMPLETED|Overall Study||0
8118065|NCT02972554|20009967|P1|NOT COMPLETED|Overall Study||0
8118066|NCT02972554|20009966|P2|COMPLETED|Overall Study||48
8118067|NCT02972554|20009967|P1|COMPLETED|Overall Study||44
8118068|NCT02972554|20009966|P2|STARTED|Overall Study||48
8118069|NCT02972554|20009967|P1|STARTED|Overall Study||44
8118070|NCT02972515|20009983|P1|NOT COMPLETED|Overall Study||78
8118071|NCT02972515|20009983|P1|COMPLETED|Overall Study||88
8118072|NCT02972515|20009983|P1|STARTED|Overall Study||166
8118073|NCT02972502|20009992|P2|NOT COMPLETED|Overall Study||2
8118074|NCT02972502|20009993|P1|NOT COMPLETED|Overall Study||4
8118075|NCT02972502|20009992|P2|COMPLETED|Overall Study||29
8118076|NCT02972502|20009993|P1|COMPLETED|Overall Study||31
8118077|NCT02972502|20009992|P2|STARTED|Overall Study||31
8118078|NCT02972502|20009993|P1|STARTED|Overall Study||35
8118079|NCT02972359|20010003|P1|NOT COMPLETED|Overall Study||71
8118080|NCT02972359|20010003|P1|COMPLETED|Overall Study||247
8118081|NCT02972359|20010003|P1|STARTED|Overall Study||318
8118082|NCT02972242|20010016|P2|NOT COMPLETED|Overall Study||0
8118083|NCT02972242|20010017|P1|NOT COMPLETED|Overall Study||1
8118084|NCT02972242|20010016|P2|COMPLETED|Overall Study||93
8118085|NCT02972242|20010017|P1|COMPLETED|Overall Study||81
8118086|NCT02972242|20010016|P2|STARTED|Overall Study||93
8118087|NCT02972242|20010017|P1|STARTED|Overall Study||82
8118088|NCT02971839|20010044|P5|NOT COMPLETED|Overall Study||0
8118089|NCT02971839|20010045|P4|NOT COMPLETED|Overall Study||0
8118090|NCT02971839|20010046|P3|NOT COMPLETED|Overall Study||0
8118091|NCT02971839|20010047|P2|NOT COMPLETED|Overall Study||0
8118092|NCT02971839|20010048|P1|NOT COMPLETED|Overall Study||0
8118093|NCT02971839|20010044|P5|COMPLETED|Overall Study||3
8118094|NCT02971839|20010045|P4|COMPLETED|Overall Study||2
8118095|NCT02971839|20010046|P3|COMPLETED|Overall Study||2
8118096|NCT02971839|20010047|P2|COMPLETED|Overall Study||2
8118097|NCT02971839|20010048|P1|COMPLETED|Overall Study||2
8118098|NCT02971839|20010044|P5|STARTED|Overall Study||3
8118099|NCT02971839|20010045|P4|STARTED|Overall Study||2
8118100|NCT02971839|20010046|P3|STARTED|Overall Study||2
8118101|NCT02971839|20010047|P2|STARTED|Overall Study||2
8118102|NCT02971839|20010048|P1|STARTED|Overall Study||2
8118103|NCT02971670|20010074|P4|NOT COMPLETED|Overall Study||2
8118104|NCT02971670|20010075|P3|NOT COMPLETED|Overall Study||1
8118105|NCT02971670|20010076|P2|NOT COMPLETED|Overall Study||1
8118106|NCT02971670|20010077|P1|NOT COMPLETED|Overall Study||4
8118107|NCT02971670|20010074|P4|COMPLETED|Overall Study||1
8118108|NCT02971670|20010075|P3|COMPLETED|Overall Study||4
8118109|NCT02971670|20010076|P2|COMPLETED|Overall Study||1
8118110|NCT02971670|20010077|P1|COMPLETED|Overall Study||9
8118111|NCT02971670|20010074|P4|STARTED|Overall Study||3
8118112|NCT02971670|20010075|P3|STARTED|Overall Study||5
8118113|NCT02971670|20010076|P2|STARTED|Overall Study||2
8118114|NCT02971670|20010077|P1|STARTED|Overall Study||13
8118115|NCT02971631|20010095|P2|NOT COMPLETED|Second Intervention - One Day||0
8118116|NCT02971631|20010096|P1|NOT COMPLETED|Second Intervention - One Day||0
8118117|NCT02971631|20010095|P2|COMPLETED|Second Intervention - One Day||2
8118118|NCT02971631|20010096|P1|COMPLETED|Second Intervention - One Day||3
8118119|NCT02971631|20010095|P2|STARTED|Second Intervention - One Day||2
8118120|NCT02971631|20010096|P1|STARTED|Second Intervention - One Day||3
8118121|NCT02971631|20010095|P2|NOT COMPLETED|First Intervention - One Day||0
8118122|NCT02971631|20010096|P1|NOT COMPLETED|First Intervention - One Day||0
8118123|NCT02971631|20010095|P2|COMPLETED|First Intervention - One Day||2
8118124|NCT02971631|20010096|P1|COMPLETED|First Intervention - One Day||3
8118125|NCT02971631|20010095|P2|STARTED|First Intervention - One Day||2
8118126|NCT02971631|20010096|P1|STARTED|First Intervention - One Day||3
8118127|NCT02971605|20010116|P1|NOT COMPLETED|Overall Study||1
8118128|NCT02971605|20010116|P1|COMPLETED|Overall Study||12
8118129|NCT02971605|20010116|P1|STARTED|Overall Study||13
8118130|NCT02971488|20010131|P1|NOT COMPLETED|Overall Study||0
8118131|NCT02971488|20010131|P1|COMPLETED|Overall Study||529
8118132|NCT02971488|20010131|P1|STARTED|Overall Study||529
8118133|NCT02971293|20010141|P1|NOT COMPLETED|Overall Study||11
8118134|NCT02971293|20010141|P1|COMPLETED|Overall Study||31
8118135|NCT02971293|20010141|P1|STARTED|Overall Study||42
8118136|NCT02971202|20010230|P3|NOT COMPLETED|Overall Study||1
8118137|NCT02971202|20010231|P2|NOT COMPLETED|Overall Study||0
8118138|NCT02971202|20010232|P1|NOT COMPLETED|Overall Study||2
8118139|NCT02971202|20010230|P3|COMPLETED|Overall Study||10
8118140|NCT02971202|20010231|P2|COMPLETED|Overall Study||10
8118141|NCT02971202|20010232|P1|COMPLETED|Overall Study||10
8118142|NCT02971202|20010230|P3|Started Study|Overall Study||10
8118143|NCT02971202|20010231|P2|Started Study|Overall Study||10
8118144|NCT02971202|20010232|P1|Started Study|Overall Study||11
8118145|NCT02971202|20010230|P3|STARTED|Overall Study||11
8118146|NCT02971202|20010231|P2|STARTED|Overall Study||10
8118147|NCT02971202|20010232|P1|STARTED|Overall Study||12
8118148|NCT02971163|20010248|P2|NOT COMPLETED|Overall Study||2
8118149|NCT02971163|20010249|P1|NOT COMPLETED|Overall Study||4
8118150|NCT02971163|20010248|P2|COMPLETED|Overall Study||24
8118151|NCT02971163|20010249|P1|COMPLETED|Overall Study||20
8118152|NCT02971163|20010248|P2|STARTED|Overall Study||26
8118153|NCT02971163|20010249|P1|STARTED|Overall Study||24
8118154|NCT02971007|20010272|P3|NOT COMPLETED|Overall Study||1
8118155|NCT02971007|20010273|P2|NOT COMPLETED|Overall Study||3
8118156|NCT02971007|20010274|P1|NOT COMPLETED|Overall Study||2
8118157|NCT02971007|20010272|P3|COMPLETED|Overall Study||45
8118158|NCT02971007|20010273|P2|COMPLETED|Overall Study||42
8118159|NCT02971007|20010274|P1|COMPLETED|Overall Study||44
8118160|NCT02971007|20010272|P3|STARTED|Overall Study||46
8118161|NCT02971007|20010273|P2|STARTED|Overall Study||45
8118162|NCT02971007|20010274|P1|STARTED|Overall Study||46
8118166|NCT02970812|20010297|P2|NOT COMPLETED|Overall Study||2
8118167|NCT02970812|20010298|P1|NOT COMPLETED|Overall Study||8
8118168|NCT02970812|20010297|P2|COMPLETED|Overall Study||28
8118169|NCT02970812|20010298|P1|COMPLETED|Overall Study||22
8118170|NCT02970812|20010297|P2|STARTED|Overall Study||30
8118171|NCT02970812|20010298|P1|STARTED|Overall Study||30
8118172|NCT02970669|20010306|P2|NOT COMPLETED|Open-label Period||2
8118173|NCT02970669|20010307|P1|NOT COMPLETED|Open-label Period||4
8118174|NCT02970669|20010306|P2|COMPLETED|Open-label Period||62
8118175|NCT02970669|20010307|P1|COMPLETED|Open-label Period||58
8118176|NCT02970669|20010306|P2|STARTED|Open-label Period||64
8118177|NCT02970669|20010307|P1|STARTED|Open-label Period||62
8118178|NCT02970669|20010306|P2|NOT COMPLETED|Double-blind Period||6
8118179|NCT02970669|20010307|P1|NOT COMPLETED|Double-blind Period||8
8118180|NCT02970669|20010306|P2|COMPLETED|Double-blind Period||64
8118181|NCT02970669|20010307|P1|COMPLETED|Double-blind Period||62
8118182|NCT02970669|20010306|P2|STARTED|Double-blind Period||70
8118183|NCT02970669|20010307|P1|STARTED|Double-blind Period||70
8118184|NCT02970552|20010327|P2|NOT COMPLETED|Overall Study||3
8118185|NCT02970552|20010328|P1|NOT COMPLETED|Overall Study||3
8118186|NCT02970552|20010327|P2|COMPLETED|Overall Study||67
8118187|NCT02970552|20010328|P1|COMPLETED|Overall Study||67
8118188|NCT02970552|20010327|P2|STARTED|Overall Study||70
8118189|NCT02970552|20010328|P1|STARTED|Overall Study||70
8118190|NCT02970422|20010356|P1|NOT COMPLETED|Overall Study||0
8118191|NCT02970422|20010356|P1|COMPLETED|Overall Study||200
8118192|NCT02970422|20010356|P1|STARTED|Overall Study||200
8118193|NCT02970305|20010461|P2|NOT COMPLETED|Overall Study||28
8118194|NCT02970305|20010462|P1|NOT COMPLETED|Overall Study||29
8118195|NCT02970305|20010461|P2|COMPLETED|Overall Study||174
8118196|NCT02970305|20010462|P1|COMPLETED|Overall Study||172
8118197|NCT02970305|20010461|P2|STARTED|Overall Study||202
8118198|NCT02970305|20010462|P1|STARTED|Overall Study||201
8118199|NCT02970292|20010494|P2|NOT COMPLETED|Overall Study||8
8118200|NCT02970292|20010495|P1|NOT COMPLETED|Overall Study||24
8118201|NCT02970292|20010494|P2|COMPLETED|Overall Study||190
8118202|NCT02970292|20010495|P1|COMPLETED|Overall Study||174
8118203|NCT02970292|20010494|P2|STARTED|Overall Study||198
8118204|NCT02970292|20010495|P1|STARTED|Overall Study||198
8118205|NCT02970162|20010519|P2|NOT COMPLETED|Overall Study||0
8118206|NCT02970162|20010520|P1|NOT COMPLETED|Overall Study||0
8118207|NCT02970162|20010519|P2|COMPLETED|Overall Study||13
8118208|NCT02970162|20010520|P1|COMPLETED|Overall Study||13
8118209|NCT02970162|20010519|P2|STARTED|Overall Study||13
8118210|NCT02970162|20010520|P1|STARTED|Overall Study||13
8118211|NCT02970032|20010532|P1|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
8118212|NCT02970032|20010532|P1|COMPLETED|Real Time Heparin Dose Adjustment||20
8118213|NCT02970032|20010532|P1|STARTED|Real Time Heparin Dose Adjustment||20
8118214|NCT02970032|20010532|P1|NOT COMPLETED|Standard Heparin Dose||0
8118215|NCT02970032|20010532|P1|COMPLETED|Standard Heparin Dose||20
8118216|NCT02970032|20010532|P1|STARTED|Standard Heparin Dose||20
8118217|NCT02969928|20010540|P2|NOT COMPLETED|Overall Study||0
8118218|NCT02969928|20010541|P1|NOT COMPLETED|Overall Study||0
8118219|NCT02969928|20010540|P2|COMPLETED|Overall Study||23
8118220|NCT02969928|20010541|P1|COMPLETED|Overall Study||23
8118221|NCT02969928|20010540|P2|STARTED|Overall Study||23
8118222|NCT02969928|20010541|P1|STARTED|Overall Study||23
8118223|NCT02969876|20010555|P1|NOT COMPLETED|Overall Study||0
8118224|NCT02969876|20010555|P1|COMPLETED|Overall Study||2
8118225|NCT02969876|20010555|P1|STARTED|Overall Study||2
8118226|NCT02969863|20010561|P6|NOT COMPLETED|Overall Study||0
8118227|NCT02969863|20010562|P5|NOT COMPLETED|Overall Study||0
8118228|NCT02969863|20010563|P4|NOT COMPLETED|Overall Study||0
8118229|NCT02969863|20010564|P3|NOT COMPLETED|Overall Study||0
8118230|NCT02969863|20010565|P2|NOT COMPLETED|Overall Study||0
8118231|NCT02969863|20010566|P1|NOT COMPLETED|Overall Study||1
8118232|NCT02969863|20010561|P6|COMPLETED|Overall Study||4
8118233|NCT02969863|20010562|P5|COMPLETED|Overall Study||4
8118234|NCT02969863|20010563|P4|COMPLETED|Overall Study||4
8118235|NCT02969863|20010564|P3|COMPLETED|Overall Study||4
8118236|NCT02969863|20010565|P2|COMPLETED|Overall Study||4
8118237|NCT02969863|20010566|P1|COMPLETED|Overall Study||3
8118238|NCT02969863|20010561|P6|STARTED|Overall Study||4
8118239|NCT02969863|20010562|P5|STARTED|Overall Study||4
8118240|NCT02969863|20010563|P4|STARTED|Overall Study||4
8118241|NCT02969863|20010564|P3|STARTED|Overall Study||4
8118242|NCT02969863|20010565|P2|STARTED|Overall Study||4
8118243|NCT02969863|20010566|P1|STARTED|Overall Study||4
8118244|NCT02969655|20010582|P2|NOT COMPLETED|Overall Study||15
8118245|NCT02969655|20010583|P1|NOT COMPLETED|Overall Study||21
8118246|NCT02969655|20010582|P2|COMPLETED|Overall Study||120
8118247|NCT02969655|20010583|P1|COMPLETED|Overall Study||115
8118248|NCT02969655|20010582|P2|STARTED|Overall Study||135
8118249|NCT02969655|20010583|P1|STARTED|Overall Study||136
8118250|NCT02969590|20010618|P3|NOT COMPLETED|Treatment Period 2||0
8118251|NCT02969590|20010619|P2|NOT COMPLETED|Treatment Period 2||0
8118252|NCT02969590|20010620|P1|NOT COMPLETED|Treatment Period 2||0
8118253|NCT02969590|20010618|P3|COMPLETED|Treatment Period 2||2
8118254|NCT02969590|20010619|P2|COMPLETED|Treatment Period 2||2
8118255|NCT02969590|20010620|P1|COMPLETED|Treatment Period 2||0
8118256|NCT02969590|20010618|P3|STARTED|Treatment Period 2||2
8118257|NCT02969590|20010619|P2|STARTED|Treatment Period 2||2
8118258|NCT02969590|20010620|P1|STARTED|Treatment Period 2||0
8118259|NCT02969590|20010618|P3|NOT COMPLETED|Treatment Period 1||0
8118260|NCT02969590|20010619|P2|NOT COMPLETED|Treatment Period 1||0
8118261|NCT02969590|20010620|P1|NOT COMPLETED|Treatment Period 1||0
8118262|NCT02969590|20010618|P3|COMPLETED|Treatment Period 1||2
8118263|NCT02969590|20010619|P2|COMPLETED|Treatment Period 1||2
8118264|NCT02969590|20010620|P1|COMPLETED|Treatment Period 1||0
8118265|NCT02969590|20010618|P3|STARTED|Treatment Period 1||2
8118266|NCT02969590|20010619|P2|STARTED|Treatment Period 1||2
8118267|NCT02969590|20010620|P1|STARTED|Treatment Period 1||0
8118268|NCT02969590|20010618|P3|NOT COMPLETED|Screening Period||0
8118269|NCT02969590|20010619|P2|NOT COMPLETED|Screening Period||0
8118270|NCT02969590|20010620|P1|NOT COMPLETED|Screening Period||1
8118271|NCT02969590|20010618|P3|COMPLETED|Screening Period||0
8118272|NCT02969590|20010619|P2|COMPLETED|Screening Period||0
8118273|NCT02969590|20010620|P1|COMPLETED|Screening Period||4
8118274|NCT02969590|20010618|P3|STARTED|Screening Period||0
8118275|NCT02969590|20010619|P2|STARTED|Screening Period||0
8118276|NCT02969590|20010620|P1|STARTED|Screening Period||5
8118277|NCT02969525|20010643|P12|NOT COMPLETED|Dose-Blind Period||2
8118278|NCT02969525|20010644|P11|NOT COMPLETED|Dose-Blind Period||2
8118279|NCT02969525|20010645|P10|NOT COMPLETED|Dose-Blind Period||3
8118280|NCT02969525|20010646|P9|NOT COMPLETED|Dose-Blind Period||1
8118281|NCT02969525|20010647|P8|NOT COMPLETED|Dose-Blind Period||0
8118282|NCT02969525|20010648|P7|NOT COMPLETED|Dose-Blind Period||2
8118283|NCT02969525|20010649|P6|NOT COMPLETED|Dose-Blind Period||0
8118284|NCT02969525|20010650|P5|NOT COMPLETED|Dose-Blind Period||0
8118285|NCT02969525|20010651|P4|NOT COMPLETED|Dose-Blind Period||0
8118286|NCT02969525|20010652|P3|NOT COMPLETED|Dose-Blind Period||0
8118287|NCT02969525|20010653|P2|NOT COMPLETED|Dose-Blind Period||0
8118288|NCT02969525|20010654|P1|NOT COMPLETED|Dose-Blind Period||0
8118289|NCT02969525|20010643|P12|COMPLETED|Dose-Blind Period||39
8118290|NCT02969525|20010644|P11|COMPLETED|Dose-Blind Period||38
8118291|NCT02969525|20010645|P10|COMPLETED|Dose-Blind Period||34
8118292|NCT02969525|20010646|P9|COMPLETED|Dose-Blind Period||18
8118293|NCT02969525|20010647|P8|COMPLETED|Dose-Blind Period||22
8118294|NCT02969525|20010648|P7|COMPLETED|Dose-Blind Period||18
8118295|NCT02969525|20010649|P6|COMPLETED|Dose-Blind Period||20
8118296|NCT02969525|20010650|P5|COMPLETED|Dose-Blind Period||0
8118297|NCT02969525|20010651|P4|COMPLETED|Dose-Blind Period||0
8118298|NCT02969525|20010652|P3|COMPLETED|Dose-Blind Period||0
8118299|NCT02969525|20010653|P2|COMPLETED|Dose-Blind Period||0
8118300|NCT02969525|20010654|P1|COMPLETED|Dose-Blind Period||0
8118301|NCT02969525|20010643|P12|STARTED|Dose-Blind Period||41
8118302|NCT02969525|20010644|P11|STARTED|Dose-Blind Period||40
8118303|NCT02969525|20010645|P10|STARTED|Dose-Blind Period||37
8118304|NCT02969525|20010646|P9|STARTED|Dose-Blind Period||19
8118305|NCT02969525|20010647|P8|STARTED|Dose-Blind Period||22
8118306|NCT02969525|20010648|P7|STARTED|Dose-Blind Period||20
8118307|NCT02969525|20010649|P6|STARTED|Dose-Blind Period||20
8118308|NCT02969525|20010650|P5|STARTED|Dose-Blind Period||0
8118309|NCT02969525|20010651|P4|STARTED|Dose-Blind Period||0
8118310|NCT02969525|20010652|P3|STARTED|Dose-Blind Period||0
8118311|NCT02969525|20010653|P2|STARTED|Dose-Blind Period||0
8118312|NCT02969525|20010654|P1|STARTED|Dose-Blind Period||0
8118313|NCT02969525|20010643|P12|NOT COMPLETED|Double-Blind Period||0
8118314|NCT02969525|20010644|P11|NOT COMPLETED|Double-Blind Period||0
8118315|NCT02969525|20010645|P10|NOT COMPLETED|Double-Blind Period||0
8118316|NCT02969525|20010646|P9|NOT COMPLETED|Double-Blind Period||0
8118317|NCT02969525|20010647|P8|NOT COMPLETED|Double-Blind Period||0
8118318|NCT02969525|20010648|P7|NOT COMPLETED|Double-Blind Period||0
8118319|NCT02969525|20010649|P6|NOT COMPLETED|Double-Blind Period||0
8118320|NCT02969525|20010650|P5|NOT COMPLETED|Double-Blind Period||0
8118321|NCT02969525|20010651|P4|NOT COMPLETED|Double-Blind Period||4
8118322|NCT02969525|20010652|P3|NOT COMPLETED|Double-Blind Period||1
8118323|NCT02969525|20010653|P2|NOT COMPLETED|Double-Blind Period||0
8118324|NCT02969525|20010654|P1|NOT COMPLETED|Double-Blind Period||2
8118325|NCT02969525|20010643|P12|COMPLETED|Double-Blind Period||0
8118326|NCT02969525|20010644|P11|COMPLETED|Double-Blind Period||0
8118327|NCT02969525|20010645|P10|COMPLETED|Double-Blind Period||0
8118328|NCT02969525|20010646|P9|COMPLETED|Double-Blind Period||0
8118329|NCT02969525|20010647|P8|COMPLETED|Double-Blind Period||0
8118330|NCT02969525|20010648|P7|COMPLETED|Double-Blind Period||0
8118331|NCT02969525|20010649|P6|COMPLETED|Double-Blind Period||0
8118332|NCT02969525|20010650|P5|COMPLETED|Double-Blind Period||41
8118333|NCT02969525|20010651|P4|COMPLETED|Double-Blind Period||37
8118334|NCT02969525|20010652|P3|COMPLETED|Double-Blind Period||40
8118335|NCT02969525|20010653|P2|COMPLETED|Double-Blind Period||41
8118336|NCT02969525|20010654|P1|COMPLETED|Double-Blind Period||40
8118337|NCT02969525|20010643|P12|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118338|NCT02969525|20010644|P11|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118339|NCT02969525|20010645|P10|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118340|NCT02969525|20010646|P9|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118341|NCT02969525|20010647|P8|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118342|NCT02969525|20010648|P7|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118343|NCT02969525|20010649|P6|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118344|NCT02969525|20010650|P5|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
8118345|NCT02969525|20010651|P4|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
8118346|NCT02969525|20010652|P3|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
8118347|NCT02969525|20010653|P2|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
8118348|NCT02969525|20010654|P1|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
8118349|NCT02969525|20010643|P12|Completed Double-Blind Period|Double-Blind Period||0
8118350|NCT02969525|20010644|P11|Completed Double-Blind Period|Double-Blind Period||0
8118351|NCT02969525|20010645|P10|Completed Double-Blind Period|Double-Blind Period||0
8118352|NCT02969525|20010646|P9|Completed Double-Blind Period|Double-Blind Period||0
8118353|NCT02969525|20010647|P8|Completed Double-Blind Period|Double-Blind Period||0
8118354|NCT02969525|20010648|P7|Completed Double-Blind Period|Double-Blind Period||0
8118355|NCT02969525|20010649|P6|Completed Double-Blind Period|Double-Blind Period||0
8118356|NCT02969525|20010650|P5|Completed Double-Blind Period|Double-Blind Period||41
8118357|NCT02969525|20010651|P4|Completed Double-Blind Period|Double-Blind Period||39
8118358|NCT02969525|20010652|P3|Completed Double-Blind Period|Double-Blind Period||40
8118359|NCT02969525|20010653|P2|Completed Double-Blind Period|Double-Blind Period||41
8118360|NCT02969525|20010654|P1|Completed Double-Blind Period|Double-Blind Period||42
8118361|NCT02969525|20010643|P12|STARTED|Double-Blind Period||0
8118362|NCT02969525|20010644|P11|STARTED|Double-Blind Period||0
8118363|NCT02969525|20010645|P10|STARTED|Double-Blind Period||0
8118364|NCT02969525|20010646|P9|STARTED|Double-Blind Period||0
8118365|NCT02969525|20010647|P8|STARTED|Double-Blind Period||0
8118366|NCT02969525|20010648|P7|STARTED|Double-Blind Period||0
8118367|NCT02969525|20010649|P6|STARTED|Double-Blind Period||0
8118368|NCT02969525|20010650|P5|STARTED|Double-Blind Period||41
8118369|NCT02969525|20010651|P4|STARTED|Double-Blind Period||41
8118370|NCT02969525|20010652|P3|STARTED|Double-Blind Period||41
8118371|NCT02969525|20010653|P2|STARTED|Double-Blind Period||41
8118372|NCT02969525|20010654|P1|STARTED|Double-Blind Period||42
8118373|NCT02969421|20010794|P2|NOT COMPLETED|Overall Study||0
8118374|NCT02969421|20010795|P1|NOT COMPLETED|Overall Study||0
8118375|NCT02969421|20010794|P2|COMPLETED|Overall Study||33
8118376|NCT02969421|20010795|P1|COMPLETED|Overall Study||33
8118377|NCT02969421|20010794|P2|STARTED|Overall Study||33
8118378|NCT02969421|20010795|P1|STARTED|Overall Study||33
8118379|NCT02969408|20010805|P1|NOT COMPLETED|Overall Study||16
8118380|NCT02969408|20010805|P1|COMPLETED|Overall Study||381
8118381|NCT02969408|20010805|P1|Used ABS eMDPI at Least Once|Overall Study||370
8118382|NCT02969408|20010805|P1|STARTED|Overall Study||397
8118383|NCT02969356|20010813|P1|NOT COMPLETED|Overall Study||23
8118384|NCT02969356|20010813|P1|COMPLETED|Overall Study||134
8118385|NCT02969356|20010813|P1|Intent-to-Treat (ITT) Population|Overall Study||153
8118386|NCT02969356|20010813|P1|STARTED|Overall Study||157
8118387|NCT02969317|20010831|P1|NOT COMPLETED|Overall Study||0
8118388|NCT02969317|20010831|P1|COMPLETED|Overall Study||12
8118389|NCT02969317|20010831|P1|STARTED|Overall Study||12
8118390|NCT02969187|20010856|P2|NOT COMPLETED|Overall Study||13
8118391|NCT02969187|20010857|P1|NOT COMPLETED|Overall Study||12
8118392|NCT02969187|20010856|P2|COMPLETED|Overall Study||50
8118393|NCT02969187|20010857|P1|COMPLETED|Overall Study||51
8118394|NCT02969187|20010856|P2|STARTED|Overall Study||63
8118395|NCT02969187|20010857|P1|STARTED|Overall Study||63
8118396|NCT02969044|20010869|P2|NOT COMPLETED|Overall Study||6
8118397|NCT02969044|20010870|P1|NOT COMPLETED|Overall Study||5
8118398|NCT02969044|20010869|P2|COMPLETED|Overall Study||22
8118399|NCT02969044|20010870|P1|COMPLETED|Overall Study||37
8118400|NCT02969044|20010869|P2|STARTED|Overall Study||28
8118401|NCT02969044|20010870|P1|STARTED|Overall Study||42
8118402|NCT02969031|20010912|P2|NOT COMPLETED|Completed and Analyzed||0
8118403|NCT02969031|20010913|P1|NOT COMPLETED|Completed and Analyzed||0
8118404|NCT02969031|20010912|P2|COMPLETED|Completed and Analyzed||12
8118405|NCT02969031|20010913|P1|COMPLETED|Completed and Analyzed||15
8118406|NCT02969031|20010912|P2|STARTED|Completed and Analyzed||12
8118407|NCT02969031|20010913|P1|STARTED|Completed and Analyzed||15
8118408|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Follow-Up Recordings||0
8118409|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Follow-Up Recordings||0
8118410|NCT02969031|20010912|P2|COMPLETED|Collection of Follow-Up Recordings||12
8118411|NCT02969031|20010913|P1|COMPLETED|Collection of Follow-Up Recordings||15
8118412|NCT02969031|20010912|P2|STARTED|Collection of Follow-Up Recordings||12
8118413|NCT02969031|20010913|P1|STARTED|Collection of Follow-Up Recordings||15
8118414|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Follow-Up Surveys||2
8118415|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Follow-Up Surveys||0
8118416|NCT02969031|20010912|P2|COMPLETED|Collection of Follow-Up Surveys||12
8118417|NCT02969031|20010913|P1|COMPLETED|Collection of Follow-Up Surveys||15
8118418|NCT02969031|20010912|P2|STARTED|Collection of Follow-Up Surveys||14
8118419|NCT02969031|20010913|P1|STARTED|Collection of Follow-Up Surveys||15
8118420|NCT02969031|20010912|P2|NOT COMPLETED|Completed Intervention||4
8118421|NCT02969031|20010913|P1|NOT COMPLETED|Completed Intervention||7
8118422|NCT02969031|20010912|P2|COMPLETED|Completed Intervention||14
8118423|NCT02969031|20010913|P1|COMPLETED|Completed Intervention||15
8118424|NCT02969031|20010912|P2|STARTED|Completed Intervention||18
8118425|NCT02969031|20010913|P1|STARTED|Completed Intervention||22
8118426|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Baseline Recordings||5
8118427|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Baseline Recordings||12
8118428|NCT02969031|20010912|P2|COMPLETED|Collection of Baseline Recordings||18
8118429|NCT02969031|20010913|P1|COMPLETED|Collection of Baseline Recordings||22
8118430|NCT02969031|20010912|P2|STARTED|Collection of Baseline Recordings||23
8118431|NCT02969031|20010913|P1|STARTED|Collection of Baseline Recordings||34
8118432|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Baseline Surveys||52
8118433|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Baseline Surveys||39
8118434|NCT02969031|20010912|P2|COMPLETED|Collection of Baseline Surveys||23
8118435|NCT02969031|20010913|P1|COMPLETED|Collection of Baseline Surveys||34
8118436|NCT02969031|20010912|P2|STARTED|Collection of Baseline Surveys||75
8118437|NCT02969031|20010913|P1|STARTED|Collection of Baseline Surveys||73
8118438|NCT02969031|20010912|P2|NOT COMPLETED|Enrolled and Randomized||0
8118439|NCT02969031|20010913|P1|NOT COMPLETED|Enrolled and Randomized||0
8118440|NCT02969031|20010912|P2|COMPLETED|Enrolled and Randomized||75
8118441|NCT02969031|20010913|P1|COMPLETED|Enrolled and Randomized||73
8118442|NCT02969031|20010912|P2|STARTED|Enrolled and Randomized||75
8118443|NCT02969031|20010913|P1|STARTED|Enrolled and Randomized||73
8118444|NCT02969018|20010929|P8|NOT COMPLETED|Overall Study||7
8118445|NCT02969018|20010930|P7|NOT COMPLETED|Overall Study||8
8118446|NCT02969018|20010931|P6|NOT COMPLETED|Overall Study||8
8118447|NCT02969018|20010932|P5|NOT COMPLETED|Overall Study||2
8118448|NCT02969018|20010933|P4|NOT COMPLETED|Overall Study||5
8118449|NCT02969018|20010934|P3|NOT COMPLETED|Overall Study||6
8118450|NCT02969018|20010935|P2|NOT COMPLETED|Overall Study||8
8118451|NCT02969018|20010936|P1|NOT COMPLETED|Overall Study||4
8118452|NCT02969018|20010929|P8|COMPLETED|Overall Study||16
8118453|NCT02969018|20010930|P7|COMPLETED|Overall Study||22
8118454|NCT02969018|20010931|P6|COMPLETED|Overall Study||17
8118455|NCT02969018|20010932|P5|COMPLETED|Overall Study||27
8118456|NCT02969018|20010933|P4|COMPLETED|Overall Study||20
8118457|NCT02969018|20010934|P3|COMPLETED|Overall Study||20
8118458|NCT02969018|20010935|P2|COMPLETED|Overall Study||21
8118459|NCT02969018|20010936|P1|COMPLETED|Overall Study||21
8118460|NCT02969018|20010929|P8|STARTED|Overall Study||23
8118461|NCT02969018|20010930|P7|STARTED|Overall Study||30
8118462|NCT02969018|20010931|P6|STARTED|Overall Study||25
8118463|NCT02969018|20010932|P5|STARTED|Overall Study||29
8118464|NCT02969018|20010933|P4|STARTED|Overall Study||25
8118465|NCT02969018|20010934|P3|STARTED|Overall Study||26
8118466|NCT02969018|20010935|P2|STARTED|Overall Study||29
8118467|NCT02969018|20010936|P1|STARTED|Overall Study||25
8118468|NCT02968992|20011055|P2|NOT COMPLETED|Overall Study||1
8118469|NCT02968992|20011056|P1|NOT COMPLETED|Overall Study||0
8118470|NCT02968992|20011055|P2|COMPLETED|Overall Study||17
8118471|NCT02968992|20011056|P1|COMPLETED|Overall Study||18
8118472|NCT02968992|20011055|P2|STARTED|Overall Study||18
8118473|NCT02968992|20011056|P1|STARTED|Overall Study||18
8118474|NCT02968979|20011076|P1|NOT COMPLETED|Overall Study||8
8118475|NCT02968979|20011076|P1|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
8118476|NCT02968979|20011076|P1|STARTED|Overall Study||539
8118477|NCT02968914|20011164|P2|NOT COMPLETED|Overall Study||0
8118478|NCT02968914|20011165|P1|NOT COMPLETED|Overall Study||0
8118479|NCT02968914|20011164|P2|COMPLETED|Overall Study||90
8118480|NCT02968914|20011165|P1|COMPLETED|Overall Study||90
8118481|NCT02968914|20011164|P2|STARTED|Overall Study||90
8118482|NCT02968914|20011165|P1|STARTED|Overall Study||90
8118483|NCT02968758|20011189|P2|NOT COMPLETED|Overall Study||0
8118484|NCT02968758|20011190|P1|NOT COMPLETED|Overall Study||0
8118485|NCT02968758|20011189|P2|COMPLETED|Overall Study||1664
8118486|NCT02968758|20011190|P1|COMPLETED|Overall Study||797
8118487|NCT02968758|20011189|P2|STARTED|Overall Study||1664
8118488|NCT02968758|20011190|P1|STARTED|Overall Study||797
8118489|NCT02968576|20011201|P2|NOT COMPLETED|Overall Study||1
8118490|NCT02968576|20011202|P1|NOT COMPLETED|Overall Study||0
8118491|NCT02968576|20011201|P2|COMPLETED|Overall Study||13
8118492|NCT02968576|20011202|P1|COMPLETED|Overall Study||11
8118493|NCT02968576|20011201|P2|STARTED|Overall Study||14
8118494|NCT02968576|20011202|P1|STARTED|Overall Study||11
8118501|NCT02968433|20011224|P1|NOT COMPLETED|Overall Study||1
8118502|NCT02968433|20011224|P1|COMPLETED|Overall Study||15
8118503|NCT02968433|20011224|P1|STARTED|Overall Study||16
8118504|NCT02968381|20011239|P2|NOT COMPLETED|Overall Study||10
8118505|NCT02968381|20011240|P1|NOT COMPLETED|Overall Study||5
8118506|NCT02968381|20011239|P2|COMPLETED|Overall Study||50
8118507|NCT02968381|20011240|P1|COMPLETED|Overall Study||56
8118508|NCT02968381|20011239|P2|STARTED|Overall Study||60
8118509|NCT02968381|20011240|P1|STARTED|Overall Study||61
8118510|NCT02968368|20011256|P2|NOT COMPLETED|Open Label Phase||14
8118511|NCT02968368|20011257|P1|NOT COMPLETED|Open Label Phase||19
8118512|NCT02968368|20011256|P2|COMPLETED|Open Label Phase||25
8118513|NCT02968368|20011257|P1|COMPLETED|Open Label Phase||67
8118514|NCT02968368|20011256|P2|STARTED|Open Label Phase||39
8118515|NCT02968368|20011257|P1|STARTED|Open Label Phase||86
8118516|NCT02968368|20011256|P2|NOT COMPLETED|Double Blind Phase||17
8118517|NCT02968368|20011257|P1|NOT COMPLETED|Double Blind Phase||21
8118518|NCT02968368|20011256|P2|COMPLETED|Double Blind Phase||39
8118519|NCT02968368|20011257|P1|COMPLETED|Double Blind Phase||90
8118520|NCT02968368|20011256|P2|STARTED|Double Blind Phase||56
8118521|NCT02968368|20011257|P1|STARTED|Double Blind Phase||111
8118522|NCT02968277|20011290|P3|NOT COMPLETED|Overall Study||0
8118523|NCT02968277|20011291|P2|NOT COMPLETED|Overall Study||0
8118524|NCT02968277|20011292|P1|NOT COMPLETED|Overall Study||0
8118525|NCT02968277|20011290|P3|COMPLETED|Overall Study||13
8118526|NCT02968277|20011291|P2|COMPLETED|Overall Study||7
8118527|NCT02968277|20011292|P1|COMPLETED|Overall Study||10
8118528|NCT02968277|20011290|P3|STARTED|Overall Study||13
8118529|NCT02968277|20011291|P2|STARTED|Overall Study||7
8118530|NCT02968277|20011292|P1|STARTED|Overall Study||10
8118531|NCT02968173|20011318|P1|NOT COMPLETED|Overall Study||1
8118532|NCT02968173|20011318|P1|COMPLETED|Overall Study||49
8118533|NCT02968173|20011318|P1|STARTED|Overall Study||50
8118534|NCT02968134|20011330|P1|NOT COMPLETED|Overall Study||0
8118535|NCT02968134|20011330|P1|COMPLETED|Overall Study||8
8118536|NCT02968134|20011330|P1|STARTED|Overall Study||8
8118537|NCT02967991|20011335|P2|NOT COMPLETED|Overall Study||0
8118538|NCT02967991|20011336|P1|NOT COMPLETED|Overall Study||0
8118539|NCT02967991|20011335|P2|COMPLETED|Overall Study||10
8118540|NCT02967991|20011336|P1|COMPLETED|Overall Study||10
8118541|NCT02967991|20011335|P2|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
8118542|NCT02967991|20011336|P1|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
8118543|NCT02967679|20011355|P1|NOT COMPLETED|Overall Study||1
8118544|NCT02967679|20011355|P1|COMPLETED|Overall Study||14
8118545|NCT02967679|20011355|P1|STARTED|Overall Study||15
8118546|NCT02967562|20011376|P2|NOT COMPLETED|Overall Study||1
8118547|NCT02967562|20011377|P1|NOT COMPLETED|Overall Study||2
8118548|NCT02967562|20011376|P2|COMPLETED|Overall Study||30
8118549|NCT02967562|20011377|P1|COMPLETED|Overall Study||30
8118550|NCT02967562|20011376|P2|STARTED|Overall Study||31
8118551|NCT02967562|20011377|P1|STARTED|Overall Study||32
8118552|NCT02967510|20011391|P4|NOT COMPLETED|Overall Study||8
8118553|NCT02967510|20011392|P3|NOT COMPLETED|Overall Study||7
8118554|NCT02967510|20011393|P2|NOT COMPLETED|Overall Study||3
8118555|NCT02967510|20011394|P1|NOT COMPLETED|Overall Study||4
8118556|NCT02967510|20011391|P4|COMPLETED|Overall Study||63
8118557|NCT02967510|20011392|P3|COMPLETED|Overall Study||65
8118558|NCT02967510|20011393|P2|COMPLETED|Overall Study||67
8118559|NCT02967510|20011394|P1|COMPLETED|Overall Study||66
8118560|NCT02967510|20011391|P4|STARTED|Overall Study||71
8118561|NCT02967510|20011392|P3|STARTED|Overall Study||72
8118562|NCT02967510|20011393|P2|STARTED|Overall Study||70
8118563|NCT02967510|20011394|P1|STARTED|Overall Study||70
8118564|NCT02967458|20011520|P1|NOT COMPLETED|Overall Study||0
8118565|NCT02967458|20011520|P1|COMPLETED|Overall Study||55
8118566|NCT02967458|20011520|P1|STARTED|Overall Study||55
8118567|NCT02967393|20011528|P2|NOT COMPLETED|Overall Study||0
8118568|NCT02967393|20011529|P1|NOT COMPLETED|Overall Study||0
8118569|NCT02967393|20011528|P2|COMPLETED|Overall Study||20
8118570|NCT02967393|20011529|P1|COMPLETED|Overall Study||20
8118571|NCT02967393|20011528|P2|STARTED|Overall Study||20
8118572|NCT02967393|20011529|P1|STARTED|Overall Study||20
8118573|NCT02967367|20011554|P1|NOT COMPLETED|Overall Study||14
8118574|NCT02967367|20011554|P1|COMPLETED|Overall Study||22
8118575|NCT02967367|20011554|P1|STARTED|Overall Study||36
8118576|NCT02967354|20011567|P5|NOT COMPLETED|Overall Study||0
8118577|NCT02967354|20011568|P4|NOT COMPLETED|Overall Study||0
8118578|NCT02967354|20011569|P3|NOT COMPLETED|Overall Study||0
8118579|NCT02967354|20011570|P2|NOT COMPLETED|Overall Study||0
8118580|NCT02967354|20011571|P1|NOT COMPLETED|Overall Study||0
8118581|NCT02967354|20011567|P5|COMPLETED|Overall Study||8
8118582|NCT02967354|20011568|P4|COMPLETED|Overall Study||7
8118583|NCT02967354|20011569|P3|COMPLETED|Overall Study||9
8118584|NCT02967354|20011570|P2|COMPLETED|Overall Study||7
8118585|NCT02967354|20011571|P1|COMPLETED|Overall Study||8
8118586|NCT02967354|20011567|P5|STARTED|Overall Study||8
8118587|NCT02967354|20011568|P4|STARTED|Overall Study||7
8118588|NCT02967354|20011569|P3|STARTED|Overall Study||9
8118589|NCT02967354|20011570|P2|STARTED|Overall Study||7
8118590|NCT02967354|20011571|P1|STARTED|Overall Study||8
8118591|NCT02967055|20011603|P1|NOT COMPLETED|Overall Study||49
8118592|NCT02967055|20011603|P1|COMPLETED|Overall Study||5
8118593|NCT02967055|20011603|P1|Completed 4 Week Follow-up Visit|Overall Study||8
8118594|NCT02967055|20011603|P1|Enrolled|Overall Study|Enrolled|9
8118595|NCT02967055|20011603|P1|In-person Screening|Overall Study||14
8118596|NCT02967055|20011603|P1|STARTED|Overall Study|Assessed for eligibility|54
8118597|NCT02967016|20011611|P2|NOT COMPLETED|Overall Study||0
8118598|NCT02967016|20011612|P1|NOT COMPLETED|Overall Study||0
8118599|NCT02967016|20011611|P2|COMPLETED|Overall Study||25
8118600|NCT02967016|20011612|P1|COMPLETED|Overall Study||25
8118601|NCT02967016|20011611|P2|STARTED|Overall Study||25
8118602|NCT02967016|20011612|P1|STARTED|Overall Study||25
8118603|NCT02966795|20011624|P2|NOT COMPLETED|Overall Study||1
8118604|NCT02966795|20011625|P1|NOT COMPLETED|Overall Study||0
8118605|NCT02966795|20011624|P2|COMPLETED|Overall Study||60
8118606|NCT02966795|20011625|P1|COMPLETED|Overall Study||23
8118607|NCT02966795|20011624|P2|STARTED|Overall Study||61
8118608|NCT02966795|20011625|P1|STARTED|Overall Study||23
8118609|NCT02966509|20011636|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
8118610|NCT02966509|20011637|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
8118611|NCT02966509|20011636|P2|COMPLETED|End of Life Utilization and Cost 15month||60
8118612|NCT02966509|20011637|P1|COMPLETED|End of Life Utilization and Cost 15month||60
8118613|NCT02966509|20011636|P2|STARTED|End of Life Utilization and Cost 15month||108
8118614|NCT02966509|20011637|P1|STARTED|End of Life Utilization and Cost 15month||105
8118615|NCT02966509|20011636|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
8118616|NCT02966509|20011637|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
8118617|NCT02966509|20011636|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
8118618|NCT02966509|20011637|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
8118619|NCT02966509|20011636|P2|STARTED|End of Life Utilization and Cost 6 Month||108
8118620|NCT02966509|20011637|P1|STARTED|End of Life Utilization and Cost 6 Month||105
8118621|NCT02966509|20011636|P2|NOT COMPLETED|15-Month Utilization and Cost||0
8118622|NCT02966509|20011637|P1|NOT COMPLETED|15-Month Utilization and Cost||0
8118623|NCT02966509|20011636|P2|COMPLETED|15-Month Utilization and Cost||108
8118624|NCT02966509|20011637|P1|COMPLETED|15-Month Utilization and Cost||105
8118625|NCT02966509|20011636|P2|STARTED|15-Month Utilization and Cost||108
8118626|NCT02966509|20011637|P1|STARTED|15-Month Utilization and Cost||105
8118627|NCT02966509|20011636|P2|NOT COMPLETED|6-Month Utilization and Cost||0
8118628|NCT02966509|20011637|P1|NOT COMPLETED|6-Month Utilization and Cost||0
8118629|NCT02966509|20011636|P2|COMPLETED|6-Month Utilization and Cost||108
8118630|NCT02966509|20011637|P1|COMPLETED|6-Month Utilization and Cost||105
8118631|NCT02966509|20011636|P2|STARTED|6-Month Utilization and Cost||108
8118632|NCT02966509|20011637|P1|STARTED|6-Month Utilization and Cost||105
8118633|NCT02966509|20011636|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
8118634|NCT02966509|20011637|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
8118635|NCT02966509|20011636|P2|COMPLETED|6 Month Satisfaction Survey||60
8118636|NCT02966509|20011637|P1|COMPLETED|6 Month Satisfaction Survey||58
8118637|NCT02966509|20011636|P2|STARTED|6 Month Satisfaction Survey||108
8118638|NCT02966509|20011637|P1|STARTED|6 Month Satisfaction Survey||105
8118639|NCT02966509|20011636|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
8118640|NCT02966509|20011637|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
8118641|NCT02966509|20011636|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
8118642|NCT02966509|20011637|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
8118643|NCT02966509|20011636|P2|STARTED|6 Month Satisfaction Decision Survey||108
8118644|NCT02966509|20011637|P1|STARTED|6 Month Satisfaction Decision Survey||105
8118645|NCT02966509|20011636|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
8118646|NCT02966509|20011637|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
8118647|NCT02966509|20011636|P2|COMPLETED|Baseline Satisfaction Survey||101
8118648|NCT02966509|20011637|P1|COMPLETED|Baseline Satisfaction Survey||101
8118649|NCT02966509|20011636|P2|STARTED|Baseline Satisfaction Survey||108
8118650|NCT02966509|20011637|P1|STARTED|Baseline Satisfaction Survey||105
8118651|NCT02966353|20011661|P1|NOT COMPLETED|Overall Study||22
8118652|NCT02966353|20011661|P1|COMPLETED|Overall Study||29
8118653|NCT02966353|20011661|P1|Completed After Data Cutoff|Overall Study||1
8118654|NCT02966353|20011661|P1|STARTED|Overall Study||51
8118655|NCT02966340|20011670|P2|NOT COMPLETED|Overall Study||3
8118656|NCT02966340|20011671|P1|NOT COMPLETED|Overall Study||3
8118657|NCT02966340|20011670|P2|COMPLETED|Overall Study||30
8118658|NCT02966340|20011671|P1|COMPLETED|Overall Study||34
8118659|NCT02966340|20011670|P2|STARTED|Overall Study||33
8118660|NCT02966340|20011671|P1|STARTED|Overall Study||37
8118661|NCT02966275|20011679|P1|NOT COMPLETED|Overall Study||0
8118662|NCT02966275|20011679|P1|COMPLETED|Overall Study||10
8118663|NCT02966275|20011679|P1|STARTED|Overall Study||10
8118664|NCT02966223|20011714|P1|NOT COMPLETED|Overall Study||15
8118665|NCT02966223|20011714|P1|COMPLETED|Overall Study||5
8118666|NCT02966223|20011714|P1|STARTED|Overall Study||20
8118667|NCT02966015|20011722|P2|NOT COMPLETED|Test Period||0
8118668|NCT02966015|20011723|P1|NOT COMPLETED|Test Period||0
8118669|NCT02966015|20011722|P2|COMPLETED|Test Period||55
8118670|NCT02966015|20011723|P1|COMPLETED|Test Period||87
8118671|NCT02966015|20011722|P2|STARTED|Test Period||55
8118672|NCT02966015|20011723|P1|STARTED|Test Period||87
8118673|NCT02966015|20011722|P2|NOT COMPLETED|Inclusion Visit||3
8118674|NCT02966015|20011723|P1|NOT COMPLETED|Inclusion Visit||8
8118675|NCT02966015|20011722|P2|COMPLETED|Inclusion Visit||55
8118676|NCT02966015|20011723|P1|COMPLETED|Inclusion Visit||87
8118677|NCT02966015|20011722|P2|STARTED|Inclusion Visit||58
8118678|NCT02966015|20011723|P1|STARTED|Inclusion Visit||95
8118679|NCT02966002|20011729|P1|NOT COMPLETED|Overall Study||4
8118680|NCT02966002|20011729|P1|COMPLETED|Overall Study||5
8118681|NCT02966002|20011729|P1|STARTED|Overall Study||9
8118682|NCT02965924|20011736|P1|NOT COMPLETED|Overall Study||0
8118683|NCT02965924|20011736|P1|COMPLETED|Overall Study||20
8118684|NCT02965924|20011736|P1|STARTED|Overall Study||20
8118685|NCT02965846|20011744|P3|NOT COMPLETED|Overall Study||33
8118686|NCT02965846|20011745|P2|NOT COMPLETED|Overall Study||5
8118687|NCT02965846|20011746|P1|NOT COMPLETED|Overall Study||5
8118688|NCT02965846|20011744|P3|COMPLETED|Overall Study||0
8118689|NCT02965846|20011745|P2|COMPLETED|Overall Study||0
8118690|NCT02965846|20011746|P1|COMPLETED|Overall Study||0
8118691|NCT02965846|20011744|P3|STARTED|Overall Study||33
8118692|NCT02965846|20011745|P2|STARTED|Overall Study||5
8118693|NCT02965846|20011746|P1|STARTED|Overall Study||5
8118694|NCT02965833|20011754|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8118695|NCT02965833|20011755|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
8118696|NCT02965833|20011754|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
8118697|NCT02965833|20011755|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
8118698|NCT02965833|20011754|P2|STARTED|Period 2, Second 30 Days of Wear||52
8118699|NCT02965833|20011755|P1|STARTED|Period 2, Second 30 Days of Wear||64
8118700|NCT02965833|20011754|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
8118701|NCT02965833|20011755|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
8118702|NCT02965833|20011754|P2|COMPLETED|Period 1, First 30 Days of Wear||52
8118703|NCT02965833|20011755|P1|COMPLETED|Period 1, First 30 Days of Wear||64
8118704|NCT02965833|20011754|P2|STARTED|Period 1, First 30 Days of Wear||54
8118705|NCT02965833|20011755|P1|STARTED|Period 1, First 30 Days of Wear||67
8118706|NCT02965820|20011761|P2|NOT COMPLETED|Period 2, Second 30 Days||1
8118707|NCT02965820|20011762|P1|NOT COMPLETED|Period 2, Second 30 Days||1
8118708|NCT02965820|20011761|P2|COMPLETED|Period 2, Second 30 Days||61
8118709|NCT02965820|20011762|P1|COMPLETED|Period 2, Second 30 Days||57
8118710|NCT02965820|20011761|P2|STARTED|Period 2, Second 30 Days||62
8118711|NCT02965820|20011762|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
8118712|NCT02965820|20011761|P2|NOT COMPLETED|Period 1, First 30 Days||0
8118713|NCT02965820|20011762|P1|NOT COMPLETED|Period 1, First 30 Days||0
8118714|NCT02965820|20011761|P2|COMPLETED|Period 1, First 30 Days||62
8118715|NCT02965820|20011762|P1|COMPLETED|Period 1, First 30 Days||59
8118716|NCT02965820|20011761|P2|STARTED|Period 1, First 30 Days||62
8118717|NCT02965820|20011762|P1|STARTED|Period 1, First 30 Days||59
8118718|NCT02965729|20011771|P3|NOT COMPLETED|Overall Study||11
8118719|NCT02965729|20011772|P2|NOT COMPLETED|Overall Study||3
8118720|NCT02965729|20011773|P1|NOT COMPLETED|Overall Study||7
8118721|NCT02965729|20011771|P3|COMPLETED|Overall Study||45
8118722|NCT02965729|20011772|P2|COMPLETED|Overall Study||22
8118723|NCT02965729|20011773|P1|COMPLETED|Overall Study||17
8118724|NCT02965729|20011771|P3|STARTED|Overall Study||56
8118725|NCT02965729|20011772|P2|STARTED|Overall Study||25
8118726|NCT02965729|20011773|P1|STARTED|Overall Study||24
8118727|NCT02965599|20011801|P2|NOT COMPLETED|Overall Study||0
8118728|NCT02965599|20011802|P1|NOT COMPLETED|Overall Study||1
8118729|NCT02965599|20011801|P2|COMPLETED|Overall Study||1
8118730|NCT02965599|20011802|P1|COMPLETED|Overall Study||1
8118731|NCT02965599|20011801|P2|STARTED|Overall Study||1
8118732|NCT02965599|20011802|P1|STARTED|Overall Study||2
8118733|NCT02965573|20011866|P2|NOT COMPLETED|Overall Study||0
8118734|NCT02965573|20011867|P1|NOT COMPLETED|Overall Study||1
8118735|NCT02965573|20011866|P2|COMPLETED|Overall Study||12
8118736|NCT02965573|20011867|P1|COMPLETED|Overall Study||11
8118737|NCT02965573|20011866|P2|STARTED|Overall Study||12
8118738|NCT02965573|20011867|P1|STARTED|Overall Study||12
8118739|NCT02965534|20011911|P2|NOT COMPLETED|Overall Study||0
8118740|NCT02965534|20011912|P1|NOT COMPLETED|Overall Study||0
8118741|NCT02965534|20011911|P2|COMPLETED|Overall Study||55
8118742|NCT02965534|20011912|P1|COMPLETED|Overall Study||45
8118743|NCT02965534|20011911|P2|STARTED|Overall Study|test period: 14 days with each test glasses|55
8118744|NCT02965534|20011912|P1|STARTED|Overall Study|test period: 14 days with each test glasses|45
8118745|NCT02965456|20011928|P2|NOT COMPLETED|Overall Study||43
8118746|NCT02965456|20011929|P1|NOT COMPLETED|Overall Study||71
8118747|NCT02965456|20011928|P2|COMPLETED|Overall Study||364
8118748|NCT02965456|20011929|P1|COMPLETED|Overall Study||342
8118749|NCT02965456|20011928|P2|Safety Population|Overall Study||398
8118750|NCT02965456|20011929|P1|Safety Population|Overall Study||389
8118751|NCT02965456|20011928|P2|Intent-to-treat (ITT) Population|Overall Study||407
8118752|NCT02965456|20011929|P1|Intent-to-treat (ITT) Population|Overall Study||413
8118753|NCT02965456|20011928|P2|STARTED|Overall Study||407
8118754|NCT02965456|20011929|P1|STARTED|Overall Study||413
8118755|NCT02965144|20011943|P1|NOT COMPLETED|Overall Study||0
8118756|NCT02965144|20011943|P1|COMPLETED|Overall Study||13
8118757|NCT02965144|20011943|P1|STARTED|Overall Study||13
8118758|NCT02964910|20011953|P2|NOT COMPLETED|Overall Study||44
8118759|NCT02964910|20011954|P1|NOT COMPLETED|Overall Study||43
8118760|NCT02964910|20011953|P2|COMPLETED|Overall Study||196
8118761|NCT02964910|20011954|P1|COMPLETED|Overall Study||192
8118762|NCT02964910|20011953|P2|STARTED|Overall Study||240
8118763|NCT02964910|20011954|P1|STARTED|Overall Study||235
8118764|NCT02964767|20011980|P2|NOT COMPLETED|Overall Study||0
8118765|NCT02964767|20011981|P1|NOT COMPLETED|Overall Study||0
8118766|NCT02964767|20011980|P2|COMPLETED|Overall Study||48
8118767|NCT02964767|20011981|P1|COMPLETED|Overall Study||171
8118768|NCT02964767|20011980|P2|STARTED|Overall Study||48
8118769|NCT02964767|20011981|P1|STARTED|Overall Study||171
8118770|NCT02964416|20011990|P2|NOT COMPLETED|Overall Study||0
8118771|NCT02964416|20011991|P1|NOT COMPLETED|Overall Study||1
8118772|NCT02964416|20011990|P2|COMPLETED|Overall Study||41
8118773|NCT02964416|20011991|P1|COMPLETED|Overall Study||38
8118774|NCT02964416|20011990|P2|STARTED|Overall Study||41
8118775|NCT02964416|20011991|P1|STARTED|Overall Study||39
8118791|NCT02964312|20012066|P1|NOT COMPLETED|Overall Study||64
8118792|NCT02964312|20012066|P1|COMPLETED|Overall Study||102
8118793|NCT02964312|20012066|P1|24-Month Follow-up|Overall Study||102
8118794|NCT02964312|20012066|P1|18-Month Follow-up|Overall Study||112
8118795|NCT02964312|20012066|P1|12-Month Follow-up|Overall Study||139
8118796|NCT02964312|20012066|P1|6-Month Follow-up|Overall Study||152
8118797|NCT02964312|20012066|P1|3-Month Follow-up|Overall Study||159
8118798|NCT02964312|20012066|P1|1-Month Follow-up|Overall Study||164
8118799|NCT02964312|20012066|P1|STARTED|Overall Study||166
8118800|NCT02964247|20012077|P2|NOT COMPLETED|Overall Study||2
8118801|NCT02964247|20012078|P1|NOT COMPLETED|Overall Study||3
8118802|NCT02964247|20012077|P2|COMPLETED|Overall Study||98
8118803|NCT02964247|20012078|P1|COMPLETED|Overall Study||200
8118804|NCT02964247|20012077|P2|Exposed to Trial Product|Overall Study||100
8118805|NCT02964247|20012078|P1|Exposed to Trial Product|Overall Study||202
8118806|NCT02964247|20012077|P2|STARTED|Overall Study||100
8118807|NCT02964247|20012078|P1|STARTED|Overall Study||203
8118808|NCT02964234|20012136|P2|NOT COMPLETED|Overall Study||13
8118809|NCT02964234|20012137|P1|NOT COMPLETED|Overall Study||22
8118810|NCT02964234|20012136|P2|COMPLETED|Overall Study||56
8118811|NCT02964234|20012137|P1|COMPLETED|Overall Study||54
8118812|NCT02964234|20012136|P2|STARTED|Overall Study||69
8118813|NCT02964234|20012137|P1|STARTED|Overall Study||76
8118817|NCT02963987|20012153|P2|NOT COMPLETED|Second Intervention Period||0
8118818|NCT02963987|20012154|P1|NOT COMPLETED|Second Intervention Period||0
8118819|NCT02963987|20012153|P2|COMPLETED|Second Intervention Period||19
8118820|NCT02963987|20012154|P1|COMPLETED|Second Intervention Period||31
8118821|NCT02963987|20012153|P2|STARTED|Second Intervention Period||19
8118822|NCT02963987|20012154|P1|STARTED|Second Intervention Period||31
8118823|NCT02963987|20012153|P2|NOT COMPLETED|First Intervention Period||0
8118824|NCT02963987|20012154|P1|NOT COMPLETED|First Intervention Period||0
8118825|NCT02963987|20012153|P2|COMPLETED|First Intervention Period||19
8118826|NCT02963987|20012154|P1|COMPLETED|First Intervention Period||31
8118827|NCT02963987|20012153|P2|STARTED|First Intervention Period||19
8118828|NCT02963987|20012154|P1|STARTED|First Intervention Period||31
8118829|NCT02963935|20012166|P2|NOT COMPLETED|Overall Study||37
8118830|NCT02963935|20012167|P1|NOT COMPLETED|Overall Study||28
8118831|NCT02963935|20012166|P2|COMPLETED|Overall Study||103
8118832|NCT02963935|20012167|P1|COMPLETED|Overall Study||114
8118833|NCT02963935|20012166|P2|STARTED|Overall Study||140
8118834|NCT02963935|20012167|P1|STARTED|Overall Study||142
8118835|NCT02963922|20012275|P2|NOT COMPLETED|Overall Study||30
8118836|NCT02963922|20012276|P1|NOT COMPLETED|Overall Study||32
8118837|NCT02963922|20012275|P2|COMPLETED|Overall Study||168
8118838|NCT02963922|20012276|P1|COMPLETED|Overall Study||166
8118839|NCT02963922|20012275|P2|STARTED|Overall Study||198
8118840|NCT02963922|20012276|P1|STARTED|Overall Study||198
8118841|NCT02963701|20012374|P2|NOT COMPLETED|Period 2 (2 Days)||0
8118842|NCT02963701|20012375|P1|NOT COMPLETED|Period 2 (2 Days)||0
8118843|NCT02963701|20012374|P2|COMPLETED|Period 2 (2 Days)||28
8118844|NCT02963701|20012375|P1|COMPLETED|Period 2 (2 Days)||27
8118845|NCT02963701|20012374|P2|STARTED|Period 2 (2 Days)||28
8118846|NCT02963701|20012375|P1|STARTED|Period 2 (2 Days)||27
8118847|NCT02963701|20012374|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
8118848|NCT02963701|20012375|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
8119023|NCT02962609|20012740|P2|NOT COMPLETED|Overall Study||0
8118849|NCT02963701|20012374|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
8118850|NCT02963701|20012375|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
8118851|NCT02963701|20012374|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
8118852|NCT02963701|20012375|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
8118853|NCT02963597|20012407|P2|NOT COMPLETED|Overall Study||0
8118854|NCT02963597|20012408|P1|NOT COMPLETED|Overall Study||0
8118855|NCT02963597|20012407|P2|COMPLETED|Overall Study||11
8118856|NCT02963597|20012408|P1|COMPLETED|Overall Study||10
8118857|NCT02963597|20012407|P2|STARTED|Overall Study||11
8118858|NCT02963597|20012408|P1|STARTED|Overall Study||10
8118859|NCT02963506|20012435|P13|NOT COMPLETED|Dose-Blind Period||7
8118860|NCT02963506|20012436|P12|NOT COMPLETED|Dose-Blind Period||2
8118861|NCT02963506|20012437|P11|NOT COMPLETED|Dose-Blind Period||1
8118862|NCT02963506|20012438|P10|NOT COMPLETED|Dose-Blind Period||4
8118863|NCT02963506|20012439|P9|NOT COMPLETED|Dose-Blind Period||3
8118864|NCT02963506|20012440|P8|NOT COMPLETED|Dose-Blind Period||5
8118865|NCT02963506|20012441|P7|NOT COMPLETED|Dose-Blind Period||5
8118866|NCT02963506|20012442|P6|NOT COMPLETED|Dose-Blind Period||4
8118867|NCT02963506|20012443|P5|NOT COMPLETED|Dose-Blind Period||0
8118868|NCT02963506|20012444|P4|NOT COMPLETED|Dose-Blind Period||0
8118869|NCT02963506|20012445|P3|NOT COMPLETED|Dose-Blind Period||0
8118870|NCT02963506|20012446|P2|NOT COMPLETED|Dose-Blind Period||0
8118871|NCT02963506|20012447|P1|NOT COMPLETED|Dose-Blind Period||0
8118872|NCT02963506|20012435|P13|COMPLETED|Dose-Blind Period||54
8118873|NCT02963506|20012436|P12|COMPLETED|Dose-Blind Period||56
8118874|NCT02963506|20012437|P11|COMPLETED|Dose-Blind Period||24
8118875|NCT02963506|20012438|P10|COMPLETED|Dose-Blind Period||30
8118876|NCT02963506|20012439|P9|COMPLETED|Dose-Blind Period||24
8118877|NCT02963506|20012440|P8|COMPLETED|Dose-Blind Period||26
8118878|NCT02963506|20012441|P7|COMPLETED|Dose-Blind Period||31
8118879|NCT02963506|20012442|P6|COMPLETED|Dose-Blind Period||20
8118880|NCT02963506|20012443|P5|COMPLETED|Dose-Blind Period||0
8118881|NCT02963506|20012444|P4|COMPLETED|Dose-Blind Period||0
8118882|NCT02963506|20012445|P3|COMPLETED|Dose-Blind Period||0
8118883|NCT02963506|20012446|P2|COMPLETED|Dose-Blind Period||0
8118884|NCT02963506|20012447|P1|COMPLETED|Dose-Blind Period||0
8118885|NCT02963506|20012435|P13|STARTED|Dose-Blind Period||61
8118886|NCT02963506|20012436|P12|STARTED|Dose-Blind Period||58
8118887|NCT02963506|20012437|P11|STARTED|Dose-Blind Period||25
8118888|NCT02963506|20012438|P10|STARTED|Dose-Blind Period||34
8118889|NCT02963506|20012439|P9|STARTED|Dose-Blind Period||27
8118890|NCT02963506|20012440|P8|STARTED|Dose-Blind Period||31
8118891|NCT02963506|20012441|P7|STARTED|Dose-Blind Period||36
8118892|NCT02963506|20012442|P6|STARTED|Dose-Blind Period||24
8118893|NCT02963506|20012443|P5|STARTED|Dose-Blind Period||0
8118894|NCT02963506|20012444|P4|STARTED|Dose-Blind Period||0
8118895|NCT02963506|20012445|P3|STARTED|Dose-Blind Period||0
8118896|NCT02963506|20012446|P2|STARTED|Dose-Blind Period||0
8118897|NCT02963506|20012447|P1|STARTED|Dose-Blind Period||0
8118898|NCT02963506|20012435|P13|NOT COMPLETED|Double-Blind Period||0
8118899|NCT02963506|20012436|P12|NOT COMPLETED|Double-Blind Period||0
8118900|NCT02963506|20012437|P11|NOT COMPLETED|Double-Blind Period||0
8118901|NCT02963506|20012438|P10|NOT COMPLETED|Double-Blind Period||0
8118902|NCT02963506|20012439|P9|NOT COMPLETED|Double-Blind Period||0
8118903|NCT02963506|20012440|P8|NOT COMPLETED|Double-Blind Period||0
8118904|NCT02963506|20012441|P7|NOT COMPLETED|Double-Blind Period||0
8118905|NCT02963506|20012442|P6|NOT COMPLETED|Double-Blind Period||0
8118906|NCT02963506|20012443|P5|NOT COMPLETED|Double-Blind Period||0
8118907|NCT02963506|20012444|P4|NOT COMPLETED|Double-Blind Period||2
8118908|NCT02963506|20012445|P3|NOT COMPLETED|Double-Blind Period||2
8118909|NCT02963506|20012446|P2|NOT COMPLETED|Double-Blind Period||3
8118910|NCT02963506|20012447|P1|NOT COMPLETED|Double-Blind Period||0
8118911|NCT02963506|20012435|P13|COMPLETED|Double-Blind Period||0
8118912|NCT02963506|20012436|P12|COMPLETED|Double-Blind Period||0
8118913|NCT02963506|20012437|P11|COMPLETED|Double-Blind Period||0
8118914|NCT02963506|20012438|P10|COMPLETED|Double-Blind Period||0
8118915|NCT02963506|20012439|P9|COMPLETED|Double-Blind Period||0
8118916|NCT02963506|20012440|P8|COMPLETED|Double-Blind Period||0
8118917|NCT02963506|20012441|P7|COMPLETED|Double-Blind Period||0
8118918|NCT02963506|20012442|P6|COMPLETED|Double-Blind Period||0
8118919|NCT02963506|20012443|P5|COMPLETED|Double-Blind Period||61
8118920|NCT02963506|20012444|P4|COMPLETED|Double-Blind Period||58
8118921|NCT02963506|20012445|P3|COMPLETED|Double-Blind Period||59
8118922|NCT02963506|20012446|P2|COMPLETED|Double-Blind Period||58
8118923|NCT02963506|20012447|P1|COMPLETED|Double-Blind Period||60
8118924|NCT02963506|20012435|P13|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118925|NCT02963506|20012436|P12|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118926|NCT02963506|20012437|P11|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118927|NCT02963506|20012438|P10|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118928|NCT02963506|20012439|P9|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118929|NCT02963506|20012440|P8|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118930|NCT02963506|20012441|P7|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118931|NCT02963506|20012442|P6|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118932|NCT02963506|20012443|P5|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
8118933|NCT02963506|20012444|P4|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
8118934|NCT02963506|20012445|P3|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
8119024|NCT02962609|20012741|P1|NOT COMPLETED|Overall Study||0
8118935|NCT02963506|20012446|P2|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
8118936|NCT02963506|20012447|P1|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
8118937|NCT02963506|20012435|P13|Completed Double-Blind Period|Double-Blind Period||0
8118938|NCT02963506|20012436|P12|Completed Double-Blind Period|Double-Blind Period||0
8118939|NCT02963506|20012437|P11|Completed Double-Blind Period|Double-Blind Period||0
8118940|NCT02963506|20012438|P10|Completed Double-Blind Period|Double-Blind Period||0
8118941|NCT02963506|20012439|P9|Completed Double-Blind Period|Double-Blind Period||0
8118942|NCT02963506|20012440|P8|Completed Double-Blind Period|Double-Blind Period||0
8118943|NCT02963506|20012441|P7|Completed Double-Blind Period|Double-Blind Period||0
8118944|NCT02963506|20012442|P6|Completed Double-Blind Period|Double-Blind Period||0
8118945|NCT02963506|20012443|P5|Completed Double-Blind Period|Double-Blind Period||61
8118946|NCT02963506|20012444|P4|Completed Double-Blind Period|Double-Blind Period||58
8118947|NCT02963506|20012445|P3|Completed Double-Blind Period|Double-Blind Period||59
8118948|NCT02963506|20012446|P2|Completed Double-Blind Period|Double-Blind Period||59
8118949|NCT02963506|20012447|P1|Completed Double-Blind Period|Double-Blind Period||60
8118950|NCT02963506|20012435|P13|STARTED|Double-Blind Period||0
8118951|NCT02963506|20012436|P12|STARTED|Double-Blind Period||0
8118952|NCT02963506|20012437|P11|STARTED|Double-Blind Period||0
8118953|NCT02963506|20012438|P10|STARTED|Double-Blind Period||0
8118954|NCT02963506|20012439|P9|STARTED|Double-Blind Period||0
8118955|NCT02963506|20012440|P8|STARTED|Double-Blind Period||0
8118956|NCT02963506|20012441|P7|STARTED|Double-Blind Period||0
8118957|NCT02963506|20012442|P6|STARTED|Double-Blind Period||0
8118958|NCT02963506|20012443|P5|STARTED|Double-Blind Period||61
8118959|NCT02963506|20012444|P4|STARTED|Double-Blind Period||60
8118960|NCT02963506|20012445|P3|STARTED|Double-Blind Period||61
8118961|NCT02963506|20012446|P2|STARTED|Double-Blind Period||61
8118962|NCT02963506|20012447|P1|STARTED|Double-Blind Period||60
8118963|NCT02963311|20012499|P1|NOT COMPLETED|Overall Study||5
8118964|NCT02963311|20012499|P1|COMPLETED|Overall Study||4
8118965|NCT02963311|20012499|P1|STARTED|Overall Study||9
8118966|NCT02962960|20012526|P3|NOT COMPLETED|Overall Study||0
8118967|NCT02962960|20012527|P2|NOT COMPLETED|Overall Study||2
8118968|NCT02962960|20012528|P1|NOT COMPLETED|Overall Study||3
8118969|NCT02962960|20012526|P3|COMPLETED|Overall Study||9
8118970|NCT02962960|20012527|P2|COMPLETED|Overall Study||11
8118971|NCT02962960|20012528|P1|COMPLETED|Overall Study||11
8118972|NCT02962960|20012526|P3|STARTED|Overall Study||9
8118973|NCT02962960|20012527|P2|STARTED|Overall Study||13
8118974|NCT02962960|20012528|P1|STARTED|Overall Study||14
8118975|NCT02962934|20012601|P2|NOT COMPLETED|Overall Study||0
8118976|NCT02962934|20012602|P1|NOT COMPLETED|Overall Study||0
8118977|NCT02962934|20012601|P2|COMPLETED|Overall Study||6
8118978|NCT02962934|20012602|P1|COMPLETED|Overall Study||12
8118979|NCT02962934|20012601|P2|STARTED|Overall Study||6
8118980|NCT02962934|20012602|P1|STARTED|Overall Study||12
8118981|NCT02962908|20012612|P4|NOT COMPLETED|Overall Study||3
8118982|NCT02962908|20012613|P3|NOT COMPLETED|Overall Study||0
8118983|NCT02962908|20012614|P2|NOT COMPLETED|Overall Study||8
8118984|NCT02962908|20012615|P1|NOT COMPLETED|Overall Study||0
8118985|NCT02962908|20012612|P4|COMPLETED|Overall Study||24
8118986|NCT02962908|20012613|P3|COMPLETED|Overall Study||32
8118987|NCT02962908|20012614|P2|COMPLETED|Overall Study||50
8118988|NCT02962908|20012615|P1|COMPLETED|Overall Study||58
8118989|NCT02962908|20012612|P4|STARTED|Overall Study||27
8118990|NCT02962908|20012613|P3|STARTED|Overall Study||32
8118991|NCT02962908|20012614|P2|STARTED|Overall Study||58
8118992|NCT02962908|20012615|P1|STARTED|Overall Study||58
8118993|NCT02962882|20012679|P1|NOT COMPLETED|Overall Study||36
8118994|NCT02962882|20012679|P1|COMPLETED|Overall Study||14
8118995|NCT02962882|20012679|P1|STARTED|Overall Study||50
8118996|NCT02962739|20012688|P6|NOT COMPLETED|Overall Study||0
8118997|NCT02962739|20012689|P5|NOT COMPLETED|Overall Study||1
8118998|NCT02962739|20012690|P4|NOT COMPLETED|Overall Study||0
8118999|NCT02962739|20012691|P3|NOT COMPLETED|Overall Study||1
8119000|NCT02962739|20012692|P2|NOT COMPLETED|Overall Study||1
8119001|NCT02962739|20012693|P1|NOT COMPLETED|Overall Study||0
8119002|NCT02962739|20012688|P6|COMPLETED|Overall Study||6
8119003|NCT02962739|20012689|P5|COMPLETED|Overall Study||5
8119004|NCT02962739|20012690|P4|COMPLETED|Overall Study||6
8119005|NCT02962739|20012691|P3|COMPLETED|Overall Study||6
8119006|NCT02962739|20012692|P2|COMPLETED|Overall Study||6
8119007|NCT02962739|20012693|P1|COMPLETED|Overall Study||6
8119008|NCT02962739|20012688|P6|STARTED|Overall Study||6
8119009|NCT02962739|20012689|P5|STARTED|Overall Study||6
8119010|NCT02962739|20012690|P4|STARTED|Overall Study||6
8119011|NCT02962739|20012691|P3|STARTED|Overall Study||7
8119012|NCT02962739|20012692|P2|STARTED|Overall Study||7
8119013|NCT02962739|20012693|P1|STARTED|Overall Study||6
8119014|NCT02962687|20012701|P2|NOT COMPLETED|Overall Study||8
8119015|NCT02962687|20012702|P1|NOT COMPLETED|Overall Study||10
8119016|NCT02962687|20012701|P2|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
8119017|NCT02962687|20012702|P1|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
8119018|NCT02962687|20012701|P2|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
8119019|NCT02962687|20012702|P1|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
8119020|NCT02962648|20012726|P1|NOT COMPLETED|Overall Study||9
8119021|NCT02962648|20012726|P1|COMPLETED|Overall Study||94
8119022|NCT02962648|20012726|P1|STARTED|Overall Study||103
8119025|NCT02962609|20012740|P2|COMPLETED|Overall Study||42
8119026|NCT02962609|20012741|P1|COMPLETED|Overall Study||38
8119027|NCT02962609|20012740|P2|STARTED|Overall Study||42
8119028|NCT02962609|20012741|P1|STARTED|Overall Study||38
8119029|NCT02962427|20012753|P2|NOT COMPLETED|Overall Study||0
8119030|NCT02962427|20012754|P1|NOT COMPLETED|Overall Study||0
8119031|NCT02962427|20012753|P2|COMPLETED|Overall Study||1
8119032|NCT02962427|20012754|P1|COMPLETED|Overall Study||3
8119033|NCT02962427|20012753|P2|STARTED|Overall Study||1
8119034|NCT02962427|20012754|P1|STARTED|Overall Study||3
8119035|NCT02962284|20012764|P2|NOT COMPLETED|Overall Study||3
8119036|NCT02962284|20012765|P1|NOT COMPLETED|Overall Study||5
8119037|NCT02962284|20012764|P2|COMPLETED|Overall Study||8
8119038|NCT02962284|20012765|P1|COMPLETED|Overall Study||4
8119039|NCT02962284|20012764|P2|STARTED|Overall Study||11
8119040|NCT02962284|20012765|P1|STARTED|Overall Study||9
8119041|NCT02961946|20012784|P3|NOT COMPLETED|Overall Study||0
8119042|NCT02961946|20012785|P2|NOT COMPLETED|Overall Study||0
8119043|NCT02961946|20012786|P1|NOT COMPLETED|Overall Study||0
8119044|NCT02961946|20012784|P3|COMPLETED|Overall Study||66
8119045|NCT02961946|20012785|P2|COMPLETED|Overall Study||66
8119046|NCT02961946|20012786|P1|COMPLETED|Overall Study||66
8119047|NCT02961946|20012784|P3|STARTED|Overall Study||66
8119048|NCT02961946|20012785|P2|STARTED|Overall Study||66
8119049|NCT02961946|20012786|P1|STARTED|Overall Study||66
8119050|NCT02961920|20012796|P2|NOT COMPLETED|Overall Study||1
8119051|NCT02961920|20012797|P1|NOT COMPLETED|Overall Study||1
8119052|NCT02961920|20012796|P2|COMPLETED|Overall Study||24
8119053|NCT02961920|20012797|P1|COMPLETED|Overall Study||24
8119054|NCT02961920|20012796|P2|STARTED|Overall Study||25
8119055|NCT02961920|20012797|P1|STARTED|Overall Study||25
8119056|NCT02961894|20012803|P1|NOT COMPLETED|Overall Study||0
8119057|NCT02961894|20012803|P1|COMPLETED|Overall Study||121
8119058|NCT02961894|20012803|P1|STARTED|Overall Study||121
8119059|NCT02961790|20012825|P4|NOT COMPLETED|Overall Study||5
8119060|NCT02961790|20012826|P3|NOT COMPLETED|Overall Study||6
8119061|NCT02961790|20012827|P2|NOT COMPLETED|Overall Study||11
8119062|NCT02961790|20012828|P1|NOT COMPLETED|Overall Study||15
8119063|NCT02961790|20012825|P4|COMPLETED|Overall Study||20
8119064|NCT02961790|20012826|P3|COMPLETED|Overall Study||18
8119065|NCT02961790|20012827|P2|COMPLETED|Overall Study||40
8119066|NCT02961790|20012828|P1|COMPLETED|Overall Study||35
8119067|NCT02961790|20012825|P4|STARTED|Overall Study||25
8119068|NCT02961790|20012826|P3|STARTED|Overall Study||24
8119069|NCT02961790|20012827|P2|STARTED|Overall Study||51
8119070|NCT02961790|20012828|P1|STARTED|Overall Study||50
8119071|NCT02961764|20012851|P2|NOT COMPLETED|Overall Study||25
8119072|NCT02961764|20012852|P1|NOT COMPLETED|Overall Study||39
8119073|NCT02961764|20012851|P2|COMPLETED|Overall Study||128
8119074|NCT02961764|20012852|P1|COMPLETED|Overall Study||121
8119075|NCT02961764|20012851|P2|STARTED|Overall Study||153
8119076|NCT02961764|20012852|P1|STARTED|Overall Study||160
8119077|NCT02961751|20012926|P1|NOT COMPLETED|Overall Study||15
8119078|NCT02961751|20012926|P1|COMPLETED|Overall Study||196
8119079|NCT02961751|20012926|P1|STARTED|Overall Study||211
8119080|NCT02961244|20012939|P2|NOT COMPLETED|Overall Study||9
8119081|NCT02961244|20012940|P1|NOT COMPLETED|Overall Study||1
8119082|NCT02961244|20012939|P2|COMPLETED|Overall Study||55
8119083|NCT02961244|20012940|P1|COMPLETED|Overall Study||63
8119084|NCT02961244|20012939|P2|Patients Excluded During Randomization|Overall Study||1
8119085|NCT02961244|20012940|P1|Patients Excluded During Randomization|Overall Study||0
8119086|NCT02961244|20012939|P2|STARTED|Overall Study||64
8119087|NCT02961244|20012940|P1|STARTED|Overall Study||64
8119088|NCT02961218|20012950|P2|NOT COMPLETED|Overall Study||5
8119089|NCT02961218|20012951|P1|NOT COMPLETED|Overall Study||3
8119090|NCT02961218|20012950|P2|COMPLETED|Overall Study||19
8119091|NCT02961218|20012951|P1|COMPLETED|Overall Study||22
8119092|NCT02961218|20012950|P2|Primary PD Analysis Set|Overall Study||24
8119093|NCT02961218|20012951|P1|Primary PD Analysis Set|Overall Study||25
8119094|NCT02961218|20012950|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
8119095|NCT02961218|20012951|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||25
8119096|NCT02961218|20012950|P2|Safety Analysis Set|Overall Study||24
8119097|NCT02961218|20012951|P1|Safety Analysis Set|Overall Study||25
8119098|NCT02961218|20012950|P2|STARTED|Overall Study||24
8119099|NCT02961218|20012951|P1|STARTED|Overall Study||25
8119100|NCT02961062|20012988|P2|NOT COMPLETED|Overall Study||0
8119101|NCT02961062|20012989|P1|NOT COMPLETED|Overall Study||0
8119102|NCT02961062|20012988|P2|COMPLETED|Overall Study||20
8119103|NCT02961062|20012989|P1|COMPLETED|Overall Study||20
8119104|NCT02961062|20012988|P2|STARTED|Overall Study||20
8119105|NCT02961062|20012989|P1|STARTED|Overall Study||20
8119106|NCT02960997|20013005|P2|NOT COMPLETED|Follow-up Period, 4 Weeks||0
8119107|NCT02960997|20013006|P1|NOT COMPLETED|Follow-up Period, 4 Weeks||0
8119108|NCT02960997|20013005|P2|COMPLETED|Follow-up Period, 4 Weeks||4
8119109|NCT02960997|20013006|P1|COMPLETED|Follow-up Period, 4 Weeks||4
8119110|NCT02960997|20013005|P2|STARTED|Follow-up Period, 4 Weeks||4
8119111|NCT02960997|20013006|P1|STARTED|Follow-up Period, 4 Weeks||4
8119112|NCT02960997|20013005|P2|NOT COMPLETED|Second Treatment, 12 Weeks||0
8119113|NCT02960997|20013006|P1|NOT COMPLETED|Second Treatment, 12 Weeks||0
8119114|NCT02960997|20013005|P2|COMPLETED|Second Treatment, 12 Weeks||4
8119115|NCT02960997|20013006|P1|COMPLETED|Second Treatment, 12 Weeks||4
8119116|NCT02960997|20013005|P2|STARTED|Second Treatment, 12 Weeks||4
8119117|NCT02960997|20013006|P1|STARTED|Second Treatment, 12 Weeks||4
8119118|NCT02960997|20013005|P2|NOT COMPLETED|Washout Period, 4 Weeks||0
8119119|NCT02960997|20013006|P1|NOT COMPLETED|Washout Period, 4 Weeks||0
8119120|NCT02960997|20013005|P2|COMPLETED|Washout Period, 4 Weeks||4
8119121|NCT02960997|20013006|P1|COMPLETED|Washout Period, 4 Weeks||4
8119122|NCT02960997|20013005|P2|STARTED|Washout Period, 4 Weeks||4
8119123|NCT02960997|20013006|P1|STARTED|Washout Period, 4 Weeks||4
8119124|NCT02960997|20013005|P2|NOT COMPLETED|First Intervention, 12 Weeks||0
8119125|NCT02960997|20013006|P1|NOT COMPLETED|First Intervention, 12 Weeks||0
8119126|NCT02960997|20013005|P2|COMPLETED|First Intervention, 12 Weeks||4
8119127|NCT02960997|20013006|P1|COMPLETED|First Intervention, 12 Weeks||4
8119128|NCT02960997|20013005|P2|STARTED|First Intervention, 12 Weeks||4
8119129|NCT02960997|20013006|P1|STARTED|First Intervention, 12 Weeks||4
8119130|NCT02960893|20013031|P2|NOT COMPLETED|Extension Phase (48-week)||13
8119131|NCT02960893|20013032|P1|NOT COMPLETED|Extension Phase (48-week)||14
8119132|NCT02960893|20013031|P2|COMPLETED|Extension Phase (48-week)||54
8119133|NCT02960893|20013032|P1|COMPLETED|Extension Phase (48-week)||50
8119134|NCT02960893|20013031|P2|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
8119135|NCT02960893|20013032|P1|STARTED|Extension Phase (48-week)||64
8119136|NCT02960893|20013031|P2|NOT COMPLETED|Randomization Phase (8-week)||2
8119137|NCT02960893|20013032|P1|NOT COMPLETED|Randomization Phase (8-week)||7
8119138|NCT02960893|20013031|P2|COMPLETED|Randomization Phase (8-week)||68
8119139|NCT02960893|20013032|P1|COMPLETED|Randomization Phase (8-week)||64
8119140|NCT02960893|20013031|P2|STARTED|Randomization Phase (8-week)||70
8119141|NCT02960893|20013032|P1|STARTED|Randomization Phase (8-week)||71
8119142|NCT02960854|20013050|P2|NOT COMPLETED|Overall Study||9
8119143|NCT02960854|20013051|P1|NOT COMPLETED|Overall Study||7
8119144|NCT02960854|20013050|P2|COMPLETED|Overall Study||7
8119145|NCT02960854|20013051|P1|COMPLETED|Overall Study||8
8119146|NCT02960854|20013050|P2|STARTED|Overall Study||16
8119147|NCT02960854|20013051|P1|STARTED|Overall Study||15
8119148|NCT02960295|20013081|P1|NOT COMPLETED|Overall Study||0
8119149|NCT02960295|20013081|P1|COMPLETED|Overall Study||10
8119150|NCT02960295|20013081|P1|STARTED|Overall Study||10
8119151|NCT02960217|20013090|P2|NOT COMPLETED|Open-Label Extension Phase||13
8119152|NCT02960217|20013091|P1|NOT COMPLETED|Open-Label Extension Phase||20
8119153|NCT02960217|20013090|P2|COMPLETED|Open-Label Extension Phase||0
8119154|NCT02960217|20013091|P1|COMPLETED|Open-Label Extension Phase||0
8119155|NCT02960217|20013090|P2|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
8119156|NCT02960217|20013091|P1|STARTED|Open-Label Extension Phase||20
8119157|NCT02960217|20013090|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
8119158|NCT02960217|20013091|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
8119159|NCT02960217|20013090|P2|COMPLETED|Maintenance Phase: Treatment Period 2||18
8119160|NCT02960217|20013091|P1|COMPLETED|Maintenance Phase: Treatment Period 2||20
8119161|NCT02960217|20013090|P2|STARTED|Maintenance Phase: Treatment Period 2||21
8119162|NCT02960217|20013091|P1|STARTED|Maintenance Phase: Treatment Period 2||21
8119163|NCT02960217|20013090|P2|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
8119164|NCT02960217|20013091|P1|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
8119165|NCT02960217|20013090|P2|COMPLETED|Maintenance Phase: Crossover Washout||21
8119166|NCT02960217|20013091|P1|COMPLETED|Maintenance Phase: Crossover Washout||21
8119167|NCT02960217|20013090|P2|STARTED|Maintenance Phase: Crossover Washout||21
8119168|NCT02960217|20013091|P1|STARTED|Maintenance Phase: Crossover Washout||21
8119169|NCT02960217|20013090|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
8119170|NCT02960217|20013091|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
8119171|NCT02960217|20013090|P2|COMPLETED|Maintenance Phase: Treatment Period 1||21
8119172|NCT02960217|20013091|P1|COMPLETED|Maintenance Phase: Treatment Period 1||21
8119173|NCT02960217|20013090|P2|STARTED|Maintenance Phase: Treatment Period 1||21
8119174|NCT02960217|20013091|P1|STARTED|Maintenance Phase: Treatment Period 1||22
8119175|NCT02959996|20013145|P2|NOT COMPLETED|Overall Study||0
8119176|NCT02959996|20013146|P1|NOT COMPLETED|Overall Study||0
8119177|NCT02959996|20013145|P2|COMPLETED|Overall Study||39
8119178|NCT02959996|20013146|P1|COMPLETED|Overall Study||40
8119179|NCT02959996|20013145|P2|STARTED|Overall Study||39
8119180|NCT02959996|20013146|P1|STARTED|Overall Study||40
8119181|NCT02959983|20013170|P2|NOT COMPLETED|Overall Study||25
8119182|NCT02959983|20013171|P1|NOT COMPLETED|Overall Study||26
8119183|NCT02959983|20013170|P2|COMPLETED|Overall Study||149
8119184|NCT02959983|20013171|P1|COMPLETED|Overall Study||146
8119185|NCT02959983|20013170|P2|STARTED|Overall Study||174
8119186|NCT02959983|20013171|P1|STARTED|Overall Study||172
8119187|NCT02959970|20013185|P2|NOT COMPLETED|Overall Study||7
8119188|NCT02959970|20013186|P1|NOT COMPLETED|Overall Study||2
8119189|NCT02959970|20013185|P2|COMPLETED|Overall Study||76
8119190|NCT02959970|20013186|P1|COMPLETED|Overall Study||15
8119191|NCT02959970|20013185|P2|STARTED|Overall Study||83
8119192|NCT02959970|20013186|P1|STARTED|Overall Study||17
8119193|NCT02959892|20013220|P2|NOT COMPLETED|Overall Study||1
8119194|NCT02959892|20013221|P1|NOT COMPLETED|Overall Study||1
8119195|NCT02959892|20013220|P2|COMPLETED|Overall Study||5
8119196|NCT02959892|20013221|P1|COMPLETED|Overall Study||5
8119197|NCT02959892|20013220|P2|STARTED|Overall Study||6
8119198|NCT02959892|20013221|P1|STARTED|Overall Study||6
8119199|NCT02959866|20013229|P1|NOT COMPLETED|Overall Study||1
8119200|NCT02959866|20013229|P1|COMPLETED|Overall Study||58
8119201|NCT02959866|20013229|P1|Telephone Interview at 1 Month Follow-up|Overall Study||59
8119202|NCT02959866|20013229|P1|STARTED|Overall Study||59
8119203|NCT02959853|20013236|P2|NOT COMPLETED|Overall Study||2
8119204|NCT02959853|20013237|P1|NOT COMPLETED|Overall Study||4
8119205|NCT02959853|20013236|P2|COMPLETED|Overall Study||10
8119206|NCT02959853|20013237|P1|COMPLETED|Overall Study||7
8119207|NCT02959853|20013236|P2|STARTED|Overall Study||12
8119208|NCT02959853|20013237|P1|STARTED|Overall Study||11
8119209|NCT02959840|20013256|P3|NOT COMPLETED|Overall Study||0
8119210|NCT02959840|20013257|P2|NOT COMPLETED|Overall Study||0
8119211|NCT02959840|20013258|P1|NOT COMPLETED|Overall Study||0
8119212|NCT02959840|20013256|P3|COMPLETED|Overall Study||60
8119213|NCT02959840|20013257|P2|COMPLETED|Overall Study||60
8119214|NCT02959840|20013258|P1|COMPLETED|Overall Study||60
8119215|NCT02959840|20013256|P3|STARTED|Overall Study||60
8119216|NCT02959840|20013257|P2|STARTED|Overall Study||60
8119217|NCT02959840|20013258|P1|STARTED|Overall Study||60
8119218|NCT02959827|20013299|P1|NOT COMPLETED|Overall Study||0
8119219|NCT02959827|20013299|P1|COMPLETED|Overall Study||2320
8119220|NCT02959827|20013299|P1|STARTED|Overall Study||2320
8119221|NCT02959814|20013318|P1|NOT COMPLETED|Overall Study||57
8119222|NCT02959814|20013318|P1|COMPLETED|Overall Study|17-10-2017|272
8119223|NCT02959814|20013318|P1|STARTED|Overall Study|22-02-2017|329
8119224|NCT02959671|20013337|P1|NOT COMPLETED|Overall Study||5
8119225|NCT02959671|20013337|P1|COMPLETED|Overall Study||29
8119226|NCT02959671|20013337|P1|STARTED|Overall Study||34
8119227|NCT02959437|20013349|P4|NOT COMPLETED|Overall Study||0
8119228|NCT02959437|20013350|P3|NOT COMPLETED|Overall Study||0
8119229|NCT02959437|20013351|P2|NOT COMPLETED|Overall Study||8
8119230|NCT02959437|20013352|P1|NOT COMPLETED|Overall Study||62
8119231|NCT02959437|20013349|P4|COMPLETED|Overall Study||0
8119232|NCT02959437|20013350|P3|COMPLETED|Overall Study||0
8119233|NCT02959437|20013351|P2|COMPLETED|Overall Study||0
8119234|NCT02959437|20013352|P1|COMPLETED|Overall Study||0
8119235|NCT02959437|20013349|P4|STARTED|Overall Study||0
8119236|NCT02959437|20013350|P3|STARTED|Overall Study||0
8119237|NCT02959437|20013351|P2|STARTED|Overall Study||8
8119238|NCT02959437|20013352|P1|STARTED|Overall Study||62
8119239|NCT02959307|20013366|P2|NOT COMPLETED|Phase 2||0
8119240|NCT02959307|20013367|P1|NOT COMPLETED|Phase 2||2
8119241|NCT02959307|20013366|P2|COMPLETED|Phase 2||10
8119242|NCT02959307|20013367|P1|COMPLETED|Phase 2||26
8119243|NCT02959307|20013366|P2|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
8119244|NCT02959307|20013367|P1|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
8119245|NCT02959307|20013366|P2|NOT COMPLETED|Phase 1||8
8119246|NCT02959307|20013367|P1|NOT COMPLETED|Phase 1||3
8119247|NCT02959307|20013366|P2|COMPLETED|Phase 1||23
8119248|NCT02959307|20013367|P1|COMPLETED|Phase 1||15
8119249|NCT02959307|20013366|P2|STARTED|Phase 1||31
8119250|NCT02959307|20013367|P1|STARTED|Phase 1||18
8119251|NCT02959190|20013385|P4|NOT COMPLETED|Post Treatment Follow Up||0
8119252|NCT02959190|20013386|P3|NOT COMPLETED|Post Treatment Follow Up||1
8119253|NCT02959190|20013387|P2|NOT COMPLETED|Post Treatment Follow Up||1
8119254|NCT02959190|20013388|P1|NOT COMPLETED|Post Treatment Follow Up||3
8119255|NCT02959190|20013385|P4|COMPLETED|Post Treatment Follow Up||32
8119256|NCT02959190|20013386|P3|COMPLETED|Post Treatment Follow Up||31
8119257|NCT02959190|20013387|P2|COMPLETED|Post Treatment Follow Up||119
8119258|NCT02959190|20013388|P1|COMPLETED|Post Treatment Follow Up||114
8119259|NCT02959190|20013385|P4|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
8119260|NCT02959190|20013386|P3|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
8119261|NCT02959190|20013387|P2|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
8119262|NCT02959190|20013388|P1|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
8119263|NCT02959190|20013385|P4|NOT COMPLETED|Open Label||6
8119264|NCT02959190|20013386|P3|NOT COMPLETED|Open Label||4
8119265|NCT02959190|20013387|P2|NOT COMPLETED|Open Label||16
8119266|NCT02959190|20013388|P1|NOT COMPLETED|Open Label||7
8119267|NCT02959190|20013385|P4|COMPLETED|Open Label||27
8119268|NCT02959190|20013386|P3|COMPLETED|Open Label||28
8119269|NCT02959190|20013387|P2|COMPLETED|Open Label||110
8119270|NCT02959190|20013388|P1|COMPLETED|Open Label||113
8119271|NCT02959190|20013385|P4|Placebo/ 240mg Galcanezumab - EM|Open Label||0
8119272|NCT02959190|20013386|P3|Placebo/ 240mg Galcanezumab - EM|Open Label||0
8119273|NCT02959190|20013387|P2|Placebo/ 240mg Galcanezumab - EM|Open Label||64
8119274|NCT02959190|20013388|P1|Placebo/ 240mg Galcanezumab - EM|Open Label||0
8119275|NCT02959190|20013385|P4|Placebo/ 120mg Galcanezumab - EM|Open Label||0
8119276|NCT02959190|20013386|P3|Placebo/ 120mg Galcanezumab - EM|Open Label||0
8119277|NCT02959190|20013387|P2|Placebo/ 120mg Galcanezumab - EM|Open Label||0
8119278|NCT02959190|20013388|P1|Placebo/ 120mg Galcanezumab - EM|Open Label||62
8119279|NCT02959190|20013385|P4|240mg/240mg Galcanezumab - EM|Open Label||0
8119280|NCT02959190|20013386|P3|240mg/240mg Galcanezumab - EM|Open Label||0
8119281|NCT02959190|20013387|P2|240mg/240mg Galcanezumab - EM|Open Label||62
8119282|NCT02959190|20013388|P1|240mg/240mg Galcanezumab - EM|Open Label||0
8119283|NCT02959190|20013385|P4|120mg/120mg Galcanezumab - EM|Open Label||0
8119284|NCT02959190|20013386|P3|120mg/120mg Galcanezumab - EM|Open Label||0
8119285|NCT02959190|20013387|P2|120mg/120mg Galcanezumab - EM|Open Label||0
8119286|NCT02959190|20013388|P1|120mg/120mg Galcanezumab - EM|Open Label||58
8119287|NCT02959190|20013385|P4|Received at Least 1 Dose of Study Drug|Open Label||33
8119288|NCT02959190|20013386|P3|Received at Least 1 Dose of Study Drug|Open Label||32
8119289|NCT02959190|20013387|P2|Received at Least 1 Dose of Study Drug|Open Label||126
8119290|NCT02959190|20013388|P1|Received at Least 1 Dose of Study Drug|Open Label||120
8119291|NCT02959190|20013385|P4|STARTED|Open Label||33
8119292|NCT02959190|20013386|P3|STARTED|Open Label||32
8119293|NCT02959190|20013387|P2|STARTED|Open Label||126
8119294|NCT02959190|20013388|P1|STARTED|Open Label||120
8119295|NCT02959177|20013481|P3|NOT COMPLETED|Follow-up Post Treatment Phase||2
8119296|NCT02959177|20013482|P2|NOT COMPLETED|Follow-up Post Treatment Phase||1
8119297|NCT02959177|20013483|P1|NOT COMPLETED|Follow-up Post Treatment Phase||1
8119298|NCT02959177|20013481|P3|COMPLETED|Follow-up Post Treatment Phase||98
8119299|NCT02959177|20013482|P2|COMPLETED|Follow-up Post Treatment Phase||51
8119300|NCT02959177|20013483|P1|COMPLETED|Follow-up Post Treatment Phase||51
8119301|NCT02959177|20013481|P3|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
8119302|NCT02959177|20013482|P2|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
8119303|NCT02959177|20013483|P1|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
8119304|NCT02959177|20013481|P3|NOT COMPLETED|Double-Blind Treatment Phase||5
8119305|NCT02959177|20013482|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
8119306|NCT02959177|20013483|P1|NOT COMPLETED|Double-Blind Treatment Phase||11
8119307|NCT02959177|20013481|P3|COMPLETED|Double-Blind Treatment Phase||225
8119308|NCT02959177|20013482|P2|COMPLETED|Double-Blind Treatment Phase||111
8119309|NCT02959177|20013483|P1|COMPLETED|Double-Blind Treatment Phase||104
8119310|NCT02959177|20013481|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
8119311|NCT02959177|20013482|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
8119312|NCT02959177|20013483|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
8119313|NCT02959177|20013481|P3|STARTED|Double-Blind Treatment Phase||230
8119314|NCT02959177|20013482|P2|STARTED|Double-Blind Treatment Phase||114
8119315|NCT02959177|20013483|P1|STARTED|Double-Blind Treatment Phase||115
8119316|NCT02959138|20013538|P3|NOT COMPLETED|Overall Study||0
8119317|NCT02959138|20013539|P2|NOT COMPLETED|Overall Study||1
8119318|NCT02959138|20013540|P1|NOT COMPLETED|Overall Study||0
8119319|NCT02959138|20013538|P3|COMPLETED|Overall Study||16
8119320|NCT02959138|20013539|P2|COMPLETED|Overall Study||9
8119321|NCT02959138|20013540|P1|COMPLETED|Overall Study||10
8119322|NCT02959138|20013538|P3|STARTED|Overall Study||16
8119323|NCT02959138|20013539|P2|STARTED|Overall Study||10
8119324|NCT02959138|20013540|P1|STARTED|Overall Study||10
8119325|NCT02958995|20013565|P2|NOT COMPLETED|Overall Study||0
8119326|NCT02958995|20013566|P1|NOT COMPLETED|Overall Study||0
8119327|NCT02958995|20013565|P2|COMPLETED|Overall Study||107495
8119328|NCT02958995|20013566|P1|COMPLETED|Overall Study||2630666
8119329|NCT02958995|20013565|P2|STARTED|Overall Study||107495
8119330|NCT02958995|20013566|P1|STARTED|Overall Study||2630666
8119331|NCT02958982|20013585|P11|NOT COMPLETED|Proof of Concept Study||0
8119332|NCT02958982|20013586|P10|NOT COMPLETED|Proof of Concept Study||0
8119333|NCT02958982|20013587|P9|NOT COMPLETED|Proof of Concept Study||0
8119334|NCT02958982|20013588|P8|NOT COMPLETED|Proof of Concept Study||0
8119335|NCT02958982|20013589|P7|NOT COMPLETED|Proof of Concept Study||0
8119336|NCT02958982|20013590|P6|NOT COMPLETED|Proof of Concept Study||0
8119337|NCT02958982|20013591|P5|NOT COMPLETED|Proof of Concept Study||0
8119338|NCT02958982|20013592|P4|NOT COMPLETED|Proof of Concept Study||0
8119339|NCT02958982|20013593|P3|NOT COMPLETED|Proof of Concept Study||0
8119340|NCT02958982|20013594|P2|NOT COMPLETED|Proof of Concept Study||0
8119341|NCT02958982|20013595|P1|NOT COMPLETED|Proof of Concept Study||0
8119342|NCT02958982|20013585|P11|COMPLETED|Proof of Concept Study||1
8119343|NCT02958982|20013586|P10|COMPLETED|Proof of Concept Study||0
8119344|NCT02958982|20013587|P9|COMPLETED|Proof of Concept Study||0
8119345|NCT02958982|20013588|P8|COMPLETED|Proof of Concept Study||0
8119346|NCT02958982|20013589|P7|COMPLETED|Proof of Concept Study||0
8119347|NCT02958982|20013590|P6|COMPLETED|Proof of Concept Study||0
8119348|NCT02958982|20013591|P5|COMPLETED|Proof of Concept Study||0
8119349|NCT02958982|20013592|P4|COMPLETED|Proof of Concept Study||0
8119350|NCT02958982|20013593|P3|COMPLETED|Proof of Concept Study||0
8119351|NCT02958982|20013594|P2|COMPLETED|Proof of Concept Study||0
8119352|NCT02958982|20013595|P1|COMPLETED|Proof of Concept Study||0
8119353|NCT02958982|20013585|P11|STARTED|Proof of Concept Study||1
8119354|NCT02958982|20013586|P10|STARTED|Proof of Concept Study||0
8119355|NCT02958982|20013587|P9|STARTED|Proof of Concept Study||0
8119356|NCT02958982|20013588|P8|STARTED|Proof of Concept Study||0
8119357|NCT02958982|20013589|P7|STARTED|Proof of Concept Study||0
8119358|NCT02958982|20013590|P6|STARTED|Proof of Concept Study||0
8119359|NCT02958982|20013591|P5|STARTED|Proof of Concept Study||0
8119360|NCT02958982|20013592|P4|STARTED|Proof of Concept Study||0
8119361|NCT02958982|20013593|P3|STARTED|Proof of Concept Study||0
8119362|NCT02958982|20013594|P2|STARTED|Proof of Concept Study||0
8119363|NCT02958982|20013595|P1|STARTED|Proof of Concept Study||0
8119364|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119365|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119366|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119367|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119368|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119369|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119370|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119371|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119372|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119373|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119374|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119375|NCT02958982|20013585|P11|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119376|NCT02958982|20013586|P10|COMPLETED|Cohort 3: 400 mg in MAD Study||6
8119377|NCT02958982|20013587|P9|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119378|NCT02958982|20013588|P8|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119379|NCT02958982|20013589|P7|COMPLETED|Cohort 3: 400 mg in MAD Study||2
8119380|NCT02958982|20013590|P6|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119381|NCT02958982|20013591|P5|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119382|NCT02958982|20013592|P4|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119383|NCT02958982|20013593|P3|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119384|NCT02958982|20013594|P2|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119385|NCT02958982|20013595|P1|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119386|NCT02958982|20013585|P11|STARTED|Cohort 3: 400 mg in MAD Study||0
8119387|NCT02958982|20013586|P10|STARTED|Cohort 3: 400 mg in MAD Study||6
8119388|NCT02958982|20013587|P9|STARTED|Cohort 3: 400 mg in MAD Study||0
8119389|NCT02958982|20013588|P8|STARTED|Cohort 3: 400 mg in MAD Study||0
8119390|NCT02958982|20013589|P7|STARTED|Cohort 3: 400 mg in MAD Study||2
8119391|NCT02958982|20013590|P6|STARTED|Cohort 3: 400 mg in MAD Study||0
8119392|NCT02958982|20013591|P5|STARTED|Cohort 3: 400 mg in MAD Study||0
8119393|NCT02958982|20013592|P4|STARTED|Cohort 3: 400 mg in MAD Study||0
8119394|NCT02958982|20013593|P3|STARTED|Cohort 3: 400 mg in MAD Study||0
8119395|NCT02958982|20013594|P2|STARTED|Cohort 3: 400 mg in MAD Study||0
8119396|NCT02958982|20013595|P1|STARTED|Cohort 3: 400 mg in MAD Study||0
8119397|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119398|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119399|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119400|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119401|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119402|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119403|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119404|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119405|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119406|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119407|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119408|NCT02958982|20013585|P11|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119409|NCT02958982|20013586|P10|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119410|NCT02958982|20013587|P9|COMPLETED|Cohort 2: 100 mg in MAD Study||6
8119411|NCT02958982|20013588|P8|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119412|NCT02958982|20013589|P7|COMPLETED|Cohort 2: 100 mg in MAD Study||2
8119413|NCT02958982|20013590|P6|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119414|NCT02958982|20013591|P5|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119415|NCT02958982|20013592|P4|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119416|NCT02958982|20013593|P3|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119417|NCT02958982|20013594|P2|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119418|NCT02958982|20013595|P1|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119419|NCT02958982|20013585|P11|STARTED|Cohort 2: 100 mg in MAD Study||0
8119420|NCT02958982|20013586|P10|STARTED|Cohort 2: 100 mg in MAD Study||0
8119421|NCT02958982|20013587|P9|STARTED|Cohort 2: 100 mg in MAD Study||6
8119422|NCT02958982|20013588|P8|STARTED|Cohort 2: 100 mg in MAD Study||0
8119423|NCT02958982|20013589|P7|STARTED|Cohort 2: 100 mg in MAD Study||2
8119424|NCT02958982|20013590|P6|STARTED|Cohort 2: 100 mg in MAD Study||0
8119425|NCT02958982|20013591|P5|STARTED|Cohort 2: 100 mg in MAD Study||0
8119426|NCT02958982|20013592|P4|STARTED|Cohort 2: 100 mg in MAD Study||0
8119427|NCT02958982|20013593|P3|STARTED|Cohort 2: 100 mg in MAD Study||0
8119428|NCT02958982|20013594|P2|STARTED|Cohort 2: 100 mg in MAD Study||0
8119429|NCT02958982|20013595|P1|STARTED|Cohort 2: 100 mg in MAD Study||0
8119430|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119431|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119432|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119433|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119434|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119435|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119436|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119437|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119438|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119439|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119440|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119441|NCT02958982|20013585|P11|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119442|NCT02958982|20013586|P10|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119443|NCT02958982|20013587|P9|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119444|NCT02958982|20013588|P8|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
8119445|NCT02958982|20013589|P7|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
8119446|NCT02958982|20013590|P6|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119447|NCT02958982|20013591|P5|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119448|NCT02958982|20013592|P4|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119449|NCT02958982|20013593|P3|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119450|NCT02958982|20013594|P2|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119451|NCT02958982|20013595|P1|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119452|NCT02958982|20013585|P11|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119453|NCT02958982|20013586|P10|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119454|NCT02958982|20013587|P9|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119455|NCT02958982|20013588|P8|STARTED|Cohort 1 : 25 mg in MAD Study||6
8119456|NCT02958982|20013589|P7|STARTED|Cohort 1 : 25 mg in MAD Study||2
8119457|NCT02958982|20013590|P6|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119458|NCT02958982|20013591|P5|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119459|NCT02958982|20013592|P4|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119460|NCT02958982|20013593|P3|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119461|NCT02958982|20013594|P2|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119462|NCT02958982|20013595|P1|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119463|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119464|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119465|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119466|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119467|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119468|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119469|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119470|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119471|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119472|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119473|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119474|NCT02958982|20013585|P11|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119475|NCT02958982|20013586|P10|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119476|NCT02958982|20013587|P9|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119477|NCT02958982|20013588|P8|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119478|NCT02958982|20013589|P7|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119479|NCT02958982|20013590|P6|COMPLETED|Cohort 5: 400 mg in SAD Study||6
8119480|NCT02958982|20013591|P5|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119481|NCT02958982|20013592|P4|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119482|NCT02958982|20013593|P3|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119483|NCT02958982|20013594|P2|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119484|NCT02958982|20013595|P1|COMPLETED|Cohort 5: 400 mg in SAD Study||2
8119485|NCT02958982|20013585|P11|STARTED|Cohort 5: 400 mg in SAD Study||0
8119486|NCT02958982|20013586|P10|STARTED|Cohort 5: 400 mg in SAD Study||0
8119487|NCT02958982|20013587|P9|STARTED|Cohort 5: 400 mg in SAD Study||0
8119488|NCT02958982|20013588|P8|STARTED|Cohort 5: 400 mg in SAD Study||0
8119489|NCT02958982|20013589|P7|STARTED|Cohort 5: 400 mg in SAD Study||0
8119490|NCT02958982|20013590|P6|STARTED|Cohort 5: 400 mg in SAD Study||6
8119491|NCT02958982|20013591|P5|STARTED|Cohort 5: 400 mg in SAD Study||0
8119492|NCT02958982|20013592|P4|STARTED|Cohort 5: 400 mg in SAD Study||0
8119493|NCT02958982|20013593|P3|STARTED|Cohort 5: 400 mg in SAD Study||0
8119494|NCT02958982|20013594|P2|STARTED|Cohort 5: 400 mg in SAD Study||0
8119495|NCT02958982|20013595|P1|STARTED|Cohort 5: 400 mg in SAD Study||2
8119496|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119497|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119498|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119499|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119500|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119501|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119502|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119503|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119504|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119505|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119506|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119507|NCT02958982|20013585|P11|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119508|NCT02958982|20013586|P10|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119509|NCT02958982|20013587|P9|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119510|NCT02958982|20013588|P8|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119511|NCT02958982|20013589|P7|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119512|NCT02958982|20013590|P6|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119513|NCT02958982|20013591|P5|COMPLETED|Cohort 4: 200 mg in SAD Study||6
8119514|NCT02958982|20013592|P4|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119515|NCT02958982|20013593|P3|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119516|NCT02958982|20013594|P2|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119517|NCT02958982|20013595|P1|COMPLETED|Cohort 4: 200 mg in SAD Study||2
8119518|NCT02958982|20013585|P11|STARTED|Cohort 4: 200 mg in SAD Study||0
8119519|NCT02958982|20013586|P10|STARTED|Cohort 4: 200 mg in SAD Study||0
8119520|NCT02958982|20013587|P9|STARTED|Cohort 4: 200 mg in SAD Study||0
8119521|NCT02958982|20013588|P8|STARTED|Cohort 4: 200 mg in SAD Study||0
8119522|NCT02958982|20013589|P7|STARTED|Cohort 4: 200 mg in SAD Study||0
8119523|NCT02958982|20013590|P6|STARTED|Cohort 4: 200 mg in SAD Study||0
8119524|NCT02958982|20013591|P5|STARTED|Cohort 4: 200 mg in SAD Study||6
8119525|NCT02958982|20013592|P4|STARTED|Cohort 4: 200 mg in SAD Study||0
8119526|NCT02958982|20013593|P3|STARTED|Cohort 4: 200 mg in SAD Study||0
8119527|NCT02958982|20013594|P2|STARTED|Cohort 4: 200 mg in SAD Study||0
8119528|NCT02958982|20013595|P1|STARTED|Cohort 4: 200 mg in SAD Study||2
8119529|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119530|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119531|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119532|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119533|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119534|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119535|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119536|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119537|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119538|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119539|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119540|NCT02958982|20013585|P11|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119541|NCT02958982|20013586|P10|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119542|NCT02958982|20013587|P9|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119543|NCT02958982|20013588|P8|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119544|NCT02958982|20013589|P7|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119545|NCT02958982|20013590|P6|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119546|NCT02958982|20013591|P5|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119547|NCT02958982|20013592|P4|COMPLETED|Cohort 3: 100 mg in SAD Study||4
8119548|NCT02958982|20013593|P3|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119549|NCT02958982|20013594|P2|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119550|NCT02958982|20013595|P1|COMPLETED|Cohort 3: 100 mg in SAD Study||2
8119551|NCT02958982|20013585|P11|STARTED|Cohort 3: 100 mg in SAD Study||0
8119552|NCT02958982|20013586|P10|STARTED|Cohort 3: 100 mg in SAD Study||0
8119553|NCT02958982|20013587|P9|STARTED|Cohort 3: 100 mg in SAD Study||0
8119554|NCT02958982|20013588|P8|STARTED|Cohort 3: 100 mg in SAD Study||0
8119555|NCT02958982|20013589|P7|STARTED|Cohort 3: 100 mg in SAD Study||0
8119556|NCT02958982|20013590|P6|STARTED|Cohort 3: 100 mg in SAD Study||0
8119557|NCT02958982|20013591|P5|STARTED|Cohort 3: 100 mg in SAD Study||0
8119558|NCT02958982|20013592|P4|STARTED|Cohort 3: 100 mg in SAD Study||4
8119559|NCT02958982|20013593|P3|STARTED|Cohort 3: 100 mg in SAD Study||0
8119560|NCT02958982|20013594|P2|STARTED|Cohort 3: 100 mg in SAD Study||0
8119561|NCT02958982|20013595|P1|STARTED|Cohort 3: 100 mg in SAD Study||2
8119562|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119563|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119564|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119565|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119566|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119567|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119568|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119569|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119570|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119571|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119572|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119573|NCT02958982|20013585|P11|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119574|NCT02958982|20013586|P10|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119575|NCT02958982|20013587|P9|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119576|NCT02958982|20013588|P8|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119577|NCT02958982|20013589|P7|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119578|NCT02958982|20013590|P6|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119579|NCT02958982|20013591|P5|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119580|NCT02958982|20013592|P4|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119581|NCT02958982|20013593|P3|COMPLETED|Cohort 2: 50 mg in SAD Study||4
8119582|NCT02958982|20013594|P2|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119583|NCT02958982|20013595|P1|COMPLETED|Cohort 2: 50 mg in SAD Study||2
8119584|NCT02958982|20013585|P11|STARTED|Cohort 2: 50 mg in SAD Study||0
8119585|NCT02958982|20013586|P10|STARTED|Cohort 2: 50 mg in SAD Study||0
8119586|NCT02958982|20013587|P9|STARTED|Cohort 2: 50 mg in SAD Study||0
8119587|NCT02958982|20013588|P8|STARTED|Cohort 2: 50 mg in SAD Study||0
8119588|NCT02958982|20013589|P7|STARTED|Cohort 2: 50 mg in SAD Study||0
8119589|NCT02958982|20013590|P6|STARTED|Cohort 2: 50 mg in SAD Study||0
8119590|NCT02958982|20013591|P5|STARTED|Cohort 2: 50 mg in SAD Study||0
8119591|NCT02958982|20013592|P4|STARTED|Cohort 2: 50 mg in SAD Study||0
8119592|NCT02958982|20013593|P3|STARTED|Cohort 2: 50 mg in SAD Study||4
8119593|NCT02958982|20013594|P2|STARTED|Cohort 2: 50 mg in SAD Study||0
8119594|NCT02958982|20013595|P1|STARTED|Cohort 2: 50 mg in SAD Study||2
8119595|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119596|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119597|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119598|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119599|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119600|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119601|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119602|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119603|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119604|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119605|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119606|NCT02958982|20013585|P11|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119607|NCT02958982|20013586|P10|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119608|NCT02958982|20013587|P9|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119609|NCT02958982|20013588|P8|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119610|NCT02958982|20013589|P7|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119611|NCT02958982|20013590|P6|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119612|NCT02958982|20013591|P5|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119613|NCT02958982|20013592|P4|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119614|NCT02958982|20013593|P3|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119615|NCT02958982|20013594|P2|COMPLETED|Cohort 1: 25 mg in SAD Study||3
8119616|NCT02958982|20013595|P1|COMPLETED|Cohort 1: 25 mg in SAD Study||1
8119617|NCT02958982|20013585|P11|STARTED|Cohort 1: 25 mg in SAD Study||0
8119618|NCT02958982|20013586|P10|STARTED|Cohort 1: 25 mg in SAD Study||0
8119619|NCT02958982|20013587|P9|STARTED|Cohort 1: 25 mg in SAD Study||0
8119620|NCT02958982|20013588|P8|STARTED|Cohort 1: 25 mg in SAD Study||0
8119621|NCT02958982|20013589|P7|STARTED|Cohort 1: 25 mg in SAD Study||0
8119622|NCT02958982|20013590|P6|STARTED|Cohort 1: 25 mg in SAD Study||0
8119623|NCT02958982|20013591|P5|STARTED|Cohort 1: 25 mg in SAD Study||0
8119624|NCT02958982|20013592|P4|STARTED|Cohort 1: 25 mg in SAD Study||0
8119625|NCT02958982|20013593|P3|STARTED|Cohort 1: 25 mg in SAD Study||0
8119626|NCT02958982|20013594|P2|STARTED|Cohort 1: 25 mg in SAD Study||3
8119627|NCT02958982|20013595|P1|STARTED|Cohort 1: 25 mg in SAD Study||1
8119628|NCT02958969|20013641|P1|NOT COMPLETED|Overall Study||0
8119629|NCT02958969|20013641|P1|COMPLETED|Overall Study||50
8119630|NCT02958969|20013641|P1|STARTED|Overall Study||50
8119631|NCT02958956|20013650|P2|NOT COMPLETED|Overall Study||0
8119632|NCT02958956|20013651|P1|NOT COMPLETED|Overall Study||0
8119633|NCT02958956|20013650|P2|COMPLETED|Overall Study||198317
8119634|NCT02958956|20013651|P1|COMPLETED|Overall Study||38190
8119635|NCT02958956|20013650|P2|STARTED|Overall Study||198317
8119636|NCT02958956|20013651|P1|STARTED|Overall Study||38190
8119637|NCT02958826|20013666|P2|NOT COMPLETED|Overall Study||0
8119638|NCT02958826|20013667|P1|NOT COMPLETED|Overall Study||0
8119639|NCT02958826|20013666|P2|COMPLETED|Overall Study||80
8119640|NCT02958826|20013667|P1|COMPLETED|Overall Study||80
8119641|NCT02958826|20013666|P2|STARTED|Overall Study||80
8119642|NCT02958826|20013667|P1|STARTED|Overall Study||80
8119643|NCT02958787|20013677|P1|NOT COMPLETED|Overall Study||0
8119644|NCT02958787|20013677|P1|COMPLETED|Overall Study||135
8119645|NCT02958787|20013677|P1|STARTED|Overall Study||135
8119646|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
8119647|NCT02958553|20013681|P1|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
8119648|NCT02958553|20013681|P1|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
8119649|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
8119650|NCT02958553|20013681|P1|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
8119651|NCT02958553|20013681|P1|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
8119652|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
8119653|NCT02958553|20013681|P1|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
8119654|NCT02958553|20013681|P1|STARTED|Phase II, 5th Visit -Crossover Visit||4
8119655|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
8119656|NCT02958553|20013681|P1|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
8119657|NCT02958553|20013681|P1|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
8119658|NCT02958553|20013681|P1|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
8119659|NCT02958553|20013681|P1|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
8119660|NCT02958553|20013681|P1|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
8119661|NCT02958553|20013681|P1|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
8119662|NCT02958553|20013681|P1|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
8119663|NCT02958553|20013681|P1|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
8119664|NCT02958553|20013681|P1|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
8119665|NCT02958553|20013681|P1|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
8119666|NCT02958553|20013681|P1|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
8119667|NCT02958345|20013704|P2|NOT COMPLETED|Overall Study||1
8119668|NCT02958345|20013705|P1|NOT COMPLETED|Overall Study||1
8119669|NCT02958345|20013704|P2|COMPLETED|Overall Study||13
8119670|NCT02958345|20013705|P1|COMPLETED|Overall Study||13
8119671|NCT02958345|20013704|P2|STARTED|Overall Study||14
8119672|NCT02958345|20013705|P1|STARTED|Overall Study||14
8119673|NCT02958267|20013715|P2|NOT COMPLETED|Follow-up Visits||1
8119674|NCT02958267|20013716|P1|NOT COMPLETED|Follow-up Visits||2
8119675|NCT02958267|20013715|P2|COMPLETED|Follow-up Visits||14
8119676|NCT02958267|20013716|P1|COMPLETED|Follow-up Visits||13
8119677|NCT02958267|20013715|P2|12 Month Follow-up|Follow-up Visits||14
8119678|NCT02958267|20013716|P1|12 Month Follow-up|Follow-up Visits||13
8119679|NCT02958267|20013715|P2|6 Month Follow-up|Follow-up Visits||14
8119680|NCT02958267|20013716|P1|6 Month Follow-up|Follow-up Visits||14
8119681|NCT02958267|20013715|P2|3 Month Follow-up|Follow-up Visits||15
8119682|NCT02958267|20013716|P1|3 Month Follow-up|Follow-up Visits||15
8119683|NCT02958267|20013715|P2|STARTED|Follow-up Visits||15
8119684|NCT02958267|20013716|P1|STARTED|Follow-up Visits||15
8119685|NCT02958267|20013715|P2|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
8119686|NCT02958267|20013716|P1|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
8119687|NCT02958267|20013715|P2|COMPLETED|Enrollment to Actual Treatment Complete||15
8119688|NCT02958267|20013716|P1|COMPLETED|Enrollment to Actual Treatment Complete||15
8119689|NCT02958267|20013715|P2|STARTED|Enrollment to Actual Treatment Complete||15
8119690|NCT02958267|20013716|P1|STARTED|Enrollment to Actual Treatment Complete||17
8119691|NCT02958267|20013715|P2|NOT COMPLETED|Enrollment||0
8119692|NCT02958267|20013716|P1|NOT COMPLETED|Enrollment||0
8119693|NCT02958267|20013715|P2|COMPLETED|Enrollment||15
8119694|NCT02958267|20013716|P1|COMPLETED|Enrollment||17
8119695|NCT02958267|20013715|P2|STARTED|Enrollment||15
8119696|NCT02958267|20013716|P1|STARTED|Enrollment||17
8119697|NCT02957942|20013728|P2|NOT COMPLETED|Overall Study||7
8119698|NCT02957942|20013729|P1|NOT COMPLETED|Overall Study||0
8119699|NCT02957942|20013728|P2|COMPLETED|Overall Study||6
8119700|NCT02957942|20013729|P1|COMPLETED|Overall Study||7
8119701|NCT02957942|20013728|P2|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
8119702|NCT02957942|20013729|P1|STARTED|Overall Study||7
8119703|NCT02957747|20013745|P2|NOT COMPLETED|Overall Study||8
8119704|NCT02957747|20013746|P1|NOT COMPLETED|Overall Study||10
8119705|NCT02957747|20013745|P2|COMPLETED|Overall Study||69
8119706|NCT02957747|20013746|P1|COMPLETED|Overall Study||66
8119707|NCT02957747|20013745|P2|STARTED|Overall Study||77
8119708|NCT02957747|20013746|P1|STARTED|Overall Study||76
8119709|NCT02957331|20013782|P2|NOT COMPLETED|Overall Study||0
8119710|NCT02957331|20013783|P1|NOT COMPLETED|Overall Study||1
8119711|NCT02957331|20013782|P2|COMPLETED|Overall Study||12
8119712|NCT02957331|20013783|P1|COMPLETED|Overall Study||13
8119713|NCT02957331|20013782|P2|STARTED|Overall Study||12
8119714|NCT02957331|20013783|P1|STARTED|Overall Study||14
8119715|NCT02957305|20013793|P2|NOT COMPLETED|Overall Study||0
8119716|NCT02957305|20013794|P1|NOT COMPLETED|Overall Study||0
8119717|NCT02957305|20013793|P2|COMPLETED|Overall Study||105
8119718|NCT02957305|20013794|P1|COMPLETED|Overall Study||106
8119719|NCT02957305|20013793|P2|STARTED|Overall Study||105
8119720|NCT02957305|20013794|P1|STARTED|Overall Study||106
8119721|NCT02956967|20013802|P1|NOT COMPLETED|Overall Study||48
8119722|NCT02956967|20013802|P1|COMPLETED|Overall Study||123
8119723|NCT02956967|20013802|P1|STARTED|Overall Study||171
8119724|NCT02956837|20013829|P4|NOT COMPLETED|Overall Study||3
8119725|NCT02956837|20013830|P3|NOT COMPLETED|Overall Study||2
8119726|NCT02956837|20013831|P2|NOT COMPLETED|Overall Study||3
8119727|NCT02956837|20013832|P1|NOT COMPLETED|Overall Study||0
8119728|NCT02956837|20013829|P4|COMPLETED|Overall Study||99
8119729|NCT02956837|20013830|P3|COMPLETED|Overall Study||97
8119730|NCT02956837|20013831|P2|COMPLETED|Overall Study||96
8119731|NCT02956837|20013832|P1|COMPLETED|Overall Study||100
8119732|NCT02956837|20013829|P4|STARTED|Overall Study||102
8119733|NCT02956837|20013830|P3|STARTED|Overall Study||99
8119734|NCT02956837|20013831|P2|STARTED|Overall Study||99
8119735|NCT02956837|20013832|P1|STARTED|Overall Study||100
8119736|NCT02956746|20013926|P4|NOT COMPLETED|Overall Study||4
8119737|NCT02956746|20013927|P3|NOT COMPLETED|Overall Study||6
8119738|NCT02956746|20013928|P2|NOT COMPLETED|Overall Study||3
8119739|NCT02956746|20013929|P1|NOT COMPLETED|Overall Study||2
8119740|NCT02956746|20013926|P4|COMPLETED|Overall Study||38
8119741|NCT02956746|20013927|P3|COMPLETED|Overall Study||36
8119742|NCT02956746|20013928|P2|COMPLETED|Overall Study||37
8119743|NCT02956746|20013929|P1|COMPLETED|Overall Study||38
8119744|NCT02956746|20013926|P4|STARTED|Overall Study||42
8119745|NCT02956746|20013927|P3|STARTED|Overall Study||42
8119746|NCT02956746|20013928|P2|STARTED|Overall Study||40
8119747|NCT02956746|20013929|P1|STARTED|Overall Study||40
8119766|NCT02956616|20014036|P2|NOT COMPLETED|Overall Study||0
8119767|NCT02956616|20014037|P1|NOT COMPLETED|Overall Study||0
8119768|NCT02956616|20014036|P2|COMPLETED|Overall Study||60
8119769|NCT02956616|20014037|P1|COMPLETED|Overall Study||58
8119770|NCT02956616|20014036|P2|STARTED|Overall Study||60
8119771|NCT02956616|20014037|P1|STARTED|Overall Study||58
8119772|NCT02956460|20014051|P2|NOT COMPLETED|Lens 2||0
8119773|NCT02956460|20014052|P1|NOT COMPLETED|Lens 2||0
8119774|NCT02956460|20014051|P2|COMPLETED|Lens 2||34
8119775|NCT02956460|20014052|P1|COMPLETED|Lens 2||29
8119776|NCT02956460|20014051|P2|STARTED|Lens 2||34
8119777|NCT02956460|20014052|P1|STARTED|Lens 2||29
8119778|NCT02956460|20014051|P2|NOT COMPLETED|Lens 1||0
8119779|NCT02956460|20014052|P1|NOT COMPLETED|Lens 1||1
8119780|NCT02956460|20014051|P2|COMPLETED|Lens 1||34
8119781|NCT02956460|20014052|P1|COMPLETED|Lens 1||29
8119782|NCT02956460|20014051|P2|STARTED|Lens 1||34
8119783|NCT02956460|20014052|P1|STARTED|Lens 1||30
8119784|NCT02956278|20014081|P3|NOT COMPLETED|Overall Study||0
8119785|NCT02956278|20014082|P2|NOT COMPLETED|Overall Study||2
8119786|NCT02956278|20014083|P1|NOT COMPLETED|Overall Study||6
8119787|NCT02956278|20014081|P3|COMPLETED|Overall Study||3
8119788|NCT02956278|20014082|P2|COMPLETED|Overall Study||7
8119789|NCT02956278|20014083|P1|COMPLETED|Overall Study||9
8119790|NCT02956278|20014081|P3|STARTED|Overall Study||3
8119791|NCT02956278|20014082|P2|STARTED|Overall Study||9
8119792|NCT02956278|20014083|P1|STARTED|Overall Study||15
8119793|NCT02956122|20014097|P1|NOT COMPLETED|Overall Study||0
8119794|NCT02956122|20014097|P1|COMPLETED|Overall Study||1
8119795|NCT02956122|20014097|P1|STARTED|Overall Study||1
8119796|NCT02956070|20014150|P2|NOT COMPLETED|Overall Study||0
8119797|NCT02956070|20014151|P1|NOT COMPLETED|Overall Study||0
8119798|NCT02956070|20014150|P2|COMPLETED|Overall Study||35
8119799|NCT02956070|20014151|P1|COMPLETED|Overall Study||35
8119800|NCT02956070|20014150|P2|STARTED|Overall Study||35
8119801|NCT02956070|20014151|P1|STARTED|Overall Study||35
8119802|NCT02956057|20014167|P6|NOT COMPLETED|Overall Study||17
8119803|NCT02956057|20014168|P5|NOT COMPLETED|Overall Study||5
8119804|NCT02956057|20014169|P4|NOT COMPLETED|Overall Study||15
8119805|NCT02956057|20014170|P3|NOT COMPLETED|Overall Study||8
8119806|NCT02956057|20014171|P2|NOT COMPLETED|Overall Study||12
8119807|NCT02956057|20014172|P1|NOT COMPLETED|Overall Study||14
8119808|NCT02956057|20014167|P6|COMPLETED|Overall Study||157
8119809|NCT02956057|20014168|P5|COMPLETED|Overall Study||169
8119810|NCT02956057|20014169|P4|COMPLETED|Overall Study||159
8119811|NCT02956057|20014170|P3|COMPLETED|Overall Study||166
8119812|NCT02956057|20014171|P2|COMPLETED|Overall Study||162
8119813|NCT02956057|20014172|P1|COMPLETED|Overall Study||160
8119814|NCT02956057|20014167|P6|STARTED|Overall Study||174
8119815|NCT02956057|20014168|P5|STARTED|Overall Study||174
8119816|NCT02956057|20014169|P4|STARTED|Overall Study||174
8119817|NCT02956057|20014170|P3|STARTED|Overall Study||174
8119818|NCT02956057|20014171|P2|STARTED|Overall Study||174
8119819|NCT02956057|20014172|P1|STARTED|Overall Study||174
8119820|NCT02956005|20014192|P1|NOT COMPLETED|Overall Study||16
8119821|NCT02956005|20014192|P1|COMPLETED|Overall Study||2
8119822|NCT02956005|20014192|P1|STARTED|Overall Study||18
8119823|NCT02955797|20014201|P4|NOT COMPLETED|Overall Study||2
8119824|NCT02955797|20014202|P3|NOT COMPLETED|Overall Study||0
8119825|NCT02955797|20014203|P2|NOT COMPLETED|Overall Study||3
8119826|NCT02955797|20014204|P1|NOT COMPLETED|Overall Study||3
8119827|NCT02955797|20014201|P4|COMPLETED|Overall Study||101
8119828|NCT02955797|20014202|P3|COMPLETED|Overall Study||203
8119829|NCT02955797|20014203|P2|COMPLETED|Overall Study||303
8119830|NCT02955797|20014204|P1|COMPLETED|Overall Study||303
8119831|NCT02955797|20014201|P4|Per Protocol Analysis Set (PPAS)|Overall Study||99
8119832|NCT02955797|20014202|P3|Per Protocol Analysis Set (PPAS)|Overall Study||198
8119833|NCT02955797|20014203|P2|Per Protocol Analysis Set (PPAS)|Overall Study||296
8119834|NCT02955797|20014204|P1|Per Protocol Analysis Set (PPAS)|Overall Study||293
8119835|NCT02955797|20014201|P4|Safety Analysis Set (SafAS)|Overall Study||102
8119836|NCT02955797|20014202|P3|Safety Analysis Set (SafAS)|Overall Study||203
8119837|NCT02955797|20014203|P2|Safety Analysis Set (SafAS)|Overall Study||306
8119838|NCT02955797|20014204|P1|Safety Analysis Set (SafAS)|Overall Study||303
8119839|NCT02955797|20014201|P4|STARTED|Overall Study||103
8119840|NCT02955797|20014202|P3|STARTED|Overall Study||203
8119841|NCT02955797|20014203|P2|STARTED|Overall Study||306
8119842|NCT02955797|20014204|P1|STARTED|Overall Study||306
8119843|NCT02955212|20014222|P2|NOT COMPLETED|Overall Study||12
8119844|NCT02955212|20014223|P1|NOT COMPLETED|Overall Study||16
8119845|NCT02955212|20014222|P2|COMPLETED|Overall Study||157
8119846|NCT02955212|20014223|P1|COMPLETED|Overall Study||153
8119847|NCT02955212|20014222|P2|STARTED|Overall Study||169
8119848|NCT02955212|20014223|P1|STARTED|Overall Study||169
8119849|NCT02955186|20014249|P2|NOT COMPLETED|Overall Study||2
8119850|NCT02955186|20014250|P1|NOT COMPLETED|Overall Study||7
8119851|NCT02955186|20014249|P2|COMPLETED|Overall Study||15
8119852|NCT02955186|20014250|P1|COMPLETED|Overall Study||26
8119853|NCT02955186|20014249|P2|STARTED|Overall Study||17
8119854|NCT02955186|20014250|P1|STARTED|Overall Study||33
8119855|NCT02955147|20014262|P1|NOT COMPLETED|Overall Study||0
8119856|NCT02955147|20014262|P1|COMPLETED|Overall Study||13
8119857|NCT02955147|20014262|P1|STARTED|Overall Study||13
8119858|NCT02954952|20014272|P3|NOT COMPLETED|Overall Study||0
8119859|NCT02954952|20014273|P2|NOT COMPLETED|Overall Study||1
8119860|NCT02954952|20014274|P1|NOT COMPLETED|Overall Study||1
8119861|NCT02954952|20014272|P3|COMPLETED|Overall Study||3
8119862|NCT02954952|20014273|P2|COMPLETED|Overall Study||4
8119863|NCT02954952|20014274|P1|COMPLETED|Overall Study||35
8119864|NCT02954952|20014272|P3|STARTED|Overall Study||3
8119865|NCT02954952|20014273|P2|STARTED|Overall Study||5
8119866|NCT02954952|20014274|P1|STARTED|Overall Study||36
8119867|NCT02954887|20014282|P1|NOT COMPLETED|Overall Study||7
8119868|NCT02954887|20014282|P1|COMPLETED|Overall Study||2
8119869|NCT02954887|20014282|P1|STARTED|Overall Study||9
8119870|NCT02954848|20014311|P2|NOT COMPLETED|Overall Study||5
8119871|NCT02954848|20014312|P1|NOT COMPLETED|Overall Study||2
8119872|NCT02954848|20014311|P2|COMPLETED|Overall Study||234
8119873|NCT02954848|20014312|P1|COMPLETED|Overall Study||243
8119874|NCT02954848|20014311|P2|Treated|Overall Study||238
8119875|NCT02954848|20014312|P1|Treated|Overall Study||245
8119876|NCT02954848|20014311|P2|STARTED|Overall Study||239
8119877|NCT02954848|20014312|P1|STARTED|Overall Study||245
8119878|NCT02954653|20014372|P9|NOT COMPLETED|Overall Study||0
8119879|NCT02954653|20014373|P8|NOT COMPLETED|Overall Study||0
8119880|NCT02954653|20014374|P7|NOT COMPLETED|Overall Study||0
8119881|NCT02954653|20014375|P6|NOT COMPLETED|Overall Study||0
8119882|NCT02954653|20014376|P5|NOT COMPLETED|Overall Study||0
8119883|NCT02954653|20014377|P4|NOT COMPLETED|Overall Study||0
8119884|NCT02954653|20014378|P3|NOT COMPLETED|Overall Study||0
8119885|NCT02954653|20014379|P2|NOT COMPLETED|Overall Study||3
8119886|NCT02954653|20014380|P1|NOT COMPLETED|Overall Study||4
8119887|NCT02954653|20014372|P9|COMPLETED|Overall Study||0
8119888|NCT02954653|20014373|P8|COMPLETED|Overall Study||0
8119889|NCT02954653|20014374|P7|COMPLETED|Overall Study||0
8119890|NCT02954653|20014375|P6|COMPLETED|Overall Study||0
8119891|NCT02954653|20014376|P5|COMPLETED|Overall Study||0
8119892|NCT02954653|20014377|P4|COMPLETED|Overall Study||0
8119893|NCT02954653|20014378|P3|COMPLETED|Overall Study||0
8119894|NCT02954653|20014379|P2|COMPLETED|Overall Study||1
8119895|NCT02954653|20014380|P1|COMPLETED|Overall Study||0
8119896|NCT02954653|20014372|P9|Received Treatment|Overall Study||0
8119897|NCT02954653|20014373|P8|Received Treatment|Overall Study||0
8119898|NCT02954653|20014374|P7|Received Treatment|Overall Study||0
8119899|NCT02954653|20014375|P6|Received Treatment|Overall Study||0
8119900|NCT02954653|20014376|P5|Received Treatment|Overall Study||0
8119901|NCT02954653|20014377|P4|Received Treatment|Overall Study||0
8119902|NCT02954653|20014378|P3|Received Treatment|Overall Study||0
8119903|NCT02954653|20014379|P2|Received Treatment|Overall Study||4
8119904|NCT02954653|20014380|P1|Received Treatment|Overall Study||3
8119905|NCT02954653|20014372|P9|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119906|NCT02954653|20014373|P8|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119907|NCT02954653|20014374|P7|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119908|NCT02954653|20014375|P6|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119909|NCT02954653|20014376|P5|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119910|NCT02954653|20014377|P4|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119911|NCT02954653|20014378|P3|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119912|NCT02954653|20014379|P2|STARTED|Overall Study||4
8119913|NCT02954653|20014380|P1|STARTED|Overall Study||4
8119914|NCT02954601|20014499|P4|NOT COMPLETED|Third Intervention (Five Days)||0
8119915|NCT02954601|20014500|P3|NOT COMPLETED|Third Intervention (Five Days)||0
8119916|NCT02954601|20014501|P2|NOT COMPLETED|Third Intervention (Five Days)||0
8119917|NCT02954601|20014502|P1|NOT COMPLETED|Third Intervention (Five Days)||0
8119918|NCT02954601|20014499|P4|COMPLETED|Third Intervention (Five Days)||8
8119919|NCT02954601|20014500|P3|COMPLETED|Third Intervention (Five Days)||6
8119920|NCT02954601|20014501|P2|COMPLETED|Third Intervention (Five Days)||8
8119921|NCT02954601|20014502|P1|COMPLETED|Third Intervention (Five Days)||9
8119922|NCT02954601|20014499|P4|STARTED|Third Intervention (Five Days)||8
8119923|NCT02954601|20014500|P3|STARTED|Third Intervention (Five Days)||6
8119924|NCT02954601|20014501|P2|STARTED|Third Intervention (Five Days)||8
8119925|NCT02954601|20014502|P1|STARTED|Third Intervention (Five Days)||9
8119926|NCT02954601|20014499|P4|NOT COMPLETED|Second Intervention (Five Days)||0
8119927|NCT02954601|20014500|P3|NOT COMPLETED|Second Intervention (Five Days)||0
8119928|NCT02954601|20014501|P2|NOT COMPLETED|Second Intervention (Five Days)||0
8119929|NCT02954601|20014502|P1|NOT COMPLETED|Second Intervention (Five Days)||0
8119930|NCT02954601|20014499|P4|COMPLETED|Second Intervention (Five Days)||6
8119931|NCT02954601|20014500|P3|COMPLETED|Second Intervention (Five Days)||8
8119932|NCT02954601|20014501|P2|COMPLETED|Second Intervention (Five Days)||6
8119933|NCT02954601|20014502|P1|COMPLETED|Second Intervention (Five Days)||11
8119934|NCT02954601|20014499|P4|STARTED|Second Intervention (Five Days)||6
8119935|NCT02954601|20014500|P3|STARTED|Second Intervention (Five Days)||8
8119936|NCT02954601|20014501|P2|STARTED|Second Intervention (Five Days)||6
8119937|NCT02954601|20014502|P1|STARTED|Second Intervention (Five Days)||11
8119938|NCT02954601|20014499|P4|NOT COMPLETED|First Intervention (Five Days)||0
8119939|NCT02954601|20014500|P3|NOT COMPLETED|First Intervention (Five Days)||1
8119940|NCT02954601|20014501|P2|NOT COMPLETED|First Intervention (Five Days)||0
8119941|NCT02954601|20014502|P1|NOT COMPLETED|First Intervention (Five Days)||0
8119942|NCT02954601|20014499|P4|COMPLETED|First Intervention (Five Days)||7
8119943|NCT02954601|20014500|P3|COMPLETED|First Intervention (Five Days)||7
8119944|NCT02954601|20014501|P2|COMPLETED|First Intervention (Five Days)||6
8119945|NCT02954601|20014502|P1|COMPLETED|First Intervention (Five Days)||11
8119946|NCT02954601|20014499|P4|STARTED|First Intervention (Five Days)||7
8119947|NCT02954601|20014500|P3|STARTED|First Intervention (Five Days)||8
8119948|NCT02954601|20014501|P2|STARTED|First Intervention (Five Days)||6
8119949|NCT02954601|20014502|P1|STARTED|First Intervention (Five Days)||11
8119950|NCT02954575|20014524|P1|NOT COMPLETED|Overall Study||3
8119951|NCT02954575|20014524|P1|COMPLETED|Overall Study||54
8119952|NCT02954575|20014524|P1|SURG Population|Overall Study||1
8119953|NCT02954575|20014524|P1|PK Population|Overall Study||21
8119954|NCT02954575|20014524|P1|PP Population|Overall Study||52
8119955|NCT02954575|20014524|P1|FAS Population|Overall Study||55
8119956|NCT02954575|20014524|P1|SAF Population|Overall Study||55
8119957|NCT02954575|20014524|P1|Received Treatment|Overall Study||55
8119958|NCT02954575|20014524|P1|STARTED|Overall Study||57
8119959|NCT02954354|20014544|P3|NOT COMPLETED|Overall Study||16
8119960|NCT02954354|20014545|P2|NOT COMPLETED|Overall Study||20
8119961|NCT02954354|20014546|P1|NOT COMPLETED|Overall Study||34
8119962|NCT02954354|20014544|P3|COMPLETED|Overall Study||498
8119963|NCT02954354|20014545|P2|COMPLETED|Overall Study||290
8119964|NCT02954354|20014546|P1|COMPLETED|Overall Study||578
8119965|NCT02954354|20014544|P3|Intention to Treat Infected Population|Overall Study||377
8119966|NCT02954354|20014545|P2|Intention to Treat Infected Population|Overall Study||231
8119967|NCT02954354|20014546|P1|Intention to Treat Infected Population|Overall Study||456
8119968|NCT02954354|20014544|P3|Received Study Drug|Overall Study||513
8119969|NCT02954354|20014545|P2|Received Study Drug|Overall Study||309
8119970|NCT02954354|20014546|P1|Received Study Drug|Overall Study||610
8119971|NCT02954354|20014544|P3|STARTED|Overall Study||514
8119972|NCT02954354|20014545|P2|STARTED|Overall Study||310
8119973|NCT02954354|20014546|P1|STARTED|Overall Study||612
8119974|NCT02954198|20014632|P2|NOT COMPLETED|Overall Study||0
8119975|NCT02954198|20014633|P1|NOT COMPLETED|Overall Study||0
8119976|NCT02954198|20014632|P2|COMPLETED|Overall Study||20
8119977|NCT02954198|20014633|P1|COMPLETED|Overall Study||20
8119978|NCT02954198|20014632|P2|STARTED|Overall Study||20
8119979|NCT02954198|20014633|P1|STARTED|Overall Study||20
8119980|NCT02954172|20014647|P2|NOT COMPLETED|Overall Study||3
8119981|NCT02954172|20014648|P1|NOT COMPLETED|Overall Study||6
8119982|NCT02954172|20014647|P2|COMPLETED|Overall Study||221
8119983|NCT02954172|20014648|P1|COMPLETED|Overall Study||220
8119984|NCT02954172|20014647|P2|STARTED|Overall Study||224
8119985|NCT02954172|20014648|P1|STARTED|Overall Study||226
8119986|NCT02954159|20014660|P2|NOT COMPLETED|Overall Study||1
8119987|NCT02954159|20014661|P1|NOT COMPLETED|Overall Study||1
8119988|NCT02954159|20014660|P2|COMPLETED|Overall Study||1
8119989|NCT02954159|20014661|P1|COMPLETED|Overall Study||1
8119990|NCT02954159|20014660|P2|STARTED|Overall Study||2
8119991|NCT02954159|20014661|P1|STARTED|Overall Study||2
8119992|NCT02953938|20014675|P2|NOT COMPLETED|Overall Study||2
8119993|NCT02953938|20014676|P1|NOT COMPLETED|Overall Study||1
8119994|NCT02953938|20014675|P2|COMPLETED|Overall Study||28
8119995|NCT02953938|20014676|P1|COMPLETED|Overall Study||28
8119996|NCT02953938|20014675|P2|STARTED|Overall Study||30
8119997|NCT02953938|20014676|P1|STARTED|Overall Study||29
8119998|NCT02953886|20014691|P1|NOT COMPLETED|Overall Study||0
8119999|NCT02953886|20014691|P1|COMPLETED|Overall Study||20
8120000|NCT02953886|20014691|P1|STARTED|Overall Study||20
8120001|NCT02953873|20014697|P1|NOT COMPLETED|Overall Study||0
8120002|NCT02953873|20014697|P1|COMPLETED|Overall Study||25
8120003|NCT02953873|20014697|P1|STARTED|Overall Study||25
8120004|NCT02953821|20014707|P2|NOT COMPLETED|Overall Study||13
8120005|NCT02953821|20014708|P1|NOT COMPLETED|Overall Study||15
8120006|NCT02953821|20014707|P2|COMPLETED|Overall Study||73
8120007|NCT02953821|20014708|P1|COMPLETED|Overall Study||71
8120008|NCT02953821|20014707|P2|Completed Study Treatment (Week 24)|Overall Study||76
8120009|NCT02953821|20014708|P1|Completed Study Treatment (Week 24)|Overall Study||73
8120010|NCT02953821|20014707|P2|Completed Week 16 Visit|Overall Study||77
8120011|NCT02953821|20014708|P1|Completed Week 16 Visit|Overall Study||76
8120012|NCT02953821|20014707|P2|Per Protocol (PP) Population|Overall Study||75
8120013|NCT02953821|20014708|P1|Per Protocol (PP) Population|Overall Study||72
8120014|NCT02953821|20014707|P2|Modified Intent to Treat (mITT) Populati|Overall Study||84
8120015|NCT02953821|20014708|P1|Modified Intent to Treat (mITT) Populati|Overall Study||85
8120016|NCT02953821|20014707|P2|Safety Population|Overall Study||86
8120017|NCT02953821|20014708|P1|Safety Population|Overall Study||86
8120018|NCT02953821|20014707|P2|STARTED|Overall Study||86
8120019|NCT02953821|20014708|P1|STARTED|Overall Study||86
8120020|NCT02953678|20014726|P1|NOT COMPLETED|Overall Study||60
8120021|NCT02953678|20014726|P1|COMPLETED|Overall Study||11
8120022|NCT02953678|20014726|P1|Participants Continuing in Study|Overall Study||19
8120023|NCT02953678|20014726|P1|Participants Discontinued From Study|Overall Study||41
8120024|NCT02953678|20014726|P1|STARTED|Overall Study||71
8120025|NCT02953561|20014735|P1|NOT COMPLETED|Overall Study||0
8120026|NCT02953561|20014735|P1|COMPLETED|Overall Study||19
8120027|NCT02953561|20014735|P1|STARTED|Overall Study||19
8120028|NCT02953548|20014742|P2|NOT COMPLETED|Overall Study||0
8120029|NCT02953548|20014743|P1|NOT COMPLETED|Overall Study||0
8120030|NCT02953548|20014742|P2|COMPLETED|Overall Study||4
8120031|NCT02953548|20014743|P1|COMPLETED|Overall Study||5
8120032|NCT02953548|20014742|P2|STARTED|Overall Study||4
8120033|NCT02953548|20014743|P1|STARTED|Overall Study||5
8120034|NCT02953418|20014765|P1|NOT COMPLETED|Overall Study||0
8120035|NCT02953418|20014765|P1|COMPLETED|Overall Study||34
8120036|NCT02953418|20014765|P1|STARTED|Overall Study||34
8120037|NCT02953314|20014774|P2|NOT COMPLETED|Overall Study||3
8120038|NCT02953314|20014775|P1|NOT COMPLETED|Overall Study||0
8120039|NCT02953314|20014774|P2|COMPLETED|Overall Study||67
8120040|NCT02953314|20014775|P1|COMPLETED|Overall Study||13
8120041|NCT02953314|20014774|P2|STARTED|Overall Study||70
8120042|NCT02953314|20014775|P1|STARTED|Overall Study||13
8120043|NCT02952898|20014801|P3|NOT COMPLETED|Overall Study||15
8120044|NCT02952898|20014802|P2|NOT COMPLETED|Overall Study||19
8120045|NCT02952898|20014803|P1|NOT COMPLETED|Overall Study||22
8120046|NCT02952898|20014801|P3|COMPLETED|Overall Study||209
8120047|NCT02952898|20014802|P2|COMPLETED|Overall Study||202
8120048|NCT02952898|20014803|P1|COMPLETED|Overall Study||198
8120049|NCT02952898|20014801|P3|STARTED|Overall Study||224
8120050|NCT02952898|20014802|P2|STARTED|Overall Study||221
8120051|NCT02952898|20014803|P1|STARTED|Overall Study||220
8120052|NCT02952872|20014827|P16|NOT COMPLETED|Overall Study||0
8120053|NCT02952872|20014828|P15|NOT COMPLETED|Overall Study||0
8120054|NCT02952872|20014829|P14|NOT COMPLETED|Overall Study||0
8120055|NCT02952872|20014830|P13|NOT COMPLETED|Overall Study||0
8120056|NCT02952872|20014831|P12|NOT COMPLETED|Overall Study||0
8120057|NCT02952872|20014832|P11|NOT COMPLETED|Overall Study||0
8120058|NCT02952872|20014833|P10|NOT COMPLETED|Overall Study||0
8120059|NCT02952872|20014834|P9|NOT COMPLETED|Overall Study||0
8120060|NCT02952872|20014835|P8|NOT COMPLETED|Overall Study||0
8120061|NCT02952872|20014836|P7|NOT COMPLETED|Overall Study||0
8120062|NCT02952872|20014837|P6|NOT COMPLETED|Overall Study||0
8120063|NCT02952872|20014838|P5|NOT COMPLETED|Overall Study||0
8120064|NCT02952872|20014839|P4|NOT COMPLETED|Overall Study||0
8120065|NCT02952872|20014840|P3|NOT COMPLETED|Overall Study||0
8120066|NCT02952872|20014841|P2|NOT COMPLETED|Overall Study||0
8120067|NCT02952872|20014842|P1|NOT COMPLETED|Overall Study||0
8120068|NCT02952872|20014827|P16|COMPLETED|Overall Study||23
8120069|NCT02952872|20014828|P15|COMPLETED|Overall Study||22
8120070|NCT02952872|20014829|P14|COMPLETED|Overall Study||22
8120071|NCT02952872|20014830|P13|COMPLETED|Overall Study||22
8120072|NCT02952872|20014831|P12|COMPLETED|Overall Study||22
8120073|NCT02952872|20014832|P11|COMPLETED|Overall Study||23
8120074|NCT02952872|20014833|P10|COMPLETED|Overall Study||22
8120075|NCT02952872|20014834|P9|COMPLETED|Overall Study||22
8120076|NCT02952872|20014835|P8|COMPLETED|Overall Study||21
8120077|NCT02952872|20014836|P7|COMPLETED|Overall Study||22
8120078|NCT02952872|20014837|P6|COMPLETED|Overall Study||21
8120079|NCT02952872|20014838|P5|COMPLETED|Overall Study||22
8120080|NCT02952872|20014839|P4|COMPLETED|Overall Study||22
8120081|NCT02952872|20014840|P3|COMPLETED|Overall Study||22
8120082|NCT02952872|20014841|P2|COMPLETED|Overall Study||22
8120083|NCT02952872|20014842|P1|COMPLETED|Overall Study||22
8120084|NCT02952872|20014827|P16|STARTED|Overall Study||23
8120085|NCT02952872|20014828|P15|STARTED|Overall Study||22
8120086|NCT02952872|20014829|P14|STARTED|Overall Study||22
8120087|NCT02952872|20014830|P13|STARTED|Overall Study||22
8120088|NCT02952872|20014831|P12|STARTED|Overall Study||22
8120089|NCT02952872|20014832|P11|STARTED|Overall Study||23
8120090|NCT02952872|20014833|P10|STARTED|Overall Study||22
8120091|NCT02952872|20014834|P9|STARTED|Overall Study||22
8120092|NCT02952872|20014835|P8|STARTED|Overall Study||21
8120093|NCT02952872|20014836|P7|STARTED|Overall Study||22
8120094|NCT02952872|20014837|P6|STARTED|Overall Study||21
8120095|NCT02952872|20014838|P5|STARTED|Overall Study||22
8120096|NCT02952872|20014839|P4|STARTED|Overall Study||22
8120097|NCT02952872|20014840|P3|STARTED|Overall Study||22
8120098|NCT02952872|20014841|P2|STARTED|Overall Study||22
8120099|NCT02952872|20014842|P1|STARTED|Overall Study||22
8120100|NCT02952820|20014927|P3|NOT COMPLETED|Active Treatment Period (6 Months)||31
8120101|NCT02952820|20014928|P2|NOT COMPLETED|Active Treatment Period (6 Months)||38
8120102|NCT02952820|20014929|P1|NOT COMPLETED|Active Treatment Period (6 Months)||0
8120103|NCT02952820|20014927|P3|COMPLETED|Active Treatment Period (6 Months)||321
8120104|NCT02952820|20014928|P2|COMPLETED|Active Treatment Period (6 Months)||346
8120105|NCT02952820|20014929|P1|COMPLETED|Active Treatment Period (6 Months)||0
8120106|NCT02952820|20014927|P3|STARTED|Active Treatment Period (6 Months)||352
8120107|NCT02952820|20014928|P2|STARTED|Active Treatment Period (6 Months)||384
8120108|NCT02952820|20014929|P1|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
8120109|NCT02952820|20014927|P3|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
8120110|NCT02952820|20014928|P2|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
8120111|NCT02952820|20014929|P1|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
8120112|NCT02952820|20014927|P3|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
8120113|NCT02952820|20014928|P2|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
8120114|NCT02952820|20014929|P1|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
8120115|NCT02952820|20014927|P3|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
8120116|NCT02952820|20014928|P2|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
8120117|NCT02952820|20014929|P1|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
8120118|NCT02952820|20014927|P3|Treated|Placebo-Controlled Treatment (6 Months)||319
8120119|NCT02952820|20014928|P2|Treated|Placebo-Controlled Treatment (6 Months)||319
8120120|NCT02952820|20014929|P1|Treated|Placebo-Controlled Treatment (6 Months)||321
8120121|NCT02952820|20014927|P3|STARTED|Placebo-Controlled Treatment (6 Months)||323
8120122|NCT02952820|20014928|P2|STARTED|Placebo-Controlled Treatment (6 Months)||323
8120123|NCT02952820|20014929|P1|STARTED|Placebo-Controlled Treatment (6 Months)||325
8120124|NCT02952313|20014989|P1|NOT COMPLETED|Long-term Follow-up||32
8120125|NCT02952313|20014989|P1|COMPLETED|Long-term Follow-up||75
8120126|NCT02952313|20014989|P1|18-Month|Long-term Follow-up||79
8120127|NCT02952313|20014989|P1|12-Month|Long-term Follow-up||93
8120128|NCT02952313|20014989|P1|STARTED|Long-term Follow-up||107
8120129|NCT02952313|20014989|P1|NOT COMPLETED|Primary Endpoint||7
8120130|NCT02952313|20014989|P1|COMPLETED|Primary Endpoint||106
8120131|NCT02952313|20014989|P1|6 Months|Primary Endpoint||106
8120132|NCT02952313|20014989|P1|STARTED|Primary Endpoint||113
8120133|NCT02952261|20015000|P2|NOT COMPLETED|Overall Study||5
8120134|NCT02952261|20015001|P1|NOT COMPLETED|Overall Study||5
8120135|NCT02952261|20015000|P2|COMPLETED|Overall Study||95
8120136|NCT02952261|20015001|P1|COMPLETED|Overall Study||95
8120137|NCT02952261|20015000|P2|STARTED|Overall Study||100
8120138|NCT02952261|20015001|P1|STARTED|Overall Study||100
8120139|NCT02951988|20015016|P4|NOT COMPLETED|Double-Blind Treatment Period||115
8120140|NCT02951988|20015017|P3|NOT COMPLETED|Double-Blind Treatment Period||101
8120141|NCT02951988|20015018|P2|NOT COMPLETED|Double-Blind Treatment Period||101
8120142|NCT02951988|20015019|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8120143|NCT02951988|20015016|P4|COMPLETED|Double-Blind Treatment Period||85
8120144|NCT02951988|20015017|P3|COMPLETED|Double-Blind Treatment Period||101
8120145|NCT02951988|20015018|P2|COMPLETED|Double-Blind Treatment Period||101
8120146|NCT02951988|20015019|P1|COMPLETED|Double-Blind Treatment Period||0
8120147|NCT02951988|20015016|P4|STARTED|Double-Blind Treatment Period||200
8120148|NCT02951988|20015017|P3|STARTED|Double-Blind Treatment Period||202
8120149|NCT02951988|20015018|P2|STARTED|Double-Blind Treatment Period||202
8120150|NCT02951988|20015019|P1|STARTED|Double-Blind Treatment Period||0
8120151|NCT02951988|20015016|P4|NOT COMPLETED|Open-Label Treatment Period||0
8120152|NCT02951988|20015017|P3|NOT COMPLETED|Open-Label Treatment Period||0
8120153|NCT02951988|20015018|P2|NOT COMPLETED|Open-Label Treatment Period||0
8120154|NCT02951988|20015019|P1|NOT COMPLETED|Open-Label Treatment Period||248
8120155|NCT02951988|20015016|P4|COMPLETED|Open-Label Treatment Period||0
8120156|NCT02951988|20015017|P3|COMPLETED|Open-Label Treatment Period||0
8120157|NCT02951988|20015018|P2|COMPLETED|Open-Label Treatment Period||0
8120158|NCT02951988|20015019|P1|COMPLETED|Open-Label Treatment Period||1056
8120159|NCT02951988|20015016|P4|STARTED|Open-Label Treatment Period||0
8120160|NCT02951988|20015017|P3|STARTED|Open-Label Treatment Period||0
8120161|NCT02951988|20015018|P2|STARTED|Open-Label Treatment Period||0
8120162|NCT02951988|20015019|P1|STARTED|Open-Label Treatment Period||1304
8120163|NCT02951884|20015037|P3|NOT COMPLETED|Overall Study||0
8120164|NCT02951884|20015038|P2|NOT COMPLETED|Overall Study||0
8120165|NCT02951884|20015039|P1|NOT COMPLETED|Overall Study||0
8120166|NCT02951884|20015037|P3|COMPLETED|Overall Study||1
8120167|NCT02951884|20015038|P2|COMPLETED|Overall Study||1
8120168|NCT02951884|20015039|P1|COMPLETED|Overall Study||0
8120169|NCT02951884|20015037|P3|STARTED|Overall Study||1
8120170|NCT02951884|20015038|P2|STARTED|Overall Study||1
8120171|NCT02951884|20015039|P1|STARTED|Overall Study||0
8120172|NCT02951819|20015052|P2|NOT COMPLETED|Overall Study||14
8120173|NCT02951819|20015053|P1|NOT COMPLETED|Overall Study||87
8120174|NCT02951819|20015052|P2|COMPLETED|Overall Study||0
8120175|NCT02951819|20015053|P1|COMPLETED|Overall Study||0
8120176|NCT02951819|20015052|P2|Treated|Overall Study||14
8120177|NCT02951819|20015053|P1|Treated|Overall Study||86
8120178|NCT02951819|20015052|P2|STARTED|Overall Study||14
8120179|NCT02951819|20015053|P1|STARTED|Overall Study||87
8120180|NCT02951780|20015084|P9|NOT COMPLETED|Period 3||0
8120181|NCT02951780|20015085|P8|NOT COMPLETED|Period 3||0
8120182|NCT02951780|20015086|P7|NOT COMPLETED|Period 3||0
8120183|NCT02951780|20015087|P6|NOT COMPLETED|Period 3||0
8120184|NCT02951780|20015088|P5|NOT COMPLETED|Period 3||0
8120185|NCT02951780|20015089|P4|NOT COMPLETED|Period 3||0
8120186|NCT02951780|20015090|P3|NOT COMPLETED|Period 3||0
8120187|NCT02951780|20015091|P2|NOT COMPLETED|Period 3||0
8120188|NCT02951780|20015092|P1|NOT COMPLETED|Period 3||0
8120189|NCT02951780|20015084|P9|COMPLETED|Period 3||2
8120190|NCT02951780|20015085|P8|COMPLETED|Period 3||1
8120191|NCT02951780|20015086|P7|COMPLETED|Period 3||2
8120192|NCT02951780|20015087|P6|COMPLETED|Period 3||3
8120193|NCT02951780|20015088|P5|COMPLETED|Period 3||2
8120194|NCT02951780|20015089|P4|COMPLETED|Period 3||2
8120195|NCT02951780|20015090|P3|COMPLETED|Period 3||3
8120196|NCT02951780|20015091|P2|COMPLETED|Period 3||2
8120197|NCT02951780|20015092|P1|COMPLETED|Period 3||3
8120198|NCT02951780|20015084|P9|STARTED|Period 3||2
8120199|NCT02951780|20015085|P8|STARTED|Period 3||1
8120200|NCT02951780|20015086|P7|STARTED|Period 3||2
8120201|NCT02951780|20015087|P6|STARTED|Period 3||3
8120202|NCT02951780|20015088|P5|STARTED|Period 3||2
8120203|NCT02951780|20015089|P4|STARTED|Period 3||2
8120204|NCT02951780|20015090|P3|STARTED|Period 3||3
8120205|NCT02951780|20015091|P2|STARTED|Period 3||2
8120206|NCT02951780|20015092|P1|STARTED|Period 3||3
8120207|NCT02951780|20015084|P9|NOT COMPLETED|Period 2||0
8120208|NCT02951780|20015085|P8|NOT COMPLETED|Period 2||1
8120209|NCT02951780|20015086|P7|NOT COMPLETED|Period 2||0
8120210|NCT02951780|20015087|P6|NOT COMPLETED|Period 2||0
8120211|NCT02951780|20015088|P5|NOT COMPLETED|Period 2||0
8120212|NCT02951780|20015089|P4|NOT COMPLETED|Period 2||0
8120213|NCT02951780|20015090|P3|NOT COMPLETED|Period 2||0
8120214|NCT02951780|20015091|P2|NOT COMPLETED|Period 2||0
8120215|NCT02951780|20015092|P1|NOT COMPLETED|Period 2||0
8120216|NCT02951780|20015084|P9|COMPLETED|Period 2||2
8120217|NCT02951780|20015085|P8|COMPLETED|Period 2||1
8120218|NCT02951780|20015086|P7|COMPLETED|Period 2||2
8120219|NCT02951780|20015087|P6|COMPLETED|Period 2||3
8120220|NCT02951780|20015088|P5|COMPLETED|Period 2||2
8120221|NCT02951780|20015089|P4|COMPLETED|Period 2||2
8120222|NCT02951780|20015090|P3|COMPLETED|Period 2||3
8120223|NCT02951780|20015091|P2|COMPLETED|Period 2||2
8120224|NCT02951780|20015092|P1|COMPLETED|Period 2||3
8120225|NCT02951780|20015084|P9|STARTED|Period 2||2
8120226|NCT02951780|20015085|P8|STARTED|Period 2||2
8120227|NCT02951780|20015086|P7|STARTED|Period 2||2
8120228|NCT02951780|20015087|P6|STARTED|Period 2||3
8120229|NCT02951780|20015088|P5|STARTED|Period 2||2
8120230|NCT02951780|20015089|P4|STARTED|Period 2||2
8120231|NCT02951780|20015090|P3|STARTED|Period 2||3
8120232|NCT02951780|20015091|P2|STARTED|Period 2||2
8120233|NCT02951780|20015092|P1|STARTED|Period 2||3
8120234|NCT02951780|20015084|P9|NOT COMPLETED|Period 1||0
8120235|NCT02951780|20015085|P8|NOT COMPLETED|Period 1||1
8120236|NCT02951780|20015086|P7|NOT COMPLETED|Period 1||0
8120237|NCT02951780|20015087|P6|NOT COMPLETED|Period 1||0
8120238|NCT02951780|20015088|P5|NOT COMPLETED|Period 1||0
8120239|NCT02951780|20015089|P4|NOT COMPLETED|Period 1||1
8120240|NCT02951780|20015090|P3|NOT COMPLETED|Period 1||0
8120241|NCT02951780|20015091|P2|NOT COMPLETED|Period 1||0
8120242|NCT02951780|20015092|P1|NOT COMPLETED|Period 1||0
8120243|NCT02951780|20015084|P9|COMPLETED|Period 1||2
8120244|NCT02951780|20015085|P8|COMPLETED|Period 1||2
8120245|NCT02951780|20015086|P7|COMPLETED|Period 1||2
8120246|NCT02951780|20015087|P6|COMPLETED|Period 1||3
8120247|NCT02951780|20015088|P5|COMPLETED|Period 1||2
8120248|NCT02951780|20015089|P4|COMPLETED|Period 1||2
8120249|NCT02951780|20015090|P3|COMPLETED|Period 1||3
8120250|NCT02951780|20015091|P2|COMPLETED|Period 1||2
8120251|NCT02951780|20015092|P1|COMPLETED|Period 1||3
8120252|NCT02951780|20015084|P9|STARTED|Period 1||2
8120253|NCT02951780|20015085|P8|STARTED|Period 1||3
8120254|NCT02951780|20015086|P7|STARTED|Period 1||2
8120255|NCT02951780|20015087|P6|STARTED|Period 1||3
8120256|NCT02951780|20015088|P5|STARTED|Period 1||2
8120257|NCT02951780|20015089|P4|STARTED|Period 1||3
8120258|NCT02951780|20015090|P3|STARTED|Period 1||3
8120259|NCT02951780|20015091|P2|STARTED|Period 1||2
8120260|NCT02951780|20015092|P1|STARTED|Period 1||3
8120261|NCT02951767|20015157|P1|NOT COMPLETED|Overall Study||119
8120262|NCT02951767|20015157|P1|COMPLETED|Overall Study||0
8120263|NCT02951767|20015157|P1|STARTED|Overall Study||119
8120264|NCT02951702|20015176|P2|NOT COMPLETED|Overall Study||0
8120265|NCT02951702|20015177|P1|NOT COMPLETED|Overall Study||0
8120266|NCT02951702|20015176|P2|COMPLETED|Overall Study||17
8120267|NCT02951702|20015177|P1|COMPLETED|Overall Study||34
8120268|NCT02951702|20015176|P2|STARTED|Overall Study||17
8120269|NCT02951702|20015177|P1|STARTED|Overall Study||34
8120270|NCT02951533|20015189|P3|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
8120271|NCT02951533|20015190|P2|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
8120272|NCT02951533|20015191|P1|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
8120273|NCT02951533|20015189|P3|COMPLETED|Part III (Week 64 Through Week 100)||10
8120274|NCT02951533|20015190|P2|COMPLETED|Part III (Week 64 Through Week 100)||0
8120275|NCT02951533|20015191|P1|COMPLETED|Part III (Week 64 Through Week 100)||32
8120276|NCT02951533|20015189|P3|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
8120277|NCT02951533|20015190|P2|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
8120278|NCT02951533|20015191|P1|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
8120279|NCT02951533|20015189|P3|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
8120280|NCT02951533|20015190|P2|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
8120281|NCT02951533|20015191|P1|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
8120282|NCT02951533|20015189|P3|COMPLETED|Part IIb (Week 32 Through Week 56)||20
8120283|NCT02951533|20015190|P2|COMPLETED|Part IIb (Week 32 Through Week 56)||10
8120284|NCT02951533|20015191|P1|COMPLETED|Part IIb (Week 32 Through Week 56)||54
8120285|NCT02951533|20015189|P3|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
8120286|NCT02951533|20015190|P2|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
8120287|NCT02951533|20015191|P1|STARTED|Part IIb (Week 32 Through Week 56)||55
8120288|NCT02951533|20015189|P3|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
8120289|NCT02951533|20015190|P2|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
8120290|NCT02951533|20015191|P1|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
8120291|NCT02951533|20015189|P3|COMPLETED|Part IIa (Week 24 Through Week 32)||0
8120292|NCT02951533|20015190|P2|COMPLETED|Part IIa (Week 24 Through Week 32)||34
8120293|NCT02951533|20015191|P1|COMPLETED|Part IIa (Week 24 Through Week 32)||55
8120294|NCT02951533|20015189|P3|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
8120295|NCT02951533|20015190|P2|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
8120296|NCT02951533|20015191|P1|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
8120297|NCT02951533|20015189|P3|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
8120298|NCT02951533|20015190|P2|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
8120299|NCT02951533|20015191|P1|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
8120300|NCT02951533|20015189|P3|STARTED|Part IIa (Week 24 Through Week 32)||0
8120301|NCT02951533|20015190|P2|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
8120302|NCT02951533|20015191|P1|STARTED|Part IIa (Week 24 Through Week 32)||56
8120303|NCT02951533|20015189|P3|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
8120304|NCT02951533|20015190|P2|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
8120305|NCT02951533|20015191|P1|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
8120306|NCT02951533|20015189|P3|COMPLETED|Part I (Week 0 Through Week 24)||0
8120307|NCT02951533|20015190|P2|COMPLETED|Part I (Week 0 Through Week 24)||36
8120308|NCT02951533|20015191|P1|COMPLETED|Part I (Week 0 Through Week 24)||56
8120309|NCT02951533|20015189|P3|Treated|Part I (Week 0 Through Week 24)||0
8120310|NCT02951533|20015190|P2|Treated|Part I (Week 0 Through Week 24)||58
8120311|NCT02951533|20015191|P1|Treated|Part I (Week 0 Through Week 24)||60
8120312|NCT02951533|20015189|P3|STARTED|Part I (Week 0 Through Week 24)||0
8120313|NCT02951533|20015190|P2|STARTED|Part I (Week 0 Through Week 24)||59
8120314|NCT02951533|20015191|P1|STARTED|Part I (Week 0 Through Week 24)||60
8120315|NCT02951481|20015290|P2|NOT COMPLETED|Overall Study||0
8120316|NCT02951481|20015291|P1|NOT COMPLETED|Overall Study||0
8120317|NCT02951481|20015290|P2|COMPLETED|Overall Study||172
8120318|NCT02951481|20015291|P1|COMPLETED|Overall Study||231
8120319|NCT02951481|20015290|P2|STARTED|Overall Study||172
8120320|NCT02951481|20015291|P1|STARTED|Overall Study||231
8120321|NCT02951429|20015313|P2|NOT COMPLETED|Overall Study||83
8120322|NCT02951429|20015314|P1|NOT COMPLETED|Overall Study||72
8120323|NCT02951429|20015313|P2|COMPLETED|Overall Study||6
8120324|NCT02951429|20015314|P1|COMPLETED|Overall Study||16
8120325|NCT02951429|20015313|P2|STARTED|Overall Study||89
8120326|NCT02951429|20015314|P1|STARTED|Overall Study||88
8120327|NCT02951351|20015374|P2|NOT COMPLETED|Overall Study||0
8120328|NCT02951351|20015375|P1|NOT COMPLETED|Overall Study||0
8120329|NCT02951351|20015374|P2|COMPLETED|Overall Study||17
8120330|NCT02951351|20015375|P1|COMPLETED|Overall Study||19
8120331|NCT02951351|20015374|P2|STARTED|Overall Study||17
8120332|NCT02951351|20015375|P1|STARTED|Overall Study||19
8120333|NCT02951312|20015399|P4|NOT COMPLETED|Study Part 2||0
8120334|NCT02951312|20015400|P3|NOT COMPLETED|Study Part 2||0
8120335|NCT02951312|20015401|P2|NOT COMPLETED|Study Part 2||0
8120336|NCT02951312|20015402|P1|NOT COMPLETED|Study Part 2||0
8120337|NCT02951312|20015399|P4|COMPLETED|Study Part 2||6
8120338|NCT02951312|20015400|P3|COMPLETED|Study Part 2||6
8120339|NCT02951312|20015401|P2|COMPLETED|Study Part 2||0
8120340|NCT02951312|20015402|P1|COMPLETED|Study Part 2||0
8120341|NCT02951312|20015399|P4|STARTED|Study Part 2||6
8120342|NCT02951312|20015400|P3|STARTED|Study Part 2||6
8120343|NCT02951312|20015401|P2|STARTED|Study Part 2||0
8120344|NCT02951312|20015402|P1|STARTED|Study Part 2||0
8120345|NCT02951312|20015399|P4|NOT COMPLETED|Study Part 1||0
8120346|NCT02951312|20015400|P3|NOT COMPLETED|Study Part 1||0
8120347|NCT02951312|20015401|P2|NOT COMPLETED|Study Part 1||0
8120348|NCT02951312|20015402|P1|NOT COMPLETED|Study Part 1||0
8120349|NCT02951312|20015399|P4|COMPLETED|Study Part 1||0
8120350|NCT02951312|20015400|P3|COMPLETED|Study Part 1||0
8120351|NCT02951312|20015401|P2|COMPLETED|Study Part 1||6
8120352|NCT02951312|20015402|P1|COMPLETED|Study Part 1||6
8120353|NCT02951312|20015399|P4|STARTED|Study Part 1||0
8120354|NCT02951312|20015400|P3|STARTED|Study Part 1||0
8120355|NCT02951312|20015401|P2|STARTED|Study Part 1||6
8120356|NCT02951312|20015402|P1|STARTED|Study Part 1||6
8120357|NCT02951273|20015522|P1|NOT COMPLETED|Overall Study||3
8120358|NCT02951273|20015522|P1|COMPLETED|Overall Study||27
8120359|NCT02951273|20015522|P1|STARTED|Overall Study||30
8120360|NCT02951182|20015543|P6|NOT COMPLETED|Overall Study||0
8120361|NCT02951182|20015544|P5|NOT COMPLETED|Overall Study||0
8120362|NCT02951182|20015545|P4|NOT COMPLETED|Overall Study||0
8120363|NCT02951182|20015546|P3|NOT COMPLETED|Overall Study||0
8120364|NCT02951182|20015547|P2|NOT COMPLETED|Overall Study||0
8120365|NCT02951182|20015548|P1|NOT COMPLETED|Overall Study||0
8120366|NCT02951182|20015543|P6|COMPLETED|Overall Study||20
8120367|NCT02951182|20015544|P5|COMPLETED|Overall Study||6
8120368|NCT02951182|20015545|P4|COMPLETED|Overall Study||18
8120369|NCT02951182|20015546|P3|COMPLETED|Overall Study||9
8120370|NCT02951182|20015547|P2|COMPLETED|Overall Study||9
8120371|NCT02951182|20015548|P1|COMPLETED|Overall Study||11
8120372|NCT02951182|20015543|P6|STARTED|Overall Study||20
8120373|NCT02951182|20015544|P5|STARTED|Overall Study||6
8120374|NCT02951182|20015545|P4|STARTED|Overall Study||18
8120375|NCT02951182|20015546|P3|STARTED|Overall Study||9
8120376|NCT02951182|20015547|P2|STARTED|Overall Study||9
8120377|NCT02951182|20015548|P1|STARTED|Overall Study||11
8120378|NCT02951156|20015590|P3|NOT COMPLETED|Overall Study||10
8120379|NCT02951156|20015591|P2|NOT COMPLETED|Overall Study||9
8120380|NCT02951156|20015592|P1|NOT COMPLETED|Overall Study||9
8120381|NCT02951156|20015590|P3|COMPLETED|Overall Study||1
8120382|NCT02951156|20015591|P2|COMPLETED|Overall Study||0
8120383|NCT02951156|20015592|P1|COMPLETED|Overall Study||0
8120384|NCT02951156|20015590|P3|STARTED|Overall Study||11
8120385|NCT02951156|20015591|P2|STARTED|Overall Study||9
8120386|NCT02951156|20015592|P1|STARTED|Overall Study||9
8120387|NCT02951052|20015652|P2|NOT COMPLETED|Overall Study||18
8120388|NCT02951052|20015653|P1|NOT COMPLETED|Overall Study||27
8120389|NCT02951052|20015652|P2|COMPLETED|Overall Study||290
8120390|NCT02951052|20015653|P1|COMPLETED|Overall Study||281
8120391|NCT02951052|20015652|P2|STARTED|Overall Study||308
8120392|NCT02951052|20015653|P1|STARTED|Overall Study||308
8120393|NCT02950896|20015817|P1|NOT COMPLETED|Overall Study||0
8120394|NCT02950896|20015817|P1|COMPLETED|Overall Study||4
8120395|NCT02950896|20015817|P1|STARTED|Overall Study||4
8120396|NCT02950831|20015821|P1|NOT COMPLETED|Overall Study||9
8120397|NCT02950831|20015821|P1|COMPLETED|Overall Study||18
8120398|NCT02950831|20015821|P1|8 Weeks Follow up|Overall Study||19
8120399|NCT02950831|20015821|P1|4 Week Follow up|Overall Study||20
8120400|NCT02950831|20015821|P1|Permanent Implant|Overall Study||20
8120401|NCT02950831|20015821|P1|Complete Trial|Overall Study||26
8120402|NCT02950831|20015821|P1|STARTED|Overall Study||27
8120403|NCT02950753|20015846|P2|NOT COMPLETED|Overall Study||0
8120404|NCT02950753|20015847|P1|NOT COMPLETED|Overall Study||0
8120405|NCT02950753|20015846|P2|COMPLETED|Overall Study||15
8120406|NCT02950753|20015847|P1|COMPLETED|Overall Study||15
8120407|NCT02950753|20015846|P2|STARTED|Overall Study||15
8120408|NCT02950753|20015847|P1|STARTED|Overall Study||15
8120409|NCT02950545|20015863|P6|NOT COMPLETED|Session 3 (70 Minutes)||1
8120410|NCT02950545|20015864|P5|NOT COMPLETED|Session 3 (70 Minutes)||0
8120411|NCT02950545|20015865|P4|NOT COMPLETED|Session 3 (70 Minutes)||0
8120412|NCT02950545|20015866|P3|NOT COMPLETED|Session 3 (70 Minutes)||0
8120413|NCT02950545|20015867|P2|NOT COMPLETED|Session 3 (70 Minutes)||0
8120414|NCT02950545|20015868|P1|NOT COMPLETED|Session 3 (70 Minutes)||0
8120415|NCT02950545|20015863|P6|COMPLETED|Session 3 (70 Minutes)||7
8120416|NCT02950545|20015864|P5|COMPLETED|Session 3 (70 Minutes)||7
8120417|NCT02950545|20015865|P4|COMPLETED|Session 3 (70 Minutes)||7
8120418|NCT02950545|20015866|P3|COMPLETED|Session 3 (70 Minutes)||7
8120419|NCT02950545|20015867|P2|COMPLETED|Session 3 (70 Minutes)||9
8120420|NCT02950545|20015868|P1|COMPLETED|Session 3 (70 Minutes)||7
8120421|NCT02950545|20015863|P6|STARTED|Session 3 (70 Minutes)||8
8120422|NCT02950545|20015864|P5|STARTED|Session 3 (70 Minutes)||7
8120423|NCT02950545|20015865|P4|STARTED|Session 3 (70 Minutes)||7
8120424|NCT02950545|20015866|P3|STARTED|Session 3 (70 Minutes)||7
8120425|NCT02950545|20015867|P2|STARTED|Session 3 (70 Minutes)||9
8120426|NCT02950545|20015868|P1|STARTED|Session 3 (70 Minutes)||7
8120427|NCT02950545|20015863|P6|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120428|NCT02950545|20015864|P5|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120429|NCT02950545|20015865|P4|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120430|NCT02950545|20015866|P3|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120431|NCT02950545|20015867|P2|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120432|NCT02950545|20015868|P1|NOT COMPLETED|Washout 2 (5 Minutes)||1
8120433|NCT02950545|20015863|P6|COMPLETED|Washout 2 (5 Minutes)||8
8120434|NCT02950545|20015864|P5|COMPLETED|Washout 2 (5 Minutes)||7
8120435|NCT02950545|20015865|P4|COMPLETED|Washout 2 (5 Minutes)||7
8120436|NCT02950545|20015866|P3|COMPLETED|Washout 2 (5 Minutes)||7
8120437|NCT02950545|20015867|P2|COMPLETED|Washout 2 (5 Minutes)||9
8120438|NCT02950545|20015868|P1|COMPLETED|Washout 2 (5 Minutes)||7
8120439|NCT02950545|20015863|P6|STARTED|Washout 2 (5 Minutes)||8
8120440|NCT02950545|20015864|P5|STARTED|Washout 2 (5 Minutes)||7
8120441|NCT02950545|20015865|P4|STARTED|Washout 2 (5 Minutes)||7
8120442|NCT02950545|20015866|P3|STARTED|Washout 2 (5 Minutes)||7
8120443|NCT02950545|20015867|P2|STARTED|Washout 2 (5 Minutes)||9
8120444|NCT02950545|20015868|P1|STARTED|Washout 2 (5 Minutes)||8
8120445|NCT02950545|20015863|P6|NOT COMPLETED|Session 2 (70 Minutes)||0
8120446|NCT02950545|20015864|P5|NOT COMPLETED|Session 2 (70 Minutes)||1
8120447|NCT02950545|20015865|P4|NOT COMPLETED|Session 2 (70 Minutes)||0
8120448|NCT02950545|20015866|P3|NOT COMPLETED|Session 2 (70 Minutes)||0
8120449|NCT02950545|20015867|P2|NOT COMPLETED|Session 2 (70 Minutes)||0
8120450|NCT02950545|20015868|P1|NOT COMPLETED|Session 2 (70 Minutes)||0
8120451|NCT02950545|20015863|P6|COMPLETED|Session 2 (70 Minutes)||8
8120452|NCT02950545|20015864|P5|COMPLETED|Session 2 (70 Minutes)||7
8120453|NCT02950545|20015865|P4|COMPLETED|Session 2 (70 Minutes)||7
8120454|NCT02950545|20015866|P3|COMPLETED|Session 2 (70 Minutes)||7
8120455|NCT02950545|20015867|P2|COMPLETED|Session 2 (70 Minutes)||9
8120456|NCT02950545|20015868|P1|COMPLETED|Session 2 (70 Minutes)||8
8120457|NCT02950545|20015863|P6|STARTED|Session 2 (70 Minutes)||8
8120458|NCT02950545|20015864|P5|STARTED|Session 2 (70 Minutes)||8
8120459|NCT02950545|20015865|P4|STARTED|Session 2 (70 Minutes)||7
8120460|NCT02950545|20015866|P3|STARTED|Session 2 (70 Minutes)||7
8120461|NCT02950545|20015867|P2|STARTED|Session 2 (70 Minutes)||9
8120462|NCT02950545|20015868|P1|STARTED|Session 2 (70 Minutes)||8
8120463|NCT02950545|20015863|P6|NOT COMPLETED|Washout 1 (5 Minutes)||1
8120464|NCT02950545|20015864|P5|NOT COMPLETED|Washout 1 (5 Minutes)||0
8120465|NCT02950545|20015865|P4|NOT COMPLETED|Washout 1 (5 Minutes)||1
8120466|NCT02950545|20015866|P3|NOT COMPLETED|Washout 1 (5 Minutes)||0
8120467|NCT02950545|20015867|P2|NOT COMPLETED|Washout 1 (5 Minutes)||0
8120468|NCT02950545|20015868|P1|NOT COMPLETED|Washout 1 (5 Minutes)||1
8120469|NCT02950545|20015863|P6|COMPLETED|Washout 1 (5 Minutes)||8
8120470|NCT02950545|20015864|P5|COMPLETED|Washout 1 (5 Minutes)||8
8120471|NCT02950545|20015865|P4|COMPLETED|Washout 1 (5 Minutes)||7
8120472|NCT02950545|20015866|P3|COMPLETED|Washout 1 (5 Minutes)||7
8120473|NCT02950545|20015867|P2|COMPLETED|Washout 1 (5 Minutes)||9
8120474|NCT02950545|20015868|P1|COMPLETED|Washout 1 (5 Minutes)||8
8120475|NCT02950545|20015863|P6|STARTED|Washout 1 (5 Minutes)||9
8120476|NCT02950545|20015864|P5|STARTED|Washout 1 (5 Minutes)||8
8120477|NCT02950545|20015865|P4|STARTED|Washout 1 (5 Minutes)||8
8120478|NCT02950545|20015866|P3|STARTED|Washout 1 (5 Minutes)||7
8120479|NCT02950545|20015867|P2|STARTED|Washout 1 (5 Minutes)||9
8120480|NCT02950545|20015868|P1|STARTED|Washout 1 (5 Minutes)||9
8120481|NCT02950545|20015863|P6|NOT COMPLETED|Session 1 (70 Minutes)||1
8120482|NCT02950545|20015864|P5|NOT COMPLETED|Session 1 (70 Minutes)||0
8120483|NCT02950545|20015865|P4|NOT COMPLETED|Session 1 (70 Minutes)||0
8120484|NCT02950545|20015866|P3|NOT COMPLETED|Session 1 (70 Minutes)||0
8120485|NCT02950545|20015867|P2|NOT COMPLETED|Session 1 (70 Minutes)||0
8120486|NCT02950545|20015868|P1|NOT COMPLETED|Session 1 (70 Minutes)||0
8120487|NCT02950545|20015863|P6|COMPLETED|Session 1 (70 Minutes)||9
8120488|NCT02950545|20015864|P5|COMPLETED|Session 1 (70 Minutes)||8
8120489|NCT02950545|20015865|P4|COMPLETED|Session 1 (70 Minutes)||8
8120490|NCT02950545|20015866|P3|COMPLETED|Session 1 (70 Minutes)||7
8120491|NCT02950545|20015867|P2|COMPLETED|Session 1 (70 Minutes)||9
8120492|NCT02950545|20015868|P1|COMPLETED|Session 1 (70 Minutes)||9
8120493|NCT02950545|20015863|P6|STARTED|Session 1 (70 Minutes)||10
8120494|NCT02950545|20015864|P5|STARTED|Session 1 (70 Minutes)||8
8120495|NCT02950545|20015865|P4|STARTED|Session 1 (70 Minutes)||8
8120496|NCT02950545|20015866|P3|STARTED|Session 1 (70 Minutes)||7
8120497|NCT02950545|20015867|P2|STARTED|Session 1 (70 Minutes)||9
8120498|NCT02950545|20015868|P1|STARTED|Session 1 (70 Minutes)||9
8120499|NCT02950480|20015877|P2|NOT COMPLETED|Overall Study||0
8120500|NCT02950480|20015878|P1|NOT COMPLETED|Overall Study||1
8120501|NCT02950480|20015877|P2|COMPLETED|Overall Study||2
8120502|NCT02950480|20015878|P1|COMPLETED|Overall Study||1
8120503|NCT02950480|20015877|P2|STARTED|Overall Study||2
8120504|NCT02950480|20015878|P1|STARTED|Overall Study||2
8120505|NCT02950467|20015888|P1|NOT COMPLETED|3-month Follow-up||0
8120506|NCT02950467|20015888|P1|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
8120507|NCT02950467|20015888|P1|STARTED|3-month Follow-up||18
8120508|NCT02950467|20015888|P1|NOT COMPLETED|Open-label Treatment||0
8120509|NCT02950467|20015888|P1|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
8120510|NCT02950467|20015888|P1|STARTED|Open-label Treatment||18
8120511|NCT02950025|20015918|P2|NOT COMPLETED|Overall Study||0
8120512|NCT02950025|20015919|P1|NOT COMPLETED|Overall Study||0
8120513|NCT02950025|20015918|P2|COMPLETED|Overall Study||3
8120514|NCT02950025|20015919|P1|COMPLETED|Overall Study||2
8120515|NCT02950025|20015918|P2|STARTED|Overall Study||3
8120516|NCT02950025|20015919|P1|STARTED|Overall Study||2
8120517|NCT02949947|20015939|P2|NOT COMPLETED|Overall Study||1
8120518|NCT02949947|20015940|P1|NOT COMPLETED|Overall Study||1
8120519|NCT02949947|20015939|P2|COMPLETED|Overall Study||1
8120520|NCT02949947|20015940|P1|COMPLETED|Overall Study||0
8120521|NCT02949947|20015939|P2|STARTED|Overall Study||2
8120522|NCT02949947|20015940|P1|STARTED|Overall Study||1
8120523|NCT02949921|20015948|P2|NOT COMPLETED|Overall Study||0
8120524|NCT02949921|20015949|P1|NOT COMPLETED|Overall Study||0
8120525|NCT02949921|20015948|P2|COMPLETED|Overall Study||10
8120526|NCT02949921|20015949|P1|COMPLETED|Overall Study||10
8120527|NCT02949921|20015948|P2|STARTED|Overall Study||10
8120528|NCT02949921|20015949|P1|STARTED|Overall Study||10
8120529|NCT02949908|20015973|P1|NOT COMPLETED|Overall Study||2
8120530|NCT02949908|20015973|P1|COMPLETED|Overall Study||0
8120531|NCT02949908|20015973|P1|STARTED|Overall Study||2
8120532|NCT02949674|20015996|P3|NOT COMPLETED|Overall Study||0
8120533|NCT02949674|20015997|P2|NOT COMPLETED|Overall Study||0
8120534|NCT02949674|20015998|P1|NOT COMPLETED|Overall Study||0
8120535|NCT02949674|20015996|P3|COMPLETED|Overall Study||31
8120536|NCT02949674|20015997|P2|COMPLETED|Overall Study||31
8120537|NCT02949674|20015998|P1|COMPLETED|Overall Study||31
8120538|NCT02949674|20015996|P3|STARTED|Overall Study||31
8120539|NCT02949674|20015997|P2|STARTED|Overall Study||31
8120540|NCT02949674|20015998|P1|STARTED|Overall Study||31
8120541|NCT02949518|20016008|P2|NOT COMPLETED|Overall Study||2
8120542|NCT02949518|20016009|P1|NOT COMPLETED|Overall Study||3
8120543|NCT02949518|20016008|P2|COMPLETED|Overall Study||26
8120544|NCT02949518|20016009|P1|COMPLETED|Overall Study||25
8120545|NCT02949518|20016008|P2|STARTED|Overall Study||28
8120546|NCT02949518|20016009|P1|STARTED|Overall Study||28
8120547|NCT02949271|20016037|P2|NOT COMPLETED|Overall Study||30
8120548|NCT02949271|20016038|P1|NOT COMPLETED|Overall Study||29
8120549|NCT02949271|20016037|P2|COMPLETED|Overall Study||59
8120550|NCT02949271|20016038|P1|COMPLETED|Overall Study||61
8120551|NCT02949271|20016037|P2|STARTED|Overall Study||89
8120552|NCT02949271|20016038|P1|STARTED|Overall Study||90
8120556|NCT02949141|20016071|P1|NOT COMPLETED|Overall Study||0
8120557|NCT02949141|20016071|P1|COMPLETED|Overall Study||62
8120558|NCT02949141|20016071|P1|STARTED|Overall Study||62
8120559|NCT02949128|20016078|P1|NOT COMPLETED|Extension Period||2
8120560|NCT02949128|20016078|P1|COMPLETED|Extension Period||47
8120561|NCT02949128|20016078|P1|Received At Least 1 Dose of Study Drug|Extension Period||47
8120562|NCT02949128|20016078|P1|STARTED|Extension Period||49
8120563|NCT02949128|20016078|P1|NOT COMPLETED|Initial Evaluation Period||9
8120564|NCT02949128|20016078|P1|COMPLETED|Initial Evaluation Period||49
8120565|NCT02949128|20016078|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
8120566|NCT02949128|20016078|P1|STARTED|Initial Evaluation Period||58
8120567|NCT02949011|20016095|P3|NOT COMPLETED|Overall Study||42
8120568|NCT02949011|20016096|P2|NOT COMPLETED|Overall Study||34
8120569|NCT02949011|20016097|P1|NOT COMPLETED|Overall Study||33
8120570|NCT02949011|20016095|P3|COMPLETED|Overall Study||683
8120571|NCT02949011|20016096|P2|COMPLETED|Overall Study||695
8120572|NCT02949011|20016097|P1|COMPLETED|Overall Study||697
8120573|NCT02949011|20016095|P3|Intention to Treat Infected Population|Overall Study||389
8120574|NCT02949011|20016096|P2|Intention to Treat Infected Population|Overall Study||386
8120575|NCT02949011|20016097|P1|Intention to Treat Infected Population|Overall Study||388
8120576|NCT02949011|20016095|P3|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
8120577|NCT02949011|20016096|P2|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
8120578|NCT02949011|20016097|P1|Received Study Drug|Overall Study||728
8120579|NCT02949011|20016095|P3|STARTED|Overall Study||725
8120580|NCT02949011|20016096|P2|STARTED|Overall Study||729
8120581|NCT02949011|20016097|P1|STARTED|Overall Study||730
8120582|NCT02948634|20016167|P2|NOT COMPLETED|Overall Study||2
8120583|NCT02948634|20016168|P1|NOT COMPLETED|Overall Study||10
8120584|NCT02948634|20016167|P2|COMPLETED|Overall Study||9
8120585|NCT02948634|20016168|P1|COMPLETED|Overall Study||7
8120586|NCT02948634|20016167|P2|STARTED|Overall Study||11
8120587|NCT02948634|20016168|P1|STARTED|Overall Study||17
8120588|NCT02948582|20016178|P6|NOT COMPLETED|Wshout Period 6||0
8120589|NCT02948582|20016179|P5|NOT COMPLETED|Wshout Period 6||0
8120590|NCT02948582|20016180|P4|NOT COMPLETED|Wshout Period 6||0
8120591|NCT02948582|20016181|P3|NOT COMPLETED|Wshout Period 6||0
8120592|NCT02948582|20016182|P2|NOT COMPLETED|Wshout Period 6||0
8120593|NCT02948582|20016183|P1|NOT COMPLETED|Wshout Period 6||0
8120594|NCT02948582|20016178|P6|COMPLETED|Wshout Period 6||6
8120595|NCT02948582|20016179|P5|COMPLETED|Wshout Period 6||7
8120596|NCT02948582|20016180|P4|COMPLETED|Wshout Period 6||6
8120597|NCT02948582|20016181|P3|COMPLETED|Wshout Period 6||6
8120598|NCT02948582|20016182|P2|COMPLETED|Wshout Period 6||4
8120599|NCT02948582|20016183|P1|COMPLETED|Wshout Period 6||6
8120600|NCT02948582|20016178|P6|STARTED|Wshout Period 6||6
8120601|NCT02948582|20016179|P5|STARTED|Wshout Period 6||7
8120602|NCT02948582|20016180|P4|STARTED|Wshout Period 6||6
8120603|NCT02948582|20016181|P3|STARTED|Wshout Period 6||6
8120604|NCT02948582|20016182|P2|STARTED|Wshout Period 6||4
8120605|NCT02948582|20016183|P1|STARTED|Wshout Period 6||6
8120606|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 6||0
8120607|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 6||0
8120608|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 6||0
8120609|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 6||0
8120610|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 6||0
8120611|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 6||0
8120612|NCT02948582|20016178|P6|COMPLETED|Treatment Period 6||6
8120613|NCT02948582|20016179|P5|COMPLETED|Treatment Period 6||7
8120614|NCT02948582|20016180|P4|COMPLETED|Treatment Period 6||6
8120615|NCT02948582|20016181|P3|COMPLETED|Treatment Period 6||6
8120616|NCT02948582|20016182|P2|COMPLETED|Treatment Period 6||4
8120617|NCT02948582|20016183|P1|COMPLETED|Treatment Period 6||6
8120618|NCT02948582|20016178|P6|STARTED|Treatment Period 6||6
8120619|NCT02948582|20016179|P5|STARTED|Treatment Period 6||7
8120620|NCT02948582|20016180|P4|STARTED|Treatment Period 6||6
8120621|NCT02948582|20016181|P3|STARTED|Treatment Period 6||6
8120622|NCT02948582|20016182|P2|STARTED|Treatment Period 6||4
8120623|NCT02948582|20016183|P1|STARTED|Treatment Period 6||6
8120624|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 5||0
8120625|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 5||0
8120626|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 5||0
8120627|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 5||0
8120628|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 5||0
8120629|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 5||0
8120630|NCT02948582|20016178|P6|COMPLETED|Washout Period 5||6
8120631|NCT02948582|20016179|P5|COMPLETED|Washout Period 5||7
8120632|NCT02948582|20016180|P4|COMPLETED|Washout Period 5||6
8120633|NCT02948582|20016181|P3|COMPLETED|Washout Period 5||6
8120634|NCT02948582|20016182|P2|COMPLETED|Washout Period 5||4
8120635|NCT02948582|20016183|P1|COMPLETED|Washout Period 5||6
8120636|NCT02948582|20016178|P6|STARTED|Washout Period 5||6
8120637|NCT02948582|20016179|P5|STARTED|Washout Period 5||7
8120638|NCT02948582|20016180|P4|STARTED|Washout Period 5||6
8120639|NCT02948582|20016181|P3|STARTED|Washout Period 5||6
8120640|NCT02948582|20016182|P2|STARTED|Washout Period 5||4
8120641|NCT02948582|20016183|P1|STARTED|Washout Period 5||6
8120642|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 5||0
8120643|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 5||0
8120644|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 5||0
8120645|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 5||0
8120646|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 5||0
8120647|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 5||0
8120648|NCT02948582|20016178|P6|COMPLETED|Treatment Period 5||6
8120649|NCT02948582|20016179|P5|COMPLETED|Treatment Period 5||7
8120650|NCT02948582|20016180|P4|COMPLETED|Treatment Period 5||6
8120651|NCT02948582|20016181|P3|COMPLETED|Treatment Period 5||6
8120652|NCT02948582|20016182|P2|COMPLETED|Treatment Period 5||4
8120653|NCT02948582|20016183|P1|COMPLETED|Treatment Period 5||6
8120654|NCT02948582|20016178|P6|STARTED|Treatment Period 5||6
8120655|NCT02948582|20016179|P5|STARTED|Treatment Period 5||7
8120656|NCT02948582|20016180|P4|STARTED|Treatment Period 5||6
8120657|NCT02948582|20016181|P3|STARTED|Treatment Period 5||6
8120658|NCT02948582|20016182|P2|STARTED|Treatment Period 5||4
8120659|NCT02948582|20016183|P1|STARTED|Treatment Period 5||6
8120660|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 4||0
8120661|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 4||0
8120662|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 4||0
8120663|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 4||1
8120664|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 4||0
8120665|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 4||1
8120666|NCT02948582|20016178|P6|COMPLETED|Washout Period 4||6
8120667|NCT02948582|20016179|P5|COMPLETED|Washout Period 4||7
8120668|NCT02948582|20016180|P4|COMPLETED|Washout Period 4||6
8120669|NCT02948582|20016181|P3|COMPLETED|Washout Period 4||6
8120670|NCT02948582|20016182|P2|COMPLETED|Washout Period 4||4
8120671|NCT02948582|20016183|P1|COMPLETED|Washout Period 4||6
8120672|NCT02948582|20016178|P6|STARTED|Washout Period 4||6
8120673|NCT02948582|20016179|P5|STARTED|Washout Period 4||7
8120674|NCT02948582|20016180|P4|STARTED|Washout Period 4||6
8120675|NCT02948582|20016181|P3|STARTED|Washout Period 4||7
8120676|NCT02948582|20016182|P2|STARTED|Washout Period 4||4
8120677|NCT02948582|20016183|P1|STARTED|Washout Period 4||7
8120678|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 4||0
8120679|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 4||0
8120680|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 4||0
8120681|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 4||0
8120682|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 4||0
8120683|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 4||0
8120684|NCT02948582|20016178|P6|COMPLETED|Treatment Period 4||6
8120685|NCT02948582|20016179|P5|COMPLETED|Treatment Period 4||7
8120686|NCT02948582|20016180|P4|COMPLETED|Treatment Period 4||6
8120687|NCT02948582|20016181|P3|COMPLETED|Treatment Period 4||7
8120688|NCT02948582|20016182|P2|COMPLETED|Treatment Period 4||4
8120689|NCT02948582|20016183|P1|COMPLETED|Treatment Period 4||7
8120690|NCT02948582|20016178|P6|STARTED|Treatment Period 4||6
8120691|NCT02948582|20016179|P5|STARTED|Treatment Period 4||7
8120692|NCT02948582|20016180|P4|STARTED|Treatment Period 4||6
8120693|NCT02948582|20016181|P3|STARTED|Treatment Period 4||7
8120694|NCT02948582|20016182|P2|STARTED|Treatment Period 4||4
8120695|NCT02948582|20016183|P1|STARTED|Treatment Period 4||7
8120696|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 3||0
8120697|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 3||0
8120698|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 3||0
8120699|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 3||0
8120700|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 3||0
8120701|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 3||0
8120702|NCT02948582|20016178|P6|COMPLETED|Washout Period 3||6
8120703|NCT02948582|20016179|P5|COMPLETED|Washout Period 3||7
8120704|NCT02948582|20016180|P4|COMPLETED|Washout Period 3||6
8120705|NCT02948582|20016181|P3|COMPLETED|Washout Period 3||7
8120706|NCT02948582|20016182|P2|COMPLETED|Washout Period 3||4
8120707|NCT02948582|20016183|P1|COMPLETED|Washout Period 3||7
8120708|NCT02948582|20016178|P6|STARTED|Washout Period 3||6
8120709|NCT02948582|20016179|P5|STARTED|Washout Period 3||7
8120710|NCT02948582|20016180|P4|STARTED|Washout Period 3||6
8120711|NCT02948582|20016181|P3|STARTED|Washout Period 3||7
8120712|NCT02948582|20016182|P2|STARTED|Washout Period 3||4
8120713|NCT02948582|20016183|P1|STARTED|Washout Period 3||7
8120714|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 3||0
8120715|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 3||0
8120716|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 3||0
8120717|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 3||0
8120718|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 3||0
8120719|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 3||0
8120720|NCT02948582|20016178|P6|COMPLETED|Treatment Period 3||6
8120721|NCT02948582|20016179|P5|COMPLETED|Treatment Period 3||7
8120722|NCT02948582|20016180|P4|COMPLETED|Treatment Period 3||6
8120723|NCT02948582|20016181|P3|COMPLETED|Treatment Period 3||7
8120724|NCT02948582|20016182|P2|COMPLETED|Treatment Period 3||4
8120725|NCT02948582|20016183|P1|COMPLETED|Treatment Period 3||7
8120726|NCT02948582|20016178|P6|STARTED|Treatment Period 3||6
8120727|NCT02948582|20016179|P5|STARTED|Treatment Period 3||7
8120728|NCT02948582|20016180|P4|STARTED|Treatment Period 3||6
8120729|NCT02948582|20016181|P3|STARTED|Treatment Period 3||7
8120730|NCT02948582|20016182|P2|STARTED|Treatment Period 3||4
8120731|NCT02948582|20016183|P1|STARTED|Treatment Period 3||7
8120732|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 2||0
8120733|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 2||0
8120734|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 2||1
8120735|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 2||0
8120736|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 2||1
8120737|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 2||0
8120738|NCT02948582|20016178|P6|COMPLETED|Washout Period 2||6
8120739|NCT02948582|20016179|P5|COMPLETED|Washout Period 2||7
8120740|NCT02948582|20016180|P4|COMPLETED|Washout Period 2||6
8120741|NCT02948582|20016181|P3|COMPLETED|Washout Period 2||7
8120742|NCT02948582|20016182|P2|COMPLETED|Washout Period 2||4
8120743|NCT02948582|20016183|P1|COMPLETED|Washout Period 2||7
8120744|NCT02948582|20016178|P6|STARTED|Washout Period 2||6
8120745|NCT02948582|20016179|P5|STARTED|Washout Period 2||7
8120746|NCT02948582|20016180|P4|STARTED|Washout Period 2||7
8120747|NCT02948582|20016181|P3|STARTED|Washout Period 2||7
8120748|NCT02948582|20016182|P2|STARTED|Washout Period 2||5
8120749|NCT02948582|20016183|P1|STARTED|Washout Period 2||7
8120750|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 2||0
8120751|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 2||0
8120752|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 2||0
8120753|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 2||0
8120754|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 2||0
8120755|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 2||0
8120756|NCT02948582|20016178|P6|COMPLETED|Treatment Period 2||6
8120757|NCT02948582|20016179|P5|COMPLETED|Treatment Period 2||7
8120758|NCT02948582|20016180|P4|COMPLETED|Treatment Period 2||7
8120759|NCT02948582|20016181|P3|COMPLETED|Treatment Period 2||7
8120760|NCT02948582|20016182|P2|COMPLETED|Treatment Period 2||5
8120761|NCT02948582|20016183|P1|COMPLETED|Treatment Period 2||7
8120762|NCT02948582|20016178|P6|STARTED|Treatment Period 2||6
8120763|NCT02948582|20016179|P5|STARTED|Treatment Period 2||7
8120764|NCT02948582|20016180|P4|STARTED|Treatment Period 2||7
8120765|NCT02948582|20016181|P3|STARTED|Treatment Period 2||7
8120766|NCT02948582|20016182|P2|STARTED|Treatment Period 2||5
8120767|NCT02948582|20016183|P1|STARTED|Treatment Period 2||7
8120768|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 1||1
8120769|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 1||0
8120770|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 1||0
8120771|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 1||0
8120772|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 1||2
8120773|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 1||0
8120774|NCT02948582|20016178|P6|COMPLETED|Washout Period 1||6
8120775|NCT02948582|20016179|P5|COMPLETED|Washout Period 1||7
8120776|NCT02948582|20016180|P4|COMPLETED|Washout Period 1||7
8120777|NCT02948582|20016181|P3|COMPLETED|Washout Period 1||7
8120778|NCT02948582|20016182|P2|COMPLETED|Washout Period 1||5
8120779|NCT02948582|20016183|P1|COMPLETED|Washout Period 1||7
8120780|NCT02948582|20016178|P6|STARTED|Washout Period 1||7
8120781|NCT02948582|20016179|P5|STARTED|Washout Period 1||7
8120782|NCT02948582|20016180|P4|STARTED|Washout Period 1||7
8120783|NCT02948582|20016181|P3|STARTED|Washout Period 1||7
8120784|NCT02948582|20016182|P2|STARTED|Washout Period 1||7
8120785|NCT02948582|20016183|P1|STARTED|Washout Period 1||7
8120786|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 1||0
8120787|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 1||0
8120788|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 1||0
8120789|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 1||0
8120790|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 1||0
8120791|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 1||0
8120792|NCT02948582|20016178|P6|COMPLETED|Treatment Period 1||7
8120793|NCT02948582|20016179|P5|COMPLETED|Treatment Period 1||7
8120794|NCT02948582|20016180|P4|COMPLETED|Treatment Period 1||7
8120795|NCT02948582|20016181|P3|COMPLETED|Treatment Period 1||7
8120796|NCT02948582|20016182|P2|COMPLETED|Treatment Period 1||7
8120797|NCT02948582|20016183|P1|COMPLETED|Treatment Period 1||7
8120798|NCT02948582|20016178|P6|STARTED|Treatment Period 1||7
8120799|NCT02948582|20016179|P5|STARTED|Treatment Period 1||7
8120800|NCT02948582|20016180|P4|STARTED|Treatment Period 1||7
8120801|NCT02948582|20016181|P3|STARTED|Treatment Period 1||7
8120802|NCT02948582|20016182|P2|STARTED|Treatment Period 1||7
8120803|NCT02948582|20016183|P1|STARTED|Treatment Period 1||7
8120804|NCT02948257|20016276|P1|NOT COMPLETED|Overall Study||0
8120805|NCT02948257|20016276|P1|COMPLETED|Overall Study||52
8120806|NCT02948257|20016276|P1|STARTED|Overall Study||52
8120807|NCT02947997|20016286|P1|NOT COMPLETED|Overall Study||0
8120808|NCT02947997|20016286|P1|COMPLETED|Overall Study||4
8120809|NCT02947997|20016286|P1|STARTED|Overall Study||4
8120810|NCT02947984|20016292|P2|NOT COMPLETED|Overall Study||0
8120811|NCT02947984|20016293|P1|NOT COMPLETED|Overall Study||0
8120812|NCT02947984|20016292|P2|COMPLETED|Overall Study||22
8120813|NCT02947984|20016293|P1|COMPLETED|Overall Study||22
8120814|NCT02947984|20016292|P2|STARTED|Overall Study||22
8120815|NCT02947984|20016293|P1|STARTED|Overall Study||22
8120816|NCT02947100|20016305|P1|NOT COMPLETED|Overall Study||4
8120817|NCT02947100|20016305|P1|COMPLETED|Overall Study||0
8120818|NCT02947100|20016305|P1|STARTED|Overall Study||4
8120819|NCT02947022|20016313|P1|NOT COMPLETED|Overall Study||1
8120820|NCT02947022|20016313|P1|COMPLETED|Overall Study||0
8120821|NCT02947022|20016313|P1|STARTED|Overall Study||1
8120822|NCT02946918|20016334|P2|NOT COMPLETED|Overall Study||3
8120823|NCT02946918|20016335|P1|NOT COMPLETED|Overall Study||1
8120824|NCT02946918|20016334|P2|COMPLETED|Overall Study||5
8120825|NCT02946918|20016335|P1|COMPLETED|Overall Study||5
8120826|NCT02946918|20016334|P2|STARTED|Overall Study||8
8120827|NCT02946918|20016335|P1|STARTED|Overall Study||6
8120828|NCT02946892|20016347|P2|NOT COMPLETED|Second Intervention||0
8120829|NCT02946892|20016348|P1|NOT COMPLETED|Second Intervention||0
8120830|NCT02946892|20016347|P2|COMPLETED|Second Intervention||14
8120831|NCT02946892|20016348|P1|COMPLETED|Second Intervention||9
8120832|NCT02946892|20016347|P2|STARTED|Second Intervention||14
8120833|NCT02946892|20016348|P1|STARTED|Second Intervention||9
8120834|NCT02946892|20016347|P2|NOT COMPLETED|Washout (6 Weeks)||0
8120835|NCT02946892|20016348|P1|NOT COMPLETED|Washout (6 Weeks)||2
8120836|NCT02946892|20016347|P2|COMPLETED|Washout (6 Weeks)||14
8120837|NCT02946892|20016348|P1|COMPLETED|Washout (6 Weeks)||9
8120838|NCT02946892|20016347|P2|STARTED|Washout (6 Weeks)||14
8120839|NCT02946892|20016348|P1|STARTED|Washout (6 Weeks)||11
8120840|NCT02946892|20016347|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8120841|NCT02946892|20016348|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8120842|NCT02946892|20016347|P2|COMPLETED|First Intervention (12 Weeks)||14
8120843|NCT02946892|20016348|P1|COMPLETED|First Intervention (12 Weeks)||11
8120844|NCT02946892|20016347|P2|STARTED|First Intervention (12 Weeks)||15
8120845|NCT02946892|20016348|P1|STARTED|First Intervention (12 Weeks)||11
8120846|NCT02946580|20016360|P2|NOT COMPLETED|Overall Study||5
8120847|NCT02946580|20016361|P1|NOT COMPLETED|Overall Study||1
8120848|NCT02946580|20016360|P2|COMPLETED|Overall Study||20
8120849|NCT02946580|20016361|P1|COMPLETED|Overall Study||27
8120850|NCT02946580|20016360|P2|STARTED|Overall Study||25
8120851|NCT02946580|20016361|P1|STARTED|Overall Study||28
8120852|NCT02946515|20016379|P2|NOT COMPLETED|Overall Study||1
8120853|NCT02946515|20016380|P1|NOT COMPLETED|Overall Study||2
8120854|NCT02946515|20016379|P2|COMPLETED|Overall Study||21
8120855|NCT02946515|20016380|P1|COMPLETED|Overall Study||20
8120856|NCT02946515|20016379|P2|STARTED|Overall Study||22
8120857|NCT02946515|20016380|P1|STARTED|Overall Study||22
8120858|NCT02946489|20016386|P1|NOT COMPLETED|Overall Study||0
8120859|NCT02946489|20016386|P1|COMPLETED|Overall Study||8
8120860|NCT02946489|20016386|P1|STARTED|Overall Study||8
8120861|NCT02946463|20016393|P2|NOT COMPLETED|Extension Period||119
8120862|NCT02946463|20016394|P1|NOT COMPLETED|Extension Period||124
8120863|NCT02946463|20016393|P2|COMPLETED|Extension Period||0
8120864|NCT02946463|20016394|P1|COMPLETED|Extension Period||0
8120865|NCT02946463|20016393|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||119
8120866|NCT02946463|20016394|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||124
8120867|NCT02946463|20016393|P2|STARTED|Extension Period||119
8120868|NCT02946463|20016394|P1|STARTED|Extension Period||124
8120869|NCT02946463|20016393|P2|NOT COMPLETED|Primary Evaluation Period||2
8120870|NCT02946463|20016394|P1|NOT COMPLETED|Primary Evaluation Period||0
8120871|NCT02946463|20016393|P2|COMPLETED|Primary Evaluation Period||119
8120872|NCT02946463|20016394|P1|COMPLETED|Primary Evaluation Period||125
8120873|NCT02946463|20016393|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
8120874|NCT02946463|20016394|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
8120875|NCT02946463|20016393|P2|STARTED|Primary Evaluation Period||121
8120876|NCT02946463|20016394|P1|STARTED|Primary Evaluation Period||125
8120877|NCT02946385|20016416|P6|NOT COMPLETED|Overall Study||1
8120878|NCT02946385|20016417|P5|NOT COMPLETED|Overall Study||2
8120879|NCT02946385|20016418|P4|NOT COMPLETED|Overall Study||0
8120880|NCT02946385|20016419|P3|NOT COMPLETED|Overall Study||3
8120881|NCT02946385|20016420|P2|NOT COMPLETED|Overall Study||0
8120882|NCT02946385|20016421|P1|NOT COMPLETED|Overall Study||0
8120883|NCT02946385|20016416|P6|COMPLETED|Overall Study||76
8120884|NCT02946385|20016417|P5|COMPLETED|Overall Study||99
8120885|NCT02946385|20016418|P4|COMPLETED|Overall Study||74
8120886|NCT02946385|20016419|P3|COMPLETED|Overall Study||96
8120887|NCT02946385|20016420|P2|COMPLETED|Overall Study||127
8120888|NCT02946385|20016421|P1|COMPLETED|Overall Study||126
8120889|NCT02946385|20016416|P6|STARTED|Overall Study||77
8120890|NCT02946385|20016417|P5|STARTED|Overall Study||101
8120891|NCT02946385|20016418|P4|STARTED|Overall Study||74
8120892|NCT02946385|20016419|P3|STARTED|Overall Study||99
8120893|NCT02946385|20016420|P2|STARTED|Overall Study||127
8120894|NCT02946385|20016421|P1|STARTED|Overall Study||126
8120895|NCT02946229|20016505|P1|NOT COMPLETED|Overall Study||0
8120896|NCT02946229|20016505|P1|COMPLETED|Overall Study||142
8120897|NCT02946229|20016505|P1|STARTED|Overall Study||142
8120898|NCT02946021|20016511|P2|NOT COMPLETED|Overall Study||0
8120899|NCT02946021|20016512|P1|NOT COMPLETED|Overall Study||0
8120900|NCT02946021|20016511|P2|COMPLETED|Overall Study||5
8120901|NCT02946021|20016512|P1|COMPLETED|Overall Study||6
8120902|NCT02946021|20016511|P2|STARTED|Overall Study||5
8120903|NCT02946021|20016512|P1|STARTED|Overall Study||6
8120904|NCT02945657|20016524|P1|NOT COMPLETED|Overall Study||4
8120905|NCT02945657|20016524|P1|COMPLETED|Overall Study||28
8120906|NCT02945657|20016524|P1|STARTED|Overall Study||32
8120907|NCT02945553|20016543|P2|NOT COMPLETED|Overall Study||2
8120908|NCT02945553|20016544|P1|NOT COMPLETED|Overall Study||3
8120909|NCT02945553|20016543|P2|COMPLETED|Overall Study|Included in analysis for primary aim.|9
8120910|NCT02945553|20016544|P1|COMPLETED|Overall Study|Included in analysis for primary aim.|11
8120911|NCT02945553|20016543|P2|STARTED|Overall Study||11
8120912|NCT02945553|20016544|P1|STARTED|Overall Study||14
8120913|NCT02945410|20016566|P6|NOT COMPLETED|Intervention 3 (5 Days)||0
8120914|NCT02945410|20016567|P5|NOT COMPLETED|Intervention 3 (5 Days)||0
8120915|NCT02945410|20016568|P4|NOT COMPLETED|Intervention 3 (5 Days)||0
8120916|NCT02945410|20016569|P3|NOT COMPLETED|Intervention 3 (5 Days)||0
8120917|NCT02945410|20016570|P2|NOT COMPLETED|Intervention 3 (5 Days)||0
8120918|NCT02945410|20016571|P1|NOT COMPLETED|Intervention 3 (5 Days)||0
8120919|NCT02945410|20016566|P6|COMPLETED|Intervention 3 (5 Days)||0
8120920|NCT02945410|20016567|P5|COMPLETED|Intervention 3 (5 Days)||1
8120921|NCT02945410|20016568|P4|COMPLETED|Intervention 3 (5 Days)||3
8120922|NCT02945410|20016569|P3|COMPLETED|Intervention 3 (5 Days)||0
8120923|NCT02945410|20016570|P2|COMPLETED|Intervention 3 (5 Days)||1
8120924|NCT02945410|20016571|P1|COMPLETED|Intervention 3 (5 Days)||2
8120925|NCT02945410|20016566|P6|STARTED|Intervention 3 (5 Days)||0
8120926|NCT02945410|20016567|P5|STARTED|Intervention 3 (5 Days)||1
8120927|NCT02945410|20016568|P4|STARTED|Intervention 3 (5 Days)||3
8120928|NCT02945410|20016569|P3|STARTED|Intervention 3 (5 Days)||0
8120929|NCT02945410|20016570|P2|STARTED|Intervention 3 (5 Days)||1
8120930|NCT02945410|20016571|P1|STARTED|Intervention 3 (5 Days)||2
8120931|NCT02945410|20016566|P6|NOT COMPLETED|Washout 2 (14 Days)||0
8120932|NCT02945410|20016567|P5|NOT COMPLETED|Washout 2 (14 Days)||0
8120933|NCT02945410|20016568|P4|NOT COMPLETED|Washout 2 (14 Days)||0
8120934|NCT02945410|20016569|P3|NOT COMPLETED|Washout 2 (14 Days)||0
8120935|NCT02945410|20016570|P2|NOT COMPLETED|Washout 2 (14 Days)||0
8120936|NCT02945410|20016571|P1|NOT COMPLETED|Washout 2 (14 Days)||0
8120937|NCT02945410|20016566|P6|COMPLETED|Washout 2 (14 Days)||0
8120938|NCT02945410|20016567|P5|COMPLETED|Washout 2 (14 Days)||1
8120939|NCT02945410|20016568|P4|COMPLETED|Washout 2 (14 Days)||3
8120940|NCT02945410|20016569|P3|COMPLETED|Washout 2 (14 Days)||0
8120941|NCT02945410|20016570|P2|COMPLETED|Washout 2 (14 Days)||1
8120942|NCT02945410|20016571|P1|COMPLETED|Washout 2 (14 Days)||2
8120943|NCT02945410|20016566|P6|STARTED|Washout 2 (14 Days)||0
8120944|NCT02945410|20016567|P5|STARTED|Washout 2 (14 Days)||1
8120945|NCT02945410|20016568|P4|STARTED|Washout 2 (14 Days)||3
8120946|NCT02945410|20016569|P3|STARTED|Washout 2 (14 Days)||0
8120947|NCT02945410|20016570|P2|STARTED|Washout 2 (14 Days)||1
8120948|NCT02945410|20016571|P1|STARTED|Washout 2 (14 Days)||2
8120949|NCT02945410|20016566|P6|NOT COMPLETED|Intervention 2 (5 Days)||0
8120950|NCT02945410|20016567|P5|NOT COMPLETED|Intervention 2 (5 Days)||0
8120951|NCT02945410|20016568|P4|NOT COMPLETED|Intervention 2 (5 Days)||0
8120952|NCT02945410|20016569|P3|NOT COMPLETED|Intervention 2 (5 Days)||0
8120953|NCT02945410|20016570|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
8120954|NCT02945410|20016571|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
8120955|NCT02945410|20016566|P6|COMPLETED|Intervention 2 (5 Days)||0
8120956|NCT02945410|20016567|P5|COMPLETED|Intervention 2 (5 Days)||1
8120957|NCT02945410|20016568|P4|COMPLETED|Intervention 2 (5 Days)||3
8120958|NCT02945410|20016569|P3|COMPLETED|Intervention 2 (5 Days)||0
8120959|NCT02945410|20016570|P2|COMPLETED|Intervention 2 (5 Days)||1
8120960|NCT02945410|20016571|P1|COMPLETED|Intervention 2 (5 Days)||2
8120961|NCT02945410|20016566|P6|STARTED|Intervention 2 (5 Days)||0
8120962|NCT02945410|20016567|P5|STARTED|Intervention 2 (5 Days)||1
8120963|NCT02945410|20016568|P4|STARTED|Intervention 2 (5 Days)||3
8120964|NCT02945410|20016569|P3|STARTED|Intervention 2 (5 Days)||0
8120965|NCT02945410|20016570|P2|STARTED|Intervention 2 (5 Days)||1
8120966|NCT02945410|20016571|P1|STARTED|Intervention 2 (5 Days)||2
8120967|NCT02945410|20016566|P6|NOT COMPLETED|Washout 1 (14 Days)||0
8120968|NCT02945410|20016567|P5|NOT COMPLETED|Washout 1 (14 Days)||1
8120969|NCT02945410|20016568|P4|NOT COMPLETED|Washout 1 (14 Days)||0
8120970|NCT02945410|20016569|P3|NOT COMPLETED|Washout 1 (14 Days)||2
8120971|NCT02945410|20016570|P2|NOT COMPLETED|Washout 1 (14 Days)||0
8120972|NCT02945410|20016571|P1|NOT COMPLETED|Washout 1 (14 Days)||0
8120973|NCT02945410|20016566|P6|COMPLETED|Washout 1 (14 Days)||0
8120974|NCT02945410|20016567|P5|COMPLETED|Washout 1 (14 Days)||1
8120975|NCT02945410|20016568|P4|COMPLETED|Washout 1 (14 Days)||3
8120976|NCT02945410|20016569|P3|COMPLETED|Washout 1 (14 Days)||0
8120977|NCT02945410|20016570|P2|COMPLETED|Washout 1 (14 Days)||1
8120978|NCT02945410|20016571|P1|COMPLETED|Washout 1 (14 Days)||2
8120979|NCT02945410|20016566|P6|STARTED|Washout 1 (14 Days)||0
8120980|NCT02945410|20016567|P5|STARTED|Washout 1 (14 Days)||2
8120981|NCT02945410|20016568|P4|STARTED|Washout 1 (14 Days)||3
8120982|NCT02945410|20016569|P3|STARTED|Washout 1 (14 Days)||2
8120983|NCT02945410|20016570|P2|STARTED|Washout 1 (14 Days)||1
8120984|NCT02945410|20016571|P1|STARTED|Washout 1 (14 Days)||2
8120985|NCT02945410|20016566|P6|NOT COMPLETED|Intervention 1 (5 Days)||1
8120986|NCT02945410|20016567|P5|NOT COMPLETED|Intervention 1 (5 Days)||0
8120987|NCT02945410|20016568|P4|NOT COMPLETED|Intervention 1 (5 Days)||0
8120988|NCT02945410|20016569|P3|NOT COMPLETED|Intervention 1 (5 Days)||0
8120989|NCT02945410|20016570|P2|NOT COMPLETED|Intervention 1 (5 Days)||3
8120990|NCT02945410|20016571|P1|NOT COMPLETED|Intervention 1 (5 Days)||1
8120991|NCT02945410|20016566|P6|COMPLETED|Intervention 1 (5 Days)||0
8120992|NCT02945410|20016567|P5|COMPLETED|Intervention 1 (5 Days)||2
8120993|NCT02945410|20016568|P4|COMPLETED|Intervention 1 (5 Days)||3
8120994|NCT02945410|20016569|P3|COMPLETED|Intervention 1 (5 Days)||2
8120995|NCT02945410|20016570|P2|COMPLETED|Intervention 1 (5 Days)||1
8120996|NCT02945410|20016571|P1|COMPLETED|Intervention 1 (5 Days)||2
8120997|NCT02945410|20016566|P6|STARTED|Intervention 1 (5 Days)||1
8120998|NCT02945410|20016567|P5|STARTED|Intervention 1 (5 Days)||2
8120999|NCT02945410|20016568|P4|STARTED|Intervention 1 (5 Days)||3
8121000|NCT02945410|20016569|P3|STARTED|Intervention 1 (5 Days)||2
8121001|NCT02945410|20016570|P2|STARTED|Intervention 1 (5 Days)||4
8121002|NCT02945410|20016571|P1|STARTED|Intervention 1 (5 Days)||3
8121003|NCT02945254|20016602|P2|NOT COMPLETED|Overall Study||0
8121004|NCT02945254|20016603|P1|NOT COMPLETED|Overall Study||2
8121005|NCT02945254|20016602|P2|COMPLETED|Overall Study||10
8121006|NCT02945254|20016603|P1|COMPLETED|Overall Study||8
8121007|NCT02945254|20016602|P2|STARTED|Overall Study||10
8121008|NCT02945254|20016603|P1|STARTED|Overall Study||10
8121009|NCT02945150|20016611|P1|NOT COMPLETED|Overall Study||0
8121010|NCT02945150|20016611|P1|COMPLETED|Overall Study||8
8121011|NCT02945150|20016611|P1|SVR12|Overall Study||8
8121012|NCT02945150|20016611|P1|STARTED|Overall Study||8
8121013|NCT02945046|20016619|P3|NOT COMPLETED|Overall Study||15
8121014|NCT02945046|20016620|P2|NOT COMPLETED|Overall Study||13
8121015|NCT02945046|20016621|P1|NOT COMPLETED|Overall Study||13
8121016|NCT02945046|20016619|P3|COMPLETED|Overall Study||40
8121017|NCT02945046|20016620|P2|COMPLETED|Overall Study||42
8121018|NCT02945046|20016621|P1|COMPLETED|Overall Study||46
8121019|NCT02945046|20016619|P3|Full Analysis Set|Overall Study||55
8121020|NCT02945046|20016620|P2|Full Analysis Set|Overall Study||53
8121021|NCT02945046|20016621|P1|Full Analysis Set|Overall Study||57
8121022|NCT02945046|20016619|P3|Safety Analysis Set|Overall Study||55
8121023|NCT02945046|20016620|P2|Safety Analysis Set|Overall Study||55
8121024|NCT02945046|20016621|P1|Safety Analysis Set|Overall Study||59
8121025|NCT02945046|20016619|P3|STARTED|Overall Study||55
8121026|NCT02945046|20016620|P2|STARTED|Overall Study||55
8121027|NCT02945046|20016621|P1|STARTED|Overall Study||59
8121028|NCT02944968|20016674|P1|NOT COMPLETED|Overall Study||3
8121029|NCT02944968|20016674|P1|COMPLETED|Overall Study||48
8121030|NCT02944968|20016674|P1|STARTED|Overall Study||51
8121031|NCT02944656|20016681|P2|NOT COMPLETED|Overall Study||10
8121032|NCT02944656|20016682|P1|NOT COMPLETED|Overall Study||10
8121033|NCT02944656|20016681|P2|COMPLETED|Overall Study||47
8121034|NCT02944656|20016682|P1|COMPLETED|Overall Study||47
8121035|NCT02944656|20016681|P2|Completed Day 1 Follow up|Overall Study||47
8121036|NCT02944656|20016682|P1|Completed Day 1 Follow up|Overall Study||47
8121037|NCT02944656|20016681|P2|Completed Procedure Day|Overall Study||57
8121038|NCT02944656|20016682|P1|Completed Procedure Day|Overall Study||54
8121039|NCT02944656|20016681|P2|STARTED|Overall Study||57
8121040|NCT02944656|20016682|P1|STARTED|Overall Study||57
8121041|NCT02944565|20016710|P1|NOT COMPLETED|Overall Study||0
8121042|NCT02944565|20016710|P1|COMPLETED|Overall Study||28
8121043|NCT02944565|20016710|P1|STARTED|Overall Study||28
8121044|NCT02944513|20016718|P2|NOT COMPLETED|Overall Study||1
8121045|NCT02944513|20016719|P1|NOT COMPLETED|Overall Study||4
8121046|NCT02944513|20016718|P2|COMPLETED|Overall Study||32
8121047|NCT02944513|20016719|P1|COMPLETED|Overall Study||31
8121048|NCT02944513|20016718|P2|STARTED|Overall Study||33
8121049|NCT02944513|20016719|P1|STARTED|Overall Study||35
8121050|NCT02944461|20016735|P1|NOT COMPLETED|Overall Study||5
8121051|NCT02944461|20016735|P1|COMPLETED|Overall Study||15
8121052|NCT02944461|20016735|P1|STARTED|Overall Study||20
8121053|NCT02944448|20016744|P2|NOT COMPLETED|Overall Study||24
8121054|NCT02944448|20016745|P1|NOT COMPLETED|Overall Study||89
8121055|NCT02944448|20016744|P2|COMPLETED|Overall Study||136
8121056|NCT02944448|20016745|P1|COMPLETED|Overall Study||227
8121057|NCT02944448|20016744|P2|STARTED|Overall Study||160
8121058|NCT02944448|20016745|P1|STARTED|Overall Study||316
8121059|NCT02944383|20016772|P3|NOT COMPLETED|Overall Study||1
8121060|NCT02944383|20016773|P2|NOT COMPLETED|Overall Study||0
8121061|NCT02944383|20016774|P1|NOT COMPLETED|Overall Study||1
8121062|NCT02944383|20016772|P3|COMPLETED|Overall Study||30
8121063|NCT02944383|20016773|P2|COMPLETED|Overall Study||30
8121064|NCT02944383|20016774|P1|COMPLETED|Overall Study||29
8121065|NCT02944383|20016772|P3|STARTED|Overall Study||31
8121066|NCT02944383|20016773|P2|STARTED|Overall Study||30
8121067|NCT02944383|20016774|P1|STARTED|Overall Study||30
8121068|NCT02943941|20016929|P1|NOT COMPLETED|Overall Study||0
8121069|NCT02943941|20016929|P1|COMPLETED|Overall Study||16
8121070|NCT02943941|20016929|P1|STARTED|Overall Study||16
8121071|NCT02943668|20016935|P1|NOT COMPLETED|Overall Study||1
8121072|NCT02943668|20016935|P1|COMPLETED|Overall Study||1
8121073|NCT02943668|20016935|P1|STARTED|Overall Study||2
8121074|NCT02943577|20016946|P2|NOT COMPLETED|Overall Study||5
8121075|NCT02943577|20016947|P1|NOT COMPLETED|Overall Study||5
8121076|NCT02943577|20016946|P2|COMPLETED|Overall Study||201
8121077|NCT02943577|20016947|P1|COMPLETED|Overall Study||204
8121078|NCT02943577|20016946|P2|STARTED|Overall Study||206
8121079|NCT02943577|20016947|P1|STARTED|Overall Study||209
8121080|NCT02943564|20016962|P3|NOT COMPLETED|Overall Study||9
8121081|NCT02943564|20016963|P2|NOT COMPLETED|Overall Study||13
8121082|NCT02943564|20016964|P1|NOT COMPLETED|Overall Study||10
8121083|NCT02943564|20016962|P3|COMPLETED|Overall Study||201
8121084|NCT02943564|20016963|P2|COMPLETED|Overall Study||198
8121085|NCT02943564|20016964|P1|COMPLETED|Overall Study||207
8121086|NCT02943564|20016962|P3|Non-Responder|Overall Study||133
8121087|NCT02943564|20016963|P2|Non-Responder|Overall Study||134
8121088|NCT02943564|20016964|P1|Non-Responder|Overall Study||134
8121089|NCT02943564|20016962|P3|Responder|Overall Study||77
8121090|NCT02943564|20016963|P2|Responder|Overall Study||77
8121091|NCT02943564|20016964|P1|Responder|Overall Study||83
8121092|NCT02943564|20016962|P3|STARTED|Overall Study||210
8121093|NCT02943564|20016963|P2|STARTED|Overall Study||211
8121094|NCT02943564|20016964|P1|STARTED|Overall Study||217
8121095|NCT02943499|20016977|P2|NOT COMPLETED|Overall Study||5
8121096|NCT02943499|20016978|P1|NOT COMPLETED|Overall Study||7
8121097|NCT02943499|20016977|P2|COMPLETED|Overall Study||34
8121098|NCT02943499|20016978|P1|COMPLETED|Overall Study||34
8121099|NCT02943499|20016977|P2|STARTED|Overall Study||39
8121100|NCT02943499|20016978|P1|STARTED|Overall Study||41
8121101|NCT02943473|20016984|P1|NOT COMPLETED|Overall Study||6
8121102|NCT02943473|20016984|P1|COMPLETED|Overall Study||3
8121103|NCT02943473|20016984|P1|STARTED|Overall Study||9
8121104|NCT02943460|20016991|P3|NOT COMPLETED|Open Label Extension (OLE)||9
8121105|NCT02943460|20016992|P2|NOT COMPLETED|Open Label Extension (OLE)||18
8121106|NCT02943460|20016993|P1|NOT COMPLETED|Open Label Extension (OLE)||19
8121107|NCT02943460|20016991|P3|COMPLETED|Open Label Extension (OLE)||0
8121108|NCT02943460|20016992|P2|COMPLETED|Open Label Extension (OLE)||0
8121109|NCT02943460|20016993|P1|COMPLETED|Open Label Extension (OLE)||0
8121110|NCT02943460|20016991|P3|STARTED|Open Label Extension (OLE)|1 participant who discontinued study drug in the Blinded Phase did not enter the OLE Phase.|9
8121111|NCT02943460|20016992|P2|STARTED|Open Label Extension (OLE)|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
8121112|NCT02943460|20016993|P1|STARTED|Open Label Extension (OLE)||19
8121113|NCT02943460|20016991|P3|NOT COMPLETED|Blinded Study||0
8121114|NCT02943460|20016992|P2|NOT COMPLETED|Blinded Study||1
8121115|NCT02943460|20016993|P1|NOT COMPLETED|Blinded Study||3
8121116|NCT02943460|20016991|P3|COMPLETED|Blinded Study|1 participant discontinued from study drug in the Blinded Phase, but did not discontinue the study.|10
8121117|NCT02943460|20016992|P2|COMPLETED|Blinded Study||19
8121118|NCT02943460|20016993|P1|COMPLETED|Blinded Study||19
8121119|NCT02943460|20016991|P3|STARTED|Blinded Study||10
8121120|NCT02943460|20016992|P2|STARTED|Blinded Study||20
8121121|NCT02943460|20016993|P1|STARTED|Blinded Study||22
8121122|NCT02943447|20017011|P3|NOT COMPLETED|Open-Label Extension Phase||10
8121123|NCT02943447|20017012|P2|NOT COMPLETED|Open-Label Extension Phase||25
8121124|NCT02943447|20017013|P1|NOT COMPLETED|Open-Label Extension Phase||18
8121125|NCT02943447|20017011|P3|COMPLETED|Open-Label Extension Phase||2
8121126|NCT02943447|20017012|P2|COMPLETED|Open-Label Extension Phase||3
8121127|NCT02943447|20017013|P1|COMPLETED|Open-Label Extension Phase||5
8121128|NCT02943447|20017011|P3|STARTED|Open-Label Extension Phase||12
8121129|NCT02943447|20017012|P2|STARTED|Open-Label Extension Phase||28
8121130|NCT02943447|20017013|P1|STARTED|Open-Label Extension Phase||23
8121131|NCT02943447|20017011|P3|NOT COMPLETED|Blinded Study Phase||1
8121132|NCT02943447|20017012|P2|NOT COMPLETED|Blinded Study Phase||2
8121133|NCT02943447|20017013|P1|NOT COMPLETED|Blinded Study Phase||5
8121134|NCT02943447|20017011|P3|COMPLETED|Blinded Study Phase||12
8121135|NCT02943447|20017012|P2|COMPLETED|Blinded Study Phase||28
8121136|NCT02943447|20017013|P1|COMPLETED|Blinded Study Phase||23
8121137|NCT02943447|20017011|P3|STARTED|Blinded Study Phase||13
8121138|NCT02943447|20017012|P2|STARTED|Blinded Study Phase||30
8121139|NCT02943447|20017013|P1|STARTED|Blinded Study Phase||28
8121140|NCT02943226|20017035|P2|NOT COMPLETED|Overall Study||0
8121141|NCT02943226|20017036|P1|NOT COMPLETED|Overall Study||0
8121142|NCT02943226|20017035|P2|COMPLETED|Overall Study||30
8121143|NCT02943226|20017036|P1|COMPLETED|Overall Study||31
8121144|NCT02943226|20017035|P2|STARTED|Overall Study||30
8121145|NCT02943226|20017036|P1|STARTED|Overall Study||31
8121146|NCT02943213|20017052|P1|NOT COMPLETED|Treatment Period 2||0
8121147|NCT02943213|20017052|P1|COMPLETED|Treatment Period 2||20
8121148|NCT02943213|20017052|P1|STARTED|Treatment Period 2||20
8121149|NCT02943213|20017052|P1|NOT COMPLETED|Treatment Period 1||0
8121150|NCT02943213|20017052|P1|COMPLETED|Treatment Period 1||20
8121151|NCT02943213|20017052|P1|STARTED|Treatment Period 1||20
8121152|NCT02943096|20017082|P2|NOT COMPLETED|Overall Study||1
8121153|NCT02943096|20017083|P1|NOT COMPLETED|Overall Study||0
8121154|NCT02943096|20017082|P2|COMPLETED|Overall Study||2
8121155|NCT02943096|20017083|P1|COMPLETED|Overall Study||3
8121156|NCT02943096|20017082|P2|STARTED|Overall Study||3
8121157|NCT02943096|20017083|P1|STARTED|Overall Study||3
8121158|NCT02942771|20017102|P5|NOT COMPLETED|Overall Study||4
8121159|NCT02942771|20017103|P4|NOT COMPLETED|Overall Study||0
8121160|NCT02942771|20017104|P3|NOT COMPLETED|Overall Study||0
8121161|NCT02942771|20017105|P2|NOT COMPLETED|Overall Study||0
8121162|NCT02942771|20017106|P1|NOT COMPLETED|Overall Study||3
8121163|NCT02942771|20017102|P5|COMPLETED|Overall Study||4
8121164|NCT02942771|20017103|P4|COMPLETED|Overall Study||6
8121165|NCT02942771|20017104|P3|COMPLETED|Overall Study||6
8121166|NCT02942771|20017105|P2|COMPLETED|Overall Study||6
8121167|NCT02942771|20017106|P1|COMPLETED|Overall Study||6
8121168|NCT02942771|20017102|P5|STARTED|Overall Study||8
8121169|NCT02942771|20017103|P4|STARTED|Overall Study||6
8121170|NCT02942771|20017104|P3|STARTED|Overall Study||6
8121171|NCT02942771|20017105|P2|STARTED|Overall Study||6
8121172|NCT02942771|20017106|P1|STARTED|Overall Study||9
8121173|NCT02942654|20017148|P2|NOT COMPLETED|Period 2||0
8121174|NCT02942654|20017149|P1|NOT COMPLETED|Period 2||0
8121175|NCT02942654|20017148|P2|COMPLETED|Period 2||16
8121176|NCT02942654|20017149|P1|COMPLETED|Period 2||16
8121177|NCT02942654|20017148|P2|STARTED|Period 2||16
8121178|NCT02942654|20017149|P1|STARTED|Period 2||16
8121179|NCT02942654|20017148|P2|NOT COMPLETED|Washout||0
8121180|NCT02942654|20017149|P1|NOT COMPLETED|Washout||0
8121181|NCT02942654|20017148|P2|COMPLETED|Washout||16
8121182|NCT02942654|20017149|P1|COMPLETED|Washout||16
8121183|NCT02942654|20017148|P2|STARTED|Washout||16
8121184|NCT02942654|20017149|P1|STARTED|Washout||16
8121185|NCT02942654|20017148|P2|NOT COMPLETED|Period 1||0
8121186|NCT02942654|20017149|P1|NOT COMPLETED|Period 1||0
8121187|NCT02942654|20017148|P2|COMPLETED|Period 1||16
8121188|NCT02942654|20017149|P1|COMPLETED|Period 1||16
8121189|NCT02942654|20017148|P2|Received at Least 1 Dose of Study Drug|Period 1||16
8121190|NCT02942654|20017149|P1|Received at Least 1 Dose of Study Drug|Period 1||16
8121191|NCT02942654|20017148|P2|STARTED|Period 1||16
8121192|NCT02942654|20017149|P1|STARTED|Period 1||16
8121193|NCT02942576|20017159|P2|NOT COMPLETED|Overall Study||23
8121194|NCT02942576|20017160|P1|NOT COMPLETED|Overall Study||46
8121195|NCT02942576|20017159|P2|COMPLETED|Overall Study||174
8121196|NCT02942576|20017160|P1|COMPLETED|Overall Study||359
8121197|NCT02942576|20017159|P2|STARTED|Overall Study||197
8121198|NCT02942576|20017160|P1|STARTED|Overall Study||405
8121199|NCT02942485|20017174|P2|NOT COMPLETED|Overall Study||0
8121200|NCT02942485|20017175|P1|NOT COMPLETED|Overall Study||1
8121201|NCT02942485|20017174|P2|COMPLETED|Overall Study||1
8121202|NCT02942485|20017175|P1|COMPLETED|Overall Study||6
8121203|NCT02942485|20017174|P2|STARTED|Overall Study||1
8121204|NCT02942485|20017175|P1|STARTED|Overall Study||7
8121205|NCT02942407|20017187|P2|NOT COMPLETED|Overall Study||24
8121206|NCT02942407|20017188|P1|NOT COMPLETED|Overall Study||26
8121207|NCT02942407|20017187|P2|COMPLETED|Overall Study||48
8121208|NCT02942407|20017188|P1|COMPLETED|Overall Study||56
8121209|NCT02942407|20017187|P2|STARTED|Overall Study||72
8121210|NCT02942407|20017188|P1|STARTED|Overall Study||82
8121211|NCT02942160|20017216|P1|NOT COMPLETED|Overall Study||103
8121212|NCT02942160|20017216|P1|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
8121213|NCT02942160|20017216|P1|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
8121214|NCT02942160|20017216|P1|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
8121215|NCT02942160|20017216|P1|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
8121216|NCT02942017|20017250|P2|NOT COMPLETED|Overall Study||6
8121217|NCT02942017|20017251|P1|NOT COMPLETED|Overall Study||2
8121218|NCT02942017|20017250|P2|COMPLETED|Overall Study||48
8121219|NCT02942017|20017251|P1|COMPLETED|Overall Study||52
8121220|NCT02942017|20017250|P2|Treated|Overall Study||51
8121221|NCT02942017|20017251|P1|Treated|Overall Study||53
8121222|NCT02942017|20017250|P2|STARTED|Overall Study||54
8121223|NCT02942017|20017251|P1|STARTED|Overall Study||54
8121224|NCT02942004|20017282|P3|NOT COMPLETED|Overall Study||9
8121225|NCT02942004|20017283|P2|NOT COMPLETED|Overall Study||12
8121226|NCT02942004|20017284|P1|NOT COMPLETED|Overall Study||4
8121227|NCT02942004|20017282|P3|COMPLETED|Overall Study||36
8121228|NCT02942004|20017283|P2|COMPLETED|Overall Study||35
8121229|NCT02942004|20017284|P1|COMPLETED|Overall Study||42
8121230|NCT02942004|20017282|P3|Participants Who Received Study Drug|Overall Study||41
8121231|NCT02942004|20017283|P2|Participants Who Received Study Drug|Overall Study||38
8121232|NCT02942004|20017284|P1|Participants Who Received Study Drug|Overall Study||43
8121233|NCT02942004|20017282|P3|STARTED|Overall Study||45
8121234|NCT02942004|20017283|P2|STARTED|Overall Study||47
8121235|NCT02942004|20017284|P1|STARTED|Overall Study||46
8121236|NCT02941692|20017327|P2|NOT COMPLETED|Overall Study||0
8121237|NCT02941692|20017328|P1|NOT COMPLETED|Overall Study||0
8121238|NCT02941692|20017327|P2|COMPLETED|Overall Study||34
8121239|NCT02941692|20017328|P1|COMPLETED|Overall Study||32
8121240|NCT02941692|20017327|P2|STARTED|Overall Study||34
8121241|NCT02941692|20017328|P1|STARTED|Overall Study||32
8121242|NCT02941640|20017340|P4|NOT COMPLETED|Overall Study||0
8121243|NCT02941640|20017341|P3|NOT COMPLETED|Overall Study||0
8121244|NCT02941640|20017342|P2|NOT COMPLETED|Overall Study||0
8121245|NCT02941640|20017343|P1|NOT COMPLETED|Overall Study||0
8121246|NCT02941640|20017340|P4|COMPLETED|Overall Study||30
8121247|NCT02941640|20017341|P3|COMPLETED|Overall Study||30
8121248|NCT02941640|20017342|P2|COMPLETED|Overall Study||30
8121249|NCT02941640|20017343|P1|COMPLETED|Overall Study||30
8121250|NCT02941640|20017340|P4|STARTED|Overall Study||30
8121251|NCT02941640|20017341|P3|STARTED|Overall Study||30
8121252|NCT02941640|20017342|P2|STARTED|Overall Study||30
8121253|NCT02941640|20017343|P1|STARTED|Overall Study||30
8121254|NCT02941614|20017375|P2|NOT COMPLETED|Overall Study||246
8121255|NCT02941614|20017376|P1|NOT COMPLETED|Overall Study||141
8121256|NCT02941614|20017375|P2|COMPLETED|Overall Study||446
8121257|NCT02941614|20017376|P1|COMPLETED|Overall Study||603
8121258|NCT02941614|20017375|P2|STARTED|Overall Study||692
8121259|NCT02941614|20017376|P1|STARTED|Overall Study||744
8121260|NCT02941146|20017396|P1|NOT COMPLETED|Overall Study||0
8121261|NCT02941146|20017396|P1|COMPLETED|Overall Study||15
8121262|NCT02941146|20017396|P1|STARTED|Overall Study||15
8121263|NCT02940886|20017404|P2|NOT COMPLETED|Overall Study||54
8121264|NCT02940886|20017405|P1|NOT COMPLETED|Overall Study||102
8121265|NCT02940886|20017404|P2|COMPLETED|Overall Study||449
8121266|NCT02940886|20017405|P1|COMPLETED|Overall Study||907
8121267|NCT02940886|20017404|P2|Safety Analysis Set|Overall Study||494
8121268|NCT02940886|20017405|P1|Safety Analysis Set|Overall Study||989
8121269|NCT02940886|20017404|P2|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
8121270|NCT02940886|20017405|P1|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
8121271|NCT02940860|20017451|P2|NOT COMPLETED|Overall Study||35
8121272|NCT02940860|20017452|P1|NOT COMPLETED|Overall Study||56
8121273|NCT02940860|20017451|P2|COMPLETED|Overall Study||476
8121274|NCT02940860|20017452|P1|COMPLETED|Overall Study||971
8121275|NCT02940860|20017451|P2|STARTED|Overall Study||511
8121276|NCT02940860|20017452|P1|STARTED|Overall Study||1027
8121277|NCT02940691|20017496|P1|NOT COMPLETED|Overall Study||6
8121278|NCT02940691|20017496|P1|COMPLETED|Overall Study||26
8121279|NCT02940691|20017496|P1|STARTED|Overall Study||32
8121280|NCT02940626|20017505|P2|NOT COMPLETED|Overall Study||35
8121281|NCT02940626|20017506|P1|NOT COMPLETED|Overall Study||47
8121282|NCT02940626|20017505|P2|COMPLETED|Overall Study||43
8121283|NCT02940626|20017506|P1|COMPLETED|Overall Study||30
8121284|NCT02940626|20017505|P2|Completed Through Study Day 22|Overall Study||49
8121285|NCT02940626|20017506|P1|Completed Through Study Day 22|Overall Study||42
8121286|NCT02940626|20017505|P2|Received Study Treatment|Overall Study||77
8121287|NCT02940626|20017506|P1|Received Study Treatment|Overall Study||77
8121288|NCT02940626|20017505|P2|Randomized Into Treatment Sub-study|Overall Study||1
8121289|NCT02940626|20017506|P1|Randomized Into Treatment Sub-study|Overall Study||0
8121290|NCT02940626|20017505|P2|Randomized Into Primary Prevention Study|Overall Study||77
8121291|NCT02940626|20017506|P1|Randomized Into Primary Prevention Study|Overall Study||77
8121292|NCT02940626|20017505|P2|STARTED|Overall Study||78
8121293|NCT02940626|20017506|P1|STARTED|Overall Study||77
8121306|NCT02940522|20017567|P2|NOT COMPLETED|Overall Study||2
8121307|NCT02940522|20017568|P1|NOT COMPLETED|Overall Study||2
8121308|NCT02940522|20017567|P2|COMPLETED|Overall Study||59
8121309|NCT02940522|20017568|P1|COMPLETED|Overall Study||57
8121310|NCT02940522|20017567|P2|STARTED|Overall Study||61
8121311|NCT02940522|20017568|P1|STARTED|Overall Study||59
8121312|NCT02940327|20017584|P1|NOT COMPLETED|Overall Study||0
8121313|NCT02940327|20017584|P1|COMPLETED|Overall Study||24
8121314|NCT02940327|20017584|P1|STARTED|Overall Study||24
8121315|NCT02940249|20017647|P1|NOT COMPLETED|Overall Study||4
8121316|NCT02940249|20017647|P1|COMPLETED|Overall Study||30
8121317|NCT02940249|20017647|P1|STARTED|Overall Study||34
8121318|NCT02939950|20017659|P2|NOT COMPLETED|Overall Study||81
8121319|NCT02939950|20017660|P1|NOT COMPLETED|Overall Study||66
8121320|NCT02939950|20017659|P2|COMPLETED|Overall Study||329
8121321|NCT02939950|20017660|P1|COMPLETED|Overall Study||340
8121322|NCT02939950|20017659|P2|Eligible at Baseline|Overall Study||402
8121323|NCT02939950|20017660|P1|Eligible at Baseline|Overall Study||403
8121324|NCT02939950|20017659|P2|Dispensed the Assigned Lenses|Overall Study||410
8121325|NCT02939950|20017660|P1|Dispensed the Assigned Lenses|Overall Study||405
8121326|NCT02939950|20017659|P2|STARTED|Overall Study||410
8121327|NCT02939950|20017660|P1|STARTED|Overall Study||406
8121328|NCT02939937|20017670|P2|NOT COMPLETED|Overall Study||3
8121329|NCT02939937|20017671|P1|NOT COMPLETED|Overall Study||6
8121330|NCT02939937|20017670|P2|COMPLETED|Overall Study||47
8121331|NCT02939937|20017671|P1|COMPLETED|Overall Study||15
8121332|NCT02939937|20017670|P2|STARTED|Overall Study|3 patients excluded from study|50
8121333|NCT02939937|20017671|P1|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
8121334|NCT02939716|20017685|P6|NOT COMPLETED|Overall Study||1
8121335|NCT02939716|20017686|P5|NOT COMPLETED|Overall Study||1
8121336|NCT02939716|20017687|P4|NOT COMPLETED|Overall Study||1
8121337|NCT02939716|20017688|P3|NOT COMPLETED|Overall Study||0
8121338|NCT02939716|20017689|P2|NOT COMPLETED|Overall Study||0
8121339|NCT02939716|20017690|P1|NOT COMPLETED|Overall Study||0
8121340|NCT02939716|20017685|P6|COMPLETED|Overall Study||2
8121341|NCT02939716|20017686|P5|COMPLETED|Overall Study||2
8121342|NCT02939716|20017687|P4|COMPLETED|Overall Study||2
8121343|NCT02939716|20017688|P3|COMPLETED|Overall Study||3
8121344|NCT02939716|20017689|P2|COMPLETED|Overall Study||3
8121345|NCT02939716|20017690|P1|COMPLETED|Overall Study||3
8121346|NCT02939716|20017685|P6|STARTED|Overall Study||3
8121347|NCT02939716|20017686|P5|STARTED|Overall Study||3
8121348|NCT02939716|20017687|P4|STARTED|Overall Study||3
8121349|NCT02939716|20017688|P3|STARTED|Overall Study||3
8121350|NCT02939716|20017689|P2|STARTED|Overall Study||3
8121351|NCT02939716|20017690|P1|STARTED|Overall Study||3
8121352|NCT02939599|20017715|P2|NOT COMPLETED|Overall Study||2
8121353|NCT02939599|20017716|P1|NOT COMPLETED|Overall Study||3
8121354|NCT02939599|20017715|P2|COMPLETED|Overall Study||0
8121355|NCT02939599|20017716|P1|COMPLETED|Overall Study||0
8121356|NCT02939599|20017715|P2|STARTED|Overall Study||2
8121357|NCT02939599|20017716|P1|STARTED|Overall Study||3
8121358|NCT02939560|20017730|P1|NOT COMPLETED|Overall Study||3
8121359|NCT02939560|20017730|P1|COMPLETED|Overall Study||10
8121360|NCT02939560|20017730|P1|STARTED|Overall Study||13
8121361|NCT02939326|20017747|P8|NOT COMPLETED|Overall Study||0
8121362|NCT02939326|20017748|P7|NOT COMPLETED|Overall Study||0
8121363|NCT02939326|20017749|P6|NOT COMPLETED|Overall Study||0
8121364|NCT02939326|20017750|P5|NOT COMPLETED|Overall Study||0
8121365|NCT02939326|20017751|P4|NOT COMPLETED|Overall Study||0
8121366|NCT02939326|20017752|P3|NOT COMPLETED|Overall Study||0
8121367|NCT02939326|20017753|P2|NOT COMPLETED|Overall Study||0
8121368|NCT02939326|20017754|P1|NOT COMPLETED|Overall Study||0
8121369|NCT02939326|20017747|P8|COMPLETED|Overall Study||5
8121370|NCT02939326|20017748|P7|COMPLETED|Overall Study||5
8121371|NCT02939326|20017749|P6|COMPLETED|Overall Study||5
8121372|NCT02939326|20017750|P5|COMPLETED|Overall Study||5
8121373|NCT02939326|20017751|P4|COMPLETED|Overall Study||5
8121374|NCT02939326|20017752|P3|COMPLETED|Overall Study||5
8121375|NCT02939326|20017753|P2|COMPLETED|Overall Study||5
8121376|NCT02939326|20017754|P1|COMPLETED|Overall Study||7
8121377|NCT02939326|20017747|P8|STARTED|Overall Study||5
8121378|NCT02939326|20017748|P7|STARTED|Overall Study||5
8121379|NCT02939326|20017749|P6|STARTED|Overall Study||5
8121380|NCT02939326|20017750|P5|STARTED|Overall Study||5
8121381|NCT02939326|20017751|P4|STARTED|Overall Study||5
8121382|NCT02939326|20017752|P3|STARTED|Overall Study||5
8121383|NCT02939326|20017753|P2|STARTED|Overall Study||5
8121384|NCT02939326|20017754|P1|STARTED|Overall Study||7
8121385|NCT02939170|20017774|P2|NOT COMPLETED|Overall Study||0
8121386|NCT02939170|20017775|P1|NOT COMPLETED|Overall Study||0
8121387|NCT02939170|20017774|P2|COMPLETED|Overall Study||40
8121388|NCT02939170|20017775|P1|COMPLETED|Overall Study||40
8121389|NCT02939170|20017774|P2|STARTED|Overall Study||40
8121390|NCT02939170|20017775|P1|STARTED|Overall Study||40
8121391|NCT02939131|20017788|P2|NOT COMPLETED|Overall Study||9
8121392|NCT02939131|20017789|P1|NOT COMPLETED|Overall Study||11
8121393|NCT02939131|20017788|P2|COMPLETED|Overall Study||66
8121394|NCT02939131|20017789|P1|COMPLETED|Overall Study||70
8121395|NCT02939131|20017788|P2|Week 24 Visit|Overall Study||72
8121396|NCT02939131|20017789|P1|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
8121397|NCT02939131|20017788|P2|STARTED|Overall Study||75
8121398|NCT02939131|20017789|P1|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
8121399|NCT02939079|20017807|P2|NOT COMPLETED|Overall Study||5
8121400|NCT02939079|20017808|P1|NOT COMPLETED|Overall Study||4
8121401|NCT02939079|20017807|P2|COMPLETED|Overall Study||20
8121402|NCT02939079|20017808|P1|COMPLETED|Overall Study||21
8121403|NCT02939079|20017807|P2|STARTED|Overall Study||25
8121404|NCT02939079|20017808|P1|STARTED|Overall Study||25
8121411|NCT02938949|20017868|P2|NOT COMPLETED|Overall Study||0
8121412|NCT02938949|20017869|P1|NOT COMPLETED|Overall Study||0
8121413|NCT02938949|20017868|P2|COMPLETED|Overall Study||10
8121414|NCT02938949|20017869|P1|COMPLETED|Overall Study||10
8121415|NCT02938949|20017868|P2|STARTED|Overall Study||10
8121416|NCT02938949|20017869|P1|STARTED|Overall Study||10
8121417|NCT02938585|20017883|P4|NOT COMPLETED|Overall Study||5
8121418|NCT02938585|20017884|P3|NOT COMPLETED|Overall Study||0
8121419|NCT02938585|20017885|P2|NOT COMPLETED|Overall Study||1
8121420|NCT02938585|20017886|P1|NOT COMPLETED|Overall Study||0
8121421|NCT02938585|20017883|P4|COMPLETED|Overall Study||10
8121422|NCT02938585|20017884|P3|COMPLETED|Overall Study||11
8121423|NCT02938585|20017885|P2|COMPLETED|Overall Study||32
8121424|NCT02938585|20017886|P1|COMPLETED|Overall Study||9
8121425|NCT02938585|20017883|P4|Exposed to On-demand Regimen|Overall Study||8
8121426|NCT02938585|20017884|P3|Exposed to On-demand Regimen|Overall Study||1
8121427|NCT02938585|20017885|P2|Exposed to On-demand Regimen|Overall Study||7
8121428|NCT02938585|20017886|P1|Exposed to On-demand Regimen|Overall Study||1
8121429|NCT02938585|20017883|P4|Exposed to Prophylaxis Regimen|Overall Study||12
8121430|NCT02938585|20017884|P3|Exposed to Prophylaxis Regimen|Overall Study||11
8121431|NCT02938585|20017885|P2|Exposed to Prophylaxis Regimen|Overall Study||31
8121432|NCT02938585|20017886|P1|Exposed to Prophylaxis Regimen|Overall Study||9
8121433|NCT02938585|20017883|P4|STARTED|Overall Study||15
8121434|NCT02938585|20017884|P3|STARTED|Overall Study||11
8121435|NCT02938585|20017885|P2|STARTED|Overall Study||33
8121436|NCT02938585|20017886|P1|STARTED|Overall Study||9
8121437|NCT02938520|20018050|P2|NOT COMPLETED|Overall Study||283
8121438|NCT02938520|20018051|P1|NOT COMPLETED|Overall Study||283
8121439|NCT02938520|20018050|P2|COMPLETED|Overall Study||0
8121440|NCT02938520|20018051|P1|COMPLETED|Overall Study||0
8121441|NCT02938520|20018050|P2|STARTED|Overall Study||283
8121442|NCT02938520|20018051|P1|STARTED|Overall Study||283
8121443|NCT02938494|20018180|P4|NOT COMPLETED|Overall Study||4
8121444|NCT02938494|20018181|P3|NOT COMPLETED|Overall Study||4
8121445|NCT02938494|20018182|P2|NOT COMPLETED|Overall Study||9
8121446|NCT02938494|20018183|P1|NOT COMPLETED|Overall Study||4
8121447|NCT02938494|20018180|P4|COMPLETED|Overall Study||31
8121448|NCT02938494|20018181|P3|COMPLETED|Overall Study||30
8121449|NCT02938494|20018182|P2|COMPLETED|Overall Study||63
8121450|NCT02938494|20018183|P1|COMPLETED|Overall Study||65
8121451|NCT02938494|20018180|P4|STARTED|Overall Study||35
8121452|NCT02938494|20018181|P3|STARTED|Overall Study||34
8121453|NCT02938494|20018182|P2|STARTED|Overall Study||72
8121454|NCT02938494|20018183|P1|STARTED|Overall Study||69
8121455|NCT02938169|20018202|P4|NOT COMPLETED|Overall Study||3
8121456|NCT02938169|20018203|P3|NOT COMPLETED|Overall Study||5
8121457|NCT02938169|20018204|P2|NOT COMPLETED|Overall Study||2
8121458|NCT02938169|20018205|P1|NOT COMPLETED|Overall Study||2
8121459|NCT02938169|20018202|P4|COMPLETED|Overall Study||12
8121460|NCT02938169|20018203|P3|COMPLETED|Overall Study||10
8121461|NCT02938169|20018204|P2|COMPLETED|Overall Study||13
8121462|NCT02938169|20018205|P1|COMPLETED|Overall Study||13
8121463|NCT02938169|20018202|P4|STARTED|Overall Study||15
8121464|NCT02938169|20018203|P3|STARTED|Overall Study||15
8121465|NCT02938169|20018204|P2|STARTED|Overall Study||15
8121466|NCT02938169|20018205|P1|STARTED|Overall Study||15
8121467|NCT02938052|20018231|P1|NOT COMPLETED|Overall Study||0
8121468|NCT02938052|20018231|P1|COMPLETED|Overall Study||10
8121469|NCT02938052|20018231|P1|STARTED|Overall Study||10
8121470|NCT02938013|20018254|P3|NOT COMPLETED|Overall Study||0
8121471|NCT02938013|20018255|P2|NOT COMPLETED|Overall Study||0
8121472|NCT02938013|20018256|P1|NOT COMPLETED|Overall Study||0
8121473|NCT02938013|20018254|P3|COMPLETED|Overall Study||5
8121474|NCT02938013|20018255|P2|COMPLETED|Overall Study||5
8121475|NCT02938013|20018256|P1|COMPLETED|Overall Study||5
8121476|NCT02938013|20018254|P3|STARTED|Overall Study||5
8121477|NCT02938013|20018255|P2|STARTED|Overall Study||5
8121478|NCT02938013|20018256|P1|STARTED|Overall Study||5
8121479|NCT02937870|20018273|P1|NOT COMPLETED|Overall Study||3
8121480|NCT02937870|20018273|P1|COMPLETED|Overall Study||20
8121481|NCT02937870|20018273|P1|Received no Adhesive|Overall Study||20
8121482|NCT02937870|20018273|P1|Received Positive Control Adhesive|Overall Study||21
8121483|NCT02937870|20018273|P1|Received Test Adhesive 2|Overall Study||22
8121484|NCT02937870|20018273|P1|Received Test Adhesive 1|Overall Study||21
8121485|NCT02937870|20018273|P1|STARTED|Overall Study||23
8121486|NCT02937766|20018291|P2|NOT COMPLETED|Overall Study||0
8121487|NCT02937766|20018292|P1|NOT COMPLETED|Overall Study||7
8121488|NCT02937766|20018291|P2|COMPLETED|Overall Study||30
8121489|NCT02937766|20018292|P1|COMPLETED|Overall Study||23
8121490|NCT02937766|20018291|P2|STARTED|Overall Study||30
8121491|NCT02937766|20018292|P1|STARTED|Overall Study||30
8121492|NCT02937740|20018304|P2|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
8121493|NCT02937740|20018305|P1|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
8121494|NCT02937740|20018304|P2|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
8121495|NCT02937740|20018305|P1|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
8121496|NCT02937740|20018304|P2|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
8121497|NCT02937740|20018305|P1|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
8121498|NCT02937740|20018304|P2|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
8121499|NCT02937740|20018305|P1|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
8121500|NCT02937740|20018304|P2|COMPLETED|BID for 90 Days, 22 mg/Day||62
8121501|NCT02937740|20018305|P1|COMPLETED|BID for 90 Days, 22 mg/Day||19
8121502|NCT02937740|20018304|P2|STARTED|BID for 90 Days, 22 mg/Day||93
8121503|NCT02937740|20018305|P1|STARTED|BID for 90 Days, 22 mg/Day||24
8121504|NCT02937701|20018321|P5|NOT COMPLETED|Week 22 to Week 50||9
8121505|NCT02937701|20018322|P4|NOT COMPLETED|Week 22 to Week 50||8
8121506|NCT02937701|20018323|P3|NOT COMPLETED|Week 22 to Week 50||32
8121507|NCT02937701|20018324|P2|NOT COMPLETED|Week 22 to Week 50||0
8121508|NCT02937701|20018325|P1|NOT COMPLETED|Week 22 to Week 50||0
8121509|NCT02937701|20018321|P5|COMPLETED|Week 22 to Week 50||110
8121510|NCT02937701|20018322|P4|COMPLETED|Week 22 to Week 50||113
8121511|NCT02937701|20018323|P3|COMPLETED|Week 22 to Week 50||212
8121512|NCT02937701|20018324|P2|COMPLETED|Week 22 to Week 50||0
8121513|NCT02937701|20018325|P1|COMPLETED|Week 22 to Week 50||0
8121514|NCT02937701|20018321|P5|STARTED|Week 22 to Week 50||119
8121515|NCT02937701|20018322|P4|STARTED|Week 22 to Week 50||121
8121516|NCT02937701|20018323|P3|STARTED|Week 22 to Week 50||244
8121517|NCT02937701|20018324|P2|STARTED|Week 22 to Week 50||0
8121518|NCT02937701|20018325|P1|STARTED|Week 22 to Week 50||0
8121519|NCT02937701|20018321|P5|NOT COMPLETED|Day 1 to Week 22||0
8121520|NCT02937701|20018322|P4|NOT COMPLETED|Day 1 to Week 22||0
8121521|NCT02937701|20018323|P3|NOT COMPLETED|Day 1 to Week 22||0
8121522|NCT02937701|20018324|P2|NOT COMPLETED|Day 1 to Week 22||39
8121523|NCT02937701|20018325|P1|NOT COMPLETED|Day 1 to Week 22||35
8121524|NCT02937701|20018321|P5|COMPLETED|Day 1 to Week 22||0
8121525|NCT02937701|20018322|P4|COMPLETED|Day 1 to Week 22||0
8121526|NCT02937701|20018323|P3|COMPLETED|Day 1 to Week 22||0
8121527|NCT02937701|20018324|P2|COMPLETED|Day 1 to Week 22||240
8121528|NCT02937701|20018325|P1|COMPLETED|Day 1 to Week 22||244
8121529|NCT02937701|20018321|P5|Received Treatment|Day 1 to Week 22||0
8121530|NCT02937701|20018322|P4|Received Treatment|Day 1 to Week 22||0
8121531|NCT02937701|20018323|P3|Received Treatment|Day 1 to Week 22||0
8121532|NCT02937701|20018324|P2|Received Treatment|Day 1 to Week 22||278
8121533|NCT02937701|20018325|P1|Received Treatment|Day 1 to Week 22||278
8121534|NCT02937701|20018321|P5|STARTED|Day 1 to Week 22||0
8121535|NCT02937701|20018322|P4|STARTED|Day 1 to Week 22||0
8121536|NCT02937701|20018323|P3|STARTED|Day 1 to Week 22||0
8121537|NCT02937701|20018324|P2|STARTED|Day 1 to Week 22||279
8121538|NCT02937701|20018325|P1|STARTED|Day 1 to Week 22||279
8121539|NCT02937636|20018356|P2|NOT COMPLETED|Overall Study||2
8121540|NCT02937636|20018357|P1|NOT COMPLETED|Overall Study||3
8121541|NCT02937636|20018356|P2|COMPLETED|Overall Study||63
8121542|NCT02937636|20018357|P1|COMPLETED|Overall Study||60
8121543|NCT02937636|20018356|P2|STARTED|Overall Study||65
8121544|NCT02937636|20018357|P1|STARTED|Overall Study||63
8121545|NCT02937623|20018371|P2|NOT COMPLETED|Overall Study||0
8121546|NCT02937623|20018372|P1|NOT COMPLETED|Overall Study||0
8121547|NCT02937623|20018371|P2|COMPLETED|Overall Study||60
8121548|NCT02937623|20018372|P1|COMPLETED|Overall Study||60
8121549|NCT02937623|20018371|P2|STARTED|Overall Study||60
8121550|NCT02937623|20018372|P1|STARTED|Overall Study||60
8121551|NCT02937584|20018384|P2|NOT COMPLETED|Period 2||0
8121552|NCT02937584|20018385|P1|NOT COMPLETED|Period 2||0
8121553|NCT02937584|20018384|P2|COMPLETED|Period 2||9
8121554|NCT02937584|20018385|P1|COMPLETED|Period 2||10
8121555|NCT02937584|20018384|P2|STARTED|Period 2||9
8121556|NCT02937584|20018385|P1|STARTED|Period 2||10
8121557|NCT02937584|20018384|P2|NOT COMPLETED|Washout||1
8121558|NCT02937584|20018385|P1|NOT COMPLETED|Washout||0
8121559|NCT02937584|20018384|P2|COMPLETED|Washout||9
8121560|NCT02937584|20018385|P1|COMPLETED|Washout||10
8121561|NCT02937584|20018384|P2|STARTED|Washout||10
8121562|NCT02937584|20018385|P1|STARTED|Washout||10
8121563|NCT02937584|20018384|P2|NOT COMPLETED|Period 1||2
8121564|NCT02937584|20018385|P1|NOT COMPLETED|Period 1||1
8121565|NCT02937584|20018384|P2|COMPLETED|Period 1||10
8121566|NCT02937584|20018385|P1|COMPLETED|Period 1||10
8121567|NCT02937584|20018384|P2|STARTED|Period 1||12
8121568|NCT02937584|20018385|P1|STARTED|Period 1||11
8121569|NCT02937558|20018403|P2|NOT COMPLETED|Open-label Phase||0
8121570|NCT02937558|20018404|P1|NOT COMPLETED|Open-label Phase||0
8121571|NCT02937558|20018403|P2|COMPLETED|Open-label Phase||0
8121572|NCT02937558|20018404|P1|COMPLETED|Open-label Phase||5
8121573|NCT02937558|20018403|P2|STARTED|Open-label Phase||0
8121574|NCT02937558|20018404|P1|STARTED|Open-label Phase||5
8121575|NCT02937558|20018403|P2|NOT COMPLETED|Double-blind Phase||0
8121576|NCT02937558|20018404|P1|NOT COMPLETED|Double-blind Phase||0
8121577|NCT02937558|20018403|P2|COMPLETED|Double-blind Phase||2
8121578|NCT02937558|20018404|P1|COMPLETED|Double-blind Phase||3
8121579|NCT02937558|20018403|P2|STARTED|Double-blind Phase||2
8121580|NCT02937558|20018404|P1|STARTED|Double-blind Phase||3
8121581|NCT02937506|20018419|P2|NOT COMPLETED|Overall Study||0
8121582|NCT02937506|20018420|P1|NOT COMPLETED|Overall Study||0
8121583|NCT02937506|20018419|P2|COMPLETED|Overall Study||300
8121584|NCT02937506|20018420|P1|COMPLETED|Overall Study||300
8121585|NCT02937506|20018419|P2|STARTED|Overall Study||300
8121586|NCT02937506|20018420|P1|STARTED|Overall Study||300
8121587|NCT02937168|20018426|P3|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121588|NCT02937168|20018427|P2|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121589|NCT02937168|20018428|P1|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121590|NCT02937168|20018426|P3|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121591|NCT02937168|20018427|P2|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121592|NCT02937168|20018428|P1|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121593|NCT02937168|20018426|P3|STARTED|Double-Blind Treatment Period (6 Weeks)||0
8121594|NCT02937168|20018427|P2|STARTED|Double-Blind Treatment Period (6 Weeks)||0
8121595|NCT02937168|20018428|P1|STARTED|Double-Blind Treatment Period (6 Weeks)||0
8121596|NCT02937168|20018426|P3|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
8121597|NCT02937168|20018427|P2|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
8121598|NCT02937168|20018428|P1|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
8121599|NCT02937168|20018426|P3|COMPLETED|PET/CT Screening Period (21 Days)||0
8121600|NCT02937168|20018427|P2|COMPLETED|PET/CT Screening Period (21 Days)||0
8121601|NCT02937168|20018428|P1|COMPLETED|PET/CT Screening Period (21 Days)||5
8121602|NCT02937168|20018426|P3|STARTED|PET/CT Screening Period (21 Days)||0
8121603|NCT02937168|20018427|P2|STARTED|PET/CT Screening Period (21 Days)||0
8121604|NCT02937168|20018428|P1|STARTED|PET/CT Screening Period (21 Days)||5
8121605|NCT02936999|20018446|P1|NOT COMPLETED|Overall Study||0
8121606|NCT02936999|20018446|P1|COMPLETED|Overall Study||8
8121607|NCT02936999|20018446|P1|STARTED|Overall Study||8
8121608|NCT02936869|20018456|P2|NOT COMPLETED|Overall Study||5
8121609|NCT02936869|20018457|P1|NOT COMPLETED|Overall Study||2
8121610|NCT02936869|20018456|P2|COMPLETED|Overall Study||98
8121611|NCT02936869|20018457|P1|COMPLETED|Overall Study||102
8121612|NCT02936869|20018456|P2|STARTED|Overall Study||103
8121613|NCT02936869|20018457|P1|STARTED|Overall Study||104
8121614|NCT02936648|20018465|P1|NOT COMPLETED|Overall Study||0
8121615|NCT02936648|20018465|P1|COMPLETED|Overall Study||2209
8121616|NCT02936648|20018465|P1|STARTED|Overall Study||2209
8121617|NCT02936479|20018469|P1|NOT COMPLETED|Overall Study||0
8121618|NCT02936479|20018469|P1|COMPLETED|Overall Study||1
8121619|NCT02936479|20018469|P1|STARTED|Overall Study||1
8121620|NCT02936076|20018475|P2|NOT COMPLETED|Overall Study||4
8121621|NCT02936076|20018476|P1|NOT COMPLETED|Overall Study||6
8121622|NCT02936076|20018475|P2|COMPLETED|Overall Study||20
8121623|NCT02936076|20018476|P1|COMPLETED|Overall Study||19
8121624|NCT02936076|20018475|P2|STARTED|Overall Study||24
8121625|NCT02936076|20018476|P1|STARTED|Overall Study||25
8121626|NCT02936037|20018490|P2|NOT COMPLETED|Open Label Extension||10
8121627|NCT02936037|20018491|P1|NOT COMPLETED|Open Label Extension||0
8121628|NCT02936037|20018490|P2|COMPLETED|Open Label Extension||518
8121629|NCT02936037|20018491|P1|COMPLETED|Open Label Extension||0
8121630|NCT02936037|20018490|P2|STARTED|Open Label Extension||528
8121631|NCT02936037|20018491|P1|STARTED|Open Label Extension||0
8121632|NCT02936037|20018490|P2|NOT COMPLETED|Double-Blind Treatment Period||65
8121633|NCT02936037|20018491|P1|NOT COMPLETED|Double-Blind Treatment Period||49
8121634|NCT02936037|20018490|P2|COMPLETED|Double-Blind Treatment Period||261
8121635|NCT02936037|20018491|P1|COMPLETED|Double-Blind Treatment Period||267
8121636|NCT02936037|20018490|P2|STARTED|Double-Blind Treatment Period||326
8121637|NCT02936037|20018491|P1|STARTED|Double-Blind Treatment Period||316
8121638|NCT02935894|20018497|P1|NOT COMPLETED|Overall Study||1
8121639|NCT02935894|20018497|P1|COMPLETED|Overall Study||13
8121640|NCT02935894|20018497|P1|STARTED|Overall Study||14
8121641|NCT02935842|20018512|P4|NOT COMPLETED|Testing and Therapy Period 3||1
8121642|NCT02935842|20018513|P3|NOT COMPLETED|Testing and Therapy Period 3||5
8121643|NCT02935842|20018514|P2|NOT COMPLETED|Testing and Therapy Period 3||4
8121644|NCT02935842|20018515|P1|NOT COMPLETED|Testing and Therapy Period 3||3
8121645|NCT02935842|20018512|P4|COMPLETED|Testing and Therapy Period 3||17
8121646|NCT02935842|20018513|P3|COMPLETED|Testing and Therapy Period 3||1
8121647|NCT02935842|20018514|P2|COMPLETED|Testing and Therapy Period 3||2
8121648|NCT02935842|20018515|P1|COMPLETED|Testing and Therapy Period 3||3
8121649|NCT02935842|20018512|P4|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
8121650|NCT02935842|20018513|P3|STARTED|Testing and Therapy Period 3||6
8121651|NCT02935842|20018514|P2|STARTED|Testing and Therapy Period 3||6
8121652|NCT02935842|20018515|P1|STARTED|Testing and Therapy Period 3||6
8121653|NCT02935842|20018512|P4|NOT COMPLETED|Testing and Therapy Period 2||0
8121654|NCT02935842|20018513|P3|NOT COMPLETED|Testing and Therapy Period 2||0
8121655|NCT02935842|20018514|P2|NOT COMPLETED|Testing and Therapy Period 2||0
8121656|NCT02935842|20018515|P1|NOT COMPLETED|Testing and Therapy Period 2||2
8121657|NCT02935842|20018512|P4|COMPLETED|Testing and Therapy Period 2||0
8121658|NCT02935842|20018513|P3|COMPLETED|Testing and Therapy Period 2||6
8121659|NCT02935842|20018514|P2|COMPLETED|Testing and Therapy Period 2||6
8121660|NCT02935842|20018515|P1|COMPLETED|Testing and Therapy Period 2||6
8121661|NCT02935842|20018512|P4|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
8121662|NCT02935842|20018513|P3|STARTED|Testing and Therapy Period 2||6
8121663|NCT02935842|20018514|P2|STARTED|Testing and Therapy Period 2||6
8121664|NCT02935842|20018515|P1|STARTED|Testing and Therapy Period 2||8
8121665|NCT02935842|20018512|P4|NOT COMPLETED|Testing and Therapy Period 1||0
8121666|NCT02935842|20018513|P3|NOT COMPLETED|Testing and Therapy Period 1||0
8121667|NCT02935842|20018514|P2|NOT COMPLETED|Testing and Therapy Period 1||0
8121668|NCT02935842|20018515|P1|NOT COMPLETED|Testing and Therapy Period 1||0
8121669|NCT02935842|20018512|P4|COMPLETED|Testing and Therapy Period 1||0
8121670|NCT02935842|20018513|P3|COMPLETED|Testing and Therapy Period 1||6
8121671|NCT02935842|20018514|P2|COMPLETED|Testing and Therapy Period 1||6
8121672|NCT02935842|20018515|P1|COMPLETED|Testing and Therapy Period 1||8
8121673|NCT02935842|20018512|P4|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
8121674|NCT02935842|20018513|P3|STARTED|Testing and Therapy Period 1||6
8121675|NCT02935842|20018514|P2|STARTED|Testing and Therapy Period 1||6
8121676|NCT02935842|20018515|P1|STARTED|Testing and Therapy Period 1||8
8121677|NCT02935738|20018553|P4|NOT COMPLETED|Overall Study||5
8121678|NCT02935738|20018554|P3|NOT COMPLETED|Overall Study||1
8121679|NCT02935738|20018555|P2|NOT COMPLETED|Overall Study||21
8121680|NCT02935738|20018556|P1|NOT COMPLETED|Overall Study||17
8121681|NCT02935738|20018553|P4|COMPLETED|Overall Study||48
8121682|NCT02935738|20018554|P3|COMPLETED|Overall Study||46
8121683|NCT02935738|20018555|P2|COMPLETED|Overall Study||53
8121684|NCT02935738|20018556|P1|COMPLETED|Overall Study||50
8121685|NCT02935738|20018553|P4|STARTED|Overall Study||53
8121686|NCT02935738|20018554|P3|STARTED|Overall Study||47
8121687|NCT02935738|20018555|P2|STARTED|Overall Study||74
8121688|NCT02935738|20018556|P1|STARTED|Overall Study||67
8121689|NCT02935699|20018568|P2|NOT COMPLETED|Overall Study||0
8121690|NCT02935699|20018569|P1|NOT COMPLETED|Overall Study||0
8121691|NCT02935699|20018568|P2|COMPLETED|Overall Study||135
8121692|NCT02935699|20018569|P1|COMPLETED|Overall Study||127
8121693|NCT02935699|20018568|P2|STARTED|Overall Study||135
8121694|NCT02935699|20018569|P1|STARTED|Overall Study||127
8121695|NCT02935673|20018584|P3|NOT COMPLETED|Overall Study||0
8121696|NCT02935673|20018585|P2|NOT COMPLETED|Overall Study||3
8121697|NCT02935673|20018586|P1|NOT COMPLETED|Overall Study||1
8121698|NCT02935673|20018584|P3|COMPLETED|Overall Study||6
8121699|NCT02935673|20018585|P2|COMPLETED|Overall Study||24
8121700|NCT02935673|20018586|P1|COMPLETED|Overall Study||15
8121701|NCT02935673|20018584|P3|STARTED|Overall Study||6
8121702|NCT02935673|20018585|P2|STARTED|Overall Study||27
8121703|NCT02935673|20018586|P1|STARTED|Overall Study||16
8121704|NCT02935595|20018708|P1|NOT COMPLETED|Overall Study||1
8121705|NCT02935595|20018708|P1|COMPLETED|Overall Study||4
8121706|NCT02935595|20018708|P1|STARTED|Overall Study||5
8121707|NCT02935543|20018719|P1|NOT COMPLETED|Overall Study||0
8121708|NCT02935543|20018719|P1|COMPLETED|Overall Study||1
8121709|NCT02935543|20018719|P1|STARTED|Overall Study||1
8121710|NCT02935192|20018731|P2|NOT COMPLETED|Overall Study||4
8121711|NCT02935192|20018732|P1|NOT COMPLETED|Overall Study||8
8121712|NCT02935192|20018731|P2|COMPLETED|Overall Study||156
8121713|NCT02935192|20018732|P1|COMPLETED|Overall Study||312
8121714|NCT02935192|20018731|P2|Received Vaccine/Placebo|Overall Study||156
8121715|NCT02935192|20018732|P1|Received Vaccine/Placebo|Overall Study||312
8121716|NCT02935192|20018731|P2|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
8121717|NCT02935192|20018732|P1|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
8121718|NCT02935179|20018756|P2|NOT COMPLETED|Overall Study||1
8121719|NCT02935179|20018757|P1|NOT COMPLETED|Overall Study||1
8121720|NCT02935179|20018756|P2|COMPLETED|Overall Study||29
8121721|NCT02935179|20018757|P1|COMPLETED|Overall Study||29
8121722|NCT02935179|20018756|P2|STARTED|Overall Study||30
8121723|NCT02935179|20018757|P1|STARTED|Overall Study||30
8121724|NCT02935088|20018765|P1|NOT COMPLETED|Overall Study||102
8121725|NCT02935088|20018765|P1|COMPLETED|Overall Study||2115
8121726|NCT02935088|20018765|P1|STARTED|Overall Study||2217
8121727|NCT02935062|20018780|P3|NOT COMPLETED|Overall Study||0
8121728|NCT02935062|20018781|P2|NOT COMPLETED|Overall Study||0
8121729|NCT02935062|20018782|P1|NOT COMPLETED|Overall Study||0
8121730|NCT02935062|20018780|P3|COMPLETED|Overall Study||8
8121731|NCT02935062|20018781|P2|COMPLETED|Overall Study||8
8121732|NCT02935062|20018782|P1|COMPLETED|Overall Study||8
8121733|NCT02935062|20018780|P3|STARTED|Overall Study||8
8121734|NCT02935062|20018781|P2|STARTED|Overall Study||8
8121735|NCT02935062|20018782|P1|STARTED|Overall Study||8
8121736|NCT02935036|20018795|P2|NOT COMPLETED|Overall Study||11
8121737|NCT02935036|20018796|P1|NOT COMPLETED|Overall Study||10
8121738|NCT02935036|20018795|P2|COMPLETED|Overall Study||136
8121739|NCT02935036|20018796|P1|COMPLETED|Overall Study||137
8121740|NCT02935036|20018795|P2|STARTED|Overall Study||147
8121741|NCT02935036|20018796|P1|STARTED|Overall Study||147
8121742|NCT02934932|20018806|P1|NOT COMPLETED|Overall Study||3
8121743|NCT02934932|20018806|P1|COMPLETED|Overall Study||6
8121744|NCT02934932|20018806|P1|STARTED|Overall Study||9
8121745|NCT02934698|20018815|P1|NOT COMPLETED|Overall Study||0
8121746|NCT02934698|20018815|P1|COMPLETED|Overall Study||2
8121747|NCT02934698|20018815|P1|STARTED|Overall Study||2
8121748|NCT02934347|20018823|P2|NOT COMPLETED|Overall Study||0
8121749|NCT02934347|20018824|P1|NOT COMPLETED|Overall Study||0
8121750|NCT02934347|20018823|P2|COMPLETED|Overall Study||407
8121751|NCT02934347|20018824|P1|COMPLETED|Overall Study||374
8121752|NCT02934347|20018823|P2|STARTED|Overall Study||407
8121753|NCT02934347|20018824|P1|STARTED|Overall Study||374
8121754|NCT02934191|20018838|P2|NOT COMPLETED|Overall Study||0
8121755|NCT02934191|20018839|P1|NOT COMPLETED|Overall Study||0
8121756|NCT02934191|20018838|P2|COMPLETED|Overall Study||85
8121757|NCT02934191|20018839|P1|COMPLETED|Overall Study||87
8121758|NCT02934191|20018838|P2|STARTED|Overall Study||85
8121759|NCT02934191|20018839|P1|STARTED|Overall Study||87
8121760|NCT02934178|20018849|P2|NOT COMPLETED|Received Vaccination 3||0
8121761|NCT02934178|20018850|P1|NOT COMPLETED|Received Vaccination 3||1
8121762|NCT02934178|20018849|P2|COMPLETED|Received Vaccination 3||3
8121763|NCT02934178|20018850|P1|COMPLETED|Received Vaccination 3||11
8121764|NCT02934178|20018849|P2|STARTED|Received Vaccination 3||3
8121765|NCT02934178|20018850|P1|STARTED|Received Vaccination 3||12
8121766|NCT02934178|20018849|P2|NOT COMPLETED|Received Vaccination 2||1
8121767|NCT02934178|20018850|P1|NOT COMPLETED|Received Vaccination 2||0
8121768|NCT02934178|20018849|P2|COMPLETED|Received Vaccination 2||3
8121769|NCT02934178|20018850|P1|COMPLETED|Received Vaccination 2||12
8121770|NCT02934178|20018849|P2|STARTED|Received Vaccination 2||4
8121771|NCT02934178|20018850|P1|STARTED|Received Vaccination 2||12
8121772|NCT02934178|20018849|P2|NOT COMPLETED|Received Vaccination 1||0
8121773|NCT02934178|20018850|P1|NOT COMPLETED|Received Vaccination 1||0
8121774|NCT02934178|20018849|P2|COMPLETED|Received Vaccination 1||4
8121775|NCT02934178|20018850|P1|COMPLETED|Received Vaccination 1||12
8121776|NCT02934178|20018849|P2|STARTED|Received Vaccination 1||4
8121777|NCT02934178|20018850|P1|STARTED|Received Vaccination 1||12
8121778|NCT02933879|20018945|P3|NOT COMPLETED|Overall Study||17
8121779|NCT02933879|20018946|P2|NOT COMPLETED|Overall Study||14
8121780|NCT02933879|20018947|P1|NOT COMPLETED|Overall Study||16
8121781|NCT02933879|20018945|P3|COMPLETED|Overall Study||41
8121782|NCT02933879|20018946|P2|COMPLETED|Overall Study||48
8121783|NCT02933879|20018947|P1|COMPLETED|Overall Study||48
8121784|NCT02933879|20018945|P3|STARTED|Overall Study||58
8121785|NCT02933879|20018946|P2|STARTED|Overall Study||62
8121786|NCT02933879|20018947|P1|STARTED|Overall Study||64
8121787|NCT02933866|20018983|P2|NOT COMPLETED|Overall Study||9
8121788|NCT02933866|20018984|P1|NOT COMPLETED|Overall Study||12
8121789|NCT02933866|20018983|P2|COMPLETED|Overall Study||176
8121790|NCT02933866|20018984|P1|COMPLETED|Overall Study||174
8121791|NCT02933866|20018983|P2|STARTED|Overall Study||185
8121792|NCT02933866|20018984|P1|STARTED|Overall Study||186
8121793|NCT02933528|20018990|P1|NOT COMPLETED|Overall Study||2
8121794|NCT02933528|20018990|P1|COMPLETED|Overall Study||22
8121795|NCT02933528|20018990|P1|STARTED|Overall Study||24
8121796|NCT02933502|20018994|P1|NOT COMPLETED|Overall Study||0
8121797|NCT02933502|20018994|P1|COMPLETED|Overall Study||3
8121798|NCT02933502|20018994|P1|STARTED|Overall Study||3
8121799|NCT02933476|20018998|P1|NOT COMPLETED|Overall Study||0
8121800|NCT02933476|20018998|P1|COMPLETED|Overall Study||5
8121801|NCT02933476|20018998|P1|STARTED|Overall Study||5
8121802|NCT02933450|20019007|P2|NOT COMPLETED|Overall Study||8
8121803|NCT02933450|20019008|P1|NOT COMPLETED|Overall Study||5
8121804|NCT02933450|20019007|P2|COMPLETED|Overall Study||15
8121805|NCT02933450|20019008|P1|COMPLETED|Overall Study||15
8121806|NCT02933450|20019007|P2|STARTED|Overall Study||23
8121807|NCT02933450|20019008|P1|STARTED|Overall Study||20
8121808|NCT02933060|20019018|P2|NOT COMPLETED|Overall Study||1
8121809|NCT02933060|20019019|P1|NOT COMPLETED|Overall Study||0
8121810|NCT02933060|20019018|P2|COMPLETED|Overall Study||24
8121811|NCT02933060|20019019|P1|COMPLETED|Overall Study||25
8121812|NCT02933060|20019018|P2|STARTED|Overall Study||25
8121813|NCT02933060|20019019|P1|STARTED|Overall Study||25
8121814|NCT02933034|20019043|P1|NOT COMPLETED|Overall Study||9
8121815|NCT02933034|20019043|P1|COMPLETED|Overall Study||24
8121816|NCT02933034|20019043|P1|Received Both MEMRI and DEMRI Scans|Overall Study||24
8121817|NCT02933034|20019043|P1|STARTED|Overall Study||33
8121818|NCT02932943|20019060|P2|NOT COMPLETED|Overall Study||7
8121819|NCT02932943|20019061|P1|NOT COMPLETED|Overall Study||5
8121820|NCT02932943|20019060|P2|COMPLETED|Overall Study||224
8121821|NCT02932943|20019061|P1|COMPLETED|Overall Study||222
8121822|NCT02932943|20019060|P2|STARTED|Overall Study||231
8121823|NCT02932943|20019061|P1|STARTED|Overall Study||227
8121824|NCT02932904|20019077|P4|NOT COMPLETED|Overall Study||14
8121825|NCT02932904|20019078|P3|NOT COMPLETED|Overall Study||23
8121826|NCT02932904|20019079|P2|NOT COMPLETED|Overall Study||18
8121827|NCT02932904|20019080|P1|NOT COMPLETED|Overall Study||16
8121828|NCT02932904|20019077|P4|COMPLETED|Overall Study||79
8121829|NCT02932904|20019078|P3|COMPLETED|Overall Study||68
8121830|NCT02932904|20019079|P2|COMPLETED|Overall Study||67
8121831|NCT02932904|20019080|P1|COMPLETED|Overall Study||76
8121832|NCT02932904|20019077|P4|Treated|Overall Study||91
8121833|NCT02932904|20019078|P3|Treated|Overall Study||91
8121834|NCT02932904|20019079|P2|Treated|Overall Study||84
8121835|NCT02932904|20019080|P1|Treated|Overall Study||91
8121836|NCT02932904|20019077|P4|STARTED|Overall Study||93
8121837|NCT02932904|20019078|P3|STARTED|Overall Study||91
8121838|NCT02932904|20019079|P2|STARTED|Overall Study||85
8121839|NCT02932904|20019080|P1|STARTED|Overall Study||92
8121840|NCT02932891|20019115|P1|NOT COMPLETED|Overall Study||4
8121841|NCT02932891|20019115|P1|COMPLETED|Overall Study||24
8121842|NCT02932891|20019115|P1|STARTED|Overall Study||28
8121843|NCT02932878|20019121|P2|NOT COMPLETED|Overall Study||1
8121844|NCT02932878|20019122|P1|NOT COMPLETED|Overall Study||2
8121845|NCT02932878|20019121|P2|COMPLETED|Overall Study||0
8121846|NCT02932878|20019122|P1|COMPLETED|Overall Study||13
8121847|NCT02932878|20019121|P2|STARTED|Overall Study||1
8121848|NCT02932878|20019122|P1|STARTED|Overall Study||15
8121849|NCT02932787|20019130|P2|NOT COMPLETED|Overall Study||0
8121850|NCT02932787|20019131|P1|NOT COMPLETED|Overall Study||0
8121851|NCT02932787|20019130|P2|COMPLETED|Overall Study||9
8121852|NCT02932787|20019131|P1|COMPLETED|Overall Study||22
8121853|NCT02932787|20019130|P2|STARTED|Overall Study||9
8121854|NCT02932787|20019131|P1|STARTED|Overall Study||22
8121855|NCT02932462|20019143|P2|NOT COMPLETED|Overall Study||13
8121856|NCT02932462|20019144|P1|NOT COMPLETED|Overall Study||7
8121857|NCT02932462|20019143|P2|COMPLETED|Overall Study||176
8121858|NCT02932462|20019144|P1|COMPLETED|Overall Study||177
8121859|NCT02932462|20019143|P2|STARTED|Overall Study||189
8121860|NCT02932462|20019144|P1|STARTED|Overall Study||184
8121861|NCT02932306|20019156|P2|NOT COMPLETED|Overall Study||77
8121862|NCT02932306|20019157|P1|NOT COMPLETED|Overall Study||68
8121863|NCT02932306|20019156|P2|COMPLETED|Overall Study||337
8121864|NCT02932306|20019157|P1|COMPLETED|Overall Study||338
8121865|NCT02932306|20019156|P2|Safety Population|Overall Study||385
8121866|NCT02932306|20019157|P1|Safety Population|Overall Study||378
8121867|NCT02932306|20019156|P2|Intent-to-treat (ITT) Population|Overall Study||414
8121868|NCT02932306|20019157|P1|Intent-to-treat (ITT) Population|Overall Study||406
8121869|NCT02932306|20019156|P2|STARTED|Overall Study||414
8121870|NCT02932306|20019157|P1|STARTED|Overall Study||406
8121874|NCT02932228|20019177|P2|NOT COMPLETED|Overall Study||28
8121875|NCT02932228|20019178|P1|NOT COMPLETED|Overall Study||10
8121876|NCT02932228|20019177|P2|COMPLETED|Overall Study||405
8121877|NCT02932228|20019178|P1|COMPLETED|Overall Study||140
8121878|NCT02932228|20019177|P2|STARTED|Overall Study||433
8121879|NCT02932228|20019178|P1|STARTED|Overall Study||150
8121880|NCT02931838|20019203|P6|NOT COMPLETED|Overall Study||2
8121881|NCT02931838|20019204|P5|NOT COMPLETED|Overall Study||6
8121882|NCT02931838|20019205|P4|NOT COMPLETED|Overall Study||3
8121883|NCT02931838|20019206|P3|NOT COMPLETED|Overall Study||8
8121884|NCT02931838|20019207|P2|NOT COMPLETED|Overall Study||10
8121885|NCT02931838|20019208|P1|NOT COMPLETED|Overall Study||14
8121886|NCT02931838|20019203|P6|COMPLETED|Overall Study||42
8121887|NCT02931838|20019204|P5|COMPLETED|Overall Study||39
8121888|NCT02931838|20019205|P4|COMPLETED|Overall Study||42
8121889|NCT02931838|20019206|P3|COMPLETED|Overall Study||36
8121890|NCT02931838|20019207|P2|COMPLETED|Overall Study||34
8121891|NCT02931838|20019208|P1|COMPLETED|Overall Study||31
8121892|NCT02931838|20019203|P6|STARTED|Overall Study||44
8121893|NCT02931838|20019204|P5|STARTED|Overall Study||45
8121894|NCT02931838|20019205|P4|STARTED|Overall Study||45
8121895|NCT02931838|20019206|P3|STARTED|Overall Study||44
8121896|NCT02931838|20019207|P2|STARTED|Overall Study||44
8121897|NCT02931838|20019208|P1|STARTED|Overall Study||45
8121898|NCT02931396|20019259|P2|NOT COMPLETED|Overall Study||0
8121899|NCT02931396|20019260|P1|NOT COMPLETED|Overall Study||5
8121900|NCT02931396|20019259|P2|COMPLETED|Overall Study||10
8121901|NCT02931396|20019260|P1|COMPLETED|Overall Study||5
8121902|NCT02931396|20019259|P2|STARTED|Overall Study||10
8121903|NCT02931396|20019260|P1|STARTED|Overall Study||10
8121904|NCT02931253|20019272|P2|NOT COMPLETED|Overall Study||0
8121905|NCT02931253|20019273|P1|NOT COMPLETED|Overall Study||0
8121906|NCT02931253|20019272|P2|COMPLETED|Overall Study||4
8121907|NCT02931253|20019273|P1|COMPLETED|Overall Study||2
8121908|NCT02931253|20019272|P2|STARTED|Overall Study||4
8121909|NCT02931253|20019273|P1|STARTED|Overall Study||2
8121910|NCT02931045|20019295|P2|NOT COMPLETED|Overall Study||2
8121911|NCT02931045|20019296|P1|NOT COMPLETED|Overall Study||3
8121912|NCT02931045|20019295|P2|COMPLETED|Overall Study||28
8121913|NCT02931045|20019296|P1|COMPLETED|Overall Study||27
8121914|NCT02931045|20019295|P2|STARTED|Overall Study||30
8121915|NCT02931045|20019296|P1|STARTED|Overall Study||30
8121916|NCT02930980|20019302|P1|NOT COMPLETED|Overall Study||0
8121917|NCT02930980|20019302|P1|COMPLETED|Overall Study||43
8121918|NCT02930980|20019302|P1|STARTED|Overall Study||43
8121919|NCT02930837|20019306|P1|NOT COMPLETED|Overall Study||12
8121920|NCT02930837|20019306|P1|COMPLETED|Overall Study|Completed the trial|108
8121921|NCT02930837|20019306|P1|STARTED|Overall Study|Started are treated patients|120
8121922|NCT02930590|20019316|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
8121923|NCT02930590|20019317|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
8121924|NCT02930590|20019318|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
8121925|NCT02930590|20019319|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
8121926|NCT02930590|20019320|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
8121927|NCT02930590|20019321|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
8121928|NCT02930590|20019316|P6|COMPLETED|Third Intervention (2 Hours)||2
8121929|NCT02930590|20019317|P5|COMPLETED|Third Intervention (2 Hours)||2
8121930|NCT02930590|20019318|P4|COMPLETED|Third Intervention (2 Hours)||2
8121931|NCT02930590|20019319|P3|COMPLETED|Third Intervention (2 Hours)||3
8121932|NCT02930590|20019320|P2|COMPLETED|Third Intervention (2 Hours)||3
8121933|NCT02930590|20019321|P1|COMPLETED|Third Intervention (2 Hours)||3
8121934|NCT02930590|20019316|P6|STARTED|Third Intervention (2 Hours)||2
8121935|NCT02930590|20019317|P5|STARTED|Third Intervention (2 Hours)||2
8121936|NCT02930590|20019318|P4|STARTED|Third Intervention (2 Hours)||2
8121937|NCT02930590|20019319|P3|STARTED|Third Intervention (2 Hours)||3
8121938|NCT02930590|20019320|P2|STARTED|Third Intervention (2 Hours)||3
8121939|NCT02930590|20019321|P1|STARTED|Third Intervention (2 Hours)||3
8121940|NCT02930590|20019316|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
8121941|NCT02930590|20019317|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
8121942|NCT02930590|20019318|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
8121943|NCT02930590|20019319|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
8121944|NCT02930590|20019320|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
8121945|NCT02930590|20019321|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
8121946|NCT02930590|20019316|P6|COMPLETED|Second Intervention (2 Hours)||2
8121947|NCT02930590|20019317|P5|COMPLETED|Second Intervention (2 Hours)||2
8121948|NCT02930590|20019318|P4|COMPLETED|Second Intervention (2 Hours)||2
8121949|NCT02930590|20019319|P3|COMPLETED|Second Intervention (2 Hours)||3
8121950|NCT02930590|20019320|P2|COMPLETED|Second Intervention (2 Hours)||3
8121951|NCT02930590|20019321|P1|COMPLETED|Second Intervention (2 Hours)||3
8121952|NCT02930590|20019316|P6|STARTED|Second Intervention (2 Hours)||2
8121953|NCT02930590|20019317|P5|STARTED|Second Intervention (2 Hours)||2
8121954|NCT02930590|20019318|P4|STARTED|Second Intervention (2 Hours)||2
8121955|NCT02930590|20019319|P3|STARTED|Second Intervention (2 Hours)||3
8121956|NCT02930590|20019320|P2|STARTED|Second Intervention (2 Hours)||3
8121957|NCT02930590|20019321|P1|STARTED|Second Intervention (2 Hours)||3
8121958|NCT02930590|20019316|P6|NOT COMPLETED|First Intervention (2 Hours)||0
8121959|NCT02930590|20019317|P5|NOT COMPLETED|First Intervention (2 Hours)||0
8121960|NCT02930590|20019318|P4|NOT COMPLETED|First Intervention (2 Hours)||0
8121961|NCT02930590|20019319|P3|NOT COMPLETED|First Intervention (2 Hours)||0
8121962|NCT02930590|20019320|P2|NOT COMPLETED|First Intervention (2 Hours)||0
8121963|NCT02930590|20019321|P1|NOT COMPLETED|First Intervention (2 Hours)||0
8121964|NCT02930590|20019316|P6|COMPLETED|First Intervention (2 Hours)||2
8121965|NCT02930590|20019317|P5|COMPLETED|First Intervention (2 Hours)||2
8121966|NCT02930590|20019318|P4|COMPLETED|First Intervention (2 Hours)||2
8121967|NCT02930590|20019319|P3|COMPLETED|First Intervention (2 Hours)||3
8121968|NCT02930590|20019320|P2|COMPLETED|First Intervention (2 Hours)||3
8121969|NCT02930590|20019321|P1|COMPLETED|First Intervention (2 Hours)||3
8121970|NCT02930590|20019316|P6|STARTED|First Intervention (2 Hours)||2
8121971|NCT02930590|20019317|P5|STARTED|First Intervention (2 Hours)||2
8121972|NCT02930590|20019318|P4|STARTED|First Intervention (2 Hours)||2
8121973|NCT02930590|20019319|P3|STARTED|First Intervention (2 Hours)||3
8121974|NCT02930590|20019320|P2|STARTED|First Intervention (2 Hours)||3
8121975|NCT02930590|20019321|P1|STARTED|First Intervention (2 Hours)||3
8121994|NCT02930174|20019643|P2|NOT COMPLETED|Overall Study||0
8121995|NCT02930174|20019644|P1|NOT COMPLETED|Overall Study||0
8121996|NCT02930174|20019643|P2|COMPLETED|Overall Study||8
8121997|NCT02930174|20019644|P1|COMPLETED|Overall Study||12
8121998|NCT02930174|20019643|P2|STARTED|Overall Study||8
8121999|NCT02930174|20019644|P1|STARTED|Overall Study||12
8122000|NCT02930018|20019661|P2|NOT COMPLETED|Overall Study||3
8122001|NCT02930018|20019662|P1|NOT COMPLETED|Overall Study||6
8122002|NCT02930018|20019661|P2|COMPLETED|Overall Study||546
8122003|NCT02930018|20019662|P1|COMPLETED|Overall Study||550
8122004|NCT02930018|20019661|P2|STARTED|Overall Study||549
8122005|NCT02930018|20019662|P1|STARTED|Overall Study||556
8122006|NCT02930005|20019686|P2|NOT COMPLETED|Overall Study||5
8122007|NCT02930005|20019687|P1|NOT COMPLETED|Overall Study||1
8122008|NCT02930005|20019686|P2|COMPLETED|Overall Study||1
8122009|NCT02930005|20019687|P1|COMPLETED|Overall Study||1
8122010|NCT02930005|20019686|P2|Completed 2 Weeks|Overall Study||2
8122011|NCT02930005|20019687|P1|Completed 2 Weeks|Overall Study||2
8122012|NCT02930005|20019686|P2|STARTED|Overall Study||6
8122013|NCT02930005|20019687|P1|STARTED|Overall Study||2
8122014|NCT02929823|20019698|P3|NOT COMPLETED|Overall Study||4
8122015|NCT02929823|20019699|P2|NOT COMPLETED|Overall Study||6
8122016|NCT02929823|20019700|P1|NOT COMPLETED|Overall Study||3
8122017|NCT02929823|20019698|P3|COMPLETED|Overall Study||38
8122018|NCT02929823|20019699|P2|COMPLETED|Overall Study||40
8122019|NCT02929823|20019700|P1|COMPLETED|Overall Study||39
8122020|NCT02929823|20019698|P3|STARTED|Overall Study||42
8122021|NCT02929823|20019699|P2|STARTED|Overall Study||46
8122022|NCT02929823|20019700|P1|STARTED|Overall Study||42
8122023|NCT02929667|20019710|P2|NOT COMPLETED|Overall Study||0
8122024|NCT02929667|20019711|P1|NOT COMPLETED|Overall Study||0
8122025|NCT02929667|20019710|P2|COMPLETED|Overall Study||11
8122026|NCT02929667|20019711|P1|COMPLETED|Overall Study||11
8122027|NCT02929667|20019710|P2|STARTED|Overall Study||11
8122028|NCT02929667|20019711|P1|STARTED|Overall Study||11
8122029|NCT02929498|20019727|P3|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122030|NCT02929498|20019728|P2|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122031|NCT02929498|20019729|P1|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122032|NCT02929498|20019727|P3|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122033|NCT02929498|20019728|P2|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122034|NCT02929498|20019729|P1|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122035|NCT02929498|20019727|P3|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122036|NCT02929498|20019728|P2|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122037|NCT02929498|20019729|P1|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122038|NCT02929498|20019727|P3|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122039|NCT02929498|20019728|P2|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122040|NCT02929498|20019729|P1|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
8122041|NCT02929498|20019727|P3|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122042|NCT02929498|20019728|P2|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122043|NCT02929498|20019729|P1|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122044|NCT02929498|20019727|P3|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122045|NCT02929498|20019728|P2|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122046|NCT02929498|20019729|P1|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
8122047|NCT02929407|20019823|P1|NOT COMPLETED|Overall Study||1
8122048|NCT02929407|20019823|P1|COMPLETED|Overall Study||3
8122049|NCT02929407|20019823|P1|STARTED|Overall Study||4
8122050|NCT02928770|20019838|P1|NOT COMPLETED|Overall Study||2
8122051|NCT02928770|20019838|P1|COMPLETED|Overall Study||30
8122052|NCT02928770|20019838|P1|STARTED|Overall Study||32
8122053|NCT02928536|20019842|P1|NOT COMPLETED|Overall Study||0
8122054|NCT02928536|20019842|P1|COMPLETED|Overall Study||11902
8122055|NCT02928536|20019842|P1|STARTED|Overall Study||11902
8122056|NCT02928380|20019849|P6|NOT COMPLETED|Period 3||0
8122057|NCT02928380|20019850|P5|NOT COMPLETED|Period 3||0
8122058|NCT02928380|20019851|P4|NOT COMPLETED|Period 3||0
8122059|NCT02928380|20019852|P3|NOT COMPLETED|Period 3||0
8122060|NCT02928380|20019853|P2|NOT COMPLETED|Period 3||0
8122061|NCT02928380|20019854|P1|NOT COMPLETED|Period 3||0
8122062|NCT02928380|20019849|P6|COMPLETED|Period 3||14
8122063|NCT02928380|20019850|P5|COMPLETED|Period 3||14
8122064|NCT02928380|20019851|P4|COMPLETED|Period 3||14
8122065|NCT02928380|20019852|P3|COMPLETED|Period 3||14
8122066|NCT02928380|20019853|P2|COMPLETED|Period 3||14
8122067|NCT02928380|20019854|P1|COMPLETED|Period 3||13
8122068|NCT02928380|20019849|P6|STARTED|Period 3||14
8122069|NCT02928380|20019850|P5|STARTED|Period 3||14
8122070|NCT02928380|20019851|P4|STARTED|Period 3||14
8122071|NCT02928380|20019852|P3|STARTED|Period 3||14
8122072|NCT02928380|20019853|P2|STARTED|Period 3||14
8122073|NCT02928380|20019854|P1|STARTED|Period 3||13
8122074|NCT02928380|20019849|P6|NOT COMPLETED|Wash Out Period 2||0
8122075|NCT02928380|20019850|P5|NOT COMPLETED|Wash Out Period 2||0
8122076|NCT02928380|20019851|P4|NOT COMPLETED|Wash Out Period 2||0
8122077|NCT02928380|20019852|P3|NOT COMPLETED|Wash Out Period 2||0
8122078|NCT02928380|20019853|P2|NOT COMPLETED|Wash Out Period 2||0
8122079|NCT02928380|20019854|P1|NOT COMPLETED|Wash Out Period 2||0
8122080|NCT02928380|20019849|P6|COMPLETED|Wash Out Period 2||14
8122081|NCT02928380|20019850|P5|COMPLETED|Wash Out Period 2||14
8122082|NCT02928380|20019851|P4|COMPLETED|Wash Out Period 2||14
8122083|NCT02928380|20019852|P3|COMPLETED|Wash Out Period 2||14
8122084|NCT02928380|20019853|P2|COMPLETED|Wash Out Period 2||14
8122085|NCT02928380|20019854|P1|COMPLETED|Wash Out Period 2||13
8122086|NCT02928380|20019849|P6|STARTED|Wash Out Period 2||14
8122087|NCT02928380|20019850|P5|STARTED|Wash Out Period 2||14
8122088|NCT02928380|20019851|P4|STARTED|Wash Out Period 2||14
8122089|NCT02928380|20019852|P3|STARTED|Wash Out Period 2||14
8122090|NCT02928380|20019853|P2|STARTED|Wash Out Period 2||14
8122091|NCT02928380|20019854|P1|STARTED|Wash Out Period 2||13
8122092|NCT02928380|20019849|P6|NOT COMPLETED|Period 2||0
8122093|NCT02928380|20019850|P5|NOT COMPLETED|Period 2||0
8122094|NCT02928380|20019851|P4|NOT COMPLETED|Period 2||0
8122095|NCT02928380|20019852|P3|NOT COMPLETED|Period 2||0
8122096|NCT02928380|20019853|P2|NOT COMPLETED|Period 2||0
8122097|NCT02928380|20019854|P1|NOT COMPLETED|Period 2||0
8122098|NCT02928380|20019849|P6|COMPLETED|Period 2||14
8122099|NCT02928380|20019850|P5|COMPLETED|Period 2||14
8122100|NCT02928380|20019851|P4|COMPLETED|Period 2||14
8122101|NCT02928380|20019852|P3|COMPLETED|Period 2||14
8122102|NCT02928380|20019853|P2|COMPLETED|Period 2||14
8122103|NCT02928380|20019854|P1|COMPLETED|Period 2||13
8122104|NCT02928380|20019849|P6|STARTED|Period 2||14
8122105|NCT02928380|20019850|P5|STARTED|Period 2||14
8122106|NCT02928380|20019851|P4|STARTED|Period 2||14
8122107|NCT02928380|20019852|P3|STARTED|Period 2||14
8122108|NCT02928380|20019853|P2|STARTED|Period 2||14
8122109|NCT02928380|20019854|P1|STARTED|Period 2||13
8122110|NCT02928380|20019849|P6|NOT COMPLETED|Wash Out Period 1||0
8122111|NCT02928380|20019850|P5|NOT COMPLETED|Wash Out Period 1||0
8122112|NCT02928380|20019851|P4|NOT COMPLETED|Wash Out Period 1||0
8122113|NCT02928380|20019852|P3|NOT COMPLETED|Wash Out Period 1||0
8122114|NCT02928380|20019853|P2|NOT COMPLETED|Wash Out Period 1||0
8122115|NCT02928380|20019854|P1|NOT COMPLETED|Wash Out Period 1||0
8122116|NCT02928380|20019849|P6|COMPLETED|Wash Out Period 1||14
8122117|NCT02928380|20019850|P5|COMPLETED|Wash Out Period 1||14
8122118|NCT02928380|20019851|P4|COMPLETED|Wash Out Period 1||14
8122119|NCT02928380|20019852|P3|COMPLETED|Wash Out Period 1||14
8122120|NCT02928380|20019853|P2|COMPLETED|Wash Out Period 1||14
8122121|NCT02928380|20019854|P1|COMPLETED|Wash Out Period 1||13
8122122|NCT02928380|20019849|P6|STARTED|Wash Out Period 1||14
8122123|NCT02928380|20019850|P5|STARTED|Wash Out Period 1||14
8122124|NCT02928380|20019851|P4|STARTED|Wash Out Period 1||14
8122125|NCT02928380|20019852|P3|STARTED|Wash Out Period 1||14
8122126|NCT02928380|20019853|P2|STARTED|Wash Out Period 1||14
8122127|NCT02928380|20019854|P1|STARTED|Wash Out Period 1||13
8122128|NCT02928380|20019849|P6|NOT COMPLETED|Period 1||0
8122129|NCT02928380|20019850|P5|NOT COMPLETED|Period 1||0
8122130|NCT02928380|20019851|P4|NOT COMPLETED|Period 1||0
8122131|NCT02928380|20019852|P3|NOT COMPLETED|Period 1||0
8122132|NCT02928380|20019853|P2|NOT COMPLETED|Period 1||0
8122133|NCT02928380|20019854|P1|NOT COMPLETED|Period 1||0
8122134|NCT02928380|20019849|P6|COMPLETED|Period 1||14
8122135|NCT02928380|20019850|P5|COMPLETED|Period 1||14
8122136|NCT02928380|20019851|P4|COMPLETED|Period 1||14
8122137|NCT02928380|20019852|P3|COMPLETED|Period 1||14
8122138|NCT02928380|20019853|P2|COMPLETED|Period 1||14
8122139|NCT02928380|20019854|P1|COMPLETED|Period 1||13
8122140|NCT02928380|20019849|P6|STARTED|Period 1||14
8122141|NCT02928380|20019850|P5|STARTED|Period 1||14
8122142|NCT02928380|20019851|P4|STARTED|Period 1||14
8122143|NCT02928380|20019852|P3|STARTED|Period 1||14
8122144|NCT02928380|20019853|P2|STARTED|Period 1||14
8122145|NCT02928380|20019854|P1|STARTED|Period 1||13
8122158|NCT02928029|20019985|P2|NOT COMPLETED|Overall Study||4
8122159|NCT02928029|20019986|P1|NOT COMPLETED|Overall Study||3
8122160|NCT02928029|20019985|P2|COMPLETED|Overall Study||0
8122161|NCT02928029|20019986|P1|COMPLETED|Overall Study||0
8122162|NCT02928029|20019985|P2|STARTED|Overall Study||4
8122163|NCT02928029|20019986|P1|STARTED|Overall Study||3
8122164|NCT02927938|20020000|P4|NOT COMPLETED|Overall Study||7
8122165|NCT02927938|20020001|P3|NOT COMPLETED|Overall Study||4
8122166|NCT02927938|20020002|P2|NOT COMPLETED|Overall Study||6
8122167|NCT02927938|20020003|P1|NOT COMPLETED|Overall Study||1
8122168|NCT02927938|20020000|P4|COMPLETED|Overall Study||0
8122169|NCT02927938|20020001|P3|COMPLETED|Overall Study||0
8122170|NCT02927938|20020002|P2|COMPLETED|Overall Study||0
8122171|NCT02927938|20020003|P1|COMPLETED|Overall Study||0
8122172|NCT02927938|20020000|P4|STARTED|Overall Study||7
8122173|NCT02927938|20020001|P3|STARTED|Overall Study||4
8122174|NCT02927938|20020002|P2|STARTED|Overall Study||6
8122175|NCT02927938|20020003|P1|STARTED|Overall Study||1
8122176|NCT02927925|20020011|P1|NOT COMPLETED|Overall Study||32
8122177|NCT02927925|20020011|P1|COMPLETED|Overall Study||0
8122178|NCT02927925|20020011|P1|STARTED|Overall Study||32
8122179|NCT02927834|20020028|P3|NOT COMPLETED|Overall Study||2
8122180|NCT02927834|20020029|P2|NOT COMPLETED|Overall Study||2
8122181|NCT02927834|20020030|P1|NOT COMPLETED|Overall Study||1
8122182|NCT02927834|20020028|P3|COMPLETED|Overall Study||6
8122183|NCT02927834|20020029|P2|COMPLETED|Overall Study||6
8122184|NCT02927834|20020030|P1|COMPLETED|Overall Study||7
8122185|NCT02927834|20020028|P3|STARTED|Overall Study||8
8122186|NCT02927834|20020029|P2|STARTED|Overall Study||8
8122187|NCT02927834|20020030|P1|STARTED|Overall Study||8
8122188|NCT02927795|20020044|P1|NOT COMPLETED|Overall Study||23
8122189|NCT02927795|20020044|P1|COMPLETED|Overall Study||234
8122190|NCT02927795|20020044|P1|Treated|Overall Study||253
8122191|NCT02927795|20020044|P1|STARTED|Overall Study||257
8122192|NCT02927639|20020055|P2|NOT COMPLETED|Overall Study||69
8122193|NCT02927639|20020056|P1|NOT COMPLETED|Overall Study||73
8122194|NCT02927639|20020055|P2|COMPLETED|Overall Study||13
8122195|NCT02927639|20020056|P1|COMPLETED|Overall Study||10
8122196|NCT02927639|20020055|P2|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
8122197|NCT02927639|20020056|P1|STARTED|Overall Study||83
8122198|NCT02927457|20020064|P2|NOT COMPLETED|Overall Study||0
8122199|NCT02927457|20020065|P1|NOT COMPLETED|Overall Study||0
8122200|NCT02927457|20020064|P2|COMPLETED|Overall Study||11
8122201|NCT02927457|20020065|P1|COMPLETED|Overall Study||0
8122202|NCT02927457|20020064|P2|STARTED|Overall Study||11
8122203|NCT02927457|20020065|P1|STARTED|Overall Study||0
8122204|NCT02927431|20020100|P3|NOT COMPLETED|Overall Study||1
8122205|NCT02927431|20020101|P2|NOT COMPLETED|Overall Study||0
8122206|NCT02927431|20020102|P1|NOT COMPLETED|Overall Study||0
8122207|NCT02927431|20020100|P3|COMPLETED|Overall Study||3
8122208|NCT02927431|20020101|P2|COMPLETED|Overall Study||4
8122209|NCT02927431|20020102|P1|COMPLETED|Overall Study||2
8122210|NCT02927431|20020100|P3|STARTED|Overall Study||4
8122211|NCT02927431|20020101|P2|STARTED|Overall Study||4
8122212|NCT02927431|20020102|P1|STARTED|Overall Study||2
8122213|NCT02927366|20020180|P2|NOT COMPLETED|Overall Study||0
8122214|NCT02927366|20020181|P1|NOT COMPLETED|Overall Study||2
8122215|NCT02927366|20020180|P2|COMPLETED|Overall Study||2
8122216|NCT02927366|20020181|P1|COMPLETED|Overall Study||4
8122217|NCT02927366|20020180|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8122218|NCT02927366|20020181|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8122219|NCT02927366|20020180|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8122220|NCT02927366|20020181|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||6
8122221|NCT02927366|20020180|P2|STARTED|Overall Study||2
8122222|NCT02927366|20020181|P1|STARTED|Overall Study||6
8122223|NCT02927327|20020215|P2|NOT COMPLETED|Overall Study||0
8122224|NCT02927327|20020216|P1|NOT COMPLETED|Overall Study||0
8122225|NCT02927327|20020215|P2|COMPLETED|Overall Study||31
8122226|NCT02927327|20020216|P1|COMPLETED|Overall Study||30
8122227|NCT02927327|20020215|P2|STARTED|Overall Study||31
8122228|NCT02927327|20020216|P1|STARTED|Overall Study||30
8122229|NCT02927223|20020228|P1|NOT COMPLETED|Overall Study||0
8122230|NCT02927223|20020228|P1|COMPLETED|Overall Study||6
8122231|NCT02927223|20020228|P1|STARTED|Overall Study||6
8122232|NCT02927171|20020236|P2|NOT COMPLETED|Overall Study||1
8122233|NCT02927171|20020237|P1|NOT COMPLETED|Overall Study||0
8122234|NCT02927171|20020236|P2|COMPLETED|Overall Study||50
8122235|NCT02927171|20020237|P1|COMPLETED|Overall Study||53
8122236|NCT02927171|20020236|P2|STARTED|Overall Study||51
8122237|NCT02927171|20020237|P1|STARTED|Overall Study||53
8122238|NCT02926833|20020251|P4|NOT COMPLETED|Overall Study||23
8122239|NCT02926833|20020252|P3|NOT COMPLETED|Overall Study||7
8122240|NCT02926833|20020253|P2|NOT COMPLETED|Overall Study||4
8122241|NCT02926833|20020254|P1|NOT COMPLETED|Overall Study||3
8122242|NCT02926833|20020251|P4|COMPLETED|Overall Study||0
8122243|NCT02926833|20020252|P3|COMPLETED|Overall Study||0
8122244|NCT02926833|20020253|P2|COMPLETED|Overall Study||0
8122245|NCT02926833|20020254|P1|COMPLETED|Overall Study||0
8122246|NCT02926833|20020251|P4|STARTED|Overall Study||23
8122247|NCT02926833|20020252|P3|STARTED|Overall Study||7
8122248|NCT02926833|20020253|P2|STARTED|Overall Study||4
8122249|NCT02926833|20020254|P1|STARTED|Overall Study||3
8122250|NCT02926638|20020310|P2|NOT COMPLETED|Overall Study||5
8122251|NCT02926638|20020311|P1|NOT COMPLETED|Overall Study||4
8122252|NCT02926638|20020310|P2|COMPLETED|Overall Study||0
8122253|NCT02926638|20020311|P1|COMPLETED|Overall Study||0
8122254|NCT02926638|20020310|P2|Eligible|Overall Study||5
8122255|NCT02926638|20020311|P1|Eligible|Overall Study||3
8122256|NCT02926638|20020310|P2|STARTED|Overall Study||5
8122257|NCT02926638|20020311|P1|STARTED|Overall Study||4
8122258|NCT02926573|20020325|P2|NOT COMPLETED|Overall Study||9
8122259|NCT02926573|20020326|P1|NOT COMPLETED|Overall Study||11
8122260|NCT02926573|20020325|P2|COMPLETED|Overall Study||46
8122261|NCT02926573|20020326|P1|COMPLETED|Overall Study||44
8122262|NCT02926573|20020325|P2|STARTED|Overall Study||55
8122263|NCT02926573|20020326|P1|STARTED|Overall Study||55
8122264|NCT02926209|20020344|P2|NOT COMPLETED|Training Cohort - First Patients||0
8122265|NCT02926209|20020345|P1|NOT COMPLETED|Training Cohort - First Patients||0
8122266|NCT02926209|20020344|P2|COMPLETED|Training Cohort - First Patients||0
8122267|NCT02926209|20020345|P1|COMPLETED|Training Cohort - First Patients||20
8122268|NCT02926209|20020344|P2|STARTED|Training Cohort - First Patients||0
8122269|NCT02926209|20020345|P1|STARTED|Training Cohort - First Patients||20
8122270|NCT02926209|20020344|P2|NOT COMPLETED|Study Cohort||0
8122271|NCT02926209|20020345|P1|NOT COMPLETED|Study Cohort||1
8122272|NCT02926209|20020344|P2|COMPLETED|Study Cohort||37
8122273|NCT02926209|20020345|P1|COMPLETED|Study Cohort||41
8122274|NCT02926209|20020344|P2|STARTED|Study Cohort||37
8122275|NCT02926209|20020345|P1|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
8122276|NCT02925923|20020358|P2|NOT COMPLETED|Overall Study||2
8122277|NCT02925923|20020359|P1|NOT COMPLETED|Overall Study||0
8122278|NCT02925923|20020358|P2|COMPLETED|Overall Study||48
8122279|NCT02925923|20020359|P1|COMPLETED|Overall Study||50
8122280|NCT02925923|20020358|P2|STARTED|Overall Study||50
8122281|NCT02925923|20020359|P1|STARTED|Overall Study||50
8122282|NCT02925858|20020389|P2|NOT COMPLETED|Overall Study||0
8122283|NCT02925858|20020390|P1|NOT COMPLETED|Overall Study||0
8122284|NCT02925858|20020389|P2|COMPLETED|Overall Study||38
8122285|NCT02925858|20020390|P1|COMPLETED|Overall Study||42
8122286|NCT02925858|20020389|P2|STARTED|Overall Study||38
8122287|NCT02925858|20020390|P1|STARTED|Overall Study||42
8122288|NCT02925741|20020416|P2|NOT COMPLETED|Overall Study||0
8122289|NCT02925741|20020417|P1|NOT COMPLETED|Overall Study||11
8122290|NCT02925741|20020416|P2|COMPLETED|Overall Study||1706
8122291|NCT02925741|20020417|P1|COMPLETED|Overall Study||1626
8122292|NCT02925741|20020416|P2|STARTED|Overall Study||1706
8122293|NCT02925741|20020417|P1|STARTED|Overall Study||1637
8122294|NCT02925611|20020429|P2|NOT COMPLETED|Overall Study||0
8122295|NCT02925611|20020430|P1|NOT COMPLETED|Overall Study||0
8122296|NCT02925611|20020429|P2|COMPLETED|Overall Study||30
8122297|NCT02925611|20020430|P1|COMPLETED|Overall Study||30
8122298|NCT02925611|20020429|P2|STARTED|Overall Study||30
8122299|NCT02925611|20020430|P1|STARTED|Overall Study||30
8122300|NCT02925494|20020450|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||50
8122301|NCT02925494|20020451|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||24
8122302|NCT02925494|20020452|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||10
8122303|NCT02925494|20020453|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||14
8122304|NCT02925494|20020450|P4|COMPLETED|Post-Treatment Follow-Up Period||134
8122305|NCT02925494|20020451|P3|COMPLETED|Post-Treatment Follow-Up Period||64
8122306|NCT02925494|20020452|P2|COMPLETED|Post-Treatment Follow-Up Period||37
8122307|NCT02925494|20020453|P1|COMPLETED|Post-Treatment Follow-Up Period||40
8122308|NCT02925494|20020450|P4|STARTED|Post-Treatment Follow-Up Period||184
8122309|NCT02925494|20020451|P3|STARTED|Post-Treatment Follow-Up Period||88
8122310|NCT02925494|20020452|P2|STARTED|Post-Treatment Follow-Up Period||47
8122311|NCT02925494|20020453|P1|STARTED|Post-Treatment Follow-Up Period||54
8122312|NCT02925494|20020450|P4|NOT COMPLETED|Treatment Period||36
8122313|NCT02925494|20020451|P3|NOT COMPLETED|Treatment Period||19
8122314|NCT02925494|20020452|P2|NOT COMPLETED|Treatment Period||15
8122315|NCT02925494|20020453|P1|NOT COMPLETED|Treatment Period||9
8122316|NCT02925494|20020450|P4|COMPLETED|Treatment Period||182
8122317|NCT02925494|20020451|P3|COMPLETED|Treatment Period||79
8122318|NCT02925494|20020452|P2|COMPLETED|Treatment Period||43
8122319|NCT02925494|20020453|P1|COMPLETED|Treatment Period||50
8122320|NCT02925494|20020450|P4|STARTED|Treatment Period||218
8122321|NCT02925494|20020451|P3|STARTED|Treatment Period||98
8122322|NCT02925494|20020452|P2|STARTED|Treatment Period||58
8122323|NCT02925494|20020453|P1|STARTED|Treatment Period||59
8122324|NCT02925403|20020481|P2|NOT COMPLETED|Overall Study||1
8122325|NCT02925403|20020482|P1|NOT COMPLETED|Overall Study||0
8122326|NCT02925403|20020481|P2|COMPLETED|Overall Study||4
8122327|NCT02925403|20020482|P1|COMPLETED|Overall Study||8
8122328|NCT02925403|20020481|P2|STARTED|Overall Study||5
8122329|NCT02925403|20020482|P1|STARTED|Overall Study||8
8122330|NCT02925312|20020496|P2|NOT COMPLETED|Overall Study||0
8122331|NCT02925312|20020497|P1|NOT COMPLETED|Overall Study||27
8122332|NCT02925312|20020496|P2|COMPLETED|Overall Study||294
8122333|NCT02925312|20020497|P1|COMPLETED|Overall Study||98
8122334|NCT02925312|20020496|P2|STARTED|Overall Study||294
8122335|NCT02925312|20020497|P1|STARTED|Overall Study||125
8122336|NCT02925117|20020513|P12|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
8122337|NCT02925117|20020514|P11|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
8122338|NCT02925117|20020515|P10|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
8122339|NCT02925117|20020516|P9|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
8122340|NCT02925117|20020517|P8|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
8122341|NCT02925117|20020518|P7|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
8122342|NCT02925117|20020519|P6|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
8122343|NCT02925117|20020520|P5|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
8122344|NCT02925117|20020521|P4|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122345|NCT02925117|20020522|P3|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122346|NCT02925117|20020523|P2|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122347|NCT02925117|20020524|P1|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122348|NCT02925117|20020513|P12|COMPLETED|Period 2 (Weeks 16 - 88)||14
8122349|NCT02925117|20020514|P11|COMPLETED|Period 2 (Weeks 16 - 88)||11
8122350|NCT02925117|20020515|P10|COMPLETED|Period 2 (Weeks 16 - 88)||12
8122351|NCT02925117|20020516|P9|COMPLETED|Period 2 (Weeks 16 - 88)||13
8122352|NCT02925117|20020517|P8|COMPLETED|Period 2 (Weeks 16 - 88)||11
8122353|NCT02925117|20020518|P7|COMPLETED|Period 2 (Weeks 16 - 88)||9
8122354|NCT02925117|20020519|P6|COMPLETED|Period 2 (Weeks 16 - 88)||5
8122355|NCT02925117|20020520|P5|COMPLETED|Period 2 (Weeks 16 - 88)||8
8122356|NCT02925117|20020521|P4|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122357|NCT02925117|20020522|P3|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122358|NCT02925117|20020523|P2|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122359|NCT02925117|20020524|P1|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122360|NCT02925117|20020513|P12|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
8122361|NCT02925117|20020514|P11|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
8122362|NCT02925117|20020515|P10|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
8122363|NCT02925117|20020516|P9|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
8122364|NCT02925117|20020517|P8|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
8122365|NCT02925117|20020518|P7|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
8122366|NCT02925117|20020519|P6|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
8122367|NCT02925117|20020520|P5|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
8122368|NCT02925117|20020521|P4|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122369|NCT02925117|20020522|P3|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122370|NCT02925117|20020523|P2|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122371|NCT02925117|20020524|P1|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122372|NCT02925117|20020513|P12|STARTED|Period 2 (Weeks 16 - 88)||19
8122373|NCT02925117|20020514|P11|STARTED|Period 2 (Weeks 16 - 88)||19
8122374|NCT02925117|20020515|P10|STARTED|Period 2 (Weeks 16 - 88)||18
8122375|NCT02925117|20020516|P9|STARTED|Period 2 (Weeks 16 - 88)||19
8122376|NCT02925117|20020517|P8|STARTED|Period 2 (Weeks 16 - 88)||16
8122377|NCT02925117|20020518|P7|STARTED|Period 2 (Weeks 16 - 88)||15
8122378|NCT02925117|20020519|P6|STARTED|Period 2 (Weeks 16 - 88)||10
8122379|NCT02925117|20020520|P5|STARTED|Period 2 (Weeks 16 - 88)||10
8122380|NCT02925117|20020521|P4|STARTED|Period 2 (Weeks 16 - 88)||0
8122381|NCT02925117|20020522|P3|STARTED|Period 2 (Weeks 16 - 88)||0
8122382|NCT02925117|20020523|P2|STARTED|Period 2 (Weeks 16 - 88)||0
8122383|NCT02925117|20020524|P1|STARTED|Period 2 (Weeks 16 - 88)||0
8122384|NCT02925117|20020513|P12|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122385|NCT02925117|20020514|P11|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122386|NCT02925117|20020515|P10|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122387|NCT02925117|20020516|P9|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122388|NCT02925117|20020517|P8|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122389|NCT02925117|20020518|P7|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122390|NCT02925117|20020519|P6|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122391|NCT02925117|20020520|P5|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122392|NCT02925117|20020521|P4|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
8122393|NCT02925117|20020522|P3|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
8122394|NCT02925117|20020523|P2|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
8122395|NCT02925117|20020524|P1|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
8122396|NCT02925117|20020513|P12|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122397|NCT02925117|20020514|P11|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122398|NCT02925117|20020515|P10|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122399|NCT02925117|20020516|P9|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122400|NCT02925117|20020517|P8|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122401|NCT02925117|20020518|P7|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122402|NCT02925117|20020519|P6|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122403|NCT02925117|20020520|P5|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122404|NCT02925117|20020521|P4|COMPLETED|Period 1 (Weeks 0 - 16)||39
8122405|NCT02925117|20020522|P3|COMPLETED|Period 1 (Weeks 0 - 16)||37
8122406|NCT02925117|20020523|P2|COMPLETED|Period 1 (Weeks 0 - 16)||31
8122407|NCT02925117|20020524|P1|COMPLETED|Period 1 (Weeks 0 - 16)||23
8122408|NCT02925117|20020513|P12|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122409|NCT02925117|20020514|P11|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122410|NCT02925117|20020515|P10|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122411|NCT02925117|20020516|P9|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122412|NCT02925117|20020517|P8|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122413|NCT02925117|20020518|P7|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122414|NCT02925117|20020519|P6|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122415|NCT02925117|20020520|P5|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122416|NCT02925117|20020521|P4|Received Treatment|Period 1 (Weeks 0 - 16)||42
8122417|NCT02925117|20020522|P3|Received Treatment|Period 1 (Weeks 0 - 16)||42
8122418|NCT02925117|20020523|P2|Received Treatment|Period 1 (Weeks 0 - 16)||42
8122419|NCT02925117|20020524|P1|Received Treatment|Period 1 (Weeks 0 - 16)||40
8122420|NCT02925117|20020513|P12|STARTED|Period 1 (Weeks 0 - 16)||0
8122421|NCT02925117|20020514|P11|STARTED|Period 1 (Weeks 0 - 16)||0
8122422|NCT02925117|20020515|P10|STARTED|Period 1 (Weeks 0 - 16)||0
8122423|NCT02925117|20020516|P9|STARTED|Period 1 (Weeks 0 - 16)||0
8122424|NCT02925117|20020517|P8|STARTED|Period 1 (Weeks 0 - 16)||0
8122425|NCT02925117|20020518|P7|STARTED|Period 1 (Weeks 0 - 16)||0
8122426|NCT02925117|20020519|P6|STARTED|Period 1 (Weeks 0 - 16)||0
8122427|NCT02925117|20020520|P5|STARTED|Period 1 (Weeks 0 - 16)||0
8122428|NCT02925117|20020521|P4|STARTED|Period 1 (Weeks 0 - 16)||42
8122429|NCT02925117|20020522|P3|STARTED|Period 1 (Weeks 0 - 16)||42
8122430|NCT02925117|20020523|P2|STARTED|Period 1 (Weeks 0 - 16)||42
8122431|NCT02925117|20020524|P1|STARTED|Period 1 (Weeks 0 - 16)||41
8122432|NCT02925078|20020624|P2|NOT COMPLETED|Overall Study||3
8122433|NCT02925078|20020625|P1|NOT COMPLETED|Overall Study||1
8122434|NCT02925078|20020624|P2|COMPLETED|Overall Study||13
8122435|NCT02925078|20020625|P1|COMPLETED|Overall Study||13
8122436|NCT02925078|20020624|P2|STARTED|Overall Study||16
8122437|NCT02925078|20020625|P1|STARTED|Overall Study||14
8122444|NCT02924688|20020661|P6|NOT COMPLETED|Overall Study||24
8122445|NCT02924688|20020662|P5|NOT COMPLETED|Overall Study||23
8122446|NCT02924688|20020663|P4|NOT COMPLETED|Overall Study||28
8122447|NCT02924688|20020664|P3|NOT COMPLETED|Overall Study||23
8122448|NCT02924688|20020665|P2|NOT COMPLETED|Overall Study||31
8122449|NCT02924688|20020666|P1|NOT COMPLETED|Overall Study||33
8122450|NCT02924688|20020661|P6|COMPLETED|Overall Study||384
8122451|NCT02924688|20020662|P5|COMPLETED|Overall Study||381
8122452|NCT02924688|20020663|P4|COMPLETED|Overall Study||378
8122453|NCT02924688|20020664|P3|COMPLETED|Overall Study||383
8122454|NCT02924688|20020665|P2|COMPLETED|Overall Study||374
8122455|NCT02924688|20020666|P1|COMPLETED|Overall Study||374
8122456|NCT02924688|20020661|P6|STARTED|Overall Study||408
8122457|NCT02924688|20020662|P5|STARTED|Overall Study||404
8122458|NCT02924688|20020663|P4|STARTED|Overall Study||406
8122459|NCT02924688|20020664|P3|STARTED|Overall Study||406
8122460|NCT02924688|20020665|P2|STARTED|Overall Study||405
8122461|NCT02924688|20020666|P1|STARTED|Overall Study||407
8122462|NCT02924428|20020736|P2|NOT COMPLETED|Overall Study||5
8122463|NCT02924428|20020737|P1|NOT COMPLETED|Overall Study||4
8122464|NCT02924428|20020736|P2|COMPLETED|Overall Study||14
8122465|NCT02924428|20020737|P1|COMPLETED|Overall Study||16
8122466|NCT02924428|20020736|P2|STARTED|Overall Study||19
8122467|NCT02924428|20020737|P1|STARTED|Overall Study||20
8122468|NCT02924350|20020759|P2|NOT COMPLETED|Overall Study||2
8122469|NCT02924350|20020760|P1|NOT COMPLETED|Overall Study||0
8122470|NCT02924350|20020759|P2|COMPLETED|Overall Study||100
8122471|NCT02924350|20020760|P1|COMPLETED|Overall Study||102
8122472|NCT02924350|20020759|P2|STARTED|Overall Study||102
8122473|NCT02924350|20020760|P1|STARTED|Overall Study||102
8122474|NCT02924051|20020772|P2|NOT COMPLETED|Overall Study||9
8122475|NCT02924051|20020773|P1|NOT COMPLETED|Overall Study||1
8122476|NCT02924051|20020772|P2|COMPLETED|Overall Study||97
8122477|NCT02924051|20020773|P1|COMPLETED|Overall Study||81
8122478|NCT02924051|20020772|P2|STARTED|Overall Study||106
8122479|NCT02924051|20020773|P1|STARTED|Overall Study||82
8122480|NCT02923921|20020785|P2|NOT COMPLETED|Overall Study||57
8122481|NCT02923921|20020786|P1|NOT COMPLETED|Overall Study||53
8122482|NCT02923921|20020785|P2|COMPLETED|Overall Study||227
8122483|NCT02923921|20020786|P1|COMPLETED|Overall Study||230
8122484|NCT02923921|20020785|P2|Safety Population|Overall Study||251
8122485|NCT02923921|20020786|P1|Safety Population|Overall Study||278
8122486|NCT02923921|20020785|P2|Received at Least 1 Dose of Study Drug|Overall Study||251
8122487|NCT02923921|20020786|P1|Received at Least 1 Dose of Study Drug|Overall Study||278
8122488|NCT02923921|20020785|P2|STARTED|Overall Study||284
8122489|NCT02923921|20020786|P1|STARTED|Overall Study||283
8122490|NCT02923895|20020804|P2|NOT COMPLETED|Overall Study||0
8122491|NCT02923895|20020805|P1|NOT COMPLETED|Overall Study||0
8122492|NCT02923895|20020804|P2|COMPLETED|Overall Study||95
8122493|NCT02923895|20020805|P1|COMPLETED|Overall Study||97
8122494|NCT02923895|20020804|P2|STARTED|Overall Study||95
8122495|NCT02923895|20020805|P1|STARTED|Overall Study||97
8122496|NCT02923830|20020819|P2|NOT COMPLETED|Overall Study||15
8122497|NCT02923830|20020820|P1|NOT COMPLETED|Overall Study||13
8122498|NCT02923830|20020819|P2|COMPLETED|Overall Study|Study terminated|0
8122499|NCT02923830|20020820|P1|COMPLETED|Overall Study|Study terminated|0
8122500|NCT02923830|20020819|P2|STARTED|Overall Study||15
8122501|NCT02923830|20020820|P1|STARTED|Overall Study||13
8122502|NCT02923427|20020840|P2|NOT COMPLETED|Overall Study||2
8122503|NCT02923427|20020841|P1|NOT COMPLETED|Overall Study||4
8122504|NCT02923427|20020840|P2|COMPLETED|Overall Study|"The reasons:
~n = 2 Convert to Laparotomy"|55
8122505|NCT02923427|20020841|P1|COMPLETED|Overall Study|"The reasons:
~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
8122506|NCT02923427|20020840|P2|STARTED|Overall Study||57
8122507|NCT02923427|20020841|P1|STARTED|Overall Study||55
8122508|NCT02923349|20020868|P7|NOT COMPLETED|Overall Study||3
8122509|NCT02923349|20020869|P6|NOT COMPLETED|Overall Study||7
8122510|NCT02923349|20020870|P5|NOT COMPLETED|Overall Study||19
8122511|NCT02923349|20020871|P4|NOT COMPLETED|Overall Study||16
8122512|NCT02923349|20020872|P3|NOT COMPLETED|Overall Study||17
8122513|NCT02923349|20020873|P2|NOT COMPLETED|Overall Study||4
8122514|NCT02923349|20020874|P1|NOT COMPLETED|Overall Study||4
8122515|NCT02923349|20020868|P7|COMPLETED|Overall Study||1
8122516|NCT02923349|20020869|P6|COMPLETED|Overall Study||5
8122517|NCT02923349|20020870|P5|COMPLETED|Overall Study||4
8122518|NCT02923349|20020871|P4|COMPLETED|Overall Study||2
8122519|NCT02923349|20020872|P3|COMPLETED|Overall Study||5
8122520|NCT02923349|20020873|P2|COMPLETED|Overall Study||0
8122521|NCT02923349|20020874|P1|COMPLETED|Overall Study||0
8122522|NCT02923349|20020868|P7|STARTED|Overall Study||4
8122523|NCT02923349|20020869|P6|STARTED|Overall Study||12
8122524|NCT02923349|20020870|P5|STARTED|Overall Study||23
8122525|NCT02923349|20020871|P4|STARTED|Overall Study||18
8122526|NCT02923349|20020872|P3|STARTED|Overall Study||22
8122527|NCT02923349|20020873|P2|STARTED|Overall Study||4
8122528|NCT02923349|20020874|P1|STARTED|Overall Study||4
8122529|NCT02923271|20020948|P2|NOT COMPLETED|Overall Study||2
8122530|NCT02923271|20020949|P1|NOT COMPLETED|Overall Study||8
8122531|NCT02923271|20020948|P2|COMPLETED|Overall Study||14
8122532|NCT02923271|20020949|P1|COMPLETED|Overall Study||10
8122533|NCT02923271|20020948|P2|STARTED|Overall Study||16
8122534|NCT02923271|20020949|P1|STARTED|Overall Study||18
8122535|NCT02923245|20020959|P2|NOT COMPLETED|Overall Study||1
8122536|NCT02923245|20020960|P1|NOT COMPLETED|Overall Study||2
8122537|NCT02923245|20020959|P2|COMPLETED|Overall Study||59
8122538|NCT02923245|20020960|P1|COMPLETED|Overall Study||58
8122539|NCT02923245|20020959|P2|STARTED|Overall Study||60
8122540|NCT02923245|20020960|P1|STARTED|Overall Study||60
8122541|NCT02923115|20020983|P6|NOT COMPLETED|Overall Study||0
8122542|NCT02923115|20020984|P5|NOT COMPLETED|Overall Study||5
8122543|NCT02923115|20020985|P4|NOT COMPLETED|Overall Study||2
8122544|NCT02923115|20020986|P3|NOT COMPLETED|Overall Study||3
8122545|NCT02923115|20020987|P2|NOT COMPLETED|Overall Study||1
8122546|NCT02923115|20020988|P1|NOT COMPLETED|Overall Study||0
8122547|NCT02923115|20020983|P6|COMPLETED|Overall Study||38
8122548|NCT02923115|20020984|P5|COMPLETED|Overall Study||17
8122549|NCT02923115|20020985|P4|COMPLETED|Overall Study||21
8122550|NCT02923115|20020986|P3|COMPLETED|Overall Study||20
8122551|NCT02923115|20020987|P2|COMPLETED|Overall Study||15
8122552|NCT02923115|20020988|P1|COMPLETED|Overall Study||12
8122553|NCT02923115|20020983|P6|Treated|Overall Study||38
8122554|NCT02923115|20020984|P5|Treated|Overall Study||17
8122555|NCT02923115|20020985|P4|Treated|Overall Study||22
8122556|NCT02923115|20020986|P3|Treated|Overall Study||20
8122557|NCT02923115|20020987|P2|Treated|Overall Study||16
8122558|NCT02923115|20020988|P1|Treated|Overall Study||12
8122559|NCT02923115|20020983|P6|STARTED|Overall Study||38
8122560|NCT02923115|20020984|P5|STARTED|Overall Study||22
8122561|NCT02923115|20020985|P4|STARTED|Overall Study||23
8122562|NCT02923115|20020986|P3|STARTED|Overall Study||23
8122563|NCT02923115|20020987|P2|STARTED|Overall Study||16
8122564|NCT02923115|20020988|P1|STARTED|Overall Study||12
8122565|NCT02922985|20021031|P2|NOT COMPLETED|Overall Study||0
8122566|NCT02922985|20021032|P1|NOT COMPLETED|Overall Study||0
8122567|NCT02922985|20021031|P2|COMPLETED|Overall Study||60
8122568|NCT02922985|20021032|P1|COMPLETED|Overall Study||60
8122569|NCT02922985|20021031|P2|STARTED|Overall Study||60
8122570|NCT02922985|20021032|P1|STARTED|Overall Study||60
8122571|NCT02922959|20021058|P2|NOT COMPLETED|Overall Study||17
8122572|NCT02922959|20021059|P1|NOT COMPLETED|Overall Study||19
8122573|NCT02922959|20021058|P2|COMPLETED|Overall Study||23
8122574|NCT02922959|20021059|P1|COMPLETED|Overall Study||21
8122575|NCT02922959|20021058|P2|12 Months|Overall Study|n=23 (57.5%)|23
8122576|NCT02922959|20021059|P1|12 Months|Overall Study|n=21 (52.5%)|21
8122577|NCT02922959|20021058|P2|6 Months|Overall Study|n=30 (75.0%)|30
8122578|NCT02922959|20021059|P1|6 Months|Overall Study|n=28 (70.0%)|28
8122579|NCT02922959|20021058|P2|3 Months|Overall Study|n=31 (77.5%)|31
8122580|NCT02922959|20021059|P1|3 Months|Overall Study|n=35 (87.5%)|35
8122581|NCT02922959|20021058|P2|3 Weeks|Overall Study|n=36 (90.0%)|36
8122582|NCT02922959|20021059|P1|3 Weeks|Overall Study|n=38 (95.0%)|38
8122583|NCT02922959|20021058|P2|STARTED|Overall Study||40
8122584|NCT02922959|20021059|P1|STARTED|Overall Study||40
8122585|NCT02922868|20021073|P2|NOT COMPLETED|Overall Study||0
8122586|NCT02922868|20021074|P1|NOT COMPLETED|Overall Study||0
8122587|NCT02922868|20021073|P2|COMPLETED|Overall Study||30
8122588|NCT02922868|20021074|P1|COMPLETED|Overall Study||30
8122589|NCT02922868|20021073|P2|STARTED|Overall Study||30
8122590|NCT02922868|20021074|P1|STARTED|Overall Study||30
8122591|NCT02922738|20021094|P2|NOT COMPLETED|Overall Study||0
8122592|NCT02922738|20021095|P1|NOT COMPLETED|Overall Study||0
8122593|NCT02922738|20021094|P2|COMPLETED|Overall Study||290
8122594|NCT02922738|20021095|P1|COMPLETED|Overall Study||175
8122595|NCT02922738|20021094|P2|STARTED|Overall Study|275 patients and 15 providers|290
8122596|NCT02922738|20021095|P1|STARTED|Overall Study|158 patients and 17 providers|175
8122597|NCT02922582|20021107|P4|NOT COMPLETED|Overall Study||0
8122598|NCT02922582|20021108|P3|NOT COMPLETED|Overall Study||0
8122599|NCT02922582|20021109|P2|NOT COMPLETED|Overall Study||1
8122600|NCT02922582|20021110|P1|NOT COMPLETED|Overall Study||0
8122601|NCT02922582|20021107|P4|COMPLETED|Overall Study||4
8122602|NCT02922582|20021108|P3|COMPLETED|Overall Study||4
8122603|NCT02922582|20021109|P2|COMPLETED|Overall Study||3
8122604|NCT02922582|20021110|P1|COMPLETED|Overall Study||4
8122605|NCT02922582|20021107|P4|STARTED|Overall Study||4
8122606|NCT02922582|20021108|P3|STARTED|Overall Study||4
8122607|NCT02922582|20021109|P2|STARTED|Overall Study||4
8122608|NCT02922582|20021110|P1|STARTED|Overall Study||4
8122609|NCT02922153|20021170|P2|NOT COMPLETED|Overall Study||2
8122610|NCT02922153|20021171|P1|NOT COMPLETED|Overall Study||10
8122611|NCT02922153|20021170|P2|COMPLETED|Overall Study||17
8122612|NCT02922153|20021171|P1|COMPLETED|Overall Study||55
8122613|NCT02922153|20021170|P2|STARTED|Overall Study||19
8122614|NCT02922153|20021171|P1|STARTED|Overall Study||65
8122615|NCT02921841|20021195|P2|NOT COMPLETED|Overall Study||13
8122616|NCT02921841|20021196|P1|NOT COMPLETED|Overall Study||16
8122617|NCT02921841|20021195|P2|COMPLETED|Overall Study||44
8122618|NCT02921841|20021196|P1|COMPLETED|Overall Study||52
8122619|NCT02921841|20021195|P2|STARTED|Overall Study||57
8122620|NCT02921841|20021196|P1|STARTED|Overall Study||68
8122621|NCT02921750|20021230|P2|NOT COMPLETED|Overall Study||11
8122622|NCT02921750|20021231|P1|NOT COMPLETED|Overall Study||9
8122623|NCT02921750|20021230|P2|COMPLETED|Overall Study||113
8122624|NCT02921750|20021231|P1|COMPLETED|Overall Study||115
8122625|NCT02921750|20021230|P2|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
8122626|NCT02921750|20021231|P1|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
8122627|NCT02921750|20021230|P2|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
8122628|NCT02921750|20021231|P1|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
8122629|NCT02921750|20021230|P2|Completed 6 Weeks Follow-up (PP)|Overall Study||104
8122630|NCT02921750|20021231|P1|Completed 6 Weeks Follow-up (PP)|Overall Study||97
8122631|NCT02921750|20021230|P2|Per Protocol (PP)|Overall Study||107
8122632|NCT02921750|20021231|P1|Per Protocol (PP)|Overall Study||100
8122633|NCT02921750|20021230|P2|Intention to Treat (ITT)|Overall Study||123
8122634|NCT02921750|20021231|P1|Intention to Treat (ITT)|Overall Study||122
8122635|NCT02921750|20021230|P2|STARTED|Overall Study||124
8122636|NCT02921750|20021231|P1|STARTED|Overall Study||124
8122637|NCT02921490|20021251|P1|NOT COMPLETED|Overall Study||0
8122638|NCT02921490|20021251|P1|COMPLETED|Overall Study||10
8122639|NCT02921490|20021251|P1|STARTED|Overall Study||10
8122640|NCT02921425|20021262|P1|NOT COMPLETED|Overall Study||9
8122641|NCT02921425|20021262|P1|COMPLETED|Overall Study||38
8122642|NCT02921425|20021262|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
8122643|NCT02921425|20021262|P1|STARTED|Overall Study||47
8122644|NCT02921412|20021276|P1|NOT COMPLETED|Overall Study||0
8122645|NCT02921412|20021276|P1|COMPLETED|Overall Study||36
8122646|NCT02921412|20021276|P1|STARTED|Overall Study||36
8122647|NCT02921386|20021299|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
8122648|NCT02921386|20021299|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
8122649|NCT02921386|20021299|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
8122650|NCT02921386|20021299|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
8122651|NCT02921386|20021299|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
8122652|NCT02921386|20021299|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
8122653|NCT02921386|20021299|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
8122654|NCT02921386|20021299|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
8122655|NCT02921386|20021299|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
8122656|NCT02921386|20021299|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
8122657|NCT02921386|20021299|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
8122658|NCT02921386|20021299|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
8122659|NCT02921386|20021299|P1|NOT COMPLETED|Sequence A: Fasting||0
8122660|NCT02921386|20021299|P1|COMPLETED|Sequence A: Fasting||18
8122661|NCT02921386|20021299|P1|STARTED|Sequence A: Fasting||18
8122662|NCT02921295|20021322|P1|NOT COMPLETED|Conventional Prostheses||0
8122663|NCT02921295|20021322|P1|COMPLETED|Conventional Prostheses||1
8122664|NCT02921295|20021322|P1|STARTED|Conventional Prostheses||1
8122665|NCT02921295|20021322|P1|NOT COMPLETED|Sidekicks||0
8122666|NCT02921295|20021322|P1|COMPLETED|Sidekicks||1
8122667|NCT02921295|20021322|P1|STARTED|Sidekicks||1
8122668|NCT02921087|20021334|P2|NOT COMPLETED|Overall Study||1
8122669|NCT02921087|20021335|P1|NOT COMPLETED|Overall Study||0
8122670|NCT02921087|20021334|P2|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
8122671|NCT02921087|20021335|P1|COMPLETED|Overall Study||12
8122672|NCT02921087|20021334|P2|STARTED|Overall Study||11
8122673|NCT02921087|20021335|P1|STARTED|Overall Study||12
8122674|NCT02921061|20021355|P1|NOT COMPLETED|Overall Study||0
8122675|NCT02921061|20021355|P1|COMPLETED|Overall Study||28
8122676|NCT02921061|20021355|P1|STARTED|Overall Study||28
8122677|NCT02920983|20021364|P6|NOT COMPLETED|Dispense 3||0
8122678|NCT02920983|20021365|P5|NOT COMPLETED|Dispense 3||1
8122679|NCT02920983|20021366|P4|NOT COMPLETED|Dispense 3||0
8122680|NCT02920983|20021367|P3|NOT COMPLETED|Dispense 3||0
8122681|NCT02920983|20021368|P2|NOT COMPLETED|Dispense 3||1
8122682|NCT02920983|20021369|P1|NOT COMPLETED|Dispense 3||1
8122683|NCT02920983|20021364|P6|COMPLETED|Dispense 3||7
8122684|NCT02920983|20021365|P5|COMPLETED|Dispense 3||12
8122685|NCT02920983|20021366|P4|COMPLETED|Dispense 3||6
8122686|NCT02920983|20021367|P3|COMPLETED|Dispense 3||7
8122687|NCT02920983|20021368|P2|COMPLETED|Dispense 3||9
8122688|NCT02920983|20021369|P1|COMPLETED|Dispense 3||7
8122689|NCT02920983|20021364|P6|STARTED|Dispense 3||7
8122690|NCT02920983|20021365|P5|STARTED|Dispense 3||13
8122691|NCT02920983|20021366|P4|STARTED|Dispense 3||6
8122692|NCT02920983|20021367|P3|STARTED|Dispense 3||7
8122693|NCT02920983|20021368|P2|STARTED|Dispense 3||10
8122694|NCT02920983|20021369|P1|STARTED|Dispense 3||8
8122695|NCT02920983|20021364|P6|NOT COMPLETED|Dispense 2||0
8122696|NCT02920983|20021365|P5|NOT COMPLETED|Dispense 2||1
8122697|NCT02920983|20021366|P4|NOT COMPLETED|Dispense 2||0
8122698|NCT02920983|20021367|P3|NOT COMPLETED|Dispense 2||0
8122699|NCT02920983|20021368|P2|NOT COMPLETED|Dispense 2||0
8122700|NCT02920983|20021369|P1|NOT COMPLETED|Dispense 2||1
8122701|NCT02920983|20021364|P6|COMPLETED|Dispense 2||7
8122702|NCT02920983|20021365|P5|COMPLETED|Dispense 2||12
8122703|NCT02920983|20021366|P4|COMPLETED|Dispense 2||6
8122704|NCT02920983|20021367|P3|COMPLETED|Dispense 2||7
8122705|NCT02920983|20021368|P2|COMPLETED|Dispense 2||10
8122706|NCT02920983|20021369|P1|COMPLETED|Dispense 2||7
8122707|NCT02920983|20021364|P6|STARTED|Dispense 2||7
8122708|NCT02920983|20021365|P5|STARTED|Dispense 2||13
8122709|NCT02920983|20021366|P4|STARTED|Dispense 2||6
8122710|NCT02920983|20021367|P3|STARTED|Dispense 2||7
8122711|NCT02920983|20021368|P2|STARTED|Dispense 2||10
8122712|NCT02920983|20021369|P1|STARTED|Dispense 2||8
8122713|NCT02920983|20021364|P6|NOT COMPLETED|Dispense 1||0
8122714|NCT02920983|20021365|P5|NOT COMPLETED|Dispense 1||1
8122715|NCT02920983|20021366|P4|NOT COMPLETED|Dispense 1||0
8122716|NCT02920983|20021367|P3|NOT COMPLETED|Dispense 1||0
8122717|NCT02920983|20021368|P2|NOT COMPLETED|Dispense 1||0
8122718|NCT02920983|20021369|P1|NOT COMPLETED|Dispense 1||0
8122719|NCT02920983|20021364|P6|COMPLETED|Dispense 1||7
8122720|NCT02920983|20021365|P5|COMPLETED|Dispense 1||12
8122721|NCT02920983|20021366|P4|COMPLETED|Dispense 1||6
8122722|NCT02920983|20021367|P3|COMPLETED|Dispense 1||7
8122723|NCT02920983|20021368|P2|COMPLETED|Dispense 1||10
8122724|NCT02920983|20021369|P1|COMPLETED|Dispense 1||8
8122725|NCT02920983|20021364|P6|STARTED|Dispense 1||7
8122726|NCT02920983|20021365|P5|STARTED|Dispense 1||13
8122727|NCT02920983|20021366|P4|STARTED|Dispense 1||6
8122728|NCT02920983|20021367|P3|STARTED|Dispense 1||7
8122729|NCT02920983|20021368|P2|STARTED|Dispense 1||10
8122730|NCT02920983|20021369|P1|STARTED|Dispense 1||8
8122731|NCT02920970|20021398|P2|NOT COMPLETED|Second Intervention||0
8122732|NCT02920970|20021399|P1|NOT COMPLETED|Second Intervention||1
8122733|NCT02920970|20021398|P2|COMPLETED|Second Intervention||30
8122734|NCT02920970|20021399|P1|COMPLETED|Second Intervention||37
8122735|NCT02920970|20021398|P2|STARTED|Second Intervention||30
8122736|NCT02920970|20021399|P1|STARTED|Second Intervention||38
8122737|NCT02920970|20021398|P2|NOT COMPLETED|First Intervention||2
8122738|NCT02920970|20021399|P1|NOT COMPLETED|First Intervention||0
8122739|NCT02920970|20021398|P2|COMPLETED|First Intervention||30
8122740|NCT02920970|20021399|P1|COMPLETED|First Intervention||38
8122741|NCT02920970|20021398|P2|STARTED|First Intervention||32
8122742|NCT02920970|20021399|P1|STARTED|First Intervention||38
8122743|NCT02920957|20021425|P2|NOT COMPLETED|Second Intervention: 1 Month||1
8122744|NCT02920957|20021426|P1|NOT COMPLETED|Second Intervention: 1 Month||0
8122745|NCT02920957|20021425|P2|COMPLETED|Second Intervention: 1 Month||40
8122746|NCT02920957|20021426|P1|COMPLETED|Second Intervention: 1 Month||42
8122747|NCT02920957|20021425|P2|STARTED|Second Intervention: 1 Month||41
8122748|NCT02920957|20021426|P1|STARTED|Second Intervention: 1 Month||42
8122749|NCT02920957|20021425|P2|NOT COMPLETED|First Intervention : 1 Month||0
8122750|NCT02920957|20021426|P1|NOT COMPLETED|First Intervention : 1 Month||4
8122751|NCT02920957|20021425|P2|COMPLETED|First Intervention : 1 Month||41
8122752|NCT02920957|20021426|P1|COMPLETED|First Intervention : 1 Month||42
8122753|NCT02920957|20021425|P2|STARTED|First Intervention : 1 Month||41
8122754|NCT02920957|20021426|P1|STARTED|First Intervention : 1 Month||46
8122755|NCT02920918|20021480|P2|NOT COMPLETED|Overall Study||0
8122756|NCT02920918|20021481|P1|NOT COMPLETED|Overall Study||0
8122757|NCT02920918|20021480|P2|COMPLETED|Overall Study||19
8122758|NCT02920918|20021481|P1|COMPLETED|Overall Study||17
8122759|NCT02920918|20021480|P2|STARTED|Overall Study||19
8122760|NCT02920918|20021481|P1|STARTED|Overall Study||17
8122761|NCT02920749|20021493|P4|NOT COMPLETED|Overall Study||0
8122762|NCT02920749|20021494|P3|NOT COMPLETED|Overall Study||0
8122763|NCT02920749|20021495|P2|NOT COMPLETED|Overall Study||0
8122764|NCT02920749|20021496|P1|NOT COMPLETED|Overall Study||0
8122765|NCT02920749|20021493|P4|COMPLETED|Overall Study||30
8122766|NCT02920749|20021494|P3|COMPLETED|Overall Study||30
8122767|NCT02920749|20021495|P2|COMPLETED|Overall Study||30
8122768|NCT02920749|20021496|P1|COMPLETED|Overall Study||30
8122769|NCT02920749|20021493|P4|STARTED|Overall Study||30
8122770|NCT02920749|20021494|P3|STARTED|Overall Study||30
8122771|NCT02920749|20021495|P2|STARTED|Overall Study||30
8122772|NCT02920749|20021496|P1|STARTED|Overall Study||30
8122776|NCT02920450|20021515|P4|NOT COMPLETED|Overall Study||0
8122777|NCT02920450|20021516|P3|NOT COMPLETED|Overall Study||0
8122778|NCT02920450|20021517|P2|NOT COMPLETED|Overall Study||0
8122779|NCT02920450|20021518|P1|NOT COMPLETED|Overall Study||2
8122780|NCT02920450|20021515|P4|COMPLETED|Overall Study||0
8122781|NCT02920450|20021516|P3|COMPLETED|Overall Study||0
8122782|NCT02920450|20021517|P2|COMPLETED|Overall Study||0
8122783|NCT02920450|20021518|P1|COMPLETED|Overall Study||1
8122784|NCT02920450|20021515|P4|STARTED|Overall Study||0
8122785|NCT02920450|20021516|P3|STARTED|Overall Study||0
8122786|NCT02920450|20021517|P2|STARTED|Overall Study||0
8122787|NCT02920450|20021518|P1|STARTED|Overall Study||3
8122788|NCT02920242|20021529|P3|NOT COMPLETED|Overall Study||1
8122789|NCT02920242|20021530|P2|NOT COMPLETED|Overall Study||0
8122790|NCT02920242|20021531|P1|NOT COMPLETED|Overall Study||2
8122791|NCT02920242|20021529|P3|COMPLETED|Overall Study||3
8122792|NCT02920242|20021530|P2|COMPLETED|Overall Study||11
8122793|NCT02920242|20021531|P1|COMPLETED|Overall Study||11
8122794|NCT02920242|20021529|P3|Safety Set|Overall Study||4
8122795|NCT02920242|20021530|P2|Safety Set|Overall Study||11
8122796|NCT02920242|20021531|P1|Safety Set|Overall Study||12
8122797|NCT02920242|20021529|P3|STARTED|Overall Study||4
8122798|NCT02920242|20021530|P2|STARTED|Overall Study||11
8122799|NCT02920242|20021531|P1|STARTED|Overall Study||13
8122800|NCT02920177|20021559|P2|NOT COMPLETED|Overall Study||2
8122801|NCT02920177|20021560|P1|NOT COMPLETED|Overall Study||2
8122802|NCT02920177|20021559|P2|COMPLETED|Overall Study||0
8122803|NCT02920177|20021560|P1|COMPLETED|Overall Study||0
8122804|NCT02920177|20021559|P2|STARTED|Overall Study||2
8122805|NCT02920177|20021560|P1|STARTED|Overall Study||2
8122806|NCT02919995|20021580|P6|NOT COMPLETED|Overall Study||1
8122807|NCT02919995|20021581|P5|NOT COMPLETED|Overall Study||0
8122808|NCT02919995|20021582|P4|NOT COMPLETED|Overall Study||0
8122809|NCT02919995|20021583|P3|NOT COMPLETED|Overall Study||0
8122810|NCT02919995|20021584|P2|NOT COMPLETED|Overall Study||0
8122811|NCT02919995|20021585|P1|NOT COMPLETED|Overall Study||0
8122812|NCT02919995|20021580|P6|COMPLETED|Overall Study||1
8122813|NCT02919995|20021581|P5|COMPLETED|Overall Study||1
8122814|NCT02919995|20021582|P4|COMPLETED|Overall Study||2
8122815|NCT02919995|20021583|P3|COMPLETED|Overall Study||2
8122816|NCT02919995|20021584|P2|COMPLETED|Overall Study||2
8122817|NCT02919995|20021585|P1|COMPLETED|Overall Study||1
8122818|NCT02919995|20021580|P6|STARTED|Overall Study||2
8122819|NCT02919995|20021581|P5|STARTED|Overall Study||1
8122820|NCT02919995|20021582|P4|STARTED|Overall Study||2
8122821|NCT02919995|20021583|P3|STARTED|Overall Study||2
8122822|NCT02919995|20021584|P2|STARTED|Overall Study||2
8122823|NCT02919995|20021585|P1|STARTED|Overall Study||1
8122824|NCT02919826|20021612|P2|NOT COMPLETED|Overall Study||2
8122825|NCT02919826|20021613|P1|NOT COMPLETED|Overall Study||0
8122826|NCT02919826|20021612|P2|COMPLETED|Overall Study||8
8122827|NCT02919826|20021613|P1|COMPLETED|Overall Study||10
8122828|NCT02919826|20021612|P2|STARTED|Overall Study||10
8122829|NCT02919826|20021613|P1|STARTED|Overall Study||10
8122830|NCT02919813|20021629|P2|NOT COMPLETED|Overall Study||0
8122831|NCT02919813|20021630|P1|NOT COMPLETED|Overall Study||0
8122832|NCT02919813|20021629|P2|COMPLETED|Overall Study||17
8122833|NCT02919813|20021630|P1|COMPLETED|Overall Study||14
8122834|NCT02919813|20021629|P2|STARTED|Overall Study||17
8122835|NCT02919813|20021630|P1|STARTED|Overall Study||14
8122836|NCT02919761|20021648|P3|NOT COMPLETED|Part 2: Double-blind||21
8122837|NCT02919761|20021649|P2|NOT COMPLETED|Part 2: Double-blind||6
8122838|NCT02919761|20021650|P1|NOT COMPLETED|Part 2: Double-blind||0
8122839|NCT02919761|20021648|P3|COMPLETED|Part 2: Double-blind||56
8122840|NCT02919761|20021649|P2|COMPLETED|Part 2: Double-blind||71
8122841|NCT02919761|20021650|P1|COMPLETED|Part 2: Double-blind||0
8122842|NCT02919761|20021648|P3|Per Protocol Population|Part 2: Double-blind||73
8122843|NCT02919761|20021649|P2|Per Protocol Population|Part 2: Double-blind||76
8122844|NCT02919761|20021650|P1|Per Protocol Population|Part 2: Double-blind||0
8122845|NCT02919761|20021648|P3|mITT Population|Part 2: Double-blind||76
8122846|NCT02919761|20021649|P2|mITT Population|Part 2: Double-blind||77
8122847|NCT02919761|20021650|P1|mITT Population|Part 2: Double-blind||0
8122848|NCT02919761|20021648|P3|Safety Population|Part 2: Double-blind||77
8122849|NCT02919761|20021649|P2|Safety Population|Part 2: Double-blind||77
8122850|NCT02919761|20021650|P1|Safety Population|Part 2: Double-blind||0
8122851|NCT02919761|20021648|P3|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
8122852|NCT02919761|20021649|P2|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
8122853|NCT02919761|20021650|P1|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
8122854|NCT02919761|20021648|P3|NOT COMPLETED|Part 1: Open Label||0
8122855|NCT02919761|20021649|P2|NOT COMPLETED|Part 1: Open Label||0
8122856|NCT02919761|20021650|P1|NOT COMPLETED|Part 1: Open Label||24
8122857|NCT02919761|20021648|P3|COMPLETED|Part 1: Open Label||0
8122858|NCT02919761|20021649|P2|COMPLETED|Part 1: Open Label||0
8122859|NCT02919761|20021650|P1|COMPLETED|Part 1: Open Label||235
8122860|NCT02919761|20021648|P3|Per Protocol Population|Part 1: Open Label||0
8122861|NCT02919761|20021649|P2|Per Protocol Population|Part 1: Open Label||0
8122862|NCT02919761|20021650|P1|Per Protocol Population|Part 1: Open Label||236
8122863|NCT02919761|20021648|P3|Safety Population|Part 1: Open Label||0
8122864|NCT02919761|20021649|P2|Safety Population|Part 1: Open Label||0
8122865|NCT02919761|20021650|P1|Safety Population|Part 1: Open Label||259
8122866|NCT02919761|20021648|P3|mITT Population|Part 1: Open Label||0
8122867|NCT02919761|20021649|P2|mITT Population|Part 1: Open Label||0
8122868|NCT02919761|20021650|P1|mITT Population|Part 1: Open Label||259
8122869|NCT02919761|20021648|P3|STARTED|Part 1: Open Label||0
8122870|NCT02919761|20021649|P2|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
8122871|NCT02919761|20021650|P1|STARTED|Part 1: Open Label||259
8122872|NCT02919696|20021678|P2|NOT COMPLETED|Overall Study||5
8122873|NCT02919696|20021679|P1|NOT COMPLETED|Overall Study||4
8122874|NCT02919696|20021678|P2|COMPLETED|Overall Study||9
8122875|NCT02919696|20021679|P1|COMPLETED|Overall Study||8
8122876|NCT02919696|20021678|P2|Progressive Disease|Overall Study||9
8122877|NCT02919696|20021679|P1|Progressive Disease|Overall Study||7
8122878|NCT02919696|20021678|P2|Death On Treatment|Overall Study||0
8122879|NCT02919696|20021679|P1|Death On Treatment|Overall Study||1
8122880|NCT02919696|20021678|P2|PK 150 mg Abemaciclib Dose|Overall Study||2
8122881|NCT02919696|20021679|P1|PK 150 mg Abemaciclib Dose|Overall Study||0
8122882|NCT02919696|20021678|P2|PK 100 mg Abemaciclib Dose|Overall Study||0
8122883|NCT02919696|20021679|P1|PK 100 mg Abemaciclib Dose|Overall Study||5
8122884|NCT02919696|20021678|P2|Received at Least One Dose of Study Drug|Overall Study||13
8122885|NCT02919696|20021679|P1|Received at Least One Dose of Study Drug|Overall Study||12
8122886|NCT02919696|20021678|P2|STARTED|Overall Study||14
8122887|NCT02919696|20021679|P1|STARTED|Overall Study||12
8122888|NCT02919683|20021701|P2|NOT COMPLETED|Post-Surgery Follow-Up||2
8122889|NCT02919683|20021702|P1|NOT COMPLETED|Post-Surgery Follow-Up||3
8122890|NCT02919683|20021701|P2|COMPLETED|Post-Surgery Follow-Up||13
8122891|NCT02919683|20021702|P1|COMPLETED|Post-Surgery Follow-Up||12
8122892|NCT02919683|20021701|P2|STARTED|Post-Surgery Follow-Up||15
8122893|NCT02919683|20021702|P1|STARTED|Post-Surgery Follow-Up||15
8122894|NCT02919683|20021701|P2|NOT COMPLETED|Pre-Surgery Intervention||0
8122895|NCT02919683|20021702|P1|NOT COMPLETED|Pre-Surgery Intervention||0
8122896|NCT02919683|20021701|P2|COMPLETED|Pre-Surgery Intervention||15
8122897|NCT02919683|20021702|P1|COMPLETED|Pre-Surgery Intervention||15
8122898|NCT02919683|20021701|P2|STARTED|Pre-Surgery Intervention||15
8122899|NCT02919683|20021702|P1|STARTED|Pre-Surgery Intervention||15
8122900|NCT02919657|20021708|P2|NOT COMPLETED|Overall Study||0
8122901|NCT02919657|20021709|P1|NOT COMPLETED|Overall Study||0
8122902|NCT02919657|20021708|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
8122903|NCT02919657|20021709|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
8122904|NCT02919657|20021708|P2|STARTED|Overall Study|10 Participants|10
8122905|NCT02919657|20021709|P1|STARTED|Overall Study|10 Participants|10
8122906|NCT02919618|20021715|P1|NOT COMPLETED|Overall Study||1
8122907|NCT02919618|20021715|P1|COMPLETED|Overall Study||18
8122908|NCT02919618|20021715|P1|Primary Efficacy Endpoint (6 Months)|Overall Study||18
8122909|NCT02919618|20021715|P1|Primary Safety Endpoint (</=90 Days)|Overall Study||19
8122910|NCT02919618|20021715|P1|STARTED|Overall Study||19
8122911|NCT02919423|20021734|P2|NOT COMPLETED|Overall Study||9
8122912|NCT02919423|20021735|P1|NOT COMPLETED|Overall Study||2
8122913|NCT02919423|20021734|P2|COMPLETED|Overall Study||16
8122914|NCT02919423|20021735|P1|COMPLETED|Overall Study||4
8122915|NCT02919423|20021734|P2|STARTED|Overall Study||25
8122916|NCT02919423|20021735|P1|STARTED|Overall Study||6
8122917|NCT02919267|20021745|P4|NOT COMPLETED|Overall Study||4
8122918|NCT02919267|20021746|P3|NOT COMPLETED|Overall Study||3
8122919|NCT02919267|20021747|P2|NOT COMPLETED|Overall Study||3
8122920|NCT02919267|20021748|P1|NOT COMPLETED|Overall Study||0
8122921|NCT02919267|20021745|P4|COMPLETED|Overall Study||10
8122922|NCT02919267|20021746|P3|COMPLETED|Overall Study||10
8122923|NCT02919267|20021747|P2|COMPLETED|Overall Study||9
8122924|NCT02919267|20021748|P1|COMPLETED|Overall Study||10
8122925|NCT02919267|20021745|P4|STARTED|Overall Study||14
8122926|NCT02919267|20021746|P3|STARTED|Overall Study||13
8122927|NCT02919267|20021747|P2|STARTED|Overall Study||12
8122928|NCT02919267|20021748|P1|STARTED|Overall Study||10
8122929|NCT02919111|20021758|P1|NOT COMPLETED|Overall Study||0
8122930|NCT02919111|20021758|P1|COMPLETED|Overall Study||299
8122931|NCT02919111|20021758|P1|STARTED|Overall Study||299
8122932|NCT02919007|20021778|P1|NOT COMPLETED|Overall Study||0
8122933|NCT02919007|20021778|P1|COMPLETED|Overall Study||25
8122934|NCT02919007|20021778|P1|STARTED|Overall Study||25
8122935|NCT02918773|20021784|P2|NOT COMPLETED|Overall Study||0
8122936|NCT02918773|20021785|P1|NOT COMPLETED|Overall Study||0
8122937|NCT02918773|20021784|P2|COMPLETED|Overall Study||11
8122938|NCT02918773|20021785|P1|COMPLETED|Overall Study||11
8122939|NCT02918773|20021784|P2|STARTED|Overall Study||11
8122940|NCT02918773|20021785|P1|STARTED|Overall Study||11
8122941|NCT02918721|20021796|P1|NOT COMPLETED|Overall Study||0
8122942|NCT02918721|20021796|P1|COMPLETED|Overall Study||70
8122943|NCT02918721|20021796|P1|STARTED|Overall Study||70
8122944|NCT02918669|20021801|P1|NOT COMPLETED|Overall Study||4
8122945|NCT02918669|20021801|P1|COMPLETED|Overall Study||8
8122946|NCT02918669|20021801|P1|STARTED|Overall Study||12
8122947|NCT02918656|20021811|P3|NOT COMPLETED|Overall Study||0
8122948|NCT02918656|20021812|P2|NOT COMPLETED|Overall Study||0
8122949|NCT02918656|20021813|P1|NOT COMPLETED|Overall Study||0
8122950|NCT02918656|20021811|P3|COMPLETED|Overall Study||57
8122951|NCT02918656|20021812|P2|COMPLETED|Overall Study||60
8122952|NCT02918656|20021813|P1|COMPLETED|Overall Study||54
8122953|NCT02918656|20021811|P3|STARTED|Overall Study||57
8122954|NCT02918656|20021812|P2|STARTED|Overall Study||60
8122955|NCT02918656|20021813|P1|STARTED|Overall Study||54
8122956|NCT02918630|20021832|P2|NOT COMPLETED|Overall Study||0
8122957|NCT02918630|20021833|P1|NOT COMPLETED|Overall Study||0
8122958|NCT02918630|20021832|P2|COMPLETED|Overall Study||3
8122959|NCT02918630|20021833|P1|COMPLETED|Overall Study||4
8122960|NCT02918630|20021832|P2|STARTED|Overall Study||3
8122961|NCT02918630|20021833|P1|STARTED|Overall Study||4
8122962|NCT02918617|20021856|P9|NOT COMPLETED|Overall Study||0
8122963|NCT02918617|20021857|P8|NOT COMPLETED|Overall Study||1
8122964|NCT02918617|20021858|P7|NOT COMPLETED|Overall Study||0
8122965|NCT02918617|20021859|P6|NOT COMPLETED|Overall Study||0
8122966|NCT02918617|20021860|P5|NOT COMPLETED|Overall Study||0
8122967|NCT02918617|20021861|P4|NOT COMPLETED|Overall Study||0
8122968|NCT02918617|20021862|P3|NOT COMPLETED|Overall Study||3
8122969|NCT02918617|20021863|P2|NOT COMPLETED|Overall Study||0
8122970|NCT02918617|20021864|P1|NOT COMPLETED|Overall Study||1
8122971|NCT02918617|20021856|P9|COMPLETED|Overall Study||26
8122972|NCT02918617|20021857|P8|COMPLETED|Overall Study||25
8122973|NCT02918617|20021858|P7|COMPLETED|Overall Study||22
8122974|NCT02918617|20021859|P6|COMPLETED|Overall Study||20
8122975|NCT02918617|20021860|P5|COMPLETED|Overall Study||24
8122976|NCT02918617|20021861|P4|COMPLETED|Overall Study||22
8122977|NCT02918617|20021862|P3|COMPLETED|Overall Study||19
8122978|NCT02918617|20021863|P2|COMPLETED|Overall Study||20
8122979|NCT02918617|20021864|P1|COMPLETED|Overall Study||20
8122980|NCT02918617|20021856|P9|STARTED|Overall Study||26
8122981|NCT02918617|20021857|P8|STARTED|Overall Study||26
8122982|NCT02918617|20021858|P7|STARTED|Overall Study||22
8122983|NCT02918617|20021859|P6|STARTED|Overall Study||20
8122984|NCT02918617|20021860|P5|STARTED|Overall Study||24
8122985|NCT02918617|20021861|P4|STARTED|Overall Study||22
8122986|NCT02918617|20021862|P3|STARTED|Overall Study||22
8122987|NCT02918617|20021863|P2|STARTED|Overall Study||20
8122988|NCT02918617|20021864|P1|STARTED|Overall Study||21
8122989|NCT02918552|20021913|P2|NOT COMPLETED|Overall Study||2
8122990|NCT02918552|20021914|P1|NOT COMPLETED|Overall Study||1
8122991|NCT02918552|20021913|P2|COMPLETED|Overall Study||6
8122992|NCT02918552|20021914|P1|COMPLETED|Overall Study||6
8122993|NCT02918552|20021913|P2|STARTED|Overall Study||8
8122994|NCT02918552|20021914|P1|STARTED|Overall Study||7
8122995|NCT02918396|20021951|P3|NOT COMPLETED|Overall Study||0
8122996|NCT02918396|20021952|P2|NOT COMPLETED|Overall Study||0
8122997|NCT02918396|20021953|P1|NOT COMPLETED|Overall Study||0
8122998|NCT02918396|20021951|P3|COMPLETED|Overall Study||2
8122999|NCT02918396|20021952|P2|COMPLETED|Overall Study||1
8123000|NCT02918396|20021953|P1|COMPLETED|Overall Study||2
8123001|NCT02918396|20021951|P3|STARTED|Overall Study||2
8123002|NCT02918396|20021952|P2|STARTED|Overall Study||1
8123003|NCT02918396|20021953|P1|STARTED|Overall Study||2
8123004|NCT02918357|20021961|P1|NOT COMPLETED|Overall Study||0
8123005|NCT02918357|20021961|P1|COMPLETED|Overall Study||385
8123006|NCT02918357|20021961|P1|PET/CT Scan|Overall Study||385
8123007|NCT02918357|20021961|P1|Investigational Drug Administration|Overall Study||385
8123008|NCT02918357|20021961|P1|STARTED|Overall Study||385
8123009|NCT02918318|20021990|P5|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
8123010|NCT02918318|20021991|P4|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123011|NCT02918318|20021992|P3|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123012|NCT02918318|20021993|P2|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123013|NCT02918318|20021994|P1|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123014|NCT02918318|20021990|P5|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
8123015|NCT02918318|20021991|P4|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123016|NCT02918318|20021992|P3|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123017|NCT02918318|20021993|P2|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123018|NCT02918318|20021994|P1|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123019|NCT02918318|20021990|P5|STARTED|Open Label Follow-up Phase: 4 Weeks||48
8123020|NCT02918318|20021991|P4|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123021|NCT02918318|20021992|P3|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123022|NCT02918318|20021993|P2|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123023|NCT02918318|20021994|P1|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123024|NCT02918318|20021990|P5|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
8123025|NCT02918318|20021991|P4|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123026|NCT02918318|20021992|P3|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123027|NCT02918318|20021993|P2|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123028|NCT02918318|20021994|P1|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123029|NCT02918318|20021990|P5|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
8123030|NCT02918318|20021991|P4|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123031|NCT02918318|20021992|P3|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123032|NCT02918318|20021993|P2|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123033|NCT02918318|20021994|P1|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123034|NCT02918318|20021990|P5|STARTED|Open Label Treatment Phase: 4 Weeks||48
8123035|NCT02918318|20021991|P4|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123036|NCT02918318|20021992|P3|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123037|NCT02918318|20021993|P2|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123038|NCT02918318|20021994|P1|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123039|NCT02918318|20021990|P5|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
8123040|NCT02918318|20021991|P4|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
8123041|NCT02918318|20021992|P3|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
8123042|NCT02918318|20021993|P2|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
8123043|NCT02918318|20021994|P1|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
8123044|NCT02918318|20021990|P5|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
8123045|NCT02918318|20021991|P4|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
8123046|NCT02918318|20021992|P3|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
8123047|NCT02918318|20021993|P2|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
8123048|NCT02918318|20021994|P1|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
8123049|NCT02918318|20021990|P5|STARTED|Posttreatment Phase: Up to 24 Weeks||0
8123050|NCT02918318|20021991|P4|STARTED|Posttreatment Phase: Up to 24 Weeks||27
8123051|NCT02918318|20021992|P3|STARTED|Posttreatment Phase: Up to 24 Weeks||17
8123052|NCT02918318|20021993|P2|STARTED|Posttreatment Phase: Up to 24 Weeks||11
8123053|NCT02918318|20021994|P1|STARTED|Posttreatment Phase: Up to 24 Weeks||13
8123054|NCT02918318|20021990|P5|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
8123055|NCT02918318|20021991|P4|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
8123056|NCT02918318|20021992|P3|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
8123057|NCT02918318|20021993|P2|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
8123058|NCT02918318|20021994|P1|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
8123059|NCT02918318|20021990|P5|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
8123060|NCT02918318|20021991|P4|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
8123061|NCT02918318|20021992|P3|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
8123062|NCT02918318|20021993|P2|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
8123063|NCT02918318|20021994|P1|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
8123064|NCT02918318|20021990|P5|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
8123065|NCT02918318|20021991|P4|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
8123066|NCT02918318|20021992|P3|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
8123067|NCT02918318|20021993|P2|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
8123068|NCT02918318|20021994|P1|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
8123069|NCT02918318|20021990|P5|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
8123070|NCT02918318|20021991|P4|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
8123071|NCT02918318|20021992|P3|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
8123072|NCT02918318|20021993|P2|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
8123073|NCT02918318|20021994|P1|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
8123074|NCT02918318|20021990|P5|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
8123075|NCT02918318|20021991|P4|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
8123076|NCT02918318|20021992|P3|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
8123077|NCT02918318|20021993|P2|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
8123078|NCT02918318|20021994|P1|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
8123079|NCT02918318|20021990|P5|Responders|Double-blind Induction Phase: 4 Weeks||0
8123080|NCT02918318|20021991|P4|Responders|Double-blind Induction Phase: 4 Weeks||27
8123081|NCT02918318|20021992|P3|Responders|Double-blind Induction Phase: 4 Weeks||17
8123082|NCT02918318|20021993|P2|Responders|Double-blind Induction Phase: 4 Weeks||11
8123083|NCT02918318|20021994|P1|Responders|Double-blind Induction Phase: 4 Weeks||13
8123084|NCT02918318|20021990|P5|STARTED|Double-blind Induction Phase: 4 Weeks||0
8123085|NCT02918318|20021991|P4|STARTED|Double-blind Induction Phase: 4 Weeks||80
8123086|NCT02918318|20021992|P3|STARTED|Double-blind Induction Phase: 4 Weeks||41
8123087|NCT02918318|20021993|P2|STARTED|Double-blind Induction Phase: 4 Weeks||40
8123088|NCT02918318|20021994|P1|STARTED|Double-blind Induction Phase: 4 Weeks||41
8123089|NCT02918279|20022055|P2|NOT COMPLETED|Overall Study||23
8123090|NCT02918279|20022056|P1|NOT COMPLETED|Overall Study||13
8123091|NCT02918279|20022055|P2|COMPLETED|Overall Study||103
8123092|NCT02918279|20022056|P1|COMPLETED|Overall Study||112
8123093|NCT02918279|20022055|P2|Safety Analysis Set|Overall Study||126
8123094|NCT02918279|20022056|P1|Safety Analysis Set|Overall Study||125
8123095|NCT02918279|20022055|P2|Full Analysis Set|Overall Study||126
8123096|NCT02918279|20022056|P1|Full Analysis Set|Overall Study||125
8123097|NCT02918279|20022055|P2|STARTED|Overall Study||126
8123098|NCT02918279|20022056|P1|STARTED|Overall Study||125
8123099|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123100|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123101|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123102|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123103|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123104|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123105|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123106|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123107|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123108|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123109|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123110|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123111|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123112|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123113|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123114|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123115|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123116|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123117|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123118|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123119|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123120|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123121|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123122|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123123|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123124|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123125|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123126|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123127|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123128|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123129|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123130|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123131|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123132|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123133|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123134|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123135|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123136|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123137|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123138|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123139|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123140|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123141|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123142|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123143|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123144|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123145|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123146|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123147|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123148|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123149|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123150|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123151|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123152|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123153|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123154|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123155|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123156|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123157|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123158|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123159|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123160|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123161|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123162|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123163|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123164|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123165|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123166|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123167|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123168|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123169|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123170|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123171|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123172|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123173|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123174|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123175|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123176|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123177|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123178|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123179|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123180|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123181|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123182|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123183|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123184|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123185|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123186|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123187|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123188|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123189|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123190|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123191|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123192|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123193|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123194|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123195|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123196|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123197|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123198|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123199|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123200|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123201|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123202|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123203|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123204|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123205|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123206|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123207|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123208|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123209|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123210|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123211|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123212|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123213|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123214|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123215|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123216|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123217|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123218|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123219|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123220|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123221|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123222|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123223|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123224|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123225|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123226|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123227|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123228|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123229|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123230|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123231|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123232|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123233|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123234|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123235|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123236|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123237|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123238|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123239|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123240|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123241|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123242|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123243|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123244|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123245|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123246|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123247|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123248|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123249|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123250|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123251|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123252|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123253|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123254|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123255|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123256|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123257|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123258|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123259|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123260|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123261|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123262|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123263|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123264|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123265|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123266|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123267|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123268|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123269|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123270|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123271|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123272|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123273|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123274|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123275|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123276|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123277|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123278|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123279|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123280|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123281|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123282|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123283|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123284|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123285|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123286|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123287|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123288|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123289|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123290|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123291|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123292|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123293|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123294|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123295|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123296|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123297|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123298|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123299|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123300|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123301|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123302|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123303|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123304|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123305|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123306|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123307|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123308|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123309|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123310|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123311|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123312|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123313|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123314|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123315|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123316|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123317|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123318|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123319|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123320|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123321|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123322|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123323|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123324|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123325|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123326|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123327|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123328|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123329|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123330|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123331|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123332|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123333|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123334|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123335|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123336|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123337|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123338|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123339|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123340|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123341|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123342|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123343|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123344|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123345|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123346|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123347|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123348|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123349|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123350|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123351|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123352|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123353|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123354|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123355|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123356|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123357|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123358|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123359|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123360|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123361|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123362|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123363|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123364|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123365|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
8123366|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123367|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
8123368|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123369|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123370|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123371|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123372|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123373|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123374|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123375|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123376|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123377|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123378|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123379|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123380|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123381|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123382|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123383|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123384|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123385|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123386|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123387|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 1 (2 Days)||2
8123388|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123389|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 1 (2 Days)||2
8123390|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123391|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123392|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123393|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123394|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123395|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 1 (2 Days)||0
8123396|NCT02918266|20022192|P11|NOT COMPLETED|Part 1||0
8123397|NCT02918266|20022193|P10|NOT COMPLETED|Part 1||0
8123398|NCT02918266|20022194|P9|NOT COMPLETED|Part 1||0
8123399|NCT02918266|20022195|P8|NOT COMPLETED|Part 1||0
8123400|NCT02918266|20022196|P7|NOT COMPLETED|Part 1||0
8123401|NCT02918266|20022197|P6|NOT COMPLETED|Part 1||0
8123402|NCT02918266|20022198|P5|NOT COMPLETED|Part 1||0
8123403|NCT02918266|20022199|P4|NOT COMPLETED|Part 1||0
8123404|NCT02918266|20022200|P3|NOT COMPLETED|Part 1||0
8123405|NCT02918266|20022201|P2|NOT COMPLETED|Part 1||0
8123406|NCT02918266|20022202|P1|NOT COMPLETED|Part 1||0
8123407|NCT02918266|20022192|P11|COMPLETED|Part 1||0
8123408|NCT02918266|20022193|P10|COMPLETED|Part 1||0
8123409|NCT02918266|20022194|P9|COMPLETED|Part 1||0
8123410|NCT02918266|20022195|P8|COMPLETED|Part 1||0
8123411|NCT02918266|20022196|P7|COMPLETED|Part 1||0
8123412|NCT02918266|20022197|P6|COMPLETED|Part 1||0
8123413|NCT02918266|20022198|P5|COMPLETED|Part 1||0
8123414|NCT02918266|20022199|P4|COMPLETED|Part 1||0
8123415|NCT02918266|20022200|P3|COMPLETED|Part 1||0
8123416|NCT02918266|20022201|P2|COMPLETED|Part 1||0
8123417|NCT02918266|20022202|P1|COMPLETED|Part 1||6
8123418|NCT02918266|20022192|P11|STARTED|Part 1||0
8123419|NCT02918266|20022193|P10|STARTED|Part 1||0
8123420|NCT02918266|20022194|P9|STARTED|Part 1||0
8123421|NCT02918266|20022195|P8|STARTED|Part 1||0
8123422|NCT02918266|20022196|P7|STARTED|Part 1||0
8123423|NCT02918266|20022197|P6|STARTED|Part 1||0
8123424|NCT02918266|20022198|P5|STARTED|Part 1||0
8123425|NCT02918266|20022199|P4|STARTED|Part 1||0
8123426|NCT02918266|20022200|P3|STARTED|Part 1||0
8123427|NCT02918266|20022201|P2|STARTED|Part 1||0
8123428|NCT02918266|20022202|P1|STARTED|Part 1||6
8123429|NCT02918097|20022301|P1|NOT COMPLETED|Overall Study||20
8123430|NCT02918097|20022301|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
8123431|NCT02918097|20022301|P1|STARTED|Overall Study||78
8123432|NCT02918071|20022307|P1|NOT COMPLETED|Overall Study||3
8123433|NCT02918071|20022307|P1|COMPLETED|Overall Study||118
8123434|NCT02918071|20022307|P1|STARTED|Overall Study||121
8123435|NCT02917941|20022317|P1|NOT COMPLETED|Survival Follow-up Period||5
8123436|NCT02917941|20022317|P1|COMPLETED|Survival Follow-up Period||26
8123437|NCT02917941|20022317|P1|STARTED|Survival Follow-up Period||31
8123438|NCT02917941|20022317|P1|NOT COMPLETED|Treatment Period||24
8123439|NCT02917941|20022317|P1|COMPLETED|Treatment Period||10
8123440|NCT02917941|20022317|P1|STARTED|Treatment Period||34
8123441|NCT02917642|20022331|P2|NOT COMPLETED|Overall Study||0
8123442|NCT02917642|20022332|P1|NOT COMPLETED|Overall Study||0
8123443|NCT02917642|20022331|P2|COMPLETED|Overall Study||25
8123444|NCT02917642|20022332|P1|COMPLETED|Overall Study||25
8123445|NCT02917642|20022331|P2|STARTED|Overall Study||25
8123446|NCT02917642|20022332|P1|STARTED|Overall Study||25
8123447|NCT02917603|20022342|P2|NOT COMPLETED|Overall Study||4
8123448|NCT02917603|20022343|P1|NOT COMPLETED|Overall Study||1
8123449|NCT02917603|20022342|P2|COMPLETED|Overall Study||16
8123450|NCT02917603|20022343|P1|COMPLETED|Overall Study||19
8123451|NCT02917603|20022342|P2|STARTED|Overall Study||20
8123452|NCT02917603|20022343|P1|STARTED|Overall Study||20
8123453|NCT02917447|20022357|P2|NOT COMPLETED|Overall Study||3
8123454|NCT02917447|20022358|P1|NOT COMPLETED|Overall Study||7
8123455|NCT02917447|20022357|P2|COMPLETED|Overall Study||48
8123456|NCT02917447|20022358|P1|COMPLETED|Overall Study||44
8123457|NCT02917447|20022357|P2|STARTED|Overall Study||51
8123458|NCT02917447|20022358|P1|STARTED|Overall Study||51
8123459|NCT02917265|20022370|P2|NOT COMPLETED|Overall Study||0
8123460|NCT02917265|20022371|P1|NOT COMPLETED|Overall Study||2
8123461|NCT02917265|20022370|P2|COMPLETED|Overall Study||2
8123462|NCT02917265|20022371|P1|COMPLETED|Overall Study||3
8123463|NCT02917265|20022370|P2|STARTED|Overall Study||2
8123464|NCT02917265|20022371|P1|STARTED|Overall Study||5
8123465|NCT02916927|20022387|P2|NOT COMPLETED|Overall Study||3
8123466|NCT02916927|20022388|P1|NOT COMPLETED|Overall Study||1
8123467|NCT02916927|20022387|P2|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
8123468|NCT02916927|20022388|P1|COMPLETED|Overall Study||30
8123469|NCT02916927|20022387|P2|Received Study Drug|Overall Study||29
8123470|NCT02916927|20022388|P1|Received Study Drug|Overall Study||31
8123471|NCT02916927|20022387|P2|STARTED|Overall Study||31
8123472|NCT02916927|20022388|P1|STARTED|Overall Study||31
8123473|NCT02916745|20022402|P1|NOT COMPLETED|Overall Study||0
8123474|NCT02916745|20022402|P1|COMPLETED|Overall Study||5
8123475|NCT02916745|20022402|P1|STARTED|Overall Study||5
8123476|NCT02916693|20022432|P1|NOT COMPLETED|Overall Study||7
8123477|NCT02916693|20022432|P1|COMPLETED|Overall Study||13
8123478|NCT02916693|20022432|P1|STARTED|Overall Study||20
8123479|NCT02916563|20022445|P1|NOT COMPLETED|Overall Study||0
8123480|NCT02916563|20022445|P1|COMPLETED|Overall Study||50
8123481|NCT02916563|20022445|P1|STARTED|Overall Study||50
8123482|NCT02916433|20022451|P2|NOT COMPLETED|Overall Study||0
8123483|NCT02916433|20022452|P1|NOT COMPLETED|Overall Study||2
8123484|NCT02916433|20022451|P2|COMPLETED|Overall Study||2
8123485|NCT02916433|20022452|P1|COMPLETED|Overall Study||1
8123486|NCT02916433|20022451|P2|STARTED|Overall Study||2
8123487|NCT02916433|20022452|P1|STARTED|Overall Study||3
8123488|NCT02916407|20022463|P2|NOT COMPLETED|Overall Study||0
8123489|NCT02916407|20022464|P1|NOT COMPLETED|Overall Study||0
8123490|NCT02916407|20022463|P2|COMPLETED|Overall Study||28
8123491|NCT02916407|20022464|P1|COMPLETED|Overall Study||28
8123492|NCT02916407|20022463|P2|STARTED|Overall Study||28
8123493|NCT02916407|20022464|P1|STARTED|Overall Study||28
8123494|NCT02915978|20022475|P3|NOT COMPLETED|Overall Study||0
8123495|NCT02915978|20022476|P2|NOT COMPLETED|Overall Study||1
8123496|NCT02915978|20022477|P1|NOT COMPLETED|Overall Study||2
8123497|NCT02915978|20022475|P3|COMPLETED|Overall Study||15
8123498|NCT02915978|20022476|P2|COMPLETED|Overall Study||14
8123499|NCT02915978|20022477|P1|COMPLETED|Overall Study||13
8123500|NCT02915978|20022475|P3|STARTED|Overall Study||15
8123501|NCT02915978|20022476|P2|STARTED|Overall Study||15
8123502|NCT02915978|20022477|P1|STARTED|Overall Study||15
8123503|NCT02915874|20022529|P2|NOT COMPLETED|Overall Study||6
8123504|NCT02915874|20022530|P1|NOT COMPLETED|Overall Study||6
8123505|NCT02915874|20022529|P2|COMPLETED|Overall Study||22
8123506|NCT02915874|20022530|P1|COMPLETED|Overall Study||38
8123507|NCT02915874|20022529|P2|Week 6 Follow Up|Overall Study||26
8123508|NCT02915874|20022530|P1|Week 6 Follow Up|Overall Study||41
8123509|NCT02915874|20022529|P2|STARTED|Overall Study||28
8123510|NCT02915874|20022530|P1|STARTED|Overall Study||44
8123511|NCT02915835|20022550|P2|NOT COMPLETED|Overall Study||1
8123512|NCT02915835|20022551|P1|NOT COMPLETED|Overall Study||1
8123513|NCT02915835|20022550|P2|COMPLETED|Overall Study||7
8123514|NCT02915835|20022551|P1|COMPLETED|Overall Study||8
8123515|NCT02915835|20022550|P2|STARTED|Overall Study||8
8123516|NCT02915835|20022551|P1|STARTED|Overall Study||9
8123517|NCT02915783|20022675|P1|NOT COMPLETED|Overall Study||14
8123518|NCT02915783|20022675|P1|COMPLETED|Overall Study||17
8123519|NCT02915783|20022675|P1|STARTED|Overall Study||31
8123520|NCT02915705|20022683|P2|NOT COMPLETED|Long Term Extension Period||0
8123521|NCT02915705|20022684|P1|NOT COMPLETED|Long Term Extension Period||0
8123522|NCT02915705|20022683|P2|COMPLETED|Long Term Extension Period||25
8123523|NCT02915705|20022684|P1|COMPLETED|Long Term Extension Period||26
8123524|NCT02915705|20022683|P2|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
8123525|NCT02915705|20022684|P1|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
8123526|NCT02915705|20022683|P2|NOT COMPLETED|Treatment Period||0
8123527|NCT02915705|20022684|P1|NOT COMPLETED|Treatment Period||0
8123528|NCT02915705|20022683|P2|COMPLETED|Treatment Period||29
8123529|NCT02915705|20022684|P1|COMPLETED|Treatment Period||32
8123530|NCT02915705|20022683|P2|Completed Week 64|Treatment Period||29
8123531|NCT02915705|20022684|P1|Completed Week 64|Treatment Period||32
8123532|NCT02915705|20022683|P2|Completed Week 40|Treatment Period||29
8123533|NCT02915705|20022684|P1|Completed Week 40|Treatment Period||32
8123534|NCT02915705|20022683|P2|STARTED|Treatment Period||29
8123535|NCT02915705|20022684|P1|STARTED|Treatment Period||32
8123536|NCT02915302|20022757|P2|NOT COMPLETED|Overall Study||78
8123537|NCT02915302|20022758|P1|NOT COMPLETED|Overall Study||65
8123538|NCT02915302|20022757|P2|COMPLETED|Overall Study||917
8123539|NCT02915302|20022758|P1|COMPLETED|Overall Study||890
8123540|NCT02915302|20022757|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
8123541|NCT02915302|20022758|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
8123542|NCT02915302|20022757|P2|STARTED|Overall Study||995
8123543|NCT02915302|20022758|P1|STARTED|Overall Study||955
8123544|NCT02915159|20022770|P2|NOT COMPLETED|Overall Study||8
8123545|NCT02915159|20022771|P1|NOT COMPLETED|Overall Study||11
8123546|NCT02915159|20022770|P2|COMPLETED|Overall Study||87
8123547|NCT02915159|20022771|P1|COMPLETED|Overall Study||81
8123548|NCT02915159|20022770|P2|STARTED|Overall Study||95
8123549|NCT02915159|20022771|P1|STARTED|Overall Study||92
8123550|NCT02915029|20022857|P2|NOT COMPLETED|Overall Study||14
8123551|NCT02915029|20022858|P1|NOT COMPLETED|Overall Study||13
8123552|NCT02915029|20022857|P2|COMPLETED|Overall Study||48
8123553|NCT02915029|20022858|P1|COMPLETED|Overall Study||50
8123554|NCT02915029|20022857|P2|STARTED|Overall Study||62
8123555|NCT02915029|20022858|P1|STARTED|Overall Study||63
8123556|NCT02915016|20022910|P8|NOT COMPLETED|Overall Study||4
8123557|NCT02915016|20022911|P7|NOT COMPLETED|Overall Study||12
8123558|NCT02915016|20022912|P6|NOT COMPLETED|Overall Study||6
8123559|NCT02915016|20022913|P5|NOT COMPLETED|Overall Study||7
8123560|NCT02915016|20022914|P4|NOT COMPLETED|Overall Study||4
8123561|NCT02915016|20022915|P3|NOT COMPLETED|Overall Study||8
8123562|NCT02915016|20022916|P2|NOT COMPLETED|Overall Study||3
8123563|NCT02915016|20022917|P1|NOT COMPLETED|Overall Study||7
8123564|NCT02915016|20022910|P8|COMPLETED|Overall Study||20
8123565|NCT02915016|20022911|P7|COMPLETED|Overall Study||38
8123566|NCT02915016|20022912|P6|COMPLETED|Overall Study||44
8123567|NCT02915016|20022913|P5|COMPLETED|Overall Study||43
8123568|NCT02915016|20022914|P4|COMPLETED|Overall Study||26
8123569|NCT02915016|20022915|P3|COMPLETED|Overall Study||42
8123570|NCT02915016|20022916|P2|COMPLETED|Overall Study||47
8123571|NCT02915016|20022917|P1|COMPLETED|Overall Study||23
8123572|NCT02915016|20022910|P8|Month 6.5 Immunogenicity Timepoint|Overall Study||21
8123573|NCT02915016|20022911|P7|Month 6.5 Immunogenicity Timepoint|Overall Study||42
8123574|NCT02915016|20022912|P6|Month 6.5 Immunogenicity Timepoint|Overall Study||42
8123575|NCT02915016|20022913|P5|Month 6.5 Immunogenicity Timepoint|Overall Study||43
8123576|NCT02915016|20022914|P4|Month 6.5 Immunogenicity Timepoint|Overall Study||26
8123577|NCT02915016|20022915|P3|Month 6.5 Immunogenicity Timepoint|Overall Study||46
8123578|NCT02915016|20022916|P2|Month 6.5 Immunogenicity Timepoint|Overall Study||49
8123579|NCT02915016|20022917|P1|Month 6.5 Immunogenicity Timepoint|Overall Study||23
8123580|NCT02915016|20022910|P8|STARTED|Overall Study||24
8123581|NCT02915016|20022911|P7|STARTED|Overall Study||50
8123582|NCT02915016|20022912|P6|STARTED|Overall Study||50
8123583|NCT02915016|20022913|P5|STARTED|Overall Study||50
8123584|NCT02915016|20022914|P4|STARTED|Overall Study||30
8123585|NCT02915016|20022915|P3|STARTED|Overall Study||50
8123586|NCT02915016|20022916|P2|STARTED|Overall Study||50
8123587|NCT02915016|20022917|P1|STARTED|Overall Study||30
8123588|NCT02914795|20023129|P2|NOT COMPLETED|Overall Study||0
8123589|NCT02914795|20023130|P1|NOT COMPLETED|Overall Study||0
8123590|NCT02914795|20023129|P2|COMPLETED|Overall Study||22
8123591|NCT02914795|20023130|P1|COMPLETED|Overall Study||77
8123592|NCT02914795|20023129|P2|STARTED|Overall Study||22
8123593|NCT02914795|20023130|P1|STARTED|Overall Study||77
8123594|NCT02914548|20023141|P3|NOT COMPLETED|Overall Study||20
8123595|NCT02914548|20023142|P2|NOT COMPLETED|Overall Study||14
8123596|NCT02914548|20023143|P1|NOT COMPLETED|Overall Study||21
8123597|NCT02914548|20023141|P3|COMPLETED|Overall Study||46
8123598|NCT02914548|20023142|P2|COMPLETED|Overall Study||53
8123599|NCT02914548|20023143|P1|COMPLETED|Overall Study||46
8123600|NCT02914548|20023141|P3|STARTED|Overall Study||66
8123601|NCT02914548|20023142|P2|STARTED|Overall Study||67
8123602|NCT02914548|20023143|P1|STARTED|Overall Study||67
8123603|NCT02914457|20023174|P1|NOT COMPLETED|Overall Study||6
8123604|NCT02914457|20023174|P1|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
8123605|NCT02914457|20023174|P1|STARTED|Overall Study||31
8123606|NCT02914275|20023184|P2|NOT COMPLETED|Overall Study||42
8123607|NCT02914275|20023185|P1|NOT COMPLETED|Overall Study||121
8123608|NCT02914275|20023184|P2|COMPLETED|Overall Study||521
8123609|NCT02914275|20023185|P1|COMPLETED|Overall Study||1566
8123610|NCT02914275|20023184|P2|Included in Clinical Database / FAS|Overall Study||563
8123611|NCT02914275|20023185|P1|Included in Clinical Database / FAS|Overall Study||1684
8123612|NCT02914275|20023184|P2|STARTED|Overall Study||563
8123613|NCT02914275|20023185|P1|STARTED|Overall Study||1687
8123614|NCT02914236|20023217|P1|NOT COMPLETED|Overall Study||1
8123615|NCT02914236|20023217|P1|COMPLETED|Overall Study||49
8123616|NCT02914236|20023217|P1|26-week Follow-up Visit|Overall Study||49
8123617|NCT02914236|20023217|P1|12-week Follow-up Visit|Overall Study||50
8123618|NCT02914236|20023217|P1|4-week Follow-up Visit|Overall Study||50
8123619|NCT02914236|20023217|P1|STARTED|Overall Study||50
8123620|NCT02914210|20023227|P2|NOT COMPLETED|Overall Study||9
8123621|NCT02914210|20023228|P1|NOT COMPLETED|Overall Study||10
8123622|NCT02914210|20023227|P2|COMPLETED|Overall Study||144
8123623|NCT02914210|20023228|P1|COMPLETED|Overall Study||143
8123624|NCT02914210|20023227|P2|STARTED|Overall Study||153
8123625|NCT02914210|20023228|P1|STARTED|Overall Study||153
8123626|NCT02914184|20023263|P4|NOT COMPLETED|Overall Study||11
8123627|NCT02914184|20023264|P3|NOT COMPLETED|Overall Study||17
8123628|NCT02914184|20023265|P2|NOT COMPLETED|Overall Study||13
8123629|NCT02914184|20023266|P1|NOT COMPLETED|Overall Study||14
8123630|NCT02914184|20023263|P4|COMPLETED|Overall Study||391
8123631|NCT02914184|20023264|P3|COMPLETED|Overall Study||385
8123632|NCT02914184|20023265|P2|COMPLETED|Overall Study||383
8123633|NCT02914184|20023266|P1|COMPLETED|Overall Study||386
8123634|NCT02914184|20023263|P4|STARTED|Overall Study||402
8123635|NCT02914184|20023264|P3|STARTED|Overall Study||402
8123636|NCT02914184|20023265|P2|STARTED|Overall Study||396
8123637|NCT02914184|20023266|P1|STARTED|Overall Study||400
8123638|NCT02914132|20023305|P1|NOT COMPLETED|Overall Study||0
8123639|NCT02914132|20023305|P1|COMPLETED|Overall Study||15
8123640|NCT02914132|20023305|P1|STARTED|Overall Study||15
8123641|NCT02914119|20023310|P1|NOT COMPLETED|Overall Study||0
8123642|NCT02914119|20023310|P1|COMPLETED|Overall Study||30430
8123643|NCT02914119|20023310|P1|STARTED|Overall Study||30430
8123644|NCT02913482|20023324|P3|NOT COMPLETED|Overall Study||3
8123645|NCT02913482|20023325|P2|NOT COMPLETED|Overall Study||2
8123646|NCT02913482|20023326|P1|NOT COMPLETED|Overall Study||1
8123647|NCT02913482|20023324|P3|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 14 Nov 2019|38
8123648|NCT02913482|20023325|P2|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 27 Feb 2019|15
8123649|NCT02913482|20023326|P1|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 27 Feb 2019|3
8123650|NCT02913482|20023324|P3|STARTED|Overall Study||41
8123651|NCT02913482|20023325|P2|STARTED|Overall Study||17
8123652|NCT02913482|20023326|P1|STARTED|Overall Study||4
8123653|NCT02913326|20023359|P2|NOT COMPLETED|Overall Study||2
8123654|NCT02913326|20023360|P1|NOT COMPLETED|Overall Study||1
8123655|NCT02913326|20023359|P2|COMPLETED|Overall Study||58
8123656|NCT02913326|20023360|P1|COMPLETED|Overall Study||59
8123657|NCT02913326|20023359|P2|STARTED|Overall Study||60
8123658|NCT02913326|20023360|P1|STARTED|Overall Study||60
8123659|NCT02913105|20023383|P3|NOT COMPLETED|Overall Study||7
8123660|NCT02913105|20023384|P2|NOT COMPLETED|Overall Study||5
8123661|NCT02913105|20023385|P1|NOT COMPLETED|Overall Study||15
8123662|NCT02913105|20023383|P3|COMPLETED|Overall Study||33
8123663|NCT02913105|20023384|P2|COMPLETED|Overall Study||39
8123664|NCT02913105|20023385|P1|COMPLETED|Overall Study||22
8123665|NCT02913105|20023383|P3|STARTED|Overall Study||40
8123666|NCT02913105|20023384|P2|STARTED|Overall Study||44
8123667|NCT02913105|20023385|P1|STARTED|Overall Study||37
8123668|NCT02912650|20023438|P4|NOT COMPLETED|Overall Study||5
8123669|NCT02912650|20023439|P3|NOT COMPLETED|Overall Study||2
8123670|NCT02912650|20023440|P2|NOT COMPLETED|Overall Study||0
8123671|NCT02912650|20023441|P1|NOT COMPLETED|Overall Study||1
8123672|NCT02912650|20023438|P4|COMPLETED|Overall Study||160
8123673|NCT02912650|20023439|P3|COMPLETED|Overall Study||173
8123674|NCT02912650|20023440|P2|COMPLETED|Overall Study||172
8123675|NCT02912650|20023441|P1|COMPLETED|Overall Study||55
8123676|NCT02912650|20023438|P4|STARTED|Overall Study||165
8123677|NCT02912650|20023439|P3|STARTED|Overall Study||175
8123678|NCT02912650|20023440|P2|STARTED|Overall Study||172
8123679|NCT02912650|20023441|P1|STARTED|Overall Study||56
8123680|NCT02912468|20023525|P2|NOT COMPLETED|Overall Study||5
8123681|NCT02912468|20023526|P1|NOT COMPLETED|Overall Study||9
8123682|NCT02912468|20023525|P2|COMPLETED|Overall Study||138
8123683|NCT02912468|20023526|P1|COMPLETED|Overall Study||124
8123684|NCT02912468|20023525|P2|Safety Population|Overall Study||143
8123685|NCT02912468|20023526|P1|Safety Population|Overall Study||132
8123686|NCT02912468|20023525|P2|Treated|Overall Study||142
8123687|NCT02912468|20023526|P1|Treated|Overall Study||133
8123688|NCT02912468|20023525|P2|STARTED|Overall Study||143
8123689|NCT02912468|20023526|P1|STARTED|Overall Study||133
8123690|NCT02912455|20023605|P2|NOT COMPLETED|Overall Study||3
8123691|NCT02912455|20023606|P1|NOT COMPLETED|Overall Study||2
8123692|NCT02912455|20023605|P2|COMPLETED|Overall Study||2
8123693|NCT02912455|20023606|P1|COMPLETED|Overall Study||9
8123694|NCT02912455|20023605|P2|STARTED|Overall Study||5
8123695|NCT02912455|20023606|P1|STARTED|Overall Study||11
8123696|NCT02912364|20023644|P2|NOT COMPLETED|Treatment 2||0
8123697|NCT02912364|20023645|P1|NOT COMPLETED|Treatment 2||1
8123698|NCT02912364|20023644|P2|COMPLETED|Treatment 2||11
8123699|NCT02912364|20023645|P1|COMPLETED|Treatment 2||12
8123700|NCT02912364|20023644|P2|Received Intervention|Treatment 2||11
8123701|NCT02912364|20023645|P1|Received Intervention|Treatment 2||12
8123702|NCT02912364|20023644|P2|STARTED|Treatment 2||11
8123703|NCT02912364|20023645|P1|STARTED|Treatment 2||13
8123704|NCT02912364|20023644|P2|NOT COMPLETED|Washout Period||0
8123705|NCT02912364|20023645|P1|NOT COMPLETED|Washout Period||0
8123706|NCT02912364|20023644|P2|COMPLETED|Washout Period||11
8123707|NCT02912364|20023645|P1|COMPLETED|Washout Period||13
8123708|NCT02912364|20023644|P2|STARTED|Washout Period||11
8123709|NCT02912364|20023645|P1|STARTED|Washout Period||13
8123710|NCT02912364|20023644|P2|NOT COMPLETED|Treatment 1||12
8123711|NCT02912364|20023645|P1|NOT COMPLETED|Treatment 1||10
8123712|NCT02912364|20023644|P2|COMPLETED|Treatment 1||11
8123713|NCT02912364|20023645|P1|COMPLETED|Treatment 1||13
8123714|NCT02912364|20023644|P2|Received Intervention|Treatment 1||18
8123715|NCT02912364|20023645|P1|Received Intervention|Treatment 1||18
8123716|NCT02912364|20023644|P2|STARTED|Treatment 1||23
8123717|NCT02912364|20023645|P1|STARTED|Treatment 1||23
8123718|NCT02912195|20023664|P2|NOT COMPLETED|Overall Study||0
8123719|NCT02912195|20023665|P1|NOT COMPLETED|Overall Study||0
8123720|NCT02912195|20023664|P2|COMPLETED|Overall Study||16
8123721|NCT02912195|20023665|P1|COMPLETED|Overall Study||16
8123722|NCT02912195|20023664|P2|STARTED|Overall Study||16
8123723|NCT02912195|20023665|P1|STARTED|Overall Study||16
8123724|NCT02911948|20023701|P2|NOT COMPLETED|Overall Study||7
8123725|NCT02911948|20023702|P1|NOT COMPLETED|Overall Study||0
8123726|NCT02911948|20023701|P2|COMPLETED|Overall Study||98
8123727|NCT02911948|20023702|P1|COMPLETED|Overall Study||105
8123728|NCT02911948|20023701|P2|STARTED|Overall Study||105
8123729|NCT02911948|20023702|P1|STARTED|Overall Study||105
8123730|NCT02911922|20023764|P2|NOT COMPLETED|Overall Study||0
8123731|NCT02911922|20023765|P1|NOT COMPLETED|Overall Study||0
8123732|NCT02911922|20023764|P2|COMPLETED|Overall Study||0
8123733|NCT02911922|20023765|P1|COMPLETED|Overall Study||1
8123734|NCT02911922|20023764|P2|STARTED|Overall Study||0
8123735|NCT02911922|20023765|P1|STARTED|Overall Study||1
8123736|NCT02911909|20023785|P2|NOT COMPLETED|Overall Study||3
8123737|NCT02911909|20023786|P1|NOT COMPLETED|Overall Study||2
8123738|NCT02911909|20023785|P2|COMPLETED|Overall Study|No Data was obtained in the study group.|0
8123739|NCT02911909|20023786|P1|COMPLETED|Overall Study||2
8123740|NCT02911909|20023785|P2|STARTED|Overall Study||3
8123741|NCT02911909|20023786|P1|STARTED|Overall Study||4
8123742|NCT02911857|20023815|P3|NOT COMPLETED|Overall Study||0
8123743|NCT02911857|20023816|P2|NOT COMPLETED|Overall Study||0
8123744|NCT02911857|20023817|P1|NOT COMPLETED|Overall Study||0
8123745|NCT02911857|20023815|P3|COMPLETED|Overall Study||1
8123746|NCT02911857|20023816|P2|COMPLETED|Overall Study||1
8123747|NCT02911857|20023817|P1|COMPLETED|Overall Study||2
8123748|NCT02911857|20023815|P3|STARTED|Overall Study||1
8123749|NCT02911857|20023816|P2|STARTED|Overall Study||1
8123750|NCT02911857|20023817|P1|STARTED|Overall Study||2
8123751|NCT02911844|20023825|P1|NOT COMPLETED|Overall Study||0
8123752|NCT02911844|20023825|P1|COMPLETED|Overall Study||5
8123753|NCT02911844|20023825|P1|STARTED|Overall Study||5
8123754|NCT02911818|20023835|P5|NOT COMPLETED|12 Week Extension Study||1
8123755|NCT02911818|20023836|P4|NOT COMPLETED|12 Week Extension Study||0
8123756|NCT02911818|20023837|P3|NOT COMPLETED|12 Week Extension Study||0
8123757|NCT02911818|20023838|P2|NOT COMPLETED|12 Week Extension Study||0
8123758|NCT02911818|20023839|P1|NOT COMPLETED|12 Week Extension Study||0
8123759|NCT02911818|20023835|P5|COMPLETED|12 Week Extension Study||22
8123760|NCT02911818|20023836|P4|COMPLETED|12 Week Extension Study||22
8123761|NCT02911818|20023837|P3|COMPLETED|12 Week Extension Study||0
8123762|NCT02911818|20023838|P2|COMPLETED|12 Week Extension Study||0
8123763|NCT02911818|20023839|P1|COMPLETED|12 Week Extension Study||0
8123764|NCT02911818|20023835|P5|STARTED|12 Week Extension Study||23
8123765|NCT02911818|20023836|P4|STARTED|12 Week Extension Study||22
8123766|NCT02911818|20023837|P3|STARTED|12 Week Extension Study||0
8123767|NCT02911818|20023838|P2|STARTED|12 Week Extension Study||0
8123768|NCT02911818|20023839|P1|STARTED|12 Week Extension Study||0
8123769|NCT02911818|20023835|P5|NOT COMPLETED|52 Week Study||0
8123770|NCT02911818|20023836|P4|NOT COMPLETED|52 Week Study||0
8123771|NCT02911818|20023837|P3|NOT COMPLETED|52 Week Study||4
8123772|NCT02911818|20023838|P2|NOT COMPLETED|52 Week Study||5
8123773|NCT02911818|20023839|P1|NOT COMPLETED|52 Week Study||4
8123774|NCT02911818|20023835|P5|COMPLETED|52 Week Study||0
8123775|NCT02911818|20023836|P4|COMPLETED|52 Week Study||0
8123776|NCT02911818|20023837|P3|COMPLETED|52 Week Study||46
8123777|NCT02911818|20023838|P2|COMPLETED|52 Week Study||45
8123778|NCT02911818|20023839|P1|COMPLETED|52 Week Study||46
8123779|NCT02911818|20023835|P5|STARTED|52 Week Study||0
8123780|NCT02911818|20023836|P4|STARTED|52 Week Study||0
8123781|NCT02911818|20023837|P3|STARTED|52 Week Study||50
8123782|NCT02911818|20023838|P2|STARTED|52 Week Study||50
8123783|NCT02911818|20023839|P1|STARTED|52 Week Study||50
8123784|NCT02911753|20023934|P3|NOT COMPLETED|Overall Study||0
8123785|NCT02911753|20023935|P2|NOT COMPLETED|Overall Study||3
8123786|NCT02911753|20023936|P1|NOT COMPLETED|Overall Study||3
8123787|NCT02911753|20023934|P3|COMPLETED|Overall Study||10
8123788|NCT02911753|20023935|P2|COMPLETED|Overall Study||16
8123789|NCT02911753|20023936|P1|COMPLETED|Overall Study||18
8123790|NCT02911753|20023934|P3|STARTED|Overall Study||10
8123791|NCT02911753|20023935|P2|STARTED|Overall Study||19
8123792|NCT02911753|20023936|P1|STARTED|Overall Study||21
8123793|NCT02911688|20023964|P2|NOT COMPLETED|Second Intervention||0
8123794|NCT02911688|20023965|P1|NOT COMPLETED|Second Intervention||0
8123795|NCT02911688|20023964|P2|COMPLETED|Second Intervention||7
8123796|NCT02911688|20023965|P1|COMPLETED|Second Intervention||8
8123797|NCT02911688|20023964|P2|STARTED|Second Intervention||7
8123798|NCT02911688|20023965|P1|STARTED|Second Intervention||8
8123799|NCT02911688|20023964|P2|NOT COMPLETED|Washout||2
8123800|NCT02911688|20023965|P1|NOT COMPLETED|Washout||1
8123801|NCT02911688|20023964|P2|COMPLETED|Washout||7
8123802|NCT02911688|20023965|P1|COMPLETED|Washout||8
8123803|NCT02911688|20023964|P2|STARTED|Washout||9
8123804|NCT02911688|20023965|P1|STARTED|Washout||9
8123805|NCT02911688|20023964|P2|NOT COMPLETED|First Intervention||0
8123806|NCT02911688|20023965|P1|NOT COMPLETED|First Intervention||0
8123807|NCT02911688|20023964|P2|COMPLETED|First Intervention||9
8123808|NCT02911688|20023965|P1|COMPLETED|First Intervention||9
8123809|NCT02911688|20023964|P2|Received Intervention|First Intervention||9
8123810|NCT02911688|20023965|P1|Received Intervention|First Intervention||9
8123811|NCT02911688|20023964|P2|STARTED|First Intervention||9
8123812|NCT02911688|20023965|P1|STARTED|First Intervention||9
8123813|NCT02911519|20023989|P2|NOT COMPLETED|Overall Study||4
8123814|NCT02911519|20023990|P1|NOT COMPLETED|Overall Study||2
8123815|NCT02911519|20023989|P2|COMPLETED|Overall Study||82
8123816|NCT02911519|20023990|P1|COMPLETED|Overall Study||88
8123817|NCT02911519|20023989|P2|STARTED|Overall Study||86
8123818|NCT02911519|20023990|P1|STARTED|Overall Study||90
8123819|NCT02911324|20024012|P2|NOT COMPLETED|Overall Study||1
8123820|NCT02911324|20024013|P1|NOT COMPLETED|Overall Study||3
8123821|NCT02911324|20024012|P2|COMPLETED|Overall Study||6
8123822|NCT02911324|20024013|P1|COMPLETED|Overall Study||6
8123823|NCT02911324|20024012|P2|STARTED|Overall Study||7
8123824|NCT02911324|20024013|P1|STARTED|Overall Study||9
8123825|NCT02910739|20024022|P4|NOT COMPLETED|Overall Study||0
8123826|NCT02910739|20024023|P3|NOT COMPLETED|Overall Study||0
8123827|NCT02910739|20024024|P2|NOT COMPLETED|Overall Study||0
8123828|NCT02910739|20024025|P1|NOT COMPLETED|Overall Study||1
8123829|NCT02910739|20024022|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123830|NCT02910739|20024023|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123831|NCT02910739|20024024|P2|COMPLETED|Overall Study||8
8123832|NCT02910739|20024025|P1|COMPLETED|Overall Study||7
8123833|NCT02910739|20024022|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123834|NCT02910739|20024023|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123835|NCT02910739|20024024|P2|STARTED|Overall Study||8
8123836|NCT02910739|20024025|P1|STARTED|Overall Study||8
8123837|NCT02910713|20024051|P1|NOT COMPLETED|Overall Study||42
8123838|NCT02910713|20024051|P1|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
8123839|NCT02910713|20024051|P1|Safety Population: Entered CAE|Overall Study||171
8123840|NCT02910713|20024051|P1|STARTED|Overall Study||185
8123841|NCT02910362|20024060|P2|NOT COMPLETED|Overall Study||0
8123842|NCT02910362|20024061|P1|NOT COMPLETED|Overall Study||0
8123843|NCT02910362|20024060|P2|COMPLETED|Overall Study||7
8123844|NCT02910362|20024061|P1|COMPLETED|Overall Study||8
8123845|NCT02910362|20024060|P2|STARTED|Overall Study||7
8123846|NCT02910362|20024061|P1|STARTED|Overall Study||8
8123847|NCT02910167|20024067|P1|NOT COMPLETED|Overall Study||19
8123848|NCT02910167|20024067|P1|COMPLETED|Overall Study||341
8123849|NCT02910167|20024067|P1|STARTED|Overall Study||360
8123850|NCT02910102|20024077|P2|NOT COMPLETED|Overall Study||0
8123851|NCT02910102|20024078|P1|NOT COMPLETED|Overall Study||0
8123852|NCT02910102|20024077|P2|COMPLETED|Overall Study||17
8123853|NCT02910102|20024078|P1|COMPLETED|Overall Study||21
8123854|NCT02910102|20024077|P2|Per-Protocol Population|Overall Study||17
8123855|NCT02910102|20024078|P1|Per-Protocol Population|Overall Study||20
8123856|NCT02910102|20024077|P2|Intent to Treat (ITT) Population|Overall Study||17
8123857|NCT02910102|20024078|P1|Intent to Treat (ITT) Population|Overall Study||21
8123858|NCT02910102|20024077|P2|Safety Population|Overall Study||17
8123859|NCT02910102|20024078|P1|Safety Population|Overall Study||21
8123860|NCT02910102|20024077|P2|STARTED|Overall Study||17
8123861|NCT02910102|20024078|P1|STARTED|Overall Study||21
8123862|NCT02910089|20024092|P2|NOT COMPLETED|Overall Study||16
8123863|NCT02910089|20024093|P1|NOT COMPLETED|Overall Study||22
8123864|NCT02910089|20024092|P2|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
8123865|NCT02910089|20024093|P1|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
8123866|NCT02910089|20024092|P2|STARTED|Overall Study|Patients allocated to control|700
8123867|NCT02910089|20024093|P1|STARTED|Overall Study|Patients allocated to intervention|700
8123868|NCT02910063|20024105|P3|NOT COMPLETED|Phase 3||0
8123869|NCT02910063|20024106|P2|NOT COMPLETED|Phase 3||0
8123870|NCT02910063|20024107|P1|NOT COMPLETED|Phase 3||0
8123871|NCT02910063|20024105|P3|COMPLETED|Phase 3||0
8123872|NCT02910063|20024106|P2|COMPLETED|Phase 3||0
8123873|NCT02910063|20024107|P1|COMPLETED|Phase 3||0
8123874|NCT02910063|20024105|P3|STARTED|Phase 3||0
8123875|NCT02910063|20024106|P2|STARTED|Phase 3||0
8123876|NCT02910063|20024107|P1|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
8123877|NCT02910063|20024105|P3|NOT COMPLETED|Phase 2||0
8123878|NCT02910063|20024106|P2|NOT COMPLETED|Phase 2||0
8123879|NCT02910063|20024107|P1|NOT COMPLETED|Phase 2||28
8123880|NCT02910063|20024105|P3|COMPLETED|Phase 2||0
8123881|NCT02910063|20024106|P2|COMPLETED|Phase 2||0
8123882|NCT02910063|20024107|P1|COMPLETED|Phase 2||13
8123883|NCT02910063|20024105|P3|Started Optional Cycle 2|Phase 2||0
8123884|NCT02910063|20024106|P2|Started Optional Cycle 2|Phase 2||0
8123885|NCT02910063|20024107|P1|Started Optional Cycle 2|Phase 2||4
8123886|NCT02910063|20024105|P3|Started Cycle 1|Phase 2||0
8123887|NCT02910063|20024106|P2|Started Cycle 1|Phase 2||0
8123888|NCT02910063|20024107|P1|Started Cycle 1|Phase 2||41
8123889|NCT02910063|20024105|P3|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
8123890|NCT02910063|20024106|P2|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
8123891|NCT02910063|20024107|P1|STARTED|Phase 2||41
8123892|NCT02910011|20024148|P1|NOT COMPLETED|Overall Study||2
8123893|NCT02910011|20024148|P1|COMPLETED|Overall Study||13
8123894|NCT02910011|20024148|P1|STARTED|Overall Study||15
8123895|NCT02909959|20024156|P2|NOT COMPLETED|Overall Study||0
8123896|NCT02909959|20024157|P1|NOT COMPLETED|Overall Study||0
8123897|NCT02909959|20024156|P2|COMPLETED|Overall Study||24
8123898|NCT02909959|20024157|P1|COMPLETED|Overall Study||24
8123899|NCT02909959|20024156|P2|STARTED|Overall Study||24
8123900|NCT02909959|20024157|P1|STARTED|Overall Study||24
8123901|NCT02909907|20024257|P2|NOT COMPLETED|Overall Study||1
8123902|NCT02909907|20024258|P1|NOT COMPLETED|Overall Study||0
8123903|NCT02909907|20024257|P2|COMPLETED|Overall Study||9
8123904|NCT02909907|20024258|P1|COMPLETED|Overall Study||10
8123905|NCT02909907|20024257|P2|STARTED|Overall Study||10
8123906|NCT02909907|20024258|P1|STARTED|Overall Study||10
8123907|NCT02909764|20024282|P2|NOT COMPLETED|Overall Study||0
8123908|NCT02909764|20024283|P1|NOT COMPLETED|Overall Study||0
8123909|NCT02909764|20024282|P2|COMPLETED|Overall Study||20
8123910|NCT02909764|20024283|P1|COMPLETED|Overall Study||19
8123911|NCT02909764|20024282|P2|STARTED|Overall Study||20
8123912|NCT02909764|20024283|P1|STARTED|Overall Study||19
8123913|NCT02909504|20024299|P1|NOT COMPLETED|Overall Study||12
8123914|NCT02909504|20024299|P1|COMPLETED|Overall Study||12
8123915|NCT02909504|20024299|P1|STARTED|Overall Study||24
8123916|NCT02909439|20024306|P2|NOT COMPLETED|Overall Study||0
8123917|NCT02909439|20024307|P1|NOT COMPLETED|Overall Study||0
8123918|NCT02909439|20024306|P2|COMPLETED|Overall Study||31
8123919|NCT02909439|20024307|P1|COMPLETED|Overall Study||31
8123920|NCT02909439|20024306|P2|STARTED|Overall Study||31
8123921|NCT02909439|20024307|P1|STARTED|Overall Study||31
8123922|NCT02909153|20024336|P5|NOT COMPLETED|Overall Study||0
8123923|NCT02909153|20024337|P4|NOT COMPLETED|Overall Study||0
8123924|NCT02909153|20024338|P3|NOT COMPLETED|Overall Study||0
8123925|NCT02909153|20024339|P2|NOT COMPLETED|Overall Study||1
8123926|NCT02909153|20024340|P1|NOT COMPLETED|Overall Study||0
8123927|NCT02909153|20024336|P5|COMPLETED|Overall Study||6
8123928|NCT02909153|20024337|P4|COMPLETED|Overall Study||6
8123929|NCT02909153|20024338|P3|COMPLETED|Overall Study||6
8123930|NCT02909153|20024339|P2|COMPLETED|Overall Study||5
8123931|NCT02909153|20024340|P1|COMPLETED|Overall Study||6
8123932|NCT02909153|20024336|P5|Triferic in Extraneal PD Solution|Overall Study||6
8123933|NCT02909153|20024337|P4|Triferic in Extraneal PD Solution|Overall Study||6
8123934|NCT02909153|20024338|P3|Triferic in Extraneal PD Solution|Overall Study||0
8123935|NCT02909153|20024339|P2|Triferic in Extraneal PD Solution|Overall Study||0
8123936|NCT02909153|20024340|P1|Triferic in Extraneal PD Solution|Overall Study||0
8123937|NCT02909153|20024336|P5|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123938|NCT02909153|20024337|P4|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123939|NCT02909153|20024338|P3|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123940|NCT02909153|20024339|P2|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
8123941|NCT02909153|20024340|P1|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123942|NCT02909153|20024336|P5|Triferic in Dianeal PD Solution|Overall Study||0
8123943|NCT02909153|20024337|P4|Triferic in Dianeal PD Solution|Overall Study||0
8123944|NCT02909153|20024338|P3|Triferic in Dianeal PD Solution|Overall Study||6
8123945|NCT02909153|20024339|P2|Triferic in Dianeal PD Solution|Overall Study||6
8123946|NCT02909153|20024340|P1|Triferic in Dianeal PD Solution|Overall Study||6
8123947|NCT02909153|20024336|P5|STARTED|Overall Study||6
8123948|NCT02909153|20024337|P4|STARTED|Overall Study||6
8123949|NCT02909153|20024338|P3|STARTED|Overall Study||6
8123950|NCT02909153|20024339|P2|STARTED|Overall Study||6
8123951|NCT02909153|20024340|P1|STARTED|Overall Study||6
8123952|NCT02909140|20024385|P3|NOT COMPLETED|Overall Study||0
8123953|NCT02909140|20024386|P2|NOT COMPLETED|Overall Study||0
8123954|NCT02909140|20024387|P1|NOT COMPLETED|Overall Study||0
8123955|NCT02909140|20024385|P3|COMPLETED|Overall Study||0
8123956|NCT02909140|20024386|P2|COMPLETED|Overall Study||2
8123957|NCT02909140|20024387|P1|COMPLETED|Overall Study||0
8123958|NCT02909140|20024385|P3|STARTED|Overall Study||0
8123959|NCT02909140|20024386|P2|STARTED|Overall Study||2
8123960|NCT02909140|20024387|P1|STARTED|Overall Study||0
8123961|NCT02909101|20024430|P2|NOT COMPLETED|Overall Study||1
8123962|NCT02909101|20024431|P1|NOT COMPLETED|Overall Study||1
8123963|NCT02909101|20024430|P2|COMPLETED|Overall Study||28
8123964|NCT02909101|20024431|P1|COMPLETED|Overall Study||28
8123965|NCT02909101|20024430|P2|STARTED|Overall Study||29
8123966|NCT02909101|20024431|P1|STARTED|Overall Study||29
8123967|NCT02908880|20024449|P1|NOT COMPLETED|Overall Study||27
8123968|NCT02908880|20024449|P1|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
8123969|NCT02908880|20024449|P1|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
8123970|NCT02908841|20024459|P2|NOT COMPLETED|Overall Study||0
8123971|NCT02908841|20024460|P1|NOT COMPLETED|Overall Study||4
8123972|NCT02908841|20024459|P2|COMPLETED|Overall Study||12
8123973|NCT02908841|20024460|P1|COMPLETED|Overall Study||6
8123974|NCT02908841|20024459|P2|STARTED|Overall Study||12
8123975|NCT02908841|20024460|P1|STARTED|Overall Study||10
8123976|NCT02908672|20024478|P2|NOT COMPLETED|Overall Study||256
8123977|NCT02908672|20024479|P1|NOT COMPLETED|Overall Study||258
8123978|NCT02908672|20024478|P2|COMPLETED|Overall Study||0
8123979|NCT02908672|20024479|P1|COMPLETED|Overall Study||0
8123980|NCT02908672|20024478|P2|STARTED|Overall Study||256
8123981|NCT02908672|20024479|P1|STARTED|Overall Study||258
8123982|NCT02908620|20024515|P4|NOT COMPLETED|Overall Study||0
8123983|NCT02908620|20024516|P3|NOT COMPLETED|Overall Study||0
8123984|NCT02908620|20024517|P2|NOT COMPLETED|Overall Study||0
8123985|NCT02908620|20024518|P1|NOT COMPLETED|Overall Study||0
8123986|NCT02908620|20024515|P4|COMPLETED|Overall Study||10
8123987|NCT02908620|20024516|P3|COMPLETED|Overall Study||10
8123988|NCT02908620|20024517|P2|COMPLETED|Overall Study||10
8123989|NCT02908620|20024518|P1|COMPLETED|Overall Study||10
8123990|NCT02908620|20024515|P4|STARTED|Overall Study||10
8123991|NCT02908620|20024516|P3|STARTED|Overall Study||10
8123992|NCT02908620|20024517|P2|STARTED|Overall Study||10
8123993|NCT02908620|20024518|P1|STARTED|Overall Study||10
8123994|NCT02908529|20024552|P2|NOT COMPLETED|Overall Study||2
8123995|NCT02908529|20024553|P1|NOT COMPLETED|Overall Study||0
8123996|NCT02908529|20024552|P2|COMPLETED|Overall Study||10
8123997|NCT02908529|20024553|P1|COMPLETED|Overall Study||10
8123998|NCT02908529|20024552|P2|STARTED|Overall Study||12
8123999|NCT02908529|20024553|P1|STARTED|Overall Study||10
8124000|NCT02908516|20024563|P2|NOT COMPLETED|Overall Study||3
8124001|NCT02908516|20024564|P1|NOT COMPLETED|Overall Study||3
8124002|NCT02908516|20024563|P2|COMPLETED|Overall Study||0
8124003|NCT02908516|20024564|P1|COMPLETED|Overall Study||0
8124004|NCT02908516|20024563|P2|STARTED|Overall Study||3
8124005|NCT02908516|20024564|P1|STARTED|Overall Study||3
8124006|NCT02908464|20024580|P2|NOT COMPLETED|Overall Study||3
8124007|NCT02908464|20024581|P1|NOT COMPLETED|Overall Study||2
8124008|NCT02908464|20024580|P2|COMPLETED|Overall Study||20
8124009|NCT02908464|20024581|P1|COMPLETED|Overall Study||20
8124010|NCT02908464|20024580|P2|STARTED|Overall Study||23
8124011|NCT02908464|20024581|P1|STARTED|Overall Study||22
8124012|NCT02908347|20024602|P2|NOT COMPLETED|Overall Study||1
8124013|NCT02908347|20024603|P1|NOT COMPLETED|Overall Study||1
8124014|NCT02908347|20024602|P2|COMPLETED|Overall Study||22
8124015|NCT02908347|20024603|P1|COMPLETED|Overall Study||22
8124016|NCT02908347|20024602|P2|STARTED|Overall Study||23
8124017|NCT02908347|20024603|P1|STARTED|Overall Study||23
8124018|NCT02908269|20024654|P3|NOT COMPLETED|Overall Study||0
8124019|NCT02908269|20024655|P2|NOT COMPLETED|Overall Study||0
8124020|NCT02908269|20024656|P1|NOT COMPLETED|Overall Study||0
8124021|NCT02908269|20024654|P3|COMPLETED|Overall Study||60
8124022|NCT02908269|20024655|P2|COMPLETED|Overall Study||60
8124023|NCT02908269|20024656|P1|COMPLETED|Overall Study||60
8124024|NCT02908269|20024654|P3|STARTED|Overall Study||60
8124025|NCT02908269|20024655|P2|STARTED|Overall Study||60
8124026|NCT02908269|20024656|P1|STARTED|Overall Study||60
8124027|NCT02908178|20024674|P4|NOT COMPLETED|Overall Study||6819
8124028|NCT02908178|20024675|P3|NOT COMPLETED|Overall Study||0
8124029|NCT02908178|20024676|P2|NOT COMPLETED|Overall Study||8388
8124030|NCT02908178|20024677|P1|NOT COMPLETED|Overall Study||0
8124031|NCT02908178|20024674|P4|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
8124032|NCT02908178|20024675|P3|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
8124033|NCT02908178|20024676|P2|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
8124034|NCT02908178|20024677|P1|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
8124035|NCT02908178|20024674|P4|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
8124036|NCT02908178|20024675|P3|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
8124037|NCT02908178|20024676|P2|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
8124038|NCT02908178|20024677|P1|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
8124039|NCT02908100|20024699|P3|NOT COMPLETED|Overall Study||21
8124040|NCT02908100|20024700|P2|NOT COMPLETED|Overall Study||21
8124041|NCT02908100|20024701|P1|NOT COMPLETED|Overall Study||23
8124042|NCT02908100|20024699|P3|COMPLETED|Overall Study||66
8124043|NCT02908100|20024700|P2|COMPLETED|Overall Study||66
8124044|NCT02908100|20024701|P1|COMPLETED|Overall Study||63
8124045|NCT02908100|20024699|P3|STARTED|Overall Study||87
8124046|NCT02908100|20024700|P2|STARTED|Overall Study||87
8124047|NCT02908100|20024701|P1|STARTED|Overall Study||86
8124048|NCT02907892|20024737|P2|NOT COMPLETED|Overall Study||40
8124049|NCT02907892|20024738|P1|NOT COMPLETED|Overall Study||27
8124050|NCT02907892|20024737|P2|COMPLETED|Overall Study||236
8124051|NCT02907892|20024738|P1|COMPLETED|Overall Study||250
8124052|NCT02907892|20024737|P2|STARTED|Overall Study||276
8124053|NCT02907892|20024738|P1|STARTED|Overall Study||277
8124054|NCT02907814|20024746|P2|NOT COMPLETED|Overall Study||0
8124055|NCT02907814|20024747|P1|NOT COMPLETED|Overall Study||6
8124056|NCT02907814|20024746|P2|COMPLETED|Overall Study||0
8124057|NCT02907814|20024747|P1|COMPLETED|Overall Study||0
8124058|NCT02907814|20024746|P2|STARTED|Overall Study||0
8124059|NCT02907814|20024747|P1|STARTED|Overall Study||6
8124060|NCT02907619|20024758|P3|NOT COMPLETED|Overall Study||20
8124061|NCT02907619|20024759|P2|NOT COMPLETED|Overall Study||20
8124062|NCT02907619|20024760|P1|NOT COMPLETED|Overall Study||19
8124063|NCT02907619|20024758|P3|COMPLETED|Overall Study||0
8124064|NCT02907619|20024759|P2|COMPLETED|Overall Study||0
8124065|NCT02907619|20024760|P1|COMPLETED|Overall Study||0
8124066|NCT02907619|20024758|P3|Received Treatment|Overall Study||20
8124067|NCT02907619|20024759|P2|Received Treatment|Overall Study||20
8124068|NCT02907619|20024760|P1|Received Treatment|Overall Study||19
8124069|NCT02907619|20024758|P3|STARTED|Overall Study||20
8124070|NCT02907619|20024759|P2|STARTED|Overall Study||20
8124071|NCT02907619|20024760|P1|STARTED|Overall Study||19
8124072|NCT02907489|20024967|P2|NOT COMPLETED|Overall Study||1
8124073|NCT02907489|20024968|P1|NOT COMPLETED|Overall Study||2
8124074|NCT02907489|20024967|P2|COMPLETED|Overall Study||41
8124075|NCT02907489|20024968|P1|COMPLETED|Overall Study||40
8124076|NCT02907489|20024967|P2|STARTED|Overall Study||42
8124077|NCT02907489|20024968|P1|STARTED|Overall Study||42
8124078|NCT02907463|20024976|P1|NOT COMPLETED|Overall Study||37
8124079|NCT02907463|20024976|P1|COMPLETED|Overall Study||243
8124080|NCT02907463|20024976|P1|Per Protocol Cohort|Overall Study||276
8124081|NCT02907463|20024976|P1|Enrolled Cohort|Overall Study||280
8124082|NCT02907463|20024976|P1|STARTED|Overall Study||280
8124083|NCT02907268|20025048|P2|NOT COMPLETED|Overall Study||0
8124084|NCT02907268|20025049|P1|NOT COMPLETED|Overall Study||0
8124085|NCT02907268|20025048|P2|COMPLETED|Overall Study||5
8124086|NCT02907268|20025049|P1|COMPLETED|Overall Study||5
8124087|NCT02907268|20025048|P2|STARTED|Overall Study||5
8124088|NCT02907268|20025049|P1|STARTED|Overall Study||5
8124089|NCT02907216|20025058|P2|NOT COMPLETED|Overall Study||1
8124090|NCT02907216|20025059|P1|NOT COMPLETED|Overall Study||1
8124091|NCT02907216|20025058|P2|COMPLETED|Overall Study||144
8124092|NCT02907216|20025059|P1|COMPLETED|Overall Study||146
8124093|NCT02907216|20025058|P2|STARTED|Overall Study||145
8124094|NCT02907216|20025059|P1|STARTED|Overall Study||147
8124095|NCT02907073|20025094|P3|NOT COMPLETED|Overall Study||0
8124096|NCT02907073|20025095|P2|NOT COMPLETED|Overall Study||0
8124097|NCT02907073|20025096|P1|NOT COMPLETED|Overall Study||0
8124098|NCT02907073|20025094|P3|COMPLETED|Overall Study||0
8124099|NCT02907073|20025095|P2|COMPLETED|Overall Study||0
8124100|NCT02907073|20025096|P1|COMPLETED|Overall Study||8
8124101|NCT02907073|20025094|P3|STARTED|Overall Study||0
8124102|NCT02907073|20025095|P2|STARTED|Overall Study||0
8124103|NCT02907073|20025096|P1|STARTED|Overall Study||8
8124104|NCT02906930|20025111|P4|NOT COMPLETED|Overall Study||8
8124105|NCT02906930|20025112|P3|NOT COMPLETED|Overall Study||12
8124106|NCT02906930|20025113|P2|NOT COMPLETED|Overall Study||14
8124107|NCT02906930|20025114|P1|NOT COMPLETED|Overall Study||6
8124108|NCT02906930|20025111|P4|COMPLETED|Overall Study||170
8124109|NCT02906930|20025112|P3|COMPLETED|Overall Study||163
8124110|NCT02906930|20025113|P2|COMPLETED|Overall Study||161
8124111|NCT02906930|20025114|P1|COMPLETED|Overall Study||169
8124112|NCT02906930|20025111|P4|Safety Analysis Set (SAS)|Overall Study||178
8124113|NCT02906930|20025112|P3|Safety Analysis Set (SAS)|Overall Study||175
8124114|NCT02906930|20025113|P2|Safety Analysis Set (SAS)|Overall Study||175
8124115|NCT02906930|20025114|P1|Safety Analysis Set (SAS)|Overall Study||175
8124116|NCT02906930|20025111|P4|Full Analysis Set (FAS)|Overall Study||178
8124117|NCT02906930|20025112|P3|Full Analysis Set (FAS)|Overall Study||175
8124118|NCT02906930|20025113|P2|Full Analysis Set (FAS)|Overall Study||175
8124119|NCT02906930|20025114|P1|Full Analysis Set (FAS)|Overall Study||175
8124120|NCT02906930|20025111|P4|STARTED|Overall Study||178
8124121|NCT02906930|20025112|P3|STARTED|Overall Study||175
8124122|NCT02906930|20025113|P2|STARTED|Overall Study||175
8124123|NCT02906930|20025114|P1|STARTED|Overall Study||175
8124124|NCT02906917|20025307|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
8124125|NCT02906917|20025308|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
8124126|NCT02906917|20025307|P2|COMPLETED|Intensification Period (Week 26-38)||247
8124127|NCT02906917|20025308|P1|COMPLETED|Intensification Period (Week 26-38)||252
8124128|NCT02906917|20025307|P2|STARTED|Intensification Period (Week 26-38)||254
8124129|NCT02906917|20025308|P1|STARTED|Intensification Period (Week 26-38)||261
8124130|NCT02906917|20025307|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
8124131|NCT02906917|20025308|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
8124132|NCT02906917|20025307|P2|COMPLETED|Initiation Period (Week 0-26)||254
8124133|NCT02906917|20025308|P1|COMPLETED|Initiation Period (Week 0-26)||261
8124134|NCT02906917|20025307|P2|Exposed|Initiation Period (Week 0-26)||263
8124135|NCT02906917|20025308|P1|Exposed|Initiation Period (Week 0-26)||265
8124136|NCT02906917|20025307|P2|STARTED|Initiation Period (Week 0-26)||265
8124137|NCT02906917|20025308|P1|STARTED|Initiation Period (Week 0-26)||267
8124138|NCT02906813|20025339|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8124139|NCT02906813|20025340|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8124140|NCT02906813|20025341|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8124141|NCT02906813|20025339|P3|COMPLETED|Intervention Period 3 (3 Days)||3
8124142|NCT02906813|20025340|P2|COMPLETED|Intervention Period 3 (3 Days)||3
8124143|NCT02906813|20025341|P1|COMPLETED|Intervention Period 3 (3 Days)||3
8124144|NCT02906813|20025339|P3|STARTED|Intervention Period 3 (3 Days)||3
8124145|NCT02906813|20025340|P2|STARTED|Intervention Period 3 (3 Days)||3
8124146|NCT02906813|20025341|P1|STARTED|Intervention Period 3 (3 Days)||3
8124147|NCT02906813|20025339|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
8124148|NCT02906813|20025340|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
8124149|NCT02906813|20025341|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
8124150|NCT02906813|20025339|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
8124151|NCT02906813|20025340|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
8124152|NCT02906813|20025341|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
8124153|NCT02906813|20025339|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
8124154|NCT02906813|20025340|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
8124155|NCT02906813|20025341|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
8124156|NCT02906813|20025339|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8124157|NCT02906813|20025340|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8124158|NCT02906813|20025341|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8124159|NCT02906813|20025339|P3|COMPLETED|Intervention Period 2 (3 Days)||3
8124160|NCT02906813|20025340|P2|COMPLETED|Intervention Period 2 (3 Days)||3
8124161|NCT02906813|20025341|P1|COMPLETED|Intervention Period 2 (3 Days)||3
8124162|NCT02906813|20025339|P3|STARTED|Intervention Period 2 (3 Days)||3
8124163|NCT02906813|20025340|P2|STARTED|Intervention Period 2 (3 Days)||3
8124164|NCT02906813|20025341|P1|STARTED|Intervention Period 2 (3 Days)||3
8124165|NCT02906813|20025339|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
8124166|NCT02906813|20025340|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
8124167|NCT02906813|20025341|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
8124168|NCT02906813|20025339|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
8124169|NCT02906813|20025340|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
8124170|NCT02906813|20025341|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
8124171|NCT02906813|20025339|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
8124172|NCT02906813|20025340|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
8124173|NCT02906813|20025341|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
8124174|NCT02906813|20025339|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8124175|NCT02906813|20025340|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8124176|NCT02906813|20025341|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8124177|NCT02906813|20025339|P3|COMPLETED|Intervention Period 1 (3 Days)||3
8124178|NCT02906813|20025340|P2|COMPLETED|Intervention Period 1 (3 Days)||3
8124179|NCT02906813|20025341|P1|COMPLETED|Intervention Period 1 (3 Days)||3
8124180|NCT02906813|20025339|P3|STARTED|Intervention Period 1 (3 Days)||3
8124181|NCT02906813|20025340|P2|STARTED|Intervention Period 1 (3 Days)||3
8124182|NCT02906813|20025341|P1|STARTED|Intervention Period 1 (3 Days)||3
8124183|NCT02906709|20025369|P2|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
8124184|NCT02906709|20025370|P1|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
8124185|NCT02906709|20025369|P2|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
8124186|NCT02906709|20025370|P1|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
8124187|NCT02906709|20025369|P2|STARTED|Phase B (Extension, Week 17 to Week 52)||58
8124188|NCT02906709|20025370|P1|STARTED|Phase B (Extension, Week 17 to Week 52)||122
8124189|NCT02906709|20025369|P2|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
8124190|NCT02906709|20025370|P1|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
8124191|NCT02906709|20025369|P2|COMPLETED|Phase A (Week 0 to Week 16)||58
8124192|NCT02906709|20025370|P1|COMPLETED|Phase A (Week 0 to Week 16)||122
8124193|NCT02906709|20025369|P2|STARTED|Phase A (Week 0 to Week 16)||61
8124194|NCT02906709|20025370|P1|STARTED|Phase A (Week 0 to Week 16)||123
8124195|NCT02906696|20025402|P1|NOT COMPLETED|Overall Study||0
8124196|NCT02906696|20025402|P1|COMPLETED|Overall Study||8
8124197|NCT02906696|20025402|P1|STARTED|Overall Study||8
8124198|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 5P, QW||0
8124199|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 5P, QW||0
8124200|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 5P, QW||0
8124201|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 5P, QW||0
8124202|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 5P, QW||0
8124203|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 5P, QW||3
8124204|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 5P, QW||0
8124205|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 5P, QW||0
8124206|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 5P, QW||0
8124207|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 5P, QW||0
8124208|NCT02906670|20025424|P10|COMPLETED|Cohort 5P, QW||0
8124209|NCT02906670|20025425|P9|COMPLETED|Cohort 5P, QW||0
8124210|NCT02906670|20025426|P8|COMPLETED|Cohort 5P, QW||0
8124211|NCT02906670|20025427|P7|COMPLETED|Cohort 5P, QW||0
8124212|NCT02906670|20025428|P6|COMPLETED|Cohort 5P, QW||0
8124213|NCT02906670|20025429|P5|COMPLETED|Cohort 5P, QW||0
8124214|NCT02906670|20025430|P4|COMPLETED|Cohort 5P, QW||0
8124215|NCT02906670|20025431|P3|COMPLETED|Cohort 5P, QW||0
8124216|NCT02906670|20025432|P2|COMPLETED|Cohort 5P, QW||0
8124217|NCT02906670|20025433|P1|COMPLETED|Cohort 5P, QW||0
8124218|NCT02906670|20025424|P10|STARTED|Cohort 5P, QW||0
8124219|NCT02906670|20025425|P9|STARTED|Cohort 5P, QW||0
8124220|NCT02906670|20025426|P8|STARTED|Cohort 5P, QW||0
8124221|NCT02906670|20025427|P7|STARTED|Cohort 5P, QW||0
8124222|NCT02906670|20025428|P6|STARTED|Cohort 5P, QW||0
8124223|NCT02906670|20025429|P5|STARTED|Cohort 5P, QW||3
8124224|NCT02906670|20025430|P4|STARTED|Cohort 5P, QW||0
8124225|NCT02906670|20025431|P3|STARTED|Cohort 5P, QW||0
8124226|NCT02906670|20025432|P2|STARTED|Cohort 5P, QW||0
8124227|NCT02906670|20025433|P1|STARTED|Cohort 5P, QW||0
8124228|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 7P, Q2W||3
8124229|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 7P, Q2W||0
8124230|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 7P, Q2W||0
8124231|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 7P, Q2W||0
8124232|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 7P, Q2W||0
8124233|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 7P, Q2W||0
8124234|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 7P, Q2W||0
8124235|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 7P, Q2W||0
8124236|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 7P, Q2W||0
8124237|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 7P, Q2W||0
8124238|NCT02906670|20025424|P10|COMPLETED|Cohort 7P, Q2W||0
8124239|NCT02906670|20025425|P9|COMPLETED|Cohort 7P, Q2W||0
8124240|NCT02906670|20025426|P8|COMPLETED|Cohort 7P, Q2W||0
8124241|NCT02906670|20025427|P7|COMPLETED|Cohort 7P, Q2W||0
8124242|NCT02906670|20025428|P6|COMPLETED|Cohort 7P, Q2W||0
8124243|NCT02906670|20025429|P5|COMPLETED|Cohort 7P, Q2W||0
8124244|NCT02906670|20025430|P4|COMPLETED|Cohort 7P, Q2W||0
8124245|NCT02906670|20025431|P3|COMPLETED|Cohort 7P, Q2W||0
8124246|NCT02906670|20025432|P2|COMPLETED|Cohort 7P, Q2W||0
8124247|NCT02906670|20025433|P1|COMPLETED|Cohort 7P, Q2W||0
8124248|NCT02906670|20025424|P10|STARTED|Cohort 7P, Q2W||3
8124249|NCT02906670|20025425|P9|STARTED|Cohort 7P, Q2W||0
8124250|NCT02906670|20025426|P8|STARTED|Cohort 7P, Q2W||0
8124251|NCT02906670|20025427|P7|STARTED|Cohort 7P, Q2W||0
8124252|NCT02906670|20025428|P6|STARTED|Cohort 7P, Q2W||0
8124253|NCT02906670|20025429|P5|STARTED|Cohort 7P, Q2W||0
8124254|NCT02906670|20025430|P4|STARTED|Cohort 7P, Q2W||0
8124255|NCT02906670|20025431|P3|STARTED|Cohort 7P, Q2W||0
8124256|NCT02906670|20025432|P2|STARTED|Cohort 7P, Q2W||0
8124257|NCT02906670|20025433|P1|STARTED|Cohort 7P, Q2W||0
8124258|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 4P, QW||0
8124259|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 4P, QW||0
8124260|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 4P, QW||0
8124261|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 4P, QW||0
8124262|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 4P, QW||0
8124263|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 4P, QW||0
8124264|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 4P, QW||3
8124265|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 4P, QW||0
8124266|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 4P, QW||0
8124267|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 4P, QW||0
8124268|NCT02906670|20025424|P10|COMPLETED|Cohort 4P, QW||0
8124269|NCT02906670|20025425|P9|COMPLETED|Cohort 4P, QW||0
8124270|NCT02906670|20025426|P8|COMPLETED|Cohort 4P, QW||0
8124271|NCT02906670|20025427|P7|COMPLETED|Cohort 4P, QW||0
8124272|NCT02906670|20025428|P6|COMPLETED|Cohort 4P, QW||0
8124273|NCT02906670|20025429|P5|COMPLETED|Cohort 4P, QW||0
8124274|NCT02906670|20025430|P4|COMPLETED|Cohort 4P, QW||0
8124275|NCT02906670|20025431|P3|COMPLETED|Cohort 4P, QW||0
8124276|NCT02906670|20025432|P2|COMPLETED|Cohort 4P, QW||0
8124277|NCT02906670|20025433|P1|COMPLETED|Cohort 4P, QW||0
8124278|NCT02906670|20025424|P10|STARTED|Cohort 4P, QW||0
8124279|NCT02906670|20025425|P9|STARTED|Cohort 4P, QW||0
8124280|NCT02906670|20025426|P8|STARTED|Cohort 4P, QW||0
8124281|NCT02906670|20025427|P7|STARTED|Cohort 4P, QW||0
8124282|NCT02906670|20025428|P6|STARTED|Cohort 4P, QW||0
8124283|NCT02906670|20025429|P5|STARTED|Cohort 4P, QW||0
8124284|NCT02906670|20025430|P4|STARTED|Cohort 4P, QW||3
8124285|NCT02906670|20025431|P3|STARTED|Cohort 4P, QW||0
8124286|NCT02906670|20025432|P2|STARTED|Cohort 4P, QW||0
8124287|NCT02906670|20025433|P1|STARTED|Cohort 4P, QW||0
8124288|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 6P, Q2W||0
8124289|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 6P, Q2W||4
8124290|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 6P, Q2W||0
8124291|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 6P, Q2W||0
8124292|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 6P, Q2W||0
8124293|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 6P, Q2W||0
8124294|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 6P, Q2W||0
8124295|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 6P, Q2W||0
8124296|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 6P, Q2W||0
8124297|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 6P, Q2W||0
8124298|NCT02906670|20025424|P10|COMPLETED|Cohort 6P, Q2W||0
8124299|NCT02906670|20025425|P9|COMPLETED|Cohort 6P, Q2W||0
8124300|NCT02906670|20025426|P8|COMPLETED|Cohort 6P, Q2W||0
8124301|NCT02906670|20025427|P7|COMPLETED|Cohort 6P, Q2W||0
8124302|NCT02906670|20025428|P6|COMPLETED|Cohort 6P, Q2W||0
8124303|NCT02906670|20025429|P5|COMPLETED|Cohort 6P, Q2W||0
8124304|NCT02906670|20025430|P4|COMPLETED|Cohort 6P, Q2W||0
8124305|NCT02906670|20025431|P3|COMPLETED|Cohort 6P, Q2W||0
8124306|NCT02906670|20025432|P2|COMPLETED|Cohort 6P, Q2W||0
8124307|NCT02906670|20025433|P1|COMPLETED|Cohort 6P, Q2W||0
8124308|NCT02906670|20025424|P10|STARTED|Cohort 6P, Q2W||0
8124309|NCT02906670|20025425|P9|STARTED|Cohort 6P, Q2W||4
8124310|NCT02906670|20025426|P8|STARTED|Cohort 6P, Q2W||0
8124311|NCT02906670|20025427|P7|STARTED|Cohort 6P, Q2W||0
8124312|NCT02906670|20025428|P6|STARTED|Cohort 6P, Q2W||0
8124313|NCT02906670|20025429|P5|STARTED|Cohort 6P, Q2W||0
8124314|NCT02906670|20025430|P4|STARTED|Cohort 6P, Q2W||0
8124315|NCT02906670|20025431|P3|STARTED|Cohort 6P, Q2W||0
8124316|NCT02906670|20025432|P2|STARTED|Cohort 6P, Q2W||0
8124317|NCT02906670|20025433|P1|STARTED|Cohort 6P, Q2W||0
8124318|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 5P, Q2W||0
8124319|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 5P, Q2W||0
8124320|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 5P, Q2W||3
8124321|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 5P, Q2W||0
8124322|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 5P, Q2W||0
8124323|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 5P, Q2W||0
8124324|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 5P, Q2W||0
8124325|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 5P, Q2W||0
8124326|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 5P, Q2W||0
8124327|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 5P, Q2W||0
8124328|NCT02906670|20025424|P10|COMPLETED|Cohort 5P, Q2W||0
8124329|NCT02906670|20025425|P9|COMPLETED|Cohort 5P, Q2W||0
8124330|NCT02906670|20025426|P8|COMPLETED|Cohort 5P, Q2W||0
8124331|NCT02906670|20025427|P7|COMPLETED|Cohort 5P, Q2W||0
8124332|NCT02906670|20025428|P6|COMPLETED|Cohort 5P, Q2W||0
8124333|NCT02906670|20025429|P5|COMPLETED|Cohort 5P, Q2W||0
8124334|NCT02906670|20025430|P4|COMPLETED|Cohort 5P, Q2W||0
8124335|NCT02906670|20025431|P3|COMPLETED|Cohort 5P, Q2W||0
8124336|NCT02906670|20025432|P2|COMPLETED|Cohort 5P, Q2W||0
8124337|NCT02906670|20025433|P1|COMPLETED|Cohort 5P, Q2W||0
8124338|NCT02906670|20025424|P10|STARTED|Cohort 5P, Q2W||0
8124339|NCT02906670|20025425|P9|STARTED|Cohort 5P, Q2W||0
8124340|NCT02906670|20025426|P8|STARTED|Cohort 5P, Q2W||3
8124341|NCT02906670|20025427|P7|STARTED|Cohort 5P, Q2W||0
8124342|NCT02906670|20025428|P6|STARTED|Cohort 5P, Q2W||0
8124343|NCT02906670|20025429|P5|STARTED|Cohort 5P, Q2W||0
8124344|NCT02906670|20025430|P4|STARTED|Cohort 5P, Q2W||0
8124345|NCT02906670|20025431|P3|STARTED|Cohort 5P, Q2W||0
8124346|NCT02906670|20025432|P2|STARTED|Cohort 5P, Q2W||0
8124347|NCT02906670|20025433|P1|STARTED|Cohort 5P, Q2W||0
8124348|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 5, Q2W||0
8124349|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 5, Q2W||0
8124350|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 5, Q2W||0
8124351|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 5, Q2W||7
8124352|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 5, Q2W||0
8124353|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 5, Q2W||0
8124354|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 5, Q2W||0
8124355|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 5, Q2W||0
8124356|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 5, Q2W||0
8124357|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 5, Q2W||0
8124358|NCT02906670|20025424|P10|COMPLETED|Cohort 5, Q2W||0
8124359|NCT02906670|20025425|P9|COMPLETED|Cohort 5, Q2W||0
8124360|NCT02906670|20025426|P8|COMPLETED|Cohort 5, Q2W||0
8124361|NCT02906670|20025427|P7|COMPLETED|Cohort 5, Q2W||0
8124362|NCT02906670|20025428|P6|COMPLETED|Cohort 5, Q2W||0
8124363|NCT02906670|20025429|P5|COMPLETED|Cohort 5, Q2W||0
8124364|NCT02906670|20025430|P4|COMPLETED|Cohort 5, Q2W||0
8124365|NCT02906670|20025431|P3|COMPLETED|Cohort 5, Q2W||0
8124366|NCT02906670|20025432|P2|COMPLETED|Cohort 5, Q2W||0
8124367|NCT02906670|20025433|P1|COMPLETED|Cohort 5, Q2W||0
8124368|NCT02906670|20025424|P10|STARTED|Cohort 5, Q2W||0
8124369|NCT02906670|20025425|P9|STARTED|Cohort 5, Q2W||0
8124370|NCT02906670|20025426|P8|STARTED|Cohort 5, Q2W||0
8124371|NCT02906670|20025427|P7|STARTED|Cohort 5, Q2W||7
8124372|NCT02906670|20025428|P6|STARTED|Cohort 5, Q2W||0
8124373|NCT02906670|20025429|P5|STARTED|Cohort 5, Q2W||0
8124374|NCT02906670|20025430|P4|STARTED|Cohort 5, Q2W||0
8124375|NCT02906670|20025431|P3|STARTED|Cohort 5, Q2W||0
8124376|NCT02906670|20025432|P2|STARTED|Cohort 5, Q2W||0
8124377|NCT02906670|20025433|P1|STARTED|Cohort 5, Q2W||0
8124378|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 4, Q2W||0
8124379|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 4, Q2W||0
8124380|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 4, Q2W||0
8124381|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 4, Q2W||0
8124382|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 4, Q2W||3
8124383|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 4, Q2W||0
8124384|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 4, Q2W||0
8124385|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 4, Q2W||0
8124386|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 4, Q2W||0
8124387|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 4, Q2W||0
8124388|NCT02906670|20025424|P10|COMPLETED|Cohort 4, Q2W||0
8124389|NCT02906670|20025425|P9|COMPLETED|Cohort 4, Q2W||0
8124390|NCT02906670|20025426|P8|COMPLETED|Cohort 4, Q2W||0
8124391|NCT02906670|20025427|P7|COMPLETED|Cohort 4, Q2W||0
8124392|NCT02906670|20025428|P6|COMPLETED|Cohort 4, Q2W||0
8124393|NCT02906670|20025429|P5|COMPLETED|Cohort 4, Q2W||0
8124394|NCT02906670|20025430|P4|COMPLETED|Cohort 4, Q2W||0
8124395|NCT02906670|20025431|P3|COMPLETED|Cohort 4, Q2W||0
8124396|NCT02906670|20025432|P2|COMPLETED|Cohort 4, Q2W||0
8124397|NCT02906670|20025433|P1|COMPLETED|Cohort 4, Q2W||0
8124398|NCT02906670|20025424|P10|STARTED|Cohort 4, Q2W||0
8124399|NCT02906670|20025425|P9|STARTED|Cohort 4, Q2W||0
8124400|NCT02906670|20025426|P8|STARTED|Cohort 4, Q2W||0
8124401|NCT02906670|20025427|P7|STARTED|Cohort 4, Q2W||0
8124402|NCT02906670|20025428|P6|STARTED|Cohort 4, Q2W||3
8124403|NCT02906670|20025429|P5|STARTED|Cohort 4, Q2W||0
8124404|NCT02906670|20025430|P4|STARTED|Cohort 4, Q2W||0
8124405|NCT02906670|20025431|P3|STARTED|Cohort 4, Q2W||0
8124406|NCT02906670|20025432|P2|STARTED|Cohort 4, Q2W||0
8124407|NCT02906670|20025433|P1|STARTED|Cohort 4, Q2W||0
8124408|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 3, QW||0
8124409|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 3, QW||0
8124410|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 3, QW||0
8124411|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 3, QW||0
8124412|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 3, QW||0
8124413|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 3, QW||0
8124414|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 3, QW||0
8124415|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 3, QW||4
8124416|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 3, QW||0
8124417|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 3, QW||0
8124418|NCT02906670|20025424|P10|COMPLETED|Cohort 3, QW||0
8124419|NCT02906670|20025425|P9|COMPLETED|Cohort 3, QW||0
8124420|NCT02906670|20025426|P8|COMPLETED|Cohort 3, QW||0
8124421|NCT02906670|20025427|P7|COMPLETED|Cohort 3, QW||0
8124422|NCT02906670|20025428|P6|COMPLETED|Cohort 3, QW||0
8124423|NCT02906670|20025429|P5|COMPLETED|Cohort 3, QW||0
8124424|NCT02906670|20025430|P4|COMPLETED|Cohort 3, QW||0
8124425|NCT02906670|20025431|P3|COMPLETED|Cohort 3, QW||0
8124426|NCT02906670|20025432|P2|COMPLETED|Cohort 3, QW||0
8124427|NCT02906670|20025433|P1|COMPLETED|Cohort 3, QW||0
8124428|NCT02906670|20025424|P10|STARTED|Cohort 3, QW||0
8124429|NCT02906670|20025425|P9|STARTED|Cohort 3, QW||0
8124430|NCT02906670|20025426|P8|STARTED|Cohort 3, QW||0
8124431|NCT02906670|20025427|P7|STARTED|Cohort 3, QW||0
8124432|NCT02906670|20025428|P6|STARTED|Cohort 3, QW||0
8124433|NCT02906670|20025429|P5|STARTED|Cohort 3, QW||0
8124434|NCT02906670|20025430|P4|STARTED|Cohort 3, QW||0
8124435|NCT02906670|20025431|P3|STARTED|Cohort 3, QW||4
8124436|NCT02906670|20025432|P2|STARTED|Cohort 3, QW||0
8124437|NCT02906670|20025433|P1|STARTED|Cohort 3, QW||0
8124438|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 2, QW||0
8124439|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 2, QW||0
8124440|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 2, QW||0
8124441|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 2, QW||0
8124442|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 2, QW||0
8124443|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 2, QW||0
8124444|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 2, QW||0
8124445|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 2, QW||0
8124446|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 2, QW||1
8124447|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 2, QW||0
8124448|NCT02906670|20025424|P10|COMPLETED|Cohort 2, QW||0
8124449|NCT02906670|20025425|P9|COMPLETED|Cohort 2, QW||0
8124450|NCT02906670|20025426|P8|COMPLETED|Cohort 2, QW||0
8124451|NCT02906670|20025427|P7|COMPLETED|Cohort 2, QW||0
8124452|NCT02906670|20025428|P6|COMPLETED|Cohort 2, QW||0
8124453|NCT02906670|20025429|P5|COMPLETED|Cohort 2, QW||0
8124454|NCT02906670|20025430|P4|COMPLETED|Cohort 2, QW||0
8124455|NCT02906670|20025431|P3|COMPLETED|Cohort 2, QW||0
8124456|NCT02906670|20025432|P2|COMPLETED|Cohort 2, QW||0
8124457|NCT02906670|20025433|P1|COMPLETED|Cohort 2, QW||0
8124458|NCT02906670|20025424|P10|STARTED|Cohort 2, QW||0
8124459|NCT02906670|20025425|P9|STARTED|Cohort 2, QW||0
8124460|NCT02906670|20025426|P8|STARTED|Cohort 2, QW||0
8124461|NCT02906670|20025427|P7|STARTED|Cohort 2, QW||0
8124462|NCT02906670|20025428|P6|STARTED|Cohort 2, QW||0
8124463|NCT02906670|20025429|P5|STARTED|Cohort 2, QW||0
8124464|NCT02906670|20025430|P4|STARTED|Cohort 2, QW||0
8124465|NCT02906670|20025431|P3|STARTED|Cohort 2, QW||0
8124466|NCT02906670|20025432|P2|STARTED|Cohort 2, QW||1
8124467|NCT02906670|20025433|P1|STARTED|Cohort 2, QW||0
8124468|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 1, QW||0
8124469|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 1, QW||0
8124470|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 1, QW||0
8124471|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 1, QW||0
8124472|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 1, QW||0
8124473|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 1, QW||0
8124474|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 1, QW||0
8124475|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 1, QW||0
8124476|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 1, QW||0
8124477|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 1, QW||1
8124478|NCT02906670|20025424|P10|COMPLETED|Cohort 1, QW||0
8124479|NCT02906670|20025425|P9|COMPLETED|Cohort 1, QW||0
8124480|NCT02906670|20025426|P8|COMPLETED|Cohort 1, QW||0
8124481|NCT02906670|20025427|P7|COMPLETED|Cohort 1, QW||0
8124482|NCT02906670|20025428|P6|COMPLETED|Cohort 1, QW||0
8124483|NCT02906670|20025429|P5|COMPLETED|Cohort 1, QW||0
8124484|NCT02906670|20025430|P4|COMPLETED|Cohort 1, QW||0
8124485|NCT02906670|20025431|P3|COMPLETED|Cohort 1, QW||0
8124486|NCT02906670|20025432|P2|COMPLETED|Cohort 1, QW||0
8124487|NCT02906670|20025433|P1|COMPLETED|Cohort 1, QW||0
8124488|NCT02906670|20025424|P10|STARTED|Cohort 1, QW||0
8124489|NCT02906670|20025425|P9|STARTED|Cohort 1, QW||0
8124490|NCT02906670|20025426|P8|STARTED|Cohort 1, QW||0
8124491|NCT02906670|20025427|P7|STARTED|Cohort 1, QW||0
8124492|NCT02906670|20025428|P6|STARTED|Cohort 1, QW||0
8124493|NCT02906670|20025429|P5|STARTED|Cohort 1, QW||0
8124494|NCT02906670|20025430|P4|STARTED|Cohort 1, QW||0
8124495|NCT02906670|20025431|P3|STARTED|Cohort 1, QW||0
8124496|NCT02906670|20025432|P2|STARTED|Cohort 1, QW||0
8124497|NCT02906670|20025433|P1|STARTED|Cohort 1, QW||1
8124498|NCT02906644|20025550|P2|NOT COMPLETED|Weeks 3 to 14||11
8124499|NCT02906644|20025551|P1|NOT COMPLETED|Weeks 3 to 14||16
8124500|NCT02906644|20025550|P2|COMPLETED|Weeks 3 to 14||16
8124501|NCT02906644|20025551|P1|COMPLETED|Weeks 3 to 14||14
8124502|NCT02906644|20025550|P2|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
8124503|NCT02906644|20025551|P1|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
8124504|NCT02906644|20025550|P2|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
8124505|NCT02906644|20025551|P1|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
8124506|NCT02906644|20025550|P2|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
8124507|NCT02906644|20025551|P1|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
8124508|NCT02906644|20025550|P2|NOT COMPLETED|First 2 Weeks||3
8124509|NCT02906644|20025551|P1|NOT COMPLETED|First 2 Weeks||1
8124510|NCT02906644|20025550|P2|COMPLETED|First 2 Weeks||27
8124511|NCT02906644|20025551|P1|COMPLETED|First 2 Weeks||30
8124512|NCT02906644|20025550|P2|STARTED|First 2 Weeks||30
8124513|NCT02906644|20025551|P1|STARTED|First 2 Weeks||31
8124514|NCT02906579|20025567|P1|NOT COMPLETED|Overall Study||2
8124515|NCT02906579|20025567|P1|COMPLETED|Overall Study||9
8124516|NCT02906579|20025567|P1|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
8124517|NCT02906579|20025567|P1|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
8124518|NCT02906579|20025567|P1|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
8124519|NCT02906579|20025567|P1|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
8124520|NCT02906579|20025567|P1|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
8124521|NCT02906579|20025567|P1|Completed Cycle 1 (Placebo)|Overall Study||11
8124522|NCT02906579|20025567|P1|STARTED|Overall Study||11
8124523|NCT02906566|20025754|P2|NOT COMPLETED|Overall Study||0
8124524|NCT02906566|20025755|P1|NOT COMPLETED|Overall Study||3
8124525|NCT02906566|20025754|P2|COMPLETED|Overall Study||10
8124526|NCT02906566|20025755|P1|COMPLETED|Overall Study||21
8124527|NCT02906566|20025754|P2|STARTED|Overall Study||10
8124528|NCT02906566|20025755|P1|STARTED|Overall Study||24
8124529|NCT02906358|20025771|P2|NOT COMPLETED|Overall Study||22
8124530|NCT02906358|20025772|P1|NOT COMPLETED|Overall Study||22
8124531|NCT02906358|20025771|P2|COMPLETED|Overall Study||31
8124532|NCT02906358|20025772|P1|COMPLETED|Overall Study||36
8124533|NCT02906358|20025771|P2|Completed 3 Month Measures|Overall Study||33
8124534|NCT02906358|20025772|P1|Completed 3 Month Measures|Overall Study||36
8124535|NCT02906358|20025771|P2|STARTED|Overall Study||53
8124536|NCT02906358|20025772|P1|STARTED|Overall Study||58
8124537|NCT02905981|20025800|P1|NOT COMPLETED|Overall Study||1
8124538|NCT02905981|20025800|P1|COMPLETED|Overall Study||0
8124539|NCT02905981|20025800|P1|STARTED|Overall Study||1
8124540|NCT02905825|20025806|P1|NOT COMPLETED|Overall Study||12
8124541|NCT02905825|20025806|P1|COMPLETED|Overall Study||41
8124542|NCT02905825|20025806|P1|STARTED|Overall Study||53
8124543|NCT02905331|20025814|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
8124544|NCT02905331|20025815|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
8124545|NCT02905331|20025816|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
8124546|NCT02905331|20025814|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
8124547|NCT02905331|20025815|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
8124548|NCT02905331|20025816|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
8124549|NCT02905331|20025814|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
8124550|NCT02905331|20025815|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
8124551|NCT02905331|20025816|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
8124552|NCT02905331|20025814|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
8124553|NCT02905331|20025815|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
8124554|NCT02905331|20025816|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
8124555|NCT02905331|20025814|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
8124556|NCT02905331|20025815|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
8124557|NCT02905331|20025816|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
8124558|NCT02905331|20025814|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
8124559|NCT02905331|20025815|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
8124560|NCT02905331|20025816|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
8124561|NCT02905266|20025844|P2|NOT COMPLETED|Maintenance Phase Part 2||8
8124562|NCT02905266|20025845|P1|NOT COMPLETED|Maintenance Phase Part 2||12
8124563|NCT02905266|20025844|P2|COMPLETED|Maintenance Phase Part 2||14
8124564|NCT02905266|20025845|P1|COMPLETED|Maintenance Phase Part 2||8
8124565|NCT02905266|20025844|P2|STARTED|Maintenance Phase Part 2||22
8124566|NCT02905266|20025845|P1|STARTED|Maintenance Phase Part 2||20
8124567|NCT02905266|20025844|P2|NOT COMPLETED|Transition From Part 1 to Part 2||8
8124568|NCT02905266|20025845|P1|NOT COMPLETED|Transition From Part 1 to Part 2||4
8124569|NCT02905266|20025844|P2|COMPLETED|Transition From Part 1 to Part 2||22
8124570|NCT02905266|20025845|P1|COMPLETED|Transition From Part 1 to Part 2||20
8124571|NCT02905266|20025844|P2|STARTED|Transition From Part 1 to Part 2||30
8124572|NCT02905266|20025845|P1|STARTED|Transition From Part 1 to Part 2||24
8124573|NCT02905266|20025844|P2|NOT COMPLETED|Treatment Phase Part 1||23
8124574|NCT02905266|20025845|P1|NOT COMPLETED|Treatment Phase Part 1||29
8124575|NCT02905266|20025844|P2|COMPLETED|Treatment Phase Part 1||30
8124576|NCT02905266|20025845|P1|COMPLETED|Treatment Phase Part 1||24
8124577|NCT02905266|20025844|P2|STARTED|Treatment Phase Part 1||53
8124578|NCT02905266|20025845|P1|STARTED|Treatment Phase Part 1||53
8124579|NCT02905149|20025873|P2|NOT COMPLETED|Overall Study||0
8124580|NCT02905149|20025874|P1|NOT COMPLETED|Overall Study||2
8124581|NCT02905149|20025873|P2|COMPLETED|Overall Study||30
8124582|NCT02905149|20025874|P1|COMPLETED|Overall Study||28
8124583|NCT02905149|20025873|P2|STARTED|Overall Study||30
8124584|NCT02905149|20025874|P1|STARTED|Overall Study||30
8124585|NCT02905006|20025892|P6|NOT COMPLETED|Overall Study||4
8124586|NCT02905006|20025893|P5|NOT COMPLETED|Overall Study||3
8124587|NCT02905006|20025894|P4|NOT COMPLETED|Overall Study||6
8124588|NCT02905006|20025895|P3|NOT COMPLETED|Overall Study||5
8124589|NCT02905006|20025896|P2|NOT COMPLETED|Overall Study||3
8124590|NCT02905006|20025897|P1|NOT COMPLETED|Overall Study||5
8124591|NCT02905006|20025892|P6|COMPLETED|Overall Study||39
8124592|NCT02905006|20025893|P5|COMPLETED|Overall Study||40
8124593|NCT02905006|20025894|P4|COMPLETED|Overall Study||34
8124594|NCT02905006|20025895|P3|COMPLETED|Overall Study||38
8124595|NCT02905006|20025896|P2|COMPLETED|Overall Study||36
8124596|NCT02905006|20025897|P1|COMPLETED|Overall Study||37
8124597|NCT02905006|20025892|P6|Entered Safety Follow-up Period|Overall Study||3
8124598|NCT02905006|20025893|P5|Entered Safety Follow-up Period|Overall Study||1
8124599|NCT02905006|20025894|P4|Entered Safety Follow-up Period|Overall Study||2
8124600|NCT02905006|20025895|P3|Entered Safety Follow-up Period|Overall Study||4
8124601|NCT02905006|20025896|P2|Entered Safety Follow-up Period|Overall Study||4
8124602|NCT02905006|20025897|P1|Entered Safety Follow-up Period|Overall Study||4
8124603|NCT02905006|20025892|P6|Enrolled in Extension Study (PS0011)|Overall Study||40
8124604|NCT02905006|20025893|P5|Enrolled in Extension Study (PS0011)|Overall Study||42
8124605|NCT02905006|20025894|P4|Enrolled in Extension Study (PS0011)|Overall Study||38
8124606|NCT02905006|20025895|P3|Enrolled in Extension Study (PS0011)|Overall Study||39
8124607|NCT02905006|20025896|P2|Enrolled in Extension Study (PS0011)|Overall Study||35
8124608|NCT02905006|20025897|P1|Enrolled in Extension Study (PS0011)|Overall Study||38
8124609|NCT02905006|20025892|P6|Completed Treatment Period|Overall Study||39
8124610|NCT02905006|20025893|P5|Completed Treatment Period|Overall Study||40
8124611|NCT02905006|20025894|P4|Completed Treatment Period|Overall Study||34
8124612|NCT02905006|20025895|P3|Completed Treatment Period|Overall Study||38
8124613|NCT02905006|20025896|P2|Completed Treatment Period|Overall Study||36
8124614|NCT02905006|20025897|P1|Completed Treatment Period|Overall Study||37
8124615|NCT02905006|20025892|P6|STARTED|Overall Study||43
8124616|NCT02905006|20025893|P5|STARTED|Overall Study||43
8124617|NCT02905006|20025894|P4|STARTED|Overall Study||40
8124618|NCT02905006|20025895|P3|STARTED|Overall Study||43
8124619|NCT02905006|20025896|P2|STARTED|Overall Study||39
8124620|NCT02905006|20025897|P1|STARTED|Overall Study||42
8124621|NCT02904915|20026113|P2|NOT COMPLETED|Overall Study||0
8124622|NCT02904915|20026114|P1|NOT COMPLETED|Overall Study||0
8124623|NCT02904915|20026113|P2|COMPLETED|Overall Study||25
8124624|NCT02904915|20026114|P1|COMPLETED|Overall Study||25
8124625|NCT02904915|20026113|P2|STARTED|Overall Study||25
8124626|NCT02904915|20026114|P1|STARTED|Overall Study||25
8124627|NCT02904902|20026124|P1|NOT COMPLETED|Overall Study||1
8124628|NCT02904902|20026124|P1|COMPLETED|Overall Study||14
8124629|NCT02904902|20026124|P1|STARTED|Overall Study||15
8124630|NCT02904356|20026131|P1|NOT COMPLETED|Overall Study||0
8124631|NCT02904356|20026131|P1|COMPLETED|Overall Study||2
8124632|NCT02904356|20026131|P1|STARTED|Overall Study||2
8124633|NCT02904265|20026137|P2|NOT COMPLETED|Overall Study||2
8124634|NCT02904265|20026138|P1|NOT COMPLETED|Overall Study||1
8124635|NCT02904265|20026137|P2|COMPLETED|Overall Study||0
8124636|NCT02904265|20026138|P1|COMPLETED|Overall Study||0
8124637|NCT02904265|20026137|P2|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
8124638|NCT02904265|20026138|P1|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
8124639|NCT02904096|20026146|P2|NOT COMPLETED|Overall Study||21
8124640|NCT02904096|20026147|P1|NOT COMPLETED|Overall Study||19
8124641|NCT02904096|20026146|P2|COMPLETED|Overall Study||105
8124642|NCT02904096|20026147|P1|COMPLETED|Overall Study||111
8124643|NCT02904096|20026146|P2|STARTED|Overall Study||126
8124644|NCT02904096|20026147|P1|STARTED|Overall Study||130
8124645|NCT02904057|20026173|P2|NOT COMPLETED|Overall Study||0
8124646|NCT02904057|20026174|P1|NOT COMPLETED|Overall Study||0
8124647|NCT02904057|20026173|P2|COMPLETED|Overall Study||10
8124648|NCT02904057|20026174|P1|COMPLETED|Overall Study||19
8124649|NCT02904057|20026173|P2|STARTED|Overall Study||10
8124650|NCT02904057|20026174|P1|STARTED|Overall Study||19
8124651|NCT02903966|20026183|P2|NOT COMPLETED|Part B (Day 44 to 112)||2
8124652|NCT02903966|20026184|P1|NOT COMPLETED|Part B (Day 44 to 112)||0
8124653|NCT02903966|20026183|P2|COMPLETED|Part B (Day 44 to 112)||22
8124654|NCT02903966|20026184|P1|COMPLETED|Part B (Day 44 to 112)||11
8124655|NCT02903966|20026183|P2|STARTED|Part B (Day 44 to 112)||24
8124656|NCT02903966|20026184|P1|STARTED|Part B (Day 44 to 112)||11
8124657|NCT02903966|20026183|P2|NOT COMPLETED|Part A (Day 1 to 43)||0
8124658|NCT02903966|20026184|P1|NOT COMPLETED|Part A (Day 1 to 43)||1
8124659|NCT02903966|20026183|P2|COMPLETED|Part A (Day 1 to 43)||24
8124660|NCT02903966|20026184|P1|COMPLETED|Part A (Day 1 to 43)||11
8124661|NCT02903966|20026183|P2|STARTED|Part A (Day 1 to 43)||24
8124662|NCT02903966|20026184|P1|STARTED|Part A (Day 1 to 43)||12
8124663|NCT02903836|20026253|P3|NOT COMPLETED|Overall Study||4
8124664|NCT02903836|20026254|P2|NOT COMPLETED|Overall Study||4
8124665|NCT02903836|20026255|P1|NOT COMPLETED|Overall Study||3
8124666|NCT02903836|20026253|P3|COMPLETED|Overall Study||73
8124667|NCT02903836|20026254|P2|COMPLETED|Overall Study||69
8124668|NCT02903836|20026255|P1|COMPLETED|Overall Study||71
8124669|NCT02903836|20026253|P3|STARTED|Overall Study||77
8124670|NCT02903836|20026254|P2|STARTED|Overall Study||73
8124671|NCT02903836|20026255|P1|STARTED|Overall Study||74
8124672|NCT02903420|20026266|P1|NOT COMPLETED|Overall Study||3
8124673|NCT02903420|20026266|P1|COMPLETED|Overall Study||25
8124674|NCT02903420|20026266|P1|STARTED|Overall Study||28
8124675|NCT02903407|20026274|P2|NOT COMPLETED|Overall Study||0
8124676|NCT02903407|20026275|P1|NOT COMPLETED|Overall Study||0
8124677|NCT02903407|20026274|P2|COMPLETED|Overall Study||3
8124678|NCT02903407|20026275|P1|COMPLETED|Overall Study||4
8124679|NCT02903407|20026274|P2|STARTED|Overall Study||3
8124680|NCT02903407|20026275|P1|STARTED|Overall Study||4
8124681|NCT02903394|20026307|P2|NOT COMPLETED|Overall Study||0
8124682|NCT02903394|20026308|P1|NOT COMPLETED|Overall Study||0
8124683|NCT02903394|20026307|P2|COMPLETED|Overall Study||50
8124684|NCT02903394|20026308|P1|COMPLETED|Overall Study||5
8124685|NCT02903394|20026307|P2|STARTED|Overall Study||50
8124686|NCT02903394|20026308|P1|STARTED|Overall Study||5
8124687|NCT02903238|20026318|P1|NOT COMPLETED|Overall Study||4
8124688|NCT02903238|20026318|P1|COMPLETED|Overall Study||17
8124689|NCT02903238|20026318|P1|STARTED|Overall Study||21
8124690|NCT02903121|20026329|P2|NOT COMPLETED|Overall Study||14
8124691|NCT02903121|20026330|P1|NOT COMPLETED|Overall Study||23
8124692|NCT02903121|20026329|P2|COMPLETED|Overall Study||38
8124693|NCT02903121|20026330|P1|COMPLETED|Overall Study||34
8124694|NCT02903121|20026329|P2|STARTED|Overall Study||52
8124695|NCT02903121|20026330|P1|STARTED|Overall Study||57
8124696|NCT02903030|20026344|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8124697|NCT02903030|20026345|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8124698|NCT02903030|20026344|P2|COMPLETED|Second Intervention (8 Weeks)||4
8124699|NCT02903030|20026345|P1|COMPLETED|Second Intervention (8 Weeks)||6
8124700|NCT02903030|20026344|P2|STARTED|Second Intervention (8 Weeks)||4
8124701|NCT02903030|20026345|P1|STARTED|Second Intervention (8 Weeks)||6
8124702|NCT02903030|20026344|P2|NOT COMPLETED|Washout (3 Weeks)||0
8124703|NCT02903030|20026345|P1|NOT COMPLETED|Washout (3 Weeks)||0
8124704|NCT02903030|20026344|P2|COMPLETED|Washout (3 Weeks)||4
8124705|NCT02903030|20026345|P1|COMPLETED|Washout (3 Weeks)||6
8124706|NCT02903030|20026344|P2|STARTED|Washout (3 Weeks)||4
8124707|NCT02903030|20026345|P1|STARTED|Washout (3 Weeks)||6
8124708|NCT02903030|20026344|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
8124709|NCT02903030|20026345|P1|NOT COMPLETED|First Intervention (8 Weeks)||2
8124710|NCT02903030|20026344|P2|COMPLETED|First Intervention (8 Weeks)||4
8124711|NCT02903030|20026345|P1|COMPLETED|First Intervention (8 Weeks)||6
8124712|NCT02903030|20026344|P2|Received Intervention|First Intervention (8 Weeks)||4
8124713|NCT02903030|20026345|P1|Received Intervention|First Intervention (8 Weeks)||6
8124714|NCT02903030|20026344|P2|STARTED|First Intervention (8 Weeks)||5
8124715|NCT02903030|20026345|P1|STARTED|First Intervention (8 Weeks)||8
8124716|NCT02902965|20026363|P1|NOT COMPLETED|Overall Study||10
8124717|NCT02902965|20026363|P1|COMPLETED|Overall Study||64
8124718|NCT02902965|20026363|P1|STARTED|Overall Study||74
8124719|NCT02902913|20026373|P1|NOT COMPLETED|Overall Study||0
8124720|NCT02902913|20026373|P1|COMPLETED|Overall Study||9
8124721|NCT02902913|20026373|P1|Ibuprofen (400mg)|Overall Study||9
8124722|NCT02902913|20026373|P1|Washout (7 Days)|Overall Study||9
8124723|NCT02902913|20026373|P1|Third Intervention (1 Day)|Overall Study||9
8124724|NCT02902913|20026373|P1|Washout (7 Days)|Overall Study||9
8124725|NCT02902913|20026373|P1|Second Intervention (1 Day)|Overall Study||9
8124726|NCT02902913|20026373|P1|Washout (7 Days)|Overall Study||9
8124727|NCT02902913|20026373|P1|First Intervention (1 Day)|Overall Study||9
8124728|NCT02902913|20026373|P1|STARTED|Overall Study||9
8124729|NCT02902809|20026381|P1|NOT COMPLETED|Overall Study||28
8124730|NCT02902809|20026381|P1|COMPLETED|Overall Study||0
8124731|NCT02902809|20026381|P1|Treatment Completed|Overall Study||2
8124732|NCT02902809|20026381|P1|Treatment Received|Overall Study||28
8124733|NCT02902809|20026381|P1|STARTED|Overall Study||28
8124734|NCT02902770|20026392|P3|NOT COMPLETED|Overall Study||0
8124735|NCT02902770|20026393|P2|NOT COMPLETED|Overall Study||0
8124736|NCT02902770|20026394|P1|NOT COMPLETED|Overall Study||0
8124737|NCT02902770|20026392|P3|COMPLETED|Overall Study||50
8124738|NCT02902770|20026393|P2|COMPLETED|Overall Study||50
8124739|NCT02902770|20026394|P1|COMPLETED|Overall Study||50
8124740|NCT02902770|20026392|P3|STARTED|Overall Study||50
8124741|NCT02902770|20026393|P2|STARTED|Overall Study||50
8124742|NCT02902770|20026394|P1|STARTED|Overall Study||50
8124743|NCT02902237|20026402|P1|NOT COMPLETED|Overall Study||0
8124744|NCT02902237|20026402|P1|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
8124745|NCT02902237|20026402|P1|STARTED|Overall Study||17
8124746|NCT02902172|20026415|P2|NOT COMPLETED|Overall Study||0
8124747|NCT02902172|20026416|P1|NOT COMPLETED|Overall Study||0
8124748|NCT02902172|20026415|P2|COMPLETED|Overall Study||20
8124749|NCT02902172|20026416|P1|COMPLETED|Overall Study||16
8124750|NCT02902172|20026415|P2|STARTED|Overall Study||20
8124751|NCT02902172|20026416|P1|STARTED|Overall Study||16
8124752|NCT02902146|20026426|P2|NOT COMPLETED|Overall Study||0
8124753|NCT02902146|20026427|P1|NOT COMPLETED|Overall Study||0
8124754|NCT02902146|20026426|P2|COMPLETED|Overall Study||376
8124755|NCT02902146|20026427|P1|COMPLETED|Overall Study||381
8124756|NCT02902146|20026426|P2|STARTED|Overall Study||376
8124757|NCT02902146|20026427|P1|STARTED|Overall Study||381
8124758|NCT02902081|20026441|P1|NOT COMPLETED|Overall Study||0
8124759|NCT02902081|20026441|P1|COMPLETED|Overall Study||38
8124760|NCT02902081|20026441|P1|STARTED|Overall Study||38
8124761|NCT02901951|20026449|P1|NOT COMPLETED|Overall Study||0
8124762|NCT02901951|20026449|P1|COMPLETED|Overall Study||103
8124763|NCT02901951|20026449|P1|STARTED|Overall Study||103
8124764|NCT02901249|20026460|P1|NOT COMPLETED|Overall Study||25
8124765|NCT02901249|20026460|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
8124766|NCT02901249|20026460|P1|STARTED|Overall Study||68
8124767|NCT02901080|20026466|P1|NOT COMPLETED|Overall Study||49
8124768|NCT02901080|20026466|P1|COMPLETED|Overall Study||112
8124769|NCT02901080|20026466|P1|STARTED|Overall Study||161
8124770|NCT02901054|20026473|P1|NOT COMPLETED|Overall Study||4
8124771|NCT02901054|20026473|P1|COMPLETED|Overall Study||15
8124772|NCT02901054|20026473|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
8124773|NCT02900781|20026479|P2|NOT COMPLETED|Overall Study||5
8124774|NCT02900781|20026480|P1|NOT COMPLETED|Overall Study||4
8124775|NCT02900781|20026479|P2|COMPLETED|Overall Study||0
8124776|NCT02900781|20026480|P1|COMPLETED|Overall Study||0
8124777|NCT02900781|20026479|P2|STARTED|Overall Study||5
8124778|NCT02900781|20026480|P1|STARTED|Overall Study||4
8124779|NCT02900378|20026488|P2|NOT COMPLETED|Treatment Phase||0
8124780|NCT02900378|20026489|P1|NOT COMPLETED|Treatment Phase||0
8124781|NCT02900378|20026488|P2|COMPLETED|Treatment Phase||310
8124782|NCT02900378|20026489|P1|COMPLETED|Treatment Phase||309
8124783|NCT02900378|20026488|P2|Full Analysis Set|Treatment Phase||302
8124784|NCT02900378|20026489|P1|Full Analysis Set|Treatment Phase||302
8124785|NCT02900378|20026488|P2|STARTED|Treatment Phase||310
8124786|NCT02900378|20026489|P1|STARTED|Treatment Phase||309
8124787|NCT02900378|20026488|P2|NOT COMPLETED|Randomization (Visit 2)||28
8124788|NCT02900378|20026489|P1|NOT COMPLETED|Randomization (Visit 2)||23
8124789|NCT02900378|20026488|P2|COMPLETED|Randomization (Visit 2)||283
8124790|NCT02900378|20026489|P1|COMPLETED|Randomization (Visit 2)||287
8124791|NCT02900378|20026488|P2|STARTED|Randomization (Visit 2)||311
8124792|NCT02900378|20026489|P1|STARTED|Randomization (Visit 2)||310
8124793|NCT02900170|20026533|P1|NOT COMPLETED|Overall Study||8
8124794|NCT02900170|20026533|P1|COMPLETED|Overall Study||0
8124795|NCT02900170|20026533|P1|STARTED|Overall Study||8
8124796|NCT02900092|20026537|P1|NOT COMPLETED|Overall Study||1
8124797|NCT02900092|20026537|P1|COMPLETED|Overall Study||9
8124798|NCT02900092|20026537|P1|STARTED|Overall Study||10
8124799|NCT02899988|20026545|P11|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124800|NCT02899988|20026546|P10|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124801|NCT02899988|20026547|P9|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124802|NCT02899988|20026548|P8|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124803|NCT02899988|20026549|P7|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124804|NCT02899988|20026550|P6|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124805|NCT02899988|20026551|P5|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124806|NCT02899988|20026552|P4|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124807|NCT02899988|20026553|P3|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124808|NCT02899988|20026554|P2|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124809|NCT02899988|20026555|P1|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124810|NCT02899988|20026545|P11|COMPLETED|Follow-Up (16 Weeks)||0
8124811|NCT02899988|20026546|P10|COMPLETED|Follow-Up (16 Weeks)||2
8124812|NCT02899988|20026547|P9|COMPLETED|Follow-Up (16 Weeks)||6
8124813|NCT02899988|20026548|P8|COMPLETED|Follow-Up (16 Weeks)||3
8124814|NCT02899988|20026549|P7|COMPLETED|Follow-Up (16 Weeks)||3
8124815|NCT02899988|20026550|P6|COMPLETED|Follow-Up (16 Weeks)||4
8124816|NCT02899988|20026551|P5|COMPLETED|Follow-Up (16 Weeks)||2
8124817|NCT02899988|20026552|P4|COMPLETED|Follow-Up (16 Weeks)||0
8124818|NCT02899988|20026553|P3|COMPLETED|Follow-Up (16 Weeks)||0
8124819|NCT02899988|20026554|P2|COMPLETED|Follow-Up (16 Weeks)||0
8124820|NCT02899988|20026555|P1|COMPLETED|Follow-Up (16 Weeks)||0
8124821|NCT02899988|20026545|P11|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
8124822|NCT02899988|20026546|P10|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
8124823|NCT02899988|20026547|P9|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
8124824|NCT02899988|20026548|P8|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
8124825|NCT02899988|20026549|P7|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
8124826|NCT02899988|20026550|P6|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
8124827|NCT02899988|20026551|P5|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
8124828|NCT02899988|20026552|P4|STARTED|Follow-Up (16 Weeks)||0
8124829|NCT02899988|20026553|P3|STARTED|Follow-Up (16 Weeks)||0
8124830|NCT02899988|20026554|P2|STARTED|Follow-Up (16 Weeks)||0
8124831|NCT02899988|20026555|P1|STARTED|Follow-Up (16 Weeks)||0
8124832|NCT02899988|20026545|P11|NOT COMPLETED|Maintenance Period (88 Weeks)||2
8124833|NCT02899988|20026546|P10|NOT COMPLETED|Maintenance Period (88 Weeks)||2
8124834|NCT02899988|20026547|P9|NOT COMPLETED|Maintenance Period (88 Weeks)||4
8124835|NCT02899988|20026548|P8|NOT COMPLETED|Maintenance Period (88 Weeks)||5
8124836|NCT02899988|20026549|P7|NOT COMPLETED|Maintenance Period (88 Weeks)||4
8124837|NCT02899988|20026550|P6|NOT COMPLETED|Maintenance Period (88 Weeks)||3
8124838|NCT02899988|20026551|P5|NOT COMPLETED|Maintenance Period (88 Weeks)||2
8124839|NCT02899988|20026552|P4|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124840|NCT02899988|20026553|P3|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124841|NCT02899988|20026554|P2|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124842|NCT02899988|20026555|P1|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124843|NCT02899988|20026545|P11|COMPLETED|Maintenance Period (88 Weeks)||13
8124844|NCT02899988|20026546|P10|COMPLETED|Maintenance Period (88 Weeks)||19
8124845|NCT02899988|20026547|P9|COMPLETED|Maintenance Period (88 Weeks)||30
8124846|NCT02899988|20026548|P8|COMPLETED|Maintenance Period (88 Weeks)||45
8124847|NCT02899988|20026549|P7|COMPLETED|Maintenance Period (88 Weeks)||30
8124848|NCT02899988|20026550|P6|COMPLETED|Maintenance Period (88 Weeks)||27
8124849|NCT02899988|20026551|P5|COMPLETED|Maintenance Period (88 Weeks)||13
8124850|NCT02899988|20026552|P4|COMPLETED|Maintenance Period (88 Weeks)||0
8124851|NCT02899988|20026553|P3|COMPLETED|Maintenance Period (88 Weeks)||0
8124852|NCT02899988|20026554|P2|COMPLETED|Maintenance Period (88 Weeks)||0
8124853|NCT02899988|20026555|P1|COMPLETED|Maintenance Period (88 Weeks)||0
8124854|NCT02899988|20026545|P11|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124855|NCT02899988|20026546|P10|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
8124856|NCT02899988|20026547|P9|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
8124857|NCT02899988|20026548|P8|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
8124858|NCT02899988|20026549|P7|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
8124859|NCT02899988|20026550|P6|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
8124860|NCT02899988|20026551|P5|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
8124861|NCT02899988|20026552|P4|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
8124862|NCT02899988|20026553|P3|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124863|NCT02899988|20026554|P2|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124864|NCT02899988|20026555|P1|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124865|NCT02899988|20026545|P11|Rescue Participants|Maintenance Period (88 Weeks)||0
8124866|NCT02899988|20026546|P10|Rescue Participants|Maintenance Period (88 Weeks)||0
8124867|NCT02899988|20026547|P9|Rescue Participants|Maintenance Period (88 Weeks)||0
8124868|NCT02899988|20026548|P8|Rescue Participants|Maintenance Period (88 Weeks)||0
8124869|NCT02899988|20026549|P7|Rescue Participants|Maintenance Period (88 Weeks)||0
8124870|NCT02899988|20026550|P6|Rescue Participants|Maintenance Period (88 Weeks)||0
8124871|NCT02899988|20026551|P5|Rescue Participants|Maintenance Period (88 Weeks)||0
8124872|NCT02899988|20026552|P4|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
8124873|NCT02899988|20026553|P3|Rescue Participants|Maintenance Period (88 Weeks)||0
8124874|NCT02899988|20026554|P2|Rescue Participants|Maintenance Period (88 Weeks)||0
8124875|NCT02899988|20026555|P1|Rescue Participants|Maintenance Period (88 Weeks)||0
8124876|NCT02899988|20026545|P11|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
8124877|NCT02899988|20026546|P10|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
8124878|NCT02899988|20026547|P9|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
8124879|NCT02899988|20026548|P8|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
8124880|NCT02899988|20026549|P7|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
8124881|NCT02899988|20026550|P6|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
8124882|NCT02899988|20026551|P5|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
8124883|NCT02899988|20026552|P4|STARTED|Maintenance Period (88 Weeks)||0
8124884|NCT02899988|20026553|P3|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
8124885|NCT02899988|20026554|P2|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
8124886|NCT02899988|20026555|P1|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
8124887|NCT02899988|20026545|P11|NOT COMPLETED|Induction Period (16 Weeks)||0
8124888|NCT02899988|20026546|P10|NOT COMPLETED|Induction Period (16 Weeks)||0
8124889|NCT02899988|20026547|P9|NOT COMPLETED|Induction Period (16 Weeks)||0
8124890|NCT02899988|20026548|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
8124891|NCT02899988|20026549|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
8124892|NCT02899988|20026550|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
8124893|NCT02899988|20026551|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
8124894|NCT02899988|20026552|P4|NOT COMPLETED|Induction Period (16 Weeks)||2
8124895|NCT02899988|20026553|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
8124896|NCT02899988|20026554|P2|NOT COMPLETED|Induction Period (16 Weeks)||2
8124897|NCT02899988|20026555|P1|NOT COMPLETED|Induction Period (16 Weeks)||2
8124898|NCT02899988|20026545|P11|COMPLETED|Induction Period (16 Weeks)||0
8124899|NCT02899988|20026546|P10|COMPLETED|Induction Period (16 Weeks)||0
8124900|NCT02899988|20026547|P9|COMPLETED|Induction Period (16 Weeks)||0
8124901|NCT02899988|20026548|P8|COMPLETED|Induction Period (16 Weeks)||0
8124902|NCT02899988|20026549|P7|COMPLETED|Induction Period (16 Weeks)||0
8124903|NCT02899988|20026550|P6|COMPLETED|Induction Period (16 Weeks)||0
8124904|NCT02899988|20026551|P5|COMPLETED|Induction Period (16 Weeks)||0
8124905|NCT02899988|20026552|P4|COMPLETED|Induction Period (16 Weeks)||49
8124906|NCT02899988|20026553|P3|COMPLETED|Induction Period (16 Weeks)||51
8124907|NCT02899988|20026554|P2|COMPLETED|Induction Period (16 Weeks)||49
8124908|NCT02899988|20026555|P1|COMPLETED|Induction Period (16 Weeks)||50
8124909|NCT02899988|20026545|P11|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124910|NCT02899988|20026546|P10|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124911|NCT02899988|20026547|P9|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124912|NCT02899988|20026548|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124913|NCT02899988|20026549|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124914|NCT02899988|20026550|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124915|NCT02899988|20026551|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124916|NCT02899988|20026552|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
8124917|NCT02899988|20026553|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
8124918|NCT02899988|20026554|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
8124919|NCT02899988|20026555|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
8124920|NCT02899988|20026545|P11|STARTED|Induction Period (16 Weeks)||0
8124921|NCT02899988|20026546|P10|STARTED|Induction Period (16 Weeks)||0
8124922|NCT02899988|20026547|P9|STARTED|Induction Period (16 Weeks)||0
8124923|NCT02899988|20026548|P8|STARTED|Induction Period (16 Weeks)||0
8124924|NCT02899988|20026549|P7|STARTED|Induction Period (16 Weeks)||0
8124925|NCT02899988|20026550|P6|STARTED|Induction Period (16 Weeks)||0
8124926|NCT02899988|20026551|P5|STARTED|Induction Period (16 Weeks)||0
8124927|NCT02899988|20026552|P4|STARTED|Induction Period (16 Weeks)||51
8124928|NCT02899988|20026553|P3|STARTED|Induction Period (16 Weeks)||51
8124929|NCT02899988|20026554|P2|STARTED|Induction Period (16 Weeks)||51
8124930|NCT02899988|20026555|P1|STARTED|Induction Period (16 Weeks)||52
8124931|NCT02899962|20026614|P3|NOT COMPLETED|Maintenance Phase||153
8124932|NCT02899962|20026615|P2|NOT COMPLETED|Maintenance Phase||141
8124933|NCT02899962|20026616|P1|NOT COMPLETED|Maintenance Phase||0
8124934|NCT02899962|20026614|P3|COMPLETED|Maintenance Phase||120
8124935|NCT02899962|20026615|P2|COMPLETED|Maintenance Phase||131
8124936|NCT02899962|20026616|P1|COMPLETED|Maintenance Phase||0
8124937|NCT02899962|20026614|P3|STARTED|Maintenance Phase||273
8124938|NCT02899962|20026615|P2|STARTED|Maintenance Phase||272
8124939|NCT02899962|20026616|P1|STARTED|Maintenance Phase||0
8124940|NCT02899962|20026614|P3|NOT COMPLETED|Open-label Phase||0
8124941|NCT02899962|20026615|P2|NOT COMPLETED|Open-label Phase||0
8124942|NCT02899962|20026616|P1|NOT COMPLETED|Open-label Phase||27
8124943|NCT02899962|20026614|P3|COMPLETED|Open-label Phase||0
8124944|NCT02899962|20026615|P2|COMPLETED|Open-label Phase||0
8124945|NCT02899962|20026616|P1|COMPLETED|Open-label Phase||623
8124946|NCT02899962|20026614|P3|STARTED|Open-label Phase||0
8124947|NCT02899962|20026615|P2|STARTED|Open-label Phase||0
8124948|NCT02899962|20026616|P1|STARTED|Open-label Phase||650
8124949|NCT02899884|20026627|P1|NOT COMPLETED|Overall Study||0
8124950|NCT02899884|20026627|P1|COMPLETED|Overall Study||3765
8124951|NCT02899884|20026627|P1|STARTED|Overall Study||3765
8124952|NCT02899689|20026641|P2|NOT COMPLETED|Overall Study||2
8124953|NCT02899689|20026642|P1|NOT COMPLETED|Overall Study||0
8124954|NCT02899689|20026641|P2|COMPLETED|Overall Study||208
8124955|NCT02899689|20026642|P1|COMPLETED|Overall Study||209
8124956|NCT02899689|20026641|P2|STARTED|Overall Study||210
8124957|NCT02899689|20026642|P1|STARTED|Overall Study||209
8124958|NCT02899650|20026667|P4|NOT COMPLETED|Overall Study||0
8124959|NCT02899650|20026668|P3|NOT COMPLETED|Overall Study||0
8124960|NCT02899650|20026669|P2|NOT COMPLETED|Overall Study||0
8124961|NCT02899650|20026670|P1|NOT COMPLETED|Overall Study||0
8124962|NCT02899650|20026667|P4|COMPLETED|Overall Study||0
8124963|NCT02899650|20026668|P3|COMPLETED|Overall Study||14
8124964|NCT02899650|20026669|P2|COMPLETED|Overall Study||10
8124965|NCT02899650|20026670|P1|COMPLETED|Overall Study||15
8124966|NCT02899650|20026667|P4|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
8124967|NCT02899650|20026668|P3|STARTED|Overall Study||14
8124968|NCT02899650|20026669|P2|STARTED|Overall Study||10
8124969|NCT02899650|20026670|P1|STARTED|Overall Study||15
8124970|NCT02899377|20026684|P2|NOT COMPLETED|Overall Study||0
8124971|NCT02899377|20026685|P1|NOT COMPLETED|Overall Study||1
8124972|NCT02899377|20026684|P2|COMPLETED|Overall Study||12
8124973|NCT02899377|20026685|P1|COMPLETED|Overall Study||12
8124974|NCT02899377|20026684|P2|STARTED|Overall Study||12
8124975|NCT02899377|20026685|P1|STARTED|Overall Study||13
8124976|NCT02899338|20026718|P2|NOT COMPLETED|Overall Study||2
8124977|NCT02899338|20026719|P1|NOT COMPLETED|Overall Study||3
8124978|NCT02899338|20026718|P2|COMPLETED|Overall Study||79
8124979|NCT02899338|20026719|P1|COMPLETED|Overall Study||78
8124980|NCT02899338|20026718|P2|STARTED|Overall Study||81
8124981|NCT02899338|20026719|P1|STARTED|Overall Study||81
8124982|NCT02899156|20026733|P2|NOT COMPLETED|Overall Study||1
8124983|NCT02899156|20026734|P1|NOT COMPLETED|Overall Study||1
8124984|NCT02899156|20026733|P2|COMPLETED|Overall Study||10
8124985|NCT02899156|20026734|P1|COMPLETED|Overall Study||10
8124986|NCT02899156|20026733|P2|STARTED|Overall Study||11
8124987|NCT02899156|20026734|P1|STARTED|Overall Study||11
8124988|NCT02898974|20026754|P2|NOT COMPLETED|Overall Study||0
8124989|NCT02898974|20026755|P1|NOT COMPLETED|Overall Study||0
8124990|NCT02898974|20026754|P2|COMPLETED|Overall Study||9
8124991|NCT02898974|20026755|P1|COMPLETED|Overall Study||13
8124992|NCT02898974|20026754|P2|STARTED|Overall Study||9
8124993|NCT02898974|20026755|P1|STARTED|Overall Study||13
8124994|NCT02898740|20026767|P2|NOT COMPLETED|Overall Study||0
8124995|NCT02898740|20026768|P1|NOT COMPLETED|Overall Study||0
8124996|NCT02898740|20026767|P2|COMPLETED|Overall Study||19
8124997|NCT02898740|20026768|P1|COMPLETED|Overall Study||21
8124998|NCT02898740|20026767|P2|STARTED|Overall Study||19
8124999|NCT02898740|20026768|P1|STARTED|Overall Study||21
8125000|NCT02898662|20026776|P2|NOT COMPLETED|Overall Study||28
8125001|NCT02898662|20026777|P1|NOT COMPLETED|Overall Study||29
8125002|NCT02898662|20026776|P2|COMPLETED|Overall Study||13
8125003|NCT02898662|20026777|P1|COMPLETED|Overall Study||11
8125004|NCT02898662|20026776|P2|Completed Treatment|Overall Study||29
8125005|NCT02898662|20026777|P1|Completed Treatment|Overall Study||25
8125006|NCT02898662|20026776|P2|STARTED|Overall Study||41
8125007|NCT02898662|20026777|P1|STARTED|Overall Study||40
8125008|NCT02898597|20026801|P2|NOT COMPLETED|Overall Study||12
8125009|NCT02898597|20026802|P1|NOT COMPLETED|Overall Study||4
8125010|NCT02898597|20026801|P2|COMPLETED|Overall Study||12
8125011|NCT02898597|20026802|P1|COMPLETED|Overall Study||21
8125012|NCT02898597|20026801|P2|STARTED|Overall Study||24
8125013|NCT02898597|20026802|P1|STARTED|Overall Study||25
8125014|NCT02898454|20026811|P3|NOT COMPLETED|Overall Study||6
8125015|NCT02898454|20026812|P2|NOT COMPLETED|Overall Study||5
8125016|NCT02898454|20026813|P1|NOT COMPLETED|Overall Study||17
8125017|NCT02898454|20026811|P3|COMPLETED|Overall Study||144
8125018|NCT02898454|20026812|P2|COMPLETED|Overall Study||140
8125019|NCT02898454|20026813|P1|COMPLETED|Overall Study||136
8125020|NCT02898454|20026811|P3|Safety Population|Overall Study||149
8125021|NCT02898454|20026812|P2|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
8125022|NCT02898454|20026813|P1|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
8125023|NCT02898454|20026811|P3|Treated|Overall Study||150
8125024|NCT02898454|20026812|P2|Treated|Overall Study||145
8125025|NCT02898454|20026813|P1|Treated|Overall Study||152
8125026|NCT02898454|20026811|P3|Intent-to-Treat (ITT) Population|Overall Study||150
8125027|NCT02898454|20026812|P2|Intent-to-Treat (ITT) Population|Overall Study||145
8125028|NCT02898454|20026813|P1|Intent-to-Treat (ITT) Population|Overall Study||153
8125029|NCT02898454|20026811|P3|STARTED|Overall Study||150
8125030|NCT02898454|20026812|P2|STARTED|Overall Study||145
8125031|NCT02898454|20026813|P1|STARTED|Overall Study||153
8125032|NCT02898259|20026931|P5|NOT COMPLETED|Overall Study||0
8125033|NCT02898259|20026932|P4|NOT COMPLETED|Overall Study||1
8125034|NCT02898259|20026933|P3|NOT COMPLETED|Overall Study||5
8125035|NCT02898259|20026934|P2|NOT COMPLETED|Overall Study||1
8125036|NCT02898259|20026935|P1|NOT COMPLETED|Overall Study||1
8125037|NCT02898259|20026931|P5|COMPLETED|Overall Study||0
8125038|NCT02898259|20026932|P4|COMPLETED|Overall Study||6
8125039|NCT02898259|20026933|P3|COMPLETED|Overall Study||1
8125040|NCT02898259|20026934|P2|COMPLETED|Overall Study||2
8125041|NCT02898259|20026935|P1|COMPLETED|Overall Study||2
8125042|NCT02898259|20026931|P5|STARTED|Overall Study||0
8125043|NCT02898259|20026932|P4|STARTED|Overall Study||7
8125044|NCT02898259|20026933|P3|STARTED|Overall Study||6
8125045|NCT02898259|20026934|P2|STARTED|Overall Study||3
8125046|NCT02898259|20026935|P1|STARTED|Overall Study||3
8125047|NCT02898116|20026943|P1|NOT COMPLETED|Overall Study||2
8125048|NCT02898116|20026943|P1|COMPLETED|Overall Study||0
8125049|NCT02898116|20026943|P1|STARTED|Overall Study||2
8125050|NCT02897349|20026951|P2|NOT COMPLETED|Overall Study||6
8125051|NCT02897349|20026952|P1|NOT COMPLETED|Overall Study||5
8125052|NCT02897349|20026951|P2|COMPLETED|Overall Study||98
8125053|NCT02897349|20026952|P1|COMPLETED|Overall Study||97
8125054|NCT02897349|20026951|P2|STARTED|Overall Study||104
8125055|NCT02897349|20026952|P1|STARTED|Overall Study||102
8125056|NCT02897141|20026974|P2|NOT COMPLETED|Overall Study||1
8125057|NCT02897141|20026975|P1|NOT COMPLETED|Overall Study||2
8125058|NCT02897141|20026974|P2|COMPLETED|Overall Study||39
8125059|NCT02897141|20026975|P1|COMPLETED|Overall Study||38
8125060|NCT02897141|20026974|P2|STARTED|Overall Study||40
8125061|NCT02897141|20026975|P1|STARTED|Overall Study||40
8125062|NCT02897115|20026994|P2|NOT COMPLETED|Overall Study||8
8125063|NCT02897115|20026995|P1|NOT COMPLETED|Overall Study||11
8125064|NCT02897115|20026994|P2|COMPLETED|Overall Study||0
8125065|NCT02897115|20026995|P1|COMPLETED|Overall Study||3
8125066|NCT02897115|20026994|P2|STARTED|Overall Study||8
8125067|NCT02897115|20026995|P1|STARTED|Overall Study||14
8125068|NCT02896907|20027065|P1|NOT COMPLETED|Overall Study||0
8125069|NCT02896907|20027065|P1|COMPLETED|Overall Study||8
8125070|NCT02896907|20027065|P1|STARTED|Overall Study||8
8125071|NCT02896855|20027072|P2|NOT COMPLETED|Overall Study||122
8125072|NCT02896855|20027073|P1|NOT COMPLETED|Overall Study||121
8125073|NCT02896855|20027072|P2|COMPLETED|Overall Study||0
8125074|NCT02896855|20027073|P1|COMPLETED|Overall Study||0
8125075|NCT02896855|20027072|P2|Received Any Study Treatment|Overall Study||122
8125076|NCT02896855|20027073|P1|Received Any Study Treatment|Overall Study||120
8125077|NCT02896855|20027072|P2|STARTED|Overall Study||122
8125078|NCT02896855|20027073|P1|STARTED|Overall Study||121
8125079|NCT02896595|20027105|P2|NOT COMPLETED|Overall Study||0
8125080|NCT02896595|20027106|P1|NOT COMPLETED|Overall Study||0
8125081|NCT02896595|20027105|P2|COMPLETED|Overall Study||50
8125082|NCT02896595|20027106|P1|COMPLETED|Overall Study||50
8125083|NCT02896595|20027105|P2|STARTED|Overall Study||50
8125084|NCT02896595|20027106|P1|STARTED|Overall Study||50
8125085|NCT02896569|20027156|P2|NOT COMPLETED|Overall Study||5
8125086|NCT02896569|20027157|P1|NOT COMPLETED|Overall Study||4
8125087|NCT02896569|20027156|P2|COMPLETED|Overall Study||19
8125088|NCT02896569|20027157|P1|COMPLETED|Overall Study||21
8125089|NCT02896569|20027156|P2|STARTED|Overall Study||24
8125090|NCT02896569|20027157|P1|STARTED|Overall Study||25
8125091|NCT02896400|20027191|P16|NOT COMPLETED|Biochemical Verification at 3 Months||57
8125092|NCT02896400|20027192|P15|NOT COMPLETED|Biochemical Verification at 3 Months||55
8125093|NCT02896400|20027193|P14|NOT COMPLETED|Biochemical Verification at 3 Months||48
8125094|NCT02896400|20027194|P13|NOT COMPLETED|Biochemical Verification at 3 Months||53
8125095|NCT02896400|20027195|P12|NOT COMPLETED|Biochemical Verification at 3 Months||41
8125096|NCT02896400|20027196|P11|NOT COMPLETED|Biochemical Verification at 3 Months||55
8125097|NCT02896400|20027197|P10|NOT COMPLETED|Biochemical Verification at 3 Months||53
8125098|NCT02896400|20027198|P9|NOT COMPLETED|Biochemical Verification at 3 Months||45
8125099|NCT02896400|20027199|P8|NOT COMPLETED|Biochemical Verification at 3 Months||49
8125100|NCT02896400|20027200|P7|NOT COMPLETED|Biochemical Verification at 3 Months||51
8125101|NCT02896400|20027201|P6|NOT COMPLETED|Biochemical Verification at 3 Months||49
8125102|NCT02896400|20027202|P5|NOT COMPLETED|Biochemical Verification at 3 Months||45
8125103|NCT02896400|20027203|P4|NOT COMPLETED|Biochemical Verification at 3 Months||41
8125104|NCT02896400|20027204|P3|NOT COMPLETED|Biochemical Verification at 3 Months||47
8125105|NCT02896400|20027205|P2|NOT COMPLETED|Biochemical Verification at 3 Months||48
8125106|NCT02896400|20027206|P1|NOT COMPLETED|Biochemical Verification at 3 Months||46
8125107|NCT02896400|20027191|P16|COMPLETED|Biochemical Verification at 3 Months||6
8125108|NCT02896400|20027192|P15|COMPLETED|Biochemical Verification at 3 Months||7
8125109|NCT02896400|20027193|P14|COMPLETED|Biochemical Verification at 3 Months||12
8125110|NCT02896400|20027194|P13|COMPLETED|Biochemical Verification at 3 Months||10
8125111|NCT02896400|20027195|P12|COMPLETED|Biochemical Verification at 3 Months||19
8125112|NCT02896400|20027196|P11|COMPLETED|Biochemical Verification at 3 Months||5
8125113|NCT02896400|20027197|P10|COMPLETED|Biochemical Verification at 3 Months||8
8125114|NCT02896400|20027198|P9|COMPLETED|Biochemical Verification at 3 Months||15
8125115|NCT02896400|20027199|P8|COMPLETED|Biochemical Verification at 3 Months||14
8125116|NCT02896400|20027200|P7|COMPLETED|Biochemical Verification at 3 Months||11
8125117|NCT02896400|20027201|P6|COMPLETED|Biochemical Verification at 3 Months||11
8125118|NCT02896400|20027202|P5|COMPLETED|Biochemical Verification at 3 Months||9
8125119|NCT02896400|20027203|P4|COMPLETED|Biochemical Verification at 3 Months||14
8125120|NCT02896400|20027204|P3|COMPLETED|Biochemical Verification at 3 Months||13
8125121|NCT02896400|20027205|P2|COMPLETED|Biochemical Verification at 3 Months||15
8125122|NCT02896400|20027206|P1|COMPLETED|Biochemical Verification at 3 Months||14
8125123|NCT02896400|20027191|P16|STARTED|Biochemical Verification at 3 Months||63
8125124|NCT02896400|20027192|P15|STARTED|Biochemical Verification at 3 Months||62
8125125|NCT02896400|20027193|P14|STARTED|Biochemical Verification at 3 Months||60
8125126|NCT02896400|20027194|P13|STARTED|Biochemical Verification at 3 Months||63
8125127|NCT02896400|20027195|P12|STARTED|Biochemical Verification at 3 Months||60
8125128|NCT02896400|20027196|P11|STARTED|Biochemical Verification at 3 Months||60
8125129|NCT02896400|20027197|P10|STARTED|Biochemical Verification at 3 Months||61
8125130|NCT02896400|20027198|P9|STARTED|Biochemical Verification at 3 Months||60
8125131|NCT02896400|20027199|P8|STARTED|Biochemical Verification at 3 Months||63
8125132|NCT02896400|20027200|P7|STARTED|Biochemical Verification at 3 Months||62
8125133|NCT02896400|20027201|P6|STARTED|Biochemical Verification at 3 Months||60
8125134|NCT02896400|20027202|P5|STARTED|Biochemical Verification at 3 Months||54
8125135|NCT02896400|20027203|P4|STARTED|Biochemical Verification at 3 Months||55
8125136|NCT02896400|20027204|P3|STARTED|Biochemical Verification at 3 Months||60
8125137|NCT02896400|20027205|P2|STARTED|Biochemical Verification at 3 Months||63
8125138|NCT02896400|20027206|P1|STARTED|Biochemical Verification at 3 Months||60
8125139|NCT02896400|20027191|P16|NOT COMPLETED|3 Month Follow-up||2
8125140|NCT02896400|20027192|P15|NOT COMPLETED|3 Month Follow-up||4
8125141|NCT02896400|20027193|P14|NOT COMPLETED|3 Month Follow-up||6
8125142|NCT02896400|20027194|P13|NOT COMPLETED|3 Month Follow-up||3
8125143|NCT02896400|20027195|P12|NOT COMPLETED|3 Month Follow-up||6
8125144|NCT02896400|20027196|P11|NOT COMPLETED|3 Month Follow-up||6
8125145|NCT02896400|20027197|P10|NOT COMPLETED|3 Month Follow-up||5
8125146|NCT02896400|20027198|P9|NOT COMPLETED|3 Month Follow-up||6
8125147|NCT02896400|20027199|P8|NOT COMPLETED|3 Month Follow-up||3
8125148|NCT02896400|20027200|P7|NOT COMPLETED|3 Month Follow-up||4
8125149|NCT02896400|20027201|P6|NOT COMPLETED|3 Month Follow-up||6
8125150|NCT02896400|20027202|P5|NOT COMPLETED|3 Month Follow-up||12
8125151|NCT02896400|20027203|P4|NOT COMPLETED|3 Month Follow-up||11
8125152|NCT02896400|20027204|P3|NOT COMPLETED|3 Month Follow-up||6
8125153|NCT02896400|20027205|P2|NOT COMPLETED|3 Month Follow-up||3
8125154|NCT02896400|20027206|P1|NOT COMPLETED|3 Month Follow-up||6
8125155|NCT02896400|20027191|P16|COMPLETED|3 Month Follow-up||63
8125156|NCT02896400|20027192|P15|COMPLETED|3 Month Follow-up||62
8125157|NCT02896400|20027193|P14|COMPLETED|3 Month Follow-up||60
8125158|NCT02896400|20027194|P13|COMPLETED|3 Month Follow-up||63
8125159|NCT02896400|20027195|P12|COMPLETED|3 Month Follow-up||60
8125160|NCT02896400|20027196|P11|COMPLETED|3 Month Follow-up||60
8125161|NCT02896400|20027197|P10|COMPLETED|3 Month Follow-up||61
8125162|NCT02896400|20027198|P9|COMPLETED|3 Month Follow-up||60
8125163|NCT02896400|20027199|P8|COMPLETED|3 Month Follow-up||63
8125164|NCT02896400|20027200|P7|COMPLETED|3 Month Follow-up||62
8125165|NCT02896400|20027201|P6|COMPLETED|3 Month Follow-up||60
8125166|NCT02896400|20027202|P5|COMPLETED|3 Month Follow-up||54
8125167|NCT02896400|20027203|P4|COMPLETED|3 Month Follow-up||55
8125168|NCT02896400|20027204|P3|COMPLETED|3 Month Follow-up||60
8125169|NCT02896400|20027205|P2|COMPLETED|3 Month Follow-up||63
8125170|NCT02896400|20027206|P1|COMPLETED|3 Month Follow-up||60
8125171|NCT02896400|20027191|P16|STARTED|3 Month Follow-up||65
8125172|NCT02896400|20027192|P15|STARTED|3 Month Follow-up||66
8125173|NCT02896400|20027193|P14|STARTED|3 Month Follow-up||66
8125174|NCT02896400|20027194|P13|STARTED|3 Month Follow-up||66
8125175|NCT02896400|20027195|P12|STARTED|3 Month Follow-up||66
8125176|NCT02896400|20027196|P11|STARTED|3 Month Follow-up||66
8125177|NCT02896400|20027197|P10|STARTED|3 Month Follow-up||66
8125178|NCT02896400|20027198|P9|STARTED|3 Month Follow-up||66
8125179|NCT02896400|20027199|P8|STARTED|3 Month Follow-up||66
8125180|NCT02896400|20027200|P7|STARTED|3 Month Follow-up||66
8125181|NCT02896400|20027201|P6|STARTED|3 Month Follow-up||66
8125182|NCT02896400|20027202|P5|STARTED|3 Month Follow-up||66
8125183|NCT02896400|20027203|P4|STARTED|3 Month Follow-up||66
8125184|NCT02896400|20027204|P3|STARTED|3 Month Follow-up||66
8125185|NCT02896400|20027205|P2|STARTED|3 Month Follow-up||66
8125186|NCT02896400|20027206|P1|STARTED|3 Month Follow-up||66
8125187|NCT02896400|20027191|P16|NOT COMPLETED|1 Month Follow-up||3
8125188|NCT02896400|20027192|P15|NOT COMPLETED|1 Month Follow-up||1
8125189|NCT02896400|20027193|P14|NOT COMPLETED|1 Month Follow-up||4
8125190|NCT02896400|20027194|P13|NOT COMPLETED|1 Month Follow-up||3
8125191|NCT02896400|20027195|P12|NOT COMPLETED|1 Month Follow-up||5
8125192|NCT02896400|20027196|P11|NOT COMPLETED|1 Month Follow-up||5
8125193|NCT02896400|20027197|P10|NOT COMPLETED|1 Month Follow-up||7
8125194|NCT02896400|20027198|P9|NOT COMPLETED|1 Month Follow-up||4
8125195|NCT02896400|20027199|P8|NOT COMPLETED|1 Month Follow-up||6
8125196|NCT02896400|20027200|P7|NOT COMPLETED|1 Month Follow-up||5
8125197|NCT02896400|20027201|P6|NOT COMPLETED|1 Month Follow-up||6
8125198|NCT02896400|20027202|P5|NOT COMPLETED|1 Month Follow-up||9
8125199|NCT02896400|20027203|P4|NOT COMPLETED|1 Month Follow-up||8
8125200|NCT02896400|20027204|P3|NOT COMPLETED|1 Month Follow-up||5
8125201|NCT02896400|20027205|P2|NOT COMPLETED|1 Month Follow-up||7
8125202|NCT02896400|20027206|P1|NOT COMPLETED|1 Month Follow-up||7
8125203|NCT02896400|20027191|P16|COMPLETED|1 Month Follow-up||63
8125204|NCT02896400|20027192|P15|COMPLETED|1 Month Follow-up||65
8125205|NCT02896400|20027193|P14|COMPLETED|1 Month Follow-up||62
8125206|NCT02896400|20027194|P13|COMPLETED|1 Month Follow-up||63
8125207|NCT02896400|20027195|P12|COMPLETED|1 Month Follow-up||61
8125208|NCT02896400|20027196|P11|COMPLETED|1 Month Follow-up||61
8125209|NCT02896400|20027197|P10|COMPLETED|1 Month Follow-up||59
8125210|NCT02896400|20027198|P9|COMPLETED|1 Month Follow-up||62
8125211|NCT02896400|20027199|P8|COMPLETED|1 Month Follow-up||60
8125212|NCT02896400|20027200|P7|COMPLETED|1 Month Follow-up||61
8125213|NCT02896400|20027201|P6|COMPLETED|1 Month Follow-up||60
8125214|NCT02896400|20027202|P5|COMPLETED|1 Month Follow-up||57
8125215|NCT02896400|20027203|P4|COMPLETED|1 Month Follow-up||58
8125216|NCT02896400|20027204|P3|COMPLETED|1 Month Follow-up||61
8125217|NCT02896400|20027205|P2|COMPLETED|1 Month Follow-up||59
8125218|NCT02896400|20027206|P1|COMPLETED|1 Month Follow-up||59
8125219|NCT02896400|20027191|P16|STARTED|1 Month Follow-up||66
8125220|NCT02896400|20027192|P15|STARTED|1 Month Follow-up||66
8125221|NCT02896400|20027193|P14|STARTED|1 Month Follow-up||66
8125222|NCT02896400|20027194|P13|STARTED|1 Month Follow-up||66
8125223|NCT02896400|20027195|P12|STARTED|1 Month Follow-up||66
8125224|NCT02896400|20027196|P11|STARTED|1 Month Follow-up||66
8125225|NCT02896400|20027197|P10|STARTED|1 Month Follow-up||66
8125226|NCT02896400|20027198|P9|STARTED|1 Month Follow-up||66
8125227|NCT02896400|20027199|P8|STARTED|1 Month Follow-up||66
8125228|NCT02896400|20027200|P7|STARTED|1 Month Follow-up||66
8125229|NCT02896400|20027201|P6|STARTED|1 Month Follow-up||66
8125230|NCT02896400|20027202|P5|STARTED|1 Month Follow-up||66
8125231|NCT02896400|20027203|P4|STARTED|1 Month Follow-up||66
8125232|NCT02896400|20027204|P3|STARTED|1 Month Follow-up||66
8125233|NCT02896400|20027205|P2|STARTED|1 Month Follow-up||66
8125234|NCT02896400|20027206|P1|STARTED|1 Month Follow-up||66
8125235|NCT02896400|20027191|P16|NOT COMPLETED|Baseline||0
8125236|NCT02896400|20027192|P15|NOT COMPLETED|Baseline||0
8125237|NCT02896400|20027193|P14|NOT COMPLETED|Baseline||0
8125238|NCT02896400|20027194|P13|NOT COMPLETED|Baseline||0
8125239|NCT02896400|20027195|P12|NOT COMPLETED|Baseline||0
8125240|NCT02896400|20027196|P11|NOT COMPLETED|Baseline||0
8125241|NCT02896400|20027197|P10|NOT COMPLETED|Baseline||0
8125242|NCT02896400|20027198|P9|NOT COMPLETED|Baseline||0
8125243|NCT02896400|20027199|P8|NOT COMPLETED|Baseline||0
8125244|NCT02896400|20027200|P7|NOT COMPLETED|Baseline||0
8125245|NCT02896400|20027201|P6|NOT COMPLETED|Baseline||0
8125246|NCT02896400|20027202|P5|NOT COMPLETED|Baseline||0
8125247|NCT02896400|20027203|P4|NOT COMPLETED|Baseline||0
8125248|NCT02896400|20027204|P3|NOT COMPLETED|Baseline||0
8125249|NCT02896400|20027205|P2|NOT COMPLETED|Baseline||0
8125250|NCT02896400|20027206|P1|NOT COMPLETED|Baseline||0
8125251|NCT02896400|20027191|P16|COMPLETED|Baseline||66
8125252|NCT02896400|20027192|P15|COMPLETED|Baseline||66
8125253|NCT02896400|20027193|P14|COMPLETED|Baseline||66
8125254|NCT02896400|20027194|P13|COMPLETED|Baseline||66
8125255|NCT02896400|20027195|P12|COMPLETED|Baseline||66
8125256|NCT02896400|20027196|P11|COMPLETED|Baseline||66
8125257|NCT02896400|20027197|P10|COMPLETED|Baseline||66
8125258|NCT02896400|20027198|P9|COMPLETED|Baseline||66
8125259|NCT02896400|20027199|P8|COMPLETED|Baseline||66
8125260|NCT02896400|20027200|P7|COMPLETED|Baseline||66
8125261|NCT02896400|20027201|P6|COMPLETED|Baseline||66
8125262|NCT02896400|20027202|P5|COMPLETED|Baseline||66
8125263|NCT02896400|20027203|P4|COMPLETED|Baseline||66
8125264|NCT02896400|20027204|P3|COMPLETED|Baseline||66
8125265|NCT02896400|20027205|P2|COMPLETED|Baseline||66
8125266|NCT02896400|20027206|P1|COMPLETED|Baseline||66
8125267|NCT02896400|20027191|P16|STARTED|Baseline||66
8125268|NCT02896400|20027192|P15|STARTED|Baseline||66
8125269|NCT02896400|20027193|P14|STARTED|Baseline||66
8125270|NCT02896400|20027194|P13|STARTED|Baseline||66
8125271|NCT02896400|20027195|P12|STARTED|Baseline||66
8125272|NCT02896400|20027196|P11|STARTED|Baseline||66
8125273|NCT02896400|20027197|P10|STARTED|Baseline||66
8125274|NCT02896400|20027198|P9|STARTED|Baseline||66
8125275|NCT02896400|20027199|P8|STARTED|Baseline||66
8125276|NCT02896400|20027200|P7|STARTED|Baseline||66
8125277|NCT02896400|20027201|P6|STARTED|Baseline||66
8125278|NCT02896400|20027202|P5|STARTED|Baseline||66
8125279|NCT02896400|20027203|P4|STARTED|Baseline||66
8125280|NCT02896400|20027204|P3|STARTED|Baseline||66
8125281|NCT02896400|20027205|P2|STARTED|Baseline||66
8125282|NCT02896400|20027206|P1|STARTED|Baseline||66
8125283|NCT02896361|20027232|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
8125284|NCT02896361|20027233|P2|NOT COMPLETED|Third Intervention (2 Weeks)||1
8125285|NCT02896361|20027234|P1|NOT COMPLETED|Third Intervention (2 Weeks)||1
8125286|NCT02896361|20027232|P3|COMPLETED|Third Intervention (2 Weeks)||8
8125287|NCT02896361|20027233|P2|COMPLETED|Third Intervention (2 Weeks)||9
8125288|NCT02896361|20027234|P1|COMPLETED|Third Intervention (2 Weeks)||8
8125289|NCT02896361|20027232|P3|STARTED|Third Intervention (2 Weeks)||8
8125290|NCT02896361|20027233|P2|STARTED|Third Intervention (2 Weeks)||10
8125291|NCT02896361|20027234|P1|STARTED|Third Intervention (2 Weeks)||9
8125292|NCT02896361|20027232|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
8125293|NCT02896361|20027233|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8125294|NCT02896361|20027234|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8125295|NCT02896361|20027232|P3|COMPLETED|Second Intervention (2 Weeks)||8
8125296|NCT02896361|20027233|P2|COMPLETED|Second Intervention (2 Weeks)||10
8125297|NCT02896361|20027234|P1|COMPLETED|Second Intervention (2 Weeks)||9
8125298|NCT02896361|20027232|P3|STARTED|Second Intervention (2 Weeks)||8
8125299|NCT02896361|20027233|P2|STARTED|Second Intervention (2 Weeks)||10
8125300|NCT02896361|20027234|P1|STARTED|Second Intervention (2 Weeks)||9
8125301|NCT02896361|20027232|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
8125302|NCT02896361|20027233|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8125303|NCT02896361|20027234|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8125304|NCT02896361|20027232|P3|COMPLETED|First Intervention (2 Weeks)||8
8125305|NCT02896361|20027233|P2|COMPLETED|First Intervention (2 Weeks)||10
8125306|NCT02896361|20027234|P1|COMPLETED|First Intervention (2 Weeks)||9
8125307|NCT02896361|20027232|P3|STARTED|First Intervention (2 Weeks)||8
8125308|NCT02896361|20027233|P2|STARTED|First Intervention (2 Weeks)||10
8125309|NCT02896361|20027234|P1|STARTED|First Intervention (2 Weeks)||9
8125310|NCT02896296|20027252|P1|NOT COMPLETED|Overall Study||42
8125311|NCT02896296|20027252|P1|COMPLETED|Overall Study||166
8125312|NCT02896296|20027252|P1|STARTED|Overall Study||208
8125313|NCT02896127|20027260|P2|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
8125314|NCT02896127|20027261|P1|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
8125315|NCT02896127|20027260|P2|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
8125316|NCT02896127|20027261|P1|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
8125317|NCT02896127|20027260|P2|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
8125318|NCT02896127|20027261|P1|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
8125319|NCT02896127|20027260|P2|NOT COMPLETED|COMPLETED WEEK 52||11
8125320|NCT02896127|20027261|P1|NOT COMPLETED|COMPLETED WEEK 52||27
8125321|NCT02896127|20027260|P2|COMPLETED|COMPLETED WEEK 52||142
8125322|NCT02896127|20027261|P1|COMPLETED|COMPLETED WEEK 52||278
8125323|NCT02896127|20027260|P2|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
8125324|NCT02896127|20027261|P1|STARTED|COMPLETED WEEK 52||305
8125325|NCT02895347|20027283|P2|NOT COMPLETED|Overall Study||1
8125326|NCT02895347|20027284|P1|NOT COMPLETED|Overall Study||3
8125327|NCT02895347|20027283|P2|COMPLETED|Overall Study||19
8125328|NCT02895347|20027284|P1|COMPLETED|Overall Study||17
8125329|NCT02895347|20027283|P2|STARTED|Overall Study||20
8125330|NCT02895347|20027284|P1|STARTED|Overall Study||20
8125331|NCT02895295|20027296|P3|NOT COMPLETED|Overall Study||92
8125332|NCT02895295|20027297|P2|NOT COMPLETED|Overall Study||94
8125333|NCT02895295|20027298|P1|NOT COMPLETED|Overall Study||71
8125334|NCT02895295|20027296|P3|COMPLETED|Overall Study||299
8125335|NCT02895295|20027297|P2|COMPLETED|Overall Study||316
8125336|NCT02895295|20027298|P1|COMPLETED|Overall Study||313
8125337|NCT02895295|20027296|P3|STARTED|Overall Study||391
8125338|NCT02895295|20027297|P2|STARTED|Overall Study||410
8125339|NCT02895295|20027298|P1|STARTED|Overall Study||384
8125340|NCT02895035|20027315|P2|NOT COMPLETED|Overall Study||12
8125341|NCT02895035|20027316|P1|NOT COMPLETED|Overall Study||5
8125342|NCT02895035|20027315|P2|COMPLETED|Overall Study||24
8125343|NCT02895035|20027316|P1|COMPLETED|Overall Study||18
8125344|NCT02895035|20027315|P2|STARTED|Overall Study||36
8125345|NCT02895035|20027316|P1|STARTED|Overall Study||23
8125346|NCT02894840|20027332|P4|NOT COMPLETED|Overall Study||0
8125347|NCT02894840|20027333|P3|NOT COMPLETED|Overall Study||3
8125348|NCT02894840|20027334|P2|NOT COMPLETED|Overall Study||0
8125349|NCT02894840|20027335|P1|NOT COMPLETED|Overall Study||1
8125350|NCT02894840|20027332|P4|COMPLETED|Overall Study||100
8125351|NCT02894840|20027333|P3|COMPLETED|Overall Study||197
8125352|NCT02894840|20027334|P2|COMPLETED|Overall Study||20
8125353|NCT02894840|20027335|P1|COMPLETED|Overall Study||19
8125354|NCT02894840|20027332|P4|STARTED|Overall Study||100
8125355|NCT02894840|20027333|P3|STARTED|Overall Study||200
8125356|NCT02894840|20027334|P2|STARTED|Overall Study||20
8125357|NCT02894840|20027335|P1|STARTED|Overall Study||20
8125358|NCT02893878|20027360|P3|NOT COMPLETED|Overall Study||0
8125359|NCT02893878|20027361|P2|NOT COMPLETED|Overall Study||0
8125360|NCT02893878|20027362|P1|NOT COMPLETED|Overall Study||0
8125361|NCT02893878|20027360|P3|COMPLETED|Overall Study||3178
8125362|NCT02893878|20027361|P2|COMPLETED|Overall Study||2295
8125363|NCT02893878|20027362|P1|COMPLETED|Overall Study||13861
8125364|NCT02893878|20027360|P3|STARTED|Overall Study||3178
8125365|NCT02893878|20027361|P2|STARTED|Overall Study||2295
8125366|NCT02893878|20027362|P1|STARTED|Overall Study||13861
8125367|NCT02892734|20027607|P1|NOT COMPLETED|Follow up for 2 Years||3
8125368|NCT02892734|20027607|P1|COMPLETED|Follow up for 2 Years||0
8125369|NCT02892734|20027607|P1|STARTED|Follow up for 2 Years||3
8125370|NCT02892734|20027607|P1|NOT COMPLETED|Treatment on Study||2
8125371|NCT02892734|20027607|P1|COMPLETED|Treatment on Study||1
8125372|NCT02892734|20027607|P1|Went on to Start Cycle 2|Treatment on Study||1
8125373|NCT02892734|20027607|P1|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
8125374|NCT02892734|20027607|P1|STARTED|Treatment on Study||3
8125375|NCT02892513|20027617|P2|NOT COMPLETED|Overall Study||1
8125376|NCT02892513|20027618|P1|NOT COMPLETED|Overall Study||0
8125377|NCT02892513|20027617|P2|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
8125378|NCT02892513|20027618|P1|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
8125379|NCT02892513|20027617|P2|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
8125380|NCT02892513|20027618|P1|STARTED|Overall Study||28
8125381|NCT02892500|20027626|P2|NOT COMPLETED|Overall Study||0
8125382|NCT02892500|20027627|P1|NOT COMPLETED|Overall Study||0
8125383|NCT02892500|20027626|P2|COMPLETED|Overall Study||0
8125384|NCT02892500|20027627|P1|COMPLETED|Overall Study||0
8125385|NCT02892500|20027626|P2|STARTED|Overall Study||0
8125386|NCT02892500|20027627|P1|STARTED|Overall Study||0
8125387|NCT02892448|20027638|P3|NOT COMPLETED|Overall Study||1
8125388|NCT02892448|20027639|P2|NOT COMPLETED|Overall Study||2
8125389|NCT02892448|20027640|P1|NOT COMPLETED|Overall Study||2
8125390|NCT02892448|20027638|P3|COMPLETED|Overall Study||10
8125391|NCT02892448|20027639|P2|COMPLETED|Overall Study||10
8125392|NCT02892448|20027640|P1|COMPLETED|Overall Study||10
8125393|NCT02892448|20027638|P3|STARTED|Overall Study||11
8125394|NCT02892448|20027639|P2|STARTED|Overall Study||12
8125395|NCT02892448|20027640|P1|STARTED|Overall Study||12
8125396|NCT02892422|20027660|P1|NOT COMPLETED|Overall Study||210
8125397|NCT02892422|20027660|P1|COMPLETED|Overall Study||318
8125398|NCT02892422|20027660|P1|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
8125399|NCT02892409|20027666|P2|NOT COMPLETED|Overall Study||1
8125400|NCT02892409|20027667|P1|NOT COMPLETED|Overall Study||3
8125401|NCT02892409|20027666|P2|COMPLETED|Overall Study||14
8125402|NCT02892409|20027667|P1|COMPLETED|Overall Study||12
8125403|NCT02892409|20027666|P2|STARTED|Overall Study||15
8125404|NCT02892409|20027667|P1|STARTED|Overall Study||15
8125405|NCT02892344|20027689|P2|NOT COMPLETED|Overall Study||21
8125406|NCT02892344|20027690|P1|NOT COMPLETED|Overall Study||4
8125407|NCT02892344|20027689|P2|COMPLETED|Overall Study||383
8125408|NCT02892344|20027690|P1|COMPLETED|Overall Study||394
8125409|NCT02892344|20027689|P2|Full Analysis Set|Overall Study||399
8125410|NCT02892344|20027690|P1|Full Analysis Set|Overall Study||395
8125411|NCT02892344|20027689|P2|STARTED|Overall Study||404
8125412|NCT02892344|20027690|P1|STARTED|Overall Study||398
8125413|NCT02892110|20027726|P2|NOT COMPLETED|Overall Study||12
8125414|NCT02892110|20027727|P1|NOT COMPLETED|Overall Study||13
8125415|NCT02892110|20027726|P2|COMPLETED|Overall Study||25
8125416|NCT02892110|20027727|P1|COMPLETED|Overall Study||22
8125417|NCT02892110|20027726|P2|STARTED|Overall Study||37
8125418|NCT02892110|20027727|P1|STARTED|Overall Study||35
8125419|NCT02892019|20027739|P2|NOT COMPLETED|Overall Study||3
8125420|NCT02892019|20027740|P1|NOT COMPLETED|Overall Study||1
8125421|NCT02892019|20027739|P2|COMPLETED|Overall Study||36
8125422|NCT02892019|20027740|P1|COMPLETED|Overall Study||40
8125423|NCT02892019|20027739|P2|STARTED|Overall Study||39
8125424|NCT02892019|20027740|P1|STARTED|Overall Study||41
8125425|NCT02891863|20027762|P1|NOT COMPLETED|Overall Study||0
8125426|NCT02891863|20027762|P1|COMPLETED|Overall Study||9
8125427|NCT02891863|20027762|P1|STARTED|Overall Study||9
8125434|NCT02891629|20027786|P2|NOT COMPLETED|Overall Study||1
8125435|NCT02891629|20027787|P1|NOT COMPLETED|Overall Study||0
8125436|NCT02891629|20027786|P2|COMPLETED|Overall Study||4
8125437|NCT02891629|20027787|P1|COMPLETED|Overall Study||10
8125438|NCT02891629|20027786|P2|STARTED|Overall Study||5
8125439|NCT02891629|20027787|P1|STARTED|Overall Study||10
8125440|NCT02891408|20027802|P7|NOT COMPLETED|Overall Study||0
8125441|NCT02891408|20027803|P6|NOT COMPLETED|Overall Study||0
8125442|NCT02891408|20027804|P5|NOT COMPLETED|Overall Study||0
8125443|NCT02891408|20027805|P4|NOT COMPLETED|Overall Study||0
8125444|NCT02891408|20027806|P3|NOT COMPLETED|Overall Study||1
8125445|NCT02891408|20027807|P2|NOT COMPLETED|Overall Study||0
8125446|NCT02891408|20027808|P1|NOT COMPLETED|Overall Study||0
8125447|NCT02891408|20027802|P7|COMPLETED|Overall Study||10
8125448|NCT02891408|20027803|P6|COMPLETED|Overall Study||10
8125449|NCT02891408|20027804|P5|COMPLETED|Overall Study||10
8125450|NCT02891408|20027805|P4|COMPLETED|Overall Study||10
8125451|NCT02891408|20027806|P3|COMPLETED|Overall Study||13
8125452|NCT02891408|20027807|P2|COMPLETED|Overall Study||10
8125453|NCT02891408|20027808|P1|COMPLETED|Overall Study||10
8125454|NCT02891408|20027802|P7|STARTED|Overall Study||10
8125455|NCT02891408|20027803|P6|STARTED|Overall Study||10
8125456|NCT02891408|20027804|P5|STARTED|Overall Study||10
8125457|NCT02891408|20027805|P4|STARTED|Overall Study||10
8125458|NCT02891408|20027806|P3|STARTED|Overall Study||14
8125459|NCT02891408|20027807|P2|STARTED|Overall Study||10
8125460|NCT02891408|20027808|P1|STARTED|Overall Study||10
8125461|NCT02891200|20027921|P2|NOT COMPLETED|Overall Study||49
8125462|NCT02891200|20027922|P1|NOT COMPLETED|Overall Study||42
8125463|NCT02891200|20027921|P2|COMPLETED|Overall Study||98
8125464|NCT02891200|20027922|P1|COMPLETED|Overall Study||103
8125465|NCT02891200|20027921|P2|STARTED|Overall Study||147
8125466|NCT02891200|20027922|P1|STARTED|Overall Study||145
8125467|NCT02891174|20027950|P2|NOT COMPLETED|Second Intervention (24 Hours)||7
8125468|NCT02891174|20027951|P1|NOT COMPLETED|Second Intervention (24 Hours)||6
8125469|NCT02891174|20027950|P2|COMPLETED|Second Intervention (24 Hours)||3
8125470|NCT02891174|20027951|P1|COMPLETED|Second Intervention (24 Hours)||11
8125471|NCT02891174|20027950|P2|STARTED|Second Intervention (24 Hours)||10
8125472|NCT02891174|20027951|P1|STARTED|Second Intervention (24 Hours)||17
8125473|NCT02891174|20027950|P2|NOT COMPLETED|First Intervention (24 Hours)||13
8125474|NCT02891174|20027951|P1|NOT COMPLETED|First Intervention (24 Hours)||3
8125475|NCT02891174|20027950|P2|COMPLETED|First Intervention (24 Hours)||10
8125476|NCT02891174|20027951|P1|COMPLETED|First Intervention (24 Hours)||17
8125477|NCT02891174|20027950|P2|Received First Intervention|First Intervention (24 Hours)||18
8125478|NCT02891174|20027951|P1|Received First Intervention|First Intervention (24 Hours)||19
8125479|NCT02891174|20027950|P2|STARTED|First Intervention (24 Hours)||23
8125480|NCT02891174|20027951|P1|STARTED|First Intervention (24 Hours)||20
8125481|NCT02891070|20027965|P2|NOT COMPLETED|Overall Study||8
8125482|NCT02891070|20027966|P1|NOT COMPLETED|Overall Study||10
8125483|NCT02891070|20027965|P2|COMPLETED|Overall Study||106
8125484|NCT02891070|20027966|P1|COMPLETED|Overall Study||100
8125485|NCT02891070|20027965|P2|STARTED|Overall Study||114
8125486|NCT02891070|20027966|P1|STARTED|Overall Study||110
8125487|NCT02890992|20027992|P8|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
8125488|NCT02890992|20027993|P7|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
8125489|NCT02890992|20027994|P6|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125490|NCT02890992|20027995|P5|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125491|NCT02890992|20027996|P4|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125492|NCT02890992|20027997|P3|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125493|NCT02890992|20027998|P2|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
8125494|NCT02890992|20027999|P1|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125495|NCT02890992|20027992|P8|COMPLETED|130 Weeks Open-Label Extension Period||4
8125496|NCT02890992|20027993|P7|COMPLETED|130 Weeks Open-Label Extension Period||5
8125497|NCT02890992|20027994|P6|COMPLETED|130 Weeks Open-Label Extension Period||5
8125498|NCT02890992|20027995|P5|COMPLETED|130 Weeks Open-Label Extension Period||6
8125499|NCT02890992|20027996|P4|COMPLETED|130 Weeks Open-Label Extension Period||6
8125500|NCT02890992|20027997|P3|COMPLETED|130 Weeks Open-Label Extension Period||4
8125501|NCT02890992|20027998|P2|COMPLETED|130 Weeks Open-Label Extension Period||3
8125502|NCT02890992|20027999|P1|COMPLETED|130 Weeks Open-Label Extension Period||3
8125503|NCT02890992|20027992|P8|Treated|130 Weeks Open-Label Extension Period||4
8125504|NCT02890992|20027993|P7|Treated|130 Weeks Open-Label Extension Period||5
8125505|NCT02890992|20027994|P6|Treated|130 Weeks Open-Label Extension Period||5
8125506|NCT02890992|20027995|P5|Treated|130 Weeks Open-Label Extension Period||6
8125507|NCT02890992|20027996|P4|Treated|130 Weeks Open-Label Extension Period||6
8125508|NCT02890992|20027997|P3|Treated|130 Weeks Open-Label Extension Period||4
8125509|NCT02890992|20027998|P2|Treated|130 Weeks Open-Label Extension Period||6
8125510|NCT02890992|20027999|P1|Treated|130 Weeks Open-Label Extension Period||3
8125511|NCT02890992|20027992|P8|STARTED|130 Weeks Open-Label Extension Period||5
8125512|NCT02890992|20027993|P7|STARTED|130 Weeks Open-Label Extension Period||6
8125513|NCT02890992|20027994|P6|STARTED|130 Weeks Open-Label Extension Period||5
8125514|NCT02890992|20027995|P5|STARTED|130 Weeks Open-Label Extension Period||6
8125515|NCT02890992|20027996|P4|STARTED|130 Weeks Open-Label Extension Period||6
8125516|NCT02890992|20027997|P3|STARTED|130 Weeks Open-Label Extension Period||4
8125517|NCT02890992|20027998|P2|STARTED|130 Weeks Open-Label Extension Period||6
8125518|NCT02890992|20027999|P1|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
8125519|NCT02890992|20027992|P8|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125520|NCT02890992|20027993|P7|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125521|NCT02890992|20027994|P6|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125522|NCT02890992|20027995|P5|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125523|NCT02890992|20027996|P4|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125524|NCT02890992|20027997|P3|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125525|NCT02890992|20027998|P2|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125526|NCT02890992|20027999|P1|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125527|NCT02890992|20027992|P8|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
8125528|NCT02890992|20027993|P7|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125529|NCT02890992|20027994|P6|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
8125530|NCT02890992|20027995|P5|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125531|NCT02890992|20027996|P4|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125532|NCT02890992|20027997|P3|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
8125533|NCT02890992|20027998|P2|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125534|NCT02890992|20027999|P1|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
8125535|NCT02890992|20027992|P8|Treated|12 Weeks Open-Label Dose Finding Period||5
8125536|NCT02890992|20027993|P7|Treated|12 Weeks Open-Label Dose Finding Period||6
8125537|NCT02890992|20027994|P6|Treated|12 Weeks Open-Label Dose Finding Period||5
8125538|NCT02890992|20027995|P5|Treated|12 Weeks Open-Label Dose Finding Period||6
8125539|NCT02890992|20027996|P4|Treated|12 Weeks Open-Label Dose Finding Period||6
8125540|NCT02890992|20027997|P3|Treated|12 Weeks Open-Label Dose Finding Period||4
8125541|NCT02890992|20027998|P2|Treated|12 Weeks Open-Label Dose Finding Period||6
8125542|NCT02890992|20027999|P1|Treated|12 Weeks Open-Label Dose Finding Period||4
8125543|NCT02890992|20027992|P8|STARTED|12 Weeks Open-Label Dose Finding Period||5
8125544|NCT02890992|20027993|P7|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125545|NCT02890992|20027994|P6|STARTED|12 Weeks Open-Label Dose Finding Period||5
8125546|NCT02890992|20027995|P5|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125547|NCT02890992|20027996|P4|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125548|NCT02890992|20027997|P3|STARTED|12 Weeks Open-Label Dose Finding Period||4
8125549|NCT02890992|20027998|P2|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125550|NCT02890992|20027999|P1|STARTED|12 Weeks Open-Label Dose Finding Period||4
8125551|NCT02890381|20028167|P2|NOT COMPLETED|Overall Study||0
8125552|NCT02890381|20028168|P1|NOT COMPLETED|Overall Study||0
8125553|NCT02890381|20028167|P2|COMPLETED|Overall Study||6
8125554|NCT02890381|20028168|P1|COMPLETED|Overall Study||11
8125555|NCT02890381|20028167|P2|STARTED|Overall Study||6
8125556|NCT02890381|20028168|P1|STARTED|Overall Study||11
8125565|NCT02890303|20028213|P1|NOT COMPLETED|Overall Study||0
8125566|NCT02890303|20028213|P1|COMPLETED|Overall Study||100
8125567|NCT02890303|20028213|P1|STARTED|Overall Study||100
8125572|NCT02889861|20028229|P1|NOT COMPLETED|Overall Study||2
8125573|NCT02889861|20028229|P1|COMPLETED|Overall Study||1
8125574|NCT02889861|20028229|P1|STARTED|Overall Study||3
8125575|NCT02889796|20028254|P6|NOT COMPLETED|Overall Study||72
8125576|NCT02889796|20028255|P5|NOT COMPLETED|Overall Study||6
8125577|NCT02889796|20028256|P4|NOT COMPLETED|Overall Study||9
8125578|NCT02889796|20028257|P3|NOT COMPLETED|Overall Study||44
8125579|NCT02889796|20028258|P2|NOT COMPLETED|Overall Study||58
8125580|NCT02889796|20028259|P1|NOT COMPLETED|Overall Study||53
8125581|NCT02889796|20028254|P6|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
8125582|NCT02889796|20028255|P5|COMPLETED|Overall Study||185
8125583|NCT02889796|20028256|P4|COMPLETED|Overall Study||181
8125584|NCT02889796|20028257|P3|COMPLETED|Overall Study||281
8125585|NCT02889796|20028258|P2|COMPLETED|Overall Study||422
8125586|NCT02889796|20028259|P1|COMPLETED|Overall Study||424
8125587|NCT02889796|20028254|P6|STARTED|Overall Study||96
8125588|NCT02889796|20028255|P5|STARTED|Overall Study||191
8125589|NCT02889796|20028256|P4|STARTED|Overall Study||190
8125590|NCT02889796|20028257|P3|STARTED|Overall Study||325
8125591|NCT02889796|20028258|P2|STARTED|Overall Study||480
8125592|NCT02889796|20028259|P1|STARTED|Overall Study||477
8125593|NCT02889562|20028626|P2|NOT COMPLETED|Overall Study||2
8125594|NCT02889562|20028627|P1|NOT COMPLETED|Overall Study||0
8125595|NCT02889562|20028626|P2|COMPLETED|Overall Study||26
8125596|NCT02889562|20028627|P1|COMPLETED|Overall Study||28
8125597|NCT02889562|20028626|P2|STARTED|Overall Study||28
8125598|NCT02889562|20028627|P1|STARTED|Overall Study||28
8125599|NCT02889289|20028641|P1|NOT COMPLETED|Overall Study||0
8125600|NCT02889289|20028641|P1|COMPLETED|Overall Study||1
8125601|NCT02889289|20028641|P1|STARTED|Overall Study||1
8125602|NCT02888756|20028653|P3|NOT COMPLETED|Analytical Treatment Interruption||5
8125603|NCT02888756|20028654|P2|NOT COMPLETED|Analytical Treatment Interruption||6
8125604|NCT02888756|20028655|P1|NOT COMPLETED|Analytical Treatment Interruption||10
8125605|NCT02888756|20028653|P3|COMPLETED|Analytical Treatment Interruption||3
8125606|NCT02888756|20028654|P2|COMPLETED|Analytical Treatment Interruption||3
8125607|NCT02888756|20028655|P1|COMPLETED|Analytical Treatment Interruption||5
8125608|NCT02888756|20028653|P3|STARTED|Analytical Treatment Interruption||8
8125609|NCT02888756|20028654|P2|STARTED|Analytical Treatment Interruption||9
8125610|NCT02888756|20028655|P1|STARTED|Analytical Treatment Interruption||15
8125611|NCT02888756|20028653|P3|NOT COMPLETED|Vaccination Period||0
8125612|NCT02888756|20028654|P2|NOT COMPLETED|Vaccination Period||0
8125613|NCT02888756|20028655|P1|NOT COMPLETED|Vaccination Period||0
8125614|NCT02888756|20028653|P3|COMPLETED|Vaccination Period||8
8125615|NCT02888756|20028654|P2|COMPLETED|Vaccination Period||9
8125616|NCT02888756|20028655|P1|COMPLETED|Vaccination Period||16
8125617|NCT02888756|20028653|P3|STARTED|Vaccination Period||8
8125618|NCT02888756|20028654|P2|STARTED|Vaccination Period||9
8125619|NCT02888756|20028655|P1|STARTED|Vaccination Period||16
8125620|NCT02888691|20028696|P2|NOT COMPLETED|Second Intervention Period||2
8125621|NCT02888691|20028697|P1|NOT COMPLETED|Second Intervention Period||0
8125622|NCT02888691|20028696|P2|COMPLETED|Second Intervention Period||3
8125623|NCT02888691|20028697|P1|COMPLETED|Second Intervention Period||7
8125624|NCT02888691|20028696|P2|STARTED|Second Intervention Period||5
8125625|NCT02888691|20028697|P1|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
8125626|NCT02888691|20028696|P2|NOT COMPLETED|First Intervention Period||0
8125627|NCT02888691|20028697|P1|NOT COMPLETED|First Intervention Period||1
8125628|NCT02888691|20028696|P2|COMPLETED|First Intervention Period||7
8125629|NCT02888691|20028697|P1|COMPLETED|First Intervention Period||6
8125630|NCT02888691|20028696|P2|STARTED|First Intervention Period||7
8125631|NCT02888691|20028697|P1|STARTED|First Intervention Period||7
8125632|NCT02888171|20028795|P2|NOT COMPLETED|Overall Study||4
8125633|NCT02888171|20028796|P1|NOT COMPLETED|Overall Study||5
8125634|NCT02888171|20028795|P2|COMPLETED|Overall Study||26
8125635|NCT02888171|20028796|P1|COMPLETED|Overall Study||25
8125636|NCT02888171|20028795|P2|STARTED|Overall Study||30
8125637|NCT02888171|20028796|P1|STARTED|Overall Study||30
8125638|NCT02888093|20028812|P2|NOT COMPLETED|Overall Study||2
8125639|NCT02888093|20028813|P1|NOT COMPLETED|Overall Study||2
8125640|NCT02888093|20028812|P2|COMPLETED|Overall Study||20
8125641|NCT02888093|20028813|P1|COMPLETED|Overall Study||20
8125642|NCT02888093|20028812|P2|STARTED|Overall Study||22
8125643|NCT02888093|20028813|P1|STARTED|Overall Study||22
8125644|NCT02888080|20028825|P2|NOT COMPLETED|Overall Study||5
8125645|NCT02888080|20028826|P1|NOT COMPLETED|Overall Study||2
8125646|NCT02888080|20028825|P2|COMPLETED|Overall Study||15
8125647|NCT02888080|20028826|P1|COMPLETED|Overall Study||18
8125648|NCT02888080|20028825|P2|STARTED|Overall Study||20
8125649|NCT02888080|20028826|P1|STARTED|Overall Study||20
8125650|NCT02887989|20028852|P2|NOT COMPLETED|Overall Study||11
8125651|NCT02887989|20028853|P1|NOT COMPLETED|Overall Study||9
8125652|NCT02887989|20028852|P2|COMPLETED|Overall Study||59
8125653|NCT02887989|20028853|P1|COMPLETED|Overall Study||61
8125654|NCT02887989|20028852|P2|STARTED|Overall Study||70
8125655|NCT02887989|20028853|P1|STARTED|Overall Study||70
8125656|NCT02887521|20028865|P2|NOT COMPLETED|Overall Study||3
8125657|NCT02887521|20028866|P1|NOT COMPLETED|Overall Study||0
8125658|NCT02887521|20028865|P2|COMPLETED|Overall Study||2
8125659|NCT02887521|20028866|P1|COMPLETED|Overall Study||4
8125660|NCT02887521|20028865|P2|STARTED|Overall Study||5
8125661|NCT02887521|20028866|P1|STARTED|Overall Study||4
8125662|NCT02887404|20028880|P2|NOT COMPLETED|Overall Study||0
8125663|NCT02887404|20028881|P1|NOT COMPLETED|Overall Study||0
8125664|NCT02887404|20028880|P2|COMPLETED|Overall Study||149
8125665|NCT02887404|20028881|P1|COMPLETED|Overall Study||150
8125666|NCT02887404|20028880|P2|STARTED|Overall Study||149
8125667|NCT02887404|20028881|P1|STARTED|Overall Study||150
8125668|NCT02887183|20028929|P1|NOT COMPLETED|Overall Study||141
8125669|NCT02887183|20028929|P1|COMPLETED|Overall Study||654
8125670|NCT02887183|20028929|P1|Full Analysis Set|Overall Study||794
8125671|NCT02887183|20028929|P1|STARTED|Overall Study||795
8125672|NCT02886923|20028942|P2|NOT COMPLETED|Period 2||0
8125673|NCT02886923|20028943|P1|NOT COMPLETED|Period 2||0
8125674|NCT02886923|20028942|P2|COMPLETED|Period 2||11
8125675|NCT02886923|20028943|P1|COMPLETED|Period 2||12
8125676|NCT02886923|20028942|P2|STARTED|Period 2||11
8125677|NCT02886923|20028943|P1|STARTED|Period 2||12
8125678|NCT02886923|20028942|P2|NOT COMPLETED|Period 1||0
8125679|NCT02886923|20028943|P1|NOT COMPLETED|Period 1||0
8125680|NCT02886923|20028942|P2|COMPLETED|Period 1||11
8125681|NCT02886923|20028943|P1|COMPLETED|Period 1||12
8125682|NCT02886923|20028942|P2|STARTED|Period 1||11
8125683|NCT02886923|20028943|P1|STARTED|Period 1||12
8125684|NCT02886728|20028957|P4|NOT COMPLETED|Overall Study||87
8125685|NCT02886728|20028958|P3|NOT COMPLETED|Overall Study||36
8125686|NCT02886728|20028959|P2|NOT COMPLETED|Overall Study||32
8125687|NCT02886728|20028960|P1|NOT COMPLETED|Overall Study||72
8125688|NCT02886728|20028957|P4|COMPLETED|Overall Study||331
8125689|NCT02886728|20028958|P3|COMPLETED|Overall Study||174
8125690|NCT02886728|20028959|P2|COMPLETED|Overall Study||175
8125691|NCT02886728|20028960|P1|COMPLETED|Overall Study||345
8125692|NCT02886728|20028957|P4|STARTED|Overall Study||418
8125693|NCT02886728|20028958|P3|STARTED|Overall Study||210
8125694|NCT02886728|20028959|P2|STARTED|Overall Study||207
8125695|NCT02886728|20028960|P1|STARTED|Overall Study||417
8125696|NCT02886715|20029141|P3|NOT COMPLETED|Overall Study||20
8125697|NCT02886715|20029142|P2|NOT COMPLETED|Overall Study||55
8125698|NCT02886715|20029143|P1|NOT COMPLETED|Overall Study||64
8125699|NCT02886715|20029141|P3|COMPLETED|Overall Study||203
8125700|NCT02886715|20029142|P2|COMPLETED|Overall Study||390
8125701|NCT02886715|20029143|P1|COMPLETED|Overall Study||378
8125702|NCT02886715|20029141|P3|Per Protocol (PP) Population|Overall Study||176
8125703|NCT02886715|20029142|P2|Per Protocol (PP) Population|Overall Study||351
8125704|NCT02886715|20029143|P1|Per Protocol (PP) Population|Overall Study||346
8125705|NCT02886715|20029141|P3|Modified ITT (mITT)|Overall Study||217
8125706|NCT02886715|20029142|P2|Modified ITT (mITT)|Overall Study||418
8125707|NCT02886715|20029143|P1|Modified ITT (mITT)|Overall Study||421
8125708|NCT02886715|20029141|P3|STARTED|Overall Study||223
8125709|NCT02886715|20029142|P2|STARTED|Overall Study||445
8125710|NCT02886715|20029143|P1|STARTED|Overall Study||442
8125711|NCT02886702|20029160|P3|NOT COMPLETED|Overall Study||53
8125712|NCT02886702|20029161|P2|NOT COMPLETED|Overall Study||51
8125713|NCT02886702|20029162|P1|NOT COMPLETED|Overall Study||48
8125714|NCT02886702|20029160|P3|COMPLETED|Overall Study||232
8125715|NCT02886702|20029161|P2|COMPLETED|Overall Study||235
8125716|NCT02886702|20029162|P1|COMPLETED|Overall Study||236
8125717|NCT02886702|20029160|P3|Per-Protocol Population (PP)|Overall Study||201
8125718|NCT02886702|20029161|P2|Per-Protocol Population (PP)|Overall Study||209
8125719|NCT02886702|20029162|P1|Per-Protocol Population (PP)|Overall Study||208
8125720|NCT02886702|20029160|P3|Modified Intent-to Treat (mITT)|Overall Study||275
8125721|NCT02886702|20029161|P2|Modified Intent-to Treat (mITT)|Overall Study||266
8125722|NCT02886702|20029162|P1|Modified Intent-to Treat (mITT)|Overall Study||263
8125723|NCT02886702|20029160|P3|STARTED|Overall Study||285
8125724|NCT02886702|20029161|P2|STARTED|Overall Study||286
8125725|NCT02886702|20029162|P1|STARTED|Overall Study||284
8125726|NCT02886624|20029176|P1|NOT COMPLETED|48-week Post Treatment Follow-up||1
8125727|NCT02886624|20029176|P1|COMPLETED|48-week Post Treatment Follow-up||28
8125728|NCT02886624|20029176|P1|STARTED|48-week Post Treatment Follow-up||29
8125729|NCT02886624|20029176|P1|NOT COMPLETED|12-week Post Treatment Follow-up||1
8125730|NCT02886624|20029176|P1|COMPLETED|12-week Post Treatment Follow-up||29
8125731|NCT02886624|20029176|P1|STARTED|12-week Post Treatment Follow-up||30
8125732|NCT02886624|20029176|P1|NOT COMPLETED|8-week Treatment||0
8125733|NCT02886624|20029176|P1|COMPLETED|8-week Treatment||30
8125734|NCT02886624|20029176|P1|STARTED|8-week Treatment||30
8125735|NCT02886338|20029185|P1|NOT COMPLETED|Overall Study||1
8125736|NCT02886338|20029185|P1|COMPLETED|Overall Study||9
8125737|NCT02886338|20029185|P1|STARTED|Overall Study||10
8125738|NCT02886234|20029191|P2|NOT COMPLETED|Overall Study||2
8125739|NCT02886234|20029192|P1|NOT COMPLETED|Overall Study||0
8125740|NCT02886234|20029191|P2|COMPLETED|Overall Study||22
8125741|NCT02886234|20029192|P1|COMPLETED|Overall Study||20
8125742|NCT02886234|20029191|P2|STARTED|Overall Study||24
8125743|NCT02886234|20029192|P1|STARTED|Overall Study||20
8125744|NCT02885636|20029214|P2|NOT COMPLETED|Overall Study||0
8125745|NCT02885636|20029215|P1|NOT COMPLETED|Overall Study||0
8125746|NCT02885636|20029214|P2|COMPLETED|Overall Study||15
8125747|NCT02885636|20029215|P1|COMPLETED|Overall Study||15
8125748|NCT02885636|20029214|P2|STARTED|Overall Study||15
8125749|NCT02885636|20029215|P1|STARTED|Overall Study||15
8125750|NCT02885506|20029257|P10|NOT COMPLETED|Part B||0
8125751|NCT02885506|20029258|P9|NOT COMPLETED|Part B||0
8125752|NCT02885506|20029259|P8|NOT COMPLETED|Part B||0
8125753|NCT02885506|20029260|P7|NOT COMPLETED|Part B||0
8125754|NCT02885506|20029261|P6|NOT COMPLETED|Part B||0
8125755|NCT02885506|20029262|P5|NOT COMPLETED|Part B||0
8125756|NCT02885506|20029263|P4|NOT COMPLETED|Part B||0
8125757|NCT02885506|20029264|P3|NOT COMPLETED|Part B||0
8125758|NCT02885506|20029265|P2|NOT COMPLETED|Part B||0
8125759|NCT02885506|20029266|P1|NOT COMPLETED|Part B||0
8125760|NCT02885506|20029257|P10|COMPLETED|Part B||4
8125761|NCT02885506|20029258|P9|COMPLETED|Part B||4
8125762|NCT02885506|20029259|P8|COMPLETED|Part B||0
8125763|NCT02885506|20029260|P7|COMPLETED|Part B||0
8125764|NCT02885506|20029261|P6|COMPLETED|Part B||0
8125765|NCT02885506|20029262|P5|COMPLETED|Part B||0
8125766|NCT02885506|20029263|P4|COMPLETED|Part B||0
8125767|NCT02885506|20029264|P3|COMPLETED|Part B||0
8125768|NCT02885506|20029265|P2|COMPLETED|Part B||0
8125769|NCT02885506|20029266|P1|COMPLETED|Part B||0
8125770|NCT02885506|20029257|P10|STARTED|Part B||4
8125771|NCT02885506|20029258|P9|STARTED|Part B||4
8125772|NCT02885506|20029259|P8|STARTED|Part B||0
8125773|NCT02885506|20029260|P7|STARTED|Part B||0
8125774|NCT02885506|20029261|P6|STARTED|Part B||0
8125775|NCT02885506|20029262|P5|STARTED|Part B||0
8125776|NCT02885506|20029263|P4|STARTED|Part B||0
8125777|NCT02885506|20029264|P3|STARTED|Part B||0
8125778|NCT02885506|20029265|P2|STARTED|Part B||0
8125779|NCT02885506|20029266|P1|STARTED|Part B||0
8125780|NCT02885506|20029257|P10|NOT COMPLETED|Part A||0
8125781|NCT02885506|20029258|P9|NOT COMPLETED|Part A||0
8125782|NCT02885506|20029259|P8|NOT COMPLETED|Part A||0
8125783|NCT02885506|20029260|P7|NOT COMPLETED|Part A||0
8125784|NCT02885506|20029261|P6|NOT COMPLETED|Part A||0
8125785|NCT02885506|20029262|P5|NOT COMPLETED|Part A||0
8125786|NCT02885506|20029263|P4|NOT COMPLETED|Part A||0
8125787|NCT02885506|20029264|P3|NOT COMPLETED|Part A||0
8125788|NCT02885506|20029265|P2|NOT COMPLETED|Part A||0
8125789|NCT02885506|20029266|P1|NOT COMPLETED|Part A||0
8125790|NCT02885506|20029257|P10|COMPLETED|Part A||0
8125791|NCT02885506|20029258|P9|COMPLETED|Part A||0
8125792|NCT02885506|20029259|P8|COMPLETED|Part A||14
8125793|NCT02885506|20029260|P7|COMPLETED|Part A||6
8125794|NCT02885506|20029261|P6|COMPLETED|Part A||6
8125795|NCT02885506|20029262|P5|COMPLETED|Part A||6
8125796|NCT02885506|20029263|P4|COMPLETED|Part A||6
8125797|NCT02885506|20029264|P3|COMPLETED|Part A||6
8125798|NCT02885506|20029265|P2|COMPLETED|Part A||6
8125799|NCT02885506|20029266|P1|COMPLETED|Part A||6
8125800|NCT02885506|20029257|P10|STARTED|Part A||0
8125801|NCT02885506|20029258|P9|STARTED|Part A||0
8125802|NCT02885506|20029259|P8|STARTED|Part A||14
8125803|NCT02885506|20029260|P7|STARTED|Part A||6
8125804|NCT02885506|20029261|P6|STARTED|Part A||6
8125805|NCT02885506|20029262|P5|STARTED|Part A||6
8125806|NCT02885506|20029263|P4|STARTED|Part A||6
8125807|NCT02885506|20029264|P3|STARTED|Part A||6
8125808|NCT02885506|20029265|P2|STARTED|Part A||6
8125809|NCT02885506|20029266|P1|STARTED|Part A||6
8125810|NCT02885246|20029358|P1|NOT COMPLETED|Overall Study||0
8125811|NCT02885246|20029358|P1|COMPLETED|Overall Study||1839
8125812|NCT02885246|20029358|P1|STARTED|Overall Study||1839
8125813|NCT02885181|20029374|P4|NOT COMPLETED|Overall Study||3
8125814|NCT02885181|20029375|P3|NOT COMPLETED|Overall Study||0
8125815|NCT02885181|20029376|P2|NOT COMPLETED|Overall Study||1
8125816|NCT02885181|20029377|P1|NOT COMPLETED|Overall Study||0
8125817|NCT02885181|20029374|P4|COMPLETED|Overall Study||19
8125818|NCT02885181|20029375|P3|COMPLETED|Overall Study||21
8125819|NCT02885181|20029376|P2|COMPLETED|Overall Study||19
8125820|NCT02885181|20029377|P1|COMPLETED|Overall Study||20
8125821|NCT02885181|20029374|P4|STARTED|Overall Study||22
8125822|NCT02885181|20029375|P3|STARTED|Overall Study||21
8125823|NCT02885181|20029376|P2|STARTED|Overall Study||20
8125824|NCT02885181|20029377|P1|STARTED|Overall Study||20
8125825|NCT02885025|20029407|P4|NOT COMPLETED|Overall Study||0
8125826|NCT02885025|20029408|P3|NOT COMPLETED|Overall Study||0
8125827|NCT02885025|20029409|P2|NOT COMPLETED|Overall Study||2
8125828|NCT02885025|20029410|P1|NOT COMPLETED|Overall Study||0
8125829|NCT02885025|20029407|P4|COMPLETED|Overall Study||8
8125830|NCT02885025|20029408|P3|COMPLETED|Overall Study||9
8125831|NCT02885025|20029409|P2|COMPLETED|Overall Study||12
8125832|NCT02885025|20029410|P1|COMPLETED|Overall Study||16
8125833|NCT02885025|20029407|P4|STARTED|Overall Study||8
8125834|NCT02885025|20029408|P3|STARTED|Overall Study||9
8125835|NCT02885025|20029409|P2|STARTED|Overall Study||14
8125836|NCT02885025|20029410|P1|STARTED|Overall Study||16
8125837|NCT02885012|20029450|P2|NOT COMPLETED|Overall Study||0
8125838|NCT02885012|20029451|P1|NOT COMPLETED|Overall Study||0
8125839|NCT02885012|20029450|P2|COMPLETED|Overall Study||2
8125840|NCT02885012|20029451|P1|COMPLETED|Overall Study||1
8125841|NCT02885012|20029450|P2|STARTED|Overall Study||2
8125842|NCT02885012|20029451|P1|STARTED|Overall Study||1
8125843|NCT02884492|20029463|P2|NOT COMPLETED|Overall Study||0
8125844|NCT02884492|20029464|P1|NOT COMPLETED|Overall Study||0
8125845|NCT02884492|20029463|P2|COMPLETED|Overall Study||10
8125846|NCT02884492|20029464|P1|COMPLETED|Overall Study||7
8125847|NCT02884492|20029463|P2|STARTED|Overall Study||10
8125848|NCT02884492|20029464|P1|STARTED|Overall Study||7
8125849|NCT02884427|20029473|P3|NOT COMPLETED|Overall Study||0
8125850|NCT02884427|20029474|P2|NOT COMPLETED|Overall Study||0
8125851|NCT02884427|20029475|P1|NOT COMPLETED|Overall Study||0
8125852|NCT02884427|20029473|P3|COMPLETED|Overall Study||50
8125853|NCT02884427|20029474|P2|COMPLETED|Overall Study||52
8125854|NCT02884427|20029475|P1|COMPLETED|Overall Study||48
8125855|NCT02884427|20029473|P3|STARTED|Overall Study||50
8125856|NCT02884427|20029474|P2|STARTED|Overall Study||52
8125857|NCT02884427|20029475|P1|STARTED|Overall Study||48
8125858|NCT02884414|20029489|P1|NOT COMPLETED|Overall Study||0
8125859|NCT02884414|20029489|P1|COMPLETED|Overall Study||56
8125860|NCT02884414|20029489|P1|STARTED|Overall Study||56
8125861|NCT02884089|20029493|P4|NOT COMPLETED|Follow-up Visit||1
8125862|NCT02884089|20029494|P3|NOT COMPLETED|Follow-up Visit||0
8125863|NCT02884089|20029495|P2|NOT COMPLETED|Follow-up Visit||0
8125864|NCT02884089|20029496|P1|NOT COMPLETED|Follow-up Visit||1
8125865|NCT02884089|20029493|P4|COMPLETED|Follow-up Visit||6
8125866|NCT02884089|20029494|P3|COMPLETED|Follow-up Visit||7
8125867|NCT02884089|20029495|P2|COMPLETED|Follow-up Visit||6
8125868|NCT02884089|20029496|P1|COMPLETED|Follow-up Visit||6
8125869|NCT02884089|20029493|P4|STARTED|Follow-up Visit||7
8125870|NCT02884089|20029494|P3|STARTED|Follow-up Visit||7
8125871|NCT02884089|20029495|P2|STARTED|Follow-up Visit||6
8125872|NCT02884089|20029496|P1|STARTED|Follow-up Visit||7
8125873|NCT02884089|20029493|P4|NOT COMPLETED|Period 4||0
8125874|NCT02884089|20029494|P3|NOT COMPLETED|Period 4||0
8125875|NCT02884089|20029495|P2|NOT COMPLETED|Period 4||1
8125876|NCT02884089|20029496|P1|NOT COMPLETED|Period 4||1
8125877|NCT02884089|20029493|P4|COMPLETED|Period 4||7
8125878|NCT02884089|20029494|P3|COMPLETED|Period 4||7
8125879|NCT02884089|20029495|P2|COMPLETED|Period 4||6
8125880|NCT02884089|20029496|P1|COMPLETED|Period 4||7
8125881|NCT02884089|20029493|P4|STARTED|Period 4||7
8125882|NCT02884089|20029494|P3|STARTED|Period 4||7
8125883|NCT02884089|20029495|P2|STARTED|Period 4||7
8125884|NCT02884089|20029496|P1|STARTED|Period 4||8
8125885|NCT02884089|20029493|P4|NOT COMPLETED|Washout Period 3||1
8125886|NCT02884089|20029494|P3|NOT COMPLETED|Washout Period 3||1
8125887|NCT02884089|20029495|P2|NOT COMPLETED|Washout Period 3||0
8125888|NCT02884089|20029496|P1|NOT COMPLETED|Washout Period 3||0
8125889|NCT02884089|20029493|P4|COMPLETED|Washout Period 3||7
8125890|NCT02884089|20029494|P3|COMPLETED|Washout Period 3||7
8125891|NCT02884089|20029495|P2|COMPLETED|Washout Period 3||7
8125892|NCT02884089|20029496|P1|COMPLETED|Washout Period 3||8
8125893|NCT02884089|20029493|P4|STARTED|Washout Period 3||8
8125894|NCT02884089|20029494|P3|STARTED|Washout Period 3||8
8125895|NCT02884089|20029495|P2|STARTED|Washout Period 3||7
8125896|NCT02884089|20029496|P1|STARTED|Washout Period 3||8
8125897|NCT02884089|20029493|P4|NOT COMPLETED|Period 3||0
8125898|NCT02884089|20029494|P3|NOT COMPLETED|Period 3||1
8125899|NCT02884089|20029495|P2|NOT COMPLETED|Period 3||0
8125900|NCT02884089|20029496|P1|NOT COMPLETED|Period 3||0
8125901|NCT02884089|20029493|P4|COMPLETED|Period 3||8
8125902|NCT02884089|20029494|P3|COMPLETED|Period 3||8
8125903|NCT02884089|20029495|P2|COMPLETED|Period 3||7
8125904|NCT02884089|20029496|P1|COMPLETED|Period 3||8
8125905|NCT02884089|20029493|P4|STARTED|Period 3||8
8125906|NCT02884089|20029494|P3|STARTED|Period 3||9
8125907|NCT02884089|20029495|P2|STARTED|Period 3||7
8125908|NCT02884089|20029496|P1|STARTED|Period 3||8
8125909|NCT02884089|20029493|P4|NOT COMPLETED|Washout Period 2||0
8125910|NCT02884089|20029494|P3|NOT COMPLETED|Washout Period 2||0
8125911|NCT02884089|20029495|P2|NOT COMPLETED|Washout Period 2||0
8125912|NCT02884089|20029496|P1|NOT COMPLETED|Washout Period 2||0
8125913|NCT02884089|20029493|P4|COMPLETED|Washout Period 2||8
8125914|NCT02884089|20029494|P3|COMPLETED|Washout Period 2||9
8125915|NCT02884089|20029495|P2|COMPLETED|Washout Period 2||7
8125916|NCT02884089|20029496|P1|COMPLETED|Washout Period 2||8
8125917|NCT02884089|20029493|P4|STARTED|Washout Period 2||8
8125918|NCT02884089|20029494|P3|STARTED|Washout Period 2||9
8125919|NCT02884089|20029495|P2|STARTED|Washout Period 2||7
8125920|NCT02884089|20029496|P1|STARTED|Washout Period 2||8
8125921|NCT02884089|20029493|P4|NOT COMPLETED|Period 2||0
8125922|NCT02884089|20029494|P3|NOT COMPLETED|Period 2||0
8125923|NCT02884089|20029495|P2|NOT COMPLETED|Period 2||0
8125924|NCT02884089|20029496|P1|NOT COMPLETED|Period 2||1
8125925|NCT02884089|20029493|P4|COMPLETED|Period 2||8
8125926|NCT02884089|20029494|P3|COMPLETED|Period 2||9
8125927|NCT02884089|20029495|P2|COMPLETED|Period 2||7
8125928|NCT02884089|20029496|P1|COMPLETED|Period 2||8
8125929|NCT02884089|20029493|P4|STARTED|Period 2||8
8125930|NCT02884089|20029494|P3|STARTED|Period 2||9
8125931|NCT02884089|20029495|P2|STARTED|Period 2||7
8125932|NCT02884089|20029496|P1|STARTED|Period 2||9
8125933|NCT02884089|20029493|P4|NOT COMPLETED|Washout Period 1||1
8125934|NCT02884089|20029494|P3|NOT COMPLETED|Washout Period 1||0
8125935|NCT02884089|20029495|P2|NOT COMPLETED|Washout Period 1||2
8125936|NCT02884089|20029496|P1|NOT COMPLETED|Washout Period 1||0
8125937|NCT02884089|20029493|P4|COMPLETED|Washout Period 1||8
8125938|NCT02884089|20029494|P3|COMPLETED|Washout Period 1||9
8125939|NCT02884089|20029495|P2|COMPLETED|Washout Period 1||7
8125940|NCT02884089|20029496|P1|COMPLETED|Washout Period 1||9
8125941|NCT02884089|20029493|P4|STARTED|Washout Period 1||9
8125942|NCT02884089|20029494|P3|STARTED|Washout Period 1||9
8125943|NCT02884089|20029495|P2|STARTED|Washout Period 1||9
8125944|NCT02884089|20029496|P1|STARTED|Washout Period 1||9
8125945|NCT02884089|20029493|P4|NOT COMPLETED|Period 1||0
8125946|NCT02884089|20029494|P3|NOT COMPLETED|Period 1||0
8125947|NCT02884089|20029495|P2|NOT COMPLETED|Period 1||2
8125948|NCT02884089|20029496|P1|NOT COMPLETED|Period 1||2
8125949|NCT02884089|20029493|P4|COMPLETED|Period 1||9
8125950|NCT02884089|20029494|P3|COMPLETED|Period 1||9
8125951|NCT02884089|20029495|P2|COMPLETED|Period 1||9
8125952|NCT02884089|20029496|P1|COMPLETED|Period 1||9
8125953|NCT02884089|20029493|P4|Received at Least One Dose of Study Drug|Period 1||9
8125954|NCT02884089|20029494|P3|Received at Least One Dose of Study Drug|Period 1||9
8125955|NCT02884089|20029495|P2|Received at Least One Dose of Study Drug|Period 1||11
8125956|NCT02884089|20029496|P1|Received at Least One Dose of Study Drug|Period 1||11
8125957|NCT02884089|20029493|P4|STARTED|Period 1||9
8125958|NCT02884089|20029494|P3|STARTED|Period 1||9
8125959|NCT02884089|20029495|P2|STARTED|Period 1||11
8125960|NCT02884089|20029496|P1|STARTED|Period 1||11
8125961|NCT02883452|20029516|P6|NOT COMPLETED|Overall Study||15
8125962|NCT02883452|20029517|P5|NOT COMPLETED|Overall Study||11
8125963|NCT02883452|20029518|P4|NOT COMPLETED|Overall Study||2
8125964|NCT02883452|20029519|P3|NOT COMPLETED|Overall Study||5
8125965|NCT02883452|20029520|P2|NOT COMPLETED|Overall Study||2
8125966|NCT02883452|20029521|P1|NOT COMPLETED|Overall Study||5
8125967|NCT02883452|20029516|P6|COMPLETED|Overall Study||50
8125968|NCT02883452|20029517|P5|COMPLETED|Overall Study||55
8125969|NCT02883452|20029518|P4|COMPLETED|Overall Study||6
8125970|NCT02883452|20029519|P3|COMPLETED|Overall Study||7
8125971|NCT02883452|20029520|P2|COMPLETED|Overall Study||9
8125972|NCT02883452|20029521|P1|COMPLETED|Overall Study||8
8125973|NCT02883452|20029516|P6|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
8125974|NCT02883452|20029517|P5|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
8125975|NCT02883452|20029518|P4|STARTED|Overall Study|This cohort is only for Part 1.|8
8125976|NCT02883452|20029519|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
8125977|NCT02883452|20029520|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
8125978|NCT02883452|20029521|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
8125979|NCT02883244|20029549|P2|NOT COMPLETED|Overall Study||1
8125980|NCT02883244|20029550|P1|NOT COMPLETED|Overall Study||0
8125981|NCT02883244|20029549|P2|COMPLETED|Overall Study||25
8125982|NCT02883244|20029550|P1|COMPLETED|Overall Study||24
8125983|NCT02883244|20029549|P2|STARTED|Overall Study||26
8125984|NCT02883244|20029550|P1|STARTED|Overall Study||24
8125985|NCT02882854|20029568|P2|NOT COMPLETED|Overall Study||3
8125986|NCT02882854|20029569|P1|NOT COMPLETED|Overall Study||1
8125987|NCT02882854|20029568|P2|COMPLETED|Overall Study||41
8125988|NCT02882854|20029569|P1|COMPLETED|Overall Study||39
8125989|NCT02882854|20029568|P2|STARTED|Overall Study||44
8125990|NCT02882854|20029569|P1|STARTED|Overall Study||40
8125991|NCT02882711|20029591|P1|NOT COMPLETED|Overall Study||4
8125992|NCT02882711|20029591|P1|COMPLETED|Overall Study||2
8125993|NCT02882711|20029591|P1|STARTED|Overall Study||6
8125994|NCT02882633|20029599|P2|NOT COMPLETED|Overall Study||0
8125995|NCT02882633|20029600|P1|NOT COMPLETED|Overall Study||2
8125996|NCT02882633|20029599|P2|COMPLETED|Overall Study||25
8125997|NCT02882633|20029600|P1|COMPLETED|Overall Study||23
8125998|NCT02882633|20029599|P2|STARTED|Overall Study||25
8125999|NCT02882633|20029600|P1|STARTED|Overall Study||25
8126000|NCT02882178|20029610|P1|NOT COMPLETED|Overall Study||0
8126001|NCT02882178|20029610|P1|COMPLETED|Overall Study||18
8126002|NCT02882178|20029610|P1|STARTED|Overall Study||18
8126003|NCT02882152|20029616|P2|NOT COMPLETED|Overall Study||0
8126004|NCT02882152|20029617|P1|NOT COMPLETED|Overall Study||1
8126005|NCT02882152|20029616|P2|COMPLETED|Overall Study||20
8126006|NCT02882152|20029617|P1|COMPLETED|Overall Study||19
8126007|NCT02882152|20029616|P2|STARTED|Overall Study||20
8126008|NCT02882152|20029617|P1|STARTED|Overall Study||20
8126009|NCT02881996|20029627|P2|NOT COMPLETED|Overall Study||2
8126010|NCT02881996|20029628|P1|NOT COMPLETED|Overall Study||6
8126011|NCT02881996|20029627|P2|COMPLETED|Overall Study||43
8126012|NCT02881996|20029628|P1|COMPLETED|Overall Study||39
8126013|NCT02881996|20029627|P2|STARTED|Overall Study||45
8126014|NCT02881996|20029628|P1|STARTED|Overall Study||45
8126015|NCT02881957|20029638|P2|NOT COMPLETED|Overall Study||4
8126016|NCT02881957|20029639|P1|NOT COMPLETED|Overall Study||3
8126017|NCT02881957|20029638|P2|COMPLETED|Overall Study||134
8126018|NCT02881957|20029639|P1|COMPLETED|Overall Study||133
8126019|NCT02881957|20029638|P2|STARTED|Overall Study||138
8126020|NCT02881957|20029639|P1|STARTED|Overall Study||136
8126021|NCT02881840|20029663|P1|NOT COMPLETED|Overall Study||0
8126022|NCT02881840|20029663|P1|COMPLETED|Overall Study||6
8126023|NCT02881840|20029663|P1|STARTED|Overall Study||6
8126024|NCT02881775|20029667|P2|NOT COMPLETED|Second Intervention (1-Hour Session)||0
8126025|NCT02881775|20029668|P1|NOT COMPLETED|Second Intervention (1-Hour Session)||0
8126026|NCT02881775|20029667|P2|COMPLETED|Second Intervention (1-Hour Session)||7
8126027|NCT02881775|20029668|P1|COMPLETED|Second Intervention (1-Hour Session)||9
8126028|NCT02881775|20029667|P2|STARTED|Second Intervention (1-Hour Session)||7
8126029|NCT02881775|20029668|P1|STARTED|Second Intervention (1-Hour Session)||9
8126030|NCT02881775|20029667|P2|NOT COMPLETED|Washout (1 Week)||0
8126031|NCT02881775|20029668|P1|NOT COMPLETED|Washout (1 Week)||0
8126032|NCT02881775|20029667|P2|COMPLETED|Washout (1 Week)||7
8126033|NCT02881775|20029668|P1|COMPLETED|Washout (1 Week)||9
8126034|NCT02881775|20029667|P2|STARTED|Washout (1 Week)||7
8126035|NCT02881775|20029668|P1|STARTED|Washout (1 Week)||9
8126036|NCT02881775|20029667|P2|NOT COMPLETED|First Intervention (1-hr Session)||0
8126037|NCT02881775|20029668|P1|NOT COMPLETED|First Intervention (1-hr Session)||0
8126038|NCT02881775|20029667|P2|COMPLETED|First Intervention (1-hr Session)||7
8126039|NCT02881775|20029668|P1|COMPLETED|First Intervention (1-hr Session)||9
8126040|NCT02881775|20029667|P2|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
8126041|NCT02881775|20029668|P1|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
8126042|NCT02881775|20029667|P2|NOT COMPLETED|Baseline||0
8126043|NCT02881775|20029668|P1|NOT COMPLETED|Baseline||0
8126044|NCT02881775|20029667|P2|COMPLETED|Baseline||9
8126045|NCT02881775|20029668|P1|COMPLETED|Baseline||11
8126046|NCT02881775|20029667|P2|STARTED|Baseline||9
8126047|NCT02881775|20029668|P1|STARTED|Baseline||11
8126048|NCT02881658|20029690|P2|NOT COMPLETED|Overall Study||5
8126049|NCT02881658|20029691|P1|NOT COMPLETED|Overall Study||2
8126050|NCT02881658|20029690|P2|COMPLETED|Overall Study||96
8126051|NCT02881658|20029691|P1|COMPLETED|Overall Study||98
8126052|NCT02881658|20029690|P2|STARTED|Overall Study||101
8126053|NCT02881658|20029691|P1|STARTED|Overall Study||100
8126054|NCT02881567|20029725|P1|NOT COMPLETED|Overall Study||18
8126055|NCT02881567|20029725|P1|COMPLETED|Overall Study||23
8126056|NCT02881567|20029725|P1|STARTED|Overall Study||41
8126057|NCT02881112|20029737|P1|NOT COMPLETED|Overall Study||28
8126058|NCT02881112|20029737|P1|COMPLETED|Overall Study||152
8126059|NCT02881112|20029737|P1|STARTED|Overall Study||180
8126060|NCT02881047|20029741|P1|NOT COMPLETED|Overall Study||2
8126061|NCT02881047|20029741|P1|COMPLETED|Overall Study||6
8126062|NCT02881047|20029741|P1|STARTED|Overall Study||8
8126063|NCT02881008|20029753|P6|NOT COMPLETED|Overall Study||0
8126064|NCT02881008|20029754|P5|NOT COMPLETED|Overall Study||0
8126065|NCT02881008|20029755|P4|NOT COMPLETED|Overall Study||0
8126066|NCT02881008|20029756|P3|NOT COMPLETED|Overall Study||0
8126067|NCT02881008|20029757|P2|NOT COMPLETED|Overall Study||0
8126068|NCT02881008|20029758|P1|NOT COMPLETED|Overall Study||0
8126069|NCT02881008|20029753|P6|COMPLETED|Overall Study||8
8126070|NCT02881008|20029754|P5|COMPLETED|Overall Study||8
8126071|NCT02881008|20029755|P4|COMPLETED|Overall Study||8
8126072|NCT02881008|20029756|P3|COMPLETED|Overall Study||8
8126073|NCT02881008|20029757|P2|COMPLETED|Overall Study||8
8126074|NCT02881008|20029758|P1|COMPLETED|Overall Study||8
8126075|NCT02881008|20029753|P6|STARTED|Overall Study||8
8126076|NCT02881008|20029754|P5|STARTED|Overall Study||8
8126077|NCT02881008|20029755|P4|STARTED|Overall Study||8
8126078|NCT02881008|20029756|P3|STARTED|Overall Study||8
8126079|NCT02881008|20029757|P2|STARTED|Overall Study||8
8126080|NCT02881008|20029758|P1|STARTED|Overall Study||8
8126081|NCT02880865|20029793|P2|NOT COMPLETED|Overall Study||3
8126082|NCT02880865|20029794|P1|NOT COMPLETED|Overall Study||1
8126083|NCT02880865|20029793|P2|COMPLETED|Overall Study||311
8126084|NCT02880865|20029794|P1|COMPLETED|Overall Study||313
8126085|NCT02880865|20029793|P2|Received MMR Dose 2|Overall Study||311
8126086|NCT02880865|20029794|P1|Received MMR Dose 2|Overall Study||313
8126087|NCT02880865|20029793|P2|Received CD-JEV|Overall Study||309
8126088|NCT02880865|20029794|P1|Received CD-JEV|Overall Study||314
8126089|NCT02880865|20029793|P2|Received MMR Dose 1|Overall Study||314
8126090|NCT02880865|20029794|P1|Received MMR Dose 1|Overall Study||314
8126091|NCT02880865|20029793|P2|STARTED|Overall Study||314
8126092|NCT02880865|20029794|P1|STARTED|Overall Study||314
8126093|NCT02880852|20029849|P1|NOT COMPLETED|Overall Study||0
8126094|NCT02880852|20029849|P1|COMPLETED|Overall Study||20
8126095|NCT02880852|20029849|P1|STARTED|Overall Study||20
8126096|NCT02880761|20029877|P2|NOT COMPLETED|Overall Study||21
8126097|NCT02880761|20029878|P1|NOT COMPLETED|Overall Study||16
8126098|NCT02880761|20029877|P2|COMPLETED|Overall Study||85
8126099|NCT02880761|20029878|P1|COMPLETED|Overall Study||87
8126100|NCT02880761|20029877|P2|STARTED|Overall Study||106
8126101|NCT02880761|20029878|P1|STARTED|Overall Study||103
8126102|NCT02880514|20029888|P2|NOT COMPLETED|Overall Study||0
8126103|NCT02880514|20029889|P1|NOT COMPLETED|Overall Study||0
8126104|NCT02880514|20029888|P2|COMPLETED|Overall Study||50
8126105|NCT02880514|20029889|P1|COMPLETED|Overall Study||50
8126106|NCT02880514|20029888|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
8126107|NCT02880514|20029889|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
8126108|NCT02880475|20029898|P2|NOT COMPLETED|Overall Study||0
8126109|NCT02880475|20029899|P1|NOT COMPLETED|Overall Study||0
8126110|NCT02880475|20029898|P2|COMPLETED|Overall Study||17
8126111|NCT02880475|20029899|P1|COMPLETED|Overall Study||13
8126112|NCT02880475|20029898|P2|STARTED|Overall Study||17
8126113|NCT02880475|20029899|P1|STARTED|Overall Study||13
8126114|NCT02880254|20030033|P2|NOT COMPLETED|Overall Study||10
8126115|NCT02880254|20030034|P1|NOT COMPLETED|Overall Study||9
8126116|NCT02880254|20030033|P2|COMPLETED|Overall Study||4
8126117|NCT02880254|20030034|P1|COMPLETED|Overall Study||4
8126118|NCT02880254|20030033|P2|STARTED|Overall Study||14
8126119|NCT02880254|20030034|P1|STARTED|Overall Study||13
8126120|NCT02880228|20030042|P1|NOT COMPLETED|Overall Study||0
8126121|NCT02880228|20030042|P1|COMPLETED|Overall Study||11
8126122|NCT02880228|20030042|P1|STARTED|Overall Study||11
8126123|NCT02880189|20030050|P1|NOT COMPLETED|Overall Study||0
8126124|NCT02880189|20030050|P1|COMPLETED|Overall Study||21
8126125|NCT02880189|20030050|P1|STARTED|Overall Study||21
8126126|NCT02880137|20030055|P1|NOT COMPLETED|Overall Study||0
8126127|NCT02880137|20030055|P1|COMPLETED|Overall Study||36
8126128|NCT02880137|20030055|P1|STARTED|Overall Study||36
8126129|NCT02879812|20030061|P2|NOT COMPLETED|Overall Study||1451
8126130|NCT02879812|20030062|P1|NOT COMPLETED|Overall Study||1217
8126131|NCT02879812|20030061|P2|COMPLETED|Overall Study||21029
8126132|NCT02879812|20030062|P1|COMPLETED|Overall Study||22153
8126133|NCT02879812|20030061|P2|STARTED|Overall Study||22480
8126134|NCT02879812|20030062|P1|STARTED|Overall Study||23370
8126135|NCT02879747|20030081|P3|NOT COMPLETED|Overall Study||2
8126136|NCT02879747|20030082|P2|NOT COMPLETED|Overall Study||6
8126137|NCT02879747|20030083|P1|NOT COMPLETED|Overall Study||4
8126138|NCT02879747|20030081|P3|COMPLETED|Overall Study||31
8126139|NCT02879747|20030082|P2|COMPLETED|Overall Study||32
8126140|NCT02879747|20030083|P1|COMPLETED|Overall Study||23
8126141|NCT02879747|20030081|P3|STARTED|Overall Study||33
8126142|NCT02879747|20030082|P2|STARTED|Overall Study||38
8126143|NCT02879747|20030083|P1|STARTED|Overall Study||27
8126144|NCT02879032|20030100|P1|NOT COMPLETED|Overall Study||0
8126145|NCT02879032|20030100|P1|COMPLETED|Overall Study||130
8126146|NCT02879032|20030100|P1|STARTED|Overall Study||130
8126147|NCT02878590|20030106|P1|NOT COMPLETED|Overall Study||2
8126148|NCT02878590|20030106|P1|COMPLETED|Overall Study||10
8126149|NCT02878590|20030106|P1|STARTED|Overall Study||12
8126150|NCT02878486|20030112|P2|NOT COMPLETED|Overall Study||0
8126151|NCT02878486|20030113|P1|NOT COMPLETED|Overall Study||0
8126152|NCT02878486|20030112|P2|COMPLETED|Overall Study||3
8126153|NCT02878486|20030113|P1|COMPLETED|Overall Study||3
8126154|NCT02878486|20030112|P2|STARTED|Overall Study||3
8126155|NCT02878486|20030113|P1|STARTED|Overall Study||3
8126156|NCT02878382|20030129|P2|NOT COMPLETED|Overall Study||0
8126157|NCT02878382|20030130|P1|NOT COMPLETED|Overall Study||0
8126158|NCT02878382|20030129|P2|COMPLETED|Overall Study||20
8126159|NCT02878382|20030130|P1|COMPLETED|Overall Study||20
8126160|NCT02878382|20030129|P2|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
8126161|NCT02878382|20030130|P1|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
8126162|NCT02878330|20030144|P2|NOT COMPLETED|Overall Study||56
8126163|NCT02878330|20030145|P1|NOT COMPLETED|Overall Study||29
8126164|NCT02878330|20030144|P2|COMPLETED|Overall Study||913
8126165|NCT02878330|20030145|P1|COMPLETED|Overall Study||455
8126166|NCT02878330|20030144|P2|STARTED|Overall Study||969
8126167|NCT02878330|20030145|P1|STARTED|Overall Study||484
8126168|NCT02878213|20030161|P1|NOT COMPLETED|Overall Study||3
8126169|NCT02878213|20030161|P1|COMPLETED|Overall Study||36
8126170|NCT02878213|20030161|P1|STARTED|Overall Study||39
8126171|NCT02878057|20030166|P1|NOT COMPLETED|Overall Study||4
8126172|NCT02878057|20030166|P1|COMPLETED|Overall Study||26
8126173|NCT02878057|20030166|P1|STARTED|Overall Study||30
8126174|NCT02877927|20030176|P2|NOT COMPLETED|Overall Study||57
8126175|NCT02877927|20030177|P1|NOT COMPLETED|Overall Study||54
8126176|NCT02877927|20030176|P2|COMPLETED|Overall Study||310
8126177|NCT02877927|20030177|P1|COMPLETED|Overall Study||314
8126178|NCT02877927|20030176|P2|STARTED|Overall Study||367
8126179|NCT02877927|20030177|P1|STARTED|Overall Study||368
8126180|NCT02877732|20030189|P2|NOT COMPLETED|Overall Study||6
8126181|NCT02877732|20030190|P1|NOT COMPLETED|Overall Study||6
8126182|NCT02877732|20030189|P2|COMPLETED|Overall Study||0
8126183|NCT02877732|20030190|P1|COMPLETED|Overall Study||0
8126184|NCT02877732|20030189|P2|STARTED|Overall Study||6
8126185|NCT02877732|20030190|P1|STARTED|Overall Study||6
8126186|NCT02877680|20030208|P2|NOT COMPLETED|Overall Study||1
8126187|NCT02877680|20030209|P1|NOT COMPLETED|Overall Study||1
8126188|NCT02877680|20030208|P2|COMPLETED|Overall Study||24
8126189|NCT02877680|20030209|P1|COMPLETED|Overall Study||54
8126190|NCT02877680|20030208|P2|STARTED|Overall Study||25
8126191|NCT02877680|20030209|P1|STARTED|Overall Study||55
8126192|NCT02877485|20030250|P2|NOT COMPLETED|Overall Study||0
8126193|NCT02877485|20030251|P1|NOT COMPLETED|Overall Study||0
8126194|NCT02877485|20030250|P2|COMPLETED|Overall Study||20
8126195|NCT02877485|20030251|P1|COMPLETED|Overall Study||22
8126196|NCT02877485|20030250|P2|STARTED|Overall Study||20
8126197|NCT02877485|20030251|P1|STARTED|Overall Study||22
8126198|NCT02877095|20030260|P2|NOT COMPLETED|Overall Study||0
8126199|NCT02877095|20030261|P1|NOT COMPLETED|Overall Study||0
8126200|NCT02877095|20030260|P2|COMPLETED|Overall Study||20
8126201|NCT02877095|20030261|P1|COMPLETED|Overall Study||20
8126202|NCT02877095|20030260|P2|STARTED|Overall Study||20
8126203|NCT02877095|20030261|P1|STARTED|Overall Study|First patient enrolled 1/9/17.|20
8126204|NCT02877082|20030267|P1|NOT COMPLETED|Overall Study||5
8126205|NCT02877082|20030267|P1|COMPLETED|Overall Study||0
8126206|NCT02877082|20030267|P1|STARTED|Overall Study||5
8126207|NCT02877004|20030278|P3|NOT COMPLETED|Overall Study||1
8126208|NCT02877004|20030279|P2|NOT COMPLETED|Overall Study||0
8126209|NCT02877004|20030280|P1|NOT COMPLETED|Overall Study||0
8126210|NCT02877004|20030278|P3|COMPLETED|Overall Study||19
8126211|NCT02877004|20030279|P2|COMPLETED|Overall Study||20
8126212|NCT02877004|20030280|P1|COMPLETED|Overall Study||20
8126213|NCT02877004|20030278|P3|STARTED|Overall Study||20
8126214|NCT02877004|20030279|P2|STARTED|Overall Study||20
8126215|NCT02877004|20030280|P1|STARTED|Overall Study||20
8126216|NCT02876926|20030294|P3|NOT COMPLETED|Overall Study||20
8126217|NCT02876926|20030295|P2|NOT COMPLETED|Overall Study||19
8126218|NCT02876926|20030296|P1|NOT COMPLETED|Overall Study||18
8126219|NCT02876926|20030294|P3|COMPLETED|Overall Study||2
8126220|NCT02876926|20030295|P2|COMPLETED|Overall Study||3
8126221|NCT02876926|20030296|P1|COMPLETED|Overall Study||3
8126222|NCT02876926|20030294|P3|STARTED|Overall Study||22
8126223|NCT02876926|20030295|P2|STARTED|Overall Study||22
8126224|NCT02876926|20030296|P1|STARTED|Overall Study||21
8126225|NCT02876900|20030313|P3|NOT COMPLETED|Overall Study||44
8126226|NCT02876900|20030314|P2|NOT COMPLETED|Overall Study||48
8126227|NCT02876900|20030315|P1|NOT COMPLETED|Overall Study||39
8126228|NCT02876900|20030313|P3|COMPLETED|Overall Study||162
8126229|NCT02876900|20030314|P2|COMPLETED|Overall Study||158
8126230|NCT02876900|20030315|P1|COMPLETED|Overall Study||166
8126231|NCT02876900|20030313|P3|STARTED|Overall Study||206
8126232|NCT02876900|20030314|P2|STARTED|Overall Study||206
8126233|NCT02876900|20030315|P1|STARTED|Overall Study||205
8126234|NCT02876887|20030328|P2|NOT COMPLETED|Overall Study||0
8126235|NCT02876887|20030329|P1|NOT COMPLETED|Overall Study||4
8126236|NCT02876887|20030328|P2|COMPLETED|Overall Study||21
8126237|NCT02876887|20030329|P1|COMPLETED|Overall Study||19
8126238|NCT02876887|20030328|P2|STARTED|Overall Study||21
8126239|NCT02876887|20030329|P1|STARTED|Overall Study||23
8126240|NCT02876757|20030349|P2|NOT COMPLETED|Overall Study||0
8126241|NCT02876757|20030350|P1|NOT COMPLETED|Overall Study||0
8126242|NCT02876757|20030349|P2|COMPLETED|Overall Study||93197
8126243|NCT02876757|20030350|P1|COMPLETED|Overall Study||93197
8126244|NCT02876757|20030349|P2|STARTED|Overall Study||93197
8126245|NCT02876757|20030350|P1|STARTED|Overall Study||93197
8126246|NCT02876601|20030364|P4|NOT COMPLETED|Second Intervention (24 Hours)||0
8126247|NCT02876601|20030365|P3|NOT COMPLETED|Second Intervention (24 Hours)||0
8126248|NCT02876601|20030366|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
8126249|NCT02876601|20030367|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
8126250|NCT02876601|20030364|P4|COMPLETED|Second Intervention (24 Hours)||2
8126251|NCT02876601|20030365|P3|COMPLETED|Second Intervention (24 Hours)||1
8126252|NCT02876601|20030366|P2|COMPLETED|Second Intervention (24 Hours)||8
8126253|NCT02876601|20030367|P1|COMPLETED|Second Intervention (24 Hours)||8
8126254|NCT02876601|20030364|P4|STARTED|Second Intervention (24 Hours)||2
8126255|NCT02876601|20030365|P3|STARTED|Second Intervention (24 Hours)||1
8126256|NCT02876601|20030366|P2|STARTED|Second Intervention (24 Hours)||8
8126257|NCT02876601|20030367|P1|STARTED|Second Intervention (24 Hours)||8
8126258|NCT02876601|20030364|P4|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8126259|NCT02876601|20030365|P3|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
8126260|NCT02876601|20030366|P2|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8126261|NCT02876601|20030367|P1|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8126262|NCT02876601|20030364|P4|COMPLETED|Washout (Minimum of 6 Weeks)||2
8126263|NCT02876601|20030365|P3|COMPLETED|Washout (Minimum of 6 Weeks)||1
8126264|NCT02876601|20030366|P2|COMPLETED|Washout (Minimum of 6 Weeks)||8
8126265|NCT02876601|20030367|P1|COMPLETED|Washout (Minimum of 6 Weeks)||8
8126266|NCT02876601|20030364|P4|STARTED|Washout (Minimum of 6 Weeks)||2
8126267|NCT02876601|20030365|P3|STARTED|Washout (Minimum of 6 Weeks)||2
8126268|NCT02876601|20030366|P2|STARTED|Washout (Minimum of 6 Weeks)||8
8126269|NCT02876601|20030367|P1|STARTED|Washout (Minimum of 6 Weeks)||8
8126270|NCT02876601|20030364|P4|NOT COMPLETED|First Intervention (24 Hours)||0
8126271|NCT02876601|20030365|P3|NOT COMPLETED|First Intervention (24 Hours)||0
8126272|NCT02876601|20030366|P2|NOT COMPLETED|First Intervention (24 Hours)||0
8126273|NCT02876601|20030367|P1|NOT COMPLETED|First Intervention (24 Hours)||0
8126274|NCT02876601|20030364|P4|COMPLETED|First Intervention (24 Hours)||2
8126275|NCT02876601|20030365|P3|COMPLETED|First Intervention (24 Hours)||2
8126276|NCT02876601|20030366|P2|COMPLETED|First Intervention (24 Hours)||8
8126277|NCT02876601|20030367|P1|COMPLETED|First Intervention (24 Hours)||8
8126278|NCT02876601|20030364|P4|STARTED|First Intervention (24 Hours)||2
8126279|NCT02876601|20030365|P3|STARTED|First Intervention (24 Hours)||2
8126280|NCT02876601|20030366|P2|STARTED|First Intervention (24 Hours)||8
8126281|NCT02876601|20030367|P1|STARTED|First Intervention (24 Hours)||8
8126282|NCT02876575|20030417|P1|NOT COMPLETED|Overall Study||0
8126283|NCT02876575|20030417|P1|COMPLETED|Overall Study||48
8126284|NCT02876575|20030417|P1|STARTED|Overall Study||48
8126285|NCT02876159|20030433|P2|NOT COMPLETED|Overall Study||0
8126286|NCT02876159|20030434|P1|NOT COMPLETED|Overall Study||0
8126287|NCT02876159|20030433|P2|COMPLETED|Overall Study||10
8126288|NCT02876159|20030434|P1|COMPLETED|Overall Study||10
8126289|NCT02876159|20030433|P2|STARTED|Overall Study||10
8126290|NCT02876159|20030434|P1|STARTED|Overall Study||10
8126291|NCT02876055|20030453|P3|NOT COMPLETED|Overall Study||0
8126292|NCT02876055|20030454|P2|NOT COMPLETED|Overall Study||0
8126293|NCT02876055|20030455|P1|NOT COMPLETED|Overall Study||0
8126294|NCT02876055|20030453|P3|COMPLETED|Overall Study||42
8126295|NCT02876055|20030454|P2|COMPLETED|Overall Study||41
8126296|NCT02876055|20030455|P1|COMPLETED|Overall Study||42
8126297|NCT02876055|20030453|P3|STARTED|Overall Study||42
8126298|NCT02876055|20030454|P2|STARTED|Overall Study||41
8126299|NCT02876055|20030455|P1|STARTED|Overall Study||42
8126300|NCT02875977|20030465|P2|NOT COMPLETED|Overall Study||29
8126301|NCT02875977|20030466|P1|NOT COMPLETED|Overall Study||42
8126302|NCT02875977|20030465|P2|COMPLETED|Overall Study||71
8126303|NCT02875977|20030466|P1|COMPLETED|Overall Study||58
8126304|NCT02875977|20030465|P2|STARTED|Overall Study||100
8126305|NCT02875977|20030466|P1|STARTED|Overall Study||100
8126306|NCT02875834|20030484|P4|NOT COMPLETED|Randomized Treatment Phase||9
8126307|NCT02875834|20030485|P3|NOT COMPLETED|Randomized Treatment Phase||11
8126308|NCT02875834|20030486|P2|NOT COMPLETED|Randomized Treatment Phase||14
8126309|NCT02875834|20030487|P1|NOT COMPLETED|Randomized Treatment Phase||0
8126310|NCT02875834|20030484|P4|COMPLETED|Randomized Treatment Phase||41
8126311|NCT02875834|20030485|P3|COMPLETED|Randomized Treatment Phase||88
8126312|NCT02875834|20030486|P2|COMPLETED|Randomized Treatment Phase||85
8126313|NCT02875834|20030487|P1|COMPLETED|Randomized Treatment Phase||0
8126314|NCT02875834|20030484|P4|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
8126406|NCT02874066|20030812|P1|COMPLETED|Overall Study||46
8126315|NCT02875834|20030485|P3|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
8126316|NCT02875834|20030486|P2|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
8126317|NCT02875834|20030487|P1|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
8126318|NCT02875834|20030484|P4|NOT COMPLETED|Open-label Phase||0
8126319|NCT02875834|20030485|P3|NOT COMPLETED|Open-label Phase||0
8126320|NCT02875834|20030486|P2|NOT COMPLETED|Open-label Phase||0
8126321|NCT02875834|20030487|P1|NOT COMPLETED|Open-label Phase||7
8126322|NCT02875834|20030484|P4|COMPLETED|Open-label Phase||0
8126323|NCT02875834|20030485|P3|COMPLETED|Open-label Phase||0
8126324|NCT02875834|20030486|P2|COMPLETED|Open-label Phase||0
8126325|NCT02875834|20030487|P1|COMPLETED|Open-label Phase||260
8126326|NCT02875834|20030484|P4|STARTED|Open-label Phase||0
8126327|NCT02875834|20030485|P3|STARTED|Open-label Phase||0
8126328|NCT02875834|20030486|P2|STARTED|Open-label Phase||0
8126329|NCT02875834|20030487|P1|STARTED|Open-label Phase||267
8126330|NCT02875613|20030545|P1|NOT COMPLETED|Overall Study||1
8126331|NCT02875613|20030545|P1|COMPLETED|Overall Study||4
8126332|NCT02875613|20030545|P1|STARTED|Overall Study||5
8126333|NCT02875366|20030551|P2|NOT COMPLETED|Overall Study||3
8126334|NCT02875366|20030552|P1|NOT COMPLETED|Overall Study||0
8126335|NCT02875366|20030551|P2|COMPLETED|Overall Study||31
8126336|NCT02875366|20030552|P1|COMPLETED|Overall Study||36
8126337|NCT02875366|20030551|P2|STARTED|Overall Study||34
8126338|NCT02875366|20030552|P1|STARTED|Overall Study||36
8126339|NCT02875340|20030604|P1|NOT COMPLETED|Overall Study||8
8126340|NCT02875340|20030604|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
8126341|NCT02875340|20030604|P1|STARTED|Overall Study||8
8126342|NCT02875067|20030626|P1|NOT COMPLETED|Overall Study||6
8126343|NCT02875067|20030626|P1|COMPLETED|Overall Study||0
8126344|NCT02875067|20030626|P1|STARTED|Overall Study||6
8126345|NCT02875028|20030641|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
8126346|NCT02875028|20030642|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
8126347|NCT02875028|20030641|P2|COMPLETED|Second Intervention (24 Hours)||7
8126348|NCT02875028|20030642|P1|COMPLETED|Second Intervention (24 Hours)||8
8126349|NCT02875028|20030641|P2|STARTED|Second Intervention (24 Hours)||7
8126350|NCT02875028|20030642|P1|STARTED|Second Intervention (24 Hours)||8
8126351|NCT02875028|20030641|P2|NOT COMPLETED|Washout Period||1
8126352|NCT02875028|20030642|P1|NOT COMPLETED|Washout Period||0
8126353|NCT02875028|20030641|P2|COMPLETED|Washout Period||7
8126354|NCT02875028|20030642|P1|COMPLETED|Washout Period||8
8126355|NCT02875028|20030641|P2|STARTED|Washout Period||8
8126356|NCT02875028|20030642|P1|STARTED|Washout Period||8
8126357|NCT02875028|20030641|P2|NOT COMPLETED|First Intervention (24 Hours)||0
8126358|NCT02875028|20030642|P1|NOT COMPLETED|First Intervention (24 Hours)||0
8126359|NCT02875028|20030641|P2|COMPLETED|First Intervention (24 Hours)||8
8126360|NCT02875028|20030642|P1|COMPLETED|First Intervention (24 Hours)||8
8126361|NCT02875028|20030641|P2|STARTED|First Intervention (24 Hours)||8
8126362|NCT02875028|20030642|P1|STARTED|First Intervention (24 Hours)||8
8126363|NCT02874924|20030673|P3|NOT COMPLETED|Overall Study||0
8126364|NCT02874924|20030674|P2|NOT COMPLETED|Overall Study||0
8126365|NCT02874924|20030675|P1|NOT COMPLETED|Overall Study||3
8126366|NCT02874924|20030673|P3|COMPLETED|Overall Study||6
8126367|NCT02874924|20030674|P2|COMPLETED|Overall Study||14
8126368|NCT02874924|20030675|P1|COMPLETED|Overall Study||11
8126369|NCT02874924|20030673|P3|STARTED|Overall Study||6
8126370|NCT02874924|20030674|P2|STARTED|Overall Study||14
8126371|NCT02874924|20030675|P1|STARTED|Overall Study||14
8126372|NCT02874846|20030697|P2|NOT COMPLETED|Overall Study||0
8126373|NCT02874846|20030698|P1|NOT COMPLETED|Overall Study||0
8126374|NCT02874846|20030697|P2|COMPLETED|Overall Study||4
8126375|NCT02874846|20030698|P1|COMPLETED|Overall Study||8
8126376|NCT02874846|20030697|P2|STARTED|Overall Study||4
8126377|NCT02874846|20030698|P1|STARTED|Overall Study||8
8126378|NCT02874794|20030708|P2|NOT COMPLETED|Overall Study||11
8126379|NCT02874794|20030709|P1|NOT COMPLETED|Overall Study||7
8126380|NCT02874794|20030708|P2|COMPLETED|Overall Study||221
8126381|NCT02874794|20030709|P1|COMPLETED|Overall Study||226
8126382|NCT02874794|20030708|P2|STARTED|Overall Study||232
8126383|NCT02874794|20030709|P1|STARTED|Overall Study||233
8126396|NCT02874534|20030797|P2|NOT COMPLETED|Overall Study||11
8126397|NCT02874534|20030798|P1|NOT COMPLETED|Overall Study||8
8126398|NCT02874534|20030797|P2|COMPLETED|Overall Study||15
8126399|NCT02874534|20030798|P1|COMPLETED|Overall Study||23
8126400|NCT02874534|20030797|P2|STARTED|Overall Study||26
8126401|NCT02874534|20030798|P1|STARTED|Overall Study||31
8126402|NCT02874404|20030806|P1|NOT COMPLETED|Overall Study||0
8126403|NCT02874404|20030806|P1|COMPLETED|Overall Study||13
8126404|NCT02874404|20030806|P1|STARTED|Overall Study||13
8126405|NCT02874066|20030812|P1|NOT COMPLETED|Overall Study||0
8126407|NCT02874066|20030812|P1|STARTED|Overall Study||46
8126408|NCT02873936|20030823|P3|NOT COMPLETED|Overall Study||32
8126409|NCT02873936|20030824|P2|NOT COMPLETED|Overall Study||23
8126410|NCT02873936|20030825|P1|NOT COMPLETED|Overall Study||13
8126411|NCT02873936|20030823|P3|COMPLETED|Overall Study||116
8126412|NCT02873936|20030824|P2|COMPLETED|Overall Study||130
8126413|NCT02873936|20030825|P1|COMPLETED|Overall Study||135
8126414|NCT02873936|20030823|P3|STARTED|Overall Study||148
8126415|NCT02873936|20030824|P2|STARTED|Overall Study||153
8126416|NCT02873936|20030825|P1|STARTED|Overall Study||148
8126417|NCT02873923|20030953|P1|NOT COMPLETED|Overall Study||0
8126418|NCT02873923|20030953|P1|COMPLETED|Overall Study||2846
8126419|NCT02873923|20030953|P1|STARTED|Overall Study||2846
8126420|NCT02873754|20030960|P1|NOT COMPLETED|Overall Study||6
8126421|NCT02873754|20030960|P1|COMPLETED|Overall Study||5
8126422|NCT02873754|20030960|P1|STARTED|Overall Study||11
8126423|NCT02873702|20030977|P4|NOT COMPLETED|Maintenance Period (up to Month 6)||2
8126424|NCT02873702|20030978|P3|NOT COMPLETED|Maintenance Period (up to Month 6)||7
8126425|NCT02873702|20030979|P2|NOT COMPLETED|Maintenance Period (up to Month 6)||0
8126426|NCT02873702|20030980|P1|NOT COMPLETED|Maintenance Period (up to Month 6)||0
8126427|NCT02873702|20030977|P4|COMPLETED|Maintenance Period (up to Month 6)||6
8126428|NCT02873702|20030978|P3|COMPLETED|Maintenance Period (up to Month 6)||1
8126429|NCT02873702|20030979|P2|COMPLETED|Maintenance Period (up to Month 6)||0
8126430|NCT02873702|20030980|P1|COMPLETED|Maintenance Period (up to Month 6)||0
8126431|NCT02873702|20030977|P4|STARTED|Maintenance Period (up to Month 6)||8
8126432|NCT02873702|20030978|P3|STARTED|Maintenance Period (up to Month 6)||8
8126433|NCT02873702|20030979|P2|STARTED|Maintenance Period (up to Month 6)||0
8126434|NCT02873702|20030980|P1|STARTED|Maintenance Period (up to Month 6)||0
8126435|NCT02873702|20030977|P4|NOT COMPLETED|Healing Period (up to Week 8)||0
8126436|NCT02873702|20030978|P3|NOT COMPLETED|Healing Period (up to Week 8)||0
8126437|NCT02873702|20030979|P2|NOT COMPLETED|Healing Period (up to Week 8)||1
8126438|NCT02873702|20030980|P1|NOT COMPLETED|Healing Period (up to Week 8)||1
8126439|NCT02873702|20030977|P4|COMPLETED|Healing Period (up to Week 8)||0
8126440|NCT02873702|20030978|P3|COMPLETED|Healing Period (up to Week 8)||0
8126441|NCT02873702|20030979|P2|COMPLETED|Healing Period (up to Week 8)||16
8126442|NCT02873702|20030980|P1|COMPLETED|Healing Period (up to Week 8)||19
8126443|NCT02873702|20030977|P4|STARTED|Healing Period (up to Week 8)||0
8126444|NCT02873702|20030978|P3|STARTED|Healing Period (up to Week 8)||0
8126445|NCT02873702|20030979|P2|STARTED|Healing Period (up to Week 8)||17
8126446|NCT02873702|20030980|P1|STARTED|Healing Period (up to Week 8)||20
8126447|NCT02873689|20030992|P2|NOT COMPLETED|Overall Study||5
8126448|NCT02873689|20030993|P1|NOT COMPLETED|Overall Study||7
8126449|NCT02873689|20030992|P2|COMPLETED|Overall Study||103
8126450|NCT02873689|20030993|P1|COMPLETED|Overall Study||102
8126451|NCT02873689|20030992|P2|Treated|Overall Study||107
8126452|NCT02873689|20030993|P1|Treated|Overall Study||108
8126453|NCT02873689|20030992|P2|STARTED|Overall Study||108
8126454|NCT02873689|20030993|P1|STARTED|Overall Study||109
8126455|NCT02873585|20031001|P1|NOT COMPLETED|Overall Study||0
8126456|NCT02873585|20031001|P1|COMPLETED|Overall Study||32
8126457|NCT02873585|20031001|P1|STARTED|Overall Study||32
8126458|NCT02873481|20031016|P2|NOT COMPLETED|Overall Study||0
8126459|NCT02873481|20031017|P1|NOT COMPLETED|Overall Study||0
8126460|NCT02873481|20031016|P2|COMPLETED|Overall Study||17
8126461|NCT02873481|20031017|P1|COMPLETED|Overall Study||15
8126462|NCT02873481|20031016|P2|STARTED|Overall Study||17
8126463|NCT02873481|20031017|P1|STARTED|Overall Study||15
8126464|NCT02873429|20031034|P2|NOT COMPLETED|16 Weeks||2
8126465|NCT02873429|20031035|P1|NOT COMPLETED|16 Weeks||5
8126466|NCT02873429|20031034|P2|COMPLETED|16 Weeks||96
8126467|NCT02873429|20031035|P1|COMPLETED|16 Weeks||100
8126468|NCT02873429|20031034|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
8126469|NCT02873429|20031035|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
8126470|NCT02873429|20031034|P2|NOT COMPLETED|6-8 Weeks||1
8126471|NCT02873429|20031035|P1|NOT COMPLETED|6-8 Weeks||10
8126472|NCT02873429|20031034|P2|COMPLETED|6-8 Weeks||97
8126473|NCT02873429|20031035|P1|COMPLETED|6-8 Weeks||95
8126474|NCT02873429|20031034|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
8126475|NCT02873429|20031035|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
8126476|NCT02873429|20031034|P2|NOT COMPLETED|Baseline||0
8126477|NCT02873429|20031035|P1|NOT COMPLETED|Baseline||0
8126478|NCT02873429|20031034|P2|COMPLETED|Baseline||100
8126479|NCT02873429|20031035|P1|COMPLETED|Baseline||109
8126480|NCT02873429|20031034|P2|STARTED|Baseline||100
8126481|NCT02873429|20031035|P1|STARTED|Baseline||109
8126482|NCT02873377|20031047|P2|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
8126483|NCT02873377|20031048|P1|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
8126484|NCT02873377|20031047|P2|COMPLETED|Period Title 3: 6 Months Follow up||46
8126485|NCT02873377|20031048|P1|COMPLETED|Period Title 3: 6 Months Follow up||50
8126486|NCT02873377|20031047|P2|STARTED|Period Title 3: 6 Months Follow up||69
8126487|NCT02873377|20031048|P1|STARTED|Period Title 3: 6 Months Follow up||65
8126488|NCT02873377|20031047|P2|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
8126489|NCT02873377|20031048|P1|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
8126490|NCT02873377|20031047|P2|COMPLETED|Period Title 2: 3 Months Follow up||47
8126491|NCT02873377|20031048|P1|COMPLETED|Period Title 2: 3 Months Follow up||43
8126492|NCT02873377|20031047|P2|STARTED|Period Title 2: 3 Months Follow up||69
8126493|NCT02873377|20031048|P1|STARTED|Period Title 2: 3 Months Follow up||65
8126494|NCT02873377|20031047|P2|NOT COMPLETED|Period 1: Enrollment||0
8126495|NCT02873377|20031048|P1|NOT COMPLETED|Period 1: Enrollment||0
8126496|NCT02873377|20031047|P2|COMPLETED|Period 1: Enrollment||69
8126497|NCT02873377|20031048|P1|COMPLETED|Period 1: Enrollment||65
8126498|NCT02873377|20031047|P2|STARTED|Period 1: Enrollment||69
8126499|NCT02873377|20031048|P1|STARTED|Period 1: Enrollment||65
8126500|NCT02873286|20031072|P5|NOT COMPLETED|Booster Substudy||0
8126501|NCT02873286|20031073|P4|NOT COMPLETED|Booster Substudy||0
8126502|NCT02873286|20031074|P3|NOT COMPLETED|Booster Substudy||0
8126503|NCT02873286|20031075|P2|NOT COMPLETED|Booster Substudy||0
8126504|NCT02873286|20031076|P1|NOT COMPLETED|Booster Substudy||0
8126505|NCT02873286|20031072|P5|COMPLETED|Booster Substudy||0
8126506|NCT02873286|20031073|P4|COMPLETED|Booster Substudy||0
8126507|NCT02873286|20031074|P3|COMPLETED|Booster Substudy||45
8126508|NCT02873286|20031075|P2|COMPLETED|Booster Substudy||0
8126509|NCT02873286|20031076|P1|COMPLETED|Booster Substudy||43
8126510|NCT02873286|20031072|P5|STARTED|Booster Substudy||0
8126511|NCT02873286|20031073|P4|STARTED|Booster Substudy||0
8126512|NCT02873286|20031074|P3|STARTED|Booster Substudy||45
8126513|NCT02873286|20031075|P2|STARTED|Booster Substudy||0
8126514|NCT02873286|20031076|P1|STARTED|Booster Substudy||43
8126515|NCT02873286|20031072|P5|NOT COMPLETED|Main Study||2
8126516|NCT02873286|20031073|P4|NOT COMPLETED|Main Study||1
8126517|NCT02873286|20031074|P3|NOT COMPLETED|Main Study||2
8126518|NCT02873286|20031075|P2|NOT COMPLETED|Main Study||5
8126519|NCT02873286|20031076|P1|NOT COMPLETED|Main Study||2
8126520|NCT02873286|20031072|P5|COMPLETED|Main Study||81
8126521|NCT02873286|20031073|P4|COMPLETED|Main Study||89
8126522|NCT02873286|20031074|P3|COMPLETED|Main Study||78
8126523|NCT02873286|20031075|P2|COMPLETED|Main Study||84
8126524|NCT02873286|20031076|P1|COMPLETED|Main Study||76
8126525|NCT02873286|20031072|P5|STARTED|Main Study||83
8126526|NCT02873286|20031073|P4|STARTED|Main Study||90
8126527|NCT02873286|20031074|P3|STARTED|Main Study||80
8126528|NCT02873286|20031075|P2|STARTED|Main Study||89
8126529|NCT02873286|20031076|P1|STARTED|Main Study||78
8126530|NCT02873221|20031306|P3|NOT COMPLETED|Safety Follow-up Period||14
8126531|NCT02873221|20031307|P2|NOT COMPLETED|Safety Follow-up Period||17
8126532|NCT02873221|20031308|P1|NOT COMPLETED|Safety Follow-up Period||7
8126533|NCT02873221|20031306|P3|COMPLETED|Safety Follow-up Period||350
8126534|NCT02873221|20031307|P2|COMPLETED|Safety Follow-up Period||339
8126535|NCT02873221|20031308|P1|COMPLETED|Safety Follow-up Period||343
8126536|NCT02873221|20031306|P3|STARTED|Safety Follow-up Period||364
8126537|NCT02873221|20031307|P2|STARTED|Safety Follow-up Period||356
8126538|NCT02873221|20031308|P1|STARTED|Safety Follow-up Period||350
8126539|NCT02873221|20031306|P3|NOT COMPLETED|Treatment Period||105
8126540|NCT02873221|20031307|P2|NOT COMPLETED|Treatment Period||126
8126541|NCT02873221|20031308|P1|NOT COMPLETED|Treatment Period||88
8126542|NCT02873221|20031306|P3|COMPLETED|Treatment Period||315
8126543|NCT02873221|20031307|P2|COMPLETED|Treatment Period||291
8126544|NCT02873221|20031308|P1|COMPLETED|Treatment Period||329
8126545|NCT02873221|20031306|P3|Safety Population: Received Study Drug|Treatment Period||409
8126546|NCT02873221|20031307|P2|Safety Population: Received Study Drug|Treatment Period||404
8126547|NCT02873221|20031308|P1|Safety Population: Received Study Drug|Treatment Period||417
8126548|NCT02873221|20031306|P3|STARTED|Treatment Period||420
8126549|NCT02873221|20031307|P2|STARTED|Treatment Period||417
8126550|NCT02873221|20031308|P1|STARTED|Treatment Period||417
8126559|NCT02873104|20031345|P2|NOT COMPLETED|Overall Study||0
8126560|NCT02873104|20031346|P1|NOT COMPLETED|Overall Study||1
8126561|NCT02873104|20031345|P2|COMPLETED|Overall Study||23
8126562|NCT02873104|20031346|P1|COMPLETED|Overall Study||46
8126563|NCT02873104|20031345|P2|STARTED|Overall Study||23
8126564|NCT02873104|20031346|P1|STARTED|Overall Study||47
8126565|NCT02872935|20031360|P2|NOT COMPLETED|Overall Study||1
8126566|NCT02872935|20031361|P1|NOT COMPLETED|Overall Study||0
8126567|NCT02872935|20031360|P2|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
8126568|NCT02872935|20031361|P1|COMPLETED|Overall Study||11
8126569|NCT02872935|20031360|P2|STARTED|Overall Study||11
8126570|NCT02872935|20031361|P1|STARTED|Overall Study||11
8126571|NCT02872909|20031371|P2|NOT COMPLETED|Overall Study||0
8126572|NCT02872909|20031372|P1|NOT COMPLETED|Overall Study||0
8126573|NCT02872909|20031371|P2|COMPLETED|Overall Study||18
8126574|NCT02872909|20031372|P1|COMPLETED|Overall Study||32
8126575|NCT02872909|20031371|P2|STARTED|Overall Study||18
8126576|NCT02872909|20031372|P1|STARTED|Overall Study||32
8126577|NCT02872311|20031389|P5|NOT COMPLETED|Overall Study||0
8126578|NCT02872311|20031390|P4|NOT COMPLETED|Overall Study||0
8126579|NCT02872311|20031391|P3|NOT COMPLETED|Overall Study||1
8126580|NCT02872311|20031392|P2|NOT COMPLETED|Overall Study||2
8126581|NCT02872311|20031393|P1|NOT COMPLETED|Overall Study||4
8126582|NCT02872311|20031389|P5|COMPLETED|Overall Study||20
8126583|NCT02872311|20031390|P4|COMPLETED|Overall Study||20
8126584|NCT02872311|20031391|P3|COMPLETED|Overall Study||19
8126585|NCT02872311|20031392|P2|COMPLETED|Overall Study||58
8126586|NCT02872311|20031393|P1|COMPLETED|Overall Study||55
8126587|NCT02872311|20031389|P5|STARTED|Overall Study||20
8126588|NCT02872311|20031390|P4|STARTED|Overall Study||20
8126589|NCT02872311|20031391|P3|STARTED|Overall Study||20
8126590|NCT02872311|20031392|P2|STARTED|Overall Study||60
8126591|NCT02872311|20031393|P1|STARTED|Overall Study||59
8126592|NCT02872285|20031454|P2|NOT COMPLETED|Overall Study||2
8126593|NCT02872285|20031455|P1|NOT COMPLETED|Overall Study||5
8126594|NCT02872285|20031454|P2|COMPLETED|Overall Study||9
8126595|NCT02872285|20031455|P1|COMPLETED|Overall Study||17
8126596|NCT02872285|20031454|P2|STARTED|Overall Study||11
8126597|NCT02872285|20031455|P1|STARTED|Overall Study||22
8126598|NCT02872103|20031471|P2|NOT COMPLETED|Cycle 2-4||1
8126599|NCT02872103|20031472|P1|NOT COMPLETED|Cycle 2-4||2
8126600|NCT02872103|20031471|P2|COMPLETED|Cycle 2-4||37
8126601|NCT02872103|20031472|P1|COMPLETED|Cycle 2-4||81
8126602|NCT02872103|20031471|P2|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
8126603|NCT02872103|20031472|P1|STARTED|Cycle 2-4||83
8126604|NCT02872103|20031471|P2|NOT COMPLETED|Cycle 1||1
8126605|NCT02872103|20031472|P1|NOT COMPLETED|Cycle 1||0
8126606|NCT02872103|20031471|P2|COMPLETED|Cycle 1||38
8126607|NCT02872103|20031472|P1|COMPLETED|Cycle 1||83
8126608|NCT02872103|20031471|P2|STARTED|Cycle 1||39
8126609|NCT02872103|20031472|P1|STARTED|Cycle 1||83
8126610|NCT02872012|20031501|P5|NOT COMPLETED|Overall Study||0
8126611|NCT02872012|20031502|P4|NOT COMPLETED|Overall Study||0
8126612|NCT02872012|20031503|P3|NOT COMPLETED|Overall Study||0
8126613|NCT02872012|20031504|P2|NOT COMPLETED|Overall Study||0
8126614|NCT02872012|20031505|P1|NOT COMPLETED|Overall Study||1
8126615|NCT02872012|20031501|P5|COMPLETED|Overall Study||5
8126616|NCT02872012|20031502|P4|COMPLETED|Overall Study||3
8126617|NCT02872012|20031503|P3|COMPLETED|Overall Study||4
8126618|NCT02872012|20031504|P2|COMPLETED|Overall Study||7
8126619|NCT02872012|20031505|P1|COMPLETED|Overall Study||3
8126620|NCT02872012|20031501|P5|STARTED|Overall Study||5
8126621|NCT02872012|20031502|P4|STARTED|Overall Study||3
8126622|NCT02872012|20031503|P3|STARTED|Overall Study||4
8126623|NCT02872012|20031504|P2|STARTED|Overall Study||7
8126624|NCT02872012|20031505|P1|STARTED|Overall Study||4
8126625|NCT02871739|20031523|P4|NOT COMPLETED|Overall Study||2
8126626|NCT02871739|20031524|P3|NOT COMPLETED|Overall Study||0
8126627|NCT02871739|20031525|P2|NOT COMPLETED|Overall Study||2
8126628|NCT02871739|20031526|P1|NOT COMPLETED|Overall Study||3
8126629|NCT02871739|20031523|P4|COMPLETED|Overall Study||5
8126630|NCT02871739|20031524|P3|COMPLETED|Overall Study||4
8126631|NCT02871739|20031525|P2|COMPLETED|Overall Study||4
8126632|NCT02871739|20031526|P1|COMPLETED|Overall Study||3
8126633|NCT02871739|20031523|P4|Complete Final Survey|Overall Study||5
8126634|NCT02871739|20031524|P3|Complete Final Survey|Overall Study||4
8126635|NCT02871739|20031525|P2|Complete Final Survey|Overall Study||4
8126636|NCT02871739|20031526|P1|Complete Final Survey|Overall Study||3
8126637|NCT02871739|20031523|P4|Completed Second SPI|Overall Study||5
8126638|NCT02871739|20031524|P3|Completed Second SPI|Overall Study||4
8126639|NCT02871739|20031525|P2|Completed Second SPI|Overall Study||4
8126640|NCT02871739|20031526|P1|Completed Second SPI|Overall Study||3
8126641|NCT02871739|20031523|P4|Completed First SPI|Overall Study||6
8126642|NCT02871739|20031524|P3|Completed First SPI|Overall Study||4
8126643|NCT02871739|20031525|P2|Completed First SPI|Overall Study||5
8126644|NCT02871739|20031526|P1|Completed First SPI|Overall Study||3
8126645|NCT02871739|20031523|P4|STARTED|Overall Study||7
8126646|NCT02871739|20031524|P3|STARTED|Overall Study||4
8126647|NCT02871739|20031525|P2|STARTED|Overall Study||6
8126648|NCT02871739|20031526|P1|STARTED|Overall Study||6
8126649|NCT02871635|20031538|P2|NOT COMPLETED|Overall Study||19
8126650|NCT02871635|20031539|P1|NOT COMPLETED|Overall Study||18
8126651|NCT02871635|20031538|P2|COMPLETED|Overall Study||56
8126652|NCT02871635|20031539|P1|COMPLETED|Overall Study||54
8126653|NCT02871635|20031538|P2|STARTED|Overall Study||75
8126654|NCT02871635|20031539|P1|STARTED|Overall Study||72
8126655|NCT02871570|20031565|P2|NOT COMPLETED|Overall Study||0
8126656|NCT02871570|20031566|P1|NOT COMPLETED|Overall Study||0
8126657|NCT02871570|20031565|P2|COMPLETED|Overall Study||8
8126658|NCT02871570|20031566|P1|COMPLETED|Overall Study||8
8126659|NCT02871570|20031565|P2|STARTED|Overall Study||8
8126660|NCT02871570|20031566|P1|STARTED|Overall Study||8
8126661|NCT02871479|20031597|P3|NOT COMPLETED|Overall Study||0
8126662|NCT02871479|20031598|P2|NOT COMPLETED|Overall Study||3
8126663|NCT02871479|20031599|P1|NOT COMPLETED|Overall Study||3
8126664|NCT02871479|20031597|P3|COMPLETED|Overall Study||11
8126665|NCT02871479|20031598|P2|COMPLETED|Overall Study||21
8126666|NCT02871479|20031599|P1|COMPLETED|Overall Study||33
8126667|NCT02871479|20031597|P3|STARTED|Overall Study||11
8126668|NCT02871479|20031598|P2|STARTED|Overall Study||24
8126669|NCT02871479|20031599|P1|STARTED|Overall Study||36
8126670|NCT02871440|20031613|P3|NOT COMPLETED|Overall Study||0
8126671|NCT02871440|20031614|P2|NOT COMPLETED|Overall Study||0
8126672|NCT02871440|20031615|P1|NOT COMPLETED|Overall Study||0
8126673|NCT02871440|20031613|P3|COMPLETED|Overall Study||15
8126674|NCT02871440|20031614|P2|COMPLETED|Overall Study||13
8126675|NCT02871440|20031615|P1|COMPLETED|Overall Study||12
8126676|NCT02871440|20031613|P3|STARTED|Overall Study||15
8126677|NCT02871440|20031614|P2|STARTED|Overall Study||13
8126678|NCT02871440|20031615|P1|STARTED|Overall Study||12
8126679|NCT02871375|20031629|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8126774|NCT02868242|20031901|P1|STARTED|Overall Study||19
8126680|NCT02871375|20031630|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8126681|NCT02871375|20031629|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
8126682|NCT02871375|20031630|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
8126683|NCT02871375|20031629|P2|STARTED|Period 2, Second 14 Days of Wear||76
8126684|NCT02871375|20031630|P1|STARTED|Period 2, Second 14 Days of Wear||89
8126685|NCT02871375|20031629|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8126686|NCT02871375|20031630|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
8126687|NCT02871375|20031629|P2|COMPLETED|Period 1, First 14 Days of Wear||76
8126688|NCT02871375|20031630|P1|COMPLETED|Period 1, First 14 Days of Wear||89
8126689|NCT02871375|20031629|P2|STARTED|Period 1, First 14 Days of Wear||77
8126690|NCT02871375|20031630|P1|STARTED|Period 1, First 14 Days of Wear||89
8126691|NCT02871128|20031642|P3|NOT COMPLETED|Overall Study||1
8126692|NCT02871128|20031643|P2|NOT COMPLETED|Overall Study||1
8126693|NCT02871128|20031644|P1|NOT COMPLETED|Overall Study||0
8126694|NCT02871128|20031642|P3|COMPLETED|Overall Study||15
8126695|NCT02871128|20031643|P2|COMPLETED|Overall Study||19
8126696|NCT02871128|20031644|P1|COMPLETED|Overall Study||20
8126697|NCT02871128|20031642|P3|STARTED|Overall Study||16
8126698|NCT02871128|20031643|P2|STARTED|Overall Study||20
8126699|NCT02871128|20031644|P1|STARTED|Overall Study||20
8126700|NCT02871011|20031657|P2|NOT COMPLETED|Overall Study||0
8126701|NCT02871011|20031658|P1|NOT COMPLETED|Overall Study||0
8126702|NCT02871011|20031657|P2|COMPLETED|Overall Study||13
8126703|NCT02871011|20031658|P1|COMPLETED|Overall Study||7
8126704|NCT02871011|20031657|P2|STARTED|Overall Study||13
8126705|NCT02871011|20031658|P1|STARTED|Overall Study||7
8126706|NCT02870933|20031676|P2|NOT COMPLETED|Overall Study||2
8126707|NCT02870933|20031677|P1|NOT COMPLETED|Overall Study||2
8126708|NCT02870933|20031676|P2|COMPLETED|Overall Study||13
8126709|NCT02870933|20031677|P1|COMPLETED|Overall Study||13
8126710|NCT02870933|20031676|P2|STARTED|Overall Study||15
8126711|NCT02870933|20031677|P1|STARTED|Overall Study||15
8126712|NCT02870920|20031701|P2|NOT COMPLETED|Overall Study||0
8126713|NCT02870920|20031702|P1|NOT COMPLETED|Overall Study||0
8126714|NCT02870920|20031701|P2|COMPLETED|Overall Study||119
8126715|NCT02870920|20031702|P1|COMPLETED|Overall Study||61
8126716|NCT02870920|20031701|P2|STARTED|Overall Study||119
8126717|NCT02870920|20031702|P1|STARTED|Overall Study||61
8126718|NCT02870283|20031715|P3|NOT COMPLETED|Overall Study||19
8126719|NCT02870283|20031716|P2|NOT COMPLETED|Overall Study||9
8126720|NCT02870283|20031717|P1|NOT COMPLETED|Overall Study||3
8126721|NCT02870283|20031715|P3|COMPLETED|Overall Study||15
8126722|NCT02870283|20031716|P2|COMPLETED|Overall Study||26
8126723|NCT02870283|20031717|P1|COMPLETED|Overall Study||35
8126724|NCT02870283|20031715|P3|STARTED|Overall Study||34
8126725|NCT02870283|20031716|P2|STARTED|Overall Study||35
8126726|NCT02870283|20031717|P1|STARTED|Overall Study||38
8126727|NCT02870205|20031735|P4|NOT COMPLETED|Overall Study||7
8126728|NCT02870205|20031736|P3|NOT COMPLETED|Overall Study||7
8126729|NCT02870205|20031737|P2|NOT COMPLETED|Overall Study||5
8126730|NCT02870205|20031738|P1|NOT COMPLETED|Overall Study||10
8126731|NCT02870205|20031735|P4|COMPLETED|Overall Study||287
8126732|NCT02870205|20031736|P3|COMPLETED|Overall Study||287
8126733|NCT02870205|20031737|P2|COMPLETED|Overall Study||289
8126734|NCT02870205|20031738|P1|COMPLETED|Overall Study||284
8126735|NCT02870205|20031735|P4|STARTED|Overall Study||294
8126736|NCT02870205|20031736|P3|STARTED|Overall Study||294
8126737|NCT02870205|20031737|P2|STARTED|Overall Study||294
8126738|NCT02870205|20031738|P1|STARTED|Overall Study||294
8126739|NCT02870101|20031748|P1|NOT COMPLETED|Overall Study||169
8126740|NCT02870101|20031748|P1|COMPLETED|Overall Study||2598
8126741|NCT02870101|20031748|P1|STARTED|Overall Study||2767
8126742|NCT02869893|20031763|P1|NOT COMPLETED|Overall Study||7
8126743|NCT02869893|20031763|P1|COMPLETED|Overall Study||50
8126744|NCT02869893|20031763|P1|STARTED|Overall Study||57
8126745|NCT02869451|20031769|P1|NOT COMPLETED|Overall Study||0
8126746|NCT02869451|20031769|P1|COMPLETED|Overall Study||5
8126747|NCT02869451|20031769|P1|STARTED|Overall Study||5
8126748|NCT02869438|20031793|P2|NOT COMPLETED|Overall Study||2
8126749|NCT02869438|20031794|P1|NOT COMPLETED|Overall Study||3
8126750|NCT02869438|20031793|P2|COMPLETED|Overall Study||113
8126751|NCT02869438|20031794|P1|COMPLETED|Overall Study||115
8126752|NCT02869438|20031793|P2|STARTED|Overall Study||115
8126753|NCT02869438|20031794|P1|STARTED|Overall Study||118
8126754|NCT02868892|20031842|P1|NOT COMPLETED|Overall Study||6
8126755|NCT02868892|20031842|P1|COMPLETED|Overall Study||0
8126756|NCT02868892|20031842|P1|STARTED|Overall Study||6
8126757|NCT02868554|20031851|P3|NOT COMPLETED|Overall Study||1
8126758|NCT02868554|20031852|P2|NOT COMPLETED|Overall Study||0
8126759|NCT02868554|20031853|P1|NOT COMPLETED|Overall Study||3
8126760|NCT02868554|20031851|P3|COMPLETED|Overall Study||11
8126761|NCT02868554|20031852|P2|COMPLETED|Overall Study||12
8126762|NCT02868554|20031853|P1|COMPLETED|Overall Study||7
8126763|NCT02868554|20031851|P3|STARTED|Overall Study||12
8126764|NCT02868554|20031852|P2|STARTED|Overall Study||12
8126765|NCT02868554|20031853|P1|STARTED|Overall Study||10
8126766|NCT02868281|20031878|P2|NOT COMPLETED|Overall Study||44
8126767|NCT02868281|20031879|P1|NOT COMPLETED|Overall Study||43
8126768|NCT02868281|20031878|P2|COMPLETED|Overall Study||234
8126769|NCT02868281|20031879|P1|COMPLETED|Overall Study||209
8126770|NCT02868281|20031878|P2|STARTED|Overall Study||278
8126771|NCT02868281|20031879|P1|STARTED|Overall Study||252
8126772|NCT02868242|20031901|P1|NOT COMPLETED|Overall Study||0
8126773|NCT02868242|20031901|P1|COMPLETED|Overall Study||19
8126775|NCT02868216|20031913|P2|NOT COMPLETED|Overall Study||6
8126776|NCT02868216|20031914|P1|NOT COMPLETED|Overall Study||8
8126777|NCT02868216|20031913|P2|COMPLETED|Overall Study||41
8126778|NCT02868216|20031914|P1|COMPLETED|Overall Study||35
8126779|NCT02868216|20031913|P2|STARTED|Overall Study||47
8126780|NCT02868216|20031914|P1|STARTED|Overall Study||43
8126781|NCT02867995|20031922|P2|NOT COMPLETED|Overall Study||3
8126782|NCT02867995|20031923|P1|NOT COMPLETED|Overall Study||0
8126783|NCT02867995|20031922|P2|COMPLETED|Overall Study|Total patients completed|27
8126784|NCT02867995|20031923|P1|COMPLETED|Overall Study|Total patients completed|9
8126785|NCT02867995|20031922|P2|STARTED|Overall Study|Total patients consented|30
8126786|NCT02867995|20031923|P1|STARTED|Overall Study|Total patients consented|9
8126787|NCT02867709|20031942|P3|NOT COMPLETED|Safety Follow-up Period||14
8126788|NCT02867709|20031943|P2|NOT COMPLETED|Safety Follow-up Period||15
8126789|NCT02867709|20031944|P1|NOT COMPLETED|Safety Follow-up Period||11
8126790|NCT02867709|20031942|P3|COMPLETED|Safety Follow-up Period||473
8126791|NCT02867709|20031943|P2|COMPLETED|Safety Follow-up Period||459
8126792|NCT02867709|20031944|P1|COMPLETED|Safety Follow-up Period||482
8126793|NCT02867709|20031942|P3|STARTED|Safety Follow-up Period||487
8126794|NCT02867709|20031943|P2|STARTED|Safety Follow-up Period||474
8126795|NCT02867709|20031944|P1|STARTED|Safety Follow-up Period||493
8126796|NCT02867709|20031942|P3|NOT COMPLETED|Treatment Period||75
8126797|NCT02867709|20031943|P2|NOT COMPLETED|Treatment Period||87
8126798|NCT02867709|20031944|P1|NOT COMPLETED|Treatment Period||70
8126799|NCT02867709|20031942|P3|COMPLETED|Treatment Period||487
8126800|NCT02867709|20031943|P2|COMPLETED|Treatment Period||474
8126801|NCT02867709|20031944|P1|COMPLETED|Treatment Period||493
8126802|NCT02867709|20031942|P3|Safety Population: Received Study Drug|Treatment Period||488
8126803|NCT02867709|20031943|P2|Safety Population: Received Study Drug|Treatment Period||478
8126804|NCT02867709|20031944|P1|Safety Population: Received Study Drug|Treatment Period||499
8126805|NCT02867709|20031942|P3|STARTED|Treatment Period||562
8126806|NCT02867709|20031943|P2|STARTED|Treatment Period||561
8126807|NCT02867709|20031944|P1|STARTED|Treatment Period||563
8126808|NCT02867605|20031973|P1|NOT COMPLETED|Overall Study||0
8126809|NCT02867605|20031973|P1|COMPLETED|Overall Study||20
8126810|NCT02867605|20031973|P1|STARTED|Overall Study||20
8126811|NCT02867202|20032025|P2|NOT COMPLETED|Overall Study||32
8126812|NCT02867202|20032026|P1|NOT COMPLETED|Overall Study||21
8126813|NCT02867202|20032025|P2|COMPLETED|Overall Study||56
8126814|NCT02867202|20032026|P1|COMPLETED|Overall Study||62
8126815|NCT02867202|20032025|P2|STARTED|Overall Study||88
8126816|NCT02867202|20032026|P1|STARTED|Overall Study||83
8126817|NCT02867163|20032032|P1|NOT COMPLETED|Overall Study||0
8126818|NCT02867163|20032032|P1|COMPLETED|Overall Study||25
8126819|NCT02867163|20032032|P1|STARTED|Overall Study||25
8126820|NCT02867150|20032036|P1|NOT COMPLETED|Overall Study||0
8126821|NCT02867150|20032036|P1|COMPLETED|Overall Study||58
8126822|NCT02867150|20032036|P1|STARTED|Overall Study||58
8126823|NCT02867059|20032042|P2|NOT COMPLETED|Overall Study||2
8126824|NCT02867059|20032043|P1|NOT COMPLETED|Overall Study||0
8126825|NCT02867059|20032042|P2|COMPLETED|Overall Study||8
8126826|NCT02867059|20032043|P1|COMPLETED|Overall Study||7
8126827|NCT02867059|20032042|P2|STARTED|Overall Study||10
8126828|NCT02867059|20032043|P1|STARTED|Overall Study||7
8126829|NCT02866942|20032051|P1|NOT COMPLETED|Overall Study||1
8126830|NCT02866942|20032051|P1|COMPLETED|Overall Study||478
8126831|NCT02866942|20032051|P1|STARTED|Overall Study||479
8126832|NCT02866695|20032056|P1|NOT COMPLETED|Overall Study||2
8126833|NCT02866695|20032056|P1|COMPLETED|Overall Study||18
8126834|NCT02866695|20032056|P1|STARTED|Overall Study||20
8126835|NCT02866643|20032064|P2|NOT COMPLETED|Overall Study||12
8126836|NCT02866643|20032065|P1|NOT COMPLETED|Overall Study||13
8126837|NCT02866643|20032064|P2|COMPLETED|Overall Study||35
8126838|NCT02866643|20032065|P1|COMPLETED|Overall Study||35
8126839|NCT02866643|20032064|P2|Per Protocol Population|Overall Study||35
8126840|NCT02866643|20032065|P1|Per Protocol Population|Overall Study||35
8126841|NCT02866643|20032064|P2|Intent-to-Treat (ITT) Population|Overall Study||39
8126842|NCT02866643|20032065|P1|Intent-to-Treat (ITT) Population|Overall Study||38
8126843|NCT02866643|20032064|P2|STARTED|Overall Study||47
8126844|NCT02866643|20032065|P1|STARTED|Overall Study||48
8126845|NCT02866175|20032073|P2|NOT COMPLETED|Overall Study||175
8126846|NCT02866175|20032074|P1|NOT COMPLETED|Overall Study||135
8126847|NCT02866175|20032073|P2|COMPLETED|Overall Study||580
8126848|NCT02866175|20032074|P1|COMPLETED|Overall Study||616
8126849|NCT02866175|20032073|P2|STARTED|Overall Study||755
8126850|NCT02866175|20032074|P1|STARTED|Overall Study||751
8126857|NCT02865720|20032105|P2|NOT COMPLETED|Overall Study||0
8126858|NCT02865720|20032106|P1|NOT COMPLETED|Overall Study||0
8126859|NCT02865720|20032105|P2|COMPLETED|Overall Study||8
8126860|NCT02865720|20032106|P1|COMPLETED|Overall Study||0
8126861|NCT02865720|20032105|P2|STARTED|Overall Study||8
8126862|NCT02865720|20032106|P1|STARTED|Overall Study||0
8126863|NCT02865590|20032131|P2|NOT COMPLETED|Overall Study||0
8126864|NCT02865590|20032132|P1|NOT COMPLETED|Overall Study||0
8126865|NCT02865590|20032131|P2|COMPLETED|Overall Study||8
8126866|NCT02865590|20032132|P1|COMPLETED|Overall Study||8
8126867|NCT02865590|20032131|P2|STARTED|Overall Study||8
8126868|NCT02865590|20032132|P1|STARTED|Overall Study||8
8126869|NCT02865499|20032138|P1|NOT COMPLETED|12 Weeks||0
8126870|NCT02865499|20032138|P1|COMPLETED|12 Weeks||6
8126871|NCT02865499|20032138|P1|STARTED|12 Weeks||6
8126872|NCT02865499|20032138|P1|NOT COMPLETED|8 Weeks||0
8126873|NCT02865499|20032138|P1|COMPLETED|8 Weeks||6
8126874|NCT02865499|20032138|P1|STARTED|8 Weeks||6
8126875|NCT02865499|20032138|P1|NOT COMPLETED|Baseline||2
8126876|NCT02865499|20032138|P1|COMPLETED|Baseline||6
8126877|NCT02865499|20032138|P1|STARTED|Baseline||8
8126878|NCT02865395|20032145|P3|NOT COMPLETED|Overall Study||7
8126879|NCT02865395|20032146|P2|NOT COMPLETED|Overall Study||10
8126880|NCT02865395|20032147|P1|NOT COMPLETED|Overall Study||6
8126881|NCT02865395|20032145|P3|COMPLETED|Overall Study|Data Not Collected|0
8126882|NCT02865395|20032146|P2|COMPLETED|Overall Study|Data Not Collected|0
8126883|NCT02865395|20032147|P1|COMPLETED|Overall Study|Data Not Collected|0
8126884|NCT02865395|20032145|P3|STARTED|Overall Study||7
8126885|NCT02865395|20032146|P2|STARTED|Overall Study||10
8126886|NCT02865395|20032147|P1|STARTED|Overall Study||6
8126887|NCT02865343|20032160|P2|NOT COMPLETED|Overall Study||2
8126888|NCT02865343|20032161|P1|NOT COMPLETED|Overall Study||0
8126889|NCT02865343|20032160|P2|COMPLETED|Overall Study||3
8126890|NCT02865343|20032161|P1|COMPLETED|Overall Study||6
8126891|NCT02865343|20032160|P2|STARTED|Overall Study||5
8126892|NCT02865343|20032161|P1|STARTED|Overall Study||6
8126893|NCT02865083|20032173|P2|NOT COMPLETED|Overall Study||1
8126894|NCT02865083|20032174|P1|NOT COMPLETED|Overall Study||3
8126895|NCT02865083|20032173|P2|COMPLETED|Overall Study||0
8126896|NCT02865083|20032174|P1|COMPLETED|Overall Study||0
8126897|NCT02865083|20032173|P2|STARTED|Overall Study||1
8126898|NCT02865083|20032174|P1|STARTED|Overall Study||3
8126899|NCT02864732|20032194|P2|NOT COMPLETED|Overall Study||2
8126900|NCT02864732|20032195|P1|NOT COMPLETED|Overall Study||2
8126901|NCT02864732|20032194|P2|COMPLETED|Overall Study||13
8126902|NCT02864732|20032195|P1|COMPLETED|Overall Study||13
8126903|NCT02864732|20032194|P2|STARTED|Overall Study||15
8126904|NCT02864732|20032195|P1|STARTED|Overall Study||15
8126905|NCT02864706|20032212|P2|NOT COMPLETED|Overall Study||0
8126906|NCT02864706|20032213|P1|NOT COMPLETED|Overall Study||0
8126907|NCT02864706|20032212|P2|COMPLETED|Overall Study||47
8126908|NCT02864706|20032213|P1|COMPLETED|Overall Study||48
8126909|NCT02864706|20032212|P2|Intent to Treat|Overall Study||47
8126910|NCT02864706|20032213|P1|Intent to Treat|Overall Study||46
8126911|NCT02864706|20032212|P2|Safety Set|Overall Study||47
8126912|NCT02864706|20032213|P1|Safety Set|Overall Study||48
8126913|NCT02864706|20032212|P2|STARTED|Overall Study||47
8126914|NCT02864706|20032213|P1|STARTED|Overall Study||48
8126915|NCT02864394|20032235|P2|NOT COMPLETED|Overall Study||212
8126916|NCT02864394|20032236|P1|NOT COMPLETED|Overall Study||213
8126917|NCT02864394|20032235|P2|COMPLETED|Overall Study||0
8126918|NCT02864394|20032236|P1|COMPLETED|Overall Study||0
8126919|NCT02864394|20032235|P2|Treated|Overall Study||198
8126920|NCT02864394|20032236|P1|Treated|Overall Study||213
8126921|NCT02864394|20032235|P2|STARTED|Overall Study||212
8126922|NCT02864394|20032236|P1|STARTED|Overall Study||213
8126923|NCT02864381|20032262|P2|NOT COMPLETED|Overall Study||72
8126924|NCT02864381|20032263|P1|NOT COMPLETED|Overall Study||72
8126925|NCT02864381|20032262|P2|COMPLETED|Overall Study||0
8126926|NCT02864381|20032263|P1|COMPLETED|Overall Study||0
8126927|NCT02864381|20032262|P2|STARTED|Overall Study||72
8126928|NCT02864381|20032263|P1|STARTED|Overall Study||72
8126929|NCT02864342|20032281|P2|NOT COMPLETED|Overall Study||19
8126930|NCT02864342|20032282|P1|NOT COMPLETED|Overall Study||15
8126931|NCT02864342|20032281|P2|COMPLETED|Overall Study||49
8126932|NCT02864342|20032282|P1|COMPLETED|Overall Study||55
8126933|NCT02864342|20032281|P2|Full Analysis Set (FAS)|Overall Study||67
8126934|NCT02864342|20032282|P1|Full Analysis Set (FAS)|Overall Study||70
8126935|NCT02864342|20032281|P2|STARTED|Overall Study||68
8126936|NCT02864342|20032282|P1|STARTED|Overall Study||70
8126937|NCT02864316|20032299|P2|NOT COMPLETED|Overall Study||2
8126938|NCT02864316|20032300|P1|NOT COMPLETED|Overall Study||2
8126939|NCT02864316|20032299|P2|COMPLETED|Overall Study||0
8126940|NCT02864316|20032300|P1|COMPLETED|Overall Study||0
8126941|NCT02864316|20032299|P2|STARTED|Overall Study||2
8126942|NCT02864316|20032300|P1|STARTED|Overall Study||2
8126943|NCT02864069|20032319|P3|NOT COMPLETED|Overall Study||8
8126944|NCT02864069|20032320|P2|NOT COMPLETED|Overall Study||8
8126945|NCT02864069|20032321|P1|NOT COMPLETED|Overall Study||6
8126946|NCT02864069|20032319|P3|COMPLETED|Overall Study||13
8126947|NCT02864069|20032320|P2|COMPLETED|Overall Study||5
8126948|NCT02864069|20032321|P1|COMPLETED|Overall Study||12
8126949|NCT02864069|20032319|P3|STARTED|Overall Study||21
8126950|NCT02864069|20032320|P2|STARTED|Overall Study||13
8126951|NCT02864069|20032321|P1|STARTED|Overall Study||18
8126952|NCT02863575|20032338|P3|NOT COMPLETED|Overall Study||1
8126953|NCT02863575|20032339|P2|NOT COMPLETED|Overall Study||2
8126954|NCT02863575|20032340|P1|NOT COMPLETED|Overall Study||1
8126955|NCT02863575|20032338|P3|COMPLETED|Overall Study||51
8126956|NCT02863575|20032339|P2|COMPLETED|Overall Study||159
8126957|NCT02863575|20032340|P1|COMPLETED|Overall Study||160
8126958|NCT02863575|20032338|P3|STARTED|Overall Study||52
8126959|NCT02863575|20032339|P2|STARTED|Overall Study||161
8126960|NCT02863575|20032340|P1|STARTED|Overall Study||161
8126961|NCT02863419|20032392|P3|NOT COMPLETED|Overall Study||8
8126962|NCT02863419|20032393|P2|NOT COMPLETED|Overall Study||10
8126963|NCT02863419|20032394|P1|NOT COMPLETED|Overall Study||8
8126964|NCT02863419|20032392|P3|COMPLETED|Overall Study||134
8126965|NCT02863419|20032393|P2|COMPLETED|Overall Study||274
8126966|NCT02863419|20032394|P1|COMPLETED|Overall Study||277
8126967|NCT02863419|20032392|P3|Safety Analysis Set (SAS)|Overall Study||142
8126968|NCT02863419|20032393|P2|Safety Analysis Set (SAS)|Overall Study||284
8126969|NCT02863419|20032394|P1|Safety Analysis Set (SAS)|Overall Study||285
8126970|NCT02863419|20032392|P3|Full Analysis Set (FAS)|Overall Study||142
8126971|NCT02863419|20032393|P2|Full Analysis Set (FAS)|Overall Study||284
8126972|NCT02863419|20032394|P1|Full Analysis Set (FAS)|Overall Study||285
8126973|NCT02863419|20032392|P3|STARTED|Overall Study||142
8126974|NCT02863419|20032393|P2|STARTED|Overall Study||284
8126975|NCT02863419|20032394|P1|STARTED|Overall Study||285
8126976|NCT02863328|20032511|P2|NOT COMPLETED|Overall Study||23
8126977|NCT02863328|20032512|P1|NOT COMPLETED|Overall Study||11
8126978|NCT02863328|20032511|P2|COMPLETED|Overall Study||387
8126979|NCT02863328|20032512|P1|COMPLETED|Overall Study||400
8126980|NCT02863328|20032511|P2|Safety Analysis Set (SAS)|Overall Study||409
8126981|NCT02863328|20032512|P1|Safety Analysis Set (SAS)|Overall Study||410
8126982|NCT02863328|20032511|P2|Full Analysis Set (FAS)|Overall Study||410
8126983|NCT02863328|20032512|P1|Full Analysis Set (FAS)|Overall Study||411
8126984|NCT02863328|20032511|P2|STARTED|Overall Study||410
8126985|NCT02863328|20032512|P1|STARTED|Overall Study||411
8126986|NCT02863289|20032609|P1|NOT COMPLETED|Overall Study||83
8126987|NCT02863289|20032609|P1|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
8126988|NCT02863289|20032609|P1|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
8126989|NCT02863263|20032616|P2|NOT COMPLETED|Overall Study||1
8126990|NCT02863263|20032617|P1|NOT COMPLETED|Overall Study||1
8126991|NCT02863263|20032616|P2|COMPLETED|Overall Study||1
8126992|NCT02863263|20032617|P1|COMPLETED|Overall Study||2
8126993|NCT02863263|20032616|P2|STARTED|Overall Study||2
8126994|NCT02863263|20032617|P1|STARTED|Overall Study||3
8126995|NCT02863198|20032639|P2|NOT COMPLETED|Overall Study||0
8126996|NCT02863198|20032640|P1|NOT COMPLETED|Overall Study||0
8126997|NCT02863198|20032639|P2|COMPLETED|Overall Study||60
8126998|NCT02863198|20032640|P1|COMPLETED|Overall Study||60
8126999|NCT02863198|20032639|P2|STARTED|Overall Study||60
8127000|NCT02863198|20032640|P1|STARTED|Overall Study||60
8127001|NCT02862912|20032658|P2|NOT COMPLETED|Overall Study||0
8127002|NCT02862912|20032659|P1|NOT COMPLETED|Overall Study||1
8127003|NCT02862912|20032658|P2|COMPLETED|Overall Study||20
8127004|NCT02862912|20032659|P1|COMPLETED|Overall Study||22
8127005|NCT02862912|20032658|P2|STARTED|Overall Study||20
8127006|NCT02862912|20032659|P1|STARTED|Overall Study||23
8127007|NCT02862730|20032669|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127008|NCT02862730|20032670|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127009|NCT02862730|20032671|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127010|NCT02862730|20032672|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127011|NCT02862730|20032673|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127012|NCT02862730|20032674|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127013|NCT02862730|20032675|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127014|NCT02862730|20032669|P7|COMPLETED|Fourth Intervention (84 Hours)||1
8127015|NCT02862730|20032670|P6|COMPLETED|Fourth Intervention (84 Hours)||1
8127016|NCT02862730|20032671|P5|COMPLETED|Fourth Intervention (84 Hours)||4
8127017|NCT02862730|20032672|P4|COMPLETED|Fourth Intervention (84 Hours)||4
8127018|NCT02862730|20032673|P3|COMPLETED|Fourth Intervention (84 Hours)||6
8127019|NCT02862730|20032674|P2|COMPLETED|Fourth Intervention (84 Hours)||1
8127020|NCT02862730|20032675|P1|COMPLETED|Fourth Intervention (84 Hours)||3
8127021|NCT02862730|20032669|P7|STARTED|Fourth Intervention (84 Hours)||1
8127022|NCT02862730|20032670|P6|STARTED|Fourth Intervention (84 Hours)||1
8127023|NCT02862730|20032671|P5|STARTED|Fourth Intervention (84 Hours)||4
8127024|NCT02862730|20032672|P4|STARTED|Fourth Intervention (84 Hours)||4
8127025|NCT02862730|20032673|P3|STARTED|Fourth Intervention (84 Hours)||6
8127026|NCT02862730|20032674|P2|STARTED|Fourth Intervention (84 Hours)||1
8127027|NCT02862730|20032675|P1|STARTED|Fourth Intervention (84 Hours)||3
8127028|NCT02862730|20032669|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127029|NCT02862730|20032670|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127030|NCT02862730|20032671|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127031|NCT02862730|20032672|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127032|NCT02862730|20032673|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127033|NCT02862730|20032674|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127034|NCT02862730|20032675|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127035|NCT02862730|20032669|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
8127036|NCT02862730|20032670|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
8127037|NCT02862730|20032671|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
8127038|NCT02862730|20032672|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
8127039|NCT02862730|20032673|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
8127040|NCT02862730|20032674|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
8127041|NCT02862730|20032675|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
8127042|NCT02862730|20032669|P7|STARTED|Fourth Rest Period (7-45 Days)||1
8127043|NCT02862730|20032670|P6|STARTED|Fourth Rest Period (7-45 Days)||1
8127044|NCT02862730|20032671|P5|STARTED|Fourth Rest Period (7-45 Days)||4
8127045|NCT02862730|20032672|P4|STARTED|Fourth Rest Period (7-45 Days)||4
8127046|NCT02862730|20032673|P3|STARTED|Fourth Rest Period (7-45 Days)||6
8127047|NCT02862730|20032674|P2|STARTED|Fourth Rest Period (7-45 Days)||1
8127048|NCT02862730|20032675|P1|STARTED|Fourth Rest Period (7-45 Days)||3
8127049|NCT02862730|20032669|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
8127050|NCT02862730|20032670|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
8127051|NCT02862730|20032671|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
8127052|NCT02862730|20032672|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
8127053|NCT02862730|20032673|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
8127054|NCT02862730|20032674|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
8127055|NCT02862730|20032675|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
8127056|NCT02862730|20032669|P7|COMPLETED|Third Intervention (84 Hours)||1
8127057|NCT02862730|20032670|P6|COMPLETED|Third Intervention (84 Hours)||1
8127058|NCT02862730|20032671|P5|COMPLETED|Third Intervention (84 Hours)||4
8127059|NCT02862730|20032672|P4|COMPLETED|Third Intervention (84 Hours)||4
8127060|NCT02862730|20032673|P3|COMPLETED|Third Intervention (84 Hours)||6
8127061|NCT02862730|20032674|P2|COMPLETED|Third Intervention (84 Hours)||1
8127062|NCT02862730|20032675|P1|COMPLETED|Third Intervention (84 Hours)||3
8127063|NCT02862730|20032669|P7|STARTED|Third Intervention (84 Hours)||1
8127064|NCT02862730|20032670|P6|STARTED|Third Intervention (84 Hours)||1
8127065|NCT02862730|20032671|P5|STARTED|Third Intervention (84 Hours)||4
8127066|NCT02862730|20032672|P4|STARTED|Third Intervention (84 Hours)||5
8127067|NCT02862730|20032673|P3|STARTED|Third Intervention (84 Hours)||6
8127068|NCT02862730|20032674|P2|STARTED|Third Intervention (84 Hours)||1
8127069|NCT02862730|20032675|P1|STARTED|Third Intervention (84 Hours)||3
8127070|NCT02862730|20032669|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127071|NCT02862730|20032670|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127072|NCT02862730|20032671|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
8127073|NCT02862730|20032672|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127074|NCT02862730|20032673|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
8127075|NCT02862730|20032674|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127076|NCT02862730|20032675|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127077|NCT02862730|20032669|P7|COMPLETED|Third Rest Period (7-45 Days)||1
8127078|NCT02862730|20032670|P6|COMPLETED|Third Rest Period (7-45 Days)||1
8127079|NCT02862730|20032671|P5|COMPLETED|Third Rest Period (7-45 Days)||4
8127080|NCT02862730|20032672|P4|COMPLETED|Third Rest Period (7-45 Days)||5
8127081|NCT02862730|20032673|P3|COMPLETED|Third Rest Period (7-45 Days)||6
8127082|NCT02862730|20032674|P2|COMPLETED|Third Rest Period (7-45 Days)||1
8127083|NCT02862730|20032675|P1|COMPLETED|Third Rest Period (7-45 Days)||3
8127084|NCT02862730|20032669|P7|STARTED|Third Rest Period (7-45 Days)||1
8127085|NCT02862730|20032670|P6|STARTED|Third Rest Period (7-45 Days)||1
8127086|NCT02862730|20032671|P5|STARTED|Third Rest Period (7-45 Days)||5
8127087|NCT02862730|20032672|P4|STARTED|Third Rest Period (7-45 Days)||5
8127088|NCT02862730|20032673|P3|STARTED|Third Rest Period (7-45 Days)||7
8127089|NCT02862730|20032674|P2|STARTED|Third Rest Period (7-45 Days)||1
8127090|NCT02862730|20032675|P1|STARTED|Third Rest Period (7-45 Days)||3
8127091|NCT02862730|20032669|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
8127092|NCT02862730|20032670|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
8127093|NCT02862730|20032671|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
8127094|NCT02862730|20032672|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
8127095|NCT02862730|20032673|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
8127096|NCT02862730|20032674|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
8127097|NCT02862730|20032675|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
8127098|NCT02862730|20032669|P7|COMPLETED|Second Intervention (84 Hours)||1
8127099|NCT02862730|20032670|P6|COMPLETED|Second Intervention (84 Hours)||1
8127100|NCT02862730|20032671|P5|COMPLETED|Second Intervention (84 Hours)||5
8127101|NCT02862730|20032672|P4|COMPLETED|Second Intervention (84 Hours)||5
8127102|NCT02862730|20032673|P3|COMPLETED|Second Intervention (84 Hours)||7
8127103|NCT02862730|20032674|P2|COMPLETED|Second Intervention (84 Hours)||1
8127104|NCT02862730|20032675|P1|COMPLETED|Second Intervention (84 Hours)||3
8127105|NCT02862730|20032669|P7|STARTED|Second Intervention (84 Hours)||1
8127106|NCT02862730|20032670|P6|STARTED|Second Intervention (84 Hours)||1
8127107|NCT02862730|20032671|P5|STARTED|Second Intervention (84 Hours)||5
8127108|NCT02862730|20032672|P4|STARTED|Second Intervention (84 Hours)||5
8127109|NCT02862730|20032673|P3|STARTED|Second Intervention (84 Hours)||7
8127110|NCT02862730|20032674|P2|STARTED|Second Intervention (84 Hours)||1
8127111|NCT02862730|20032675|P1|STARTED|Second Intervention (84 Hours)||4
8127112|NCT02862730|20032669|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127113|NCT02862730|20032670|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127114|NCT02862730|20032671|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127115|NCT02862730|20032672|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127116|NCT02862730|20032673|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127117|NCT02862730|20032674|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127118|NCT02862730|20032675|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127119|NCT02862730|20032669|P7|COMPLETED|Second Rest Period (7-45 Days)||1
8127120|NCT02862730|20032670|P6|COMPLETED|Second Rest Period (7-45 Days)||1
8127121|NCT02862730|20032671|P5|COMPLETED|Second Rest Period (7-45 Days)||5
8127122|NCT02862730|20032672|P4|COMPLETED|Second Rest Period (7-45 Days)||5
8127123|NCT02862730|20032673|P3|COMPLETED|Second Rest Period (7-45 Days)||7
8127124|NCT02862730|20032674|P2|COMPLETED|Second Rest Period (7-45 Days)||1
8127125|NCT02862730|20032675|P1|COMPLETED|Second Rest Period (7-45 Days)||4
8127126|NCT02862730|20032669|P7|STARTED|Second Rest Period (7-45 Days)||1
8127127|NCT02862730|20032670|P6|STARTED|Second Rest Period (7-45 Days)||1
8127128|NCT02862730|20032671|P5|STARTED|Second Rest Period (7-45 Days)||5
8127129|NCT02862730|20032672|P4|STARTED|Second Rest Period (7-45 Days)||5
8127130|NCT02862730|20032673|P3|STARTED|Second Rest Period (7-45 Days)||7
8127131|NCT02862730|20032674|P2|STARTED|Second Rest Period (7-45 Days)||1
8127132|NCT02862730|20032675|P1|STARTED|Second Rest Period (7-45 Days)||4
8127133|NCT02862730|20032669|P7|NOT COMPLETED|First Intervention (84 Hours)||0
8127134|NCT02862730|20032670|P6|NOT COMPLETED|First Intervention (84 Hours)||0
8127135|NCT02862730|20032671|P5|NOT COMPLETED|First Intervention (84 Hours)||0
8127136|NCT02862730|20032672|P4|NOT COMPLETED|First Intervention (84 Hours)||0
8127137|NCT02862730|20032673|P3|NOT COMPLETED|First Intervention (84 Hours)||0
8127138|NCT02862730|20032674|P2|NOT COMPLETED|First Intervention (84 Hours)||0
8127139|NCT02862730|20032675|P1|NOT COMPLETED|First Intervention (84 Hours)||0
8127140|NCT02862730|20032669|P7|COMPLETED|First Intervention (84 Hours)||1
8127141|NCT02862730|20032670|P6|COMPLETED|First Intervention (84 Hours)||1
8127142|NCT02862730|20032671|P5|COMPLETED|First Intervention (84 Hours)||5
8127143|NCT02862730|20032672|P4|COMPLETED|First Intervention (84 Hours)||5
8127144|NCT02862730|20032673|P3|COMPLETED|First Intervention (84 Hours)||7
8127145|NCT02862730|20032674|P2|COMPLETED|First Intervention (84 Hours)||1
8127146|NCT02862730|20032675|P1|COMPLETED|First Intervention (84 Hours)||4
8127147|NCT02862730|20032669|P7|STARTED|First Intervention (84 Hours)||1
8127148|NCT02862730|20032670|P6|STARTED|First Intervention (84 Hours)||1
8127149|NCT02862730|20032671|P5|STARTED|First Intervention (84 Hours)||5
8127150|NCT02862730|20032672|P4|STARTED|First Intervention (84 Hours)||5
8127151|NCT02862730|20032673|P3|STARTED|First Intervention (84 Hours)||7
8127152|NCT02862730|20032674|P2|STARTED|First Intervention (84 Hours)||1
8127153|NCT02862730|20032675|P1|STARTED|First Intervention (84 Hours)||4
8127154|NCT02862730|20032669|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127155|NCT02862730|20032670|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127156|NCT02862730|20032671|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127157|NCT02862730|20032672|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127158|NCT02862730|20032673|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127159|NCT02862730|20032674|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127160|NCT02862730|20032675|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127161|NCT02862730|20032669|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
8127162|NCT02862730|20032670|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
8127163|NCT02862730|20032671|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
8127164|NCT02862730|20032672|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
8127165|NCT02862730|20032673|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
8127166|NCT02862730|20032674|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
8127167|NCT02862730|20032675|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
8127168|NCT02862730|20032669|P7|STARTED|First Rest Period (1-12 Weeks)||1
8127169|NCT02862730|20032670|P6|STARTED|First Rest Period (1-12 Weeks)||1
8127170|NCT02862730|20032671|P5|STARTED|First Rest Period (1-12 Weeks)||5
8127171|NCT02862730|20032672|P4|STARTED|First Rest Period (1-12 Weeks)||5
8127172|NCT02862730|20032673|P3|STARTED|First Rest Period (1-12 Weeks)||7
8127173|NCT02862730|20032674|P2|STARTED|First Rest Period (1-12 Weeks)||1
8127174|NCT02862730|20032675|P1|STARTED|First Rest Period (1-12 Weeks)||4
8127175|NCT02862730|20032669|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127176|NCT02862730|20032670|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127177|NCT02862730|20032671|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127178|NCT02862730|20032672|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127179|NCT02862730|20032673|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
8127180|NCT02862730|20032674|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127181|NCT02862730|20032675|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127182|NCT02862730|20032669|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
8127183|NCT02862730|20032670|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
8127184|NCT02862730|20032671|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
8127185|NCT02862730|20032672|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
8127186|NCT02862730|20032673|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
8127187|NCT02862730|20032674|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
8127188|NCT02862730|20032675|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
8127189|NCT02862730|20032669|P7|STARTED|Tslim Training Visit (2 Weeks)||1
8127190|NCT02862730|20032670|P6|STARTED|Tslim Training Visit (2 Weeks)||1
8127191|NCT02862730|20032671|P5|STARTED|Tslim Training Visit (2 Weeks)||5
8127192|NCT02862730|20032672|P4|STARTED|Tslim Training Visit (2 Weeks)||5
8127193|NCT02862730|20032673|P3|STARTED|Tslim Training Visit (2 Weeks)||8
8127194|NCT02862730|20032674|P2|STARTED|Tslim Training Visit (2 Weeks)||1
8127195|NCT02862730|20032675|P1|STARTED|Tslim Training Visit (2 Weeks)||4
8127196|NCT02862600|20032730|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
8127197|NCT02862600|20032730|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
8127198|NCT02862600|20032730|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
8127199|NCT02862600|20032730|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
8127200|NCT02862600|20032730|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
8127201|NCT02862600|20032730|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
8127202|NCT02862574|20032740|P3|NOT COMPLETED|Open-Label Treatment Period||1
8127203|NCT02862574|20032741|P2|NOT COMPLETED|Open-Label Treatment Period||3
8127204|NCT02862574|20032742|P1|NOT COMPLETED|Open-Label Treatment Period||2
8127205|NCT02862574|20032740|P3|COMPLETED|Open-Label Treatment Period||0
8127206|NCT02862574|20032741|P2|COMPLETED|Open-Label Treatment Period||0
8127207|NCT02862574|20032742|P1|COMPLETED|Open-Label Treatment Period||0
8127208|NCT02862574|20032740|P3|STARTED|Open-Label Treatment Period||1
8127209|NCT02862574|20032741|P2|STARTED|Open-Label Treatment Period||3
8127210|NCT02862574|20032742|P1|STARTED|Open-Label Treatment Period||2
8127211|NCT02862574|20032740|P3|NOT COMPLETED|Double-Blind Treatment Period||4
8127212|NCT02862574|20032741|P2|NOT COMPLETED|Double-Blind Treatment Period||2
8127213|NCT02862574|20032742|P1|NOT COMPLETED|Double-Blind Treatment Period||3
8127214|NCT02862574|20032740|P3|COMPLETED|Double-Blind Treatment Period||1
8127215|NCT02862574|20032741|P2|COMPLETED|Double-Blind Treatment Period||3
8127216|NCT02862574|20032742|P1|COMPLETED|Double-Blind Treatment Period||2
8127217|NCT02862574|20032740|P3|STARTED|Double-Blind Treatment Period||5
8127218|NCT02862574|20032741|P2|STARTED|Double-Blind Treatment Period||5
8127219|NCT02862574|20032742|P1|STARTED|Double-Blind Treatment Period||5
8127220|NCT02862548|20032762|P2|NOT COMPLETED|Open-Label Extension Phase||24
8127221|NCT02862548|20032763|P1|NOT COMPLETED|Open-Label Extension Phase||26
8127222|NCT02862548|20032762|P2|COMPLETED|Open-Label Extension Phase||0
8127223|NCT02862548|20032763|P1|COMPLETED|Open-Label Extension Phase||0
8127224|NCT02862548|20032762|P2|STARTED|Open-Label Extension Phase||24
8127225|NCT02862548|20032763|P1|STARTED|Open-Label Extension Phase||26
8127226|NCT02862548|20032762|P2|NOT COMPLETED|Open-Label Phase||1
8127227|NCT02862548|20032763|P1|NOT COMPLETED|Open-Label Phase||0
8127228|NCT02862548|20032762|P2|COMPLETED|Open-Label Phase||24
8127229|NCT02862548|20032763|P1|COMPLETED|Open-Label Phase||26
8127230|NCT02862548|20032762|P2|STARTED|Open-Label Phase||25
8127231|NCT02862548|20032763|P1|STARTED|Open-Label Phase||26
8127232|NCT02862535|20032791|P4|NOT COMPLETED|Overall Study||11
8127233|NCT02862535|20032792|P3|NOT COMPLETED|Overall Study||10
8127234|NCT02862535|20032793|P2|NOT COMPLETED|Overall Study||6
8127235|NCT02862535|20032794|P1|NOT COMPLETED|Overall Study||9
8127236|NCT02862535|20032791|P4|COMPLETED|Overall Study||0
8127237|NCT02862535|20032792|P3|COMPLETED|Overall Study||0
8127238|NCT02862535|20032793|P2|COMPLETED|Overall Study||0
8127239|NCT02862535|20032794|P1|COMPLETED|Overall Study||0
8127240|NCT02862535|20032791|P4|STARTED|Overall Study||11
8127241|NCT02862535|20032792|P3|STARTED|Overall Study||10
8127242|NCT02862535|20032793|P2|STARTED|Overall Study||6
8127243|NCT02862535|20032794|P1|STARTED|Overall Study||9
8127244|NCT02862106|20032822|P2|NOT COMPLETED|Overall Study||6
8127245|NCT02862106|20032823|P1|NOT COMPLETED|Overall Study||38
8127246|NCT02862106|20032822|P2|COMPLETED|Overall Study||20
8127247|NCT02862106|20032823|P1|COMPLETED|Overall Study||145
8127248|NCT02862106|20032822|P2|STARTED|Overall Study||26
8127249|NCT02862106|20032823|P1|STARTED|Overall Study||183
8127250|NCT02862080|20032883|P4|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127251|NCT02862080|20032884|P3|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127252|NCT02862080|20032885|P2|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127253|NCT02862080|20032886|P1|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127254|NCT02862080|20032883|P4|COMPLETED|Intervention 1 Again (1 Week)||1
8127255|NCT02862080|20032884|P3|COMPLETED|Intervention 1 Again (1 Week)||1
8127256|NCT02862080|20032885|P2|COMPLETED|Intervention 1 Again (1 Week)||1
8127257|NCT02862080|20032886|P1|COMPLETED|Intervention 1 Again (1 Week)||1
8127258|NCT02862080|20032883|P4|STARTED|Intervention 1 Again (1 Week)||1
8127259|NCT02862080|20032884|P3|STARTED|Intervention 1 Again (1 Week)||1
8127260|NCT02862080|20032885|P2|STARTED|Intervention 1 Again (1 Week)||1
8127261|NCT02862080|20032886|P1|STARTED|Intervention 1 Again (1 Week)||1
8127262|NCT02862080|20032883|P4|NOT COMPLETED|Washout (1 Week)||0
8127263|NCT02862080|20032884|P3|NOT COMPLETED|Washout (1 Week)||0
8127264|NCT02862080|20032885|P2|NOT COMPLETED|Washout (1 Week)||0
8127265|NCT02862080|20032886|P1|NOT COMPLETED|Washout (1 Week)||0
8127266|NCT02862080|20032883|P4|COMPLETED|Washout (1 Week)||1
8127267|NCT02862080|20032884|P3|COMPLETED|Washout (1 Week)||1
8127268|NCT02862080|20032885|P2|COMPLETED|Washout (1 Week)||1
8127269|NCT02862080|20032886|P1|COMPLETED|Washout (1 Week)||1
8127270|NCT02862080|20032883|P4|STARTED|Washout (1 Week)||1
8127271|NCT02862080|20032884|P3|STARTED|Washout (1 Week)||1
8127272|NCT02862080|20032885|P2|STARTED|Washout (1 Week)||1
8127273|NCT02862080|20032886|P1|STARTED|Washout (1 Week)||1
8127274|NCT02862080|20032883|P4|NOT COMPLETED|Intervention 2 (1 Week)||0
8127275|NCT02862080|20032884|P3|NOT COMPLETED|Intervention 2 (1 Week)||0
8127276|NCT02862080|20032885|P2|NOT COMPLETED|Intervention 2 (1 Week)||0
8127277|NCT02862080|20032886|P1|NOT COMPLETED|Intervention 2 (1 Week)||0
8127278|NCT02862080|20032883|P4|COMPLETED|Intervention 2 (1 Week)||1
8127279|NCT02862080|20032884|P3|COMPLETED|Intervention 2 (1 Week)||1
8127280|NCT02862080|20032885|P2|COMPLETED|Intervention 2 (1 Week)||1
8127281|NCT02862080|20032886|P1|COMPLETED|Intervention 2 (1 Week)||1
8127282|NCT02862080|20032883|P4|STARTED|Intervention 2 (1 Week)||1
8127283|NCT02862080|20032884|P3|STARTED|Intervention 2 (1 Week)||1
8127284|NCT02862080|20032885|P2|STARTED|Intervention 2 (1 Week)||1
8127285|NCT02862080|20032886|P1|STARTED|Intervention 2 (1 Week)||1
8127286|NCT02862080|20032883|P4|NOT COMPLETED|Washout (1 Week)||0
8127287|NCT02862080|20032884|P3|NOT COMPLETED|Washout (1 Week)||0
8127288|NCT02862080|20032885|P2|NOT COMPLETED|Washout (1 Week)||0
8127289|NCT02862080|20032886|P1|NOT COMPLETED|Washout (1 Week)||0
8127290|NCT02862080|20032883|P4|COMPLETED|Washout (1 Week)||1
8127291|NCT02862080|20032884|P3|COMPLETED|Washout (1 Week)||1
8127292|NCT02862080|20032885|P2|COMPLETED|Washout (1 Week)||1
8127293|NCT02862080|20032886|P1|COMPLETED|Washout (1 Week)||1
8127294|NCT02862080|20032883|P4|STARTED|Washout (1 Week)||1
8127295|NCT02862080|20032884|P3|STARTED|Washout (1 Week)||1
8127296|NCT02862080|20032885|P2|STARTED|Washout (1 Week)||1
8127297|NCT02862080|20032886|P1|STARTED|Washout (1 Week)||1
8127298|NCT02862080|20032883|P4|NOT COMPLETED|Intervention 1 (1 Week)||0
8127299|NCT02862080|20032884|P3|NOT COMPLETED|Intervention 1 (1 Week)||0
8127300|NCT02862080|20032885|P2|NOT COMPLETED|Intervention 1 (1 Week)||0
8127301|NCT02862080|20032886|P1|NOT COMPLETED|Intervention 1 (1 Week)||0
8127302|NCT02862080|20032883|P4|COMPLETED|Intervention 1 (1 Week)||1
8127303|NCT02862080|20032884|P3|COMPLETED|Intervention 1 (1 Week)||1
8127304|NCT02862080|20032885|P2|COMPLETED|Intervention 1 (1 Week)||1
8127305|NCT02862080|20032886|P1|COMPLETED|Intervention 1 (1 Week)||1
8127306|NCT02862080|20032883|P4|STARTED|Intervention 1 (1 Week)||1
8127307|NCT02862080|20032884|P3|STARTED|Intervention 1 (1 Week)||1
8127308|NCT02862080|20032885|P2|STARTED|Intervention 1 (1 Week)||1
8127309|NCT02862080|20032886|P1|STARTED|Intervention 1 (1 Week)||1
8127310|NCT02862080|20032883|P4|NOT COMPLETED|3 Days Before Any Intervention||0
8127311|NCT02862080|20032884|P3|NOT COMPLETED|3 Days Before Any Intervention||0
8127312|NCT02862080|20032885|P2|NOT COMPLETED|3 Days Before Any Intervention||0
8127313|NCT02862080|20032886|P1|NOT COMPLETED|3 Days Before Any Intervention||0
8127314|NCT02862080|20032883|P4|COMPLETED|3 Days Before Any Intervention||1
8127315|NCT02862080|20032884|P3|COMPLETED|3 Days Before Any Intervention||1
8127316|NCT02862080|20032885|P2|COMPLETED|3 Days Before Any Intervention||1
8127317|NCT02862080|20032886|P1|COMPLETED|3 Days Before Any Intervention||1
8127318|NCT02862080|20032883|P4|STARTED|3 Days Before Any Intervention||1
8127319|NCT02862080|20032884|P3|STARTED|3 Days Before Any Intervention||1
8127320|NCT02862080|20032885|P2|STARTED|3 Days Before Any Intervention||1
8127321|NCT02862080|20032886|P1|STARTED|3 Days Before Any Intervention||1
8127322|NCT02862080|20032883|P4|NOT COMPLETED|7 Days Before Any Intervention||0
8127323|NCT02862080|20032884|P3|NOT COMPLETED|7 Days Before Any Intervention||0
8127324|NCT02862080|20032885|P2|NOT COMPLETED|7 Days Before Any Intervention||0
8127325|NCT02862080|20032886|P1|NOT COMPLETED|7 Days Before Any Intervention||0
8127326|NCT02862080|20032883|P4|COMPLETED|7 Days Before Any Intervention||1
8127327|NCT02862080|20032884|P3|COMPLETED|7 Days Before Any Intervention||1
8127328|NCT02862080|20032885|P2|COMPLETED|7 Days Before Any Intervention||1
8127329|NCT02862080|20032886|P1|COMPLETED|7 Days Before Any Intervention||1
8127330|NCT02862080|20032883|P4|STARTED|7 Days Before Any Intervention||1
8127331|NCT02862080|20032884|P3|STARTED|7 Days Before Any Intervention||1
8127332|NCT02862080|20032885|P2|STARTED|7 Days Before Any Intervention||1
8127333|NCT02862080|20032886|P1|STARTED|7 Days Before Any Intervention||1
8127334|NCT02861937|20032920|P3|NOT COMPLETED|Overall Study||0
8127335|NCT02861937|20032921|P2|NOT COMPLETED|Overall Study||0
8127336|NCT02861937|20032922|P1|NOT COMPLETED|Overall Study||0
8127337|NCT02861937|20032920|P3|COMPLETED|Overall Study||12
8127338|NCT02861937|20032921|P2|COMPLETED|Overall Study||12
8127339|NCT02861937|20032922|P1|COMPLETED|Overall Study||10
8127340|NCT02861937|20032920|P3|STARTED|Overall Study||12
8127341|NCT02861937|20032921|P2|STARTED|Overall Study||12
8127342|NCT02861937|20032922|P1|STARTED|Overall Study||10
8127343|NCT02861807|20032944|P2|NOT COMPLETED|Overall Study||14
8127344|NCT02861807|20032945|P1|NOT COMPLETED|Overall Study||12
8127345|NCT02861807|20032944|P2|COMPLETED|Overall Study||23
8127346|NCT02861807|20032945|P1|COMPLETED|Overall Study||35
8127347|NCT02861807|20032944|P2|Attended 2-month Follow-up|Overall Study||20
8127348|NCT02861807|20032945|P1|Attended 2-month Follow-up|Overall Study||32
8127349|NCT02861807|20032944|P2|Attended Post-treatment Assessment|Overall Study||18
8127350|NCT02861807|20032945|P1|Attended Post-treatment Assessment|Overall Study||34
8127351|NCT02861807|20032944|P2|STARTED|Overall Study||37
8127352|NCT02861807|20032945|P1|STARTED|Overall Study||47
8127353|NCT02861664|20032961|P2|NOT COMPLETED|Overall Study||1
8127354|NCT02861664|20032962|P1|NOT COMPLETED|Overall Study||0
8127355|NCT02861664|20032961|P2|COMPLETED|Overall Study||67
8127356|NCT02861664|20032962|P1|COMPLETED|Overall Study||67
8127357|NCT02861664|20032961|P2|STARTED|Overall Study||68
8127358|NCT02861664|20032962|P1|STARTED|Overall Study||67
8127359|NCT02861534|20032974|P2|NOT COMPLETED|Overall Study||587
8127360|NCT02861534|20032975|P1|NOT COMPLETED|Overall Study||574
8127361|NCT02861534|20032974|P2|COMPLETED|Overall Study||1937
8127362|NCT02861534|20032975|P1|COMPLETED|Overall Study||1952
8127363|NCT02861534|20032974|P2|Treated|Overall Study||2515
8127364|NCT02861534|20032975|P1|Treated|Overall Study||2519
8127365|NCT02861534|20032974|P2|STARTED|Overall Study||2524
8127366|NCT02861534|20032975|P1|STARTED|Overall Study||2526
8127367|NCT02861131|20033001|P2|NOT COMPLETED|Overall Study||0
8127368|NCT02861131|20033002|P1|NOT COMPLETED|Overall Study||0
8127369|NCT02861131|20033001|P2|COMPLETED|Overall Study||100
8127370|NCT02861131|20033002|P1|COMPLETED|Overall Study||100
8127371|NCT02861131|20033001|P2|STARTED|Overall Study||100
8127372|NCT02861131|20033002|P1|STARTED|Overall Study||100
8127373|NCT02861118|20033020|P2|NOT COMPLETED|Overall Study||0
8127374|NCT02861118|20033021|P1|NOT COMPLETED|Overall Study||0
8127375|NCT02861118|20033020|P2|COMPLETED|Overall Study||116
8127376|NCT02861118|20033021|P1|COMPLETED|Overall Study||194
8127377|NCT02861118|20033020|P2|STARTED|Overall Study||116
8127378|NCT02861118|20033021|P1|STARTED|Overall Study||194
8127379|NCT02860845|20033035|P2|NOT COMPLETED|Overall Study||1
8127380|NCT02860845|20033036|P1|NOT COMPLETED|Overall Study||2
8127381|NCT02860845|20033035|P2|COMPLETED|Overall Study||23
8127382|NCT02860845|20033036|P1|COMPLETED|Overall Study||22
8127383|NCT02860845|20033035|P2|Analyzed Patients|Overall Study||23
8127384|NCT02860845|20033036|P1|Analyzed Patients|Overall Study||22
8127385|NCT02860845|20033035|P2|STARTED|Overall Study||24
8127386|NCT02860845|20033036|P1|STARTED|Overall Study||24
8127387|NCT02860507|20033052|P2|NOT COMPLETED|Overall Study||0
8127388|NCT02860507|20033053|P1|NOT COMPLETED|Overall Study||0
8127389|NCT02860507|20033052|P2|COMPLETED|Overall Study||25
8127390|NCT02860507|20033053|P1|COMPLETED|Overall Study||25
8127391|NCT02860507|20033052|P2|STARTED|Overall Study||25
8127392|NCT02860507|20033053|P1|STARTED|Overall Study||25
8127393|NCT02860169|20033063|P1|NOT COMPLETED|Part C||1
8127394|NCT02860169|20033063|P1|COMPLETED|Part C||47
8127395|NCT02860169|20033063|P1|Participants With Cold and Flu|Part C||42
8127396|NCT02860169|20033063|P1|Healthy Participants|Part C||6
8127397|NCT02860169|20033063|P1|STARTED|Part C||48
8127398|NCT02860169|20033063|P1|NOT COMPLETED|Part B||11
8127399|NCT02860169|20033063|P1|COMPLETED|Part B||9
8127400|NCT02860169|20033063|P1|Participants With Cold and Flu|Part B||10
8127401|NCT02860169|20033063|P1|Healthy Participants|Part B||10
8127402|NCT02860169|20033063|P1|STARTED|Part B||20
8127403|NCT02860169|20033063|P1|NOT COMPLETED|Part A||11
8127404|NCT02860169|20033063|P1|COMPLETED|Part A||35
8127405|NCT02860169|20033063|P1|Participants With Cold and Flu|Part A||0
8127406|NCT02860169|20033063|P1|Healthy Participants|Part A||46
8127407|NCT02860169|20033063|P1|STARTED|Part A||46
8127408|NCT02860130|20033081|P2|NOT COMPLETED|Overall Study||9
8127409|NCT02860130|20033082|P1|NOT COMPLETED|Overall Study||7
8127410|NCT02860130|20033081|P2|COMPLETED|Overall Study||8
8127411|NCT02860130|20033082|P1|COMPLETED|Overall Study||10
8127412|NCT02860130|20033081|P2|STARTED|Overall Study||17
8127413|NCT02860130|20033082|P1|STARTED|Overall Study||17
8127414|NCT02859597|20033136|P2|NOT COMPLETED|Overall Study||0
8127415|NCT02859597|20033137|P1|NOT COMPLETED|Overall Study||0
8127416|NCT02859597|20033136|P2|COMPLETED|Overall Study|September 2018|19
8127417|NCT02859597|20033137|P1|COMPLETED|Overall Study|September 2018|22
8127418|NCT02859597|20033136|P2|STARTED|Overall Study|Started Dec 2016|19
8127419|NCT02859597|20033137|P1|STARTED|Overall Study|started Dec 2016|22
8127423|NCT02859441|20033158|P1|NOT COMPLETED|Overall Study||0
8127424|NCT02859441|20033158|P1|COMPLETED|Overall Study||3
8127425|NCT02859441|20033158|P1|STARTED|Overall Study||3
8127426|NCT02859246|20033203|P1|NOT COMPLETED|Overall Study||5
8127427|NCT02859246|20033203|P1|COMPLETED|Overall Study|10 subjects completed the study|10
8127428|NCT02859246|20033203|P1|STARTED|Overall Study|15 subjects were enrolled into study|15
8127429|NCT02858726|20033212|P4|NOT COMPLETED|Overall Study||3
8127430|NCT02858726|20033213|P3|NOT COMPLETED|Overall Study||11
8127431|NCT02858726|20033214|P2|NOT COMPLETED|Overall Study||7
8127432|NCT02858726|20033215|P1|NOT COMPLETED|Overall Study||5
8127433|NCT02858726|20033212|P4|COMPLETED|Overall Study||42
8127434|NCT02858726|20033213|P3|COMPLETED|Overall Study||33
8127435|NCT02858726|20033214|P2|COMPLETED|Overall Study||35
8127436|NCT02858726|20033215|P1|COMPLETED|Overall Study||39
8127437|NCT02858726|20033212|P4|STARTED|Overall Study||45
8127438|NCT02858726|20033213|P3|STARTED|Overall Study||44
8127439|NCT02858726|20033214|P2|STARTED|Overall Study||42
8127440|NCT02858726|20033215|P1|STARTED|Overall Study||44
8127441|NCT02858713|20033231|P2|NOT COMPLETED|Overall Study||5
8127442|NCT02858713|20033232|P1|NOT COMPLETED|Overall Study||7
8127443|NCT02858713|20033231|P2|COMPLETED|Overall Study||61
8127444|NCT02858713|20033232|P1|COMPLETED|Overall Study||61
8127445|NCT02858713|20033231|P2|STARTED|Overall Study||66
8127446|NCT02858713|20033232|P1|STARTED|Overall Study||68
8127447|NCT02858492|20033246|P4|NOT COMPLETED|Overall Study||6
8127448|NCT02858492|20033247|P3|NOT COMPLETED|Overall Study||0
8127449|NCT02858492|20033248|P2|NOT COMPLETED|Overall Study||1
8127450|NCT02858492|20033249|P1|NOT COMPLETED|Overall Study||0
8127451|NCT02858492|20033246|P4|COMPLETED|Overall Study||22
8127452|NCT02858492|20033247|P3|COMPLETED|Overall Study||5
8127453|NCT02858492|20033248|P2|COMPLETED|Overall Study||14
8127454|NCT02858492|20033249|P1|COMPLETED|Overall Study||3
8127455|NCT02858492|20033246|P4|STARTED|Overall Study||28
8127456|NCT02858492|20033247|P3|STARTED|Overall Study||5
8127457|NCT02858492|20033248|P2|STARTED|Overall Study||15
8127458|NCT02858492|20033249|P1|STARTED|Overall Study||3
8127459|NCT02858440|20033425|P1|NOT COMPLETED|Overall Study||12
8127460|NCT02858440|20033425|P1|COMPLETED|Overall Study||223
8127461|NCT02858440|20033425|P1|STARTED|Overall Study||235
8127462|NCT02858401|20033458|P7|NOT COMPLETED|Overall Study||0
8127463|NCT02858401|20033459|P6|NOT COMPLETED|Overall Study||1
8127464|NCT02858401|20033460|P5|NOT COMPLETED|Overall Study||0
8127465|NCT02858401|20033461|P4|NOT COMPLETED|Overall Study||0
8127466|NCT02858401|20033462|P3|NOT COMPLETED|Overall Study||0
8127467|NCT02858401|20033463|P2|NOT COMPLETED|Overall Study||1
8127468|NCT02858401|20033464|P1|NOT COMPLETED|Overall Study||0
8127469|NCT02858401|20033458|P7|COMPLETED|Overall Study||12
8127470|NCT02858401|20033459|P6|COMPLETED|Overall Study||5
8127471|NCT02858401|20033460|P5|COMPLETED|Overall Study||6
8127472|NCT02858401|20033461|P4|COMPLETED|Overall Study||6
8127473|NCT02858401|20033462|P3|COMPLETED|Overall Study||6
8127474|NCT02858401|20033463|P2|COMPLETED|Overall Study||5
8127475|NCT02858401|20033464|P1|COMPLETED|Overall Study||6
8127476|NCT02858401|20033458|P7|STARTED|Overall Study||12
8127477|NCT02858401|20033459|P6|STARTED|Overall Study||6
8127478|NCT02858401|20033460|P5|STARTED|Overall Study||6
8127479|NCT02858401|20033461|P4|STARTED|Overall Study||6
8127480|NCT02858401|20033462|P3|STARTED|Overall Study||6
8127481|NCT02858401|20033463|P2|STARTED|Overall Study||6
8127482|NCT02858401|20033464|P1|STARTED|Overall Study||6
8127483|NCT02858362|20033875|P3|NOT COMPLETED|Overall Study||3
8127484|NCT02858362|20033876|P2|NOT COMPLETED|Overall Study||1
8127485|NCT02858362|20033877|P1|NOT COMPLETED|Overall Study||2
8127486|NCT02858362|20033875|P3|COMPLETED|Overall Study||0
8127487|NCT02858362|20033876|P2|COMPLETED|Overall Study||9
8127488|NCT02858362|20033877|P1|COMPLETED|Overall Study||28
8127489|NCT02858362|20033875|P3|Did Not Enter Extension Phase|Overall Study||0
8127490|NCT02858362|20033876|P2|Did Not Enter Extension Phase|Overall Study||2
8127491|NCT02858362|20033877|P1|Did Not Enter Extension Phase|Overall Study||1
8127492|NCT02858362|20033875|P3|STARTED|Overall Study||3
8127493|NCT02858362|20033876|P2|STARTED|Overall Study||10
8127494|NCT02858362|20033877|P1|STARTED|Overall Study||30
8127495|NCT02858349|20033912|P1|NOT COMPLETED|Overall Study||0
8127496|NCT02858349|20033912|P1|COMPLETED|Overall Study||10
8127497|NCT02858349|20033912|P1|STARTED|Overall Study||10
8127498|NCT02858180|20033918|P2|NOT COMPLETED|Overall Study||2
8127499|NCT02858180|20033919|P1|NOT COMPLETED|Overall Study||0
8127500|NCT02858180|20033918|P2|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
8127501|NCT02858180|20033919|P1|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
8127502|NCT02858180|20033918|P2|STARTED|Overall Study||5
8127503|NCT02858180|20033919|P1|STARTED|Overall Study||10
8127504|NCT02858076|20033933|P2|NOT COMPLETED|Overall Study||18
8127505|NCT02858076|20033934|P1|NOT COMPLETED|Overall Study||10
8127506|NCT02858076|20033933|P2|COMPLETED|Overall Study||87
8127507|NCT02858076|20033934|P1|COMPLETED|Overall Study||90
8127508|NCT02858076|20033933|P2|STARTED|Overall Study||105
8127509|NCT02858076|20033934|P1|STARTED|Overall Study||100
8127510|NCT02858050|20033972|P2|NOT COMPLETED|Overall Study||0
8127511|NCT02858050|20033973|P1|NOT COMPLETED|Overall Study||0
8127512|NCT02858050|20033972|P2|COMPLETED|Overall Study||20
8127513|NCT02858050|20033973|P1|COMPLETED|Overall Study||20
8127514|NCT02858050|20033972|P2|STARTED|Overall Study||20
8127515|NCT02858050|20033973|P1|STARTED|Overall Study||20
8127516|NCT02857816|20033979|P1|NOT COMPLETED|Overall Study||38
8127517|NCT02857816|20033979|P1|COMPLETED|Overall Study||116
8127518|NCT02857816|20033979|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
8127519|NCT02857816|20033979|P1|STARTED|Overall Study||154
8127520|NCT02857426|20033987|P2|NOT COMPLETED|Follow-up||6
8127521|NCT02857426|20033988|P1|NOT COMPLETED|Follow-up||10
8127522|NCT02857426|20033987|P2|COMPLETED|Follow-up||13
8127523|NCT02857426|20033988|P1|COMPLETED|Follow-up||37
8127524|NCT02857426|20033987|P2|STARTED|Follow-up||19
8127525|NCT02857426|20033988|P1|STARTED|Follow-up||47
8127526|NCT02857426|20033987|P2|NOT COMPLETED|Treatment||17
8127527|NCT02857426|20033988|P1|NOT COMPLETED|Treatment||46
8127528|NCT02857426|20033987|P2|COMPLETED|Treatment||2
8127529|NCT02857426|20033988|P1|COMPLETED|Treatment||1
8127530|NCT02857426|20033987|P2|STARTED|Treatment||19
8127531|NCT02857426|20033988|P1|STARTED|Treatment||47
8127532|NCT02857283|20034004|P2|NOT COMPLETED|Second Exposure||0
8127533|NCT02857283|20034005|P1|NOT COMPLETED|Second Exposure||0
8127534|NCT02857283|20034004|P2|COMPLETED|Second Exposure||7
8127535|NCT02857283|20034005|P1|COMPLETED|Second Exposure||7
8127536|NCT02857283|20034004|P2|STARTED|Second Exposure||7
8127537|NCT02857283|20034005|P1|STARTED|Second Exposure||7
8127538|NCT02857283|20034004|P2|NOT COMPLETED|Washout (2 Weeks)||0
8127539|NCT02857283|20034005|P1|NOT COMPLETED|Washout (2 Weeks)||0
8127540|NCT02857283|20034004|P2|COMPLETED|Washout (2 Weeks)||7
8127541|NCT02857283|20034005|P1|COMPLETED|Washout (2 Weeks)||7
8127542|NCT02857283|20034004|P2|STARTED|Washout (2 Weeks)||7
8127543|NCT02857283|20034005|P1|STARTED|Washout (2 Weeks)||7
8127544|NCT02857283|20034004|P2|NOT COMPLETED|First Exposure||0
8127545|NCT02857283|20034005|P1|NOT COMPLETED|First Exposure||1
8127546|NCT02857283|20034004|P2|COMPLETED|First Exposure||7
8127547|NCT02857283|20034005|P1|COMPLETED|First Exposure||7
8127548|NCT02857283|20034004|P2|STARTED|First Exposure||7
8127549|NCT02857283|20034005|P1|STARTED|First Exposure||8
8127550|NCT02856880|20034039|P1|NOT COMPLETED|Overall Study||1
8127551|NCT02856880|20034039|P1|COMPLETED|Overall Study||44
8127552|NCT02856880|20034039|P1|Received SLS Negative Control|Overall Study||44
8127553|NCT02856880|20034039|P1|Received Non-SLS Negative Control|Overall Study||44
8127554|NCT02856880|20034039|P1|Received Positive Control|Overall Study||45
8127555|NCT02856880|20034039|P1|Received Test Zinc Non-IPMP|Overall Study||44
8127556|NCT02856880|20034039|P1|Received Test Zinc-IPMP|Overall Study||44
8127557|NCT02856880|20034039|P1|STARTED|Overall Study||45
8127558|NCT02856828|20034065|P2|NOT COMPLETED|Overall Study||0
8127559|NCT02856828|20034066|P1|NOT COMPLETED|Overall Study||0
8127560|NCT02856828|20034065|P2|COMPLETED|Overall Study||3
8127561|NCT02856828|20034066|P1|COMPLETED|Overall Study||2
8127562|NCT02856828|20034065|P2|STARTED|Overall Study||3
8127563|NCT02856828|20034066|P1|STARTED|Overall Study||2
8127564|NCT02856555|20034083|P3|NOT COMPLETED|Overall Study||0
8127565|NCT02856555|20034084|P2|NOT COMPLETED|Overall Study||4
8127566|NCT02856555|20034085|P1|NOT COMPLETED|Overall Study||5
8127567|NCT02856555|20034083|P3|COMPLETED|Overall Study||26
8127568|NCT02856555|20034084|P2|COMPLETED|Overall Study||46
8127569|NCT02856555|20034085|P1|COMPLETED|Overall Study||46
8127570|NCT02856555|20034083|P3|STARTED|Overall Study||26
8127571|NCT02856555|20034084|P2|STARTED|Overall Study||50
8127572|NCT02856555|20034085|P1|STARTED|Overall Study||51
8127573|NCT02856282|20034093|P1|NOT COMPLETED|Overall Study||1
8127574|NCT02856282|20034093|P1|COMPLETED|Overall Study||45
8127575|NCT02856282|20034093|P1|STARTED|Overall Study||46
8127576|NCT02856035|20034103|P1|NOT COMPLETED|Overall Study||0
8127577|NCT02856035|20034103|P1|COMPLETED|Overall Study||4
8127578|NCT02856035|20034103|P1|STARTED|Overall Study||4
8127579|NCT02855567|20034110|P2|NOT COMPLETED|Overall Study||0
8127580|NCT02855567|20034111|P1|NOT COMPLETED|Overall Study||0
8127581|NCT02855567|20034110|P2|COMPLETED|Overall Study||56
8127582|NCT02855567|20034111|P1|COMPLETED|Overall Study||54
8127583|NCT02855567|20034110|P2|STARTED|Overall Study||56
8127584|NCT02855567|20034111|P1|STARTED|Overall Study||54
8127585|NCT02855541|20034125|P1|NOT COMPLETED|Overall Study||4
8127586|NCT02855541|20034125|P1|COMPLETED|Overall Study||21
8127587|NCT02855541|20034125|P1|STARTED|Overall Study||25
8127588|NCT02855450|20034138|P2|NOT COMPLETED|Overall Study||0
8127589|NCT02855450|20034139|P1|NOT COMPLETED|Overall Study||5
8127590|NCT02855450|20034138|P2|COMPLETED|Overall Study||20
8127591|NCT02855450|20034139|P1|COMPLETED|Overall Study||35
8127592|NCT02855450|20034138|P2|STARTED|Overall Study||20
8127593|NCT02855450|20034139|P1|STARTED|Overall Study||40
8127594|NCT02855437|20034147|P2|NOT COMPLETED|Phase 2||1
8127595|NCT02855437|20034148|P1|NOT COMPLETED|Phase 2||1
8127596|NCT02855437|20034147|P2|COMPLETED|Phase 2||18
8127597|NCT02855437|20034148|P1|COMPLETED|Phase 2||20
8127598|NCT02855437|20034147|P2|STARTED|Phase 2||19
8127599|NCT02855437|20034148|P1|STARTED|Phase 2||21
8127600|NCT02855437|20034147|P2|NOT COMPLETED|Crossover Period (Same Day)||0
8127601|NCT02855437|20034148|P1|NOT COMPLETED|Crossover Period (Same Day)||0
8127602|NCT02855437|20034147|P2|COMPLETED|Crossover Period (Same Day)||19
8127603|NCT02855437|20034148|P1|COMPLETED|Crossover Period (Same Day)||21
8127604|NCT02855437|20034147|P2|STARTED|Crossover Period (Same Day)||19
8127605|NCT02855437|20034148|P1|STARTED|Crossover Period (Same Day)||21
8127606|NCT02855437|20034147|P2|NOT COMPLETED|Phase 1||2
8127607|NCT02855437|20034148|P1|NOT COMPLETED|Phase 1||2
8127608|NCT02855437|20034147|P2|COMPLETED|Phase 1||19
8127609|NCT02855437|20034148|P1|COMPLETED|Phase 1||21
8127610|NCT02855437|20034147|P2|STARTED|Phase 1||21
8127611|NCT02855437|20034148|P1|STARTED|Phase 1||23
8127612|NCT02855411|20034156|P1|NOT COMPLETED|Overall Study||35
8127613|NCT02855411|20034156|P1|COMPLETED|Overall Study||0
8127614|NCT02855411|20034156|P1|Assigned to Study Treatment|Overall Study||0
8127615|NCT02855411|20034156|P1|STARTED|Overall Study||35
8127616|NCT02855359|20034178|P4|NOT COMPLETED|Overall Study||0
8127617|NCT02855359|20034179|P3|NOT COMPLETED|Overall Study||0
8127618|NCT02855359|20034180|P2|NOT COMPLETED|Overall Study||13
8127619|NCT02855359|20034181|P1|NOT COMPLETED|Overall Study||11
8127620|NCT02855359|20034178|P4|COMPLETED|Overall Study||0
8127621|NCT02855359|20034179|P3|COMPLETED|Overall Study||0
8127622|NCT02855359|20034180|P2|COMPLETED|Overall Study||0
8127623|NCT02855359|20034181|P1|COMPLETED|Overall Study||0
8127624|NCT02855359|20034178|P4|STARTED|Overall Study||0
8127625|NCT02855359|20034179|P3|STARTED|Overall Study||0
8127626|NCT02855359|20034180|P2|STARTED|Overall Study||13
8127627|NCT02855359|20034181|P1|STARTED|Overall Study||11
8127628|NCT02855086|20034215|P2|NOT COMPLETED|Overall Study||0
8127629|NCT02855086|20034216|P1|NOT COMPLETED|Overall Study||0
8127630|NCT02855086|20034215|P2|COMPLETED|Overall Study||1
8127631|NCT02855086|20034216|P1|COMPLETED|Overall Study||2
8127632|NCT02855086|20034215|P2|STARTED|Overall Study||1
8127633|NCT02855086|20034216|P1|STARTED|Overall Study||2
8127634|NCT02854800|20034227|P3|NOT COMPLETED|Overall Study||6
8127635|NCT02854800|20034228|P2|NOT COMPLETED|Overall Study||13
8127636|NCT02854800|20034229|P1|NOT COMPLETED|Overall Study||20
8127637|NCT02854800|20034227|P3|COMPLETED|Overall Study||8
8127638|NCT02854800|20034228|P2|COMPLETED|Overall Study||15
8127639|NCT02854800|20034229|P1|COMPLETED|Overall Study||12
8127640|NCT02854800|20034227|P3|STARTED|Overall Study||14
8127641|NCT02854800|20034228|P2|STARTED|Overall Study||28
8127642|NCT02854800|20034229|P1|STARTED|Overall Study||32
8127643|NCT02854631|20034269|P2|NOT COMPLETED|Overall Study||15
8127644|NCT02854631|20034270|P1|NOT COMPLETED|Overall Study||26
8127645|NCT02854631|20034269|P2|COMPLETED|Overall Study||37
8127646|NCT02854631|20034270|P1|COMPLETED|Overall Study||26
8127647|NCT02854631|20034269|P2|STARTED|Overall Study||52
8127648|NCT02854631|20034270|P1|STARTED|Overall Study||52
8127649|NCT02854605|20034331|P3|NOT COMPLETED|Overall Study||4
8127650|NCT02854605|20034332|P2|NOT COMPLETED|Overall Study||7
8127651|NCT02854605|20034333|P1|NOT COMPLETED|Overall Study||3
8127652|NCT02854605|20034331|P3|COMPLETED|Overall Study||24
8127653|NCT02854605|20034332|P2|COMPLETED|Overall Study||49
8127654|NCT02854605|20034333|P1|COMPLETED|Overall Study||53
8127655|NCT02854605|20034331|P3|STARTED|Overall Study||28
8127656|NCT02854605|20034332|P2|STARTED|Overall Study||56
8127657|NCT02854605|20034333|P1|STARTED|Overall Study||56
8127658|NCT02854540|20034344|P1|NOT COMPLETED|Overall Study||2
8127659|NCT02854540|20034344|P1|COMPLETED|Overall Study||11
8127660|NCT02854540|20034344|P1|STARTED|Overall Study||13
8127661|NCT02854527|20034363|P10|NOT COMPLETED|Overall Study||0
8127662|NCT02854527|20034364|P9|NOT COMPLETED|Overall Study||0
8127663|NCT02854527|20034365|P8|NOT COMPLETED|Overall Study||0
8127664|NCT02854527|20034366|P7|NOT COMPLETED|Overall Study||0
8127665|NCT02854527|20034367|P6|NOT COMPLETED|Overall Study||0
8127666|NCT02854527|20034368|P5|NOT COMPLETED|Overall Study||1
8127667|NCT02854527|20034369|P4|NOT COMPLETED|Overall Study||1
8127668|NCT02854527|20034370|P3|NOT COMPLETED|Overall Study||0
8127669|NCT02854527|20034371|P2|NOT COMPLETED|Overall Study||0
8127670|NCT02854527|20034372|P1|NOT COMPLETED|Overall Study||0
8127671|NCT02854527|20034363|P10|COMPLETED|Overall Study||3
8127672|NCT02854527|20034364|P9|COMPLETED|Overall Study||3
8127673|NCT02854527|20034365|P8|COMPLETED|Overall Study||3
8127674|NCT02854527|20034366|P7|COMPLETED|Overall Study||3
8127675|NCT02854527|20034367|P6|COMPLETED|Overall Study||3
8127676|NCT02854527|20034368|P5|COMPLETED|Overall Study||2
8127677|NCT02854527|20034369|P4|COMPLETED|Overall Study||2
8127678|NCT02854527|20034370|P3|COMPLETED|Overall Study||3
8127679|NCT02854527|20034371|P2|COMPLETED|Overall Study||3
8127680|NCT02854527|20034372|P1|COMPLETED|Overall Study||3
8127681|NCT02854527|20034363|P10|Received T|Overall Study||3
8127682|NCT02854527|20034364|P9|Received T|Overall Study||3
8127683|NCT02854527|20034365|P8|Received T|Overall Study||3
8127684|NCT02854527|20034366|P7|Received T|Overall Study||3
8127685|NCT02854527|20034367|P6|Received T|Overall Study||3
8127686|NCT02854527|20034368|P5|Received T|Overall Study||2
8127687|NCT02854527|20034369|P4|Received T|Overall Study||2
8127688|NCT02854527|20034370|P3|Received T|Overall Study||3
8127689|NCT02854527|20034371|P2|Received T|Overall Study||3
8127690|NCT02854527|20034372|P1|Received T|Overall Study||3
8127691|NCT02854527|20034363|P10|Received R4|Overall Study||3
8127692|NCT02854527|20034364|P9|Received R4|Overall Study||3
8127693|NCT02854527|20034365|P8|Received R4|Overall Study||3
8127694|NCT02854527|20034366|P7|Received R4|Overall Study||3
8127695|NCT02854527|20034367|P6|Received R4|Overall Study||3
8127696|NCT02854527|20034368|P5|Received R4|Overall Study||3
8127697|NCT02854527|20034369|P4|Received R4|Overall Study||2
8127698|NCT02854527|20034370|P3|Received R4|Overall Study||3
8127699|NCT02854527|20034371|P2|Received R4|Overall Study||3
8127700|NCT02854527|20034372|P1|Received R4|Overall Study||3
8127701|NCT02854527|20034363|P10|Received R3|Overall Study||3
8127702|NCT02854527|20034364|P9|Received R3|Overall Study||3
8127703|NCT02854527|20034365|P8|Received R3|Overall Study||3
8127704|NCT02854527|20034366|P7|Received R3|Overall Study||3
8127705|NCT02854527|20034367|P6|Received R3|Overall Study||3
8127706|NCT02854527|20034368|P5|Received R3|Overall Study||3
8127707|NCT02854527|20034369|P4|Received R3|Overall Study||2
8127708|NCT02854527|20034370|P3|Received R3|Overall Study||3
8127709|NCT02854527|20034371|P2|Received R3|Overall Study||3
8127710|NCT02854527|20034372|P1|Received R3|Overall Study||3
8127711|NCT02854527|20034363|P10|Received R2|Overall Study||3
8127712|NCT02854527|20034364|P9|Received R2|Overall Study||3
8127713|NCT02854527|20034365|P8|Received R2|Overall Study||3
8127714|NCT02854527|20034366|P7|Received R2|Overall Study||3
8127715|NCT02854527|20034367|P6|Received R2|Overall Study||3
8127716|NCT02854527|20034368|P5|Received R2|Overall Study||3
8127717|NCT02854527|20034369|P4|Received R2|Overall Study||3
8127718|NCT02854527|20034370|P3|Received R2|Overall Study||3
8127719|NCT02854527|20034371|P2|Received R2|Overall Study||3
8127720|NCT02854527|20034372|P1|Received R2|Overall Study||3
8127721|NCT02854527|20034363|P10|Received R1|Overall Study||3
8127722|NCT02854527|20034364|P9|Received R1|Overall Study||3
8127723|NCT02854527|20034365|P8|Received R1|Overall Study||3
8127724|NCT02854527|20034366|P7|Received R1|Overall Study||3
8127725|NCT02854527|20034367|P6|Received R1|Overall Study||3
8127726|NCT02854527|20034368|P5|Received R1|Overall Study||2
8127727|NCT02854527|20034369|P4|Received R1|Overall Study||2
8127728|NCT02854527|20034370|P3|Received R1|Overall Study||3
8127729|NCT02854527|20034371|P2|Received R1|Overall Study||3
8127730|NCT02854527|20034372|P1|Received R1|Overall Study||3
8127731|NCT02854527|20034363|P10|STARTED|Overall Study||3
8127732|NCT02854527|20034364|P9|STARTED|Overall Study||3
8127733|NCT02854527|20034365|P8|STARTED|Overall Study||3
8127734|NCT02854527|20034366|P7|STARTED|Overall Study||3
8127735|NCT02854527|20034367|P6|STARTED|Overall Study||3
8127736|NCT02854527|20034368|P5|STARTED|Overall Study||3
8127737|NCT02854527|20034369|P4|STARTED|Overall Study||3
8127738|NCT02854527|20034370|P3|STARTED|Overall Study||3
8127739|NCT02854527|20034371|P2|STARTED|Overall Study||3
8127740|NCT02854527|20034372|P1|STARTED|Overall Study||3
8127741|NCT02854059|20034405|P2|NOT COMPLETED|Overall Study||0
8127742|NCT02854059|20034406|P1|NOT COMPLETED|Overall Study||0
8127743|NCT02854059|20034405|P2|COMPLETED|Overall Study||0
8127744|NCT02854059|20034406|P1|COMPLETED|Overall Study||2
8127745|NCT02854059|20034405|P2|STARTED|Overall Study||0
8127746|NCT02854059|20034406|P1|STARTED|Overall Study||2
8127747|NCT02853929|20034430|P2|NOT COMPLETED|Overall Study||4
8127748|NCT02853929|20034431|P1|NOT COMPLETED|Overall Study||11
8127749|NCT02853929|20034430|P2|COMPLETED|Overall Study||277
8127750|NCT02853929|20034431|P1|COMPLETED|Overall Study||259
8127751|NCT02853929|20034430|P2|Vaccinated|Overall Study||277
8127752|NCT02853929|20034431|P1|Vaccinated|Overall Study||263
8127753|NCT02853929|20034430|P2|STARTED|Overall Study||281
8127754|NCT02853929|20034431|P1|STARTED|Overall Study||270
8127755|NCT02853760|20034469|P6|NOT COMPLETED|Third Intervention (3 Hours)||0
8127756|NCT02853760|20034470|P5|NOT COMPLETED|Third Intervention (3 Hours)||0
8127757|NCT02853760|20034471|P4|NOT COMPLETED|Third Intervention (3 Hours)||0
8127758|NCT02853760|20034472|P3|NOT COMPLETED|Third Intervention (3 Hours)||0
8127759|NCT02853760|20034473|P2|NOT COMPLETED|Third Intervention (3 Hours)||0
8127760|NCT02853760|20034474|P1|NOT COMPLETED|Third Intervention (3 Hours)||0
8127761|NCT02853760|20034469|P6|COMPLETED|Third Intervention (3 Hours)||5
8127762|NCT02853760|20034470|P5|COMPLETED|Third Intervention (3 Hours)||8
8127763|NCT02853760|20034471|P4|COMPLETED|Third Intervention (3 Hours)||6
8127764|NCT02853760|20034472|P3|COMPLETED|Third Intervention (3 Hours)||6
8127765|NCT02853760|20034473|P2|COMPLETED|Third Intervention (3 Hours)||10
8127766|NCT02853760|20034474|P1|COMPLETED|Third Intervention (3 Hours)||7
8127767|NCT02853760|20034469|P6|STARTED|Third Intervention (3 Hours)||5
8127768|NCT02853760|20034470|P5|STARTED|Third Intervention (3 Hours)||8
8127769|NCT02853760|20034471|P4|STARTED|Third Intervention (3 Hours)||6
8127770|NCT02853760|20034472|P3|STARTED|Third Intervention (3 Hours)||6
8127771|NCT02853760|20034473|P2|STARTED|Third Intervention (3 Hours)||10
8127772|NCT02853760|20034474|P1|STARTED|Third Intervention (3 Hours)||7
8127773|NCT02853760|20034469|P6|NOT COMPLETED|Washout (1 Week)||0
8127774|NCT02853760|20034470|P5|NOT COMPLETED|Washout (1 Week)||0
8127775|NCT02853760|20034471|P4|NOT COMPLETED|Washout (1 Week)||0
8127776|NCT02853760|20034472|P3|NOT COMPLETED|Washout (1 Week)||0
8127777|NCT02853760|20034473|P2|NOT COMPLETED|Washout (1 Week)||0
8127778|NCT02853760|20034474|P1|NOT COMPLETED|Washout (1 Week)||0
8127779|NCT02853760|20034469|P6|COMPLETED|Washout (1 Week)||5
8127780|NCT02853760|20034470|P5|COMPLETED|Washout (1 Week)||8
8127781|NCT02853760|20034471|P4|COMPLETED|Washout (1 Week)||6
8127782|NCT02853760|20034472|P3|COMPLETED|Washout (1 Week)||6
8127783|NCT02853760|20034473|P2|COMPLETED|Washout (1 Week)||10
8127784|NCT02853760|20034474|P1|COMPLETED|Washout (1 Week)||7
8127785|NCT02853760|20034469|P6|STARTED|Washout (1 Week)||5
8127786|NCT02853760|20034470|P5|STARTED|Washout (1 Week)||8
8127787|NCT02853760|20034471|P4|STARTED|Washout (1 Week)||6
8127788|NCT02853760|20034472|P3|STARTED|Washout (1 Week)||6
8127789|NCT02853760|20034473|P2|STARTED|Washout (1 Week)||10
8127790|NCT02853760|20034474|P1|STARTED|Washout (1 Week)||7
8127791|NCT02853760|20034469|P6|NOT COMPLETED|Second Intervention (3 Hours)||0
8127792|NCT02853760|20034470|P5|NOT COMPLETED|Second Intervention (3 Hours)||0
8127793|NCT02853760|20034471|P4|NOT COMPLETED|Second Intervention (3 Hours)||0
8127794|NCT02853760|20034472|P3|NOT COMPLETED|Second Intervention (3 Hours)||0
8127795|NCT02853760|20034473|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
8127796|NCT02853760|20034474|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
8127797|NCT02853760|20034469|P6|COMPLETED|Second Intervention (3 Hours)||5
8127798|NCT02853760|20034470|P5|COMPLETED|Second Intervention (3 Hours)||8
8127799|NCT02853760|20034471|P4|COMPLETED|Second Intervention (3 Hours)||6
8127800|NCT02853760|20034472|P3|COMPLETED|Second Intervention (3 Hours)||6
8127801|NCT02853760|20034473|P2|COMPLETED|Second Intervention (3 Hours)||10
8127802|NCT02853760|20034474|P1|COMPLETED|Second Intervention (3 Hours)||7
8127803|NCT02853760|20034469|P6|STARTED|Second Intervention (3 Hours)||5
8127804|NCT02853760|20034470|P5|STARTED|Second Intervention (3 Hours)||8
8127805|NCT02853760|20034471|P4|STARTED|Second Intervention (3 Hours)||6
8127806|NCT02853760|20034472|P3|STARTED|Second Intervention (3 Hours)||6
8127807|NCT02853760|20034473|P2|STARTED|Second Intervention (3 Hours)||10
8127808|NCT02853760|20034474|P1|STARTED|Second Intervention (3 Hours)||7
8127809|NCT02853760|20034469|P6|NOT COMPLETED|Washout (1 Week)||2
8127810|NCT02853760|20034470|P5|NOT COMPLETED|Washout (1 Week)||0
8127811|NCT02853760|20034471|P4|NOT COMPLETED|Washout (1 Week)||2
8127812|NCT02853760|20034472|P3|NOT COMPLETED|Washout (1 Week)||1
8127813|NCT02853760|20034473|P2|NOT COMPLETED|Washout (1 Week)||0
8127814|NCT02853760|20034474|P1|NOT COMPLETED|Washout (1 Week)||0
8127815|NCT02853760|20034469|P6|COMPLETED|Washout (1 Week)||5
8127816|NCT02853760|20034470|P5|COMPLETED|Washout (1 Week)||8
8127817|NCT02853760|20034471|P4|COMPLETED|Washout (1 Week)||6
8127818|NCT02853760|20034472|P3|COMPLETED|Washout (1 Week)||6
8127819|NCT02853760|20034473|P2|COMPLETED|Washout (1 Week)||10
8127820|NCT02853760|20034474|P1|COMPLETED|Washout (1 Week)||7
8127821|NCT02853760|20034469|P6|STARTED|Washout (1 Week)||7
8127822|NCT02853760|20034470|P5|STARTED|Washout (1 Week)||8
8127823|NCT02853760|20034471|P4|STARTED|Washout (1 Week)||8
8127824|NCT02853760|20034472|P3|STARTED|Washout (1 Week)||7
8127825|NCT02853760|20034473|P2|STARTED|Washout (1 Week)||10
8127826|NCT02853760|20034474|P1|STARTED|Washout (1 Week)||7
8127827|NCT02853760|20034469|P6|NOT COMPLETED|First Intervention (3 Hours)||0
8127828|NCT02853760|20034470|P5|NOT COMPLETED|First Intervention (3 Hours)||0
8127829|NCT02853760|20034471|P4|NOT COMPLETED|First Intervention (3 Hours)||0
8127830|NCT02853760|20034472|P3|NOT COMPLETED|First Intervention (3 Hours)||0
8127831|NCT02853760|20034473|P2|NOT COMPLETED|First Intervention (3 Hours)||0
8127832|NCT02853760|20034474|P1|NOT COMPLETED|First Intervention (3 Hours)||0
8127833|NCT02853760|20034469|P6|COMPLETED|First Intervention (3 Hours)||7
8127834|NCT02853760|20034470|P5|COMPLETED|First Intervention (3 Hours)||8
8127835|NCT02853760|20034471|P4|COMPLETED|First Intervention (3 Hours)||8
8127836|NCT02853760|20034472|P3|COMPLETED|First Intervention (3 Hours)||7
8127837|NCT02853760|20034473|P2|COMPLETED|First Intervention (3 Hours)||10
8127838|NCT02853760|20034474|P1|COMPLETED|First Intervention (3 Hours)||7
8127839|NCT02853760|20034469|P6|STARTED|First Intervention (3 Hours)||7
8127840|NCT02853760|20034470|P5|STARTED|First Intervention (3 Hours)||8
8127841|NCT02853760|20034471|P4|STARTED|First Intervention (3 Hours)||8
8127842|NCT02853760|20034472|P3|STARTED|First Intervention (3 Hours)||7
8127843|NCT02853760|20034473|P2|STARTED|First Intervention (3 Hours)||10
8127844|NCT02853760|20034474|P1|STARTED|First Intervention (3 Hours)||7
8127845|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127846|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127847|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127848|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127849|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127850|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127851|NCT02853435|20034500|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
8127852|NCT02853435|20034501|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
8127853|NCT02853435|20034502|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
8127854|NCT02853435|20034503|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
8127855|NCT02853435|20034504|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
8127856|NCT02853435|20034505|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
8127857|NCT02853435|20034500|P6|STARTED|Part 3, Period 3 (3 Days)||2
8127858|NCT02853435|20034501|P5|STARTED|Part 3, Period 3 (3 Days)||9
8127859|NCT02853435|20034502|P4|STARTED|Part 3, Period 3 (3 Days)||0
8127860|NCT02853435|20034503|P3|STARTED|Part 3, Period 3 (3 Days)||0
8127861|NCT02853435|20034504|P2|STARTED|Part 3, Period 3 (3 Days)||0
8127862|NCT02853435|20034505|P1|STARTED|Part 3, Period 3 (3 Days)||0
8127863|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127864|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
8127865|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127866|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127867|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127868|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127869|NCT02853435|20034500|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
8127870|NCT02853435|20034501|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
8127871|NCT02853435|20034502|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127872|NCT02853435|20034503|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127873|NCT02853435|20034504|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127874|NCT02853435|20034505|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127875|NCT02853435|20034500|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
8127876|NCT02853435|20034501|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
8127877|NCT02853435|20034502|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127878|NCT02853435|20034503|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127879|NCT02853435|20034504|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127880|NCT02853435|20034505|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127881|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127882|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127883|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127884|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127885|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127886|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127887|NCT02853435|20034500|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
8127888|NCT02853435|20034501|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
8127889|NCT02853435|20034502|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
8127890|NCT02853435|20034503|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
8127891|NCT02853435|20034504|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
8127892|NCT02853435|20034505|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
8127893|NCT02853435|20034500|P6|STARTED|Part 3, Period 2 (3 Days)||2
8127894|NCT02853435|20034501|P5|STARTED|Part 3, Period 2 (3 Days)||10
8127895|NCT02853435|20034502|P4|STARTED|Part 3, Period 2 (3 Days)||0
8127896|NCT02853435|20034503|P3|STARTED|Part 3, Period 2 (3 Days)||0
8127897|NCT02853435|20034504|P2|STARTED|Part 3, Period 2 (3 Days)||0
8127898|NCT02853435|20034505|P1|STARTED|Part 3, Period 2 (3 Days)||0
8127899|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127900|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127901|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127902|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127903|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127904|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127905|NCT02853435|20034500|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
8127906|NCT02853435|20034501|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
8127907|NCT02853435|20034502|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127908|NCT02853435|20034503|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127909|NCT02853435|20034504|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127910|NCT02853435|20034505|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127911|NCT02853435|20034500|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
8127912|NCT02853435|20034501|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
8127913|NCT02853435|20034502|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127914|NCT02853435|20034503|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127915|NCT02853435|20034504|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127916|NCT02853435|20034505|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127917|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127918|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127919|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127920|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127921|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127922|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127923|NCT02853435|20034500|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
8127924|NCT02853435|20034501|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
8127925|NCT02853435|20034502|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
8127926|NCT02853435|20034503|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
8127927|NCT02853435|20034504|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
8127928|NCT02853435|20034505|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
8127929|NCT02853435|20034500|P6|STARTED|Part 3, Period 1 (3 Days)||2
8127930|NCT02853435|20034501|P5|STARTED|Part 3, Period 1 (3 Days)||10
8127931|NCT02853435|20034502|P4|STARTED|Part 3, Period 1 (3 Days)||0
8127932|NCT02853435|20034503|P3|STARTED|Part 3, Period 1 (3 Days)||0
8127933|NCT02853435|20034504|P2|STARTED|Part 3, Period 1 (3 Days)||0
8127934|NCT02853435|20034505|P1|STARTED|Part 3, Period 1 (3 Days)||0
8127935|NCT02853435|20034500|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127936|NCT02853435|20034501|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127937|NCT02853435|20034502|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127938|NCT02853435|20034503|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127939|NCT02853435|20034504|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127940|NCT02853435|20034505|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127941|NCT02853435|20034500|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
8127942|NCT02853435|20034501|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
8127943|NCT02853435|20034502|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
8127944|NCT02853435|20034503|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
8127945|NCT02853435|20034504|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
8127946|NCT02853435|20034505|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
8127947|NCT02853435|20034500|P6|STARTED|Part 2, Period 2 (3 Days)||0
8127948|NCT02853435|20034501|P5|STARTED|Part 2, Period 2 (3 Days)||0
8127949|NCT02853435|20034502|P4|STARTED|Part 2, Period 2 (3 Days)||10
8127950|NCT02853435|20034503|P3|STARTED|Part 2, Period 2 (3 Days)||0
8127951|NCT02853435|20034504|P2|STARTED|Part 2, Period 2 (3 Days)||0
8127952|NCT02853435|20034505|P1|STARTED|Part 2, Period 2 (3 Days)||0
8127953|NCT02853435|20034500|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127954|NCT02853435|20034501|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127955|NCT02853435|20034502|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127956|NCT02853435|20034503|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127957|NCT02853435|20034504|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127958|NCT02853435|20034505|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127959|NCT02853435|20034500|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127960|NCT02853435|20034501|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127961|NCT02853435|20034502|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
8127962|NCT02853435|20034503|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127963|NCT02853435|20034504|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127964|NCT02853435|20034505|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127965|NCT02853435|20034500|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127966|NCT02853435|20034501|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127967|NCT02853435|20034502|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
8127968|NCT02853435|20034503|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127969|NCT02853435|20034504|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127970|NCT02853435|20034505|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127971|NCT02853435|20034500|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127972|NCT02853435|20034501|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127973|NCT02853435|20034502|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127974|NCT02853435|20034503|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127975|NCT02853435|20034504|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127976|NCT02853435|20034505|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127977|NCT02853435|20034500|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
8127978|NCT02853435|20034501|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
8127979|NCT02853435|20034502|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
8127980|NCT02853435|20034503|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
8127981|NCT02853435|20034504|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
8127982|NCT02853435|20034505|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
8127983|NCT02853435|20034500|P6|STARTED|Part 2, Period 1 (3 Days)||0
8127984|NCT02853435|20034501|P5|STARTED|Part 2, Period 1 (3 Days)||0
8127985|NCT02853435|20034502|P4|STARTED|Part 2, Period 1 (3 Days)||10
8127986|NCT02853435|20034503|P3|STARTED|Part 2, Period 1 (3 Days)||0
8127987|NCT02853435|20034504|P2|STARTED|Part 2, Period 1 (3 Days)||0
8127988|NCT02853435|20034505|P1|STARTED|Part 2, Period 1 (3 Days)||0
8127989|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127990|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127991|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127992|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127993|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127994|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127995|NCT02853435|20034500|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
8127996|NCT02853435|20034501|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
8127997|NCT02853435|20034502|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
8127998|NCT02853435|20034503|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
8127999|NCT02853435|20034504|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
8128000|NCT02853435|20034505|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
8128001|NCT02853435|20034500|P6|STARTED|Part 1a, Period 3 (3 Days)||0
8128002|NCT02853435|20034501|P5|STARTED|Part 1a, Period 3 (3 Days)||0
8128003|NCT02853435|20034502|P4|STARTED|Part 1a, Period 3 (3 Days)||0
8128004|NCT02853435|20034503|P3|STARTED|Part 1a, Period 3 (3 Days)||8
8128005|NCT02853435|20034504|P2|STARTED|Part 1a, Period 3 (3 Days)||9
8128006|NCT02853435|20034505|P1|STARTED|Part 1a, Period 3 (3 Days)||9
8128007|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128008|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128009|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128010|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128011|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128012|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128013|NCT02853435|20034500|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128014|NCT02853435|20034501|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128015|NCT02853435|20034502|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128016|NCT02853435|20034503|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
8128017|NCT02853435|20034504|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
8128018|NCT02853435|20034505|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
8128019|NCT02853435|20034500|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8128020|NCT02853435|20034501|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8128021|NCT02853435|20034502|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8128022|NCT02853435|20034503|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
8128023|NCT02853435|20034504|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
8128024|NCT02853435|20034505|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
8128025|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128026|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128027|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128028|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128029|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128030|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128031|NCT02853435|20034500|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
8128032|NCT02853435|20034501|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
8128033|NCT02853435|20034502|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
8128034|NCT02853435|20034503|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
8128035|NCT02853435|20034504|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
8128036|NCT02853435|20034505|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
8128037|NCT02853435|20034500|P6|STARTED|Part 1a, Period 2 (3 Days)||0
8128038|NCT02853435|20034501|P5|STARTED|Part 1a, Period 2 (3 Days)||0
8128039|NCT02853435|20034502|P4|STARTED|Part 1a, Period 2 (3 Days)||0
8128040|NCT02853435|20034503|P3|STARTED|Part 1a, Period 2 (3 Days)||8
8128041|NCT02853435|20034504|P2|STARTED|Part 1a, Period 2 (3 Days)||9
8128042|NCT02853435|20034505|P1|STARTED|Part 1a, Period 2 (3 Days)||9
8128043|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128044|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128045|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128046|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128047|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128048|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128049|NCT02853435|20034500|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128050|NCT02853435|20034501|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128051|NCT02853435|20034502|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128052|NCT02853435|20034503|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
8128053|NCT02853435|20034504|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
8128054|NCT02853435|20034505|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
8128055|NCT02853435|20034500|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8128056|NCT02853435|20034501|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8128057|NCT02853435|20034502|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8128058|NCT02853435|20034503|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
8128059|NCT02853435|20034504|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
8128060|NCT02853435|20034505|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
8128061|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128062|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128063|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128064|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128065|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128066|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128067|NCT02853435|20034500|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
8128068|NCT02853435|20034501|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
8128069|NCT02853435|20034502|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
8128070|NCT02853435|20034503|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
8128071|NCT02853435|20034504|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
8128072|NCT02853435|20034505|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
8128073|NCT02853435|20034500|P6|STARTED|Part 1a, Period 1 (3 Days)||0
8128074|NCT02853435|20034501|P5|STARTED|Part 1a, Period 1 (3 Days)||0
8128075|NCT02853435|20034502|P4|STARTED|Part 1a, Period 1 (3 Days)||0
8128076|NCT02853435|20034503|P3|STARTED|Part 1a, Period 1 (3 Days)||8
8128077|NCT02853435|20034504|P2|STARTED|Part 1a, Period 1 (3 Days)||9
8128078|NCT02853435|20034505|P1|STARTED|Part 1a, Period 1 (3 Days)||9
8128079|NCT02853331|20034815|P2|NOT COMPLETED|Overall Study||429
8128080|NCT02853331|20034816|P1|NOT COMPLETED|Overall Study||432
8128081|NCT02853331|20034815|P2|COMPLETED|Overall Study||0
8128082|NCT02853331|20034816|P1|COMPLETED|Overall Study||0
8128083|NCT02853331|20034815|P2|Treated|Overall Study||425
8128084|NCT02853331|20034816|P1|Treated|Overall Study||429
8128085|NCT02853331|20034815|P2|STARTED|Overall Study||429
8128086|NCT02853331|20034816|P1|STARTED|Overall Study||432
8128087|NCT02853318|20034848|P1|NOT COMPLETED|Overall Study||1
8128088|NCT02853318|20034848|P1|COMPLETED|Overall Study||39
8128089|NCT02853318|20034848|P1|STARTED|Overall Study||40
8128090|NCT02853123|20034856|P2|NOT COMPLETED|Treatment Period 2||0
8128091|NCT02853123|20034857|P1|NOT COMPLETED|Treatment Period 2||0
8128092|NCT02853123|20034856|P2|COMPLETED|Treatment Period 2||48
8128093|NCT02853123|20034857|P1|COMPLETED|Treatment Period 2||51
8128094|NCT02853123|20034856|P2|STARTED|Treatment Period 2||48
8128095|NCT02853123|20034857|P1|STARTED|Treatment Period 2||51
8128096|NCT02853123|20034856|P2|NOT COMPLETED|Washout Period||3
8128097|NCT02853123|20034857|P1|NOT COMPLETED|Washout Period||1
8128098|NCT02853123|20034856|P2|COMPLETED|Washout Period||48
8128099|NCT02853123|20034857|P1|COMPLETED|Washout Period||51
8128100|NCT02853123|20034856|P2|STARTED|Washout Period||51
8128101|NCT02853123|20034857|P1|STARTED|Washout Period||52
8128102|NCT02853123|20034856|P2|NOT COMPLETED|Treatment Period 1||3
8128103|NCT02853123|20034857|P1|NOT COMPLETED|Treatment Period 1||0
8128104|NCT02853123|20034856|P2|COMPLETED|Treatment Period 1||51
8128105|NCT02853123|20034857|P1|COMPLETED|Treatment Period 1||52
8128106|NCT02853123|20034856|P2|STARTED|Treatment Period 1||54
8128107|NCT02853123|20034857|P1|STARTED|Treatment Period 1||52
8128108|NCT02853032|20034880|P2|NOT COMPLETED|Overall Study||3
8128109|NCT02853032|20034881|P1|NOT COMPLETED|Overall Study||9
8128110|NCT02853032|20034880|P2|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
8128111|NCT02853032|20034881|P1|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
8128112|NCT02853032|20034880|P2|STARTED|Overall Study||59
8128113|NCT02853032|20034881|P1|STARTED|Overall Study||60
8128114|NCT02852434|20034957|P2|NOT COMPLETED|Overall Study||1
8128115|NCT02852434|20034958|P1|NOT COMPLETED|Overall Study||2
8128116|NCT02852434|20034957|P2|COMPLETED|Overall Study||35
8128117|NCT02852434|20034958|P1|COMPLETED|Overall Study||34
8128118|NCT02852434|20034957|P2|STARTED|Overall Study||36
8128119|NCT02852434|20034958|P1|STARTED|Overall Study||36
8128120|NCT02852265|20034974|P2|NOT COMPLETED|6-month Follow-up||0
8128121|NCT02852265|20034975|P1|NOT COMPLETED|6-month Follow-up||0
8128122|NCT02852265|20034974|P2|COMPLETED|6-month Follow-up||9
8128123|NCT02852265|20034975|P1|COMPLETED|6-month Follow-up||9
8128124|NCT02852265|20034974|P2|STARTED|6-month Follow-up||9
8128125|NCT02852265|20034975|P1|STARTED|6-month Follow-up||9
8128126|NCT02852265|20034974|P2|NOT COMPLETED|3-month Follow-up||1
8128127|NCT02852265|20034975|P1|NOT COMPLETED|3-month Follow-up||1
8128128|NCT02852265|20034974|P2|COMPLETED|3-month Follow-up||9
8128129|NCT02852265|20034975|P1|COMPLETED|3-month Follow-up||9
8128130|NCT02852265|20034974|P2|STARTED|3-month Follow-up||10
8128131|NCT02852265|20034975|P1|STARTED|3-month Follow-up||10
8128132|NCT02852265|20034974|P2|NOT COMPLETED|1-month Follow-up||0
8128133|NCT02852265|20034975|P1|NOT COMPLETED|1-month Follow-up||0
8128134|NCT02852265|20034974|P2|COMPLETED|1-month Follow-up||10
8128135|NCT02852265|20034975|P1|COMPLETED|1-month Follow-up||10
8128136|NCT02852265|20034974|P2|STARTED|1-month Follow-up||10
8128137|NCT02852265|20034975|P1|STARTED|1-month Follow-up||10
8128138|NCT02851823|20034991|P1|NOT COMPLETED|Overall Study||0
8128139|NCT02851823|20034991|P1|COMPLETED|Overall Study||25
8128140|NCT02851823|20034991|P1|3 Months|Overall Study||25
8128141|NCT02851823|20034991|P1|1 Month|Overall Study||25
8128142|NCT02851823|20034991|P1|STARTED|Overall Study||25
8128143|NCT02851108|20035001|P2|NOT COMPLETED|Overall Study||1
8128144|NCT02851108|20035002|P1|NOT COMPLETED|Overall Study||8
8128145|NCT02851108|20035001|P2|COMPLETED|Overall Study||49
8128146|NCT02851108|20035002|P1|COMPLETED|Overall Study||42
8128147|NCT02851108|20035001|P2|STARTED|Overall Study||50
8128148|NCT02851108|20035002|P1|STARTED|Overall Study||50
8128149|NCT02851069|20035008|P1|NOT COMPLETED|Overall Study||6
8128150|NCT02851069|20035008|P1|COMPLETED|Overall Study||59
8128151|NCT02851069|20035008|P1|STARTED|Overall Study||65
8128152|NCT02850978|20035030|P1|NOT COMPLETED|Overall Study||426
8128153|NCT02850978|20035030|P1|COMPLETED|Overall Study||909
8128154|NCT02850978|20035030|P1|Treated|Overall Study||1308
8128155|NCT02850978|20035030|P1|Case Report Form (CRF) Collected|Overall Study||1308
8128156|NCT02850978|20035030|P1|STARTED|Overall Study||1335
8128157|NCT02850965|20035037|P2|NOT COMPLETED|Overall Study||25
8128158|NCT02850965|20035038|P1|NOT COMPLETED|Overall Study||18
8128159|NCT02850965|20035037|P2|COMPLETED|Overall Study||134
8128160|NCT02850965|20035038|P1|COMPLETED|Overall Study||141
8128161|NCT02850965|20035037|P2|Treated|Overall Study||158
8128162|NCT02850965|20035038|P1|Treated|Overall Study||159
8128163|NCT02850965|20035037|P2|STARTED|Overall Study||159
8128164|NCT02850965|20035038|P1|STARTED|Overall Study||159
8128165|NCT02850276|20035054|P1|NOT COMPLETED|Overall Study||61
8128166|NCT02850276|20035054|P1|COMPLETED|Overall Study||15
8128167|NCT02850276|20035054|P1|STARTED|Overall Study||76
8128168|NCT02850159|20035067|P2|NOT COMPLETED|Overall Study||0
8128169|NCT02850159|20035068|P1|NOT COMPLETED|Overall Study||0
8128170|NCT02850159|20035067|P2|COMPLETED|Overall Study||16
8128171|NCT02850159|20035068|P1|COMPLETED|Overall Study||16
8128172|NCT02850159|20035067|P2|STARTED|Overall Study||16
8128173|NCT02850159|20035068|P1|STARTED|Overall Study||16
8128174|NCT02850068|20035074|P1|NOT COMPLETED|Overall Study||20
8128175|NCT02850068|20035074|P1|COMPLETED|Overall Study||0
8128176|NCT02850068|20035074|P1|STARTED|Overall Study||20
8128177|NCT02849990|20035081|P1|NOT COMPLETED|Overall Study||2
8128178|NCT02849990|20035081|P1|COMPLETED|Overall Study||20
8128179|NCT02849990|20035081|P1|STARTED|Overall Study||22
8128180|NCT02849938|20035093|P2|NOT COMPLETED|Overall Study||0
8128181|NCT02849938|20035094|P1|NOT COMPLETED|Overall Study||0
8128182|NCT02849938|20035093|P2|COMPLETED|Overall Study||15
8128183|NCT02849938|20035094|P1|COMPLETED|Overall Study||9
8128184|NCT02849938|20035093|P2|STARTED|Overall Study||15
8128185|NCT02849938|20035094|P1|STARTED|Overall Study||9
8128186|NCT02849704|20035106|P2|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
8128187|NCT02849704|20035107|P1|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
8128188|NCT02849704|20035106|P2|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
8128189|NCT02849704|20035107|P1|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
8128190|NCT02849704|20035106|P2|STARTED|Assessment on PERT - CP Subj - 16 Days||0
8128191|NCT02849704|20035107|P1|STARTED|Assessment on PERT - CP Subj - 16 Days||24
8128192|NCT02849704|20035106|P2|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
8128193|NCT02849704|20035107|P1|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
8128194|NCT02849704|20035106|P2|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
8128195|NCT02849704|20035107|P1|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
8128196|NCT02849704|20035106|P2|STARTED|Baseline Assessments - All Subj - 7 Days||24
8128197|NCT02849704|20035107|P1|STARTED|Baseline Assessments - All Subj - 7 Days||24
8128198|NCT02849704|20035106|P2|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8128199|NCT02849704|20035107|P1|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8128200|NCT02849704|20035106|P2|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8128201|NCT02849704|20035107|P1|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
8128202|NCT02849704|20035106|P2|STARTED|Washout Period - CP Subj on PERT - 3days||0
8128203|NCT02849704|20035107|P1|STARTED|Washout Period - CP Subj on PERT - 3days||11
8128204|NCT02849678|20035122|P2|NOT COMPLETED|Overall Study||6
8128205|NCT02849678|20035123|P1|NOT COMPLETED|Overall Study||3
8128206|NCT02849678|20035122|P2|COMPLETED|Overall Study||18
8128207|NCT02849678|20035123|P1|COMPLETED|Overall Study||17
8128208|NCT02849678|20035122|P2|STARTED|Overall Study||24
8128209|NCT02849678|20035123|P1|STARTED|Overall Study||20
8128210|NCT02849626|20035143|P2|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
8128211|NCT02849626|20035144|P1|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
8128212|NCT02849626|20035143|P2|COMPLETED|Extension Phase A (up to 29 Weeks)||17
8128213|NCT02849626|20035144|P1|COMPLETED|Extension Phase A (up to 29 Weeks)||105
8128214|NCT02849626|20035143|P2|STARTED|Extension Phase A (up to 29 Weeks)||20
8128215|NCT02849626|20035144|P1|STARTED|Extension Phase A (up to 29 Weeks)||116
8128216|NCT02849626|20035143|P2|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
8128217|NCT02849626|20035144|P1|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
8128218|NCT02849626|20035143|P2|COMPLETED|Core Phase (up to 23 Weeks)||24
8128219|NCT02849626|20035144|P1|COMPLETED|Core Phase (up to 23 Weeks)||122
8128220|NCT02849626|20035143|P2|STARTED|Core Phase (up to 23 Weeks)||31
8128221|NCT02849626|20035144|P1|STARTED|Core Phase (up to 23 Weeks)||149
8128222|NCT02849509|20035207|P3|NOT COMPLETED|Overall Study||85
8128223|NCT02849509|20035208|P2|NOT COMPLETED|Overall Study||166
8128224|NCT02849509|20035209|P1|NOT COMPLETED|Overall Study||90
8128225|NCT02849509|20035207|P3|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
8128226|NCT02849509|20035208|P2|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
8128227|NCT02849509|20035209|P1|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
8128228|NCT02849509|20035207|P3|STARTED|Overall Study||343
8128229|NCT02849509|20035208|P2|STARTED|Overall Study||591
8128230|NCT02849509|20035209|P1|STARTED|Overall Study||379
8128231|NCT02849418|20035238|P6|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128232|NCT02849418|20035239|P5|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128233|NCT02849418|20035240|P4|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128234|NCT02849418|20035241|P3|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128235|NCT02849418|20035242|P2|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128236|NCT02849418|20035243|P1|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128237|NCT02849418|20035238|P6|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
8128238|NCT02849418|20035239|P5|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
8128239|NCT02849418|20035240|P4|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128240|NCT02849418|20035241|P3|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128241|NCT02849418|20035242|P2|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128242|NCT02849418|20035243|P1|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8128243|NCT02849418|20035238|P6|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
8128244|NCT02849418|20035239|P5|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
8128245|NCT02849418|20035240|P4|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8128246|NCT02849418|20035241|P3|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8128247|NCT02849418|20035242|P2|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8128248|NCT02849418|20035243|P1|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8128249|NCT02849418|20035238|P6|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128250|NCT02849418|20035239|P5|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128251|NCT02849418|20035240|P4|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128252|NCT02849418|20035241|P3|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128253|NCT02849418|20035242|P2|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128254|NCT02849418|20035243|P1|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128255|NCT02849418|20035238|P6|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128256|NCT02849418|20035239|P5|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128257|NCT02849418|20035240|P4|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
8128258|NCT02849418|20035241|P3|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
8128259|NCT02849418|20035242|P2|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128260|NCT02849418|20035243|P1|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8128261|NCT02849418|20035238|P6|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8128262|NCT02849418|20035239|P5|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8128263|NCT02849418|20035240|P4|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
8128264|NCT02849418|20035241|P3|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
8128265|NCT02849418|20035242|P2|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8128266|NCT02849418|20035243|P1|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8128267|NCT02849418|20035238|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128268|NCT02849418|20035239|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128269|NCT02849418|20035240|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128270|NCT02849418|20035241|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128271|NCT02849418|20035242|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128272|NCT02849418|20035243|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128273|NCT02849418|20035238|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128274|NCT02849418|20035239|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128275|NCT02849418|20035240|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128276|NCT02849418|20035241|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8128277|NCT02849418|20035242|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||11
8128278|NCT02849418|20035243|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||10
8128279|NCT02849418|20035238|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
8128280|NCT02849418|20035239|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
8128281|NCT02849418|20035240|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
8128282|NCT02849418|20035241|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
8128283|NCT02849418|20035242|P2|STARTED|Double-blinded (Up to 48 Weeks)||11
8128284|NCT02849418|20035243|P1|STARTED|Double-blinded (Up to 48 Weeks)||10
8128285|NCT02849184|20035393|P2|NOT COMPLETED|Overall Study||0
8128286|NCT02849184|20035394|P1|NOT COMPLETED|Overall Study||0
8128287|NCT02849184|20035393|P2|COMPLETED|Overall Study||42
8128288|NCT02849184|20035394|P1|COMPLETED|Overall Study||40
8128289|NCT02849184|20035393|P2|STARTED|Overall Study||42
8128290|NCT02849184|20035394|P1|STARTED|Overall Study||40
8128291|NCT02849080|20035416|P4|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
8128292|NCT02849080|20035417|P3|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
8128293|NCT02849080|20035418|P2|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
8128294|NCT02849080|20035419|P1|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
8128295|NCT02849080|20035416|P4|COMPLETED|Extension Phase: 53 - 104 Weeks||98
8128296|NCT02849080|20035417|P3|COMPLETED|Extension Phase: 53 - 104 Weeks||99
8128297|NCT02849080|20035418|P2|COMPLETED|Extension Phase: 53 - 104 Weeks||0
8128298|NCT02849080|20035419|P1|COMPLETED|Extension Phase: 53 - 104 Weeks||182
8128299|NCT02849080|20035416|P4|Exposed|Extension Phase: 53 - 104 Weeks||97
8128300|NCT02849080|20035417|P3|Exposed|Extension Phase: 53 - 104 Weeks||100
8128301|NCT02849080|20035418|P2|Exposed|Extension Phase: 53 - 104 Weeks||0
8128302|NCT02849080|20035419|P1|Exposed|Extension Phase: 53 - 104 Weeks||184
8128303|NCT02849080|20035416|P4|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
8128304|NCT02849080|20035417|P3|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
8128305|NCT02849080|20035418|P2|STARTED|Extension Phase: 53 - 104 Weeks||0
8128306|NCT02849080|20035419|P1|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
8128307|NCT02849080|20035416|P4|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
8128308|NCT02849080|20035417|P3|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
8128309|NCT02849080|20035418|P2|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
8128310|NCT02849080|20035419|P1|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
8128311|NCT02849080|20035416|P4|COMPLETED|Main Phase: 0 - 52 Weeks||0
8128312|NCT02849080|20035417|P3|COMPLETED|Main Phase: 0 - 52 Weeks||0
8128313|NCT02849080|20035418|P2|COMPLETED|Main Phase: 0 - 52 Weeks||244
8128314|NCT02849080|20035419|P1|COMPLETED|Main Phase: 0 - 52 Weeks||241
8128315|NCT02849080|20035416|P4|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
8128316|NCT02849080|20035417|P3|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
8128317|NCT02849080|20035418|P2|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
8128318|NCT02849080|20035419|P1|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
8128319|NCT02849080|20035416|P4|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
8128320|NCT02849080|20035417|P3|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
8128321|NCT02849080|20035418|P2|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
8128322|NCT02849080|20035419|P1|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
8128323|NCT02849080|20035416|P4|Exposed|Main Phase: 0 - 52 Weeks||0
8128324|NCT02849080|20035417|P3|Exposed|Main Phase: 0 - 52 Weeks||0
8128325|NCT02849080|20035418|P2|Exposed|Main Phase: 0 - 52 Weeks||250
8128326|NCT02849080|20035419|P1|Exposed|Main Phase: 0 - 52 Weeks||253
8128327|NCT02849080|20035416|P4|STARTED|Main Phase: 0 - 52 Weeks||0
8128328|NCT02849080|20035417|P3|STARTED|Main Phase: 0 - 52 Weeks||0
8128329|NCT02849080|20035418|P2|STARTED|Main Phase: 0 - 52 Weeks||251
8128330|NCT02849080|20035419|P1|STARTED|Main Phase: 0 - 52 Weeks||253
8128331|NCT02848729|20035546|P2|NOT COMPLETED|Overall Study||11
8128332|NCT02848729|20035547|P1|NOT COMPLETED|Overall Study||16
8128333|NCT02848729|20035546|P2|COMPLETED|Overall Study||12
8128334|NCT02848729|20035547|P1|COMPLETED|Overall Study||11
8128335|NCT02848729|20035546|P2|Safety Population|Overall Study||23
8128336|NCT02848729|20035547|P1|Safety Population|Overall Study||27
8128337|NCT02848729|20035546|P2|Per Protocol Population|Overall Study||11
8128338|NCT02848729|20035547|P1|Per Protocol Population|Overall Study||11
8128339|NCT02848729|20035546|P2|STARTED|Overall Study||23
8128340|NCT02848729|20035547|P1|STARTED|Overall Study||27
8128341|NCT02848664|20035564|P1|NOT COMPLETED|Overall Study||4
8128342|NCT02848664|20035564|P1|COMPLETED|Overall Study||7
8128343|NCT02848664|20035564|P1|STARTED|Overall Study||11
8128344|NCT02848651|20035572|P1|NOT COMPLETED|Overall Study||106
8128345|NCT02848651|20035572|P1|COMPLETED|Overall Study||47
8128346|NCT02848651|20035572|P1|Received Treatment|Overall Study||152
8128347|NCT02848651|20035572|P1|STARTED|Overall Study||153
8128348|NCT02848599|20035601|P2|NOT COMPLETED|Overall Study||9
8128349|NCT02848599|20035602|P1|NOT COMPLETED|Overall Study||7
8128350|NCT02848599|20035601|P2|COMPLETED|Overall Study||35
8128351|NCT02848599|20035602|P1|COMPLETED|Overall Study||35
8128352|NCT02848599|20035601|P2|STARTED|Overall Study||44
8128353|NCT02848599|20035602|P1|STARTED|Overall Study||42
8128354|NCT02848326|20035624|P6|NOT COMPLETED|Safety Follow-up Period||5
8128355|NCT02848326|20035625|P5|NOT COMPLETED|Safety Follow-up Period||1
8128356|NCT02848326|20035626|P4|NOT COMPLETED|Safety Follow-up Period||0
8128357|NCT02848326|20035627|P3|NOT COMPLETED|Safety Follow-up Period||3
8128358|NCT02848326|20035628|P2|NOT COMPLETED|Safety Follow-up Period||1
8128359|NCT02848326|20035629|P1|NOT COMPLETED|Safety Follow-up Period||4
8128360|NCT02848326|20035624|P6|COMPLETED|Safety Follow-up Period||77
8128361|NCT02848326|20035625|P5|COMPLETED|Safety Follow-up Period||76
8128362|NCT02848326|20035626|P4|COMPLETED|Safety Follow-up Period||169
8128363|NCT02848326|20035627|P3|COMPLETED|Safety Follow-up Period||153
8128364|NCT02848326|20035628|P2|COMPLETED|Safety Follow-up Period||83
8128365|NCT02848326|20035629|P1|COMPLETED|Safety Follow-up Period||157
8128366|NCT02848326|20035624|P6|STARTED|Safety Follow-up Period||82
8128367|NCT02848326|20035625|P5|STARTED|Safety Follow-up Period||77
8128368|NCT02848326|20035626|P4|STARTED|Safety Follow-up Period||169
8128369|NCT02848326|20035627|P3|STARTED|Safety Follow-up Period||156
8128370|NCT02848326|20035628|P2|STARTED|Safety Follow-up Period||84
8128371|NCT02848326|20035629|P1|STARTED|Safety Follow-up Period||161
8128372|NCT02848326|20035624|P6|NOT COMPLETED|Treatment Period||20
8128373|NCT02848326|20035625|P5|NOT COMPLETED|Treatment Period||19
8128374|NCT02848326|20035626|P4|NOT COMPLETED|Treatment Period||23
8128375|NCT02848326|20035627|P3|NOT COMPLETED|Treatment Period||36
8128376|NCT02848326|20035628|P2|NOT COMPLETED|Treatment Period||14
8128377|NCT02848326|20035629|P1|NOT COMPLETED|Treatment Period||38
8128378|NCT02848326|20035624|P6|COMPLETED|Treatment Period||73
8128379|NCT02848326|20035625|P5|COMPLETED|Treatment Period||70
8128380|NCT02848326|20035626|P4|COMPLETED|Treatment Period||164
8128381|NCT02848326|20035627|P3|COMPLETED|Treatment Period||149
8128382|NCT02848326|20035628|P2|COMPLETED|Treatment Period||80
8128383|NCT02848326|20035629|P1|COMPLETED|Treatment Period||148
8128384|NCT02848326|20035624|P6|Safety Population: Received Study Drug|Treatment Period||91
8128385|NCT02848326|20035625|P5|Safety Population: Received Study Drug|Treatment Period||86
8128386|NCT02848326|20035626|P4|Safety Population: Received Study Drug|Treatment Period||186
8128387|NCT02848326|20035627|P3|Safety Population: Received Study Drug|Treatment Period||183
8128388|NCT02848326|20035628|P2|Safety Population: Received Study Drug|Treatment Period||93
8128389|NCT02848326|20035629|P1|Safety Population: Received Study Drug|Treatment Period||186
8128390|NCT02848326|20035624|P6|STARTED|Treatment Period||93
8128391|NCT02848326|20035625|P5|STARTED|Treatment Period||89
8128392|NCT02848326|20035626|P4|STARTED|Treatment Period||187
8128393|NCT02848326|20035627|P3|STARTED|Treatment Period||185
8128394|NCT02848326|20035628|P2|STARTED|Treatment Period||94
8128395|NCT02848326|20035629|P1|STARTED|Treatment Period||186
8128396|NCT02848313|20035663|P2|NOT COMPLETED|Overall Study||4
8128397|NCT02848313|20035664|P1|NOT COMPLETED|Overall Study||3
8128398|NCT02848313|20035663|P2|COMPLETED|Overall Study||15
8128399|NCT02848313|20035664|P1|COMPLETED|Overall Study||18
8128400|NCT02848313|20035663|P2|STARTED|Overall Study||19
8128401|NCT02848313|20035664|P1|STARTED|Overall Study||21
8128402|NCT02848222|20035699|P3|NOT COMPLETED|Overall Study||0
8128403|NCT02848222|20035700|P2|NOT COMPLETED|Overall Study||1
8128404|NCT02848222|20035701|P1|NOT COMPLETED|Overall Study||7
8128405|NCT02848222|20035699|P3|COMPLETED|Overall Study||17
8128406|NCT02848222|20035700|P2|COMPLETED|Overall Study||17
8128407|NCT02848222|20035701|P1|COMPLETED|Overall Study||18
8128408|NCT02848222|20035699|P3|STARTED|Overall Study||17
8128409|NCT02848222|20035700|P2|STARTED|Overall Study||18
8128410|NCT02848222|20035701|P1|STARTED|Overall Study||25
8128411|NCT02847858|20035711|P2|NOT COMPLETED|Overall Study||269
8128412|NCT02847858|20035712|P1|NOT COMPLETED|Overall Study||401
8128413|NCT02847858|20035711|P2|COMPLETED|Overall Study||398
8128414|NCT02847858|20035712|P1|COMPLETED|Overall Study||292
8128415|NCT02847858|20035711|P2|STARTED|Overall Study||667
8128416|NCT02847858|20035712|P1|STARTED|Overall Study||693
8128417|NCT02847650|20035738|P2|NOT COMPLETED|Overall Study||6
8128418|NCT02847650|20035739|P1|NOT COMPLETED|Overall Study||4
8128419|NCT02847650|20035738|P2|COMPLETED|Overall Study||22
8128420|NCT02847650|20035739|P1|COMPLETED|Overall Study||25
8128421|NCT02847650|20035738|P2|STARTED|Overall Study||28
8128422|NCT02847650|20035739|P1|STARTED|Overall Study||29
8128423|NCT02847637|20035763|P4|NOT COMPLETED|Overall Study||63
8128424|NCT02847637|20035764|P3|NOT COMPLETED|Overall Study||35
8128425|NCT02847637|20035765|P2|NOT COMPLETED|Overall Study||35
8128426|NCT02847637|20035766|P1|NOT COMPLETED|Overall Study||17
8128427|NCT02847637|20035763|P4|COMPLETED|Overall Study||0
8128428|NCT02847637|20035764|P3|COMPLETED|Overall Study||0
8128429|NCT02847637|20035765|P2|COMPLETED|Overall Study||1
8128430|NCT02847637|20035766|P1|COMPLETED|Overall Study||1
8128431|NCT02847637|20035763|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
8128432|NCT02847637|20035764|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
8128433|NCT02847637|20035765|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
8128434|NCT02847637|20035766|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
8128435|NCT02847637|20035763|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8128436|NCT02847637|20035764|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8128437|NCT02847637|20035765|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8128438|NCT02847637|20035766|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
8128439|NCT02847637|20035763|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8128440|NCT02847637|20035764|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8128441|NCT02847637|20035765|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8128442|NCT02847637|20035766|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
8128443|NCT02847637|20035763|P4|STARTED|Overall Study||63
8128444|NCT02847637|20035764|P3|STARTED|Overall Study||35
8128445|NCT02847637|20035765|P2|STARTED|Overall Study||36
8128446|NCT02847637|20035766|P1|STARTED|Overall Study||18
8128447|NCT02847494|20035880|P2|NOT COMPLETED|Overall Study||5
8128448|NCT02847494|20035881|P1|NOT COMPLETED|Overall Study||8
8128449|NCT02847494|20035880|P2|COMPLETED|Overall Study||106
8128450|NCT02847494|20035881|P1|COMPLETED|Overall Study||101
8128451|NCT02847494|20035880|P2|STARTED|Overall Study||111
8128452|NCT02847494|20035881|P1|STARTED|Overall Study||109
8128453|NCT02847260|20035891|P1|NOT COMPLETED|Overall Study||7
8128454|NCT02847260|20035891|P1|COMPLETED|Overall Study||32
8128455|NCT02847260|20035891|P1|STARTED|Overall Study||39
8128456|NCT02847182|20035905|P2|NOT COMPLETED|Overall Study||1
8128457|NCT02847182|20035906|P1|NOT COMPLETED|Overall Study||0
8128458|NCT02847182|20035905|P2|COMPLETED|Overall Study||60
8128459|NCT02847182|20035906|P1|COMPLETED|Overall Study||119
8128460|NCT02847182|20035905|P2|Second Intervention (6 Months)|Overall Study||119
8128461|NCT02847182|20035906|P1|Second Intervention (6 Months)|Overall Study||61
8128462|NCT02847182|20035905|P2|First Intervention (6 Months)|Overall Study||61
8128463|NCT02847182|20035906|P1|First Intervention (6 Months)|Overall Study||119
8128464|NCT02847182|20035905|P2|STARTED|Overall Study||61
8128465|NCT02847182|20035906|P1|STARTED|Overall Study||119
8128466|NCT02847169|20035982|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8128467|NCT02847169|20035983|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8128468|NCT02847169|20035982|P2|COMPLETED|Second Intervention (1 Week)||15
8128469|NCT02847169|20035983|P1|COMPLETED|Second Intervention (1 Week)||15
8128470|NCT02847169|20035982|P2|STARTED|Second Intervention (1 Week)||15
8128471|NCT02847169|20035983|P1|STARTED|Second Intervention (1 Week)||15
8128472|NCT02847169|20035982|P2|NOT COMPLETED|First Intervention (1 Week)||0
8128473|NCT02847169|20035983|P1|NOT COMPLETED|First Intervention (1 Week)||0
8128474|NCT02847169|20035982|P2|COMPLETED|First Intervention (1 Week)||15
8128475|NCT02847169|20035983|P1|COMPLETED|First Intervention (1 Week)||15
8128476|NCT02847169|20035982|P2|STARTED|First Intervention (1 Week)||15
8128477|NCT02847169|20035983|P1|STARTED|First Intervention (1 Week)||15
8128478|NCT02846792|20036017|P1|NOT COMPLETED|Overall Study||0
8128479|NCT02846792|20036017|P1|COMPLETED|Overall Study||5
8128480|NCT02846792|20036017|P1|STARTED|Overall Study||5
8128481|NCT02846779|20036030|P3|NOT COMPLETED|Overall Study||138
8128482|NCT02846779|20036031|P2|NOT COMPLETED|Overall Study||127
8128483|NCT02846779|20036032|P1|NOT COMPLETED|Overall Study||139
8128484|NCT02846779|20036030|P3|COMPLETED|Overall Study||1862
8128485|NCT02846779|20036031|P2|COMPLETED|Overall Study||1873
8128486|NCT02846779|20036032|P1|COMPLETED|Overall Study||1861
8128487|NCT02846779|20036030|P3|STARTED|Overall Study||2000
8128488|NCT02846779|20036031|P2|STARTED|Overall Study||2000
8128489|NCT02846779|20036032|P1|STARTED|Overall Study||2000
8128490|NCT02846740|20036057|P2|NOT COMPLETED|Overall Study||1
8128491|NCT02846740|20036058|P1|NOT COMPLETED|Overall Study||0
8128492|NCT02846740|20036057|P2|COMPLETED|Overall Study||14
8128493|NCT02846740|20036058|P1|COMPLETED|Overall Study||15
8128494|NCT02846740|20036057|P2|STARTED|Overall Study||15
8128495|NCT02846740|20036058|P1|STARTED|Overall Study||15
8128496|NCT02846714|20036068|P1|NOT COMPLETED|Overall Study||6
8128497|NCT02846714|20036068|P1|COMPLETED|Overall Study||36
8128498|NCT02846714|20036068|P1|STARTED|Overall Study||42
8128499|NCT02846558|20036088|P4|NOT COMPLETED|Overall Study||2
8128500|NCT02846558|20036089|P3|NOT COMPLETED|Overall Study||2
8128501|NCT02846558|20036090|P2|NOT COMPLETED|Overall Study||4
8128502|NCT02846558|20036091|P1|NOT COMPLETED|Overall Study||8
8128503|NCT02846558|20036088|P4|COMPLETED|Overall Study||11
8128504|NCT02846558|20036089|P3|COMPLETED|Overall Study||12
8128505|NCT02846558|20036090|P2|COMPLETED|Overall Study||8
8128506|NCT02846558|20036091|P1|COMPLETED|Overall Study||7
8128507|NCT02846558|20036088|P4|3 Month Study Visit|Overall Study||11
8128508|NCT02846558|20036089|P3|3 Month Study Visit|Overall Study||12
8128509|NCT02846558|20036090|P2|3 Month Study Visit|Overall Study||8
8128510|NCT02846558|20036091|P1|3 Month Study Visit|Overall Study||7
8128511|NCT02846558|20036088|P4|Baseline Study Visit|Overall Study||12
8128512|NCT02846558|20036089|P3|Baseline Study Visit|Overall Study||14
8128513|NCT02846558|20036090|P2|Baseline Study Visit|Overall Study||9
8128514|NCT02846558|20036091|P1|Baseline Study Visit|Overall Study||10
8128515|NCT02846558|20036088|P4|STARTED|Overall Study||13
8128516|NCT02846558|20036089|P3|STARTED|Overall Study||14
8128517|NCT02846558|20036090|P2|STARTED|Overall Study||12
8128518|NCT02846558|20036091|P1|STARTED|Overall Study||15
8128519|NCT02846415|20036129|P2|NOT COMPLETED|Overall Study||1
8128520|NCT02846415|20036130|P1|NOT COMPLETED|Overall Study||3
8128521|NCT02846415|20036129|P2|COMPLETED|Overall Study||11
8128522|NCT02846415|20036130|P1|COMPLETED|Overall Study||15
8128523|NCT02846415|20036129|P2|STARTED|Overall Study||12
8128524|NCT02846415|20036130|P1|STARTED|Overall Study||18
8128525|NCT02846324|20036144|P4|NOT COMPLETED|Overall Study||0
8128526|NCT02846324|20036145|P3|NOT COMPLETED|Overall Study||4
8128527|NCT02846324|20036146|P2|NOT COMPLETED|Overall Study||0
8128528|NCT02846324|20036147|P1|NOT COMPLETED|Overall Study||2
8128529|NCT02846324|20036144|P4|COMPLETED|Overall Study||10
8128530|NCT02846324|20036145|P3|COMPLETED|Overall Study||10
8128531|NCT02846324|20036146|P2|COMPLETED|Overall Study||6
8128532|NCT02846324|20036147|P1|COMPLETED|Overall Study||7
8128533|NCT02846324|20036144|P4|Completed Study Treatment|Overall Study||10
8128534|NCT02846324|20036145|P3|Completed Study Treatment|Overall Study||11
8128535|NCT02846324|20036146|P2|Completed Study Treatment|Overall Study||5
8128536|NCT02846324|20036147|P1|Completed Study Treatment|Overall Study||7
8128537|NCT02846324|20036144|P4|STARTED|Overall Study||10
8128538|NCT02846324|20036145|P3|STARTED|Overall Study||14
8128539|NCT02846324|20036146|P2|STARTED|Overall Study||6
8128540|NCT02846324|20036147|P1|STARTED|Overall Study||9
8128541|NCT02846233|20036179|P2|NOT COMPLETED|Overall Study||2
8128542|NCT02846233|20036180|P1|NOT COMPLETED|Overall Study||2
8128543|NCT02846233|20036179|P2|COMPLETED|Overall Study||8
8128544|NCT02846233|20036180|P1|COMPLETED|Overall Study||10
8128545|NCT02846233|20036179|P2|STARTED|Overall Study||10
8128546|NCT02846233|20036180|P1|STARTED|Overall Study||12
8128547|NCT02845752|20036202|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8128548|NCT02845752|20036203|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8128549|NCT02845752|20036202|P2|COMPLETED|Second Intervention (7 Days)||7
8128550|NCT02845752|20036203|P1|COMPLETED|Second Intervention (7 Days)||7
8128551|NCT02845752|20036202|P2|STARTED|Second Intervention (7 Days)||7
8128552|NCT02845752|20036203|P1|STARTED|Second Intervention (7 Days)||7
8128553|NCT02845752|20036202|P2|NOT COMPLETED|Washout (14 Days)||0
8128554|NCT02845752|20036203|P1|NOT COMPLETED|Washout (14 Days)||0
8128555|NCT02845752|20036202|P2|COMPLETED|Washout (14 Days)||7
8128556|NCT02845752|20036203|P1|COMPLETED|Washout (14 Days)||7
8128557|NCT02845752|20036202|P2|STARTED|Washout (14 Days)||7
8128558|NCT02845752|20036203|P1|STARTED|Washout (14 Days)||7
8128559|NCT02845752|20036202|P2|NOT COMPLETED|First Intervention (7 Days)||0
8128560|NCT02845752|20036203|P1|NOT COMPLETED|First Intervention (7 Days)||0
8128561|NCT02845752|20036202|P2|COMPLETED|First Intervention (7 Days)||7
8128562|NCT02845752|20036203|P1|COMPLETED|First Intervention (7 Days)||7
8128563|NCT02845752|20036202|P2|STARTED|First Intervention (7 Days)||7
8128564|NCT02845752|20036203|P1|STARTED|First Intervention (7 Days)||7
8128565|NCT02845700|20036237|P2|NOT COMPLETED|Month 1 Follow-Up||0
8128566|NCT02845700|20036238|P1|NOT COMPLETED|Month 1 Follow-Up||0
8128567|NCT02845700|20036237|P2|COMPLETED|Month 1 Follow-Up||4
8128568|NCT02845700|20036238|P1|COMPLETED|Month 1 Follow-Up||2
8128569|NCT02845700|20036237|P2|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
8128570|NCT02845700|20036238|P1|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
8128571|NCT02845700|20036237|P2|NOT COMPLETED|Intervention Session 2||0
8128572|NCT02845700|20036238|P1|NOT COMPLETED|Intervention Session 2||0
8128573|NCT02845700|20036237|P2|COMPLETED|Intervention Session 2||6
8128574|NCT02845700|20036238|P1|COMPLETED|Intervention Session 2||5
8128575|NCT02845700|20036237|P2|STARTED|Intervention Session 2||6
8128576|NCT02845700|20036238|P1|STARTED|Intervention Session 2||5
8128577|NCT02845700|20036237|P2|NOT COMPLETED|Intervention Session 1||0
8128578|NCT02845700|20036238|P1|NOT COMPLETED|Intervention Session 1||0
8128579|NCT02845700|20036237|P2|COMPLETED|Intervention Session 1||6
8128580|NCT02845700|20036238|P1|COMPLETED|Intervention Session 1||5
8128581|NCT02845700|20036237|P2|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
8128582|NCT02845700|20036238|P1|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
8128583|NCT02845700|20036237|P2|NOT COMPLETED|Baseline Appointment||0
8128584|NCT02845700|20036238|P1|NOT COMPLETED|Baseline Appointment||0
8128585|NCT02845700|20036237|P2|COMPLETED|Baseline Appointment||7
8128586|NCT02845700|20036238|P1|COMPLETED|Baseline Appointment||6
8128587|NCT02845700|20036237|P2|STARTED|Baseline Appointment||7
8128588|NCT02845700|20036238|P1|STARTED|Baseline Appointment||6
8128589|NCT02845674|20036254|P2|NOT COMPLETED|Overall Study||50
8128590|NCT02845674|20036255|P1|NOT COMPLETED|Overall Study||18
8128591|NCT02845674|20036254|P2|COMPLETED|Overall Study||79
8128592|NCT02845674|20036255|P1|COMPLETED|Overall Study||111
8128593|NCT02845674|20036254|P2|STARTED|Overall Study||129
8128594|NCT02845674|20036255|P1|STARTED|Overall Study||129
8128595|NCT02845375|20036264|P3|NOT COMPLETED|Overall Study||1
8128596|NCT02845375|20036265|P2|NOT COMPLETED|Overall Study||2
8128597|NCT02845375|20036266|P1|NOT COMPLETED|Overall Study||1
8128598|NCT02845375|20036264|P3|COMPLETED|Overall Study||12
8128599|NCT02845375|20036265|P2|COMPLETED|Overall Study||12
8128600|NCT02845375|20036266|P1|COMPLETED|Overall Study||12
8128601|NCT02845375|20036264|P3|STARTED|Overall Study||13
8128602|NCT02845375|20036265|P2|STARTED|Overall Study||14
8128603|NCT02845375|20036266|P1|STARTED|Overall Study||13
8128604|NCT02845336|20036279|P2|NOT COMPLETED|Overall Study||1
8128605|NCT02845336|20036280|P1|NOT COMPLETED|Overall Study||5
8128606|NCT02845336|20036279|P2|COMPLETED|Overall Study||0
8128607|NCT02845336|20036280|P1|COMPLETED|Overall Study||1
8128608|NCT02845336|20036279|P2|STARTED|Overall Study||1
8128609|NCT02845336|20036280|P1|STARTED|Overall Study||6
8128610|NCT02844998|20036307|P3|NOT COMPLETED|Overall Study||4
8128611|NCT02844998|20036308|P2|NOT COMPLETED|Overall Study||4
8128612|NCT02844998|20036309|P1|NOT COMPLETED|Overall Study||7
8128613|NCT02844998|20036307|P3|COMPLETED|Overall Study||35
8128614|NCT02844998|20036308|P2|COMPLETED|Overall Study||35
8128615|NCT02844998|20036309|P1|COMPLETED|Overall Study||35
8128616|NCT02844998|20036307|P3|STARTED|Overall Study||39
8128617|NCT02844998|20036308|P2|STARTED|Overall Study||39
8128618|NCT02844998|20036309|P1|STARTED|Overall Study||42
8128619|NCT02844946|20036322|P2|NOT COMPLETED|Overall Study||0
8128620|NCT02844946|20036323|P1|NOT COMPLETED|Overall Study||7
8128621|NCT02844946|20036322|P2|COMPLETED|Overall Study||12
8128622|NCT02844946|20036323|P1|COMPLETED|Overall Study||20
8128623|NCT02844946|20036322|P2|STARTED|Overall Study||12
8128624|NCT02844946|20036323|P1|STARTED|Overall Study||27
8128625|NCT02844920|20036341|P1|NOT COMPLETED|Overall Study||2
8128626|NCT02844920|20036341|P1|COMPLETED|Overall Study|Participants with completed the follow-up|35
8128627|NCT02844920|20036341|P1|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
8128628|NCT02844920|20036341|P1|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
8128629|NCT02844920|20036341|P1|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
8128630|NCT02844920|20036341|P1|STARTED|Overall Study||37
8128631|NCT02844582|20036346|P1|NOT COMPLETED|Overall Study||0
8128632|NCT02844582|20036346|P1|COMPLETED|Overall Study||2
8128633|NCT02844582|20036346|P1|STARTED|Overall Study||2
8128634|NCT02844569|20036356|P2|NOT COMPLETED|Overall Study||0
8128635|NCT02844569|20036357|P1|NOT COMPLETED|Overall Study||0
8128636|NCT02844569|20036356|P2|COMPLETED|Overall Study||12
8128637|NCT02844569|20036357|P1|COMPLETED|Overall Study||12
8128638|NCT02844569|20036356|P2|STARTED|Overall Study||12
8128639|NCT02844569|20036357|P1|STARTED|Overall Study||12
8128640|NCT02844543|20036367|P1|NOT COMPLETED|Overall Study||5
8128641|NCT02844543|20036367|P1|COMPLETED|Overall Study||150
8128642|NCT02844543|20036367|P1|STARTED|Overall Study||155
8128643|NCT02843659|20036377|P3|NOT COMPLETED|Overall Study||5
8128644|NCT02843659|20036378|P2|NOT COMPLETED|Overall Study||6
8128645|NCT02843659|20036379|P1|NOT COMPLETED|Overall Study||4
8128646|NCT02843659|20036377|P3|COMPLETED|Overall Study||2
8128647|NCT02843659|20036378|P2|COMPLETED|Overall Study||0
8128648|NCT02843659|20036379|P1|COMPLETED|Overall Study||1
8128649|NCT02843659|20036377|P3|STARTED|Overall Study||7
8128650|NCT02843659|20036378|P2|STARTED|Overall Study||6
8128651|NCT02843659|20036379|P1|STARTED|Overall Study||5
8128652|NCT02843529|20036446|P2|NOT COMPLETED|Overall Study||21
8128653|NCT02843529|20036447|P1|NOT COMPLETED|Overall Study||31
8128654|NCT02843529|20036446|P2|COMPLETED|Overall Study||283
8128655|NCT02843529|20036447|P1|COMPLETED|Overall Study||213
8128656|NCT02843529|20036446|P2|STARTED|Overall Study||304
8128657|NCT02843529|20036447|P1|STARTED|Overall Study||244
8128658|NCT02843178|20036457|P4|NOT COMPLETED|Overall Study||4
8128659|NCT02843178|20036458|P3|NOT COMPLETED|Overall Study||7
8128660|NCT02843178|20036459|P2|NOT COMPLETED|Overall Study||8
8128661|NCT02843178|20036460|P1|NOT COMPLETED|Overall Study||8
8128662|NCT02843178|20036457|P4|COMPLETED|Overall Study||87
8128663|NCT02843178|20036458|P3|COMPLETED|Overall Study||85
8128664|NCT02843178|20036459|P2|COMPLETED|Overall Study||82
8128665|NCT02843178|20036460|P1|COMPLETED|Overall Study||78
8128666|NCT02843178|20036457|P4|STARTED|Overall Study||91
8128667|NCT02843178|20036458|P3|STARTED|Overall Study||92
8128668|NCT02843178|20036459|P2|STARTED|Overall Study||90
8128669|NCT02843178|20036460|P1|STARTED|Overall Study||86
8128670|NCT02842866|20036500|P2|NOT COMPLETED|Overall Study||3
8128671|NCT02842866|20036501|P1|NOT COMPLETED|Overall Study||7
8128672|NCT02842866|20036500|P2|COMPLETED|Overall Study||452
8128673|NCT02842866|20036501|P1|COMPLETED|Overall Study||444
8128674|NCT02842866|20036500|P2|Vaccinated|Overall Study||453
8128675|NCT02842866|20036501|P1|Vaccinated|Overall Study||448
8128676|NCT02842866|20036500|P2|STARTED|Overall Study||455
8128677|NCT02842866|20036501|P1|STARTED|Overall Study||451
8128678|NCT02842853|20036513|P4|NOT COMPLETED|Overall Study||24
8128679|NCT02842853|20036514|P3|NOT COMPLETED|Overall Study||21
8128680|NCT02842853|20036515|P2|NOT COMPLETED|Overall Study||34
8128681|NCT02842853|20036516|P1|NOT COMPLETED|Overall Study||23
8128682|NCT02842853|20036513|P4|COMPLETED|Overall Study||617
8128683|NCT02842853|20036514|P3|COMPLETED|Overall Study||885
8128684|NCT02842853|20036515|P2|COMPLETED|Overall Study||861
8128685|NCT02842853|20036516|P1|COMPLETED|Overall Study||879
8128686|NCT02842853|20036513|P4|Safety Analysis Set (SafAS)|Overall Study||635
8128687|NCT02842853|20036514|P3|Safety Analysis Set (SafAS)|Overall Study||898
8128688|NCT02842853|20036515|P2|Safety Analysis Set (SafAS)|Overall Study||883
8128689|NCT02842853|20036516|P1|Safety Analysis Set (SafAS)|Overall Study||895
8128690|NCT02842853|20036513|P4|Vaccinated|Overall Study||636
8128691|NCT02842853|20036514|P3|Vaccinated|Overall Study||900
8128692|NCT02842853|20036515|P2|Vaccinated|Overall Study||886
8128693|NCT02842853|20036516|P1|Vaccinated|Overall Study||895
8128694|NCT02842853|20036513|P4|STARTED|Overall Study||641
8128695|NCT02842853|20036514|P3|STARTED|Overall Study||906
8128696|NCT02842853|20036515|P2|STARTED|Overall Study||895
8128697|NCT02842853|20036516|P1|STARTED|Overall Study||902
8128698|NCT02842736|20036536|P1|NOT COMPLETED|Overall Study||41
8128699|NCT02842736|20036536|P1|COMPLETED|Overall Study|36 Month Visit Completed|201
8128700|NCT02842736|20036536|P1|24 Month Visit Performed|Overall Study||210
8128701|NCT02842736|20036536|P1|Known Month 12 Outcome|Overall Study||230
8128702|NCT02842736|20036536|P1|STARTED|Overall Study|Treated|242
8128703|NCT02842242|20036556|P2|NOT COMPLETED|Overall Study||0
8128704|NCT02842242|20036557|P1|NOT COMPLETED|Overall Study||1
8128705|NCT02842242|20036556|P2|COMPLETED|Overall Study||10
8128706|NCT02842242|20036557|P1|COMPLETED|Overall Study||10
8128707|NCT02842242|20036556|P2|STARTED|Overall Study||10
8128708|NCT02842242|20036557|P1|STARTED|Overall Study||11
8128709|NCT02842151|20036579|P1|NOT COMPLETED|Overall Study||2
8128710|NCT02842151|20036579|P1|COMPLETED|Overall Study||148
8128711|NCT02842151|20036579|P1|STARTED|Overall Study||150
8128712|NCT02842086|20036587|P2|NOT COMPLETED|Overall Study||493
8128713|NCT02842086|20036588|P1|NOT COMPLETED|Overall Study||544
8128714|NCT02842086|20036587|P2|COMPLETED|Overall Study||2206
8128715|NCT02842086|20036588|P1|COMPLETED|Overall Study||2156
8128716|NCT02842086|20036587|P2|STARTED|Overall Study||2699
8128717|NCT02842086|20036588|P1|STARTED|Overall Study||2700
8128718|NCT02842073|20036624|P1|NOT COMPLETED|Overall Study||1
8128719|NCT02842073|20036624|P1|COMPLETED|Overall Study||11
8128720|NCT02842073|20036624|P1|STARTED|Overall Study||12
8128721|NCT02842060|20036634|P2|NOT COMPLETED|Overall Study||0
8128722|NCT02842060|20036635|P1|NOT COMPLETED|Overall Study||0
8128723|NCT02842060|20036634|P2|COMPLETED|Overall Study||60
8128724|NCT02842060|20036635|P1|COMPLETED|Overall Study||120
8128725|NCT02842060|20036634|P2|STARTED|Overall Study||60
8128726|NCT02842060|20036635|P1|STARTED|Overall Study||120
8128727|NCT02841787|20036650|P3|NOT COMPLETED|Overall Study||0
8128728|NCT02841787|20036651|P2|NOT COMPLETED|Overall Study||4
8128729|NCT02841787|20036652|P1|NOT COMPLETED|Overall Study||3
8128730|NCT02841787|20036650|P3|COMPLETED|Overall Study||12
8128731|NCT02841787|20036651|P2|COMPLETED|Overall Study||19
8128732|NCT02841787|20036652|P1|COMPLETED|Overall Study||9
8128733|NCT02841787|20036650|P3|STARTED|Overall Study||12
8128734|NCT02841787|20036651|P2|STARTED|Overall Study||23
8128735|NCT02841787|20036652|P1|STARTED|Overall Study||12
8128736|NCT02841709|20036666|P5|NOT COMPLETED|5th Intervention||2
8128737|NCT02841709|20036667|P4|NOT COMPLETED|5th Intervention||0
8128738|NCT02841709|20036668|P3|NOT COMPLETED|5th Intervention||0
8128739|NCT02841709|20036669|P2|NOT COMPLETED|5th Intervention||0
8128740|NCT02841709|20036670|P1|NOT COMPLETED|5th Intervention||2
8128741|NCT02841709|20036666|P5|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
8128742|NCT02841709|20036667|P4|COMPLETED|5th Intervention||12
8128743|NCT02841709|20036668|P3|COMPLETED|5th Intervention||12
8128744|NCT02841709|20036669|P2|COMPLETED|5th Intervention||11
8128745|NCT02841709|20036670|P1|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
8128746|NCT02841709|20036666|P5|STARTED|5th Intervention||11
8128747|NCT02841709|20036667|P4|STARTED|5th Intervention||12
8128748|NCT02841709|20036668|P3|STARTED|5th Intervention||12
8128749|NCT02841709|20036669|P2|STARTED|5th Intervention||11
8128750|NCT02841709|20036670|P1|STARTED|5th Intervention||12
8128751|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 4||0
8128752|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 4||0
8128753|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 4||0
8128754|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 4||0
8128755|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 4||0
8128756|NCT02841709|20036666|P5|COMPLETED|Washout Period 4||11
8128757|NCT02841709|20036667|P4|COMPLETED|Washout Period 4||12
8128758|NCT02841709|20036668|P3|COMPLETED|Washout Period 4||12
8128759|NCT02841709|20036669|P2|COMPLETED|Washout Period 4||11
8128760|NCT02841709|20036670|P1|COMPLETED|Washout Period 4||12
8128761|NCT02841709|20036666|P5|STARTED|Washout Period 4||11
8128762|NCT02841709|20036667|P4|STARTED|Washout Period 4||12
8128763|NCT02841709|20036668|P3|STARTED|Washout Period 4||12
8128764|NCT02841709|20036669|P2|STARTED|Washout Period 4||11
8128765|NCT02841709|20036670|P1|STARTED|Washout Period 4||12
8128766|NCT02841709|20036666|P5|NOT COMPLETED|4th Intervention||0
8128767|NCT02841709|20036667|P4|NOT COMPLETED|4th Intervention||0
8128768|NCT02841709|20036668|P3|NOT COMPLETED|4th Intervention||0
8128769|NCT02841709|20036669|P2|NOT COMPLETED|4th Intervention||0
8128770|NCT02841709|20036670|P1|NOT COMPLETED|4th Intervention||0
8128771|NCT02841709|20036666|P5|COMPLETED|4th Intervention||11
8128772|NCT02841709|20036667|P4|COMPLETED|4th Intervention||12
8128773|NCT02841709|20036668|P3|COMPLETED|4th Intervention||12
8128774|NCT02841709|20036669|P2|COMPLETED|4th Intervention||11
8128775|NCT02841709|20036670|P1|COMPLETED|4th Intervention||12
8128776|NCT02841709|20036666|P5|STARTED|4th Intervention||11
8128777|NCT02841709|20036667|P4|STARTED|4th Intervention||12
8128778|NCT02841709|20036668|P3|STARTED|4th Intervention||12
8128779|NCT02841709|20036669|P2|STARTED|4th Intervention||11
8128780|NCT02841709|20036670|P1|STARTED|4th Intervention||12
8128781|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 3||0
8128782|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 3||0
8128783|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 3||0
8128784|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 3||0
8128785|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 3||0
8128786|NCT02841709|20036666|P5|COMPLETED|Washout Period 3||11
8128787|NCT02841709|20036667|P4|COMPLETED|Washout Period 3||12
8128788|NCT02841709|20036668|P3|COMPLETED|Washout Period 3||12
8128789|NCT02841709|20036669|P2|COMPLETED|Washout Period 3||11
8128790|NCT02841709|20036670|P1|COMPLETED|Washout Period 3||12
8128791|NCT02841709|20036666|P5|STARTED|Washout Period 3||11
8128792|NCT02841709|20036667|P4|STARTED|Washout Period 3||12
8128793|NCT02841709|20036668|P3|STARTED|Washout Period 3||12
8128794|NCT02841709|20036669|P2|STARTED|Washout Period 3||11
8128795|NCT02841709|20036670|P1|STARTED|Washout Period 3||12
8128796|NCT02841709|20036666|P5|NOT COMPLETED|3rd Intervention||0
8128797|NCT02841709|20036667|P4|NOT COMPLETED|3rd Intervention||0
8128798|NCT02841709|20036668|P3|NOT COMPLETED|3rd Intervention||0
8128799|NCT02841709|20036669|P2|NOT COMPLETED|3rd Intervention||0
8128800|NCT02841709|20036670|P1|NOT COMPLETED|3rd Intervention||0
8128801|NCT02841709|20036666|P5|COMPLETED|3rd Intervention||11
8128802|NCT02841709|20036667|P4|COMPLETED|3rd Intervention||12
8128803|NCT02841709|20036668|P3|COMPLETED|3rd Intervention||12
8128804|NCT02841709|20036669|P2|COMPLETED|3rd Intervention||11
8128805|NCT02841709|20036670|P1|COMPLETED|3rd Intervention||12
8128806|NCT02841709|20036666|P5|STARTED|3rd Intervention||11
8128807|NCT02841709|20036667|P4|STARTED|3rd Intervention||12
8128808|NCT02841709|20036668|P3|STARTED|3rd Intervention||12
8128809|NCT02841709|20036669|P2|STARTED|3rd Intervention||11
8128810|NCT02841709|20036670|P1|STARTED|3rd Intervention||12
8128811|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 2||0
8128812|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 2||0
8128813|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 2||0
8128814|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 2||0
8128815|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 2||0
8128816|NCT02841709|20036666|P5|COMPLETED|Washout Period 2||11
8128817|NCT02841709|20036667|P4|COMPLETED|Washout Period 2||12
8128818|NCT02841709|20036668|P3|COMPLETED|Washout Period 2||12
8128819|NCT02841709|20036669|P2|COMPLETED|Washout Period 2||11
8128820|NCT02841709|20036670|P1|COMPLETED|Washout Period 2||12
8128821|NCT02841709|20036666|P5|STARTED|Washout Period 2||11
8128822|NCT02841709|20036667|P4|STARTED|Washout Period 2||12
8128823|NCT02841709|20036668|P3|STARTED|Washout Period 2||12
8128824|NCT02841709|20036669|P2|STARTED|Washout Period 2||11
8128825|NCT02841709|20036670|P1|STARTED|Washout Period 2||12
8128826|NCT02841709|20036666|P5|NOT COMPLETED|2nd Intervention||0
8128827|NCT02841709|20036667|P4|NOT COMPLETED|2nd Intervention||0
8128828|NCT02841709|20036668|P3|NOT COMPLETED|2nd Intervention||0
8128829|NCT02841709|20036669|P2|NOT COMPLETED|2nd Intervention||0
8128830|NCT02841709|20036670|P1|NOT COMPLETED|2nd Intervention||0
8128831|NCT02841709|20036666|P5|COMPLETED|2nd Intervention||11
8128832|NCT02841709|20036667|P4|COMPLETED|2nd Intervention||12
8128833|NCT02841709|20036668|P3|COMPLETED|2nd Intervention||12
8128834|NCT02841709|20036669|P2|COMPLETED|2nd Intervention||11
8128835|NCT02841709|20036670|P1|COMPLETED|2nd Intervention||12
8128836|NCT02841709|20036666|P5|STARTED|2nd Intervention||11
8128837|NCT02841709|20036667|P4|STARTED|2nd Intervention||12
8128838|NCT02841709|20036668|P3|STARTED|2nd Intervention||12
8128839|NCT02841709|20036669|P2|STARTED|2nd Intervention||11
8128840|NCT02841709|20036670|P1|STARTED|2nd Intervention||12
8128841|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 1||0
8128842|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 1||0
8128843|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 1||0
8128844|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 1||0
8128845|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 1||0
8128846|NCT02841709|20036666|P5|COMPLETED|Washout Period 1||11
8128847|NCT02841709|20036667|P4|COMPLETED|Washout Period 1||12
8128848|NCT02841709|20036668|P3|COMPLETED|Washout Period 1||12
8128849|NCT02841709|20036669|P2|COMPLETED|Washout Period 1||11
8128850|NCT02841709|20036670|P1|COMPLETED|Washout Period 1||12
8128851|NCT02841709|20036666|P5|STARTED|Washout Period 1||11
8128852|NCT02841709|20036667|P4|STARTED|Washout Period 1||12
8128853|NCT02841709|20036668|P3|STARTED|Washout Period 1||12
8128854|NCT02841709|20036669|P2|STARTED|Washout Period 1||11
8128855|NCT02841709|20036670|P1|STARTED|Washout Period 1||12
8128856|NCT02841709|20036666|P5|NOT COMPLETED|1st Intervention||0
8128857|NCT02841709|20036667|P4|NOT COMPLETED|1st Intervention||0
8128858|NCT02841709|20036668|P3|NOT COMPLETED|1st Intervention||0
8128859|NCT02841709|20036669|P2|NOT COMPLETED|1st Intervention||0
8128860|NCT02841709|20036670|P1|NOT COMPLETED|1st Intervention||0
8128861|NCT02841709|20036666|P5|COMPLETED|1st Intervention||11
8128862|NCT02841709|20036667|P4|COMPLETED|1st Intervention||12
8128863|NCT02841709|20036668|P3|COMPLETED|1st Intervention||12
8128864|NCT02841709|20036669|P2|COMPLETED|1st Intervention||11
8128865|NCT02841709|20036670|P1|COMPLETED|1st Intervention||12
8128866|NCT02841709|20036666|P5|STARTED|1st Intervention||11
8128867|NCT02841709|20036667|P4|STARTED|1st Intervention||12
8128868|NCT02841709|20036668|P3|STARTED|1st Intervention||12
8128869|NCT02841709|20036669|P2|STARTED|1st Intervention||11
8128870|NCT02841709|20036670|P1|STARTED|1st Intervention||12
8128871|NCT02841449|20036690|P2|NOT COMPLETED|Overall Study||0
8128872|NCT02841449|20036691|P1|NOT COMPLETED|Overall Study||0
8128873|NCT02841449|20036690|P2|COMPLETED|Overall Study||9
8128874|NCT02841449|20036691|P1|COMPLETED|Overall Study||7
8128875|NCT02841449|20036690|P2|STARTED|Overall Study||9
8128876|NCT02841449|20036691|P1|STARTED|Overall Study||7
8128877|NCT02841267|20036718|P3|NOT COMPLETED|Extension Study||0
8128878|NCT02841267|20036719|P2|NOT COMPLETED|Extension Study||0
8128879|NCT02841267|20036720|P1|NOT COMPLETED|Extension Study||0
8128880|NCT02841267|20036718|P3|COMPLETED|Extension Study||6
8128881|NCT02841267|20036719|P2|COMPLETED|Extension Study||6
8128882|NCT02841267|20036720|P1|COMPLETED|Extension Study||4
8128883|NCT02841267|20036718|P3|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
8128884|NCT02841267|20036719|P2|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
8128885|NCT02841267|20036720|P1|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
8128886|NCT02841267|20036718|P3|NOT COMPLETED|Treatment Period||0
8128887|NCT02841267|20036719|P2|NOT COMPLETED|Treatment Period||0
8128888|NCT02841267|20036720|P1|NOT COMPLETED|Treatment Period||0
8128889|NCT02841267|20036718|P3|COMPLETED|Treatment Period||8
8128890|NCT02841267|20036719|P2|COMPLETED|Treatment Period||7
8128891|NCT02841267|20036720|P1|COMPLETED|Treatment Period||4
8128892|NCT02841267|20036718|P3|STARTED|Treatment Period||8
8128893|NCT02841267|20036719|P2|STARTED|Treatment Period||7
8128894|NCT02841267|20036720|P1|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
8128895|NCT02841267|20036718|P3|NOT COMPLETED|Lead-in (Untreated)||0
8128896|NCT02841267|20036719|P2|NOT COMPLETED|Lead-in (Untreated)||0
8128897|NCT02841267|20036720|P1|NOT COMPLETED|Lead-in (Untreated)||0
8128898|NCT02841267|20036718|P3|COMPLETED|Lead-in (Untreated)||8
8128899|NCT02841267|20036719|P2|COMPLETED|Lead-in (Untreated)||7
8128900|NCT02841267|20036720|P1|COMPLETED|Lead-in (Untreated)||4
8128901|NCT02841267|20036718|P3|STARTED|Lead-in (Untreated)||8
8128902|NCT02841267|20036719|P2|STARTED|Lead-in (Untreated)||7
8128903|NCT02841267|20036720|P1|STARTED|Lead-in (Untreated)||4
8128904|NCT02841241|20036763|P1|NOT COMPLETED|Overall Study||0
8128905|NCT02841241|20036763|P1|COMPLETED|Overall Study||7
8128906|NCT02841241|20036763|P1|STARTED|Overall Study||7
8128907|NCT02841189|20036774|P1|NOT COMPLETED|Overall Study||35
8128908|NCT02841189|20036774|P1|COMPLETED|Overall Study||65
8128909|NCT02841189|20036774|P1|STARTED|Overall Study||100
8128910|NCT02841046|20036780|P2|NOT COMPLETED|Overall Study||0
8128911|NCT02841046|20036781|P1|NOT COMPLETED|Overall Study||0
8128912|NCT02841046|20036780|P2|COMPLETED|Overall Study||25
8128913|NCT02841046|20036781|P1|COMPLETED|Overall Study||25
8128914|NCT02841046|20036780|P2|STARTED|Overall Study||25
8128915|NCT02841046|20036781|P1|STARTED|Overall Study||25
8128916|NCT02840916|20036789|P2|NOT COMPLETED|Overall Study||3
8128917|NCT02840916|20036790|P1|NOT COMPLETED|Overall Study||1
8128918|NCT02840916|20036789|P2|COMPLETED|Overall Study||30
8128919|NCT02840916|20036790|P1|COMPLETED|Overall Study||32
8128920|NCT02840916|20036789|P2|STARTED|Overall Study||33
8128921|NCT02840916|20036790|P1|STARTED|Overall Study||33
8128922|NCT02840721|20036800|P1|NOT COMPLETED|Follow-Up||7
8128923|NCT02840721|20036800|P1|COMPLETED|Follow-Up||42
8128924|NCT02840721|20036800|P1|STARTED|Follow-Up||49
8128925|NCT02840721|20036800|P1|NOT COMPLETED|Treatment Period||1
8128926|NCT02840721|20036800|P1|COMPLETED|Treatment Period||49
8128927|NCT02840721|20036800|P1|STARTED|Treatment Period||50
8128928|NCT02840461|20036822|P3|NOT COMPLETED|Overall Study||14
8128929|NCT02840461|20036823|P2|NOT COMPLETED|Overall Study||22
8128930|NCT02840461|20036824|P1|NOT COMPLETED|Overall Study||23
8128931|NCT02840461|20036822|P3|COMPLETED|Overall Study||100
8128932|NCT02840461|20036823|P2|COMPLETED|Overall Study||235
8128933|NCT02840461|20036824|P1|COMPLETED|Overall Study||236
8128934|NCT02840461|20036822|P3|STARTED|Overall Study||114
8128935|NCT02840461|20036823|P2|STARTED|Overall Study||257
8128936|NCT02840461|20036824|P1|STARTED|Overall Study||259
8128937|NCT02840253|20036835|P1|NOT COMPLETED|Overall Study||4
8128938|NCT02840253|20036835|P1|COMPLETED|Overall Study||19
8128939|NCT02840253|20036835|P1|STARTED|Overall Study||23
8128940|NCT02839902|20036842|P2|NOT COMPLETED|Overall Study||0
8128941|NCT02839902|20036843|P1|NOT COMPLETED|Overall Study||0
8128942|NCT02839902|20036842|P2|COMPLETED|Overall Study||29
8128943|NCT02839902|20036843|P1|COMPLETED|Overall Study||24
8128944|NCT02839902|20036842|P2|STARTED|Overall Study||29
8128945|NCT02839902|20036843|P1|STARTED|Overall Study||24
8128946|NCT02839889|20036881|P2|NOT COMPLETED|Open-Label Period||1
8128947|NCT02839889|20036882|P1|NOT COMPLETED|Open-Label Period||0
8128948|NCT02839889|20036881|P2|COMPLETED|Open-Label Period||4
8128949|NCT02839889|20036882|P1|COMPLETED|Open-Label Period||0
8128950|NCT02839889|20036881|P2|STARTED|Open-Label Period||5
8128951|NCT02839889|20036882|P1|STARTED|Open-Label Period||0
8128952|NCT02839889|20036881|P2|NOT COMPLETED|Randomization Period||0
8128953|NCT02839889|20036882|P1|NOT COMPLETED|Randomization Period||0
8128954|NCT02839889|20036881|P2|COMPLETED|Randomization Period||3
8128955|NCT02839889|20036882|P1|COMPLETED|Randomization Period||2
8128956|NCT02839889|20036881|P2|STARTED|Randomization Period||3
8128957|NCT02839889|20036882|P1|STARTED|Randomization Period||2
8128958|NCT02839876|20036920|P2|NOT COMPLETED|Overall Study||11
8128959|NCT02839876|20036921|P1|NOT COMPLETED|Overall Study||10
8128960|NCT02839876|20036920|P2|COMPLETED|Overall Study||29
8128961|NCT02839876|20036921|P1|COMPLETED|Overall Study||31
8128962|NCT02839876|20036920|P2|STARTED|Overall Study||40
8128963|NCT02839876|20036921|P1|STARTED|Overall Study||41
8128964|NCT02839798|20036983|P1|NOT COMPLETED|Overall Study||2
8128965|NCT02839798|20036983|P1|COMPLETED|Overall Study||4
8128966|NCT02839798|20036983|P1|STARTED|Overall Study||6
8128967|NCT02839772|20036991|P2|NOT COMPLETED|Overall Study||0
8128968|NCT02839772|20036992|P1|NOT COMPLETED|Overall Study||1
8128969|NCT02839772|20036991|P2|COMPLETED|Overall Study||96
8128970|NCT02839772|20036992|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
8128971|NCT02839772|20036991|P2|STARTED|Overall Study||96
8128972|NCT02839772|20036992|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
8128973|NCT02839746|20037029|P1|NOT COMPLETED|Overall Study||12
8128974|NCT02839746|20037029|P1|COMPLETED|Overall Study||659
8128975|NCT02839746|20037029|P1|STARTED|Overall Study||671
8128976|NCT02839681|20037043|P1|NOT COMPLETED|Overall Study||2
8128977|NCT02839681|20037043|P1|COMPLETED|Overall Study||0
8128978|NCT02839681|20037043|P1|STARTED|Overall Study||2
8128979|NCT02839330|20037056|P4|NOT COMPLETED|Overall Study||51
8128980|NCT02839330|20037057|P3|NOT COMPLETED|Overall Study||48
8128981|NCT02839330|20037058|P2|NOT COMPLETED|Overall Study||58
8128982|NCT02839330|20037059|P1|NOT COMPLETED|Overall Study||58
8128983|NCT02839330|20037056|P4|COMPLETED|Overall Study||747
8128984|NCT02839330|20037057|P3|COMPLETED|Overall Study||747
8128985|NCT02839330|20037058|P2|COMPLETED|Overall Study||741
8128986|NCT02839330|20037059|P1|COMPLETED|Overall Study||746
8128987|NCT02839330|20037056|P4|Exposed|Overall Study||797
8128988|NCT02839330|20037057|P3|Exposed|Overall Study||793
8128989|NCT02839330|20037058|P2|Exposed|Overall Study||797
8128990|NCT02839330|20037059|P1|Exposed|Overall Study||804
8128991|NCT02839330|20037056|P4|STARTED|Overall Study||798
8128992|NCT02839330|20037057|P3|STARTED|Overall Study||795
8128993|NCT02839330|20037058|P2|STARTED|Overall Study||799
8128994|NCT02839330|20037059|P1|STARTED|Overall Study||804
8128995|NCT02839200|20037094|P6|NOT COMPLETED|Overall Study||1
8128996|NCT02839200|20037095|P5|NOT COMPLETED|Overall Study||2
8128997|NCT02839200|20037096|P4|NOT COMPLETED|Overall Study||0
8128998|NCT02839200|20037097|P3|NOT COMPLETED|Overall Study||1
8128999|NCT02839200|20037098|P2|NOT COMPLETED|Overall Study||1
8129000|NCT02839200|20037099|P1|NOT COMPLETED|Overall Study||4
8129001|NCT02839200|20037094|P6|COMPLETED|Overall Study||59
8129002|NCT02839200|20037095|P5|COMPLETED|Overall Study||58
8129003|NCT02839200|20037096|P4|COMPLETED|Overall Study||61
8129004|NCT02839200|20037097|P3|COMPLETED|Overall Study||59
8129005|NCT02839200|20037098|P2|COMPLETED|Overall Study||58
8129006|NCT02839200|20037099|P1|COMPLETED|Overall Study||56
8129007|NCT02839200|20037094|P6|STARTED|Overall Study||60
8129008|NCT02839200|20037095|P5|STARTED|Overall Study||60
8129009|NCT02839200|20037096|P4|STARTED|Overall Study||61
8129010|NCT02839200|20037097|P3|STARTED|Overall Study||60
8129011|NCT02839200|20037098|P2|STARTED|Overall Study||59
8129012|NCT02839200|20037099|P1|STARTED|Overall Study||60
8129013|NCT02838901|20037133|P2|NOT COMPLETED|Overall Study||2
8129014|NCT02838901|20037134|P1|NOT COMPLETED|Overall Study||2
8129015|NCT02838901|20037133|P2|COMPLETED|Overall Study||7
8129016|NCT02838901|20037134|P1|COMPLETED|Overall Study||7
8129017|NCT02838901|20037133|P2|STARTED|Overall Study||9
8129018|NCT02838901|20037134|P1|STARTED|Overall Study||9
8129019|NCT02838420|20037164|P2|NOT COMPLETED|Overall Study||62
8129020|NCT02838420|20037165|P1|NOT COMPLETED|Overall Study||125
8129021|NCT02838420|20037164|P2|COMPLETED|Overall Study||0
8129022|NCT02838420|20037165|P1|COMPLETED|Overall Study||0
8129023|NCT02838420|20037164|P2|STARTED|Overall Study||62
8129024|NCT02838420|20037165|P1|STARTED|Overall Study||125
8129025|NCT02838407|20037179|P1|NOT COMPLETED|Overall Study||0
8129026|NCT02838407|20037179|P1|COMPLETED|Overall Study||197
8129027|NCT02838407|20037179|P1|STARTED|Overall Study||197
8129028|NCT02838134|20037228|P2|NOT COMPLETED|Overall Study||3
8129029|NCT02838134|20037229|P1|NOT COMPLETED|Overall Study||2
8129030|NCT02838134|20037228|P2|COMPLETED|Overall Study||48
8129031|NCT02838134|20037229|P1|COMPLETED|Overall Study||48
8129032|NCT02838134|20037228|P2|STARTED|Overall Study||51
8129033|NCT02838134|20037229|P1|STARTED|Overall Study||50
8129034|NCT02838017|20037261|P2|NOT COMPLETED|Overall Study||11
8129035|NCT02838017|20037262|P1|NOT COMPLETED|Overall Study||14
8129036|NCT02838017|20037261|P2|COMPLETED|Overall Study||241
8129037|NCT02838017|20037262|P1|COMPLETED|Overall Study||238
8129038|NCT02838017|20037261|P2|STARTED|Overall Study||252
8129039|NCT02838017|20037262|P1|STARTED|Overall Study||252
8129040|NCT02837952|20037280|P2|NOT COMPLETED|Overall Study||6
8129041|NCT02837952|20037281|P1|NOT COMPLETED|Overall Study||5
8129042|NCT02837952|20037280|P2|COMPLETED|Overall Study||76
8129043|NCT02837952|20037281|P1|COMPLETED|Overall Study||36
8129044|NCT02837952|20037280|P2|STARTED|Overall Study||82
8129045|NCT02837952|20037281|P1|STARTED|Overall Study||41
8129046|NCT02837913|20037295|P2|NOT COMPLETED|Overall Study||0
8129047|NCT02837913|20037296|P1|NOT COMPLETED|Overall Study||0
8129048|NCT02837913|20037295|P2|COMPLETED|Overall Study||9
8129049|NCT02837913|20037296|P1|COMPLETED|Overall Study||10
8129050|NCT02837913|20037295|P2|STARTED|Overall Study||9
8129051|NCT02837913|20037296|P1|STARTED|Overall Study||10
8129052|NCT02837731|20037318|P2|NOT COMPLETED|Analysis||0
8129053|NCT02837731|20037319|P1|NOT COMPLETED|Analysis||0
8129054|NCT02837731|20037318|P2|COMPLETED|Analysis||41
8129055|NCT02837731|20037319|P1|COMPLETED|Analysis||83
8129056|NCT02837731|20037318|P2|STARTED|Analysis||41
8129057|NCT02837731|20037319|P1|STARTED|Analysis||83
8129058|NCT02837731|20037318|P2|NOT COMPLETED|Follow-up||0
8129059|NCT02837731|20037319|P1|NOT COMPLETED|Follow-up||0
8129060|NCT02837731|20037318|P2|COMPLETED|Follow-up||41
8129061|NCT02837731|20037319|P1|COMPLETED|Follow-up||83
8129062|NCT02837731|20037318|P2|STARTED|Follow-up||41
8129063|NCT02837731|20037319|P1|STARTED|Follow-up||83
8129064|NCT02837731|20037318|P2|NOT COMPLETED|Allocation||7
8129065|NCT02837731|20037319|P1|NOT COMPLETED|Allocation||19
8129066|NCT02837731|20037318|P2|COMPLETED|Allocation||41
8129067|NCT02837731|20037319|P1|COMPLETED|Allocation||83
8129068|NCT02837731|20037318|P2|STARTED|Allocation||48
8129069|NCT02837731|20037319|P1|STARTED|Allocation||102
8129070|NCT02837328|20037351|P2|NOT COMPLETED|Overall Study||0
8129071|NCT02837328|20037352|P1|NOT COMPLETED|Overall Study||0
8129072|NCT02837328|20037351|P2|COMPLETED|Overall Study||30
8129073|NCT02837328|20037352|P1|COMPLETED|Overall Study||29
8129074|NCT02837328|20037351|P2|STARTED|Overall Study||30
8129075|NCT02837328|20037352|P1|STARTED|Overall Study||29
8129076|NCT02837237|20037360|P1|NOT COMPLETED|Overall Study||0
8129077|NCT02837237|20037360|P1|COMPLETED|Overall Study||11
8129078|NCT02837237|20037360|P1|STARTED|Overall Study||11
8129079|NCT02837029|20037367|P3|NOT COMPLETED|2 Year Follow-up||0
8129080|NCT02837029|20037368|P2|NOT COMPLETED|2 Year Follow-up||7
8129081|NCT02837029|20037369|P1|NOT COMPLETED|2 Year Follow-up||6
8129082|NCT02837029|20037367|P3|COMPLETED|2 Year Follow-up||0
8129083|NCT02837029|20037368|P2|COMPLETED|2 Year Follow-up||0
8129084|NCT02837029|20037369|P1|COMPLETED|2 Year Follow-up||0
8129085|NCT02837029|20037367|P3|STARTED|2 Year Follow-up||0
8129086|NCT02837029|20037368|P2|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
8129087|NCT02837029|20037369|P1|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
8129088|NCT02837029|20037367|P3|NOT COMPLETED|Cycle 2 and Beyond||0
8129089|NCT02837029|20037368|P2|NOT COMPLETED|Cycle 2 and Beyond||0
8129090|NCT02837029|20037369|P1|NOT COMPLETED|Cycle 2 and Beyond||1
8129091|NCT02837029|20037367|P3|COMPLETED|Cycle 2 and Beyond||0
8129092|NCT02837029|20037368|P2|COMPLETED|Cycle 2 and Beyond||6
8129093|NCT02837029|20037369|P1|COMPLETED|Cycle 2 and Beyond||5
8129094|NCT02837029|20037367|P3|STARTED|Cycle 2 and Beyond||0
8129095|NCT02837029|20037368|P2|STARTED|Cycle 2 and Beyond||6
8129096|NCT02837029|20037369|P1|STARTED|Cycle 2 and Beyond||6
8129097|NCT02837029|20037367|P3|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
8129098|NCT02837029|20037368|P2|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
8129099|NCT02837029|20037369|P1|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
8129100|NCT02837029|20037367|P3|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
8129101|NCT02837029|20037368|P2|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
8129102|NCT02837029|20037369|P1|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
8129103|NCT02837029|20037367|P3|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
8129104|NCT02837029|20037368|P2|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
8129105|NCT02837029|20037369|P1|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
8129106|NCT02837029|20037367|P3|STARTED|Cycle 1 (DLT Monitoring Period)||0
8129107|NCT02837029|20037368|P2|STARTED|Cycle 1 (DLT Monitoring Period)||9
8129108|NCT02837029|20037369|P1|STARTED|Cycle 1 (DLT Monitoring Period)||8
8129109|NCT02837029|20037367|P3|NOT COMPLETED|Induction Treatment With Y90||0
8129110|NCT02837029|20037368|P2|NOT COMPLETED|Induction Treatment With Y90||0
8129111|NCT02837029|20037369|P1|NOT COMPLETED|Induction Treatment With Y90||0
8129112|NCT02837029|20037367|P3|COMPLETED|Induction Treatment With Y90||0
8129113|NCT02837029|20037368|P2|COMPLETED|Induction Treatment With Y90||9
8129114|NCT02837029|20037369|P1|COMPLETED|Induction Treatment With Y90||8
8129115|NCT02837029|20037367|P3|STARTED|Induction Treatment With Y90||0
8129116|NCT02837029|20037368|P2|STARTED|Induction Treatment With Y90||9
8129117|NCT02837029|20037369|P1|STARTED|Induction Treatment With Y90||8
8129118|NCT02837029|20037367|P3|NOT COMPLETED|Screening||0
8129119|NCT02837029|20037368|P2|NOT COMPLETED|Screening||3
8129120|NCT02837029|20037369|P1|NOT COMPLETED|Screening||7
8129121|NCT02837029|20037367|P3|COMPLETED|Screening||0
8129122|NCT02837029|20037368|P2|COMPLETED|Screening||9
8129123|NCT02837029|20037369|P1|COMPLETED|Screening||8
8129124|NCT02837029|20037367|P3|STARTED|Screening||0
8129125|NCT02837029|20037368|P2|STARTED|Screening||12
8129126|NCT02837029|20037369|P1|STARTED|Screening||15
8129127|NCT02836990|20037378|P2|NOT COMPLETED|Overall Study||0
8129128|NCT02836990|20037379|P1|NOT COMPLETED|Overall Study||0
8129129|NCT02836990|20037378|P2|COMPLETED|Overall Study||55
8129130|NCT02836990|20037379|P1|COMPLETED|Overall Study||50
8129131|NCT02836990|20037378|P2|STARTED|Overall Study||55
8129132|NCT02836990|20037379|P1|STARTED|Overall Study||50
8129133|NCT02836652|20037391|P2|NOT COMPLETED|Overall Study||19
8129134|NCT02836652|20037392|P1|NOT COMPLETED|Overall Study||18
8129135|NCT02836652|20037391|P2|COMPLETED|Overall Study||18
8129136|NCT02836652|20037392|P1|COMPLETED|Overall Study||17
8129137|NCT02836652|20037391|P2|As-treated Population|Overall Study||34
8129138|NCT02836652|20037392|P1|As-treated Population|Overall Study||31
8129139|NCT02836652|20037391|P2|STARTED|Overall Study||37
8129140|NCT02836652|20037392|P1|STARTED|Overall Study||35
8129141|NCT02836613|20037406|P2|NOT COMPLETED|Overall Study||3
8129142|NCT02836613|20037407|P1|NOT COMPLETED|Overall Study||1
8129143|NCT02836613|20037406|P2|COMPLETED|Overall Study||77
8129144|NCT02836613|20037407|P1|COMPLETED|Overall Study||79
8129145|NCT02836613|20037406|P2|STARTED|Overall Study||80
8129146|NCT02836613|20037407|P1|STARTED|Overall Study||80
8129147|NCT02836496|20037421|P2|NOT COMPLETED|Overall Study||2
8129148|NCT02836496|20037422|P1|NOT COMPLETED|Overall Study||2
8129149|NCT02836496|20037421|P2|COMPLETED|Overall Study||52
8129150|NCT02836496|20037422|P1|COMPLETED|Overall Study||52
8129151|NCT02836496|20037421|P2|STARTED|Overall Study||54
8129152|NCT02836496|20037422|P1|STARTED|Overall Study||54
8129159|NCT02836236|20037457|P2|NOT COMPLETED|Overall Study||50
8129160|NCT02836236|20037458|P1|NOT COMPLETED|Overall Study||105
8129161|NCT02836236|20037457|P2|COMPLETED|Overall Study||0
8129162|NCT02836236|20037458|P1|COMPLETED|Overall Study||0
8129163|NCT02836236|20037457|P2|STARTED|Overall Study||50
8129164|NCT02836236|20037458|P1|STARTED|Overall Study||105
8129165|NCT02835820|20037474|P2|NOT COMPLETED|Overall Study||3
8129166|NCT02835820|20037475|P1|NOT COMPLETED|Overall Study||0
8129167|NCT02835820|20037474|P2|COMPLETED|Overall Study||7
8129168|NCT02835820|20037475|P1|COMPLETED|Overall Study||7
8129169|NCT02835820|20037474|P2|Baseline Screen (OGTT)|Overall Study||7
8129170|NCT02835820|20037475|P1|Baseline Screen (OGTT)|Overall Study||7
8129171|NCT02835820|20037474|P2|STARTED|Overall Study||10
8129172|NCT02835820|20037475|P1|STARTED|Overall Study||7
8129173|NCT02835690|20037522|P3|NOT COMPLETED|Overall Study||15
8129174|NCT02835690|20037523|P2|NOT COMPLETED|Overall Study||15
8129175|NCT02835690|20037524|P1|NOT COMPLETED|Overall Study||14
8129176|NCT02835690|20037522|P3|COMPLETED|Overall Study||0
8129177|NCT02835690|20037523|P2|COMPLETED|Overall Study||0
8129178|NCT02835690|20037524|P1|COMPLETED|Overall Study||0
8129179|NCT02835690|20037522|P3|Treated|Overall Study||15
8129180|NCT02835690|20037523|P2|Treated|Overall Study||13
8129181|NCT02835690|20037524|P1|Treated|Overall Study||14
8129182|NCT02835690|20037522|P3|STARTED|Overall Study||15
8129183|NCT02835690|20037523|P2|STARTED|Overall Study||15
8129184|NCT02835690|20037524|P1|STARTED|Overall Study||14
8129185|NCT02835677|20037577|P1|NOT COMPLETED|Overall Study||0
8129186|NCT02835677|20037577|P1|COMPLETED|Overall Study||25
8129187|NCT02835677|20037577|P1|STARTED|Overall Study||25
8129188|NCT02835625|20037587|P2|NOT COMPLETED|Overall Study||0
8129189|NCT02835625|20037588|P1|NOT COMPLETED|Overall Study||0
8129190|NCT02835625|20037587|P2|COMPLETED|Overall Study||14719
8129191|NCT02835625|20037588|P1|COMPLETED|Overall Study||14734
8129192|NCT02835625|20037587|P2|STARTED|Overall Study||14719
8129193|NCT02835625|20037588|P1|STARTED|Overall Study||14734
8129194|NCT02835495|20037607|P2|NOT COMPLETED|Overall Study||2
8129195|NCT02835495|20037608|P1|NOT COMPLETED|Overall Study||5
8129196|NCT02835495|20037607|P2|COMPLETED|Overall Study||23
8129197|NCT02835495|20037608|P1|COMPLETED|Overall Study||21
8129198|NCT02835495|20037607|P2|Intervention Start|Overall Study||25
8129199|NCT02835495|20037608|P1|Intervention Start|Overall Study||25
8129200|NCT02835495|20037607|P2|STARTED|Overall Study||25
8129201|NCT02835495|20037608|P1|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
8129202|NCT02835339|20037634|P2|NOT COMPLETED|Overall Study||16
8129203|NCT02835339|20037635|P1|NOT COMPLETED|Overall Study||13
8129204|NCT02835339|20037634|P2|COMPLETED|Overall Study||19
8129205|NCT02835339|20037635|P1|COMPLETED|Overall Study||18
8129206|NCT02835339|20037634|P2|STARTED|Overall Study||35
8129207|NCT02835339|20037635|P1|STARTED|Overall Study||31
8129208|NCT02835274|20037647|P2|NOT COMPLETED|Overall Study||0
8129209|NCT02835274|20037648|P1|NOT COMPLETED|Overall Study||0
8129210|NCT02835274|20037647|P2|COMPLETED|Overall Study||6
8129211|NCT02835274|20037648|P1|COMPLETED|Overall Study||6
8129212|NCT02835274|20037647|P2|STARTED|Overall Study||6
8129213|NCT02835274|20037648|P1|STARTED|Overall Study||6
8129214|NCT02835092|20037657|P3|NOT COMPLETED|Overall Study||3
8129215|NCT02835092|20037658|P2|NOT COMPLETED|Overall Study||8
8129216|NCT02835092|20037659|P1|NOT COMPLETED|Overall Study||3
8129217|NCT02835092|20037657|P3|COMPLETED|Overall Study||64
8129218|NCT02835092|20037658|P2|COMPLETED|Overall Study||57
8129219|NCT02835092|20037659|P1|COMPLETED|Overall Study||63
8129220|NCT02835092|20037657|P3|STARTED|Overall Study||67
8129221|NCT02835092|20037658|P2|STARTED|Overall Study||65
8129222|NCT02835092|20037659|P1|STARTED|Overall Study||66
8129223|NCT02834819|20037669|P2|NOT COMPLETED|Overall Study||0
8129224|NCT02834819|20037670|P1|NOT COMPLETED|Overall Study||5
8129225|NCT02834819|20037669|P2|COMPLETED|Overall Study||9
8129226|NCT02834819|20037670|P1|COMPLETED|Overall Study||4
8129227|NCT02834819|20037669|P2|STARTED|Overall Study||9
8129228|NCT02834819|20037670|P1|STARTED|Overall Study||9
8129229|NCT02834806|20037690|P1|NOT COMPLETED|Overall Study||0
8129230|NCT02834806|20037690|P1|COMPLETED|Overall Study||58
8129231|NCT02834806|20037690|P1|STARTED|Overall Study||58
8129232|NCT02834663|20037694|P1|NOT COMPLETED|Overall Study||0
8129233|NCT02834663|20037694|P1|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
8129234|NCT02834663|20037694|P1|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
8129235|NCT02834624|20037714|P2|NOT COMPLETED|Overall Study||0
8129236|NCT02834624|20037715|P1|NOT COMPLETED|Overall Study||0
8129237|NCT02834624|20037714|P2|COMPLETED|Overall Study||15
8129238|NCT02834624|20037715|P1|COMPLETED|Overall Study||15
8129239|NCT02834624|20037714|P2|STARTED|Overall Study||15
8129240|NCT02834624|20037715|P1|STARTED|Overall Study||15
8129241|NCT02834247|20037729|P4|NOT COMPLETED|Dose Expansion Phase||17
8129242|NCT02834247|20037730|P3|NOT COMPLETED|Dose Expansion Phase||0
8129243|NCT02834247|20037731|P2|NOT COMPLETED|Dose Expansion Phase||0
8129244|NCT02834247|20037732|P1|NOT COMPLETED|Dose Expansion Phase||0
8129245|NCT02834247|20037729|P4|COMPLETED|Dose Expansion Phase||0
8129246|NCT02834247|20037730|P3|COMPLETED|Dose Expansion Phase||0
8129247|NCT02834247|20037731|P2|COMPLETED|Dose Expansion Phase||0
8129248|NCT02834247|20037732|P1|COMPLETED|Dose Expansion Phase||0
8129249|NCT02834247|20037729|P4|STARTED|Dose Expansion Phase||17
8129250|NCT02834247|20037730|P3|STARTED|Dose Expansion Phase||0
8129251|NCT02834247|20037731|P2|STARTED|Dose Expansion Phase||0
8129252|NCT02834247|20037732|P1|STARTED|Dose Expansion Phase||0
8129253|NCT02834247|20037729|P4|NOT COMPLETED|Dose Escalation Phase||0
8129254|NCT02834247|20037730|P3|NOT COMPLETED|Dose Escalation Phase||5
8129255|NCT02834247|20037731|P2|NOT COMPLETED|Dose Escalation Phase||11
8129256|NCT02834247|20037732|P1|NOT COMPLETED|Dose Escalation Phase||8
8129257|NCT02834247|20037729|P4|COMPLETED|Dose Escalation Phase||0
8129258|NCT02834247|20037730|P3|COMPLETED|Dose Escalation Phase||0
8129259|NCT02834247|20037731|P2|COMPLETED|Dose Escalation Phase||0
8129260|NCT02834247|20037732|P1|COMPLETED|Dose Escalation Phase||0
8129261|NCT02834247|20037729|P4|STARTED|Dose Escalation Phase||0
8129262|NCT02834247|20037730|P3|STARTED|Dose Escalation Phase||5
8129263|NCT02834247|20037731|P2|STARTED|Dose Escalation Phase||11
8129264|NCT02834247|20037732|P1|STARTED|Dose Escalation Phase||8
8129265|NCT02833974|20037761|P2|NOT COMPLETED|Overall Study||3
8129266|NCT02833974|20037762|P1|NOT COMPLETED|Overall Study||1
8129267|NCT02833974|20037761|P2|COMPLETED|Overall Study||19
8129268|NCT02833974|20037762|P1|COMPLETED|Overall Study||13
8129269|NCT02833974|20037761|P2|STARTED|Overall Study||22
8129270|NCT02833974|20037762|P1|STARTED|Overall Study||14
8129271|NCT02833948|20037788|P2|NOT COMPLETED|Overall Study||18
8129272|NCT02833948|20037789|P1|NOT COMPLETED|Overall Study||15
8129273|NCT02833948|20037788|P2|COMPLETED|Overall Study||97
8129274|NCT02833948|20037789|P1|COMPLETED|Overall Study||101
8129275|NCT02833948|20037788|P2|STARTED|Overall Study||115
8129276|NCT02833948|20037789|P1|STARTED|Overall Study||116
8129277|NCT02833922|20037813|P1|NOT COMPLETED|Overall Study||382
8129278|NCT02833922|20037813|P1|COMPLETED|Overall Study||336
8129279|NCT02833922|20037813|P1|STARTED|Overall Study||718
8129280|NCT02833857|20037821|P1|NOT COMPLETED|Overall Study||0
8129281|NCT02833857|20037821|P1|COMPLETED|Overall Study||11
8129282|NCT02833857|20037821|P1|STARTED|Overall Study||11
8129283|NCT02833415|20037848|P2|NOT COMPLETED|Overall Study||3
8129284|NCT02833415|20037849|P1|NOT COMPLETED|Overall Study||2
8129285|NCT02833415|20037848|P2|COMPLETED|Overall Study||17
8129286|NCT02833415|20037849|P1|COMPLETED|Overall Study||18
8129287|NCT02833415|20037848|P2|STARTED|Overall Study||20
8129288|NCT02833415|20037849|P1|STARTED|Overall Study||20
8129289|NCT02833350|20037862|P7|NOT COMPLETED|Overall Study||5
8129290|NCT02833350|20037863|P6|NOT COMPLETED|Overall Study||1
8129291|NCT02833350|20037864|P5|NOT COMPLETED|Overall Study||3
8129292|NCT02833350|20037865|P4|NOT COMPLETED|Overall Study||8
8129293|NCT02833350|20037866|P3|NOT COMPLETED|Overall Study||8
8129294|NCT02833350|20037867|P2|NOT COMPLETED|Overall Study||9
8129295|NCT02833350|20037868|P1|NOT COMPLETED|Overall Study||3
8129296|NCT02833350|20037862|P7|COMPLETED|Overall Study||44
8129297|NCT02833350|20037863|P6|COMPLETED|Overall Study||48
8129298|NCT02833350|20037864|P5|COMPLETED|Overall Study||108
8129299|NCT02833350|20037865|P4|COMPLETED|Overall Study||102
8129300|NCT02833350|20037866|P3|COMPLETED|Overall Study||102
8129301|NCT02833350|20037867|P2|COMPLETED|Overall Study||100
8129302|NCT02833350|20037868|P1|COMPLETED|Overall Study||37
8129303|NCT02833350|20037862|P7|Randomized|Overall Study||50
8129304|NCT02833350|20037863|P6|Randomized|Overall Study||48
8129305|NCT02833350|20037864|P5|Randomized|Overall Study||111
8129306|NCT02833350|20037865|P4|Randomized|Overall Study||110
8129307|NCT02833350|20037866|P3|Randomized|Overall Study||110
8129308|NCT02833350|20037867|P2|Randomized|Overall Study||109
8129309|NCT02833350|20037868|P1|Randomized|Overall Study||40
8129310|NCT02833350|20037862|P7|STARTED|Overall Study||49
8129311|NCT02833350|20037863|P6|STARTED|Overall Study||49
8129312|NCT02833350|20037864|P5|STARTED|Overall Study||111
8129313|NCT02833350|20037865|P4|STARTED|Overall Study||110
8129314|NCT02833350|20037866|P3|STARTED|Overall Study||110
8129315|NCT02833350|20037867|P2|STARTED|Overall Study||109
8129316|NCT02833350|20037868|P1|STARTED|Overall Study||40
8129317|NCT02833337|20038069|P1|NOT COMPLETED|Overall Study||0
8129318|NCT02833337|20038069|P1|COMPLETED|Overall Study||180
8129319|NCT02833337|20038069|P1|STARTED|Overall Study||180
8129320|NCT02833077|20038075|P2|NOT COMPLETED|Overall Study||8
8129321|NCT02833077|20038076|P1|NOT COMPLETED|Overall Study||17
8129322|NCT02833077|20038075|P2|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
8129323|NCT02833077|20038076|P1|COMPLETED|Overall Study||127
8129324|NCT02833077|20038075|P2|Participants Treated|Overall Study||38
8129325|NCT02833077|20038076|P1|Participants Treated|Overall Study||144
8129326|NCT02833077|20038075|P2|STARTED|Overall Study||48
8129327|NCT02833077|20038076|P1|STARTED|Overall Study||144
8129328|NCT02832674|20038088|P1|NOT COMPLETED|Overall Study||5
8129329|NCT02832674|20038088|P1|COMPLETED|Overall Study||67
8129330|NCT02832674|20038088|P1|STARTED|Overall Study||72
8129331|NCT02832375|20038099|P2|NOT COMPLETED|Overall Study||0
8129332|NCT02832375|20038100|P1|NOT COMPLETED|Overall Study||2
8129333|NCT02832375|20038099|P2|COMPLETED|Overall Study||121
8129334|NCT02832375|20038100|P1|COMPLETED|Overall Study||119
8129335|NCT02832375|20038099|P2|STARTED|Overall Study||121
8129336|NCT02832375|20038100|P1|STARTED|Overall Study||121
8129340|NCT02832167|20038118|P1|NOT COMPLETED|Treatment Period 2||83
8129341|NCT02832167|20038118|P1|COMPLETED|Treatment Period 2||20
8129342|NCT02832167|20038118|P1|STARTED|Treatment Period 2||103
8129343|NCT02832167|20038118|P1|NOT COMPLETED|Transition From Period 1 to Period 2||7
8129344|NCT02832167|20038118|P1|COMPLETED|Transition From Period 1 to Period 2||103
8129345|NCT02832167|20038118|P1|STARTED|Transition From Period 1 to Period 2||110
8129346|NCT02832167|20038118|P1|NOT COMPLETED|Treatment Period 1||129
8129347|NCT02832167|20038118|P1|COMPLETED|Treatment Period 1||110
8129348|NCT02832167|20038118|P1|STARTED|Treatment Period 1||239
8129349|NCT02832154|20038129|P1|NOT COMPLETED|Overall Study||0
8129350|NCT02832154|20038129|P1|COMPLETED|Overall Study||43
8129351|NCT02832154|20038129|P1|STARTED|Overall Study||43
8129352|NCT02832115|20038144|P2|NOT COMPLETED|Overall Study||0
8129353|NCT02832115|20038145|P1|NOT COMPLETED|Overall Study||0
8129354|NCT02832115|20038144|P2|COMPLETED|Overall Study||52
8129355|NCT02832115|20038145|P1|COMPLETED|Overall Study||48
8129356|NCT02832115|20038144|P2|STARTED|Overall Study||52
8129357|NCT02832115|20038145|P1|STARTED|Overall Study||48
8129358|NCT02831855|20038159|P3|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
8129359|NCT02831855|20038160|P2|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
8129360|NCT02831855|20038161|P1|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
8129361|NCT02831855|20038159|P3|COMPLETED|Double Blind Phase (24 Weeks)||247
8129362|NCT02831855|20038160|P2|COMPLETED|Double Blind Phase (24 Weeks)||238
8129363|NCT02831855|20038161|P1|COMPLETED|Double Blind Phase (24 Weeks)||0
8129364|NCT02831855|20038159|P3|Treated|Double Blind Phase (24 Weeks)||266
8129365|NCT02831855|20038160|P2|Treated|Double Blind Phase (24 Weeks)||264
8129366|NCT02831855|20038161|P1|Treated|Double Blind Phase (24 Weeks)||0
8129367|NCT02831855|20038159|P3|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
8129368|NCT02831855|20038160|P2|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
8129369|NCT02831855|20038161|P1|STARTED|Double Blind Phase (24 Weeks)||0
8129370|NCT02831855|20038159|P3|NOT COMPLETED|Open Label Phase (24 Weeks)||0
8129371|NCT02831855|20038160|P2|NOT COMPLETED|Open Label Phase (24 Weeks)||0
8129372|NCT02831855|20038161|P1|NOT COMPLETED|Open Label Phase (24 Weeks)||71
8129373|NCT02831855|20038159|P3|COMPLETED|Open Label Phase (24 Weeks)||0
8129374|NCT02831855|20038160|P2|COMPLETED|Open Label Phase (24 Weeks)||0
8129375|NCT02831855|20038161|P1|COMPLETED|Open Label Phase (24 Weeks)||623
8129376|NCT02831855|20038159|P3|STARTED|Open Label Phase (24 Weeks)||0
8129377|NCT02831855|20038160|P2|STARTED|Open Label Phase (24 Weeks)||0
8129378|NCT02831855|20038161|P1|STARTED|Open Label Phase (24 Weeks)||694
8129379|NCT02831764|20038222|P2|NOT COMPLETED|Overall Study||359
8129380|NCT02831764|20038223|P1|NOT COMPLETED|Overall Study||360
8129381|NCT02831764|20038222|P2|COMPLETED|Overall Study||0
8129382|NCT02831764|20038223|P1|COMPLETED|Overall Study||0
8129383|NCT02831764|20038222|P2|STARTED|Overall Study||359
8129384|NCT02831764|20038223|P1|STARTED|Overall Study||360
8129385|NCT02831673|20038287|P2|NOT COMPLETED|Overall Study||358
8129386|NCT02831673|20038288|P1|NOT COMPLETED|Overall Study||356
8129387|NCT02831673|20038287|P2|COMPLETED|Overall Study||0
8129388|NCT02831673|20038288|P1|COMPLETED|Overall Study||0
8129389|NCT02831673|20038287|P2|STARTED|Overall Study||358
8129390|NCT02831673|20038288|P1|STARTED|Overall Study||356
8129391|NCT02831660|20038350|P1|NOT COMPLETED|Overall Study||0
8129392|NCT02831660|20038350|P1|COMPLETED|Overall Study||1
8129393|NCT02831660|20038350|P1|STARTED|Overall Study||1
8129394|NCT02831569|20038354|P1|NOT COMPLETED|Overall Study||0
8129395|NCT02831569|20038354|P1|COMPLETED|Overall Study||80
8129396|NCT02831569|20038354|P1|STARTED|Overall Study||80
8129397|NCT02831387|20038361|P2|NOT COMPLETED|Overall Study||2
8129398|NCT02831387|20038362|P1|NOT COMPLETED|Overall Study||1
8129399|NCT02831387|20038361|P2|COMPLETED|Overall Study||22
8129400|NCT02831387|20038362|P1|COMPLETED|Overall Study||22
8129401|NCT02831387|20038361|P2|STARTED|Overall Study||24
8129402|NCT02831387|20038362|P1|STARTED|Overall Study||23
8129403|NCT02831257|20038380|P1|NOT COMPLETED|Overall Study||12
8129404|NCT02831257|20038380|P1|COMPLETED|Overall Study||6
8129405|NCT02831257|20038380|P1|STARTED|Overall Study||18
8129406|NCT02830893|20038394|P2|NOT COMPLETED|Overall Study||3
8129407|NCT02830893|20038395|P1|NOT COMPLETED|Overall Study||1
8129408|NCT02830893|20038394|P2|COMPLETED|Overall Study||8
8129409|NCT02830893|20038395|P1|COMPLETED|Overall Study||11
8129410|NCT02830893|20038394|P2|STARTED|Overall Study||11
8129411|NCT02830893|20038395|P1|STARTED|Overall Study||12
8129412|NCT02830880|20038407|P1|NOT COMPLETED|Overall Study||3
8129413|NCT02830880|20038407|P1|COMPLETED|Overall Study||4
8129414|NCT02830880|20038407|P1|Completed Visit After Cyle 1|Overall Study||7
8129415|NCT02830880|20038407|P1|STARTED|Overall Study||7
8129416|NCT02830438|20038416|P1|NOT COMPLETED|Overall Study||0
8129417|NCT02830438|20038416|P1|COMPLETED|Overall Study||8
8129418|NCT02830438|20038416|P1|STARTED|Overall Study||8
8129419|NCT02830087|20038426|P6|NOT COMPLETED|Overall Study||3
8129420|NCT02830087|20038427|P5|NOT COMPLETED|Overall Study||3
8129421|NCT02830087|20038428|P4|NOT COMPLETED|Overall Study||3
8129422|NCT02830087|20038429|P3|NOT COMPLETED|Overall Study||4
8129423|NCT02830087|20038430|P2|NOT COMPLETED|Overall Study||4
8129424|NCT02830087|20038431|P1|NOT COMPLETED|Overall Study||4
8129425|NCT02830087|20038426|P6|COMPLETED|Overall Study||0
8129426|NCT02830087|20038427|P5|COMPLETED|Overall Study||0
8129427|NCT02830087|20038428|P4|COMPLETED|Overall Study||0
8129428|NCT02830087|20038429|P3|COMPLETED|Overall Study||0
8129429|NCT02830087|20038430|P2|COMPLETED|Overall Study||0
8129430|NCT02830087|20038431|P1|COMPLETED|Overall Study||0
8129431|NCT02830087|20038426|P6|STARTED|Overall Study||3
8129432|NCT02830087|20038427|P5|STARTED|Overall Study||3
8129433|NCT02830087|20038428|P4|STARTED|Overall Study||3
8129434|NCT02830087|20038429|P3|STARTED|Overall Study||4
8129435|NCT02830087|20038430|P2|STARTED|Overall Study||4
8129436|NCT02830087|20038431|P1|STARTED|Overall Study||4
8129437|NCT02829996|20038498|P5|NOT COMPLETED|Overall Study||0
8129438|NCT02829996|20038499|P4|NOT COMPLETED|Overall Study||0
8129439|NCT02829996|20038500|P3|NOT COMPLETED|Overall Study||0
8129440|NCT02829996|20038501|P2|NOT COMPLETED|Overall Study||0
8129441|NCT02829996|20038502|P1|NOT COMPLETED|Overall Study||1
8129442|NCT02829996|20038498|P5|COMPLETED|Overall Study||42
8129443|NCT02829996|20038499|P4|COMPLETED|Overall Study||41
8129444|NCT02829996|20038500|P3|COMPLETED|Overall Study||40
8129445|NCT02829996|20038501|P2|COMPLETED|Overall Study||39
8129446|NCT02829996|20038502|P1|COMPLETED|Overall Study||38
8129447|NCT02829996|20038498|P5|STARTED|Overall Study||42
8129448|NCT02829996|20038499|P4|STARTED|Overall Study||41
8129449|NCT02829996|20038500|P3|STARTED|Overall Study||40
8129450|NCT02829996|20038501|P2|STARTED|Overall Study||39
8129451|NCT02829996|20038502|P1|STARTED|Overall Study||39
8129452|NCT02829983|20038516|P2|NOT COMPLETED|Overall Study||0
8129453|NCT02829983|20038517|P1|NOT COMPLETED|Overall Study||0
8129454|NCT02829983|20038516|P2|COMPLETED|Overall Study||20
8129455|NCT02829983|20038517|P1|COMPLETED|Overall Study||20
8129456|NCT02829983|20038516|P2|STARTED|Overall Study||20
8129457|NCT02829983|20038517|P1|STARTED|Overall Study||20
8129458|NCT02829944|20038527|P2|NOT COMPLETED|Overall Study||7
8129459|NCT02829944|20038528|P1|NOT COMPLETED|Overall Study||6
8129460|NCT02829944|20038527|P2|COMPLETED|Overall Study||33
8129461|NCT02829944|20038528|P1|COMPLETED|Overall Study||38
8129462|NCT02829944|20038527|P2|STARTED|Overall Study||40
8129463|NCT02829944|20038528|P1|STARTED|Overall Study||44
8129464|NCT02829918|20038578|P1|NOT COMPLETED|Overall Study||8
8129465|NCT02829918|20038578|P1|COMPLETED|Overall Study||46
8129466|NCT02829918|20038578|P1|STARTED|Overall Study||54
8129467|NCT02829775|20038583|P1|NOT COMPLETED|Overall Study||5
8129468|NCT02829775|20038583|P1|COMPLETED|Overall Study||4
8129469|NCT02829775|20038583|P1|STARTED|Overall Study||9
8129470|NCT02829463|20038590|P2|NOT COMPLETED|Overall Study||0
8129471|NCT02829463|20038591|P1|NOT COMPLETED|Overall Study||0
8129472|NCT02829463|20038590|P2|COMPLETED|Overall Study||62
8129473|NCT02829463|20038591|P1|COMPLETED|Overall Study||59
8129474|NCT02829463|20038590|P2|STARTED|Overall Study||62
8129475|NCT02829463|20038591|P1|STARTED|Overall Study||59
8129476|NCT02829320|20038597|P1|NOT COMPLETED|Overall Study||0
8129477|NCT02829320|20038597|P1|COMPLETED|Overall Study||28
8129478|NCT02829320|20038597|P1|STARTED|Overall Study||28
8129479|NCT02829307|20038634|P1|NOT COMPLETED|Overall Study||0
8129480|NCT02829307|20038634|P1|COMPLETED|Overall Study||8
8129481|NCT02829307|20038634|P1|STARTED|Overall Study||8
8129482|NCT02829294|20038657|P1|NOT COMPLETED|Overall Study||0
8129483|NCT02829294|20038657|P1|COMPLETED|Overall Study||19
8129484|NCT02829294|20038657|P1|STARTED|Overall Study||19
8129485|NCT02829138|20038665|P2|NOT COMPLETED|Overall Study||0
8129486|NCT02829138|20038666|P1|NOT COMPLETED|Overall Study||1
8129487|NCT02829138|20038665|P2|COMPLETED|Overall Study||28
8129488|NCT02829138|20038666|P1|COMPLETED|Overall Study||28
8129489|NCT02829138|20038665|P2|STARTED|Overall Study||28
8129490|NCT02829138|20038666|P1|STARTED|Overall Study||29
8129491|NCT02829034|20038678|P2|NOT COMPLETED|Overall Study||2
8129492|NCT02829034|20038679|P1|NOT COMPLETED|Overall Study||5
8129493|NCT02829034|20038678|P2|COMPLETED|Overall Study||6
8129494|NCT02829034|20038679|P1|COMPLETED|Overall Study||9
8129495|NCT02829034|20038678|P2|STARTED|Overall Study||8
8129496|NCT02829034|20038679|P1|STARTED|Overall Study||14
8129497|NCT02828982|20038689|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8129498|NCT02828982|20038690|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8129499|NCT02828982|20038689|P2|COMPLETED|Second Intervention (3 Weeks)||6
8129500|NCT02828982|20038690|P1|COMPLETED|Second Intervention (3 Weeks)||4
8129501|NCT02828982|20038689|P2|Received Intervention|Second Intervention (3 Weeks)||6
8129502|NCT02828982|20038690|P1|Received Intervention|Second Intervention (3 Weeks)||4
8129503|NCT02828982|20038689|P2|STARTED|Second Intervention (3 Weeks)||6
8129504|NCT02828982|20038690|P1|STARTED|Second Intervention (3 Weeks)||4
8129505|NCT02828982|20038689|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
8129506|NCT02828982|20038690|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
8129507|NCT02828982|20038689|P2|COMPLETED|First Intervention (3 Weeks)||6
8129508|NCT02828982|20038690|P1|COMPLETED|First Intervention (3 Weeks)||4
8129509|NCT02828982|20038689|P2|Received Intervention|First Intervention (3 Weeks)||7
8129510|NCT02828982|20038690|P1|Received Intervention|First Intervention (3 Weeks)||5
8129511|NCT02828982|20038689|P2|STARTED|First Intervention (3 Weeks)||7
8129512|NCT02828982|20038690|P1|STARTED|First Intervention (3 Weeks)||5
8129513|NCT02828917|20038706|P1|NOT COMPLETED|Overall Study||0
8129514|NCT02828917|20038706|P1|COMPLETED|Overall Study||104
8129515|NCT02828917|20038706|P1|STARTED|Overall Study||104
8129516|NCT02828644|20038712|P2|NOT COMPLETED|Overall Study||22
8129517|NCT02828644|20038713|P1|NOT COMPLETED|Overall Study||23
8129518|NCT02828644|20038712|P2|COMPLETED|Overall Study||65
8129519|NCT02828644|20038713|P1|COMPLETED|Overall Study||65
8129520|NCT02828644|20038712|P2|STARTED|Overall Study||87
8129521|NCT02828644|20038713|P1|STARTED|Overall Study||88
8129522|NCT02828436|20038720|P2|NOT COMPLETED|Period 2||0
8129523|NCT02828436|20038721|P1|NOT COMPLETED|Period 2||8
8129524|NCT02828436|20038720|P2|COMPLETED|Period 2||0
8129525|NCT02828436|20038721|P1|COMPLETED|Period 2||1
8129526|NCT02828436|20038720|P2|STARTED|Period 2||0
8129527|NCT02828436|20038721|P1|STARTED|Period 2||9
8129528|NCT02828436|20038720|P2|NOT COMPLETED|Period 1||4
8129529|NCT02828436|20038721|P1|NOT COMPLETED|Period 1||0
8129530|NCT02828436|20038720|P2|COMPLETED|Period 1||5
8129531|NCT02828436|20038721|P1|COMPLETED|Period 1||0
8129532|NCT02828436|20038720|P2|STARTED|Period 1||9
8129533|NCT02828436|20038721|P1|STARTED|Period 1||0
8129534|NCT02828241|20038729|P2|NOT COMPLETED|Overall Study||2
8129535|NCT02828241|20038730|P1|NOT COMPLETED|Overall Study||8
8129536|NCT02828241|20038729|P2|COMPLETED|Overall Study||21
8129537|NCT02828241|20038730|P1|COMPLETED|Overall Study||30
8129538|NCT02828241|20038729|P2|STARTED|Overall Study||23
8129539|NCT02828241|20038730|P1|STARTED|Overall Study||38
8129540|NCT02828137|20038743|P3|NOT COMPLETED|Overall Study||0
8129541|NCT02828137|20038744|P2|NOT COMPLETED|Overall Study||0
8129542|NCT02828137|20038745|P1|NOT COMPLETED|Overall Study||0
8129543|NCT02828137|20038743|P3|COMPLETED|Overall Study||41
8129544|NCT02828137|20038744|P2|COMPLETED|Overall Study||41
8129545|NCT02828137|20038745|P1|COMPLETED|Overall Study||41
8129546|NCT02828137|20038743|P3|STARTED|Overall Study||41
8129547|NCT02828137|20038744|P2|STARTED|Overall Study||41
8129548|NCT02828137|20038745|P1|STARTED|Overall Study||41
8129549|NCT02828124|20038757|P4|NOT COMPLETED|Overall Study||6
8129550|NCT02828124|20038758|P3|NOT COMPLETED|Overall Study||1
8129551|NCT02828124|20038759|P2|NOT COMPLETED|Overall Study||2
8129552|NCT02828124|20038760|P1|NOT COMPLETED|Overall Study||1
8129553|NCT02828124|20038757|P4|COMPLETED|Overall Study||0
8129554|NCT02828124|20038758|P3|COMPLETED|Overall Study||0
8129555|NCT02828124|20038759|P2|COMPLETED|Overall Study||0
8129556|NCT02828124|20038760|P1|COMPLETED|Overall Study||0
8129557|NCT02828124|20038757|P4|STARTED|Overall Study||6
8129558|NCT02828124|20038758|P3|STARTED|Overall Study||1
8129559|NCT02828124|20038759|P2|STARTED|Overall Study||2
8129560|NCT02828124|20038760|P1|STARTED|Overall Study||1
8129561|NCT02828111|20038875|P5|NOT COMPLETED|Overall Study||1
8129562|NCT02828111|20038876|P4|NOT COMPLETED|Overall Study||1
8129563|NCT02828111|20038877|P3|NOT COMPLETED|Overall Study||2
8129564|NCT02828111|20038878|P2|NOT COMPLETED|Overall Study||0
8129565|NCT02828111|20038879|P1|NOT COMPLETED|Overall Study||0
8129566|NCT02828111|20038875|P5|COMPLETED|Overall Study||11
8129567|NCT02828111|20038876|P4|COMPLETED|Overall Study||5
8129568|NCT02828111|20038877|P3|COMPLETED|Overall Study||4
8129569|NCT02828111|20038878|P2|COMPLETED|Overall Study||6
8129570|NCT02828111|20038879|P1|COMPLETED|Overall Study||6
8129571|NCT02828111|20038875|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
8129572|NCT02828111|20038876|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8129573|NCT02828111|20038877|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8129574|NCT02828111|20038878|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8129575|NCT02828111|20038879|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8129576|NCT02828111|20038875|P5|STARTED|Overall Study||12
8129577|NCT02828111|20038876|P4|STARTED|Overall Study||6
8129578|NCT02828111|20038877|P3|STARTED|Overall Study||6
8129579|NCT02828111|20038878|P2|STARTED|Overall Study||6
8129580|NCT02828111|20038879|P1|STARTED|Overall Study||6
8129581|NCT02828020|20038940|P3|NOT COMPLETED|Safety Follow-up Period||19
8129582|NCT02828020|20038941|P2|NOT COMPLETED|Safety Follow-up Period||18
8129583|NCT02828020|20038942|P1|NOT COMPLETED|Safety Follow-up Period||20
8129584|NCT02828020|20038940|P3|COMPLETED|Safety Follow-up Period||461
8129585|NCT02828020|20038941|P2|COMPLETED|Safety Follow-up Period||440
8129586|NCT02828020|20038942|P1|COMPLETED|Safety Follow-up Period||460
8129587|NCT02828020|20038940|P3|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
8129588|NCT02828020|20038941|P2|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
8129589|NCT02828020|20038942|P1|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
8129590|NCT02828020|20038940|P3|NOT COMPLETED|Treatment Period||78
8129591|NCT02828020|20038941|P2|NOT COMPLETED|Treatment Period||99
8129592|NCT02828020|20038942|P1|NOT COMPLETED|Treatment Period||80
8129593|NCT02828020|20038940|P3|COMPLETED|Treatment Period||479
8129594|NCT02828020|20038941|P2|COMPLETED|Treatment Period||457
8129595|NCT02828020|20038942|P1|COMPLETED|Treatment Period||479
8129596|NCT02828020|20038940|P3|Safety Population: Received Study Drug|Treatment Period||485
8129597|NCT02828020|20038941|P2|Safety Population: Received Study Drug|Treatment Period||466
8129598|NCT02828020|20038942|P1|Safety Population: Received Study Drug|Treatment Period||485
8129599|NCT02828020|20038940|P3|STARTED|Treatment Period||557
8129600|NCT02828020|20038941|P2|STARTED|Treatment Period||556
8129601|NCT02828020|20038942|P1|STARTED|Treatment Period||559
8129602|NCT02827708|20038973|P2|NOT COMPLETED|Overall Study||5
8129603|NCT02827708|20038974|P1|NOT COMPLETED|Overall Study||5
8129604|NCT02827708|20038973|P2|COMPLETED|Overall Study||156
8129605|NCT02827708|20038974|P1|COMPLETED|Overall Study||158
8129606|NCT02827708|20038973|P2|Safety Analysis Set (SAS)|Overall Study||161
8129607|NCT02827708|20038974|P1|Safety Analysis Set (SAS)|Overall Study||163
8129608|NCT02827708|20038973|P2|Full Analysis Set (FAS)|Overall Study||161
8129609|NCT02827708|20038974|P1|Full Analysis Set (FAS)|Overall Study||163
8129610|NCT02827708|20038973|P2|STARTED|Overall Study||161
8129611|NCT02827708|20038974|P1|STARTED|Overall Study||163
8129612|NCT02827500|20039053|P2|NOT COMPLETED|Overall Study||7
8129613|NCT02827500|20039054|P1|NOT COMPLETED|Overall Study||19
8129614|NCT02827500|20039053|P2|COMPLETED|Overall Study||45
8129615|NCT02827500|20039054|P1|COMPLETED|Overall Study||33
8129616|NCT02827500|20039053|P2|STARTED|Overall Study||52
8129617|NCT02827500|20039054|P1|STARTED|Overall Study||52
8129618|NCT02826798|20039075|P5|NOT COMPLETED|Overall Study||0
8129619|NCT02826798|20039076|P4|NOT COMPLETED|Overall Study||1
8129620|NCT02826798|20039077|P3|NOT COMPLETED|Overall Study||0
8129621|NCT02826798|20039078|P2|NOT COMPLETED|Overall Study||1
8129622|NCT02826798|20039079|P1|NOT COMPLETED|Overall Study||0
8129623|NCT02826798|20039075|P5|COMPLETED|Overall Study||26
8129624|NCT02826798|20039076|P4|COMPLETED|Overall Study||24
8129625|NCT02826798|20039077|P3|COMPLETED|Overall Study||26
8129626|NCT02826798|20039078|P2|COMPLETED|Overall Study||25
8129627|NCT02826798|20039079|P1|COMPLETED|Overall Study||25
8129628|NCT02826798|20039075|P5|STARTED|Overall Study||26
8129629|NCT02826798|20039076|P4|STARTED|Overall Study||25
8129630|NCT02826798|20039077|P3|STARTED|Overall Study||26
8129631|NCT02826798|20039078|P2|STARTED|Overall Study||26
8129632|NCT02826798|20039079|P1|STARTED|Overall Study||25
8129633|NCT02826694|20039128|P2|NOT COMPLETED|Overall Study||0
8129634|NCT02826694|20039129|P1|NOT COMPLETED|Overall Study||0
8129635|NCT02826694|20039128|P2|COMPLETED|Overall Study||45
8129636|NCT02826694|20039129|P1|COMPLETED|Overall Study||61
8129637|NCT02826694|20039128|P2|Control Group|Overall Study||15
8129638|NCT02826694|20039129|P1|Control Group|Overall Study||20
8129639|NCT02826694|20039128|P2|Decision Group|Overall Study||30
8129640|NCT02826694|20039129|P1|Decision Group|Overall Study||41
8129641|NCT02826694|20039128|P2|STARTED|Overall Study||45
8129642|NCT02826694|20039129|P1|STARTED|Overall Study||61
8129643|NCT02826603|20039141|P2|NOT COMPLETED|Overall Study||64
8129644|NCT02826603|20039142|P1|NOT COMPLETED|Overall Study||61
8129645|NCT02826603|20039141|P2|COMPLETED|Overall Study||488
8129646|NCT02826603|20039142|P1|COMPLETED|Overall Study||489
8129647|NCT02826603|20039141|P2|STARTED|Overall Study||552
8129648|NCT02826603|20039142|P1|STARTED|Overall Study||550
8129649|NCT02826551|20039169|P2|NOT COMPLETED|Overall Study||0
8129650|NCT02826551|20039170|P1|NOT COMPLETED|Overall Study||0
8129651|NCT02826551|20039169|P2|COMPLETED|Overall Study||12
8129652|NCT02826551|20039170|P1|COMPLETED|Overall Study||11
8129653|NCT02826551|20039169|P2|STARTED|Overall Study||12
8129654|NCT02826551|20039170|P1|STARTED|Overall Study||11
8129655|NCT02826421|20039182|P4|NOT COMPLETED|Overall Study||2
8129656|NCT02826421|20039183|P3|NOT COMPLETED|Overall Study||2
8129657|NCT02826421|20039184|P2|NOT COMPLETED|Overall Study||3
8129658|NCT02826421|20039185|P1|NOT COMPLETED|Overall Study||3
8129659|NCT02826421|20039182|P4|COMPLETED|Overall Study||28
8129660|NCT02826421|20039183|P3|COMPLETED|Overall Study||26
8129661|NCT02826421|20039184|P2|COMPLETED|Overall Study||26
8129662|NCT02826421|20039185|P1|COMPLETED|Overall Study||19
8129663|NCT02826421|20039182|P4|Treated|Overall Study||28
8129664|NCT02826421|20039183|P3|Treated|Overall Study||26
8129665|NCT02826421|20039184|P2|Treated|Overall Study||26
8129666|NCT02826421|20039185|P1|Treated|Overall Study||19
8129667|NCT02826421|20039182|P4|STARTED|Overall Study||30
8129668|NCT02826421|20039183|P3|STARTED|Overall Study||28
8129669|NCT02826421|20039184|P2|STARTED|Overall Study||29
8129670|NCT02826421|20039185|P1|STARTED|Overall Study||22
8129671|NCT02825992|20039197|P1|NOT COMPLETED|Overall Study||8
8129672|NCT02825992|20039197|P1|COMPLETED|Overall Study||121
8129673|NCT02825992|20039197|P1|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
8129674|NCT02825966|20039209|P1|NOT COMPLETED|Overall Study||0
8129675|NCT02825966|20039209|P1|COMPLETED|Overall Study||35
8129676|NCT02825966|20039209|P1|STARTED|Overall Study||35
8129677|NCT02825680|20039218|P2|NOT COMPLETED|Overall Study||16
8129678|NCT02825680|20039219|P1|NOT COMPLETED|Overall Study||0
8129679|NCT02825680|20039218|P2|COMPLETED|Overall Study||39
8129680|NCT02825680|20039219|P1|COMPLETED|Overall Study||82
8129681|NCT02825680|20039218|P2|STARTED|Overall Study||55
8129682|NCT02825680|20039219|P1|STARTED|Overall Study||82
8129683|NCT02825550|20039225|P1|NOT COMPLETED|Overall Study||1
8129684|NCT02825550|20039225|P1|COMPLETED|Overall Study||12
8129685|NCT02825550|20039225|P1|STARTED|Overall Study||13
8129686|NCT02825251|20039233|P2|NOT COMPLETED|Overall Study||6
8129687|NCT02825251|20039234|P1|NOT COMPLETED|Overall Study||3
8129688|NCT02825251|20039233|P2|COMPLETED|Overall Study||230
8129689|NCT02825251|20039234|P1|COMPLETED|Overall Study||233
8129690|NCT02825251|20039233|P2|STARTED|Overall Study||236
8129691|NCT02825251|20039234|P1|STARTED|Overall Study||236
8129692|NCT02825212|20039420|P1|NOT COMPLETED|Overall Study||0
8129693|NCT02825212|20039420|P1|COMPLETED|Overall Study||10
8129694|NCT02825212|20039420|P1|STARTED|Overall Study||10
8129695|NCT02825043|20039425|P1|NOT COMPLETED|Overall Study||4
8129696|NCT02825043|20039425|P1|COMPLETED|Overall Study||2
8129697|NCT02825043|20039425|P1|STARTED|Overall Study||6
8129698|NCT02824913|20039432|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8129699|NCT02824913|20039433|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8129700|NCT02824913|20039432|P2|COMPLETED|Second Intervention (1 Day)||0
8129701|NCT02824913|20039433|P1|COMPLETED|Second Intervention (1 Day)||1
8129702|NCT02824913|20039432|P2|STARTED|Second Intervention (1 Day)||0
8129703|NCT02824913|20039433|P1|STARTED|Second Intervention (1 Day)||1
8129704|NCT02824913|20039432|P2|NOT COMPLETED|Washout (7-14 Days)||0
8129705|NCT02824913|20039433|P1|NOT COMPLETED|Washout (7-14 Days)||0
8129706|NCT02824913|20039432|P2|COMPLETED|Washout (7-14 Days)||0
8129707|NCT02824913|20039433|P1|COMPLETED|Washout (7-14 Days)||1
8129708|NCT02824913|20039432|P2|STARTED|Washout (7-14 Days)||0
8129709|NCT02824913|20039433|P1|STARTED|Washout (7-14 Days)||1
8129710|NCT02824913|20039432|P2|NOT COMPLETED|First Intervention (1 Day)||0
8129711|NCT02824913|20039433|P1|NOT COMPLETED|First Intervention (1 Day)||0
8129712|NCT02824913|20039432|P2|COMPLETED|First Intervention (1 Day)||0
8129713|NCT02824913|20039433|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
8129714|NCT02824913|20039432|P2|STARTED|First Intervention (1 Day)||0
8129715|NCT02824913|20039433|P1|STARTED|First Intervention (1 Day)||1
8129716|NCT02824562|20039447|P2|NOT COMPLETED|Overall Study||5
8129717|NCT02824562|20039448|P1|NOT COMPLETED|Overall Study||3
8129718|NCT02824562|20039447|P2|COMPLETED|Overall Study||17
8129719|NCT02824562|20039448|P1|COMPLETED|Overall Study||19
8129720|NCT02824562|20039447|P2|STARTED|Overall Study||22
8129721|NCT02824562|20039448|P1|STARTED|Overall Study||22
8129722|NCT02824432|20039457|P2|NOT COMPLETED|Overall Study||0
8129723|NCT02824432|20039458|P1|NOT COMPLETED|Overall Study||1
8129724|NCT02824432|20039457|P2|COMPLETED|Overall Study||19
8129725|NCT02824432|20039458|P1|COMPLETED|Overall Study||17
8129726|NCT02824432|20039457|P2|STARTED|Overall Study||19
8129727|NCT02824432|20039458|P1|STARTED|Overall Study||18
8129728|NCT02824224|20039534|P2|NOT COMPLETED|Overall Study||1
8129729|NCT02824224|20039535|P1|NOT COMPLETED|Overall Study||2
8129730|NCT02824224|20039534|P2|COMPLETED|Overall Study||17
8129731|NCT02824224|20039535|P1|COMPLETED|Overall Study||17
8129732|NCT02824224|20039534|P2|STARTED|Overall Study||18
8129733|NCT02824224|20039535|P1|STARTED|Overall Study||19
8129734|NCT02824198|20039555|P2|NOT COMPLETED|Overall Study||3
8129735|NCT02824198|20039556|P1|NOT COMPLETED|Overall Study||15
8129736|NCT02824198|20039555|P2|COMPLETED|Overall Study||26
8129737|NCT02824198|20039556|P1|COMPLETED|Overall Study||74
8129738|NCT02824198|20039555|P2|STARTED|Overall Study||29
8129739|NCT02824198|20039556|P1|STARTED|Overall Study||89
8129740|NCT02823964|20039586|P1|NOT COMPLETED|Overall Study||5
8129741|NCT02823964|20039586|P1|COMPLETED|Overall Study||20
8129742|NCT02823964|20039586|P1|STARTED|Overall Study||25
8129743|NCT02823600|20039590|P1|NOT COMPLETED|Overall Study||0
8129744|NCT02823600|20039590|P1|COMPLETED|Overall Study||68
8129745|NCT02823600|20039590|P1|STARTED|Overall Study||68
8129746|NCT02823470|20039600|P2|NOT COMPLETED|Overall Study||15
8129747|NCT02823470|20039601|P1|NOT COMPLETED|Overall Study||9
8129748|NCT02823470|20039600|P2|COMPLETED|Overall Study||0
8129749|NCT02823470|20039601|P1|COMPLETED|Overall Study||0
8129750|NCT02823470|20039600|P2|STARTED|Overall Study||15
8129751|NCT02823470|20039601|P1|STARTED|Overall Study||9
8129752|NCT02823457|20039613|P1|NOT COMPLETED|Overall Study||5
8129753|NCT02823457|20039613|P1|COMPLETED|Overall Study||15
8129754|NCT02823457|20039613|P1|STARTED|Overall Study||20
8129755|NCT02823431|20039620|P2|NOT COMPLETED|Overall Study||0
8129756|NCT02823431|20039621|P1|NOT COMPLETED|Overall Study||0
8129757|NCT02823431|20039620|P2|COMPLETED|Overall Study||12
8129758|NCT02823431|20039621|P1|COMPLETED|Overall Study||11
8129759|NCT02823431|20039620|P2|STARTED|Overall Study||12
8129760|NCT02823431|20039621|P1|STARTED|Overall Study||11
8129761|NCT02823080|20039635|P2|NOT COMPLETED|Overall Study||0
8129762|NCT02823080|20039636|P1|NOT COMPLETED|Overall Study||0
8129763|NCT02823080|20039635|P2|COMPLETED|Overall Study||24
8129764|NCT02823080|20039636|P1|COMPLETED|Overall Study||24
8129765|NCT02823080|20039635|P2|STARTED|Overall Study||24
8129766|NCT02823080|20039636|P1|STARTED|Overall Study||24
8129767|NCT02822950|20039654|P1|NOT COMPLETED|Overall Study||0
8129768|NCT02822950|20039654|P1|COMPLETED|Overall Study||10
8129769|NCT02822950|20039654|P1|STARTED|Overall Study||10
8129770|NCT02822885|20039662|P1|NOT COMPLETED|Overall Study||0
8129771|NCT02822885|20039662|P1|COMPLETED|Overall Study||70
8129772|NCT02822885|20039662|P1|STARTED|Overall Study||70
8129773|NCT02822794|20039674|P2|NOT COMPLETED|Overall Study||0
8129774|NCT02822794|20039675|P1|NOT COMPLETED|Overall Study||1
8129775|NCT02822794|20039674|P2|COMPLETED|Overall Study||60
8129776|NCT02822794|20039675|P1|COMPLETED|Overall Study||56
8129777|NCT02822794|20039674|P2|STARTED|Overall Study||60
8129778|NCT02822794|20039675|P1|STARTED|Overall Study||57
8129779|NCT02822612|20039738|P5|NOT COMPLETED|Overall Study||0
8129780|NCT02822612|20039739|P4|NOT COMPLETED|Overall Study||0
8129781|NCT02822612|20039740|P3|NOT COMPLETED|Overall Study||0
8129782|NCT02822612|20039741|P2|NOT COMPLETED|Overall Study||0
8129783|NCT02822612|20039742|P1|NOT COMPLETED|Overall Study||0
8129784|NCT02822612|20039738|P5|COMPLETED|Overall Study||15
8129785|NCT02822612|20039739|P4|COMPLETED|Overall Study||4
8129786|NCT02822612|20039740|P3|COMPLETED|Overall Study||14
8129787|NCT02822612|20039741|P2|COMPLETED|Overall Study||13
8129788|NCT02822612|20039742|P1|COMPLETED|Overall Study||14
8129789|NCT02822612|20039738|P5|STARTED|Overall Study||15
8129790|NCT02822612|20039739|P4|STARTED|Overall Study||4
8129791|NCT02822612|20039740|P3|STARTED|Overall Study||14
8129792|NCT02822612|20039741|P2|STARTED|Overall Study||13
8129793|NCT02822612|20039742|P1|STARTED|Overall Study||14
8129794|NCT02822287|20039764|P1|NOT COMPLETED|Overall Study||0
8129795|NCT02822287|20039764|P1|COMPLETED|Overall Study||57
8129796|NCT02822287|20039764|P1|STARTED|Overall Study||57
8129797|NCT02822235|20039776|P2|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
8129798|NCT02822235|20039777|P1|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
8129799|NCT02822235|20039776|P2|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
8129800|NCT02822235|20039777|P1|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
8129801|NCT02822235|20039776|P2|STARTED|Prospective Phase (Day 1 up to Month 12)||36
8129802|NCT02822235|20039777|P1|STARTED|Prospective Phase (Day 1 up to Month 12)||118
8129803|NCT02822235|20039776|P2|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
8129804|NCT02822235|20039777|P1|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
8129805|NCT02822235|20039776|P2|COMPLETED|Cross-sectional Phase (Day 1)||36
8129806|NCT02822235|20039777|P1|COMPLETED|Cross-sectional Phase (Day 1)||118
8129807|NCT02822235|20039776|P2|STARTED|Cross-sectional Phase (Day 1)||143
8129808|NCT02822235|20039777|P1|STARTED|Cross-sectional Phase (Day 1)||264
8129809|NCT02822222|20039832|P2|NOT COMPLETED|Overall Study||0
8129810|NCT02822222|20039833|P1|NOT COMPLETED|Overall Study||1
8129811|NCT02822222|20039832|P2|COMPLETED|Overall Study||6
8129812|NCT02822222|20039833|P1|COMPLETED|Overall Study||15
8129813|NCT02822222|20039832|P2|STARTED|Overall Study||6
8129814|NCT02822222|20039833|P1|STARTED|Overall Study||16
8129815|NCT02821962|20039883|P2|NOT COMPLETED|Overall Study||0
8129816|NCT02821962|20039884|P1|NOT COMPLETED|Overall Study||2
8129817|NCT02821962|20039883|P2|COMPLETED|Overall Study||21
8129818|NCT02821962|20039884|P1|COMPLETED|Overall Study||17
8129819|NCT02821962|20039883|P2|STARTED|Overall Study||21
8129820|NCT02821962|20039884|P1|STARTED|Overall Study||19
8129821|NCT02821910|20039928|P6|NOT COMPLETED|Overall Study||1
8129822|NCT02821910|20039929|P5|NOT COMPLETED|Overall Study||0
8129823|NCT02821910|20039930|P4|NOT COMPLETED|Overall Study||0
8129824|NCT02821910|20039931|P3|NOT COMPLETED|Overall Study||2
8129825|NCT02821910|20039932|P2|NOT COMPLETED|Overall Study||0
8129826|NCT02821910|20039933|P1|NOT COMPLETED|Overall Study||1
8129827|NCT02821910|20039928|P6|COMPLETED|Overall Study||7
8129828|NCT02821910|20039929|P5|COMPLETED|Overall Study||7
8129829|NCT02821910|20039930|P4|COMPLETED|Overall Study||10
8129830|NCT02821910|20039931|P3|COMPLETED|Overall Study||8
8129831|NCT02821910|20039932|P2|COMPLETED|Overall Study||8
8129832|NCT02821910|20039933|P1|COMPLETED|Overall Study||6
8129833|NCT02821910|20039928|P6|STARTED|Overall Study||8
8129834|NCT02821910|20039929|P5|STARTED|Overall Study||7
8129835|NCT02821910|20039930|P4|STARTED|Overall Study||10
8129836|NCT02821910|20039931|P3|STARTED|Overall Study||10
8129837|NCT02821910|20039932|P2|STARTED|Overall Study||8
8129838|NCT02821910|20039933|P1|STARTED|Overall Study||7
8129839|NCT02821819|20039995|P1|NOT COMPLETED|Overall Study||1
8129840|NCT02821819|20039995|P1|COMPLETED|Overall Study||14
8129841|NCT02821819|20039995|P1|STARTED|Overall Study||15
8129842|NCT02821715|20040000|P6|NOT COMPLETED|Overall Study||0
8129843|NCT02821715|20040001|P5|NOT COMPLETED|Overall Study||0
8129844|NCT02821715|20040002|P4|NOT COMPLETED|Overall Study||0
8129845|NCT02821715|20040003|P3|NOT COMPLETED|Overall Study||0
8129846|NCT02821715|20040004|P2|NOT COMPLETED|Overall Study||0
8129847|NCT02821715|20040005|P1|NOT COMPLETED|Overall Study||1
8129848|NCT02821715|20040000|P6|COMPLETED|Overall Study||9
8129849|NCT02821715|20040001|P5|COMPLETED|Overall Study||6
8129850|NCT02821715|20040002|P4|COMPLETED|Overall Study||9
8129851|NCT02821715|20040003|P3|COMPLETED|Overall Study||8
8129852|NCT02821715|20040004|P2|COMPLETED|Overall Study||8
8129853|NCT02821715|20040005|P1|COMPLETED|Overall Study||7
8129854|NCT02821715|20040000|P6|STARTED|Overall Study||9
8129855|NCT02821715|20040001|P5|STARTED|Overall Study||6
8129856|NCT02821715|20040002|P4|STARTED|Overall Study||9
8129857|NCT02821715|20040003|P3|STARTED|Overall Study||8
8129858|NCT02821715|20040004|P2|STARTED|Overall Study||8
8129859|NCT02821715|20040005|P1|STARTED|Overall Study||8
8129860|NCT02821455|20040049|P1|NOT COMPLETED|Overall Study||0
8129861|NCT02821455|20040049|P1|COMPLETED|Overall Study||19
8129862|NCT02821455|20040049|P1|STARTED|Overall Study||19
8129863|NCT02821416|20040056|P2|NOT COMPLETED|Overall Study||1
8129864|NCT02821416|20040057|P1|NOT COMPLETED|Overall Study||3
8129865|NCT02821416|20040056|P2|COMPLETED|Overall Study||22
8129866|NCT02821416|20040057|P1|COMPLETED|Overall Study||20
8129867|NCT02821416|20040056|P2|STARTED|Overall Study||23
8129868|NCT02821416|20040057|P1|STARTED|Overall Study||23
8129869|NCT02821403|20040067|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
8129870|NCT02821403|20040068|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
8129871|NCT02821403|20040067|P2|COMPLETED|"Third Intervention (1 Month)"||40
8129872|NCT02821403|20040068|P1|COMPLETED|"Third Intervention (1 Month)"||40
8129873|NCT02821403|20040067|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
8129874|NCT02821403|20040068|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
8129875|NCT02821403|20040067|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
8129876|NCT02821403|20040068|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
8129877|NCT02821403|20040067|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
8129878|NCT02821403|20040068|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
8129879|NCT02821403|20040067|P2|STARTED|"Third Intervention (1 Month)"||40
8129880|NCT02821403|20040068|P1|STARTED|"Third Intervention (1 Month)"||40
8129881|NCT02821403|20040067|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
8129882|NCT02821403|20040068|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
8129883|NCT02821403|20040067|P2|COMPLETED|"Second Intervention (1 Month)"||40
8129884|NCT02821403|20040068|P1|COMPLETED|"Second Intervention (1 Month)"||40
8129885|NCT02821403|20040067|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
8129886|NCT02821403|20040068|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
8129887|NCT02821403|20040067|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
8129888|NCT02821403|20040068|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
8129889|NCT02821403|20040067|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
8129890|NCT02821403|20040068|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
8129891|NCT02821403|20040067|P2|STARTED|"Second Intervention (1 Month)"||40
8129892|NCT02821403|20040068|P1|STARTED|"Second Intervention (1 Month)"||40
8129893|NCT02821403|20040067|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
8129894|NCT02821403|20040068|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
8129895|NCT02821403|20040067|P2|COMPLETED|"First Intervention (1 Month)"||40
8129896|NCT02821403|20040068|P1|COMPLETED|"First Intervention (1 Month)"||40
8129897|NCT02821403|20040067|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
8129898|NCT02821403|20040068|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
8129899|NCT02821403|20040067|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
8129900|NCT02821403|20040068|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
8129901|NCT02821403|20040067|P2|Used Clear Lens|"First Intervention (1 Month)"||13
8129902|NCT02821403|20040068|P1|Used Clear Lens|"First Intervention (1 Month)"||13
8129903|NCT02821403|20040067|P2|STARTED|"First Intervention (1 Month)"||40
8129904|NCT02821403|20040068|P1|STARTED|"First Intervention (1 Month)"||40
8129905|NCT02821338|20040086|P2|NOT COMPLETED|Overall Study||2
8129906|NCT02821338|20040087|P1|NOT COMPLETED|Overall Study||3
8129907|NCT02821338|20040086|P2|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
8129908|NCT02821338|20040087|P1|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
8129909|NCT02821338|20040086|P2|STARTED|Overall Study||15
8129910|NCT02821338|20040087|P1|STARTED|Overall Study||15
8129911|NCT02821000|20040103|P1|NOT COMPLETED|Overall Study||103
8129912|NCT02821000|20040103|P1|COMPLETED|Overall Study||0
8129913|NCT02821000|20040103|P1|Treated|Overall Study||103
8129914|NCT02821000|20040103|P1|STARTED|Overall Study||103
8129915|NCT02820870|20040128|P2|NOT COMPLETED|Post Intervention||0
8129916|NCT02820870|20040129|P1|NOT COMPLETED|Post Intervention||0
8129917|NCT02820870|20040128|P2|COMPLETED|Post Intervention||28
8129918|NCT02820870|20040129|P1|COMPLETED|Post Intervention||15
8129919|NCT02820870|20040128|P2|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
8129920|NCT02820870|20040129|P1|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
8129921|NCT02820870|20040128|P2|NOT COMPLETED|Intervention||0
8129922|NCT02820870|20040129|P1|NOT COMPLETED|Intervention||0
8129923|NCT02820870|20040128|P2|COMPLETED|Intervention||28
8129924|NCT02820870|20040129|P1|COMPLETED|Intervention||15
8129925|NCT02820870|20040128|P2|STARTED|Intervention||28
8129926|NCT02820870|20040129|P1|STARTED|Intervention||15
8129927|NCT02820870|20040128|P2|NOT COMPLETED|Before Intervention||0
8129928|NCT02820870|20040129|P1|NOT COMPLETED|Before Intervention||0
8129929|NCT02820870|20040128|P2|COMPLETED|Before Intervention||28
8129930|NCT02820870|20040129|P1|COMPLETED|Before Intervention||15
8129931|NCT02820870|20040128|P2|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
8129932|NCT02820870|20040129|P1|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
8129933|NCT02820844|20040141|P6|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
8129934|NCT02820844|20040142|P5|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
8129935|NCT02820844|20040143|P4|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129936|NCT02820844|20040144|P3|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129937|NCT02820844|20040145|P2|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129938|NCT02820844|20040146|P1|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129939|NCT02820844|20040141|P6|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
8129940|NCT02820844|20040142|P5|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
8129941|NCT02820844|20040143|P4|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129942|NCT02820844|20040144|P3|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129943|NCT02820844|20040145|P2|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129944|NCT02820844|20040146|P1|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129945|NCT02820844|20040141|P6|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
8129946|NCT02820844|20040142|P5|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
8129947|NCT02820844|20040143|P4|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129948|NCT02820844|20040144|P3|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129949|NCT02820844|20040145|P2|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129950|NCT02820844|20040146|P1|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129951|NCT02820844|20040141|P6|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129952|NCT02820844|20040142|P5|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129953|NCT02820844|20040143|P4|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
8129954|NCT02820844|20040144|P3|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
8129955|NCT02820844|20040145|P2|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129956|NCT02820844|20040146|P1|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129957|NCT02820844|20040141|P6|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129958|NCT02820844|20040142|P5|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129959|NCT02820844|20040143|P4|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
8129960|NCT02820844|20040144|P3|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
8129961|NCT02820844|20040145|P2|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129962|NCT02820844|20040146|P1|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129963|NCT02820844|20040141|P6|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129964|NCT02820844|20040142|P5|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129965|NCT02820844|20040143|P4|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
8129966|NCT02820844|20040144|P3|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
8129967|NCT02820844|20040145|P2|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129968|NCT02820844|20040146|P1|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129969|NCT02820844|20040141|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129970|NCT02820844|20040142|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129971|NCT02820844|20040143|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129972|NCT02820844|20040144|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129973|NCT02820844|20040145|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
8129974|NCT02820844|20040146|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
8129975|NCT02820844|20040141|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129976|NCT02820844|20040142|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129977|NCT02820844|20040143|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129978|NCT02820844|20040144|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129979|NCT02820844|20040145|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||115
8129980|NCT02820844|20040146|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||119
8129981|NCT02820844|20040141|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
8129982|NCT02820844|20040142|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
8129983|NCT02820844|20040143|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
8129984|NCT02820844|20040144|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
8129985|NCT02820844|20040145|P2|STARTED|Double-blinded (Up to 48 Weeks)||124
8129986|NCT02820844|20040146|P1|STARTED|Double-blinded (Up to 48 Weeks)||124
8129987|NCT02820597|20040360|P1|NOT COMPLETED|Overall Study||12
8129988|NCT02820597|20040360|P1|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
8129989|NCT02820597|20040360|P1|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
8129990|NCT02820597|20040360|P1|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
8129991|NCT02820597|20040360|P1|30-day Post Treatment|Overall Study||27
8129992|NCT02820597|20040360|P1|7-day Post Treatment|Overall Study||27
8129993|NCT02820597|20040360|P1|1-day Post Treatment|Overall Study||27
8129994|NCT02820597|20040360|P1|STARTED|Overall Study||27
8129995|NCT02820324|20040373|P5|NOT COMPLETED|Overall Study||3
8129996|NCT02820324|20040374|P4|NOT COMPLETED|Overall Study||3
8129997|NCT02820324|20040375|P3|NOT COMPLETED|Overall Study||3
8129998|NCT02820324|20040376|P2|NOT COMPLETED|Overall Study||3
8129999|NCT02820324|20040377|P1|NOT COMPLETED|Overall Study||2
8130000|NCT02820324|20040373|P5|COMPLETED|Overall Study||80
8130001|NCT02820324|20040374|P4|COMPLETED|Overall Study||79
8130002|NCT02820324|20040375|P3|COMPLETED|Overall Study||79
8130003|NCT02820324|20040376|P2|COMPLETED|Overall Study||79
8130004|NCT02820324|20040377|P1|COMPLETED|Overall Study||76
8130005|NCT02820324|20040373|P5|Treated With Study Medication|Overall Study||83
8130006|NCT02820324|20040374|P4|Treated With Study Medication|Overall Study||81
8130007|NCT02820324|20040375|P3|Treated With Study Medication|Overall Study||80
8130008|NCT02820324|20040376|P2|Treated With Study Medication|Overall Study||80
8130009|NCT02820324|20040377|P1|Treated With Study Medication|Overall Study||77
8130010|NCT02820324|20040373|P5|STARTED|Overall Study||83
8130011|NCT02820324|20040374|P4|STARTED|Overall Study||82
8130012|NCT02820324|20040375|P3|STARTED|Overall Study||82
8130013|NCT02820324|20040376|P2|STARTED|Overall Study||82
8130014|NCT02820324|20040377|P1|STARTED|Overall Study||78
8130015|NCT02820038|20040411|P4|NOT COMPLETED|Overall Study||22
8130016|NCT02820038|20040412|P3|NOT COMPLETED|Overall Study||5
8130017|NCT02820038|20040413|P2|NOT COMPLETED|Overall Study||25
8130018|NCT02820038|20040414|P1|NOT COMPLETED|Overall Study||10
8130019|NCT02820038|20040411|P4|COMPLETED|Overall Study||44
8130020|NCT02820038|20040412|P3|COMPLETED|Overall Study||60
8130021|NCT02820038|20040413|P2|COMPLETED|Overall Study||52
8130022|NCT02820038|20040414|P1|COMPLETED|Overall Study||68
8130023|NCT02820038|20040411|P4|STARTED|Overall Study||66
8130024|NCT02820038|20040412|P3|STARTED|Overall Study||65
8130025|NCT02820038|20040413|P2|STARTED|Overall Study||77
8130026|NCT02820038|20040414|P1|STARTED|Overall Study||78
8130027|NCT02819908|20040518|P2|NOT COMPLETED|Overall Study||0
8130028|NCT02819908|20040519|P1|NOT COMPLETED|Overall Study||0
8130029|NCT02819908|20040518|P2|COMPLETED|Overall Study||13
8130030|NCT02819908|20040519|P1|COMPLETED|Overall Study||12
8130031|NCT02819908|20040518|P2|STARTED|Overall Study||13
8130032|NCT02819908|20040519|P1|STARTED|Overall Study||12
8130033|NCT02819804|20040541|P1|NOT COMPLETED|Follow-up for 1 Year||0
8130034|NCT02819804|20040541|P1|COMPLETED|Follow-up for 1 Year||1
8130035|NCT02819804|20040541|P1|STARTED|Follow-up for 1 Year||1
8130036|NCT02819804|20040541|P1|NOT COMPLETED|Start Cycle 2 and Beyond||0
8130037|NCT02819804|20040541|P1|COMPLETED|Start Cycle 2 and Beyond||0
8130038|NCT02819804|20040541|P1|STARTED|Start Cycle 2 and Beyond||0
8130039|NCT02819804|20040541|P1|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
8130040|NCT02819804|20040541|P1|COMPLETED|Complete Cycle 1 (28 Days)||0
8130041|NCT02819804|20040541|P1|STARTED|Complete Cycle 1 (28 Days)||1
8130042|NCT02819726|20040548|P4|NOT COMPLETED|Part B (All Participants)||2
8130043|NCT02819726|20040549|P3|NOT COMPLETED|Part B (All Participants)||4
8130044|NCT02819726|20040550|P2|NOT COMPLETED|Part B (All Participants)||2
8130045|NCT02819726|20040551|P1|NOT COMPLETED|Part B (All Participants)||3
8130046|NCT02819726|20040548|P4|COMPLETED|Part B (All Participants)||36
8130047|NCT02819726|20040549|P3|COMPLETED|Part B (All Participants)||35
8130048|NCT02819726|20040550|P2|COMPLETED|Part B (All Participants)||68
8130049|NCT02819726|20040551|P1|COMPLETED|Part B (All Participants)||70
8130050|NCT02819726|20040548|P4|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
8130051|NCT02819726|20040549|P3|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
8130052|NCT02819726|20040550|P2|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
8130053|NCT02819726|20040551|P1|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
8130054|NCT02819726|20040548|P4|NOT COMPLETED|Part A (All Participants)||0
8130055|NCT02819726|20040549|P3|NOT COMPLETED|Part A (All Participants)||11
8130056|NCT02819726|20040550|P2|NOT COMPLETED|Part A (All Participants)||10
8130057|NCT02819726|20040551|P1|NOT COMPLETED|Part A (All Participants)||6
8130058|NCT02819726|20040548|P4|COMPLETED|Part A (All Participants)||0
8130059|NCT02819726|20040549|P3|COMPLETED|Part A (All Participants)||87
8130060|NCT02819726|20040550|P2|COMPLETED|Part A (All Participants)||88
8130061|NCT02819726|20040551|P1|COMPLETED|Part A (All Participants)||92
8130062|NCT02819726|20040548|P4|STARTED|Part A (All Participants)||0
8130063|NCT02819726|20040549|P3|STARTED|Part A (All Participants)||98
8130064|NCT02819726|20040550|P2|STARTED|Part A (All Participants)||98
8130065|NCT02819726|20040551|P1|STARTED|Part A (All Participants)||98
8130066|NCT02819557|20040661|P1|NOT COMPLETED|Overall Study||0
8130067|NCT02819557|20040661|P1|COMPLETED|Overall Study||14
8130068|NCT02819557|20040661|P1|Evaluable Population|Overall Study||14
8130069|NCT02819557|20040661|P1|Pharmacokinetics (PK) Population|Overall Study||14
8130070|NCT02819557|20040661|P1|Safety Population|Overall Study||14
8130071|NCT02819557|20040661|P1|STARTED|Overall Study||14
8130072|NCT02819310|20040678|P1|NOT COMPLETED|Overall Study||109
8130073|NCT02819310|20040678|P1|COMPLETED|Overall Study||221
8130074|NCT02819310|20040678|P1|STARTED|Overall Study||330
8130075|NCT02819297|20040684|P2|NOT COMPLETED|Overall Study||52
8130076|NCT02819297|20040685|P1|NOT COMPLETED|Overall Study||60
8130077|NCT02819297|20040684|P2|COMPLETED|Overall Study||252
8130078|NCT02819297|20040685|P1|COMPLETED|Overall Study||239
8130079|NCT02819297|20040684|P2|STARTED|Overall Study||304
8130080|NCT02819297|20040685|P1|STARTED|Overall Study||299
8130081|NCT02819284|20040693|P2|NOT COMPLETED|Overall Study||5
8130082|NCT02819284|20040694|P1|NOT COMPLETED|Overall Study||5
8130083|NCT02819284|20040693|P2|COMPLETED|Overall Study||448
8130084|NCT02819284|20040694|P1|COMPLETED|Overall Study||447
8130085|NCT02819284|20040693|P2|STARTED|Overall Study||453
8130086|NCT02819284|20040694|P1|STARTED|Overall Study||452
8130087|NCT02819011|20040728|P2|NOT COMPLETED|Overall Study||5
8130088|NCT02819011|20040729|P1|NOT COMPLETED|Overall Study||7
8130089|NCT02819011|20040728|P2|COMPLETED|Overall Study||17
8130090|NCT02819011|20040729|P1|COMPLETED|Overall Study||15
8130091|NCT02819011|20040728|P2|STARTED|Overall Study||22
8130092|NCT02819011|20040729|P1|STARTED|Overall Study||22
8130093|NCT02818998|20040759|P3|NOT COMPLETED|Overall Study||18
8130094|NCT02818998|20040760|P2|NOT COMPLETED|Overall Study||16
8130095|NCT02818998|20040761|P1|NOT COMPLETED|Overall Study||18
8130096|NCT02818998|20040759|P3|COMPLETED|Overall Study||136
8130097|NCT02818998|20040760|P2|COMPLETED|Overall Study||138
8130098|NCT02818998|20040761|P1|COMPLETED|Overall Study||137
8130099|NCT02818998|20040759|P3|Completed Week 52 Visit|Overall Study||140
8130100|NCT02818998|20040760|P2|Completed Week 52 Visit|Overall Study||146
8130101|NCT02818998|20040761|P1|Completed Week 52 Visit|Overall Study||144
8130102|NCT02818998|20040759|P3|STARTED|Overall Study||154
8130103|NCT02818998|20040760|P2|STARTED|Overall Study||154
8130104|NCT02818998|20040761|P1|STARTED|Overall Study||155
8130105|NCT02818946|20040787|P1|NOT COMPLETED|Overall Study||0
8130106|NCT02818946|20040787|P1|COMPLETED|Overall Study||30
8130107|NCT02818946|20040787|P1|STARTED|Overall Study||30
8130108|NCT02818920|20040794|P1|NOT COMPLETED|Overall Study||18
8130109|NCT02818920|20040794|P1|COMPLETED|Overall Study||12
8130110|NCT02818920|20040794|P1|Received Adjuvant Therapy|Overall Study||17
8130111|NCT02818920|20040794|P1|Completed Surgery|Overall Study||25
8130112|NCT02818920|20040794|P1|STARTED|Overall Study||30
8130113|NCT02818777|20040798|P1|NOT COMPLETED|Overall Study||3
8130114|NCT02818777|20040798|P1|COMPLETED|Overall Study||10
8130115|NCT02818777|20040798|P1|STARTED|Overall Study|The number of baseline participants was 13.|13
8130116|NCT02818569|20040826|P2|NOT COMPLETED|Overall Study||0
8130117|NCT02818569|20040827|P1|NOT COMPLETED|Overall Study||0
8130118|NCT02818569|20040826|P2|COMPLETED|Overall Study||7
8130119|NCT02818569|20040827|P1|COMPLETED|Overall Study||8
8130120|NCT02818569|20040826|P2|STARTED|Overall Study||7
8130121|NCT02818569|20040827|P1|STARTED|Overall Study||8
8130122|NCT02818244|20040845|P4|NOT COMPLETED|Overall Study||0
8130123|NCT02818244|20040846|P3|NOT COMPLETED|Overall Study||0
8130124|NCT02818244|20040847|P2|NOT COMPLETED|Overall Study||0
8130125|NCT02818244|20040848|P1|NOT COMPLETED|Overall Study||0
8130126|NCT02818244|20040845|P4|COMPLETED|Overall Study||25
8130127|NCT02818244|20040846|P3|COMPLETED|Overall Study||25
8130128|NCT02818244|20040847|P2|COMPLETED|Overall Study||25
8130129|NCT02818244|20040848|P1|COMPLETED|Overall Study||25
8130130|NCT02818244|20040845|P4|STARTED|Overall Study||25
8130131|NCT02818244|20040846|P3|STARTED|Overall Study||25
8130132|NCT02818244|20040847|P2|STARTED|Overall Study||25
8130133|NCT02818244|20040848|P1|STARTED|Overall Study||25
8130134|NCT02818114|20040858|P1|NOT COMPLETED|Overall Study||1
8130135|NCT02818114|20040858|P1|COMPLETED|Overall Study||7
8130136|NCT02818114|20040858|P1|STARTED|Overall Study||8
8130137|NCT02818036|20040865|P2|NOT COMPLETED|Overall Study||0
8130138|NCT02818036|20040866|P1|NOT COMPLETED|Overall Study||2
8130139|NCT02818036|20040865|P2|COMPLETED|Overall Study||40
8130140|NCT02818036|20040866|P1|COMPLETED|Overall Study||40
8130141|NCT02818036|20040865|P2|STARTED|Overall Study||40
8130142|NCT02818036|20040866|P1|STARTED|Overall Study||42
8130143|NCT02817841|20040874|P1|NOT COMPLETED|Overall Study||848
8130144|NCT02817841|20040874|P1|COMPLETED|Overall Study||1016
8130145|NCT02817841|20040874|P1|STARTED|Overall Study||1864
8130146|NCT02817828|20040901|P1|NOT COMPLETED|Overall Study||335
8130147|NCT02817828|20040901|P1|COMPLETED|Overall Study||1218
8130148|NCT02817828|20040901|P1|STARTED|Overall Study||1553
8130149|NCT02817776|20040925|P1|NOT COMPLETED|Overall Study||88
8130150|NCT02817776|20040925|P1|COMPLETED|Overall Study||293
8130244|NCT02815735|20041204|P2|STARTED|First Intervention (4 Weeks)||38
8130151|NCT02817776|20040925|P1|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
8130152|NCT02817763|20040937|P2|NOT COMPLETED|Overall Study||0
8130153|NCT02817763|20040938|P1|NOT COMPLETED|Overall Study||0
8130154|NCT02817763|20040937|P2|COMPLETED|Overall Study||20
8130155|NCT02817763|20040938|P1|COMPLETED|Overall Study||20
8130156|NCT02817763|20040937|P2|STARTED|Overall Study||20
8130157|NCT02817763|20040938|P1|STARTED|Overall Study||20
8130158|NCT02817594|20040946|P1|NOT COMPLETED|Overall Study||3
8130159|NCT02817594|20040946|P1|COMPLETED|Overall Study||48
8130160|NCT02817594|20040946|P1|Received Treatment|Overall Study||50
8130161|NCT02817594|20040946|P1|STARTED|Overall Study||51
8130162|NCT02817555|20040967|P2|NOT COMPLETED|Overall Study||5
8130163|NCT02817555|20040968|P1|NOT COMPLETED|Overall Study||3
8130164|NCT02817555|20040967|P2|COMPLETED|Overall Study||21
8130165|NCT02817555|20040968|P1|COMPLETED|Overall Study||21
8130166|NCT02817555|20040967|P2|STARTED|Overall Study||26
8130167|NCT02817555|20040968|P1|STARTED|Overall Study||24
8130168|NCT02817516|20040988|P4|NOT COMPLETED|Overall Study||0
8130169|NCT02817516|20040989|P3|NOT COMPLETED|Overall Study||1
8130170|NCT02817516|20040990|P2|NOT COMPLETED|Overall Study||0
8130171|NCT02817516|20040991|P1|NOT COMPLETED|Overall Study||0
8130172|NCT02817516|20040988|P4|COMPLETED|Overall Study||6
8130173|NCT02817516|20040989|P3|COMPLETED|Overall Study||5
8130174|NCT02817516|20040990|P2|COMPLETED|Overall Study||6
8130175|NCT02817516|20040991|P1|COMPLETED|Overall Study||6
8130176|NCT02817516|20040988|P4|STARTED|Overall Study||6
8130177|NCT02817516|20040989|P3|STARTED|Overall Study||6
8130178|NCT02817516|20040990|P2|STARTED|Overall Study||6
8130179|NCT02817516|20040991|P1|STARTED|Overall Study||6
8130180|NCT02817087|20041028|P2|NOT COMPLETED|Overall Study||0
8130181|NCT02817087|20041029|P1|NOT COMPLETED|Overall Study||2
8130182|NCT02817087|20041028|P2|COMPLETED|Overall Study||15
8130183|NCT02817087|20041029|P1|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
8130184|NCT02817087|20041028|P2|STARTED|Overall Study||15
8130185|NCT02817087|20041029|P1|STARTED|Overall Study||16
8130186|NCT02816723|20041049|P2|NOT COMPLETED|Overall Study||2
8130187|NCT02816723|20041050|P1|NOT COMPLETED|Overall Study||6
8130188|NCT02816723|20041049|P2|COMPLETED|Overall Study||28
8130189|NCT02816723|20041050|P1|COMPLETED|Overall Study||24
8130190|NCT02816723|20041049|P2|STARTED|Overall Study||30
8130191|NCT02816723|20041050|P1|STARTED|Overall Study||30
8130192|NCT02816710|20041063|P3|NOT COMPLETED|Overall Study||7
8130193|NCT02816710|20041064|P2|NOT COMPLETED|Overall Study||3
8130194|NCT02816710|20041065|P1|NOT COMPLETED|Overall Study||4
8130195|NCT02816710|20041063|P3|COMPLETED|Overall Study||29
8130196|NCT02816710|20041064|P2|COMPLETED|Overall Study||35
8130197|NCT02816710|20041065|P1|COMPLETED|Overall Study||34
8130198|NCT02816710|20041063|P3|STARTED|Overall Study||36
8130199|NCT02816710|20041064|P2|STARTED|Overall Study||38
8130200|NCT02816710|20041065|P1|STARTED|Overall Study||38
8130204|NCT02816346|20041112|P5|NOT COMPLETED|Overall Study||0
8130205|NCT02816346|20041113|P4|NOT COMPLETED|Overall Study||0
8130206|NCT02816346|20041114|P3|NOT COMPLETED|Overall Study||0
8130207|NCT02816346|20041115|P2|NOT COMPLETED|Overall Study||0
8130208|NCT02816346|20041116|P1|NOT COMPLETED|Overall Study||0
8130209|NCT02816346|20041112|P5|COMPLETED|Overall Study||16
8130210|NCT02816346|20041113|P4|COMPLETED|Overall Study||10
8130211|NCT02816346|20041114|P3|COMPLETED|Overall Study||10
8130212|NCT02816346|20041115|P2|COMPLETED|Overall Study||10
8130213|NCT02816346|20041116|P1|COMPLETED|Overall Study||10
8130214|NCT02816346|20041112|P5|STARTED|Overall Study||16
8130215|NCT02816346|20041113|P4|STARTED|Overall Study||10
8130216|NCT02816346|20041114|P3|STARTED|Overall Study||10
8130217|NCT02816346|20041115|P2|STARTED|Overall Study||10
8130218|NCT02816346|20041116|P1|STARTED|Overall Study||10
8130219|NCT02816138|20041158|P1|NOT COMPLETED|Overall Study||1
8130220|NCT02816138|20041158|P1|COMPLETED|Overall Study||14
8130221|NCT02816138|20041158|P1|STARTED|Overall Study||15
8130222|NCT02815982|20041175|P4|NOT COMPLETED|Overall Study||0
8130223|NCT02815982|20041176|P3|NOT COMPLETED|Overall Study||0
8130224|NCT02815982|20041177|P2|NOT COMPLETED|Overall Study||0
8130225|NCT02815982|20041178|P1|NOT COMPLETED|Overall Study||0
8130226|NCT02815982|20041175|P4|COMPLETED|Overall Study||26
8130227|NCT02815982|20041176|P3|COMPLETED|Overall Study||27
8130228|NCT02815982|20041177|P2|COMPLETED|Overall Study||26
8130229|NCT02815982|20041178|P1|COMPLETED|Overall Study||27
8130230|NCT02815982|20041175|P4|STARTED|Overall Study||26
8130231|NCT02815982|20041176|P3|STARTED|Overall Study||27
8130232|NCT02815982|20041177|P2|STARTED|Overall Study||26
8130233|NCT02815982|20041178|P1|STARTED|Overall Study||27
8130234|NCT02815735|20041204|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8130235|NCT02815735|20041205|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8130236|NCT02815735|20041204|P2|COMPLETED|Second Intervention (4 Weeks)||37
8130237|NCT02815735|20041205|P1|COMPLETED|Second Intervention (4 Weeks)||33
8130238|NCT02815735|20041204|P2|STARTED|Second Intervention (4 Weeks)||37
8130239|NCT02815735|20041205|P1|STARTED|Second Intervention (4 Weeks)||34
8130240|NCT02815735|20041204|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8130241|NCT02815735|20041205|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8130242|NCT02815735|20041204|P2|COMPLETED|First Intervention (4 Weeks)||37
8130243|NCT02815735|20041205|P1|COMPLETED|First Intervention (4 Weeks)||34
8130245|NCT02815735|20041205|P1|STARTED|First Intervention (4 Weeks)||36
8130246|NCT02815709|20041225|P5|NOT COMPLETED|Overall Study||10
8130247|NCT02815709|20041226|P4|NOT COMPLETED|Overall Study||8
8130248|NCT02815709|20041227|P3|NOT COMPLETED|Overall Study||7
8130249|NCT02815709|20041228|P2|NOT COMPLETED|Overall Study||8
8130250|NCT02815709|20041229|P1|NOT COMPLETED|Overall Study||7
8130251|NCT02815709|20041225|P5|COMPLETED|Overall Study|Completed Study|74
8130252|NCT02815709|20041226|P4|COMPLETED|Overall Study|Completed Study|76
8130253|NCT02815709|20041227|P3|COMPLETED|Overall Study|Completed Study|75
8130254|NCT02815709|20041228|P2|COMPLETED|Overall Study|Completed Study|78
8130255|NCT02815709|20041229|P1|COMPLETED|Overall Study|Completed Study|75
8130256|NCT02815709|20041225|P5|Treated With Study Medication|Overall Study||76
8130257|NCT02815709|20041226|P4|Treated With Study Medication|Overall Study||79
8130258|NCT02815709|20041227|P3|Treated With Study Medication|Overall Study||79
8130259|NCT02815709|20041228|P2|Treated With Study Medication|Overall Study||79
8130260|NCT02815709|20041229|P1|Treated With Study Medication|Overall Study||76
8130261|NCT02815709|20041225|P5|STARTED|Overall Study||84
8130262|NCT02815709|20041226|P4|STARTED|Overall Study||84
8130263|NCT02815709|20041227|P3|STARTED|Overall Study||82
8130264|NCT02815709|20041228|P2|STARTED|Overall Study||86
8130265|NCT02815709|20041229|P1|STARTED|Overall Study||82
8130266|NCT02815670|20041259|P1|NOT COMPLETED|Overall Study||1
8130267|NCT02815670|20041259|P1|COMPLETED|Overall Study||0
8130268|NCT02815670|20041259|P1|STARTED|Overall Study||1
8130269|NCT02815644|20041272|P2|NOT COMPLETED|Treatment Period 2||0
8130270|NCT02815644|20041273|P1|NOT COMPLETED|Treatment Period 2||0
8130271|NCT02815644|20041272|P2|COMPLETED|Treatment Period 2||11
8130272|NCT02815644|20041273|P1|COMPLETED|Treatment Period 2||11
8130273|NCT02815644|20041272|P2|STARTED|Treatment Period 2||11
8130274|NCT02815644|20041273|P1|STARTED|Treatment Period 2||11
8130275|NCT02815644|20041272|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
8130276|NCT02815644|20041273|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
8130277|NCT02815644|20041272|P2|COMPLETED|Treatment Period 1 + Washout||11
8130278|NCT02815644|20041273|P1|COMPLETED|Treatment Period 1 + Washout||11
8130279|NCT02815644|20041272|P2|STARTED|Treatment Period 1 + Washout||11
8130280|NCT02815644|20041273|P1|STARTED|Treatment Period 1 + Washout||11
8130281|NCT02815397|20041291|P1|NOT COMPLETED|Overall Study||2
8130282|NCT02815397|20041291|P1|COMPLETED|Overall Study||0
8130283|NCT02815397|20041291|P1|STARTED|Overall Study||2
8130284|NCT02815293|20041301|P3|NOT COMPLETED|Overall Study||18
8130285|NCT02815293|20041302|P2|NOT COMPLETED|Overall Study||8
8130286|NCT02815293|20041303|P1|NOT COMPLETED|Overall Study||10
8130287|NCT02815293|20041301|P3|COMPLETED|Overall Study||0
8130288|NCT02815293|20041302|P2|COMPLETED|Overall Study||0
8130289|NCT02815293|20041303|P1|COMPLETED|Overall Study||0
8130290|NCT02815293|20041301|P3|STARTED|Overall Study||18
8130291|NCT02815293|20041302|P2|STARTED|Overall Study||8
8130292|NCT02815293|20041303|P1|STARTED|Overall Study||10
8130293|NCT02815280|20041313|P2|NOT COMPLETED|Open-Label Phase||44
8130294|NCT02815280|20041314|P1|NOT COMPLETED|Open-Label Phase||87
8130295|NCT02815280|20041313|P2|COMPLETED|Open-Label Phase||73
8130296|NCT02815280|20041314|P1|COMPLETED|Open-Label Phase||169
8130297|NCT02815280|20041313|P2|STARTED|Open-Label Phase||117
8130298|NCT02815280|20041314|P1|STARTED|Open-Label Phase||256
8130299|NCT02815280|20041313|P2|NOT COMPLETED|Double-Blind Phase||25
8130300|NCT02815280|20041314|P1|NOT COMPLETED|Double-Blind Phase||36
8130301|NCT02815280|20041313|P2|COMPLETED|Double-Blind Phase||137
8130302|NCT02815280|20041314|P1|COMPLETED|Double-Blind Phase||297
8130303|NCT02815280|20041313|P2|STARTED|Double-Blind Phase||162
8130304|NCT02815280|20041314|P1|STARTED|Double-Blind Phase||333
8130305|NCT02815267|20041334|P2|NOT COMPLETED|Open-Label Phase||41
8130306|NCT02815267|20041335|P1|NOT COMPLETED|Open-Label Phase||71
8130307|NCT02815267|20041334|P2|COMPLETED|Open-Label Phase||50
8130308|NCT02815267|20041335|P1|COMPLETED|Open-Label Phase||122
8130309|NCT02815267|20041334|P2|STARTED|Open-Label Phase||91
8130310|NCT02815267|20041335|P1|STARTED|Open-Label Phase||193
8130311|NCT02815267|20041334|P2|NOT COMPLETED|Double-Blind Phase||31
8130312|NCT02815267|20041335|P1|NOT COMPLETED|Double-Blind Phase||33
8130313|NCT02815267|20041334|P2|COMPLETED|Double-Blind Phase||128
8130314|NCT02815267|20041335|P1|COMPLETED|Double-Blind Phase||274
8130315|NCT02815267|20041334|P2|STARTED|Double-Blind Phase||159
8130316|NCT02815267|20041335|P1|STARTED|Double-Blind Phase||307
8130317|NCT02814890|20041355|P2|NOT COMPLETED|Overall Study||2
8130318|NCT02814890|20041356|P1|NOT COMPLETED|Overall Study||3
8130319|NCT02814890|20041355|P2|COMPLETED|Overall Study||30
8130320|NCT02814890|20041356|P1|COMPLETED|Overall Study||30
8130321|NCT02814890|20041355|P2|STARTED|Overall Study||32
8130322|NCT02814890|20041356|P1|STARTED|Overall Study||33
8130323|NCT02814838|20041370|P2|NOT COMPLETED|Overall Study||1
8130324|NCT02814838|20041371|P1|NOT COMPLETED|Overall Study||2
8130325|NCT02814838|20041370|P2|COMPLETED|Overall Study||25
8130326|NCT02814838|20041371|P1|COMPLETED|Overall Study||48
8130327|NCT02814838|20041370|P2|STARTED|Overall Study||26
8130328|NCT02814838|20041371|P1|STARTED|Overall Study||50
8130329|NCT02814656|20041407|P4|NOT COMPLETED|Overall Study||0
8130330|NCT02814656|20041408|P3|NOT COMPLETED|Overall Study||0
8130331|NCT02814656|20041409|P2|NOT COMPLETED|Overall Study||0
8130332|NCT02814656|20041410|P1|NOT COMPLETED|Overall Study||0
8130333|NCT02814656|20041407|P4|COMPLETED|Overall Study||6
8130334|NCT02814656|20041408|P3|COMPLETED|Overall Study||6
8130335|NCT02814656|20041409|P2|COMPLETED|Overall Study||6
8130336|NCT02814656|20041410|P1|COMPLETED|Overall Study||6
8130337|NCT02814656|20041407|P4|STARTED|Overall Study||6
8130338|NCT02814656|20041408|P3|STARTED|Overall Study||6
8130339|NCT02814656|20041409|P2|STARTED|Overall Study||6
8130340|NCT02814656|20041410|P1|STARTED|Overall Study||6
8130341|NCT02814643|20041510|P2|NOT COMPLETED|Overall Study||3
8130342|NCT02814643|20041511|P1|NOT COMPLETED|Overall Study||1
8130343|NCT02814643|20041510|P2|COMPLETED|Overall Study||49
8130344|NCT02814643|20041511|P1|COMPLETED|Overall Study||50
8130345|NCT02814643|20041510|P2|STARTED|Overall Study||52
8130346|NCT02814643|20041511|P1|STARTED|Overall Study||51
8130347|NCT02814565|20041535|P2|NOT COMPLETED|Overall Study||2
8130348|NCT02814565|20041536|P1|NOT COMPLETED|Overall Study||1
8130349|NCT02814565|20041535|P2|COMPLETED|Overall Study||88
8130350|NCT02814565|20041536|P1|COMPLETED|Overall Study||89
8130351|NCT02814565|20041535|P2|STARTED|Overall Study||90
8130352|NCT02814565|20041536|P1|STARTED|Overall Study||90
8130353|NCT02814448|20041565|P5|NOT COMPLETED|Overall Study||2
8130354|NCT02814448|20041566|P4|NOT COMPLETED|Overall Study||0
8130355|NCT02814448|20041567|P3|NOT COMPLETED|Overall Study||1
8130356|NCT02814448|20041568|P2|NOT COMPLETED|Overall Study||0
8130357|NCT02814448|20041569|P1|NOT COMPLETED|Overall Study||0
8130358|NCT02814448|20041565|P5|COMPLETED|Overall Study||26
8130359|NCT02814448|20041566|P4|COMPLETED|Overall Study||25
8130360|NCT02814448|20041567|P3|COMPLETED|Overall Study||25
8130361|NCT02814448|20041568|P2|COMPLETED|Overall Study||24
8130362|NCT02814448|20041569|P1|COMPLETED|Overall Study||27
8130363|NCT02814448|20041565|P5|STARTED|Overall Study||28
8130364|NCT02814448|20041566|P4|STARTED|Overall Study||25
8130365|NCT02814448|20041567|P3|STARTED|Overall Study||26
8130366|NCT02814448|20041568|P2|STARTED|Overall Study||24
8130367|NCT02814448|20041569|P1|STARTED|Overall Study||27
8130368|NCT02814279|20041588|P2|NOT COMPLETED|Overall Study||0
8130369|NCT02814279|20041589|P1|NOT COMPLETED|Overall Study||0
8130370|NCT02814279|20041588|P2|COMPLETED|Overall Study||21
8130371|NCT02814279|20041589|P1|COMPLETED|Overall Study||21
8130372|NCT02814279|20041588|P2|STARTED|Overall Study||21
8130373|NCT02814279|20041589|P1|STARTED|Overall Study||21
8130374|NCT02814227|20041597|P1|NOT COMPLETED|Overall Study||0
8130375|NCT02814227|20041597|P1|COMPLETED|Overall Study||52
8130376|NCT02814227|20041597|P1|STARTED|Overall Study||52
8130377|NCT02814175|20041606|P6|NOT COMPLETED|Part 2||6
8130378|NCT02814175|20041607|P5|NOT COMPLETED|Part 2||2
8130379|NCT02814175|20041608|P4|NOT COMPLETED|Part 2||4
8130380|NCT02814175|20041609|P3|NOT COMPLETED|Part 2||0
8130381|NCT02814175|20041610|P2|NOT COMPLETED|Part 2||0
8130382|NCT02814175|20041611|P1|NOT COMPLETED|Part 2||0
8130383|NCT02814175|20041606|P6|COMPLETED|Part 2||57
8130384|NCT02814175|20041607|P5|COMPLETED|Part 2||52
8130385|NCT02814175|20041608|P4|COMPLETED|Part 2||91
8130386|NCT02814175|20041609|P3|COMPLETED|Part 2||15
8130387|NCT02814175|20041610|P2|COMPLETED|Part 2||0
8130388|NCT02814175|20041611|P1|COMPLETED|Part 2||0
8130389|NCT02814175|20041606|P6|STARTED|Part 2||63
8130390|NCT02814175|20041607|P5|STARTED|Part 2||54
8130391|NCT02814175|20041608|P4|STARTED|Part 2||95
8130392|NCT02814175|20041609|P3|STARTED|Part 2||15
8130393|NCT02814175|20041610|P2|STARTED|Part 2||0
8130394|NCT02814175|20041611|P1|STARTED|Part 2||0
8130395|NCT02814175|20041606|P6|NOT COMPLETED|Part 1||0
8130396|NCT02814175|20041607|P5|NOT COMPLETED|Part 1||0
8130397|NCT02814175|20041608|P4|NOT COMPLETED|Part 1||0
8130398|NCT02814175|20041609|P3|NOT COMPLETED|Part 1||0
8130399|NCT02814175|20041610|P2|NOT COMPLETED|Part 1||6
8130400|NCT02814175|20041611|P1|NOT COMPLETED|Part 1||12
8130401|NCT02814175|20041606|P6|COMPLETED|Part 1||0
8130402|NCT02814175|20041607|P5|COMPLETED|Part 1||0
8130403|NCT02814175|20041608|P4|COMPLETED|Part 1||0
8130404|NCT02814175|20041609|P3|COMPLETED|Part 1||0
8130405|NCT02814175|20041610|P2|COMPLETED|Part 1||117
8130406|NCT02814175|20041611|P1|COMPLETED|Part 1||110
8130407|NCT02814175|20041606|P6|STARTED|Part 1||0
8130408|NCT02814175|20041607|P5|STARTED|Part 1||0
8130409|NCT02814175|20041608|P4|STARTED|Part 1||0
8130410|NCT02814175|20041609|P3|STARTED|Part 1||0
8130411|NCT02814175|20041610|P2|STARTED|Part 1||123
8130412|NCT02814175|20041611|P1|STARTED|Part 1||122
8130413|NCT02813694|20041649|P2|NOT COMPLETED|Overall Study||14
8130414|NCT02813694|20041650|P1|NOT COMPLETED|Overall Study||17
8130415|NCT02813694|20041649|P2|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
8130416|NCT02813694|20041650|P1|COMPLETED|Overall Study||353
8130417|NCT02813694|20041649|P2|STARTED|Overall Study|Intent to Treat Analysis Set|368
8130418|NCT02813694|20041650|P1|STARTED|Overall Study|Intent to Treat Analysis Set|370
8130419|NCT02813681|20041663|P3|NOT COMPLETED|Overall Study||0
8130420|NCT02813681|20041664|P2|NOT COMPLETED|Overall Study||6
8130421|NCT02813681|20041665|P1|NOT COMPLETED|Overall Study||5
8130422|NCT02813681|20041663|P3|COMPLETED|Overall Study||19
8130423|NCT02813681|20041664|P2|COMPLETED|Overall Study||28
8130424|NCT02813681|20041665|P1|COMPLETED|Overall Study||22
8130425|NCT02813681|20041663|P3|STARTED|Overall Study||19
8130426|NCT02813681|20041664|P2|STARTED|Overall Study||34
8130427|NCT02813681|20041665|P1|STARTED|Overall Study||27
8130428|NCT02813577|20041686|P1|NOT COMPLETED|Overall Study||4
8130429|NCT02813577|20041686|P1|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
8130430|NCT02813577|20041686|P1|STARTED|Overall Study||4
8130431|NCT02813551|20041704|P2|NOT COMPLETED|Overall Study||2
8130432|NCT02813551|20041705|P1|NOT COMPLETED|Overall Study||1
8130433|NCT02813551|20041704|P2|COMPLETED|Overall Study||57
8130434|NCT02813551|20041705|P1|COMPLETED|Overall Study||58
8130435|NCT02813551|20041704|P2|STARTED|Overall Study||59
8130436|NCT02813551|20041705|P1|STARTED|Overall Study||59
8130437|NCT02813473|20041731|P1|NOT COMPLETED|Overall Study||0
8130438|NCT02813473|20041731|P1|COMPLETED|Overall Study||223
8130439|NCT02813473|20041731|P1|STARTED|Overall Study||223
8130446|NCT02813070|20041771|P3|NOT COMPLETED|Overall Study||11
8130447|NCT02813070|20041772|P2|NOT COMPLETED|Overall Study||3
8130448|NCT02813070|20041773|P1|NOT COMPLETED|Overall Study||3
8130449|NCT02813070|20041771|P3|COMPLETED|Overall Study||25
8130450|NCT02813070|20041772|P2|COMPLETED|Overall Study||20
8130451|NCT02813070|20041773|P1|COMPLETED|Overall Study||25
8130452|NCT02813070|20041771|P3|Treated (Safety Population)|Overall Study||25
8130453|NCT02813070|20041772|P2|Treated (Safety Population)|Overall Study||20
8130454|NCT02813070|20041773|P1|Treated (Safety Population)|Overall Study||25
8130455|NCT02813070|20041771|P3|STARTED|Overall Study||36
8130456|NCT02813070|20041772|P2|STARTED|Overall Study||23
8130457|NCT02813070|20041773|P1|STARTED|Overall Study||28
8130458|NCT02812342|20041782|P1|NOT COMPLETED|Overall Study||0
8130459|NCT02812342|20041782|P1|COMPLETED|Overall Study||10
8130460|NCT02812342|20041782|P1|STARTED|Overall Study||10
8130461|NCT02812238|20041787|P2|NOT COMPLETED|Second Intervention||1
8130462|NCT02812238|20041788|P1|NOT COMPLETED|Second Intervention||0
8130463|NCT02812238|20041787|P2|COMPLETED|Second Intervention||18
8130464|NCT02812238|20041788|P1|COMPLETED|Second Intervention||18
8130465|NCT02812238|20041787|P2|STARTED|Second Intervention||19
8130466|NCT02812238|20041788|P1|STARTED|Second Intervention||18
8130467|NCT02812238|20041787|P2|NOT COMPLETED|First Intervention||0
8130468|NCT02812238|20041788|P1|NOT COMPLETED|First Intervention||1
8130469|NCT02812238|20041787|P2|COMPLETED|First Intervention||19
8130470|NCT02812238|20041788|P1|COMPLETED|First Intervention||18
8130471|NCT02812238|20041787|P2|STARTED|First Intervention||19
8130472|NCT02812238|20041788|P1|STARTED|First Intervention||19
8130473|NCT02812186|20041796|P2|NOT COMPLETED|Period 2||0
8130474|NCT02812186|20041797|P1|NOT COMPLETED|Period 2||0
8130475|NCT02812186|20041796|P2|COMPLETED|Period 2||24
8130476|NCT02812186|20041797|P1|COMPLETED|Period 2||29
8130477|NCT02812186|20041796|P2|STARTED|Period 2||24
8130478|NCT02812186|20041797|P1|STARTED|Period 2||29
8130479|NCT02812186|20041796|P2|NOT COMPLETED|Period 1||15
8130480|NCT02812186|20041797|P1|NOT COMPLETED|Period 1||11
8130481|NCT02812186|20041796|P2|COMPLETED|Period 1||24
8130482|NCT02812186|20041797|P1|COMPLETED|Period 1||29
8130483|NCT02812186|20041796|P2|STARTED|Period 1||39
8130484|NCT02812186|20041797|P1|STARTED|Period 1||40
8130485|NCT02811965|20041807|P1|NOT COMPLETED|Overall Study||0
8130486|NCT02811965|20041807|P1|COMPLETED|Overall Study||21
8130487|NCT02811965|20041807|P1|STARTED|Overall Study||21
8130488|NCT02811913|20041830|P1|NOT COMPLETED|Overall Study||4
8130489|NCT02811913|20041830|P1|COMPLETED|Overall Study||16
8130490|NCT02811913|20041830|P1|STARTED|Overall Study||20
8130491|NCT02811640|20041841|P1|NOT COMPLETED|Overall Study||2
8130492|NCT02811640|20041841|P1|COMPLETED|Overall Study||10
8130493|NCT02811640|20041841|P1|STARTED|Overall Study||12
8130494|NCT02811445|20041847|P2|NOT COMPLETED|Overall Study||0
8130495|NCT02811445|20041848|P1|NOT COMPLETED|Overall Study||0
8130496|NCT02811445|20041847|P2|COMPLETED|Overall Study||11
8130497|NCT02811445|20041848|P1|COMPLETED|Overall Study||18
8130498|NCT02811445|20041847|P2|STARTED|Overall Study||11
8130499|NCT02811445|20041848|P1|STARTED|Overall Study||18
8130500|NCT02811419|20041862|P2|NOT COMPLETED|Overall Study||13
8130501|NCT02811419|20041863|P1|NOT COMPLETED|Overall Study||12
8130502|NCT02811419|20041862|P2|COMPLETED|Overall Study||358
8130503|NCT02811419|20041863|P1|COMPLETED|Overall Study||357
8130504|NCT02811419|20041862|P2|STARTED|Overall Study||371
8130505|NCT02811419|20041863|P1|STARTED|Overall Study||369
8130506|NCT02811302|20041871|P1|NOT COMPLETED|Overall Study||213
8130507|NCT02811302|20041871|P1|COMPLETED|Overall Study||1282
8130508|NCT02811302|20041871|P1|STARTED|Overall Study||1495
8130509|NCT02811159|20041876|P1|NOT COMPLETED|Treatment Course 2||0
8130510|NCT02811159|20041876|P1|COMPLETED|Treatment Course 2||4
8130511|NCT02811159|20041876|P1|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
8130512|NCT02811159|20041876|P1|NOT COMPLETED|Treatment Course 1||1
8130513|NCT02811159|20041876|P1|COMPLETED|Treatment Course 1||19
8130514|NCT02811159|20041876|P1|STARTED|Treatment Course 1||20
8130515|NCT02810873|20041893|P2|NOT COMPLETED|Overall Study||0
8130516|NCT02810873|20041894|P1|NOT COMPLETED|Overall Study||0
8130517|NCT02810873|20041893|P2|COMPLETED|Overall Study||13
8130518|NCT02810873|20041894|P1|COMPLETED|Overall Study||6
8130519|NCT02810873|20041893|P2|STARTED|Overall Study||13
8130520|NCT02810873|20041894|P1|STARTED|Overall Study||6
8130521|NCT02810509|20041904|P2|NOT COMPLETED|Overall Study||0
8130522|NCT02810509|20041905|P1|NOT COMPLETED|Overall Study||0
8130523|NCT02810509|20041904|P2|COMPLETED|Overall Study||1230
8130524|NCT02810509|20041905|P1|COMPLETED|Overall Study||584
8130525|NCT02810509|20041904|P2|STARTED|Overall Study||1230
8130526|NCT02810509|20041905|P1|STARTED|Overall Study||584
8130527|NCT02810457|20041915|P2|NOT COMPLETED|Overall Study||329
8130528|NCT02810457|20041916|P1|NOT COMPLETED|Overall Study||327
8130529|NCT02810457|20041915|P2|COMPLETED|Overall Study||38
8130530|NCT02810457|20041916|P1|COMPLETED|Overall Study||37
8130531|NCT02810457|20041915|P2|STARTED|Overall Study|366 patients received study treatment|367
8130532|NCT02810457|20041916|P1|STARTED|Overall Study|362 patients received study treatment|364
8130533|NCT02810327|20041938|P2|NOT COMPLETED|Overall Study||7
8130534|NCT02810327|20041939|P1|NOT COMPLETED|Overall Study||7
8130535|NCT02810327|20041938|P2|COMPLETED|Overall Study||34
8130536|NCT02810327|20041939|P1|COMPLETED|Overall Study||69
8130537|NCT02810327|20041938|P2|STARTED|Overall Study||41
8130538|NCT02810327|20041939|P1|STARTED|Overall Study||76
8130539|NCT02809976|20041945|P1|NOT COMPLETED|Overall Study||2
8130540|NCT02809976|20041945|P1|COMPLETED|Overall Study||9
8130541|NCT02809976|20041945|P1|STARTED|Overall Study||11
8130542|NCT02809911|20041957|P2|NOT COMPLETED|Overall Study||0
8130543|NCT02809911|20041958|P1|NOT COMPLETED|Overall Study||0
8130544|NCT02809911|20041957|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
8130545|NCT02809911|20041958|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
8130546|NCT02809911|20041957|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
8130547|NCT02809911|20041958|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
8130548|NCT02809859|20041966|P1|NOT COMPLETED|Overall Study||14
8130549|NCT02809859|20041966|P1|COMPLETED|Overall Study||125
8130550|NCT02809859|20041966|P1|STARTED|Overall Study||139
8130551|NCT02809846|20041976|P2|NOT COMPLETED|Overall Study||7
8130552|NCT02809846|20041977|P1|NOT COMPLETED|Overall Study||9
8130553|NCT02809846|20041976|P2|COMPLETED|Overall Study||9
8130554|NCT02809846|20041977|P1|COMPLETED|Overall Study||8
8130555|NCT02809846|20041976|P2|STARTED|Overall Study||16
8130556|NCT02809846|20041977|P1|STARTED|Overall Study||17
8130557|NCT02809833|20041983|P1|NOT COMPLETED|Overall Study||300
8130558|NCT02809833|20041983|P1|COMPLETED|Overall Study||550
8130559|NCT02809833|20041983|P1|STARTED|Overall Study||850
8130560|NCT02809430|20042057|P1|NOT COMPLETED|Overall Study||38
8130561|NCT02809430|20042057|P1|COMPLETED|Overall Study||52
8130562|NCT02809430|20042057|P1|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
8130563|NCT02809430|20042057|P1|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
8130564|NCT02809430|20042057|P1|STARTED|Overall Study||90
8130565|NCT02809183|20042073|P6|NOT COMPLETED|Overall Study||0
8130566|NCT02809183|20042074|P5|NOT COMPLETED|Overall Study||0
8130567|NCT02809183|20042075|P4|NOT COMPLETED|Overall Study||0
8130568|NCT02809183|20042076|P3|NOT COMPLETED|Overall Study||0
8130569|NCT02809183|20042077|P2|NOT COMPLETED|Overall Study||0
8130570|NCT02809183|20042078|P1|NOT COMPLETED|Overall Study||0
8130571|NCT02809183|20042073|P6|COMPLETED|Overall Study||28
8130572|NCT02809183|20042074|P5|COMPLETED|Overall Study||6
8130573|NCT02809183|20042075|P4|COMPLETED|Overall Study||26
8130574|NCT02809183|20042076|P3|COMPLETED|Overall Study||25
8130575|NCT02809183|20042077|P2|COMPLETED|Overall Study||25
8130576|NCT02809183|20042078|P1|COMPLETED|Overall Study||25
8130577|NCT02809183|20042073|P6|STARTED|Overall Study||28
8130578|NCT02809183|20042074|P5|STARTED|Overall Study||6
8130579|NCT02809183|20042075|P4|STARTED|Overall Study||26
8130580|NCT02809183|20042076|P3|STARTED|Overall Study||25
8130581|NCT02809183|20042077|P2|STARTED|Overall Study||25
8130582|NCT02809183|20042078|P1|STARTED|Overall Study||25
8130583|NCT02809118|20042115|P3|NOT COMPLETED|Overall Study||1
8130584|NCT02809118|20042116|P2|NOT COMPLETED|Overall Study||1
8130585|NCT02809118|20042117|P1|NOT COMPLETED|Overall Study||0
8130586|NCT02809118|20042115|P3|COMPLETED|Overall Study||18
8130587|NCT02809118|20042116|P2|COMPLETED|Overall Study||18
8130588|NCT02809118|20042117|P1|COMPLETED|Overall Study||18
8130589|NCT02809118|20042115|P3|STARTED|Overall Study||19
8130590|NCT02809118|20042116|P2|STARTED|Overall Study||19
8130591|NCT02809118|20042117|P1|STARTED|Overall Study||18
8130592|NCT02809053|20042130|P2|NOT COMPLETED|Overall Study||6
8130593|NCT02809053|20042131|P1|NOT COMPLETED|Overall Study||7
8130594|NCT02809053|20042130|P2|COMPLETED|Overall Study||152
8130595|NCT02809053|20042131|P1|COMPLETED|Overall Study||150
8130596|NCT02809053|20042130|P2|Completed Treatment|Overall Study||156
8130597|NCT02809053|20042131|P1|Completed Treatment|Overall Study||156
8130598|NCT02809053|20042130|P2|STARTED|Overall Study||158
8130599|NCT02809053|20042131|P1|STARTED|Overall Study||157
8130600|NCT02808975|20042177|P2|NOT COMPLETED|Overall Study||19
8130601|NCT02808975|20042178|P1|NOT COMPLETED|Overall Study||22
8130602|NCT02808975|20042177|P2|COMPLETED|Overall Study||84
8130603|NCT02808975|20042178|P1|COMPLETED|Overall Study||81
8130604|NCT02808975|20042177|P2|STARTED|Overall Study||103
8130605|NCT02808975|20042178|P1|STARTED|Overall Study||103
8130606|NCT02808390|20042195|P3|NOT COMPLETED|Overall Study||3
8130607|NCT02808390|20042196|P2|NOT COMPLETED|Overall Study||6
8130608|NCT02808390|20042197|P1|NOT COMPLETED|Overall Study||2
8130609|NCT02808390|20042195|P3|COMPLETED|Overall Study||4
8130610|NCT02808390|20042196|P2|COMPLETED|Overall Study||2
8130611|NCT02808390|20042197|P1|COMPLETED|Overall Study||2
8130612|NCT02808390|20042195|P3|STARTED|Overall Study||7
8130613|NCT02808390|20042196|P2|STARTED|Overall Study||8
8130614|NCT02808390|20042197|P1|STARTED|Overall Study||4
8130615|NCT02808338|20042205|P1|NOT COMPLETED|Take Home Period||0
8130616|NCT02808338|20042205|P1|COMPLETED|Take Home Period||13
8130617|NCT02808338|20042205|P1|STARTED|Take Home Period||13
8130618|NCT02808338|20042205|P1|NOT COMPLETED|Overnight In-lab Polysomonography||2
8130619|NCT02808338|20042205|P1|COMPLETED|Overnight In-lab Polysomonography||13
8130620|NCT02808338|20042205|P1|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
8130621|NCT02808338|20042205|P1|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
8130622|NCT02808338|20042205|P1|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
8130623|NCT02808338|20042205|P1|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
8130624|NCT02808338|20042205|P1|STARTED|Overnight In-lab Polysomonography||15
8130625|NCT02808338|20042205|P1|NOT COMPLETED|Screening||10
8130626|NCT02808338|20042205|P1|COMPLETED|Screening||15
8130627|NCT02808338|20042205|P1|STARTED|Screening||25
8130628|NCT02808312|20042221|P5|NOT COMPLETED|Overall Study||0
8130629|NCT02808312|20042222|P4|NOT COMPLETED|Overall Study||0
8130630|NCT02808312|20042223|P3|NOT COMPLETED|Overall Study||1
8130631|NCT02808312|20042224|P2|NOT COMPLETED|Overall Study||0
8130632|NCT02808312|20042225|P1|NOT COMPLETED|Overall Study||0
8130633|NCT02808312|20042221|P5|COMPLETED|Overall Study||10
8130634|NCT02808312|20042222|P4|COMPLETED|Overall Study||10
8130635|NCT02808312|20042223|P3|COMPLETED|Overall Study||16
8130636|NCT02808312|20042224|P2|COMPLETED|Overall Study||10
8130637|NCT02808312|20042225|P1|COMPLETED|Overall Study||10
8130638|NCT02808312|20042221|P5|STARTED|Overall Study||10
8130639|NCT02808312|20042222|P4|STARTED|Overall Study||10
8130640|NCT02808312|20042223|P3|STARTED|Overall Study||17
8130641|NCT02808312|20042224|P2|STARTED|Overall Study||10
8130642|NCT02808312|20042225|P1|STARTED|Overall Study||10
8130643|NCT02808130|20042338|P6|NOT COMPLETED|Overall Study||0
8130644|NCT02808130|20042339|P5|NOT COMPLETED|Overall Study||0
8130645|NCT02808130|20042340|P4|NOT COMPLETED|Overall Study||0
8130646|NCT02808130|20042341|P3|NOT COMPLETED|Overall Study||0
8130647|NCT02808130|20042342|P2|NOT COMPLETED|Overall Study||0
8130648|NCT02808130|20042343|P1|NOT COMPLETED|Overall Study||0
8130649|NCT02808130|20042338|P6|COMPLETED|Overall Study||15
8130650|NCT02808130|20042339|P5|COMPLETED|Overall Study||15
8130651|NCT02808130|20042340|P4|COMPLETED|Overall Study||15
8130652|NCT02808130|20042341|P3|COMPLETED|Overall Study||15
8130653|NCT02808130|20042342|P2|COMPLETED|Overall Study||15
8130654|NCT02808130|20042343|P1|COMPLETED|Overall Study||15
8130655|NCT02808130|20042338|P6|STARTED|Overall Study||15
8130656|NCT02808130|20042339|P5|STARTED|Overall Study||15
8130657|NCT02808130|20042340|P4|STARTED|Overall Study||15
8130658|NCT02808130|20042341|P3|STARTED|Overall Study||15
8130659|NCT02808130|20042342|P2|STARTED|Overall Study||15
8130660|NCT02808130|20042343|P1|STARTED|Overall Study||15
8130661|NCT02808052|20042372|P3|NOT COMPLETED|Overall Study||0
8130662|NCT02808052|20042373|P2|NOT COMPLETED|Overall Study||0
8130663|NCT02808052|20042374|P1|NOT COMPLETED|Overall Study||0
8130664|NCT02808052|20042372|P3|COMPLETED|Overall Study||2
8130665|NCT02808052|20042373|P2|COMPLETED|Overall Study||3
8130666|NCT02808052|20042374|P1|COMPLETED|Overall Study||4
8130667|NCT02808052|20042372|P3|STARTED|Overall Study||2
8130668|NCT02808052|20042373|P2|STARTED|Overall Study||3
8130669|NCT02808052|20042374|P1|STARTED|Overall Study||4
8130670|NCT02807948|20042382|P2|NOT COMPLETED|Overall Study||0
8130671|NCT02807948|20042383|P1|NOT COMPLETED|Overall Study||1
8130672|NCT02807948|20042382|P2|COMPLETED|Overall Study||57
8130673|NCT02807948|20042383|P1|COMPLETED|Overall Study||131
8130674|NCT02807948|20042382|P2|STARTED|Overall Study||57
8130675|NCT02807948|20042383|P1|STARTED|Overall Study||132
8130682|NCT02807623|20042437|P3|NOT COMPLETED|Overall Study||23
8130683|NCT02807623|20042438|P2|NOT COMPLETED|Overall Study||21
8130684|NCT02807623|20042439|P1|NOT COMPLETED|Overall Study||23
8130685|NCT02807623|20042437|P3|COMPLETED|Overall Study||79
8130686|NCT02807623|20042438|P2|COMPLETED|Overall Study||79
8130687|NCT02807623|20042439|P1|COMPLETED|Overall Study||75
8130688|NCT02807623|20042437|P3|STARTED|Overall Study||102
8130689|NCT02807623|20042438|P2|STARTED|Overall Study||100
8130690|NCT02807623|20042439|P1|STARTED|Overall Study||98
8130691|NCT02807402|20042466|P1|NOT COMPLETED|Overall Study||6
8130692|NCT02807402|20042466|P1|COMPLETED|Overall Study||516
8130693|NCT02807402|20042466|P1|STARTED|Overall Study||522
8130694|NCT02807376|20042504|P2|NOT COMPLETED|Overall Study||1
8130695|NCT02807376|20042505|P1|NOT COMPLETED|Overall Study||3
8130696|NCT02807376|20042504|P2|COMPLETED|Overall Study||130
8130697|NCT02807376|20042505|P1|COMPLETED|Overall Study||136
8130698|NCT02807376|20042504|P2|STARTED|Overall Study||131
8130699|NCT02807376|20042505|P1|STARTED|Overall Study||139
8130700|NCT02807259|20042515|P2|NOT COMPLETED|Endline (3 Months)||87
8130701|NCT02807259|20042516|P1|NOT COMPLETED|Endline (3 Months)||35
8130702|NCT02807259|20042515|P2|COMPLETED|Endline (3 Months)||259
8130703|NCT02807259|20042516|P1|COMPLETED|Endline (3 Months)||288
8130704|NCT02807259|20042515|P2|STARTED|Endline (3 Months)||346
8130705|NCT02807259|20042516|P1|STARTED|Endline (3 Months)||323
8130706|NCT02807259|20042515|P2|NOT COMPLETED|Midline (3 Months)||34
8130707|NCT02807259|20042516|P1|NOT COMPLETED|Midline (3 Months)||30
8130708|NCT02807259|20042515|P2|COMPLETED|Midline (3 Months)||189
8130709|NCT02807259|20042516|P1|COMPLETED|Midline (3 Months)||322
8130710|NCT02807259|20042515|P2|STARTED|Midline (3 Months)||223
8130711|NCT02807259|20042516|P1|STARTED|Midline (3 Months)||352
8130712|NCT02807259|20042515|P2|NOT COMPLETED|Baseline (3 Months)||112
8130713|NCT02807259|20042516|P1|NOT COMPLETED|Baseline (3 Months)||77
8130714|NCT02807259|20042515|P2|COMPLETED|Baseline (3 Months)||292
8130715|NCT02807259|20042516|P1|COMPLETED|Baseline (3 Months)||328
8130716|NCT02807259|20042515|P2|STARTED|Baseline (3 Months)||404
8130717|NCT02807259|20042516|P1|STARTED|Baseline (3 Months)||405
8130718|NCT02806986|20042534|P1|NOT COMPLETED|Treatment Stage 2||5
8130719|NCT02806986|20042534|P1|COMPLETED|Treatment Stage 2||55
8130720|NCT02806986|20042534|P1|STARTED|Treatment Stage 2||60
8130721|NCT02806986|20042534|P1|NOT COMPLETED|Treatment Stage 1||1
8130722|NCT02806986|20042534|P1|COMPLETED|Treatment Stage 1||60
8130723|NCT02806986|20042534|P1|STARTED|Treatment Stage 1||61
8130724|NCT02806973|20042554|P4|NOT COMPLETED|Period 4||0
8130725|NCT02806973|20042555|P3|NOT COMPLETED|Period 4||0
8130726|NCT02806973|20042556|P2|NOT COMPLETED|Period 4||0
8130727|NCT02806973|20042557|P1|NOT COMPLETED|Period 4||0
8130728|NCT02806973|20042554|P4|COMPLETED|Period 4||3
8130729|NCT02806973|20042555|P3|COMPLETED|Period 4||6
8130730|NCT02806973|20042556|P2|COMPLETED|Period 4||6
8130731|NCT02806973|20042557|P1|COMPLETED|Period 4||8
8130732|NCT02806973|20042554|P4|STARTED|Period 4||3
8130733|NCT02806973|20042555|P3|STARTED|Period 4||6
8130734|NCT02806973|20042556|P2|STARTED|Period 4||6
8130735|NCT02806973|20042557|P1|STARTED|Period 4||8
8130736|NCT02806973|20042554|P4|NOT COMPLETED|Period 3||3
8130737|NCT02806973|20042555|P3|NOT COMPLETED|Period 3||1
8130738|NCT02806973|20042556|P2|NOT COMPLETED|Period 3||0
8130739|NCT02806973|20042557|P1|NOT COMPLETED|Period 3||0
8130740|NCT02806973|20042554|P4|COMPLETED|Period 3||3
8130741|NCT02806973|20042555|P3|COMPLETED|Period 3||6
8130742|NCT02806973|20042556|P2|COMPLETED|Period 3||6
8130743|NCT02806973|20042557|P1|COMPLETED|Period 3||8
8130744|NCT02806973|20042554|P4|STARTED|Period 3||6
8130745|NCT02806973|20042555|P3|STARTED|Period 3||7
8130746|NCT02806973|20042556|P2|STARTED|Period 3||6
8130747|NCT02806973|20042557|P1|STARTED|Period 3||8
8130748|NCT02806973|20042554|P4|NOT COMPLETED|Period 2||0
8130749|NCT02806973|20042555|P3|NOT COMPLETED|Period 2||0
8130750|NCT02806973|20042556|P2|NOT COMPLETED|Period 2||0
8130751|NCT02806973|20042557|P1|NOT COMPLETED|Period 2||0
8130752|NCT02806973|20042554|P4|COMPLETED|Period 2||6
8130753|NCT02806973|20042555|P3|COMPLETED|Period 2||7
8130754|NCT02806973|20042556|P2|COMPLETED|Period 2||6
8130755|NCT02806973|20042557|P1|COMPLETED|Period 2||8
8130756|NCT02806973|20042554|P4|STARTED|Period 2||6
8130757|NCT02806973|20042555|P3|STARTED|Period 2||7
8130758|NCT02806973|20042556|P2|STARTED|Period 2||6
8130759|NCT02806973|20042557|P1|STARTED|Period 2||8
8130760|NCT02806973|20042554|P4|NOT COMPLETED|Period 1||2
8130761|NCT02806973|20042555|P3|NOT COMPLETED|Period 1||1
8130762|NCT02806973|20042556|P2|NOT COMPLETED|Period 1||2
8130763|NCT02806973|20042557|P1|NOT COMPLETED|Period 1||0
8130764|NCT02806973|20042554|P4|COMPLETED|Period 1||6
8130765|NCT02806973|20042555|P3|COMPLETED|Period 1||7
8130766|NCT02806973|20042556|P2|COMPLETED|Period 1||6
8130767|NCT02806973|20042557|P1|COMPLETED|Period 1||8
8130768|NCT02806973|20042554|P4|STARTED|Period 1||8
8130769|NCT02806973|20042555|P3|STARTED|Period 1||8
8130770|NCT02806973|20042556|P2|STARTED|Period 1||8
8130771|NCT02806973|20042557|P1|STARTED|Period 1||8
8130772|NCT02806960|20042591|P4|NOT COMPLETED|Period 4||0
8130773|NCT02806960|20042592|P3|NOT COMPLETED|Period 4||0
8130774|NCT02806960|20042593|P2|NOT COMPLETED|Period 4||0
8130775|NCT02806960|20042594|P1|NOT COMPLETED|Period 4||0
8130776|NCT02806960|20042591|P4|COMPLETED|Period 4||0
8130777|NCT02806960|20042592|P3|COMPLETED|Period 4||0
8130778|NCT02806960|20042593|P2|COMPLETED|Period 4||0
8130779|NCT02806960|20042594|P1|COMPLETED|Period 4||0
8130780|NCT02806960|20042591|P4|STARTED|Period 4||0
8130781|NCT02806960|20042592|P3|STARTED|Period 4||0
8130782|NCT02806960|20042593|P2|STARTED|Period 4||0
8130783|NCT02806960|20042594|P1|STARTED|Period 4||0
8130784|NCT02806960|20042591|P4|NOT COMPLETED|Period 3||0
8130785|NCT02806960|20042592|P3|NOT COMPLETED|Period 3||0
8130786|NCT02806960|20042593|P2|NOT COMPLETED|Period 3||0
8130787|NCT02806960|20042594|P1|NOT COMPLETED|Period 3||0
8130788|NCT02806960|20042591|P4|COMPLETED|Period 3||0
8130789|NCT02806960|20042592|P3|COMPLETED|Period 3||0
8130790|NCT02806960|20042593|P2|COMPLETED|Period 3||0
8130791|NCT02806960|20042594|P1|COMPLETED|Period 3||0
8130792|NCT02806960|20042591|P4|STARTED|Period 3||0
8130793|NCT02806960|20042592|P3|STARTED|Period 3||0
8130794|NCT02806960|20042593|P2|STARTED|Period 3||0
8130795|NCT02806960|20042594|P1|STARTED|Period 3||0
8130796|NCT02806960|20042591|P4|NOT COMPLETED|Period 2||0
8130797|NCT02806960|20042592|P3|NOT COMPLETED|Period 2||0
8130798|NCT02806960|20042593|P2|NOT COMPLETED|Period 2||0
8130799|NCT02806960|20042594|P1|NOT COMPLETED|Period 2||0
8130800|NCT02806960|20042591|P4|COMPLETED|Period 2||0
8130801|NCT02806960|20042592|P3|COMPLETED|Period 2||0
8130802|NCT02806960|20042593|P2|COMPLETED|Period 2||0
8130803|NCT02806960|20042594|P1|COMPLETED|Period 2||0
8130804|NCT02806960|20042591|P4|STARTED|Period 2||0
8130805|NCT02806960|20042592|P3|STARTED|Period 2||0
8130806|NCT02806960|20042593|P2|STARTED|Period 2||0
8130807|NCT02806960|20042594|P1|STARTED|Period 2||0
8130808|NCT02806960|20042591|P4|NOT COMPLETED|Period 1||3
8130809|NCT02806960|20042592|P3|NOT COMPLETED|Period 1||3
8130810|NCT02806960|20042593|P2|NOT COMPLETED|Period 1||3
8130811|NCT02806960|20042594|P1|NOT COMPLETED|Period 1||3
8130812|NCT02806960|20042591|P4|COMPLETED|Period 1||0
8130813|NCT02806960|20042592|P3|COMPLETED|Period 1||0
8130814|NCT02806960|20042593|P2|COMPLETED|Period 1||0
8130815|NCT02806960|20042594|P1|COMPLETED|Period 1||0
8130816|NCT02806960|20042591|P4|STARTED|Period 1||3
8130817|NCT02806960|20042592|P3|STARTED|Period 1||3
8130818|NCT02806960|20042593|P2|STARTED|Period 1||3
8130819|NCT02806960|20042594|P1|STARTED|Period 1||3
8130820|NCT02806947|20042630|P2|NOT COMPLETED|Overall Study||1
8130821|NCT02806947|20042631|P1|NOT COMPLETED|Overall Study||5
8130822|NCT02806947|20042630|P2|COMPLETED|Overall Study||63
8130823|NCT02806947|20042631|P1|COMPLETED|Overall Study||53
8130824|NCT02806947|20042630|P2|STARTED|Overall Study||64
8130825|NCT02806947|20042631|P1|STARTED|Overall Study||58
8130826|NCT02806908|20042661|P2|NOT COMPLETED|Overall Study||1
8130827|NCT02806908|20042662|P1|NOT COMPLETED|Overall Study||1
8130828|NCT02806908|20042661|P2|COMPLETED|Overall Study||12
8130829|NCT02806908|20042662|P1|COMPLETED|Overall Study||10
8130830|NCT02806908|20042661|P2|STARTED|Overall Study||13
8130831|NCT02806908|20042662|P1|STARTED|Overall Study||11
8130832|NCT02806895|20042710|P2|NOT COMPLETED|Overall Study||0
8130833|NCT02806895|20042711|P1|NOT COMPLETED|Overall Study||1
8130834|NCT02806895|20042710|P2|COMPLETED|Overall Study||17
8130835|NCT02806895|20042711|P1|COMPLETED|Overall Study||16
8130836|NCT02806895|20042710|P2|STARTED|Overall Study||17
8130837|NCT02806895|20042711|P1|STARTED|Overall Study||17
8130838|NCT02806869|20042759|P2|NOT COMPLETED|Second Intervention (1 Day)||2
8130839|NCT02806869|20042760|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8130840|NCT02806869|20042759|P2|COMPLETED|Second Intervention (1 Day)||5
8130841|NCT02806869|20042760|P1|COMPLETED|Second Intervention (1 Day)||7
8130842|NCT02806869|20042759|P2|STARTED|Second Intervention (1 Day)||7
8130843|NCT02806869|20042760|P1|STARTED|Second Intervention (1 Day)||7
8130844|NCT02806869|20042759|P2|NOT COMPLETED|Washout (7 Days)||0
8130845|NCT02806869|20042760|P1|NOT COMPLETED|Washout (7 Days)||0
8130846|NCT02806869|20042759|P2|COMPLETED|Washout (7 Days)||7
8130847|NCT02806869|20042760|P1|COMPLETED|Washout (7 Days)||7
8130848|NCT02806869|20042759|P2|STARTED|Washout (7 Days)||7
8130849|NCT02806869|20042760|P1|STARTED|Washout (7 Days)||7
8130850|NCT02806869|20042759|P2|NOT COMPLETED|First Intervention (1 Day)||12
8130851|NCT02806869|20042760|P1|NOT COMPLETED|First Intervention (1 Day)||11
8130852|NCT02806869|20042759|P2|COMPLETED|First Intervention (1 Day)||12
8130853|NCT02806869|20042760|P1|COMPLETED|First Intervention (1 Day)||13
8130854|NCT02806869|20042759|P2|STARTED|First Intervention (1 Day)||24
8130855|NCT02806869|20042760|P1|STARTED|First Intervention (1 Day)||24
8130856|NCT02806726|20042770|P1|NOT COMPLETED|Overall Study||1
8130857|NCT02806726|20042770|P1|COMPLETED|Overall Study|Subjects were treated contralaterally|6
8130858|NCT02806726|20042770|P1|STARTED|Overall Study|Subjects were treated contralaterally|7
8130859|NCT02806713|20042779|P2|NOT COMPLETED|Overall Study||2
8130860|NCT02806713|20042780|P1|NOT COMPLETED|Overall Study||2
8130861|NCT02806713|20042779|P2|COMPLETED|Overall Study||44
8130862|NCT02806713|20042780|P1|COMPLETED|Overall Study||44
8130863|NCT02806713|20042779|P2|STARTED|Overall Study||46
8130864|NCT02806713|20042780|P1|STARTED|Overall Study||46
8130865|NCT02806544|20042788|P1|NOT COMPLETED|Overall Study||4
8130866|NCT02806544|20042788|P1|COMPLETED|Overall Study||31
8130867|NCT02806544|20042788|P1|STARTED|Overall Study||35
8130868|NCT02806505|20042799|P2|NOT COMPLETED|Overall Study||11
8130869|NCT02806505|20042800|P1|NOT COMPLETED|Overall Study||10
8130870|NCT02806505|20042799|P2|COMPLETED|Overall Study||32
8130871|NCT02806505|20042800|P1|COMPLETED|Overall Study||28
8130872|NCT02806505|20042799|P2|STARTED|Overall Study||43
8130873|NCT02806505|20042800|P1|STARTED|Overall Study||38
8130874|NCT02806414|20042810|P1|NOT COMPLETED|Overall Study||2
8130875|NCT02806414|20042810|P1|COMPLETED|Overall Study||13
8130876|NCT02806414|20042810|P1|STARTED|Overall Study||15
8130877|NCT02806232|20042824|P9|NOT COMPLETED|Overall Study||0
8130878|NCT02806232|20042825|P8|NOT COMPLETED|Overall Study||0
8130879|NCT02806232|20042826|P7|NOT COMPLETED|Overall Study||0
8130880|NCT02806232|20042827|P6|NOT COMPLETED|Overall Study||2
8130881|NCT02806232|20042828|P5|NOT COMPLETED|Overall Study||2
8130882|NCT02806232|20042829|P4|NOT COMPLETED|Overall Study||0
8130883|NCT02806232|20042830|P3|NOT COMPLETED|Overall Study||1
8130884|NCT02806232|20042831|P2|NOT COMPLETED|Overall Study||4
8130885|NCT02806232|20042832|P1|NOT COMPLETED|Overall Study||1
8130886|NCT02806232|20042824|P9|COMPLETED|Overall Study||4
8130887|NCT02806232|20042825|P8|COMPLETED|Overall Study||20
8130888|NCT02806232|20042826|P7|COMPLETED|Overall Study||60
8130889|NCT02806232|20042827|P6|COMPLETED|Overall Study||58
8130890|NCT02806232|20042828|P5|COMPLETED|Overall Study||58
8130891|NCT02806232|20042829|P4|COMPLETED|Overall Study||60
8130892|NCT02806232|20042830|P3|COMPLETED|Overall Study||59
8130893|NCT02806232|20042831|P2|COMPLETED|Overall Study||56
8130894|NCT02806232|20042832|P1|COMPLETED|Overall Study||59
8130895|NCT02806232|20042824|P9|STARTED|Overall Study||4
8130896|NCT02806232|20042825|P8|STARTED|Overall Study||20
8130897|NCT02806232|20042826|P7|STARTED|Overall Study||60
8130898|NCT02806232|20042827|P6|STARTED|Overall Study||60
8130899|NCT02806232|20042828|P5|STARTED|Overall Study||60
8130900|NCT02806232|20042829|P4|STARTED|Overall Study||60
8130901|NCT02806232|20042830|P3|STARTED|Overall Study||60
8130902|NCT02806232|20042831|P2|STARTED|Overall Study||60
8130903|NCT02806232|20042832|P1|STARTED|Overall Study||60
8130904|NCT02806024|20042872|P2|NOT COMPLETED|Overall Study||2
8130905|NCT02806024|20042873|P1|NOT COMPLETED|Overall Study||1
8130906|NCT02806024|20042872|P2|COMPLETED|Overall Study||5
8130907|NCT02806024|20042873|P1|COMPLETED|Overall Study||6
8130908|NCT02806024|20042872|P2|STARTED|Overall Study||7
8130909|NCT02806024|20042873|P1|STARTED|Overall Study||7
8130910|NCT02805907|20042883|P2|NOT COMPLETED|Overall Study||3
8130911|NCT02805907|20042884|P1|NOT COMPLETED|Overall Study||3
8130912|NCT02805907|20042883|P2|COMPLETED|Overall Study||53
8130913|NCT02805907|20042884|P1|COMPLETED|Overall Study||53
8130914|NCT02805907|20042883|P2|STARTED|Overall Study||56
8130915|NCT02805907|20042884|P1|STARTED|Overall Study||56
8130916|NCT02805790|20042898|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8130917|NCT02805790|20042899|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8130918|NCT02805790|20042898|P2|COMPLETED|Second Intervention (4 Weeks)||15
8130919|NCT02805790|20042899|P1|COMPLETED|Second Intervention (4 Weeks)||14
8130920|NCT02805790|20042898|P2|STARTED|Second Intervention (4 Weeks)||16
8130921|NCT02805790|20042899|P1|STARTED|Second Intervention (4 Weeks)||14
8130922|NCT02805790|20042898|P2|NOT COMPLETED|Washout (4 Weeks)||0
8130923|NCT02805790|20042899|P1|NOT COMPLETED|Washout (4 Weeks)||0
8130924|NCT02805790|20042898|P2|COMPLETED|Washout (4 Weeks)||16
8130925|NCT02805790|20042899|P1|COMPLETED|Washout (4 Weeks)||14
8130926|NCT02805790|20042898|P2|STARTED|Washout (4 Weeks)||16
8130927|NCT02805790|20042899|P1|STARTED|Washout (4 Weeks)||14
8130928|NCT02805790|20042898|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8130929|NCT02805790|20042899|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8130930|NCT02805790|20042898|P2|COMPLETED|First Intervention (4 Weeks)||16
8130931|NCT02805790|20042899|P1|COMPLETED|First Intervention (4 Weeks)||14
8130932|NCT02805790|20042898|P2|STARTED|First Intervention (4 Weeks)||16
8130933|NCT02805790|20042899|P1|STARTED|First Intervention (4 Weeks)||14
8130934|NCT02805647|20042925|P2|NOT COMPLETED|Overall Study||0
8130935|NCT02805647|20042926|P1|NOT COMPLETED|Overall Study||0
8130936|NCT02805647|20042925|P2|COMPLETED|Overall Study|after laboratory tests|122
8130937|NCT02805647|20042926|P1|COMPLETED|Overall Study|after laboratory tests|100
8130938|NCT02805647|20042925|P2|STARTED|Overall Study|at the moment of submision|122
8130939|NCT02805647|20042926|P1|STARTED|Overall Study|at the moment of submision|100
8130940|NCT02804750|20042934|P2|NOT COMPLETED|Period 4||5
8130941|NCT02804750|20042935|P1|NOT COMPLETED|Period 4||0
8130942|NCT02804750|20042934|P2|COMPLETED|Period 4||7
8130943|NCT02804750|20042935|P1|COMPLETED|Period 4||0
8130944|NCT02804750|20042934|P2|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
8130945|NCT02804750|20042935|P1|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
8130946|NCT02804750|20042934|P2|NOT COMPLETED|Period 3||2
8130947|NCT02804750|20042935|P1|NOT COMPLETED|Period 3||0
8130948|NCT02804750|20042934|P2|COMPLETED|Period 3||13
8130949|NCT02804750|20042935|P1|COMPLETED|Period 3||16
8130950|NCT02804750|20042934|P2|STARTED|Period 3||15
8130951|NCT02804750|20042935|P1|STARTED|Period 3||16
8130952|NCT02804750|20042934|P2|NOT COMPLETED|Period 2||0
8130953|NCT02804750|20042935|P1|NOT COMPLETED|Period 2||1
8130954|NCT02804750|20042934|P2|COMPLETED|Period 2||15
8130955|NCT02804750|20042935|P1|COMPLETED|Period 2||16
8130956|NCT02804750|20042934|P2|STARTED|Period 2||15
8130957|NCT02804750|20042935|P1|STARTED|Period 2||17
8130958|NCT02804750|20042934|P2|NOT COMPLETED|Period 1||3
8130959|NCT02804750|20042935|P1|NOT COMPLETED|Period 1||0
8130960|NCT02804750|20042934|P2|COMPLETED|Period 1||15
8130961|NCT02804750|20042935|P1|COMPLETED|Period 1||17
8130962|NCT02804750|20042934|P2|STARTED|Period 1||18
8130963|NCT02804750|20042935|P1|STARTED|Period 1||17
8130964|NCT02804594|20042951|P2|NOT COMPLETED|Overall Study||0
8130965|NCT02804594|20042952|P1|NOT COMPLETED|Overall Study||0
8130966|NCT02804594|20042951|P2|COMPLETED|Overall Study||5
8130967|NCT02804594|20042952|P1|COMPLETED|Overall Study||10
8130968|NCT02804594|20042951|P2|STARTED|Overall Study||5
8130969|NCT02804594|20042952|P1|STARTED|Overall Study||10
8130970|NCT02804399|20042962|P2|NOT COMPLETED|Period 2||1
8130971|NCT02804399|20042963|P1|NOT COMPLETED|Period 2||0
8130972|NCT02804399|20042962|P2|COMPLETED|Period 2||11
8130973|NCT02804399|20042963|P1|COMPLETED|Period 2||0
8130974|NCT02804399|20042962|P2|STARTED|Period 2||12
8130975|NCT02804399|20042963|P1|STARTED|Period 2||0
8130976|NCT02804399|20042962|P2|NOT COMPLETED|Washout Period at Least 10 Days||0
8130977|NCT02804399|20042963|P1|NOT COMPLETED|Washout Period at Least 10 Days||0
8130978|NCT02804399|20042962|P2|COMPLETED|Washout Period at Least 10 Days||0
8130979|NCT02804399|20042963|P1|COMPLETED|Washout Period at Least 10 Days||12
8130980|NCT02804399|20042962|P2|STARTED|Washout Period at Least 10 Days||0
8130981|NCT02804399|20042963|P1|STARTED|Washout Period at Least 10 Days||12
8130982|NCT02804399|20042962|P2|NOT COMPLETED|Period 1||0
8130983|NCT02804399|20042963|P1|NOT COMPLETED|Period 1||0
8130984|NCT02804399|20042962|P2|COMPLETED|Period 1||0
8130985|NCT02804399|20042963|P1|COMPLETED|Period 1||12
8130986|NCT02804399|20042962|P2|STARTED|Period 1||0
8130987|NCT02804399|20042963|P1|STARTED|Period 1||12
8130988|NCT02803749|20043014|P2|NOT COMPLETED|Overall Study||0
8130989|NCT02803749|20043015|P1|NOT COMPLETED|Overall Study||5
8130990|NCT02803749|20043014|P2|COMPLETED|Overall Study||4
8130991|NCT02803749|20043015|P1|COMPLETED|Overall Study||12
8130992|NCT02803749|20043014|P2|STARTED|Overall Study||4
8130993|NCT02803749|20043015|P1|STARTED|Overall Study||17
8130994|NCT02803580|20043035|P1|NOT COMPLETED|Overall Study||36
8130995|NCT02803580|20043035|P1|COMPLETED|Overall Study||173
8130996|NCT02803580|20043035|P1|STARTED|Overall Study||209
8130997|NCT02803138|20043074|P1|NOT COMPLETED|Overall Study||70
8130998|NCT02803138|20043074|P1|COMPLETED|Overall Study||166
8130999|NCT02803138|20043074|P1|STARTED|Overall Study||236
8131000|NCT02802878|20043090|P2|NOT COMPLETED|Overall Study||3
8131001|NCT02802878|20043091|P1|NOT COMPLETED|Overall Study||4
8131002|NCT02802878|20043090|P2|COMPLETED|Overall Study||18
8131003|NCT02802878|20043091|P1|COMPLETED|Overall Study||17
8131004|NCT02802878|20043090|P2|STARTED|Overall Study||21
8131005|NCT02802878|20043091|P1|STARTED|Overall Study||21
8131006|NCT02802865|20043107|P2|NOT COMPLETED|Overall Study||2
8131007|NCT02802865|20043108|P1|NOT COMPLETED|Overall Study||1
8131008|NCT02802865|20043107|P2|COMPLETED|Overall Study||33
8131009|NCT02802865|20043108|P1|COMPLETED|Overall Study||34
8131010|NCT02802865|20043107|P2|STARTED|Overall Study||35
8131011|NCT02802865|20043108|P1|STARTED|Overall Study||35
8131012|NCT02802592|20043130|P1|NOT COMPLETED|Overall Study||4
8131013|NCT02802592|20043130|P1|COMPLETED|Overall Study||0
8131014|NCT02802592|20043130|P1|STARTED|Overall Study||4
8131015|NCT02802514|20043141|P4|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131016|NCT02802514|20043142|P3|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131017|NCT02802514|20043143|P2|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131018|NCT02802514|20043144|P1|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131019|NCT02802514|20043141|P4|COMPLETED|Session 2 (Up to Day 8)||1
8131020|NCT02802514|20043142|P3|COMPLETED|Session 2 (Up to Day 8)||1
8131021|NCT02802514|20043143|P2|COMPLETED|Session 2 (Up to Day 8)||1
8131022|NCT02802514|20043144|P1|COMPLETED|Session 2 (Up to Day 8)||1
8131023|NCT02802514|20043141|P4|STARTED|Session 2 (Up to Day 8)||1
8131024|NCT02802514|20043142|P3|STARTED|Session 2 (Up to Day 8)||1
8131025|NCT02802514|20043143|P2|STARTED|Session 2 (Up to Day 8)||1
8131026|NCT02802514|20043144|P1|STARTED|Session 2 (Up to Day 8)||1
8131027|NCT02802514|20043141|P4|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131028|NCT02802514|20043142|P3|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131029|NCT02802514|20043143|P2|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131030|NCT02802514|20043144|P1|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131031|NCT02802514|20043141|P4|COMPLETED|Wash Out Period (up to Week 9)||1
8131032|NCT02802514|20043142|P3|COMPLETED|Wash Out Period (up to Week 9)||1
8131033|NCT02802514|20043143|P2|COMPLETED|Wash Out Period (up to Week 9)||1
8131034|NCT02802514|20043144|P1|COMPLETED|Wash Out Period (up to Week 9)||1
8131035|NCT02802514|20043141|P4|STARTED|Wash Out Period (up to Week 9)||1
8131036|NCT02802514|20043142|P3|STARTED|Wash Out Period (up to Week 9)||1
8131037|NCT02802514|20043143|P2|STARTED|Wash Out Period (up to Week 9)||1
8131038|NCT02802514|20043144|P1|STARTED|Wash Out Period (up to Week 9)||1
8131039|NCT02802514|20043141|P4|NOT COMPLETED|Session 1 (up to Day 8)||0
8131040|NCT02802514|20043142|P3|NOT COMPLETED|Session 1 (up to Day 8)||0
8131041|NCT02802514|20043143|P2|NOT COMPLETED|Session 1 (up to Day 8)||0
8131042|NCT02802514|20043144|P1|NOT COMPLETED|Session 1 (up to Day 8)||0
8131043|NCT02802514|20043141|P4|COMPLETED|Session 1 (up to Day 8)||1
8131044|NCT02802514|20043142|P3|COMPLETED|Session 1 (up to Day 8)||1
8131045|NCT02802514|20043143|P2|COMPLETED|Session 1 (up to Day 8)||1
8131046|NCT02802514|20043144|P1|COMPLETED|Session 1 (up to Day 8)||1
8131047|NCT02802514|20043141|P4|STARTED|Session 1 (up to Day 8)||1
8131048|NCT02802514|20043142|P3|STARTED|Session 1 (up to Day 8)||1
8131049|NCT02802514|20043143|P2|STARTED|Session 1 (up to Day 8)||1
8131050|NCT02802514|20043144|P1|STARTED|Session 1 (up to Day 8)||1
8131051|NCT02802501|20043220|P3|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8131052|NCT02802501|20043221|P2|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8131053|NCT02802501|20043222|P1|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8131054|NCT02802501|20043220|P3|COMPLETED|Open-Label (Day 180 to Day 195)||26
8131055|NCT02802501|20043221|P2|COMPLETED|Open-Label (Day 180 to Day 195)||12
8131056|NCT02802501|20043222|P1|COMPLETED|Open-Label (Day 180 to Day 195)||6
8131057|NCT02802501|20043220|P3|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
8131058|NCT02802501|20043221|P2|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
8131059|NCT02802501|20043222|P1|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
8131060|NCT02802501|20043220|P3|NOT COMPLETED|Double-blind (Up to Day 180)||0
8131061|NCT02802501|20043221|P2|NOT COMPLETED|Double-blind (Up to Day 180)||0
8131062|NCT02802501|20043222|P1|NOT COMPLETED|Double-blind (Up to Day 180)||0
8131063|NCT02802501|20043220|P3|COMPLETED|Double-blind (Up to Day 180)||50
8131064|NCT02802501|20043221|P2|COMPLETED|Double-blind (Up to Day 180)||50
8131065|NCT02802501|20043222|P1|COMPLETED|Double-blind (Up to Day 180)||50
8131066|NCT02802501|20043220|P3|STARTED|Double-blind (Up to Day 180)||50
8131067|NCT02802501|20043221|P2|STARTED|Double-blind (Up to Day 180)||50
8131068|NCT02802501|20043222|P1|STARTED|Double-blind (Up to Day 180)||50
8131069|NCT02802449|20043288|P2|NOT COMPLETED|Overall Study||17
8131070|NCT02802449|20043289|P1|NOT COMPLETED|Overall Study||9
8131071|NCT02802449|20043288|P2|COMPLETED|Overall Study||202
8131072|NCT02802449|20043289|P1|COMPLETED|Overall Study||102
8131073|NCT02802449|20043288|P2|STARTED|Overall Study||219
8131074|NCT02802449|20043289|P1|STARTED|Overall Study||111
8131075|NCT02802345|20043307|P2|NOT COMPLETED|Overall Study||30
8131076|NCT02802345|20043308|P1|NOT COMPLETED|Overall Study||32
8131077|NCT02802345|20043307|P2|COMPLETED|Overall Study||108
8131078|NCT02802345|20043308|P1|COMPLETED|Overall Study||104
8131079|NCT02802345|20043307|P2|Treated|Overall Study||137
8131080|NCT02802345|20043308|P1|Treated|Overall Study||136
8131081|NCT02802345|20043307|P2|STARTED|Overall Study||138
8131082|NCT02802345|20043308|P1|STARTED|Overall Study||136
8131083|NCT02802319|20043324|P2|NOT COMPLETED|Overall Study||5
8131084|NCT02802319|20043325|P1|NOT COMPLETED|Overall Study||2
8131085|NCT02802319|20043324|P2|COMPLETED|Overall Study||17
8131086|NCT02802319|20043325|P1|COMPLETED|Overall Study||20
8131087|NCT02802319|20043324|P2|STARTED|Overall Study||22
8131088|NCT02802319|20043325|P1|STARTED|Overall Study||22
8131089|NCT02802241|20043337|P4|NOT COMPLETED|Overall Study||26
8131090|NCT02802241|20043338|P3|NOT COMPLETED|Overall Study||48
8131091|NCT02802241|20043339|P2|NOT COMPLETED|Overall Study||26
8131092|NCT02802241|20043340|P1|NOT COMPLETED|Overall Study||29
8131093|NCT02802241|20043337|P4|COMPLETED|Overall Study||72
8131094|NCT02802241|20043338|P3|COMPLETED|Overall Study|Not included in primary analysis|0
8131095|NCT02802241|20043339|P2|COMPLETED|Overall Study||71
8131096|NCT02802241|20043340|P1|COMPLETED|Overall Study||68
8131097|NCT02802241|20043337|P4|Planned Analysis|Overall Study||87
8131098|NCT02802241|20043338|P3|Planned Analysis|Overall Study|Not included in primary analysis|0
8131099|NCT02802241|20043339|P2|Planned Analysis|Overall Study||86
8131100|NCT02802241|20043340|P1|Planned Analysis|Overall Study||89
8131101|NCT02802241|20043337|P4|STARTED|Overall Study||98
8131102|NCT02802241|20043338|P3|STARTED|Overall Study||48
8131103|NCT02802241|20043339|P2|STARTED|Overall Study||97
8131104|NCT02802241|20043340|P1|STARTED|Overall Study||97
8131105|NCT02802111|20043352|P2|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
8131106|NCT02802111|20043353|P1|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
8131107|NCT02802111|20043352|P2|COMPLETED|Second Intervention (5 Min of Drug)||12
8131108|NCT02802111|20043353|P1|COMPLETED|Second Intervention (5 Min of Drug)||12
8131109|NCT02802111|20043352|P2|STARTED|Second Intervention (5 Min of Drug)||12
8131110|NCT02802111|20043353|P1|STARTED|Second Intervention (5 Min of Drug)||12
8131111|NCT02802111|20043352|P2|NOT COMPLETED|Washout (4 Hours)||0
8131112|NCT02802111|20043353|P1|NOT COMPLETED|Washout (4 Hours)||0
8131113|NCT02802111|20043352|P2|COMPLETED|Washout (4 Hours)||12
8131114|NCT02802111|20043353|P1|COMPLETED|Washout (4 Hours)||12
8131115|NCT02802111|20043352|P2|STARTED|Washout (4 Hours)||12
8131116|NCT02802111|20043353|P1|STARTED|Washout (4 Hours)||12
8131117|NCT02802111|20043352|P2|NOT COMPLETED|First Intervention (5 Min of Drug)||0
8131118|NCT02802111|20043353|P1|NOT COMPLETED|First Intervention (5 Min of Drug)||0
8131119|NCT02802111|20043352|P2|COMPLETED|First Intervention (5 Min of Drug)||12
8131120|NCT02802111|20043353|P1|COMPLETED|First Intervention (5 Min of Drug)||12
8131121|NCT02802111|20043352|P2|STARTED|First Intervention (5 Min of Drug)||12
8131122|NCT02802111|20043353|P1|STARTED|First Intervention (5 Min of Drug)||12
8131123|NCT02801942|20043363|P2|NOT COMPLETED|Overall Study||0
8131124|NCT02801942|20043364|P1|NOT COMPLETED|Overall Study||0
8131125|NCT02801942|20043363|P2|COMPLETED|Overall Study||10
8131126|NCT02801942|20043364|P1|COMPLETED|Overall Study||12
8131127|NCT02801942|20043363|P2|STARTED|Overall Study||10
8131128|NCT02801942|20043364|P1|STARTED|Overall Study||12
8131129|NCT02801877|20043488|P4|NOT COMPLETED|Overall Study||0
8131130|NCT02801877|20043489|P3|NOT COMPLETED|Overall Study||6
8131131|NCT02801877|20043490|P2|NOT COMPLETED|Overall Study||1
8131132|NCT02801877|20043491|P1|NOT COMPLETED|Overall Study||3
8131133|NCT02801877|20043488|P4|COMPLETED|Overall Study||76
8131134|NCT02801877|20043489|P3|COMPLETED|Overall Study||70
8131135|NCT02801877|20043490|P2|COMPLETED|Overall Study||74
8131136|NCT02801877|20043491|P1|COMPLETED|Overall Study||71
8131137|NCT02801877|20043488|P4|STARTED|Overall Study||76
8131138|NCT02801877|20043489|P3|STARTED|Overall Study||76
8131139|NCT02801877|20043490|P2|STARTED|Overall Study||75
8131140|NCT02801877|20043491|P1|STARTED|Overall Study||74
8131141|NCT02801669|20043511|P2|NOT COMPLETED|Overall Study||152
8131142|NCT02801669|20043512|P1|NOT COMPLETED|Overall Study||151
8131143|NCT02801669|20043511|P2|COMPLETED|Overall Study||340
8131144|NCT02801669|20043512|P1|COMPLETED|Overall Study||341
8131145|NCT02801669|20043511|P2|Received at Least 1 Dose of Study Drug|Overall Study||490
8131146|NCT02801669|20043512|P1|Received at Least 1 Dose of Study Drug|Overall Study||492
8131147|NCT02801669|20043511|P2|STARTED|Overall Study||492
8131148|NCT02801669|20043512|P1|STARTED|Overall Study||492
8131149|NCT02801617|20043539|P2|NOT COMPLETED|Overall Study||6
8131150|NCT02801617|20043540|P1|NOT COMPLETED|Overall Study||2
8131151|NCT02801617|20043539|P2|COMPLETED|Overall Study||50
8131152|NCT02801617|20043540|P1|COMPLETED|Overall Study||49
8131153|NCT02801617|20043539|P2|STARTED|Overall Study||56
8131154|NCT02801617|20043540|P1|STARTED|Overall Study||51
8131155|NCT02801578|20043558|P1|NOT COMPLETED|Overall Study||2
8131156|NCT02801578|20043558|P1|COMPLETED|Overall Study||9
8131157|NCT02801578|20043558|P1|STARTED|Overall Study||11
8131158|NCT02801396|20043562|P6|NOT COMPLETED|Period 3||0
8131159|NCT02801396|20043563|P5|NOT COMPLETED|Period 3||0
8131160|NCT02801396|20043564|P4|NOT COMPLETED|Period 3||0
8131161|NCT02801396|20043565|P3|NOT COMPLETED|Period 3||0
8131162|NCT02801396|20043566|P2|NOT COMPLETED|Period 3||0
8131163|NCT02801396|20043567|P1|NOT COMPLETED|Period 3||0
8131164|NCT02801396|20043562|P6|COMPLETED|Period 3||17
8131165|NCT02801396|20043563|P5|COMPLETED|Period 3||16
8131166|NCT02801396|20043564|P4|COMPLETED|Period 3||16
8131167|NCT02801396|20043565|P3|COMPLETED|Period 3||17
8131168|NCT02801396|20043566|P2|COMPLETED|Period 3||17
8131169|NCT02801396|20043567|P1|COMPLETED|Period 3||17
8131170|NCT02801396|20043562|P6|STARTED|Period 3||17
8131171|NCT02801396|20043563|P5|STARTED|Period 3||16
8131172|NCT02801396|20043564|P4|STARTED|Period 3||16
8131173|NCT02801396|20043565|P3|STARTED|Period 3||17
8131174|NCT02801396|20043566|P2|STARTED|Period 3||17
8131175|NCT02801396|20043567|P1|STARTED|Period 3||17
8131176|NCT02801396|20043562|P6|NOT COMPLETED|Period 2||0
8131177|NCT02801396|20043563|P5|NOT COMPLETED|Period 2||0
8131178|NCT02801396|20043564|P4|NOT COMPLETED|Period 2||0
8131179|NCT02801396|20043565|P3|NOT COMPLETED|Period 2||0
8131180|NCT02801396|20043566|P2|NOT COMPLETED|Period 2||0
8131181|NCT02801396|20043567|P1|NOT COMPLETED|Period 2||0
8131182|NCT02801396|20043562|P6|COMPLETED|Period 2||17
8131183|NCT02801396|20043563|P5|COMPLETED|Period 2||16
8131184|NCT02801396|20043564|P4|COMPLETED|Period 2||16
8131185|NCT02801396|20043565|P3|COMPLETED|Period 2||17
8131186|NCT02801396|20043566|P2|COMPLETED|Period 2||17
8131187|NCT02801396|20043567|P1|COMPLETED|Period 2||17
8131188|NCT02801396|20043562|P6|STARTED|Period 2||17
8131189|NCT02801396|20043563|P5|STARTED|Period 2||16
8131190|NCT02801396|20043564|P4|STARTED|Period 2||16
8131191|NCT02801396|20043565|P3|STARTED|Period 2||17
8131192|NCT02801396|20043566|P2|STARTED|Period 2||17
8131193|NCT02801396|20043567|P1|STARTED|Period 2||17
8131194|NCT02801396|20043562|P6|NOT COMPLETED|Period 1||0
8131195|NCT02801396|20043563|P5|NOT COMPLETED|Period 1||1
8131196|NCT02801396|20043564|P4|NOT COMPLETED|Period 1||0
8131197|NCT02801396|20043565|P3|NOT COMPLETED|Period 1||0
8131198|NCT02801396|20043566|P2|NOT COMPLETED|Period 1||0
8131199|NCT02801396|20043567|P1|NOT COMPLETED|Period 1||0
8131200|NCT02801396|20043562|P6|COMPLETED|Period 1||17
8131201|NCT02801396|20043563|P5|COMPLETED|Period 1||16
8131202|NCT02801396|20043564|P4|COMPLETED|Period 1||16
8131203|NCT02801396|20043565|P3|COMPLETED|Period 1||17
8131204|NCT02801396|20043566|P2|COMPLETED|Period 1||17
8131205|NCT02801396|20043567|P1|COMPLETED|Period 1||17
8131206|NCT02801396|20043562|P6|STARTED|Period 1||17
8131207|NCT02801396|20043563|P5|STARTED|Period 1||17
8131208|NCT02801396|20043564|P4|STARTED|Period 1||16
8131209|NCT02801396|20043565|P3|STARTED|Period 1||17
8131210|NCT02801396|20043566|P2|STARTED|Period 1||17
8131211|NCT02801396|20043567|P1|STARTED|Period 1||17
8131212|NCT02801370|20043586|P2|NOT COMPLETED|Overall Study||0
8131213|NCT02801370|20043587|P1|NOT COMPLETED|Overall Study||7
8131214|NCT02801370|20043586|P2|COMPLETED|Overall Study||132
8131215|NCT02801370|20043587|P1|COMPLETED|Overall Study||123
8131216|NCT02801370|20043586|P2|STARTED|Overall Study||132
8131217|NCT02801370|20043587|P1|STARTED|Overall Study||130
8131218|NCT02801006|20043595|P2|NOT COMPLETED|Lens 2||0
8131219|NCT02801006|20043596|P1|NOT COMPLETED|Lens 2||0
8131220|NCT02801006|20043595|P2|COMPLETED|Lens 2||19
8131221|NCT02801006|20043596|P1|COMPLETED|Lens 2||22
8131222|NCT02801006|20043595|P2|STARTED|Lens 2||19
8131223|NCT02801006|20043596|P1|STARTED|Lens 2||22
8131224|NCT02801006|20043595|P2|NOT COMPLETED|Lens 1||0
8131225|NCT02801006|20043596|P1|NOT COMPLETED|Lens 1||0
8131226|NCT02801006|20043595|P2|COMPLETED|Lens 1||19
8131227|NCT02801006|20043596|P1|COMPLETED|Lens 1||22
8131228|NCT02801006|20043595|P2|STARTED|Lens 1||19
8131229|NCT02801006|20043596|P1|STARTED|Lens 1||22
8131230|NCT02800928|20043612|P2|NOT COMPLETED|Overall Study||2
8131231|NCT02800928|20043613|P1|NOT COMPLETED|Overall Study||2
8131232|NCT02800928|20043612|P2|COMPLETED|Overall Study||6
8131233|NCT02800928|20043613|P1|COMPLETED|Overall Study||7
8131234|NCT02800928|20043612|P2|STARTED|Overall Study||8
8131235|NCT02800928|20043613|P1|STARTED|Overall Study||9
8131236|NCT02800642|20043621|P1|NOT COMPLETED|Overall Study||25
8131237|NCT02800642|20043621|P1|COMPLETED|Overall Study||137
8131238|NCT02800642|20043621|P1|STARTED|Overall Study||162
8131239|NCT02800356|20043634|P1|NOT COMPLETED|Overall Study||0
8131240|NCT02800356|20043634|P1|COMPLETED|Overall Study||20
8131241|NCT02800356|20043634|P1|STARTED|Overall Study||20
8131242|NCT02800213|20043645|P2|NOT COMPLETED|Second Intervention||0
8131243|NCT02800213|20043646|P1|NOT COMPLETED|Second Intervention||0
8131244|NCT02800213|20043645|P2|COMPLETED|Second Intervention||35
8131245|NCT02800213|20043646|P1|COMPLETED|Second Intervention||35
8131246|NCT02800213|20043645|P2|STARTED|Second Intervention||35
8131247|NCT02800213|20043646|P1|STARTED|Second Intervention||35
8131248|NCT02800213|20043645|P2|NOT COMPLETED|First Intervention||0
8131249|NCT02800213|20043646|P1|NOT COMPLETED|First Intervention||0
8131250|NCT02800213|20043645|P2|COMPLETED|First Intervention||35
8131251|NCT02800213|20043646|P1|COMPLETED|First Intervention||35
8131252|NCT02800213|20043645|P2|STARTED|First Intervention||35
8131253|NCT02800213|20043646|P1|STARTED|First Intervention||35
8131254|NCT02800148|20043655|P3|NOT COMPLETED|Overall Study||25
8131255|NCT02800148|20043656|P2|NOT COMPLETED|Overall Study||20
8131256|NCT02800148|20043657|P1|NOT COMPLETED|Overall Study||25
8131257|NCT02800148|20043655|P3|COMPLETED|Overall Study||194
8131258|NCT02800148|20043656|P2|COMPLETED|Overall Study||204
8131259|NCT02800148|20043657|P1|COMPLETED|Overall Study||199
8131260|NCT02800148|20043655|P3|STARTED|Overall Study||219
8131261|NCT02800148|20043656|P2|STARTED|Overall Study||224
8131262|NCT02800148|20043657|P1|STARTED|Overall Study||224
8131263|NCT02799784|20043665|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
8131264|NCT02799784|20043666|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
8131265|NCT02799784|20043665|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
8131266|NCT02799784|20043666|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
8131267|NCT02799784|20043665|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
8131268|NCT02799784|20043666|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
8131269|NCT02799784|20043665|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
8131270|NCT02799784|20043666|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
8131271|NCT02799784|20043665|P2|COMPLETED|Washout Period (3 Weeks)||118
8131272|NCT02799784|20043666|P1|COMPLETED|Washout Period (3 Weeks)||111
8131273|NCT02799784|20043665|P2|STARTED|Washout Period (3 Weeks)||118
8131274|NCT02799784|20043666|P1|STARTED|Washout Period (3 Weeks)||111
8131275|NCT02799784|20043665|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
8131276|NCT02799784|20043666|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
8131277|NCT02799784|20043665|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
8131278|NCT02799784|20043666|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
8131279|NCT02799784|20043665|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
8131280|NCT02799784|20043666|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
8131281|NCT02799472|20043674|P2|NOT COMPLETED|Overall Study||5
8131282|NCT02799472|20043675|P1|NOT COMPLETED|Overall Study||4
8131283|NCT02799472|20043674|P2|COMPLETED|Overall Study||23
8131284|NCT02799472|20043675|P1|COMPLETED|Overall Study||7
8131285|NCT02799472|20043674|P2|STARTED|Overall Study||28
8131286|NCT02799472|20043675|P1|STARTED|Overall Study||11
8131287|NCT02799381|20043735|P2|NOT COMPLETED|Overall Study||3
8131288|NCT02799381|20043736|P1|NOT COMPLETED|Overall Study||4
8131289|NCT02799381|20043735|P2|COMPLETED|Overall Study||25
8131290|NCT02799381|20043736|P1|COMPLETED|Overall Study||29
8131291|NCT02799381|20043735|P2|STARTED|Overall Study||28
8131292|NCT02799381|20043736|P1|STARTED|Overall Study||33
8131293|NCT02799290|20043757|P3|NOT COMPLETED|Overall Study||0
8131294|NCT02799290|20043758|P2|NOT COMPLETED|Overall Study||0
8131295|NCT02799290|20043759|P1|NOT COMPLETED|Overall Study||0
8131296|NCT02799290|20043757|P3|COMPLETED|Overall Study||11
8131297|NCT02799290|20043758|P2|COMPLETED|Overall Study||13
8131298|NCT02799290|20043759|P1|COMPLETED|Overall Study||24
8131299|NCT02799290|20043757|P3|STARTED|Overall Study||11
8131300|NCT02799290|20043758|P2|STARTED|Overall Study||13
8131301|NCT02799290|20043759|P1|STARTED|Overall Study||24
8131302|NCT02799082|20043781|P2|NOT COMPLETED|Overall Study||4
8131303|NCT02799082|20043782|P1|NOT COMPLETED|Overall Study||4
8131304|NCT02799082|20043781|P2|COMPLETED|Overall Study||77
8131305|NCT02799082|20043782|P1|COMPLETED|Overall Study||37
8131306|NCT02799082|20043781|P2|STARTED|Overall Study||81
8131307|NCT02799082|20043782|P1|STARTED|Overall Study||41
8131308|NCT02799069|20043819|P3|NOT COMPLETED|Overall Study||7
8131309|NCT02799069|20043820|P2|NOT COMPLETED|Overall Study||7
8131310|NCT02799069|20043821|P1|NOT COMPLETED|Overall Study||8
8131311|NCT02799069|20043819|P3|COMPLETED|Overall Study||240
8131312|NCT02799069|20043820|P2|COMPLETED|Overall Study||241
8131313|NCT02799069|20043821|P1|COMPLETED|Overall Study||68
8131314|NCT02799069|20043819|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
8131315|NCT02799069|20043820|P2|ITT/Safety|Overall Study||248
8131316|NCT02799069|20043821|P1|ITT/Safety|Overall Study||76
8131317|NCT02799069|20043819|P3|STARTED|Overall Study||247
8131318|NCT02799069|20043820|P2|STARTED|Overall Study||248
8131319|NCT02799069|20043821|P1|STARTED|Overall Study||76
8131320|NCT02798978|20043938|P7|NOT COMPLETED|Part 2 (45 Days)||0
8131321|NCT02798978|20043939|P6|NOT COMPLETED|Part 2 (45 Days)||0
8131322|NCT02798978|20043940|P5|NOT COMPLETED|Part 2 (45 Days)||0
8131323|NCT02798978|20043941|P4|NOT COMPLETED|Part 2 (45 Days)||0
8131324|NCT02798978|20043942|P3|NOT COMPLETED|Part 2 (45 Days)||0
8131325|NCT02798978|20043943|P2|NOT COMPLETED|Part 2 (45 Days)||0
8131326|NCT02798978|20043944|P1|NOT COMPLETED|Part 2 (45 Days)||0
8131327|NCT02798978|20043938|P7|COMPLETED|Part 2 (45 Days)||0
8131328|NCT02798978|20043939|P6|COMPLETED|Part 2 (45 Days)||0
8131329|NCT02798978|20043940|P5|COMPLETED|Part 2 (45 Days)||0
8131330|NCT02798978|20043941|P4|COMPLETED|Part 2 (45 Days)||0
8131331|NCT02798978|20043942|P3|COMPLETED|Part 2 (45 Days)||0
8131332|NCT02798978|20043943|P2|COMPLETED|Part 2 (45 Days)||0
8131333|NCT02798978|20043944|P1|COMPLETED|Part 2 (45 Days)||0
8131334|NCT02798978|20043938|P7|STARTED|Part 2 (45 Days)||0
8131335|NCT02798978|20043939|P6|STARTED|Part 2 (45 Days)||0
8131336|NCT02798978|20043940|P5|STARTED|Part 2 (45 Days)||0
8131337|NCT02798978|20043941|P4|STARTED|Part 2 (45 Days)||0
8131338|NCT02798978|20043942|P3|STARTED|Part 2 (45 Days)||0
8131339|NCT02798978|20043943|P2|STARTED|Part 2 (45 Days)||0
8131340|NCT02798978|20043944|P1|STARTED|Part 2 (45 Days)||0
8131341|NCT02798978|20043938|P7|NOT COMPLETED|Part 1 (30 Days)||0
8131342|NCT02798978|20043939|P6|NOT COMPLETED|Part 1 (30 Days)||0
8131343|NCT02798978|20043940|P5|NOT COMPLETED|Part 1 (30 Days)||0
8131344|NCT02798978|20043941|P4|NOT COMPLETED|Part 1 (30 Days)||0
8131345|NCT02798978|20043942|P3|NOT COMPLETED|Part 1 (30 Days)||0
8131346|NCT02798978|20043943|P2|NOT COMPLETED|Part 1 (30 Days)||0
8131347|NCT02798978|20043944|P1|NOT COMPLETED|Part 1 (30 Days)||0
8131348|NCT02798978|20043938|P7|COMPLETED|Part 1 (30 Days)||0
8131349|NCT02798978|20043939|P6|COMPLETED|Part 1 (30 Days)||6
8131350|NCT02798978|20043940|P5|COMPLETED|Part 1 (30 Days)||6
8131351|NCT02798978|20043941|P4|COMPLETED|Part 1 (30 Days)||6
8131352|NCT02798978|20043942|P3|COMPLETED|Part 1 (30 Days)||6
8131353|NCT02798978|20043943|P2|COMPLETED|Part 1 (30 Days)||6
8131354|NCT02798978|20043944|P1|COMPLETED|Part 1 (30 Days)||10
8131355|NCT02798978|20043938|P7|STARTED|Part 1 (30 Days)||0
8131356|NCT02798978|20043939|P6|STARTED|Part 1 (30 Days)||6
8131357|NCT02798978|20043940|P5|STARTED|Part 1 (30 Days)||6
8131358|NCT02798978|20043941|P4|STARTED|Part 1 (30 Days)||6
8131359|NCT02798978|20043942|P3|STARTED|Part 1 (30 Days)||6
8131360|NCT02798978|20043943|P2|STARTED|Part 1 (30 Days)||6
8131361|NCT02798978|20043944|P1|STARTED|Part 1 (30 Days)||10
8131362|NCT02798952|20044147|P1|NOT COMPLETED|Overall Study||0
8131363|NCT02798952|20044147|P1|COMPLETED|Overall Study||302
8131364|NCT02798952|20044147|P1|STARTED|Overall Study||302
8131365|NCT02798861|20044159|P1|NOT COMPLETED|Overall Study||23
8131366|NCT02798861|20044159|P1|COMPLETED|Overall Study||137
8131367|NCT02798861|20044159|P1|STARTED|Overall Study||160
8131368|NCT02798835|20044167|P3|NOT COMPLETED|Overall Study||3
8131369|NCT02798835|20044168|P2|NOT COMPLETED|Overall Study||0
8131370|NCT02798835|20044169|P1|NOT COMPLETED|Overall Study||0
8131371|NCT02798835|20044167|P3|COMPLETED|Overall Study||57
8131372|NCT02798835|20044168|P2|COMPLETED|Overall Study||60
8131373|NCT02798835|20044169|P1|COMPLETED|Overall Study||60
8131374|NCT02798835|20044167|P3|STARTED|Overall Study||60
8131375|NCT02798835|20044168|P2|STARTED|Overall Study||60
8131376|NCT02798835|20044169|P1|STARTED|Overall Study||60
8131377|NCT02798380|20044204|P1|NOT COMPLETED|Overall Study||0
8131378|NCT02798380|20044204|P1|COMPLETED|Overall Study||30
8131379|NCT02798380|20044204|P1|STARTED|Overall Study||30
8131380|NCT02798354|20044211|P3|NOT COMPLETED|Third Intervention Period||0
8131381|NCT02798354|20044212|P2|NOT COMPLETED|Third Intervention Period||0
8131382|NCT02798354|20044213|P1|NOT COMPLETED|Third Intervention Period||0
8131383|NCT02798354|20044211|P3|COMPLETED|Third Intervention Period||2715
8131384|NCT02798354|20044212|P2|COMPLETED|Third Intervention Period||1010
8131385|NCT02798354|20044213|P1|COMPLETED|Third Intervention Period||746
8131386|NCT02798354|20044211|P3|Intervention Data Error 3|Third Intervention Period||1248
8131387|NCT02798354|20044212|P2|Intervention Data Error 3|Third Intervention Period||390
8131388|NCT02798354|20044213|P1|Intervention Data Error 3|Third Intervention Period||327
8131389|NCT02798354|20044211|P3|Control Data Error 3|Third Intervention Period||1467
8131390|NCT02798354|20044212|P2|Control Data Error 3|Third Intervention Period||620
8131391|NCT02798354|20044213|P1|Control Data Error 3|Third Intervention Period||419
8131392|NCT02798354|20044211|P3|STARTED|Third Intervention Period||2715
8131393|NCT02798354|20044212|P2|STARTED|Third Intervention Period||1010
8131394|NCT02798354|20044213|P1|STARTED|Third Intervention Period||746
8131395|NCT02798354|20044211|P3|NOT COMPLETED|Second Intervention Period||0
8131396|NCT02798354|20044212|P2|NOT COMPLETED|Second Intervention Period||0
8131397|NCT02798354|20044213|P1|NOT COMPLETED|Second Intervention Period||0
8131398|NCT02798354|20044211|P3|COMPLETED|Second Intervention Period||1368
8131399|NCT02798354|20044212|P2|COMPLETED|Second Intervention Period||1047
8131400|NCT02798354|20044213|P1|COMPLETED|Second Intervention Period||2617
8131401|NCT02798354|20044211|P3|Intervention Data Error 2|Second Intervention Period||700
8131402|NCT02798354|20044212|P2|Intervention Data Error 2|Second Intervention Period||454
8131403|NCT02798354|20044213|P1|Intervention Data Error 2|Second Intervention Period||1239
8131404|NCT02798354|20044211|P3|Control Data Error 2|Second Intervention Period||668
8131405|NCT02798354|20044212|P2|Control Data Error 2|Second Intervention Period||593
8131406|NCT02798354|20044213|P1|Control Data Error 2|Second Intervention Period||1378
8131407|NCT02798354|20044211|P3|STARTED|Second Intervention Period||1368
8131408|NCT02798354|20044212|P2|STARTED|Second Intervention Period||1047
8131409|NCT02798354|20044213|P1|STARTED|Second Intervention Period||2617
8131410|NCT02798354|20044211|P3|NOT COMPLETED|First Intervention Period||0
8131411|NCT02798354|20044212|P2|NOT COMPLETED|First Intervention Period||0
8131412|NCT02798354|20044213|P1|NOT COMPLETED|First Intervention Period||0
8131413|NCT02798354|20044211|P3|COMPLETED|First Intervention Period||990
8131414|NCT02798354|20044212|P2|COMPLETED|First Intervention Period||2176
8131415|NCT02798354|20044213|P1|COMPLETED|First Intervention Period||1184
8131416|NCT02798354|20044211|P3|Intervention Data Error 1|First Intervention Period||645
8131417|NCT02798354|20044212|P2|Intervention Data Error 1|First Intervention Period||1627
8131418|NCT02798354|20044213|P1|Intervention Data Error 1|First Intervention Period||744
8131419|NCT02798354|20044211|P3|Control Data Error 1|First Intervention Period||345
8131420|NCT02798354|20044212|P2|Control Data Error 1|First Intervention Period||549
8131421|NCT02798354|20044213|P1|Control Data Error 1|First Intervention Period||440
8131422|NCT02798354|20044211|P3|STARTED|First Intervention Period||990
8131423|NCT02798354|20044212|P2|STARTED|First Intervention Period||2176
8131424|NCT02798354|20044213|P1|STARTED|First Intervention Period||1184
8131425|NCT02798315|20044235|P1|NOT COMPLETED|Overall Study||1
8131426|NCT02798315|20044235|P1|COMPLETED|Overall Study||39
8131427|NCT02798315|20044235|P1|STARTED|Overall Study||40
8131428|NCT02798289|20044249|P1|NOT COMPLETED|Overall Study||0
8131429|NCT02798289|20044249|P1|COMPLETED|Overall Study||55
8131430|NCT02798289|20044249|P1|STARTED|Overall Study||55
8131431|NCT02797821|20044256|P3|NOT COMPLETED|Overall Study||0
8131432|NCT02797821|20044257|P2|NOT COMPLETED|Overall Study||0
8131433|NCT02797821|20044258|P1|NOT COMPLETED|Overall Study||0
8131434|NCT02797821|20044256|P3|COMPLETED|Overall Study||9
8131435|NCT02797821|20044257|P2|COMPLETED|Overall Study||10
8131436|NCT02797821|20044258|P1|COMPLETED|Overall Study||8
8131437|NCT02797821|20044256|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8131438|NCT02797821|20044257|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8131439|NCT02797821|20044258|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8131440|NCT02797821|20044256|P3|STARTED|Overall Study||9
8131441|NCT02797821|20044257|P2|STARTED|Overall Study||10
8131442|NCT02797821|20044258|P1|STARTED|Overall Study||8
8131443|NCT02797808|20044271|P2|NOT COMPLETED|Overall Study||3
8131444|NCT02797808|20044272|P1|NOT COMPLETED|Overall Study||7
8131445|NCT02797808|20044271|P2|COMPLETED|Overall Study||15
8131446|NCT02797808|20044272|P1|COMPLETED|Overall Study||16
8131447|NCT02797808|20044271|P2|STARTED|Overall Study||18
8131448|NCT02797808|20044272|P1|STARTED|Overall Study||23
8131449|NCT02797678|20044280|P4|NOT COMPLETED|Sub-Study||0
8131450|NCT02797678|20044281|P3|NOT COMPLETED|Sub-Study||0
8131451|NCT02797678|20044282|P2|NOT COMPLETED|Sub-Study||0
8131452|NCT02797678|20044283|P1|NOT COMPLETED|Sub-Study||0
8131453|NCT02797678|20044280|P4|COMPLETED|Sub-Study||9
8131454|NCT02797678|20044281|P3|COMPLETED|Sub-Study||0
8131455|NCT02797678|20044282|P2|COMPLETED|Sub-Study||0
8131456|NCT02797678|20044283|P1|COMPLETED|Sub-Study||0
8131457|NCT02797678|20044280|P4|STARTED|Sub-Study||9
8131458|NCT02797678|20044281|P3|STARTED|Sub-Study||0
8131459|NCT02797678|20044282|P2|STARTED|Sub-Study||0
8131460|NCT02797678|20044283|P1|STARTED|Sub-Study||0
8131461|NCT02797678|20044280|P4|NOT COMPLETED|Second Intervention (5 Nights)||0
8131462|NCT02797678|20044281|P3|NOT COMPLETED|Second Intervention (5 Nights)||1
8131463|NCT02797678|20044282|P2|NOT COMPLETED|Second Intervention (5 Nights)||0
8131464|NCT02797678|20044283|P1|NOT COMPLETED|Second Intervention (5 Nights)||0
8131465|NCT02797678|20044280|P4|COMPLETED|Second Intervention (5 Nights)||0
8131466|NCT02797678|20044281|P3|COMPLETED|Second Intervention (5 Nights)||16
8131467|NCT02797678|20044282|P2|COMPLETED|Second Intervention (5 Nights)||19
8131468|NCT02797678|20044283|P1|COMPLETED|Second Intervention (5 Nights)||0
8131469|NCT02797678|20044280|P4|STARTED|Second Intervention (5 Nights)||0
8131470|NCT02797678|20044281|P3|STARTED|Second Intervention (5 Nights)||17
8131471|NCT02797678|20044282|P2|STARTED|Second Intervention (5 Nights)||19
8131472|NCT02797678|20044283|P1|STARTED|Second Intervention (5 Nights)||0
8131473|NCT02797678|20044280|P4|NOT COMPLETED|Washout||0
8131474|NCT02797678|20044281|P3|NOT COMPLETED|Washout||0
8131475|NCT02797678|20044282|P2|NOT COMPLETED|Washout||0
8131476|NCT02797678|20044283|P1|NOT COMPLETED|Washout||0
8131477|NCT02797678|20044280|P4|COMPLETED|Washout||0
8131478|NCT02797678|20044281|P3|COMPLETED|Washout||17
8131479|NCT02797678|20044282|P2|COMPLETED|Washout||19
8131480|NCT02797678|20044283|P1|COMPLETED|Washout||0
8131481|NCT02797678|20044280|P4|STARTED|Washout||0
8131482|NCT02797678|20044281|P3|STARTED|Washout||17
8131483|NCT02797678|20044282|P2|STARTED|Washout||19
8131484|NCT02797678|20044283|P1|STARTED|Washout||0
8131485|NCT02797678|20044280|P4|NOT COMPLETED|First Intervention (5 Nights)||0
8131486|NCT02797678|20044281|P3|NOT COMPLETED|First Intervention (5 Nights)||0
8131487|NCT02797678|20044282|P2|NOT COMPLETED|First Intervention (5 Nights)||1
8131488|NCT02797678|20044283|P1|NOT COMPLETED|First Intervention (5 Nights)||0
8131489|NCT02797678|20044280|P4|COMPLETED|First Intervention (5 Nights)||0
8131490|NCT02797678|20044281|P3|COMPLETED|First Intervention (5 Nights)||17
8131491|NCT02797678|20044282|P2|COMPLETED|First Intervention (5 Nights)||19
8131492|NCT02797678|20044283|P1|COMPLETED|First Intervention (5 Nights)||0
8131493|NCT02797678|20044280|P4|STARTED|First Intervention (5 Nights)||0
8131494|NCT02797678|20044281|P3|STARTED|First Intervention (5 Nights)||17
8131495|NCT02797678|20044282|P2|STARTED|First Intervention (5 Nights)||20
8131496|NCT02797678|20044283|P1|STARTED|First Intervention (5 Nights)||0
8131497|NCT02797678|20044280|P4|NOT COMPLETED|Screening Phase||0
8131498|NCT02797678|20044281|P3|NOT COMPLETED|Screening Phase||0
8131499|NCT02797678|20044282|P2|NOT COMPLETED|Screening Phase||0
8131500|NCT02797678|20044283|P1|NOT COMPLETED|Screening Phase||25
8131501|NCT02797678|20044280|P4|COMPLETED|Screening Phase||0
8131502|NCT02797678|20044281|P3|COMPLETED|Screening Phase||0
8131503|NCT02797678|20044282|P2|COMPLETED|Screening Phase||0
8131504|NCT02797678|20044283|P1|COMPLETED|Screening Phase||37
8131505|NCT02797678|20044280|P4|STARTED|Screening Phase||0
8131506|NCT02797678|20044281|P3|STARTED|Screening Phase||0
8131507|NCT02797678|20044282|P2|STARTED|Screening Phase||0
8131508|NCT02797678|20044283|P1|STARTED|Screening Phase||62
8131509|NCT02797613|20044300|P2|NOT COMPLETED|Overall Study||0
8131510|NCT02797613|20044301|P1|NOT COMPLETED|Overall Study||0
8131511|NCT02797613|20044300|P2|COMPLETED|Overall Study||55
8131512|NCT02797613|20044301|P1|COMPLETED|Overall Study||55
8131513|NCT02797613|20044300|P2|STARTED|Overall Study||55
8131514|NCT02797613|20044301|P1|STARTED|Overall Study||55
8131515|NCT02797522|20044318|P11|NOT COMPLETED|Overall Study||1
8131516|NCT02797522|20044319|P10|NOT COMPLETED|Overall Study||4
8131517|NCT02797522|20044320|P9|NOT COMPLETED|Overall Study||2
8131518|NCT02797522|20044321|P8|NOT COMPLETED|Overall Study||4
8131519|NCT02797522|20044322|P7|NOT COMPLETED|Overall Study||0
8131520|NCT02797522|20044323|P6|NOT COMPLETED|Overall Study||0
8131521|NCT02797522|20044324|P5|NOT COMPLETED|Overall Study||0
8131522|NCT02797522|20044325|P4|NOT COMPLETED|Overall Study||0
8131523|NCT02797522|20044326|P3|NOT COMPLETED|Overall Study||0
8131524|NCT02797522|20044327|P2|NOT COMPLETED|Overall Study||0
8131525|NCT02797522|20044328|P1|NOT COMPLETED|Overall Study||0
8131526|NCT02797522|20044318|P11|COMPLETED|Overall Study||0
8131527|NCT02797522|20044319|P10|COMPLETED|Overall Study||0
8131528|NCT02797522|20044320|P9|COMPLETED|Overall Study||0
8131529|NCT02797522|20044321|P8|COMPLETED|Overall Study||0
8131530|NCT02797522|20044322|P7|COMPLETED|Overall Study||12
8131531|NCT02797522|20044323|P6|COMPLETED|Overall Study||4
8131532|NCT02797522|20044324|P5|COMPLETED|Overall Study||4
8131533|NCT02797522|20044325|P4|COMPLETED|Overall Study||4
8131534|NCT02797522|20044326|P3|COMPLETED|Overall Study||4
8131535|NCT02797522|20044327|P2|COMPLETED|Overall Study||4
8131536|NCT02797522|20044328|P1|COMPLETED|Overall Study||4
8131537|NCT02797522|20044318|P11|STARTED|Overall Study||1
8131538|NCT02797522|20044319|P10|STARTED|Overall Study||4
8131539|NCT02797522|20044320|P9|STARTED|Overall Study||2
8131540|NCT02797522|20044321|P8|STARTED|Overall Study||4
8131541|NCT02797522|20044322|P7|STARTED|Overall Study||12
8131542|NCT02797522|20044323|P6|STARTED|Overall Study||4
8131543|NCT02797522|20044324|P5|STARTED|Overall Study||4
8131544|NCT02797522|20044325|P4|STARTED|Overall Study||4
8131545|NCT02797522|20044326|P3|STARTED|Overall Study||4
8131546|NCT02797522|20044327|P2|STARTED|Overall Study||4
8131547|NCT02797522|20044328|P1|STARTED|Overall Study||4
8131548|NCT02797171|20044440|P6|NOT COMPLETED|Overall Study||1
8131549|NCT02797171|20044441|P5|NOT COMPLETED|Overall Study||2
8131550|NCT02797171|20044442|P4|NOT COMPLETED|Overall Study||1
8131551|NCT02797171|20044443|P3|NOT COMPLETED|Overall Study||2
8131552|NCT02797171|20044444|P2|NOT COMPLETED|Overall Study||2
8131553|NCT02797171|20044445|P1|NOT COMPLETED|Overall Study||4
8131554|NCT02797171|20044440|P6|COMPLETED|Overall Study||0
8131555|NCT02797171|20044441|P5|COMPLETED|Overall Study||8
8131556|NCT02797171|20044442|P4|COMPLETED|Overall Study||15
8131557|NCT02797171|20044443|P3|COMPLETED|Overall Study||5
8131558|NCT02797171|20044444|P2|COMPLETED|Overall Study||21
8131559|NCT02797171|20044445|P1|COMPLETED|Overall Study||19
8131560|NCT02797171|20044440|P6|Safety Population|Overall Study||1
8131561|NCT02797171|20044441|P5|Safety Population|Overall Study||10
8131562|NCT02797171|20044442|P4|Safety Population|Overall Study||16
8131563|NCT02797171|20044443|P3|Safety Population|Overall Study||7
8131564|NCT02797171|20044444|P2|Safety Population|Overall Study||23
8131565|NCT02797171|20044445|P1|Safety Population|Overall Study||23
8131566|NCT02797171|20044440|P6|STARTED|Overall Study||1
8131567|NCT02797171|20044441|P5|STARTED|Overall Study||10
8131568|NCT02797171|20044442|P4|STARTED|Overall Study||16
8131569|NCT02797171|20044443|P3|STARTED|Overall Study||7
8131570|NCT02797171|20044444|P2|STARTED|Overall Study||23
8131571|NCT02797171|20044445|P1|STARTED|Overall Study||23
8131572|NCT02797132|20044507|P1|NOT COMPLETED|Part B (24 Weeks)||3
8131573|NCT02797132|20044507|P1|COMPLETED|Part B (24 Weeks)||57
8131574|NCT02797132|20044507|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
8131575|NCT02797132|20044507|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
8131576|NCT02797132|20044507|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
8131577|NCT02797132|20044507|P1|NOT COMPLETED|Part A (15 Days)||1
8131578|NCT02797132|20044507|P1|COMPLETED|Part A (15 Days)||11
8131579|NCT02797132|20044507|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
8131580|NCT02797132|20044507|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
8131581|NCT02797132|20044507|P1|STARTED|Part A (15 Days)||12
8131582|NCT02797080|20044559|P1|NOT COMPLETED|Overall Study||2
8131583|NCT02797080|20044559|P1|COMPLETED|Overall Study||36
8131584|NCT02797080|20044559|P1|STARTED|Overall Study||38
8131585|NCT02797054|20044566|P3|NOT COMPLETED|Follow-up||285
8131586|NCT02797054|20044567|P2|NOT COMPLETED|Follow-up||228
8131587|NCT02797054|20044568|P1|NOT COMPLETED|Follow-up||209
8131588|NCT02797054|20044566|P3|COMPLETED|Follow-up||150
8131589|NCT02797054|20044567|P2|COMPLETED|Follow-up||155
8131590|NCT02797054|20044568|P1|COMPLETED|Follow-up||178
8131591|NCT02797054|20044566|P3|STARTED|Follow-up||435
8131592|NCT02797054|20044567|P2|STARTED|Follow-up||383
8131593|NCT02797054|20044568|P1|STARTED|Follow-up||387
8131594|NCT02797054|20044566|P3|NOT COMPLETED|Post-test||348
8131595|NCT02797054|20044567|P2|NOT COMPLETED|Post-test||11
8131596|NCT02797054|20044568|P1|NOT COMPLETED|Post-test||7
8131597|NCT02797054|20044566|P3|COMPLETED|Post-test||87
8131598|NCT02797054|20044567|P2|COMPLETED|Post-test||372
8131599|NCT02797054|20044568|P1|COMPLETED|Post-test||380
8131600|NCT02797054|20044566|P3|STARTED|Post-test||435
8131601|NCT02797054|20044567|P2|STARTED|Post-test||383
8131602|NCT02797054|20044568|P1|STARTED|Post-test||387
8131603|NCT02796963|20044601|P4|NOT COMPLETED|Overall Study||72
8131604|NCT02796963|20044602|P3|NOT COMPLETED|Overall Study||69
8131605|NCT02796963|20044603|P2|NOT COMPLETED|Overall Study||76
8131606|NCT02796963|20044604|P1|NOT COMPLETED|Overall Study||89
8131607|NCT02796963|20044601|P4|COMPLETED|Overall Study||282
8131608|NCT02796963|20044602|P3|COMPLETED|Overall Study||247
8131609|NCT02796963|20044603|P2|COMPLETED|Overall Study||252
8131610|NCT02796963|20044604|P1|COMPLETED|Overall Study||294
8131611|NCT02796963|20044601|P4|HIV Sero Converted|Overall Study||19
8131612|NCT02796963|20044602|P3|HIV Sero Converted|Overall Study||11
8131613|NCT02796963|20044603|P2|HIV Sero Converted|Overall Study||19
8131614|NCT02796963|20044604|P1|HIV Sero Converted|Overall Study||19
8131615|NCT02796963|20044601|P4|Fourth Follow up|Overall Study||263
8131616|NCT02796963|20044602|P3|Fourth Follow up|Overall Study||236
8131617|NCT02796963|20044603|P2|Fourth Follow up|Overall Study||233
8131618|NCT02796963|20044604|P1|Fourth Follow up|Overall Study||275
8131619|NCT02796963|20044601|P4|Third Follow up|Overall Study||286
8131620|NCT02796963|20044602|P3|Third Follow up|Overall Study||245
8131621|NCT02796963|20044603|P2|Third Follow up|Overall Study||237
8131622|NCT02796963|20044604|P1|Third Follow up|Overall Study||276
8131623|NCT02796963|20044601|P4|Second Follow up|Overall Study||293
8131624|NCT02796963|20044602|P3|Second Follow up|Overall Study||255
8131625|NCT02796963|20044603|P2|Second Follow up|Overall Study||260
8131626|NCT02796963|20044604|P1|Second Follow up|Overall Study||280
8131627|NCT02796963|20044601|P4|First Follow up|Overall Study||291
8131628|NCT02796963|20044602|P3|First Follow up|Overall Study||257
8131629|NCT02796963|20044603|P2|First Follow up|Overall Study||279
8131630|NCT02796963|20044604|P1|First Follow up|Overall Study||293
8131631|NCT02796963|20044601|P4|STARTED|Overall Study||354
8131632|NCT02796963|20044602|P3|STARTED|Overall Study||316
8131633|NCT02796963|20044603|P2|STARTED|Overall Study||328
8131634|NCT02796963|20044604|P1|STARTED|Overall Study||383
8131635|NCT02796924|20044666|P1|NOT COMPLETED|Overall Study||0
8131636|NCT02796924|20044666|P1|COMPLETED|Overall Study||10
8131637|NCT02796924|20044666|P1|STARTED|Overall Study||10
8131638|NCT02796677|20044674|P4|NOT COMPLETED|Overall Study||74
8131639|NCT02796677|20044675|P3|NOT COMPLETED|Overall Study||53
8131640|NCT02796677|20044676|P2|NOT COMPLETED|Overall Study||73
8131641|NCT02796677|20044677|P1|NOT COMPLETED|Overall Study||38
8131642|NCT02796677|20044674|P4|COMPLETED|Overall Study||405
8131643|NCT02796677|20044675|P3|COMPLETED|Overall Study||267
8131644|NCT02796677|20044676|P2|COMPLETED|Overall Study||405
8131645|NCT02796677|20044677|P1|COMPLETED|Overall Study||279
8131646|NCT02796677|20044674|P4|Completed Treatment and Follow-up|Overall Study||403
8131647|NCT02796677|20044675|P3|Completed Treatment and Follow-up|Overall Study||267
8131648|NCT02796677|20044676|P2|Completed Treatment and Follow-up|Overall Study||405
8131649|NCT02796677|20044677|P1|Completed Treatment and Follow-up|Overall Study||279
8131650|NCT02796677|20044674|P4|STARTED|Overall Study||479
8131651|NCT02796677|20044675|P3|STARTED|Overall Study||320
8131652|NCT02796677|20044676|P2|STARTED|Overall Study||478
8131653|NCT02796677|20044677|P1|STARTED|Overall Study||317
8131654|NCT02796651|20044701|P1|NOT COMPLETED|Overall Study||26
8131655|NCT02796651|20044701|P1|COMPLETED|Overall Study||106
8131656|NCT02796651|20044701|P1|Placebo (Lactose Monohydrate)|Overall Study||38
8131657|NCT02796651|20044701|P1|Perforomist 40 μg|Overall Study||108
8131658|NCT02796651|20044701|P1|Perforomist 20 μg|Overall Study||118
8131659|NCT02796651|20044701|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
8131660|NCT02796651|20044701|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
8131661|NCT02796651|20044701|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
8131662|NCT02796651|20044701|P1|STARTED|Overall Study||132
8131663|NCT02796560|20044732|P2|NOT COMPLETED|Overall Study||2
8131664|NCT02796560|20044733|P1|NOT COMPLETED|Overall Study||4
8131665|NCT02796560|20044732|P2|COMPLETED|Overall Study||36
8131666|NCT02796560|20044733|P1|COMPLETED|Overall Study||34
8131667|NCT02796560|20044732|P2|STARTED|Overall Study||38
8131668|NCT02796560|20044733|P1|STARTED|Overall Study||38
8131669|NCT02796352|20044741|P1|NOT COMPLETED|Overall Study||0
8131670|NCT02796352|20044741|P1|COMPLETED|Overall Study||1
8131671|NCT02796352|20044741|P1|STARTED|Overall Study||1
8131672|NCT02796300|20044750|P2|NOT COMPLETED|Overall Study||0
8131673|NCT02796300|20044751|P1|NOT COMPLETED|Overall Study||0
8131674|NCT02796300|20044750|P2|COMPLETED|Overall Study||22
8131675|NCT02796300|20044751|P1|COMPLETED|Overall Study||10
8131676|NCT02796300|20044750|P2|STARTED|Overall Study||22
8131677|NCT02796300|20044751|P1|STARTED|Overall Study||10
8131678|NCT02796274|20044763|P1|NOT COMPLETED|Overall Study||0
8131679|NCT02796274|20044763|P1|COMPLETED|Overall Study||219
8131680|NCT02796274|20044763|P1|STARTED|Overall Study||219
8131681|NCT02796092|20044769|P2|NOT COMPLETED|Overall Study||0
8131682|NCT02796092|20044770|P1|NOT COMPLETED|Overall Study||0
8131683|NCT02796092|20044769|P2|COMPLETED|Overall Study||50
8131684|NCT02796092|20044770|P1|COMPLETED|Overall Study||50
8131685|NCT02796092|20044769|P2|STARTED|Overall Study||50
8131686|NCT02796092|20044770|P1|STARTED|Overall Study||50
8131687|NCT02795832|20044808|P6|NOT COMPLETED|Overall Study||3
8131688|NCT02795832|20044809|P5|NOT COMPLETED|Overall Study||0
8131689|NCT02795832|20044810|P4|NOT COMPLETED|Overall Study||0
8131690|NCT02795832|20044811|P3|NOT COMPLETED|Overall Study||0
8131691|NCT02795832|20044812|P2|NOT COMPLETED|Overall Study||0
8131692|NCT02795832|20044813|P1|NOT COMPLETED|Overall Study||0
8131693|NCT02795832|20044808|P6|COMPLETED|Overall Study||7
8131694|NCT02795832|20044809|P5|COMPLETED|Overall Study||20
8131695|NCT02795832|20044810|P4|COMPLETED|Overall Study||3
8131696|NCT02795832|20044811|P3|COMPLETED|Overall Study||8
8131697|NCT02795832|20044812|P2|COMPLETED|Overall Study||4
8131698|NCT02795832|20044813|P1|COMPLETED|Overall Study||8
8131699|NCT02795832|20044808|P6|STARTED|Overall Study||10
8131700|NCT02795832|20044809|P5|STARTED|Overall Study||20
8131701|NCT02795832|20044810|P4|STARTED|Overall Study||3
8131702|NCT02795832|20044811|P3|STARTED|Overall Study||8
8131703|NCT02795832|20044812|P2|STARTED|Overall Study||4
8131704|NCT02795832|20044813|P1|STARTED|Overall Study||8
8131705|NCT02795819|20044847|P7|NOT COMPLETED|Overall Study||0
8131706|NCT02795819|20044848|P6|NOT COMPLETED|Overall Study||0
8131707|NCT02795819|20044849|P5|NOT COMPLETED|Overall Study||0
8131708|NCT02795819|20044850|P4|NOT COMPLETED|Overall Study||0
8131709|NCT02795819|20044851|P3|NOT COMPLETED|Overall Study||0
8131710|NCT02795819|20044852|P2|NOT COMPLETED|Overall Study||0
8131711|NCT02795819|20044853|P1|NOT COMPLETED|Overall Study||0
8131712|NCT02795819|20044847|P7|COMPLETED|Overall Study||0
8131713|NCT02795819|20044848|P6|COMPLETED|Overall Study||0
8131714|NCT02795819|20044849|P5|COMPLETED|Overall Study||0
8131715|NCT02795819|20044850|P4|COMPLETED|Overall Study||0
8131716|NCT02795819|20044851|P3|COMPLETED|Overall Study||0
8131717|NCT02795819|20044852|P2|COMPLETED|Overall Study||6
8131718|NCT02795819|20044853|P1|COMPLETED|Overall Study||0
8131719|NCT02795819|20044847|P7|STARTED|Overall Study||0
8131720|NCT02795819|20044848|P6|STARTED|Overall Study||0
8131721|NCT02795819|20044849|P5|STARTED|Overall Study||0
8131722|NCT02795819|20044850|P4|STARTED|Overall Study||0
8131723|NCT02795819|20044851|P3|STARTED|Overall Study||0
8131724|NCT02795819|20044852|P2|STARTED|Overall Study||6
8131725|NCT02795819|20044853|P1|STARTED|Overall Study||0
8131726|NCT02795780|20044879|P2|NOT COMPLETED|Overall Study||0
8131727|NCT02795780|20044880|P1|NOT COMPLETED|Overall Study||0
8131728|NCT02795780|20044879|P2|COMPLETED|Overall Study||54
8131729|NCT02795780|20044880|P1|COMPLETED|Overall Study||25
8131730|NCT02795780|20044879|P2|STARTED|Overall Study||54
8131731|NCT02795780|20044880|P1|STARTED|Overall Study||25
8131732|NCT02795767|20044891|P3|NOT COMPLETED|Overall Study||10
8131733|NCT02795767|20044892|P2|NOT COMPLETED|Overall Study||10
8131734|NCT02795767|20044893|P1|NOT COMPLETED|Overall Study||68
8131735|NCT02795767|20044891|P3|COMPLETED|Overall Study||0
8131736|NCT02795767|20044892|P2|COMPLETED|Overall Study||0
8131737|NCT02795767|20044893|P1|COMPLETED|Overall Study||0
8131738|NCT02795767|20044891|P3|Discontinued From Study Treatment|Overall Study||1
8131739|NCT02795767|20044892|P2|Discontinued From Study Treatment|Overall Study||0
8131740|NCT02795767|20044893|P1|Discontinued From Study Treatment|Overall Study||2
8131741|NCT02795767|20044891|P3|Completed 52 Weeks in Study|Overall Study||0
8131742|NCT02795767|20044892|P2|Completed 52 Weeks in Study|Overall Study||0
8131743|NCT02795767|20044893|P1|Completed 52 Weeks in Study|Overall Study||59
8131744|NCT02795767|20044891|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
8131745|NCT02795767|20044892|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8131746|NCT02795767|20044893|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8131747|NCT02795767|20044891|P3|STARTED|Overall Study||10
8131748|NCT02795767|20044892|P2|STARTED|Overall Study||10
8131749|NCT02795767|20044893|P1|STARTED|Overall Study||68
8131750|NCT02795117|20045015|P3|NOT COMPLETED|Overall Study||12
8131751|NCT02795117|20045016|P2|NOT COMPLETED|Overall Study||27
8131752|NCT02795117|20045017|P1|NOT COMPLETED|Overall Study||18
8131753|NCT02795117|20045015|P3|COMPLETED|Overall Study||88
8131754|NCT02795117|20045016|P2|COMPLETED|Overall Study||166
8131755|NCT02795117|20045017|P1|COMPLETED|Overall Study||175
8131756|NCT02795117|20045015|P3|STARTED|Overall Study||100
8131757|NCT02795117|20045016|P2|STARTED|Overall Study||193
8131758|NCT02795117|20045017|P1|STARTED|Overall Study||193
8131759|NCT02794974|20045030|P2|NOT COMPLETED|Overall Study||1
8131760|NCT02794974|20045031|P1|NOT COMPLETED|Overall Study||0
8131761|NCT02794974|20045030|P2|COMPLETED|Overall Study||14
8131762|NCT02794974|20045031|P1|COMPLETED|Overall Study||14
8131763|NCT02794974|20045030|P2|STARTED|Overall Study||15
8131764|NCT02794974|20045031|P1|STARTED|Overall Study||14
8131765|NCT02794870|20045047|P2|NOT COMPLETED|Overall Study||0
8131766|NCT02794870|20045048|P1|NOT COMPLETED|Overall Study||2
8131767|NCT02794870|20045047|P2|COMPLETED|Overall Study||11
8131768|NCT02794870|20045048|P1|COMPLETED|Overall Study||20
8131769|NCT02794870|20045047|P2|Received Inoculation|Overall Study||11
8131770|NCT02794870|20045048|P1|Received Inoculation|Overall Study||21
8131771|NCT02794870|20045047|P2|STARTED|Overall Study||11
8131772|NCT02794870|20045048|P1|STARTED|Overall Study||22
8131773|NCT02794844|20045074|P1|NOT COMPLETED|Overall Study||5
8131774|NCT02794844|20045074|P1|COMPLETED|Overall Study||23
8131775|NCT02794844|20045074|P1|STARTED|Overall Study||28
8131776|NCT02794766|20045085|P3|NOT COMPLETED|Overall Study||1
8131777|NCT02794766|20045086|P2|NOT COMPLETED|Overall Study||0
8131778|NCT02794766|20045087|P1|NOT COMPLETED|Overall Study||0
8131779|NCT02794766|20045085|P3|COMPLETED|Overall Study||14
8131780|NCT02794766|20045086|P2|COMPLETED|Overall Study||15
8131781|NCT02794766|20045087|P1|COMPLETED|Overall Study||15
8131782|NCT02794766|20045085|P3|STARTED|Overall Study||15
8131783|NCT02794766|20045086|P2|STARTED|Overall Study||15
8131784|NCT02794766|20045087|P1|STARTED|Overall Study||15
8131785|NCT02794727|20045107|P3|NOT COMPLETED|Overall Study||1
8131786|NCT02794727|20045108|P2|NOT COMPLETED|Overall Study||0
8131787|NCT02794727|20045109|P1|NOT COMPLETED|Overall Study||0
8131788|NCT02794727|20045107|P3|COMPLETED|Overall Study||44
8131789|NCT02794727|20045108|P2|COMPLETED|Overall Study||46
8131790|NCT02794727|20045109|P1|COMPLETED|Overall Study||44
8131791|NCT02794727|20045107|P3|STARTED|Overall Study||45
8131792|NCT02794727|20045108|P2|STARTED|Overall Study||46
8131793|NCT02794727|20045109|P1|STARTED|Overall Study||44
8131794|NCT02794597|20045118|P2|NOT COMPLETED|Overall Study||0
8131795|NCT02794597|20045119|P1|NOT COMPLETED|Overall Study||0
8131796|NCT02794597|20045118|P2|COMPLETED|Overall Study||56
8131797|NCT02794597|20045119|P1|COMPLETED|Overall Study||63
8131798|NCT02794597|20045118|P2|STARTED|Overall Study||56
8131799|NCT02794597|20045119|P1|STARTED|Overall Study||63
8131800|NCT02794480|20045145|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
8131801|NCT02794480|20045146|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
8131802|NCT02794480|20045147|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
8131803|NCT02794480|20045148|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
8131804|NCT02794480|20045145|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
8131805|NCT02794480|20045146|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
8131806|NCT02794480|20045147|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
8131807|NCT02794480|20045148|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
8131808|NCT02794480|20045145|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
8131809|NCT02794480|20045146|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
8131810|NCT02794480|20045147|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
8131811|NCT02794480|20045148|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
8131812|NCT02794480|20045145|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
8131813|NCT02794480|20045146|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
8131814|NCT02794480|20045147|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
8131815|NCT02794480|20045148|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
8131816|NCT02794480|20045145|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
8131817|NCT02794480|20045146|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
8131818|NCT02794480|20045147|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
8131819|NCT02794480|20045148|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
8131820|NCT02794480|20045145|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
8131821|NCT02794480|20045146|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
8131822|NCT02794480|20045147|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
8131823|NCT02794480|20045148|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
8131824|NCT02794441|20045168|P2|NOT COMPLETED|Overall Study||0
8131825|NCT02794441|20045169|P1|NOT COMPLETED|Overall Study||1
8131826|NCT02794441|20045168|P2|COMPLETED|Overall Study||5
8131827|NCT02794441|20045169|P1|COMPLETED|Overall Study||6
8131828|NCT02794441|20045168|P2|STARTED|Overall Study||5
8131829|NCT02794441|20045169|P1|STARTED|Overall Study||7
8131830|NCT02794246|20045191|P1|NOT COMPLETED|Overall Study||6
8131831|NCT02794246|20045191|P1|COMPLETED|Overall Study||0
8131832|NCT02794246|20045191|P1|Treated|Overall Study||3
8131833|NCT02794246|20045191|P1|STARTED|Overall Study||6
8131834|NCT02794207|20045197|P2|NOT COMPLETED|Overall Study||0
8131835|NCT02794207|20045198|P1|NOT COMPLETED|Overall Study||0
8131836|NCT02794207|20045197|P2|COMPLETED|Overall Study||54
8131837|NCT02794207|20045198|P1|COMPLETED|Overall Study||32
8131838|NCT02794207|20045197|P2|STARTED|Overall Study||54
8131839|NCT02794207|20045198|P1|STARTED|Overall Study||32
8131840|NCT02794103|20045203|P1|NOT COMPLETED|Overall Study||3
8131841|NCT02794103|20045203|P1|COMPLETED|Overall Study||15
8131842|NCT02794103|20045203|P1|STARTED|Overall Study||18
8131843|NCT02793947|20045214|P2|NOT COMPLETED|Overall Study||5
8131844|NCT02793947|20045215|P1|NOT COMPLETED|Overall Study||2
8131845|NCT02793947|20045214|P2|COMPLETED|Overall Study||50
8131846|NCT02793947|20045215|P1|COMPLETED|Overall Study||45
8131847|NCT02793947|20045214|P2|STARTED|Overall Study||55
8131848|NCT02793947|20045215|P1|STARTED|Overall Study||47
8131849|NCT02793856|20045229|P4|NOT COMPLETED|Overall Study||0
8131850|NCT02793856|20045230|P3|NOT COMPLETED|Overall Study||0
8131851|NCT02793856|20045231|P2|NOT COMPLETED|Overall Study||0
8131852|NCT02793856|20045232|P1|NOT COMPLETED|Overall Study||0
8131853|NCT02793856|20045229|P4|COMPLETED|Overall Study||3
8131854|NCT02793856|20045230|P3|COMPLETED|Overall Study||3
8131855|NCT02793856|20045231|P2|COMPLETED|Overall Study||4
8131856|NCT02793856|20045232|P1|COMPLETED|Overall Study||2
8131857|NCT02793856|20045229|P4|STARTED|Overall Study||3
8131858|NCT02793856|20045230|P3|STARTED|Overall Study||3
8131859|NCT02793856|20045231|P2|STARTED|Overall Study||4
8131860|NCT02793856|20045232|P1|STARTED|Overall Study||2
8131861|NCT02793817|20045276|P2|NOT COMPLETED|Overall Study||5
8131862|NCT02793817|20045277|P1|NOT COMPLETED|Overall Study||3
8131863|NCT02793817|20045276|P2|COMPLETED|Overall Study||254
8131864|NCT02793817|20045277|P1|COMPLETED|Overall Study||258
8131865|NCT02793817|20045276|P2|STARTED|Overall Study||259
8131866|NCT02793817|20045277|P1|STARTED|Overall Study||261
8131867|NCT02793674|20045297|P2|NOT COMPLETED|Overall Study||0
8131868|NCT02793674|20045298|P1|NOT COMPLETED|Overall Study||0
8131869|NCT02793674|20045297|P2|COMPLETED|Overall Study||12
8131870|NCT02793674|20045298|P1|COMPLETED|Overall Study||9
8131871|NCT02793674|20045297|P2|STARTED|Overall Study||12
8131872|NCT02793674|20045298|P1|STARTED|Overall Study||9
8131873|NCT02793232|20045319|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131874|NCT02793232|20045320|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131875|NCT02793232|20045321|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131876|NCT02793232|20045322|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131877|NCT02793232|20045323|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131878|NCT02793232|20045324|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131879|NCT02793232|20045325|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131880|NCT02793232|20045326|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131881|NCT02793232|20045327|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131882|NCT02793232|20045319|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
8131883|NCT02793232|20045320|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
8131884|NCT02793232|20045321|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
8131885|NCT02793232|20045322|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
8131886|NCT02793232|20045323|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
8131887|NCT02793232|20045324|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
8131888|NCT02793232|20045325|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
8131889|NCT02793232|20045326|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
8131890|NCT02793232|20045327|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
8131891|NCT02793232|20045319|P9|STARTED|Period 4 (Part A: 5 Days)||0
8131892|NCT02793232|20045320|P8|STARTED|Period 4 (Part A: 5 Days)||0
8131893|NCT02793232|20045321|P7|STARTED|Period 4 (Part A: 5 Days)||0
8131894|NCT02793232|20045322|P6|STARTED|Period 4 (Part A: 5 Days)||0
8131895|NCT02793232|20045323|P5|STARTED|Period 4 (Part A: 5 Days)||0
8131896|NCT02793232|20045324|P4|STARTED|Period 4 (Part A: 5 Days)||2
8131897|NCT02793232|20045325|P3|STARTED|Period 4 (Part A: 5 Days)||2
8131898|NCT02793232|20045326|P2|STARTED|Period 4 (Part A: 5 Days)||2
8131899|NCT02793232|20045327|P1|STARTED|Period 4 (Part A: 5 Days)||2
8131900|NCT02793232|20045319|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131901|NCT02793232|20045320|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131902|NCT02793232|20045321|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131903|NCT02793232|20045322|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131904|NCT02793232|20045323|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131905|NCT02793232|20045324|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131906|NCT02793232|20045325|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131907|NCT02793232|20045326|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131908|NCT02793232|20045327|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131909|NCT02793232|20045319|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131910|NCT02793232|20045320|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131911|NCT02793232|20045321|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131912|NCT02793232|20045322|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131913|NCT02793232|20045323|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131914|NCT02793232|20045324|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131915|NCT02793232|20045325|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131916|NCT02793232|20045326|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131917|NCT02793232|20045327|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131918|NCT02793232|20045319|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131919|NCT02793232|20045320|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131920|NCT02793232|20045321|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131921|NCT02793232|20045322|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131922|NCT02793232|20045323|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131923|NCT02793232|20045324|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131924|NCT02793232|20045325|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131925|NCT02793232|20045326|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131926|NCT02793232|20045327|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131927|NCT02793232|20045319|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131928|NCT02793232|20045320|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131929|NCT02793232|20045321|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131930|NCT02793232|20045322|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131931|NCT02793232|20045323|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131932|NCT02793232|20045324|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131933|NCT02793232|20045325|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131934|NCT02793232|20045326|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131935|NCT02793232|20045327|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131936|NCT02793232|20045319|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
8131937|NCT02793232|20045320|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
8131938|NCT02793232|20045321|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
8131939|NCT02793232|20045322|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
8131940|NCT02793232|20045323|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
8131941|NCT02793232|20045324|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
8131942|NCT02793232|20045325|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
8131943|NCT02793232|20045326|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
8131944|NCT02793232|20045327|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
8131945|NCT02793232|20045319|P9|STARTED|Period 3 (Part A: 5 Days)||0
8131946|NCT02793232|20045320|P8|STARTED|Period 3 (Part A: 5 Days)||0
8131947|NCT02793232|20045321|P7|STARTED|Period 3 (Part A: 5 Days)||0
8131948|NCT02793232|20045322|P6|STARTED|Period 3 (Part A: 5 Days)||0
8131949|NCT02793232|20045323|P5|STARTED|Period 3 (Part A: 5 Days)||0
8131950|NCT02793232|20045324|P4|STARTED|Period 3 (Part A: 5 Days)||2
8131951|NCT02793232|20045325|P3|STARTED|Period 3 (Part A: 5 Days)||2
8131952|NCT02793232|20045326|P2|STARTED|Period 3 (Part A: 5 Days)||2
8131953|NCT02793232|20045327|P1|STARTED|Period 3 (Part A: 5 Days)||2
8131954|NCT02793232|20045319|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131955|NCT02793232|20045320|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131956|NCT02793232|20045321|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131957|NCT02793232|20045322|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131958|NCT02793232|20045323|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131959|NCT02793232|20045324|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131960|NCT02793232|20045325|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131961|NCT02793232|20045326|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131962|NCT02793232|20045327|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131963|NCT02793232|20045319|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131964|NCT02793232|20045320|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131965|NCT02793232|20045321|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131966|NCT02793232|20045322|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131967|NCT02793232|20045323|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131968|NCT02793232|20045324|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131969|NCT02793232|20045325|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131970|NCT02793232|20045326|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131971|NCT02793232|20045327|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131972|NCT02793232|20045319|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131973|NCT02793232|20045320|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131974|NCT02793232|20045321|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131975|NCT02793232|20045322|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131976|NCT02793232|20045323|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131977|NCT02793232|20045324|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131978|NCT02793232|20045325|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131979|NCT02793232|20045326|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131980|NCT02793232|20045327|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131981|NCT02793232|20045319|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131982|NCT02793232|20045320|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131983|NCT02793232|20045321|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131984|NCT02793232|20045322|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131985|NCT02793232|20045323|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131986|NCT02793232|20045324|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131987|NCT02793232|20045325|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131988|NCT02793232|20045326|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131989|NCT02793232|20045327|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131990|NCT02793232|20045319|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
8131991|NCT02793232|20045320|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
8131992|NCT02793232|20045321|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
8131993|NCT02793232|20045322|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
8131994|NCT02793232|20045323|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
8131995|NCT02793232|20045324|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
8131996|NCT02793232|20045325|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
8131997|NCT02793232|20045326|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
8131998|NCT02793232|20045327|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
8131999|NCT02793232|20045319|P9|STARTED|Period 2 (Part A: 5 Days)||0
8132000|NCT02793232|20045320|P8|STARTED|Period 2 (Part A: 5 Days)||0
8132001|NCT02793232|20045321|P7|STARTED|Period 2 (Part A: 5 Days)||0
8132002|NCT02793232|20045322|P6|STARTED|Period 2 (Part A: 5 Days)||0
8132003|NCT02793232|20045323|P5|STARTED|Period 2 (Part A: 5 Days)||0
8132004|NCT02793232|20045324|P4|STARTED|Period 2 (Part A: 5 Days)||2
8132005|NCT02793232|20045325|P3|STARTED|Period 2 (Part A: 5 Days)||2
8132006|NCT02793232|20045326|P2|STARTED|Period 2 (Part A: 5 Days)||2
8132007|NCT02793232|20045327|P1|STARTED|Period 2 (Part A: 5 Days)||2
8132008|NCT02793232|20045319|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132009|NCT02793232|20045320|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132010|NCT02793232|20045321|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132011|NCT02793232|20045322|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132012|NCT02793232|20045323|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132013|NCT02793232|20045324|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132014|NCT02793232|20045325|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132015|NCT02793232|20045326|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132016|NCT02793232|20045327|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132017|NCT02793232|20045319|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132018|NCT02793232|20045320|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132019|NCT02793232|20045321|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132020|NCT02793232|20045322|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132021|NCT02793232|20045323|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132022|NCT02793232|20045324|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132023|NCT02793232|20045325|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132024|NCT02793232|20045326|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132025|NCT02793232|20045327|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132026|NCT02793232|20045319|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132027|NCT02793232|20045320|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132028|NCT02793232|20045321|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132029|NCT02793232|20045322|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132030|NCT02793232|20045323|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132031|NCT02793232|20045324|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132032|NCT02793232|20045325|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132033|NCT02793232|20045326|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132034|NCT02793232|20045327|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132035|NCT02793232|20045319|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132036|NCT02793232|20045320|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132037|NCT02793232|20045321|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
8132038|NCT02793232|20045322|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132039|NCT02793232|20045323|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
8132040|NCT02793232|20045324|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132041|NCT02793232|20045325|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132042|NCT02793232|20045326|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132043|NCT02793232|20045327|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132044|NCT02793232|20045319|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8132045|NCT02793232|20045320|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132046|NCT02793232|20045321|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8132047|NCT02793232|20045322|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
8132048|NCT02793232|20045323|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
8132049|NCT02793232|20045324|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132050|NCT02793232|20045325|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132051|NCT02793232|20045326|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132052|NCT02793232|20045327|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132053|NCT02793232|20045319|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8132054|NCT02793232|20045320|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132055|NCT02793232|20045321|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
8132056|NCT02793232|20045322|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
8132057|NCT02793232|20045323|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
8132058|NCT02793232|20045324|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132059|NCT02793232|20045325|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132060|NCT02793232|20045326|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132061|NCT02793232|20045327|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132062|NCT02793154|20045512|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132063|NCT02793154|20045513|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132064|NCT02793154|20045514|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132065|NCT02793154|20045512|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132066|NCT02793154|20045513|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132067|NCT02793154|20045514|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132068|NCT02793154|20045512|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
8132069|NCT02793154|20045513|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
8132070|NCT02793154|20045514|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
8132071|NCT02793154|20045512|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8132072|NCT02793154|20045513|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8132073|NCT02793154|20045514|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8132074|NCT02793154|20045512|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
8132075|NCT02793154|20045513|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
8132076|NCT02793154|20045514|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
8132077|NCT02793154|20045512|P3|STARTED|Part A (Single Group-up to 12 Days)||0
8132078|NCT02793154|20045513|P2|STARTED|Part A (Single Group-up to 12 Days)||0
8132079|NCT02793154|20045514|P1|STARTED|Part A (Single Group-up to 12 Days)||4
8132080|NCT02793128|20045580|P1|NOT COMPLETED|Overall Study||9
8132081|NCT02793128|20045580|P1|COMPLETED|Overall Study||62
8132082|NCT02793128|20045580|P1|STARTED|Overall Study||71
8132083|NCT02792829|20045602|P8|NOT COMPLETED|Treatment Period 2||2
8132084|NCT02792829|20045603|P7|NOT COMPLETED|Treatment Period 2||1
8132085|NCT02792829|20045604|P6|NOT COMPLETED|Treatment Period 2||0
8132086|NCT02792829|20045605|P5|NOT COMPLETED|Treatment Period 2||1
8132087|NCT02792829|20045606|P4|NOT COMPLETED|Treatment Period 2||0
8132088|NCT02792829|20045607|P3|NOT COMPLETED|Treatment Period 2||0
8132089|NCT02792829|20045608|P2|NOT COMPLETED|Treatment Period 2||1
8132090|NCT02792829|20045609|P1|NOT COMPLETED|Treatment Period 2||0
8132091|NCT02792829|20045602|P8|COMPLETED|Treatment Period 2||8
8132092|NCT02792829|20045603|P7|COMPLETED|Treatment Period 2||9
8132093|NCT02792829|20045604|P6|COMPLETED|Treatment Period 2||5
8132094|NCT02792829|20045605|P5|COMPLETED|Treatment Period 2||4
8132095|NCT02792829|20045606|P4|COMPLETED|Treatment Period 2||5
8132096|NCT02792829|20045607|P3|COMPLETED|Treatment Period 2||5
8132097|NCT02792829|20045608|P2|COMPLETED|Treatment Period 2||9
8132098|NCT02792829|20045609|P1|COMPLETED|Treatment Period 2||10
8132099|NCT02792829|20045602|P8|STARTED|Treatment Period 2||10
8132100|NCT02792829|20045603|P7|STARTED|Treatment Period 2||10
8132101|NCT02792829|20045604|P6|STARTED|Treatment Period 2||5
8132102|NCT02792829|20045605|P5|STARTED|Treatment Period 2||5
8132103|NCT02792829|20045606|P4|STARTED|Treatment Period 2||5
8132104|NCT02792829|20045607|P3|STARTED|Treatment Period 2||5
8132105|NCT02792829|20045608|P2|STARTED|Treatment Period 2||10
8132106|NCT02792829|20045609|P1|STARTED|Treatment Period 2||10
8132107|NCT02792829|20045602|P8|NOT COMPLETED|Wash Out Period||0
8132108|NCT02792829|20045603|P7|NOT COMPLETED|Wash Out Period||0
8132109|NCT02792829|20045604|P6|NOT COMPLETED|Wash Out Period||0
8132110|NCT02792829|20045605|P5|NOT COMPLETED|Wash Out Period||0
8132111|NCT02792829|20045606|P4|NOT COMPLETED|Wash Out Period||0
8132112|NCT02792829|20045607|P3|NOT COMPLETED|Wash Out Period||0
8132113|NCT02792829|20045608|P2|NOT COMPLETED|Wash Out Period||0
8132114|NCT02792829|20045609|P1|NOT COMPLETED|Wash Out Period||0
8132115|NCT02792829|20045602|P8|COMPLETED|Wash Out Period||10
8132116|NCT02792829|20045603|P7|COMPLETED|Wash Out Period||10
8132117|NCT02792829|20045604|P6|COMPLETED|Wash Out Period||5
8132118|NCT02792829|20045605|P5|COMPLETED|Wash Out Period||5
8132119|NCT02792829|20045606|P4|COMPLETED|Wash Out Period||5
8132120|NCT02792829|20045607|P3|COMPLETED|Wash Out Period||5
8132121|NCT02792829|20045608|P2|COMPLETED|Wash Out Period||10
8132122|NCT02792829|20045609|P1|COMPLETED|Wash Out Period||10
8132123|NCT02792829|20045602|P8|STARTED|Wash Out Period||10
8132124|NCT02792829|20045603|P7|STARTED|Wash Out Period||10
8132125|NCT02792829|20045604|P6|STARTED|Wash Out Period||5
8132126|NCT02792829|20045605|P5|STARTED|Wash Out Period||5
8132127|NCT02792829|20045606|P4|STARTED|Wash Out Period||5
8132128|NCT02792829|20045607|P3|STARTED|Wash Out Period||5
8132129|NCT02792829|20045608|P2|STARTED|Wash Out Period||10
8132130|NCT02792829|20045609|P1|STARTED|Wash Out Period||10
8132131|NCT02792829|20045602|P8|NOT COMPLETED|Treatment Period 1||0
8132132|NCT02792829|20045603|P7|NOT COMPLETED|Treatment Period 1||0
8132133|NCT02792829|20045604|P6|NOT COMPLETED|Treatment Period 1||0
8132134|NCT02792829|20045605|P5|NOT COMPLETED|Treatment Period 1||0
8132135|NCT02792829|20045606|P4|NOT COMPLETED|Treatment Period 1||0
8132136|NCT02792829|20045607|P3|NOT COMPLETED|Treatment Period 1||0
8132137|NCT02792829|20045608|P2|NOT COMPLETED|Treatment Period 1||0
8132138|NCT02792829|20045609|P1|NOT COMPLETED|Treatment Period 1||0
8132139|NCT02792829|20045602|P8|COMPLETED|Treatment Period 1||10
8132140|NCT02792829|20045603|P7|COMPLETED|Treatment Period 1||10
8132141|NCT02792829|20045604|P6|COMPLETED|Treatment Period 1||5
8132142|NCT02792829|20045605|P5|COMPLETED|Treatment Period 1||5
8132143|NCT02792829|20045606|P4|COMPLETED|Treatment Period 1||5
8132144|NCT02792829|20045607|P3|COMPLETED|Treatment Period 1||5
8132145|NCT02792829|20045608|P2|COMPLETED|Treatment Period 1||10
8132146|NCT02792829|20045609|P1|COMPLETED|Treatment Period 1||10
8132147|NCT02792829|20045602|P8|STARTED|Treatment Period 1||10
8132148|NCT02792829|20045603|P7|STARTED|Treatment Period 1||10
8132149|NCT02792829|20045604|P6|STARTED|Treatment Period 1||5
8132150|NCT02792829|20045605|P5|STARTED|Treatment Period 1||5
8132151|NCT02792829|20045606|P4|STARTED|Treatment Period 1||5
8132152|NCT02792829|20045607|P3|STARTED|Treatment Period 1||5
8132153|NCT02792829|20045608|P2|STARTED|Treatment Period 1||10
8132154|NCT02792829|20045609|P1|STARTED|Treatment Period 1||10
8132155|NCT02792777|20045717|P2|NOT COMPLETED|Overall Study||0
8132156|NCT02792777|20045718|P1|NOT COMPLETED|Overall Study||7
8132157|NCT02792777|20045717|P2|COMPLETED|Overall Study||52
8132158|NCT02792777|20045718|P1|COMPLETED|Overall Study||89
8132159|NCT02792777|20045717|P2|STARTED|Overall Study||52
8132160|NCT02792777|20045718|P1|STARTED|Overall Study||96
8132161|NCT02792699|20045734|P3|NOT COMPLETED|Overall Study||10
8132162|NCT02792699|20045735|P2|NOT COMPLETED|Overall Study||10
8132163|NCT02792699|20045736|P1|NOT COMPLETED|Overall Study||9
8132164|NCT02792699|20045734|P3|COMPLETED|Overall Study||93
8132165|NCT02792699|20045735|P2|COMPLETED|Overall Study||94
8132166|NCT02792699|20045736|P1|COMPLETED|Overall Study||95
8132167|NCT02792699|20045734|P3|Received Second Infusion of Second Dose|Overall Study||93
8132168|NCT02792699|20045735|P2|Received Second Infusion of Second Dose|Overall Study||99
8132169|NCT02792699|20045736|P1|Received Second Infusion of Second Dose|Overall Study||97
8132170|NCT02792699|20045734|P3|Received First Infusion of Second Dose|Overall Study||95
8132171|NCT02792699|20045735|P2|Received First Infusion of Second Dose|Overall Study||99
8132172|NCT02792699|20045736|P1|Received First Infusion of Second Dose|Overall Study||97
8132173|NCT02792699|20045734|P3|Received Second Infusion of First Dose|Overall Study||99
8132174|NCT02792699|20045735|P2|Received Second Infusion of First Dose|Overall Study||103
8132175|NCT02792699|20045736|P1|Received Second Infusion of First Dose|Overall Study||102
8132176|NCT02792699|20045734|P3|Received First Infusion of First Dose|Overall Study||103
8132177|NCT02792699|20045735|P2|Received First Infusion of First Dose|Overall Study||104
8132178|NCT02792699|20045736|P1|Received First Infusion of First Dose|Overall Study||104
8132179|NCT02792699|20045734|P3|STARTED|Overall Study||103
8132180|NCT02792699|20045735|P2|STARTED|Overall Study||104
8132181|NCT02792699|20045736|P1|STARTED|Overall Study||104
8132182|NCT02792517|20045817|P1|NOT COMPLETED|Overall Study||20
8132183|NCT02792517|20045817|P1|COMPLETED|Overall Study||21
8132184|NCT02792517|20045817|P1|Received Erenumab|Overall Study||24
8132185|NCT02792517|20045817|P1|STARTED|Overall Study||41
8132186|NCT02792231|20045833|P2|NOT COMPLETED|Overall Study||85
8132187|NCT02792231|20045834|P1|NOT COMPLETED|Overall Study||84
8132188|NCT02792231|20045833|P2|COMPLETED|Overall Study||389
8132189|NCT02792231|20045834|P1|COMPLETED|Overall Study||397
8132190|NCT02792231|20045833|P2|Off Study Drug at Interim Cut Off|Overall Study||19
8132191|NCT02792231|20045834|P1|Off Study Drug at Interim Cut Off|Overall Study||14
8132192|NCT02792231|20045833|P2|On Study Drug at Interim Cut Off|Overall Study||370
8132193|NCT02792231|20045834|P1|On Study Drug at Interim Cut Off|Overall Study||383
8132194|NCT02792231|20045833|P2|STARTED|Overall Study||474
8132195|NCT02792231|20045834|P1|STARTED|Overall Study||481
8132196|NCT02792218|20045856|P2|NOT COMPLETED|Overall Study||86
8132197|NCT02792218|20045857|P1|NOT COMPLETED|Overall Study||49
8132198|NCT02792218|20045856|P2|COMPLETED|Overall Study||376
8132199|NCT02792218|20045857|P1|COMPLETED|Overall Study||416
8132200|NCT02792218|20045856|P2|Off Study Drug at Interim Cut Off|Overall Study||17
8132201|NCT02792218|20045857|P1|Off Study Drug at Interim Cut Off|Overall Study||16
8132202|NCT02792218|20045856|P2|On Study Drug at Interim Cut Off|Overall Study||359
8132203|NCT02792218|20045857|P1|On Study Drug at Interim Cut Off|Overall Study||400
8132204|NCT02792218|20045856|P2|STARTED|Overall Study||462
8132205|NCT02792218|20045857|P1|STARTED|Overall Study||465
8132206|NCT02792062|20045883|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132207|NCT02792062|20045884|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132208|NCT02792062|20045885|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132209|NCT02792062|20045886|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132210|NCT02792062|20045887|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132211|NCT02792062|20045888|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132212|NCT02792062|20045883|P6|COMPLETED|Intervention Period 3 (6 Days)||2
8132213|NCT02792062|20045884|P5|COMPLETED|Intervention Period 3 (6 Days)||2
8132214|NCT02792062|20045885|P4|COMPLETED|Intervention Period 3 (6 Days)||2
8132215|NCT02792062|20045886|P3|COMPLETED|Intervention Period 3 (6 Days)||2
8132216|NCT02792062|20045887|P2|COMPLETED|Intervention Period 3 (6 Days)||2
8132217|NCT02792062|20045888|P1|COMPLETED|Intervention Period 3 (6 Days)||1
8132218|NCT02792062|20045883|P6|STARTED|Intervention Period 3 (6 Days)||2
8132219|NCT02792062|20045884|P5|STARTED|Intervention Period 3 (6 Days)||2
8132220|NCT02792062|20045885|P4|STARTED|Intervention Period 3 (6 Days)||2
8132221|NCT02792062|20045886|P3|STARTED|Intervention Period 3 (6 Days)||2
8132222|NCT02792062|20045887|P2|STARTED|Intervention Period 3 (6 Days)||2
8132223|NCT02792062|20045888|P1|STARTED|Intervention Period 3 (6 Days)||1
8132224|NCT02792062|20045883|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132225|NCT02792062|20045884|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132226|NCT02792062|20045885|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132227|NCT02792062|20045886|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132228|NCT02792062|20045887|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132229|NCT02792062|20045888|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8132230|NCT02792062|20045883|P6|COMPLETED|Washout Period (at Least 14 Days)||2
8132231|NCT02792062|20045884|P5|COMPLETED|Washout Period (at Least 14 Days)||2
8132232|NCT02792062|20045885|P4|COMPLETED|Washout Period (at Least 14 Days)||2
8132233|NCT02792062|20045886|P3|COMPLETED|Washout Period (at Least 14 Days)||2
8132234|NCT02792062|20045887|P2|COMPLETED|Washout Period (at Least 14 Days)||2
8132235|NCT02792062|20045888|P1|COMPLETED|Washout Period (at Least 14 Days)||1
8132236|NCT02792062|20045883|P6|STARTED|Washout Period (at Least 14 Days)||2
8132237|NCT02792062|20045884|P5|STARTED|Washout Period (at Least 14 Days)||2
8132238|NCT02792062|20045885|P4|STARTED|Washout Period (at Least 14 Days)||2
8132239|NCT02792062|20045886|P3|STARTED|Washout Period (at Least 14 Days)||2
8132240|NCT02792062|20045887|P2|STARTED|Washout Period (at Least 14 Days)||2
8132241|NCT02792062|20045888|P1|STARTED|Washout Period (at Least 14 Days)||2
8132242|NCT02792062|20045883|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132243|NCT02792062|20045884|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132244|NCT02792062|20045885|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132245|NCT02792062|20045886|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132246|NCT02792062|20045887|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132247|NCT02792062|20045888|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132248|NCT02792062|20045883|P6|COMPLETED|Intervention Period 2 (6 Days)||2
8132249|NCT02792062|20045884|P5|COMPLETED|Intervention Period 2 (6 Days)||2
8132250|NCT02792062|20045885|P4|COMPLETED|Intervention Period 2 (6 Days)||2
8132251|NCT02792062|20045886|P3|COMPLETED|Intervention Period 2 (6 Days)||2
8132252|NCT02792062|20045887|P2|COMPLETED|Intervention Period 2 (6 Days)||2
8132253|NCT02792062|20045888|P1|COMPLETED|Intervention Period 2 (6 Days)||2
8132254|NCT02792062|20045883|P6|STARTED|Intervention Period 2 (6 Days)||2
8132255|NCT02792062|20045884|P5|STARTED|Intervention Period 2 (6 Days)||2
8132256|NCT02792062|20045885|P4|STARTED|Intervention Period 2 (6 Days)||2
8132257|NCT02792062|20045886|P3|STARTED|Intervention Period 2 (6 Days)||2
8132258|NCT02792062|20045887|P2|STARTED|Intervention Period 2 (6 Days)||2
8132259|NCT02792062|20045888|P1|STARTED|Intervention Period 2 (6 Days)||2
8132260|NCT02792062|20045883|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132261|NCT02792062|20045884|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132262|NCT02792062|20045885|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132263|NCT02792062|20045886|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132264|NCT02792062|20045887|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132265|NCT02792062|20045888|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132266|NCT02792062|20045883|P6|COMPLETED|Washout Period (at Least 14 Days)||2
8132267|NCT02792062|20045884|P5|COMPLETED|Washout Period (at Least 14 Days)||2
8132268|NCT02792062|20045885|P4|COMPLETED|Washout Period (at Least 14 Days)||2
8132269|NCT02792062|20045886|P3|COMPLETED|Washout Period (at Least 14 Days)||2
8132270|NCT02792062|20045887|P2|COMPLETED|Washout Period (at Least 14 Days)||2
8132271|NCT02792062|20045888|P1|COMPLETED|Washout Period (at Least 14 Days)||2
8132272|NCT02792062|20045883|P6|STARTED|Washout Period (at Least 14 Days)||2
8132273|NCT02792062|20045884|P5|STARTED|Washout Period (at Least 14 Days)||2
8132274|NCT02792062|20045885|P4|STARTED|Washout Period (at Least 14 Days)||2
8132275|NCT02792062|20045886|P3|STARTED|Washout Period (at Least 14 Days)||2
8132276|NCT02792062|20045887|P2|STARTED|Washout Period (at Least 14 Days)||2
8132277|NCT02792062|20045888|P1|STARTED|Washout Period (at Least 14 Days)||2
8132278|NCT02792062|20045883|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132279|NCT02792062|20045884|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132280|NCT02792062|20045885|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132281|NCT02792062|20045886|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132282|NCT02792062|20045887|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132283|NCT02792062|20045888|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132284|NCT02792062|20045883|P6|COMPLETED|Intervention Period 1 (6 Days)||2
8132285|NCT02792062|20045884|P5|COMPLETED|Intervention Period 1 (6 Days)||2
8132286|NCT02792062|20045885|P4|COMPLETED|Intervention Period 1 (6 Days)||2
8132287|NCT02792062|20045886|P3|COMPLETED|Intervention Period 1 (6 Days)||2
8132288|NCT02792062|20045887|P2|COMPLETED|Intervention Period 1 (6 Days)||2
8132289|NCT02792062|20045888|P1|COMPLETED|Intervention Period 1 (6 Days)||2
8132290|NCT02792062|20045883|P6|STARTED|Intervention Period 1 (6 Days)||2
8132291|NCT02792062|20045884|P5|STARTED|Intervention Period 1 (6 Days)||2
8132292|NCT02792062|20045885|P4|STARTED|Intervention Period 1 (6 Days)||2
8132293|NCT02792062|20045886|P3|STARTED|Intervention Period 1 (6 Days)||2
8132294|NCT02792062|20045887|P2|STARTED|Intervention Period 1 (6 Days)||2
8132295|NCT02792062|20045888|P1|STARTED|Intervention Period 1 (6 Days)||2
8132296|NCT02792049|20045922|P2|NOT COMPLETED|Overall Study||0
8132297|NCT02792049|20045923|P1|NOT COMPLETED|Overall Study||0
8132298|NCT02792049|20045922|P2|COMPLETED|Overall Study||35
8132299|NCT02792049|20045923|P1|COMPLETED|Overall Study||35
8132300|NCT02792049|20045922|P2|STARTED|Overall Study||35
8132301|NCT02792049|20045923|P1|STARTED|Overall Study||35
8132302|NCT02791945|20045939|P2|NOT COMPLETED|Overall Study||2
8132303|NCT02791945|20045940|P1|NOT COMPLETED|Overall Study||2
8132304|NCT02791945|20045939|P2|COMPLETED|Overall Study||14
8132305|NCT02791945|20045940|P1|COMPLETED|Overall Study||12
8132306|NCT02791945|20045939|P2|STARTED|Overall Study||16
8132307|NCT02791945|20045940|P1|STARTED|Overall Study||14
8132308|NCT02791906|20045952|P2|NOT COMPLETED|Overall Study||1
8132309|NCT02791906|20045953|P1|NOT COMPLETED|Overall Study||2
8132310|NCT02791906|20045952|P2|COMPLETED|Overall Study||2
8132311|NCT02791906|20045953|P1|COMPLETED|Overall Study||2
8132312|NCT02791906|20045952|P2|STARTED|Overall Study||3
8132313|NCT02791906|20045953|P1|STARTED|Overall Study||4
8132314|NCT02791763|20045970|P3|NOT COMPLETED|Overall Study||13
8132315|NCT02791763|20045971|P2|NOT COMPLETED|Overall Study||37
8132316|NCT02791763|20045972|P1|NOT COMPLETED|Overall Study||38
8132317|NCT02791763|20045970|P3|COMPLETED|Overall Study||43
8132318|NCT02791763|20045971|P2|COMPLETED|Overall Study||113
8132319|NCT02791763|20045972|P1|COMPLETED|Overall Study||111
8132320|NCT02791763|20045970|P3|STARTED|Overall Study||56
8132321|NCT02791763|20045971|P2|STARTED|Overall Study||150
8132322|NCT02791763|20045972|P1|STARTED|Overall Study||149
8132323|NCT02791659|20046091|P2|NOT COMPLETED|Overall Study||1
8132324|NCT02791659|20046092|P1|NOT COMPLETED|Overall Study||0
8132325|NCT02791659|20046091|P2|COMPLETED|Overall Study||27
8132326|NCT02791659|20046092|P1|COMPLETED|Overall Study||27
8132327|NCT02791659|20046091|P2|STARTED|Overall Study||28
8132328|NCT02791659|20046092|P1|STARTED|Overall Study||27
8132329|NCT02791516|20046100|P2|NOT COMPLETED|Overall Study||1
8132330|NCT02791516|20046101|P1|NOT COMPLETED|Overall Study||1
8132331|NCT02791516|20046100|P2|COMPLETED|Overall Study||33
8132332|NCT02791516|20046101|P1|COMPLETED|Overall Study||32
8132333|NCT02791516|20046100|P2|Completed 6-month Treatment Period|Overall Study||33
8132334|NCT02791516|20046101|P1|Completed 6-month Treatment Period|Overall Study||33
8132335|NCT02791516|20046100|P2|STARTED|Overall Study||34
8132336|NCT02791516|20046101|P1|STARTED|Overall Study||33
8132337|NCT02791490|20046113|P2|NOT COMPLETED|Overall Study||8
8132338|NCT02791490|20046114|P1|NOT COMPLETED|Overall Study||3
8132339|NCT02791490|20046113|P2|COMPLETED|Overall Study||221
8132340|NCT02791490|20046114|P1|COMPLETED|Overall Study||226
8132341|NCT02791490|20046113|P2|STARTED|Overall Study||229
8132342|NCT02791490|20046114|P1|STARTED|Overall Study||229
8132343|NCT02791438|20046134|P2|NOT COMPLETED|Treatment Period||1
8132344|NCT02791438|20046135|P1|NOT COMPLETED|Treatment Period||3
8132345|NCT02791438|20046134|P2|COMPLETED|Treatment Period||4
8132346|NCT02791438|20046135|P1|COMPLETED|Treatment Period||19
8132347|NCT02791438|20046134|P2|STARTED|Treatment Period||5
8132348|NCT02791438|20046135|P1|STARTED|Treatment Period||22
8132349|NCT02791438|20046134|P2|NOT COMPLETED|Run-In Period||0
8132350|NCT02791438|20046135|P1|NOT COMPLETED|Run-In Period||0
8132351|NCT02791438|20046134|P2|COMPLETED|Run-In Period||5
8132352|NCT02791438|20046135|P1|COMPLETED|Run-In Period||22
8132353|NCT02791438|20046134|P2|STARTED|Run-In Period||5
8132354|NCT02791438|20046135|P1|STARTED|Run-In Period||22
8132355|NCT02791308|20046164|P3|NOT COMPLETED|Overall Study||17
8132356|NCT02791308|20046165|P2|NOT COMPLETED|Overall Study||9
8132357|NCT02791308|20046166|P1|NOT COMPLETED|Overall Study||10
8132358|NCT02791308|20046164|P3|COMPLETED|Overall Study||179
8132359|NCT02791308|20046165|P2|COMPLETED|Overall Study||187
8132360|NCT02791308|20046166|P1|COMPLETED|Overall Study||185
8132361|NCT02791308|20046164|P3|STARTED|Overall Study||196
8132362|NCT02791308|20046165|P2|STARTED|Overall Study||196
8132363|NCT02791308|20046166|P1|STARTED|Overall Study||195
8132364|NCT02791269|20046176|P2|NOT COMPLETED|Overall Study||1
8132365|NCT02791269|20046177|P1|NOT COMPLETED|Overall Study||0
8132366|NCT02791269|20046176|P2|COMPLETED|Overall Study||19
8132367|NCT02791269|20046177|P1|COMPLETED|Overall Study||4
8132368|NCT02791269|20046176|P2|STARTED|Overall Study||20
8132369|NCT02791269|20046177|P1|STARTED|Overall Study||4
8132370|NCT02790788|20046193|P2|NOT COMPLETED|Overall Study||0
8132371|NCT02790788|20046194|P1|NOT COMPLETED|Overall Study||0
8132372|NCT02790788|20046193|P2|COMPLETED|Overall Study||54
8132373|NCT02790788|20046194|P1|COMPLETED|Overall Study||46
8132374|NCT02790788|20046193|P2|STARTED|Overall Study||54
8132375|NCT02790788|20046194|P1|STARTED|Overall Study||46
8132376|NCT02790736|20046246|P2|NOT COMPLETED|Overall Study||0
8132377|NCT02790736|20046247|P1|NOT COMPLETED|Overall Study||0
8132378|NCT02790736|20046246|P2|COMPLETED|Overall Study||1
8132379|NCT02790736|20046247|P1|COMPLETED|Overall Study||5
8132380|NCT02790736|20046246|P2|STARTED|Overall Study||1
8132381|NCT02790736|20046247|P1|STARTED|Overall Study||5
8132382|NCT02790606|20046255|P1|NOT COMPLETED|Overall Study||35
8132383|NCT02790606|20046255|P1|COMPLETED|Overall Study||75
8132384|NCT02790606|20046255|P1|STARTED|Overall Study||110
8132385|NCT02790463|20046272|P2|NOT COMPLETED|Overall Study||309
8132386|NCT02790463|20046273|P1|NOT COMPLETED|Overall Study||0
8132387|NCT02790463|20046272|P2|COMPLETED|Overall Study||372
8132388|NCT02790463|20046273|P1|COMPLETED|Overall Study||782
8132389|NCT02790463|20046272|P2|STARTED|Overall Study||681
8132390|NCT02790463|20046273|P1|STARTED|Overall Study||782
8132391|NCT02790281|20046281|P1|NOT COMPLETED|Overall Study||0
8132392|NCT02790281|20046281|P1|COMPLETED|Overall Study||33
8132393|NCT02790281|20046281|P1|STARTED|Overall Study||33
8132394|NCT02790073|20046287|P1|NOT COMPLETED|Overall Study||3
8132395|NCT02790073|20046287|P1|COMPLETED|Overall Study||11
8132396|NCT02790073|20046287|P1|STARTED|Overall Study||14
8132397|NCT02789410|20046295|P2|NOT COMPLETED|Overall Study||0
8132398|NCT02789410|20046296|P1|NOT COMPLETED|Overall Study||0
8132399|NCT02789410|20046295|P2|COMPLETED|Overall Study||68
8132400|NCT02789410|20046296|P1|COMPLETED|Overall Study||66
8132401|NCT02789410|20046295|P2|STARTED|Overall Study||68
8132402|NCT02789410|20046296|P1|STARTED|Overall Study||66
8132403|NCT02789176|20046310|P4|NOT COMPLETED|Overall Study||1
8132404|NCT02789176|20046311|P3|NOT COMPLETED|Overall Study||10
8132405|NCT02789176|20046312|P2|NOT COMPLETED|Overall Study||2
8132406|NCT02789176|20046313|P1|NOT COMPLETED|Overall Study||8
8132407|NCT02789176|20046310|P4|COMPLETED|Overall Study||53
8132408|NCT02789176|20046311|P3|COMPLETED|Overall Study||85
8132409|NCT02789176|20046312|P2|COMPLETED|Overall Study||53
8132410|NCT02789176|20046313|P1|COMPLETED|Overall Study||91
8132411|NCT02789176|20046310|P4|STARTED|Overall Study||54
8132412|NCT02789176|20046311|P3|STARTED|Overall Study||95
8132413|NCT02789176|20046312|P2|STARTED|Overall Study||55
8132414|NCT02789176|20046313|P1|STARTED|Overall Study||99
8132415|NCT02789111|20046337|P2|NOT COMPLETED|Overall Study||4
8132416|NCT02789111|20046338|P1|NOT COMPLETED|Overall Study||1
8132417|NCT02789111|20046337|P2|COMPLETED|Overall Study||21
8132418|NCT02789111|20046338|P1|COMPLETED|Overall Study||23
8132419|NCT02789111|20046337|P2|STARTED|Overall Study||25
8132420|NCT02789111|20046338|P1|STARTED|Overall Study||24
8132421|NCT02789033|20046350|P4|NOT COMPLETED|Overall Study||2
8132422|NCT02789033|20046351|P3|NOT COMPLETED|Overall Study||1
8132423|NCT02789033|20046352|P2|NOT COMPLETED|Overall Study||2
8132424|NCT02789033|20046353|P1|NOT COMPLETED|Overall Study||2
8132425|NCT02789033|20046350|P4|COMPLETED|Overall Study||15
8132426|NCT02789033|20046351|P3|COMPLETED|Overall Study||16
8132427|NCT02789033|20046352|P2|COMPLETED|Overall Study||15
8132428|NCT02789033|20046353|P1|COMPLETED|Overall Study||15
8132429|NCT02789033|20046350|P4|STARTED|Overall Study||17
8132430|NCT02789033|20046351|P3|STARTED|Overall Study||17
8132431|NCT02789033|20046352|P2|STARTED|Overall Study||17
8132432|NCT02789033|20046353|P1|STARTED|Overall Study||17
8132433|NCT02788747|20046366|P3|NOT COMPLETED|Overall Study||0
8132434|NCT02788747|20046367|P2|NOT COMPLETED|Overall Study||0
8132435|NCT02788747|20046368|P1|NOT COMPLETED|Overall Study||1
8132436|NCT02788747|20046366|P3|COMPLETED|Overall Study||24
8132437|NCT02788747|20046367|P2|COMPLETED|Overall Study||24
8132438|NCT02788747|20046368|P1|COMPLETED|Overall Study||22
8132439|NCT02788747|20046366|P3|STARTED|Overall Study||24
8132440|NCT02788747|20046367|P2|STARTED|Overall Study||24
8132441|NCT02788747|20046368|P1|STARTED|Overall Study||23
8132442|NCT02788656|20046438|P2|NOT COMPLETED|Overall Study||0
8132443|NCT02788656|20046439|P1|NOT COMPLETED|Overall Study||1
8132444|NCT02788656|20046438|P2|COMPLETED|Overall Study||2
8132445|NCT02788656|20046439|P1|COMPLETED|Overall Study||1
8132446|NCT02788656|20046438|P2|STARTED|Overall Study||2
8132447|NCT02788656|20046439|P1|STARTED|Overall Study||2
8132448|NCT02788513|20046464|P5|NOT COMPLETED|Overall Study||5
8132449|NCT02788513|20046465|P4|NOT COMPLETED|Overall Study||6
8132450|NCT02788513|20046466|P3|NOT COMPLETED|Overall Study||8
8132451|NCT02788513|20046467|P2|NOT COMPLETED|Overall Study||8
8132452|NCT02788513|20046468|P1|NOT COMPLETED|Overall Study||9
8132453|NCT02788513|20046464|P5|COMPLETED|Overall Study||115
8132454|NCT02788513|20046465|P4|COMPLETED|Overall Study||117
8132455|NCT02788513|20046466|P3|COMPLETED|Overall Study||114
8132456|NCT02788513|20046467|P2|COMPLETED|Overall Study||114
8132457|NCT02788513|20046468|P1|COMPLETED|Overall Study||114
8132458|NCT02788513|20046464|P5|STARTED|Overall Study||120
8132459|NCT02788513|20046465|P4|STARTED|Overall Study||123
8132460|NCT02788513|20046466|P3|STARTED|Overall Study||122
8132461|NCT02788513|20046467|P2|STARTED|Overall Study||122
8132462|NCT02788513|20046468|P1|STARTED|Overall Study||123
8132463|NCT02788474|20046492|P2|NOT COMPLETED|Open Label Treatment Period||12
8132464|NCT02788474|20046493|P1|NOT COMPLETED|Open Label Treatment Period||32
8132465|NCT02788474|20046492|P2|COMPLETED|Open Label Treatment Period||100
8132466|NCT02788474|20046493|P1|COMPLETED|Open Label Treatment Period||189
8132467|NCT02788474|20046492|P2|STARTED|Open Label Treatment Period||112
8132468|NCT02788474|20046493|P1|STARTED|Open Label Treatment Period||221
8132469|NCT02788474|20046492|P2|NOT COMPLETED|Double Blind Treatment Period||4
8132470|NCT02788474|20046493|P1|NOT COMPLETED|Double Blind Treatment Period||10
8132471|NCT02788474|20046492|P2|COMPLETED|Double Blind Treatment Period||112
8132472|NCT02788474|20046493|P1|COMPLETED|Double Blind Treatment Period||221
8132473|NCT02788474|20046492|P2|Treated|Double Blind Treatment Period||116
8132474|NCT02788474|20046493|P1|Treated|Double Blind Treatment Period||230
8132475|NCT02788474|20046492|P2|STARTED|Double Blind Treatment Period||116
8132476|NCT02788474|20046493|P1|STARTED|Double Blind Treatment Period||231
8132477|NCT02788357|20046508|P2|NOT COMPLETED|Overall Study||0
8132478|NCT02788357|20046509|P1|NOT COMPLETED|Overall Study||3
8132479|NCT02788357|20046508|P2|COMPLETED|Overall Study||6
8132480|NCT02788357|20046509|P1|COMPLETED|Overall Study||3
8132481|NCT02788357|20046508|P2|STARTED|Overall Study||6
8132482|NCT02788357|20046509|P1|STARTED|Overall Study||6
8132483|NCT02788279|20046524|P3|NOT COMPLETED|Overall Study||90
8132484|NCT02788279|20046525|P2|NOT COMPLETED|Overall Study||183
8132485|NCT02788279|20046526|P1|NOT COMPLETED|Overall Study||90
8132486|NCT02788279|20046524|P3|COMPLETED|Overall Study||0
8132487|NCT02788279|20046525|P2|COMPLETED|Overall Study||0
8132488|NCT02788279|20046526|P1|COMPLETED|Overall Study||0
8132489|NCT02788279|20046524|P3|Modified ITT Population|Overall Study||61
8132490|NCT02788279|20046525|P2|Modified ITT Population|Overall Study||125
8132491|NCT02788279|20046526|P1|Modified ITT Population|Overall Study||57
8132492|NCT02788279|20046524|P3|Received Treatment (Safety Population)|Overall Study||90
8132493|NCT02788279|20046525|P2|Received Treatment (Safety Population)|Overall Study||179
8132494|NCT02788279|20046526|P1|Received Treatment (Safety Population)|Overall Study||80
8132495|NCT02788279|20046524|P3|STARTED|Overall Study||90
8132496|NCT02788279|20046525|P2|STARTED|Overall Study||183
8132497|NCT02788279|20046526|P1|STARTED|Overall Study||90
8132498|NCT02788201|20046563|P6|NOT COMPLETED|Overall Study||3
8132499|NCT02788201|20046564|P5|NOT COMPLETED|Overall Study||0
8132500|NCT02788201|20046565|P4|NOT COMPLETED|Overall Study||1
8132501|NCT02788201|20046566|P3|NOT COMPLETED|Overall Study||1
8132502|NCT02788201|20046567|P2|NOT COMPLETED|Overall Study||1
8132503|NCT02788201|20046568|P1|NOT COMPLETED|Overall Study||1
8132504|NCT02788201|20046563|P6|COMPLETED|Overall Study||0
8132505|NCT02788201|20046564|P5|COMPLETED|Overall Study||1
8132506|NCT02788201|20046565|P4|COMPLETED|Overall Study||0
8132507|NCT02788201|20046566|P3|COMPLETED|Overall Study||0
8132508|NCT02788201|20046567|P2|COMPLETED|Overall Study||0
8132509|NCT02788201|20046568|P1|COMPLETED|Overall Study||0
8132510|NCT02788201|20046563|P6|Did Not Start Treatment|Overall Study||3
8132511|NCT02788201|20046564|P5|Did Not Start Treatment|Overall Study||0
8132512|NCT02788201|20046565|P4|Did Not Start Treatment|Overall Study||0
8132513|NCT02788201|20046566|P3|Did Not Start Treatment|Overall Study||0
8132514|NCT02788201|20046567|P2|Did Not Start Treatment|Overall Study||0
8132515|NCT02788201|20046568|P1|Did Not Start Treatment|Overall Study||0
8132516|NCT02788201|20046563|P6|STARTED|Overall Study||3
8132517|NCT02788201|20046564|P5|STARTED|Overall Study||1
8132518|NCT02788201|20046565|P4|STARTED|Overall Study||1
8132519|NCT02788201|20046566|P3|STARTED|Overall Study||1
8132520|NCT02788201|20046567|P2|STARTED|Overall Study||1
8132521|NCT02788201|20046568|P1|STARTED|Overall Study||1
8132522|NCT02788188|20046599|P7|NOT COMPLETED|Overall Study||0
8132523|NCT02788188|20046600|P6|NOT COMPLETED|Overall Study||0
8132524|NCT02788188|20046601|P5|NOT COMPLETED|Overall Study||0
8132525|NCT02788188|20046602|P4|NOT COMPLETED|Overall Study||0
8132526|NCT02788188|20046603|P3|NOT COMPLETED|Overall Study||0
8132527|NCT02788188|20046604|P2|NOT COMPLETED|Overall Study||0
8132528|NCT02788188|20046605|P1|NOT COMPLETED|Overall Study||0
8132529|NCT02788188|20046599|P7|COMPLETED|Overall Study||10
8132530|NCT02788188|20046600|P6|COMPLETED|Overall Study||8
8132531|NCT02788188|20046601|P5|COMPLETED|Overall Study||8
8132532|NCT02788188|20046602|P4|COMPLETED|Overall Study||4
8132533|NCT02788188|20046603|P3|COMPLETED|Overall Study||4
8132534|NCT02788188|20046604|P2|COMPLETED|Overall Study||2
8132535|NCT02788188|20046605|P1|COMPLETED|Overall Study||2
8132536|NCT02788188|20046599|P7|STARTED|Overall Study||10
8132537|NCT02788188|20046600|P6|STARTED|Overall Study||8
8132538|NCT02788188|20046601|P5|STARTED|Overall Study||8
8132539|NCT02788188|20046602|P4|STARTED|Overall Study||4
8132540|NCT02788188|20046603|P3|STARTED|Overall Study||4
8132541|NCT02788188|20046604|P2|STARTED|Overall Study||2
8132542|NCT02788188|20046605|P1|STARTED|Overall Study||2
8132543|NCT02788175|20046621|P1|NOT COMPLETED|Overall Study||13
8132544|NCT02788175|20046621|P1|COMPLETED|Overall Study||13
8132545|NCT02788175|20046621|P1|Received Study Agent|Overall Study||20
8132546|NCT02788175|20046621|P1|STARTED|Overall Study||26
8132547|NCT02788097|20046628|P2|NOT COMPLETED|Overall Study||0
8132548|NCT02788097|20046629|P1|NOT COMPLETED|Overall Study||0
8132549|NCT02788097|20046628|P2|COMPLETED|Overall Study||69
8132550|NCT02788097|20046629|P1|COMPLETED|Overall Study||61
8132551|NCT02788097|20046628|P2|STARTED|Overall Study||69
8132552|NCT02788097|20046629|P1|STARTED|Overall Study||61
8132553|NCT02787863|20046643|P8|NOT COMPLETED|Overall Study||0
8132554|NCT02787863|20046644|P7|NOT COMPLETED|Overall Study||0
8132555|NCT02787863|20046645|P6|NOT COMPLETED|Overall Study||0
8132556|NCT02787863|20046646|P5|NOT COMPLETED|Overall Study||0
8132557|NCT02787863|20046647|P4|NOT COMPLETED|Overall Study||0
8132558|NCT02787863|20046648|P3|NOT COMPLETED|Overall Study||2
8132559|NCT02787863|20046649|P2|NOT COMPLETED|Overall Study||1
8132560|NCT02787863|20046650|P1|NOT COMPLETED|Overall Study||1
8132561|NCT02787863|20046643|P8|COMPLETED|Overall Study||27
8132562|NCT02787863|20046644|P7|COMPLETED|Overall Study||25
8132563|NCT02787863|20046645|P6|COMPLETED|Overall Study||18
8132564|NCT02787863|20046646|P5|COMPLETED|Overall Study||32
8132565|NCT02787863|20046647|P4|COMPLETED|Overall Study||25
8132566|NCT02787863|20046648|P3|COMPLETED|Overall Study||23
8132567|NCT02787863|20046649|P2|COMPLETED|Overall Study||33
8132568|NCT02787863|20046650|P1|COMPLETED|Overall Study||32
8132569|NCT02787863|20046643|P8|4 Years After Vaccination|Overall Study||27
8132570|NCT02787863|20046644|P7|4 Years After Vaccination|Overall Study||25
8132571|NCT02787863|20046645|P6|4 Years After Vaccination|Overall Study||18
8132572|NCT02787863|20046646|P5|4 Years After Vaccination|Overall Study||32
8132573|NCT02787863|20046647|P4|4 Years After Vaccination|Overall Study||25
8132574|NCT02787863|20046648|P3|4 Years After Vaccination|Overall Study||23
8132575|NCT02787863|20046649|P2|4 Years After Vaccination|Overall Study||33
8132576|NCT02787863|20046650|P1|4 Years After Vaccination|Overall Study||32
8132577|NCT02787863|20046643|P8|1 Year After Vaccination|Overall Study||27
8132578|NCT02787863|20046644|P7|1 Year After Vaccination|Overall Study||25
8132579|NCT02787863|20046645|P6|1 Year After Vaccination|Overall Study||18
8132580|NCT02787863|20046646|P5|1 Year After Vaccination|Overall Study||32
8132581|NCT02787863|20046647|P4|1 Year After Vaccination|Overall Study||25
8132582|NCT02787863|20046648|P3|1 Year After Vaccination|Overall Study||23
8132583|NCT02787863|20046649|P2|1 Year After Vaccination|Overall Study||33
8132584|NCT02787863|20046650|P1|1 Year After Vaccination|Overall Study||32
8132585|NCT02787863|20046643|P8|STARTED|Overall Study||27
8132586|NCT02787863|20046644|P7|STARTED|Overall Study||25
8132587|NCT02787863|20046645|P6|STARTED|Overall Study||18
8132588|NCT02787863|20046646|P5|STARTED|Overall Study||32
8132589|NCT02787863|20046647|P4|STARTED|Overall Study||25
8132590|NCT02787863|20046648|P3|STARTED|Overall Study||25
8132591|NCT02787863|20046649|P2|STARTED|Overall Study||34
8132592|NCT02787863|20046650|P1|STARTED|Overall Study||33
8132593|NCT02787694|20046710|P1|NOT COMPLETED|Overall Study||5
8132594|NCT02787694|20046710|P1|COMPLETED|Overall Study||17
8132595|NCT02787694|20046710|P1|STARTED|Overall Study||22
8132596|NCT02787681|20046714|P1|NOT COMPLETED|Overall Study||2
8132597|NCT02787681|20046714|P1|COMPLETED|Overall Study||69
8132598|NCT02787681|20046714|P1|STARTED|Overall Study||71
8132599|NCT02787655|20046720|P2|NOT COMPLETED|Overall Study||12
8132600|NCT02787655|20046721|P1|NOT COMPLETED|Overall Study||11
8132601|NCT02787655|20046720|P2|COMPLETED|Overall Study||26
8132602|NCT02787655|20046721|P1|COMPLETED|Overall Study||29
8132603|NCT02787655|20046720|P2|STARTED|Overall Study||38
8132604|NCT02787655|20046721|P1|STARTED|Overall Study||40
8132605|NCT02787564|20046729|P2|NOT COMPLETED|Overall Study||2
8132606|NCT02787564|20046730|P1|NOT COMPLETED|Overall Study||7
8132607|NCT02787564|20046729|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
8132608|NCT02787564|20046730|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
8132609|NCT02787564|20046729|P2|STARTED|Overall Study||29
8132610|NCT02787564|20046730|P1|STARTED|Overall Study||32
8132611|NCT02787551|20046748|P2|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
8132612|NCT02787551|20046749|P1|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
8132613|NCT02787551|20046748|P2|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
8132614|NCT02787551|20046749|P1|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
8132615|NCT02787551|20046748|P2|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
8132616|NCT02787551|20046749|P1|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
8132617|NCT02787551|20046748|P2|NOT COMPLETED|Core Period: 26 Weeks||11
8132618|NCT02787551|20046749|P1|NOT COMPLETED|Core Period: 26 Weeks||27
8132619|NCT02787551|20046748|P2|COMPLETED|Core Period: 26 Weeks||246
8132620|NCT02787551|20046749|P1|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
8132621|NCT02787551|20046748|P2|Treated|Core Period: 26 Weeks||256
8132622|NCT02787551|20046749|P1|Treated|Core Period: 26 Weeks||255
8132623|NCT02787551|20046748|P2|STARTED|Core Period: 26 Weeks||257
8132624|NCT02787551|20046749|P1|STARTED|Core Period: 26 Weeks||257
8132625|NCT02787304|20046785|P4|NOT COMPLETED|Overall Study||34
8132626|NCT02787304|20046786|P3|NOT COMPLETED|Overall Study||41
8132627|NCT02787304|20046787|P2|NOT COMPLETED|Overall Study||38
8132628|NCT02787304|20046788|P1|NOT COMPLETED|Overall Study||36
8132629|NCT02787304|20046785|P4|COMPLETED|Overall Study||15
8132630|NCT02787304|20046786|P3|COMPLETED|Overall Study||8
8132631|NCT02787304|20046787|P2|COMPLETED|Overall Study||12
8132632|NCT02787304|20046788|P1|COMPLETED|Overall Study||13
8132633|NCT02787304|20046785|P4|STARTED|Overall Study||49
8132634|NCT02787304|20046786|P3|STARTED|Overall Study||49
8132635|NCT02787304|20046787|P2|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
8132636|NCT02787304|20046788|P1|STARTED|Overall Study||49
8132637|NCT02787291|20046834|P1|NOT COMPLETED|Overall Study||0
8132638|NCT02787291|20046834|P1|COMPLETED|Overall Study||227
8132639|NCT02787291|20046834|P1|STARTED|Overall Study||227
8132640|NCT02787083|20046842|P2|NOT COMPLETED|Overall Study||2
8132641|NCT02787083|20046843|P1|NOT COMPLETED|Overall Study||3
8132642|NCT02787083|20046842|P2|COMPLETED|Overall Study||3
8132643|NCT02787083|20046843|P1|COMPLETED|Overall Study||1
8132644|NCT02787083|20046842|P2|STARTED|Overall Study||5
8132645|NCT02787083|20046843|P1|STARTED|Overall Study||4
8132646|NCT02787057|20046853|P2|NOT COMPLETED|Overall Study||0
8132647|NCT02787057|20046854|P1|NOT COMPLETED|Overall Study||0
8132648|NCT02787057|20046853|P2|COMPLETED|Overall Study||40
8132649|NCT02787057|20046854|P1|COMPLETED|Overall Study||40
8132650|NCT02787057|20046853|P2|STARTED|Overall Study||40
8132651|NCT02787057|20046854|P1|STARTED|Overall Study||40
8132652|NCT02786953|20046868|P2|NOT COMPLETED|Overall Study||1
8132653|NCT02786953|20046869|P1|NOT COMPLETED|Overall Study||3
8132654|NCT02786953|20046868|P2|COMPLETED|Overall Study||18
8132655|NCT02786953|20046869|P1|COMPLETED|Overall Study||17
8132656|NCT02786953|20046868|P2|A1C 3 Month|Overall Study||17
8132657|NCT02786953|20046869|P1|A1C 3 Month|Overall Study||15
8132658|NCT02786953|20046868|P2|3 Month Parent Survey Completed|Overall Study||18
8132659|NCT02786953|20046869|P1|3 Month Parent Survey Completed|Overall Study||17
8132660|NCT02786953|20046868|P2|3 Month Teen Survey Completed|Overall Study||18
8132661|NCT02786953|20046869|P1|3 Month Teen Survey Completed|Overall Study||17
8132662|NCT02786953|20046868|P2|Session 3 Completed|Overall Study||0
8132663|NCT02786953|20046869|P1|Session 3 Completed|Overall Study||16
8132664|NCT02786953|20046868|P2|Session 2 Completed|Overall Study||0
8132665|NCT02786953|20046869|P1|Session 2 Completed|Overall Study||16
8132666|NCT02786953|20046868|P2|Session 1 Completed|Overall Study||0
8132667|NCT02786953|20046869|P1|Session 1 Completed|Overall Study||17
8132668|NCT02786953|20046868|P2|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8132669|NCT02786953|20046869|P1|A1C Data Baseline|Overall Study||20
8132670|NCT02786953|20046868|P2|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
8132671|NCT02786953|20046869|P1|Actigraph Data Complete|Overall Study||14
8132672|NCT02786953|20046868|P2|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8132673|NCT02786953|20046869|P1|Baseline Parent Survey Completed|Overall Study||20
8132674|NCT02786953|20046868|P2|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8132675|NCT02786953|20046869|P1|Baseline Teen Survey Data Completed|Overall Study||20
8132676|NCT02786953|20046868|P2|STARTED|Overall Study||19
8132677|NCT02786953|20046869|P1|STARTED|Overall Study||20
8132678|NCT02786927|20046891|P1|NOT COMPLETED|Overall Study||5
8132679|NCT02786927|20046891|P1|COMPLETED|Overall Study||207
8132680|NCT02786927|20046891|P1|STARTED|Overall Study||212
8132681|NCT02786901|20046901|P3|NOT COMPLETED|Overall Study||41
8132682|NCT02786901|20046902|P2|NOT COMPLETED|Overall Study||56
8132683|NCT02786901|20046903|P1|NOT COMPLETED|Overall Study||77
8132684|NCT02786901|20046901|P3|COMPLETED|Overall Study||159
8132685|NCT02786901|20046902|P2|COMPLETED|Overall Study||145
8132686|NCT02786901|20046903|P1|COMPLETED|Overall Study||122
8132687|NCT02786901|20046901|P3|STARTED|Overall Study||200
8132688|NCT02786901|20046902|P2|STARTED|Overall Study||201
8132689|NCT02786901|20046903|P1|STARTED|Overall Study||199
8132690|NCT02786836|20046932|P1|NOT COMPLETED|Overall Study||14
8132691|NCT02786836|20046932|P1|COMPLETED|Overall Study||62
8132692|NCT02786836|20046932|P1|Eligible Patients Enrolled Into the Stud|Overall Study||76
8132693|NCT02786836|20046932|P1|STARTED|Overall Study||76
8132694|NCT02786810|20046938|P1|NOT COMPLETED|Overall Study||0
8132695|NCT02786810|20046938|P1|COMPLETED|Overall Study||10
8132696|NCT02786810|20046938|P1|STARTED|Overall Study||10
8132697|NCT02786771|20046945|P2|NOT COMPLETED|Overall Study||6
8132698|NCT02786771|20046946|P1|NOT COMPLETED|Overall Study||10
8132699|NCT02786771|20046945|P2|COMPLETED|Overall Study||56
8132700|NCT02786771|20046946|P1|COMPLETED|Overall Study||53
8132701|NCT02786771|20046945|P2|STARTED|Overall Study||62
8132702|NCT02786771|20046946|P1|STARTED|Overall Study||63
8132703|NCT02786719|20046952|P1|NOT COMPLETED|Overall Study||1
8132704|NCT02786719|20046952|P1|COMPLETED|Overall Study||12
8132705|NCT02786719|20046952|P1|STARTED|Overall Study||13
8132706|NCT02786537|20046964|P6|NOT COMPLETED|As Treated||7
8132707|NCT02786537|20046965|P5|NOT COMPLETED|As Treated||12
8132708|NCT02786537|20046966|P4|NOT COMPLETED|As Treated||35
8132709|NCT02786537|20046967|P3|NOT COMPLETED|As Treated||0
8132710|NCT02786537|20046968|P2|NOT COMPLETED|As Treated||62
8132711|NCT02786537|20046969|P1|NOT COMPLETED|As Treated||6
8132712|NCT02786537|20046964|P6|COMPLETED|As Treated||40
8132713|NCT02786537|20046965|P5|COMPLETED|As Treated||87
8132714|NCT02786537|20046966|P4|COMPLETED|As Treated||359
8132715|NCT02786537|20046967|P3|COMPLETED|As Treated||15
8132716|NCT02786537|20046968|P2|COMPLETED|As Treated||602
8132717|NCT02786537|20046969|P1|COMPLETED|As Treated||50
8132718|NCT02786537|20046964|P6|STARTED|As Treated||47
8132719|NCT02786537|20046965|P5|STARTED|As Treated||99
8132720|NCT02786537|20046966|P4|STARTED|As Treated||394
8132721|NCT02786537|20046967|P3|STARTED|As Treated||15
8132722|NCT02786537|20046968|P2|STARTED|As Treated||664
8132723|NCT02786537|20046969|P1|STARTED|As Treated||56
8132724|NCT02786537|20046964|P6|NOT COMPLETED|As Randomized||7
8132725|NCT02786537|20046965|P5|NOT COMPLETED|As Randomized||12
8132726|NCT02786537|20046966|P4|NOT COMPLETED|As Randomized||35
8132727|NCT02786537|20046967|P3|NOT COMPLETED|As Randomized||0
8132728|NCT02786537|20046968|P2|NOT COMPLETED|As Randomized||62
8132729|NCT02786537|20046969|P1|NOT COMPLETED|As Randomized||6
8132730|NCT02786537|20046964|P6|COMPLETED|As Randomized||41
8132731|NCT02786537|20046965|P5|COMPLETED|As Randomized||87
8132732|NCT02786537|20046966|P4|COMPLETED|As Randomized||378
8132733|NCT02786537|20046967|P3|COMPLETED|As Randomized||15
8132734|NCT02786537|20046968|P2|COMPLETED|As Randomized||582
8132735|NCT02786537|20046969|P1|COMPLETED|As Randomized||50
8132736|NCT02786537|20046964|P6|STARTED|As Randomized||48
8132737|NCT02786537|20046965|P5|STARTED|As Randomized||99
8132738|NCT02786537|20046966|P4|STARTED|As Randomized||413
8132739|NCT02786537|20046967|P3|STARTED|As Randomized||15
8132740|NCT02786537|20046968|P2|STARTED|As Randomized||644
8132741|NCT02786537|20046969|P1|STARTED|As Randomized||56
8132742|NCT02786355|20047017|P1|NOT COMPLETED|Overall Study||0
8132743|NCT02786355|20047017|P1|COMPLETED|Overall Study||35
8132744|NCT02786355|20047017|P1|STARTED|Overall Study||35
8132745|NCT02786134|20047026|P2|NOT COMPLETED|Overall Study||0
8132746|NCT02786134|20047027|P1|NOT COMPLETED|Overall Study||0
8132747|NCT02786134|20047026|P2|COMPLETED|Overall Study||25
8132748|NCT02786134|20047027|P1|COMPLETED|Overall Study||25
8132749|NCT02786134|20047026|P2|STARTED|Overall Study||25
8132750|NCT02786134|20047027|P1|STARTED|Overall Study||25
8132751|NCT02786004|20047035|P2|NOT COMPLETED|Overall Study||1
8132752|NCT02786004|20047036|P1|NOT COMPLETED|Overall Study||0
8132753|NCT02786004|20047035|P2|COMPLETED|Overall Study||9
8132754|NCT02786004|20047036|P1|COMPLETED|Overall Study||14
8132755|NCT02786004|20047035|P2|STARTED|Overall Study||10
8132756|NCT02786004|20047036|P1|STARTED|Overall Study||14
8132757|NCT02785913|20047044|P1|NOT COMPLETED|Overall Study||26
8132758|NCT02785913|20047044|P1|COMPLETED|Overall Study||0
8132759|NCT02785913|20047044|P1|STARTED|Overall Study||26
8132760|NCT02785900|20047055|P2|NOT COMPLETED|Overall Study||123
8132761|NCT02785900|20047056|P1|NOT COMPLETED|Overall Study||117
8132762|NCT02785900|20047055|P2|COMPLETED|Overall Study||0
8132763|NCT02785900|20047056|P1|COMPLETED|Overall Study||0
8132764|NCT02785900|20047055|P2|STARTED|Overall Study||123
8132765|NCT02785900|20047056|P1|STARTED|Overall Study||117
8132766|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132767|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132768|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132769|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132770|NCT02785770|20047080|P4|COMPLETED|Intervention Period 4 (1 Day)||10
8132771|NCT02785770|20047081|P3|COMPLETED|Intervention Period 4 (1 Day)||10
8132772|NCT02785770|20047082|P2|COMPLETED|Intervention Period 4 (1 Day)||10
8132773|NCT02785770|20047083|P1|COMPLETED|Intervention Period 4 (1 Day)||11
8132774|NCT02785770|20047080|P4|STARTED|Intervention Period 4 (1 Day)||10
8132775|NCT02785770|20047081|P3|STARTED|Intervention Period 4 (1 Day)||10
8132776|NCT02785770|20047082|P2|STARTED|Intervention Period 4 (1 Day)||10
8132777|NCT02785770|20047083|P1|STARTED|Intervention Period 4 (1 Day)||11
8132778|NCT02785770|20047080|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132779|NCT02785770|20047081|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132780|NCT02785770|20047082|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132781|NCT02785770|20047083|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132782|NCT02785770|20047080|P4|COMPLETED|Washout Period 3 (7 Days)||10
8132783|NCT02785770|20047081|P3|COMPLETED|Washout Period 3 (7 Days)||10
8132784|NCT02785770|20047082|P2|COMPLETED|Washout Period 3 (7 Days)||10
8132785|NCT02785770|20047083|P1|COMPLETED|Washout Period 3 (7 Days)||11
8132786|NCT02785770|20047080|P4|STARTED|Washout Period 3 (7 Days)||10
8132787|NCT02785770|20047081|P3|STARTED|Washout Period 3 (7 Days)||10
8132788|NCT02785770|20047082|P2|STARTED|Washout Period 3 (7 Days)||10
8132789|NCT02785770|20047083|P1|STARTED|Washout Period 3 (7 Days)||11
8132790|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
8132791|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8132792|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8132793|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8132794|NCT02785770|20047080|P4|COMPLETED|Intervention Period 3 (1 Day)||10
8132795|NCT02785770|20047081|P3|COMPLETED|Intervention Period 3 (1 Day)||10
8132796|NCT02785770|20047082|P2|COMPLETED|Intervention Period 3 (1 Day)||10
8132797|NCT02785770|20047083|P1|COMPLETED|Intervention Period 3 (1 Day)||11
8132798|NCT02785770|20047080|P4|STARTED|Intervention Period 3 (1 Day)||11
8132799|NCT02785770|20047081|P3|STARTED|Intervention Period 3 (1 Day)||10
8132800|NCT02785770|20047082|P2|STARTED|Intervention Period 3 (1 Day)||10
8132801|NCT02785770|20047083|P1|STARTED|Intervention Period 3 (1 Day)||11
8132802|NCT02785770|20047080|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132803|NCT02785770|20047081|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132804|NCT02785770|20047082|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132805|NCT02785770|20047083|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132806|NCT02785770|20047080|P4|COMPLETED|Washout Period 2 (7 Days)||11
8132807|NCT02785770|20047081|P3|COMPLETED|Washout Period 2 (7 Days)||10
8132808|NCT02785770|20047082|P2|COMPLETED|Washout Period 2 (7 Days)||10
8132809|NCT02785770|20047083|P1|COMPLETED|Washout Period 2 (7 Days)||11
8132810|NCT02785770|20047080|P4|STARTED|Washout Period 2 (7 Days)||11
8132811|NCT02785770|20047081|P3|STARTED|Washout Period 2 (7 Days)||10
8132812|NCT02785770|20047082|P2|STARTED|Washout Period 2 (7 Days)||10
8132813|NCT02785770|20047083|P1|STARTED|Washout Period 2 (7 Days)||11
8132814|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8132815|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
8132816|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
8132817|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8132818|NCT02785770|20047080|P4|COMPLETED|Intervention Period 2 (1 Day)||11
8132819|NCT02785770|20047081|P3|COMPLETED|Intervention Period 2 (1 Day)||10
8132820|NCT02785770|20047082|P2|COMPLETED|Intervention Period 2 (1 Day)||10
8132821|NCT02785770|20047083|P1|COMPLETED|Intervention Period 2 (1 Day)||11
8132822|NCT02785770|20047080|P4|STARTED|Intervention Period 2 (1 Day)||11
8132823|NCT02785770|20047081|P3|STARTED|Intervention Period 2 (1 Day)||11
8132824|NCT02785770|20047082|P2|STARTED|Intervention Period 2 (1 Day)||11
8132825|NCT02785770|20047083|P1|STARTED|Intervention Period 2 (1 Day)||11
8132826|NCT02785770|20047080|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132827|NCT02785770|20047081|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132828|NCT02785770|20047082|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132829|NCT02785770|20047083|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132830|NCT02785770|20047080|P4|COMPLETED|Washout Period 1 (7 Days)||11
8132831|NCT02785770|20047081|P3|COMPLETED|Washout Period 1 (7 Days)||11
8132832|NCT02785770|20047082|P2|COMPLETED|Washout Period 1 (7 Days)||11
8132833|NCT02785770|20047083|P1|COMPLETED|Washout Period 1 (7 Days)||11
8132834|NCT02785770|20047080|P4|STARTED|Washout Period 1 (7 Days)||11
8132835|NCT02785770|20047081|P3|STARTED|Washout Period 1 (7 Days)||11
8132836|NCT02785770|20047082|P2|STARTED|Washout Period 1 (7 Days)||11
8132837|NCT02785770|20047083|P1|STARTED|Washout Period 1 (7 Days)||11
8132838|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132839|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132840|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132841|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132842|NCT02785770|20047080|P4|COMPLETED|Intervention Period 1 (1 Day)||11
8132843|NCT02785770|20047081|P3|COMPLETED|Intervention Period 1 (1 Day)||11
8132844|NCT02785770|20047082|P2|COMPLETED|Intervention Period 1 (1 Day)||11
8132845|NCT02785770|20047083|P1|COMPLETED|Intervention Period 1 (1 Day)||11
8132846|NCT02785770|20047080|P4|STARTED|Intervention Period 1 (1 Day)||11
8132847|NCT02785770|20047081|P3|STARTED|Intervention Period 1 (1 Day)||11
8132848|NCT02785770|20047082|P2|STARTED|Intervention Period 1 (1 Day)||11
8132849|NCT02785770|20047083|P1|STARTED|Intervention Period 1 (1 Day)||11
8132850|NCT02785588|20047150|P1|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
8132851|NCT02785588|20047150|P1|COMPLETED|Phase2 Controlled Image &Data Collection||5
8132852|NCT02785588|20047150|P1|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
8132853|NCT02785588|20047150|P1|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
8132854|NCT02785588|20047150|P1|COMPLETED|Phase 1: Initial Feasibility Assessment||47
8132855|NCT02785588|20047150|P1|STARTED|Phase 1: Initial Feasibility Assessment||49
8132856|NCT02785458|20047166|P2|NOT COMPLETED|3 Months||111
8132857|NCT02785458|20047167|P1|NOT COMPLETED|3 Months||128
8132858|NCT02785458|20047166|P2|COMPLETED|3 Months||293
8132859|NCT02785458|20047167|P1|COMPLETED|3 Months||315
8132860|NCT02785458|20047166|P2|STARTED|3 Months||404
8132861|NCT02785458|20047167|P1|STARTED|3 Months||443
8132862|NCT02785458|20047166|P2|NOT COMPLETED|1 Month||75
8132863|NCT02785458|20047167|P1|NOT COMPLETED|1 Month||83
8132864|NCT02785458|20047166|P2|COMPLETED|1 Month||404
8132865|NCT02785458|20047167|P1|COMPLETED|1 Month||443
8132866|NCT02785458|20047166|P2|STARTED|1 Month||479
8132867|NCT02785458|20047167|P1|STARTED|1 Month||526
8132868|NCT02785458|20047166|P2|NOT COMPLETED|Baseline||0
8132869|NCT02785458|20047167|P1|NOT COMPLETED|Baseline||0
8132870|NCT02785458|20047166|P2|COMPLETED|Baseline||479
8132871|NCT02785458|20047167|P1|COMPLETED|Baseline||526
8132872|NCT02785458|20047166|P2|STARTED|Baseline||479
8132873|NCT02785458|20047167|P1|STARTED|Baseline||526
8132874|NCT02785432|20047177|P2|NOT COMPLETED|Overall Study||0
8132875|NCT02785432|20047178|P1|NOT COMPLETED|Overall Study||0
8132876|NCT02785432|20047177|P2|COMPLETED|Overall Study||7
8132877|NCT02785432|20047178|P1|COMPLETED|Overall Study||4
8132878|NCT02785432|20047177|P2|STARTED|Overall Study||7
8132879|NCT02785432|20047178|P1|STARTED|Overall Study||4
8132880|NCT02785406|20047192|P2|NOT COMPLETED|Overall Study||0
8132881|NCT02785406|20047193|P1|NOT COMPLETED|Overall Study||0
8132882|NCT02785406|20047192|P2|COMPLETED|Overall Study||10
8132883|NCT02785406|20047193|P1|COMPLETED|Overall Study||10
8132884|NCT02785406|20047192|P2|Completed Second Week|Overall Study||10
8132885|NCT02785406|20047193|P1|Completed Second Week|Overall Study||10
8132886|NCT02785406|20047192|P2|Completed First Week|Overall Study||10
8132887|NCT02785406|20047193|P1|Completed First Week|Overall Study||10
8132888|NCT02785406|20047192|P2|STARTED|Overall Study||10
8132889|NCT02785406|20047193|P1|STARTED|Overall Study||10
8132890|NCT02785354|20047268|P3|NOT COMPLETED|Overall Study||0
8132891|NCT02785354|20047269|P2|NOT COMPLETED|Overall Study||0
8132892|NCT02785354|20047270|P1|NOT COMPLETED|Overall Study||0
8132893|NCT02785354|20047268|P3|COMPLETED|Overall Study||44653
8132894|NCT02785354|20047269|P2|COMPLETED|Overall Study||31388
8132895|NCT02785354|20047270|P1|COMPLETED|Overall Study||27060
8132896|NCT02785354|20047268|P3|STARTED|Overall Study||44653
8132897|NCT02785354|20047269|P2|STARTED|Overall Study||31388
8132898|NCT02785354|20047270|P1|STARTED|Overall Study||27060
8132899|NCT02785185|20047303|P4|NOT COMPLETED|Overall Study||0
8132900|NCT02785185|20047304|P3|NOT COMPLETED|Overall Study||2
8132901|NCT02785185|20047305|P2|NOT COMPLETED|Overall Study||1
8132902|NCT02785185|20047306|P1|NOT COMPLETED|Overall Study||1
8132903|NCT02785185|20047303|P4|COMPLETED|Overall Study||16
8132904|NCT02785185|20047304|P3|COMPLETED|Overall Study||15
8132905|NCT02785185|20047305|P2|COMPLETED|Overall Study||56
8132906|NCT02785185|20047306|P1|COMPLETED|Overall Study||59
8132907|NCT02785185|20047303|P4|STARTED|Overall Study||16
8132908|NCT02785185|20047304|P3|STARTED|Overall Study||17
8132909|NCT02785185|20047305|P2|STARTED|Overall Study||57
8132910|NCT02785185|20047306|P1|STARTED|Overall Study||60
8132911|NCT02785172|20047320|P4|NOT COMPLETED|Overall Study||0
8132912|NCT02785172|20047321|P3|NOT COMPLETED|Overall Study||1
8132913|NCT02785172|20047322|P2|NOT COMPLETED|Overall Study||1
8132914|NCT02785172|20047323|P1|NOT COMPLETED|Overall Study||0
8132915|NCT02785172|20047320|P4|COMPLETED|Overall Study||14
8132916|NCT02785172|20047321|P3|COMPLETED|Overall Study||15
8132917|NCT02785172|20047322|P2|COMPLETED|Overall Study||62
8132918|NCT02785172|20047323|P1|COMPLETED|Overall Study||61
8132919|NCT02785172|20047320|P4|STARTED|Overall Study||14
8132920|NCT02785172|20047321|P3|STARTED|Overall Study||16
8132921|NCT02785172|20047322|P2|STARTED|Overall Study||63
8132922|NCT02785172|20047323|P1|STARTED|Overall Study||61
8132923|NCT02785159|20047337|P4|NOT COMPLETED|Overall Study||3
8132924|NCT02785159|20047338|P3|NOT COMPLETED|Overall Study||3
8132925|NCT02785159|20047339|P2|NOT COMPLETED|Overall Study||13
8132926|NCT02785159|20047340|P1|NOT COMPLETED|Overall Study||11
8132927|NCT02785159|20047337|P4|COMPLETED|Overall Study||14
8132928|NCT02785159|20047338|P3|COMPLETED|Overall Study||12
8132929|NCT02785159|20047339|P2|COMPLETED|Overall Study||45
8132930|NCT02785159|20047340|P1|COMPLETED|Overall Study||51
8132931|NCT02785159|20047337|P4|STARTED|Overall Study||17
8132932|NCT02785159|20047338|P3|STARTED|Overall Study||15
8132933|NCT02785159|20047339|P2|STARTED|Overall Study||58
8132934|NCT02785159|20047340|P1|STARTED|Overall Study||62
8132935|NCT02784925|20047350|P1|NOT COMPLETED|Overall Study||0
8132936|NCT02784925|20047350|P1|COMPLETED|Overall Study||30
8132937|NCT02784925|20047350|P1|STARTED|Overall Study||30
8132938|NCT02784834|20047354|P1|NOT COMPLETED|Overall Study||1
8132939|NCT02784834|20047354|P1|COMPLETED|Overall Study||1
8132940|NCT02784834|20047354|P1|STARTED|Overall Study||2
8132941|NCT02784704|20047360|P2|NOT COMPLETED|Overall Study||9
8132942|NCT02784704|20047361|P1|NOT COMPLETED|Overall Study||13
8132943|NCT02784704|20047360|P2|COMPLETED|Overall Study||241
8132944|NCT02784704|20047361|P1|COMPLETED|Overall Study||237
8132945|NCT02784704|20047360|P2|Treated|Overall Study||249
8132946|NCT02784704|20047361|P1|Treated|Overall Study||250
8132947|NCT02784704|20047360|P2|STARTED|Overall Study||250
8132948|NCT02784704|20047361|P1|STARTED|Overall Study||250
8132949|NCT02784613|20047371|P1|NOT COMPLETED|Overall Study||2
8132950|NCT02784613|20047371|P1|COMPLETED|Overall Study||8
8132951|NCT02784613|20047371|P1|STARTED|Overall Study||10
8132952|NCT02784587|20047377|P1|NOT COMPLETED|Overall Study||0
8132953|NCT02784587|20047377|P1|COMPLETED|Overall Study||25
8132954|NCT02784587|20047377|P1|STARTED|Overall Study||25
8132955|NCT02784548|20047381|P1|NOT COMPLETED|Overall Study||0
8132956|NCT02784548|20047381|P1|COMPLETED|Overall Study||15
8132957|NCT02784548|20047381|P1|STARTED|Overall Study||15
8132958|NCT02784444|20047390|P4|NOT COMPLETED|Overall Study||13
8132959|NCT02784444|20047391|P3|NOT COMPLETED|Overall Study||12
8132960|NCT02784444|20047392|P2|NOT COMPLETED|Overall Study||9
8132961|NCT02784444|20047393|P1|NOT COMPLETED|Overall Study||16
8132962|NCT02784444|20047390|P4|COMPLETED|Overall Study||88
8132963|NCT02784444|20047391|P3|COMPLETED|Overall Study||86
8132964|NCT02784444|20047392|P2|COMPLETED|Overall Study||90
8132965|NCT02784444|20047393|P1|COMPLETED|Overall Study||78
8132966|NCT02784444|20047390|P4|STARTED|Overall Study||101
8132967|NCT02784444|20047391|P3|STARTED|Overall Study||98
8132968|NCT02784444|20047392|P2|STARTED|Overall Study||99
8132969|NCT02784444|20047393|P1|STARTED|Overall Study||94
8132970|NCT02784275|20047435|P4|NOT COMPLETED|Overall Study||1
8132971|NCT02784275|20047436|P3|NOT COMPLETED|Overall Study||1
8132972|NCT02784275|20047437|P2|NOT COMPLETED|Overall Study||0
8132973|NCT02784275|20047438|P1|NOT COMPLETED|Overall Study||1
8132974|NCT02784275|20047435|P4|COMPLETED|Overall Study||14
8132975|NCT02784275|20047436|P3|COMPLETED|Overall Study||16
8132976|NCT02784275|20047437|P2|COMPLETED|Overall Study||16
8132977|NCT02784275|20047438|P1|COMPLETED|Overall Study||15
8132978|NCT02784275|20047435|P4|STARTED|Overall Study||15
8132979|NCT02784275|20047436|P3|STARTED|Overall Study||17
8132980|NCT02784275|20047437|P2|STARTED|Overall Study||16
8132981|NCT02784275|20047438|P1|STARTED|Overall Study||16
8132982|NCT02784106|20047482|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
8132983|NCT02784106|20047483|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
8132984|NCT02784106|20047484|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132985|NCT02784106|20047485|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132986|NCT02784106|20047482|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
8132987|NCT02784106|20047483|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
8132988|NCT02784106|20047484|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132989|NCT02784106|20047485|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132990|NCT02784106|20047482|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
8132991|NCT02784106|20047483|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
8132992|NCT02784106|20047484|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
8132993|NCT02784106|20047485|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
8132994|NCT02784106|20047482|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8132995|NCT02784106|20047483|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8132996|NCT02784106|20047484|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
8132997|NCT02784106|20047485|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
8132998|NCT02784106|20047482|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8132999|NCT02784106|20047483|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8133000|NCT02784106|20047484|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
8133001|NCT02784106|20047485|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
8133002|NCT02784106|20047482|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
8133003|NCT02784106|20047483|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
8133004|NCT02784106|20047484|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
8133005|NCT02784106|20047485|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
8133006|NCT02783898|20047548|P2|NOT COMPLETED|Overall Study||1
8133007|NCT02783898|20047549|P1|NOT COMPLETED|Overall Study||1
8133008|NCT02783898|20047548|P2|COMPLETED|Overall Study||116
8133009|NCT02783898|20047549|P1|COMPLETED|Overall Study||124
8133010|NCT02783898|20047548|P2|STARTED|Overall Study||117
8133011|NCT02783898|20047549|P1|STARTED|Overall Study||125
8133012|NCT02783820|20047573|P4|NOT COMPLETED|Overall Study||0
8133013|NCT02783820|20047574|P3|NOT COMPLETED|Overall Study||0
8133014|NCT02783820|20047575|P2|NOT COMPLETED|Overall Study||0
8133015|NCT02783820|20047576|P1|NOT COMPLETED|Overall Study||0
8133016|NCT02783820|20047573|P4|COMPLETED|Overall Study||6
8133017|NCT02783820|20047574|P3|COMPLETED|Overall Study||6
8133018|NCT02783820|20047575|P2|COMPLETED|Overall Study||6
8133019|NCT02783820|20047576|P1|COMPLETED|Overall Study||6
8133020|NCT02783820|20047573|P4|STARTED|Overall Study||6
8133021|NCT02783820|20047574|P3|STARTED|Overall Study||6
8133022|NCT02783820|20047575|P2|STARTED|Overall Study||6
8133023|NCT02783820|20047576|P1|STARTED|Overall Study||6
8133024|NCT02783768|20047586|P2|NOT COMPLETED|Overall Study||0
8133025|NCT02783768|20047587|P1|NOT COMPLETED|Overall Study||1
8133026|NCT02783768|20047586|P2|COMPLETED|Overall Study||5
8133027|NCT02783768|20047587|P1|COMPLETED|Overall Study||5
8133028|NCT02783768|20047586|P2|STARTED|Overall Study||5
8133029|NCT02783768|20047587|P1|STARTED|Overall Study||6
8133030|NCT02783729|20047609|P4|NOT COMPLETED|Overall Study||9
8133031|NCT02783729|20047610|P3|NOT COMPLETED|Overall Study||8
8133032|NCT02783729|20047611|P2|NOT COMPLETED|Overall Study||17
8133033|NCT02783729|20047612|P1|NOT COMPLETED|Overall Study||10
8133034|NCT02783729|20047609|P4|COMPLETED|Overall Study||260
8133035|NCT02783729|20047610|P3|COMPLETED|Overall Study||258
8133036|NCT02783729|20047611|P2|COMPLETED|Overall Study||246
8133037|NCT02783729|20047612|P1|COMPLETED|Overall Study||198
8133038|NCT02783729|20047609|P4|STARTED|Overall Study||269
8133039|NCT02783729|20047610|P3|STARTED|Overall Study||266
8133040|NCT02783729|20047611|P2|STARTED|Overall Study||263
8133041|NCT02783729|20047612|P1|STARTED|Overall Study||208
8133042|NCT02783599|20047678|P1|NOT COMPLETED|Overall Study||40
8133043|NCT02783599|20047678|P1|COMPLETED|Overall Study||11
8133044|NCT02783599|20047678|P1|Received At Least One Dose of Study Drug|Overall Study||51
8133045|NCT02783599|20047678|P1|STARTED|Overall Study||51
8133046|NCT02783573|20047694|P3|NOT COMPLETED|Delayed-Start Period||12
8133047|NCT02783573|20047695|P2|NOT COMPLETED|Delayed-Start Period||17
8133048|NCT02783573|20047696|P1|NOT COMPLETED|Delayed-Start Period||0
8133049|NCT02783573|20047694|P3|COMPLETED|Delayed-Start Period||0
8133050|NCT02783573|20047695|P2|COMPLETED|Delayed-Start Period||0
8133051|NCT02783573|20047696|P1|COMPLETED|Delayed-Start Period||0
8133052|NCT02783573|20047694|P3|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
8133053|NCT02783573|20047695|P2|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
8133054|NCT02783573|20047696|P1|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
8133055|NCT02783573|20047694|P3|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
8133056|NCT02783573|20047695|P2|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
8133057|NCT02783573|20047696|P1|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
8133058|NCT02783573|20047694|P3|NOT COMPLETED|Placebo-Controlled Treatment Period||548
8133059|NCT02783573|20047695|P2|NOT COMPLETED|Placebo-Controlled Treatment Period||562
8133060|NCT02783573|20047696|P1|NOT COMPLETED|Placebo-Controlled Treatment Period||536
8133061|NCT02783573|20047694|P3|COMPLETED|Placebo-Controlled Treatment Period||22
8133062|NCT02783573|20047695|P2|COMPLETED|Placebo-Controlled Treatment Period||28
8133063|NCT02783573|20047696|P1|COMPLETED|Placebo-Controlled Treatment Period||26
8133064|NCT02783573|20047694|P3|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
8133065|NCT02783573|20047695|P2|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
8133066|NCT02783573|20047696|P1|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
8133067|NCT02783573|20047694|P3|STARTED|Placebo-Controlled Treatment Period||570
8133068|NCT02783573|20047695|P2|STARTED|Placebo-Controlled Treatment Period||590
8133069|NCT02783573|20047696|P1|STARTED|Placebo-Controlled Treatment Period||562
8133070|NCT02783443|20047752|P2|NOT COMPLETED|Overall Study||0
8133071|NCT02783443|20047753|P1|NOT COMPLETED|Overall Study||0
8133072|NCT02783443|20047752|P2|COMPLETED|Overall Study||30
8133073|NCT02783443|20047753|P1|COMPLETED|Overall Study||30
8133074|NCT02783443|20047752|P2|STARTED|Overall Study||30
8133075|NCT02783443|20047753|P1|STARTED|Overall Study||30
8133076|NCT02783170|20047761|P2|NOT COMPLETED|Overall Study||0
8133077|NCT02783170|20047762|P1|NOT COMPLETED|Overall Study||1
8133078|NCT02783170|20047761|P2|COMPLETED|Overall Study||38
8133079|NCT02783170|20047762|P1|COMPLETED|Overall Study||42
8133080|NCT02783170|20047761|P2|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
8133081|NCT02783170|20047762|P1|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
8133082|NCT02783170|20047761|P2|STARTED|Overall Study||38
8133083|NCT02783170|20047762|P1|STARTED|Overall Study||43
8133084|NCT02783066|20047803|P1|NOT COMPLETED|Overall Study||13
8133085|NCT02783066|20047803|P1|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
8133086|NCT02783066|20047803|P1|STARTED|Overall Study||16
8133087|NCT02783027|20047819|P2|NOT COMPLETED|Overall Study||17
8133088|NCT02783027|20047820|P1|NOT COMPLETED|Overall Study||23
8133089|NCT02783027|20047819|P2|COMPLETED|Overall Study||27
8133090|NCT02783027|20047820|P1|COMPLETED|Overall Study||16
8133091|NCT02783027|20047819|P2|STARTED|Overall Study||44
8133092|NCT02783027|20047820|P1|STARTED|Overall Study||39
8133093|NCT02782923|20047834|P1|NOT COMPLETED|Overall Study||15
8133094|NCT02782923|20047834|P1|COMPLETED|Overall Study||4
8133095|NCT02782923|20047834|P1|STARTED|Overall Study||19
8133102|NCT02782676|20047871|P2|NOT COMPLETED|Overall Study||1
8133103|NCT02782676|20047872|P1|NOT COMPLETED|Overall Study||0
8133104|NCT02782676|20047871|P2|COMPLETED|Overall Study||209
8133105|NCT02782676|20047872|P1|COMPLETED|Overall Study||211
8133106|NCT02782676|20047871|P2|STARTED|Overall Study||210
8133107|NCT02782676|20047872|P1|STARTED|Overall Study||211
8133108|NCT02782377|20047900|P1|NOT COMPLETED|Overall Study||5
8133109|NCT02782377|20047900|P1|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
8133110|NCT02782377|20047900|P1|STARTED|Overall Study||40
8133111|NCT02782364|20047913|P2|NOT COMPLETED|Overall Study||0
8133112|NCT02782364|20047914|P1|NOT COMPLETED|Overall Study||0
8133113|NCT02782364|20047913|P2|COMPLETED|Overall Study||18
8133114|NCT02782364|20047914|P1|COMPLETED|Overall Study||18
8133115|NCT02782364|20047913|P2|STARTED|Overall Study||18
8133116|NCT02782364|20047914|P1|STARTED|Overall Study||18
8133117|NCT02782325|20047935|P3|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
8133118|NCT02782325|20047936|P2|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133119|NCT02782325|20047937|P1|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133120|NCT02782325|20047935|P3|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
8133121|NCT02782325|20047936|P2|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133122|NCT02782325|20047937|P1|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133123|NCT02782325|20047935|P3|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
8133124|NCT02782325|20047936|P2|STARTED|Open Label FMT Period (up to 24 Weeks)||0
8133125|NCT02782325|20047937|P1|STARTED|Open Label FMT Period (up to 24 Weeks)||0
8133126|NCT02782325|20047935|P3|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133127|NCT02782325|20047936|P2|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
8133128|NCT02782325|20047937|P1|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
8133129|NCT02782325|20047935|P3|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133130|NCT02782325|20047936|P2|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133131|NCT02782325|20047937|P1|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133132|NCT02782325|20047935|P3|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
8133133|NCT02782325|20047936|P2|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
8133134|NCT02782325|20047937|P1|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
8133135|NCT02782169|20047965|P2|NOT COMPLETED|Overall Study||2
8133136|NCT02782169|20047966|P1|NOT COMPLETED|Overall Study||1
8133137|NCT02782169|20047965|P2|COMPLETED|Overall Study||52
8133138|NCT02782169|20047966|P1|COMPLETED|Overall Study||55
8133139|NCT02782169|20047965|P2|STARTED|Overall Study||54
8133140|NCT02782169|20047966|P1|STARTED|Overall Study||56
8133141|NCT02781844|20047984|P8|NOT COMPLETED|Treatment Period 2||0
8133142|NCT02781844|20047985|P7|NOT COMPLETED|Treatment Period 2||0
8133143|NCT02781844|20047986|P6|NOT COMPLETED|Treatment Period 2||0
8133144|NCT02781844|20047987|P5|NOT COMPLETED|Treatment Period 2||0
8133145|NCT02781844|20047988|P4|NOT COMPLETED|Treatment Period 2||0
8133146|NCT02781844|20047989|P3|NOT COMPLETED|Treatment Period 2||0
8133147|NCT02781844|20047990|P2|NOT COMPLETED|Treatment Period 2||0
8133148|NCT02781844|20047991|P1|NOT COMPLETED|Treatment Period 2||0
8133149|NCT02781844|20047984|P8|COMPLETED|Treatment Period 2||4
8133150|NCT02781844|20047985|P7|COMPLETED|Treatment Period 2||4
8133151|NCT02781844|20047986|P6|COMPLETED|Treatment Period 2||4
8133152|NCT02781844|20047987|P5|COMPLETED|Treatment Period 2||4
8133153|NCT02781844|20047988|P4|COMPLETED|Treatment Period 2||4
8133154|NCT02781844|20047989|P3|COMPLETED|Treatment Period 2||4
8133155|NCT02781844|20047990|P2|COMPLETED|Treatment Period 2||4
8133156|NCT02781844|20047991|P1|COMPLETED|Treatment Period 2||5
8133157|NCT02781844|20047984|P8|STARTED|Treatment Period 2||4
8133158|NCT02781844|20047985|P7|STARTED|Treatment Period 2||4
8133159|NCT02781844|20047986|P6|STARTED|Treatment Period 2||4
8133160|NCT02781844|20047987|P5|STARTED|Treatment Period 2||4
8133161|NCT02781844|20047988|P4|STARTED|Treatment Period 2||4
8133162|NCT02781844|20047989|P3|STARTED|Treatment Period 2||4
8133163|NCT02781844|20047990|P2|STARTED|Treatment Period 2||4
8133164|NCT02781844|20047991|P1|STARTED|Treatment Period 2||5
8133165|NCT02781844|20047984|P8|NOT COMPLETED|Treatment Period 1||0
8133166|NCT02781844|20047985|P7|NOT COMPLETED|Treatment Period 1||0
8133167|NCT02781844|20047986|P6|NOT COMPLETED|Treatment Period 1||1
8133168|NCT02781844|20047987|P5|NOT COMPLETED|Treatment Period 1||0
8133169|NCT02781844|20047988|P4|NOT COMPLETED|Treatment Period 1||0
8133170|NCT02781844|20047989|P3|NOT COMPLETED|Treatment Period 1||0
8133171|NCT02781844|20047990|P2|NOT COMPLETED|Treatment Period 1||0
8133172|NCT02781844|20047991|P1|NOT COMPLETED|Treatment Period 1||0
8133173|NCT02781844|20047984|P8|COMPLETED|Treatment Period 1||4
8133174|NCT02781844|20047985|P7|COMPLETED|Treatment Period 1||4
8133175|NCT02781844|20047986|P6|COMPLETED|Treatment Period 1||4
8133176|NCT02781844|20047987|P5|COMPLETED|Treatment Period 1||4
8133177|NCT02781844|20047988|P4|COMPLETED|Treatment Period 1||4
8133178|NCT02781844|20047989|P3|COMPLETED|Treatment Period 1||4
8133179|NCT02781844|20047990|P2|COMPLETED|Treatment Period 1||4
8133180|NCT02781844|20047991|P1|COMPLETED|Treatment Period 1||5
8133181|NCT02781844|20047984|P8|STARTED|Treatment Period 1||4
8133182|NCT02781844|20047985|P7|STARTED|Treatment Period 1||4
8133183|NCT02781844|20047986|P6|STARTED|Treatment Period 1||5
8133184|NCT02781844|20047987|P5|STARTED|Treatment Period 1||4
8133185|NCT02781844|20047988|P4|STARTED|Treatment Period 1||4
8133186|NCT02781844|20047989|P3|STARTED|Treatment Period 1||4
8133187|NCT02781844|20047990|P2|STARTED|Treatment Period 1||4
8133188|NCT02781844|20047991|P1|STARTED|Treatment Period 1||5
8133189|NCT02781818|20048124|P3|NOT COMPLETED|Overall Study||1
8133190|NCT02781818|20048125|P2|NOT COMPLETED|Overall Study||2
8133191|NCT02781818|20048126|P1|NOT COMPLETED|Overall Study||4
8133192|NCT02781818|20048124|P3|COMPLETED|Overall Study||16
8133193|NCT02781818|20048125|P2|COMPLETED|Overall Study||16
8133194|NCT02781818|20048126|P1|COMPLETED|Overall Study||16
8133195|NCT02781818|20048124|P3|STARTED|Overall Study||17
8133196|NCT02781818|20048125|P2|STARTED|Overall Study||18
8133197|NCT02781818|20048126|P1|STARTED|Overall Study||20
8133198|NCT02781649|20048143|P3|NOT COMPLETED|Overall Study||0
8133199|NCT02781649|20048144|P2|NOT COMPLETED|Overall Study||0
8133200|NCT02781649|20048145|P1|NOT COMPLETED|Overall Study||0
8133201|NCT02781649|20048143|P3|COMPLETED|Overall Study||3
8133202|NCT02781649|20048144|P2|COMPLETED|Overall Study||0
8133203|NCT02781649|20048145|P1|COMPLETED|Overall Study||7
8133204|NCT02781649|20048143|P3|STARTED|Overall Study||3
8133205|NCT02781649|20048144|P2|STARTED|Overall Study||0
8133206|NCT02781649|20048145|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
8133207|NCT02781571|20048171|P1|NOT COMPLETED|Overall Study||0
8133208|NCT02781571|20048171|P1|COMPLETED|Overall Study||79
8133209|NCT02781571|20048171|P1|STARTED|Overall Study||79
8133210|NCT02781558|20048192|P2|NOT COMPLETED|Overall Study||2
8133211|NCT02781558|20048193|P1|NOT COMPLETED|Overall Study||3
8133212|NCT02781558|20048192|P2|COMPLETED|Overall Study||101
8133213|NCT02781558|20048193|P1|COMPLETED|Overall Study||98
8133214|NCT02781558|20048192|P2|STARTED|Overall Study||103
8133215|NCT02781558|20048193|P1|STARTED|Overall Study||101
8133216|NCT02781454|20048232|P3|NOT COMPLETED|Overall Study||1
8133217|NCT02781454|20048233|P2|NOT COMPLETED|Overall Study||0
8133218|NCT02781454|20048234|P1|NOT COMPLETED|Overall Study||0
8133219|NCT02781454|20048232|P3|COMPLETED|Overall Study||5
8133220|NCT02781454|20048233|P2|COMPLETED|Overall Study||6
8133221|NCT02781454|20048234|P1|COMPLETED|Overall Study||8
8133222|NCT02781454|20048232|P3|STARTED|Overall Study||6
8133223|NCT02781454|20048233|P2|STARTED|Overall Study||6
8133224|NCT02781454|20048234|P1|STARTED|Overall Study||8
8133225|NCT02781324|20048280|P2|NOT COMPLETED|Overall Study||2
8133226|NCT02781324|20048281|P1|NOT COMPLETED|Overall Study||2
8133227|NCT02781324|20048280|P2|COMPLETED|Overall Study||31
8133228|NCT02781324|20048281|P1|COMPLETED|Overall Study||31
8133229|NCT02781324|20048280|P2|STARTED|Overall Study||33
8133230|NCT02781324|20048281|P1|STARTED|Overall Study||33
8133231|NCT02781311|20048310|P3|NOT COMPLETED|Overall Study||4
8133232|NCT02781311|20048311|P2|NOT COMPLETED|Overall Study||26
8133233|NCT02781311|20048312|P1|NOT COMPLETED|Overall Study||26
8133234|NCT02781311|20048310|P3|COMPLETED|Overall Study||8
8133235|NCT02781311|20048311|P2|COMPLETED|Overall Study||57
8133236|NCT02781311|20048312|P1|COMPLETED|Overall Study||48
8133237|NCT02781311|20048310|P3|mITT Population|Overall Study||11
8133238|NCT02781311|20048311|P2|mITT Population|Overall Study||78
8133239|NCT02781311|20048312|P1|mITT Population|Overall Study||70
8133240|NCT02781311|20048310|P3|Safety Population (Treated)|Overall Study||12
8133241|NCT02781311|20048311|P2|Safety Population (Treated)|Overall Study||81
8133242|NCT02781311|20048312|P1|Safety Population (Treated)|Overall Study||73
8133243|NCT02781311|20048310|P3|STARTED|Overall Study||12
8133244|NCT02781311|20048311|P2|STARTED|Overall Study||83
8133245|NCT02781311|20048312|P1|STARTED|Overall Study||74
8133246|NCT02781051|20048321|P1|NOT COMPLETED|Overall Study||2
8133247|NCT02781051|20048321|P1|COMPLETED|Overall Study||14
8133248|NCT02781051|20048321|P1|STARTED|Overall Study||16
8133249|NCT02780869|20048328|P2|NOT COMPLETED|Overall Study||9
8133250|NCT02780869|20048329|P1|NOT COMPLETED|Overall Study||13
8133251|NCT02780869|20048328|P2|COMPLETED|Overall Study||74
8133252|NCT02780869|20048329|P1|COMPLETED|Overall Study||162
8133253|NCT02780869|20048328|P2|STARTED|Overall Study||83
8133254|NCT02780869|20048329|P1|STARTED|Overall Study||175
8133255|NCT02780856|20048339|P1|NOT COMPLETED|Overall Study||1
8133256|NCT02780856|20048339|P1|COMPLETED|Overall Study||109
8133257|NCT02780856|20048339|P1|STARTED|Overall Study||110
8133258|NCT02780765|20048349|P2|NOT COMPLETED|Overall Study||0
8133259|NCT02780765|20048350|P1|NOT COMPLETED|Overall Study||0
8133260|NCT02780765|20048349|P2|COMPLETED|Overall Study||30
8133261|NCT02780765|20048350|P1|COMPLETED|Overall Study||30
8133262|NCT02780765|20048349|P2|STARTED|Overall Study||30
8133263|NCT02780765|20048350|P1|STARTED|Overall Study||30
8133264|NCT02780700|20048358|P1|NOT COMPLETED|Overall Study||1
8133265|NCT02780700|20048358|P1|COMPLETED|Overall Study||0
8133266|NCT02780700|20048358|P1|STARTED|Overall Study||1
8133267|NCT02780687|20048368|P2|NOT COMPLETED|Overall Study||8
8133268|NCT02780687|20048369|P1|NOT COMPLETED|Overall Study||34
8133269|NCT02780687|20048368|P2|COMPLETED|Overall Study||0
8133270|NCT02780687|20048369|P1|COMPLETED|Overall Study||0
8133271|NCT02780687|20048368|P2|STARTED|Overall Study||8
8133272|NCT02780687|20048369|P1|STARTED|Overall Study||34
8133273|NCT02780661|20048380|P2|NOT COMPLETED|Period 2||0
8133274|NCT02780661|20048381|P1|NOT COMPLETED|Period 2||0
8133275|NCT02780661|20048380|P2|COMPLETED|Period 2||9
8133276|NCT02780661|20048381|P1|COMPLETED|Period 2||10
8133277|NCT02780661|20048380|P2|STARTED|Period 2||9
8133278|NCT02780661|20048381|P1|STARTED|Period 2||10
8133279|NCT02780661|20048380|P2|NOT COMPLETED|Wash Out Period||0
8133280|NCT02780661|20048381|P1|NOT COMPLETED|Wash Out Period||0
8133281|NCT02780661|20048380|P2|COMPLETED|Wash Out Period||9
8133282|NCT02780661|20048381|P1|COMPLETED|Wash Out Period||10
8133283|NCT02780661|20048380|P2|STARTED|Wash Out Period||9
8133284|NCT02780661|20048381|P1|STARTED|Wash Out Period||10
8133285|NCT02780661|20048380|P2|NOT COMPLETED|Period 1||0
8133286|NCT02780661|20048381|P1|NOT COMPLETED|Period 1||0
8133287|NCT02780661|20048380|P2|COMPLETED|Period 1||9
8133288|NCT02780661|20048381|P1|COMPLETED|Period 1||10
8133289|NCT02780661|20048380|P2|STARTED|Period 1||9
8133290|NCT02780661|20048381|P1|STARTED|Period 1||10
8133291|NCT02780622|20048397|P2|NOT COMPLETED|Treatment Period 2||0
8133292|NCT02780622|20048398|P1|NOT COMPLETED|Treatment Period 2||0
8133293|NCT02780622|20048397|P2|COMPLETED|Treatment Period 2||10
8133294|NCT02780622|20048398|P1|COMPLETED|Treatment Period 2||10
8133295|NCT02780622|20048397|P2|STARTED|Treatment Period 2||10
8133296|NCT02780622|20048398|P1|STARTED|Treatment Period 2||10
8133297|NCT02780622|20048397|P2|NOT COMPLETED|Treatment Period 1||0
8133298|NCT02780622|20048398|P1|NOT COMPLETED|Treatment Period 1||0
8133299|NCT02780622|20048397|P2|COMPLETED|Treatment Period 1||10
8133300|NCT02780622|20048398|P1|COMPLETED|Treatment Period 1||10
8133301|NCT02780622|20048397|P2|STARTED|Treatment Period 1||10
8133302|NCT02780622|20048398|P1|STARTED|Treatment Period 1||10
8133303|NCT02780388|20048441|P5|NOT COMPLETED|Overall Study||0
8133304|NCT02780388|20048442|P4|NOT COMPLETED|Overall Study||0
8133305|NCT02780388|20048443|P3|NOT COMPLETED|Overall Study||0
8133306|NCT02780388|20048444|P2|NOT COMPLETED|Overall Study||2
8133307|NCT02780388|20048445|P1|NOT COMPLETED|Overall Study||1
8133308|NCT02780388|20048441|P5|COMPLETED|Overall Study||12
8133309|NCT02780388|20048442|P4|COMPLETED|Overall Study||12
8133310|NCT02780388|20048443|P3|COMPLETED|Overall Study||10
8133311|NCT02780388|20048444|P2|COMPLETED|Overall Study||6
8133312|NCT02780388|20048445|P1|COMPLETED|Overall Study||14
8133313|NCT02780388|20048441|P5|STARTED|Overall Study||12
8133314|NCT02780388|20048442|P4|STARTED|Overall Study||12
8133315|NCT02780388|20048443|P3|STARTED|Overall Study||10
8133316|NCT02780388|20048444|P2|STARTED|Overall Study||8
8133317|NCT02780388|20048445|P1|STARTED|Overall Study||15
8133318|NCT02780349|20048502|P1|NOT COMPLETED|Overall Study||2
8133319|NCT02780349|20048502|P1|COMPLETED|Overall Study||101
8133320|NCT02780349|20048502|P1|STARTED|Overall Study||103
8133321|NCT02780167|20048511|P5|NOT COMPLETED|Overall Study||17
8133322|NCT02780167|20048512|P4|NOT COMPLETED|Overall Study||19
8133323|NCT02780167|20048513|P3|NOT COMPLETED|Overall Study||24
8133324|NCT02780167|20048514|P2|NOT COMPLETED|Overall Study||22
8133325|NCT02780167|20048515|P1|NOT COMPLETED|Overall Study||28
8133326|NCT02780167|20048511|P5|COMPLETED|Overall Study||38
8133327|NCT02780167|20048512|P4|COMPLETED|Overall Study||37
8133328|NCT02780167|20048513|P3|COMPLETED|Overall Study||27
8133329|NCT02780167|20048514|P2|COMPLETED|Overall Study||27
8133330|NCT02780167|20048515|P1|COMPLETED|Overall Study||28
8133331|NCT02780167|20048511|P5|STARTED|Overall Study||55
8133332|NCT02780167|20048512|P4|STARTED|Overall Study||56
8133333|NCT02780167|20048513|P3|STARTED|Overall Study||51
8133334|NCT02780167|20048514|P2|STARTED|Overall Study||49
8133335|NCT02780167|20048515|P1|STARTED|Overall Study||56
8133336|NCT02780115|20048652|P5|NOT COMPLETED|Overall Study||1
8133337|NCT02780115|20048653|P4|NOT COMPLETED|Overall Study||1
8133338|NCT02780115|20048654|P3|NOT COMPLETED|Overall Study||1
8133339|NCT02780115|20048655|P2|NOT COMPLETED|Overall Study||1
8133340|NCT02780115|20048656|P1|NOT COMPLETED|Overall Study||0
8133341|NCT02780115|20048652|P5|COMPLETED|Overall Study||30
8133342|NCT02780115|20048653|P4|COMPLETED|Overall Study||31
8133343|NCT02780115|20048654|P3|COMPLETED|Overall Study||29
8133344|NCT02780115|20048655|P2|COMPLETED|Overall Study||29
8133345|NCT02780115|20048656|P1|COMPLETED|Overall Study||28
8133346|NCT02780115|20048652|P5|STARTED|Overall Study||31
8133347|NCT02780115|20048653|P4|STARTED|Overall Study||32
8133348|NCT02780115|20048654|P3|STARTED|Overall Study||30
8133349|NCT02780115|20048655|P2|STARTED|Overall Study||30
8133350|NCT02780115|20048656|P1|STARTED|Overall Study||28
8133351|NCT02779543|20048675|P2|NOT COMPLETED|Overall Study||0
8133352|NCT02779543|20048676|P1|NOT COMPLETED|Overall Study||0
8133353|NCT02779543|20048675|P2|COMPLETED|Overall Study||100
8133354|NCT02779543|20048676|P1|COMPLETED|Overall Study||100
8133355|NCT02779543|20048675|P2|STARTED|Overall Study||100
8133356|NCT02779543|20048676|P1|STARTED|Overall Study||100
8133357|NCT02779491|20048692|P4|NOT COMPLETED|Overall Study||2
8133358|NCT02779491|20048693|P3|NOT COMPLETED|Overall Study||1
8133359|NCT02779491|20048694|P2|NOT COMPLETED|Overall Study||1
8133360|NCT02779491|20048695|P1|NOT COMPLETED|Overall Study||0
8133361|NCT02779491|20048692|P4|COMPLETED|Overall Study||15
8133362|NCT02779491|20048693|P3|COMPLETED|Overall Study||17
8133363|NCT02779491|20048694|P2|COMPLETED|Overall Study||26
8133364|NCT02779491|20048695|P1|COMPLETED|Overall Study||32
8133365|NCT02779491|20048692|P4|STARTED|Overall Study||17
8133366|NCT02779491|20048693|P3|STARTED|Overall Study||18
8133367|NCT02779491|20048694|P2|STARTED|Overall Study||27
8133368|NCT02779491|20048695|P1|STARTED|Overall Study||32
8133369|NCT02779166|20048715|P2|NOT COMPLETED|Overall Study||0
8133370|NCT02779166|20048716|P1|NOT COMPLETED|Overall Study||0
8133371|NCT02779166|20048715|P2|COMPLETED|Overall Study||48
8133372|NCT02779166|20048716|P1|COMPLETED|Overall Study||50
8133373|NCT02779166|20048715|P2|STARTED|Overall Study||48
8133374|NCT02779166|20048716|P1|STARTED|Overall Study||50
8133375|NCT02779075|20048726|P2|NOT COMPLETED|Overall Study||3
8133376|NCT02779075|20048727|P1|NOT COMPLETED|Overall Study||2
8133377|NCT02779075|20048726|P2|COMPLETED|Overall Study||10
8133378|NCT02779075|20048727|P1|COMPLETED|Overall Study||14
8133379|NCT02779075|20048726|P2|STARTED|Overall Study||13
8133380|NCT02779075|20048727|P1|STARTED|Overall Study||16
8133381|NCT02778880|20048737|P2|NOT COMPLETED|Overall Study||3
8133382|NCT02778880|20048738|P1|NOT COMPLETED|Overall Study||1
8133383|NCT02778880|20048737|P2|COMPLETED|Overall Study||42
8133384|NCT02778880|20048738|P1|COMPLETED|Overall Study||44
8133385|NCT02778880|20048737|P2|STARTED|Overall Study||45
8133386|NCT02778880|20048738|P1|STARTED|Overall Study||45
8133387|NCT02778867|20048790|P4|NOT COMPLETED|Phase 2||2
8133388|NCT02778867|20048791|P3|NOT COMPLETED|Phase 2||1
8133389|NCT02778867|20048792|P2|NOT COMPLETED|Phase 2||0
8133390|NCT02778867|20048793|P1|NOT COMPLETED|Phase 2||0
8133391|NCT02778867|20048790|P4|COMPLETED|Phase 2||9
8133392|NCT02778867|20048791|P3|COMPLETED|Phase 2||20
8133393|NCT02778867|20048792|P2|COMPLETED|Phase 2||0
8133394|NCT02778867|20048793|P1|COMPLETED|Phase 2||0
8133395|NCT02778867|20048790|P4|STARTED|Phase 2|Optional phase for 6FED non-responders|11
8133396|NCT02778867|20048791|P3|STARTED|Phase 2|Optional phase for 1FED non-responders|21
8133397|NCT02778867|20048792|P2|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
8133398|NCT02778867|20048793|P1|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
8133399|NCT02778867|20048790|P4|NOT COMPLETED|Phase 1||0
8133400|NCT02778867|20048791|P3|NOT COMPLETED|Phase 1||0
8133401|NCT02778867|20048792|P2|NOT COMPLETED|Phase 1||3
8133402|NCT02778867|20048793|P1|NOT COMPLETED|Phase 1||2
8133403|NCT02778867|20048790|P4|COMPLETED|Phase 1||0
8133404|NCT02778867|20048791|P3|COMPLETED|Phase 1||0
8133405|NCT02778867|20048792|P2|COMPLETED|Phase 1||59
8133406|NCT02778867|20048793|P1|COMPLETED|Phase 1||65
8133407|NCT02778867|20048790|P4|STARTED|Phase 1||0
8133408|NCT02778867|20048791|P3|STARTED|Phase 1||0
8133409|NCT02778867|20048792|P2|STARTED|Phase 1||62
8133410|NCT02778867|20048793|P1|STARTED|Phase 1||67
8133411|NCT02778555|20048814|P3|NOT COMPLETED|Overall Study||107
8133412|NCT02778555|20048815|P2|NOT COMPLETED|Overall Study||32
8133413|NCT02778555|20048816|P1|NOT COMPLETED|Overall Study||55
8133414|NCT02778555|20048814|P3|COMPLETED|Overall Study||211
8133415|NCT02778555|20048815|P2|COMPLETED|Overall Study||177
8133416|NCT02778555|20048816|P1|COMPLETED|Overall Study||131
8133417|NCT02778555|20048814|P3|STARTED|Overall Study||318
8133418|NCT02778555|20048815|P2|STARTED|Overall Study||209
8133419|NCT02778555|20048816|P1|STARTED|Overall Study||186
8133420|NCT02778204|20048828|P4|NOT COMPLETED|Overall Study||4
8133421|NCT02778204|20048829|P3|NOT COMPLETED|Overall Study||4
8133422|NCT02778204|20048830|P2|NOT COMPLETED|Overall Study||0
8133423|NCT02778204|20048831|P1|NOT COMPLETED|Overall Study||2
8133424|NCT02778204|20048828|P4|COMPLETED|Overall Study||12
8133425|NCT02778204|20048829|P3|COMPLETED|Overall Study||12
8133426|NCT02778204|20048830|P2|COMPLETED|Overall Study||7
8133427|NCT02778204|20048831|P1|COMPLETED|Overall Study||6
8133428|NCT02778204|20048828|P4|STARTED|Overall Study||16
8133429|NCT02778204|20048829|P3|STARTED|Overall Study||16
8133430|NCT02778204|20048830|P2|STARTED|Overall Study||7
8133431|NCT02778204|20048831|P1|STARTED|Overall Study||8
8133432|NCT02778152|20048875|P1|NOT COMPLETED|Overall Study||0
8133433|NCT02778152|20048875|P1|COMPLETED|Overall Study||13
8133434|NCT02778152|20048875|P1|STARTED|Overall Study||13
8133435|NCT02778113|20048880|P4|NOT COMPLETED|Study Period Four||0
8133436|NCT02778113|20048881|P3|NOT COMPLETED|Study Period Four||0
8133437|NCT02778113|20048882|P2|NOT COMPLETED|Study Period Four||0
8133438|NCT02778113|20048883|P1|NOT COMPLETED|Study Period Four||0
8133439|NCT02778113|20048880|P4|COMPLETED|Study Period Four||4
8133440|NCT02778113|20048881|P3|COMPLETED|Study Period Four||2
8133441|NCT02778113|20048882|P2|COMPLETED|Study Period Four||4
8133442|NCT02778113|20048883|P1|COMPLETED|Study Period Four||3
8133443|NCT02778113|20048880|P4|Received Study Drug|Study Period Four||4
8133444|NCT02778113|20048881|P3|Received Study Drug|Study Period Four||2
8133445|NCT02778113|20048882|P2|Received Study Drug|Study Period Four||4
8133446|NCT02778113|20048883|P1|Received Study Drug|Study Period Four||3
8133447|NCT02778113|20048880|P4|STARTED|Study Period Four||4
8133448|NCT02778113|20048881|P3|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
8133449|NCT02778113|20048882|P2|STARTED|Study Period Four||4
8133450|NCT02778113|20048883|P1|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
8133451|NCT02778113|20048880|P4|NOT COMPLETED|Study Period Three||0
8133452|NCT02778113|20048881|P3|NOT COMPLETED|Study Period Three||0
8133453|NCT02778113|20048882|P2|NOT COMPLETED|Study Period Three||0
8133454|NCT02778113|20048883|P1|NOT COMPLETED|Study Period Three||0
8133455|NCT02778113|20048880|P4|COMPLETED|Study Period Three||4
8133456|NCT02778113|20048881|P3|COMPLETED|Study Period Three||3
8133457|NCT02778113|20048882|P2|COMPLETED|Study Period Three||4
8133458|NCT02778113|20048883|P1|COMPLETED|Study Period Three||4
8133459|NCT02778113|20048880|P4|Received Study Drug|Study Period Three||4
8133460|NCT02778113|20048881|P3|Received Study Drug|Study Period Three||3
8133461|NCT02778113|20048882|P2|Received Study Drug|Study Period Three||4
8133462|NCT02778113|20048883|P1|Received Study Drug|Study Period Three||4
8133463|NCT02778113|20048880|P4|STARTED|Study Period Three||4
8133464|NCT02778113|20048881|P3|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
8133465|NCT02778113|20048882|P2|STARTED|Study Period Three||4
8133466|NCT02778113|20048883|P1|STARTED|Study Period Three||4
8133467|NCT02778113|20048880|P4|NOT COMPLETED|Study Period Two||0
8133468|NCT02778113|20048881|P3|NOT COMPLETED|Study Period Two||0
8133469|NCT02778113|20048882|P2|NOT COMPLETED|Study Period Two||0
8133470|NCT02778113|20048883|P1|NOT COMPLETED|Study Period Two||0
8133471|NCT02778113|20048880|P4|COMPLETED|Study Period Two||4
8133472|NCT02778113|20048881|P3|COMPLETED|Study Period Two||4
8133473|NCT02778113|20048882|P2|COMPLETED|Study Period Two||4
8133474|NCT02778113|20048883|P1|COMPLETED|Study Period Two||4
8133475|NCT02778113|20048880|P4|Received Study Drug|Study Period Two||4
8133476|NCT02778113|20048881|P3|Received Study Drug|Study Period Two||4
8133477|NCT02778113|20048882|P2|Received Study Drug|Study Period Two||4
8133478|NCT02778113|20048883|P1|Received Study Drug|Study Period Two||4
8133479|NCT02778113|20048880|P4|STARTED|Study Period Two||4
8133480|NCT02778113|20048881|P3|STARTED|Study Period Two||4
8133481|NCT02778113|20048882|P2|STARTED|Study Period Two||4
8133482|NCT02778113|20048883|P1|STARTED|Study Period Two||4
8133483|NCT02778113|20048880|P4|NOT COMPLETED|Study Period One||0
8133484|NCT02778113|20048881|P3|NOT COMPLETED|Study Period One||0
8133485|NCT02778113|20048882|P2|NOT COMPLETED|Study Period One||0
8133486|NCT02778113|20048883|P1|NOT COMPLETED|Study Period One||0
8133487|NCT02778113|20048880|P4|COMPLETED|Study Period One||4
8133488|NCT02778113|20048881|P3|COMPLETED|Study Period One||4
8133489|NCT02778113|20048882|P2|COMPLETED|Study Period One||4
8133490|NCT02778113|20048883|P1|COMPLETED|Study Period One||4
8133491|NCT02778113|20048880|P4|Received Study Drug|Study Period One||4
8133492|NCT02778113|20048881|P3|Received Study Drug|Study Period One||4
8133493|NCT02778113|20048882|P2|Received Study Drug|Study Period One||4
8133494|NCT02778113|20048883|P1|Received Study Drug|Study Period One||4
8133495|NCT02778113|20048880|P4|STARTED|Study Period One||4
8133496|NCT02778113|20048881|P3|STARTED|Study Period One||4
8133497|NCT02778113|20048882|P2|STARTED|Study Period One||4
8133498|NCT02778113|20048883|P1|STARTED|Study Period One||4
8133499|NCT02778100|20048923|P2|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
8133500|NCT02778100|20048924|P1|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
8133501|NCT02778100|20048923|P2|COMPLETED|Period 2 (No Cold Symptoms)||0
8133502|NCT02778100|20048924|P1|COMPLETED|Period 2 (No Cold Symptoms)||17
8133503|NCT02778100|20048923|P2|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
8133504|NCT02778100|20048924|P1|STARTED|Period 2 (No Cold Symptoms)||17
8133505|NCT02778100|20048923|P2|NOT COMPLETED|Period 1 (Common Cold)||0
8133506|NCT02778100|20048924|P1|NOT COMPLETED|Period 1 (Common Cold)||1
8133507|NCT02778100|20048923|P2|COMPLETED|Period 1 (Common Cold)||18
8133508|NCT02778100|20048924|P1|COMPLETED|Period 1 (Common Cold)||17
8133509|NCT02778100|20048923|P2|STARTED|Period 1 (Common Cold)||18
8133510|NCT02778100|20048924|P1|STARTED|Period 1 (Common Cold)||18
8133511|NCT02778074|20048955|P2|NOT COMPLETED|Overall Study||10
8133512|NCT02778074|20048956|P1|NOT COMPLETED|Overall Study||7
8133513|NCT02778074|20048955|P2|COMPLETED|Overall Study||62
8133514|NCT02778074|20048956|P1|COMPLETED|Overall Study||65
8133515|NCT02778074|20048955|P2|STARTED|Overall Study||72
8133516|NCT02778074|20048956|P1|STARTED|Overall Study||72
8133517|NCT02777944|20048964|P2|NOT COMPLETED|Overall Study||0
8133518|NCT02777944|20048965|P1|NOT COMPLETED|Overall Study||0
8133519|NCT02777944|20048964|P2|COMPLETED|Overall Study||156
8133520|NCT02777944|20048965|P1|COMPLETED|Overall Study||157
8133521|NCT02777944|20048964|P2|STARTED|Overall Study||156
8133522|NCT02777944|20048965|P1|STARTED|Overall Study||157
8133523|NCT02777931|20048977|P2|NOT COMPLETED|Overall Study||13
8133524|NCT02777931|20048978|P1|NOT COMPLETED|Overall Study||12
8133525|NCT02777931|20048977|P2|COMPLETED|Overall Study||39
8133526|NCT02777931|20048978|P1|COMPLETED|Overall Study||37
8133527|NCT02777931|20048977|P2|Modified Intent to Treat Population|Overall Study||50
8133528|NCT02777931|20048978|P1|Modified Intent to Treat Population|Overall Study||46
8133529|NCT02777931|20048977|P2|Safety Population|Overall Study||50
8133530|NCT02777931|20048978|P1|Safety Population|Overall Study||47
8133531|NCT02777931|20048977|P2|STARTED|Overall Study||52
8133532|NCT02777931|20048978|P1|STARTED|Overall Study||49
8133533|NCT02777918|20048988|P2|NOT COMPLETED|Overall Study||4
8133534|NCT02777918|20048989|P1|NOT COMPLETED|Overall Study||3
8133535|NCT02777918|20048988|P2|COMPLETED|Overall Study||43
8133536|NCT02777918|20048989|P1|COMPLETED|Overall Study||50
8133537|NCT02777918|20048988|P2|STARTED|Overall Study||47
8133538|NCT02777918|20048989|P1|STARTED|Overall Study||53
8133539|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 6||0
8133540|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 6||0
8133541|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 6||0
8133542|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 6||0
8133543|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 6||0
8133544|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 6||0
8133545|NCT02777827|20049007|P6|COMPLETED|Treatment Period 6||6
8133546|NCT02777827|20049008|P5|COMPLETED|Treatment Period 6||4
8133547|NCT02777827|20049009|P4|COMPLETED|Treatment Period 6||5
8133548|NCT02777827|20049010|P3|COMPLETED|Treatment Period 6||4
8133549|NCT02777827|20049011|P2|COMPLETED|Treatment Period 6||5
8133550|NCT02777827|20049012|P1|COMPLETED|Treatment Period 6||5
8133551|NCT02777827|20049007|P6|STARTED|Treatment Period 6||6
8133552|NCT02777827|20049008|P5|STARTED|Treatment Period 6||4
8133553|NCT02777827|20049009|P4|STARTED|Treatment Period 6||5
8133554|NCT02777827|20049010|P3|STARTED|Treatment Period 6||4
8133555|NCT02777827|20049011|P2|STARTED|Treatment Period 6||5
8133556|NCT02777827|20049012|P1|STARTED|Treatment Period 6||5
8133557|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133558|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133559|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133560|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133561|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133562|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133563|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 5 and 6||6
8133564|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 5 and 6||4
8133565|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 5 and 6||5
8133566|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 5 and 6||4
8133567|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 5 and 6||5
8133568|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 5 and 6||5
8133569|NCT02777827|20049007|P6|STARTED|Washout Between Periods 5 and 6||6
8133570|NCT02777827|20049008|P5|STARTED|Washout Between Periods 5 and 6||4
8133571|NCT02777827|20049009|P4|STARTED|Washout Between Periods 5 and 6||5
8133572|NCT02777827|20049010|P3|STARTED|Washout Between Periods 5 and 6||4
8133573|NCT02777827|20049011|P2|STARTED|Washout Between Periods 5 and 6||5
8133574|NCT02777827|20049012|P1|STARTED|Washout Between Periods 5 and 6||5
8133575|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 5||0
8133576|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 5||0
8133577|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 5||0
8133578|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 5||0
8133579|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 5||0
8133580|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 5||0
8133581|NCT02777827|20049007|P6|COMPLETED|Treatment Period 5||6
8133582|NCT02777827|20049008|P5|COMPLETED|Treatment Period 5||4
8133583|NCT02777827|20049009|P4|COMPLETED|Treatment Period 5||5
8133584|NCT02777827|20049010|P3|COMPLETED|Treatment Period 5||4
8133585|NCT02777827|20049011|P2|COMPLETED|Treatment Period 5||5
8133586|NCT02777827|20049012|P1|COMPLETED|Treatment Period 5||5
8133587|NCT02777827|20049007|P6|STARTED|Treatment Period 5||6
8133588|NCT02777827|20049008|P5|STARTED|Treatment Period 5||4
8133589|NCT02777827|20049009|P4|STARTED|Treatment Period 5||5
8133590|NCT02777827|20049010|P3|STARTED|Treatment Period 5||4
8133591|NCT02777827|20049011|P2|STARTED|Treatment Period 5||5
8133592|NCT02777827|20049012|P1|STARTED|Treatment Period 5||5
8133593|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133594|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133595|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133596|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133597|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133598|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133599|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 4 and 5||6
8133600|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 4 and 5||4
8133601|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 4 and 5||5
8133602|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 4 and 5||4
8133603|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 4 and 5||5
8133604|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 4 and 5||5
8133605|NCT02777827|20049007|P6|STARTED|Washout Between Periods 4 and 5||6
8133606|NCT02777827|20049008|P5|STARTED|Washout Between Periods 4 and 5||4
8133607|NCT02777827|20049009|P4|STARTED|Washout Between Periods 4 and 5||5
8133608|NCT02777827|20049010|P3|STARTED|Washout Between Periods 4 and 5||4
8133609|NCT02777827|20049011|P2|STARTED|Washout Between Periods 4 and 5||5
8133610|NCT02777827|20049012|P1|STARTED|Washout Between Periods 4 and 5||5
8133611|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 4||0
8133612|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 4||0
8133613|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 4||0
8133614|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 4||0
8133615|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 4||0
8133616|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 4||0
8133617|NCT02777827|20049007|P6|COMPLETED|Treatment Period 4||6
8133618|NCT02777827|20049008|P5|COMPLETED|Treatment Period 4||4
8133619|NCT02777827|20049009|P4|COMPLETED|Treatment Period 4||5
8133620|NCT02777827|20049010|P3|COMPLETED|Treatment Period 4||4
8133621|NCT02777827|20049011|P2|COMPLETED|Treatment Period 4||5
8133622|NCT02777827|20049012|P1|COMPLETED|Treatment Period 4||5
8133623|NCT02777827|20049007|P6|STARTED|Treatment Period 4||6
8133624|NCT02777827|20049008|P5|STARTED|Treatment Period 4||4
8133625|NCT02777827|20049009|P4|STARTED|Treatment Period 4||5
8133626|NCT02777827|20049010|P3|STARTED|Treatment Period 4||4
8133627|NCT02777827|20049011|P2|STARTED|Treatment Period 4||5
8133628|NCT02777827|20049012|P1|STARTED|Treatment Period 4||5
8133629|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133630|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133631|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133632|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 3 and 4||1
8133633|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133634|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133635|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 3 and 4||6
8133636|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 3 and 4||4
8133637|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 3 and 4||5
8133638|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 3 and 4||4
8133639|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 3 and 4||5
8133640|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 3 and 4||5
8133641|NCT02777827|20049007|P6|STARTED|Washout Between Periods 3 and 4||6
8133642|NCT02777827|20049008|P5|STARTED|Washout Between Periods 3 and 4||4
8133643|NCT02777827|20049009|P4|STARTED|Washout Between Periods 3 and 4||5
8133644|NCT02777827|20049010|P3|STARTED|Washout Between Periods 3 and 4||5
8133645|NCT02777827|20049011|P2|STARTED|Washout Between Periods 3 and 4||5
8133646|NCT02777827|20049012|P1|STARTED|Washout Between Periods 3 and 4||5
8133647|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 3||0
8133648|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 3||0
8133649|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 3||0
8133650|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 3||0
8133651|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 3||0
8133652|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 3||0
8133653|NCT02777827|20049007|P6|COMPLETED|Treatment Period 3||6
8133654|NCT02777827|20049008|P5|COMPLETED|Treatment Period 3||4
8133655|NCT02777827|20049009|P4|COMPLETED|Treatment Period 3||5
8133656|NCT02777827|20049010|P3|COMPLETED|Treatment Period 3||5
8133657|NCT02777827|20049011|P2|COMPLETED|Treatment Period 3||5
8133658|NCT02777827|20049012|P1|COMPLETED|Treatment Period 3||5
8133659|NCT02777827|20049007|P6|STARTED|Treatment Period 3||6
8133660|NCT02777827|20049008|P5|STARTED|Treatment Period 3||4
8133661|NCT02777827|20049009|P4|STARTED|Treatment Period 3||5
8133662|NCT02777827|20049010|P3|STARTED|Treatment Period 3||5
8133663|NCT02777827|20049011|P2|STARTED|Treatment Period 3||5
8133664|NCT02777827|20049012|P1|STARTED|Treatment Period 3||5
8133665|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133666|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133667|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133668|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133669|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133670|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133671|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 2 and 3||6
8133672|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 2 and 3||4
8133673|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 2 and 3||5
8133674|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 2 and 3||5
8133675|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 2 and 3||5
8133676|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 2 and 3||5
8133677|NCT02777827|20049007|P6|STARTED|Washout Between Periods 2 and 3||6
8133678|NCT02777827|20049008|P5|STARTED|Washout Between Periods 2 and 3||4
8133679|NCT02777827|20049009|P4|STARTED|Washout Between Periods 2 and 3||5
8133680|NCT02777827|20049010|P3|STARTED|Washout Between Periods 2 and 3||5
8133681|NCT02777827|20049011|P2|STARTED|Washout Between Periods 2 and 3||5
8133682|NCT02777827|20049012|P1|STARTED|Washout Between Periods 2 and 3||5
8133683|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 2||0
8133684|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 2||0
8133685|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 2||0
8133686|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 2||0
8133687|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 2||0
8133688|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 2||0
8133689|NCT02777827|20049007|P6|COMPLETED|Treatment Period 2||6
8133690|NCT02777827|20049008|P5|COMPLETED|Treatment Period 2||4
8133691|NCT02777827|20049009|P4|COMPLETED|Treatment Period 2||5
8133692|NCT02777827|20049010|P3|COMPLETED|Treatment Period 2||5
8133693|NCT02777827|20049011|P2|COMPLETED|Treatment Period 2||5
8133694|NCT02777827|20049012|P1|COMPLETED|Treatment Period 2||5
8133695|NCT02777827|20049007|P6|STARTED|Treatment Period 2||6
8133696|NCT02777827|20049008|P5|STARTED|Treatment Period 2||4
8133697|NCT02777827|20049009|P4|STARTED|Treatment Period 2||5
8133698|NCT02777827|20049010|P3|STARTED|Treatment Period 2||5
8133699|NCT02777827|20049011|P2|STARTED|Treatment Period 2||5
8133700|NCT02777827|20049012|P1|STARTED|Treatment Period 2||5
8133701|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133702|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133703|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133704|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133705|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133706|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133707|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 1 and 2||6
8133708|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 1 and 2||4
8133709|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 1 and 2||5
8133710|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 1 and 2||5
8133711|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 1 and 2||5
8133712|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 1 and 2||5
8133713|NCT02777827|20049007|P6|STARTED|Washout Between Periods 1 and 2||6
8133714|NCT02777827|20049008|P5|STARTED|Washout Between Periods 1 and 2||4
8133715|NCT02777827|20049009|P4|STARTED|Washout Between Periods 1 and 2||5
8133716|NCT02777827|20049010|P3|STARTED|Washout Between Periods 1 and 2||5
8133717|NCT02777827|20049011|P2|STARTED|Washout Between Periods 1 and 2||5
8133718|NCT02777827|20049012|P1|STARTED|Washout Between Periods 1 and 2||5
8133719|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 1||0
8133720|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 1||0
8133721|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 1||0
8133722|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 1||0
8133723|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 1||0
8133724|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 1||0
8133725|NCT02777827|20049007|P6|COMPLETED|Treatment Period 1||6
8133726|NCT02777827|20049008|P5|COMPLETED|Treatment Period 1||4
8133727|NCT02777827|20049009|P4|COMPLETED|Treatment Period 1||5
8133728|NCT02777827|20049010|P3|COMPLETED|Treatment Period 1||5
8133729|NCT02777827|20049011|P2|COMPLETED|Treatment Period 1||5
8133730|NCT02777827|20049012|P1|COMPLETED|Treatment Period 1||5
8133731|NCT02777827|20049007|P6|STARTED|Treatment Period 1||6
8133732|NCT02777827|20049008|P5|STARTED|Treatment Period 1||4
8133733|NCT02777827|20049009|P4|STARTED|Treatment Period 1||5
8133734|NCT02777827|20049010|P3|STARTED|Treatment Period 1||5
8133735|NCT02777827|20049011|P2|STARTED|Treatment Period 1||5
8133736|NCT02777827|20049012|P1|STARTED|Treatment Period 1||5
8133737|NCT02777749|20049167|P3|NOT COMPLETED|Overall Study||0
8133738|NCT02777749|20049168|P2|NOT COMPLETED|Overall Study||0
8133739|NCT02777749|20049169|P1|NOT COMPLETED|Overall Study||0
8133740|NCT02777749|20049167|P3|COMPLETED|Overall Study||51
8133741|NCT02777749|20049168|P2|COMPLETED|Overall Study||51
8133742|NCT02777749|20049169|P1|COMPLETED|Overall Study||53
8133743|NCT02777749|20049167|P3|STARTED|Overall Study||51
8133744|NCT02777749|20049168|P2|STARTED|Overall Study||51
8133745|NCT02777749|20049169|P1|STARTED|Overall Study||53
8133746|NCT02777268|20049189|P1|NOT COMPLETED|Overall Study||0
8133747|NCT02777268|20049189|P1|COMPLETED|Overall Study||16
8133748|NCT02777268|20049189|P1|STARTED|Overall Study||16
8133749|NCT02777242|20049215|P1|NOT COMPLETED|Overall Study||6
8133750|NCT02777242|20049215|P1|COMPLETED|Overall Study||59
8133751|NCT02777242|20049215|P1|STARTED|Overall Study||65
8133752|NCT02777125|20049221|P2|NOT COMPLETED|Overall Study||47
8133753|NCT02777125|20049222|P1|NOT COMPLETED|Overall Study||43
8133754|NCT02777125|20049221|P2|COMPLETED|Overall Study||445
8133755|NCT02777125|20049222|P1|COMPLETED|Overall Study||445
8133756|NCT02777125|20049221|P2|STARTED|Overall Study||492
8133757|NCT02777125|20049222|P1|STARTED|Overall Study||488
8133758|NCT02777086|20049238|P2|NOT COMPLETED|Overall Study||99
8133759|NCT02777086|20049239|P1|NOT COMPLETED|Overall Study||96
8133760|NCT02777086|20049238|P2|COMPLETED|Overall Study||151
8133761|NCT02777086|20049239|P1|COMPLETED|Overall Study||165
8133762|NCT02777086|20049238|P2|STARTED|Overall Study||250
8133763|NCT02777086|20049239|P1|STARTED|Overall Study||261
8133764|NCT02777021|20049253|P2|NOT COMPLETED|Overall Study||17
8133765|NCT02777021|20049254|P1|NOT COMPLETED|Overall Study||17
8133766|NCT02777021|20049253|P2|COMPLETED|Overall Study||77
8133767|NCT02777021|20049254|P1|COMPLETED|Overall Study||43
8133768|NCT02777021|20049253|P2|STARTED|Overall Study||94
8133769|NCT02777021|20049254|P1|STARTED|Overall Study||60
8133770|NCT02776904|20049262|P2|NOT COMPLETED|Overall Study||0
8133771|NCT02776904|20049263|P1|NOT COMPLETED|Overall Study||0
8133772|NCT02776904|20049262|P2|COMPLETED|Overall Study||46
8133773|NCT02776904|20049263|P1|COMPLETED|Overall Study||281
8133774|NCT02776904|20049262|P2|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
8133775|NCT02776904|20049263|P1|ImPACT|Overall Study||21
8133776|NCT02776904|20049262|P2|Gait Assessment|Overall Study||32
8133777|NCT02776904|20049263|P1|Gait Assessment|Overall Study||178
8133778|NCT02776904|20049262|P2|STARTED|Overall Study||46
8133779|NCT02776904|20049263|P1|STARTED|Overall Study||281
8133780|NCT02776774|20049277|P1|NOT COMPLETED|Overall Study||0
8133781|NCT02776774|20049277|P1|COMPLETED|Overall Study|Total after data cleaning|91
8133782|NCT02776774|20049277|P1|STARTED|Overall Study||91
8133783|NCT02776683|20049282|P2|NOT COMPLETED|Post-switch Period||43
8133784|NCT02776683|20049283|P1|NOT COMPLETED|Post-switch Period||0
8133785|NCT02776683|20049282|P2|COMPLETED|Post-switch Period||0
8133786|NCT02776683|20049283|P1|COMPLETED|Post-switch Period||0
8133787|NCT02776683|20049282|P2|STARTED|Post-switch Period|Entered into Switch Set|43
8133788|NCT02776683|20049283|P1|STARTED|Post-switch Period||0
8133789|NCT02776683|20049282|P2|NOT COMPLETED|Pre-switch Period||0
8133790|NCT02776683|20049283|P1|NOT COMPLETED|Pre-switch Period||80
8133791|NCT02776683|20049282|P2|COMPLETED|Pre-switch Period||0
8133792|NCT02776683|20049283|P1|COMPLETED|Pre-switch Period|Entered into Switch Set|43
8133793|NCT02776683|20049282|P2|STARTED|Pre-switch Period||0
8133794|NCT02776683|20049283|P1|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
8133795|NCT02776670|20049294|P2|NOT COMPLETED|Overall Study||6
8133796|NCT02776670|20049295|P1|NOT COMPLETED|Overall Study||0
8133797|NCT02776670|20049294|P2|COMPLETED|Overall Study||108
8133798|NCT02776670|20049295|P1|COMPLETED|Overall Study||117
8133799|NCT02776670|20049294|P2|Safety Analysis Set|Overall Study||114
8133800|NCT02776670|20049295|P1|Safety Analysis Set|Overall Study||117
8133801|NCT02776670|20049294|P2|Per Protocol Analysis Set (PPS)|Overall Study||113
8133802|NCT02776670|20049295|P1|Per Protocol Analysis Set (PPS)|Overall Study||115
8133803|NCT02776670|20049294|P2|Full Analysis Set (FAS)|Overall Study||114
8133804|NCT02776670|20049295|P1|Full Analysis Set (FAS)|Overall Study||117
8133805|NCT02776670|20049294|P2|STARTED|Overall Study||114
8133806|NCT02776670|20049295|P1|STARTED|Overall Study||117
8133807|NCT02776644|20049309|P2|NOT COMPLETED|Overall Study||0
8133808|NCT02776644|20049310|P1|NOT COMPLETED|Overall Study||0
8133809|NCT02776644|20049309|P2|COMPLETED|Overall Study||126
8133810|NCT02776644|20049310|P1|COMPLETED|Overall Study||1223
8133811|NCT02776644|20049309|P2|STARTED|Overall Study||126
8133812|NCT02776644|20049310|P1|STARTED|Overall Study||1223
8133813|NCT02776553|20049352|P2|NOT COMPLETED|Overall Study||3
8133814|NCT02776553|20049353|P1|NOT COMPLETED|Overall Study||3
8133815|NCT02776553|20049352|P2|COMPLETED|Overall Study||5
8133816|NCT02776553|20049353|P1|COMPLETED|Overall Study||6
8133817|NCT02776553|20049352|P2|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
8133818|NCT02776553|20049353|P1|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
8133819|NCT02776033|20049366|P3|NOT COMPLETED|Overall Study||2
8133820|NCT02776033|20049367|P2|NOT COMPLETED|Overall Study||2
8133821|NCT02776033|20049368|P1|NOT COMPLETED|Overall Study||4
8133822|NCT02776033|20049366|P3|COMPLETED|Overall Study||22
8133823|NCT02776033|20049367|P2|COMPLETED|Overall Study||21
8133824|NCT02776033|20049368|P1|COMPLETED|Overall Study||14
8133825|NCT02776033|20049366|P3|STARTED|Overall Study||24
8133826|NCT02776033|20049367|P2|STARTED|Overall Study||23
8133827|NCT02776033|20049368|P1|STARTED|Overall Study||18
8133828|NCT02775916|20049433|P2|NOT COMPLETED|Overall Study||0
8133829|NCT02775916|20049434|P1|NOT COMPLETED|Overall Study||3
8133830|NCT02775916|20049433|P2|COMPLETED|Overall Study||10
8133831|NCT02775916|20049434|P1|COMPLETED|Overall Study||17
8133832|NCT02775916|20049433|P2|STARTED|Overall Study||10
8133833|NCT02775916|20049434|P1|STARTED|Overall Study||20
8133834|NCT02775903|20049456|P4|NOT COMPLETED|Overall Study||65
8133835|NCT02775903|20049457|P3|NOT COMPLETED|Overall Study||64
8133836|NCT02775903|20049458|P2|NOT COMPLETED|Overall Study||41
8133837|NCT02775903|20049459|P1|NOT COMPLETED|Overall Study||42
8133838|NCT02775903|20049456|P4|COMPLETED|Overall Study||0
8133839|NCT02775903|20049457|P3|COMPLETED|Overall Study||0
8133840|NCT02775903|20049458|P2|COMPLETED|Overall Study||1
8133841|NCT02775903|20049459|P1|COMPLETED|Overall Study||0
8133842|NCT02775903|20049456|P4|Received Study Treatment|Overall Study||62
8133843|NCT02775903|20049457|P3|Received Study Treatment|Overall Study||64
8133844|NCT02775903|20049458|P2|Received Study Treatment|Overall Study||41
8133845|NCT02775903|20049459|P1|Received Study Treatment|Overall Study||38
8133846|NCT02775903|20049456|P4|STARTED|Overall Study||65
8133847|NCT02775903|20049457|P3|STARTED|Overall Study||64
8133848|NCT02775903|20049458|P2|STARTED|Overall Study||42
8133849|NCT02775903|20049459|P1|STARTED|Overall Study||42
8133850|NCT02775864|20049511|P4|NOT COMPLETED|Overall Study||2084
8133851|NCT02775864|20049512|P3|NOT COMPLETED|Overall Study||1860
8133852|NCT02775864|20049513|P2|NOT COMPLETED|Overall Study||4899
8133853|NCT02775864|20049514|P1|NOT COMPLETED|Overall Study||3242
8133854|NCT02775864|20049511|P4|COMPLETED|Overall Study||10765
8133855|NCT02775864|20049512|P3|COMPLETED|Overall Study||10081
8133856|NCT02775864|20049513|P2|COMPLETED|Overall Study||26218
8133857|NCT02775864|20049514|P1|COMPLETED|Overall Study||22772
8133858|NCT02775864|20049511|P4|STARTED|Overall Study||12849
8133859|NCT02775864|20049512|P3|STARTED|Overall Study||11941
8133860|NCT02775864|20049513|P2|STARTED|Overall Study||31117
8133861|NCT02775864|20049514|P1|STARTED|Overall Study||26014
8133862|NCT02775617|20049534|P2|NOT COMPLETED|Overall Study||160
8133863|NCT02775617|20049535|P1|NOT COMPLETED|Overall Study||48
8133864|NCT02775617|20049534|P2|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
8133865|NCT02775617|20049535|P1|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
8133866|NCT02775617|20049534|P2|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
8133867|NCT02775617|20049535|P1|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
8133868|NCT02775435|20049547|P2|NOT COMPLETED|Overall Study||281
8133869|NCT02775435|20049548|P1|NOT COMPLETED|Overall Study||278
8133870|NCT02775435|20049547|P2|COMPLETED|Overall Study||0
8133871|NCT02775435|20049548|P1|COMPLETED|Overall Study||0
8133872|NCT02775435|20049547|P2|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
8133873|NCT02775435|20049548|P1|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
8133874|NCT02775435|20049547|P2|Treated|Overall Study||280
8133875|NCT02775435|20049548|P1|Treated|Overall Study||278
8133876|NCT02775435|20049547|P2|STARTED|Overall Study||281
8133877|NCT02775435|20049548|P1|STARTED|Overall Study||278
8133878|NCT02775344|20049566|P2|NOT COMPLETED|Overall Study||2
8133879|NCT02775344|20049567|P1|NOT COMPLETED|Overall Study||3
8133880|NCT02775344|20049566|P2|COMPLETED|Overall Study||38
8133881|NCT02775344|20049567|P1|COMPLETED|Overall Study||37
8133882|NCT02775344|20049566|P2|STARTED|Overall Study||40
8133883|NCT02775344|20049567|P1|STARTED|Overall Study||40
8133884|NCT02775240|20049585|P1|NOT COMPLETED|Overall Study||1
8133885|NCT02775240|20049585|P1|COMPLETED|Overall Study||17
8133886|NCT02775240|20049585|P1|Started Treatment B|Overall Study||17
8133887|NCT02775240|20049585|P1|Started Treatment A|Overall Study||18
8133888|NCT02775240|20049585|P1|STARTED|Overall Study||18
8133889|NCT02774941|20049650|P2|NOT COMPLETED|Overall Study||2
8133890|NCT02774941|20049651|P1|NOT COMPLETED|Overall Study||1
8133891|NCT02774941|20049650|P2|COMPLETED|Overall Study||108
8133892|NCT02774941|20049651|P1|COMPLETED|Overall Study||109
8133893|NCT02774941|20049650|P2|Subjects Excluded|Overall Study||2
8133894|NCT02774941|20049651|P1|Subjects Excluded|Overall Study||1
8133895|NCT02774941|20049650|P2|STARTED|Overall Study||110
8133896|NCT02774941|20049651|P1|STARTED|Overall Study||110
8133897|NCT02774850|20049661|P1|NOT COMPLETED|Overall Study||35
8133898|NCT02774850|20049661|P1|COMPLETED|Overall Study||575
8133899|NCT02774850|20049661|P1|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
8133900|NCT02774850|20049661|P1|Intensification III|Overall Study||48
8133901|NCT02774850|20049661|P1|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
8133902|NCT02774850|20049661|P1|Intensification II|Overall Study||342
8133903|NCT02774850|20049661|P1|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
8133904|NCT02774850|20049661|P1|Intensification I|Overall Study||476
8133905|NCT02774850|20049661|P1|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
8133906|NCT02774850|20049661|P1|Induction II|Overall Study||564
8133907|NCT02774850|20049661|P1|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
8133908|NCT02774850|20049661|P1|Induction I|Overall Study||585
8133909|NCT02774850|20049661|P1|STARTED|Overall Study||610
8133910|NCT02774798|20049672|P3|NOT COMPLETED|Overall Study||0
8133911|NCT02774798|20049673|P2|NOT COMPLETED|Overall Study||0
8133912|NCT02774798|20049674|P1|NOT COMPLETED|Overall Study||0
8133913|NCT02774798|20049672|P3|COMPLETED|Overall Study||7
8133914|NCT02774798|20049673|P2|COMPLETED|Overall Study||17
8133915|NCT02774798|20049674|P1|COMPLETED|Overall Study||7
8133916|NCT02774798|20049672|P3|STARTED|Overall Study||7
8133917|NCT02774798|20049673|P2|STARTED|Overall Study||17
8133918|NCT02774798|20049674|P1|STARTED|Overall Study||7
8133919|NCT02774681|20049700|P1|NOT COMPLETED|Follow-Up for 3 Years||12
8133920|NCT02774681|20049700|P1|COMPLETED|Follow-Up for 3 Years||0
8133921|NCT02774681|20049700|P1|STARTED|Follow-Up for 3 Years||12
8133922|NCT02774681|20049700|P1|NOT COMPLETED|Treatment on Study||7
8133923|NCT02774681|20049700|P1|COMPLETED|Treatment on Study||5
8133924|NCT02774681|20049700|P1|Went on to Start Cycle 3|Treatment on Study||5
8133925|NCT02774681|20049700|P1|Reached 1st Response/2 Cycles|Treatment on Study||10
8133926|NCT02774681|20049700|P1|STARTED|Treatment on Study||12
8133927|NCT02774616|20049712|P3|NOT COMPLETED|Overall Study||3
8133928|NCT02774616|20049713|P2|NOT COMPLETED|Overall Study||11
8133929|NCT02774616|20049714|P1|NOT COMPLETED|Overall Study||15
8133930|NCT02774616|20049712|P3|COMPLETED|Overall Study||13
8133931|NCT02774616|20049713|P2|COMPLETED|Overall Study||156
8133932|NCT02774616|20049714|P1|COMPLETED|Overall Study||80
8133933|NCT02774616|20049712|P3|Other|Overall Study||1
8133934|NCT02774616|20049713|P2|Other|Overall Study||4
8133935|NCT02774616|20049714|P1|Other|Overall Study||2
8133936|NCT02774616|20049712|P3|Device Explanted|Overall Study||1
8133937|NCT02774616|20049713|P2|Device Explanted|Overall Study||1
8133938|NCT02774616|20049714|P1|Device Explanted|Overall Study||2
8133939|NCT02774616|20049712|P3|Lost to FU|Overall Study||0
8133940|NCT02774616|20049713|P2|Lost to FU|Overall Study||0
8133941|NCT02774616|20049714|P1|Lost to FU|Overall Study||2
8133942|NCT02774616|20049712|P3|Withdrew Consent|Overall Study||0
8133943|NCT02774616|20049713|P2|Withdrew Consent|Overall Study||3
8133944|NCT02774616|20049714|P1|Withdrew Consent|Overall Study||3
8133945|NCT02774616|20049712|P3|Died|Overall Study||1
8133946|NCT02774616|20049713|P2|Died|Overall Study||3
8133947|NCT02774616|20049714|P1|Died|Overall Study||6
8133948|NCT02774616|20049712|P3|STARTED|Overall Study||16
8133949|NCT02774616|20049713|P2|STARTED|Overall Study||167
8133950|NCT02774616|20049714|P1|STARTED|Overall Study||95
8133951|NCT02774343|20049727|P2|NOT COMPLETED|Overall Study||3
8133952|NCT02774343|20049728|P1|NOT COMPLETED|Overall Study||6
8133953|NCT02774343|20049727|P2|COMPLETED|Overall Study||12
8133954|NCT02774343|20049728|P1|COMPLETED|Overall Study||9
8133955|NCT02774343|20049727|P2|Received at Least One Capsule|Overall Study||14
8133956|NCT02774343|20049728|P1|Received at Least One Capsule|Overall Study||12
8133957|NCT02774343|20049727|P2|STARTED|Overall Study||15
8133958|NCT02774343|20049728|P1|STARTED|Overall Study||15
8133959|NCT02774278|20049764|P1|NOT COMPLETED|Overall Study||264
8133960|NCT02774278|20049764|P1|COMPLETED|Overall Study||0
8133961|NCT02774278|20049764|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
8133962|NCT02774278|20049764|P1|STARTED|Overall Study||264
8133963|NCT02774265|20049774|P2|NOT COMPLETED|Overall Study||6
8133964|NCT02774265|20049775|P1|NOT COMPLETED|Overall Study||13
8133965|NCT02774265|20049774|P2|COMPLETED|Overall Study||159
8133966|NCT02774265|20049775|P1|COMPLETED|Overall Study||151
8133967|NCT02774265|20049774|P2|STARTED|Overall Study||165
8133968|NCT02774265|20049775|P1|STARTED|Overall Study||164
8133969|NCT02774213|20049785|P1|NOT COMPLETED|Overall Study||19
8133970|NCT02774213|20049785|P1|COMPLETED|Overall Study||55
8133971|NCT02774213|20049785|P1|STARTED|Overall Study||74
8133972|NCT02774148|20049798|P2|NOT COMPLETED|Overall Study||0
8133973|NCT02774148|20049799|P1|NOT COMPLETED|Overall Study||0
8133974|NCT02774148|20049798|P2|COMPLETED|Overall Study||0
8133975|NCT02774148|20049799|P1|COMPLETED|Overall Study||0
8133976|NCT02774148|20049798|P2|STARTED|Overall Study||0
8133977|NCT02774148|20049799|P1|STARTED|Overall Study||0
8133978|NCT02773836|20049819|P6|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133979|NCT02773836|20049820|P5|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133980|NCT02773836|20049821|P4|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133981|NCT02773836|20049822|P3|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133982|NCT02773836|20049823|P2|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133983|NCT02773836|20049824|P1|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133984|NCT02773836|20049819|P6|COMPLETED|Wave 2- Post-TPD Implementation||998
8133985|NCT02773836|20049820|P5|COMPLETED|Wave 2- Post-TPD Implementation||1002
8133986|NCT02773836|20049821|P4|COMPLETED|Wave 2- Post-TPD Implementation||1010
8133987|NCT02773836|20049822|P3|COMPLETED|Wave 2- Post-TPD Implementation||1003
8133988|NCT02773836|20049823|P2|COMPLETED|Wave 2- Post-TPD Implementation||1013
8133989|NCT02773836|20049824|P1|COMPLETED|Wave 2- Post-TPD Implementation||1010
8133990|NCT02773836|20049819|P6|STARTED|Wave 2- Post-TPD Implementation||998
8133991|NCT02773836|20049820|P5|STARTED|Wave 2- Post-TPD Implementation||1002
8133992|NCT02773836|20049821|P4|STARTED|Wave 2- Post-TPD Implementation||1010
8133993|NCT02773836|20049822|P3|STARTED|Wave 2- Post-TPD Implementation||1003
8133994|NCT02773836|20049823|P2|STARTED|Wave 2- Post-TPD Implementation||1013
8133995|NCT02773836|20049824|P1|STARTED|Wave 2- Post-TPD Implementation||1010
8133996|NCT02773836|20049819|P6|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8133997|NCT02773836|20049820|P5|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8133998|NCT02773836|20049821|P4|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8133999|NCT02773836|20049822|P3|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8134000|NCT02773836|20049823|P2|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8134001|NCT02773836|20049824|P1|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8134002|NCT02773836|20049819|P6|COMPLETED|Wave 1- Pre-TPD Implementation||1006
8134003|NCT02773836|20049820|P5|COMPLETED|Wave 1- Pre-TPD Implementation||1000
8134004|NCT02773836|20049821|P4|COMPLETED|Wave 1- Pre-TPD Implementation||1001
8134005|NCT02773836|20049822|P3|COMPLETED|Wave 1- Pre-TPD Implementation||1001
8134006|NCT02773836|20049823|P2|COMPLETED|Wave 1- Pre-TPD Implementation||1003
8134007|NCT02773836|20049824|P1|COMPLETED|Wave 1- Pre-TPD Implementation||1000
8134008|NCT02773836|20049819|P6|STARTED|Wave 1- Pre-TPD Implementation||1006
8134009|NCT02773836|20049820|P5|STARTED|Wave 1- Pre-TPD Implementation||1000
8134010|NCT02773836|20049821|P4|STARTED|Wave 1- Pre-TPD Implementation||1001
8134011|NCT02773836|20049822|P3|STARTED|Wave 1- Pre-TPD Implementation||1001
8134012|NCT02773836|20049823|P2|STARTED|Wave 1- Pre-TPD Implementation||1003
8134013|NCT02773836|20049824|P1|STARTED|Wave 1- Pre-TPD Implementation||1000
8134014|NCT02773758|20049912|P2|NOT COMPLETED|Overall Study||0
8134015|NCT02773758|20049913|P1|NOT COMPLETED|Overall Study||0
8134016|NCT02773758|20049912|P2|COMPLETED|Overall Study||70
8134017|NCT02773758|20049913|P1|COMPLETED|Overall Study||71
8134018|NCT02773758|20049912|P2|STARTED|Overall Study||70
8134019|NCT02773758|20049913|P1|STARTED|Overall Study||71
8134020|NCT02773576|20049925|P2|NOT COMPLETED|Overall Study||0
8134021|NCT02773576|20049926|P1|NOT COMPLETED|Overall Study||0
8134022|NCT02773576|20049925|P2|COMPLETED|Overall Study||0
8134023|NCT02773576|20049926|P1|COMPLETED|Overall Study||0
8134024|NCT02773576|20049925|P2|STARTED|Overall Study||0
8134025|NCT02773576|20049926|P1|STARTED|Overall Study||0
8134026|NCT02773537|20049939|P3|NOT COMPLETED|Overall Study||4
8134027|NCT02773537|20049940|P2|NOT COMPLETED|Overall Study||1
8134028|NCT02773537|20049941|P1|NOT COMPLETED|Overall Study||0
8134029|NCT02773537|20049939|P3|COMPLETED|Overall Study||21
8134030|NCT02773537|20049940|P2|COMPLETED|Overall Study||24
8134031|NCT02773537|20049941|P1|COMPLETED|Overall Study||25
8134032|NCT02773537|20049939|P3|STARTED|Overall Study||25
8134033|NCT02773537|20049940|P2|STARTED|Overall Study||25
8134034|NCT02773537|20049941|P1|STARTED|Overall Study||25
8134035|NCT02773446|20049976|P6|NOT COMPLETED|Second Admission||0
8134036|NCT02773446|20049977|P5|NOT COMPLETED|Second Admission||0
8134037|NCT02773446|20049978|P4|NOT COMPLETED|Second Admission||0
8134038|NCT02773446|20049979|P3|NOT COMPLETED|Second Admission||0
8134039|NCT02773446|20049980|P2|NOT COMPLETED|Second Admission||0
8134040|NCT02773446|20049981|P1|NOT COMPLETED|Second Admission||0
8134041|NCT02773446|20049976|P6|COMPLETED|Second Admission||19
8134042|NCT02773446|20049977|P5|COMPLETED|Second Admission||11
8134043|NCT02773446|20049978|P4|COMPLETED|Second Admission||0
8134044|NCT02773446|20049979|P3|COMPLETED|Second Admission||0
8134045|NCT02773446|20049980|P2|COMPLETED|Second Admission||0
8134046|NCT02773446|20049981|P1|COMPLETED|Second Admission||0
8134047|NCT02773446|20049976|P6|STARTED|Second Admission||19
8134048|NCT02773446|20049977|P5|STARTED|Second Admission||11
8134049|NCT02773446|20049978|P4|STARTED|Second Admission||0
8134050|NCT02773446|20049979|P3|STARTED|Second Admission||0
8134051|NCT02773446|20049980|P2|STARTED|Second Admission||0
8134052|NCT02773446|20049981|P1|STARTED|Second Admission||0
8134053|NCT02773446|20049976|P6|NOT COMPLETED|First Admission||0
8134054|NCT02773446|20049977|P5|NOT COMPLETED|First Admission||0
8134055|NCT02773446|20049978|P4|NOT COMPLETED|First Admission||1
8134056|NCT02773446|20049979|P3|NOT COMPLETED|First Admission||0
8134057|NCT02773446|20049980|P2|NOT COMPLETED|First Admission||0
8134058|NCT02773446|20049981|P1|NOT COMPLETED|First Admission||1
8134059|NCT02773446|20049976|P6|COMPLETED|First Admission||0
8134060|NCT02773446|20049977|P5|COMPLETED|First Admission||0
8134061|NCT02773446|20049978|P4|COMPLETED|First Admission||6
8134062|NCT02773446|20049979|P3|COMPLETED|First Admission||7
8134063|NCT02773446|20049980|P2|COMPLETED|First Admission||7
8134064|NCT02773446|20049981|P1|COMPLETED|First Admission||6
8134065|NCT02773446|20049976|P6|STARTED|First Admission||0
8134066|NCT02773446|20049977|P5|STARTED|First Admission||0
8134067|NCT02773446|20049978|P4|STARTED|First Admission||7
8134068|NCT02773446|20049979|P3|STARTED|First Admission||7
8134069|NCT02773446|20049980|P2|STARTED|First Admission||7
8134070|NCT02773446|20049981|P1|STARTED|First Admission||7
8134071|NCT02773368|20050022|P2|NOT COMPLETED|Overall Study||4
8134072|NCT02773368|20050023|P1|NOT COMPLETED|Overall Study||10
8134073|NCT02773368|20050022|P2|COMPLETED|Overall Study||206
8134074|NCT02773368|20050023|P1|COMPLETED|Overall Study||200
8134075|NCT02773368|20050022|P2|Exposed|Overall Study||210
8134076|NCT02773368|20050023|P1|Exposed|Overall Study||209
8134077|NCT02773368|20050022|P2|STARTED|Overall Study||210
8134078|NCT02773368|20050023|P1|STARTED|Overall Study||210
8134079|NCT02772809|20050093|P1|NOT COMPLETED|Overall Study||6
8134080|NCT02772809|20050093|P1|COMPLETED|Overall Study||17
8134081|NCT02772809|20050093|P1|STARTED|Overall Study||23
8134082|NCT02772757|20050105|P3|NOT COMPLETED|Overall Study||5
8134083|NCT02772757|20050106|P2|NOT COMPLETED|Overall Study||3
8134084|NCT02772757|20050107|P1|NOT COMPLETED|Overall Study||1
8134085|NCT02772757|20050105|P3|COMPLETED|Overall Study||21
8134086|NCT02772757|20050106|P2|COMPLETED|Overall Study||21
8134087|NCT02772757|20050107|P1|COMPLETED|Overall Study||21
8134088|NCT02772757|20050105|P3|STARTED|Overall Study||26
8134089|NCT02772757|20050106|P2|STARTED|Overall Study||24
8134090|NCT02772757|20050107|P1|STARTED|Overall Study||22
8134091|NCT02772666|20050124|P1|NOT COMPLETED|SFT Then O-Glass||0
8134092|NCT02772666|20050124|P1|COMPLETED|SFT Then O-Glass||44
8134093|NCT02772666|20050124|P1|STARTED|SFT Then O-Glass||44
8134094|NCT02772666|20050124|P1|NOT COMPLETED|O-Glas Then SFT||0
8134095|NCT02772666|20050124|P1|COMPLETED|O-Glas Then SFT||44
8134096|NCT02772666|20050124|P1|STARTED|O-Glas Then SFT||44
8134097|NCT02772432|20050131|P2|NOT COMPLETED|Overall Study||1
8134098|NCT02772432|20050132|P1|NOT COMPLETED|Overall Study||12
8134099|NCT02772432|20050131|P2|COMPLETED|Overall Study||21
8134100|NCT02772432|20050132|P1|COMPLETED|Overall Study||19
8134101|NCT02772432|20050131|P2|STARTED|Overall Study||22
8134102|NCT02772432|20050132|P1|STARTED|Overall Study||31
8134103|NCT02771574|20050147|P5|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134104|NCT02771574|20050148|P4|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134105|NCT02771574|20050149|P3|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134106|NCT02771574|20050150|P2|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134107|NCT02771574|20050151|P1|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134108|NCT02771574|20050147|P5|COMPLETED|Liq Avexitide (3 Days)||5
8134109|NCT02771574|20050148|P4|COMPLETED|Liq Avexitide (3 Days)||0
8134110|NCT02771574|20050149|P3|COMPLETED|Liq Avexitide (3 Days)||0
8134111|NCT02771574|20050150|P2|COMPLETED|Liq Avexitide (3 Days)||0
8134112|NCT02771574|20050151|P1|COMPLETED|Liq Avexitide (3 Days)||0
8134113|NCT02771574|20050147|P5|STARTED|Liq Avexitide (3 Days)||5
8134114|NCT02771574|20050148|P4|STARTED|Liq Avexitide (3 Days)||0
8134115|NCT02771574|20050149|P3|STARTED|Liq Avexitide (3 Days)||0
8134116|NCT02771574|20050150|P2|STARTED|Liq Avexitide (3 Days)||0
8134117|NCT02771574|20050151|P1|STARTED|Liq Avexitide (3 Days)||0
8134118|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134119|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134120|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134121|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134122|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134123|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134124|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
8134125|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134126|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134127|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134128|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134129|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
8134130|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134131|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134132|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134133|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134134|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134135|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134136|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134137|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134138|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134139|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134140|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
8134141|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134142|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134143|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134144|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134145|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
8134146|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134147|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134148|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134149|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134150|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134151|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134152|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134153|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134154|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134155|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134156|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
8134157|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134158|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134159|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134160|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134161|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
8134162|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134163|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134164|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134165|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134166|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134167|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134168|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134169|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134170|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134171|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134172|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
8134173|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134174|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134175|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134176|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134177|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
8134178|NCT02771522|20050190|P1|NOT COMPLETED|Overall Study||8
8134179|NCT02771522|20050190|P1|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
8134180|NCT02771522|20050190|P1|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
8134181|NCT02771366|20050201|P2|NOT COMPLETED|Period 2 (Crossover)||0
8134182|NCT02771366|20050202|P1|NOT COMPLETED|Period 2 (Crossover)||2
8134183|NCT02771366|20050201|P2|COMPLETED|Period 2 (Crossover)||13
8134184|NCT02771366|20050202|P1|COMPLETED|Period 2 (Crossover)||13
8134185|NCT02771366|20050201|P2|STARTED|Period 2 (Crossover)||13
8134186|NCT02771366|20050202|P1|STARTED|Period 2 (Crossover)||15
8134187|NCT02771366|20050201|P2|NOT COMPLETED|Period 1||2
8134188|NCT02771366|20050202|P1|NOT COMPLETED|Period 1||0
8134189|NCT02771366|20050201|P2|COMPLETED|Period 1||13
8134190|NCT02771366|20050202|P1|COMPLETED|Period 1||15
8134191|NCT02771366|20050201|P2|STARTED|Period 1||15
8134192|NCT02771366|20050202|P1|STARTED|Period 1||15
8134193|NCT02771340|20050212|P3|NOT COMPLETED|Overall Study||0
8134194|NCT02771340|20050213|P2|NOT COMPLETED|Overall Study||0
8134195|NCT02771340|20050214|P1|NOT COMPLETED|Overall Study||0
8134196|NCT02771340|20050212|P3|COMPLETED|Overall Study||5
8134197|NCT02771340|20050213|P2|COMPLETED|Overall Study||3
8134198|NCT02771340|20050214|P1|COMPLETED|Overall Study||2
8134199|NCT02771340|20050212|P3|STARTED|Overall Study||5
8134200|NCT02771340|20050213|P2|STARTED|Overall Study||3
8134201|NCT02771340|20050214|P1|STARTED|Overall Study||2
8134202|NCT02771275|20050228|P1|NOT COMPLETED|Overall Study||13
8134203|NCT02771275|20050228|P1|COMPLETED|Overall Study||0
8134204|NCT02771275|20050228|P1|STARTED|Overall Study||13
8134205|NCT02771210|20050238|P2|NOT COMPLETED|Period 2||3
8134206|NCT02771210|20050239|P1|NOT COMPLETED|Period 2||2
8134207|NCT02771210|20050238|P2|COMPLETED|Period 2||81
8134208|NCT02771210|20050239|P1|COMPLETED|Period 2||89
8134209|NCT02771210|20050238|P2|STARTED|Period 2||84
8134210|NCT02771210|20050239|P1|STARTED|Period 2||91
8134211|NCT02771210|20050238|P2|NOT COMPLETED|Period 1||18
8134212|NCT02771210|20050239|P1|NOT COMPLETED|Period 1||11
8134213|NCT02771210|20050238|P2|COMPLETED|Period 1||84
8134214|NCT02771210|20050239|P1|COMPLETED|Period 1||91
8134215|NCT02771210|20050238|P2|STARTED|Period 1||102
8134216|NCT02771210|20050239|P1|STARTED|Period 1||102
8134217|NCT02771145|20050265|P1|NOT COMPLETED|Overall Study||4
8134218|NCT02771145|20050265|P1|COMPLETED|Overall Study||86
8134219|NCT02771145|20050265|P1|STARTED|Overall Study||90
8134220|NCT02771093|20050306|P2|NOT COMPLETED|Overall Study||0
8134221|NCT02771093|20050307|P1|NOT COMPLETED|Overall Study||0
8134222|NCT02771093|20050306|P2|COMPLETED|Overall Study||14
8134223|NCT02771093|20050307|P1|COMPLETED|Overall Study||13
8134224|NCT02771093|20050306|P2|STARTED|Overall Study||14
8134225|NCT02771093|20050307|P1|STARTED|Overall Study||13
8134226|NCT02770846|20050361|P2|NOT COMPLETED|Overall Study||0
8134227|NCT02770846|20050362|P1|NOT COMPLETED|Overall Study||0
8134228|NCT02770846|20050361|P2|COMPLETED|Overall Study||25
8134229|NCT02770846|20050362|P1|COMPLETED|Overall Study||25
8134230|NCT02770846|20050361|P2|STARTED|Overall Study||25
8134231|NCT02770846|20050362|P1|STARTED|Overall Study||25
8134232|NCT02770625|20050386|P1|NOT COMPLETED|Overall Study||0
8134233|NCT02770625|20050386|P1|COMPLETED|Overall Study||8
8134234|NCT02770625|20050386|P1|STARTED|Overall Study||8
8134235|NCT02770612|20050399|P1|NOT COMPLETED|Overall Study||1
8134236|NCT02770612|20050399|P1|COMPLETED|Overall Study||50
8134237|NCT02770612|20050399|P1|STARTED|Overall Study||51
8134238|NCT02770547|20050405|P2|NOT COMPLETED|Overall Study||1
8134239|NCT02770547|20050406|P1|NOT COMPLETED|Overall Study||1
8134240|NCT02770547|20050405|P2|COMPLETED|Overall Study||15
8134241|NCT02770547|20050406|P1|COMPLETED|Overall Study||15
8134242|NCT02770547|20050405|P2|STARTED|Overall Study||16
8134243|NCT02770547|20050406|P1|STARTED|Overall Study||16
8134244|NCT02770521|20050428|P6|NOT COMPLETED|Period Three||0
8134245|NCT02770521|20050429|P5|NOT COMPLETED|Period Three||0
8134246|NCT02770521|20050430|P4|NOT COMPLETED|Period Three||0
8134247|NCT02770521|20050431|P3|NOT COMPLETED|Period Three||0
8134248|NCT02770521|20050432|P2|NOT COMPLETED|Period Three||0
8134249|NCT02770521|20050433|P1|NOT COMPLETED|Period Three||0
8134250|NCT02770521|20050428|P6|COMPLETED|Period Three||9
8134251|NCT02770521|20050429|P5|COMPLETED|Period Three||2
8134252|NCT02770521|20050430|P4|COMPLETED|Period Three||2
8134253|NCT02770521|20050431|P3|COMPLETED|Period Three||2
8134254|NCT02770521|20050432|P2|COMPLETED|Period Three||0
8134255|NCT02770521|20050433|P1|COMPLETED|Period Three||0
8134256|NCT02770521|20050428|P6|Received Study Drug|Period Three||9
8134257|NCT02770521|20050429|P5|Received Study Drug|Period Three||2
8134258|NCT02770521|20050430|P4|Received Study Drug|Period Three||2
8134259|NCT02770521|20050431|P3|Received Study Drug|Period Three||2
8134260|NCT02770521|20050432|P2|Received Study Drug|Period Three||0
8134261|NCT02770521|20050433|P1|Received Study Drug|Period Three||0
8134262|NCT02770521|20050428|P6|STARTED|Period Three||9
8134263|NCT02770521|20050429|P5|STARTED|Period Three||2
8134264|NCT02770521|20050430|P4|STARTED|Period Three||2
8134265|NCT02770521|20050431|P3|STARTED|Period Three||2
8134266|NCT02770521|20050432|P2|STARTED|Period Three|Not applicable. Part A only had two periods.|0
8134267|NCT02770521|20050433|P1|STARTED|Period Three|Not applicable. Part A only had two periods.|0
8134268|NCT02770521|20050428|P6|NOT COMPLETED|Period Two||0
8134269|NCT02770521|20050429|P5|NOT COMPLETED|Period Two||0
8134270|NCT02770521|20050430|P4|NOT COMPLETED|Period Two||0
8134271|NCT02770521|20050431|P3|NOT COMPLETED|Period Two||0
8134272|NCT02770521|20050432|P2|NOT COMPLETED|Period Two||0
8134273|NCT02770521|20050433|P1|NOT COMPLETED|Period Two||0
8134274|NCT02770521|20050428|P6|COMPLETED|Period Two||9
8134275|NCT02770521|20050429|P5|COMPLETED|Period Two||2
8134276|NCT02770521|20050430|P4|COMPLETED|Period Two||2
8134277|NCT02770521|20050431|P3|COMPLETED|Period Two||2
8134278|NCT02770521|20050432|P2|COMPLETED|Period Two||4
8134279|NCT02770521|20050433|P1|COMPLETED|Period Two||4
8134280|NCT02770521|20050428|P6|Received Study Drug|Period Two||9
8134281|NCT02770521|20050429|P5|Received Study Drug|Period Two||2
8134282|NCT02770521|20050430|P4|Received Study Drug|Period Two||2
8134283|NCT02770521|20050431|P3|Received Study Drug|Period Two||2
8134284|NCT02770521|20050432|P2|Received Study Drug|Period Two||4
8134285|NCT02770521|20050433|P1|Received Study Drug|Period Two||4
8134286|NCT02770521|20050428|P6|STARTED|Period Two||9
8134287|NCT02770521|20050429|P5|STARTED|Period Two||2
8134288|NCT02770521|20050430|P4|STARTED|Period Two||2
8134289|NCT02770521|20050431|P3|STARTED|Period Two||2
8134290|NCT02770521|20050432|P2|STARTED|Period Two||4
8134291|NCT02770521|20050433|P1|STARTED|Period Two||4
8134292|NCT02770521|20050428|P6|NOT COMPLETED|Period One||0
8134293|NCT02770521|20050429|P5|NOT COMPLETED|Period One||0
8134294|NCT02770521|20050430|P4|NOT COMPLETED|Period One||0
8134295|NCT02770521|20050431|P3|NOT COMPLETED|Period One||0
8134296|NCT02770521|20050432|P2|NOT COMPLETED|Period One||0
8134297|NCT02770521|20050433|P1|NOT COMPLETED|Period One||0
8134298|NCT02770521|20050428|P6|COMPLETED|Period One||9
8134299|NCT02770521|20050429|P5|COMPLETED|Period One||2
8134300|NCT02770521|20050430|P4|COMPLETED|Period One||2
8134301|NCT02770521|20050431|P3|COMPLETED|Period One||2
8134302|NCT02770521|20050432|P2|COMPLETED|Period One||4
8134303|NCT02770521|20050433|P1|COMPLETED|Period One||4
8134304|NCT02770521|20050428|P6|Received Study Drug|Period One||9
8134305|NCT02770521|20050429|P5|Received Study Drug|Period One||2
8134306|NCT02770521|20050430|P4|Received Study Drug|Period One||2
8134307|NCT02770521|20050431|P3|Received Study Drug|Period One||2
8134308|NCT02770521|20050432|P2|Received Study Drug|Period One||4
8134309|NCT02770521|20050433|P1|Received Study Drug|Period One||4
8134310|NCT02770521|20050428|P6|STARTED|Period One||9
8134311|NCT02770521|20050429|P5|STARTED|Period One||2
8134312|NCT02770521|20050430|P4|STARTED|Period One||2
8134313|NCT02770521|20050431|P3|STARTED|Period One||2
8134314|NCT02770521|20050432|P2|STARTED|Period One||4
8134315|NCT02770521|20050433|P1|STARTED|Period One||4
8134316|NCT02770365|20050458|P3|NOT COMPLETED|Overall Study||0
8134317|NCT02770365|20050459|P2|NOT COMPLETED|Overall Study||4
8134318|NCT02770365|20050460|P1|NOT COMPLETED|Overall Study||5
8134319|NCT02770365|20050458|P3|COMPLETED|Overall Study||139
8134320|NCT02770365|20050459|P2|COMPLETED|Overall Study||275
8134321|NCT02770365|20050460|P1|COMPLETED|Overall Study||272
8134322|NCT02770365|20050458|P3|STARTED|Overall Study||139
8134323|NCT02770365|20050459|P2|STARTED|Overall Study||279
8134324|NCT02770365|20050460|P1|STARTED|Overall Study||277
8134325|NCT02770287|20050470|P1|NOT COMPLETED|Overall Study||0
8134326|NCT02770287|20050470|P1|COMPLETED|Overall Study||11
8134327|NCT02770287|20050470|P1|STARTED|Overall Study||11
8134328|NCT02770248|20050479|P2|NOT COMPLETED|Overall Study||2
8134329|NCT02770248|20050480|P1|NOT COMPLETED|Overall Study||0
8134330|NCT02770248|20050479|P2|COMPLETED|Overall Study||61
8134331|NCT02770248|20050480|P1|COMPLETED|Overall Study||62
8134332|NCT02770248|20050479|P2|STARTED|Overall Study||63
8134333|NCT02770248|20050480|P1|STARTED|Overall Study||62
8134334|NCT02770014|20050492|P1|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
8134335|NCT02770014|20050492|P1|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
8134336|NCT02770014|20050492|P1|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
8134337|NCT02770014|20050492|P1|NOT COMPLETED|Plasma Genotyping||0
8134338|NCT02770014|20050492|P1|COMPLETED|Plasma Genotyping||43
8134339|NCT02770014|20050492|P1|STARTED|Plasma Genotyping||43
8134340|NCT02769858|20050498|P1|NOT COMPLETED|Overall Study||2
8134341|NCT02769858|20050498|P1|COMPLETED|Overall Study||8
8134342|NCT02769858|20050498|P1|STARTED|Overall Study||10
8134343|NCT02769702|20050504|P1|NOT COMPLETED|Overall Study||0
8134344|NCT02769702|20050504|P1|COMPLETED|Overall Study||2
8134345|NCT02769702|20050504|P1|STARTED|Overall Study||2
8134346|NCT02769624|20050509|P2|NOT COMPLETED|Overall Study||1
8134347|NCT02769624|20050510|P1|NOT COMPLETED|Overall Study||0
8134348|NCT02769624|20050509|P2|COMPLETED|Overall Study||7
8134349|NCT02769624|20050510|P1|COMPLETED|Overall Study||7
8134350|NCT02769624|20050509|P2|STARTED|Overall Study||8
8134351|NCT02769624|20050510|P1|STARTED|Overall Study||7
8134352|NCT02769442|20050528|P2|NOT COMPLETED|Overall Study||0
8134353|NCT02769442|20050529|P1|NOT COMPLETED|Overall Study||0
8134354|NCT02769442|20050528|P2|COMPLETED|Overall Study||291
8134355|NCT02769442|20050529|P1|COMPLETED|Overall Study||309
8134356|NCT02769442|20050528|P2|STARTED|Overall Study||291
8134357|NCT02769442|20050529|P1|STARTED|Overall Study||309
8134358|NCT02769312|20050539|P2|NOT COMPLETED|Follow-up||1
8134359|NCT02769312|20050540|P1|NOT COMPLETED|Follow-up||1
8134360|NCT02769312|20050539|P2|COMPLETED|Follow-up||23
8134361|NCT02769312|20050540|P1|COMPLETED|Follow-up||22
8134362|NCT02769312|20050539|P2|STARTED|Follow-up||24
8134363|NCT02769312|20050540|P1|STARTED|Follow-up||23
8134364|NCT02769312|20050539|P2|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
8134365|NCT02769312|20050540|P1|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
8134366|NCT02769312|20050539|P2|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
8134367|NCT02769312|20050540|P1|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
8134368|NCT02769312|20050539|P2|STARTED|Unblinded (Optional 2-4 Weeks)||24
8134369|NCT02769312|20050540|P1|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
8134370|NCT02769312|20050539|P2|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
8134371|NCT02769312|20050540|P1|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
8134372|NCT02769312|20050539|P2|COMPLETED|Double-Blind (0-2 Weeks)||24
8134373|NCT02769312|20050540|P1|COMPLETED|Double-Blind (0-2 Weeks)||23
8134374|NCT02769312|20050539|P2|STARTED|Double-Blind (0-2 Weeks)||25
8134375|NCT02769312|20050540|P1|STARTED|Double-Blind (0-2 Weeks)||25
8134376|NCT02769247|20050557|P4|NOT COMPLETED|Overall Study||1
8134377|NCT02769247|20050558|P3|NOT COMPLETED|Overall Study||1
8134378|NCT02769247|20050559|P2|NOT COMPLETED|Overall Study||0
8134379|NCT02769247|20050560|P1|NOT COMPLETED|Overall Study||2
8134380|NCT02769247|20050557|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
8134381|NCT02769247|20050558|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
8134382|NCT02769247|20050559|P2|COMPLETED|Overall Study||40
8134383|NCT02769247|20050560|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
8134384|NCT02769247|20050557|P4|STARTED|Overall Study||40
8134385|NCT02769247|20050558|P3|STARTED|Overall Study||40
8134386|NCT02769247|20050559|P2|STARTED|Overall Study||40
8134387|NCT02769247|20050560|P1|STARTED|Overall Study||40
8134388|NCT02769065|20050628|P30|NOT COMPLETED|Overall Study||0
8134389|NCT02769065|20050629|P29|NOT COMPLETED|Overall Study||0
8134390|NCT02769065|20050630|P28|NOT COMPLETED|Overall Study||0
8134391|NCT02769065|20050631|P27|NOT COMPLETED|Overall Study||0
8134392|NCT02769065|20050632|P26|NOT COMPLETED|Overall Study||0
8134393|NCT02769065|20050633|P25|NOT COMPLETED|Overall Study||0
8134394|NCT02769065|20050634|P24|NOT COMPLETED|Overall Study||0
8134395|NCT02769065|20050635|P23|NOT COMPLETED|Overall Study||0
8134396|NCT02769065|20050636|P22|NOT COMPLETED|Overall Study||0
8134397|NCT02769065|20050637|P21|NOT COMPLETED|Overall Study||0
8134398|NCT02769065|20050638|P20|NOT COMPLETED|Overall Study||0
8134399|NCT02769065|20050639|P19|NOT COMPLETED|Overall Study||0
8134400|NCT02769065|20050640|P18|NOT COMPLETED|Overall Study||0
8134401|NCT02769065|20050641|P17|NOT COMPLETED|Overall Study||0
8134402|NCT02769065|20050642|P16|NOT COMPLETED|Overall Study||0
8134403|NCT02769065|20050643|P15|NOT COMPLETED|Overall Study||0
8134404|NCT02769065|20050644|P14|NOT COMPLETED|Overall Study||0
8134405|NCT02769065|20050645|P13|NOT COMPLETED|Overall Study||0
8134406|NCT02769065|20050646|P12|NOT COMPLETED|Overall Study||0
8134407|NCT02769065|20050647|P11|NOT COMPLETED|Overall Study||1
8134408|NCT02769065|20050648|P10|NOT COMPLETED|Overall Study||0
8134409|NCT02769065|20050649|P9|NOT COMPLETED|Overall Study||0
8134410|NCT02769065|20050650|P8|NOT COMPLETED|Overall Study||0
8134411|NCT02769065|20050651|P7|NOT COMPLETED|Overall Study||1
8134412|NCT02769065|20050652|P6|NOT COMPLETED|Overall Study||0
8134413|NCT02769065|20050653|P5|NOT COMPLETED|Overall Study||0
8134414|NCT02769065|20050654|P4|NOT COMPLETED|Overall Study||0
8134415|NCT02769065|20050655|P3|NOT COMPLETED|Overall Study||0
8134416|NCT02769065|20050656|P2|NOT COMPLETED|Overall Study||0
8134417|NCT02769065|20050657|P1|NOT COMPLETED|Overall Study||1
8134418|NCT02769065|20050628|P30|COMPLETED|Overall Study||6
8134419|NCT02769065|20050629|P29|COMPLETED|Overall Study||6
8134420|NCT02769065|20050630|P28|COMPLETED|Overall Study||5
8134421|NCT02769065|20050631|P27|COMPLETED|Overall Study||9
8134422|NCT02769065|20050632|P26|COMPLETED|Overall Study||9
8134423|NCT02769065|20050633|P25|COMPLETED|Overall Study||6
8134424|NCT02769065|20050634|P24|COMPLETED|Overall Study||6
8134425|NCT02769065|20050635|P23|COMPLETED|Overall Study||4
8134426|NCT02769065|20050636|P22|COMPLETED|Overall Study||4
8134427|NCT02769065|20050637|P21|COMPLETED|Overall Study||4
8134428|NCT02769065|20050638|P20|COMPLETED|Overall Study||0
8134429|NCT02769065|20050639|P19|COMPLETED|Overall Study||5
8134430|NCT02769065|20050640|P18|COMPLETED|Overall Study||5
8134431|NCT02769065|20050641|P17|COMPLETED|Overall Study||5
8134432|NCT02769065|20050642|P16|COMPLETED|Overall Study||3
8134433|NCT02769065|20050643|P15|COMPLETED|Overall Study||6
8134434|NCT02769065|20050644|P14|COMPLETED|Overall Study||6
8134435|NCT02769065|20050645|P13|COMPLETED|Overall Study||6
8134436|NCT02769065|20050646|P12|COMPLETED|Overall Study||6
8134437|NCT02769065|20050647|P11|COMPLETED|Overall Study||5
8134438|NCT02769065|20050648|P10|COMPLETED|Overall Study||6
8134439|NCT02769065|20050649|P9|COMPLETED|Overall Study||6
8134440|NCT02769065|20050650|P8|COMPLETED|Overall Study||6
8134441|NCT02769065|20050651|P7|COMPLETED|Overall Study||6
8134442|NCT02769065|20050652|P6|COMPLETED|Overall Study||6
8134443|NCT02769065|20050653|P5|COMPLETED|Overall Study||6
8134444|NCT02769065|20050654|P4|COMPLETED|Overall Study||6
8134445|NCT02769065|20050655|P3|COMPLETED|Overall Study||6
8134446|NCT02769065|20050656|P2|COMPLETED|Overall Study||6
8134447|NCT02769065|20050657|P1|COMPLETED|Overall Study||16
8134448|NCT02769065|20050628|P30|STARTED|Overall Study||6
8134449|NCT02769065|20050629|P29|STARTED|Overall Study||6
8134450|NCT02769065|20050630|P28|STARTED|Overall Study||5
8134451|NCT02769065|20050631|P27|STARTED|Overall Study||9
8134452|NCT02769065|20050632|P26|STARTED|Overall Study||9
8134453|NCT02769065|20050633|P25|STARTED|Overall Study||6
8134454|NCT02769065|20050634|P24|STARTED|Overall Study||6
8134455|NCT02769065|20050635|P23|STARTED|Overall Study||4
8134456|NCT02769065|20050636|P22|STARTED|Overall Study||4
8134457|NCT02769065|20050637|P21|STARTED|Overall Study||4
8134458|NCT02769065|20050638|P20|STARTED|Overall Study||0
8134459|NCT02769065|20050639|P19|STARTED|Overall Study||5
8134460|NCT02769065|20050640|P18|STARTED|Overall Study||5
8134461|NCT02769065|20050641|P17|STARTED|Overall Study||5
8134462|NCT02769065|20050642|P16|STARTED|Overall Study||3
8134463|NCT02769065|20050643|P15|STARTED|Overall Study||6
8134464|NCT02769065|20050644|P14|STARTED|Overall Study||6
8134465|NCT02769065|20050645|P13|STARTED|Overall Study||6
8134466|NCT02769065|20050646|P12|STARTED|Overall Study||6
8134467|NCT02769065|20050647|P11|STARTED|Overall Study||6
8134468|NCT02769065|20050648|P10|STARTED|Overall Study||6
8134469|NCT02769065|20050649|P9|STARTED|Overall Study||6
8134470|NCT02769065|20050650|P8|STARTED|Overall Study||6
8134471|NCT02769065|20050651|P7|STARTED|Overall Study||7
8134472|NCT02769065|20050652|P6|STARTED|Overall Study||6
8134473|NCT02769065|20050653|P5|STARTED|Overall Study||6
8134474|NCT02769065|20050654|P4|STARTED|Overall Study||6
8134475|NCT02769065|20050655|P3|STARTED|Overall Study||6
8134476|NCT02769065|20050656|P2|STARTED|Overall Study||6
8134477|NCT02769065|20050657|P1|STARTED|Overall Study||17
8134478|NCT02768870|20051067|P1|NOT COMPLETED|Overall Study||26
8134479|NCT02768870|20051067|P1|COMPLETED|Overall Study||0
8134480|NCT02768870|20051067|P1|Implanted With Device|Overall Study||24
8134481|NCT02768870|20051067|P1|STARTED|Overall Study||26
8134482|NCT02768753|20051077|P2|NOT COMPLETED|Overall Study||0
8134483|NCT02768753|20051078|P1|NOT COMPLETED|Overall Study||0
8134484|NCT02768753|20051077|P2|COMPLETED|Overall Study||30
8134485|NCT02768753|20051078|P1|COMPLETED|Overall Study||30
8134486|NCT02768753|20051077|P2|STARTED|Overall Study||30
8134487|NCT02768753|20051078|P1|STARTED|Overall Study||30
8134488|NCT02768558|20051092|P2|NOT COMPLETED|Overall Study||0
8134489|NCT02768558|20051093|P1|NOT COMPLETED|Overall Study||0
8134490|NCT02768558|20051092|P2|COMPLETED|Overall Study||5
8134491|NCT02768558|20051093|P1|COMPLETED|Overall Study||3
8134492|NCT02768558|20051092|P2|Eligible|Overall Study||5
8134493|NCT02768558|20051093|P1|Eligible|Overall Study||3
8134494|NCT02768558|20051092|P2|STARTED|Overall Study||5
8134495|NCT02768558|20051093|P1|STARTED|Overall Study||3
8134496|NCT02768298|20051111|P2|NOT COMPLETED|Overall Study||7
8134497|NCT02768298|20051112|P1|NOT COMPLETED|Overall Study||4
8134498|NCT02768298|20051111|P2|COMPLETED|Overall Study||91
8134499|NCT02768298|20051112|P1|COMPLETED|Overall Study||99
8134500|NCT02768298|20051111|P2|STARTED|Overall Study||98
8134501|NCT02768298|20051112|P1|STARTED|Overall Study||103
8134502|NCT02768194|20051126|P6|NOT COMPLETED|Period 3||0
8134503|NCT02768194|20051127|P5|NOT COMPLETED|Period 3||0
8134504|NCT02768194|20051128|P4|NOT COMPLETED|Period 3||0
8134505|NCT02768194|20051129|P3|NOT COMPLETED|Period 3||0
8134506|NCT02768194|20051130|P2|NOT COMPLETED|Period 3||1
8134507|NCT02768194|20051131|P1|NOT COMPLETED|Period 3||0
8134508|NCT02768194|20051126|P6|COMPLETED|Period 3||4
8134509|NCT02768194|20051127|P5|COMPLETED|Period 3||4
8134510|NCT02768194|20051128|P4|COMPLETED|Period 3||3
8134511|NCT02768194|20051129|P3|COMPLETED|Period 3||4
8134512|NCT02768194|20051130|P2|COMPLETED|Period 3||3
8134513|NCT02768194|20051131|P1|COMPLETED|Period 3||3
8134514|NCT02768194|20051126|P6|STARTED|Period 3||4
8134515|NCT02768194|20051127|P5|STARTED|Period 3||4
8134516|NCT02768194|20051128|P4|STARTED|Period 3||3
8134517|NCT02768194|20051129|P3|STARTED|Period 3||4
8134518|NCT02768194|20051130|P2|STARTED|Period 3||4
8134519|NCT02768194|20051131|P1|STARTED|Period 3||3
8134520|NCT02768194|20051126|P6|NOT COMPLETED|Period 2||0
8134521|NCT02768194|20051127|P5|NOT COMPLETED|Period 2||0
8134522|NCT02768194|20051128|P4|NOT COMPLETED|Period 2||0
8134523|NCT02768194|20051129|P3|NOT COMPLETED|Period 2||0
8134524|NCT02768194|20051130|P2|NOT COMPLETED|Period 2||0
8134525|NCT02768194|20051131|P1|NOT COMPLETED|Period 2||1
8134526|NCT02768194|20051126|P6|COMPLETED|Period 2||4
8134527|NCT02768194|20051127|P5|COMPLETED|Period 2||4
8134528|NCT02768194|20051128|P4|COMPLETED|Period 2||3
8134529|NCT02768194|20051129|P3|COMPLETED|Period 2||4
8134530|NCT02768194|20051130|P2|COMPLETED|Period 2||4
8134531|NCT02768194|20051131|P1|COMPLETED|Period 2||3
8134532|NCT02768194|20051126|P6|STARTED|Period 2||4
8134533|NCT02768194|20051127|P5|STARTED|Period 2||4
8134534|NCT02768194|20051128|P4|STARTED|Period 2||3
8134535|NCT02768194|20051129|P3|STARTED|Period 2||4
8134536|NCT02768194|20051130|P2|STARTED|Period 2||4
8134537|NCT02768194|20051131|P1|STARTED|Period 2||4
8134538|NCT02768194|20051126|P6|NOT COMPLETED|Period 1||0
8134539|NCT02768194|20051127|P5|NOT COMPLETED|Period 1||0
8134540|NCT02768194|20051128|P4|NOT COMPLETED|Period 1||1
8134541|NCT02768194|20051129|P3|NOT COMPLETED|Period 1||0
8134542|NCT02768194|20051130|P2|NOT COMPLETED|Period 1||0
8134543|NCT02768194|20051131|P1|NOT COMPLETED|Period 1||0
8134544|NCT02768194|20051126|P6|COMPLETED|Period 1||4
8134545|NCT02768194|20051127|P5|COMPLETED|Period 1||4
8134546|NCT02768194|20051128|P4|COMPLETED|Period 1||3
8134547|NCT02768194|20051129|P3|COMPLETED|Period 1||4
8134548|NCT02768194|20051130|P2|COMPLETED|Period 1||4
8134549|NCT02768194|20051131|P1|COMPLETED|Period 1||4
8134550|NCT02768194|20051126|P6|STARTED|Period 1||4
8134551|NCT02768194|20051127|P5|STARTED|Period 1||4
8134552|NCT02768194|20051128|P4|STARTED|Period 1||4
8134553|NCT02768194|20051129|P3|STARTED|Period 1||4
8134554|NCT02768194|20051130|P2|STARTED|Period 1||4
8134555|NCT02768194|20051131|P1|STARTED|Period 1||4
8134556|NCT02768129|20051144|P2|NOT COMPLETED|Overall Study||0
8134557|NCT02768129|20051145|P1|NOT COMPLETED|Overall Study||0
8134558|NCT02768129|20051144|P2|COMPLETED|Overall Study||10
8134559|NCT02768129|20051145|P1|COMPLETED|Overall Study||11
8134560|NCT02768129|20051144|P2|STARTED|Overall Study||10
8134561|NCT02768129|20051145|P1|STARTED|Overall Study||11
8134562|NCT02768103|20051153|P1|NOT COMPLETED|Overall Study||1
8134563|NCT02768103|20051153|P1|COMPLETED|Overall Study||4
8134564|NCT02768103|20051153|P1|STARTED|Overall Study||5
8134565|NCT02767947|20051160|P2|NOT COMPLETED|Overall Study||0
8134566|NCT02767947|20051161|P1|NOT COMPLETED|Overall Study||0
8134567|NCT02767947|20051160|P2|COMPLETED|Overall Study||15
8134568|NCT02767947|20051161|P1|COMPLETED|Overall Study||60
8134569|NCT02767947|20051160|P2|Pharmacokinetic (PK) Population|Overall Study||3
8134570|NCT02767947|20051161|P1|Pharmacokinetic (PK) Population|Overall Study||12
8134571|NCT02767947|20051160|P2|Safety Population|Overall Study||15
8134572|NCT02767947|20051161|P1|Safety Population|Overall Study||60
8134573|NCT02767947|20051160|P2|STARTED|Overall Study||15
8134574|NCT02767947|20051161|P1|STARTED|Overall Study||60
8134575|NCT02767934|20051169|P1|NOT COMPLETED|Overall Study||0
8134576|NCT02767934|20051169|P1|COMPLETED|Overall Study||12
8134577|NCT02767934|20051169|P1|STARTED|Overall Study||12
8134578|NCT02767869|20051177|P2|NOT COMPLETED|Overall Study||0
8134579|NCT02767869|20051178|P1|NOT COMPLETED|Overall Study||0
8134580|NCT02767869|20051177|P2|COMPLETED|Overall Study||12
8134581|NCT02767869|20051178|P1|COMPLETED|Overall Study||12
8134582|NCT02767869|20051177|P2|STARTED|Overall Study||12
8134583|NCT02767869|20051178|P1|STARTED|Overall Study||12
8134584|NCT02767843|20051208|P1|NOT COMPLETED|Overall Study||0
8134585|NCT02767843|20051208|P1|COMPLETED|Overall Study||4
8134586|NCT02767843|20051208|P1|STARTED|Overall Study||4
8134587|NCT02767765|20051214|P1|NOT COMPLETED|Overall Study||11
8134588|NCT02767765|20051214|P1|COMPLETED|Overall Study||50
8134589|NCT02767765|20051214|P1|STARTED|Overall Study||61
8134590|NCT02767609|20051223|P1|NOT COMPLETED|Overall Study||0
8134591|NCT02767609|20051223|P1|COMPLETED|Overall Study||1
8134592|NCT02767609|20051223|P1|STARTED|Overall Study||1
8134617|NCT02767427|20051236|P2|NOT COMPLETED|Overall Study||0
8134618|NCT02767427|20051237|P1|NOT COMPLETED|Overall Study||0
8134619|NCT02767427|20051236|P2|COMPLETED|Overall Study||19
8134620|NCT02767427|20051237|P1|COMPLETED|Overall Study||21
8134621|NCT02767427|20051236|P2|STARTED|Overall Study||19
8134622|NCT02767427|20051237|P1|STARTED|Overall Study||21
8134623|NCT02767388|20051246|P3|NOT COMPLETED|Overall Study||3
8134624|NCT02767388|20051247|P2|NOT COMPLETED|Overall Study||5
8134625|NCT02767388|20051248|P1|NOT COMPLETED|Overall Study||7
8134626|NCT02767388|20051246|P3|COMPLETED|Overall Study||12
8134627|NCT02767388|20051247|P2|COMPLETED|Overall Study||10
8134628|NCT02767388|20051248|P1|COMPLETED|Overall Study||8
8134629|NCT02767388|20051246|P3|STARTED|Overall Study||15
8134630|NCT02767388|20051247|P2|STARTED|Overall Study||15
8134631|NCT02767388|20051248|P1|STARTED|Overall Study||15
8134632|NCT02767271|20051267|P2|NOT COMPLETED|Overall Study||0
8134633|NCT02767271|20051268|P1|NOT COMPLETED|Overall Study||0
8134634|NCT02767271|20051267|P2|COMPLETED|Overall Study||15
8134635|NCT02767271|20051268|P1|COMPLETED|Overall Study||15
8134636|NCT02767271|20051267|P2|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
8134637|NCT02767271|20051268|P1|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
8134638|NCT02767271|20051267|P2|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
8134639|NCT02767271|20051268|P1|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
8134640|NCT02767271|20051267|P2|Safety Population|Overall Study||15
8134641|NCT02767271|20051268|P1|Safety Population|Overall Study||15
8134642|NCT02767271|20051267|P2|STARTED|Overall Study||15
8134643|NCT02767271|20051268|P1|STARTED|Overall Study||15
8134644|NCT02767128|20051278|P1|NOT COMPLETED|Overall Study||0
8134645|NCT02767128|20051278|P1|COMPLETED|Overall Study||14
8134646|NCT02767128|20051278|P1|Shohl's + Triferic Immediately|Overall Study||14
8134647|NCT02767128|20051278|P1|Shohl's + Triferic After 10 Min|Overall Study||14
8134648|NCT02767128|20051278|P1|Triferic|Overall Study||14
8134649|NCT02767128|20051278|P1|Shohl's + Fer-In-Sol|Overall Study||14
8134650|NCT02767128|20051278|P1|Fer-In-Sol|Overall Study||14
8134651|NCT02767128|20051278|P1|Baseline|Overall Study||14
8134652|NCT02767128|20051278|P1|STARTED|Overall Study||14
8134653|NCT02767011|20051306|P2|NOT COMPLETED|Overall Study||0
8134654|NCT02767011|20051307|P1|NOT COMPLETED|Overall Study||0
8134655|NCT02767011|20051306|P2|COMPLETED|Overall Study||14
8134656|NCT02767011|20051307|P1|COMPLETED|Overall Study||16
8134657|NCT02767011|20051306|P2|STARTED|Overall Study||14
8134658|NCT02767011|20051307|P1|STARTED|Overall Study||16
8134659|NCT02766907|20051331|P2|NOT COMPLETED|Overall Study||1
8134660|NCT02766907|20051332|P1|NOT COMPLETED|Overall Study||1
8134661|NCT02766907|20051331|P2|COMPLETED|Overall Study||9
8134662|NCT02766907|20051332|P1|COMPLETED|Overall Study||9
8134663|NCT02766907|20051331|P2|STARTED|Overall Study||10
8134664|NCT02766907|20051332|P1|STARTED|Overall Study||10
8134665|NCT02766777|20051340|P1|NOT COMPLETED|Overall Study||34
8134666|NCT02766777|20051340|P1|COMPLETED|Overall Study||53
8134667|NCT02766777|20051340|P1|Treated (Safety [SAF] Population)|Overall Study||87
8134668|NCT02766777|20051340|P1|STARTED|Overall Study||87
8134669|NCT02766673|20051344|P6|NOT COMPLETED|Overall Study||1
8134670|NCT02766673|20051345|P5|NOT COMPLETED|Overall Study||0
8134671|NCT02766673|20051346|P4|NOT COMPLETED|Overall Study||0
8134672|NCT02766673|20051347|P3|NOT COMPLETED|Overall Study||0
8134673|NCT02766673|20051348|P2|NOT COMPLETED|Overall Study||0
8134674|NCT02766673|20051349|P1|NOT COMPLETED|Overall Study||1
8134675|NCT02766673|20051344|P6|COMPLETED|Overall Study||3
8134676|NCT02766673|20051345|P5|COMPLETED|Overall Study||4
8134677|NCT02766673|20051346|P4|COMPLETED|Overall Study||4
8134678|NCT02766673|20051347|P3|COMPLETED|Overall Study||4
8134679|NCT02766673|20051348|P2|COMPLETED|Overall Study||4
8134680|NCT02766673|20051349|P1|COMPLETED|Overall Study||3
8134681|NCT02766673|20051344|P6|STARTED|Overall Study||4
8134682|NCT02766673|20051345|P5|STARTED|Overall Study||4
8134683|NCT02766673|20051346|P4|STARTED|Overall Study||4
8134684|NCT02766673|20051347|P3|STARTED|Overall Study||4
8134685|NCT02766673|20051348|P2|STARTED|Overall Study||4
8134686|NCT02766673|20051349|P1|STARTED|Overall Study||4
8134687|NCT02766608|20051365|P5|NOT COMPLETED|Overall Study||29
8134688|NCT02766608|20051366|P4|NOT COMPLETED|Overall Study||37
8134689|NCT02766608|20051367|P3|NOT COMPLETED|Overall Study||90
8134690|NCT02766608|20051368|P2|NOT COMPLETED|Overall Study||70
8134691|NCT02766608|20051369|P1|NOT COMPLETED|Overall Study||79
8134692|NCT02766608|20051365|P5|COMPLETED|Overall Study||190
8134693|NCT02766608|20051366|P4|COMPLETED|Overall Study||169
8134694|NCT02766608|20051367|P3|COMPLETED|Overall Study||554
8134695|NCT02766608|20051368|P2|COMPLETED|Overall Study||567
8134696|NCT02766608|20051369|P1|COMPLETED|Overall Study||576
8134697|NCT02766608|20051365|P5|STARTED|Overall Study||219
8134698|NCT02766608|20051366|P4|STARTED|Overall Study||206
8134699|NCT02766608|20051367|P3|STARTED|Overall Study||644
8134700|NCT02766608|20051368|P2|STARTED|Overall Study||637
8134701|NCT02766608|20051369|P1|STARTED|Overall Study||655
8134702|NCT02766517|20051446|P3|NOT COMPLETED|Overall Study||0
8134703|NCT02766517|20051447|P2|NOT COMPLETED|Overall Study||0
8134704|NCT02766517|20051448|P1|NOT COMPLETED|Overall Study||0
8134705|NCT02766517|20051446|P3|COMPLETED|Overall Study||9
8134706|NCT02766517|20051447|P2|COMPLETED|Overall Study||9
8134707|NCT02766517|20051448|P1|COMPLETED|Overall Study||19
8134708|NCT02766517|20051446|P3|STARTED|Overall Study||9
8134709|NCT02766517|20051447|P2|STARTED|Overall Study||9
8134710|NCT02766517|20051448|P1|STARTED|Overall Study||19
8134711|NCT02766400|20051461|P2|NOT COMPLETED|Overall Study||2
8134712|NCT02766400|20051462|P1|NOT COMPLETED|Overall Study||2
8134713|NCT02766400|20051461|P2|COMPLETED|Overall Study||20
8134714|NCT02766400|20051462|P1|COMPLETED|Overall Study||19
8134715|NCT02766400|20051461|P2|STARTED|Overall Study||22
8134716|NCT02766400|20051462|P1|STARTED|Overall Study||21
8134717|NCT02766374|20051470|P2|NOT COMPLETED|Overall Study||3
8134718|NCT02766374|20051471|P1|NOT COMPLETED|Overall Study||10
8134719|NCT02766374|20051470|P2|COMPLETED|Overall Study||30
8134720|NCT02766374|20051471|P1|COMPLETED|Overall Study||25
8134721|NCT02766374|20051470|P2|STARTED|Overall Study||33
8134722|NCT02766374|20051471|P1|STARTED|Overall Study||35
8134723|NCT02766283|20051477|P1|NOT COMPLETED|Overall Study||27
8134724|NCT02766283|20051477|P1|COMPLETED|Overall Study||816
8134725|NCT02766283|20051477|P1|STARTED|Overall Study||843
8134726|NCT02766244|20051501|P1|NOT COMPLETED|Overall Study||0
8134727|NCT02766244|20051501|P1|COMPLETED|Overall Study||3
8134728|NCT02766244|20051501|P1|STARTED|Overall Study||3
8134729|NCT02766088|20051510|P1|NOT COMPLETED|Overall Study||506
8134730|NCT02766088|20051510|P1|COMPLETED|Overall Study||344
8134731|NCT02766088|20051510|P1|STARTED|Overall Study||850
8134732|NCT02766023|20051525|P2|NOT COMPLETED|Overall Study||17
8134733|NCT02766023|20051526|P1|NOT COMPLETED|Overall Study||30
8134734|NCT02766023|20051525|P2|COMPLETED|Overall Study||59
8134735|NCT02766023|20051526|P1|COMPLETED|Overall Study||122
8134736|NCT02766023|20051525|P2|STARTED|Overall Study||76
8134737|NCT02766023|20051526|P1|STARTED|Overall Study||152
8134738|NCT02765490|20051576|P2|NOT COMPLETED|Overall Study||3
8134739|NCT02765490|20051577|P1|NOT COMPLETED|Overall Study||1
8134740|NCT02765490|20051576|P2|COMPLETED|Overall Study||179
8134741|NCT02765490|20051577|P1|COMPLETED|Overall Study||182
8134742|NCT02765490|20051576|P2|STARTED|Overall Study||182
8134743|NCT02765490|20051577|P1|STARTED|Overall Study||183
8134744|NCT02765269|20051595|P2|NOT COMPLETED|Overall Study||0
8134745|NCT02765269|20051596|P1|NOT COMPLETED|Overall Study||0
8134746|NCT02765269|20051595|P2|COMPLETED|Overall Study||21
8134747|NCT02765269|20051596|P1|COMPLETED|Overall Study||25
8134748|NCT02765269|20051595|P2|STARTED|Overall Study||21
8134749|NCT02765269|20051596|P1|STARTED|Overall Study||25
8134750|NCT02765100|20051610|P2|NOT COMPLETED|Overall Study||2
8134751|NCT02765100|20051611|P1|NOT COMPLETED|Overall Study||1
8134752|NCT02765100|20051610|P2|COMPLETED|Overall Study||10
8134753|NCT02765100|20051611|P1|COMPLETED|Overall Study||8
8134754|NCT02765100|20051610|P2|STARTED|Overall Study||12
8134755|NCT02765100|20051611|P1|STARTED|Overall Study||9
8134756|NCT02764970|20051619|P2|NOT COMPLETED|Overall Study||0
8134757|NCT02764970|20051620|P1|NOT COMPLETED|Overall Study||0
8134758|NCT02764970|20051619|P2|COMPLETED|Overall Study||47
8134759|NCT02764970|20051620|P1|COMPLETED|Overall Study||65
8134760|NCT02764970|20051619|P2|STARTED|Overall Study||47
8134761|NCT02764970|20051620|P1|STARTED|Overall Study||65
8134762|NCT02764775|20051632|P1|NOT COMPLETED|Overall Study||6
8134763|NCT02764775|20051632|P1|COMPLETED|Overall Study||8
8134764|NCT02764775|20051632|P1|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
8134765|NCT02764697|20051636|P1|NOT COMPLETED|Overall Study||3
8134766|NCT02764697|20051636|P1|COMPLETED|Overall Study||2
8134767|NCT02764697|20051636|P1|STARTED|Overall Study||5
8134768|NCT02764229|20051641|P1|NOT COMPLETED|Overall Study||102
8134769|NCT02764229|20051641|P1|COMPLETED|Overall Study||10
8134770|NCT02764229|20051641|P1|STARTED|Overall Study||112
8134771|NCT02764190|20051647|P2|NOT COMPLETED|Overall Study||13
8134772|NCT02764190|20051648|P1|NOT COMPLETED|Overall Study||17
8134773|NCT02764190|20051647|P2|COMPLETED|Overall Study||122
8134774|NCT02764190|20051648|P1|COMPLETED|Overall Study||150
8134775|NCT02764190|20051647|P2|12 Month Follow-up|Overall Study||122
8134776|NCT02764190|20051648|P1|12 Month Follow-up|Overall Study||150
8134777|NCT02764190|20051647|P2|6 Month Follow-up|Overall Study||128
8134778|NCT02764190|20051648|P1|6 Month Follow-up|Overall Study||155
8134779|NCT02764190|20051647|P2|3 Month Follow-up|Overall Study||128
8134780|NCT02764190|20051648|P1|3 Month Follow-up|Overall Study||156
8134781|NCT02764190|20051647|P2|1 Day Follow-up|Overall Study||131
8134782|NCT02764190|20051648|P1|1 Day Follow-up|Overall Study||161
8134783|NCT02764190|20051647|P2|STARTED|Overall Study||135
8134784|NCT02764190|20051648|P1|STARTED|Overall Study||167
8134785|NCT02764164|20051692|P1|NOT COMPLETED|Overall Study||0
8134786|NCT02764164|20051692|P1|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
8134787|NCT02764164|20051692|P1|STARTED|Overall Study||1
8134788|NCT02764151|20051702|P4|NOT COMPLETED|Overall Study||3
8134789|NCT02764151|20051703|P3|NOT COMPLETED|Overall Study||0
8134790|NCT02764151|20051704|P2|NOT COMPLETED|Overall Study||0
8134791|NCT02764151|20051705|P1|NOT COMPLETED|Overall Study||0
8134792|NCT02764151|20051702|P4|COMPLETED|Overall Study||5
8134793|NCT02764151|20051703|P3|COMPLETED|Overall Study||3
8134794|NCT02764151|20051704|P2|COMPLETED|Overall Study||4
8134795|NCT02764151|20051705|P1|COMPLETED|Overall Study||2
8134796|NCT02764151|20051702|P4|STARTED|Overall Study||8
8134797|NCT02764151|20051703|P3|STARTED|Overall Study||3
8134798|NCT02764151|20051704|P2|STARTED|Overall Study||4
8134799|NCT02764151|20051705|P1|STARTED|Overall Study||2
8134800|NCT02763865|20051829|P2|NOT COMPLETED|Overall Study||0
8134801|NCT02763865|20051830|P1|NOT COMPLETED|Overall Study||0
8134802|NCT02763865|20051829|P2|COMPLETED|Overall Study||5
8134803|NCT02763865|20051830|P1|COMPLETED|Overall Study||5
8134804|NCT02763865|20051829|P2|STARTED|Overall Study||5
8134805|NCT02763865|20051830|P1|STARTED|Overall Study||5
8134806|NCT02763644|20051844|P2|NOT COMPLETED|Overall Study||2
8134807|NCT02763644|20051845|P1|NOT COMPLETED|Overall Study||3
8134808|NCT02763644|20051844|P2|COMPLETED|Overall Study||2
8134809|NCT02763644|20051845|P1|COMPLETED|Overall Study||0
8134810|NCT02763644|20051844|P2|STARTED|Overall Study||4
8134811|NCT02763644|20051845|P1|STARTED|Overall Study||3
8134812|NCT02763579|20051865|P2|NOT COMPLETED|Overall Study||202
8134813|NCT02763579|20051866|P1|NOT COMPLETED|Overall Study||201
8134814|NCT02763579|20051865|P2|COMPLETED|Overall Study||0
8134815|NCT02763579|20051866|P1|COMPLETED|Overall Study||0
8134816|NCT02763579|20051865|P2|STARTED|Overall Study||202
8134817|NCT02763579|20051866|P1|STARTED|Overall Study||201
8134830|NCT02763254|20051909|P1|NOT COMPLETED|Overall Study||1
8134831|NCT02763254|20051909|P1|COMPLETED|Overall Study||0
8134832|NCT02763254|20051909|P1|STARTED|Overall Study||1
8134833|NCT02763215|20051914|P1|NOT COMPLETED|Overall Study||7
8134834|NCT02763215|20051914|P1|COMPLETED|Overall Study||57
8134835|NCT02763215|20051914|P1|STARTED|Overall Study||64
8134836|NCT02763189|20051937|P2|NOT COMPLETED|Overall Study||2
8134837|NCT02763189|20051938|P1|NOT COMPLETED|Overall Study||0
8134838|NCT02763189|20051937|P2|COMPLETED|Overall Study||2
8134839|NCT02763189|20051938|P1|COMPLETED|Overall Study||4
8134840|NCT02763189|20051937|P2|STARTED|Overall Study||4
8134841|NCT02763189|20051938|P1|STARTED|Overall Study||4
8134842|NCT02763124|20051946|P1|NOT COMPLETED|Overall Study||0
8134843|NCT02763124|20051946|P1|COMPLETED|Overall Study||18
8134844|NCT02763124|20051946|P1|STARTED|Overall Study||18
8134845|NCT02763046|20051956|P3|NOT COMPLETED|Overall Study||8
8134846|NCT02763046|20051957|P2|NOT COMPLETED|Overall Study||5
8134847|NCT02763046|20051958|P1|NOT COMPLETED|Overall Study||9
8134848|NCT02763046|20051956|P3|COMPLETED|Overall Study||62
8134849|NCT02763046|20051957|P2|COMPLETED|Overall Study||65
8134850|NCT02763046|20051958|P1|COMPLETED|Overall Study||62
8134851|NCT02763046|20051956|P3|STARTED|Overall Study||70
8134852|NCT02763046|20051957|P2|STARTED|Overall Study||70
8134853|NCT02763046|20051958|P1|STARTED|Overall Study||71
8134854|NCT02762877|20051987|P2|NOT COMPLETED|Overall Study||0
8134855|NCT02762877|20051988|P1|NOT COMPLETED|Overall Study||0
8134856|NCT02762877|20051987|P2|COMPLETED|Overall Study||19
8134857|NCT02762877|20051988|P1|COMPLETED|Overall Study||121
8134858|NCT02762877|20051987|P2|STARTED|Overall Study||19
8134859|NCT02762877|20051988|P1|STARTED|Overall Study||121
8134860|NCT02762799|20051999|P4|NOT COMPLETED|Overall Study||0
8134861|NCT02762799|20052000|P3|NOT COMPLETED|Overall Study||1
8134862|NCT02762799|20052001|P2|NOT COMPLETED|Overall Study||0
8134863|NCT02762799|20052002|P1|NOT COMPLETED|Overall Study||0
8134864|NCT02762799|20051999|P4|COMPLETED|Overall Study||12
8134865|NCT02762799|20052000|P3|COMPLETED|Overall Study||11
8134866|NCT02762799|20052001|P2|COMPLETED|Overall Study||18
8134867|NCT02762799|20052002|P1|COMPLETED|Overall Study||18
8134868|NCT02762799|20051999|P4|STARTED|Overall Study||12
8134869|NCT02762799|20052000|P3|STARTED|Overall Study||12
8134870|NCT02762799|20052001|P2|STARTED|Overall Study||18
8134871|NCT02762799|20052002|P1|STARTED|Overall Study||18
8134872|NCT02762578|20052074|P2|NOT COMPLETED|Overall Study||10
8134873|NCT02762578|20052075|P1|NOT COMPLETED|Overall Study||15
8134874|NCT02762578|20052074|P2|COMPLETED|Overall Study||172
8134875|NCT02762578|20052075|P1|COMPLETED|Overall Study||346
8134876|NCT02762578|20052074|P2|Exposed|Overall Study||181
8134877|NCT02762578|20052075|P1|Exposed|Overall Study||360
8134878|NCT02762578|20052074|P2|STARTED|Overall Study||182
8134879|NCT02762578|20052075|P1|STARTED|Overall Study||361
8134880|NCT02762500|20052177|P2|NOT COMPLETED|Overall Study||3
8134881|NCT02762500|20052178|P1|NOT COMPLETED|Overall Study||2
8134882|NCT02762500|20052177|P2|COMPLETED|Overall Study||59
8134883|NCT02762500|20052178|P1|COMPLETED|Overall Study||60
8134884|NCT02762500|20052177|P2|STARTED|Overall Study||62
8134885|NCT02762500|20052178|P1|STARTED|Overall Study||62
8134886|NCT02762370|20052198|P2|NOT COMPLETED|Overall Study||0
8134887|NCT02762370|20052199|P1|NOT COMPLETED|Overall Study||1
8134888|NCT02762370|20052198|P2|COMPLETED|Overall Study||15
8134889|NCT02762370|20052199|P1|COMPLETED|Overall Study||17
8134890|NCT02762370|20052198|P2|STARTED|Overall Study||15
8134891|NCT02762370|20052199|P1|STARTED|Overall Study||18
8134892|NCT02762331|20052219|P2|NOT COMPLETED|Overall Study||0
8134893|NCT02762331|20052220|P1|NOT COMPLETED|Overall Study||0
8134894|NCT02762331|20052219|P2|COMPLETED|Overall Study||2
8134895|NCT02762331|20052220|P1|COMPLETED|Overall Study||4
8134896|NCT02762331|20052219|P2|STARTED|Overall Study||2
8134897|NCT02762331|20052220|P1|STARTED|Overall Study||4
8134898|NCT02762084|20052239|P3|NOT COMPLETED|Overall Study||1
8134899|NCT02762084|20052240|P2|NOT COMPLETED|Overall Study||0
8134900|NCT02762084|20052241|P1|NOT COMPLETED|Overall Study||1
8134901|NCT02762084|20052239|P3|COMPLETED|Overall Study||4
8134902|NCT02762084|20052240|P2|COMPLETED|Overall Study||6
8134903|NCT02762084|20052241|P1|COMPLETED|Overall Study||5
8134904|NCT02762084|20052239|P3|By Tumor Per Protocol Population (PP)|Overall Study||4
8134905|NCT02762084|20052240|P2|By Tumor Per Protocol Population (PP)|Overall Study||6
8134906|NCT02762084|20052241|P1|By Tumor Per Protocol Population (PP)|Overall Study||6
8134907|NCT02762084|20052239|P3|Received at Least 1 Dose of Study Drug|Overall Study||5
8134908|NCT02762084|20052240|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8134909|NCT02762084|20052241|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8134910|NCT02762084|20052239|P3|STARTED|Overall Study||5
8134911|NCT02762084|20052240|P2|STARTED|Overall Study||6
8134912|NCT02762084|20052241|P1|STARTED|Overall Study||6
8134913|NCT02762071|20052281|P2|NOT COMPLETED|Overall Study||0
8134914|NCT02762071|20052282|P1|NOT COMPLETED|Overall Study||0
8134915|NCT02762071|20052281|P2|COMPLETED|Overall Study||54
8134916|NCT02762071|20052282|P1|COMPLETED|Overall Study||54
8134917|NCT02762071|20052281|P2|STARTED|Overall Study||54
8134918|NCT02762071|20052282|P1|STARTED|Overall Study||54
8134919|NCT02761980|20052302|P4|NOT COMPLETED|Overall Study||6
8134920|NCT02761980|20052303|P3|NOT COMPLETED|Overall Study||6
8134921|NCT02761980|20052304|P2|NOT COMPLETED|Overall Study||7
8134922|NCT02761980|20052305|P1|NOT COMPLETED|Overall Study||4
8134923|NCT02761980|20052302|P4|COMPLETED|Overall Study||81
8134924|NCT02761980|20052303|P3|COMPLETED|Overall Study||81
8134925|NCT02761980|20052304|P2|COMPLETED|Overall Study||80
8134926|NCT02761980|20052305|P1|COMPLETED|Overall Study||25
8134927|NCT02761980|20052302|P4|STARTED|Overall Study||87
8134928|NCT02761980|20052303|P3|STARTED|Overall Study||87
8134929|NCT02761980|20052304|P2|STARTED|Overall Study||87
8134930|NCT02761980|20052305|P1|STARTED|Overall Study||29
8134931|NCT02761967|20052337|P2|NOT COMPLETED|Overall Study||6
8134932|NCT02761967|20052338|P1|NOT COMPLETED|Overall Study||5
8134933|NCT02761967|20052337|P2|COMPLETED|Overall Study||64
8134934|NCT02761967|20052338|P1|COMPLETED|Overall Study||65
8134935|NCT02761967|20052337|P2|STARTED|Overall Study||70
8134936|NCT02761967|20052338|P1|STARTED|Overall Study||70
8134937|NCT02761733|20052352|P4|NOT COMPLETED|Overall Study||15
8134938|NCT02761733|20052353|P3|NOT COMPLETED|Overall Study||27
8134939|NCT02761733|20052354|P2|NOT COMPLETED|Overall Study||21
8134940|NCT02761733|20052355|P1|NOT COMPLETED|Overall Study||30
8134941|NCT02761733|20052352|P4|COMPLETED|Overall Study||45
8134942|NCT02761733|20052353|P3|COMPLETED|Overall Study||33
8134943|NCT02761733|20052354|P2|COMPLETED|Overall Study||39
8134944|NCT02761733|20052355|P1|COMPLETED|Overall Study||30
8134945|NCT02761733|20052352|P4|9/30/2015|Overall Study||50
8134946|NCT02761733|20052353|P3|9/30/2015|Overall Study||33
8134947|NCT02761733|20052354|P2|9/30/2015|Overall Study||44
8134948|NCT02761733|20052355|P1|9/30/2015|Overall Study||40
8134949|NCT02761733|20052352|P4|3/31/2015|Overall Study||50
8134950|NCT02761733|20052353|P3|3/31/2015|Overall Study||43
8134951|NCT02761733|20052354|P2|3/31/2015|Overall Study||47
8134952|NCT02761733|20052355|P1|3/31/2015|Overall Study||48
8134953|NCT02761733|20052352|P4|9/30/2014|Overall Study||55
8134954|NCT02761733|20052353|P3|9/30/2014|Overall Study||48
8134955|NCT02761733|20052354|P2|9/30/2014|Overall Study||56
8134956|NCT02761733|20052355|P1|9/30/2014|Overall Study||53
8134957|NCT02761733|20052352|P4|STARTED|Overall Study||60
8134958|NCT02761733|20052353|P3|STARTED|Overall Study||60
8134959|NCT02761733|20052354|P2|STARTED|Overall Study||60
8134960|NCT02761733|20052355|P1|STARTED|Overall Study||60
8134961|NCT02761642|20052385|P1|NOT COMPLETED|Overall Study||70
8134962|NCT02761642|20052385|P1|COMPLETED|Overall Study||130
8134963|NCT02761642|20052385|P1|Treated|Overall Study||197
8134964|NCT02761642|20052385|P1|STARTED|Overall Study||200
8134965|NCT02761629|20052398|P2|NOT COMPLETED|Overall Study||32
8134966|NCT02761629|20052399|P1|NOT COMPLETED|Overall Study||27
8134967|NCT02761629|20052398|P2|COMPLETED|Overall Study||58
8134968|NCT02761629|20052399|P1|COMPLETED|Overall Study||63
8134969|NCT02761629|20052398|P2|Treated|Overall Study||86
8134970|NCT02761629|20052399|P1|Treated|Overall Study||82
8134971|NCT02761629|20052398|P2|STARTED|Overall Study||90
8134972|NCT02761629|20052399|P1|STARTED|Overall Study||90
8134973|NCT02761252|20052422|P3|NOT COMPLETED|Overall Study||14
8134974|NCT02761252|20052423|P2|NOT COMPLETED|Overall Study||8
8134975|NCT02761252|20052424|P1|NOT COMPLETED|Overall Study||10
8134976|NCT02761252|20052422|P3|COMPLETED|Overall Study||123
8134977|NCT02761252|20052423|P2|COMPLETED|Overall Study||132
8134978|NCT02761252|20052424|P1|COMPLETED|Overall Study||133
8134979|NCT02761252|20052422|P3|STARTED|Overall Study||137
8134980|NCT02761252|20052423|P2|STARTED|Overall Study||140
8134981|NCT02761252|20052424|P1|STARTED|Overall Study||143
8134982|NCT02760927|20052446|P1|NOT COMPLETED|Overall Study||1
8134983|NCT02760927|20052446|P1|COMPLETED|Overall Study||3
8134984|NCT02760927|20052446|P1|STARTED|Overall Study||4
8134985|NCT02760862|20052456|P2|NOT COMPLETED|Overall Study||0
8134986|NCT02760862|20052457|P1|NOT COMPLETED|Overall Study||0
8134987|NCT02760862|20052456|P2|COMPLETED|Overall Study||25
8134988|NCT02760862|20052457|P1|COMPLETED|Overall Study||25
8134989|NCT02760862|20052456|P2|STARTED|Overall Study||25
8134990|NCT02760862|20052457|P1|STARTED|Overall Study||25
8134991|NCT02760810|20052463|P1|NOT COMPLETED|Overall Study||1
8134992|NCT02760810|20052463|P1|COMPLETED|Overall Study||29
8134993|NCT02760810|20052463|P1|STARTED|Overall Study||30
8134994|NCT02760654|20052471|P2|NOT COMPLETED|Overall Study||6
8134995|NCT02760654|20052472|P1|NOT COMPLETED|Overall Study||7
8134996|NCT02760654|20052471|P2|COMPLETED|Overall Study||24
8134997|NCT02760654|20052472|P1|COMPLETED|Overall Study||23
8134998|NCT02760654|20052471|P2|STARTED|Overall Study||30
8134999|NCT02760654|20052472|P1|STARTED|Overall Study||30
8135000|NCT02760602|20052498|P2|NOT COMPLETED|Overall Study||13
8135001|NCT02760602|20052499|P1|NOT COMPLETED|Overall Study||13
8135002|NCT02760602|20052498|P2|COMPLETED|Overall Study||0
8135003|NCT02760602|20052499|P1|COMPLETED|Overall Study||0
8135004|NCT02760602|20052498|P2|STARTED|Overall Study||13
8135005|NCT02760602|20052499|P1|STARTED|Overall Study||13
8135006|NCT02760368|20052540|P3|NOT COMPLETED|Overall Study||11
8135007|NCT02760368|20052541|P2|NOT COMPLETED|Overall Study||8
8135008|NCT02760368|20052542|P1|NOT COMPLETED|Overall Study||13
8135009|NCT02760368|20052540|P3|COMPLETED|Overall Study||132
8135010|NCT02760368|20052541|P2|COMPLETED|Overall Study||134
8135011|NCT02760368|20052542|P1|COMPLETED|Overall Study||130
8135012|NCT02760368|20052540|P3|STARTED|Overall Study||143
8135013|NCT02760368|20052541|P2|STARTED|Overall Study||142
8135014|NCT02760368|20052542|P1|STARTED|Overall Study||143
8135015|NCT02760277|20052566|P4|NOT COMPLETED|6.0 mg/kg/Day||0
8135016|NCT02760277|20052567|P3|NOT COMPLETED|6.0 mg/kg/Day||0
8135017|NCT02760277|20052568|P2|NOT COMPLETED|6.0 mg/kg/Day||0
8135018|NCT02760277|20052569|P1|NOT COMPLETED|6.0 mg/kg/Day||0
8135019|NCT02760277|20052566|P4|COMPLETED|6.0 mg/kg/Day||12
8135020|NCT02760277|20052567|P3|COMPLETED|6.0 mg/kg/Day||0
8135021|NCT02760277|20052568|P2|COMPLETED|6.0 mg/kg/Day||0
8135022|NCT02760277|20052569|P1|COMPLETED|6.0 mg/kg/Day||0
8135023|NCT02760277|20052566|P4|STARTED|6.0 mg/kg/Day||12
8135024|NCT02760277|20052567|P3|STARTED|6.0 mg/kg/Day||0
8135025|NCT02760277|20052568|P2|STARTED|6.0 mg/kg/Day||0
8135026|NCT02760277|20052569|P1|STARTED|6.0 mg/kg/Day||0
8135027|NCT02760277|20052566|P4|NOT COMPLETED|2.0 mg/kg/Day||0
8135028|NCT02760277|20052567|P3|NOT COMPLETED|2.0 mg/kg/Day||0
8135029|NCT02760277|20052568|P2|NOT COMPLETED|2.0 mg/kg/Day||0
8135030|NCT02760277|20052569|P1|NOT COMPLETED|2.0 mg/kg/Day||0
8135031|NCT02760277|20052566|P4|COMPLETED|2.0 mg/kg/Day||0
8135032|NCT02760277|20052567|P3|COMPLETED|2.0 mg/kg/Day||12
8135033|NCT02760277|20052568|P2|COMPLETED|2.0 mg/kg/Day||0
8135034|NCT02760277|20052569|P1|COMPLETED|2.0 mg/kg/Day||0
8135035|NCT02760277|20052566|P4|STARTED|2.0 mg/kg/Day||0
8135036|NCT02760277|20052567|P3|STARTED|2.0 mg/kg/Day||12
8135037|NCT02760277|20052568|P2|STARTED|2.0 mg/kg/Day||0
8135038|NCT02760277|20052569|P1|STARTED|2.0 mg/kg/Day||0
8135039|NCT02760277|20052566|P4|NOT COMPLETED|0.75 mg/kg/Day||0
8135040|NCT02760277|20052567|P3|NOT COMPLETED|0.75 mg/kg/Day||0
8135041|NCT02760277|20052568|P2|NOT COMPLETED|0.75 mg/kg/Day||0
8135042|NCT02760277|20052569|P1|NOT COMPLETED|0.75 mg/kg/Day||0
8135043|NCT02760277|20052566|P4|COMPLETED|0.75 mg/kg/Day||0
8135044|NCT02760277|20052567|P3|COMPLETED|0.75 mg/kg/Day||0
8135045|NCT02760277|20052568|P2|COMPLETED|0.75 mg/kg/Day||12
8135046|NCT02760277|20052569|P1|COMPLETED|0.75 mg/kg/Day||0
8135047|NCT02760277|20052566|P4|STARTED|0.75 mg/kg/Day||0
8135048|NCT02760277|20052567|P3|STARTED|0.75 mg/kg/Day||0
8135049|NCT02760277|20052568|P2|STARTED|0.75 mg/kg/Day||12
8135050|NCT02760277|20052569|P1|STARTED|0.75 mg/kg/Day||0
8135051|NCT02760277|20052566|P4|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135052|NCT02760277|20052567|P3|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135053|NCT02760277|20052568|P2|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135054|NCT02760277|20052569|P1|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135055|NCT02760277|20052566|P4|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135056|NCT02760277|20052567|P3|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135057|NCT02760277|20052568|P2|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135058|NCT02760277|20052569|P1|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
8135059|NCT02760277|20052566|P4|STARTED|Vamorolone 0.25 mg/kg/Day||0
8135060|NCT02760277|20052567|P3|STARTED|Vamorolone 0.25 mg/kg/Day||0
8135061|NCT02760277|20052568|P2|STARTED|Vamorolone 0.25 mg/kg/Day||0
8135062|NCT02760277|20052569|P1|STARTED|Vamorolone 0.25 mg/kg/Day||12
8135063|NCT02760264|20052643|P4|NOT COMPLETED|6.0 mg/kg/Day||0
8135064|NCT02760264|20052644|P3|NOT COMPLETED|6.0 mg/kg/Day||0
8135065|NCT02760264|20052645|P2|NOT COMPLETED|6.0 mg/kg/Day||0
8135066|NCT02760264|20052646|P1|NOT COMPLETED|6.0 mg/kg/Day||0
8135067|NCT02760264|20052643|P4|COMPLETED|6.0 mg/kg/Day||12
8135068|NCT02760264|20052644|P3|COMPLETED|6.0 mg/kg/Day||0
8135069|NCT02760264|20052645|P2|COMPLETED|6.0 mg/kg/Day||0
8135070|NCT02760264|20052646|P1|COMPLETED|6.0 mg/kg/Day||0
8135071|NCT02760264|20052643|P4|STARTED|6.0 mg/kg/Day||12
8135072|NCT02760264|20052644|P3|STARTED|6.0 mg/kg/Day||0
8135073|NCT02760264|20052645|P2|STARTED|6.0 mg/kg/Day||0
8135074|NCT02760264|20052646|P1|STARTED|6.0 mg/kg/Day||0
8135075|NCT02760264|20052643|P4|NOT COMPLETED|2.0 mg/kg/Day||0
8135076|NCT02760264|20052644|P3|NOT COMPLETED|2.0 mg/kg/Day||0
8135077|NCT02760264|20052645|P2|NOT COMPLETED|2.0 mg/kg/Day||0
8135078|NCT02760264|20052646|P1|NOT COMPLETED|2.0 mg/kg/Day||0
8135079|NCT02760264|20052643|P4|COMPLETED|2.0 mg/kg/Day||0
8135080|NCT02760264|20052644|P3|COMPLETED|2.0 mg/kg/Day||12
8135081|NCT02760264|20052645|P2|COMPLETED|2.0 mg/kg/Day||0
8135082|NCT02760264|20052646|P1|COMPLETED|2.0 mg/kg/Day||0
8135083|NCT02760264|20052643|P4|STARTED|2.0 mg/kg/Day||0
8135084|NCT02760264|20052644|P3|STARTED|2.0 mg/kg/Day||12
8135085|NCT02760264|20052645|P2|STARTED|2.0 mg/kg/Day||0
8135086|NCT02760264|20052646|P1|STARTED|2.0 mg/kg/Day||0
8135087|NCT02760264|20052643|P4|NOT COMPLETED|0.75 mg/kg/Day||0
8135088|NCT02760264|20052644|P3|NOT COMPLETED|0.75 mg/kg/Day||0
8135089|NCT02760264|20052645|P2|NOT COMPLETED|0.75 mg/kg/Day||0
8135090|NCT02760264|20052646|P1|NOT COMPLETED|0.75 mg/kg/Day||0
8135091|NCT02760264|20052643|P4|COMPLETED|0.75 mg/kg/Day||0
8135092|NCT02760264|20052644|P3|COMPLETED|0.75 mg/kg/Day||0
8135093|NCT02760264|20052645|P2|COMPLETED|0.75 mg/kg/Day||12
8135094|NCT02760264|20052646|P1|COMPLETED|0.75 mg/kg/Day||0
8135095|NCT02760264|20052643|P4|STARTED|0.75 mg/kg/Day||0
8135096|NCT02760264|20052644|P3|STARTED|0.75 mg/kg/Day||0
8135097|NCT02760264|20052645|P2|STARTED|0.75 mg/kg/Day||12
8135098|NCT02760264|20052646|P1|STARTED|0.75 mg/kg/Day||0
8135099|NCT02760264|20052643|P4|NOT COMPLETED|0.25 mg/kg/Day||0
8135100|NCT02760264|20052644|P3|NOT COMPLETED|0.25 mg/kg/Day||0
8135101|NCT02760264|20052645|P2|NOT COMPLETED|0.25 mg/kg/Day||0
8135102|NCT02760264|20052646|P1|NOT COMPLETED|0.25 mg/kg/Day||0
8135103|NCT02760264|20052643|P4|COMPLETED|0.25 mg/kg/Day||0
8135104|NCT02760264|20052644|P3|COMPLETED|0.25 mg/kg/Day||0
8135105|NCT02760264|20052645|P2|COMPLETED|0.25 mg/kg/Day||0
8135106|NCT02760264|20052646|P1|COMPLETED|0.25 mg/kg/Day||12
8135107|NCT02760264|20052643|P4|STARTED|0.25 mg/kg/Day||0
8135108|NCT02760264|20052644|P3|STARTED|0.25 mg/kg/Day||0
8135109|NCT02760264|20052645|P2|STARTED|0.25 mg/kg/Day||0
8135110|NCT02760264|20052646|P1|STARTED|0.25 mg/kg/Day||12
8135111|NCT02760069|20052724|P3|NOT COMPLETED|Overall Study||1
8135112|NCT02760069|20052725|P2|NOT COMPLETED|Overall Study||1
8135113|NCT02760069|20052726|P1|NOT COMPLETED|Overall Study||0
8135114|NCT02760069|20052724|P3|COMPLETED|Overall Study||40
8135115|NCT02760069|20052725|P2|COMPLETED|Overall Study||40
8135116|NCT02760069|20052726|P1|COMPLETED|Overall Study||40
8135117|NCT02760069|20052724|P3|STARTED|Overall Study||41
8135118|NCT02760069|20052725|P2|STARTED|Overall Study||41
8135119|NCT02760069|20052726|P1|STARTED|Overall Study||40
8135120|NCT02760056|20052739|P2|NOT COMPLETED|Overall Study||0
8135121|NCT02760056|20052740|P1|NOT COMPLETED|Overall Study||0
8135122|NCT02760056|20052739|P2|COMPLETED|Overall Study||5
8135123|NCT02760056|20052740|P1|COMPLETED|Overall Study||10
8135124|NCT02760056|20052739|P2|STARTED|Overall Study||5
8135125|NCT02760056|20052740|P1|STARTED|Overall Study||10
8135126|NCT02759939|20052752|P4|NOT COMPLETED|Overall Study||1043
8135127|NCT02759939|20052753|P3|NOT COMPLETED|Overall Study||1154
8135128|NCT02759939|20052754|P2|NOT COMPLETED|Overall Study||972
8135129|NCT02759939|20052755|P1|NOT COMPLETED|Overall Study||1056
8135130|NCT02759939|20052752|P4|COMPLETED|Overall Study||203
8135131|NCT02759939|20052753|P3|COMPLETED|Overall Study||239
8135132|NCT02759939|20052754|P2|COMPLETED|Overall Study||171
8135133|NCT02759939|20052755|P1|COMPLETED|Overall Study||200
8135134|NCT02759939|20052752|P4|Consented to T2 and T3|Overall Study||564
8135135|NCT02759939|20052753|P3|Consented to T2 and T3|Overall Study||702
8135136|NCT02759939|20052754|P2|Consented to T2 and T3|Overall Study||626
8135137|NCT02759939|20052755|P1|Consented to T2 and T3|Overall Study||579
8135138|NCT02759939|20052752|P4|Analyzed at T2 and/or T3|Overall Study||304
8135139|NCT02759939|20052753|P3|Analyzed at T2 and/or T3|Overall Study||373
8135140|NCT02759939|20052754|P2|Analyzed at T2 and/or T3|Overall Study||278
8135141|NCT02759939|20052755|P1|Analyzed at T2 and/or T3|Overall Study||303
8135142|NCT02759939|20052752|P4|Eligible for T2 and T3|Overall Study||853
8135143|NCT02759939|20052753|P3|Eligible for T2 and T3|Overall Study||1022
8135144|NCT02759939|20052754|P2|Eligible for T2 and T3|Overall Study||962
8135145|NCT02759939|20052755|P1|Eligible for T2 and T3|Overall Study||935
8135146|NCT02759939|20052752|P4|Analyzed at T1|Overall Study||1244
8135147|NCT02759939|20052753|P3|Analyzed at T1|Overall Study||1388
8135148|NCT02759939|20052754|P2|Analyzed at T1|Overall Study||1141
8135149|NCT02759939|20052755|P1|Analyzed at T1|Overall Study||1245
8135150|NCT02759939|20052752|P4|STARTED|Overall Study||1246
8135151|NCT02759939|20052753|P3|STARTED|Overall Study||1393
8135152|NCT02759939|20052754|P2|STARTED|Overall Study||1143
8135153|NCT02759939|20052755|P1|STARTED|Overall Study||1256
8135154|NCT02759692|20052765|P2|NOT COMPLETED|Period 3||0
8135155|NCT02759692|20052766|P1|NOT COMPLETED|Period 3||0
8135156|NCT02759692|20052765|P2|COMPLETED|Period 3||139
8135157|NCT02759692|20052766|P1|COMPLETED|Period 3||137
8135158|NCT02759692|20052765|P2|STARTED|Period 3||139
8135159|NCT02759692|20052766|P1|STARTED|Period 3||137
8135160|NCT02759692|20052765|P2|NOT COMPLETED|Period 2||1
8135161|NCT02759692|20052766|P1|NOT COMPLETED|Period 2||1
8135162|NCT02759692|20052765|P2|COMPLETED|Period 2||139
8135163|NCT02759692|20052766|P1|COMPLETED|Period 2||137
8135164|NCT02759692|20052765|P2|STARTED|Period 2||140
8135165|NCT02759692|20052766|P1|STARTED|Period 2||138
8135166|NCT02759692|20052765|P2|NOT COMPLETED|Period 1||2
8135167|NCT02759692|20052766|P1|NOT COMPLETED|Period 1||3
8135168|NCT02759692|20052765|P2|COMPLETED|Period 1||140
8135169|NCT02759692|20052766|P1|COMPLETED|Period 1||138
8135170|NCT02759692|20052765|P2|STARTED|Period 1||142
8135171|NCT02759692|20052766|P1|STARTED|Period 1||141
8135172|NCT02759562|20052784|P2|NOT COMPLETED|Open-Label Treatment Period||2
8135173|NCT02759562|20052785|P1|NOT COMPLETED|Open-Label Treatment Period||2
8135174|NCT02759562|20052784|P2|COMPLETED|Open-Label Treatment Period||0
8135175|NCT02759562|20052785|P1|COMPLETED|Open-Label Treatment Period||0
8135176|NCT02759562|20052784|P2|STARTED|Open-Label Treatment Period||2
8135177|NCT02759562|20052785|P1|STARTED|Open-Label Treatment Period||2
8135178|NCT02759562|20052784|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
8135179|NCT02759562|20052785|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
8135180|NCT02759562|20052784|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
8135181|NCT02759562|20052785|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
8135182|NCT02759562|20052784|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
8135183|NCT02759562|20052785|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
8135184|NCT02759471|20052798|P1|NOT COMPLETED|Overall Study||2
8135185|NCT02759471|20052798|P1|COMPLETED|Overall Study||52
8135186|NCT02759471|20052798|P1|STARTED|Overall Study||54
8135187|NCT02759354|20052812|P4|NOT COMPLETED|Overall Study||0
8135188|NCT02759354|20052813|P3|NOT COMPLETED|Overall Study||0
8135189|NCT02759354|20052814|P2|NOT COMPLETED|Overall Study||0
8135190|NCT02759354|20052815|P1|NOT COMPLETED|Overall Study||0
8135191|NCT02759354|20052812|P4|COMPLETED|Overall Study||191
8135192|NCT02759354|20052813|P3|COMPLETED|Overall Study||181
8135193|NCT02759354|20052814|P2|COMPLETED|Overall Study||190
8135194|NCT02759354|20052815|P1|COMPLETED|Overall Study||192
8135195|NCT02759354|20052812|P4|STARTED|Overall Study||191
8135196|NCT02759354|20052813|P3|STARTED|Overall Study||181
8135197|NCT02759354|20052814|P2|STARTED|Overall Study||190
8135198|NCT02759354|20052815|P1|STARTED|Overall Study||192
8135199|NCT02759315|20052854|P5|NOT COMPLETED|Overall Study||1
8135200|NCT02759315|20052855|P4|NOT COMPLETED|Overall Study||1
8135201|NCT02759315|20052856|P3|NOT COMPLETED|Overall Study||10
8135202|NCT02759315|20052857|P2|NOT COMPLETED|Overall Study||1
8135203|NCT02759315|20052858|P1|NOT COMPLETED|Overall Study||4
8135204|NCT02759315|20052854|P5|COMPLETED|Overall Study||2
8135205|NCT02759315|20052855|P4|COMPLETED|Overall Study||19
8135206|NCT02759315|20052856|P3|COMPLETED|Overall Study||29
8135207|NCT02759315|20052857|P2|COMPLETED|Overall Study||28
8135208|NCT02759315|20052858|P1|COMPLETED|Overall Study||65
8135209|NCT02759315|20052854|P5|STARTED|Overall Study||3
8135210|NCT02759315|20052855|P4|STARTED|Overall Study||20
8135211|NCT02759315|20052856|P3|STARTED|Overall Study||39
8135212|NCT02759315|20052857|P2|STARTED|Overall Study||29
8135213|NCT02759315|20052858|P1|STARTED|Overall Study||69
8135214|NCT02759146|20052908|P7|NOT COMPLETED|Week 5-8||6
8135215|NCT02759146|20052909|P6|NOT COMPLETED|Week 5-8||6
8135216|NCT02759146|20052910|P5|NOT COMPLETED|Week 5-8||5
8135217|NCT02759146|20052911|P4|NOT COMPLETED|Week 5-8||7
8135218|NCT02759146|20052912|P3|NOT COMPLETED|Week 5-8||10
8135219|NCT02759146|20052913|P2|NOT COMPLETED|Week 5-8||5
8135220|NCT02759146|20052914|P1|NOT COMPLETED|Week 5-8||10
8135221|NCT02759146|20052908|P7|COMPLETED|Week 5-8||20
8135222|NCT02759146|20052909|P6|COMPLETED|Week 5-8||23
8135223|NCT02759146|20052910|P5|COMPLETED|Week 5-8||44
8135224|NCT02759146|20052911|P4|COMPLETED|Week 5-8||37
8135225|NCT02759146|20052912|P3|COMPLETED|Week 5-8||22
8135226|NCT02759146|20052913|P2|COMPLETED|Week 5-8||29
8135227|NCT02759146|20052914|P1|COMPLETED|Week 5-8||46
8135228|NCT02759146|20052908|P7|STARTED|Week 5-8||26
8135229|NCT02759146|20052909|P6|STARTED|Week 5-8||29
8135230|NCT02759146|20052910|P5|STARTED|Week 5-8||49
8135231|NCT02759146|20052911|P4|STARTED|Week 5-8||44
8135232|NCT02759146|20052912|P3|STARTED|Week 5-8||32
8135233|NCT02759146|20052913|P2|STARTED|Week 5-8||34
8135234|NCT02759146|20052914|P1|STARTED|Week 5-8||56
8135235|NCT02759146|20052908|P7|NOT COMPLETED|Week 1-4||1
8135236|NCT02759146|20052909|P6|NOT COMPLETED|Week 1-4||1
8135237|NCT02759146|20052910|P5|NOT COMPLETED|Week 1-4||0
8135238|NCT02759146|20052911|P4|NOT COMPLETED|Week 1-4||0
8135239|NCT02759146|20052912|P3|NOT COMPLETED|Week 1-4||1
8135240|NCT02759146|20052913|P2|NOT COMPLETED|Week 1-4||2
8135241|NCT02759146|20052914|P1|NOT COMPLETED|Week 1-4||1
8135242|NCT02759146|20052908|P7|COMPLETED|Week 1-4||26
8135243|NCT02759146|20052909|P6|COMPLETED|Week 1-4||29
8135244|NCT02759146|20052910|P5|COMPLETED|Week 1-4||49
8135245|NCT02759146|20052911|P4|COMPLETED|Week 1-4||44
8135246|NCT02759146|20052912|P3|COMPLETED|Week 1-4||32
8135247|NCT02759146|20052913|P2|COMPLETED|Week 1-4||34
8135248|NCT02759146|20052914|P1|COMPLETED|Week 1-4||56
8135249|NCT02759146|20052908|P7|STARTED|Week 1-4||27
8135250|NCT02759146|20052909|P6|STARTED|Week 1-4||30
8135251|NCT02759146|20052910|P5|STARTED|Week 1-4||49
8135252|NCT02759146|20052911|P4|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
8135253|NCT02759146|20052912|P3|STARTED|Week 1-4||33
8135254|NCT02759146|20052913|P2|STARTED|Week 1-4||36
8135255|NCT02759146|20052914|P1|STARTED|Week 1-4||57
8135256|NCT02759016|20052961|P2|NOT COMPLETED|Overall Study||3
8135257|NCT02759016|20052962|P1|NOT COMPLETED|Overall Study||4
8135258|NCT02759016|20052961|P2|COMPLETED|Overall Study||0
8135259|NCT02759016|20052962|P1|COMPLETED|Overall Study||0
8135260|NCT02759016|20052961|P2|Treated With BI 836826 and Ibrutinib|Overall Study||3
8135261|NCT02759016|20052962|P1|Treated With BI 836826 and Ibrutinib|Overall Study||3
8135262|NCT02759016|20052961|P2|STARTED|Overall Study||3
8135263|NCT02759016|20052962|P1|STARTED|Overall Study||4
8135270|NCT02758717|20052981|P1|NOT COMPLETED|Overall Study||0
8135271|NCT02758717|20052981|P1|COMPLETED|Overall Study||46
8135272|NCT02758717|20052981|P1|STARTED|Overall Study||46
8135273|NCT02758613|20052991|P4|NOT COMPLETED|Follow-up||0
8135274|NCT02758613|20052992|P3|NOT COMPLETED|Follow-up||0
8135275|NCT02758613|20052993|P2|NOT COMPLETED|Follow-up||0
8135276|NCT02758613|20052994|P1|NOT COMPLETED|Follow-up||0
8135277|NCT02758613|20052991|P4|COMPLETED|Follow-up||8
8135278|NCT02758613|20052992|P3|COMPLETED|Follow-up||8
8135279|NCT02758613|20052993|P2|COMPLETED|Follow-up||8
8135280|NCT02758613|20052994|P1|COMPLETED|Follow-up||6
8135281|NCT02758613|20052991|P4|STARTED|Follow-up||8
8135282|NCT02758613|20052992|P3|STARTED|Follow-up||8
8135283|NCT02758613|20052993|P2|STARTED|Follow-up||8
8135284|NCT02758613|20052994|P1|STARTED|Follow-up||6
8135285|NCT02758613|20052991|P4|NOT COMPLETED|Treatment||0
8135286|NCT02758613|20052992|P3|NOT COMPLETED|Treatment||1
8135287|NCT02758613|20052993|P2|NOT COMPLETED|Treatment||0
8135288|NCT02758613|20052994|P1|NOT COMPLETED|Treatment||2
8135289|NCT02758613|20052991|P4|COMPLETED|Treatment||8
8135290|NCT02758613|20052992|P3|COMPLETED|Treatment||8
8135291|NCT02758613|20052993|P2|COMPLETED|Treatment||8
8135292|NCT02758613|20052994|P1|COMPLETED|Treatment||6
8135293|NCT02758613|20052991|P4|Received at Least One Dose of Study Drug|Treatment||8
8135294|NCT02758613|20052992|P3|Received at Least One Dose of Study Drug|Treatment||9
8135295|NCT02758613|20052993|P2|Received at Least One Dose of Study Drug|Treatment||8
8135296|NCT02758613|20052994|P1|Received at Least One Dose of Study Drug|Treatment||8
8135297|NCT02758613|20052991|P4|STARTED|Treatment||8
8135298|NCT02758613|20052992|P3|STARTED|Treatment||9
8135299|NCT02758613|20052993|P2|STARTED|Treatment||8
8135300|NCT02758613|20052994|P1|STARTED|Treatment||8
8135301|NCT02758301|20053012|P2|NOT COMPLETED|Overall Study||8
8135302|NCT02758301|20053013|P1|NOT COMPLETED|Overall Study||34
8135303|NCT02758301|20053012|P2|COMPLETED|Overall Study||0
8135304|NCT02758301|20053013|P1|COMPLETED|Overall Study||70
8135305|NCT02758301|20053012|P2|STARTED|Overall Study||8
8135306|NCT02758301|20053013|P1|STARTED|Overall Study||104
8135307|NCT02758210|20053021|P1|NOT COMPLETED|Overall Study||0
8135308|NCT02758210|20053021|P1|COMPLETED|Overall Study||20
8135309|NCT02758210|20053021|P1|STARTED|Overall Study||20
8135310|NCT02758171|20053032|P2|NOT COMPLETED|Treatment Period 2||0
8135311|NCT02758171|20053033|P1|NOT COMPLETED|Treatment Period 2||0
8135312|NCT02758171|20053032|P2|COMPLETED|Treatment Period 2||28
8135313|NCT02758171|20053033|P1|COMPLETED|Treatment Period 2||26
8135314|NCT02758171|20053032|P2|STARTED|Treatment Period 2||28
8135315|NCT02758171|20053033|P1|STARTED|Treatment Period 2||26
8135316|NCT02758171|20053032|P2|NOT COMPLETED|Wash-out||0
8135317|NCT02758171|20053033|P1|NOT COMPLETED|Wash-out||2
8135318|NCT02758171|20053032|P2|COMPLETED|Wash-out||28
8135319|NCT02758171|20053033|P1|COMPLETED|Wash-out||26
8135320|NCT02758171|20053032|P2|STARTED|Wash-out||28
8135321|NCT02758171|20053033|P1|STARTED|Wash-out||28
8135322|NCT02758171|20053032|P2|NOT COMPLETED|Treatment Period 1||0
8135323|NCT02758171|20053033|P1|NOT COMPLETED|Treatment Period 1||0
8135324|NCT02758171|20053032|P2|COMPLETED|Treatment Period 1||28
8135325|NCT02758171|20053033|P1|COMPLETED|Treatment Period 1||28
8135326|NCT02758171|20053032|P2|STARTED|Treatment Period 1||28
8135327|NCT02758171|20053033|P1|STARTED|Treatment Period 1||28
8135328|NCT02758132|20053051|P2|NOT COMPLETED|Overall Study||1
8135329|NCT02758132|20053052|P1|NOT COMPLETED|Overall Study||0
8135330|NCT02758132|20053051|P2|COMPLETED|Overall Study||0
8135331|NCT02758132|20053052|P1|COMPLETED|Overall Study||0
8135332|NCT02758132|20053051|P2|STARTED|Overall Study||1
8135333|NCT02758132|20053052|P1|STARTED|Overall Study||0
8135334|NCT02758119|20053074|P2|NOT COMPLETED|Overall Study||1
8135335|NCT02758119|20053075|P1|NOT COMPLETED|Overall Study||2
8135336|NCT02758119|20053074|P2|COMPLETED|Overall Study||40
8135337|NCT02758119|20053075|P1|COMPLETED|Overall Study||39
8135338|NCT02758119|20053074|P2|STARTED|Overall Study||41
8135339|NCT02758119|20053075|P1|STARTED|Overall Study||41
8135340|NCT02757963|20053087|P1|NOT COMPLETED|Overall Study||1097
8135341|NCT02757963|20053087|P1|COMPLETED|Overall Study||561
8135342|NCT02757963|20053087|P1|STARTED|Overall Study||1658
8135343|NCT02757950|20053105|P2|NOT COMPLETED|Overall Study||11
8135344|NCT02757950|20053106|P1|NOT COMPLETED|Overall Study||4
8135345|NCT02757950|20053105|P2|COMPLETED|Overall Study||1248
8135346|NCT02757950|20053106|P1|COMPLETED|Overall Study||1199
8135347|NCT02757950|20053105|P2|STARTED|Overall Study||1259
8135348|NCT02757950|20053106|P1|STARTED|Overall Study||1203
8135349|NCT02757768|20053127|P2|NOT COMPLETED|Overall Study||28
8135350|NCT02757768|20053128|P1|NOT COMPLETED|Overall Study||33
8135351|NCT02757768|20053127|P2|COMPLETED|Overall Study||331
8135352|NCT02757768|20053128|P1|COMPLETED|Overall Study||323
8135353|NCT02757768|20053127|P2|Treated|Overall Study||354
8135354|NCT02757768|20053128|P1|Treated|Overall Study||352
8135355|NCT02757768|20053127|P2|STARTED|Overall Study||359
8135356|NCT02757768|20053128|P1|STARTED|Overall Study||356
8135357|NCT02757625|20053178|P4|NOT COMPLETED|Overall Study||0
8135358|NCT02757625|20053179|P3|NOT COMPLETED|Overall Study||2
8135359|NCT02757625|20053180|P2|NOT COMPLETED|Overall Study||0
8135360|NCT02757625|20053181|P1|NOT COMPLETED|Overall Study||0
8135361|NCT02757625|20053178|P4|COMPLETED|Overall Study||12
8135362|NCT02757625|20053179|P3|COMPLETED|Overall Study||17
8135363|NCT02757625|20053180|P2|COMPLETED|Overall Study||18
8135364|NCT02757625|20053181|P1|COMPLETED|Overall Study||14
8135365|NCT02757625|20053178|P4|STARTED|Overall Study||12
8135366|NCT02757625|20053179|P3|STARTED|Overall Study||19
8135367|NCT02757625|20053180|P2|STARTED|Overall Study||18
8135368|NCT02757625|20053181|P1|STARTED|Overall Study||14
8135369|NCT02757547|20053333|P1|NOT COMPLETED|Overall Study||0
8135370|NCT02757547|20053333|P1|COMPLETED|Overall Study||2
8135371|NCT02757547|20053333|P1|STARTED|Overall Study||2
8135372|NCT02757521|20053340|P2|NOT COMPLETED|Overall Study||0
8135373|NCT02757521|20053341|P1|NOT COMPLETED|Overall Study||1
8135374|NCT02757521|20053340|P2|COMPLETED|Overall Study||0
8135375|NCT02757521|20053341|P1|COMPLETED|Overall Study||0
8135376|NCT02757521|20053340|P2|STARTED|Overall Study||0
8135377|NCT02757521|20053341|P1|STARTED|Overall Study||1
8135378|NCT02757430|20053347|P1|NOT COMPLETED|Overall Study||12
8135379|NCT02757430|20053347|P1|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
8135380|NCT02757430|20053347|P1|EP Mapping/Ablation Procedure|Overall Study||503
8135381|NCT02757430|20053347|P1|Baseline Visits|Overall Study||503
8135382|NCT02757430|20053347|P1|STARTED|Overall Study||515
8135383|NCT02757352|20053366|P10|NOT COMPLETED|Follow-Up Period||3
8135384|NCT02757352|20053367|P9|NOT COMPLETED|Follow-Up Period||10
8135385|NCT02757352|20053368|P8|NOT COMPLETED|Follow-Up Period||1
8135386|NCT02757352|20053369|P7|NOT COMPLETED|Follow-Up Period||1
8135387|NCT02757352|20053370|P6|NOT COMPLETED|Follow-Up Period||0
8135388|NCT02757352|20053371|P5|NOT COMPLETED|Follow-Up Period||0
8135389|NCT02757352|20053372|P4|NOT COMPLETED|Follow-Up Period||0
8135390|NCT02757352|20053373|P3|NOT COMPLETED|Follow-Up Period||0
8135391|NCT02757352|20053374|P2|NOT COMPLETED|Follow-Up Period||0
8135392|NCT02757352|20053375|P1|NOT COMPLETED|Follow-Up Period||0
8135393|NCT02757352|20053366|P10|COMPLETED|Follow-Up Period||2
8135394|NCT02757352|20053367|P9|COMPLETED|Follow-Up Period||18
8135395|NCT02757352|20053368|P8|COMPLETED|Follow-Up Period||4
8135396|NCT02757352|20053369|P7|COMPLETED|Follow-Up Period||2
8135397|NCT02757352|20053370|P6|COMPLETED|Follow-Up Period||0
8135398|NCT02757352|20053371|P5|COMPLETED|Follow-Up Period||0
8135399|NCT02757352|20053372|P4|COMPLETED|Follow-Up Period||0
8135400|NCT02757352|20053373|P3|COMPLETED|Follow-Up Period||0
8135401|NCT02757352|20053374|P2|COMPLETED|Follow-Up Period||0
8135402|NCT02757352|20053375|P1|COMPLETED|Follow-Up Period||0
8135403|NCT02757352|20053366|P10|STARTED|Follow-Up Period||5
8135404|NCT02757352|20053367|P9|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
8135405|NCT02757352|20053368|P8|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
8135406|NCT02757352|20053369|P7|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
8135407|NCT02757352|20053370|P6|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8135408|NCT02757352|20053371|P5|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8135409|NCT02757352|20053372|P4|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8135410|NCT02757352|20053373|P3|STARTED|Follow-Up Period||0
8135411|NCT02757352|20053374|P2|STARTED|Follow-Up Period||0
8135412|NCT02757352|20053375|P1|STARTED|Follow-Up Period||0
8135413|NCT02757352|20053366|P10|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135414|NCT02757352|20053367|P9|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135415|NCT02757352|20053368|P8|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135416|NCT02757352|20053369|P7|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135417|NCT02757352|20053370|P6|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
8135418|NCT02757352|20053371|P5|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
8135419|NCT02757352|20053372|P4|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
8135420|NCT02757352|20053373|P3|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135421|NCT02757352|20053374|P2|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135422|NCT02757352|20053375|P1|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135423|NCT02757352|20053366|P10|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135424|NCT02757352|20053367|P9|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135425|NCT02757352|20053368|P8|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135426|NCT02757352|20053369|P7|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135427|NCT02757352|20053370|P6|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
8135428|NCT02757352|20053371|P5|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
8135429|NCT02757352|20053372|P4|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
8135430|NCT02757352|20053373|P3|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135431|NCT02757352|20053374|P2|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135432|NCT02757352|20053375|P1|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135433|NCT02757352|20053366|P10|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135434|NCT02757352|20053367|P9|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135435|NCT02757352|20053368|P8|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135436|NCT02757352|20053369|P7|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135437|NCT02757352|20053370|P6|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
8135438|NCT02757352|20053371|P5|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135439|NCT02757352|20053372|P4|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
8135440|NCT02757352|20053373|P3|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135441|NCT02757352|20053374|P2|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135442|NCT02757352|20053375|P1|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135443|NCT02757352|20053366|P10|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135444|NCT02757352|20053367|P9|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135445|NCT02757352|20053368|P8|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135446|NCT02757352|20053369|P7|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135447|NCT02757352|20053370|P6|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
8135448|NCT02757352|20053371|P5|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
8135449|NCT02757352|20053372|P4|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
8135450|NCT02757352|20053373|P3|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8135451|NCT02757352|20053374|P2|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8135452|NCT02757352|20053375|P1|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8135453|NCT02757352|20053366|P10|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135454|NCT02757352|20053367|P9|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135455|NCT02757352|20053368|P8|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135456|NCT02757352|20053369|P7|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135457|NCT02757352|20053370|P6|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135458|NCT02757352|20053371|P5|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135459|NCT02757352|20053372|P4|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135460|NCT02757352|20053373|P3|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
8135461|NCT02757352|20053374|P2|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
8135462|NCT02757352|20053375|P1|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
8135463|NCT02757352|20053366|P10|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135464|NCT02757352|20053367|P9|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135465|NCT02757352|20053368|P8|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135466|NCT02757352|20053369|P7|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135467|NCT02757352|20053370|P6|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135468|NCT02757352|20053371|P5|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135469|NCT02757352|20053372|P4|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135470|NCT02757352|20053373|P3|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
8135471|NCT02757352|20053374|P2|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
8135472|NCT02757352|20053375|P1|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
8135473|NCT02757352|20053366|P10|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135474|NCT02757352|20053367|P9|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135475|NCT02757352|20053368|P8|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135476|NCT02757352|20053369|P7|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135477|NCT02757352|20053370|P6|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135478|NCT02757352|20053371|P5|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135479|NCT02757352|20053372|P4|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135480|NCT02757352|20053373|P3|STARTED|Double-Blind Period (Week 16 - Week 52)||98
8135481|NCT02757352|20053374|P2|STARTED|Double-Blind Period (Week 16 - Week 52)||95
8135482|NCT02757352|20053375|P1|STARTED|Double-Blind Period (Week 16 - Week 52)||97
8135483|NCT02757352|20053366|P10|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135484|NCT02757352|20053367|P9|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135485|NCT02757352|20053368|P8|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135486|NCT02757352|20053369|P7|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135487|NCT02757352|20053370|P6|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135488|NCT02757352|20053371|P5|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135489|NCT02757352|20053372|P4|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135490|NCT02757352|20053373|P3|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
8135491|NCT02757352|20053374|P2|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
8135492|NCT02757352|20053375|P1|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
8135493|NCT02757352|20053366|P10|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135494|NCT02757352|20053367|P9|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135495|NCT02757352|20053368|P8|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135496|NCT02757352|20053369|P7|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135497|NCT02757352|20053370|P6|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135498|NCT02757352|20053371|P5|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135499|NCT02757352|20053372|P4|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135500|NCT02757352|20053373|P3|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
8135501|NCT02757352|20053374|P2|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
8135502|NCT02757352|20053375|P1|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
8135503|NCT02757352|20053366|P10|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135504|NCT02757352|20053367|P9|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135505|NCT02757352|20053368|P8|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135506|NCT02757352|20053369|P7|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135507|NCT02757352|20053370|P6|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135508|NCT02757352|20053371|P5|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135509|NCT02757352|20053372|P4|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135510|NCT02757352|20053373|P3|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
8135511|NCT02757352|20053374|P2|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
8135512|NCT02757352|20053375|P1|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
8135513|NCT02757352|20053366|P10|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135514|NCT02757352|20053367|P9|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135515|NCT02757352|20053368|P8|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135516|NCT02757352|20053369|P7|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135517|NCT02757352|20053370|P6|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135518|NCT02757352|20053371|P5|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135519|NCT02757352|20053372|P4|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135520|NCT02757352|20053373|P3|STARTED|Double-Blind Period (Week 0 - Week 16)||102
8135521|NCT02757352|20053374|P2|STARTED|Double-Blind Period (Week 0 - Week 16)||96
8135522|NCT02757352|20053375|P1|STARTED|Double-Blind Period (Week 0 - Week 16)||105
8135523|NCT02757105|20053484|P2|NOT COMPLETED|Overall Study||11
8135524|NCT02757105|20053485|P1|NOT COMPLETED|Overall Study||12
8135525|NCT02757105|20053484|P2|COMPLETED|Overall Study||41
8135526|NCT02757105|20053485|P1|COMPLETED|Overall Study||63
8135527|NCT02757105|20053484|P2|Treated|Overall Study||51
8135528|NCT02757105|20053485|P1|Treated|Overall Study||75
8135529|NCT02757105|20053484|P2|STARTED|Overall Study||52
8135530|NCT02757105|20053485|P1|STARTED|Overall Study||75
8135531|NCT02757092|20053507|P2|NOT COMPLETED|Overall Study||0
8135532|NCT02757092|20053508|P1|NOT COMPLETED|Overall Study||0
8135533|NCT02757092|20053507|P2|COMPLETED|Overall Study|All subjects completed the study|18
8135534|NCT02757092|20053508|P1|COMPLETED|Overall Study|All subjects completed the study|18
8135535|NCT02757092|20053507|P2|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
8135536|NCT02757092|20053508|P1|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
8135537|NCT02757053|20053574|P2|NOT COMPLETED|Overall Study||5
8135538|NCT02757053|20053575|P1|NOT COMPLETED|Overall Study||3
8135539|NCT02757053|20053574|P2|COMPLETED|Overall Study||0
8135540|NCT02757053|20053575|P1|COMPLETED|Overall Study||0
8135541|NCT02757053|20053574|P2|STARTED|Overall Study||5
8135542|NCT02757053|20053575|P1|STARTED|Overall Study||3
8135543|NCT02756949|20053589|P2|NOT COMPLETED|Overall Study||8
8135544|NCT02756949|20053590|P1|NOT COMPLETED|Overall Study||0
8135545|NCT02756949|20053589|P2|COMPLETED|Overall Study||164
8135546|NCT02756949|20053590|P1|COMPLETED|Overall Study||181
8135547|NCT02756949|20053589|P2|STARTED|Overall Study||172
8135548|NCT02756949|20053590|P1|STARTED|Overall Study||181
8135549|NCT02756832|20053598|P1|NOT COMPLETED|Overall Study||53
8135550|NCT02756832|20053598|P1|COMPLETED|Overall Study||1356
8135551|NCT02756832|20053598|P1|Included in Efficacy and Safety Analysis|Overall Study||1399
8135552|NCT02756832|20053598|P1|Received Therapy|Overall Study||1393
8135553|NCT02756832|20053598|P1|STARTED|Overall Study||1409
8135554|NCT02756819|20053612|P1|NOT COMPLETED|Overall Study||52
8135555|NCT02756819|20053612|P1|COMPLETED|Overall Study||1893
8135556|NCT02756819|20053612|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
8135557|NCT02756819|20053612|P1|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
8135558|NCT02756819|20053612|P1|STARTED|Overall Study||1945
8135559|NCT02756689|20053624|P2|NOT COMPLETED|Overall Study||0
8135560|NCT02756689|20053625|P1|NOT COMPLETED|Overall Study||0
8135561|NCT02756689|20053624|P2|COMPLETED|Overall Study||65
8135562|NCT02756689|20053625|P1|COMPLETED|Overall Study||64
8135563|NCT02756689|20053624|P2|STARTED|Overall Study||65
8135564|NCT02756689|20053625|P1|STARTED|Overall Study||64
8135565|NCT02756650|20053711|P1|NOT COMPLETED|Overall Study||2
8135566|NCT02756650|20053711|P1|COMPLETED|Overall Study||6
8135567|NCT02756650|20053711|P1|STARTED|Overall Study||8
8135568|NCT02756637|20053734|P2|NOT COMPLETED|Overall Study||54
8135569|NCT02756637|20053735|P1|NOT COMPLETED|Overall Study||87
8135570|NCT02756637|20053734|P2|COMPLETED|Overall Study||263
8135571|NCT02756637|20053735|P1|COMPLETED|Overall Study||230
8135572|NCT02756637|20053734|P2|Completed Curative Treatment|Overall Study||0
8135573|NCT02756637|20053735|P1|Completed Curative Treatment|Overall Study||230
8135574|NCT02756637|20053734|P2|Had NLR Value|Overall Study||263
8135575|NCT02756637|20053735|P1|Had NLR Value|Overall Study||263
8135576|NCT02756637|20053734|P2|Eligible for SWOG 8710|Overall Study||307
8135577|NCT02756637|20053735|P1|Eligible for SWOG 8710|Overall Study||307
8135578|NCT02756637|20053734|P2|STARTED|Overall Study||317
8135579|NCT02756637|20053735|P1|STARTED|Overall Study||317
8135580|NCT02756624|20053743|P2|NOT COMPLETED|Overall Study||7
8135581|NCT02756624|20053744|P1|NOT COMPLETED|Overall Study||16
8135582|NCT02756624|20053743|P2|COMPLETED|Overall Study||166
8135583|NCT02756624|20053744|P1|COMPLETED|Overall Study||327
8135584|NCT02756624|20053743|P2|STARTED|Overall Study||173
8135585|NCT02756624|20053744|P1|STARTED|Overall Study||343
8135586|NCT02756611|20053756|P1|NOT COMPLETED|Overall Study||256
8135587|NCT02756611|20053756|P1|COMPLETED|Overall Study||2
8135588|NCT02756611|20053756|P1|STARTED|Overall Study||258
8135589|NCT02756364|20053770|P3|NOT COMPLETED|Overall Study||48
8135590|NCT02756364|20053771|P2|NOT COMPLETED|Overall Study||47
8135591|NCT02756364|20053772|P1|NOT COMPLETED|Overall Study||46
8135592|NCT02756364|20053770|P3|COMPLETED|Overall Study||0
8135593|NCT02756364|20053771|P2|COMPLETED|Overall Study||0
8135594|NCT02756364|20053772|P1|COMPLETED|Overall Study||0
8135595|NCT02756364|20053770|P3|Treated Participants|Overall Study||47
8135596|NCT02756364|20053771|P2|Treated Participants|Overall Study||47
8135597|NCT02756364|20053772|P1|Treated Participants|Overall Study||46
8135598|NCT02756364|20053770|P3|STARTED|Overall Study||48
8135599|NCT02756364|20053771|P2|STARTED|Overall Study||47
8135600|NCT02756364|20053772|P1|STARTED|Overall Study||46
8135601|NCT02756351|20053797|P2|NOT COMPLETED|Overall Study||0
8135602|NCT02756351|20053798|P1|NOT COMPLETED|Overall Study||0
8135603|NCT02756351|20053797|P2|COMPLETED|Overall Study||24
8135604|NCT02756351|20053798|P1|COMPLETED|Overall Study||24
8135605|NCT02756351|20053797|P2|STARTED|Overall Study||24
8135606|NCT02756351|20053798|P1|STARTED|Overall Study||24
8135607|NCT02756338|20053806|P1|NOT COMPLETED|Overall Study||5
8135608|NCT02756338|20053806|P1|COMPLETED|Overall Study||72
8135609|NCT02756338|20053806|P1|STARTED|Overall Study||77
8135610|NCT02756182|20053815|P1|NOT COMPLETED|Overall Study||4
8135611|NCT02756182|20053815|P1|COMPLETED|Overall Study||21
8135612|NCT02756182|20053815|P1|STARTED|Overall Study||25
8135613|NCT02756078|20053830|P2|NOT COMPLETED|Period 2||7
8135614|NCT02756078|20053831|P1|NOT COMPLETED|Period 2||6
8135615|NCT02756078|20053830|P2|COMPLETED|Period 2||57
8135616|NCT02756078|20053831|P1|COMPLETED|Period 2||70
8135617|NCT02756078|20053830|P2|STARTED|Period 2||64
8135618|NCT02756078|20053831|P1|STARTED|Period 2||76
8135619|NCT02756078|20053830|P2|NOT COMPLETED|Period 1||22
8135620|NCT02756078|20053831|P1|NOT COMPLETED|Period 1||9
8135621|NCT02756078|20053830|P2|COMPLETED|Period 1||64
8135622|NCT02756078|20053831|P1|COMPLETED|Period 1||76
8135623|NCT02756078|20053830|P2|STARTED|Period 1||86
8135624|NCT02756078|20053831|P1|STARTED|Period 1||85
8135625|NCT02756013|20053849|P1|NOT COMPLETED|Overall Study||2
8135626|NCT02756013|20053849|P1|COMPLETED|Overall Study||1
8135627|NCT02756013|20053849|P1|STARTED|Overall Study||3
8135628|NCT02755935|20053854|P1|NOT COMPLETED|Overall Study||2
8135629|NCT02755935|20053854|P1|COMPLETED|Overall Study||22
8135630|NCT02755935|20053854|P1|STARTED|Overall Study||24
8135631|NCT02755831|20053861|P2|NOT COMPLETED|Overall Study||3
8135632|NCT02755831|20053862|P1|NOT COMPLETED|Overall Study||3
8135633|NCT02755831|20053861|P2|COMPLETED|Overall Study||90
8135634|NCT02755831|20053862|P1|COMPLETED|Overall Study||97
8135635|NCT02755831|20053861|P2|STARTED|Overall Study||93
8135636|NCT02755831|20053862|P1|STARTED|Overall Study||100
8135649|NCT02755805|20053917|P2|NOT COMPLETED|Overall Study||4
8135650|NCT02755805|20053918|P1|NOT COMPLETED|Overall Study||2
8135651|NCT02755805|20053917|P2|COMPLETED|Overall Study||11
8135652|NCT02755805|20053918|P1|COMPLETED|Overall Study||13
8135653|NCT02755805|20053917|P2|STARTED|Overall Study||15
8135654|NCT02755805|20053918|P1|STARTED|Overall Study||15
8135655|NCT02755649|20053933|P3|NOT COMPLETED|Overall Study||102
8135656|NCT02755649|20053934|P2|NOT COMPLETED|Overall Study||99
8135657|NCT02755649|20053935|P1|NOT COMPLETED|Overall Study||101
8135658|NCT02755649|20053933|P3|COMPLETED|Overall Study||8
8135659|NCT02755649|20053934|P2|COMPLETED|Overall Study||8
8135660|NCT02755649|20053935|P1|COMPLETED|Overall Study||7
8135661|NCT02755649|20053933|P3|Completed Study (Week 28)|Overall Study||8
8135662|NCT02755649|20053934|P2|Completed Study (Week 28)|Overall Study||8
8135663|NCT02755649|20053935|P1|Completed Study (Week 28)|Overall Study||7
8135664|NCT02755649|20053933|P3|Completed Treatment (Week 16)|Overall Study||109
8135665|NCT02755649|20053934|P2|Completed Treatment (Week 16)|Overall Study||106
8135666|NCT02755649|20053935|P1|Completed Treatment (Week 16)|Overall Study||107
8135667|NCT02755649|20053933|P3|STARTED|Overall Study||110
8135668|NCT02755649|20053934|P2|STARTED|Overall Study||107
8135669|NCT02755649|20053935|P1|STARTED|Overall Study||108
8135670|NCT02755285|20053997|P1|NOT COMPLETED|Overall Study||0
8135671|NCT02755285|20053997|P1|COMPLETED|Overall Study||20
8135672|NCT02755285|20053997|P1|STARTED|Overall Study||20
8135673|NCT02755129|20054001|P1|NOT COMPLETED|Overall Study||0
8135674|NCT02755129|20054001|P1|COMPLETED|Overall Study||15
8135675|NCT02755129|20054001|P1|STARTED|Overall Study||15
8135676|NCT02755116|20054010|P2|NOT COMPLETED|Overall Study||1
8135677|NCT02755116|20054011|P1|NOT COMPLETED|Overall Study||3
8135678|NCT02755116|20054010|P2|COMPLETED|Overall Study||69
8135679|NCT02755116|20054011|P1|COMPLETED|Overall Study||71
8135680|NCT02755116|20054010|P2|STARTED|Overall Study||70
8135681|NCT02755116|20054011|P1|STARTED|Overall Study||74
8135682|NCT02755090|20054027|P2|NOT COMPLETED|Overall Study||0
8135683|NCT02755090|20054028|P1|NOT COMPLETED|Overall Study||1
8135684|NCT02755090|20054027|P2|COMPLETED|Overall Study||20
8135685|NCT02755090|20054028|P1|COMPLETED|Overall Study||18
8135686|NCT02755090|20054027|P2|STARTED|Overall Study||20
8135687|NCT02755090|20054028|P1|STARTED|Overall Study||19
8135688|NCT02754674|20054038|P2|NOT COMPLETED|Overall Study||7
8135689|NCT02754674|20054039|P1|NOT COMPLETED|Overall Study||6
8135690|NCT02754674|20054038|P2|COMPLETED|Overall Study||26
8135691|NCT02754674|20054039|P1|COMPLETED|Overall Study||28
8135692|NCT02754674|20054038|P2|STARTED|Overall Study||33
8135693|NCT02754674|20054039|P1|STARTED|Overall Study||34
8135694|NCT02754661|20054055|P2|NOT COMPLETED|Overall Study||19
8135695|NCT02754661|20054056|P1|NOT COMPLETED|Overall Study||15
8135696|NCT02754661|20054055|P2|COMPLETED|Overall Study||141
8135697|NCT02754661|20054056|P1|COMPLETED|Overall Study||145
8135698|NCT02754661|20054055|P2|STARTED|Overall Study||160
8135699|NCT02754661|20054056|P1|STARTED|Overall Study||160
8135700|NCT02754570|20054070|P1|NOT COMPLETED|Overall Study||0
8135701|NCT02754570|20054070|P1|COMPLETED|Overall Study||27
8135702|NCT02754570|20054070|P1|Visit 3 (PGA + Pilocarpine)|Overall Study||27
8135703|NCT02754570|20054070|P1|Visits 1 and 2 (PGA Only)|Overall Study||27
8135704|NCT02754570|20054070|P1|STARTED|Overall Study||27
8135705|NCT02754492|20054080|P4|NOT COMPLETED|Overall Study||23
8135706|NCT02754492|20054081|P3|NOT COMPLETED|Overall Study||2
8135707|NCT02754492|20054082|P2|NOT COMPLETED|Overall Study||2
8135708|NCT02754492|20054083|P1|NOT COMPLETED|Overall Study||4
8135709|NCT02754492|20054080|P4|COMPLETED|Overall Study||0
8135710|NCT02754492|20054081|P3|COMPLETED|Overall Study||93
8135711|NCT02754492|20054082|P2|COMPLETED|Overall Study||93
8135712|NCT02754492|20054083|P1|COMPLETED|Overall Study||93
8135713|NCT02754492|20054080|P4|STARTED|Overall Study||23
8135714|NCT02754492|20054081|P3|STARTED|Overall Study||95
8135715|NCT02754492|20054082|P2|STARTED|Overall Study||95
8135716|NCT02754492|20054083|P1|STARTED|Overall Study||97
8135717|NCT02754440|20054099|P4|NOT COMPLETED|Overall Study||35
8135718|NCT02754440|20054100|P3|NOT COMPLETED|Overall Study||7
8135719|NCT02754440|20054101|P2|NOT COMPLETED|Overall Study||8
8135720|NCT02754440|20054102|P1|NOT COMPLETED|Overall Study||6
8135721|NCT02754440|20054099|P4|COMPLETED|Overall Study||0
8135722|NCT02754440|20054100|P3|COMPLETED|Overall Study||93
8135723|NCT02754440|20054101|P2|COMPLETED|Overall Study||93
8135724|NCT02754440|20054102|P1|COMPLETED|Overall Study||93
8135725|NCT02754440|20054099|P4|STARTED|Overall Study||35
8135726|NCT02754440|20054100|P3|STARTED|Overall Study||100
8135727|NCT02754440|20054101|P2|STARTED|Overall Study||101
8135728|NCT02754440|20054102|P1|STARTED|Overall Study||99
8135729|NCT02754427|20054116|P2|NOT COMPLETED|Overall Study||1
8135730|NCT02754427|20054117|P1|NOT COMPLETED|Overall Study||0
8135731|NCT02754427|20054116|P2|COMPLETED|Overall Study||19
8135732|NCT02754427|20054117|P1|COMPLETED|Overall Study||21
8135733|NCT02754427|20054116|P2|STARTED|Overall Study||20
8135734|NCT02754427|20054117|P1|STARTED|Overall Study||21
8135735|NCT02754310|20054131|P2|NOT COMPLETED|Overall Study||0
8135736|NCT02754310|20054132|P1|NOT COMPLETED|Overall Study||0
8135737|NCT02754310|20054131|P2|COMPLETED|Overall Study||43
8135738|NCT02754310|20054132|P1|COMPLETED|Overall Study||42
8135739|NCT02754310|20054131|P2|STARTED|Overall Study||43
8135740|NCT02754310|20054132|P1|STARTED|Overall Study||42
8135741|NCT02753946|20054154|P2|NOT COMPLETED|Overall Study||9
8135742|NCT02753946|20054155|P1|NOT COMPLETED|Overall Study||14
8135743|NCT02753946|20054154|P2|COMPLETED|Overall Study||222
8135744|NCT02753946|20054155|P1|COMPLETED|Overall Study||219
8135745|NCT02753946|20054154|P2|STARTED|Overall Study||231
8135746|NCT02753946|20054155|P1|STARTED|Overall Study||233
8135747|NCT02753920|20054167|P2|NOT COMPLETED|Overall Study||0
8135748|NCT02753920|20054168|P1|NOT COMPLETED|Overall Study||0
8135749|NCT02753920|20054167|P2|COMPLETED|Overall Study||86
8135750|NCT02753920|20054168|P1|COMPLETED|Overall Study||87
8135751|NCT02753920|20054167|P2|STARTED|Overall Study||86
8135752|NCT02753920|20054168|P1|STARTED|Overall Study||87
8135753|NCT02753881|20054181|P3|NOT COMPLETED|Overall Study||0
8135754|NCT02753881|20054182|P2|NOT COMPLETED|Overall Study||0
8135755|NCT02753881|20054183|P1|NOT COMPLETED|Overall Study||0
8135756|NCT02753881|20054181|P3|COMPLETED|Overall Study||10
8135757|NCT02753881|20054182|P2|COMPLETED|Overall Study||10
8135758|NCT02753881|20054183|P1|COMPLETED|Overall Study||10
8135759|NCT02753881|20054181|P3|STARTED|Overall Study||10
8135760|NCT02753881|20054182|P2|STARTED|Overall Study||10
8135761|NCT02753881|20054183|P1|STARTED|Overall Study||10
8135762|NCT02753842|20054215|P6|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
8135763|NCT02753842|20054216|P5|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
8135764|NCT02753842|20054217|P4|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
8135765|NCT02753842|20054218|P3|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
8135766|NCT02753842|20054219|P2|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
8135767|NCT02753842|20054220|P1|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
8135768|NCT02753842|20054215|P6|COMPLETED|Third Follow-Up (Set of Condoms)||69
8135769|NCT02753842|20054216|P5|COMPLETED|Third Follow-Up (Set of Condoms)||71
8135770|NCT02753842|20054217|P4|COMPLETED|Third Follow-Up (Set of Condoms)||70
8135771|NCT02753842|20054218|P3|COMPLETED|Third Follow-Up (Set of Condoms)||68
8135772|NCT02753842|20054219|P2|COMPLETED|Third Follow-Up (Set of Condoms)||66
8135773|NCT02753842|20054220|P1|COMPLETED|Third Follow-Up (Set of Condoms)||65
8135774|NCT02753842|20054215|P6|STARTED|Third Follow-Up (Set of Condoms)||72
8135775|NCT02753842|20054216|P5|STARTED|Third Follow-Up (Set of Condoms)||75
8135776|NCT02753842|20054217|P4|STARTED|Third Follow-Up (Set of Condoms)||76
8135777|NCT02753842|20054218|P3|STARTED|Third Follow-Up (Set of Condoms)||71
8135778|NCT02753842|20054219|P2|STARTED|Third Follow-Up (Set of Condoms)||71
8135779|NCT02753842|20054220|P1|STARTED|Third Follow-Up (Set of Condoms)||71
8135780|NCT02753842|20054215|P6|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
8135781|NCT02753842|20054216|P5|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
8135782|NCT02753842|20054217|P4|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8135783|NCT02753842|20054218|P3|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8135784|NCT02753842|20054219|P2|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8135785|NCT02753842|20054220|P1|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
8135786|NCT02753842|20054215|P6|COMPLETED|Second Follow-Up (Set of Condoms)||72
8135787|NCT02753842|20054216|P5|COMPLETED|Second Follow-Up (Set of Condoms)||75
8135788|NCT02753842|20054217|P4|COMPLETED|Second Follow-Up (Set of Condoms)||76
8135789|NCT02753842|20054218|P3|COMPLETED|Second Follow-Up (Set of Condoms)||71
8135790|NCT02753842|20054219|P2|COMPLETED|Second Follow-Up (Set of Condoms)||71
8135791|NCT02753842|20054220|P1|COMPLETED|Second Follow-Up (Set of Condoms)||71
8135792|NCT02753842|20054215|P6|STARTED|Second Follow-Up (Set of Condoms)||79
8135793|NCT02753842|20054216|P5|STARTED|Second Follow-Up (Set of Condoms)||76
8135794|NCT02753842|20054217|P4|STARTED|Second Follow-Up (Set of Condoms)||81
8135795|NCT02753842|20054218|P3|STARTED|Second Follow-Up (Set of Condoms)||76
8135796|NCT02753842|20054219|P2|STARTED|Second Follow-Up (Set of Condoms)||76
8135797|NCT02753842|20054220|P1|STARTED|Second Follow-Up (Set of Condoms)||75
8135798|NCT02753842|20054215|P6|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
8135799|NCT02753842|20054216|P5|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
8135800|NCT02753842|20054217|P4|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
8135801|NCT02753842|20054218|P3|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
8135802|NCT02753842|20054219|P2|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
8135803|NCT02753842|20054220|P1|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
8135804|NCT02753842|20054215|P6|COMPLETED|First Follow-Up (Set of Condoms)||79
8135805|NCT02753842|20054216|P5|COMPLETED|First Follow-Up (Set of Condoms)||76
8135806|NCT02753842|20054217|P4|COMPLETED|First Follow-Up (Set of Condoms)||81
8135807|NCT02753842|20054218|P3|COMPLETED|First Follow-Up (Set of Condoms)||76
8135808|NCT02753842|20054219|P2|COMPLETED|First Follow-Up (Set of Condoms)||76
8135809|NCT02753842|20054220|P1|COMPLETED|First Follow-Up (Set of Condoms)||75
8135810|NCT02753842|20054215|P6|STARTED|First Follow-Up (Set of Condoms)||84
8135811|NCT02753842|20054216|P5|STARTED|First Follow-Up (Set of Condoms)||83
8135812|NCT02753842|20054217|P4|STARTED|First Follow-Up (Set of Condoms)||83
8135813|NCT02753842|20054218|P3|STARTED|First Follow-Up (Set of Condoms)||85
8135814|NCT02753842|20054219|P2|STARTED|First Follow-Up (Set of Condoms)||84
8135815|NCT02753842|20054220|P1|STARTED|First Follow-Up (Set of Condoms)||85
8135816|NCT02753699|20054238|P3|NOT COMPLETED|Overall Study||23
8135817|NCT02753699|20054239|P2|NOT COMPLETED|Overall Study||43
8135818|NCT02753699|20054240|P1|NOT COMPLETED|Overall Study||14
8135819|NCT02753699|20054238|P3|COMPLETED|Overall Study||139
8135820|NCT02753699|20054239|P2|COMPLETED|Overall Study||354
8135821|NCT02753699|20054240|P1|COMPLETED|Overall Study||150
8135822|NCT02753699|20054238|P3|STARTED|Overall Study||162
8135823|NCT02753699|20054239|P2|STARTED|Overall Study||397
8135824|NCT02753699|20054240|P1|STARTED|Overall Study||164
8135825|NCT02753595|20054256|P2|NOT COMPLETED|Overall Study||2
8135826|NCT02753595|20054257|P1|NOT COMPLETED|Overall Study||2
8135827|NCT02753595|20054256|P2|COMPLETED|Overall Study||7
8135828|NCT02753595|20054257|P1|COMPLETED|Overall Study||3
8135829|NCT02753595|20054256|P2|STARTED|Overall Study||9
8135830|NCT02753595|20054257|P1|STARTED|Overall Study||5
8135831|NCT02753413|20054265|P2|NOT COMPLETED|Overall Study||0
8135832|NCT02753413|20054266|P1|NOT COMPLETED|Overall Study||0
8135833|NCT02753413|20054265|P2|COMPLETED|Overall Study||51
8135834|NCT02753413|20054266|P1|COMPLETED|Overall Study||49
8135835|NCT02753413|20054265|P2|STARTED|Overall Study||51
8135836|NCT02753413|20054266|P1|STARTED|Overall Study||49
8135837|NCT02753075|20054301|P3|NOT COMPLETED|Overall Study||3
8135838|NCT02753075|20054302|P2|NOT COMPLETED|Overall Study||3
8135839|NCT02753075|20054303|P1|NOT COMPLETED|Overall Study||8
8135840|NCT02753075|20054301|P3|COMPLETED|Overall Study||78
8135841|NCT02753075|20054302|P2|COMPLETED|Overall Study||77
8135842|NCT02753075|20054303|P1|COMPLETED|Overall Study||71
8135843|NCT02753075|20054301|P3|STARTED|Overall Study||81
8135844|NCT02753075|20054302|P2|STARTED|Overall Study||80
8135845|NCT02753075|20054303|P1|STARTED|Overall Study||79
8135846|NCT02752958|20054328|P1|NOT COMPLETED|Overall Study||9
8135847|NCT02752958|20054328|P1|COMPLETED|Overall Study||66
8135848|NCT02752958|20054328|P1|STARTED|Overall Study||75
8135849|NCT02752906|20054399|P2|NOT COMPLETED|Overall Study||5
8135850|NCT02752906|20054400|P1|NOT COMPLETED|Overall Study||7
8135851|NCT02752906|20054399|P2|COMPLETED|Overall Study||402
8135852|NCT02752906|20054400|P1|COMPLETED|Overall Study||396
8135853|NCT02752906|20054399|P2|Vaccinated|Overall Study||407
8135854|NCT02752906|20054400|P1|Vaccinated|Overall Study||402
8135855|NCT02752906|20054399|P2|STARTED|Overall Study||407
8135856|NCT02752906|20054400|P1|STARTED|Overall Study||403
8135857|NCT02752880|20054414|P2|NOT COMPLETED|Overall Study||3
8135858|NCT02752880|20054415|P1|NOT COMPLETED|Overall Study||2
8135859|NCT02752880|20054414|P2|COMPLETED|Overall Study||20
8135860|NCT02752880|20054415|P1|COMPLETED|Overall Study||21
8135861|NCT02752880|20054414|P2|STARTED|Overall Study||23
8135862|NCT02752880|20054415|P1|STARTED|Overall Study||23
8135863|NCT02752802|20054425|P2|NOT COMPLETED|Overall Study||0
8135864|NCT02752802|20054426|P1|NOT COMPLETED|Overall Study||1
8135865|NCT02752802|20054425|P2|COMPLETED|Overall Study||48
8135866|NCT02752802|20054426|P1|COMPLETED|Overall Study||47
8135867|NCT02752802|20054425|P2|STARTED|Overall Study||48
8135868|NCT02752802|20054426|P1|STARTED|Overall Study||48
8135869|NCT02752776|20054438|P3|NOT COMPLETED|Overall Study||48
8135870|NCT02752776|20054439|P2|NOT COMPLETED|Overall Study||76
8135871|NCT02752776|20054440|P1|NOT COMPLETED|Overall Study||52
8135872|NCT02752776|20054438|P3|COMPLETED|Overall Study||276
8135873|NCT02752776|20054439|P2|COMPLETED|Overall Study||597
8135874|NCT02752776|20054440|P1|COMPLETED|Overall Study||611
8135875|NCT02752776|20054438|P3|STARTED|Overall Study||324
8135876|NCT02752776|20054439|P2|STARTED|Overall Study||673
8135877|NCT02752776|20054440|P1|STARTED|Overall Study||663
8135878|NCT02752633|20054486|P1|NOT COMPLETED|Overall Study||1
8135879|NCT02752633|20054486|P1|COMPLETED|Overall Study||8
8135880|NCT02752633|20054486|P1|STARTED|Overall Study||9
8135881|NCT02752490|20054492|P2|NOT COMPLETED|Overall Study||0
8135882|NCT02752490|20054493|P1|NOT COMPLETED|Overall Study||0
8135883|NCT02752490|20054492|P2|COMPLETED|Overall Study||435
8135884|NCT02752490|20054493|P1|COMPLETED|Overall Study||409
8135885|NCT02752490|20054492|P2|STARTED|Overall Study||435
8135886|NCT02752490|20054493|P1|STARTED|Overall Study||409
8135887|NCT02752256|20054515|P2|NOT COMPLETED|Overall Study||0
8135888|NCT02752256|20054516|P1|NOT COMPLETED|Overall Study||0
8135889|NCT02752256|20054515|P2|COMPLETED|Overall Study||41
8135890|NCT02752256|20054516|P1|COMPLETED|Overall Study||35
8135891|NCT02752256|20054515|P2|STARTED|Overall Study||41
8135892|NCT02752256|20054516|P1|STARTED|Overall Study||35
8135893|NCT02752087|20054524|P2|NOT COMPLETED|Follow-up||0
8135894|NCT02752087|20054525|P1|NOT COMPLETED|Follow-up||0
8135895|NCT02752087|20054524|P2|COMPLETED|Follow-up||12
8135896|NCT02752087|20054525|P1|COMPLETED|Follow-up||11
8135897|NCT02752087|20054524|P2|STARTED|Follow-up||12
8135898|NCT02752087|20054525|P1|STARTED|Follow-up||11
8135899|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 4||0
8135900|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 4||0
8135901|NCT02752087|20054524|P2|COMPLETED|Study Period 4||12
8135902|NCT02752087|20054525|P1|COMPLETED|Study Period 4||11
8135903|NCT02752087|20054524|P2|Received Study Drug|Study Period 4||12
8135904|NCT02752087|20054525|P1|Received Study Drug|Study Period 4||11
8135905|NCT02752087|20054524|P2|STARTED|Study Period 4||12
8135906|NCT02752087|20054525|P1|STARTED|Study Period 4||11
8135907|NCT02752087|20054524|P2|NOT COMPLETED|Washout||0
8135908|NCT02752087|20054525|P1|NOT COMPLETED|Washout||0
8135909|NCT02752087|20054524|P2|COMPLETED|Washout||12
8135910|NCT02752087|20054525|P1|COMPLETED|Washout||11
8135911|NCT02752087|20054524|P2|STARTED|Washout||12
8135912|NCT02752087|20054525|P1|STARTED|Washout||11
8135913|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 3||0
8135914|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 3||0
8135915|NCT02752087|20054524|P2|COMPLETED|Study Period 3||12
8135916|NCT02752087|20054525|P1|COMPLETED|Study Period 3||11
8135917|NCT02752087|20054524|P2|Received Study Drug|Study Period 3||12
8135918|NCT02752087|20054525|P1|Received Study Drug|Study Period 3||11
8135919|NCT02752087|20054524|P2|STARTED|Study Period 3||12
8135920|NCT02752087|20054525|P1|STARTED|Study Period 3||11
8135921|NCT02752087|20054524|P2|NOT COMPLETED|Washout||0
8135922|NCT02752087|20054525|P1|NOT COMPLETED|Washout||0
8135923|NCT02752087|20054524|P2|COMPLETED|Washout||12
8135924|NCT02752087|20054525|P1|COMPLETED|Washout||11
8135925|NCT02752087|20054524|P2|STARTED|Washout||12
8135926|NCT02752087|20054525|P1|STARTED|Washout||11
8135927|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 2||0
8135928|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 2||0
8135929|NCT02752087|20054524|P2|COMPLETED|Study Period 2||12
8135930|NCT02752087|20054525|P1|COMPLETED|Study Period 2||11
8135931|NCT02752087|20054524|P2|Received Study Drug|Study Period 2||12
8135932|NCT02752087|20054525|P1|Received Study Drug|Study Period 2||11
8135933|NCT02752087|20054524|P2|STARTED|Study Period 2||12
8135934|NCT02752087|20054525|P1|STARTED|Study Period 2||11
8135935|NCT02752087|20054524|P2|NOT COMPLETED|Washout||0
8135936|NCT02752087|20054525|P1|NOT COMPLETED|Washout||1
8135937|NCT02752087|20054524|P2|COMPLETED|Washout||12
8135938|NCT02752087|20054525|P1|COMPLETED|Washout||11
8135939|NCT02752087|20054524|P2|STARTED|Washout||12
8135940|NCT02752087|20054525|P1|STARTED|Washout||12
8135941|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 1||0
8135942|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 1||0
8135943|NCT02752087|20054524|P2|COMPLETED|Study Period 1||12
8135944|NCT02752087|20054525|P1|COMPLETED|Study Period 1||12
8135945|NCT02752087|20054524|P2|Received Study Drug|Study Period 1||12
8135946|NCT02752087|20054525|P1|Received Study Drug|Study Period 1||12
8135947|NCT02752087|20054524|P2|STARTED|Study Period 1||12
8135948|NCT02752087|20054525|P1|STARTED|Study Period 1||12
8135949|NCT02752074|20054535|P2|NOT COMPLETED|Overall Study||143
8135950|NCT02752074|20054536|P1|NOT COMPLETED|Overall Study||156
8135951|NCT02752074|20054535|P2|COMPLETED|Overall Study||209
8135952|NCT02752074|20054536|P1|COMPLETED|Overall Study||198
8135953|NCT02752074|20054535|P2|Treated|Overall Study||352
8135954|NCT02752074|20054536|P1|Treated|Overall Study||353
8135955|NCT02752074|20054535|P2|STARTED|Overall Study||352
8135956|NCT02752074|20054536|P1|STARTED|Overall Study||354
8135957|NCT02752048|20054561|P3|NOT COMPLETED|Overall Study||3
8135958|NCT02752048|20054562|P2|NOT COMPLETED|Overall Study||0
8135959|NCT02752048|20054563|P1|NOT COMPLETED|Overall Study||0
8135960|NCT02752048|20054561|P3|COMPLETED|Overall Study||10
8135961|NCT02752048|20054562|P2|COMPLETED|Overall Study||12
8135962|NCT02752048|20054563|P1|COMPLETED|Overall Study||11
8135963|NCT02752048|20054561|P3|STARTED|Overall Study||13
8135964|NCT02752048|20054562|P2|STARTED|Overall Study||12
8135965|NCT02752048|20054563|P1|STARTED|Overall Study||11
8135966|NCT02751983|20054582|P2|NOT COMPLETED|Three-Month Follow-Up Assessments||16
8135967|NCT02751983|20054583|P1|NOT COMPLETED|Three-Month Follow-Up Assessments||12
8135968|NCT02751983|20054582|P2|COMPLETED|Three-Month Follow-Up Assessments||19
8135969|NCT02751983|20054583|P1|COMPLETED|Three-Month Follow-Up Assessments||23
8135970|NCT02751983|20054582|P2|STARTED|Three-Month Follow-Up Assessments||35
8135971|NCT02751983|20054583|P1|STARTED|Three-Month Follow-Up Assessments||35
8135972|NCT02751983|20054582|P2|NOT COMPLETED|One-Month Follow-Up Assessments||12
8135973|NCT02751983|20054583|P1|NOT COMPLETED|One-Month Follow-Up Assessments||14
8135974|NCT02751983|20054582|P2|COMPLETED|One-Month Follow-Up Assessments||23
8135975|NCT02751983|20054583|P1|COMPLETED|One-Month Follow-Up Assessments||21
8135976|NCT02751983|20054582|P2|STARTED|One-Month Follow-Up Assessments||35
8135977|NCT02751983|20054583|P1|STARTED|One-Month Follow-Up Assessments||35
8135978|NCT02751983|20054582|P2|NOT COMPLETED|Post-Treatment Assessment||0
8135979|NCT02751983|20054583|P1|NOT COMPLETED|Post-Treatment Assessment||5
8135980|NCT02751983|20054582|P2|COMPLETED|Post-Treatment Assessment||0
8135981|NCT02751983|20054583|P1|COMPLETED|Post-Treatment Assessment||30
8135982|NCT02751983|20054582|P2|STARTED|Post-Treatment Assessment||0
8135983|NCT02751983|20054583|P1|STARTED|Post-Treatment Assessment||35
8135984|NCT02751983|20054582|P2|NOT COMPLETED|Treatment||0
8135985|NCT02751983|20054583|P1|NOT COMPLETED|Treatment||4
8135986|NCT02751983|20054582|P2|COMPLETED|Treatment||35
8135987|NCT02751983|20054583|P1|COMPLETED|Treatment||31
8135988|NCT02751983|20054582|P2|STARTED|Treatment||35
8135989|NCT02751983|20054583|P1|STARTED|Treatment||35
8135990|NCT02751983|20054582|P2|NOT COMPLETED|Baseline and Randomization||0
8135991|NCT02751983|20054583|P1|NOT COMPLETED|Baseline and Randomization||0
8135992|NCT02751983|20054582|P2|COMPLETED|Baseline and Randomization||35
8135993|NCT02751983|20054583|P1|COMPLETED|Baseline and Randomization||35
8135994|NCT02751983|20054582|P2|STARTED|Baseline and Randomization||35
8135995|NCT02751983|20054583|P1|STARTED|Baseline and Randomization||35
8135996|NCT02751931|20054604|P2|NOT COMPLETED|Overall Study||8
8135997|NCT02751931|20054605|P1|NOT COMPLETED|Overall Study||13
8135998|NCT02751931|20054604|P2|COMPLETED|Overall Study||27
8135999|NCT02751931|20054605|P1|COMPLETED|Overall Study||43
8136000|NCT02751931|20054604|P2|Treated|Overall Study||31
8136001|NCT02751931|20054605|P1|Treated|Overall Study||55
8136002|NCT02751931|20054604|P2|STARTED|Overall Study||35
8136003|NCT02751931|20054605|P1|STARTED|Overall Study||56
8136004|NCT02751879|20054679|P2|NOT COMPLETED|Overall Study||0
8136005|NCT02751879|20054680|P1|NOT COMPLETED|Overall Study||0
8136006|NCT02751879|20054679|P2|COMPLETED|Overall Study||71
8136007|NCT02751879|20054680|P1|COMPLETED|Overall Study||157
8136008|NCT02751879|20054679|P2|On Treatment at Study Completion|Overall Study||41
8136009|NCT02751879|20054680|P1|On Treatment at Study Completion|Overall Study||81
8136010|NCT02751879|20054679|P2|STARTED|Overall Study||71
8136011|NCT02751879|20054680|P1|STARTED|Overall Study||157
8136012|NCT02751580|20054693|P1|NOT COMPLETED|Overall Study||6
8136013|NCT02751580|20054693|P1|COMPLETED|Overall Study||31
8136014|NCT02751580|20054693|P1|STARTED|Overall Study||37
8136015|NCT02751450|20054706|P2|NOT COMPLETED|Overall Study||0
8136016|NCT02751450|20054707|P1|NOT COMPLETED|Overall Study||1
8136017|NCT02751450|20054706|P2|COMPLETED|Overall Study||116
8136018|NCT02751450|20054707|P1|COMPLETED|Overall Study||116
8136019|NCT02751450|20054706|P2|STARTED|Overall Study||116
8136020|NCT02751450|20054707|P1|STARTED|Overall Study||117
8136021|NCT02751424|20054728|P9|NOT COMPLETED|Part 2||0
8136022|NCT02751424|20054729|P8|NOT COMPLETED|Part 2||5
8136023|NCT02751424|20054730|P7|NOT COMPLETED|Part 2||0
8136024|NCT02751424|20054731|P6|NOT COMPLETED|Part 2||0
8136025|NCT02751424|20054732|P5|NOT COMPLETED|Part 2||0
8136026|NCT02751424|20054733|P4|NOT COMPLETED|Part 2||0
8136027|NCT02751424|20054734|P3|NOT COMPLETED|Part 2||0
8136028|NCT02751424|20054735|P2|NOT COMPLETED|Part 2||0
8136029|NCT02751424|20054736|P1|NOT COMPLETED|Part 2||0
8136030|NCT02751424|20054728|P9|COMPLETED|Part 2||3
8136031|NCT02751424|20054729|P8|COMPLETED|Part 2||6
8136032|NCT02751424|20054730|P7|COMPLETED|Part 2||0
8136033|NCT02751424|20054731|P6|COMPLETED|Part 2||0
8136034|NCT02751424|20054732|P5|COMPLETED|Part 2||0
8136035|NCT02751424|20054733|P4|COMPLETED|Part 2||0
8136036|NCT02751424|20054734|P3|COMPLETED|Part 2||0
8136037|NCT02751424|20054735|P2|COMPLETED|Part 2||0
8136038|NCT02751424|20054736|P1|COMPLETED|Part 2||0
8136039|NCT02751424|20054728|P9|STARTED|Part 2||3
8136040|NCT02751424|20054729|P8|STARTED|Part 2||11
8136041|NCT02751424|20054730|P7|STARTED|Part 2||0
8136042|NCT02751424|20054731|P6|STARTED|Part 2||0
8136043|NCT02751424|20054732|P5|STARTED|Part 2||0
8136044|NCT02751424|20054733|P4|STARTED|Part 2||0
8136045|NCT02751424|20054734|P3|STARTED|Part 2||0
8136046|NCT02751424|20054735|P2|STARTED|Part 2||0
8136047|NCT02751424|20054736|P1|STARTED|Part 2||0
8136048|NCT02751424|20054728|P9|NOT COMPLETED|Part 1||0
8136049|NCT02751424|20054729|P8|NOT COMPLETED|Part 1||0
8136050|NCT02751424|20054730|P7|NOT COMPLETED|Part 1||0
8136051|NCT02751424|20054731|P6|NOT COMPLETED|Part 1||0
8136052|NCT02751424|20054732|P5|NOT COMPLETED|Part 1||0
8136053|NCT02751424|20054733|P4|NOT COMPLETED|Part 1||0
8136054|NCT02751424|20054734|P3|NOT COMPLETED|Part 1||0
8136055|NCT02751424|20054735|P2|NOT COMPLETED|Part 1||0
8136056|NCT02751424|20054736|P1|NOT COMPLETED|Part 1||0
8136057|NCT02751424|20054728|P9|COMPLETED|Part 1||0
8136058|NCT02751424|20054729|P8|COMPLETED|Part 1||0
8136059|NCT02751424|20054730|P7|COMPLETED|Part 1||12
8136060|NCT02751424|20054731|P6|COMPLETED|Part 1||6
8136061|NCT02751424|20054732|P5|COMPLETED|Part 1||6
8136062|NCT02751424|20054733|P4|COMPLETED|Part 1||6
8136063|NCT02751424|20054734|P3|COMPLETED|Part 1||6
8136064|NCT02751424|20054735|P2|COMPLETED|Part 1||6
8136065|NCT02751424|20054736|P1|COMPLETED|Part 1||6
8136066|NCT02751424|20054728|P9|STARTED|Part 1||0
8136067|NCT02751424|20054729|P8|STARTED|Part 1||0
8136068|NCT02751424|20054730|P7|STARTED|Part 1||12
8136069|NCT02751424|20054731|P6|STARTED|Part 1||6
8136070|NCT02751424|20054732|P5|STARTED|Part 1||6
8136071|NCT02751424|20054733|P4|STARTED|Part 1||6
8136072|NCT02751424|20054734|P3|STARTED|Part 1||6
8136073|NCT02751424|20054735|P2|STARTED|Part 1||6
8136074|NCT02751424|20054736|P1|STARTED|Part 1||6
8136075|NCT02751385|20054879|P2|NOT COMPLETED|Period 2||0
8136076|NCT02751385|20054880|P1|NOT COMPLETED|Period 2||0
8136077|NCT02751385|20054879|P2|COMPLETED|Period 2||2
8136078|NCT02751385|20054880|P1|COMPLETED|Period 2||0
8136079|NCT02751385|20054879|P2|STARTED|Period 2||2
8136080|NCT02751385|20054880|P1|STARTED|Period 2||0
8136081|NCT02751385|20054879|P2|NOT COMPLETED|Period 1||0
8136082|NCT02751385|20054880|P1|NOT COMPLETED|Period 1||0
8136083|NCT02751385|20054879|P2|COMPLETED|Period 1||0
8136084|NCT02751385|20054880|P1|COMPLETED|Period 1||2
8136085|NCT02751385|20054879|P2|STARTED|Period 1||0
8136086|NCT02751385|20054880|P1|STARTED|Period 1||2
8136087|NCT02751320|20054892|P1|NOT COMPLETED|Overall Study||3
8136088|NCT02751320|20054892|P1|COMPLETED|Overall Study||42
8136089|NCT02751320|20054892|P1|Received Reference Product 3|Overall Study||28
8136090|NCT02751320|20054892|P1|Received Reference Product 2|Overall Study||28
8136091|NCT02751320|20054892|P1|Received Reference Product 1|Overall Study||29
8136092|NCT02751320|20054892|P1|Received Test Prodcut 3|Overall Study||28
8136093|NCT02751320|20054892|P1|Received Test Prodcut 2|Overall Study||28
8136094|NCT02751320|20054892|P1|Received Test Product 1|Overall Study||29
8136095|NCT02751320|20054892|P1|STARTED|Overall Study||45
8136096|NCT02750943|20054930|P2|NOT COMPLETED|Overall Study||9
8136097|NCT02750943|20054931|P1|NOT COMPLETED|Overall Study||6
8136098|NCT02750943|20054930|P2|COMPLETED|Overall Study||119
8136099|NCT02750943|20054931|P1|COMPLETED|Overall Study||119
8136100|NCT02750943|20054930|P2|STARTED|Overall Study||128
8136101|NCT02750943|20054931|P1|STARTED|Overall Study||125
8136102|NCT02750930|20054945|P1|NOT COMPLETED|Overall Study||8
8136103|NCT02750930|20054945|P1|COMPLETED|Overall Study||0
8136104|NCT02750930|20054945|P1|STARTED|Overall Study||8
8136105|NCT02750813|20054957|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8136106|NCT02750813|20054958|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8136107|NCT02750813|20054957|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
8136108|NCT02750813|20054958|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
8136109|NCT02750813|20054957|P2|STARTED|Period 2, Second 14 Days of Wear||120
8136110|NCT02750813|20054958|P1|STARTED|Period 2, Second 14 Days of Wear||124
8136111|NCT02750813|20054957|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8136112|NCT02750813|20054958|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8136113|NCT02750813|20054957|P2|COMPLETED|Period 1, First 14 Days of Wear||120
8136114|NCT02750813|20054958|P1|COMPLETED|Period 1, First 14 Days of Wear||124
8136115|NCT02750813|20054957|P2|STARTED|Period 1, First 14 Days of Wear||121
8136116|NCT02750813|20054958|P1|STARTED|Period 1, First 14 Days of Wear||125
8136117|NCT02750800|20054973|P1|NOT COMPLETED|Overall Study||98
8136118|NCT02750800|20054973|P1|COMPLETED|Overall Study||314
8136119|NCT02750800|20054973|P1|STARTED|Overall Study||412
8136120|NCT02750761|20055078|P6|NOT COMPLETED|Overall Study||0
8136121|NCT02750761|20055079|P5|NOT COMPLETED|Overall Study||0
8136122|NCT02750761|20055080|P4|NOT COMPLETED|Overall Study||0
8136123|NCT02750761|20055081|P3|NOT COMPLETED|Overall Study||1
8136124|NCT02750761|20055082|P2|NOT COMPLETED|Overall Study||0
8136125|NCT02750761|20055083|P1|NOT COMPLETED|Overall Study||0
8136126|NCT02750761|20055078|P6|COMPLETED|Overall Study||6
8136127|NCT02750761|20055079|P5|COMPLETED|Overall Study||6
8136128|NCT02750761|20055080|P4|COMPLETED|Overall Study||5
8136129|NCT02750761|20055081|P3|COMPLETED|Overall Study||4
8136130|NCT02750761|20055082|P2|COMPLETED|Overall Study||5
8136131|NCT02750761|20055083|P1|COMPLETED|Overall Study||5
8136132|NCT02750761|20055078|P6|STARTED|Overall Study||6
8136133|NCT02750761|20055079|P5|STARTED|Overall Study||6
8136134|NCT02750761|20055080|P4|STARTED|Overall Study||5
8136135|NCT02750761|20055081|P3|STARTED|Overall Study||5
8136136|NCT02750761|20055082|P2|STARTED|Overall Study||5
8136137|NCT02750761|20055083|P1|STARTED|Overall Study||5
8136138|NCT02750709|20055179|P6|NOT COMPLETED|Treatment Period 3||0
8136139|NCT02750709|20055180|P5|NOT COMPLETED|Treatment Period 3||0
8136140|NCT02750709|20055181|P4|NOT COMPLETED|Treatment Period 3||0
8136141|NCT02750709|20055182|P3|NOT COMPLETED|Treatment Period 3||0
8136142|NCT02750709|20055183|P2|NOT COMPLETED|Treatment Period 3||0
8136143|NCT02750709|20055184|P1|NOT COMPLETED|Treatment Period 3||0
8136144|NCT02750709|20055179|P6|COMPLETED|Treatment Period 3||3
8136145|NCT02750709|20055180|P5|COMPLETED|Treatment Period 3||4
8136146|NCT02750709|20055181|P4|COMPLETED|Treatment Period 3||4
8136147|NCT02750709|20055182|P3|COMPLETED|Treatment Period 3||4
8136148|NCT02750709|20055183|P2|COMPLETED|Treatment Period 3||4
8136149|NCT02750709|20055184|P1|COMPLETED|Treatment Period 3||4
8136150|NCT02750709|20055179|P6|STARTED|Treatment Period 3||3
8136151|NCT02750709|20055180|P5|STARTED|Treatment Period 3||4
8136152|NCT02750709|20055181|P4|STARTED|Treatment Period 3||4
8136153|NCT02750709|20055182|P3|STARTED|Treatment Period 3||4
8136154|NCT02750709|20055183|P2|STARTED|Treatment Period 3||4
8136155|NCT02750709|20055184|P1|STARTED|Treatment Period 3||4
8136156|NCT02750709|20055179|P6|NOT COMPLETED|Treatment Period 2||0
8136157|NCT02750709|20055180|P5|NOT COMPLETED|Treatment Period 2||0
8136158|NCT02750709|20055181|P4|NOT COMPLETED|Treatment Period 2||0
8136159|NCT02750709|20055182|P3|NOT COMPLETED|Treatment Period 2||0
8136160|NCT02750709|20055183|P2|NOT COMPLETED|Treatment Period 2||0
8136161|NCT02750709|20055184|P1|NOT COMPLETED|Treatment Period 2||0
8136162|NCT02750709|20055179|P6|COMPLETED|Treatment Period 2||3
8136163|NCT02750709|20055180|P5|COMPLETED|Treatment Period 2||4
8136164|NCT02750709|20055181|P4|COMPLETED|Treatment Period 2||4
8136165|NCT02750709|20055182|P3|COMPLETED|Treatment Period 2||4
8136166|NCT02750709|20055183|P2|COMPLETED|Treatment Period 2||4
8136167|NCT02750709|20055184|P1|COMPLETED|Treatment Period 2||4
8136168|NCT02750709|20055179|P6|STARTED|Treatment Period 2||3
8136169|NCT02750709|20055180|P5|STARTED|Treatment Period 2||4
8136170|NCT02750709|20055181|P4|STARTED|Treatment Period 2||4
8136171|NCT02750709|20055182|P3|STARTED|Treatment Period 2||4
8136172|NCT02750709|20055183|P2|STARTED|Treatment Period 2||4
8136173|NCT02750709|20055184|P1|STARTED|Treatment Period 2||4
8136174|NCT02750709|20055179|P6|NOT COMPLETED|Treatment Period 1||1
8136175|NCT02750709|20055180|P5|NOT COMPLETED|Treatment Period 1||0
8136176|NCT02750709|20055181|P4|NOT COMPLETED|Treatment Period 1||0
8136177|NCT02750709|20055182|P3|NOT COMPLETED|Treatment Period 1||0
8136178|NCT02750709|20055183|P2|NOT COMPLETED|Treatment Period 1||0
8136179|NCT02750709|20055184|P1|NOT COMPLETED|Treatment Period 1||0
8136180|NCT02750709|20055179|P6|COMPLETED|Treatment Period 1||3
8136181|NCT02750709|20055180|P5|COMPLETED|Treatment Period 1||4
8136182|NCT02750709|20055181|P4|COMPLETED|Treatment Period 1||4
8136183|NCT02750709|20055182|P3|COMPLETED|Treatment Period 1||4
8136184|NCT02750709|20055183|P2|COMPLETED|Treatment Period 1||4
8136185|NCT02750709|20055184|P1|COMPLETED|Treatment Period 1||4
8136186|NCT02750709|20055179|P6|STARTED|Treatment Period 1||4
8136187|NCT02750709|20055180|P5|STARTED|Treatment Period 1||4
8136188|NCT02750709|20055181|P4|STARTED|Treatment Period 1||4
8136189|NCT02750709|20055182|P3|STARTED|Treatment Period 1||4
8136190|NCT02750709|20055183|P2|STARTED|Treatment Period 1||4
8136191|NCT02750709|20055184|P1|STARTED|Treatment Period 1||4
8136192|NCT02750618|20055210|P1|NOT COMPLETED|Overall Study||1
8136193|NCT02750618|20055210|P1|COMPLETED|Overall Study||12
8136194|NCT02750618|20055210|P1|Completed Week 64|Overall Study||13
8136195|NCT02750618|20055210|P1|Completed Week 40|Overall Study||13
8136196|NCT02750618|20055210|P1|STARTED|Overall Study||13
8136197|NCT02750592|20055226|P1|NOT COMPLETED|Overall Study||5
8136198|NCT02750592|20055226|P1|COMPLETED|Overall Study||25
8136199|NCT02750592|20055226|P1|STARTED|Overall Study||30
8136200|NCT02750501|20055245|P1|NOT COMPLETED|Overall Study||8
8136201|NCT02750501|20055245|P1|COMPLETED|Overall Study||36
8136202|NCT02750501|20055245|P1|Treated|Overall Study||39
8136203|NCT02750501|20055245|P1|Enrolled|Overall Study||44
8136204|NCT02750501|20055245|P1|STARTED|Overall Study||44
8136205|NCT02750410|20055259|P2|NOT COMPLETED|Open-Label Extension Period||6
8136206|NCT02750410|20055260|P1|NOT COMPLETED|Open-Label Extension Period||6
8136207|NCT02750410|20055259|P2|COMPLETED|Open-Label Extension Period||111
8136208|NCT02750410|20055260|P1|COMPLETED|Open-Label Extension Period||31
8136209|NCT02750410|20055259|P2|STARTED|Open-Label Extension Period||117
8136210|NCT02750410|20055260|P1|STARTED|Open-Label Extension Period||37
8136211|NCT02750410|20055259|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8136212|NCT02750410|20055260|P1|NOT COMPLETED|Double-Blind Treatment Period||2
8136213|NCT02750410|20055259|P2|COMPLETED|Double-Blind Treatment Period||117
8136214|NCT02750410|20055260|P1|COMPLETED|Double-Blind Treatment Period||37
8136215|NCT02750410|20055259|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
8136216|NCT02750410|20055260|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
8136217|NCT02750410|20055259|P2|STARTED|Double-Blind Treatment Period||120
8136218|NCT02750410|20055260|P1|STARTED|Double-Blind Treatment Period||39
8136219|NCT02750345|20055278|P6|NOT COMPLETED|Intervention 3||0
8136220|NCT02750345|20055279|P5|NOT COMPLETED|Intervention 3||0
8136221|NCT02750345|20055280|P4|NOT COMPLETED|Intervention 3||0
8136222|NCT02750345|20055281|P3|NOT COMPLETED|Intervention 3||0
8136223|NCT02750345|20055282|P2|NOT COMPLETED|Intervention 3||0
8136224|NCT02750345|20055283|P1|NOT COMPLETED|Intervention 3||0
8136225|NCT02750345|20055278|P6|COMPLETED|Intervention 3||4
8136226|NCT02750345|20055279|P5|COMPLETED|Intervention 3||3
8136227|NCT02750345|20055280|P4|COMPLETED|Intervention 3||4
8136228|NCT02750345|20055281|P3|COMPLETED|Intervention 3||4
8136229|NCT02750345|20055282|P2|COMPLETED|Intervention 3||4
8136230|NCT02750345|20055283|P1|COMPLETED|Intervention 3||4
8136231|NCT02750345|20055278|P6|STARTED|Intervention 3||4
8136232|NCT02750345|20055279|P5|STARTED|Intervention 3||3
8136233|NCT02750345|20055280|P4|STARTED|Intervention 3||4
8136234|NCT02750345|20055281|P3|STARTED|Intervention 3||4
8136235|NCT02750345|20055282|P2|STARTED|Intervention 3||4
8136236|NCT02750345|20055283|P1|STARTED|Intervention 3||4
8136237|NCT02750345|20055278|P6|NOT COMPLETED|Intervention 2||0
8136238|NCT02750345|20055279|P5|NOT COMPLETED|Intervention 2||0
8136239|NCT02750345|20055280|P4|NOT COMPLETED|Intervention 2||0
8136240|NCT02750345|20055281|P3|NOT COMPLETED|Intervention 2||0
8136241|NCT02750345|20055282|P2|NOT COMPLETED|Intervention 2||0
8136242|NCT02750345|20055283|P1|NOT COMPLETED|Intervention 2||0
8136243|NCT02750345|20055278|P6|COMPLETED|Intervention 2||4
8136244|NCT02750345|20055279|P5|COMPLETED|Intervention 2||3
8136245|NCT02750345|20055280|P4|COMPLETED|Intervention 2||4
8136246|NCT02750345|20055281|P3|COMPLETED|Intervention 2||4
8136247|NCT02750345|20055282|P2|COMPLETED|Intervention 2||4
8136248|NCT02750345|20055283|P1|COMPLETED|Intervention 2||4
8136249|NCT02750345|20055278|P6|STARTED|Intervention 2||4
8136250|NCT02750345|20055279|P5|STARTED|Intervention 2||3
8136251|NCT02750345|20055280|P4|STARTED|Intervention 2||4
8136252|NCT02750345|20055281|P3|STARTED|Intervention 2||4
8136253|NCT02750345|20055282|P2|STARTED|Intervention 2||4
8136254|NCT02750345|20055283|P1|STARTED|Intervention 2||4
8136255|NCT02750345|20055278|P6|NOT COMPLETED|Intervention 1||0
8136256|NCT02750345|20055279|P5|NOT COMPLETED|Intervention 1||1
8136257|NCT02750345|20055280|P4|NOT COMPLETED|Intervention 1||0
8136258|NCT02750345|20055281|P3|NOT COMPLETED|Intervention 1||0
8136259|NCT02750345|20055282|P2|NOT COMPLETED|Intervention 1||0
8136260|NCT02750345|20055283|P1|NOT COMPLETED|Intervention 1||0
8136261|NCT02750345|20055278|P6|COMPLETED|Intervention 1||4
8136262|NCT02750345|20055279|P5|COMPLETED|Intervention 1||3
8136263|NCT02750345|20055280|P4|COMPLETED|Intervention 1||4
8136264|NCT02750345|20055281|P3|COMPLETED|Intervention 1||4
8136265|NCT02750345|20055282|P2|COMPLETED|Intervention 1||4
8136266|NCT02750345|20055283|P1|COMPLETED|Intervention 1||4
8136267|NCT02750345|20055278|P6|STARTED|Intervention 1||4
8136268|NCT02750345|20055279|P5|STARTED|Intervention 1||4
8136269|NCT02750345|20055280|P4|STARTED|Intervention 1||4
8136270|NCT02750345|20055281|P3|STARTED|Intervention 1||4
8136271|NCT02750345|20055282|P2|STARTED|Intervention 1||4
8136272|NCT02750345|20055283|P1|STARTED|Intervention 1||4
8136273|NCT02750332|20055309|P2|NOT COMPLETED|Treatment Period 2||0
8136274|NCT02750332|20055310|P1|NOT COMPLETED|Treatment Period 2||0
8136275|NCT02750332|20055309|P2|COMPLETED|Treatment Period 2||9
8136276|NCT02750332|20055310|P1|COMPLETED|Treatment Period 2||10
8136277|NCT02750332|20055309|P2|STARTED|Treatment Period 2||9
8136278|NCT02750332|20055310|P1|STARTED|Treatment Period 2||10
8136279|NCT02750332|20055309|P2|NOT COMPLETED|Treatment Period 1||1
8136280|NCT02750332|20055310|P1|NOT COMPLETED|Treatment Period 1||0
8136281|NCT02750332|20055309|P2|COMPLETED|Treatment Period 1||9
8136282|NCT02750332|20055310|P1|COMPLETED|Treatment Period 1||10
8136283|NCT02750332|20055309|P2|STARTED|Treatment Period 1||10
8136284|NCT02750332|20055310|P1|STARTED|Treatment Period 1||10
8136285|NCT02750306|20055330|P2|NOT COMPLETED|Overall Study||2
8136286|NCT02750306|20055331|P1|NOT COMPLETED|Overall Study||6
8136287|NCT02750306|20055330|P2|COMPLETED|Overall Study||141
8136288|NCT02750306|20055331|P1|COMPLETED|Overall Study||136
8136289|NCT02750306|20055330|P2|STARTED|Overall Study||143
8136290|NCT02750306|20055331|P1|STARTED|Overall Study||142
8136291|NCT02750267|20055345|P2|NOT COMPLETED|Overall Study||0
8136292|NCT02750267|20055346|P1|NOT COMPLETED|Overall Study||0
8136293|NCT02750267|20055345|P2|COMPLETED|Overall Study||6
8136294|NCT02750267|20055346|P1|COMPLETED|Overall Study||6
8136295|NCT02750267|20055345|P2|STARTED|Overall Study||6
8136296|NCT02750267|20055346|P1|STARTED|Overall Study||6
8136297|NCT02749903|20055384|P1|NOT COMPLETED|Overall Study||0
8136298|NCT02749903|20055384|P1|COMPLETED|Overall Study||46
8136299|NCT02749903|20055384|P1|STARTED|Overall Study||46
8136303|NCT02749370|20055396|P1|NOT COMPLETED|Overall Study||14
8136304|NCT02749370|20055396|P1|COMPLETED|Overall Study||66
8136305|NCT02749370|20055396|P1|STARTED|Overall Study||80
8136306|NCT02749201|20055423|P1|NOT COMPLETED|Overall Study||0
8136307|NCT02749201|20055423|P1|COMPLETED|Overall Study||10
8136308|NCT02749201|20055423|P1|STARTED|Overall Study||10
8136309|NCT02748928|20055427|P1|NOT COMPLETED|Overall Study||0
8136310|NCT02748928|20055427|P1|COMPLETED|Overall Study||62
8136311|NCT02748928|20055427|P1|STARTED|Overall Study||62
8136312|NCT02748889|20055438|P2|NOT COMPLETED|Overall Study||0
8136313|NCT02748889|20055439|P1|NOT COMPLETED|Overall Study||0
8136314|NCT02748889|20055438|P2|COMPLETED|Overall Study||1
8136315|NCT02748889|20055439|P1|COMPLETED|Overall Study||0
8136316|NCT02748889|20055438|P2|STARTED|Overall Study||1
8136317|NCT02748889|20055439|P1|STARTED|Overall Study||0
8136318|NCT02748863|20055446|P5|NOT COMPLETED|Treatment Period 2||1
8136319|NCT02748863|20055447|P4|NOT COMPLETED|Treatment Period 2||2
8136320|NCT02748863|20055448|P3|NOT COMPLETED|Treatment Period 2||0
8136321|NCT02748863|20055449|P2|NOT COMPLETED|Treatment Period 2||3
8136322|NCT02748863|20055450|P1|NOT COMPLETED|Treatment Period 2||5
8136323|NCT02748863|20055446|P5|COMPLETED|Treatment Period 2||33
8136324|NCT02748863|20055447|P4|COMPLETED|Treatment Period 2||32
8136325|NCT02748863|20055448|P3|COMPLETED|Treatment Period 2||0
8136326|NCT02748863|20055449|P2|COMPLETED|Treatment Period 2||66
8136327|NCT02748863|20055450|P1|COMPLETED|Treatment Period 2||67
8136328|NCT02748863|20055446|P5|STARTED|Treatment Period 2||34
8136329|NCT02748863|20055447|P4|STARTED|Treatment Period 2||34
8136330|NCT02748863|20055448|P3|STARTED|Treatment Period 2||0
8136331|NCT02748863|20055449|P2|STARTED|Treatment Period 2||69
8136332|NCT02748863|20055450|P1|STARTED|Treatment Period 2||72
8136333|NCT02748863|20055446|P5|NOT COMPLETED|Treatment Period 1||0
8136334|NCT02748863|20055447|P4|NOT COMPLETED|Treatment Period 1||0
8136335|NCT02748863|20055448|P3|NOT COMPLETED|Treatment Period 1||2
8136336|NCT02748863|20055449|P2|NOT COMPLETED|Treatment Period 1||2
8136337|NCT02748863|20055450|P1|NOT COMPLETED|Treatment Period 1||0
8136338|NCT02748863|20055446|P5|COMPLETED|Treatment Period 1||0
8136339|NCT02748863|20055447|P4|COMPLETED|Treatment Period 1||0
8136340|NCT02748863|20055448|P3|COMPLETED|Treatment Period 1||69
8136341|NCT02748863|20055449|P2|COMPLETED|Treatment Period 1||69
8136342|NCT02748863|20055450|P1|COMPLETED|Treatment Period 1||72
8136343|NCT02748863|20055446|P5|STARTED|Treatment Period 1|Not applicable for this period|0
8136344|NCT02748863|20055447|P4|STARTED|Treatment Period 1|Not applicable for this period|0
8136345|NCT02748863|20055448|P3|STARTED|Treatment Period 1||71
8136346|NCT02748863|20055449|P2|STARTED|Treatment Period 1||71
8136347|NCT02748863|20055450|P1|STARTED|Treatment Period 1||72
8136348|NCT02748785|20055476|P4|NOT COMPLETED|Visit 3- Visit 4||2
8136349|NCT02748785|20055477|P3|NOT COMPLETED|Visit 3- Visit 4||2
8136350|NCT02748785|20055478|P2|NOT COMPLETED|Visit 3- Visit 4||1
8136351|NCT02748785|20055479|P1|NOT COMPLETED|Visit 3- Visit 4||1
8136352|NCT02748785|20055476|P4|COMPLETED|Visit 3- Visit 4||50
8136353|NCT02748785|20055477|P3|COMPLETED|Visit 3- Visit 4||47
8136354|NCT02748785|20055478|P2|COMPLETED|Visit 3- Visit 4||43
8136355|NCT02748785|20055479|P1|COMPLETED|Visit 3- Visit 4||53
8136356|NCT02748785|20055476|P4|STARTED|Visit 3- Visit 4||52
8136357|NCT02748785|20055477|P3|STARTED|Visit 3- Visit 4||49
8136358|NCT02748785|20055478|P2|STARTED|Visit 3- Visit 4||44
8136359|NCT02748785|20055479|P1|STARTED|Visit 3- Visit 4||54
8136360|NCT02748785|20055476|P4|NOT COMPLETED|Visit 2-Visit 3||11
8136361|NCT02748785|20055477|P3|NOT COMPLETED|Visit 2-Visit 3||8
8136362|NCT02748785|20055478|P2|NOT COMPLETED|Visit 2-Visit 3||5
8136363|NCT02748785|20055479|P1|NOT COMPLETED|Visit 2-Visit 3||5
8136364|NCT02748785|20055476|P4|COMPLETED|Visit 2-Visit 3||52
8136365|NCT02748785|20055477|P3|COMPLETED|Visit 2-Visit 3||49
8136366|NCT02748785|20055478|P2|COMPLETED|Visit 2-Visit 3||44
8136367|NCT02748785|20055479|P1|COMPLETED|Visit 2-Visit 3||54
8136368|NCT02748785|20055476|P4|STARTED|Visit 2-Visit 3||63
8136369|NCT02748785|20055477|P3|STARTED|Visit 2-Visit 3||57
8136370|NCT02748785|20055478|P2|STARTED|Visit 2-Visit 3||49
8136371|NCT02748785|20055479|P1|STARTED|Visit 2-Visit 3||59
8136372|NCT02748785|20055476|P4|NOT COMPLETED|Visit 1- Visit 2||6
8136373|NCT02748785|20055477|P3|NOT COMPLETED|Visit 1- Visit 2||14
8136374|NCT02748785|20055478|P2|NOT COMPLETED|Visit 1- Visit 2||19
8136375|NCT02748785|20055479|P1|NOT COMPLETED|Visit 1- Visit 2||10
8136376|NCT02748785|20055476|P4|COMPLETED|Visit 1- Visit 2||63
8136377|NCT02748785|20055477|P3|COMPLETED|Visit 1- Visit 2||57
8136378|NCT02748785|20055478|P2|COMPLETED|Visit 1- Visit 2||49
8136379|NCT02748785|20055479|P1|COMPLETED|Visit 1- Visit 2||59
8136380|NCT02748785|20055476|P4|STARTED|Visit 1- Visit 2||69
8136381|NCT02748785|20055477|P3|STARTED|Visit 1- Visit 2||71
8136382|NCT02748785|20055478|P2|STARTED|Visit 1- Visit 2||68
8136383|NCT02748785|20055479|P1|STARTED|Visit 1- Visit 2||69
8136384|NCT02748525|20055525|P1|NOT COMPLETED|Overall Study||11
8136385|NCT02748525|20055525|P1|COMPLETED|Overall Study|Completed 6 months follow up|39
8136386|NCT02748525|20055525|P1|Completed Study Intervention|Overall Study||50
8136387|NCT02748525|20055525|P1|STARTED|Overall Study||50
8136388|NCT02748512|20055534|P2|NOT COMPLETED|Overall Study||1
8136389|NCT02748512|20055535|P1|NOT COMPLETED|Overall Study||1
8136390|NCT02748512|20055534|P2|COMPLETED|Overall Study||11
8136391|NCT02748512|20055535|P1|COMPLETED|Overall Study||13
8136392|NCT02748512|20055534|P2|STARTED|Overall Study||12
8136393|NCT02748512|20055535|P1|STARTED|Overall Study||14
8136394|NCT02748356|20055543|P1|NOT COMPLETED|Overall Study||1
8136395|NCT02748356|20055543|P1|COMPLETED|Overall Study||6
8136396|NCT02748356|20055543|P1|STARTED|Overall Study||7
8136397|NCT02748317|20055548|P1|NOT COMPLETED|Overall Study||23
8136398|NCT02748317|20055548|P1|COMPLETED|Overall Study||73
8136399|NCT02748317|20055548|P1|STARTED|Overall Study||96
8136400|NCT02748213|20055555|P2|NOT COMPLETED|Overall Study||112
8136401|NCT02748213|20055556|P1|NOT COMPLETED|Overall Study||113
8136402|NCT02748213|20055555|P2|COMPLETED|Overall Study||0
8136403|NCT02748213|20055556|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
8136404|NCT02748213|20055555|P2|Treated|Overall Study||110
8136405|NCT02748213|20055556|P1|Treated|Overall Study||112
8136406|NCT02748213|20055555|P2|STARTED|Overall Study||112
8136407|NCT02748213|20055556|P1|STARTED|Overall Study||113
8136408|NCT02748070|20055574|P2|NOT COMPLETED|Overall Study||1
8136409|NCT02748070|20055575|P1|NOT COMPLETED|Overall Study||8
8136410|NCT02748070|20055574|P2|COMPLETED|Overall Study||39
8136411|NCT02748070|20055575|P1|COMPLETED|Overall Study||33
8136412|NCT02748070|20055574|P2|Randomized and Treated|Overall Study||40
8136413|NCT02748070|20055575|P1|Randomized and Treated|Overall Study||40
8136414|NCT02748070|20055574|P2|STARTED|Overall Study||40
8136415|NCT02748070|20055575|P1|STARTED|Overall Study||41
8136416|NCT02748057|20055585|P2|NOT COMPLETED|Overall Study||2
8136417|NCT02748057|20055586|P1|NOT COMPLETED|Overall Study||5
8136418|NCT02748057|20055585|P2|COMPLETED|Overall Study||19
8136419|NCT02748057|20055586|P1|COMPLETED|Overall Study||109
8136420|NCT02748057|20055585|P2|STARTED|Overall Study||21
8136421|NCT02748057|20055586|P1|STARTED|Overall Study||114
8136422|NCT02747628|20055599|P3|NOT COMPLETED|Overall Study||0
8136423|NCT02747628|20055600|P2|NOT COMPLETED|Overall Study||0
8136424|NCT02747628|20055601|P1|NOT COMPLETED|Overall Study||0
8136425|NCT02747628|20055599|P3|COMPLETED|Overall Study||20
8136426|NCT02747628|20055600|P2|COMPLETED|Overall Study||20
8136427|NCT02747628|20055601|P1|COMPLETED|Overall Study||20
8136428|NCT02747628|20055599|P3|STARTED|Overall Study||20
8136429|NCT02747628|20055600|P2|STARTED|Overall Study||20
8136430|NCT02747628|20055601|P1|STARTED|Overall Study||20
8136431|NCT02747615|20055611|P2|NOT COMPLETED|Overall Study||0
8136432|NCT02747615|20055612|P1|NOT COMPLETED|Overall Study||0
8136433|NCT02747615|20055611|P2|COMPLETED|Overall Study||30
8136434|NCT02747615|20055612|P1|COMPLETED|Overall Study||30
8136435|NCT02747615|20055611|P2|STARTED|Overall Study||30
8136436|NCT02747615|20055612|P1|STARTED|Overall Study||30
8136437|NCT02747433|20055622|P2|NOT COMPLETED|Overall Study||0
8136438|NCT02747433|20055623|P1|NOT COMPLETED|Overall Study||0
8136439|NCT02747433|20055622|P2|COMPLETED|Overall Study||5
8136440|NCT02747433|20055623|P1|COMPLETED|Overall Study||5
8136441|NCT02747433|20055622|P2|STARTED|Overall Study||5
8136442|NCT02747433|20055623|P1|STARTED|Overall Study||5
8136443|NCT02747420|20055655|P2|NOT COMPLETED|Overall Study||4
8136444|NCT02747420|20055656|P1|NOT COMPLETED|Overall Study||7
8136445|NCT02747420|20055655|P2|COMPLETED|Overall Study||18
8136446|NCT02747420|20055656|P1|COMPLETED|Overall Study||11
8136447|NCT02747420|20055655|P2|STARTED|Overall Study||22
8136448|NCT02747420|20055656|P1|STARTED|Overall Study||18
8136449|NCT02747186|20055662|P2|NOT COMPLETED|Second Intervention||0
8136450|NCT02747186|20055663|P1|NOT COMPLETED|Second Intervention||0
8136451|NCT02747186|20055662|P2|COMPLETED|Second Intervention||12
8136452|NCT02747186|20055663|P1|COMPLETED|Second Intervention||12
8136453|NCT02747186|20055662|P2|STARTED|Second Intervention||12
8136454|NCT02747186|20055663|P1|STARTED|Second Intervention||12
8136455|NCT02747186|20055662|P2|NOT COMPLETED|Washout (1 Week)||0
8136456|NCT02747186|20055663|P1|NOT COMPLETED|Washout (1 Week)||0
8136457|NCT02747186|20055662|P2|COMPLETED|Washout (1 Week)||12
8136458|NCT02747186|20055663|P1|COMPLETED|Washout (1 Week)||12
8136459|NCT02747186|20055662|P2|STARTED|Washout (1 Week)||12
8136460|NCT02747186|20055663|P1|STARTED|Washout (1 Week)||12
8136461|NCT02747186|20055662|P2|NOT COMPLETED|First Intervention||0
8136462|NCT02747186|20055663|P1|NOT COMPLETED|First Intervention||0
8136463|NCT02747186|20055662|P2|COMPLETED|First Intervention||12
8136464|NCT02747186|20055663|P1|COMPLETED|First Intervention||12
8136465|NCT02747186|20055662|P2|STARTED|First Intervention||12
8136466|NCT02747186|20055663|P1|STARTED|First Intervention||12
8136467|NCT02747108|20055673|P2|NOT COMPLETED|Overall Study||2
8136468|NCT02747108|20055674|P1|NOT COMPLETED|Overall Study||5
8136469|NCT02747108|20055673|P2|COMPLETED|Overall Study||60
8136470|NCT02747108|20055674|P1|COMPLETED|Overall Study||248
8136471|NCT02747108|20055673|P2|STARTED|Overall Study||62
8136472|NCT02747108|20055674|P1|STARTED|Overall Study||253
8136473|NCT02747043|20055716|P2|NOT COMPLETED|Overall Study||5
8136474|NCT02747043|20055717|P1|NOT COMPLETED|Overall Study||10
8136475|NCT02747043|20055716|P2|COMPLETED|Overall Study||123
8136476|NCT02747043|20055717|P1|COMPLETED|Overall Study||118
8136477|NCT02747043|20055716|P2|Treated|Overall Study||126
8136478|NCT02747043|20055717|P1|Treated|Overall Study||128
8136479|NCT02747043|20055716|P2|STARTED|Overall Study||128
8136480|NCT02747043|20055717|P1|STARTED|Overall Study||128
8136481|NCT02747004|20055746|P3|NOT COMPLETED|Overall Study||47
8136482|NCT02747004|20055747|P2|NOT COMPLETED|Overall Study||49
8136483|NCT02747004|20055748|P1|NOT COMPLETED|Overall Study||57
8136484|NCT02747004|20055746|P3|COMPLETED|Overall Study||30
8136485|NCT02747004|20055747|P2|COMPLETED|Overall Study||30
8136486|NCT02747004|20055748|P1|COMPLETED|Overall Study||21
8136487|NCT02747004|20055746|P3|Received at Least One Dose of Study Drug|Overall Study||77
8136488|NCT02747004|20055747|P2|Received at Least One Dose of Study Drug|Overall Study||79
8136489|NCT02747004|20055748|P1|Received at Least One Dose of Study Drug|Overall Study||78
8136490|NCT02747004|20055746|P3|STARTED|Overall Study||77
8136491|NCT02747004|20055747|P2|STARTED|Overall Study||79
8136492|NCT02747004|20055748|P1|STARTED|Overall Study||78
8136493|NCT02746991|20055778|P2|NOT COMPLETED|Overall Study||34
8136494|NCT02746991|20055779|P1|NOT COMPLETED|Overall Study||28
8136495|NCT02746991|20055778|P2|COMPLETED|Overall Study||67
8136496|NCT02746991|20055779|P1|COMPLETED|Overall Study||24
8136497|NCT02746991|20055778|P2|STARTED|Overall Study||101
8136498|NCT02746991|20055779|P1|STARTED|Overall Study||52
8136499|NCT02746809|20055787|P1|NOT COMPLETED|Baseline-6 Months||5
8136500|NCT02746809|20055787|P1|COMPLETED|Baseline-6 Months||54
8136501|NCT02746809|20055787|P1|STARTED|Baseline-6 Months||59
8136502|NCT02746809|20055787|P1|NOT COMPLETED|Baseline- 30 Days||1
8136503|NCT02746809|20055787|P1|COMPLETED|Baseline- 30 Days||59
8136504|NCT02746809|20055787|P1|STARTED|Baseline- 30 Days||60
8136505|NCT02746705|20055807|P2|NOT COMPLETED|Overall Study||2
8136506|NCT02746705|20055808|P1|NOT COMPLETED|Overall Study||2
8136507|NCT02746705|20055807|P2|COMPLETED|Overall Study||12
8136508|NCT02746705|20055808|P1|COMPLETED|Overall Study||15
8136509|NCT02746705|20055807|P2|STARTED|Overall Study||14
8136510|NCT02746705|20055808|P1|STARTED|Overall Study||17
8136511|NCT02746679|20055822|P2|NOT COMPLETED|Overall Study||6
8136512|NCT02746679|20055823|P1|NOT COMPLETED|Overall Study||4
8136513|NCT02746679|20055822|P2|COMPLETED|Overall Study||75
8136514|NCT02746679|20055823|P1|COMPLETED|Overall Study||76
8136515|NCT02746679|20055822|P2|STARTED|Overall Study||81
8136516|NCT02746679|20055823|P1|STARTED|Overall Study||80
8136517|NCT02746627|20055856|P3|NOT COMPLETED|Overall Study||1
8136518|NCT02746627|20055857|P2|NOT COMPLETED|Overall Study||1
8136519|NCT02746627|20055858|P1|NOT COMPLETED|Overall Study||1
8136520|NCT02746627|20055856|P3|COMPLETED|Overall Study||29
8136521|NCT02746627|20055857|P2|COMPLETED|Overall Study||29
8136522|NCT02746627|20055858|P1|COMPLETED|Overall Study||59
8136523|NCT02746627|20055856|P3|STARTED|Overall Study||30
8136524|NCT02746627|20055857|P2|STARTED|Overall Study||30
8136525|NCT02746627|20055858|P1|STARTED|Overall Study||60
8136526|NCT02746575|20055881|P1|NOT COMPLETED|Overall Study||50
8136527|NCT02746575|20055881|P1|COMPLETED|Overall Study||20
8136528|NCT02746575|20055881|P1|STARTED|Overall Study||70
8136529|NCT02746406|20055885|P1|NOT COMPLETED|Overall Study||0
8136530|NCT02746406|20055885|P1|COMPLETED|Overall Study||5
8136531|NCT02746406|20055885|P1|STARTED|Overall Study||5
8136532|NCT02746263|20055891|P2|NOT COMPLETED|Overall Study||0
8136533|NCT02746263|20055892|P1|NOT COMPLETED|Overall Study||0
8136534|NCT02746263|20055891|P2|COMPLETED|Overall Study||1
8136535|NCT02746263|20055892|P1|COMPLETED|Overall Study||0
8136536|NCT02746263|20055891|P2|Per Protocol Analysis Set|Overall Study||0
8136537|NCT02746263|20055892|P1|Per Protocol Analysis Set|Overall Study||0
8136538|NCT02746263|20055891|P2|STARTED|Overall Study||1
8136539|NCT02746263|20055892|P1|STARTED|Overall Study||0
8136540|NCT02746107|20055898|P1|NOT COMPLETED|Overall Study||0
8136541|NCT02746107|20055898|P1|COMPLETED|Overall Study||968
8136542|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 5|Overall Study||192
8136543|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 4|Overall Study||197
8136544|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 3|Overall Study||195
8136545|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 2|Overall Study||189
8136546|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 1|Overall Study||195
8136547|NCT02746107|20055898|P1|Target=Physician|Overall Study||482
8136548|NCT02746107|20055898|P1|Target=Patient|Overall Study||486
8136549|NCT02746107|20055898|P1|5year Risk Estimate|Overall Study||485
8136550|NCT02746107|20055898|P1|1year Risk Estimate|Overall Study||483
8136551|NCT02746107|20055898|P1|1 Diagram DA|Overall Study||486
8136552|NCT02746107|20055898|P1|2 Diagrams DA|Overall Study||482
8136553|NCT02746107|20055898|P1|STARTED|Overall Study||968
8136554|NCT02745626|20055916|P3|NOT COMPLETED|Overall Study||3
8136555|NCT02745626|20055917|P2|NOT COMPLETED|Overall Study||6
8136556|NCT02745626|20055918|P1|NOT COMPLETED|Overall Study||3
8136557|NCT02745626|20055916|P3|COMPLETED|Overall Study||19
8136558|NCT02745626|20055917|P2|COMPLETED|Overall Study||16
8136559|NCT02745626|20055918|P1|COMPLETED|Overall Study||21
8136560|NCT02745626|20055916|P3|STARTED|Overall Study||22
8136561|NCT02745626|20055917|P2|STARTED|Overall Study||22
8136562|NCT02745626|20055918|P1|STARTED|Overall Study||24
8136563|NCT02745535|20055944|P1|NOT COMPLETED|Overall Study||6
8136564|NCT02745535|20055944|P1|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
8136565|NCT02745535|20055944|P1|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
8136566|NCT02745535|20055944|P1|STARTED|Overall Study||77
8136567|NCT02745392|20055956|P4|NOT COMPLETED|Overall Study||0
8136568|NCT02745392|20055957|P3|NOT COMPLETED|Overall Study||0
8136569|NCT02745392|20055958|P2|NOT COMPLETED|Overall Study||1
8136570|NCT02745392|20055959|P1|NOT COMPLETED|Overall Study||0
8136571|NCT02745392|20055956|P4|COMPLETED|Overall Study||92
8136572|NCT02745392|20055957|P3|COMPLETED|Overall Study||92
8136573|NCT02745392|20055958|P2|COMPLETED|Overall Study||89
8136574|NCT02745392|20055959|P1|COMPLETED|Overall Study||91
8136575|NCT02745392|20055956|P4|STARTED|Overall Study||92
8136576|NCT02745392|20055957|P3|STARTED|Overall Study||92
8136577|NCT02745392|20055958|P2|STARTED|Overall Study||90
8136578|NCT02745392|20055959|P1|STARTED|Overall Study||91
8136579|NCT02745353|20055975|P2|NOT COMPLETED|Second Intervention (2 Weeks)||1
8136580|NCT02745353|20055976|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8136581|NCT02745353|20055975|P2|COMPLETED|Second Intervention (2 Weeks)||0
8136582|NCT02745353|20055976|P1|COMPLETED|Second Intervention (2 Weeks)||1
8136583|NCT02745353|20055975|P2|STARTED|Second Intervention (2 Weeks)||1
8136584|NCT02745353|20055976|P1|STARTED|Second Intervention (2 Weeks)||1
8136585|NCT02745353|20055975|P2|NOT COMPLETED|Washout (3 Days)||0
8136586|NCT02745353|20055976|P1|NOT COMPLETED|Washout (3 Days)||0
8136587|NCT02745353|20055975|P2|COMPLETED|Washout (3 Days)||1
8136588|NCT02745353|20055976|P1|COMPLETED|Washout (3 Days)||1
8136589|NCT02745353|20055975|P2|STARTED|Washout (3 Days)||1
8136590|NCT02745353|20055976|P1|STARTED|Washout (3 Days)||1
8136591|NCT02745353|20055975|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
8136592|NCT02745353|20055976|P1|NOT COMPLETED|First Intervention (2 Weeks)||3
8136593|NCT02745353|20055975|P2|COMPLETED|First Intervention (2 Weeks)||1
8136594|NCT02745353|20055976|P1|COMPLETED|First Intervention (2 Weeks)||1
8136595|NCT02745353|20055975|P2|STARTED|First Intervention (2 Weeks)||3
8136596|NCT02745353|20055976|P1|STARTED|First Intervention (2 Weeks)||4
8136597|NCT02745210|20055984|P2|NOT COMPLETED|Overall Study||0
8136598|NCT02745210|20055985|P1|NOT COMPLETED|Overall Study||0
8136599|NCT02745210|20055984|P2|COMPLETED|Overall Study||9
8136600|NCT02745210|20055985|P1|COMPLETED|Overall Study||0
8136601|NCT02745210|20055984|P2|STARTED|Overall Study||9
8136602|NCT02745210|20055985|P1|STARTED|Overall Study||0
8136603|NCT02745145|20055992|P3|NOT COMPLETED|Overall Study||9
8136604|NCT02745145|20055993|P2|NOT COMPLETED|Overall Study||5
8136605|NCT02745145|20055994|P1|NOT COMPLETED|Overall Study||10
8136606|NCT02745145|20055992|P3|COMPLETED|Overall Study||0
8136607|NCT02745145|20055993|P2|COMPLETED|Overall Study||0
8136608|NCT02745145|20055994|P1|COMPLETED|Overall Study||0
8136609|NCT02745145|20055992|P3|STARTED|Overall Study||9
8136610|NCT02745145|20055993|P2|STARTED|Overall Study||5
8136611|NCT02745145|20055994|P1|STARTED|Overall Study||10
8136612|NCT02745119|20056033|P4|NOT COMPLETED|Overall Study||277
8136613|NCT02745119|20056034|P3|NOT COMPLETED|Overall Study||146
8136614|NCT02745119|20056035|P2|NOT COMPLETED|Overall Study||274
8136615|NCT02745119|20056036|P1|NOT COMPLETED|Overall Study||145
8136616|NCT02745119|20056033|P4|COMPLETED|Overall Study||0
8136617|NCT02745119|20056034|P3|COMPLETED|Overall Study||0
8136618|NCT02745119|20056035|P2|COMPLETED|Overall Study||0
8136619|NCT02745119|20056036|P1|COMPLETED|Overall Study||0
8136620|NCT02745119|20056033|P4|STARTED|Overall Study||277
8136621|NCT02745119|20056034|P3|STARTED|Overall Study||146
8136622|NCT02745119|20056035|P2|STARTED|Overall Study||274
8136623|NCT02745119|20056036|P1|STARTED|Overall Study||145
8136624|NCT02745080|20056060|P2|NOT COMPLETED|Overall Study||89
8136625|NCT02745080|20056061|P1|NOT COMPLETED|Overall Study||55
8136626|NCT02745080|20056060|P2|COMPLETED|Overall Study||338
8136627|NCT02745080|20056061|P1|COMPLETED|Overall Study||371
8136628|NCT02745080|20056060|P2|STARTED|Overall Study||427
8136629|NCT02745080|20056061|P1|STARTED|Overall Study||426
8136630|NCT02744898|20056076|P1|NOT COMPLETED|Overall Study||4
8136631|NCT02744898|20056076|P1|COMPLETED|Overall Study||19
8136632|NCT02744898|20056076|P1|STARTED|Overall Study||23
8136633|NCT02744846|20056080|P1|NOT COMPLETED|10 Year Outcome Assessment||305820
8136634|NCT02744846|20056080|P1|COMPLETED|10 Year Outcome Assessment||56730
8136635|NCT02744846|20056080|P1|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
8136636|NCT02744846|20056080|P1|STARTED|10 Year Outcome Assessment||362550
8136637|NCT02744846|20056080|P1|NOT COMPLETED|5 Year Outcome Assessment||319189
8136638|NCT02744846|20056080|P1|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
8136639|NCT02744846|20056080|P1|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
8136640|NCT02744846|20056080|P1|STARTED|5 Year Outcome Assessment||681739
8136641|NCT02744755|20056090|P2|NOT COMPLETED|Study Period 2||8
8136642|NCT02744755|20056091|P1|NOT COMPLETED|Study Period 2||14
8136643|NCT02744755|20056090|P2|COMPLETED|Study Period 2||158
8136644|NCT02744755|20056091|P1|COMPLETED|Study Period 2||145
8136645|NCT02744755|20056090|P2|STARTED|Study Period 2||166
8136646|NCT02744755|20056091|P1|STARTED|Study Period 2||159
8136647|NCT02744755|20056090|P2|NOT COMPLETED|Study Period 1||8
8136648|NCT02744755|20056091|P1|NOT COMPLETED|Study Period 1||14
8136649|NCT02744755|20056090|P2|COMPLETED|Study Period 1||168
8136650|NCT02744755|20056091|P1|COMPLETED|Study Period 1||163
8136651|NCT02744755|20056090|P2|STARTED|Study Period 1||176
8136652|NCT02744755|20056091|P1|STARTED|Study Period 1||177
8136653|NCT02744534|20056145|P1|NOT COMPLETED|Overall Study||0
8136654|NCT02744534|20056145|P1|COMPLETED|Overall Study||21
8136655|NCT02744534|20056145|P1|STARTED|Overall Study||21
8136656|NCT02744391|20056151|P1|NOT COMPLETED|Overall Study||14
8136657|NCT02744391|20056151|P1|COMPLETED|Overall Study||33
8136658|NCT02744391|20056151|P1|STARTED|Overall Study||47
8136659|NCT02744352|20056175|P2|NOT COMPLETED|Overall Study||0
8136660|NCT02744352|20056176|P1|NOT COMPLETED|Overall Study||0
8136661|NCT02744352|20056175|P2|COMPLETED|Overall Study||4
8136662|NCT02744352|20056176|P1|COMPLETED|Overall Study||4
8136663|NCT02744352|20056175|P2|STARTED|Overall Study||4
8136664|NCT02744352|20056176|P1|STARTED|Overall Study||4
8136665|NCT02744066|20056192|P2|NOT COMPLETED|Overall Study||5
8136666|NCT02744066|20056193|P1|NOT COMPLETED|Overall Study||0
8136667|NCT02744066|20056192|P2|COMPLETED|Overall Study||25
8136668|NCT02744066|20056193|P1|COMPLETED|Overall Study||25
8136669|NCT02744066|20056192|P2|STARTED|Overall Study||30
8136670|NCT02744066|20056193|P1|STARTED|Overall Study||25
8136671|NCT02743962|20056203|P2|NOT COMPLETED|Overall Study||0
8136672|NCT02743962|20056204|P1|NOT COMPLETED|Overall Study||1
8136673|NCT02743962|20056203|P2|COMPLETED|Overall Study||5
8136674|NCT02743962|20056204|P1|COMPLETED|Overall Study||4
8136675|NCT02743962|20056203|P2|STARTED|Overall Study||5
8136676|NCT02743962|20056204|P1|STARTED|Overall Study||5
8136677|NCT02743949|20056226|P3|NOT COMPLETED|Overall Study||3
8136678|NCT02743949|20056227|P2|NOT COMPLETED|Overall Study||1
8136679|NCT02743949|20056228|P1|NOT COMPLETED|Overall Study||4
8136680|NCT02743949|20056226|P3|COMPLETED|Overall Study||82
8136681|NCT02743949|20056227|P2|COMPLETED|Overall Study||84
8136682|NCT02743949|20056228|P1|COMPLETED|Overall Study||82
8136683|NCT02743949|20056226|P3|STARTED|Overall Study||85
8136684|NCT02743949|20056227|P2|STARTED|Overall Study||85
8136685|NCT02743949|20056228|P1|STARTED|Overall Study||86
8136686|NCT02743936|20056241|P2|NOT COMPLETED|Overall Study||0
8136687|NCT02743936|20056242|P1|NOT COMPLETED|Overall Study||0
8136688|NCT02743936|20056241|P2|COMPLETED|Overall Study||32
8136689|NCT02743936|20056242|P1|COMPLETED|Overall Study||32
8136690|NCT02743936|20056241|P2|STARTED|Overall Study||32
8136691|NCT02743936|20056242|P1|STARTED|Overall Study||32
8136692|NCT02743780|20056255|P5|NOT COMPLETED|Part 3 (7 Days)||0
8136693|NCT02743780|20056256|P4|NOT COMPLETED|Part 3 (7 Days)||0
8136694|NCT02743780|20056257|P3|NOT COMPLETED|Part 3 (7 Days)||1
8136695|NCT02743780|20056258|P2|NOT COMPLETED|Part 3 (7 Days)||0
8136696|NCT02743780|20056259|P1|NOT COMPLETED|Part 3 (7 Days)||0
8136697|NCT02743780|20056255|P5|COMPLETED|Part 3 (7 Days)||25
8136698|NCT02743780|20056256|P4|COMPLETED|Part 3 (7 Days)||0
8136699|NCT02743780|20056257|P3|COMPLETED|Part 3 (7 Days)||24
8136700|NCT02743780|20056258|P2|COMPLETED|Part 3 (7 Days)||0
8136701|NCT02743780|20056259|P1|COMPLETED|Part 3 (7 Days)||0
8136702|NCT02743780|20056255|P5|STARTED|Part 3 (7 Days)||25
8136703|NCT02743780|20056256|P4|STARTED|Part 3 (7 Days)||0
8136704|NCT02743780|20056257|P3|STARTED|Part 3 (7 Days)||25
8136705|NCT02743780|20056258|P2|STARTED|Part 3 (7 Days)||0
8136706|NCT02743780|20056259|P1|STARTED|Part 3 (7 Days)||0
8136707|NCT02743780|20056255|P5|NOT COMPLETED|Part 2 (8 Days)||0
8136708|NCT02743780|20056256|P4|NOT COMPLETED|Part 2 (8 Days)||0
8136709|NCT02743780|20056257|P3|NOT COMPLETED|Part 2 (8 Days)||0
8136710|NCT02743780|20056258|P2|NOT COMPLETED|Part 2 (8 Days)||0
8136711|NCT02743780|20056259|P1|NOT COMPLETED|Part 2 (8 Days)||0
8136712|NCT02743780|20056255|P5|COMPLETED|Part 2 (8 Days)||4
8136713|NCT02743780|20056256|P4|COMPLETED|Part 2 (8 Days)||0
8136714|NCT02743780|20056257|P3|COMPLETED|Part 2 (8 Days)||6
8136715|NCT02743780|20056258|P2|COMPLETED|Part 2 (8 Days)||6
8136716|NCT02743780|20056259|P1|COMPLETED|Part 2 (8 Days)||0
8136717|NCT02743780|20056255|P5|STARTED|Part 2 (8 Days)||4
8136718|NCT02743780|20056256|P4|STARTED|Part 2 (8 Days)||0
8136719|NCT02743780|20056257|P3|STARTED|Part 2 (8 Days)||6
8136720|NCT02743780|20056258|P2|STARTED|Part 2 (8 Days)||6
8136721|NCT02743780|20056259|P1|STARTED|Part 2 (8 Days)||0
8136722|NCT02743780|20056255|P5|NOT COMPLETED|Part 1 (3 Days)||0
8136723|NCT02743780|20056256|P4|NOT COMPLETED|Part 1 (3 Days)||0
8136724|NCT02743780|20056257|P3|NOT COMPLETED|Part 1 (3 Days)||0
8136725|NCT02743780|20056258|P2|NOT COMPLETED|Part 1 (3 Days)||0
8136726|NCT02743780|20056259|P1|NOT COMPLETED|Part 1 (3 Days)||0
8136727|NCT02743780|20056255|P5|COMPLETED|Part 1 (3 Days)||8
8136728|NCT02743780|20056256|P4|COMPLETED|Part 1 (3 Days)||6
8136729|NCT02743780|20056257|P3|COMPLETED|Part 1 (3 Days)||6
8136730|NCT02743780|20056258|P2|COMPLETED|Part 1 (3 Days)||6
8136731|NCT02743780|20056259|P1|COMPLETED|Part 1 (3 Days)||6
8136732|NCT02743780|20056255|P5|STARTED|Part 1 (3 Days)||8
8136733|NCT02743780|20056256|P4|STARTED|Part 1 (3 Days)||6
8136734|NCT02743780|20056257|P3|STARTED|Part 1 (3 Days)||6
8136735|NCT02743780|20056258|P2|STARTED|Part 1 (3 Days)||6
8136736|NCT02743780|20056259|P1|STARTED|Part 1 (3 Days)||6
8136737|NCT02743702|20056306|P2|NOT COMPLETED|Overall Study||0
8136738|NCT02743702|20056307|P1|NOT COMPLETED|Overall Study||0
8136739|NCT02743702|20056306|P2|COMPLETED|Overall Study||10
8136740|NCT02743702|20056307|P1|COMPLETED|Overall Study||11
8136741|NCT02743702|20056306|P2|STARTED|Overall Study||10
8136742|NCT02743702|20056307|P1|STARTED|Overall Study||11
8136743|NCT02743520|20056313|P1|NOT COMPLETED|Overall Study||1
8136744|NCT02743520|20056313|P1|COMPLETED|Overall Study||85
8136745|NCT02743520|20056313|P1|STARTED|Overall Study||86
8136746|NCT02743377|20056323|P2|NOT COMPLETED|Overall Study||0
8136747|NCT02743377|20056324|P1|NOT COMPLETED|Overall Study||2
8136748|NCT02743377|20056323|P2|COMPLETED|Overall Study||6
8136749|NCT02743377|20056324|P1|COMPLETED|Overall Study||7
8136750|NCT02743377|20056323|P2|Whole Body PET Baseline & Blocked|Overall Study||2
8136751|NCT02743377|20056324|P1|Whole Body PET Baseline & Blocked|Overall Study||0
8136752|NCT02743377|20056323|P2|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
8136753|NCT02743377|20056324|P1|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
8136754|NCT02743377|20056323|P2|Brain PET With 11C Rolipram|Overall Study||3
8136755|NCT02743377|20056324|P1|Brain PET With 11C Rolipram|Overall Study||8
8136756|NCT02743377|20056323|P2|STARTED|Overall Study||6
8136757|NCT02743377|20056324|P1|STARTED|Overall Study||9
8136758|NCT02743312|20056352|P2|NOT COMPLETED|Overall Study||0
8136759|NCT02743312|20056353|P1|NOT COMPLETED|Overall Study||0
8136760|NCT02743312|20056352|P2|COMPLETED|Overall Study||2
8136761|NCT02743312|20056353|P1|COMPLETED|Overall Study||3
8136762|NCT02743312|20056352|P2|STARTED|Overall Study||2
8136763|NCT02743312|20056353|P1|STARTED|Overall Study||3
8136764|NCT02743221|20056386|P2|NOT COMPLETED|Overall Study||60
8136765|NCT02743221|20056387|P1|NOT COMPLETED|Overall Study||56
8136766|NCT02743221|20056386|P2|COMPLETED|Overall Study||17
8136767|NCT02743221|20056387|P1|COMPLETED|Overall Study||21
8136768|NCT02743221|20056386|P2|STARTED|Overall Study||77
8136769|NCT02743221|20056387|P1|STARTED|Overall Study||77
8136770|NCT02743117|20056403|P2|NOT COMPLETED|Overall Study||1
8136771|NCT02743117|20056404|P1|NOT COMPLETED|Overall Study||1
8136772|NCT02743117|20056403|P2|COMPLETED|Overall Study||240
8136773|NCT02743117|20056404|P1|COMPLETED|Overall Study||59
8136774|NCT02743117|20056403|P2|Treated|Overall Study||241
8136775|NCT02743117|20056404|P1|Treated|Overall Study||59
8136776|NCT02743117|20056403|P2|STARTED|Overall Study||241
8136777|NCT02743117|20056404|P1|STARTED|Overall Study||60
8136778|NCT02743078|20056418|P1|NOT COMPLETED|Overall Study||0
8136779|NCT02743078|20056418|P1|COMPLETED|Overall Study||3
8136780|NCT02743078|20056418|P1|Eligible With Six-month Follow-up Data|Overall Study||3
8136781|NCT02743078|20056418|P1|Eligible Populaton|Overall Study||3
8136782|NCT02743078|20056418|P1|STARTED|Overall Study||3
8136783|NCT02742987|20056428|P2|NOT COMPLETED|Overall Study||0
8136784|NCT02742987|20056429|P1|NOT COMPLETED|Overall Study||0
8136785|NCT02742987|20056428|P2|COMPLETED|Overall Study||21
8136786|NCT02742987|20056429|P1|COMPLETED|Overall Study||21
8136787|NCT02742987|20056428|P2|STARTED|Overall Study||21
8136788|NCT02742987|20056429|P1|STARTED|Overall Study||21
8136789|NCT02742818|20056437|P2|NOT COMPLETED|Overall Study||2
8136790|NCT02742818|20056438|P1|NOT COMPLETED|Overall Study||0
8136791|NCT02742818|20056437|P2|COMPLETED|Overall Study||23
8136792|NCT02742818|20056438|P1|COMPLETED|Overall Study||25
8136793|NCT02742818|20056437|P2|STARTED|Overall Study||25
8136794|NCT02742818|20056438|P1|STARTED|Overall Study||25
8136795|NCT02742766|20056471|P19|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136796|NCT02742766|20056472|P18|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136797|NCT02742766|20056473|P17|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136798|NCT02742766|20056474|P16|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136799|NCT02742766|20056475|P15|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136800|NCT02742766|20056476|P14|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136801|NCT02742766|20056477|P13|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136802|NCT02742766|20056478|P12|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136803|NCT02742766|20056479|P11|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136804|NCT02742766|20056480|P10|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136805|NCT02742766|20056481|P9|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136806|NCT02742766|20056482|P8|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136807|NCT02742766|20056483|P7|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136808|NCT02742766|20056484|P6|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136809|NCT02742766|20056485|P5|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136810|NCT02742766|20056486|P4|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136811|NCT02742766|20056487|P3|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136812|NCT02742766|20056488|P2|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136813|NCT02742766|20056489|P1|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136814|NCT02742766|20056471|P19|COMPLETED|Part 3 (Up to 36 Days)||0
8136815|NCT02742766|20056472|P18|COMPLETED|Part 3 (Up to 36 Days)||0
8136816|NCT02742766|20056473|P17|COMPLETED|Part 3 (Up to 36 Days)||0
8136817|NCT02742766|20056474|P16|COMPLETED|Part 3 (Up to 36 Days)||0
8136818|NCT02742766|20056475|P15|COMPLETED|Part 3 (Up to 36 Days)||0
8136819|NCT02742766|20056476|P14|COMPLETED|Part 3 (Up to 36 Days)||0
8136820|NCT02742766|20056477|P13|COMPLETED|Part 3 (Up to 36 Days)||0
8136821|NCT02742766|20056478|P12|COMPLETED|Part 3 (Up to 36 Days)||0
8136822|NCT02742766|20056479|P11|COMPLETED|Part 3 (Up to 36 Days)||0
8136823|NCT02742766|20056480|P10|COMPLETED|Part 3 (Up to 36 Days)||0
8136824|NCT02742766|20056481|P9|COMPLETED|Part 3 (Up to 36 Days)||0
8136825|NCT02742766|20056482|P8|COMPLETED|Part 3 (Up to 36 Days)||0
8136826|NCT02742766|20056483|P7|COMPLETED|Part 3 (Up to 36 Days)||0
8136827|NCT02742766|20056484|P6|COMPLETED|Part 3 (Up to 36 Days)||0
8136828|NCT02742766|20056485|P5|COMPLETED|Part 3 (Up to 36 Days)||0
8136829|NCT02742766|20056486|P4|COMPLETED|Part 3 (Up to 36 Days)||0
8136830|NCT02742766|20056487|P3|COMPLETED|Part 3 (Up to 36 Days)||0
8136831|NCT02742766|20056488|P2|COMPLETED|Part 3 (Up to 36 Days)||0
8136832|NCT02742766|20056489|P1|COMPLETED|Part 3 (Up to 36 Days)||0
8136833|NCT02742766|20056471|P19|STARTED|Part 3 (Up to 36 Days)||0
8136834|NCT02742766|20056472|P18|STARTED|Part 3 (Up to 36 Days)||0
8136835|NCT02742766|20056473|P17|STARTED|Part 3 (Up to 36 Days)||0
8136836|NCT02742766|20056474|P16|STARTED|Part 3 (Up to 36 Days)||0
8136837|NCT02742766|20056475|P15|STARTED|Part 3 (Up to 36 Days)||0
8136838|NCT02742766|20056476|P14|STARTED|Part 3 (Up to 36 Days)||0
8136839|NCT02742766|20056477|P13|STARTED|Part 3 (Up to 36 Days)||0
8136840|NCT02742766|20056478|P12|STARTED|Part 3 (Up to 36 Days)||0
8136841|NCT02742766|20056479|P11|STARTED|Part 3 (Up to 36 Days)||0
8136842|NCT02742766|20056480|P10|STARTED|Part 3 (Up to 36 Days)||0
8136843|NCT02742766|20056481|P9|STARTED|Part 3 (Up to 36 Days)||0
8136844|NCT02742766|20056482|P8|STARTED|Part 3 (Up to 36 Days)||0
8136845|NCT02742766|20056483|P7|STARTED|Part 3 (Up to 36 Days)||0
8136846|NCT02742766|20056484|P6|STARTED|Part 3 (Up to 36 Days)||0
8136847|NCT02742766|20056485|P5|STARTED|Part 3 (Up to 36 Days)||0
8136848|NCT02742766|20056486|P4|STARTED|Part 3 (Up to 36 Days)||0
8136849|NCT02742766|20056487|P3|STARTED|Part 3 (Up to 36 Days)||0
8136850|NCT02742766|20056488|P2|STARTED|Part 3 (Up to 36 Days)||0
8136851|NCT02742766|20056489|P1|STARTED|Part 3 (Up to 36 Days)||0
8136852|NCT02742766|20056471|P19|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136853|NCT02742766|20056472|P18|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136854|NCT02742766|20056473|P17|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136855|NCT02742766|20056474|P16|NOT COMPLETED|Part 2 (Up to 22 Days)||1
8136856|NCT02742766|20056475|P15|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136857|NCT02742766|20056476|P14|NOT COMPLETED|Part 2 (Up to 22 Days)||6
8136858|NCT02742766|20056477|P13|NOT COMPLETED|Part 2 (Up to 22 Days)||2
8136859|NCT02742766|20056478|P12|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136860|NCT02742766|20056479|P11|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136861|NCT02742766|20056480|P10|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136862|NCT02742766|20056481|P9|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136863|NCT02742766|20056482|P8|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136864|NCT02742766|20056483|P7|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136865|NCT02742766|20056484|P6|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136866|NCT02742766|20056485|P5|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136867|NCT02742766|20056486|P4|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136868|NCT02742766|20056487|P3|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136869|NCT02742766|20056488|P2|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136870|NCT02742766|20056489|P1|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136871|NCT02742766|20056471|P19|COMPLETED|Part 2 (Up to 22 Days)||0
8136872|NCT02742766|20056472|P18|COMPLETED|Part 2 (Up to 22 Days)||0
8136873|NCT02742766|20056473|P17|COMPLETED|Part 2 (Up to 22 Days)||0
8136874|NCT02742766|20056474|P16|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
8136875|NCT02742766|20056475|P15|COMPLETED|Part 2 (Up to 22 Days)||6
8136876|NCT02742766|20056476|P14|COMPLETED|Part 2 (Up to 22 Days)||0
8136877|NCT02742766|20056477|P13|COMPLETED|Part 2 (Up to 22 Days)||4
8136878|NCT02742766|20056478|P12|COMPLETED|Part 2 (Up to 22 Days)||0
8136879|NCT02742766|20056479|P11|COMPLETED|Part 2 (Up to 22 Days)||0
8136880|NCT02742766|20056480|P10|COMPLETED|Part 2 (Up to 22 Days)||0
8136881|NCT02742766|20056481|P9|COMPLETED|Part 2 (Up to 22 Days)||0
8136882|NCT02742766|20056482|P8|COMPLETED|Part 2 (Up to 22 Days)||0
8136883|NCT02742766|20056483|P7|COMPLETED|Part 2 (Up to 22 Days)||0
8136884|NCT02742766|20056484|P6|COMPLETED|Part 2 (Up to 22 Days)||0
8136885|NCT02742766|20056485|P5|COMPLETED|Part 2 (Up to 22 Days)||0
8136886|NCT02742766|20056486|P4|COMPLETED|Part 2 (Up to 22 Days)||0
8136887|NCT02742766|20056487|P3|COMPLETED|Part 2 (Up to 22 Days)||0
8136888|NCT02742766|20056488|P2|COMPLETED|Part 2 (Up to 22 Days)||0
8136889|NCT02742766|20056489|P1|COMPLETED|Part 2 (Up to 22 Days)||0
8136890|NCT02742766|20056471|P19|STARTED|Part 2 (Up to 22 Days)||0
8136891|NCT02742766|20056472|P18|STARTED|Part 2 (Up to 22 Days)||0
8136892|NCT02742766|20056473|P17|STARTED|Part 2 (Up to 22 Days)||0
8136893|NCT02742766|20056474|P16|STARTED|Part 2 (Up to 22 Days)||6
8136894|NCT02742766|20056475|P15|STARTED|Part 2 (Up to 22 Days)||6
8136895|NCT02742766|20056476|P14|STARTED|Part 2 (Up to 22 Days)||6
8136896|NCT02742766|20056477|P13|STARTED|Part 2 (Up to 22 Days)||6
8136897|NCT02742766|20056478|P12|STARTED|Part 2 (Up to 22 Days)||0
8136898|NCT02742766|20056479|P11|STARTED|Part 2 (Up to 22 Days)||0
8136899|NCT02742766|20056480|P10|STARTED|Part 2 (Up to 22 Days)||0
8136900|NCT02742766|20056481|P9|STARTED|Part 2 (Up to 22 Days)||0
8136901|NCT02742766|20056482|P8|STARTED|Part 2 (Up to 22 Days)||0
8136902|NCT02742766|20056483|P7|STARTED|Part 2 (Up to 22 Days)||0
8136903|NCT02742766|20056484|P6|STARTED|Part 2 (Up to 22 Days)||0
8136904|NCT02742766|20056485|P5|STARTED|Part 2 (Up to 22 Days)||0
8136905|NCT02742766|20056486|P4|STARTED|Part 2 (Up to 22 Days)||0
8136906|NCT02742766|20056487|P3|STARTED|Part 2 (Up to 22 Days)||0
8136907|NCT02742766|20056488|P2|STARTED|Part 2 (Up to 22 Days)||0
8136908|NCT02742766|20056489|P1|STARTED|Part 2 (Up to 22 Days)||0
8136909|NCT02742766|20056471|P19|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136910|NCT02742766|20056472|P18|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136911|NCT02742766|20056473|P17|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136912|NCT02742766|20056474|P16|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136913|NCT02742766|20056475|P15|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136914|NCT02742766|20056476|P14|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136915|NCT02742766|20056477|P13|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136916|NCT02742766|20056478|P12|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136917|NCT02742766|20056479|P11|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136918|NCT02742766|20056480|P10|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136919|NCT02742766|20056481|P9|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136920|NCT02742766|20056482|P8|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136921|NCT02742766|20056483|P7|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136922|NCT02742766|20056484|P6|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136923|NCT02742766|20056485|P5|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136924|NCT02742766|20056486|P4|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136925|NCT02742766|20056487|P3|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136926|NCT02742766|20056488|P2|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136927|NCT02742766|20056489|P1|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136928|NCT02742766|20056471|P19|COMPLETED|Part 1 (Up to 8 Days)||0
8136929|NCT02742766|20056472|P18|COMPLETED|Part 1 (Up to 8 Days)||0
8136930|NCT02742766|20056473|P17|COMPLETED|Part 1 (Up to 8 Days)||0
8136931|NCT02742766|20056474|P16|COMPLETED|Part 1 (Up to 8 Days)||0
8136932|NCT02742766|20056475|P15|COMPLETED|Part 1 (Up to 8 Days)||0
8136933|NCT02742766|20056476|P14|COMPLETED|Part 1 (Up to 8 Days)||0
8136934|NCT02742766|20056477|P13|COMPLETED|Part 1 (Up to 8 Days)||0
8136935|NCT02742766|20056478|P12|COMPLETED|Part 1 (Up to 8 Days)||6
8136936|NCT02742766|20056479|P11|COMPLETED|Part 1 (Up to 8 Days)||6
8136937|NCT02742766|20056480|P10|COMPLETED|Part 1 (Up to 8 Days)||0
8136938|NCT02742766|20056481|P9|COMPLETED|Part 1 (Up to 8 Days)||6
8136939|NCT02742766|20056482|P8|COMPLETED|Part 1 (Up to 8 Days)||6
8136940|NCT02742766|20056483|P7|COMPLETED|Part 1 (Up to 8 Days)||6
8136941|NCT02742766|20056484|P6|COMPLETED|Part 1 (Up to 8 Days)||6
8136942|NCT02742766|20056485|P5|COMPLETED|Part 1 (Up to 8 Days)||6
8136943|NCT02742766|20056486|P4|COMPLETED|Part 1 (Up to 8 Days)||6
8136944|NCT02742766|20056487|P3|COMPLETED|Part 1 (Up to 8 Days)||6
8136945|NCT02742766|20056488|P2|COMPLETED|Part 1 (Up to 8 Days)||6
8136946|NCT02742766|20056489|P1|COMPLETED|Part 1 (Up to 8 Days)||20
8136947|NCT02742766|20056471|P19|STARTED|Part 1 (Up to 8 Days)||0
8136948|NCT02742766|20056472|P18|STARTED|Part 1 (Up to 8 Days)||0
8136949|NCT02742766|20056473|P17|STARTED|Part 1 (Up to 8 Days)||0
8136950|NCT02742766|20056474|P16|STARTED|Part 1 (Up to 8 Days)||0
8136951|NCT02742766|20056475|P15|STARTED|Part 1 (Up to 8 Days)||0
8136952|NCT02742766|20056476|P14|STARTED|Part 1 (Up to 8 Days)||0
8136953|NCT02742766|20056477|P13|STARTED|Part 1 (Up to 8 Days)||0
8136954|NCT02742766|20056478|P12|STARTED|Part 1 (Up to 8 Days)||6
8136955|NCT02742766|20056479|P11|STARTED|Part 1 (Up to 8 Days)||6
8136956|NCT02742766|20056480|P10|STARTED|Part 1 (Up to 8 Days)||0
8136957|NCT02742766|20056481|P9|STARTED|Part 1 (Up to 8 Days)||6
8136958|NCT02742766|20056482|P8|STARTED|Part 1 (Up to 8 Days)||6
8136959|NCT02742766|20056483|P7|STARTED|Part 1 (Up to 8 Days)||6
8136960|NCT02742766|20056484|P6|STARTED|Part 1 (Up to 8 Days)||6
8136961|NCT02742766|20056485|P5|STARTED|Part 1 (Up to 8 Days)||6
8136962|NCT02742766|20056486|P4|STARTED|Part 1 (Up to 8 Days)||6
8136963|NCT02742766|20056487|P3|STARTED|Part 1 (Up to 8 Days)||6
8136964|NCT02742766|20056488|P2|STARTED|Part 1 (Up to 8 Days)||6
8136965|NCT02742766|20056489|P1|STARTED|Part 1 (Up to 8 Days)||20
8136966|NCT02742649|20056749|P5|NOT COMPLETED|Open-Label Period||1
8136967|NCT02742649|20056750|P4|NOT COMPLETED|Open-Label Period||0
8136968|NCT02742649|20056751|P3|NOT COMPLETED|Open-Label Period||0
8136969|NCT02742649|20056752|P2|NOT COMPLETED|Open-Label Period||0
8136970|NCT02742649|20056753|P1|NOT COMPLETED|Open-Label Period||0
8136971|NCT02742649|20056749|P5|COMPLETED|Open-Label Period||48
8136972|NCT02742649|20056750|P4|COMPLETED|Open-Label Period||0
8136973|NCT02742649|20056751|P3|COMPLETED|Open-Label Period||0
8136974|NCT02742649|20056752|P2|COMPLETED|Open-Label Period||0
8136975|NCT02742649|20056753|P1|COMPLETED|Open-Label Period||0
8136976|NCT02742649|20056749|P5|STARTED|Open-Label Period||49
8136977|NCT02742649|20056750|P4|STARTED|Open-Label Period||0
8136978|NCT02742649|20056751|P3|STARTED|Open-Label Period||0
8136979|NCT02742649|20056752|P2|STARTED|Open-Label Period||0
8136980|NCT02742649|20056753|P1|STARTED|Open-Label Period||0
8136981|NCT02742649|20056749|P5|NOT COMPLETED|Double-Blind Treatment Period||0
8136982|NCT02742649|20056750|P4|NOT COMPLETED|Double-Blind Treatment Period||0
8136983|NCT02742649|20056751|P3|NOT COMPLETED|Double-Blind Treatment Period||0
8136984|NCT02742649|20056752|P2|NOT COMPLETED|Double-Blind Treatment Period||1
8136985|NCT02742649|20056753|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8136986|NCT02742649|20056749|P5|COMPLETED|Double-Blind Treatment Period||0
8136987|NCT02742649|20056750|P4|COMPLETED|Double-Blind Treatment Period||16
8136988|NCT02742649|20056751|P3|COMPLETED|Double-Blind Treatment Period||17
8136989|NCT02742649|20056752|P2|COMPLETED|Double-Blind Treatment Period||16
8136990|NCT02742649|20056753|P1|COMPLETED|Double-Blind Treatment Period||0
8136991|NCT02742649|20056749|P5|STARTED|Double-Blind Treatment Period||0
8136992|NCT02742649|20056750|P4|STARTED|Double-Blind Treatment Period||16
8136993|NCT02742649|20056751|P3|STARTED|Double-Blind Treatment Period||17
8136994|NCT02742649|20056752|P2|STARTED|Double-Blind Treatment Period||17
8136995|NCT02742649|20056753|P1|STARTED|Double-Blind Treatment Period||0
8136996|NCT02742649|20056749|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
8136997|NCT02742649|20056750|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
8136998|NCT02742649|20056751|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
8136999|NCT02742649|20056752|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
8137000|NCT02742649|20056753|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
8137001|NCT02742649|20056749|P5|COMPLETED|Pre-Randomization Washout Period||0
8137002|NCT02742649|20056750|P4|COMPLETED|Pre-Randomization Washout Period||0
8137003|NCT02742649|20056751|P3|COMPLETED|Pre-Randomization Washout Period||0
8137004|NCT02742649|20056752|P2|COMPLETED|Pre-Randomization Washout Period||0
8137005|NCT02742649|20056753|P1|COMPLETED|Pre-Randomization Washout Period||50
8137006|NCT02742649|20056749|P5|STARTED|Pre-Randomization Washout Period||0
8137007|NCT02742649|20056750|P4|STARTED|Pre-Randomization Washout Period||0
8137008|NCT02742649|20056751|P3|STARTED|Pre-Randomization Washout Period||0
8137009|NCT02742649|20056752|P2|STARTED|Pre-Randomization Washout Period||0
8137010|NCT02742649|20056753|P1|STARTED|Pre-Randomization Washout Period||55
8137011|NCT02742532|20056781|P2|NOT COMPLETED|Overall Study||1
8137012|NCT02742532|20056782|P1|NOT COMPLETED|Overall Study||3
8137013|NCT02742532|20056781|P2|COMPLETED|Overall Study||31
8137014|NCT02742532|20056782|P1|COMPLETED|Overall Study||28
8137015|NCT02742532|20056781|P2|STARTED|Overall Study||32
8137016|NCT02742532|20056782|P1|STARTED|Overall Study||31
8137017|NCT02742519|20056792|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
8137018|NCT02742519|20056793|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137019|NCT02742519|20056794|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137020|NCT02742519|20056792|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137021|NCT02742519|20056793|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137022|NCT02742519|20056794|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137114|NCT02741271|20057035|P1|NOT COMPLETED|Overall Study||2
8137115|NCT02741271|20057034|P2|COMPLETED|Overall Study||88
8137023|NCT02742519|20056792|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
8137024|NCT02742519|20056793|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
8137025|NCT02742519|20056794|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
8137026|NCT02742519|20056792|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
8137027|NCT02742519|20056793|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
8137028|NCT02742519|20056794|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
8137029|NCT02742519|20056792|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
8137030|NCT02742519|20056793|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
8137031|NCT02742519|20056794|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
8137032|NCT02742519|20056792|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
8137033|NCT02742519|20056793|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
8137034|NCT02742519|20056794|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
8137035|NCT02742519|20056792|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137036|NCT02742519|20056793|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137037|NCT02742519|20056794|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137038|NCT02742519|20056792|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137039|NCT02742519|20056793|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
8137040|NCT02742519|20056794|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
8137041|NCT02742519|20056792|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
8137042|NCT02742519|20056793|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
8137043|NCT02742519|20056794|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
8137044|NCT02742441|20056814|P2|NOT COMPLETED|Overall Study||8
8137045|NCT02742441|20056815|P1|NOT COMPLETED|Overall Study||6
8137046|NCT02742441|20056814|P2|COMPLETED|Overall Study||196
8137047|NCT02742441|20056815|P1|COMPLETED|Overall Study||199
8137048|NCT02742441|20056814|P2|STARTED|Overall Study||204
8137049|NCT02742441|20056815|P1|STARTED|Overall Study||205
8137050|NCT02742129|20056833|P2|NOT COMPLETED|Phase 2||2
8137051|NCT02742129|20056834|P1|NOT COMPLETED|Phase 2||1
8137052|NCT02742129|20056833|P2|COMPLETED|Phase 2||48
8137053|NCT02742129|20056834|P1|COMPLETED|Phase 2||50
8137054|NCT02742129|20056833|P2|STARTED|Phase 2||50
8137055|NCT02742129|20056834|P1|STARTED|Phase 2||51
8137056|NCT02742129|20056833|P2|NOT COMPLETED|Phase 1||2
8137057|NCT02742129|20056834|P1|NOT COMPLETED|Phase 1||2
8137058|NCT02742129|20056833|P2|COMPLETED|Phase 1||50
8137059|NCT02742129|20056834|P1|COMPLETED|Phase 1||51
8137060|NCT02742129|20056833|P2|STARTED|Phase 1||52
8137061|NCT02742129|20056834|P1|STARTED|Phase 1||53
8137062|NCT02742103|20056862|P2|NOT COMPLETED|Overall Study||5
8137063|NCT02742103|20056863|P1|NOT COMPLETED|Overall Study||9
8137064|NCT02742103|20056862|P2|COMPLETED|Overall Study||23
8137065|NCT02742103|20056863|P1|COMPLETED|Overall Study||46
8137066|NCT02742103|20056862|P2|STARTED|Overall Study||28
8137067|NCT02742103|20056863|P1|STARTED|Overall Study||55
8137068|NCT02742077|20056900|P1|NOT COMPLETED|Overall Study||0
8137069|NCT02742077|20056900|P1|COMPLETED|Overall Study||20
8137070|NCT02742077|20056900|P1|STARTED|Overall Study||20
8137071|NCT02741713|20056909|P2|NOT COMPLETED|Overall Study||1
8137072|NCT02741713|20056910|P1|NOT COMPLETED|Overall Study||2
8137073|NCT02741713|20056909|P2|COMPLETED|Overall Study||19
8137074|NCT02741713|20056910|P1|COMPLETED|Overall Study||18
8137075|NCT02741713|20056909|P2|STARTED|Overall Study||20
8137076|NCT02741713|20056910|P1|STARTED|Overall Study||20
8137077|NCT02741687|20056925|P2|NOT COMPLETED|Overall Study||0
8137078|NCT02741687|20056926|P1|NOT COMPLETED|Overall Study||0
8137079|NCT02741687|20056925|P2|COMPLETED|Overall Study||44
8137080|NCT02741687|20056926|P1|COMPLETED|Overall Study||36
8137081|NCT02741687|20056925|P2|STARTED|Overall Study||44
8137082|NCT02741687|20056926|P1|STARTED|Overall Study||36
8137083|NCT02741635|20056950|P1|NOT COMPLETED|Overall Study||1
8137084|NCT02741635|20056950|P1|COMPLETED|Overall Study||14
8137085|NCT02741635|20056950|P1|STARTED|Overall Study||15
8137086|NCT02741596|20056958|P2|NOT COMPLETED|Overall Study||78
8137087|NCT02741596|20056959|P1|NOT COMPLETED|Overall Study||78
8137088|NCT02741596|20056958|P2|COMPLETED|Overall Study||25
8137089|NCT02741596|20056959|P1|COMPLETED|Overall Study||31
8137090|NCT02741596|20056958|P2|STARTED|Overall Study||103
8137091|NCT02741596|20056959|P1|STARTED|Overall Study||109
8137092|NCT02741518|20056977|P2|NOT COMPLETED|Overall Study||1
8137093|NCT02741518|20056978|P1|NOT COMPLETED|Overall Study||1
8137094|NCT02741518|20056977|P2|COMPLETED|Overall Study||10
8137095|NCT02741518|20056978|P1|COMPLETED|Overall Study||10
8137096|NCT02741518|20056977|P2|STARTED|Overall Study||11
8137097|NCT02741518|20056978|P1|STARTED|Overall Study||11
8137098|NCT02741310|20056988|P2|NOT COMPLETED|Overall Study||2
8137099|NCT02741310|20056989|P1|NOT COMPLETED|Overall Study||2
8137100|NCT02741310|20056988|P2|COMPLETED|Overall Study||20
8137101|NCT02741310|20056989|P1|COMPLETED|Overall Study||10
8137102|NCT02741310|20056988|P2|STARTED|Overall Study||22
8137103|NCT02741310|20056989|P1|STARTED|Overall Study||12
8137104|NCT02741297|20057009|P1|NOT COMPLETED|Overall Study||14
8137105|NCT02741297|20057009|P1|COMPLETED|Overall Study||59
8137106|NCT02741297|20057009|P1|STARTED|Overall Study||73
8137107|NCT02741284|20057015|P2|NOT COMPLETED|Overall Study||9
8137108|NCT02741284|20057016|P1|NOT COMPLETED|Overall Study||6
8137109|NCT02741284|20057015|P2|COMPLETED|Overall Study||48
8137110|NCT02741284|20057016|P1|COMPLETED|Overall Study||51
8137111|NCT02741284|20057015|P2|STARTED|Overall Study||57
8137112|NCT02741284|20057016|P1|STARTED|Overall Study||57
8137113|NCT02741271|20057034|P2|NOT COMPLETED|Overall Study||2
8137116|NCT02741271|20057035|P1|COMPLETED|Overall Study||89
8137117|NCT02741271|20057034|P2|STARTED|Overall Study||90
8137118|NCT02741271|20057035|P1|STARTED|Overall Study||91
8137119|NCT02741245|20057068|P5|NOT COMPLETED|Overall Study||2
8137120|NCT02741245|20057069|P4|NOT COMPLETED|Overall Study||4
8137121|NCT02741245|20057070|P3|NOT COMPLETED|Overall Study||0
8137122|NCT02741245|20057071|P2|NOT COMPLETED|Overall Study||1
8137123|NCT02741245|20057072|P1|NOT COMPLETED|Overall Study||0
8137124|NCT02741245|20057068|P5|COMPLETED|Overall Study||70
8137125|NCT02741245|20057069|P4|COMPLETED|Overall Study||67
8137126|NCT02741245|20057070|P3|COMPLETED|Overall Study||71
8137127|NCT02741245|20057071|P2|COMPLETED|Overall Study||71
8137128|NCT02741245|20057072|P1|COMPLETED|Overall Study||35
8137129|NCT02741245|20057068|P5|STARTED|Overall Study||72
8137130|NCT02741245|20057069|P4|STARTED|Overall Study||71
8137131|NCT02741245|20057070|P3|STARTED|Overall Study||71
8137132|NCT02741245|20057071|P2|STARTED|Overall Study||72
8137133|NCT02741245|20057072|P1|STARTED|Overall Study||35
8137134|NCT02741076|20057178|P4|NOT COMPLETED|Overall Study||2
8137135|NCT02741076|20057179|P3|NOT COMPLETED|Overall Study||2
8137136|NCT02741076|20057180|P2|NOT COMPLETED|Overall Study||5
8137137|NCT02741076|20057181|P1|NOT COMPLETED|Overall Study||3
8137138|NCT02741076|20057178|P4|COMPLETED|Overall Study||2
8137139|NCT02741076|20057179|P3|COMPLETED|Overall Study||1
8137140|NCT02741076|20057180|P2|COMPLETED|Overall Study||7
8137141|NCT02741076|20057181|P1|COMPLETED|Overall Study||10
8137142|NCT02741076|20057178|P4|STARTED|Overall Study||4
8137143|NCT02741076|20057179|P3|STARTED|Overall Study||3
8137144|NCT02741076|20057180|P2|STARTED|Overall Study||12
8137145|NCT02741076|20057181|P1|STARTED|Overall Study||13
8137146|NCT02740920|20057239|P1|NOT COMPLETED|Overall Study||0
8137147|NCT02740920|20057239|P1|COMPLETED|Overall Study||9
8137148|NCT02740920|20057239|P1|STARTED|Overall Study||9
8137149|NCT02740660|20057246|P2|NOT COMPLETED|Overall Study||0
8137150|NCT02740660|20057247|P1|NOT COMPLETED|Overall Study||0
8137151|NCT02740660|20057246|P2|COMPLETED|Overall Study||6
8137152|NCT02740660|20057247|P1|COMPLETED|Overall Study||6
8137153|NCT02740660|20057246|P2|STARTED|Overall Study||6
8137154|NCT02740660|20057247|P1|STARTED|Overall Study||6
8137155|NCT02740582|20057261|P2|NOT COMPLETED|Second Intervention||3
8137156|NCT02740582|20057262|P1|NOT COMPLETED|Second Intervention||1
8137157|NCT02740582|20057261|P2|COMPLETED|Second Intervention||28
8137158|NCT02740582|20057262|P1|COMPLETED|Second Intervention||23
8137159|NCT02740582|20057261|P2|STARTED|Second Intervention||31
8137160|NCT02740582|20057262|P1|STARTED|Second Intervention||24
8137161|NCT02740582|20057261|P2|NOT COMPLETED|Washout||0
8137162|NCT02740582|20057262|P1|NOT COMPLETED|Washout||0
8137163|NCT02740582|20057261|P2|COMPLETED|Washout||31
8137164|NCT02740582|20057262|P1|COMPLETED|Washout||24
8137165|NCT02740582|20057261|P2|STARTED|Washout||31
8137166|NCT02740582|20057262|P1|STARTED|Washout||24
8137167|NCT02740582|20057261|P2|NOT COMPLETED|First Intervention||2
8137168|NCT02740582|20057262|P1|NOT COMPLETED|First Intervention||5
8137169|NCT02740582|20057261|P2|COMPLETED|First Intervention||31
8137170|NCT02740582|20057262|P1|COMPLETED|First Intervention||24
8137171|NCT02740582|20057261|P2|STARTED|First Intervention||33
8137172|NCT02740582|20057262|P1|STARTED|First Intervention||29
8137173|NCT02740413|20057268|P1|NOT COMPLETED|Overall Study||0
8137174|NCT02740413|20057268|P1|COMPLETED|Overall Study||86
8137175|NCT02740413|20057268|P1|STARTED|Overall Study||86
8137176|NCT02740153|20057308|P2|NOT COMPLETED|Overall Study||0
8137177|NCT02740153|20057309|P1|NOT COMPLETED|Overall Study||0
8137178|NCT02740153|20057308|P2|COMPLETED|Overall Study||86
8137179|NCT02740153|20057309|P1|COMPLETED|Overall Study||101
8137180|NCT02740153|20057308|P2|STARTED|Overall Study||86
8137181|NCT02740153|20057309|P1|STARTED|Overall Study||101
8137182|NCT02740049|20057319|P1|NOT COMPLETED|Overall Study||1
8137183|NCT02740049|20057319|P1|COMPLETED|Overall Study||8
8137184|NCT02740049|20057319|P1|STARTED|Overall Study||9
8137185|NCT02739997|20057325|P1|NOT COMPLETED|Overall Study||2
8137186|NCT02739997|20057325|P1|COMPLETED|Overall Study||98
8137187|NCT02739997|20057325|P1|STARTED|Overall Study||100
8137188|NCT02739984|20057339|P2|NOT COMPLETED|Overall Study||2
8137189|NCT02739984|20057340|P1|NOT COMPLETED|Overall Study||5
8137190|NCT02739984|20057339|P2|COMPLETED|Overall Study||279
8137191|NCT02739984|20057340|P1|COMPLETED|Overall Study||138
8137192|NCT02739984|20057339|P2|Received Study Drug|Overall Study||280
8137193|NCT02739984|20057340|P1|Received Study Drug|Overall Study||141
8137194|NCT02739984|20057339|P2|STARTED|Overall Study||281
8137195|NCT02739984|20057340|P1|STARTED|Overall Study||143
8137196|NCT02739828|20057388|P1|NOT COMPLETED|Overall Study||5
8137197|NCT02739828|20057388|P1|COMPLETED|Overall Study||19
8137198|NCT02739828|20057388|P1|STARTED|Overall Study||24
8137199|NCT02739789|20057424|P2|NOT COMPLETED|Second fMRI Scan||0
8137200|NCT02739789|20057425|P1|NOT COMPLETED|Second fMRI Scan||0
8137201|NCT02739789|20057424|P2|COMPLETED|Second fMRI Scan||7
8137202|NCT02739789|20057425|P1|COMPLETED|Second fMRI Scan||9
8137203|NCT02739789|20057424|P2|STARTED|Second fMRI Scan||7
8137204|NCT02739789|20057425|P1|STARTED|Second fMRI Scan||9
8137205|NCT02739789|20057424|P2|NOT COMPLETED|~1 Week Waiting Period||3
8137206|NCT02739789|20057425|P1|NOT COMPLETED|~1 Week Waiting Period||0
8137207|NCT02739789|20057424|P2|COMPLETED|~1 Week Waiting Period||7
8137208|NCT02739789|20057425|P1|COMPLETED|~1 Week Waiting Period||9
8137209|NCT02739789|20057424|P2|STARTED|~1 Week Waiting Period||10
8137210|NCT02739789|20057425|P1|STARTED|~1 Week Waiting Period||9
8137211|NCT02739789|20057424|P2|NOT COMPLETED|First fMRI Scan||0
8137212|NCT02739789|20057425|P1|NOT COMPLETED|First fMRI Scan||0
8137213|NCT02739789|20057424|P2|COMPLETED|First fMRI Scan||10
8137214|NCT02739789|20057425|P1|COMPLETED|First fMRI Scan||9
8137215|NCT02739789|20057424|P2|STARTED|First fMRI Scan||10
8137216|NCT02739789|20057425|P1|STARTED|First fMRI Scan||9
8137217|NCT02739698|20057439|P2|NOT COMPLETED|Overall Study||5
8137218|NCT02739698|20057440|P1|NOT COMPLETED|Overall Study||6
8137219|NCT02739698|20057439|P2|COMPLETED|Overall Study||16
8137220|NCT02739698|20057440|P1|COMPLETED|Overall Study||16
8137221|NCT02739698|20057439|P2|STARTED|Overall Study||21
8137222|NCT02739698|20057440|P1|STARTED|Overall Study||22
8137223|NCT02739594|20057448|P2|NOT COMPLETED|Overall Study||28
8137224|NCT02739594|20057449|P1|NOT COMPLETED|Overall Study||25
8137225|NCT02739594|20057448|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
8137226|NCT02739594|20057449|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
8137227|NCT02739594|20057448|P2|Completed at Week 96|Overall Study||10
8137228|NCT02739594|20057449|P1|Completed at Week 96|Overall Study||10
8137229|NCT02739594|20057448|P2|Completed at Week 44|Overall Study||5
8137230|NCT02739594|20057449|P1|Completed at Week 44|Overall Study||11
8137231|NCT02739594|20057448|P2|STARTED|Overall Study||43
8137232|NCT02739594|20057449|P1|STARTED|Overall Study||46
8137233|NCT02739360|20057479|P1|NOT COMPLETED|Overall Study||3
8137234|NCT02739360|20057479|P1|COMPLETED|Overall Study||0
8137235|NCT02739360|20057479|P1|STARTED|Overall Study||3
8137236|NCT02739321|20057485|P2|NOT COMPLETED|Overall Study||4
8137237|NCT02739321|20057486|P1|NOT COMPLETED|Overall Study||3
8137238|NCT02739321|20057485|P2|COMPLETED|Overall Study||18
8137239|NCT02739321|20057486|P1|COMPLETED|Overall Study||20
8137240|NCT02739321|20057485|P2|STARTED|Overall Study||22
8137241|NCT02739321|20057486|P1|STARTED|Overall Study||23
8137242|NCT02739269|20057532|P2|NOT COMPLETED|Overall Study||4
8137243|NCT02739269|20057533|P1|NOT COMPLETED|Overall Study||7
8137244|NCT02739269|20057532|P2|COMPLETED|Overall Study||96
8137245|NCT02739269|20057533|P1|COMPLETED|Overall Study||93
8137246|NCT02739269|20057532|P2|STARTED|Overall Study||100
8137247|NCT02739269|20057533|P1|STARTED|Overall Study||100
8137248|NCT02739100|20057541|P1|NOT COMPLETED|Overall Study||0
8137249|NCT02739100|20057541|P1|COMPLETED|Overall Study||13
8137250|NCT02739100|20057541|P1|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
8137251|NCT02739100|20057541|P1|Triferic 6.6 mg IV Predialyzer|Overall Study||13
8137252|NCT02739100|20057541|P1|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
8137253|NCT02739100|20057541|P1|STARTED|Overall Study||13
8137254|NCT02738879|20057560|P2|NOT COMPLETED|Overall Study||25
8137255|NCT02738879|20057561|P1|NOT COMPLETED|Overall Study||13
8137256|NCT02738879|20057560|P2|COMPLETED|Overall Study||347
8137257|NCT02738879|20057561|P1|COMPLETED|Overall Study||361
8137258|NCT02738879|20057560|P2|Treated|Overall Study||370
8137259|NCT02738879|20057561|P1|Treated|Overall Study||373
8137260|NCT02738879|20057560|P2|STARTED|Overall Study||372
8137261|NCT02738879|20057561|P1|STARTED|Overall Study||374
8137262|NCT02738853|20057595|P1|NOT COMPLETED|30 Days- 6 Months||2
8137263|NCT02738853|20057595|P1|COMPLETED|30 Days- 6 Months||57
8137264|NCT02738853|20057595|P1|STARTED|30 Days- 6 Months||59
8137265|NCT02738853|20057595|P1|NOT COMPLETED|Baseline -30 Days||1
8137266|NCT02738853|20057595|P1|COMPLETED|Baseline -30 Days||59
8137267|NCT02738853|20057595|P1|STARTED|Baseline -30 Days||60
8137268|NCT02738801|20057613|P2|NOT COMPLETED|Overall Study||2
8137269|NCT02738801|20057614|P1|NOT COMPLETED|Overall Study||1
8137270|NCT02738801|20057613|P2|COMPLETED|Overall Study||15
8137271|NCT02738801|20057614|P1|COMPLETED|Overall Study||5
8137272|NCT02738801|20057613|P2|STARTED|Overall Study||17
8137273|NCT02738801|20057614|P1|STARTED|Overall Study||6
8137274|NCT02738580|20057630|P2|NOT COMPLETED|Overall Study||4
8137275|NCT02738580|20057631|P1|NOT COMPLETED|Overall Study||4
8137276|NCT02738580|20057630|P2|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation
~1 patient withdrawal
~1 excluded"|52
8137277|NCT02738580|20057631|P1|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.
~1 cycle cancelled due to SAE."|52
8137278|NCT02738580|20057630|P2|STARTED|Overall Study||56
8137279|NCT02738580|20057631|P1|STARTED|Overall Study|56 patients were assigned to this arms.|56
8137280|NCT02738333|20057642|P3|NOT COMPLETED|Overall Study||0
8137281|NCT02738333|20057643|P2|NOT COMPLETED|Overall Study||0
8137282|NCT02738333|20057644|P1|NOT COMPLETED|Overall Study||2
8137283|NCT02738333|20057642|P3|COMPLETED|Overall Study||25
8137284|NCT02738333|20057643|P2|COMPLETED|Overall Study||108
8137285|NCT02738333|20057644|P1|COMPLETED|Overall Study||104
8137286|NCT02738333|20057642|P3|STARTED|Overall Study||25
8137287|NCT02738333|20057643|P2|STARTED|Overall Study||108
8137288|NCT02738333|20057644|P1|STARTED|Overall Study||106
8137289|NCT02738255|20057720|P2|NOT COMPLETED|Overall Study||1
8137290|NCT02738255|20057721|P1|NOT COMPLETED|Overall Study||0
8137291|NCT02738255|20057720|P2|COMPLETED|Overall Study||14
8137292|NCT02738255|20057721|P1|COMPLETED|Overall Study||11
8137293|NCT02738255|20057720|P2|STARTED|Overall Study||15
8137294|NCT02738255|20057721|P1|STARTED|Overall Study||11
8137295|NCT02738203|20057733|P2|NOT COMPLETED|Overall Study||3
8137296|NCT02738203|20057734|P1|NOT COMPLETED|Overall Study||2
8137297|NCT02738203|20057733|P2|COMPLETED|Overall Study||107
8137298|NCT02738203|20057734|P1|COMPLETED|Overall Study||108
8137299|NCT02738203|20057733|P2|STARTED|Overall Study||110
8137300|NCT02738203|20057734|P1|STARTED|Overall Study||110
8137301|NCT02738151|20057750|P2|NOT COMPLETED|Overall Study||31
8137302|NCT02738151|20057751|P1|NOT COMPLETED|Overall Study||23
8137303|NCT02738151|20057750|P2|COMPLETED|Overall Study||432
8137304|NCT02738151|20057751|P1|COMPLETED|Overall Study||443
8137305|NCT02738151|20057750|P2|Treated|Overall Study||462
8137306|NCT02738151|20057751|P1|Treated|Overall Study||462
8137307|NCT02738151|20057750|P2|STARTED|Overall Study||463
8137308|NCT02738151|20057751|P1|STARTED|Overall Study||466
8137309|NCT02738138|20057795|P2|NOT COMPLETED|Overall Study||1
8137310|NCT02738138|20057796|P1|NOT COMPLETED|Overall Study||3
8137311|NCT02738138|20057795|P2|COMPLETED|Overall Study||15
8137312|NCT02738138|20057796|P1|COMPLETED|Overall Study||134
8137313|NCT02738138|20057795|P2|STARTED|Overall Study||16
8137314|NCT02738138|20057796|P1|STARTED|Overall Study||137
8137315|NCT02738086|20057805|P2|NOT COMPLETED|Overall Study||2
8137316|NCT02738086|20057806|P1|NOT COMPLETED|Overall Study||2
8137317|NCT02738086|20057805|P2|COMPLETED|Overall Study||13
8137318|NCT02738086|20057806|P1|COMPLETED|Overall Study||14
8137319|NCT02738086|20057805|P2|STARTED|Overall Study||15
8137320|NCT02738086|20057806|P1|STARTED|Overall Study||16
8137321|NCT02738008|20057833|P3|NOT COMPLETED|Overall Study||5
8137322|NCT02738008|20057834|P2|NOT COMPLETED|Overall Study||6
8137323|NCT02738008|20057835|P1|NOT COMPLETED|Overall Study||1
8137324|NCT02738008|20057833|P3|COMPLETED|Overall Study||0
8137325|NCT02738008|20057834|P2|COMPLETED|Overall Study||0
8137326|NCT02738008|20057835|P1|COMPLETED|Overall Study||0
8137327|NCT02738008|20057833|P3|STARTED|Overall Study||5
8137328|NCT02738008|20057834|P2|STARTED|Overall Study||6
8137329|NCT02738008|20057835|P1|STARTED|Overall Study||1
8137330|NCT02737917|20057851|P2|NOT COMPLETED|Overall Study||3
8137331|NCT02737917|20057852|P1|NOT COMPLETED|Overall Study||3
8137332|NCT02737917|20057851|P2|COMPLETED|Overall Study||100
8137333|NCT02737917|20057852|P1|COMPLETED|Overall Study||100
8137334|NCT02737917|20057851|P2|STARTED|Overall Study||103
8137335|NCT02737917|20057852|P1|STARTED|Overall Study||103
8137336|NCT02737891|20057862|P2|NOT COMPLETED|Overall Study||2
8137337|NCT02737891|20057863|P1|NOT COMPLETED|Overall Study||0
8137338|NCT02737891|20057862|P2|COMPLETED|Overall Study||28
8137339|NCT02737891|20057863|P1|COMPLETED|Overall Study||30
8137340|NCT02737891|20057862|P2|STARTED|Overall Study||30
8137341|NCT02737891|20057863|P1|STARTED|Overall Study||30
8137342|NCT02737852|20057873|P1|NOT COMPLETED|Overall Study||2
8137343|NCT02737852|20057873|P1|COMPLETED|Overall Study||30
8137344|NCT02737852|20057873|P1|STARTED|Overall Study||32
8137345|NCT02737722|20057882|P4|NOT COMPLETED|Overall Study||0
8137346|NCT02737722|20057883|P3|NOT COMPLETED|Overall Study||1
8137347|NCT02737722|20057884|P2|NOT COMPLETED|Overall Study||0
8137348|NCT02737722|20057885|P1|NOT COMPLETED|Overall Study||0
8137349|NCT02737722|20057882|P4|COMPLETED|Overall Study||6
8137350|NCT02737722|20057883|P3|COMPLETED|Overall Study||7
8137351|NCT02737722|20057884|P2|COMPLETED|Overall Study||8
8137352|NCT02737722|20057885|P1|COMPLETED|Overall Study||8
8137353|NCT02737722|20057882|P4|STARTED|Overall Study||6
8137354|NCT02737722|20057883|P3|STARTED|Overall Study||8
8137355|NCT02737722|20057884|P2|STARTED|Overall Study||8
8137356|NCT02737722|20057885|P1|STARTED|Overall Study||8
8137357|NCT02737631|20057931|P1|NOT COMPLETED|Overall Study||0
8137358|NCT02737631|20057931|P1|COMPLETED|Overall Study||222
8137359|NCT02737631|20057931|P1|STARTED|Overall Study||222
8137360|NCT02737618|20057936|P1|NOT COMPLETED|Overall Study||9
8137361|NCT02737618|20057936|P1|COMPLETED|Overall Study||34
8137362|NCT02737618|20057936|P1|STARTED|Overall Study||43
8137363|NCT02737592|20057941|P1|NOT COMPLETED|Overall Study||1
8137364|NCT02737592|20057941|P1|COMPLETED|Overall Study||33
8137365|NCT02737592|20057941|P1|STARTED|Overall Study||34
8137366|NCT02737397|20057946|P1|NOT COMPLETED|Overall Study||0
8137367|NCT02737397|20057946|P1|COMPLETED|Overall Study||13
8137368|NCT02737397|20057946|P1|Placebo|Overall Study||13
8137369|NCT02737397|20057946|P1|SJP-223|Overall Study||13
8137370|NCT02737397|20057946|P1|SJP-304|Overall Study||12
8137371|NCT02737397|20057946|P1|JMI-001|Overall Study||13
8137372|NCT02737397|20057946|P1|STARTED|Overall Study||13
8137373|NCT02737358|20057962|P2|NOT COMPLETED|Overall Study||15
8137374|NCT02737358|20057963|P1|NOT COMPLETED|Overall Study||9
8137375|NCT02737358|20057962|P2|COMPLETED|Overall Study||44
8137376|NCT02737358|20057963|P1|COMPLETED|Overall Study||46
8137377|NCT02737358|20057962|P2|STARTED|Overall Study||59
8137378|NCT02737358|20057963|P1|STARTED|Overall Study||55
8137385|NCT02737163|20057998|P1|NOT COMPLETED|Overall Study||0
8137386|NCT02737163|20057998|P1|COMPLETED|Overall Study||95
8137387|NCT02737163|20057998|P1|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
8137388|NCT02737072|20058008|P3|NOT COMPLETED|Overall Study||0
8137389|NCT02737072|20058009|P2|NOT COMPLETED|Overall Study||0
8137390|NCT02737072|20058010|P1|NOT COMPLETED|Overall Study||0
8137391|NCT02737072|20058008|P3|COMPLETED|Overall Study||3
8137392|NCT02737072|20058009|P2|COMPLETED|Overall Study||3
8137393|NCT02737072|20058010|P1|COMPLETED|Overall Study||3
8137394|NCT02737072|20058008|P3|Received at Least One Dose of Drug|Overall Study||3
8137395|NCT02737072|20058009|P2|Received at Least One Dose of Drug|Overall Study||3
8137396|NCT02737072|20058010|P1|Received at Least One Dose of Drug|Overall Study||3
8137397|NCT02737072|20058008|P3|STARTED|Overall Study||3
8137398|NCT02737072|20058009|P2|STARTED|Overall Study||3
8137399|NCT02737072|20058010|P1|STARTED|Overall Study||3
8137400|NCT02736955|20058034|P3|NOT COMPLETED|Overall Study||2
8137401|NCT02736955|20058035|P2|NOT COMPLETED|Overall Study||14
8137402|NCT02736955|20058036|P1|NOT COMPLETED|Overall Study||7
8137403|NCT02736955|20058034|P3|COMPLETED|Overall Study||6
8137404|NCT02736955|20058035|P2|COMPLETED|Overall Study||103
8137405|NCT02736955|20058036|P1|COMPLETED|Overall Study||29
8137406|NCT02736955|20058034|P3|STARTED|Overall Study||8
8137407|NCT02736955|20058035|P2|STARTED|Overall Study||117
8137408|NCT02736955|20058036|P1|STARTED|Overall Study||36
8137409|NCT02736890|20058052|P2|NOT COMPLETED|Crossover Next 12 Weeks||2
8137410|NCT02736890|20058053|P1|NOT COMPLETED|Crossover Next 12 Weeks||2
8137411|NCT02736890|20058052|P2|COMPLETED|Crossover Next 12 Weeks||1
8137412|NCT02736890|20058053|P1|COMPLETED|Crossover Next 12 Weeks||3
8137413|NCT02736890|20058052|P2|STARTED|Crossover Next 12 Weeks||3
8137414|NCT02736890|20058053|P1|STARTED|Crossover Next 12 Weeks||5
8137415|NCT02736890|20058052|P2|NOT COMPLETED|First 12 Weeks||0
8137416|NCT02736890|20058053|P1|NOT COMPLETED|First 12 Weeks||0
8137417|NCT02736890|20058052|P2|COMPLETED|First 12 Weeks||3
8137418|NCT02736890|20058053|P1|COMPLETED|First 12 Weeks||5
8137419|NCT02736890|20058052|P2|STARTED|First 12 Weeks||3
8137420|NCT02736890|20058053|P1|STARTED|First 12 Weeks||5
8137421|NCT02736825|20058075|P2|NOT COMPLETED|Overall Study||12
8137422|NCT02736825|20058076|P1|NOT COMPLETED|Overall Study||10
8137423|NCT02736825|20058075|P2|COMPLETED|Overall Study||123
8137424|NCT02736825|20058076|P1|COMPLETED|Overall Study||117
8137425|NCT02736825|20058075|P2|STARTED|Overall Study||135
8137426|NCT02736825|20058076|P1|STARTED|Overall Study||127
8137427|NCT02736721|20058116|P1|NOT COMPLETED|Overall Study||16
8137428|NCT02736721|20058116|P1|COMPLETED|Overall Study||25
8137429|NCT02736721|20058116|P1|STARTED|Overall Study||41
8137430|NCT02736578|20058127|P2|NOT COMPLETED|Overall Study||0
8137431|NCT02736578|20058128|P1|NOT COMPLETED|Overall Study||1
8137432|NCT02736578|20058127|P2|COMPLETED|Overall Study||2
8137433|NCT02736578|20058128|P1|COMPLETED|Overall Study||5
8137434|NCT02736578|20058127|P2|STARTED|Overall Study||2
8137435|NCT02736578|20058128|P1|STARTED|Overall Study||6
8137436|NCT02736409|20058150|P4|NOT COMPLETED|Overall Study||12
8137437|NCT02736409|20058151|P3|NOT COMPLETED|Overall Study||26
8137438|NCT02736409|20058152|P2|NOT COMPLETED|Overall Study||3
8137439|NCT02736409|20058153|P1|NOT COMPLETED|Overall Study||4
8137440|NCT02736409|20058150|P4|COMPLETED|Overall Study||53
8137441|NCT02736409|20058151|P3|COMPLETED|Overall Study||80
8137442|NCT02736409|20058152|P2|COMPLETED|Overall Study||22
8137443|NCT02736409|20058153|P1|COMPLETED|Overall Study||19
8137444|NCT02736409|20058150|P4|STARTED|Overall Study||65
8137445|NCT02736409|20058151|P3|STARTED|Overall Study||106
8137446|NCT02736409|20058152|P2|STARTED|Overall Study||25
8137447|NCT02736409|20058153|P1|STARTED|Overall Study||23
8137448|NCT02736188|20058293|P1|NOT COMPLETED|Overall Study||142
8137449|NCT02736188|20058293|P1|COMPLETED|Overall Study||0
8137450|NCT02736188|20058293|P1|STARTED|Overall Study||142
8137451|NCT02736175|20058319|P2|NOT COMPLETED|Overall Study||1
8137452|NCT02736175|20058320|P1|NOT COMPLETED|Overall Study||2
8137453|NCT02736175|20058319|P2|COMPLETED|Overall Study||221
8137454|NCT02736175|20058320|P1|COMPLETED|Overall Study||214
8137455|NCT02736175|20058319|P2|STARTED|Overall Study||222
8137456|NCT02736175|20058320|P1|STARTED|Overall Study||216
8137457|NCT02735980|20058331|P3|NOT COMPLETED|Overall Study||1
8137458|NCT02735980|20058332|P2|NOT COMPLETED|Overall Study||11
8137459|NCT02735980|20058333|P1|NOT COMPLETED|Overall Study||10
8137460|NCT02735980|20058331|P3|COMPLETED|Overall Study||14
8137461|NCT02735980|20058332|P2|COMPLETED|Overall Study||49
8137462|NCT02735980|20058333|P1|COMPLETED|Overall Study||48
8137463|NCT02735980|20058331|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
8137464|NCT02735980|20058332|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
8137465|NCT02735980|20058333|P1|Received at Least 1 Dose of Study Drug|Overall Study||56
8137466|NCT02735980|20058331|P3|STARTED|Overall Study||15
8137467|NCT02735980|20058332|P2|STARTED|Overall Study||60
8137468|NCT02735980|20058333|P1|STARTED|Overall Study||58
8137469|NCT02735915|20058362|P1|NOT COMPLETED|Overall Study||11
8137470|NCT02735915|20058362|P1|COMPLETED|Overall Study||59
8137471|NCT02735915|20058362|P1|Vaccinated|Overall Study||62
8137472|NCT02735915|20058362|P1|STARTED|Overall Study||70
8137473|NCT02735642|20058383|P2|NOT COMPLETED|Overall Study||0
8137474|NCT02735642|20058384|P1|NOT COMPLETED|Overall Study||0
8137475|NCT02735642|20058383|P2|COMPLETED|Overall Study||152
8137476|NCT02735642|20058384|P1|COMPLETED|Overall Study||1046
8137477|NCT02735642|20058383|P2|STARTED|Overall Study||152
8137478|NCT02735642|20058384|P1|STARTED|Overall Study||1046
8137479|NCT02735577|20058394|P1|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
8137480|NCT02735577|20058394|P1|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
8137481|NCT02735577|20058394|P1|STARTED|Optional 28 Days of Disulfiram Treatment||6
8137482|NCT02735577|20058394|P1|NOT COMPLETED|Disulfiram Treatment||1
8137483|NCT02735577|20058394|P1|COMPLETED|Disulfiram Treatment||6
8137484|NCT02735577|20058394|P1|STARTED|Disulfiram Treatment||7
8137485|NCT02735551|20058401|P3|NOT COMPLETED|Overall Study||0
8137486|NCT02735551|20058402|P2|NOT COMPLETED|Overall Study||0
8137487|NCT02735551|20058403|P1|NOT COMPLETED|Overall Study||0
8137488|NCT02735551|20058401|P3|COMPLETED|Overall Study||0
8137489|NCT02735551|20058402|P2|COMPLETED|Overall Study||0
8137490|NCT02735551|20058403|P1|COMPLETED|Overall Study||3
8137491|NCT02735551|20058401|P3|STARTED|Overall Study||0
8137492|NCT02735551|20058402|P2|STARTED|Overall Study||0
8137493|NCT02735551|20058403|P1|STARTED|Overall Study||3
8137497|NCT02735382|20058422|P4|NOT COMPLETED|Overall Study||0
8137498|NCT02735382|20058423|P3|NOT COMPLETED|Overall Study||0
8137499|NCT02735382|20058424|P2|NOT COMPLETED|Overall Study||0
8137500|NCT02735382|20058425|P1|NOT COMPLETED|Overall Study||0
8137501|NCT02735382|20058422|P4|COMPLETED|Overall Study||110
8137502|NCT02735382|20058423|P3|COMPLETED|Overall Study||184
8137503|NCT02735382|20058424|P2|COMPLETED|Overall Study||7155
8137504|NCT02735382|20058425|P1|COMPLETED|Overall Study||7481
8137505|NCT02735382|20058422|P4|STARTED|Overall Study||110
8137506|NCT02735382|20058423|P3|STARTED|Overall Study||184
8137507|NCT02735382|20058424|P2|STARTED|Overall Study||7155
8137508|NCT02735382|20058425|P1|STARTED|Overall Study||7481
8137509|NCT02735200|20058441|P2|NOT COMPLETED|Overall Study||5
8137510|NCT02735200|20058442|P1|NOT COMPLETED|Overall Study||8
8137511|NCT02735200|20058441|P2|COMPLETED|Overall Study||345
8137512|NCT02735200|20058442|P1|COMPLETED|Overall Study||192
8137513|NCT02735200|20058441|P2|STARTED|Overall Study||350
8137514|NCT02735200|20058442|P1|STARTED|Overall Study||200
8137515|NCT02735187|20058450|P2|NOT COMPLETED|Overall Study||1
8137516|NCT02735187|20058451|P1|NOT COMPLETED|Overall Study||4
8137517|NCT02735187|20058450|P2|COMPLETED|Overall Study||25
8137518|NCT02735187|20058451|P1|COMPLETED|Overall Study||21
8137519|NCT02735187|20058450|P2|STARTED|Overall Study||26
8137520|NCT02735187|20058451|P1|STARTED|Overall Study||25
8137521|NCT02735174|20058481|P1|NOT COMPLETED|Overall Study||0
8137522|NCT02735174|20058481|P1|COMPLETED|Overall Study||21
8137523|NCT02735174|20058481|P1|STARTED|Overall Study||21
8137524|NCT02735096|20058485|P1|NOT COMPLETED|Overall Study||1
8137525|NCT02735096|20058485|P1|COMPLETED|Overall Study||3
8137526|NCT02735096|20058485|P1|STARTED|Overall Study||4
8137527|NCT02735044|20058494|P2|NOT COMPLETED|Overall Study||23
8137528|NCT02735044|20058495|P1|NOT COMPLETED|Overall Study||16
8137529|NCT02735044|20058494|P2|COMPLETED|Overall Study||207
8137530|NCT02735044|20058495|P1|COMPLETED|Overall Study||217
8137531|NCT02735044|20058494|P2|Treated|Overall Study||228
8137532|NCT02735044|20058495|P1|Treated|Overall Study||233
8137533|NCT02735044|20058494|P2|STARTED|Overall Study||230
8137534|NCT02735044|20058495|P1|STARTED|Overall Study||233
8137535|NCT02734953|20058521|P1|NOT COMPLETED|Overall Study||0
8137536|NCT02734953|20058521|P1|COMPLETED|Overall Study||10
8137537|NCT02734953|20058521|P1|STARTED|Overall Study||10
8137538|NCT02734940|20058538|P2|NOT COMPLETED|Overall Study||0
8137539|NCT02734940|20058539|P1|NOT COMPLETED|Overall Study||0
8137540|NCT02734940|20058538|P2|COMPLETED|Overall Study||0
8137541|NCT02734940|20058539|P1|COMPLETED|Overall Study||0
8137542|NCT02734940|20058538|P2|STARTED|Overall Study||0
8137543|NCT02734940|20058539|P1|STARTED|Overall Study||0
8137544|NCT02734862|20058564|P3|NOT COMPLETED|Part B||5
8137545|NCT02734862|20058565|P2|NOT COMPLETED|Part B||7
8137546|NCT02734862|20058566|P1|NOT COMPLETED|Part B||13
8137547|NCT02734862|20058564|P3|COMPLETED|Part B||28
8137548|NCT02734862|20058565|P2|COMPLETED|Part B||14
8137549|NCT02734862|20058566|P1|COMPLETED|Part B||33
8137550|NCT02734862|20058564|P3|STARTED|Part B||33
8137551|NCT02734862|20058565|P2|STARTED|Part B||21
8137552|NCT02734862|20058566|P1|STARTED|Part B||46
8137553|NCT02734862|20058564|P3|NOT COMPLETED|Part A||14
8137554|NCT02734862|20058565|P2|NOT COMPLETED|Part A||8
8137555|NCT02734862|20058566|P1|NOT COMPLETED|Part A||12
8137556|NCT02734862|20058564|P3|COMPLETED|Part A||22
8137557|NCT02734862|20058565|P2|COMPLETED|Part A||28
8137558|NCT02734862|20058566|P1|COMPLETED|Part A||23
8137559|NCT02734862|20058564|P3|STARTED|Part A||36
8137560|NCT02734862|20058565|P2|STARTED|Part A||36
8137561|NCT02734862|20058566|P1|STARTED|Part A||35
8137562|NCT02734849|20058595|P3|NOT COMPLETED|Overall Study||1
8137563|NCT02734849|20058596|P2|NOT COMPLETED|Overall Study||0
8137564|NCT02734849|20058597|P1|NOT COMPLETED|Overall Study||4
8137565|NCT02734849|20058595|P3|COMPLETED|Overall Study||9
8137566|NCT02734849|20058596|P2|COMPLETED|Overall Study||14
8137567|NCT02734849|20058597|P1|COMPLETED|Overall Study||12
8137568|NCT02734849|20058595|P3|STARTED|Overall Study||10
8137569|NCT02734849|20058596|P2|STARTED|Overall Study||14
8137570|NCT02734849|20058597|P1|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
8137571|NCT02734810|20058607|P2|NOT COMPLETED|Overall Study||0
8137572|NCT02734810|20058608|P1|NOT COMPLETED|Overall Study||2
8137573|NCT02734810|20058607|P2|COMPLETED|Overall Study||0
8137574|NCT02734810|20058608|P1|COMPLETED|Overall Study||13
8137575|NCT02734810|20058607|P2|STARTED|Overall Study||0
8137576|NCT02734810|20058608|P1|STARTED|Overall Study||15
8137577|NCT02734693|20058617|P3|NOT COMPLETED|Overall Study||3
8137578|NCT02734693|20058618|P2|NOT COMPLETED|Overall Study||3
8137579|NCT02734693|20058619|P1|NOT COMPLETED|Overall Study||6
8137580|NCT02734693|20058617|P3|COMPLETED|Overall Study||17
8137581|NCT02734693|20058618|P2|COMPLETED|Overall Study||53
8137582|NCT02734693|20058619|P1|COMPLETED|Overall Study||50
8137583|NCT02734693|20058617|P3|STARTED|Overall Study||20
8137584|NCT02734693|20058618|P2|STARTED|Overall Study||56
8137585|NCT02734693|20058619|P1|STARTED|Overall Study||56
8137586|NCT02734498|20058639|P3|NOT COMPLETED|Overall Study||0
8137587|NCT02734498|20058640|P2|NOT COMPLETED|Overall Study||0
8137588|NCT02734498|20058641|P1|NOT COMPLETED|Overall Study||0
8137589|NCT02734498|20058639|P3|COMPLETED|Overall Study||0
8137590|NCT02734498|20058640|P2|COMPLETED|Overall Study||0
8137591|NCT02734498|20058641|P1|COMPLETED|Overall Study||2
8137592|NCT02734498|20058639|P3|STARTED|Overall Study||0
8137593|NCT02734498|20058640|P2|STARTED|Overall Study||0
8137594|NCT02734498|20058641|P1|STARTED|Overall Study||2
8137601|NCT02734355|20058695|P2|NOT COMPLETED|Overall Study||0
8137602|NCT02734355|20058696|P1|NOT COMPLETED|Overall Study||0
8137603|NCT02734355|20058695|P2|COMPLETED|Overall Study||30
8137604|NCT02734355|20058696|P1|COMPLETED|Overall Study||34
8137605|NCT02734355|20058695|P2|STARTED|Overall Study||30
8137606|NCT02734355|20058696|P1|STARTED|Overall Study||34
8137607|NCT02734238|20058728|P2|NOT COMPLETED|Overall Study||0
8137608|NCT02734238|20058729|P1|NOT COMPLETED|Overall Study||0
8137609|NCT02734238|20058728|P2|COMPLETED|Overall Study||24
8137610|NCT02734238|20058729|P1|COMPLETED|Overall Study||26
8137611|NCT02734238|20058728|P2|STARTED|Overall Study||24
8137612|NCT02734238|20058729|P1|STARTED|Overall Study||26
8137613|NCT02734212|20058737|P2|NOT COMPLETED|Overall Study||10
8137614|NCT02734212|20058738|P1|NOT COMPLETED|Overall Study||5
8137615|NCT02734212|20058737|P2|COMPLETED|Overall Study||18
8137616|NCT02734212|20058738|P1|COMPLETED|Overall Study||24
8137617|NCT02734212|20058737|P2|STARTED|Overall Study||28
8137618|NCT02734212|20058738|P1|STARTED|Overall Study||29
8137619|NCT02734056|20058750|P2|NOT COMPLETED|Overall Study||1
8137620|NCT02734056|20058751|P1|NOT COMPLETED|Overall Study||0
8137621|NCT02734056|20058750|P2|COMPLETED|Overall Study||49
8137622|NCT02734056|20058751|P1|COMPLETED|Overall Study||50
8137623|NCT02734056|20058750|P2|STARTED|Overall Study||50
8137624|NCT02734056|20058751|P1|STARTED|Overall Study||50
8137625|NCT02733991|20058759|P2|NOT COMPLETED|Overall Study||5
8137626|NCT02733991|20058760|P1|NOT COMPLETED|Overall Study||1
8137627|NCT02733991|20058759|P2|COMPLETED|Overall Study||72
8137628|NCT02733991|20058760|P1|COMPLETED|Overall Study||75
8137629|NCT02733991|20058759|P2|STARTED|Overall Study||77
8137630|NCT02733991|20058760|P1|STARTED|Overall Study||76
8137631|NCT02733757|20058774|P4|NOT COMPLETED|Overall Study||0
8137632|NCT02733757|20058775|P3|NOT COMPLETED|Overall Study||0
8137633|NCT02733757|20058776|P2|NOT COMPLETED|Overall Study||0
8137634|NCT02733757|20058777|P1|NOT COMPLETED|Overall Study||0
8137635|NCT02733757|20058774|P4|COMPLETED|Overall Study||20
8137636|NCT02733757|20058775|P3|COMPLETED|Overall Study||20
8137637|NCT02733757|20058776|P2|COMPLETED|Overall Study||20
8137638|NCT02733757|20058777|P1|COMPLETED|Overall Study||20
8137639|NCT02733757|20058774|P4|STARTED|Overall Study||20
8137640|NCT02733757|20058775|P3|STARTED|Overall Study||20
8137641|NCT02733757|20058776|P2|STARTED|Overall Study||20
8137642|NCT02733757|20058777|P1|STARTED|Overall Study||20
8137643|NCT02733653|20058787|P1|NOT COMPLETED|Overall Study||1
8137644|NCT02733653|20058787|P1|COMPLETED|Overall Study||49
8137645|NCT02733653|20058787|P1|STARTED|Overall Study||50
8137646|NCT02733588|20058793|P1|NOT COMPLETED|Overall Study||0
8137647|NCT02733588|20058793|P1|COMPLETED|Overall Study||7
8137648|NCT02733588|20058793|P1|STARTED|Overall Study||7
8137649|NCT02733367|20058800|P1|NOT COMPLETED|Overall Study||6
8137650|NCT02733367|20058800|P1|COMPLETED|Overall Study||12
8137651|NCT02733367|20058800|P1|STARTED|Overall Study||18
8137652|NCT02733042|20058826|P19|NOT COMPLETED|Follow-up Period||2
8137653|NCT02733042|20058827|P18|NOT COMPLETED|Follow-up Period||2
8137654|NCT02733042|20058828|P17|NOT COMPLETED|Follow-up Period||0
8137655|NCT02733042|20058829|P16|NOT COMPLETED|Follow-up Period||5
8137656|NCT02733042|20058830|P15|NOT COMPLETED|Follow-up Period||1
8137657|NCT02733042|20058831|P14|NOT COMPLETED|Follow-up Period||4
8137658|NCT02733042|20058832|P13|NOT COMPLETED|Follow-up Period||9
8137659|NCT02733042|20058833|P12|NOT COMPLETED|Follow-up Period||9
8137660|NCT02733042|20058834|P11|NOT COMPLETED|Follow-up Period||5
8137661|NCT02733042|20058835|P10|NOT COMPLETED|Follow-up Period||2
8137662|NCT02733042|20058836|P9|NOT COMPLETED|Follow-up Period||4
8137663|NCT02733042|20058837|P8|NOT COMPLETED|Follow-up Period||4
8137664|NCT02733042|20058838|P7|NOT COMPLETED|Follow-up Period||0
8137665|NCT02733042|20058839|P6|NOT COMPLETED|Follow-up Period||2
8137666|NCT02733042|20058840|P5|NOT COMPLETED|Follow-up Period||1
8137667|NCT02733042|20058841|P4|NOT COMPLETED|Follow-up Period||3
8137668|NCT02733042|20058842|P3|NOT COMPLETED|Follow-up Period||6
8137669|NCT02733042|20058843|P2|NOT COMPLETED|Follow-up Period||3
8137670|NCT02733042|20058844|P1|NOT COMPLETED|Follow-up Period||3
8137671|NCT02733042|20058826|P19|COMPLETED|Follow-up Period||0
8137672|NCT02733042|20058827|P18|COMPLETED|Follow-up Period||1
8137673|NCT02733042|20058828|P17|COMPLETED|Follow-up Period||0
8137674|NCT02733042|20058829|P16|COMPLETED|Follow-up Period||0
8137675|NCT02733042|20058830|P15|COMPLETED|Follow-up Period||0
8137676|NCT02733042|20058831|P14|COMPLETED|Follow-up Period||0
8137677|NCT02733042|20058832|P13|COMPLETED|Follow-up Period||0
8137678|NCT02733042|20058833|P12|COMPLETED|Follow-up Period||0
8137679|NCT02733042|20058834|P11|COMPLETED|Follow-up Period||0
8137680|NCT02733042|20058835|P10|COMPLETED|Follow-up Period||0
8137681|NCT02733042|20058836|P9|COMPLETED|Follow-up Period||0
8137682|NCT02733042|20058837|P8|COMPLETED|Follow-up Period||0
8137683|NCT02733042|20058838|P7|COMPLETED|Follow-up Period||0
8137684|NCT02733042|20058839|P6|COMPLETED|Follow-up Period||0
8137685|NCT02733042|20058840|P5|COMPLETED|Follow-up Period||0
8137686|NCT02733042|20058841|P4|COMPLETED|Follow-up Period||0
8137687|NCT02733042|20058842|P3|COMPLETED|Follow-up Period||0
8137688|NCT02733042|20058843|P2|COMPLETED|Follow-up Period||0
8137689|NCT02733042|20058844|P1|COMPLETED|Follow-up Period||0
8137690|NCT02733042|20058826|P19|STARTED|Follow-up Period||2
8137691|NCT02733042|20058827|P18|STARTED|Follow-up Period||3
8137692|NCT02733042|20058828|P17|STARTED|Follow-up Period||0
8137693|NCT02733042|20058829|P16|STARTED|Follow-up Period||5
8137694|NCT02733042|20058830|P15|STARTED|Follow-up Period||1
8137695|NCT02733042|20058831|P14|STARTED|Follow-up Period||4
8137696|NCT02733042|20058832|P13|STARTED|Follow-up Period||9
8137697|NCT02733042|20058833|P12|STARTED|Follow-up Period||9
8137698|NCT02733042|20058834|P11|STARTED|Follow-up Period||5
8137699|NCT02733042|20058835|P10|STARTED|Follow-up Period||2
8137700|NCT02733042|20058836|P9|STARTED|Follow-up Period||4
8137701|NCT02733042|20058837|P8|STARTED|Follow-up Period||4
8137702|NCT02733042|20058838|P7|STARTED|Follow-up Period||0
8137703|NCT02733042|20058839|P6|STARTED|Follow-up Period||2
8137704|NCT02733042|20058840|P5|STARTED|Follow-up Period||1
8137705|NCT02733042|20058841|P4|STARTED|Follow-up Period||3
8137706|NCT02733042|20058842|P3|STARTED|Follow-up Period||6
8137707|NCT02733042|20058843|P2|STARTED|Follow-up Period||3
8137708|NCT02733042|20058844|P1|STARTED|Follow-up Period||3
8137709|NCT02733042|20058826|P19|NOT COMPLETED|Treatment Period||5
8137710|NCT02733042|20058827|P18|NOT COMPLETED|Treatment Period||5
8137711|NCT02733042|20058828|P17|NOT COMPLETED|Treatment Period||2
8137712|NCT02733042|20058829|P16|NOT COMPLETED|Treatment Period||10
8137713|NCT02733042|20058830|P15|NOT COMPLETED|Treatment Period||5
8137714|NCT02733042|20058831|P14|NOT COMPLETED|Treatment Period||4
8137715|NCT02733042|20058832|P13|NOT COMPLETED|Treatment Period||9
8137716|NCT02733042|20058833|P12|NOT COMPLETED|Treatment Period||6
8137717|NCT02733042|20058834|P11|NOT COMPLETED|Treatment Period||10
8137718|NCT02733042|20058835|P10|NOT COMPLETED|Treatment Period||10
8137719|NCT02733042|20058836|P9|NOT COMPLETED|Treatment Period||5
8137720|NCT02733042|20058837|P8|NOT COMPLETED|Treatment Period||3
8137721|NCT02733042|20058838|P7|NOT COMPLETED|Treatment Period||1
8137722|NCT02733042|20058839|P6|NOT COMPLETED|Treatment Period||3
8137723|NCT02733042|20058840|P5|NOT COMPLETED|Treatment Period||4
8137724|NCT02733042|20058841|P4|NOT COMPLETED|Treatment Period||3
8137725|NCT02733042|20058842|P3|NOT COMPLETED|Treatment Period||7
8137726|NCT02733042|20058843|P2|NOT COMPLETED|Treatment Period||2
8137727|NCT02733042|20058844|P1|NOT COMPLETED|Treatment Period||3
8137728|NCT02733042|20058826|P19|COMPLETED|Treatment Period||0
8137729|NCT02733042|20058827|P18|COMPLETED|Treatment Period||0
8137730|NCT02733042|20058828|P17|COMPLETED|Treatment Period||0
8137731|NCT02733042|20058829|P16|COMPLETED|Treatment Period||0
8137732|NCT02733042|20058830|P15|COMPLETED|Treatment Period||0
8137733|NCT02733042|20058831|P14|COMPLETED|Treatment Period||1
8137734|NCT02733042|20058832|P13|COMPLETED|Treatment Period||1
8137735|NCT02733042|20058833|P12|COMPLETED|Treatment Period||4
8137736|NCT02733042|20058834|P11|COMPLETED|Treatment Period||0
8137737|NCT02733042|20058835|P10|COMPLETED|Treatment Period||0
8137738|NCT02733042|20058836|P9|COMPLETED|Treatment Period||0
8137739|NCT02733042|20058837|P8|COMPLETED|Treatment Period||1
8137740|NCT02733042|20058838|P7|COMPLETED|Treatment Period||0
8137741|NCT02733042|20058839|P6|COMPLETED|Treatment Period||0
8137742|NCT02733042|20058840|P5|COMPLETED|Treatment Period||0
8137743|NCT02733042|20058841|P4|COMPLETED|Treatment Period||0
8137744|NCT02733042|20058842|P3|COMPLETED|Treatment Period||1
8137745|NCT02733042|20058843|P2|COMPLETED|Treatment Period||1
8137746|NCT02733042|20058844|P1|COMPLETED|Treatment Period||0
8137747|NCT02733042|20058826|P19|STARTED|Treatment Period||5
8137748|NCT02733042|20058827|P18|STARTED|Treatment Period||5
8137749|NCT02733042|20058828|P17|STARTED|Treatment Period||2
8137750|NCT02733042|20058829|P16|STARTED|Treatment Period||10
8137751|NCT02733042|20058830|P15|STARTED|Treatment Period||5
8137752|NCT02733042|20058831|P14|STARTED|Treatment Period||5
8137753|NCT02733042|20058832|P13|STARTED|Treatment Period||10
8137754|NCT02733042|20058833|P12|STARTED|Treatment Period||10
8137755|NCT02733042|20058834|P11|STARTED|Treatment Period||10
8137756|NCT02733042|20058835|P10|STARTED|Treatment Period||10
8137757|NCT02733042|20058836|P9|STARTED|Treatment Period||5
8137758|NCT02733042|20058837|P8|STARTED|Treatment Period||4
8137759|NCT02733042|20058838|P7|STARTED|Treatment Period||1
8137760|NCT02733042|20058839|P6|STARTED|Treatment Period||3
8137761|NCT02733042|20058840|P5|STARTED|Treatment Period||4
8137762|NCT02733042|20058841|P4|STARTED|Treatment Period||3
8137763|NCT02733042|20058842|P3|STARTED|Treatment Period||8
8137764|NCT02733042|20058843|P2|STARTED|Treatment Period||3
8137765|NCT02733042|20058844|P1|STARTED|Treatment Period||3
8137766|NCT02732951|20059049|P2|NOT COMPLETED|Overall Study||6
8137767|NCT02732951|20059050|P1|NOT COMPLETED|Overall Study||5
8137768|NCT02732951|20059049|P2|COMPLETED|Overall Study||46
8137769|NCT02732951|20059050|P1|COMPLETED|Overall Study||48
8137770|NCT02732951|20059049|P2|STARTED|Overall Study||52
8137771|NCT02732951|20059050|P1|STARTED|Overall Study||53
8137772|NCT02732938|20059060|P3|NOT COMPLETED|Overall Study||0
8137773|NCT02732938|20059061|P2|NOT COMPLETED|Overall Study||18
8137774|NCT02732938|20059062|P1|NOT COMPLETED|Overall Study||4
8137775|NCT02732938|20059060|P3|COMPLETED|Overall Study||0
8137776|NCT02732938|20059061|P2|COMPLETED|Overall Study||0
8137777|NCT02732938|20059062|P1|COMPLETED|Overall Study||0
8137778|NCT02732938|20059060|P3|Received Treatment|Overall Study||0
8137779|NCT02732938|20059061|P2|Received Treatment|Overall Study||17
8137780|NCT02732938|20059062|P1|Received Treatment|Overall Study||4
8137781|NCT02732938|20059060|P3|STARTED|Overall Study||0
8137782|NCT02732938|20059061|P2|STARTED|Overall Study||18
8137783|NCT02732938|20059062|P1|STARTED|Overall Study||4
8137784|NCT02732912|20059108|P2|NOT COMPLETED|Overall Study||18
8137785|NCT02732912|20059109|P1|NOT COMPLETED|Overall Study||10
8137786|NCT02732912|20059108|P2|COMPLETED|Overall Study||91
8137787|NCT02732912|20059109|P1|COMPLETED|Overall Study||87
8137788|NCT02732912|20059108|P2|STARTED|Overall Study||109
8137789|NCT02732912|20059109|P1|STARTED|Overall Study||97
8137790|NCT02732899|20059125|P2|NOT COMPLETED|Overall Study||0
8137791|NCT02732899|20059126|P1|NOT COMPLETED|Overall Study||0
8137792|NCT02732899|20059125|P2|COMPLETED|Overall Study||10
8137793|NCT02732899|20059126|P1|COMPLETED|Overall Study||10
8137794|NCT02732899|20059125|P2|STARTED|Overall Study||10
8137795|NCT02732899|20059126|P1|STARTED|Overall Study||10
8137796|NCT02732639|20059134|P1|NOT COMPLETED|Overall Study||1
8137797|NCT02732639|20059134|P1|COMPLETED|Overall Study||30
8137798|NCT02732639|20059134|P1|STARTED|Overall Study||31
8137799|NCT02732600|20059147|P2|NOT COMPLETED|Overall Study||108
8137800|NCT02732600|20059148|P1|NOT COMPLETED|Overall Study||94
8137801|NCT02732600|20059147|P2|COMPLETED|Overall Study||113
8137802|NCT02732600|20059148|P1|COMPLETED|Overall Study||100
8137803|NCT02732600|20059147|P2|1-Year|Overall Study||113
8137804|NCT02732600|20059148|P1|1-Year|Overall Study||100
8137805|NCT02732600|20059147|P2|6-months|Overall Study||129
8137806|NCT02732600|20059148|P1|6-months|Overall Study||121
8137807|NCT02732600|20059147|P2|STARTED|Overall Study||221
8137808|NCT02732600|20059148|P1|STARTED|Overall Study||194
8137809|NCT02732587|20059154|P1|NOT COMPLETED|Overall Study||0
8137810|NCT02732587|20059154|P1|COMPLETED|Overall Study||5
8137811|NCT02732587|20059154|P1|STARTED|Overall Study||5
8137812|NCT02732561|20059160|P2|NOT COMPLETED|Overall Study||1
8137813|NCT02732561|20059161|P1|NOT COMPLETED|Overall Study||2
8137814|NCT02732561|20059160|P2|COMPLETED|Overall Study||4
8137815|NCT02732561|20059161|P1|COMPLETED|Overall Study||3
8137816|NCT02732561|20059160|P2|STARTED|Overall Study||5
8137817|NCT02732561|20059161|P1|STARTED|Overall Study||5
8137818|NCT02732366|20059171|P2|NOT COMPLETED|Overall Study||2
8137819|NCT02732366|20059172|P1|NOT COMPLETED|Overall Study||5
8137820|NCT02732366|20059171|P2|COMPLETED|Overall Study||21
8137821|NCT02732366|20059172|P1|COMPLETED|Overall Study||18
8137822|NCT02732366|20059171|P2|Withdrawal by Participant|Overall Study||2
8137823|NCT02732366|20059172|P1|Withdrawal by Participant|Overall Study||5
8137824|NCT02732366|20059171|P2|STARTED|Overall Study||23
8137825|NCT02732366|20059172|P1|STARTED|Overall Study||23
8137826|NCT02732327|20059187|P2|NOT COMPLETED|Overall Study||1
8137827|NCT02732327|20059188|P1|NOT COMPLETED|Overall Study||0
8137828|NCT02732327|20059187|P2|COMPLETED|Overall Study||1
8137829|NCT02732327|20059188|P1|COMPLETED|Overall Study||0
8137830|NCT02732327|20059187|P2|STARTED|Overall Study||2
8137831|NCT02732327|20059188|P1|STARTED|Overall Study||0
8137832|NCT02732210|20059196|P2|NOT COMPLETED|Overall Study||294
8137833|NCT02732210|20059197|P1|NOT COMPLETED|Overall Study||85
8137834|NCT02732210|20059196|P2|COMPLETED|Overall Study||338
8137835|NCT02732210|20059197|P1|COMPLETED|Overall Study||218
8137836|NCT02732210|20059196|P2|STARTED|Overall Study||632
8137837|NCT02732210|20059197|P1|STARTED|Overall Study||303
8137838|NCT02732145|20059217|P4|NOT COMPLETED|Overall Study||0
8137839|NCT02732145|20059218|P3|NOT COMPLETED|Overall Study||0
8137840|NCT02732145|20059219|P2|NOT COMPLETED|Overall Study||0
8137841|NCT02732145|20059220|P1|NOT COMPLETED|Overall Study||0
8137842|NCT02732145|20059217|P4|COMPLETED|Overall Study||82
8137843|NCT02732145|20059218|P3|COMPLETED|Overall Study||82
8137844|NCT02732145|20059219|P2|COMPLETED|Overall Study||82
8137845|NCT02732145|20059220|P1|COMPLETED|Overall Study||82
8137846|NCT02732145|20059217|P4|STARTED|Overall Study||82
8137847|NCT02732145|20059218|P3|STARTED|Overall Study||82
8137848|NCT02732145|20059219|P2|STARTED|Overall Study||82
8137849|NCT02732145|20059220|P1|STARTED|Overall Study||82
8137850|NCT02731833|20059348|P2|NOT COMPLETED|Overall Study||0
8137851|NCT02731833|20059349|P1|NOT COMPLETED|Overall Study||0
8137852|NCT02731833|20059348|P2|COMPLETED|Overall Study||111
8137853|NCT02731833|20059349|P1|COMPLETED|Overall Study||111
8137854|NCT02731833|20059348|P2|STARTED|Overall Study||111
8137855|NCT02731833|20059349|P1|STARTED|Overall Study||111
8137856|NCT02731820|20059363|P2|NOT COMPLETED|Overall Study||2
8137857|NCT02731820|20059364|P1|NOT COMPLETED|Overall Study||3
8137858|NCT02731820|20059363|P2|COMPLETED|Overall Study||18
8137859|NCT02731820|20059364|P1|COMPLETED|Overall Study||17
8137860|NCT02731820|20059363|P2|STARTED|Overall Study||20
8137861|NCT02731820|20059364|P1|STARTED|Overall Study||20
8137862|NCT02731755|20059376|P2|NOT COMPLETED|Second Intervention||0
8137863|NCT02731755|20059377|P1|NOT COMPLETED|Second Intervention||0
8137864|NCT02731755|20059376|P2|COMPLETED|Second Intervention||8
8137865|NCT02731755|20059377|P1|COMPLETED|Second Intervention||8
8137866|NCT02731755|20059376|P2|STARTED|Second Intervention||8
8137867|NCT02731755|20059377|P1|STARTED|Second Intervention||8
8137868|NCT02731755|20059376|P2|NOT COMPLETED|First Intervention||2
8137869|NCT02731755|20059377|P1|NOT COMPLETED|First Intervention||0
8137870|NCT02731755|20059376|P2|COMPLETED|First Intervention||8
8137871|NCT02731755|20059377|P1|COMPLETED|First Intervention||8
8137872|NCT02731755|20059376|P2|STARTED|First Intervention||10
8137873|NCT02731755|20059377|P1|STARTED|First Intervention||8
8137874|NCT02731742|20059401|P4|NOT COMPLETED|Overall Study||2
8137875|NCT02731742|20059402|P3|NOT COMPLETED|Overall Study||6
8137876|NCT02731742|20059403|P2|NOT COMPLETED|Overall Study||3
8137877|NCT02731742|20059404|P1|NOT COMPLETED|Overall Study||3
8137878|NCT02731742|20059401|P4|COMPLETED|Overall Study||0
8137879|NCT02731742|20059402|P3|COMPLETED|Overall Study||0
8137880|NCT02731742|20059403|P2|COMPLETED|Overall Study||0
8137881|NCT02731742|20059404|P1|COMPLETED|Overall Study||0
8137882|NCT02731742|20059401|P4|STARTED|Overall Study||2
8137883|NCT02731742|20059402|P3|STARTED|Overall Study||6
8137884|NCT02731742|20059403|P2|STARTED|Overall Study||3
8137885|NCT02731742|20059404|P1|STARTED|Overall Study||3
8137886|NCT02731690|20059422|P1|NOT COMPLETED|Overall Study||30
8137887|NCT02731690|20059422|P1|COMPLETED|Overall Study||12
8137888|NCT02731690|20059422|P1|STARTED|Overall Study||42
8137889|NCT02731638|20059442|P2|NOT COMPLETED|Overall Study||9
8137890|NCT02731638|20059443|P1|NOT COMPLETED|Overall Study||6
8137891|NCT02731638|20059442|P2|COMPLETED|Overall Study||26
8137892|NCT02731638|20059443|P1|COMPLETED|Overall Study||29
8137893|NCT02731638|20059442|P2|STARTED|Overall Study||35
8137894|NCT02731638|20059443|P1|STARTED|Overall Study||35
8137895|NCT02731469|20059468|P11|NOT COMPLETED|Overall Study||0
8137896|NCT02731469|20059469|P10|NOT COMPLETED|Overall Study||0
8137897|NCT02731469|20059470|P9|NOT COMPLETED|Overall Study||0
8137898|NCT02731469|20059471|P8|NOT COMPLETED|Overall Study||0
8137899|NCT02731469|20059472|P7|NOT COMPLETED|Overall Study||0
8137900|NCT02731469|20059473|P6|NOT COMPLETED|Overall Study||0
8137901|NCT02731469|20059474|P5|NOT COMPLETED|Overall Study||0
8137902|NCT02731469|20059475|P4|NOT COMPLETED|Overall Study||0
8137903|NCT02731469|20059476|P3|NOT COMPLETED|Overall Study||0
8137904|NCT02731469|20059477|P2|NOT COMPLETED|Overall Study||0
8137905|NCT02731469|20059478|P1|NOT COMPLETED|Overall Study||0
8137906|NCT02731469|20059468|P11|COMPLETED|Overall Study||6
8137907|NCT02731469|20059469|P10|COMPLETED|Overall Study||6
8137908|NCT02731469|20059470|P9|COMPLETED|Overall Study||6
8137909|NCT02731469|20059471|P8|COMPLETED|Overall Study||6
8137910|NCT02731469|20059472|P7|COMPLETED|Overall Study||3
8137911|NCT02731469|20059473|P6|COMPLETED|Overall Study||3
8137912|NCT02731469|20059474|P5|COMPLETED|Overall Study||3
8137913|NCT02731469|20059475|P4|COMPLETED|Overall Study||3
8137914|NCT02731469|20059476|P3|COMPLETED|Overall Study||3
8137915|NCT02731469|20059477|P2|COMPLETED|Overall Study||3
8137916|NCT02731469|20059478|P1|COMPLETED|Overall Study||3
8137917|NCT02731469|20059468|P11|STARTED|Overall Study||6
8137918|NCT02731469|20059469|P10|STARTED|Overall Study||6
8137919|NCT02731469|20059470|P9|STARTED|Overall Study||6
8137920|NCT02731469|20059471|P8|STARTED|Overall Study||6
8137921|NCT02731469|20059472|P7|STARTED|Overall Study||3
8137922|NCT02731469|20059473|P6|STARTED|Overall Study||3
8137923|NCT02731469|20059474|P5|STARTED|Overall Study||3
8137924|NCT02731469|20059475|P4|STARTED|Overall Study||3
8137925|NCT02731469|20059476|P3|STARTED|Overall Study||3
8137926|NCT02731469|20059477|P2|STARTED|Overall Study||3
8137927|NCT02731469|20059478|P1|STARTED|Overall Study||3
8137928|NCT02731313|20059667|P1|NOT COMPLETED|Overall Study||0
8137929|NCT02731313|20059667|P1|COMPLETED|Overall Study||367
8137930|NCT02731313|20059667|P1|STARTED|Overall Study||367
8137931|NCT02731300|20059677|P2|NOT COMPLETED|Overall Study||0
8137932|NCT02731300|20059678|P1|NOT COMPLETED|Overall Study||0
8137933|NCT02731300|20059677|P2|COMPLETED|Overall Study||7
8137934|NCT02731300|20059678|P1|COMPLETED|Overall Study||15
8137935|NCT02731300|20059677|P2|STARTED|Overall Study||7
8137936|NCT02731300|20059678|P1|STARTED|Overall Study||15
8137937|NCT02731157|20059686|P1|NOT COMPLETED|Third Standard RCE||0
8137938|NCT02731157|20059686|P1|COMPLETED|Third Standard RCE||3
8137939|NCT02731157|20059686|P1|STARTED|Third Standard RCE||3
8137940|NCT02731157|20059686|P1|NOT COMPLETED|Second Standard RCE||0
8137941|NCT02731157|20059686|P1|COMPLETED|Second Standard RCE||3
8137942|NCT02731157|20059686|P1|STARTED|Second Standard RCE||3
8137943|NCT02731157|20059686|P1|NOT COMPLETED|Third Rejuvenated RCE||0
8137944|NCT02731157|20059686|P1|COMPLETED|Third Rejuvenated RCE||3
8137945|NCT02731157|20059686|P1|STARTED|Third Rejuvenated RCE||3
8137946|NCT02731157|20059686|P1|NOT COMPLETED|Second Rejuvenated RCE||0
8137947|NCT02731157|20059686|P1|COMPLETED|Second Rejuvenated RCE||3
8137948|NCT02731157|20059686|P1|STARTED|Second Rejuvenated RCE||3
8137949|NCT02731157|20059686|P1|NOT COMPLETED|First Rejuvenated RCE||1
8137950|NCT02731157|20059686|P1|COMPLETED|First Rejuvenated RCE||3
8137951|NCT02731157|20059686|P1|STARTED|First Rejuvenated RCE||4
8137952|NCT02731157|20059686|P1|NOT COMPLETED|First Standard RCE||0
8137953|NCT02731157|20059686|P1|COMPLETED|First Standard RCE||4
8137954|NCT02731157|20059686|P1|STARTED|First Standard RCE||4
8137955|NCT02731131|20059704|P2|NOT COMPLETED|Overall Study||2
8137956|NCT02731131|20059705|P1|NOT COMPLETED|Overall Study||0
8137957|NCT02731131|20059704|P2|COMPLETED|Overall Study||4
8137958|NCT02731131|20059705|P1|COMPLETED|Overall Study||6
8137959|NCT02731131|20059704|P2|STARTED|Overall Study||6
8137960|NCT02731131|20059705|P1|STARTED|Overall Study||6
8137961|NCT02730988|20059723|P2|NOT COMPLETED|Overall Study||10
8137962|NCT02730988|20059724|P1|NOT COMPLETED|Overall Study||4
8137963|NCT02730988|20059723|P2|COMPLETED|Overall Study||39
8137964|NCT02730988|20059724|P1|COMPLETED|Overall Study||43
8137965|NCT02730988|20059723|P2|STARTED|Overall Study||49
8137966|NCT02730988|20059724|P1|STARTED|Overall Study||47
8137967|NCT02730962|20059734|P2|NOT COMPLETED|Overall Study||0
8137968|NCT02730962|20059735|P1|NOT COMPLETED|Overall Study||0
8137969|NCT02730962|20059734|P2|COMPLETED|Overall Study||5
8137970|NCT02730962|20059735|P1|COMPLETED|Overall Study||7
8137971|NCT02730962|20059734|P2|STARTED|Overall Study||5
8137972|NCT02730962|20059735|P1|STARTED|Overall Study||7
8137973|NCT02730884|20059747|P1|NOT COMPLETED|Overall Study||0
8137974|NCT02730884|20059747|P1|COMPLETED|Overall Study||3
8137975|NCT02730884|20059747|P1|STARTED|Overall Study||3
8137976|NCT02730871|20059755|P2|NOT COMPLETED|Overall Study||0
8137977|NCT02730871|20059756|P1|NOT COMPLETED|Overall Study||6
8137978|NCT02730871|20059755|P2|COMPLETED|Overall Study||67
8137979|NCT02730871|20059756|P1|COMPLETED|Overall Study||61
8137980|NCT02730871|20059755|P2|Safety Analysis Set|Overall Study||67
8137981|NCT02730871|20059756|P1|Safety Analysis Set|Overall Study||67
8137982|NCT02730871|20059755|P2|Full Analysis Set (FAS)|Overall Study||67
8137983|NCT02730871|20059756|P1|Full Analysis Set (FAS)|Overall Study||67
8137984|NCT02730871|20059755|P2|STARTED|Overall Study||67
8137985|NCT02730871|20059756|P1|STARTED|Overall Study||67
8137986|NCT02730819|20059770|P1|NOT COMPLETED|Overall Study||9
8137987|NCT02730819|20059770|P1|COMPLETED|Overall Study||10
8137988|NCT02730819|20059770|P1|Follow-up Week 20|Overall Study||10
8137989|NCT02730819|20059770|P1|Follow-up Week 16|Overall Study||11
8137990|NCT02730819|20059770|P1|Follow-up Week 12|Overall Study||11
8137991|NCT02730819|20059770|P1|Follow-up Week 8|Overall Study||14
8137992|NCT02730819|20059770|P1|Follow-up Week 4|Overall Study||16
8137993|NCT02730819|20059770|P1|Follow-up Week 2|Overall Study||15
8137994|NCT02730819|20059770|P1|STARTED|Overall Study||19
8137995|NCT02730728|20059779|P3|NOT COMPLETED|Overall Study||1
8137996|NCT02730728|20059780|P2|NOT COMPLETED|Overall Study||2
8137997|NCT02730728|20059781|P1|NOT COMPLETED|Overall Study||0
8137998|NCT02730728|20059779|P3|COMPLETED|Overall Study||52
8137999|NCT02730728|20059780|P2|COMPLETED|Overall Study||51
8138000|NCT02730728|20059781|P1|COMPLETED|Overall Study||53
8138001|NCT02730728|20059779|P3|STARTED|Overall Study||53
8138002|NCT02730728|20059780|P2|STARTED|Overall Study||53
8138003|NCT02730728|20059781|P1|STARTED|Overall Study||53
8138004|NCT02730663|20059798|P1|NOT COMPLETED|Overall Study||1
8138005|NCT02730663|20059798|P1|COMPLETED|Overall Study||35
8138006|NCT02730663|20059798|P1|STARTED|Overall Study||36
8138007|NCT02730598|20059810|P2|NOT COMPLETED|Overall Study||4
8138008|NCT02730598|20059811|P1|NOT COMPLETED|Overall Study||4
8138009|NCT02730598|20059810|P2|COMPLETED|Overall Study||10
8138010|NCT02730598|20059811|P1|COMPLETED|Overall Study||10
8138011|NCT02730598|20059810|P2|STARTED|Overall Study||14
8138012|NCT02730598|20059811|P1|STARTED|Overall Study||14
8138013|NCT02730455|20059834|P3|NOT COMPLETED|Overall Study||11
8138014|NCT02730455|20059835|P2|NOT COMPLETED|Overall Study||14
8138015|NCT02730455|20059836|P1|NOT COMPLETED|Overall Study||13
8138016|NCT02730455|20059834|P3|COMPLETED|Overall Study||81
8138017|NCT02730455|20059835|P2|COMPLETED|Overall Study||77
8138018|NCT02730455|20059836|P1|COMPLETED|Overall Study||81
8138019|NCT02730455|20059834|P3|Who Received Total Volume of Study Drug|Overall Study||89
8138020|NCT02730455|20059835|P2|Who Received Total Volume of Study Drug|Overall Study||88
8138021|NCT02730455|20059836|P1|Who Received Total Volume of Study Drug|Overall Study||90
8138022|NCT02730455|20059834|P3|Participants Dosed|Overall Study||91
8138023|NCT02730455|20059835|P2|Participants Dosed|Overall Study||88
8138024|NCT02730455|20059836|P1|Participants Dosed|Overall Study||91
8138025|NCT02730455|20059834|P3|Safety Population|Overall Study||89
8138026|NCT02730455|20059835|P2|Safety Population|Overall Study||90
8138027|NCT02730455|20059836|P1|Safety Population|Overall Study||91
8138028|NCT02730455|20059834|P3|STARTED|Overall Study||92
8138029|NCT02730455|20059835|P2|STARTED|Overall Study||91
8138030|NCT02730455|20059836|P1|STARTED|Overall Study||94
8138031|NCT02730403|20059868|P1|NOT COMPLETED|Overall Study||54
8138032|NCT02730403|20059868|P1|COMPLETED|Overall Study||157
8138033|NCT02730403|20059868|P1|STARTED|Overall Study||211
8138034|NCT02730377|20059886|P2|NOT COMPLETED|Overall Study||633
8138035|NCT02730377|20059887|P1|NOT COMPLETED|Overall Study||550
8138036|NCT02730377|20059886|P2|COMPLETED|Overall Study||362
8138037|NCT02730377|20059887|P1|COMPLETED|Overall Study||446
8138038|NCT02730377|20059886|P2|Safety Analysis Set (SAS)|Overall Study||984
8138039|NCT02730377|20059887|P1|Safety Analysis Set (SAS)|Overall Study||980
8138040|NCT02730377|20059886|P2|Full Analysis Set (FAS)|Overall Study||995
8138041|NCT02730377|20059887|P1|Full Analysis Set (FAS)|Overall Study||996
8138042|NCT02730377|20059886|P2|Treated|Overall Study||984
8138043|NCT02730377|20059887|P1|Treated|Overall Study||980
8138044|NCT02730377|20059886|P2|STARTED|Overall Study||995
8138045|NCT02730377|20059887|P1|STARTED|Overall Study||996
8138046|NCT02730351|20059937|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8138047|NCT02730351|20059938|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
8138048|NCT02730351|20059937|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
8138049|NCT02730351|20059938|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
8138050|NCT02730351|20059937|P2|STARTED|Treatment Period 2 (2 Weeks)||36
8138051|NCT02730351|20059938|P1|STARTED|Treatment Period 2 (2 Weeks)||35
8138052|NCT02730351|20059937|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
8138053|NCT02730351|20059938|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
8138054|NCT02730351|20059937|P2|COMPLETED|Wash-out Period (2 Weeks)||36
8138055|NCT02730351|20059938|P1|COMPLETED|Wash-out Period (2 Weeks)||35
8138056|NCT02730351|20059937|P2|STARTED|Wash-out Period (2 Weeks)||37
8138057|NCT02730351|20059938|P1|STARTED|Wash-out Period (2 Weeks)||36
8138058|NCT02730351|20059937|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8138059|NCT02730351|20059938|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
8138060|NCT02730351|20059937|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
8138061|NCT02730351|20059938|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
8138062|NCT02730351|20059937|P2|STARTED|Treatment Period 1 (2 Weeks)||37
8138063|NCT02730351|20059938|P1|STARTED|Treatment Period 1 (2 Weeks)||37
8138064|NCT02730260|20059952|P2|NOT COMPLETED|Overall Study||75
8138065|NCT02730260|20059953|P1|NOT COMPLETED|Overall Study||82
8138066|NCT02730260|20059952|P2|COMPLETED|Overall Study||185
8138067|NCT02730260|20059953|P1|COMPLETED|Overall Study||176
8138068|NCT02730260|20059952|P2|STARTED|Overall Study||260
8138069|NCT02730260|20059953|P1|STARTED|Overall Study||258
8138070|NCT02730247|20059959|P1|NOT COMPLETED|Overall Study||0
8138071|NCT02730247|20059959|P1|COMPLETED|Overall Study||7
8138072|NCT02730247|20059959|P1|STARTED|Overall Study||7
8138073|NCT02730208|20059972|P2|NOT COMPLETED|Overall Study||1
8138074|NCT02730208|20059973|P1|NOT COMPLETED|Overall Study||0
8138075|NCT02730208|20059972|P2|COMPLETED|Overall Study||20
8138076|NCT02730208|20059973|P1|COMPLETED|Overall Study||20
8138077|NCT02730208|20059972|P2|STARTED|Overall Study||21
8138078|NCT02730208|20059973|P1|STARTED|Overall Study||20
8138079|NCT02730195|20059981|P1|NOT COMPLETED|Overall Study||1
8138080|NCT02730195|20059981|P1|COMPLETED|Overall Study||8
8138081|NCT02730195|20059981|P1|STARTED|Overall Study||9
8138082|NCT02730169|20059991|P4|NOT COMPLETED|Overall Study||16
8138083|NCT02730169|20059992|P3|NOT COMPLETED|Overall Study||17
8138084|NCT02730169|20059993|P2|NOT COMPLETED|Overall Study||21
8138085|NCT02730169|20059994|P1|NOT COMPLETED|Overall Study||14
8138086|NCT02730169|20059991|P4|COMPLETED|Overall Study||55
8138087|NCT02730169|20059992|P3|COMPLETED|Overall Study||50
8138088|NCT02730169|20059993|P2|COMPLETED|Overall Study||45
8138089|NCT02730169|20059994|P1|COMPLETED|Overall Study||53
8138090|NCT02730169|20059991|P4|STARTED|Overall Study||71
8138091|NCT02730169|20059992|P3|STARTED|Overall Study||67
8138092|NCT02730169|20059993|P2|STARTED|Overall Study||66
8138093|NCT02730169|20059994|P1|STARTED|Overall Study||67
8138094|NCT02730130|20060054|P1|NOT COMPLETED|Overall Study||0
8138095|NCT02730130|20060054|P1|COMPLETED|Overall Study||17
8138096|NCT02730130|20060054|P1|STARTED|Overall Study||17
8138097|NCT02729909|20060062|P2|NOT COMPLETED|Overall Study||5
8138098|NCT02729909|20060063|P1|NOT COMPLETED|Overall Study||1
8138099|NCT02729909|20060062|P2|COMPLETED|Overall Study||101
8138100|NCT02729909|20060063|P1|COMPLETED|Overall Study||104
8138101|NCT02729909|20060062|P2|STARTED|Overall Study||106
8138102|NCT02729909|20060063|P1|STARTED|Overall Study||105
8138103|NCT02729896|20060082|P3|NOT COMPLETED|Overall Study||22
8138104|NCT02729896|20060083|P2|NOT COMPLETED|Overall Study||9
8138105|NCT02729896|20060084|P1|NOT COMPLETED|Overall Study||2
8138106|NCT02729896|20060082|P3|COMPLETED|Overall Study||1
8138107|NCT02729896|20060083|P2|COMPLETED|Overall Study||1
8138108|NCT02729896|20060084|P1|COMPLETED|Overall Study||1
8138109|NCT02729896|20060082|P3|STARTED|Overall Study||23
8138110|NCT02729896|20060083|P2|STARTED|Overall Study||10
8138111|NCT02729896|20060084|P1|STARTED|Overall Study||3
8138112|NCT02729831|20060129|P4|NOT COMPLETED|6 Month Follow-up||43
8138113|NCT02729831|20060130|P3|NOT COMPLETED|6 Month Follow-up||48
8138114|NCT02729831|20060131|P2|NOT COMPLETED|6 Month Follow-up||54
8138115|NCT02729831|20060132|P1|NOT COMPLETED|6 Month Follow-up||55
8138116|NCT02729831|20060129|P4|COMPLETED|6 Month Follow-up||232
8138117|NCT02729831|20060130|P3|COMPLETED|6 Month Follow-up||227
8138118|NCT02729831|20060131|P2|COMPLETED|6 Month Follow-up||238
8138119|NCT02729831|20060132|P1|COMPLETED|6 Month Follow-up||227
8138120|NCT02729831|20060129|P4|STARTED|6 Month Follow-up||275
8138121|NCT02729831|20060130|P3|STARTED|6 Month Follow-up||275
8138122|NCT02729831|20060131|P2|STARTED|6 Month Follow-up||292
8138123|NCT02729831|20060132|P1|STARTED|6 Month Follow-up||282
8138124|NCT02729831|20060129|P4|NOT COMPLETED|1 Week Post-visit||36
8138125|NCT02729831|20060130|P3|NOT COMPLETED|1 Week Post-visit||38
8138126|NCT02729831|20060131|P2|NOT COMPLETED|1 Week Post-visit||40
8138127|NCT02729831|20060132|P1|NOT COMPLETED|1 Week Post-visit||43
8138128|NCT02729831|20060129|P4|COMPLETED|1 Week Post-visit||239
8138129|NCT02729831|20060130|P3|COMPLETED|1 Week Post-visit||237
8138130|NCT02729831|20060131|P2|COMPLETED|1 Week Post-visit||252
8138131|NCT02729831|20060132|P1|COMPLETED|1 Week Post-visit||239
8138132|NCT02729831|20060129|P4|STARTED|1 Week Post-visit||275
8138133|NCT02729831|20060130|P3|STARTED|1 Week Post-visit||275
8138134|NCT02729831|20060131|P2|STARTED|1 Week Post-visit||292
8138135|NCT02729831|20060132|P1|STARTED|1 Week Post-visit||282
8138136|NCT02729831|20060129|P4|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
8138137|NCT02729831|20060130|P3|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
8138138|NCT02729831|20060131|P2|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
8138139|NCT02729831|20060132|P1|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
8138140|NCT02729831|20060129|P4|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
8138141|NCT02729831|20060130|P3|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
8138142|NCT02729831|20060131|P2|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
8138143|NCT02729831|20060132|P1|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
8138144|NCT02729831|20060129|P4|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
8138145|NCT02729831|20060130|P3|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
8138146|NCT02729831|20060131|P2|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
8138147|NCT02729831|20060132|P1|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
8138148|NCT02729753|20060160|P2|NOT COMPLETED|Overall Study||1
8138149|NCT02729753|20060161|P1|NOT COMPLETED|Overall Study||0
8138150|NCT02729753|20060160|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
8138151|NCT02729753|20060161|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
8138152|NCT02729753|20060160|P2|STARTED|Overall Study|First patient enrolled April 2016|7
8138153|NCT02729753|20060161|P1|STARTED|Overall Study|First patient enrolled April 2016|3
8138154|NCT02729545|20060175|P2|NOT COMPLETED|Overall Study||5
8138155|NCT02729545|20060176|P1|NOT COMPLETED|Overall Study||3
8138156|NCT02729545|20060175|P2|COMPLETED|Overall Study||25
8138157|NCT02729545|20060176|P1|COMPLETED|Overall Study||27
8138158|NCT02729545|20060175|P2|STARTED|Overall Study||30
8138159|NCT02729545|20060176|P1|STARTED|Overall Study||30
8138160|NCT02729194|20060198|P1|NOT COMPLETED|Overall Study||3
8138161|NCT02729194|20060198|P1|COMPLETED|Overall Study||13
8138162|NCT02729194|20060198|P1|STARTED|Overall Study||16
8138163|NCT02729051|20060210|P2|NOT COMPLETED|Overall Study||32
8138164|NCT02729051|20060211|P1|NOT COMPLETED|Overall Study||30
8138165|NCT02729051|20060210|P2|COMPLETED|Overall Study||496
8138166|NCT02729051|20060211|P1|COMPLETED|Overall Study||497
8138167|NCT02729051|20060210|P2|STARTED|Overall Study||528
8138168|NCT02729051|20060211|P1|STARTED|Overall Study||527
8138169|NCT02729038|20060231|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138170|NCT02729038|20060232|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138171|NCT02729038|20060233|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138172|NCT02729038|20060234|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138173|NCT02729038|20060231|P4|COMPLETED|Part 2 (Up to 50 Days)||8
8138174|NCT02729038|20060232|P3|COMPLETED|Part 2 (Up to 50 Days)||0
8138175|NCT02729038|20060233|P2|COMPLETED|Part 2 (Up to 50 Days)||0
8138176|NCT02729038|20060234|P1|COMPLETED|Part 2 (Up to 50 Days)||0
8138177|NCT02729038|20060231|P4|STARTED|Part 2 (Up to 50 Days)||8
8138178|NCT02729038|20060232|P3|STARTED|Part 2 (Up to 50 Days)||0
8138179|NCT02729038|20060233|P2|STARTED|Part 2 (Up to 50 Days)||0
8138180|NCT02729038|20060234|P1|STARTED|Part 2 (Up to 50 Days)||0
8138181|NCT02729038|20060231|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138182|NCT02729038|20060232|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138183|NCT02729038|20060233|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138184|NCT02729038|20060234|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138185|NCT02729038|20060231|P4|COMPLETED|Part 1 (Up to 44 Days)||0
8138186|NCT02729038|20060232|P3|COMPLETED|Part 1 (Up to 44 Days)||8
8138187|NCT02729038|20060233|P2|COMPLETED|Part 1 (Up to 44 Days)||8
8138188|NCT02729038|20060234|P1|COMPLETED|Part 1 (Up to 44 Days)||8
8138189|NCT02729038|20060231|P4|STARTED|Part 1 (Up to 44 Days)||0
8138190|NCT02729038|20060232|P3|STARTED|Part 1 (Up to 44 Days)||8
8138191|NCT02729038|20060233|P2|STARTED|Part 1 (Up to 44 Days)||8
8138192|NCT02729038|20060234|P1|STARTED|Part 1 (Up to 44 Days)||8
8138193|NCT02729025|20060355|P2|NOT COMPLETED|Overall Study||1
8138194|NCT02729025|20060356|P1|NOT COMPLETED|Overall Study||0
8138195|NCT02729025|20060355|P2|COMPLETED|Overall Study||64
8138196|NCT02729025|20060356|P1|COMPLETED|Overall Study||64
8138197|NCT02729025|20060355|P2|STARTED|Overall Study||65
8138198|NCT02729025|20060356|P1|STARTED|Overall Study||64
8138199|NCT02728895|20060370|P2|NOT COMPLETED|Overall Study||5
8138200|NCT02728895|20060371|P1|NOT COMPLETED|Overall Study||1
8138201|NCT02728895|20060370|P2|COMPLETED|Overall Study||16
8138202|NCT02728895|20060371|P1|COMPLETED|Overall Study||2
8138203|NCT02728895|20060370|P2|STARTED|Overall Study||21
8138204|NCT02728895|20060371|P1|STARTED|Overall Study||3
8138208|NCT02728206|20060398|P1|NOT COMPLETED|Overall Study||1
8138209|NCT02728206|20060398|P1|COMPLETED|Overall Study||8
8138210|NCT02728206|20060398|P1|STARTED|Overall Study||9
8138211|NCT02728089|20060406|P1|NOT COMPLETED|Overall Study||3
8138212|NCT02728089|20060406|P1|COMPLETED|Overall Study||112
8138213|NCT02728089|20060406|P1|Treated|Overall Study||114
8138214|NCT02728089|20060406|P1|STARTED|Overall Study||115
8138215|NCT02727894|20060423|P2|NOT COMPLETED|Overall Study||0
8138216|NCT02727894|20060424|P1|NOT COMPLETED|Overall Study||0
8138217|NCT02727894|20060423|P2|COMPLETED|Overall Study|September 2015|192
8138218|NCT02727894|20060424|P1|COMPLETED|Overall Study|September 2015|73
8138219|NCT02727894|20060423|P2|STARTED|Overall Study|March 2013|192
8138220|NCT02727894|20060424|P1|STARTED|Overall Study|March 2013|73
8138221|NCT02727842|20060440|P1|NOT COMPLETED|Overall Study||0
8138222|NCT02727842|20060440|P1|COMPLETED|Overall Study||30
8138223|NCT02727842|20060440|P1|STARTED|Overall Study||30
8138224|NCT02727816|20060444|P1|NOT COMPLETED|Overall Study||0
8138225|NCT02727816|20060444|P1|COMPLETED|Overall Study||35
8138226|NCT02727816|20060444|P1|STARTED|Overall Study||35
8138227|NCT02727777|20060494|P3|NOT COMPLETED|Overall Study||0
8138228|NCT02727777|20060495|P2|NOT COMPLETED|Overall Study||0
8138229|NCT02727777|20060496|P1|NOT COMPLETED|Overall Study||4
8138230|NCT02727777|20060494|P3|COMPLETED|Overall Study||0
8138231|NCT02727777|20060495|P2|COMPLETED|Overall Study||0
8138232|NCT02727777|20060496|P1|COMPLETED|Overall Study||0
8138233|NCT02727777|20060494|P3|STARTED|Overall Study||0
8138234|NCT02727777|20060495|P2|STARTED|Overall Study||0
8138235|NCT02727777|20060496|P1|STARTED|Overall Study||4
8138236|NCT02727751|20060510|P1|NOT COMPLETED|Overall Study||50
8138237|NCT02727751|20060510|P1|COMPLETED|Overall Study||262
8138238|NCT02727751|20060510|P1|STARTED|Overall Study||312
8138239|NCT02727660|20060517|P3|NOT COMPLETED|Overall Study||165
8138240|NCT02727660|20060518|P2|NOT COMPLETED|Overall Study||116
8138241|NCT02727660|20060519|P1|NOT COMPLETED|Overall Study||116
8138242|NCT02727660|20060517|P3|COMPLETED|Overall Study||442
8138243|NCT02727660|20060518|P2|COMPLETED|Overall Study||501
8138244|NCT02727660|20060519|P1|COMPLETED|Overall Study||503
8138245|NCT02727660|20060517|P3|STARTED|Overall Study||607
8138246|NCT02727660|20060518|P2|STARTED|Overall Study||617
8138247|NCT02727660|20060519|P1|STARTED|Overall Study||619
8138248|NCT02727322|20060538|P2|NOT COMPLETED|Overall Study||1
8138249|NCT02727322|20060539|P1|NOT COMPLETED|Overall Study||2
8138250|NCT02727322|20060538|P2|COMPLETED|Overall Study||76
8138251|NCT02727322|20060539|P1|COMPLETED|Overall Study||75
8138252|NCT02727322|20060538|P2|STARTED|Overall Study||77
8138253|NCT02727322|20060539|P1|STARTED|Overall Study||77
8138254|NCT02726971|20060551|P2|NOT COMPLETED|Overall Study||9
8138255|NCT02726971|20060552|P1|NOT COMPLETED|Overall Study||11
8138256|NCT02726971|20060551|P2|COMPLETED|Overall Study||62
8138257|NCT02726971|20060552|P1|COMPLETED|Overall Study||59
8138258|NCT02726971|20060551|P2|STARTED|Overall Study||71
8138259|NCT02726971|20060552|P1|STARTED|Overall Study||70
8138260|NCT02726945|20060565|P3|NOT COMPLETED|Overall Study||1
8138261|NCT02726945|20060566|P2|NOT COMPLETED|Overall Study||1
8138262|NCT02726945|20060567|P1|NOT COMPLETED|Overall Study||0
8138263|NCT02726945|20060565|P3|COMPLETED|Overall Study||12
8138264|NCT02726945|20060566|P2|COMPLETED|Overall Study||12
8138265|NCT02726945|20060567|P1|COMPLETED|Overall Study||13
8138266|NCT02726945|20060565|P3|STARTED|Overall Study||13
8138267|NCT02726945|20060566|P2|STARTED|Overall Study||13
8138268|NCT02726945|20060567|P1|STARTED|Overall Study||13
8138269|NCT02726789|20060578|P1|NOT COMPLETED|Overall Study||0
8138270|NCT02726789|20060578|P1|COMPLETED|Overall Study||5
8138271|NCT02726789|20060578|P1|STARTED|Overall Study||5
8138272|NCT02726620|20060587|P2|NOT COMPLETED|Through End of Study: All Interventions||0
8138273|NCT02726620|20060588|P1|NOT COMPLETED|Through End of Study: All Interventions||0
8138274|NCT02726620|20060587|P2|COMPLETED|Through End of Study: All Interventions||3234
8138275|NCT02726620|20060588|P1|COMPLETED|Through End of Study: All Interventions||0
8138276|NCT02726620|20060587|P2|Correct IOH Notifications|Through End of Study: All Interventions||2072
8138277|NCT02726620|20060588|P1|Correct IOH Notifications|Through End of Study: All Interventions||0
8138278|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
8138279|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
8138280|NCT02726620|20060587|P2|STARTED|Through End of Study: All Interventions||3234
8138281|NCT02726620|20060588|P1|STARTED|Through End of Study: All Interventions||0
8138282|NCT02726620|20060587|P2|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
8138283|NCT02726620|20060588|P1|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
8138284|NCT02726620|20060587|P2|COMPLETED|Months 2-3: In-room Providers Randomized||1253
8138285|NCT02726620|20060588|P1|COMPLETED|Months 2-3: In-room Providers Randomized||0
8138286|NCT02726620|20060587|P2|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
8138287|NCT02726620|20060588|P1|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
8138288|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
8138289|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
8138290|NCT02726620|20060587|P2|STARTED|Months 2-3: In-room Providers Randomized||1253
8138291|NCT02726620|20060588|P1|STARTED|Months 2-3: In-room Providers Randomized||0
8138292|NCT02726620|20060587|P2|NOT COMPLETED|Month 1: Attending Randomization||0
8138293|NCT02726620|20060588|P1|NOT COMPLETED|Month 1: Attending Randomization||0
8138294|NCT02726620|20060587|P2|COMPLETED|Month 1: Attending Randomization||485
8138295|NCT02726620|20060588|P1|COMPLETED|Month 1: Attending Randomization||0
8138296|NCT02726620|20060587|P2|Correct IOH Notifications|Month 1: Attending Randomization||313
8138297|NCT02726620|20060588|P1|Correct IOH Notifications|Month 1: Attending Randomization||0
8138298|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
8138299|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
8138300|NCT02726620|20060587|P2|STARTED|Month 1: Attending Randomization||485
8138301|NCT02726620|20060588|P1|STARTED|Month 1: Attending Randomization||0
8138302|NCT02726620|20060587|P2|NOT COMPLETED|Historic Cohort - Three Years||0
8138303|NCT02726620|20060588|P1|NOT COMPLETED|Historic Cohort - Three Years||0
8138304|NCT02726620|20060587|P2|COMPLETED|Historic Cohort - Three Years||0
8138305|NCT02726620|20060588|P1|COMPLETED|Historic Cohort - Three Years||17463
8138306|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
8138307|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
8138308|NCT02726620|20060587|P2|STARTED|Historic Cohort - Three Years||0
8138309|NCT02726620|20060588|P1|STARTED|Historic Cohort - Three Years||17463
8138310|NCT02726451|20060686|P2|NOT COMPLETED|Overall Study||0
8138311|NCT02726451|20060687|P1|NOT COMPLETED|Overall Study||0
8138312|NCT02726451|20060686|P2|COMPLETED|Overall Study||10
8138313|NCT02726451|20060687|P1|COMPLETED|Overall Study||10
8138314|NCT02726451|20060686|P2|STARTED|Overall Study||10
8138315|NCT02726451|20060687|P1|STARTED|Overall Study||10
8138316|NCT02726399|20060701|P1|NOT COMPLETED|Overall Study||7
8138317|NCT02726399|20060701|P1|COMPLETED|Overall Study||0
8138318|NCT02726399|20060701|P1|STARTED|Overall Study||7
8138319|NCT02726178|20060707|P2|NOT COMPLETED|Overall Study||0
8138320|NCT02726178|20060708|P1|NOT COMPLETED|Overall Study||0
8138321|NCT02726178|20060707|P2|COMPLETED|Overall Study||28
8138322|NCT02726178|20060708|P1|COMPLETED|Overall Study||28
8138323|NCT02726178|20060707|P2|STARTED|Overall Study||28
8138324|NCT02726178|20060708|P1|STARTED|Overall Study||28
8138325|NCT02726113|20060718|P2|NOT COMPLETED|Genomic Analysis||2
8138326|NCT02726113|20060719|P1|NOT COMPLETED|Genomic Analysis||4
8138327|NCT02726113|20060718|P2|COMPLETED|Genomic Analysis||12
8138328|NCT02726113|20060719|P1|COMPLETED|Genomic Analysis||15
8138329|NCT02726113|20060718|P2|STARTED|Genomic Analysis||14
8138330|NCT02726113|20060719|P1|STARTED|Genomic Analysis||19
8138331|NCT02726113|20060718|P2|NOT COMPLETED|Total Enrollment||3
8138332|NCT02726113|20060719|P1|NOT COMPLETED|Total Enrollment||4
8138333|NCT02726113|20060718|P2|COMPLETED|Total Enrollment||19
8138334|NCT02726113|20060719|P1|COMPLETED|Total Enrollment||24
8138335|NCT02726113|20060718|P2|STARTED|Total Enrollment||22
8138336|NCT02726113|20060719|P1|STARTED|Total Enrollment||28
8138337|NCT02726074|20060726|P1|NOT COMPLETED|Overall Study||26
8138338|NCT02726074|20060726|P1|COMPLETED|Overall Study||80
8138339|NCT02726074|20060726|P1|Treated|Overall Study||102
8138340|NCT02726074|20060726|P1|STARTED|Overall Study||106
8138341|NCT02726022|20060738|P1|NOT COMPLETED|Overall Study||36
8138342|NCT02726022|20060738|P1|COMPLETED|Overall Study||78
8138343|NCT02726022|20060738|P1|STARTED|Overall Study||114
8138344|NCT02725866|20060747|P1|NOT COMPLETED|Overall Study||14
8138345|NCT02725866|20060747|P1|COMPLETED|Overall Study||202
8138346|NCT02725866|20060747|P1|STARTED|Overall Study||216
8138347|NCT02725801|20060760|P2|NOT COMPLETED|Overall Study||0
8138348|NCT02725801|20060761|P1|NOT COMPLETED|Overall Study||0
8138349|NCT02725801|20060760|P2|COMPLETED|Overall Study||12
8138350|NCT02725801|20060761|P1|COMPLETED|Overall Study||8
8138351|NCT02725801|20060760|P2|STARTED|Overall Study||12
8138352|NCT02725801|20060761|P1|STARTED|Overall Study||8
8138353|NCT02725788|20060771|P2|NOT COMPLETED|Overall Study||2
8138354|NCT02725788|20060772|P1|NOT COMPLETED|Overall Study||1
8138355|NCT02725788|20060771|P2|COMPLETED|Overall Study||122
8138356|NCT02725788|20060772|P1|COMPLETED|Overall Study||122
8138357|NCT02725788|20060771|P2|STARTED|Overall Study||124
8138358|NCT02725788|20060772|P1|STARTED|Overall Study||123
8138359|NCT02725710|20060780|P2|NOT COMPLETED|Overall Study||0
8138360|NCT02725710|20060781|P1|NOT COMPLETED|Overall Study||1
8138361|NCT02725710|20060780|P2|COMPLETED|Overall Study||47
8138362|NCT02725710|20060781|P1|COMPLETED|Overall Study||47
8138363|NCT02725710|20060780|P2|STARTED|Overall Study||47
8138364|NCT02725710|20060781|P1|STARTED|Overall Study||48
8138365|NCT02725671|20060809|P1|NOT COMPLETED|Overall Study||1
8138366|NCT02725671|20060809|P1|COMPLETED|Overall Study||1
8138367|NCT02725671|20060809|P1|STARTED|Overall Study||2
8138368|NCT02725645|20060818|P1|NOT COMPLETED|Overall Study||0
8138369|NCT02725645|20060818|P1|COMPLETED|Overall Study||14
8138370|NCT02725645|20060818|P1|STARTED|Overall Study||14
8138371|NCT02725593|20060824|P2|NOT COMPLETED|Long Term Extension||3
8138372|NCT02725593|20060825|P1|NOT COMPLETED|Long Term Extension||1
8138373|NCT02725593|20060824|P2|COMPLETED|Long Term Extension||24
8138374|NCT02725593|20060825|P1|COMPLETED|Long Term Extension||32
8138375|NCT02725593|20060824|P2|STARTED|Long Term Extension||27
8138376|NCT02725593|20060825|P1|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
8138377|NCT02725593|20060824|P2|NOT COMPLETED|Blinded Treatment Period||6
8138378|NCT02725593|20060825|P1|NOT COMPLETED|Blinded Treatment Period||5
8138379|NCT02725593|20060824|P2|COMPLETED|Blinded Treatment Period||27
8138380|NCT02725593|20060825|P1|COMPLETED|Blinded Treatment Period||34
8138381|NCT02725593|20060824|P2|Received Treatment|Blinded Treatment Period||33
8138382|NCT02725593|20060825|P1|Received Treatment|Blinded Treatment Period||39
8138383|NCT02725593|20060824|P2|STARTED|Blinded Treatment Period||33
8138384|NCT02725593|20060825|P1|STARTED|Blinded Treatment Period||39
8138385|NCT02725515|20060839|P2|NOT COMPLETED|Overall Study||35
8138386|NCT02725515|20060840|P1|NOT COMPLETED|Overall Study||25
8138387|NCT02725515|20060839|P2|COMPLETED|Overall Study||17
8138388|NCT02725515|20060840|P1|COMPLETED|Overall Study||28
8138389|NCT02725515|20060839|P2|STARTED|Overall Study||52
8138390|NCT02725515|20060840|P1|STARTED|Overall Study||53
8138391|NCT02725476|20060852|P2|NOT COMPLETED|Overall Study||1
8138392|NCT02725476|20060853|P1|NOT COMPLETED|Overall Study||3
8138393|NCT02725476|20060852|P2|COMPLETED|Overall Study||4
8138394|NCT02725476|20060853|P1|COMPLETED|Overall Study||12
8138395|NCT02725476|20060852|P2|STARTED|Overall Study||5
8138396|NCT02725476|20060853|P1|STARTED|Overall Study||15
8138397|NCT02725411|20060864|P3|NOT COMPLETED|Follow-up Period (24 Weeks)||5
8138398|NCT02725411|20060865|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||11
8138399|NCT02725411|20060866|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||4
8138400|NCT02725411|20060864|P3|COMPLETED|Follow-up Period (24 Weeks)||87
8138401|NCT02725411|20060865|P2|COMPLETED|Follow-up Period (24 Weeks)||82
8138402|NCT02725411|20060866|P1|COMPLETED|Follow-up Period (24 Weeks)||88
8138403|NCT02725411|20060864|P3|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
8138404|NCT02725411|20060865|P2|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
8138405|NCT02725411|20060866|P1|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
8138406|NCT02725411|20060864|P3|NOT COMPLETED|Treatment Period (56 Weeks)||49
8138407|NCT02725411|20060865|P2|NOT COMPLETED|Treatment Period (56 Weeks)||50
8138408|NCT02725411|20060866|P1|NOT COMPLETED|Treatment Period (56 Weeks)||30
8138409|NCT02725411|20060864|P3|COMPLETED|Treatment Period (56 Weeks)||43
8138410|NCT02725411|20060865|P2|COMPLETED|Treatment Period (56 Weeks)||43
8138411|NCT02725411|20060866|P1|COMPLETED|Treatment Period (56 Weeks)||62
8138412|NCT02725411|20060864|P3|Treated|Treatment Period (56 Weeks)||92
8138413|NCT02725411|20060865|P2|Treated|Treatment Period (56 Weeks)||93
8138414|NCT02725411|20060866|P1|Treated|Treatment Period (56 Weeks)||92
8138415|NCT02725411|20060864|P3|STARTED|Treatment Period (56 Weeks)||92
8138416|NCT02725411|20060865|P2|STARTED|Treatment Period (56 Weeks)||93
8138417|NCT02725411|20060866|P1|STARTED|Treatment Period (56 Weeks)||92
8138418|NCT02725268|20061082|P4|NOT COMPLETED|Overall Study||17
8138419|NCT02725268|20061083|P3|NOT COMPLETED|Overall Study||37
8138420|NCT02725268|20061084|P2|NOT COMPLETED|Overall Study||59
8138421|NCT02725268|20061085|P1|NOT COMPLETED|Overall Study||59
8138422|NCT02725268|20061082|P4|COMPLETED|Overall Study||3
8138423|NCT02725268|20061083|P3|COMPLETED|Overall Study||4
8138424|NCT02725268|20061084|P2|COMPLETED|Overall Study||31
8138425|NCT02725268|20061085|P1|COMPLETED|Overall Study||31
8138426|NCT02725268|20061082|P4|STARTED|Overall Study||20
8138427|NCT02725268|20061083|P3|STARTED|Overall Study||41
8138428|NCT02725268|20061084|P2|STARTED|Overall Study||90
8138429|NCT02725268|20061085|P1|STARTED|Overall Study||90
8138430|NCT02725008|20061121|P2|NOT COMPLETED|Overall Study||12
8138431|NCT02725008|20061122|P1|NOT COMPLETED|Overall Study||9
8138432|NCT02725008|20061121|P2|COMPLETED|Overall Study||39
8138433|NCT02725008|20061122|P1|COMPLETED|Overall Study||37
8138434|NCT02725008|20061121|P2|STARTED|Overall Study||51
8138435|NCT02725008|20061122|P1|STARTED|Overall Study||46
8138436|NCT02724839|20061133|P3|NOT COMPLETED|Overall Study||5
8138437|NCT02724839|20061134|P2|NOT COMPLETED|Overall Study||4
8138438|NCT02724839|20061135|P1|NOT COMPLETED|Overall Study||1
8138439|NCT02724839|20061133|P3|COMPLETED|Overall Study||6
8138440|NCT02724839|20061134|P2|COMPLETED|Overall Study||8
8138441|NCT02724839|20061135|P1|COMPLETED|Overall Study||12
8138442|NCT02724839|20061133|P3|STARTED|Overall Study||11
8138443|NCT02724839|20061134|P2|STARTED|Overall Study||12
8138444|NCT02724839|20061135|P1|STARTED|Overall Study||13
8138445|NCT02724800|20061169|P2|NOT COMPLETED|Overall Study||9
8138446|NCT02724800|20061170|P1|NOT COMPLETED|Overall Study||17
8138447|NCT02724800|20061169|P2|COMPLETED|Overall Study||22
8138448|NCT02724800|20061170|P1|COMPLETED|Overall Study||15
8138449|NCT02724800|20061169|P2|STARTED|Overall Study||31
8138450|NCT02724800|20061170|P1|STARTED|Overall Study||32
8138451|NCT02724787|20061202|P1|NOT COMPLETED|Overall Study||2
8138452|NCT02724787|20061202|P1|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
8138453|NCT02724787|20061202|P1|STARTED|Overall Study||24
8138454|NCT02724644|20061212|P2|NOT COMPLETED|Overall Study||4
8138455|NCT02724644|20061213|P1|NOT COMPLETED|Overall Study||21
8138456|NCT02724644|20061212|P2|COMPLETED|Overall Study||182
8138457|NCT02724644|20061213|P1|COMPLETED|Overall Study||168
8138458|NCT02724644|20061212|P2|STARTED|Overall Study||186
8138459|NCT02724644|20061213|P1|STARTED|Overall Study||189
8138460|NCT02724462|20061243|P2|NOT COMPLETED|12 Month Follow-up Survey||182
8138461|NCT02724462|20061244|P1|NOT COMPLETED|12 Month Follow-up Survey||214
8138462|NCT02724462|20061243|P2|COMPLETED|12 Month Follow-up Survey||1067
8138463|NCT02724462|20061244|P1|COMPLETED|12 Month Follow-up Survey||1040
8138464|NCT02724462|20061243|P2|STARTED|12 Month Follow-up Survey||1249
8138465|NCT02724462|20061244|P1|STARTED|12 Month Follow-up Survey||1254
8138466|NCT02724462|20061243|P2|NOT COMPLETED|6 Month Follow-up Survey||171
8138467|NCT02724462|20061244|P1|NOT COMPLETED|6 Month Follow-up Survey||196
8138468|NCT02724462|20061243|P2|COMPLETED|6 Month Follow-up Survey||1078
8138469|NCT02724462|20061244|P1|COMPLETED|6 Month Follow-up Survey||1058
8138470|NCT02724462|20061243|P2|STARTED|6 Month Follow-up Survey||1249
8138471|NCT02724462|20061244|P1|STARTED|6 Month Follow-up Survey||1254
8138472|NCT02724462|20061243|P2|NOT COMPLETED|3 Month Follow-up Survey||199
8138473|NCT02724462|20061244|P1|NOT COMPLETED|3 Month Follow-up Survey||211
8138474|NCT02724462|20061243|P2|COMPLETED|3 Month Follow-up Survey||1050
8138475|NCT02724462|20061244|P1|COMPLETED|3 Month Follow-up Survey||1043
8138476|NCT02724462|20061243|P2|STARTED|3 Month Follow-up Survey||1249
8138477|NCT02724462|20061244|P1|STARTED|3 Month Follow-up Survey||1254
8138478|NCT02724449|20061252|P1|NOT COMPLETED|Overall Study||0
8138479|NCT02724449|20061252|P1|COMPLETED|Overall Study||16
8138480|NCT02724449|20061252|P1|STARTED|Overall Study||16
8138481|NCT02724111|20061258|P2|NOT COMPLETED|Overall Study||5
8138482|NCT02724111|20061259|P1|NOT COMPLETED|Overall Study||2
8138483|NCT02724111|20061258|P2|COMPLETED|Overall Study||40
8138484|NCT02724111|20061259|P1|COMPLETED|Overall Study||43
8138485|NCT02724111|20061258|P2|STARTED|Overall Study||45
8138486|NCT02724111|20061259|P1|STARTED|Overall Study||45
8138487|NCT02724033|20061282|P3|NOT COMPLETED|Overall Study||0
8138488|NCT02724033|20061283|P2|NOT COMPLETED|Overall Study||0
8138489|NCT02724033|20061284|P1|NOT COMPLETED|Overall Study||0
8138490|NCT02724033|20061282|P3|COMPLETED|Overall Study||12
8138491|NCT02724033|20061283|P2|COMPLETED|Overall Study||14
8138492|NCT02724033|20061284|P1|COMPLETED|Overall Study||11
8138493|NCT02724033|20061282|P3|STARTED|Overall Study||12
8138494|NCT02724033|20061283|P2|STARTED|Overall Study||14
8138495|NCT02724033|20061284|P1|STARTED|Overall Study||11
8138496|NCT02723916|20061294|P2|NOT COMPLETED|Overall Study||6
8138497|NCT02723916|20061295|P1|NOT COMPLETED|Overall Study||9
8138498|NCT02723916|20061294|P2|COMPLETED|Overall Study||137
8138499|NCT02723916|20061295|P1|COMPLETED|Overall Study||135
8138500|NCT02723916|20061294|P2|STARTED|Overall Study||143
8138501|NCT02723916|20061295|P1|STARTED|Overall Study||144
8138502|NCT02723786|20061311|P1|NOT COMPLETED|Overall Study||1
8138503|NCT02723786|20061311|P1|COMPLETED|Overall Study||6
8138504|NCT02723786|20061311|P1|STARTED|Overall Study||7
8138505|NCT02723630|20061339|P6|NOT COMPLETED|Intervention Period 3||0
8138506|NCT02723630|20061340|P5|NOT COMPLETED|Intervention Period 3||0
8138507|NCT02723630|20061341|P4|NOT COMPLETED|Intervention Period 3||0
8138508|NCT02723630|20061342|P3|NOT COMPLETED|Intervention Period 3||0
8138509|NCT02723630|20061343|P2|NOT COMPLETED|Intervention Period 3||1
8138510|NCT02723630|20061344|P1|NOT COMPLETED|Intervention Period 3||0
8138511|NCT02723630|20061339|P6|COMPLETED|Intervention Period 3||10
8138512|NCT02723630|20061340|P5|COMPLETED|Intervention Period 3||10
8138513|NCT02723630|20061341|P4|COMPLETED|Intervention Period 3||10
8138514|NCT02723630|20061342|P3|COMPLETED|Intervention Period 3||10
8138515|NCT02723630|20061343|P2|COMPLETED|Intervention Period 3||9
8138516|NCT02723630|20061344|P1|COMPLETED|Intervention Period 3||9
8138517|NCT02723630|20061339|P6|STARTED|Intervention Period 3||10
8138518|NCT02723630|20061340|P5|STARTED|Intervention Period 3||10
8138519|NCT02723630|20061341|P4|STARTED|Intervention Period 3||10
8138520|NCT02723630|20061342|P3|STARTED|Intervention Period 3||10
8138521|NCT02723630|20061343|P2|STARTED|Intervention Period 3||10
8138522|NCT02723630|20061344|P1|STARTED|Intervention Period 3||9
8138523|NCT02723630|20061339|P6|NOT COMPLETED|Intervention Period 2||0
8138524|NCT02723630|20061340|P5|NOT COMPLETED|Intervention Period 2||0
8138525|NCT02723630|20061341|P4|NOT COMPLETED|Intervention Period 2||0
8138526|NCT02723630|20061342|P3|NOT COMPLETED|Intervention Period 2||0
8138527|NCT02723630|20061343|P2|NOT COMPLETED|Intervention Period 2||0
8138528|NCT02723630|20061344|P1|NOT COMPLETED|Intervention Period 2||0
8138529|NCT02723630|20061339|P6|COMPLETED|Intervention Period 2||10
8138530|NCT02723630|20061340|P5|COMPLETED|Intervention Period 2||10
8138531|NCT02723630|20061341|P4|COMPLETED|Intervention Period 2||10
8138532|NCT02723630|20061342|P3|COMPLETED|Intervention Period 2||10
8138533|NCT02723630|20061343|P2|COMPLETED|Intervention Period 2||10
8138534|NCT02723630|20061344|P1|COMPLETED|Intervention Period 2||9
8138535|NCT02723630|20061339|P6|STARTED|Intervention Period 2||10
8138536|NCT02723630|20061340|P5|STARTED|Intervention Period 2||10
8138537|NCT02723630|20061341|P4|STARTED|Intervention Period 2||10
8138538|NCT02723630|20061342|P3|STARTED|Intervention Period 2||10
8138539|NCT02723630|20061343|P2|STARTED|Intervention Period 2||10
8138540|NCT02723630|20061344|P1|STARTED|Intervention Period 2||9
8138541|NCT02723630|20061339|P6|NOT COMPLETED|Intervention Period 1||0
8138542|NCT02723630|20061340|P5|NOT COMPLETED|Intervention Period 1||0
8138543|NCT02723630|20061341|P4|NOT COMPLETED|Intervention Period 1||0
8138544|NCT02723630|20061342|P3|NOT COMPLETED|Intervention Period 1||0
8138545|NCT02723630|20061343|P2|NOT COMPLETED|Intervention Period 1||0
8138546|NCT02723630|20061344|P1|NOT COMPLETED|Intervention Period 1||1
8138547|NCT02723630|20061339|P6|COMPLETED|Intervention Period 1||10
8138548|NCT02723630|20061340|P5|COMPLETED|Intervention Period 1||10
8138549|NCT02723630|20061341|P4|COMPLETED|Intervention Period 1||10
8138550|NCT02723630|20061342|P3|COMPLETED|Intervention Period 1||10
8138551|NCT02723630|20061343|P2|COMPLETED|Intervention Period 1||10
8138552|NCT02723630|20061344|P1|COMPLETED|Intervention Period 1||9
8138553|NCT02723630|20061339|P6|STARTED|Intervention Period 1||10
8138554|NCT02723630|20061340|P5|STARTED|Intervention Period 1||10
8138555|NCT02723630|20061341|P4|STARTED|Intervention Period 1||10
8138556|NCT02723630|20061342|P3|STARTED|Intervention Period 1||10
8138557|NCT02723630|20061343|P2|STARTED|Intervention Period 1||10
8138558|NCT02723630|20061344|P1|STARTED|Intervention Period 1||10
8138559|NCT02723591|20061375|P2|NOT COMPLETED|Overall Study||101
8138560|NCT02723591|20061376|P1|NOT COMPLETED|Overall Study||96
8138561|NCT02723591|20061375|P2|COMPLETED|Overall Study||198
8138562|NCT02723591|20061376|P1|COMPLETED|Overall Study||204
8138563|NCT02723591|20061375|P2|STARTED|Overall Study||299
8138564|NCT02723591|20061376|P1|STARTED|Overall Study||300
8138565|NCT02723344|20061504|P2|NOT COMPLETED|Overall Study||4
8138566|NCT02723344|20061505|P1|NOT COMPLETED|Overall Study||0
8138567|NCT02723344|20061504|P2|COMPLETED|Overall Study||12
8138568|NCT02723344|20061505|P1|COMPLETED|Overall Study||15
8138569|NCT02723344|20061504|P2|STARTED|Overall Study||16
8138570|NCT02723344|20061505|P1|STARTED|Overall Study||15
8138571|NCT02723201|20061528|P3|NOT COMPLETED|Fourth Intervention Period||0
8138572|NCT02723201|20061529|P2|NOT COMPLETED|Fourth Intervention Period||0
8138573|NCT02723201|20061530|P1|NOT COMPLETED|Fourth Intervention Period||0
8138574|NCT02723201|20061528|P3|COMPLETED|Fourth Intervention Period||0
8138575|NCT02723201|20061529|P2|COMPLETED|Fourth Intervention Period||0
8138576|NCT02723201|20061530|P1|COMPLETED|Fourth Intervention Period||9
8138577|NCT02723201|20061528|P3|STARTED|Fourth Intervention Period||0
8138578|NCT02723201|20061529|P2|STARTED|Fourth Intervention Period||0
8138579|NCT02723201|20061530|P1|STARTED|Fourth Intervention Period||9
8138580|NCT02723201|20061528|P3|NOT COMPLETED|Washout Period 3||0
8138581|NCT02723201|20061529|P2|NOT COMPLETED|Washout Period 3||0
8138582|NCT02723201|20061530|P1|NOT COMPLETED|Washout Period 3||0
8138583|NCT02723201|20061528|P3|COMPLETED|Washout Period 3||0
8138584|NCT02723201|20061529|P2|COMPLETED|Washout Period 3||0
8138585|NCT02723201|20061530|P1|COMPLETED|Washout Period 3||9
8138586|NCT02723201|20061528|P3|STARTED|Washout Period 3||0
8138587|NCT02723201|20061529|P2|STARTED|Washout Period 3||0
8138588|NCT02723201|20061530|P1|STARTED|Washout Period 3||9
8138589|NCT02723201|20061528|P3|NOT COMPLETED|Third Intervention Period||0
8138590|NCT02723201|20061529|P2|NOT COMPLETED|Third Intervention Period||0
8138591|NCT02723201|20061530|P1|NOT COMPLETED|Third Intervention Period||0
8138592|NCT02723201|20061528|P3|COMPLETED|Third Intervention Period||0
8138593|NCT02723201|20061529|P2|COMPLETED|Third Intervention Period||0
8138594|NCT02723201|20061530|P1|COMPLETED|Third Intervention Period||9
8138595|NCT02723201|20061528|P3|STARTED|Third Intervention Period||0
8138596|NCT02723201|20061529|P2|STARTED|Third Intervention Period||0
8138597|NCT02723201|20061530|P1|STARTED|Third Intervention Period||9
8138598|NCT02723201|20061528|P3|NOT COMPLETED|Washout Period 2||0
8138599|NCT02723201|20061529|P2|NOT COMPLETED|Washout Period 2||0
8138600|NCT02723201|20061530|P1|NOT COMPLETED|Washout Period 2||0
8138601|NCT02723201|20061528|P3|COMPLETED|Washout Period 2||0
8138602|NCT02723201|20061529|P2|COMPLETED|Washout Period 2||0
8138603|NCT02723201|20061530|P1|COMPLETED|Washout Period 2||9
8138604|NCT02723201|20061528|P3|STARTED|Washout Period 2||0
8138605|NCT02723201|20061529|P2|STARTED|Washout Period 2||0
8138606|NCT02723201|20061530|P1|STARTED|Washout Period 2||9
8138607|NCT02723201|20061528|P3|NOT COMPLETED|Second Intervention Period||0
8138608|NCT02723201|20061529|P2|NOT COMPLETED|Second Intervention Period||0
8138609|NCT02723201|20061530|P1|NOT COMPLETED|Second Intervention Period||2
8138610|NCT02723201|20061528|P3|COMPLETED|Second Intervention Period||7
8138611|NCT02723201|20061529|P2|COMPLETED|Second Intervention Period||7
8138612|NCT02723201|20061530|P1|COMPLETED|Second Intervention Period||9
8138613|NCT02723201|20061528|P3|STARTED|Second Intervention Period||7
8138614|NCT02723201|20061529|P2|STARTED|Second Intervention Period||7
8138615|NCT02723201|20061530|P1|STARTED|Second Intervention Period||11
8138616|NCT02723201|20061528|P3|NOT COMPLETED|Washout Period 1||0
8138617|NCT02723201|20061529|P2|NOT COMPLETED|Washout Period 1||0
8138618|NCT02723201|20061530|P1|NOT COMPLETED|Washout Period 1||0
8138619|NCT02723201|20061528|P3|COMPLETED|Washout Period 1||7
8138620|NCT02723201|20061529|P2|COMPLETED|Washout Period 1||7
8138621|NCT02723201|20061530|P1|COMPLETED|Washout Period 1||11
8138622|NCT02723201|20061528|P3|STARTED|Washout Period 1||7
8138623|NCT02723201|20061529|P2|STARTED|Washout Period 1||7
8138624|NCT02723201|20061530|P1|STARTED|Washout Period 1||11
8138625|NCT02723201|20061528|P3|NOT COMPLETED|First Intervention Period||0
8138626|NCT02723201|20061529|P2|NOT COMPLETED|First Intervention Period||0
8138627|NCT02723201|20061530|P1|NOT COMPLETED|First Intervention Period||0
8138628|NCT02723201|20061528|P3|COMPLETED|First Intervention Period||7
8138629|NCT02723201|20061529|P2|COMPLETED|First Intervention Period||7
8138630|NCT02723201|20061530|P1|COMPLETED|First Intervention Period||11
8138631|NCT02723201|20061528|P3|STARTED|First Intervention Period||7
8138632|NCT02723201|20061529|P2|STARTED|First Intervention Period||7
8138633|NCT02723201|20061530|P1|STARTED|First Intervention Period||11
8138634|NCT02723188|20061589|P3|NOT COMPLETED|Overall Study||0
8138635|NCT02723188|20061590|P2|NOT COMPLETED|Overall Study||0
8138636|NCT02723188|20061591|P1|NOT COMPLETED|Overall Study||1
8138637|NCT02723188|20061589|P3|COMPLETED|Overall Study||15
8138638|NCT02723188|20061590|P2|COMPLETED|Overall Study||15
8138639|NCT02723188|20061591|P1|COMPLETED|Overall Study||14
8138640|NCT02723188|20061589|P3|STARTED|Overall Study||15
8138641|NCT02723188|20061590|P2|STARTED|Overall Study||15
8138642|NCT02723188|20061591|P1|STARTED|Overall Study||15
8138643|NCT02723175|20061604|P2|NOT COMPLETED|Overall Study||3
8138644|NCT02723175|20061605|P1|NOT COMPLETED|Overall Study||4
8138645|NCT02723175|20061604|P2|COMPLETED|Overall Study||4
8138646|NCT02723175|20061605|P1|COMPLETED|Overall Study||4
8138647|NCT02723175|20061604|P2|STARTED|Overall Study||7
8138648|NCT02723175|20061605|P1|STARTED|Overall Study||8
8138649|NCT02723084|20061647|P2|NOT COMPLETED|Overall Study||1
8138650|NCT02723084|20061648|P1|NOT COMPLETED|Overall Study||4
8138651|NCT02723084|20061647|P2|COMPLETED|Overall Study||45
8138652|NCT02723084|20061648|P1|COMPLETED|Overall Study||86
8138653|NCT02723084|20061647|P2|STARTED|Overall Study||46
8138654|NCT02723084|20061648|P1|STARTED|Overall Study||90
8138655|NCT02722967|20061662|P3|NOT COMPLETED|Overall Study||4
8138656|NCT02722967|20061663|P2|NOT COMPLETED|Overall Study||2
8138657|NCT02722967|20061664|P1|NOT COMPLETED|Overall Study||5
8138658|NCT02722967|20061662|P3|COMPLETED|Overall Study||11
8138659|NCT02722967|20061663|P2|COMPLETED|Overall Study||10
8138660|NCT02722967|20061664|P1|COMPLETED|Overall Study||17
8138661|NCT02722967|20061662|P3|STARTED|Overall Study||15
8138662|NCT02722967|20061663|P2|STARTED|Overall Study||12
8138663|NCT02722967|20061664|P1|STARTED|Overall Study||22
8138664|NCT02722928|20061674|P2|NOT COMPLETED|Overall Study||20
8138665|NCT02722928|20061675|P1|NOT COMPLETED|Overall Study||10
8138666|NCT02722928|20061674|P2|COMPLETED|Overall Study||31
8138667|NCT02722928|20061675|P1|COMPLETED|Overall Study||39
8138668|NCT02722928|20061674|P2|STARTED|Overall Study||51
8138669|NCT02722928|20061675|P1|STARTED|Overall Study||49
8138670|NCT02722863|20061689|P1|NOT COMPLETED|Overall Study||0
8138671|NCT02722863|20061689|P1|COMPLETED|Overall Study||908
8138672|NCT02722863|20061689|P1|STARTED|Overall Study||908
8138673|NCT02722837|20061694|P1|NOT COMPLETED|Overall Study||0
8138674|NCT02722837|20061694|P1|COMPLETED|Overall Study||119
8138675|NCT02722837|20061694|P1|STARTED|Overall Study||119
8138676|NCT02722577|20061712|P1|NOT COMPLETED|Overall Study||0
8138677|NCT02722577|20061712|P1|COMPLETED|Overall Study||20
8138678|NCT02722577|20061712|P1|STARTED|Overall Study||20
8138679|NCT02722564|20061716|P1|NOT COMPLETED|Overall Study||0
8138680|NCT02722564|20061716|P1|COMPLETED|Overall Study||55
8138681|NCT02722564|20061716|P1|STARTED|Overall Study||55
8138682|NCT02722408|20061720|P1|NOT COMPLETED|Overall Study||0
8138683|NCT02722408|20061720|P1|COMPLETED|Overall Study||8
8138684|NCT02722408|20061720|P1|STARTED|Overall Study||8
8138685|NCT02722330|20061774|P1|NOT COMPLETED|Overall Study||0
8138686|NCT02722330|20061774|P1|COMPLETED|Overall Study||23
8138687|NCT02722330|20061774|P1|STARTED|Overall Study||23
8138688|NCT02722304|20061805|P5|NOT COMPLETED|Overall Study||2
8138689|NCT02722304|20061806|P4|NOT COMPLETED|Overall Study||2
8138690|NCT02722304|20061807|P3|NOT COMPLETED|Overall Study||2
8138691|NCT02722304|20061808|P2|NOT COMPLETED|Overall Study||0
8138692|NCT02722304|20061809|P1|NOT COMPLETED|Overall Study||1
8138693|NCT02722304|20061805|P5|COMPLETED|Overall Study||0
8138694|NCT02722304|20061806|P4|COMPLETED|Overall Study||0
8138695|NCT02722304|20061807|P3|COMPLETED|Overall Study||0
8138696|NCT02722304|20061808|P2|COMPLETED|Overall Study||0
8138697|NCT02722304|20061809|P1|COMPLETED|Overall Study||0
8138698|NCT02722304|20061805|P5|Treated|Overall Study||2
8138699|NCT02722304|20061806|P4|Treated|Overall Study||1
8138700|NCT02722304|20061807|P3|Treated|Overall Study||1
8138701|NCT02722304|20061808|P2|Treated|Overall Study||0
8138702|NCT02722304|20061809|P1|Treated|Overall Study||1
8138703|NCT02722304|20061805|P5|STARTED|Overall Study||2
8138704|NCT02722304|20061806|P4|STARTED|Overall Study||2
8138705|NCT02722304|20061807|P3|STARTED|Overall Study||2
8138706|NCT02722304|20061808|P2|STARTED|Overall Study||0
8138707|NCT02722304|20061809|P1|STARTED|Overall Study||1
8138708|NCT02722278|20061861|P2|NOT COMPLETED|Overall Study||7
8138709|NCT02722278|20061862|P1|NOT COMPLETED|Overall Study||12
8138710|NCT02722278|20061861|P2|COMPLETED|Overall Study||49
8138711|NCT02722278|20061862|P1|COMPLETED|Overall Study||154
8138712|NCT02722278|20061861|P2|STARTED|Overall Study||56
8138713|NCT02722278|20061862|P1|STARTED|Overall Study||166
8138714|NCT02722239|20061872|P2|NOT COMPLETED|Overall Study||0
8138715|NCT02722239|20061873|P1|NOT COMPLETED|Overall Study||0
8138716|NCT02722239|20061872|P2|COMPLETED|Overall Study||20
8138717|NCT02722239|20061873|P1|COMPLETED|Overall Study||20
8138718|NCT02722239|20061872|P2|Second Intervention (1 Day)|Overall Study||20
8138719|NCT02722239|20061873|P1|Second Intervention (1 Day)|Overall Study||20
8138720|NCT02722239|20061872|P2|Washout (7 Days)|Overall Study||20
8138721|NCT02722239|20061873|P1|Washout (7 Days)|Overall Study||20
8138722|NCT02722239|20061872|P2|First Intervention (1 Day)|Overall Study||20
8138723|NCT02722239|20061873|P1|First Intervention (1 Day)|Overall Study||20
8138724|NCT02722239|20061872|P2|STARTED|Overall Study||20
8138725|NCT02722239|20061873|P1|STARTED|Overall Study||20
8138726|NCT02722148|20061886|P1|NOT COMPLETED|Overall Study||5
8138727|NCT02722148|20061886|P1|COMPLETED|Overall Study||19
8138728|NCT02722148|20061886|P1|STARTED|Overall Study||24
8138729|NCT02722044|20061893|P1|NOT COMPLETED|Overall Study||5
8138730|NCT02722044|20061893|P1|COMPLETED|Overall Study||28
8138731|NCT02722044|20061893|P1|STARTED|Overall Study||33
8138732|NCT02721966|20061923|P5|NOT COMPLETED|Overall Study||5
8138733|NCT02721966|20061924|P4|NOT COMPLETED|Overall Study||7
8138734|NCT02721966|20061925|P3|NOT COMPLETED|Overall Study||9
8138735|NCT02721966|20061926|P2|NOT COMPLETED|Overall Study||23
8138736|NCT02721966|20061927|P1|NOT COMPLETED|Overall Study||29
8138737|NCT02721966|20061923|P5|COMPLETED|Overall Study||0
8138738|NCT02721966|20061924|P4|COMPLETED|Overall Study||73
8138739|NCT02721966|20061925|P3|COMPLETED|Overall Study||72
8138740|NCT02721966|20061926|P2|COMPLETED|Overall Study||142
8138741|NCT02721966|20061927|P1|COMPLETED|Overall Study||138
8138742|NCT02721966|20061923|P5|Completed Period 1 & Went to Period 2|Overall Study||0
8138743|NCT02721966|20061924|P4|Completed Period 1 & Went to Period 2|Overall Study||80
8138744|NCT02721966|20061925|P3|Completed Period 1 & Went to Period 2|Overall Study||81
8138745|NCT02721966|20061926|P2|Completed Period 1 & Went to Period 2|Overall Study||153
8138746|NCT02721966|20061927|P1|Completed Period 1 & Went to Period 2|Overall Study||162
8138747|NCT02721966|20061923|P5|STARTED|Overall Study||5
8138748|NCT02721966|20061924|P4|STARTED|Overall Study||80
8138749|NCT02721966|20061925|P3|STARTED|Overall Study||81
8138750|NCT02721966|20061926|P2|STARTED|Overall Study||165
8138751|NCT02721966|20061927|P1|STARTED|Overall Study||167
8138752|NCT02721875|20061967|P2|NOT COMPLETED|Overall Study||0
8138753|NCT02721875|20061968|P1|NOT COMPLETED|Overall Study||1
8138754|NCT02721875|20061967|P2|COMPLETED|Overall Study||0
8138755|NCT02721875|20061968|P1|COMPLETED|Overall Study||0
8138756|NCT02721875|20061967|P2|STARTED|Overall Study||0
8138757|NCT02721875|20061968|P1|STARTED|Overall Study||1
8138758|NCT02721641|20061981|P1|NOT COMPLETED|Overall Study||0
8138759|NCT02721641|20061981|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
8138760|NCT02721641|20061981|P1|STARTED|Overall Study||69
8138761|NCT02721277|20061987|P1|NOT COMPLETED|Overall Study||0
8138762|NCT02721277|20061987|P1|COMPLETED|Overall Study||2
8138763|NCT02721277|20061987|P1|STARTED|Overall Study||2
8138764|NCT02721147|20062019|P3|NOT COMPLETED|Overall Study||0
8138765|NCT02721147|20062020|P2|NOT COMPLETED|Overall Study||0
8138766|NCT02721147|20062021|P1|NOT COMPLETED|Overall Study||2
8138767|NCT02721147|20062019|P3|COMPLETED|Overall Study||31
8138768|NCT02721147|20062020|P2|COMPLETED|Overall Study||18
8138769|NCT02721147|20062021|P1|COMPLETED|Overall Study||38
8138770|NCT02721147|20062019|P3|STARTED|Overall Study||31
8138771|NCT02721147|20062020|P2|STARTED|Overall Study||18
8138772|NCT02721147|20062021|P1|STARTED|Overall Study||40
8138773|NCT02720952|20062056|P1|NOT COMPLETED|Overall Study||0
8138774|NCT02720952|20062056|P1|COMPLETED|Overall Study||24
8138775|NCT02720952|20062056|P1|STARTED|Overall Study||24
8138776|NCT02720757|20062065|P1|NOT COMPLETED|Overall Study||18
8138777|NCT02720757|20062065|P1|COMPLETED|Overall Study||114
8138778|NCT02720757|20062065|P1|STARTED|Overall Study||132
8138779|NCT02720627|20062074|P1|NOT COMPLETED|Overall Study||0
8138780|NCT02720627|20062074|P1|COMPLETED|Overall Study||27
8138781|NCT02720627|20062074|P1|STARTED|Overall Study||27
8138782|NCT02720536|20062079|P1|NOT COMPLETED|Overall Study||19
8138783|NCT02720536|20062079|P1|COMPLETED|Overall Study||34
8138784|NCT02720536|20062079|P1|STARTED|Overall Study||53
8138785|NCT02720523|20062114|P7|NOT COMPLETED|Period 2: Long-term Extension Period||60
8138786|NCT02720523|20062115|P6|NOT COMPLETED|Period 2: Long-term Extension Period||62
8138787|NCT02720523|20062116|P5|NOT COMPLETED|Period 2: Long-term Extension Period||65
8138788|NCT02720523|20062117|P4|NOT COMPLETED|Period 2: Long-term Extension Period||0
8138789|NCT02720523|20062118|P3|NOT COMPLETED|Period 2: Long-term Extension Period||0
8138790|NCT02720523|20062119|P2|NOT COMPLETED|Period 2: Long-term Extension Period||0
8138791|NCT02720523|20062120|P1|NOT COMPLETED|Period 2: Long-term Extension Period||0
8138792|NCT02720523|20062114|P7|COMPLETED|Period 2: Long-term Extension Period||0
8138793|NCT02720523|20062115|P6|COMPLETED|Period 2: Long-term Extension Period||0
8138794|NCT02720523|20062116|P5|COMPLETED|Period 2: Long-term Extension Period||0
8138795|NCT02720523|20062117|P4|COMPLETED|Period 2: Long-term Extension Period||0
8138796|NCT02720523|20062118|P3|COMPLETED|Period 2: Long-term Extension Period||0
8138797|NCT02720523|20062119|P2|COMPLETED|Period 2: Long-term Extension Period||0
8138798|NCT02720523|20062120|P1|COMPLETED|Period 2: Long-term Extension Period||0
8138799|NCT02720523|20062114|P7|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
8138800|NCT02720523|20062115|P6|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
8138801|NCT02720523|20062116|P5|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
8138802|NCT02720523|20062117|P4|STARTED|Period 2: Long-term Extension Period||0
8138803|NCT02720523|20062118|P3|STARTED|Period 2: Long-term Extension Period||0
8138804|NCT02720523|20062119|P2|STARTED|Period 2: Long-term Extension Period||0
8138805|NCT02720523|20062120|P1|STARTED|Period 2: Long-term Extension Period||0
8138806|NCT02720523|20062114|P7|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8138807|NCT02720523|20062115|P6|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8138808|NCT02720523|20062116|P5|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8138809|NCT02720523|20062117|P4|NOT COMPLETED|Period 1: Placebo-controlled Period||6
8138810|NCT02720523|20062118|P3|NOT COMPLETED|Period 1: Placebo-controlled Period||2
8138811|NCT02720523|20062119|P2|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8138812|NCT02720523|20062120|P1|NOT COMPLETED|Period 1: Placebo-controlled Period||2
8138813|NCT02720523|20062114|P7|COMPLETED|Period 1: Placebo-controlled Period||0
8138814|NCT02720523|20062115|P6|COMPLETED|Period 1: Placebo-controlled Period||0
8138815|NCT02720523|20062116|P5|COMPLETED|Period 1: Placebo-controlled Period||0
8138816|NCT02720523|20062117|P4|COMPLETED|Period 1: Placebo-controlled Period||44
8138817|NCT02720523|20062118|P3|COMPLETED|Period 1: Placebo-controlled Period||47
8138818|NCT02720523|20062119|P2|COMPLETED|Period 1: Placebo-controlled Period||49
8138819|NCT02720523|20062120|P1|COMPLETED|Period 1: Placebo-controlled Period||47
8138820|NCT02720523|20062114|P7|STARTED|Period 1: Placebo-controlled Period||0
8138821|NCT02720523|20062115|P6|STARTED|Period 1: Placebo-controlled Period||0
8138822|NCT02720523|20062116|P5|STARTED|Period 1: Placebo-controlled Period||0
8138823|NCT02720523|20062117|P4|STARTED|Period 1: Placebo-controlled Period||50
8138824|NCT02720523|20062118|P3|STARTED|Period 1: Placebo-controlled Period||49
8138825|NCT02720523|20062119|P2|STARTED|Period 1: Placebo-controlled Period||49
8138826|NCT02720523|20062120|P1|STARTED|Period 1: Placebo-controlled Period||49
8138827|NCT02720510|20062179|P2|NOT COMPLETED|Overall Study||3
8138828|NCT02720510|20062180|P1|NOT COMPLETED|Overall Study||3
8138829|NCT02720510|20062179|P2|COMPLETED|Overall Study||0
8138830|NCT02720510|20062180|P1|COMPLETED|Overall Study||0
8138831|NCT02720510|20062179|P2|STARTED|Overall Study||3
8138832|NCT02720510|20062180|P1|STARTED|Overall Study||3
8138833|NCT02720484|20062198|P1|NOT COMPLETED|Follow Up for 2 Years||6
8138834|NCT02720484|20062198|P1|COMPLETED|Follow Up for 2 Years||1
8138835|NCT02720484|20062198|P1|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
8138836|NCT02720484|20062198|P1|NOT COMPLETED|Treatment on Study||6
8138837|NCT02720484|20062198|P1|COMPLETED|Treatment on Study||4
8138838|NCT02720484|20062198|P1|Treated Cycle 3|Treatment on Study||4
8138839|NCT02720484|20062198|P1|Reached 1st Response/2 Cycles|Treatment on Study||7
8138840|NCT02720484|20062198|P1|STARTED|Treatment on Study||10
8138841|NCT02720224|20062206|P1|NOT COMPLETED|Overall Study||0
8138842|NCT02720224|20062206|P1|COMPLETED|Overall Study||6
8138843|NCT02720224|20062206|P1|STARTED|Overall Study||6
8138844|NCT02720198|20062230|P2|NOT COMPLETED|Overall Study||1
8138845|NCT02720198|20062231|P1|NOT COMPLETED|Overall Study||0
8138846|NCT02720198|20062230|P2|COMPLETED|Overall Study||30
8138847|NCT02720198|20062231|P1|COMPLETED|Overall Study||29
8138848|NCT02720198|20062230|P2|STARTED|Overall Study||31
8138849|NCT02720198|20062231|P1|STARTED|Overall Study||29
8138850|NCT02720107|20062257|P1|NOT COMPLETED|Overall Study||0
8138851|NCT02720107|20062257|P1|COMPLETED|Overall Study||130
8138852|NCT02720107|20062257|P1|STARTED|Overall Study||130
8138853|NCT02720081|20062266|P2|NOT COMPLETED|Overall Study||4
8138854|NCT02720081|20062267|P1|NOT COMPLETED|Overall Study||4
8138855|NCT02720081|20062266|P2|COMPLETED|Overall Study||66
8138856|NCT02720081|20062267|P1|COMPLETED|Overall Study||68
8138857|NCT02720081|20062266|P2|Treated|Overall Study||69
8138858|NCT02720081|20062267|P1|Treated|Overall Study||70
8138859|NCT02720081|20062266|P2|STARTED|Overall Study||70
8138860|NCT02720081|20062267|P1|STARTED|Overall Study||72
8138861|NCT02720042|20062323|P1|NOT COMPLETED|Overall Study||15
8138862|NCT02720042|20062323|P1|COMPLETED|Overall Study||69
8138863|NCT02720042|20062323|P1|STARTED|Overall Study||84
8138864|NCT02719938|20062340|P2|NOT COMPLETED|Overall Study||1
8138865|NCT02719938|20062341|P1|NOT COMPLETED|Overall Study||4
8138866|NCT02719938|20062340|P2|COMPLETED|Overall Study||31
8138867|NCT02719938|20062341|P1|COMPLETED|Overall Study||26
8138868|NCT02719938|20062340|P2|STARTED|Overall Study||32
8138869|NCT02719938|20062341|P1|STARTED|Overall Study||30
8138870|NCT02719743|20062364|P5|NOT COMPLETED|Overall Study||2
8138871|NCT02719743|20062365|P4|NOT COMPLETED|Overall Study||1
8138872|NCT02719743|20062366|P3|NOT COMPLETED|Overall Study||0
8138873|NCT02719743|20062367|P2|NOT COMPLETED|Overall Study||3
8138874|NCT02719743|20062368|P1|NOT COMPLETED|Overall Study||1
8138875|NCT02719743|20062364|P5|COMPLETED|Overall Study||33
8138876|NCT02719743|20062365|P4|COMPLETED|Overall Study||36
8138877|NCT02719743|20062366|P3|COMPLETED|Overall Study||38
8138878|NCT02719743|20062367|P2|COMPLETED|Overall Study||34
8138879|NCT02719743|20062368|P1|COMPLETED|Overall Study||37
8138880|NCT02719743|20062364|P5|STARTED|Overall Study||35
8138881|NCT02719743|20062365|P4|STARTED|Overall Study||37
8138882|NCT02719743|20062366|P3|STARTED|Overall Study||38
8138883|NCT02719743|20062367|P2|STARTED|Overall Study||37
8138884|NCT02719743|20062368|P1|STARTED|Overall Study||38
8138885|NCT02719639|20062495|P1|NOT COMPLETED|Overall Study||0
8138886|NCT02719639|20062495|P1|COMPLETED|Overall Study||7443
8138887|NCT02719639|20062495|P1|STARTED|Overall Study||7443
8138888|NCT02719535|20062504|P1|NOT COMPLETED|Overall Study||22
8138889|NCT02719535|20062504|P1|COMPLETED|Overall Study||37
8138890|NCT02719535|20062504|P1|STARTED|Overall Study||59
8138891|NCT02719522|20062509|P1|NOT COMPLETED|Overall Study||11
8138892|NCT02719522|20062509|P1|COMPLETED|Overall Study||193
8138893|NCT02719522|20062509|P1|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
8138894|NCT02719366|20062517|P2|NOT COMPLETED|Second Intervention||0
8138895|NCT02719366|20062518|P1|NOT COMPLETED|Second Intervention||0
8138896|NCT02719366|20062517|P2|COMPLETED|Second Intervention||6
8138897|NCT02719366|20062518|P1|COMPLETED|Second Intervention||6
8138898|NCT02719366|20062517|P2|STARTED|Second Intervention||6
8138899|NCT02719366|20062518|P1|STARTED|Second Intervention||6
8138900|NCT02719366|20062517|P2|NOT COMPLETED|First Intervention||0
8138901|NCT02719366|20062518|P1|NOT COMPLETED|First Intervention||0
8138902|NCT02719366|20062517|P2|COMPLETED|First Intervention||6
8138903|NCT02719366|20062518|P1|COMPLETED|First Intervention||6
8138904|NCT02719366|20062517|P2|STARTED|First Intervention||6
8138905|NCT02719366|20062518|P1|STARTED|First Intervention||6
8138906|NCT02719353|20062551|P2|NOT COMPLETED|Second Intervention||0
8138907|NCT02719353|20062552|P1|NOT COMPLETED|Second Intervention||0
8138908|NCT02719353|20062551|P2|COMPLETED|Second Intervention||6
8138909|NCT02719353|20062552|P1|COMPLETED|Second Intervention||7
8138910|NCT02719353|20062551|P2|STARTED|Second Intervention||6
8138911|NCT02719353|20062552|P1|STARTED|Second Intervention||7
8138912|NCT02719353|20062551|P2|NOT COMPLETED|First Intervention||1
8138913|NCT02719353|20062552|P1|NOT COMPLETED|First Intervention||0
8138914|NCT02719353|20062551|P2|COMPLETED|First Intervention||6
8138915|NCT02719353|20062552|P1|COMPLETED|First Intervention||7
8138916|NCT02719353|20062551|P2|STARTED|First Intervention||7
8138917|NCT02719353|20062552|P1|STARTED|First Intervention||7
8138918|NCT02719171|20062591|P5|NOT COMPLETED|Overall Study||2
8138919|NCT02719171|20062592|P4|NOT COMPLETED|Overall Study||2
8138920|NCT02719171|20062593|P3|NOT COMPLETED|Overall Study||3
8138921|NCT02719171|20062594|P2|NOT COMPLETED|Overall Study||4
8138922|NCT02719171|20062595|P1|NOT COMPLETED|Overall Study||1
8138923|NCT02719171|20062591|P5|COMPLETED|Overall Study||18
8138924|NCT02719171|20062592|P4|COMPLETED|Overall Study||37
8138925|NCT02719171|20062593|P3|COMPLETED|Overall Study||39
8138926|NCT02719171|20062594|P2|COMPLETED|Overall Study||38
8138927|NCT02719171|20062595|P1|COMPLETED|Overall Study||41
8138928|NCT02719171|20062591|P5|STARTED|Overall Study||20
8138929|NCT02719171|20062592|P4|STARTED|Overall Study||39
8138930|NCT02719171|20062593|P3|STARTED|Overall Study||42
8138931|NCT02719171|20062594|P2|STARTED|Overall Study||42
8138932|NCT02719171|20062595|P1|STARTED|Overall Study||42
8138933|NCT02719158|20062689|P3|NOT COMPLETED|Overall Study||1
8138934|NCT02719158|20062690|P2|NOT COMPLETED|Overall Study||0
8138935|NCT02719158|20062691|P1|NOT COMPLETED|Overall Study||0
8138936|NCT02719158|20062689|P3|COMPLETED|Overall Study||18
8138937|NCT02719158|20062690|P2|COMPLETED|Overall Study||38
8138938|NCT02719158|20062691|P1|COMPLETED|Overall Study||38
8138939|NCT02719158|20062689|P3|STARTED|Overall Study||19
8138940|NCT02719158|20062690|P2|STARTED|Overall Study||38
8138941|NCT02719158|20062691|P1|STARTED|Overall Study||38
8138942|NCT02719028|20062712|P4|NOT COMPLETED|Overall Study||10
8138943|NCT02719028|20062713|P3|NOT COMPLETED|Overall Study||6
8138944|NCT02719028|20062714|P2|NOT COMPLETED|Overall Study||2
8138945|NCT02719028|20062715|P1|NOT COMPLETED|Overall Study||2
8138946|NCT02719028|20062712|P4|COMPLETED|Overall Study||20
8138947|NCT02719028|20062713|P3|COMPLETED|Overall Study||24
8138948|NCT02719028|20062714|P2|COMPLETED|Overall Study||28
8138949|NCT02719028|20062715|P1|COMPLETED|Overall Study||28
8138950|NCT02719028|20062712|P4|STARTED|Overall Study||30
8138951|NCT02719028|20062713|P3|STARTED|Overall Study||30
8138952|NCT02719028|20062714|P2|STARTED|Overall Study||30
8138953|NCT02719028|20062715|P1|STARTED|Overall Study||30
8138954|NCT02718963|20062739|P2|NOT COMPLETED|Overall Study||1
8138955|NCT02718963|20062740|P1|NOT COMPLETED|Overall Study||1
8138956|NCT02718963|20062739|P2|COMPLETED|Overall Study||9
8138957|NCT02718963|20062740|P1|COMPLETED|Overall Study||9
8138958|NCT02718963|20062739|P2|STARTED|Overall Study||10
8138959|NCT02718963|20062740|P1|STARTED|Overall Study||10
8138960|NCT02718898|20062748|P7|NOT COMPLETED|Post Treatment Follow-up Period||5
8138961|NCT02718898|20062749|P6|NOT COMPLETED|Post Treatment Follow-up Period||11
8138962|NCT02718898|20062750|P5|NOT COMPLETED|Post Treatment Follow-up Period||1
8138963|NCT02718898|20062751|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
8138964|NCT02718898|20062752|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
8138965|NCT02718898|20062753|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
8138966|NCT02718898|20062754|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
8138967|NCT02718898|20062748|P7|COMPLETED|Post Treatment Follow-up Period||44
8138968|NCT02718898|20062749|P6|COMPLETED|Post Treatment Follow-up Period||67
8138969|NCT02718898|20062750|P5|COMPLETED|Post Treatment Follow-up Period||0
8138970|NCT02718898|20062751|P4|COMPLETED|Post Treatment Follow-up Period||0
8138971|NCT02718898|20062752|P3|COMPLETED|Post Treatment Follow-up Period||0
8138972|NCT02718898|20062753|P2|COMPLETED|Post Treatment Follow-up Period||0
8138973|NCT02718898|20062754|P1|COMPLETED|Post Treatment Follow-up Period||0
8138974|NCT02718898|20062748|P7|STARTED|Post Treatment Follow-up Period||49
8138975|NCT02718898|20062749|P6|STARTED|Post Treatment Follow-up Period||78
8138976|NCT02718898|20062750|P5|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
8138977|NCT02718898|20062751|P4|STARTED|Post Treatment Follow-up Period||0
8138978|NCT02718898|20062752|P3|STARTED|Post Treatment Follow-up Period||0
8138979|NCT02718898|20062753|P2|STARTED|Post Treatment Follow-up Period||0
8138980|NCT02718898|20062754|P1|STARTED|Post Treatment Follow-up Period||0
8138981|NCT02718898|20062748|P7|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138982|NCT02718898|20062749|P6|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138983|NCT02718898|20062750|P5|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138984|NCT02718898|20062751|P4|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
8138985|NCT02718898|20062752|P3|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
8138986|NCT02718898|20062753|P2|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138987|NCT02718898|20062754|P1|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138988|NCT02718898|20062748|P7|COMPLETED|Open Label Treatment Period (OLTP)||0
8138989|NCT02718898|20062749|P6|COMPLETED|Open Label Treatment Period (OLTP)||0
8138990|NCT02718898|20062750|P5|COMPLETED|Open Label Treatment Period (OLTP)||0
8138991|NCT02718898|20062751|P4|COMPLETED|Open Label Treatment Period (OLTP)||64
8138992|NCT02718898|20062752|P3|COMPLETED|Open Label Treatment Period (OLTP)||62
8138993|NCT02718898|20062753|P2|COMPLETED|Open Label Treatment Period (OLTP)||0
8138994|NCT02718898|20062754|P1|COMPLETED|Open Label Treatment Period (OLTP)||0
8138995|NCT02718898|20062748|P7|STARTED|Open Label Treatment Period (OLTP)||0
8138996|NCT02718898|20062749|P6|STARTED|Open Label Treatment Period (OLTP)||0
8138997|NCT02718898|20062750|P5|STARTED|Open Label Treatment Period (OLTP)||0
8138998|NCT02718898|20062751|P4|STARTED|Open Label Treatment Period (OLTP)||74
8138999|NCT02718898|20062752|P3|STARTED|Open Label Treatment Period (OLTP)||65
8139000|NCT02718898|20062753|P2|STARTED|Open Label Treatment Period (OLTP)||0
8139001|NCT02718898|20062754|P1|STARTED|Open Label Treatment Period (OLTP)||0
8139002|NCT02718898|20062748|P7|NOT COMPLETED|Blinded Treatment Period||0
8139003|NCT02718898|20062749|P6|NOT COMPLETED|Blinded Treatment Period||0
8139004|NCT02718898|20062750|P5|NOT COMPLETED|Blinded Treatment Period||0
8139005|NCT02718898|20062751|P4|NOT COMPLETED|Blinded Treatment Period||0
8139006|NCT02718898|20062752|P3|NOT COMPLETED|Blinded Treatment Period||0
8139007|NCT02718898|20062753|P2|NOT COMPLETED|Blinded Treatment Period||1
8139008|NCT02718898|20062754|P1|NOT COMPLETED|Blinded Treatment Period||9
8139009|NCT02718898|20062748|P7|COMPLETED|Blinded Treatment Period||0
8139010|NCT02718898|20062749|P6|COMPLETED|Blinded Treatment Period||0
8139011|NCT02718898|20062750|P5|COMPLETED|Blinded Treatment Period||0
8139012|NCT02718898|20062751|P4|COMPLETED|Blinded Treatment Period||0
8139013|NCT02718898|20062752|P3|COMPLETED|Blinded Treatment Period||0
8139014|NCT02718898|20062753|P2|COMPLETED|Blinded Treatment Period||74
8139015|NCT02718898|20062754|P1|COMPLETED|Blinded Treatment Period||65
8139016|NCT02718898|20062748|P7|STARTED|Blinded Treatment Period||0
8139017|NCT02718898|20062749|P6|STARTED|Blinded Treatment Period||0
8139018|NCT02718898|20062750|P5|STARTED|Blinded Treatment Period||0
8139019|NCT02718898|20062751|P4|STARTED|Blinded Treatment Period||0
8139020|NCT02718898|20062752|P3|STARTED|Blinded Treatment Period||0
8139021|NCT02718898|20062753|P2|STARTED|Blinded Treatment Period||75
8139022|NCT02718898|20062754|P1|STARTED|Blinded Treatment Period||74
8139023|NCT02718625|20062789|P2|NOT COMPLETED|Overall Study||2
8139024|NCT02718625|20062790|P1|NOT COMPLETED|Overall Study||0
8139025|NCT02718625|20062789|P2|COMPLETED|Overall Study||0
8139026|NCT02718625|20062790|P1|COMPLETED|Overall Study||1
8139027|NCT02718625|20062789|P2|STARTED|Overall Study||2
8139028|NCT02718625|20062790|P1|STARTED|Overall Study||1
8139029|NCT02718417|20062809|P3|NOT COMPLETED|Long-term Follow-up Phase||135
8139030|NCT02718417|20062810|P2|NOT COMPLETED|Long-term Follow-up Phase||112
8139031|NCT02718417|20062811|P1|NOT COMPLETED|Long-term Follow-up Phase||139
8139032|NCT02718417|20062809|P3|COMPLETED|Long-term Follow-up Phase||0
8139033|NCT02718417|20062810|P2|COMPLETED|Long-term Follow-up Phase||0
8139034|NCT02718417|20062811|P1|COMPLETED|Long-term Follow-up Phase||0
8139035|NCT02718417|20062809|P3|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
8139036|NCT02718417|20062810|P2|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
8139037|NCT02718417|20062811|P1|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
8139038|NCT02718417|20062809|P3|NOT COMPLETED|Follow-up Phase||19
8139039|NCT02718417|20062810|P2|NOT COMPLETED|Follow-up Phase||172
8139040|NCT02718417|20062811|P1|NOT COMPLETED|Follow-up Phase||135
8139041|NCT02718417|20062809|P3|COMPLETED|Follow-up Phase||20
8139042|NCT02718417|20062810|P2|COMPLETED|Follow-up Phase||91
8139043|NCT02718417|20062811|P1|COMPLETED|Follow-up Phase||103
8139044|NCT02718417|20062809|P3|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
8139045|NCT02718417|20062810|P2|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
8139046|NCT02718417|20062811|P1|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
8139047|NCT02718417|20062809|P3|NOT COMPLETED|Observation Phase (OP)||282
8139048|NCT02718417|20062810|P2|NOT COMPLETED|Observation Phase (OP)||0
8139049|NCT02718417|20062811|P1|NOT COMPLETED|Observation Phase (OP)||0
8139050|NCT02718417|20062809|P3|COMPLETED|Observation Phase (OP)||2
8139051|NCT02718417|20062810|P2|COMPLETED|Observation Phase (OP)||0
8139052|NCT02718417|20062811|P1|COMPLETED|Observation Phase (OP)||0
8139053|NCT02718417|20062809|P3|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
8139054|NCT02718417|20062810|P2|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
8139055|NCT02718417|20062811|P1|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
8139056|NCT02718417|20062809|P3|NOT COMPLETED|Maintenance Phase (MP)||0
8139057|NCT02718417|20062810|P2|NOT COMPLETED|Maintenance Phase (MP)||287
8139058|NCT02718417|20062811|P1|NOT COMPLETED|Maintenance Phase (MP)||266
8139059|NCT02718417|20062809|P3|COMPLETED|Maintenance Phase (MP)||0
8139060|NCT02718417|20062810|P2|COMPLETED|Maintenance Phase (MP)||1
8139061|NCT02718417|20062811|P1|COMPLETED|Maintenance Phase (MP)||1
8139062|NCT02718417|20062809|P3|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
8139063|NCT02718417|20062810|P2|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
8139064|NCT02718417|20062811|P1|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
8139065|NCT02718417|20062809|P3|NOT COMPLETED|Chemotherapy Phase (CP)||46
8139066|NCT02718417|20062810|P2|NOT COMPLETED|Chemotherapy Phase (CP)||37
8139067|NCT02718417|20062811|P1|NOT COMPLETED|Chemotherapy Phase (CP)||52
8139068|NCT02718417|20062809|P3|COMPLETED|Chemotherapy Phase (CP)||289
8139069|NCT02718417|20062810|P2|COMPLETED|Chemotherapy Phase (CP)||294
8139070|NCT02718417|20062811|P1|COMPLETED|Chemotherapy Phase (CP)||280
8139071|NCT02718417|20062809|P3|Safety Population|Chemotherapy Phase (CP)||334
8139072|NCT02718417|20062810|P2|Safety Population|Chemotherapy Phase (CP)||329
8139073|NCT02718417|20062811|P1|Safety Population|Chemotherapy Phase (CP)||328
8139074|NCT02718417|20062809|P3|STARTED|Chemotherapy Phase (CP)||335
8139075|NCT02718417|20062810|P2|STARTED|Chemotherapy Phase (CP)||331
8139076|NCT02718417|20062811|P1|STARTED|Chemotherapy Phase (CP)||332
8139077|NCT02718326|20062917|P3|NOT COMPLETED|Overall Study||22
8139078|NCT02718326|20062918|P2|NOT COMPLETED|Overall Study||24
8139079|NCT02718326|20062919|P1|NOT COMPLETED|Overall Study||36
8139080|NCT02718326|20062917|P3|COMPLETED|Overall Study||112
8139081|NCT02718326|20062918|P2|COMPLETED|Overall Study||111
8139082|NCT02718326|20062919|P1|COMPLETED|Overall Study||97
8139083|NCT02718326|20062917|P3|Completed Week 52|Overall Study||124
8139084|NCT02718326|20062918|P2|Completed Week 52|Overall Study||122
8139085|NCT02718326|20062919|P1|Completed Week 52|Overall Study||109
8139086|NCT02718326|20062917|P3|STARTED|Overall Study||134
8139087|NCT02718326|20062918|P2|STARTED|Overall Study||135
8139088|NCT02718326|20062919|P1|STARTED|Overall Study||133
8139089|NCT02718248|20062950|P1|NOT COMPLETED|Overall Study||0
8139090|NCT02718248|20062950|P1|COMPLETED|Overall Study||7
8139091|NCT02718248|20062950|P1|STARTED|Overall Study||7
8139092|NCT02718157|20062966|P1|NOT COMPLETED|Overall Study||162
8139093|NCT02718157|20062966|P1|COMPLETED|Overall Study||609
8139094|NCT02718157|20062966|P1|STARTED|Overall Study||771
8139095|NCT02718118|20062975|P2|NOT COMPLETED|Overall Study||1
8139096|NCT02718118|20062976|P1|NOT COMPLETED|Overall Study||2
8139097|NCT02718118|20062975|P2|COMPLETED|Overall Study||29
8139098|NCT02718118|20062976|P1|COMPLETED|Overall Study||28
8139099|NCT02718118|20062975|P2|STARTED|Overall Study||30
8139100|NCT02718118|20062976|P1|STARTED|Overall Study||30
8139101|NCT02718040|20063010|P1|NOT COMPLETED|Overall Study||0
8139102|NCT02718040|20063010|P1|COMPLETED|Overall Study||30
8139103|NCT02718040|20063010|P1|STARTED|Overall Study||30
8139104|NCT02717949|20063025|P2|NOT COMPLETED|Overall Study||0
8139105|NCT02717949|20063026|P1|NOT COMPLETED|Overall Study||0
8139106|NCT02717949|20063025|P2|COMPLETED|Overall Study||0
8139107|NCT02717949|20063026|P1|COMPLETED|Overall Study||0
8139108|NCT02717949|20063025|P2|STARTED|Overall Study||0
8139109|NCT02717949|20063026|P1|STARTED|Overall Study||0
8139110|NCT02717754|20063040|P6|NOT COMPLETED|Overall Study||20
8139111|NCT02717754|20063041|P5|NOT COMPLETED|Overall Study||20
8139112|NCT02717754|20063042|P4|NOT COMPLETED|Overall Study||10
8139113|NCT02717754|20063043|P3|NOT COMPLETED|Overall Study||0
8139114|NCT02717754|20063044|P2|NOT COMPLETED|Overall Study||0
8139115|NCT02717754|20063045|P1|NOT COMPLETED|Overall Study||0
8139116|NCT02717754|20063040|P6|COMPLETED|Overall Study||0
8139117|NCT02717754|20063041|P5|COMPLETED|Overall Study||0
8139118|NCT02717754|20063042|P4|COMPLETED|Overall Study||0
8139119|NCT02717754|20063043|P3|COMPLETED|Overall Study||20
8139120|NCT02717754|20063044|P2|COMPLETED|Overall Study||19
8139121|NCT02717754|20063045|P1|COMPLETED|Overall Study||10
8139122|NCT02717754|20063040|P6|STARTED|Overall Study||20
8139123|NCT02717754|20063041|P5|STARTED|Overall Study||20
8139124|NCT02717754|20063042|P4|STARTED|Overall Study||10
8139125|NCT02717754|20063043|P3|STARTED|Overall Study||20
8139126|NCT02717754|20063044|P2|STARTED|Overall Study||19
8139127|NCT02717754|20063045|P1|STARTED|Overall Study||10
8139128|NCT02717494|20063076|P3|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
8139129|NCT02717494|20063077|P2|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139130|NCT02717494|20063078|P1|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139131|NCT02717494|20063076|P3|COMPLETED|Second Intervention (Step 2 or Step 3)||106
8139132|NCT02717494|20063077|P2|COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139133|NCT02717494|20063078|P1|COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139134|NCT02717494|20063076|P3|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
8139135|NCT02717494|20063077|P2|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
8139136|NCT02717494|20063078|P1|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
8139137|NCT02717494|20063076|P3|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
8139138|NCT02717494|20063077|P2|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
8139139|NCT02717494|20063078|P1|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
8139140|NCT02717494|20063076|P3|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
8139141|NCT02717494|20063077|P2|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
8139142|NCT02717494|20063078|P1|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
8139143|NCT02717494|20063076|P3|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
8139144|NCT02717494|20063077|P2|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
8139145|NCT02717494|20063078|P1|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
8139146|NCT02717494|20063076|P3|NOT COMPLETED|First Intervention (Step 1)||5
8139147|NCT02717494|20063077|P2|NOT COMPLETED|First Intervention (Step 1)||7
8139148|NCT02717494|20063078|P1|NOT COMPLETED|First Intervention (Step 1)||6
8139149|NCT02717494|20063076|P3|COMPLETED|First Intervention (Step 1)||111
8139150|NCT02717494|20063077|P2|COMPLETED|First Intervention (Step 1)||108
8139151|NCT02717494|20063078|P1|COMPLETED|First Intervention (Step 1)||109
8139152|NCT02717494|20063076|P3|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
8139153|NCT02717494|20063077|P2|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
8139154|NCT02717494|20063078|P1|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
8139155|NCT02717494|20063076|P3|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
8139156|NCT02717494|20063077|P2|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
8139157|NCT02717494|20063078|P1|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
8139158|NCT02717494|20063076|P3|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
8139159|NCT02717494|20063077|P2|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
8139160|NCT02717494|20063078|P1|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
8139161|NCT02717494|20063076|P3|STARTED|First Intervention (Step 1)||116
8139162|NCT02717494|20063077|P2|STARTED|First Intervention (Step 1)||115
8139163|NCT02717494|20063078|P1|STARTED|First Intervention (Step 1)||115
8139164|NCT02717273|20063117|P2|NOT COMPLETED|Overall Study||2
8139165|NCT02717273|20063118|P1|NOT COMPLETED|Overall Study||3
8139166|NCT02717273|20063117|P2|COMPLETED|Overall Study||48
8139167|NCT02717273|20063118|P1|COMPLETED|Overall Study||49
8139168|NCT02717273|20063117|P2|STARTED|Overall Study||50
8139169|NCT02717273|20063118|P1|STARTED|Overall Study||52
8139170|NCT02717195|20063140|P5|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
8139171|NCT02717195|20063141|P4|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
8139172|NCT02717195|20063142|P3|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
8139173|NCT02717195|20063143|P2|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
8139174|NCT02717195|20063144|P1|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
8139175|NCT02717195|20063140|P5|COMPLETED|Double-blind Treatment (DBT) Period||200
8139176|NCT02717195|20063141|P4|COMPLETED|Double-blind Treatment (DBT) Period||188
8139177|NCT02717195|20063142|P3|COMPLETED|Double-blind Treatment (DBT) Period||198
8139178|NCT02717195|20063143|P2|COMPLETED|Double-blind Treatment (DBT) Period||0
8139179|NCT02717195|20063144|P1|COMPLETED|Double-blind Treatment (DBT) Period||0
8139180|NCT02717195|20063140|P5|STARTED|Double-blind Treatment (DBT) Period||230
8139181|NCT02717195|20063141|P4|STARTED|Double-blind Treatment (DBT) Period||232
8139182|NCT02717195|20063142|P3|STARTED|Double-blind Treatment (DBT) Period||235
8139183|NCT02717195|20063143|P2|STARTED|Double-blind Treatment (DBT) Period||0
8139184|NCT02717195|20063144|P1|STARTED|Double-blind Treatment (DBT) Period||0
8139185|NCT02717195|20063140|P5|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8139186|NCT02717195|20063141|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8139187|NCT02717195|20063142|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8139188|NCT02717195|20063143|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||111
8139189|NCT02717195|20063144|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||290
8139190|NCT02717195|20063140|P5|COMPLETED|Prospective Confirmation (PC) Period||0
8139191|NCT02717195|20063141|P4|COMPLETED|Prospective Confirmation (PC) Period||0
8139192|NCT02717195|20063142|P3|COMPLETED|Prospective Confirmation (PC) Period||0
8139193|NCT02717195|20063143|P2|COMPLETED|Prospective Confirmation (PC) Period||276
8139194|NCT02717195|20063144|P1|COMPLETED|Prospective Confirmation (PC) Period||421
8139195|NCT02717195|20063140|P5|STARTED|Prospective Confirmation (PC) Period||0
8139196|NCT02717195|20063141|P4|STARTED|Prospective Confirmation (PC) Period||0
8139197|NCT02717195|20063142|P3|STARTED|Prospective Confirmation (PC) Period||0
8139198|NCT02717195|20063143|P2|STARTED|Prospective Confirmation (PC) Period||387
8139199|NCT02717195|20063144|P1|STARTED|Prospective Confirmation (PC) Period||711
8139200|NCT02717130|20063175|P1|NOT COMPLETED|Overall Study||7
8139201|NCT02717130|20063175|P1|COMPLETED|Overall Study||1
8139202|NCT02717130|20063175|P1|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
8139203|NCT02716987|20063185|P6|NOT COMPLETED|Overall Study||1
8139204|NCT02716987|20063186|P5|NOT COMPLETED|Overall Study||1
8139205|NCT02716987|20063187|P4|NOT COMPLETED|Overall Study||0
8139206|NCT02716987|20063188|P3|NOT COMPLETED|Overall Study||1
8139207|NCT02716987|20063189|P2|NOT COMPLETED|Overall Study||0
8139208|NCT02716987|20063190|P1|NOT COMPLETED|Overall Study||0
8139209|NCT02716987|20063185|P6|COMPLETED|Overall Study||0
8139210|NCT02716987|20063186|P5|COMPLETED|Overall Study||5
8139211|NCT02716987|20063187|P4|COMPLETED|Overall Study||2
8139212|NCT02716987|20063188|P3|COMPLETED|Overall Study||4
8139213|NCT02716987|20063189|P2|COMPLETED|Overall Study||2
8139214|NCT02716987|20063190|P1|COMPLETED|Overall Study||4
8139215|NCT02716987|20063185|P6|STARTED|Overall Study||1
8139216|NCT02716987|20063186|P5|STARTED|Overall Study||6
8139217|NCT02716987|20063187|P4|STARTED|Overall Study||2
8139218|NCT02716987|20063188|P3|STARTED|Overall Study||5
8139219|NCT02716987|20063189|P2|STARTED|Overall Study||2
8139220|NCT02716987|20063190|P1|STARTED|Overall Study||4
8139221|NCT02716896|20063256|P2|NOT COMPLETED|Overall Study||1
8139222|NCT02716896|20063257|P1|NOT COMPLETED|Overall Study||0
8139223|NCT02716896|20063256|P2|COMPLETED|Overall Study||0
8139224|NCT02716896|20063257|P1|COMPLETED|Overall Study||1
8139225|NCT02716896|20063256|P2|STARTED|Overall Study||1
8139226|NCT02716896|20063257|P1|STARTED|Overall Study||1
8139227|NCT02716818|20063277|P2|NOT COMPLETED|Overall Study||2
8139228|NCT02716818|20063278|P1|NOT COMPLETED|Overall Study||3
8139229|NCT02716818|20063277|P2|COMPLETED|Overall Study||59
8139230|NCT02716818|20063278|P1|COMPLETED|Overall Study||58
8139231|NCT02716818|20063277|P2|STARTED|Overall Study||61
8139232|NCT02716818|20063278|P1|STARTED|Overall Study||61
8139233|NCT02716805|20063308|P4|NOT COMPLETED|Overall Study||0
8139234|NCT02716805|20063309|P3|NOT COMPLETED|Overall Study||0
8139235|NCT02716805|20063310|P2|NOT COMPLETED|Overall Study||0
8139236|NCT02716805|20063311|P1|NOT COMPLETED|Overall Study||2
8139237|NCT02716805|20063308|P4|COMPLETED|Overall Study||0
8139238|NCT02716805|20063309|P3|COMPLETED|Overall Study||0
8139239|NCT02716805|20063310|P2|COMPLETED|Overall Study||0
8139240|NCT02716805|20063311|P1|COMPLETED|Overall Study||4
8139241|NCT02716805|20063308|P4|STARTED|Overall Study||0
8139242|NCT02716805|20063309|P3|STARTED|Overall Study||0
8139243|NCT02716805|20063310|P2|STARTED|Overall Study||0
8139244|NCT02716805|20063311|P1|STARTED|Overall Study||6
8139245|NCT02716779|20063319|P3|NOT COMPLETED|Combination Therapy||1
8139246|NCT02716779|20063320|P2|NOT COMPLETED|Combination Therapy||2
8139247|NCT02716779|20063321|P1|NOT COMPLETED|Combination Therapy||0
8139248|NCT02716779|20063319|P3|COMPLETED|Combination Therapy||25
8139249|NCT02716779|20063320|P2|COMPLETED|Combination Therapy||23
8139250|NCT02716779|20063321|P1|COMPLETED|Combination Therapy||14
8139251|NCT02716779|20063319|P3|STARTED|Combination Therapy||26
8139252|NCT02716779|20063320|P2|STARTED|Combination Therapy||25
8139253|NCT02716779|20063321|P1|STARTED|Combination Therapy||14
8139254|NCT02716779|20063319|P3|NOT COMPLETED|Monotherapy||1
8139255|NCT02716779|20063320|P2|NOT COMPLETED|Monotherapy||1
8139256|NCT02716779|20063321|P1|NOT COMPLETED|Monotherapy||0
8139257|NCT02716779|20063319|P3|COMPLETED|Monotherapy||26
8139258|NCT02716779|20063320|P2|COMPLETED|Monotherapy||25
8139259|NCT02716779|20063321|P1|COMPLETED|Monotherapy||14
8139260|NCT02716779|20063319|P3|STARTED|Monotherapy||27
8139261|NCT02716779|20063320|P2|STARTED|Monotherapy||26
8139262|NCT02716779|20063321|P1|STARTED|Monotherapy||14
8139263|NCT02716727|20063367|P2|NOT COMPLETED|Overall Study||0
8139264|NCT02716727|20063368|P1|NOT COMPLETED|Overall Study||0
8139265|NCT02716727|20063367|P2|COMPLETED|Overall Study||9
8139266|NCT02716727|20063368|P1|COMPLETED|Overall Study||7
8139267|NCT02716727|20063367|P2|STARTED|Overall Study||9
8139268|NCT02716727|20063368|P1|STARTED|Overall Study||7
8139269|NCT02716714|20063392|P2|NOT COMPLETED|Overall Study||2
8139270|NCT02716714|20063393|P1|NOT COMPLETED|Overall Study||12
8139271|NCT02716714|20063392|P2|COMPLETED|Overall Study||8
8139272|NCT02716714|20063393|P1|COMPLETED|Overall Study||55
8139273|NCT02716714|20063392|P2|STARTED|Overall Study||10
8139274|NCT02716714|20063393|P1|STARTED|Overall Study||67
8139275|NCT02716584|20063421|P2|NOT COMPLETED|Overall Study||5
8139276|NCT02716584|20063422|P1|NOT COMPLETED|Overall Study||8
8139277|NCT02716584|20063421|P2|COMPLETED|Overall Study||13
8139278|NCT02716584|20063422|P1|COMPLETED|Overall Study||27
8139279|NCT02716584|20063421|P2|STARTED|Overall Study||18
8139280|NCT02716584|20063422|P1|STARTED|Overall Study||35
8139281|NCT02716506|20063446|P1|NOT COMPLETED|Overall Study||1164
8139282|NCT02716506|20063446|P1|COMPLETED|Overall Study||2351
8139283|NCT02716506|20063446|P1|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
8139284|NCT02716506|20063446|P1|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
8139285|NCT02716506|20063446|P1|STARTED|Overall Study||3515
8139286|NCT02716324|20063453|P2|NOT COMPLETED|Overall Study||11
8139287|NCT02716324|20063454|P1|NOT COMPLETED|Overall Study||19
8139288|NCT02716324|20063453|P2|COMPLETED|Overall Study||143
8139289|NCT02716324|20063454|P1|COMPLETED|Overall Study||130
8139290|NCT02716324|20063453|P2|STARTED|Overall Study||154
8139291|NCT02716324|20063454|P1|STARTED|Overall Study||149
8139292|NCT02716298|20063478|P2|NOT COMPLETED|Second Intervention (1 Month)||0
8139293|NCT02716298|20063479|P1|NOT COMPLETED|Second Intervention (1 Month)||0
8139294|NCT02716298|20063478|P2|COMPLETED|Second Intervention (1 Month)||23
8139295|NCT02716298|20063479|P1|COMPLETED|Second Intervention (1 Month)||24
8139296|NCT02716298|20063478|P2|STARTED|Second Intervention (1 Month)||23
8139297|NCT02716298|20063479|P1|STARTED|Second Intervention (1 Month)||24
8139298|NCT02716298|20063478|P2|NOT COMPLETED|First Intervention (1 Month)||1
8139299|NCT02716298|20063479|P1|NOT COMPLETED|First Intervention (1 Month)||1
8139300|NCT02716298|20063478|P2|COMPLETED|First Intervention (1 Month)||23
8139301|NCT02716298|20063479|P1|COMPLETED|First Intervention (1 Month)||24
8139302|NCT02716298|20063478|P2|STARTED|First Intervention (1 Month)||24
8139303|NCT02716298|20063479|P1|STARTED|First Intervention (1 Month)||25
8139304|NCT02716194|20063497|P3|NOT COMPLETED|Period 2 - BAX 826||0
8139305|NCT02716194|20063498|P2|NOT COMPLETED|Period 2 - BAX 826||0
8139306|NCT02716194|20063499|P1|NOT COMPLETED|Period 2 - BAX 826||0
8139307|NCT02716194|20063497|P3|COMPLETED|Period 2 - BAX 826||13
8139308|NCT02716194|20063498|P2|COMPLETED|Period 2 - BAX 826||15
8139309|NCT02716194|20063499|P1|COMPLETED|Period 2 - BAX 826||10
8139310|NCT02716194|20063497|P3|STARTED|Period 2 - BAX 826||13
8139311|NCT02716194|20063498|P2|STARTED|Period 2 - BAX 826||15
8139312|NCT02716194|20063499|P1|STARTED|Period 2 - BAX 826||10
8139313|NCT02716194|20063497|P3|NOT COMPLETED|Period 1 - ADVATE||0
8139314|NCT02716194|20063498|P2|NOT COMPLETED|Period 1 - ADVATE||1
8139315|NCT02716194|20063499|P1|NOT COMPLETED|Period 1 - ADVATE||1
8139316|NCT02716194|20063497|P3|COMPLETED|Period 1 - ADVATE||13
8139317|NCT02716194|20063498|P2|COMPLETED|Period 1 - ADVATE||15
8139318|NCT02716194|20063499|P1|COMPLETED|Period 1 - ADVATE||10
8139319|NCT02716194|20063497|P3|STARTED|Period 1 - ADVATE||13
8139320|NCT02716194|20063498|P2|STARTED|Period 1 - ADVATE||16
8139321|NCT02716194|20063499|P1|STARTED|Period 1 - ADVATE||11
8139322|NCT02715804|20063579|P2|NOT COMPLETED|Overall Study||113
8139323|NCT02715804|20063580|P1|NOT COMPLETED|Overall Study||229
8139324|NCT02715804|20063579|P2|COMPLETED|Overall Study||52
8139325|NCT02715804|20063580|P1|COMPLETED|Overall Study||98
8139326|NCT02715804|20063579|P2|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
8139327|NCT02715804|20063580|P1|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
8139328|NCT02715804|20063579|P2|Received at Least 1 Dose of Study Drug|Overall Study||158
8139329|NCT02715804|20063580|P1|Received at Least 1 Dose of Study Drug|Overall Study||323
8139330|NCT02715804|20063579|P2|STARTED|Overall Study||165
8139331|NCT02715804|20063580|P1|STARTED|Overall Study||327
8139332|NCT02715765|20063603|P3|NOT COMPLETED|Overall Study||0
8139333|NCT02715765|20063604|P2|NOT COMPLETED|Overall Study||0
8139334|NCT02715765|20063605|P1|NOT COMPLETED|Overall Study||3
8139335|NCT02715765|20063603|P3|COMPLETED|Overall Study||0
8139336|NCT02715765|20063604|P2|COMPLETED|Overall Study||0
8139337|NCT02715765|20063605|P1|COMPLETED|Overall Study||0
8139338|NCT02715765|20063603|P3|STARTED|Overall Study||0
8139339|NCT02715765|20063604|P2|STARTED|Overall Study||0
8139340|NCT02715765|20063605|P1|STARTED|Overall Study||3
8139341|NCT02715726|20063618|P2|NOT COMPLETED|Overall Study||27
8139342|NCT02715726|20063619|P1|NOT COMPLETED|Overall Study||18
8139343|NCT02715726|20063618|P2|COMPLETED|Overall Study||380
8139344|NCT02715726|20063619|P1|COMPLETED|Overall Study||190
8139345|NCT02715726|20063618|P2|Safety Population|Overall Study||406
8139346|NCT02715726|20063619|P1|Safety Population|Overall Study||206
8139347|NCT02715726|20063618|P2|Treated|Overall Study||405
8139348|NCT02715726|20063619|P1|Treated|Overall Study||207
8139349|NCT02715726|20063618|P2|STARTED|Overall Study|Randomized|407
8139350|NCT02715726|20063619|P1|STARTED|Overall Study|Randomized|208
8139351|NCT02715700|20063667|P1|NOT COMPLETED|Overall Study||0
8139352|NCT02715700|20063667|P1|COMPLETED|Overall Study||14
8139353|NCT02715700|20063667|P1|STARTED|Overall Study||14
8139354|NCT02714868|20063699|P2|NOT COMPLETED|Overall Study||0
8139355|NCT02714868|20063700|P1|NOT COMPLETED|Overall Study||5
8139356|NCT02714868|20063699|P2|COMPLETED|Overall Study||35
8139357|NCT02714868|20063700|P1|COMPLETED|Overall Study||42
8139358|NCT02714868|20063699|P2|STARTED|Overall Study||35
8139359|NCT02714868|20063700|P1|STARTED|Overall Study||47
8139360|NCT02714595|20063718|P2|NOT COMPLETED|Overall Study||13
8139361|NCT02714595|20063719|P1|NOT COMPLETED|Overall Study||32
8139362|NCT02714595|20063718|P2|COMPLETED|Overall Study||38
8139363|NCT02714595|20063719|P1|COMPLETED|Overall Study||69
8139364|NCT02714595|20063718|P2|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
8139365|NCT02714595|20063719|P1|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
8139366|NCT02714595|20063718|P2|Received Treatment|Overall Study||49
8139367|NCT02714595|20063719|P1|Received Treatment|Overall Study||101
8139368|NCT02714595|20063718|P2|STARTED|Overall Study||51
8139369|NCT02714595|20063719|P1|STARTED|Overall Study||101
8139370|NCT02714504|20063967|P2|NOT COMPLETED|Overall Study||0
8139371|NCT02714504|20063968|P1|NOT COMPLETED|Overall Study||0
8139372|NCT02714504|20063967|P2|COMPLETED|Overall Study||178
8139373|NCT02714504|20063968|P1|COMPLETED|Overall Study||61
8139374|NCT02714504|20063967|P2|STARTED|Overall Study||178
8139375|NCT02714504|20063968|P1|STARTED|Overall Study||61
8139376|NCT02714426|20063976|P2|NOT COMPLETED|Overall Study||2
8139377|NCT02714426|20063977|P1|NOT COMPLETED|Overall Study||2
8139378|NCT02714426|20063976|P2|COMPLETED|Overall Study||19
8139379|NCT02714426|20063977|P1|COMPLETED|Overall Study||19
8139380|NCT02714426|20063976|P2|STARTED|Overall Study||21
8139381|NCT02714426|20063977|P1|STARTED|Overall Study||21
8139382|NCT02714400|20063993|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8139383|NCT02714400|20063994|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8139384|NCT02714400|20063993|P2|COMPLETED|Second Intervention (1 Day)||8
8139385|NCT02714400|20063994|P1|COMPLETED|Second Intervention (1 Day)||12
8139386|NCT02714400|20063993|P2|STARTED|Second Intervention (1 Day)||8
8139387|NCT02714400|20063994|P1|STARTED|Second Intervention (1 Day)||12
8139388|NCT02714400|20063993|P2|NOT COMPLETED|Washout (>4 Days)||0
8139389|NCT02714400|20063994|P1|NOT COMPLETED|Washout (>4 Days)||0
8139390|NCT02714400|20063993|P2|COMPLETED|Washout (>4 Days)||8
8139391|NCT02714400|20063994|P1|COMPLETED|Washout (>4 Days)||12
8139392|NCT02714400|20063993|P2|STARTED|Washout (>4 Days)||8
8139393|NCT02714400|20063994|P1|STARTED|Washout (>4 Days)||12
8139394|NCT02714400|20063993|P2|NOT COMPLETED|First Intervention (1 Day)||0
8139395|NCT02714400|20063994|P1|NOT COMPLETED|First Intervention (1 Day)||0
8139396|NCT02714400|20063993|P2|COMPLETED|First Intervention (1 Day)||8
8139397|NCT02714400|20063994|P1|COMPLETED|First Intervention (1 Day)||12
8139398|NCT02714400|20063993|P2|STARTED|First Intervention (1 Day)||8
8139399|NCT02714400|20063994|P1|STARTED|First Intervention (1 Day)||12
8139400|NCT02714283|20064010|P2|NOT COMPLETED|Overall Study||0
8139401|NCT02714283|20064011|P1|NOT COMPLETED|Overall Study||0
8139402|NCT02714283|20064010|P2|COMPLETED|Overall Study||6500
8139403|NCT02714283|20064011|P1|COMPLETED|Overall Study||83589
8139404|NCT02714283|20064010|P2|STARTED|Overall Study||6500
8139405|NCT02714283|20064011|P1|STARTED|Overall Study||83589
8139406|NCT02714218|20064038|P3|NOT COMPLETED|Overall Study||19
8139407|NCT02714218|20064039|P2|NOT COMPLETED|Overall Study||143
8139408|NCT02714218|20064040|P1|NOT COMPLETED|Overall Study||130
8139409|NCT02714218|20064038|P3|COMPLETED|Overall Study||8
8139410|NCT02714218|20064039|P2|COMPLETED|Overall Study||35
8139411|NCT02714218|20064040|P1|COMPLETED|Overall Study||50
8139412|NCT02714218|20064038|P3|STARTED|Overall Study||27
8139413|NCT02714218|20064039|P2|STARTED|Overall Study||178
8139414|NCT02714218|20064040|P1|STARTED|Overall Study||180
8139415|NCT02714062|20064090|P3|NOT COMPLETED|Overall Study||3
8139416|NCT02714062|20064091|P2|NOT COMPLETED|Overall Study||1
8139417|NCT02714062|20064092|P1|NOT COMPLETED|Overall Study||1
8139418|NCT02714062|20064090|P3|COMPLETED|Overall Study||10
8139419|NCT02714062|20064091|P2|COMPLETED|Overall Study||14
8139420|NCT02714062|20064092|P1|COMPLETED|Overall Study||13
8139421|NCT02714062|20064090|P3|STARTED|Overall Study||13
8139422|NCT02714062|20064091|P2|STARTED|Overall Study||15
8139423|NCT02714062|20064092|P1|STARTED|Overall Study||14
8139424|NCT02713867|20064138|P2|NOT COMPLETED|Treatment Period||150
8139425|NCT02713867|20064139|P1|NOT COMPLETED|Treatment Period||147
8139426|NCT02713867|20064138|P2|COMPLETED|Treatment Period||30
8139427|NCT02713867|20064139|P1|COMPLETED|Treatment Period||31
8139428|NCT02713867|20064138|P2|STARTED|Treatment Period||180
8139429|NCT02713867|20064139|P1|STARTED|Treatment Period||178
8139430|NCT02713867|20064138|P2|NOT COMPLETED|Randomization||3
8139431|NCT02713867|20064139|P1|NOT COMPLETED|Randomization||2
8139432|NCT02713867|20064138|P2|COMPLETED|Randomization||180
8139433|NCT02713867|20064139|P1|COMPLETED|Randomization||178
8139434|NCT02713867|20064138|P2|STARTED|Randomization||183
8139435|NCT02713867|20064139|P1|STARTED|Randomization||180
8139436|NCT02713828|20064177|P2|NOT COMPLETED|Overall Study||0
8139437|NCT02713828|20064178|P1|NOT COMPLETED|Overall Study||5
8139438|NCT02713828|20064177|P2|COMPLETED|Overall Study||0
8139439|NCT02713828|20064178|P1|COMPLETED|Overall Study||8
8139440|NCT02713828|20064177|P2|STARTED|Overall Study||0
8139441|NCT02713828|20064178|P1|STARTED|Overall Study||13
8139442|NCT02713789|20064190|P3|NOT COMPLETED|Overall Study||1
8139443|NCT02713789|20064191|P2|NOT COMPLETED|Overall Study||1
8139444|NCT02713789|20064192|P1|NOT COMPLETED|Overall Study||0
8139445|NCT02713789|20064190|P3|COMPLETED|Overall Study||7
8139446|NCT02713789|20064191|P2|COMPLETED|Overall Study||9
8139447|NCT02713789|20064192|P1|COMPLETED|Overall Study||8
8139448|NCT02713789|20064190|P3|STARTED|Overall Study||8
8139449|NCT02713789|20064191|P2|STARTED|Overall Study||10
8139450|NCT02713789|20064192|P1|STARTED|Overall Study||8
8139451|NCT02713698|20064230|P3|NOT COMPLETED|Overall Study||0
8139452|NCT02713698|20064231|P2|NOT COMPLETED|Overall Study||0
8139453|NCT02713698|20064232|P1|NOT COMPLETED|Overall Study||0
8139454|NCT02713698|20064230|P3|COMPLETED|Overall Study||20
8139455|NCT02713698|20064231|P2|COMPLETED|Overall Study||20
8139456|NCT02713698|20064232|P1|COMPLETED|Overall Study||20
8139457|NCT02713698|20064230|P3|STARTED|Overall Study||20
8139458|NCT02713698|20064231|P2|STARTED|Overall Study||20
8139459|NCT02713698|20064232|P1|STARTED|Overall Study||20
8139460|NCT02713659|20064242|P2|NOT COMPLETED|24 Month Study Visit||8
8139461|NCT02713659|20064243|P1|NOT COMPLETED|24 Month Study Visit||8
8139462|NCT02713659|20064242|P2|COMPLETED|24 Month Study Visit||44
8139463|NCT02713659|20064243|P1|COMPLETED|24 Month Study Visit||49
8139464|NCT02713659|20064242|P2|STARTED|24 Month Study Visit||52
8139465|NCT02713659|20064243|P1|STARTED|24 Month Study Visit||57
8139466|NCT02713659|20064242|P2|NOT COMPLETED|18 Month Study Visit||3
8139467|NCT02713659|20064243|P1|NOT COMPLETED|18 Month Study Visit||8
8139468|NCT02713659|20064242|P2|COMPLETED|18 Month Study Visit||50
8139469|NCT02713659|20064243|P1|COMPLETED|18 Month Study Visit||50
8139470|NCT02713659|20064242|P2|STARTED|18 Month Study Visit||53
8139471|NCT02713659|20064243|P1|STARTED|18 Month Study Visit||58
8139472|NCT02713659|20064242|P2|NOT COMPLETED|12 Month Study Visit||3
8139473|NCT02713659|20064243|P1|NOT COMPLETED|12 Month Study Visit||3
8139474|NCT02713659|20064242|P2|COMPLETED|12 Month Study Visit||52
8139475|NCT02713659|20064243|P1|COMPLETED|12 Month Study Visit||54
8139476|NCT02713659|20064242|P2|STARTED|12 Month Study Visit||55
8139477|NCT02713659|20064243|P1|STARTED|12 Month Study Visit||57
8139478|NCT02713659|20064242|P2|NOT COMPLETED|6 Month Study Visit||13
8139479|NCT02713659|20064243|P1|NOT COMPLETED|6 Month Study Visit||7
8139480|NCT02713659|20064242|P2|COMPLETED|6 Month Study Visit||47
8139481|NCT02713659|20064243|P1|COMPLETED|6 Month Study Visit||53
8139482|NCT02713659|20064242|P2|STARTED|6 Month Study Visit||60
8139483|NCT02713659|20064243|P1|STARTED|6 Month Study Visit||60
8139484|NCT02713659|20064242|P2|NOT COMPLETED|Baseline||0
8139485|NCT02713659|20064243|P1|NOT COMPLETED|Baseline||0
8139486|NCT02713659|20064242|P2|COMPLETED|Baseline||60
8139487|NCT02713659|20064243|P1|COMPLETED|Baseline||60
8139488|NCT02713659|20064242|P2|STARTED|Baseline||60
8139489|NCT02713659|20064243|P1|STARTED|Baseline||60
8139490|NCT02713594|20064255|P2|NOT COMPLETED|Overall Study||396
8139491|NCT02713594|20064256|P1|NOT COMPLETED|Overall Study||390
8139492|NCT02713594|20064255|P2|COMPLETED|Overall Study||552
8139493|NCT02713594|20064256|P1|COMPLETED|Overall Study||562
8139494|NCT02713594|20064255|P2|STARTED|Overall Study||948
8139495|NCT02713594|20064256|P1|STARTED|Overall Study||952
8139496|NCT02713542|20064268|P2|NOT COMPLETED|Overall Study||6
8139497|NCT02713542|20064269|P1|NOT COMPLETED|Overall Study||18
8139498|NCT02713542|20064268|P2|COMPLETED|Overall Study||24
8139499|NCT02713542|20064269|P1|COMPLETED|Overall Study||42
8139500|NCT02713542|20064268|P2|STARTED|Overall Study||30
8139501|NCT02713542|20064269|P1|STARTED|Overall Study||60
8139502|NCT02713529|20064282|P7|NOT COMPLETED|Overall Study||4
8139503|NCT02713529|20064283|P6|NOT COMPLETED|Overall Study||14
8139504|NCT02713529|20064284|P5|NOT COMPLETED|Overall Study||3
8139505|NCT02713529|20064285|P4|NOT COMPLETED|Overall Study||29
8139506|NCT02713529|20064286|P3|NOT COMPLETED|Overall Study||31
8139507|NCT02713529|20064287|P2|NOT COMPLETED|Overall Study||4
8139508|NCT02713529|20064288|P1|NOT COMPLETED|Overall Study||7
8139509|NCT02713529|20064282|P7|COMPLETED|Overall Study||2
8139510|NCT02713529|20064283|P6|COMPLETED|Overall Study||5
8139511|NCT02713529|20064284|P5|COMPLETED|Overall Study||1
8139512|NCT02713529|20064285|P4|COMPLETED|Overall Study||2
8139513|NCT02713529|20064286|P3|COMPLETED|Overall Study||11
8139514|NCT02713529|20064287|P2|COMPLETED|Overall Study||3
8139515|NCT02713529|20064288|P1|COMPLETED|Overall Study||1
8139516|NCT02713529|20064282|P7|STARTED|Overall Study||6
8139517|NCT02713529|20064283|P6|STARTED|Overall Study||19
8139518|NCT02713529|20064284|P5|STARTED|Overall Study||4
8139519|NCT02713529|20064285|P4|STARTED|Overall Study||31
8139520|NCT02713529|20064286|P3|STARTED|Overall Study||42
8139521|NCT02713529|20064287|P2|STARTED|Overall Study||7
8139522|NCT02713529|20064288|P1|STARTED|Overall Study||8
8139523|NCT02713490|20064370|P2|NOT COMPLETED|Overall Study||2
8139524|NCT02713490|20064371|P1|NOT COMPLETED|Overall Study||3
8139525|NCT02713490|20064370|P2|COMPLETED|Overall Study||67
8139526|NCT02713490|20064371|P1|COMPLETED|Overall Study||68
8139527|NCT02713490|20064370|P2|STARTED|Overall Study||69
8139528|NCT02713490|20064371|P1|STARTED|Overall Study||71
8139529|NCT02713425|20064385|P1|NOT COMPLETED|Overall Study||0
8139530|NCT02713425|20064385|P1|COMPLETED|Overall Study||20
8139531|NCT02713425|20064385|P1|STARTED|Overall Study||20
8139532|NCT02713256|20064390|P1|NOT COMPLETED|Overall Study||0
8139533|NCT02713256|20064390|P1|COMPLETED|Overall Study||15
8139534|NCT02713256|20064390|P1|STARTED|Overall Study||15
8139535|NCT02713243|20064398|P2|NOT COMPLETED|Overall Study||2
8139536|NCT02713243|20064399|P1|NOT COMPLETED|Overall Study||1
8139537|NCT02713243|20064398|P2|COMPLETED|Overall Study||8
8139538|NCT02713243|20064399|P1|COMPLETED|Overall Study||9
8139539|NCT02713243|20064398|P2|PK Analysis Set|Overall Study||9
8139540|NCT02713243|20064399|P1|PK Analysis Set|Overall Study||8
8139541|NCT02713243|20064398|P2|PD Analysis Set|Overall Study||10
8139542|NCT02713243|20064399|P1|PD Analysis Set|Overall Study||9
8139543|NCT02713243|20064398|P2|STARTED|Overall Study||10
8139544|NCT02713243|20064399|P1|STARTED|Overall Study||10
8139545|NCT02713230|20064417|P3|NOT COMPLETED|Overall Study||0
8139546|NCT02713230|20064418|P2|NOT COMPLETED|Overall Study||0
8139547|NCT02713230|20064419|P1|NOT COMPLETED|Overall Study||1
8139548|NCT02713230|20064417|P3|COMPLETED|Overall Study||71
8139549|NCT02713230|20064418|P2|COMPLETED|Overall Study||15
8139550|NCT02713230|20064419|P1|COMPLETED|Overall Study||68
8139551|NCT02713230|20064417|P3|STARTED|Overall Study||71
8139552|NCT02713230|20064418|P2|STARTED|Overall Study||15
8139553|NCT02713230|20064419|P1|STARTED|Overall Study||69
8139554|NCT02713204|20064435|P8|NOT COMPLETED|From Week 12 up to Week 36||4
8139555|NCT02713204|20064436|P7|NOT COMPLETED|From Week 12 up to Week 36||2
8139556|NCT02713204|20064437|P6|NOT COMPLETED|From Week 12 up to Week 36||1
8139557|NCT02713204|20064438|P5|NOT COMPLETED|From Week 12 up to Week 36||2
8139558|NCT02713204|20064439|P4|NOT COMPLETED|From Week 12 up to Week 36||4
8139559|NCT02713204|20064440|P3|NOT COMPLETED|From Week 12 up to Week 36||0
8139560|NCT02713204|20064441|P2|NOT COMPLETED|From Week 12 up to Week 36||0
8139561|NCT02713204|20064442|P1|NOT COMPLETED|From Week 12 up to Week 36||1
8139562|NCT02713204|20064435|P8|COMPLETED|From Week 12 up to Week 36||54
8139563|NCT02713204|20064436|P7|COMPLETED|From Week 12 up to Week 36||60
8139564|NCT02713204|20064437|P6|COMPLETED|From Week 12 up to Week 36||59
8139565|NCT02713204|20064438|P5|COMPLETED|From Week 12 up to Week 36||60
8139566|NCT02713204|20064439|P4|COMPLETED|From Week 12 up to Week 36||53
8139567|NCT02713204|20064440|P3|COMPLETED|From Week 12 up to Week 36||0
8139568|NCT02713204|20064441|P2|COMPLETED|From Week 12 up to Week 36||0
8139569|NCT02713204|20064442|P1|COMPLETED|From Week 12 up to Week 36||57
8139570|NCT02713204|20064435|P8|STARTED|From Week 12 up to Week 36||58
8139571|NCT02713204|20064436|P7|STARTED|From Week 12 up to Week 36||62
8139572|NCT02713204|20064437|P6|STARTED|From Week 12 up to Week 36||60
8139573|NCT02713204|20064438|P5|STARTED|From Week 12 up to Week 36||62
8139574|NCT02713204|20064439|P4|STARTED|From Week 12 up to Week 36||57
8139575|NCT02713204|20064440|P3|STARTED|From Week 12 up to Week 36||0
8139576|NCT02713204|20064441|P2|STARTED|From Week 12 up to Week 36||0
8139577|NCT02713204|20064442|P1|STARTED|From Week 12 up to Week 36||58
8139578|NCT02713204|20064435|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139579|NCT02713204|20064436|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139580|NCT02713204|20064437|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139581|NCT02713204|20064438|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139582|NCT02713204|20064439|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139583|NCT02713204|20064440|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
8139584|NCT02713204|20064441|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
8139585|NCT02713204|20064442|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
8139586|NCT02713204|20064435|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
8139587|NCT02713204|20064436|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
8139588|NCT02713204|20064437|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
8139589|NCT02713204|20064438|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
8139590|NCT02713204|20064439|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
8139591|NCT02713204|20064440|P3|COMPLETED|Baseline (Day 1) up to Week 12||181
8139592|NCT02713204|20064441|P2|COMPLETED|Baseline (Day 1) up to Week 12||121
8139593|NCT02713204|20064442|P1|COMPLETED|Baseline (Day 1) up to Week 12||59
8139594|NCT02713204|20064435|P8|STARTED|Baseline (Day 1) up to Week 12||0
8139595|NCT02713204|20064436|P7|STARTED|Baseline (Day 1) up to Week 12||0
8139596|NCT02713204|20064437|P6|STARTED|Baseline (Day 1) up to Week 12||0
8139597|NCT02713204|20064438|P5|STARTED|Baseline (Day 1) up to Week 12||0
8139598|NCT02713204|20064439|P4|STARTED|Baseline (Day 1) up to Week 12||0
8139599|NCT02713204|20064440|P3|STARTED|Baseline (Day 1) up to Week 12||183
8139600|NCT02713204|20064441|P2|STARTED|Baseline (Day 1) up to Week 12||122
8139601|NCT02713204|20064442|P1|STARTED|Baseline (Day 1) up to Week 12||60
8139602|NCT02713178|20064502|P3|NOT COMPLETED|Overall Study||5
8139603|NCT02713178|20064503|P2|NOT COMPLETED|Overall Study||4
8139604|NCT02713178|20064504|P1|NOT COMPLETED|Overall Study||1
8139605|NCT02713178|20064502|P3|COMPLETED|Overall Study||74
8139606|NCT02713178|20064503|P2|COMPLETED|Overall Study||73
8139607|NCT02713178|20064504|P1|COMPLETED|Overall Study||75
8139608|NCT02713178|20064502|P3|STARTED|Overall Study||79
8139609|NCT02713178|20064503|P2|STARTED|Overall Study||77
8139610|NCT02713178|20064504|P1|STARTED|Overall Study||76
8139611|NCT02712996|20064523|P2|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
8139612|NCT02712996|20064524|P1|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
8139613|NCT02712996|20064523|P2|COMPLETED|Second Intervention (Study Days 43-84)||8
8139614|NCT02712996|20064524|P1|COMPLETED|Second Intervention (Study Days 43-84)||8
8139615|NCT02712996|20064523|P2|STARTED|Second Intervention (Study Days 43-84)||9
8139616|NCT02712996|20064524|P1|STARTED|Second Intervention (Study Days 43-84)||8
8139617|NCT02712996|20064523|P2|NOT COMPLETED|First Intervention (Study Days 1-42)||0
8139618|NCT02712996|20064524|P1|NOT COMPLETED|First Intervention (Study Days 1-42)||0
8139619|NCT02712996|20064523|P2|COMPLETED|First Intervention (Study Days 1-42)||9
8139620|NCT02712996|20064524|P1|COMPLETED|First Intervention (Study Days 1-42)||8
8139621|NCT02712996|20064523|P2|STARTED|First Intervention (Study Days 1-42)||9
8139622|NCT02712996|20064524|P1|STARTED|First Intervention (Study Days 1-42)||8
8139623|NCT02712983|20064583|P9|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139624|NCT02712983|20064584|P8|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
8139625|NCT02712983|20064585|P7|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8139626|NCT02712983|20064586|P6|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8139627|NCT02712983|20064587|P5|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8139628|NCT02712983|20064588|P4|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8139629|NCT02712983|20064589|P3|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139630|NCT02712983|20064590|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8139631|NCT02712983|20064591|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139632|NCT02712983|20064583|P9|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139633|NCT02712983|20064584|P8|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139634|NCT02712983|20064585|P7|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139635|NCT02712983|20064586|P6|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139636|NCT02712983|20064587|P5|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139637|NCT02712983|20064588|P4|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139638|NCT02712983|20064589|P3|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139639|NCT02712983|20064590|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139640|NCT02712983|20064591|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139641|NCT02712983|20064583|P9|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8139722|NCT02712359|20064971|P3|STARTED|Epoch 002: Persistence at Year 10||299
8139642|NCT02712983|20064584|P8|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
8139643|NCT02712983|20064585|P7|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8139644|NCT02712983|20064586|P6|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8139645|NCT02712983|20064587|P5|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8139646|NCT02712983|20064588|P4|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8139647|NCT02712983|20064589|P3|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8139648|NCT02712983|20064590|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8139649|NCT02712983|20064591|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8139650|NCT02712983|20064583|P9|NOT COMPLETED|Treatment Phase||2
8139651|NCT02712983|20064584|P8|NOT COMPLETED|Treatment Phase||9
8139652|NCT02712983|20064585|P7|NOT COMPLETED|Treatment Phase||9
8139653|NCT02712983|20064586|P6|NOT COMPLETED|Treatment Phase||0
8139654|NCT02712983|20064587|P5|NOT COMPLETED|Treatment Phase||4
8139655|NCT02712983|20064588|P4|NOT COMPLETED|Treatment Phase||8
8139656|NCT02712983|20064589|P3|NOT COMPLETED|Treatment Phase||1
8139657|NCT02712983|20064590|P2|NOT COMPLETED|Treatment Phase||1
8139658|NCT02712983|20064591|P1|NOT COMPLETED|Treatment Phase||5
8139659|NCT02712983|20064583|P9|COMPLETED|Treatment Phase||5
8139660|NCT02712983|20064584|P8|COMPLETED|Treatment Phase||6
8139661|NCT02712983|20064585|P7|COMPLETED|Treatment Phase||6
8139662|NCT02712983|20064586|P6|COMPLETED|Treatment Phase||7
8139663|NCT02712983|20064587|P5|COMPLETED|Treatment Phase||10
8139664|NCT02712983|20064588|P4|COMPLETED|Treatment Phase||7
8139665|NCT02712983|20064589|P3|COMPLETED|Treatment Phase||6
8139666|NCT02712983|20064590|P2|COMPLETED|Treatment Phase||12
8139667|NCT02712983|20064591|P1|COMPLETED|Treatment Phase||9
8139668|NCT02712983|20064583|P9|Pharmacokinetic Analysis Set|Treatment Phase||0
8139669|NCT02712983|20064584|P8|Pharmacokinetic Analysis Set|Treatment Phase||14
8139670|NCT02712983|20064585|P7|Pharmacokinetic Analysis Set|Treatment Phase||15
8139671|NCT02712983|20064586|P6|Pharmacokinetic Analysis Set|Treatment Phase||0
8139672|NCT02712983|20064587|P5|Pharmacokinetic Analysis Set|Treatment Phase||14
8139673|NCT02712983|20064588|P4|Pharmacokinetic Analysis Set|Treatment Phase||15
8139674|NCT02712983|20064589|P3|Pharmacokinetic Analysis Set|Treatment Phase||0
8139675|NCT02712983|20064590|P2|Pharmacokinetic Analysis Set|Treatment Phase||13
8139676|NCT02712983|20064591|P1|Pharmacokinetic Analysis Set|Treatment Phase||14
8139677|NCT02712983|20064583|P9|STARTED|Treatment Phase||7
8139678|NCT02712983|20064584|P8|STARTED|Treatment Phase||15
8139679|NCT02712983|20064585|P7|STARTED|Treatment Phase||15
8139680|NCT02712983|20064586|P6|STARTED|Treatment Phase||7
8139681|NCT02712983|20064587|P5|STARTED|Treatment Phase||14
8139682|NCT02712983|20064588|P4|STARTED|Treatment Phase||15
8139683|NCT02712983|20064589|P3|STARTED|Treatment Phase||7
8139684|NCT02712983|20064590|P2|STARTED|Treatment Phase||13
8139685|NCT02712983|20064591|P1|STARTED|Treatment Phase||14
8139686|NCT02712788|20064823|P2|NOT COMPLETED|Overall Study||0
8139687|NCT02712788|20064824|P1|NOT COMPLETED|Overall Study||2
8139688|NCT02712788|20064823|P2|COMPLETED|Overall Study||2
8139689|NCT02712788|20064824|P1|COMPLETED|Overall Study||0
8139690|NCT02712788|20064823|P2|STARTED|Overall Study||2
8139691|NCT02712788|20064824|P1|STARTED|Overall Study||2
8139692|NCT02712554|20064834|P2|NOT COMPLETED|Part B: Treatment Phase||3
8139693|NCT02712554|20064835|P1|NOT COMPLETED|Part B: Treatment Phase||0
8139694|NCT02712554|20064834|P2|COMPLETED|Part B: Treatment Phase||37
8139695|NCT02712554|20064835|P1|COMPLETED|Part B: Treatment Phase||0
8139696|NCT02712554|20064834|P2|STARTED|Part B: Treatment Phase||40
8139697|NCT02712554|20064835|P1|STARTED|Part B: Treatment Phase||0
8139698|NCT02712554|20064834|P2|NOT COMPLETED|Part B: Qualification Phase||21
8139699|NCT02712554|20064835|P1|NOT COMPLETED|Part B: Qualification Phase||0
8139700|NCT02712554|20064834|P2|COMPLETED|Part B: Qualification Phase||40
8139701|NCT02712554|20064835|P1|COMPLETED|Part B: Qualification Phase||0
8139702|NCT02712554|20064834|P2|STARTED|Part B: Qualification Phase||61
8139703|NCT02712554|20064835|P1|STARTED|Part B: Qualification Phase||0
8139704|NCT02712554|20064834|P2|NOT COMPLETED|Part A: Dose Selection Phase||0
8139705|NCT02712554|20064835|P1|NOT COMPLETED|Part A: Dose Selection Phase||0
8139706|NCT02712554|20064834|P2|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
8139707|NCT02712554|20064835|P1|COMPLETED|Part A: Dose Selection Phase||12
8139708|NCT02712554|20064834|P2|STARTED|Part A: Dose Selection Phase||0
8139709|NCT02712554|20064835|P1|STARTED|Part A: Dose Selection Phase||12
8139710|NCT02712398|20064953|P1|NOT COMPLETED|Overall Study||37
8139711|NCT02712398|20064953|P1|COMPLETED|Overall Study||83
8139712|NCT02712398|20064953|P1|STARTED|Overall Study||120
8139713|NCT02712359|20064970|P4|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139714|NCT02712359|20064971|P3|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139715|NCT02712359|20064972|P2|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139716|NCT02712359|20064973|P1|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139717|NCT02712359|20064970|P4|COMPLETED|Epoch 002: Persistence at Year 10||300
8139718|NCT02712359|20064971|P3|COMPLETED|Epoch 002: Persistence at Year 10||299
8139719|NCT02712359|20064972|P2|COMPLETED|Epoch 002: Persistence at Year 10||0
8139720|NCT02712359|20064973|P1|COMPLETED|Epoch 002: Persistence at Year 10||0
8139721|NCT02712359|20064970|P4|STARTED|Epoch 002: Persistence at Year 10||300
8139723|NCT02712359|20064972|P2|STARTED|Epoch 002: Persistence at Year 10||0
8139724|NCT02712359|20064973|P1|STARTED|Epoch 002: Persistence at Year 10||0
8139725|NCT02712359|20064970|P4|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139726|NCT02712359|20064971|P3|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139727|NCT02712359|20064972|P2|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139728|NCT02712359|20064973|P1|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139729|NCT02712359|20064970|P4|COMPLETED|Epoch 001: Persistence at Year 8||0
8139730|NCT02712359|20064971|P3|COMPLETED|Epoch 001: Persistence at Year 8||0
8139731|NCT02712359|20064972|P2|COMPLETED|Epoch 001: Persistence at Year 8||300
8139732|NCT02712359|20064973|P1|COMPLETED|Epoch 001: Persistence at Year 8||300
8139733|NCT02712359|20064970|P4|STARTED|Epoch 001: Persistence at Year 8||0
8139734|NCT02712359|20064971|P3|STARTED|Epoch 001: Persistence at Year 8||0
8139735|NCT02712359|20064972|P2|STARTED|Epoch 001: Persistence at Year 8||300
8139736|NCT02712359|20064973|P1|STARTED|Epoch 001: Persistence at Year 8||300
8139737|NCT02712333|20064993|P2|NOT COMPLETED|Second Period||0
8139738|NCT02712333|20064994|P1|NOT COMPLETED|Second Period||0
8139739|NCT02712333|20064993|P2|COMPLETED|Second Period||24
8139740|NCT02712333|20064994|P1|COMPLETED|Second Period||31
8139741|NCT02712333|20064993|P2|STARTED|Second Period||24
8139742|NCT02712333|20064994|P1|STARTED|Second Period||31
8139743|NCT02712333|20064993|P2|NOT COMPLETED|First Period||2
8139744|NCT02712333|20064994|P1|NOT COMPLETED|First Period||3
8139745|NCT02712333|20064993|P2|COMPLETED|First Period||24
8139746|NCT02712333|20064994|P1|COMPLETED|First Period||31
8139747|NCT02712333|20064993|P2|STARTED|First Period||26
8139748|NCT02712333|20064994|P1|STARTED|First Period||34
8139749|NCT02712320|20065012|P1|NOT COMPLETED|Overall Study||5
8139750|NCT02712320|20065012|P1|COMPLETED|Overall Study||25
8139751|NCT02712320|20065012|P1|STARTED|Overall Study||30
8139752|NCT02712099|20065022|P2|NOT COMPLETED|Overall Study||0
8139753|NCT02712099|20065023|P1|NOT COMPLETED|Overall Study||0
8139754|NCT02712099|20065022|P2|COMPLETED|Overall Study||20
8139755|NCT02712099|20065023|P1|COMPLETED|Overall Study||30
8139756|NCT02712099|20065022|P2|STARTED|Overall Study||20
8139757|NCT02712099|20065023|P1|STARTED|Overall Study||30
8139758|NCT02712047|20065039|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
8139759|NCT02712047|20065040|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
8139760|NCT02712047|20065039|P2|COMPLETED|Treatment Period 2 (35 Days)||13
8139761|NCT02712047|20065040|P1|COMPLETED|Treatment Period 2 (35 Days)||14
8139762|NCT02712047|20065039|P2|STARTED|Treatment Period 2 (35 Days)||13
8139763|NCT02712047|20065040|P1|STARTED|Treatment Period 2 (35 Days)||14
8139764|NCT02712047|20065039|P2|NOT COMPLETED|Washout Period (21 Days)||0
8139765|NCT02712047|20065040|P1|NOT COMPLETED|Washout Period (21 Days)||0
8139766|NCT02712047|20065039|P2|COMPLETED|Washout Period (21 Days)||13
8139767|NCT02712047|20065040|P1|COMPLETED|Washout Period (21 Days)||14
8139768|NCT02712047|20065039|P2|STARTED|Washout Period (21 Days)||13
8139769|NCT02712047|20065040|P1|STARTED|Washout Period (21 Days)||14
8139770|NCT02712047|20065039|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
8139771|NCT02712047|20065040|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
8139772|NCT02712047|20065039|P2|COMPLETED|Treatment Period 1 (35 Days)||13
8139773|NCT02712047|20065040|P1|COMPLETED|Treatment Period 1 (35 Days)||14
8139774|NCT02712047|20065039|P2|STARTED|Treatment Period 1 (35 Days)||13
8139775|NCT02712047|20065040|P1|STARTED|Treatment Period 1 (35 Days)||14
8139776|NCT02712008|20065055|P8|NOT COMPLETED|From Week 12 up to Week 36||4
8139777|NCT02712008|20065056|P7|NOT COMPLETED|From Week 12 up to Week 36||5
8139778|NCT02712008|20065057|P6|NOT COMPLETED|From Week 12 up to Week 36||0
8139779|NCT02712008|20065058|P5|NOT COMPLETED|From Week 12 up to Week 36||2
8139780|NCT02712008|20065059|P4|NOT COMPLETED|From Week 12 up to Week 36||2
8139781|NCT02712008|20065060|P3|NOT COMPLETED|From Week 12 up to Week 36||0
8139782|NCT02712008|20065061|P2|NOT COMPLETED|From Week 12 up to Week 36||0
8139783|NCT02712008|20065062|P1|NOT COMPLETED|From Week 12 up to Week 36||1
8139784|NCT02712008|20065055|P8|COMPLETED|From Week 12 up to Week 36||45
8139785|NCT02712008|20065056|P7|COMPLETED|From Week 12 up to Week 36||43
8139786|NCT02712008|20065057|P6|COMPLETED|From Week 12 up to Week 36||46
8139787|NCT02712008|20065058|P5|COMPLETED|From Week 12 up to Week 36||50
8139788|NCT02712008|20065059|P4|COMPLETED|From Week 12 up to Week 36||42
8139789|NCT02712008|20065060|P3|COMPLETED|From Week 12 up to Week 36||0
8139790|NCT02712008|20065061|P2|COMPLETED|From Week 12 up to Week 36||0
8139791|NCT02712008|20065062|P1|COMPLETED|From Week 12 up to Week 36||44
8139792|NCT02712008|20065055|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
8139793|NCT02712008|20065056|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
8139794|NCT02712008|20065057|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
8139795|NCT02712008|20065058|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
8139796|NCT02712008|20065059|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
8139797|NCT02712008|20065060|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
8139798|NCT02712008|20065061|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
8139799|NCT02712008|20065062|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
8139800|NCT02712008|20065055|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139801|NCT02712008|20065056|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139802|NCT02712008|20065057|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139803|NCT02712008|20065058|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139804|NCT02712008|20065059|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139805|NCT02712008|20065060|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
8139806|NCT02712008|20065061|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
8139807|NCT02712008|20065062|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
8139808|NCT02712008|20065055|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
8139809|NCT02712008|20065056|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
8139810|NCT02712008|20065057|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
8139811|NCT02712008|20065058|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
8139812|NCT02712008|20065059|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
8139813|NCT02712008|20065060|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
8139814|NCT02712008|20065061|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
8139815|NCT02712008|20065062|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
8139816|NCT02712008|20065055|P8|STARTED|Baseline (Day 1) up to Week 12||0
8139817|NCT02712008|20065056|P7|STARTED|Baseline (Day 1) up to Week 12||0
8139818|NCT02712008|20065057|P6|STARTED|Baseline (Day 1) up to Week 12||0
8139819|NCT02712008|20065058|P5|STARTED|Baseline (Day 1) up to Week 12||0
8139820|NCT02712008|20065059|P4|STARTED|Baseline (Day 1) up to Week 12||0
8139821|NCT02712008|20065060|P3|STARTED|Baseline (Day 1) up to Week 12||152
8139822|NCT02712008|20065061|P2|STARTED|Baseline (Day 1) up to Week 12||100
8139823|NCT02712008|20065062|P1|STARTED|Baseline (Day 1) up to Week 12||50
8139824|NCT02711995|20065094|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8139825|NCT02711995|20065094|P1|COMPLETED|Second Intervention (30 Days)||7
8139826|NCT02711995|20065094|P1|STARTED|Second Intervention (30 Days)||7
8139827|NCT02711995|20065094|P1|NOT COMPLETED|Washout (90 Days)||1
8139828|NCT02711995|20065094|P1|COMPLETED|Washout (90 Days)||7
8139829|NCT02711995|20065094|P1|STARTED|Washout (90 Days)||8
8139830|NCT02711995|20065094|P1|NOT COMPLETED|First Intervention (30 Days)||0
8139831|NCT02711995|20065094|P1|COMPLETED|First Intervention (30 Days)||8
8139832|NCT02711995|20065094|P1|STARTED|First Intervention (30 Days)||8
8139833|NCT02711839|20065118|P2|NOT COMPLETED|Overall Study||10
8139834|NCT02711839|20065119|P1|NOT COMPLETED|Overall Study||4
8139835|NCT02711839|20065118|P2|COMPLETED|Overall Study||24
8139836|NCT02711839|20065119|P1|COMPLETED|Overall Study||16
8139837|NCT02711839|20065118|P2|STARTED|Overall Study||34
8139838|NCT02711839|20065119|P1|STARTED|Overall Study||20
8139839|NCT02711800|20065133|P1|NOT COMPLETED|Overall Study||2
8139840|NCT02711800|20065133|P1|COMPLETED|Overall Study||7
8139841|NCT02711800|20065133|P1|STARTED|Overall Study||9
8139842|NCT02711345|20065152|P10|NOT COMPLETED|Overall Study||12
8139843|NCT02711345|20065153|P9|NOT COMPLETED|Overall Study||6
8139844|NCT02711345|20065154|P8|NOT COMPLETED|Overall Study||6
8139845|NCT02711345|20065155|P7|NOT COMPLETED|Overall Study||12
8139846|NCT02711345|20065156|P6|NOT COMPLETED|Overall Study||6
8139847|NCT02711345|20065157|P5|NOT COMPLETED|Overall Study||8
8139848|NCT02711345|20065158|P4|NOT COMPLETED|Overall Study||4
8139849|NCT02711345|20065159|P3|NOT COMPLETED|Overall Study||6
8139850|NCT02711345|20065160|P2|NOT COMPLETED|Overall Study||3
8139851|NCT02711345|20065161|P1|NOT COMPLETED|Overall Study||2
8139852|NCT02711345|20065152|P10|COMPLETED|Overall Study||0
8139853|NCT02711345|20065153|P9|COMPLETED|Overall Study||0
8139854|NCT02711345|20065154|P8|COMPLETED|Overall Study||0
8139855|NCT02711345|20065155|P7|COMPLETED|Overall Study||0
8139856|NCT02711345|20065156|P6|COMPLETED|Overall Study||0
8139857|NCT02711345|20065157|P5|COMPLETED|Overall Study||0
8139858|NCT02711345|20065158|P4|COMPLETED|Overall Study||0
8139859|NCT02711345|20065159|P3|COMPLETED|Overall Study||0
8139860|NCT02711345|20065160|P2|COMPLETED|Overall Study||0
8139861|NCT02711345|20065161|P1|COMPLETED|Overall Study||0
8139862|NCT02711345|20065152|P10|STARTED|Overall Study||12
8139863|NCT02711345|20065153|P9|STARTED|Overall Study||6
8139864|NCT02711345|20065154|P8|STARTED|Overall Study||6
8139865|NCT02711345|20065155|P7|STARTED|Overall Study||12
8139866|NCT02711345|20065156|P6|STARTED|Overall Study||6
8139867|NCT02711345|20065157|P5|STARTED|Overall Study||8
8139868|NCT02711345|20065158|P4|STARTED|Overall Study||4
8139869|NCT02711345|20065159|P3|STARTED|Overall Study||6
8139870|NCT02711345|20065160|P2|STARTED|Overall Study||3
8139871|NCT02711345|20065161|P1|STARTED|Overall Study||2
8139872|NCT02711306|20065347|P2|NOT COMPLETED|Overall Study||2
8139873|NCT02711306|20065348|P1|NOT COMPLETED|Overall Study||2
8139874|NCT02711306|20065347|P2|COMPLETED|Overall Study||16
8139875|NCT02711306|20065348|P1|COMPLETED|Overall Study||16
8139876|NCT02711306|20065347|P2|STARTED|Overall Study||18
8139877|NCT02711306|20065348|P1|STARTED|Overall Study||18
8139878|NCT02710981|20065360|P2|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
8139879|NCT02710981|20065361|P1|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
8139880|NCT02710981|20065360|P2|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
8139881|NCT02710981|20065361|P1|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
8139882|NCT02710981|20065360|P2|STARTED|7th Ovulation Induction Cycle (5 Days)||41
8139883|NCT02710981|20065361|P1|STARTED|7th Ovulation Induction Cycle (5 Days)||0
8139884|NCT02710981|20065360|P2|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
8139885|NCT02710981|20065361|P1|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
8139886|NCT02710981|20065360|P2|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
8139887|NCT02710981|20065361|P1|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
8139888|NCT02710981|20065360|P2|STARTED|6th Ovulation Induction Cycle (5 Days)||0
8139889|NCT02710981|20065361|P1|STARTED|6th Ovulation Induction Cycle (5 Days)||42
8139890|NCT02710890|20065373|P2|NOT COMPLETED|Overall Study||0
8139891|NCT02710890|20065374|P1|NOT COMPLETED|Overall Study||0
8139892|NCT02710890|20065373|P2|COMPLETED|Overall Study||55
8139893|NCT02710890|20065374|P1|COMPLETED|Overall Study||48
8139894|NCT02710890|20065373|P2|STARTED|Overall Study||55
8139895|NCT02710890|20065374|P1|STARTED|Overall Study||48
8139896|NCT02710630|20065387|P5|NOT COMPLETED|Period 6||0
8139897|NCT02710630|20065388|P4|NOT COMPLETED|Period 6||0
8139898|NCT02710630|20065389|P3|NOT COMPLETED|Period 6||0
8139899|NCT02710630|20065390|P2|NOT COMPLETED|Period 6||0
8139900|NCT02710630|20065391|P1|NOT COMPLETED|Period 6||0
8139901|NCT02710630|20065387|P5|COMPLETED|Period 6||7
8139902|NCT02710630|20065388|P4|COMPLETED|Period 6||7
8139903|NCT02710630|20065389|P3|COMPLETED|Period 6||7
8139904|NCT02710630|20065390|P2|COMPLETED|Period 6||7
8139905|NCT02710630|20065391|P1|COMPLETED|Period 6||7
8139906|NCT02710630|20065387|P5|STARTED|Period 6||7
8139907|NCT02710630|20065388|P4|STARTED|Period 6||7
8139908|NCT02710630|20065389|P3|STARTED|Period 6||7
8139909|NCT02710630|20065390|P2|STARTED|Period 6||7
8139910|NCT02710630|20065391|P1|STARTED|Period 6||7
8139911|NCT02710630|20065387|P5|NOT COMPLETED|Period 5||0
8139912|NCT02710630|20065388|P4|NOT COMPLETED|Period 5||0
8139913|NCT02710630|20065389|P3|NOT COMPLETED|Period 5||0
8139914|NCT02710630|20065390|P2|NOT COMPLETED|Period 5||0
8139915|NCT02710630|20065391|P1|NOT COMPLETED|Period 5||0
8139916|NCT02710630|20065387|P5|COMPLETED|Period 5||7
8139917|NCT02710630|20065388|P4|COMPLETED|Period 5||7
8139918|NCT02710630|20065389|P3|COMPLETED|Period 5||7
8139919|NCT02710630|20065390|P2|COMPLETED|Period 5||7
8139920|NCT02710630|20065391|P1|COMPLETED|Period 5||7
8139921|NCT02710630|20065387|P5|STARTED|Period 5||7
8139922|NCT02710630|20065388|P4|STARTED|Period 5||7
8139923|NCT02710630|20065389|P3|STARTED|Period 5||7
8139924|NCT02710630|20065390|P2|STARTED|Period 5||7
8139925|NCT02710630|20065391|P1|STARTED|Period 5||7
8139926|NCT02710630|20065387|P5|NOT COMPLETED|Period 4||0
8139927|NCT02710630|20065388|P4|NOT COMPLETED|Period 4||0
8139928|NCT02710630|20065389|P3|NOT COMPLETED|Period 4||0
8139929|NCT02710630|20065390|P2|NOT COMPLETED|Period 4||0
8139930|NCT02710630|20065391|P1|NOT COMPLETED|Period 4||0
8139931|NCT02710630|20065387|P5|COMPLETED|Period 4||7
8139932|NCT02710630|20065388|P4|COMPLETED|Period 4||7
8139933|NCT02710630|20065389|P3|COMPLETED|Period 4||7
8139934|NCT02710630|20065390|P2|COMPLETED|Period 4||7
8139935|NCT02710630|20065391|P1|COMPLETED|Period 4||7
8139936|NCT02710630|20065387|P5|STARTED|Period 4||7
8139937|NCT02710630|20065388|P4|STARTED|Period 4||7
8139938|NCT02710630|20065389|P3|STARTED|Period 4||7
8139939|NCT02710630|20065390|P2|STARTED|Period 4||7
8139940|NCT02710630|20065391|P1|STARTED|Period 4||7
8139941|NCT02710630|20065387|P5|NOT COMPLETED|Period 3||0
8139942|NCT02710630|20065388|P4|NOT COMPLETED|Period 3||0
8139943|NCT02710630|20065389|P3|NOT COMPLETED|Period 3||0
8139944|NCT02710630|20065390|P2|NOT COMPLETED|Period 3||0
8139945|NCT02710630|20065391|P1|NOT COMPLETED|Period 3||0
8139946|NCT02710630|20065387|P5|COMPLETED|Period 3||7
8139947|NCT02710630|20065388|P4|COMPLETED|Period 3||7
8139948|NCT02710630|20065389|P3|COMPLETED|Period 3||7
8139949|NCT02710630|20065390|P2|COMPLETED|Period 3||7
8139950|NCT02710630|20065391|P1|COMPLETED|Period 3||7
8139951|NCT02710630|20065387|P5|STARTED|Period 3||7
8139952|NCT02710630|20065388|P4|STARTED|Period 3||7
8139953|NCT02710630|20065389|P3|STARTED|Period 3||7
8139954|NCT02710630|20065390|P2|STARTED|Period 3||7
8139955|NCT02710630|20065391|P1|STARTED|Period 3||7
8139956|NCT02710630|20065387|P5|NOT COMPLETED|Period 2||0
8139957|NCT02710630|20065388|P4|NOT COMPLETED|Period 2||0
8139958|NCT02710630|20065389|P3|NOT COMPLETED|Period 2||0
8139959|NCT02710630|20065390|P2|NOT COMPLETED|Period 2||0
8139960|NCT02710630|20065391|P1|NOT COMPLETED|Period 2||0
8139961|NCT02710630|20065387|P5|COMPLETED|Period 2||7
8139962|NCT02710630|20065388|P4|COMPLETED|Period 2||7
8139963|NCT02710630|20065389|P3|COMPLETED|Period 2||7
8139964|NCT02710630|20065390|P2|COMPLETED|Period 2||7
8139965|NCT02710630|20065391|P1|COMPLETED|Period 2||7
8139966|NCT02710630|20065387|P5|Not Treated|Period 2||0
8139967|NCT02710630|20065388|P4|Not Treated|Period 2||0
8139968|NCT02710630|20065389|P3|Not Treated|Period 2||0
8139969|NCT02710630|20065390|P2|Not Treated|Period 2||0
8139970|NCT02710630|20065391|P1|Not Treated|Period 2||1
8139971|NCT02710630|20065387|P5|STARTED|Period 2||7
8139972|NCT02710630|20065388|P4|STARTED|Period 2||7
8139973|NCT02710630|20065389|P3|STARTED|Period 2||7
8139974|NCT02710630|20065390|P2|STARTED|Period 2||7
8139975|NCT02710630|20065391|P1|STARTED|Period 2||7
8139976|NCT02710630|20065387|P5|NOT COMPLETED|Period 1||0
8139977|NCT02710630|20065388|P4|NOT COMPLETED|Period 1||0
8139978|NCT02710630|20065389|P3|NOT COMPLETED|Period 1||0
8139979|NCT02710630|20065390|P2|NOT COMPLETED|Period 1||0
8139980|NCT02710630|20065391|P1|NOT COMPLETED|Period 1||0
8139981|NCT02710630|20065387|P5|COMPLETED|Period 1||7
8139982|NCT02710630|20065388|P4|COMPLETED|Period 1||7
8139983|NCT02710630|20065389|P3|COMPLETED|Period 1||7
8139984|NCT02710630|20065390|P2|COMPLETED|Period 1||7
8139985|NCT02710630|20065391|P1|COMPLETED|Period 1||7
8139986|NCT02710630|20065387|P5|STARTED|Period 1||7
8139987|NCT02710630|20065388|P4|STARTED|Period 1||7
8139988|NCT02710630|20065389|P3|STARTED|Period 1||7
8139989|NCT02710630|20065390|P2|STARTED|Period 1||7
8139990|NCT02710630|20065391|P1|STARTED|Period 1||7
8139991|NCT02710591|20065439|P4|NOT COMPLETED|Overall Study||0
8139992|NCT02710591|20065440|P3|NOT COMPLETED|Overall Study||0
8139993|NCT02710591|20065441|P2|NOT COMPLETED|Overall Study||0
8139994|NCT02710591|20065442|P1|NOT COMPLETED|Overall Study||0
8139995|NCT02710591|20065439|P4|COMPLETED|Overall Study||5
8139996|NCT02710591|20065440|P3|COMPLETED|Overall Study||5
8139997|NCT02710591|20065441|P2|COMPLETED|Overall Study||5
8139998|NCT02710591|20065442|P1|COMPLETED|Overall Study||5
8139999|NCT02710591|20065439|P4|STARTED|Overall Study||5
8140000|NCT02710591|20065440|P3|STARTED|Overall Study||5
8140001|NCT02710591|20065441|P2|STARTED|Overall Study||5
8140002|NCT02710591|20065442|P1|STARTED|Overall Study||5
8140003|NCT02710526|20065459|P3|NOT COMPLETED|Safety Extension||0
8140004|NCT02710526|20065460|P2|NOT COMPLETED|Safety Extension||0
8140005|NCT02710526|20065461|P1|NOT COMPLETED|Safety Extension||1
8140006|NCT02710526|20065459|P3|COMPLETED|Safety Extension||0
8140007|NCT02710526|20065460|P2|COMPLETED|Safety Extension||12
8140008|NCT02710526|20065461|P1|COMPLETED|Safety Extension||14
8140009|NCT02710526|20065459|P3|STARTED|Safety Extension||0
8140010|NCT02710526|20065460|P2|STARTED|Safety Extension||12
8140011|NCT02710526|20065461|P1|STARTED|Safety Extension||15
8140012|NCT02710526|20065459|P3|NOT COMPLETED|Treatment Phase||6
8140013|NCT02710526|20065460|P2|NOT COMPLETED|Treatment Phase||4
8140014|NCT02710526|20065461|P1|NOT COMPLETED|Treatment Phase||6
8140015|NCT02710526|20065459|P3|COMPLETED|Treatment Phase||12
8140016|NCT02710526|20065460|P2|COMPLETED|Treatment Phase||16
8140017|NCT02710526|20065461|P1|COMPLETED|Treatment Phase||22
8140018|NCT02710526|20065459|P3|STARTED|Treatment Phase||18
8140019|NCT02710526|20065460|P2|STARTED|Treatment Phase||20
8140020|NCT02710526|20065461|P1|STARTED|Treatment Phase||28
8140021|NCT02710422|20065541|P2|NOT COMPLETED|Overall Study||9
8140022|NCT02710422|20065542|P1|NOT COMPLETED|Overall Study||9
8140023|NCT02710422|20065541|P2|COMPLETED|Overall Study||3
8140024|NCT02710422|20065542|P1|COMPLETED|Overall Study||3
8140025|NCT02710422|20065541|P2|12 Month Visit|Overall Study||3
8140026|NCT02710422|20065542|P1|12 Month Visit|Overall Study||3
8140027|NCT02710422|20065541|P2|9 Month Visit|Overall Study||5
8140028|NCT02710422|20065542|P1|9 Month Visit|Overall Study||5
8140029|NCT02710422|20065541|P2|6 Month Visit|Overall Study||8
8140030|NCT02710422|20065542|P1|6 Month Visit|Overall Study||7
8140031|NCT02710422|20065541|P2|3 Month Visit|Overall Study||11
8140032|NCT02710422|20065542|P1|3 Month Visit|Overall Study||9
8140033|NCT02710422|20065541|P2|STARTED|Overall Study||12
8140034|NCT02710422|20065542|P1|STARTED|Overall Study||12
8140035|NCT02710292|20065558|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
8140036|NCT02710292|20065559|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
8140037|NCT02710292|20065558|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
8140038|NCT02710292|20065559|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
8140039|NCT02710292|20065558|P2|STARTED|Period 2, Second 10 Days of Wear||49
8140040|NCT02710292|20065559|P1|STARTED|Period 2, Second 10 Days of Wear||46
8140041|NCT02710292|20065558|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
8140042|NCT02710292|20065559|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
8140043|NCT02710292|20065558|P2|COMPLETED|Period 1, First 10 Days of Wear||49
8140044|NCT02710292|20065559|P1|COMPLETED|Period 1, First 10 Days of Wear||46
8140045|NCT02710292|20065558|P2|STARTED|Period 1, First 10 Days of Wear||52
8140046|NCT02710292|20065559|P1|STARTED|Period 1, First 10 Days of Wear||47
8140047|NCT02710214|20065568|P2|NOT COMPLETED|Overall Study||2
8140048|NCT02710214|20065569|P1|NOT COMPLETED|Overall Study||1
8140049|NCT02710214|20065568|P2|COMPLETED|Overall Study||10
8140050|NCT02710214|20065569|P1|COMPLETED|Overall Study||11
8140051|NCT02710214|20065568|P2|STARTED|Overall Study||12
8140052|NCT02710214|20065569|P1|STARTED|Overall Study||12
8140053|NCT02710136|20065603|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8140054|NCT02710136|20065604|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8140055|NCT02710136|20065603|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
8140056|NCT02710136|20065604|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8140057|NCT02710136|20065603|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
8140058|NCT02710136|20065604|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
8140059|NCT02710136|20065603|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8140060|NCT02710136|20065604|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8140061|NCT02710136|20065603|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8140062|NCT02710136|20065604|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
8140063|NCT02710136|20065603|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
8140064|NCT02710136|20065604|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
8140065|NCT02710136|20065603|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
8140066|NCT02710136|20065604|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
8140067|NCT02710136|20065603|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
8140068|NCT02710136|20065604|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
8140069|NCT02710136|20065603|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
8140070|NCT02710136|20065604|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
8140071|NCT02710136|20065603|P2|NOT COMPLETED|Study Enrollment||0
8140072|NCT02710136|20065604|P1|NOT COMPLETED|Study Enrollment||0
8140073|NCT02710136|20065603|P2|COMPLETED|Study Enrollment||25
8140074|NCT02710136|20065604|P1|COMPLETED|Study Enrollment||10
8140075|NCT02710136|20065603|P2|STARTED|Study Enrollment||25
8140076|NCT02710136|20065604|P1|STARTED|Study Enrollment||10
8140077|NCT02710071|20065629|P2|NOT COMPLETED|Second Intervention (6 Weeks).||2
8140078|NCT02710071|20065630|P1|NOT COMPLETED|Second Intervention (6 Weeks).||1
8140079|NCT02710071|20065629|P2|COMPLETED|Second Intervention (6 Weeks).||14
8140080|NCT02710071|20065630|P1|COMPLETED|Second Intervention (6 Weeks).||17
8140081|NCT02710071|20065629|P2|STARTED|Second Intervention (6 Weeks).||16
8140082|NCT02710071|20065630|P1|STARTED|Second Intervention (6 Weeks).||18
8140083|NCT02710071|20065629|P2|NOT COMPLETED|First Intervention (6 Weeks).||4
8140084|NCT02710071|20065630|P1|NOT COMPLETED|First Intervention (6 Weeks).||3
8140085|NCT02710071|20065629|P2|COMPLETED|First Intervention (6 Weeks).||16
8140086|NCT02710071|20065630|P1|COMPLETED|First Intervention (6 Weeks).||18
8140087|NCT02710071|20065629|P2|STARTED|First Intervention (6 Weeks).||20
8140088|NCT02710071|20065630|P1|STARTED|First Intervention (6 Weeks).||21
8140089|NCT02710071|20065629|P2|NOT COMPLETED|Placebo (2 Weeks).||0
8140090|NCT02710071|20065630|P1|NOT COMPLETED|Placebo (2 Weeks).||0
8140091|NCT02710071|20065629|P2|COMPLETED|Placebo (2 Weeks).||20
8140092|NCT02710071|20065630|P1|COMPLETED|Placebo (2 Weeks).||21
8140093|NCT02710071|20065629|P2|STARTED|Placebo (2 Weeks).||20
8140094|NCT02710071|20065630|P1|STARTED|Placebo (2 Weeks).||21
8140095|NCT02710045|20065640|P3|NOT COMPLETED|Overall Study||13
8140096|NCT02710045|20065641|P2|NOT COMPLETED|Overall Study||17
8140097|NCT02710045|20065642|P1|NOT COMPLETED|Overall Study||11
8140098|NCT02710045|20065640|P3|COMPLETED|Overall Study||68
8140099|NCT02710045|20065641|P2|COMPLETED|Overall Study||98
8140100|NCT02710045|20065642|P1|COMPLETED|Overall Study||95
8140101|NCT02710045|20065640|P3|STARTED|Overall Study||81
8140102|NCT02710045|20065641|P2|STARTED|Overall Study||115
8140103|NCT02710045|20065642|P1|STARTED|Overall Study||106
8140104|NCT02709889|20065676|P4|NOT COMPLETED|Overall Study||88
8140105|NCT02709889|20065677|P3|NOT COMPLETED|Overall Study||12
8140106|NCT02709889|20065678|P2|NOT COMPLETED|Overall Study||57
8140107|NCT02709889|20065679|P1|NOT COMPLETED|Overall Study||43
8140108|NCT02709889|20065676|P4|COMPLETED|Overall Study||0
8140109|NCT02709889|20065677|P3|COMPLETED|Overall Study||0
8140110|NCT02709889|20065678|P2|COMPLETED|Overall Study||0
8140111|NCT02709889|20065679|P1|COMPLETED|Overall Study||0
8140112|NCT02709889|20065676|P4|Other Solid Tumors|Overall Study||15
8140113|NCT02709889|20065677|P3|Other Solid Tumors|Overall Study||3
8140114|NCT02709889|20065678|P2|Other Solid Tumors|Overall Study||16
8140115|NCT02709889|20065679|P1|Other Solid Tumors|Overall Study||9
8140116|NCT02709889|20065676|P4|Glioblastoma|Overall Study||14
8140117|NCT02709889|20065677|P3|Glioblastoma|Overall Study||1
8140118|NCT02709889|20065678|P2|Glioblastoma|Overall Study||4
8140119|NCT02709889|20065679|P1|Glioblastoma|Overall Study||4
8140120|NCT02709889|20065676|P4|Medullary Thyroid Cancer|Overall Study||7
8140121|NCT02709889|20065677|P3|Medullary Thyroid Cancer|Overall Study||0
8140122|NCT02709889|20065678|P2|Medullary Thyroid Cancer|Overall Study||3
8140123|NCT02709889|20065679|P1|Medullary Thyroid Cancer|Overall Study||3
8140124|NCT02709889|20065676|P4|Malignant Melanoma|Overall Study||11
8140125|NCT02709889|20065677|P3|Malignant Melanoma|Overall Study||0
8140126|NCT02709889|20065678|P2|Malignant Melanoma|Overall Study||6
8140127|NCT02709889|20065679|P1|Malignant Melanoma|Overall Study||3
8140128|NCT02709889|20065676|P4|Other NEC|Overall Study||7
8140129|NCT02709889|20065677|P3|Other NEC|Overall Study||1
8140130|NCT02709889|20065678|P2|Other NEC|Overall Study||12
8140131|NCT02709889|20065679|P1|Other NEC|Overall Study||11
8140132|NCT02709889|20065676|P4|Gastroenteropancreatic NEC|Overall Study||23
8140133|NCT02709889|20065677|P3|Gastroenteropancreatic NEC|Overall Study||2
8140134|NCT02709889|20065678|P2|Gastroenteropancreatic NEC|Overall Study||5
8140135|NCT02709889|20065679|P1|Gastroenteropancreatic NEC|Overall Study||6
8140136|NCT02709889|20065676|P4|Neuroendocrine Prostate Cancer|Overall Study||7
8140137|NCT02709889|20065677|P3|Neuroendocrine Prostate Cancer|Overall Study||3
8140138|NCT02709889|20065678|P2|Neuroendocrine Prostate Cancer|Overall Study||7
8140139|NCT02709889|20065679|P1|Neuroendocrine Prostate Cancer|Overall Study||4
8140140|NCT02709889|20065676|P4|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
8140141|NCT02709889|20065677|P3|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
8140142|NCT02709889|20065678|P2|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
8140143|NCT02709889|20065679|P1|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
8140144|NCT02709889|20065676|P4|STARTED|Overall Study||88
8140145|NCT02709889|20065677|P3|STARTED|Overall Study||12
8140146|NCT02709889|20065678|P2|STARTED|Overall Study||57
8140147|NCT02709889|20065679|P1|STARTED|Overall Study||43
8140148|NCT02709785|20065760|P3|NOT COMPLETED|Overall Study||1
8140149|NCT02709785|20065761|P2|NOT COMPLETED|Overall Study||2
8140150|NCT02709785|20065762|P1|NOT COMPLETED|Overall Study||1
8140151|NCT02709785|20065760|P3|COMPLETED|Overall Study||27
8140152|NCT02709785|20065761|P2|COMPLETED|Overall Study||26
8140153|NCT02709785|20065762|P1|COMPLETED|Overall Study||23
8140154|NCT02709785|20065760|P3|6 Weeks|Overall Study||27
8140155|NCT02709785|20065761|P2|6 Weeks|Overall Study||26
8140156|NCT02709785|20065762|P1|6 Weeks|Overall Study||23
8140157|NCT02709785|20065760|P3|3 Weeks|Overall Study||27
8140158|NCT02709785|20065761|P2|3 Weeks|Overall Study||27
8140159|NCT02709785|20065762|P1|3 Weeks|Overall Study||23
8140160|NCT02709785|20065760|P3|STARTED|Overall Study||28
8140161|NCT02709785|20065761|P2|STARTED|Overall Study||28
8140162|NCT02709785|20065762|P1|STARTED|Overall Study||24
8140163|NCT02709746|20065787|P5|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
8140164|NCT02709746|20065788|P4|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
8140165|NCT02709746|20065789|P3|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
8140166|NCT02709746|20065790|P2|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
8140167|NCT02709746|20065791|P1|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
8140168|NCT02709746|20065787|P5|COMPLETED|Phase B (Double-blind Treatment Period)||138
8140169|NCT02709746|20065788|P4|COMPLETED|Phase B (Double-blind Treatment Period)||138
8140170|NCT02709746|20065789|P3|COMPLETED|Phase B (Double-blind Treatment Period)||140
8140171|NCT02709746|20065790|P2|COMPLETED|Phase B (Double-blind Treatment Period)||126
8140172|NCT02709746|20065791|P1|COMPLETED|Phase B (Double-blind Treatment Period)||0
8140173|NCT02709746|20065787|P5|STARTED|Phase B (Double-blind Treatment Period)||154
8140174|NCT02709746|20065788|P4|STARTED|Phase B (Double-blind Treatment Period)||153
8140175|NCT02709746|20065789|P3|STARTED|Phase B (Double-blind Treatment Period)||162
8140176|NCT02709746|20065790|P2|STARTED|Phase B (Double-blind Treatment Period)||147
8140177|NCT02709746|20065791|P1|STARTED|Phase B (Double-blind Treatment Period)||0
8140178|NCT02709746|20065787|P5|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140179|NCT02709746|20065788|P4|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140180|NCT02709746|20065789|P3|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140181|NCT02709746|20065790|P2|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140182|NCT02709746|20065791|P1|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
8140183|NCT02709746|20065787|P5|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140184|NCT02709746|20065788|P4|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140185|NCT02709746|20065789|P3|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140186|NCT02709746|20065790|P2|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140187|NCT02709746|20065791|P1|COMPLETED|Phase A (Single-blind Treatment Period)||616
8140188|NCT02709746|20065787|P5|STARTED|Phase A (Single-blind Treatment Period)||0
8140189|NCT02709746|20065788|P4|STARTED|Phase A (Single-blind Treatment Period)||0
8140190|NCT02709746|20065789|P3|STARTED|Phase A (Single-blind Treatment Period)||0
8140191|NCT02709746|20065790|P2|STARTED|Phase A (Single-blind Treatment Period)||0
8140192|NCT02709746|20065791|P1|STARTED|Phase A (Single-blind Treatment Period)||784
8140193|NCT02709577|20065913|P4|NOT COMPLETED|Overall Study||0
8140194|NCT02709577|20065914|P3|NOT COMPLETED|Overall Study||2
8140195|NCT02709577|20065915|P2|NOT COMPLETED|Overall Study||5
8140196|NCT02709577|20065916|P1|NOT COMPLETED|Overall Study||2
8140197|NCT02709577|20065913|P4|COMPLETED|Overall Study||5
8140198|NCT02709577|20065914|P3|COMPLETED|Overall Study||4
8140199|NCT02709577|20065915|P2|COMPLETED|Overall Study||8
8140200|NCT02709577|20065916|P1|COMPLETED|Overall Study||10
8140201|NCT02709577|20065913|P4|STARTED|Overall Study||5
8140202|NCT02709577|20065914|P3|STARTED|Overall Study||6
8140203|NCT02709577|20065915|P2|STARTED|Overall Study||13
8140204|NCT02709577|20065916|P1|STARTED|Overall Study||12
8140205|NCT02709538|20065931|P3|NOT COMPLETED|Overall Study||20
8140206|NCT02709538|20065932|P2|NOT COMPLETED|Overall Study||28
8140207|NCT02709538|20065933|P1|NOT COMPLETED|Overall Study||113
8140208|NCT02709538|20065931|P3|COMPLETED|Overall Study||81
8140209|NCT02709538|20065932|P2|COMPLETED|Overall Study||72
8140210|NCT02709538|20065933|P1|COMPLETED|Overall Study||287
8140211|NCT02709538|20065931|P3|STARTED|Overall Study||101
8140212|NCT02709538|20065932|P2|STARTED|Overall Study||100
8140213|NCT02709538|20065933|P1|STARTED|Overall Study||400
8140214|NCT02709486|20065944|P3|NOT COMPLETED|Overall Study||45
8140215|NCT02709486|20065945|P2|NOT COMPLETED|Overall Study||34
8140216|NCT02709486|20065946|P1|NOT COMPLETED|Overall Study||44
8140217|NCT02709486|20065944|P3|COMPLETED|Overall Study||239
8140218|NCT02709486|20065945|P2|COMPLETED|Overall Study||249
8140219|NCT02709486|20065946|P1|COMPLETED|Overall Study||238
8140220|NCT02709486|20065944|P3|STARTED|Overall Study||284
8140221|NCT02709486|20065945|P2|STARTED|Overall Study||283
8140222|NCT02709486|20065946|P1|STARTED|Overall Study||282
8140223|NCT02709369|20066137|P1|NOT COMPLETED|Overall Study||27
8140224|NCT02709369|20066137|P1|COMPLETED|Overall Study||273
8140225|NCT02709369|20066137|P1|STARTED|Overall Study||300
8140226|NCT02709330|20066171|P2|NOT COMPLETED|Overall Study||0
8140227|NCT02709330|20066172|P1|NOT COMPLETED|Overall Study||13
8140228|NCT02709330|20066171|P2|COMPLETED|Overall Study||10
8140229|NCT02709330|20066172|P1|COMPLETED|Overall Study||37
8140230|NCT02709330|20066171|P2|STARTED|Overall Study||10
8140231|NCT02709330|20066172|P1|STARTED|Overall Study||50
8140232|NCT02709096|20066186|P2|NOT COMPLETED|Overall Study||1
8140233|NCT02709096|20066187|P1|NOT COMPLETED|Overall Study||1
8140234|NCT02709096|20066186|P2|COMPLETED|Overall Study||10
8140235|NCT02709096|20066187|P1|COMPLETED|Overall Study||21
8140236|NCT02709096|20066186|P2|STARTED|Overall Study||11
8140237|NCT02709096|20066187|P1|STARTED|Overall Study||22
8140238|NCT02709083|20066193|P1|NOT COMPLETED|Overall Study||7
8140239|NCT02709083|20066193|P1|COMPLETED|Overall Study||0
8140240|NCT02709083|20066193|P1|STARTED|Overall Study||7
8140241|NCT02709005|20066206|P2|NOT COMPLETED|Overall Study||1
8140242|NCT02709005|20066207|P1|NOT COMPLETED|Overall Study||4
8140243|NCT02709005|20066206|P2|COMPLETED|Overall Study||35
8140244|NCT02709005|20066207|P1|COMPLETED|Overall Study||69
8140245|NCT02709005|20066206|P2|STARTED|Overall Study||36
8140246|NCT02709005|20066207|P1|STARTED|Overall Study||73
8140253|NCT02708862|20066280|P1|NOT COMPLETED|Overall Study||0
8140254|NCT02708862|20066280|P1|COMPLETED|Overall Study||26
8140255|NCT02708862|20066280|P1|STARTED|Overall Study||26
8140256|NCT02708849|20066289|P2|NOT COMPLETED|Overall Study||0
8140257|NCT02708849|20066290|P1|NOT COMPLETED|Overall Study||1
8140258|NCT02708849|20066289|P2|COMPLETED|Overall Study||1
8140259|NCT02708849|20066290|P1|COMPLETED|Overall Study||1
8140260|NCT02708849|20066289|P2|STARTED|Overall Study||1
8140261|NCT02708849|20066290|P1|STARTED|Overall Study||2
8140262|NCT02708745|20066302|P4|NOT COMPLETED|Overall Study||82
8140263|NCT02708745|20066303|P3|NOT COMPLETED|Overall Study||83
8140264|NCT02708745|20066304|P2|NOT COMPLETED|Overall Study||4
8140265|NCT02708745|20066305|P1|NOT COMPLETED|Overall Study||0
8140266|NCT02708745|20066302|P4|COMPLETED|Overall Study||116
8140267|NCT02708745|20066303|P3|COMPLETED|Overall Study||121
8140268|NCT02708745|20066304|P2|COMPLETED|Overall Study||65
8140269|NCT02708745|20066305|P1|COMPLETED|Overall Study||91
8140270|NCT02708745|20066302|P4|STARTED|Overall Study||198
8140271|NCT02708745|20066303|P3|STARTED|Overall Study||204
8140272|NCT02708745|20066304|P2|STARTED|Overall Study||69
8140273|NCT02708745|20066305|P1|STARTED|Overall Study||91
8140274|NCT02708524|20066321|P4|NOT COMPLETED|Overall Study||0
8140275|NCT02708524|20066322|P3|NOT COMPLETED|Overall Study||3
8140276|NCT02708524|20066323|P2|NOT COMPLETED|Overall Study||6
8140277|NCT02708524|20066324|P1|NOT COMPLETED|Overall Study||4
8140278|NCT02708524|20066321|P4|COMPLETED|Overall Study||136
8140279|NCT02708524|20066322|P3|COMPLETED|Overall Study||134
8140280|NCT02708524|20066323|P2|COMPLETED|Overall Study||130
8140281|NCT02708524|20066324|P1|COMPLETED|Overall Study||135
8140282|NCT02708524|20066321|P4|STARTED|Overall Study||136
8140283|NCT02708524|20066322|P3|STARTED|Overall Study||137
8140284|NCT02708524|20066323|P2|STARTED|Overall Study||136
8140285|NCT02708524|20066324|P1|STARTED|Overall Study||139
8140286|NCT02708498|20066378|P8|NOT COMPLETED|Overall Study||0
8140287|NCT02708498|20066379|P7|NOT COMPLETED|Overall Study||0
8140288|NCT02708498|20066380|P6|NOT COMPLETED|Overall Study||132
8140289|NCT02708498|20066381|P5|NOT COMPLETED|Overall Study||196
8140290|NCT02708498|20066382|P4|NOT COMPLETED|Overall Study||51
8140291|NCT02708498|20066383|P3|NOT COMPLETED|Overall Study||62
8140292|NCT02708498|20066384|P2|NOT COMPLETED|Overall Study||19
8140293|NCT02708498|20066385|P1|NOT COMPLETED|Overall Study||20
8140294|NCT02708498|20066378|P8|COMPLETED|Overall Study||48
8140295|NCT02708498|20066379|P7|COMPLETED|Overall Study||20
8140296|NCT02708498|20066380|P6|COMPLETED|Overall Study||198
8140297|NCT02708498|20066381|P5|COMPLETED|Overall Study||167
8140298|NCT02708498|20066382|P4|COMPLETED|Overall Study||105
8140299|NCT02708498|20066383|P3|COMPLETED|Overall Study||90
8140300|NCT02708498|20066384|P2|COMPLETED|Overall Study||21
8140301|NCT02708498|20066385|P1|COMPLETED|Overall Study||22
8140302|NCT02708498|20066378|P8|STARTED|Overall Study||48
8140303|NCT02708498|20066379|P7|STARTED|Overall Study||20
8140304|NCT02708498|20066380|P6|STARTED|Overall Study||330
8140305|NCT02708498|20066381|P5|STARTED|Overall Study||363
8140306|NCT02708498|20066382|P4|STARTED|Overall Study||156
8140307|NCT02708498|20066383|P3|STARTED|Overall Study||152
8140308|NCT02708498|20066384|P2|STARTED|Overall Study||40
8140309|NCT02708498|20066385|P1|STARTED|Overall Study||42
8140310|NCT02708485|20066413|P2|NOT COMPLETED|Overall Study||2
8140311|NCT02708485|20066414|P1|NOT COMPLETED|Overall Study||3
8140312|NCT02708485|20066413|P2|COMPLETED|Overall Study||10
8140313|NCT02708485|20066414|P1|COMPLETED|Overall Study||0
8140314|NCT02708485|20066413|P2|STARTED|Overall Study||12
8140315|NCT02708485|20066414|P1|STARTED|Overall Study||3
8140316|NCT02708433|20066422|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
8140317|NCT02708433|20066423|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
8140318|NCT02708433|20066422|P2|COMPLETED|Second Intervention (Visit 2)||11
8140319|NCT02708433|20066423|P1|COMPLETED|Second Intervention (Visit 2)||12
8140320|NCT02708433|20066422|P2|STARTED|Second Intervention (Visit 2)||11
8140321|NCT02708433|20066423|P1|STARTED|Second Intervention (Visit 2)||12
8140322|NCT02708433|20066422|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
8140323|NCT02708433|20066423|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
8140324|NCT02708433|20066422|P2|COMPLETED|Washout (at Least 1 Week)||11
8140325|NCT02708433|20066423|P1|COMPLETED|Washout (at Least 1 Week)||12
8140326|NCT02708433|20066422|P2|STARTED|Washout (at Least 1 Week)||11
8140327|NCT02708433|20066423|P1|STARTED|Washout (at Least 1 Week)||12
8140328|NCT02708433|20066422|P2|NOT COMPLETED|First Intervention (Visit 1)||0
8140329|NCT02708433|20066423|P1|NOT COMPLETED|First Intervention (Visit 1)||0
8140330|NCT02708433|20066422|P2|COMPLETED|First Intervention (Visit 1)||11
8140331|NCT02708433|20066423|P1|COMPLETED|First Intervention (Visit 1)||12
8140332|NCT02708433|20066422|P2|STARTED|First Intervention (Visit 1)||11
8140333|NCT02708433|20066423|P1|STARTED|First Intervention (Visit 1)||12
8140334|NCT02708355|20066434|P3|NOT COMPLETED|Overall Study||0
8140335|NCT02708355|20066435|P2|NOT COMPLETED|Overall Study||0
8140336|NCT02708355|20066436|P1|NOT COMPLETED|Overall Study||1
8140337|NCT02708355|20066434|P3|COMPLETED|Overall Study||12
8140338|NCT02708355|20066435|P2|COMPLETED|Overall Study||22
8140339|NCT02708355|20066436|P1|COMPLETED|Overall Study||20
8140340|NCT02708355|20066434|P3|STARTED|Overall Study||12
8140341|NCT02708355|20066435|P2|STARTED|Overall Study||22
8140342|NCT02708355|20066436|P1|STARTED|Overall Study||21
8140343|NCT02708290|20066449|P2|NOT COMPLETED|Overall Study||0
8140344|NCT02708290|20066450|P1|NOT COMPLETED|Overall Study||0
8140345|NCT02708290|20066449|P2|COMPLETED|Overall Study||1009
8140346|NCT02708290|20066450|P1|COMPLETED|Overall Study||1009
8140347|NCT02708290|20066449|P2|STARTED|Overall Study||1009
8140348|NCT02708290|20066450|P1|STARTED|Overall Study||1009
8140349|NCT02708277|20066458|P2|NOT COMPLETED|Overall Study||4
8140350|NCT02708277|20066459|P1|NOT COMPLETED|Overall Study||7
8140351|NCT02708277|20066458|P2|COMPLETED|Overall Study||39
8140352|NCT02708277|20066459|P1|COMPLETED|Overall Study||43
8140353|NCT02708277|20066458|P2|STARTED|Overall Study||43
8140354|NCT02708277|20066459|P1|STARTED|Overall Study||50
8140355|NCT02708238|20066474|P3|NOT COMPLETED|Overall Study||3
8140356|NCT02708238|20066475|P2|NOT COMPLETED|Overall Study||1
8140357|NCT02708238|20066476|P1|NOT COMPLETED|Overall Study||0
8140358|NCT02708238|20066474|P3|COMPLETED|Overall Study||57
8140359|NCT02708238|20066475|P2|COMPLETED|Overall Study||59
8140360|NCT02708238|20066476|P1|COMPLETED|Overall Study||60
8140361|NCT02708238|20066474|P3|STARTED|Overall Study||60
8140362|NCT02708238|20066475|P2|STARTED|Overall Study||60
8140363|NCT02708238|20066476|P1|STARTED|Overall Study||60
8140364|NCT02708212|20066489|P2|NOT COMPLETED|Overall Study||0
8140365|NCT02708212|20066490|P1|NOT COMPLETED|Overall Study||0
8140366|NCT02708212|20066489|P2|COMPLETED|Overall Study||60
8140367|NCT02708212|20066490|P1|COMPLETED|Overall Study||60
8140368|NCT02708212|20066489|P2|STARTED|Overall Study||60
8140369|NCT02708212|20066490|P1|STARTED|Overall Study||60
8140370|NCT02708186|20066502|P2|NOT COMPLETED|Overall Study||2
8140371|NCT02708186|20066503|P1|NOT COMPLETED|Overall Study||2
8140372|NCT02708186|20066502|P2|COMPLETED|Overall Study||16
8140373|NCT02708186|20066503|P1|COMPLETED|Overall Study||14
8140374|NCT02708186|20066502|P2|STARTED|Overall Study||18
8140375|NCT02708186|20066503|P1|STARTED|Overall Study||16
8140376|NCT02708121|20066511|P2|NOT COMPLETED|Overall Study||5
8140377|NCT02708121|20066512|P1|NOT COMPLETED|Overall Study||1
8140378|NCT02708121|20066511|P2|COMPLETED|Overall Study||26
8140379|NCT02708121|20066512|P1|COMPLETED|Overall Study||34
8140380|NCT02708121|20066511|P2|6 Month Weight Data Via EHR|Overall Study||13
8140381|NCT02708121|20066512|P1|6 Month Weight Data Via EHR|Overall Study||14
8140382|NCT02708121|20066511|P2|6 Month In-Person Follow Up Data|Overall Study||19
8140383|NCT02708121|20066512|P1|6 Month In-Person Follow Up Data|Overall Study||22
8140384|NCT02708121|20066511|P2|Treatment Program Use Data Available|Overall Study||24
8140385|NCT02708121|20066512|P1|Treatment Program Use Data Available|Overall Study||34
8140386|NCT02708121|20066511|P2|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
8140387|NCT02708121|20066512|P1|Provided Acceptability Data|Overall Study||20
8140388|NCT02708121|20066511|P2|STARTED|Overall Study||31
8140389|NCT02708121|20066512|P1|STARTED|Overall Study||35
8140390|NCT02708095|20066524|P3|NOT COMPLETED|Overall Study||18
8140391|NCT02708095|20066525|P2|NOT COMPLETED|Overall Study||19
8140392|NCT02708095|20066526|P1|NOT COMPLETED|Overall Study||22
8140393|NCT02708095|20066524|P3|COMPLETED|Overall Study||86
8140394|NCT02708095|20066525|P2|COMPLETED|Overall Study||86
8140395|NCT02708095|20066526|P1|COMPLETED|Overall Study||83
8140396|NCT02708095|20066524|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
8140397|NCT02708095|20066525|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
8140398|NCT02708095|20066526|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
8140399|NCT02708095|20066524|P3|STARTED|Overall Study||104
8140400|NCT02708095|20066525|P2|STARTED|Overall Study||105
8140401|NCT02708095|20066526|P1|STARTED|Overall Study||105
8140402|NCT02707991|20066549|P2|NOT COMPLETED|Overall Study||1
8140403|NCT02707991|20066550|P1|NOT COMPLETED|Overall Study||1
8140404|NCT02707991|20066549|P2|COMPLETED|Overall Study||34
8140405|NCT02707991|20066550|P1|COMPLETED|Overall Study||32
8140406|NCT02707991|20066549|P2|Month 6 Data Collection|Overall Study||34
8140407|NCT02707991|20066550|P1|Month 6 Data Collection|Overall Study||32
8140408|NCT02707991|20066549|P2|Day 60 Data Collectio|Overall Study||34
8140409|NCT02707991|20066550|P1|Day 60 Data Collectio|Overall Study||32
8140410|NCT02707991|20066549|P2|STARTED|Overall Study||35
8140411|NCT02707991|20066550|P1|STARTED|Overall Study||33
8140412|NCT02707965|20066567|P16|NOT COMPLETED|Overall Study||0
8140413|NCT02707965|20066568|P15|NOT COMPLETED|Overall Study||2
8140414|NCT02707965|20066569|P14|NOT COMPLETED|Overall Study||0
8140415|NCT02707965|20066570|P13|NOT COMPLETED|Overall Study||0
8140416|NCT02707965|20066571|P12|NOT COMPLETED|Overall Study||0
8140417|NCT02707965|20066572|P11|NOT COMPLETED|Overall Study||0
8140418|NCT02707965|20066573|P10|NOT COMPLETED|Overall Study||0
8140419|NCT02707965|20066574|P9|NOT COMPLETED|Overall Study||0
8140420|NCT02707965|20066575|P8|NOT COMPLETED|Overall Study||3
8140421|NCT02707965|20066576|P7|NOT COMPLETED|Overall Study||0
8140422|NCT02707965|20066577|P6|NOT COMPLETED|Overall Study||0
8140423|NCT02707965|20066578|P5|NOT COMPLETED|Overall Study||0
8140424|NCT02707965|20066579|P4|NOT COMPLETED|Overall Study||0
8140425|NCT02707965|20066580|P3|NOT COMPLETED|Overall Study||1
8140426|NCT02707965|20066581|P2|NOT COMPLETED|Overall Study||1
8140427|NCT02707965|20066582|P1|NOT COMPLETED|Overall Study||1
8140428|NCT02707965|20066567|P16|COMPLETED|Overall Study||0
8140429|NCT02707965|20066568|P15|COMPLETED|Overall Study||0
8140430|NCT02707965|20066569|P14|COMPLETED|Overall Study||2
8140431|NCT02707965|20066570|P13|COMPLETED|Overall Study||0
8140432|NCT02707965|20066571|P12|COMPLETED|Overall Study||0
8140433|NCT02707965|20066572|P11|COMPLETED|Overall Study||1
8140434|NCT02707965|20066573|P10|COMPLETED|Overall Study||0
8140435|NCT02707965|20066574|P9|COMPLETED|Overall Study||1
8140436|NCT02707965|20066575|P8|COMPLETED|Overall Study||0
8140437|NCT02707965|20066576|P7|COMPLETED|Overall Study||0
8140438|NCT02707965|20066577|P6|COMPLETED|Overall Study||1
8140439|NCT02707965|20066578|P5|COMPLETED|Overall Study||2
8140440|NCT02707965|20066579|P4|COMPLETED|Overall Study||0
8140441|NCT02707965|20066580|P3|COMPLETED|Overall Study||3
8140442|NCT02707965|20066581|P2|COMPLETED|Overall Study||1
8140443|NCT02707965|20066582|P1|COMPLETED|Overall Study||2
8140444|NCT02707965|20066567|P16|STARTED|Overall Study||0
8140445|NCT02707965|20066568|P15|STARTED|Overall Study||2
8140446|NCT02707965|20066569|P14|STARTED|Overall Study||2
8140447|NCT02707965|20066570|P13|STARTED|Overall Study||0
8140448|NCT02707965|20066571|P12|STARTED|Overall Study||0
8140449|NCT02707965|20066572|P11|STARTED|Overall Study||1
8140450|NCT02707965|20066573|P10|STARTED|Overall Study||0
8140451|NCT02707965|20066574|P9|STARTED|Overall Study||1
8140452|NCT02707965|20066575|P8|STARTED|Overall Study||3
8140453|NCT02707965|20066576|P7|STARTED|Overall Study||0
8140454|NCT02707965|20066577|P6|STARTED|Overall Study||1
8140455|NCT02707965|20066578|P5|STARTED|Overall Study||2
8140456|NCT02707965|20066579|P4|STARTED|Overall Study||0
8140457|NCT02707965|20066580|P3|STARTED|Overall Study||4
8140458|NCT02707965|20066581|P2|STARTED|Overall Study||2
8140459|NCT02707965|20066582|P1|STARTED|Overall Study||3
8140460|NCT02707952|20066634|P4|NOT COMPLETED|Overall Study||0
8140461|NCT02707952|20066635|P3|NOT COMPLETED|Overall Study||2
8140462|NCT02707952|20066636|P2|NOT COMPLETED|Overall Study||1
8140463|NCT02707952|20066637|P1|NOT COMPLETED|Overall Study||2
8140464|NCT02707952|20066634|P4|COMPLETED|Overall Study||10
8140465|NCT02707952|20066635|P3|COMPLETED|Overall Study||101
8140466|NCT02707952|20066636|P2|COMPLETED|Overall Study||52
8140467|NCT02707952|20066637|P1|COMPLETED|Overall Study||127
8140468|NCT02707952|20066634|P4|Participants Who Received Study Drug|Overall Study||10
8140469|NCT02707952|20066635|P3|Participants Who Received Study Drug|Overall Study||103
8140470|NCT02707952|20066636|P2|Participants Who Received Study Drug|Overall Study||52
8140471|NCT02707952|20066637|P1|Participants Who Received Study Drug|Overall Study||129
8140472|NCT02707952|20066634|P4|STARTED|Overall Study||10
8140473|NCT02707952|20066635|P3|STARTED|Overall Study||103
8140474|NCT02707952|20066636|P2|STARTED|Overall Study||53
8140475|NCT02707952|20066637|P1|STARTED|Overall Study||129
8140476|NCT02707640|20066658|P2|NOT COMPLETED|Overall Study||7
8140477|NCT02707640|20066659|P1|NOT COMPLETED|Overall Study||9
8140478|NCT02707640|20066658|P2|COMPLETED|Overall Study||55
8140479|NCT02707640|20066659|P1|COMPLETED|Overall Study||52
8140480|NCT02707640|20066658|P2|STARTED|Overall Study||62
8140481|NCT02707640|20066659|P1|STARTED|Overall Study||61
8140482|NCT02707601|20066679|P2|NOT COMPLETED|Overall Study||4
8140483|NCT02707601|20066680|P1|NOT COMPLETED|Overall Study||4
8140484|NCT02707601|20066679|P2|COMPLETED|Overall Study||70
8140485|NCT02707601|20066680|P1|COMPLETED|Overall Study||72
8140486|NCT02707601|20066679|P2|STARTED|Overall Study||74
8140487|NCT02707601|20066680|P1|STARTED|Overall Study||76
8140488|NCT02707523|20066697|P3|NOT COMPLETED|Overall Study||0
8140489|NCT02707523|20066698|P2|NOT COMPLETED|Overall Study||0
8140490|NCT02707523|20066699|P1|NOT COMPLETED|Overall Study||0
8140491|NCT02707523|20066697|P3|COMPLETED|Overall Study||16
8140492|NCT02707523|20066698|P2|COMPLETED|Overall Study||16
8140493|NCT02707523|20066699|P1|COMPLETED|Overall Study||16
8140494|NCT02707523|20066697|P3|STARTED|Overall Study||16
8140495|NCT02707523|20066698|P2|STARTED|Overall Study||16
8140496|NCT02707523|20066699|P1|STARTED|Overall Study||16
8140497|NCT02707432|20066739|P2|NOT COMPLETED|Overall Study||20
8140498|NCT02707432|20066740|P1|NOT COMPLETED|Overall Study||15
8140499|NCT02707432|20066739|P2|COMPLETED|Overall Study||51
8140500|NCT02707432|20066740|P1|COMPLETED|Overall Study||57
8140501|NCT02707432|20066739|P2|STARTED|Overall Study||71
8140502|NCT02707432|20066740|P1|STARTED|Overall Study||72
8140503|NCT02707172|20066750|P1|NOT COMPLETED|2nd Set of Experiment||0
8140504|NCT02707172|20066750|P1|COMPLETED|2nd Set of Experiment||28
8140505|NCT02707172|20066750|P1|STARTED|2nd Set of Experiment||28
8140506|NCT02707172|20066750|P1|NOT COMPLETED|Wash Out||0
8140507|NCT02707172|20066750|P1|COMPLETED|Wash Out||28
8140508|NCT02707172|20066750|P1|STARTED|Wash Out||28
8140509|NCT02707172|20066750|P1|NOT COMPLETED|1st Set of Experiment||0
8140510|NCT02707172|20066750|P1|COMPLETED|1st Set of Experiment||28
8140511|NCT02707172|20066750|P1|STARTED|1st Set of Experiment||28
8140512|NCT02707146|20066757|P2|NOT COMPLETED|Overall Study||3
8140513|NCT02707146|20066758|P1|NOT COMPLETED|Overall Study||0
8140514|NCT02707146|20066757|P2|COMPLETED|Overall Study||388
8140515|NCT02707146|20066758|P1|COMPLETED|Overall Study||359
8140516|NCT02707146|20066757|P2|STARTED|Overall Study||391
8140517|NCT02707146|20066758|P1|STARTED|Overall Study||359
8140527|NCT02706938|20066805|P2|NOT COMPLETED|Second Period, 6 Weeks||10
8140528|NCT02706938|20066806|P1|NOT COMPLETED|Second Period, 6 Weeks||0
8140529|NCT02706938|20066805|P2|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
8140530|NCT02706938|20066806|P1|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
8140531|NCT02706938|20066805|P2|STARTED|Second Period, 6 Weeks||31
8140532|NCT02706938|20066806|P1|STARTED|Second Period, 6 Weeks||21
8140533|NCT02706938|20066805|P2|NOT COMPLETED|First Period, 6 Weeks||2
8140534|NCT02706938|20066806|P1|NOT COMPLETED|First Period, 6 Weeks||11
8140535|NCT02706938|20066805|P2|COMPLETED|First Period, 6 Weeks||31
8140536|NCT02706938|20066806|P1|COMPLETED|First Period, 6 Weeks||21
8140537|NCT02706938|20066805|P2|STARTED|First Period, 6 Weeks||33
8140538|NCT02706938|20066806|P1|STARTED|First Period, 6 Weeks||32
8140539|NCT02706925|20066824|P9|NOT COMPLETED|Overall Study||0
8140540|NCT02706925|20066825|P8|NOT COMPLETED|Overall Study||0
8140541|NCT02706925|20066826|P7|NOT COMPLETED|Overall Study||0
8140542|NCT02706925|20066827|P6|NOT COMPLETED|Overall Study||0
8140543|NCT02706925|20066828|P5|NOT COMPLETED|Overall Study||0
8140544|NCT02706925|20066829|P4|NOT COMPLETED|Overall Study||0
8140545|NCT02706925|20066830|P3|NOT COMPLETED|Overall Study||0
8140546|NCT02706925|20066831|P2|NOT COMPLETED|Overall Study||0
8140547|NCT02706925|20066832|P1|NOT COMPLETED|Overall Study||0
8140548|NCT02706925|20066824|P9|COMPLETED|Overall Study||6
8140549|NCT02706925|20066825|P8|COMPLETED|Overall Study||6
8140550|NCT02706925|20066826|P7|COMPLETED|Overall Study||6
8140551|NCT02706925|20066827|P6|COMPLETED|Overall Study||5
8140552|NCT02706925|20066828|P5|COMPLETED|Overall Study||6
8140553|NCT02706925|20066829|P4|COMPLETED|Overall Study||6
8140554|NCT02706925|20066830|P3|COMPLETED|Overall Study||6
8140555|NCT02706925|20066831|P2|COMPLETED|Overall Study||6
8140556|NCT02706925|20066832|P1|COMPLETED|Overall Study||16
8140557|NCT02706925|20066824|P9|STARTED|Overall Study||6
8140558|NCT02706925|20066825|P8|STARTED|Overall Study||6
8140559|NCT02706925|20066826|P7|STARTED|Overall Study||6
8140560|NCT02706925|20066827|P6|STARTED|Overall Study||5
8140561|NCT02706925|20066828|P5|STARTED|Overall Study||6
8140562|NCT02706925|20066829|P4|STARTED|Overall Study||6
8140563|NCT02706925|20066830|P3|STARTED|Overall Study||6
8140564|NCT02706925|20066831|P2|STARTED|Overall Study||6
8140565|NCT02706925|20066832|P1|STARTED|Overall Study||16
8140566|NCT02706899|20066870|P2|NOT COMPLETED|Overall Study||6
8140567|NCT02706899|20066871|P1|NOT COMPLETED|Overall Study||13
8140568|NCT02706899|20066870|P2|COMPLETED|Overall Study||0
8140569|NCT02706899|20066871|P1|COMPLETED|Overall Study||0
8140570|NCT02706899|20066870|P2|STARTED|Overall Study||6
8140571|NCT02706899|20066871|P1|STARTED|Overall Study||13
8140572|NCT02706886|20066902|P9|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140573|NCT02706886|20066903|P8|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140574|NCT02706886|20066904|P7|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140575|NCT02706886|20066905|P6|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140576|NCT02706886|20066906|P5|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140577|NCT02706886|20066907|P4|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140578|NCT02706886|20066908|P3|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140579|NCT02706886|20066909|P2|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140580|NCT02706886|20066910|P1|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140581|NCT02706886|20066902|P9|COMPLETED|Part B: MAD Study Day 85-End of Study||4
8140582|NCT02706886|20066903|P8|COMPLETED|Part B: MAD Study Day 85-End of Study||8
8140583|NCT02706886|20066904|P7|COMPLETED|Part B: MAD Study Day 85-End of Study||8
8140584|NCT02706886|20066905|P6|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140585|NCT02706886|20066906|P5|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140586|NCT02706886|20066907|P4|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140587|NCT02706886|20066908|P3|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140588|NCT02706886|20066909|P2|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140589|NCT02706886|20066910|P1|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140590|NCT02706886|20066902|P9|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
8140591|NCT02706886|20066903|P8|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
8140592|NCT02706886|20066904|P7|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
8140593|NCT02706886|20066905|P6|STARTED|Part B: MAD Study Day 85-End of Study||0
8140594|NCT02706886|20066906|P5|STARTED|Part B: MAD Study Day 85-End of Study||0
8140595|NCT02706886|20066907|P4|STARTED|Part B: MAD Study Day 85-End of Study||0
8140596|NCT02706886|20066908|P3|STARTED|Part B: MAD Study Day 85-End of Study||0
8140597|NCT02706886|20066909|P2|STARTED|Part B: MAD Study Day 85-End of Study||0
8140598|NCT02706886|20066910|P1|STARTED|Part B: MAD Study Day 85-End of Study||0
8140599|NCT02706886|20066902|P9|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140600|NCT02706886|20066903|P8|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140601|NCT02706886|20066904|P7|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140602|NCT02706886|20066905|P6|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140603|NCT02706886|20066906|P5|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140604|NCT02706886|20066907|P4|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140605|NCT02706886|20066908|P3|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140606|NCT02706886|20066909|P2|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140607|NCT02706886|20066910|P1|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140608|NCT02706886|20066902|P9|COMPLETED|Part B: MAD Study Days 1-85||3
8140609|NCT02706886|20066903|P8|COMPLETED|Part B: MAD Study Days 1-85||7
8140610|NCT02706886|20066904|P7|COMPLETED|Part B: MAD Study Days 1-85||7
8140611|NCT02706886|20066905|P6|COMPLETED|Part B: MAD Study Days 1-85||3
8140612|NCT02706886|20066906|P5|COMPLETED|Part B: MAD Study Days 1-85||0
8140613|NCT02706886|20066907|P4|COMPLETED|Part B: MAD Study Days 1-85||0
8140614|NCT02706886|20066908|P3|COMPLETED|Part B: MAD Study Days 1-85||0
8140615|NCT02706886|20066909|P2|COMPLETED|Part B: MAD Study Days 1-85||0
8140616|NCT02706886|20066910|P1|COMPLETED|Part B: MAD Study Days 1-85||0
8140617|NCT02706886|20066902|P9|STARTED|Part B: MAD Study Days 1-85||3
8140618|NCT02706886|20066903|P8|STARTED|Part B: MAD Study Days 1-85||7
8140619|NCT02706886|20066904|P7|STARTED|Part B: MAD Study Days 1-85||7
8140620|NCT02706886|20066905|P6|STARTED|Part B: MAD Study Days 1-85||3
8140621|NCT02706886|20066906|P5|STARTED|Part B: MAD Study Days 1-85||0
8140622|NCT02706886|20066907|P4|STARTED|Part B: MAD Study Days 1-85||0
8140623|NCT02706886|20066908|P3|STARTED|Part B: MAD Study Days 1-85||0
8140624|NCT02706886|20066909|P2|STARTED|Part B: MAD Study Days 1-85||0
8140625|NCT02706886|20066910|P1|STARTED|Part B: MAD Study Days 1-85||0
8140626|NCT02706886|20066902|P9|NOT COMPLETED|Part A: SAD Period||0
8140627|NCT02706886|20066903|P8|NOT COMPLETED|Part A: SAD Period||0
8140628|NCT02706886|20066904|P7|NOT COMPLETED|Part A: SAD Period||0
8140629|NCT02706886|20066905|P6|NOT COMPLETED|Part A: SAD Period||0
8140630|NCT02706886|20066906|P5|NOT COMPLETED|Part A: SAD Period||0
8140631|NCT02706886|20066907|P4|NOT COMPLETED|Part A: SAD Period||2
8140632|NCT02706886|20066908|P3|NOT COMPLETED|Part A: SAD Period||0
8140633|NCT02706886|20066909|P2|NOT COMPLETED|Part A: SAD Period||0
8140634|NCT02706886|20066910|P1|NOT COMPLETED|Part A: SAD Period||0
8140635|NCT02706886|20066902|P9|COMPLETED|Part A: SAD Period||0
8140636|NCT02706886|20066903|P8|COMPLETED|Part A: SAD Period||0
8140637|NCT02706886|20066904|P7|COMPLETED|Part A: SAD Period||0
8140638|NCT02706886|20066905|P6|COMPLETED|Part A: SAD Period||0
8140639|NCT02706886|20066906|P5|COMPLETED|Part A: SAD Period||6
8140640|NCT02706886|20066907|P4|COMPLETED|Part A: SAD Period||4
8140641|NCT02706886|20066908|P3|COMPLETED|Part A: SAD Period||6
8140642|NCT02706886|20066909|P2|COMPLETED|Part A: SAD Period||6
8140643|NCT02706886|20066910|P1|COMPLETED|Part A: SAD Period||8
8140644|NCT02706886|20066902|P9|STARTED|Part A: SAD Period||0
8140645|NCT02706886|20066903|P8|STARTED|Part A: SAD Period||0
8140646|NCT02706886|20066904|P7|STARTED|Part A: SAD Period||0
8140647|NCT02706886|20066905|P6|STARTED|Part A: SAD Period||0
8140648|NCT02706886|20066906|P5|STARTED|Part A: SAD Period||6
8140649|NCT02706886|20066907|P4|STARTED|Part A: SAD Period||6
8140650|NCT02706886|20066908|P3|STARTED|Part A: SAD Period||6
8140651|NCT02706886|20066909|P2|STARTED|Part A: SAD Period||6
8140652|NCT02706886|20066910|P1|STARTED|Part A: SAD Period||8
8140709|NCT02706834|20067175|P11|NOT COMPLETED|Overall Study||1
8140710|NCT02706834|20067176|P10|NOT COMPLETED|Overall Study||1
8140711|NCT02706834|20067177|P9|NOT COMPLETED|Overall Study||0
8140712|NCT02706834|20067178|P8|NOT COMPLETED|Overall Study||0
8140713|NCT02706834|20067179|P7|NOT COMPLETED|Overall Study||0
8140714|NCT02706834|20067180|P6|NOT COMPLETED|Overall Study||0
8140715|NCT02706834|20067181|P5|NOT COMPLETED|Overall Study||1
8140716|NCT02706834|20067182|P4|NOT COMPLETED|Overall Study||0
8140717|NCT02706834|20067183|P3|NOT COMPLETED|Overall Study||1
8140718|NCT02706834|20067184|P2|NOT COMPLETED|Overall Study||1
8140719|NCT02706834|20067185|P1|NOT COMPLETED|Overall Study||2
8140720|NCT02706834|20067175|P11|COMPLETED|Overall Study||3
8140721|NCT02706834|20067176|P10|COMPLETED|Overall Study||3
8140722|NCT02706834|20067177|P9|COMPLETED|Overall Study||4
8140723|NCT02706834|20067178|P8|COMPLETED|Overall Study||3
8140724|NCT02706834|20067179|P7|COMPLETED|Overall Study||3
8140725|NCT02706834|20067180|P6|COMPLETED|Overall Study||3
8140726|NCT02706834|20067181|P5|COMPLETED|Overall Study||2
8140727|NCT02706834|20067182|P4|COMPLETED|Overall Study||3
8140728|NCT02706834|20067183|P3|COMPLETED|Overall Study||2
8140729|NCT02706834|20067184|P2|COMPLETED|Overall Study||2
8140730|NCT02706834|20067185|P1|COMPLETED|Overall Study|Completed = completed study drug|1
8140731|NCT02706834|20067175|P11|STARTED|Overall Study||4
8140732|NCT02706834|20067176|P10|STARTED|Overall Study||4
8140733|NCT02706834|20067177|P9|STARTED|Overall Study||4
8140734|NCT02706834|20067178|P8|STARTED|Overall Study||3
8140735|NCT02706834|20067179|P7|STARTED|Overall Study||3
8140736|NCT02706834|20067180|P6|STARTED|Overall Study||3
8140737|NCT02706834|20067181|P5|STARTED|Overall Study||3
8140738|NCT02706834|20067182|P4|STARTED|Overall Study||3
8140739|NCT02706834|20067183|P3|STARTED|Overall Study||3
8140740|NCT02706834|20067184|P2|STARTED|Overall Study||3
8140741|NCT02706834|20067185|P1|STARTED|Overall Study||3
8140742|NCT02706717|20067329|P2|NOT COMPLETED|Overall Study||11
8140743|NCT02706717|20067330|P1|NOT COMPLETED|Overall Study||1
8140744|NCT02706717|20067329|P2|COMPLETED|Overall Study||35
8140745|NCT02706717|20067330|P1|COMPLETED|Overall Study||46
8140746|NCT02706717|20067329|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
8140747|NCT02706717|20067330|P1|STARTED|Overall Study||47
8140748|NCT02706691|20067394|P1|NOT COMPLETED|Overall Study||1
8140749|NCT02706691|20067394|P1|COMPLETED|Overall Study||0
8140750|NCT02706691|20067394|P1|STARTED|Overall Study||1
8140751|NCT02706483|20067401|P1|NOT COMPLETED|Overall Study||430
8140752|NCT02706483|20067401|P1|COMPLETED|Overall Study||1842
8140753|NCT02706483|20067401|P1|STARTED|Overall Study||2272
8140754|NCT02706327|20067408|P3|NOT COMPLETED|Overall Study||2
8140755|NCT02706327|20067409|P2|NOT COMPLETED|Overall Study||1
8140756|NCT02706327|20067410|P1|NOT COMPLETED|Overall Study||1
8140757|NCT02706327|20067408|P3|COMPLETED|Overall Study||21
8140758|NCT02706327|20067409|P2|COMPLETED|Overall Study||21
8140759|NCT02706327|20067410|P1|COMPLETED|Overall Study||21
8140760|NCT02706327|20067408|P3|STARTED|Overall Study||23
8140761|NCT02706327|20067409|P2|STARTED|Overall Study||22
8140762|NCT02706327|20067410|P1|STARTED|Overall Study||22
8140763|NCT02705807|20067430|P1|NOT COMPLETED|Overall Study||0
8140764|NCT02705807|20067430|P1|COMPLETED|Overall Study||10
8140765|NCT02705807|20067430|P1|STARTED|Overall Study||10
8140766|NCT02705716|20067462|P2|NOT COMPLETED|Overall Study||2
8140767|NCT02705716|20067463|P1|NOT COMPLETED|Overall Study||4
8140768|NCT02705716|20067462|P2|COMPLETED|Overall Study||68
8140769|NCT02705716|20067463|P1|COMPLETED|Overall Study||68
8140770|NCT02705716|20067462|P2|STARTED|Overall Study||70
8140771|NCT02705716|20067463|P1|STARTED|Overall Study||72
8140772|NCT02705625|20067476|P3|NOT COMPLETED|Overall Study||11
8140773|NCT02705625|20067477|P2|NOT COMPLETED|Overall Study||10
8140774|NCT02705625|20067478|P1|NOT COMPLETED|Overall Study||8
8140775|NCT02705625|20067476|P3|COMPLETED|Overall Study||69
8140776|NCT02705625|20067477|P2|COMPLETED|Overall Study||72
8140777|NCT02705625|20067478|P1|COMPLETED|Overall Study||74
8140778|NCT02705625|20067476|P3|STARTED|Overall Study||80
8140779|NCT02705625|20067477|P2|STARTED|Overall Study||82
8140780|NCT02705625|20067478|P1|STARTED|Overall Study||82
8140781|NCT02705586|20067507|P1|NOT COMPLETED|Overall Study||8
8140782|NCT02705586|20067507|P1|COMPLETED|Overall Study||5
8140783|NCT02705586|20067507|P1|STARTED|Overall Study||13
8140784|NCT02705365|20067513|P2|NOT COMPLETED|Overall Study||0
8140785|NCT02705365|20067514|P1|NOT COMPLETED|Overall Study||0
8140786|NCT02705365|20067513|P2|COMPLETED|Overall Study||800
8140787|NCT02705365|20067514|P1|COMPLETED|Overall Study||400
8140788|NCT02705365|20067513|P2|STARTED|Overall Study||800
8140789|NCT02705365|20067514|P1|STARTED|Overall Study||400
8140790|NCT02705352|20067524|P2|NOT COMPLETED|Overall Study||0
8140791|NCT02705352|20067525|P1|NOT COMPLETED|Overall Study||0
8140792|NCT02705352|20067524|P2|COMPLETED|Overall Study||0
8140793|NCT02705352|20067525|P1|COMPLETED|Overall Study||1
8140794|NCT02705352|20067524|P2|STARTED|Overall Study||0
8140795|NCT02705352|20067525|P1|STARTED|Overall Study||1
8140796|NCT02705105|20067545|P2|NOT COMPLETED|Follow-Up||110
8140797|NCT02705105|20067546|P1|NOT COMPLETED|Follow-Up||4
8140798|NCT02705105|20067545|P2|COMPLETED|Follow-Up||0
8140799|NCT02705105|20067546|P1|COMPLETED|Follow-Up||0
8140800|NCT02705105|20067545|P2|STARTED|Follow-Up||110
8140801|NCT02705105|20067546|P1|STARTED|Follow-Up||4
8140802|NCT02705105|20067545|P2|NOT COMPLETED|Treatment||109
8140803|NCT02705105|20067546|P1|NOT COMPLETED|Treatment||4
8140804|NCT02705105|20067545|P2|COMPLETED|Treatment||1
8140805|NCT02705105|20067546|P1|COMPLETED|Treatment||0
8140806|NCT02705105|20067545|P2|D/C From Follow-Up|Treatment||110
8140807|NCT02705105|20067546|P1|D/C From Follow-Up|Treatment||4
8140808|NCT02705105|20067545|P2|D/C From Treatment Phase|Treatment||107
8140809|NCT02705105|20067546|P1|D/C From Treatment Phase|Treatment||4
8140810|NCT02705105|20067545|P2|Subjects Who Were Replaced|Treatment||0
8140811|NCT02705105|20067546|P1|Subjects Who Were Replaced|Treatment||1
8140812|NCT02705105|20067545|P2|STARTED|Treatment||110
8140813|NCT02705105|20067546|P1|STARTED|Treatment||4
8140814|NCT02704702|20067572|P6|NOT COMPLETED|Overall Study||2
8140815|NCT02704702|20067573|P5|NOT COMPLETED|Overall Study||2
8140816|NCT02704702|20067574|P4|NOT COMPLETED|Overall Study||1
8140817|NCT02704702|20067575|P3|NOT COMPLETED|Overall Study||0
8140818|NCT02704702|20067576|P2|NOT COMPLETED|Overall Study||0
8140819|NCT02704702|20067577|P1|NOT COMPLETED|Overall Study||1
8140820|NCT02704702|20067572|P6|COMPLETED|Overall Study||4
8140821|NCT02704702|20067573|P5|COMPLETED|Overall Study||4
8140822|NCT02704702|20067574|P4|COMPLETED|Overall Study||5
8140823|NCT02704702|20067575|P3|COMPLETED|Overall Study||6
8140824|NCT02704702|20067576|P2|COMPLETED|Overall Study||6
8140825|NCT02704702|20067577|P1|COMPLETED|Overall Study||5
8140826|NCT02704702|20067572|P6|STARTED|Overall Study||6
8140827|NCT02704702|20067573|P5|STARTED|Overall Study||6
8140828|NCT02704702|20067574|P4|STARTED|Overall Study||6
8140829|NCT02704702|20067575|P3|STARTED|Overall Study||6
8140830|NCT02704702|20067576|P2|STARTED|Overall Study||6
8140831|NCT02704702|20067577|P1|STARTED|Overall Study||6
8140832|NCT02704689|20067609|P1|NOT COMPLETED|Overall Study||3
8140833|NCT02704689|20067609|P1|COMPLETED|Overall Study||6
8140834|NCT02704689|20067609|P1|STARTED|Overall Study||9
8140835|NCT02704143|20067626|P1|NOT COMPLETED|Overall Study||10
8140836|NCT02704143|20067626|P1|COMPLETED|Overall Study||53
8140837|NCT02704143|20067626|P1|STARTED|Overall Study||63
8140838|NCT02704104|20067635|P1|NOT COMPLETED|Overall Study||0
8140839|NCT02704104|20067635|P1|COMPLETED|Overall Study||46
8140840|NCT02704104|20067635|P1|STARTED|Overall Study||46
8140841|NCT02704091|20067651|P2|NOT COMPLETED|Overall Study||23
8140842|NCT02704091|20067652|P1|NOT COMPLETED|Overall Study||28
8140843|NCT02704091|20067651|P2|COMPLETED|Overall Study||400
8140844|NCT02704091|20067652|P1|COMPLETED|Overall Study||402
8140845|NCT02704091|20067651|P2|STARTED|Overall Study||423
8140846|NCT02704091|20067652|P1|STARTED|Overall Study||430
8140847|NCT02703987|20067674|P2|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
8140848|NCT02703987|20067675|P1|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
8140849|NCT02703987|20067674|P2|COMPLETED|Visit 4 Intervention (1 Day)||10
8140850|NCT02703987|20067675|P1|COMPLETED|Visit 4 Intervention (1 Day)||12
8140851|NCT02703987|20067674|P2|STARTED|Visit 4 Intervention (1 Day)||11
8140852|NCT02703987|20067675|P1|STARTED|Visit 4 Intervention (1 Day)||13
8140853|NCT02703987|20067674|P2|NOT COMPLETED|Washout (Minimum 5 Days)||0
8140854|NCT02703987|20067675|P1|NOT COMPLETED|Washout (Minimum 5 Days)||0
8140855|NCT02703987|20067674|P2|COMPLETED|Washout (Minimum 5 Days)||11
8140856|NCT02703987|20067675|P1|COMPLETED|Washout (Minimum 5 Days)||13
8140857|NCT02703987|20067674|P2|STARTED|Washout (Minimum 5 Days)||11
8140858|NCT02703987|20067675|P1|STARTED|Washout (Minimum 5 Days)||13
8140859|NCT02703987|20067674|P2|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
8140860|NCT02703987|20067675|P1|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
8140861|NCT02703987|20067674|P2|COMPLETED|Visit 3 Intervention (1 Day)||11
8140862|NCT02703987|20067675|P1|COMPLETED|Visit 3 Intervention (1 Day)||13
8140863|NCT02703987|20067674|P2|STARTED|Visit 3 Intervention (1 Day)||14
8140864|NCT02703987|20067675|P1|STARTED|Visit 3 Intervention (1 Day)||14
8140865|NCT02703948|20067685|P1|NOT COMPLETED|Overall Study||3
8140866|NCT02703948|20067685|P1|COMPLETED|Overall Study||57
8140867|NCT02703948|20067685|P1|STARTED|Overall Study||60
8140868|NCT02703909|20067693|P4|NOT COMPLETED|Overall Study||0
8140869|NCT02703909|20067694|P3|NOT COMPLETED|Overall Study||0
8140870|NCT02703909|20067695|P2|NOT COMPLETED|Overall Study||0
8140871|NCT02703909|20067696|P1|NOT COMPLETED|Overall Study||0
8140872|NCT02703909|20067693|P4|COMPLETED|Overall Study||35
8140873|NCT02703909|20067694|P3|COMPLETED|Overall Study||36
8140874|NCT02703909|20067695|P2|COMPLETED|Overall Study||37
8140875|NCT02703909|20067696|P1|COMPLETED|Overall Study||36
8140876|NCT02703909|20067693|P4|STARTED|Overall Study||35
8140877|NCT02703909|20067694|P3|STARTED|Overall Study||36
8140878|NCT02703909|20067695|P2|STARTED|Overall Study||37
8140879|NCT02703909|20067696|P1|STARTED|Overall Study||36
8140880|NCT02703636|20067712|P1|NOT COMPLETED|Overall Study||16
8140881|NCT02703636|20067712|P1|COMPLETED|Overall Study||102
8140882|NCT02703636|20067712|P1|STARTED|Overall Study||118
8140883|NCT02703532|20067727|P4|NOT COMPLETED|Overall Study||1
8140884|NCT02703532|20067728|P3|NOT COMPLETED|Overall Study||2
8140885|NCT02703532|20067729|P2|NOT COMPLETED|Overall Study||1
8140886|NCT02703532|20067730|P1|NOT COMPLETED|Overall Study||2
8140887|NCT02703532|20067727|P4|COMPLETED|Overall Study||10
8140888|NCT02703532|20067728|P3|COMPLETED|Overall Study||19
8140889|NCT02703532|20067729|P2|COMPLETED|Overall Study||10
8140890|NCT02703532|20067730|P1|COMPLETED|Overall Study||19
8140891|NCT02703532|20067727|P4|STARTED|Overall Study||11
8140892|NCT02703532|20067728|P3|STARTED|Overall Study||21
8140893|NCT02703532|20067729|P2|STARTED|Overall Study||11
8140894|NCT02703532|20067730|P1|STARTED|Overall Study||21
8140895|NCT02703467|20067768|P3|NOT COMPLETED|Overall Study||0
8140896|NCT02703467|20067769|P2|NOT COMPLETED|Overall Study||0
8140897|NCT02703467|20067770|P1|NOT COMPLETED|Overall Study||0
8140898|NCT02703467|20067768|P3|COMPLETED|Overall Study||45
8140899|NCT02703467|20067769|P2|COMPLETED|Overall Study||5
8140900|NCT02703467|20067770|P1|COMPLETED|Overall Study||20
8140901|NCT02703467|20067768|P3|STARTED|Overall Study||45
8140902|NCT02703467|20067769|P2|STARTED|Overall Study||5
8140903|NCT02703467|20067770|P1|STARTED|Overall Study||20
8140904|NCT02703454|20067792|P2|NOT COMPLETED|Overall Study||16
8140905|NCT02703454|20067793|P1|NOT COMPLETED|Overall Study||11
8140906|NCT02703454|20067792|P2|COMPLETED|Overall Study||11
8140907|NCT02703454|20067793|P1|COMPLETED|Overall Study||13
8140908|NCT02703454|20067792|P2|Treated|Overall Study||24
8140909|NCT02703454|20067793|P1|Treated|Overall Study||23
8140910|NCT02703454|20067792|P2|STARTED|Overall Study||27
8140911|NCT02703454|20067793|P1|STARTED|Overall Study||24
8140912|NCT02703350|20067801|P8|NOT COMPLETED|Part B||0
8140913|NCT02703350|20067802|P7|NOT COMPLETED|Part B||0
8140914|NCT02703350|20067803|P6|NOT COMPLETED|Part B||0
8140915|NCT02703350|20067804|P5|NOT COMPLETED|Part B||0
8140916|NCT02703350|20067805|P4|NOT COMPLETED|Part B||0
8140917|NCT02703350|20067806|P3|NOT COMPLETED|Part B||0
8140918|NCT02703350|20067807|P2|NOT COMPLETED|Part B||0
8140919|NCT02703350|20067808|P1|NOT COMPLETED|Part B||0
8140920|NCT02703350|20067801|P8|COMPLETED|Part B||15
8140921|NCT02703350|20067802|P7|COMPLETED|Part B||15
8140922|NCT02703350|20067803|P6|COMPLETED|Part B||0
8140923|NCT02703350|20067804|P5|COMPLETED|Part B||0
8140924|NCT02703350|20067805|P4|COMPLETED|Part B||0
8140925|NCT02703350|20067806|P3|COMPLETED|Part B||0
8140926|NCT02703350|20067807|P2|COMPLETED|Part B||0
8140927|NCT02703350|20067808|P1|COMPLETED|Part B||0
8140928|NCT02703350|20067801|P8|Received Study Drug|Part B||15
8140929|NCT02703350|20067802|P7|Received Study Drug|Part B||15
8140930|NCT02703350|20067803|P6|Received Study Drug|Part B||0
8140931|NCT02703350|20067804|P5|Received Study Drug|Part B||0
8140932|NCT02703350|20067805|P4|Received Study Drug|Part B||0
8140933|NCT02703350|20067806|P3|Received Study Drug|Part B||0
8140934|NCT02703350|20067807|P2|Received Study Drug|Part B||0
8140935|NCT02703350|20067808|P1|Received Study Drug|Part B||0
8140936|NCT02703350|20067801|P8|STARTED|Part B||15
8140937|NCT02703350|20067802|P7|STARTED|Part B||15
8140938|NCT02703350|20067803|P6|STARTED|Part B||0
8140939|NCT02703350|20067804|P5|STARTED|Part B||0
8140940|NCT02703350|20067805|P4|STARTED|Part B||0
8140941|NCT02703350|20067806|P3|STARTED|Part B||0
8140942|NCT02703350|20067807|P2|STARTED|Part B||0
8140943|NCT02703350|20067808|P1|STARTED|Part B||0
8140944|NCT02703350|20067801|P8|NOT COMPLETED|Period Six (Part A)||0
8140945|NCT02703350|20067802|P7|NOT COMPLETED|Period Six (Part A)||0
8140946|NCT02703350|20067803|P6|NOT COMPLETED|Period Six (Part A)||0
8140947|NCT02703350|20067804|P5|NOT COMPLETED|Period Six (Part A)||0
8140948|NCT02703350|20067805|P4|NOT COMPLETED|Period Six (Part A)||0
8140949|NCT02703350|20067806|P3|NOT COMPLETED|Period Six (Part A)||0
8140950|NCT02703350|20067807|P2|NOT COMPLETED|Period Six (Part A)||0
8140951|NCT02703350|20067808|P1|NOT COMPLETED|Period Six (Part A)||0
8140952|NCT02703350|20067801|P8|COMPLETED|Period Six (Part A)||0
8140953|NCT02703350|20067802|P7|COMPLETED|Period Six (Part A)||0
8140954|NCT02703350|20067803|P6|COMPLETED|Period Six (Part A)||5
8140955|NCT02703350|20067804|P5|COMPLETED|Period Six (Part A)||5
8140956|NCT02703350|20067805|P4|COMPLETED|Period Six (Part A)||5
8140957|NCT02703350|20067806|P3|COMPLETED|Period Six (Part A)||5
8140958|NCT02703350|20067807|P2|COMPLETED|Period Six (Part A)||5
8140959|NCT02703350|20067808|P1|COMPLETED|Period Six (Part A)||5
8140960|NCT02703350|20067801|P8|Received Study Drug|Period Six (Part A)||0
8140961|NCT02703350|20067802|P7|Received Study Drug|Period Six (Part A)||0
8140962|NCT02703350|20067803|P6|Received Study Drug|Period Six (Part A)||5
8140963|NCT02703350|20067804|P5|Received Study Drug|Period Six (Part A)||5
8140964|NCT02703350|20067805|P4|Received Study Drug|Period Six (Part A)||5
8140965|NCT02703350|20067806|P3|Received Study Drug|Period Six (Part A)||5
8140966|NCT02703350|20067807|P2|Received Study Drug|Period Six (Part A)||5
8140967|NCT02703350|20067808|P1|Received Study Drug|Period Six (Part A)||5
8140968|NCT02703350|20067801|P8|STARTED|Period Six (Part A)||0
8140969|NCT02703350|20067802|P7|STARTED|Period Six (Part A)||0
8140970|NCT02703350|20067803|P6|STARTED|Period Six (Part A)||5
8140971|NCT02703350|20067804|P5|STARTED|Period Six (Part A)||5
8140972|NCT02703350|20067805|P4|STARTED|Period Six (Part A)||5
8140973|NCT02703350|20067806|P3|STARTED|Period Six (Part A)||5
8140974|NCT02703350|20067807|P2|STARTED|Period Six (Part A)||5
8140975|NCT02703350|20067808|P1|STARTED|Period Six (Part A)||5
8140976|NCT02703350|20067801|P8|NOT COMPLETED|Period Five (Part A)||0
8140977|NCT02703350|20067802|P7|NOT COMPLETED|Period Five (Part A)||0
8140978|NCT02703350|20067803|P6|NOT COMPLETED|Period Five (Part A)||0
8140979|NCT02703350|20067804|P5|NOT COMPLETED|Period Five (Part A)||0
8140980|NCT02703350|20067805|P4|NOT COMPLETED|Period Five (Part A)||0
8140981|NCT02703350|20067806|P3|NOT COMPLETED|Period Five (Part A)||0
8140982|NCT02703350|20067807|P2|NOT COMPLETED|Period Five (Part A)||0
8140983|NCT02703350|20067808|P1|NOT COMPLETED|Period Five (Part A)||0
8140984|NCT02703350|20067801|P8|COMPLETED|Period Five (Part A)||0
8140985|NCT02703350|20067802|P7|COMPLETED|Period Five (Part A)||0
8140986|NCT02703350|20067803|P6|COMPLETED|Period Five (Part A)||5
8140987|NCT02703350|20067804|P5|COMPLETED|Period Five (Part A)||5
8140988|NCT02703350|20067805|P4|COMPLETED|Period Five (Part A)||5
8140989|NCT02703350|20067806|P3|COMPLETED|Period Five (Part A)||5
8140990|NCT02703350|20067807|P2|COMPLETED|Period Five (Part A)||5
8140991|NCT02703350|20067808|P1|COMPLETED|Period Five (Part A)||5
8140992|NCT02703350|20067801|P8|Received Study Drug|Period Five (Part A)||0
8140993|NCT02703350|20067802|P7|Received Study Drug|Period Five (Part A)||0
8140994|NCT02703350|20067803|P6|Received Study Drug|Period Five (Part A)||5
8140995|NCT02703350|20067804|P5|Received Study Drug|Period Five (Part A)||5
8140996|NCT02703350|20067805|P4|Received Study Drug|Period Five (Part A)||5
8140997|NCT02703350|20067806|P3|Received Study Drug|Period Five (Part A)||5
8140998|NCT02703350|20067807|P2|Received Study Drug|Period Five (Part A)||5
8140999|NCT02703350|20067808|P1|Received Study Drug|Period Five (Part A)||5
8141000|NCT02703350|20067801|P8|STARTED|Period Five (Part A)||0
8141001|NCT02703350|20067802|P7|STARTED|Period Five (Part A)||0
8141002|NCT02703350|20067803|P6|STARTED|Period Five (Part A)||5
8141003|NCT02703350|20067804|P5|STARTED|Period Five (Part A)||5
8141004|NCT02703350|20067805|P4|STARTED|Period Five (Part A)||5
8141005|NCT02703350|20067806|P3|STARTED|Period Five (Part A)||5
8141006|NCT02703350|20067807|P2|STARTED|Period Five (Part A)||5
8141007|NCT02703350|20067808|P1|STARTED|Period Five (Part A)||5
8141008|NCT02703350|20067801|P8|NOT COMPLETED|Period Four (Part A)||0
8141009|NCT02703350|20067802|P7|NOT COMPLETED|Period Four (Part A)||0
8141010|NCT02703350|20067803|P6|NOT COMPLETED|Period Four (Part A)||0
8141011|NCT02703350|20067804|P5|NOT COMPLETED|Period Four (Part A)||0
8141012|NCT02703350|20067805|P4|NOT COMPLETED|Period Four (Part A)||0
8141013|NCT02703350|20067806|P3|NOT COMPLETED|Period Four (Part A)||0
8141014|NCT02703350|20067807|P2|NOT COMPLETED|Period Four (Part A)||0
8141015|NCT02703350|20067808|P1|NOT COMPLETED|Period Four (Part A)||0
8141016|NCT02703350|20067801|P8|COMPLETED|Period Four (Part A)||0
8141017|NCT02703350|20067802|P7|COMPLETED|Period Four (Part A)||0
8141018|NCT02703350|20067803|P6|COMPLETED|Period Four (Part A)||5
8141019|NCT02703350|20067804|P5|COMPLETED|Period Four (Part A)||5
8141020|NCT02703350|20067805|P4|COMPLETED|Period Four (Part A)||5
8141021|NCT02703350|20067806|P3|COMPLETED|Period Four (Part A)||5
8141022|NCT02703350|20067807|P2|COMPLETED|Period Four (Part A)||5
8141023|NCT02703350|20067808|P1|COMPLETED|Period Four (Part A)||5
8141024|NCT02703350|20067801|P8|Received Study Drug|Period Four (Part A)||0
8141025|NCT02703350|20067802|P7|Received Study Drug|Period Four (Part A)||0
8141026|NCT02703350|20067803|P6|Received Study Drug|Period Four (Part A)||5
8141027|NCT02703350|20067804|P5|Received Study Drug|Period Four (Part A)||5
8141028|NCT02703350|20067805|P4|Received Study Drug|Period Four (Part A)||5
8141029|NCT02703350|20067806|P3|Received Study Drug|Period Four (Part A)||5
8141030|NCT02703350|20067807|P2|Received Study Drug|Period Four (Part A)||5
8141031|NCT02703350|20067808|P1|Received Study Drug|Period Four (Part A)||5
8141032|NCT02703350|20067801|P8|STARTED|Period Four (Part A)||0
8141033|NCT02703350|20067802|P7|STARTED|Period Four (Part A)||0
8141034|NCT02703350|20067803|P6|STARTED|Period Four (Part A)||5
8141035|NCT02703350|20067804|P5|STARTED|Period Four (Part A)||5
8141036|NCT02703350|20067805|P4|STARTED|Period Four (Part A)||5
8141037|NCT02703350|20067806|P3|STARTED|Period Four (Part A)||5
8141038|NCT02703350|20067807|P2|STARTED|Period Four (Part A)||5
8141039|NCT02703350|20067808|P1|STARTED|Period Four (Part A)||5
8141040|NCT02703350|20067801|P8|NOT COMPLETED|Period Three (Part A)||0
8141041|NCT02703350|20067802|P7|NOT COMPLETED|Period Three (Part A)||0
8141042|NCT02703350|20067803|P6|NOT COMPLETED|Period Three (Part A)||0
8141043|NCT02703350|20067804|P5|NOT COMPLETED|Period Three (Part A)||0
8141044|NCT02703350|20067805|P4|NOT COMPLETED|Period Three (Part A)||0
8141045|NCT02703350|20067806|P3|NOT COMPLETED|Period Three (Part A)||0
8141046|NCT02703350|20067807|P2|NOT COMPLETED|Period Three (Part A)||0
8141047|NCT02703350|20067808|P1|NOT COMPLETED|Period Three (Part A)||0
8141048|NCT02703350|20067801|P8|COMPLETED|Period Three (Part A)||0
8141049|NCT02703350|20067802|P7|COMPLETED|Period Three (Part A)||0
8141050|NCT02703350|20067803|P6|COMPLETED|Period Three (Part A)||5
8141051|NCT02703350|20067804|P5|COMPLETED|Period Three (Part A)||5
8141052|NCT02703350|20067805|P4|COMPLETED|Period Three (Part A)||5
8141053|NCT02703350|20067806|P3|COMPLETED|Period Three (Part A)||5
8141054|NCT02703350|20067807|P2|COMPLETED|Period Three (Part A)||5
8141055|NCT02703350|20067808|P1|COMPLETED|Period Three (Part A)||5
8141056|NCT02703350|20067801|P8|Received Study Drug|Period Three (Part A)||0
8141057|NCT02703350|20067802|P7|Received Study Drug|Period Three (Part A)||0
8141058|NCT02703350|20067803|P6|Received Study Drug|Period Three (Part A)||5
8141059|NCT02703350|20067804|P5|Received Study Drug|Period Three (Part A)||5
8141060|NCT02703350|20067805|P4|Received Study Drug|Period Three (Part A)||5
8141061|NCT02703350|20067806|P3|Received Study Drug|Period Three (Part A)||5
8141062|NCT02703350|20067807|P2|Received Study Drug|Period Three (Part A)||5
8141063|NCT02703350|20067808|P1|Received Study Drug|Period Three (Part A)||5
8141064|NCT02703350|20067801|P8|STARTED|Period Three (Part A)||0
8141065|NCT02703350|20067802|P7|STARTED|Period Three (Part A)||0
8141066|NCT02703350|20067803|P6|STARTED|Period Three (Part A)||5
8141067|NCT02703350|20067804|P5|STARTED|Period Three (Part A)||5
8141068|NCT02703350|20067805|P4|STARTED|Period Three (Part A)||5
8141069|NCT02703350|20067806|P3|STARTED|Period Three (Part A)||5
8141070|NCT02703350|20067807|P2|STARTED|Period Three (Part A)||5
8141071|NCT02703350|20067808|P1|STARTED|Period Three (Part A)||5
8141072|NCT02703350|20067801|P8|NOT COMPLETED|Period Two (Part A)||0
8141073|NCT02703350|20067802|P7|NOT COMPLETED|Period Two (Part A)||0
8141074|NCT02703350|20067803|P6|NOT COMPLETED|Period Two (Part A)||0
8141075|NCT02703350|20067804|P5|NOT COMPLETED|Period Two (Part A)||0
8141076|NCT02703350|20067805|P4|NOT COMPLETED|Period Two (Part A)||0
8141077|NCT02703350|20067806|P3|NOT COMPLETED|Period Two (Part A)||0
8141078|NCT02703350|20067807|P2|NOT COMPLETED|Period Two (Part A)||0
8141079|NCT02703350|20067808|P1|NOT COMPLETED|Period Two (Part A)||0
8141080|NCT02703350|20067801|P8|COMPLETED|Period Two (Part A)||0
8141081|NCT02703350|20067802|P7|COMPLETED|Period Two (Part A)||0
8141082|NCT02703350|20067803|P6|COMPLETED|Period Two (Part A)||5
8141083|NCT02703350|20067804|P5|COMPLETED|Period Two (Part A)||5
8141084|NCT02703350|20067805|P4|COMPLETED|Period Two (Part A)||5
8141085|NCT02703350|20067806|P3|COMPLETED|Period Two (Part A)||5
8141086|NCT02703350|20067807|P2|COMPLETED|Period Two (Part A)||5
8141087|NCT02703350|20067808|P1|COMPLETED|Period Two (Part A)||5
8141088|NCT02703350|20067801|P8|Received Study Drug|Period Two (Part A)||0
8141089|NCT02703350|20067802|P7|Received Study Drug|Period Two (Part A)||0
8141090|NCT02703350|20067803|P6|Received Study Drug|Period Two (Part A)||5
8141091|NCT02703350|20067804|P5|Received Study Drug|Period Two (Part A)||5
8141092|NCT02703350|20067805|P4|Received Study Drug|Period Two (Part A)||5
8141093|NCT02703350|20067806|P3|Received Study Drug|Period Two (Part A)||5
8141094|NCT02703350|20067807|P2|Received Study Drug|Period Two (Part A)||5
8141095|NCT02703350|20067808|P1|Received Study Drug|Period Two (Part A)||5
8141096|NCT02703350|20067801|P8|STARTED|Period Two (Part A)||0
8141097|NCT02703350|20067802|P7|STARTED|Period Two (Part A)||0
8141098|NCT02703350|20067803|P6|STARTED|Period Two (Part A)||5
8141099|NCT02703350|20067804|P5|STARTED|Period Two (Part A)||5
8141100|NCT02703350|20067805|P4|STARTED|Period Two (Part A)||5
8141101|NCT02703350|20067806|P3|STARTED|Period Two (Part A)||5
8141102|NCT02703350|20067807|P2|STARTED|Period Two (Part A)||5
8141103|NCT02703350|20067808|P1|STARTED|Period Two (Part A)||5
8141104|NCT02703350|20067801|P8|NOT COMPLETED|Period One (Part A)||0
8141105|NCT02703350|20067802|P7|NOT COMPLETED|Period One (Part A)||0
8141106|NCT02703350|20067803|P6|NOT COMPLETED|Period One (Part A)||0
8141107|NCT02703350|20067804|P5|NOT COMPLETED|Period One (Part A)||0
8141108|NCT02703350|20067805|P4|NOT COMPLETED|Period One (Part A)||0
8141109|NCT02703350|20067806|P3|NOT COMPLETED|Period One (Part A)||0
8141110|NCT02703350|20067807|P2|NOT COMPLETED|Period One (Part A)||0
8141111|NCT02703350|20067808|P1|NOT COMPLETED|Period One (Part A)||0
8141112|NCT02703350|20067801|P8|COMPLETED|Period One (Part A)||0
8141113|NCT02703350|20067802|P7|COMPLETED|Period One (Part A)||0
8141114|NCT02703350|20067803|P6|COMPLETED|Period One (Part A)||5
8141115|NCT02703350|20067804|P5|COMPLETED|Period One (Part A)||5
8141116|NCT02703350|20067805|P4|COMPLETED|Period One (Part A)||5
8141117|NCT02703350|20067806|P3|COMPLETED|Period One (Part A)||5
8141118|NCT02703350|20067807|P2|COMPLETED|Period One (Part A)||5
8141119|NCT02703350|20067808|P1|COMPLETED|Period One (Part A)||5
8141120|NCT02703350|20067801|P8|Received Study Drug|Period One (Part A)||0
8141121|NCT02703350|20067802|P7|Received Study Drug|Period One (Part A)||0
8141122|NCT02703350|20067803|P6|Received Study Drug|Period One (Part A)||5
8141123|NCT02703350|20067804|P5|Received Study Drug|Period One (Part A)||5
8141124|NCT02703350|20067805|P4|Received Study Drug|Period One (Part A)||5
8141125|NCT02703350|20067806|P3|Received Study Drug|Period One (Part A)||5
8141126|NCT02703350|20067807|P2|Received Study Drug|Period One (Part A)||5
8141127|NCT02703350|20067808|P1|Received Study Drug|Period One (Part A)||5
8141128|NCT02703350|20067801|P8|STARTED|Period One (Part A)||0
8141129|NCT02703350|20067802|P7|STARTED|Period One (Part A)||0
8141130|NCT02703350|20067803|P6|STARTED|Period One (Part A)||5
8141131|NCT02703350|20067804|P5|STARTED|Period One (Part A)||5
8141132|NCT02703350|20067805|P4|STARTED|Period One (Part A)||5
8141133|NCT02703350|20067806|P3|STARTED|Period One (Part A)||5
8141134|NCT02703350|20067807|P2|STARTED|Period One (Part A)||5
8141135|NCT02703350|20067808|P1|STARTED|Period One (Part A)||5
8141136|NCT02703337|20067828|P8|NOT COMPLETED|Part B||0
8141137|NCT02703337|20067829|P7|NOT COMPLETED|Part B||0
8141138|NCT02703337|20067830|P6|NOT COMPLETED|Part B||0
8141139|NCT02703337|20067831|P5|NOT COMPLETED|Part B||0
8141140|NCT02703337|20067832|P4|NOT COMPLETED|Part B||0
8141141|NCT02703337|20067833|P3|NOT COMPLETED|Part B||0
8141142|NCT02703337|20067834|P2|NOT COMPLETED|Part B||0
8141143|NCT02703337|20067835|P1|NOT COMPLETED|Part B||0
8141144|NCT02703337|20067828|P8|COMPLETED|Part B||14
8141145|NCT02703337|20067829|P7|COMPLETED|Part B||15
8141146|NCT02703337|20067830|P6|COMPLETED|Part B||0
8141147|NCT02703337|20067831|P5|COMPLETED|Part B||0
8141148|NCT02703337|20067832|P4|COMPLETED|Part B||0
8141149|NCT02703337|20067833|P3|COMPLETED|Part B||0
8141150|NCT02703337|20067834|P2|COMPLETED|Part B||0
8141151|NCT02703337|20067835|P1|COMPLETED|Part B||0
8141152|NCT02703337|20067828|P8|Received Study Drug|Part B||14
8141153|NCT02703337|20067829|P7|Received Study Drug|Part B||15
8141154|NCT02703337|20067830|P6|Received Study Drug|Part B||0
8141155|NCT02703337|20067831|P5|Received Study Drug|Part B||0
8141156|NCT02703337|20067832|P4|Received Study Drug|Part B||0
8141157|NCT02703337|20067833|P3|Received Study Drug|Part B||0
8141158|NCT02703337|20067834|P2|Received Study Drug|Part B||0
8141159|NCT02703337|20067835|P1|Received Study Drug|Part B||0
8141160|NCT02703337|20067828|P8|STARTED|Part B||14
8141161|NCT02703337|20067829|P7|STARTED|Part B||15
8141162|NCT02703337|20067830|P6|STARTED|Part B||0
8141163|NCT02703337|20067831|P5|STARTED|Part B||0
8141164|NCT02703337|20067832|P4|STARTED|Part B||0
8141165|NCT02703337|20067833|P3|STARTED|Part B||0
8141166|NCT02703337|20067834|P2|STARTED|Part B||0
8141167|NCT02703337|20067835|P1|STARTED|Part B||0
8141168|NCT02703337|20067828|P8|NOT COMPLETED|Period Six (Part A)||0
8141169|NCT02703337|20067829|P7|NOT COMPLETED|Period Six (Part A)||0
8141170|NCT02703337|20067830|P6|NOT COMPLETED|Period Six (Part A)||0
8141171|NCT02703337|20067831|P5|NOT COMPLETED|Period Six (Part A)||0
8141172|NCT02703337|20067832|P4|NOT COMPLETED|Period Six (Part A)||0
8141173|NCT02703337|20067833|P3|NOT COMPLETED|Period Six (Part A)||0
8141174|NCT02703337|20067834|P2|NOT COMPLETED|Period Six (Part A)||0
8141175|NCT02703337|20067835|P1|NOT COMPLETED|Period Six (Part A)||0
8141176|NCT02703337|20067828|P8|COMPLETED|Period Six (Part A)||0
8141177|NCT02703337|20067829|P7|COMPLETED|Period Six (Part A)||0
8141178|NCT02703337|20067830|P6|COMPLETED|Period Six (Part A)||5
8141179|NCT02703337|20067831|P5|COMPLETED|Period Six (Part A)||4
8141180|NCT02703337|20067832|P4|COMPLETED|Period Six (Part A)||5
8141181|NCT02703337|20067833|P3|COMPLETED|Period Six (Part A)||5
8141182|NCT02703337|20067834|P2|COMPLETED|Period Six (Part A)||5
8141183|NCT02703337|20067835|P1|COMPLETED|Period Six (Part A)||5
8141184|NCT02703337|20067828|P8|Received Study Drug|Period Six (Part A)||0
8141185|NCT02703337|20067829|P7|Received Study Drug|Period Six (Part A)||0
8141186|NCT02703337|20067830|P6|Received Study Drug|Period Six (Part A)||5
8141187|NCT02703337|20067831|P5|Received Study Drug|Period Six (Part A)||4
8141188|NCT02703337|20067832|P4|Received Study Drug|Period Six (Part A)||5
8141189|NCT02703337|20067833|P3|Received Study Drug|Period Six (Part A)||5
8141190|NCT02703337|20067834|P2|Received Study Drug|Period Six (Part A)||5
8141191|NCT02703337|20067835|P1|Received Study Drug|Period Six (Part A)||5
8141192|NCT02703337|20067828|P8|STARTED|Period Six (Part A)||0
8141193|NCT02703337|20067829|P7|STARTED|Period Six (Part A)||0
8141194|NCT02703337|20067830|P6|STARTED|Period Six (Part A)||5
8141195|NCT02703337|20067831|P5|STARTED|Period Six (Part A)||4
8141196|NCT02703337|20067832|P4|STARTED|Period Six (Part A)||5
8141197|NCT02703337|20067833|P3|STARTED|Period Six (Part A)||5
8141198|NCT02703337|20067834|P2|STARTED|Period Six (Part A)||5
8141199|NCT02703337|20067835|P1|STARTED|Period Six (Part A)||5
8141200|NCT02703337|20067828|P8|NOT COMPLETED|Period Five (Part A)||0
8141201|NCT02703337|20067829|P7|NOT COMPLETED|Period Five (Part A)||0
8141202|NCT02703337|20067830|P6|NOT COMPLETED|Period Five (Part A)||0
8141203|NCT02703337|20067831|P5|NOT COMPLETED|Period Five (Part A)||0
8141204|NCT02703337|20067832|P4|NOT COMPLETED|Period Five (Part A)||0
8141205|NCT02703337|20067833|P3|NOT COMPLETED|Period Five (Part A)||0
8141206|NCT02703337|20067834|P2|NOT COMPLETED|Period Five (Part A)||0
8141207|NCT02703337|20067835|P1|NOT COMPLETED|Period Five (Part A)||0
8141208|NCT02703337|20067828|P8|COMPLETED|Period Five (Part A)||0
8141209|NCT02703337|20067829|P7|COMPLETED|Period Five (Part A)||0
8141210|NCT02703337|20067830|P6|COMPLETED|Period Five (Part A)||5
8141211|NCT02703337|20067831|P5|COMPLETED|Period Five (Part A)||4
8141212|NCT02703337|20067832|P4|COMPLETED|Period Five (Part A)||5
8141213|NCT02703337|20067833|P3|COMPLETED|Period Five (Part A)||5
8141214|NCT02703337|20067834|P2|COMPLETED|Period Five (Part A)||5
8141215|NCT02703337|20067835|P1|COMPLETED|Period Five (Part A)||5
8141216|NCT02703337|20067828|P8|Received Study Drug|Period Five (Part A)||0
8141217|NCT02703337|20067829|P7|Received Study Drug|Period Five (Part A)||0
8141218|NCT02703337|20067830|P6|Received Study Drug|Period Five (Part A)||5
8141219|NCT02703337|20067831|P5|Received Study Drug|Period Five (Part A)||4
8141220|NCT02703337|20067832|P4|Received Study Drug|Period Five (Part A)||5
8141221|NCT02703337|20067833|P3|Received Study Drug|Period Five (Part A)||5
8141222|NCT02703337|20067834|P2|Received Study Drug|Period Five (Part A)||5
8141223|NCT02703337|20067835|P1|Received Study Drug|Period Five (Part A)||5
8141224|NCT02703337|20067828|P8|STARTED|Period Five (Part A)||0
8141225|NCT02703337|20067829|P7|STARTED|Period Five (Part A)||0
8141226|NCT02703337|20067830|P6|STARTED|Period Five (Part A)||5
8141227|NCT02703337|20067831|P5|STARTED|Period Five (Part A)||4
8141228|NCT02703337|20067832|P4|STARTED|Period Five (Part A)||5
8141229|NCT02703337|20067833|P3|STARTED|Period Five (Part A)||5
8141230|NCT02703337|20067834|P2|STARTED|Period Five (Part A)||5
8141231|NCT02703337|20067835|P1|STARTED|Period Five (Part A)||5
8141232|NCT02703337|20067828|P8|NOT COMPLETED|Period Four (Part A)||0
8141233|NCT02703337|20067829|P7|NOT COMPLETED|Period Four (Part A)||0
8141234|NCT02703337|20067830|P6|NOT COMPLETED|Period Four (Part A)||0
8141235|NCT02703337|20067831|P5|NOT COMPLETED|Period Four (Part A)||0
8141236|NCT02703337|20067832|P4|NOT COMPLETED|Period Four (Part A)||0
8141237|NCT02703337|20067833|P3|NOT COMPLETED|Period Four (Part A)||0
8141238|NCT02703337|20067834|P2|NOT COMPLETED|Period Four (Part A)||0
8141239|NCT02703337|20067835|P1|NOT COMPLETED|Period Four (Part A)||0
8141240|NCT02703337|20067828|P8|COMPLETED|Period Four (Part A)||0
8141241|NCT02703337|20067829|P7|COMPLETED|Period Four (Part A)||0
8141242|NCT02703337|20067830|P6|COMPLETED|Period Four (Part A)||5
8141243|NCT02703337|20067831|P5|COMPLETED|Period Four (Part A)||4
8141244|NCT02703337|20067832|P4|COMPLETED|Period Four (Part A)||5
8141245|NCT02703337|20067833|P3|COMPLETED|Period Four (Part A)||5
8141246|NCT02703337|20067834|P2|COMPLETED|Period Four (Part A)||5
8141247|NCT02703337|20067835|P1|COMPLETED|Period Four (Part A)||5
8141248|NCT02703337|20067828|P8|Received Study Drug|Period Four (Part A)||0
8141249|NCT02703337|20067829|P7|Received Study Drug|Period Four (Part A)||0
8141250|NCT02703337|20067830|P6|Received Study Drug|Period Four (Part A)||5
8141251|NCT02703337|20067831|P5|Received Study Drug|Period Four (Part A)||4
8141252|NCT02703337|20067832|P4|Received Study Drug|Period Four (Part A)||5
8141253|NCT02703337|20067833|P3|Received Study Drug|Period Four (Part A)||5
8141254|NCT02703337|20067834|P2|Received Study Drug|Period Four (Part A)||5
8141255|NCT02703337|20067835|P1|Received Study Drug|Period Four (Part A)||5
8141256|NCT02703337|20067828|P8|STARTED|Period Four (Part A)||0
8141257|NCT02703337|20067829|P7|STARTED|Period Four (Part A)||0
8141258|NCT02703337|20067830|P6|STARTED|Period Four (Part A)||5
8141259|NCT02703337|20067831|P5|STARTED|Period Four (Part A)||4
8141260|NCT02703337|20067832|P4|STARTED|Period Four (Part A)||5
8141261|NCT02703337|20067833|P3|STARTED|Period Four (Part A)||5
8141262|NCT02703337|20067834|P2|STARTED|Period Four (Part A)||5
8141263|NCT02703337|20067835|P1|STARTED|Period Four (Part A)||5
8141264|NCT02703337|20067828|P8|NOT COMPLETED|Period Three (Part A)||0
8141265|NCT02703337|20067829|P7|NOT COMPLETED|Period Three (Part A)||0
8141266|NCT02703337|20067830|P6|NOT COMPLETED|Period Three (Part A)||0
8141267|NCT02703337|20067831|P5|NOT COMPLETED|Period Three (Part A)||0
8141268|NCT02703337|20067832|P4|NOT COMPLETED|Period Three (Part A)||0
8141269|NCT02703337|20067833|P3|NOT COMPLETED|Period Three (Part A)||0
8141270|NCT02703337|20067834|P2|NOT COMPLETED|Period Three (Part A)||0
8141271|NCT02703337|20067835|P1|NOT COMPLETED|Period Three (Part A)||0
8141272|NCT02703337|20067828|P8|COMPLETED|Period Three (Part A)||0
8141273|NCT02703337|20067829|P7|COMPLETED|Period Three (Part A)||0
8141274|NCT02703337|20067830|P6|COMPLETED|Period Three (Part A)||5
8141275|NCT02703337|20067831|P5|COMPLETED|Period Three (Part A)||4
8141276|NCT02703337|20067832|P4|COMPLETED|Period Three (Part A)||5
8141277|NCT02703337|20067833|P3|COMPLETED|Period Three (Part A)||5
8141278|NCT02703337|20067834|P2|COMPLETED|Period Three (Part A)||5
8141279|NCT02703337|20067835|P1|COMPLETED|Period Three (Part A)||5
8141280|NCT02703337|20067828|P8|Received Study Drug|Period Three (Part A)||0
8141281|NCT02703337|20067829|P7|Received Study Drug|Period Three (Part A)||0
8141282|NCT02703337|20067830|P6|Received Study Drug|Period Three (Part A)||5
8141283|NCT02703337|20067831|P5|Received Study Drug|Period Three (Part A)||4
8141284|NCT02703337|20067832|P4|Received Study Drug|Period Three (Part A)||5
8141285|NCT02703337|20067833|P3|Received Study Drug|Period Three (Part A)||5
8141286|NCT02703337|20067834|P2|Received Study Drug|Period Three (Part A)||5
8141287|NCT02703337|20067835|P1|Received Study Drug|Period Three (Part A)||5
8141288|NCT02703337|20067828|P8|STARTED|Period Three (Part A)||0
8141289|NCT02703337|20067829|P7|STARTED|Period Three (Part A)||0
8141290|NCT02703337|20067830|P6|STARTED|Period Three (Part A)||5
8141291|NCT02703337|20067831|P5|STARTED|Period Three (Part A)||4
8141292|NCT02703337|20067832|P4|STARTED|Period Three (Part A)||5
8141293|NCT02703337|20067833|P3|STARTED|Period Three (Part A)||5
8141294|NCT02703337|20067834|P2|STARTED|Period Three (Part A)||5
8141295|NCT02703337|20067835|P1|STARTED|Period Three (Part A)||5
8141296|NCT02703337|20067828|P8|NOT COMPLETED|Period Two (Part A)||0
8141297|NCT02703337|20067829|P7|NOT COMPLETED|Period Two (Part A)||0
8141298|NCT02703337|20067830|P6|NOT COMPLETED|Period Two (Part A)||0
8141299|NCT02703337|20067831|P5|NOT COMPLETED|Period Two (Part A)||0
8141300|NCT02703337|20067832|P4|NOT COMPLETED|Period Two (Part A)||0
8141301|NCT02703337|20067833|P3|NOT COMPLETED|Period Two (Part A)||0
8141302|NCT02703337|20067834|P2|NOT COMPLETED|Period Two (Part A)||0
8141303|NCT02703337|20067835|P1|NOT COMPLETED|Period Two (Part A)||0
8141304|NCT02703337|20067828|P8|COMPLETED|Period Two (Part A)||0
8141305|NCT02703337|20067829|P7|COMPLETED|Period Two (Part A)||0
8141306|NCT02703337|20067830|P6|COMPLETED|Period Two (Part A)||5
8141307|NCT02703337|20067831|P5|COMPLETED|Period Two (Part A)||4
8141308|NCT02703337|20067832|P4|COMPLETED|Period Two (Part A)||5
8141309|NCT02703337|20067833|P3|COMPLETED|Period Two (Part A)||5
8141310|NCT02703337|20067834|P2|COMPLETED|Period Two (Part A)||5
8141311|NCT02703337|20067835|P1|COMPLETED|Period Two (Part A)||5
8141312|NCT02703337|20067828|P8|Received Study Drug|Period Two (Part A)||0
8141313|NCT02703337|20067829|P7|Received Study Drug|Period Two (Part A)||0
8141314|NCT02703337|20067830|P6|Received Study Drug|Period Two (Part A)||5
8141315|NCT02703337|20067831|P5|Received Study Drug|Period Two (Part A)||4
8141316|NCT02703337|20067832|P4|Received Study Drug|Period Two (Part A)||5
8141317|NCT02703337|20067833|P3|Received Study Drug|Period Two (Part A)||5
8141318|NCT02703337|20067834|P2|Received Study Drug|Period Two (Part A)||5
8141319|NCT02703337|20067835|P1|Received Study Drug|Period Two (Part A)||5
8141320|NCT02703337|20067828|P8|STARTED|Period Two (Part A)||0
8141321|NCT02703337|20067829|P7|STARTED|Period Two (Part A)||0
8141322|NCT02703337|20067830|P6|STARTED|Period Two (Part A)||5
8141323|NCT02703337|20067831|P5|STARTED|Period Two (Part A)||4
8141324|NCT02703337|20067832|P4|STARTED|Period Two (Part A)||5
8141325|NCT02703337|20067833|P3|STARTED|Period Two (Part A)||5
8141326|NCT02703337|20067834|P2|STARTED|Period Two (Part A)||5
8141327|NCT02703337|20067835|P1|STARTED|Period Two (Part A)||5
8141328|NCT02703337|20067828|P8|NOT COMPLETED|Period One (Part A)||0
8141329|NCT02703337|20067829|P7|NOT COMPLETED|Period One (Part A)||0
8141330|NCT02703337|20067830|P6|NOT COMPLETED|Period One (Part A)||0
8141331|NCT02703337|20067831|P5|NOT COMPLETED|Period One (Part A)||1
8141332|NCT02703337|20067832|P4|NOT COMPLETED|Period One (Part A)||0
8141333|NCT02703337|20067833|P3|NOT COMPLETED|Period One (Part A)||0
8141334|NCT02703337|20067834|P2|NOT COMPLETED|Period One (Part A)||0
8141335|NCT02703337|20067835|P1|NOT COMPLETED|Period One (Part A)||0
8141336|NCT02703337|20067828|P8|COMPLETED|Period One (Part A)||0
8141337|NCT02703337|20067829|P7|COMPLETED|Period One (Part A)||0
8141338|NCT02703337|20067830|P6|COMPLETED|Period One (Part A)||5
8141339|NCT02703337|20067831|P5|COMPLETED|Period One (Part A)||4
8141340|NCT02703337|20067832|P4|COMPLETED|Period One (Part A)||5
8141341|NCT02703337|20067833|P3|COMPLETED|Period One (Part A)||5
8141342|NCT02703337|20067834|P2|COMPLETED|Period One (Part A)||5
8141343|NCT02703337|20067835|P1|COMPLETED|Period One (Part A)||5
8141344|NCT02703337|20067828|P8|Received Study Drug|Period One (Part A)||0
8141345|NCT02703337|20067829|P7|Received Study Drug|Period One (Part A)||0
8141346|NCT02703337|20067830|P6|Received Study Drug|Period One (Part A)||5
8141347|NCT02703337|20067831|P5|Received Study Drug|Period One (Part A)||5
8141348|NCT02703337|20067832|P4|Received Study Drug|Period One (Part A)||5
8141349|NCT02703337|20067833|P3|Received Study Drug|Period One (Part A)||5
8141350|NCT02703337|20067834|P2|Received Study Drug|Period One (Part A)||5
8141351|NCT02703337|20067835|P1|Received Study Drug|Period One (Part A)||5
8141352|NCT02703337|20067828|P8|STARTED|Period One (Part A)||0
8141353|NCT02703337|20067829|P7|STARTED|Period One (Part A)||0
8141354|NCT02703337|20067830|P6|STARTED|Period One (Part A)||5
8141355|NCT02703337|20067831|P5|STARTED|Period One (Part A)||5
8141356|NCT02703337|20067832|P4|STARTED|Period One (Part A)||5
8141357|NCT02703337|20067833|P3|STARTED|Period One (Part A)||5
8141358|NCT02703337|20067834|P2|STARTED|Period One (Part A)||5
8141359|NCT02703337|20067835|P1|STARTED|Period One (Part A)||5
8141360|NCT02703324|20067855|P6|NOT COMPLETED|Period Four||0
8141361|NCT02703324|20067856|P5|NOT COMPLETED|Period Four||0
8141362|NCT02703324|20067857|P4|NOT COMPLETED|Period Four||0
8141363|NCT02703324|20067858|P3|NOT COMPLETED|Period Four||0
8141364|NCT02703324|20067859|P2|NOT COMPLETED|Period Four||0
8141365|NCT02703324|20067860|P1|NOT COMPLETED|Period Four||0
8141366|NCT02703324|20067855|P6|COMPLETED|Period Four||5
8141367|NCT02703324|20067856|P5|COMPLETED|Period Four||5
8141368|NCT02703324|20067857|P4|COMPLETED|Period Four||5
8141369|NCT02703324|20067858|P3|COMPLETED|Period Four||4
8141370|NCT02703324|20067859|P2|COMPLETED|Period Four||4
8141371|NCT02703324|20067860|P1|COMPLETED|Period Four||5
8141372|NCT02703324|20067855|P6|Received Study Drug|Period Four||5
8141373|NCT02703324|20067856|P5|Received Study Drug|Period Four||5
8141374|NCT02703324|20067857|P4|Received Study Drug|Period Four||5
8141375|NCT02703324|20067858|P3|Received Study Drug|Period Four||4
8141376|NCT02703324|20067859|P2|Received Study Drug|Period Four||4
8141377|NCT02703324|20067860|P1|Received Study Drug|Period Four||5
8141378|NCT02703324|20067855|P6|STARTED|Period Four||5
8141379|NCT02703324|20067856|P5|STARTED|Period Four||5
8141380|NCT02703324|20067857|P4|STARTED|Period Four||5
8141381|NCT02703324|20067858|P3|STARTED|Period Four||4
8141382|NCT02703324|20067859|P2|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
8141383|NCT02703324|20067860|P1|STARTED|Period Four||5
8141384|NCT02703324|20067855|P6|NOT COMPLETED|Period Three||0
8141385|NCT02703324|20067856|P5|NOT COMPLETED|Period Three||0
8141386|NCT02703324|20067857|P4|NOT COMPLETED|Period Three||0
8141387|NCT02703324|20067858|P3|NOT COMPLETED|Period Three||0
8141388|NCT02703324|20067859|P2|NOT COMPLETED|Period Three||0
8141389|NCT02703324|20067860|P1|NOT COMPLETED|Period Three||0
8141390|NCT02703324|20067855|P6|COMPLETED|Period Three||5
8141391|NCT02703324|20067856|P5|COMPLETED|Period Three||5
8141392|NCT02703324|20067857|P4|COMPLETED|Period Three||5
8141393|NCT02703324|20067858|P3|COMPLETED|Period Three||4
8141394|NCT02703324|20067859|P2|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
8141395|NCT02703324|20067860|P1|COMPLETED|Period Three||5
8141396|NCT02703324|20067855|P6|Received Study Drug|Period Three||5
8141397|NCT02703324|20067856|P5|Received Study Drug|Period Three||5
8141398|NCT02703324|20067857|P4|Received Study Drug|Period Three||5
8141399|NCT02703324|20067858|P3|Received Study Drug|Period Three||4
8141400|NCT02703324|20067859|P2|Received Study Drug|Period Three||5
8141401|NCT02703324|20067860|P1|Received Study Drug|Period Three||5
8141402|NCT02703324|20067855|P6|STARTED|Period Three||5
8141403|NCT02703324|20067856|P5|STARTED|Period Three||5
8141404|NCT02703324|20067857|P4|STARTED|Period Three||5
8141405|NCT02703324|20067858|P3|STARTED|Period Three||4
8141406|NCT02703324|20067859|P2|STARTED|Period Three||5
8141407|NCT02703324|20067860|P1|STARTED|Period Three||5
8141408|NCT02703324|20067855|P6|NOT COMPLETED|Period Two||0
8141409|NCT02703324|20067856|P5|NOT COMPLETED|Period Two||0
8141410|NCT02703324|20067857|P4|NOT COMPLETED|Period Two||0
8141411|NCT02703324|20067858|P3|NOT COMPLETED|Period Two||1
8141412|NCT02703324|20067859|P2|NOT COMPLETED|Period Two||0
8141413|NCT02703324|20067860|P1|NOT COMPLETED|Period Two||0
8141414|NCT02703324|20067855|P6|COMPLETED|Period Two||5
8141415|NCT02703324|20067856|P5|COMPLETED|Period Two||5
8141416|NCT02703324|20067857|P4|COMPLETED|Period Two||5
8141417|NCT02703324|20067858|P3|COMPLETED|Period Two||4
8141418|NCT02703324|20067859|P2|COMPLETED|Period Two||5
8141419|NCT02703324|20067860|P1|COMPLETED|Period Two||5
8141420|NCT02703324|20067855|P6|Received Study Drug|Period Two||5
8141421|NCT02703324|20067856|P5|Received Study Drug|Period Two||5
8141422|NCT02703324|20067857|P4|Received Study Drug|Period Two||5
8141423|NCT02703324|20067858|P3|Received Study Drug|Period Two||5
8141424|NCT02703324|20067859|P2|Received Study Drug|Period Two||5
8141425|NCT02703324|20067860|P1|Received Study Drug|Period Two||5
8141426|NCT02703324|20067855|P6|STARTED|Period Two||5
8141427|NCT02703324|20067856|P5|STARTED|Period Two||5
8141428|NCT02703324|20067857|P4|STARTED|Period Two||5
8141429|NCT02703324|20067858|P3|STARTED|Period Two||5
8141430|NCT02703324|20067859|P2|STARTED|Period Two||5
8141431|NCT02703324|20067860|P1|STARTED|Period Two||5
8141432|NCT02703324|20067855|P6|NOT COMPLETED|Period One||0
8141433|NCT02703324|20067856|P5|NOT COMPLETED|Period One||0
8141434|NCT02703324|20067857|P4|NOT COMPLETED|Period One||0
8141435|NCT02703324|20067858|P3|NOT COMPLETED|Period One||0
8141436|NCT02703324|20067859|P2|NOT COMPLETED|Period One||0
8141437|NCT02703324|20067860|P1|NOT COMPLETED|Period One||0
8141438|NCT02703324|20067855|P6|COMPLETED|Period One||5
8141439|NCT02703324|20067856|P5|COMPLETED|Period One||5
8141440|NCT02703324|20067857|P4|COMPLETED|Period One||5
8141441|NCT02703324|20067858|P3|COMPLETED|Period One||5
8141442|NCT02703324|20067859|P2|COMPLETED|Period One||5
8141443|NCT02703324|20067860|P1|COMPLETED|Period One||5
8141444|NCT02703324|20067855|P6|Received Study Drug|Period One||5
8141445|NCT02703324|20067856|P5|Received Study Drug|Period One||5
8141446|NCT02703324|20067857|P4|Received Study Drug|Period One||5
8141447|NCT02703324|20067858|P3|Received Study Drug|Period One||5
8141448|NCT02703324|20067859|P2|Received Study Drug|Period One||5
8141449|NCT02703324|20067860|P1|Received Study Drug|Period One||5
8141450|NCT02703324|20067855|P6|STARTED|Period One||5
8141451|NCT02703324|20067856|P5|STARTED|Period One||5
8141452|NCT02703324|20067857|P4|STARTED|Period One||5
8141453|NCT02703324|20067858|P3|STARTED|Period One||5
8141454|NCT02703324|20067859|P2|STARTED|Period One||5
8141455|NCT02703324|20067860|P1|STARTED|Period One||5
8141456|NCT02703311|20067869|P1|NOT COMPLETED|Overall Study||8
8141457|NCT02703311|20067869|P1|COMPLETED|Overall Study||3
8141458|NCT02703311|20067869|P1|30 Day Follow-Up Completed|Overall Study||9
8141459|NCT02703311|20067869|P1|Implanted|Overall Study||11
8141460|NCT02703311|20067869|P1|STARTED|Overall Study||11
8141461|NCT02703259|20067887|P2|NOT COMPLETED|2 Weeks Postoperative Assessment||10
8141462|NCT02703259|20067888|P1|NOT COMPLETED|2 Weeks Postoperative Assessment||10
8141463|NCT02703259|20067887|P2|COMPLETED|2 Weeks Postoperative Assessment||51
8141464|NCT02703259|20067888|P1|COMPLETED|2 Weeks Postoperative Assessment||58
8141465|NCT02703259|20067887|P2|STARTED|2 Weeks Postoperative Assessment||61
8141466|NCT02703259|20067888|P1|STARTED|2 Weeks Postoperative Assessment||68
8141467|NCT02703259|20067887|P2|NOT COMPLETED|24 Hours Postoperative Assessment||6
8141468|NCT02703259|20067888|P1|NOT COMPLETED|24 Hours Postoperative Assessment||2
8141469|NCT02703259|20067887|P2|COMPLETED|24 Hours Postoperative Assessment||61
8141470|NCT02703259|20067888|P1|COMPLETED|24 Hours Postoperative Assessment||68
8141471|NCT02703259|20067887|P2|STARTED|24 Hours Postoperative Assessment||67
8141472|NCT02703259|20067888|P1|STARTED|24 Hours Postoperative Assessment||70
8141473|NCT02702999|20067906|P2|NOT COMPLETED|Overall Study||0
8141474|NCT02702999|20067907|P1|NOT COMPLETED|Overall Study||0
8141475|NCT02702999|20067906|P2|COMPLETED|Overall Study||104
8141476|NCT02702999|20067907|P1|COMPLETED|Overall Study||102
8141477|NCT02702999|20067906|P2|STARTED|Overall Study||104
8141478|NCT02702999|20067907|P1|STARTED|Overall Study||102
8141479|NCT02702921|20067925|P2|NOT COMPLETED|Overall Study||8
8141480|NCT02702921|20067926|P1|NOT COMPLETED|Overall Study||14
8141481|NCT02702921|20067925|P2|COMPLETED|Overall Study||95
8141482|NCT02702921|20067926|P1|COMPLETED|Overall Study||84
8141483|NCT02702921|20067925|P2|STARTED|Overall Study||103
8141484|NCT02702921|20067926|P1|STARTED|Overall Study||98
8141485|NCT02702609|20067936|P2|NOT COMPLETED|Overall Study||4
8141486|NCT02702609|20067937|P1|NOT COMPLETED|Overall Study||9
8141487|NCT02702609|20067936|P2|COMPLETED|Overall Study||17
8141488|NCT02702609|20067937|P1|COMPLETED|Overall Study||15
8141489|NCT02702609|20067936|P2|Crown Delivery|Overall Study||18
8141490|NCT02702609|20067937|P1|Crown Delivery|Overall Study||16
8141491|NCT02702609|20067936|P2|Implant Placement|Overall Study||21
8141492|NCT02702609|20067937|P1|Implant Placement|Overall Study||23
8141493|NCT02702609|20067936|P2|STARTED|Overall Study||21
8141494|NCT02702609|20067937|P1|STARTED|Overall Study||24
8141495|NCT02702401|20067955|P2|NOT COMPLETED|Overall Study||135
8141496|NCT02702401|20067956|P1|NOT COMPLETED|Overall Study||278
8141497|NCT02702401|20067955|P2|COMPLETED|Overall Study||0
8141498|NCT02702401|20067956|P1|COMPLETED|Overall Study||0
8141499|NCT02702401|20067955|P2|Treated|Overall Study||135
8141500|NCT02702401|20067956|P1|Treated|Overall Study||278
8141501|NCT02702401|20067955|P2|STARTED|Overall Study||135
8141502|NCT02702401|20067956|P1|STARTED|Overall Study||278
8141503|NCT02702388|20067978|P2|NOT COMPLETED|Overall Study||77
8141504|NCT02702388|20067979|P1|NOT COMPLETED|Overall Study||75
8141505|NCT02702388|20067978|P2|COMPLETED|Overall Study||0
8141506|NCT02702388|20067979|P1|COMPLETED|Overall Study||0
8141507|NCT02702388|20067978|P2|STARTED|Overall Study||77
8141508|NCT02702388|20067979|P1|STARTED|Overall Study||75
8141509|NCT02702193|20068001|P2|NOT COMPLETED|12 Month Follow up||18
8141510|NCT02702193|20068002|P1|NOT COMPLETED|12 Month Follow up||17
8141511|NCT02702193|20068001|P2|COMPLETED|12 Month Follow up||69
8141512|NCT02702193|20068002|P1|COMPLETED|12 Month Follow up||69
8141513|NCT02702193|20068001|P2|STARTED|12 Month Follow up||87
8141514|NCT02702193|20068002|P1|STARTED|12 Month Follow up||86
8141515|NCT02702193|20068001|P2|NOT COMPLETED|8 Month Follow up||18
8141516|NCT02702193|20068002|P1|NOT COMPLETED|8 Month Follow up||15
8141517|NCT02702193|20068001|P2|COMPLETED|8 Month Follow up||69
8141518|NCT02702193|20068002|P1|COMPLETED|8 Month Follow up||71
8141519|NCT02702193|20068001|P2|STARTED|8 Month Follow up||87
8141520|NCT02702193|20068002|P1|STARTED|8 Month Follow up||86
8141521|NCT02702193|20068001|P2|NOT COMPLETED|4 Month Follow up||18
8141522|NCT02702193|20068002|P1|NOT COMPLETED|4 Month Follow up||18
8141523|NCT02702193|20068001|P2|COMPLETED|4 Month Follow up||69
8141524|NCT02702193|20068002|P1|COMPLETED|4 Month Follow up||68
8141525|NCT02702193|20068001|P2|STARTED|4 Month Follow up||87
8141526|NCT02702193|20068002|P1|STARTED|4 Month Follow up||86
8141527|NCT02702193|20068001|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
8141528|NCT02702193|20068002|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
8141529|NCT02702193|20068001|P2|COMPLETED|Baseline Assessment/Randomization||87
8141530|NCT02702193|20068002|P1|COMPLETED|Baseline Assessment/Randomization||85
8141531|NCT02702193|20068001|P2|STARTED|Baseline Assessment/Randomization||87
8141532|NCT02702193|20068002|P1|STARTED|Baseline Assessment/Randomization||86
8141533|NCT02702011|20068030|P4|NOT COMPLETED|Overall Study||0
8141534|NCT02702011|20068031|P3|NOT COMPLETED|Overall Study||0
8141535|NCT02702011|20068032|P2|NOT COMPLETED|Overall Study||1
8141536|NCT02702011|20068033|P1|NOT COMPLETED|Overall Study||0
8141537|NCT02702011|20068030|P4|COMPLETED|Overall Study||12
8141538|NCT02702011|20068031|P3|COMPLETED|Overall Study||12
8141539|NCT02702011|20068032|P2|COMPLETED|Overall Study||12
8141540|NCT02702011|20068033|P1|COMPLETED|Overall Study||11
8141541|NCT02702011|20068030|P4|STARTED|Overall Study|Started are the treated patients.|12
8141542|NCT02702011|20068031|P3|STARTED|Overall Study|Started are the treated patients.|12
8141543|NCT02702011|20068032|P2|STARTED|Overall Study|Started are the treated patients.|13
8141544|NCT02702011|20068033|P1|STARTED|Overall Study|Started are the treated patients.|11
8141545|NCT02701985|20068045|P2|NOT COMPLETED|Overall Study||6
8141546|NCT02701985|20068046|P1|NOT COMPLETED|Overall Study||3
8141547|NCT02701985|20068045|P2|COMPLETED|Overall Study||32
8141548|NCT02701985|20068046|P1|COMPLETED|Overall Study||34
8141549|NCT02701985|20068045|P2|STARTED|Overall Study||38
8141550|NCT02701985|20068046|P1|STARTED|Overall Study||37
8141551|NCT02701868|20068090|P3|NOT COMPLETED|Overall Study||0
8141552|NCT02701868|20068091|P2|NOT COMPLETED|Overall Study||0
8141553|NCT02701868|20068092|P1|NOT COMPLETED|Overall Study||0
8141554|NCT02701868|20068090|P3|COMPLETED|Overall Study||75
8141555|NCT02701868|20068091|P2|COMPLETED|Overall Study||75
8141556|NCT02701868|20068092|P1|COMPLETED|Overall Study||21
8141557|NCT02701868|20068090|P3|STARTED|Overall Study||75
8141558|NCT02701868|20068091|P2|STARTED|Overall Study||75
8141559|NCT02701868|20068092|P1|STARTED|Overall Study||21
8141560|NCT02701777|20068105|P3|NOT COMPLETED|Overall Study||4
8141561|NCT02701777|20068106|P2|NOT COMPLETED|Overall Study||3
8141562|NCT02701777|20068107|P1|NOT COMPLETED|Overall Study||4
8141563|NCT02701777|20068105|P3|COMPLETED|Overall Study||12
8141564|NCT02701777|20068106|P2|COMPLETED|Overall Study||13
8141565|NCT02701777|20068107|P1|COMPLETED|Overall Study||8
8141566|NCT02701777|20068105|P3|STARTED|Overall Study||16
8141567|NCT02701777|20068106|P2|STARTED|Overall Study||16
8141568|NCT02701777|20068107|P1|STARTED|Overall Study||12
8141569|NCT02701764|20068123|P2|NOT COMPLETED|Overall Study||1
8141570|NCT02701764|20068124|P1|NOT COMPLETED|Overall Study||0
8141571|NCT02701764|20068123|P2|COMPLETED|Overall Study||21
8141572|NCT02701764|20068124|P1|COMPLETED|Overall Study||21
8141573|NCT02701764|20068123|P2|STARTED|Overall Study||22
8141574|NCT02701764|20068124|P1|STARTED|Overall Study||21
8141575|NCT02701647|20068147|P3|NOT COMPLETED|Overall Study||1
8141576|NCT02701647|20068148|P2|NOT COMPLETED|Overall Study||0
8141577|NCT02701647|20068149|P1|NOT COMPLETED|Overall Study||0
8141578|NCT02701647|20068147|P3|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
8141579|NCT02701647|20068148|P2|COMPLETED|Overall Study||17
8141580|NCT02701647|20068149|P1|COMPLETED|Overall Study||17
8141581|NCT02701647|20068147|P3|STARTED|Overall Study||17
8141582|NCT02701647|20068148|P2|STARTED|Overall Study||17
8141583|NCT02701647|20068149|P1|STARTED|Overall Study||17
8141584|NCT02701634|20068183|P2|NOT COMPLETED|Overall Study||31
8141585|NCT02701634|20068184|P1|NOT COMPLETED|Overall Study||32
8141586|NCT02701634|20068183|P2|COMPLETED|Overall Study||2
8141587|NCT02701634|20068184|P1|COMPLETED|Overall Study||1
8141588|NCT02701634|20068183|P2|STARTED|Overall Study||33
8141589|NCT02701634|20068184|P1|STARTED|Overall Study||33
8141590|NCT02701582|20068214|P2|NOT COMPLETED|Overall Study||0
8141591|NCT02701582|20068215|P1|NOT COMPLETED|Overall Study||2
8141592|NCT02701582|20068214|P2|COMPLETED|Overall Study||33
8141593|NCT02701582|20068215|P1|COMPLETED|Overall Study||33
8141594|NCT02701582|20068214|P2|STARTED|Overall Study||33
8141595|NCT02701582|20068215|P1|STARTED|Overall Study||35
8141596|NCT02701556|20068239|P2|NOT COMPLETED|Overall Study||20
8141597|NCT02701556|20068240|P1|NOT COMPLETED|Overall Study||23
8141598|NCT02701556|20068239|P2|COMPLETED|Overall Study||178
8141599|NCT02701556|20068240|P1|COMPLETED|Overall Study||175
8141600|NCT02701556|20068239|P2|STARTED|Overall Study||198
8141601|NCT02701556|20068240|P1|STARTED|Overall Study||198
8141602|NCT02701387|20068246|P1|NOT COMPLETED|Overall Study||0
8141603|NCT02701387|20068246|P1|COMPLETED|Overall Study||7
8141604|NCT02701387|20068246|P1|STARTED|Overall Study||7
8141605|NCT02701361|20068254|P3|NOT COMPLETED|Overall Study||2
8141606|NCT02701361|20068255|P2|NOT COMPLETED|Overall Study||3
8141607|NCT02701361|20068256|P1|NOT COMPLETED|Overall Study||9
8141608|NCT02701361|20068254|P3|COMPLETED|Overall Study||16
8141609|NCT02701361|20068255|P2|COMPLETED|Overall Study||28
8141610|NCT02701361|20068256|P1|COMPLETED|Overall Study||22
8141611|NCT02701361|20068254|P3|STARTED|Overall Study||18
8141612|NCT02701361|20068255|P2|STARTED|Overall Study||31
8141613|NCT02701361|20068256|P1|STARTED|Overall Study||31
8141614|NCT02701296|20068297|P2|NOT COMPLETED|Overall Study||2
8141615|NCT02701296|20068298|P1|NOT COMPLETED|Overall Study||0
8141616|NCT02701296|20068297|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
8141617|NCT02701296|20068298|P1|COMPLETED|Overall Study||42
8141618|NCT02701296|20068297|P2|STARTED|Overall Study||38
8141619|NCT02701296|20068298|P1|STARTED|Overall Study||42
8141620|NCT02701270|20068314|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141621|NCT02701270|20068315|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141622|NCT02701270|20068316|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141623|NCT02701270|20068317|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141624|NCT02701270|20068314|P4|COMPLETED|Fourth Intervention at Visit 4||3
8141625|NCT02701270|20068315|P3|COMPLETED|Fourth Intervention at Visit 4||3
8141626|NCT02701270|20068316|P2|COMPLETED|Fourth Intervention at Visit 4||3
8141627|NCT02701270|20068317|P1|COMPLETED|Fourth Intervention at Visit 4||2
8141628|NCT02701270|20068314|P4|STARTED|Fourth Intervention at Visit 4||3
8141629|NCT02701270|20068315|P3|STARTED|Fourth Intervention at Visit 4||3
8141630|NCT02701270|20068316|P2|STARTED|Fourth Intervention at Visit 4||3
8141631|NCT02701270|20068317|P1|STARTED|Fourth Intervention at Visit 4||2
8141632|NCT02701270|20068314|P4|NOT COMPLETED|Third Intervention at Visit 3||0
8141633|NCT02701270|20068315|P3|NOT COMPLETED|Third Intervention at Visit 3||0
8141634|NCT02701270|20068316|P2|NOT COMPLETED|Third Intervention at Visit 3||0
8141635|NCT02701270|20068317|P1|NOT COMPLETED|Third Intervention at Visit 3||0
8141636|NCT02701270|20068314|P4|COMPLETED|Third Intervention at Visit 3||3
8141637|NCT02701270|20068315|P3|COMPLETED|Third Intervention at Visit 3||3
8141638|NCT02701270|20068316|P2|COMPLETED|Third Intervention at Visit 3||3
8141639|NCT02701270|20068317|P1|COMPLETED|Third Intervention at Visit 3||2
8141640|NCT02701270|20068314|P4|STARTED|Third Intervention at Visit 3||3
8141641|NCT02701270|20068315|P3|STARTED|Third Intervention at Visit 3||3
8141642|NCT02701270|20068316|P2|STARTED|Third Intervention at Visit 3||3
8141643|NCT02701270|20068317|P1|STARTED|Third Intervention at Visit 3||2
8141644|NCT02701270|20068314|P4|NOT COMPLETED|Second Intervention at Visit 2||0
8141645|NCT02701270|20068315|P3|NOT COMPLETED|Second Intervention at Visit 2||0
8141646|NCT02701270|20068316|P2|NOT COMPLETED|Second Intervention at Visit 2||0
8141647|NCT02701270|20068317|P1|NOT COMPLETED|Second Intervention at Visit 2||0
8141648|NCT02701270|20068314|P4|COMPLETED|Second Intervention at Visit 2||3
8141649|NCT02701270|20068315|P3|COMPLETED|Second Intervention at Visit 2||3
8141650|NCT02701270|20068316|P2|COMPLETED|Second Intervention at Visit 2||3
8141651|NCT02701270|20068317|P1|COMPLETED|Second Intervention at Visit 2||2
8141652|NCT02701270|20068314|P4|STARTED|Second Intervention at Visit 2||3
8141653|NCT02701270|20068315|P3|STARTED|Second Intervention at Visit 2||3
8141654|NCT02701270|20068316|P2|STARTED|Second Intervention at Visit 2||3
8141655|NCT02701270|20068317|P1|STARTED|Second Intervention at Visit 2||2
8141656|NCT02701270|20068314|P4|NOT COMPLETED|First Intervention at Visit 1||0
8141657|NCT02701270|20068315|P3|NOT COMPLETED|First Intervention at Visit 1||0
8141658|NCT02701270|20068316|P2|NOT COMPLETED|First Intervention at Visit 1||0
8141659|NCT02701270|20068317|P1|NOT COMPLETED|First Intervention at Visit 1||0
8141660|NCT02701270|20068314|P4|COMPLETED|First Intervention at Visit 1||3
8141661|NCT02701270|20068315|P3|COMPLETED|First Intervention at Visit 1||3
8141662|NCT02701270|20068316|P2|COMPLETED|First Intervention at Visit 1||3
8141663|NCT02701270|20068317|P1|COMPLETED|First Intervention at Visit 1||2
8141664|NCT02701270|20068314|P4|STARTED|First Intervention at Visit 1||3
8141665|NCT02701270|20068315|P3|STARTED|First Intervention at Visit 1||3
8141666|NCT02701270|20068316|P2|STARTED|First Intervention at Visit 1||3
8141667|NCT02701270|20068317|P1|STARTED|First Intervention at Visit 1||2
8141668|NCT02701257|20068336|P5|NOT COMPLETED|Overall Study||3
8141669|NCT02701257|20068337|P4|NOT COMPLETED|Overall Study||1
8141670|NCT02701257|20068338|P3|NOT COMPLETED|Overall Study||0
8141671|NCT02701257|20068339|P2|NOT COMPLETED|Overall Study||3
8141672|NCT02701257|20068340|P1|NOT COMPLETED|Overall Study||0
8141673|NCT02701257|20068336|P5|COMPLETED|Overall Study||1
8141674|NCT02701257|20068337|P4|COMPLETED|Overall Study||3
8141675|NCT02701257|20068338|P3|COMPLETED|Overall Study||0
8141676|NCT02701257|20068339|P2|COMPLETED|Overall Study||3
8141677|NCT02701257|20068340|P1|COMPLETED|Overall Study||6
8141678|NCT02701257|20068336|P5|STARTED|Overall Study||4
8141679|NCT02701257|20068337|P4|STARTED|Overall Study||4
8141680|NCT02701257|20068338|P3|STARTED|Overall Study||0
8141681|NCT02701257|20068339|P2|STARTED|Overall Study||6
8141682|NCT02701257|20068340|P1|STARTED|Overall Study||6
8141683|NCT02701101|20068527|P1|NOT COMPLETED|Overall Study||0
8141684|NCT02701101|20068527|P1|COMPLETED|Overall Study||189
8141685|NCT02701101|20068527|P1|STARTED|Overall Study||189
8141686|NCT02701049|20068536|P3|NOT COMPLETED|Overall Study||0
8141687|NCT02701049|20068537|P2|NOT COMPLETED|Overall Study||0
8141688|NCT02701049|20068538|P1|NOT COMPLETED|Overall Study||0
8141689|NCT02701049|20068536|P3|COMPLETED|Overall Study|Total patients included in analysis|198
8141690|NCT02701049|20068537|P2|COMPLETED|Overall Study|Total patients included in analysis|342
8141691|NCT02701049|20068538|P1|COMPLETED|Overall Study|Total patients included in analysis|209
8141692|NCT02701049|20068536|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
8141693|NCT02701049|20068537|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
8141694|NCT02701049|20068538|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
8141695|NCT02700997|20068550|P1|NOT COMPLETED|Overall Study||2
8141696|NCT02700997|20068550|P1|COMPLETED|Overall Study||15
8141697|NCT02700997|20068550|P1|STARTED|Overall Study||17
8141698|NCT02700984|20068556|P2|NOT COMPLETED|Overall Study||14
8141699|NCT02700984|20068557|P1|NOT COMPLETED|Overall Study||15
8141700|NCT02700984|20068556|P2|COMPLETED|Overall Study||53
8141701|NCT02700984|20068557|P1|COMPLETED|Overall Study||200
8141702|NCT02700984|20068556|P2|STARTED|Overall Study||67
8141703|NCT02700984|20068557|P1|STARTED|Overall Study||215
8141704|NCT02700919|20068609|P3|NOT COMPLETED|Overall Study||4
8141705|NCT02700919|20068610|P2|NOT COMPLETED|Overall Study||12
8141706|NCT02700919|20068611|P1|NOT COMPLETED|Overall Study||12
8141707|NCT02700919|20068609|P3|COMPLETED|Overall Study||87
8141708|NCT02700919|20068610|P2|COMPLETED|Overall Study||85
8141709|NCT02700919|20068611|P1|COMPLETED|Overall Study||82
8141710|NCT02700919|20068609|P3|STARTED|Overall Study||91
8141711|NCT02700919|20068610|P2|STARTED|Overall Study||97
8141712|NCT02700919|20068611|P1|STARTED|Overall Study||94
8141713|NCT02700815|20068673|P4|NOT COMPLETED|Overall Study||7
8141714|NCT02700815|20068674|P3|NOT COMPLETED|Overall Study||4
8141715|NCT02700815|20068675|P2|NOT COMPLETED|Overall Study||7
8141716|NCT02700815|20068676|P1|NOT COMPLETED|Overall Study||1
8141717|NCT02700815|20068673|P4|COMPLETED|Overall Study||218
8141718|NCT02700815|20068674|P3|COMPLETED|Overall Study||219
8141719|NCT02700815|20068675|P2|COMPLETED|Overall Study||216
8141720|NCT02700815|20068676|P1|COMPLETED|Overall Study||74
8141721|NCT02700815|20068673|P4|STARTED|Overall Study||225
8141722|NCT02700815|20068674|P3|STARTED|Overall Study||223
8141723|NCT02700815|20068675|P2|STARTED|Overall Study||223
8141724|NCT02700815|20068676|P1|STARTED|Overall Study||75
8141725|NCT02700412|20068714|P1|NOT COMPLETED|Overall Study||33
8141726|NCT02700412|20068714|P1|COMPLETED|Overall Study||47
8141727|NCT02700412|20068714|P1|STARTED|Overall Study||80
8141728|NCT02700334|20068724|P2|NOT COMPLETED|Overall Study||0
8141729|NCT02700334|20068725|P1|NOT COMPLETED|Overall Study||0
8141730|NCT02700334|20068724|P2|COMPLETED|Overall Study||12
8141731|NCT02700334|20068725|P1|COMPLETED|Overall Study||12
8141732|NCT02700334|20068724|P2|STARTED|Overall Study||12
8141733|NCT02700334|20068725|P1|STARTED|Overall Study||12
8141734|NCT02699996|20068765|P2|NOT COMPLETED|Overall Study||2
8141735|NCT02699996|20068766|P1|NOT COMPLETED|Overall Study||5
8141736|NCT02699996|20068765|P2|COMPLETED|Overall Study||9
8141737|NCT02699996|20068766|P1|COMPLETED|Overall Study||15
8141738|NCT02699996|20068765|P2|STARTED|Overall Study||11
8141739|NCT02699996|20068766|P1|STARTED|Overall Study||20
8141740|NCT02699983|20068784|P2|NOT COMPLETED|Overall Study||0
8141741|NCT02699983|20068785|P1|NOT COMPLETED|Overall Study||1
8141742|NCT02699983|20068784|P2|COMPLETED|Overall Study||17
8141743|NCT02699983|20068785|P1|COMPLETED|Overall Study||17
8141744|NCT02699983|20068784|P2|STARTED|Overall Study||17
8141745|NCT02699983|20068785|P1|STARTED|Overall Study||18
8141746|NCT02699970|20068845|P1|NOT COMPLETED|Overall Study||0
8141747|NCT02699970|20068845|P1|COMPLETED|Overall Study||399
8141748|NCT02699970|20068845|P1|Inter-system|Overall Study||399
8141749|NCT02699970|20068845|P1|Intra-system|Overall Study||399
8141750|NCT02699970|20068845|P1|STARTED|Overall Study||399
8141751|NCT02699892|20068850|P1|NOT COMPLETED|Overall Study||36
8141752|NCT02699892|20068850|P1|COMPLETED|Overall Study||94
8141753|NCT02699892|20068850|P1|STARTED|Overall Study||130
8141754|NCT02699866|20068855|P1|NOT COMPLETED|Overall Study||8
8141755|NCT02699866|20068855|P1|COMPLETED|Overall Study|Last study centre close-out.|38
8141756|NCT02699866|20068855|P1|Included|Overall Study||41
8141757|NCT02699866|20068855|P1|STARTED|Overall Study|First study centre initiation.|46
8141758|NCT02699684|20068863|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8141759|NCT02699684|20068864|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8141760|NCT02699684|20068863|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
8141761|NCT02699684|20068864|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
8141762|NCT02699684|20068863|P2|STARTED|Period 2, Second 30 Days of Wear||38
8141763|NCT02699684|20068864|P1|STARTED|Period 2, Second 30 Days of Wear||37
8141764|NCT02699684|20068863|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8141765|NCT02699684|20068864|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8141766|NCT02699684|20068863|P2|COMPLETED|Period 1, First 30 Days of Wear||38
8141767|NCT02699684|20068864|P1|COMPLETED|Period 1, First 30 Days of Wear||37
8141768|NCT02699684|20068863|P2|STARTED|Period 1, First 30 Days of Wear||38
8141769|NCT02699684|20068864|P1|STARTED|Period 1, First 30 Days of Wear||37
8141770|NCT02699632|20068874|P1|NOT COMPLETED|Overall Study||2
8141771|NCT02699632|20068874|P1|COMPLETED|Overall Study||358
8141772|NCT02699632|20068874|P1|STARTED|Overall Study||360
8141773|NCT02699593|20068881|P2|NOT COMPLETED|Period 2||2
8141774|NCT02699593|20068882|P1|NOT COMPLETED|Period 2||2
8141775|NCT02699593|20068881|P2|COMPLETED|Period 2||60
8141776|NCT02699593|20068882|P1|COMPLETED|Period 2||65
8141777|NCT02699593|20068881|P2|STARTED|Period 2||62
8141778|NCT02699593|20068882|P1|STARTED|Period 2||67
8141779|NCT02699593|20068881|P2|NOT COMPLETED|Period 1||7
8141780|NCT02699593|20068882|P1|NOT COMPLETED|Period 1||5
8141781|NCT02699593|20068881|P2|COMPLETED|Period 1||62
8141782|NCT02699593|20068882|P1|COMPLETED|Period 1||67
8141783|NCT02699593|20068881|P2|STARTED|Period 1||69
8141784|NCT02699593|20068882|P1|STARTED|Period 1||72
8141785|NCT02699463|20068892|P2|NOT COMPLETED|Overall Study||9
8141786|NCT02699463|20068893|P1|NOT COMPLETED|Overall Study||15
8141787|NCT02699463|20068892|P2|COMPLETED|Overall Study||109
8141788|NCT02699463|20068893|P1|COMPLETED|Overall Study||100
8141789|NCT02699463|20068892|P2|STARTED|Overall Study||118
8141790|NCT02699463|20068893|P1|STARTED|Overall Study||115
8141791|NCT02699450|20068902|P3|NOT COMPLETED|Overall Study||15
8141792|NCT02699450|20068903|P2|NOT COMPLETED|Overall Study||5
8141793|NCT02699450|20068904|P1|NOT COMPLETED|Overall Study||15
8141794|NCT02699450|20068902|P3|COMPLETED|Overall Study||67
8141795|NCT02699450|20068903|P2|COMPLETED|Overall Study||50
8141796|NCT02699450|20068904|P1|COMPLETED|Overall Study||75
8141797|NCT02699450|20068902|P3|Completed up to Week 24|Overall Study||73
8141798|NCT02699450|20068903|P2|Completed up to Week 24|Overall Study||53
8141799|NCT02699450|20068904|P1|Completed up to Week 24|Overall Study||81
8141800|NCT02699450|20068902|P3|Received at Least One Dose of Study Drug|Overall Study||80
8141801|NCT02699450|20068903|P2|Received at Least One Dose of Study Drug|Overall Study||55
8141802|NCT02699450|20068904|P1|Received at Least One Dose of Study Drug|Overall Study||89
8141803|NCT02699450|20068902|P3|STARTED|Overall Study||82
8141804|NCT02699450|20068903|P2|STARTED|Overall Study||55
8141805|NCT02699450|20068904|P1|STARTED|Overall Study||90
8141806|NCT02699125|20069039|P2|NOT COMPLETED|Second Intervention (6 Weeks).||2
8141807|NCT02699125|20069040|P1|NOT COMPLETED|Second Intervention (6 Weeks).||7
8141808|NCT02699125|20069039|P2|COMPLETED|Second Intervention (6 Weeks).||14
8141809|NCT02699125|20069040|P1|COMPLETED|Second Intervention (6 Weeks).||11
8141810|NCT02699125|20069039|P2|STARTED|Second Intervention (6 Weeks).||16
8141811|NCT02699125|20069040|P1|STARTED|Second Intervention (6 Weeks).||18
8141812|NCT02699125|20069039|P2|NOT COMPLETED|First Intervention (6 Weeks).||0
8141813|NCT02699125|20069040|P1|NOT COMPLETED|First Intervention (6 Weeks).||0
8141814|NCT02699125|20069039|P2|COMPLETED|First Intervention (6 Weeks).||16
8141815|NCT02699125|20069040|P1|COMPLETED|First Intervention (6 Weeks).||18
8141816|NCT02699125|20069039|P2|STARTED|First Intervention (6 Weeks).||16
8141817|NCT02699125|20069040|P1|STARTED|First Intervention (6 Weeks).||18
8141818|NCT02699125|20069039|P2|NOT COMPLETED|Placebo||4
8141819|NCT02699125|20069040|P1|NOT COMPLETED|Placebo||3
8141820|NCT02699125|20069039|P2|COMPLETED|Placebo||16
8141821|NCT02699125|20069040|P1|COMPLETED|Placebo||18
8141822|NCT02699125|20069039|P2|STARTED|Placebo||20
8141823|NCT02699125|20069040|P1|STARTED|Placebo||21
8141824|NCT02699099|20069054|P3|NOT COMPLETED|Overall Study||3
8141825|NCT02699099|20069055|P2|NOT COMPLETED|Overall Study||2
8141826|NCT02699099|20069056|P1|NOT COMPLETED|Overall Study||7
8141827|NCT02699099|20069054|P3|COMPLETED|Overall Study||229
8141828|NCT02699099|20069055|P2|COMPLETED|Overall Study||234
8141829|NCT02699099|20069056|P1|COMPLETED|Overall Study||224
8141830|NCT02699099|20069054|P3|STARTED|Overall Study||232
8141831|NCT02699099|20069055|P2|STARTED|Overall Study||236
8141832|NCT02699099|20069056|P1|STARTED|Overall Study||231
8141833|NCT02698865|20069132|P2|NOT COMPLETED|Overall Study||33
8141834|NCT02698865|20069133|P1|NOT COMPLETED|Overall Study||35
8141835|NCT02698865|20069132|P2|COMPLETED|Overall Study||47
8141836|NCT02698865|20069133|P1|COMPLETED|Overall Study||105
8141837|NCT02698865|20069132|P2|Treated|Overall Study||80
8141838|NCT02698865|20069133|P1|Treated|Overall Study||140
8141839|NCT02698865|20069132|P2|STARTED|Overall Study||80
8141840|NCT02698865|20069133|P1|STARTED|Overall Study||140
8141841|NCT02698800|20069141|P2|NOT COMPLETED|Overall Study||0
8141842|NCT02698800|20069142|P1|NOT COMPLETED|Overall Study||1
8141843|NCT02698800|20069141|P2|COMPLETED|Overall Study||8
8141844|NCT02698800|20069142|P1|COMPLETED|Overall Study||6
8141845|NCT02698800|20069141|P2|STARTED|Overall Study||8
8141846|NCT02698800|20069142|P1|STARTED|Overall Study||7
8141847|NCT02698735|20069150|P1|NOT COMPLETED|Overall Study||0
8141848|NCT02698735|20069150|P1|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
8141849|NCT02698735|20069150|P1|STARTED|Overall Study||5
8141850|NCT02698566|20069164|P2|NOT COMPLETED|Overall Study||0
8141851|NCT02698566|20069165|P1|NOT COMPLETED|Overall Study||0
8141852|NCT02698566|20069164|P2|COMPLETED|Overall Study||3
8141853|NCT02698566|20069165|P1|COMPLETED|Overall Study||35
8141854|NCT02698566|20069164|P2|STARTED|Overall Study||3
8141855|NCT02698566|20069165|P1|STARTED|Overall Study||35
8141856|NCT02698475|20069171|P1|NOT COMPLETED|Overall Study||5
8141857|NCT02698475|20069171|P1|COMPLETED|Overall Study||39
8141858|NCT02698475|20069171|P1|Ongoing|Overall Study||28
8141859|NCT02698475|20069171|P1|STARTED|Overall Study||44
8141860|NCT02698436|20069188|P2|NOT COMPLETED|Overall Study||7
8141861|NCT02698436|20069189|P1|NOT COMPLETED|Overall Study||7
8141862|NCT02698436|20069188|P2|COMPLETED|Overall Study||51
8141863|NCT02698436|20069189|P1|COMPLETED|Overall Study||52
8141864|NCT02698436|20069188|P2|STARTED|Overall Study||58
8141865|NCT02698436|20069189|P1|STARTED|Overall Study||59
8141866|NCT02698423|20069229|P2|NOT COMPLETED|Overall Study||24
8141867|NCT02698423|20069230|P1|NOT COMPLETED|Overall Study||19
8141868|NCT02698423|20069229|P2|COMPLETED|Overall Study||307
8141869|NCT02698423|20069230|P1|COMPLETED|Overall Study||317
8141870|NCT02698423|20069229|P2|STARTED|Overall Study||331
8141871|NCT02698423|20069230|P1|STARTED|Overall Study||336
8141872|NCT02698410|20069238|P1|NOT COMPLETED|Overall Study||4
8141873|NCT02698410|20069238|P1|COMPLETED|Overall Study||36
8141874|NCT02698410|20069238|P1|STARTED|Overall Study||40
8141875|NCT02698371|20069257|P1|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
8141876|NCT02698371|20069257|P1|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
8141877|NCT02698371|20069257|P1|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
8141878|NCT02698371|20069257|P1|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
8141879|NCT02698371|20069257|P1|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
8141880|NCT02698371|20069257|P1|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
8141881|NCT02698371|20069257|P1|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
8141882|NCT02698371|20069257|P1|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
8141883|NCT02698371|20069257|P1|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
8141884|NCT02698371|20069257|P1|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
8141885|NCT02698371|20069257|P1|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
8141886|NCT02698371|20069257|P1|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
8141887|NCT02698371|20069257|P1|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
8141888|NCT02698371|20069257|P1|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
8141889|NCT02698371|20069257|P1|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
8141890|NCT02698371|20069257|P1|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
8141891|NCT02698371|20069257|P1|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
8141892|NCT02698371|20069257|P1|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
8141893|NCT02698371|20069257|P1|NOT COMPLETED|All Participants Flow||3
8141894|NCT02698371|20069257|P1|COMPLETED|All Participants Flow||35
8141895|NCT02698371|20069257|P1|STARTED|All Participants Flow||38
8141896|NCT02698241|20069379|P1|NOT COMPLETED|Overall Study||34
8141897|NCT02698241|20069379|P1|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
8141898|NCT02698241|20069379|P1|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
8141899|NCT02698241|20069379|P1|STARTED|Overall Study|Number of subjects enrolled the study|79
8141900|NCT02698189|20069386|P2|NOT COMPLETED|Overall Study||6
8141901|NCT02698189|20069387|P1|NOT COMPLETED|Overall Study||3
8141902|NCT02698189|20069386|P2|COMPLETED|Overall Study||0
8141903|NCT02698189|20069387|P1|COMPLETED|Overall Study||0
8141904|NCT02698189|20069386|P2|STARTED|Overall Study||6
8141905|NCT02698189|20069387|P1|STARTED|Overall Study||3
8141906|NCT02698176|20069417|P4|NOT COMPLETED|Overall Study||0
8141907|NCT02698176|20069418|P3|NOT COMPLETED|Overall Study||1
8141908|NCT02698176|20069419|P2|NOT COMPLETED|Overall Study||3
8141909|NCT02698176|20069420|P1|NOT COMPLETED|Overall Study||9
8141910|NCT02698176|20069417|P4|COMPLETED|Overall Study||0
8141911|NCT02698176|20069418|P3|COMPLETED|Overall Study||0
8141912|NCT02698176|20069419|P2|COMPLETED|Overall Study||0
8141913|NCT02698176|20069420|P1|COMPLETED|Overall Study||0
8141914|NCT02698176|20069417|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
8141915|NCT02698176|20069418|P3|STARTED|Overall Study||1
8141916|NCT02698176|20069419|P2|STARTED|Overall Study||3
8141917|NCT02698176|20069420|P1|STARTED|Overall Study||9
8141918|NCT02698033|20069455|P1|NOT COMPLETED|Overall Study||1
8141919|NCT02698033|20069455|P1|COMPLETED|Overall Study||6
8141920|NCT02698033|20069455|P1|STARTED|Overall Study||7
8141921|NCT02697890|20069461|P2|NOT COMPLETED|Overall Study||0
8141922|NCT02697890|20069462|P1|NOT COMPLETED|Overall Study||0
8141923|NCT02697890|20069461|P2|COMPLETED|Overall Study||14
8141924|NCT02697890|20069462|P1|COMPLETED|Overall Study||14
8141925|NCT02697890|20069461|P2|STARTED|Overall Study||14
8141926|NCT02697890|20069462|P1|STARTED|Overall Study||14
8141927|NCT02697773|20069477|P3|NOT COMPLETED|Overall Study||40
8141928|NCT02697773|20069478|P2|NOT COMPLETED|Overall Study||38
8141929|NCT02697773|20069479|P1|NOT COMPLETED|Overall Study||38
8141930|NCT02697773|20069477|P3|COMPLETED|Overall Study||193
8141931|NCT02697773|20069478|P2|COMPLETED|Overall Study||194
8141932|NCT02697773|20069479|P1|COMPLETED|Overall Study||195
8141933|NCT02697773|20069477|P3|Treated|Overall Study||233
8141934|NCT02697773|20069478|P2|Treated|Overall Study||231
8141935|NCT02697773|20069479|P1|Treated|Overall Study||232
8141936|NCT02697773|20069477|P3|STARTED|Overall Study||233
8141937|NCT02697773|20069478|P2|STARTED|Overall Study||232
8141938|NCT02697773|20069479|P1|STARTED|Overall Study||233
8141939|NCT02697617|20069658|P2|NOT COMPLETED|Overall Study||2
8141940|NCT02697617|20069659|P1|NOT COMPLETED|Overall Study||1
8141941|NCT02697617|20069658|P2|COMPLETED|Overall Study||7
8141942|NCT02697617|20069659|P1|COMPLETED|Overall Study|15 completed both arms|8
8141943|NCT02697617|20069658|P2|STARTED|Overall Study||9
8141944|NCT02697617|20069659|P1|STARTED|Overall Study||9
8141945|NCT02697435|20069679|P2|NOT COMPLETED|Overall Study||4
8141946|NCT02697435|20069680|P1|NOT COMPLETED|Overall Study||1
8141947|NCT02697435|20069679|P2|COMPLETED|Overall Study||26
8141948|NCT02697435|20069680|P1|COMPLETED|Overall Study||24
8141949|NCT02697435|20069679|P2|STARTED|Overall Study||30
8141950|NCT02697435|20069680|P1|STARTED|Overall Study||25
8141951|NCT02697292|20069690|P2|NOT COMPLETED|Overall Study||0
8141952|NCT02697292|20069691|P1|NOT COMPLETED|Overall Study||0
8141953|NCT02697292|20069690|P2|COMPLETED|Overall Study||8
8141954|NCT02697292|20069691|P1|COMPLETED|Overall Study||9
8141955|NCT02697292|20069690|P2|STARTED|Overall Study||8
8141956|NCT02697292|20069691|P1|STARTED|Overall Study||9
8141957|NCT02697240|20069699|P1|NOT COMPLETED|Overall Study||0
8141958|NCT02697240|20069699|P1|COMPLETED|Overall Study||4
8141959|NCT02697240|20069699|P1|STARTED|Overall Study||4
8141960|NCT02697214|20069708|P6|NOT COMPLETED|Overall Study||0
8141961|NCT02697214|20069709|P5|NOT COMPLETED|Overall Study||0
8141962|NCT02697214|20069710|P4|NOT COMPLETED|Overall Study||0
8141963|NCT02697214|20069711|P3|NOT COMPLETED|Overall Study||0
8141964|NCT02697214|20069712|P2|NOT COMPLETED|Overall Study||0
8141965|NCT02697214|20069713|P1|NOT COMPLETED|Overall Study||0
8141966|NCT02697214|20069708|P6|COMPLETED|Overall Study||50
8141967|NCT02697214|20069709|P5|COMPLETED|Overall Study||50
8141968|NCT02697214|20069710|P4|COMPLETED|Overall Study||24
8141969|NCT02697214|20069711|P3|COMPLETED|Overall Study||25
8141970|NCT02697214|20069712|P2|COMPLETED|Overall Study||25
8141971|NCT02697214|20069713|P1|COMPLETED|Overall Study||26
8141972|NCT02697214|20069708|P6|Heart Rate at 6mph|Overall Study||50
8141973|NCT02697214|20069709|P5|Heart Rate at 6mph|Overall Study||50
8141974|NCT02697214|20069710|P4|Heart Rate at 6mph|Overall Study||24
8141975|NCT02697214|20069711|P3|Heart Rate at 6mph|Overall Study||25
8141976|NCT02697214|20069712|P2|Heart Rate at 6mph|Overall Study||25
8141977|NCT02697214|20069713|P1|Heart Rate at 6mph|Overall Study||26
8141978|NCT02697214|20069708|P6|Heart Rate at 4mph|Overall Study||50
8141979|NCT02697214|20069709|P5|Heart Rate at 4mph|Overall Study||50
8141980|NCT02697214|20069710|P4|Heart Rate at 4mph|Overall Study||24
8141981|NCT02697214|20069711|P3|Heart Rate at 4mph|Overall Study||25
8141982|NCT02697214|20069712|P2|Heart Rate at 4mph|Overall Study||25
8141983|NCT02697214|20069713|P1|Heart Rate at 4mph|Overall Study||26
8141984|NCT02697214|20069708|P6|Heart Rate at 3mph|Overall Study||50
8141985|NCT02697214|20069709|P5|Heart Rate at 3mph|Overall Study||50
8141986|NCT02697214|20069710|P4|Heart Rate at 3mph|Overall Study||24
8141987|NCT02697214|20069711|P3|Heart Rate at 3mph|Overall Study||25
8141988|NCT02697214|20069712|P2|Heart Rate at 3mph|Overall Study||25
8141989|NCT02697214|20069713|P1|Heart Rate at 3mph|Overall Study||26
8141990|NCT02697214|20069708|P6|Heart Rate at 2mph|Overall Study||50
8141991|NCT02697214|20069709|P5|Heart Rate at 2mph|Overall Study||50
8141992|NCT02697214|20069710|P4|Heart Rate at 2mph|Overall Study||24
8141993|NCT02697214|20069711|P3|Heart Rate at 2mph|Overall Study||25
8141994|NCT02697214|20069712|P2|Heart Rate at 2mph|Overall Study||25
8141995|NCT02697214|20069713|P1|Heart Rate at 2mph|Overall Study||26
8141996|NCT02697214|20069708|P6|STARTED|Overall Study||50
8141997|NCT02697214|20069709|P5|STARTED|Overall Study||50
8141998|NCT02697214|20069710|P4|STARTED|Overall Study||24
8141999|NCT02697214|20069711|P3|STARTED|Overall Study||25
8142000|NCT02697214|20069712|P2|STARTED|Overall Study||25
8142001|NCT02697214|20069713|P1|STARTED|Overall Study||26
8142002|NCT02697188|20069723|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
8142003|NCT02697188|20069723|P1|COMPLETED|TE Period 5 - 800 mg BID||12
8142004|NCT02697188|20069723|P1|STARTED|TE Period 5 - 800 mg BID||12
8142005|NCT02697188|20069723|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
8142006|NCT02697188|20069723|P1|COMPLETED|TU Period 4 - 400 BID||12
8142007|NCT02697188|20069723|P1|STARTED|TU Period 4 - 400 BID||12
8142008|NCT02697188|20069723|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
8142009|NCT02697188|20069723|P1|COMPLETED|TU Period 3 - 200 mg BID||12
8142010|NCT02697188|20069723|P1|STARTED|TU Period 3 - 200 mg BID||12
8142011|NCT02697188|20069723|P1|NOT COMPLETED|TU Period 2 - 200 mg QD||0
8142012|NCT02697188|20069723|P1|COMPLETED|TU Period 2 - 200 mg QD||12
8142013|NCT02697188|20069723|P1|STARTED|TU Period 2 - 200 mg QD||12
8142014|NCT02697188|20069723|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
8142015|NCT02697188|20069723|P1|COMPLETED|TE Period 1 - 400 mg QD||12
8142016|NCT02697188|20069723|P1|STARTED|TE Period 1 - 400 mg QD||12
8142017|NCT02696967|20069736|P4|NOT COMPLETED|Overall Study||0
8142018|NCT02696967|20069737|P3|NOT COMPLETED|Overall Study||0
8142019|NCT02696967|20069738|P2|NOT COMPLETED|Overall Study||0
8142020|NCT02696967|20069739|P1|NOT COMPLETED|Overall Study||0
8142021|NCT02696967|20069736|P4|COMPLETED|Overall Study||10
8142022|NCT02696967|20069737|P3|COMPLETED|Overall Study||6
8142023|NCT02696967|20069738|P2|COMPLETED|Overall Study||6
8142024|NCT02696967|20069739|P1|COMPLETED|Overall Study||4
8142025|NCT02696967|20069736|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8142026|NCT02696967|20069737|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8142027|NCT02696967|20069738|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||6
8142028|NCT02696967|20069739|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8142029|NCT02696967|20069736|P4|STARTED|Overall Study||10
8142030|NCT02696967|20069737|P3|STARTED|Overall Study||6
8142031|NCT02696967|20069738|P2|STARTED|Overall Study||6
8142032|NCT02696967|20069739|P1|STARTED|Overall Study||4
8142045|NCT02696850|20069823|P2|NOT COMPLETED|Overall Study||8
8142046|NCT02696850|20069824|P1|NOT COMPLETED|Overall Study||11
8142047|NCT02696850|20069823|P2|COMPLETED|Overall Study||32
8142048|NCT02696850|20069824|P1|COMPLETED|Overall Study||29
8142049|NCT02696850|20069823|P2|STARTED|Overall Study||40
8142050|NCT02696850|20069824|P1|STARTED|Overall Study||40
8142051|NCT02696798|20069837|P3|NOT COMPLETED|Post-treatment Follow-up Period||19
8142052|NCT02696798|20069838|P2|NOT COMPLETED|Post-treatment Follow-up Period||26
8142053|NCT02696798|20069839|P1|NOT COMPLETED|Post-treatment Follow-up Period||5
8142054|NCT02696798|20069837|P3|COMPLETED|Post-treatment Follow-up Period||3
8142055|NCT02696798|20069838|P2|COMPLETED|Post-treatment Follow-up Period||8
8142056|NCT02696798|20069839|P1|COMPLETED|Post-treatment Follow-up Period||0
8142057|NCT02696798|20069837|P3|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
8142058|NCT02696798|20069838|P2|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
8142059|NCT02696798|20069839|P1|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
8142060|NCT02696798|20069837|P3|NOT COMPLETED|Extended Treatment Period||10
8142061|NCT02696798|20069838|P2|NOT COMPLETED|Extended Treatment Period||9
8142062|NCT02696798|20069839|P1|NOT COMPLETED|Extended Treatment Period||12
8142063|NCT02696798|20069837|P3|COMPLETED|Extended Treatment Period||80
8142064|NCT02696798|20069838|P2|COMPLETED|Extended Treatment Period||89
8142065|NCT02696798|20069839|P1|COMPLETED|Extended Treatment Period||81
8142066|NCT02696798|20069837|P3|STARTED|Extended Treatment Period||90
8142067|NCT02696798|20069838|P2|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
8142068|NCT02696798|20069839|P1|STARTED|Extended Treatment Period||93
8142069|NCT02696798|20069837|P3|NOT COMPLETED|Blinded Treatment Dosing Period||8
8142070|NCT02696798|20069838|P2|NOT COMPLETED|Blinded Treatment Dosing Period||15
8142071|NCT02696798|20069839|P1|NOT COMPLETED|Blinded Treatment Dosing Period||11
8142072|NCT02696798|20069837|P3|COMPLETED|Blinded Treatment Dosing Period||90
8142073|NCT02696798|20069838|P2|COMPLETED|Blinded Treatment Dosing Period||99
8142074|NCT02696798|20069839|P1|COMPLETED|Blinded Treatment Dosing Period||93
8142075|NCT02696798|20069837|P3|STARTED|Blinded Treatment Dosing Period||98
8142076|NCT02696798|20069838|P2|STARTED|Blinded Treatment Dosing Period||114
8142077|NCT02696798|20069839|P1|STARTED|Blinded Treatment Dosing Period||104
8142078|NCT02696785|20069936|P4|NOT COMPLETED|Follow-up Period||8
8142079|NCT02696785|20069937|P3|NOT COMPLETED|Follow-up Period||13
8142080|NCT02696785|20069938|P2|NOT COMPLETED|Follow-up Period||0
8142081|NCT02696785|20069939|P1|NOT COMPLETED|Follow-up Period||1
8142082|NCT02696785|20069936|P4|COMPLETED|Follow-up Period||8
8142083|NCT02696785|20069937|P3|COMPLETED|Follow-up Period||11
8142084|NCT02696785|20069938|P2|COMPLETED|Follow-up Period||0
8142085|NCT02696785|20069939|P1|COMPLETED|Follow-up Period||0
8142086|NCT02696785|20069936|P4|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
8142087|NCT02696785|20069937|P3|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
8142088|NCT02696785|20069938|P2|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
8142089|NCT02696785|20069939|P1|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
8142090|NCT02696785|20069936|P4|NOT COMPLETED|Extended Treatment Period||6
8142091|NCT02696785|20069937|P3|NOT COMPLETED|Extended Treatment Period||5
8142092|NCT02696785|20069938|P2|NOT COMPLETED|Extended Treatment Period||6
8142093|NCT02696785|20069939|P1|NOT COMPLETED|Extended Treatment Period||3
8142094|NCT02696785|20069936|P4|COMPLETED|Extended Treatment Period||72
8142095|NCT02696785|20069937|P3|COMPLETED|Extended Treatment Period||74
8142096|NCT02696785|20069938|P2|COMPLETED|Extended Treatment Period||80
8142097|NCT02696785|20069939|P1|COMPLETED|Extended Treatment Period||83
8142098|NCT02696785|20069936|P4|STARTED|Extended Treatment Period||78
8142099|NCT02696785|20069937|P3|STARTED|Extended Treatment Period||79
8142100|NCT02696785|20069938|P2|STARTED|Extended Treatment Period||86
8142101|NCT02696785|20069939|P1|STARTED|Extended Treatment Period||86
8142102|NCT02696785|20069936|P4|NOT COMPLETED|Washout Period||0
8142103|NCT02696785|20069937|P3|NOT COMPLETED|Washout Period||0
8142104|NCT02696785|20069938|P2|NOT COMPLETED|Washout Period||2
8142105|NCT02696785|20069939|P1|NOT COMPLETED|Washout Period||0
8142106|NCT02696785|20069936|P4|COMPLETED|Washout Period||0
8142107|NCT02696785|20069937|P3|COMPLETED|Washout Period||0
8142108|NCT02696785|20069938|P2|COMPLETED|Washout Period||86
8142109|NCT02696785|20069939|P1|COMPLETED|Washout Period||0
8142110|NCT02696785|20069936|P4|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8142111|NCT02696785|20069937|P3|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8142112|NCT02696785|20069938|P2|STARTED|Washout Period||88
8142113|NCT02696785|20069939|P1|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8142114|NCT02696785|20069936|P4|NOT COMPLETED|Blinded Treatment Period||3
8142115|NCT02696785|20069937|P3|NOT COMPLETED|Blinded Treatment Period||4
8142116|NCT02696785|20069938|P2|NOT COMPLETED|Blinded Treatment Period||2
8142117|NCT02696785|20069939|P1|NOT COMPLETED|Blinded Treatment Period||1
8142118|NCT02696785|20069936|P4|COMPLETED|Blinded Treatment Period||78
8142119|NCT02696785|20069937|P3|COMPLETED|Blinded Treatment Period||79
8142120|NCT02696785|20069938|P2|COMPLETED|Blinded Treatment Period||88
8142121|NCT02696785|20069939|P1|COMPLETED|Blinded Treatment Period||86
8142122|NCT02696785|20069936|P4|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
8142123|NCT02696785|20069937|P3|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
8142124|NCT02696785|20069938|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
8142125|NCT02696785|20069939|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
8142126|NCT02696785|20069936|P4|STARTED|Blinded Treatment Period||81
8142127|NCT02696785|20069937|P3|STARTED|Blinded Treatment Period||83
8142128|NCT02696785|20069938|P2|STARTED|Blinded Treatment Period||90
8142129|NCT02696785|20069939|P1|STARTED|Blinded Treatment Period||87
8142130|NCT02696434|20070059|P2|NOT COMPLETED|Overall Study||18
8142131|NCT02696434|20070060|P1|NOT COMPLETED|Overall Study||22
8142132|NCT02696434|20070059|P2|COMPLETED|Overall Study||33
8142133|NCT02696434|20070060|P1|COMPLETED|Overall Study||28
8142134|NCT02696434|20070059|P2|STARTED|Overall Study||51
8142135|NCT02696434|20070060|P1|STARTED|Overall Study||50
8142136|NCT02696317|20070078|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
8142137|NCT02696317|20070079|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
8142138|NCT02696317|20070078|P2|COMPLETED|Period 2, 10 Days of Wear||36
8142139|NCT02696317|20070079|P1|COMPLETED|Period 2, 10 Days of Wear||39
8142140|NCT02696317|20070078|P2|STARTED|Period 2, 10 Days of Wear||36
8142141|NCT02696317|20070079|P1|STARTED|Period 2, 10 Days of Wear||40
8142142|NCT02696317|20070078|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
8142143|NCT02696317|20070079|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
8142144|NCT02696317|20070078|P2|COMPLETED|Period 1, 10 Days of Wear||36
8142145|NCT02696317|20070079|P1|COMPLETED|Period 1, 10 Days of Wear||40
8142146|NCT02696317|20070078|P2|STARTED|Period 1, 10 Days of Wear||36
8142147|NCT02696317|20070079|P1|STARTED|Period 1, 10 Days of Wear||40
8142148|NCT02696317|20070078|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
8142149|NCT02696317|20070079|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
8142150|NCT02696317|20070078|P2|COMPLETED|Habitual, 10 Days of Wear||36
8142151|NCT02696317|20070079|P1|COMPLETED|Habitual, 10 Days of Wear||40
8142152|NCT02696317|20070078|P2|STARTED|Habitual, 10 Days of Wear||40
8142153|NCT02696317|20070079|P1|STARTED|Habitual, 10 Days of Wear||42
8142154|NCT02696291|20070095|P2|NOT COMPLETED|Overall Study||0
8142155|NCT02696291|20070096|P1|NOT COMPLETED|Overall Study||0
8142156|NCT02696291|20070095|P2|COMPLETED|Overall Study||2
8142157|NCT02696291|20070096|P1|COMPLETED|Overall Study||5
8142158|NCT02696291|20070095|P2|STARTED|Overall Study||2
8142159|NCT02696291|20070096|P1|STARTED|Overall Study||5
8142160|NCT02696226|20070123|P4|NOT COMPLETED|Overall Study||0
8142161|NCT02696226|20070124|P3|NOT COMPLETED|Overall Study||2
8142162|NCT02696226|20070125|P2|NOT COMPLETED|Overall Study||0
8142163|NCT02696226|20070126|P1|NOT COMPLETED|Overall Study||1
8142164|NCT02696226|20070123|P4|COMPLETED|Overall Study||0
8142165|NCT02696226|20070124|P3|COMPLETED|Overall Study||0
8142166|NCT02696226|20070125|P2|COMPLETED|Overall Study||0
8142167|NCT02696226|20070126|P1|COMPLETED|Overall Study||0
8142168|NCT02696226|20070123|P4|STARTED|Overall Study||0
8142169|NCT02696226|20070124|P3|STARTED|Overall Study||2
8142170|NCT02696226|20070125|P2|STARTED|Overall Study||0
8142171|NCT02696226|20070126|P1|STARTED|Overall Study||1
8142172|NCT02696200|20070138|P2|NOT COMPLETED|Overall Study||0
8142173|NCT02696200|20070139|P1|NOT COMPLETED|Overall Study||0
8142174|NCT02696200|20070138|P2|COMPLETED|Overall Study||30
8142175|NCT02696200|20070139|P1|COMPLETED|Overall Study||32
8142176|NCT02696200|20070138|P2|STARTED|Overall Study||30
8142177|NCT02696200|20070139|P1|STARTED|Overall Study||32
8142178|NCT02696083|20070149|P1|NOT COMPLETED|Overall Study||6
8142179|NCT02696083|20070149|P1|COMPLETED|Overall Study||13
8142180|NCT02696083|20070149|P1|STARTED|Overall Study||19
8142181|NCT02696070|20070160|P2|NOT COMPLETED|Overall Study||2
8142182|NCT02696070|20070161|P1|NOT COMPLETED|Overall Study||1
8142183|NCT02696070|20070160|P2|COMPLETED|Overall Study||12
8142184|NCT02696070|20070161|P1|COMPLETED|Overall Study||7
8142185|NCT02696070|20070160|P2|STARTED|Overall Study||14
8142186|NCT02696070|20070161|P1|STARTED|Overall Study||8
8142187|NCT02696031|20070170|P3|NOT COMPLETED|Week 52||26
8142188|NCT02696031|20070171|P2|NOT COMPLETED|Week 52||19
8142189|NCT02696031|20070172|P1|NOT COMPLETED|Week 52||29
8142190|NCT02696031|20070170|P3|COMPLETED|Week 52||160
8142191|NCT02696031|20070171|P2|COMPLETED|Week 52||165
8142192|NCT02696031|20070172|P1|COMPLETED|Week 52||156
8142193|NCT02696031|20070170|P3|STARTED|Week 52||186
8142194|NCT02696031|20070171|P2|STARTED|Week 52||184
8142195|NCT02696031|20070172|P1|STARTED|Week 52||185
8142196|NCT02696031|20070170|P3|NOT COMPLETED|Week 24||11
8142197|NCT02696031|20070171|P2|NOT COMPLETED|Week 24||7
8142198|NCT02696031|20070172|P1|NOT COMPLETED|Week 24||10
8142199|NCT02696031|20070170|P3|COMPLETED|Week 24||175
8142200|NCT02696031|20070171|P2|COMPLETED|Week 24||177
8142201|NCT02696031|20070172|P1|COMPLETED|Week 24||175
8142202|NCT02696031|20070170|P3|STARTED|Week 24||186
8142203|NCT02696031|20070171|P2|STARTED|Week 24||184
8142204|NCT02696031|20070172|P1|STARTED|Week 24||185
8142205|NCT02695719|20070186|P2|NOT COMPLETED|Overall Study||10
8142206|NCT02695719|20070187|P1|NOT COMPLETED|Overall Study||3
8142207|NCT02695719|20070186|P2|COMPLETED|Overall Study||72
8142208|NCT02695719|20070187|P1|COMPLETED|Overall Study||71
8142209|NCT02695719|20070186|P2|STARTED|Overall Study||82
8142210|NCT02695719|20070187|P1|STARTED|Overall Study||74
8142211|NCT02695628|20070205|P1|NOT COMPLETED|Overall Study||1
8142212|NCT02695628|20070205|P1|COMPLETED|Overall Study||4
8142213|NCT02695628|20070205|P1|STARTED|Overall Study||5
8142214|NCT02695537|20070211|P1|NOT COMPLETED|Overall Study||38
8142215|NCT02695537|20070211|P1|COMPLETED|Overall Study||51
8142216|NCT02695537|20070211|P1|STARTED|Overall Study||89
8142217|NCT02695524|20070221|P2|NOT COMPLETED|Overall Study||3
8142218|NCT02695524|20070222|P1|NOT COMPLETED|Overall Study||3
8142219|NCT02695524|20070221|P2|COMPLETED|Overall Study||27
8142220|NCT02695524|20070222|P1|COMPLETED|Overall Study||27
8142221|NCT02695524|20070221|P2|STARTED|Overall Study||30
8142222|NCT02695524|20070222|P1|STARTED|Overall Study||30
8142223|NCT02695446|20070242|P1|NOT COMPLETED|Overall Study||0
8142224|NCT02695446|20070242|P1|COMPLETED|Overall Study||12
8142225|NCT02695446|20070242|P1|STARTED|Overall Study||12
8142226|NCT02695420|20070251|P4|NOT COMPLETED|Overall Study||0
8142227|NCT02695420|20070252|P3|NOT COMPLETED|Overall Study||0
8142228|NCT02695420|20070253|P2|NOT COMPLETED|Overall Study||1
8142229|NCT02695420|20070254|P1|NOT COMPLETED|Overall Study||0
8142230|NCT02695420|20070251|P4|COMPLETED|Overall Study||20
8142231|NCT02695420|20070252|P3|COMPLETED|Overall Study||19
8142232|NCT02695420|20070253|P2|COMPLETED|Overall Study||20
8142233|NCT02695420|20070254|P1|COMPLETED|Overall Study||21
8142234|NCT02695420|20070251|P4|STARTED|Overall Study||20
8142235|NCT02695420|20070252|P3|STARTED|Overall Study||19
8142236|NCT02695420|20070253|P2|STARTED|Overall Study||21
8142237|NCT02695420|20070254|P1|STARTED|Overall Study||21
8142238|NCT02695329|20070276|P2|NOT COMPLETED|Overall Study||5
8142239|NCT02695329|20070277|P1|NOT COMPLETED|Overall Study||5
8142240|NCT02695329|20070276|P2|COMPLETED|Overall Study||45
8142241|NCT02695329|20070277|P1|COMPLETED|Overall Study||45
8142242|NCT02695329|20070276|P2|STARTED|Overall Study||50
8142243|NCT02695329|20070277|P1|STARTED|Overall Study||50
8142244|NCT02695290|20070289|P1|NOT COMPLETED|Overall Study||0
8142245|NCT02695290|20070289|P1|COMPLETED|Overall Study||1
8142246|NCT02695290|20070289|P1|STARTED|Overall Study||1
8142247|NCT02694978|20070297|P2|NOT COMPLETED|Overall Study||60
8142248|NCT02694978|20070298|P1|NOT COMPLETED|Overall Study||71
8142249|NCT02694978|20070297|P2|COMPLETED|Overall Study||948
8142250|NCT02694978|20070298|P1|COMPLETED|Overall Study||935
8142251|NCT02694978|20070297|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
8142252|NCT02694978|20070298|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
8142253|NCT02694978|20070297|P2|STARTED|Overall Study||1008
8142254|NCT02694978|20070298|P1|STARTED|Overall Study||1006
8142255|NCT02694835|20070312|P2|NOT COMPLETED|Overall Study||0
8142256|NCT02694835|20070313|P1|NOT COMPLETED|Overall Study||0
8142257|NCT02694835|20070312|P2|COMPLETED|Overall Study||39
8142258|NCT02694835|20070313|P1|COMPLETED|Overall Study||41
8142259|NCT02694835|20070312|P2|STARTED|Overall Study||39
8142260|NCT02694835|20070313|P1|STARTED|Overall Study||41
8142261|NCT02694757|20070319|P1|NOT COMPLETED|Overall Study||3
8142262|NCT02694757|20070319|P1|COMPLETED|Overall Study||0
8142263|NCT02694757|20070319|P1|STARTED|Overall Study||3
8142264|NCT02694744|20070325|P2|NOT COMPLETED|Overall Study||5
8142265|NCT02694744|20070326|P1|NOT COMPLETED|Overall Study||6
8142266|NCT02694744|20070325|P2|COMPLETED|Overall Study||52
8142267|NCT02694744|20070326|P1|COMPLETED|Overall Study||51
8142268|NCT02694744|20070325|P2|ITT|Overall Study||55
8142269|NCT02694744|20070326|P1|ITT|Overall Study||57
8142270|NCT02694744|20070325|P2|Safety Population|Overall Study||56
8142271|NCT02694744|20070326|P1|Safety Population|Overall Study||57
8142272|NCT02694744|20070325|P2|STARTED|Overall Study||57
8142273|NCT02694744|20070326|P1|STARTED|Overall Study||57
8142274|NCT02694718|20070334|P1|NOT COMPLETED|Overall Study||2
8142275|NCT02694718|20070334|P1|COMPLETED|Overall Study||58
8142276|NCT02694718|20070334|P1|STARTED|Overall Study||60
8142277|NCT02694601|20070344|P1|NOT COMPLETED|Overall Study||0
8142278|NCT02694601|20070344|P1|COMPLETED|Overall Study||10
8142279|NCT02694601|20070344|P1|STARTED|Overall Study||10
8142280|NCT02694562|20070352|P1|NOT COMPLETED|Overall Study||18
8142281|NCT02694562|20070352|P1|COMPLETED|Overall Study||2
8142282|NCT02694562|20070352|P1|STARTED|Overall Study||20
8142283|NCT02694549|20070361|P1|NOT COMPLETED|Overall Study||2
8142284|NCT02694549|20070361|P1|COMPLETED|Overall Study||10
8142285|NCT02694549|20070361|P1|STARTED|Overall Study||12
8142286|NCT02694536|20070367|P1|NOT COMPLETED|Overall Study||80
8142287|NCT02694536|20070367|P1|COMPLETED|Overall Study||0
8142288|NCT02694536|20070367|P1|STARTED|Overall Study||80
8142289|NCT02694523|20070378|P7|NOT COMPLETED|Part B||2
8142290|NCT02694523|20070379|P6|NOT COMPLETED|Part B||5
8142291|NCT02694523|20070380|P5|NOT COMPLETED|Part B||4
8142292|NCT02694523|20070381|P4|NOT COMPLETED|Part B||4
8142293|NCT02694523|20070382|P3|NOT COMPLETED|Part B||20
8142294|NCT02694523|20070383|P2|NOT COMPLETED|Part B||0
8142295|NCT02694523|20070384|P1|NOT COMPLETED|Part B||0
8142296|NCT02694523|20070378|P7|COMPLETED|Part B||51
8142297|NCT02694523|20070379|P6|COMPLETED|Part B||51
8142298|NCT02694523|20070380|P5|COMPLETED|Part B||34
8142299|NCT02694523|20070381|P4|COMPLETED|Part B||140
8142300|NCT02694523|20070382|P3|COMPLETED|Part B||274
8142301|NCT02694523|20070383|P2|COMPLETED|Part B||0
8142302|NCT02694523|20070384|P1|COMPLETED|Part B||0
8142303|NCT02694523|20070378|P7|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
8142304|NCT02694523|20070379|P6|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
8142305|NCT02694523|20070380|P5|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
8142306|NCT02694523|20070381|P4|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
8142307|NCT02694523|20070382|P3|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
8142308|NCT02694523|20070383|P2|STARTED|Part B||0
8142309|NCT02694523|20070384|P1|STARTED|Part B||0
8142310|NCT02694523|20070378|P7|NOT COMPLETED|Part A||0
8142311|NCT02694523|20070379|P6|NOT COMPLETED|Part A||0
8142312|NCT02694523|20070380|P5|NOT COMPLETED|Part A||0
8142313|NCT02694523|20070381|P4|NOT COMPLETED|Part A||0
8142314|NCT02694523|20070382|P3|NOT COMPLETED|Part A||0
8142315|NCT02694523|20070383|P2|NOT COMPLETED|Part A||7
8142316|NCT02694523|20070384|P1|NOT COMPLETED|Part A||13
8142317|NCT02694523|20070378|P7|COMPLETED|Part A||0
8142318|NCT02694523|20070379|P6|COMPLETED|Part A||0
8142319|NCT02694523|20070380|P5|COMPLETED|Part A||0
8142320|NCT02694523|20070381|P4|COMPLETED|Part A||0
8142321|NCT02694523|20070382|P3|COMPLETED|Part A||0
8142322|NCT02694523|20070383|P2|COMPLETED|Part A||294
8142323|NCT02694523|20070384|P1|COMPLETED|Part A||291
8142324|NCT02694523|20070378|P7|STARTED|Part A||0
8142325|NCT02694523|20070379|P6|STARTED|Part A||0
8142326|NCT02694523|20070380|P5|STARTED|Part A||0
8142327|NCT02694523|20070381|P4|STARTED|Part A||0
8142328|NCT02694523|20070382|P3|STARTED|Part A||0
8142329|NCT02694523|20070383|P2|STARTED|Part A||301
8142330|NCT02694523|20070384|P1|STARTED|Part A||304
8142331|NCT02694445|20070408|P1|NOT COMPLETED|Overall Study||52
8142332|NCT02694445|20070408|P1|COMPLETED|Overall Study||3046
8142333|NCT02694445|20070408|P1|STARTED|Overall Study||3098
8142334|NCT02694328|20070414|P2|NOT COMPLETED|Overall Study||98
8142335|NCT02694328|20070415|P1|NOT COMPLETED|Overall Study||100
8142336|NCT02694328|20070414|P2|COMPLETED|Overall Study||176
8142337|NCT02694328|20070415|P1|COMPLETED|Overall Study||176
8142338|NCT02694328|20070414|P2|STARTED|Overall Study||274
8142339|NCT02694328|20070415|P1|STARTED|Overall Study||276
8142340|NCT02694315|20070427|P1|NOT COMPLETED|Overall Study||0
8142341|NCT02694315|20070427|P1|COMPLETED|Overall Study||200
8142342|NCT02694315|20070427|P1|STARTED|Overall Study||200
8142343|NCT02694198|20070432|P1|NOT COMPLETED|Overall Study||0
8142344|NCT02694198|20070432|P1|COMPLETED|Overall Study||135
8142345|NCT02694198|20070432|P1|STARTED|Overall Study||135
8142346|NCT02693834|20070437|P2|NOT COMPLETED|Week 2 Practice||1
8142347|NCT02693834|20070438|P1|NOT COMPLETED|Week 2 Practice||0
8142348|NCT02693834|20070437|P2|COMPLETED|Week 2 Practice||10
8142349|NCT02693834|20070438|P1|COMPLETED|Week 2 Practice||10
8142350|NCT02693834|20070437|P2|STARTED|Week 2 Practice||11
8142351|NCT02693834|20070438|P1|STARTED|Week 2 Practice||10
8142352|NCT02693834|20070437|P2|NOT COMPLETED|Week 1 Practice||0
8142353|NCT02693834|20070438|P1|NOT COMPLETED|Week 1 Practice||0
8142354|NCT02693834|20070437|P2|COMPLETED|Week 1 Practice||11
8142355|NCT02693834|20070438|P1|COMPLETED|Week 1 Practice||10
8142356|NCT02693834|20070437|P2|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
8142357|NCT02693834|20070438|P1|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
8142358|NCT02693834|20070437|P2|NOT COMPLETED|Baseline Measurement||0
8142359|NCT02693834|20070438|P1|NOT COMPLETED|Baseline Measurement||2
8142360|NCT02693834|20070437|P2|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
8142361|NCT02693834|20070438|P1|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
8142362|NCT02693834|20070437|P2|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
8142363|NCT02693834|20070438|P1|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
8142364|NCT02693743|20070448|P2|NOT COMPLETED|Overall Study||0
8142365|NCT02693743|20070449|P1|NOT COMPLETED|Overall Study||1
8142366|NCT02693743|20070448|P2|COMPLETED|Overall Study||0
8142367|NCT02693743|20070449|P1|COMPLETED|Overall Study||0
8142368|NCT02693743|20070448|P2|STARTED|Overall Study||0
8142369|NCT02693743|20070449|P1|STARTED|Overall Study||1
8142370|NCT02693704|20070459|P4|NOT COMPLETED|Overall Study||0
8142371|NCT02693704|20070460|P3|NOT COMPLETED|Overall Study||0
8142372|NCT02693704|20070461|P2|NOT COMPLETED|Overall Study||0
8142373|NCT02693704|20070462|P1|NOT COMPLETED|Overall Study||0
8142374|NCT02693704|20070459|P4|COMPLETED|Overall Study||10
8142375|NCT02693704|20070460|P3|COMPLETED|Overall Study||10
8142376|NCT02693704|20070461|P2|COMPLETED|Overall Study||10
8142377|NCT02693704|20070462|P1|COMPLETED|Overall Study||10
8142378|NCT02693704|20070459|P4|STARTED|Overall Study||10
8142379|NCT02693704|20070460|P3|STARTED|Overall Study||10
8142380|NCT02693704|20070461|P2|STARTED|Overall Study||10
8142381|NCT02693704|20070462|P1|STARTED|Overall Study||10
8142382|NCT02693691|20070480|P1|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
8142383|NCT02693691|20070480|P1|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
8142384|NCT02693691|20070480|P1|STARTED|Extended Follow-Up (Until Last pt 12M)||184
8142385|NCT02693691|20070480|P1|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
8142386|NCT02693691|20070480|P1|COMPLETED|Primary Endpoint Analysis (First 12M)||184
8142387|NCT02693691|20070480|P1|STARTED|Primary Endpoint Analysis (First 12M)||234
8142388|NCT02693418|20070492|P5|NOT COMPLETED|Overall Study||0
8142389|NCT02693418|20070493|P4|NOT COMPLETED|Overall Study||0
8142390|NCT02693418|20070494|P3|NOT COMPLETED|Overall Study||2
8142391|NCT02693418|20070495|P2|NOT COMPLETED|Overall Study||2
8142392|NCT02693418|20070496|P1|NOT COMPLETED|Overall Study||1
8142393|NCT02693418|20070492|P5|COMPLETED|Overall Study||21
8142394|NCT02693418|20070493|P4|COMPLETED|Overall Study||20
8142395|NCT02693418|20070494|P3|COMPLETED|Overall Study||19
8142396|NCT02693418|20070495|P2|COMPLETED|Overall Study||19
8142397|NCT02693418|20070496|P1|COMPLETED|Overall Study||21
8142398|NCT02693418|20070492|P5|STARTED|Overall Study||21
8142399|NCT02693418|20070493|P4|STARTED|Overall Study||20
8142400|NCT02693418|20070494|P3|STARTED|Overall Study||21
8142401|NCT02693418|20070495|P2|STARTED|Overall Study||21
8142402|NCT02693418|20070496|P1|STARTED|Overall Study||22
8142403|NCT02693171|20070513|P1|NOT COMPLETED|Overall Study||9
8142404|NCT02693171|20070513|P1|COMPLETED|Overall Study||3
8142405|NCT02693171|20070513|P1|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
8142406|NCT02693132|20070523|P3|NOT COMPLETED|Overall Study||1
8142407|NCT02693132|20070524|P2|NOT COMPLETED|Overall Study||1
8142408|NCT02693132|20070525|P1|NOT COMPLETED|Overall Study||1
8142409|NCT02693132|20070523|P3|COMPLETED|Overall Study||17
8142410|NCT02693132|20070524|P2|COMPLETED|Overall Study||16
8142411|NCT02693132|20070525|P1|COMPLETED|Overall Study||16
8142412|NCT02693132|20070523|P3|STARTED|Overall Study||18
8142413|NCT02693132|20070524|P2|STARTED|Overall Study||17
8142414|NCT02693132|20070525|P1|STARTED|Overall Study||17
8142415|NCT02693106|20070545|P1|NOT COMPLETED|Overall Study||3
8142416|NCT02693106|20070545|P1|COMPLETED|Overall Study||10
8142417|NCT02693106|20070545|P1|STARTED|Overall Study||13
8142418|NCT02693002|20070557|P2|NOT COMPLETED|Overall Study||0
8142419|NCT02693002|20070558|P1|NOT COMPLETED|Overall Study||1
8142420|NCT02693002|20070557|P2|COMPLETED|Overall Study||2
8142421|NCT02693002|20070558|P1|COMPLETED|Overall Study||1
8142422|NCT02693002|20070557|P2|STARTED|Overall Study||2
8142423|NCT02693002|20070558|P1|STARTED|Overall Study||2
8142424|NCT02692859|20070572|P2|NOT COMPLETED|Overall Study||95
8142425|NCT02692859|20070573|P1|NOT COMPLETED|Overall Study||84
8142426|NCT02692859|20070572|P2|COMPLETED|Overall Study||901
8142427|NCT02692859|20070573|P1|COMPLETED|Overall Study||912
8142428|NCT02692859|20070572|P2|STARTED|Overall Study||996
8142429|NCT02692859|20070573|P1|STARTED|Overall Study||996
8142430|NCT02692716|20070581|P2|NOT COMPLETED|Overall Study||6
8142431|NCT02692716|20070582|P1|NOT COMPLETED|Overall Study||5
8142432|NCT02692716|20070581|P2|COMPLETED|Overall Study||1586
8142433|NCT02692716|20070582|P1|COMPLETED|Overall Study||1586
8142434|NCT02692716|20070581|P2|Exposed|Overall Study||1591
8142435|NCT02692716|20070582|P1|Exposed|Overall Study||1591
8142436|NCT02692716|20070581|P2|Full Analysis Set (FAS)|Overall Study||1592
8142437|NCT02692716|20070582|P1|Full Analysis Set (FAS)|Overall Study||1591
8142438|NCT02692716|20070581|P2|STARTED|Overall Study||1592
8142439|NCT02692716|20070582|P1|STARTED|Overall Study||1591
8142440|NCT02692703|20070622|P1|NOT COMPLETED|Overall Study||2
8142441|NCT02692703|20070622|P1|COMPLETED|Overall Study||98
8142442|NCT02692703|20070622|P1|STARTED|Overall Study||100
8142443|NCT02692560|20070630|P2|NOT COMPLETED|Overall Study||6
8142444|NCT02692560|20070631|P1|NOT COMPLETED|Overall Study||0
8142445|NCT02692560|20070630|P2|COMPLETED|Overall Study||25
8142446|NCT02692560|20070631|P1|COMPLETED|Overall Study||29
8142447|NCT02692560|20070630|P2|STARTED|Overall Study||31
8142448|NCT02692560|20070631|P1|STARTED|Overall Study||29
8142449|NCT02692495|20070653|P2|NOT COMPLETED|Overall Study||0
8142450|NCT02692495|20070654|P1|NOT COMPLETED|Overall Study||0
8142451|NCT02692495|20070653|P2|COMPLETED|Overall Study||4
8142452|NCT02692495|20070654|P1|COMPLETED|Overall Study||12
8142453|NCT02692495|20070653|P2|STARTED|Overall Study||4
8142454|NCT02692495|20070654|P1|STARTED|Overall Study||12
8142455|NCT02692482|20070671|P2|NOT COMPLETED|Overall Study||4
8142456|NCT02692482|20070672|P1|NOT COMPLETED|Overall Study||3
8142457|NCT02692482|20070671|P2|COMPLETED|Overall Study||178
8142458|NCT02692482|20070672|P1|COMPLETED|Overall Study||174
8142459|NCT02692482|20070671|P2|STARTED|Overall Study||182
8142460|NCT02692482|20070672|P1|STARTED|Overall Study||177
8142461|NCT02692417|20070686|P2|NOT COMPLETED|Overall Study||1
8142462|NCT02692417|20070687|P1|NOT COMPLETED|Overall Study||6
8142463|NCT02692417|20070686|P2|COMPLETED|Overall Study||6
8142464|NCT02692417|20070687|P1|COMPLETED|Overall Study||3
8142465|NCT02692417|20070686|P2|STARTED|Overall Study||7
8142466|NCT02692417|20070687|P1|STARTED|Overall Study||9
8142467|NCT02692235|20070699|P2|NOT COMPLETED|Overall Study||3
8142468|NCT02692235|20070700|P1|NOT COMPLETED|Overall Study||3
8142469|NCT02692235|20070699|P2|COMPLETED|Overall Study||11
8142470|NCT02692235|20070700|P1|COMPLETED|Overall Study||11
8142471|NCT02692235|20070699|P2|STARTED|Overall Study||14
8142472|NCT02692235|20070700|P1|STARTED|Overall Study||14
8142473|NCT02692209|20070708|P1|NOT COMPLETED|Overall Study||0
8142474|NCT02692209|20070708|P1|COMPLETED|Overall Study||298
8142475|NCT02692209|20070708|P1|STARTED|Overall Study||298
8142476|NCT02692040|20070731|P17|NOT COMPLETED|Overall Study||0
8142477|NCT02692040|20070732|P16|NOT COMPLETED|Overall Study||1
8142478|NCT02692040|20070733|P15|NOT COMPLETED|Overall Study||1
8142479|NCT02692040|20070734|P14|NOT COMPLETED|Overall Study||3
8142480|NCT02692040|20070735|P13|NOT COMPLETED|Overall Study||1
8142481|NCT02692040|20070736|P12|NOT COMPLETED|Overall Study||0
8142482|NCT02692040|20070737|P11|NOT COMPLETED|Overall Study||0
8142483|NCT02692040|20070738|P10|NOT COMPLETED|Overall Study||0
8142484|NCT02692040|20070739|P9|NOT COMPLETED|Overall Study||0
8142485|NCT02692040|20070740|P8|NOT COMPLETED|Overall Study||0
8142486|NCT02692040|20070741|P7|NOT COMPLETED|Overall Study||0
8142487|NCT02692040|20070742|P6|NOT COMPLETED|Overall Study||0
8142488|NCT02692040|20070743|P5|NOT COMPLETED|Overall Study||0
8142489|NCT02692040|20070744|P4|NOT COMPLETED|Overall Study||0
8142490|NCT02692040|20070745|P3|NOT COMPLETED|Overall Study||0
8142491|NCT02692040|20070746|P2|NOT COMPLETED|Overall Study||0
8142492|NCT02692040|20070747|P1|NOT COMPLETED|Overall Study||0
8142493|NCT02692040|20070731|P17|COMPLETED|Overall Study||4
8142494|NCT02692040|20070732|P16|COMPLETED|Overall Study||5
8142495|NCT02692040|20070733|P15|COMPLETED|Overall Study||5
8142496|NCT02692040|20070734|P14|COMPLETED|Overall Study||3
8142497|NCT02692040|20070735|P13|COMPLETED|Overall Study||5
8142498|NCT02692040|20070736|P12|COMPLETED|Overall Study||5
8142499|NCT02692040|20070737|P11|COMPLETED|Overall Study||5
8142500|NCT02692040|20070738|P10|COMPLETED|Overall Study||4
8142501|NCT02692040|20070739|P9|COMPLETED|Overall Study||5
8142502|NCT02692040|20070740|P8|COMPLETED|Overall Study||5
8142503|NCT02692040|20070741|P7|COMPLETED|Overall Study||5
8142504|NCT02692040|20070742|P6|COMPLETED|Overall Study||5
8142505|NCT02692040|20070743|P5|COMPLETED|Overall Study||4
8142506|NCT02692040|20070744|P4|COMPLETED|Overall Study||5
8142507|NCT02692040|20070745|P3|COMPLETED|Overall Study||5
8142508|NCT02692040|20070746|P2|COMPLETED|Overall Study||4
8142509|NCT02692040|20070747|P1|COMPLETED|Overall Study||10
8142510|NCT02692040|20070731|P17|STARTED|Overall Study||4
8142511|NCT02692040|20070732|P16|STARTED|Overall Study||6
8142512|NCT02692040|20070733|P15|STARTED|Overall Study||6
8142513|NCT02692040|20070734|P14|STARTED|Overall Study||6
8142514|NCT02692040|20070735|P13|STARTED|Overall Study||6
8142515|NCT02692040|20070736|P12|STARTED|Overall Study||5
8142516|NCT02692040|20070737|P11|STARTED|Overall Study||5
8142517|NCT02692040|20070738|P10|STARTED|Overall Study||4
8142518|NCT02692040|20070739|P9|STARTED|Overall Study||5
8142519|NCT02692040|20070740|P8|STARTED|Overall Study||5
8142520|NCT02692040|20070741|P7|STARTED|Overall Study||5
8142521|NCT02692040|20070742|P6|STARTED|Overall Study||5
8142522|NCT02692040|20070743|P5|STARTED|Overall Study||4
8142523|NCT02692040|20070744|P4|STARTED|Overall Study||5
8142524|NCT02692040|20070745|P3|STARTED|Overall Study||5
8142525|NCT02692040|20070746|P2|STARTED|Overall Study||4
8142526|NCT02692040|20070747|P1|STARTED|Overall Study||10
8142527|NCT02691936|20070839|P2|NOT COMPLETED|Overall Study||5
8142528|NCT02691936|20070840|P1|NOT COMPLETED|Overall Study||2
8142529|NCT02691936|20070839|P2|COMPLETED|Overall Study||29
8142530|NCT02691936|20070840|P1|COMPLETED|Overall Study||33
8142531|NCT02691936|20070839|P2|STARTED|Overall Study||34
8142532|NCT02691936|20070840|P1|STARTED|Overall Study||35
8142533|NCT02691741|20070862|P2|NOT COMPLETED|Overall Study||7
8142534|NCT02691741|20070863|P1|NOT COMPLETED|Overall Study||1
8142535|NCT02691741|20070862|P2|COMPLETED|Overall Study||87
8142536|NCT02691741|20070863|P1|COMPLETED|Overall Study||93
8142537|NCT02691741|20070862|P2|Safety Analysis Set|Overall Study||89
8142538|NCT02691741|20070863|P1|Safety Analysis Set|Overall Study||93
8142539|NCT02691741|20070862|P2|Best-Case Analysis Set|Overall Study||85
8142540|NCT02691741|20070863|P1|Best-Case Analysis Set|Overall Study||86
8142541|NCT02691741|20070862|P2|All-Implanted Analysis Set|Overall Study||89
8142542|NCT02691741|20070863|P1|All-Implanted Analysis Set|Overall Study||93
8142543|NCT02691741|20070862|P2|STARTED|Overall Study||94
8142544|NCT02691741|20070863|P1|STARTED|Overall Study||94
8142578|NCT02691572|20071199|P2|NOT COMPLETED|Overall Study||1
8142579|NCT02691572|20071200|P1|NOT COMPLETED|Overall Study||1
8142580|NCT02691572|20071199|P2|COMPLETED|Overall Study||39
8142581|NCT02691572|20071200|P1|COMPLETED|Overall Study||39
8142582|NCT02691572|20071199|P2|STARTED|Overall Study||40
8142583|NCT02691572|20071200|P1|STARTED|Overall Study||40
8142584|NCT02691507|20071208|P2|NOT COMPLETED|Overall Study||1
8142585|NCT02691507|20071209|P1|NOT COMPLETED|Overall Study||0
8142586|NCT02691507|20071208|P2|COMPLETED|Overall Study||12
8142587|NCT02691507|20071209|P1|COMPLETED|Overall Study||40
8142588|NCT02691507|20071208|P2|STARTED|Overall Study||13
8142589|NCT02691507|20071209|P1|STARTED|Overall Study||40
8142590|NCT02691494|20071342|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||17
8142591|NCT02691494|20071343|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||7
8142592|NCT02691494|20071344|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||5
8142593|NCT02691494|20071342|P3|COMPLETED|Post-Treatment Follow-Up Period||42
8142594|NCT02691494|20071343|P2|COMPLETED|Post-Treatment Follow-Up Period||18
8142595|NCT02691494|20071344|P1|COMPLETED|Post-Treatment Follow-Up Period||9
8142596|NCT02691494|20071342|P3|STARTED|Post-Treatment Follow-Up Period||59
8142597|NCT02691494|20071343|P2|STARTED|Post-Treatment Follow-Up Period||25
8142598|NCT02691494|20071344|P1|STARTED|Post-Treatment Follow-Up Period||14
8142599|NCT02691494|20071342|P3|NOT COMPLETED|Treatment Period||41
8142600|NCT02691494|20071343|P2|NOT COMPLETED|Treatment Period||26
8142601|NCT02691494|20071344|P1|NOT COMPLETED|Treatment Period||22
8142602|NCT02691494|20071342|P3|COMPLETED|Treatment Period|completed treatment period|148
8142603|NCT02691494|20071343|P2|COMPLETED|Treatment Period|completed treatment period|69
8142604|NCT02691494|20071344|P1|COMPLETED|Treatment Period|completed treatment period|72
8142605|NCT02691494|20071342|P3|STARTED|Treatment Period||189
8142606|NCT02691494|20071343|P2|STARTED|Treatment Period||95
8142607|NCT02691494|20071344|P1|STARTED|Treatment Period||94
8142608|NCT02691468|20071372|P2|NOT COMPLETED|Overall Study||2
8142609|NCT02691468|20071373|P1|NOT COMPLETED|Overall Study||6
8142610|NCT02691468|20071372|P2|COMPLETED|Overall Study||52
8142611|NCT02691468|20071373|P1|COMPLETED|Overall Study||48
8142612|NCT02691468|20071372|P2|STARTED|Overall Study||54
8142613|NCT02691468|20071373|P1|STARTED|Overall Study||54
8142614|NCT02691416|20071383|P2|NOT COMPLETED|Overall Study||0
8142615|NCT02691416|20071384|P1|NOT COMPLETED|Overall Study||0
8142616|NCT02691416|20071383|P2|COMPLETED|Overall Study||30
8142617|NCT02691416|20071384|P1|COMPLETED|Overall Study||30
8142618|NCT02691416|20071383|P2|STARTED|Overall Study||30
8142619|NCT02691416|20071384|P1|STARTED|Overall Study||30
8142620|NCT02691260|20071408|P4|NOT COMPLETED|Overall Study||3
8142621|NCT02691260|20071409|P3|NOT COMPLETED|Overall Study||2
8142622|NCT02691260|20071410|P2|NOT COMPLETED|Overall Study||2
8142623|NCT02691260|20071411|P1|NOT COMPLETED|Overall Study||2
8142624|NCT02691260|20071408|P4|COMPLETED|Overall Study||23
8142625|NCT02691260|20071409|P3|COMPLETED|Overall Study||25
8142626|NCT02691260|20071410|P2|COMPLETED|Overall Study||24
8142627|NCT02691260|20071411|P1|COMPLETED|Overall Study||24
8142628|NCT02691260|20071408|P4|STARTED|Overall Study||26
8142629|NCT02691260|20071409|P3|STARTED|Overall Study||27
8142630|NCT02691260|20071410|P2|STARTED|Overall Study||26
8142631|NCT02691260|20071411|P1|STARTED|Overall Study||26
8142632|NCT02691247|20071424|P3|NOT COMPLETED|Overall Study||3
8142633|NCT02691247|20071425|P2|NOT COMPLETED|Overall Study||2
8142634|NCT02691247|20071426|P1|NOT COMPLETED|Overall Study||3
8142635|NCT02691247|20071424|P3|COMPLETED|Overall Study||43
8142636|NCT02691247|20071425|P2|COMPLETED|Overall Study||22
8142637|NCT02691247|20071426|P1|COMPLETED|Overall Study||37
8142638|NCT02691247|20071424|P3|STARTED|Overall Study||46
8142639|NCT02691247|20071425|P2|STARTED|Overall Study||24
8142640|NCT02691247|20071426|P1|STARTED|Overall Study||40
8142641|NCT02691143|20071445|P2|NOT COMPLETED|Overall Study||0
8142642|NCT02691143|20071446|P1|NOT COMPLETED|Overall Study||0
8142643|NCT02691143|20071445|P2|COMPLETED|Overall Study||23
8142644|NCT02691143|20071446|P1|COMPLETED|Overall Study||27
8142645|NCT02691143|20071445|P2|STARTED|Overall Study||23
8142646|NCT02691143|20071446|P1|STARTED|Overall Study||27
8142647|NCT02691013|20071456|P2|NOT COMPLETED|Overall Study||0
8142648|NCT02691013|20071457|P1|NOT COMPLETED|Overall Study||3
8142649|NCT02691013|20071456|P2|COMPLETED|Overall Study||59
8142650|NCT02691013|20071457|P1|COMPLETED|Overall Study||58
8142651|NCT02691013|20071456|P2|STARTED|Overall Study||59
8142652|NCT02691013|20071457|P1|STARTED|Overall Study||61
8142653|NCT02690974|20071471|P1|NOT COMPLETED|Overall Study||40
8142654|NCT02690974|20071471|P1|COMPLETED|Overall Study||262
8142655|NCT02690974|20071471|P1|STARTED|Overall Study||302
8142656|NCT02690948|20071484|P2|NOT COMPLETED|Overall Study||0
8142657|NCT02690948|20071485|P1|NOT COMPLETED|Overall Study||0
8142658|NCT02690948|20071484|P2|COMPLETED|Overall Study||7
8142659|NCT02690948|20071485|P1|COMPLETED|Overall Study||9
8142660|NCT02690948|20071484|P2|STARTED|Overall Study||7
8142661|NCT02690948|20071485|P1|STARTED|Overall Study||9
8142662|NCT02690935|20071503|P2|NOT COMPLETED|Overall Study||0
8142663|NCT02690935|20071504|P1|NOT COMPLETED|Overall Study||0
8142664|NCT02690935|20071503|P2|COMPLETED|Overall Study|Count of participants|51
8142665|NCT02690935|20071504|P1|COMPLETED|Overall Study|Count of participants|51
8142666|NCT02690935|20071503|P2|STARTED|Overall Study|Count of participants|51
8142667|NCT02690935|20071504|P1|STARTED|Overall Study|Count of participants|51
8142668|NCT02690727|20071512|P2|NOT COMPLETED|Overall Study||2
8142669|NCT02690727|20071513|P1|NOT COMPLETED|Overall Study||2
8142670|NCT02690727|20071512|P2|COMPLETED|Overall Study||7
8142671|NCT02690727|20071513|P1|COMPLETED|Overall Study||7
8142672|NCT02690727|20071512|P2|STARTED|Overall Study||9
8142673|NCT02690727|20071513|P1|STARTED|Overall Study||9
8142674|NCT02690701|20071525|P2|NOT COMPLETED|Treatment Period 2||5
8142675|NCT02690701|20071526|P1|NOT COMPLETED|Treatment Period 2||3
8142676|NCT02690701|20071525|P2|COMPLETED|Treatment Period 2||37
8142677|NCT02690701|20071526|P1|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
8142678|NCT02690701|20071525|P2|STARTED|Treatment Period 2||42
8142679|NCT02690701|20071526|P1|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
8142680|NCT02690701|20071525|P2|NOT COMPLETED|Treatment Period 1||3
8142681|NCT02690701|20071526|P1|NOT COMPLETED|Treatment Period 1||2
8142682|NCT02690701|20071525|P2|COMPLETED|Treatment Period 1||42
8142683|NCT02690701|20071526|P1|COMPLETED|Treatment Period 1||44
8142684|NCT02690701|20071525|P2|STARTED|Treatment Period 1||45
8142685|NCT02690701|20071526|P1|STARTED|Treatment Period 1||46
8142686|NCT02690207|20071591|P1|NOT COMPLETED|Overall Study||253
8142687|NCT02690207|20071591|P1|COMPLETED|Overall Study||8434
8142688|NCT02690207|20071591|P1|STARTED|Overall Study||8687
8142689|NCT02690194|20071601|P3|NOT COMPLETED|Overall Study||0
8142690|NCT02690194|20071602|P2|NOT COMPLETED|Overall Study||4
8142691|NCT02690194|20071603|P1|NOT COMPLETED|Overall Study||1
8142692|NCT02690194|20071601|P3|COMPLETED|Overall Study||19
8142693|NCT02690194|20071602|P2|COMPLETED|Overall Study||14
8142694|NCT02690194|20071603|P1|COMPLETED|Overall Study||16
8142695|NCT02690194|20071601|P3|STARTED|Overall Study||19
8142696|NCT02690194|20071602|P2|STARTED|Overall Study||18
8142697|NCT02690194|20071603|P1|STARTED|Overall Study||17
8142698|NCT02690181|20071652|P6|NOT COMPLETED|Overall Study||0
8142699|NCT02690181|20071653|P5|NOT COMPLETED|Overall Study||0
8142700|NCT02690181|20071654|P4|NOT COMPLETED|Overall Study||0
8142701|NCT02690181|20071655|P3|NOT COMPLETED|Overall Study||0
8142702|NCT02690181|20071656|P2|NOT COMPLETED|Overall Study||0
8142703|NCT02690181|20071657|P1|NOT COMPLETED|Overall Study||0
8142704|NCT02690181|20071652|P6|COMPLETED|Overall Study||21
8142705|NCT02690181|20071653|P5|COMPLETED|Overall Study||6
8142706|NCT02690181|20071654|P4|COMPLETED|Overall Study||10
8142707|NCT02690181|20071655|P3|COMPLETED|Overall Study||15
8142708|NCT02690181|20071656|P2|COMPLETED|Overall Study||14
8142709|NCT02690181|20071657|P1|COMPLETED|Overall Study||14
8142710|NCT02690181|20071652|P6|STARTED|Overall Study||21
8142711|NCT02690181|20071653|P5|STARTED|Overall Study||6
8142712|NCT02690181|20071654|P4|STARTED|Overall Study||10
8142713|NCT02690181|20071655|P3|STARTED|Overall Study||15
8142714|NCT02690181|20071656|P2|STARTED|Overall Study||14
8142715|NCT02690181|20071657|P1|STARTED|Overall Study||14
8142716|NCT02689973|20071783|P4|NOT COMPLETED|Overall Study||53
8142717|NCT02689973|20071784|P3|NOT COMPLETED|Overall Study||72
8142718|NCT02689973|20071785|P2|NOT COMPLETED|Overall Study||49
8142719|NCT02689973|20071786|P1|NOT COMPLETED|Overall Study||54
8142720|NCT02689973|20071783|P4|COMPLETED|Overall Study||232
8142721|NCT02689973|20071784|P3|COMPLETED|Overall Study||279
8142722|NCT02689973|20071785|P2|COMPLETED|Overall Study||221
8142723|NCT02689973|20071786|P1|COMPLETED|Overall Study||257
8142724|NCT02689973|20071783|P4|STARTED|Overall Study||285
8142725|NCT02689973|20071784|P3|STARTED|Overall Study||351
8142726|NCT02689973|20071785|P2|STARTED|Overall Study||270
8142727|NCT02689973|20071786|P1|STARTED|Overall Study||311
8142728|NCT02689804|20071810|P2|NOT COMPLETED|Overall Study||0
8142729|NCT02689804|20071811|P1|NOT COMPLETED|Overall Study||2
8142730|NCT02689804|20071810|P2|COMPLETED|Overall Study||16
8142731|NCT02689804|20071811|P1|COMPLETED|Overall Study||16
8142732|NCT02689804|20071810|P2|STARTED|Overall Study||16
8142733|NCT02689804|20071811|P1|STARTED|Overall Study||18
8142734|NCT02689492|20071837|P1|NOT COMPLETED|Overall Study||86
8142735|NCT02689492|20071837|P1|COMPLETED|Overall Study||315
8142736|NCT02689492|20071837|P1|STARTED|Overall Study||401
8142737|NCT02689219|20071853|P2|NOT COMPLETED|Overall Study||7
8142738|NCT02689219|20071854|P1|NOT COMPLETED|Overall Study||11
8142739|NCT02689219|20071853|P2|COMPLETED|Overall Study||0
8142740|NCT02689219|20071854|P1|COMPLETED|Overall Study||0
8142741|NCT02689219|20071853|P2|STARTED|Overall Study||7
8142742|NCT02689219|20071854|P1|STARTED|Overall Study||11
8142743|NCT02689206|20071871|P5|NOT COMPLETED|Overall Study||8
8142744|NCT02689206|20071872|P4|NOT COMPLETED|Overall Study||4
8142745|NCT02689206|20071873|P3|NOT COMPLETED|Overall Study||4
8142746|NCT02689206|20071874|P2|NOT COMPLETED|Overall Study||1
8142747|NCT02689206|20071875|P1|NOT COMPLETED|Overall Study||3
8142748|NCT02689206|20071871|P5|COMPLETED|Overall Study||14
8142749|NCT02689206|20071872|P4|COMPLETED|Overall Study||17
8142750|NCT02689206|20071873|P3|COMPLETED|Overall Study||16
8142751|NCT02689206|20071874|P2|COMPLETED|Overall Study||19
8142752|NCT02689206|20071875|P1|COMPLETED|Overall Study||17
8142753|NCT02689206|20071871|P5|STARTED|Overall Study||22
8142754|NCT02689206|20071872|P4|STARTED|Overall Study||21
8142755|NCT02689206|20071873|P3|STARTED|Overall Study||20
8142756|NCT02689206|20071874|P2|STARTED|Overall Study||20
8142757|NCT02689206|20071875|P1|STARTED|Overall Study||20
8142758|NCT02689154|20072079|P1|NOT COMPLETED|Overall Study||0
8142759|NCT02689154|20072079|P1|COMPLETED|Overall Study||18
8142760|NCT02689154|20072079|P1|STARTED|Overall Study||18
8142761|NCT02688933|20072088|P2|NOT COMPLETED|Overall Study||37
8142762|NCT02688933|20072089|P1|NOT COMPLETED|Overall Study||29
8142763|NCT02688933|20072088|P2|COMPLETED|Overall Study||281
8142764|NCT02688933|20072089|P1|COMPLETED|Overall Study||291
8142765|NCT02688933|20072088|P2|STARTED|Overall Study||318
8142766|NCT02688933|20072089|P1|STARTED|Overall Study||320
8142767|NCT02688868|20072109|P1|NOT COMPLETED|Overall Study||4
8142768|NCT02688868|20072109|P1|COMPLETED|Overall Study||34
8142769|NCT02688868|20072109|P1|STARTED|Overall Study||38
8142770|NCT02688842|20072121|P1|NOT COMPLETED|Overall Study||0
8142771|NCT02688842|20072121|P1|COMPLETED|Overall Study||38
8142772|NCT02688842|20072121|P1|STARTED|Overall Study||38
8142773|NCT02688829|20072137|P1|NOT COMPLETED|Overall Study||2
8142774|NCT02688829|20072137|P1|COMPLETED|Overall Study||19
8142775|NCT02688829|20072137|P1|STARTED|Overall Study||21
8142776|NCT02688764|20072149|P2|NOT COMPLETED|Overall Study||17
8142777|NCT02688764|20072150|P1|NOT COMPLETED|Overall Study||40
8142778|NCT02688764|20072149|P2|COMPLETED|Overall Study||2
8142779|NCT02688764|20072150|P1|COMPLETED|Overall Study||26
8142780|NCT02688764|20072149|P2|Treated in Stage 2|Overall Study||8
8142781|NCT02688764|20072150|P1|Treated in Stage 2|Overall Study||43
8142782|NCT02688764|20072149|P2|Treated in Stage 1|Overall Study||19
8142783|NCT02688764|20072150|P1|Treated in Stage 1|Overall Study||66
8142784|NCT02688764|20072149|P2|STARTED|Overall Study||19
8142785|NCT02688764|20072150|P1|STARTED|Overall Study||66
8142786|NCT02688556|20072200|P2|NOT COMPLETED|Overall Study||12
8142787|NCT02688556|20072201|P1|NOT COMPLETED|Overall Study||25
8142788|NCT02688556|20072200|P2|COMPLETED|Overall Study||361
8142789|NCT02688556|20072201|P1|COMPLETED|Overall Study||347
8142790|NCT02688556|20072200|P2|STARTED|Overall Study||373
8142791|NCT02688556|20072201|P1|STARTED|Overall Study||372
8142792|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142793|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142794|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142795|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142796|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142797|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142798|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142799|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142800|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142801|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142802|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142803|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142804|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142805|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142806|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142807|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142808|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142809|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142810|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142811|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142812|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142813|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142814|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
8142815|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
8142816|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
8142817|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
8142818|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142819|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142820|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142821|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142822|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142823|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142824|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142825|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142826|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142827|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142828|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142829|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142830|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142831|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142832|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142833|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142834|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142835|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142836|NCT02688387|20072217|P22|STARTED|Part 3B, Period 4 (up to 6 Days)||8
8142837|NCT02688387|20072218|P21|STARTED|Part 3B, Period 4 (up to 6 Days)||6
8142838|NCT02688387|20072219|P20|STARTED|Part 3B, Period 4 (up to 6 Days)||7
8142839|NCT02688387|20072220|P19|STARTED|Part 3B, Period 4 (up to 6 Days)||7
8142840|NCT02688387|20072221|P18|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142841|NCT02688387|20072222|P17|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142842|NCT02688387|20072223|P16|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142843|NCT02688387|20072224|P15|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142844|NCT02688387|20072225|P14|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142845|NCT02688387|20072226|P13|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142846|NCT02688387|20072227|P12|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142847|NCT02688387|20072228|P11|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142848|NCT02688387|20072229|P10|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142849|NCT02688387|20072230|P9|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142850|NCT02688387|20072231|P8|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142851|NCT02688387|20072232|P7|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142852|NCT02688387|20072233|P6|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142853|NCT02688387|20072234|P5|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142854|NCT02688387|20072235|P4|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142855|NCT02688387|20072236|P3|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142856|NCT02688387|20072237|P2|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142857|NCT02688387|20072238|P1|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142858|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142859|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8142860|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8142861|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8142862|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142863|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142864|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142865|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142866|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142867|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142868|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142869|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142870|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142871|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142872|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142873|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142874|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142875|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142876|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142877|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142878|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142879|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142880|NCT02688387|20072217|P22|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
8142881|NCT02688387|20072218|P21|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
8142882|NCT02688387|20072219|P20|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
8142883|NCT02688387|20072220|P19|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
8142884|NCT02688387|20072221|P18|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142885|NCT02688387|20072222|P17|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142886|NCT02688387|20072223|P16|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142887|NCT02688387|20072224|P15|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142888|NCT02688387|20072225|P14|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142889|NCT02688387|20072226|P13|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142890|NCT02688387|20072227|P12|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142891|NCT02688387|20072228|P11|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142892|NCT02688387|20072229|P10|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142893|NCT02688387|20072230|P9|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142894|NCT02688387|20072231|P8|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142895|NCT02688387|20072232|P7|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142896|NCT02688387|20072233|P6|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142897|NCT02688387|20072234|P5|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142898|NCT02688387|20072235|P4|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142899|NCT02688387|20072236|P3|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142900|NCT02688387|20072237|P2|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142901|NCT02688387|20072238|P1|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142902|NCT02688387|20072217|P22|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8142903|NCT02688387|20072218|P21|STARTED|Part 3B, Washout Period 3 (10 Days)||7
8142904|NCT02688387|20072219|P20|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8142905|NCT02688387|20072220|P19|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8142906|NCT02688387|20072221|P18|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142907|NCT02688387|20072222|P17|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142908|NCT02688387|20072223|P16|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142909|NCT02688387|20072224|P15|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142910|NCT02688387|20072225|P14|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142911|NCT02688387|20072226|P13|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142912|NCT02688387|20072227|P12|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142913|NCT02688387|20072228|P11|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142914|NCT02688387|20072229|P10|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142915|NCT02688387|20072230|P9|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142916|NCT02688387|20072231|P8|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142917|NCT02688387|20072232|P7|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142918|NCT02688387|20072233|P6|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142919|NCT02688387|20072234|P5|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142920|NCT02688387|20072235|P4|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142921|NCT02688387|20072236|P3|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142922|NCT02688387|20072237|P2|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142923|NCT02688387|20072238|P1|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142924|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142925|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
8142926|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142927|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142928|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142929|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142930|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142931|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142932|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142933|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142934|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142935|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142936|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142937|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142938|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142939|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142940|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142941|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142942|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142943|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142944|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142945|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142946|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8142947|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
8142948|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8142949|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8142950|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142951|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142952|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142953|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142954|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142955|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142956|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142957|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142958|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142959|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142960|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142961|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142962|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142963|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142964|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142965|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142966|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142967|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142968|NCT02688387|20072217|P22|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142969|NCT02688387|20072218|P21|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142970|NCT02688387|20072219|P20|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142971|NCT02688387|20072220|P19|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142972|NCT02688387|20072221|P18|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142973|NCT02688387|20072222|P17|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142974|NCT02688387|20072223|P16|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142975|NCT02688387|20072224|P15|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142976|NCT02688387|20072225|P14|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142977|NCT02688387|20072226|P13|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142978|NCT02688387|20072227|P12|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142979|NCT02688387|20072228|P11|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142980|NCT02688387|20072229|P10|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142981|NCT02688387|20072230|P9|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142982|NCT02688387|20072231|P8|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142983|NCT02688387|20072232|P7|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142984|NCT02688387|20072233|P6|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142985|NCT02688387|20072234|P5|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142986|NCT02688387|20072235|P4|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142987|NCT02688387|20072236|P3|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142988|NCT02688387|20072237|P2|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142989|NCT02688387|20072238|P1|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142990|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142991|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142992|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142993|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142994|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142995|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142996|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142997|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142998|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142999|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143000|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143001|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143002|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143003|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143004|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143005|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143006|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143007|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143008|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143009|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143010|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143011|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143012|NCT02688387|20072217|P22|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143013|NCT02688387|20072218|P21|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143014|NCT02688387|20072219|P20|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143015|NCT02688387|20072220|P19|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143016|NCT02688387|20072221|P18|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143017|NCT02688387|20072222|P17|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143018|NCT02688387|20072223|P16|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143019|NCT02688387|20072224|P15|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143020|NCT02688387|20072225|P14|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143021|NCT02688387|20072226|P13|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143022|NCT02688387|20072227|P12|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143023|NCT02688387|20072228|P11|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143024|NCT02688387|20072229|P10|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143025|NCT02688387|20072230|P9|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143026|NCT02688387|20072231|P8|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143027|NCT02688387|20072232|P7|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143028|NCT02688387|20072233|P6|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143029|NCT02688387|20072234|P5|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143030|NCT02688387|20072235|P4|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143031|NCT02688387|20072236|P3|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143032|NCT02688387|20072237|P2|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143033|NCT02688387|20072238|P1|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143034|NCT02688387|20072217|P22|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143035|NCT02688387|20072218|P21|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143036|NCT02688387|20072219|P20|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143037|NCT02688387|20072220|P19|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143038|NCT02688387|20072221|P18|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143039|NCT02688387|20072222|P17|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143040|NCT02688387|20072223|P16|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143041|NCT02688387|20072224|P15|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143042|NCT02688387|20072225|P14|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143043|NCT02688387|20072226|P13|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143044|NCT02688387|20072227|P12|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143045|NCT02688387|20072228|P11|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143046|NCT02688387|20072229|P10|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143047|NCT02688387|20072230|P9|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143048|NCT02688387|20072231|P8|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143049|NCT02688387|20072232|P7|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143050|NCT02688387|20072233|P6|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143051|NCT02688387|20072234|P5|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143052|NCT02688387|20072235|P4|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143053|NCT02688387|20072236|P3|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143054|NCT02688387|20072237|P2|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143055|NCT02688387|20072238|P1|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143056|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143057|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143058|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143059|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143060|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143061|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143062|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143063|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143064|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143065|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143066|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143067|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143068|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143069|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143070|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143071|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143072|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143073|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143074|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143075|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143076|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143077|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143078|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143079|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143080|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143081|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143082|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143083|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143084|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143085|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143086|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143087|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143088|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143089|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143090|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143091|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143092|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143093|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143094|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143095|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143096|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143097|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143098|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143099|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143100|NCT02688387|20072217|P22|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143101|NCT02688387|20072218|P21|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143102|NCT02688387|20072219|P20|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143103|NCT02688387|20072220|P19|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143104|NCT02688387|20072221|P18|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143105|NCT02688387|20072222|P17|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143106|NCT02688387|20072223|P16|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143107|NCT02688387|20072224|P15|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143108|NCT02688387|20072225|P14|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143109|NCT02688387|20072226|P13|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143110|NCT02688387|20072227|P12|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143111|NCT02688387|20072228|P11|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143112|NCT02688387|20072229|P10|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143113|NCT02688387|20072230|P9|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143114|NCT02688387|20072231|P8|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143115|NCT02688387|20072232|P7|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143116|NCT02688387|20072233|P6|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143117|NCT02688387|20072234|P5|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143118|NCT02688387|20072235|P4|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143119|NCT02688387|20072236|P3|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143120|NCT02688387|20072237|P2|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143121|NCT02688387|20072238|P1|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143122|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143123|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143124|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143125|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143126|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143127|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143128|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143129|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143130|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143131|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143132|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143133|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143134|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143135|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143136|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143137|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143138|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143139|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143140|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143141|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143142|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143143|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143144|NCT02688387|20072217|P22|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143145|NCT02688387|20072218|P21|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143146|NCT02688387|20072219|P20|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143147|NCT02688387|20072220|P19|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143148|NCT02688387|20072221|P18|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143149|NCT02688387|20072222|P17|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143150|NCT02688387|20072223|P16|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143151|NCT02688387|20072224|P15|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143152|NCT02688387|20072225|P14|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143153|NCT02688387|20072226|P13|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143154|NCT02688387|20072227|P12|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143155|NCT02688387|20072228|P11|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143156|NCT02688387|20072229|P10|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143157|NCT02688387|20072230|P9|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143158|NCT02688387|20072231|P8|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143159|NCT02688387|20072232|P7|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143160|NCT02688387|20072233|P6|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143161|NCT02688387|20072234|P5|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143162|NCT02688387|20072235|P4|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143163|NCT02688387|20072236|P3|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143164|NCT02688387|20072237|P2|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143165|NCT02688387|20072238|P1|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143166|NCT02688387|20072217|P22|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143167|NCT02688387|20072218|P21|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143168|NCT02688387|20072219|P20|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143169|NCT02688387|20072220|P19|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143170|NCT02688387|20072221|P18|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143171|NCT02688387|20072222|P17|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143172|NCT02688387|20072223|P16|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143173|NCT02688387|20072224|P15|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143174|NCT02688387|20072225|P14|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143175|NCT02688387|20072226|P13|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143176|NCT02688387|20072227|P12|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143177|NCT02688387|20072228|P11|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143178|NCT02688387|20072229|P10|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143179|NCT02688387|20072230|P9|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143180|NCT02688387|20072231|P8|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143181|NCT02688387|20072232|P7|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143182|NCT02688387|20072233|P6|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143183|NCT02688387|20072234|P5|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143184|NCT02688387|20072235|P4|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143185|NCT02688387|20072236|P3|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143186|NCT02688387|20072237|P2|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143187|NCT02688387|20072238|P1|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143188|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143189|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143190|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143191|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143192|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143193|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143194|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143195|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143196|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143197|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143198|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143199|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143200|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143201|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143202|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143203|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143204|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143205|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143206|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143207|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143208|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143209|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143210|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143211|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143212|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143213|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143214|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143215|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143216|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143217|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143218|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143219|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143220|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143221|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143222|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143223|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143224|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143225|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143226|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143227|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143228|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143229|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143230|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143231|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143232|NCT02688387|20072217|P22|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143233|NCT02688387|20072218|P21|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143234|NCT02688387|20072219|P20|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143235|NCT02688387|20072220|P19|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143236|NCT02688387|20072221|P18|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143237|NCT02688387|20072222|P17|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143238|NCT02688387|20072223|P16|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143239|NCT02688387|20072224|P15|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143240|NCT02688387|20072225|P14|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143241|NCT02688387|20072226|P13|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143242|NCT02688387|20072227|P12|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143243|NCT02688387|20072228|P11|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143244|NCT02688387|20072229|P10|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143245|NCT02688387|20072230|P9|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143246|NCT02688387|20072231|P8|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143247|NCT02688387|20072232|P7|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143248|NCT02688387|20072233|P6|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143249|NCT02688387|20072234|P5|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143250|NCT02688387|20072235|P4|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143251|NCT02688387|20072236|P3|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143252|NCT02688387|20072237|P2|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143253|NCT02688387|20072238|P1|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143254|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143255|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143256|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143257|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143258|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143259|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143260|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143261|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143262|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143263|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143264|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143265|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143266|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143267|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143268|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143269|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143270|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143271|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143272|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143273|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143274|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143275|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143276|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143277|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143278|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143279|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143280|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143281|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143282|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143283|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143284|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143285|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143286|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143287|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143288|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143289|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143290|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143291|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143292|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143293|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143294|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143295|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143296|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143297|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143298|NCT02688387|20072217|P22|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143299|NCT02688387|20072218|P21|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143300|NCT02688387|20072219|P20|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143301|NCT02688387|20072220|P19|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143302|NCT02688387|20072221|P18|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143303|NCT02688387|20072222|P17|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143304|NCT02688387|20072223|P16|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143305|NCT02688387|20072224|P15|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143306|NCT02688387|20072225|P14|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143307|NCT02688387|20072226|P13|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143308|NCT02688387|20072227|P12|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143309|NCT02688387|20072228|P11|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143310|NCT02688387|20072229|P10|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143311|NCT02688387|20072230|P9|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143312|NCT02688387|20072231|P8|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143313|NCT02688387|20072232|P7|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143314|NCT02688387|20072233|P6|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143315|NCT02688387|20072234|P5|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143316|NCT02688387|20072235|P4|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143317|NCT02688387|20072236|P3|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143318|NCT02688387|20072237|P2|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143319|NCT02688387|20072238|P1|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143320|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143321|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143322|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143323|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143324|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143325|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143326|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143327|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143328|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143329|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143330|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143331|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143332|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143333|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143334|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143335|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143336|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143337|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143338|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143339|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143340|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143341|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143342|NCT02688387|20072217|P22|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143343|NCT02688387|20072218|P21|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143344|NCT02688387|20072219|P20|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143345|NCT02688387|20072220|P19|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143346|NCT02688387|20072221|P18|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143347|NCT02688387|20072222|P17|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143348|NCT02688387|20072223|P16|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143349|NCT02688387|20072224|P15|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143350|NCT02688387|20072225|P14|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143351|NCT02688387|20072226|P13|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143352|NCT02688387|20072227|P12|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143353|NCT02688387|20072228|P11|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143354|NCT02688387|20072229|P10|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143355|NCT02688387|20072230|P9|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143356|NCT02688387|20072231|P8|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143357|NCT02688387|20072232|P7|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143358|NCT02688387|20072233|P6|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143359|NCT02688387|20072234|P5|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143360|NCT02688387|20072235|P4|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143361|NCT02688387|20072236|P3|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143362|NCT02688387|20072237|P2|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143363|NCT02688387|20072238|P1|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143364|NCT02688387|20072217|P22|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143365|NCT02688387|20072218|P21|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143366|NCT02688387|20072219|P20|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143367|NCT02688387|20072220|P19|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143368|NCT02688387|20072221|P18|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143369|NCT02688387|20072222|P17|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143370|NCT02688387|20072223|P16|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143371|NCT02688387|20072224|P15|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143372|NCT02688387|20072225|P14|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143373|NCT02688387|20072226|P13|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143374|NCT02688387|20072227|P12|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143375|NCT02688387|20072228|P11|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143376|NCT02688387|20072229|P10|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143377|NCT02688387|20072230|P9|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143378|NCT02688387|20072231|P8|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143379|NCT02688387|20072232|P7|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143380|NCT02688387|20072233|P6|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143381|NCT02688387|20072234|P5|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143382|NCT02688387|20072235|P4|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143383|NCT02688387|20072236|P3|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143384|NCT02688387|20072237|P2|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143385|NCT02688387|20072238|P1|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143386|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143387|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143388|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143389|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143390|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143391|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143392|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143393|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143394|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143395|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143396|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143397|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143398|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143399|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143400|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143401|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143402|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143403|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143404|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143405|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143406|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143407|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143408|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143409|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143410|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143411|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143412|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143413|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143414|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143415|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143416|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143417|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143418|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143419|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143420|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143421|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143422|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143423|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143424|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143425|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143426|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143427|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143428|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143429|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143430|NCT02688387|20072217|P22|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143431|NCT02688387|20072218|P21|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143432|NCT02688387|20072219|P20|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143433|NCT02688387|20072220|P19|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143434|NCT02688387|20072221|P18|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143435|NCT02688387|20072222|P17|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143436|NCT02688387|20072223|P16|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143437|NCT02688387|20072224|P15|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143438|NCT02688387|20072225|P14|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143439|NCT02688387|20072226|P13|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143440|NCT02688387|20072227|P12|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143441|NCT02688387|20072228|P11|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143442|NCT02688387|20072229|P10|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143443|NCT02688387|20072230|P9|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143444|NCT02688387|20072231|P8|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143445|NCT02688387|20072232|P7|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143446|NCT02688387|20072233|P6|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143447|NCT02688387|20072234|P5|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143448|NCT02688387|20072235|P4|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143449|NCT02688387|20072236|P3|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143450|NCT02688387|20072237|P2|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143451|NCT02688387|20072238|P1|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143452|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143453|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143454|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143455|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143456|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143457|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143458|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143459|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143460|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143461|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143462|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143463|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143464|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143465|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143466|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143467|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143468|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143469|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143470|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143471|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143472|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143473|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143474|NCT02688387|20072217|P22|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143475|NCT02688387|20072218|P21|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143476|NCT02688387|20072219|P20|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143477|NCT02688387|20072220|P19|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143478|NCT02688387|20072221|P18|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143479|NCT02688387|20072222|P17|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143480|NCT02688387|20072223|P16|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143481|NCT02688387|20072224|P15|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143482|NCT02688387|20072225|P14|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143483|NCT02688387|20072226|P13|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143484|NCT02688387|20072227|P12|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143485|NCT02688387|20072228|P11|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143486|NCT02688387|20072229|P10|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143487|NCT02688387|20072230|P9|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143488|NCT02688387|20072231|P8|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143489|NCT02688387|20072232|P7|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143490|NCT02688387|20072233|P6|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143491|NCT02688387|20072234|P5|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143492|NCT02688387|20072235|P4|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143493|NCT02688387|20072236|P3|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143494|NCT02688387|20072237|P2|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143495|NCT02688387|20072238|P1|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143496|NCT02688387|20072217|P22|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143497|NCT02688387|20072218|P21|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143498|NCT02688387|20072219|P20|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143499|NCT02688387|20072220|P19|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143500|NCT02688387|20072221|P18|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143501|NCT02688387|20072222|P17|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143502|NCT02688387|20072223|P16|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143503|NCT02688387|20072224|P15|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143504|NCT02688387|20072225|P14|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143505|NCT02688387|20072226|P13|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143506|NCT02688387|20072227|P12|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143507|NCT02688387|20072228|P11|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143508|NCT02688387|20072229|P10|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143509|NCT02688387|20072230|P9|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143510|NCT02688387|20072231|P8|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143511|NCT02688387|20072232|P7|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143512|NCT02688387|20072233|P6|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143513|NCT02688387|20072234|P5|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143514|NCT02688387|20072235|P4|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143515|NCT02688387|20072236|P3|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143516|NCT02688387|20072237|P2|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143517|NCT02688387|20072238|P1|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143518|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143519|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143520|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143521|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143522|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143523|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143524|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143525|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143526|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143527|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143528|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143529|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143530|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143531|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143532|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143533|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143534|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143535|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143536|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143537|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143538|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143539|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143540|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143541|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143542|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143543|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143544|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143545|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143546|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143547|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143548|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143549|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143550|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143551|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143552|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143553|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143554|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143555|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143556|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143557|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143558|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143559|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143560|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143561|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143562|NCT02688387|20072217|P22|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143563|NCT02688387|20072218|P21|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143564|NCT02688387|20072219|P20|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143565|NCT02688387|20072220|P19|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143566|NCT02688387|20072221|P18|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143567|NCT02688387|20072222|P17|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143568|NCT02688387|20072223|P16|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143569|NCT02688387|20072224|P15|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143570|NCT02688387|20072225|P14|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143571|NCT02688387|20072226|P13|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143572|NCT02688387|20072227|P12|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143573|NCT02688387|20072228|P11|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143574|NCT02688387|20072229|P10|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143575|NCT02688387|20072230|P9|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143576|NCT02688387|20072231|P8|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143577|NCT02688387|20072232|P7|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143578|NCT02688387|20072233|P6|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143579|NCT02688387|20072234|P5|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143580|NCT02688387|20072235|P4|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143581|NCT02688387|20072236|P3|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143582|NCT02688387|20072237|P2|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143583|NCT02688387|20072238|P1|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143584|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143585|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143586|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143587|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143588|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143589|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143590|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143591|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143592|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143593|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143594|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143595|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143596|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143597|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143598|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143599|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143600|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143601|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143602|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143603|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143604|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143605|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143606|NCT02688387|20072217|P22|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143607|NCT02688387|20072218|P21|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143608|NCT02688387|20072219|P20|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143609|NCT02688387|20072220|P19|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143610|NCT02688387|20072221|P18|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143611|NCT02688387|20072222|P17|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143612|NCT02688387|20072223|P16|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143613|NCT02688387|20072224|P15|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143614|NCT02688387|20072225|P14|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143615|NCT02688387|20072226|P13|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143616|NCT02688387|20072227|P12|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143617|NCT02688387|20072228|P11|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143618|NCT02688387|20072229|P10|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143619|NCT02688387|20072230|P9|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143620|NCT02688387|20072231|P8|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143621|NCT02688387|20072232|P7|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143622|NCT02688387|20072233|P6|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143623|NCT02688387|20072234|P5|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143624|NCT02688387|20072235|P4|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143625|NCT02688387|20072236|P3|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143626|NCT02688387|20072237|P2|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143627|NCT02688387|20072238|P1|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143628|NCT02688387|20072217|P22|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143629|NCT02688387|20072218|P21|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143630|NCT02688387|20072219|P20|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143631|NCT02688387|20072220|P19|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143632|NCT02688387|20072221|P18|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143633|NCT02688387|20072222|P17|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143634|NCT02688387|20072223|P16|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143635|NCT02688387|20072224|P15|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143636|NCT02688387|20072225|P14|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143637|NCT02688387|20072226|P13|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143638|NCT02688387|20072227|P12|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143639|NCT02688387|20072228|P11|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143640|NCT02688387|20072229|P10|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143641|NCT02688387|20072230|P9|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143642|NCT02688387|20072231|P8|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143643|NCT02688387|20072232|P7|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143644|NCT02688387|20072233|P6|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143645|NCT02688387|20072234|P5|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143646|NCT02688387|20072235|P4|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143647|NCT02688387|20072236|P3|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143648|NCT02688387|20072237|P2|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143649|NCT02688387|20072238|P1|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143650|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143651|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143652|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143653|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143654|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143655|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143656|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143657|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
8143658|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143659|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143660|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143661|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143662|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143663|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143664|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143665|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143666|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143667|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143668|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143669|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143670|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143671|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143672|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143673|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143674|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143675|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143676|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143677|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143678|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143679|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143680|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143681|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143682|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143683|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143684|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143685|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143686|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143687|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143688|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143689|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143690|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143691|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143692|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143693|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143694|NCT02688387|20072217|P22|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143695|NCT02688387|20072218|P21|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143696|NCT02688387|20072219|P20|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143697|NCT02688387|20072220|P19|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143698|NCT02688387|20072221|P18|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8143699|NCT02688387|20072222|P17|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8143700|NCT02688387|20072223|P16|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8143701|NCT02688387|20072224|P15|STARTED|Part 3A, Period 1 (up to 6 Days)||9
8143702|NCT02688387|20072225|P14|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143703|NCT02688387|20072226|P13|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143704|NCT02688387|20072227|P12|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143705|NCT02688387|20072228|P11|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143706|NCT02688387|20072229|P10|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143707|NCT02688387|20072230|P9|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143708|NCT02688387|20072231|P8|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143709|NCT02688387|20072232|P7|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143710|NCT02688387|20072233|P6|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143711|NCT02688387|20072234|P5|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143712|NCT02688387|20072235|P4|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143713|NCT02688387|20072236|P3|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143714|NCT02688387|20072237|P2|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143715|NCT02688387|20072238|P1|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143716|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143717|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143718|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143719|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143720|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143721|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143722|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143723|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143724|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143725|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143726|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143727|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143728|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143729|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143730|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143731|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143732|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143733|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143734|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143735|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143736|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143737|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143738|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143739|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143740|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143741|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143742|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143743|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143744|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143745|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143746|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143747|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143748|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143749|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143750|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143751|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143752|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143753|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143754|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143755|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143756|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143757|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143758|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143759|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143760|NCT02688387|20072217|P22|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143761|NCT02688387|20072218|P21|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143762|NCT02688387|20072219|P20|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143763|NCT02688387|20072220|P19|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143764|NCT02688387|20072221|P18|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143765|NCT02688387|20072222|P17|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143766|NCT02688387|20072223|P16|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143767|NCT02688387|20072224|P15|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143768|NCT02688387|20072225|P14|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143769|NCT02688387|20072226|P13|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143770|NCT02688387|20072227|P12|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143771|NCT02688387|20072228|P11|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143772|NCT02688387|20072229|P10|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143773|NCT02688387|20072230|P9|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143774|NCT02688387|20072231|P8|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143775|NCT02688387|20072232|P7|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143776|NCT02688387|20072233|P6|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143777|NCT02688387|20072234|P5|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143778|NCT02688387|20072235|P4|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143779|NCT02688387|20072236|P3|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143780|NCT02688387|20072237|P2|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143781|NCT02688387|20072238|P1|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143782|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143783|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143784|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143785|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143786|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143787|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143788|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143789|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143790|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143791|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143792|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143793|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143794|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143795|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143796|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143797|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143798|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143799|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143800|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143801|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143802|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143803|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143804|NCT02688387|20072217|P22|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143805|NCT02688387|20072218|P21|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143806|NCT02688387|20072219|P20|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143807|NCT02688387|20072220|P19|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143808|NCT02688387|20072221|P18|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143809|NCT02688387|20072222|P17|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143810|NCT02688387|20072223|P16|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143811|NCT02688387|20072224|P15|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143812|NCT02688387|20072225|P14|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143813|NCT02688387|20072226|P13|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143814|NCT02688387|20072227|P12|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143815|NCT02688387|20072228|P11|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143816|NCT02688387|20072229|P10|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143817|NCT02688387|20072230|P9|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143818|NCT02688387|20072231|P8|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143819|NCT02688387|20072232|P7|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143820|NCT02688387|20072233|P6|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143821|NCT02688387|20072234|P5|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143822|NCT02688387|20072235|P4|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143823|NCT02688387|20072236|P3|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143824|NCT02688387|20072237|P2|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143825|NCT02688387|20072238|P1|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143826|NCT02688387|20072217|P22|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143827|NCT02688387|20072218|P21|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143828|NCT02688387|20072219|P20|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143829|NCT02688387|20072220|P19|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143830|NCT02688387|20072221|P18|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143831|NCT02688387|20072222|P17|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143832|NCT02688387|20072223|P16|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143833|NCT02688387|20072224|P15|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143834|NCT02688387|20072225|P14|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143835|NCT02688387|20072226|P13|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143836|NCT02688387|20072227|P12|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143837|NCT02688387|20072228|P11|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143838|NCT02688387|20072229|P10|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143839|NCT02688387|20072230|P9|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143840|NCT02688387|20072231|P8|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143841|NCT02688387|20072232|P7|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143842|NCT02688387|20072233|P6|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143843|NCT02688387|20072234|P5|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143844|NCT02688387|20072235|P4|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143845|NCT02688387|20072236|P3|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143846|NCT02688387|20072237|P2|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143847|NCT02688387|20072238|P1|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143848|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143849|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143850|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143851|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143852|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143853|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143854|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143855|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143856|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143857|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143858|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143859|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143860|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143861|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143862|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143863|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143864|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143865|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143866|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143867|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143868|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143869|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143870|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143871|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143872|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143873|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143874|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143875|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143876|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143877|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143878|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143879|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143880|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143881|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143882|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143883|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143884|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143885|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143886|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143887|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143888|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143889|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143890|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143891|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143892|NCT02688387|20072217|P22|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143893|NCT02688387|20072218|P21|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143894|NCT02688387|20072219|P20|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143895|NCT02688387|20072220|P19|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143896|NCT02688387|20072221|P18|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143897|NCT02688387|20072222|P17|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143898|NCT02688387|20072223|P16|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143899|NCT02688387|20072224|P15|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143900|NCT02688387|20072225|P14|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143901|NCT02688387|20072226|P13|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143902|NCT02688387|20072227|P12|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143903|NCT02688387|20072228|P11|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143904|NCT02688387|20072229|P10|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143905|NCT02688387|20072230|P9|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143906|NCT02688387|20072231|P8|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143907|NCT02688387|20072232|P7|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143908|NCT02688387|20072233|P6|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143909|NCT02688387|20072234|P5|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143910|NCT02688387|20072235|P4|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143911|NCT02688387|20072236|P3|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143912|NCT02688387|20072237|P2|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143913|NCT02688387|20072238|P1|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143914|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143915|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143916|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143917|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143918|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143919|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143920|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143921|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143922|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143923|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143924|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143925|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143926|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143927|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143928|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143929|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143930|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143931|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143932|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143933|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143934|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143935|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143936|NCT02688387|20072217|P22|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143937|NCT02688387|20072218|P21|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143938|NCT02688387|20072219|P20|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143939|NCT02688387|20072220|P19|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143940|NCT02688387|20072221|P18|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143941|NCT02688387|20072222|P17|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143942|NCT02688387|20072223|P16|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143943|NCT02688387|20072224|P15|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143944|NCT02688387|20072225|P14|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143945|NCT02688387|20072226|P13|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143946|NCT02688387|20072227|P12|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143947|NCT02688387|20072228|P11|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143948|NCT02688387|20072229|P10|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143949|NCT02688387|20072230|P9|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143950|NCT02688387|20072231|P8|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143951|NCT02688387|20072232|P7|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143952|NCT02688387|20072233|P6|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143953|NCT02688387|20072234|P5|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143954|NCT02688387|20072235|P4|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143955|NCT02688387|20072236|P3|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143956|NCT02688387|20072237|P2|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143957|NCT02688387|20072238|P1|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143958|NCT02688387|20072217|P22|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143959|NCT02688387|20072218|P21|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143960|NCT02688387|20072219|P20|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143961|NCT02688387|20072220|P19|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143962|NCT02688387|20072221|P18|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143963|NCT02688387|20072222|P17|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143964|NCT02688387|20072223|P16|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143965|NCT02688387|20072224|P15|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143966|NCT02688387|20072225|P14|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143967|NCT02688387|20072226|P13|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143968|NCT02688387|20072227|P12|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143969|NCT02688387|20072228|P11|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143970|NCT02688387|20072229|P10|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143971|NCT02688387|20072230|P9|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143972|NCT02688387|20072231|P8|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143973|NCT02688387|20072232|P7|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143974|NCT02688387|20072233|P6|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143975|NCT02688387|20072234|P5|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143976|NCT02688387|20072235|P4|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143977|NCT02688387|20072236|P3|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143978|NCT02688387|20072237|P2|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143979|NCT02688387|20072238|P1|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143980|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143981|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143982|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143983|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143984|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143985|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143986|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143987|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143988|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143989|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143990|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143991|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143992|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143993|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143994|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143995|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143996|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143997|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143998|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143999|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144000|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144001|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144002|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144003|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144004|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144005|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144006|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144007|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144008|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144009|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144010|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144011|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144012|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144013|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144014|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144015|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144016|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144017|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144018|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144019|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144020|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144021|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144022|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144023|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144024|NCT02688387|20072217|P22|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144025|NCT02688387|20072218|P21|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144026|NCT02688387|20072219|P20|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144027|NCT02688387|20072220|P19|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144028|NCT02688387|20072221|P18|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144029|NCT02688387|20072222|P17|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144030|NCT02688387|20072223|P16|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144031|NCT02688387|20072224|P15|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144032|NCT02688387|20072225|P14|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144033|NCT02688387|20072226|P13|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144034|NCT02688387|20072227|P12|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144035|NCT02688387|20072228|P11|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144036|NCT02688387|20072229|P10|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144037|NCT02688387|20072230|P9|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144038|NCT02688387|20072231|P8|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144039|NCT02688387|20072232|P7|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144040|NCT02688387|20072233|P6|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144041|NCT02688387|20072234|P5|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144042|NCT02688387|20072235|P4|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144043|NCT02688387|20072236|P3|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144044|NCT02688387|20072237|P2|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144045|NCT02688387|20072238|P1|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144046|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144047|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144048|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144049|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144050|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144051|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144052|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144053|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144054|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144055|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144056|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144057|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144058|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144059|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144060|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144061|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144062|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144063|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144064|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144065|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144066|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144067|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144068|NCT02688387|20072217|P22|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144069|NCT02688387|20072218|P21|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144070|NCT02688387|20072219|P20|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144071|NCT02688387|20072220|P19|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144072|NCT02688387|20072221|P18|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144073|NCT02688387|20072222|P17|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144074|NCT02688387|20072223|P16|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144075|NCT02688387|20072224|P15|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144076|NCT02688387|20072225|P14|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144077|NCT02688387|20072226|P13|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144078|NCT02688387|20072227|P12|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144079|NCT02688387|20072228|P11|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144080|NCT02688387|20072229|P10|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144081|NCT02688387|20072230|P9|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144082|NCT02688387|20072231|P8|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144083|NCT02688387|20072232|P7|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144084|NCT02688387|20072233|P6|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144085|NCT02688387|20072234|P5|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144086|NCT02688387|20072235|P4|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144087|NCT02688387|20072236|P3|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144088|NCT02688387|20072237|P2|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144089|NCT02688387|20072238|P1|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144090|NCT02688387|20072217|P22|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144091|NCT02688387|20072218|P21|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144092|NCT02688387|20072219|P20|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144093|NCT02688387|20072220|P19|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144094|NCT02688387|20072221|P18|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144095|NCT02688387|20072222|P17|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144096|NCT02688387|20072223|P16|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144097|NCT02688387|20072224|P15|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144098|NCT02688387|20072225|P14|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144099|NCT02688387|20072226|P13|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144100|NCT02688387|20072227|P12|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144101|NCT02688387|20072228|P11|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144102|NCT02688387|20072229|P10|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144103|NCT02688387|20072230|P9|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144104|NCT02688387|20072231|P8|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144105|NCT02688387|20072232|P7|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144106|NCT02688387|20072233|P6|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144107|NCT02688387|20072234|P5|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144108|NCT02688387|20072235|P4|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144109|NCT02688387|20072236|P3|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144110|NCT02688387|20072237|P2|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144111|NCT02688387|20072238|P1|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144112|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144113|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144349|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144114|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144115|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144116|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144117|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144118|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144119|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144120|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144121|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144122|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144123|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
8144124|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144125|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144126|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144127|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144128|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144129|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144130|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144131|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144132|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144133|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144134|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144135|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144136|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144137|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144138|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144139|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144140|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144141|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144142|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144143|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144144|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144145|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144146|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144147|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144148|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144149|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144150|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144151|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144152|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144153|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144154|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144155|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144156|NCT02688387|20072217|P22|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144157|NCT02688387|20072218|P21|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144158|NCT02688387|20072219|P20|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144159|NCT02688387|20072220|P19|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144160|NCT02688387|20072221|P18|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144161|NCT02688387|20072222|P17|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144162|NCT02688387|20072223|P16|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144163|NCT02688387|20072224|P15|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144164|NCT02688387|20072225|P14|STARTED|Part 2, Period 1 (up to 6 Days)||5
8144165|NCT02688387|20072226|P13|STARTED|Part 2, Period 1 (up to 6 Days)||5
8144166|NCT02688387|20072227|P12|STARTED|Part 2, Period 1 (up to 6 Days)||5
8144167|NCT02688387|20072228|P11|STARTED|Part 2, Period 1 (up to 6 Days)||6
8144168|NCT02688387|20072229|P10|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144169|NCT02688387|20072230|P9|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144170|NCT02688387|20072231|P8|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144171|NCT02688387|20072232|P7|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144172|NCT02688387|20072233|P6|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144173|NCT02688387|20072234|P5|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144174|NCT02688387|20072235|P4|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144175|NCT02688387|20072236|P3|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144176|NCT02688387|20072237|P2|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144177|NCT02688387|20072238|P1|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144178|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144179|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144180|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144181|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144182|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144183|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144184|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144185|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144186|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144187|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144188|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144189|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144190|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144191|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144192|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144193|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144194|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144195|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144196|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144197|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144198|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144199|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144200|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144201|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144202|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144203|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144204|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144205|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144206|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144207|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144208|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144209|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144210|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144211|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144212|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144213|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144214|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144215|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144216|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144217|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144218|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144219|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144220|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144221|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144222|NCT02688387|20072217|P22|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144223|NCT02688387|20072218|P21|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144224|NCT02688387|20072219|P20|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144225|NCT02688387|20072220|P19|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144226|NCT02688387|20072221|P18|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144227|NCT02688387|20072222|P17|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144228|NCT02688387|20072223|P16|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144229|NCT02688387|20072224|P15|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144230|NCT02688387|20072225|P14|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144231|NCT02688387|20072226|P13|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144232|NCT02688387|20072227|P12|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144233|NCT02688387|20072228|P11|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144234|NCT02688387|20072229|P10|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144235|NCT02688387|20072230|P9|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144236|NCT02688387|20072231|P8|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144237|NCT02688387|20072232|P7|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144238|NCT02688387|20072233|P6|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144239|NCT02688387|20072234|P5|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144240|NCT02688387|20072235|P4|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144241|NCT02688387|20072236|P3|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144242|NCT02688387|20072237|P2|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144243|NCT02688387|20072238|P1|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144244|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144245|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144246|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144247|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144248|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144249|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144250|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144251|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144252|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144253|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144254|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144255|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144256|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144257|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144258|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144259|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144260|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144261|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144262|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144263|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144264|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144265|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144266|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144267|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144268|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144269|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144270|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144271|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144272|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144273|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144274|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144275|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144276|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144277|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144278|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144279|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144280|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144281|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144282|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144283|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144284|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144285|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144286|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144287|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144288|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144289|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144290|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144291|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144292|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144293|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144294|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144295|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144296|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144297|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144298|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144299|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144300|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144301|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144302|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144303|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144304|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144305|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144306|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144307|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144308|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144309|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144310|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144311|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144312|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144313|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144314|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144315|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144316|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144317|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144318|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144319|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144320|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144321|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144322|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144323|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144324|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144325|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144326|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144327|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144328|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144329|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144330|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144331|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144332|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144333|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144334|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144335|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144336|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144337|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144338|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144339|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144340|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144341|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144342|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144343|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144344|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144345|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144346|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144347|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144348|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144350|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144351|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144352|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144353|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144354|NCT02688387|20072217|P22|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144355|NCT02688387|20072218|P21|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144356|NCT02688387|20072219|P20|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144357|NCT02688387|20072220|P19|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144358|NCT02688387|20072221|P18|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144359|NCT02688387|20072222|P17|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144360|NCT02688387|20072223|P16|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144361|NCT02688387|20072224|P15|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144362|NCT02688387|20072225|P14|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144363|NCT02688387|20072226|P13|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144364|NCT02688387|20072227|P12|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144365|NCT02688387|20072228|P11|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144366|NCT02688387|20072229|P10|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144367|NCT02688387|20072230|P9|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144368|NCT02688387|20072231|P8|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144369|NCT02688387|20072232|P7|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144370|NCT02688387|20072233|P6|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144371|NCT02688387|20072234|P5|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144372|NCT02688387|20072235|P4|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144373|NCT02688387|20072236|P3|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144374|NCT02688387|20072237|P2|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144375|NCT02688387|20072238|P1|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144376|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144377|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144378|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144379|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144380|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144381|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144382|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144383|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144384|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144385|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144386|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144387|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144388|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144389|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144390|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144391|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144392|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144393|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144394|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144395|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144396|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144397|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
8144398|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144399|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144400|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144401|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144402|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144403|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144404|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144405|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144406|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144407|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144408|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144409|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144410|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144411|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144412|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144413|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144414|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144415|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144416|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144417|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144418|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144419|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144420|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144421|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144422|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144423|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144424|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144425|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144426|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144427|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144428|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144429|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144430|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144431|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144432|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144433|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144434|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144435|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144436|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144437|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144438|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144439|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144440|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144441|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 3 (7 Days)||3
8144442|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144443|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144444|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144445|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144446|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144447|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144448|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144449|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144450|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144451|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144452|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144453|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144454|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144455|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144456|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144457|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144458|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144459|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144460|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144461|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144462|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144463|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144464|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144465|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144466|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144467|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144468|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144469|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144470|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144471|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144472|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144473|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144474|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144475|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144476|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144477|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144478|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144479|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144480|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144481|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144482|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144483|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144484|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144485|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
8144486|NCT02688387|20072217|P22|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144487|NCT02688387|20072218|P21|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144488|NCT02688387|20072219|P20|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144489|NCT02688387|20072220|P19|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144490|NCT02688387|20072221|P18|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144491|NCT02688387|20072222|P17|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144492|NCT02688387|20072223|P16|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144493|NCT02688387|20072224|P15|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144494|NCT02688387|20072225|P14|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144495|NCT02688387|20072226|P13|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144496|NCT02688387|20072227|P12|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144497|NCT02688387|20072228|P11|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144498|NCT02688387|20072229|P10|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144499|NCT02688387|20072230|P9|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144500|NCT02688387|20072231|P8|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144501|NCT02688387|20072232|P7|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144502|NCT02688387|20072233|P6|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144503|NCT02688387|20072234|P5|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144504|NCT02688387|20072235|P4|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144505|NCT02688387|20072236|P3|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144506|NCT02688387|20072237|P2|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144507|NCT02688387|20072238|P1|STARTED|Part 1, Period 3 (up to 6 Days)||3
8144508|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144509|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144510|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144511|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144512|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144513|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144514|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144515|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144516|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144517|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144518|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144519|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144520|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144521|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144522|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144523|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144524|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144525|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144526|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144527|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144528|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144529|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144530|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144531|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144532|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144533|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144534|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144535|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144536|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144537|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144538|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144539|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144540|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144541|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144542|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144543|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144544|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144545|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144546|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144547|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144548|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144549|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144550|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144551|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
8144552|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144553|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144554|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144555|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144556|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144557|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144558|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144559|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144560|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144561|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144562|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144563|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144564|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144565|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144566|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144567|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144568|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144569|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144570|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144571|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144572|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144573|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 2 (7 Days)||3
8144574|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144575|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144576|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144577|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144578|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144579|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144580|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144581|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144582|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144583|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144584|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144585|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144586|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144587|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144588|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144589|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144590|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144591|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
8144592|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144593|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
8144594|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144595|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144596|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144597|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144598|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144599|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144600|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144601|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144602|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144603|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144604|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144605|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144606|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144607|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144608|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144609|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144610|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144611|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144612|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144613|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144614|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144615|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144616|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144617|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
8144618|NCT02688387|20072217|P22|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144619|NCT02688387|20072218|P21|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144620|NCT02688387|20072219|P20|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144621|NCT02688387|20072220|P19|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144622|NCT02688387|20072221|P18|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144623|NCT02688387|20072222|P17|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144624|NCT02688387|20072223|P16|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144625|NCT02688387|20072224|P15|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144626|NCT02688387|20072225|P14|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144627|NCT02688387|20072226|P13|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144628|NCT02688387|20072227|P12|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144629|NCT02688387|20072228|P11|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144630|NCT02688387|20072229|P10|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144631|NCT02688387|20072230|P9|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144632|NCT02688387|20072231|P8|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144633|NCT02688387|20072232|P7|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144634|NCT02688387|20072233|P6|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144635|NCT02688387|20072234|P5|STARTED|Part 1, Period 2 (up to 6 Days)||3
8144636|NCT02688387|20072235|P4|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144637|NCT02688387|20072236|P3|STARTED|Part 1, Period 2 (up to 6 Days)||3
8144638|NCT02688387|20072237|P2|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144639|NCT02688387|20072238|P1|STARTED|Part 1, Period 2 (up to 6 Days)||3
8144640|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144641|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144642|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144643|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144644|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144645|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144646|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144647|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144648|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144649|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144650|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144651|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144652|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144653|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144654|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144655|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144656|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144657|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144658|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144659|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144660|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
8144661|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144662|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144663|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144664|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144665|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144666|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144667|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144668|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144669|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144670|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144671|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144672|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144673|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144674|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144675|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144676|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144677|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144678|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144679|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8144680|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144681|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8144682|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144683|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8144684|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144685|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144686|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144687|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144688|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144689|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144690|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144691|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144692|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144693|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144694|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144695|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144696|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144697|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144698|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144699|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144700|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144701|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144702|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144703|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144704|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144705|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144706|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144707|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144708|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144709|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144710|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144711|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144712|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144713|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144714|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144715|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144716|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144717|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144718|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144719|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144720|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144721|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144722|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144723|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144724|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
8144725|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
8144726|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144727|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144728|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144729|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144730|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144731|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144732|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144733|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144734|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144735|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144736|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144737|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144738|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144739|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144740|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144741|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144742|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144743|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144744|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144745|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144746|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144747|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144748|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144749|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144750|NCT02688387|20072217|P22|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144751|NCT02688387|20072218|P21|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144752|NCT02688387|20072219|P20|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144753|NCT02688387|20072220|P19|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144754|NCT02688387|20072221|P18|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144755|NCT02688387|20072222|P17|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144756|NCT02688387|20072223|P16|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144757|NCT02688387|20072224|P15|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144758|NCT02688387|20072225|P14|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144759|NCT02688387|20072226|P13|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144760|NCT02688387|20072227|P12|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144761|NCT02688387|20072228|P11|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144762|NCT02688387|20072229|P10|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144763|NCT02688387|20072230|P9|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144764|NCT02688387|20072231|P8|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144765|NCT02688387|20072232|P7|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144766|NCT02688387|20072233|P6|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144767|NCT02688387|20072234|P5|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144768|NCT02688387|20072235|P4|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144769|NCT02688387|20072236|P3|STARTED|Part 1, Period 1 (up to 6 Days)||4
8144770|NCT02688387|20072237|P2|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144771|NCT02688387|20072238|P1|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144772|NCT02688218|20072497|P2|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
8144773|NCT02688218|20072498|P1|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
8144774|NCT02688218|20072497|P2|COMPLETED|Second Exercise Intervention (2 Hours)||6
8144775|NCT02688218|20072498|P1|COMPLETED|Second Exercise Intervention (2 Hours)||24
8144776|NCT02688218|20072497|P2|STARTED|Second Exercise Intervention (2 Hours)||6
8144777|NCT02688218|20072498|P1|STARTED|Second Exercise Intervention (2 Hours)||24
8144778|NCT02688218|20072497|P2|NOT COMPLETED|Washout (30 Minutes)||0
8144779|NCT02688218|20072498|P1|NOT COMPLETED|Washout (30 Minutes)||0
8144780|NCT02688218|20072497|P2|COMPLETED|Washout (30 Minutes)||6
8144781|NCT02688218|20072498|P1|COMPLETED|Washout (30 Minutes)||24
8144782|NCT02688218|20072497|P2|STARTED|Washout (30 Minutes)||6
8144783|NCT02688218|20072498|P1|STARTED|Washout (30 Minutes)||24
8144784|NCT02688218|20072497|P2|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
8144785|NCT02688218|20072498|P1|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
8144786|NCT02688218|20072497|P2|COMPLETED|First Exercise Intervention (2 Hours)||6
8144787|NCT02688218|20072498|P1|COMPLETED|First Exercise Intervention (2 Hours)||24
8144788|NCT02688218|20072497|P2|STARTED|First Exercise Intervention (2 Hours)||6
8144789|NCT02688218|20072498|P1|STARTED|First Exercise Intervention (2 Hours)||24
8144790|NCT02688192|20072506|P2|NOT COMPLETED|Overall Study||5
8144791|NCT02688192|20072507|P1|NOT COMPLETED|Overall Study||12
8144792|NCT02688192|20072506|P2|COMPLETED|Overall Study||19
8144793|NCT02688192|20072507|P1|COMPLETED|Overall Study||13
8144794|NCT02688192|20072506|P2|STARTED|Overall Study||24
8144795|NCT02688192|20072507|P1|STARTED|Overall Study||25
8144796|NCT02688153|20072526|P2|NOT COMPLETED|Overall Study||7
8144797|NCT02688153|20072527|P1|NOT COMPLETED|Overall Study||15
8144798|NCT02688153|20072526|P2|COMPLETED|Overall Study||51
8144799|NCT02688153|20072527|P1|COMPLETED|Overall Study||47
8144800|NCT02688153|20072526|P2|Final Randomized Arm/Group|Overall Study||61
8144801|NCT02688153|20072527|P1|Final Randomized Arm/Group|Overall Study||59
8144802|NCT02688153|20072526|P2|STARTED|Overall Study||58
8144803|NCT02688153|20072527|P1|STARTED|Overall Study||62
8144804|NCT02687919|20072587|P2|NOT COMPLETED|Overall Study||6
8144805|NCT02687919|20072588|P1|NOT COMPLETED|Overall Study||8
8144806|NCT02687919|20072587|P2|COMPLETED|Overall Study||9
8144807|NCT02687919|20072588|P1|COMPLETED|Overall Study||8
8144808|NCT02687919|20072587|P2|STARTED|Overall Study||15
8144809|NCT02687919|20072588|P1|STARTED|Overall Study||16
8144810|NCT02687815|20072618|P2|NOT COMPLETED|Overall Study||8
8144811|NCT02687815|20072619|P1|NOT COMPLETED|Overall Study||4
8144812|NCT02687815|20072618|P2|COMPLETED|Overall Study||88
8144813|NCT02687815|20072619|P1|COMPLETED|Overall Study||92
8144814|NCT02687815|20072618|P2|STARTED|Overall Study||96
8144815|NCT02687815|20072619|P1|STARTED|Overall Study||96
8144816|NCT02687542|20072636|P5|NOT COMPLETED|Overall Study||20
8144817|NCT02687542|20072637|P4|NOT COMPLETED|Overall Study||10
8144818|NCT02687542|20072638|P3|NOT COMPLETED|Overall Study||14
8144819|NCT02687542|20072639|P2|NOT COMPLETED|Overall Study||12
8144820|NCT02687542|20072640|P1|NOT COMPLETED|Overall Study||8
8144821|NCT02687542|20072636|P5|COMPLETED|Overall Study||24
8144822|NCT02687542|20072637|P4|COMPLETED|Overall Study||3
8144823|NCT02687542|20072638|P3|COMPLETED|Overall Study||1
8144824|NCT02687542|20072639|P2|COMPLETED|Overall Study||1
8144825|NCT02687542|20072640|P1|COMPLETED|Overall Study||15
8144826|NCT02687542|20072636|P5|STARTED|Overall Study||44
8144827|NCT02687542|20072637|P4|STARTED|Overall Study||13
8144828|NCT02687542|20072638|P3|STARTED|Overall Study||15
8144829|NCT02687542|20072639|P2|STARTED|Overall Study||13
8144830|NCT02687542|20072640|P1|STARTED|Overall Study||23
8144831|NCT02687529|20072714|P2|NOT COMPLETED|Overall Study||0
8144832|NCT02687529|20072715|P1|NOT COMPLETED|Overall Study||0
8144833|NCT02687529|20072714|P2|COMPLETED|Overall Study||32
8144834|NCT02687529|20072715|P1|COMPLETED|Overall Study||34
8144835|NCT02687529|20072714|P2|STARTED|Overall Study||32
8144836|NCT02687529|20072715|P1|STARTED|Overall Study||34
8144837|NCT02687412|20072723|P2|NOT COMPLETED|Overall Study||0
8144838|NCT02687412|20072724|P1|NOT COMPLETED|Overall Study||0
8144839|NCT02687412|20072723|P2|COMPLETED|Overall Study||57
8144840|NCT02687412|20072724|P1|COMPLETED|Overall Study||50
8144841|NCT02687412|20072723|P2|STARTED|Overall Study||57
8144842|NCT02687412|20072724|P1|STARTED|Overall Study||50
8144843|NCT02687217|20072752|P2|NOT COMPLETED|Overall Study||0
8144844|NCT02687217|20072753|P1|NOT COMPLETED|Overall Study||0
8144845|NCT02687217|20072752|P2|COMPLETED|Overall Study||30
8144846|NCT02687217|20072753|P1|COMPLETED|Overall Study||30
8144847|NCT02687217|20072752|P2|STARTED|Overall Study||30
8144848|NCT02687217|20072753|P1|STARTED|Overall Study||30
8144849|NCT02687191|20072769|P6|NOT COMPLETED|Overall Study||1
8144850|NCT02687191|20072770|P5|NOT COMPLETED|Overall Study||1
8144851|NCT02687191|20072771|P4|NOT COMPLETED|Overall Study||1
8144852|NCT02687191|20072772|P3|NOT COMPLETED|Overall Study||1
8144853|NCT02687191|20072773|P2|NOT COMPLETED|Overall Study||1
8144854|NCT02687191|20072774|P1|NOT COMPLETED|Overall Study||0
8144855|NCT02687191|20072769|P6|COMPLETED|Overall Study||2
8144856|NCT02687191|20072770|P5|COMPLETED|Overall Study||2
8144857|NCT02687191|20072771|P4|COMPLETED|Overall Study||5
8144858|NCT02687191|20072772|P3|COMPLETED|Overall Study||2
8144859|NCT02687191|20072773|P2|COMPLETED|Overall Study||2
8144860|NCT02687191|20072774|P1|COMPLETED|Overall Study||3
8144861|NCT02687191|20072769|P6|STARTED|Overall Study||3
8144862|NCT02687191|20072770|P5|STARTED|Overall Study||3
8144863|NCT02687191|20072771|P4|STARTED|Overall Study||6
8144864|NCT02687191|20072772|P3|STARTED|Overall Study||3
8144865|NCT02687191|20072773|P2|STARTED|Overall Study||3
8144866|NCT02687191|20072774|P1|STARTED|Overall Study||3
8144867|NCT02687165|20072908|P2|NOT COMPLETED|Overall Study||0
8144868|NCT02687165|20072909|P1|NOT COMPLETED|Overall Study||0
8144869|NCT02687165|20072908|P2|COMPLETED|Overall Study||0
8144870|NCT02687165|20072909|P1|COMPLETED|Overall Study||0
8144871|NCT02687165|20072908|P2|STARTED|Overall Study||0
8144872|NCT02687165|20072909|P1|STARTED|Overall Study||0
8144873|NCT02687139|20072915|P1|NOT COMPLETED|Overall Study||0
8144874|NCT02687139|20072915|P1|COMPLETED|Overall Study||34
8144875|NCT02687139|20072915|P1|STARTED|Overall Study||34
8144876|NCT02687126|20072920|P1|NOT COMPLETED|Data Analysis||0
8144877|NCT02687126|20072920|P1|COMPLETED|Data Analysis||106
8144878|NCT02687126|20072920|P1|STARTED|Data Analysis||106
8144879|NCT02687126|20072920|P1|NOT COMPLETED|Data Collection||0
8144880|NCT02687126|20072920|P1|COMPLETED|Data Collection||106
8144881|NCT02687126|20072920|P1|STARTED|Data Collection||106
8144882|NCT02686437|20072929|P2|NOT COMPLETED|Overall Study||8
8144883|NCT02686437|20072930|P1|NOT COMPLETED|Overall Study||3
8144884|NCT02686437|20072929|P2|COMPLETED|Overall Study||12
8144885|NCT02686437|20072930|P1|COMPLETED|Overall Study||13
8144886|NCT02686437|20072929|P2|STARTED|Overall Study||20
8144887|NCT02686437|20072930|P1|STARTED|Overall Study||16
8144888|NCT02686164|20072938|P1|NOT COMPLETED|Overall Study||3
8144889|NCT02686164|20072938|P1|COMPLETED|Overall Study||27
8144890|NCT02686164|20072938|P1|STARTED|Overall Study||30
8144891|NCT02686138|20072950|P2|NOT COMPLETED|Overall Study||65
8144892|NCT02686138|20072951|P1|NOT COMPLETED|Overall Study||74
8144893|NCT02686138|20072950|P2|COMPLETED|Overall Study||235
8144894|NCT02686138|20072951|P1|COMPLETED|Overall Study||219
8144895|NCT02686138|20072950|P2|STARTED|Overall Study||300
8144896|NCT02686138|20072951|P1|STARTED|Overall Study||293
8144897|NCT02686034|20072975|P2|NOT COMPLETED|Open Label Period 3||1
8144898|NCT02686034|20072976|P1|NOT COMPLETED|Open Label Period 3||0
8144899|NCT02686034|20072975|P2|COMPLETED|Open Label Period 3||121
8144900|NCT02686034|20072976|P1|COMPLETED|Open Label Period 3||117
8144901|NCT02686034|20072975|P2|STARTED|Open Label Period 3||122
8144902|NCT02686034|20072976|P1|STARTED|Open Label Period 3||117
8144903|NCT02686034|20072975|P2|NOT COMPLETED|Randomized Controlled Period 2||4
8144904|NCT02686034|20072976|P1|NOT COMPLETED|Randomized Controlled Period 2||5
8144905|NCT02686034|20072975|P2|COMPLETED|Randomized Controlled Period 2||122
8144906|NCT02686034|20072976|P1|COMPLETED|Randomized Controlled Period 2||117
8144907|NCT02686034|20072975|P2|STARTED|Randomized Controlled Period 2||126
8144908|NCT02686034|20072976|P1|STARTED|Randomized Controlled Period 2||122
8144909|NCT02686034|20072975|P2|NOT COMPLETED|Run-In Period 1||17
8144910|NCT02686034|20072976|P1|NOT COMPLETED|Run-In Period 1||20
8144911|NCT02686034|20072975|P2|COMPLETED|Run-In Period 1||126
8144912|NCT02686034|20072976|P1|COMPLETED|Run-In Period 1||122
8144913|NCT02686034|20072975|P2|STARTED|Run-In Period 1||143
8144914|NCT02686034|20072976|P1|STARTED|Run-In Period 1||142
8144915|NCT02685956|20073014|P2|NOT COMPLETED|Overall Study||0
8144916|NCT02685956|20073015|P1|NOT COMPLETED|Overall Study||0
8144917|NCT02685956|20073014|P2|COMPLETED|Overall Study||1978
8144918|NCT02685956|20073015|P1|COMPLETED|Overall Study||317
8144919|NCT02685956|20073014|P2|STARTED|Overall Study||1978
8144920|NCT02685956|20073015|P1|STARTED|Overall Study||317
8144921|NCT02685826|20073026|P3|NOT COMPLETED|Overall Study||21
8144922|NCT02685826|20073027|P2|NOT COMPLETED|Overall Study||10
8144923|NCT02685826|20073028|P1|NOT COMPLETED|Overall Study||25
8144924|NCT02685826|20073026|P3|COMPLETED|Overall Study||0
8144925|NCT02685826|20073027|P2|COMPLETED|Overall Study||0
8144926|NCT02685826|20073028|P1|COMPLETED|Overall Study||0
8144927|NCT02685826|20073026|P3|STARTED|Overall Study||21
8144928|NCT02685826|20073027|P2|STARTED|Overall Study||10
8144929|NCT02685826|20073028|P1|STARTED|Overall Study||25
8144930|NCT02685566|20073111|P2|NOT COMPLETED|Second Reading Session||0
8144931|NCT02685566|20073112|P1|NOT COMPLETED|Second Reading Session||0
8144932|NCT02685566|20073111|P2|COMPLETED|Second Reading Session||50
8144933|NCT02685566|20073112|P1|COMPLETED|Second Reading Session||50
8144934|NCT02685566|20073111|P2|STARTED|Second Reading Session||50
8144935|NCT02685566|20073112|P1|STARTED|Second Reading Session||50
8144936|NCT02685566|20073111|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8144937|NCT02685566|20073112|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8144938|NCT02685566|20073111|P2|COMPLETED|4 Week Memory Washout Period||50
8144939|NCT02685566|20073112|P1|COMPLETED|4 Week Memory Washout Period||50
8144940|NCT02685566|20073111|P2|STARTED|4 Week Memory Washout Period||50
8144941|NCT02685566|20073112|P1|STARTED|4 Week Memory Washout Period||50
8144942|NCT02685566|20073111|P2|NOT COMPLETED|First Reading Session||0
8144943|NCT02685566|20073112|P1|NOT COMPLETED|First Reading Session||0
8144944|NCT02685566|20073111|P2|COMPLETED|First Reading Session||50
8144945|NCT02685566|20073112|P1|COMPLETED|First Reading Session||50
8144946|NCT02685566|20073111|P2|STARTED|First Reading Session||50
8144947|NCT02685566|20073112|P1|STARTED|First Reading Session||50
8144948|NCT02685488|20073122|P2|NOT COMPLETED|Overall Study||1
8144949|NCT02685488|20073123|P1|NOT COMPLETED|Overall Study||0
8144950|NCT02685488|20073122|P2|COMPLETED|Overall Study||13
8144951|NCT02685488|20073123|P1|COMPLETED|Overall Study||12
8144952|NCT02685488|20073122|P2|STARTED|Overall Study||14
8144953|NCT02685488|20073123|P1|STARTED|Overall Study||12
8144954|NCT02685436|20073137|P1|NOT COMPLETED|Overall Study||14
8144955|NCT02685436|20073137|P1|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
8144956|NCT02685436|20073137|P1|STARTED|Overall Study|the overall studied group|52
8144957|NCT02685293|20073141|P2|NOT COMPLETED|Treatment Period 2||0
8144958|NCT02685293|20073142|P1|NOT COMPLETED|Treatment Period 2||0
8144959|NCT02685293|20073141|P2|COMPLETED|Treatment Period 2||3
8144960|NCT02685293|20073142|P1|COMPLETED|Treatment Period 2||1
8144961|NCT02685293|20073141|P2|STARTED|Treatment Period 2||3
8144962|NCT02685293|20073142|P1|STARTED|Treatment Period 2||1
8144963|NCT02685293|20073141|P2|NOT COMPLETED|Washout Period||0
8144964|NCT02685293|20073142|P1|NOT COMPLETED|Washout Period||0
8144965|NCT02685293|20073141|P2|COMPLETED|Washout Period||3
8144966|NCT02685293|20073142|P1|COMPLETED|Washout Period||1
8144967|NCT02685293|20073141|P2|STARTED|Washout Period||3
8144968|NCT02685293|20073142|P1|STARTED|Washout Period||1
8144969|NCT02685293|20073141|P2|NOT COMPLETED|Treatment Period 1||0
8144970|NCT02685293|20073142|P1|NOT COMPLETED|Treatment Period 1||0
8144971|NCT02685293|20073141|P2|COMPLETED|Treatment Period 1||3
8144972|NCT02685293|20073142|P1|COMPLETED|Treatment Period 1||1
8144973|NCT02685293|20073141|P2|STARTED|Treatment Period 1||3
8144974|NCT02685293|20073142|P1|STARTED|Treatment Period 1||1
8144975|NCT02685202|20073176|P1|NOT COMPLETED|Overall Study||9
8144976|NCT02685202|20073176|P1|COMPLETED|Overall Study||0
8144977|NCT02685202|20073176|P1|STARTED|Overall Study||9
8144978|NCT02685072|20073184|P2|NOT COMPLETED|3-Month Follow-Up||0
8144979|NCT02685072|20073185|P1|NOT COMPLETED|3-Month Follow-Up||0
8144980|NCT02685072|20073184|P2|COMPLETED|3-Month Follow-Up||22
8144981|NCT02685072|20073185|P1|COMPLETED|3-Month Follow-Up||19
8144982|NCT02685072|20073184|P2|STARTED|3-Month Follow-Up||22
8144983|NCT02685072|20073185|P1|STARTED|3-Month Follow-Up||19
8144984|NCT02685072|20073184|P2|NOT COMPLETED|1-Month Follow-Up||0
8144985|NCT02685072|20073185|P1|NOT COMPLETED|1-Month Follow-Up||1
8144986|NCT02685072|20073184|P2|COMPLETED|1-Month Follow-Up||22
8144987|NCT02685072|20073185|P1|COMPLETED|1-Month Follow-Up||19
8144988|NCT02685072|20073184|P2|STARTED|1-Month Follow-Up||22
8144989|NCT02685072|20073185|P1|STARTED|1-Month Follow-Up||20
8144990|NCT02685072|20073184|P2|NOT COMPLETED|Treatment Period||9
8144991|NCT02685072|20073185|P1|NOT COMPLETED|Treatment Period||13
8144992|NCT02685072|20073184|P2|COMPLETED|Treatment Period||22
8144993|NCT02685072|20073185|P1|COMPLETED|Treatment Period||20
8144994|NCT02685072|20073184|P2|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
8144995|NCT02685072|20073185|P1|Completed Week 8 Visit|Treatment Period||20
8144996|NCT02685072|20073184|P2|Completed Week 7 Visit|Treatment Period||18
8144997|NCT02685072|20073185|P1|Completed Week 7 Visit|Treatment Period||17
8144998|NCT02685072|20073184|P2|Completed Week 6 Visit|Treatment Period||19
8144999|NCT02685072|20073185|P1|Completed Week 6 Visit|Treatment Period||18
8145000|NCT02685072|20073184|P2|Completed Week 5 Visit|Treatment Period||22
8145001|NCT02685072|20073185|P1|Completed Week 5 Visit|Treatment Period||19
8145002|NCT02685072|20073184|P2|Completed Week 4 Visit|Treatment Period||23
8145003|NCT02685072|20073185|P1|Completed Week 4 Visit|Treatment Period||19
8145004|NCT02685072|20073184|P2|Completed Week 3 Visit|Treatment Period||23
8145005|NCT02685072|20073185|P1|Completed Week 3 Visit|Treatment Period||20
8145006|NCT02685072|20073184|P2|Completed Week 2 Visit|Treatment Period||26
8145007|NCT02685072|20073185|P1|Completed Week 2 Visit|Treatment Period||23
8145008|NCT02685072|20073184|P2|STARTED|Treatment Period||31
8145009|NCT02685072|20073185|P1|STARTED|Treatment Period||33
8145010|NCT02685033|20073229|P2|NOT COMPLETED|Overall Study||2
8145011|NCT02685033|20073230|P1|NOT COMPLETED|Overall Study||3
8145012|NCT02685033|20073229|P2|COMPLETED|Overall Study||8
8145013|NCT02685033|20073230|P1|COMPLETED|Overall Study||67
8145014|NCT02685033|20073229|P2|STARTED|Overall Study||10
8145015|NCT02685033|20073230|P1|STARTED|Overall Study||70
8145016|NCT02685007|20073256|P1|NOT COMPLETED|Overall Study||0
8145017|NCT02685007|20073256|P1|COMPLETED|Overall Study||131
8145018|NCT02685007|20073256|P1|STARTED|Overall Study||131
8145019|NCT02684981|20073266|P3|NOT COMPLETED|Overall Study||127
8145020|NCT02684981|20073267|P2|NOT COMPLETED|Overall Study||210
8145021|NCT02684981|20073268|P1|NOT COMPLETED|Overall Study||240
8145022|NCT02684981|20073266|P3|COMPLETED|Overall Study||2059
8145023|NCT02684981|20073267|P2|COMPLETED|Overall Study||2969
8145024|NCT02684981|20073268|P1|COMPLETED|Overall Study||3860
8145025|NCT02684981|20073266|P3|STARTED|Overall Study||2186
8145026|NCT02684981|20073267|P2|STARTED|Overall Study||3179
8145027|NCT02684981|20073268|P1|STARTED|Overall Study||4100
8145028|NCT02684942|20073304|P6|NOT COMPLETED|Overall Study||0
8145029|NCT02684942|20073305|P5|NOT COMPLETED|Overall Study||0
8145030|NCT02684942|20073306|P4|NOT COMPLETED|Overall Study||0
8145031|NCT02684942|20073307|P3|NOT COMPLETED|Overall Study||0
8145032|NCT02684942|20073308|P2|NOT COMPLETED|Overall Study||0
8145033|NCT02684942|20073309|P1|NOT COMPLETED|Overall Study||0
8145034|NCT02684942|20073304|P6|COMPLETED|Overall Study||6
8145035|NCT02684942|20073305|P5|COMPLETED|Overall Study||6
8145036|NCT02684942|20073306|P4|COMPLETED|Overall Study||7
8145037|NCT02684942|20073307|P3|COMPLETED|Overall Study||7
8145038|NCT02684942|20073308|P2|COMPLETED|Overall Study||7
8145039|NCT02684942|20073309|P1|COMPLETED|Overall Study||7
8145040|NCT02684942|20073304|P6|STARTED|Overall Study||6
8145041|NCT02684942|20073305|P5|STARTED|Overall Study||6
8145042|NCT02684942|20073306|P4|STARTED|Overall Study||7
8145043|NCT02684942|20073307|P3|STARTED|Overall Study||7
8145044|NCT02684942|20073308|P2|STARTED|Overall Study||7
8145045|NCT02684942|20073309|P1|STARTED|Overall Study||7
8145046|NCT02684851|20073325|P2|NOT COMPLETED|Overall Study||0
8145047|NCT02684851|20073326|P1|NOT COMPLETED|Overall Study||0
8145048|NCT02684851|20073325|P2|COMPLETED|Overall Study||45
8145049|NCT02684851|20073326|P1|COMPLETED|Overall Study||42
8145050|NCT02684851|20073325|P2|STARTED|Overall Study||45
8145051|NCT02684851|20073326|P1|STARTED|Overall Study||42
8145052|NCT02684630|20073340|P2|NOT COMPLETED|Overall Study||3
8145053|NCT02684630|20073341|P1|NOT COMPLETED|Overall Study||5
8145054|NCT02684630|20073340|P2|COMPLETED|Overall Study||60
8145055|NCT02684630|20073341|P1|COMPLETED|Overall Study||60
8145056|NCT02684630|20073340|P2|STARTED|Overall Study||63
8145057|NCT02684630|20073341|P1|STARTED|Overall Study||65
8145058|NCT02684604|20073351|P2|NOT COMPLETED|Overall Study||0
8145059|NCT02684604|20073352|P1|NOT COMPLETED|Overall Study||0
8145060|NCT02684604|20073351|P2|COMPLETED|Overall Study||44
8145061|NCT02684604|20073352|P1|COMPLETED|Overall Study||44
8145062|NCT02684604|20073351|P2|STARTED|Overall Study||44
8145063|NCT02684604|20073352|P1|STARTED|Overall Study||44
8145064|NCT02684591|20073360|P2|NOT COMPLETED|Overall Study||3
8145065|NCT02684591|20073361|P1|NOT COMPLETED|Overall Study||1
8145066|NCT02684591|20073360|P2|COMPLETED|Overall Study||22
8145067|NCT02684591|20073361|P1|COMPLETED|Overall Study||24
8145068|NCT02684591|20073360|P2|STARTED|Overall Study||25
8145069|NCT02684591|20073361|P1|STARTED|Overall Study||25
8145070|NCT02684435|20073369|P1|NOT COMPLETED|Overall Study||0
8145071|NCT02684435|20073369|P1|COMPLETED|Overall Study||63
8145072|NCT02684435|20073369|P1|STARTED|Overall Study||63
8145073|NCT02684396|20073383|P6|NOT COMPLETED|Overall Study||0
8145074|NCT02684396|20073384|P5|NOT COMPLETED|Overall Study||0
8145075|NCT02684396|20073385|P4|NOT COMPLETED|Overall Study||0
8145076|NCT02684396|20073386|P3|NOT COMPLETED|Overall Study||0
8145077|NCT02684396|20073387|P2|NOT COMPLETED|Overall Study||0
8145078|NCT02684396|20073388|P1|NOT COMPLETED|Overall Study||0
8145079|NCT02684396|20073383|P6|COMPLETED|Overall Study||10
8145080|NCT02684396|20073384|P5|COMPLETED|Overall Study||5
8145081|NCT02684396|20073385|P4|COMPLETED|Overall Study||6
8145082|NCT02684396|20073386|P3|COMPLETED|Overall Study||6
8145083|NCT02684396|20073387|P2|COMPLETED|Overall Study||6
8145084|NCT02684396|20073388|P1|COMPLETED|Overall Study||6
8145085|NCT02684396|20073383|P6|STARTED|Overall Study||10
8145086|NCT02684396|20073384|P5|STARTED|Overall Study||5
8145087|NCT02684396|20073385|P4|STARTED|Overall Study||6
8145088|NCT02684396|20073386|P3|STARTED|Overall Study||6
8145089|NCT02684396|20073387|P2|STARTED|Overall Study||6
8145090|NCT02684396|20073388|P1|STARTED|Overall Study||6
8145091|NCT02684370|20073443|P6|NOT COMPLETED|Part B||8
8145092|NCT02684370|20073444|P5|NOT COMPLETED|Part B||5
8145093|NCT02684370|20073445|P4|NOT COMPLETED|Part B||2
8145094|NCT02684370|20073446|P3|NOT COMPLETED|Part B||0
8145095|NCT02684370|20073447|P2|NOT COMPLETED|Part B||0
8145096|NCT02684370|20073448|P1|NOT COMPLETED|Part B||0
8145097|NCT02684370|20073443|P6|COMPLETED|Part B||289
8145098|NCT02684370|20073444|P5|COMPLETED|Part B||94
8145099|NCT02684370|20073445|P4|COMPLETED|Part B||95
8145100|NCT02684370|20073446|P3|COMPLETED|Part B||0
8145101|NCT02684370|20073447|P2|COMPLETED|Part B||0
8145102|NCT02684370|20073448|P1|COMPLETED|Part B||0
8145103|NCT02684370|20073443|P6|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
8145104|NCT02684370|20073444|P5|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
8145105|NCT02684370|20073445|P4|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
8145106|NCT02684370|20073446|P3|STARTED|Part B||0
8145107|NCT02684370|20073447|P2|STARTED|Part B||0
8145108|NCT02684370|20073448|P1|STARTED|Part B||0
8145109|NCT02684370|20073443|P6|NOT COMPLETED|Part A||0
8145110|NCT02684370|20073444|P5|NOT COMPLETED|Part A||0
8145111|NCT02684370|20073445|P4|NOT COMPLETED|Part A||0
8145112|NCT02684370|20073446|P3|NOT COMPLETED|Part A||5
8145113|NCT02684370|20073447|P2|NOT COMPLETED|Part A||1
8145114|NCT02684370|20073448|P1|NOT COMPLETED|Part A||4
8145115|NCT02684370|20073443|P6|COMPLETED|Part A||0
8145116|NCT02684370|20073444|P5|COMPLETED|Part A||0
8145117|NCT02684370|20073445|P4|COMPLETED|Part A||0
8145118|NCT02684370|20073446|P3|COMPLETED|Part A||299
8145119|NCT02684370|20073447|P2|COMPLETED|Part A||99
8145120|NCT02684370|20073448|P1|COMPLETED|Part A||98
8145121|NCT02684370|20073443|P6|STARTED|Part A||0
8145122|NCT02684370|20073444|P5|STARTED|Part A||0
8145123|NCT02684370|20073445|P4|STARTED|Part A||0
8145124|NCT02684370|20073446|P3|STARTED|Part A||304
8145125|NCT02684370|20073447|P2|STARTED|Part A||100
8145126|NCT02684370|20073448|P1|STARTED|Part A||102
8145127|NCT02684357|20073493|P6|NOT COMPLETED|Part B||13
8145128|NCT02684357|20073494|P5|NOT COMPLETED|Part B||4
8145129|NCT02684357|20073495|P4|NOT COMPLETED|Part B||3
8145130|NCT02684357|20073496|P3|NOT COMPLETED|Part B||0
8145131|NCT02684357|20073497|P2|NOT COMPLETED|Part B||0
8145132|NCT02684357|20073498|P1|NOT COMPLETED|Part B||0
8145133|NCT02684357|20073493|P6|COMPLETED|Part B||278
8145134|NCT02684357|20073494|P5|COMPLETED|Part B||90
8145135|NCT02684357|20073495|P4|COMPLETED|Part B||91
8145136|NCT02684357|20073496|P3|COMPLETED|Part B||0
8145137|NCT02684357|20073497|P2|COMPLETED|Part B||0
8145138|NCT02684357|20073498|P1|COMPLETED|Part B||0
8145139|NCT02684357|20073493|P6|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
8145140|NCT02684357|20073494|P5|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
8145141|NCT02684357|20073495|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
8145142|NCT02684357|20073496|P3|STARTED|Part B||0
8145143|NCT02684357|20073497|P2|STARTED|Part B||0
8145144|NCT02684357|20073498|P1|STARTED|Part B||0
8145145|NCT02684357|20073493|P6|NOT COMPLETED|Part A||0
8145146|NCT02684357|20073494|P5|NOT COMPLETED|Part A||0
8145147|NCT02684357|20073495|P4|NOT COMPLETED|Part A||0
8145148|NCT02684357|20073496|P3|NOT COMPLETED|Part A||2
8145149|NCT02684357|20073497|P2|NOT COMPLETED|Part A||3
8145150|NCT02684357|20073498|P1|NOT COMPLETED|Part A||4
8145151|NCT02684357|20073493|P6|COMPLETED|Part A||0
8145152|NCT02684357|20073494|P5|COMPLETED|Part A||0
8145153|NCT02684357|20073495|P4|COMPLETED|Part A||0
8145154|NCT02684357|20073496|P3|COMPLETED|Part A||292
8145155|NCT02684357|20073497|P2|COMPLETED|Part A||96
8145156|NCT02684357|20073498|P1|COMPLETED|Part A||94
8145157|NCT02684357|20073493|P6|STARTED|Part A||0
8145158|NCT02684357|20073494|P5|STARTED|Part A||0
8145159|NCT02684357|20073495|P4|STARTED|Part A||0
8145160|NCT02684357|20073496|P3|STARTED|Part A||294
8145161|NCT02684357|20073497|P2|STARTED|Part A||99
8145162|NCT02684357|20073498|P1|STARTED|Part A||98
8145163|NCT02684344|20073548|P2|NOT COMPLETED|Overall Study||1
8145164|NCT02684344|20073549|P1|NOT COMPLETED|Overall Study||0
8145165|NCT02684344|20073548|P2|COMPLETED|Overall Study||3
8145166|NCT02684344|20073549|P1|COMPLETED|Overall Study||1
8145167|NCT02684344|20073548|P2|STARTED|Overall Study||4
8145168|NCT02684344|20073549|P1|STARTED|Overall Study||1
8145169|NCT02684279|20073555|P1|NOT COMPLETED|Overall Study||279
8145170|NCT02684279|20073555|P1|COMPLETED|Overall Study||249
8145171|NCT02684279|20073555|P1|STARTED|Overall Study||528
8145172|NCT02684188|20073580|P2|NOT COMPLETED|Overall Study||3
8145173|NCT02684188|20073581|P1|NOT COMPLETED|Overall Study||2
8145174|NCT02684188|20073580|P2|COMPLETED|Overall Study||47
8145175|NCT02684188|20073581|P1|COMPLETED|Overall Study||75
8145176|NCT02684188|20073580|P2|STARTED|Overall Study||50
8145177|NCT02684188|20073581|P1|STARTED|Overall Study||77
8145178|NCT02684097|20073607|P2|NOT COMPLETED|Overall Study||6
8145179|NCT02684097|20073608|P1|NOT COMPLETED|Overall Study||13
8145180|NCT02684097|20073607|P2|COMPLETED|Overall Study||1
8145181|NCT02684097|20073608|P1|COMPLETED|Overall Study||2
8145182|NCT02684097|20073607|P2|STARTED|Overall Study||7
8145183|NCT02684097|20073608|P1|STARTED|Overall Study||15
8145184|NCT02683954|20073626|P2|NOT COMPLETED|Overall Study||0
8145185|NCT02683954|20073627|P1|NOT COMPLETED|Overall Study||0
8145186|NCT02683954|20073626|P2|COMPLETED|Overall Study||30
8145187|NCT02683954|20073627|P1|COMPLETED|Overall Study||30
8145188|NCT02683954|20073626|P2|STARTED|Overall Study||30
8145189|NCT02683954|20073627|P1|STARTED|Overall Study||30
8145190|NCT02683928|20073635|P2|NOT COMPLETED|Overall Study||8
8145191|NCT02683928|20073636|P1|NOT COMPLETED|Overall Study||22
8145192|NCT02683928|20073635|P2|COMPLETED|Overall Study||8
8145193|NCT02683928|20073636|P1|COMPLETED|Overall Study||26
8145194|NCT02683928|20073635|P2|STARTED|Overall Study||16
8145195|NCT02683928|20073636|P1|STARTED|Overall Study||48
8145196|NCT02683876|20073656|P2|NOT COMPLETED|Overall Study||0
8145197|NCT02683876|20073657|P1|NOT COMPLETED|Overall Study||2
8145198|NCT02683876|20073656|P2|COMPLETED|Overall Study||22
8145199|NCT02683876|20073657|P1|COMPLETED|Overall Study||15
8145200|NCT02683876|20073656|P2|STARTED|Overall Study||22
8145201|NCT02683876|20073657|P1|STARTED|Overall Study||17
8145202|NCT02683785|20073667|P2|NOT COMPLETED|Overall Study||4
8145203|NCT02683785|20073668|P1|NOT COMPLETED|Overall Study||1
8145204|NCT02683785|20073667|P2|COMPLETED|Overall Study||18
8145205|NCT02683785|20073668|P1|COMPLETED|Overall Study||21
8145206|NCT02683785|20073667|P2|STARTED|Overall Study||22
8145207|NCT02683785|20073668|P1|STARTED|Overall Study||22
8145208|NCT02683772|20073708|P2|NOT COMPLETED|Overall Study||0
8145209|NCT02683772|20073709|P1|NOT COMPLETED|Overall Study||0
8145210|NCT02683772|20073708|P2|COMPLETED|Overall Study||23
8145211|NCT02683772|20073709|P1|COMPLETED|Overall Study||15
8145212|NCT02683772|20073708|P2|STARTED|Overall Study||23
8145213|NCT02683772|20073709|P1|STARTED|Overall Study||15
8145214|NCT02683746|20073725|P2|NOT COMPLETED|Overall Study||14
8145215|NCT02683746|20073726|P1|NOT COMPLETED|Overall Study||16
8145216|NCT02683746|20073725|P2|COMPLETED|Overall Study||140
8145217|NCT02683746|20073726|P1|COMPLETED|Overall Study||138
8145218|NCT02683746|20073725|P2|STARTED|Overall Study||154
8145219|NCT02683746|20073726|P1|STARTED|Overall Study||154
8145220|NCT02683707|20073756|P2|NOT COMPLETED|Overall Study||0
8145221|NCT02683707|20073757|P1|NOT COMPLETED|Overall Study||0
8145222|NCT02683707|20073756|P2|COMPLETED|Overall Study||107
8145223|NCT02683707|20073757|P1|COMPLETED|Overall Study||105
8145224|NCT02683707|20073756|P2|STARTED|Overall Study||107
8145225|NCT02683707|20073757|P1|STARTED|Overall Study||105
8145226|NCT02683668|20073769|P3|NOT COMPLETED|Period 3||0
8145227|NCT02683668|20073770|P2|NOT COMPLETED|Period 3||0
8145228|NCT02683668|20073771|P1|NOT COMPLETED|Period 3||0
8145229|NCT02683668|20073769|P3|COMPLETED|Period 3||43
8145230|NCT02683668|20073770|P2|COMPLETED|Period 3||0
8145231|NCT02683668|20073771|P1|COMPLETED|Period 3||0
8145232|NCT02683668|20073769|P3|STARTED|Period 3||43
8145233|NCT02683668|20073770|P2|STARTED|Period 3||0
8145234|NCT02683668|20073771|P1|STARTED|Period 3||0
8145235|NCT02683668|20073769|P3|NOT COMPLETED|Period 2||0
8145236|NCT02683668|20073770|P2|NOT COMPLETED|Period 2||1
8145237|NCT02683668|20073771|P1|NOT COMPLETED|Period 2||0
8145238|NCT02683668|20073769|P3|COMPLETED|Period 2||0
8145239|NCT02683668|20073770|P2|COMPLETED|Period 2||43
8145240|NCT02683668|20073771|P1|COMPLETED|Period 2||0
8145241|NCT02683668|20073769|P3|STARTED|Period 2||0
8145242|NCT02683668|20073770|P2|STARTED|Period 2||44
8145243|NCT02683668|20073771|P1|STARTED|Period 2||0
8145244|NCT02683668|20073769|P3|NOT COMPLETED|Period 1||0
8145245|NCT02683668|20073770|P2|NOT COMPLETED|Period 1||0
8145246|NCT02683668|20073771|P1|NOT COMPLETED|Period 1||0
8145247|NCT02683668|20073769|P3|COMPLETED|Period 1||0
8145248|NCT02683668|20073770|P2|COMPLETED|Period 1||0
8145249|NCT02683668|20073771|P1|COMPLETED|Period 1||44
8145250|NCT02683668|20073769|P3|STARTED|Period 1||0
8145251|NCT02683668|20073770|P2|STARTED|Period 1||0
8145252|NCT02683668|20073771|P1|STARTED|Period 1||44
8145253|NCT02683577|20073789|P3|NOT COMPLETED|Overall Study||0
8145254|NCT02683577|20073790|P2|NOT COMPLETED|Overall Study||0
8145255|NCT02683577|20073791|P1|NOT COMPLETED|Overall Study||0
8145256|NCT02683577|20073789|P3|COMPLETED|Overall Study||8
8145257|NCT02683577|20073790|P2|COMPLETED|Overall Study||8
8145258|NCT02683577|20073791|P1|COMPLETED|Overall Study||8
8145259|NCT02683577|20073789|P3|STARTED|Overall Study||8
8145260|NCT02683577|20073790|P2|STARTED|Overall Study||8
8145261|NCT02683577|20073791|P1|STARTED|Overall Study||8
8145262|NCT02683525|20073837|P1|NOT COMPLETED|Overall Study||8
8145263|NCT02683525|20073837|P1|COMPLETED|Overall Study||29
8145264|NCT02683525|20073837|P1|STARTED|Overall Study||37
8145265|NCT02683421|20073855|P4|NOT COMPLETED|Overall Study||0
8145266|NCT02683421|20073856|P3|NOT COMPLETED|Overall Study||0
8145267|NCT02683421|20073857|P2|NOT COMPLETED|Overall Study||0
8145268|NCT02683421|20073858|P1|NOT COMPLETED|Overall Study||0
8145269|NCT02683421|20073855|P4|COMPLETED|Overall Study||5
8145270|NCT02683421|20073856|P3|COMPLETED|Overall Study||4
8145271|NCT02683421|20073857|P2|COMPLETED|Overall Study||4
8145272|NCT02683421|20073858|P1|COMPLETED|Overall Study||5
8145273|NCT02683421|20073855|P4|STARTED|Overall Study||5
8145274|NCT02683421|20073856|P3|STARTED|Overall Study||4
8145275|NCT02683421|20073857|P2|STARTED|Overall Study||4
8145276|NCT02683421|20073858|P1|STARTED|Overall Study||5
8145277|NCT02683174|20073876|P1|NOT COMPLETED|Overall Study||0
8145278|NCT02683174|20073876|P1|COMPLETED|Overall Study||86
8145279|NCT02683174|20073876|P1|STARTED|Overall Study||86
8145280|NCT02683161|20073886|P1|NOT COMPLETED|Overall Study||0
8145281|NCT02683161|20073886|P1|COMPLETED|Overall Study||5
8145282|NCT02683161|20073886|P1|STARTED|Overall Study||5
8145283|NCT02683109|20073892|P2|NOT COMPLETED|Overall Study||0
8145284|NCT02683109|20073893|P1|NOT COMPLETED|Overall Study||1
8145285|NCT02683109|20073892|P2|COMPLETED|Overall Study||111
8145286|NCT02683109|20073893|P1|COMPLETED|Overall Study||109
8145287|NCT02683109|20073892|P2|STARTED|Overall Study||111
8145288|NCT02683109|20073893|P1|STARTED|Overall Study||110
8145289|NCT02683083|20073904|P1|NOT COMPLETED|Overall Study||0
8145290|NCT02683083|20073904|P1|COMPLETED|Overall Study||9
8145291|NCT02683083|20073904|P1|STARTED|Overall Study||9
8145292|NCT02682823|20073914|P5|NOT COMPLETED|Overall Study||1
8145293|NCT02682823|20073915|P4|NOT COMPLETED|Overall Study||1
8145294|NCT02682823|20073916|P3|NOT COMPLETED|Overall Study||1
8145295|NCT02682823|20073917|P2|NOT COMPLETED|Overall Study||1
8145296|NCT02682823|20073918|P1|NOT COMPLETED|Overall Study||0
8145297|NCT02682823|20073914|P5|COMPLETED|Overall Study||18
8145298|NCT02682823|20073915|P4|COMPLETED|Overall Study||16
8145299|NCT02682823|20073916|P3|COMPLETED|Overall Study||18
8145300|NCT02682823|20073917|P2|COMPLETED|Overall Study||18
8145301|NCT02682823|20073918|P1|COMPLETED|Overall Study||17
8145302|NCT02682823|20073914|P5|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
8145303|NCT02682823|20073915|P4|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
8145304|NCT02682823|20073916|P3|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
8145305|NCT02682823|20073917|P2|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
8145306|NCT02682823|20073918|P1|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
8145307|NCT02682823|20073914|P5|STARTED|Overall Study||19
8145308|NCT02682823|20073915|P4|STARTED|Overall Study||17
8145309|NCT02682823|20073916|P3|STARTED|Overall Study||19
8145310|NCT02682823|20073917|P2|STARTED|Overall Study||19
8145311|NCT02682823|20073918|P1|STARTED|Overall Study||17
8145312|NCT02682602|20073954|P2|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
8145313|NCT02682602|20073955|P1|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
8145314|NCT02682602|20073954|P2|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
8145315|NCT02682602|20073955|P1|COMPLETED|Post-operative Fluoroscopy for Implanted||7
8145316|NCT02682602|20073954|P2|STARTED|Post-operative Fluoroscopy for Implanted||0
8145317|NCT02682602|20073955|P1|STARTED|Post-operative Fluoroscopy for Implanted||10
8145318|NCT02682602|20073954|P2|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
8145319|NCT02682602|20073955|P1|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
8145320|NCT02682602|20073954|P2|COMPLETED|Pre-operative Diseased & Normal Hips||10
8145321|NCT02682602|20073955|P1|COMPLETED|Pre-operative Diseased & Normal Hips||10
8145322|NCT02682602|20073954|P2|STARTED|Pre-operative Diseased & Normal Hips||10
8145323|NCT02682602|20073955|P1|STARTED|Pre-operative Diseased & Normal Hips||11
8145324|NCT02682563|20073974|P2|NOT COMPLETED|Overall Study||0
8145325|NCT02682563|20073975|P1|NOT COMPLETED|Overall Study||0
8145326|NCT02682563|20073974|P2|COMPLETED|Overall Study||20
8145327|NCT02682563|20073975|P1|COMPLETED|Overall Study||24
8145328|NCT02682563|20073974|P2|STARTED|Overall Study||20
8145329|NCT02682563|20073975|P1|STARTED|Overall Study||24
8145330|NCT02682498|20074001|P2|NOT COMPLETED|Overall Study||0
8145331|NCT02682498|20074002|P1|NOT COMPLETED|Overall Study||0
8145332|NCT02682498|20074001|P2|COMPLETED|Overall Study||20
8145333|NCT02682498|20074002|P1|COMPLETED|Overall Study||18
8145334|NCT02682498|20074001|P2|STARTED|Overall Study||20
8145335|NCT02682498|20074002|P1|STARTED|Overall Study||18
8145336|NCT02682381|20074019|P3|NOT COMPLETED|Overall Study||0
8145337|NCT02682381|20074020|P2|NOT COMPLETED|Overall Study||0
8145338|NCT02682381|20074021|P1|NOT COMPLETED|Overall Study||0
8145339|NCT02682381|20074019|P3|COMPLETED|Overall Study||9
8145340|NCT02682381|20074020|P2|COMPLETED|Overall Study||26
8145341|NCT02682381|20074021|P1|COMPLETED|Overall Study||24
8145342|NCT02682381|20074019|P3|STARTED|Overall Study||9
8145343|NCT02682381|20074020|P2|STARTED|Overall Study||26
8145344|NCT02682381|20074021|P1|STARTED|Overall Study||24
8145345|NCT02682264|20074088|P2|NOT COMPLETED|Overall Study||122
8145346|NCT02682264|20074089|P1|NOT COMPLETED|Overall Study||138
8145347|NCT02682264|20074088|P2|COMPLETED|Overall Study||168
8145348|NCT02682264|20074089|P1|COMPLETED|Overall Study||179
8145349|NCT02682264|20074088|P2|STARTED|Overall Study||290
8145350|NCT02682264|20074089|P1|STARTED|Overall Study||317
8145351|NCT02682069|20074095|P1|NOT COMPLETED|Overall Study||0
8145352|NCT02682069|20074095|P1|COMPLETED|Overall Study||30
8145353|NCT02682069|20074095|P1|STARTED|Overall Study||30
8145354|NCT02682056|20074099|P1|NOT COMPLETED|Overall Study||0
8145355|NCT02682056|20074099|P1|COMPLETED|Overall Study||15
8145356|NCT02682056|20074099|P1|STARTED|Overall Study||15
8145357|NCT02682030|20074115|P2|NOT COMPLETED|Overall Study||2
8145358|NCT02682030|20074116|P1|NOT COMPLETED|Overall Study||1
8145359|NCT02682030|20074115|P2|COMPLETED|Overall Study||2
8145360|NCT02682030|20074116|P1|COMPLETED|Overall Study||0
8145361|NCT02682030|20074115|P2|STARTED|Overall Study||4
8145362|NCT02682030|20074116|P1|STARTED|Overall Study||1
8145363|NCT02681809|20074135|P3|NOT COMPLETED|Overall Study||1
8145364|NCT02681809|20074136|P2|NOT COMPLETED|Overall Study||4
8145365|NCT02681809|20074137|P1|NOT COMPLETED|Overall Study||5
8145366|NCT02681809|20074135|P3|COMPLETED|Overall Study||8
8145367|NCT02681809|20074136|P2|COMPLETED|Overall Study||15
8145368|NCT02681809|20074137|P1|COMPLETED|Overall Study||15
8145369|NCT02681809|20074135|P3|STARTED|Overall Study||9
8145370|NCT02681809|20074136|P2|STARTED|Overall Study||19
8145371|NCT02681809|20074137|P1|STARTED|Overall Study||20
8145372|NCT02681757|20074150|P2|NOT COMPLETED|Overall Study||0
8145373|NCT02681757|20074151|P1|NOT COMPLETED|Overall Study||0
8145374|NCT02681757|20074150|P2|COMPLETED|Overall Study||49
8145375|NCT02681757|20074151|P1|COMPLETED|Overall Study||47
8145376|NCT02681757|20074150|P2|STARTED|Overall Study||49
8145377|NCT02681757|20074151|P1|STARTED|Overall Study||47
8145378|NCT02681614|20074161|P1|NOT COMPLETED|Overall Study||0
8145379|NCT02681614|20074161|P1|COMPLETED|Overall Study||5
8145380|NCT02681614|20074161|P1|STARTED|Overall Study||5
8145381|NCT02681510|20074175|P1|NOT COMPLETED|Overall Study||10
8145382|NCT02681510|20074175|P1|COMPLETED|Overall Study||26
8145383|NCT02681510|20074175|P1|STARTED|Overall Study||36
8145384|NCT02681458|20074184|P2|NOT COMPLETED|Overall Study||656
8145385|NCT02681458|20074185|P1|NOT COMPLETED|Overall Study||645
8145386|NCT02681458|20074184|P2|COMPLETED|Overall Study||62
8145387|NCT02681458|20074185|P1|COMPLETED|Overall Study||73
8145388|NCT02681458|20074184|P2|STARTED|Overall Study||718
8145389|NCT02681458|20074185|P1|STARTED|Overall Study||718
8145390|NCT02681172|20074191|P1|NOT COMPLETED|Overall Study||13
8145391|NCT02681172|20074191|P1|COMPLETED|Overall Study||205
8145392|NCT02681172|20074191|P1|Per Protocol Set|Overall Study||205
8145393|NCT02681172|20074191|P1|Full Analysis Set|Overall Study||205
8145394|NCT02681172|20074191|P1|Safety Analysis Set|Overall Study||205
8145395|NCT02681172|20074191|P1|STARTED|Overall Study||218
8145396|NCT02681094|20074205|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
8145397|NCT02681094|20074206|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
8145398|NCT02681094|20074207|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
8145399|NCT02681094|20074205|P3|COMPLETED|2 - Enrolled Participants Set||248
8145400|NCT02681094|20074206|P2|COMPLETED|2 - Enrolled Participants Set||261
8145401|NCT02681094|20074207|P1|COMPLETED|2 - Enrolled Participants Set||261
8145402|NCT02681094|20074205|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
8145403|NCT02681094|20074206|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
8145404|NCT02681094|20074207|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
8145405|NCT02681094|20074205|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
8145406|NCT02681094|20074206|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
8145407|NCT02681094|20074207|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
8145408|NCT02681094|20074205|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
8145409|NCT02681094|20074206|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
8145410|NCT02681094|20074207|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
8145411|NCT02681094|20074205|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
8145412|NCT02681094|20074206|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
8145413|NCT02681094|20074207|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
8145414|NCT02681094|20074205|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
8145415|NCT02681094|20074206|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
8145416|NCT02681094|20074207|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
8145417|NCT02681094|20074205|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
8145418|NCT02681094|20074206|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
8145419|NCT02681094|20074207|P1|STARTED|1 -Modified Enrolled Participants Set||293
8145420|NCT02680847|20074226|P3|NOT COMPLETED|Overall Study||3
8145421|NCT02680847|20074227|P2|NOT COMPLETED|Overall Study||3
8145422|NCT02680847|20074228|P1|NOT COMPLETED|Overall Study||5
8145423|NCT02680847|20074226|P3|COMPLETED|Overall Study||4
8145424|NCT02680847|20074227|P2|COMPLETED|Overall Study||6
8145425|NCT02680847|20074228|P1|COMPLETED|Overall Study||11
8145426|NCT02680847|20074226|P3|STARTED|Overall Study||7
8145427|NCT02680847|20074227|P2|STARTED|Overall Study||9
8145428|NCT02680847|20074228|P1|STARTED|Overall Study||16
8145429|NCT02680834|20074265|P2|NOT COMPLETED|Overall Study||3
8145430|NCT02680834|20074266|P1|NOT COMPLETED|Overall Study||11
8145431|NCT02680834|20074265|P2|COMPLETED|Overall Study||27
8145432|NCT02680834|20074266|P1|COMPLETED|Overall Study||15
8145433|NCT02680834|20074265|P2|STARTED|Overall Study||30
8145434|NCT02680834|20074266|P1|STARTED|Overall Study||26
8145435|NCT02680756|20074278|P2|NOT COMPLETED|Overall Study||19
8145436|NCT02680756|20074279|P1|NOT COMPLETED|Overall Study||32
8145437|NCT02680756|20074278|P2|COMPLETED|Overall Study||106
8145438|NCT02680756|20074279|P1|COMPLETED|Overall Study||93
8145439|NCT02680756|20074278|P2|Received Treatment|Overall Study||120
8145440|NCT02680756|20074279|P1|Received Treatment|Overall Study||127
8145441|NCT02680756|20074278|P2|STARTED|Overall Study||125
8145442|NCT02680756|20074279|P1|STARTED|Overall Study||125
8145443|NCT02680665|20074327|P1|NOT COMPLETED|Overall Study||5
8145444|NCT02680665|20074327|P1|COMPLETED|Overall Study||115
8145445|NCT02680665|20074327|P1|STARTED|Overall Study||120
8145446|NCT02680639|20074333|P3|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145447|NCT02680639|20074334|P2|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145448|NCT02680639|20074335|P1|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145449|NCT02680639|20074333|P3|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
8145450|NCT02680639|20074334|P2|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
8145451|NCT02680639|20074335|P1|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145452|NCT02680639|20074333|P3|STARTED|High Frequency Oscillation (HFO) Therapy||1
8145453|NCT02680639|20074334|P2|STARTED|High Frequency Oscillation (HFO) Therapy||2
8145454|NCT02680639|20074335|P1|STARTED|High Frequency Oscillation (HFO) Therapy||0
8145455|NCT02680639|20074333|P3|NOT COMPLETED|Screening Period||0
8145456|NCT02680639|20074334|P2|NOT COMPLETED|Screening Period||0
8145457|NCT02680639|20074335|P1|NOT COMPLETED|Screening Period||7
8145458|NCT02680639|20074333|P3|COMPLETED|Screening Period||0
8145459|NCT02680639|20074334|P2|COMPLETED|Screening Period||0
8145460|NCT02680639|20074335|P1|COMPLETED|Screening Period||3
8145461|NCT02680639|20074333|P3|STARTED|Screening Period||0
8145462|NCT02680639|20074334|P2|STARTED|Screening Period||0
8145463|NCT02680639|20074335|P1|STARTED|Screening Period||10
8145464|NCT02680457|20074356|P2|NOT COMPLETED|Cross-over Intervention||0
8145465|NCT02680457|20074357|P1|NOT COMPLETED|Cross-over Intervention||0
8145466|NCT02680457|20074356|P2|COMPLETED|Cross-over Intervention||6
8145467|NCT02680457|20074357|P1|COMPLETED|Cross-over Intervention||6
8145468|NCT02680457|20074356|P2|STARTED|Cross-over Intervention||6
8145469|NCT02680457|20074357|P1|STARTED|Cross-over Intervention||6
8145470|NCT02680457|20074356|P2|NOT COMPLETED|Washout Period||0
8145471|NCT02680457|20074357|P1|NOT COMPLETED|Washout Period||0
8145472|NCT02680457|20074356|P2|COMPLETED|Washout Period||6
8145473|NCT02680457|20074357|P1|COMPLETED|Washout Period||6
8145474|NCT02680457|20074356|P2|STARTED|Washout Period||6
8145475|NCT02680457|20074357|P1|STARTED|Washout Period||6
8145476|NCT02680457|20074356|P2|NOT COMPLETED|Initial Intervention||0
8145477|NCT02680457|20074357|P1|NOT COMPLETED|Initial Intervention||0
8145478|NCT02680457|20074356|P2|COMPLETED|Initial Intervention||6
8145479|NCT02680457|20074357|P1|COMPLETED|Initial Intervention||6
8145480|NCT02680457|20074356|P2|STARTED|Initial Intervention||6
8145481|NCT02680457|20074357|P1|STARTED|Initial Intervention||6
8145482|NCT02680301|20074367|P2|NOT COMPLETED|Overall Study||1
8145483|NCT02680301|20074368|P1|NOT COMPLETED|Overall Study||0
8145484|NCT02680301|20074367|P2|COMPLETED|Overall Study||17
8145485|NCT02680301|20074368|P1|COMPLETED|Overall Study||22
8145486|NCT02680301|20074367|P2|STARTED|Overall Study||18
8145487|NCT02680301|20074368|P1|STARTED|Overall Study||22
8145488|NCT02680158|20074376|P6|NOT COMPLETED|Overall Study||0
8145489|NCT02680158|20074377|P5|NOT COMPLETED|Overall Study||0
8145490|NCT02680158|20074378|P4|NOT COMPLETED|Overall Study||0
8145491|NCT02680158|20074379|P3|NOT COMPLETED|Overall Study||0
8145492|NCT02680158|20074380|P2|NOT COMPLETED|Overall Study||0
8145493|NCT02680158|20074381|P1|NOT COMPLETED|Overall Study||0
8145494|NCT02680158|20074376|P6|COMPLETED|Overall Study||8
8145495|NCT02680158|20074377|P5|COMPLETED|Overall Study||8
8145496|NCT02680158|20074378|P4|COMPLETED|Overall Study||8
8145497|NCT02680158|20074379|P3|COMPLETED|Overall Study||8
8145498|NCT02680158|20074380|P2|COMPLETED|Overall Study||8
8145499|NCT02680158|20074381|P1|COMPLETED|Overall Study||8
8145500|NCT02680158|20074376|P6|STARTED|Overall Study||8
8145501|NCT02680158|20074377|P5|STARTED|Overall Study||8
8145502|NCT02680158|20074378|P4|STARTED|Overall Study||8
8145503|NCT02680158|20074379|P3|STARTED|Overall Study||8
8145504|NCT02680158|20074380|P2|STARTED|Overall Study||8
8145505|NCT02680158|20074381|P1|STARTED|Overall Study||8
8145506|NCT02680145|20074392|P1|NOT COMPLETED|Overall Study||11
8145507|NCT02680145|20074392|P1|COMPLETED|Overall Study||47
8145508|NCT02680145|20074392|P1|STARTED|Overall Study||58
8145509|NCT02680054|20074399|P1|NOT COMPLETED|Overall Study||11
8145510|NCT02680054|20074399|P1|COMPLETED|Overall Study||27
8145511|NCT02680054|20074399|P1|STARTED|Overall Study||38
8145512|NCT02680041|20074417|P1|NOT COMPLETED|Overall Study||10
8145513|NCT02680041|20074417|P1|COMPLETED|Overall Study||211
8145514|NCT02680041|20074417|P1|Received 18F-fluciclovine|Overall Study||213
8145515|NCT02680041|20074417|P1|STARTED|Overall Study||221
8145516|NCT02680002|20074432|P6|NOT COMPLETED|Overall Study||9
8145517|NCT02680002|20074433|P5|NOT COMPLETED|Overall Study||11
8145518|NCT02680002|20074434|P4|NOT COMPLETED|Overall Study||4
8145519|NCT02680002|20074435|P3|NOT COMPLETED|Overall Study||10
8145520|NCT02680002|20074436|P2|NOT COMPLETED|Overall Study||4
8145521|NCT02680002|20074437|P1|NOT COMPLETED|Overall Study||13
8145522|NCT02680002|20074432|P6|COMPLETED|Overall Study||61
8145523|NCT02680002|20074433|P5|COMPLETED|Overall Study||59
8145524|NCT02680002|20074434|P4|COMPLETED|Overall Study||67
8145525|NCT02680002|20074435|P3|COMPLETED|Overall Study||60
8145526|NCT02680002|20074436|P2|COMPLETED|Overall Study||66
8145527|NCT02680002|20074437|P1|COMPLETED|Overall Study||58
8145528|NCT02680002|20074432|P6|Day 201|Overall Study||61
8145529|NCT02680002|20074433|P5|Day 201|Overall Study||59
8145530|NCT02680002|20074434|P4|Day 201|Overall Study||67
8145531|NCT02680002|20074435|P3|Day 201|Overall Study||60
8145532|NCT02680002|20074436|P2|Day 201|Overall Study||66
8145533|NCT02680002|20074437|P1|Day 201|Overall Study||58
8145534|NCT02680002|20074432|P6|Day 21 (Dose 2)|Overall Study||63
8145535|NCT02680002|20074433|P5|Day 21 (Dose 2)|Overall Study||65
8145536|NCT02680002|20074434|P4|Day 21 (Dose 2)|Overall Study||69
8145537|NCT02680002|20074435|P3|Day 21 (Dose 2)|Overall Study||65
8145538|NCT02680002|20074436|P2|Day 21 (Dose 2)|Overall Study||68
8145539|NCT02680002|20074437|P1|Day 21 (Dose 2)|Overall Study||63
8145540|NCT02680002|20074432|P6|Day 0 (Dose 1)|Overall Study||68
8145541|NCT02680002|20074433|P5|Day 0 (Dose 1)|Overall Study||70
8145542|NCT02680002|20074434|P4|Day 0 (Dose 1)|Overall Study||71
8145543|NCT02680002|20074435|P3|Day 0 (Dose 1)|Overall Study||70
8145544|NCT02680002|20074436|P2|Day 0 (Dose 1)|Overall Study||70
8145545|NCT02680002|20074437|P1|Day 0 (Dose 1)|Overall Study||70
8145546|NCT02680002|20074432|P6|STARTED|Overall Study||70
8145547|NCT02680002|20074433|P5|STARTED|Overall Study||70
8145548|NCT02680002|20074434|P4|STARTED|Overall Study||71
8145549|NCT02680002|20074435|P3|STARTED|Overall Study||70
8145550|NCT02680002|20074436|P2|STARTED|Overall Study||70
8145551|NCT02680002|20074437|P1|STARTED|Overall Study||71
8145552|NCT02679976|20074553|P1|NOT COMPLETED|Overall Study||0
8145553|NCT02679976|20074553|P1|COMPLETED|Overall Study||30
8145554|NCT02679976|20074553|P1|Myopes|Overall Study||14
8145555|NCT02679976|20074553|P1|Hyperopes|Overall Study||16
8145556|NCT02679976|20074553|P1|STARTED|Overall Study||30
8145557|NCT02679911|20074562|P1|NOT COMPLETED|Overall Study||0
8145558|NCT02679911|20074562|P1|COMPLETED|Overall Study||20
8145559|NCT02679911|20074562|P1|STARTED|Overall Study|Intra-individual study|20
8145560|NCT02679807|20074571|P2|NOT COMPLETED|Overall Study||16
8145561|NCT02679807|20074572|P1|NOT COMPLETED|Overall Study||22
8145562|NCT02679807|20074571|P2|COMPLETED|Overall Study||153
8145563|NCT02679807|20074572|P1|COMPLETED|Overall Study||143
8145564|NCT02679807|20074571|P2|STARTED|Overall Study||169
8145565|NCT02679807|20074572|P1|STARTED|Overall Study||165
8145566|NCT02679755|20074580|P2|NOT COMPLETED|Overall Study||105
8145567|NCT02679755|20074581|P1|NOT COMPLETED|Overall Study||34
8145568|NCT02679755|20074580|P2|COMPLETED|Overall Study||47
8145569|NCT02679755|20074581|P1|COMPLETED|Overall Study||66
8145570|NCT02679755|20074580|P2|STARTED|Overall Study||152
8145571|NCT02679755|20074581|P1|STARTED|Overall Study||100
8145572|NCT02679729|20074623|P9|NOT COMPLETED|Overall Study||0
8145573|NCT02679729|20074624|P8|NOT COMPLETED|Overall Study||0
8145574|NCT02679729|20074625|P7|NOT COMPLETED|Overall Study||1
8145575|NCT02679729|20074626|P6|NOT COMPLETED|Overall Study||0
8145576|NCT02679729|20074627|P5|NOT COMPLETED|Overall Study||1
8145577|NCT02679729|20074628|P4|NOT COMPLETED|Overall Study||0
8145578|NCT02679729|20074629|P3|NOT COMPLETED|Overall Study||0
8145579|NCT02679729|20074630|P2|NOT COMPLETED|Overall Study||2
8145580|NCT02679729|20074631|P1|NOT COMPLETED|Overall Study||0
8145581|NCT02679729|20074623|P9|COMPLETED|Overall Study||6
8145582|NCT02679729|20074624|P8|COMPLETED|Overall Study||14
8145583|NCT02679729|20074625|P7|COMPLETED|Overall Study||5
8145584|NCT02679729|20074626|P6|COMPLETED|Overall Study||6
8145585|NCT02679729|20074627|P5|COMPLETED|Overall Study||5
8145586|NCT02679729|20074628|P4|COMPLETED|Overall Study||6
8145587|NCT02679729|20074629|P3|COMPLETED|Overall Study||6
8145588|NCT02679729|20074630|P2|COMPLETED|Overall Study||5
8145589|NCT02679729|20074631|P1|COMPLETED|Overall Study||6
8145590|NCT02679729|20074623|P9|STARTED|Overall Study||6
8145591|NCT02679729|20074624|P8|STARTED|Overall Study||14
8145592|NCT02679729|20074625|P7|STARTED|Overall Study||6
8145593|NCT02679729|20074626|P6|STARTED|Overall Study||6
8145594|NCT02679729|20074627|P5|STARTED|Overall Study||6
8145595|NCT02679729|20074628|P4|STARTED|Overall Study||6
8145596|NCT02679729|20074629|P3|STARTED|Overall Study||6
8145597|NCT02679729|20074630|P2|STARTED|Overall Study||7
8145598|NCT02679729|20074631|P1|STARTED|Overall Study||6
8145599|NCT02679690|20074735|P1|NOT COMPLETED|Overall Study||1
8145600|NCT02679690|20074735|P1|COMPLETED|Overall Study||9
8145601|NCT02679690|20074735|P1|STARTED|Overall Study||10
8145602|NCT02679573|20074743|P2|NOT COMPLETED|Overall Study||39
8145603|NCT02679573|20074744|P1|NOT COMPLETED|Overall Study||37
8145604|NCT02679573|20074743|P2|COMPLETED|Overall Study||389
8145605|NCT02679573|20074744|P1|COMPLETED|Overall Study||394
8145606|NCT02679573|20074743|P2|STARTED|Overall Study||428
8145607|NCT02679573|20074744|P1|STARTED|Overall Study||431
8145608|NCT02679469|20074760|P1|NOT COMPLETED|Overall Study||0
8145609|NCT02679469|20074760|P1|COMPLETED|Overall Study||7
8145610|NCT02679469|20074760|P1|STARTED|Overall Study||7
8145611|NCT02679287|20074768|P2|NOT COMPLETED|Phase 4||0
8145612|NCT02679287|20074769|P1|NOT COMPLETED|Phase 4||0
8145613|NCT02679287|20074768|P2|COMPLETED|Phase 4||39
8145614|NCT02679287|20074769|P1|COMPLETED|Phase 4||40
8145615|NCT02679287|20074768|P2|STARTED|Phase 4||39
8145616|NCT02679287|20074769|P1|STARTED|Phase 4||40
8145617|NCT02679287|20074768|P2|NOT COMPLETED|Period 3||1
8145618|NCT02679287|20074769|P1|NOT COMPLETED|Period 3||0
8145619|NCT02679287|20074768|P2|COMPLETED|Period 3||39
8145620|NCT02679287|20074769|P1|COMPLETED|Period 3||40
8145621|NCT02679287|20074768|P2|STARTED|Period 3||40
8145622|NCT02679287|20074769|P1|STARTED|Period 3||40
8145623|NCT02679287|20074768|P2|NOT COMPLETED|Period 2||0
8145624|NCT02679287|20074769|P1|NOT COMPLETED|Period 2||3
8145625|NCT02679287|20074768|P2|COMPLETED|Period 2||40
8145626|NCT02679287|20074769|P1|COMPLETED|Period 2||40
8145627|NCT02679287|20074768|P2|STARTED|Period 2||40
8145628|NCT02679287|20074769|P1|STARTED|Period 2||43
8145629|NCT02679287|20074768|P2|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
8145630|NCT02679287|20074769|P1|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
8145631|NCT02679287|20074768|P2|COMPLETED|Period 1: Randomization-Study Session 1||40
8145632|NCT02679287|20074769|P1|COMPLETED|Period 1: Randomization-Study Session 1||43
8145633|NCT02679287|20074768|P2|STARTED|Period 1: Randomization-Study Session 1||46
8145634|NCT02679287|20074769|P1|STARTED|Period 1: Randomization-Study Session 1||47
8145635|NCT02679274|20074799|P2|NOT COMPLETED|Overall Study||0
8145636|NCT02679274|20074800|P1|NOT COMPLETED|Overall Study||1
8145637|NCT02679274|20074799|P2|COMPLETED|Overall Study||1
8145638|NCT02679274|20074800|P1|COMPLETED|Overall Study||1
8145639|NCT02679274|20074799|P2|STARTED|Overall Study||1
8145640|NCT02679274|20074800|P1|STARTED|Overall Study||2
8145641|NCT02679235|20074830|P1|NOT COMPLETED|Overall Study||4
8145642|NCT02679235|20074830|P1|COMPLETED|Overall Study||11
8145643|NCT02679235|20074830|P1|STARTED|Overall Study||15
8145644|NCT02679222|20074837|P1|NOT COMPLETED|Overall Study||1
8145645|NCT02679222|20074837|P1|COMPLETED|Overall Study||9
8145646|NCT02679222|20074837|P1|STARTED|Overall Study||10
8145647|NCT02679079|20074857|P3|NOT COMPLETED|Overall Study||2
8145648|NCT02679079|20074858|P2|NOT COMPLETED|Overall Study||2
8145649|NCT02679079|20074859|P1|NOT COMPLETED|Overall Study||4
8145650|NCT02679079|20074857|P3|COMPLETED|Overall Study||31
8145651|NCT02679079|20074858|P2|COMPLETED|Overall Study||30
8145652|NCT02679079|20074859|P1|COMPLETED|Overall Study||29
8145653|NCT02679079|20074857|P3|ITT Analysis Set|Overall Study||32
8145654|NCT02679079|20074858|P2|ITT Analysis Set|Overall Study||32
8145655|NCT02679079|20074859|P1|ITT Analysis Set|Overall Study||31
8145656|NCT02679079|20074857|P3|STARTED|Overall Study||33
8145657|NCT02679079|20074858|P2|STARTED|Overall Study||32
8145658|NCT02679079|20074859|P1|STARTED|Overall Study||33
8145659|NCT02679066|20074893|P2|NOT COMPLETED|Overall Study||0
8145660|NCT02679066|20074894|P1|NOT COMPLETED|Overall Study||0
8145661|NCT02679066|20074893|P2|COMPLETED|Overall Study||100
8145662|NCT02679066|20074894|P1|COMPLETED|Overall Study||100
8145663|NCT02679066|20074893|P2|STARTED|Overall Study||100
8145664|NCT02679066|20074894|P1|STARTED|Overall Study||100
8145665|NCT02678923|20074904|P2|NOT COMPLETED|Overall Study||5
8145666|NCT02678923|20074905|P1|NOT COMPLETED|Overall Study||6
8145667|NCT02678923|20074904|P2|COMPLETED|Overall Study||62
8145668|NCT02678923|20074905|P1|COMPLETED|Overall Study||53
8145669|NCT02678923|20074904|P2|mITT Population|Overall Study||61
8145670|NCT02678923|20074905|P1|mITT Population|Overall Study||52
8145671|NCT02678923|20074904|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
8145672|NCT02678923|20074905|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
8145673|NCT02678923|20074904|P2|STARTED|Overall Study||67
8145674|NCT02678923|20074905|P1|STARTED|Overall Study||59
8145675|NCT02678676|20074921|P2|NOT COMPLETED|Overall Study||872
8145676|NCT02678676|20074922|P1|NOT COMPLETED|Overall Study||888
8145677|NCT02678676|20074921|P2|COMPLETED|Overall Study||907
8145678|NCT02678676|20074922|P1|COMPLETED|Overall Study||932
8145679|NCT02678676|20074921|P2|STARTED|Overall Study||1779
8145680|NCT02678676|20074922|P1|STARTED|Overall Study||1820
8145681|NCT02678442|20074932|P2|NOT COMPLETED|Second Intervention||2
8145682|NCT02678442|20074933|P1|NOT COMPLETED|Second Intervention||2
8145683|NCT02678442|20074932|P2|COMPLETED|Second Intervention||23
8145684|NCT02678442|20074933|P1|COMPLETED|Second Intervention||23
8145685|NCT02678442|20074932|P2|STARTED|Second Intervention||25
8145686|NCT02678442|20074933|P1|STARTED|Second Intervention||25
8145687|NCT02678442|20074932|P2|NOT COMPLETED|First Intervention||0
8145688|NCT02678442|20074933|P1|NOT COMPLETED|First Intervention||0
8145689|NCT02678442|20074932|P2|COMPLETED|First Intervention||25
8145690|NCT02678442|20074933|P1|COMPLETED|First Intervention||25
8145691|NCT02678442|20074932|P2|STARTED|First Intervention||25
8145692|NCT02678442|20074933|P1|STARTED|First Intervention||25
8145693|NCT02678416|20074953|P1|NOT COMPLETED|Part 2||3
8145694|NCT02678416|20074953|P1|COMPLETED|Part 2||64
8145695|NCT02678416|20074953|P1|Per Protocol Population|Part 2||64
8145696|NCT02678416|20074953|P1|Pharmacokinetic Population|Part 2||65
8145697|NCT02678416|20074953|P1|Modified Intent to Treat Population|Part 2||66
8145698|NCT02678416|20074953|P1|Treated (Safety Population)|Part 2||66
8145699|NCT02678416|20074953|P1|STARTED|Part 2|Part 2 enrolled all new participants|67
8145700|NCT02678416|20074953|P1|NOT COMPLETED|Part 1||1
8145701|NCT02678416|20074953|P1|COMPLETED|Part 1||11
8145702|NCT02678416|20074953|P1|Per Protocol Population|Part 1||8
8145703|NCT02678416|20074953|P1|Modified Intent to Treat (mITT)|Part 1||12
8145704|NCT02678416|20074953|P1|Safety Population|Part 1||12
8145705|NCT02678416|20074953|P1|STARTED|Part 1||12
8145706|NCT02678390|20074973|P2|NOT COMPLETED|MCT + AE (5 Days)||0
8145707|NCT02678390|20074974|P1|NOT COMPLETED|MCT + AE (5 Days)||0
8145708|NCT02678390|20074973|P2|COMPLETED|MCT + AE (5 Days)||9
8145709|NCT02678390|20074974|P1|COMPLETED|MCT + AE (5 Days)||10
8145710|NCT02678390|20074973|P2|STARTED|MCT + AE (5 Days)||9
8145711|NCT02678390|20074974|P1|STARTED|MCT + AE (5 Days)||10
8145712|NCT02678390|20074973|P2|NOT COMPLETED|AE (1 Day)||1
8145713|NCT02678390|20074974|P1|NOT COMPLETED|AE (1 Day)||0
8145714|NCT02678390|20074973|P2|COMPLETED|AE (1 Day)||9
8145715|NCT02678390|20074974|P1|COMPLETED|AE (1 Day)||10
8145716|NCT02678390|20074973|P2|STARTED|AE (1 Day)||10
8145717|NCT02678390|20074974|P1|STARTED|AE (1 Day)||10
8145718|NCT02678390|20074973|P2|NOT COMPLETED|MCT (5 Days)||0
8145719|NCT02678390|20074974|P1|NOT COMPLETED|MCT (5 Days)||0
8145720|NCT02678390|20074973|P2|COMPLETED|MCT (5 Days)||10
8145721|NCT02678390|20074974|P1|COMPLETED|MCT (5 Days)||10
8145722|NCT02678390|20074973|P2|STARTED|MCT (5 Days)||10
8145723|NCT02678390|20074974|P1|STARTED|MCT (5 Days)||10
8145724|NCT02678390|20074973|P2|NOT COMPLETED|Control (5 Days)||0
8145725|NCT02678390|20074974|P1|NOT COMPLETED|Control (5 Days)||0
8145726|NCT02678390|20074973|P2|COMPLETED|Control (5 Days)||10
8145727|NCT02678390|20074974|P1|COMPLETED|Control (5 Days)||10
8145728|NCT02678390|20074973|P2|STARTED|Control (5 Days)||10
8145729|NCT02678390|20074974|P1|STARTED|Control (5 Days)||10
8145730|NCT02678286|20074990|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
8145731|NCT02678286|20074991|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
8145732|NCT02678286|20074990|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
8145733|NCT02678286|20074991|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
8145734|NCT02678286|20074990|P2|STARTED|Study Overall (28 Day Follow-Up)||109
8145735|NCT02678286|20074991|P1|STARTED|Study Overall (28 Day Follow-Up)||110
8145736|NCT02678286|20074990|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
8145737|NCT02678286|20074991|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
8145738|NCT02678286|20074990|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
8145739|NCT02678286|20074991|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
8145740|NCT02678286|20074990|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
8145741|NCT02678286|20074991|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
8145742|NCT02678039|20075023|P2|NOT COMPLETED|Overall Study||0
8145743|NCT02678039|20075024|P1|NOT COMPLETED|Overall Study||0
8145744|NCT02678039|20075023|P2|COMPLETED|Overall Study||47
8145745|NCT02678039|20075024|P1|COMPLETED|Overall Study||53
8145746|NCT02678039|20075023|P2|STARTED|Overall Study||47
8145747|NCT02678039|20075024|P1|STARTED|Overall Study||53
8145748|NCT02678000|20075043|P5|NOT COMPLETED|PART 2||0
8145749|NCT02678000|20075044|P4|NOT COMPLETED|PART 2||1
8145750|NCT02678000|20075045|P3|NOT COMPLETED|PART 2||3
8145751|NCT02678000|20075046|P2|NOT COMPLETED|PART 2||0
8145752|NCT02678000|20075047|P1|NOT COMPLETED|PART 2||0
8145753|NCT02678000|20075043|P5|COMPLETED|PART 2||18
8145754|NCT02678000|20075044|P4|COMPLETED|PART 2||26
8145755|NCT02678000|20075045|P3|COMPLETED|PART 2||25
8145756|NCT02678000|20075046|P2|COMPLETED|PART 2||0
8145757|NCT02678000|20075047|P1|COMPLETED|PART 2||0
8145758|NCT02678000|20075043|P5|STARTED|PART 2||18
8145759|NCT02678000|20075044|P4|STARTED|PART 2||27
8145760|NCT02678000|20075045|P3|STARTED|PART 2||28
8145761|NCT02678000|20075046|P2|STARTED|PART 2||0
8145762|NCT02678000|20075047|P1|STARTED|PART 2||0
8145763|NCT02678000|20075043|P5|NOT COMPLETED|PART 1||0
8145764|NCT02678000|20075044|P4|NOT COMPLETED|PART 1||0
8145765|NCT02678000|20075045|P3|NOT COMPLETED|PART 1||0
8145766|NCT02678000|20075046|P2|NOT COMPLETED|PART 1||0
8145767|NCT02678000|20075047|P1|NOT COMPLETED|PART 1||0
8145768|NCT02678000|20075043|P5|COMPLETED|PART 1||0
8145769|NCT02678000|20075044|P4|COMPLETED|PART 1||0
8145770|NCT02678000|20075045|P3|COMPLETED|PART 1||0
8145771|NCT02678000|20075046|P2|COMPLETED|PART 1||4
8145772|NCT02678000|20075047|P1|COMPLETED|PART 1||7
8145773|NCT02678000|20075043|P5|STARTED|PART 1||0
8145774|NCT02678000|20075044|P4|STARTED|PART 1||0
8145775|NCT02678000|20075045|P3|STARTED|PART 1||0
8145776|NCT02678000|20075046|P2|STARTED|PART 1||4
8145777|NCT02678000|20075047|P1|STARTED|PART 1||7
8145778|NCT02677896|20075085|P2|NOT COMPLETED|Overall Study||244
8145779|NCT02677896|20075086|P1|NOT COMPLETED|Overall Study||137
8145780|NCT02677896|20075085|P2|COMPLETED|Overall Study||332
8145781|NCT02677896|20075086|P1|COMPLETED|Overall Study||437
8145782|NCT02677896|20075085|P2|Treated|Overall Study||574
8145783|NCT02677896|20075086|P1|Treated|Overall Study||572
8145784|NCT02677896|20075085|P2|STARTED|Overall Study||576
8145785|NCT02677896|20075086|P1|STARTED|Overall Study||574
8145786|NCT02677844|20075114|P7|NOT COMPLETED|Period 7||0
8145787|NCT02677844|20075115|P6|NOT COMPLETED|Period 7||0
8145788|NCT02677844|20075116|P5|NOT COMPLETED|Period 7||0
8145789|NCT02677844|20075117|P4|NOT COMPLETED|Period 7||0
8145790|NCT02677844|20075118|P3|NOT COMPLETED|Period 7||0
8145791|NCT02677844|20075119|P2|NOT COMPLETED|Period 7||0
8145792|NCT02677844|20075120|P1|NOT COMPLETED|Period 7||0
8145793|NCT02677844|20075114|P7|COMPLETED|Period 7||4
8145794|NCT02677844|20075115|P6|COMPLETED|Period 7||4
8145795|NCT02677844|20075116|P5|COMPLETED|Period 7||7
8145796|NCT02677844|20075117|P4|COMPLETED|Period 7||0
8145797|NCT02677844|20075118|P3|COMPLETED|Period 7||0
8145798|NCT02677844|20075119|P2|COMPLETED|Period 7||0
8145799|NCT02677844|20075120|P1|COMPLETED|Period 7||0
8145800|NCT02677844|20075114|P7|STARTED|Period 7||4
8145801|NCT02677844|20075115|P6|STARTED|Period 7||4
8145802|NCT02677844|20075116|P5|STARTED|Period 7||7
8145803|NCT02677844|20075117|P4|STARTED|Period 7||0
8145804|NCT02677844|20075118|P3|STARTED|Period 7||0
8145805|NCT02677844|20075119|P2|STARTED|Period 7||0
8145806|NCT02677844|20075120|P1|STARTED|Period 7||0
8145807|NCT02677844|20075114|P7|NOT COMPLETED|Period 6||0
8145808|NCT02677844|20075115|P6|NOT COMPLETED|Period 6||0
8145809|NCT02677844|20075116|P5|NOT COMPLETED|Period 6||0
8145810|NCT02677844|20075117|P4|NOT COMPLETED|Period 6||0
8145811|NCT02677844|20075118|P3|NOT COMPLETED|Period 6||0
8145812|NCT02677844|20075119|P2|NOT COMPLETED|Period 6||0
8145813|NCT02677844|20075120|P1|NOT COMPLETED|Period 6||0
8145814|NCT02677844|20075114|P7|COMPLETED|Period 6||4
8145815|NCT02677844|20075115|P6|COMPLETED|Period 6||4
8145816|NCT02677844|20075116|P5|COMPLETED|Period 6||7
8145817|NCT02677844|20075117|P4|COMPLETED|Period 6||0
8145818|NCT02677844|20075118|P3|COMPLETED|Period 6||0
8145819|NCT02677844|20075119|P2|COMPLETED|Period 6||0
8145820|NCT02677844|20075120|P1|COMPLETED|Period 6||0
8145821|NCT02677844|20075114|P7|STARTED|Period 6||4
8145822|NCT02677844|20075115|P6|STARTED|Period 6||4
8145823|NCT02677844|20075116|P5|STARTED|Period 6||7
8145824|NCT02677844|20075117|P4|STARTED|Period 6||0
8145825|NCT02677844|20075118|P3|STARTED|Period 6||0
8145826|NCT02677844|20075119|P2|STARTED|Period 6||0
8145827|NCT02677844|20075120|P1|STARTED|Period 6||0
8145828|NCT02677844|20075114|P7|NOT COMPLETED|Period 5||0
8145829|NCT02677844|20075115|P6|NOT COMPLETED|Period 5||0
8145830|NCT02677844|20075116|P5|NOT COMPLETED|Period 5||0
8145831|NCT02677844|20075117|P4|NOT COMPLETED|Period 5||0
8145832|NCT02677844|20075118|P3|NOT COMPLETED|Period 5||0
8145833|NCT02677844|20075119|P2|NOT COMPLETED|Period 5||0
8145834|NCT02677844|20075120|P1|NOT COMPLETED|Period 5||0
8145835|NCT02677844|20075114|P7|COMPLETED|Period 5||4
8145836|NCT02677844|20075115|P6|COMPLETED|Period 5||4
8145837|NCT02677844|20075116|P5|COMPLETED|Period 5||7
8145838|NCT02677844|20075117|P4|COMPLETED|Period 5||0
8145839|NCT02677844|20075118|P3|COMPLETED|Period 5||0
8145840|NCT02677844|20075119|P2|COMPLETED|Period 5||0
8145841|NCT02677844|20075120|P1|COMPLETED|Period 5||0
8145842|NCT02677844|20075114|P7|STARTED|Period 5||4
8145843|NCT02677844|20075115|P6|STARTED|Period 5||4
8145844|NCT02677844|20075116|P5|STARTED|Period 5||7
8145845|NCT02677844|20075117|P4|STARTED|Period 5||0
8145846|NCT02677844|20075118|P3|STARTED|Period 5||0
8145847|NCT02677844|20075119|P2|STARTED|Period 5||0
8145848|NCT02677844|20075120|P1|STARTED|Period 5||0
8145849|NCT02677844|20075114|P7|NOT COMPLETED|Period 4 (DDI)||0
8145850|NCT02677844|20075115|P6|NOT COMPLETED|Period 4 (DDI)||0
8145851|NCT02677844|20075116|P5|NOT COMPLETED|Period 4 (DDI)||0
8145852|NCT02677844|20075117|P4|NOT COMPLETED|Period 4 (DDI)||0
8145853|NCT02677844|20075118|P3|NOT COMPLETED|Period 4 (DDI)||0
8145854|NCT02677844|20075119|P2|NOT COMPLETED|Period 4 (DDI)||0
8145855|NCT02677844|20075120|P1|NOT COMPLETED|Period 4 (DDI)||0
8145856|NCT02677844|20075114|P7|COMPLETED|Period 4 (DDI)||4
8145857|NCT02677844|20075115|P6|COMPLETED|Period 4 (DDI)||4
8145858|NCT02677844|20075116|P5|COMPLETED|Period 4 (DDI)||7
8145859|NCT02677844|20075117|P4|COMPLETED|Period 4 (DDI)||0
8145860|NCT02677844|20075118|P3|COMPLETED|Period 4 (DDI)||0
8145861|NCT02677844|20075119|P2|COMPLETED|Period 4 (DDI)||0
8145862|NCT02677844|20075120|P1|COMPLETED|Period 4 (DDI)||0
8145863|NCT02677844|20075114|P7|STARTED|Period 4 (DDI)||4
8145864|NCT02677844|20075115|P6|STARTED|Period 4 (DDI)||4
8145865|NCT02677844|20075116|P5|STARTED|Period 4 (DDI)||7
8145866|NCT02677844|20075117|P4|STARTED|Period 4 (DDI)||0
8145867|NCT02677844|20075118|P3|STARTED|Period 4 (DDI)||0
8145868|NCT02677844|20075119|P2|STARTED|Period 4 (DDI)||0
8145869|NCT02677844|20075120|P1|STARTED|Period 4 (DDI)||0
8145870|NCT02677844|20075114|P7|NOT COMPLETED|Period 4||0
8145871|NCT02677844|20075115|P6|NOT COMPLETED|Period 4||0
8145872|NCT02677844|20075116|P5|NOT COMPLETED|Period 4||0
8145873|NCT02677844|20075117|P4|NOT COMPLETED|Period 4||0
8145874|NCT02677844|20075118|P3|NOT COMPLETED|Period 4||0
8145875|NCT02677844|20075119|P2|NOT COMPLETED|Period 4||0
8145876|NCT02677844|20075120|P1|NOT COMPLETED|Period 4||0
8145877|NCT02677844|20075114|P7|COMPLETED|Period 4||0
8145878|NCT02677844|20075115|P6|COMPLETED|Period 4||0
8145879|NCT02677844|20075116|P5|COMPLETED|Period 4||0
8145880|NCT02677844|20075117|P4|COMPLETED|Period 4||4
8145881|NCT02677844|20075118|P3|COMPLETED|Period 4||5
8145882|NCT02677844|20075119|P2|COMPLETED|Period 4||5
8145883|NCT02677844|20075120|P1|COMPLETED|Period 4||5
8145884|NCT02677844|20075114|P7|STARTED|Period 4||0
8145885|NCT02677844|20075115|P6|STARTED|Period 4||0
8145886|NCT02677844|20075116|P5|STARTED|Period 4||0
8145887|NCT02677844|20075117|P4|STARTED|Period 4||4
8145888|NCT02677844|20075118|P3|STARTED|Period 4||5
8145889|NCT02677844|20075119|P2|STARTED|Period 4||5
8145890|NCT02677844|20075120|P1|STARTED|Period 4||5
8145891|NCT02677844|20075114|P7|NOT COMPLETED|Period 3||0
8145892|NCT02677844|20075115|P6|NOT COMPLETED|Period 3||0
8145893|NCT02677844|20075116|P5|NOT COMPLETED|Period 3||0
8145894|NCT02677844|20075117|P4|NOT COMPLETED|Period 3||1
8145895|NCT02677844|20075118|P3|NOT COMPLETED|Period 3||0
8145896|NCT02677844|20075119|P2|NOT COMPLETED|Period 3||0
8145897|NCT02677844|20075120|P1|NOT COMPLETED|Period 3||0
8145898|NCT02677844|20075114|P7|COMPLETED|Period 3||0
8145899|NCT02677844|20075115|P6|COMPLETED|Period 3||0
8145900|NCT02677844|20075116|P5|COMPLETED|Period 3||0
8145901|NCT02677844|20075117|P4|COMPLETED|Period 3||4
8145902|NCT02677844|20075118|P3|COMPLETED|Period 3||5
8145903|NCT02677844|20075119|P2|COMPLETED|Period 3||5
8145904|NCT02677844|20075120|P1|COMPLETED|Period 3||5
8145905|NCT02677844|20075114|P7|STARTED|Period 3||0
8145906|NCT02677844|20075115|P6|STARTED|Period 3||0
8145907|NCT02677844|20075116|P5|STARTED|Period 3||0
8145908|NCT02677844|20075117|P4|STARTED|Period 3||5
8145909|NCT02677844|20075118|P3|STARTED|Period 3||5
8145910|NCT02677844|20075119|P2|STARTED|Period 3||5
8145911|NCT02677844|20075120|P1|STARTED|Period 3||5
8145912|NCT02677844|20075114|P7|NOT COMPLETED|Period 2||0
8145913|NCT02677844|20075115|P6|NOT COMPLETED|Period 2||0
8145914|NCT02677844|20075116|P5|NOT COMPLETED|Period 2||0
8145915|NCT02677844|20075117|P4|NOT COMPLETED|Period 2||0
8145916|NCT02677844|20075118|P3|NOT COMPLETED|Period 2||0
8145917|NCT02677844|20075119|P2|NOT COMPLETED|Period 2||0
8145918|NCT02677844|20075120|P1|NOT COMPLETED|Period 2||0
8145919|NCT02677844|20075114|P7|COMPLETED|Period 2||0
8145920|NCT02677844|20075115|P6|COMPLETED|Period 2||0
8145921|NCT02677844|20075116|P5|COMPLETED|Period 2||0
8145922|NCT02677844|20075117|P4|COMPLETED|Period 2||5
8145923|NCT02677844|20075118|P3|COMPLETED|Period 2||5
8145924|NCT02677844|20075119|P2|COMPLETED|Period 2||5
8145925|NCT02677844|20075120|P1|COMPLETED|Period 2||5
8145926|NCT02677844|20075114|P7|STARTED|Period 2||0
8145927|NCT02677844|20075115|P6|STARTED|Period 2||0
8145928|NCT02677844|20075116|P5|STARTED|Period 2||0
8145929|NCT02677844|20075117|P4|STARTED|Period 2||5
8145930|NCT02677844|20075118|P3|STARTED|Period 2||5
8145931|NCT02677844|20075119|P2|STARTED|Period 2||5
8145932|NCT02677844|20075120|P1|STARTED|Period 2||5
8145933|NCT02677844|20075114|P7|NOT COMPLETED|Period 1||0
8145934|NCT02677844|20075115|P6|NOT COMPLETED|Period 1||0
8145935|NCT02677844|20075116|P5|NOT COMPLETED|Period 1||0
8145936|NCT02677844|20075117|P4|NOT COMPLETED|Period 1||0
8145937|NCT02677844|20075118|P3|NOT COMPLETED|Period 1||0
8145938|NCT02677844|20075119|P2|NOT COMPLETED|Period 1||0
8145939|NCT02677844|20075120|P1|NOT COMPLETED|Period 1||0
8145940|NCT02677844|20075114|P7|COMPLETED|Period 1||0
8145941|NCT02677844|20075115|P6|COMPLETED|Period 1||0
8145942|NCT02677844|20075116|P5|COMPLETED|Period 1||0
8145943|NCT02677844|20075117|P4|COMPLETED|Period 1||5
8145944|NCT02677844|20075118|P3|COMPLETED|Period 1||5
8145945|NCT02677844|20075119|P2|COMPLETED|Period 1||5
8145946|NCT02677844|20075120|P1|COMPLETED|Period 1||5
8145947|NCT02677844|20075114|P7|STARTED|Period 1||0
8145948|NCT02677844|20075115|P6|STARTED|Period 1||0
8145949|NCT02677844|20075116|P5|STARTED|Period 1||0
8145950|NCT02677844|20075117|P4|STARTED|Period 1||5
8145951|NCT02677844|20075118|P3|STARTED|Period 1||5
8145952|NCT02677844|20075119|P2|STARTED|Period 1||5
8145953|NCT02677844|20075120|P1|STARTED|Period 1||5
8145954|NCT02677779|20075150|P2|NOT COMPLETED|Overall Study||0
8145955|NCT02677779|20075151|P1|NOT COMPLETED|Overall Study||0
8145956|NCT02677779|20075150|P2|COMPLETED|Overall Study||10
8145957|NCT02677779|20075151|P1|COMPLETED|Overall Study||10
8145958|NCT02677779|20075150|P2|STARTED|Overall Study||10
8145959|NCT02677779|20075151|P1|STARTED|Overall Study||10
8145960|NCT02677766|20075167|P2|NOT COMPLETED|Overall Study||3
8145961|NCT02677766|20075168|P1|NOT COMPLETED|Overall Study||5
8145962|NCT02677766|20075167|P2|COMPLETED|Overall Study||17
8145963|NCT02677766|20075168|P1|COMPLETED|Overall Study||15
8145964|NCT02677766|20075167|P2|STARTED|Overall Study||20
8145965|NCT02677766|20075168|P1|STARTED|Overall Study||20
8145966|NCT02677753|20075176|P2|NOT COMPLETED|Overall Study||0
8145967|NCT02677753|20075177|P1|NOT COMPLETED|Overall Study||1
8145968|NCT02677753|20075176|P2|COMPLETED|Overall Study||38
8145969|NCT02677753|20075177|P1|COMPLETED|Overall Study||36
8145970|NCT02677753|20075176|P2|STARTED|Overall Study||38
8145971|NCT02677753|20075177|P1|STARTED|Overall Study||37
8145972|NCT02677740|20075185|P2|NOT COMPLETED|Overall Study||0
8145973|NCT02677740|20075186|P1|NOT COMPLETED|Overall Study||0
8145974|NCT02677740|20075185|P2|COMPLETED|Overall Study||1
8145975|NCT02677740|20075186|P1|COMPLETED|Overall Study||7
8145976|NCT02677740|20075185|P2|STARTED|Overall Study||1
8145977|NCT02677740|20075186|P1|STARTED|Overall Study||7
8145978|NCT02677714|20075200|P2|NOT COMPLETED|Overall Study||0
8145979|NCT02677714|20075201|P1|NOT COMPLETED|Overall Study||2
8145980|NCT02677714|20075200|P2|COMPLETED|Overall Study||2
8145981|NCT02677714|20075201|P1|COMPLETED|Overall Study||10
8145982|NCT02677714|20075200|P2|STARTED|Overall Study||2
8145983|NCT02677714|20075201|P1|STARTED|Overall Study||12
8145984|NCT02677623|20075216|P4|NOT COMPLETED|Overall Study||0
8145985|NCT02677623|20075217|P3|NOT COMPLETED|Overall Study||0
8145986|NCT02677623|20075218|P2|NOT COMPLETED|Overall Study||0
8145987|NCT02677623|20075219|P1|NOT COMPLETED|Overall Study||0
8145988|NCT02677623|20075216|P4|COMPLETED|Overall Study||33
8145989|NCT02677623|20075217|P3|COMPLETED|Overall Study||32
8145990|NCT02677623|20075218|P2|COMPLETED|Overall Study||32
8145991|NCT02677623|20075219|P1|COMPLETED|Overall Study||33
8145992|NCT02677623|20075216|P4|STARTED|Overall Study||33
8145993|NCT02677623|20075217|P3|STARTED|Overall Study||32
8145994|NCT02677623|20075218|P2|STARTED|Overall Study||32
8145995|NCT02677623|20075219|P1|STARTED|Overall Study||33
8145996|NCT02677493|20075232|P3|NOT COMPLETED|Overall Study||3
8145997|NCT02677493|20075233|P2|NOT COMPLETED|Overall Study||2
8145998|NCT02677493|20075234|P1|NOT COMPLETED|Overall Study||11
8145999|NCT02677493|20075232|P3|COMPLETED|Overall Study||296
8146000|NCT02677493|20075233|P2|COMPLETED|Overall Study||296
8146001|NCT02677493|20075234|P1|COMPLETED|Overall Study||1186
8146002|NCT02677493|20075232|P3|STARTED|Overall Study||299
8146003|NCT02677493|20075233|P2|STARTED|Overall Study||298
8146004|NCT02677493|20075234|P1|STARTED|Overall Study||1197
8146005|NCT02677428|20075263|P2|NOT COMPLETED|Overall Study||0
8146006|NCT02677428|20075264|P1|NOT COMPLETED|Overall Study||0
8146007|NCT02677428|20075263|P2|COMPLETED|Overall Study||55
8146008|NCT02677428|20075264|P1|COMPLETED|Overall Study||63
8146009|NCT02677428|20075263|P2|STARTED|Overall Study||55
8146010|NCT02677428|20075264|P1|STARTED|Overall Study||63
8146011|NCT02677220|20075272|P1|NOT COMPLETED|Overall Study||1
8146012|NCT02677220|20075272|P1|COMPLETED|Overall Study||0
8146013|NCT02677220|20075272|P1|STARTED|Overall Study||1
8146014|NCT02677116|20075287|P9|NOT COMPLETED|Overall Study||2
8146015|NCT02677116|20075288|P8|NOT COMPLETED|Overall Study||2
8146016|NCT02677116|20075289|P7|NOT COMPLETED|Overall Study||4
8146017|NCT02677116|20075290|P6|NOT COMPLETED|Overall Study||4
8146018|NCT02677116|20075291|P5|NOT COMPLETED|Overall Study||1
8146019|NCT02677116|20075292|P4|NOT COMPLETED|Overall Study||3
8146020|NCT02677116|20075293|P3|NOT COMPLETED|Overall Study||3
8146021|NCT02677116|20075294|P2|NOT COMPLETED|Overall Study||4
8146022|NCT02677116|20075295|P1|NOT COMPLETED|Overall Study||3
8146023|NCT02677116|20075287|P9|COMPLETED|Overall Study||2
8146024|NCT02677116|20075288|P8|COMPLETED|Overall Study||2
8146025|NCT02677116|20075289|P7|COMPLETED|Overall Study||2
8146026|NCT02677116|20075290|P6|COMPLETED|Overall Study||9
8146027|NCT02677116|20075291|P5|COMPLETED|Overall Study||0
8146028|NCT02677116|20075292|P4|COMPLETED|Overall Study||7
8146029|NCT02677116|20075293|P3|COMPLETED|Overall Study||6
8146030|NCT02677116|20075294|P2|COMPLETED|Overall Study||7
8146031|NCT02677116|20075295|P1|COMPLETED|Overall Study||7
8146032|NCT02677116|20075287|P9|Progressive Disease|Overall Study||2
8146033|NCT02677116|20075288|P8|Progressive Disease|Overall Study||2
8146034|NCT02677116|20075289|P7|Progressive Disease|Overall Study||2
8146035|NCT02677116|20075290|P6|Progressive Disease|Overall Study||9
8146036|NCT02677116|20075291|P5|Progressive Disease|Overall Study||0
8146037|NCT02677116|20075292|P4|Progressive Disease|Overall Study||7
8146038|NCT02677116|20075293|P3|Progressive Disease|Overall Study||6
8146039|NCT02677116|20075294|P2|Progressive Disease|Overall Study||7
8146040|NCT02677116|20075295|P1|Progressive Disease|Overall Study||7
8146041|NCT02677116|20075287|P9|Cycle 1 Olaratumab Alone|Overall Study||4
8146042|NCT02677116|20075288|P8|Cycle 1 Olaratumab Alone|Overall Study||4
8146043|NCT02677116|20075289|P7|Cycle 1 Olaratumab Alone|Overall Study||6
8146044|NCT02677116|20075290|P6|Cycle 1 Olaratumab Alone|Overall Study||13
8146045|NCT02677116|20075291|P5|Cycle 1 Olaratumab Alone|Overall Study||1
8146046|NCT02677116|20075292|P4|Cycle 1 Olaratumab Alone|Overall Study||10
8146047|NCT02677116|20075293|P3|Cycle 1 Olaratumab Alone|Overall Study||9
8146048|NCT02677116|20075294|P2|Cycle 1 Olaratumab Alone|Overall Study||11
8146049|NCT02677116|20075295|P1|Cycle 1 Olaratumab Alone|Overall Study||10
8146050|NCT02677116|20075287|P9|STARTED|Overall Study||4
8146051|NCT02677116|20075288|P8|STARTED|Overall Study||4
8146052|NCT02677116|20075289|P7|STARTED|Overall Study||6
8146053|NCT02677116|20075290|P6|STARTED|Overall Study||13
8146054|NCT02677116|20075291|P5|STARTED|Overall Study||1
8146055|NCT02677116|20075292|P4|STARTED|Overall Study||10
8146056|NCT02677116|20075293|P3|STARTED|Overall Study||9
8146057|NCT02677116|20075294|P2|STARTED|Overall Study||11
8146058|NCT02677116|20075295|P1|STARTED|Overall Study||10
8146059|NCT02676895|20075368|P3|NOT COMPLETED|Overall Study||3
8146060|NCT02676895|20075369|P2|NOT COMPLETED|Overall Study||3
8146061|NCT02676895|20075370|P1|NOT COMPLETED|Overall Study||2
8146062|NCT02676895|20075368|P3|COMPLETED|Overall Study||21
8146063|NCT02676895|20075369|P2|COMPLETED|Overall Study||23
8146064|NCT02676895|20075370|P1|COMPLETED|Overall Study||20
8146065|NCT02676895|20075368|P3|STARTED|Overall Study||24
8146066|NCT02676895|20075369|P2|STARTED|Overall Study||26
8146067|NCT02676895|20075370|P1|STARTED|Overall Study||22
8146068|NCT02676882|20075413|P2|NOT COMPLETED|Overall Study||2
8146069|NCT02676882|20075414|P1|NOT COMPLETED|Overall Study||3
8146070|NCT02676882|20075413|P2|COMPLETED|Overall Study||5
8146071|NCT02676882|20075414|P1|COMPLETED|Overall Study||10
8146072|NCT02676882|20075413|P2|Evaluable|Overall Study||6
8146073|NCT02676882|20075414|P1|Evaluable|Overall Study||11
8146074|NCT02676882|20075413|P2|STARTED|Overall Study||7
8146075|NCT02676882|20075414|P1|STARTED|Overall Study||13
8146076|NCT02676843|20075420|P1|NOT COMPLETED|Overall Study||0
8146077|NCT02676843|20075420|P1|COMPLETED|Overall Study||7
8146078|NCT02676843|20075420|P1|STARTED|Overall Study||7
8146079|NCT02676466|20075433|P8|NOT COMPLETED|Overall Study||1
8146080|NCT02676466|20075434|P7|NOT COMPLETED|Overall Study||1
8146081|NCT02676466|20075435|P6|NOT COMPLETED|Overall Study||1
8146082|NCT02676466|20075436|P5|NOT COMPLETED|Overall Study||3
8146083|NCT02676466|20075437|P4|NOT COMPLETED|Overall Study||0
8146084|NCT02676466|20075438|P3|NOT COMPLETED|Overall Study||2
8146085|NCT02676466|20075439|P2|NOT COMPLETED|Overall Study||5
8146086|NCT02676466|20075440|P1|NOT COMPLETED|Overall Study||4
8146087|NCT02676466|20075433|P8|COMPLETED|Overall Study||13
8146088|NCT02676466|20075434|P7|COMPLETED|Overall Study||12
8146089|NCT02676466|20075435|P6|COMPLETED|Overall Study||12
8146090|NCT02676466|20075436|P5|COMPLETED|Overall Study||23
8146091|NCT02676466|20075437|P4|COMPLETED|Overall Study||17
8146092|NCT02676466|20075438|P3|COMPLETED|Overall Study||24
8146093|NCT02676466|20075439|P2|COMPLETED|Overall Study||66
8146094|NCT02676466|20075440|P1|COMPLETED|Overall Study||105
8146095|NCT02676466|20075433|P8|STARTED|Overall Study||14
8146096|NCT02676466|20075434|P7|STARTED|Overall Study||13
8146097|NCT02676466|20075435|P6|STARTED|Overall Study||13
8146098|NCT02676466|20075436|P5|STARTED|Overall Study||26
8146099|NCT02676466|20075437|P4|STARTED|Overall Study||17
8146100|NCT02676466|20075438|P3|STARTED|Overall Study||26
8146101|NCT02676466|20075439|P2|STARTED|Overall Study||71
8146102|NCT02676466|20075440|P1|STARTED|Overall Study||109
8146103|NCT02676375|20075509|P3|NOT COMPLETED|Overall Study||3
8146104|NCT02676375|20075510|P2|NOT COMPLETED|Overall Study||4
8146105|NCT02676375|20075511|P1|NOT COMPLETED|Overall Study||1
8146106|NCT02676375|20075509|P3|COMPLETED|Overall Study||11
8146107|NCT02676375|20075510|P2|COMPLETED|Overall Study||10
8146108|NCT02676375|20075511|P1|COMPLETED|Overall Study||13
8146109|NCT02676375|20075509|P3|STARTED|Overall Study||14
8146110|NCT02676375|20075510|P2|STARTED|Overall Study||14
8146111|NCT02676375|20075511|P1|STARTED|Overall Study||14
8146112|NCT02675998|20075523|P4|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
8146113|NCT02675998|20075524|P3|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
8146114|NCT02675998|20075525|P2|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
8146115|NCT02675998|20075526|P1|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
8146116|NCT02675998|20075523|P4|COMPLETED|4-Week Randomized Withdrawal Period||74
8146117|NCT02675998|20075524|P3|COMPLETED|4-Week Randomized Withdrawal Period||32
8146118|NCT02675998|20075525|P2|COMPLETED|4-Week Randomized Withdrawal Period||22
8146119|NCT02675998|20075526|P1|COMPLETED|4-Week Randomized Withdrawal Period||24
8146120|NCT02675998|20075523|P4|STARTED|4-Week Randomized Withdrawal Period||82
8146121|NCT02675998|20075524|P3|STARTED|4-Week Randomized Withdrawal Period||34
8146122|NCT02675998|20075525|P2|STARTED|4-Week Randomized Withdrawal Period||23
8146123|NCT02675998|20075526|P1|STARTED|4-Week Randomized Withdrawal Period||25
8146124|NCT02675998|20075523|P4|NOT COMPLETED|8-Week Treatment Period||0
8146125|NCT02675998|20075524|P3|NOT COMPLETED|8-Week Treatment Period||19
8146126|NCT02675998|20075525|P2|NOT COMPLETED|8-Week Treatment Period||19
8146127|NCT02675998|20075526|P1|NOT COMPLETED|8-Week Treatment Period||17
8146128|NCT02675998|20075523|P4|COMPLETED|8-Week Treatment Period||0
8146129|NCT02675998|20075524|P3|COMPLETED|8-Week Treatment Period||53
8146130|NCT02675998|20075525|P2|COMPLETED|8-Week Treatment Period||54
8146131|NCT02675998|20075526|P1|COMPLETED|8-Week Treatment Period||57
8146132|NCT02675998|20075523|P4|STARTED|8-Week Treatment Period||0
8146133|NCT02675998|20075524|P3|STARTED|8-Week Treatment Period||72
8146134|NCT02675998|20075525|P2|STARTED|8-Week Treatment Period||73
8146135|NCT02675998|20075526|P1|STARTED|8-Week Treatment Period||74
8146136|NCT02675907|20075542|P2|NOT COMPLETED|Study Overall||4
8146137|NCT02675907|20075543|P1|NOT COMPLETED|Study Overall||3
8146138|NCT02675907|20075542|P2|COMPLETED|Study Overall||97
8146139|NCT02675907|20075543|P1|COMPLETED|Study Overall||97
8146140|NCT02675907|20075542|P2|STARTED|Study Overall||101
8146141|NCT02675907|20075543|P1|STARTED|Study Overall||100
8146142|NCT02675907|20075542|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
8146143|NCT02675907|20075543|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
8146144|NCT02675907|20075542|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
8146145|NCT02675907|20075543|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
8146146|NCT02675907|20075542|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
8146147|NCT02675907|20075543|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
8146148|NCT02675764|20075575|P2|NOT COMPLETED|Overall Study||0
8146149|NCT02675764|20075576|P1|NOT COMPLETED|Overall Study||0
8146150|NCT02675764|20075575|P2|COMPLETED|Overall Study||6
8146151|NCT02675764|20075576|P1|COMPLETED|Overall Study||6
8146152|NCT02675764|20075575|P2|STARTED|Overall Study||6
8146153|NCT02675764|20075576|P1|STARTED|Overall Study||6
8146154|NCT02675751|20075588|P1|NOT COMPLETED|Overall Study||16
8146155|NCT02675751|20075588|P1|COMPLETED|Overall Study||151
8146156|NCT02675751|20075588|P1|STARTED|Overall Study||167
8146157|NCT02675634|20075592|P6|NOT COMPLETED|Test Period 3||0
8146158|NCT02675634|20075593|P5|NOT COMPLETED|Test Period 3||0
8146159|NCT02675634|20075594|P4|NOT COMPLETED|Test Period 3||0
8146160|NCT02675634|20075595|P3|NOT COMPLETED|Test Period 3||0
8146161|NCT02675634|20075596|P2|NOT COMPLETED|Test Period 3||0
8146162|NCT02675634|20075597|P1|NOT COMPLETED|Test Period 3||0
8146163|NCT02675634|20075592|P6|COMPLETED|Test Period 3||8
8146164|NCT02675634|20075593|P5|COMPLETED|Test Period 3||10
8146165|NCT02675634|20075594|P4|COMPLETED|Test Period 3||8
8146166|NCT02675634|20075595|P3|COMPLETED|Test Period 3||8
8146167|NCT02675634|20075596|P2|COMPLETED|Test Period 3||7
8146168|NCT02675634|20075597|P1|COMPLETED|Test Period 3||9
8146169|NCT02675634|20075592|P6|STARTED|Test Period 3||8
8146170|NCT02675634|20075593|P5|STARTED|Test Period 3||10
8146171|NCT02675634|20075594|P4|STARTED|Test Period 3||8
8146172|NCT02675634|20075595|P3|STARTED|Test Period 3||8
8146173|NCT02675634|20075596|P2|STARTED|Test Period 3||7
8146174|NCT02675634|20075597|P1|STARTED|Test Period 3||9
8146175|NCT02675634|20075592|P6|NOT COMPLETED|Test Period 2||1
8146176|NCT02675634|20075593|P5|NOT COMPLETED|Test Period 2||0
8146177|NCT02675634|20075594|P4|NOT COMPLETED|Test Period 2||0
8146178|NCT02675634|20075595|P3|NOT COMPLETED|Test Period 2||0
8146179|NCT02675634|20075596|P2|NOT COMPLETED|Test Period 2||0
8146180|NCT02675634|20075597|P1|NOT COMPLETED|Test Period 2||1
8146181|NCT02675634|20075592|P6|COMPLETED|Test Period 2||8
8146182|NCT02675634|20075593|P5|COMPLETED|Test Period 2||10
8146183|NCT02675634|20075594|P4|COMPLETED|Test Period 2||8
8146184|NCT02675634|20075595|P3|COMPLETED|Test Period 2||8
8146185|NCT02675634|20075596|P2|COMPLETED|Test Period 2||7
8146186|NCT02675634|20075597|P1|COMPLETED|Test Period 2||9
8146187|NCT02675634|20075592|P6|STARTED|Test Period 2||9
8146188|NCT02675634|20075593|P5|STARTED|Test Period 2||10
8146189|NCT02675634|20075594|P4|STARTED|Test Period 2||8
8146190|NCT02675634|20075595|P3|STARTED|Test Period 2||8
8146191|NCT02675634|20075596|P2|STARTED|Test Period 2||7
8146192|NCT02675634|20075597|P1|STARTED|Test Period 2||10
8146193|NCT02675634|20075592|P6|NOT COMPLETED|Test Period 1||0
8146194|NCT02675634|20075593|P5|NOT COMPLETED|Test Period 1||0
8146195|NCT02675634|20075594|P4|NOT COMPLETED|Test Period 1||1
8146196|NCT02675634|20075595|P3|NOT COMPLETED|Test Period 1||1
8146197|NCT02675634|20075596|P2|NOT COMPLETED|Test Period 1||1
8146198|NCT02675634|20075597|P1|NOT COMPLETED|Test Period 1||0
8146199|NCT02675634|20075592|P6|COMPLETED|Test Period 1||9
8146200|NCT02675634|20075593|P5|COMPLETED|Test Period 1||10
8146201|NCT02675634|20075594|P4|COMPLETED|Test Period 1||8
8146202|NCT02675634|20075595|P3|COMPLETED|Test Period 1||8
8146203|NCT02675634|20075596|P2|COMPLETED|Test Period 1||7
8146204|NCT02675634|20075597|P1|COMPLETED|Test Period 1||10
8146205|NCT02675634|20075592|P6|STARTED|Test Period 1||9
8146206|NCT02675634|20075593|P5|STARTED|Test Period 1||10
8146207|NCT02675634|20075594|P4|STARTED|Test Period 1||9
8146208|NCT02675634|20075595|P3|STARTED|Test Period 1||9
8146209|NCT02675634|20075596|P2|STARTED|Test Period 1||8
8146210|NCT02675634|20075597|P1|STARTED|Test Period 1||10
8146211|NCT02675543|20075607|P2|NOT COMPLETED|Overall Study||0
8146212|NCT02675543|20075608|P1|NOT COMPLETED|Overall Study||0
8146213|NCT02675543|20075607|P2|COMPLETED|Overall Study||20
8146214|NCT02675543|20075608|P1|COMPLETED|Overall Study||15
8146215|NCT02675543|20075607|P2|STARTED|Overall Study||20
8146216|NCT02675543|20075608|P1|STARTED|Overall Study||15
8146217|NCT02675517|20075614|P1|NOT COMPLETED|Overall Study||159
8146218|NCT02675517|20075614|P1|COMPLETED|Overall Study||1578
8146219|NCT02675517|20075614|P1|STARTED|Overall Study||1737
8146220|NCT02675426|20075626|P3|NOT COMPLETED|Overall Study||18
8146221|NCT02675426|20075627|P2|NOT COMPLETED|Overall Study||8
8146222|NCT02675426|20075628|P1|NOT COMPLETED|Overall Study||13
8146223|NCT02675426|20075626|P3|COMPLETED|Overall Study||201
8146224|NCT02675426|20075627|P2|COMPLETED|Overall Study||213
8146225|NCT02675426|20075628|P1|COMPLETED|Overall Study||208
8146226|NCT02675426|20075626|P3|Treated|Overall Study||219
8146227|NCT02675426|20075627|P2|Treated|Overall Study||221
8146228|NCT02675426|20075628|P1|Treated|Overall Study||221
8146229|NCT02675426|20075626|P3|STARTED|Overall Study||219
8146230|NCT02675426|20075627|P2|STARTED|Overall Study||221
8146231|NCT02675426|20075628|P1|STARTED|Overall Study||221
8146244|NCT02675075|20075710|P2|NOT COMPLETED|Overall Study||0
8146245|NCT02675075|20075711|P1|NOT COMPLETED|Overall Study||3
8146246|NCT02675075|20075710|P2|COMPLETED|Overall Study||19
8146247|NCT02675075|20075711|P1|COMPLETED|Overall Study||12
8146248|NCT02675075|20075710|P2|STARTED|Overall Study||19
8146249|NCT02675075|20075711|P1|STARTED|Overall Study||15
8146250|NCT02674854|20075723|P3|NOT COMPLETED|Overall Study||14
8146251|NCT02674854|20075724|P2|NOT COMPLETED|Overall Study||27
8146252|NCT02674854|20075725|P1|NOT COMPLETED|Overall Study||24
8146253|NCT02674854|20075723|P3|COMPLETED|Overall Study||236
8146254|NCT02674854|20075724|P2|COMPLETED|Overall Study||228
8146255|NCT02674854|20075725|P1|COMPLETED|Overall Study||221
8146256|NCT02674854|20075723|P3|STARTED|Overall Study||250
8146257|NCT02674854|20075724|P2|STARTED|Overall Study||255
8146258|NCT02674854|20075725|P1|STARTED|Overall Study||245
8146259|NCT02674685|20075733|P1|NOT COMPLETED|Overall Study||4
8146260|NCT02674685|20075733|P1|COMPLETED|Overall Study||233
8146261|NCT02674685|20075733|P1|STARTED|Overall Study||237
8146262|NCT02674659|20075749|P2|NOT COMPLETED|Overall Study||4
8146263|NCT02674659|20075750|P1|NOT COMPLETED|Overall Study||4
8146264|NCT02674659|20075749|P2|COMPLETED|Overall Study||40
8146265|NCT02674659|20075750|P1|COMPLETED|Overall Study||39
8146266|NCT02674659|20075749|P2|STARTED|Overall Study||44
8146267|NCT02674659|20075750|P1|STARTED|Overall Study||43
8146268|NCT02674633|20075774|P2|NOT COMPLETED|Overall Study||4
8146269|NCT02674633|20075775|P1|NOT COMPLETED|Overall Study||5
8146270|NCT02674633|20075774|P2|COMPLETED|Overall Study||164
8146271|NCT02674633|20075775|P1|COMPLETED|Overall Study||175
8146272|NCT02674633|20075774|P2|STARTED|Overall Study||168
8146273|NCT02674633|20075775|P1|STARTED|Overall Study||180
8146274|NCT02674568|20075795|P1|NOT COMPLETED|Overall Study||339
8146275|NCT02674568|20075795|P1|COMPLETED|Overall Study||0
8146276|NCT02674568|20075795|P1|DLL3 Positive|Overall Study||287
8146277|NCT02674568|20075795|P1|Delta-like Protein 3 (DLL3) High|Overall Study||238
8146278|NCT02674568|20075795|P1|STARTED|Overall Study|Enrolled and dosed.|339
8146279|NCT02674477|20075820|P2|NOT COMPLETED|Overall Study||2
8146280|NCT02674477|20075821|P1|NOT COMPLETED|Overall Study||8
8146281|NCT02674477|20075820|P2|COMPLETED|Overall Study||45
8146282|NCT02674477|20075821|P1|COMPLETED|Overall Study||40
8146283|NCT02674477|20075820|P2|STARTED|Overall Study||47
8146284|NCT02674477|20075821|P1|STARTED|Overall Study||48
8146285|NCT02674412|20075831|P2|NOT COMPLETED|Overall Study||0
8146286|NCT02674412|20075832|P1|NOT COMPLETED|Overall Study||0
8146287|NCT02674412|20075831|P2|COMPLETED|Overall Study||5
8146288|NCT02674412|20075832|P1|COMPLETED|Overall Study||5
8146289|NCT02674412|20075831|P2|STARTED|Overall Study||5
8146290|NCT02674412|20075832|P1|STARTED|Overall Study||5
8146291|NCT02674386|20075845|P3|NOT COMPLETED|Overall Study||1
8146292|NCT02674386|20075846|P2|NOT COMPLETED|Overall Study||10
8146293|NCT02674386|20075847|P1|NOT COMPLETED|Overall Study||0
8146294|NCT02674386|20075845|P3|COMPLETED|Overall Study||16
8146295|NCT02674386|20075846|P2|COMPLETED|Overall Study||107
8146296|NCT02674386|20075847|P1|COMPLETED|Overall Study||20
8146297|NCT02674386|20075845|P3|Safety Analysis Set|Overall Study||17
8146298|NCT02674386|20075846|P2|Safety Analysis Set|Overall Study||113
8146299|NCT02674386|20075847|P1|Safety Analysis Set|Overall Study||20
8146300|NCT02674386|20075845|P3|STARTED|Overall Study||17
8146301|NCT02674386|20075846|P2|STARTED|Overall Study||117
8146302|NCT02674386|20075847|P1|STARTED|Overall Study||20
8146303|NCT02674334|20075902|P2|NOT COMPLETED|Overall Study||3
8146304|NCT02674334|20075903|P1|NOT COMPLETED|Overall Study||7
8146305|NCT02674334|20075902|P2|COMPLETED|Overall Study||40
8146306|NCT02674334|20075903|P1|COMPLETED|Overall Study||40
8146307|NCT02674334|20075902|P2|STARTED|Overall Study||43
8146308|NCT02674334|20075903|P1|STARTED|Overall Study||47
8146309|NCT02674204|20075913|P2|NOT COMPLETED|Overall Study||0
8146310|NCT02674204|20075914|P1|NOT COMPLETED|Overall Study||1
8146311|NCT02674204|20075913|P2|COMPLETED|Overall Study||1
8146312|NCT02674204|20075914|P1|COMPLETED|Overall Study||0
8146313|NCT02674204|20075913|P2|STARTED|Overall Study||1
8146314|NCT02674204|20075914|P1|STARTED|Overall Study||1
8146321|NCT02673944|20076139|P1|NOT COMPLETED|Overall Study||0
8146322|NCT02673944|20076139|P1|COMPLETED|Overall Study||10
8146323|NCT02673944|20076139|P1|STARTED|Overall Study||10
8146324|NCT02673918|20076146|P2|NOT COMPLETED|Overall Study||4
8146325|NCT02673918|20076147|P1|NOT COMPLETED|Overall Study||6
8146326|NCT02673918|20076146|P2|COMPLETED|Overall Study||20
8146327|NCT02673918|20076147|P1|COMPLETED|Overall Study||29
8146328|NCT02673918|20076146|P2|STARTED|Overall Study||24
8146329|NCT02673918|20076147|P1|STARTED|Overall Study||35
8146330|NCT02673684|20076175|P2|NOT COMPLETED|Overall Study||8
8146331|NCT02673684|20076176|P1|NOT COMPLETED|Overall Study||9
8146332|NCT02673684|20076175|P2|COMPLETED|Overall Study||0
8146333|NCT02673684|20076176|P1|COMPLETED|Overall Study||0
8146334|NCT02673684|20076175|P2|STARTED|Overall Study||8
8146335|NCT02673684|20076176|P1|STARTED|Overall Study||9
8146336|NCT02673619|20076192|P4|NOT COMPLETED|Overall Study||0
8146337|NCT02673619|20076193|P3|NOT COMPLETED|Overall Study||3
8146338|NCT02673619|20076194|P2|NOT COMPLETED|Overall Study||1
8146339|NCT02673619|20076195|P1|NOT COMPLETED|Overall Study||2
8146340|NCT02673619|20076192|P4|COMPLETED|Overall Study||7
8146341|NCT02673619|20076193|P3|COMPLETED|Overall Study||23
8146342|NCT02673619|20076194|P2|COMPLETED|Overall Study||4
8146343|NCT02673619|20076195|P1|COMPLETED|Overall Study||18
8146344|NCT02673619|20076192|P4|STARTED|Overall Study||7
8146345|NCT02673619|20076193|P3|STARTED|Overall Study||26
8146346|NCT02673619|20076194|P2|STARTED|Overall Study||5
8146347|NCT02673619|20076195|P1|STARTED|Overall Study||20
8146348|NCT02673541|20076287|P2|NOT COMPLETED|Overall Study||0
8146349|NCT02673541|20076288|P1|NOT COMPLETED|Overall Study||0
8146350|NCT02673541|20076287|P2|COMPLETED|Overall Study||2
8146351|NCT02673541|20076288|P1|COMPLETED|Overall Study||3
8146352|NCT02673541|20076287|P2|STARTED|Overall Study||2
8146353|NCT02673541|20076288|P1|STARTED|Overall Study||3
8146354|NCT02673515|20076306|P2|NOT COMPLETED|Overall Study||1
8146355|NCT02673515|20076307|P1|NOT COMPLETED|Overall Study||2
8146356|NCT02673515|20076306|P2|COMPLETED|Overall Study||29
8146357|NCT02673515|20076307|P1|COMPLETED|Overall Study||28
8146358|NCT02673515|20076306|P2|STARTED|Overall Study||30
8146359|NCT02673515|20076307|P1|STARTED|Overall Study||30
8146360|NCT02673489|20076323|P2|NOT COMPLETED|Follow Up Period||2
8146361|NCT02673489|20076324|P1|NOT COMPLETED|Follow Up Period||0
8146362|NCT02673489|20076323|P2|COMPLETED|Follow Up Period||21
8146363|NCT02673489|20076324|P1|COMPLETED|Follow Up Period||50
8146364|NCT02673489|20076323|P2|STARTED|Follow Up Period||23
8146365|NCT02673489|20076324|P1|STARTED|Follow Up Period||50
8146366|NCT02673489|20076323|P2|NOT COMPLETED|Treatment Period||3
8146367|NCT02673489|20076324|P1|NOT COMPLETED|Treatment Period||5
8146368|NCT02673489|20076323|P2|COMPLETED|Treatment Period||21
8146369|NCT02673489|20076324|P1|COMPLETED|Treatment Period||49
8146370|NCT02673489|20076323|P2|STARTED|Treatment Period||24
8146371|NCT02673489|20076324|P1|STARTED|Treatment Period||54
8146372|NCT02673372|20076339|P2|NOT COMPLETED|Overall Study||0
8146373|NCT02673372|20076340|P1|NOT COMPLETED|Overall Study||0
8146374|NCT02673372|20076339|P2|COMPLETED|Overall Study||30
8146375|NCT02673372|20076340|P1|COMPLETED|Overall Study||30
8146376|NCT02673372|20076339|P2|STARTED|Overall Study||30
8146377|NCT02673372|20076340|P1|STARTED|Overall Study||30
8146378|NCT02673333|20076346|P1|NOT COMPLETED|Overall Study||0
8146379|NCT02673333|20076346|P1|COMPLETED|Overall Study||39
8146380|NCT02673333|20076346|P1|STARTED|Overall Study||39
8146381|NCT02673203|20076352|P2|NOT COMPLETED|Overall Study||0
8146382|NCT02673203|20076353|P1|NOT COMPLETED|Overall Study||0
8146383|NCT02673203|20076352|P2|COMPLETED|Overall Study||15
8146384|NCT02673203|20076353|P1|COMPLETED|Overall Study||16
8146385|NCT02673203|20076352|P2|STARTED|Overall Study||15
8146386|NCT02673203|20076353|P1|STARTED|Overall Study||16
8146387|NCT02673138|20076375|P1|NOT COMPLETED|Overall Study||0
8146388|NCT02673138|20076375|P1|COMPLETED|Overall Study||10
8146389|NCT02673138|20076375|P1|STARTED|Overall Study||10
8146390|NCT02672852|20076389|P7|NOT COMPLETED|Part B||12
8146391|NCT02672852|20076390|P6|NOT COMPLETED|Part B||11
8146392|NCT02672852|20076391|P5|NOT COMPLETED|Part B||16
8146393|NCT02672852|20076392|P4|NOT COMPLETED|Part B||0
8146394|NCT02672852|20076393|P3|NOT COMPLETED|Part B||0
8146395|NCT02672852|20076394|P2|NOT COMPLETED|Part B||0
8146396|NCT02672852|20076395|P1|NOT COMPLETED|Part B||0
8146397|NCT02672852|20076389|P7|COMPLETED|Part B||51
8146398|NCT02672852|20076390|P6|COMPLETED|Part B||100
8146399|NCT02672852|20076391|P5|COMPLETED|Part B||209
8146400|NCT02672852|20076392|P4|COMPLETED|Part B||0
8146401|NCT02672852|20076393|P3|COMPLETED|Part B||0
8146402|NCT02672852|20076394|P2|COMPLETED|Part B||0
8146403|NCT02672852|20076395|P1|COMPLETED|Part B||0
8146404|NCT02672852|20076389|P7|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
8146405|NCT02672852|20076390|P6|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
8146406|NCT02672852|20076391|P5|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
8146407|NCT02672852|20076392|P4|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
8146408|NCT02672852|20076393|P3|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
8146409|NCT02672852|20076394|P2|STARTED|Part B||0
8146410|NCT02672852|20076395|P1|STARTED|Part B||0
8146411|NCT02672852|20076389|P7|NOT COMPLETED|Part A2||0
8146412|NCT02672852|20076390|P6|NOT COMPLETED|Part A2||0
8146413|NCT02672852|20076391|P5|NOT COMPLETED|Part A2||0
8146414|NCT02672852|20076392|P4|NOT COMPLETED|Part A2||4
8146415|NCT02672852|20076393|P3|NOT COMPLETED|Part A2||10
8146416|NCT02672852|20076394|P2|NOT COMPLETED|Part A2||0
8146417|NCT02672852|20076395|P1|NOT COMPLETED|Part A2||0
8146418|NCT02672852|20076389|P7|COMPLETED|Part A2||0
8146419|NCT02672852|20076390|P6|COMPLETED|Part A2||0
8146420|NCT02672852|20076391|P5|COMPLETED|Part A2||0
8146421|NCT02672852|20076392|P4|COMPLETED|Part A2||399
8146422|NCT02672852|20076393|P3|COMPLETED|Part A2||83
8146423|NCT02672852|20076394|P2|COMPLETED|Part A2||0
8146424|NCT02672852|20076395|P1|COMPLETED|Part A2||0
8146425|NCT02672852|20076389|P7|STARTED|Part A2||0
8146426|NCT02672852|20076390|P6|STARTED|Part A2||0
8146427|NCT02672852|20076391|P5|STARTED|Part A2||0
8146428|NCT02672852|20076392|P4|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
8146429|NCT02672852|20076393|P3|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
8146430|NCT02672852|20076394|P2|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
8146431|NCT02672852|20076395|P1|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
8146432|NCT02672852|20076389|P7|NOT COMPLETED|Part A1||0
8146433|NCT02672852|20076390|P6|NOT COMPLETED|Part A1||0
8146434|NCT02672852|20076391|P5|NOT COMPLETED|Part A1||0
8146435|NCT02672852|20076392|P4|NOT COMPLETED|Part A1||0
8146436|NCT02672852|20076393|P3|NOT COMPLETED|Part A1||0
8146437|NCT02672852|20076394|P2|NOT COMPLETED|Part A1||4
8146438|NCT02672852|20076395|P1|NOT COMPLETED|Part A1||3
8146439|NCT02672852|20076389|P7|COMPLETED|Part A1||0
8146440|NCT02672852|20076390|P6|COMPLETED|Part A1||0
8146441|NCT02672852|20076391|P5|COMPLETED|Part A1||0
8146442|NCT02672852|20076392|P4|COMPLETED|Part A1||0
8146443|NCT02672852|20076393|P3|COMPLETED|Part A1||0
8146444|NCT02672852|20076394|P2|COMPLETED|Part A1||403
8146445|NCT02672852|20076395|P1|COMPLETED|Part A1||97
8146446|NCT02672852|20076389|P7|STARTED|Part A1||0
8146447|NCT02672852|20076390|P6|STARTED|Part A1||0
8146448|NCT02672852|20076391|P5|STARTED|Part A1||0
8146449|NCT02672852|20076392|P4|STARTED|Part A1||0
8146450|NCT02672852|20076393|P3|STARTED|Part A1||0
8146451|NCT02672852|20076394|P2|STARTED|Part A1||407
8146452|NCT02672852|20076395|P1|STARTED|Part A1||100
8146453|NCT02672553|20076426|P2|NOT COMPLETED|Overall Study||8
8146454|NCT02672553|20076427|P1|NOT COMPLETED|Overall Study||12
8146455|NCT02672553|20076426|P2|COMPLETED|Overall Study||41
8146456|NCT02672553|20076427|P1|COMPLETED|Overall Study||39
8146457|NCT02672553|20076426|P2|As Intended (AI) Randomized Arm/Group|Overall Study||48
8146458|NCT02672553|20076427|P1|As Intended (AI) Randomized Arm/Group|Overall Study||46
8146459|NCT02672553|20076426|P2|As Treated (AT) Randomized Arm/Group|Overall Study||51
8146460|NCT02672553|20076427|P1|As Treated (AT) Randomized Arm/Group|Overall Study||46
8146461|NCT02672553|20076426|P2|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
8146462|NCT02672553|20076427|P1|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
8146463|NCT02672553|20076426|P2|STARTED|Overall Study||49
8146464|NCT02672553|20076427|P1|STARTED|Overall Study||51
8146465|NCT02672514|20076489|P2|NOT COMPLETED|Overall Study||0
8146466|NCT02672514|20076490|P1|NOT COMPLETED|Overall Study||0
8146467|NCT02672514|20076489|P2|COMPLETED|Overall Study||51
8146468|NCT02672514|20076490|P1|COMPLETED|Overall Study||53
8146469|NCT02672514|20076489|P2|STARTED|Overall Study||51
8146470|NCT02672514|20076490|P1|STARTED|Overall Study||53
8146471|NCT02672423|20076499|P10|NOT COMPLETED|Period 3||0
8146472|NCT02672423|20076500|P9|NOT COMPLETED|Period 3||0
8146473|NCT02672423|20076501|P8|NOT COMPLETED|Period 3||1
8146474|NCT02672423|20076502|P7|NOT COMPLETED|Period 3||0
8146475|NCT02672423|20076503|P6|NOT COMPLETED|Period 3||1
8146476|NCT02672423|20076504|P5|NOT COMPLETED|Period 3||0
8146477|NCT02672423|20076505|P4|NOT COMPLETED|Period 3||0
8146478|NCT02672423|20076506|P3|NOT COMPLETED|Period 3||0
8146479|NCT02672423|20076507|P2|NOT COMPLETED|Period 3||0
8146480|NCT02672423|20076508|P1|NOT COMPLETED|Period 3||0
8146481|NCT02672423|20076499|P10|COMPLETED|Period 3||0
8146482|NCT02672423|20076500|P9|COMPLETED|Period 3||0
8146483|NCT02672423|20076501|P8|COMPLETED|Period 3||14
8146484|NCT02672423|20076502|P7|COMPLETED|Period 3||15
8146485|NCT02672423|20076503|P6|COMPLETED|Period 3||14
8146486|NCT02672423|20076504|P5|COMPLETED|Period 3||14
8146487|NCT02672423|20076505|P4|COMPLETED|Period 3||15
8146488|NCT02672423|20076506|P3|COMPLETED|Period 3||13
8146489|NCT02672423|20076507|P2|COMPLETED|Period 3||0
8146490|NCT02672423|20076508|P1|COMPLETED|Period 3||0
8146491|NCT02672423|20076499|P10|STARTED|Period 3|Part C was a 2-period study design.|0
8146492|NCT02672423|20076500|P9|STARTED|Period 3|Part C was a 2-period study design.|0
8146493|NCT02672423|20076501|P8|STARTED|Period 3||15
8146494|NCT02672423|20076502|P7|STARTED|Period 3||15
8146495|NCT02672423|20076503|P6|STARTED|Period 3||15
8146496|NCT02672423|20076504|P5|STARTED|Period 3||14
8146497|NCT02672423|20076505|P4|STARTED|Period 3||15
8146498|NCT02672423|20076506|P3|STARTED|Period 3||13
8146499|NCT02672423|20076507|P2|STARTED|Period 3|Part A was a 2-period study design.|0
8146500|NCT02672423|20076508|P1|STARTED|Period 3|Part A was a 2-period study design.|0
8146501|NCT02672423|20076499|P10|NOT COMPLETED|Washout 2||0
8146502|NCT02672423|20076500|P9|NOT COMPLETED|Washout 2||0
8146503|NCT02672423|20076501|P8|NOT COMPLETED|Washout 2||0
8146504|NCT02672423|20076502|P7|NOT COMPLETED|Washout 2||0
8146505|NCT02672423|20076503|P6|NOT COMPLETED|Washout 2||0
8146506|NCT02672423|20076504|P5|NOT COMPLETED|Washout 2||0
8146507|NCT02672423|20076505|P4|NOT COMPLETED|Washout 2||0
8146508|NCT02672423|20076506|P3|NOT COMPLETED|Washout 2||0
8146509|NCT02672423|20076507|P2|NOT COMPLETED|Washout 2||0
8146510|NCT02672423|20076508|P1|NOT COMPLETED|Washout 2||0
8146511|NCT02672423|20076499|P10|COMPLETED|Washout 2||12
8146512|NCT02672423|20076500|P9|COMPLETED|Washout 2||12
8146513|NCT02672423|20076501|P8|COMPLETED|Washout 2||15
8146514|NCT02672423|20076502|P7|COMPLETED|Washout 2||15
8146515|NCT02672423|20076503|P6|COMPLETED|Washout 2||15
8146516|NCT02672423|20076504|P5|COMPLETED|Washout 2||14
8146517|NCT02672423|20076505|P4|COMPLETED|Washout 2||15
8146518|NCT02672423|20076506|P3|COMPLETED|Washout 2||13
8146519|NCT02672423|20076507|P2|COMPLETED|Washout 2||7
8146520|NCT02672423|20076508|P1|COMPLETED|Washout 2||7
8146521|NCT02672423|20076499|P10|STARTED|Washout 2||12
8146522|NCT02672423|20076500|P9|STARTED|Washout 2||12
8146523|NCT02672423|20076501|P8|STARTED|Washout 2||15
8146524|NCT02672423|20076502|P7|STARTED|Washout 2||15
8146525|NCT02672423|20076503|P6|STARTED|Washout 2||15
8146526|NCT02672423|20076504|P5|STARTED|Washout 2||14
8146527|NCT02672423|20076505|P4|STARTED|Washout 2||15
8146528|NCT02672423|20076506|P3|STARTED|Washout 2||13
8146529|NCT02672423|20076507|P2|STARTED|Washout 2||7
8146530|NCT02672423|20076508|P1|STARTED|Washout 2||7
8146531|NCT02672423|20076499|P10|NOT COMPLETED|Period 2||0
8146532|NCT02672423|20076500|P9|NOT COMPLETED|Period 2||0
8146533|NCT02672423|20076501|P8|NOT COMPLETED|Period 2||0
8146534|NCT02672423|20076502|P7|NOT COMPLETED|Period 2||0
8146535|NCT02672423|20076503|P6|NOT COMPLETED|Period 2||0
8146536|NCT02672423|20076504|P5|NOT COMPLETED|Period 2||0
8146537|NCT02672423|20076505|P4|NOT COMPLETED|Period 2||0
8146538|NCT02672423|20076506|P3|NOT COMPLETED|Period 2||1
8146539|NCT02672423|20076507|P2|NOT COMPLETED|Period 2||0
8146540|NCT02672423|20076508|P1|NOT COMPLETED|Period 2||0
8146541|NCT02672423|20076499|P10|COMPLETED|Period 2||12
8146542|NCT02672423|20076500|P9|COMPLETED|Period 2||12
8146543|NCT02672423|20076501|P8|COMPLETED|Period 2||15
8146544|NCT02672423|20076502|P7|COMPLETED|Period 2||15
8146545|NCT02672423|20076503|P6|COMPLETED|Period 2||15
8146546|NCT02672423|20076504|P5|COMPLETED|Period 2||14
8146547|NCT02672423|20076505|P4|COMPLETED|Period 2||15
8146548|NCT02672423|20076506|P3|COMPLETED|Period 2||13
8146549|NCT02672423|20076507|P2|COMPLETED|Period 2||7
8146550|NCT02672423|20076508|P1|COMPLETED|Period 2||7
8146551|NCT02672423|20076499|P10|STARTED|Period 2||12
8146552|NCT02672423|20076500|P9|STARTED|Period 2||12
8146553|NCT02672423|20076501|P8|STARTED|Period 2||15
8146554|NCT02672423|20076502|P7|STARTED|Period 2||15
8146555|NCT02672423|20076503|P6|STARTED|Period 2||15
8146556|NCT02672423|20076504|P5|STARTED|Period 2||14
8146557|NCT02672423|20076505|P4|STARTED|Period 2||15
8146558|NCT02672423|20076506|P3|STARTED|Period 2||14
8146559|NCT02672423|20076507|P2|STARTED|Period 2||7
8146560|NCT02672423|20076508|P1|STARTED|Period 2||7
8146561|NCT02672423|20076499|P10|NOT COMPLETED|Washout 1||0
8146562|NCT02672423|20076500|P9|NOT COMPLETED|Washout 1||0
8146563|NCT02672423|20076501|P8|NOT COMPLETED|Washout 1||0
8146564|NCT02672423|20076502|P7|NOT COMPLETED|Washout 1||0
8146565|NCT02672423|20076503|P6|NOT COMPLETED|Washout 1||0
8146566|NCT02672423|20076504|P5|NOT COMPLETED|Washout 1||0
8146567|NCT02672423|20076505|P4|NOT COMPLETED|Washout 1||0
8146568|NCT02672423|20076506|P3|NOT COMPLETED|Washout 1||0
8146569|NCT02672423|20076507|P2|NOT COMPLETED|Washout 1||0
8146570|NCT02672423|20076508|P1|NOT COMPLETED|Washout 1||0
8146571|NCT02672423|20076499|P10|COMPLETED|Washout 1||12
8146572|NCT02672423|20076500|P9|COMPLETED|Washout 1||12
8146573|NCT02672423|20076501|P8|COMPLETED|Washout 1||15
8146574|NCT02672423|20076502|P7|COMPLETED|Washout 1||15
8146575|NCT02672423|20076503|P6|COMPLETED|Washout 1||15
8146576|NCT02672423|20076504|P5|COMPLETED|Washout 1||14
8146577|NCT02672423|20076505|P4|COMPLETED|Washout 1||15
8146578|NCT02672423|20076506|P3|COMPLETED|Washout 1||14
8146579|NCT02672423|20076507|P2|COMPLETED|Washout 1||7
8146580|NCT02672423|20076508|P1|COMPLETED|Washout 1||7
8146581|NCT02672423|20076499|P10|STARTED|Washout 1||12
8146582|NCT02672423|20076500|P9|STARTED|Washout 1||12
8146583|NCT02672423|20076501|P8|STARTED|Washout 1||15
8146584|NCT02672423|20076502|P7|STARTED|Washout 1||15
8146585|NCT02672423|20076503|P6|STARTED|Washout 1||15
8146586|NCT02672423|20076504|P5|STARTED|Washout 1||14
8146587|NCT02672423|20076505|P4|STARTED|Washout 1||15
8146588|NCT02672423|20076506|P3|STARTED|Washout 1||14
8146589|NCT02672423|20076507|P2|STARTED|Washout 1||7
8146590|NCT02672423|20076508|P1|STARTED|Washout 1||7
8146591|NCT02672423|20076499|P10|NOT COMPLETED|Period 1||0
8146592|NCT02672423|20076500|P9|NOT COMPLETED|Period 1||0
8146593|NCT02672423|20076501|P8|NOT COMPLETED|Period 1||0
8146594|NCT02672423|20076502|P7|NOT COMPLETED|Period 1||0
8146595|NCT02672423|20076503|P6|NOT COMPLETED|Period 1||0
8146596|NCT02672423|20076504|P5|NOT COMPLETED|Period 1||1
8146597|NCT02672423|20076505|P4|NOT COMPLETED|Period 1||0
8146598|NCT02672423|20076506|P3|NOT COMPLETED|Period 1||0
8146599|NCT02672423|20076507|P2|NOT COMPLETED|Period 1||0
8146600|NCT02672423|20076508|P1|NOT COMPLETED|Period 1||0
8146601|NCT02672423|20076499|P10|COMPLETED|Period 1||12
8146602|NCT02672423|20076500|P9|COMPLETED|Period 1||12
8146603|NCT02672423|20076501|P8|COMPLETED|Period 1||15
8146604|NCT02672423|20076502|P7|COMPLETED|Period 1||15
8146605|NCT02672423|20076503|P6|COMPLETED|Period 1||15
8146606|NCT02672423|20076504|P5|COMPLETED|Period 1||14
8146607|NCT02672423|20076505|P4|COMPLETED|Period 1||15
8146608|NCT02672423|20076506|P3|COMPLETED|Period 1||14
8146609|NCT02672423|20076507|P2|COMPLETED|Period 1||7
8146610|NCT02672423|20076508|P1|COMPLETED|Period 1||7
8146611|NCT02672423|20076499|P10|Received at Least One Dose of Study Drug|Period 1||12
8146612|NCT02672423|20076500|P9|Received at Least One Dose of Study Drug|Period 1||12
8146613|NCT02672423|20076501|P8|Received at Least One Dose of Study Drug|Period 1||15
8146614|NCT02672423|20076502|P7|Received at Least One Dose of Study Drug|Period 1||15
8146615|NCT02672423|20076503|P6|Received at Least One Dose of Study Drug|Period 1||15
8146616|NCT02672423|20076504|P5|Received at Least One Dose of Study Drug|Period 1||15
8146617|NCT02672423|20076505|P4|Received at Least One Dose of Study Drug|Period 1||15
8146618|NCT02672423|20076506|P3|Received at Least One Dose of Study Drug|Period 1||14
8146619|NCT02672423|20076507|P2|Received at Least One Dose of Study Drug|Period 1||7
8146620|NCT02672423|20076508|P1|Received at Least One Dose of Study Drug|Period 1||7
8146621|NCT02672423|20076499|P10|STARTED|Period 1||12
8146622|NCT02672423|20076500|P9|STARTED|Period 1||12
8146623|NCT02672423|20076501|P8|STARTED|Period 1||15
8146624|NCT02672423|20076502|P7|STARTED|Period 1||15
8146625|NCT02672423|20076503|P6|STARTED|Period 1||15
8146626|NCT02672423|20076504|P5|STARTED|Period 1||15
8146627|NCT02672423|20076505|P4|STARTED|Period 1||15
8146628|NCT02672423|20076506|P3|STARTED|Period 1||14
8146629|NCT02672423|20076507|P2|STARTED|Period 1||7
8146630|NCT02672423|20076508|P1|STARTED|Period 1||7
8146631|NCT02672176|20076533|P2|NOT COMPLETED|Overall Study||26
8146632|NCT02672176|20076534|P1|NOT COMPLETED|Overall Study||6
8146633|NCT02672176|20076533|P2|COMPLETED|Overall Study||132
8146634|NCT02672176|20076534|P1|COMPLETED|Overall Study||155
8146635|NCT02672176|20076533|P2|STARTED|Overall Study||158
8146636|NCT02672176|20076534|P1|STARTED|Overall Study||161
8146637|NCT02672111|20076570|P2|NOT COMPLETED|Overall Study||12
8146638|NCT02672111|20076571|P1|NOT COMPLETED|Overall Study||58
8146639|NCT02672111|20076570|P2|COMPLETED|Overall Study||25
8146640|NCT02672111|20076571|P1|COMPLETED|Overall Study||132
8146641|NCT02672111|20076570|P2|Completed Treatment|Overall Study||29
8146642|NCT02672111|20076571|P1|Completed Treatment|Overall Study||138
8146643|NCT02672111|20076570|P2|STARTED|Overall Study||37
8146644|NCT02672111|20076571|P1|STARTED|Overall Study||190
8146645|NCT02672033|20076593|P1|NOT COMPLETED|Overall Study||0
8146646|NCT02672033|20076593|P1|COMPLETED|Overall Study||2
8146647|NCT02672033|20076593|P1|STARTED|Overall Study||2
8146648|NCT02671760|20076603|P3|NOT COMPLETED|Overall Study||0
8146649|NCT02671760|20076604|P2|NOT COMPLETED|Overall Study||1
8146650|NCT02671760|20076605|P1|NOT COMPLETED|Overall Study||0
8146651|NCT02671760|20076603|P3|COMPLETED|Overall Study||13
8146652|NCT02671760|20076604|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
8146653|NCT02671760|20076605|P1|COMPLETED|Overall Study||13
8146654|NCT02671760|20076603|P3|STARTED|Overall Study||13
8146655|NCT02671760|20076604|P2|STARTED|Overall Study||13
8146656|NCT02671760|20076605|P1|STARTED|Overall Study||13
8146657|NCT02671500|20076631|P1|NOT COMPLETED|Overall Study||14
8146658|NCT02671500|20076631|P1|COMPLETED|Overall Study||361
8146659|NCT02671500|20076631|P1|STARTED|Overall Study||375
8146660|NCT02671461|20076646|P3|NOT COMPLETED|Follow-up||1
8146661|NCT02671461|20076647|P2|NOT COMPLETED|Follow-up||1
8146662|NCT02671461|20076648|P1|NOT COMPLETED|Follow-up||1
8146663|NCT02671461|20076646|P3|COMPLETED|Follow-up||6
8146664|NCT02671461|20076647|P2|COMPLETED|Follow-up||4
8146665|NCT02671461|20076648|P1|COMPLETED|Follow-up||1
8146666|NCT02671461|20076646|P3|STARTED|Follow-up||7
8146667|NCT02671461|20076647|P2|STARTED|Follow-up||5
8146668|NCT02671461|20076648|P1|STARTED|Follow-up||2
8146669|NCT02671461|20076646|P3|NOT COMPLETED|Treatment||5
8146670|NCT02671461|20076647|P2|NOT COMPLETED|Treatment||3
8146671|NCT02671461|20076648|P1|NOT COMPLETED|Treatment||2
8146672|NCT02671461|20076646|P3|COMPLETED|Treatment||2
8146673|NCT02671461|20076647|P2|COMPLETED|Treatment||2
8146674|NCT02671461|20076648|P1|COMPLETED|Treatment||1
8146675|NCT02671461|20076646|P3|STARTED|Treatment||7
8146676|NCT02671461|20076647|P2|STARTED|Treatment||5
8146677|NCT02671461|20076648|P1|STARTED|Treatment||3
8146678|NCT02671422|20076671|P1|NOT COMPLETED|Overall Study||260
8146679|NCT02671422|20076671|P1|COMPLETED|Overall Study||0
8146680|NCT02671422|20076671|P1|Not Treated With Vargatef®|Overall Study||3
8146681|NCT02671422|20076671|P1|STARTED|Overall Study||260
8146682|NCT02671266|20076677|P2|NOT COMPLETED|Overall Study||1
8146683|NCT02671266|20076678|P1|NOT COMPLETED|Overall Study||1
8146684|NCT02671266|20076677|P2|COMPLETED|Overall Study||20
8146685|NCT02671266|20076678|P1|COMPLETED|Overall Study||19
8146686|NCT02671266|20076677|P2|Healthy Participants|Overall Study||8
8146687|NCT02671266|20076678|P1|Healthy Participants|Overall Study||8
8146688|NCT02671266|20076677|P2|OCD Participants|Overall Study||3
8146689|NCT02671266|20076678|P1|OCD Participants|Overall Study||2
8146690|NCT02671266|20076677|P2|BDD Participants|Overall Study||9
8146691|NCT02671266|20076678|P1|BDD Participants|Overall Study||9
8146692|NCT02671266|20076677|P2|STARTED|Overall Study||21
8146693|NCT02671266|20076678|P1|STARTED|Overall Study||20
8146694|NCT02671136|20076692|P2|NOT COMPLETED|Overall Study||0
8146695|NCT02671136|20076693|P1|NOT COMPLETED|Overall Study||0
8146696|NCT02671136|20076692|P2|COMPLETED|Overall Study||0
8146697|NCT02671136|20076693|P1|COMPLETED|Overall Study||3
8146698|NCT02671136|20076692|P2|STARTED|Overall Study||0
8146699|NCT02671136|20076693|P1|STARTED|Overall Study||3
8146700|NCT02671032|20076699|P1|NOT COMPLETED|Overall Study||0
8146701|NCT02671032|20076699|P1|COMPLETED|Overall Study||12
8146702|NCT02671032|20076699|P1|STARTED|Overall Study||12
8146703|NCT02670928|20076709|P2|NOT COMPLETED|Overall Study||1
8146704|NCT02670928|20076710|P1|NOT COMPLETED|Overall Study||10
8146705|NCT02670928|20076709|P2|COMPLETED|Overall Study||29
8146706|NCT02670928|20076710|P1|COMPLETED|Overall Study||90
8146707|NCT02670928|20076709|P2|STARTED|Overall Study||30
8146708|NCT02670928|20076710|P1|STARTED|Overall Study||100
8146709|NCT02670915|20076737|P3|NOT COMPLETED|Overall Study||5
8146710|NCT02670915|20076738|P2|NOT COMPLETED|Overall Study||8
8146711|NCT02670915|20076739|P1|NOT COMPLETED|Overall Study||4
8146712|NCT02670915|20076737|P3|COMPLETED|Overall Study||253
8146713|NCT02670915|20076738|P2|COMPLETED|Overall Study||251
8146714|NCT02670915|20076739|P1|COMPLETED|Overall Study||256
8146715|NCT02670915|20076737|P3|STARTED|Overall Study||258
8146716|NCT02670915|20076738|P2|STARTED|Overall Study||259
8146717|NCT02670915|20076739|P1|STARTED|Overall Study||260
8146718|NCT02670811|20076986|P2|NOT COMPLETED|Overall Study||0
8146719|NCT02670811|20076987|P1|NOT COMPLETED|Overall Study||1
8146720|NCT02670811|20076986|P2|COMPLETED|Overall Study||18
8146721|NCT02670811|20076987|P1|COMPLETED|Overall Study||17
8146722|NCT02670811|20076986|P2|STARTED|Overall Study||18
8146723|NCT02670811|20076987|P1|STARTED|Overall Study||18
8146724|NCT02670629|20077005|P2|NOT COMPLETED|Overall Study||0
8146725|NCT02670629|20077006|P1|NOT COMPLETED|Overall Study||0
8146726|NCT02670629|20077005|P2|COMPLETED|Overall Study||29
8146727|NCT02670629|20077006|P1|COMPLETED|Overall Study||29
8146728|NCT02670629|20077005|P2|STARTED|Overall Study||29
8146729|NCT02670629|20077006|P1|STARTED|Overall Study||29
8146730|NCT02670551|20077023|P3|NOT COMPLETED|Overall Study||31
8146731|NCT02670551|20077024|P2|NOT COMPLETED|Overall Study||26
8146732|NCT02670551|20077025|P1|NOT COMPLETED|Overall Study||28
8146733|NCT02670551|20077023|P3|COMPLETED|Overall Study||134
8146734|NCT02670551|20077024|P2|COMPLETED|Overall Study||134
8146735|NCT02670551|20077025|P1|COMPLETED|Overall Study||135
8146736|NCT02670551|20077023|P3|Received Treatment (Safety Population)|Overall Study||165
8146737|NCT02670551|20077024|P2|Received Treatment (Safety Population)|Overall Study||157
8146738|NCT02670551|20077025|P1|Received Treatment (Safety Population)|Overall Study||158
8146739|NCT02670551|20077023|P3|STARTED|Overall Study||165
8146740|NCT02670551|20077024|P2|STARTED|Overall Study||160
8146741|NCT02670551|20077025|P1|STARTED|Overall Study||163
8146742|NCT02670538|20077039|P3|NOT COMPLETED|Overall Study||30
8146743|NCT02670538|20077040|P2|NOT COMPLETED|Overall Study||32
8146744|NCT02670538|20077041|P1|NOT COMPLETED|Overall Study||32
8146745|NCT02670538|20077039|P3|COMPLETED|Overall Study||128
8146746|NCT02670538|20077040|P2|COMPLETED|Overall Study||136
8146747|NCT02670538|20077041|P1|COMPLETED|Overall Study||135
8146748|NCT02670538|20077039|P3|Intent-to-Treat Population|Overall Study||153
8146749|NCT02670538|20077040|P2|Intent-to-Treat Population|Overall Study||162
8146750|NCT02670538|20077041|P1|Intent-to-Treat Population|Overall Study||163
8146751|NCT02670538|20077039|P3|Safety Population : Received Study Drug|Overall Study||158
8146752|NCT02670538|20077040|P2|Safety Population : Received Study Drug|Overall Study||167
8146753|NCT02670538|20077041|P1|Safety Population : Received Study Drug|Overall Study||165
8146754|NCT02670538|20077039|P3|STARTED|Overall Study||158
8146755|NCT02670538|20077040|P2|STARTED|Overall Study||168
8146756|NCT02670538|20077041|P1|STARTED|Overall Study||167
8146757|NCT02670473|20077052|P1|NOT COMPLETED|Overall Study||1
8146758|NCT02670473|20077052|P1|COMPLETED|Overall Study||34
8146759|NCT02670473|20077052|P1|STARTED|Overall Study||35
8146760|NCT02670343|20077105|P1|NOT COMPLETED|Overall Study||0
8146761|NCT02670343|20077105|P1|COMPLETED|Overall Study||8
8146762|NCT02670343|20077105|P1|STARTED|Overall Study||8
8146763|NCT02670330|20077111|P2|NOT COMPLETED|Overall Study||77
8146764|NCT02670330|20077112|P1|NOT COMPLETED|Overall Study||75
8146765|NCT02670330|20077111|P2|COMPLETED|Overall Study||0
8146766|NCT02670330|20077112|P1|COMPLETED|Overall Study||0
8146767|NCT02670330|20077111|P2|Received At Least 1 Dose Of Study Drug|Overall Study||77
8146768|NCT02670330|20077112|P1|Received At Least 1 Dose Of Study Drug|Overall Study||75
8146769|NCT02670330|20077111|P2|STARTED|Overall Study||77
8146770|NCT02670330|20077112|P1|STARTED|Overall Study||75
8146771|NCT02670083|20077124|P2|NOT COMPLETED|Overall Study||319
8146772|NCT02670083|20077125|P1|NOT COMPLETED|Overall Study||321
8146773|NCT02670083|20077124|P2|COMPLETED|Overall Study||85
8146774|NCT02670083|20077125|P1|COMPLETED|Overall Study||88
8146775|NCT02670083|20077124|P2|STARTED|Overall Study||404
8146776|NCT02670083|20077125|P1|STARTED|Overall Study||409
8146777|NCT02669940|20077170|P2|NOT COMPLETED|Overall Study||3
8146778|NCT02669940|20077171|P1|NOT COMPLETED|Overall Study||1
8146779|NCT02669940|20077170|P2|COMPLETED|Overall Study||92
8146780|NCT02669940|20077171|P1|COMPLETED|Overall Study||62
8146781|NCT02669940|20077170|P2|STARTED|Overall Study||95
8146782|NCT02669940|20077171|P1|STARTED|Overall Study||63
8146783|NCT02669914|20077227|P3|NOT COMPLETED|Overall Study||0
8146784|NCT02669914|20077228|P2|NOT COMPLETED|Overall Study||0
8146785|NCT02669914|20077229|P1|NOT COMPLETED|Overall Study||0
8146786|NCT02669914|20077227|P3|COMPLETED|Overall Study||0
8146787|NCT02669914|20077228|P2|COMPLETED|Overall Study||0
8146788|NCT02669914|20077229|P1|COMPLETED|Overall Study||4
8146789|NCT02669914|20077227|P3|STARTED|Overall Study||0
8146790|NCT02669914|20077228|P2|STARTED|Overall Study||0
8146791|NCT02669914|20077229|P1|STARTED|Overall Study||4
8146792|NCT02669862|20077273|P3|NOT COMPLETED|Overall Study||5
8146793|NCT02669862|20077274|P2|NOT COMPLETED|Overall Study||5
8146794|NCT02669862|20077275|P1|NOT COMPLETED|Overall Study||2
8146795|NCT02669862|20077273|P3|COMPLETED|Overall Study||26
8146796|NCT02669862|20077274|P2|COMPLETED|Overall Study||29
8146797|NCT02669862|20077275|P1|COMPLETED|Overall Study||31
8146798|NCT02669862|20077273|P3|STARTED|Overall Study||31
8146799|NCT02669862|20077274|P2|STARTED|Overall Study||34
8146800|NCT02669862|20077275|P1|STARTED|Overall Study||33
8146801|NCT02669849|20077291|P3|NOT COMPLETED|Overall Study||24
8146802|NCT02669849|20077292|P2|NOT COMPLETED|Overall Study||2
8146803|NCT02669849|20077293|P1|NOT COMPLETED|Overall Study||18
8146804|NCT02669849|20077291|P3|COMPLETED|Overall Study||8
8146805|NCT02669849|20077292|P2|COMPLETED|Overall Study||4
8146806|NCT02669849|20077293|P1|COMPLETED|Overall Study||11
8146807|NCT02669849|20077291|P3|STARTED|Overall Study||32
8146808|NCT02669849|20077292|P2|STARTED|Overall Study||6
8146809|NCT02669849|20077293|P1|STARTED|Overall Study||29
8146810|NCT02669784|20077315|P2|NOT COMPLETED|Overall Study||0
8146811|NCT02669784|20077316|P1|NOT COMPLETED|Overall Study||0
8146812|NCT02669784|20077315|P2|COMPLETED|Overall Study||16
8146813|NCT02669784|20077316|P1|COMPLETED|Overall Study||18
8146814|NCT02669784|20077315|P2|STARTED|Overall Study||16
8146815|NCT02669784|20077316|P1|STARTED|Overall Study||18
8146816|NCT02669758|20077336|P1|NOT COMPLETED|Overall Study||94
8146817|NCT02669758|20077336|P1|COMPLETED|Overall Study||183
8146818|NCT02669758|20077336|P1|STARTED|Overall Study||277
8146819|NCT02669667|20077347|P7|NOT COMPLETED|Overall Study||0
8146820|NCT02669667|20077348|P6|NOT COMPLETED|Overall Study||1
8146821|NCT02669667|20077349|P5|NOT COMPLETED|Overall Study||0
8146822|NCT02669667|20077350|P4|NOT COMPLETED|Overall Study||0
8146823|NCT02669667|20077351|P3|NOT COMPLETED|Overall Study||0
8146824|NCT02669667|20077352|P2|NOT COMPLETED|Overall Study||0
8146825|NCT02669667|20077353|P1|NOT COMPLETED|Overall Study||0
8146826|NCT02669667|20077347|P7|COMPLETED|Overall Study||6
8146827|NCT02669667|20077348|P6|COMPLETED|Overall Study||5
8146828|NCT02669667|20077349|P5|COMPLETED|Overall Study||6
8146829|NCT02669667|20077350|P4|COMPLETED|Overall Study||6
8146830|NCT02669667|20077351|P3|COMPLETED|Overall Study||4
8146831|NCT02669667|20077352|P2|COMPLETED|Overall Study||4
8146832|NCT02669667|20077353|P1|COMPLETED|Overall Study||12
8146833|NCT02669667|20077347|P7|STARTED|Overall Study||6
8146834|NCT02669667|20077348|P6|STARTED|Overall Study||6
8146835|NCT02669667|20077349|P5|STARTED|Overall Study||6
8146836|NCT02669667|20077350|P4|STARTED|Overall Study||6
8146837|NCT02669667|20077351|P3|STARTED|Overall Study||4
8146838|NCT02669667|20077352|P2|STARTED|Overall Study||4
8146839|NCT02669667|20077353|P1|STARTED|Overall Study||12
8146840|NCT02669615|20077447|P1|NOT COMPLETED|Overall Study||0
8146841|NCT02669615|20077447|P1|COMPLETED|Overall Study||24
8146842|NCT02669615|20077447|P1|STARTED|Overall Study||24
8146843|NCT02669433|20077456|P3|NOT COMPLETED|Overall Study||15
8146844|NCT02669433|20077457|P2|NOT COMPLETED|Overall Study||14
8146845|NCT02669433|20077458|P1|NOT COMPLETED|Overall Study||15
8146846|NCT02669433|20077456|P3|COMPLETED|Overall Study||74
8146847|NCT02669433|20077457|P2|COMPLETED|Overall Study||75
8146848|NCT02669433|20077458|P1|COMPLETED|Overall Study||76
8146849|NCT02669433|20077456|P3|UPDRS Primary Population|Overall Study||84
8146850|NCT02669433|20077457|P2|UPDRS Primary Population|Overall Study||87
8146851|NCT02669433|20077458|P1|UPDRS Primary Population|Overall Study||87
8146852|NCT02669433|20077456|P3|Completers Population|Overall Study||69
8146853|NCT02669433|20077457|P2|Completers Population|Overall Study||72
8146854|NCT02669433|20077458|P1|Completers Population|Overall Study||73
8146855|NCT02669433|20077456|P3|Per-Protocol Population|Overall Study||82
8146856|NCT02669433|20077457|P2|Per-Protocol Population|Overall Study||79
8146857|NCT02669433|20077458|P1|Per-Protocol Population|Overall Study||78
8146858|NCT02669433|20077456|P3|Intent to Treat (ITT) Population|Overall Study||87
8146859|NCT02669433|20077457|P2|Intent to Treat (ITT) Population|Overall Study||89
8146860|NCT02669433|20077458|P1|Intent to Treat (ITT) Population|Overall Study||89
8146861|NCT02669433|20077456|P3|Safety Population|Overall Study||88
8146862|NCT02669433|20077457|P2|Safety Population|Overall Study||89
8146863|NCT02669433|20077458|P1|Safety Population|Overall Study||91
8146864|NCT02669433|20077456|P3|STARTED|Overall Study||89
8146865|NCT02669433|20077457|P2|STARTED|Overall Study||89
8146866|NCT02669433|20077458|P1|STARTED|Overall Study||91
8146867|NCT02669407|20077472|P1|NOT COMPLETED|Overall Study||3
8146868|NCT02669407|20077472|P1|COMPLETED|Overall Study||11
8146869|NCT02669407|20077472|P1|STARTED|Overall Study||14
8146870|NCT02669329|20077489|P1|NOT COMPLETED|Overall Study||0
8146871|NCT02669329|20077489|P1|COMPLETED|Overall Study||30
8146872|NCT02669329|20077489|P1|STARTED|Overall Study||30
8146894|NCT02669095|20077653|P2|NOT COMPLETED|Overall Study||3
8146895|NCT02669095|20077654|P1|NOT COMPLETED|Overall Study||1
8146896|NCT02669095|20077653|P2|COMPLETED|Overall Study||72
8146897|NCT02669095|20077654|P1|COMPLETED|Overall Study||74
8146898|NCT02669095|20077653|P2|STARTED|Overall Study||75
8146899|NCT02669095|20077654|P1|STARTED|Overall Study||75
8146900|NCT02669082|20077662|P1|NOT COMPLETED|Overall Study||1
8146901|NCT02669082|20077662|P1|COMPLETED|Overall Study||25
8146902|NCT02669082|20077662|P1|STARTED|Overall Study||26
8146903|NCT02669043|20077674|P1|NOT COMPLETED|Overall Study||4
8146904|NCT02669043|20077674|P1|COMPLETED|Overall Study||4
8146905|NCT02669043|20077674|P1|STARTED|Overall Study||8
8146933|NCT02668952|20077819|P2|NOT COMPLETED|Overall Study||0
8146934|NCT02668952|20077820|P1|NOT COMPLETED|Overall Study||0
8146935|NCT02668952|20077819|P2|COMPLETED|Overall Study||14
8146936|NCT02668952|20077820|P1|COMPLETED|Overall Study||16
8146937|NCT02668952|20077819|P2|STARTED|Overall Study||14
8146938|NCT02668952|20077820|P1|STARTED|Overall Study||16
8146939|NCT02668822|20077840|P2|NOT COMPLETED|Overall Study||9
8146940|NCT02668822|20077841|P1|NOT COMPLETED|Overall Study||9
8146941|NCT02668822|20077840|P2|COMPLETED|Overall Study||0
8146942|NCT02668822|20077841|P1|COMPLETED|Overall Study||0
8146943|NCT02668822|20077840|P2|STARTED|Overall Study||9
8146944|NCT02668822|20077841|P1|STARTED|Overall Study||9
8146945|NCT02668783|20077863|P2|NOT COMPLETED|Overall Study||12
8146946|NCT02668783|20077864|P1|NOT COMPLETED|Overall Study||13
8146947|NCT02668783|20077863|P2|COMPLETED|Overall Study||0
8146948|NCT02668783|20077864|P1|COMPLETED|Overall Study||0
8146949|NCT02668783|20077863|P2|Treated|Overall Study||11
8146950|NCT02668783|20077864|P1|Treated|Overall Study||13
8146951|NCT02668783|20077863|P2|STARTED|Overall Study||12
8146952|NCT02668783|20077864|P1|STARTED|Overall Study||13
8146953|NCT02668640|20077884|P1|NOT COMPLETED|Overall Study||14
8146954|NCT02668640|20077884|P1|COMPLETED|Overall Study||41
8146955|NCT02668640|20077884|P1|STARTED|Overall Study||55
8146956|NCT02668432|20077897|P2|NOT COMPLETED|Overall Study||0
8146957|NCT02668432|20077898|P1|NOT COMPLETED|Overall Study||0
8146958|NCT02668432|20077897|P2|COMPLETED|Overall Study||4
8146959|NCT02668432|20077898|P1|COMPLETED|Overall Study||5
8146960|NCT02668432|20077897|P2|STARTED|Overall Study||4
8146961|NCT02668432|20077898|P1|STARTED|Overall Study||5
8146962|NCT02668302|20077936|P2|NOT COMPLETED|Overall Study||0
8146963|NCT02668302|20077937|P1|NOT COMPLETED|Overall Study||1
8146964|NCT02668302|20077936|P2|COMPLETED|Overall Study||20
8146965|NCT02668302|20077937|P1|COMPLETED|Overall Study||19
8146966|NCT02668302|20077936|P2|STARTED|Overall Study||20
8146967|NCT02668302|20077937|P1|STARTED|Overall Study||20
8146968|NCT02668198|20077943|P1|NOT COMPLETED|Overall Study||0
8146969|NCT02668198|20077943|P1|COMPLETED|Overall Study||230
8146970|NCT02668198|20077943|P1|STARTED|Overall Study||230
8146971|NCT02667951|20077957|P2|NOT COMPLETED|Overall Study||23
8146972|NCT02667951|20077958|P1|NOT COMPLETED|Overall Study||21
8146973|NCT02667951|20077957|P2|COMPLETED|Overall Study||40
8146974|NCT02667951|20077958|P1|COMPLETED|Overall Study||45
8146975|NCT02667951|20077957|P2|STARTED|Overall Study||63
8146976|NCT02667951|20077958|P1|STARTED|Overall Study||66
8146977|NCT02667912|20077976|P2|NOT COMPLETED|Overall Study||3
8146978|NCT02667912|20077977|P1|NOT COMPLETED|Overall Study||5
8146979|NCT02667912|20077976|P2|COMPLETED|Overall Study||24
8146980|NCT02667912|20077977|P1|COMPLETED|Overall Study||23
8146981|NCT02667912|20077976|P2|Six Months|Overall Study||24
8146982|NCT02667912|20077977|P1|Six Months|Overall Study||27
8146983|NCT02667912|20077976|P2|STARTED|Overall Study||27
8146984|NCT02667912|20077977|P1|STARTED|Overall Study||28
8146985|NCT02667821|20078029|P1|NOT COMPLETED|Overall Study||0
8146986|NCT02667821|20078029|P1|COMPLETED|Overall Study||20
8146987|NCT02667821|20078029|P1|STARTED|Overall Study||20
8146988|NCT02667704|20078035|P1|NOT COMPLETED|Treatment Period 2||0
8146989|NCT02667704|20078035|P1|COMPLETED|Treatment Period 2||13
8146990|NCT02667704|20078035|P1|STARTED|Treatment Period 2||13
8146991|NCT02667704|20078035|P1|NOT COMPLETED|Treatment Period 1||0
8146992|NCT02667704|20078035|P1|COMPLETED|Treatment Period 1||13
8146993|NCT02667704|20078035|P1|STARTED|Treatment Period 1||13
8146994|NCT02667639|20078048|P2|NOT COMPLETED|Overall Study||0
8146995|NCT02667639|20078049|P1|NOT COMPLETED|Overall Study||0
8146996|NCT02667639|20078048|P2|COMPLETED|Overall Study||10
8146997|NCT02667639|20078049|P1|COMPLETED|Overall Study||25
8146998|NCT02667639|20078048|P2|STARTED|Overall Study||10
8146999|NCT02667639|20078049|P1|STARTED|Overall Study||25
8147000|NCT02667626|20078077|P2|NOT COMPLETED|Overall Study||1
8147001|NCT02667626|20078078|P1|NOT COMPLETED|Overall Study||0
8147002|NCT02667626|20078077|P2|COMPLETED|Overall Study||95
8147003|NCT02667626|20078078|P1|COMPLETED|Overall Study||86
8147004|NCT02667626|20078077|P2|STARTED|Overall Study||96
8147005|NCT02667626|20078078|P1|STARTED|Overall Study||86
8147006|NCT02667457|20078094|P2|NOT COMPLETED|Overall Study||2
8147007|NCT02667457|20078095|P1|NOT COMPLETED|Overall Study||1
8147008|NCT02667457|20078094|P2|COMPLETED|Overall Study||10
8147009|NCT02667457|20078095|P1|COMPLETED|Overall Study||26
8147010|NCT02667457|20078094|P2|Full Analysis Set Population (FAS)|Overall Study||10
8147011|NCT02667457|20078095|P1|Full Analysis Set Population (FAS)|Overall Study||25
8147012|NCT02667457|20078094|P2|Dosed Participants|Overall Study||10
8147013|NCT02667457|20078095|P1|Dosed Participants|Overall Study||26
8147014|NCT02667457|20078094|P2|STARTED|Overall Study||12
8147015|NCT02667457|20078095|P1|STARTED|Overall Study||27
8147016|NCT02667288|20078119|P1|NOT COMPLETED|Overall Study||13
8147017|NCT02667288|20078119|P1|COMPLETED|Overall Study||134
8147018|NCT02667288|20078119|P1|STARTED|Overall Study||147
8147019|NCT02667275|20078126|P2|NOT COMPLETED|Overall Study||15
8147020|NCT02667275|20078127|P1|NOT COMPLETED|Overall Study||11
8147021|NCT02667275|20078126|P2|COMPLETED|Overall Study||228
8147022|NCT02667275|20078127|P1|COMPLETED|Overall Study||233
8147023|NCT02667275|20078126|P2|STARTED|Overall Study||243
8147024|NCT02667275|20078127|P1|STARTED|Overall Study||244
8147025|NCT02667236|20078137|P2|NOT COMPLETED|Overall Study||1
8147026|NCT02667236|20078138|P1|NOT COMPLETED|Overall Study||3
8147027|NCT02667236|20078137|P2|COMPLETED|Overall Study||226
8147028|NCT02667236|20078138|P1|COMPLETED|Overall Study||220
8147029|NCT02667236|20078137|P2|STARTED|Overall Study||227
8147030|NCT02667236|20078138|P1|STARTED|Overall Study||223
8147031|NCT02666950|20078146|P1|NOT COMPLETED|Overall Study||0
8147032|NCT02666950|20078146|P1|COMPLETED|Overall Study||3
8147033|NCT02666950|20078146|P1|STARTED|Overall Study||3
8147034|NCT02666846|20078159|P3|NOT COMPLETED|Overall Study||0
8147035|NCT02666846|20078160|P2|NOT COMPLETED|Overall Study||0
8147036|NCT02666846|20078161|P1|NOT COMPLETED|Overall Study||0
8147037|NCT02666846|20078159|P3|COMPLETED|Overall Study||20
8147038|NCT02666846|20078160|P2|COMPLETED|Overall Study||20
8147039|NCT02666846|20078161|P1|COMPLETED|Overall Study||20
8147040|NCT02666846|20078159|P3|STARTED|Overall Study||20
8147041|NCT02666846|20078160|P2|STARTED|Overall Study||20
8147042|NCT02666846|20078161|P1|STARTED|Overall Study||20
8147043|NCT02666664|20078260|P2|NOT COMPLETED|Overall Study||84
8147044|NCT02666664|20078261|P1|NOT COMPLETED|Overall Study||36
8147045|NCT02666664|20078260|P2|COMPLETED|Overall Study||1404
8147046|NCT02666664|20078261|P1|COMPLETED|Overall Study||706
8147047|NCT02666664|20078260|P2|STARTED|Overall Study||1488
8147048|NCT02666664|20078261|P1|STARTED|Overall Study||742
8147049|NCT02666560|20078325|P2|NOT COMPLETED|Condition 2 (1 Day)||0
8147050|NCT02666560|20078326|P1|NOT COMPLETED|Condition 2 (1 Day)||0
8147051|NCT02666560|20078325|P2|COMPLETED|Condition 2 (1 Day)||11
8147052|NCT02666560|20078326|P1|COMPLETED|Condition 2 (1 Day)||8
8147053|NCT02666560|20078325|P2|STARTED|Condition 2 (1 Day)||11
8147054|NCT02666560|20078326|P1|STARTED|Condition 2 (1 Day)||8
8147055|NCT02666560|20078325|P2|NOT COMPLETED|Condition 1 (1 Day)||0
8147056|NCT02666560|20078326|P1|NOT COMPLETED|Condition 1 (1 Day)||0
8147057|NCT02666560|20078325|P2|COMPLETED|Condition 1 (1 Day)||11
8147058|NCT02666560|20078326|P1|COMPLETED|Condition 1 (1 Day)||8
8147059|NCT02666560|20078325|P2|STARTED|Condition 1 (1 Day)||11
8147060|NCT02666560|20078326|P1|STARTED|Condition 1 (1 Day)||8
8147061|NCT02666508|20078344|P2|NOT COMPLETED|Overall Study||0
8147062|NCT02666508|20078345|P1|NOT COMPLETED|Overall Study||0
8147063|NCT02666508|20078344|P2|COMPLETED|Overall Study||30
8147064|NCT02666508|20078345|P1|COMPLETED|Overall Study||31
8147065|NCT02666508|20078344|P2|STARTED|Overall Study||30
8147066|NCT02666508|20078345|P1|STARTED|Overall Study||31
8147067|NCT02666430|20078359|P2|NOT COMPLETED|Period 3||0
8147068|NCT02666430|20078360|P1|NOT COMPLETED|Period 3||1
8147069|NCT02666430|20078359|P2|COMPLETED|Period 3||58
8147070|NCT02666430|20078360|P1|COMPLETED|Period 3||61
8147071|NCT02666430|20078359|P2|STARTED|Period 3||58
8147072|NCT02666430|20078360|P1|STARTED|Period 3||62
8147073|NCT02666430|20078359|P2|NOT COMPLETED|Period 2||4
8147074|NCT02666430|20078360|P1|NOT COMPLETED|Period 2||1
8147075|NCT02666430|20078359|P2|COMPLETED|Period 2||58
8147076|NCT02666430|20078360|P1|COMPLETED|Period 2||62
8147077|NCT02666430|20078359|P2|STARTED|Period 2||62
8147078|NCT02666430|20078360|P1|STARTED|Period 2||63
8147079|NCT02666430|20078359|P2|NOT COMPLETED|Period 1||1
8147080|NCT02666430|20078360|P1|NOT COMPLETED|Period 1||1
8147081|NCT02666430|20078359|P2|COMPLETED|Period 1||62
8147082|NCT02666430|20078360|P1|COMPLETED|Period 1||63
8147083|NCT02666430|20078359|P2|STARTED|Period 1||63
8147084|NCT02666430|20078360|P1|STARTED|Period 1||64
8147085|NCT02666430|20078359|P2|NOT COMPLETED|Baseline||0
8147086|NCT02666430|20078360|P1|NOT COMPLETED|Baseline||0
8147087|NCT02666430|20078359|P2|COMPLETED|Baseline||63
8147088|NCT02666430|20078360|P1|COMPLETED|Baseline||64
8147089|NCT02666430|20078359|P2|STARTED|Baseline||63
8147090|NCT02666430|20078360|P1|STARTED|Baseline||64
8147091|NCT02666352|20078389|P3|NOT COMPLETED|Overall Study||0
8147092|NCT02666352|20078390|P2|NOT COMPLETED|Overall Study||0
8147093|NCT02666352|20078391|P1|NOT COMPLETED|Overall Study||0
8147094|NCT02666352|20078389|P3|COMPLETED|Overall Study||8
8147095|NCT02666352|20078390|P2|COMPLETED|Overall Study||8
8147096|NCT02666352|20078391|P1|COMPLETED|Overall Study||8
8147097|NCT02666352|20078389|P3|STARTED|Overall Study||8
8147098|NCT02666352|20078390|P2|STARTED|Overall Study||8
8147099|NCT02666352|20078391|P1|STARTED|Overall Study||8
8147100|NCT02666222|20078495|P1|NOT COMPLETED|Overall Study||2
8147101|NCT02666222|20078495|P1|COMPLETED|Overall Study||49
8147102|NCT02666222|20078495|P1|STARTED|Overall Study||51
8147103|NCT02665741|20078506|P3|NOT COMPLETED|Overall Study||0
8147104|NCT02665741|20078507|P2|NOT COMPLETED|Overall Study||0
8147105|NCT02665741|20078508|P1|NOT COMPLETED|Overall Study||0
8147106|NCT02665741|20078506|P3|COMPLETED|Overall Study||42
8147107|NCT02665741|20078507|P2|COMPLETED|Overall Study||42
8147108|NCT02665741|20078508|P1|COMPLETED|Overall Study||42
8147109|NCT02665741|20078506|P3|STARTED|Overall Study||42
8147110|NCT02665741|20078507|P2|STARTED|Overall Study||42
8147111|NCT02665741|20078508|P1|STARTED|Overall Study||42
8147112|NCT02665728|20078525|P1|NOT COMPLETED|Overall Study||0
8147113|NCT02665728|20078525|P1|COMPLETED|Overall Study||33
8147114|NCT02665728|20078525|P1|STARTED|Overall Study||33
8147115|NCT02665689|20078531|P2|NOT COMPLETED|Overall Study||2
8147116|NCT02665689|20078532|P1|NOT COMPLETED|Overall Study||2
8147117|NCT02665689|20078531|P2|COMPLETED|Overall Study||0
8147118|NCT02665689|20078532|P1|COMPLETED|Overall Study||0
8147119|NCT02665689|20078531|P2|STARTED|Overall Study||2
8147120|NCT02665689|20078532|P1|STARTED|Overall Study||2
8147121|NCT02665468|20078554|P2|NOT COMPLETED|Overall Study||0
8147122|NCT02665468|20078555|P1|NOT COMPLETED|Overall Study||0
8147123|NCT02665468|20078554|P2|COMPLETED|Overall Study||601
8147124|NCT02665468|20078555|P1|COMPLETED|Overall Study||595
8147125|NCT02665468|20078554|P2|STARTED|Overall Study||601
8147126|NCT02665468|20078555|P1|STARTED|Overall Study||595
8147127|NCT02665455|20078567|P1|NOT COMPLETED|Overall Study||9
8147128|NCT02665455|20078567|P1|COMPLETED|Overall Study||74
8147129|NCT02665455|20078567|P1|STARTED|Overall Study||83
8147130|NCT02665364|20078573|P2|NOT COMPLETED|Overall Study||9
8147131|NCT02665364|20078574|P1|NOT COMPLETED|Overall Study||6
8147132|NCT02665364|20078573|P2|COMPLETED|Overall Study||84
8147133|NCT02665364|20078574|P1|COMPLETED|Overall Study||85
8147134|NCT02665364|20078573|P2|STARTED|Overall Study||93
8147135|NCT02665364|20078574|P1|STARTED|Overall Study||91
8147136|NCT02665286|20078611|P3|NOT COMPLETED|Overall Study||1
8147137|NCT02665286|20078612|P2|NOT COMPLETED|Overall Study||2
8147138|NCT02665286|20078613|P1|NOT COMPLETED|Overall Study||3
8147139|NCT02665286|20078611|P3|COMPLETED|Overall Study||80
8147140|NCT02665286|20078612|P2|COMPLETED|Overall Study||78
8147141|NCT02665286|20078613|P1|COMPLETED|Overall Study||76
8147142|NCT02665286|20078611|P3|STARTED|Overall Study||81
8147143|NCT02665286|20078612|P2|STARTED|Overall Study||80
8147144|NCT02665286|20078613|P1|STARTED|Overall Study||79
8147145|NCT02665273|20078632|P2|NOT COMPLETED|Overall Study||0
8147146|NCT02665273|20078633|P1|NOT COMPLETED|Overall Study||0
8147147|NCT02665273|20078632|P2|COMPLETED|Overall Study||15
8147148|NCT02665273|20078633|P1|COMPLETED|Overall Study||13
8147149|NCT02665273|20078632|P2|STARTED|Overall Study||15
8147150|NCT02665273|20078633|P1|STARTED|Overall Study||13
8147151|NCT02665260|20078649|P4|NOT COMPLETED|Overall Study||1
8147152|NCT02665260|20078650|P3|NOT COMPLETED|Overall Study||4
8147153|NCT02665260|20078651|P2|NOT COMPLETED|Overall Study||1
8147154|NCT02665260|20078652|P1|NOT COMPLETED|Overall Study||2
8147155|NCT02665260|20078649|P4|COMPLETED|Overall Study||21
8147156|NCT02665260|20078650|P3|COMPLETED|Overall Study||21
8147157|NCT02665260|20078651|P2|COMPLETED|Overall Study||22
8147158|NCT02665260|20078652|P1|COMPLETED|Overall Study||22
8147159|NCT02665260|20078649|P4|STARTED|Overall Study||22
8147160|NCT02665260|20078650|P3|STARTED|Overall Study||25
8147161|NCT02665260|20078651|P2|STARTED|Overall Study||23
8147162|NCT02665260|20078652|P1|STARTED|Overall Study||24
8147163|NCT02665221|20078668|P2|NOT COMPLETED|Overall Study||15
8147164|NCT02665221|20078669|P1|NOT COMPLETED|Overall Study||15
8147165|NCT02665221|20078668|P2|COMPLETED|Overall Study||0
8147166|NCT02665221|20078669|P1|COMPLETED|Overall Study||0
8147167|NCT02665221|20078668|P2|STARTED|Overall Study||15
8147168|NCT02665221|20078669|P1|STARTED|Overall Study||15
8147169|NCT02664987|20078681|P1|NOT COMPLETED|Overall Study||0
8147170|NCT02664987|20078681|P1|COMPLETED|Overall Study||462
8147171|NCT02664987|20078681|P1|STARTED|Overall Study||462
8147172|NCT02664961|20078690|P1|NOT COMPLETED|Overall Study||0
8147173|NCT02664961|20078690|P1|COMPLETED|Overall Study||3
8147174|NCT02664961|20078690|P1|STARTED|Overall Study||3
8147175|NCT02664922|20078703|P4|NOT COMPLETED|Overall Study||0
8147176|NCT02664922|20078704|P3|NOT COMPLETED|Overall Study||0
8147177|NCT02664922|20078705|P2|NOT COMPLETED|Overall Study||0
8147178|NCT02664922|20078706|P1|NOT COMPLETED|Overall Study||1
8147179|NCT02664922|20078703|P4|COMPLETED|Overall Study||5
8147180|NCT02664922|20078704|P3|COMPLETED|Overall Study||7
8147181|NCT02664922|20078705|P2|COMPLETED|Overall Study||12
8147182|NCT02664922|20078706|P1|COMPLETED|Overall Study||10
8147183|NCT02664922|20078703|P4|STARTED|Overall Study||5
8147184|NCT02664922|20078704|P3|STARTED|Overall Study||7
8147185|NCT02664922|20078705|P2|STARTED|Overall Study||12
8147186|NCT02664922|20078706|P1|STARTED|Overall Study||11
8147187|NCT02664610|20078738|P2|NOT COMPLETED|Overall Study||7
8147188|NCT02664610|20078739|P1|NOT COMPLETED|Overall Study||14
8147189|NCT02664610|20078738|P2|COMPLETED|Overall Study||41
8147190|NCT02664610|20078739|P1|COMPLETED|Overall Study||32
8147191|NCT02664610|20078738|P2|STARTED|Overall Study||48
8147192|NCT02664610|20078739|P1|STARTED|Overall Study||46
8147193|NCT02664532|20078749|P2|NOT COMPLETED|Overall Study||0
8147194|NCT02664532|20078750|P1|NOT COMPLETED|Overall Study||0
8147195|NCT02664532|20078749|P2|COMPLETED|Overall Study||75
8147196|NCT02664532|20078750|P1|COMPLETED|Overall Study||75
8147197|NCT02664532|20078749|P2|STARTED|Overall Study||75
8147198|NCT02664532|20078750|P1|STARTED|Overall Study||75
8147199|NCT02664415|20078764|P2|NOT COMPLETED|Overall Study||0
8147200|NCT02664415|20078765|P1|NOT COMPLETED|Overall Study||1
8147201|NCT02664415|20078764|P2|COMPLETED|Overall Study||5
8147202|NCT02664415|20078765|P1|COMPLETED|Overall Study||13
8147203|NCT02664415|20078764|P2|STARTED|Overall Study||5
8147204|NCT02664415|20078765|P1|STARTED|Overall Study||14
8147205|NCT02664363|20078793|P1|NOT COMPLETED|Overall Study||0
8147206|NCT02664363|20078793|P1|COMPLETED|Overall Study||3
8147207|NCT02664363|20078793|P1|STARTED|Overall Study||3
8147208|NCT02664311|20078800|P2|NOT COMPLETED|Overall Study||0
8147209|NCT02664311|20078801|P1|NOT COMPLETED|Overall Study||0
8147210|NCT02664311|20078800|P2|COMPLETED|Overall Study||3
8147211|NCT02664311|20078801|P1|COMPLETED|Overall Study||6
8147212|NCT02664311|20078800|P2|STARTED|Overall Study||3
8147213|NCT02664311|20078801|P1|STARTED|Overall Study||6
8147214|NCT02664272|20078811|P1|NOT COMPLETED|Overall Study||2
8147215|NCT02664272|20078811|P1|COMPLETED|Overall Study||38
8147216|NCT02664272|20078811|P1|STARTED|Overall Study||40
8147217|NCT02664220|20078819|P2|NOT COMPLETED|Overall Study||0
8147218|NCT02664220|20078820|P1|NOT COMPLETED|Overall Study||0
8147219|NCT02664220|20078819|P2|COMPLETED|Overall Study||50
8147220|NCT02664220|20078820|P1|COMPLETED|Overall Study||50
8147221|NCT02664220|20078819|P2|STARTED|Overall Study||50
8147222|NCT02664220|20078820|P1|STARTED|Overall Study||50
8147223|NCT02664181|20078834|P2|NOT COMPLETED|Overall Study||0
8147224|NCT02664181|20078835|P1|NOT COMPLETED|Overall Study||0
8147225|NCT02664181|20078834|P2|COMPLETED|Overall Study||5
8147226|NCT02664181|20078835|P1|COMPLETED|Overall Study||8
8147227|NCT02664181|20078834|P2|STARTED|Overall Study||5
8147228|NCT02664181|20078835|P1|STARTED|Overall Study||8
8147229|NCT02663882|20078847|P2|NOT COMPLETED|Overall Study||2
8147230|NCT02663882|20078848|P1|NOT COMPLETED|Overall Study||4
8147231|NCT02663882|20078847|P2|COMPLETED|Overall Study||34
8147232|NCT02663882|20078848|P1|COMPLETED|Overall Study||35
8147233|NCT02663882|20078847|P2|STARTED|Overall Study||36
8147234|NCT02663882|20078848|P1|STARTED|Overall Study||39
8147235|NCT02663817|20078860|P1|NOT COMPLETED|Overall Study||2
8147236|NCT02663817|20078860|P1|COMPLETED|Overall Study||50
8147237|NCT02663817|20078860|P1|STARTED|Overall Study||52
8147238|NCT02663752|20078866|P1|NOT COMPLETED|Overall Study||0
8147239|NCT02663752|20078866|P1|COMPLETED|Overall Study||1
8147240|NCT02663752|20078866|P1|STARTED|Overall Study||1
8147241|NCT02663687|20078880|P5|NOT COMPLETED|Overall Study||0
8147242|NCT02663687|20078881|P4|NOT COMPLETED|Overall Study||0
8147243|NCT02663687|20078882|P3|NOT COMPLETED|Overall Study||1
8147244|NCT02663687|20078883|P2|NOT COMPLETED|Overall Study||0
8147245|NCT02663687|20078884|P1|NOT COMPLETED|Overall Study||2
8147246|NCT02663687|20078880|P5|COMPLETED|Overall Study||9
8147247|NCT02663687|20078881|P4|COMPLETED|Overall Study||9
8147248|NCT02663687|20078882|P3|COMPLETED|Overall Study||8
8147249|NCT02663687|20078883|P2|COMPLETED|Overall Study||9
8147250|NCT02663687|20078884|P1|COMPLETED|Overall Study||10
8147251|NCT02663687|20078880|P5|Treatment Period 2 (SC)|Overall Study||9
8147252|NCT02663687|20078881|P4|Treatment Period 2 (SC)|Overall Study||9
8147253|NCT02663687|20078882|P3|Treatment Period 2 (SC)|Overall Study||8
8147254|NCT02663687|20078883|P2|Treatment Period 2 (SC)|Overall Study||9
8147255|NCT02663687|20078884|P1|Treatment Period 2 (SC)|Overall Study||10
8147256|NCT02663687|20078880|P5|Treatment Period 1 (IV)|Overall Study||9
8147257|NCT02663687|20078881|P4|Treatment Period 1 (IV)|Overall Study||9
8147258|NCT02663687|20078882|P3|Treatment Period 1 (IV)|Overall Study||9
8147259|NCT02663687|20078883|P2|Treatment Period 1 (IV)|Overall Study||9
8147260|NCT02663687|20078884|P1|Treatment Period 1 (IV)|Overall Study||12
8147261|NCT02663687|20078880|P5|STARTED|Overall Study||9
8147262|NCT02663687|20078881|P4|STARTED|Overall Study||9
8147263|NCT02663687|20078882|P3|STARTED|Overall Study||9
8147264|NCT02663687|20078883|P2|STARTED|Overall Study||9
8147265|NCT02663687|20078884|P1|STARTED|Overall Study||12
8147266|NCT02663674|20078938|P2|NOT COMPLETED|Overall Study||10
8147267|NCT02663674|20078939|P1|NOT COMPLETED|Overall Study||7
8147268|NCT02663674|20078938|P2|COMPLETED|Overall Study||29
8147269|NCT02663674|20078939|P1|COMPLETED|Overall Study||26
8147270|NCT02663674|20078938|P2|STARTED|Overall Study||39
8147271|NCT02663674|20078939|P1|STARTED|Overall Study||33
8147272|NCT02663453|20079203|P2|NOT COMPLETED|Overall Study||4
8147273|NCT02663453|20079204|P1|NOT COMPLETED|Overall Study||5
8147274|NCT02663453|20079203|P2|COMPLETED|Overall Study||18
8147275|NCT02663453|20079204|P1|COMPLETED|Overall Study||17
8147276|NCT02663453|20079203|P2|STARTED|Overall Study||22
8147277|NCT02663453|20079204|P1|STARTED|Overall Study||22
8147278|NCT02663232|20079226|P1|NOT COMPLETED|Overall Study||0
8147279|NCT02663232|20079226|P1|COMPLETED|Overall Study||264
8147280|NCT02663232|20079226|P1|STARTED|Overall Study||264
8147281|NCT02663128|20079249|P6|NOT COMPLETED|Period 3||0
8147282|NCT02663128|20079250|P5|NOT COMPLETED|Period 3||0
8147283|NCT02663128|20079251|P4|NOT COMPLETED|Period 3||0
8147284|NCT02663128|20079252|P3|NOT COMPLETED|Period 3||0
8147285|NCT02663128|20079253|P2|NOT COMPLETED|Period 3||0
8147286|NCT02663128|20079254|P1|NOT COMPLETED|Period 3||0
8147287|NCT02663128|20079249|P6|COMPLETED|Period 3||3
8147288|NCT02663128|20079250|P5|COMPLETED|Period 3||2
8147289|NCT02663128|20079251|P4|COMPLETED|Period 3||3
8147290|NCT02663128|20079252|P3|COMPLETED|Period 3||3
8147291|NCT02663128|20079253|P2|COMPLETED|Period 3||3
8147292|NCT02663128|20079254|P1|COMPLETED|Period 3||3
8147293|NCT02663128|20079249|P6|STARTED|Period 3||3
8147294|NCT02663128|20079250|P5|STARTED|Period 3||2
8147295|NCT02663128|20079251|P4|STARTED|Period 3||3
8147296|NCT02663128|20079252|P3|STARTED|Period 3||3
8147297|NCT02663128|20079253|P2|STARTED|Period 3||3
8147298|NCT02663128|20079254|P1|STARTED|Period 3||3
8147299|NCT02663128|20079249|P6|NOT COMPLETED|Period 2||0
8147300|NCT02663128|20079250|P5|NOT COMPLETED|Period 2||1
8147301|NCT02663128|20079251|P4|NOT COMPLETED|Period 2||0
8147302|NCT02663128|20079252|P3|NOT COMPLETED|Period 2||0
8147303|NCT02663128|20079253|P2|NOT COMPLETED|Period 2||0
8147304|NCT02663128|20079254|P1|NOT COMPLETED|Period 2||0
8147305|NCT02663128|20079249|P6|COMPLETED|Period 2||3
8147306|NCT02663128|20079250|P5|COMPLETED|Period 2||2
8147307|NCT02663128|20079251|P4|COMPLETED|Period 2||3
8147308|NCT02663128|20079252|P3|COMPLETED|Period 2||3
8147309|NCT02663128|20079253|P2|COMPLETED|Period 2||3
8147310|NCT02663128|20079254|P1|COMPLETED|Period 2||3
8147311|NCT02663128|20079249|P6|STARTED|Period 2||3
8147312|NCT02663128|20079250|P5|STARTED|Period 2||3
8147313|NCT02663128|20079251|P4|STARTED|Period 2||3
8147314|NCT02663128|20079252|P3|STARTED|Period 2||3
8147315|NCT02663128|20079253|P2|STARTED|Period 2||3
8147316|NCT02663128|20079254|P1|STARTED|Period 2||3
8147317|NCT02663128|20079249|P6|NOT COMPLETED|Period 1||0
8147318|NCT02663128|20079250|P5|NOT COMPLETED|Period 1||0
8147319|NCT02663128|20079251|P4|NOT COMPLETED|Period 1||0
8147320|NCT02663128|20079252|P3|NOT COMPLETED|Period 1||0
8147321|NCT02663128|20079253|P2|NOT COMPLETED|Period 1||0
8147322|NCT02663128|20079254|P1|NOT COMPLETED|Period 1||0
8147323|NCT02663128|20079249|P6|COMPLETED|Period 1||3
8147324|NCT02663128|20079250|P5|COMPLETED|Period 1||3
8147325|NCT02663128|20079251|P4|COMPLETED|Period 1||3
8147326|NCT02663128|20079252|P3|COMPLETED|Period 1||3
8147327|NCT02663128|20079253|P2|COMPLETED|Period 1||3
8147328|NCT02663128|20079254|P1|COMPLETED|Period 1||3
8147329|NCT02663128|20079249|P6|Received at Least One Dose of Study Drug|Period 1||3
8147330|NCT02663128|20079250|P5|Received at Least One Dose of Study Drug|Period 1||3
8147331|NCT02663128|20079251|P4|Received at Least One Dose of Study Drug|Period 1||3
8147332|NCT02663128|20079252|P3|Received at Least One Dose of Study Drug|Period 1||3
8147333|NCT02663128|20079253|P2|Received at Least One Dose of Study Drug|Period 1||3
8147334|NCT02663128|20079254|P1|Received at Least One Dose of Study Drug|Period 1||3
8147335|NCT02663128|20079249|P6|STARTED|Period 1||3
8147336|NCT02663128|20079250|P5|STARTED|Period 1||3
8147337|NCT02663128|20079251|P4|STARTED|Period 1||3
8147338|NCT02663128|20079252|P3|STARTED|Period 1||3
8147339|NCT02663128|20079253|P2|STARTED|Period 1||3
8147340|NCT02663128|20079254|P1|STARTED|Period 1||3
8147341|NCT02662764|20079268|P1|NOT COMPLETED|Overall Study||30
8147342|NCT02662764|20079268|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
8147343|NCT02662764|20079268|P1|STARTED|Overall Study||320
8147344|NCT02662608|20079328|P1|NOT COMPLETED|Overall Study||0
8147345|NCT02662608|20079328|P1|COMPLETED|Overall Study||1
8147346|NCT02662608|20079328|P1|STARTED|Overall Study||1
8147347|NCT02662569|20079336|P4|NOT COMPLETED|Overall Study||4
8147348|NCT02662569|20079337|P3|NOT COMPLETED|Overall Study||6
8147349|NCT02662569|20079338|P2|NOT COMPLETED|Overall Study||1
8147350|NCT02662569|20079339|P1|NOT COMPLETED|Overall Study||7
8147351|NCT02662569|20079336|P4|COMPLETED|Overall Study||328
8147352|NCT02662569|20079337|P3|COMPLETED|Overall Study||321
8147353|NCT02662569|20079338|P2|COMPLETED|Overall Study||160
8147354|NCT02662569|20079339|P1|COMPLETED|Overall Study||159
8147355|NCT02662569|20079336|P4|Received Study Drug|Overall Study||332
8147356|NCT02662569|20079337|P3|Received Study Drug|Overall Study||325
8147357|NCT02662569|20079338|P2|Received Study Drug|Overall Study||160
8147358|NCT02662569|20079339|P1|Received Study Drug|Overall Study||164
8147359|NCT02662569|20079336|P4|STARTED|Overall Study||332
8147360|NCT02662569|20079337|P3|STARTED|Overall Study||327
8147361|NCT02662569|20079338|P2|STARTED|Overall Study||161
8147362|NCT02662569|20079339|P1|STARTED|Overall Study||166
8147363|NCT02662556|20079437|P1|NOT COMPLETED|Overall Study||8
8147364|NCT02662556|20079437|P1|COMPLETED|Overall Study||132
8147365|NCT02662556|20079437|P1|STARTED|Overall Study||140
8147366|NCT02662387|20079446|P2|NOT COMPLETED|Overall Study||0
8147367|NCT02662387|20079447|P1|NOT COMPLETED|Overall Study||0
8147368|NCT02662387|20079446|P2|COMPLETED|Overall Study||28
8147369|NCT02662387|20079447|P1|COMPLETED|Overall Study||27
8147370|NCT02662387|20079446|P2|STARTED|Overall Study||28
8147371|NCT02662387|20079447|P1|STARTED|Overall Study||27
8147372|NCT02662244|20079455|P1|NOT COMPLETED|Overall Study||2
8147373|NCT02662244|20079455|P1|COMPLETED|Overall Study||31
8147374|NCT02662244|20079455|P1|STARTED|Overall Study||33
8147375|NCT02662036|20079465|P2|NOT COMPLETED|Overall Study||13
8147376|NCT02662036|20079466|P1|NOT COMPLETED|Overall Study||13
8147377|NCT02662036|20079465|P2|COMPLETED|Overall Study||22
8147378|NCT02662036|20079466|P1|COMPLETED|Overall Study||22
8147379|NCT02662036|20079465|P2|STARTED|Overall Study||35
8147380|NCT02662036|20079466|P1|STARTED|Overall Study||35
8147381|NCT02661828|20079494|P2|NOT COMPLETED|Overall Study||0
8147382|NCT02661828|20079495|P1|NOT COMPLETED|Overall Study||0
8147383|NCT02661828|20079494|P2|COMPLETED|Overall Study||0
8147384|NCT02661828|20079495|P1|COMPLETED|Overall Study||1
8147385|NCT02661828|20079494|P2|STARTED|Overall Study||0
8147386|NCT02661828|20079495|P1|STARTED|Overall Study||1
8147387|NCT02661815|20079506|P4|NOT COMPLETED|Overall Study||0
8147388|NCT02661815|20079507|P3|NOT COMPLETED|Overall Study||0
8147389|NCT02661815|20079508|P2|NOT COMPLETED|Overall Study||0
8147390|NCT02661815|20079509|P1|NOT COMPLETED|Overall Study||1
8147391|NCT02661815|20079506|P4|COMPLETED|Overall Study||0
8147392|NCT02661815|20079507|P3|COMPLETED|Overall Study||0
8147393|NCT02661815|20079508|P2|COMPLETED|Overall Study||0
8147394|NCT02661815|20079509|P1|COMPLETED|Overall Study||5
8147395|NCT02661815|20079506|P4|STARTED|Overall Study||0
8147396|NCT02661815|20079507|P3|STARTED|Overall Study||0
8147397|NCT02661815|20079508|P2|STARTED|Overall Study||0
8147398|NCT02661815|20079509|P1|STARTED|Overall Study||6
8147399|NCT02661737|20079523|P1|NOT COMPLETED|Overall Study||34
8147400|NCT02661737|20079523|P1|COMPLETED|Overall Study||469
8147401|NCT02661737|20079523|P1|STARTED|Overall Study||503
8147402|NCT02661594|20079531|P4|NOT COMPLETED|Overall Study||0
8147403|NCT02661594|20079532|P3|NOT COMPLETED|Overall Study||1
8147404|NCT02661594|20079533|P2|NOT COMPLETED|Overall Study||0
8147405|NCT02661594|20079534|P1|NOT COMPLETED|Overall Study||1
8147406|NCT02661594|20079531|P4|COMPLETED|Overall Study||9
8147407|NCT02661594|20079532|P3|COMPLETED|Overall Study||9
8147408|NCT02661594|20079533|P2|COMPLETED|Overall Study||11
8147409|NCT02661594|20079534|P1|COMPLETED|Overall Study||9
8147410|NCT02661594|20079531|P4|STARTED|Overall Study||9
8147411|NCT02661594|20079532|P3|STARTED|Overall Study||10
8147412|NCT02661594|20079533|P2|STARTED|Overall Study||11
8147413|NCT02661594|20079534|P1|STARTED|Overall Study||10
8147414|NCT02661490|20079549|P5|NOT COMPLETED|Overall Study||3
8147415|NCT02661490|20079550|P4|NOT COMPLETED|Overall Study||1
8147416|NCT02661490|20079551|P3|NOT COMPLETED|Overall Study||2
8147417|NCT02661490|20079552|P2|NOT COMPLETED|Overall Study||2
8147418|NCT02661490|20079553|P1|NOT COMPLETED|Overall Study||3
8147419|NCT02661490|20079549|P5|COMPLETED|Overall Study||23
8147420|NCT02661490|20079550|P4|COMPLETED|Overall Study||71
8147421|NCT02661490|20079551|P3|COMPLETED|Overall Study||70
8147422|NCT02661490|20079552|P2|COMPLETED|Overall Study||72
8147423|NCT02661490|20079553|P1|COMPLETED|Overall Study||73
8147424|NCT02661490|20079549|P5|STARTED|Overall Study||26
8147425|NCT02661490|20079550|P4|STARTED|Overall Study||72
8147426|NCT02661490|20079551|P3|STARTED|Overall Study||72
8147427|NCT02661490|20079552|P2|STARTED|Overall Study||74
8147428|NCT02661490|20079553|P1|STARTED|Overall Study||76
8147429|NCT02661256|20079690|P1|NOT COMPLETED|Overall Study||0
8147430|NCT02661256|20079690|P1|COMPLETED|Overall Study||7
8147431|NCT02661256|20079690|P1|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
8147432|NCT02661178|20079721|P15|NOT COMPLETED|Part 2||0
8147433|NCT02661178|20079722|P14|NOT COMPLETED|Part 2||0
8147434|NCT02661178|20079723|P13|NOT COMPLETED|Part 2||0
8147435|NCT02661178|20079724|P12|NOT COMPLETED|Part 2||0
8147436|NCT02661178|20079725|P11|NOT COMPLETED|Part 2||0
8147437|NCT02661178|20079726|P10|NOT COMPLETED|Part 2||0
8147438|NCT02661178|20079727|P9|NOT COMPLETED|Part 2||0
8147439|NCT02661178|20079728|P8|NOT COMPLETED|Part 2||0
8147440|NCT02661178|20079729|P7|NOT COMPLETED|Part 2||0
8147441|NCT02661178|20079730|P6|NOT COMPLETED|Part 2||0
8147442|NCT02661178|20079731|P5|NOT COMPLETED|Part 2||0
8147443|NCT02661178|20079732|P4|NOT COMPLETED|Part 2||0
8147444|NCT02661178|20079733|P3|NOT COMPLETED|Part 2||0
8147445|NCT02661178|20079734|P2|NOT COMPLETED|Part 2||0
8147446|NCT02661178|20079735|P1|NOT COMPLETED|Part 2||0
8147447|NCT02661178|20079721|P15|COMPLETED|Part 2||2
8147448|NCT02661178|20079722|P14|COMPLETED|Part 2||2
8147449|NCT02661178|20079723|P13|COMPLETED|Part 2||6
8147450|NCT02661178|20079724|P12|COMPLETED|Part 2||6
8147451|NCT02661178|20079725|P11|COMPLETED|Part 2||0
8147452|NCT02661178|20079726|P10|COMPLETED|Part 2||0
8147453|NCT02661178|20079727|P9|COMPLETED|Part 2||0
8147454|NCT02661178|20079728|P8|COMPLETED|Part 2||0
8147455|NCT02661178|20079729|P7|COMPLETED|Part 2||0
8147456|NCT02661178|20079730|P6|COMPLETED|Part 2||0
8147457|NCT02661178|20079731|P5|COMPLETED|Part 2||0
8147458|NCT02661178|20079732|P4|COMPLETED|Part 2||0
8147459|NCT02661178|20079733|P3|COMPLETED|Part 2||0
8147460|NCT02661178|20079734|P2|COMPLETED|Part 2||0
8147461|NCT02661178|20079735|P1|COMPLETED|Part 2||0
8147462|NCT02661178|20079721|P15|STARTED|Part 2||2
8147463|NCT02661178|20079722|P14|STARTED|Part 2||2
8147464|NCT02661178|20079723|P13|STARTED|Part 2||6
8147465|NCT02661178|20079724|P12|STARTED|Part 2||6
8147466|NCT02661178|20079725|P11|STARTED|Part 2||0
8147467|NCT02661178|20079726|P10|STARTED|Part 2||0
8147468|NCT02661178|20079727|P9|STARTED|Part 2||0
8147469|NCT02661178|20079728|P8|STARTED|Part 2||0
8147470|NCT02661178|20079729|P7|STARTED|Part 2||0
8147471|NCT02661178|20079730|P6|STARTED|Part 2||0
8147472|NCT02661178|20079731|P5|STARTED|Part 2||0
8147473|NCT02661178|20079732|P4|STARTED|Part 2||0
8147474|NCT02661178|20079733|P3|STARTED|Part 2||0
8147475|NCT02661178|20079734|P2|STARTED|Part 2||0
8147476|NCT02661178|20079735|P1|STARTED|Part 2||0
8147477|NCT02661178|20079721|P15|NOT COMPLETED|Part 1||0
8147478|NCT02661178|20079722|P14|NOT COMPLETED|Part 1||0
8147479|NCT02661178|20079723|P13|NOT COMPLETED|Part 1||0
8147480|NCT02661178|20079724|P12|NOT COMPLETED|Part 1||0
8147481|NCT02661178|20079725|P11|NOT COMPLETED|Part 1||0
8147482|NCT02661178|20079726|P10|NOT COMPLETED|Part 1||0
8147483|NCT02661178|20079727|P9|NOT COMPLETED|Part 1||0
8147484|NCT02661178|20079728|P8|NOT COMPLETED|Part 1||0
8147485|NCT02661178|20079729|P7|NOT COMPLETED|Part 1||0
8147486|NCT02661178|20079730|P6|NOT COMPLETED|Part 1||0
8147487|NCT02661178|20079731|P5|NOT COMPLETED|Part 1||0
8147488|NCT02661178|20079732|P4|NOT COMPLETED|Part 1||0
8147489|NCT02661178|20079733|P3|NOT COMPLETED|Part 1||0
8147490|NCT02661178|20079734|P2|NOT COMPLETED|Part 1||0
8147491|NCT02661178|20079735|P1|NOT COMPLETED|Part 1||1
8147492|NCT02661178|20079721|P15|COMPLETED|Part 1||0
8147493|NCT02661178|20079722|P14|COMPLETED|Part 1||0
8147494|NCT02661178|20079723|P13|COMPLETED|Part 1||0
8147495|NCT02661178|20079724|P12|COMPLETED|Part 1||0
8147496|NCT02661178|20079725|P11|COMPLETED|Part 1||4
8147497|NCT02661178|20079726|P10|COMPLETED|Part 1||12
8147498|NCT02661178|20079727|P9|COMPLETED|Part 1||6
8147499|NCT02661178|20079728|P8|COMPLETED|Part 1||6
8147500|NCT02661178|20079729|P7|COMPLETED|Part 1||6
8147501|NCT02661178|20079730|P6|COMPLETED|Part 1||6
8147502|NCT02661178|20079731|P5|COMPLETED|Part 1||5
8147503|NCT02661178|20079732|P4|COMPLETED|Part 1||6
8147504|NCT02661178|20079733|P3|COMPLETED|Part 1||6
8147505|NCT02661178|20079734|P2|COMPLETED|Part 1||5
8147506|NCT02661178|20079735|P1|COMPLETED|Part 1||0
8147507|NCT02661178|20079721|P15|STARTED|Part 1||0
8147508|NCT02661178|20079722|P14|STARTED|Part 1||0
8147509|NCT02661178|20079723|P13|STARTED|Part 1||0
8147510|NCT02661178|20079724|P12|STARTED|Part 1||0
8147511|NCT02661178|20079725|P11|STARTED|Part 1||4
8147512|NCT02661178|20079726|P10|STARTED|Part 1||12
8147513|NCT02661178|20079727|P9|STARTED|Part 1||6
8147514|NCT02661178|20079728|P8|STARTED|Part 1||6
8147515|NCT02661178|20079729|P7|STARTED|Part 1||6
8147516|NCT02661178|20079730|P6|STARTED|Part 1||6
8147517|NCT02661178|20079731|P5|STARTED|Part 1||5
8147518|NCT02661178|20079732|P4|STARTED|Part 1||6
8147519|NCT02661178|20079733|P3|STARTED|Part 1||6
8147520|NCT02661178|20079734|P2|STARTED|Part 1||5
8147521|NCT02661178|20079735|P1|STARTED|Part 1||1
8147522|NCT02661126|20080002|P2|NOT COMPLETED|Overall Study||0
8147523|NCT02661126|20080003|P1|NOT COMPLETED|Overall Study||0
8147524|NCT02661126|20080002|P2|COMPLETED|Overall Study||8
8147525|NCT02661126|20080003|P1|COMPLETED|Overall Study||8
8147526|NCT02661126|20080002|P2|STARTED|Overall Study||8
8147527|NCT02661126|20080003|P1|STARTED|Overall Study||8
8147528|NCT02661061|20080093|P2|NOT COMPLETED|Overall Study||2
8147529|NCT02661061|20080094|P1|NOT COMPLETED|Overall Study||2
8147530|NCT02661061|20080093|P2|COMPLETED|Overall Study||2
8147531|NCT02661061|20080094|P1|COMPLETED|Overall Study||3
8147532|NCT02661061|20080093|P2|STARTED|Overall Study||4
8147533|NCT02661061|20080094|P1|STARTED|Overall Study||5
8147534|NCT02660983|20080104|P2|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
8147535|NCT02660983|20080105|P1|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
8147536|NCT02660983|20080104|P2|COMPLETED|Open Label Extension Phase (24 Weeks)||66
8147537|NCT02660983|20080105|P1|COMPLETED|Open Label Extension Phase (24 Weeks)||83
8147538|NCT02660983|20080104|P2|Safety Set|Open Label Extension Phase (24 Weeks)||75
8147539|NCT02660983|20080105|P1|Safety Set|Open Label Extension Phase (24 Weeks)||86
8147540|NCT02660983|20080104|P2|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
8147541|NCT02660983|20080105|P1|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
8147542|NCT02660983|20080104|P2|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
8147543|NCT02660983|20080105|P1|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
8147544|NCT02660983|20080104|P2|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
8147545|NCT02660983|20080105|P1|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
8147546|NCT02660983|20080104|P2|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
8147547|NCT02660983|20080105|P1|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
8147548|NCT02660983|20080104|P2|STARTED|Double-blind (DB) Phase (24 Weeks)||148
8147549|NCT02660983|20080105|P1|STARTED|Double-blind (DB) Phase (24 Weeks)||154
8147550|NCT02660918|20080120|P2|NOT COMPLETED|Overall Study||1
8147551|NCT02660918|20080121|P1|NOT COMPLETED|Overall Study||1
8147552|NCT02660918|20080120|P2|COMPLETED|Overall Study|Age ineligible|41
8147553|NCT02660918|20080121|P1|COMPLETED|Overall Study|Age ineligible|41
8147554|NCT02660918|20080120|P2|STARTED|Overall Study||42
8147555|NCT02660918|20080121|P1|STARTED|Overall Study||42
8147556|NCT02660853|20080143|P1|NOT COMPLETED|Overall Study||0
8147557|NCT02660853|20080143|P1|COMPLETED|Overall Study||25
8147558|NCT02660853|20080143|P1|STARTED|Overall Study||25
8147559|NCT02660801|20080154|P2|NOT COMPLETED|Overall Study||0
8147560|NCT02660801|20080155|P1|NOT COMPLETED|Overall Study||0
8147561|NCT02660801|20080154|P2|COMPLETED|Overall Study||15
8147562|NCT02660801|20080155|P1|COMPLETED|Overall Study||11
8147563|NCT02660801|20080154|P2|STARTED|Overall Study||15
8147564|NCT02660801|20080155|P1|STARTED|Overall Study||11
8147565|NCT02660580|20080171|P5|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
8147566|NCT02660580|20080172|P4|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
8147567|NCT02660580|20080173|P3|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
8147568|NCT02660580|20080174|P2|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147569|NCT02660580|20080175|P1|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147570|NCT02660580|20080171|P5|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
8147571|NCT02660580|20080172|P4|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
8147572|NCT02660580|20080173|P3|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
8147573|NCT02660580|20080174|P2|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147574|NCT02660580|20080175|P1|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147575|NCT02660580|20080171|P5|STARTED|Extended Treatment Period(Week 16 to 52)||101
8147576|NCT02660580|20080172|P4|STARTED|Extended Treatment Period(Week 16 to 52)||101
8147577|NCT02660580|20080173|P3|STARTED|Extended Treatment Period(Week 16 to 52)||213
8147578|NCT02660580|20080174|P2|STARTED|Extended Treatment Period(Week 16 to 52)||0
8147579|NCT02660580|20080175|P1|STARTED|Extended Treatment Period(Week 16 to 52)||0
8147580|NCT02660580|20080171|P5|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147581|NCT02660580|20080172|P4|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147582|NCT02660580|20080173|P3|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147583|NCT02660580|20080174|P2|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
8147584|NCT02660580|20080175|P1|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
8147585|NCT02660580|20080171|P5|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147586|NCT02660580|20080172|P4|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147587|NCT02660580|20080173|P3|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147588|NCT02660580|20080174|P2|COMPLETED|Core Treatment Period (Week 1 to 16)||202
8147589|NCT02660580|20080175|P1|COMPLETED|Core Treatment Period (Week 1 to 16)||213
8147590|NCT02660580|20080171|P5|Treated|Core Treatment Period (Week 1 to 16)||0
8147591|NCT02660580|20080172|P4|Treated|Core Treatment Period (Week 1 to 16)||0
8147592|NCT02660580|20080173|P3|Treated|Core Treatment Period (Week 1 to 16)||0
8147593|NCT02660580|20080174|P2|Treated|Core Treatment Period (Week 1 to 16)||220
8147594|NCT02660580|20080175|P1|Treated|Core Treatment Period (Week 1 to 16)||221
8147595|NCT02660580|20080171|P5|STARTED|Core Treatment Period (Week 1 to 16)||0
8147596|NCT02660580|20080172|P4|STARTED|Core Treatment Period (Week 1 to 16)||0
8147597|NCT02660580|20080173|P3|STARTED|Core Treatment Period (Week 1 to 16)||0
8147598|NCT02660580|20080174|P2|STARTED|Core Treatment Period (Week 1 to 16)||221
8147599|NCT02660580|20080175|P1|STARTED|Core Treatment Period (Week 1 to 16)||222
8147600|NCT02660528|20080284|P1|NOT COMPLETED|Overall Study||0
8147601|NCT02660528|20080284|P1|COMPLETED|Overall Study||0
8147602|NCT02660528|20080284|P1|STARTED|Overall Study||0
8147603|NCT02660242|20080290|P1|NOT COMPLETED|Glucagon Injection||1
8147604|NCT02660242|20080290|P1|COMPLETED|Glucagon Injection||15
8147605|NCT02660242|20080290|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
8147606|NCT02660242|20080290|P1|NOT COMPLETED|Glucose Tabs||1
8147607|NCT02660242|20080290|P1|COMPLETED|Glucose Tabs||15
8147608|NCT02660242|20080290|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
8147609|NCT02660242|20080290|P1|NOT COMPLETED|Basal Insulin Reduction||0
8147610|NCT02660242|20080290|P1|COMPLETED|Basal Insulin Reduction||16
8147611|NCT02660242|20080290|P1|STARTED|Basal Insulin Reduction||16
8147612|NCT02660242|20080290|P1|NOT COMPLETED|Control||0
8147613|NCT02660242|20080290|P1|COMPLETED|Control||16
8147614|NCT02660242|20080290|P1|STARTED|Control||16
8147615|NCT02660229|20080346|P2|NOT COMPLETED|Overall Study||1
8147616|NCT02660229|20080347|P1|NOT COMPLETED|Overall Study||2
8147617|NCT02660229|20080346|P2|COMPLETED|Overall Study||31
8147618|NCT02660229|20080347|P1|COMPLETED|Overall Study||32
8147619|NCT02660229|20080346|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
8147620|NCT02660229|20080347|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
8147621|NCT02660229|20080346|P2|FAS Set|Overall Study||32
8147622|NCT02660229|20080347|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
8147623|NCT02660229|20080346|P2|Safety Analysis Set|Overall Study||32
8147624|NCT02660229|20080347|P1|Safety Analysis Set|Overall Study||34
8147625|NCT02660229|20080346|P2|STARTED|Overall Study|Randomization|32
8147626|NCT02660229|20080347|P1|STARTED|Overall Study|Randomization|34
8147627|NCT02660112|20080359|P1|NOT COMPLETED|Overall Study||0
8147628|NCT02660112|20080359|P1|COMPLETED|Overall Study||10
8147629|NCT02660112|20080359|P1|STARTED|Overall Study||10
8147630|NCT02659787|20080364|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8147631|NCT02659787|20080365|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8147632|NCT02659787|20080364|P2|COMPLETED|Second Intervention (1 Day)||19
8147633|NCT02659787|20080365|P1|COMPLETED|Second Intervention (1 Day)||19
8147634|NCT02659787|20080364|P2|STARTED|Second Intervention (1 Day)||19
8147635|NCT02659787|20080365|P1|STARTED|Second Intervention (1 Day)||19
8147636|NCT02659787|20080364|P2|NOT COMPLETED|Washout (3 Days)||0
8147637|NCT02659787|20080365|P1|NOT COMPLETED|Washout (3 Days)||0
8147638|NCT02659787|20080364|P2|COMPLETED|Washout (3 Days)||19
8147639|NCT02659787|20080365|P1|COMPLETED|Washout (3 Days)||19
8147640|NCT02659787|20080364|P2|STARTED|Washout (3 Days)||19
8147641|NCT02659787|20080365|P1|STARTED|Washout (3 Days)||19
8147642|NCT02659787|20080364|P2|NOT COMPLETED|First Intervention (1 Day)||0
8147643|NCT02659787|20080365|P1|NOT COMPLETED|First Intervention (1 Day)||0
8147644|NCT02659787|20080364|P2|COMPLETED|First Intervention (1 Day)||19
8147645|NCT02659787|20080365|P1|COMPLETED|First Intervention (1 Day)||19
8147646|NCT02659787|20080364|P2|STARTED|First Intervention (1 Day)||19
8147647|NCT02659787|20080365|P1|STARTED|First Intervention (1 Day)||19
8147648|NCT02659709|20080371|P1|NOT COMPLETED|Overall Study||0
8147649|NCT02659709|20080371|P1|COMPLETED|Overall Study||50
8147650|NCT02659709|20080371|P1|STARTED|Overall Study||50
8147651|NCT02659631|20080388|P10|NOT COMPLETED|Overall Study||0
8147652|NCT02659631|20080389|P9|NOT COMPLETED|Overall Study||2
8147653|NCT02659631|20080390|P8|NOT COMPLETED|Overall Study||3
8147654|NCT02659631|20080391|P7|NOT COMPLETED|Overall Study||1
8147655|NCT02659631|20080392|P6|NOT COMPLETED|Overall Study||3
8147656|NCT02659631|20080393|P5|NOT COMPLETED|Overall Study||5
8147657|NCT02659631|20080394|P4|NOT COMPLETED|Overall Study||2
8147658|NCT02659631|20080395|P3|NOT COMPLETED|Overall Study||3
8147659|NCT02659631|20080396|P2|NOT COMPLETED|Overall Study||2
8147660|NCT02659631|20080397|P1|NOT COMPLETED|Overall Study||1
8147661|NCT02659631|20080388|P10|COMPLETED|Overall Study||1
8147662|NCT02659631|20080389|P9|COMPLETED|Overall Study||0
8147663|NCT02659631|20080390|P8|COMPLETED|Overall Study||0
8147664|NCT02659631|20080391|P7|COMPLETED|Overall Study||3
8147665|NCT02659631|20080392|P6|COMPLETED|Overall Study||2
8147666|NCT02659631|20080393|P5|COMPLETED|Overall Study||0
8147667|NCT02659631|20080394|P4|COMPLETED|Overall Study||0
8147668|NCT02659631|20080395|P3|COMPLETED|Overall Study||0
8147669|NCT02659631|20080396|P2|COMPLETED|Overall Study||0
8147670|NCT02659631|20080397|P1|COMPLETED|Overall Study||0
8147671|NCT02659631|20080388|P10|STARTED|Overall Study||1
8147672|NCT02659631|20080389|P9|STARTED|Overall Study||2
8147673|NCT02659631|20080390|P8|STARTED|Overall Study||3
8147674|NCT02659631|20080391|P7|STARTED|Overall Study||4
8147675|NCT02659631|20080392|P6|STARTED|Overall Study||5
8147676|NCT02659631|20080393|P5|STARTED|Overall Study||5
8147677|NCT02659631|20080394|P4|STARTED|Overall Study||2
8147678|NCT02659631|20080395|P3|STARTED|Overall Study||3
8147679|NCT02659631|20080396|P2|STARTED|Overall Study||2
8147680|NCT02659631|20080397|P1|STARTED|Overall Study||1
8147681|NCT02659540|20080531|P2|NOT COMPLETED|Overall Study||8
8147682|NCT02659540|20080532|P1|NOT COMPLETED|Overall Study||6
8147683|NCT02659540|20080531|P2|COMPLETED|Overall Study||2
8147684|NCT02659540|20080532|P1|COMPLETED|Overall Study||4
8147685|NCT02659540|20080531|P2|STARTED|Overall Study||10
8147686|NCT02659540|20080532|P1|STARTED|Overall Study||10
8147687|NCT02659501|20080548|P2|NOT COMPLETED|Overall Study||0
8147688|NCT02659501|20080549|P1|NOT COMPLETED|Overall Study||0
8147689|NCT02659501|20080548|P2|COMPLETED|Overall Study||12
8147690|NCT02659501|20080549|P1|COMPLETED|Overall Study||12
8147691|NCT02659501|20080548|P2|STARTED|Overall Study||12
8147692|NCT02659501|20080549|P1|STARTED|Overall Study||12
8147693|NCT02659098|20080563|P1|NOT COMPLETED|Overall Study||7
8147694|NCT02659098|20080563|P1|COMPLETED|Overall Study||14
8147695|NCT02659098|20080563|P1|STARTED|Overall Study||21
8147696|NCT02658877|20080594|P2|NOT COMPLETED|Overall Study||0
8147697|NCT02658877|20080595|P1|NOT COMPLETED|Overall Study||0
8147698|NCT02658877|20080594|P2|COMPLETED|Overall Study||0
8147699|NCT02658877|20080595|P1|COMPLETED|Overall Study||3
8147700|NCT02658877|20080594|P2|STARTED|Overall Study||0
8147701|NCT02658877|20080595|P1|STARTED|Overall Study||3
8147702|NCT02658851|20080621|P1|NOT COMPLETED|Overall Study||0
8147703|NCT02658851|20080621|P1|COMPLETED|Overall Study||100
8147704|NCT02658851|20080621|P1|STARTED|Overall Study||100
8147705|NCT02658487|20080625|P1|NOT COMPLETED|Overall Study||16
8147706|NCT02658487|20080625|P1|COMPLETED|Overall Study||26
8147707|NCT02658487|20080625|P1|STARTED|Overall Study||42
8147708|NCT02658461|20080638|P3|NOT COMPLETED|Overall Study||0
8147709|NCT02658461|20080639|P2|NOT COMPLETED|Overall Study||0
8147710|NCT02658461|20080640|P1|NOT COMPLETED|Overall Study||0
8147711|NCT02658461|20080638|P3|COMPLETED|Overall Study||12
8147712|NCT02658461|20080639|P2|COMPLETED|Overall Study||12
8147713|NCT02658461|20080640|P1|COMPLETED|Overall Study||12
8147714|NCT02658461|20080638|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8147715|NCT02658461|20080639|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8147716|NCT02658461|20080640|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8147717|NCT02658357|20080668|P2|NOT COMPLETED|Overall Study||0
8147718|NCT02658357|20080669|P1|NOT COMPLETED|Overall Study||0
8147719|NCT02658357|20080668|P2|COMPLETED|Overall Study||0
8147720|NCT02658357|20080669|P1|COMPLETED|Overall Study||0
8147721|NCT02658357|20080668|P2|STARTED|Overall Study||0
8147722|NCT02658357|20080669|P1|STARTED|Overall Study||0
8147723|NCT02658240|20080681|P2|NOT COMPLETED|Overall Study||0
8147724|NCT02658240|20080682|P1|NOT COMPLETED|Overall Study||0
8147725|NCT02658240|20080681|P2|COMPLETED|Overall Study||30
8147726|NCT02658240|20080682|P1|COMPLETED|Overall Study||30
8147727|NCT02658240|20080681|P2|STARTED|Overall Study||30
8147728|NCT02658240|20080682|P1|STARTED|Overall Study||30
8147729|NCT02658149|20080696|P2|NOT COMPLETED|Overall Study||0
8147730|NCT02658149|20080697|P1|NOT COMPLETED|Overall Study||1
8147731|NCT02658149|20080696|P2|COMPLETED|Overall Study||50
8147732|NCT02658149|20080697|P1|COMPLETED|Overall Study||49
8147733|NCT02658149|20080696|P2|STARTED|Overall Study||50
8147734|NCT02658149|20080697|P1|STARTED|Overall Study||50
8147735|NCT02658084|20080713|P2|NOT COMPLETED|Overall Study||0
8147736|NCT02658084|20080714|P1|NOT COMPLETED|Overall Study||2
8147737|NCT02658084|20080713|P2|COMPLETED|Overall Study||0
8147738|NCT02658084|20080714|P1|COMPLETED|Overall Study||0
8147739|NCT02658084|20080713|P2|STARTED|Overall Study||0
8147740|NCT02658084|20080714|P1|STARTED|Overall Study||2
8147741|NCT02658019|20080723|P1|NOT COMPLETED|Overall Study||1
8147742|NCT02658019|20080723|P1|COMPLETED|Overall Study||28
8147743|NCT02658019|20080723|P1|STARTED|Overall Study||29
8147744|NCT02657928|20080734|P2|NOT COMPLETED|Overall Study||0
8147745|NCT02657928|20080735|P1|NOT COMPLETED|Overall Study||0
8147746|NCT02657928|20080734|P2|COMPLETED|Overall Study||20
8147747|NCT02657928|20080735|P1|COMPLETED|Overall Study||20
8147748|NCT02657928|20080734|P2|STARTED|Overall Study||20
8147749|NCT02657928|20080735|P1|STARTED|Overall Study||20
8147750|NCT02657915|20080751|P2|NOT COMPLETED|Overall Study||0
8147751|NCT02657915|20080752|P1|NOT COMPLETED|Overall Study||0
8147752|NCT02657915|20080751|P2|COMPLETED|Overall Study||28
8147753|NCT02657915|20080752|P1|COMPLETED|Overall Study||24
8147754|NCT02657915|20080751|P2|Per-protocol Population|Overall Study||24
8147755|NCT02657915|20080752|P1|Per-protocol Population|Overall Study||23
8147756|NCT02657915|20080751|P2|Intent-to Treat (ITT) Population|Overall Study||28
8147757|NCT02657915|20080752|P1|Intent-to Treat (ITT) Population|Overall Study||24
8147758|NCT02657915|20080751|P2|STARTED|Overall Study||28
8147759|NCT02657915|20080752|P1|STARTED|Overall Study||24
8147760|NCT02657889|20080776|P4|NOT COMPLETED|Overall Study||55
8147761|NCT02657889|20080777|P3|NOT COMPLETED|Overall Study||53
8147762|NCT02657889|20080778|P2|NOT COMPLETED|Overall Study||7
8147763|NCT02657889|20080779|P1|NOT COMPLETED|Overall Study||7
8147764|NCT02657889|20080776|P4|COMPLETED|Overall Study||0
8147765|NCT02657889|20080777|P3|COMPLETED|Overall Study||0
8147766|NCT02657889|20080778|P2|COMPLETED|Overall Study||0
8147767|NCT02657889|20080779|P1|COMPLETED|Overall Study||0
8147768|NCT02657889|20080776|P4|STARTED|Overall Study||55
8147769|NCT02657889|20080777|P3|STARTED|Overall Study||53
8147770|NCT02657889|20080778|P2|STARTED|Overall Study||7
8147771|NCT02657889|20080779|P1|STARTED|Overall Study||7
8147772|NCT02657629|20080799|P2|NOT COMPLETED|Overall Study||0
8147773|NCT02657629|20080800|P1|NOT COMPLETED|Overall Study||2
8147774|NCT02657629|20080799|P2|COMPLETED|Overall Study||14
8147775|NCT02657629|20080800|P1|COMPLETED|Overall Study||12
8147776|NCT02657629|20080799|P2|STARTED|Overall Study||14
8147777|NCT02657629|20080800|P1|STARTED|Overall Study||14
8147778|NCT02657564|20080806|P1|NOT COMPLETED|Overall Study||74
8147779|NCT02657564|20080806|P1|COMPLETED|Overall Study||1163
8147780|NCT02657564|20080806|P1|STARTED|Overall Study||1237
8147781|NCT02657538|20080811|P1|NOT COMPLETED|Overall Study||4
8147782|NCT02657538|20080811|P1|COMPLETED|Overall Study||31
8147783|NCT02657538|20080811|P1|Received Visual Caries Detection + Bite|Overall Study||35
8147784|NCT02657538|20080811|P1|Received Near Infrared Transillumination|Overall Study||35
8147785|NCT02657538|20080811|P1|STARTED|Overall Study||35
8147786|NCT02657434|20080820|P2|NOT COMPLETED|Overall Study||292
8147787|NCT02657434|20080821|P1|NOT COMPLETED|Overall Study||286
8147788|NCT02657434|20080820|P2|COMPLETED|Overall Study||0
8147789|NCT02657434|20080821|P1|COMPLETED|Overall Study||0
8147790|NCT02657434|20080820|P2|STARTED|Overall Study||292
8147791|NCT02657434|20080821|P1|STARTED|Overall Study||286
8147792|NCT02657408|20080851|P2|NOT COMPLETED|Overall Study||7
8147793|NCT02657408|20080852|P1|NOT COMPLETED|Overall Study||3
8147794|NCT02657408|20080851|P2|COMPLETED|Overall Study||22
8147795|NCT02657408|20080852|P1|COMPLETED|Overall Study||25
8147796|NCT02657408|20080851|P2|STARTED|Overall Study||29
8147797|NCT02657408|20080852|P1|STARTED|Overall Study||28
8147798|NCT02657369|20080876|P1|NOT COMPLETED|Overall Study||34
8147799|NCT02657369|20080876|P1|COMPLETED|Overall Study||0
8147800|NCT02657369|20080876|P1|STARTED|Overall Study||34
8147801|NCT02657252|20080886|P2|NOT COMPLETED|Overall Study||7
8147802|NCT02657252|20080887|P1|NOT COMPLETED|Overall Study||10
8147803|NCT02657252|20080886|P2|COMPLETED|Overall Study||51
8147804|NCT02657252|20080887|P1|COMPLETED|Overall Study||47
8147805|NCT02657252|20080886|P2|STARTED|Overall Study||58
8147806|NCT02657252|20080887|P1|STARTED|Overall Study||57
8147807|NCT02657226|20080897|P1|NOT COMPLETED|Overall Study||0
8147808|NCT02657226|20080897|P1|COMPLETED|Overall Study||15724
8147809|NCT02657226|20080897|P1|STARTED|Overall Study||15724
8147810|NCT02657031|20080907|P2|NOT COMPLETED|Overall Study||2
8147811|NCT02657031|20080908|P1|NOT COMPLETED|Overall Study||1
8147812|NCT02657031|20080907|P2|COMPLETED|Overall Study||23
8147813|NCT02657031|20080908|P1|COMPLETED|Overall Study||28
8147814|NCT02657031|20080907|P2|STARTED|Overall Study||25
8147815|NCT02657031|20080908|P1|STARTED|Overall Study||29
8147816|NCT02656875|20080922|P1|NOT COMPLETED|Overall Study||70
8147817|NCT02656875|20080922|P1|COMPLETED|Overall Study||698
8147818|NCT02656875|20080922|P1|STARTED|Overall Study||768
8147819|NCT02656836|20080926|P1|NOT COMPLETED|Overall Study||3
8147820|NCT02656836|20080926|P1|COMPLETED|Overall Study||6
8147821|NCT02656836|20080926|P1|STARTED|Overall Study||9
8147822|NCT02656745|20080930|P1|NOT COMPLETED|Overall Study||0
8147823|NCT02656745|20080930|P1|COMPLETED|Overall Study||416
8147824|NCT02656745|20080930|P1|STARTED|Overall Study||416
8147825|NCT02656693|20080940|P3|NOT COMPLETED|Overall Study||3
8147826|NCT02656693|20080941|P2|NOT COMPLETED|Overall Study||2
8147827|NCT02656693|20080942|P1|NOT COMPLETED|Overall Study||1
8147828|NCT02656693|20080940|P3|COMPLETED|Overall Study||295
8147829|NCT02656693|20080941|P2|COMPLETED|Overall Study||214
8147830|NCT02656693|20080942|P1|COMPLETED|Overall Study||325
8147831|NCT02656693|20080940|P3|STARTED|Overall Study||298
8147832|NCT02656693|20080941|P2|STARTED|Overall Study||216
8147833|NCT02656693|20080942|P1|STARTED|Overall Study||326
8147834|NCT02656485|20081029|P4|NOT COMPLETED|Overall Study||2
8147835|NCT02656485|20081030|P3|NOT COMPLETED|Overall Study||2
8147836|NCT02656485|20081031|P2|NOT COMPLETED|Overall Study||3
8147837|NCT02656485|20081032|P1|NOT COMPLETED|Overall Study||2
8147838|NCT02656485|20081029|P4|COMPLETED|Overall Study||7
8147839|NCT02656485|20081030|P3|COMPLETED|Overall Study||7
8147840|NCT02656485|20081031|P2|COMPLETED|Overall Study||6
8147841|NCT02656485|20081032|P1|COMPLETED|Overall Study||7
8147842|NCT02656485|20081029|P4|STARTED|Overall Study||9
8147843|NCT02656485|20081030|P3|STARTED|Overall Study||9
8147844|NCT02656485|20081031|P2|STARTED|Overall Study||9
8147845|NCT02656485|20081032|P1|STARTED|Overall Study||9
8147846|NCT02656420|20081048|P4|NOT COMPLETED|Overall Study||0
8147847|NCT02656420|20081049|P3|NOT COMPLETED|Overall Study||0
8147848|NCT02656420|20081050|P2|NOT COMPLETED|Overall Study||1
8147849|NCT02656420|20081051|P1|NOT COMPLETED|Overall Study||0
8147850|NCT02656420|20081048|P4|COMPLETED|Overall Study||55
8147851|NCT02656420|20081049|P3|COMPLETED|Overall Study||35
8147852|NCT02656420|20081050|P2|COMPLETED|Overall Study||24
8147853|NCT02656420|20081051|P1|COMPLETED|Overall Study||55
8147854|NCT02656420|20081048|P4|STARTED|Overall Study||55
8147855|NCT02656420|20081049|P3|STARTED|Overall Study||35
8147856|NCT02656420|20081050|P2|STARTED|Overall Study||25
8147857|NCT02656420|20081051|P1|STARTED|Overall Study||55
8147858|NCT02656329|20081067|P2|NOT COMPLETED|Overall Study||157
8147859|NCT02656329|20081068|P1|NOT COMPLETED|Overall Study||164
8147860|NCT02656329|20081067|P2|COMPLETED|Overall Study||0
8147861|NCT02656329|20081068|P1|COMPLETED|Overall Study||0
8147862|NCT02656329|20081067|P2|STARTED|Overall Study||157
8147863|NCT02656329|20081068|P1|STARTED|Overall Study||164
8147864|NCT02656290|20081091|P1|NOT COMPLETED|Overall Study||26
8147865|NCT02656290|20081091|P1|COMPLETED|Overall Study||0
8147866|NCT02656290|20081091|P1|3 Year|Overall Study||6
8147867|NCT02656290|20081091|P1|2 Year|Overall Study||17
8147868|NCT02656290|20081091|P1|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
8147869|NCT02656290|20081091|P1|STARTED|Overall Study||26
8147870|NCT02656199|20081095|P1|NOT COMPLETED|Overall Study||0
8147871|NCT02656199|20081095|P1|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
8147872|NCT02656199|20081095|P1|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
8147873|NCT02656173|20081101|P2|NOT COMPLETED|Overall Study||11
8147874|NCT02656173|20081102|P1|NOT COMPLETED|Overall Study||13
8147875|NCT02656173|20081101|P2|COMPLETED|Overall Study||272
8147876|NCT02656173|20081102|P1|COMPLETED|Overall Study||272
8147877|NCT02656173|20081101|P2|Received Treatment|Overall Study||282
8147878|NCT02656173|20081102|P1|Received Treatment|Overall Study||284
8147879|NCT02656173|20081101|P2|STARTED|Overall Study||283
8147880|NCT02656173|20081102|P1|STARTED|Overall Study||285
8147881|NCT02656160|20081138|P2|NOT COMPLETED|Second Study Night||0
8147882|NCT02656160|20081139|P1|NOT COMPLETED|Second Study Night||0
8147883|NCT02656160|20081138|P2|COMPLETED|Second Study Night||6
8147884|NCT02656160|20081139|P1|COMPLETED|Second Study Night||4
8147885|NCT02656160|20081138|P2|STARTED|Second Study Night||6
8147886|NCT02656160|20081139|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
8147887|NCT02656160|20081138|P2|NOT COMPLETED|First Study Night||0
8147888|NCT02656160|20081139|P1|NOT COMPLETED|First Study Night||0
8147889|NCT02656160|20081138|P2|COMPLETED|First Study Night||6
8147890|NCT02656160|20081139|P1|COMPLETED|First Study Night||7
8147891|NCT02656160|20081138|P2|STARTED|First Study Night||6
8147892|NCT02656160|20081139|P1|STARTED|First Study Night||7
8147893|NCT02656069|20081149|P2|NOT COMPLETED|Second Intervention||1
8147894|NCT02656069|20081150|P1|NOT COMPLETED|Second Intervention||1
8147895|NCT02656069|20081149|P2|COMPLETED|Second Intervention||35
8147896|NCT02656069|20081150|P1|COMPLETED|Second Intervention||43
8147897|NCT02656069|20081149|P2|STARTED|Second Intervention||36
8147898|NCT02656069|20081150|P1|STARTED|Second Intervention||44
8147899|NCT02656069|20081149|P2|NOT COMPLETED|First Intervention||0
8147900|NCT02656069|20081150|P1|NOT COMPLETED|First Intervention||0
8147901|NCT02656069|20081149|P2|COMPLETED|First Intervention||36
8147902|NCT02656069|20081150|P1|COMPLETED|First Intervention||44
8147903|NCT02656069|20081149|P2|STARTED|First Intervention||36
8147904|NCT02656069|20081150|P1|STARTED|First Intervention||44
8147908|NCT02655679|20081193|P5|NOT COMPLETED|Overall Study||1
8147909|NCT02655679|20081194|P4|NOT COMPLETED|Overall Study||4
8147910|NCT02655679|20081195|P3|NOT COMPLETED|Overall Study||1
8147911|NCT02655679|20081196|P2|NOT COMPLETED|Overall Study||3
8147912|NCT02655679|20081197|P1|NOT COMPLETED|Overall Study||3
8147913|NCT02655679|20081193|P5|COMPLETED|Overall Study||19
8147914|NCT02655679|20081194|P4|COMPLETED|Overall Study||20
8147915|NCT02655679|20081195|P3|COMPLETED|Overall Study||19
8147916|NCT02655679|20081196|P2|COMPLETED|Overall Study||16
8147917|NCT02655679|20081197|P1|COMPLETED|Overall Study||18
8147918|NCT02655679|20081193|P5|Received Study Drug (Safety Population)|Overall Study||20
8147919|NCT02655679|20081194|P4|Received Study Drug (Safety Population)|Overall Study||24
8147920|NCT02655679|20081195|P3|Received Study Drug (Safety Population)|Overall Study||20
8147921|NCT02655679|20081196|P2|Received Study Drug (Safety Population)|Overall Study||19
8147922|NCT02655679|20081197|P1|Received Study Drug (Safety Population)|Overall Study||20
8147923|NCT02655679|20081193|P5|STARTED|Overall Study||20
8147924|NCT02655679|20081194|P4|STARTED|Overall Study||24
8147925|NCT02655679|20081195|P3|STARTED|Overall Study||20
8147926|NCT02655679|20081196|P2|STARTED|Overall Study||19
8147927|NCT02655679|20081197|P1|STARTED|Overall Study||21
8147928|NCT02655666|20081269|P1|NOT COMPLETED|Overall Study||12
8147929|NCT02655666|20081269|P1|COMPLETED|Overall Study||4
8147930|NCT02655666|20081269|P1|STARTED|Overall Study||16
8147931|NCT02655653|20081285|P2|NOT COMPLETED|Overall Study||0
8147932|NCT02655653|20081286|P1|NOT COMPLETED|Overall Study||0
8147933|NCT02655653|20081285|P2|COMPLETED|Overall Study||58
8147934|NCT02655653|20081286|P1|COMPLETED|Overall Study||56
8147935|NCT02655653|20081285|P2|STARTED|Overall Study||58
8147936|NCT02655653|20081286|P1|STARTED|Overall Study||56
8147937|NCT02655510|20081311|P3|NOT COMPLETED|Overall Study||0
8147938|NCT02655510|20081312|P2|NOT COMPLETED|Overall Study||0
8147939|NCT02655510|20081313|P1|NOT COMPLETED|Overall Study||0
8147940|NCT02655510|20081311|P3|COMPLETED|Overall Study||6
8147941|NCT02655510|20081312|P2|COMPLETED|Overall Study||6
8147942|NCT02655510|20081313|P1|COMPLETED|Overall Study||6
8147943|NCT02655510|20081311|P3|STARTED|Overall Study||6
8147944|NCT02655510|20081312|P2|STARTED|Overall Study||6
8147945|NCT02655510|20081313|P1|STARTED|Overall Study||6
8147946|NCT02655419|20081323|P2|NOT COMPLETED|Overall Study||7
8147947|NCT02655419|20081324|P1|NOT COMPLETED|Overall Study||5
8147948|NCT02655419|20081323|P2|COMPLETED|Overall Study||16
8147949|NCT02655419|20081324|P1|COMPLETED|Overall Study||12
8147950|NCT02655419|20081323|P2|Treated|Overall Study||18
8147951|NCT02655419|20081324|P1|Treated|Overall Study||16
8147952|NCT02655419|20081323|P2|STARTED|Overall Study||23
8147953|NCT02655419|20081324|P1|STARTED|Overall Study||17
8147954|NCT02655237|20081444|P2|NOT COMPLETED|Overall Study||11
8147955|NCT02655237|20081445|P1|NOT COMPLETED|Overall Study||17
8147956|NCT02655237|20081444|P2|COMPLETED|Overall Study||131
8147957|NCT02655237|20081445|P1|COMPLETED|Overall Study||122
8147958|NCT02655237|20081444|P2|STARTED|Overall Study||142
8147959|NCT02655237|20081445|P1|STARTED|Overall Study||139
8147960|NCT02655224|20081485|P2|NOT COMPLETED|Overall Study||1
8147961|NCT02655224|20081486|P1|NOT COMPLETED|Overall Study||1
8147962|NCT02655224|20081485|P2|COMPLETED|Overall Study||31
8147963|NCT02655224|20081486|P1|COMPLETED|Overall Study||32
8147964|NCT02655224|20081485|P2|STARTED|Overall Study||32
8147965|NCT02655224|20081486|P1|STARTED|Overall Study||33
8147966|NCT02655016|20081518|P2|NOT COMPLETED|Overall Study||90
8147967|NCT02655016|20081519|P1|NOT COMPLETED|Overall Study||55
8147968|NCT02655016|20081518|P2|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
8147969|NCT02655016|20081519|P1|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
8147970|NCT02655016|20081518|P2|Ongoing With Treatment in the Study|Overall Study||177
8147971|NCT02655016|20081519|P1|Ongoing With Treatment in the Study|Overall Study||69
8147972|NCT02655016|20081518|P2|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
8147973|NCT02655016|20081519|P1|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
8147974|NCT02655016|20081518|P2|STARTED|Overall Study||487
8147975|NCT02655016|20081519|P1|STARTED|Overall Study||246
8147976|NCT02654977|20081551|P1|NOT COMPLETED|Overall Study||7
8147977|NCT02654977|20081551|P1|COMPLETED|Overall Study||4
8147978|NCT02654977|20081551|P1|STARTED|Overall Study||11
8147979|NCT02654782|20081558|P2|NOT COMPLETED|Overall Study||0
8147980|NCT02654782|20081559|P1|NOT COMPLETED|Overall Study||0
8147981|NCT02654782|20081558|P2|COMPLETED|Overall Study||5
8147982|NCT02654782|20081559|P1|COMPLETED|Overall Study||5
8147983|NCT02654782|20081558|P2|STARTED|Overall Study||5
8147984|NCT02654782|20081559|P1|STARTED|Overall Study||5
8147985|NCT02654769|20081570|P3|NOT COMPLETED|Overall Study||1
8147986|NCT02654769|20081571|P2|NOT COMPLETED|Overall Study||1
8147987|NCT02654769|20081572|P1|NOT COMPLETED|Overall Study||4
8147988|NCT02654769|20081570|P3|COMPLETED|Overall Study||142
8147989|NCT02654769|20081571|P2|COMPLETED|Overall Study||148
8147990|NCT02654769|20081572|P1|COMPLETED|Overall Study||145
8147991|NCT02654769|20081570|P3|STARTED|Overall Study||143
8147992|NCT02654769|20081571|P2|STARTED|Overall Study||149
8147993|NCT02654769|20081572|P1|STARTED|Overall Study||149
8147994|NCT02654717|20081585|P2|NOT COMPLETED|Overall Study||5
8147995|NCT02654717|20081586|P1|NOT COMPLETED|Overall Study||6
8147996|NCT02654717|20081585|P2|COMPLETED|Overall Study||50
8147997|NCT02654717|20081586|P1|COMPLETED|Overall Study||50
8147998|NCT02654717|20081585|P2|STARTED|Overall Study||55
8147999|NCT02654717|20081586|P1|STARTED|Overall Study||56
8148000|NCT02654652|20081594|P2|NOT COMPLETED|Overall Study||3
8148001|NCT02654652|20081595|P1|NOT COMPLETED|Overall Study||1
8148002|NCT02654652|20081594|P2|COMPLETED|Overall Study||18
8148003|NCT02654652|20081595|P1|COMPLETED|Overall Study||18
8148004|NCT02654652|20081594|P2|STARTED|Overall Study||21
8148005|NCT02654652|20081595|P1|STARTED|Overall Study||19
8148006|NCT02654639|20081603|P1|NOT COMPLETED|Overall Study||0
8148007|NCT02654639|20081603|P1|COMPLETED|Overall Study||4
8148008|NCT02654639|20081603|P1|STARTED|Overall Study||4
8148009|NCT02654483|20081609|P2|NOT COMPLETED|Open-label||0
8148010|NCT02654483|20081610|P1|NOT COMPLETED|Open-label||0
8148011|NCT02654483|20081609|P2|COMPLETED|Open-label||3
8148012|NCT02654483|20081610|P1|COMPLETED|Open-label||5
8148013|NCT02654483|20081609|P2|STARTED|Open-label|4 participants did not continue to open-label arm|3
8148014|NCT02654483|20081610|P1|STARTED|Open-label|2 participants did not proceed to open-label arm|5
8148015|NCT02654483|20081609|P2|NOT COMPLETED|Double-blind||0
8148016|NCT02654483|20081610|P1|NOT COMPLETED|Double-blind||0
8148017|NCT02654483|20081609|P2|COMPLETED|Double-blind||7
8148018|NCT02654483|20081610|P1|COMPLETED|Double-blind||7
8148019|NCT02654483|20081609|P2|STARTED|Double-blind||7
8148020|NCT02654483|20081610|P1|STARTED|Double-blind||7
8148021|NCT02654314|20081624|P2|NOT COMPLETED|Overall Study||0
8148022|NCT02654314|20081625|P1|NOT COMPLETED|Overall Study||0
8148023|NCT02654314|20081624|P2|COMPLETED|Overall Study||141
8148024|NCT02654314|20081625|P1|COMPLETED|Overall Study||136
8148025|NCT02654314|20081624|P2|STARTED|Overall Study||141
8148026|NCT02654314|20081625|P1|STARTED|Overall Study||136
8148027|NCT02654145|20081637|P1|NOT COMPLETED|Overall Study||7
8148028|NCT02654145|20081637|P1|COMPLETED|Overall Study||138
8148029|NCT02654145|20081637|P1|STARTED|Overall Study||145
8148030|NCT02654132|20081646|P2|NOT COMPLETED|Overall Study||46
8148031|NCT02654132|20081647|P1|NOT COMPLETED|Overall Study||36
8148032|NCT02654132|20081646|P2|COMPLETED|Overall Study||11
8148033|NCT02654132|20081647|P1|COMPLETED|Overall Study||24
8148034|NCT02654132|20081646|P2|STARTED|Overall Study||57
8148035|NCT02654132|20081647|P1|STARTED|Overall Study||60
8148036|NCT02654054|20081658|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||30
8148037|NCT02654054|20081659|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||8
8148038|NCT02654054|20081660|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||8
8148039|NCT02654054|20081658|P3|COMPLETED|Post-Treatment Follow-Up Period||29
8148040|NCT02654054|20081659|P2|COMPLETED|Post-Treatment Follow-Up Period||24
8148041|NCT02654054|20081660|P1|COMPLETED|Post-Treatment Follow-Up Period||17
8148042|NCT02654054|20081658|P3|STARTED|Post-Treatment Follow-Up Period||59
8148043|NCT02654054|20081659|P2|STARTED|Post-Treatment Follow-Up Period||32
8148044|NCT02654054|20081660|P1|STARTED|Post-Treatment Follow-Up Period||25
8148045|NCT02654054|20081658|P3|NOT COMPLETED|Treatment Period||43
8148046|NCT02654054|20081659|P2|NOT COMPLETED|Treatment Period||23
8148047|NCT02654054|20081660|P1|NOT COMPLETED|Treatment Period||19
8148048|NCT02654054|20081658|P3|COMPLETED|Treatment Period||164
8148049|NCT02654054|20081659|P2|COMPLETED|Treatment Period||81
8148050|NCT02654054|20081660|P1|COMPLETED|Treatment Period||83
8148051|NCT02654054|20081658|P3|Randomized and Treated|Treatment Period||206
8148052|NCT02654054|20081659|P2|Randomized and Treated|Treatment Period||104
8148053|NCT02654054|20081660|P1|Randomized and Treated|Treatment Period||102
8148054|NCT02654054|20081658|P3|STARTED|Treatment Period||207
8148055|NCT02654054|20081659|P2|STARTED|Treatment Period||104
8148056|NCT02654054|20081660|P1|STARTED|Treatment Period||102
8148057|NCT02654002|20081695|P9|NOT COMPLETED|Overall Study||0
8148058|NCT02654002|20081696|P8|NOT COMPLETED|Overall Study||1
8148059|NCT02654002|20081697|P7|NOT COMPLETED|Overall Study||1
8148060|NCT02654002|20081698|P6|NOT COMPLETED|Overall Study||1
8148061|NCT02654002|20081699|P5|NOT COMPLETED|Overall Study||0
8148062|NCT02654002|20081700|P4|NOT COMPLETED|Overall Study||0
8148063|NCT02654002|20081701|P3|NOT COMPLETED|Overall Study||0
8148064|NCT02654002|20081702|P2|NOT COMPLETED|Overall Study||0
8148065|NCT02654002|20081703|P1|NOT COMPLETED|Overall Study||0
8148066|NCT02654002|20081695|P9|COMPLETED|Overall Study||24
8148067|NCT02654002|20081696|P8|COMPLETED|Overall Study||11
8148068|NCT02654002|20081697|P7|COMPLETED|Overall Study||11
8148069|NCT02654002|20081698|P6|COMPLETED|Overall Study||11
8148070|NCT02654002|20081699|P5|COMPLETED|Overall Study||12
8148071|NCT02654002|20081700|P4|COMPLETED|Overall Study||12
8148072|NCT02654002|20081701|P3|COMPLETED|Overall Study||12
8148073|NCT02654002|20081702|P2|COMPLETED|Overall Study||12
8148074|NCT02654002|20081703|P1|COMPLETED|Overall Study||12
8148075|NCT02654002|20081695|P9|STARTED|Overall Study||24
8148076|NCT02654002|20081696|P8|STARTED|Overall Study||12
8148077|NCT02654002|20081697|P7|STARTED|Overall Study||12
8148078|NCT02654002|20081698|P6|STARTED|Overall Study||12
8148079|NCT02654002|20081699|P5|STARTED|Overall Study||12
8148080|NCT02654002|20081700|P4|STARTED|Overall Study||12
8148081|NCT02654002|20081701|P3|STARTED|Overall Study||12
8148082|NCT02654002|20081702|P2|STARTED|Overall Study||12
8148083|NCT02654002|20081703|P1|STARTED|Overall Study||12
8148084|NCT02653872|20081829|P1|NOT COMPLETED|Overall Study||0
8148085|NCT02653872|20081829|P1|COMPLETED|Overall Study||15
8148086|NCT02653872|20081829|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
8148087|NCT02653872|20081829|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
8148088|NCT02653872|20081829|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
8148089|NCT02653872|20081829|P1|STARTED|Overall Study||15
8148090|NCT02653768|20081866|P2|NOT COMPLETED|9-Month Follow-Up (Primary)||16
8148091|NCT02653768|20081867|P1|NOT COMPLETED|9-Month Follow-Up (Primary)||33
8148092|NCT02653768|20081866|P2|COMPLETED|9-Month Follow-Up (Primary)||95
8148093|NCT02653768|20081867|P1|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
8148094|NCT02653768|20081866|P2|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
8148095|NCT02653768|20081867|P1|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
8148096|NCT02653768|20081866|P2|NOT COMPLETED|6-Month Follow-Up||13
8148097|NCT02653768|20081867|P1|NOT COMPLETED|6-Month Follow-Up||45
8148098|NCT02653768|20081866|P2|COMPLETED|6-Month Follow-Up||100
8148099|NCT02653768|20081867|P1|COMPLETED|6-Month Follow-Up||164
8148100|NCT02653768|20081866|P2|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
8148101|NCT02653768|20081867|P1|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
8148102|NCT02653768|20081866|P2|NOT COMPLETED|3-Month Follow-Up||15
8148103|NCT02653768|20081867|P1|NOT COMPLETED|3-Month Follow-Up||66
8148104|NCT02653768|20081866|P2|COMPLETED|3-Month Follow-Up||100
8148105|NCT02653768|20081867|P1|COMPLETED|3-Month Follow-Up||164
8148106|NCT02653768|20081866|P2|STARTED|3-Month Follow-Up||115
8148107|NCT02653768|20081867|P1|STARTED|3-Month Follow-Up||230
8148108|NCT02653625|20081877|P1|NOT COMPLETED|Overall Study||4
8148109|NCT02653625|20081877|P1|COMPLETED|Overall Study||20
8148110|NCT02653625|20081877|P1|STARTED|Overall Study||24
8148111|NCT02653560|20081886|P4|NOT COMPLETED|Placebo Phase||0
8148112|NCT02653560|20081887|P3|NOT COMPLETED|Placebo Phase||0
8148113|NCT02653560|20081888|P2|NOT COMPLETED|Placebo Phase||0
8148114|NCT02653560|20081889|P1|NOT COMPLETED|Placebo Phase||0
8148115|NCT02653560|20081886|P4|COMPLETED|Placebo Phase||30
8148116|NCT02653560|20081887|P3|COMPLETED|Placebo Phase||0
8148117|NCT02653560|20081888|P2|COMPLETED|Placebo Phase||0
8148118|NCT02653560|20081889|P1|COMPLETED|Placebo Phase||0
8148119|NCT02653560|20081886|P4|STARTED|Placebo Phase||30
8148120|NCT02653560|20081887|P3|STARTED|Placebo Phase||0
8148121|NCT02653560|20081888|P2|STARTED|Placebo Phase||0
8148122|NCT02653560|20081889|P1|STARTED|Placebo Phase||0
8148123|NCT02653560|20081886|P4|NOT COMPLETED|KCl Phase||0
8148124|NCT02653560|20081887|P3|NOT COMPLETED|KCl Phase||0
8148125|NCT02653560|20081888|P2|NOT COMPLETED|KCl Phase||0
8148126|NCT02653560|20081889|P1|NOT COMPLETED|KCl Phase||0
8148127|NCT02653560|20081886|P4|COMPLETED|KCl Phase||0
8148128|NCT02653560|20081887|P3|COMPLETED|KCl Phase||30
8148129|NCT02653560|20081888|P2|COMPLETED|KCl Phase||0
8148130|NCT02653560|20081889|P1|COMPLETED|KCl Phase||0
8148131|NCT02653560|20081886|P4|STARTED|KCl Phase||0
8148132|NCT02653560|20081887|P3|STARTED|KCl Phase||30
8148133|NCT02653560|20081888|P2|STARTED|KCl Phase||0
8148134|NCT02653560|20081889|P1|STARTED|KCl Phase||0
8148135|NCT02653560|20081886|P4|NOT COMPLETED|K Citrate Phase||0
8148136|NCT02653560|20081887|P3|NOT COMPLETED|K Citrate Phase||0
8148137|NCT02653560|20081888|P2|NOT COMPLETED|K Citrate Phase||0
8148138|NCT02653560|20081889|P1|NOT COMPLETED|K Citrate Phase||0
8148139|NCT02653560|20081886|P4|COMPLETED|K Citrate Phase||0
8148140|NCT02653560|20081887|P3|COMPLETED|K Citrate Phase||0
8148141|NCT02653560|20081888|P2|COMPLETED|K Citrate Phase||30
8148142|NCT02653560|20081889|P1|COMPLETED|K Citrate Phase||0
8148143|NCT02653560|20081886|P4|STARTED|K Citrate Phase||0
8148144|NCT02653560|20081887|P3|STARTED|K Citrate Phase||0
8148145|NCT02653560|20081888|P2|STARTED|K Citrate Phase||30
8148146|NCT02653560|20081889|P1|STARTED|K Citrate Phase||0
8148147|NCT02653560|20081886|P4|NOT COMPLETED|KMgCit Phase||0
8148148|NCT02653560|20081887|P3|NOT COMPLETED|KMgCit Phase||0
8148149|NCT02653560|20081888|P2|NOT COMPLETED|KMgCit Phase||0
8148150|NCT02653560|20081889|P1|NOT COMPLETED|KMgCit Phase||0
8148151|NCT02653560|20081886|P4|COMPLETED|KMgCit Phase||0
8148152|NCT02653560|20081887|P3|COMPLETED|KMgCit Phase||0
8148153|NCT02653560|20081888|P2|COMPLETED|KMgCit Phase||0
8148154|NCT02653560|20081889|P1|COMPLETED|KMgCit Phase||30
8148155|NCT02653560|20081886|P4|STARTED|KMgCit Phase||0
8148156|NCT02653560|20081887|P3|STARTED|KMgCit Phase||0
8148157|NCT02653560|20081888|P2|STARTED|KMgCit Phase||0
8148158|NCT02653560|20081889|P1|STARTED|KMgCit Phase||30
8148159|NCT02653495|20081901|P2|NOT COMPLETED|Overall Study||0
8148160|NCT02653495|20081902|P1|NOT COMPLETED|Overall Study||12
8148161|NCT02653495|20081901|P2|COMPLETED|Overall Study||2
8148162|NCT02653495|20081902|P1|COMPLETED|Overall Study||3
8148163|NCT02653495|20081901|P2|STARTED|Overall Study||2
8148164|NCT02653495|20081902|P1|STARTED|Overall Study||15
8148165|NCT02653456|20081916|P1|NOT COMPLETED|Overall Study||5
8148166|NCT02653456|20081916|P1|COMPLETED|Overall Study||59
8148167|NCT02653456|20081916|P1|STARTED|Overall Study||64
8148168|NCT02653417|20081927|P4|NOT COMPLETED|Overall Study||5
8148169|NCT02653417|20081928|P3|NOT COMPLETED|Overall Study||3
8148170|NCT02653417|20081929|P2|NOT COMPLETED|Overall Study||2
8148171|NCT02653417|20081930|P1|NOT COMPLETED|Overall Study||1
8148172|NCT02653417|20081927|P4|COMPLETED|Overall Study||33
8148173|NCT02653417|20081928|P3|COMPLETED|Overall Study||26
8148174|NCT02653417|20081929|P2|COMPLETED|Overall Study||32
8148175|NCT02653417|20081930|P1|COMPLETED|Overall Study||37
8148176|NCT02653417|20081927|P4|STARTED|Overall Study||38
8148177|NCT02653417|20081928|P3|STARTED|Overall Study||29
8148178|NCT02653417|20081929|P2|STARTED|Overall Study||34
8148179|NCT02653417|20081930|P1|STARTED|Overall Study||38
8148180|NCT02653326|20081954|P2|NOT COMPLETED|Overall Study||7
8148181|NCT02653326|20081955|P1|NOT COMPLETED|Overall Study||10
8148182|NCT02653326|20081954|P2|COMPLETED|Overall Study||27
8148183|NCT02653326|20081955|P1|COMPLETED|Overall Study||22
8148184|NCT02653326|20081954|P2|STARTED|Overall Study||34
8148185|NCT02653326|20081955|P1|STARTED|Overall Study||32
8148186|NCT02653183|20081969|P2|NOT COMPLETED|Overall Study||4
8148187|NCT02653183|20081970|P1|NOT COMPLETED|Overall Study||4
8148188|NCT02653183|20081969|P2|COMPLETED|Overall Study||46
8148189|NCT02653183|20081970|P1|COMPLETED|Overall Study||49
8148190|NCT02653183|20081969|P2|STARTED|Overall Study||50
8148191|NCT02653183|20081970|P1|STARTED|Overall Study||53
8148192|NCT02653170|20081993|P3|NOT COMPLETED|Overall Study||18
8148193|NCT02653170|20081994|P2|NOT COMPLETED|Overall Study||16
8148194|NCT02653170|20081995|P1|NOT COMPLETED|Overall Study||17
8148195|NCT02653170|20081993|P3|COMPLETED|Overall Study||72
8148196|NCT02653170|20081994|P2|COMPLETED|Overall Study||72
8148197|NCT02653170|20081995|P1|COMPLETED|Overall Study||70
8148198|NCT02653170|20081993|P3|STARTED|Overall Study||90
8148199|NCT02653170|20081994|P2|STARTED|Overall Study||88
8148200|NCT02653170|20081995|P1|STARTED|Overall Study||87
8148201|NCT02653144|20082018|P3|NOT COMPLETED|Overall Study||0
8148202|NCT02653144|20082019|P2|NOT COMPLETED|Overall Study||0
8148203|NCT02653144|20082020|P1|NOT COMPLETED|Overall Study||0
8148204|NCT02653144|20082018|P3|COMPLETED|Overall Study||31
8148205|NCT02653144|20082019|P2|COMPLETED|Overall Study||28
8148206|NCT02653144|20082020|P1|COMPLETED|Overall Study||30
8148207|NCT02653144|20082018|P3|STARTED|Overall Study||31
8148208|NCT02653144|20082019|P2|STARTED|Overall Study||28
8148209|NCT02653144|20082020|P1|STARTED|Overall Study||30
8148222|NCT02652780|20082046|P1|NOT COMPLETED|Overall Study||0
8148223|NCT02652780|20082046|P1|COMPLETED|Overall Study||37
8148224|NCT02652780|20082046|P1|STARTED|Overall Study||37
8148225|NCT02652767|20082072|P1|NOT COMPLETED|Overall Study||4
8148226|NCT02652767|20082072|P1|COMPLETED|Overall Study||35
8148227|NCT02652767|20082072|P1|Completed Week 48|Overall Study||38
8148228|NCT02652767|20082072|P1|STARTED|Overall Study||39
8148229|NCT02652624|20082100|P2|NOT COMPLETED|Extension Phase||4
8148230|NCT02652624|20082101|P1|NOT COMPLETED|Extension Phase||4
8148231|NCT02652624|20082100|P2|COMPLETED|Extension Phase||224
8148232|NCT02652624|20082101|P1|COMPLETED|Extension Phase||227
8148233|NCT02652624|20082100|P2|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
8148234|NCT02652624|20082101|P1|STARTED|Extension Phase||231
8148235|NCT02652624|20082100|P2|NOT COMPLETED|Randomized Phase||5
8148236|NCT02652624|20082101|P1|NOT COMPLETED|Randomized Phase||3
8148237|NCT02652624|20082100|P2|COMPLETED|Randomized Phase||231
8148238|NCT02652624|20082101|P1|COMPLETED|Randomized Phase||231
8148239|NCT02652624|20082100|P2|STARTED|Randomized Phase||236
8148240|NCT02652624|20082101|P1|STARTED|Randomized Phase||234
8148241|NCT02652481|20082113|P1|NOT COMPLETED|Phase 2||18
8148242|NCT02652481|20082113|P1|COMPLETED|Phase 2||243
8148243|NCT02652481|20082113|P1|STARTED|Phase 2||261
8148244|NCT02652481|20082113|P1|NOT COMPLETED|Phase 1||98
8148245|NCT02652481|20082113|P1|COMPLETED|Phase 1||141
8148246|NCT02652481|20082113|P1|STARTED|Phase 1||239
8148247|NCT02652468|20082121|P1|NOT COMPLETED|Overall Study||0
8148248|NCT02652468|20082121|P1|COMPLETED|Overall Study||11
8148249|NCT02652468|20082121|P1|STARTED|Overall Study||11
8148250|NCT02652416|20082129|P4|NOT COMPLETED|Overall Study||0
8148251|NCT02652416|20082130|P3|NOT COMPLETED|Overall Study||0
8148252|NCT02652416|20082131|P2|NOT COMPLETED|Overall Study||0
8148253|NCT02652416|20082132|P1|NOT COMPLETED|Overall Study||0
8148254|NCT02652416|20082129|P4|COMPLETED|Overall Study||18
8148255|NCT02652416|20082130|P3|COMPLETED|Overall Study||18
8148256|NCT02652416|20082131|P2|COMPLETED|Overall Study||18
8148257|NCT02652416|20082132|P1|COMPLETED|Overall Study||18
8148258|NCT02652416|20082129|P4|Subjects Who Participated in MD Part|Overall Study||18
8148259|NCT02652416|20082130|P3|Subjects Who Participated in MD Part|Overall Study||0
8148260|NCT02652416|20082131|P2|Subjects Who Participated in MD Part|Overall Study||0
8148261|NCT02652416|20082132|P1|Subjects Who Participated in MD Part|Overall Study||6
8148262|NCT02652416|20082129|P4|STARTED|Overall Study||18
8148263|NCT02652416|20082130|P3|STARTED|Overall Study||18
8148264|NCT02652416|20082131|P2|STARTED|Overall Study||18
8148265|NCT02652416|20082132|P1|STARTED|Overall Study||18
8148266|NCT02652390|20082163|P3|NOT COMPLETED|Overall Study||0
8148267|NCT02652390|20082164|P2|NOT COMPLETED|Overall Study||0
8148268|NCT02652390|20082165|P1|NOT COMPLETED|Overall Study||0
8148269|NCT02652390|20082163|P3|COMPLETED|Overall Study||37
8148270|NCT02652390|20082164|P2|COMPLETED|Overall Study||37
8148271|NCT02652390|20082165|P1|COMPLETED|Overall Study||37
8148272|NCT02652390|20082163|P3|STARTED|Overall Study||37
8148273|NCT02652390|20082164|P2|STARTED|Overall Study||37
8148274|NCT02652390|20082165|P1|STARTED|Overall Study||37
8148275|NCT02652260|20082189|P2|NOT COMPLETED|Overall Study||2
8148276|NCT02652260|20082190|P1|NOT COMPLETED|Overall Study||0
8148277|NCT02652260|20082189|P2|COMPLETED|Overall Study||41
8148278|NCT02652260|20082190|P1|COMPLETED|Overall Study||43
8148279|NCT02652260|20082189|P2|STARTED|Overall Study||43
8148280|NCT02652260|20082190|P1|STARTED|Overall Study||43
8148281|NCT02652221|20082226|P1|NOT COMPLETED|Overall Study||0
8148282|NCT02652221|20082226|P1|COMPLETED|Overall Study||55
8148283|NCT02652221|20082226|P1|STARTED|Overall Study||55
8148284|NCT02652208|20082235|P2|NOT COMPLETED|Overall Study||2
8148285|NCT02652208|20082236|P1|NOT COMPLETED|Overall Study||4
8148286|NCT02652208|20082235|P2|COMPLETED|Overall Study||15
8148287|NCT02652208|20082236|P1|COMPLETED|Overall Study||13
8148288|NCT02652208|20082235|P2|STARTED|Overall Study||17
8148289|NCT02652208|20082236|P1|STARTED|Overall Study||17
8148290|NCT02652156|20082249|P3|NOT COMPLETED|Overall Study||0
8148291|NCT02652156|20082250|P2|NOT COMPLETED|Overall Study||0
8148292|NCT02652156|20082251|P1|NOT COMPLETED|Overall Study||1
8148293|NCT02652156|20082249|P3|COMPLETED|Overall Study||4
8148294|NCT02652156|20082250|P2|COMPLETED|Overall Study||6
8148295|NCT02652156|20082251|P1|COMPLETED|Overall Study||3
8148296|NCT02652156|20082249|P3|STARTED|Overall Study||4
8148297|NCT02652156|20082250|P2|STARTED|Overall Study||6
8148298|NCT02652156|20082251|P1|STARTED|Overall Study||4
8148299|NCT02651987|20082279|P2|NOT COMPLETED|Overall Study||5
8148300|NCT02651987|20082280|P1|NOT COMPLETED|Overall Study||5
8148301|NCT02651987|20082279|P2|COMPLETED|Overall Study||46
8148302|NCT02651987|20082280|P1|COMPLETED|Overall Study||43
8148303|NCT02651987|20082279|P2|STARTED|Overall Study||51
8148304|NCT02651987|20082280|P1|STARTED|Overall Study||48
8148305|NCT02651922|20082321|P1|NOT COMPLETED|Overall Study||2
8148306|NCT02651922|20082321|P1|COMPLETED|Overall Study||154
8148307|NCT02651922|20082321|P1|STARTED|Overall Study||156
8148308|NCT02651688|20082341|P3|NOT COMPLETED|Overall Study||3
8148309|NCT02651688|20082342|P2|NOT COMPLETED|Overall Study||5
8148310|NCT02651688|20082343|P1|NOT COMPLETED|Overall Study||2
8148311|NCT02651688|20082341|P3|COMPLETED|Overall Study||12
8148312|NCT02651688|20082342|P2|COMPLETED|Overall Study||12
8148313|NCT02651688|20082343|P1|COMPLETED|Overall Study||16
8148314|NCT02651688|20082341|P3|STARTED|Overall Study||15
8148315|NCT02651688|20082342|P2|STARTED|Overall Study||17
8148316|NCT02651688|20082343|P1|STARTED|Overall Study||18
8148317|NCT02651584|20082410|P2|NOT COMPLETED|Overall Study||92
8148318|NCT02651584|20082411|P1|NOT COMPLETED|Overall Study||89
8148319|NCT02651584|20082410|P2|COMPLETED|Overall Study||121
8148320|NCT02651584|20082411|P1|COMPLETED|Overall Study||126
8148321|NCT02651584|20082410|P2|STARTED|Overall Study||213
8148322|NCT02651584|20082411|P1|STARTED|Overall Study||215
8148323|NCT02651467|20082426|P3|NOT COMPLETED|Overall Study||4
8148324|NCT02651467|20082427|P2|NOT COMPLETED|Overall Study||0
8148325|NCT02651467|20082428|P1|NOT COMPLETED|Overall Study||1
8148326|NCT02651467|20082426|P3|COMPLETED|Overall Study||69
8148327|NCT02651467|20082427|P2|COMPLETED|Overall Study||74
8148328|NCT02651467|20082428|P1|COMPLETED|Overall Study||73
8148329|NCT02651467|20082426|P3|STARTED|Overall Study||73
8148330|NCT02651467|20082427|P2|STARTED|Overall Study||74
8148331|NCT02651467|20082428|P1|STARTED|Overall Study||74
8148332|NCT02651415|20082447|P1|NOT COMPLETED|Overall Study||2
8148333|NCT02651415|20082447|P1|COMPLETED|Overall Study|10 patients were evaluable.|10
8148334|NCT02651415|20082447|P1|STARTED|Overall Study|12 patients were enrolled.|12
8148335|NCT02651337|20082456|P1|NOT COMPLETED|Overall Study||1
8148336|NCT02651337|20082456|P1|COMPLETED|Overall Study||4
8148337|NCT02651337|20082456|P1|STARTED|Overall Study||5
8148338|NCT02651272|20082460|P1|NOT COMPLETED|Overall Study||3
8148339|NCT02651272|20082460|P1|COMPLETED|Overall Study||1
8148340|NCT02651272|20082460|P1|STARTED|Overall Study||4
8148341|NCT02651259|20082477|P2|NOT COMPLETED|Overall Study||0
8148342|NCT02651259|20082478|P1|NOT COMPLETED|Overall Study||0
8148343|NCT02651259|20082477|P2|COMPLETED|Overall Study||25
8148344|NCT02651259|20082478|P1|COMPLETED|Overall Study||25
8148345|NCT02651259|20082477|P2|STARTED|Overall Study||25
8148346|NCT02651259|20082478|P1|STARTED|Overall Study||25
8148347|NCT02651220|20082522|P3|NOT COMPLETED|Overall Study||29
8148348|NCT02651220|20082523|P2|NOT COMPLETED|Overall Study||27
8148349|NCT02651220|20082524|P1|NOT COMPLETED|Overall Study||23
8148350|NCT02651220|20082522|P3|COMPLETED|Overall Study||300
8148351|NCT02651220|20082523|P2|COMPLETED|Overall Study||308
8148352|NCT02651220|20082524|P1|COMPLETED|Overall Study||314
8148353|NCT02651220|20082522|P3|STARTED|Overall Study||329
8148354|NCT02651220|20082523|P2|STARTED|Overall Study||335
8148355|NCT02651220|20082524|P1|STARTED|Overall Study||337
8148356|NCT02651194|20082538|P1|NOT COMPLETED|Overall Study||5
8148357|NCT02651194|20082538|P1|COMPLETED|Overall Study||99
8148358|NCT02651194|20082538|P1|STARTED|Overall Study||104
8148359|NCT02651155|20082546|P2|NOT COMPLETED|Overall Study||2
8148360|NCT02651155|20082547|P1|NOT COMPLETED|Overall Study||6
8148361|NCT02651155|20082546|P2|COMPLETED|Overall Study||103
8148362|NCT02651155|20082547|P1|COMPLETED|Overall Study||93
8148363|NCT02651155|20082546|P2|STARTED|Overall Study||105
8148364|NCT02651155|20082547|P1|STARTED|Overall Study||99
8148365|NCT02651103|20082563|P1|NOT COMPLETED|Overall Study||0
8148366|NCT02651103|20082563|P1|COMPLETED|Overall Study||30
8148367|NCT02651103|20082563|P1|STARTED|Overall Study||30
8148368|NCT02650999|20082567|P1|NOT COMPLETED|Overall Study||0
8148369|NCT02650999|20082567|P1|COMPLETED|Overall Study||12
8148370|NCT02650999|20082567|P1|STARTED|Overall Study||12
8148371|NCT02650921|20082572|P1|NOT COMPLETED|Overall Study||8
8148372|NCT02650921|20082572|P1|COMPLETED|Overall Study||84
8148373|NCT02650921|20082572|P1|STARTED|Overall Study||92
8148374|NCT02650895|20082626|P6|NOT COMPLETED|Overall Study||0
8148375|NCT02650895|20082627|P5|NOT COMPLETED|Overall Study||0
8148376|NCT02650895|20082628|P4|NOT COMPLETED|Overall Study||0
8148377|NCT02650895|20082629|P3|NOT COMPLETED|Overall Study||0
8148378|NCT02650895|20082630|P2|NOT COMPLETED|Overall Study||1
8148379|NCT02650895|20082631|P1|NOT COMPLETED|Overall Study||0
8148380|NCT02650895|20082626|P6|COMPLETED|Overall Study||6
8148381|NCT02650895|20082627|P5|COMPLETED|Overall Study||6
8148382|NCT02650895|20082628|P4|COMPLETED|Overall Study||6
8148383|NCT02650895|20082629|P3|COMPLETED|Overall Study||6
8148384|NCT02650895|20082630|P2|COMPLETED|Overall Study||5
8148385|NCT02650895|20082631|P1|COMPLETED|Overall Study||10
8148386|NCT02650895|20082626|P6|STARTED|Overall Study||6
8148387|NCT02650895|20082627|P5|STARTED|Overall Study||6
8148388|NCT02650895|20082628|P4|STARTED|Overall Study||6
8148389|NCT02650895|20082629|P3|STARTED|Overall Study||6
8148390|NCT02650895|20082630|P2|STARTED|Overall Study||6
8148391|NCT02650895|20082631|P1|STARTED|Overall Study||10
8148392|NCT02650856|20082667|P2|NOT COMPLETED|Overall Study||0
8148393|NCT02650856|20082668|P1|NOT COMPLETED|Overall Study||0
8148394|NCT02650856|20082667|P2|COMPLETED|Overall Study||21
8148395|NCT02650856|20082668|P1|COMPLETED|Overall Study||19
8148396|NCT02650856|20082667|P2|72 Hours|Overall Study||21
8148397|NCT02650856|20082668|P1|72 Hours|Overall Study||19
8148398|NCT02650856|20082667|P2|48 Hours|Overall Study||21
8148399|NCT02650856|20082668|P1|48 Hours|Overall Study||19
8148400|NCT02650856|20082667|P2|24 Hours|Overall Study||21
8148401|NCT02650856|20082668|P1|24 Hours|Overall Study||19
8148402|NCT02650856|20082667|P2|Baseline|Overall Study||21
8148403|NCT02650856|20082668|P1|Baseline|Overall Study||19
8148404|NCT02650856|20082667|P2|STARTED|Overall Study||21
8148405|NCT02650856|20082668|P1|STARTED|Overall Study||19
8148406|NCT02650466|20082678|P1|NOT COMPLETED|Overall Study||7
8148407|NCT02650466|20082678|P1|COMPLETED|Overall Study||17
8148408|NCT02650466|20082678|P1|STARTED|Overall Study||24
8148409|NCT02650440|20082686|P2|NOT COMPLETED|Overall Study||2
8148410|NCT02650440|20082687|P1|NOT COMPLETED|Overall Study||0
8148411|NCT02650440|20082686|P2|COMPLETED|Overall Study||8
8148412|NCT02650440|20082687|P1|COMPLETED|Overall Study||10
8148413|NCT02650440|20082686|P2|STARTED|Overall Study||10
8148414|NCT02650440|20082687|P1|STARTED|Overall Study||10
8148415|NCT02650219|20082705|P2|NOT COMPLETED|Overall Study||0
8148416|NCT02650219|20082706|P1|NOT COMPLETED|Overall Study||0
8148417|NCT02650219|20082705|P2|COMPLETED|Overall Study||20
8148418|NCT02650219|20082706|P1|COMPLETED|Overall Study||40
8148419|NCT02650219|20082705|P2|STARTED|Overall Study||20
8148420|NCT02650219|20082706|P1|STARTED|Overall Study||40
8148421|NCT02650193|20082719|P3|NOT COMPLETED|Overall Study||0
8148422|NCT02650193|20082720|P2|NOT COMPLETED|Overall Study||0
8148423|NCT02650193|20082721|P1|NOT COMPLETED|Overall Study||0
8148424|NCT02650193|20082719|P3|COMPLETED|Overall Study||13
8148425|NCT02650193|20082720|P2|COMPLETED|Overall Study||6
8148426|NCT02650193|20082721|P1|COMPLETED|Overall Study||6
8148427|NCT02650193|20082719|P3|STARTED|Overall Study||13
8148428|NCT02650193|20082720|P2|STARTED|Overall Study||6
8148429|NCT02650193|20082721|P1|STARTED|Overall Study||6
8148430|NCT02650128|20082808|P1|NOT COMPLETED|Overall Study||2
8148431|NCT02650128|20082808|P1|COMPLETED|Overall Study||58
8148432|NCT02650128|20082808|P1|30 Day Primary and Safety Endpoint|Overall Study||60
8148433|NCT02650128|20082808|P1|STARTED|Overall Study||60
8148434|NCT02649946|20082817|P2|NOT COMPLETED|Overall Study||15
8148435|NCT02649946|20082818|P1|NOT COMPLETED|Overall Study||12
8148436|NCT02649946|20082817|P2|COMPLETED|Overall Study||123
8148437|NCT02649946|20082818|P1|COMPLETED|Overall Study||130
8148438|NCT02649946|20082817|P2|STARTED|Overall Study||138
8148439|NCT02649946|20082818|P1|STARTED|Overall Study||142
8148440|NCT02649894|20082847|P2|NOT COMPLETED|Overall Study||11
8148441|NCT02649894|20082848|P1|NOT COMPLETED|Overall Study||44
8148442|NCT02649894|20082847|P2|COMPLETED|Overall Study||27
8148443|NCT02649894|20082848|P1|COMPLETED|Overall Study||37
8148444|NCT02649894|20082847|P2|Completed Day 30|Overall Study||35
8148445|NCT02649894|20082848|P1|Completed Day 30|Overall Study||56
8148446|NCT02649894|20082847|P2|Device Inserted|Overall Study||37
8148447|NCT02649894|20082848|P1|Device Inserted|Overall Study||77
8148448|NCT02649894|20082847|P2|STARTED|Overall Study||38
8148449|NCT02649894|20082848|P1|STARTED|Overall Study||81
8148450|NCT02649842|20082868|P1|NOT COMPLETED|Overall Study||0
8148451|NCT02649842|20082868|P1|COMPLETED|Overall Study||101
8148452|NCT02649842|20082868|P1|STARTED|Overall Study||101
8148453|NCT02649634|20082876|P2|NOT COMPLETED|Overall Study||6
8148454|NCT02649634|20082877|P1|NOT COMPLETED|Overall Study||3
8148455|NCT02649634|20082876|P2|COMPLETED|Overall Study||60
8148456|NCT02649634|20082877|P1|COMPLETED|Overall Study||66
8148457|NCT02649634|20082876|P2|STARTED|Overall Study||66
8148458|NCT02649634|20082877|P1|STARTED|Overall Study||69
8148480|NCT02649556|20082985|P4|NOT COMPLETED|Overall Study||23
8148481|NCT02649556|20082986|P3|NOT COMPLETED|Overall Study||50
8148482|NCT02649556|20082987|P2|NOT COMPLETED|Overall Study||112
8148483|NCT02649556|20082988|P1|NOT COMPLETED|Overall Study||63
8148484|NCT02649556|20082985|P4|COMPLETED|Overall Study||28
8148485|NCT02649556|20082986|P3|COMPLETED|Overall Study||102
8148486|NCT02649556|20082987|P2|COMPLETED|Overall Study||312
8148487|NCT02649556|20082988|P1|COMPLETED|Overall Study||167
8148488|NCT02649556|20082985|P4|STARTED|Overall Study||51
8148489|NCT02649556|20082986|P3|STARTED|Overall Study||152
8148490|NCT02649556|20082987|P2|STARTED|Overall Study||424
8148491|NCT02649556|20082988|P1|STARTED|Overall Study||230
8148492|NCT02649322|20083028|P2|NOT COMPLETED|Overall Study||0
8148493|NCT02649322|20083029|P1|NOT COMPLETED|Overall Study||0
8148494|NCT02649322|20083028|P2|COMPLETED|Overall Study||57
8148495|NCT02649322|20083029|P1|COMPLETED|Overall Study||58
8148496|NCT02649322|20083028|P2|STARTED|Overall Study||57
8148497|NCT02649322|20083029|P1|STARTED|Overall Study||58
8148501|NCT02649192|20083051|P6|NOT COMPLETED|Overall Study||0
8148502|NCT02649192|20083052|P5|NOT COMPLETED|Overall Study||1
8148503|NCT02649192|20083053|P4|NOT COMPLETED|Overall Study||2
8148504|NCT02649192|20083054|P3|NOT COMPLETED|Overall Study||1
8148505|NCT02649192|20083055|P2|NOT COMPLETED|Overall Study||0
8148506|NCT02649192|20083056|P1|NOT COMPLETED|Overall Study||0
8148507|NCT02649192|20083051|P6|COMPLETED|Overall Study||14
8148508|NCT02649192|20083052|P5|COMPLETED|Overall Study||11
8148509|NCT02649192|20083053|P4|COMPLETED|Overall Study||20
8148510|NCT02649192|20083054|P3|COMPLETED|Overall Study||21
8148511|NCT02649192|20083055|P2|COMPLETED|Overall Study||4
8148512|NCT02649192|20083056|P1|COMPLETED|Overall Study||5
8148513|NCT02649192|20083051|P6|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
8148514|NCT02649192|20083052|P5|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
8148515|NCT02649192|20083053|P4|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
8148516|NCT02649192|20083054|P3|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
8148517|NCT02649192|20083055|P2|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
8148518|NCT02649192|20083056|P1|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
8148519|NCT02649192|20083051|P6|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
8148520|NCT02649192|20083052|P5|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
8148521|NCT02649192|20083053|P4|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
8148522|NCT02649192|20083054|P3|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
8148523|NCT02649192|20083055|P2|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
8148524|NCT02649192|20083056|P1|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
8148525|NCT02649192|20083051|P6|STARTED|Overall Study||14
8148526|NCT02649192|20083052|P5|STARTED|Overall Study||12
8148527|NCT02649192|20083053|P4|STARTED|Overall Study||22
8148528|NCT02649192|20083054|P3|STARTED|Overall Study||22
8148529|NCT02649192|20083055|P2|STARTED|Overall Study||4
8148530|NCT02649192|20083056|P1|STARTED|Overall Study||5
8148531|NCT02648971|20083114|P2|NOT COMPLETED|Overall Study||0
8148532|NCT02648971|20083115|P1|NOT COMPLETED|Overall Study||0
8148533|NCT02648971|20083114|P2|COMPLETED|Overall Study||18
8148534|NCT02648971|20083115|P1|COMPLETED|Overall Study||18
8148535|NCT02648971|20083114|P2|STARTED|Overall Study||18
8148536|NCT02648971|20083115|P1|STARTED|Overall Study||18
8148537|NCT02648698|20083137|P2|NOT COMPLETED|Overall Study||5
8148538|NCT02648698|20083138|P1|NOT COMPLETED|Overall Study||1
8148539|NCT02648698|20083137|P2|COMPLETED|Overall Study||55
8148540|NCT02648698|20083138|P1|COMPLETED|Overall Study||59
8148541|NCT02648698|20083137|P2|STARTED|Overall Study||60
8148542|NCT02648698|20083138|P1|STARTED|Overall Study||60
8148543|NCT02648646|20083144|P1|NOT COMPLETED|Overall Study||2
8148544|NCT02648646|20083144|P1|COMPLETED|Overall Study||8
8148545|NCT02648646|20083144|P1|STARTED|Overall Study||10
8148546|NCT02648438|20083195|P3|NOT COMPLETED|Overall Study||0
8148547|NCT02648438|20083196|P2|NOT COMPLETED|Overall Study||3
8148548|NCT02648438|20083197|P1|NOT COMPLETED|Overall Study||3
8148549|NCT02648438|20083195|P3|COMPLETED|Overall Study||6
8148550|NCT02648438|20083196|P2|COMPLETED|Overall Study||9
8148551|NCT02648438|20083197|P1|COMPLETED|Overall Study||9
8148552|NCT02648438|20083195|P3|STARTED|Overall Study||6
8148553|NCT02648438|20083196|P2|STARTED|Overall Study||12
8148554|NCT02648438|20083197|P1|STARTED|Overall Study||12
8148555|NCT02648230|20083237|P1|NOT COMPLETED|Overall Study||0
8148556|NCT02648230|20083237|P1|COMPLETED|Overall Study||74
8148557|NCT02648230|20083237|P1|STARTED|Overall Study||74
8148558|NCT02648217|20083243|P2|NOT COMPLETED|Overall Study||5
8148559|NCT02648217|20083244|P1|NOT COMPLETED|Overall Study||10
8148560|NCT02648217|20083243|P2|COMPLETED|Overall Study||127
8148561|NCT02648217|20083244|P1|COMPLETED|Overall Study||121
8148562|NCT02648217|20083243|P2|Exposed|Overall Study||132
8148563|NCT02648217|20083244|P1|Exposed|Overall Study||130
8148564|NCT02648217|20083243|P2|STARTED|Overall Study||132
8148565|NCT02648217|20083244|P1|STARTED|Overall Study||131
8148566|NCT02648204|20083266|P4|NOT COMPLETED|Overall Study||16
8148567|NCT02648204|20083267|P3|NOT COMPLETED|Overall Study||13
8148568|NCT02648204|20083268|P2|NOT COMPLETED|Overall Study||21
8148569|NCT02648204|20083269|P1|NOT COMPLETED|Overall Study||22
8148570|NCT02648204|20083266|P4|COMPLETED|Overall Study||284
8148571|NCT02648204|20083267|P3|COMPLETED|Overall Study||287
8148572|NCT02648204|20083268|P2|COMPLETED|Overall Study||279
8148573|NCT02648204|20083269|P1|COMPLETED|Overall Study||279
8148574|NCT02648204|20083266|P4|Exposed|Overall Study||299
8148575|NCT02648204|20083267|P3|Exposed|Overall Study||299
8148576|NCT02648204|20083268|P2|Exposed|Overall Study||300
8148577|NCT02648204|20083269|P1|Exposed|Overall Study||301
8148578|NCT02648204|20083266|P4|STARTED|Overall Study||300
8148579|NCT02648204|20083267|P3|STARTED|Overall Study||300
8148580|NCT02648204|20083268|P2|STARTED|Overall Study||300
8148581|NCT02648204|20083269|P1|STARTED|Overall Study||301
8148582|NCT02648178|20083387|P1|NOT COMPLETED|Overall Study||9
8148583|NCT02648178|20083387|P1|COMPLETED|Overall Study||10
8148584|NCT02648178|20083387|P1|STARTED|Overall Study||19
8148585|NCT02648022|20083394|P2|NOT COMPLETED|Overall Study||0
8148586|NCT02648022|20083395|P1|NOT COMPLETED|Overall Study||0
8148587|NCT02648022|20083394|P2|COMPLETED|Overall Study||39
8148588|NCT02648022|20083395|P1|COMPLETED|Overall Study||40
8148589|NCT02648022|20083394|P2|STARTED|Overall Study||39
8148590|NCT02648022|20083395|P1|STARTED|Overall Study||40
8148591|NCT02647944|20083407|P2|NOT COMPLETED|Overall Study||3
8148592|NCT02647944|20083408|P1|NOT COMPLETED|Overall Study||2
8148593|NCT02647944|20083407|P2|COMPLETED|Overall Study||18
8148594|NCT02647944|20083408|P1|COMPLETED|Overall Study||17
8148595|NCT02647944|20083407|P2|STARTED|Overall Study||21
8148596|NCT02647944|20083408|P1|STARTED|Overall Study||19
8148597|NCT02647905|20083432|P1|NOT COMPLETED|Overall Study||3
8148598|NCT02647905|20083432|P1|COMPLETED|Overall Study||87
8148599|NCT02647905|20083432|P1|STARTED|Overall Study||90
8148600|NCT02647866|20083442|P5|NOT COMPLETED|Overall Study||8
8148601|NCT02647866|20083443|P4|NOT COMPLETED|Overall Study||6
8148602|NCT02647866|20083444|P3|NOT COMPLETED|Overall Study||5
8148603|NCT02647866|20083445|P2|NOT COMPLETED|Overall Study||4
8148604|NCT02647866|20083446|P1|NOT COMPLETED|Overall Study||5
8148605|NCT02647866|20083442|P5|COMPLETED|Overall Study||9
8148606|NCT02647866|20083443|P4|COMPLETED|Overall Study||15
8148607|NCT02647866|20083444|P3|COMPLETED|Overall Study||4
8148608|NCT02647866|20083445|P2|COMPLETED|Overall Study||6
8148609|NCT02647866|20083446|P1|COMPLETED|Overall Study||4
8148610|NCT02647866|20083442|P5|Discontinued the Study|Overall Study||8
8148611|NCT02647866|20083443|P4|Discontinued the Study|Overall Study||6
8148612|NCT02647866|20083444|P3|Discontinued the Study|Overall Study||5
8148613|NCT02647866|20083445|P2|Discontinued the Study|Overall Study||4
8148614|NCT02647866|20083446|P1|Discontinued the Study|Overall Study||5
8148615|NCT02647866|20083442|P5|Discontinued the Treatment|Overall Study||8
8148616|NCT02647866|20083443|P4|Discontinued the Treatment|Overall Study||5
8148617|NCT02647866|20083444|P3|Discontinued the Treatment|Overall Study||5
8148618|NCT02647866|20083445|P2|Discontinued the Treatment|Overall Study||5
8148619|NCT02647866|20083446|P1|Discontinued the Treatment|Overall Study||4
8148620|NCT02647866|20083442|P5|Moved From LTE to OLE Therapy|Overall Study||2
8148621|NCT02647866|20083443|P4|Moved From LTE to OLE Therapy|Overall Study||0
8148622|NCT02647866|20083444|P3|Moved From LTE to OLE Therapy|Overall Study||0
8148623|NCT02647866|20083445|P2|Moved From LTE to OLE Therapy|Overall Study||5
8148624|NCT02647866|20083446|P1|Moved From LTE to OLE Therapy|Overall Study||0
8148625|NCT02647866|20083442|P5|Completed OLE Follow-up|Overall Study||10
8148626|NCT02647866|20083443|P4|Completed OLE Follow-up|Overall Study||14
8148627|NCT02647866|20083444|P3|Completed OLE Follow-up|Overall Study||4
8148628|NCT02647866|20083445|P2|Completed OLE Follow-up|Overall Study||6
8148629|NCT02647866|20083446|P1|Completed OLE Follow-up|Overall Study||0
8148630|NCT02647866|20083442|P5|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
8148631|NCT02647866|20083443|P4|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
8148632|NCT02647866|20083444|P3|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
8148633|NCT02647866|20083445|P2|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
8148634|NCT02647866|20083446|P1|Completed Open-Label Extension Therapy|Overall Study||0
8148635|NCT02647866|20083442|P5|Completed LTE Follow-up|Overall Study||0
8148636|NCT02647866|20083443|P4|Completed LTE Follow-up|Overall Study||0
8148637|NCT02647866|20083444|P3|Completed LTE Follow-up|Overall Study||0
8148638|NCT02647866|20083445|P2|Completed LTE Follow-up|Overall Study||0
8148639|NCT02647866|20083446|P1|Completed LTE Follow-up|Overall Study||2
8148640|NCT02647866|20083442|P5|Completed Long-Term Extension Therapy|Overall Study||0
8148641|NCT02647866|20083443|P4|Completed Long-Term Extension Therapy|Overall Study||0
8148642|NCT02647866|20083444|P3|Completed Long-Term Extension Therapy|Overall Study||0
8148643|NCT02647866|20083445|P2|Completed Long-Term Extension Therapy|Overall Study||0
8148644|NCT02647866|20083446|P1|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
8148645|NCT02647866|20083442|P5|Completed Induction Therapy Follow-Up|Overall Study||2
8148646|NCT02647866|20083443|P4|Completed Induction Therapy Follow-Up|Overall Study||0
8148647|NCT02647866|20083444|P3|Completed Induction Therapy Follow-Up|Overall Study||2
8148648|NCT02647866|20083445|P2|Completed Induction Therapy Follow-Up|Overall Study||1
8148649|NCT02647866|20083446|P1|Completed Induction Therapy Follow-Up|Overall Study||5
8148650|NCT02647866|20083442|P5|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
8148651|NCT02647866|20083443|P4|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
8148652|NCT02647866|20083444|P3|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
8148823|NCT02646826|20084027|P4|COMPLETED|Overall Study||21
8148653|NCT02647866|20083445|P2|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
8148654|NCT02647866|20083446|P1|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
8148655|NCT02647866|20083442|P5|STARTED|Overall Study||17
8148656|NCT02647866|20083443|P4|STARTED|Overall Study||21
8148657|NCT02647866|20083444|P3|STARTED|Overall Study||9
8148658|NCT02647866|20083445|P2|STARTED|Overall Study||10
8148659|NCT02647866|20083446|P1|STARTED|Overall Study||9
8148660|NCT02647788|20083523|P2|NOT COMPLETED|Overall Study||13
8148661|NCT02647788|20083524|P1|NOT COMPLETED|Overall Study||16
8148662|NCT02647788|20083523|P2|COMPLETED|Overall Study||57
8148663|NCT02647788|20083524|P1|COMPLETED|Overall Study||54
8148664|NCT02647788|20083523|P2|STARTED|Overall Study||70
8148665|NCT02647788|20083524|P1|STARTED|Overall Study||70
8148666|NCT02647658|20083536|P2|NOT COMPLETED|Overall Study||24
8148667|NCT02647658|20083537|P1|NOT COMPLETED|Overall Study||15
8148668|NCT02647658|20083536|P2|COMPLETED|Overall Study||1069
8148669|NCT02647658|20083537|P1|COMPLETED|Overall Study||1192
8148670|NCT02647658|20083536|P2|6 Month Assessment|Overall Study||635
8148671|NCT02647658|20083537|P1|6 Month Assessment|Overall Study||658
8148672|NCT02647658|20083536|P2|STARTED|Overall Study||1093
8148673|NCT02647658|20083537|P1|STARTED|Overall Study||1207
8148674|NCT02647645|20083565|P2|NOT COMPLETED|Overall Study||1
8148675|NCT02647645|20083566|P1|NOT COMPLETED|Overall Study||2
8148676|NCT02647645|20083565|P2|COMPLETED|Overall Study||9
8148677|NCT02647645|20083566|P1|COMPLETED|Overall Study||9
8148678|NCT02647645|20083565|P2|STARTED|Overall Study||10
8148679|NCT02647645|20083566|P1|STARTED|Overall Study||11
8148680|NCT02647346|20083576|P1|NOT COMPLETED|Overall Study||3
8148681|NCT02647346|20083576|P1|COMPLETED|Overall Study||129
8148682|NCT02647346|20083576|P1|STARTED|Overall Study||132
8148683|NCT02647320|20083588|P5|NOT COMPLETED|Overall Study||17
8148684|NCT02647320|20083589|P4|NOT COMPLETED|Overall Study||10
8148685|NCT02647320|20083590|P3|NOT COMPLETED|Overall Study||15
8148686|NCT02647320|20083591|P2|NOT COMPLETED|Overall Study||11
8148687|NCT02647320|20083592|P1|NOT COMPLETED|Overall Study||12
8148688|NCT02647320|20083588|P5|COMPLETED|Overall Study||52
8148689|NCT02647320|20083589|P4|COMPLETED|Overall Study||58
8148690|NCT02647320|20083590|P3|COMPLETED|Overall Study||54
8148691|NCT02647320|20083591|P2|COMPLETED|Overall Study||35
8148692|NCT02647320|20083592|P1|COMPLETED|Overall Study||34
8148693|NCT02647320|20083588|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
8148694|NCT02647320|20083589|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
8148695|NCT02647320|20083590|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
8148696|NCT02647320|20083591|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
8148697|NCT02647320|20083592|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
8148698|NCT02647320|20083588|P5|Safety Set|Overall Study||69
8148699|NCT02647320|20083589|P4|Safety Set|Overall Study||68
8148700|NCT02647320|20083590|P3|Safety Set|Overall Study||68
8148701|NCT02647320|20083591|P2|Safety Set|Overall Study||44
8148702|NCT02647320|20083592|P1|Safety Set|Overall Study||43
8148703|NCT02647320|20083588|P5|Inadvertently Randomized|Overall Study||0
8148704|NCT02647320|20083589|P4|Inadvertently Randomized|Overall Study||1
8148705|NCT02647320|20083590|P3|Inadvertently Randomized|Overall Study||0
8148706|NCT02647320|20083591|P2|Inadvertently Randomized|Overall Study||0
8148707|NCT02647320|20083592|P1|Inadvertently Randomized|Overall Study||0
8148708|NCT02647320|20083588|P5|STARTED|Overall Study||69
8148709|NCT02647320|20083589|P4|STARTED|Overall Study||68
8148710|NCT02647320|20083590|P3|STARTED|Overall Study||69
8148711|NCT02647320|20083591|P2|STARTED|Overall Study||46
8148712|NCT02647320|20083592|P1|STARTED|Overall Study||46
8148713|NCT02647281|20083683|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
8148714|NCT02647281|20083684|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148715|NCT02647281|20083685|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148716|NCT02647281|20083686|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148717|NCT02647281|20083687|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148718|NCT02647281|20083688|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148719|NCT02647281|20083689|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148720|NCT02647281|20083690|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148721|NCT02647281|20083691|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148722|NCT02647281|20083683|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
8148723|NCT02647281|20083684|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148724|NCT02647281|20083685|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148725|NCT02647281|20083686|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148726|NCT02647281|20083687|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148727|NCT02647281|20083688|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148728|NCT02647281|20083689|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148729|NCT02647281|20083690|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148730|NCT02647281|20083691|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148731|NCT02647281|20083683|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148732|NCT02647281|20083684|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148733|NCT02647281|20083685|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148734|NCT02647281|20083686|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148735|NCT02647281|20083687|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148736|NCT02647281|20083688|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148737|NCT02647281|20083689|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148738|NCT02647281|20083690|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148739|NCT02647281|20083691|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148740|NCT02647281|20083683|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148741|NCT02647281|20083684|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148742|NCT02647281|20083685|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148743|NCT02647281|20083686|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148744|NCT02647281|20083687|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148745|NCT02647281|20083688|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148746|NCT02647281|20083689|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148747|NCT02647281|20083690|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148748|NCT02647281|20083691|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148749|NCT02647281|20083683|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148750|NCT02647281|20083684|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148751|NCT02647281|20083685|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148752|NCT02647281|20083686|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148753|NCT02647281|20083687|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148754|NCT02647281|20083688|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148755|NCT02647281|20083689|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148756|NCT02647281|20083690|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148757|NCT02647281|20083691|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
8148758|NCT02647281|20083683|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148759|NCT02647281|20083684|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148760|NCT02647281|20083685|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148761|NCT02647281|20083686|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148762|NCT02647281|20083687|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148763|NCT02647281|20083688|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148764|NCT02647281|20083689|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148765|NCT02647281|20083690|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148766|NCT02647281|20083691|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
8148767|NCT02647203|20083871|P2|NOT COMPLETED|24 Month Follow-up||11
8148768|NCT02647203|20083872|P1|NOT COMPLETED|24 Month Follow-up||6
8148769|NCT02647203|20083871|P2|COMPLETED|24 Month Follow-up||138
8148770|NCT02647203|20083872|P1|COMPLETED|24 Month Follow-up||142
8148771|NCT02647203|20083871|P2|STARTED|24 Month Follow-up||149
8148772|NCT02647203|20083872|P1|STARTED|24 Month Follow-up||148
8148773|NCT02647203|20083871|P2|NOT COMPLETED|12 Month Follow-up||23
8148774|NCT02647203|20083872|P1|NOT COMPLETED|12 Month Follow-up||25
8148775|NCT02647203|20083871|P2|COMPLETED|12 Month Follow-up||149
8148776|NCT02647203|20083872|P1|COMPLETED|12 Month Follow-up||148
8148777|NCT02647203|20083871|P2|STARTED|12 Month Follow-up||172
8148778|NCT02647203|20083872|P1|STARTED|12 Month Follow-up||173
8148779|NCT02646891|20083890|P10|NOT COMPLETED|Overall Study||5
8148780|NCT02646891|20083891|P9|NOT COMPLETED|Overall Study||10
8148781|NCT02646891|20083892|P8|NOT COMPLETED|Overall Study||13
8148782|NCT02646891|20083893|P7|NOT COMPLETED|Overall Study||9
8148783|NCT02646891|20083894|P6|NOT COMPLETED|Overall Study||0
8148784|NCT02646891|20083895|P5|NOT COMPLETED|Overall Study||0
8148785|NCT02646891|20083896|P4|NOT COMPLETED|Overall Study||0
8148786|NCT02646891|20083897|P3|NOT COMPLETED|Overall Study||1
8148787|NCT02646891|20083898|P2|NOT COMPLETED|Overall Study||1
8148788|NCT02646891|20083899|P1|NOT COMPLETED|Overall Study||2
8148789|NCT02646891|20083890|P10|COMPLETED|Overall Study||134
8148790|NCT02646891|20083891|P9|COMPLETED|Overall Study||130
8148791|NCT02646891|20083892|P8|COMPLETED|Overall Study||127
8148792|NCT02646891|20083893|P7|COMPLETED|Overall Study||130
8148793|NCT02646891|20083894|P6|COMPLETED|Overall Study||12
8148794|NCT02646891|20083895|P5|COMPLETED|Overall Study||12
8148795|NCT02646891|20083896|P4|COMPLETED|Overall Study||6
8148796|NCT02646891|20083897|P3|COMPLETED|Overall Study||11
8148797|NCT02646891|20083898|P2|COMPLETED|Overall Study||11
8148798|NCT02646891|20083899|P1|COMPLETED|Overall Study||4
8148799|NCT02646891|20083890|P10|Received at Least 1 Dose|Overall Study||139
8148800|NCT02646891|20083891|P9|Received at Least 1 Dose|Overall Study||140
8148801|NCT02646891|20083892|P8|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
8148802|NCT02646891|20083893|P7|Received at Least 1 Dose|Overall Study||139
8148803|NCT02646891|20083894|P6|Received at Least 1 Dose|Overall Study||12
8148804|NCT02646891|20083895|P5|Received at Least 1 Dose|Overall Study||12
8148805|NCT02646891|20083896|P4|Received at Least 1 Dose|Overall Study||6
8148806|NCT02646891|20083897|P3|Received at Least 1 Dose|Overall Study||12
8148807|NCT02646891|20083898|P2|Received at Least 1 Dose|Overall Study||12
8148808|NCT02646891|20083899|P1|Received at Least 1 Dose|Overall Study||6
8148809|NCT02646891|20083890|P10|STARTED|Overall Study||139
8148810|NCT02646891|20083891|P9|STARTED|Overall Study||140
8148811|NCT02646891|20083892|P8|STARTED|Overall Study||140
8148812|NCT02646891|20083893|P7|STARTED|Overall Study||139
8148813|NCT02646891|20083894|P6|STARTED|Overall Study||12
8148814|NCT02646891|20083895|P5|STARTED|Overall Study||12
8148815|NCT02646891|20083896|P4|STARTED|Overall Study||6
8148816|NCT02646891|20083897|P3|STARTED|Overall Study||12
8148817|NCT02646891|20083898|P2|STARTED|Overall Study||12
8148818|NCT02646891|20083899|P1|STARTED|Overall Study||6
8148819|NCT02646826|20084027|P4|NOT COMPLETED|Overall Study||1
8148820|NCT02646826|20084028|P3|NOT COMPLETED|Overall Study||1
8148821|NCT02646826|20084029|P2|NOT COMPLETED|Overall Study||0
8148822|NCT02646826|20084030|P1|NOT COMPLETED|Overall Study||2
8148824|NCT02646826|20084028|P3|COMPLETED|Overall Study||20
8148825|NCT02646826|20084029|P2|COMPLETED|Overall Study||22
8148826|NCT02646826|20084030|P1|COMPLETED|Overall Study||19
8148827|NCT02646826|20084027|P4|STARTED|Overall Study||22
8148828|NCT02646826|20084028|P3|STARTED|Overall Study||21
8148829|NCT02646826|20084029|P2|STARTED|Overall Study||22
8148830|NCT02646826|20084030|P1|STARTED|Overall Study||21
8148831|NCT02646761|20084054|P2|NOT COMPLETED|Overall Study||10
8148832|NCT02646761|20084055|P1|NOT COMPLETED|Overall Study||8
8148833|NCT02646761|20084054|P2|COMPLETED|Overall Study||10
8148834|NCT02646761|20084055|P1|COMPLETED|Overall Study||10
8148835|NCT02646761|20084054|P2|5-week Assessment|Overall Study||10
8148836|NCT02646761|20084055|P1|5-week Assessment|Overall Study||12
8148837|NCT02646761|20084054|P2|Baseline Assessment|Overall Study||12
8148838|NCT02646761|20084055|P1|Baseline Assessment|Overall Study||13
8148839|NCT02646761|20084054|P2|Subject Withdrew Before Baseline|Overall Study||8
8148840|NCT02646761|20084055|P1|Subject Withdrew Before Baseline|Overall Study||5
8148841|NCT02646761|20084054|P2|STARTED|Overall Study||20
8148842|NCT02646761|20084055|P1|STARTED|Overall Study||18
8148843|NCT02646566|20084073|P3|NOT COMPLETED|Overall Study||5
8148844|NCT02646566|20084074|P2|NOT COMPLETED|Overall Study||4
8148845|NCT02646566|20084075|P1|NOT COMPLETED|Overall Study||6
8148846|NCT02646566|20084073|P3|COMPLETED|Overall Study||230
8148847|NCT02646566|20084074|P2|COMPLETED|Overall Study||226
8148848|NCT02646566|20084075|P1|COMPLETED|Overall Study||231
8148849|NCT02646566|20084073|P3|STARTED|Overall Study||235
8148850|NCT02646566|20084074|P2|STARTED|Overall Study||230
8148851|NCT02646566|20084075|P1|STARTED|Overall Study||237
8148852|NCT02646449|20084115|P2|NOT COMPLETED|Overall Study||0
8148853|NCT02646449|20084116|P1|NOT COMPLETED|Overall Study||0
8148854|NCT02646449|20084115|P2|COMPLETED|Overall Study||3
8148855|NCT02646449|20084116|P1|COMPLETED|Overall Study||4
8148856|NCT02646449|20084115|P2|STARTED|Overall Study||3
8148857|NCT02646449|20084116|P1|STARTED|Overall Study||4
8148858|NCT02646371|20084126|P2|NOT COMPLETED|Overall Study||0
8148859|NCT02646371|20084127|P1|NOT COMPLETED|Overall Study||0
8148860|NCT02646371|20084126|P2|COMPLETED|Overall Study||33
8148861|NCT02646371|20084127|P1|COMPLETED|Overall Study||34
8148862|NCT02646371|20084126|P2|STARTED|Overall Study||33
8148863|NCT02646371|20084127|P1|STARTED|Overall Study||34
8148864|NCT02646332|20084135|P2|NOT COMPLETED|Overall Study||3
8148865|NCT02646332|20084136|P1|NOT COMPLETED|Overall Study||0
8148866|NCT02646332|20084135|P2|COMPLETED|Overall Study||121
8148867|NCT02646332|20084136|P1|COMPLETED|Overall Study||124
8148868|NCT02646332|20084135|P2|STARTED|Overall Study||124
8148869|NCT02646332|20084136|P1|STARTED|Overall Study||124
8148870|NCT02646124|20084144|P2|NOT COMPLETED|Overall Study||2
8148871|NCT02646124|20084145|P1|NOT COMPLETED|Overall Study||0
8148872|NCT02646124|20084144|P2|COMPLETED|Overall Study||55
8148873|NCT02646124|20084145|P1|COMPLETED|Overall Study||57
8148874|NCT02646124|20084144|P2|STARTED|Overall Study||57
8148875|NCT02646124|20084145|P1|STARTED|Overall Study||57
8148876|NCT02645760|20084161|P2|NOT COMPLETED|Overall Study||0
8148877|NCT02645760|20084162|P1|NOT COMPLETED|Overall Study||0
8148878|NCT02645760|20084161|P2|COMPLETED|Overall Study||19
8148879|NCT02645760|20084162|P1|COMPLETED|Overall Study||19
8148880|NCT02645760|20084161|P2|STARTED|Overall Study||19
8148881|NCT02645760|20084162|P1|STARTED|Overall Study||19
8148882|NCT02645617|20084174|P1|NOT COMPLETED|Overall Study||0
8148883|NCT02645617|20084174|P1|COMPLETED|Overall Study||12
8148884|NCT02645617|20084174|P1|STARTED|Overall Study||12
8148885|NCT02645409|20084181|P2|NOT COMPLETED|Overall Study||0
8148886|NCT02645409|20084182|P1|NOT COMPLETED|Overall Study||4
8148887|NCT02645409|20084181|P2|COMPLETED|Overall Study||0
8148888|NCT02645409|20084182|P1|COMPLETED|Overall Study||10
8148889|NCT02645409|20084181|P2|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
8148890|NCT02645409|20084182|P1|STARTED|Overall Study||14
8148891|NCT02645253|20084191|P4|NOT COMPLETED|Overall Study||0
8148892|NCT02645253|20084192|P3|NOT COMPLETED|Overall Study||0
8148893|NCT02645253|20084193|P2|NOT COMPLETED|Overall Study||0
8148894|NCT02645253|20084194|P1|NOT COMPLETED|Overall Study||0
8148895|NCT02645253|20084191|P4|COMPLETED|Overall Study||6
8148896|NCT02645253|20084192|P3|COMPLETED|Overall Study||7
8148897|NCT02645253|20084193|P2|COMPLETED|Overall Study||7
8148898|NCT02645253|20084194|P1|COMPLETED|Overall Study||7
8148899|NCT02645253|20084191|P4|STARTED|Overall Study||6
8148900|NCT02645253|20084192|P3|STARTED|Overall Study||7
8148901|NCT02645253|20084193|P2|STARTED|Overall Study||7
8148902|NCT02645253|20084194|P1|STARTED|Overall Study||7
8148903|NCT02645123|20084316|P3|NOT COMPLETED|Overall Study||0
8148904|NCT02645123|20084317|P2|NOT COMPLETED|Overall Study||0
8148905|NCT02645123|20084318|P1|NOT COMPLETED|Overall Study||0
8148906|NCT02645123|20084316|P3|COMPLETED|Overall Study||25
8148907|NCT02645123|20084317|P2|COMPLETED|Overall Study||25
8148908|NCT02645123|20084318|P1|COMPLETED|Overall Study||25
8148909|NCT02645123|20084316|P3|STARTED|Overall Study||25
8148910|NCT02645123|20084317|P2|STARTED|Overall Study||25
8148911|NCT02645123|20084318|P1|STARTED|Overall Study||25
8148912|NCT02645019|20084340|P5|NOT COMPLETED|Overall Study||0
8148913|NCT02645019|20084341|P4|NOT COMPLETED|Overall Study||0
8148914|NCT02645019|20084342|P3|NOT COMPLETED|Overall Study||0
8148915|NCT02645019|20084343|P2|NOT COMPLETED|Overall Study||0
8148916|NCT02645019|20084344|P1|NOT COMPLETED|Overall Study||0
8148917|NCT02645019|20084340|P5|COMPLETED|Overall Study||24
8148918|NCT02645019|20084341|P4|COMPLETED|Overall Study||33
8148919|NCT02645019|20084342|P3|COMPLETED|Overall Study||15
8148920|NCT02645019|20084343|P2|COMPLETED|Overall Study||15
8148921|NCT02645019|20084344|P1|COMPLETED|Overall Study||13
8148922|NCT02645019|20084340|P5|STARTED|Overall Study||24
8148923|NCT02645019|20084341|P4|STARTED|Overall Study||33
8148924|NCT02645019|20084342|P3|STARTED|Overall Study||15
8148925|NCT02645019|20084343|P2|STARTED|Overall Study||15
8148926|NCT02645019|20084344|P1|STARTED|Overall Study||13
8148927|NCT02644668|20084369|P3|NOT COMPLETED|Overall Study||3
8148928|NCT02644668|20084370|P2|NOT COMPLETED|Overall Study||0
8148929|NCT02644668|20084371|P1|NOT COMPLETED|Overall Study||2
8148930|NCT02644668|20084369|P3|COMPLETED|Overall Study||17
8148931|NCT02644668|20084370|P2|COMPLETED|Overall Study||24
8148932|NCT02644668|20084371|P1|COMPLETED|Overall Study||24
8148933|NCT02644668|20084369|P3|STARTED|Overall Study||20
8148934|NCT02644668|20084370|P2|STARTED|Overall Study||24
8148935|NCT02644668|20084371|P1|STARTED|Overall Study||26
8148936|NCT02644356|20084410|P1|NOT COMPLETED|Overall Study||2
8148937|NCT02644356|20084410|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
8148938|NCT02644356|20084410|P1|STARTED|Overall Study||51
8148939|NCT02644343|20084420|P1|NOT COMPLETED|Overall Study||1
8148940|NCT02644343|20084420|P1|COMPLETED|Overall Study||39
8148941|NCT02644343|20084420|P1|STARTED|Overall Study||40
8148942|NCT02644278|20084428|P4|NOT COMPLETED|Overall Study||0
8148943|NCT02644278|20084429|P3|NOT COMPLETED|Overall Study||0
8148944|NCT02644278|20084430|P2|NOT COMPLETED|Overall Study||0
8148945|NCT02644278|20084431|P1|NOT COMPLETED|Overall Study||0
8148946|NCT02644278|20084428|P4|COMPLETED|Overall Study||3
8148947|NCT02644278|20084429|P3|COMPLETED|Overall Study||6
8148948|NCT02644278|20084430|P2|COMPLETED|Overall Study||3
8148949|NCT02644278|20084431|P1|COMPLETED|Overall Study||3
8148950|NCT02644278|20084428|P4|STARTED|Overall Study||3
8148951|NCT02644278|20084429|P3|STARTED|Overall Study||6
8148952|NCT02644278|20084430|P2|STARTED|Overall Study||3
8148953|NCT02644278|20084431|P1|STARTED|Overall Study||3
8148954|NCT02644122|20084497|P1|NOT COMPLETED|Overall Study||1
8148955|NCT02644122|20084497|P1|COMPLETED|Overall Study||0
8148956|NCT02644122|20084497|P1|STARTED|Overall Study||1
8148957|NCT02644109|20084507|P2|NOT COMPLETED|Overall Study||4
8148958|NCT02644109|20084508|P1|NOT COMPLETED|Overall Study||0
8148959|NCT02644109|20084507|P2|COMPLETED|Overall Study||24
8148960|NCT02644109|20084508|P1|COMPLETED|Overall Study||24
8148961|NCT02644109|20084507|P2|STARTED|Overall Study||28
8148962|NCT02644109|20084508|P1|STARTED|Overall Study||24
8148963|NCT02644096|20084516|P2|NOT COMPLETED|Overall Study||25
8148964|NCT02644096|20084517|P1|NOT COMPLETED|Overall Study||28
8148965|NCT02644096|20084516|P2|COMPLETED|Overall Study||57
8148966|NCT02644096|20084517|P1|COMPLETED|Overall Study||65
8148967|NCT02644096|20084516|P2|9 Month SF-36 Questionnaire|Overall Study||57
8148968|NCT02644096|20084517|P1|9 Month SF-36 Questionnaire|Overall Study||65
8148969|NCT02644096|20084516|P2|12 Week SF-36 Questionnaire|Overall Study||59
8148970|NCT02644096|20084517|P1|12 Week SF-36 Questionnaire|Overall Study||68
8148971|NCT02644096|20084516|P2|10 Week Interview|Overall Study||59
8148972|NCT02644096|20084517|P1|10 Week Interview|Overall Study|Not done in control group|0
8148973|NCT02644096|20084516|P2|2 Week Interview|Overall Study||68
8148974|NCT02644096|20084517|P1|2 Week Interview|Overall Study|Not done in control group|0
8148975|NCT02644096|20084516|P2|STARTED|Overall Study||82
8148976|NCT02644096|20084517|P1|STARTED|Overall Study||93
8148977|NCT02643979|20084525|P2|NOT COMPLETED|Overall Study||0
8148978|NCT02643979|20084526|P1|NOT COMPLETED|Overall Study||0
8148979|NCT02643979|20084525|P2|COMPLETED|Overall Study||11
8148980|NCT02643979|20084526|P1|COMPLETED|Overall Study||11
8148981|NCT02643979|20084525|P2|STARTED|Overall Study||11
8148982|NCT02643979|20084526|P1|STARTED|Overall Study||11
8148983|NCT02643875|20084544|P1|NOT COMPLETED|Overall Study||8
8148984|NCT02643875|20084544|P1|COMPLETED|Overall Study||28
8148985|NCT02643875|20084544|P1|Received 1.75 D|Overall Study||36
8148986|NCT02643875|20084544|P1|Received 0.75|Overall Study||36
8148987|NCT02643875|20084544|P1|STARTED|Overall Study||36
8148988|NCT02643862|20084553|P2|NOT COMPLETED|Overall Study||0
8148989|NCT02643862|20084554|P1|NOT COMPLETED|Overall Study||0
8148990|NCT02643862|20084553|P2|COMPLETED|Overall Study||12
8148991|NCT02643862|20084554|P1|COMPLETED|Overall Study||36
8148992|NCT02643862|20084553|P2|STARTED|Overall Study||12
8148993|NCT02643862|20084554|P1|STARTED|Overall Study||36
8148994|NCT02643849|20084562|P1|NOT COMPLETED|Overall Study||25
8148995|NCT02643849|20084562|P1|COMPLETED|Overall Study||82
8148996|NCT02643849|20084562|P1|STARTED|Overall Study||107
8148997|NCT02643693|20084569|P6|NOT COMPLETED|Overall Study||1
8148998|NCT02643693|20084570|P5|NOT COMPLETED|Overall Study||0
8148999|NCT02643693|20084571|P4|NOT COMPLETED|Overall Study||0
8149000|NCT02643693|20084572|P3|NOT COMPLETED|Overall Study||1
8149001|NCT02643693|20084573|P2|NOT COMPLETED|Overall Study||2
8149002|NCT02643693|20084574|P1|NOT COMPLETED|Overall Study||2
8149003|NCT02643693|20084569|P6|COMPLETED|Overall Study||3
8149004|NCT02643693|20084570|P5|COMPLETED|Overall Study||4
8149005|NCT02643693|20084571|P4|COMPLETED|Overall Study||4
8149006|NCT02643693|20084572|P3|COMPLETED|Overall Study||3
8149007|NCT02643693|20084573|P2|COMPLETED|Overall Study||2
8149008|NCT02643693|20084574|P1|COMPLETED|Overall Study||2
8149009|NCT02643693|20084569|P6|STARTED|Overall Study||4
8149010|NCT02643693|20084570|P5|STARTED|Overall Study||4
8149011|NCT02643693|20084571|P4|STARTED|Overall Study||4
8149012|NCT02643693|20084572|P3|STARTED|Overall Study||4
8149013|NCT02643693|20084573|P2|STARTED|Overall Study||4
8149014|NCT02643693|20084574|P1|STARTED|Overall Study||4
8149015|NCT02643628|20084587|P2|NOT COMPLETED|Overall Study||6
8149016|NCT02643628|20084588|P1|NOT COMPLETED|Overall Study||1
8149017|NCT02643628|20084587|P2|COMPLETED|Overall Study||17
8149018|NCT02643628|20084588|P1|COMPLETED|Overall Study||20
8149019|NCT02643628|20084587|P2|STARTED|Overall Study||23
8149020|NCT02643628|20084588|P1|STARTED|Overall Study||21
8149021|NCT02643615|20084604|P2|NOT COMPLETED|Overall Study||0
8149022|NCT02643615|20084605|P1|NOT COMPLETED|Overall Study||0
8149023|NCT02643615|20084604|P2|COMPLETED|Overall Study||11
8149024|NCT02643615|20084605|P1|COMPLETED|Overall Study||9
8149025|NCT02643615|20084604|P2|STARTED|Overall Study||11
8149026|NCT02643615|20084605|P1|STARTED|Overall Study||9
8149027|NCT02643472|20084619|P2|NOT COMPLETED|Overall Study||34
8149028|NCT02643472|20084620|P1|NOT COMPLETED|Overall Study||27
8149029|NCT02643472|20084619|P2|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
8149030|NCT02643472|20084620|P1|COMPLETED|Overall Study||123
8149031|NCT02643472|20084619|P2|STARTED|Overall Study||150
8149032|NCT02643472|20084620|P1|STARTED|Overall Study||150
8149033|NCT02643394|20084646|P2|NOT COMPLETED|Overall Study||5
8149034|NCT02643394|20084647|P1|NOT COMPLETED|Overall Study||4
8149035|NCT02643394|20084646|P2|COMPLETED|Overall Study||50
8149036|NCT02643394|20084647|P1|COMPLETED|Overall Study||51
8149037|NCT02643394|20084646|P2|STARTED|Overall Study||55
8149038|NCT02643394|20084647|P1|STARTED|Overall Study||55
8149039|NCT02643355|20084657|P2|NOT COMPLETED|Overall Study||5
8149040|NCT02643355|20084658|P1|NOT COMPLETED|Overall Study||1
8149041|NCT02643355|20084657|P2|COMPLETED|Overall Study||30
8149042|NCT02643355|20084658|P1|COMPLETED|Overall Study||33
8149043|NCT02643355|20084657|P2|STARTED|Overall Study||35
8149044|NCT02643355|20084658|P1|STARTED|Overall Study||34
8149045|NCT02643251|20084672|P2|NOT COMPLETED|Overall Study||2
8149046|NCT02643251|20084673|P1|NOT COMPLETED|Overall Study||11
8149047|NCT02643251|20084672|P2|COMPLETED|Overall Study||67
8149048|NCT02643251|20084673|P1|COMPLETED|Overall Study||58
8149049|NCT02643251|20084672|P2|STARTED|Overall Study||69
8149050|NCT02643251|20084673|P1|STARTED|Overall Study||69
8149051|NCT02643225|20084683|P2|NOT COMPLETED|Overall Study||0
8149052|NCT02643225|20084684|P1|NOT COMPLETED|Overall Study||0
8149053|NCT02643225|20084683|P2|COMPLETED|Overall Study||40
8149054|NCT02643225|20084684|P1|COMPLETED|Overall Study||40
8149055|NCT02643225|20084683|P2|STARTED|Overall Study||40
8149056|NCT02643225|20084684|P1|STARTED|Overall Study||40
8149057|NCT02643199|20084696|P1|NOT COMPLETED|Overall Study||0
8149058|NCT02643199|20084696|P1|COMPLETED|Overall Study||90
8149059|NCT02643199|20084696|P1|STARTED|Overall Study||90
8149060|NCT02643095|20084701|P1|NOT COMPLETED|Overall Study||1
8149061|NCT02643095|20084701|P1|COMPLETED|Overall Study||21
8149062|NCT02643095|20084701|P1|STARTED|Overall Study||22
8149063|NCT02643082|20084705|P2|NOT COMPLETED|Period 2||0
8149064|NCT02643082|20084706|P1|NOT COMPLETED|Period 2||0
8149065|NCT02643082|20084705|P2|COMPLETED|Period 2||10
8149066|NCT02643082|20084706|P1|COMPLETED|Period 2||9
8149067|NCT02643082|20084705|P2|STARTED|Period 2||10
8149068|NCT02643082|20084706|P1|STARTED|Period 2||9
8149069|NCT02643082|20084705|P2|NOT COMPLETED|Washout||0
8149070|NCT02643082|20084706|P1|NOT COMPLETED|Washout||0
8149071|NCT02643082|20084705|P2|COMPLETED|Washout||10
8149072|NCT02643082|20084706|P1|COMPLETED|Washout||9
8149073|NCT02643082|20084705|P2|STARTED|Washout||10
8149074|NCT02643082|20084706|P1|STARTED|Washout||9
8149075|NCT02643082|20084705|P2|NOT COMPLETED|Period 1||0
8149076|NCT02643082|20084706|P1|NOT COMPLETED|Period 1||1
8149077|NCT02643082|20084705|P2|COMPLETED|Period 1||10
8149078|NCT02643082|20084706|P1|COMPLETED|Period 1||9
8149079|NCT02643082|20084705|P2|STARTED|Period 1||10
8149080|NCT02643082|20084706|P1|STARTED|Period 1||10
8149081|NCT02643004|20084723|P2|NOT COMPLETED|Second Intervention (One Week)||0
8149082|NCT02643004|20084724|P1|NOT COMPLETED|Second Intervention (One Week)||0
8149083|NCT02643004|20084723|P2|COMPLETED|Second Intervention (One Week)||35
8149084|NCT02643004|20084724|P1|COMPLETED|Second Intervention (One Week)||35
8149085|NCT02643004|20084723|P2|STARTED|Second Intervention (One Week)||35
8149086|NCT02643004|20084724|P1|STARTED|Second Intervention (One Week)||35
8149087|NCT02643004|20084723|P2|NOT COMPLETED|First Intervention (One Week)||0
8149088|NCT02643004|20084724|P1|NOT COMPLETED|First Intervention (One Week)||0
8149089|NCT02643004|20084723|P2|COMPLETED|First Intervention (One Week)||35
8149090|NCT02643004|20084724|P1|COMPLETED|First Intervention (One Week)||35
8149091|NCT02643004|20084723|P2|STARTED|First Intervention (One Week)||35
8149092|NCT02643004|20084724|P1|STARTED|First Intervention (One Week)||35
8149093|NCT02642991|20084764|P2|NOT COMPLETED|Second Intervention||0
8149094|NCT02642991|20084765|P1|NOT COMPLETED|Second Intervention||0
8149095|NCT02642991|20084764|P2|COMPLETED|Second Intervention||22
8149096|NCT02642991|20084765|P1|COMPLETED|Second Intervention||22
8149097|NCT02642991|20084764|P2|STARTED|Second Intervention||22
8149098|NCT02642991|20084765|P1|STARTED|Second Intervention||22
8149099|NCT02642991|20084764|P2|NOT COMPLETED|First Intervention||0
8149100|NCT02642991|20084765|P1|NOT COMPLETED|First Intervention||0
8149101|NCT02642991|20084764|P2|COMPLETED|First Intervention||22
8149102|NCT02642991|20084765|P1|COMPLETED|First Intervention||22
8149103|NCT02642991|20084764|P2|STARTED|First Intervention||22
8149104|NCT02642991|20084765|P1|STARTED|First Intervention||22
8149105|NCT02642965|20084846|P1|NOT COMPLETED|Overall Study||13
8149106|NCT02642965|20084846|P1|COMPLETED|Overall Study||25
8149107|NCT02642965|20084846|P1|STARTED|Overall Study||38
8149108|NCT02642952|20084862|P2|NOT COMPLETED|Overall Study||5
8149109|NCT02642952|20084863|P1|NOT COMPLETED|Overall Study||2
8149110|NCT02642952|20084862|P2|COMPLETED|Overall Study||25
8149111|NCT02642952|20084863|P1|COMPLETED|Overall Study||19
8149112|NCT02642952|20084862|P2|STARTED|Overall Study||30
8149113|NCT02642952|20084863|P1|STARTED|Overall Study||21
8149114|NCT02642835|20084877|P1|NOT COMPLETED|Overall Study||0
8149115|NCT02642835|20084877|P1|COMPLETED|Overall Study||48
8149116|NCT02642835|20084877|P1|STARTED|Overall Study||48
8149117|NCT02642679|20084890|P1|NOT COMPLETED|Overall Study||3
8149118|NCT02642679|20084890|P1|COMPLETED|Overall Study||16
8149119|NCT02642679|20084890|P1|STARTED|Overall Study||19
8149120|NCT02642653|20084898|P2|NOT COMPLETED|Overall Study||0
8149121|NCT02642653|20084899|P1|NOT COMPLETED|Overall Study||2
8149122|NCT02642653|20084898|P2|COMPLETED|Overall Study||16
8149123|NCT02642653|20084899|P1|COMPLETED|Overall Study||12
8149124|NCT02642653|20084898|P2|STARTED|Overall Study||16
8149125|NCT02642653|20084899|P1|STARTED|Overall Study||14
8149126|NCT02642627|20084931|P1|NOT COMPLETED|Overall Study||3
8149127|NCT02642627|20084931|P1|COMPLETED|Overall Study||39
8149128|NCT02642627|20084931|P1|STARTED|Overall Study||42
8149129|NCT02642614|20084940|P4|NOT COMPLETED|Overall Study||2
8149130|NCT02642614|20084941|P3|NOT COMPLETED|Overall Study||2
8149131|NCT02642614|20084942|P2|NOT COMPLETED|Overall Study||2
8149132|NCT02642614|20084943|P1|NOT COMPLETED|Overall Study||3
8149133|NCT02642614|20084940|P4|COMPLETED|Overall Study||28
8149134|NCT02642614|20084941|P3|COMPLETED|Overall Study||28
8149135|NCT02642614|20084942|P2|COMPLETED|Overall Study||28
8149136|NCT02642614|20084943|P1|COMPLETED|Overall Study||27
8149137|NCT02642614|20084940|P4|STARTED|Overall Study||30
8149138|NCT02642614|20084941|P3|STARTED|Overall Study||30
8149139|NCT02642614|20084942|P2|STARTED|Overall Study||30
8149140|NCT02642614|20084943|P1|STARTED|Overall Study||30
8149141|NCT02642575|20084975|P1|NOT COMPLETED|Overall Study||0
8149142|NCT02642575|20084975|P1|COMPLETED|Overall Study||67
8149143|NCT02642575|20084975|P1|STARTED|Overall Study||67
8149144|NCT02642536|20084983|P2|NOT COMPLETED|Overall Study||5
8149145|NCT02642536|20084984|P1|NOT COMPLETED|Overall Study||2
8149146|NCT02642536|20084983|P2|COMPLETED|Overall Study||18
8149147|NCT02642536|20084984|P1|COMPLETED|Overall Study||19
8149148|NCT02642536|20084983|P2|STARTED|Overall Study||23
8149149|NCT02642536|20084984|P1|STARTED|Overall Study||21
8149150|NCT02642432|20085010|P1|NOT COMPLETED|Overall Study||8
8149151|NCT02642432|20085010|P1|COMPLETED|Overall Study||138
8149152|NCT02642432|20085010|P1|STARTED|Overall Study||146
8149153|NCT02642393|20085018|P2|NOT COMPLETED|Overall Study||92
8149154|NCT02642393|20085019|P1|NOT COMPLETED|Overall Study||99
8149155|NCT02642393|20085018|P2|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
8149156|NCT02642393|20085019|P1|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
8149157|NCT02642393|20085018|P2|STARTED|Overall Study||149
8149158|NCT02642393|20085019|P1|STARTED|Overall Study||149
8149159|NCT02642237|20085047|P2|NOT COMPLETED|Overall Study||0
8149160|NCT02642237|20085048|P1|NOT COMPLETED|Overall Study||0
8149161|NCT02642237|20085047|P2|COMPLETED|Overall Study||15
8149162|NCT02642237|20085048|P1|COMPLETED|Overall Study||15
8149163|NCT02642237|20085047|P2|STARTED|Overall Study||15
8149164|NCT02642237|20085048|P1|STARTED|Overall Study||15
8149165|NCT02642159|20085056|P2|NOT COMPLETED|Overall Study||8
8149166|NCT02642159|20085057|P1|NOT COMPLETED|Overall Study||31
8149167|NCT02642159|20085056|P2|COMPLETED|Overall Study||129
8149168|NCT02642159|20085057|P1|COMPLETED|Overall Study||245
8149169|NCT02642159|20085056|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
8149170|NCT02642159|20085057|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
8149171|NCT02642159|20085056|P2|ITT Population|Overall Study||136
8149172|NCT02642159|20085057|P1|ITT Population|Overall Study||273
8149173|NCT02642159|20085056|P2|Treated (Safety Population)|Overall Study||137
8149174|NCT02642159|20085057|P1|Treated (Safety Population)|Overall Study||275
8149175|NCT02642159|20085056|P2|STARTED|Overall Study|Randomized|137
8149176|NCT02642159|20085057|P1|STARTED|Overall Study|Randomized|276
8149177|NCT02641912|20085109|P2|NOT COMPLETED|Overall Study||0
8149178|NCT02641912|20085110|P1|NOT COMPLETED|Overall Study||0
8149179|NCT02641912|20085109|P2|COMPLETED|Overall Study||47
8149180|NCT02641912|20085110|P1|COMPLETED|Overall Study||53
8149181|NCT02641912|20085109|P2|STARTED|Overall Study||47
8149182|NCT02641912|20085110|P1|STARTED|Overall Study||53
8149183|NCT02641730|20085181|P5|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
8149184|NCT02641730|20085182|P4|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149185|NCT02641730|20085183|P3|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149186|NCT02641730|20085184|P2|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149187|NCT02641730|20085185|P1|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149188|NCT02641730|20085181|P5|COMPLETED|Observational Period (Week 60 - Week 84)||43
8149189|NCT02641730|20085182|P4|COMPLETED|Observational Period (Week 60 - Week 84)||45
8149190|NCT02641730|20085183|P3|COMPLETED|Observational Period (Week 60 - Week 84)||24
8149191|NCT02641730|20085184|P2|COMPLETED|Observational Period (Week 60 - Week 84)||21
8149192|NCT02641730|20085185|P1|COMPLETED|Observational Period (Week 60 - Week 84)||0
8149193|NCT02641730|20085181|P5|STARTED|Observational Period (Week 60 - Week 84)||44
8149194|NCT02641730|20085182|P4|STARTED|Observational Period (Week 60 - Week 84)||45
8149195|NCT02641730|20085183|P3|STARTED|Observational Period (Week 60 - Week 84)||24
8149196|NCT02641730|20085184|P2|STARTED|Observational Period (Week 60 - Week 84)||21
8149197|NCT02641730|20085185|P1|STARTED|Observational Period (Week 60 - Week 84)||0
8149198|NCT02641730|20085181|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
8149199|NCT02641730|20085182|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
8149200|NCT02641730|20085183|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
8149201|NCT02641730|20085184|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
8149202|NCT02641730|20085185|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8149203|NCT02641730|20085181|P5|COMPLETED|After Controlled Period (Week 16 - 52)||44
8149204|NCT02641730|20085182|P4|COMPLETED|After Controlled Period (Week 16 - 52)||45
8149205|NCT02641730|20085183|P3|COMPLETED|After Controlled Period (Week 16 - 52)||24
8149206|NCT02641730|20085184|P2|COMPLETED|After Controlled Period (Week 16 - 52)||21
8149207|NCT02641730|20085185|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
8149208|NCT02641730|20085181|P5|STARTED|After Controlled Period (Week 16 - 52)||50
8149209|NCT02641730|20085182|P4|STARTED|After Controlled Period (Week 16 - 52)||53
8149210|NCT02641730|20085183|P3|STARTED|After Controlled Period (Week 16 - 52)||26
8149211|NCT02641730|20085184|P2|STARTED|After Controlled Period (Week 16 - 52)||25
8149212|NCT02641730|20085185|P1|STARTED|After Controlled Period (Week 16 - 52)||0
8149213|NCT02641730|20085181|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
8149214|NCT02641730|20085182|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
8149215|NCT02641730|20085183|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149216|NCT02641730|20085184|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149217|NCT02641730|20085185|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
8149218|NCT02641730|20085181|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
8149219|NCT02641730|20085182|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
8149220|NCT02641730|20085183|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149221|NCT02641730|20085184|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149222|NCT02641730|20085185|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
8149223|NCT02641730|20085181|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||52
8149224|NCT02641730|20085182|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||54
8149225|NCT02641730|20085183|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8149226|NCT02641730|20085184|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8149227|NCT02641730|20085185|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||53
8149228|NCT02641587|20085289|P2|NOT COMPLETED|Ambulatory Period||0
8149229|NCT02641587|20085290|P1|NOT COMPLETED|Ambulatory Period||1
8149230|NCT02641587|20085289|P2|COMPLETED|Ambulatory Period||39
8149231|NCT02641587|20085290|P1|COMPLETED|Ambulatory Period||76
8149232|NCT02641587|20085289|P2|STARTED|Ambulatory Period||39
8149233|NCT02641587|20085290|P1|STARTED|Ambulatory Period||77
8149234|NCT02641587|20085289|P2|NOT COMPLETED|Confinement Period||1
8149235|NCT02641587|20085290|P1|NOT COMPLETED|Confinement Period||3
8149236|NCT02641587|20085289|P2|COMPLETED|Confinement Period||39
8149237|NCT02641587|20085290|P1|COMPLETED|Confinement Period||77
8149238|NCT02641587|20085289|P2|STARTED|Confinement Period||40
8149239|NCT02641587|20085290|P1|STARTED|Confinement Period||80
8149240|NCT02641561|20085315|P4|NOT COMPLETED|Overall Study||0
8149241|NCT02641561|20085316|P3|NOT COMPLETED|Overall Study||0
8149242|NCT02641561|20085317|P2|NOT COMPLETED|Overall Study||0
8149243|NCT02641561|20085318|P1|NOT COMPLETED|Overall Study||0
8149244|NCT02641561|20085315|P4|COMPLETED|Overall Study||48
8149245|NCT02641561|20085316|P3|COMPLETED|Overall Study||48
8149246|NCT02641561|20085317|P2|COMPLETED|Overall Study||48
8149247|NCT02641561|20085318|P1|COMPLETED|Overall Study||48
8149248|NCT02641561|20085315|P4|STARTED|Overall Study||48
8149249|NCT02641561|20085316|P3|STARTED|Overall Study||48
8149250|NCT02641561|20085317|P2|STARTED|Overall Study||48
8149251|NCT02641561|20085318|P1|STARTED|Overall Study||48
8149252|NCT02641522|20085404|P1|NOT COMPLETED|Overall Study||0
8149253|NCT02641522|20085404|P1|COMPLETED|Overall Study||10
8149254|NCT02641522|20085404|P1|STARTED|Overall Study||10
8149255|NCT02641392|20085411|P3|NOT COMPLETED|Overall Study||293
8149256|NCT02641392|20085412|P2|NOT COMPLETED|Overall Study||13
8149257|NCT02641392|20085413|P1|NOT COMPLETED|Overall Study||4
8149258|NCT02641392|20085411|P3|COMPLETED|Overall Study||0
8149259|NCT02641392|20085412|P2|COMPLETED|Overall Study||0
8149260|NCT02641392|20085413|P1|COMPLETED|Overall Study||0
8149261|NCT02641392|20085411|P3|STARTED|Overall Study||293
8149262|NCT02641392|20085412|P2|STARTED|Overall Study||13
8149263|NCT02641392|20085413|P1|STARTED|Overall Study||4
8149264|NCT02641379|20085432|P11|NOT COMPLETED|Overall Study||8
8149265|NCT02641379|20085433|P10|NOT COMPLETED|Overall Study||9
8149266|NCT02641379|20085434|P9|NOT COMPLETED|Overall Study||6
8149267|NCT02641379|20085435|P8|NOT COMPLETED|Overall Study||19
8149268|NCT02641379|20085436|P7|NOT COMPLETED|Overall Study||13
8149269|NCT02641379|20085437|P6|NOT COMPLETED|Overall Study||16
8149270|NCT02641379|20085438|P5|NOT COMPLETED|Overall Study||17
8149271|NCT02641379|20085439|P4|NOT COMPLETED|Overall Study||17
8149272|NCT02641379|20085440|P3|NOT COMPLETED|Overall Study||71
8149273|NCT02641379|20085441|P2|NOT COMPLETED|Overall Study||51
8149274|NCT02641379|20085442|P1|NOT COMPLETED|Overall Study||35
8149275|NCT02641379|20085432|P11|COMPLETED|Overall Study||0
8149276|NCT02641379|20085433|P10|COMPLETED|Overall Study||36
8149277|NCT02641379|20085434|P9|COMPLETED|Overall Study||36
8149278|NCT02641379|20085435|P8|COMPLETED|Overall Study||1
8149279|NCT02641379|20085436|P7|COMPLETED|Overall Study||12
8149280|NCT02641379|20085437|P6|COMPLETED|Overall Study||20
8149281|NCT02641379|20085438|P5|COMPLETED|Overall Study||0
8149282|NCT02641379|20085439|P4|COMPLETED|Overall Study||139
8149283|NCT02641379|20085440|P3|COMPLETED|Overall Study||7
8149284|NCT02641379|20085441|P2|COMPLETED|Overall Study||101
8149285|NCT02641379|20085442|P1|COMPLETED|Overall Study||107
8149286|NCT02641379|20085432|P11|STARTED|Overall Study||8
8149287|NCT02641379|20085433|P10|STARTED|Overall Study||45
8149288|NCT02641379|20085434|P9|STARTED|Overall Study||42
8149289|NCT02641379|20085435|P8|STARTED|Overall Study||20
8149290|NCT02641379|20085436|P7|STARTED|Overall Study||25
8149291|NCT02641379|20085437|P6|STARTED|Overall Study||36
8149292|NCT02641379|20085438|P5|STARTED|Overall Study||17
8149293|NCT02641379|20085439|P4|STARTED|Overall Study||156
8149294|NCT02641379|20085440|P3|STARTED|Overall Study||78
8149295|NCT02641379|20085441|P2|STARTED|Overall Study||152
8149296|NCT02641379|20085442|P1|STARTED|Overall Study||142
8149297|NCT02641249|20085507|P1|NOT COMPLETED|Overall Study||4
8149298|NCT02641249|20085507|P1|COMPLETED|Overall Study||15
8149299|NCT02641249|20085507|P1|STARTED|Overall Study||19
8149300|NCT02641080|20085518|P2|NOT COMPLETED|Overall Study||7
8149301|NCT02641080|20085519|P1|NOT COMPLETED|Overall Study||2
8149302|NCT02641080|20085518|P2|COMPLETED|Overall Study||33
8149303|NCT02641080|20085519|P1|COMPLETED|Overall Study||38
8149304|NCT02641080|20085518|P2|STARTED|Overall Study||40
8149305|NCT02641080|20085519|P1|STARTED|Overall Study||40
8149306|NCT02641067|20085533|P2|NOT COMPLETED|Overall Study||0
8149307|NCT02641067|20085534|P1|NOT COMPLETED|Overall Study||0
8149308|NCT02641067|20085533|P2|COMPLETED|Overall Study||8
8149309|NCT02641067|20085534|P1|COMPLETED|Overall Study||8
8149310|NCT02641067|20085533|P2|STARTED|Overall Study||8
8149311|NCT02641067|20085534|P1|STARTED|Overall Study||8
8149312|NCT02640807|20085557|P3|NOT COMPLETED|Overall Study||0
8149313|NCT02640807|20085558|P2|NOT COMPLETED|Overall Study||0
8149314|NCT02640807|20085559|P1|NOT COMPLETED|Overall Study||0
8149315|NCT02640807|20085557|P3|COMPLETED|Overall Study||10
8149316|NCT02640807|20085558|P2|COMPLETED|Overall Study||8
8149317|NCT02640807|20085559|P1|COMPLETED|Overall Study||9
8149318|NCT02640807|20085557|P3|STARTED|Overall Study||10
8149319|NCT02640807|20085558|P2|STARTED|Overall Study||8
8149320|NCT02640807|20085559|P1|STARTED|Overall Study||9
8149321|NCT02640755|20085575|P2|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
8149322|NCT02640755|20085576|P1|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
8149323|NCT02640755|20085575|P2|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
8149324|NCT02640755|20085576|P1|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
8149325|NCT02640755|20085575|P2|STARTED|Multiple Dose Period (Day 8 - EoS)||1
8149326|NCT02640755|20085576|P1|STARTED|Multiple Dose Period (Day 8 - EoS)||3
8149327|NCT02640755|20085575|P2|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
8149328|NCT02640755|20085576|P1|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
8149329|NCT02640755|20085575|P2|COMPLETED|Single Dose Period (Day 1 - 8)||1
8149330|NCT02640755|20085576|P1|COMPLETED|Single Dose Period (Day 1 - 8)||3
8149331|NCT02640755|20085575|P2|STARTED|Single Dose Period (Day 1 - 8)||1
8149332|NCT02640755|20085576|P1|STARTED|Single Dose Period (Day 1 - 8)||3
8149333|NCT02640716|20085613|P2|NOT COMPLETED|Overall Study||9
8149334|NCT02640716|20085614|P1|NOT COMPLETED|Overall Study||7
8149335|NCT02640716|20085613|P2|COMPLETED|Overall Study||21
8149336|NCT02640716|20085614|P1|COMPLETED|Overall Study||23
8149337|NCT02640716|20085613|P2|Training Completion|Overall Study||27
8149338|NCT02640716|20085614|P1|Training Completion|Overall Study||27
8149339|NCT02640716|20085613|P2|STARTED|Overall Study||30
8149340|NCT02640716|20085614|P1|STARTED|Overall Study||30
8149341|NCT02640677|20085630|P1|NOT COMPLETED|Overall Study||2
8149342|NCT02640677|20085630|P1|COMPLETED|Overall Study||0
8149343|NCT02640677|20085630|P1|STARTED|Overall Study||2
8149344|NCT02640625|20085637|P1|NOT COMPLETED|Overall Study||1
8149345|NCT02640625|20085637|P1|COMPLETED|Overall Study||19
8149346|NCT02640625|20085637|P1|STARTED|Overall Study||20
8149347|NCT02640612|20085646|P3|NOT COMPLETED|Overall Study||6
8149348|NCT02640612|20085647|P2|NOT COMPLETED|Overall Study||14
8149349|NCT02640612|20085648|P1|NOT COMPLETED|Overall Study||22
8149350|NCT02640612|20085646|P3|COMPLETED|Overall Study||96
8149351|NCT02640612|20085647|P2|COMPLETED|Overall Study||89
8149352|NCT02640612|20085648|P1|COMPLETED|Overall Study||203
8149353|NCT02640612|20085646|P3|STARTED|Overall Study||102
8149354|NCT02640612|20085647|P2|STARTED|Overall Study||103
8149355|NCT02640612|20085648|P1|STARTED|Overall Study||225
8149356|NCT02640573|20085668|P1|NOT COMPLETED|Overall Study||1
8149357|NCT02640573|20085668|P1|COMPLETED|Overall Study||0
8149358|NCT02640573|20085668|P1|STARTED|Overall Study||1
8149359|NCT02640547|20085672|P1|NOT COMPLETED|Overall Study||11
8149360|NCT02640547|20085672|P1|COMPLETED|Overall Study||383
8149361|NCT02640547|20085672|P1|STARTED|Overall Study||394
8149362|NCT02640482|20085749|P2|NOT COMPLETED|Overall Study||0
8149363|NCT02640482|20085750|P1|NOT COMPLETED|Overall Study||3
8149364|NCT02640482|20085749|P2|COMPLETED|Overall Study||100
8149365|NCT02640482|20085750|P1|COMPLETED|Overall Study||199
8149366|NCT02640482|20085749|P2|STARTED|Overall Study||100
8149367|NCT02640482|20085750|P1|STARTED|Overall Study||202
8149368|NCT02640404|20085762|P2|NOT COMPLETED|Overall Study||0
8149369|NCT02640404|20085763|P1|NOT COMPLETED|Overall Study||2
8149370|NCT02640404|20085762|P2|COMPLETED|Overall Study||112
8149371|NCT02640404|20085763|P1|COMPLETED|Overall Study||110
8149372|NCT02640404|20085762|P2|STARTED|Overall Study||112
8149373|NCT02640404|20085763|P1|STARTED|Overall Study||112
8149374|NCT02640235|20085773|P2|NOT COMPLETED|Overall Study||14
8149375|NCT02640235|20085774|P1|NOT COMPLETED|Overall Study||14
8149376|NCT02640235|20085773|P2|COMPLETED|Overall Study||115
8149377|NCT02640235|20085774|P1|COMPLETED|Overall Study||117
8149378|NCT02640235|20085773|P2|STARTED|Overall Study||129
8149379|NCT02640235|20085774|P1|STARTED|Overall Study||131
8149380|NCT02640157|20085797|P3|NOT COMPLETED|Overall Study||10
8149381|NCT02640157|20085798|P2|NOT COMPLETED|Overall Study||5
8149382|NCT02640157|20085799|P1|NOT COMPLETED|Overall Study||13
8149383|NCT02640157|20085797|P3|COMPLETED|Overall Study||147
8149384|NCT02640157|20085798|P2|COMPLETED|Overall Study||111
8149385|NCT02640157|20085799|P1|COMPLETED|Overall Study||220
8149386|NCT02640157|20085797|P3|Discontinued Study Drug|Overall Study||3
8149387|NCT02640157|20085798|P2|Discontinued Study Drug|Overall Study||3
8149388|NCT02640157|20085799|P1|Discontinued Study Drug|Overall Study||8
8149389|NCT02640157|20085797|P3|Completed Study Drug|Overall Study||154
8149390|NCT02640157|20085798|P2|Completed Study Drug|Overall Study||112
8149391|NCT02640157|20085799|P1|Completed Study Drug|Overall Study||225
8149392|NCT02640157|20085797|P3|Received Study Drug|Overall Study||157
8149393|NCT02640157|20085798|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
8149394|NCT02640157|20085799|P1|Received Study Drug|Overall Study||233
8149395|NCT02640157|20085797|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
8149396|NCT02640157|20085798|P2|STARTED|Overall Study||116
8149397|NCT02640157|20085799|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
8149398|NCT02640053|20085818|P2|NOT COMPLETED|Overall Study||4
8149399|NCT02640053|20085819|P1|NOT COMPLETED|Overall Study||4
8149400|NCT02640053|20085818|P2|COMPLETED|Overall Study||17
8149401|NCT02640053|20085819|P1|COMPLETED|Overall Study||17
8149402|NCT02640053|20085818|P2|STARTED|Overall Study||21
8149403|NCT02640053|20085819|P1|STARTED|Overall Study||21
8149404|NCT02639910|20085841|P2|NOT COMPLETED|Overall Study||8
8149405|NCT02639910|20085842|P1|NOT COMPLETED|Overall Study||4
8149406|NCT02639910|20085841|P2|COMPLETED|Overall Study||5
8149407|NCT02639910|20085842|P1|COMPLETED|Overall Study||7
8149408|NCT02639910|20085841|P2|STARTED|Overall Study||13
8149409|NCT02639910|20085842|P1|STARTED|Overall Study||11
8149410|NCT02639637|20085859|P4|NOT COMPLETED|Overall Study||0
8149411|NCT02639637|20085860|P3|NOT COMPLETED|Overall Study||0
8149412|NCT02639637|20085861|P2|NOT COMPLETED|Overall Study||0
8149413|NCT02639637|20085862|P1|NOT COMPLETED|Overall Study||0
8149414|NCT02639637|20085859|P4|COMPLETED|Overall Study||3
8149415|NCT02639637|20085860|P3|COMPLETED|Overall Study||2
8149416|NCT02639637|20085861|P2|COMPLETED|Overall Study||6
8149417|NCT02639637|20085862|P1|COMPLETED|Overall Study||7
8149418|NCT02639637|20085859|P4|STARTED|Overall Study||3
8149419|NCT02639637|20085860|P3|STARTED|Overall Study||2
8149420|NCT02639637|20085861|P2|STARTED|Overall Study||6
8149421|NCT02639637|20085862|P1|STARTED|Overall Study||7
8149422|NCT02639559|20085926|P2|NOT COMPLETED|Overall Study||3
8149423|NCT02639559|20085927|P1|NOT COMPLETED|Overall Study||1
8149424|NCT02639559|20085926|P2|COMPLETED|Overall Study||22
8149425|NCT02639559|20085927|P1|COMPLETED|Overall Study||24
8149426|NCT02639559|20085926|P2|STARTED|Overall Study||25
8149427|NCT02639559|20085927|P1|STARTED|Overall Study||25
8149428|NCT02639494|20085953|P1|NOT COMPLETED|Overall Study||0
8149429|NCT02639494|20085953|P1|COMPLETED|Overall Study||20
8149430|NCT02639494|20085953|P1|STARTED|Overall Study||20
8149431|NCT02639429|20085970|P2|NOT COMPLETED|Overall Study||0
8149432|NCT02639429|20085971|P1|NOT COMPLETED|Overall Study||0
8149433|NCT02639429|20085970|P2|COMPLETED|Overall Study||123
8149434|NCT02639429|20085971|P1|COMPLETED|Overall Study||113
8149435|NCT02639429|20085970|P2|STARTED|Overall Study||123
8149436|NCT02639429|20085971|P1|STARTED|Overall Study||113
8149437|NCT02639390|20086007|P2|NOT COMPLETED|Overall Study||2
8149438|NCT02639390|20086008|P1|NOT COMPLETED|Overall Study||0
8149439|NCT02639390|20086007|P2|COMPLETED|Overall Study||3
8149440|NCT02639390|20086008|P1|COMPLETED|Overall Study||0
8149441|NCT02639390|20086007|P2|STARTED|Overall Study||5
8149442|NCT02639390|20086008|P1|STARTED|Overall Study||0
8149443|NCT02639351|20086029|P5|NOT COMPLETED|Overall Study||0
8149444|NCT02639351|20086030|P4|NOT COMPLETED|Overall Study||0
8149445|NCT02639351|20086031|P3|NOT COMPLETED|Overall Study||0
8149446|NCT02639351|20086032|P2|NOT COMPLETED|Overall Study||0
8149447|NCT02639351|20086033|P1|NOT COMPLETED|Overall Study||0
8149448|NCT02639351|20086029|P5|COMPLETED|Overall Study||16
8149449|NCT02639351|20086030|P4|COMPLETED|Overall Study||16
8149450|NCT02639351|20086031|P3|COMPLETED|Overall Study||16
8149451|NCT02639351|20086032|P2|COMPLETED|Overall Study||16
8149452|NCT02639351|20086033|P1|COMPLETED|Overall Study||16
8149453|NCT02639351|20086029|P5|STARTED|Overall Study||16
8149454|NCT02639351|20086030|P4|STARTED|Overall Study||16
8149455|NCT02639351|20086031|P3|STARTED|Overall Study||16
8149456|NCT02639351|20086032|P2|STARTED|Overall Study||16
8149457|NCT02639351|20086033|P1|STARTED|Overall Study||16
8149458|NCT02639338|20086382|P2|NOT COMPLETED|Overall Study||5
8149459|NCT02639338|20086383|P1|NOT COMPLETED|Overall Study||4
8149460|NCT02639338|20086382|P2|COMPLETED|Overall Study||105
8149461|NCT02639338|20086383|P1|COMPLETED|Overall Study||106
8149462|NCT02639338|20086382|P2|STARTED|Overall Study||110
8149463|NCT02639338|20086383|P1|STARTED|Overall Study||110
8149464|NCT02639286|20086401|P2|NOT COMPLETED|Overall Study||0
8149465|NCT02639286|20086402|P1|NOT COMPLETED|Overall Study||0
8149466|NCT02639286|20086401|P2|COMPLETED|Overall Study||2
8149467|NCT02639286|20086402|P1|COMPLETED|Overall Study||3
8149468|NCT02639286|20086401|P2|STARTED|Overall Study||2
8149469|NCT02639286|20086402|P1|STARTED|Overall Study||3
8149470|NCT02639247|20086428|P2|NOT COMPLETED|Overall Study||2
8149471|NCT02639247|20086429|P1|NOT COMPLETED|Overall Study||5
8149472|NCT02639247|20086428|P2|COMPLETED|Overall Study||149
8149473|NCT02639247|20086429|P1|COMPLETED|Overall Study||177
8149474|NCT02639247|20086428|P2|STARTED|Overall Study||151
8149475|NCT02639247|20086429|P1|STARTED|Overall Study||182
8149476|NCT02639182|20086447|P2|NOT COMPLETED|Overall Study||66
8149477|NCT02639182|20086448|P1|NOT COMPLETED|Overall Study||67
8149478|NCT02639182|20086447|P2|COMPLETED|Overall Study||0
8149479|NCT02639182|20086448|P1|COMPLETED|Overall Study||0
8149480|NCT02639182|20086447|P2|STARTED|Overall Study||66
8149481|NCT02639182|20086448|P1|STARTED|Overall Study||67
8149482|NCT02639052|20086481|P1|NOT COMPLETED|Overall Study||1
8149483|NCT02639052|20086481|P1|COMPLETED|Overall Study||34
8149484|NCT02639052|20086481|P1|Visit 4 (3-month Follow-up)|Overall Study||34
8149485|NCT02639052|20086481|P1|Visit 3 (1-month Follow-up)|Overall Study||35
8149486|NCT02639052|20086481|P1|Visit 2 (1-week Follow-up)|Overall Study||35
8149487|NCT02639052|20086481|P1|Visit 1 (Baseline)|Overall Study||35
8149488|NCT02639052|20086481|P1|STARTED|Overall Study||35
8149489|NCT02638974|20086497|P2|NOT COMPLETED|Overall Study||3
8149490|NCT02638974|20086498|P1|NOT COMPLETED|Overall Study||3
8149491|NCT02638974|20086497|P2|COMPLETED|Overall Study||22
8149492|NCT02638974|20086498|P1|COMPLETED|Overall Study||23
8149493|NCT02638974|20086497|P2|STARTED|Overall Study||25
8149494|NCT02638974|20086498|P1|STARTED|Overall Study||26
8149495|NCT02638948|20086518|P4|NOT COMPLETED|Overall Study||8
8149496|NCT02638948|20086519|P3|NOT COMPLETED|Overall Study||7
8149497|NCT02638948|20086520|P2|NOT COMPLETED|Overall Study||11
8149498|NCT02638948|20086521|P1|NOT COMPLETED|Overall Study||9
8149499|NCT02638948|20086518|P4|COMPLETED|Overall Study||18
8149500|NCT02638948|20086519|P3|COMPLETED|Overall Study||66
8149501|NCT02638948|20086520|P2|COMPLETED|Overall Study||62
8149502|NCT02638948|20086521|P1|COMPLETED|Overall Study||66
8149503|NCT02638948|20086518|P4|STARTED|Overall Study||26
8149504|NCT02638948|20086519|P3|STARTED|Overall Study||73
8149505|NCT02638948|20086520|P2|STARTED|Overall Study||73
8149506|NCT02638948|20086521|P1|STARTED|Overall Study||75
8149507|NCT02638623|20086608|P2|NOT COMPLETED|Overall Study||6
8149508|NCT02638623|20086609|P1|NOT COMPLETED|Overall Study||7
8149509|NCT02638623|20086608|P2|COMPLETED|Overall Study||19
8149510|NCT02638623|20086609|P1|COMPLETED|Overall Study||20
8149511|NCT02638623|20086608|P2|STARTED|Overall Study||25
8149512|NCT02638623|20086609|P1|STARTED|Overall Study||27
8149513|NCT02638597|20086627|P2|NOT COMPLETED|Overall Study||5
8149514|NCT02638597|20086628|P1|NOT COMPLETED|Overall Study||4
8149515|NCT02638597|20086627|P2|COMPLETED|Overall Study||3
8149516|NCT02638597|20086628|P1|COMPLETED|Overall Study||4
8149517|NCT02638597|20086627|P2|STARTED|Overall Study||8
8149518|NCT02638597|20086628|P1|STARTED|Overall Study||8
8149519|NCT02638493|20086639|P3|NOT COMPLETED|Overall Study||0
8149520|NCT02638493|20086640|P2|NOT COMPLETED|Overall Study||0
8149521|NCT02638493|20086641|P1|NOT COMPLETED|Overall Study||2
8149522|NCT02638493|20086639|P3|COMPLETED|Overall Study||8
8149523|NCT02638493|20086640|P2|COMPLETED|Overall Study||8
8149524|NCT02638493|20086641|P1|COMPLETED|Overall Study||8
8149525|NCT02638493|20086639|P3|STARTED|Overall Study||8
8149526|NCT02638493|20086640|P2|STARTED|Overall Study||8
8149527|NCT02638493|20086641|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
8149528|NCT02638337|20086672|P2|NOT COMPLETED|Overall Study||36
8149529|NCT02638337|20086673|P1|NOT COMPLETED|Overall Study||33
8149530|NCT02638337|20086672|P2|COMPLETED|Overall Study||279
8149531|NCT02638337|20086673|P1|COMPLETED|Overall Study||283
8149532|NCT02638337|20086672|P2|Received Treatment|Overall Study||315
8149533|NCT02638337|20086673|P1|Received Treatment|Overall Study||313
8149534|NCT02638337|20086672|P2|STARTED|Overall Study||315
8149535|NCT02638337|20086673|P1|STARTED|Overall Study||316
8149536|NCT02638259|20086757|P2|NOT COMPLETED|Treatment Period 2||11
8149537|NCT02638259|20086758|P1|NOT COMPLETED|Treatment Period 2||6
8149538|NCT02638259|20086757|P2|COMPLETED|Treatment Period 2||155
8149539|NCT02638259|20086758|P1|COMPLETED|Treatment Period 2||169
8149540|NCT02638259|20086757|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
8149541|NCT02638259|20086758|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
8149542|NCT02638259|20086757|P2|NOT COMPLETED|Treatment Period 1||18
8149543|NCT02638259|20086758|P1|NOT COMPLETED|Treatment Period 1||5
8149544|NCT02638259|20086757|P2|COMPLETED|Treatment Period 1||172
8149545|NCT02638259|20086758|P1|COMPLETED|Treatment Period 1||181
8149546|NCT02638259|20086757|P2|STARTED|Treatment Period 1||190
8149547|NCT02638259|20086758|P1|STARTED|Treatment Period 1||186
8149548|NCT02638168|20086832|P2|NOT COMPLETED|Overall Study||0
8149549|NCT02638168|20086833|P1|NOT COMPLETED|Overall Study||0
8149550|NCT02638168|20086832|P2|COMPLETED|Overall Study||0
8149551|NCT02638168|20086833|P1|COMPLETED|Overall Study||3
8149552|NCT02638168|20086832|P2|STARTED|Overall Study||0
8149553|NCT02638168|20086833|P1|STARTED|Overall Study||3
8149554|NCT02638129|20086850|P2|NOT COMPLETED|Overall Study||30
8149555|NCT02638129|20086851|P1|NOT COMPLETED|Overall Study||28
8149556|NCT02638129|20086850|P2|COMPLETED|Overall Study||0
8149557|NCT02638129|20086851|P1|COMPLETED|Overall Study||0
8149558|NCT02638129|20086850|P2|STARTED|Overall Study||30
8149559|NCT02638129|20086851|P1|STARTED|Overall Study||28
8149560|NCT02638103|20086867|P4|NOT COMPLETED|Overall Study||142
8149561|NCT02638103|20086868|P3|NOT COMPLETED|Overall Study||85
8149562|NCT02638103|20086869|P2|NOT COMPLETED|Overall Study||118
8149563|NCT02638103|20086870|P1|NOT COMPLETED|Overall Study||106
8149564|NCT02638103|20086867|P4|COMPLETED|Overall Study||383
8149565|NCT02638103|20086868|P3|COMPLETED|Overall Study||335
8149566|NCT02638103|20086869|P2|COMPLETED|Overall Study||408
8149567|NCT02638103|20086870|P1|COMPLETED|Overall Study||313
8149568|NCT02638103|20086867|P4|Full Analysis Set (FAS)|Overall Study||523
8149569|NCT02638103|20086868|P3|Full Analysis Set (FAS)|Overall Study||419
8149570|NCT02638103|20086869|P2|Full Analysis Set (FAS)|Overall Study||520
8149571|NCT02638103|20086870|P1|Full Analysis Set (FAS)|Overall Study||416
8149572|NCT02638103|20086867|P4|Safety Analysis Set|Overall Study||525
8149573|NCT02638103|20086868|P3|Safety Analysis Set|Overall Study||419
8149574|NCT02638103|20086869|P2|Safety Analysis Set|Overall Study||526
8149575|NCT02638103|20086870|P1|Safety Analysis Set|Overall Study||418
8149576|NCT02638103|20086867|P4|STARTED|Overall Study||525
8149577|NCT02638103|20086868|P3|STARTED|Overall Study||420
8149578|NCT02638103|20086869|P2|STARTED|Overall Study||526
8149579|NCT02638103|20086870|P1|STARTED|Overall Study||419
8149580|NCT02638051|20086946|P2|NOT COMPLETED|Overall Study||0
8149581|NCT02638051|20086947|P1|NOT COMPLETED|Overall Study||0
8149582|NCT02638051|20086946|P2|COMPLETED|Overall Study||130
8149583|NCT02638051|20086947|P1|COMPLETED|Overall Study||130
8149584|NCT02638051|20086946|P2|STARTED|Overall Study||130
8149585|NCT02638051|20086947|P1|STARTED|Overall Study||130
8149586|NCT02638012|20086957|P1|NOT COMPLETED|Overall Study||1
8149587|NCT02638012|20086957|P1|COMPLETED|Overall Study||7
8149588|NCT02638012|20086957|P1|STARTED|Overall Study||8
8149589|NCT02637999|20086968|P3|NOT COMPLETED|Overall Study||2
8149590|NCT02637999|20086969|P2|NOT COMPLETED|Overall Study||2
8149591|NCT02637999|20086970|P1|NOT COMPLETED|Overall Study||1
8149592|NCT02637999|20086968|P3|COMPLETED|Overall Study||6
8149593|NCT02637999|20086969|P2|COMPLETED|Overall Study||6
8149594|NCT02637999|20086970|P1|COMPLETED|Overall Study||7
8149595|NCT02637999|20086968|P3|STARTED|Overall Study||8
8149596|NCT02637999|20086969|P2|STARTED|Overall Study||8
8149597|NCT02637999|20086970|P1|STARTED|Overall Study||8
8149598|NCT02637856|20087002|P2|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
8149599|NCT02637856|20087003|P1|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
8149600|NCT02637856|20087002|P2|COMPLETED|Sub-Study (Week 72 to Week 100)||125
8149601|NCT02637856|20087003|P1|COMPLETED|Sub-Study (Week 72 to Week 100)||0
8149602|NCT02637856|20087002|P2|STARTED|Sub-Study (Week 72 to Week 100)||129
8149603|NCT02637856|20087003|P1|STARTED|Sub-Study (Week 72 to Week 100)||0
8149604|NCT02637856|20087002|P2|NOT COMPLETED|Main Study (Baseline to Week 100)||0
8149605|NCT02637856|20087003|P1|NOT COMPLETED|Main Study (Baseline to Week 100)||219
8149606|NCT02637856|20087002|P2|COMPLETED|Main Study (Baseline to Week 100)||0
8149607|NCT02637856|20087003|P1|COMPLETED|Main Study (Baseline to Week 100)||389
8149608|NCT02637856|20087002|P2|STARTED|Main Study (Baseline to Week 100)||0
8149609|NCT02637856|20087003|P1|STARTED|Main Study (Baseline to Week 100)||608
8149610|NCT02637804|20087022|P4|NOT COMPLETED|Second Intervention (1 Week)||0
8149611|NCT02637804|20087023|P3|NOT COMPLETED|Second Intervention (1 Week)||0
8149612|NCT02637804|20087024|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8149613|NCT02637804|20087025|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8149614|NCT02637804|20087022|P4|COMPLETED|Second Intervention (1 Week)||26
8149615|NCT02637804|20087023|P3|COMPLETED|Second Intervention (1 Week)||25
8149616|NCT02637804|20087024|P2|COMPLETED|Second Intervention (1 Week)||28
8149617|NCT02637804|20087025|P1|COMPLETED|Second Intervention (1 Week)||27
8149618|NCT02637804|20087022|P4|STARTED|Second Intervention (1 Week)||26
8149619|NCT02637804|20087023|P3|STARTED|Second Intervention (1 Week)||25
8149620|NCT02637804|20087024|P2|STARTED|Second Intervention (1 Week)||28
8149621|NCT02637804|20087025|P1|STARTED|Second Intervention (1 Week)||27
8149622|NCT02637804|20087022|P4|NOT COMPLETED|First Intervention (1 Week)||0
8149623|NCT02637804|20087023|P3|NOT COMPLETED|First Intervention (1 Week)||0
8149624|NCT02637804|20087024|P2|NOT COMPLETED|First Intervention (1 Week)||0
8149625|NCT02637804|20087025|P1|NOT COMPLETED|First Intervention (1 Week)||0
8149626|NCT02637804|20087022|P4|COMPLETED|First Intervention (1 Week)||26
8149627|NCT02637804|20087023|P3|COMPLETED|First Intervention (1 Week)||25
8149628|NCT02637804|20087024|P2|COMPLETED|First Intervention (1 Week)||28
8149629|NCT02637804|20087025|P1|COMPLETED|First Intervention (1 Week)||27
8149630|NCT02637804|20087022|P4|STARTED|First Intervention (1 Week)||26
8149631|NCT02637804|20087023|P3|STARTED|First Intervention (1 Week)||25
8149632|NCT02637804|20087024|P2|STARTED|First Intervention (1 Week)||28
8149633|NCT02637804|20087025|P1|STARTED|First Intervention (1 Week)||27
8149634|NCT02637557|20087133|P4|NOT COMPLETED|Overall Study||7
8149635|NCT02637557|20087134|P3|NOT COMPLETED|Overall Study||9
8149636|NCT02637557|20087135|P2|NOT COMPLETED|Overall Study||5
8149637|NCT02637557|20087136|P1|NOT COMPLETED|Overall Study||8
8149638|NCT02637557|20087133|P4|COMPLETED|Overall Study||62
8149639|NCT02637557|20087134|P3|COMPLETED|Overall Study||62
8149640|NCT02637557|20087135|P2|COMPLETED|Overall Study||66
8149641|NCT02637557|20087136|P1|COMPLETED|Overall Study||63
8149642|NCT02637557|20087133|P4|STARTED|Overall Study||69
8149643|NCT02637557|20087134|P3|STARTED|Overall Study||71
8149644|NCT02637557|20087135|P2|STARTED|Overall Study||71
8149645|NCT02637557|20087136|P1|STARTED|Overall Study||71
8149646|NCT02637323|20087228|P2|NOT COMPLETED|Overall Study||1
8149647|NCT02637323|20087229|P1|NOT COMPLETED|Overall Study||2
8149648|NCT02637323|20087228|P2|COMPLETED|Overall Study||17
8149649|NCT02637323|20087229|P1|COMPLETED|Overall Study||61
8149650|NCT02637323|20087228|P2|STARTED|Overall Study||18
8149651|NCT02637323|20087229|P1|STARTED|Overall Study||63
8149652|NCT02637141|20087240|P3|NOT COMPLETED|Overall Study||1
8149653|NCT02637141|20087241|P2|NOT COMPLETED|Overall Study||2
8149654|NCT02637141|20087242|P1|NOT COMPLETED|Overall Study||2
8149655|NCT02637141|20087240|P3|COMPLETED|Overall Study||19
8149656|NCT02637141|20087241|P2|COMPLETED|Overall Study||20
8149657|NCT02637141|20087242|P1|COMPLETED|Overall Study||20
8149658|NCT02637141|20087240|P3|Received Study Drug|Overall Study||19
8149659|NCT02637141|20087241|P2|Received Study Drug|Overall Study||21
8149660|NCT02637141|20087242|P1|Received Study Drug|Overall Study||22
8149661|NCT02637141|20087240|P3|STARTED|Overall Study||20
8149662|NCT02637141|20087241|P2|STARTED|Overall Study||22
8149663|NCT02637141|20087242|P1|STARTED|Overall Study||22
8149664|NCT02637063|20087277|P3|NOT COMPLETED|Overall Study||6
8149665|NCT02637063|20087278|P2|NOT COMPLETED|Overall Study||4
8149666|NCT02637063|20087279|P1|NOT COMPLETED|Overall Study||5
8149667|NCT02637063|20087277|P3|COMPLETED|Overall Study||62
8149668|NCT02637063|20087278|P2|COMPLETED|Overall Study||64
8149669|NCT02637063|20087279|P1|COMPLETED|Overall Study||62
8149670|NCT02637063|20087277|P3|STARTED|Overall Study||68
8149671|NCT02637063|20087278|P2|STARTED|Overall Study||68
8149672|NCT02637063|20087279|P1|STARTED|Overall Study||67
8149673|NCT02637037|20087307|P2|NOT COMPLETED|Overall Study||1
8149674|NCT02637037|20087308|P1|NOT COMPLETED|Overall Study||4
8149675|NCT02637037|20087307|P2|COMPLETED|Overall Study||39
8149676|NCT02637037|20087308|P1|COMPLETED|Overall Study||36
8149677|NCT02637037|20087307|P2|STARTED|Overall Study||40
8149678|NCT02637037|20087308|P1|STARTED|Overall Study||40
8149679|NCT02636907|20087374|P1|NOT COMPLETED|Extension Phase||10
8149680|NCT02636907|20087374|P1|COMPLETED|Extension Phase||62
8149681|NCT02636907|20087374|P1|STARTED|Extension Phase||72
8149682|NCT02636907|20087374|P1|NOT COMPLETED|Autoinjector Assessment Period||4
8149683|NCT02636907|20087374|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
8149684|NCT02636907|20087374|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
8149685|NCT02636712|20087383|P1|NOT COMPLETED|Overall Study||0
8149686|NCT02636712|20087383|P1|COMPLETED|Overall Study||10
8149687|NCT02636712|20087383|P1|STARTED|Overall Study||10
8149688|NCT02636608|20087391|P1|NOT COMPLETED|Overall Study||11
8149689|NCT02636608|20087391|P1|COMPLETED|Overall Study||233
8149690|NCT02636608|20087391|P1|Received Treatment|Overall Study||243
8149691|NCT02636608|20087391|P1|STARTED|Overall Study||244
8149692|NCT02636595|20087419|P1|NOT COMPLETED|Overall Study||2
8149693|NCT02636595|20087419|P1|COMPLETED|Overall Study||119
8149694|NCT02636595|20087419|P1|STARTED|Overall Study||121
8149695|NCT02636361|20087425|P5|NOT COMPLETED|Period 5||0
8149696|NCT02636361|20087426|P4|NOT COMPLETED|Period 5||0
8149697|NCT02636361|20087427|P3|NOT COMPLETED|Period 5||0
8149698|NCT02636361|20087428|P2|NOT COMPLETED|Period 5||0
8149699|NCT02636361|20087429|P1|NOT COMPLETED|Period 5||0
8149700|NCT02636361|20087425|P5|COMPLETED|Period 5||4
8149701|NCT02636361|20087426|P4|COMPLETED|Period 5||4
8149702|NCT02636361|20087427|P3|COMPLETED|Period 5||5
8149703|NCT02636361|20087428|P2|COMPLETED|Period 5||5
8149704|NCT02636361|20087429|P1|COMPLETED|Period 5||5
8149705|NCT02636361|20087425|P5|STARTED|Period 5||4
8149706|NCT02636361|20087426|P4|STARTED|Period 5||4
8149707|NCT02636361|20087427|P3|STARTED|Period 5||5
8149708|NCT02636361|20087428|P2|STARTED|Period 5||5
8149709|NCT02636361|20087429|P1|STARTED|Period 5||5
8149710|NCT02636361|20087425|P5|NOT COMPLETED|Period 4||0
8149711|NCT02636361|20087426|P4|NOT COMPLETED|Period 4||1
8149712|NCT02636361|20087427|P3|NOT COMPLETED|Period 4||0
8149713|NCT02636361|20087428|P2|NOT COMPLETED|Period 4||0
8149714|NCT02636361|20087429|P1|NOT COMPLETED|Period 4||0
8149715|NCT02636361|20087425|P5|COMPLETED|Period 4||4
8149716|NCT02636361|20087426|P4|COMPLETED|Period 4||4
8149717|NCT02636361|20087427|P3|COMPLETED|Period 4||5
8149718|NCT02636361|20087428|P2|COMPLETED|Period 4||5
8149719|NCT02636361|20087429|P1|COMPLETED|Period 4||5
8149720|NCT02636361|20087425|P5|STARTED|Period 4||4
8149721|NCT02636361|20087426|P4|STARTED|Period 4||5
8149722|NCT02636361|20087427|P3|STARTED|Period 4||5
8149723|NCT02636361|20087428|P2|STARTED|Period 4||5
8149724|NCT02636361|20087429|P1|STARTED|Period 4||5
8149725|NCT02636361|20087425|P5|NOT COMPLETED|Period 3||0
8149726|NCT02636361|20087426|P4|NOT COMPLETED|Period 3||0
8149727|NCT02636361|20087427|P3|NOT COMPLETED|Period 3||0
8149728|NCT02636361|20087428|P2|NOT COMPLETED|Period 3||0
8149729|NCT02636361|20087429|P1|NOT COMPLETED|Period 3||0
8149730|NCT02636361|20087425|P5|COMPLETED|Period 3||4
8149731|NCT02636361|20087426|P4|COMPLETED|Period 3||5
8149732|NCT02636361|20087427|P3|COMPLETED|Period 3||5
8149733|NCT02636361|20087428|P2|COMPLETED|Period 3||5
8149734|NCT02636361|20087429|P1|COMPLETED|Period 3||5
8149735|NCT02636361|20087425|P5|STARTED|Period 3||4
8149736|NCT02636361|20087426|P4|STARTED|Period 3||5
8149737|NCT02636361|20087427|P3|STARTED|Period 3||5
8149738|NCT02636361|20087428|P2|STARTED|Period 3||5
8149739|NCT02636361|20087429|P1|STARTED|Period 3||5
8149740|NCT02636361|20087425|P5|NOT COMPLETED|Period 2||0
8149741|NCT02636361|20087426|P4|NOT COMPLETED|Period 2||0
8149742|NCT02636361|20087427|P3|NOT COMPLETED|Period 2||0
8149743|NCT02636361|20087428|P2|NOT COMPLETED|Period 2||0
8149744|NCT02636361|20087429|P1|NOT COMPLETED|Period 2||0
8149745|NCT02636361|20087425|P5|COMPLETED|Period 2||4
8149746|NCT02636361|20087426|P4|COMPLETED|Period 2||5
8149747|NCT02636361|20087427|P3|COMPLETED|Period 2||5
8149748|NCT02636361|20087428|P2|COMPLETED|Period 2||5
8149749|NCT02636361|20087429|P1|COMPLETED|Period 2||5
8149750|NCT02636361|20087425|P5|STARTED|Period 2||4
8149751|NCT02636361|20087426|P4|STARTED|Period 2||5
8149752|NCT02636361|20087427|P3|STARTED|Period 2||5
8149753|NCT02636361|20087428|P2|STARTED|Period 2||5
8149754|NCT02636361|20087429|P1|STARTED|Period 2||5
8149755|NCT02636361|20087425|P5|NOT COMPLETED|Period 1||1
8149756|NCT02636361|20087426|P4|NOT COMPLETED|Period 1||0
8149757|NCT02636361|20087427|P3|NOT COMPLETED|Period 1||0
8149758|NCT02636361|20087428|P2|NOT COMPLETED|Period 1||1
8149759|NCT02636361|20087429|P1|NOT COMPLETED|Period 1||0
8149760|NCT02636361|20087425|P5|COMPLETED|Period 1||4
8149761|NCT02636361|20087426|P4|COMPLETED|Period 1||5
8149762|NCT02636361|20087427|P3|COMPLETED|Period 1||5
8149763|NCT02636361|20087428|P2|COMPLETED|Period 1||5
8149764|NCT02636361|20087429|P1|COMPLETED|Period 1||5
8149765|NCT02636361|20087425|P5|Received at Least One Dose of Study Drug|Period 1||4
8149766|NCT02636361|20087426|P4|Received at Least One Dose of Study Drug|Period 1||5
8149767|NCT02636361|20087427|P3|Received at Least One Dose of Study Drug|Period 1||5
8149768|NCT02636361|20087428|P2|Received at Least One Dose of Study Drug|Period 1||5
8149769|NCT02636361|20087429|P1|Received at Least One Dose of Study Drug|Period 1||5
8149770|NCT02636361|20087425|P5|STARTED|Period 1||5
8149771|NCT02636361|20087426|P4|STARTED|Period 1||5
8149772|NCT02636361|20087427|P3|STARTED|Period 1||5
8149773|NCT02636361|20087428|P2|STARTED|Period 1||6
8149774|NCT02636361|20087429|P1|STARTED|Period 1||5
8149775|NCT02636283|20087448|P2|NOT COMPLETED|Overall Study||3
8149776|NCT02636283|20087449|P1|NOT COMPLETED|Overall Study||2
8149777|NCT02636283|20087448|P2|COMPLETED|Overall Study||0
8149778|NCT02636283|20087449|P1|COMPLETED|Overall Study||1
8149779|NCT02636283|20087448|P2|STARTED|Overall Study||3
8149780|NCT02636283|20087449|P1|STARTED|Overall Study||3
8149781|NCT02636049|20087463|P1|NOT COMPLETED|Overall Study||0
8149782|NCT02636049|20087463|P1|COMPLETED|Overall Study||12
8149783|NCT02636049|20087463|P1|Triferic 35 Micrograms/kg IV Push|Overall Study||12
8149784|NCT02636049|20087463|P1|Triferic 6 mg IV Over 3 Hours|Overall Study||12
8149785|NCT02636049|20087463|P1|STARTED|Overall Study||12
8149786|NCT02635984|20087477|P2|NOT COMPLETED|Overall Study||4
8149787|NCT02635984|20087478|P1|NOT COMPLETED|Overall Study||3
8149788|NCT02635984|20087477|P2|COMPLETED|Overall Study||51
8149789|NCT02635984|20087478|P1|COMPLETED|Overall Study||50
8149790|NCT02635984|20087477|P2|STARTED|Overall Study||55
8149791|NCT02635984|20087478|P1|STARTED|Overall Study||53
8149792|NCT02635880|20087498|P1|NOT COMPLETED|Overall Study||0
8149793|NCT02635880|20087498|P1|COMPLETED|Overall Study||32
8149794|NCT02635880|20087498|P1|STARTED|Overall Study||32
8149795|NCT02635828|20087503|P1|NOT COMPLETED|Overall Study||14
8149796|NCT02635828|20087503|P1|COMPLETED|Overall Study||40
8149797|NCT02635828|20087503|P1|STARTED|Overall Study||54
8149798|NCT02635737|20087508|P1|NOT COMPLETED|Overall Study||1
8149799|NCT02635737|20087508|P1|COMPLETED|Overall Study||28
8149800|NCT02635737|20087508|P1|STARTED|Overall Study||29
8149801|NCT02635646|20087521|P2|NOT COMPLETED|Overall Study||26
8149802|NCT02635646|20087522|P1|NOT COMPLETED|Overall Study||25
8149803|NCT02635646|20087521|P2|COMPLETED|Overall Study||39
8149804|NCT02635646|20087522|P1|COMPLETED|Overall Study||32
8149805|NCT02635646|20087521|P2|STARTED|Overall Study||65
8149806|NCT02635646|20087522|P1|STARTED|Overall Study||57
8149807|NCT02635542|20087538|P2|NOT COMPLETED|Overall Study||0
8149808|NCT02635542|20087539|P1|NOT COMPLETED|Overall Study||0
8149809|NCT02635542|20087538|P2|COMPLETED|Overall Study||50
8149810|NCT02635542|20087539|P1|COMPLETED|Overall Study||50
8149811|NCT02635542|20087538|P2|STARTED|Overall Study||50
8149812|NCT02635542|20087539|P1|STARTED|Overall Study||50
8149813|NCT02635425|20087549|P2|NOT COMPLETED|Overall Study||0
8149814|NCT02635425|20087550|P1|NOT COMPLETED|Overall Study||0
8149815|NCT02635425|20087549|P2|COMPLETED|Overall Study||15
8149816|NCT02635425|20087550|P1|COMPLETED|Overall Study||15
8149817|NCT02635425|20087549|P2|STARTED|Overall Study||15
8149818|NCT02635425|20087550|P1|STARTED|Overall Study||15
8149819|NCT02635347|20087558|P2|NOT COMPLETED|Overall Study||7
8149820|NCT02635347|20087559|P1|NOT COMPLETED|Overall Study||20
8149821|NCT02635347|20087558|P2|COMPLETED|Overall Study||63
8149822|NCT02635347|20087559|P1|COMPLETED|Overall Study||31
8149823|NCT02635347|20087558|P2|Analyses|Overall Study||63
8149824|NCT02635347|20087559|P1|Analyses|Overall Study||30
8149825|NCT02635347|20087558|P2|Follow up|Overall Study||63
8149826|NCT02635347|20087559|P1|Follow up|Overall Study||31
8149827|NCT02635347|20087558|P2|Protocol Completion|Overall Study||63
8149828|NCT02635347|20087559|P1|Protocol Completion|Overall Study||22
8149829|NCT02635347|20087558|P2|Enrollment|Overall Study||63
8149830|NCT02635347|20087559|P1|Enrollment|Overall Study||31
8149831|NCT02635347|20087558|P2|Screening|Overall Study||70
8149832|NCT02635347|20087559|P1|Screening|Overall Study||51
8149833|NCT02635347|20087558|P2|STARTED|Overall Study||70
8149834|NCT02635347|20087559|P1|STARTED|Overall Study||51
8149835|NCT02635204|20087590|P2|NOT COMPLETED|Overall Study||1
8149836|NCT02635204|20087591|P1|NOT COMPLETED|Overall Study||2
8149837|NCT02635204|20087590|P2|COMPLETED|Overall Study||88
8149838|NCT02635204|20087591|P1|COMPLETED|Overall Study||176
8149839|NCT02635204|20087590|P2|STARTED|Overall Study||89
8149840|NCT02635204|20087591|P1|STARTED|Overall Study||178
8149841|NCT02634983|20087601|P2|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
8149842|NCT02634983|20087602|P1|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
8149843|NCT02634983|20087601|P2|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
8149844|NCT02634983|20087602|P1|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
8149845|NCT02634983|20087601|P2|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
8149846|NCT02634983|20087602|P1|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
8149847|NCT02634983|20087601|P2|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
8149848|NCT02634983|20087602|P1|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
8149849|NCT02634983|20087601|P2|COMPLETED|Washout (Approximately 7-14 Days)||15
8149850|NCT02634983|20087602|P1|COMPLETED|Washout (Approximately 7-14 Days)||16
8149851|NCT02634983|20087601|P2|STARTED|Washout (Approximately 7-14 Days)||15
8149852|NCT02634983|20087602|P1|STARTED|Washout (Approximately 7-14 Days)||16
8149853|NCT02634983|20087601|P2|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
8149854|NCT02634983|20087602|P1|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
8149855|NCT02634983|20087601|P2|COMPLETED|Period One (First Treatment, 8-10 Days)||15
8149856|NCT02634983|20087602|P1|COMPLETED|Period One (First Treatment, 8-10 Days)||16
8149857|NCT02634983|20087601|P2|STARTED|Period One (First Treatment, 8-10 Days)||15
8149858|NCT02634983|20087602|P1|STARTED|Period One (First Treatment, 8-10 Days)||16
8149859|NCT02634827|20087622|P1|NOT COMPLETED|Overall Study||0
8149860|NCT02634827|20087622|P1|COMPLETED|Overall Study||1
8149861|NCT02634827|20087622|P1|STARTED|Overall Study||1
8149862|NCT02634814|20087636|P3|NOT COMPLETED|Overall Study||0
8149863|NCT02634814|20087637|P2|NOT COMPLETED|Overall Study||6
8149864|NCT02634814|20087638|P1|NOT COMPLETED|Overall Study||2
8149865|NCT02634814|20087636|P3|COMPLETED|Overall Study||29
8149866|NCT02634814|20087637|P2|COMPLETED|Overall Study||23
8149867|NCT02634814|20087638|P1|COMPLETED|Overall Study||30
8149868|NCT02634814|20087636|P3|STARTED|Overall Study||29
8149869|NCT02634814|20087637|P2|STARTED|Overall Study||29
8149870|NCT02634814|20087638|P1|STARTED|Overall Study||32
8149871|NCT02634801|20087661|P3|NOT COMPLETED|Follow-up Period||8
8149872|NCT02634801|20087662|P2|NOT COMPLETED|Follow-up Period||8
8149873|NCT02634801|20087663|P1|NOT COMPLETED|Follow-up Period||5
8149874|NCT02634801|20087661|P3|COMPLETED|Follow-up Period||38
8149875|NCT02634801|20087662|P2|COMPLETED|Follow-up Period||18
8149876|NCT02634801|20087663|P1|COMPLETED|Follow-up Period||36
8149877|NCT02634801|20087661|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
8149878|NCT02634801|20087662|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
8149879|NCT02634801|20087663|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
8149880|NCT02634801|20087661|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
8149881|NCT02634801|20087662|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
8149882|NCT02634801|20087663|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
8149883|NCT02634801|20087661|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
8149884|NCT02634801|20087662|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
8149885|NCT02634801|20087663|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
8149886|NCT02634801|20087661|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
8149887|NCT02634801|20087662|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
8149888|NCT02634801|20087663|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
8149889|NCT02634801|20087661|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
8149890|NCT02634801|20087662|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
8149891|NCT02634801|20087663|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
8149892|NCT02634801|20087661|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
8149893|NCT02634801|20087662|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
8149894|NCT02634801|20087663|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
8149895|NCT02634801|20087661|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
8149896|NCT02634801|20087662|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
8149897|NCT02634801|20087663|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
8149898|NCT02634801|20087661|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
8149899|NCT02634801|20087662|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
8149900|NCT02634801|20087663|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
8149901|NCT02634788|20087763|P4|NOT COMPLETED|Overall Study||5
8149902|NCT02634788|20087764|P3|NOT COMPLETED|Overall Study||5
8149903|NCT02634788|20087765|P2|NOT COMPLETED|Overall Study||10
8149904|NCT02634788|20087766|P1|NOT COMPLETED|Overall Study||4
8149905|NCT02634788|20087763|P4|COMPLETED|Overall Study||77
8149906|NCT02634788|20087764|P3|COMPLETED|Overall Study||75
8149907|NCT02634788|20087765|P2|COMPLETED|Overall Study||71
8149908|NCT02634788|20087766|P1|COMPLETED|Overall Study||75
8149909|NCT02634788|20087763|P4|STARTED|Overall Study||82
8149910|NCT02634788|20087764|P3|STARTED|Overall Study||80
8149911|NCT02634788|20087765|P2|STARTED|Overall Study||81
8149912|NCT02634788|20087766|P1|STARTED|Overall Study||79
8149913|NCT02634606|20087832|P1|NOT COMPLETED|Overall Study||13
8149914|NCT02634606|20087832|P1|COMPLETED|Overall Study||0
8149915|NCT02634606|20087832|P1|STARTED|Overall Study||13
8149916|NCT02634580|20087844|P4|NOT COMPLETED|Open-label Extension Period||1
8149917|NCT02634580|20087845|P3|NOT COMPLETED|Open-label Extension Period||0
8149918|NCT02634580|20087846|P2|NOT COMPLETED|Open-label Extension Period||1
8149919|NCT02634580|20087847|P1|NOT COMPLETED|Open-label Extension Period||0
8149920|NCT02634580|20087844|P4|COMPLETED|Open-label Extension Period||20
8149921|NCT02634580|20087845|P3|COMPLETED|Open-label Extension Period||18
8149922|NCT02634580|20087846|P2|COMPLETED|Open-label Extension Period||10
8149923|NCT02634580|20087847|P1|COMPLETED|Open-label Extension Period||9
8149924|NCT02634580|20087844|P4|Received Open-label Treatment|Open-label Extension Period||20
8149925|NCT02634580|20087845|P3|Received Open-label Treatment|Open-label Extension Period||18
8149926|NCT02634580|20087846|P2|Received Open-label Treatment|Open-label Extension Period||11
8149927|NCT02634580|20087847|P1|Received Open-label Treatment|Open-label Extension Period||9
8149928|NCT02634580|20087844|P4|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
8149929|NCT02634580|20087845|P3|STARTED|Open-label Extension Period||18
8149930|NCT02634580|20087846|P2|STARTED|Open-label Extension Period||11
8149931|NCT02634580|20087847|P1|STARTED|Open-label Extension Period||9
8149932|NCT02634580|20087844|P4|NOT COMPLETED|Double-blind Treatment Period||1
8149933|NCT02634580|20087845|P3|NOT COMPLETED|Double-blind Treatment Period||1
8149934|NCT02634580|20087846|P2|NOT COMPLETED|Double-blind Treatment Period||0
8149935|NCT02634580|20087847|P1|NOT COMPLETED|Double-blind Treatment Period||1
8149936|NCT02634580|20087844|P4|COMPLETED|Double-blind Treatment Period||20
8149937|NCT02634580|20087845|P3|COMPLETED|Double-blind Treatment Period||18
8149938|NCT02634580|20087846|P2|COMPLETED|Double-blind Treatment Period||11
8149939|NCT02634580|20087847|P1|COMPLETED|Double-blind Treatment Period||9
8149940|NCT02634580|20087844|P4|STARTED|Double-blind Treatment Period||21
8149941|NCT02634580|20087845|P3|STARTED|Double-blind Treatment Period||19
8149942|NCT02634580|20087846|P2|STARTED|Double-blind Treatment Period||11
8149943|NCT02634580|20087847|P1|STARTED|Double-blind Treatment Period||10
8149944|NCT02634346|20087905|P3|NOT COMPLETED|Overall Study||23
8149945|NCT02634346|20087906|P2|NOT COMPLETED|Overall Study||14
8149946|NCT02634346|20087907|P1|NOT COMPLETED|Overall Study||12
8149947|NCT02634346|20087905|P3|COMPLETED|Overall Study||111
8149948|NCT02634346|20087906|P2|COMPLETED|Overall Study||119
8149949|NCT02634346|20087907|P1|COMPLETED|Overall Study||122
8149950|NCT02634346|20087905|P3|STARTED|Overall Study||134
8149951|NCT02634346|20087906|P2|STARTED|Overall Study||133
8149952|NCT02634346|20087907|P1|STARTED|Overall Study||134
8149953|NCT02634320|20087921|P1|NOT COMPLETED|Overall Study||16
8149954|NCT02634320|20087921|P1|COMPLETED|Overall Study||35
8149955|NCT02634320|20087921|P1|STARTED|Overall Study||51
8149956|NCT02634177|20087932|P2|NOT COMPLETED|Overall Study||12
8149957|NCT02634177|20087933|P1|NOT COMPLETED|Overall Study||11
8149958|NCT02634177|20087932|P2|COMPLETED|Overall Study||141
8149959|NCT02634177|20087933|P1|COMPLETED|Overall Study||140
8149960|NCT02634177|20087932|P2|STARTED|Overall Study||153
8149961|NCT02634177|20087933|P1|STARTED|Overall Study||151
8149962|NCT02634151|20087957|P2|NOT COMPLETED|Overall Study||2
8149963|NCT02634151|20087958|P1|NOT COMPLETED|Overall Study||1
8149964|NCT02634151|20087957|P2|COMPLETED|Overall Study||50
8149965|NCT02634151|20087958|P1|COMPLETED|Overall Study||52
8149966|NCT02634151|20087957|P2|Safety Set|Overall Study||51
8149967|NCT02634151|20087958|P1|Safety Set|Overall Study||54
8149968|NCT02634151|20087957|P2|Full Analysis Set|Overall Study||52
8149969|NCT02634151|20087958|P1|Full Analysis Set|Overall Study||53
8149970|NCT02634151|20087957|P2|STARTED|Overall Study||52
8149971|NCT02634151|20087958|P1|STARTED|Overall Study||53
8149972|NCT02634073|20088044|P4|NOT COMPLETED|Overall Study||0
8149973|NCT02634073|20088045|P3|NOT COMPLETED|Overall Study||0
8149974|NCT02634073|20088046|P2|NOT COMPLETED|Overall Study||0
8149975|NCT02634073|20088047|P1|NOT COMPLETED|Overall Study||0
8149976|NCT02634073|20088044|P4|COMPLETED|Overall Study||4
8149977|NCT02634073|20088045|P3|COMPLETED|Overall Study||4
8149978|NCT02634073|20088046|P2|COMPLETED|Overall Study||4
8149979|NCT02634073|20088047|P1|COMPLETED|Overall Study||4
8149980|NCT02634073|20088044|P4|STARTED|Overall Study||4
8149981|NCT02634073|20088045|P3|STARTED|Overall Study||4
8149982|NCT02634073|20088046|P2|STARTED|Overall Study||4
8149983|NCT02634073|20088047|P1|STARTED|Overall Study||4
8149984|NCT02633956|20088137|P4|NOT COMPLETED|Overall Study||0
8149985|NCT02633956|20088138|P3|NOT COMPLETED|Overall Study||2
8149986|NCT02633956|20088139|P2|NOT COMPLETED|Overall Study||2
8149987|NCT02633956|20088140|P1|NOT COMPLETED|Overall Study||1
8149988|NCT02633956|20088137|P4|COMPLETED|Overall Study||21
8149989|NCT02633956|20088138|P3|COMPLETED|Overall Study||20
8149990|NCT02633956|20088139|P2|COMPLETED|Overall Study||19
8149991|NCT02633956|20088140|P1|COMPLETED|Overall Study||19
8149992|NCT02633956|20088137|P4|STARTED|Overall Study||21
8149993|NCT02633956|20088138|P3|STARTED|Overall Study||22
8149994|NCT02633956|20088139|P2|STARTED|Overall Study||21
8149995|NCT02633956|20088140|P1|STARTED|Overall Study||20
8149996|NCT02633800|20088160|P2|NOT COMPLETED|Overall Study||43
8149997|NCT02633800|20088161|P1|NOT COMPLETED|Overall Study||44
8149998|NCT02633800|20088160|P2|COMPLETED|Overall Study||0
8149999|NCT02633800|20088161|P1|COMPLETED|Overall Study||0
8150000|NCT02633800|20088160|P2|STARTED|Overall Study||43
8150001|NCT02633800|20088161|P1|STARTED|Overall Study||44
8150002|NCT02633787|20088171|P1|NOT COMPLETED|Overall Study||1
8150003|NCT02633787|20088171|P1|COMPLETED|Overall Study||109
8150004|NCT02633787|20088171|P1|STARTED|Overall Study||110
8150005|NCT02633735|20088179|P2|NOT COMPLETED|Implementation Phase||0
8150006|NCT02633735|20088180|P1|NOT COMPLETED|Implementation Phase||0
8150007|NCT02633735|20088179|P2|COMPLETED|Implementation Phase||2150
8150008|NCT02633735|20088180|P1|COMPLETED|Implementation Phase||1991
8150009|NCT02633735|20088179|P2|STARTED|Implementation Phase||2150
8150010|NCT02633735|20088180|P1|STARTED|Implementation Phase||1991
8150011|NCT02633735|20088179|P2|NOT COMPLETED|Pre-implementation Phase||0
8150012|NCT02633735|20088180|P1|NOT COMPLETED|Pre-implementation Phase||0
8150013|NCT02633735|20088179|P2|COMPLETED|Pre-implementation Phase||1011
8150014|NCT02633735|20088180|P1|COMPLETED|Pre-implementation Phase||788
8150015|NCT02633735|20088179|P2|STARTED|Pre-implementation Phase||1011
8150016|NCT02633735|20088180|P1|STARTED|Pre-implementation Phase||788
8150017|NCT02633501|20088192|P6|NOT COMPLETED|Overall Study||15
8150018|NCT02633501|20088193|P5|NOT COMPLETED|Overall Study||11
8150019|NCT02633501|20088194|P4|NOT COMPLETED|Overall Study||4
8150020|NCT02633501|20088195|P3|NOT COMPLETED|Overall Study||7
8150021|NCT02633501|20088196|P2|NOT COMPLETED|Overall Study||3
8150022|NCT02633501|20088197|P1|NOT COMPLETED|Overall Study||2
8150023|NCT02633501|20088192|P6|COMPLETED|Overall Study||48
8150024|NCT02633501|20088193|P5|COMPLETED|Overall Study||53
8150025|NCT02633501|20088194|P4|COMPLETED|Overall Study||59
8150026|NCT02633501|20088195|P3|COMPLETED|Overall Study||55
8150027|NCT02633501|20088196|P2|COMPLETED|Overall Study||11
8150028|NCT02633501|20088197|P1|COMPLETED|Overall Study||12
8150029|NCT02633501|20088192|P6|STARTED|Overall Study||63
8150030|NCT02633501|20088193|P5|STARTED|Overall Study||64
8150031|NCT02633501|20088194|P4|STARTED|Overall Study||63
8150032|NCT02633501|20088195|P3|STARTED|Overall Study||62
8150033|NCT02633501|20088196|P2|STARTED|Overall Study||14
8150034|NCT02633501|20088197|P1|STARTED|Overall Study||14
8150035|NCT02633488|20088218|P2|NOT COMPLETED|Overall Study||0
8150036|NCT02633488|20088219|P1|NOT COMPLETED|Overall Study||0
8150037|NCT02633488|20088218|P2|COMPLETED|Overall Study||5
8150038|NCT02633488|20088219|P1|COMPLETED|Overall Study||6
8150039|NCT02633488|20088218|P2|STARTED|Overall Study||5
8150040|NCT02633488|20088219|P1|STARTED|Overall Study||6
8150041|NCT02633371|20088225|P1|NOT COMPLETED|Overall Study||3
8150042|NCT02633371|20088225|P1|COMPLETED|Overall Study||7
8150043|NCT02633371|20088225|P1|STARTED|Overall Study||10
8150044|NCT02633358|20088231|P2|NOT COMPLETED|Overall Study||0
8150045|NCT02633358|20088232|P1|NOT COMPLETED|Overall Study||0
8150046|NCT02633358|20088231|P2|COMPLETED|Overall Study||54
8150047|NCT02633358|20088232|P1|COMPLETED|Overall Study||87
8150048|NCT02633358|20088231|P2|STARTED|Overall Study||54
8150049|NCT02633358|20088232|P1|STARTED|Overall Study||87
8150050|NCT02633241|20088246|P1|NOT COMPLETED|Overall Study||3
8150051|NCT02633241|20088246|P1|COMPLETED|Overall Study||27
8150052|NCT02633241|20088246|P1|STARTED|Overall Study||30
8150053|NCT02633215|20088259|P2|NOT COMPLETED|Overall Study||3
8150054|NCT02633215|20088260|P1|NOT COMPLETED|Overall Study||2
8150055|NCT02633215|20088259|P2|COMPLETED|Overall Study||15
8150056|NCT02633215|20088260|P1|COMPLETED|Overall Study||16
8150057|NCT02633215|20088259|P2|STARTED|Overall Study||18
8150058|NCT02633215|20088260|P1|STARTED|Overall Study||18
8150059|NCT02633020|20088272|P2|NOT COMPLETED|Overall Study||0
8150060|NCT02633020|20088273|P1|NOT COMPLETED|Overall Study||1
8150061|NCT02633020|20088272|P2|COMPLETED|Overall Study||9
8150062|NCT02633020|20088273|P1|COMPLETED|Overall Study||18
8150063|NCT02633020|20088272|P2|STARTED|Overall Study||9
8150064|NCT02633020|20088273|P1|STARTED|Overall Study||19
8150065|NCT02632838|20088297|P2|NOT COMPLETED|Overall Study||2
8150066|NCT02632838|20088298|P1|NOT COMPLETED|Overall Study||3
8150067|NCT02632838|20088297|P2|COMPLETED|Overall Study||13
8150068|NCT02632838|20088298|P1|COMPLETED|Overall Study||12
8150069|NCT02632838|20088297|P2|STARTED|Overall Study||15
8150070|NCT02632838|20088298|P1|STARTED|Overall Study||15
8150071|NCT02632812|20088314|P2|NOT COMPLETED|Overall Study||0
8150072|NCT02632812|20088315|P1|NOT COMPLETED|Overall Study||0
8150073|NCT02632812|20088314|P2|COMPLETED|Overall Study||12
8150074|NCT02632812|20088315|P1|COMPLETED|Overall Study||12
8150075|NCT02632812|20088314|P2|STARTED|Overall Study||12
8150076|NCT02632812|20088315|P1|STARTED|Overall Study||12
8150077|NCT02632786|20088335|P2|NOT COMPLETED|Overall Study||7
8150078|NCT02632786|20088336|P1|NOT COMPLETED|Overall Study||11
8150079|NCT02632786|20088335|P2|COMPLETED|Overall Study||56
8150080|NCT02632786|20088336|P1|COMPLETED|Overall Study||55
8150081|NCT02632786|20088335|P2|Randomized and Dosed|Overall Study||63
8150082|NCT02632786|20088336|P1|Randomized and Dosed|Overall Study||66
8150083|NCT02632786|20088335|P2|Informed Consent Obtained|Overall Study||63
8150084|NCT02632786|20088336|P1|Informed Consent Obtained|Overall Study||66
8150085|NCT02632786|20088335|P2|STARTED|Overall Study||63
8150086|NCT02632786|20088336|P1|STARTED|Overall Study||66
8150087|NCT02632747|20088356|P2|NOT COMPLETED|Treatment Period 2||0
8150088|NCT02632747|20088357|P1|NOT COMPLETED|Treatment Period 2||0
8150089|NCT02632747|20088356|P2|COMPLETED|Treatment Period 2||15
8150090|NCT02632747|20088357|P1|COMPLETED|Treatment Period 2||15
8150091|NCT02632747|20088356|P2|STARTED|Treatment Period 2||15
8150092|NCT02632747|20088357|P1|STARTED|Treatment Period 2||15
8150093|NCT02632747|20088356|P2|NOT COMPLETED|Wash-out Period||0
8150094|NCT02632747|20088357|P1|NOT COMPLETED|Wash-out Period||1
8150095|NCT02632747|20088356|P2|COMPLETED|Wash-out Period||15
8150096|NCT02632747|20088357|P1|COMPLETED|Wash-out Period||15
8150097|NCT02632747|20088356|P2|STARTED|Wash-out Period||15
8150098|NCT02632747|20088357|P1|STARTED|Wash-out Period||16
8150099|NCT02632747|20088356|P2|NOT COMPLETED|Treatment Period 1||0
8150100|NCT02632747|20088357|P1|NOT COMPLETED|Treatment Period 1||0
8150101|NCT02632747|20088356|P2|COMPLETED|Treatment Period 1||15
8150102|NCT02632747|20088357|P1|COMPLETED|Treatment Period 1||16
8150103|NCT02632747|20088356|P2|STARTED|Treatment Period 1||15
8150104|NCT02632747|20088357|P1|STARTED|Treatment Period 1||16
8150105|NCT02632526|20088371|P6|NOT COMPLETED|Overall Study||0
8150106|NCT02632526|20088372|P5|NOT COMPLETED|Overall Study||0
8150107|NCT02632526|20088373|P4|NOT COMPLETED|Overall Study||0
8150108|NCT02632526|20088374|P3|NOT COMPLETED|Overall Study||0
8150109|NCT02632526|20088375|P2|NOT COMPLETED|Overall Study||0
8150110|NCT02632526|20088376|P1|NOT COMPLETED|Overall Study||0
8150111|NCT02632526|20088371|P6|COMPLETED|Overall Study||8
8150112|NCT02632526|20088372|P5|COMPLETED|Overall Study||4
8150113|NCT02632526|20088373|P4|COMPLETED|Overall Study||12
8150114|NCT02632526|20088374|P3|COMPLETED|Overall Study||24
8150115|NCT02632526|20088375|P2|COMPLETED|Overall Study||12
8150116|NCT02632526|20088376|P1|COMPLETED|Overall Study||36
8150117|NCT02632526|20088371|P6|STARTED|Overall Study||8
8150118|NCT02632526|20088372|P5|STARTED|Overall Study||4
8150119|NCT02632526|20088373|P4|STARTED|Overall Study||12
8150120|NCT02632526|20088374|P3|STARTED|Overall Study||24
8150121|NCT02632526|20088375|P2|STARTED|Overall Study||12
8150122|NCT02632526|20088376|P1|STARTED|Overall Study||36
8150123|NCT02632110|20088557|P10|NOT COMPLETED|Overall Study||1
8150124|NCT02632110|20088558|P9|NOT COMPLETED|Overall Study||1
8150125|NCT02632110|20088559|P8|NOT COMPLETED|Overall Study||3
8150126|NCT02632110|20088560|P7|NOT COMPLETED|Overall Study||3
8150127|NCT02632110|20088561|P6|NOT COMPLETED|Overall Study||1
8150128|NCT02632110|20088562|P5|NOT COMPLETED|Overall Study||1
8150129|NCT02632110|20088563|P4|NOT COMPLETED|Overall Study||0
8150130|NCT02632110|20088564|P3|NOT COMPLETED|Overall Study||0
8150131|NCT02632110|20088565|P2|NOT COMPLETED|Overall Study||1
8150132|NCT02632110|20088566|P1|NOT COMPLETED|Overall Study||1
8150133|NCT02632110|20088557|P10|COMPLETED|Overall Study||29
8150134|NCT02632110|20088558|P9|COMPLETED|Overall Study||29
8150135|NCT02632110|20088559|P8|COMPLETED|Overall Study||23
8150136|NCT02632110|20088560|P7|COMPLETED|Overall Study||23
8150137|NCT02632110|20088561|P6|COMPLETED|Overall Study||28
8150138|NCT02632110|20088562|P5|COMPLETED|Overall Study||28
8150139|NCT02632110|20088563|P4|COMPLETED|Overall Study||27
8150140|NCT02632110|20088564|P3|COMPLETED|Overall Study||27
8150141|NCT02632110|20088565|P2|COMPLETED|Overall Study||24
8150142|NCT02632110|20088566|P1|COMPLETED|Overall Study||24
8150143|NCT02632110|20088557|P10|STARTED|Overall Study||30
8150144|NCT02632110|20088558|P9|STARTED|Overall Study||30
8150145|NCT02632110|20088559|P8|STARTED|Overall Study||26
8150146|NCT02632110|20088560|P7|STARTED|Overall Study||26
8150147|NCT02632110|20088561|P6|STARTED|Overall Study||29
8150148|NCT02632110|20088562|P5|STARTED|Overall Study||29
8150149|NCT02632110|20088563|P4|STARTED|Overall Study||27
8150150|NCT02632110|20088564|P3|STARTED|Overall Study||27
8150151|NCT02632110|20088565|P2|STARTED|Overall Study||25
8150152|NCT02632110|20088566|P1|STARTED|Overall Study||25
8150153|NCT02631954|20089035|P2|NOT COMPLETED|Overall Study||0
8150154|NCT02631954|20089036|P1|NOT COMPLETED|Overall Study||0
8150155|NCT02631954|20089035|P2|COMPLETED|Overall Study||12
8150156|NCT02631954|20089036|P1|COMPLETED|Overall Study||12
8150157|NCT02631954|20089035|P2|STARTED|Overall Study||12
8150158|NCT02631954|20089036|P1|STARTED|Overall Study||12
8150159|NCT02631876|20089056|P2|NOT COMPLETED|Overall Study||63
8150160|NCT02631876|20089057|P1|NOT COMPLETED|Overall Study||119
8150161|NCT02631876|20089056|P2|COMPLETED|Overall Study||55
8150162|NCT02631876|20089057|P1|COMPLETED|Overall Study||129
8150163|NCT02631876|20089056|P2|Safety Population|Overall Study||109
8150164|NCT02631876|20089057|P1|Safety Population|Overall Study||243
8150165|NCT02631876|20089056|P2|STARTED|Overall Study||118
8150166|NCT02631876|20089057|P1|STARTED|Overall Study||248
8150167|NCT02631837|20089083|P2|NOT COMPLETED|Overall Study||0
8150168|NCT02631837|20089084|P1|NOT COMPLETED|Overall Study||0
8150169|NCT02631837|20089083|P2|COMPLETED|Overall Study||35
8150170|NCT02631837|20089084|P1|COMPLETED|Overall Study||35
8150171|NCT02631837|20089083|P2|STARTED|Overall Study||35
8150172|NCT02631837|20089084|P1|STARTED|Overall Study||35
8150173|NCT02631772|20089122|P2|NOT COMPLETED|Overall Study||0
8150174|NCT02631772|20089123|P1|NOT COMPLETED|Overall Study||0
8150175|NCT02631772|20089122|P2|COMPLETED|Overall Study||16
8150176|NCT02631772|20089123|P1|COMPLETED|Overall Study||16
8150177|NCT02631772|20089122|P2|STARTED|Overall Study||16
8150178|NCT02631772|20089123|P1|STARTED|Overall Study||16
8150179|NCT02631746|20089133|P1|NOT COMPLETED|Overall Study||3
8150180|NCT02631746|20089133|P1|COMPLETED|Overall Study||0
8150181|NCT02631746|20089133|P1|STARTED|Overall Study||3
8150182|NCT02631590|20089144|P1|NOT COMPLETED|Overall Study||0
8150183|NCT02631590|20089144|P1|COMPLETED|Overall Study||24
8150184|NCT02631590|20089144|P1|STARTED|Overall Study||24
8150185|NCT02631551|20089154|P4|NOT COMPLETED|Overall Study||11
8150186|NCT02631551|20089155|P3|NOT COMPLETED|Overall Study||11
8150187|NCT02631551|20089156|P2|NOT COMPLETED|Overall Study||19
8150188|NCT02631551|20089157|P1|NOT COMPLETED|Overall Study||13
8150189|NCT02631551|20089154|P4|COMPLETED|Overall Study||276
8150190|NCT02631551|20089155|P3|COMPLETED|Overall Study||283
8150191|NCT02631551|20089156|P2|COMPLETED|Overall Study||278
8150192|NCT02631551|20089157|P1|COMPLETED|Overall Study||289
8150193|NCT02631551|20089154|P4|STARTED|Overall Study||287
8150194|NCT02631551|20089155|P3|STARTED|Overall Study||294
8150195|NCT02631551|20089156|P2|STARTED|Overall Study||297
8150196|NCT02631551|20089157|P1|STARTED|Overall Study||302
8150197|NCT02631525|20089169|P2|NOT COMPLETED|Overall Study||0
8150198|NCT02631525|20089170|P1|NOT COMPLETED|Overall Study||0
8150199|NCT02631525|20089169|P2|COMPLETED|Overall Study||20
8150200|NCT02631525|20089170|P1|COMPLETED|Overall Study||20
8150201|NCT02631525|20089169|P2|STARTED|Overall Study||20
8150202|NCT02631525|20089170|P1|STARTED|Overall Study||20
8150203|NCT02631070|20089178|P2|NOT COMPLETED|Overall Study||76
8150204|NCT02631070|20089179|P1|NOT COMPLETED|Overall Study||112
8150205|NCT02631070|20089178|P2|COMPLETED|Overall Study||0
8150206|NCT02631070|20089179|P1|COMPLETED|Overall Study||41
8150207|NCT02631070|20089178|P2|Completed 48 Weeks of Treatment|Overall Study||12
8150208|NCT02631070|20089179|P1|Completed 48 Weeks of Treatment|Overall Study||83
8150209|NCT02631070|20089178|P2|Completed 24 Weeks of Treatment|Overall Study||68
8150210|NCT02631070|20089179|P1|Completed 24 Weeks of Treatment|Overall Study||128
8150211|NCT02631070|20089178|P2|STARTED|Overall Study||76
8150212|NCT02631070|20089179|P1|STARTED|Overall Study||153
8150213|NCT02631057|20089247|P2|NOT COMPLETED|Overall Study||0
8150214|NCT02631057|20089248|P1|NOT COMPLETED|Overall Study||0
8150215|NCT02631057|20089247|P2|COMPLETED|Overall Study||3414
8150216|NCT02631057|20089248|P1|COMPLETED|Overall Study||899
8150217|NCT02631057|20089247|P2|STARTED|Overall Study||3414
8150218|NCT02631057|20089248|P1|STARTED|Overall Study||899
8150219|NCT02630992|20089254|P1|NOT COMPLETED|Overall Study||13
8150220|NCT02630992|20089254|P1|COMPLETED|Overall Study||99
8150221|NCT02630992|20089254|P1|STARTED|Overall Study||112
8150222|NCT02630966|20089273|P2|NOT COMPLETED|Overall Study||8
8150223|NCT02630966|20089274|P1|NOT COMPLETED|Overall Study||2
8150224|NCT02630966|20089273|P2|COMPLETED|Overall Study||10
8150225|NCT02630966|20089274|P1|COMPLETED|Overall Study||14
8150226|NCT02630966|20089273|P2|STARTED|Overall Study||18
8150227|NCT02630966|20089274|P1|STARTED|Overall Study||16
8150228|NCT02630719|20089292|P2|NOT COMPLETED|Overall Study||0
8150229|NCT02630719|20089293|P1|NOT COMPLETED|Overall Study||0
8150230|NCT02630719|20089292|P2|COMPLETED|Overall Study||6
8150231|NCT02630719|20089293|P1|COMPLETED|Overall Study||4
8150232|NCT02630719|20089292|P2|STARTED|Overall Study||6
8150233|NCT02630719|20089293|P1|STARTED|Overall Study||4
8150234|NCT02630706|20089302|P3|NOT COMPLETED|Overall Study||10
8150235|NCT02630706|20089303|P2|NOT COMPLETED|Overall Study||9
8150236|NCT02630706|20089304|P1|NOT COMPLETED|Overall Study||7
8150237|NCT02630706|20089302|P3|COMPLETED|Overall Study||157
8150238|NCT02630706|20089303|P2|COMPLETED|Overall Study||160
8150239|NCT02630706|20089304|P1|COMPLETED|Overall Study||163
8150240|NCT02630706|20089302|P3|Treated|Overall Study||167
8150241|NCT02630706|20089303|P2|Treated|Overall Study||169
8150242|NCT02630706|20089304|P1|Treated|Overall Study||170
8150243|NCT02630706|20089302|P3|STARTED|Overall Study||167
8150244|NCT02630706|20089303|P2|STARTED|Overall Study||169
8150245|NCT02630706|20089304|P1|STARTED|Overall Study||170
8150246|NCT02630693|20089413|P2|NOT COMPLETED|Overall Study||1
8150247|NCT02630693|20089414|P1|NOT COMPLETED|Overall Study||0
8150248|NCT02630693|20089413|P2|COMPLETED|Overall Study||89
8150249|NCT02630693|20089414|P1|COMPLETED|Overall Study||90
8150250|NCT02630693|20089413|P2|STARTED|Overall Study||90
8150251|NCT02630693|20089414|P1|STARTED|Overall Study||90
8150252|NCT02630563|20089426|P1|NOT COMPLETED|Overall Study||1
8150253|NCT02630563|20089426|P1|COMPLETED|Overall Study||8
8150254|NCT02630563|20089426|P1|STARTED|Overall Study||9
8150255|NCT02630472|20089437|P2|NOT COMPLETED|Overall Study||0
8150256|NCT02630472|20089438|P1|NOT COMPLETED|Overall Study||10
8150257|NCT02630472|20089437|P2|COMPLETED|Overall Study||0
8150258|NCT02630472|20089438|P1|COMPLETED|Overall Study||0
8150259|NCT02630472|20089437|P2|STARTED|Overall Study||0
8150260|NCT02630472|20089438|P1|STARTED|Overall Study||10
8150261|NCT02630459|20089456|P8|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150262|NCT02630459|20089457|P7|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150263|NCT02630459|20089458|P6|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150264|NCT02630459|20089459|P5|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150265|NCT02630459|20089460|P4|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150266|NCT02630459|20089461|P3|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150267|NCT02630459|20089462|P2|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150268|NCT02630459|20089463|P1|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150269|NCT02630459|20089456|P8|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
8150270|NCT02630459|20089457|P7|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
8150271|NCT02630459|20089458|P6|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150272|NCT02630459|20089459|P5|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150273|NCT02630459|20089460|P4|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150274|NCT02630459|20089461|P3|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150275|NCT02630459|20089462|P2|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150276|NCT02630459|20089463|P1|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150277|NCT02630459|20089456|P8|STARTED|Optional CHU Sub-Study (During OLTP)||25
8150278|NCT02630459|20089457|P7|STARTED|Optional CHU Sub-Study (During OLTP)||24
8150279|NCT02630459|20089458|P6|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150280|NCT02630459|20089459|P5|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150281|NCT02630459|20089460|P4|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150282|NCT02630459|20089461|P3|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150283|NCT02630459|20089462|P2|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150284|NCT02630459|20089463|P1|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150285|NCT02630459|20089456|P8|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150286|NCT02630459|20089457|P7|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150287|NCT02630459|20089458|P6|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
8150288|NCT02630459|20089459|P5|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
8150289|NCT02630459|20089460|P4|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150290|NCT02630459|20089461|P3|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150291|NCT02630459|20089462|P2|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150292|NCT02630459|20089463|P1|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150293|NCT02630459|20089456|P8|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150294|NCT02630459|20089457|P7|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150295|NCT02630459|20089458|P6|COMPLETED|Open-Label Treatment Phase (OLTP)||69
8150296|NCT02630459|20089459|P5|COMPLETED|Open-Label Treatment Phase (OLTP)||357
8150297|NCT02630459|20089460|P4|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150298|NCT02630459|20089461|P3|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150299|NCT02630459|20089462|P2|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150300|NCT02630459|20089463|P1|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150301|NCT02630459|20089456|P8|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150302|NCT02630459|20089457|P7|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150303|NCT02630459|20089458|P6|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150304|NCT02630459|20089459|P5|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
8150305|NCT02630459|20089460|P4|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150306|NCT02630459|20089461|P3|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150307|NCT02630459|20089462|P2|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150308|NCT02630459|20089463|P1|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150309|NCT02630459|20089456|P8|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150310|NCT02630459|20089457|P7|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150311|NCT02630459|20089458|P6|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
8150312|NCT02630459|20089459|P5|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150313|NCT02630459|20089460|P4|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150314|NCT02630459|20089461|P3|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150315|NCT02630459|20089462|P2|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150316|NCT02630459|20089463|P1|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150317|NCT02630459|20089456|P8|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150318|NCT02630459|20089457|P7|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150319|NCT02630459|20089458|P6|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150320|NCT02630459|20089459|P5|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
8150321|NCT02630459|20089460|P4|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150322|NCT02630459|20089461|P3|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150323|NCT02630459|20089462|P2|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150324|NCT02630459|20089463|P1|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150325|NCT02630459|20089456|P8|STARTED|Open-Label Treatment Phase (OLTP)||0
8150326|NCT02630459|20089457|P7|STARTED|Open-Label Treatment Phase (OLTP)||0
8150327|NCT02630459|20089458|P6|STARTED|Open-Label Treatment Phase (OLTP)||73
8150328|NCT02630459|20089459|P5|STARTED|Open-Label Treatment Phase (OLTP)||386
8150329|NCT02630459|20089460|P4|STARTED|Open-Label Treatment Phase (OLTP)||0
8150330|NCT02630459|20089461|P3|STARTED|Open-Label Treatment Phase (OLTP)||0
8150331|NCT02630459|20089462|P2|STARTED|Open-Label Treatment Phase (OLTP)||0
8150332|NCT02630459|20089463|P1|STARTED|Open-Label Treatment Phase (OLTP)||0
8150333|NCT02630459|20089456|P8|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150334|NCT02630459|20089457|P7|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150335|NCT02630459|20089458|P6|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150336|NCT02630459|20089459|P5|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150337|NCT02630459|20089460|P4|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
8150338|NCT02630459|20089461|P3|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
8150339|NCT02630459|20089462|P2|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
8150340|NCT02630459|20089463|P1|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
8150341|NCT02630459|20089456|P8|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150342|NCT02630459|20089457|P7|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150343|NCT02630459|20089458|P6|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150344|NCT02630459|20089459|P5|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150345|NCT02630459|20089460|P4|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
8150346|NCT02630459|20089461|P3|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
8150347|NCT02630459|20089462|P2|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
8150348|NCT02630459|20089463|P1|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
8150349|NCT02630459|20089456|P8|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150350|NCT02630459|20089457|P7|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150351|NCT02630459|20089458|P6|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150352|NCT02630459|20089459|P5|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150353|NCT02630459|20089460|P4|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
8150354|NCT02630459|20089461|P3|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
8150355|NCT02630459|20089462|P2|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
8150356|NCT02630459|20089463|P1|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
8150357|NCT02630459|20089456|P8|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150358|NCT02630459|20089457|P7|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150359|NCT02630459|20089458|P6|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150360|NCT02630459|20089459|P5|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150361|NCT02630459|20089460|P4|STARTED|Double-Blind Treatment Phase (DBTP)||137
8150362|NCT02630459|20089461|P3|STARTED|Double-Blind Treatment Phase (DBTP)||135
8150363|NCT02630459|20089462|P2|STARTED|Double-Blind Treatment Phase (DBTP)||67
8150364|NCT02630459|20089463|P1|STARTED|Double-Blind Treatment Phase (DBTP)||136
8150365|NCT02630251|20089522|P4|NOT COMPLETED|Overall Study||0
8150366|NCT02630251|20089523|P3|NOT COMPLETED|Overall Study||1
8150367|NCT02630251|20089524|P2|NOT COMPLETED|Overall Study||0
8150368|NCT02630251|20089525|P1|NOT COMPLETED|Overall Study||0
8150369|NCT02630251|20089522|P4|COMPLETED|Overall Study||1
8150370|NCT02630251|20089523|P3|COMPLETED|Overall Study||0
8150371|NCT02630251|20089524|P2|COMPLETED|Overall Study||1
8150372|NCT02630251|20089525|P1|COMPLETED|Overall Study||2
8150373|NCT02630251|20089522|P4|STARTED|Overall Study||1
8150374|NCT02630251|20089523|P3|STARTED|Overall Study||1
8150375|NCT02630251|20089524|P2|STARTED|Overall Study||1
8150376|NCT02630251|20089525|P1|STARTED|Overall Study||2
8150377|NCT02630186|20089639|P1|NOT COMPLETED|Overall Study||1
8150378|NCT02630186|20089639|P1|COMPLETED|Overall Study||2
8150379|NCT02630186|20089639|P1|STARTED|Overall Study||3
8150380|NCT02629965|20089655|P2|NOT COMPLETED|Period 2||0
8150381|NCT02629965|20089656|P1|NOT COMPLETED|Period 2||1
8150382|NCT02629965|20089655|P2|COMPLETED|Period 2||90
8150383|NCT02629965|20089656|P1|COMPLETED|Period 2||87
8150384|NCT02629965|20089655|P2|STARTED|Period 2||90
8150385|NCT02629965|20089656|P1|STARTED|Period 2||88
8150386|NCT02629965|20089655|P2|NOT COMPLETED|Period 1||2
8150387|NCT02629965|20089656|P1|NOT COMPLETED|Period 1||4
8150388|NCT02629965|20089655|P2|COMPLETED|Period 1||90
8150389|NCT02629965|20089656|P1|COMPLETED|Period 1||88
8150390|NCT02629965|20089655|P2|STARTED|Period 1||92
8150391|NCT02629965|20089656|P1|STARTED|Period 1||92
8150392|NCT02629861|20089695|P3|NOT COMPLETED|Overall Study||28
8150393|NCT02629861|20089696|P2|NOT COMPLETED|Overall Study||27
8150394|NCT02629861|20089697|P1|NOT COMPLETED|Overall Study||29
8150395|NCT02629861|20089695|P3|COMPLETED|Overall Study||262
8150396|NCT02629861|20089696|P2|COMPLETED|Overall Study||264
8150397|NCT02629861|20089697|P1|COMPLETED|Overall Study||265
8150398|NCT02629861|20089695|P3|Full Analysis Set|Overall Study||287
8150399|NCT02629861|20089696|P2|Full Analysis Set|Overall Study||288
8150400|NCT02629861|20089697|P1|Full Analysis Set|Overall Study||290
8150401|NCT02629861|20089695|P3|Safety Population|Overall Study||289
8150402|NCT02629861|20089696|P2|Safety Population|Overall Study||291
8150403|NCT02629861|20089697|P1|Safety Population|Overall Study||294
8150404|NCT02629861|20089695|P3|Intent to Treat (ITT)|Overall Study||290
8150405|NCT02629861|20089696|P2|Intent to Treat (ITT)|Overall Study||291
8150406|NCT02629861|20089697|P1|Intent to Treat (ITT)|Overall Study||294
8150407|NCT02629861|20089695|P3|STARTED|Overall Study||290
8150408|NCT02629861|20089696|P2|STARTED|Overall Study||291
8150409|NCT02629861|20089697|P1|STARTED|Overall Study||294
8150410|NCT02629822|20089744|P1|NOT COMPLETED|Extension Study||6
8150411|NCT02629822|20089744|P1|COMPLETED|Extension Study||0
8150412|NCT02629822|20089744|P1|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
8150413|NCT02629822|20089744|P1|NOT COMPLETED|Base Study||3
8150414|NCT02629822|20089744|P1|COMPLETED|Base Study||7
8150415|NCT02629822|20089744|P1|STARTED|Base Study||10
8150416|NCT02629354|20089760|P2|NOT COMPLETED|Follow-up||0
8150417|NCT02629354|20089761|P1|NOT COMPLETED|Follow-up||0
8150418|NCT02629354|20089760|P2|COMPLETED|Follow-up||18
8150419|NCT02629354|20089761|P1|COMPLETED|Follow-up||18
8150420|NCT02629354|20089760|P2|STARTED|Follow-up||18
8150421|NCT02629354|20089761|P1|STARTED|Follow-up||18
8150422|NCT02629354|20089760|P2|NOT COMPLETED|Period 2||0
8150423|NCT02629354|20089761|P1|NOT COMPLETED|Period 2||0
8150424|NCT02629354|20089760|P2|COMPLETED|Period 2||18
8150425|NCT02629354|20089761|P1|COMPLETED|Period 2||18
8150426|NCT02629354|20089760|P2|STARTED|Period 2||18
8150427|NCT02629354|20089761|P1|STARTED|Period 2||18
8150428|NCT02629354|20089760|P2|NOT COMPLETED|Washout Period||0
8150429|NCT02629354|20089761|P1|NOT COMPLETED|Washout Period||0
8150430|NCT02629354|20089760|P2|COMPLETED|Washout Period||18
8150431|NCT02629354|20089761|P1|COMPLETED|Washout Period||18
8150432|NCT02629354|20089760|P2|STARTED|Washout Period||18
8150433|NCT02629354|20089761|P1|STARTED|Washout Period||18
8150434|NCT02629354|20089760|P2|NOT COMPLETED|Period 1||0
8150435|NCT02629354|20089761|P1|NOT COMPLETED|Period 1||0
8150436|NCT02629354|20089760|P2|COMPLETED|Period 1||18
8150437|NCT02629354|20089761|P1|COMPLETED|Period 1||18
8150438|NCT02629354|20089760|P2|STARTED|Period 1||18
8150439|NCT02629354|20089761|P1|STARTED|Period 1||18
8150440|NCT02629159|20089786|P3|NOT COMPLETED|Overall Study||51
8150441|NCT02629159|20089787|P2|NOT COMPLETED|Overall Study||39
8150442|NCT02629159|20089788|P1|NOT COMPLETED|Overall Study||56
8150443|NCT02629159|20089786|P3|COMPLETED|Overall Study||600
8150444|NCT02629159|20089787|P2|COMPLETED|Overall Study||288
8150445|NCT02629159|20089788|P1|COMPLETED|Overall Study||595
8150446|NCT02629159|20089786|P3|Rescued at Week 22|Overall Study||18
8150447|NCT02629159|20089787|P2|Rescued at Week 22|Overall Study||7
8150448|NCT02629159|20089788|P1|Rescued at Week 22|Overall Study||26
8150449|NCT02629159|20089786|P3|Rescued at Week 18|Overall Study||29
8150450|NCT02629159|20089787|P2|Rescued at Week 18|Overall Study||14
8150451|NCT02629159|20089788|P1|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
8150452|NCT02629159|20089786|P3|Rescued at Week 14|Overall Study||78
8150453|NCT02629159|20089787|P2|Rescued at Week 14|Overall Study||56
8150454|NCT02629159|20089788|P1|Rescued at Week 14|Overall Study||231
8150455|NCT02629159|20089786|P3|Completed Week 14 on Study Drug|Overall Study||620
8150456|NCT02629159|20089787|P2|Completed Week 14 on Study Drug|Overall Study||300
8150457|NCT02629159|20089788|P1|Completed Week 14 on Study Drug|Overall Study||620
8150458|NCT02629159|20089786|P3|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
8150459|NCT02629159|20089787|P2|Received Assigned Study Drug|Overall Study||327
8150460|NCT02629159|20089788|P1|Received Assigned Study Drug|Overall Study||651
8150461|NCT02629159|20089786|P3|STARTED|Overall Study||651
8150462|NCT02629159|20089787|P2|STARTED|Overall Study||327
8150463|NCT02629159|20089788|P1|STARTED|Overall Study||651
8150464|NCT02629133|20089840|P2|NOT COMPLETED|Overall Study||2
8150465|NCT02629133|20089841|P1|NOT COMPLETED|Overall Study||4
8150466|NCT02629133|20089840|P2|COMPLETED|Overall Study||23
8150467|NCT02629133|20089841|P1|COMPLETED|Overall Study||21
8150468|NCT02629133|20089840|P2|STARTED|Overall Study||25
8150469|NCT02629133|20089841|P1|STARTED|Overall Study||25
8150470|NCT02629094|20089855|P1|NOT COMPLETED|Overall Study||0
8150471|NCT02629094|20089855|P1|COMPLETED|Overall Study||5
8150472|NCT02629094|20089855|P1|STARTED|Overall Study||5
8150473|NCT02628964|20089862|P2|NOT COMPLETED|Overall Study||1
8150474|NCT02628964|20089863|P1|NOT COMPLETED|Overall Study||0
8150475|NCT02628964|20089862|P2|COMPLETED|Overall Study||49
8150476|NCT02628964|20089863|P1|COMPLETED|Overall Study||50
8150477|NCT02628964|20089862|P2|STARTED|Overall Study||50
8150478|NCT02628964|20089863|P1|STARTED|Overall Study||50
8150479|NCT02628938|20089884|P3|NOT COMPLETED|Overall Study||4
8150480|NCT02628938|20089885|P2|NOT COMPLETED|Overall Study||2
8150481|NCT02628938|20089886|P1|NOT COMPLETED|Overall Study||5
8150482|NCT02628938|20089884|P3|COMPLETED|Overall Study||11
8150483|NCT02628938|20089885|P2|COMPLETED|Overall Study||13
8150484|NCT02628938|20089886|P1|COMPLETED|Overall Study||10
8150485|NCT02628938|20089884|P3|STARTED|Overall Study||15
8150486|NCT02628938|20089885|P2|STARTED|Overall Study||15
8150487|NCT02628938|20089886|P1|STARTED|Overall Study||15
8150488|NCT02628873|20089902|P2|NOT COMPLETED|Second Test (1 Hour)||0
8150489|NCT02628873|20089903|P1|NOT COMPLETED|Second Test (1 Hour)||1
8150490|NCT02628873|20089902|P2|COMPLETED|Second Test (1 Hour)||6
8150491|NCT02628873|20089903|P1|COMPLETED|Second Test (1 Hour)||13
8150492|NCT02628873|20089902|P2|STARTED|Second Test (1 Hour)||6
8150493|NCT02628873|20089903|P1|STARTED|Second Test (1 Hour)||14
8150494|NCT02628873|20089902|P2|NOT COMPLETED|Break (1 Hour)||1
8150495|NCT02628873|20089903|P1|NOT COMPLETED|Break (1 Hour)||0
8150496|NCT02628873|20089902|P2|COMPLETED|Break (1 Hour)||6
8150497|NCT02628873|20089903|P1|COMPLETED|Break (1 Hour)||14
8150498|NCT02628873|20089902|P2|STARTED|Break (1 Hour)||7
8150499|NCT02628873|20089903|P1|STARTED|Break (1 Hour)||14
8150500|NCT02628873|20089902|P2|NOT COMPLETED|First Test (1 Hour)||0
8150501|NCT02628873|20089903|P1|NOT COMPLETED|First Test (1 Hour)||0
8150502|NCT02628873|20089902|P2|COMPLETED|First Test (1 Hour)||7
8150503|NCT02628873|20089903|P1|COMPLETED|First Test (1 Hour)||14
8150504|NCT02628873|20089902|P2|STARTED|First Test (1 Hour)||7
8150505|NCT02628873|20089903|P1|STARTED|First Test (1 Hour)||14
8150506|NCT02628769|20089913|P2|NOT COMPLETED|Second Intervention||1
8150507|NCT02628769|20089914|P1|NOT COMPLETED|Second Intervention||2
8150508|NCT02628769|20089913|P2|COMPLETED|Second Intervention||1
8150509|NCT02628769|20089914|P1|COMPLETED|Second Intervention||0
8150510|NCT02628769|20089913|P2|STARTED|Second Intervention||2
8150511|NCT02628769|20089914|P1|STARTED|Second Intervention||2
8150512|NCT02628769|20089913|P2|NOT COMPLETED|Wash Out (28 Days)||0
8150513|NCT02628769|20089914|P1|NOT COMPLETED|Wash Out (28 Days)||0
8150514|NCT02628769|20089913|P2|COMPLETED|Wash Out (28 Days)||2
8150515|NCT02628769|20089914|P1|COMPLETED|Wash Out (28 Days)||2
8150516|NCT02628769|20089913|P2|STARTED|Wash Out (28 Days)||2
8150517|NCT02628769|20089914|P1|STARTED|Wash Out (28 Days)||2
8150518|NCT02628769|20089913|P2|NOT COMPLETED|First Intervention||1
8150519|NCT02628769|20089914|P1|NOT COMPLETED|First Intervention||1
8150520|NCT02628769|20089913|P2|COMPLETED|First Intervention||2
8150521|NCT02628769|20089914|P1|COMPLETED|First Intervention||2
8150522|NCT02628769|20089913|P2|STARTED|First Intervention||3
8150523|NCT02628769|20089914|P1|STARTED|First Intervention||3
8150524|NCT02628743|20089952|P1|NOT COMPLETED|Overall Study||131
8150525|NCT02628743|20089952|P1|COMPLETED|Overall Study||0
8150526|NCT02628743|20089952|P1|STARTED|Overall Study||131
8150527|NCT02628600|20089978|P2|NOT COMPLETED|Overall Study||32
8150528|NCT02628600|20089979|P1|NOT COMPLETED|Overall Study||24
8150529|NCT02628600|20089978|P2|COMPLETED|Overall Study||58
8150530|NCT02628600|20089979|P1|COMPLETED|Overall Study||49
8150531|NCT02628600|20089978|P2|Participant Discontinued the Study|Overall Study||32
8150532|NCT02628600|20089979|P1|Participant Discontinued the Study|Overall Study||24
8150533|NCT02628600|20089978|P2|STARTED|Overall Study||90
8150534|NCT02628600|20089979|P1|STARTED|Overall Study||73
8150535|NCT02628418|20089993|P2|NOT COMPLETED|Overall Study||2
8150536|NCT02628418|20089994|P1|NOT COMPLETED|Overall Study||1
8150537|NCT02628418|20089993|P2|COMPLETED|Overall Study||13
8150538|NCT02628418|20089994|P1|COMPLETED|Overall Study||14
8150539|NCT02628418|20089993|P2|STARTED|Overall Study||15
8150540|NCT02628418|20089994|P1|STARTED|Overall Study||15
8150541|NCT02628236|20090015|P1|NOT COMPLETED|Overall Study||0
8150542|NCT02628236|20090015|P1|COMPLETED|Overall Study||14
8150543|NCT02628236|20090015|P1|STARTED|Overall Study||14
8150544|NCT02628223|20090054|P2|NOT COMPLETED|Overall Study||2
8150545|NCT02628223|20090055|P1|NOT COMPLETED|Overall Study||0
8150546|NCT02628223|20090054|P2|COMPLETED|Overall Study||36
8150547|NCT02628223|20090055|P1|COMPLETED|Overall Study||38
8150548|NCT02628223|20090054|P2|STARTED|Overall Study||38
8150549|NCT02628223|20090055|P1|STARTED|Overall Study||38
8150550|NCT02628106|20090071|P1|NOT COMPLETED|Overall Study||0
8150551|NCT02628106|20090071|P1|COMPLETED|Overall Study||21
8150552|NCT02628106|20090071|P1|STARTED|Overall Study||21
8150553|NCT02628093|20090077|P2|NOT COMPLETED|Overall Study||0
8150554|NCT02628093|20090078|P1|NOT COMPLETED|Overall Study||0
8150555|NCT02628093|20090077|P2|COMPLETED|Overall Study||29
8150556|NCT02628093|20090078|P1|COMPLETED|Overall Study||31
8150557|NCT02628093|20090077|P2|STARTED|Overall Study||29
8150558|NCT02628093|20090078|P1|STARTED|Overall Study||31
8150559|NCT02628028|20090104|P8|NOT COMPLETED|Long-term Extension (LTE) Period||61
8150560|NCT02628028|20090105|P7|NOT COMPLETED|Long-term Extension (LTE) Period||58
8150561|NCT02628028|20090106|P6|NOT COMPLETED|Long-term Extension (LTE) Period||60
8150562|NCT02628028|20090107|P5|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150563|NCT02628028|20090108|P4|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150564|NCT02628028|20090109|P3|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150565|NCT02628028|20090110|P2|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150566|NCT02628028|20090111|P1|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150567|NCT02628028|20090104|P8|COMPLETED|Long-term Extension (LTE) Period||0
8150568|NCT02628028|20090105|P7|COMPLETED|Long-term Extension (LTE) Period||0
8150569|NCT02628028|20090106|P6|COMPLETED|Long-term Extension (LTE) Period||1
8150570|NCT02628028|20090107|P5|COMPLETED|Long-term Extension (LTE) Period||0
8150571|NCT02628028|20090108|P4|COMPLETED|Long-term Extension (LTE) Period||0
8150572|NCT02628028|20090109|P3|COMPLETED|Long-term Extension (LTE) Period||0
8150573|NCT02628028|20090110|P2|COMPLETED|Long-term Extension (LTE) Period||0
8150574|NCT02628028|20090111|P1|COMPLETED|Long-term Extension (LTE) Period||0
8150575|NCT02628028|20090104|P8|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8150576|NCT02628028|20090105|P7|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8150577|NCT02628028|20090106|P6|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8150578|NCT02628028|20090107|P5|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150579|NCT02628028|20090108|P4|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150580|NCT02628028|20090109|P3|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150581|NCT02628028|20090110|P2|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150582|NCT02628028|20090111|P1|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150583|NCT02628028|20090104|P8|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
8150584|NCT02628028|20090105|P7|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
8150585|NCT02628028|20090106|P6|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
8150586|NCT02628028|20090107|P5|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
8150587|NCT02628028|20090108|P4|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150588|NCT02628028|20090109|P3|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150589|NCT02628028|20090110|P2|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150590|NCT02628028|20090111|P1|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150591|NCT02628028|20090104|P8|NOT COMPLETED|Dosing Period||15
8150592|NCT02628028|20090105|P7|NOT COMPLETED|Dosing Period||16
8150593|NCT02628028|20090106|P6|NOT COMPLETED|Dosing Period||14
8150594|NCT02628028|20090107|P5|NOT COMPLETED|Dosing Period||16
8150595|NCT02628028|20090108|P4|NOT COMPLETED|Dosing Period||0
8150596|NCT02628028|20090109|P3|NOT COMPLETED|Dosing Period||1
8150597|NCT02628028|20090110|P2|NOT COMPLETED|Dosing Period||0
8150598|NCT02628028|20090111|P1|NOT COMPLETED|Dosing Period||0
8150599|NCT02628028|20090104|P8|COMPLETED|Dosing Period||48
8150600|NCT02628028|20090105|P7|COMPLETED|Dosing Period||46
8150601|NCT02628028|20090106|P6|COMPLETED|Dosing Period||49
8150602|NCT02628028|20090107|P5|COMPLETED|Dosing Period||46
8150603|NCT02628028|20090108|P4|COMPLETED|Dosing Period||8
8150604|NCT02628028|20090109|P3|COMPLETED|Dosing Period||9
8150605|NCT02628028|20090110|P2|COMPLETED|Dosing Period||9
8150606|NCT02628028|20090111|P1|COMPLETED|Dosing Period||9
8150607|NCT02628028|20090104|P8|Received at Least 1dose of Study Drug|Dosing Period||63
8150608|NCT02628028|20090105|P7|Received at Least 1dose of Study Drug|Dosing Period||62
8150609|NCT02628028|20090106|P6|Received at Least 1dose of Study Drug|Dosing Period||63
8150610|NCT02628028|20090107|P5|Received at Least 1dose of Study Drug|Dosing Period||62
8150611|NCT02628028|20090108|P4|Received at Least 1dose of Study Drug|Dosing Period||8
8150612|NCT02628028|20090109|P3|Received at Least 1dose of Study Drug|Dosing Period||10
8150613|NCT02628028|20090110|P2|Received at Least 1dose of Study Drug|Dosing Period||9
8150614|NCT02628028|20090111|P1|Received at Least 1dose of Study Drug|Dosing Period||9
8150615|NCT02628028|20090104|P8|STARTED|Dosing Period||63
8150616|NCT02628028|20090105|P7|STARTED|Dosing Period||62
8150617|NCT02628028|20090106|P6|STARTED|Dosing Period||63
8150618|NCT02628028|20090107|P5|STARTED|Dosing Period||62
8150619|NCT02628028|20090108|P4|STARTED|Dosing Period||8
8150620|NCT02628028|20090109|P3|STARTED|Dosing Period||10
8150621|NCT02628028|20090110|P2|STARTED|Dosing Period||9
8150622|NCT02628028|20090111|P1|STARTED|Dosing Period||9
8150629|NCT02627924|20090166|P1|NOT COMPLETED|Overall Study||12
8150630|NCT02627924|20090166|P1|COMPLETED|Overall Study||79
8150631|NCT02627924|20090166|P1|STARTED|Overall Study||91
8150632|NCT02627794|20090183|P1|NOT COMPLETED|Overall Study||0
8150633|NCT02627794|20090183|P1|COMPLETED|Overall Study||3
8150634|NCT02627794|20090183|P1|STARTED|Overall Study||3
8150635|NCT02627144|20090196|P1|NOT COMPLETED|Overall Study||365
8150636|NCT02627144|20090196|P1|COMPLETED|Overall Study||0
8150637|NCT02627144|20090196|P1|Treated|Overall Study||359
8150638|NCT02627144|20090196|P1|STARTED|Overall Study||365
8150639|NCT02627118|20090204|P1|NOT COMPLETED|Overall Study||0
8150640|NCT02627118|20090204|P1|COMPLETED|Overall Study||10
8150641|NCT02627118|20090204|P1|STARTED|Overall Study||10
8150642|NCT02627001|20090211|P2|NOT COMPLETED|Overall Study||0
8150643|NCT02627001|20090212|P1|NOT COMPLETED|Overall Study||0
8150644|NCT02627001|20090211|P2|COMPLETED|Overall Study||14
8150645|NCT02627001|20090212|P1|COMPLETED|Overall Study||13
8150646|NCT02627001|20090211|P2|STARTED|Overall Study||14
8150647|NCT02627001|20090212|P1|STARTED|Overall Study||13
8150648|NCT02626910|20090222|P4|NOT COMPLETED|Overall Study||0
8150649|NCT02626910|20090223|P3|NOT COMPLETED|Overall Study||0
8150650|NCT02626910|20090224|P2|NOT COMPLETED|Overall Study||0
8150651|NCT02626910|20090225|P1|NOT COMPLETED|Overall Study||0
8150652|NCT02626910|20090222|P4|COMPLETED|Overall Study||10
8150653|NCT02626910|20090223|P3|COMPLETED|Overall Study||6
8150654|NCT02626910|20090224|P2|COMPLETED|Overall Study||10
8150655|NCT02626910|20090225|P1|COMPLETED|Overall Study||23
8150656|NCT02626910|20090222|P4|STARTED|Overall Study||10
8150657|NCT02626910|20090223|P3|STARTED|Overall Study||6
8150658|NCT02626910|20090224|P2|STARTED|Overall Study||10
8150659|NCT02626910|20090225|P1|STARTED|Overall Study||23
8150660|NCT02626819|20090237|P2|NOT COMPLETED|Overall Study||3
8150661|NCT02626819|20090238|P1|NOT COMPLETED|Overall Study||4
8150662|NCT02626819|20090237|P2|COMPLETED|Overall Study||20
8150663|NCT02626819|20090238|P1|COMPLETED|Overall Study||18
8150664|NCT02626819|20090237|P2|STARTED|Overall Study||23
8150665|NCT02626819|20090238|P1|STARTED|Overall Study||22
8150666|NCT02626780|20090258|P1|NOT COMPLETED|Overall Study||3
8150667|NCT02626780|20090258|P1|COMPLETED|Overall Study||4
8150668|NCT02626780|20090258|P1|Withdrew From Study|Overall Study||3
8150669|NCT02626780|20090258|P1|STARTED|Overall Study||7
8150670|NCT02626611|20090266|P3|NOT COMPLETED|Overall Study||3
8150671|NCT02626611|20090267|P2|NOT COMPLETED|Overall Study||1
8150672|NCT02626611|20090268|P1|NOT COMPLETED|Overall Study||4
8150673|NCT02626611|20090266|P3|COMPLETED|Overall Study||16
8150674|NCT02626611|20090267|P2|COMPLETED|Overall Study||20
8150675|NCT02626611|20090268|P1|COMPLETED|Overall Study||16
8150676|NCT02626611|20090266|P3|STARTED|Overall Study||19
8150677|NCT02626611|20090267|P2|STARTED|Overall Study||21
8150678|NCT02626611|20090268|P1|STARTED|Overall Study||20
8150679|NCT02626520|20090291|P2|NOT COMPLETED|Overall Study||10
8150680|NCT02626520|20090292|P1|NOT COMPLETED|Overall Study||1
8150681|NCT02626520|20090291|P2|COMPLETED|Overall Study||0
8150682|NCT02626520|20090292|P1|COMPLETED|Overall Study||0
8150683|NCT02626520|20090291|P2|STARTED|Overall Study||10
8150684|NCT02626520|20090292|P1|STARTED|Overall Study||1
8150685|NCT02626182|20090304|P2|NOT COMPLETED|Overall Study||0
8150686|NCT02626182|20090305|P1|NOT COMPLETED|Overall Study||2
8150687|NCT02626182|20090304|P2|COMPLETED|Overall Study||3
8150688|NCT02626182|20090305|P1|COMPLETED|Overall Study||9
8150689|NCT02626182|20090304|P2|STARTED|Overall Study||3
8150690|NCT02626182|20090305|P1|STARTED|Overall Study||11
8150691|NCT02626026|20090321|P6|NOT COMPLETED|Overall Study||0
8150692|NCT02626026|20090322|P5|NOT COMPLETED|Overall Study||1
8150693|NCT02626026|20090323|P4|NOT COMPLETED|Overall Study||0
8150694|NCT02626026|20090324|P3|NOT COMPLETED|Overall Study||0
8150695|NCT02626026|20090325|P2|NOT COMPLETED|Overall Study||0
8150696|NCT02626026|20090326|P1|NOT COMPLETED|Overall Study||0
8150697|NCT02626026|20090321|P6|COMPLETED|Overall Study||5
8150698|NCT02626026|20090322|P5|COMPLETED|Overall Study||16
8150699|NCT02626026|20090323|P4|COMPLETED|Overall Study||2
8150700|NCT02626026|20090324|P3|COMPLETED|Overall Study||8
8150701|NCT02626026|20090325|P2|COMPLETED|Overall Study||2
8150702|NCT02626026|20090326|P1|COMPLETED|Overall Study||8
8150703|NCT02626026|20090321|P6|STARTED|Overall Study||5
8150704|NCT02626026|20090322|P5|STARTED|Overall Study||17
8150705|NCT02626026|20090323|P4|STARTED|Overall Study||2
8150706|NCT02626026|20090324|P3|STARTED|Overall Study||8
8150707|NCT02626026|20090325|P2|STARTED|Overall Study||2
8150708|NCT02626026|20090326|P1|STARTED|Overall Study||8
8150709|NCT02626000|20090404|P1|NOT COMPLETED|Overall Study||36
8150710|NCT02626000|20090404|P1|COMPLETED|Overall Study||0
8150711|NCT02626000|20090404|P1|STARTED|Overall Study||36
8150720|NCT02625922|20090529|P2|NOT COMPLETED|Overall Study||2
8150721|NCT02625922|20090530|P1|NOT COMPLETED|Overall Study||2
8150722|NCT02625922|20090529|P2|COMPLETED|Overall Study||10
8150723|NCT02625922|20090530|P1|COMPLETED|Overall Study||12
8150724|NCT02625922|20090529|P2|Completed Treatment Period 2|Overall Study||8
8150725|NCT02625922|20090530|P1|Completed Treatment Period 2|Overall Study||11
8150726|NCT02625922|20090529|P2|Completed Treatment Period 1|Overall Study||10
8150727|NCT02625922|20090530|P1|Completed Treatment Period 1|Overall Study||12
8150728|NCT02625922|20090529|P2|STARTED|Overall Study||12
8150729|NCT02625922|20090530|P1|STARTED|Overall Study||14
8150730|NCT02625844|20090543|P1|NOT COMPLETED|Overall Study||0
8150731|NCT02625844|20090543|P1|COMPLETED|Overall Study||110
8150732|NCT02625844|20090543|P1|STARTED|Overall Study||110
8150733|NCT02625623|20090549|P2|NOT COMPLETED|Overall Study||1
8150734|NCT02625623|20090550|P1|NOT COMPLETED|Overall Study||9
8150735|NCT02625623|20090549|P2|COMPLETED|Overall Study||184
8150736|NCT02625623|20090550|P1|COMPLETED|Overall Study||177
8150737|NCT02625623|20090549|P2|Treated|Overall Study||184
8150738|NCT02625623|20090550|P1|Treated|Overall Study||177
8150739|NCT02625623|20090549|P2|STARTED|Overall Study||185
8150740|NCT02625623|20090550|P1|STARTED|Overall Study||186
8150741|NCT02625571|20090570|P1|NOT COMPLETED|Overall Study||3
8150742|NCT02625571|20090570|P1|COMPLETED|Overall Study||10
8150743|NCT02625571|20090570|P1|STARTED|Overall Study||13
8150744|NCT02625545|20090575|P1|NOT COMPLETED|Overall Study||0
8150745|NCT02625545|20090575|P1|COMPLETED|Overall Study||45
8150746|NCT02625545|20090575|P1|12 Month|Overall Study||45
8150747|NCT02625545|20090575|P1|6 Month|Overall Study||45
8150748|NCT02625545|20090575|P1|3 Month|Overall Study||45
8150749|NCT02625545|20090575|P1|STARTED|Overall Study||45
8150750|NCT02625428|20090591|P2|NOT COMPLETED|Overall Study||0
8150751|NCT02625428|20090592|P1|NOT COMPLETED|Overall Study||0
8150752|NCT02625428|20090591|P2|COMPLETED|Overall Study||20
8150753|NCT02625428|20090592|P1|COMPLETED|Overall Study||20
8150754|NCT02625428|20090591|P2|STARTED|Overall Study||20
8150755|NCT02625428|20090592|P1|STARTED|Overall Study||20
8150756|NCT02625402|20090602|P2|NOT COMPLETED|Overall Study||12
8150757|NCT02625402|20090603|P1|NOT COMPLETED|Overall Study||9
8150758|NCT02625402|20090602|P2|COMPLETED|Overall Study||25
8150759|NCT02625402|20090603|P1|COMPLETED|Overall Study||33
8150760|NCT02625402|20090602|P2|STARTED|Overall Study||37
8150761|NCT02625402|20090603|P1|STARTED|Overall Study||42
8150774|NCT02625298|20090624|P2|NOT COMPLETED|Overall Study||0
8150775|NCT02625298|20090625|P1|NOT COMPLETED|Overall Study||1
8150776|NCT02625298|20090624|P2|COMPLETED|Overall Study||13
8150777|NCT02625298|20090625|P1|COMPLETED|Overall Study||10
8150778|NCT02625298|20090624|P2|STARTED|Overall Study||13
8150779|NCT02625298|20090625|P1|STARTED|Overall Study||11
8150780|NCT02625259|20090638|P5|NOT COMPLETED|Second Intervention (Day 15)||0
8150781|NCT02625259|20090639|P4|NOT COMPLETED|Second Intervention (Day 15)||0
8150782|NCT02625259|20090640|P3|NOT COMPLETED|Second Intervention (Day 15)||0
8150783|NCT02625259|20090641|P2|NOT COMPLETED|Second Intervention (Day 15)||0
8150784|NCT02625259|20090642|P1|NOT COMPLETED|Second Intervention (Day 15)||0
8150785|NCT02625259|20090638|P5|COMPLETED|Second Intervention (Day 15)||0
8150786|NCT02625259|20090639|P4|COMPLETED|Second Intervention (Day 15)||9
8150787|NCT02625259|20090640|P3|COMPLETED|Second Intervention (Day 15)||7
8150788|NCT02625259|20090641|P2|COMPLETED|Second Intervention (Day 15)||8
8150789|NCT02625259|20090642|P1|COMPLETED|Second Intervention (Day 15)||9
8150790|NCT02625259|20090638|P5|STARTED|Second Intervention (Day 15)||0
8150791|NCT02625259|20090639|P4|STARTED|Second Intervention (Day 15)||9
8150792|NCT02625259|20090640|P3|STARTED|Second Intervention (Day 15)||7
8150793|NCT02625259|20090641|P2|STARTED|Second Intervention (Day 15)||8
8150794|NCT02625259|20090642|P1|STARTED|Second Intervention (Day 15)||9
8150795|NCT02625259|20090638|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150796|NCT02625259|20090639|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150797|NCT02625259|20090640|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150798|NCT02625259|20090641|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150799|NCT02625259|20090642|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150800|NCT02625259|20090638|P5|COMPLETED|Washout (Day 2 to Day 14)||0
8150801|NCT02625259|20090639|P4|COMPLETED|Washout (Day 2 to Day 14)||9
8150802|NCT02625259|20090640|P3|COMPLETED|Washout (Day 2 to Day 14)||7
8150803|NCT02625259|20090641|P2|COMPLETED|Washout (Day 2 to Day 14)||8
8150804|NCT02625259|20090642|P1|COMPLETED|Washout (Day 2 to Day 14)||9
8150805|NCT02625259|20090638|P5|STARTED|Washout (Day 2 to Day 14)||0
8150806|NCT02625259|20090639|P4|STARTED|Washout (Day 2 to Day 14)||9
8150807|NCT02625259|20090640|P3|STARTED|Washout (Day 2 to Day 14)||7
8150808|NCT02625259|20090641|P2|STARTED|Washout (Day 2 to Day 14)||8
8150809|NCT02625259|20090642|P1|STARTED|Washout (Day 2 to Day 14)||9
8150810|NCT02625259|20090638|P5|NOT COMPLETED|First Intervention (Day 1)||0
8150811|NCT02625259|20090639|P4|NOT COMPLETED|First Intervention (Day 1)||1
8150812|NCT02625259|20090640|P3|NOT COMPLETED|First Intervention (Day 1)||1
8150813|NCT02625259|20090641|P2|NOT COMPLETED|First Intervention (Day 1)||1
8150814|NCT02625259|20090642|P1|NOT COMPLETED|First Intervention (Day 1)||2
8150815|NCT02625259|20090638|P5|COMPLETED|First Intervention (Day 1)||16
8150816|NCT02625259|20090639|P4|COMPLETED|First Intervention (Day 1)||9
8150817|NCT02625259|20090640|P3|COMPLETED|First Intervention (Day 1)||7
8150818|NCT02625259|20090641|P2|COMPLETED|First Intervention (Day 1)||8
8150819|NCT02625259|20090642|P1|COMPLETED|First Intervention (Day 1)||9
8150820|NCT02625259|20090638|P5|STARTED|First Intervention (Day 1)||16
8150821|NCT02625259|20090639|P4|STARTED|First Intervention (Day 1)||10
8150822|NCT02625259|20090640|P3|STARTED|First Intervention (Day 1)||8
8150823|NCT02625259|20090641|P2|STARTED|First Intervention (Day 1)||9
8150824|NCT02625259|20090642|P1|STARTED|First Intervention (Day 1)||11
8150825|NCT02625233|20090679|P2|NOT COMPLETED|Overall Study||0
8150826|NCT02625233|20090680|P1|NOT COMPLETED|Overall Study||2
8150827|NCT02625233|20090679|P2|COMPLETED|Overall Study||56
8150828|NCT02625233|20090680|P1|COMPLETED|Overall Study||47
8150829|NCT02625233|20090679|P2|STARTED|Overall Study||56
8150830|NCT02625233|20090680|P1|STARTED|Overall Study||49
8150831|NCT02625220|20090688|P1|NOT COMPLETED|Overall Study||7
8150832|NCT02625220|20090688|P1|COMPLETED|Overall Study||163
8150833|NCT02625220|20090688|P1|STARTED|Overall Study||170
8150834|NCT02625207|20090699|P4|NOT COMPLETED|Part 2 (11 Days)||0
8150835|NCT02625207|20090700|P3|NOT COMPLETED|Part 2 (11 Days)||0
8150836|NCT02625207|20090701|P2|NOT COMPLETED|Part 2 (11 Days)||0
8150837|NCT02625207|20090702|P1|NOT COMPLETED|Part 2 (11 Days)||0
8150838|NCT02625207|20090699|P4|COMPLETED|Part 2 (11 Days)||0
8150839|NCT02625207|20090700|P3|COMPLETED|Part 2 (11 Days)||12
8150840|NCT02625207|20090701|P2|COMPLETED|Part 2 (11 Days)||0
8150841|NCT02625207|20090702|P1|COMPLETED|Part 2 (11 Days)||11
8150842|NCT02625207|20090699|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
8150843|NCT02625207|20090700|P3|STARTED|Part 2 (11 Days)||12
8150844|NCT02625207|20090701|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
8150845|NCT02625207|20090702|P1|STARTED|Part 2 (11 Days)||11
8150846|NCT02625207|20090699|P4|NOT COMPLETED|Part 1 (6 Days)||0
8150847|NCT02625207|20090700|P3|NOT COMPLETED|Part 1 (6 Days)||0
8150848|NCT02625207|20090701|P2|NOT COMPLETED|Part 1 (6 Days)||0
8150849|NCT02625207|20090702|P1|NOT COMPLETED|Part 1 (6 Days)||0
8150850|NCT02625207|20090699|P4|COMPLETED|Part 1 (6 Days)||12
8150851|NCT02625207|20090700|P3|COMPLETED|Part 1 (6 Days)||12
8150852|NCT02625207|20090701|P2|COMPLETED|Part 1 (6 Days)||12
8150853|NCT02625207|20090702|P1|COMPLETED|Part 1 (6 Days)||11
8150854|NCT02625207|20090699|P4|STARTED|Part 1 (6 Days)||12
8150855|NCT02625207|20090700|P3|STARTED|Part 1 (6 Days)||12
8150856|NCT02625207|20090701|P2|STARTED|Part 1 (6 Days)||12
8150857|NCT02625207|20090702|P1|STARTED|Part 1 (6 Days)||11
8150858|NCT02625181|20090791|P3|NOT COMPLETED|Overall Study||0
8150859|NCT02625181|20090792|P2|NOT COMPLETED|Overall Study||0
8150860|NCT02625181|20090793|P1|NOT COMPLETED|Overall Study||0
8150861|NCT02625181|20090791|P3|COMPLETED|Overall Study||12707
8150862|NCT02625181|20090792|P2|COMPLETED|Overall Study||12809
8150863|NCT02625181|20090793|P1|COMPLETED|Overall Study||1518
8150864|NCT02625181|20090791|P3|STARTED|Overall Study||12707
8150865|NCT02625181|20090792|P2|STARTED|Overall Study||12809
8150866|NCT02625181|20090793|P1|STARTED|Overall Study||1518
8150867|NCT02624986|20090816|P8|NOT COMPLETED|Overall Study||5
8150868|NCT02624986|20090817|P7|NOT COMPLETED|Overall Study||4
8150869|NCT02624986|20090818|P6|NOT COMPLETED|Overall Study||2
8150870|NCT02624986|20090819|P5|NOT COMPLETED|Overall Study||4
8150871|NCT02624986|20090820|P4|NOT COMPLETED|Overall Study||3
8150872|NCT02624986|20090821|P3|NOT COMPLETED|Overall Study||2
8150873|NCT02624986|20090822|P2|NOT COMPLETED|Overall Study||3
8150874|NCT02624986|20090823|P1|NOT COMPLETED|Overall Study||2
8150875|NCT02624986|20090816|P8|COMPLETED|Overall Study||0
8150876|NCT02624986|20090817|P7|COMPLETED|Overall Study||0
8150877|NCT02624986|20090818|P6|COMPLETED|Overall Study||0
8150878|NCT02624986|20090819|P5|COMPLETED|Overall Study||0
8150879|NCT02624986|20090820|P4|COMPLETED|Overall Study||0
8150880|NCT02624986|20090821|P3|COMPLETED|Overall Study||0
8150881|NCT02624986|20090822|P2|COMPLETED|Overall Study||0
8150882|NCT02624986|20090823|P1|COMPLETED|Overall Study||0
8150883|NCT02624986|20090816|P8|Received Any Study Treatment|Overall Study||5
8150884|NCT02624986|20090817|P7|Received Any Study Treatment|Overall Study||4
8150885|NCT02624986|20090818|P6|Received Any Study Treatment|Overall Study||2
8150886|NCT02624986|20090819|P5|Received Any Study Treatment|Overall Study||4
8150887|NCT02624986|20090820|P4|Received Any Study Treatment|Overall Study||3
8150888|NCT02624986|20090821|P3|Received Any Study Treatment|Overall Study||2
8150889|NCT02624986|20090822|P2|Received Any Study Treatment|Overall Study||3
8150890|NCT02624986|20090823|P1|Received Any Study Treatment|Overall Study||1
8150891|NCT02624986|20090816|P8|STARTED|Overall Study||5
8150892|NCT02624986|20090817|P7|STARTED|Overall Study||4
8150893|NCT02624986|20090818|P6|STARTED|Overall Study||2
8150894|NCT02624986|20090819|P5|STARTED|Overall Study||4
8150895|NCT02624986|20090820|P4|STARTED|Overall Study||3
8150896|NCT02624986|20090821|P3|STARTED|Overall Study||2
8150897|NCT02624986|20090822|P2|STARTED|Overall Study||3
8150898|NCT02624986|20090823|P1|STARTED|Overall Study||2
8150899|NCT02624843|20091003|P3|NOT COMPLETED|Overall Study||8
8150900|NCT02624843|20091004|P2|NOT COMPLETED|Overall Study||36
8150901|NCT02624843|20091005|P1|NOT COMPLETED|Overall Study||37
8150902|NCT02624843|20091003|P3|COMPLETED|Overall Study||16
8150903|NCT02624843|20091004|P2|COMPLETED|Overall Study||72
8150904|NCT02624843|20091005|P1|COMPLETED|Overall Study||70
8150905|NCT02624843|20091003|P3|STARTED|Overall Study||24
8150906|NCT02624843|20091004|P2|STARTED|Overall Study||108
8150907|NCT02624843|20091005|P1|STARTED|Overall Study||107
8150908|NCT02624791|20091013|P6|NOT COMPLETED|Overall Study||0
8150909|NCT02624791|20091014|P5|NOT COMPLETED|Overall Study||0
8150910|NCT02624791|20091015|P4|NOT COMPLETED|Overall Study||0
8150911|NCT02624791|20091016|P3|NOT COMPLETED|Overall Study||0
8150912|NCT02624791|20091017|P2|NOT COMPLETED|Overall Study||0
8150913|NCT02624791|20091018|P1|NOT COMPLETED|Overall Study||2
8150914|NCT02624791|20091013|P6|COMPLETED|Overall Study||2
8150915|NCT02624791|20091014|P5|COMPLETED|Overall Study||2
8150916|NCT02624791|20091015|P4|COMPLETED|Overall Study||2
8150917|NCT02624791|20091016|P3|COMPLETED|Overall Study||2
8150918|NCT02624791|20091017|P2|COMPLETED|Overall Study||1
8150919|NCT02624791|20091018|P1|COMPLETED|Overall Study||0
8150920|NCT02624791|20091013|P6|STARTED|Overall Study||2
8150921|NCT02624791|20091014|P5|STARTED|Overall Study||2
8150922|NCT02624791|20091015|P4|STARTED|Overall Study||2
8150923|NCT02624791|20091016|P3|STARTED|Overall Study||2
8150924|NCT02624791|20091017|P2|STARTED|Overall Study||1
8150925|NCT02624791|20091018|P1|STARTED|Overall Study||2
8150926|NCT02624713|20091025|P2|NOT COMPLETED|Overall Study||0
8150927|NCT02624713|20091026|P1|NOT COMPLETED|Overall Study||14
8150928|NCT02624713|20091025|P2|COMPLETED|Overall Study||81
8150929|NCT02624713|20091026|P1|COMPLETED|Overall Study||64
8150930|NCT02624713|20091025|P2|STARTED|Overall Study||81
8150931|NCT02624713|20091026|P1|STARTED|Overall Study||78
8150932|NCT02624700|20091035|P2|NOT COMPLETED|Overall Study||0
8150933|NCT02624700|20091036|P1|NOT COMPLETED|Overall Study||0
8150934|NCT02624700|20091035|P2|COMPLETED|Overall Study||4
8150935|NCT02624700|20091036|P1|COMPLETED|Overall Study||9
8150936|NCT02624700|20091035|P2|STARTED|Overall Study||4
8150937|NCT02624700|20091036|P1|STARTED|Overall Study||9
8150938|NCT02624687|20091050|P2|NOT COMPLETED|Overall Study||2
8150939|NCT02624687|20091051|P1|NOT COMPLETED|Overall Study||1
8150940|NCT02624687|20091050|P2|COMPLETED|Overall Study||12
8150941|NCT02624687|20091051|P1|COMPLETED|Overall Study||12
8150942|NCT02624687|20091050|P2|STARTED|Overall Study||14
8150943|NCT02624687|20091051|P1|STARTED|Overall Study||13
8150944|NCT02624492|20091082|P3|NOT COMPLETED|Overall Study||5
8150945|NCT02624492|20091083|P2|NOT COMPLETED|Overall Study||4
8150946|NCT02624492|20091084|P1|NOT COMPLETED|Overall Study||2
8150947|NCT02624492|20091082|P3|COMPLETED|Overall Study||3
8150948|NCT02624492|20091083|P2|COMPLETED|Overall Study||4
8150949|NCT02624492|20091084|P1|COMPLETED|Overall Study||3
8150950|NCT02624492|20091082|P3|STARTED|Overall Study||8
8150951|NCT02624492|20091083|P2|STARTED|Overall Study||8
8150952|NCT02624492|20091084|P1|STARTED|Overall Study||5
8150953|NCT02624375|20091110|P1|NOT COMPLETED|Overall Study||0
8150954|NCT02624375|20091110|P1|COMPLETED|Overall Study||10
8150955|NCT02624375|20091110|P1|STARTED|Overall Study||10
8150956|NCT02624284|20091119|P3|NOT COMPLETED|Overall Study||11
8150957|NCT02624284|20091120|P2|NOT COMPLETED|Overall Study||18
8150958|NCT02624284|20091121|P1|NOT COMPLETED|Overall Study||14
8150959|NCT02624284|20091119|P3|COMPLETED|Overall Study||36
8150960|NCT02624284|20091120|P2|COMPLETED|Overall Study||35
8150961|NCT02624284|20091121|P1|COMPLETED|Overall Study||35
8150962|NCT02624284|20091119|P3|STARTED|Overall Study||47
8150963|NCT02624284|20091120|P2|STARTED|Overall Study||53
8150964|NCT02624284|20091121|P1|STARTED|Overall Study||49
8150965|NCT02624050|20091140|P2|NOT COMPLETED|Overall Study||0
8150966|NCT02624050|20091141|P1|NOT COMPLETED|Overall Study||6
8150967|NCT02624050|20091140|P2|COMPLETED|Overall Study||25
8150968|NCT02624050|20091141|P1|COMPLETED|Overall Study||20
8150969|NCT02624050|20091140|P2|STARTED|Overall Study||25
8150970|NCT02624050|20091141|P1|STARTED|Overall Study||26
8150971|NCT02623959|20091169|P2|NOT COMPLETED|Overall Study||1
8150972|NCT02623959|20091170|P1|NOT COMPLETED|Overall Study||0
8150973|NCT02623959|20091169|P2|COMPLETED|Overall Study|due to progression|0
8150974|NCT02623959|20091170|P1|COMPLETED|Overall Study||0
8150975|NCT02623959|20091169|P2|STARTED|Overall Study||1
8150976|NCT02623959|20091170|P1|STARTED|Overall Study||0
8150977|NCT02623855|20091180|P2|NOT COMPLETED|Overall Study||16
8150978|NCT02623855|20091181|P1|NOT COMPLETED|Overall Study||10
8150979|NCT02623855|20091180|P2|COMPLETED|Overall Study||84
8150980|NCT02623855|20091181|P1|COMPLETED|Overall Study||46
8150981|NCT02623855|20091180|P2|STARTED|Overall Study||100
8150982|NCT02623855|20091181|P1|STARTED|Overall Study||56
8150983|NCT02623829|20091203|P2|NOT COMPLETED|Overall Study||1
8150984|NCT02623829|20091204|P1|NOT COMPLETED|Overall Study||1
8150985|NCT02623829|20091203|P2|COMPLETED|Overall Study||20
8150986|NCT02623829|20091204|P1|COMPLETED|Overall Study||20
8150987|NCT02623829|20091203|P2|STARTED|Overall Study||21
8150988|NCT02623829|20091204|P1|STARTED|Overall Study||21
8150989|NCT02623803|20091216|P2|NOT COMPLETED|Overall Study||0
8150990|NCT02623803|20091217|P1|NOT COMPLETED|Overall Study||0
8150991|NCT02623803|20091216|P2|COMPLETED|Overall Study||23
8150992|NCT02623803|20091217|P1|COMPLETED|Overall Study||25
8150993|NCT02623803|20091216|P2|STARTED|Overall Study||23
8150994|NCT02623803|20091217|P1|STARTED|Overall Study||25
8150995|NCT02623725|20091263|P2|NOT COMPLETED|Overall Study||6
8150996|NCT02623725|20091264|P1|NOT COMPLETED|Overall Study||16
8150997|NCT02623725|20091263|P2|COMPLETED|Overall Study||58
8150998|NCT02623725|20091264|P1|COMPLETED|Overall Study||171
8150999|NCT02623725|20091263|P2|STARTED|Overall Study||64
8151000|NCT02623725|20091264|P1|STARTED|Overall Study||187
8151001|NCT02623361|20091298|P2|NOT COMPLETED|Overall Study||2
8151002|NCT02623361|20091299|P1|NOT COMPLETED|Overall Study||0
8151003|NCT02623361|20091298|P2|COMPLETED|Overall Study||38
8151004|NCT02623361|20091299|P1|COMPLETED|Overall Study||40
8151005|NCT02623361|20091298|P2|STARTED|Overall Study||40
8151006|NCT02623361|20091299|P1|STARTED|Overall Study||40
8151007|NCT02623348|20091311|P2|NOT COMPLETED|Overall Study||2
8151008|NCT02623348|20091312|P1|NOT COMPLETED|Overall Study||3
8151009|NCT02623348|20091311|P2|COMPLETED|Overall Study||28
8151010|NCT02623348|20091312|P1|COMPLETED|Overall Study||27
8151011|NCT02623348|20091311|P2|3-month Assessment|Overall Study||26
8151012|NCT02623348|20091312|P1|3-month Assessment|Overall Study||27
8151013|NCT02623348|20091311|P2|STARTED|Overall Study||30
8151014|NCT02623348|20091312|P1|STARTED|Overall Study||30
8151015|NCT02623335|20091338|P2|NOT COMPLETED|Overall Study||36
8151016|NCT02623335|20091339|P1|NOT COMPLETED|Overall Study||27
8151017|NCT02623335|20091338|P2|COMPLETED|Overall Study||187
8151018|NCT02623335|20091339|P1|COMPLETED|Overall Study||196
8151019|NCT02623335|20091338|P2|T3 Survey (12-14 Weeks)|Overall Study||187
8151020|NCT02623335|20091339|P1|T3 Survey (12-14 Weeks)|Overall Study||196
8151021|NCT02623335|20091338|P2|T2 Survey (6-8 Weeks)|Overall Study||192
8151022|NCT02623335|20091339|P1|T2 Survey (6-8 Weeks)|Overall Study||199
8151023|NCT02623335|20091338|P2|T1 Survey (24-48 Hours)|Overall Study||214
8151024|NCT02623335|20091339|P1|T1 Survey (24-48 Hours)|Overall Study||216
8151025|NCT02623335|20091338|P2|T0 Audio Recording (Day of Consultation)|Overall Study||222
8151026|NCT02623335|20091339|P1|T0 Audio Recording (Day of Consultation)|Overall Study||223
8151027|NCT02623335|20091338|P2|STARTED|Overall Study||223
8151028|NCT02623335|20091339|P1|STARTED|Overall Study||223
8151029|NCT02623322|20091366|P3|NOT COMPLETED|Overall Study||0
8151030|NCT02623322|20091367|P2|NOT COMPLETED|Overall Study||1
8151031|NCT02623322|20091368|P1|NOT COMPLETED|Overall Study||2
8151032|NCT02623322|20091366|P3|COMPLETED|Overall Study||40
8151033|NCT02623322|20091367|P2|COMPLETED|Overall Study||40
8151034|NCT02623322|20091368|P1|COMPLETED|Overall Study||41
8151035|NCT02623322|20091366|P3|STARTED|Overall Study||40
8151036|NCT02623322|20091367|P2|STARTED|Overall Study||41
8151037|NCT02623322|20091368|P1|STARTED|Overall Study||43
8151038|NCT02623218|20091406|P5|NOT COMPLETED|Overall Study||0
8151039|NCT02623218|20091407|P4|NOT COMPLETED|Overall Study||0
8151040|NCT02623218|20091408|P3|NOT COMPLETED|Overall Study||0
8151041|NCT02623218|20091409|P2|NOT COMPLETED|Overall Study||1
8151042|NCT02623218|20091410|P1|NOT COMPLETED|Overall Study||0
8151043|NCT02623218|20091406|P5|COMPLETED|Overall Study||4
8151044|NCT02623218|20091407|P4|COMPLETED|Overall Study||4
8151045|NCT02623218|20091408|P3|COMPLETED|Overall Study||4
8151046|NCT02623218|20091409|P2|COMPLETED|Overall Study||3
8151047|NCT02623218|20091410|P1|COMPLETED|Overall Study||5
8151048|NCT02623218|20091406|P5|STARTED|Overall Study||4
8151049|NCT02623218|20091407|P4|STARTED|Overall Study||4
8151050|NCT02623218|20091408|P3|STARTED|Overall Study||4
8151051|NCT02623218|20091409|P2|STARTED|Overall Study||4
8151052|NCT02623218|20091410|P1|STARTED|Overall Study||5
8151053|NCT02622828|20091432|P1|NOT COMPLETED|Overall Study||3
8151054|NCT02622828|20091432|P1|COMPLETED|Overall Study||1
8151055|NCT02622828|20091432|P1|STARTED|Overall Study||4
8151056|NCT02622724|20091439|P2|NOT COMPLETED|Overall Study||103
8151057|NCT02622724|20091440|P1|NOT COMPLETED|Overall Study||93
8151058|NCT02622724|20091439|P2|COMPLETED|Overall Study||49
8151059|NCT02622724|20091440|P1|COMPLETED|Overall Study||51
8151060|NCT02622724|20091439|P2|Long-Term Follow-Up (Day 180)|Overall Study||74
8151061|NCT02622724|20091440|P1|Long-Term Follow-Up (Day 180)|Overall Study||73
8151062|NCT02622724|20091439|P2|Long-Term Follow-Up (Day 90)|Overall Study||101
8151063|NCT02622724|20091440|P1|Long-Term Follow-Up (Day 90)|Overall Study||96
8151064|NCT02622724|20091439|P2|Short-Term Follow-Up (Day 28)|Overall Study||115
8151065|NCT02622724|20091440|P1|Short-Term Follow-Up (Day 28)|Overall Study||105
8151066|NCT02622724|20091439|P2|Subjects Randomised|Overall Study||155
8151067|NCT02622724|20091440|P1|Subjects Randomised|Overall Study||146
8151068|NCT02622724|20091439|P2|STARTED|Overall Study||152
8151069|NCT02622724|20091440|P1|STARTED|Overall Study||144
8151070|NCT02622568|20091518|P2|NOT COMPLETED|Overall Study||5
8151071|NCT02622568|20091519|P1|NOT COMPLETED|Overall Study||5
8151072|NCT02622568|20091518|P2|COMPLETED|Overall Study||9
8151073|NCT02622568|20091519|P1|COMPLETED|Overall Study||9
8151074|NCT02622568|20091518|P2|STARTED|Overall Study||14
8151075|NCT02622568|20091519|P1|STARTED|Overall Study||14
8151076|NCT02622321|20091529|P4|NOT COMPLETED|Overall Study||7
8151077|NCT02622321|20091530|P3|NOT COMPLETED|Overall Study||49
8151078|NCT02622321|20091531|P2|NOT COMPLETED|Overall Study||18
8151079|NCT02622321|20091532|P1|NOT COMPLETED|Overall Study||35
8151080|NCT02622321|20091529|P4|COMPLETED|Overall Study||0
8151081|NCT02622321|20091530|P3|COMPLETED|Overall Study||0
8151082|NCT02622321|20091531|P2|COMPLETED|Overall Study||0
8151083|NCT02622321|20091532|P1|COMPLETED|Overall Study||0
8151084|NCT02622321|20091529|P4|Treated|Overall Study||7
8151085|NCT02622321|20091530|P3|Treated|Overall Study||49
8151086|NCT02622321|20091531|P2|Treated|Overall Study||18
8151087|NCT02622321|20091532|P1|Treated|Overall Study||34
8151088|NCT02622321|20091529|P4|STARTED|Overall Study||7
8151089|NCT02622321|20091530|P3|STARTED|Overall Study||49
8151090|NCT02622321|20091531|P2|STARTED|Overall Study||18
8151091|NCT02622321|20091532|P1|STARTED|Overall Study||35
8151092|NCT02622191|20091577|P2|NOT COMPLETED|Overall Study||0
8151093|NCT02622191|20091578|P1|NOT COMPLETED|Overall Study||0
8151094|NCT02622191|20091577|P2|COMPLETED|Overall Study||14
8151095|NCT02622191|20091578|P1|COMPLETED|Overall Study||19
8151096|NCT02622191|20091577|P2|STARTED|Overall Study||14
8151097|NCT02622191|20091578|P1|STARTED|Overall Study||19
8151098|NCT02622178|20091588|P3|NOT COMPLETED|Overall Study||0
8151099|NCT02622178|20091589|P2|NOT COMPLETED|Overall Study||0
8151100|NCT02622178|20091590|P1|NOT COMPLETED|Overall Study||0
8151101|NCT02622178|20091588|P3|COMPLETED|Overall Study||49
8151102|NCT02622178|20091589|P2|COMPLETED|Overall Study||45
8151103|NCT02622178|20091590|P1|COMPLETED|Overall Study||42
8151104|NCT02622178|20091588|P3|STARTED|Overall Study||49
8151105|NCT02622178|20091589|P2|STARTED|Overall Study||45
8151106|NCT02622178|20091590|P1|STARTED|Overall Study||42
8151107|NCT02622113|20091603|P2|NOT COMPLETED|Overall Study||10
8151108|NCT02622113|20091604|P1|NOT COMPLETED|Overall Study||5
8151109|NCT02622113|20091603|P2|COMPLETED|Overall Study||66
8151110|NCT02622113|20091604|P1|COMPLETED|Overall Study||62
8151111|NCT02622113|20091603|P2|STARTED|Overall Study||76
8151112|NCT02622113|20091604|P1|STARTED|Overall Study||67
8151113|NCT02622074|20091622|P6|NOT COMPLETED|Overall Study||0
8151114|NCT02622074|20091623|P5|NOT COMPLETED|Overall Study||1
8151115|NCT02622074|20091624|P4|NOT COMPLETED|Overall Study||1
8151116|NCT02622074|20091625|P3|NOT COMPLETED|Overall Study||0
8151117|NCT02622074|20091626|P2|NOT COMPLETED|Overall Study||1
8151118|NCT02622074|20091627|P1|NOT COMPLETED|Overall Study||4
8151119|NCT02622074|20091622|P6|COMPLETED|Overall Study||10
8151120|NCT02622074|20091623|P5|COMPLETED|Overall Study||9
8151121|NCT02622074|20091624|P4|COMPLETED|Overall Study||9
8151122|NCT02622074|20091625|P3|COMPLETED|Overall Study||10
8151123|NCT02622074|20091626|P2|COMPLETED|Overall Study||9
8151124|NCT02622074|20091627|P1|COMPLETED|Overall Study||6
8151125|NCT02622074|20091622|P6|STARTED|Overall Study||10
8151126|NCT02622074|20091623|P5|STARTED|Overall Study||10
8151127|NCT02622074|20091624|P4|STARTED|Overall Study||10
8151128|NCT02622074|20091625|P3|STARTED|Overall Study||10
8151129|NCT02622074|20091626|P2|STARTED|Overall Study||10
8151130|NCT02622074|20091627|P1|STARTED|Overall Study||10
8151131|NCT02621983|20091715|P2|NOT COMPLETED|Overall Study||11
8151132|NCT02621983|20091716|P1|NOT COMPLETED|Overall Study||12
8151133|NCT02621983|20091715|P2|COMPLETED|Overall Study||6
8151134|NCT02621983|20091716|P1|COMPLETED|Overall Study||9
8151135|NCT02621983|20091715|P2|STARTED|Overall Study||17
8151136|NCT02621983|20091716|P1|STARTED|Overall Study||21
8151137|NCT02621931|20091731|P3|NOT COMPLETED|Overall Study||36
8151138|NCT02621931|20091732|P2|NOT COMPLETED|Overall Study||27
8151139|NCT02621931|20091733|P1|NOT COMPLETED|Overall Study||33
8151140|NCT02621931|20091731|P3|COMPLETED|Overall Study||343
8151141|NCT02621931|20091732|P2|COMPLETED|Overall Study||349
8151142|NCT02621931|20091733|P1|COMPLETED|Overall Study||342
8151143|NCT02621931|20091731|P3|Full Analysis Set|Overall Study||375
8151144|NCT02621931|20091732|P2|Full Analysis Set|Overall Study||375
8151145|NCT02621931|20091733|P1|Full Analysis Set|Overall Study||371
8151146|NCT02621931|20091731|P3|Safety and ITT Populations|Overall Study||379
8151147|NCT02621931|20091732|P2|Safety and ITT Populations|Overall Study||376
8151148|NCT02621931|20091733|P1|Safety and ITT Populations|Overall Study||375
8151149|NCT02621931|20091731|P3|STARTED|Overall Study||379
8151150|NCT02621931|20091732|P2|STARTED|Overall Study||376
8151151|NCT02621931|20091733|P1|STARTED|Overall Study||375
8151152|NCT02621892|20091784|P2|NOT COMPLETED|Randomized Withdrawal Period||12
8151153|NCT02621892|20091785|P1|NOT COMPLETED|Randomized Withdrawal Period||11
8151154|NCT02621892|20091784|P2|COMPLETED|Randomized Withdrawal Period||260
8151155|NCT02621892|20091785|P1|COMPLETED|Randomized Withdrawal Period||250
8151156|NCT02621892|20091784|P2|STARTED|Randomized Withdrawal Period||272
8151157|NCT02621892|20091785|P1|STARTED|Randomized Withdrawal Period||261
8151158|NCT02621892|20091784|P2|NOT COMPLETED|Treatment Period||27
8151159|NCT02621892|20091785|P1|NOT COMPLETED|Treatment Period||46
8151160|NCT02621892|20091784|P2|COMPLETED|Treatment Period||272
8151161|NCT02621892|20091785|P1|COMPLETED|Treatment Period||261
8151162|NCT02621892|20091784|P2|STARTED|Treatment Period||299
8151163|NCT02621892|20091785|P1|STARTED|Treatment Period||307
8151164|NCT02621619|20091803|P2|NOT COMPLETED|Overall Study||0
8151165|NCT02621619|20091804|P1|NOT COMPLETED|Overall Study||0
8151166|NCT02621619|20091803|P2|COMPLETED|Overall Study||79
8151167|NCT02621619|20091804|P1|COMPLETED|Overall Study||80
8151168|NCT02621619|20091803|P2|STARTED|Overall Study||79
8151169|NCT02621619|20091804|P1|STARTED|Overall Study||80
8151170|NCT02621606|20091815|P3|NOT COMPLETED|Overall Study||0
8151171|NCT02621606|20091816|P2|NOT COMPLETED|Overall Study||1
8151172|NCT02621606|20091817|P1|NOT COMPLETED|Overall Study||0
8151173|NCT02621606|20091815|P3|COMPLETED|Overall Study||10
8151174|NCT02621606|20091816|P2|COMPLETED|Overall Study||6
8151175|NCT02621606|20091817|P1|COMPLETED|Overall Study||3
8151176|NCT02621606|20091815|P3|Treated|Overall Study||10
8151177|NCT02621606|20091816|P2|Treated|Overall Study||7
8151178|NCT02621606|20091817|P1|Treated|Overall Study||3
8151179|NCT02621606|20091815|P3|STARTED|Overall Study||10
8151180|NCT02621606|20091816|P2|STARTED|Overall Study||7
8151181|NCT02621606|20091817|P1|STARTED|Overall Study||3
8151182|NCT02621424|20091845|P2|NOT COMPLETED|Overall Study||2
8151183|NCT02621424|20091846|P1|NOT COMPLETED|Overall Study||1
8151184|NCT02621424|20091845|P2|COMPLETED|Overall Study||16
8151185|NCT02621424|20091846|P1|COMPLETED|Overall Study||13
8151186|NCT02621424|20091845|P2|STARTED|Overall Study||18
8151187|NCT02621424|20091846|P1|STARTED|Overall Study||14
8151188|NCT02621073|20091854|P2|NOT COMPLETED|Overall Study||3
8151189|NCT02621073|20091855|P1|NOT COMPLETED|Overall Study||3
8151190|NCT02621073|20091854|P2|COMPLETED|Overall Study||0
8151191|NCT02621073|20091855|P1|COMPLETED|Overall Study||1
8151192|NCT02621073|20091854|P2|STARTED|Overall Study||3
8151193|NCT02621073|20091855|P1|STARTED|Overall Study||4
8151194|NCT02621060|20091865|P2|NOT COMPLETED|Overall Study||1
8151195|NCT02621060|20091866|P1|NOT COMPLETED|Overall Study||3
8151196|NCT02621060|20091865|P2|COMPLETED|Overall Study||14
8151197|NCT02621060|20091866|P1|COMPLETED|Overall Study||12
8151198|NCT02621060|20091865|P2|STARTED|Overall Study||15
8151199|NCT02621060|20091866|P1|STARTED|Overall Study||15
8151200|NCT02621047|20091917|P3|NOT COMPLETED|Overall Study||1
8151201|NCT02621047|20091918|P2|NOT COMPLETED|Overall Study||0
8151202|NCT02621047|20091919|P1|NOT COMPLETED|Overall Study||0
8151203|NCT02621047|20091917|P3|COMPLETED|Overall Study||11
8151204|NCT02621047|20091918|P2|COMPLETED|Overall Study||8
8151205|NCT02621047|20091919|P1|COMPLETED|Overall Study||8
8151206|NCT02621047|20091917|P3|STARTED|Overall Study||12
8151207|NCT02621047|20091918|P2|STARTED|Overall Study||8
8151208|NCT02621047|20091919|P1|STARTED|Overall Study||8
8151209|NCT02621034|20092035|P3|NOT COMPLETED|Overall Study||5
8151210|NCT02621034|20092036|P2|NOT COMPLETED|Overall Study||2
8151211|NCT02621034|20092037|P1|NOT COMPLETED|Overall Study||3
8151212|NCT02621034|20092035|P3|COMPLETED|Overall Study||50
8151213|NCT02621034|20092036|P2|COMPLETED|Overall Study||50
8151214|NCT02621034|20092037|P1|COMPLETED|Overall Study||50
8151215|NCT02621034|20092035|P3|STARTED|Overall Study||55
8151216|NCT02621034|20092036|P2|STARTED|Overall Study||52
8151217|NCT02621034|20092037|P1|STARTED|Overall Study||53
8151218|NCT02620917|20092050|P1|NOT COMPLETED|Overall Study||0
8151219|NCT02620917|20092050|P1|COMPLETED|Overall Study||6623
8151220|NCT02620917|20092050|P1|STARTED|Overall Study||6623
8151221|NCT02620878|20092059|P2|NOT COMPLETED|Overall Study||0
8151222|NCT02620878|20092060|P1|NOT COMPLETED|Overall Study||0
8151223|NCT02620878|20092059|P2|COMPLETED|Overall Study||16
8151224|NCT02620878|20092060|P1|COMPLETED|Overall Study||16
8151225|NCT02620878|20092059|P2|STARTED|Overall Study||16
8151226|NCT02620878|20092060|P1|STARTED|Overall Study||16
8151227|NCT02620787|20092071|P2|NOT COMPLETED|Overall Study||0
8151228|NCT02620787|20092072|P1|NOT COMPLETED|Overall Study||2
8151229|NCT02620787|20092071|P2|COMPLETED|Overall Study||6
8151230|NCT02620787|20092072|P1|COMPLETED|Overall Study||10
8151231|NCT02620787|20092071|P2|STARTED|Overall Study||6
8151232|NCT02620787|20092072|P1|STARTED|Overall Study||12
8151233|NCT02620774|20092084|P2|NOT COMPLETED|Overall Study||0
8151234|NCT02620774|20092085|P1|NOT COMPLETED|Overall Study||0
8151235|NCT02620774|20092084|P2|COMPLETED|Overall Study||6
8151236|NCT02620774|20092085|P1|COMPLETED|Overall Study||10
8151237|NCT02620774|20092084|P2|STARTED|Overall Study||6
8151238|NCT02620774|20092085|P1|STARTED|Overall Study||10
8151239|NCT02620683|20092103|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
8151240|NCT02620683|20092104|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
8151241|NCT02620683|20092103|P2|COMPLETED|Second Intervention (Visit 2)||11
8151242|NCT02620683|20092104|P1|COMPLETED|Second Intervention (Visit 2)||12
8151243|NCT02620683|20092103|P2|STARTED|Second Intervention (Visit 2)||11
8151244|NCT02620683|20092104|P1|STARTED|Second Intervention (Visit 2)||12
8151245|NCT02620683|20092103|P2|NOT COMPLETED|Washout (2 Weeks)||0
8151246|NCT02620683|20092104|P1|NOT COMPLETED|Washout (2 Weeks)||0
8151247|NCT02620683|20092103|P2|COMPLETED|Washout (2 Weeks)||11
8151248|NCT02620683|20092104|P1|COMPLETED|Washout (2 Weeks)||12
8151249|NCT02620683|20092103|P2|STARTED|Washout (2 Weeks)||11
8151250|NCT02620683|20092104|P1|STARTED|Washout (2 Weeks)||12
8151251|NCT02620683|20092103|P2|NOT COMPLETED|First Intervention (Visit 1)||0
8151252|NCT02620683|20092104|P1|NOT COMPLETED|First Intervention (Visit 1)||0
8151253|NCT02620683|20092103|P2|COMPLETED|First Intervention (Visit 1)||11
8151254|NCT02620683|20092104|P1|COMPLETED|First Intervention (Visit 1)||12
8151255|NCT02620683|20092103|P2|STARTED|First Intervention (Visit 1)||11
8151256|NCT02620683|20092104|P1|STARTED|First Intervention (Visit 1)||12
8151257|NCT02620384|20092114|P2|NOT COMPLETED|Overall Study||7
8151258|NCT02620384|20092115|P1|NOT COMPLETED|Overall Study||4
8151259|NCT02620384|20092114|P2|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
8151260|NCT02620384|20092115|P1|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
8151261|NCT02620384|20092114|P2|STARTED|Overall Study||73
8151262|NCT02620384|20092115|P1|STARTED|Overall Study||70
8151263|NCT02620020|20092147|P4|NOT COMPLETED|Overall Study||26
8151264|NCT02620020|20092148|P3|NOT COMPLETED|Overall Study||25
8151265|NCT02620020|20092149|P2|NOT COMPLETED|Overall Study||35
8151266|NCT02620020|20092150|P1|NOT COMPLETED|Overall Study||44
8151267|NCT02620020|20092147|P4|COMPLETED|Overall Study||115
8151268|NCT02620020|20092148|P3|COMPLETED|Overall Study||115
8151269|NCT02620020|20092149|P2|COMPLETED|Overall Study||106
8151270|NCT02620020|20092150|P1|COMPLETED|Overall Study||97
8151271|NCT02620020|20092147|P4|Modified Intent to Treat Set (mITT)|Overall Study||140
8151272|NCT02620020|20092148|P3|Modified Intent to Treat Set (mITT)|Overall Study||139
8151273|NCT02620020|20092149|P2|Modified Intent to Treat Set (mITT)|Overall Study||139
8151274|NCT02620020|20092150|P1|Modified Intent to Treat Set (mITT)|Overall Study||140
8151275|NCT02620020|20092147|P4|STARTED|Overall Study||141
8151276|NCT02620020|20092148|P3|STARTED|Overall Study||140
8151277|NCT02620020|20092149|P2|STARTED|Overall Study||141
8151278|NCT02620020|20092150|P1|STARTED|Overall Study||141
8151279|NCT02619812|20092176|P4|NOT COMPLETED|Overall Study||2
8151280|NCT02619812|20092177|P3|NOT COMPLETED|Overall Study||1
8151281|NCT02619812|20092178|P2|NOT COMPLETED|Overall Study||0
8151282|NCT02619812|20092179|P1|NOT COMPLETED|Overall Study||0
8151283|NCT02619812|20092176|P4|COMPLETED|Overall Study||0
8151284|NCT02619812|20092177|P3|COMPLETED|Overall Study||0
8151285|NCT02619812|20092178|P2|COMPLETED|Overall Study||0
8151286|NCT02619812|20092179|P1|COMPLETED|Overall Study||0
8151287|NCT02619812|20092176|P4|STARTED|Overall Study||2
8151288|NCT02619812|20092177|P3|STARTED|Overall Study||1
8151289|NCT02619812|20092178|P2|STARTED|Overall Study||0
8151290|NCT02619812|20092179|P1|STARTED|Overall Study||0
8151291|NCT02619799|20092195|P2|NOT COMPLETED|Overall Study||0
8151292|NCT02619799|20092196|P1|NOT COMPLETED|Overall Study||0
8151293|NCT02619799|20092195|P2|COMPLETED|Overall Study||25
8151294|NCT02619799|20092196|P1|COMPLETED|Overall Study||25
8151295|NCT02619799|20092195|P2|STARTED|Overall Study||25
8151296|NCT02619799|20092196|P1|STARTED|Overall Study||25
8151297|NCT02619617|20092212|P2|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
8151298|NCT02619617|20092213|P1|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
8151299|NCT02619617|20092212|P2|COMPLETED|Period 2 SOM230 - 2nd Attack||24
8151300|NCT02619617|20092213|P1|COMPLETED|Period 2 SOM230 - 2nd Attack||0
8151301|NCT02619617|20092212|P2|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
8151302|NCT02619617|20092213|P1|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
8151303|NCT02619617|20092212|P2|STARTED|Period 2 SOM230 - 2nd Attack||28
8151304|NCT02619617|20092213|P1|STARTED|Period 2 SOM230 - 2nd Attack||0
8151305|NCT02619617|20092212|P2|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
8151306|NCT02619617|20092213|P1|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
8151307|NCT02619617|20092212|P2|COMPLETED|Period 1 Placebo - 1st AttacK||0
8151308|NCT02619617|20092213|P1|COMPLETED|Period 1 Placebo - 1st AttacK||28
8151309|NCT02619617|20092212|P2|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
8151310|NCT02619617|20092213|P1|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
8151311|NCT02619617|20092212|P2|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
8151312|NCT02619617|20092213|P1|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
8151313|NCT02619617|20092212|P2|STARTED|Period 1 Placebo - 1st AttacK||0
8151314|NCT02619617|20092213|P1|STARTED|Period 1 Placebo - 1st AttacK||28
8151315|NCT02619591|20092225|P2|NOT COMPLETED|Overall Study||121
8151316|NCT02619591|20092226|P1|NOT COMPLETED|Overall Study||139
8151317|NCT02619591|20092225|P2|COMPLETED|Overall Study||0
8151318|NCT02619591|20092226|P1|COMPLETED|Overall Study||0
8151319|NCT02619591|20092225|P2|STARTED|Overall Study||121
8151320|NCT02619591|20092226|P1|STARTED|Overall Study||139
8151321|NCT02619409|20092237|P5|NOT COMPLETED|Overall Study||0
8151322|NCT02619409|20092238|P4|NOT COMPLETED|Overall Study||0
8151323|NCT02619409|20092239|P3|NOT COMPLETED|Overall Study||0
8151324|NCT02619409|20092240|P2|NOT COMPLETED|Overall Study||0
8151325|NCT02619409|20092241|P1|NOT COMPLETED|Overall Study||0
8151326|NCT02619409|20092237|P5|COMPLETED|Overall Study||6
8151327|NCT02619409|20092238|P4|COMPLETED|Overall Study||6
8151328|NCT02619409|20092239|P3|COMPLETED|Overall Study||6
8151329|NCT02619409|20092240|P2|COMPLETED|Overall Study||6
8151330|NCT02619409|20092241|P1|COMPLETED|Overall Study||6
8151331|NCT02619409|20092237|P5|STARTED|Overall Study||6
8151332|NCT02619409|20092238|P4|STARTED|Overall Study||6
8151333|NCT02619409|20092239|P3|STARTED|Overall Study||6
8151334|NCT02619409|20092240|P2|STARTED|Overall Study||6
8151335|NCT02619409|20092241|P1|STARTED|Overall Study||6
8151336|NCT02619396|20092262|P4|NOT COMPLETED|Overall Study||0
8151337|NCT02619396|20092263|P3|NOT COMPLETED|Overall Study||0
8151338|NCT02619396|20092264|P2|NOT COMPLETED|Overall Study||0
8151339|NCT02619396|20092265|P1|NOT COMPLETED|Overall Study||0
8151340|NCT02619396|20092262|P4|COMPLETED|Overall Study||20
8151341|NCT02619396|20092263|P3|COMPLETED|Overall Study||20
8151342|NCT02619396|20092264|P2|COMPLETED|Overall Study||20
8151343|NCT02619396|20092265|P1|COMPLETED|Overall Study||20
8151344|NCT02619396|20092262|P4|STARTED|Overall Study||20
8151345|NCT02619396|20092263|P3|STARTED|Overall Study||20
8151346|NCT02619396|20092264|P2|STARTED|Overall Study||20
8151347|NCT02619396|20092265|P1|STARTED|Overall Study||20
8151348|NCT02619175|20092309|P2|NOT COMPLETED|Overall Study||0
8151349|NCT02619175|20092310|P1|NOT COMPLETED|Overall Study||2
8151350|NCT02619175|20092309|P2|COMPLETED|Overall Study||16
8151351|NCT02619175|20092310|P1|COMPLETED|Overall Study||16
8151352|NCT02619175|20092309|P2|STARTED|Overall Study||16
8151353|NCT02619175|20092310|P1|STARTED|Overall Study||18
8151354|NCT02618928|20092324|P1|NOT COMPLETED|Overall Study||58
8151355|NCT02618928|20092324|P1|COMPLETED|Overall Study||677
8151356|NCT02618928|20092324|P1|Received Treatment|Overall Study||728
8151357|NCT02618928|20092324|P1|STARTED|Overall Study||735
8151358|NCT02618915|20092357|P2|NOT COMPLETED|Overall Study||0
8151359|NCT02618915|20092358|P1|NOT COMPLETED|Overall Study||0
8151360|NCT02618915|20092357|P2|COMPLETED|Overall Study||3
8151361|NCT02618915|20092358|P1|COMPLETED|Overall Study||3
8151362|NCT02618915|20092357|P2|STARTED|Overall Study||3
8151363|NCT02618915|20092358|P1|STARTED|Overall Study||3
8151364|NCT02618772|20092384|P2|NOT COMPLETED|Overall Study||0
8151365|NCT02618772|20092385|P1|NOT COMPLETED|Overall Study||1
8151366|NCT02618772|20092384|P2|COMPLETED|Overall Study||40
8151367|NCT02618772|20092385|P1|COMPLETED|Overall Study||38
8151368|NCT02618772|20092384|P2|Withdrawal by Subject|Overall Study||0
8151369|NCT02618772|20092385|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
8151370|NCT02618772|20092384|P2|STARTED|Overall Study||40
8151371|NCT02618772|20092385|P1|STARTED|Overall Study||39
8151372|NCT02618759|20092419|P2|NOT COMPLETED|Overall Study||5
8151373|NCT02618759|20092420|P1|NOT COMPLETED|Overall Study||2
8151374|NCT02618759|20092419|P2|COMPLETED|Overall Study||54
8151375|NCT02618759|20092420|P1|COMPLETED|Overall Study||58
8151376|NCT02618759|20092419|P2|STARTED|Overall Study||59
8151377|NCT02618759|20092420|P1|STARTED|Overall Study||60
8151378|NCT02618642|20092440|P4|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151379|NCT02618642|20092441|P3|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151380|NCT02618642|20092442|P2|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151381|NCT02618642|20092443|P1|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151382|NCT02618642|20092440|P4|COMPLETED|After 10 PILER Irradiation Treatments||15
8151383|NCT02618642|20092441|P3|COMPLETED|After 10 PILER Irradiation Treatments||15
8151384|NCT02618642|20092442|P2|COMPLETED|After 10 PILER Irradiation Treatments||15
8151385|NCT02618642|20092443|P1|COMPLETED|After 10 PILER Irradiation Treatments||15
8151386|NCT02618642|20092440|P4|STARTED|After 10 PILER Irradiation Treatments||15
8151387|NCT02618642|20092441|P3|STARTED|After 10 PILER Irradiation Treatments||15
8151388|NCT02618642|20092442|P2|STARTED|After 10 PILER Irradiation Treatments||15
8151389|NCT02618642|20092443|P1|STARTED|After 10 PILER Irradiation Treatments||15
8151390|NCT02618642|20092440|P4|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151391|NCT02618642|20092441|P3|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151392|NCT02618642|20092442|P2|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151393|NCT02618642|20092443|P1|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151394|NCT02618642|20092440|P4|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151395|NCT02618642|20092441|P3|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151396|NCT02618642|20092442|P2|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151397|NCT02618642|20092443|P1|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151398|NCT02618642|20092440|P4|STARTED|Before 10 PILER Irradiation Treatments||15
8151399|NCT02618642|20092441|P3|STARTED|Before 10 PILER Irradiation Treatments||15
8151400|NCT02618642|20092442|P2|STARTED|Before 10 PILER Irradiation Treatments||15
8151401|NCT02618642|20092443|P1|STARTED|Before 10 PILER Irradiation Treatments||15
8151402|NCT02618512|20092469|P1|NOT COMPLETED|Overall Study||0
8151403|NCT02618512|20092469|P1|COMPLETED|Overall Study||3
8151404|NCT02618512|20092469|P1|STARTED|Overall Study||3
8151405|NCT02618187|20092477|P4|NOT COMPLETED|Overall Study||5
8151406|NCT02618187|20092478|P3|NOT COMPLETED|Overall Study||4
8151407|NCT02618187|20092479|P2|NOT COMPLETED|Overall Study||2
8151408|NCT02618187|20092480|P1|NOT COMPLETED|Overall Study||2
8151409|NCT02618187|20092477|P4|COMPLETED|Overall Study||12
8151410|NCT02618187|20092478|P3|COMPLETED|Overall Study||11
8151411|NCT02618187|20092479|P2|COMPLETED|Overall Study||9
8151412|NCT02618187|20092480|P1|COMPLETED|Overall Study||13
8151413|NCT02618187|20092477|P4|Completed|Overall Study||13
8151414|NCT02618187|20092478|P3|Completed|Overall Study||13
8151415|NCT02618187|20092479|P2|Completed|Overall Study||10
8151416|NCT02618187|20092480|P1|Completed|Overall Study||13
8151417|NCT02618187|20092477|P4|STARTED|Overall Study||17
8151418|NCT02618187|20092478|P3|STARTED|Overall Study||15
8151419|NCT02618187|20092479|P2|STARTED|Overall Study||11
8151420|NCT02618187|20092480|P1|STARTED|Overall Study||15
8151421|NCT02618031|20092508|P2|NOT COMPLETED|Overall Study||0
8151422|NCT02618031|20092509|P1|NOT COMPLETED|Overall Study||1
8151423|NCT02618031|20092508|P2|COMPLETED|Overall Study||11
8151424|NCT02618031|20092509|P1|COMPLETED|Overall Study||45
8151425|NCT02618031|20092508|P2|STARTED|Overall Study||11
8151426|NCT02618031|20092509|P1|STARTED|Overall Study||46
8151427|NCT02617901|20092521|P1|NOT COMPLETED|Overall Study||0
8151428|NCT02617901|20092521|P1|COMPLETED|Overall Study||20
8151429|NCT02617901|20092521|P1|STARTED|Overall Study||20
8151430|NCT02617888|20092528|P3|NOT COMPLETED|Overall Study||0
8151431|NCT02617888|20092529|P2|NOT COMPLETED|Overall Study||7
8151432|NCT02617888|20092530|P1|NOT COMPLETED|Overall Study||1
8151433|NCT02617888|20092528|P3|COMPLETED|Overall Study||127
8151434|NCT02617888|20092529|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
8151435|NCT02617888|20092530|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
8151436|NCT02617888|20092528|P3|STARTED|Overall Study||127
8151437|NCT02617888|20092529|P2|STARTED|Overall Study||51
8151438|NCT02617888|20092530|P1|STARTED|Overall Study||50
8151439|NCT02617784|20092539|P2|NOT COMPLETED|Overall Study||0
8151440|NCT02617784|20092540|P1|NOT COMPLETED|Overall Study||0
8151441|NCT02617784|20092539|P2|COMPLETED|Overall Study||12
8151442|NCT02617784|20092540|P1|COMPLETED|Overall Study||12
8151443|NCT02617784|20092539|P2|Second Dose Assessment Period|Overall Study||12
8151444|NCT02617784|20092540|P1|Second Dose Assessment Period|Overall Study||11
8151445|NCT02617784|20092539|P2|First Dose Assessment Period|Overall Study||12
8151446|NCT02617784|20092540|P1|First Dose Assessment Period|Overall Study||12
8151447|NCT02617784|20092539|P2|STARTED|Overall Study||12
8151448|NCT02617784|20092540|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
8151449|NCT02617667|20092591|P4|NOT COMPLETED|Overall Study||1
8151450|NCT02617667|20092592|P3|NOT COMPLETED|Overall Study||4
8151451|NCT02617667|20092593|P2|NOT COMPLETED|Overall Study||1
8151452|NCT02617667|20092594|P1|NOT COMPLETED|Overall Study||1
8151453|NCT02617667|20092591|P4|COMPLETED|Overall Study||52
8151454|NCT02617667|20092592|P3|COMPLETED|Overall Study||48
8151455|NCT02617667|20092593|P2|COMPLETED|Overall Study||50
8151456|NCT02617667|20092594|P1|COMPLETED|Overall Study||50
8151457|NCT02617667|20092591|P4|STARTED|Overall Study||53
8151458|NCT02617667|20092592|P3|STARTED|Overall Study||52
8151459|NCT02617667|20092593|P2|STARTED|Overall Study||51
8151460|NCT02617667|20092594|P1|STARTED|Overall Study||51
8151461|NCT02616900|20092606|P1|NOT COMPLETED|Overall Study||23
8151462|NCT02616900|20092606|P1|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
8151463|NCT02616900|20092606|P1|Completed 3mo Trial|Overall Study||57
8151464|NCT02616900|20092606|P1|STARTED|Overall Study||74
8151465|NCT02616783|20092614|P2|NOT COMPLETED|Overall Study||2
8151466|NCT02616783|20092615|P1|NOT COMPLETED|Overall Study||6
8151467|NCT02616783|20092614|P2|COMPLETED|Overall Study||54
8151468|NCT02616783|20092615|P1|COMPLETED|Overall Study||105
8151469|NCT02616783|20092614|P2|STARTED|Overall Study||56
8151470|NCT02616783|20092615|P1|STARTED|Overall Study||111
8151471|NCT02616614|20092638|P3|NOT COMPLETED|Overall Study||29
8151472|NCT02616614|20092639|P2|NOT COMPLETED|Overall Study||60
8151473|NCT02616614|20092640|P1|NOT COMPLETED|Overall Study||65
8151474|NCT02616614|20092638|P3|COMPLETED|Overall Study||141
8151475|NCT02616614|20092639|P2|COMPLETED|Overall Study||285
8151476|NCT02616614|20092640|P1|COMPLETED|Overall Study||282
8151477|NCT02616614|20092638|P3|PP Population|Overall Study||122
8151478|NCT02616614|20092639|P2|PP Population|Overall Study||255
8151479|NCT02616614|20092640|P1|PP Population|Overall Study||253
8151480|NCT02616614|20092638|P3|mITT Population|Overall Study||160
8151481|NCT02616614|20092639|P2|mITT Population|Overall Study||325
8151482|NCT02616614|20092640|P1|mITT Population|Overall Study||325
8151483|NCT02616614|20092638|P3|Safety Population|Overall Study||161
8151484|NCT02616614|20092639|P2|Safety Population|Overall Study||328
8151485|NCT02616614|20092640|P1|Safety Population|Overall Study||329
8151486|NCT02616614|20092638|P3|STARTED|Overall Study||170
8151487|NCT02616614|20092639|P2|STARTED|Overall Study||345
8151488|NCT02616614|20092640|P1|STARTED|Overall Study||347
8151489|NCT02616601|20092657|P3|NOT COMPLETED|Overall Study||7
8151490|NCT02616601|20092658|P2|NOT COMPLETED|Overall Study||4
8151491|NCT02616601|20092659|P1|NOT COMPLETED|Overall Study||9
8151492|NCT02616601|20092657|P3|COMPLETED|Overall Study||135
8151493|NCT02616601|20092658|P2|COMPLETED|Overall Study||136
8151494|NCT02616601|20092659|P1|COMPLETED|Overall Study||131
8151495|NCT02616601|20092657|P3|PP Population|Overall Study||123
8151496|NCT02616601|20092658|P2|PP Population|Overall Study||121
8151497|NCT02616601|20092659|P1|PP Population|Overall Study||112
8151498|NCT02616601|20092657|P3|mITT Population|Overall Study||138
8151499|NCT02616601|20092658|P2|mITT Population|Overall Study||136
8151500|NCT02616601|20092659|P1|mITT Population|Overall Study||137
8151501|NCT02616601|20092657|P3|Safety Population|Overall Study||142
8151502|NCT02616601|20092658|P2|Safety Population|Overall Study||140
8151503|NCT02616601|20092659|P1|Safety Population|Overall Study||140
8151504|NCT02616601|20092657|P3|STARTED|Overall Study||142
8151505|NCT02616601|20092658|P2|STARTED|Overall Study||140
8151506|NCT02616601|20092659|P1|STARTED|Overall Study||140
8151507|NCT02616523|20092670|P3|NOT COMPLETED|Overall Study||0
8151508|NCT02616523|20092671|P2|NOT COMPLETED|Overall Study||0
8151509|NCT02616523|20092672|P1|NOT COMPLETED|Overall Study||1
8151510|NCT02616523|20092670|P3|COMPLETED|Overall Study|April 2015|20
8151511|NCT02616523|20092671|P2|COMPLETED|Overall Study|April 2015|20
8151512|NCT02616523|20092672|P1|COMPLETED|Overall Study|April 2015|19
8151513|NCT02616523|20092670|P3|STARTED|Overall Study|June 2014|20
8151514|NCT02616523|20092671|P2|STARTED|Overall Study|June 2014|20
8151515|NCT02616523|20092672|P1|STARTED|Overall Study|June 2014|20
8151516|NCT02616380|20092686|P1|NOT COMPLETED|Overall Study||3
8151517|NCT02616380|20092686|P1|COMPLETED|Overall Study||97
8151518|NCT02616380|20092686|P1|STARTED|Overall Study||100
8151531|NCT02616029|20092727|P2|NOT COMPLETED|Overall Study||2
8151532|NCT02616029|20092728|P1|NOT COMPLETED|Overall Study||4
8151533|NCT02616029|20092727|P2|COMPLETED|Overall Study||26
8151534|NCT02616029|20092728|P1|COMPLETED|Overall Study||34
8151535|NCT02616029|20092727|P2|STARTED|Overall Study||28
8151536|NCT02616029|20092728|P1|STARTED|Overall Study||38
8151537|NCT02615990|20092799|P2|NOT COMPLETED|Overall Study||1
8151538|NCT02615990|20092800|P1|NOT COMPLETED|Overall Study||1
8151539|NCT02615990|20092799|P2|COMPLETED|Overall Study||0
8151540|NCT02615990|20092800|P1|COMPLETED|Overall Study||0
8151541|NCT02615990|20092799|P2|STARTED|Overall Study||1
8151542|NCT02615990|20092800|P1|STARTED|Overall Study||1
8151543|NCT02615743|20092846|P2|NOT COMPLETED|Overall Study||3
8151544|NCT02615743|20092847|P1|NOT COMPLETED|Overall Study||6
8151545|NCT02615743|20092846|P2|COMPLETED|Overall Study||17
8151546|NCT02615743|20092847|P1|COMPLETED|Overall Study||15
8151547|NCT02615743|20092846|P2|STARTED|Overall Study||20
8151548|NCT02615743|20092847|P1|STARTED|Overall Study||21
8151549|NCT02615717|20092861|P2|NOT COMPLETED|Overall Study||0
8151550|NCT02615717|20092862|P1|NOT COMPLETED|Overall Study||0
8151551|NCT02615717|20092861|P2|COMPLETED|Overall Study||3
8151552|NCT02615717|20092862|P1|COMPLETED|Overall Study||3
8151553|NCT02615717|20092861|P2|STARTED|Overall Study||3
8151554|NCT02615717|20092862|P1|STARTED|Overall Study||3
8151555|NCT02615535|20092876|P2|NOT COMPLETED|Overall Study||1
8151556|NCT02615535|20092877|P1|NOT COMPLETED|Overall Study||4
8151557|NCT02615535|20092876|P2|COMPLETED|Overall Study||10
8151558|NCT02615535|20092877|P1|COMPLETED|Overall Study||10
8151559|NCT02615535|20092876|P2|STARTED|Overall Study||11
8151560|NCT02615535|20092877|P1|STARTED|Overall Study||14
8151561|NCT02615509|20092897|P1|NOT COMPLETED|Overall Study||146
8151562|NCT02615509|20092897|P1|COMPLETED|Overall Study||201
8151563|NCT02615509|20092897|P1|STARTED|Overall Study||347
8151564|NCT02615470|20092907|P2|NOT COMPLETED|Overall Study||32
8151565|NCT02615470|20092908|P1|NOT COMPLETED|Overall Study||21
8151566|NCT02615470|20092907|P2|COMPLETED|Overall Study||30
8151567|NCT02615470|20092908|P1|COMPLETED|Overall Study||37
8151568|NCT02615470|20092907|P2|Completed the Baseline Surveys|Overall Study||47
8151569|NCT02615470|20092908|P1|Completed the Baseline Surveys|Overall Study||46
8151570|NCT02615470|20092907|P2|STARTED|Overall Study||62
8151571|NCT02615470|20092908|P1|STARTED|Overall Study||58
8151572|NCT02615249|20092918|P1|NOT COMPLETED|Overall Study||1
8151573|NCT02615249|20092918|P1|COMPLETED|Overall Study||121
8151574|NCT02615249|20092918|P1|STARTED|Overall Study||122
8151575|NCT02615158|20092928|P3|NOT COMPLETED|Overall Study||16
8151576|NCT02615158|20092929|P2|NOT COMPLETED|Overall Study||16
8151577|NCT02615158|20092930|P1|NOT COMPLETED|Overall Study||21
8151578|NCT02615158|20092928|P3|COMPLETED|Overall Study||75
8151579|NCT02615158|20092929|P2|COMPLETED|Overall Study||76
8151580|NCT02615158|20092930|P1|COMPLETED|Overall Study||73
8151581|NCT02615158|20092928|P3|STARTED|Overall Study||91
8151582|NCT02615158|20092929|P2|STARTED|Overall Study||92
8151583|NCT02615158|20092930|P1|STARTED|Overall Study||94
8151584|NCT02615145|20092959|P4|NOT COMPLETED|Overall Study||1
8151585|NCT02615145|20092960|P3|NOT COMPLETED|Overall Study||8
8151586|NCT02615145|20092961|P2|NOT COMPLETED|Overall Study||15
8151587|NCT02615145|20092962|P1|NOT COMPLETED|Overall Study||27
8151588|NCT02615145|20092959|P4|COMPLETED|Overall Study||0
8151589|NCT02615145|20092960|P3|COMPLETED|Overall Study||40
8151590|NCT02615145|20092961|P2|COMPLETED|Overall Study||263
8151591|NCT02615145|20092962|P1|COMPLETED|Overall Study||118
8151592|NCT02615145|20092959|P4|3DAA + RBV|Overall Study||0
8151593|NCT02615145|20092960|P3|3DAA + RBV|Overall Study||2
8151594|NCT02615145|20092961|P2|3DAA + RBV|Overall Study||17
8151595|NCT02615145|20092962|P1|3DAA + RBV|Overall Study||140
8151596|NCT02615145|20092959|P4|3DAA|Overall Study||0
8151597|NCT02615145|20092960|P3|3DAA|Overall Study||0
8151598|NCT02615145|20092961|P2|3DAA|Overall Study||261
8151599|NCT02615145|20092962|P1|3DAA|Overall Study||5
8151600|NCT02615145|20092959|P4|2 DAA + Ribavirin (RBV)|Overall Study||0
8151601|NCT02615145|20092960|P3|2 DAA + Ribavirin (RBV)|Overall Study||45
8151602|NCT02615145|20092961|P2|2 DAA + Ribavirin (RBV)|Overall Study||0
8151603|NCT02615145|20092962|P1|2 DAA + Ribavirin (RBV)|Overall Study||0
8151604|NCT02615145|20092959|P4|STARTED|Overall Study||1
8151605|NCT02615145|20092960|P3|STARTED|Overall Study||48
8151606|NCT02615145|20092961|P2|STARTED|Overall Study||278
8151607|NCT02615145|20092962|P1|STARTED|Overall Study||145
8151608|NCT02614924|20093038|P2|NOT COMPLETED|Overall Study||0
8151609|NCT02614924|20093039|P1|NOT COMPLETED|Overall Study||0
8151610|NCT02614924|20093038|P2|COMPLETED|Overall Study||20
8151611|NCT02614924|20093039|P1|COMPLETED|Overall Study||20
8151612|NCT02614924|20093038|P2|STARTED|Overall Study||20
8151613|NCT02614924|20093039|P1|STARTED|Overall Study||20
8151614|NCT02614898|20093049|P2|NOT COMPLETED|Overall Study||51
8151615|NCT02614898|20093050|P1|NOT COMPLETED|Overall Study||15
8151616|NCT02614898|20093049|P2|COMPLETED|Overall Study||1
8151617|NCT02614898|20093050|P1|COMPLETED|Overall Study||0
8151618|NCT02614898|20093049|P2|Safety Population|Overall Study||52
8151619|NCT02614898|20093050|P1|Safety Population|Overall Study||15
8151620|NCT02614898|20093049|P2|STARTED|Overall Study||52
8151621|NCT02614898|20093050|P1|STARTED|Overall Study||15
8151622|NCT02614794|20093062|P2|NOT COMPLETED|Overall Study||202
8151623|NCT02614794|20093063|P1|NOT COMPLETED|Overall Study||410
8151624|NCT02614794|20093062|P2|COMPLETED|Overall Study||0
8151625|NCT02614794|20093063|P1|COMPLETED|Overall Study||0
8151626|NCT02614794|20093062|P2|STARTED|Overall Study||202
8151627|NCT02614794|20093063|P1|STARTED|Overall Study||410
8151628|NCT02614729|20093097|P2|NOT COMPLETED|Overall Study||0
8151629|NCT02614729|20093098|P1|NOT COMPLETED|Overall Study||1
8151630|NCT02614729|20093097|P2|COMPLETED|Overall Study||17
8151631|NCT02614729|20093098|P1|COMPLETED|Overall Study||17
8151632|NCT02614729|20093097|P2|STARTED|Overall Study||17
8151633|NCT02614729|20093098|P1|STARTED|Overall Study||18
8151634|NCT02614703|20093118|P2|NOT COMPLETED|Overall Study||1
8151635|NCT02614703|20093119|P1|NOT COMPLETED|Overall Study||7
8151636|NCT02614703|20093118|P2|COMPLETED|Overall Study||28
8151637|NCT02614703|20093119|P1|COMPLETED|Overall Study||24
8151638|NCT02614703|20093118|P2|STARTED|Overall Study||29
8151639|NCT02614703|20093119|P1|STARTED|Overall Study||31
8151640|NCT02614690|20093128|P3|NOT COMPLETED|Overall Study||0
8151641|NCT02614690|20093129|P2|NOT COMPLETED|Overall Study||0
8151642|NCT02614690|20093130|P1|NOT COMPLETED|Overall Study||0
8151643|NCT02614690|20093128|P3|COMPLETED|Overall Study||20
8151644|NCT02614690|20093129|P2|COMPLETED|Overall Study||20
8151645|NCT02614690|20093130|P1|COMPLETED|Overall Study||20
8151646|NCT02614690|20093128|P3|STARTED|Overall Study||20
8151647|NCT02614690|20093129|P2|STARTED|Overall Study||20
8151648|NCT02614690|20093130|P1|STARTED|Overall Study||20
8151649|NCT02614586|20093156|P1|NOT COMPLETED|Overall Study||0
8151650|NCT02614586|20093156|P1|COMPLETED|Overall Study||11
8151651|NCT02614586|20093156|P1|STARTED|Overall Study||11
8151652|NCT02614560|20093163|P2|NOT COMPLETED|Overall Study||2
8151653|NCT02614560|20093164|P1|NOT COMPLETED|Overall Study||6
8151654|NCT02614560|20093163|P2|COMPLETED|Overall Study||6
8151655|NCT02614560|20093164|P1|COMPLETED|Overall Study||0
8151656|NCT02614560|20093163|P2|STARTED|Overall Study||8
8151657|NCT02614560|20093164|P1|STARTED|Overall Study||6
8151658|NCT02614469|20093181|P2|NOT COMPLETED|Period 2||0
8151659|NCT02614469|20093182|P1|NOT COMPLETED|Period 2||0
8151660|NCT02614469|20093181|P2|COMPLETED|Period 2||9
8151661|NCT02614469|20093182|P1|COMPLETED|Period 2||9
8151662|NCT02614469|20093181|P2|STARTED|Period 2||9
8151663|NCT02614469|20093182|P1|STARTED|Period 2||9
8151664|NCT02614469|20093181|P2|NOT COMPLETED|Period 1||0
8151665|NCT02614469|20093182|P1|NOT COMPLETED|Period 1||0
8151666|NCT02614469|20093181|P2|COMPLETED|Period 1||9
8151667|NCT02614469|20093182|P1|COMPLETED|Period 1||9
8151668|NCT02614469|20093181|P2|STARTED|Period 1||9
8151669|NCT02614469|20093182|P1|STARTED|Period 1||9
8151670|NCT02614287|20093212|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
8151671|NCT02614287|20093213|P1|NOT COMPLETED|Post Treatment Follow-up Phase||9
8151672|NCT02614287|20093212|P2|COMPLETED|Post Treatment Follow-up Phase||119
8151673|NCT02614287|20093213|P1|COMPLETED|Post Treatment Follow-up Phase||103
8151674|NCT02614287|20093212|P2|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
8151675|NCT02614287|20093213|P1|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
8151676|NCT02614287|20093212|P2|NOT COMPLETED|Open Label (OL) Treatment Phase||22
8151677|NCT02614287|20093213|P1|NOT COMPLETED|Open Label (OL) Treatment Phase||38
8151678|NCT02614287|20093212|P2|COMPLETED|Open Label (OL) Treatment Phase||113
8151679|NCT02614287|20093213|P1|COMPLETED|Open Label (OL) Treatment Phase||97
8151680|NCT02614287|20093212|P2|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
8151681|NCT02614287|20093213|P1|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
8151682|NCT02614287|20093212|P2|STARTED|Open Label (OL) Treatment Phase||135
8151683|NCT02614287|20093213|P1|STARTED|Open Label (OL) Treatment Phase||135
8151684|NCT02614274|20093247|P1|NOT COMPLETED|Overall Study||4
8151685|NCT02614274|20093247|P1|COMPLETED|Overall Study||5
8151686|NCT02614274|20093247|P1|STARTED|Overall Study||9
8151687|NCT02614261|20093259|P3|NOT COMPLETED|Overall Study||11
8151688|NCT02614261|20093260|P2|NOT COMPLETED|Overall Study||15
8151689|NCT02614261|20093261|P1|NOT COMPLETED|Overall Study||49
8151690|NCT02614261|20093259|P3|COMPLETED|Overall Study||266
8151691|NCT02614261|20093260|P2|COMPLETED|Overall Study||263
8151692|NCT02614261|20093261|P1|COMPLETED|Overall Study||509
8151693|NCT02614261|20093259|P3|Received at Least One Dose of Study Drug|Overall Study||277
8151694|NCT02614261|20093260|P2|Received at Least One Dose of Study Drug|Overall Study||278
8151695|NCT02614261|20093261|P1|Received at Least One Dose of Study Drug|Overall Study||558
8151696|NCT02614261|20093259|P3|STARTED|Overall Study||277
8151697|NCT02614261|20093260|P2|STARTED|Overall Study||278
8151698|NCT02614261|20093261|P1|STARTED|Overall Study||558
8151699|NCT02614222|20093300|P2|NOT COMPLETED|Overall Study||0
8151700|NCT02614222|20093301|P1|NOT COMPLETED|Overall Study||0
8151701|NCT02614222|20093300|P2|COMPLETED|Overall Study||14
8151702|NCT02614222|20093301|P1|COMPLETED|Overall Study||13
8151703|NCT02614222|20093300|P2|STARTED|Overall Study||14
8151704|NCT02614222|20093301|P1|STARTED|Overall Study||13
8151705|NCT02614196|20093327|P6|NOT COMPLETED|Post Treatment Follow-up Phase||0
8151706|NCT02614196|20093328|P5|NOT COMPLETED|Post Treatment Follow-up Phase||2
8151707|NCT02614196|20093329|P4|NOT COMPLETED|Post Treatment Follow-up Phase||1
8151708|NCT02614196|20093330|P3|NOT COMPLETED|Post Treatment Follow-up Phase||8
8151709|NCT02614196|20093331|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
8151710|NCT02614196|20093332|P1|NOT COMPLETED|Post Treatment Follow-up Phase||20
8151711|NCT02614196|20093327|P6|COMPLETED|Post Treatment Follow-up Phase||19
8151712|NCT02614196|20093328|P5|COMPLETED|Post Treatment Follow-up Phase||13
8151713|NCT02614196|20093329|P4|COMPLETED|Post Treatment Follow-up Phase||24
8151714|NCT02614196|20093330|P3|COMPLETED|Post Treatment Follow-up Phase||199
8151715|NCT02614196|20093331|P2|COMPLETED|Post Treatment Follow-up Phase||208
8151716|NCT02614196|20093332|P1|COMPLETED|Post Treatment Follow-up Phase||390
8151717|NCT02614196|20093327|P6|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
8151718|NCT02614196|20093328|P5|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
8151719|NCT02614196|20093329|P4|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
8151720|NCT02614196|20093330|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
8151721|NCT02614196|20093331|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
8151722|NCT02614196|20093332|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
8151723|NCT02614196|20093327|P6|NOT COMPLETED|Double Blind Treatment Phase||0
8151724|NCT02614196|20093328|P5|NOT COMPLETED|Double Blind Treatment Phase||1
8151725|NCT02614196|20093329|P4|NOT COMPLETED|Double Blind Treatment Phase||4
8151726|NCT02614196|20093330|P3|NOT COMPLETED|Double Blind Treatment Phase||31
8151727|NCT02614196|20093331|P2|NOT COMPLETED|Double Blind Treatment Phase||30
8151728|NCT02614196|20093332|P1|NOT COMPLETED|Double Blind Treatment Phase||76
8151729|NCT02614196|20093327|P6|COMPLETED|Double Blind Treatment Phase||19
8151730|NCT02614196|20093328|P5|COMPLETED|Double Blind Treatment Phase||14
8151731|NCT02614196|20093329|P4|COMPLETED|Double Blind Treatment Phase||26
8151732|NCT02614196|20093330|P3|COMPLETED|Double Blind Treatment Phase||195
8151733|NCT02614196|20093331|P2|COMPLETED|Double Blind Treatment Phase||203
8151734|NCT02614196|20093332|P1|COMPLETED|Double Blind Treatment Phase||387
8151735|NCT02614196|20093327|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
8151736|NCT02614196|20093328|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
8151737|NCT02614196|20093329|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
8151738|NCT02614196|20093330|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
8151739|NCT02614196|20093331|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
8151740|NCT02614196|20093332|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
8151741|NCT02614196|20093327|P6|STARTED|Double Blind Treatment Phase||19
8151742|NCT02614196|20093328|P5|STARTED|Double Blind Treatment Phase||15
8151743|NCT02614196|20093329|P4|STARTED|Double Blind Treatment Phase||30
8151744|NCT02614196|20093330|P3|STARTED|Double Blind Treatment Phase||226
8151745|NCT02614196|20093331|P2|STARTED|Double Blind Treatment Phase||233
8151746|NCT02614196|20093332|P1|STARTED|Double Blind Treatment Phase||463
8151747|NCT02614183|20093378|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
8151748|NCT02614183|20093379|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
8151749|NCT02614183|20093380|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
8151750|NCT02614183|20093378|P3|COMPLETED|Post Treatment Follow-up Phase||171
8151751|NCT02614183|20093379|P2|COMPLETED|Post Treatment Follow-up Phase||179
8151752|NCT02614183|20093380|P1|COMPLETED|Post Treatment Follow-up Phase||354
8151753|NCT02614183|20093378|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
8151754|NCT02614183|20093379|P2|Safety Population|Post Treatment Follow-up Phase||183
8151755|NCT02614183|20093380|P1|Safety Population|Post Treatment Follow-up Phase||372
8151756|NCT02614183|20093378|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
8151757|NCT02614183|20093379|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
8151758|NCT02614183|20093380|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
8151759|NCT02614183|20093378|P3|NOT COMPLETED|Double Blind Treatment Phase||39
8151760|NCT02614183|20093379|P2|NOT COMPLETED|Double Blind Treatment Phase||37
8151761|NCT02614183|20093380|P1|NOT COMPLETED|Double Blind Treatment Phase||83
8151762|NCT02614183|20093378|P3|COMPLETED|Double Blind Treatment Phase||175
8151763|NCT02614183|20093379|P2|COMPLETED|Double Blind Treatment Phase||177
8151764|NCT02614183|20093380|P1|COMPLETED|Double Blind Treatment Phase||351
8151765|NCT02614183|20093378|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
8151766|NCT02614183|20093379|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
8151767|NCT02614183|20093380|P1|Safety Population|Double Blind Treatment Phase||432
8151768|NCT02614183|20093378|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
8151769|NCT02614183|20093379|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
8151770|NCT02614183|20093380|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
8151771|NCT02614183|20093378|P3|STARTED|Double Blind Treatment Phase||214
8151772|NCT02614183|20093379|P2|STARTED|Double Blind Treatment Phase||214
8151773|NCT02614183|20093380|P1|STARTED|Double Blind Treatment Phase||434
8151774|NCT02614131|20093424|P7|NOT COMPLETED|Overall Study||1
8151775|NCT02614131|20093425|P6|NOT COMPLETED|Overall Study||0
8151776|NCT02614131|20093426|P5|NOT COMPLETED|Overall Study||0
8151777|NCT02614131|20093427|P4|NOT COMPLETED|Overall Study||0
8151778|NCT02614131|20093428|P3|NOT COMPLETED|Overall Study||0
8151779|NCT02614131|20093429|P2|NOT COMPLETED|Overall Study||0
8151780|NCT02614131|20093430|P1|NOT COMPLETED|Overall Study||1
8151781|NCT02614131|20093424|P7|COMPLETED|Overall Study||4
8151782|NCT02614131|20093425|P6|COMPLETED|Overall Study||2
8151783|NCT02614131|20093426|P5|COMPLETED|Overall Study||8
8151784|NCT02614131|20093427|P4|COMPLETED|Overall Study||8
8151785|NCT02614131|20093428|P3|COMPLETED|Overall Study||8
8151786|NCT02614131|20093429|P2|COMPLETED|Overall Study||8
8151787|NCT02614131|20093430|P1|COMPLETED|Overall Study||10
8151788|NCT02614131|20093424|P7|Received at Least One Dose of Drug|Overall Study||5
8151789|NCT02614131|20093425|P6|Received at Least One Dose of Drug|Overall Study||2
8151790|NCT02614131|20093426|P5|Received at Least One Dose of Drug|Overall Study||8
8151791|NCT02614131|20093427|P4|Received at Least One Dose of Drug|Overall Study||8
8151792|NCT02614131|20093428|P3|Received at Least One Dose of Drug|Overall Study||8
8151793|NCT02614131|20093429|P2|Received at Least One Dose of Drug|Overall Study||8
8151794|NCT02614131|20093430|P1|Received at Least One Dose of Drug|Overall Study||11
8151795|NCT02614131|20093424|P7|STARTED|Overall Study||5
8151796|NCT02614131|20093425|P6|STARTED|Overall Study||2
8151797|NCT02614131|20093426|P5|STARTED|Overall Study||8
8151798|NCT02614131|20093427|P4|STARTED|Overall Study||8
8151799|NCT02614131|20093428|P3|STARTED|Overall Study||8
8151800|NCT02614131|20093429|P2|STARTED|Overall Study||8
8151801|NCT02614131|20093430|P1|STARTED|Overall Study||11
8151802|NCT02614079|20093461|P1|NOT COMPLETED|Overall Study||1
8151803|NCT02614079|20093461|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
8151804|NCT02614079|20093461|P1|STARTED|Overall Study||6
8151805|NCT02613910|20093465|P1|NOT COMPLETED|Overall Study||1
8151806|NCT02613910|20093465|P1|COMPLETED|Overall Study||0
8151807|NCT02613910|20093465|P1|STARTED|Overall Study||1
8151808|NCT02613897|20093517|P3|NOT COMPLETED|Overall Study||0
8151809|NCT02613897|20093518|P2|NOT COMPLETED|Overall Study||0
8151810|NCT02613897|20093519|P1|NOT COMPLETED|Overall Study||0
8151811|NCT02613897|20093517|P3|COMPLETED|Overall Study||12
8151812|NCT02613897|20093518|P2|COMPLETED|Overall Study||22
8151813|NCT02613897|20093519|P1|COMPLETED|Overall Study||22
8151814|NCT02613897|20093517|P3|STARTED|Overall Study||12
8151815|NCT02613897|20093518|P2|STARTED|Overall Study||22
8151816|NCT02613897|20093519|P1|STARTED|Overall Study||22
8151817|NCT02613871|20093551|P1|NOT COMPLETED|Overall Study||3
8151818|NCT02613871|20093551|P1|COMPLETED|Overall Study||108
8151819|NCT02613871|20093551|P1|STARTED|Overall Study||111
8151820|NCT02613572|20093573|P3|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8151821|NCT02613572|20093574|P2|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
8151822|NCT02613572|20093575|P1|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8151823|NCT02613572|20093573|P3|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
8151824|NCT02613572|20093574|P2|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
8151825|NCT02613572|20093575|P1|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8151826|NCT02613572|20093573|P3|STARTED|Phase II: Double-Blind Rand Plac Control||26
8151827|NCT02613572|20093574|P2|STARTED|Phase II: Double-Blind Rand Plac Control||27
8151828|NCT02613572|20093575|P1|STARTED|Phase II: Double-Blind Rand Plac Control||0
8151829|NCT02613572|20093573|P3|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151830|NCT02613572|20093574|P2|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151831|NCT02613572|20093575|P1|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
8151832|NCT02613572|20093573|P3|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151833|NCT02613572|20093574|P2|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151834|NCT02613572|20093575|P1|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
8151835|NCT02613572|20093573|P3|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151836|NCT02613572|20093574|P2|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151837|NCT02613572|20093575|P1|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
8151838|NCT02613572|20093573|P3|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151839|NCT02613572|20093574|P2|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151840|NCT02613572|20093575|P1|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
8151841|NCT02613572|20093573|P3|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151842|NCT02613572|20093574|P2|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151843|NCT02613572|20093575|P1|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
8151844|NCT02613572|20093573|P3|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151845|NCT02613572|20093574|P2|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151846|NCT02613572|20093575|P1|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
8151847|NCT02613507|20093597|P2|NOT COMPLETED|Overall Study||164
8151848|NCT02613507|20093598|P1|NOT COMPLETED|Overall Study||288
8151849|NCT02613507|20093597|P2|COMPLETED|Overall Study||2
8151850|NCT02613507|20093598|P1|COMPLETED|Overall Study||50
8151851|NCT02613507|20093597|P2|STARTED|Overall Study||166
8151852|NCT02613507|20093598|P1|STARTED|Overall Study||338
8151853|NCT02613481|20093614|P1|NOT COMPLETED|Overall Study||9
8151854|NCT02613481|20093614|P1|COMPLETED|Overall Study||41
8151855|NCT02613481|20093614|P1|STARTED|Overall Study||50
8151856|NCT02613403|20093625|P5|NOT COMPLETED|Overall Study||0
8151857|NCT02613403|20093626|P4|NOT COMPLETED|Overall Study||0
8151858|NCT02613403|20093627|P3|NOT COMPLETED|Overall Study||0
8151859|NCT02613403|20093628|P2|NOT COMPLETED|Overall Study||1
8151860|NCT02613403|20093629|P1|NOT COMPLETED|Overall Study||2
8151861|NCT02613403|20093625|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8151862|NCT02613403|20093626|P4|COMPLETED|Overall Study||13
8151863|NCT02613403|20093627|P3|COMPLETED|Overall Study||9
8151864|NCT02613403|20093628|P2|COMPLETED|Overall Study||35
8151865|NCT02613403|20093629|P1|COMPLETED|Overall Study||34
8151866|NCT02613403|20093625|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8151867|NCT02613403|20093626|P4|Treated|Overall Study||13
8151868|NCT02613403|20093627|P3|Treated|Overall Study||9
8151869|NCT02613403|20093628|P2|Treated|Overall Study||36
8151870|NCT02613403|20093629|P1|Treated|Overall Study||35
8151871|NCT02613403|20093625|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8151872|NCT02613403|20093626|P4|STARTED|Overall Study||13
8151873|NCT02613403|20093627|P3|STARTED|Overall Study||9
8151874|NCT02613403|20093628|P2|STARTED|Overall Study||36
8151875|NCT02613403|20093629|P1|STARTED|Overall Study||36
8151876|NCT02613338|20093671|P1|NOT COMPLETED|Overall Study||0
8151877|NCT02613338|20093671|P1|COMPLETED|Overall Study||30
8151878|NCT02613338|20093671|P1|STARTED|Overall Study||30
8151879|NCT02613221|20093681|P1|NOT COMPLETED|Overall Study||55
8151880|NCT02613221|20093681|P1|COMPLETED|Overall Study||1
8151881|NCT02613221|20093681|P1|Safety Population: Received Study Drug|Overall Study||55
8151882|NCT02613221|20093681|P1|STARTED|Overall Study||56
8151883|NCT02613208|20093693|P1|NOT COMPLETED|Overall Study||47
8151884|NCT02613208|20093693|P1|COMPLETED|Overall Study||64
8151885|NCT02613208|20093693|P1|STARTED|Overall Study||111
8151886|NCT02613182|20093707|P1|NOT COMPLETED|Overall Study||34
8151887|NCT02613182|20093707|P1|COMPLETED|Overall Study||0
8151888|NCT02613182|20093707|P1|Number of Patients Dosed|Overall Study||34
8151889|NCT02613182|20093707|P1|STARTED|Overall Study||34
8151890|NCT02613117|20093713|P2|NOT COMPLETED|Overall Study||0
8151891|NCT02613117|20093714|P1|NOT COMPLETED|Overall Study||0
8151892|NCT02613117|20093713|P2|COMPLETED|Overall Study||47
8151893|NCT02613117|20093714|P1|COMPLETED|Overall Study||57
8151894|NCT02613117|20093713|P2|STARTED|Overall Study||47
8151895|NCT02613117|20093714|P1|STARTED|Overall Study||57
8151896|NCT02612909|20093729|P5|NOT COMPLETED|Phase 3||0
8151897|NCT02612909|20093730|P4|NOT COMPLETED|Phase 3||1
8151898|NCT02612909|20093731|P3|NOT COMPLETED|Phase 3||0
8151899|NCT02612909|20093732|P2|NOT COMPLETED|Phase 3||0
8151900|NCT02612909|20093733|P1|NOT COMPLETED|Phase 3||0
8151901|NCT02612909|20093729|P5|COMPLETED|Phase 3||525
8151902|NCT02612909|20093730|P4|COMPLETED|Phase 3||104
8151903|NCT02612909|20093731|P3|COMPLETED|Phase 3||0
8151904|NCT02612909|20093732|P2|COMPLETED|Phase 3||0
8151905|NCT02612909|20093733|P1|COMPLETED|Phase 3||0
8151906|NCT02612909|20093729|P5|Completed Day 43 Clinic Visit|Phase 3||524
8151907|NCT02612909|20093730|P4|Completed Day 43 Clinic Visit|Phase 3||104
8151908|NCT02612909|20093731|P3|Completed Day 43 Clinic Visit|Phase 3||0
8151909|NCT02612909|20093732|P2|Completed Day 43 Clinic Visit|Phase 3||0
8151910|NCT02612909|20093733|P1|Completed Day 43 Clinic Visit|Phase 3||0
8151911|NCT02612909|20093729|P5|Completed Day 29 Clinic Visit|Phase 3||525
8151912|NCT02612909|20093730|P4|Completed Day 29 Clinic Visit|Phase 3||104
8151913|NCT02612909|20093731|P3|Completed Day 29 Clinic Visit|Phase 3||0
8151914|NCT02612909|20093732|P2|Completed Day 29 Clinic Visit|Phase 3||0
8151915|NCT02612909|20093733|P1|Completed Day 29 Clinic Visit|Phase 3||0
8151916|NCT02612909|20093729|P5|Received Injection 2|Phase 3||520
8151917|NCT02612909|20093730|P4|Received Injection 2|Phase 3||103
8151918|NCT02612909|20093731|P3|Received Injection 2|Phase 3||0
8151919|NCT02612909|20093732|P2|Received Injection 2|Phase 3||0
8151920|NCT02612909|20093733|P1|Received Injection 2|Phase 3||0
8151921|NCT02612909|20093729|P5|Received Injection 1|Phase 3||525
8151922|NCT02612909|20093730|P4|Received Injection 1|Phase 3||105
8151923|NCT02612909|20093731|P3|Received Injection 1|Phase 3||0
8151924|NCT02612909|20093732|P2|Received Injection 1|Phase 3||0
8151925|NCT02612909|20093733|P1|Received Injection 1|Phase 3||0
8151926|NCT02612909|20093729|P5|STARTED|Phase 3||525
8151927|NCT02612909|20093730|P4|STARTED|Phase 3||105
8151928|NCT02612909|20093731|P3|STARTED|Phase 3||0
8151929|NCT02612909|20093732|P2|STARTED|Phase 3||0
8151930|NCT02612909|20093733|P1|STARTED|Phase 3||0
8151931|NCT02612909|20093729|P5|NOT COMPLETED|Phase 2||0
8151932|NCT02612909|20093730|P4|NOT COMPLETED|Phase 2||0
8151933|NCT02612909|20093731|P3|NOT COMPLETED|Phase 2||1
8151934|NCT02612909|20093732|P2|NOT COMPLETED|Phase 2||5
8151935|NCT02612909|20093733|P1|NOT COMPLETED|Phase 2||2
8151936|NCT02612909|20093729|P5|COMPLETED|Phase 2||0
8151937|NCT02612909|20093730|P4|COMPLETED|Phase 2||0
8151938|NCT02612909|20093731|P3|COMPLETED|Phase 2||99
8151939|NCT02612909|20093732|P2|COMPLETED|Phase 2||95
8151940|NCT02612909|20093733|P1|COMPLETED|Phase 2||98
8151941|NCT02612909|20093729|P5|Completed Day 43 Clinic Visit|Phase 2||0
8151942|NCT02612909|20093730|P4|Completed Day 43 Clinic Visit|Phase 2||0
8151943|NCT02612909|20093731|P3|Completed Day 43 Clinic Visit|Phase 2||99
8151944|NCT02612909|20093732|P2|Completed Day 43 Clinic Visit|Phase 2||94
8151945|NCT02612909|20093733|P1|Completed Day 43 Clinic Visit|Phase 2||97
8151946|NCT02612909|20093729|P5|Completed Day 29 Clinic Visit|Phase 2||0
8151947|NCT02612909|20093730|P4|Completed Day 29 Clinic Visit|Phase 2||0
8151948|NCT02612909|20093731|P3|Completed Day 29 Clinic Visit|Phase 2||99
8151949|NCT02612909|20093732|P2|Completed Day 29 Clinic Visit|Phase 2||95
8151950|NCT02612909|20093733|P1|Completed Day 29 Clinic Visit|Phase 2||98
8151951|NCT02612909|20093729|P5|Received Injection 2|Phase 2||0
8151952|NCT02612909|20093730|P4|Received Injection 2|Phase 2||0
8151953|NCT02612909|20093731|P3|Received Injection 2|Phase 2||99
8151954|NCT02612909|20093732|P2|Received Injection 2|Phase 2||95
8151955|NCT02612909|20093733|P1|Received Injection 2|Phase 2||98
8151956|NCT02612909|20093729|P5|Received Injection 1|Phase 2||0
8151957|NCT02612909|20093730|P4|Received Injection 1|Phase 2||0
8151958|NCT02612909|20093731|P3|Received Injection 1|Phase 2||100
8151959|NCT02612909|20093732|P2|Received Injection 1|Phase 2||100
8151960|NCT02612909|20093733|P1|Received Injection 1|Phase 2||100
8151961|NCT02612909|20093729|P5|STARTED|Phase 2||0
8151962|NCT02612909|20093730|P4|STARTED|Phase 2||0
8151963|NCT02612909|20093731|P3|STARTED|Phase 2||100
8151964|NCT02612909|20093732|P2|STARTED|Phase 2||100
8151965|NCT02612909|20093733|P1|STARTED|Phase 2||100
8151966|NCT02612857|20093801|P3|NOT COMPLETED|Overall Study||4
8151967|NCT02612857|20093802|P2|NOT COMPLETED|Overall Study||4
8151968|NCT02612857|20093803|P1|NOT COMPLETED|Overall Study||3
8151969|NCT02612857|20093801|P3|COMPLETED|Overall Study||6
8151970|NCT02612857|20093802|P2|COMPLETED|Overall Study||5
8151971|NCT02612857|20093803|P1|COMPLETED|Overall Study||8
8151972|NCT02612857|20093801|P3|STARTED|Overall Study||10
8151973|NCT02612857|20093802|P2|STARTED|Overall Study||9
8151974|NCT02612857|20093803|P1|STARTED|Overall Study||11
8151975|NCT02612779|20093816|P2|NOT COMPLETED|Overall Study||5
8151976|NCT02612779|20093817|P1|NOT COMPLETED|Overall Study||64
8151977|NCT02612779|20093816|P2|COMPLETED|Overall Study||1
8151978|NCT02612779|20093817|P1|COMPLETED|Overall Study||4
8151979|NCT02612779|20093816|P2|STARTED|Overall Study||6
8151980|NCT02612779|20093817|P1|STARTED|Overall Study||68
8151981|NCT02612727|20093829|P2|NOT COMPLETED|Overall Study||4
8151982|NCT02612727|20093830|P1|NOT COMPLETED|Overall Study||5
8151983|NCT02612727|20093829|P2|COMPLETED|Overall Study||83
8151984|NCT02612727|20093830|P1|COMPLETED|Overall Study||82
8151985|NCT02612727|20093829|P2|STARTED|Overall Study||87
8151986|NCT02612727|20093830|P1|STARTED|Overall Study||87
8151987|NCT02612688|20093840|P2|NOT COMPLETED|Overall Study||0
8151988|NCT02612688|20093841|P1|NOT COMPLETED|Overall Study||0
8151989|NCT02612688|20093840|P2|COMPLETED|Overall Study||70013
8151990|NCT02612688|20093841|P1|COMPLETED|Overall Study||33035
8151991|NCT02612688|20093840|P2|STARTED|Overall Study||70013
8151992|NCT02612688|20093841|P1|STARTED|Overall Study||33035
8151993|NCT02612623|20093889|P4|NOT COMPLETED|Overall Study||0
8151994|NCT02612623|20093890|P3|NOT COMPLETED|Overall Study||1
8151995|NCT02612623|20093891|P2|NOT COMPLETED|Overall Study||1
8151996|NCT02612623|20093892|P1|NOT COMPLETED|Overall Study||1
8151997|NCT02612623|20093889|P4|COMPLETED|Overall Study||4
8151998|NCT02612623|20093890|P3|COMPLETED|Overall Study||5
8151999|NCT02612623|20093891|P2|COMPLETED|Overall Study||5
8152000|NCT02612623|20093892|P1|COMPLETED|Overall Study||7
8152001|NCT02612623|20093889|P4|Treated|Overall Study||4
8152002|NCT02612623|20093890|P3|Treated|Overall Study||6
8152003|NCT02612623|20093891|P2|Treated|Overall Study||5
8152004|NCT02612623|20093892|P1|Treated|Overall Study||8
8152005|NCT02612623|20093889|P4|STARTED|Overall Study||4
8152006|NCT02612623|20093890|P3|STARTED|Overall Study||6
8152007|NCT02612623|20093891|P2|STARTED|Overall Study||6
8152008|NCT02612623|20093892|P1|STARTED|Overall Study||8
8152009|NCT02612610|20093906|P4|NOT COMPLETED|Overall Study||13
8152010|NCT02612610|20093907|P3|NOT COMPLETED|Overall Study||5
8152011|NCT02612610|20093908|P2|NOT COMPLETED|Overall Study||8
8152012|NCT02612610|20093909|P1|NOT COMPLETED|Overall Study||5
8152013|NCT02612610|20093906|P4|COMPLETED|Overall Study||50
8152014|NCT02612610|20093907|P3|COMPLETED|Overall Study||58
8152015|NCT02612610|20093908|P2|COMPLETED|Overall Study||56
8152016|NCT02612610|20093909|P1|COMPLETED|Overall Study||58
8152017|NCT02612610|20093906|P4|Treated|Overall Study||63
8152018|NCT02612610|20093907|P3|Treated|Overall Study||63
8152019|NCT02612610|20093908|P2|Treated|Overall Study||63
8152020|NCT02612610|20093909|P1|Treated|Overall Study||63
8152021|NCT02612610|20093906|P4|STARTED|Overall Study||63
8152022|NCT02612610|20093907|P3|STARTED|Overall Study||63
8152023|NCT02612610|20093908|P2|STARTED|Overall Study||64
8152024|NCT02612610|20093909|P1|STARTED|Overall Study||63
8152025|NCT02612428|20094153|P2|NOT COMPLETED|VTL-308E||7
8152026|NCT02612428|20094154|P1|NOT COMPLETED|VTL-308E||11
8152027|NCT02612428|20094153|P2|COMPLETED|VTL-308E||49
8152028|NCT02612428|20094154|P1|COMPLETED|VTL-308E||53
8152029|NCT02612428|20094153|P2|STARTED|VTL-308E||56
8152030|NCT02612428|20094154|P1|STARTED|VTL-308E||64
8152031|NCT02612428|20094153|P2|NOT COMPLETED|VTL-308||17
8152032|NCT02612428|20094154|P1|NOT COMPLETED|VTL-308||14
8152033|NCT02612428|20094153|P2|COMPLETED|VTL-308||56
8152034|NCT02612428|20094154|P1|COMPLETED|VTL-308||64
8152035|NCT02612428|20094153|P2|STARTED|VTL-308||73
8152036|NCT02612428|20094154|P1|STARTED|VTL-308||78
8152037|NCT02612285|20094164|P1|NOT COMPLETED|Overall Study||1
8152038|NCT02612285|20094164|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
8152039|NCT02612285|20094164|P1|STARTED|Overall Study||1
8152040|NCT02612155|20094170|P2|NOT COMPLETED|Overall Study||3
8152041|NCT02612155|20094171|P1|NOT COMPLETED|Overall Study||3
8152042|NCT02612155|20094170|P2|COMPLETED|Overall Study||15
8152043|NCT02612155|20094171|P1|COMPLETED|Overall Study||14
8152044|NCT02612155|20094170|P2|STARTED|Overall Study||18
8152045|NCT02612155|20094171|P1|STARTED|Overall Study||17
8152046|NCT02612077|20094191|P1|NOT COMPLETED|Overall Study||466
8152047|NCT02612077|20094191|P1|COMPLETED|Overall Study||299
8152048|NCT02612077|20094191|P1|Efficacy Analysis Set|Overall Study||737
8152049|NCT02612077|20094191|P1|Safety Analysis Set|Overall Study||760
8152050|NCT02612077|20094191|P1|Did Not Receive Study Product|Overall Study||5
8152051|NCT02612077|20094191|P1|STARTED|Overall Study||765
8152052|NCT02612064|20094203|P2|NOT COMPLETED|Overall Study||3
8152053|NCT02612064|20094204|P1|NOT COMPLETED|Overall Study||1
8152054|NCT02612064|20094203|P2|COMPLETED|Overall Study||112
8152055|NCT02612064|20094204|P1|COMPLETED|Overall Study||114
8152056|NCT02612064|20094203|P2|STARTED|Overall Study||115
8152057|NCT02612064|20094204|P1|STARTED|Overall Study||115
8152058|NCT02611882|20094217|P3|NOT COMPLETED|Overall Study||0
8152059|NCT02611882|20094218|P2|NOT COMPLETED|Overall Study||0
8152060|NCT02611882|20094219|P1|NOT COMPLETED|Overall Study||33
8152061|NCT02611882|20094217|P3|COMPLETED|Overall Study||0
8152062|NCT02611882|20094218|P2|COMPLETED|Overall Study||150
8152063|NCT02611882|20094219|P1|COMPLETED|Overall Study||42
8152064|NCT02611882|20094217|P3|Completed Surgery Per Protocol|Overall Study||0
8152065|NCT02611882|20094218|P2|Completed Surgery Per Protocol|Overall Study||0
8152066|NCT02611882|20094219|P1|Completed Surgery Per Protocol|Overall Study||42
8152067|NCT02611882|20094217|P3|STARTED|Overall Study||0
8152068|NCT02611882|20094218|P2|STARTED|Overall Study||150
8152069|NCT02611882|20094219|P1|STARTED|Overall Study||75
8152070|NCT02611830|20094237|P4|NOT COMPLETED|Maintenance Phase||15
8152071|NCT02611830|20094238|P3|NOT COMPLETED|Maintenance Phase||31
8152072|NCT02611830|20094239|P2|NOT COMPLETED|Maintenance Phase||36
8152073|NCT02611830|20094240|P1|NOT COMPLETED|Maintenance Phase||0
8152074|NCT02611830|20094237|P4|COMPLETED|Maintenance Phase||39
8152075|NCT02611830|20094238|P3|COMPLETED|Maintenance Phase||75
8152076|NCT02611830|20094239|P2|COMPLETED|Maintenance Phase||20
8152077|NCT02611830|20094240|P1|COMPLETED|Maintenance Phase||0
8152078|NCT02611830|20094237|P4|STARTED|Maintenance Phase||54
8152079|NCT02611830|20094238|P3|STARTED|Maintenance Phase||106
8152080|NCT02611830|20094239|P2|STARTED|Maintenance Phase||56
8152081|NCT02611830|20094240|P1|STARTED|Maintenance Phase||0
8152082|NCT02611830|20094237|P4|NOT COMPLETED|OL Induction Phase||0
8152083|NCT02611830|20094238|P3|NOT COMPLETED|OL Induction Phase||0
8152084|NCT02611830|20094239|P2|NOT COMPLETED|OL Induction Phase||0
8152085|NCT02611830|20094240|P1|NOT COMPLETED|OL Induction Phase||30
8152086|NCT02611830|20094237|P4|COMPLETED|OL Induction Phase||0
8152087|NCT02611830|20094238|P3|COMPLETED|OL Induction Phase||0
8152088|NCT02611830|20094239|P2|COMPLETED|OL Induction Phase||0
8152089|NCT02611830|20094240|P1|COMPLETED|OL Induction Phase||353
8152090|NCT02611830|20094237|P4|STARTED|OL Induction Phase||0
8152091|NCT02611830|20094238|P3|STARTED|OL Induction Phase||0
8152092|NCT02611830|20094239|P2|STARTED|OL Induction Phase||0
8152093|NCT02611830|20094240|P1|STARTED|OL Induction Phase||383
8152094|NCT02611817|20094264|P3|NOT COMPLETED|Double-blind Maintenance Phase||107
8152095|NCT02611817|20094265|P2|NOT COMPLETED|Double-blind Maintenance Phase||62
8152096|NCT02611817|20094266|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
8152097|NCT02611817|20094264|P3|COMPLETED|Double-blind Maintenance Phase||168
8152098|NCT02611817|20094265|P2|COMPLETED|Double-blind Maintenance Phase||73
8152099|NCT02611817|20094266|P1|COMPLETED|Double-blind Maintenance Phase||0
8152100|NCT02611817|20094264|P3|STARTED|Double-blind Maintenance Phase||275
8152101|NCT02611817|20094265|P2|STARTED|Double-blind Maintenance Phase||135
8152102|NCT02611817|20094266|P1|STARTED|Double-blind Maintenance Phase||0
8152103|NCT02611817|20094264|P3|NOT COMPLETED|Open-label Induction Phase||0
8152104|NCT02611817|20094265|P2|NOT COMPLETED|Open-label Induction Phase||0
8152105|NCT02611817|20094266|P1|NOT COMPLETED|Open-label Induction Phase||50
8152106|NCT02611817|20094264|P3|COMPLETED|Open-label Induction Phase||0
8152107|NCT02611817|20094265|P2|COMPLETED|Open-label Induction Phase||0
8152108|NCT02611817|20094266|P1|COMPLETED|Open-label Induction Phase||594
8152109|NCT02611817|20094264|P3|STARTED|Open-label Induction Phase||0
8152110|NCT02611817|20094265|P2|STARTED|Open-label Induction Phase||0
8152111|NCT02611817|20094266|P1|STARTED|Open-label Induction Phase||644
8152112|NCT02611765|20094281|P2|NOT COMPLETED|Overall Study||6
8152113|NCT02611765|20094282|P1|NOT COMPLETED|Overall Study||2
8152114|NCT02611765|20094281|P2|COMPLETED|Overall Study||29
8152115|NCT02611765|20094282|P1|COMPLETED|Overall Study||27
8152116|NCT02611765|20094281|P2|STARTED|Overall Study||35
8152117|NCT02611765|20094282|P1|STARTED|Overall Study||29
8152118|NCT02611752|20094290|P2|NOT COMPLETED|Overall Study||1
8152119|NCT02611752|20094291|P1|NOT COMPLETED|Overall Study||0
8152120|NCT02611752|20094290|P2|COMPLETED|Overall Study||24
8152121|NCT02611752|20094291|P1|COMPLETED|Overall Study||22
8152122|NCT02611752|20094290|P2|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
8152123|NCT02611752|20094291|P1|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
8152124|NCT02611752|20094290|P2|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
8152125|NCT02611752|20094291|P1|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
8152126|NCT02611752|20094290|P2|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
8152127|NCT02611752|20094291|P1|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
8152128|NCT02611752|20094290|P2|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
8152129|NCT02611752|20094291|P1|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
8152130|NCT02611752|20094290|P2|STARTED|Overall Study||25
8152131|NCT02611752|20094291|P1|STARTED|Overall Study||22
8152132|NCT02611479|20094323|P1|NOT COMPLETED|Data Cleaning||2
8152133|NCT02611479|20094323|P1|COMPLETED|Data Cleaning||149
8152134|NCT02611479|20094323|P1|STARTED|Data Cleaning||151
8152135|NCT02611479|20094323|P1|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
8152136|NCT02611479|20094323|P1|COMPLETED|Post-Surgery Follow-up at 1-Year||151
8152137|NCT02611479|20094323|P1|STARTED|Post-Surgery Follow-up at 1-Year||169
8152138|NCT02611479|20094323|P1|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
8152139|NCT02611479|20094323|P1|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
8152140|NCT02611479|20094323|P1|STARTED|Post-Surgery Follow-up at 30-90 Days||171
8152141|NCT02611479|20094323|P1|NOT COMPLETED|Baseline Enrollment||13
8152142|NCT02611479|20094323|P1|COMPLETED|Baseline Enrollment||171
8152143|NCT02611479|20094323|P1|STARTED|Baseline Enrollment||184
8152144|NCT02611362|20094329|P2|NOT COMPLETED|Overall Study||6
8152145|NCT02611362|20094330|P1|NOT COMPLETED|Overall Study||9
8152146|NCT02611362|20094329|P2|COMPLETED|Overall Study||35
8152147|NCT02611362|20094330|P1|COMPLETED|Overall Study||32
8152148|NCT02611362|20094329|P2|6-month Follow-up|Overall Study||35
8152149|NCT02611362|20094330|P1|6-month Follow-up|Overall Study||32
8152150|NCT02611362|20094329|P2|Immediate Posttest (3 Months)|Overall Study||34
8152151|NCT02611362|20094330|P1|Immediate Posttest (3 Months)|Overall Study||33
8152152|NCT02611362|20094329|P2|STARTED|Overall Study||41
8152153|NCT02611362|20094330|P1|STARTED|Overall Study||41
8152154|NCT02611154|20094346|P1|NOT COMPLETED|Overall Study||0
8152155|NCT02611154|20094346|P1|COMPLETED|Overall Study||5
8152156|NCT02611154|20094346|P1|STARTED|Overall Study||5
8152157|NCT02610972|20094367|P2|NOT COMPLETED|Overall Study||0
8152158|NCT02610972|20094368|P1|NOT COMPLETED|Overall Study||0
8152159|NCT02610972|20094367|P2|COMPLETED|Overall Study||50
8152160|NCT02610972|20094368|P1|COMPLETED|Overall Study||100
8152161|NCT02610972|20094367|P2|STARTED|Overall Study||50
8152162|NCT02610972|20094368|P1|STARTED|Overall Study||100
8152163|NCT02610868|20094374|P1|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
8152164|NCT02610868|20094374|P1|COMPLETED|MYOBLOC: Treatment Session 4||22
8152165|NCT02610868|20094374|P1|STARTED|MYOBLOC: Treatment Session 4||24
8152166|NCT02610868|20094374|P1|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
8152167|NCT02610868|20094374|P1|COMPLETED|MYOBLOC: Treatment Session 3||43
8152168|NCT02610868|20094374|P1|STARTED|MYOBLOC: Treatment Session 3||50
8152169|NCT02610868|20094374|P1|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
8152170|NCT02610868|20094374|P1|COMPLETED|MYOBLOC: Treatment Session 2||165
8152171|NCT02610868|20094374|P1|STARTED|MYOBLOC: Treatment Session 2||177
8152172|NCT02610868|20094374|P1|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
8152173|NCT02610868|20094374|P1|COMPLETED|MYOBLOC: Treatment Session 1||180
8152174|NCT02610868|20094374|P1|STARTED|MYOBLOC: Treatment Session 1||187
8152175|NCT02610842|20094474|P1|NOT COMPLETED|Overall Study||5
8152176|NCT02610842|20094474|P1|COMPLETED|Overall Study||22
8152177|NCT02610842|20094474|P1|STARTED|Overall Study||27
8152178|NCT02610816|20094483|P4|NOT COMPLETED|Phase 2||6
8152179|NCT02610816|20094484|P3|NOT COMPLETED|Phase 2||11
8152180|NCT02610816|20094485|P2|NOT COMPLETED|Phase 2||0
8152181|NCT02610816|20094486|P1|NOT COMPLETED|Phase 2||0
8152182|NCT02610816|20094483|P4|COMPLETED|Phase 2||4
8152183|NCT02610816|20094484|P3|COMPLETED|Phase 2||8
8152184|NCT02610816|20094485|P2|COMPLETED|Phase 2||0
8152185|NCT02610816|20094486|P1|COMPLETED|Phase 2||0
8152186|NCT02610816|20094483|P4|STARTED|Phase 2||10
8152187|NCT02610816|20094484|P3|STARTED|Phase 2||19
8152188|NCT02610816|20094485|P2|STARTED|Phase 2||0
8152189|NCT02610816|20094486|P1|STARTED|Phase 2||0
8152190|NCT02610816|20094483|P4|NOT COMPLETED|Phase 1||0
8152191|NCT02610816|20094484|P3|NOT COMPLETED|Phase 1||0
8152192|NCT02610816|20094485|P2|NOT COMPLETED|Phase 1||8
8152193|NCT02610816|20094486|P1|NOT COMPLETED|Phase 1||4
8152194|NCT02610816|20094483|P4|COMPLETED|Phase 1||0
8152195|NCT02610816|20094484|P3|COMPLETED|Phase 1||0
8152196|NCT02610816|20094485|P2|COMPLETED|Phase 1||17
8152197|NCT02610816|20094486|P1|COMPLETED|Phase 1||34
8152198|NCT02610816|20094483|P4|STARTED|Phase 1||0
8152199|NCT02610816|20094484|P3|STARTED|Phase 1||0
8152200|NCT02610816|20094485|P2|STARTED|Phase 1||25
8152201|NCT02610816|20094486|P1|STARTED|Phase 1||38
8152202|NCT02610777|20094509|P2|NOT COMPLETED|Overall Study||22
8152203|NCT02610777|20094510|P1|NOT COMPLETED|Overall Study||21
8152204|NCT02610777|20094509|P2|COMPLETED|Overall Study||36
8152205|NCT02610777|20094510|P1|COMPLETED|Overall Study||41
8152206|NCT02610777|20094509|P2|STARTED|Overall Study||58
8152207|NCT02610777|20094510|P1|STARTED|Overall Study||62
8152208|NCT02610725|20094516|P1|NOT COMPLETED|Overall Study||206
8152209|NCT02610725|20094516|P1|COMPLETED|Overall Study||75
8152210|NCT02610725|20094516|P1|STARTED|Overall Study||281
8152211|NCT02610634|20094524|P2|NOT COMPLETED|Overall Study||0
8152212|NCT02610634|20094525|P1|NOT COMPLETED|Overall Study||0
8152213|NCT02610634|20094524|P2|COMPLETED|Overall Study||40
8152214|NCT02610634|20094525|P1|COMPLETED|Overall Study||60
8152215|NCT02610634|20094524|P2|STARTED|Overall Study||40
8152216|NCT02610634|20094525|P1|STARTED|Overall Study||60
8152217|NCT02610231|20094531|P1|NOT COMPLETED|Overall Study||60
8152218|NCT02610231|20094531|P1|COMPLETED|Overall Study||179
8152219|NCT02610231|20094531|P1|STARTED|Overall Study||239
8152220|NCT02610192|20094538|P1|NOT COMPLETED|Overall Study||9
8152221|NCT02610192|20094538|P1|COMPLETED|Overall Study||41
8152222|NCT02610192|20094538|P1|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
8152223|NCT02610140|20094553|P2|NOT COMPLETED|Long-term Follow-up||66
8152224|NCT02610140|20094554|P1|NOT COMPLETED|Long-term Follow-up||123
8152225|NCT02610140|20094553|P2|COMPLETED|Long-term Follow-up||0
8152226|NCT02610140|20094554|P1|COMPLETED|Long-term Follow-up||0
8152227|NCT02610140|20094553|P2|STARTED|Long-term Follow-up||66
8152228|NCT02610140|20094554|P1|STARTED|Long-term Follow-up||123
8152229|NCT02610140|20094553|P2|NOT COMPLETED|Active Follow-up||26
8152230|NCT02610140|20094554|P1|NOT COMPLETED|Active Follow-up||48
8152231|NCT02610140|20094553|P2|COMPLETED|Active Follow-up||0
8152232|NCT02610140|20094554|P1|COMPLETED|Active Follow-up||0
8152233|NCT02610140|20094553|P2|STARTED|Active Follow-up||26
8152234|NCT02610140|20094554|P1|STARTED|Active Follow-up||48
8152235|NCT02610140|20094553|P2|NOT COMPLETED|Safety Follow-up||24
8152236|NCT02610140|20094554|P1|NOT COMPLETED|Safety Follow-up||45
8152237|NCT02610140|20094553|P2|COMPLETED|Safety Follow-up||21
8152238|NCT02610140|20094554|P1|COMPLETED|Safety Follow-up||57
8152239|NCT02610140|20094553|P2|STARTED|Safety Follow-up||45
8152240|NCT02610140|20094554|P1|STARTED|Safety Follow-up||102
8152241|NCT02610140|20094553|P2|NOT COMPLETED|Randomization and Treatment Period||82
8152242|NCT02610140|20094554|P1|NOT COMPLETED|Randomization and Treatment Period||166
8152243|NCT02610140|20094553|P2|COMPLETED|Randomization and Treatment Period||0
8152244|NCT02610140|20094554|P1|COMPLETED|Randomization and Treatment Period||0
8152245|NCT02610140|20094553|P2|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
8152246|NCT02610140|20094554|P1|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
8152247|NCT02610140|20094553|P2|STARTED|Randomization and Treatment Period||82
8152248|NCT02610140|20094554|P1|STARTED|Randomization and Treatment Period||166
8152249|NCT02609984|20094586|P2|NOT COMPLETED|Overall Study||39
8152250|NCT02609984|20094587|P1|NOT COMPLETED|Overall Study||44
8152251|NCT02609984|20094586|P2|COMPLETED|Overall Study||5
8152252|NCT02609984|20094587|P1|COMPLETED|Overall Study||1
8152253|NCT02609984|20094586|P2|Treated|Overall Study||43
8152254|NCT02609984|20094587|P1|Treated|Overall Study||45
8152255|NCT02609984|20094586|P2|STARTED|Overall Study||44
8152256|NCT02609984|20094587|P1|STARTED|Overall Study||45
8152257|NCT02609841|20094621|P1|NOT COMPLETED|Overall Study||28
8152258|NCT02609841|20094621|P1|COMPLETED|Overall Study||212
8152259|NCT02609841|20094621|P1|STARTED|Overall Study||240
8152260|NCT02609672|20094629|P2|NOT COMPLETED|Overall Study||1
8152261|NCT02609672|20094630|P1|NOT COMPLETED|Overall Study||3
8152262|NCT02609672|20094629|P2|COMPLETED|Overall Study||11
8152263|NCT02609672|20094630|P1|COMPLETED|Overall Study||9
8152264|NCT02609672|20094629|P2|STARTED|Overall Study||12
8152265|NCT02609672|20094630|P1|STARTED|Overall Study||12
8152266|NCT02609659|20094664|P1|NOT COMPLETED|Overall Study||8
8152267|NCT02609659|20094664|P1|COMPLETED|Overall Study||97
8152268|NCT02609659|20094664|P1|STARTED|Overall Study||105
8152269|NCT02609633|20094674|P2|NOT COMPLETED|Overall Study||2
8152270|NCT02609633|20094675|P1|NOT COMPLETED|Overall Study||5
8152271|NCT02609633|20094674|P2|COMPLETED|Overall Study||54
8152272|NCT02609633|20094675|P1|COMPLETED|Overall Study||37
8152273|NCT02609633|20094674|P2|Full Analysis Set (FAS)|Overall Study||46
8152274|NCT02609633|20094675|P1|Full Analysis Set (FAS)|Overall Study||32
8152275|NCT02609633|20094674|P2|STARTED|Overall Study||56
8152276|NCT02609633|20094675|P1|STARTED|Overall Study||42
8152277|NCT02609607|20094702|P2|NOT COMPLETED|Overall Study||1
8152278|NCT02609607|20094703|P1|NOT COMPLETED|Overall Study||0
8152279|NCT02609607|20094702|P2|COMPLETED|Overall Study||4
8152280|NCT02609607|20094703|P1|COMPLETED|Overall Study||6
8152281|NCT02609607|20094702|P2|STARTED|Overall Study||5
8152282|NCT02609607|20094703|P1|STARTED|Overall Study||6
8152283|NCT02609399|20094727|P2|NOT COMPLETED|Influenza Season 2016-2017||5
8152284|NCT02609399|20094728|P1|NOT COMPLETED|Influenza Season 2016-2017||9
8152285|NCT02609399|20094727|P2|COMPLETED|Influenza Season 2016-2017||59
8152286|NCT02609399|20094728|P1|COMPLETED|Influenza Season 2016-2017||49
8152287|NCT02609399|20094727|P2|STARTED|Influenza Season 2016-2017||64
8152288|NCT02609399|20094728|P1|STARTED|Influenza Season 2016-2017||58
8152289|NCT02609399|20094727|P2|NOT COMPLETED|Influenza Season 2015-2016||2
8152290|NCT02609399|20094728|P1|NOT COMPLETED|Influenza Season 2015-2016||3
8152291|NCT02609399|20094727|P2|COMPLETED|Influenza Season 2015-2016||29
8152292|NCT02609399|20094728|P1|COMPLETED|Influenza Season 2015-2016||24
8152293|NCT02609399|20094727|P2|STARTED|Influenza Season 2015-2016||31
8152294|NCT02609399|20094728|P1|STARTED|Influenza Season 2015-2016||27
8152295|NCT02609308|20094742|P2|NOT COMPLETED|Overall Study||0
8152296|NCT02609308|20094743|P1|NOT COMPLETED|Overall Study||0
8152297|NCT02609308|20094742|P2|COMPLETED|Overall Study||11
8152298|NCT02609308|20094743|P1|COMPLETED|Overall Study||10
8152299|NCT02609308|20094742|P2|STARTED|Overall Study||11
8152300|NCT02609308|20094743|P1|STARTED|Overall Study||10
8152301|NCT02609204|20094753|P1|NOT COMPLETED|Overall Study||0
8152302|NCT02609204|20094753|P1|COMPLETED|Overall Study||51
8152303|NCT02609204|20094753|P1|STARTED|Overall Study||51
8152304|NCT02609178|20094758|P6|NOT COMPLETED|Third Crown||0
8152305|NCT02609178|20094759|P5|NOT COMPLETED|Third Crown||0
8152306|NCT02609178|20094760|P4|NOT COMPLETED|Third Crown||0
8152307|NCT02609178|20094761|P3|NOT COMPLETED|Third Crown||0
8152308|NCT02609178|20094762|P2|NOT COMPLETED|Third Crown||0
8152309|NCT02609178|20094763|P1|NOT COMPLETED|Third Crown||0
8152310|NCT02609178|20094758|P6|COMPLETED|Third Crown||2
8152311|NCT02609178|20094759|P5|COMPLETED|Third Crown||0
8152312|NCT02609178|20094760|P4|COMPLETED|Third Crown||2
8152313|NCT02609178|20094761|P3|COMPLETED|Third Crown||5
8152314|NCT02609178|20094762|P2|COMPLETED|Third Crown||1
8152315|NCT02609178|20094763|P1|COMPLETED|Third Crown||0
8152316|NCT02609178|20094758|P6|STARTED|Third Crown||2
8152317|NCT02609178|20094759|P5|STARTED|Third Crown||0
8152318|NCT02609178|20094760|P4|STARTED|Third Crown||2
8152319|NCT02609178|20094761|P3|STARTED|Third Crown||5
8152320|NCT02609178|20094762|P2|STARTED|Third Crown||1
8152321|NCT02609178|20094763|P1|STARTED|Third Crown||0
8152322|NCT02609178|20094758|P6|NOT COMPLETED|5-minute Washout Time||0
8152323|NCT02609178|20094759|P5|NOT COMPLETED|5-minute Washout Time||0
8152324|NCT02609178|20094760|P4|NOT COMPLETED|5-minute Washout Time||0
8152325|NCT02609178|20094761|P3|NOT COMPLETED|5-minute Washout Time||0
8152326|NCT02609178|20094762|P2|NOT COMPLETED|5-minute Washout Time||0
8152327|NCT02609178|20094763|P1|NOT COMPLETED|5-minute Washout Time||0
8152328|NCT02609178|20094758|P6|COMPLETED|5-minute Washout Time||2
8152329|NCT02609178|20094759|P5|COMPLETED|5-minute Washout Time||0
8152330|NCT02609178|20094760|P4|COMPLETED|5-minute Washout Time||2
8152331|NCT02609178|20094761|P3|COMPLETED|5-minute Washout Time||5
8152332|NCT02609178|20094762|P2|COMPLETED|5-minute Washout Time||1
8152333|NCT02609178|20094763|P1|COMPLETED|5-minute Washout Time||0
8152334|NCT02609178|20094758|P6|STARTED|5-minute Washout Time||2
8152335|NCT02609178|20094759|P5|STARTED|5-minute Washout Time||0
8152336|NCT02609178|20094760|P4|STARTED|5-minute Washout Time||2
8152337|NCT02609178|20094761|P3|STARTED|5-minute Washout Time||5
8152338|NCT02609178|20094762|P2|STARTED|5-minute Washout Time||1
8152339|NCT02609178|20094763|P1|STARTED|5-minute Washout Time||0
8152340|NCT02609178|20094758|P6|NOT COMPLETED|Second Crown||0
8152341|NCT02609178|20094759|P5|NOT COMPLETED|Second Crown||0
8152342|NCT02609178|20094760|P4|NOT COMPLETED|Second Crown||0
8152343|NCT02609178|20094761|P3|NOT COMPLETED|Second Crown||0
8152344|NCT02609178|20094762|P2|NOT COMPLETED|Second Crown||0
8152345|NCT02609178|20094763|P1|NOT COMPLETED|Second Crown||0
8152346|NCT02609178|20094758|P6|COMPLETED|Second Crown||2
8152347|NCT02609178|20094759|P5|COMPLETED|Second Crown||0
8152348|NCT02609178|20094760|P4|COMPLETED|Second Crown||2
8152349|NCT02609178|20094761|P3|COMPLETED|Second Crown||5
8152350|NCT02609178|20094762|P2|COMPLETED|Second Crown||1
8152351|NCT02609178|20094763|P1|COMPLETED|Second Crown||0
8152352|NCT02609178|20094758|P6|STARTED|Second Crown||2
8152353|NCT02609178|20094759|P5|STARTED|Second Crown||0
8152354|NCT02609178|20094760|P4|STARTED|Second Crown||2
8152355|NCT02609178|20094761|P3|STARTED|Second Crown||5
8152356|NCT02609178|20094762|P2|STARTED|Second Crown||1
8152357|NCT02609178|20094763|P1|STARTED|Second Crown||0
8152358|NCT02609178|20094758|P6|NOT COMPLETED|5-minute Washout Time||0
8152359|NCT02609178|20094759|P5|NOT COMPLETED|5-minute Washout Time||0
8152360|NCT02609178|20094760|P4|NOT COMPLETED|5-minute Washout Time||0
8152361|NCT02609178|20094761|P3|NOT COMPLETED|5-minute Washout Time||0
8152362|NCT02609178|20094762|P2|NOT COMPLETED|5-minute Washout Time||0
8152363|NCT02609178|20094763|P1|NOT COMPLETED|5-minute Washout Time||0
8152364|NCT02609178|20094758|P6|COMPLETED|5-minute Washout Time||2
8152365|NCT02609178|20094759|P5|COMPLETED|5-minute Washout Time||0
8152366|NCT02609178|20094760|P4|COMPLETED|5-minute Washout Time||2
8152367|NCT02609178|20094761|P3|COMPLETED|5-minute Washout Time||5
8152368|NCT02609178|20094762|P2|COMPLETED|5-minute Washout Time||1
8152369|NCT02609178|20094763|P1|COMPLETED|5-minute Washout Time||0
8152370|NCT02609178|20094758|P6|STARTED|5-minute Washout Time||2
8152371|NCT02609178|20094759|P5|STARTED|5-minute Washout Time||0
8152372|NCT02609178|20094760|P4|STARTED|5-minute Washout Time||2
8152373|NCT02609178|20094761|P3|STARTED|5-minute Washout Time||5
8152374|NCT02609178|20094762|P2|STARTED|5-minute Washout Time||1
8152375|NCT02609178|20094763|P1|STARTED|5-minute Washout Time||0
8152376|NCT02609178|20094758|P6|NOT COMPLETED|First Crown||0
8152377|NCT02609178|20094759|P5|NOT COMPLETED|First Crown||0
8152378|NCT02609178|20094760|P4|NOT COMPLETED|First Crown||1
8152379|NCT02609178|20094761|P3|NOT COMPLETED|First Crown||1
8152380|NCT02609178|20094762|P2|NOT COMPLETED|First Crown||0
8152381|NCT02609178|20094763|P1|NOT COMPLETED|First Crown||0
8152382|NCT02609178|20094758|P6|COMPLETED|First Crown||2
8152383|NCT02609178|20094759|P5|COMPLETED|First Crown||0
8152384|NCT02609178|20094760|P4|COMPLETED|First Crown||2
8152385|NCT02609178|20094761|P3|COMPLETED|First Crown||5
8152386|NCT02609178|20094762|P2|COMPLETED|First Crown||1
8152387|NCT02609178|20094763|P1|COMPLETED|First Crown||0
8152388|NCT02609178|20094758|P6|STARTED|First Crown||2
8152389|NCT02609178|20094759|P5|STARTED|First Crown||0
8152390|NCT02609178|20094760|P4|STARTED|First Crown||3
8152391|NCT02609178|20094761|P3|STARTED|First Crown||6
8152392|NCT02609178|20094762|P2|STARTED|First Crown||1
8152393|NCT02609178|20094763|P1|STARTED|First Crown||0
8152394|NCT02609113|20094780|P2|NOT COMPLETED|Overall Study||2
8152395|NCT02609113|20094781|P1|NOT COMPLETED|Overall Study||2
8152396|NCT02609113|20094780|P2|COMPLETED|Overall Study||9
8152397|NCT02609113|20094781|P1|COMPLETED|Overall Study||9
8152398|NCT02609113|20094780|P2|STARTED|Overall Study||11
8152399|NCT02609113|20094781|P1|STARTED|Overall Study||11
8152400|NCT02609100|20094795|P2|NOT COMPLETED|Overall Study||0
8152401|NCT02609100|20094796|P1|NOT COMPLETED|Overall Study||0
8152402|NCT02609100|20094795|P2|COMPLETED|Overall Study||2
8152403|NCT02609100|20094796|P1|COMPLETED|Overall Study||2
8152404|NCT02609100|20094795|P2|STARTED|Overall Study||2
8152405|NCT02609100|20094796|P1|STARTED|Overall Study||2
8152406|NCT02608905|20094814|P2|NOT COMPLETED|Overall Study||0
8152407|NCT02608905|20094815|P1|NOT COMPLETED|Overall Study||2
8152408|NCT02608905|20094814|P2|COMPLETED|Overall Study||10
8152409|NCT02608905|20094815|P1|COMPLETED|Overall Study||5
8152410|NCT02608905|20094814|P2|STARTED|Overall Study||10
8152411|NCT02608905|20094815|P1|STARTED|Overall Study||7
8152412|NCT02608892|20094825|P2|NOT COMPLETED|Overall Study||0
8152413|NCT02608892|20094826|P1|NOT COMPLETED|Overall Study||1
8152414|NCT02608892|20094825|P2|COMPLETED|Overall Study||49
8152415|NCT02608892|20094826|P1|COMPLETED|Overall Study||50
8152416|NCT02608892|20094825|P2|STARTED|Overall Study||49
8152417|NCT02608892|20094826|P1|STARTED|Overall Study||51
8152418|NCT02608879|20094838|P3|NOT COMPLETED|Overall Study||3
8152419|NCT02608879|20094839|P2|NOT COMPLETED|Overall Study||0
8152420|NCT02608879|20094840|P1|NOT COMPLETED|Overall Study||1
8152421|NCT02608879|20094838|P3|COMPLETED|Overall Study||0
8152422|NCT02608879|20094839|P2|COMPLETED|Overall Study||6
8152423|NCT02608879|20094840|P1|COMPLETED|Overall Study||9
8152424|NCT02608879|20094838|P3|STARTED|Overall Study||3
8152425|NCT02608879|20094839|P2|STARTED|Overall Study||6
8152426|NCT02608879|20094840|P1|STARTED|Overall Study||10
8152427|NCT02608684|20094859|P1|NOT COMPLETED|Overall Study||3
8152428|NCT02608684|20094859|P1|COMPLETED|Overall Study||18
8152429|NCT02608684|20094859|P1|STARTED|Overall Study||21
8152430|NCT02608489|20094871|P2|NOT COMPLETED|Overall Study||10
8152431|NCT02608489|20094872|P1|NOT COMPLETED|Overall Study||13
8152432|NCT02608489|20094871|P2|COMPLETED|Overall Study||33
8152433|NCT02608489|20094872|P1|COMPLETED|Overall Study||30
8152434|NCT02608489|20094871|P2|STARTED|Overall Study||43
8152435|NCT02608489|20094872|P1|STARTED|Overall Study||43
8152436|NCT02608476|20094894|P2|NOT COMPLETED|Overall Study||81
8152437|NCT02608476|20094895|P1|NOT COMPLETED|Overall Study||67
8152438|NCT02608476|20094894|P2|COMPLETED|Overall Study||282
8152439|NCT02608476|20094895|P1|COMPLETED|Overall Study||302
8152440|NCT02608476|20094894|P2|STARTED|Overall Study||363
8152441|NCT02608476|20094895|P1|STARTED|Overall Study||369
8152442|NCT02608463|20094915|P3|NOT COMPLETED|Overall Study||0
8152443|NCT02608463|20094916|P2|NOT COMPLETED|Overall Study||0
8152444|NCT02608463|20094917|P1|NOT COMPLETED|Overall Study||3
8152445|NCT02608463|20094915|P3|COMPLETED|Overall Study||0
8152446|NCT02608463|20094916|P2|COMPLETED|Overall Study||1
8152447|NCT02608463|20094917|P1|COMPLETED|Overall Study||10
8152448|NCT02608463|20094915|P3|STARTED|Overall Study|No study participants were enrolled in Part B.|0
8152449|NCT02608463|20094916|P2|STARTED|Overall Study||1
8152450|NCT02608463|20094917|P1|STARTED|Overall Study||13
8152451|NCT02608450|20094925|P2|NOT COMPLETED|Overall Study||65
8152452|NCT02608450|20094926|P1|NOT COMPLETED|Overall Study||66
8152453|NCT02608450|20094925|P2|COMPLETED|Overall Study||290
8152454|NCT02608450|20094926|P1|COMPLETED|Overall Study||287
8152455|NCT02608450|20094925|P2|STARTED|Overall Study||355
8152456|NCT02608450|20094926|P1|STARTED|Overall Study||353
8152457|NCT02608229|20094946|P2|NOT COMPLETED|Overall Study||0
8152458|NCT02608229|20094947|P1|NOT COMPLETED|Overall Study||0
8152459|NCT02608229|20094946|P2|COMPLETED|Overall Study||8
8152460|NCT02608229|20094947|P1|COMPLETED|Overall Study||10
8152461|NCT02608229|20094946|P2|450 mg BVD-523|Overall Study||6
8152462|NCT02608229|20094947|P1|450 mg BVD-523|Overall Study||0
8152463|NCT02608229|20094946|P2|600 mg BVD-523|Overall Study||2
8152464|NCT02608229|20094947|P1|600 mg BVD-523|Overall Study||10
8152465|NCT02608229|20094946|P2|STARTED|Overall Study||8
8152466|NCT02608229|20094947|P1|STARTED|Overall Study||10
8152467|NCT02608177|20094965|P2|NOT COMPLETED|Overall Study||0
8152468|NCT02608177|20094966|P1|NOT COMPLETED|Overall Study||0
8152469|NCT02608177|20094965|P2|COMPLETED|Overall Study||1
8152470|NCT02608177|20094966|P1|COMPLETED|Overall Study||2
8152471|NCT02608177|20094965|P2|STARTED|Overall Study||1
8152472|NCT02608177|20094966|P1|STARTED|Overall Study||2
8152473|NCT02608099|20094988|P2|NOT COMPLETED|Overall Study||2
8152474|NCT02608099|20094989|P1|NOT COMPLETED|Overall Study||3
8152475|NCT02608099|20094988|P2|COMPLETED|Overall Study||150
8152476|NCT02608099|20094989|P1|COMPLETED|Overall Study||145
8152477|NCT02608099|20094988|P2|Safety|Overall Study||151
8152478|NCT02608099|20094989|P1|Safety|Overall Study||149
8152479|NCT02608099|20094988|P2|STARTED|Overall Study||152
8152480|NCT02608099|20094989|P1|STARTED|Overall Study||148
8152481|NCT02607956|20095027|P2|NOT COMPLETED|Overall Study||330
8152482|NCT02607956|20095028|P1|NOT COMPLETED|Overall Study||327
8152483|NCT02607956|20095027|P2|COMPLETED|Overall Study||0
8152484|NCT02607956|20095028|P1|COMPLETED|Overall Study||0
8152485|NCT02607956|20095027|P2|STARTED|Overall Study||330
8152486|NCT02607956|20095028|P1|STARTED|Overall Study||327
8152487|NCT02607930|20095058|P2|NOT COMPLETED|Overall Study||315
8152488|NCT02607930|20095059|P1|NOT COMPLETED|Overall Study||316
8152489|NCT02607930|20095058|P2|COMPLETED|Overall Study||0
8152490|NCT02607930|20095059|P1|COMPLETED|Overall Study||0
8152491|NCT02607930|20095058|P2|STARTED|Overall Study||315
8152492|NCT02607930|20095059|P1|STARTED|Overall Study||316
8152493|NCT02607865|20095103|P4|NOT COMPLETED|Overall Study||16
8152494|NCT02607865|20095104|P3|NOT COMPLETED|Overall Study||27
8152495|NCT02607865|20095105|P2|NOT COMPLETED|Overall Study||30
8152496|NCT02607865|20095106|P1|NOT COMPLETED|Overall Study||33
8152497|NCT02607865|20095103|P4|COMPLETED|Overall Study||451
8152498|NCT02607865|20095104|P3|COMPLETED|Overall Study||438
8152499|NCT02607865|20095105|P2|COMPLETED|Overall Study||436
8152500|NCT02607865|20095106|P1|COMPLETED|Overall Study||433
8152501|NCT02607865|20095103|P4|Safety Analysis Set (SAS)|Overall Study||466
8152502|NCT02607865|20095104|P3|Safety Analysis Set (SAS)|Overall Study||465
8152503|NCT02607865|20095105|P2|Safety Analysis Set (SAS)|Overall Study||464
8152504|NCT02607865|20095106|P1|Safety Analysis Set (SAS)|Overall Study||466
8152505|NCT02607865|20095103|P4|Full Analysis Set (FAS)|Overall Study||467
8152506|NCT02607865|20095104|P3|Full Analysis Set (FAS)|Overall Study||465
8152507|NCT02607865|20095105|P2|Full Analysis Set (FAS)|Overall Study||465
8152508|NCT02607865|20095106|P1|Full Analysis Set (FAS)|Overall Study||466
8152509|NCT02607865|20095103|P4|STARTED|Overall Study||467
8152510|NCT02607865|20095104|P3|STARTED|Overall Study||465
8152511|NCT02607865|20095105|P2|STARTED|Overall Study||466
8152512|NCT02607865|20095106|P1|STARTED|Overall Study||466
8152513|NCT02607800|20095280|P2|NOT COMPLETED|Overall Study||11
8152514|NCT02607800|20095281|P1|NOT COMPLETED|Overall Study||10
8152515|NCT02607800|20095280|P2|COMPLETED|Overall Study||430
8152516|NCT02607800|20095281|P1|COMPLETED|Overall Study||492
8152517|NCT02607800|20095280|P2|STARTED|Overall Study||441
8152518|NCT02607800|20095281|P1|STARTED|Overall Study||502
8152519|NCT02607735|20095299|P3|NOT COMPLETED|Deferred Treatment Substudy||5
8152520|NCT02607735|20095300|P2|NOT COMPLETED|Deferred Treatment Substudy||0
8152521|NCT02607735|20095301|P1|NOT COMPLETED|Deferred Treatment Substudy||0
8152522|NCT02607735|20095299|P3|COMPLETED|Deferred Treatment Substudy||142
8152523|NCT02607735|20095300|P2|COMPLETED|Deferred Treatment Substudy||0
8152524|NCT02607735|20095301|P1|COMPLETED|Deferred Treatment Substudy||0
8152525|NCT02607735|20095299|P3|STARTED|Deferred Treatment Substudy||147
8152526|NCT02607735|20095300|P2|STARTED|Deferred Treatment Substudy||0
8152527|NCT02607735|20095301|P1|STARTED|Deferred Treatment Substudy||0
8152528|NCT02607735|20095299|P3|NOT COMPLETED|Primary Study||0
8152529|NCT02607735|20095300|P2|NOT COMPLETED|Primary Study||0
8152530|NCT02607735|20095301|P1|NOT COMPLETED|Primary Study||7
8152531|NCT02607735|20095299|P3|COMPLETED|Primary Study||0
8152532|NCT02607735|20095300|P2|COMPLETED|Primary Study||152
8152533|NCT02607735|20095301|P1|COMPLETED|Primary Study||257
8152534|NCT02607735|20095299|P3|STARTED|Primary Study||0
8152535|NCT02607735|20095300|P2|STARTED|Primary Study||152
8152536|NCT02607735|20095301|P1|STARTED|Primary Study||264
8152537|NCT02607618|20095323|P2|NOT COMPLETED|Overall Study||2
8152538|NCT02607618|20095324|P1|NOT COMPLETED|Overall Study||11
8152539|NCT02607618|20095323|P2|COMPLETED|Overall Study||305
8152540|NCT02607618|20095324|P1|COMPLETED|Overall Study||295
8152541|NCT02607618|20095323|P2|STARTED|Overall Study||307
8152542|NCT02607618|20095324|P1|STARTED|Overall Study||306
8152543|NCT02607306|20095335|P3|NOT COMPLETED|Overall Study||10
8152544|NCT02607306|20095336|P2|NOT COMPLETED|Overall Study||23
8152545|NCT02607306|20095337|P1|NOT COMPLETED|Overall Study||21
8152546|NCT02607306|20095335|P3|COMPLETED|Overall Study||263
8152547|NCT02607306|20095336|P2|COMPLETED|Overall Study||248
8152548|NCT02607306|20095337|P1|COMPLETED|Overall Study||254
8152549|NCT02607306|20095335|P3|STARTED|Overall Study||273
8152550|NCT02607306|20095336|P2|STARTED|Overall Study||271
8152551|NCT02607306|20095337|P1|STARTED|Overall Study||275
8152552|NCT02607280|20095459|P2|NOT COMPLETED|Overall Study||1
8152553|NCT02607280|20095460|P1|NOT COMPLETED|Overall Study||4
8152554|NCT02607280|20095459|P2|COMPLETED|Overall Study||4
8152555|NCT02607280|20095460|P1|COMPLETED|Overall Study||26
8152556|NCT02607280|20095459|P2|Received Study Drug|Overall Study||5
8152557|NCT02607280|20095460|P1|Received Study Drug|Overall Study||30
8152558|NCT02607280|20095459|P2|STARTED|Overall Study||5
8152559|NCT02607280|20095460|P1|STARTED|Overall Study||30
8152560|NCT02607254|20095469|P3|NOT COMPLETED|Overall Study||0
8152561|NCT02607254|20095470|P2|NOT COMPLETED|Overall Study||0
8152562|NCT02607254|20095471|P1|NOT COMPLETED|Overall Study||0
8152563|NCT02607254|20095469|P3|COMPLETED|Overall Study||5
8152564|NCT02607254|20095470|P2|COMPLETED|Overall Study||3
8152565|NCT02607254|20095471|P1|COMPLETED|Overall Study||3
8152566|NCT02607254|20095469|P3|STARTED|Overall Study||5
8152567|NCT02607254|20095470|P2|STARTED|Overall Study||3
8152568|NCT02607254|20095471|P1|STARTED|Overall Study||3
8152569|NCT02607228|20095495|P7|NOT COMPLETED|Overall Study||2
8152570|NCT02607228|20095496|P6|NOT COMPLETED|Overall Study||6
8152571|NCT02607228|20095497|P5|NOT COMPLETED|Overall Study||5
8152572|NCT02607228|20095498|P4|NOT COMPLETED|Overall Study||6
8152573|NCT02607228|20095499|P3|NOT COMPLETED|Overall Study||3
8152574|NCT02607228|20095500|P2|NOT COMPLETED|Overall Study||4
8152575|NCT02607228|20095501|P1|NOT COMPLETED|Overall Study||5
8152576|NCT02607228|20095495|P7|COMPLETED|Overall Study||0
8152577|NCT02607228|20095496|P6|COMPLETED|Overall Study||0
8152578|NCT02607228|20095497|P5|COMPLETED|Overall Study||0
8152579|NCT02607228|20095498|P4|COMPLETED|Overall Study||0
8152580|NCT02607228|20095499|P3|COMPLETED|Overall Study||0
8152581|NCT02607228|20095500|P2|COMPLETED|Overall Study||0
8152582|NCT02607228|20095501|P1|COMPLETED|Overall Study||0
8152583|NCT02607228|20095495|P7|STARTED|Overall Study||2
8152584|NCT02607228|20095496|P6|STARTED|Overall Study||6
8152585|NCT02607228|20095497|P5|STARTED|Overall Study||5
8152586|NCT02607228|20095498|P4|STARTED|Overall Study||6
8152587|NCT02607228|20095499|P3|STARTED|Overall Study||3
8152588|NCT02607228|20095500|P2|STARTED|Overall Study||4
8152589|NCT02607228|20095501|P1|STARTED|Overall Study||5
8152590|NCT02607124|20095580|P1|NOT COMPLETED|Overall Study||0
8152591|NCT02607124|20095580|P1|COMPLETED|Overall Study||10
8152592|NCT02607124|20095580|P1|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
8152593|NCT02606903|20095589|P2|NOT COMPLETED|Overall Study||0
8152594|NCT02606903|20095590|P1|NOT COMPLETED|Overall Study||0
8152595|NCT02606903|20095589|P2|COMPLETED|Overall Study||36
8152596|NCT02606903|20095590|P1|COMPLETED|Overall Study||35
8152597|NCT02606903|20095589|P2|STARTED|Overall Study||36
8152598|NCT02606903|20095590|P1|STARTED|Overall Study||35
8152599|NCT02606877|20095604|P2|NOT COMPLETED|Overall Study||1
8152600|NCT02606877|20095605|P1|NOT COMPLETED|Overall Study||4
8152601|NCT02606877|20095604|P2|COMPLETED|Overall Study||16
8152602|NCT02606877|20095605|P1|COMPLETED|Overall Study||16
8152603|NCT02606877|20095604|P2|STARTED|Overall Study||17
8152604|NCT02606877|20095605|P1|STARTED|Overall Study||20
8152605|NCT02606838|20095619|P1|NOT COMPLETED|Overall Study||0
8152606|NCT02606838|20095619|P1|COMPLETED|Overall Study||119
8152607|NCT02606838|20095619|P1|STARTED|Overall Study||119
8152608|NCT02606734|20095627|P1|NOT COMPLETED|Overall Study||0
8152609|NCT02606734|20095627|P1|COMPLETED|Overall Study||44
8152610|NCT02606734|20095627|P1|STARTED|Overall Study||44
8152611|NCT02606708|20095631|P1|NOT COMPLETED|Overall Study||0
8152612|NCT02606708|20095631|P1|COMPLETED|Overall Study||314
8152613|NCT02606708|20095631|P1|STARTED|Overall Study||314
8152614|NCT02606643|20095644|P2|NOT COMPLETED|Overall Study||3
8152615|NCT02606643|20095645|P1|NOT COMPLETED|Overall Study||1
8152616|NCT02606643|20095644|P2|COMPLETED|Overall Study||73
8152617|NCT02606643|20095645|P1|COMPLETED|Overall Study||67
8152618|NCT02606643|20095644|P2|STARTED|Overall Study||76
8152619|NCT02606643|20095645|P1|STARTED|Overall Study||68
8152620|NCT02606604|20095657|P2|NOT COMPLETED|Overall Study||0
8152621|NCT02606604|20095658|P1|NOT COMPLETED|Overall Study||1
8152622|NCT02606604|20095657|P2|COMPLETED|Overall Study||7
8152623|NCT02606604|20095658|P1|COMPLETED|Overall Study||7
8152624|NCT02606604|20095657|P2|STARTED|Overall Study||7
8152625|NCT02606604|20095658|P1|STARTED|Overall Study||8
8152626|NCT02606500|20095684|P2|NOT COMPLETED|Overall Study||0
8152627|NCT02606500|20095685|P1|NOT COMPLETED|Overall Study||0
8152628|NCT02606500|20095684|P2|COMPLETED|Overall Study||35
8152629|NCT02606500|20095685|P1|COMPLETED|Overall Study||35
8152630|NCT02606500|20095684|P2|STARTED|Overall Study||35
8152631|NCT02606500|20095685|P1|STARTED|Overall Study||35
8152632|NCT02606279|20095703|P2|NOT COMPLETED|Overall Study||1
8152633|NCT02606279|20095704|P1|NOT COMPLETED|Overall Study||0
8152634|NCT02606279|20095703|P2|COMPLETED|Overall Study||0
8152635|NCT02606279|20095704|P1|COMPLETED|Overall Study||0
8152636|NCT02606279|20095703|P2|STARTED|Overall Study||1
8152637|NCT02606279|20095704|P1|STARTED|Overall Study||0
8152638|NCT02606253|20095719|P3|NOT COMPLETED|Overall Study||0
8152639|NCT02606253|20095720|P2|NOT COMPLETED|Overall Study||2
8152640|NCT02606253|20095721|P1|NOT COMPLETED|Overall Study||5
8152641|NCT02606253|20095719|P3|COMPLETED|Overall Study||20
8152642|NCT02606253|20095720|P2|COMPLETED|Overall Study||18
8152643|NCT02606253|20095721|P1|COMPLETED|Overall Study||15
8152644|NCT02606253|20095719|P3|STARTED|Overall Study||20
8152645|NCT02606253|20095720|P2|STARTED|Overall Study||20
8152646|NCT02606253|20095721|P1|STARTED|Overall Study||20
8152647|NCT02605993|20095784|P4|NOT COMPLETED|Extension Period||7
8152648|NCT02605993|20095785|P3|NOT COMPLETED|Extension Period||7
8152649|NCT02605993|20095786|P2|NOT COMPLETED|Extension Period||6
8152650|NCT02605993|20095787|P1|NOT COMPLETED|Extension Period||6
8152651|NCT02605993|20095784|P4|COMPLETED|Extension Period||0
8152652|NCT02605993|20095785|P3|COMPLETED|Extension Period||0
8152653|NCT02605993|20095786|P2|COMPLETED|Extension Period||0
8152654|NCT02605993|20095787|P1|COMPLETED|Extension Period||0
8152655|NCT02605993|20095784|P4|STARTED|Extension Period||7
8152656|NCT02605993|20095785|P3|STARTED|Extension Period||7
8152657|NCT02605993|20095786|P2|STARTED|Extension Period||6
8152658|NCT02605993|20095787|P1|STARTED|Extension Period||6
8152659|NCT02605993|20095784|P4|NOT COMPLETED|Treatment Period||0
8152660|NCT02605993|20095785|P3|NOT COMPLETED|Treatment Period||0
8152661|NCT02605993|20095786|P2|NOT COMPLETED|Treatment Period||0
8152662|NCT02605993|20095787|P1|NOT COMPLETED|Treatment Period||0
8152663|NCT02605993|20095784|P4|COMPLETED|Treatment Period||7
8152664|NCT02605993|20095785|P3|COMPLETED|Treatment Period||7
8152665|NCT02605993|20095786|P2|COMPLETED|Treatment Period||6
8152666|NCT02605993|20095787|P1|COMPLETED|Treatment Period||6
8152667|NCT02605993|20095784|P4|Received at Least 1 Dose of Study Drug|Treatment Period||7
8152668|NCT02605993|20095785|P3|Received at Least 1 Dose of Study Drug|Treatment Period||7
8152669|NCT02605993|20095786|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
8152670|NCT02605993|20095787|P1|Received at Least 1 Dose of Study Drug|Treatment Period||6
8152671|NCT02605993|20095784|P4|STARTED|Treatment Period||7
8152672|NCT02605993|20095785|P3|STARTED|Treatment Period||7
8152673|NCT02605993|20095786|P2|STARTED|Treatment Period||6
8152674|NCT02605993|20095787|P1|STARTED|Treatment Period||6
8152675|NCT02605954|20095823|P2|NOT COMPLETED|Overall Study||4
8152676|NCT02605954|20095824|P1|NOT COMPLETED|Overall Study||12
8152677|NCT02605954|20095823|P2|COMPLETED|Overall Study||88
8152678|NCT02605954|20095824|P1|COMPLETED|Overall Study||171
8152679|NCT02605954|20095823|P2|STARTED|Overall Study||92
8152680|NCT02605954|20095824|P1|STARTED|Overall Study||183
8152681|NCT02605928|20095841|P1|NOT COMPLETED|Overall Study||33
8152682|NCT02605928|20095841|P1|COMPLETED|Overall Study||46
8152683|NCT02605928|20095841|P1|Pivotal Phase, Statistical Phase|Overall Study||51
8152684|NCT02605928|20095841|P1|STARTED|Overall Study||79
8152685|NCT02605876|20095848|P3|NOT COMPLETED|Overall Study||0
8152686|NCT02605876|20095849|P2|NOT COMPLETED|Overall Study||0
8152687|NCT02605876|20095850|P1|NOT COMPLETED|Overall Study||0
8152688|NCT02605876|20095848|P3|COMPLETED|Overall Study||25
8152689|NCT02605876|20095849|P2|COMPLETED|Overall Study||25
8152690|NCT02605876|20095850|P1|COMPLETED|Overall Study||25
8152691|NCT02605876|20095848|P3|STARTED|Overall Study||25
8152692|NCT02605876|20095849|P2|STARTED|Overall Study||25
8152693|NCT02605876|20095850|P1|STARTED|Overall Study||25
8152694|NCT02605863|20095875|P2|NOT COMPLETED|Overall Study||0
8152695|NCT02605863|20095876|P1|NOT COMPLETED|Overall Study||0
8152696|NCT02605863|20095875|P2|COMPLETED|Overall Study||0
8152697|NCT02605863|20095876|P1|COMPLETED|Overall Study||1
8152698|NCT02605863|20095875|P2|STARTED|Overall Study||0
8152699|NCT02605863|20095876|P1|STARTED|Overall Study||1
8152700|NCT02605837|20095884|P2|NOT COMPLETED|Overall Study||11
8152701|NCT02605837|20095885|P1|NOT COMPLETED|Overall Study||11
8152702|NCT02605837|20095884|P2|COMPLETED|Overall Study||202
8152703|NCT02605837|20095885|P1|COMPLETED|Overall Study||94
8152704|NCT02605837|20095884|P2|STARTED|Overall Study||213
8152705|NCT02605837|20095885|P1|STARTED|Overall Study||105
8152706|NCT02605824|20095924|P2|NOT COMPLETED|Overall Study||0
8152707|NCT02605824|20095925|P1|NOT COMPLETED|Overall Study||1
8152708|NCT02605824|20095924|P2|COMPLETED|Overall Study||0
8152709|NCT02605824|20095925|P1|COMPLETED|Overall Study||0
8152710|NCT02605824|20095924|P2|STARTED|Overall Study||0
8152711|NCT02605824|20095925|P1|STARTED|Overall Study||1
8152712|NCT02605642|20095935|P2|NOT COMPLETED|Overall Study||21
8152713|NCT02605642|20095936|P1|NOT COMPLETED|Overall Study||96
8152714|NCT02605642|20095935|P2|COMPLETED|Overall Study||86
8152715|NCT02605642|20095936|P1|COMPLETED|Overall Study||131
8152716|NCT02605642|20095935|P2|Safety Set|Overall Study||107
8152717|NCT02605642|20095936|P1|Safety Set|Overall Study||221
8152718|NCT02605642|20095935|P2|STARTED|Overall Study||107
8152719|NCT02605642|20095936|P1|STARTED|Overall Study||227
8152720|NCT02605447|20095978|P1|NOT COMPLETED|Overall Study||102
8152721|NCT02605447|20095978|P1|COMPLETED|Overall Study||1385
8152722|NCT02605447|20095978|P1|STARTED|Overall Study||1487
8152723|NCT02605395|20095984|P2|NOT COMPLETED|Period 2, Day 8||0
8152724|NCT02605395|20095985|P1|NOT COMPLETED|Period 2, Day 8||0
8152725|NCT02605395|20095984|P2|COMPLETED|Period 2, Day 8||35
8152726|NCT02605395|20095985|P1|COMPLETED|Period 2, Day 8||35
8152727|NCT02605395|20095984|P2|STARTED|Period 2, Day 8||35
8152728|NCT02605395|20095985|P1|STARTED|Period 2, Day 8||35
8152729|NCT02605395|20095984|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
8152730|NCT02605395|20095985|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
8152731|NCT02605395|20095984|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
8152732|NCT02605395|20095985|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
8152733|NCT02605395|20095984|P2|STARTED|Washout Period, Day 2 to Day 7||35
8152734|NCT02605395|20095985|P1|STARTED|Washout Period, Day 2 to Day 7||35
8152735|NCT02605395|20095984|P2|NOT COMPLETED|Period 1, Day 1||0
8152736|NCT02605395|20095985|P1|NOT COMPLETED|Period 1, Day 1||0
8152737|NCT02605395|20095984|P2|COMPLETED|Period 1, Day 1||35
8152738|NCT02605395|20095985|P1|COMPLETED|Period 1, Day 1||35
8152739|NCT02605395|20095984|P2|STARTED|Period 1, Day 1||35
8152740|NCT02605395|20095985|P1|STARTED|Period 1, Day 1||35
8152741|NCT02605304|20096003|P2|NOT COMPLETED|Overall Study||0
8152742|NCT02605304|20096004|P1|NOT COMPLETED|Overall Study||0
8152743|NCT02605304|20096003|P2|COMPLETED|Overall Study||3
8152744|NCT02605304|20096004|P1|COMPLETED|Overall Study||4
8152745|NCT02605304|20096003|P2|STARTED|Overall Study||3
8152746|NCT02605304|20096004|P1|STARTED|Overall Study||4
8152747|NCT02605187|20096028|P4|NOT COMPLETED|Overall Study||1
8152748|NCT02605187|20096029|P3|NOT COMPLETED|Overall Study||11
8152749|NCT02605187|20096030|P2|NOT COMPLETED|Overall Study||2
8152750|NCT02605187|20096031|P1|NOT COMPLETED|Overall Study||8
8152751|NCT02605187|20096028|P4|COMPLETED|Overall Study||15
8152752|NCT02605187|20096029|P3|COMPLETED|Overall Study||72
8152753|NCT02605187|20096030|P2|COMPLETED|Overall Study||19
8152754|NCT02605187|20096031|P1|COMPLETED|Overall Study||32
8152755|NCT02605187|20096028|P4|STARTED|Overall Study||16
8152756|NCT02605187|20096029|P3|STARTED|Overall Study||83
8152757|NCT02605187|20096030|P2|STARTED|Overall Study||21
8152758|NCT02605187|20096031|P1|STARTED|Overall Study||40
8152759|NCT02605174|20096089|P7|NOT COMPLETED|Overall Study||89
8152760|NCT02605174|20096090|P6|NOT COMPLETED|Overall Study||32
8152761|NCT02605174|20096091|P5|NOT COMPLETED|Overall Study||53
8152762|NCT02605174|20096092|P4|NOT COMPLETED|Overall Study||36
8152763|NCT02605174|20096093|P3|NOT COMPLETED|Overall Study||76
8152764|NCT02605174|20096094|P2|NOT COMPLETED|Overall Study||23
8152765|NCT02605174|20096095|P1|NOT COMPLETED|Overall Study||64
8152766|NCT02605174|20096089|P7|COMPLETED|Overall Study||662
8152767|NCT02605174|20096090|P6|COMPLETED|Overall Study||217
8152768|NCT02605174|20096091|P5|COMPLETED|Overall Study||448
8152769|NCT02605174|20096092|P4|COMPLETED|Overall Study||216
8152770|NCT02605174|20096093|P3|COMPLETED|Overall Study||426
8152771|NCT02605174|20096094|P2|COMPLETED|Overall Study||226
8152772|NCT02605174|20096095|P1|COMPLETED|Overall Study||437
8152773|NCT02605174|20096089|P7|Received Optional 2nd Dose|Overall Study||361
8152774|NCT02605174|20096090|P6|Received Optional 2nd Dose|Overall Study||74
8152775|NCT02605174|20096091|P5|Received Optional 2nd Dose|Overall Study||144
8152776|NCT02605174|20096092|P4|Received Optional 2nd Dose|Overall Study||83
8152777|NCT02605174|20096093|P3|Received Optional 2nd Dose|Overall Study||177
8152778|NCT02605174|20096094|P2|Received Optional 2nd Dose|Overall Study||96
8152779|NCT02605174|20096095|P1|Received Optional 2nd Dose|Overall Study||206
8152780|NCT02605174|20096089|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
8152781|NCT02605174|20096090|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
8152782|NCT02605174|20096091|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
8152783|NCT02605174|20096092|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
8152784|NCT02605174|20096093|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
8152785|NCT02605174|20096094|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
8152786|NCT02605174|20096095|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
8152787|NCT02605174|20096089|P7|STARTED|Overall Study||751
8152788|NCT02605174|20096090|P6|STARTED|Overall Study||249
8152789|NCT02605174|20096091|P5|STARTED|Overall Study||501
8152790|NCT02605174|20096092|P4|STARTED|Overall Study||252
8152791|NCT02605174|20096093|P3|STARTED|Overall Study||502
8152792|NCT02605174|20096094|P2|STARTED|Overall Study||249
8152793|NCT02605174|20096095|P1|STARTED|Overall Study||501
8152794|NCT02605122|20096157|P2|NOT COMPLETED|Overall Study||2
8152795|NCT02605122|20096158|P1|NOT COMPLETED|Overall Study||5
8152796|NCT02605122|20096157|P2|COMPLETED|Overall Study||22
8152797|NCT02605122|20096158|P1|COMPLETED|Overall Study||68
8152798|NCT02605122|20096157|P2|Received Study Drug|Overall Study||24
8152799|NCT02605122|20096158|P1|Received Study Drug|Overall Study||70
8152800|NCT02605122|20096157|P2|STARTED|Overall Study||24
8152801|NCT02605122|20096158|P1|STARTED|Overall Study||73
8152802|NCT02604810|20096170|P1|NOT COMPLETED|IGSC 20%, 24 Weeks||7
8152803|NCT02604810|20096170|P1|COMPLETED|IGSC 20%, 24 Weeks||42
8152804|NCT02604810|20096170|P1|STARTED|IGSC 20%, 24 Weeks||49
8152805|NCT02604810|20096170|P1|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
8152806|NCT02604810|20096170|P1|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
8152807|NCT02604810|20096170|P1|STARTED|IGIV-C 10%, 4-5 Weeks||52
8152808|NCT02604589|20096181|P3|NOT COMPLETED|Overall Study||1
8152809|NCT02604589|20096182|P2|NOT COMPLETED|Overall Study||0
8152810|NCT02604589|20096183|P1|NOT COMPLETED|Overall Study||0
8152811|NCT02604589|20096181|P3|COMPLETED|Overall Study||1
8152812|NCT02604589|20096182|P2|COMPLETED|Overall Study||5
8152813|NCT02604589|20096183|P1|COMPLETED|Overall Study||3
8152814|NCT02604589|20096181|P3|STARTED|Overall Study||2
8152815|NCT02604589|20096182|P2|STARTED|Overall Study||5
8152816|NCT02604589|20096183|P1|STARTED|Overall Study||3
8152817|NCT02604550|20096211|P2|NOT COMPLETED|Overall Study||26
8152818|NCT02604550|20096212|P1|NOT COMPLETED|Overall Study||25
8152819|NCT02604550|20096211|P2|COMPLETED|Overall Study||33
8152820|NCT02604550|20096212|P1|COMPLETED|Overall Study||31
8152821|NCT02604550|20096211|P2|STARTED|Overall Study||59
8152822|NCT02604550|20096212|P1|STARTED|Overall Study||56
8152823|NCT02604433|20096238|P2|NOT COMPLETED|Post Treatment Follow-up Period||24
8152824|NCT02604433|20096239|P1|NOT COMPLETED|Post Treatment Follow-up Period||42
8152825|NCT02604433|20096238|P2|COMPLETED|Post Treatment Follow-up Period||0
8152826|NCT02604433|20096239|P1|COMPLETED|Post Treatment Follow-up Period||0
8152827|NCT02604433|20096238|P2|STARTED|Post Treatment Follow-up Period||24
8152828|NCT02604433|20096239|P1|STARTED|Post Treatment Follow-up Period||42
8152829|NCT02604433|20096238|P2|NOT COMPLETED|Open-Label Treatment Period||0
8152830|NCT02604433|20096239|P1|NOT COMPLETED|Open-Label Treatment Period||0
8152831|NCT02604433|20096238|P2|COMPLETED|Open-Label Treatment Period||0
8152832|NCT02604433|20096239|P1|COMPLETED|Open-Label Treatment Period||0
8152833|NCT02604433|20096238|P2|STARTED|Open-Label Treatment Period||0
8152834|NCT02604433|20096239|P1|STARTED|Open-Label Treatment Period||0
8152835|NCT02604433|20096238|P2|NOT COMPLETED|Double-blind Treatment Period||106
8152836|NCT02604433|20096239|P1|NOT COMPLETED|Double-blind Treatment Period||218
8152837|NCT02604433|20096238|P2|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
8152838|NCT02604433|20096239|P1|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
8152839|NCT02604433|20096238|P2|Completed 48 Weeks of Treatment|Double-blind Treatment Period||96
8152840|NCT02604433|20096239|P1|Completed 48 Weeks of Treatment|Double-blind Treatment Period||200
8152841|NCT02604433|20096238|P2|Completed 24 Weeks of Treatment|Double-blind Treatment Period||102
8152842|NCT02604433|20096239|P1|Completed 24 Weeks of Treatment|Double-blind Treatment Period||210
8152843|NCT02604433|20096238|P2|Health-Related Quality of Life Populatio|Double-blind Treatment Period||103
8152844|NCT02604433|20096239|P1|Health-Related Quality of Life Populatio|Double-blind Treatment Period||211
8152845|NCT02604433|20096238|P2|Pharmacokinetic Population|Double-blind Treatment Period|Participants did not take luspatercept.|0
8152846|NCT02604433|20096239|P1|Pharmacokinetic Population|Double-blind Treatment Period||221
8152847|NCT02604433|20096238|P2|Safety Population|Double-blind Treatment Period||109
8152848|NCT02604433|20096239|P1|Safety Population|Double-blind Treatment Period||223
8152849|NCT02604433|20096238|P2|Intent to Treat Population|Double-blind Treatment Period||112
8152850|NCT02604433|20096239|P1|Intent to Treat Population|Double-blind Treatment Period||224
8152851|NCT02604433|20096238|P2|STARTED|Double-blind Treatment Period||112
8152852|NCT02604433|20096239|P1|STARTED|Double-blind Treatment Period||224
8152853|NCT02604407|20096308|P3|NOT COMPLETED|Overall Study||16
8152854|NCT02604407|20096309|P2|NOT COMPLETED|Overall Study||12
8152855|NCT02604407|20096310|P1|NOT COMPLETED|Overall Study||11
8152856|NCT02604407|20096308|P3|COMPLETED|Overall Study||76
8152857|NCT02604407|20096309|P2|COMPLETED|Overall Study||80
8152858|NCT02604407|20096310|P1|COMPLETED|Overall Study||80
8152859|NCT02604407|20096308|P3|TREATED|Overall Study||90
8152860|NCT02604407|20096309|P2|TREATED|Overall Study||92
8152861|NCT02604407|20096310|P1|TREATED|Overall Study||89
8152862|NCT02604407|20096308|P3|STARTED|Overall Study||92
8152863|NCT02604407|20096309|P2|STARTED|Overall Study||92
8152864|NCT02604407|20096310|P1|STARTED|Overall Study||91
8152865|NCT02604342|20096323|P2|NOT COMPLETED|Overall Study||23
8152866|NCT02604342|20096324|P1|NOT COMPLETED|Overall Study||43
8152867|NCT02604342|20096323|P2|COMPLETED|Overall Study||17
8152868|NCT02604342|20096324|P1|COMPLETED|Overall Study||36
8152869|NCT02604342|20096323|P2|STARTED|Overall Study||40
8152870|NCT02604342|20096324|P1|STARTED|Overall Study||79
8152871|NCT02604264|20096376|P2|NOT COMPLETED|Intervention||242
8152872|NCT02604264|20096377|P1|NOT COMPLETED|Intervention||200
8152873|NCT02604264|20096376|P2|COMPLETED|Intervention||1225
8152874|NCT02604264|20096377|P1|COMPLETED|Intervention||1245
8152875|NCT02604264|20096376|P2|STARTED|Intervention||1467
8152876|NCT02604264|20096377|P1|STARTED|Intervention||1445
8152877|NCT02604264|20096376|P2|NOT COMPLETED|Run-In||0
8152878|NCT02604264|20096377|P1|NOT COMPLETED|Run-In||0
8152879|NCT02604264|20096376|P2|COMPLETED|Run-In||611
8152880|NCT02604264|20096377|P1|COMPLETED|Run-In||618
8152881|NCT02604264|20096376|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
8152882|NCT02604264|20096377|P1|STARTED|Run-In||618
8152883|NCT02604212|20096387|P4|NOT COMPLETED|Overall Study||3
8152884|NCT02604212|20096388|P3|NOT COMPLETED|Overall Study||4
8152885|NCT02604212|20096389|P2|NOT COMPLETED|Overall Study||1
8152886|NCT02604212|20096390|P1|NOT COMPLETED|Overall Study||2
8152887|NCT02604212|20096387|P4|COMPLETED|Overall Study||8
8152888|NCT02604212|20096388|P3|COMPLETED|Overall Study||6
8152889|NCT02604212|20096389|P2|COMPLETED|Overall Study||4
8152890|NCT02604212|20096390|P1|COMPLETED|Overall Study||4
8152891|NCT02604212|20096387|P4|STARTED|Overall Study||11
8152892|NCT02604212|20096388|P3|STARTED|Overall Study||10
8152893|NCT02604212|20096389|P2|STARTED|Overall Study||5
8152894|NCT02604212|20096390|P1|STARTED|Overall Study||6
8152895|NCT02604199|20096458|P4|NOT COMPLETED|Overall Study||3
8152896|NCT02604199|20096459|P3|NOT COMPLETED|Overall Study||0
8152897|NCT02604199|20096460|P2|NOT COMPLETED|Overall Study||3
8152898|NCT02604199|20096461|P1|NOT COMPLETED|Overall Study||0
8152899|NCT02604199|20096458|P4|COMPLETED|Overall Study||18
8152900|NCT02604199|20096459|P3|COMPLETED|Overall Study||17
8152901|NCT02604199|20096460|P2|COMPLETED|Overall Study||8
8152902|NCT02604199|20096461|P1|COMPLETED|Overall Study||9
8152903|NCT02604199|20096458|P4|STARTED|Overall Study||21
8152904|NCT02604199|20096459|P3|STARTED|Overall Study||17
8152905|NCT02604199|20096460|P2|STARTED|Overall Study||11
8152906|NCT02604199|20096461|P1|STARTED|Overall Study||9
8152907|NCT02604173|20096512|P3|NOT COMPLETED|Overall Study||0
8152908|NCT02604173|20096513|P2|NOT COMPLETED|Overall Study||0
8152909|NCT02604173|20096514|P1|NOT COMPLETED|Overall Study||0
8152910|NCT02604173|20096512|P3|COMPLETED|Overall Study||35
8152911|NCT02604173|20096513|P2|COMPLETED|Overall Study||35
8152912|NCT02604173|20096514|P1|COMPLETED|Overall Study||33
8152913|NCT02604173|20096512|P3|STARTED|Overall Study||35
8152914|NCT02604173|20096513|P2|STARTED|Overall Study||35
8152915|NCT02604173|20096514|P1|STARTED|Overall Study||33
8152916|NCT02604160|20096530|P2|NOT COMPLETED|Overall Study||2
8152917|NCT02604160|20096531|P1|NOT COMPLETED|Overall Study||0
8152918|NCT02604160|20096530|P2|COMPLETED|Overall Study||3
8152919|NCT02604160|20096531|P1|COMPLETED|Overall Study||2
8152920|NCT02604160|20096530|P2|Received at Least One Dose of Study Drug|Overall Study||5
8152921|NCT02604160|20096531|P1|Received at Least One Dose of Study Drug|Overall Study||2
8152922|NCT02604160|20096530|P2|STARTED|Overall Study||5
8152923|NCT02604160|20096531|P1|STARTED|Overall Study||2
8152924|NCT02604017|20096545|P2|NOT COMPLETED|Overall Study||8
8152925|NCT02604017|20096546|P1|NOT COMPLETED|Overall Study||6
8152926|NCT02604017|20096545|P2|COMPLETED|Overall Study||343
8152927|NCT02604017|20096546|P1|COMPLETED|Overall Study||346
8152928|NCT02604017|20096545|P2|STARTED|Overall Study||351
8152929|NCT02604017|20096546|P1|STARTED|Overall Study||352
8152930|NCT02603952|20096575|P4|NOT COMPLETED|Overall Study||1
8152931|NCT02603952|20096576|P3|NOT COMPLETED|Overall Study||0
8152932|NCT02603952|20096577|P2|NOT COMPLETED|Overall Study||0
8152933|NCT02603952|20096578|P1|NOT COMPLETED|Overall Study||1
8152934|NCT02603952|20096575|P4|COMPLETED|Overall Study||31
8152935|NCT02603952|20096576|P3|COMPLETED|Overall Study||31
8152936|NCT02603952|20096577|P2|COMPLETED|Overall Study||31
8152937|NCT02603952|20096578|P1|COMPLETED|Overall Study||31
8152938|NCT02603952|20096575|P4|Treated|Overall Study||31
8152939|NCT02603952|20096576|P3|Treated|Overall Study||31
8152940|NCT02603952|20096577|P2|Treated|Overall Study||31
8152941|NCT02603952|20096578|P1|Treated|Overall Study||32
8152942|NCT02603952|20096575|P4|STARTED|Overall Study||32
8152943|NCT02603952|20096576|P3|STARTED|Overall Study||31
8152944|NCT02603952|20096577|P2|STARTED|Overall Study||31
8152945|NCT02603952|20096578|P1|STARTED|Overall Study||32
8152946|NCT02603926|20096619|P1|NOT COMPLETED|Overall Study||0
8152947|NCT02603926|20096619|P1|COMPLETED|Overall Study||6
8152948|NCT02603926|20096619|P1|STARTED|Overall Study||6
8152949|NCT02603887|20096626|P1|NOT COMPLETED|Overall Study||6
8152950|NCT02603887|20096626|P1|COMPLETED|Overall Study||7
8152951|NCT02603887|20096626|P1|Cycle 8|Overall Study||7
8152952|NCT02603887|20096626|P1|Cycle 1|Overall Study||13
8152953|NCT02603887|20096626|P1|STARTED|Overall Study||13
8152954|NCT02603809|20096639|P6|NOT COMPLETED|Overall Study||10
8152955|NCT02603809|20096640|P5|NOT COMPLETED|Overall Study||11
8152956|NCT02603809|20096641|P4|NOT COMPLETED|Overall Study||12
8152957|NCT02603809|20096642|P3|NOT COMPLETED|Overall Study||7
8152958|NCT02603809|20096643|P2|NOT COMPLETED|Overall Study||8
8152959|NCT02603809|20096644|P1|NOT COMPLETED|Overall Study||12
8152960|NCT02603809|20096639|P6|COMPLETED|Overall Study||71
8152961|NCT02603809|20096640|P5|COMPLETED|Overall Study||70
8152962|NCT02603809|20096641|P4|COMPLETED|Overall Study||70
8152963|NCT02603809|20096642|P3|COMPLETED|Overall Study||75
8152964|NCT02603809|20096643|P2|COMPLETED|Overall Study||74
8152965|NCT02603809|20096644|P1|COMPLETED|Overall Study||70
8152966|NCT02603809|20096639|P6|Completed Study|Overall Study||75
8152967|NCT02603809|20096640|P5|Completed Study|Overall Study||78
8152968|NCT02603809|20096641|P4|Completed Study|Overall Study||76
8152969|NCT02603809|20096642|P3|Completed Study|Overall Study||79
8152970|NCT02603809|20096643|P2|Completed Study|Overall Study||79
8152971|NCT02603809|20096644|P1|Completed Study|Overall Study||75
8152972|NCT02603809|20096639|P6|Modified Per-Protocol Set|Overall Study||69
8152973|NCT02603809|20096640|P5|Modified Per-Protocol Set|Overall Study||68
8152974|NCT02603809|20096641|P4|Modified Per-Protocol Set|Overall Study||67
8152975|NCT02603809|20096642|P3|Modified Per-Protocol Set|Overall Study||71
8152976|NCT02603809|20096643|P2|Modified Per-Protocol Set|Overall Study||68
8152977|NCT02603809|20096644|P1|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
8152978|NCT02603809|20096639|P6|Per-protocol Set|Overall Study||69
8152979|NCT02603809|20096640|P5|Per-protocol Set|Overall Study||68
8152980|NCT02603809|20096641|P4|Per-protocol Set|Overall Study||67
8152981|NCT02603809|20096642|P3|Per-protocol Set|Overall Study||71
8152982|NCT02603809|20096643|P2|Per-protocol Set|Overall Study||68
8152983|NCT02603809|20096644|P1|Per-protocol Set|Overall Study||67
8152984|NCT02603809|20096639|P6|STARTED|Overall Study||81
8152985|NCT02603809|20096640|P5|STARTED|Overall Study||81
8152986|NCT02603809|20096641|P4|STARTED|Overall Study||82
8152987|NCT02603809|20096642|P3|STARTED|Overall Study||82
8152988|NCT02603809|20096643|P2|STARTED|Overall Study||82
8152989|NCT02603809|20096644|P1|STARTED|Overall Study||82
8152990|NCT02603666|20096700|P1|NOT COMPLETED|Overall Study||0
8152991|NCT02603666|20096700|P1|COMPLETED|Overall Study||130
8152992|NCT02603666|20096700|P1|STARTED|Overall Study||130
8152999|NCT02603419|20096761|P6|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
8153000|NCT02603419|20096762|P5|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153001|NCT02603419|20096763|P4|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153002|NCT02603419|20096764|P3|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153003|NCT02603419|20096765|P2|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153004|NCT02603419|20096766|P1|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153005|NCT02603419|20096761|P6|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153006|NCT02603419|20096762|P5|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153007|NCT02603419|20096763|P4|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153008|NCT02603419|20096764|P3|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153009|NCT02603419|20096765|P2|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153010|NCT02603419|20096766|P1|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153011|NCT02603419|20096761|P6|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
8153012|NCT02603419|20096762|P5|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153013|NCT02603419|20096763|P4|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153014|NCT02603419|20096764|P3|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153015|NCT02603419|20096765|P2|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153016|NCT02603419|20096766|P1|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153017|NCT02603419|20096761|P6|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153018|NCT02603419|20096762|P5|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153019|NCT02603419|20096763|P4|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153020|NCT02603419|20096764|P3|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153021|NCT02603419|20096765|P2|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
8153022|NCT02603419|20096766|P1|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153023|NCT02603419|20096761|P6|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153024|NCT02603419|20096762|P5|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153025|NCT02603419|20096763|P4|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153026|NCT02603419|20096764|P3|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153027|NCT02603419|20096765|P2|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153028|NCT02603419|20096766|P1|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153029|NCT02603419|20096761|P6|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
8153030|NCT02603419|20096762|P5|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153031|NCT02603419|20096763|P4|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153032|NCT02603419|20096764|P3|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153033|NCT02603419|20096765|P2|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153034|NCT02603419|20096766|P1|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153035|NCT02603419|20096761|P6|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153036|NCT02603419|20096762|P5|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153037|NCT02603419|20096763|P4|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153038|NCT02603419|20096764|P3|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153039|NCT02603419|20096765|P2|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
8153040|NCT02603419|20096766|P1|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153041|NCT02603393|20096953|P2|NOT COMPLETED|Overall Study||54
8153042|NCT02603393|20096954|P1|NOT COMPLETED|Overall Study||71
8153043|NCT02603393|20096953|P2|COMPLETED|Overall Study||472
8153044|NCT02603393|20096954|P1|COMPLETED|Overall Study||456
8153045|NCT02603393|20096953|P2|STARTED|Overall Study||526
8153046|NCT02603393|20096954|P1|STARTED|Overall Study||527
8153047|NCT02603211|20096980|P1|NOT COMPLETED|Overall Study||0
8153048|NCT02603211|20096980|P1|COMPLETED|Overall Study||20
8153049|NCT02603211|20096980|P1|STARTED|Overall Study||20
8153050|NCT02603172|20096993|P8|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153051|NCT02603172|20096994|P7|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153052|NCT02603172|20096995|P6|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153053|NCT02603172|20096996|P5|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153054|NCT02603172|20096997|P4|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153055|NCT02603172|20096998|P3|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153056|NCT02603172|20096999|P2|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153057|NCT02603172|20097000|P1|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153058|NCT02603172|20096993|P8|COMPLETED|Part C (Approximately 13 Weeks)||0
8153059|NCT02603172|20096994|P7|COMPLETED|Part C (Approximately 13 Weeks)||0
8153060|NCT02603172|20096995|P6|COMPLETED|Part C (Approximately 13 Weeks)||0
8153061|NCT02603172|20096996|P5|COMPLETED|Part C (Approximately 13 Weeks)||0
8153062|NCT02603172|20096997|P4|COMPLETED|Part C (Approximately 13 Weeks)||0
8153063|NCT02603172|20096998|P3|COMPLETED|Part C (Approximately 13 Weeks)||0
8153064|NCT02603172|20096999|P2|COMPLETED|Part C (Approximately 13 Weeks)||0
8153065|NCT02603172|20097000|P1|COMPLETED|Part C (Approximately 13 Weeks)||0
8153066|NCT02603172|20096993|P8|STARTED|Part C (Approximately 13 Weeks)||0
8153067|NCT02603172|20096994|P7|STARTED|Part C (Approximately 13 Weeks)||0
8153068|NCT02603172|20096995|P6|STARTED|Part C (Approximately 13 Weeks)||0
8153069|NCT02603172|20096996|P5|STARTED|Part C (Approximately 13 Weeks)||0
8153070|NCT02603172|20096997|P4|STARTED|Part C (Approximately 13 Weeks)||0
8153071|NCT02603172|20096998|P3|STARTED|Part C (Approximately 13 Weeks)||0
8153072|NCT02603172|20096999|P2|STARTED|Part C (Approximately 13 Weeks)||0
8153073|NCT02603172|20097000|P1|STARTED|Part C (Approximately 13 Weeks)||0
8153074|NCT02603172|20096993|P8|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153075|NCT02603172|20096994|P7|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153076|NCT02603172|20096995|P6|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153077|NCT02603172|20096996|P5|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153078|NCT02603172|20096997|P4|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153079|NCT02603172|20096998|P3|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153080|NCT02603172|20096999|P2|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153081|NCT02603172|20097000|P1|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153082|NCT02603172|20096993|P8|COMPLETED|Part B (Approximately 7 Weeks)||0
8153083|NCT02603172|20096994|P7|COMPLETED|Part B (Approximately 7 Weeks)||0
8153084|NCT02603172|20096995|P6|COMPLETED|Part B (Approximately 7 Weeks)||0
8153085|NCT02603172|20096996|P5|COMPLETED|Part B (Approximately 7 Weeks)||6
8153086|NCT02603172|20096997|P4|COMPLETED|Part B (Approximately 7 Weeks)||1
8153087|NCT02603172|20096998|P3|COMPLETED|Part B (Approximately 7 Weeks)||0
8153088|NCT02603172|20096999|P2|COMPLETED|Part B (Approximately 7 Weeks)||1
8153089|NCT02603172|20097000|P1|COMPLETED|Part B (Approximately 7 Weeks)||0
8153090|NCT02603172|20096993|P8|STARTED|Part B (Approximately 7 Weeks)||0
8153091|NCT02603172|20096994|P7|STARTED|Part B (Approximately 7 Weeks)||0
8153092|NCT02603172|20096995|P6|STARTED|Part B (Approximately 7 Weeks)||0
8153093|NCT02603172|20096996|P5|STARTED|Part B (Approximately 7 Weeks)||6
8153094|NCT02603172|20096997|P4|STARTED|Part B (Approximately 7 Weeks)||1
8153095|NCT02603172|20096998|P3|STARTED|Part B (Approximately 7 Weeks)||0
8153096|NCT02603172|20096999|P2|STARTED|Part B (Approximately 7 Weeks)||1
8153097|NCT02603172|20097000|P1|STARTED|Part B (Approximately 7 Weeks)||0
8153098|NCT02603172|20096993|P8|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153099|NCT02603172|20096994|P7|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153100|NCT02603172|20096995|P6|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153101|NCT02603172|20096996|P5|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153102|NCT02603172|20096997|P4|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153103|NCT02603172|20096998|P3|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
8153104|NCT02603172|20096999|P2|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153105|NCT02603172|20097000|P1|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153106|NCT02603172|20096993|P8|COMPLETED|Part A (Approximately 16 Weeks)||0
8153107|NCT02603172|20096994|P7|COMPLETED|Part A (Approximately 16 Weeks)||0
8153108|NCT02603172|20096995|P6|COMPLETED|Part A (Approximately 16 Weeks)||0
8153109|NCT02603172|20096996|P5|COMPLETED|Part A (Approximately 16 Weeks)||0
8153110|NCT02603172|20096997|P4|COMPLETED|Part A (Approximately 16 Weeks)||1
8153111|NCT02603172|20096998|P3|COMPLETED|Part A (Approximately 16 Weeks)||7
8153112|NCT02603172|20096999|P2|COMPLETED|Part A (Approximately 16 Weeks)||1
8153113|NCT02603172|20097000|P1|COMPLETED|Part A (Approximately 16 Weeks)||7
8153114|NCT02603172|20096993|P8|STARTED|Part A (Approximately 16 Weeks)||0
8153115|NCT02603172|20096994|P7|STARTED|Part A (Approximately 16 Weeks)||0
8153116|NCT02603172|20096995|P6|STARTED|Part A (Approximately 16 Weeks)||0
8153117|NCT02603172|20096996|P5|STARTED|Part A (Approximately 16 Weeks)||0
8153118|NCT02603172|20096997|P4|STARTED|Part A (Approximately 16 Weeks)||1
8153119|NCT02603172|20096998|P3|STARTED|Part A (Approximately 16 Weeks)||8
8153120|NCT02603172|20096999|P2|STARTED|Part A (Approximately 16 Weeks)||1
8153121|NCT02603172|20097000|P1|STARTED|Part A (Approximately 16 Weeks)||7
8153122|NCT02603120|20097128|P2|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
8153123|NCT02603120|20097129|P1|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
8153124|NCT02603120|20097128|P2|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
8153125|NCT02603120|20097129|P1|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
8153126|NCT02603120|20097128|P2|STARTED|OL Extension B/F/TAF Treatment Phase||265
8153127|NCT02603120|20097129|P1|STARTED|OL Extension B/F/TAF Treatment Phase||259
8153128|NCT02603120|20097128|P2|NOT COMPLETED|Double-Blind Treatment Phase||16
8153129|NCT02603120|20097129|P1|NOT COMPLETED|Double-Blind Treatment Phase||19
8153130|NCT02603120|20097128|P2|COMPLETED|Double-Blind Treatment Phase||267
8153131|NCT02603120|20097129|P1|COMPLETED|Double-Blind Treatment Phase||265
8153132|NCT02603120|20097128|P2|STARTED|Double-Blind Treatment Phase||283
8153133|NCT02603120|20097129|P1|STARTED|Double-Blind Treatment Phase||284
8153134|NCT02603107|20097151|P2|NOT COMPLETED|Optional Extension Phase||13
8153135|NCT02603107|20097152|P1|NOT COMPLETED|Optional Extension Phase||9
8153136|NCT02603107|20097151|P2|COMPLETED|Optional Extension Phase||232
8153137|NCT02603107|20097152|P1|COMPLETED|Optional Extension Phase||263
8153138|NCT02603107|20097151|P2|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
8153139|NCT02603107|20097152|P1|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
8153140|NCT02603107|20097151|P2|NOT COMPLETED|Randomized Phase||21
8153141|NCT02603107|20097152|P1|NOT COMPLETED|Randomized Phase||15
8153142|NCT02603107|20097151|P2|COMPLETED|Randomized Phase||266
8153143|NCT02603107|20097152|P1|COMPLETED|Randomized Phase||275
8153144|NCT02603107|20097151|P2|STARTED|Randomized Phase||287
8153145|NCT02603107|20097152|P1|STARTED|Randomized Phase||290
8153146|NCT02602496|20097167|P3|NOT COMPLETED|Overall Study||0
8153147|NCT02602496|20097168|P2|NOT COMPLETED|Overall Study||2
8153148|NCT02602496|20097169|P1|NOT COMPLETED|Overall Study||1
8153149|NCT02602496|20097167|P3|COMPLETED|Overall Study||17
8153150|NCT02602496|20097168|P2|COMPLETED|Overall Study||18
8153151|NCT02602496|20097169|P1|COMPLETED|Overall Study||14
8153152|NCT02602496|20097167|P3|STARTED|Overall Study||17
8153153|NCT02602496|20097168|P2|STARTED|Overall Study||20
8153154|NCT02602496|20097169|P1|STARTED|Overall Study||15
8153155|NCT02602223|20097198|P1|NOT COMPLETED|Overall Study||0
8153156|NCT02602223|20097198|P1|COMPLETED|Overall Study||9
8153157|NCT02602223|20097198|P1|STARTED|Overall Study||9
8153158|NCT02602080|20097217|P3|NOT COMPLETED|Overall Study||3
8153159|NCT02602080|20097218|P2|NOT COMPLETED|Overall Study||1
8153160|NCT02602080|20097219|P1|NOT COMPLETED|Overall Study||6
8153161|NCT02602080|20097217|P3|COMPLETED|Overall Study||15
8153162|NCT02602080|20097218|P2|COMPLETED|Overall Study||15
8153163|NCT02602080|20097219|P1|COMPLETED|Overall Study||15
8153164|NCT02602080|20097217|P3|STARTED|Overall Study||18
8153165|NCT02602080|20097218|P2|STARTED|Overall Study||16
8153166|NCT02602080|20097219|P1|STARTED|Overall Study||21
8153167|NCT02601976|20097254|P1|NOT COMPLETED|Overall Study||0
8153168|NCT02601976|20097254|P1|COMPLETED|Overall Study||64
8153169|NCT02601976|20097254|P1|STARTED|Overall Study||64
8153170|NCT02601820|20097262|P1|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
8153171|NCT02601820|20097262|P1|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
8153172|NCT02601820|20097262|P1|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
8153173|NCT02601820|20097262|P1|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
8153174|NCT02601820|20097262|P1|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
8153175|NCT02601820|20097262|P1|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
8153176|NCT02601820|20097262|P1|NOT COMPLETED|Late On-Treatment (T3)||49
8153177|NCT02601820|20097262|P1|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
8153178|NCT02601820|20097262|P1|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
8153179|NCT02601820|20097262|P1|NOT COMPLETED|Early On-Treatment (T2)||51
8153180|NCT02601820|20097262|P1|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
8153181|NCT02601820|20097262|P1|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
8153182|NCT02601820|20097262|P1|NOT COMPLETED|Pre-Treatment (T1)||0
8153183|NCT02601820|20097262|P1|COMPLETED|Pre-Treatment (T1)||1601
8153184|NCT02601820|20097262|P1|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
8153185|NCT02601625|20097291|P4|NOT COMPLETED|Overall Study||1
8153186|NCT02601625|20097292|P3|NOT COMPLETED|Overall Study||1
8153187|NCT02601625|20097293|P2|NOT COMPLETED|Overall Study||0
8153188|NCT02601625|20097294|P1|NOT COMPLETED|Overall Study||0
8153189|NCT02601625|20097291|P4|COMPLETED|Overall Study||11
8153190|NCT02601625|20097292|P3|COMPLETED|Overall Study||5
8153191|NCT02601625|20097293|P2|COMPLETED|Overall Study||6
8153192|NCT02601625|20097294|P1|COMPLETED|Overall Study||6
8153193|NCT02601625|20097291|P4|STARTED|Overall Study||12
8153194|NCT02601625|20097292|P3|STARTED|Overall Study||6
8153195|NCT02601625|20097293|P2|STARTED|Overall Study||6
8153196|NCT02601625|20097294|P1|STARTED|Overall Study||6
8153197|NCT02601573|20097347|P5|NOT COMPLETED|Overall Study||2
8153198|NCT02601573|20097348|P4|NOT COMPLETED|Overall Study||1
8153199|NCT02601573|20097349|P3|NOT COMPLETED|Overall Study||1
8153200|NCT02601573|20097350|P2|NOT COMPLETED|Overall Study||4
8153201|NCT02601573|20097351|P1|NOT COMPLETED|Overall Study||0
8153202|NCT02601573|20097347|P5|COMPLETED|Overall Study||16
8153203|NCT02601573|20097348|P4|COMPLETED|Overall Study||17
8153204|NCT02601573|20097349|P3|COMPLETED|Overall Study||16
8153205|NCT02601573|20097350|P2|COMPLETED|Overall Study||20
8153206|NCT02601573|20097351|P1|COMPLETED|Overall Study||23
8153207|NCT02601573|20097347|P5|STARTED|Overall Study|Number randomized and treated.|18
8153208|NCT02601573|20097348|P4|STARTED|Overall Study|Number randomized and treated.|18
8153209|NCT02601573|20097349|P3|STARTED|Overall Study|Number randomized and treated.|17
8153210|NCT02601573|20097350|P2|STARTED|Overall Study|Number randomized and treated.|24
8153211|NCT02601573|20097351|P1|STARTED|Overall Study|Number randomized and treated.|23
8153212|NCT02601560|20097386|P8|NOT COMPLETED|Overall Study||0
8153213|NCT02601560|20097387|P7|NOT COMPLETED|Overall Study||1
8153214|NCT02601560|20097388|P6|NOT COMPLETED|Overall Study||0
8153215|NCT02601560|20097389|P5|NOT COMPLETED|Overall Study||0
8153216|NCT02601560|20097390|P4|NOT COMPLETED|Overall Study||0
8153217|NCT02601560|20097391|P3|NOT COMPLETED|Overall Study||0
8153218|NCT02601560|20097392|P2|NOT COMPLETED|Overall Study||0
8153219|NCT02601560|20097393|P1|NOT COMPLETED|Overall Study||0
8153220|NCT02601560|20097386|P8|COMPLETED|Overall Study||6
8153221|NCT02601560|20097387|P7|COMPLETED|Overall Study||5
8153222|NCT02601560|20097388|P6|COMPLETED|Overall Study||4
8153223|NCT02601560|20097389|P5|COMPLETED|Overall Study||6
8153224|NCT02601560|20097390|P4|COMPLETED|Overall Study||6
8153225|NCT02601560|20097391|P3|COMPLETED|Overall Study||6
8153226|NCT02601560|20097392|P2|COMPLETED|Overall Study||6
8153227|NCT02601560|20097393|P1|COMPLETED|Overall Study||8
8153228|NCT02601560|20097386|P8|STARTED|Overall Study||6
8153229|NCT02601560|20097387|P7|STARTED|Overall Study||6
8153230|NCT02601560|20097388|P6|STARTED|Overall Study||4
8153231|NCT02601560|20097389|P5|STARTED|Overall Study||6
8153232|NCT02601560|20097390|P4|STARTED|Overall Study||6
8153233|NCT02601560|20097391|P3|STARTED|Overall Study||6
8153234|NCT02601560|20097392|P2|STARTED|Overall Study||6
8153235|NCT02601560|20097393|P1|STARTED|Overall Study||8
8153236|NCT02601469|20097577|P2|NOT COMPLETED|Overall Study||0
8153237|NCT02601469|20097578|P1|NOT COMPLETED|Overall Study||1
8153238|NCT02601469|20097577|P2|COMPLETED|Overall Study||1
8153239|NCT02601469|20097578|P1|COMPLETED|Overall Study||24
8153240|NCT02601469|20097577|P2|STARTED|Overall Study||1
8153241|NCT02601469|20097578|P1|STARTED|Overall Study||25
8153251|NCT02601300|20097608|P1|NOT COMPLETED|Extension Phase||17
8153252|NCT02601300|20097608|P1|COMPLETED|Extension Phase||18
8153253|NCT02601300|20097608|P1|Treated With IP|Extension Phase||34
8153254|NCT02601300|20097608|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
8153255|NCT02601300|20097608|P1|NOT COMPLETED|Induction Phase||3
8153256|NCT02601300|20097608|P1|COMPLETED|Induction Phase||38
8153257|NCT02601300|20097608|P1|STARTED|Induction Phase||41
8153258|NCT02601209|20097628|P9|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
8153259|NCT02601209|20097629|P8|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
8153260|NCT02601209|20097630|P7|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8153261|NCT02601209|20097631|P6|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8153262|NCT02601209|20097632|P5|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8153263|NCT02601209|20097633|P4|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8153264|NCT02601209|20097634|P3|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8153265|NCT02601209|20097635|P2|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8153266|NCT02601209|20097636|P1|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8153267|NCT02601209|20097628|P9|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
8153268|NCT02601209|20097629|P8|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
8153269|NCT02601209|20097630|P7|COMPLETED|Optional Crossover (Up to 2 Months)||0
8153270|NCT02601209|20097631|P6|COMPLETED|Optional Crossover (Up to 2 Months)||0
8153271|NCT02601209|20097632|P5|COMPLETED|Optional Crossover (Up to 2 Months)||0
8153272|NCT02601209|20097633|P4|COMPLETED|Optional Crossover (Up to 2 Months)||0
8153273|NCT02601209|20097634|P3|COMPLETED|Optional Crossover (Up to 2 Months)||0
8153274|NCT02601209|20097635|P2|COMPLETED|Optional Crossover (Up to 2 Months)||0
8153275|NCT02601209|20097636|P1|COMPLETED|Optional Crossover (Up to 2 Months)||0
8153276|NCT02601209|20097628|P9|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
8153277|NCT02601209|20097629|P8|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
8153278|NCT02601209|20097630|P7|STARTED|Optional Crossover (Up to 2 Months)||0
8153279|NCT02601209|20097631|P6|STARTED|Optional Crossover (Up to 2 Months)||0
8153280|NCT02601209|20097632|P5|STARTED|Optional Crossover (Up to 2 Months)||0
8153281|NCT02601209|20097633|P4|STARTED|Optional Crossover (Up to 2 Months)||0
8153282|NCT02601209|20097634|P3|STARTED|Optional Crossover (Up to 2 Months)||0
8153283|NCT02601209|20097635|P2|STARTED|Optional Crossover (Up to 2 Months)||0
8153284|NCT02601209|20097636|P1|STARTED|Optional Crossover (Up to 2 Months)||0
8153285|NCT02601209|20097628|P9|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
8153286|NCT02601209|20097629|P8|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
8153287|NCT02601209|20097630|P7|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8153288|NCT02601209|20097631|P6|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
8153289|NCT02601209|20097632|P5|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8153290|NCT02601209|20097633|P4|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
8153291|NCT02601209|20097634|P3|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8153292|NCT02601209|20097635|P2|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8153293|NCT02601209|20097636|P1|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8153294|NCT02601209|20097628|P9|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
8153295|NCT02601209|20097629|P8|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
8153296|NCT02601209|20097630|P7|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
8153297|NCT02601209|20097631|P6|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
8153298|NCT02601209|20097632|P5|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
8153299|NCT02601209|20097633|P4|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
8153386|NCT02600351|20097841|P4|COMPLETED|Overall Study||22
8153300|NCT02601209|20097634|P3|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
8153301|NCT02601209|20097635|P2|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
8153302|NCT02601209|20097636|P1|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
8153303|NCT02601209|20097628|P9|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
8153304|NCT02601209|20097629|P8|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
8153305|NCT02601209|20097630|P7|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
8153306|NCT02601209|20097631|P6|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
8153307|NCT02601209|20097632|P5|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
8153308|NCT02601209|20097633|P4|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
8153309|NCT02601209|20097634|P3|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
8153310|NCT02601209|20097635|P2|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
8153311|NCT02601209|20097636|P1|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
8153312|NCT02601170|20097664|P2|NOT COMPLETED|Overall Study||0
8153313|NCT02601170|20097665|P1|NOT COMPLETED|Overall Study||0
8153314|NCT02601170|20097664|P2|COMPLETED|Overall Study||11
8153315|NCT02601170|20097665|P1|COMPLETED|Overall Study||11
8153316|NCT02601170|20097664|P2|STARTED|Overall Study||11
8153317|NCT02601170|20097665|P1|STARTED|Overall Study||11
8153318|NCT02600923|20097683|P1|NOT COMPLETED|Overall Study||131
8153319|NCT02600923|20097683|P1|COMPLETED|Overall Study||0
8153320|NCT02600923|20097683|P1|Treated|Overall Study||130
8153321|NCT02600923|20097683|P1|STARTED|Overall Study||131
8153322|NCT02600871|20097693|P2|NOT COMPLETED|Overall Study||10
8153323|NCT02600871|20097694|P1|NOT COMPLETED|Overall Study||13
8153324|NCT02600871|20097693|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
8153325|NCT02600871|20097694|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
8153326|NCT02600871|20097693|P2|STARTED|Overall Study||49
8153327|NCT02600871|20097694|P1|STARTED|Overall Study||52
8153328|NCT02600845|20097704|P1|NOT COMPLETED|Overall Study||18
8153329|NCT02600845|20097704|P1|COMPLETED|Overall Study||104
8153330|NCT02600845|20097704|P1|STARTED|Overall Study||122
8153331|NCT02600819|20097719|P2|NOT COMPLETED|BVY OL Extension Phase||0
8153332|NCT02600819|20097720|P1|NOT COMPLETED|BVY OL Extension Phase||0
8153333|NCT02600819|20097719|P2|COMPLETED|BVY OL Extension Phase||10
8153334|NCT02600819|20097720|P1|COMPLETED|BVY OL Extension Phase||0
8153335|NCT02600819|20097719|P2|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
8153336|NCT02600819|20097720|P1|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
8153337|NCT02600819|20097719|P2|NOT COMPLETED|GEN Phase||0
8153338|NCT02600819|20097720|P1|NOT COMPLETED|GEN Phase||16
8153339|NCT02600819|20097719|P2|COMPLETED|GEN Phase||0
8153340|NCT02600819|20097720|P1|COMPLETED|GEN Phase||39
8153341|NCT02600819|20097719|P2|STARTED|GEN Phase||0
8153342|NCT02600819|20097720|P1|STARTED|GEN Phase||55
8153343|NCT02600767|20097740|P1|NOT COMPLETED|Overall Study||5
8153344|NCT02600767|20097740|P1|COMPLETED|Overall Study||74
8153345|NCT02600767|20097740|P1|STARTED|Overall Study||79
8153346|NCT02600715|20097746|P2|NOT COMPLETED|Overall Study||0
8153347|NCT02600715|20097747|P1|NOT COMPLETED|Overall Study||0
8153348|NCT02600715|20097746|P2|COMPLETED|Overall Study||13
8153349|NCT02600715|20097747|P1|COMPLETED|Overall Study||13
8153350|NCT02600715|20097746|P2|Completed 2-week Follow-up Appointment|Overall Study||12
8153351|NCT02600715|20097747|P1|Completed 2-week Follow-up Appointment|Overall Study||13
8153352|NCT02600715|20097746|P2|Received Treatment and Suppository|Overall Study||13
8153353|NCT02600715|20097747|P1|Received Treatment and Suppository|Overall Study||13
8153354|NCT02600715|20097746|P2|Allocated to Randomization|Overall Study||13
8153355|NCT02600715|20097747|P1|Allocated to Randomization|Overall Study||13
8153356|NCT02600715|20097746|P2|STARTED|Overall Study||13
8153357|NCT02600715|20097747|P1|STARTED|Overall Study||13
8153358|NCT02600637|20097778|P2|NOT COMPLETED|Overall Study||5
8153359|NCT02600637|20097779|P1|NOT COMPLETED|Overall Study||5
8153360|NCT02600637|20097778|P2|COMPLETED|Overall Study||13
8153361|NCT02600637|20097779|P1|COMPLETED|Overall Study||14
8153362|NCT02600637|20097778|P2|STARTED|Overall Study||18
8153363|NCT02600637|20097779|P1|STARTED|Overall Study||19
8153364|NCT02600611|20097791|P2|NOT COMPLETED|Overall Study||0
8153365|NCT02600611|20097792|P1|NOT COMPLETED|Overall Study||2
8153366|NCT02600611|20097791|P2|COMPLETED|Overall Study||300
8153367|NCT02600611|20097792|P1|COMPLETED|Overall Study||298
8153368|NCT02600611|20097791|P2|STARTED|Overall Study||300
8153369|NCT02600611|20097792|P1|STARTED|Overall Study||300
8153370|NCT02600559|20097800|P1|NOT COMPLETED|Overall Study||23
8153371|NCT02600559|20097800|P1|COMPLETED|Overall Study||478
8153372|NCT02600559|20097800|P1|STARTED|Overall Study||501
8153373|NCT02600403|20097812|P3|NOT COMPLETED|Overall Study||0
8153374|NCT02600403|20097813|P2|NOT COMPLETED|Overall Study||0
8153375|NCT02600403|20097814|P1|NOT COMPLETED|Overall Study||0
8153376|NCT02600403|20097812|P3|COMPLETED|Overall Study||11
8153377|NCT02600403|20097813|P2|COMPLETED|Overall Study||6
8153378|NCT02600403|20097814|P1|COMPLETED|Overall Study||44
8153379|NCT02600403|20097812|P3|STARTED|Overall Study||11
8153380|NCT02600403|20097813|P2|STARTED|Overall Study||6
8153381|NCT02600403|20097814|P1|STARTED|Overall Study||44
8153382|NCT02600351|20097841|P4|NOT COMPLETED|Overall Study||5
8153383|NCT02600351|20097842|P3|NOT COMPLETED|Overall Study||6
8153384|NCT02600351|20097843|P2|NOT COMPLETED|Overall Study||0
8153385|NCT02600351|20097844|P1|NOT COMPLETED|Overall Study||5
8153387|NCT02600351|20097842|P3|COMPLETED|Overall Study||20
8153388|NCT02600351|20097843|P2|COMPLETED|Overall Study||17
8153389|NCT02600351|20097844|P1|COMPLETED|Overall Study||12
8153390|NCT02600351|20097841|P4|STARTED|Overall Study||27
8153391|NCT02600351|20097842|P3|STARTED|Overall Study||26
8153392|NCT02600351|20097843|P2|STARTED|Overall Study||17
8153393|NCT02600351|20097844|P1|STARTED|Overall Study||17
8153394|NCT02600325|20097874|P1|NOT COMPLETED|Overall Study||0
8153395|NCT02600325|20097874|P1|COMPLETED|Overall Study||80
8153396|NCT02600325|20097874|P1|STARTED|Overall Study||80
8153397|NCT02599961|20097879|P1|NOT COMPLETED|Overall Study||15
8153398|NCT02599961|20097879|P1|COMPLETED|Overall Study||0
8153399|NCT02599961|20097879|P1|STARTED|Overall Study||15
8153400|NCT02599766|20097889|P1|NOT COMPLETED|Overall Study||3
8153401|NCT02599766|20097889|P1|COMPLETED|Overall Study||19
8153402|NCT02599766|20097889|P1|STARTED|Overall Study||22
8153403|NCT02599688|20097921|P1|NOT COMPLETED|Overall Study||4
8153404|NCT02599688|20097921|P1|COMPLETED|Overall Study||14
8153405|NCT02599688|20097921|P1|STARTED|Overall Study||18
8153406|NCT02599649|20097929|P4|NOT COMPLETED|Overall Study||0
8153407|NCT02599649|20097930|P3|NOT COMPLETED|Overall Study||0
8153408|NCT02599649|20097931|P2|NOT COMPLETED|Overall Study||0
8153409|NCT02599649|20097932|P1|NOT COMPLETED|Overall Study||0
8153410|NCT02599649|20097929|P4|COMPLETED|Overall Study||0
8153411|NCT02599649|20097930|P3|COMPLETED|Overall Study||8
8153412|NCT02599649|20097931|P2|COMPLETED|Overall Study||0
8153413|NCT02599649|20097932|P1|COMPLETED|Overall Study||2
8153414|NCT02599649|20097929|P4|STARTED|Overall Study||0
8153415|NCT02599649|20097930|P3|STARTED|Overall Study||8
8153416|NCT02599649|20097931|P2|STARTED|Overall Study||0
8153417|NCT02599649|20097932|P1|STARTED|Overall Study||2
8153418|NCT02599441|20097942|P1|NOT COMPLETED|Overall Study||0
8153419|NCT02599441|20097942|P1|COMPLETED|Overall Study||9
8153420|NCT02599441|20097942|P1|STARTED|Overall Study||9
8153421|NCT02599194|20097948|P1|NOT COMPLETED|Overall Study||0
8153422|NCT02599194|20097948|P1|COMPLETED|Overall Study||7
8153423|NCT02599194|20097948|P1|STARTED|Overall Study||7
8153424|NCT02599129|20097957|P2|NOT COMPLETED|Overall Study||3
8153425|NCT02599129|20097958|P1|NOT COMPLETED|Overall Study||5
8153426|NCT02599129|20097957|P2|COMPLETED|Overall Study||1
8153427|NCT02599129|20097958|P1|COMPLETED|Overall Study||2
8153428|NCT02599129|20097957|P2|STARTED|Overall Study||4
8153429|NCT02599129|20097958|P1|STARTED|Overall Study||7
8153430|NCT02598934|20097974|P2|NOT COMPLETED|Overall Study||22
8153431|NCT02598934|20097975|P1|NOT COMPLETED|Overall Study||19
8153432|NCT02598934|20097974|P2|COMPLETED|Overall Study||132
8153433|NCT02598934|20097975|P1|COMPLETED|Overall Study||135
8153434|NCT02598934|20097974|P2|STARTED|Overall Study||154
8153435|NCT02598934|20097975|P1|STARTED|Overall Study||154
8153436|NCT02598622|20097987|P2|NOT COMPLETED|Overall Study||0
8153437|NCT02598622|20097988|P1|NOT COMPLETED|Overall Study||6
8153438|NCT02598622|20097987|P2|COMPLETED|Overall Study||0
8153439|NCT02598622|20097988|P1|COMPLETED|Overall Study||2
8153440|NCT02598622|20097987|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
8153441|NCT02598622|20097988|P1|STARTED|Overall Study||8
8153442|NCT02598583|20097996|P2|NOT COMPLETED|Overall Study||0
8153443|NCT02598583|20097997|P1|NOT COMPLETED|Overall Study||0
8153444|NCT02598583|20097996|P2|COMPLETED|Overall Study||7
8153445|NCT02598583|20097997|P1|COMPLETED|Overall Study||6
8153446|NCT02598583|20097996|P2|STARTED|Overall Study||7
8153447|NCT02598583|20097997|P1|STARTED|Overall Study||6
8153448|NCT02598297|20098017|P2|NOT COMPLETED|Overall Study||24
8153449|NCT02598297|20098018|P1|NOT COMPLETED|Overall Study||25
8153450|NCT02598297|20098017|P2|COMPLETED|Overall Study||0
8153451|NCT02598297|20098018|P1|COMPLETED|Overall Study||0
8153452|NCT02598297|20098017|P2|Subjects Followed for Survival|Overall Study||0
8153453|NCT02598297|20098018|P1|Subjects Followed for Survival|Overall Study||1
8153454|NCT02598297|20098017|P2|Not Treted Wit Study Drug|Overall Study||0
8153455|NCT02598297|20098018|P1|Not Treted Wit Study Drug|Overall Study||1
8153456|NCT02598297|20098017|P2|STARTED|Overall Study||24
8153457|NCT02598297|20098018|P1|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
8153458|NCT02598193|20098044|P1|NOT COMPLETED|Overall Study||16
8153459|NCT02598193|20098044|P1|COMPLETED|Overall Study||73
8153460|NCT02598193|20098044|P1|STARTED|Overall Study||89
8153461|NCT02598128|20098052|P4|NOT COMPLETED|Period C: Days 12 to 20||0
8153462|NCT02598128|20098053|P3|NOT COMPLETED|Period C: Days 12 to 20||0
8153463|NCT02598128|20098054|P2|NOT COMPLETED|Period C: Days 12 to 20||0
8153464|NCT02598128|20098055|P1|NOT COMPLETED|Period C: Days 12 to 20||0
8153465|NCT02598128|20098052|P4|COMPLETED|Period C: Days 12 to 20||33
8153466|NCT02598128|20098053|P3|COMPLETED|Period C: Days 12 to 20||0
8153467|NCT02598128|20098054|P2|COMPLETED|Period C: Days 12 to 20||0
8153468|NCT02598128|20098055|P1|COMPLETED|Period C: Days 12 to 20||0
8153469|NCT02598128|20098052|P4|STARTED|Period C: Days 12 to 20||33
8153470|NCT02598128|20098053|P3|STARTED|Period C: Days 12 to 20||0
8153471|NCT02598128|20098054|P2|STARTED|Period C: Days 12 to 20||0
8153472|NCT02598128|20098055|P1|STARTED|Period C: Days 12 to 20||0
8153473|NCT02598128|20098052|P4|NOT COMPLETED|Period B: Days 1 to 11||0
8153474|NCT02598128|20098053|P3|NOT COMPLETED|Period B: Days 1 to 11||0
8153475|NCT02598128|20098054|P2|NOT COMPLETED|Period B: Days 1 to 11||0
8153476|NCT02598128|20098055|P1|NOT COMPLETED|Period B: Days 1 to 11||0
8153477|NCT02598128|20098052|P4|COMPLETED|Period B: Days 1 to 11||0
8153478|NCT02598128|20098053|P3|COMPLETED|Period B: Days 1 to 11||16
8153479|NCT02598128|20098054|P2|COMPLETED|Period B: Days 1 to 11||17
8153480|NCT02598128|20098055|P1|COMPLETED|Period B: Days 1 to 11||0
8153481|NCT02598128|20098052|P4|STARTED|Period B: Days 1 to 11||0
8153482|NCT02598128|20098053|P3|STARTED|Period B: Days 1 to 11||16
8153483|NCT02598128|20098054|P2|STARTED|Period B: Days 1 to 11||17
8153484|NCT02598128|20098055|P1|STARTED|Period B: Days 1 to 11||0
8153485|NCT02598128|20098052|P4|NOT COMPLETED|Period A: Days -7 to -1||0
8153486|NCT02598128|20098053|P3|NOT COMPLETED|Period A: Days -7 to -1||0
8153487|NCT02598128|20098054|P2|NOT COMPLETED|Period A: Days -7 to -1||0
8153488|NCT02598128|20098055|P1|NOT COMPLETED|Period A: Days -7 to -1||1
8153489|NCT02598128|20098052|P4|COMPLETED|Period A: Days -7 to -1||0
8153490|NCT02598128|20098053|P3|COMPLETED|Period A: Days -7 to -1||0
8153491|NCT02598128|20098054|P2|COMPLETED|Period A: Days -7 to -1||0
8153492|NCT02598128|20098055|P1|COMPLETED|Period A: Days -7 to -1||33
8153493|NCT02598128|20098052|P4|STARTED|Period A: Days -7 to -1||0
8153494|NCT02598128|20098053|P3|STARTED|Period A: Days -7 to -1||0
8153495|NCT02598128|20098054|P2|STARTED|Period A: Days -7 to -1||0
8153496|NCT02598128|20098055|P1|STARTED|Period A: Days -7 to -1||34
8153497|NCT02598089|20098069|P2|NOT COMPLETED|Overall Study||0
8153498|NCT02598089|20098070|P1|NOT COMPLETED|Overall Study||0
8153499|NCT02598089|20098069|P2|COMPLETED|Overall Study||30
8153500|NCT02598089|20098070|P1|COMPLETED|Overall Study||30
8153501|NCT02598089|20098069|P2|STARTED|Overall Study||30
8153502|NCT02598089|20098070|P1|STARTED|Overall Study||30
8153503|NCT02598076|20098098|P2|NOT COMPLETED|Overall Study||3
8153504|NCT02598076|20098099|P1|NOT COMPLETED|Overall Study||2
8153505|NCT02598076|20098098|P2|COMPLETED|Overall Study||26
8153506|NCT02598076|20098099|P1|COMPLETED|Overall Study||29
8153507|NCT02598076|20098098|P2|STARTED|Overall Study||29
8153508|NCT02598076|20098099|P1|STARTED|Overall Study||31
8153509|NCT02597946|20098113|P1|NOT COMPLETED|Overall Study||18
8153510|NCT02597946|20098113|P1|COMPLETED|Overall Study||0
8153511|NCT02597946|20098113|P1|STARTED|Overall Study||18
8153512|NCT02597933|20098124|P2|NOT COMPLETED|Overall Study||51
8153513|NCT02597933|20098125|P1|NOT COMPLETED|Overall Study||38
8153514|NCT02597933|20098124|P2|COMPLETED|Overall Study||239
8153515|NCT02597933|20098125|P1|COMPLETED|Overall Study||252
8153516|NCT02597933|20098124|P2|Treated Patients|Overall Study||288
8153517|NCT02597933|20098125|P1|Treated Patients|Overall Study||288
8153518|NCT02597933|20098124|P2|STARTED|Overall Study|Started are randomised|290
8153519|NCT02597933|20098125|P1|STARTED|Overall Study|Started are randomised|290
8153520|NCT02597920|20098156|P3|NOT COMPLETED|Overall Study||6
8153521|NCT02597920|20098157|P2|NOT COMPLETED|Overall Study||84
8153522|NCT02597920|20098158|P1|NOT COMPLETED|Overall Study||41
8153523|NCT02597920|20098156|P3|COMPLETED|Overall Study||72
8153524|NCT02597920|20098157|P2|COMPLETED|Overall Study||1075
8153525|NCT02597920|20098158|P1|COMPLETED|Overall Study||544
8153526|NCT02597920|20098156|P3|STARTED|Overall Study||78
8153527|NCT02597920|20098157|P2|STARTED|Overall Study||1159
8153528|NCT02597920|20098158|P1|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
8153529|NCT02597907|20098183|P2|NOT COMPLETED|Overall Study||0
8153530|NCT02597907|20098184|P1|NOT COMPLETED|Overall Study||0
8153531|NCT02597907|20098183|P2|COMPLETED|Overall Study||44
8153532|NCT02597907|20098184|P1|COMPLETED|Overall Study||44
8153533|NCT02597907|20098183|P2|STARTED|Overall Study||44
8153534|NCT02597907|20098184|P1|STARTED|Overall Study||44
8153535|NCT02597855|20098192|P2|NOT COMPLETED|Overall Study||1
8153536|NCT02597855|20098193|P1|NOT COMPLETED|Overall Study||2
8153537|NCT02597855|20098192|P2|COMPLETED|Overall Study||13
8153538|NCT02597855|20098193|P1|COMPLETED|Overall Study||16
8153539|NCT02597855|20098192|P2|STARTED|Overall Study||14
8153540|NCT02597855|20098193|P1|STARTED|Overall Study||18
8153541|NCT02597673|20098205|P4|NOT COMPLETED|Overall Study||5
8153542|NCT02597673|20098206|P3|NOT COMPLETED|Overall Study||5
8153543|NCT02597673|20098207|P2|NOT COMPLETED|Overall Study||6
8153544|NCT02597673|20098208|P1|NOT COMPLETED|Overall Study||3
8153545|NCT02597673|20098205|P4|COMPLETED|Overall Study||25
8153546|NCT02597673|20098206|P3|COMPLETED|Overall Study||28
8153547|NCT02597673|20098207|P2|COMPLETED|Overall Study||27
8153548|NCT02597673|20098208|P1|COMPLETED|Overall Study||31
8153549|NCT02597673|20098205|P4|STARTED|Overall Study||30
8153550|NCT02597673|20098206|P3|STARTED|Overall Study||33
8153551|NCT02597673|20098207|P2|STARTED|Overall Study||33
8153552|NCT02597673|20098208|P1|STARTED|Overall Study||34
8153553|NCT02597582|20098260|P2|NOT COMPLETED|Overall Study||0
8153554|NCT02597582|20098261|P1|NOT COMPLETED|Overall Study||0
8153555|NCT02597582|20098260|P2|COMPLETED|Overall Study||20
8153556|NCT02597582|20098261|P1|COMPLETED|Overall Study||21
8153557|NCT02597582|20098260|P2|STARTED|Overall Study||20
8153558|NCT02597582|20098261|P1|STARTED|Overall Study||21
8153559|NCT02597543|20098279|P2|NOT COMPLETED|Overall Study||0
8153560|NCT02597543|20098280|P1|NOT COMPLETED|Overall Study||0
8153561|NCT02597543|20098279|P2|COMPLETED|Overall Study||8
8153562|NCT02597543|20098280|P1|COMPLETED|Overall Study||6
8153563|NCT02597543|20098279|P2|STARTED|Overall Study||8
8153564|NCT02597543|20098280|P1|STARTED|Overall Study||6
8153571|NCT02597452|20098313|P1|NOT COMPLETED|Overall Study||30
8153572|NCT02597452|20098313|P1|COMPLETED|Overall Study||486
8153573|NCT02597452|20098313|P1|STARTED|Overall Study||516
8153574|NCT02597127|20098331|P8|NOT COMPLETED|Overall Study||2
8153575|NCT02597127|20098332|P7|NOT COMPLETED|Overall Study||4
8153576|NCT02597127|20098333|P6|NOT COMPLETED|Overall Study||4
8153577|NCT02597127|20098334|P5|NOT COMPLETED|Overall Study||5
8153578|NCT02597127|20098335|P4|NOT COMPLETED|Overall Study||5
8153579|NCT02597127|20098336|P3|NOT COMPLETED|Overall Study||8
8153580|NCT02597127|20098337|P2|NOT COMPLETED|Overall Study||3
8153581|NCT02597127|20098338|P1|NOT COMPLETED|Overall Study||1
8153582|NCT02597127|20098331|P8|COMPLETED|Overall Study||60
8153583|NCT02597127|20098332|P7|COMPLETED|Overall Study||57
8153584|NCT02597127|20098333|P6|COMPLETED|Overall Study||59
8153585|NCT02597127|20098334|P5|COMPLETED|Overall Study||57
8153586|NCT02597127|20098335|P4|COMPLETED|Overall Study||60
8153587|NCT02597127|20098336|P3|COMPLETED|Overall Study||58
8153588|NCT02597127|20098337|P2|COMPLETED|Overall Study||59
8153589|NCT02597127|20098338|P1|COMPLETED|Overall Study||59
8153590|NCT02597127|20098331|P8|Treated|Overall Study||62
8153591|NCT02597127|20098332|P7|Treated|Overall Study||61
8153592|NCT02597127|20098333|P6|Treated|Overall Study||62
8153593|NCT02597127|20098334|P5|Treated|Overall Study||61
8153594|NCT02597127|20098335|P4|Treated|Overall Study||65
8153595|NCT02597127|20098336|P3|Treated|Overall Study||65
8153596|NCT02597127|20098337|P2|Treated|Overall Study||61
8153597|NCT02597127|20098338|P1|Treated|Overall Study||60
8153598|NCT02597127|20098331|P8|STARTED|Overall Study||62
8153599|NCT02597127|20098332|P7|STARTED|Overall Study||61
8153600|NCT02597127|20098333|P6|STARTED|Overall Study||63
8153601|NCT02597127|20098334|P5|STARTED|Overall Study||62
8153602|NCT02597127|20098335|P4|STARTED|Overall Study||65
8153603|NCT02597127|20098336|P3|STARTED|Overall Study||66
8153604|NCT02597127|20098337|P2|STARTED|Overall Study||62
8153605|NCT02597127|20098338|P1|STARTED|Overall Study||60
8153606|NCT02597062|20098425|P1|NOT COMPLETED|Overall Study||1
8153607|NCT02597062|20098425|P1|COMPLETED|Overall Study||75
8153608|NCT02597062|20098425|P1|STARTED|Overall Study||76
8153609|NCT02597049|20098434|P3|NOT COMPLETED|Overall Study||3
8153610|NCT02597049|20098435|P2|NOT COMPLETED|Overall Study||5
8153611|NCT02597049|20098436|P1|NOT COMPLETED|Overall Study||7
8153612|NCT02597049|20098434|P3|COMPLETED|Overall Study||137
8153613|NCT02597049|20098435|P2|COMPLETED|Overall Study||137
8153614|NCT02597049|20098436|P1|COMPLETED|Overall Study||135
8153615|NCT02597049|20098434|P3|Received at Least One Dose of Study Drug|Overall Study||140
8153616|NCT02597049|20098435|P2|Received at Least One Dose of Study Drug|Overall Study||141
8153617|NCT02597049|20098436|P1|Received at Least One Dose of Study Drug|Overall Study||142
8153618|NCT02597049|20098434|P3|STARTED|Overall Study||140
8153619|NCT02597049|20098435|P2|STARTED|Overall Study||142
8153620|NCT02597049|20098436|P1|STARTED|Overall Study||142
8153621|NCT02596971|20098477|P3|NOT COMPLETED|Overall Study||42
8153622|NCT02596971|20098478|P2|NOT COMPLETED|Overall Study||7
8153623|NCT02596971|20098479|P1|NOT COMPLETED|Overall Study||42
8153624|NCT02596971|20098477|P3|COMPLETED|Overall Study||0
8153625|NCT02596971|20098478|P2|COMPLETED|Overall Study||0
8153626|NCT02596971|20098479|P1|COMPLETED|Overall Study||0
8153627|NCT02596971|20098477|P3|STARTED|Overall Study||42
8153628|NCT02596971|20098478|P2|STARTED|Overall Study||7
8153629|NCT02596971|20098479|P1|STARTED|Overall Study||42
8153630|NCT02596958|20098508|P1|NOT COMPLETED|Overall Study||996
8153631|NCT02596958|20098508|P1|COMPLETED|Overall Study||0
8153632|NCT02596958|20098508|P1|STARTED|Overall Study||996
8153633|NCT02596945|20098520|P1|NOT COMPLETED|Overall Study||56
8153634|NCT02596945|20098520|P1|COMPLETED|Overall Study||167
8153635|NCT02596945|20098520|P1|Treated|Overall Study||220
8153636|NCT02596945|20098520|P1|STARTED|Overall Study||223
8153637|NCT02596906|20098528|P2|NOT COMPLETED|Overall Study||3
8153638|NCT02596906|20098529|P1|NOT COMPLETED|Overall Study||4
8153639|NCT02596906|20098528|P2|COMPLETED|Overall Study||7
8153640|NCT02596906|20098529|P1|COMPLETED|Overall Study||8
8153641|NCT02596906|20098528|P2|STARTED|Overall Study||10
8153642|NCT02596906|20098529|P1|STARTED|Overall Study||12
8153643|NCT02596893|20098541|P4|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153644|NCT02596893|20098542|P3|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153645|NCT02596893|20098543|P2|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153646|NCT02596893|20098544|P1|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153647|NCT02596893|20098541|P4|COMPLETED|Follow-Up Period Weeks 0 to 52||47
8153648|NCT02596893|20098542|P3|COMPLETED|Follow-Up Period Weeks 0 to 52||56
8153649|NCT02596893|20098543|P2|COMPLETED|Follow-Up Period Weeks 0 to 52||51
8153650|NCT02596893|20098544|P1|COMPLETED|Follow-Up Period Weeks 0 to 52||57
8153651|NCT02596893|20098541|P4|STARTED|Follow-Up Period Weeks 0 to 52||47
8153652|NCT02596893|20098542|P3|STARTED|Follow-Up Period Weeks 0 to 52||56
8153653|NCT02596893|20098543|P2|STARTED|Follow-Up Period Weeks 0 to 52||51
8153654|NCT02596893|20098544|P1|STARTED|Follow-Up Period Weeks 0 to 52||57
8153655|NCT02596893|20098541|P4|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
8153656|NCT02596893|20098542|P3|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
8153657|NCT02596893|20098543|P2|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
8153658|NCT02596893|20098544|P1|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
8153659|NCT02596893|20098541|P4|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
8153660|NCT02596893|20098542|P3|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
8153661|NCT02596893|20098543|P2|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
8153662|NCT02596893|20098544|P1|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
8153663|NCT02596893|20098541|P4|STARTED|Overall Double-Blind Period Weeks 0-52||175
8153664|NCT02596893|20098542|P3|STARTED|Overall Double-Blind Period Weeks 0-52||176
8153665|NCT02596893|20098543|P2|STARTED|Overall Double-Blind Period Weeks 0-52||176
8153666|NCT02596893|20098544|P1|STARTED|Overall Double-Blind Period Weeks 0-52||174
8153667|NCT02596867|20098598|P1|NOT COMPLETED|Overall Study||0
8153668|NCT02596867|20098598|P1|COMPLETED|Overall Study||2
8153669|NCT02596867|20098598|P1|2 Patients Prospectively Recruited|Overall Study||2
8153670|NCT02596867|20098598|P1|STARTED|Overall Study||2
8153671|NCT02596854|20098603|P1|NOT COMPLETED|Overall Study||8
8153672|NCT02596854|20098603|P1|COMPLETED|Overall Study||109
8153673|NCT02596854|20098603|P1|STARTED|Overall Study||117
8153674|NCT02596750|20098609|P2|NOT COMPLETED|30 Minutes||0
8153675|NCT02596750|20098610|P1|NOT COMPLETED|30 Minutes||0
8153676|NCT02596750|20098609|P2|COMPLETED|30 Minutes||21
8153677|NCT02596750|20098610|P1|COMPLETED|30 Minutes||21
8153678|NCT02596750|20098609|P2|STARTED|30 Minutes||21
8153679|NCT02596750|20098610|P1|STARTED|30 Minutes||21
8153680|NCT02596750|20098609|P2|NOT COMPLETED|10 Minutes||0
8153681|NCT02596750|20098610|P1|NOT COMPLETED|10 Minutes||0
8153682|NCT02596750|20098609|P2|COMPLETED|10 Minutes||21
8153683|NCT02596750|20098610|P1|COMPLETED|10 Minutes||21
8153684|NCT02596750|20098609|P2|STARTED|10 Minutes||21
8153685|NCT02596750|20098610|P1|STARTED|10 Minutes||21
8153686|NCT02596750|20098609|P2|NOT COMPLETED|5 Minutes||0
8153687|NCT02596750|20098610|P1|NOT COMPLETED|5 Minutes||0
8153688|NCT02596750|20098609|P2|COMPLETED|5 Minutes||21
8153689|NCT02596750|20098610|P1|COMPLETED|5 Minutes||21
8153690|NCT02596750|20098609|P2|STARTED|5 Minutes||21
8153691|NCT02596750|20098610|P1|STARTED|5 Minutes||21
8153692|NCT02596750|20098609|P2|NOT COMPLETED|2 Minutes||0
8153693|NCT02596750|20098610|P1|NOT COMPLETED|2 Minutes||0
8153694|NCT02596750|20098609|P2|COMPLETED|2 Minutes||21
8153695|NCT02596750|20098610|P1|COMPLETED|2 Minutes||21
8153696|NCT02596750|20098609|P2|STARTED|2 Minutes||21
8153697|NCT02596750|20098610|P1|STARTED|2 Minutes||21
8153698|NCT02596750|20098609|P2|NOT COMPLETED|Baseline||0
8153699|NCT02596750|20098610|P1|NOT COMPLETED|Baseline||0
8153700|NCT02596750|20098609|P2|COMPLETED|Baseline||21
8153701|NCT02596750|20098610|P1|COMPLETED|Baseline||21
8153702|NCT02596750|20098609|P2|STARTED|Baseline||21
8153703|NCT02596750|20098610|P1|STARTED|Baseline||21
8153704|NCT02596711|20098625|P3|NOT COMPLETED|Overall Study||3
8153705|NCT02596711|20098626|P2|NOT COMPLETED|Overall Study||2
8153706|NCT02596711|20098627|P1|NOT COMPLETED|Overall Study||1
8153707|NCT02596711|20098625|P3|COMPLETED|Overall Study||5
8153708|NCT02596711|20098626|P2|COMPLETED|Overall Study||6
8153709|NCT02596711|20098627|P1|COMPLETED|Overall Study||8
8153710|NCT02596711|20098625|P3|6 Month Follow-up|Overall Study||5
8153711|NCT02596711|20098626|P2|6 Month Follow-up|Overall Study||6
8153712|NCT02596711|20098627|P1|6 Month Follow-up|Overall Study||8
8153713|NCT02596711|20098625|P3|3 Month Follow-up|Overall Study||6
8153714|NCT02596711|20098626|P2|3 Month Follow-up|Overall Study||6
8153715|NCT02596711|20098627|P1|3 Month Follow-up|Overall Study||8
8153716|NCT02596711|20098625|P3|Visit 3|Overall Study||6
8153717|NCT02596711|20098626|P2|Visit 3|Overall Study||8
8153718|NCT02596711|20098627|P1|Visit 3|Overall Study||7
8153719|NCT02596711|20098625|P3|Visit 2|Overall Study||6
8153720|NCT02596711|20098626|P2|Visit 2|Overall Study||7
8153721|NCT02596711|20098627|P1|Visit 2|Overall Study||9
8153722|NCT02596711|20098625|P3|STARTED|Overall Study||8
8153723|NCT02596711|20098626|P2|STARTED|Overall Study||8
8153724|NCT02596711|20098627|P1|STARTED|Overall Study||9
8153725|NCT02596620|20098643|P2|NOT COMPLETED|Overall Study||1
8153726|NCT02596620|20098644|P1|NOT COMPLETED|Overall Study||1
8153727|NCT02596620|20098643|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
8153728|NCT02596620|20098644|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
8153729|NCT02596620|20098643|P2|STARTED|Overall Study|Started from 1st October 2013|82
8153730|NCT02596620|20098644|P1|STARTED|Overall Study|Started from 1st October 2013|82
8153731|NCT02596451|20098653|P3|NOT COMPLETED|Overall Study||14
8153732|NCT02596451|20098654|P2|NOT COMPLETED|Overall Study||18
8153733|NCT02596451|20098655|P1|NOT COMPLETED|Overall Study||4
8153734|NCT02596451|20098653|P3|COMPLETED|Overall Study||373
8153735|NCT02596451|20098654|P2|COMPLETED|Overall Study||374
8153736|NCT02596451|20098655|P1|COMPLETED|Overall Study||381
8153737|NCT02596451|20098653|P3|STARTED|Overall Study||387
8153738|NCT02596451|20098654|P2|STARTED|Overall Study||392
8153739|NCT02596451|20098655|P1|STARTED|Overall Study||385
8153740|NCT02596321|20098664|P2|NOT COMPLETED|Overall Study||0
8153741|NCT02596321|20098665|P1|NOT COMPLETED|Overall Study||3
8153742|NCT02596321|20098664|P2|COMPLETED|Overall Study||56
8153743|NCT02596321|20098665|P1|COMPLETED|Overall Study||53
8153744|NCT02596321|20098664|P2|STARTED|Overall Study||56
8153745|NCT02596321|20098665|P1|STARTED|Overall Study||56
8153746|NCT02596230|20098682|P5|NOT COMPLETED|Objective 2, One Year||78
8153747|NCT02596230|20098683|P4|NOT COMPLETED|Objective 2, One Year||58
8153748|NCT02596230|20098684|P3|NOT COMPLETED|Objective 2, One Year||98
8153749|NCT02596230|20098685|P2|NOT COMPLETED|Objective 2, One Year||68
8153750|NCT02596230|20098686|P1|NOT COMPLETED|Objective 2, One Year||0
8153751|NCT02596230|20098682|P5|COMPLETED|Objective 2, One Year||714
8153752|NCT02596230|20098683|P4|COMPLETED|Objective 2, One Year||471
8153753|NCT02596230|20098684|P3|COMPLETED|Objective 2, One Year||812
8153754|NCT02596230|20098685|P2|COMPLETED|Objective 2, One Year||710
8153755|NCT02596230|20098686|P1|COMPLETED|Objective 2, One Year||0
8153756|NCT02596230|20098682|P5|STARTED|Objective 2, One Year||792
8153757|NCT02596230|20098683|P4|STARTED|Objective 2, One Year||529
8153758|NCT02596230|20098684|P3|STARTED|Objective 2, One Year||910
8153759|NCT02596230|20098685|P2|STARTED|Objective 2, One Year||778
8153760|NCT02596230|20098686|P1|STARTED|Objective 2, One Year||0
8153761|NCT02596230|20098682|P5|NOT COMPLETED|Screening Period for Objective 2||0
8153762|NCT02596230|20098683|P4|NOT COMPLETED|Screening Period for Objective 2||846
8153763|NCT02596230|20098684|P3|NOT COMPLETED|Screening Period for Objective 2||0
8153764|NCT02596230|20098685|P2|NOT COMPLETED|Screening Period for Objective 2||228
8153765|NCT02596230|20098686|P1|NOT COMPLETED|Screening Period for Objective 2||3714
8153766|NCT02596230|20098682|P5|COMPLETED|Screening Period for Objective 2||792
8153767|NCT02596230|20098683|P4|COMPLETED|Screening Period for Objective 2||529
8153768|NCT02596230|20098684|P3|COMPLETED|Screening Period for Objective 2||910
8153769|NCT02596230|20098685|P2|COMPLETED|Screening Period for Objective 2||778
8153770|NCT02596230|20098686|P1|COMPLETED|Screening Period for Objective 2||0
8153771|NCT02596230|20098682|P5|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
8153772|NCT02596230|20098683|P4|STARTED|Screening Period for Objective 2||1375
8153773|NCT02596230|20098684|P3|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
8153774|NCT02596230|20098685|P2|STARTED|Screening Period for Objective 2||1006
8153775|NCT02596230|20098686|P1|STARTED|Screening Period for Objective 2||3714
8153776|NCT02596230|20098682|P5|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153777|NCT02596230|20098683|P4|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153778|NCT02596230|20098684|P3|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153779|NCT02596230|20098685|P2|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153780|NCT02596230|20098686|P1|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153781|NCT02596230|20098682|P5|COMPLETED|Objective 1, One Visit During 14 Days||0
8153782|NCT02596230|20098683|P4|COMPLETED|Objective 1, One Visit During 14 Days||1375
8153783|NCT02596230|20098684|P3|COMPLETED|Objective 1, One Visit During 14 Days||0
8153784|NCT02596230|20098685|P2|COMPLETED|Objective 1, One Visit During 14 Days||1006
8153785|NCT02596230|20098686|P1|COMPLETED|Objective 1, One Visit During 14 Days||3714
8153786|NCT02596230|20098682|P5|STARTED|Objective 1, One Visit During 14 Days||0
8153787|NCT02596230|20098683|P4|STARTED|Objective 1, One Visit During 14 Days||1375
8153788|NCT02596230|20098684|P3|STARTED|Objective 1, One Visit During 14 Days||0
8153789|NCT02596230|20098685|P2|STARTED|Objective 1, One Visit During 14 Days||1006
8153790|NCT02596230|20098686|P1|STARTED|Objective 1, One Visit During 14 Days||3714
8153791|NCT02596035|20098710|P3|NOT COMPLETED|Overall Study||1
8153792|NCT02596035|20098711|P2|NOT COMPLETED|Overall Study||44
8153793|NCT02596035|20098712|P1|NOT COMPLETED|Overall Study||86
8153794|NCT02596035|20098710|P3|COMPLETED|Overall Study||0
8153795|NCT02596035|20098711|P2|COMPLETED|Overall Study||0
8153796|NCT02596035|20098712|P1|COMPLETED|Overall Study||11
8153797|NCT02596035|20098710|P3|STARTED|Overall Study||1
8153798|NCT02596035|20098711|P2|STARTED|Overall Study||44
8153799|NCT02596035|20098712|P1|STARTED|Overall Study||97
8153800|NCT02596022|20098741|P2|NOT COMPLETED|Overall Study||0
8153801|NCT02596022|20098742|P1|NOT COMPLETED|Overall Study||0
8153802|NCT02596022|20098741|P2|COMPLETED|Overall Study||8
8153803|NCT02596022|20098742|P1|COMPLETED|Overall Study||10
8153804|NCT02596022|20098741|P2|STARTED|Overall Study||8
8153805|NCT02596022|20098742|P1|STARTED|Overall Study||10
8153806|NCT02596009|20098748|P6|NOT COMPLETED|Overall Study||0
8153807|NCT02596009|20098749|P5|NOT COMPLETED|Overall Study||0
8153808|NCT02596009|20098750|P4|NOT COMPLETED|Overall Study||0
8153809|NCT02596009|20098751|P3|NOT COMPLETED|Overall Study||0
8153810|NCT02596009|20098752|P2|NOT COMPLETED|Overall Study||1
8153811|NCT02596009|20098753|P1|NOT COMPLETED|Overall Study||0
8153812|NCT02596009|20098748|P6|COMPLETED|Overall Study||17
8153813|NCT02596009|20098749|P5|COMPLETED|Overall Study||18
8153814|NCT02596009|20098750|P4|COMPLETED|Overall Study||16
8153815|NCT02596009|20098751|P3|COMPLETED|Overall Study||16
8153816|NCT02596009|20098752|P2|COMPLETED|Overall Study||15
8153817|NCT02596009|20098753|P1|COMPLETED|Overall Study||14
8153818|NCT02596009|20098748|P6|STARTED|Overall Study||17
8153819|NCT02596009|20098749|P5|STARTED|Overall Study||18
8153820|NCT02596009|20098750|P4|STARTED|Overall Study||16
8153821|NCT02596009|20098751|P3|STARTED|Overall Study||16
8153822|NCT02596009|20098752|P2|STARTED|Overall Study||16
8153823|NCT02596009|20098753|P1|STARTED|Overall Study||14
8153824|NCT02595983|20098762|P1|NOT COMPLETED|Overall Study||4
8153825|NCT02595983|20098762|P1|COMPLETED|Overall Study||8
8153826|NCT02595983|20098762|P1|STARTED|Overall Study||12
8153827|NCT02595970|20098770|P1|NOT COMPLETED|Overall Study||20
8153828|NCT02595970|20098770|P1|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
8153829|NCT02595970|20098770|P1|STARTED|Overall Study||120
8153830|NCT02595723|20098787|P3|NOT COMPLETED|Third Intervention (4 Days)||0
8153831|NCT02595723|20098788|P2|NOT COMPLETED|Third Intervention (4 Days)||0
8153832|NCT02595723|20098789|P1|NOT COMPLETED|Third Intervention (4 Days)||0
8153833|NCT02595723|20098787|P3|COMPLETED|Third Intervention (4 Days)||7
8153834|NCT02595723|20098788|P2|COMPLETED|Third Intervention (4 Days)||5
8153835|NCT02595723|20098789|P1|COMPLETED|Third Intervention (4 Days)||6
8153836|NCT02595723|20098787|P3|STARTED|Third Intervention (4 Days)||7
8153837|NCT02595723|20098788|P2|STARTED|Third Intervention (4 Days)||5
8153838|NCT02595723|20098789|P1|STARTED|Third Intervention (4 Days)||6
8153839|NCT02595723|20098787|P3|NOT COMPLETED|Second Washout (21 Days)||0
8153840|NCT02595723|20098788|P2|NOT COMPLETED|Second Washout (21 Days)||1
8153841|NCT02595723|20098789|P1|NOT COMPLETED|Second Washout (21 Days)||0
8153842|NCT02595723|20098787|P3|COMPLETED|Second Washout (21 Days)||7
8153843|NCT02595723|20098788|P2|COMPLETED|Second Washout (21 Days)||5
8153844|NCT02595723|20098789|P1|COMPLETED|Second Washout (21 Days)||6
8153845|NCT02595723|20098787|P3|STARTED|Second Washout (21 Days)||7
8153846|NCT02595723|20098788|P2|STARTED|Second Washout (21 Days)||6
8153847|NCT02595723|20098789|P1|STARTED|Second Washout (21 Days)||6
8153848|NCT02595723|20098787|P3|NOT COMPLETED|Second Intervention (4 Days)||0
8153849|NCT02595723|20098788|P2|NOT COMPLETED|Second Intervention (4 Days)||0
8153850|NCT02595723|20098789|P1|NOT COMPLETED|Second Intervention (4 Days)||0
8153851|NCT02595723|20098787|P3|COMPLETED|Second Intervention (4 Days)||7
8153852|NCT02595723|20098788|P2|COMPLETED|Second Intervention (4 Days)||6
8153853|NCT02595723|20098789|P1|COMPLETED|Second Intervention (4 Days)||6
8153854|NCT02595723|20098787|P3|STARTED|Second Intervention (4 Days)||7
8153855|NCT02595723|20098788|P2|STARTED|Second Intervention (4 Days)||6
8153856|NCT02595723|20098789|P1|STARTED|Second Intervention (4 Days)||6
8153857|NCT02595723|20098787|P3|NOT COMPLETED|First Washout (21 Days)||0
8153858|NCT02595723|20098788|P2|NOT COMPLETED|First Washout (21 Days)||0
8153859|NCT02595723|20098789|P1|NOT COMPLETED|First Washout (21 Days)||2
8153860|NCT02595723|20098787|P3|COMPLETED|First Washout (21 Days)||7
8153861|NCT02595723|20098788|P2|COMPLETED|First Washout (21 Days)||6
8153862|NCT02595723|20098789|P1|COMPLETED|First Washout (21 Days)||6
8153863|NCT02595723|20098787|P3|STARTED|First Washout (21 Days)||7
8153864|NCT02595723|20098788|P2|STARTED|First Washout (21 Days)||6
8153865|NCT02595723|20098789|P1|STARTED|First Washout (21 Days)||8
8153866|NCT02595723|20098787|P3|NOT COMPLETED|First Intervention (4 Days)||0
8153867|NCT02595723|20098788|P2|NOT COMPLETED|First Intervention (4 Days)||0
8153868|NCT02595723|20098789|P1|NOT COMPLETED|First Intervention (4 Days)||0
8153869|NCT02595723|20098787|P3|COMPLETED|First Intervention (4 Days)||7
8153870|NCT02595723|20098788|P2|COMPLETED|First Intervention (4 Days)||6
8153871|NCT02595723|20098789|P1|COMPLETED|First Intervention (4 Days)||8
8153872|NCT02595723|20098787|P3|STARTED|First Intervention (4 Days)||7
8153873|NCT02595723|20098788|P2|STARTED|First Intervention (4 Days)||6
8153874|NCT02595723|20098789|P1|STARTED|First Intervention (4 Days)||8
8153875|NCT02595684|20098799|P2|NOT COMPLETED|Overall Study||0
8153876|NCT02595684|20098800|P1|NOT COMPLETED|Overall Study||0
8153877|NCT02595684|20098799|P2|COMPLETED|Overall Study||9
8153878|NCT02595684|20098800|P1|COMPLETED|Overall Study||9
8153879|NCT02595684|20098799|P2|STARTED|Overall Study||9
8153880|NCT02595684|20098800|P1|STARTED|Overall Study||9
8153881|NCT02595567|20098838|P1|NOT COMPLETED|Overall Study||0
8153882|NCT02595567|20098838|P1|COMPLETED|Overall Study||25
8153883|NCT02595567|20098838|P1|STARTED|Overall Study||25
8153884|NCT02595528|20098846|P4|NOT COMPLETED|Overall Study||4
8153885|NCT02595528|20098847|P3|NOT COMPLETED|Overall Study||1
8153886|NCT02595528|20098848|P2|NOT COMPLETED|Overall Study||3
8153887|NCT02595528|20098849|P1|NOT COMPLETED|Overall Study||2
8153888|NCT02595528|20098846|P4|COMPLETED|Overall Study||36
8153889|NCT02595528|20098847|P3|COMPLETED|Overall Study||41
8153890|NCT02595528|20098848|P2|COMPLETED|Overall Study||37
8153891|NCT02595528|20098849|P1|COMPLETED|Overall Study||39
8153892|NCT02595528|20098846|P4|STARTED|Overall Study||40
8153893|NCT02595528|20098847|P3|STARTED|Overall Study||42
8153894|NCT02595528|20098848|P2|STARTED|Overall Study||40
8153895|NCT02595528|20098849|P1|STARTED|Overall Study||41
8153896|NCT02595502|20098859|P2|NOT COMPLETED|Period 3||2
8153897|NCT02595502|20098860|P1|NOT COMPLETED|Period 3||1
8153898|NCT02595502|20098859|P2|COMPLETED|Period 3||136
8153899|NCT02595502|20098860|P1|COMPLETED|Period 3||140
8153900|NCT02595502|20098859|P2|STARTED|Period 3||138
8153901|NCT02595502|20098860|P1|STARTED|Period 3||141
8153902|NCT02595502|20098859|P2|NOT COMPLETED|Period 2||2
8153903|NCT02595502|20098860|P1|NOT COMPLETED|Period 2||1
8153904|NCT02595502|20098859|P2|COMPLETED|Period 2||138
8153905|NCT02595502|20098860|P1|COMPLETED|Period 2||141
8153906|NCT02595502|20098859|P2|STARTED|Period 2||140
8153907|NCT02595502|20098860|P1|STARTED|Period 2||142
8153908|NCT02595502|20098859|P2|NOT COMPLETED|Period 1||2
8153909|NCT02595502|20098860|P1|NOT COMPLETED|Period 1||1
8153910|NCT02595502|20098859|P2|COMPLETED|Period 1||140
8153911|NCT02595502|20098860|P1|COMPLETED|Period 1||142
8153912|NCT02595502|20098859|P2|STARTED|Period 1||142
8153913|NCT02595502|20098860|P1|STARTED|Period 1||143
8153914|NCT02595450|20098866|P1|NOT COMPLETED|Overall Study||81
8153915|NCT02595450|20098866|P1|COMPLETED|Overall Study||218
8153916|NCT02595450|20098866|P1|Treated|Overall Study||291
8153917|NCT02595450|20098866|P1|STARTED|Overall Study||299
8153918|NCT02595437|20098872|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
8153919|NCT02595437|20098872|P1|COMPLETED|Triferic Via Hemodialysate||21
8153920|NCT02595437|20098872|P1|STARTED|Triferic Via Hemodialysate||21
8153921|NCT02595437|20098872|P1|NOT COMPLETED|Triferic Via IV||1
8153922|NCT02595437|20098872|P1|COMPLETED|Triferic Via IV||21
8153923|NCT02595437|20098872|P1|STARTED|Triferic Via IV||22
8153924|NCT02595372|20098890|P1|NOT COMPLETED|Overall Study||9
8153925|NCT02595372|20098890|P1|COMPLETED|Overall Study||33
8153926|NCT02595372|20098890|P1|STARTED|Overall Study||42
8153927|NCT02595073|20098901|P2|NOT COMPLETED|Overall Study||1
8153928|NCT02595073|20098902|P1|NOT COMPLETED|Overall Study||2
8153929|NCT02595073|20098901|P2|COMPLETED|Overall Study||62
8153930|NCT02595073|20098902|P1|COMPLETED|Overall Study||59
8153931|NCT02595073|20098901|P2|STARTED|Overall Study||63
8153932|NCT02595073|20098902|P1|STARTED|Overall Study||61
8153933|NCT02595008|20098912|P2|NOT COMPLETED|Overall Study||0
8153934|NCT02595008|20098913|P1|NOT COMPLETED|Overall Study||1
8153935|NCT02595008|20098912|P2|COMPLETED|Overall Study||4
8153936|NCT02595008|20098913|P1|COMPLETED|Overall Study||19
8153937|NCT02595008|20098912|P2|STARTED|Overall Study||4
8153938|NCT02595008|20098913|P1|STARTED|Overall Study||20
8153939|NCT02594826|20098921|P2|NOT COMPLETED|Overall Study||60
8153940|NCT02594826|20098922|P1|NOT COMPLETED|Overall Study||57
8153941|NCT02594826|20098921|P2|COMPLETED|Overall Study||298
8153942|NCT02594826|20098922|P1|COMPLETED|Overall Study||290
8153943|NCT02594826|20098921|P2|STARTED|Overall Study||358
8153944|NCT02594826|20098922|P1|STARTED|Overall Study||347
8153945|NCT02594644|20098932|P2|NOT COMPLETED|Overall Study||1
8153946|NCT02594644|20098933|P1|NOT COMPLETED|Overall Study||0
8153947|NCT02594644|20098932|P2|COMPLETED|Overall Study||15
8153948|NCT02594644|20098933|P1|COMPLETED|Overall Study||16
8153949|NCT02594644|20098932|P2|STARTED|Overall Study||16
8153950|NCT02594644|20098933|P1|STARTED|Overall Study||16
8153951|NCT02594163|20098951|P2|NOT COMPLETED|Follow-up Period||12
8153952|NCT02594163|20098952|P1|NOT COMPLETED|Follow-up Period||11
8153953|NCT02594163|20098951|P2|COMPLETED|Follow-up Period||1
8153954|NCT02594163|20098952|P1|COMPLETED|Follow-up Period||1
8153955|NCT02594163|20098951|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
8153956|NCT02594163|20098952|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
8153957|NCT02594163|20098951|P2|NOT COMPLETED|Treatment Period||12
8153958|NCT02594163|20098952|P1|NOT COMPLETED|Treatment Period||7
8153959|NCT02594163|20098951|P2|COMPLETED|Treatment Period||1
8153960|NCT02594163|20098952|P1|COMPLETED|Treatment Period||5
8153961|NCT02594163|20098951|P2|STARTED|Treatment Period||13
8153962|NCT02594163|20098952|P1|STARTED|Treatment Period||12
8153969|NCT02594098|20098983|P2|NOT COMPLETED|Overall Study||13
8153970|NCT02594098|20098984|P1|NOT COMPLETED|Overall Study||26
8153971|NCT02594098|20098983|P2|COMPLETED|Overall Study||1
8153972|NCT02594098|20098984|P1|COMPLETED|Overall Study||1
8153973|NCT02594098|20098983|P2|STARTED|Overall Study||14
8153974|NCT02594098|20098984|P1|STARTED|Overall Study||27
8153975|NCT02593903|20099046|P2|NOT COMPLETED|Overall Study||1
8153976|NCT02593903|20099047|P1|NOT COMPLETED|Overall Study||0
8153977|NCT02593903|20099046|P2|COMPLETED|Overall Study||31
8153978|NCT02593903|20099047|P1|COMPLETED|Overall Study||35
8153979|NCT02593903|20099046|P2|STARTED|Overall Study||32
8153980|NCT02593903|20099047|P1|STARTED|Overall Study||35
8153981|NCT02593864|20099053|P1|NOT COMPLETED|Overall Study||6
8153982|NCT02593864|20099053|P1|COMPLETED|Overall Study||19
8153983|NCT02593864|20099053|P1|STARTED|Overall Study||25
8153984|NCT02593825|20099060|P2|NOT COMPLETED|Follow-up||0
8153985|NCT02593825|20099061|P1|NOT COMPLETED|Follow-up||0
8153986|NCT02593825|20099060|P2|COMPLETED|Follow-up||55
8153987|NCT02593825|20099061|P1|COMPLETED|Follow-up||57
8153988|NCT02593825|20099060|P2|STARTED|Follow-up||55
8153989|NCT02593825|20099061|P1|STARTED|Follow-up||57
8153990|NCT02593825|20099060|P2|NOT COMPLETED|Intervention||12
8153991|NCT02593825|20099061|P1|NOT COMPLETED|Intervention||10
8153992|NCT02593825|20099060|P2|COMPLETED|Intervention||55
8153993|NCT02593825|20099061|P1|COMPLETED|Intervention||57
8153994|NCT02593825|20099060|P2|STARTED|Intervention||67
8153995|NCT02593825|20099061|P1|STARTED|Intervention||67
8153996|NCT02593773|20099073|P1|NOT COMPLETED|Overall Study||35
8153997|NCT02593773|20099073|P1|COMPLETED|Overall Study||51
8153998|NCT02593773|20099073|P1|STARTED|Overall Study||86
8153999|NCT02593630|20099083|P1|NOT COMPLETED|Overall Study||1
8154000|NCT02593630|20099083|P1|COMPLETED|Overall Study||53
8154001|NCT02593630|20099083|P1|STARTED|Overall Study||54
8154002|NCT02593396|20099091|P2|NOT COMPLETED|Overall Study||14
8154003|NCT02593396|20099092|P1|NOT COMPLETED|Overall Study||15
8154004|NCT02593396|20099091|P2|COMPLETED|Overall Study||26
8154005|NCT02593396|20099092|P1|COMPLETED|Overall Study||25
8154006|NCT02593396|20099091|P2|At Least Done One Efficacy Assessment|Overall Study||36
8154007|NCT02593396|20099092|P1|At Least Done One Efficacy Assessment|Overall Study||36
8154008|NCT02593396|20099091|P2|STARTED|Overall Study||40
8154009|NCT02593396|20099092|P1|STARTED|Overall Study||40
8154010|NCT02593305|20099105|P3|NOT COMPLETED|Post 2||0
8154011|NCT02593305|20099106|P2|NOT COMPLETED|Post 2||0
8154012|NCT02593305|20099107|P1|NOT COMPLETED|Post 2||0
8154013|NCT02593305|20099105|P3|COMPLETED|Post 2||0
8154014|NCT02593305|20099106|P2|COMPLETED|Post 2||6
8154015|NCT02593305|20099107|P1|COMPLETED|Post 2||7
8154016|NCT02593305|20099105|P3|STARTED|Post 2||0
8154017|NCT02593305|20099106|P2|STARTED|Post 2||6
8154018|NCT02593305|20099107|P1|STARTED|Post 2||7
8154019|NCT02593305|20099105|P3|NOT COMPLETED|Baseline 2||0
8154020|NCT02593305|20099106|P2|NOT COMPLETED|Baseline 2||0
8154021|NCT02593305|20099107|P1|NOT COMPLETED|Baseline 2||0
8154022|NCT02593305|20099105|P3|COMPLETED|Baseline 2||0
8154023|NCT02593305|20099106|P2|COMPLETED|Baseline 2||6
8154024|NCT02593305|20099107|P1|COMPLETED|Baseline 2||7
8154025|NCT02593305|20099105|P3|STARTED|Baseline 2||0
8154026|NCT02593305|20099106|P2|STARTED|Baseline 2||6
8154027|NCT02593305|20099107|P1|STARTED|Baseline 2||7
8154028|NCT02593305|20099105|P3|NOT COMPLETED|Post 1||10
8154029|NCT02593305|20099106|P2|NOT COMPLETED|Post 1||0
8154030|NCT02593305|20099107|P1|NOT COMPLETED|Post 1||0
8154031|NCT02593305|20099105|P3|COMPLETED|Post 1||0
8154032|NCT02593305|20099106|P2|COMPLETED|Post 1||6
8154033|NCT02593305|20099107|P1|COMPLETED|Post 1||7
8154034|NCT02593305|20099105|P3|STARTED|Post 1||10
8154035|NCT02593305|20099106|P2|STARTED|Post 1||6
8154036|NCT02593305|20099107|P1|STARTED|Post 1||7
8154037|NCT02593305|20099105|P3|NOT COMPLETED|Baseline 1||0
8154038|NCT02593305|20099106|P2|NOT COMPLETED|Baseline 1||0
8154039|NCT02593305|20099107|P1|NOT COMPLETED|Baseline 1||0
8154040|NCT02593305|20099105|P3|COMPLETED|Baseline 1||10
8154041|NCT02593305|20099106|P2|COMPLETED|Baseline 1||6
8154042|NCT02593305|20099107|P1|COMPLETED|Baseline 1||7
8154043|NCT02593305|20099105|P3|STARTED|Baseline 1||10
8154044|NCT02593305|20099106|P2|STARTED|Baseline 1||6
8154045|NCT02593305|20099107|P1|STARTED|Baseline 1||7
8154046|NCT02593149|20099122|P2|NOT COMPLETED|Intervention||115
8154047|NCT02593149|20099123|P1|NOT COMPLETED|Intervention||116
8154048|NCT02593149|20099122|P2|COMPLETED|Intervention||845
8154049|NCT02593149|20099123|P1|COMPLETED|Intervention||826
8154050|NCT02593149|20099122|P2|STARTED|Intervention||960
8154051|NCT02593149|20099123|P1|STARTED|Intervention||942
8154052|NCT02593149|20099122|P2|NOT COMPLETED|Run-In||38
8154053|NCT02593149|20099123|P1|NOT COMPLETED|Run-In||36
8154054|NCT02593149|20099122|P2|COMPLETED|Run-In||323
8154055|NCT02593149|20099123|P1|COMPLETED|Run-In||304
8154056|NCT02593149|20099122|P2|STARTED|Run-In||361
8154057|NCT02593149|20099123|P1|STARTED|Run-In||340
8154058|NCT02593097|20099131|P2|NOT COMPLETED|Second Intervention (12 Weeks)||1
8154059|NCT02593097|20099132|P1|NOT COMPLETED|Second Intervention (12 Weeks)||3
8154060|NCT02593097|20099131|P2|COMPLETED|Second Intervention (12 Weeks)||15
8154061|NCT02593097|20099132|P1|COMPLETED|Second Intervention (12 Weeks)||9
8154062|NCT02593097|20099131|P2|STARTED|Second Intervention (12 Weeks)||16
8154063|NCT02593097|20099132|P1|STARTED|Second Intervention (12 Weeks)||12
8154064|NCT02593097|20099131|P2|NOT COMPLETED|Washout (4 Weeks)||0
8154065|NCT02593097|20099132|P1|NOT COMPLETED|Washout (4 Weeks)||0
8154066|NCT02593097|20099131|P2|COMPLETED|Washout (4 Weeks)||16
8154067|NCT02593097|20099132|P1|COMPLETED|Washout (4 Weeks)||12
8154068|NCT02593097|20099131|P2|STARTED|Washout (4 Weeks)||16
8154069|NCT02593097|20099132|P1|STARTED|Washout (4 Weeks)||12
8154070|NCT02593097|20099131|P2|NOT COMPLETED|First Intervention (12 Weeks)||4
8154071|NCT02593097|20099132|P1|NOT COMPLETED|First Intervention (12 Weeks)||2
8154072|NCT02593097|20099131|P2|COMPLETED|First Intervention (12 Weeks)||16
8154073|NCT02593097|20099132|P1|COMPLETED|First Intervention (12 Weeks)||12
8154074|NCT02593097|20099131|P2|Received Intervention|First Intervention (12 Weeks)||20
8154075|NCT02593097|20099132|P1|Received Intervention|First Intervention (12 Weeks)||14
8154076|NCT02593097|20099131|P2|STARTED|First Intervention (12 Weeks)||20
8154077|NCT02593097|20099132|P1|STARTED|First Intervention (12 Weeks)||14
8154078|NCT02593032|20099144|P2|NOT COMPLETED|Overall Study||0
8154079|NCT02593032|20099145|P1|NOT COMPLETED|Overall Study||0
8154080|NCT02593032|20099144|P2|COMPLETED|Overall Study||33
8154081|NCT02593032|20099145|P1|COMPLETED|Overall Study||17
8154082|NCT02593032|20099144|P2|STARTED|Overall Study||33
8154083|NCT02593032|20099145|P1|STARTED|Overall Study||17
8154084|NCT02592876|20099153|P2|NOT COMPLETED|Overall Study||40
8154085|NCT02592876|20099154|P1|NOT COMPLETED|Overall Study||41
8154086|NCT02592876|20099153|P2|COMPLETED|Overall Study||0
8154087|NCT02592876|20099154|P1|COMPLETED|Overall Study||0
8154088|NCT02592876|20099153|P2|Completed Treatment|Overall Study||32
8154089|NCT02592876|20099154|P1|Completed Treatment|Overall Study||34
8154090|NCT02592876|20099153|P2|Received Study Drug|Overall Study||40
8154091|NCT02592876|20099154|P1|Received Study Drug|Overall Study||40
8154092|NCT02592876|20099153|P2|STARTED|Overall Study||40
8154093|NCT02592876|20099154|P1|STARTED|Overall Study||41
8154094|NCT02592655|20099180|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
8154095|NCT02592655|20099180|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
8154096|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
8154097|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
8154098|NCT02592655|20099180|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
8154099|NCT02592655|20099180|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
8154100|NCT02592655|20099180|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
8154101|NCT02592655|20099180|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
8154102|NCT02592655|20099180|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
8154103|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
8154104|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
8154105|NCT02592655|20099180|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
8154106|NCT02592655|20099180|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
8154107|NCT02592655|20099180|P1|STARTED|Third Tourniquet, Left Thigh.||19
8154108|NCT02592655|20099180|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
8154109|NCT02592655|20099180|P1|COMPLETED|Second Tourniquet Right Thigh.||19
8154110|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
8154111|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
8154112|NCT02592655|20099180|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
8154113|NCT02592655|20099180|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
8154114|NCT02592655|20099180|P1|STARTED|Second Tourniquet Right Thigh.||19
8154115|NCT02592655|20099180|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
8154116|NCT02592655|20099180|P1|COMPLETED|First Tourniquet, Left Thigh.||19
8154117|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
8154118|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
8154119|NCT02592655|20099180|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
8154120|NCT02592655|20099180|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
8154121|NCT02592655|20099180|P1|STARTED|First Tourniquet, Left Thigh.||19
8154122|NCT02592629|20099198|P3|NOT COMPLETED|Overall Study||0
8154123|NCT02592629|20099199|P2|NOT COMPLETED|Overall Study||0
8154124|NCT02592629|20099200|P1|NOT COMPLETED|Overall Study||0
8154125|NCT02592629|20099198|P3|COMPLETED|Overall Study||5
8154126|NCT02592629|20099199|P2|COMPLETED|Overall Study||9
8154127|NCT02592629|20099200|P1|COMPLETED|Overall Study||5
8154128|NCT02592629|20099198|P3|STARTED|Overall Study||5
8154129|NCT02592629|20099199|P2|STARTED|Overall Study||9
8154130|NCT02592629|20099200|P1|STARTED|Overall Study||5
8154131|NCT02592486|20099210|P2|NOT COMPLETED|Overall Study||5
8154132|NCT02592486|20099211|P1|NOT COMPLETED|Overall Study||0
8154133|NCT02592486|20099210|P2|COMPLETED|Overall Study||76
8154134|NCT02592486|20099211|P1|COMPLETED|Overall Study||81
8154135|NCT02592486|20099210|P2|STARTED|Overall Study||81
8154136|NCT02592486|20099211|P1|STARTED|Overall Study||81
8154137|NCT02592447|20099225|P2|NOT COMPLETED|Overall Study||1
8154138|NCT02592447|20099226|P1|NOT COMPLETED|Overall Study||2
8154139|NCT02592447|20099225|P2|COMPLETED|Overall Study||14
8154140|NCT02592447|20099226|P1|COMPLETED|Overall Study||27
8154141|NCT02592447|20099225|P2|STARTED|Overall Study||15
8154142|NCT02592447|20099226|P1|STARTED|Overall Study||29
8154143|NCT02592434|20099234|P3|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
8154144|NCT02592434|20099235|P2|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
8154145|NCT02592434|20099236|P1|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
8154146|NCT02592434|20099234|P3|COMPLETED|Double Blind Phase (26 Weeks)||38
8154147|NCT02592434|20099235|P2|COMPLETED|Double Blind Phase (26 Weeks)||61
8154148|NCT02592434|20099236|P1|COMPLETED|Double Blind Phase (26 Weeks)||0
8154149|NCT02592434|20099234|P3|Treated|Double Blind Phase (26 Weeks)||85
8154150|NCT02592434|20099235|P2|Treated|Double Blind Phase (26 Weeks)||88
8154151|NCT02592434|20099236|P1|Treated|Double Blind Phase (26 Weeks)||0
8154152|NCT02592434|20099234|P3|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
8154153|NCT02592434|20099235|P2|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
8154154|NCT02592434|20099236|P1|STARTED|Double Blind Phase (26 Weeks)||0
8154155|NCT02592434|20099234|P3|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
8154156|NCT02592434|20099235|P2|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
8154157|NCT02592434|20099236|P1|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
8154158|NCT02592434|20099234|P3|COMPLETED|Open-Label Phase (18 Weeks)||0
8154159|NCT02592434|20099235|P2|COMPLETED|Open-Label Phase (18 Weeks)||0
8154160|NCT02592434|20099236|P1|COMPLETED|Open-Label Phase (18 Weeks)||185
8154161|NCT02592434|20099234|P3|Treated|Open-Label Phase (18 Weeks)||0
8154162|NCT02592434|20099235|P2|Treated|Open-Label Phase (18 Weeks)||0
8154163|NCT02592434|20099236|P1|Treated|Open-Label Phase (18 Weeks)||225
8154164|NCT02592434|20099234|P3|STARTED|Open-Label Phase (18 Weeks)||0
8154165|NCT02592434|20099235|P2|STARTED|Open-Label Phase (18 Weeks)||0
8154166|NCT02592434|20099236|P1|STARTED|Open-Label Phase (18 Weeks)||225
8154167|NCT02592421|20099354|P2|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
8154168|NCT02592421|20099355|P1|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
8154169|NCT02592421|20099354|P2|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
8154170|NCT02592421|20099355|P1|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
8154171|NCT02592421|20099354|P2|STARTED|Study 3: Pancreatic Clamp Conditions||10
8154172|NCT02592421|20099355|P1|STARTED|Study 3: Pancreatic Clamp Conditions||20
8154173|NCT02592421|20099354|P2|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
8154174|NCT02592421|20099355|P1|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
8154175|NCT02592421|20099354|P2|COMPLETED|Study 2: Glucose Clamp Conditions||10
8154176|NCT02592421|20099355|P1|COMPLETED|Study 2: Glucose Clamp Conditions||20
8154177|NCT02592421|20099354|P2|STARTED|Study 2: Glucose Clamp Conditions||10
8154178|NCT02592421|20099355|P1|STARTED|Study 2: Glucose Clamp Conditions||20
8154179|NCT02592421|20099354|P2|NOT COMPLETED|Study 1||0
8154180|NCT02592421|20099355|P1|NOT COMPLETED|Study 1||0
8154181|NCT02592421|20099354|P2|COMPLETED|Study 1||10
8154182|NCT02592421|20099355|P1|COMPLETED|Study 1||20
8154183|NCT02592421|20099354|P2|STARTED|Study 1||10
8154184|NCT02592421|20099355|P1|STARTED|Study 1||20
8154185|NCT02592018|20099367|P1|NOT COMPLETED|Overall Study||2
8154186|NCT02592018|20099367|P1|COMPLETED|Overall Study||13
8154187|NCT02592018|20099367|P1|STARTED|Overall Study||15
8154188|NCT02591537|20099384|P2|NOT COMPLETED|Overall Study||0
8154189|NCT02591537|20099385|P1|NOT COMPLETED|Overall Study||0
8154190|NCT02591537|20099384|P2|COMPLETED|Overall Study||8
8154191|NCT02591537|20099385|P1|COMPLETED|Overall Study||8
8154192|NCT02591537|20099384|P2|STARTED|Overall Study||8
8154193|NCT02591537|20099385|P1|STARTED|Overall Study||8
8154194|NCT02591511|20099407|P2|NOT COMPLETED|Overall Study||0
8154195|NCT02591511|20099408|P1|NOT COMPLETED|Overall Study||0
8154196|NCT02591511|20099407|P2|COMPLETED|Overall Study||33
8154197|NCT02591511|20099408|P1|COMPLETED|Overall Study||30
8154198|NCT02591511|20099407|P2|STARTED|Overall Study||33
8154199|NCT02591511|20099408|P1|STARTED|Overall Study||30
8154200|NCT02591290|20099414|P1|NOT COMPLETED|Overall Study||2
8154201|NCT02591290|20099414|P1|COMPLETED|Overall Study||58
8154202|NCT02591290|20099414|P1|Vaccinated Dose 2|Overall Study||58
8154203|NCT02591290|20099414|P1|Vaccinated Dose 1|Overall Study||60
8154204|NCT02591290|20099414|P1|STARTED|Overall Study||60
8154205|NCT02591238|20099424|P4|NOT COMPLETED|Overall Study||3
8154206|NCT02591238|20099425|P3|NOT COMPLETED|Overall Study||0
8154207|NCT02591238|20099426|P2|NOT COMPLETED|Overall Study||1
8154208|NCT02591238|20099427|P1|NOT COMPLETED|Overall Study||1
8154209|NCT02591238|20099424|P4|COMPLETED|Overall Study||15
8154210|NCT02591238|20099425|P3|COMPLETED|Overall Study||17
8154211|NCT02591238|20099426|P2|COMPLETED|Overall Study||16
8154212|NCT02591238|20099427|P1|COMPLETED|Overall Study||15
8154213|NCT02591238|20099424|P4|STARTED|Overall Study||18
8154214|NCT02591238|20099425|P3|STARTED|Overall Study||17
8154215|NCT02591238|20099426|P2|STARTED|Overall Study||17
8154216|NCT02591238|20099427|P1|STARTED|Overall Study||16
8154217|NCT02591056|20099457|P1|NOT COMPLETED|Overall Study||0
8154218|NCT02591056|20099457|P1|COMPLETED|Overall Study||27
8154219|NCT02591056|20099457|P1|STARTED|Overall Study||27
8154220|NCT02590939|20099463|P2|NOT COMPLETED|Overall Study||2
8154221|NCT02590939|20099464|P1|NOT COMPLETED|Overall Study||5
8154222|NCT02590939|20099463|P2|COMPLETED|Overall Study||52
8154223|NCT02590939|20099464|P1|COMPLETED|Overall Study||47
8154224|NCT02590939|20099463|P2|STARTED|Overall Study||54
8154225|NCT02590939|20099464|P1|STARTED|Overall Study||52
8154226|NCT02590588|20099484|P1|NOT COMPLETED|Overall Study||1
8154227|NCT02590588|20099484|P1|COMPLETED|Overall Study||0
8154228|NCT02590588|20099484|P1|STARTED|Overall Study||1
8154229|NCT02590562|20099492|P1|NOT COMPLETED|Overall Study||6
8154230|NCT02590562|20099492|P1|COMPLETED|Overall Study||802
8154231|NCT02590562|20099492|P1|STARTED|Overall Study||808
8154232|NCT02590432|20099551|P9|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
8154233|NCT02590432|20099552|P8|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
8154234|NCT02590432|20099553|P7|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154235|NCT02590432|20099554|P6|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154236|NCT02590432|20099555|P5|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154237|NCT02590432|20099556|P4|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154238|NCT02590432|20099557|P3|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154239|NCT02590432|20099558|P2|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154240|NCT02590432|20099559|P1|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154241|NCT02590432|20099551|P9|COMPLETED|Dose-reduced Open Label Treatment Period||8
8154242|NCT02590432|20099552|P8|COMPLETED|Dose-reduced Open Label Treatment Period||13
8154243|NCT02590432|20099553|P7|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154244|NCT02590432|20099554|P6|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154245|NCT02590432|20099555|P5|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154246|NCT02590432|20099556|P4|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154247|NCT02590432|20099557|P3|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154248|NCT02590432|20099558|P2|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154249|NCT02590432|20099559|P1|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154250|NCT02590432|20099551|P9|STARTED|Dose-reduced Open Label Treatment Period||26
8154251|NCT02590432|20099552|P8|STARTED|Dose-reduced Open Label Treatment Period||31
8154252|NCT02590432|20099553|P7|STARTED|Dose-reduced Open Label Treatment Period||0
8154253|NCT02590432|20099554|P6|STARTED|Dose-reduced Open Label Treatment Period||0
8154254|NCT02590432|20099555|P5|STARTED|Dose-reduced Open Label Treatment Period||0
8154255|NCT02590432|20099556|P4|STARTED|Dose-reduced Open Label Treatment Period||0
8154256|NCT02590432|20099557|P3|STARTED|Dose-reduced Open Label Treatment Period||0
8154257|NCT02590432|20099558|P2|STARTED|Dose-reduced Open Label Treatment Period||0
8154258|NCT02590432|20099559|P1|STARTED|Dose-reduced Open Label Treatment Period||0
8154259|NCT02590432|20099551|P9|NOT COMPLETED|Double-blind Treatment Period||0
8154260|NCT02590432|20099552|P8|NOT COMPLETED|Double-blind Treatment Period||0
8154261|NCT02590432|20099553|P7|NOT COMPLETED|Double-blind Treatment Period||21
8154262|NCT02590432|20099554|P6|NOT COMPLETED|Double-blind Treatment Period||26
8154263|NCT02590432|20099555|P5|NOT COMPLETED|Double-blind Treatment Period||9
8154264|NCT02590432|20099556|P4|NOT COMPLETED|Double-blind Treatment Period||15
8154265|NCT02590432|20099557|P3|NOT COMPLETED|Double-blind Treatment Period||17
8154266|NCT02590432|20099558|P2|NOT COMPLETED|Double-blind Treatment Period||0
8154267|NCT02590432|20099559|P1|NOT COMPLETED|Double-blind Treatment Period||0
8154268|NCT02590432|20099551|P9|COMPLETED|Double-blind Treatment Period||0
8154269|NCT02590432|20099552|P8|COMPLETED|Double-blind Treatment Period||0
8154270|NCT02590432|20099553|P7|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
8154271|NCT02590432|20099554|P6|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
8154272|NCT02590432|20099555|P5|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
8154273|NCT02590432|20099556|P4|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
8154274|NCT02590432|20099557|P3|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
8154275|NCT02590432|20099558|P2|COMPLETED|Double-blind Treatment Period||0
8154276|NCT02590432|20099559|P1|COMPLETED|Double-blind Treatment Period||0
8154277|NCT02590432|20099551|P9|STARTED|Double-blind Treatment Period||0
8154278|NCT02590432|20099552|P8|STARTED|Double-blind Treatment Period||0
8154279|NCT02590432|20099553|P7|STARTED|Double-blind Treatment Period||30
8154280|NCT02590432|20099554|P6|STARTED|Double-blind Treatment Period||32
8154281|NCT02590432|20099555|P5|STARTED|Double-blind Treatment Period||16
8154282|NCT02590432|20099556|P4|STARTED|Double-blind Treatment Period||18
8154283|NCT02590432|20099557|P3|STARTED|Double-blind Treatment Period||18
8154284|NCT02590432|20099558|P2|STARTED|Double-blind Treatment Period||0
8154285|NCT02590432|20099559|P1|STARTED|Double-blind Treatment Period||0
8154286|NCT02590432|20099551|P9|NOT COMPLETED|Open-label Treatment Period||0
8154287|NCT02590432|20099552|P8|NOT COMPLETED|Open-label Treatment Period||0
8154288|NCT02590432|20099553|P7|NOT COMPLETED|Open-label Treatment Period||0
8154289|NCT02590432|20099554|P6|NOT COMPLETED|Open-label Treatment Period||0
8154290|NCT02590432|20099555|P5|NOT COMPLETED|Open-label Treatment Period||0
8154291|NCT02590432|20099556|P4|NOT COMPLETED|Open-label Treatment Period||0
8154292|NCT02590432|20099557|P3|NOT COMPLETED|Open-label Treatment Period||0
8154293|NCT02590432|20099558|P2|NOT COMPLETED|Open-label Treatment Period||152
8154294|NCT02590432|20099559|P1|NOT COMPLETED|Open-label Treatment Period||232
8154295|NCT02590432|20099551|P9|COMPLETED|Open-label Treatment Period||0
8154296|NCT02590432|20099552|P8|COMPLETED|Open-label Treatment Period||0
8154297|NCT02590432|20099553|P7|COMPLETED|Open-label Treatment Period||0
8154298|NCT02590432|20099554|P6|COMPLETED|Open-label Treatment Period||0
8154299|NCT02590432|20099555|P5|COMPLETED|Open-label Treatment Period||0
8154300|NCT02590432|20099556|P4|COMPLETED|Open-label Treatment Period||0
8154301|NCT02590432|20099557|P3|COMPLETED|Open-label Treatment Period||0
8154302|NCT02590432|20099558|P2|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
8154303|NCT02590432|20099559|P1|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
8154304|NCT02590432|20099551|P9|STARTED|Open-label Treatment Period||0
8154305|NCT02590432|20099552|P8|STARTED|Open-label Treatment Period||0
8154306|NCT02590432|20099553|P7|STARTED|Open-label Treatment Period||0
8154307|NCT02590432|20099554|P6|STARTED|Open-label Treatment Period||0
8154308|NCT02590432|20099555|P5|STARTED|Open-label Treatment Period||0
8154309|NCT02590432|20099556|P4|STARTED|Open-label Treatment Period||0
8154310|NCT02590432|20099557|P3|STARTED|Open-label Treatment Period||0
8154311|NCT02590432|20099558|P2|STARTED|Open-label Treatment Period||318
8154312|NCT02590432|20099559|P1|STARTED|Open-label Treatment Period||508
8154313|NCT02590406|20099595|P2|NOT COMPLETED|Overall Study||1
8154314|NCT02590406|20099596|P1|NOT COMPLETED|Overall Study||1
8154315|NCT02590406|20099595|P2|COMPLETED|Overall Study||24
8154316|NCT02590406|20099596|P1|COMPLETED|Overall Study||24
8154317|NCT02590406|20099595|P2|STARTED|Overall Study||25
8154318|NCT02590406|20099596|P1|STARTED|Overall Study||25
8154319|NCT02590354|20099610|P1|NOT COMPLETED|Phase 2 - Treatment Interruption||2
8154320|NCT02590354|20099610|P1|COMPLETED|Phase 2 - Treatment Interruption||14
8154321|NCT02590354|20099610|P1|STARTED|Phase 2 - Treatment Interruption||16
8154322|NCT02590354|20099610|P1|NOT COMPLETED|Phase 1||98
8154323|NCT02590354|20099610|P1|COMPLETED|Phase 1||16
8154324|NCT02590354|20099610|P1|STARTED|Phase 1||114
8154325|NCT02590068|20099620|P2|NOT COMPLETED|Overall Study||0
8154326|NCT02590068|20099621|P1|NOT COMPLETED|Overall Study||0
8154327|NCT02590068|20099620|P2|COMPLETED|Overall Study||14
8154328|NCT02590068|20099621|P1|COMPLETED|Overall Study||0
8154329|NCT02590068|20099620|P2|STARTED|Overall Study||14
8154330|NCT02590068|20099621|P1|STARTED|Overall Study||0
8154331|NCT02590003|20099637|P2|NOT COMPLETED|Overall Study||2
8154332|NCT02590003|20099638|P1|NOT COMPLETED|Overall Study||1
8154333|NCT02590003|20099637|P2|COMPLETED|Overall Study||0
8154334|NCT02590003|20099638|P1|COMPLETED|Overall Study||0
8154335|NCT02590003|20099637|P2|STARTED|Overall Study||2
8154336|NCT02590003|20099638|P1|STARTED|Overall Study||1
8154337|NCT02589847|20099660|P2|NOT COMPLETED|Overall Study||0
8154338|NCT02589847|20099661|P1|NOT COMPLETED|Overall Study||15
8154339|NCT02589847|20099660|P2|COMPLETED|Overall Study||110
8154340|NCT02589847|20099661|P1|COMPLETED|Overall Study||136
8154341|NCT02589847|20099660|P2|STARTED|Overall Study||110
8154342|NCT02589847|20099661|P1|STARTED|Overall Study||151
8154343|NCT02589808|20099667|P1|NOT COMPLETED|Overall Study||0
8154344|NCT02589808|20099667|P1|COMPLETED|Overall Study||76
8154345|NCT02589808|20099667|P1|STARTED|Overall Study||76
8154346|NCT02589665|20099675|P10|NOT COMPLETED|Maintenance Extension Period||68
8154347|NCT02589665|20099676|P9|NOT COMPLETED|Maintenance Extension Period||0
8154348|NCT02589665|20099677|P8|NOT COMPLETED|Maintenance Extension Period||0
8154349|NCT02589665|20099678|P7|NOT COMPLETED|Maintenance Extension Period||0
8154350|NCT02589665|20099679|P6|NOT COMPLETED|Maintenance Extension Period||0
8154351|NCT02589665|20099680|P5|NOT COMPLETED|Maintenance Extension Period||0
8154352|NCT02589665|20099681|P4|NOT COMPLETED|Maintenance Extension Period||0
8154353|NCT02589665|20099682|P3|NOT COMPLETED|Maintenance Extension Period||0
8154354|NCT02589665|20099683|P2|NOT COMPLETED|Maintenance Extension Period||0
8154355|NCT02589665|20099684|P1|NOT COMPLETED|Maintenance Extension Period||0
8154356|NCT02589665|20099675|P10|COMPLETED|Maintenance Extension Period||0
8154357|NCT02589665|20099676|P9|COMPLETED|Maintenance Extension Period||0
8154358|NCT02589665|20099677|P8|COMPLETED|Maintenance Extension Period||0
8154359|NCT02589665|20099678|P7|COMPLETED|Maintenance Extension Period||0
8154360|NCT02589665|20099679|P6|COMPLETED|Maintenance Extension Period||0
8154361|NCT02589665|20099680|P5|COMPLETED|Maintenance Extension Period||0
8154362|NCT02589665|20099681|P4|COMPLETED|Maintenance Extension Period||0
8154363|NCT02589665|20099682|P3|COMPLETED|Maintenance Extension Period||0
8154364|NCT02589665|20099683|P2|COMPLETED|Maintenance Extension Period||0
8154365|NCT02589665|20099684|P1|COMPLETED|Maintenance Extension Period||0
8154366|NCT02589665|20099675|P10|STARTED|Maintenance Extension Period||68
8154367|NCT02589665|20099676|P9|STARTED|Maintenance Extension Period||0
8154368|NCT02589665|20099677|P8|STARTED|Maintenance Extension Period||0
8154369|NCT02589665|20099678|P7|STARTED|Maintenance Extension Period||0
8154370|NCT02589665|20099679|P6|STARTED|Maintenance Extension Period||0
8154371|NCT02589665|20099680|P5|STARTED|Maintenance Extension Period||0
8154372|NCT02589665|20099681|P4|STARTED|Maintenance Extension Period||0
8154373|NCT02589665|20099682|P3|STARTED|Maintenance Extension Period||0
8154374|NCT02589665|20099683|P2|STARTED|Maintenance Extension Period||0
8154375|NCT02589665|20099684|P1|STARTED|Maintenance Extension Period||0
8154376|NCT02589665|20099675|P10|NOT COMPLETED|Induction Extension Period||0
8154377|NCT02589665|20099676|P9|NOT COMPLETED|Induction Extension Period||12
8154378|NCT02589665|20099677|P8|NOT COMPLETED|Induction Extension Period||2
8154379|NCT02589665|20099678|P7|NOT COMPLETED|Induction Extension Period||0
8154380|NCT02589665|20099679|P6|NOT COMPLETED|Induction Extension Period||0
8154381|NCT02589665|20099680|P5|NOT COMPLETED|Induction Extension Period||0
8154382|NCT02589665|20099681|P4|NOT COMPLETED|Induction Extension Period||0
8154383|NCT02589665|20099682|P3|NOT COMPLETED|Induction Extension Period||0
8154384|NCT02589665|20099683|P2|NOT COMPLETED|Induction Extension Period||0
8154385|NCT02589665|20099684|P1|NOT COMPLETED|Induction Extension Period||0
8154386|NCT02589665|20099675|P10|COMPLETED|Induction Extension Period||0
8154387|NCT02589665|20099676|P9|COMPLETED|Induction Extension Period||84
8154388|NCT02589665|20099677|P8|COMPLETED|Induction Extension Period||30
8154389|NCT02589665|20099678|P7|COMPLETED|Induction Extension Period||0
8154390|NCT02589665|20099679|P6|COMPLETED|Induction Extension Period||0
8154391|NCT02589665|20099680|P5|COMPLETED|Induction Extension Period||0
8154392|NCT02589665|20099681|P4|COMPLETED|Induction Extension Period||0
8154393|NCT02589665|20099682|P3|COMPLETED|Induction Extension Period||0
8154394|NCT02589665|20099683|P2|COMPLETED|Induction Extension Period||0
8154395|NCT02589665|20099684|P1|COMPLETED|Induction Extension Period||0
8154396|NCT02589665|20099675|P10|STARTED|Induction Extension Period||0
8154397|NCT02589665|20099676|P9|STARTED|Induction Extension Period||96
8154398|NCT02589665|20099677|P8|STARTED|Induction Extension Period||32
8154399|NCT02589665|20099678|P7|STARTED|Induction Extension Period||0
8154400|NCT02589665|20099679|P6|STARTED|Induction Extension Period||0
8154401|NCT02589665|20099680|P5|STARTED|Induction Extension Period||0
8154402|NCT02589665|20099681|P4|STARTED|Induction Extension Period||0
8154403|NCT02589665|20099682|P3|STARTED|Induction Extension Period||0
8154404|NCT02589665|20099683|P2|STARTED|Induction Extension Period||0
8154405|NCT02589665|20099684|P1|STARTED|Induction Extension Period||0
8154406|NCT02589665|20099675|P10|NOT COMPLETED|Maintenance Period||0
8154407|NCT02589665|20099676|P9|NOT COMPLETED|Maintenance Period||0
8154408|NCT02589665|20099677|P8|NOT COMPLETED|Maintenance Period||0
8154409|NCT02589665|20099678|P7|NOT COMPLETED|Maintenance Period||46
8154410|NCT02589665|20099679|P6|NOT COMPLETED|Maintenance Period||47
8154411|NCT02589665|20099680|P5|NOT COMPLETED|Maintenance Period||13
8154412|NCT02589665|20099681|P4|NOT COMPLETED|Maintenance Period||0
8154413|NCT02589665|20099682|P3|NOT COMPLETED|Maintenance Period||0
8154414|NCT02589665|20099683|P2|NOT COMPLETED|Maintenance Period||0
8154415|NCT02589665|20099684|P1|NOT COMPLETED|Maintenance Period||0
8154416|NCT02589665|20099675|P10|COMPLETED|Maintenance Period||0
8154417|NCT02589665|20099676|P9|COMPLETED|Maintenance Period||0
8154418|NCT02589665|20099677|P8|COMPLETED|Maintenance Period||0
8154419|NCT02589665|20099678|P7|COMPLETED|Maintenance Period||0
8154420|NCT02589665|20099679|P6|COMPLETED|Maintenance Period||0
8154421|NCT02589665|20099680|P5|COMPLETED|Maintenance Period||0
8154422|NCT02589665|20099681|P4|COMPLETED|Maintenance Period||0
8154423|NCT02589665|20099682|P3|COMPLETED|Maintenance Period||0
8154424|NCT02589665|20099683|P2|COMPLETED|Maintenance Period||0
8154425|NCT02589665|20099684|P1|COMPLETED|Maintenance Period||0
8154426|NCT02589665|20099675|P10|STARTED|Maintenance Period||0
8154427|NCT02589665|20099676|P9|STARTED|Maintenance Period||0
8154428|NCT02589665|20099677|P8|STARTED|Maintenance Period||0
8154429|NCT02589665|20099678|P7|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
8154430|NCT02589665|20099679|P6|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
8154431|NCT02589665|20099680|P5|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
8154432|NCT02589665|20099681|P4|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154433|NCT02589665|20099682|P3|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154434|NCT02589665|20099683|P2|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154435|NCT02589665|20099684|P1|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154436|NCT02589665|20099675|P10|NOT COMPLETED|Induction Period||0
8154437|NCT02589665|20099676|P9|NOT COMPLETED|Induction Period||0
8154438|NCT02589665|20099677|P8|NOT COMPLETED|Induction Period||0
8154439|NCT02589665|20099678|P7|NOT COMPLETED|Induction Period||0
8154440|NCT02589665|20099679|P6|NOT COMPLETED|Induction Period||0
8154441|NCT02589665|20099680|P5|NOT COMPLETED|Induction Period||0
8154442|NCT02589665|20099681|P4|NOT COMPLETED|Induction Period||4
8154443|NCT02589665|20099682|P3|NOT COMPLETED|Induction Period||2
8154444|NCT02589665|20099683|P2|NOT COMPLETED|Induction Period||2
8154445|NCT02589665|20099684|P1|NOT COMPLETED|Induction Period||3
8154446|NCT02589665|20099675|P10|COMPLETED|Induction Period||0
8154447|NCT02589665|20099676|P9|COMPLETED|Induction Period||0
8154448|NCT02589665|20099677|P8|COMPLETED|Induction Period||0
8154449|NCT02589665|20099678|P7|COMPLETED|Induction Period||0
8154450|NCT02589665|20099679|P6|COMPLETED|Induction Period||0
8154451|NCT02589665|20099680|P5|COMPLETED|Induction Period||0
8154452|NCT02589665|20099681|P4|COMPLETED|Induction Period||57
8154453|NCT02589665|20099682|P3|COMPLETED|Induction Period||60
8154454|NCT02589665|20099683|P2|COMPLETED|Induction Period||61
8154455|NCT02589665|20099684|P1|COMPLETED|Induction Period||60
8154456|NCT02589665|20099675|P10|Received at Least One Dose of Study Drug|Induction Period||0
8154457|NCT02589665|20099676|P9|Received at Least One Dose of Study Drug|Induction Period||0
8154458|NCT02589665|20099677|P8|Received at Least One Dose of Study Drug|Induction Period||0
8154459|NCT02589665|20099678|P7|Received at Least One Dose of Study Drug|Induction Period||0
8154460|NCT02589665|20099679|P6|Received at Least One Dose of Study Drug|Induction Period||0
8154461|NCT02589665|20099680|P5|Received at Least One Dose of Study Drug|Induction Period||0
8154462|NCT02589665|20099681|P4|Received at Least One Dose of Study Drug|Induction Period||60
8154463|NCT02589665|20099682|P3|Received at Least One Dose of Study Drug|Induction Period||62
8154464|NCT02589665|20099683|P2|Received at Least One Dose of Study Drug|Induction Period||63
8154465|NCT02589665|20099684|P1|Received at Least One Dose of Study Drug|Induction Period||63
8154466|NCT02589665|20099675|P10|STARTED|Induction Period||0
8154467|NCT02589665|20099676|P9|STARTED|Induction Period||0
8154468|NCT02589665|20099677|P8|STARTED|Induction Period||0
8154469|NCT02589665|20099678|P7|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8154470|NCT02589665|20099679|P6|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8154471|NCT02589665|20099680|P5|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8154472|NCT02589665|20099681|P4|STARTED|Induction Period||61
8154473|NCT02589665|20099682|P3|STARTED|Induction Period||62
8154474|NCT02589665|20099683|P2|STARTED|Induction Period||63
8154475|NCT02589665|20099684|P1|STARTED|Induction Period||63
8154476|NCT02589639|20099749|P3|NOT COMPLETED|Overall Study||4
8154477|NCT02589639|20099750|P2|NOT COMPLETED|Overall Study||10
8154478|NCT02589639|20099751|P1|NOT COMPLETED|Overall Study||10
8154479|NCT02589639|20099749|P3|COMPLETED|Overall Study||86
8154480|NCT02589639|20099750|P2|COMPLETED|Overall Study||79
8154481|NCT02589639|20099751|P1|COMPLETED|Overall Study||80
8154482|NCT02589639|20099749|P3|Treated|Overall Study||90
8154483|NCT02589639|20099750|P2|Treated|Overall Study||86
8154484|NCT02589639|20099751|P1|Treated|Overall Study||90
8154485|NCT02589639|20099749|P3|STARTED|Overall Study||90
8154486|NCT02589639|20099750|P2|STARTED|Overall Study||89
8154487|NCT02589639|20099751|P1|STARTED|Overall Study||90
8154488|NCT02589626|20099764|P2|NOT COMPLETED|Overall Study||2
8154489|NCT02589626|20099765|P1|NOT COMPLETED|Overall Study||3
8154490|NCT02589626|20099764|P2|COMPLETED|Overall Study||31
8154491|NCT02589626|20099765|P1|COMPLETED|Overall Study||29
8154492|NCT02589626|20099764|P2|STARTED|Overall Study|Entered are treated patients|33
8154493|NCT02589626|20099765|P1|STARTED|Overall Study|Entered are treated patients|32
8154497|NCT02589171|20099779|P2|NOT COMPLETED|Overall Study||5
8154498|NCT02589171|20099780|P1|NOT COMPLETED|Overall Study||7
8154499|NCT02589171|20099779|P2|COMPLETED|Overall Study||30
8154500|NCT02589171|20099780|P1|COMPLETED|Overall Study||28
8154501|NCT02589171|20099779|P2|Week 6 Follow up|Overall Study||30
8154502|NCT02589171|20099780|P1|Week 6 Follow up|Overall Study||28
8154503|NCT02589171|20099779|P2|Week 1 Follow up|Overall Study||34
8154504|NCT02589171|20099780|P1|Week 1 Follow up|Overall Study||35
8154505|NCT02589171|20099779|P2|Day 1 Follow up|Overall Study||35
8154506|NCT02589171|20099780|P1|Day 1 Follow up|Overall Study||35
8154507|NCT02589171|20099779|P2|STARTED|Overall Study||35
8154508|NCT02589171|20099780|P1|STARTED|Overall Study||35
8154509|NCT02589145|20099823|P3|NOT COMPLETED|Overall Study||0
8154510|NCT02589145|20099824|P2|NOT COMPLETED|Overall Study||0
8154511|NCT02589145|20099825|P1|NOT COMPLETED|Overall Study||0
8154512|NCT02589145|20099823|P3|COMPLETED|Overall Study||2
8154513|NCT02589145|20099824|P2|COMPLETED|Overall Study||2
8154514|NCT02589145|20099825|P1|COMPLETED|Overall Study||4
8154515|NCT02589145|20099823|P3|STARTED|Overall Study||2
8154516|NCT02589145|20099824|P2|STARTED|Overall Study||2
8154517|NCT02589145|20099825|P1|STARTED|Overall Study||4
8154518|NCT02589067|20099853|P2|NOT COMPLETED|Overall Study||6
8154519|NCT02589067|20099854|P1|NOT COMPLETED|Overall Study||5
8154520|NCT02589067|20099853|P2|COMPLETED|Overall Study||28
8154521|NCT02589067|20099854|P1|COMPLETED|Overall Study||28
8154522|NCT02589067|20099853|P2|STARTED|Overall Study||34
8154523|NCT02589067|20099854|P1|STARTED|Overall Study||33
8154524|NCT02588976|20099866|P1|NOT COMPLETED|Overall Study||0
8154525|NCT02588976|20099866|P1|COMPLETED|Overall Study||30
8154526|NCT02588976|20099866|P1|STARTED|Overall Study||30
8154527|NCT02588872|20099873|P2|NOT COMPLETED|Overall Study||0
8154528|NCT02588872|20099874|P1|NOT COMPLETED|Overall Study||0
8154529|NCT02588872|20099873|P2|COMPLETED|Overall Study||52
8154530|NCT02588872|20099874|P1|COMPLETED|Overall Study||59
8154531|NCT02588872|20099873|P2|STARTED|Overall Study||52
8154532|NCT02588872|20099874|P1|STARTED|Overall Study||59
8154533|NCT02588833|20099890|P2|NOT COMPLETED|Part 3 (Safety Follow-up)||2
8154534|NCT02588833|20099891|P1|NOT COMPLETED|Part 3 (Safety Follow-up)||0
8154535|NCT02588833|20099890|P2|COMPLETED|Part 3 (Safety Follow-up)||2
8154536|NCT02588833|20099891|P1|COMPLETED|Part 3 (Safety Follow-up)||3
8154629|NCT02587962|20100207|P3|STARTED|Overall Study||6
8154537|NCT02588833|20099890|P2|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
8154538|NCT02588833|20099891|P1|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
8154539|NCT02588833|20099890|P2|NOT COMPLETED|Part 2C||2
8154540|NCT02588833|20099891|P1|NOT COMPLETED|Part 2C||0
8154541|NCT02588833|20099890|P2|COMPLETED|Part 2C||12
8154542|NCT02588833|20099891|P1|COMPLETED|Part 2C||0
8154543|NCT02588833|20099890|P2|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
8154544|NCT02588833|20099891|P1|STARTED|Part 2C||0
8154545|NCT02588833|20099890|P2|NOT COMPLETED|Part 2B||1
8154546|NCT02588833|20099891|P1|NOT COMPLETED|Part 2B||0
8154547|NCT02588833|20099890|P2|COMPLETED|Part 2B||17
8154548|NCT02588833|20099891|P1|COMPLETED|Part 2B||0
8154549|NCT02588833|20099890|P2|STARTED|Part 2B||18
8154550|NCT02588833|20099891|P1|STARTED|Part 2B||0
8154551|NCT02588833|20099890|P2|NOT COMPLETED|Part 2A||2
8154552|NCT02588833|20099891|P1|NOT COMPLETED|Part 2A||0
8154553|NCT02588833|20099890|P2|COMPLETED|Part 2A||18
8154554|NCT02588833|20099891|P1|COMPLETED|Part 2A||0
8154555|NCT02588833|20099890|P2|STARTED|Part 2A||20
8154556|NCT02588833|20099891|P1|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
8154557|NCT02588833|20099890|P2|NOT COMPLETED|Part 1||0
8154558|NCT02588833|20099891|P1|NOT COMPLETED|Part 1||1
8154559|NCT02588833|20099890|P2|COMPLETED|Part 1||20
8154560|NCT02588833|20099891|P1|COMPLETED|Part 1||2
8154561|NCT02588833|20099890|P2|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
8154562|NCT02588833|20099891|P1|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
8154563|NCT02588599|20099910|P1|NOT COMPLETED|Overall Study||0
8154564|NCT02588599|20099910|P1|COMPLETED|Overall Study||54
8154565|NCT02588599|20099910|P1|STARTED|Overall Study||54
8154566|NCT02588573|20099917|P2|NOT COMPLETED|Overall Study||0
8154567|NCT02588573|20099918|P1|NOT COMPLETED|Overall Study||0
8154568|NCT02588573|20099917|P2|COMPLETED|Overall Study||45
8154569|NCT02588573|20099918|P1|COMPLETED|Overall Study||45
8154570|NCT02588573|20099917|P2|Randomized Eye Somofilcon A|Overall Study||45
8154571|NCT02588573|20099918|P1|Randomized Eye Somofilcon A|Overall Study||45
8154572|NCT02588573|20099917|P2|Randomized Eye Etafilcon A|Overall Study||45
8154573|NCT02588573|20099918|P1|Randomized Eye Etafilcon A|Overall Study||45
8154574|NCT02588573|20099917|P2|STARTED|Overall Study||45
8154575|NCT02588573|20099918|P1|STARTED|Overall Study||45
8154576|NCT02588339|20099948|P1|NOT COMPLETED|Overall Study||3
8154577|NCT02588339|20099948|P1|COMPLETED|Overall Study||39
8154578|NCT02588339|20099948|P1|STARTED|Overall Study||42
8154579|NCT02588261|20099960|P2|NOT COMPLETED|Overall Study||263
8154580|NCT02588261|20099961|P1|NOT COMPLETED|Overall Study||267
8154581|NCT02588261|20099960|P2|COMPLETED|Overall Study||0
8154582|NCT02588261|20099961|P1|COMPLETED|Overall Study||0
8154583|NCT02588261|20099960|P2|Treated|Overall Study||262
8154584|NCT02588261|20099961|P1|Treated|Overall Study||265
8154585|NCT02588261|20099960|P2|STARTED|Overall Study||263
8154586|NCT02588261|20099961|P1|STARTED|Overall Study||267
8154587|NCT02588092|20099997|P10|NOT COMPLETED|Overall Study||3
8154588|NCT02588092|20099998|P9|NOT COMPLETED|Overall Study||6
8154589|NCT02588092|20099999|P8|NOT COMPLETED|Overall Study||4
8154590|NCT02588092|20100000|P7|NOT COMPLETED|Overall Study||3
8154591|NCT02588092|20100001|P6|NOT COMPLETED|Overall Study||3
8154592|NCT02588092|20100002|P5|NOT COMPLETED|Overall Study||3
8154593|NCT02588092|20100003|P4|NOT COMPLETED|Overall Study||3
8154594|NCT02588092|20100004|P3|NOT COMPLETED|Overall Study||3
8154595|NCT02588092|20100005|P2|NOT COMPLETED|Overall Study||3
8154596|NCT02588092|20100006|P1|NOT COMPLETED|Overall Study||4
8154597|NCT02588092|20099997|P10|COMPLETED|Overall Study||0
8154598|NCT02588092|20099998|P9|COMPLETED|Overall Study||0
8154599|NCT02588092|20099999|P8|COMPLETED|Overall Study||0
8154600|NCT02588092|20100000|P7|COMPLETED|Overall Study||0
8154601|NCT02588092|20100001|P6|COMPLETED|Overall Study||0
8154602|NCT02588092|20100002|P5|COMPLETED|Overall Study||0
8154603|NCT02588092|20100003|P4|COMPLETED|Overall Study||0
8154604|NCT02588092|20100004|P3|COMPLETED|Overall Study||0
8154605|NCT02588092|20100005|P2|COMPLETED|Overall Study||0
8154606|NCT02588092|20100006|P1|COMPLETED|Overall Study||0
8154607|NCT02588092|20099997|P10|STARTED|Overall Study||3
8154608|NCT02588092|20099998|P9|STARTED|Overall Study||6
8154609|NCT02588092|20099999|P8|STARTED|Overall Study||4
8154610|NCT02588092|20100000|P7|STARTED|Overall Study||3
8154611|NCT02588092|20100001|P6|STARTED|Overall Study||3
8154612|NCT02588092|20100002|P5|STARTED|Overall Study||3
8154613|NCT02588092|20100003|P4|STARTED|Overall Study||3
8154614|NCT02588092|20100004|P3|STARTED|Overall Study||3
8154615|NCT02588092|20100005|P2|STARTED|Overall Study||3
8154616|NCT02588092|20100006|P1|STARTED|Overall Study||4
8154617|NCT02587962|20100205|P5|NOT COMPLETED|Overall Study||15
8154618|NCT02587962|20100206|P4|NOT COMPLETED|Overall Study||6
8154619|NCT02587962|20100207|P3|NOT COMPLETED|Overall Study||6
8154620|NCT02587962|20100208|P2|NOT COMPLETED|Overall Study||3
8154621|NCT02587962|20100209|P1|NOT COMPLETED|Overall Study||2
8154622|NCT02587962|20100205|P5|COMPLETED|Overall Study||0
8154623|NCT02587962|20100206|P4|COMPLETED|Overall Study||1
8154624|NCT02587962|20100207|P3|COMPLETED|Overall Study||0
8154625|NCT02587962|20100208|P2|COMPLETED|Overall Study||0
8154626|NCT02587962|20100209|P1|COMPLETED|Overall Study||1
8154627|NCT02587962|20100205|P5|STARTED|Overall Study||15
8154628|NCT02587962|20100206|P4|STARTED|Overall Study||7
8154630|NCT02587962|20100208|P2|STARTED|Overall Study||3
8154631|NCT02587962|20100209|P1|STARTED|Overall Study||3
8154632|NCT02587819|20100281|P1|NOT COMPLETED|Overall Study||2
8154633|NCT02587819|20100281|P1|COMPLETED|Overall Study||19
8154634|NCT02587819|20100281|P1|Exposed|Overall Study||21
8154635|NCT02587819|20100281|P1|STARTED|Overall Study||21
8154636|NCT02587650|20100288|P4|NOT COMPLETED|Overall Study||0
8154637|NCT02587650|20100289|P3|NOT COMPLETED|Overall Study||0
8154638|NCT02587650|20100290|P2|NOT COMPLETED|Overall Study||0
8154639|NCT02587650|20100291|P1|NOT COMPLETED|Overall Study||0
8154640|NCT02587650|20100288|P4|COMPLETED|Overall Study||0
8154641|NCT02587650|20100289|P3|COMPLETED|Overall Study||1
8154642|NCT02587650|20100290|P2|COMPLETED|Overall Study||0
8154643|NCT02587650|20100291|P1|COMPLETED|Overall Study||0
8154644|NCT02587650|20100288|P4|STARTED|Overall Study||0
8154645|NCT02587650|20100289|P3|STARTED|Overall Study||1
8154646|NCT02587650|20100290|P2|STARTED|Overall Study||0
8154647|NCT02587650|20100291|P1|STARTED|Overall Study||0
8154648|NCT02587520|20100317|P18|NOT COMPLETED|Overall Study||0
8154649|NCT02587520|20100318|P17|NOT COMPLETED|Overall Study||0
8154650|NCT02587520|20100319|P16|NOT COMPLETED|Overall Study||0
8154651|NCT02587520|20100320|P15|NOT COMPLETED|Overall Study||0
8154652|NCT02587520|20100321|P14|NOT COMPLETED|Overall Study||1
8154653|NCT02587520|20100322|P13|NOT COMPLETED|Overall Study||0
8154654|NCT02587520|20100323|P12|NOT COMPLETED|Overall Study||4
8154655|NCT02587520|20100324|P11|NOT COMPLETED|Overall Study||3
8154656|NCT02587520|20100325|P10|NOT COMPLETED|Overall Study||5
8154657|NCT02587520|20100326|P9|NOT COMPLETED|Overall Study||3
8154658|NCT02587520|20100327|P8|NOT COMPLETED|Overall Study||2
8154659|NCT02587520|20100328|P7|NOT COMPLETED|Overall Study||3
8154660|NCT02587520|20100329|P6|NOT COMPLETED|Overall Study||3
8154661|NCT02587520|20100330|P5|NOT COMPLETED|Overall Study||0
8154662|NCT02587520|20100331|P4|NOT COMPLETED|Overall Study||5
8154663|NCT02587520|20100332|P3|NOT COMPLETED|Overall Study||1
8154664|NCT02587520|20100333|P2|NOT COMPLETED|Overall Study||2
8154665|NCT02587520|20100334|P1|NOT COMPLETED|Overall Study||2
8154666|NCT02587520|20100317|P18|COMPLETED|Overall Study||78
8154667|NCT02587520|20100318|P17|COMPLETED|Overall Study||76
8154668|NCT02587520|20100319|P16|COMPLETED|Overall Study||72
8154669|NCT02587520|20100320|P15|COMPLETED|Overall Study||78
8154670|NCT02587520|20100321|P14|COMPLETED|Overall Study||73
8154671|NCT02587520|20100322|P13|COMPLETED|Overall Study||77
8154672|NCT02587520|20100323|P12|COMPLETED|Overall Study||69
8154673|NCT02587520|20100324|P11|COMPLETED|Overall Study||73
8154674|NCT02587520|20100325|P10|COMPLETED|Overall Study||71
8154675|NCT02587520|20100326|P9|COMPLETED|Overall Study||73
8154676|NCT02587520|20100327|P8|COMPLETED|Overall Study||71
8154677|NCT02587520|20100328|P7|COMPLETED|Overall Study||73
8154678|NCT02587520|20100329|P6|COMPLETED|Overall Study||72
8154679|NCT02587520|20100330|P5|COMPLETED|Overall Study||75
8154680|NCT02587520|20100331|P4|COMPLETED|Overall Study||74
8154681|NCT02587520|20100332|P3|COMPLETED|Overall Study||77
8154682|NCT02587520|20100333|P2|COMPLETED|Overall Study||69
8154683|NCT02587520|20100334|P1|COMPLETED|Overall Study||78
8154684|NCT02587520|20100317|P18|Safety Analysis Set (SafAS)|Overall Study||78
8154685|NCT02587520|20100318|P17|Safety Analysis Set (SafAS)|Overall Study||76
8154686|NCT02587520|20100319|P16|Safety Analysis Set (SafAS)|Overall Study||72
8154687|NCT02587520|20100320|P15|Safety Analysis Set (SafAS)|Overall Study||78
8154688|NCT02587520|20100321|P14|Safety Analysis Set (SafAS)|Overall Study||73
8154689|NCT02587520|20100322|P13|Safety Analysis Set (SafAS)|Overall Study||77
8154690|NCT02587520|20100323|P12|Safety Analysis Set (SafAS)|Overall Study||72
8154691|NCT02587520|20100324|P11|Safety Analysis Set (SafAS)|Overall Study||76
8154692|NCT02587520|20100325|P10|Safety Analysis Set (SafAS)|Overall Study||76
8154693|NCT02587520|20100326|P9|Safety Analysis Set (SafAS)|Overall Study||76
8154694|NCT02587520|20100327|P8|Safety Analysis Set (SafAS)|Overall Study||73
8154695|NCT02587520|20100328|P7|Safety Analysis Set (SafAS)|Overall Study||76
8154696|NCT02587520|20100329|P6|Safety Analysis Set (SafAS)|Overall Study||75
8154697|NCT02587520|20100330|P5|Safety Analysis Set (SafAS)|Overall Study||75
8154698|NCT02587520|20100331|P4|Safety Analysis Set (SafAS)|Overall Study||77
8154699|NCT02587520|20100332|P3|Safety Analysis Set (SafAS)|Overall Study||77
8154700|NCT02587520|20100333|P2|Safety Analysis Set (SafAS)|Overall Study||71
8154701|NCT02587520|20100334|P1|Safety Analysis Set (SafAS)|Overall Study||79
8154702|NCT02587520|20100317|P18|STARTED|Overall Study||78
8154703|NCT02587520|20100318|P17|STARTED|Overall Study||76
8154704|NCT02587520|20100319|P16|STARTED|Overall Study||72
8154705|NCT02587520|20100320|P15|STARTED|Overall Study||78
8154706|NCT02587520|20100321|P14|STARTED|Overall Study||74
8154707|NCT02587520|20100322|P13|STARTED|Overall Study||77
8154708|NCT02587520|20100323|P12|STARTED|Overall Study||73
8154709|NCT02587520|20100324|P11|STARTED|Overall Study||76
8154710|NCT02587520|20100325|P10|STARTED|Overall Study||76
8154711|NCT02587520|20100326|P9|STARTED|Overall Study||76
8154712|NCT02587520|20100327|P8|STARTED|Overall Study||73
8154713|NCT02587520|20100328|P7|STARTED|Overall Study||76
8154714|NCT02587520|20100329|P6|STARTED|Overall Study||75
8154715|NCT02587520|20100330|P5|STARTED|Overall Study||75
8154716|NCT02587520|20100331|P4|STARTED|Overall Study||79
8154717|NCT02587520|20100332|P3|STARTED|Overall Study||78
8154718|NCT02587520|20100333|P2|STARTED|Overall Study||71
8154719|NCT02587520|20100334|P1|STARTED|Overall Study||80
8154720|NCT02587351|20100374|P2|NOT COMPLETED|Overall Study||0
8154721|NCT02587351|20100375|P1|NOT COMPLETED|Overall Study||0
8154722|NCT02587351|20100374|P2|COMPLETED|Overall Study||264
8154723|NCT02587351|20100375|P1|COMPLETED|Overall Study||268
8154724|NCT02587351|20100374|P2|STARTED|Overall Study||264
8154725|NCT02587351|20100375|P1|STARTED|Overall Study||268
8154726|NCT02587234|20100429|P2|NOT COMPLETED|Overall Study||3
8154727|NCT02587234|20100430|P1|NOT COMPLETED|Overall Study||1
8154728|NCT02587234|20100429|P2|COMPLETED|Overall Study||7
8154729|NCT02587234|20100430|P1|COMPLETED|Overall Study||10
8154730|NCT02587234|20100429|P2|STARTED|Overall Study||10
8154731|NCT02587234|20100430|P1|STARTED|Overall Study||11
8154732|NCT02587221|20100442|P2|NOT COMPLETED|Overall Study||123
8154733|NCT02587221|20100443|P1|NOT COMPLETED|Overall Study||131
8154734|NCT02587221|20100442|P2|COMPLETED|Overall Study||3273
8154735|NCT02587221|20100443|P1|COMPLETED|Overall Study||3263
8154736|NCT02587221|20100442|P2|Treated|Overall Study||3382
8154737|NCT02587221|20100443|P1|Treated|Overall Study||3379
8154738|NCT02587221|20100442|P2|STARTED|Overall Study||3396
8154739|NCT02587221|20100443|P1|STARTED|Overall Study||3394
8154740|NCT02587143|20100489|P2|NOT COMPLETED|Overall Study||0
8154741|NCT02587143|20100490|P1|NOT COMPLETED|Overall Study||1
8154742|NCT02587143|20100489|P2|COMPLETED|Overall Study||60
8154743|NCT02587143|20100490|P1|COMPLETED|Overall Study||65
8154744|NCT02587143|20100489|P2|STARTED|Overall Study||60
8154745|NCT02587143|20100490|P1|STARTED|Overall Study||66
8154746|NCT02587117|20100498|P2|NOT COMPLETED|Overall Study||0
8154747|NCT02587117|20100499|P1|NOT COMPLETED|Overall Study||0
8154748|NCT02587117|20100498|P2|COMPLETED|Overall Study||15
8154749|NCT02587117|20100499|P1|COMPLETED|Overall Study||13
8154750|NCT02587117|20100498|P2|STARTED|Overall Study||15
8154751|NCT02587117|20100499|P1|STARTED|Overall Study||13
8154752|NCT02587065|20100507|P1|NOT COMPLETED|Overall Study||27
8154753|NCT02587065|20100507|P1|COMPLETED|Overall Study||166
8154754|NCT02587065|20100507|P1|STARTED|Overall Study||193
8154755|NCT02586974|20100523|P2|NOT COMPLETED|Overall Study||0
8154756|NCT02586974|20100524|P1|NOT COMPLETED|Overall Study||0
8154757|NCT02586974|20100523|P2|COMPLETED|Overall Study||32
8154758|NCT02586974|20100524|P1|COMPLETED|Overall Study||32
8154759|NCT02586974|20100523|P2|STARTED|Overall Study||32
8154760|NCT02586974|20100524|P1|STARTED|Overall Study||32
8154761|NCT02586909|20100536|P1|NOT COMPLETED|Overall Study||948
8154762|NCT02586909|20100536|P1|COMPLETED|Overall Study||151
8154763|NCT02586909|20100536|P1|STARTED|Overall Study||1099
8154764|NCT02586896|20100542|P2|NOT COMPLETED|Overall Study||17
8154765|NCT02586896|20100543|P1|NOT COMPLETED|Overall Study||19
8154766|NCT02586896|20100542|P2|COMPLETED|Overall Study||133
8154767|NCT02586896|20100543|P1|COMPLETED|Overall Study||131
8154768|NCT02586896|20100542|P2|3-Month Follow-up|Overall Study||123
8154769|NCT02586896|20100543|P1|3-Month Follow-up|Overall Study||126
8154770|NCT02586896|20100542|P2|STARTED|Overall Study||150
8154771|NCT02586896|20100543|P1|STARTED|Overall Study||150
8154784|NCT02586805|20100572|P4|NOT COMPLETED|Overall Study||2
8154785|NCT02586805|20100573|P3|NOT COMPLETED|Overall Study||3
8154786|NCT02586805|20100574|P2|NOT COMPLETED|Overall Study||1
8154787|NCT02586805|20100575|P1|NOT COMPLETED|Overall Study||6
8154788|NCT02586805|20100572|P4|COMPLETED|Overall Study||25
8154789|NCT02586805|20100573|P3|COMPLETED|Overall Study||26
8154790|NCT02586805|20100574|P2|COMPLETED|Overall Study||27
8154791|NCT02586805|20100575|P1|COMPLETED|Overall Study||35
8154792|NCT02586805|20100572|P4|STARTED|Overall Study||27
8154793|NCT02586805|20100573|P3|STARTED|Overall Study||29
8154794|NCT02586805|20100574|P2|STARTED|Overall Study||28
8154795|NCT02586805|20100575|P1|STARTED|Overall Study||41
8154796|NCT02586675|20100597|P1|NOT COMPLETED|Overall Study||0
8154797|NCT02586675|20100597|P1|COMPLETED|Overall Study||7
8154798|NCT02586675|20100597|P1|STARTED|Overall Study||7
8154799|NCT02586506|20100603|P1|NOT COMPLETED|Overall Study||9
8154800|NCT02586506|20100603|P1|COMPLETED|Overall Study||250
8154801|NCT02586506|20100603|P1|STARTED|Overall Study||259
8154802|NCT02586493|20100609|P1|NOT COMPLETED|Overall Study||12
8154803|NCT02586493|20100609|P1|COMPLETED|Overall Study||266
8154804|NCT02586493|20100609|P1|STARTED|Overall Study||278
8154805|NCT02586415|20100617|P2|NOT COMPLETED|Overall Study||25
8154806|NCT02586415|20100618|P1|NOT COMPLETED|Overall Study||14
8154807|NCT02586415|20100617|P2|COMPLETED|Overall Study||65
8154808|NCT02586415|20100618|P1|COMPLETED|Overall Study||78
8154809|NCT02586415|20100617|P2|Day 90 Assessment|Overall Study||65
8154810|NCT02586415|20100618|P1|Day 90 Assessment|Overall Study||78
8154811|NCT02586415|20100617|P2|Day 30 Assessment|Overall Study||70
8154812|NCT02586415|20100618|P1|Day 30 Assessment|Overall Study||81
8154813|NCT02586415|20100617|P2|24 Hour Assessment|Overall Study||90
8154814|NCT02586415|20100618|P1|24 Hour Assessment|Overall Study||91
8154815|NCT02586415|20100617|P2|STARTED|Overall Study||90
8154816|NCT02586415|20100618|P1|STARTED|Overall Study||92
8154817|NCT02586233|20100635|P7|NOT COMPLETED|Overall Study||2
8154818|NCT02586233|20100636|P6|NOT COMPLETED|Overall Study||2
8154819|NCT02586233|20100637|P5|NOT COMPLETED|Overall Study||2
8154820|NCT02586233|20100638|P4|NOT COMPLETED|Overall Study||0
8154821|NCT02586233|20100639|P3|NOT COMPLETED|Overall Study||0
8154822|NCT02586233|20100640|P2|NOT COMPLETED|Overall Study||2
8154823|NCT02586233|20100641|P1|NOT COMPLETED|Overall Study||0
8154824|NCT02586233|20100635|P7|COMPLETED|Overall Study||24
8154825|NCT02586233|20100636|P6|COMPLETED|Overall Study||16
8154826|NCT02586233|20100637|P5|COMPLETED|Overall Study||16
8154827|NCT02586233|20100638|P4|COMPLETED|Overall Study||17
8154828|NCT02586233|20100639|P3|COMPLETED|Overall Study||13
8154829|NCT02586233|20100640|P2|COMPLETED|Overall Study||5
8154830|NCT02586233|20100641|P1|COMPLETED|Overall Study||7
8154831|NCT02586233|20100635|P7|STARTED|Overall Study||26
8154832|NCT02586233|20100636|P6|STARTED|Overall Study||18
8154833|NCT02586233|20100637|P5|STARTED|Overall Study||18
8154834|NCT02586233|20100638|P4|STARTED|Overall Study||17
8154835|NCT02586233|20100639|P3|STARTED|Overall Study||13
8154836|NCT02586233|20100640|P2|STARTED|Overall Study||7
8154837|NCT02586233|20100641|P1|STARTED|Overall Study||7
8154841|NCT02586077|20100705|P1|NOT COMPLETED|Overall Study||8
8154842|NCT02586077|20100705|P1|COMPLETED|Overall Study||28
8154843|NCT02586077|20100705|P1|STARTED|Overall Study||36
8154872|NCT02586012|20100752|P6|NOT COMPLETED|Overall Study||3
8154873|NCT02586012|20100753|P5|NOT COMPLETED|Overall Study||1
8154874|NCT02586012|20100754|P4|NOT COMPLETED|Overall Study||2
8154875|NCT02586012|20100755|P3|NOT COMPLETED|Overall Study||1
8154876|NCT02586012|20100756|P2|NOT COMPLETED|Overall Study||3
8154877|NCT02586012|20100757|P1|NOT COMPLETED|Overall Study||1
8154878|NCT02586012|20100752|P6|COMPLETED|Overall Study||2
8154879|NCT02586012|20100753|P5|COMPLETED|Overall Study||4
8154880|NCT02586012|20100754|P4|COMPLETED|Overall Study||3
8154881|NCT02586012|20100755|P3|COMPLETED|Overall Study||4
8154882|NCT02586012|20100756|P2|COMPLETED|Overall Study||2
8154883|NCT02586012|20100757|P1|COMPLETED|Overall Study||4
8154884|NCT02586012|20100752|P6|STARTED|Overall Study||5
8154885|NCT02586012|20100753|P5|STARTED|Overall Study||5
8154886|NCT02586012|20100754|P4|STARTED|Overall Study||5
8154887|NCT02586012|20100755|P3|STARTED|Overall Study||5
8154888|NCT02586012|20100756|P2|STARTED|Overall Study||5
8154889|NCT02586012|20100757|P1|STARTED|Overall Study||5
8154890|NCT02585999|20100768|P1|NOT COMPLETED|Overall Study||2
8154891|NCT02585999|20100768|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
8154892|NCT02585999|20100768|P1|STARTED|Overall Study||28
8154893|NCT02585960|20100776|P3|NOT COMPLETED|Prophylactic Treatment Period||0
8154894|NCT02585960|20100777|P2|NOT COMPLETED|Prophylactic Treatment Period||5
8154895|NCT02585960|20100778|P1|NOT COMPLETED|Prophylactic Treatment Period||0
8154896|NCT02585960|20100776|P3|COMPLETED|Prophylactic Treatment Period||0
8154897|NCT02585960|20100777|P2|COMPLETED|Prophylactic Treatment Period||43
8154898|NCT02585960|20100778|P1|COMPLETED|Prophylactic Treatment Period||52
8154899|NCT02585960|20100776|P3|STARTED|Prophylactic Treatment Period||0
8154900|NCT02585960|20100777|P2|STARTED|Prophylactic Treatment Period||48
8154901|NCT02585960|20100778|P1|STARTED|Prophylactic Treatment Period||52
8154902|NCT02585960|20100776|P3|NOT COMPLETED|PK/Safety Assessment Period||6
8154903|NCT02585960|20100777|P2|NOT COMPLETED|PK/Safety Assessment Period||10
8154904|NCT02585960|20100778|P1|NOT COMPLETED|PK/Safety Assessment Period||5
8154905|NCT02585960|20100776|P3|COMPLETED|PK/Safety Assessment Period||0
8154906|NCT02585960|20100777|P2|COMPLETED|PK/Safety Assessment Period||48
8154907|NCT02585960|20100778|P1|COMPLETED|PK/Safety Assessment Period||52
8154908|NCT02585960|20100776|P3|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
8154909|NCT02585960|20100777|P2|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
8154910|NCT02585960|20100778|P1|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
8154911|NCT02585960|20100776|P3|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
8154912|NCT02585960|20100777|P2|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
8154913|NCT02585960|20100778|P1|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
8154914|NCT02585960|20100776|P3|STARTED|PK/Safety Assessment Period||6
8154915|NCT02585960|20100777|P2|STARTED|PK/Safety Assessment Period||58
8154916|NCT02585960|20100778|P1|STARTED|PK/Safety Assessment Period||57
8154917|NCT02585934|20100848|P2|NOT COMPLETED|Overall Study||73
8154918|NCT02585934|20100849|P1|NOT COMPLETED|Overall Study||69
8154919|NCT02585934|20100848|P2|COMPLETED|Overall Study||581
8154920|NCT02585934|20100849|P1|COMPLETED|Overall Study||592
8154921|NCT02585934|20100848|P2|Per Protocol (PP)|Overall Study||582
8154922|NCT02585934|20100849|P1|Per Protocol (PP)|Overall Study||603
8154923|NCT02585934|20100848|P2|Intent to Treat (ITT)|Overall Study||633
8154924|NCT02585934|20100849|P1|Intent to Treat (ITT)|Overall Study||643
8154925|NCT02585934|20100848|P2|Safety Population|Overall Study||651
8154926|NCT02585934|20100849|P1|Safety Population|Overall Study||656
8154927|NCT02585934|20100848|P2|STARTED|Overall Study||654
8154928|NCT02585934|20100849|P1|STARTED|Overall Study||661
8154929|NCT02585895|20100872|P2|NOT COMPLETED|Post-primary Period||0
8154930|NCT02585895|20100873|P1|NOT COMPLETED|Post-primary Period||0
8154931|NCT02585895|20100872|P2|COMPLETED|Post-primary Period||19
8154932|NCT02585895|20100873|P1|COMPLETED|Post-primary Period||20
8154933|NCT02585895|20100872|P2|STARTED|Post-primary Period||19
8154934|NCT02585895|20100873|P1|STARTED|Post-primary Period||20
8154935|NCT02585895|20100872|P2|NOT COMPLETED|Primary Period||0
8154936|NCT02585895|20100873|P1|NOT COMPLETED|Primary Period||0
8154937|NCT02585895|20100872|P2|COMPLETED|Primary Period||19
8154938|NCT02585895|20100873|P1|COMPLETED|Primary Period||20
8154939|NCT02585895|20100872|P2|STARTED|Primary Period||19
8154940|NCT02585895|20100873|P1|STARTED|Primary Period||20
8154941|NCT02585843|20100890|P2|NOT COMPLETED|Overall Study||0
8154942|NCT02585843|20100891|P1|NOT COMPLETED|Overall Study||1
8154943|NCT02585843|20100890|P2|COMPLETED|Overall Study||10
8154944|NCT02585843|20100891|P1|COMPLETED|Overall Study||9
8154945|NCT02585843|20100890|P2|STARTED|Overall Study||10
8154946|NCT02585843|20100891|P1|STARTED|Overall Study||10
8154947|NCT02585830|20100905|P1|NOT COMPLETED|Overall Study||3
8154948|NCT02585830|20100905|P1|COMPLETED|Overall Study||22
8154949|NCT02585830|20100905|P1|STARTED|Overall Study||25
8154950|NCT02585778|20100914|P2|NOT COMPLETED|Overall Study||15
8154951|NCT02585778|20100915|P1|NOT COMPLETED|Overall Study||33
8154952|NCT02585778|20100914|P2|COMPLETED|Overall Study||157
8154953|NCT02585778|20100915|P1|COMPLETED|Overall Study||312
8154954|NCT02585778|20100914|P2|T2DM Participants|Overall Study||147
8154955|NCT02585778|20100915|P1|T2DM Participants|Overall Study||294
8154956|NCT02585778|20100914|P2|T1DM Participants|Overall Study||25
8154957|NCT02585778|20100915|P1|T1DM Participants|Overall Study||51
8154958|NCT02585778|20100914|P2|mITT Population|Overall Study||164
8154959|NCT02585778|20100915|P1|mITT Population|Overall Study||333
8154960|NCT02585778|20100914|P2|ITT Population|Overall Study||167
8154961|NCT02585778|20100915|P1|ITT Population|Overall Study||336
8154962|NCT02585778|20100914|P2|Treated (Safety Population)|Overall Study||170
8154963|NCT02585778|20100915|P1|Treated (Safety Population)|Overall Study||344
8154964|NCT02585778|20100914|P2|STARTED|Overall Study|Randomized|172
8154965|NCT02585778|20100915|P1|STARTED|Overall Study|Randomized|345
8154966|NCT02585713|20101031|P2|NOT COMPLETED|Overall Study||8
8154967|NCT02585713|20101032|P1|NOT COMPLETED|Overall Study||5
8154968|NCT02585713|20101031|P2|COMPLETED|Overall Study||142
8154969|NCT02585713|20101032|P1|COMPLETED|Overall Study||145
8154970|NCT02585713|20101031|P2|STARTED|Overall Study||150
8154971|NCT02585713|20101032|P1|STARTED|Overall Study||150
8154972|NCT02585700|20101044|P2|NOT COMPLETED|Overall Study||0
8154973|NCT02585700|20101045|P1|NOT COMPLETED|Overall Study||0
8154974|NCT02585700|20101044|P2|COMPLETED|Overall Study||30
8154975|NCT02585700|20101045|P1|COMPLETED|Overall Study||30
8154976|NCT02585700|20101044|P2|STARTED|Overall Study||30
8154977|NCT02585700|20101045|P1|STARTED|Overall Study||30
8154978|NCT02585245|20101071|P1|NOT COMPLETED|Overall Study||13
8154979|NCT02585245|20101071|P1|COMPLETED|Overall Study||594
8154980|NCT02585245|20101071|P1|STARTED|Overall Study||607
8154981|NCT02584998|20101079|P3|NOT COMPLETED|Overall Study||0
8154982|NCT02584998|20101080|P2|NOT COMPLETED|Overall Study||0
8154983|NCT02584998|20101081|P1|NOT COMPLETED|Overall Study||0
8154984|NCT02584998|20101079|P3|COMPLETED|Overall Study||261
8154985|NCT02584998|20101080|P2|COMPLETED|Overall Study||261
8154986|NCT02584998|20101081|P1|COMPLETED|Overall Study||260
8154987|NCT02584998|20101079|P3|STARTED|Overall Study||261
8154988|NCT02584998|20101080|P2|STARTED|Overall Study||261
8154989|NCT02584998|20101081|P1|STARTED|Overall Study||260
8154990|NCT02584959|20101095|P3|NOT COMPLETED|Period 2||2
8154991|NCT02584959|20101096|P2|NOT COMPLETED|Period 2||1
8154992|NCT02584959|20101097|P1|NOT COMPLETED|Period 2||6
8154993|NCT02584959|20101095|P3|COMPLETED|Period 2||13
8154994|NCT02584959|20101096|P2|COMPLETED|Period 2||24
8154995|NCT02584959|20101097|P1|COMPLETED|Period 2||22
8154996|NCT02584959|20101095|P3|STARTED|Period 2||15
8154997|NCT02584959|20101096|P2|STARTED|Period 2||25
8154998|NCT02584959|20101097|P1|STARTED|Period 2||28
8154999|NCT02584959|20101095|P3|NOT COMPLETED|Period 1||0
8155000|NCT02584959|20101096|P2|NOT COMPLETED|Period 1||4
8155001|NCT02584959|20101097|P1|NOT COMPLETED|Period 1||3
8155002|NCT02584959|20101095|P3|COMPLETED|Period 1||15
8155003|NCT02584959|20101096|P2|COMPLETED|Period 1||25
8155004|NCT02584959|20101097|P1|COMPLETED|Period 1||28
8155005|NCT02584959|20101095|P3|STARTED|Period 1||15
8155006|NCT02584959|20101096|P2|STARTED|Period 1||29
8155007|NCT02584959|20101097|P1|STARTED|Period 1||31
8155008|NCT02584868|20101154|P2|NOT COMPLETED|Overall Study||0
8155009|NCT02584868|20101155|P1|NOT COMPLETED|Overall Study||0
8155010|NCT02584868|20101154|P2|COMPLETED|Overall Study||44
8155011|NCT02584868|20101155|P1|COMPLETED|Overall Study||44
8155012|NCT02584868|20101154|P2|STARTED|Overall Study||44
8155013|NCT02584868|20101155|P1|STARTED|Overall Study||44
8155014|NCT02584855|20101225|P6|NOT COMPLETED|Post Treatment Follow-up Period||0
8155015|NCT02584855|20101226|P5|NOT COMPLETED|Post Treatment Follow-up Period||8
8155016|NCT02584855|20101227|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
8155017|NCT02584855|20101228|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
8155018|NCT02584855|20101229|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
8155019|NCT02584855|20101230|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
8155020|NCT02584855|20101225|P6|COMPLETED|Post Treatment Follow-up Period||12
8155021|NCT02584855|20101226|P5|COMPLETED|Post Treatment Follow-up Period||347
8155022|NCT02584855|20101227|P4|COMPLETED|Post Treatment Follow-up Period||0
8155023|NCT02584855|20101228|P3|COMPLETED|Post Treatment Follow-up Period||0
8155024|NCT02584855|20101229|P2|COMPLETED|Post Treatment Follow-up Period||0
8155025|NCT02584855|20101230|P1|COMPLETED|Post Treatment Follow-up Period||0
8155026|NCT02584855|20101225|P6|STARTED|Post Treatment Follow-up Period||12
8155027|NCT02584855|20101226|P5|STARTED|Post Treatment Follow-up Period||355
8155028|NCT02584855|20101227|P4|STARTED|Post Treatment Follow-up Period||0
8155029|NCT02584855|20101228|P3|STARTED|Post Treatment Follow-up Period||0
8155030|NCT02584855|20101229|P2|STARTED|Post Treatment Follow-up Period||0
8155031|NCT02584855|20101230|P1|STARTED|Post Treatment Follow-up Period||0
8155032|NCT02584855|20101225|P6|NOT COMPLETED|Double-Blind Withdrawal Period||0
8155033|NCT02584855|20101226|P5|NOT COMPLETED|Double-Blind Withdrawal Period||0
8155034|NCT02584855|20101227|P4|NOT COMPLETED|Double-Blind Withdrawal Period||1
8155035|NCT02584855|20101228|P3|NOT COMPLETED|Double-Blind Withdrawal Period||2
8155036|NCT02584855|20101229|P2|NOT COMPLETED|Double-Blind Withdrawal Period||15
8155037|NCT02584855|20101230|P1|NOT COMPLETED|Double-Blind Withdrawal Period||0
8155038|NCT02584855|20101225|P6|COMPLETED|Double-Blind Withdrawal Period||0
8155039|NCT02584855|20101226|P5|COMPLETED|Double-Blind Withdrawal Period||0
8155040|NCT02584855|20101227|P4|COMPLETED|Double-Blind Withdrawal Period||78
8155041|NCT02584855|20101228|P3|COMPLETED|Double-Blind Withdrawal Period||77
8155042|NCT02584855|20101229|P2|COMPLETED|Double-Blind Withdrawal Period||118
8155043|NCT02584855|20101230|P1|COMPLETED|Double-Blind Withdrawal Period||0
8155044|NCT02584855|20101225|P6|Relapsed|Double-Blind Withdrawal Period||0
8155045|NCT02584855|20101226|P5|Relapsed|Double-Blind Withdrawal Period||0
8155046|NCT02584855|20101227|P4|Relapsed|Double-Blind Withdrawal Period||30
8155047|NCT02584855|20101228|P3|Relapsed|Double-Blind Withdrawal Period||67
8155048|NCT02584855|20101229|P2|Relapsed|Double-Blind Withdrawal Period||0
8155049|NCT02584855|20101230|P1|Relapsed|Double-Blind Withdrawal Period||0
8155050|NCT02584855|20101225|P6|STARTED|Double-Blind Withdrawal Period||0
8155051|NCT02584855|20101226|P5|STARTED|Double-Blind Withdrawal Period||0
8155052|NCT02584855|20101227|P4|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
8155053|NCT02584855|20101228|P3|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
8155054|NCT02584855|20101229|P2|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
8155055|NCT02584855|20101230|P1|STARTED|Double-Blind Withdrawal Period||0
8155056|NCT02584855|20101225|P6|NOT COMPLETED|Open-Label Treatment Period||0
8155057|NCT02584855|20101226|P5|NOT COMPLETED|Open-Label Treatment Period||0
8155058|NCT02584855|20101227|P4|NOT COMPLETED|Open-Label Treatment Period||0
8155059|NCT02584855|20101228|P3|NOT COMPLETED|Open-Label Treatment Period||0
8155060|NCT02584855|20101229|P2|NOT COMPLETED|Open-Label Treatment Period||0
8155061|NCT02584855|20101230|P1|NOT COMPLETED|Open-Label Treatment Period||103
8155062|NCT02584855|20101225|P6|COMPLETED|Open-Label Treatment Period||0
8155063|NCT02584855|20101226|P5|COMPLETED|Open-Label Treatment Period||0
8155064|NCT02584855|20101227|P4|COMPLETED|Open-Label Treatment Period||0
8155065|NCT02584855|20101228|P3|COMPLETED|Open-Label Treatment Period||0
8155066|NCT02584855|20101229|P2|COMPLETED|Open-Label Treatment Period||0
8155067|NCT02584855|20101230|P1|COMPLETED|Open-Label Treatment Period||291
8155068|NCT02584855|20101225|P6|Non-randomized|Open-Label Treatment Period||0
8155069|NCT02584855|20101226|P5|Non-randomized|Open-Label Treatment Period||0
8155070|NCT02584855|20101227|P4|Non-randomized|Open-Label Treatment Period||0
8155071|NCT02584855|20101228|P3|Non-randomized|Open-Label Treatment Period||0
8155072|NCT02584855|20101229|P2|Non-randomized|Open-Label Treatment Period||0
8155073|NCT02584855|20101230|P1|Non-randomized|Open-Label Treatment Period||133
8155074|NCT02584855|20101225|P6|Met Randomization Criteria|Open-Label Treatment Period||0
8155075|NCT02584855|20101226|P5|Met Randomization Criteria|Open-Label Treatment Period||0
8155076|NCT02584855|20101227|P4|Met Randomization Criteria|Open-Label Treatment Period||0
8155077|NCT02584855|20101228|P3|Met Randomization Criteria|Open-Label Treatment Period||0
8155078|NCT02584855|20101229|P2|Met Randomization Criteria|Open-Label Treatment Period||0
8155079|NCT02584855|20101230|P1|Met Randomization Criteria|Open-Label Treatment Period||158
8155080|NCT02584855|20101225|P6|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155081|NCT02584855|20101226|P5|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155082|NCT02584855|20101227|P4|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155083|NCT02584855|20101228|P3|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155084|NCT02584855|20101229|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155085|NCT02584855|20101230|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
8155086|NCT02584855|20101225|P6|STARTED|Open-Label Treatment Period||0
8155087|NCT02584855|20101226|P5|STARTED|Open-Label Treatment Period||0
8155088|NCT02584855|20101227|P4|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
8155089|NCT02584855|20101228|P3|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
8155090|NCT02584855|20101229|P2|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
8155091|NCT02584855|20101230|P1|STARTED|Open-Label Treatment Period||394
8155092|NCT02584790|20101264|P1|NOT COMPLETED|Overall Study||15
8155093|NCT02584790|20101264|P1|COMPLETED|Overall Study||40
8155094|NCT02584790|20101264|P1|STARTED|Overall Study||55
8155095|NCT02584725|20101273|P3|NOT COMPLETED|Overall Study||0
8155096|NCT02584725|20101274|P2|NOT COMPLETED|Overall Study||0
8155097|NCT02584725|20101275|P1|NOT COMPLETED|Overall Study||0
8155098|NCT02584725|20101273|P3|COMPLETED|Overall Study||28
8155099|NCT02584725|20101274|P2|COMPLETED|Overall Study||28
8155100|NCT02584725|20101275|P1|COMPLETED|Overall Study||28
8155101|NCT02584725|20101273|P3|STARTED|Overall Study||28
8155102|NCT02584725|20101274|P2|STARTED|Overall Study||28
8155103|NCT02584725|20101275|P1|STARTED|Overall Study||28
8155104|NCT02584686|20101318|P2|NOT COMPLETED|Overall Study||0
8155105|NCT02584686|20101319|P1|NOT COMPLETED|Overall Study||0
8155106|NCT02584686|20101318|P2|COMPLETED|Overall Study||12
8155107|NCT02584686|20101319|P1|COMPLETED|Overall Study||12
8155108|NCT02584686|20101318|P2|STARTED|Overall Study||12
8155109|NCT02584686|20101319|P1|STARTED|Overall Study||12
8155110|NCT02584673|20101347|P2|NOT COMPLETED|Overall Study||0
8155111|NCT02584673|20101348|P1|NOT COMPLETED|Overall Study||0
8155112|NCT02584673|20101347|P2|COMPLETED|Overall Study||15
8155113|NCT02584673|20101348|P1|COMPLETED|Overall Study||15
8155114|NCT02584673|20101347|P2|STARTED|Overall Study||15
8155115|NCT02584673|20101348|P1|STARTED|Overall Study||15
8155116|NCT02584660|20101362|P2|NOT COMPLETED|Overall Study||8
8155117|NCT02584660|20101363|P1|NOT COMPLETED|Overall Study||7
8155118|NCT02584660|20101362|P2|COMPLETED|Overall Study||55
8155119|NCT02584660|20101363|P1|COMPLETED|Overall Study||44
8155120|NCT02584660|20101362|P2|Treated|Overall Study||63
8155121|NCT02584660|20101363|P1|Treated|Overall Study||49
8155122|NCT02584660|20101362|P2|STARTED|Overall Study||63
8155123|NCT02584660|20101363|P1|STARTED|Overall Study||51
8155124|NCT02584608|20101379|P1|NOT COMPLETED|Overall Study||0
8155125|NCT02584608|20101379|P1|COMPLETED|Overall Study||12
8155126|NCT02584608|20101379|P1|STARTED|Overall Study||12
8155127|NCT02584504|20101387|P3|NOT COMPLETED|Open-label Treatment||8
8155128|NCT02584504|20101388|P2|NOT COMPLETED|Open-label Treatment||4
8155129|NCT02584504|20101389|P1|NOT COMPLETED|Open-label Treatment||2
8155130|NCT02584504|20101387|P3|COMPLETED|Open-label Treatment||47
8155131|NCT02584504|20101388|P2|COMPLETED|Open-label Treatment||47
8155132|NCT02584504|20101389|P1|COMPLETED|Open-label Treatment||52
8155133|NCT02584504|20101387|P3|Treated|Open-label Treatment||54
8155134|NCT02584504|20101388|P2|Treated|Open-label Treatment||50
8155135|NCT02584504|20101389|P1|Treated|Open-label Treatment||54
8155136|NCT02584504|20101387|P3|STARTED|Open-label Treatment||55
8155137|NCT02584504|20101388|P2|STARTED|Open-label Treatment||51
8155138|NCT02584504|20101389|P1|STARTED|Open-label Treatment||54
8155139|NCT02584504|20101387|P3|NOT COMPLETED|Double-blind Treatment||1
8155140|NCT02584504|20101388|P2|NOT COMPLETED|Double-blind Treatment||2
8155141|NCT02584504|20101389|P1|NOT COMPLETED|Double-blind Treatment||0
8155142|NCT02584504|20101387|P3|COMPLETED|Double-blind Treatment||55
8155143|NCT02584504|20101388|P2|COMPLETED|Double-blind Treatment||51
8155144|NCT02584504|20101389|P1|COMPLETED|Double-blind Treatment||54
8155145|NCT02584504|20101387|P3|Safety Population|Double-blind Treatment||56
8155146|NCT02584504|20101388|P2|Safety Population|Double-blind Treatment||53
8155147|NCT02584504|20101389|P1|Safety Population|Double-blind Treatment||54
8155148|NCT02584504|20101387|P3|mITT Population|Double-blind Treatment||56
8155149|NCT02584504|20101388|P2|mITT Population|Double-blind Treatment||53
8155150|NCT02584504|20101389|P1|mITT Population|Double-blind Treatment||54
8155151|NCT02584504|20101387|P3|ITT Population|Double-blind Treatment||56
8155152|NCT02584504|20101388|P2|ITT Population|Double-blind Treatment||53
8155153|NCT02584504|20101389|P1|ITT Population|Double-blind Treatment||54
8155154|NCT02584504|20101387|P3|STARTED|Double-blind Treatment|Randomized|56
8155155|NCT02584504|20101388|P2|STARTED|Double-blind Treatment|Randomized|53
8155156|NCT02584504|20101389|P1|STARTED|Double-blind Treatment|Randomized|54
8155157|NCT02584452|20101445|P2|NOT COMPLETED|Overall Study||2
8155158|NCT02584452|20101446|P1|NOT COMPLETED|Overall Study||2
8155159|NCT02584452|20101445|P2|COMPLETED|Overall Study||21
8155160|NCT02584452|20101446|P1|COMPLETED|Overall Study||32
8155161|NCT02584452|20101445|P2|STARTED|Overall Study||23
8155162|NCT02584452|20101446|P1|STARTED|Overall Study||34
8155163|NCT02584257|20101474|P9|NOT COMPLETED|Period 5||0
8155164|NCT02584257|20101475|P8|NOT COMPLETED|Period 5||0
8155165|NCT02584257|20101476|P7|NOT COMPLETED|Period 5||0
8155166|NCT02584257|20101477|P6|NOT COMPLETED|Period 5||0
8155167|NCT02584257|20101478|P5|NOT COMPLETED|Period 5||0
8155168|NCT02584257|20101479|P4|NOT COMPLETED|Period 5||0
8155169|NCT02584257|20101480|P3|NOT COMPLETED|Period 5||0
8155170|NCT02584257|20101481|P2|NOT COMPLETED|Period 5||0
8155171|NCT02584257|20101482|P1|NOT COMPLETED|Period 5||0
8155172|NCT02584257|20101474|P9|COMPLETED|Period 5||9
8155173|NCT02584257|20101475|P8|COMPLETED|Period 5||9
8155174|NCT02584257|20101476|P7|COMPLETED|Period 5||17
8155175|NCT02584257|20101477|P6|COMPLETED|Period 5||10
8155176|NCT02584257|20101478|P5|COMPLETED|Period 5||10
8155177|NCT02584257|20101479|P4|COMPLETED|Period 5||8
8155178|NCT02584257|20101480|P3|COMPLETED|Period 5||9
8155179|NCT02584257|20101481|P2|COMPLETED|Period 5||8
8155180|NCT02584257|20101482|P1|COMPLETED|Period 5||8
8155181|NCT02584257|20101474|P9|STARTED|Period 5||9
8155182|NCT02584257|20101475|P8|STARTED|Period 5||9
8155183|NCT02584257|20101476|P7|STARTED|Period 5||17
8155184|NCT02584257|20101477|P6|STARTED|Period 5||10
8155185|NCT02584257|20101478|P5|STARTED|Period 5||10
8155186|NCT02584257|20101479|P4|STARTED|Period 5||8
8155187|NCT02584257|20101480|P3|STARTED|Period 5||9
8155188|NCT02584257|20101481|P2|STARTED|Period 5||8
8155189|NCT02584257|20101482|P1|STARTED|Period 5||8
8155190|NCT02584257|20101474|P9|NOT COMPLETED|Period 4||0
8155191|NCT02584257|20101475|P8|NOT COMPLETED|Period 4||0
8155192|NCT02584257|20101476|P7|NOT COMPLETED|Period 4||0
8155193|NCT02584257|20101477|P6|NOT COMPLETED|Period 4||0
8155194|NCT02584257|20101478|P5|NOT COMPLETED|Period 4||0
8155195|NCT02584257|20101479|P4|NOT COMPLETED|Period 4||0
8155196|NCT02584257|20101480|P3|NOT COMPLETED|Period 4||0
8155197|NCT02584257|20101481|P2|NOT COMPLETED|Period 4||0
8155198|NCT02584257|20101482|P1|NOT COMPLETED|Period 4||0
8155199|NCT02584257|20101474|P9|COMPLETED|Period 4||9
8155200|NCT02584257|20101475|P8|COMPLETED|Period 4||9
8155201|NCT02584257|20101476|P7|COMPLETED|Period 4||17
8155202|NCT02584257|20101477|P6|COMPLETED|Period 4||10
8155203|NCT02584257|20101478|P5|COMPLETED|Period 4||10
8155204|NCT02584257|20101479|P4|COMPLETED|Period 4||8
8155205|NCT02584257|20101480|P3|COMPLETED|Period 4||9
8155206|NCT02584257|20101481|P2|COMPLETED|Period 4||8
8155207|NCT02584257|20101482|P1|COMPLETED|Period 4||8
8155208|NCT02584257|20101474|P9|STARTED|Period 4||9
8155209|NCT02584257|20101475|P8|STARTED|Period 4||9
8155210|NCT02584257|20101476|P7|STARTED|Period 4||17
8155211|NCT02584257|20101477|P6|STARTED|Period 4||10
8155212|NCT02584257|20101478|P5|STARTED|Period 4||10
8155213|NCT02584257|20101479|P4|STARTED|Period 4||8
8155214|NCT02584257|20101480|P3|STARTED|Period 4||9
8155215|NCT02584257|20101481|P2|STARTED|Period 4||8
8155216|NCT02584257|20101482|P1|STARTED|Period 4||8
8155217|NCT02584257|20101474|P9|NOT COMPLETED|Period 3||0
8155218|NCT02584257|20101475|P8|NOT COMPLETED|Period 3||0
8155219|NCT02584257|20101476|P7|NOT COMPLETED|Period 3||0
8155220|NCT02584257|20101477|P6|NOT COMPLETED|Period 3||0
8155221|NCT02584257|20101478|P5|NOT COMPLETED|Period 3||0
8155222|NCT02584257|20101479|P4|NOT COMPLETED|Period 3||0
8155223|NCT02584257|20101480|P3|NOT COMPLETED|Period 3||0
8155224|NCT02584257|20101481|P2|NOT COMPLETED|Period 3||0
8155225|NCT02584257|20101482|P1|NOT COMPLETED|Period 3||0
8155226|NCT02584257|20101474|P9|COMPLETED|Period 3||9
8155227|NCT02584257|20101475|P8|COMPLETED|Period 3||9
8155228|NCT02584257|20101476|P7|COMPLETED|Period 3||17
8155229|NCT02584257|20101477|P6|COMPLETED|Period 3||10
8155230|NCT02584257|20101478|P5|COMPLETED|Period 3||10
8155231|NCT02584257|20101479|P4|COMPLETED|Period 3||8
8155232|NCT02584257|20101480|P3|COMPLETED|Period 3||9
8155233|NCT02584257|20101481|P2|COMPLETED|Period 3||8
8155234|NCT02584257|20101482|P1|COMPLETED|Period 3||8
8155235|NCT02584257|20101474|P9|STARTED|Period 3||9
8155236|NCT02584257|20101475|P8|STARTED|Period 3||9
8155237|NCT02584257|20101476|P7|STARTED|Period 3||17
8155238|NCT02584257|20101477|P6|STARTED|Period 3||10
8155239|NCT02584257|20101478|P5|STARTED|Period 3||10
8155240|NCT02584257|20101479|P4|STARTED|Period 3||8
8155241|NCT02584257|20101480|P3|STARTED|Period 3||9
8155242|NCT02584257|20101481|P2|STARTED|Period 3||8
8155243|NCT02584257|20101482|P1|STARTED|Period 3||8
8155244|NCT02584257|20101474|P9|NOT COMPLETED|Period 2||0
8155245|NCT02584257|20101475|P8|NOT COMPLETED|Period 2||0
8155246|NCT02584257|20101476|P7|NOT COMPLETED|Period 2||0
8155247|NCT02584257|20101477|P6|NOT COMPLETED|Period 2||0
8155248|NCT02584257|20101478|P5|NOT COMPLETED|Period 2||0
8155249|NCT02584257|20101479|P4|NOT COMPLETED|Period 2||0
8155250|NCT02584257|20101480|P3|NOT COMPLETED|Period 2||0
8155251|NCT02584257|20101481|P2|NOT COMPLETED|Period 2||1
8155252|NCT02584257|20101482|P1|NOT COMPLETED|Period 2||1
8155253|NCT02584257|20101474|P9|COMPLETED|Period 2||9
8155254|NCT02584257|20101475|P8|COMPLETED|Period 2||9
8155255|NCT02584257|20101476|P7|COMPLETED|Period 2||17
8155256|NCT02584257|20101477|P6|COMPLETED|Period 2||10
8155257|NCT02584257|20101478|P5|COMPLETED|Period 2||10
8155258|NCT02584257|20101479|P4|COMPLETED|Period 2||8
8155259|NCT02584257|20101480|P3|COMPLETED|Period 2||9
8155260|NCT02584257|20101481|P2|COMPLETED|Period 2||8
8155261|NCT02584257|20101482|P1|COMPLETED|Period 2||8
8155262|NCT02584257|20101474|P9|STARTED|Period 2||9
8155263|NCT02584257|20101475|P8|STARTED|Period 2||9
8155264|NCT02584257|20101476|P7|STARTED|Period 2||17
8155265|NCT02584257|20101477|P6|STARTED|Period 2||10
8155266|NCT02584257|20101478|P5|STARTED|Period 2||10
8155267|NCT02584257|20101479|P4|STARTED|Period 2||8
8155268|NCT02584257|20101480|P3|STARTED|Period 2||9
8155269|NCT02584257|20101481|P2|STARTED|Period 2||9
8155270|NCT02584257|20101482|P1|STARTED|Period 2||9
8155271|NCT02584257|20101474|P9|NOT COMPLETED|Period 1||0
8155272|NCT02584257|20101475|P8|NOT COMPLETED|Period 1||0
8155273|NCT02584257|20101476|P7|NOT COMPLETED|Period 1||1
8155274|NCT02584257|20101477|P6|NOT COMPLETED|Period 1||0
8155275|NCT02584257|20101478|P5|NOT COMPLETED|Period 1||0
8155276|NCT02584257|20101479|P4|NOT COMPLETED|Period 1||0
8155277|NCT02584257|20101480|P3|NOT COMPLETED|Period 1||0
8155278|NCT02584257|20101481|P2|NOT COMPLETED|Period 1||0
8155279|NCT02584257|20101482|P1|NOT COMPLETED|Period 1||0
8155280|NCT02584257|20101474|P9|COMPLETED|Period 1||9
8155281|NCT02584257|20101475|P8|COMPLETED|Period 1||9
8155282|NCT02584257|20101476|P7|COMPLETED|Period 1||17
8155283|NCT02584257|20101477|P6|COMPLETED|Period 1||10
8155284|NCT02584257|20101478|P5|COMPLETED|Period 1||10
8155285|NCT02584257|20101479|P4|COMPLETED|Period 1||8
8155286|NCT02584257|20101480|P3|COMPLETED|Period 1||9
8155287|NCT02584257|20101481|P2|COMPLETED|Period 1||9
8155288|NCT02584257|20101482|P1|COMPLETED|Period 1||9
8155289|NCT02584257|20101474|P9|STARTED|Period 1||9
8155290|NCT02584257|20101475|P8|STARTED|Period 1||9
8155291|NCT02584257|20101476|P7|STARTED|Period 1||18
8155292|NCT02584257|20101477|P6|STARTED|Period 1||10
8155293|NCT02584257|20101478|P5|STARTED|Period 1||10
8155294|NCT02584257|20101479|P4|STARTED|Period 1||8
8155295|NCT02584257|20101480|P3|STARTED|Period 1||9
8155296|NCT02584257|20101481|P2|STARTED|Period 1||9
8155297|NCT02584257|20101482|P1|STARTED|Period 1||9
8155298|NCT02584140|20101494|P1|NOT COMPLETED|Overall Study||53
8155299|NCT02584140|20101494|P1|COMPLETED|Overall Study||83
8155300|NCT02584140|20101494|P1|STARTED|Overall Study||136
8155301|NCT02583477|20101503|P2|NOT COMPLETED|Overall Study||20
8155302|NCT02583477|20101504|P1|NOT COMPLETED|Overall Study||3
8155303|NCT02583477|20101503|P2|COMPLETED|Overall Study||0
8155304|NCT02583477|20101504|P1|COMPLETED|Overall Study||0
8155305|NCT02583477|20101503|P2|Completed Treatment|Overall Study||0
8155306|NCT02583477|20101504|P1|Completed Treatment|Overall Study||0
8155307|NCT02583477|20101503|P2|Received Treatment|Overall Study||20
8155308|NCT02583477|20101504|P1|Received Treatment|Overall Study||3
8155309|NCT02583477|20101503|P2|STARTED|Overall Study||20
8155310|NCT02583477|20101504|P1|STARTED|Overall Study||3
8155311|NCT02583425|20101524|P1|NOT COMPLETED|Treatment Period||1
8155312|NCT02583425|20101524|P1|COMPLETED|Treatment Period||9
8155313|NCT02583425|20101524|P1|STARTED|Treatment Period||10
8155314|NCT02583425|20101524|P1|NOT COMPLETED|Baseline||5
8155315|NCT02583425|20101524|P1|COMPLETED|Baseline||10
8155316|NCT02583425|20101524|P1|STARTED|Baseline||15
8155317|NCT02583425|20101524|P1|NOT COMPLETED|Screening||12
8155318|NCT02583425|20101524|P1|COMPLETED|Screening||15
8155319|NCT02583425|20101524|P1|STARTED|Screening||27
8155320|NCT02583399|20101529|P1|NOT COMPLETED|Overall Study||6
8155321|NCT02583399|20101529|P1|COMPLETED|Overall Study||24
8155322|NCT02583399|20101529|P1|STARTED|Overall Study||30
8155323|NCT02583360|20101538|P2|NOT COMPLETED|Overall Study||0
8155324|NCT02583360|20101539|P1|NOT COMPLETED|Overall Study||0
8155325|NCT02583360|20101538|P2|COMPLETED|Overall Study||49
8155326|NCT02583360|20101539|P1|COMPLETED|Overall Study||60
8155327|NCT02583360|20101538|P2|STARTED|Overall Study||49
8155328|NCT02583360|20101539|P1|STARTED|Overall Study||60
8155329|NCT02583269|20101554|P5|NOT COMPLETED|Overall Study||0
8155330|NCT02583269|20101555|P4|NOT COMPLETED|Overall Study||0
8155331|NCT02583269|20101556|P3|NOT COMPLETED|Overall Study||0
8155332|NCT02583269|20101557|P2|NOT COMPLETED|Overall Study||0
8155333|NCT02583269|20101558|P1|NOT COMPLETED|Overall Study||1
8155334|NCT02583269|20101554|P5|COMPLETED|Overall Study||6
8155335|NCT02583269|20101555|P4|COMPLETED|Overall Study||5
8155336|NCT02583269|20101556|P3|COMPLETED|Overall Study||3
8155337|NCT02583269|20101557|P2|COMPLETED|Overall Study||7
8155338|NCT02583269|20101558|P1|COMPLETED|Overall Study||2
8155339|NCT02583269|20101554|P5|STARTED|Overall Study||6
8155340|NCT02583269|20101555|P4|STARTED|Overall Study||5
8155341|NCT02583269|20101556|P3|STARTED|Overall Study||3
8155342|NCT02583269|20101557|P2|STARTED|Overall Study||7
8155343|NCT02583269|20101558|P1|STARTED|Overall Study||3
8155344|NCT02583256|20101587|P4|NOT COMPLETED|Overall Study||3
8155345|NCT02583256|20101588|P3|NOT COMPLETED|Overall Study||2
8155346|NCT02583256|20101589|P2|NOT COMPLETED|Overall Study||2
8155347|NCT02583256|20101590|P1|NOT COMPLETED|Overall Study||3
8155348|NCT02583256|20101587|P4|COMPLETED|Overall Study||390
8155349|NCT02583256|20101588|P3|COMPLETED|Overall Study||400
8155350|NCT02583256|20101589|P2|COMPLETED|Overall Study||401
8155351|NCT02583256|20101590|P1|COMPLETED|Overall Study||400
8155352|NCT02583256|20101587|P4|Exposed|Overall Study||393
8155353|NCT02583256|20101588|P3|Exposed|Overall Study||402
8155354|NCT02583256|20101589|P2|Exposed|Overall Study||403
8155355|NCT02583256|20101590|P1|Exposed|Overall Study||403
8155356|NCT02583256|20101587|P4|STARTED|Overall Study||393
8155357|NCT02583256|20101588|P3|STARTED|Overall Study||402
8155358|NCT02583256|20101589|P2|STARTED|Overall Study||403
8155359|NCT02583256|20101590|P1|STARTED|Overall Study||403
8155360|NCT02583230|20101678|P1|NOT COMPLETED|Overall Study||0
8155361|NCT02583230|20101678|P1|COMPLETED|Overall Study||11
8155362|NCT02583230|20101678|P1|STARTED|Overall Study||11
8155372|NCT02582983|20101748|P1|NOT COMPLETED|Overall Study||6
8155373|NCT02582983|20101748|P1|COMPLETED|Overall Study||17
8155374|NCT02582983|20101748|P1|STARTED|Overall Study||23
8155375|NCT02582970|20101753|P1|NOT COMPLETED|Overall Study||0
8155376|NCT02582970|20101753|P1|COMPLETED|Overall Study||40
8155377|NCT02582970|20101753|P1|STARTED|Overall Study||40
8155378|NCT02582866|20101763|P1|NOT COMPLETED|Overall Study||22
8155379|NCT02582866|20101763|P1|COMPLETED|Overall Study||84
8155380|NCT02582866|20101763|P1|STARTED|Overall Study||106
8155381|NCT02582840|20101772|P3|NOT COMPLETED|Overall Study||0
8155382|NCT02582840|20101773|P2|NOT COMPLETED|Overall Study||0
8155383|NCT02582840|20101774|P1|NOT COMPLETED|Overall Study||0
8155384|NCT02582840|20101772|P3|COMPLETED|Overall Study||14
8155385|NCT02582840|20101773|P2|COMPLETED|Overall Study||14
8155386|NCT02582840|20101774|P1|COMPLETED|Overall Study||14
8155387|NCT02582840|20101772|P3|STARTED|Overall Study||14
8155388|NCT02582840|20101773|P2|STARTED|Overall Study||14
8155389|NCT02582840|20101774|P1|STARTED|Overall Study||14
8155390|NCT02582814|20101817|P2|NOT COMPLETED|Overall Study||7
8155391|NCT02582814|20101818|P1|NOT COMPLETED|Overall Study||9
8155392|NCT02582814|20101817|P2|COMPLETED|Overall Study||68
8155393|NCT02582814|20101818|P1|COMPLETED|Overall Study||67
8155394|NCT02582814|20101817|P2|STARTED|Overall Study||75
8155395|NCT02582814|20101818|P1|STARTED|Overall Study||76
8155396|NCT02582749|20101858|P2|NOT COMPLETED|Overall Study||11
8155397|NCT02582749|20101859|P1|NOT COMPLETED|Overall Study||5
8155398|NCT02582749|20101858|P2|COMPLETED|Overall Study||0
8155399|NCT02582749|20101859|P1|COMPLETED|Overall Study||0
8155400|NCT02582749|20101858|P2|STARTED|Overall Study||11
8155401|NCT02582749|20101859|P1|STARTED|Overall Study||5
8155402|NCT02582684|20101889|P1|NOT COMPLETED|Overall Study||17
8155403|NCT02582684|20101889|P1|COMPLETED|Overall Study||105
8155404|NCT02582684|20101889|P1|STARTED|Overall Study||122
8155405|NCT02582671|20101908|P1|NOT COMPLETED|Overall Study||2
8155406|NCT02582671|20101908|P1|COMPLETED|Overall Study||99
8155407|NCT02582671|20101908|P1|STARTED|Overall Study||101
8155408|NCT02582658|20101920|P1|NOT COMPLETED|Overall Study||25
8155409|NCT02582658|20101920|P1|COMPLETED|Overall Study||146
8155410|NCT02582658|20101920|P1|STARTED|Overall Study||171
8155411|NCT02582632|20101938|P1|NOT COMPLETED|Overall Study||1
8155412|NCT02582632|20101938|P1|COMPLETED|Overall Study||165
8155413|NCT02582632|20101938|P1|STARTED|Overall Study||166
8155414|NCT02582515|20101953|P2|NOT COMPLETED|Overall Study||1
8155415|NCT02582515|20101954|P1|NOT COMPLETED|Overall Study||0
8155416|NCT02582515|20101953|P2|COMPLETED|Overall Study||10
8155417|NCT02582515|20101954|P1|COMPLETED|Overall Study||9
8155418|NCT02582515|20101953|P2|Received Study Intervention|Overall Study||10
8155419|NCT02582515|20101954|P1|Received Study Intervention|Overall Study||9
8155420|NCT02582515|20101953|P2|STARTED|Overall Study||11
8155421|NCT02582515|20101954|P1|STARTED|Overall Study||9
8155422|NCT02582255|20101962|P2|NOT COMPLETED|Overall Study||3
8155423|NCT02582255|20101963|P1|NOT COMPLETED|Overall Study||0
8155424|NCT02582255|20101962|P2|COMPLETED|Overall Study||47
8155425|NCT02582255|20101963|P1|COMPLETED|Overall Study||50
8155426|NCT02582255|20101962|P2|STARTED|Overall Study||50
8155427|NCT02582255|20101963|P1|STARTED|Overall Study||50
8155428|NCT02582242|20101976|P2|NOT COMPLETED|Overall Study||17
8155429|NCT02582242|20101977|P1|NOT COMPLETED|Overall Study||20
8155430|NCT02582242|20101976|P2|COMPLETED|Overall Study||200
8155431|NCT02582242|20101977|P1|COMPLETED|Overall Study||200
8155432|NCT02582242|20101976|P2|STARTED|Overall Study||217
8155433|NCT02582242|20101977|P1|STARTED|Overall Study||220
8155434|NCT02582216|20102017|P1|NOT COMPLETED|Overall Study||0
8155435|NCT02582216|20102017|P1|COMPLETED|Overall Study||22
8155436|NCT02582216|20102017|P1|STARTED|Overall Study||22
8155437|NCT02582151|20102024|P2|NOT COMPLETED|Overall Study||0
8155438|NCT02582151|20102025|P1|NOT COMPLETED|Overall Study||2
8155439|NCT02582151|20102024|P2|COMPLETED|Overall Study||16
8155440|NCT02582151|20102025|P1|COMPLETED|Overall Study||12
8155441|NCT02582151|20102024|P2|STARTED|Overall Study||16
8155442|NCT02582151|20102025|P1|STARTED|Overall Study||14
8155443|NCT02581995|20102041|P1|NOT COMPLETED|Overall Study||31
8155444|NCT02581995|20102041|P1|COMPLETED|Overall Study||529
8155445|NCT02581995|20102041|P1|Treated|Overall Study||560
8155446|NCT02581995|20102041|P1|STARTED|Overall Study||560
8155447|NCT02581930|20102055|P1|NOT COMPLETED|Overall Study||2
8155448|NCT02581930|20102055|P1|COMPLETED|Overall Study||16
8155449|NCT02581930|20102055|P1|STARTED|Overall Study||18
8155450|NCT02581891|20102063|P2|NOT COMPLETED|Overall Study||19
8155451|NCT02581891|20102064|P1|NOT COMPLETED|Overall Study||16
8155452|NCT02581891|20102063|P2|COMPLETED|Overall Study||117
8155453|NCT02581891|20102064|P1|COMPLETED|Overall Study||119
8155454|NCT02581891|20102063|P2|Completed Treatment|Overall Study||117
8155455|NCT02581891|20102064|P1|Completed Treatment|Overall Study||120
8155456|NCT02581891|20102063|P2|STARTED|Overall Study||136
8155457|NCT02581891|20102064|P1|STARTED|Overall Study||135
8155458|NCT02581865|20102090|P3|NOT COMPLETED|Overall Study||16
8155459|NCT02581865|20102091|P2|NOT COMPLETED|Overall Study||7
8155460|NCT02581865|20102092|P1|NOT COMPLETED|Overall Study||4
8155461|NCT02581865|20102090|P3|COMPLETED|Overall Study||26
8155462|NCT02581865|20102091|P2|COMPLETED|Overall Study||35
8155463|NCT02581865|20102092|P1|COMPLETED|Overall Study||36
8155464|NCT02581865|20102090|P3|STARTED|Overall Study||42
8155465|NCT02581865|20102091|P2|STARTED|Overall Study||42
8155466|NCT02581865|20102092|P1|STARTED|Overall Study||40
8155467|NCT02581839|20102115|P1|NOT COMPLETED|Overall Study||0
8155468|NCT02581839|20102115|P1|COMPLETED|Overall Study||9
8155469|NCT02581839|20102115|P1|STARTED|Overall Study||9
8155470|NCT02581488|20102127|P2|NOT COMPLETED|Overall Study||11
8155471|NCT02581488|20102128|P1|NOT COMPLETED|Overall Study||9
8155472|NCT02581488|20102127|P2|COMPLETED|Overall Study||40
8155473|NCT02581488|20102128|P1|COMPLETED|Overall Study||42
8155474|NCT02581488|20102127|P2|STARTED|Overall Study||51
8155475|NCT02581488|20102128|P1|STARTED|Overall Study||51
8155476|NCT02581475|20102144|P2|NOT COMPLETED|Overall Study||15
8155477|NCT02581475|20102145|P1|NOT COMPLETED|Overall Study||11
8155478|NCT02581475|20102144|P2|COMPLETED|Overall Study||178
8155479|NCT02581475|20102145|P1|COMPLETED|Overall Study||182
8155480|NCT02581475|20102144|P2|STARTED|Overall Study||193
8155481|NCT02581475|20102145|P1|STARTED|Overall Study||193
8155482|NCT02581410|20102159|P2|NOT COMPLETED|End of Study Phase||11
8155483|NCT02581410|20102160|P1|NOT COMPLETED|End of Study Phase||5
8155484|NCT02581410|20102159|P2|COMPLETED|End of Study Phase||204
8155485|NCT02581410|20102160|P1|COMPLETED|End of Study Phase||210
8155486|NCT02581410|20102159|P2|STARTED|End of Study Phase||215
8155487|NCT02581410|20102160|P1|STARTED|End of Study Phase||215
8155488|NCT02581410|20102159|P2|NOT COMPLETED|Vaccination Phase||3
8155489|NCT02581410|20102160|P1|NOT COMPLETED|Vaccination Phase||2
8155490|NCT02581410|20102159|P2|COMPLETED|Vaccination Phase||212
8155491|NCT02581410|20102160|P1|COMPLETED|Vaccination Phase||213
8155492|NCT02581410|20102159|P2|STARTED|Vaccination Phase||215
8155493|NCT02581410|20102160|P1|STARTED|Vaccination Phase||215
8155494|NCT02581345|20102190|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
8155495|NCT02581345|20102191|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
8155496|NCT02581345|20102192|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
8155497|NCT02581345|20102193|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
8155498|NCT02581345|20102190|P4|COMPLETED|Part 2: Week 17 to Week 47||119
8155499|NCT02581345|20102191|P3|COMPLETED|Part 2: Week 17 to Week 47||117
8155500|NCT02581345|20102192|P2|COMPLETED|Part 2: Week 17 to Week 47||0
8155501|NCT02581345|20102193|P1|COMPLETED|Part 2: Week 17 to Week 47||242
8155502|NCT02581345|20102190|P4|STARTED|Part 2: Week 17 to Week 47||131
8155503|NCT02581345|20102191|P3|STARTED|Part 2: Week 17 to Week 47||132
8155504|NCT02581345|20102192|P2|STARTED|Part 2: Week 17 to Week 47||0
8155505|NCT02581345|20102193|P1|STARTED|Part 2: Week 17 to Week 47||271
8155506|NCT02581345|20102190|P4|NOT COMPLETED|Part 1: up to Week 16||0
8155507|NCT02581345|20102191|P3|NOT COMPLETED|Part 1: up to Week 16||0
8155508|NCT02581345|20102192|P2|NOT COMPLETED|Part 1: up to Week 16||23
8155509|NCT02581345|20102193|P1|NOT COMPLETED|Part 1: up to Week 16||15
8155510|NCT02581345|20102190|P4|COMPLETED|Part 1: up to Week 16||0
8155511|NCT02581345|20102191|P3|COMPLETED|Part 1: up to Week 16||0
8155512|NCT02581345|20102192|P2|COMPLETED|Part 1: up to Week 16||263
8155513|NCT02581345|20102193|P1|COMPLETED|Part 1: up to Week 16||271
8155514|NCT02581345|20102190|P4|STARTED|Part 1: up to Week 16||0
8155515|NCT02581345|20102191|P3|STARTED|Part 1: up to Week 16||0
8155516|NCT02581345|20102192|P2|STARTED|Part 1: up to Week 16||286
8155517|NCT02581345|20102193|P1|STARTED|Part 1: up to Week 16||286
8155518|NCT02581202|20102295|P1|NOT COMPLETED|Overall Study||14
8155519|NCT02581202|20102295|P1|COMPLETED|Overall Study||202
8155520|NCT02581202|20102295|P1|STARTED|Overall Study||216
8155521|NCT02581189|20102334|P1|NOT COMPLETED|Overall Study||53
8155522|NCT02581189|20102334|P1|COMPLETED|Overall Study||481
8155523|NCT02581189|20102334|P1|STARTED|Overall Study||534
8155524|NCT02581163|20102348|P1|NOT COMPLETED|Overall Study||29
8155525|NCT02581163|20102348|P1|COMPLETED|Overall Study||282
8155526|NCT02581163|20102348|P1|STARTED|Overall Study||311
8155527|NCT02581137|20102362|P1|NOT COMPLETED|Overall Study||4
8155528|NCT02581137|20102362|P1|COMPLETED|Overall Study||22
8155529|NCT02581137|20102362|P1|STARTED|Overall Study||26
8155530|NCT02581111|20102369|P2|NOT COMPLETED|Overall Study||7
8155531|NCT02581111|20102370|P1|NOT COMPLETED|Overall Study||2
8155532|NCT02581111|20102369|P2|COMPLETED|Overall Study||94
8155533|NCT02581111|20102370|P1|COMPLETED|Overall Study||96
8155534|NCT02581111|20102369|P2|STARTED|Overall Study||101
8155535|NCT02581111|20102370|P1|STARTED|Overall Study||98
8155536|NCT02580877|20102382|P2|NOT COMPLETED|Overall Study||4
8155537|NCT02580877|20102383|P1|NOT COMPLETED|Overall Study||1
8155538|NCT02580877|20102382|P2|COMPLETED|Overall Study||43
8155539|NCT02580877|20102383|P1|COMPLETED|Overall Study||44
8155540|NCT02580877|20102382|P2|STARTED|Overall Study||47
8155541|NCT02580877|20102383|P1|STARTED|Overall Study||45
8155542|NCT02580799|20102391|P1|NOT COMPLETED|Overall Study||0
8155543|NCT02580799|20102391|P1|COMPLETED|Overall Study||30
8155544|NCT02580799|20102391|P1|STARTED|Overall Study||30
8155545|NCT02580591|20102417|P4|NOT COMPLETED|Overall Study||12
8155546|NCT02580591|20102418|P3|NOT COMPLETED|Overall Study||13
8155547|NCT02580591|20102419|P2|NOT COMPLETED|Overall Study||10
8155548|NCT02580591|20102420|P1|NOT COMPLETED|Overall Study||18
8155549|NCT02580591|20102417|P4|COMPLETED|Overall Study||233
8155550|NCT02580591|20102418|P3|COMPLETED|Overall Study||235
8155551|NCT02580591|20102419|P2|COMPLETED|Overall Study||232
8155552|NCT02580591|20102420|P1|COMPLETED|Overall Study||224
8155553|NCT02580591|20102417|P4|Treated|Overall Study||245
8155554|NCT02580591|20102418|P3|Treated|Overall Study||248
8155555|NCT02580591|20102419|P2|Treated|Overall Study||241
8155556|NCT02580591|20102420|P1|Treated|Overall Study||241
8155557|NCT02580591|20102417|P4|STARTED|Overall Study||245
8155558|NCT02580591|20102418|P3|STARTED|Overall Study||248
8155559|NCT02580591|20102419|P2|STARTED|Overall Study||242
8155560|NCT02580591|20102420|P1|STARTED|Overall Study||242
8155561|NCT02580357|20102453|P3|NOT COMPLETED|Overall Study||0
8155562|NCT02580357|20102454|P2|NOT COMPLETED|Overall Study||0
8155563|NCT02580357|20102455|P1|NOT COMPLETED|Overall Study||3
8155564|NCT02580357|20102453|P3|COMPLETED|Overall Study||18
8155565|NCT02580357|20102454|P2|COMPLETED|Overall Study||18
8155566|NCT02580357|20102455|P1|COMPLETED|Overall Study||15
8155567|NCT02580357|20102453|P3|STARTED|Overall Study||18
8155568|NCT02580357|20102454|P2|STARTED|Overall Study||18
8155569|NCT02580357|20102455|P1|STARTED|Overall Study||18
8155570|NCT02580318|20102466|P1|NOT COMPLETED|Overall Study||0
8155571|NCT02580318|20102466|P1|COMPLETED|Overall Study||54
8155572|NCT02580318|20102466|P1|Drinking Water (5 Minutes)|Overall Study||54
8155573|NCT02580318|20102466|P1|Drinking Water (Immediate)|Overall Study||51
8155574|NCT02580318|20102466|P1|Hyperventilation (10 Minutes)|Overall Study||54
8155575|NCT02580318|20102466|P1|Hyperventilation (5 Minutes)|Overall Study||54
8155576|NCT02580318|20102466|P1|Hyperventilation (Immediate)|Overall Study||54
8155577|NCT02580318|20102466|P1|Poor Effort|Overall Study||53
8155578|NCT02580318|20102466|P1|STARTED|Overall Study||54
8155579|NCT02580240|20102472|P2|NOT COMPLETED|Overall Study||0
8155580|NCT02580240|20102473|P1|NOT COMPLETED|Overall Study||2
8155581|NCT02580240|20102472|P2|COMPLETED|Overall Study||58
8155582|NCT02580240|20102473|P1|COMPLETED|Overall Study||60
8155583|NCT02580240|20102472|P2|STARTED|Overall Study||58
8155584|NCT02580240|20102473|P1|STARTED|Overall Study||62
8155585|NCT02580201|20102483|P2|NOT COMPLETED|Overall Study||0
8155586|NCT02580201|20102484|P1|NOT COMPLETED|Overall Study||0
8155587|NCT02580201|20102483|P2|COMPLETED|Overall Study||104
8155588|NCT02580201|20102484|P1|COMPLETED|Overall Study||50
8155589|NCT02580201|20102483|P2|STARTED|Overall Study||104
8155590|NCT02580201|20102484|P1|STARTED|Overall Study||50
8155591|NCT02580188|20102497|P2|NOT COMPLETED|Overall Study||3
8155592|NCT02580188|20102498|P1|NOT COMPLETED|Overall Study||3
8155593|NCT02580188|20102497|P2|COMPLETED|Overall Study||32
8155594|NCT02580188|20102498|P1|COMPLETED|Overall Study||32
8155595|NCT02580188|20102497|P2|STARTED|Overall Study||35
8155596|NCT02580188|20102498|P1|STARTED|Overall Study||35
8155597|NCT02580058|20102511|P3|NOT COMPLETED|Overall Study||86
8155598|NCT02580058|20102512|P2|NOT COMPLETED|Overall Study||86
8155599|NCT02580058|20102513|P1|NOT COMPLETED|Overall Study||79
8155600|NCT02580058|20102511|P3|COMPLETED|Overall Study||104
8155601|NCT02580058|20102512|P2|COMPLETED|Overall Study||102
8155602|NCT02580058|20102513|P1|COMPLETED|Overall Study||109
8155603|NCT02580058|20102511|P3|Treated|Overall Study||177
8155604|NCT02580058|20102512|P2|Treated|Overall Study||182
8155605|NCT02580058|20102513|P1|Treated|Overall Study||187
8155606|NCT02580058|20102511|P3|STARTED|Overall Study||190
8155607|NCT02580058|20102512|P2|STARTED|Overall Study||188
8155608|NCT02580058|20102513|P1|STARTED|Overall Study||188
8155609|NCT02579928|20102580|P2|NOT COMPLETED|Overall Study||0
8155610|NCT02579928|20102581|P1|NOT COMPLETED|Overall Study||1
8155611|NCT02579928|20102580|P2|COMPLETED|Overall Study||11
8155612|NCT02579928|20102581|P1|COMPLETED|Overall Study||5
8155613|NCT02579928|20102580|P2|STARTED|Overall Study||11
8155614|NCT02579928|20102581|P1|STARTED|Overall Study||6
8155615|NCT02579915|20102589|P2|NOT COMPLETED|Overall Study||5
8155616|NCT02579915|20102590|P1|NOT COMPLETED|Overall Study||10
8155617|NCT02579915|20102589|P2|COMPLETED|Overall Study||16
8155618|NCT02579915|20102590|P1|COMPLETED|Overall Study||9
8155619|NCT02579915|20102589|P2|STARTED|Overall Study||21
8155620|NCT02579915|20102590|P1|STARTED|Overall Study||19
8155621|NCT02579876|20102598|P2|NOT COMPLETED|Overall Study||0
8155622|NCT02579876|20102599|P1|NOT COMPLETED|Overall Study||1
8155623|NCT02579876|20102598|P2|COMPLETED|Overall Study||5
8155624|NCT02579876|20102599|P1|COMPLETED|Overall Study||14
8155625|NCT02579876|20102598|P2|STARTED|Overall Study||5
8155626|NCT02579876|20102599|P1|STARTED|Overall Study||15
8155627|NCT02579863|20102621|P2|NOT COMPLETED|Overall Study||154
8155628|NCT02579863|20102622|P1|NOT COMPLETED|Overall Study||156
8155629|NCT02579863|20102621|P2|COMPLETED|Overall Study||0
8155630|NCT02579863|20102622|P1|COMPLETED|Overall Study||0
8155631|NCT02579863|20102621|P2|Treated|Overall Study||148
8155632|NCT02579863|20102622|P1|Treated|Overall Study||154
8155633|NCT02579863|20102621|P2|STARTED|Overall Study||154
8155634|NCT02579863|20102622|P1|STARTED|Overall Study||156
8155635|NCT02579811|20102642|P1|NOT COMPLETED|Overall Study||0
8155636|NCT02579811|20102642|P1|COMPLETED|Overall Study||40
8155637|NCT02579811|20102642|P1|STARTED|Overall Study||40
8155638|NCT02579772|20102649|P2|NOT COMPLETED|Overall Study||2
8155639|NCT02579772|20102650|P1|NOT COMPLETED|Overall Study||2
8155640|NCT02579772|20102649|P2|COMPLETED|Overall Study||3
8155641|NCT02579772|20102650|P1|COMPLETED|Overall Study||6
8155642|NCT02579772|20102649|P2|STARTED|Overall Study||5
8155643|NCT02579772|20102650|P1|STARTED|Overall Study||8
8155644|NCT02579759|20102671|P3|NOT COMPLETED|Overall Study||21
8155645|NCT02579759|20102672|P2|NOT COMPLETED|Overall Study||64
8155646|NCT02579759|20102673|P1|NOT COMPLETED|Overall Study||24
8155647|NCT02579759|20102671|P3|COMPLETED|Overall Study||80
8155648|NCT02579759|20102672|P2|COMPLETED|Overall Study||49
8155649|NCT02579759|20102673|P1|COMPLETED|Overall Study||85
8155650|NCT02579759|20102671|P3|STARTED|Overall Study||101
8155651|NCT02579759|20102672|P2|STARTED|Overall Study||113
8155652|NCT02579759|20102673|P1|STARTED|Overall Study||109
8155653|NCT02579629|20102720|P3|NOT COMPLETED|Overall Study||2
8155654|NCT02579629|20102721|P2|NOT COMPLETED|Overall Study||1
8155655|NCT02579629|20102722|P1|NOT COMPLETED|Overall Study||2
8155656|NCT02579629|20102720|P3|COMPLETED|Overall Study||20
8155657|NCT02579629|20102721|P2|COMPLETED|Overall Study||19
8155658|NCT02579629|20102722|P1|COMPLETED|Overall Study||20
8155659|NCT02579629|20102720|P3|STARTED|Overall Study||22
8155660|NCT02579629|20102721|P2|STARTED|Overall Study||20
8155661|NCT02579629|20102722|P1|STARTED|Overall Study||22
8155662|NCT02579616|20102769|P1|NOT COMPLETED|Overall Study||3
8155663|NCT02579616|20102769|P1|COMPLETED|Overall Study||26
8155664|NCT02579616|20102769|P1|Treated|Overall Study||26
8155665|NCT02579616|20102769|P1|STARTED|Overall Study||29
8155666|NCT02579603|20102782|P2|NOT COMPLETED|Overall Study||2
8155667|NCT02579603|20102783|P1|NOT COMPLETED|Overall Study||4
8155668|NCT02579603|20102782|P2|COMPLETED|Overall Study||51
8155669|NCT02579603|20102783|P1|COMPLETED|Overall Study||48
8155670|NCT02579603|20102782|P2|Number of Patients Treated|Overall Study||53
8155671|NCT02579603|20102783|P1|Number of Patients Treated|Overall Study||51
8155672|NCT02579603|20102782|P2|STARTED|Overall Study|Started are the randomised patients|53
8155673|NCT02579603|20102783|P1|STARTED|Overall Study|Started are the randomised patients|52
8155674|NCT02579421|20102796|P4|NOT COMPLETED|Overall Study||3
8155675|NCT02579421|20102797|P3|NOT COMPLETED|Overall Study||1
8155676|NCT02579421|20102798|P2|NOT COMPLETED|Overall Study||5
8155677|NCT02579421|20102799|P1|NOT COMPLETED|Overall Study||6
8155678|NCT02579421|20102796|P4|COMPLETED|Overall Study||3
8155679|NCT02579421|20102797|P3|COMPLETED|Overall Study||5
8155680|NCT02579421|20102798|P2|COMPLETED|Overall Study||18
8155681|NCT02579421|20102799|P1|COMPLETED|Overall Study||17
8155682|NCT02579421|20102796|P4|STARTED|Overall Study||6
8155683|NCT02579421|20102797|P3|STARTED|Overall Study||6
8155684|NCT02579421|20102798|P2|STARTED|Overall Study||23
8155685|NCT02579421|20102799|P1|STARTED|Overall Study||23
8155686|NCT02579382|20102813|P4|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
8155687|NCT02579382|20102814|P3|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
8155688|NCT02579382|20102815|P2|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
8155689|NCT02579382|20102816|P1|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
8155690|NCT02579382|20102813|P4|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
8155691|NCT02579382|20102814|P3|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
8155692|NCT02579382|20102815|P2|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
8155693|NCT02579382|20102816|P1|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
8155694|NCT02579382|20102813|P4|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
8155695|NCT02579382|20102814|P3|STARTED|Optional Treatment Extension Phase(OTEP)||54
8155696|NCT02579382|20102815|P2|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
8155697|NCT02579382|20102816|P1|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
8155698|NCT02579382|20102813|P4|NOT COMPLETED|Main Study Phase||3
8155699|NCT02579382|20102814|P3|NOT COMPLETED|Main Study Phase||2
8155700|NCT02579382|20102815|P2|NOT COMPLETED|Main Study Phase||0
8155701|NCT02579382|20102816|P1|NOT COMPLETED|Main Study Phase||0
8155702|NCT02579382|20102813|P4|COMPLETED|Main Study Phase||52
8155703|NCT02579382|20102814|P3|COMPLETED|Main Study Phase||54
8155704|NCT02579382|20102815|P2|COMPLETED|Main Study Phase||53
8155705|NCT02579382|20102816|P1|COMPLETED|Main Study Phase||28
8155706|NCT02579382|20102813|P4|STARTED|Main Study Phase||55
8155707|NCT02579382|20102814|P3|STARTED|Main Study Phase||56
8155708|NCT02579382|20102815|P2|STARTED|Main Study Phase||53
8155709|NCT02579382|20102816|P1|STARTED|Main Study Phase||28
8155710|NCT02579135|20102911|P2|NOT COMPLETED|Overall Study||9
8155711|NCT02579135|20102912|P1|NOT COMPLETED|Overall Study||2
8155712|NCT02579135|20102911|P2|COMPLETED|Overall Study||106
8155713|NCT02579135|20102912|P1|COMPLETED|Overall Study||105
8155714|NCT02579135|20102911|P2|STARTED|Overall Study||115
8155715|NCT02579135|20102912|P1|STARTED|Overall Study||107
8155716|NCT02579057|20102923|P2|NOT COMPLETED|Overall Study||0
8155717|NCT02579057|20102924|P1|NOT COMPLETED|Overall Study||0
8155718|NCT02579057|20102923|P2|COMPLETED|Overall Study||21
8155719|NCT02579057|20102924|P1|COMPLETED|Overall Study||19
8155720|NCT02579057|20102923|P2|STARTED|Overall Study||21
8155721|NCT02579057|20102924|P1|STARTED|Overall Study||19
8155722|NCT02578992|20102938|P2|NOT COMPLETED|Overall Study||3
8155723|NCT02578992|20102939|P1|NOT COMPLETED|Overall Study||3
8155724|NCT02578992|20102938|P2|COMPLETED|Overall Study|October 2015|62
8155725|NCT02578992|20102939|P1|COMPLETED|Overall Study|October 2015|62
8155726|NCT02578992|20102938|P2|STARTED|Overall Study|November 2014|65
8155727|NCT02578992|20102939|P1|STARTED|Overall Study|November 2014|65
8155728|NCT02578940|20102951|P1|NOT COMPLETED|Overall Study||6
8155729|NCT02578940|20102951|P1|COMPLETED|Overall Study||103
8155730|NCT02578940|20102951|P1|Received 18F-fluciclovine|Overall Study||104
8155731|NCT02578940|20102951|P1|STARTED|Overall Study||109
8155732|NCT02578862|20102960|P2|NOT COMPLETED|Overall Study||2
8155733|NCT02578862|20102961|P1|NOT COMPLETED|Overall Study||0
8155734|NCT02578862|20102960|P2|COMPLETED|Overall Study||33
8155735|NCT02578862|20102961|P1|COMPLETED|Overall Study||37
8155736|NCT02578862|20102960|P2|STARTED|Overall Study||35
8155737|NCT02578862|20102961|P1|STARTED|Overall Study||37
8155738|NCT02578745|20102979|P2|NOT COMPLETED|Overall Study||0
8155739|NCT02578745|20102980|P1|NOT COMPLETED|Overall Study||0
8155740|NCT02578745|20102979|P2|COMPLETED|Overall Study||60
8155741|NCT02578745|20102980|P1|COMPLETED|Overall Study||60
8155742|NCT02578745|20102979|P2|STARTED|Overall Study||60
8155743|NCT02578745|20102980|P1|STARTED|Overall Study||60
8155744|NCT02578706|20102999|P3|NOT COMPLETED|Overall Study||0
8155745|NCT02578706|20103000|P2|NOT COMPLETED|Overall Study||5
8155746|NCT02578706|20103001|P1|NOT COMPLETED|Overall Study||1
8155747|NCT02578706|20102999|P3|COMPLETED|Overall Study||8
8155748|NCT02578706|20103000|P2|COMPLETED|Overall Study||5
8155749|NCT02578706|20103001|P1|COMPLETED|Overall Study||8
8155750|NCT02578706|20102999|P3|STARTED|Overall Study||8
8155751|NCT02578706|20103000|P2|STARTED|Overall Study||10
8155752|NCT02578706|20103001|P1|STARTED|Overall Study||9
8155753|NCT02578680|20103080|P2|NOT COMPLETED|Overall Study||206
8155754|NCT02578680|20103081|P1|NOT COMPLETED|Overall Study||410
8155755|NCT02578680|20103080|P2|COMPLETED|Overall Study||0
8155756|NCT02578680|20103081|P1|COMPLETED|Overall Study||0
8155757|NCT02578680|20103080|P2|Switched to Pembrolizumab|Overall Study||67
8155758|NCT02578680|20103081|P1|Switched to Pembrolizumab|Overall Study||0
8155759|NCT02578680|20103080|P2|Treated|Overall Study||202
8155760|NCT02578680|20103081|P1|Treated|Overall Study||405
8155761|NCT02578680|20103080|P2|STARTED|Overall Study||206
8155762|NCT02578680|20103081|P1|STARTED|Overall Study||410
8155763|NCT02578316|20103097|P1|NOT COMPLETED|Extension Phase||6
8155764|NCT02578316|20103097|P1|COMPLETED|Extension Phase||0
8155765|NCT02578316|20103097|P1|STARTED|Extension Phase||6
8155766|NCT02578316|20103097|P1|NOT COMPLETED|Study Phase||0
8155767|NCT02578316|20103097|P1|COMPLETED|Study Phase||6
8155768|NCT02578316|20103097|P1|STARTED|Study Phase||6
8155769|NCT02578238|20103121|P1|NOT COMPLETED|Overall Study||0
8155770|NCT02578238|20103121|P1|COMPLETED|Overall Study||143
8155771|NCT02578238|20103121|P1|STARTED|Overall Study||143
8155772|NCT02578199|20103125|P1|NOT COMPLETED|Overall Study||4
8155773|NCT02578199|20103125|P1|COMPLETED|Overall Study||27
8155774|NCT02578199|20103125|P1|STARTED|Overall Study||31
8155775|NCT02578186|20103130|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
8155776|NCT02578186|20103131|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
8155777|NCT02578186|20103130|P2|COMPLETED|Period 2 (Second of Crossover)||13
8155778|NCT02578186|20103131|P1|COMPLETED|Period 2 (Second of Crossover)||12
8155779|NCT02578186|20103130|P2|STARTED|Period 2 (Second of Crossover)||13
8155780|NCT02578186|20103131|P1|STARTED|Period 2 (Second of Crossover)||12
8155781|NCT02578186|20103130|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
8155782|NCT02578186|20103131|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
8155783|NCT02578186|20103130|P2|COMPLETED|Period 1 (First of Crossover)||13
8155784|NCT02578186|20103131|P1|COMPLETED|Period 1 (First of Crossover)||12
8155785|NCT02578186|20103130|P2|STARTED|Period 1 (First of Crossover)||18
8155786|NCT02578186|20103131|P1|STARTED|Period 1 (First of Crossover)||17
8155787|NCT02577991|20103140|P3|NOT COMPLETED|Overall Study||0
8155788|NCT02577991|20103141|P2|NOT COMPLETED|Overall Study||2
8155789|NCT02577991|20103142|P1|NOT COMPLETED|Overall Study||3
8155790|NCT02577991|20103140|P3|COMPLETED|Overall Study||29
8155791|NCT02577991|20103141|P2|COMPLETED|Overall Study||25
8155792|NCT02577991|20103142|P1|COMPLETED|Overall Study||21
8155793|NCT02577991|20103140|P3|STARTED|Overall Study||29
8155794|NCT02577991|20103141|P2|STARTED|Overall Study||27
8155795|NCT02577991|20103142|P1|STARTED|Overall Study||24
8155796|NCT02577978|20103164|P2|NOT COMPLETED|Overall Study||4
8155797|NCT02577978|20103165|P1|NOT COMPLETED|Overall Study||7
8155798|NCT02577978|20103164|P2|COMPLETED|Overall Study||25
8155799|NCT02577978|20103165|P1|COMPLETED|Overall Study||25
8155800|NCT02577978|20103164|P2|STARTED|Overall Study||29
8155801|NCT02577978|20103165|P1|STARTED|Overall Study||32
8155802|NCT02577900|20103198|P3|NOT COMPLETED|Overall Study||0
8155803|NCT02577900|20103199|P2|NOT COMPLETED|Overall Study||0
8155804|NCT02577900|20103200|P1|NOT COMPLETED|Overall Study||0
8155805|NCT02577900|20103198|P3|COMPLETED|Overall Study||10
8155806|NCT02577900|20103199|P2|COMPLETED|Overall Study||10
8155807|NCT02577900|20103200|P1|COMPLETED|Overall Study||11
8155808|NCT02577900|20103198|P3|STARTED|Overall Study||10
8155809|NCT02577900|20103199|P2|STARTED|Overall Study||10
8155810|NCT02577900|20103200|P1|STARTED|Overall Study||11
8155811|NCT02577887|20103220|P1|NOT COMPLETED|Overall Study||298
8155812|NCT02577887|20103220|P1|COMPLETED|Overall Study||1803
8155813|NCT02577887|20103220|P1|6 Month Follow-up|Overall Study||1938
8155814|NCT02577887|20103220|P1|STARTED|Overall Study||2101
8155815|NCT02577822|20103229|P2|NOT COMPLETED|Overall Study||13
8155816|NCT02577822|20103230|P1|NOT COMPLETED|Overall Study||6
8155817|NCT02577822|20103229|P2|COMPLETED|Overall Study||20
8155818|NCT02577822|20103230|P1|COMPLETED|Overall Study||21
8155819|NCT02577822|20103229|P2|STARTED|Overall Study||33
8155820|NCT02577822|20103230|P1|STARTED|Overall Study||27
8155821|NCT02577718|20103246|P1|NOT COMPLETED|Overall Study||8
8155822|NCT02577718|20103246|P1|COMPLETED|Overall Study||52
8155823|NCT02577718|20103246|P1|STARTED|Overall Study||60
8155824|NCT02577601|20103252|P1|NOT COMPLETED|UPA+COC (1 Month)||0
8155825|NCT02577601|20103252|P1|COMPLETED|UPA+COC (1 Month)||33
8155826|NCT02577601|20103252|P1|STARTED|UPA+COC (1 Month)||33
8155827|NCT02577601|20103252|P1|NOT COMPLETED|Washout (1 Month)||0
8155828|NCT02577601|20103252|P1|COMPLETED|Washout (1 Month)||33
8155829|NCT02577601|20103252|P1|STARTED|Washout (1 Month)||33
8155830|NCT02577601|20103252|P1|NOT COMPLETED|UPA Only (1 Month)||0
8155831|NCT02577601|20103252|P1|COMPLETED|UPA Only (1 Month)||36
8155832|NCT02577601|20103252|P1|STARTED|UPA Only (1 Month)||36
8155833|NCT02577510|20103259|P2|NOT COMPLETED|Overall Study||0
8155834|NCT02577510|20103260|P1|NOT COMPLETED|Overall Study||0
8155835|NCT02577510|20103259|P2|COMPLETED|Overall Study||21
8155836|NCT02577510|20103260|P1|COMPLETED|Overall Study||21
8155837|NCT02577510|20103259|P2|STARTED|Overall Study||21
8155838|NCT02577510|20103260|P1|STARTED|Overall Study||21
8155839|NCT02577445|20103274|P2|NOT COMPLETED|Overall Study||17
8155840|NCT02577445|20103275|P1|NOT COMPLETED|Overall Study||14
8155841|NCT02577445|20103274|P2|COMPLETED|Overall Study|study terminated prematurely|0
8155842|NCT02577445|20103275|P1|COMPLETED|Overall Study|study terminated prematurely|0
8155843|NCT02577445|20103274|P2|STARTED|Overall Study||17
8155844|NCT02577445|20103275|P1|STARTED|Overall Study||14
8155845|NCT02577354|20103288|P2|NOT COMPLETED|Overall Study||13
8155846|NCT02577354|20103289|P1|NOT COMPLETED|Overall Study||15
8155847|NCT02577354|20103288|P2|COMPLETED|Overall Study||89
8155848|NCT02577354|20103289|P1|COMPLETED|Overall Study||87
8155849|NCT02577354|20103288|P2|120 Day Primary Endpoint|Overall Study||101
8155850|NCT02577354|20103289|P1|120 Day Primary Endpoint|Overall Study||100
8155851|NCT02577354|20103288|P2|STARTED|Overall Study||102
8155852|NCT02577354|20103289|P1|STARTED|Overall Study||102
8155853|NCT02577315|20103349|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8155854|NCT02577315|20103350|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8155855|NCT02577315|20103349|P2|COMPLETED|Treatment Period 2 (4 Days)||12
8155856|NCT02577315|20103350|P1|COMPLETED|Treatment Period 2 (4 Days)||12
8155857|NCT02577315|20103349|P2|STARTED|Treatment Period 2 (4 Days)||12
8155858|NCT02577315|20103350|P1|STARTED|Treatment Period 2 (4 Days)||12
8155859|NCT02577315|20103349|P2|NOT COMPLETED|Washout Period (5 Days)||0
8155860|NCT02577315|20103350|P1|NOT COMPLETED|Washout Period (5 Days)||0
8155861|NCT02577315|20103349|P2|COMPLETED|Washout Period (5 Days)||12
8155862|NCT02577315|20103350|P1|COMPLETED|Washout Period (5 Days)||12
8155863|NCT02577315|20103349|P2|STARTED|Washout Period (5 Days)||12
8155864|NCT02577315|20103350|P1|STARTED|Washout Period (5 Days)||12
8155865|NCT02577315|20103349|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8155866|NCT02577315|20103350|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8155867|NCT02577315|20103349|P2|COMPLETED|Treatment Period 1 (4 Days)||12
8155868|NCT02577315|20103350|P1|COMPLETED|Treatment Period 1 (4 Days)||12
8155869|NCT02577315|20103349|P2|STARTED|Treatment Period 1 (4 Days)||13
8155870|NCT02577315|20103350|P1|STARTED|Treatment Period 1 (4 Days)||12
8155871|NCT02577146|20103366|P1|NOT COMPLETED|Overall Study||28
8155872|NCT02577146|20103366|P1|COMPLETED|Overall Study||46
8155873|NCT02577146|20103366|P1|STARTED|Overall Study||74
8155874|NCT02577107|20103373|P2|NOT COMPLETED|Overall Study||1
8155875|NCT02577107|20103374|P1|NOT COMPLETED|Overall Study||0
8155876|NCT02577107|20103373|P2|COMPLETED|Overall Study||5
8155877|NCT02577107|20103374|P1|COMPLETED|Overall Study||6
8155878|NCT02577107|20103373|P2|STARTED|Overall Study||6
8155879|NCT02577107|20103374|P1|STARTED|Overall Study||6
8155880|NCT02577042|20103388|P2|NOT COMPLETED|Overall Study||3
8155881|NCT02577042|20103389|P1|NOT COMPLETED|Overall Study||5
8155882|NCT02577042|20103388|P2|COMPLETED|Overall Study||19
8155883|NCT02577042|20103389|P1|COMPLETED|Overall Study||15
8155884|NCT02577042|20103388|P2|STARTED|Overall Study||22
8155885|NCT02577042|20103389|P1|STARTED|Overall Study||20
8155886|NCT02577029|20103441|P8|NOT COMPLETED|Overall Study||12
8155887|NCT02577029|20103442|P7|NOT COMPLETED|Overall Study||12
8155888|NCT02577029|20103443|P6|NOT COMPLETED|Overall Study||13
8155889|NCT02577029|20103444|P5|NOT COMPLETED|Overall Study||11
8155890|NCT02577029|20103445|P4|NOT COMPLETED|Overall Study||12
8155891|NCT02577029|20103446|P3|NOT COMPLETED|Overall Study||7
8155892|NCT02577029|20103447|P2|NOT COMPLETED|Overall Study||2
8155893|NCT02577029|20103448|P1|NOT COMPLETED|Overall Study||10
8155894|NCT02577029|20103441|P8|COMPLETED|Overall Study||0
8155895|NCT02577029|20103442|P7|COMPLETED|Overall Study||0
8155896|NCT02577029|20103443|P6|COMPLETED|Overall Study||0
8155897|NCT02577029|20103444|P5|COMPLETED|Overall Study||0
8155898|NCT02577029|20103445|P4|COMPLETED|Overall Study||0
8155899|NCT02577029|20103446|P3|COMPLETED|Overall Study||0
8155900|NCT02577029|20103447|P2|COMPLETED|Overall Study||0
8155901|NCT02577029|20103448|P1|COMPLETED|Overall Study||0
8155902|NCT02577029|20103441|P8|STARTED|Overall Study||12
8155903|NCT02577029|20103442|P7|STARTED|Overall Study||12
8155904|NCT02577029|20103443|P6|STARTED|Overall Study||13
8155905|NCT02577029|20103444|P5|STARTED|Overall Study||11
8155906|NCT02577029|20103445|P4|STARTED|Overall Study||12
8155907|NCT02577029|20103446|P3|STARTED|Overall Study||7
8155908|NCT02577029|20103447|P2|STARTED|Overall Study||2
8155909|NCT02577029|20103448|P1|STARTED|Overall Study||10
8155910|NCT02577016|20103556|P2|NOT COMPLETED|Overall Study||2
8155911|NCT02577016|20103557|P1|NOT COMPLETED|Overall Study||2
8155912|NCT02577016|20103556|P2|COMPLETED|Overall Study||69
8155913|NCT02577016|20103557|P1|COMPLETED|Overall Study||68
8155914|NCT02577016|20103556|P2|STARTED|Overall Study||71
8155915|NCT02577016|20103557|P1|STARTED|Overall Study||70
8155916|NCT02577003|20103575|P2|NOT COMPLETED|Overall Study||5
8155917|NCT02577003|20103576|P1|NOT COMPLETED|Overall Study||2
8155918|NCT02577003|20103575|P2|COMPLETED|Overall Study||65
8155919|NCT02577003|20103576|P1|COMPLETED|Overall Study||71
8155920|NCT02577003|20103575|P2|STARTED|Overall Study||70
8155921|NCT02577003|20103576|P1|STARTED|Overall Study||73
8155922|NCT02576990|20103596|P2|NOT COMPLETED|Overall Study||24
8155923|NCT02576990|20103597|P1|NOT COMPLETED|Overall Study||43
8155924|NCT02576990|20103596|P2|COMPLETED|Overall Study||0
8155925|NCT02576990|20103597|P1|COMPLETED|Overall Study||13
8155926|NCT02576990|20103596|P2|Treated|Overall Study||23
8155927|NCT02576990|20103597|P1|Treated|Overall Study||53
8155928|NCT02576990|20103596|P2|STARTED|Overall Study||24
8155929|NCT02576990|20103597|P1|STARTED|Overall Study||56
8155930|NCT02576977|20103625|P2|NOT COMPLETED|Overall Study||125
8155931|NCT02576977|20103626|P1|NOT COMPLETED|Overall Study||126
8155932|NCT02576977|20103625|P2|COMPLETED|Overall Study||0
8155933|NCT02576977|20103626|P1|COMPLETED|Overall Study||0
8155934|NCT02576977|20103625|P2|Treated|Overall Study||123
8155935|NCT02576977|20103626|P1|Treated|Overall Study||122
8155936|NCT02576977|20103625|P2|STARTED|Overall Study||125
8155937|NCT02576977|20103626|P1|STARTED|Overall Study||126
8155938|NCT02576951|20103648|P4|NOT COMPLETED|Overall Study||5
8155939|NCT02576951|20103649|P3|NOT COMPLETED|Overall Study||2
8155940|NCT02576951|20103650|P2|NOT COMPLETED|Overall Study||0
8155941|NCT02576951|20103651|P1|NOT COMPLETED|Overall Study||1
8155942|NCT02576951|20103648|P4|COMPLETED|Overall Study||75
8155943|NCT02576951|20103649|P3|COMPLETED|Overall Study||78
8155944|NCT02576951|20103650|P2|COMPLETED|Overall Study||3
8155945|NCT02576951|20103651|P1|COMPLETED|Overall Study||14
8155946|NCT02576951|20103648|P4|Received at Least One Dose of Study Drug|Overall Study||80
8155947|NCT02576951|20103649|P3|Received at Least One Dose of Study Drug|Overall Study||80
8155948|NCT02576951|20103650|P2|Received at Least One Dose of Study Drug|Overall Study||3
8155949|NCT02576951|20103651|P1|Received at Least One Dose of Study Drug|Overall Study||15
8155950|NCT02576951|20103648|P4|STARTED|Overall Study||80
8155951|NCT02576951|20103649|P3|STARTED|Overall Study||80
8155952|NCT02576951|20103650|P2|STARTED|Overall Study||3
8155953|NCT02576951|20103651|P1|STARTED|Overall Study||15
8155954|NCT02576938|20103675|P3|NOT COMPLETED|Overall Study||12
8155955|NCT02576938|20103676|P2|NOT COMPLETED|Overall Study||12
8155956|NCT02576938|20103677|P1|NOT COMPLETED|Overall Study||20
8155957|NCT02576938|20103675|P3|COMPLETED|Overall Study||26
8155958|NCT02576938|20103676|P2|COMPLETED|Overall Study||25
8155959|NCT02576938|20103677|P1|COMPLETED|Overall Study||29
8155960|NCT02576938|20103675|P3|Received at Least One Dose of Study Drug|Overall Study||38
8155961|NCT02576938|20103676|P2|Received at Least One Dose of Study Drug|Overall Study||37
8155962|NCT02576938|20103677|P1|Received at Least One Dose of Study Drug|Overall Study||49
8155963|NCT02576938|20103675|P3|STARTED|Overall Study||38
8155964|NCT02576938|20103676|P2|STARTED|Overall Study||37
8155965|NCT02576938|20103677|P1|STARTED|Overall Study||49
8155966|NCT02576899|20103707|P2|NOT COMPLETED|Overall Study||13
8155967|NCT02576899|20103708|P1|NOT COMPLETED|Overall Study||11
8155968|NCT02576899|20103707|P2|COMPLETED|Overall Study||7
8155969|NCT02576899|20103708|P1|COMPLETED|Overall Study||5
8155970|NCT02576899|20103707|P2|STARTED|Overall Study||20
8155971|NCT02576899|20103708|P1|STARTED|Overall Study||16
8155972|NCT02576678|20103723|P3|NOT COMPLETED|Overall Study||5
8155973|NCT02576678|20103724|P2|NOT COMPLETED|Overall Study||1
8155974|NCT02576678|20103725|P1|NOT COMPLETED|Overall Study||5
8155975|NCT02576678|20103723|P3|COMPLETED|Overall Study||16
8155976|NCT02576678|20103724|P2|COMPLETED|Overall Study||7
8155977|NCT02576678|20103725|P1|COMPLETED|Overall Study||8
8155978|NCT02576678|20103723|P3|Pharmacokinetic (PK) Population|Overall Study||18
8155979|NCT02576678|20103724|P2|Pharmacokinetic (PK) Population|Overall Study||8
8155980|NCT02576678|20103725|P1|Pharmacokinetic (PK) Population|Overall Study||12
8155981|NCT02576678|20103723|P3|STARTED|Overall Study||21
8155982|NCT02576678|20103724|P2|STARTED|Overall Study||8
8155983|NCT02576678|20103725|P1|STARTED|Overall Study||13
8155984|NCT02576652|20103757|P1|NOT COMPLETED|Overall Study||2
8155985|NCT02576652|20103757|P1|COMPLETED|Overall Study||4
8155986|NCT02576652|20103757|P1|STARTED|Overall Study||6
8155987|NCT02576639|20103769|P5|NOT COMPLETED|Overall Study||4
8155988|NCT02576639|20103770|P4|NOT COMPLETED|Overall Study||1
8155989|NCT02576639|20103771|P3|NOT COMPLETED|Overall Study||2
8155990|NCT02576639|20103772|P2|NOT COMPLETED|Overall Study||2
8155991|NCT02576639|20103773|P1|NOT COMPLETED|Overall Study||2
8155992|NCT02576639|20103769|P5|COMPLETED|Overall Study||20
8155993|NCT02576639|20103770|P4|COMPLETED|Overall Study||25
8155994|NCT02576639|20103771|P3|COMPLETED|Overall Study||23
8155995|NCT02576639|20103772|P2|COMPLETED|Overall Study||23
8155996|NCT02576639|20103773|P1|COMPLETED|Overall Study||22
8155997|NCT02576639|20103769|P5|Safety Analysis Set|Overall Study||24
8155998|NCT02576639|20103770|P4|Safety Analysis Set|Overall Study||26
8155999|NCT02576639|20103771|P3|Safety Analysis Set|Overall Study||25
8156000|NCT02576639|20103772|P2|Safety Analysis Set|Overall Study||25
8156001|NCT02576639|20103773|P1|Safety Analysis Set|Overall Study||24
8156002|NCT02576639|20103769|P5|Pharmacokinetic Analysis Set|Overall Study||24
8156003|NCT02576639|20103770|P4|Pharmacokinetic Analysis Set|Overall Study||26
8156004|NCT02576639|20103771|P3|Pharmacokinetic Analysis Set|Overall Study||25
8156005|NCT02576639|20103772|P2|Pharmacokinetic Analysis Set|Overall Study||25
8156006|NCT02576639|20103773|P1|Pharmacokinetic Analysis Set|Overall Study||0
8156007|NCT02576639|20103769|P5|Pharmacodynamic Analysis Set|Overall Study||25
8156008|NCT02576639|20103770|P4|Pharmacodynamic Analysis Set|Overall Study||25
8156009|NCT02576639|20103771|P3|Pharmacodynamic Analysis Set|Overall Study||25
8156010|NCT02576639|20103772|P2|Pharmacodynamic Analysis Set|Overall Study||24
8156011|NCT02576639|20103773|P1|Pharmacodynamic Analysis Set|Overall Study||24
8156012|NCT02576639|20103769|P5|STARTED|Overall Study||24
8156013|NCT02576639|20103770|P4|STARTED|Overall Study||26
8156014|NCT02576639|20103771|P3|STARTED|Overall Study||25
8156015|NCT02576639|20103772|P2|STARTED|Overall Study||25
8156016|NCT02576639|20103773|P1|STARTED|Overall Study||24
8156017|NCT02576587|20103832|P2|NOT COMPLETED|Follow up Period (Case Only)||155
8156018|NCT02576587|20103833|P1|NOT COMPLETED|Follow up Period (Case Only)||117
8156019|NCT02576587|20103832|P2|COMPLETED|Follow up Period (Case Only)||0
8156020|NCT02576587|20103833|P1|COMPLETED|Follow up Period (Case Only)||44
8156021|NCT02576587|20103832|P2|Selected for Follow up|Follow up Period (Case Only)||0
8156022|NCT02576587|20103833|P1|Selected for Follow up|Follow up Period (Case Only)||61
8156023|NCT02576587|20103832|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
8156024|NCT02576587|20103833|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
8156025|NCT02576587|20103832|P2|NOT COMPLETED|Baseline||1
8156026|NCT02576587|20103833|P1|NOT COMPLETED|Baseline||0
8156027|NCT02576587|20103832|P2|COMPLETED|Baseline|Baseline visit completed|155
8156028|NCT02576587|20103833|P1|COMPLETED|Baseline|Baseline visit completed|161
8156029|NCT02576587|20103832|P2|STARTED|Baseline|Total controls baseline visit|156
8156030|NCT02576587|20103833|P1|STARTED|Baseline|Total cases baseline visit|161
8156031|NCT02576535|20103851|P1|NOT COMPLETED|Overall Study||2
8156032|NCT02576535|20103851|P1|COMPLETED|Overall Study||16
8156033|NCT02576535|20103851|P1|STARTED|Overall Study||18
8156052|NCT02576249|20103879|P2|NOT COMPLETED|Overall Study||0
8156053|NCT02576249|20103880|P1|NOT COMPLETED|Overall Study||0
8156054|NCT02576249|20103879|P2|COMPLETED|Overall Study||14
8156055|NCT02576249|20103880|P1|COMPLETED|Overall Study||15
8156056|NCT02576249|20103879|P2|STARTED|Overall Study||14
8156057|NCT02576249|20103880|P1|STARTED|Overall Study||15
8156058|NCT02576145|20103892|P2|NOT COMPLETED|Overall Study||1
8156059|NCT02576145|20103893|P1|NOT COMPLETED|Overall Study||3
8156060|NCT02576145|20103892|P2|COMPLETED|Overall Study||4
8156061|NCT02576145|20103893|P1|COMPLETED|Overall Study||3
8156062|NCT02576145|20103892|P2|STARTED|Overall Study||5
8156063|NCT02576145|20103893|P1|STARTED|Overall Study||6
8156064|NCT02576067|20103931|P2|NOT COMPLETED|Overall Study||36
8156065|NCT02576067|20103932|P1|NOT COMPLETED|Overall Study||34
8156066|NCT02576067|20103931|P2|COMPLETED|Overall Study||27
8156067|NCT02576067|20103932|P1|COMPLETED|Overall Study||26
8156068|NCT02576067|20103931|P2|STARTED|Overall Study||63
8156069|NCT02576067|20103932|P1|STARTED|Overall Study||60
8156070|NCT02576054|20103942|P1|NOT COMPLETED|Overall Study||1
8156071|NCT02576054|20103942|P1|COMPLETED|Overall Study||100
8156072|NCT02576054|20103942|P1|Vaccination 3|Overall Study||100
8156073|NCT02576054|20103942|P1|Vaccination 2|Overall Study||100
8156074|NCT02576054|20103942|P1|Vaccination 1|Overall Study||100
8156075|NCT02576054|20103942|P1|STARTED|Overall Study||101
8156076|NCT02576041|20103957|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
8156077|NCT02576041|20103957|P1|COMPLETED|Bilastine (Active Treatement)||18
8156078|NCT02576041|20103957|P1|STARTED|Bilastine (Active Treatement)||18
8156079|NCT02576041|20103957|P1|NOT COMPLETED|Placebo (run-in)||0
8156080|NCT02576041|20103957|P1|COMPLETED|Placebo (run-in)||18
8156081|NCT02576041|20103957|P1|STARTED|Placebo (run-in)||18
8156082|NCT02575950|20103963|P4|NOT COMPLETED|Overall Study||5
8156083|NCT02575950|20103964|P3|NOT COMPLETED|Overall Study||0
8156084|NCT02575950|20103965|P2|NOT COMPLETED|Overall Study||1
8156085|NCT02575950|20103966|P1|NOT COMPLETED|Overall Study||0
8156086|NCT02575950|20103963|P4|COMPLETED|Overall Study||20
8156087|NCT02575950|20103964|P3|COMPLETED|Overall Study||6
8156088|NCT02575950|20103965|P2|COMPLETED|Overall Study||5
8156089|NCT02575950|20103966|P1|COMPLETED|Overall Study||3
8156090|NCT02575950|20103963|P4|STARTED|Overall Study||25
8156091|NCT02575950|20103964|P3|STARTED|Overall Study||6
8156092|NCT02575950|20103965|P2|STARTED|Overall Study||6
8156093|NCT02575950|20103966|P1|STARTED|Overall Study||3
8156094|NCT02575911|20103995|P1|NOT COMPLETED|Overall Study||1
8156095|NCT02575911|20103995|P1|COMPLETED|Overall Study||29
8156096|NCT02575911|20103995|P1|STARTED|Overall Study||30
8156097|NCT02575833|20104015|P2|NOT COMPLETED|Overall Study||1
8156098|NCT02575833|20104016|P1|NOT COMPLETED|Overall Study||1
8156099|NCT02575833|20104015|P2|COMPLETED|Overall Study||44
8156100|NCT02575833|20104016|P1|COMPLETED|Overall Study||43
8156101|NCT02575833|20104015|P2|Received Study Drug|Overall Study||44
8156102|NCT02575833|20104016|P1|Received Study Drug|Overall Study||44
8156103|NCT02575833|20104015|P2|STARTED|Overall Study||45
8156104|NCT02575833|20104016|P1|STARTED|Overall Study||44
8156105|NCT02575807|20104031|P5|NOT COMPLETED|Overall Study||4
8156106|NCT02575807|20104032|P4|NOT COMPLETED|Overall Study||2
8156107|NCT02575807|20104033|P3|NOT COMPLETED|Overall Study||16
8156108|NCT02575807|20104034|P2|NOT COMPLETED|Overall Study||4
8156109|NCT02575807|20104035|P1|NOT COMPLETED|Overall Study||9
8156110|NCT02575807|20104031|P5|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156111|NCT02575807|20104032|P4|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156112|NCT02575807|20104033|P3|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156113|NCT02575807|20104034|P2|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156114|NCT02575807|20104035|P1|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156115|NCT02575807|20104031|P5|Treated|Overall Study||3
8156116|NCT02575807|20104032|P4|Treated|Overall Study||1
8156117|NCT02575807|20104033|P3|Treated|Overall Study||16
8156118|NCT02575807|20104034|P2|Treated|Overall Study||4
8156119|NCT02575807|20104035|P1|Treated|Overall Study||8
8156120|NCT02575807|20104031|P5|STARTED|Overall Study||4
8156121|NCT02575807|20104032|P4|STARTED|Overall Study||2
8156122|NCT02575807|20104033|P3|STARTED|Overall Study||16
8156123|NCT02575807|20104034|P2|STARTED|Overall Study||4
8156124|NCT02575807|20104035|P1|STARTED|Overall Study||9
8156125|NCT02575365|20104075|P1|NOT COMPLETED|Overall Study||4
8156126|NCT02575365|20104075|P1|COMPLETED|Overall Study||0
8156127|NCT02575365|20104075|P1|STARTED|Overall Study||4
8156128|NCT02575300|20104085|P1|NOT COMPLETED|Overall Study||0
8156129|NCT02575300|20104085|P1|COMPLETED|Overall Study||20
8156130|NCT02575300|20104085|P1|STARTED|Overall Study||20
8156131|NCT02575079|20104095|P2|NOT COMPLETED|Overall Study||0
8156132|NCT02575079|20104096|P1|NOT COMPLETED|Overall Study||6
8156133|NCT02575079|20104095|P2|COMPLETED|Overall Study||71
8156134|NCT02575079|20104096|P1|COMPLETED|Overall Study||42
8156135|NCT02575079|20104095|P2|STARTED|Overall Study||71
8156136|NCT02575079|20104096|P1|STARTED|Overall Study||48
8156137|NCT02574858|20104110|P1|NOT COMPLETED|Overall Study||0
8156138|NCT02574858|20104110|P1|COMPLETED|Overall Study||25
8156139|NCT02574858|20104110|P1|STARTED|Overall Study||25
8156140|NCT02574845|20104121|P6|NOT COMPLETED|Overall Study||1
8156141|NCT02574845|20104122|P5|NOT COMPLETED|Overall Study||1
8156142|NCT02574845|20104123|P4|NOT COMPLETED|Overall Study||0
8156143|NCT02574845|20104124|P3|NOT COMPLETED|Overall Study||0
8156144|NCT02574845|20104125|P2|NOT COMPLETED|Overall Study||1
8156145|NCT02574845|20104126|P1|NOT COMPLETED|Overall Study||0
8156146|NCT02574845|20104121|P6|COMPLETED|Overall Study||2
8156147|NCT02574845|20104122|P5|COMPLETED|Overall Study||2
8156148|NCT02574845|20104123|P4|COMPLETED|Overall Study||3
8156149|NCT02574845|20104124|P3|COMPLETED|Overall Study||3
8156150|NCT02574845|20104125|P2|COMPLETED|Overall Study||2
8156151|NCT02574845|20104126|P1|COMPLETED|Overall Study||3
8156152|NCT02574845|20104121|P6|Received R|Overall Study||3
8156153|NCT02574845|20104122|P5|Received R|Overall Study||2
8156154|NCT02574845|20104123|P4|Received R|Overall Study||3
8156155|NCT02574845|20104124|P3|Received R|Overall Study||3
8156156|NCT02574845|20104125|P2|Received R|Overall Study||2
8156157|NCT02574845|20104126|P1|Received R|Overall Study||3
8156158|NCT02574845|20104121|P6|Received T5|Overall Study||2
8156159|NCT02574845|20104122|P5|Received T5|Overall Study||3
8156160|NCT02574845|20104123|P4|Received T5|Overall Study||3
8156161|NCT02574845|20104124|P3|Received T5|Overall Study||3
8156162|NCT02574845|20104125|P2|Received T5|Overall Study||2
8156163|NCT02574845|20104126|P1|Received T5|Overall Study||3
8156164|NCT02574845|20104121|P6|Received T4|Overall Study||2
8156165|NCT02574845|20104122|P5|Received T4|Overall Study||2
8156166|NCT02574845|20104123|P4|Received T4|Overall Study||3
8156167|NCT02574845|20104124|P3|Received T4|Overall Study||3
8156168|NCT02574845|20104125|P2|Received T4|Overall Study||2
8156169|NCT02574845|20104126|P1|Received T4|Overall Study||3
8156170|NCT02574845|20104121|P6|Received T3|Overall Study||3
8156171|NCT02574845|20104122|P5|Received T3|Overall Study||2
8156172|NCT02574845|20104123|P4|Received T3|Overall Study||3
8156173|NCT02574845|20104124|P3|Received T3|Overall Study||3
8156174|NCT02574845|20104125|P2|Received T3|Overall Study||2
8156175|NCT02574845|20104126|P1|Received T3|Overall Study|one subject missed treatment period 2|2
8156176|NCT02574845|20104121|P6|Received T2|Overall Study||3
8156177|NCT02574845|20104122|P5|Received T2|Overall Study||2
8156178|NCT02574845|20104123|P4|Received T2|Overall Study||3
8156179|NCT02574845|20104124|P3|Received T2|Overall Study||3
8156180|NCT02574845|20104125|P2|Received T2|Overall Study||3
8156181|NCT02574845|20104126|P1|Received T2|Overall Study||3
8156182|NCT02574845|20104121|P6|Received T1|Overall Study|one subject missed treatment period 2|2
8156183|NCT02574845|20104122|P5|Received T1|Overall Study||2
8156184|NCT02574845|20104123|P4|Received T1|Overall Study||3
8156185|NCT02574845|20104124|P3|Received T1|Overall Study||3
8156186|NCT02574845|20104125|P2|Received T1|Overall Study||2
8156187|NCT02574845|20104126|P1|Received T1|Overall Study||3
8156188|NCT02574845|20104121|P6|STARTED|Overall Study||3
8156189|NCT02574845|20104122|P5|STARTED|Overall Study||3
8156190|NCT02574845|20104123|P4|STARTED|Overall Study||3
8156191|NCT02574845|20104124|P3|STARTED|Overall Study||3
8156192|NCT02574845|20104125|P2|STARTED|Overall Study||3
8156193|NCT02574845|20104126|P1|STARTED|Overall Study||3
8156194|NCT02574832|20104152|P1|NOT COMPLETED|Overall Study||0
8156195|NCT02574832|20104152|P1|COMPLETED|Overall Study||2
8156196|NCT02574832|20104152|P1|STARTED|Overall Study||2
8156197|NCT02574637|20104161|P10|NOT COMPLETED|Open-label (OL) Period||1
8156198|NCT02574637|20104162|P9|NOT COMPLETED|Open-label (OL) Period||2
8156199|NCT02574637|20104163|P8|NOT COMPLETED|Open-label (OL) Period||1
8156200|NCT02574637|20104164|P7|NOT COMPLETED|Open-label (OL) Period||2
8156201|NCT02574637|20104165|P6|NOT COMPLETED|Open-label (OL) Period||2
8156202|NCT02574637|20104166|P5|NOT COMPLETED|Open-label (OL) Period||0
8156203|NCT02574637|20104167|P4|NOT COMPLETED|Open-label (OL) Period||0
8156204|NCT02574637|20104168|P3|NOT COMPLETED|Open-label (OL) Period||0
8156205|NCT02574637|20104169|P2|NOT COMPLETED|Open-label (OL) Period||0
8156206|NCT02574637|20104170|P1|NOT COMPLETED|Open-label (OL) Period||0
8156207|NCT02574637|20104161|P10|COMPLETED|Open-label (OL) Period||0
8156208|NCT02574637|20104162|P9|COMPLETED|Open-label (OL) Period||1
8156209|NCT02574637|20104163|P8|COMPLETED|Open-label (OL) Period||1
8156210|NCT02574637|20104164|P7|COMPLETED|Open-label (OL) Period||1
8156211|NCT02574637|20104165|P6|COMPLETED|Open-label (OL) Period||0
8156212|NCT02574637|20104166|P5|COMPLETED|Open-label (OL) Period||0
8156213|NCT02574637|20104167|P4|COMPLETED|Open-label (OL) Period||0
8156214|NCT02574637|20104168|P3|COMPLETED|Open-label (OL) Period||0
8156215|NCT02574637|20104169|P2|COMPLETED|Open-label (OL) Period||0
8156216|NCT02574637|20104170|P1|COMPLETED|Open-label (OL) Period||0
8156217|NCT02574637|20104161|P10|STARTED|Open-label (OL) Period||1
8156218|NCT02574637|20104162|P9|STARTED|Open-label (OL) Period||3
8156219|NCT02574637|20104163|P8|STARTED|Open-label (OL) Period||2
8156220|NCT02574637|20104164|P7|STARTED|Open-label (OL) Period||3
8156221|NCT02574637|20104165|P6|STARTED|Open-label (OL) Period||2
8156222|NCT02574637|20104166|P5|STARTED|Open-label (OL) Period||0
8156223|NCT02574637|20104167|P4|STARTED|Open-label (OL) Period||0
8156224|NCT02574637|20104168|P3|STARTED|Open-label (OL) Period||0
8156225|NCT02574637|20104169|P2|STARTED|Open-label (OL) Period||0
8156226|NCT02574637|20104170|P1|STARTED|Open-label (OL) Period||0
8156227|NCT02574637|20104161|P10|NOT COMPLETED|Double-blind Period||0
8156228|NCT02574637|20104162|P9|NOT COMPLETED|Double-blind Period||0
8156229|NCT02574637|20104163|P8|NOT COMPLETED|Double-blind Period||0
8156230|NCT02574637|20104164|P7|NOT COMPLETED|Double-blind Period||0
8156231|NCT02574637|20104165|P6|NOT COMPLETED|Double-blind Period||0
8156232|NCT02574637|20104166|P5|NOT COMPLETED|Double-blind Period||2
8156233|NCT02574637|20104167|P4|NOT COMPLETED|Double-blind Period||4
8156234|NCT02574637|20104168|P3|NOT COMPLETED|Double-blind Period||7
8156235|NCT02574637|20104169|P2|NOT COMPLETED|Double-blind Period||1
8156236|NCT02574637|20104170|P1|NOT COMPLETED|Double-blind Period||3
8156237|NCT02574637|20104161|P10|COMPLETED|Double-blind Period||0
8156238|NCT02574637|20104162|P9|COMPLETED|Double-blind Period||0
8156239|NCT02574637|20104163|P8|COMPLETED|Double-blind Period||0
8156240|NCT02574637|20104164|P7|COMPLETED|Double-blind Period||0
8156241|NCT02574637|20104165|P6|COMPLETED|Double-blind Period||0
8156242|NCT02574637|20104166|P5|COMPLETED|Double-blind Period||1
8156243|NCT02574637|20104167|P4|COMPLETED|Double-blind Period||3
8156244|NCT02574637|20104168|P3|COMPLETED|Double-blind Period||2
8156245|NCT02574637|20104169|P2|COMPLETED|Double-blind Period||4
8156246|NCT02574637|20104170|P1|COMPLETED|Double-blind Period||2
8156247|NCT02574637|20104161|P10|STARTED|Double-blind Period||0
8156248|NCT02574637|20104162|P9|STARTED|Double-blind Period||0
8156249|NCT02574637|20104163|P8|STARTED|Double-blind Period||0
8156250|NCT02574637|20104164|P7|STARTED|Double-blind Period||0
8156251|NCT02574637|20104165|P6|STARTED|Double-blind Period||0
8156252|NCT02574637|20104166|P5|STARTED|Double-blind Period||3
8156253|NCT02574637|20104167|P4|STARTED|Double-blind Period||7
8156254|NCT02574637|20104168|P3|STARTED|Double-blind Period||9
8156255|NCT02574637|20104169|P2|STARTED|Double-blind Period||5
8156256|NCT02574637|20104170|P1|STARTED|Double-blind Period||5
8156257|NCT02574598|20104268|P2|NOT COMPLETED|Overall Study||0
8156258|NCT02574598|20104269|P1|NOT COMPLETED|Overall Study||0
8156259|NCT02574598|20104268|P2|COMPLETED|Overall Study||38
8156260|NCT02574598|20104269|P1|COMPLETED|Overall Study||40
8156261|NCT02574598|20104268|P2|STARTED|Overall Study||38
8156262|NCT02574598|20104269|P1|STARTED|Overall Study||40
8156275|NCT02574312|20104322|P2|NOT COMPLETED|3 Months Follow-up||0
8156276|NCT02574312|20104323|P1|NOT COMPLETED|3 Months Follow-up||1
8156277|NCT02574312|20104322|P2|COMPLETED|3 Months Follow-up||44
8156278|NCT02574312|20104323|P1|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
8156279|NCT02574312|20104322|P2|STARTED|3 Months Follow-up||44
8156280|NCT02574312|20104323|P1|STARTED|3 Months Follow-up||44
8156281|NCT02574312|20104322|P2|NOT COMPLETED|Pre-Operative||0
8156282|NCT02574312|20104323|P1|NOT COMPLETED|Pre-Operative||0
8156283|NCT02574312|20104322|P2|COMPLETED|Pre-Operative||44
8156284|NCT02574312|20104323|P1|COMPLETED|Pre-Operative||44
8156285|NCT02574312|20104322|P2|STARTED|Pre-Operative||44
8156286|NCT02574312|20104323|P1|STARTED|Pre-Operative||44
8156287|NCT02574260|20104339|P1|NOT COMPLETED|Overall Study||1
8156288|NCT02574260|20104339|P1|COMPLETED|Overall Study||2
8156289|NCT02574260|20104339|P1|STARTED|Overall Study||3
8156290|NCT02574247|20104348|P3|NOT COMPLETED|Overall Study||5
8156291|NCT02574247|20104349|P2|NOT COMPLETED|Overall Study||3
8156292|NCT02574247|20104350|P1|NOT COMPLETED|Overall Study||5
8156293|NCT02574247|20104348|P3|COMPLETED|Overall Study||5
8156294|NCT02574247|20104349|P2|COMPLETED|Overall Study||5
8156295|NCT02574247|20104350|P1|COMPLETED|Overall Study||5
8156296|NCT02574247|20104348|P3|STARTED|Overall Study||10
8156297|NCT02574247|20104349|P2|STARTED|Overall Study||8
8156298|NCT02574247|20104350|P1|STARTED|Overall Study||10
8156299|NCT02573948|20104362|P1|NOT COMPLETED|Longitudinal Cohort||56
8156300|NCT02573948|20104362|P1|COMPLETED|Longitudinal Cohort||194
8156301|NCT02573948|20104362|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
8156302|NCT02573948|20104362|P1|NOT COMPLETED|RDS||0
8156303|NCT02573948|20104362|P1|COMPLETED|RDS||603
8156304|NCT02573948|20104362|P1|STARTED|RDS||603
8156305|NCT02573870|20104372|P2|NOT COMPLETED|Overall Study||7
8156306|NCT02573870|20104373|P1|NOT COMPLETED|Overall Study||0
8156307|NCT02573870|20104372|P2|COMPLETED|Overall Study||35
8156308|NCT02573870|20104373|P1|COMPLETED|Overall Study||20
8156309|NCT02573870|20104372|P2|STARTED|Overall Study||42
8156310|NCT02573870|20104373|P1|STARTED|Overall Study||20
8156311|NCT02573857|20104381|P2|NOT COMPLETED|Overall Study||0
8156312|NCT02573857|20104382|P1|NOT COMPLETED|Overall Study||0
8156313|NCT02573857|20104381|P2|COMPLETED|Overall Study||8
8156314|NCT02573857|20104382|P1|COMPLETED|Overall Study||8
8156315|NCT02573857|20104381|P2|STARTED|Overall Study||8
8156316|NCT02573857|20104382|P1|STARTED|Overall Study||8
8156317|NCT02573779|20104394|P2|NOT COMPLETED|Overall Study||0
8156318|NCT02573779|20104395|P1|NOT COMPLETED|Overall Study||0
8156319|NCT02573779|20104394|P2|COMPLETED|Overall Study||43
8156320|NCT02573779|20104395|P1|COMPLETED|Overall Study||74
8156321|NCT02573779|20104394|P2|STARTED|Overall Study||43
8156322|NCT02573779|20104395|P1|STARTED|Overall Study||74
8156323|NCT02573467|20104421|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
8156324|NCT02573467|20104422|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
8156325|NCT02573467|20104423|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
8156326|NCT02573467|20104424|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
8156327|NCT02573467|20104421|P4|COMPLETED|Post-treatment Follow up Epoch||44
8156328|NCT02573467|20104422|P3|COMPLETED|Post-treatment Follow up Epoch||34
8156329|NCT02573467|20104423|P2|COMPLETED|Post-treatment Follow up Epoch||41
8156330|NCT02573467|20104424|P1|COMPLETED|Post-treatment Follow up Epoch||35
8156331|NCT02573467|20104421|P4|STARTED|Post-treatment Follow up Epoch||47
8156332|NCT02573467|20104422|P3|STARTED|Post-treatment Follow up Epoch||44
8156333|NCT02573467|20104423|P2|STARTED|Post-treatment Follow up Epoch||46
8156334|NCT02573467|20104424|P1|STARTED|Post-treatment Follow up Epoch||41
8156335|NCT02573467|20104421|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
8156336|NCT02573467|20104422|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
8156337|NCT02573467|20104423|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
8156338|NCT02573467|20104424|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
8156339|NCT02573467|20104421|P4|COMPLETED|Double-blind Treatment Epoch||0
8156340|NCT02573467|20104422|P3|COMPLETED|Double-blind Treatment Epoch||0
8156341|NCT02573467|20104423|P2|COMPLETED|Double-blind Treatment Epoch||0
8156342|NCT02573467|20104424|P1|COMPLETED|Double-blind Treatment Epoch||0
8156343|NCT02573467|20104421|P4|Full Analysis Set|Double-blind Treatment Epoch||55
8156344|NCT02573467|20104422|P3|Full Analysis Set|Double-blind Treatment Epoch||51
8156345|NCT02573467|20104423|P2|Full Analysis Set|Double-blind Treatment Epoch||52
8156346|NCT02573467|20104424|P1|Full Analysis Set|Double-blind Treatment Epoch||53
8156347|NCT02573467|20104421|P4|STARTED|Double-blind Treatment Epoch||55
8156348|NCT02573467|20104422|P3|STARTED|Double-blind Treatment Epoch||51
8156349|NCT02573467|20104423|P2|STARTED|Double-blind Treatment Epoch||52
8156350|NCT02573467|20104424|P1|STARTED|Double-blind Treatment Epoch||53
8156351|NCT02573402|20104465|P2|NOT COMPLETED|Overall Study||0
8156352|NCT02573402|20104466|P1|NOT COMPLETED|Overall Study||0
8156353|NCT02573402|20104465|P2|COMPLETED|Overall Study||7
8156354|NCT02573402|20104466|P1|COMPLETED|Overall Study||12
8156355|NCT02573402|20104465|P2|STARTED|Overall Study||7
8156356|NCT02573402|20104466|P1|STARTED|Overall Study||12
8156357|NCT02573311|20104488|P2|NOT COMPLETED|Disposition for Part 2||26
8156358|NCT02573311|20104489|P1|NOT COMPLETED|Disposition for Part 2||210
8156359|NCT02573311|20104488|P2|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
8156360|NCT02573311|20104489|P1|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
8156361|NCT02573311|20104488|P2|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
8156362|NCT02573311|20104489|P1|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
8156363|NCT02573311|20104488|P2|NOT COMPLETED|Disposition for Part 1||3
8156364|NCT02573311|20104489|P1|NOT COMPLETED|Disposition for Part 1||7
8156365|NCT02573311|20104488|P2|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
8156366|NCT02573311|20104489|P1|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
8156367|NCT02573311|20104488|P2|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
8156368|NCT02573311|20104489|P1|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
8156369|NCT02573233|20104505|P2|NOT COMPLETED|Overall Study||0
8156370|NCT02573233|20104506|P1|NOT COMPLETED|Overall Study||0
8156371|NCT02573233|20104505|P2|COMPLETED|Overall Study||20
8156372|NCT02573233|20104506|P1|COMPLETED|Overall Study||22
8156373|NCT02573233|20104505|P2|STARTED|Overall Study||20
8156374|NCT02573233|20104506|P1|STARTED|Overall Study||22
8156375|NCT02573181|20104533|P2|NOT COMPLETED|Overall Study||0
8156376|NCT02573181|20104534|P1|NOT COMPLETED|Overall Study||0
8156377|NCT02573181|20104533|P2|COMPLETED|Overall Study||126
8156378|NCT02573181|20104534|P1|COMPLETED|Overall Study||127
8156379|NCT02573181|20104533|P2|Vaccinated|Overall Study||126
8156380|NCT02573181|20104534|P1|Vaccinated|Overall Study||127
8156381|NCT02573181|20104533|P2|STARTED|Overall Study||126
8156382|NCT02573181|20104534|P1|STARTED|Overall Study||127
8156383|NCT02573155|20104558|P2|NOT COMPLETED|Period 5||0
8156384|NCT02573155|20104559|P1|NOT COMPLETED|Period 5||0
8156385|NCT02573155|20104558|P2|COMPLETED|Period 5||28
8156386|NCT02573155|20104559|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8156387|NCT02573155|20104558|P2|STARTED|Period 5||28
8156388|NCT02573155|20104559|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8156389|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
8156390|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
8156391|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
8156392|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
8156393|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 4 and 5||29
8156394|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
8156395|NCT02573155|20104558|P2|NOT COMPLETED|Period 4||0
8156396|NCT02573155|20104559|P1|NOT COMPLETED|Period 4||0
8156397|NCT02573155|20104558|P2|COMPLETED|Period 4||29
8156398|NCT02573155|20104559|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
8156399|NCT02573155|20104558|P2|STARTED|Period 4||29
8156400|NCT02573155|20104559|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
8156401|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
8156402|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
8156403|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
8156404|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
8156405|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 3 and 4||31
8156406|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
8156407|NCT02573155|20104558|P2|NOT COMPLETED|Period 3||0
8156408|NCT02573155|20104559|P1|NOT COMPLETED|Period 3||0
8156409|NCT02573155|20104558|P2|COMPLETED|Period 3||31
8156410|NCT02573155|20104559|P1|COMPLETED|Period 3||15
8156411|NCT02573155|20104558|P2|STARTED|Period 3||31
8156412|NCT02573155|20104559|P1|STARTED|Period 3||15
8156413|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
8156414|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
8156415|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
8156416|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
8156417|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 2 and 3||33
8156418|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 2 and 3||16
8156419|NCT02573155|20104558|P2|NOT COMPLETED|Period 2||0
8156420|NCT02573155|20104559|P1|NOT COMPLETED|Period 2||0
8156421|NCT02573155|20104558|P2|COMPLETED|Period 2||33
8156422|NCT02573155|20104559|P1|COMPLETED|Period 2||16
8156423|NCT02573155|20104558|P2|STARTED|Period 2||33
8156424|NCT02573155|20104559|P1|STARTED|Period 2||16
8156425|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
8156426|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
8156427|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
8156428|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
8156429|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 1 and 2||38
8156430|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 1 and 2||16
8156431|NCT02573155|20104558|P2|NOT COMPLETED|Treatment Period 1||0
8156432|NCT02573155|20104559|P1|NOT COMPLETED|Treatment Period 1||0
8156433|NCT02573155|20104558|P2|COMPLETED|Treatment Period 1||38
8156434|NCT02573155|20104559|P1|COMPLETED|Treatment Period 1||16
8156435|NCT02573155|20104558|P2|STARTED|Treatment Period 1||38
8156436|NCT02573155|20104559|P1|STARTED|Treatment Period 1||16
8156437|NCT02573012|20104707|P2|NOT COMPLETED|Overall Study||15
8156438|NCT02573012|20104708|P1|NOT COMPLETED|Overall Study||15
8156439|NCT02573012|20104707|P2|COMPLETED|Overall Study||113
8156440|NCT02573012|20104708|P1|COMPLETED|Overall Study||116
8156441|NCT02573012|20104707|P2|STARTED|Overall Study||128
8156442|NCT02573012|20104708|P1|STARTED|Overall Study||131
8156443|NCT02572817|20104760|P2|NOT COMPLETED|Overall Study||6
8156444|NCT02572817|20104761|P1|NOT COMPLETED|Overall Study||9
8156445|NCT02572817|20104760|P2|COMPLETED|Overall Study||41
8156446|NCT02572817|20104761|P1|COMPLETED|Overall Study||82
8156447|NCT02572817|20104760|P2|STARTED|Overall Study||47
8156448|NCT02572817|20104761|P1|STARTED|Overall Study||91
8156449|NCT02572752|20104828|P3|NOT COMPLETED|Period 3 Including Washout||0
8156450|NCT02572752|20104829|P2|NOT COMPLETED|Period 3 Including Washout||0
8156451|NCT02572752|20104830|P1|NOT COMPLETED|Period 3 Including Washout||0
8156452|NCT02572752|20104828|P3|COMPLETED|Period 3 Including Washout||24
8156453|NCT02572752|20104829|P2|COMPLETED|Period 3 Including Washout||23
8156454|NCT02572752|20104830|P1|COMPLETED|Period 3 Including Washout||23
8156455|NCT02572752|20104828|P3|STARTED|Period 3 Including Washout||24
8156456|NCT02572752|20104829|P2|STARTED|Period 3 Including Washout||23
8156457|NCT02572752|20104830|P1|STARTED|Period 3 Including Washout||23
8156458|NCT02572752|20104828|P3|NOT COMPLETED|Period 2 Including Washout||0
8156459|NCT02572752|20104829|P2|NOT COMPLETED|Period 2 Including Washout||0
8156460|NCT02572752|20104830|P1|NOT COMPLETED|Period 2 Including Washout||0
8156461|NCT02572752|20104828|P3|COMPLETED|Period 2 Including Washout||24
8156462|NCT02572752|20104829|P2|COMPLETED|Period 2 Including Washout||23
8156463|NCT02572752|20104830|P1|COMPLETED|Period 2 Including Washout||23
8156464|NCT02572752|20104828|P3|STARTED|Period 2 Including Washout||24
8156465|NCT02572752|20104829|P2|STARTED|Period 2 Including Washout||23
8156466|NCT02572752|20104830|P1|STARTED|Period 2 Including Washout||23
8156467|NCT02572752|20104828|P3|NOT COMPLETED|Period 1 Including Washout||0
8156468|NCT02572752|20104829|P2|NOT COMPLETED|Period 1 Including Washout||0
8156469|NCT02572752|20104830|P1|NOT COMPLETED|Period 1 Including Washout||0
8156470|NCT02572752|20104828|P3|COMPLETED|Period 1 Including Washout||24
8156471|NCT02572752|20104829|P2|COMPLETED|Period 1 Including Washout||23
8156472|NCT02572752|20104830|P1|COMPLETED|Period 1 Including Washout||23
8156473|NCT02572752|20104828|P3|STARTED|Period 1 Including Washout||24
8156474|NCT02572752|20104829|P2|STARTED|Period 1 Including Washout||23
8156475|NCT02572752|20104830|P1|STARTED|Period 1 Including Washout||23
8156476|NCT02572609|20104845|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
8156477|NCT02572609|20104846|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
8156478|NCT02572609|20104845|P2|COMPLETED|Period 2: Treatment Period 2||18
8156479|NCT02572609|20104846|P1|COMPLETED|Period 2: Treatment Period 2||18
8156480|NCT02572609|20104845|P2|STARTED|Period 2: Treatment Period 2||18
8156481|NCT02572609|20104846|P1|STARTED|Period 2: Treatment Period 2||18
8156482|NCT02572609|20104845|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8156483|NCT02572609|20104846|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8156484|NCT02572609|20104845|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
8156485|NCT02572609|20104846|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
8156486|NCT02572609|20104845|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
8156487|NCT02572609|20104846|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
8156488|NCT02572570|20104854|P1|NOT COMPLETED|Overall Study||27
8156489|NCT02572570|20104854|P1|COMPLETED|Overall Study||0
8156490|NCT02572570|20104854|P1|5 Year Follow-Up|Overall Study||0
8156491|NCT02572570|20104854|P1|3 Year Follow-Up|Overall Study||5
8156492|NCT02572570|20104854|P1|2 Year Follow-Up|Overall Study||13
8156493|NCT02572570|20104854|P1|1 Year Follow-Up|Overall Study||20
8156494|NCT02572570|20104854|P1|Filtek Supreme Ultra|Overall Study||27
8156495|NCT02572570|20104854|P1|Filtek Bulk Fill Posterior|Overall Study||27
8156496|NCT02572570|20104854|P1|STARTED|Overall Study||27
8156497|NCT02572427|20104871|P2|NOT COMPLETED|Overall Study||9
8156498|NCT02572427|20104872|P1|NOT COMPLETED|Overall Study||6
8156499|NCT02572427|20104871|P2|COMPLETED|Overall Study||36
8156500|NCT02572427|20104872|P1|COMPLETED|Overall Study||31
8156501|NCT02572427|20104871|P2|STARTED|Overall Study||45
8156502|NCT02572427|20104872|P1|STARTED|Overall Study||37
8156503|NCT02572401|20104884|P4|NOT COMPLETED|Overall Study||10
8156504|NCT02572401|20104885|P3|NOT COMPLETED|Overall Study||9
8156505|NCT02572401|20104886|P2|NOT COMPLETED|Overall Study||8
8156506|NCT02572401|20104887|P1|NOT COMPLETED|Overall Study||5
8156507|NCT02572401|20104884|P4|COMPLETED|Overall Study||88
8156508|NCT02572401|20104885|P3|COMPLETED|Overall Study||89
8156509|NCT02572401|20104886|P2|COMPLETED|Overall Study||90
8156510|NCT02572401|20104887|P1|COMPLETED|Overall Study||92
8156511|NCT02572401|20104884|P4|STARTED|Overall Study||98
8156512|NCT02572401|20104885|P3|STARTED|Overall Study||98
8156513|NCT02572401|20104886|P2|STARTED|Overall Study||98
8156514|NCT02572401|20104887|P1|STARTED|Overall Study||97
8156515|NCT02572388|20104917|P4|NOT COMPLETED|Overall Study||2
8156516|NCT02572388|20104918|P3|NOT COMPLETED|Overall Study||2
8156517|NCT02572388|20104919|P2|NOT COMPLETED|Overall Study||1
8156518|NCT02572388|20104920|P1|NOT COMPLETED|Overall Study||1
8156519|NCT02572388|20104917|P4|COMPLETED|Overall Study||4
8156520|NCT02572388|20104918|P3|COMPLETED|Overall Study||8
8156521|NCT02572388|20104919|P2|COMPLETED|Overall Study||3
8156522|NCT02572388|20104920|P1|COMPLETED|Overall Study||10
8156523|NCT02572388|20104917|P4|STARTED|Overall Study||6
8156524|NCT02572388|20104918|P3|STARTED|Overall Study||10
8156525|NCT02572388|20104919|P2|STARTED|Overall Study||4
8156526|NCT02572388|20104920|P1|STARTED|Overall Study||11
8156527|NCT02572167|20104945|P3|NOT COMPLETED|Overall Study||31
8156528|NCT02572167|20104946|P2|NOT COMPLETED|Overall Study||56
8156529|NCT02572167|20104947|P1|NOT COMPLETED|Overall Study||6
8156530|NCT02572167|20104945|P3|COMPLETED|Overall Study||0
8156531|NCT02572167|20104946|P2|COMPLETED|Overall Study||0
8156532|NCT02572167|20104947|P1|COMPLETED|Overall Study||0
8156533|NCT02572167|20104945|P3|STARTED|Overall Study||31
8156534|NCT02572167|20104946|P2|STARTED|Overall Study||56
8156535|NCT02572167|20104947|P1|STARTED|Overall Study||6
8156536|NCT02572076|20104961|P1|NOT COMPLETED|Overall Study||1
8156537|NCT02572076|20104961|P1|COMPLETED|Overall Study||9
8156538|NCT02572076|20104961|P1|STARTED|Overall Study||10
8156539|NCT02571972|20104965|P1|NOT COMPLETED|Overall Study||4
8156540|NCT02571972|20104965|P1|COMPLETED|Overall Study||10
8156541|NCT02571972|20104965|P1|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
8156542|NCT02571777|20104977|P5|NOT COMPLETED|Overall Study||36
8156543|NCT02571777|20104978|P4|NOT COMPLETED|Overall Study||37
8156544|NCT02571777|20104979|P3|NOT COMPLETED|Overall Study||41
8156545|NCT02571777|20104980|P2|NOT COMPLETED|Overall Study||38
8156546|NCT02571777|20104981|P1|NOT COMPLETED|Overall Study||39
8156547|NCT02571777|20104977|P5|COMPLETED|Overall Study||582
8156548|NCT02571777|20104978|P4|COMPLETED|Overall Study||580
8156549|NCT02571777|20104979|P3|COMPLETED|Overall Study||577
8156550|NCT02571777|20104980|P2|COMPLETED|Overall Study||582
8156551|NCT02571777|20104981|P1|COMPLETED|Overall Study||580
8156552|NCT02571777|20104977|P5|Safety Set (SAF)|Overall Study||618
8156553|NCT02571777|20104978|P4|Safety Set (SAF)|Overall Study||608
8156554|NCT02571777|20104979|P3|Safety Set (SAF)|Overall Study||613
8156555|NCT02571777|20104980|P2|Safety Set (SAF)|Overall Study||617
8156556|NCT02571777|20104981|P1|Safety Set (SAF)|Overall Study||616
8156557|NCT02571777|20104977|P5|Full Analysis Set (FAS)|Overall Study||612
8156558|NCT02571777|20104978|P4|Full Analysis Set (FAS)|Overall Study||607
8156559|NCT02571777|20104979|P3|Full Analysis Set (FAS)|Overall Study||611
8156560|NCT02571777|20104980|P2|Full Analysis Set (FAS)|Overall Study||616
8156561|NCT02571777|20104981|P1|Full Analysis Set (FAS)|Overall Study||615
8156562|NCT02571777|20104977|P5|STARTED|Overall Study||618
8156563|NCT02571777|20104978|P4|STARTED|Overall Study||617
8156564|NCT02571777|20104979|P3|STARTED|Overall Study||618
8156565|NCT02571777|20104980|P2|STARTED|Overall Study||620
8156566|NCT02571777|20104981|P1|STARTED|Overall Study||619
8156567|NCT02571634|20105108|P1|NOT COMPLETED|Overall Study||0
8156568|NCT02571634|20105108|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
8156569|NCT02571634|20105108|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
8156570|NCT02571452|20105118|P2|NOT COMPLETED|Overall Study 6-Month Follow-up||0
8156571|NCT02571452|20105119|P1|NOT COMPLETED|Overall Study 6-Month Follow-up||5
8156572|NCT02571452|20105118|P2|COMPLETED|Overall Study 6-Month Follow-up||0
8156573|NCT02571452|20105119|P1|COMPLETED|Overall Study 6-Month Follow-up||42
8156574|NCT02571452|20105118|P2|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
8156575|NCT02571452|20105119|P1|STARTED|Overall Study 6-Month Follow-up||47
8156576|NCT02571452|20105118|P2|NOT COMPLETED|Overall Study Treatment||1
8156577|NCT02571452|20105119|P1|NOT COMPLETED|Overall Study Treatment||0
8156578|NCT02571452|20105118|P2|COMPLETED|Overall Study Treatment||45
8156579|NCT02571452|20105119|P1|COMPLETED|Overall Study Treatment||47
8156580|NCT02571452|20105118|P2|STARTED|Overall Study Treatment||46
8156581|NCT02571452|20105119|P1|STARTED|Overall Study Treatment||47
8156582|NCT02571439|20105133|P2|NOT COMPLETED|Overall Study||0
8156583|NCT02571439|20105134|P1|NOT COMPLETED|Overall Study||0
8156584|NCT02571439|20105133|P2|COMPLETED|Overall Study||21
8156585|NCT02571439|20105134|P1|COMPLETED|Overall Study||20
8156586|NCT02571439|20105133|P2|STARTED|Overall Study||21
8156587|NCT02571439|20105134|P1|STARTED|Overall Study||20
8156588|NCT02571244|20105160|P2|NOT COMPLETED|Overall Study||1
8156589|NCT02571244|20105161|P1|NOT COMPLETED|Overall Study||3
8156590|NCT02571244|20105160|P2|COMPLETED|Overall Study||21
8156591|NCT02571244|20105161|P1|COMPLETED|Overall Study||41
8156592|NCT02571244|20105160|P2|STARTED|Overall Study||22
8156593|NCT02571244|20105161|P1|STARTED|Overall Study||44
8156594|NCT02571218|20105177|P2|NOT COMPLETED|Overall Study||0
8156595|NCT02571218|20105178|P1|NOT COMPLETED|Overall Study||0
8156596|NCT02571218|20105177|P2|COMPLETED|Overall Study||41
8156597|NCT02571218|20105178|P1|COMPLETED|Overall Study||40
8156598|NCT02571218|20105177|P2|STARTED|Overall Study||41
8156599|NCT02571218|20105178|P1|STARTED|Overall Study||40
8156600|NCT02571153|20105189|P3|NOT COMPLETED|Overall Study||2
8156601|NCT02571153|20105190|P2|NOT COMPLETED|Overall Study||8
8156602|NCT02571153|20105191|P1|NOT COMPLETED|Overall Study||6
8156603|NCT02571153|20105189|P3|COMPLETED|Overall Study||43
8156604|NCT02571153|20105190|P2|COMPLETED|Overall Study||37
8156605|NCT02571153|20105191|P1|COMPLETED|Overall Study||39
8156606|NCT02571153|20105189|P3|STARTED|Overall Study||45
8156607|NCT02571153|20105190|P2|STARTED|Overall Study||45
8156608|NCT02571153|20105191|P1|STARTED|Overall Study||45
8156609|NCT02571075|20105219|P2|NOT COMPLETED|Overall Study||24
8156610|NCT02571075|20105220|P1|NOT COMPLETED|Overall Study||20
8156611|NCT02571075|20105219|P2|COMPLETED|Overall Study||26
8156612|NCT02571075|20105220|P1|COMPLETED|Overall Study||25
8156613|NCT02571075|20105219|P2|STARTED|Overall Study||50
8156614|NCT02571075|20105220|P1|STARTED|Overall Study||45
8156615|NCT02571049|20105234|P2|NOT COMPLETED|Randomization||2
8156616|NCT02571049|20105235|P1|NOT COMPLETED|Randomization||0
8156617|NCT02571049|20105234|P2|COMPLETED|Randomization||10
8156618|NCT02571049|20105235|P1|COMPLETED|Randomization||8
8156619|NCT02571049|20105234|P2|STARTED|Randomization||12
8156620|NCT02571049|20105235|P1|STARTED|Randomization||8
8156621|NCT02571049|20105234|P2|NOT COMPLETED|Screening||2
8156622|NCT02571049|20105235|P1|NOT COMPLETED|Screening||2
8156623|NCT02571049|20105234|P2|COMPLETED|Screening||12
8156624|NCT02571049|20105235|P1|COMPLETED|Screening||8
8156625|NCT02571049|20105234|P2|STARTED|Screening||14
8156626|NCT02571049|20105235|P1|STARTED|Screening||10
8156627|NCT02570750|20105243|P2|NOT COMPLETED|Overall Study||5
8156628|NCT02570750|20105244|P1|NOT COMPLETED|Overall Study||14
8156629|NCT02570750|20105243|P2|COMPLETED|Overall Study||68
8156630|NCT02570750|20105244|P1|COMPLETED|Overall Study||96
8156631|NCT02570750|20105243|P2|STARTED|Overall Study||73
8156632|NCT02570750|20105244|P1|STARTED|Overall Study||110
8156633|NCT02570711|20105262|P2|NOT COMPLETED|Overall Study||2
8156634|NCT02570711|20105263|P1|NOT COMPLETED|Overall Study||1
8156635|NCT02570711|20105262|P2|COMPLETED|Overall Study||0
8156636|NCT02570711|20105263|P1|COMPLETED|Overall Study||0
8156637|NCT02570711|20105262|P2|STARTED|Overall Study||2
8156638|NCT02570711|20105263|P1|STARTED|Overall Study||1
8156639|NCT02570425|20105271|P2|NOT COMPLETED|Visit 3||0
8156640|NCT02570425|20105272|P1|NOT COMPLETED|Visit 3||0
8156641|NCT02570425|20105271|P2|COMPLETED|Visit 3||231
8156642|NCT02570425|20105272|P1|COMPLETED|Visit 3||229
8156643|NCT02570425|20105271|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
8156644|NCT02570425|20105272|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
8156645|NCT02570425|20105271|P2|NOT COMPLETED|Visit 2||0
8156646|NCT02570425|20105272|P1|NOT COMPLETED|Visit 2||0
8156647|NCT02570425|20105271|P2|COMPLETED|Visit 2||247
8156648|NCT02570425|20105272|P1|COMPLETED|Visit 2||251
8156649|NCT02570425|20105271|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
8156650|NCT02570425|20105272|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
8156651|NCT02570425|20105271|P2|NOT COMPLETED|Visit 1||0
8156652|NCT02570425|20105272|P1|NOT COMPLETED|Visit 1||0
8156653|NCT02570425|20105271|P2|COMPLETED|Visit 1||242
8156654|NCT02570425|20105272|P1|COMPLETED|Visit 1||274
8156655|NCT02570425|20105271|P2|STARTED|Visit 1||242
8156656|NCT02570425|20105272|P1|STARTED|Visit 1||274
8156657|NCT02570295|20105321|P2|NOT COMPLETED|Overall Study||58
8156658|NCT02570295|20105322|P1|NOT COMPLETED|Overall Study||11
8156659|NCT02570295|20105321|P2|COMPLETED|Overall Study||289
8156660|NCT02570295|20105322|P1|COMPLETED|Overall Study||364
8156661|NCT02570295|20105321|P2|STARTED|Overall Study||347
8156662|NCT02570295|20105322|P1|STARTED|Overall Study||375
8156663|NCT02570165|20105351|P7|NOT COMPLETED|Overall Study||0
8156664|NCT02570165|20105352|P6|NOT COMPLETED|Overall Study||2
8156665|NCT02570165|20105353|P5|NOT COMPLETED|Overall Study||6
8156666|NCT02570165|20105354|P4|NOT COMPLETED|Overall Study||5
8156667|NCT02570165|20105355|P3|NOT COMPLETED|Overall Study||5
8156668|NCT02570165|20105356|P2|NOT COMPLETED|Overall Study||3
8156669|NCT02570165|20105357|P1|NOT COMPLETED|Overall Study||2
8156670|NCT02570165|20105351|P7|COMPLETED|Overall Study||47
8156671|NCT02570165|20105352|P6|COMPLETED|Overall Study||44
8156672|NCT02570165|20105353|P5|COMPLETED|Overall Study||41
8156673|NCT02570165|20105354|P4|COMPLETED|Overall Study||40
8156674|NCT02570165|20105355|P3|COMPLETED|Overall Study||41
8156675|NCT02570165|20105356|P2|COMPLETED|Overall Study||43
8156676|NCT02570165|20105357|P1|COMPLETED|Overall Study||44
8156677|NCT02570165|20105351|P7|STARTED|Overall Study||47
8156678|NCT02570165|20105352|P6|STARTED|Overall Study||46
8156679|NCT02570165|20105353|P5|STARTED|Overall Study||47
8156680|NCT02570165|20105354|P4|STARTED|Overall Study||45
8156681|NCT02570165|20105355|P3|STARTED|Overall Study||46
8156682|NCT02570165|20105356|P2|STARTED|Overall Study||46
8156683|NCT02570165|20105357|P1|STARTED|Overall Study||46
8156684|NCT02570152|20105380|P1|NOT COMPLETED|Overall Study||15
8156685|NCT02570152|20105380|P1|COMPLETED|Overall Study||1989
8156686|NCT02570152|20105380|P1|STARTED|Overall Study||2004
8156687|NCT02570139|20105396|P2|NOT COMPLETED|Overall Study||0
8156688|NCT02570139|20105397|P1|NOT COMPLETED|Overall Study||0
8156689|NCT02570139|20105396|P2|COMPLETED|Overall Study||21
8156690|NCT02570139|20105397|P1|COMPLETED|Overall Study||24
8156691|NCT02570139|20105396|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
8156692|NCT02570139|20105397|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
8156693|NCT02570126|20105411|P2|NOT COMPLETED|Overall Study||9
8156694|NCT02570126|20105412|P1|NOT COMPLETED|Overall Study||6
8156695|NCT02570126|20105411|P2|COMPLETED|Overall Study||607
8156696|NCT02570126|20105412|P1|COMPLETED|Overall Study||609
8156697|NCT02570126|20105411|P2|STARTED|Overall Study||616
8156698|NCT02570126|20105412|P1|STARTED|Overall Study||615
8156699|NCT02570074|20105438|P2|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
8156700|NCT02570074|20105439|P1|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
8156701|NCT02570074|20105438|P2|COMPLETED|Period 2 (Second Dosing Regimen)||10
8156702|NCT02570074|20105439|P1|COMPLETED|Period 2 (Second Dosing Regimen)||8
8156703|NCT02570074|20105438|P2|STARTED|Period 2 (Second Dosing Regimen)||10
8156704|NCT02570074|20105439|P1|STARTED|Period 2 (Second Dosing Regimen)||9
8156705|NCT02570074|20105438|P2|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
8156706|NCT02570074|20105439|P1|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
8156707|NCT02570074|20105438|P2|COMPLETED|Period 1 (First Dosing Regimen)||10
8156708|NCT02570074|20105439|P1|COMPLETED|Period 1 (First Dosing Regimen)||9
8156709|NCT02570074|20105438|P2|STARTED|Period 1 (First Dosing Regimen)||10
8156710|NCT02570074|20105439|P1|STARTED|Period 1 (First Dosing Regimen)||9
8156711|NCT02570022|20105499|P2|NOT COMPLETED|Overall Study||0
8156712|NCT02570022|20105500|P1|NOT COMPLETED|Overall Study||0
8156713|NCT02570022|20105499|P2|COMPLETED|Overall Study||31
8156714|NCT02570022|20105500|P1|COMPLETED|Overall Study||26
8156715|NCT02570022|20105499|P2|STARTED|Overall Study||31
8156716|NCT02570022|20105500|P1|STARTED|Overall Study||26
8156717|NCT02569996|20105508|P1|NOT COMPLETED|Overall Study||55
8156718|NCT02569996|20105508|P1|COMPLETED|Overall Study||69
8156719|NCT02569996|20105508|P1|STARTED|Overall Study||124
8156720|NCT02569957|20105520|P2|NOT COMPLETED|Overall Study||1
8156721|NCT02569957|20105521|P1|NOT COMPLETED|Overall Study||0
8156722|NCT02569957|20105520|P2|COMPLETED|Overall Study||0
8156723|NCT02569957|20105521|P1|COMPLETED|Overall Study||0
8156724|NCT02569957|20105520|P2|STARTED|Overall Study||1
8156725|NCT02569957|20105521|P1|STARTED|Overall Study||0
8156726|NCT02569853|20105553|P2|NOT COMPLETED|Overall Study||14
8156727|NCT02569853|20105554|P1|NOT COMPLETED|Overall Study||20
8156728|NCT02569853|20105553|P2|COMPLETED|Overall Study||123
8156729|NCT02569853|20105554|P1|COMPLETED|Overall Study||111
8156730|NCT02569853|20105553|P2|STARTED|Overall Study||137
8156731|NCT02569853|20105554|P1|STARTED|Overall Study||131
8156732|NCT02569710|20105572|P10|NOT COMPLETED|Overall Study||0
8156733|NCT02569710|20105573|P9|NOT COMPLETED|Overall Study||1
8156734|NCT02569710|20105574|P8|NOT COMPLETED|Overall Study||0
8156735|NCT02569710|20105575|P7|NOT COMPLETED|Overall Study||2
8156736|NCT02569710|20105576|P6|NOT COMPLETED|Overall Study||1
8156737|NCT02569710|20105577|P5|NOT COMPLETED|Overall Study||1
8156738|NCT02569710|20105578|P4|NOT COMPLETED|Overall Study||0
8156739|NCT02569710|20105579|P3|NOT COMPLETED|Overall Study||0
8156740|NCT02569710|20105580|P2|NOT COMPLETED|Overall Study||0
8156741|NCT02569710|20105581|P1|NOT COMPLETED|Overall Study||1
8156742|NCT02569710|20105572|P10|COMPLETED|Overall Study||4
8156743|NCT02569710|20105573|P9|COMPLETED|Overall Study||14
8156744|NCT02569710|20105574|P8|COMPLETED|Overall Study||30
8156745|NCT02569710|20105575|P7|COMPLETED|Overall Study||12
8156746|NCT02569710|20105576|P6|COMPLETED|Overall Study||4
8156747|NCT02569710|20105577|P5|COMPLETED|Overall Study||7
8156748|NCT02569710|20105578|P4|COMPLETED|Overall Study||20
8156749|NCT02569710|20105579|P3|COMPLETED|Overall Study||20
8156750|NCT02569710|20105580|P2|COMPLETED|Overall Study||25
8156751|NCT02569710|20105581|P1|COMPLETED|Overall Study||19
8156752|NCT02569710|20105572|P10|STARTED|Overall Study||4
8156753|NCT02569710|20105573|P9|STARTED|Overall Study||15
8156754|NCT02569710|20105574|P8|STARTED|Overall Study||30
8156755|NCT02569710|20105575|P7|STARTED|Overall Study||14
8156756|NCT02569710|20105576|P6|STARTED|Overall Study||5
8156757|NCT02569710|20105577|P5|STARTED|Overall Study||8
8156758|NCT02569710|20105578|P4|STARTED|Overall Study||20
8156759|NCT02569710|20105579|P3|STARTED|Overall Study||20
8156760|NCT02569710|20105580|P2|STARTED|Overall Study||25
8156761|NCT02569710|20105581|P1|STARTED|Overall Study||20
8156762|NCT02569658|20105891|P2|NOT COMPLETED|Overall Study||1
8156763|NCT02569658|20105892|P1|NOT COMPLETED|Overall Study||1
8156764|NCT02569658|20105891|P2|COMPLETED|Overall Study||56
8156765|NCT02569658|20105892|P1|COMPLETED|Overall Study||52
8156766|NCT02569658|20105891|P2|STARTED|Overall Study||57
8156767|NCT02569658|20105892|P1|STARTED|Overall Study||53
8156768|NCT02569541|20105908|P1|NOT COMPLETED|Overall Study||21
8156769|NCT02569541|20105908|P1|COMPLETED|Overall Study||9
8156770|NCT02569541|20105908|P1|STARTED|Overall Study||30
8156771|NCT02569437|20105921|P2|NOT COMPLETED|Overall Study||14
8156772|NCT02569437|20105922|P1|NOT COMPLETED|Overall Study||12
8156773|NCT02569437|20105921|P2|COMPLETED|Overall Study||11
8156774|NCT02569437|20105922|P1|COMPLETED|Overall Study||12
8156775|NCT02569437|20105921|P2|STARTED|Overall Study||25
8156776|NCT02569437|20105922|P1|STARTED|Overall Study||24
8156777|NCT02569411|20105938|P2|NOT COMPLETED|Overall Study||64
8156778|NCT02569411|20105939|P1|NOT COMPLETED|Overall Study||65
8156779|NCT02569411|20105938|P2|COMPLETED|Overall Study||0
8156780|NCT02569411|20105939|P1|COMPLETED|Overall Study||0
8156781|NCT02569411|20105938|P2|STARTED|Overall Study||64
8156782|NCT02569411|20105939|P1|STARTED|Overall Study||65
8156783|NCT02569398|20105952|P3|NOT COMPLETED|Overall Study||183
8156784|NCT02569398|20105953|P2|NOT COMPLETED|Overall Study||189
8156785|NCT02569398|20105954|P1|NOT COMPLETED|Overall Study||185
8156786|NCT02569398|20105952|P3|COMPLETED|Overall Study||0
8156787|NCT02569398|20105953|P2|COMPLETED|Overall Study||0
8156788|NCT02569398|20105954|P1|COMPLETED|Overall Study||0
8156789|NCT02569398|20105952|P3|STARTED|Overall Study||183
8156790|NCT02569398|20105953|P2|STARTED|Overall Study||189
8156791|NCT02569398|20105954|P1|STARTED|Overall Study||185
8156792|NCT02569112|20105977|P2|NOT COMPLETED|Overall Study||0
8156793|NCT02569112|20105978|P1|NOT COMPLETED|Overall Study||0
8156794|NCT02569112|20105977|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
8156795|NCT02569112|20105978|P1|COMPLETED|Overall Study||10
8156796|NCT02569112|20105977|P2|STARTED|Overall Study||10
8156797|NCT02569112|20105978|P1|STARTED|Overall Study||10
8156798|NCT02569086|20105983|P1|NOT COMPLETED|Overall Study||0
8156799|NCT02569086|20105983|P1|COMPLETED|Overall Study||22
8156800|NCT02569086|20105983|P1|STARTED|Overall Study||22
8156801|NCT02568852|20105990|P2|NOT COMPLETED|Overall Study||0
8156802|NCT02568852|20105991|P1|NOT COMPLETED|Overall Study||0
8156803|NCT02568852|20105990|P2|COMPLETED|Overall Study||25
8156804|NCT02568852|20105991|P1|COMPLETED|Overall Study||25
8156805|NCT02568852|20105990|P2|STARTED|Overall Study||25
8156806|NCT02568852|20105991|P1|STARTED|Overall Study||25
8156807|NCT02568683|20106029|P2|NOT COMPLETED|Overall Study||4
8156808|NCT02568683|20106030|P1|NOT COMPLETED|Overall Study||6
8156809|NCT02568683|20106029|P2|COMPLETED|Overall Study||0
8156810|NCT02568683|20106030|P1|COMPLETED|Overall Study||0
8156811|NCT02568683|20106029|P2|STARTED|Overall Study||4
8156812|NCT02568683|20106030|P1|STARTED|Overall Study||6
8156813|NCT02568644|20106044|P2|NOT COMPLETED|Overall Study||0
8156814|NCT02568644|20106045|P1|NOT COMPLETED|Overall Study||0
8156815|NCT02568644|20106044|P2|COMPLETED|Overall Study||30
8156816|NCT02568644|20106045|P1|COMPLETED|Overall Study||30
8156817|NCT02568644|20106044|P2|STARTED|Overall Study||30
8156818|NCT02568644|20106045|P1|STARTED|Overall Study||30
8156819|NCT02568475|20106059|P2|NOT COMPLETED|Overall Study||43
8156820|NCT02568475|20106060|P1|NOT COMPLETED|Overall Study||51
8156821|NCT02568475|20106059|P2|COMPLETED|Overall Study||52
8156822|NCT02568475|20106060|P1|COMPLETED|Overall Study||46
8156823|NCT02568475|20106059|P2|Post-test|Overall Study||82
8156824|NCT02568475|20106060|P1|Post-test|Overall Study||85
8156825|NCT02568475|20106059|P2|STARTED|Overall Study||95
8156826|NCT02568475|20106060|P1|STARTED|Overall Study||97
8156827|NCT02568397|20106074|P2|NOT COMPLETED|Period 2||2
8156828|NCT02568397|20106075|P1|NOT COMPLETED|Period 2||0
8156829|NCT02568397|20106074|P2|COMPLETED|Period 2||58
8156830|NCT02568397|20106075|P1|COMPLETED|Period 2||0
8156831|NCT02568397|20106074|P2|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
8156832|NCT02568397|20106075|P1|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
8156833|NCT02568397|20106074|P2|NOT COMPLETED|Period 1||0
8156834|NCT02568397|20106075|P1|NOT COMPLETED|Period 1||0
8156835|NCT02568397|20106074|P2|COMPLETED|Period 1||0
8156836|NCT02568397|20106075|P1|COMPLETED|Period 1||60
8156837|NCT02568397|20106074|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8156838|NCT02568397|20106075|P1|Received at Least 1 Dose of Study Drug|Period 1||60
8156839|NCT02568397|20106074|P2|STARTED|Period 1||0
8156840|NCT02568397|20106075|P1|STARTED|Period 1||60
8156841|NCT02568384|20106099|P1|NOT COMPLETED|Overall Study||2
8156842|NCT02568384|20106099|P1|COMPLETED|Overall Study||43
8156843|NCT02568384|20106099|P1|STARTED|Overall Study||45
8156844|NCT02568345|20106109|P1|NOT COMPLETED|Overall Study||0
8156845|NCT02568345|20106109|P1|COMPLETED|Overall Study||31
8156846|NCT02568345|20106109|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
8156847|NCT02568345|20106109|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
8156848|NCT02568345|20106109|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
8156849|NCT02568345|20106109|P1|STARTED|Overall Study||31
8156850|NCT02568254|20106113|P6|NOT COMPLETED|Period 3||0
8156851|NCT02568254|20106114|P5|NOT COMPLETED|Period 3||1
8156852|NCT02568254|20106115|P4|NOT COMPLETED|Period 3||0
8156853|NCT02568254|20106116|P3|NOT COMPLETED|Period 3||0
8156854|NCT02568254|20106117|P2|NOT COMPLETED|Period 3||0
8156855|NCT02568254|20106118|P1|NOT COMPLETED|Period 3||0
8156856|NCT02568254|20106113|P6|COMPLETED|Period 3||12
8156857|NCT02568254|20106114|P5|COMPLETED|Period 3||11
8156858|NCT02568254|20106115|P4|COMPLETED|Period 3||12
8156859|NCT02568254|20106116|P3|COMPLETED|Period 3||12
8156860|NCT02568254|20106117|P2|COMPLETED|Period 3||12
8156861|NCT02568254|20106118|P1|COMPLETED|Period 3||13
8156862|NCT02568254|20106113|P6|STARTED|Period 3||12
8156863|NCT02568254|20106114|P5|STARTED|Period 3||12
8156864|NCT02568254|20106115|P4|STARTED|Period 3||12
8156865|NCT02568254|20106116|P3|STARTED|Period 3||12
8156866|NCT02568254|20106117|P2|STARTED|Period 3||12
8156867|NCT02568254|20106118|P1|STARTED|Period 3||13
8156868|NCT02568254|20106113|P6|NOT COMPLETED|Period 2||0
8156869|NCT02568254|20106114|P5|NOT COMPLETED|Period 2||0
8156870|NCT02568254|20106115|P4|NOT COMPLETED|Period 2||0
8156871|NCT02568254|20106116|P3|NOT COMPLETED|Period 2||1
8156872|NCT02568254|20106117|P2|NOT COMPLETED|Period 2||0
8156873|NCT02568254|20106118|P1|NOT COMPLETED|Period 2||0
8156874|NCT02568254|20106113|P6|COMPLETED|Period 2||12
8156875|NCT02568254|20106114|P5|COMPLETED|Period 2||12
8156876|NCT02568254|20106115|P4|COMPLETED|Period 2||12
8156877|NCT02568254|20106116|P3|COMPLETED|Period 2||12
8156878|NCT02568254|20106117|P2|COMPLETED|Period 2||12
8156879|NCT02568254|20106118|P1|COMPLETED|Period 2||13
8156880|NCT02568254|20106113|P6|STARTED|Period 2||12
8156881|NCT02568254|20106114|P5|STARTED|Period 2||12
8156882|NCT02568254|20106115|P4|STARTED|Period 2||12
8156883|NCT02568254|20106116|P3|STARTED|Period 2||13
8156884|NCT02568254|20106117|P2|STARTED|Period 2||12
8156885|NCT02568254|20106118|P1|STARTED|Period 2||13
8156886|NCT02568254|20106113|P6|NOT COMPLETED|Period 1||0
8156887|NCT02568254|20106114|P5|NOT COMPLETED|Period 1||0
8156888|NCT02568254|20106115|P4|NOT COMPLETED|Period 1||0
8156889|NCT02568254|20106116|P3|NOT COMPLETED|Period 1||0
8156890|NCT02568254|20106117|P2|NOT COMPLETED|Period 1||0
8156891|NCT02568254|20106118|P1|NOT COMPLETED|Period 1||0
8156892|NCT02568254|20106113|P6|COMPLETED|Period 1||12
8156893|NCT02568254|20106114|P5|COMPLETED|Period 1||12
8156894|NCT02568254|20106115|P4|COMPLETED|Period 1||12
8156895|NCT02568254|20106116|P3|COMPLETED|Period 1||13
8156896|NCT02568254|20106117|P2|COMPLETED|Period 1||12
8156897|NCT02568254|20106118|P1|COMPLETED|Period 1||13
8156898|NCT02568254|20106113|P6|STARTED|Period 1||12
8156899|NCT02568254|20106114|P5|STARTED|Period 1||12
8156900|NCT02568254|20106115|P4|STARTED|Period 1||12
8156901|NCT02568254|20106116|P3|STARTED|Period 1||13
8156902|NCT02568254|20106117|P2|STARTED|Period 1||12
8156903|NCT02568254|20106118|P1|STARTED|Period 1||13
8156904|NCT02568046|20106128|P2|NOT COMPLETED|Overall Study||3
8156905|NCT02568046|20106129|P1|NOT COMPLETED|Overall Study||5
8156906|NCT02568046|20106128|P2|COMPLETED|Overall Study||2
8156907|NCT02568046|20106129|P1|COMPLETED|Overall Study||0
8156908|NCT02568046|20106128|P2|STARTED|Overall Study||5
8156909|NCT02568046|20106129|P1|STARTED|Overall Study||5
8156910|NCT02568007|20106138|P3|NOT COMPLETED|Overall Study||0
8156911|NCT02568007|20106139|P2|NOT COMPLETED|Overall Study||0
8156912|NCT02568007|20106140|P1|NOT COMPLETED|Overall Study||0
8156913|NCT02568007|20106138|P3|COMPLETED|Overall Study||0
8156914|NCT02568007|20106139|P2|COMPLETED|Overall Study||2
8156915|NCT02568007|20106140|P1|COMPLETED|Overall Study||2
8156916|NCT02568007|20106138|P3|STARTED|Overall Study||0
8156917|NCT02568007|20106139|P2|STARTED|Overall Study||2
8156918|NCT02568007|20106140|P1|STARTED|Overall Study||2
8156919|NCT02567968|20106169|P2|NOT COMPLETED|Second Intervention||0
8156920|NCT02567968|20106170|P1|NOT COMPLETED|Second Intervention||0
8156921|NCT02567968|20106169|P2|COMPLETED|Second Intervention||4
8156922|NCT02567968|20106170|P1|COMPLETED|Second Intervention||4
8156923|NCT02567968|20106169|P2|STARTED|Second Intervention||4
8156924|NCT02567968|20106170|P1|STARTED|Second Intervention||4
8156925|NCT02567968|20106169|P2|NOT COMPLETED|Washout (2 Weeks)||0
8156926|NCT02567968|20106170|P1|NOT COMPLETED|Washout (2 Weeks)||0
8156927|NCT02567968|20106169|P2|COMPLETED|Washout (2 Weeks)||4
8156928|NCT02567968|20106170|P1|COMPLETED|Washout (2 Weeks)||4
8156929|NCT02567968|20106169|P2|STARTED|Washout (2 Weeks)||4
8156930|NCT02567968|20106170|P1|STARTED|Washout (2 Weeks)||4
8156931|NCT02567968|20106169|P2|NOT COMPLETED|First Intervention||0
8156932|NCT02567968|20106170|P1|NOT COMPLETED|First Intervention||0
8156933|NCT02567968|20106169|P2|COMPLETED|First Intervention||4
8156934|NCT02567968|20106170|P1|COMPLETED|First Intervention||4
8156935|NCT02567968|20106169|P2|STARTED|First Intervention||4
8156936|NCT02567968|20106170|P1|STARTED|First Intervention||4
8156937|NCT02567708|20106192|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
8156938|NCT02567708|20106193|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
8156939|NCT02567708|20106192|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
8156940|NCT02567708|20106193|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
8156941|NCT02567708|20106192|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
8156942|NCT02567708|20106193|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
8156943|NCT02567708|20106192|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8156944|NCT02567708|20106193|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8156945|NCT02567708|20106192|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
8156946|NCT02567708|20106193|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
8156947|NCT02567708|20106192|P2|STARTED|Washout Period (Up to 4 Weeks)||23
8156948|NCT02567708|20106193|P1|STARTED|Washout Period (Up to 4 Weeks)||22
8156949|NCT02567708|20106192|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
8156950|NCT02567708|20106193|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
8156951|NCT02567708|20106192|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
8156952|NCT02567708|20106193|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
8156953|NCT02567708|20106192|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
8156954|NCT02567708|20106193|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
8156955|NCT02567656|20106238|P6|NOT COMPLETED|Overall Study||0
8156956|NCT02567656|20106239|P5|NOT COMPLETED|Overall Study||0
8156957|NCT02567656|20106240|P4|NOT COMPLETED|Overall Study||0
8156958|NCT02567656|20106241|P3|NOT COMPLETED|Overall Study||2
8156959|NCT02567656|20106242|P2|NOT COMPLETED|Overall Study||1
8156960|NCT02567656|20106243|P1|NOT COMPLETED|Overall Study||1
8156961|NCT02567656|20106238|P6|COMPLETED|Overall Study||20
8156962|NCT02567656|20106239|P5|COMPLETED|Overall Study||19
8156963|NCT02567656|20106240|P4|COMPLETED|Overall Study||6
8156964|NCT02567656|20106241|P3|COMPLETED|Overall Study||3
8156965|NCT02567656|20106242|P2|COMPLETED|Overall Study||3
8156966|NCT02567656|20106243|P1|COMPLETED|Overall Study||3
8156967|NCT02567656|20106238|P6|STARTED|Overall Study||20
8156968|NCT02567656|20106239|P5|STARTED|Overall Study||19
8156969|NCT02567656|20106240|P4|STARTED|Overall Study||6
8156970|NCT02567656|20106241|P3|STARTED|Overall Study||5
8156971|NCT02567656|20106242|P2|STARTED|Overall Study||4
8156972|NCT02567656|20106243|P1|STARTED|Overall Study||4
8156973|NCT02567552|20106275|P2|NOT COMPLETED|Overall Study||1
8156974|NCT02567552|20106276|P1|NOT COMPLETED|Overall Study||0
8156975|NCT02567552|20106275|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
8156976|NCT02567552|20106276|P1|COMPLETED|Overall Study||12
8156977|NCT02567552|20106275|P2|STARTED|Overall Study||12
8156978|NCT02567552|20106276|P1|STARTED|Overall Study||12
8156979|NCT02567188|20106306|P1|NOT COMPLETED|Overall Study||35
8156980|NCT02567188|20106306|P1|COMPLETED|Overall Study||109
8156981|NCT02567188|20106306|P1|STARTED|Overall Study||144
8156982|NCT02566889|20106337|P2|NOT COMPLETED|Overall Study||5
8156983|NCT02566889|20106338|P1|NOT COMPLETED|Overall Study||13
8156984|NCT02566889|20106337|P2|COMPLETED|Overall Study||3
8156985|NCT02566889|20106338|P1|COMPLETED|Overall Study||32
8156986|NCT02566889|20106337|P2|Cross-over to Dose Escalation Group|Overall Study||0
8156987|NCT02566889|20106338|P1|Cross-over to Dose Escalation Group|Overall Study||1
8156988|NCT02566889|20106337|P2|STARTED|Overall Study||8
8156989|NCT02566889|20106338|P1|STARTED|Overall Study||45
8156990|NCT02566785|20106356|P2|NOT COMPLETED|Overall Study||3
8156991|NCT02566785|20106357|P1|NOT COMPLETED|Overall Study||1
8156992|NCT02566785|20106356|P2|COMPLETED|Overall Study||15
8156993|NCT02566785|20106357|P1|COMPLETED|Overall Study||14
8156994|NCT02566785|20106356|P2|STARTED|Overall Study||18
8156995|NCT02566785|20106357|P1|STARTED|Overall Study||15
8156996|NCT02566759|20106384|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8156997|NCT02566759|20106385|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8156998|NCT02566759|20106386|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8156999|NCT02566759|20106387|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157000|NCT02566759|20106388|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157001|NCT02566759|20106389|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157002|NCT02566759|20106390|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157003|NCT02566759|20106391|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157004|NCT02566759|20106392|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157005|NCT02566759|20106393|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157006|NCT02566759|20106394|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157007|NCT02566759|20106395|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157008|NCT02566759|20106396|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157009|NCT02566759|20106397|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157010|NCT02566759|20106398|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157011|NCT02566759|20106399|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157012|NCT02566759|20106400|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157013|NCT02566759|20106384|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
8157014|NCT02566759|20106385|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8157015|NCT02566759|20106386|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8157016|NCT02566759|20106387|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157017|NCT02566759|20106388|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157018|NCT02566759|20106389|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157019|NCT02566759|20106390|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157020|NCT02566759|20106391|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157021|NCT02566759|20106392|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157022|NCT02566759|20106393|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157023|NCT02566759|20106394|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157024|NCT02566759|20106395|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157025|NCT02566759|20106396|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157026|NCT02566759|20106397|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157027|NCT02566759|20106398|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157028|NCT02566759|20106399|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157029|NCT02566759|20106400|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157030|NCT02566759|20106384|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
8157031|NCT02566759|20106385|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8157032|NCT02566759|20106386|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8157033|NCT02566759|20106387|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157034|NCT02566759|20106388|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157035|NCT02566759|20106389|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157036|NCT02566759|20106390|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157037|NCT02566759|20106391|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157038|NCT02566759|20106392|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157039|NCT02566759|20106393|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157040|NCT02566759|20106394|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157041|NCT02566759|20106395|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157042|NCT02566759|20106396|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157043|NCT02566759|20106397|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157044|NCT02566759|20106398|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157045|NCT02566759|20106399|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157046|NCT02566759|20106400|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157047|NCT02566759|20106384|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157048|NCT02566759|20106385|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157049|NCT02566759|20106386|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157050|NCT02566759|20106387|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157051|NCT02566759|20106388|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157052|NCT02566759|20106389|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157053|NCT02566759|20106390|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157054|NCT02566759|20106391|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157055|NCT02566759|20106392|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157056|NCT02566759|20106393|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157057|NCT02566759|20106394|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157058|NCT02566759|20106395|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157059|NCT02566759|20106396|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157060|NCT02566759|20106397|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157061|NCT02566759|20106398|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157062|NCT02566759|20106399|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157063|NCT02566759|20106400|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157064|NCT02566759|20106384|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
8157065|NCT02566759|20106385|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8157066|NCT02566759|20106386|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8157067|NCT02566759|20106387|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157068|NCT02566759|20106388|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157069|NCT02566759|20106389|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157070|NCT02566759|20106390|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157071|NCT02566759|20106391|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157072|NCT02566759|20106392|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157073|NCT02566759|20106393|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157074|NCT02566759|20106394|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157075|NCT02566759|20106395|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157076|NCT02566759|20106396|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157077|NCT02566759|20106397|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157078|NCT02566759|20106398|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157079|NCT02566759|20106399|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157080|NCT02566759|20106400|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157081|NCT02566759|20106384|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
8157082|NCT02566759|20106385|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8157083|NCT02566759|20106386|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8157084|NCT02566759|20106387|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157085|NCT02566759|20106388|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157086|NCT02566759|20106389|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157087|NCT02566759|20106390|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157088|NCT02566759|20106391|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157089|NCT02566759|20106392|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157090|NCT02566759|20106393|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157091|NCT02566759|20106394|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157092|NCT02566759|20106395|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157093|NCT02566759|20106396|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157094|NCT02566759|20106397|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157095|NCT02566759|20106398|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157096|NCT02566759|20106399|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157097|NCT02566759|20106400|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157098|NCT02566759|20106384|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
8157099|NCT02566759|20106385|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157100|NCT02566759|20106386|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157101|NCT02566759|20106387|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157102|NCT02566759|20106388|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157103|NCT02566759|20106389|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157104|NCT02566759|20106390|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157105|NCT02566759|20106391|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157106|NCT02566759|20106392|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157107|NCT02566759|20106393|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157108|NCT02566759|20106394|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157109|NCT02566759|20106395|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157110|NCT02566759|20106396|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157111|NCT02566759|20106397|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157112|NCT02566759|20106398|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157113|NCT02566759|20106399|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157114|NCT02566759|20106400|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157115|NCT02566759|20106384|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
8157116|NCT02566759|20106385|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8157117|NCT02566759|20106386|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8157118|NCT02566759|20106387|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157119|NCT02566759|20106388|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157120|NCT02566759|20106389|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157121|NCT02566759|20106390|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157122|NCT02566759|20106391|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157123|NCT02566759|20106392|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157124|NCT02566759|20106393|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157125|NCT02566759|20106394|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157126|NCT02566759|20106395|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157127|NCT02566759|20106396|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157128|NCT02566759|20106397|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157129|NCT02566759|20106398|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157130|NCT02566759|20106399|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157131|NCT02566759|20106400|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8157132|NCT02566759|20106384|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8157133|NCT02566759|20106385|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8157134|NCT02566759|20106386|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8157135|NCT02566759|20106387|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157136|NCT02566759|20106388|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157137|NCT02566759|20106389|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157138|NCT02566759|20106390|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157139|NCT02566759|20106391|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157140|NCT02566759|20106392|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157141|NCT02566759|20106393|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157142|NCT02566759|20106394|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157143|NCT02566759|20106395|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157144|NCT02566759|20106396|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157145|NCT02566759|20106397|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157146|NCT02566759|20106398|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157147|NCT02566759|20106399|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157148|NCT02566759|20106400|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8157149|NCT02566759|20106384|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157150|NCT02566759|20106385|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157151|NCT02566759|20106386|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157152|NCT02566759|20106387|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157153|NCT02566759|20106388|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157154|NCT02566759|20106389|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157155|NCT02566759|20106390|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157156|NCT02566759|20106391|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157157|NCT02566759|20106392|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157158|NCT02566759|20106393|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157159|NCT02566759|20106394|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157160|NCT02566759|20106395|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157161|NCT02566759|20106396|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157162|NCT02566759|20106397|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157163|NCT02566759|20106398|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157164|NCT02566759|20106399|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157165|NCT02566759|20106400|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157166|NCT02566759|20106384|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8157167|NCT02566759|20106385|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8157168|NCT02566759|20106386|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8157169|NCT02566759|20106387|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157170|NCT02566759|20106388|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157171|NCT02566759|20106389|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157172|NCT02566759|20106390|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157173|NCT02566759|20106391|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157174|NCT02566759|20106392|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157175|NCT02566759|20106393|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157176|NCT02566759|20106394|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157177|NCT02566759|20106395|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157178|NCT02566759|20106396|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157179|NCT02566759|20106397|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157180|NCT02566759|20106398|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157181|NCT02566759|20106399|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157182|NCT02566759|20106400|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8157183|NCT02566759|20106384|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8157184|NCT02566759|20106385|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8157185|NCT02566759|20106386|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8157186|NCT02566759|20106387|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157187|NCT02566759|20106388|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157188|NCT02566759|20106389|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157189|NCT02566759|20106390|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157190|NCT02566759|20106391|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157191|NCT02566759|20106392|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157192|NCT02566759|20106393|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157193|NCT02566759|20106394|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157194|NCT02566759|20106395|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157195|NCT02566759|20106396|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157196|NCT02566759|20106397|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157197|NCT02566759|20106398|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157198|NCT02566759|20106399|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157199|NCT02566759|20106400|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8157200|NCT02566759|20106384|P17|NOT COMPLETED|All Parts||0
8157201|NCT02566759|20106385|P16|NOT COMPLETED|All Parts||0
8157202|NCT02566759|20106386|P15|NOT COMPLETED|All Parts||0
8157203|NCT02566759|20106387|P14|NOT COMPLETED|All Parts||5
8157204|NCT02566759|20106388|P13|NOT COMPLETED|All Parts||1
8157205|NCT02566759|20106389|P12|NOT COMPLETED|All Parts||0
8157206|NCT02566759|20106390|P11|NOT COMPLETED|All Parts||0
8157207|NCT02566759|20106391|P10|NOT COMPLETED|All Parts||0
8157208|NCT02566759|20106392|P9|NOT COMPLETED|All Parts||0
8157209|NCT02566759|20106393|P8|NOT COMPLETED|All Parts||0
8157210|NCT02566759|20106394|P7|NOT COMPLETED|All Parts||0
8157211|NCT02566759|20106395|P6|NOT COMPLETED|All Parts||0
8157212|NCT02566759|20106396|P5|NOT COMPLETED|All Parts||0
8157213|NCT02566759|20106397|P4|NOT COMPLETED|All Parts||0
8157214|NCT02566759|20106398|P3|NOT COMPLETED|All Parts||0
8157215|NCT02566759|20106399|P2|NOT COMPLETED|All Parts||1
8157216|NCT02566759|20106400|P1|NOT COMPLETED|All Parts||0
8157217|NCT02566759|20106384|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8157218|NCT02566759|20106385|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8157219|NCT02566759|20106386|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8157220|NCT02566759|20106387|P14|COMPLETED|All Parts||0
8157221|NCT02566759|20106388|P13|COMPLETED|All Parts||0
8157222|NCT02566759|20106389|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157223|NCT02566759|20106390|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157224|NCT02566759|20106391|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157225|NCT02566759|20106392|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157226|NCT02566759|20106393|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
8157227|NCT02566759|20106394|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157318|NCT02566031|20106708|P1|STARTED|Overall Study||189
8157228|NCT02566759|20106395|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157229|NCT02566759|20106396|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157230|NCT02566759|20106397|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157231|NCT02566759|20106398|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8157232|NCT02566759|20106399|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
8157233|NCT02566759|20106400|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
8157234|NCT02566759|20106384|P17|STARTED|All Parts||8
8157235|NCT02566759|20106385|P16|STARTED|All Parts||8
8157236|NCT02566759|20106386|P15|STARTED|All Parts||8
8157237|NCT02566759|20106387|P14|STARTED|All Parts||5
8157238|NCT02566759|20106388|P13|STARTED|All Parts||1
8157239|NCT02566759|20106389|P12|STARTED|All Parts||6
8157240|NCT02566759|20106390|P11|STARTED|All Parts||6
8157241|NCT02566759|20106391|P10|STARTED|All Parts||6
8157242|NCT02566759|20106392|P9|STARTED|All Parts||6
8157243|NCT02566759|20106393|P8|STARTED|All Parts||8
8157244|NCT02566759|20106394|P7|STARTED|All Parts||6
8157245|NCT02566759|20106395|P6|STARTED|All Parts||6
8157246|NCT02566759|20106396|P5|STARTED|All Parts||6
8157247|NCT02566759|20106397|P4|STARTED|All Parts||6
8157248|NCT02566759|20106398|P3|STARTED|All Parts||6
8157249|NCT02566759|20106399|P2|STARTED|All Parts||6
8157250|NCT02566759|20106400|P1|STARTED|All Parts||12
8157251|NCT02566590|20106553|P2|NOT COMPLETED|Overall Study||0
8157252|NCT02566590|20106554|P1|NOT COMPLETED|Overall Study||0
8157253|NCT02566590|20106553|P2|COMPLETED|Overall Study||10
8157254|NCT02566590|20106554|P1|COMPLETED|Overall Study||10
8157255|NCT02566590|20106553|P2|STARTED|Overall Study||10
8157256|NCT02566590|20106554|P1|STARTED|Overall Study||10
8157257|NCT02566577|20106562|P2|NOT COMPLETED|Overall Study||2
8157258|NCT02566577|20106563|P1|NOT COMPLETED|Overall Study||3
8157259|NCT02566577|20106562|P2|COMPLETED|Overall Study||4
8157260|NCT02566577|20106563|P1|COMPLETED|Overall Study||6
8157261|NCT02566577|20106562|P2|STARTED|Overall Study||6
8157262|NCT02566577|20106563|P1|STARTED|Overall Study||9
8157263|NCT02566369|20106591|P2|NOT COMPLETED|Overall Study||61
8157264|NCT02566369|20106592|P1|NOT COMPLETED|Overall Study||72
8157265|NCT02566369|20106591|P2|COMPLETED|Overall Study||535
8157266|NCT02566369|20106592|P1|COMPLETED|Overall Study||540
8157267|NCT02566369|20106591|P2|STARTED|Overall Study||596
8157268|NCT02566369|20106592|P1|STARTED|Overall Study||612
8157269|NCT02566317|20106600|P2|NOT COMPLETED|Overall Study||62
8157270|NCT02566317|20106601|P1|NOT COMPLETED|Overall Study||29
8157271|NCT02566317|20106600|P2|COMPLETED|Overall Study||292
8157272|NCT02566317|20106601|P1|COMPLETED|Overall Study||247
8157273|NCT02566317|20106600|P2|STARTED|Overall Study||354
8157274|NCT02566317|20106601|P1|STARTED|Overall Study||276
8157275|NCT02566265|20106613|P2|NOT COMPLETED|Overall Study||6
8157276|NCT02566265|20106614|P1|NOT COMPLETED|Overall Study||9
8157277|NCT02566265|20106613|P2|COMPLETED|Overall Study||35
8157278|NCT02566265|20106614|P1|COMPLETED|Overall Study||72
8157279|NCT02566265|20106613|P2|End of Study Visit (Optional)|Overall Study||18
8157280|NCT02566265|20106614|P1|End of Study Visit (Optional)|Overall Study||38
8157281|NCT02566265|20106613|P2|30 Days Following 2nd Vaccine|Overall Study||35
8157282|NCT02566265|20106614|P1|30 Days Following 2nd Vaccine|Overall Study||72
8157283|NCT02566265|20106613|P2|Day of Second Vaccine|Overall Study||41
8157284|NCT02566265|20106614|P1|Day of Second Vaccine|Overall Study||74
8157285|NCT02566265|20106613|P2|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
8157286|NCT02566265|20106614|P1|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
8157287|NCT02566265|20106613|P2|STARTED|Overall Study||41
8157288|NCT02566265|20106614|P1|STARTED|Overall Study||81
8157289|NCT02566135|20106622|P2|NOT COMPLETED|Overall Study||0
8157290|NCT02566135|20106623|P1|NOT COMPLETED|Overall Study||0
8157291|NCT02566135|20106622|P2|COMPLETED|Overall Study||29
8157292|NCT02566135|20106623|P1|COMPLETED|Overall Study||29
8157293|NCT02566135|20106622|P2|STARTED|Overall Study||29
8157294|NCT02566135|20106623|P1|STARTED|Overall Study||29
8157295|NCT02566109|20106643|P1|NOT COMPLETED|Overall Study||1
8157296|NCT02566109|20106643|P1|COMPLETED|Overall Study||5
8157297|NCT02566109|20106643|P1|STARTED|Overall Study||6
8157298|NCT02566083|20106655|P2|NOT COMPLETED|Overall Study||10
8157299|NCT02566083|20106656|P1|NOT COMPLETED|Overall Study||16
8157300|NCT02566083|20106655|P2|COMPLETED|Overall Study||141
8157301|NCT02566083|20106656|P1|COMPLETED|Overall Study||198
8157302|NCT02566083|20106655|P2|STARTED|Overall Study||151
8157303|NCT02566083|20106656|P1|STARTED|Overall Study||214
8157304|NCT02566044|20106665|P3|NOT COMPLETED|Overall Study||0
8157305|NCT02566044|20106666|P2|NOT COMPLETED|Overall Study||0
8157306|NCT02566044|20106667|P1|NOT COMPLETED|Overall Study||0
8157307|NCT02566044|20106665|P3|COMPLETED|Overall Study||4
8157308|NCT02566044|20106666|P2|COMPLETED|Overall Study||6
8157309|NCT02566044|20106667|P1|COMPLETED|Overall Study||6
8157310|NCT02566044|20106665|P3|STARTED|Overall Study||4
8157311|NCT02566044|20106666|P2|STARTED|Overall Study||6
8157312|NCT02566044|20106667|P1|STARTED|Overall Study||6
8157313|NCT02566031|20106707|P2|NOT COMPLETED|Overall Study||12
8157314|NCT02566031|20106708|P1|NOT COMPLETED|Overall Study||20
8157315|NCT02566031|20106707|P2|COMPLETED|Overall Study||178
8157316|NCT02566031|20106708|P1|COMPLETED|Overall Study||169
8157317|NCT02566031|20106707|P2|STARTED|Overall Study||190
8157319|NCT02566005|20106725|P2|NOT COMPLETED|Overall Study||6
8157320|NCT02566005|20106726|P1|NOT COMPLETED|Overall Study||8
8157321|NCT02566005|20106725|P2|COMPLETED|Overall Study||94
8157322|NCT02566005|20106726|P1|COMPLETED|Overall Study||92
8157323|NCT02566005|20106725|P2|STARTED|Overall Study||100
8157324|NCT02566005|20106726|P1|STARTED|Overall Study||100
8157325|NCT02565914|20106754|P1|NOT COMPLETED|Overall Study||93
8157326|NCT02565914|20106754|P1|COMPLETED|Overall Study||951
8157327|NCT02565914|20106754|P1|Safety Set|Overall Study||1042
8157328|NCT02565914|20106754|P1|STARTED|Overall Study||1044
8157329|NCT02565810|20106788|P1|NOT COMPLETED|Overall Study||1
8157330|NCT02565810|20106788|P1|COMPLETED|Overall Study||48
8157331|NCT02565810|20106788|P1|STARTED|Overall Study||49
8157332|NCT02565784|20106797|P1|NOT COMPLETED|Second Treatment||2
8157333|NCT02565784|20106797|P1|COMPLETED|Second Treatment||96
8157334|NCT02565784|20106797|P1|12 Months Follow-up|Second Treatment||96
8157335|NCT02565784|20106797|P1|6 Months Follow-up|Second Treatment||97
8157336|NCT02565784|20106797|P1|STARTED|Second Treatment||98
8157337|NCT02565784|20106797|P1|NOT COMPLETED|First Treatment||2
8157338|NCT02565784|20106797|P1|COMPLETED|First Treatment||98
8157339|NCT02565784|20106797|P1|12 Months Follow-up|First Treatment||98
8157340|NCT02565784|20106797|P1|6 Months Follow-up|First Treatment||99
8157341|NCT02565784|20106797|P1|STARTED|First Treatment||100
8157342|NCT02565706|20106809|P4|NOT COMPLETED|Overall Study||85
8157343|NCT02565706|20106810|P3|NOT COMPLETED|Overall Study||89
8157344|NCT02565706|20106811|P2|NOT COMPLETED|Overall Study||82
8157345|NCT02565706|20106812|P1|NOT COMPLETED|Overall Study||77
8157346|NCT02565706|20106809|P4|COMPLETED|Overall Study||116
8157347|NCT02565706|20106810|P3|COMPLETED|Overall Study||104
8157348|NCT02565706|20106811|P2|COMPLETED|Overall Study||90
8157349|NCT02565706|20106812|P1|COMPLETED|Overall Study||101
8157350|NCT02565706|20106809|P4|STARTED|Overall Study||201
8157351|NCT02565706|20106810|P3|STARTED|Overall Study||193
8157352|NCT02565706|20106811|P2|STARTED|Overall Study||172
8157353|NCT02565706|20106812|P1|STARTED|Overall Study||178
8157354|NCT02565628|20106884|P2|NOT COMPLETED|Overall Study||0
8157355|NCT02565628|20106885|P1|NOT COMPLETED|Overall Study||0
8157356|NCT02565628|20106884|P2|COMPLETED|Overall Study||9
8157357|NCT02565628|20106885|P1|COMPLETED|Overall Study||10
8157358|NCT02565628|20106884|P2|Received Treatment|Overall Study||9
8157359|NCT02565628|20106885|P1|Received Treatment|Overall Study||10
8157360|NCT02565628|20106884|P2|STARTED|Overall Study||9
8157361|NCT02565628|20106885|P1|STARTED|Overall Study||10
8157382|NCT02565576|20107036|P2|NOT COMPLETED|Overall Study||5
8157383|NCT02565576|20107037|P1|NOT COMPLETED|Overall Study||5
8157384|NCT02565576|20107036|P2|COMPLETED|Overall Study||17
8157385|NCT02565576|20107037|P1|COMPLETED|Overall Study||17
8157386|NCT02565576|20107036|P2|STARTED|Overall Study||22
8157387|NCT02565576|20107037|P1|STARTED|Overall Study||22
8157388|NCT02565485|20107064|P2|NOT COMPLETED|Overall Study||0
8157389|NCT02565485|20107065|P1|NOT COMPLETED|Overall Study||0
8157390|NCT02565485|20107064|P2|COMPLETED|Overall Study||137
8157391|NCT02565485|20107065|P1|COMPLETED|Overall Study||139
8157392|NCT02565485|20107064|P2|STARTED|Overall Study||137
8157393|NCT02565485|20107065|P1|STARTED|Overall Study||139
8157394|NCT02565381|20107080|P3|NOT COMPLETED|Overall Study||1
8157395|NCT02565381|20107081|P2|NOT COMPLETED|Overall Study||0
8157396|NCT02565381|20107082|P1|NOT COMPLETED|Overall Study||1
8157397|NCT02565381|20107080|P3|COMPLETED|Overall Study||24
8157398|NCT02565381|20107081|P2|COMPLETED|Overall Study||25
8157399|NCT02565381|20107082|P1|COMPLETED|Overall Study||24
8157400|NCT02565381|20107080|P3|STARTED|Overall Study||25
8157401|NCT02565381|20107081|P2|STARTED|Overall Study||25
8157402|NCT02565381|20107082|P1|STARTED|Overall Study||25
8157403|NCT02565186|20107122|P2|NOT COMPLETED|Overall Study||621
8157404|NCT02565186|20107123|P1|NOT COMPLETED|Overall Study||580
8157405|NCT02565186|20107122|P2|COMPLETED|Overall Study||504
8157406|NCT02565186|20107123|P1|COMPLETED|Overall Study||466
8157407|NCT02565186|20107122|P2|Received at Least One Dose of Study Drug|Overall Study||1039
8157408|NCT02565186|20107123|P1|Received at Least One Dose of Study Drug|Overall Study||991
8157409|NCT02565186|20107122|P2|STARTED|Overall Study||1125
8157410|NCT02565186|20107123|P1|STARTED|Overall Study||1046
8157411|NCT02565147|20107137|P2|NOT COMPLETED|Overall Study||3
8157412|NCT02565147|20107138|P1|NOT COMPLETED|Overall Study||6
8157413|NCT02565147|20107137|P2|COMPLETED|Overall Study||37
8157414|NCT02565147|20107138|P1|COMPLETED|Overall Study||32
8157415|NCT02565147|20107137|P2|Per-Protocol Population|Overall Study||36
8157416|NCT02565147|20107138|P1|Per-Protocol Population|Overall Study||28
8157417|NCT02565147|20107137|P2|Received Study Drug|Overall Study||40
8157418|NCT02565147|20107138|P1|Received Study Drug|Overall Study||38
8157419|NCT02565147|20107137|P2|STARTED|Overall Study||40
8157420|NCT02565147|20107138|P1|STARTED|Overall Study||38
8157421|NCT02565108|20107162|P2|NOT COMPLETED|Overall Study||0
8157422|NCT02565108|20107163|P1|NOT COMPLETED|Overall Study||2
8157423|NCT02565108|20107162|P2|COMPLETED|Overall Study||4
8157424|NCT02565108|20107163|P1|COMPLETED|Overall Study||14
8157425|NCT02565108|20107162|P2|Pharmacokinetic (PK) Set|Overall Study||3
8157426|NCT02565108|20107163|P1|Pharmacokinetic (PK) Set|Overall Study||10
8157427|NCT02565108|20107162|P2|Safety Set|Overall Study||4
8157428|NCT02565108|20107163|P1|Safety Set|Overall Study||16
8157429|NCT02565108|20107162|P2|STARTED|Overall Study||4
8157430|NCT02565108|20107163|P1|STARTED|Overall Study||16
8157431|NCT02564952|20107179|P1|NOT COMPLETED|Overall Study||11
8157432|NCT02564952|20107179|P1|COMPLETED|Overall Study||7
8157433|NCT02564952|20107179|P1|Completed OLE Titration Period|Overall Study||16
8157434|NCT02564952|20107179|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8157435|NCT02564952|20107179|P1|STARTED|Overall Study||18
8157436|NCT02564926|20107185|P2|NOT COMPLETED|Overall Study||7
8157437|NCT02564926|20107186|P1|NOT COMPLETED|Overall Study||8
8157438|NCT02564926|20107185|P2|COMPLETED|Overall Study||54
8157439|NCT02564926|20107186|P1|COMPLETED|Overall Study||52
8157440|NCT02564926|20107185|P2|STARTED|Overall Study||61
8157441|NCT02564926|20107186|P1|STARTED|Overall Study||60
8157442|NCT02564887|20107224|P2|NOT COMPLETED|Overall Study||0
8157443|NCT02564887|20107225|P1|NOT COMPLETED|Overall Study||6
8157444|NCT02564887|20107224|P2|COMPLETED|Overall Study||10
8157445|NCT02564887|20107225|P1|COMPLETED|Overall Study||10
8157446|NCT02564887|20107224|P2|STARTED|Overall Study||10
8157447|NCT02564887|20107225|P1|STARTED|Overall Study||16
8157448|NCT02564718|20107243|P2|NOT COMPLETED|Overall Study||1
8157449|NCT02564718|20107244|P1|NOT COMPLETED|Overall Study||0
8157450|NCT02564718|20107243|P2|COMPLETED|Overall Study||4
8157451|NCT02564718|20107244|P1|COMPLETED|Overall Study||5
8157452|NCT02564718|20107243|P2|STARTED|Overall Study||5
8157453|NCT02564718|20107244|P1|STARTED|Overall Study||5
8157454|NCT02564497|20107274|P2|NOT COMPLETED|Overall Study||0
8157455|NCT02564497|20107275|P1|NOT COMPLETED|Overall Study||0
8157456|NCT02564497|20107274|P2|COMPLETED|Overall Study||72
8157457|NCT02564497|20107275|P1|COMPLETED|Overall Study||74
8157458|NCT02564497|20107274|P2|STARTED|Overall Study||72
8157459|NCT02564497|20107275|P1|STARTED|Overall Study||74
8157460|NCT02564432|20107293|P1|NOT COMPLETED|Overall Study||2
8157461|NCT02564432|20107293|P1|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
8157462|NCT02564432|20107293|P1|STARTED|Overall Study||10
8157463|NCT02564354|20107301|P2|NOT COMPLETED|Overall Study||0
8157464|NCT02564354|20107302|P1|NOT COMPLETED|Overall Study||0
8157465|NCT02564354|20107301|P2|COMPLETED|Overall Study||8
8157466|NCT02564354|20107302|P1|COMPLETED|Overall Study||10
8157467|NCT02564354|20107301|P2|STARTED|Overall Study||8
8157468|NCT02564354|20107302|P1|STARTED|Overall Study||10
8157469|NCT02564263|20107332|P2|NOT COMPLETED|Overall Study||314
8157470|NCT02564263|20107333|P1|NOT COMPLETED|Overall Study||314
8157471|NCT02564263|20107332|P2|COMPLETED|Overall Study||0
8157472|NCT02564263|20107333|P1|COMPLETED|Overall Study||0
8157473|NCT02564263|20107332|P2|Treated|Overall Study||296
8157474|NCT02564263|20107333|P1|Treated|Overall Study||314
8157475|NCT02564263|20107332|P2|STARTED|Overall Study||314
8157476|NCT02564263|20107333|P1|STARTED|Overall Study||314
8157477|NCT02564211|20107355|P1|NOT COMPLETED|Overall Study||4
8157478|NCT02564211|20107355|P1|COMPLETED|Overall Study||73
8157479|NCT02564211|20107355|P1|STARTED|Overall Study||77
8157480|NCT02564120|20107366|P1|NOT COMPLETED|Overall Study||446
8157481|NCT02564120|20107366|P1|COMPLETED|Overall Study||1110
8157482|NCT02564120|20107366|P1|STARTED|Overall Study||1556
8157483|NCT02564055|20107414|P6|NOT COMPLETED|Overall Study||12
8157484|NCT02564055|20107415|P5|NOT COMPLETED|Overall Study||15
8157485|NCT02564055|20107416|P4|NOT COMPLETED|Overall Study||6
8157486|NCT02564055|20107417|P3|NOT COMPLETED|Overall Study||12
8157487|NCT02564055|20107418|P2|NOT COMPLETED|Overall Study||5
8157488|NCT02564055|20107419|P1|NOT COMPLETED|Overall Study||6
8157489|NCT02564055|20107414|P6|COMPLETED|Overall Study||28
8157490|NCT02564055|20107415|P5|COMPLETED|Overall Study||27
8157491|NCT02564055|20107416|P4|COMPLETED|Overall Study||35
8157492|NCT02564055|20107417|P3|COMPLETED|Overall Study||31
8157493|NCT02564055|20107418|P2|COMPLETED|Overall Study||36
8157494|NCT02564055|20107419|P1|COMPLETED|Overall Study||34
8157495|NCT02564055|20107414|P6|STARTED|Overall Study||40
8157496|NCT02564055|20107415|P5|STARTED|Overall Study||42
8157497|NCT02564055|20107416|P4|STARTED|Overall Study||41
8157498|NCT02564055|20107417|P3|STARTED|Overall Study||43
8157499|NCT02564055|20107418|P2|STARTED|Overall Study||41
8157500|NCT02564055|20107419|P1|STARTED|Overall Study||40
8157501|NCT02564042|20107673|P6|NOT COMPLETED|Overall Study||14
8157502|NCT02564042|20107674|P5|NOT COMPLETED|Overall Study||11
8157503|NCT02564042|20107675|P4|NOT COMPLETED|Overall Study||3
8157504|NCT02564042|20107676|P3|NOT COMPLETED|Overall Study||6
8157505|NCT02564042|20107677|P2|NOT COMPLETED|Overall Study||8
8157506|NCT02564042|20107678|P1|NOT COMPLETED|Overall Study||11
8157507|NCT02564042|20107673|P6|COMPLETED|Overall Study||24
8157508|NCT02564042|20107674|P5|COMPLETED|Overall Study||26
8157509|NCT02564042|20107675|P4|COMPLETED|Overall Study||35
8157510|NCT02564042|20107676|P3|COMPLETED|Overall Study||32
8157511|NCT02564042|20107677|P2|COMPLETED|Overall Study||30
8157512|NCT02564042|20107678|P1|COMPLETED|Overall Study||27
8157513|NCT02564042|20107673|P6|STARTED|Overall Study||38
8157514|NCT02564042|20107674|P5|STARTED|Overall Study||37
8157515|NCT02564042|20107675|P4|STARTED|Overall Study||38
8157516|NCT02564042|20107676|P3|STARTED|Overall Study||38
8157517|NCT02564042|20107677|P2|STARTED|Overall Study||38
8157518|NCT02564042|20107678|P1|STARTED|Overall Study||38
8157519|NCT02564029|20107890|P1|NOT COMPLETED|Overall Study||0
8157520|NCT02564029|20107890|P1|COMPLETED|Overall Study||7
8157521|NCT02564029|20107890|P1|STARTED|Overall Study||7
8157522|NCT02564016|20107933|P2|NOT COMPLETED|Overall Study||10
8157523|NCT02564016|20107934|P1|NOT COMPLETED|Overall Study||18
8157524|NCT02564016|20107933|P2|COMPLETED|Overall Study||4
8157525|NCT02564016|20107934|P1|COMPLETED|Overall Study||4
8157526|NCT02564016|20107933|P2|STARTED|Overall Study||14
8157527|NCT02564016|20107934|P1|STARTED|Overall Study||22
8157528|NCT02563990|20107946|P2|NOT COMPLETED|Overall Study||0
8157529|NCT02563990|20107947|P1|NOT COMPLETED|Overall Study||0
8157530|NCT02563990|20107946|P2|COMPLETED|Overall Study||14
8157531|NCT02563990|20107947|P1|COMPLETED|Overall Study||12
8157532|NCT02563990|20107946|P2|STARTED|Overall Study||14
8157533|NCT02563990|20107947|P1|STARTED|Overall Study||12
8157534|NCT02563899|20107973|P4|NOT COMPLETED|Overall Study||0
8157535|NCT02563899|20107974|P3|NOT COMPLETED|Overall Study||1
8157536|NCT02563899|20107975|P2|NOT COMPLETED|Overall Study||0
8157537|NCT02563899|20107976|P1|NOT COMPLETED|Overall Study||1
8157538|NCT02563899|20107973|P4|COMPLETED|Overall Study||6
8157539|NCT02563899|20107974|P3|COMPLETED|Overall Study||9
8157540|NCT02563899|20107975|P2|COMPLETED|Overall Study||5
8157541|NCT02563899|20107976|P1|COMPLETED|Overall Study||17
8157542|NCT02563899|20107973|P4|STARTED|Overall Study||6
8157543|NCT02563899|20107974|P3|STARTED|Overall Study||10
8157544|NCT02563899|20107975|P2|STARTED|Overall Study||5
8157545|NCT02563899|20107976|P1|STARTED|Overall Study||18
8157546|NCT02563860|20108017|P1|NOT COMPLETED|Overall Study||1
8157547|NCT02563860|20108017|P1|COMPLETED|Overall Study||19
8157548|NCT02563860|20108017|P1|STARTED|Overall Study||20
8157549|NCT02563834|20108024|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8157550|NCT02563834|20108025|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8157551|NCT02563834|20108024|P2|COMPLETED|Insulin Infusion (*Day 2)||8
8157552|NCT02563834|20108025|P1|COMPLETED|Insulin Infusion (*Day 2)||10
8157553|NCT02563834|20108024|P2|STARTED|Insulin Infusion (*Day 2)||8
8157554|NCT02563834|20108025|P1|STARTED|Insulin Infusion (*Day 2)||10
8157555|NCT02563834|20108024|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8157556|NCT02563834|20108025|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8157557|NCT02563834|20108024|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
8157558|NCT02563834|20108025|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
8157559|NCT02563834|20108024|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
8157560|NCT02563834|20108025|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
8157561|NCT02563808|20108043|P2|NOT COMPLETED|Overall Study||0
8157562|NCT02563808|20108044|P1|NOT COMPLETED|Overall Study||0
8157563|NCT02563808|20108043|P2|COMPLETED|Overall Study||88
8157564|NCT02563808|20108044|P1|COMPLETED|Overall Study||96
8157565|NCT02563808|20108043|P2|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
8157566|NCT02563808|20108044|P1|STARTED|Overall Study||96
8157567|NCT02563548|20108052|P6|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
8157568|NCT02563548|20108053|P5|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
8157569|NCT02563548|20108054|P4|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157570|NCT02563548|20108055|P3|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157571|NCT02563548|20108056|P2|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157572|NCT02563548|20108057|P1|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157573|NCT02563548|20108052|P6|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157574|NCT02563548|20108053|P5|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157575|NCT02563548|20108054|P4|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157576|NCT02563548|20108055|P3|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157577|NCT02563548|20108056|P2|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157578|NCT02563548|20108057|P1|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157579|NCT02563548|20108052|P6|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
8157580|NCT02563548|20108053|P5|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
8157581|NCT02563548|20108054|P4|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157582|NCT02563548|20108055|P3|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157583|NCT02563548|20108056|P2|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157584|NCT02563548|20108057|P1|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157585|NCT02563548|20108052|P6|STARTED|Dose Expansion (Up to 60 Weeks)||17
8157586|NCT02563548|20108053|P5|STARTED|Dose Expansion (Up to 60 Weeks)||25
8157587|NCT02563548|20108054|P4|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157588|NCT02563548|20108055|P3|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157589|NCT02563548|20108056|P2|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157590|NCT02563548|20108057|P1|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157591|NCT02563548|20108052|P6|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157592|NCT02563548|20108053|P5|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157593|NCT02563548|20108054|P4|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
8157594|NCT02563548|20108055|P3|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
8157595|NCT02563548|20108056|P2|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
8157596|NCT02563548|20108057|P1|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
8157597|NCT02563548|20108052|P6|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157598|NCT02563548|20108053|P5|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157599|NCT02563548|20108054|P4|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157600|NCT02563548|20108055|P3|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157601|NCT02563548|20108056|P2|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157602|NCT02563548|20108057|P1|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157603|NCT02563548|20108052|P6|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
8157604|NCT02563548|20108053|P5|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
8157605|NCT02563548|20108054|P4|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
8157606|NCT02563548|20108055|P3|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
8157607|NCT02563548|20108056|P2|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
8157608|NCT02563548|20108057|P1|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
8157609|NCT02563548|20108052|P6|STARTED|Dose Escalation (Up to 46 Weeks)||0
8157610|NCT02563548|20108053|P5|STARTED|Dose Escalation (Up to 46 Weeks)||0
8157611|NCT02563548|20108054|P4|STARTED|Dose Escalation (Up to 46 Weeks)||2
8157612|NCT02563548|20108055|P3|STARTED|Dose Escalation (Up to 46 Weeks)||7
8157613|NCT02563548|20108056|P2|STARTED|Dose Escalation (Up to 46 Weeks)||2
8157614|NCT02563548|20108057|P1|STARTED|Dose Escalation (Up to 46 Weeks)||3
8157615|NCT02563496|20108124|P5|NOT COMPLETED|Overall Study||0
8157616|NCT02563496|20108125|P4|NOT COMPLETED|Overall Study||0
8157617|NCT02563496|20108126|P3|NOT COMPLETED|Overall Study||0
8157618|NCT02563496|20108127|P2|NOT COMPLETED|Overall Study||0
8157619|NCT02563496|20108128|P1|NOT COMPLETED|Overall Study||0
8157620|NCT02563496|20108124|P5|COMPLETED|Overall Study||19
8157621|NCT02563496|20108125|P4|COMPLETED|Overall Study||22
8157622|NCT02563496|20108126|P3|COMPLETED|Overall Study||5
8157623|NCT02563496|20108127|P2|COMPLETED|Overall Study||14
8157624|NCT02563496|20108128|P1|COMPLETED|Overall Study||0
8157625|NCT02563496|20108124|P5|STARTED|Overall Study||19
8157626|NCT02563496|20108125|P4|STARTED|Overall Study||22
8157627|NCT02563496|20108126|P3|STARTED|Overall Study||5
8157628|NCT02563496|20108127|P2|STARTED|Overall Study||14
8157629|NCT02563496|20108128|P1|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
8157630|NCT02563106|20108166|P2|NOT COMPLETED|Overall Study||29
8157631|NCT02563106|20108167|P1|NOT COMPLETED|Overall Study||34
8157632|NCT02563106|20108166|P2|COMPLETED|Overall Study||178
8157633|NCT02563106|20108167|P1|COMPLETED|Overall Study||172
8157634|NCT02563106|20108166|P2|STARTED|Overall Study||207
8157635|NCT02563106|20108167|P1|STARTED|Overall Study||206
8157636|NCT02563093|20108177|P4|NOT COMPLETED|Overall Study||0
8157637|NCT02563093|20108178|P3|NOT COMPLETED|Overall Study||0
8157638|NCT02563093|20108179|P2|NOT COMPLETED|Overall Study||0
8157639|NCT02563093|20108180|P1|NOT COMPLETED|Overall Study||0
8157640|NCT02563093|20108177|P4|COMPLETED|Overall Study||51
8157641|NCT02563093|20108178|P3|COMPLETED|Overall Study||53
8157642|NCT02563093|20108179|P2|COMPLETED|Overall Study||52
8157643|NCT02563093|20108180|P1|COMPLETED|Overall Study||52
8157644|NCT02563093|20108177|P4|STARTED|Overall Study||51
8157645|NCT02563093|20108178|P3|STARTED|Overall Study||53
8157646|NCT02563093|20108179|P2|STARTED|Overall Study||52
8157647|NCT02563093|20108180|P1|STARTED|Overall Study||52
8157648|NCT02563028|20108206|P1|NOT COMPLETED|Overall Study||2
8157649|NCT02563028|20108206|P1|COMPLETED|Overall Study||18
8157650|NCT02563028|20108206|P1|STARTED|Overall Study||20
8157651|NCT02562989|20108216|P3|NOT COMPLETED|Overall Study||0
8157652|NCT02562989|20108217|P2|NOT COMPLETED|Overall Study||0
8157653|NCT02562989|20108218|P1|NOT COMPLETED|Overall Study||0
8157654|NCT02562989|20108216|P3|COMPLETED|Overall Study||6
8157655|NCT02562989|20108217|P2|COMPLETED|Overall Study||4
8157656|NCT02562989|20108218|P1|COMPLETED|Overall Study||3
8157657|NCT02562989|20108216|P3|STARTED|Overall Study||6
8157658|NCT02562989|20108217|P2|STARTED|Overall Study||4
8157659|NCT02562989|20108218|P1|STARTED|Overall Study||3
8157660|NCT02562924|20108244|P3|NOT COMPLETED|Overall Study||4
8157661|NCT02562924|20108245|P2|NOT COMPLETED|Overall Study||11
8157662|NCT02562924|20108246|P1|NOT COMPLETED|Overall Study||1
8157663|NCT02562924|20108244|P3|COMPLETED|Overall Study||8
8157664|NCT02562924|20108245|P2|COMPLETED|Overall Study||1
8157665|NCT02562924|20108246|P1|COMPLETED|Overall Study||12
8157666|NCT02562924|20108244|P3|STARTED|Overall Study||12
8157667|NCT02562924|20108245|P2|STARTED|Overall Study||12
8157668|NCT02562924|20108246|P1|STARTED|Overall Study||13
8157669|NCT02562898|20108265|P2|NOT COMPLETED|Overall Study||0
8157670|NCT02562898|20108266|P1|NOT COMPLETED|Overall Study||0
8157671|NCT02562898|20108265|P2|COMPLETED|Overall Study||8
8157672|NCT02562898|20108266|P1|COMPLETED|Overall Study||10
8157673|NCT02562898|20108265|P2|STARTED|Overall Study||8
8157674|NCT02562898|20108266|P1|STARTED|Overall Study||10
8157675|NCT02562755|20108278|P2|NOT COMPLETED|Overall Study||72
8157676|NCT02562755|20108279|P1|NOT COMPLETED|Overall Study||73
8157677|NCT02562755|20108278|P2|COMPLETED|Overall Study||153
8157678|NCT02562755|20108279|P1|COMPLETED|Overall Study||161
8157679|NCT02562755|20108278|P2|Safety Population|Overall Study||217
8157680|NCT02562755|20108279|P1|Safety Population|Overall Study||218
8157681|NCT02562755|20108278|P2|STARTED|Overall Study||225
8157682|NCT02562755|20108279|P1|STARTED|Overall Study||234
8157683|NCT02562521|20108287|P2|NOT COMPLETED|Overall Study||0
8157684|NCT02562521|20108288|P1|NOT COMPLETED|Overall Study||0
8157685|NCT02562521|20108287|P2|COMPLETED|Overall Study||7
8157686|NCT02562521|20108288|P1|COMPLETED|Overall Study||18
8157687|NCT02562521|20108287|P2|STARTED|Overall Study||7
8157688|NCT02562521|20108288|P1|STARTED|Overall Study||18
8157689|NCT02562482|20108304|P2|NOT COMPLETED|Overall Study||16
8157690|NCT02562482|20108305|P1|NOT COMPLETED|Overall Study||21
8157691|NCT02562482|20108304|P2|COMPLETED|Overall Study||183
8157692|NCT02562482|20108305|P1|COMPLETED|Overall Study||180
8157693|NCT02562482|20108304|P2|Received 2nd Injection|Overall Study||192
8157694|NCT02562482|20108305|P1|Received 2nd Injection|Overall Study||192
8157695|NCT02562482|20108304|P2|Received 1st Injection|Overall Study||199
8157696|NCT02562482|20108305|P1|Received 1st Injection|Overall Study||197
8157697|NCT02562482|20108304|P2|STARTED|Overall Study||199
8157698|NCT02562482|20108305|P1|STARTED|Overall Study||201
8157699|NCT02561897|20108329|P2|NOT COMPLETED|Overall Study||0
8157700|NCT02561897|20108330|P1|NOT COMPLETED|Overall Study||0
8157701|NCT02561897|20108329|P2|COMPLETED|Overall Study||3
8157702|NCT02561897|20108330|P1|COMPLETED|Overall Study||2
8157703|NCT02561897|20108329|P2|STARTED|Overall Study||3
8157704|NCT02561897|20108330|P1|STARTED|Overall Study||2
8157705|NCT02561832|20108340|P2|NOT COMPLETED|Overall Study||4
8157706|NCT02561832|20108341|P1|NOT COMPLETED|Overall Study||7
8157707|NCT02561832|20108340|P2|COMPLETED|Overall Study||3
8157708|NCT02561832|20108341|P1|COMPLETED|Overall Study||1
8157709|NCT02561832|20108340|P2|INFORMED CONSENT OBTAINED|Overall Study||7
8157710|NCT02561832|20108341|P1|INFORMED CONSENT OBTAINED|Overall Study||8
8157711|NCT02561832|20108340|P2|STARTED|Overall Study||7
8157712|NCT02561832|20108341|P1|STARTED|Overall Study||8
8157713|NCT02561806|20108349|P2|NOT COMPLETED|Post-Treatment Follow-up||1
8157714|NCT02561806|20108350|P1|NOT COMPLETED|Post-Treatment Follow-up||2
8157715|NCT02561806|20108349|P2|COMPLETED|Post-Treatment Follow-up||59
8157716|NCT02561806|20108350|P1|COMPLETED|Post-Treatment Follow-up||155
8157717|NCT02561806|20108349|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
8157718|NCT02561806|20108350|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
8157719|NCT02561806|20108349|P2|NOT COMPLETED|Maintenance Period||8
8157720|NCT02561806|20108350|P1|NOT COMPLETED|Maintenance Period||13
8157721|NCT02561806|20108349|P2|COMPLETED|Maintenance Period||123
8157722|NCT02561806|20108350|P1|COMPLETED|Maintenance Period||151
8157723|NCT02561806|20108349|P2|STARTED|Maintenance Period||131
8157724|NCT02561806|20108350|P1|STARTED|Maintenance Period||164
8157725|NCT02561806|20108349|P2|NOT COMPLETED|Induction Period||5
8157726|NCT02561806|20108350|P1|NOT COMPLETED|Induction Period||2
8157727|NCT02561806|20108349|P2|COMPLETED|Induction Period||131
8157728|NCT02561806|20108350|P1|COMPLETED|Induction Period||164
8157729|NCT02561806|20108349|P2|Received At Least One Dose of Study Drug|Induction Period||135
8157730|NCT02561806|20108350|P1|Received At Least One Dose of Study Drug|Induction Period||166
8157731|NCT02561806|20108349|P2|STARTED|Induction Period||136
8157732|NCT02561806|20108350|P1|STARTED|Induction Period||166
8157733|NCT02561702|20108406|P2|NOT COMPLETED|Second Intervention||0
8157734|NCT02561702|20108407|P1|NOT COMPLETED|Second Intervention||0
8157735|NCT02561702|20108406|P2|COMPLETED|Second Intervention||2
8157736|NCT02561702|20108407|P1|COMPLETED|Second Intervention||2
8157737|NCT02561702|20108406|P2|STARTED|Second Intervention||2
8157738|NCT02561702|20108407|P1|STARTED|Second Intervention||2
8157739|NCT02561702|20108406|P2|NOT COMPLETED|Washout||0
8157740|NCT02561702|20108407|P1|NOT COMPLETED|Washout||0
8157741|NCT02561702|20108406|P2|COMPLETED|Washout||2
8157742|NCT02561702|20108407|P1|COMPLETED|Washout||2
8157743|NCT02561702|20108406|P2|STARTED|Washout||2
8157744|NCT02561702|20108407|P1|STARTED|Washout||2
8157745|NCT02561702|20108406|P2|NOT COMPLETED|First Intervention||0
8157746|NCT02561702|20108407|P1|NOT COMPLETED|First Intervention||0
8157747|NCT02561702|20108406|P2|COMPLETED|First Intervention||2
8157748|NCT02561702|20108407|P1|COMPLETED|First Intervention||2
8157749|NCT02561702|20108406|P2|STARTED|First Intervention||2
8157750|NCT02561702|20108407|P1|STARTED|First Intervention||2
8157751|NCT02561585|20108417|P2|NOT COMPLETED|Overall Study||5
8157752|NCT02561585|20108418|P1|NOT COMPLETED|Overall Study||3
8157753|NCT02561585|20108417|P2|COMPLETED|Overall Study||6
8157754|NCT02561585|20108418|P1|COMPLETED|Overall Study||17
8157755|NCT02561585|20108417|P2|STARTED|Overall Study||11
8157756|NCT02561585|20108418|P1|STARTED|Overall Study||20
8157757|NCT02561572|20108454|P2|NOT COMPLETED|Overall Study||2
8157758|NCT02561572|20108455|P1|NOT COMPLETED|Overall Study||2
8157759|NCT02561572|20108454|P2|COMPLETED|Overall Study||62
8157760|NCT02561572|20108455|P1|COMPLETED|Overall Study||62
8157761|NCT02561572|20108454|P2|STARTED|Overall Study||64
8157762|NCT02561572|20108455|P1|STARTED|Overall Study||64
8157763|NCT02561481|20108473|P2|NOT COMPLETED|Main Trial - Open Label Phase||0
8157764|NCT02561481|20108474|P1|NOT COMPLETED|Main Trial - Open Label Phase||13
8157765|NCT02561481|20108473|P2|COMPLETED|Main Trial - Open Label Phase||0
8157766|NCT02561481|20108474|P1|COMPLETED|Main Trial - Open Label Phase||32
8157767|NCT02561481|20108473|P2|STARTED|Main Trial - Open Label Phase||0
8157768|NCT02561481|20108474|P1|STARTED|Main Trial - Open Label Phase||45
8157769|NCT02561481|20108473|P2|NOT COMPLETED|Main Trial - Double Blind Phase||2
8157770|NCT02561481|20108474|P1|NOT COMPLETED|Main Trial - Double Blind Phase||3
8157771|NCT02561481|20108473|P2|COMPLETED|Main Trial - Double Blind Phase||23
8157772|NCT02561481|20108474|P1|COMPLETED|Main Trial - Double Blind Phase||22
8157773|NCT02561481|20108473|P2|STARTED|Main Trial - Double Blind Phase||25
8157774|NCT02561481|20108474|P1|STARTED|Main Trial - Double Blind Phase||25
8157775|NCT02561481|20108473|P2|NOT COMPLETED|Pilot Trial||0
8157776|NCT02561481|20108474|P1|NOT COMPLETED|Pilot Trial||0
8157777|NCT02561481|20108473|P2|COMPLETED|Pilot Trial||0
8157778|NCT02561481|20108474|P1|COMPLETED|Pilot Trial||10
8157779|NCT02561481|20108473|P2|STARTED|Pilot Trial||0
8157780|NCT02561481|20108474|P1|STARTED|Pilot Trial||10
8157781|NCT02561338|20108517|P5|NOT COMPLETED|Overall Study||2
8157782|NCT02561338|20108518|P4|NOT COMPLETED|Overall Study||5
8157783|NCT02561338|20108519|P3|NOT COMPLETED|Overall Study||9
8157784|NCT02561338|20108520|P2|NOT COMPLETED|Overall Study||6
8157785|NCT02561338|20108521|P1|NOT COMPLETED|Overall Study||8
8157786|NCT02561338|20108517|P5|COMPLETED|Overall Study||51
8157787|NCT02561338|20108518|P4|COMPLETED|Overall Study||46
8157788|NCT02561338|20108519|P3|COMPLETED|Overall Study||42
8157789|NCT02561338|20108520|P2|COMPLETED|Overall Study||44
8157790|NCT02561338|20108521|P1|COMPLETED|Overall Study||45
8157791|NCT02561338|20108517|P5|STARTED|Overall Study||53
8157792|NCT02561338|20108518|P4|STARTED|Overall Study||51
8157793|NCT02561338|20108519|P3|STARTED|Overall Study||51
8157794|NCT02561338|20108520|P2|STARTED|Overall Study||50
8157795|NCT02561338|20108521|P1|STARTED|Overall Study||53
8157796|NCT02561221|20108550|P2|NOT COMPLETED|Overall Study||43
8157797|NCT02561221|20108551|P1|NOT COMPLETED|Overall Study||90
8157798|NCT02561221|20108550|P2|COMPLETED|Overall Study||308
8157799|NCT02561221|20108551|P1|COMPLETED|Overall Study||362
8157800|NCT02561221|20108550|P2|Month 18|Overall Study||316
8157801|NCT02561221|20108551|P1|Month 18|Overall Study||357
8157802|NCT02561221|20108550|P2|Month 12|Overall Study||326
8157803|NCT02561221|20108551|P1|Month 12|Overall Study||365
8157804|NCT02561221|20108550|P2|Month 6|Overall Study||340
8157805|NCT02561221|20108551|P1|Month 6|Overall Study||386
8157806|NCT02561221|20108550|P2|STARTED|Overall Study||351
8157807|NCT02561221|20108551|P1|STARTED|Overall Study||452
8157808|NCT02561195|20108609|P6|NOT COMPLETED|Overall Study||10
8157809|NCT02561195|20108610|P5|NOT COMPLETED|Overall Study||28
8157810|NCT02561195|20108611|P4|NOT COMPLETED|Overall Study||26
8157811|NCT02561195|20108612|P3|NOT COMPLETED|Overall Study||6
8157812|NCT02561195|20108613|P2|NOT COMPLETED|Overall Study||22
8157813|NCT02561195|20108614|P1|NOT COMPLETED|Overall Study||23
8157814|NCT02561195|20108609|P6|COMPLETED|Overall Study||51
8157815|NCT02561195|20108610|P5|COMPLETED|Overall Study||155
8157816|NCT02561195|20108611|P4|COMPLETED|Overall Study||157
8157817|NCT02561195|20108612|P3|COMPLETED|Overall Study||55
8157818|NCT02561195|20108613|P2|COMPLETED|Overall Study||162
8157819|NCT02561195|20108614|P1|COMPLETED|Overall Study||160
8157820|NCT02561195|20108609|P6|Treated|Overall Study||61
8157821|NCT02561195|20108610|P5|Treated|Overall Study||183
8157822|NCT02561195|20108611|P4|Treated|Overall Study||183
8157823|NCT02561195|20108612|P3|Treated|Overall Study||61
8157824|NCT02561195|20108613|P2|Treated|Overall Study||184
8157825|NCT02561195|20108614|P1|Treated|Overall Study||182
8157826|NCT02561195|20108609|P6|STARTED|Overall Study||61
8157827|NCT02561195|20108610|P5|STARTED|Overall Study||183
8157828|NCT02561195|20108611|P4|STARTED|Overall Study||183
8157829|NCT02561195|20108612|P3|STARTED|Overall Study||61
8157830|NCT02561195|20108613|P2|STARTED|Overall Study||184
8157831|NCT02561195|20108614|P1|STARTED|Overall Study||183
8157832|NCT02561156|20108775|P13|NOT COMPLETED|Part 2||0
8157833|NCT02561156|20108776|P12|NOT COMPLETED|Part 2||1
8157834|NCT02561156|20108777|P11|NOT COMPLETED|Part 2||0
8157835|NCT02561156|20108778|P10|NOT COMPLETED|Part 2||0
8157836|NCT02561156|20108779|P9|NOT COMPLETED|Part 2||0
8157837|NCT02561156|20108780|P8|NOT COMPLETED|Part 2||0
8157838|NCT02561156|20108781|P7|NOT COMPLETED|Part 2||0
8157839|NCT02561156|20108782|P6|NOT COMPLETED|Part 2||0
8157840|NCT02561156|20108783|P5|NOT COMPLETED|Part 2||0
8157841|NCT02561156|20108784|P4|NOT COMPLETED|Part 2||0
8157842|NCT02561156|20108785|P3|NOT COMPLETED|Part 2||0
8157843|NCT02561156|20108786|P2|NOT COMPLETED|Part 2||0
8157844|NCT02561156|20108787|P1|NOT COMPLETED|Part 2||0
8157845|NCT02561156|20108775|P13|COMPLETED|Part 2||6
8157846|NCT02561156|20108776|P12|COMPLETED|Part 2||5
8157847|NCT02561156|20108777|P11|COMPLETED|Part 2||6
8157848|NCT02561156|20108778|P10|COMPLETED|Part 2||6
8157849|NCT02561156|20108779|P9|COMPLETED|Part 2||6
8157850|NCT02561156|20108780|P8|COMPLETED|Part 2||10
8157851|NCT02561156|20108781|P7|COMPLETED|Part 2||0
8157852|NCT02561156|20108782|P6|COMPLETED|Part 2||0
8157853|NCT02561156|20108783|P5|COMPLETED|Part 2||0
8157854|NCT02561156|20108784|P4|COMPLETED|Part 2||0
8157855|NCT02561156|20108785|P3|COMPLETED|Part 2||0
8157856|NCT02561156|20108786|P2|COMPLETED|Part 2||0
8157857|NCT02561156|20108787|P1|COMPLETED|Part 2||0
8157858|NCT02561156|20108775|P13|STARTED|Part 2||6
8157859|NCT02561156|20108776|P12|STARTED|Part 2||6
8157860|NCT02561156|20108777|P11|STARTED|Part 2||6
8157861|NCT02561156|20108778|P10|STARTED|Part 2||6
8157862|NCT02561156|20108779|P9|STARTED|Part 2||6
8157863|NCT02561156|20108780|P8|STARTED|Part 2||10
8157864|NCT02561156|20108781|P7|STARTED|Part 2||0
8157865|NCT02561156|20108782|P6|STARTED|Part 2||0
8157866|NCT02561156|20108783|P5|STARTED|Part 2||0
8157867|NCT02561156|20108784|P4|STARTED|Part 2||0
8157868|NCT02561156|20108785|P3|STARTED|Part 2||0
8157869|NCT02561156|20108786|P2|STARTED|Part 2||0
8157870|NCT02561156|20108787|P1|STARTED|Part 2||0
8157871|NCT02561156|20108775|P13|NOT COMPLETED|Part 1||0
8157872|NCT02561156|20108776|P12|NOT COMPLETED|Part 1||0
8157873|NCT02561156|20108777|P11|NOT COMPLETED|Part 1||0
8157874|NCT02561156|20108778|P10|NOT COMPLETED|Part 1||0
8157875|NCT02561156|20108779|P9|NOT COMPLETED|Part 1||0
8157876|NCT02561156|20108780|P8|NOT COMPLETED|Part 1||0
8157877|NCT02561156|20108781|P7|NOT COMPLETED|Part 1||0
8157878|NCT02561156|20108782|P6|NOT COMPLETED|Part 1||0
8157879|NCT02561156|20108783|P5|NOT COMPLETED|Part 1||0
8157880|NCT02561156|20108784|P4|NOT COMPLETED|Part 1||0
8157881|NCT02561156|20108785|P3|NOT COMPLETED|Part 1||0
8157882|NCT02561156|20108786|P2|NOT COMPLETED|Part 1||0
8157883|NCT02561156|20108787|P1|NOT COMPLETED|Part 1||0
8157884|NCT02561156|20108775|P13|COMPLETED|Part 1||0
8157885|NCT02561156|20108776|P12|COMPLETED|Part 1||0
8157886|NCT02561156|20108777|P11|COMPLETED|Part 1||0
8157887|NCT02561156|20108778|P10|COMPLETED|Part 1||0
8157888|NCT02561156|20108779|P9|COMPLETED|Part 1||0
8157889|NCT02561156|20108780|P8|COMPLETED|Part 1||0
8157890|NCT02561156|20108781|P7|COMPLETED|Part 1||6
8157891|NCT02561156|20108782|P6|COMPLETED|Part 1||6
8157892|NCT02561156|20108783|P5|COMPLETED|Part 1||6
8157893|NCT02561156|20108784|P4|COMPLETED|Part 1||6
8157894|NCT02561156|20108785|P3|COMPLETED|Part 1||6
8157895|NCT02561156|20108786|P2|COMPLETED|Part 1||6
8157896|NCT02561156|20108787|P1|COMPLETED|Part 1||12
8157897|NCT02561156|20108775|P13|STARTED|Part 1||0
8157898|NCT02561156|20108776|P12|STARTED|Part 1||0
8157899|NCT02561156|20108777|P11|STARTED|Part 1||0
8157900|NCT02561156|20108778|P10|STARTED|Part 1||0
8157901|NCT02561156|20108779|P9|STARTED|Part 1||0
8157902|NCT02561156|20108780|P8|STARTED|Part 1||0
8157903|NCT02561156|20108781|P7|STARTED|Part 1||6
8157904|NCT02561156|20108782|P6|STARTED|Part 1||6
8157905|NCT02561156|20108783|P5|STARTED|Part 1||6
8157906|NCT02561156|20108784|P4|STARTED|Part 1||6
8157907|NCT02561156|20108785|P3|STARTED|Part 1||6
8157908|NCT02561156|20108786|P2|STARTED|Part 1||6
8157909|NCT02561156|20108787|P1|STARTED|Part 1||12
8157910|NCT02561130|20108959|P2|NOT COMPLETED|Overall Study||1
8157911|NCT02561130|20108960|P1|NOT COMPLETED|Overall Study||1
8157912|NCT02561130|20108959|P2|COMPLETED|Overall Study||76
8157913|NCT02561130|20108960|P1|COMPLETED|Overall Study||76
8157914|NCT02561130|20108959|P2|STARTED|Overall Study||77
8157915|NCT02561130|20108960|P1|STARTED|Overall Study||77
8157916|NCT02561078|20108984|P2|NOT COMPLETED|Overall Study||25
8157917|NCT02561078|20108985|P1|NOT COMPLETED|Overall Study||30
8157918|NCT02561078|20108984|P2|COMPLETED|Overall Study||186
8157919|NCT02561078|20108985|P1|COMPLETED|Overall Study||179
8157920|NCT02561078|20108984|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
8157921|NCT02561078|20108985|P1|Received at Least 1 Dose of Study Drug|Overall Study||208
8157922|NCT02561078|20108984|P2|STARTED|Overall Study||211
8157923|NCT02561078|20108985|P1|STARTED|Overall Study||209
8157924|NCT02560922|20109009|P2|NOT COMPLETED|Overall Study||12
8157925|NCT02560922|20109010|P1|NOT COMPLETED|Overall Study||26
8157926|NCT02560922|20109009|P2|COMPLETED|Overall Study||112
8157927|NCT02560922|20109010|P1|COMPLETED|Overall Study||98
8157928|NCT02560922|20109009|P2|STARTED|Overall Study||124
8157929|NCT02560922|20109010|P1|STARTED|Overall Study||124
8157930|NCT02560779|20109036|P2|NOT COMPLETED|Overall Study||0
8157931|NCT02560779|20109037|P1|NOT COMPLETED|Overall Study||0
8157932|NCT02560779|20109036|P2|COMPLETED|Overall Study||13
8157933|NCT02560779|20109037|P1|COMPLETED|Overall Study||14
8157934|NCT02560779|20109036|P2|STARTED|Overall Study||13
8157935|NCT02560779|20109037|P1|STARTED|Overall Study||14
8157936|NCT02560753|20109053|P4|NOT COMPLETED|Overall Study||0
8157937|NCT02560753|20109054|P3|NOT COMPLETED|Overall Study||1
8157938|NCT02560753|20109055|P2|NOT COMPLETED|Overall Study||0
8157939|NCT02560753|20109056|P1|NOT COMPLETED|Overall Study||1
8157940|NCT02560753|20109053|P4|COMPLETED|Overall Study||8
8157941|NCT02560753|20109054|P3|COMPLETED|Overall Study||9
8157942|NCT02560753|20109055|P2|COMPLETED|Overall Study||9
8157943|NCT02560753|20109056|P1|COMPLETED|Overall Study||8
8157944|NCT02560753|20109053|P4|STARTED|Overall Study||8
8157945|NCT02560753|20109054|P3|STARTED|Overall Study||10
8157946|NCT02560753|20109055|P2|STARTED|Overall Study||9
8157947|NCT02560753|20109056|P1|STARTED|Overall Study||9
8157948|NCT02560701|20109084|P2|NOT COMPLETED|Overall Study||51466
8157949|NCT02560701|20109085|P1|NOT COMPLETED|Overall Study||4543
8157950|NCT02560701|20109084|P2|COMPLETED|Overall Study||37776
8157951|NCT02560701|20109085|P1|COMPLETED|Overall Study||3517
8157952|NCT02560701|20109084|P2|Matched Cohort|Overall Study||37776
8157953|NCT02560701|20109085|P1|Matched Cohort|Overall Study||3517
8157954|NCT02560701|20109084|P2|Bipolar Diagnosis Time Constraints|Overall Study||39427
8157955|NCT02560701|20109085|P1|Bipolar Diagnosis Time Constraints|Overall Study||3533
8157956|NCT02560701|20109084|P2|Restrict to Patients Between 12 and 64|Overall Study||82367
8157957|NCT02560701|20109085|P1|Restrict to Patients Between 12 and 64|Overall Study||7598
8157958|NCT02560701|20109084|P2|Carve Out|Overall Study||88729
8157959|NCT02560701|20109085|P1|Carve Out|Overall Study||8060
8157960|NCT02560701|20109084|P2|STARTED|Overall Study||89242
8157961|NCT02560701|20109085|P1|STARTED|Overall Study||8060
8157962|NCT02560584|20109101|P1|NOT COMPLETED|Overall Study||0
8157963|NCT02560584|20109101|P1|COMPLETED|Overall Study||304
8157964|NCT02560584|20109101|P1|STARTED|Overall Study||304
8157965|NCT02560558|20109110|P2|NOT COMPLETED|Overall Study||6
8157966|NCT02560558|20109111|P1|NOT COMPLETED|Overall Study||7
8157967|NCT02560558|20109110|P2|COMPLETED|Overall Study||76
8157968|NCT02560558|20109111|P1|COMPLETED|Overall Study||77
8157969|NCT02560558|20109110|P2|STARTED|Overall Study||82
8157970|NCT02560558|20109111|P1|STARTED|Overall Study||84
8157971|NCT02560493|20109139|P2|NOT COMPLETED|Overall Study||0
8157972|NCT02560493|20109140|P1|NOT COMPLETED|Overall Study||1
8157973|NCT02560493|20109139|P2|COMPLETED|Overall Study||23
8157974|NCT02560493|20109140|P1|COMPLETED|Overall Study||22
8157975|NCT02560493|20109139|P2|STARTED|Overall Study||23
8157976|NCT02560493|20109140|P1|STARTED|Overall Study||23
8157977|NCT02560389|20109163|P3|NOT COMPLETED|Overall Study||2
8157978|NCT02560389|20109164|P2|NOT COMPLETED|Overall Study||3
8157979|NCT02560389|20109165|P1|NOT COMPLETED|Overall Study||1
8157980|NCT02560389|20109163|P3|COMPLETED|Overall Study||27
8157981|NCT02560389|20109164|P2|COMPLETED|Overall Study||25
8157982|NCT02560389|20109165|P1|COMPLETED|Overall Study||33
8157983|NCT02560389|20109163|P3|STARTED|Overall Study||29
8157984|NCT02560389|20109164|P2|STARTED|Overall Study||28
8157985|NCT02560389|20109165|P1|STARTED|Overall Study||34
8157986|NCT02560324|20109181|P2|NOT COMPLETED|Period 2 (2 Weeks)||2
8157987|NCT02560324|20109182|P1|NOT COMPLETED|Period 2 (2 Weeks)||1
8157988|NCT02560324|20109181|P2|COMPLETED|Period 2 (2 Weeks)||21
8157989|NCT02560324|20109182|P1|COMPLETED|Period 2 (2 Weeks)||22
8157990|NCT02560324|20109181|P2|STARTED|Period 2 (2 Weeks)||23
8157991|NCT02560324|20109182|P1|STARTED|Period 2 (2 Weeks)||23
8157992|NCT02560324|20109181|P2|NOT COMPLETED|Washout (2 Weeks)||2
8157993|NCT02560324|20109182|P1|NOT COMPLETED|Washout (2 Weeks)||0
8157994|NCT02560324|20109181|P2|COMPLETED|Washout (2 Weeks)||23
8157995|NCT02560324|20109182|P1|COMPLETED|Washout (2 Weeks)||23
8157996|NCT02560324|20109181|P2|STARTED|Washout (2 Weeks)||25
8157997|NCT02560324|20109182|P1|STARTED|Washout (2 Weeks)||23
8157998|NCT02560324|20109181|P2|NOT COMPLETED|Period 1 (2 Weeks)||9
8157999|NCT02560324|20109182|P1|NOT COMPLETED|Period 1 (2 Weeks)||12
8158000|NCT02560324|20109181|P2|COMPLETED|Period 1 (2 Weeks)||25
8158001|NCT02560324|20109182|P1|COMPLETED|Period 1 (2 Weeks)||23
8158002|NCT02560324|20109181|P2|STARTED|Period 1 (2 Weeks)||34
8158003|NCT02560324|20109182|P1|STARTED|Period 1 (2 Weeks)||35
8158004|NCT02560051|20109199|P3|NOT COMPLETED|Overall Study||1
8158005|NCT02560051|20109200|P2|NOT COMPLETED|Overall Study||4
8158006|NCT02560051|20109201|P1|NOT COMPLETED|Overall Study||3
8158007|NCT02560051|20109199|P3|COMPLETED|Overall Study||4
8158008|NCT02560051|20109200|P2|COMPLETED|Overall Study||4
8158009|NCT02560051|20109201|P1|COMPLETED|Overall Study||3
8158010|NCT02560051|20109199|P3|STARTED|Overall Study||5
8158011|NCT02560051|20109200|P2|STARTED|Overall Study||8
8158012|NCT02560051|20109201|P1|STARTED|Overall Study||6
8158013|NCT02560038|20109257|P1|NOT COMPLETED|Overall Study||2
8158014|NCT02560038|20109257|P1|COMPLETED|Overall Study||1
8158015|NCT02560038|20109257|P1|STARTED|Overall Study||3
8158016|NCT02560025|20109263|P1|NOT COMPLETED|Overall Study||3
8158017|NCT02560025|20109263|P1|COMPLETED|Overall Study||39
8158018|NCT02560025|20109263|P1|STARTED|Overall Study||42
8158019|NCT02560012|20109272|P1|NOT COMPLETED|Overall Study||2
8158020|NCT02560012|20109272|P1|COMPLETED|Overall Study||1
8158021|NCT02560012|20109272|P1|STARTED|Overall Study||3
8158022|NCT02559895|20109280|P4|NOT COMPLETED|Overall Study||60
8158023|NCT02559895|20109281|P3|NOT COMPLETED|Overall Study||54
8158024|NCT02559895|20109282|P2|NOT COMPLETED|Overall Study||53
8158025|NCT02559895|20109283|P1|NOT COMPLETED|Overall Study||55
8158026|NCT02559895|20109280|P4|COMPLETED|Overall Study||165
8158027|NCT02559895|20109281|P3|COMPLETED|Overall Study||170
8158028|NCT02559895|20109282|P2|COMPLETED|Overall Study||172
8158029|NCT02559895|20109283|P1|COMPLETED|Overall Study||169
8158030|NCT02559895|20109280|P4|Participants Treated|Overall Study||222
8158031|NCT02559895|20109281|P3|Participants Treated|Overall Study||223
8158032|NCT02559895|20109282|P2|Participants Treated|Overall Study||221
8158033|NCT02559895|20109283|P1|Participants Treated|Overall Study||222
8158034|NCT02559895|20109280|P4|STARTED|Overall Study||225
8158035|NCT02559895|20109281|P3|STARTED|Overall Study||224
8158036|NCT02559895|20109282|P2|STARTED|Overall Study||225
8158037|NCT02559895|20109283|P1|STARTED|Overall Study||224
8158038|NCT02559817|20109378|P5|NOT COMPLETED|Post-treatment Period||0
8158039|NCT02559817|20109379|P4|NOT COMPLETED|Post-treatment Period||0
8158040|NCT02559817|20109380|P3|NOT COMPLETED|Post-treatment Period||0
8158041|NCT02559817|20109381|P2|NOT COMPLETED|Post-treatment Period||0
8158042|NCT02559817|20109382|P1|NOT COMPLETED|Post-treatment Period||0
8158043|NCT02559817|20109378|P5|COMPLETED|Post-treatment Period||8
8158044|NCT02559817|20109379|P4|COMPLETED|Post-treatment Period||22
8158045|NCT02559817|20109380|P3|COMPLETED|Post-treatment Period||20
8158046|NCT02559817|20109381|P2|COMPLETED|Post-treatment Period||27
8158047|NCT02559817|20109382|P1|COMPLETED|Post-treatment Period||18
8158048|NCT02559817|20109378|P5|STARTED|Post-treatment Period||8
8158049|NCT02559817|20109379|P4|STARTED|Post-treatment Period||22
8158050|NCT02559817|20109380|P3|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
8158051|NCT02559817|20109381|P2|STARTED|Post-treatment Period||27
8158052|NCT02559817|20109382|P1|STARTED|Post-treatment Period||18
8158053|NCT02559817|20109378|P5|NOT COMPLETED|Treatment Period||0
8158054|NCT02559817|20109379|P4|NOT COMPLETED|Treatment Period||2
8158055|NCT02559817|20109380|P3|NOT COMPLETED|Treatment Period||2
8158056|NCT02559817|20109381|P2|NOT COMPLETED|Treatment Period||2
8158057|NCT02559817|20109382|P1|NOT COMPLETED|Treatment Period||1
8158058|NCT02559817|20109378|P5|COMPLETED|Treatment Period||8
8158059|NCT02559817|20109379|P4|COMPLETED|Treatment Period||22
8158060|NCT02559817|20109380|P3|COMPLETED|Treatment Period||19
8158061|NCT02559817|20109381|P2|COMPLETED|Treatment Period||27
8158062|NCT02559817|20109382|P1|COMPLETED|Treatment Period||18
8158063|NCT02559817|20109378|P5|STARTED|Treatment Period||8
8158064|NCT02559817|20109379|P4|STARTED|Treatment Period||24
8158065|NCT02559817|20109380|P3|STARTED|Treatment Period||21
8158066|NCT02559817|20109381|P2|STARTED|Treatment Period||29
8158067|NCT02559817|20109382|P1|STARTED|Treatment Period||19
8158068|NCT02559713|20109419|P1|NOT COMPLETED|Overall Study||1
8158069|NCT02559713|20109419|P1|COMPLETED|Overall Study||10
8158070|NCT02559713|20109419|P1|Pharmacokinetic Set|Overall Study||11
8158071|NCT02559713|20109419|P1|Safety Set|Overall Study||11
8158072|NCT02559713|20109419|P1|STARTED|Overall Study||11
8158076|NCT02559622|20109442|P4|NOT COMPLETED|Overall Study||3
8158077|NCT02559622|20109443|P3|NOT COMPLETED|Overall Study||2
8158078|NCT02559622|20109444|P2|NOT COMPLETED|Overall Study||5
8158079|NCT02559622|20109445|P1|NOT COMPLETED|Overall Study||1
8158080|NCT02559622|20109442|P4|COMPLETED|Overall Study||20
8158081|NCT02559622|20109443|P3|COMPLETED|Overall Study||24
8158082|NCT02559622|20109444|P2|COMPLETED|Overall Study||49
8158083|NCT02559622|20109445|P1|COMPLETED|Overall Study||47
8158084|NCT02559622|20109442|P4|STARTED|Overall Study||23
8158085|NCT02559622|20109443|P3|STARTED|Overall Study||26
8158086|NCT02559622|20109444|P2|STARTED|Overall Study||54
8158087|NCT02559622|20109445|P1|STARTED|Overall Study||48
8158088|NCT02559570|20109529|P5|NOT COMPLETED|Overall Study||2
8158089|NCT02559570|20109530|P4|NOT COMPLETED|Overall Study||3
8158090|NCT02559570|20109531|P3|NOT COMPLETED|Overall Study||2
8158091|NCT02559570|20109532|P2|NOT COMPLETED|Overall Study||2
8158092|NCT02559570|20109533|P1|NOT COMPLETED|Overall Study||2
8158093|NCT02559570|20109529|P5|COMPLETED|Overall Study||14
8158094|NCT02559570|20109530|P4|COMPLETED|Overall Study||36
8158095|NCT02559570|20109531|P3|COMPLETED|Overall Study||39
8158096|NCT02559570|20109532|P2|COMPLETED|Overall Study||34
8158097|NCT02559570|20109533|P1|COMPLETED|Overall Study||39
8158098|NCT02559570|20109529|P5|STARTED|Overall Study||16
8158099|NCT02559570|20109530|P4|STARTED|Overall Study||39
8158100|NCT02559570|20109531|P3|STARTED|Overall Study||41
8158101|NCT02559570|20109532|P2|STARTED|Overall Study||36
8158102|NCT02559570|20109533|P1|STARTED|Overall Study||41
8158103|NCT02559414|20109571|P3|NOT COMPLETED|Overall Study||2
8158104|NCT02559414|20109572|P2|NOT COMPLETED|Overall Study||2
8158105|NCT02559414|20109573|P1|NOT COMPLETED|Overall Study||1
8158106|NCT02559414|20109571|P3|COMPLETED|Overall Study||20
8158107|NCT02559414|20109572|P2|COMPLETED|Overall Study||20
8158108|NCT02559414|20109573|P1|COMPLETED|Overall Study||10
8158109|NCT02559414|20109571|P3|STARTED|Overall Study||22
8158110|NCT02559414|20109572|P2|STARTED|Overall Study||22
8158111|NCT02559414|20109573|P1|STARTED|Overall Study||11
8158112|NCT02559310|20109613|P2|NOT COMPLETED|Overall Study||19
8158113|NCT02559310|20109614|P1|NOT COMPLETED|Overall Study||27
8158114|NCT02559310|20109613|P2|COMPLETED|Overall Study||256
8158115|NCT02559310|20109614|P1|COMPLETED|Overall Study||249
8158116|NCT02559310|20109613|P2|STARTED|Overall Study||275
8158117|NCT02559310|20109614|P1|STARTED|Overall Study||276
8158118|NCT02559206|20109632|P8|NOT COMPLETED|Overall Study||9
8158119|NCT02559206|20109633|P7|NOT COMPLETED|Overall Study||6
8158120|NCT02559206|20109634|P6|NOT COMPLETED|Overall Study||14
8158121|NCT02559206|20109635|P5|NOT COMPLETED|Overall Study||12
8158122|NCT02559206|20109636|P4|NOT COMPLETED|Overall Study||14
8158123|NCT02559206|20109637|P3|NOT COMPLETED|Overall Study||9
8158124|NCT02559206|20109638|P2|NOT COMPLETED|Overall Study||12
8158125|NCT02559206|20109639|P1|NOT COMPLETED|Overall Study||8
8158126|NCT02559206|20109632|P8|COMPLETED|Overall Study||57
8158127|NCT02559206|20109633|P7|COMPLETED|Overall Study||60
8158128|NCT02559206|20109634|P6|COMPLETED|Overall Study||53
8158129|NCT02559206|20109635|P5|COMPLETED|Overall Study||55
8158130|NCT02559206|20109636|P4|COMPLETED|Overall Study||53
8158131|NCT02559206|20109637|P3|COMPLETED|Overall Study||58
8158132|NCT02559206|20109638|P2|COMPLETED|Overall Study||54
8158133|NCT02559206|20109639|P1|COMPLETED|Overall Study||58
8158134|NCT02559206|20109632|P8|STARTED|Overall Study||66
8158135|NCT02559206|20109633|P7|STARTED|Overall Study||66
8158136|NCT02559206|20109634|P6|STARTED|Overall Study||67
8158137|NCT02559206|20109635|P5|STARTED|Overall Study||67
8158138|NCT02559206|20109636|P4|STARTED|Overall Study||67
8158139|NCT02559206|20109637|P3|STARTED|Overall Study||67
8158140|NCT02559206|20109638|P2|STARTED|Overall Study||66
8158141|NCT02559206|20109639|P1|STARTED|Overall Study||66
8158142|NCT02558894|20109681|P2|NOT COMPLETED|Overall Study||33
8158143|NCT02558894|20109682|P1|NOT COMPLETED|Overall Study||32
8158144|NCT02558894|20109681|P2|COMPLETED|Overall Study||0
8158145|NCT02558894|20109682|P1|COMPLETED|Overall Study||0
8158146|NCT02558894|20109681|P2|Patients Who Received IP|Overall Study||32
8158147|NCT02558894|20109682|P1|Patients Who Received IP|Overall Study||32
8158148|NCT02558894|20109681|P2|STARTED|Overall Study||33
8158149|NCT02558894|20109682|P1|STARTED|Overall Study||32
8158150|NCT02558829|20109710|P8|NOT COMPLETED|Overall Study||3
8158151|NCT02558829|20109711|P7|NOT COMPLETED|Overall Study||1
8158152|NCT02558829|20109712|P6|NOT COMPLETED|Overall Study||2
8158153|NCT02558829|20109713|P5|NOT COMPLETED|Overall Study||2
8158154|NCT02558829|20109714|P4|NOT COMPLETED|Overall Study||2
8158155|NCT02558829|20109715|P3|NOT COMPLETED|Overall Study||3
8158156|NCT02558829|20109716|P2|NOT COMPLETED|Overall Study||3
8158157|NCT02558829|20109717|P1|NOT COMPLETED|Overall Study||1
8158158|NCT02558829|20109710|P8|COMPLETED|Overall Study||8
8158159|NCT02558829|20109711|P7|COMPLETED|Overall Study||17
8158160|NCT02558829|20109712|P6|COMPLETED|Overall Study||24
8158161|NCT02558829|20109713|P5|COMPLETED|Overall Study||16
8158162|NCT02558829|20109714|P4|COMPLETED|Overall Study||16
8158163|NCT02558829|20109715|P3|COMPLETED|Overall Study||21
8158164|NCT02558829|20109716|P2|COMPLETED|Overall Study||18
8158165|NCT02558829|20109717|P1|COMPLETED|Overall Study||20
8158166|NCT02558829|20109710|P8|STARTED|Overall Study||11
8158167|NCT02558829|20109711|P7|STARTED|Overall Study||18
8158168|NCT02558829|20109712|P6|STARTED|Overall Study||26
8158169|NCT02558829|20109713|P5|STARTED|Overall Study||18
8158170|NCT02558829|20109714|P4|STARTED|Overall Study||18
8158171|NCT02558829|20109715|P3|STARTED|Overall Study||24
8158172|NCT02558829|20109716|P2|STARTED|Overall Study||21
8158173|NCT02558829|20109717|P1|STARTED|Overall Study||21
8158174|NCT02558790|20109743|P1|NOT COMPLETED|Overall Study||7
8158175|NCT02558790|20109743|P1|COMPLETED|Overall Study||13
8158176|NCT02558790|20109743|P1|Treated|Overall Study||15
8158177|NCT02558790|20109743|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
8158178|NCT02558400|20109750|P3|NOT COMPLETED|Overall Study||33
8158179|NCT02558400|20109751|P2|NOT COMPLETED|Overall Study||96
8158180|NCT02558400|20109752|P1|NOT COMPLETED|Overall Study||79
8158181|NCT02558400|20109750|P3|COMPLETED|Overall Study||203
8158182|NCT02558400|20109751|P2|COMPLETED|Overall Study||148
8158183|NCT02558400|20109752|P1|COMPLETED|Overall Study||159
8158184|NCT02558400|20109750|P3|STARTED|Overall Study||236
8158185|NCT02558400|20109751|P2|STARTED|Overall Study||244
8158186|NCT02558400|20109752|P1|STARTED|Overall Study||238
8158187|NCT02558374|20109765|P2|NOT COMPLETED|Overall Study||43
8158188|NCT02558374|20109766|P1|NOT COMPLETED|Overall Study||108
8158189|NCT02558374|20109765|P2|COMPLETED|Overall Study||314
8158190|NCT02558374|20109766|P1|COMPLETED|Overall Study||243
8158191|NCT02558374|20109765|P2|STARTED|Overall Study||357
8158192|NCT02558374|20109766|P1|STARTED|Overall Study||351
8158193|NCT02558231|20109776|P2|NOT COMPLETED|Overall Study||124
8158194|NCT02558231|20109777|P1|NOT COMPLETED|Overall Study||123
8158195|NCT02558231|20109776|P2|COMPLETED|Overall Study||0
8158196|NCT02558231|20109777|P1|COMPLETED|Overall Study||0
8158197|NCT02558231|20109776|P2|Treated|Overall Study||123
8158198|NCT02558231|20109777|P1|Treated|Overall Study||123
8158199|NCT02558231|20109776|P2|STARTED|Overall Study||124
8158200|NCT02558231|20109777|P1|STARTED|Overall Study||123
8158201|NCT02557698|20109803|P2|NOT COMPLETED|Overall Study||0
8158202|NCT02557698|20109804|P1|NOT COMPLETED|Overall Study||0
8158203|NCT02557698|20109803|P2|COMPLETED|Overall Study||30
8158204|NCT02557698|20109804|P1|COMPLETED|Overall Study||30
8158205|NCT02557698|20109803|P2|STARTED|Overall Study||30
8158206|NCT02557698|20109804|P1|STARTED|Overall Study||30
8158207|NCT02557646|20109868|P1|NOT COMPLETED|Overall Study||276
8158208|NCT02557646|20109868|P1|COMPLETED|Overall Study||417
8158209|NCT02557646|20109868|P1|STARTED|Overall Study||693
8158210|NCT02557555|20109886|P1|NOT COMPLETED|Overall Study||0
8158211|NCT02557555|20109886|P1|COMPLETED|Overall Study||100
8158212|NCT02557555|20109886|P1|STARTED|Overall Study||100
8158213|NCT02557516|20109895|P4|NOT COMPLETED|Overall Study||9
8158214|NCT02557516|20109896|P3|NOT COMPLETED|Overall Study||4
8158215|NCT02557516|20109897|P2|NOT COMPLETED|Overall Study||5
8158216|NCT02557516|20109898|P1|NOT COMPLETED|Overall Study||1
8158217|NCT02557516|20109895|P4|COMPLETED|Overall Study||0
8158218|NCT02557516|20109896|P3|COMPLETED|Overall Study||0
8158219|NCT02557516|20109897|P2|COMPLETED|Overall Study||1
8158220|NCT02557516|20109898|P1|COMPLETED|Overall Study||2
8158221|NCT02557516|20109895|P4|STARTED|Overall Study||9
8158222|NCT02557516|20109896|P3|STARTED|Overall Study||4
8158223|NCT02557516|20109897|P2|STARTED|Overall Study||6
8158224|NCT02557516|20109898|P1|STARTED|Overall Study||3
8158225|NCT02557399|20109919|P2|NOT COMPLETED|Overall Study||8
8158226|NCT02557399|20109920|P1|NOT COMPLETED|Overall Study||7
8158227|NCT02557399|20109919|P2|COMPLETED|Overall Study||169
8158228|NCT02557399|20109920|P1|COMPLETED|Overall Study||165
8158229|NCT02557399|20109919|P2|STARTED|Overall Study||177
8158230|NCT02557399|20109920|P1|STARTED|Overall Study||172
8158231|NCT02557100|20109955|P3|NOT COMPLETED|Cumulative Abatacept Period||4
8158232|NCT02557100|20109956|P2|NOT COMPLETED|Cumulative Abatacept Period||0
8158233|NCT02557100|20109957|P1|NOT COMPLETED|Cumulative Abatacept Period||0
8158234|NCT02557100|20109955|P3|COMPLETED|Cumulative Abatacept Period||72
8158235|NCT02557100|20109956|P2|COMPLETED|Cumulative Abatacept Period||0
8158236|NCT02557100|20109957|P1|COMPLETED|Cumulative Abatacept Period||0
8158237|NCT02557100|20109955|P3|STARTED|Cumulative Abatacept Period||76
8158238|NCT02557100|20109956|P2|STARTED|Cumulative Abatacept Period||0
8158239|NCT02557100|20109957|P1|STARTED|Cumulative Abatacept Period||0
8158240|NCT02557100|20109955|P3|NOT COMPLETED|Transition to Open Label||0
8158241|NCT02557100|20109956|P2|NOT COMPLETED|Transition to Open Label||36
8158242|NCT02557100|20109957|P1|NOT COMPLETED|Transition to Open Label||40
8158243|NCT02557100|20109955|P3|COMPLETED|Transition to Open Label||0
8158244|NCT02557100|20109956|P2|COMPLETED|Transition to Open Label||0
8158245|NCT02557100|20109957|P1|COMPLETED|Transition to Open Label||0
8158246|NCT02557100|20109955|P3|STARTED|Transition to Open Label||0
8158247|NCT02557100|20109956|P2|STARTED|Transition to Open Label||36
8158248|NCT02557100|20109957|P1|STARTED|Transition to Open Label||40
8158249|NCT02557100|20109955|P3|NOT COMPLETED|Single Blind Treatment Period||0
8158250|NCT02557100|20109956|P2|NOT COMPLETED|Single Blind Treatment Period||4
8158251|NCT02557100|20109957|P1|NOT COMPLETED|Single Blind Treatment Period||0
8158252|NCT02557100|20109955|P3|COMPLETED|Single Blind Treatment Period||0
8158253|NCT02557100|20109956|P2|COMPLETED|Single Blind Treatment Period||36
8158254|NCT02557100|20109957|P1|COMPLETED|Single Blind Treatment Period||40
8158255|NCT02557100|20109955|P3|STARTED|Single Blind Treatment Period||0
8158256|NCT02557100|20109956|P2|STARTED|Single Blind Treatment Period||40
8158257|NCT02557100|20109957|P1|STARTED|Single Blind Treatment Period||40
8158258|NCT02557035|20109985|P2|NOT COMPLETED|Overall Study||9
8158259|NCT02557035|20109986|P1|NOT COMPLETED|Overall Study||7
8158260|NCT02557035|20109985|P2|COMPLETED|Overall Study||206
8158261|NCT02557035|20109986|P1|COMPLETED|Overall Study||218
8158262|NCT02557035|20109985|P2|STARTED|Overall Study||215
8158263|NCT02557035|20109986|P1|STARTED|Overall Study||225
8158264|NCT02556918|20110010|P2|NOT COMPLETED|Overall Study||10
8158265|NCT02556918|20110011|P1|NOT COMPLETED|Overall Study||9
8158266|NCT02556918|20110010|P2|COMPLETED|Overall Study||91
8158267|NCT02556918|20110011|P1|COMPLETED|Overall Study||91
8158268|NCT02556918|20110010|P2|STARTED|Overall Study||101
8158269|NCT02556918|20110011|P1|STARTED|Overall Study||100
8158270|NCT02556801|20110071|P4|NOT COMPLETED|Overall Study||5
8158271|NCT02556801|20110072|P3|NOT COMPLETED|Overall Study||4
8158272|NCT02556801|20110073|P2|NOT COMPLETED|Overall Study||7
8158273|NCT02556801|20110074|P1|NOT COMPLETED|Overall Study||2
8158274|NCT02556801|20110071|P4|COMPLETED|Overall Study||37
8158275|NCT02556801|20110072|P3|COMPLETED|Overall Study||38
8158276|NCT02556801|20110073|P2|COMPLETED|Overall Study||35
8158277|NCT02556801|20110074|P1|COMPLETED|Overall Study||40
8158278|NCT02556801|20110071|P4|STARTED|Overall Study||42
8158279|NCT02556801|20110072|P3|STARTED|Overall Study||42
8158280|NCT02556801|20110073|P2|STARTED|Overall Study||42
8158281|NCT02556801|20110074|P1|STARTED|Overall Study||42
8158282|NCT02556788|20110126|P2|NOT COMPLETED|Overall Study||37
8158283|NCT02556788|20110127|P1|NOT COMPLETED|Overall Study||44
8158284|NCT02556788|20110126|P2|COMPLETED|Overall Study||573
8158285|NCT02556788|20110127|P1|COMPLETED|Overall Study||558
8158286|NCT02556788|20110126|P2|STARTED|Overall Study||610
8158287|NCT02556788|20110127|P1|STARTED|Overall Study||602
8158288|NCT02556632|20110136|P3|NOT COMPLETED|Overall Study||9
8158289|NCT02556632|20110137|P2|NOT COMPLETED|Overall Study||6
8158290|NCT02556632|20110138|P1|NOT COMPLETED|Overall Study||5
8158291|NCT02556632|20110136|P3|COMPLETED|Overall Study||53
8158292|NCT02556632|20110137|P2|COMPLETED|Overall Study||59
8158293|NCT02556632|20110138|P1|COMPLETED|Overall Study||59
8158294|NCT02556632|20110136|P3|STARTED|Overall Study||62
8158295|NCT02556632|20110137|P2|STARTED|Overall Study||65
8158296|NCT02556632|20110138|P1|STARTED|Overall Study||64
8158297|NCT02556554|20110155|P5|NOT COMPLETED|Overall Study||0
8158298|NCT02556554|20110156|P4|NOT COMPLETED|Overall Study||0
8158299|NCT02556554|20110157|P3|NOT COMPLETED|Overall Study||4
8158300|NCT02556554|20110158|P2|NOT COMPLETED|Overall Study||1
8158301|NCT02556554|20110159|P1|NOT COMPLETED|Overall Study||0
8158302|NCT02556554|20110155|P5|COMPLETED|Overall Study||14
8158303|NCT02556554|20110156|P4|COMPLETED|Overall Study||12
8158304|NCT02556554|20110157|P3|COMPLETED|Overall Study||15
8158305|NCT02556554|20110158|P2|COMPLETED|Overall Study||13
8158306|NCT02556554|20110159|P1|COMPLETED|Overall Study||8
8158307|NCT02556554|20110155|P5|STARTED|Overall Study||14
8158308|NCT02556554|20110156|P4|STARTED|Overall Study||12
8158309|NCT02556554|20110157|P3|STARTED|Overall Study||19
8158310|NCT02556554|20110158|P2|STARTED|Overall Study||14
8158311|NCT02556554|20110159|P1|STARTED|Overall Study||8
8158312|NCT02556333|20110174|P1|NOT COMPLETED|Overall Study||0
8158313|NCT02556333|20110174|P1|COMPLETED|Overall Study||1
8158314|NCT02556333|20110174|P1|STARTED|Overall Study||1
8158315|NCT02556307|20110178|P1|NOT COMPLETED|Overall Study||53
8158316|NCT02556307|20110178|P1|COMPLETED|Overall Study||217
8158317|NCT02556307|20110178|P1|Treated|Overall Study||268
8158318|NCT02556307|20110178|P1|STARTED|Overall Study||270
8158319|NCT02556255|20110188|P1|NOT COMPLETED|Overall Study||4
8158320|NCT02556255|20110188|P1|COMPLETED|Overall Study||46
8158321|NCT02556255|20110188|P1|STARTED|Overall Study||50
8158322|NCT02556203|20110203|P2|NOT COMPLETED|Overall Study||26
8158323|NCT02556203|20110204|P1|NOT COMPLETED|Overall Study||27
8158324|NCT02556203|20110203|P2|COMPLETED|Overall Study||792
8158325|NCT02556203|20110204|P1|COMPLETED|Overall Study||799
8158326|NCT02556203|20110203|P2|Received Treatment|Overall Study||807
8158327|NCT02556203|20110204|P1|Received Treatment|Overall Study||801
8158328|NCT02556203|20110203|P2|STARTED|Overall Study||818
8158329|NCT02556203|20110204|P1|STARTED|Overall Study||826
8158330|NCT02556177|20110226|P2|NOT COMPLETED|Overall Study||61
8158331|NCT02556177|20110227|P1|NOT COMPLETED|Overall Study||283
8158332|NCT02556177|20110226|P2|COMPLETED|Overall Study||91
8158333|NCT02556177|20110227|P1|COMPLETED|Overall Study||42
8158334|NCT02556177|20110226|P2|STARTED|Overall Study||152
8158335|NCT02556177|20110227|P1|STARTED|Overall Study||325
8158336|NCT02556138|20110235|P1|NOT COMPLETED|Overall Study||1
8158337|NCT02556138|20110235|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
8158338|NCT02556138|20110235|P1|STARTED|Overall Study||8
8158339|NCT02556112|20110244|P3|NOT COMPLETED|Overall Study||12
8158340|NCT02556112|20110245|P2|NOT COMPLETED|Overall Study||17
8158341|NCT02556112|20110246|P1|NOT COMPLETED|Overall Study||10
8158342|NCT02556112|20110244|P3|COMPLETED|Overall Study||30
8158343|NCT02556112|20110245|P2|COMPLETED|Overall Study||23
8158344|NCT02556112|20110246|P1|COMPLETED|Overall Study||30
8158345|NCT02556112|20110244|P3|STARTED|Overall Study||42
8158346|NCT02556112|20110245|P2|STARTED|Overall Study||40
8158347|NCT02556112|20110246|P1|STARTED|Overall Study||40
8158348|NCT02555878|20110271|P2|NOT COMPLETED|Overall Study||150
8158349|NCT02555878|20110272|P1|NOT COMPLETED|Overall Study||166
8158350|NCT02555878|20110271|P2|COMPLETED|Overall Study||270
8158351|NCT02555878|20110272|P1|COMPLETED|Overall Study||255
8158352|NCT02555878|20110271|P2|Treated|Overall Study||405
8158353|NCT02555878|20110272|P1|Treated|Overall Study||404
8158354|NCT02555878|20110271|P2|STARTED|Overall Study||420
8158355|NCT02555878|20110272|P1|STARTED|Overall Study||421
8158356|NCT02555722|20110304|P2|NOT COMPLETED|Month 3||0
8158357|NCT02555722|20110305|P1|NOT COMPLETED|Month 3||0
8158358|NCT02555722|20110304|P2|COMPLETED|Month 3||29
8158359|NCT02555722|20110305|P1|COMPLETED|Month 3||54
8158360|NCT02555722|20110304|P2|STARTED|Month 3||29
8158361|NCT02555722|20110305|P1|STARTED|Month 3||54
8158362|NCT02555722|20110304|P2|NOT COMPLETED|Month 2||0
8158363|NCT02555722|20110305|P1|NOT COMPLETED|Month 2||4
8158364|NCT02555722|20110304|P2|COMPLETED|Month 2||29
8158365|NCT02555722|20110305|P1|COMPLETED|Month 2||54
8158366|NCT02555722|20110304|P2|STARTED|Month 2||29
8158367|NCT02555722|20110305|P1|STARTED|Month 2||58
8158368|NCT02555722|20110304|P2|NOT COMPLETED|Month 1||0
8158369|NCT02555722|20110305|P1|NOT COMPLETED|Month 1||1
8158370|NCT02555722|20110304|P2|COMPLETED|Month 1||29
8158371|NCT02555722|20110305|P1|COMPLETED|Month 1||58
8158372|NCT02555722|20110304|P2|STARTED|Month 1||29
8158373|NCT02555722|20110305|P1|STARTED|Month 1||59
8158374|NCT02555722|20110304|P2|NOT COMPLETED|Week 2||1
8158375|NCT02555722|20110305|P1|NOT COMPLETED|Week 2||1
8158376|NCT02555722|20110304|P2|COMPLETED|Week 2||29
8158377|NCT02555722|20110305|P1|COMPLETED|Week 2||59
8158378|NCT02555722|20110304|P2|STARTED|Week 2||30
8158379|NCT02555722|20110305|P1|STARTED|Week 2||60
8158380|NCT02555722|20110304|P2|NOT COMPLETED|Week 1||0
8158381|NCT02555722|20110305|P1|NOT COMPLETED|Week 1||0
8158382|NCT02555722|20110304|P2|COMPLETED|Week 1||30
8158383|NCT02555722|20110305|P1|COMPLETED|Week 1||60
8158384|NCT02555722|20110304|P2|STARTED|Week 1||30
8158385|NCT02555722|20110305|P1|STARTED|Week 1||60
8158386|NCT02555722|20110304|P2|NOT COMPLETED|Lens Dispensed||0
8158387|NCT02555722|20110305|P1|NOT COMPLETED|Lens Dispensed||0
8158388|NCT02555722|20110304|P2|COMPLETED|Lens Dispensed||30
8158389|NCT02555722|20110305|P1|COMPLETED|Lens Dispensed||60
8158390|NCT02555722|20110304|P2|STARTED|Lens Dispensed||30
8158391|NCT02555722|20110305|P1|STARTED|Lens Dispensed||60
8158392|NCT02555683|20110490|P3|NOT COMPLETED|Overall Study||29
8158393|NCT02555683|20110491|P2|NOT COMPLETED|Overall Study||17
8158394|NCT02555683|20110492|P1|NOT COMPLETED|Overall Study||19
8158395|NCT02555683|20110490|P3|COMPLETED|Overall Study||269
8158396|NCT02555683|20110491|P2|COMPLETED|Overall Study||278
8158397|NCT02555683|20110492|P1|COMPLETED|Overall Study||282
8158398|NCT02555683|20110490|P3|FAS/SAF: Overall Population|Overall Study||298
8158399|NCT02555683|20110491|P2|FAS/SAF: Overall Population|Overall Study||293
8158400|NCT02555683|20110492|P1|FAS/SAF: Overall Population|Overall Study||299
8158401|NCT02555683|20110490|P3|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
8158402|NCT02555683|20110491|P2|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
8158403|NCT02555683|20110492|P1|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
8158404|NCT02555683|20110490|P3|STARTED|Overall Study||298
8158405|NCT02555683|20110491|P2|STARTED|Overall Study||295
8158406|NCT02555683|20110492|P1|STARTED|Overall Study||301
8158407|NCT02555657|20110523|P2|NOT COMPLETED|Overall Study||310
8158408|NCT02555657|20110524|P1|NOT COMPLETED|Overall Study||312
8158409|NCT02555657|20110523|P2|COMPLETED|Overall Study||0
8158410|NCT02555657|20110524|P1|COMPLETED|Overall Study||0
8158411|NCT02555657|20110523|P2|Treated|Overall Study||292
8158412|NCT02555657|20110524|P1|Treated|Overall Study||309
8158413|NCT02555657|20110523|P2|STARTED|Overall Study||310
8158414|NCT02555657|20110524|P1|STARTED|Overall Study||312
8158415|NCT02555631|20110562|P1|NOT COMPLETED|Overall Study||4
8158416|NCT02555631|20110562|P1|COMPLETED|Overall Study||25
8158417|NCT02555631|20110562|P1|STARTED|Overall Study||29
8158418|NCT02555618|20110571|P2|NOT COMPLETED|Overall Study||0
8158419|NCT02555618|20110572|P1|NOT COMPLETED|Overall Study||1
8158420|NCT02555618|20110571|P2|COMPLETED|Overall Study||200
8158421|NCT02555618|20110572|P1|COMPLETED|Overall Study||199
8158422|NCT02555618|20110571|P2|STARTED|Overall Study||200
8158423|NCT02555618|20110572|P1|STARTED|Overall Study||200
8158424|NCT02555371|20110614|P5|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
8158425|NCT02555371|20110615|P4|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
8158426|NCT02555371|20110616|P3|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158427|NCT02555371|20110617|P2|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158428|NCT02555371|20110618|P1|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158429|NCT02555371|20110614|P5|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
8158430|NCT02555371|20110615|P4|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
8158431|NCT02555371|20110616|P3|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158432|NCT02555371|20110617|P2|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158433|NCT02555371|20110618|P1|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158434|NCT02555371|20110614|P5|STARTED|PartD(OL: 52W Post-randomization PartC)||45
8158435|NCT02555371|20110615|P4|STARTED|PartD(OL: 52W Post-randomization PartC)||84
8158436|NCT02555371|20110616|P3|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8158437|NCT02555371|20110617|P2|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8158438|NCT02555371|20110618|P1|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8158439|NCT02555371|20110614|P5|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8158440|NCT02555371|20110615|P4|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8158441|NCT02555371|20110616|P3|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
8158442|NCT02555371|20110617|P2|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
8158443|NCT02555371|20110618|P1|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8158444|NCT02555371|20110614|P5|COMPLETED|Part C (DB Period: Up to 52W)||0
8158445|NCT02555371|20110615|P4|COMPLETED|Part C (DB Period: Up to 52W)||0
8158446|NCT02555371|20110616|P3|COMPLETED|Part C (DB Period: Up to 52W)||96
8158447|NCT02555371|20110617|P2|COMPLETED|Part C (DB Period: Up to 52W)||62
8158448|NCT02555371|20110618|P1|COMPLETED|Part C (DB Period: Up to 52W)||0
8158449|NCT02555371|20110614|P5|STARTED|Part C (DB Period: Up to 52W)||0
8158450|NCT02555371|20110615|P4|STARTED|Part C (DB Period: Up to 52W)||0
8158451|NCT02555371|20110616|P3|STARTED|Part C (DB Period: Up to 52W)||144
8158452|NCT02555371|20110617|P2|STARTED|Part C (DB Period: Up to 52W)||151
8158453|NCT02555371|20110618|P1|STARTED|Part C (DB Period: Up to 52W)||0
8158454|NCT02555371|20110614|P5|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158455|NCT02555371|20110615|P4|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158456|NCT02555371|20110616|P3|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158457|NCT02555371|20110617|P2|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158458|NCT02555371|20110618|P1|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
8158459|NCT02555371|20110614|P5|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158460|NCT02555371|20110615|P4|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158461|NCT02555371|20110616|P3|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158462|NCT02555371|20110617|P2|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158463|NCT02555371|20110618|P1|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
8158464|NCT02555371|20110614|P5|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158465|NCT02555371|20110615|P4|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158466|NCT02555371|20110616|P3|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158467|NCT02555371|20110617|P2|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158468|NCT02555371|20110618|P1|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
8158469|NCT02555306|20110637|P4|NOT COMPLETED|Overall Study||0
8158470|NCT02555306|20110638|P3|NOT COMPLETED|Overall Study||0
8158471|NCT02555306|20110639|P2|NOT COMPLETED|Overall Study||0
8158472|NCT02555306|20110640|P1|NOT COMPLETED|Overall Study||0
8158473|NCT02555306|20110637|P4|COMPLETED|Overall Study||3
8158474|NCT02555306|20110638|P3|COMPLETED|Overall Study||3
8158475|NCT02555306|20110639|P2|COMPLETED|Overall Study||3
8158476|NCT02555306|20110640|P1|COMPLETED|Overall Study||3
8158477|NCT02555306|20110637|P4|STARTED|Overall Study||3
8158478|NCT02555306|20110638|P3|STARTED|Overall Study||3
8158479|NCT02555306|20110639|P2|STARTED|Overall Study||3
8158480|NCT02555306|20110640|P1|STARTED|Overall Study||3
8158481|NCT02555228|20110656|P2|NOT COMPLETED|Overall Study||0
8158482|NCT02555228|20110657|P1|NOT COMPLETED|Overall Study||0
8158483|NCT02555228|20110656|P2|COMPLETED|Overall Study|29th October 2015|27
8158484|NCT02555228|20110657|P1|COMPLETED|Overall Study|19th November 2015|27
8158485|NCT02555228|20110656|P2|STARTED|Overall Study|14th August 2015|27
8158486|NCT02555228|20110657|P1|STARTED|Overall Study|20th August 2015|27
8158487|NCT02555215|20110669|P1|NOT COMPLETED|Overall Study||3
8158488|NCT02555215|20110669|P1|COMPLETED|Overall Study||17
8158489|NCT02555215|20110669|P1|STARTED|Overall Study||20
8158490|NCT02555098|20110680|P2|NOT COMPLETED|Second Intervention||0
8158491|NCT02555098|20110681|P1|NOT COMPLETED|Second Intervention||0
8158492|NCT02555098|20110680|P2|COMPLETED|Second Intervention||11
8158493|NCT02555098|20110681|P1|COMPLETED|Second Intervention||12
8158494|NCT02555098|20110680|P2|STARTED|Second Intervention||11
8158495|NCT02555098|20110681|P1|STARTED|Second Intervention||12
8158496|NCT02555098|20110680|P2|NOT COMPLETED|First Intervention||0
8158497|NCT02555098|20110681|P1|NOT COMPLETED|First Intervention||0
8158498|NCT02555098|20110680|P2|COMPLETED|First Intervention||11
8158499|NCT02555098|20110681|P1|COMPLETED|First Intervention||12
8158500|NCT02555098|20110680|P2|STARTED|First Intervention||11
8158501|NCT02555098|20110681|P1|STARTED|First Intervention||12
8158502|NCT02554981|20110701|P1|NOT COMPLETED|Overall Study||5
8158503|NCT02554981|20110701|P1|COMPLETED|Overall Study||46
8158504|NCT02554981|20110701|P1|STARTED|Overall Study||51
8158505|NCT02554929|20110727|P2|NOT COMPLETED|Overall Study||12
8158506|NCT02554929|20110728|P1|NOT COMPLETED|Overall Study||6
8158507|NCT02554929|20110727|P2|COMPLETED|Overall Study||32
8158508|NCT02554929|20110728|P1|COMPLETED|Overall Study||40
8158509|NCT02554929|20110727|P2|Per Protocol 6 Month Follow-up|Overall Study||32
8158510|NCT02554929|20110728|P1|Per Protocol 6 Month Follow-up|Overall Study||40
8158511|NCT02554929|20110727|P2|Per Protocol Post-Intervention|Overall Study||36
8158512|NCT02554929|20110728|P1|Per Protocol Post-Intervention|Overall Study||42
8158513|NCT02554929|20110727|P2|Per Protocol Received Intervention|Overall Study||36
8158514|NCT02554929|20110728|P1|Per Protocol Received Intervention|Overall Study||44
8158515|NCT02554929|20110727|P2|STARTED|Overall Study||44
8158516|NCT02554929|20110728|P1|STARTED|Overall Study||46
8158517|NCT02554890|20110746|P2|NOT COMPLETED|Open-label||52
8158518|NCT02554890|20110747|P1|NOT COMPLETED|Open-label||0
8158519|NCT02554890|20110746|P2|COMPLETED|Open-label||835
8158520|NCT02554890|20110747|P1|COMPLETED|Open-label||0
8158521|NCT02554890|20110746|P2|STARTED|Open-label||887
8158522|NCT02554890|20110747|P1|STARTED|Open-label||0
8158523|NCT02554890|20110746|P2|NOT COMPLETED|Double-blind||91
8158524|NCT02554890|20110747|P1|NOT COMPLETED|Double-blind||96
8158525|NCT02554890|20110746|P2|COMPLETED|Double-blind||352
8158526|NCT02554890|20110747|P1|COMPLETED|Double-blind||348
8158527|NCT02554890|20110746|P2|Treated Patients|Double-blind||439
8158528|NCT02554890|20110747|P1|Treated Patients|Double-blind||436
8158529|NCT02554890|20110746|P2|STARTED|Double-blind||443
8158530|NCT02554890|20110747|P1|STARTED|Double-blind||444
8158531|NCT02554877|20110775|P4|NOT COMPLETED|Overall Study||7
8158532|NCT02554877|20110776|P3|NOT COMPLETED|Overall Study||6
8158533|NCT02554877|20110777|P2|NOT COMPLETED|Overall Study||7
8158534|NCT02554877|20110778|P1|NOT COMPLETED|Overall Study||12
8158535|NCT02554877|20110775|P4|COMPLETED|Overall Study||45
8158536|NCT02554877|20110776|P3|COMPLETED|Overall Study||46
8158537|NCT02554877|20110777|P2|COMPLETED|Overall Study||44
8158538|NCT02554877|20110778|P1|COMPLETED|Overall Study||39
8158539|NCT02554877|20110775|P4|STARTED|Overall Study||52
8158540|NCT02554877|20110776|P3|STARTED|Overall Study||52
8158541|NCT02554877|20110777|P2|STARTED|Overall Study||51
8158542|NCT02554877|20110778|P1|STARTED|Overall Study||51
8158543|NCT02554799|20110842|P2|NOT COMPLETED|Overall Study||0
8158544|NCT02554799|20110843|P1|NOT COMPLETED|Overall Study||0
8158545|NCT02554799|20110842|P2|COMPLETED|Overall Study||9
8158546|NCT02554799|20110843|P1|COMPLETED|Overall Study||9
8158547|NCT02554799|20110842|P2|STARTED|Overall Study||9
8158548|NCT02554799|20110843|P1|STARTED|Overall Study||9
8158549|NCT02554786|20110866|P5|NOT COMPLETED|Overall Study||30
8158550|NCT02554786|20110867|P4|NOT COMPLETED|Overall Study||41
8158551|NCT02554786|20110868|P3|NOT COMPLETED|Overall Study||30
8158552|NCT02554786|20110869|P2|NOT COMPLETED|Overall Study||26
8158553|NCT02554786|20110870|P1|NOT COMPLETED|Overall Study||35
8158554|NCT02554786|20110866|P5|COMPLETED|Overall Study||416
8158555|NCT02554786|20110867|P4|COMPLETED|Overall Study||403
8158556|NCT02554786|20110868|P3|COMPLETED|Overall Study||412
8158557|NCT02554786|20110869|P2|COMPLETED|Overall Study||413
8158558|NCT02554786|20110870|P1|COMPLETED|Overall Study||410
8158559|NCT02554786|20110866|P5|STARTED|Overall Study||446
8158560|NCT02554786|20110867|P4|STARTED|Overall Study||444
8158561|NCT02554786|20110868|P3|STARTED|Overall Study||442
8158562|NCT02554786|20110869|P2|STARTED|Overall Study||439
8158563|NCT02554786|20110870|P1|STARTED|Overall Study||445
8158564|NCT02554760|20111012|P2|NOT COMPLETED|Overall Study||0
8158565|NCT02554760|20111013|P1|NOT COMPLETED|Overall Study||0
8158566|NCT02554760|20111012|P2|COMPLETED|Overall Study||10
8158567|NCT02554760|20111013|P1|COMPLETED|Overall Study||9
8158568|NCT02554760|20111012|P2|STARTED|Overall Study||10
8158569|NCT02554760|20111013|P1|STARTED|Overall Study||9
8158570|NCT02554682|20111032|P10|NOT COMPLETED|Overall Study||2
8158571|NCT02554682|20111033|P9|NOT COMPLETED|Overall Study||2
8158572|NCT02554682|20111034|P8|NOT COMPLETED|Overall Study||6
8158573|NCT02554682|20111035|P7|NOT COMPLETED|Overall Study||6
8158574|NCT02554682|20111036|P6|NOT COMPLETED|Overall Study||1
8158575|NCT02554682|20111037|P5|NOT COMPLETED|Overall Study||2
8158576|NCT02554682|20111038|P4|NOT COMPLETED|Overall Study||3
8158577|NCT02554682|20111039|P3|NOT COMPLETED|Overall Study||4
8158578|NCT02554682|20111040|P2|NOT COMPLETED|Overall Study||12
8158579|NCT02554682|20111041|P1|NOT COMPLETED|Overall Study||15
8158580|NCT02554682|20111032|P10|COMPLETED|Overall Study||24
8158581|NCT02554682|20111033|P9|COMPLETED|Overall Study||24
8158582|NCT02554682|20111034|P8|COMPLETED|Overall Study||22
8158583|NCT02554682|20111035|P7|COMPLETED|Overall Study||22
8158584|NCT02554682|20111036|P6|COMPLETED|Overall Study||39
8158585|NCT02554682|20111037|P5|COMPLETED|Overall Study||38
8158586|NCT02554682|20111038|P4|COMPLETED|Overall Study||37
8158587|NCT02554682|20111039|P3|COMPLETED|Overall Study||36
8158588|NCT02554682|20111040|P2|COMPLETED|Overall Study||28
8158589|NCT02554682|20111041|P1|COMPLETED|Overall Study||25
8158590|NCT02554682|20111032|P10|STARTED|Overall Study||26
8158591|NCT02554682|20111033|P9|STARTED|Overall Study||26
8158592|NCT02554682|20111034|P8|STARTED|Overall Study||28
8158593|NCT02554682|20111035|P7|STARTED|Overall Study||28
8158594|NCT02554682|20111036|P6|STARTED|Overall Study||40
8158595|NCT02554682|20111037|P5|STARTED|Overall Study||40
8158596|NCT02554682|20111038|P4|STARTED|Overall Study||40
8158597|NCT02554682|20111039|P3|STARTED|Overall Study||40
8158598|NCT02554682|20111040|P2|STARTED|Overall Study||40
8158599|NCT02554682|20111041|P1|STARTED|Overall Study||40
8158600|NCT02554656|20111090|P1|NOT COMPLETED|Overall Study||3
8158601|NCT02554656|20111090|P1|COMPLETED|Overall Study||86
8158602|NCT02554656|20111090|P1|STARTED|Overall Study||89
8158603|NCT02554435|20111100|P2|NOT COMPLETED|Overall Study||1
8158604|NCT02554435|20111101|P1|NOT COMPLETED|Overall Study||6
8158605|NCT02554435|20111100|P2|COMPLETED|Overall Study||19
8158606|NCT02554435|20111101|P1|COMPLETED|Overall Study||14
8158607|NCT02554435|20111100|P2|STARTED|Overall Study||20
8158608|NCT02554435|20111101|P1|STARTED|Overall Study||20
8158609|NCT02554279|20111135|P2|NOT COMPLETED|Overall Study||18
8158610|NCT02554279|20111136|P1|NOT COMPLETED|Overall Study||32
8158611|NCT02554279|20111135|P2|COMPLETED|Overall Study||291
8158612|NCT02554279|20111136|P1|COMPLETED|Overall Study||279
8158613|NCT02554279|20111135|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
8158614|NCT02554279|20111136|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
8158615|NCT02554279|20111135|P2|Completed Oocyte Retrieval|Overall Study||306
8158616|NCT02554279|20111136|P1|Completed Oocyte Retrieval|Overall Study||292
8158617|NCT02554279|20111135|P2|Received Trigger|Overall Study||307
8158618|NCT02554279|20111136|P1|Received Trigger|Overall Study||293
8158619|NCT02554279|20111135|P2|Completed Day 6 of Stimulation|Overall Study||309
8158620|NCT02554279|20111136|P1|Completed Day 6 of Stimulation|Overall Study||308
8158621|NCT02554279|20111135|P2|Treated|Overall Study||309
8158622|NCT02554279|20111136|P1|Treated|Overall Study||310
8158623|NCT02554279|20111135|P2|STARTED|Overall Study||309
8158624|NCT02554279|20111136|P1|STARTED|Overall Study||311
8158625|NCT02554019|20111171|P3|NOT COMPLETED|Overall Study||2
8158626|NCT02554019|20111172|P2|NOT COMPLETED|Overall Study||0
8158627|NCT02554019|20111173|P1|NOT COMPLETED|Overall Study||2
8158628|NCT02554019|20111171|P3|COMPLETED|Overall Study||10
8158629|NCT02554019|20111172|P2|COMPLETED|Overall Study||12
8158630|NCT02554019|20111173|P1|COMPLETED|Overall Study||10
8158631|NCT02554019|20111171|P3|STARTED|Overall Study||12
8158632|NCT02554019|20111172|P2|STARTED|Overall Study||12
8158633|NCT02554019|20111173|P1|STARTED|Overall Study||12
8158634|NCT02553928|20111195|P2|NOT COMPLETED|Overall Study||3
8158635|NCT02553928|20111196|P1|NOT COMPLETED|Overall Study||2
8158636|NCT02553928|20111195|P2|COMPLETED|Overall Study||29
8158637|NCT02553928|20111196|P1|COMPLETED|Overall Study||28
8158638|NCT02553928|20111195|P2|STARTED|Overall Study||32
8158639|NCT02553928|20111196|P1|STARTED|Overall Study||30
8158640|NCT02553915|20111208|P4|NOT COMPLETED|Overall Study||3
8158641|NCT02553915|20111209|P3|NOT COMPLETED|Overall Study||3
8158642|NCT02553915|20111210|P2|NOT COMPLETED|Overall Study||1
8158643|NCT02553915|20111211|P1|NOT COMPLETED|Overall Study||4
8158644|NCT02553915|20111208|P4|COMPLETED|Overall Study||13
8158645|NCT02553915|20111209|P3|COMPLETED|Overall Study||12
8158646|NCT02553915|20111210|P2|COMPLETED|Overall Study||14
8158647|NCT02553915|20111211|P1|COMPLETED|Overall Study||11
8158648|NCT02553915|20111208|P4|STARTED|Overall Study||16
8158649|NCT02553915|20111209|P3|STARTED|Overall Study||15
8158650|NCT02553915|20111210|P2|STARTED|Overall Study||15
8158651|NCT02553915|20111211|P1|STARTED|Overall Study||15
8158652|NCT02553798|20111241|P1|NOT COMPLETED|Overall Study||338
8158653|NCT02553798|20111241|P1|COMPLETED|Overall Study||226
8158654|NCT02553798|20111241|P1|STARTED|Overall Study||564
8158655|NCT02553772|20111250|P2|NOT COMPLETED|Overall Study||6
8158656|NCT02553772|20111251|P1|NOT COMPLETED|Overall Study||6
8158657|NCT02553772|20111250|P2|COMPLETED|Overall Study||116
8158658|NCT02553772|20111251|P1|COMPLETED|Overall Study||114
8158659|NCT02553772|20111250|P2|STARTED|Overall Study||122
8158660|NCT02553772|20111251|P1|STARTED|Overall Study||120
8158661|NCT02553746|20111267|P2|NOT COMPLETED|Overall Study||2
8158662|NCT02553746|20111268|P1|NOT COMPLETED|Overall Study||3
8158663|NCT02553746|20111267|P2|COMPLETED|Overall Study||64
8158664|NCT02553746|20111268|P1|COMPLETED|Overall Study||77
8158665|NCT02553746|20111267|P2|STARTED|Overall Study||66
8158666|NCT02553746|20111268|P1|STARTED|Overall Study||80
8158667|NCT02553629|20111296|P2|NOT COMPLETED|Overall Study||6
8158668|NCT02553629|20111297|P1|NOT COMPLETED|Overall Study||3
8158669|NCT02553629|20111296|P2|COMPLETED|Overall Study||50
8158670|NCT02553629|20111297|P1|COMPLETED|Overall Study||50
8158671|NCT02553629|20111296|P2|STARTED|Overall Study||56
8158672|NCT02553629|20111297|P1|STARTED|Overall Study||53
8158673|NCT02553538|20111313|P2|NOT COMPLETED|Overall Study||56
8158674|NCT02553538|20111314|P1|NOT COMPLETED|Overall Study||187
8158675|NCT02553538|20111313|P2|COMPLETED|Overall Study||764
8158676|NCT02553538|20111314|P1|COMPLETED|Overall Study||605
8158677|NCT02553538|20111313|P2|STARTED|Overall Study||820
8158678|NCT02553538|20111314|P1|STARTED|Overall Study||792
8158679|NCT02553512|20111326|P1|NOT COMPLETED|Overall Study||23
8158680|NCT02553512|20111326|P1|COMPLETED|Overall Study||144
8158681|NCT02553512|20111326|P1|STARTED|Overall Study||167
8158682|NCT02553499|20111348|P14|NOT COMPLETED|Overall Study||2
8158683|NCT02553499|20111349|P13|NOT COMPLETED|Overall Study||3
8158684|NCT02553499|20111350|P12|NOT COMPLETED|Overall Study||3
8158685|NCT02553499|20111351|P11|NOT COMPLETED|Overall Study||3
8158686|NCT02553499|20111352|P10|NOT COMPLETED|Overall Study||3
8158687|NCT02553499|20111353|P9|NOT COMPLETED|Overall Study||3
8158688|NCT02553499|20111354|P8|NOT COMPLETED|Overall Study||3
8158689|NCT02553499|20111355|P7|NOT COMPLETED|Overall Study||3
8158690|NCT02553499|20111356|P6|NOT COMPLETED|Overall Study||3
8158691|NCT02553499|20111357|P5|NOT COMPLETED|Overall Study||3
8158692|NCT02553499|20111358|P4|NOT COMPLETED|Overall Study||2
8158693|NCT02553499|20111359|P3|NOT COMPLETED|Overall Study||2
8158694|NCT02553499|20111360|P2|NOT COMPLETED|Overall Study||2
8158695|NCT02553499|20111361|P1|NOT COMPLETED|Overall Study||2
8158696|NCT02553499|20111348|P14|COMPLETED|Overall Study||0
8158697|NCT02553499|20111349|P13|COMPLETED|Overall Study||0
8158698|NCT02553499|20111350|P12|COMPLETED|Overall Study||0
8158699|NCT02553499|20111351|P11|COMPLETED|Overall Study||0
8158700|NCT02553499|20111352|P10|COMPLETED|Overall Study||0
8158701|NCT02553499|20111353|P9|COMPLETED|Overall Study||0
8158702|NCT02553499|20111354|P8|COMPLETED|Overall Study||0
8158703|NCT02553499|20111355|P7|COMPLETED|Overall Study||0
8158704|NCT02553499|20111356|P6|COMPLETED|Overall Study||0
8158705|NCT02553499|20111357|P5|COMPLETED|Overall Study||0
8158706|NCT02553499|20111358|P4|COMPLETED|Overall Study||0
8158707|NCT02553499|20111359|P3|COMPLETED|Overall Study||0
8158708|NCT02553499|20111360|P2|COMPLETED|Overall Study||0
8158709|NCT02553499|20111361|P1|COMPLETED|Overall Study||0
8158710|NCT02553499|20111348|P14|STARTED|Overall Study||2
8158711|NCT02553499|20111349|P13|STARTED|Overall Study||3
8158712|NCT02553499|20111350|P12|STARTED|Overall Study||3
8158713|NCT02553499|20111351|P11|STARTED|Overall Study||3
8158714|NCT02553499|20111352|P10|STARTED|Overall Study||3
8158715|NCT02553499|20111353|P9|STARTED|Overall Study||3
8158716|NCT02553499|20111354|P8|STARTED|Overall Study||3
8158717|NCT02553499|20111355|P7|STARTED|Overall Study||3
8158718|NCT02553499|20111356|P6|STARTED|Overall Study||3
8158719|NCT02553499|20111357|P5|STARTED|Overall Study||3
8158720|NCT02553499|20111358|P4|STARTED|Overall Study||2
8158721|NCT02553499|20111359|P3|STARTED|Overall Study||2
8158722|NCT02553499|20111360|P2|STARTED|Overall Study||2
8158723|NCT02553499|20111361|P1|STARTED|Overall Study||2
8158724|NCT02553421|20111463|P2|NOT COMPLETED|Overall Study||1
8158725|NCT02553421|20111464|P1|NOT COMPLETED|Overall Study||29
8158726|NCT02553421|20111463|P2|COMPLETED|Overall Study||57
8158727|NCT02553421|20111464|P1|COMPLETED|Overall Study||156
8158728|NCT02553421|20111463|P2|STARTED|Overall Study||58
8158729|NCT02553421|20111464|P1|STARTED|Overall Study||185
8158730|NCT02553395|20111472|P2|NOT COMPLETED|Second Intervention||0
8158731|NCT02553395|20111473|P1|NOT COMPLETED|Second Intervention||0
8158732|NCT02553395|20111472|P2|COMPLETED|Second Intervention||18
8158733|NCT02553395|20111473|P1|COMPLETED|Second Intervention||12
8158734|NCT02553395|20111472|P2|STARTED|Second Intervention||18
8158735|NCT02553395|20111473|P1|STARTED|Second Intervention||12
8158736|NCT02553395|20111472|P2|NOT COMPLETED|First Intervention||0
8158737|NCT02553395|20111473|P1|NOT COMPLETED|First Intervention||0
8158738|NCT02553395|20111472|P2|COMPLETED|First Intervention||18
8158739|NCT02553395|20111473|P1|COMPLETED|First Intervention||12
8158740|NCT02553395|20111472|P2|STARTED|First Intervention||18
8158741|NCT02553395|20111473|P1|STARTED|First Intervention||12
8158742|NCT02553330|20111519|P3|NOT COMPLETED|Overall Study||37
8158743|NCT02553330|20111520|P2|NOT COMPLETED|Overall Study||39
8158744|NCT02553330|20111521|P1|NOT COMPLETED|Overall Study||5
8158745|NCT02553330|20111519|P3|COMPLETED|Overall Study||2
8158746|NCT02553330|20111520|P2|COMPLETED|Overall Study||0
8158747|NCT02553330|20111521|P1|COMPLETED|Overall Study||7
8158748|NCT02553330|20111519|P3|STARTED|Overall Study||39
8158749|NCT02553330|20111520|P2|STARTED|Overall Study||39
8158750|NCT02553330|20111521|P1|STARTED|Overall Study||12
8158751|NCT02553317|20111545|P2|NOT COMPLETED|Open-label (OL) Treatment Period||4
8158752|NCT02553317|20111546|P1|NOT COMPLETED|Open-label (OL) Treatment Period||0
8158753|NCT02553317|20111545|P2|COMPLETED|Open-label (OL) Treatment Period||22
8158754|NCT02553317|20111546|P1|COMPLETED|Open-label (OL) Treatment Period||2
8158755|NCT02553317|20111545|P2|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
8158756|NCT02553317|20111546|P1|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
8158757|NCT02553317|20111545|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||8
8158758|NCT02553317|20111546|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||3
8158759|NCT02553317|20111545|P2|COMPLETED|Double-blind (DB) Treatment Period||65
8158760|NCT02553317|20111546|P1|COMPLETED|Double-blind (DB) Treatment Period||68
8158761|NCT02553317|20111545|P2|STARTED|Double-blind (DB) Treatment Period||73
8158762|NCT02553317|20111546|P1|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
8158763|NCT02553317|20111545|P2|NOT COMPLETED|Overall Treatment Period + Follow-up||23
8158764|NCT02553317|20111546|P1|NOT COMPLETED|Overall Treatment Period + Follow-up||14
8158765|NCT02553317|20111545|P2|COMPLETED|Overall Treatment Period + Follow-up||50
8158766|NCT02553317|20111546|P1|COMPLETED|Overall Treatment Period + Follow-up||58
8158767|NCT02553317|20111545|P2|Received Study Drug|Overall Treatment Period + Follow-up||73
8158768|NCT02553317|20111546|P1|Received Study Drug|Overall Treatment Period + Follow-up||71
8158769|NCT02553317|20111545|P2|STARTED|Overall Treatment Period + Follow-up||73
8158770|NCT02553317|20111546|P1|STARTED|Overall Treatment Period + Follow-up||72
8158771|NCT02553135|20111569|P1|NOT COMPLETED|Overall Study||0
8158772|NCT02553135|20111569|P1|COMPLETED|Overall Study||6
8158773|NCT02553135|20111569|P1|STARTED|Overall Study||6
8158774|NCT02552966|20111576|P1|NOT COMPLETED|Overall Study||5
8158775|NCT02552966|20111576|P1|COMPLETED|Overall Study||15
8158776|NCT02552966|20111576|P1|STARTED|Overall Study||20
8158777|NCT02552810|20111585|P2|NOT COMPLETED|Overall Study||0
8158778|NCT02552810|20111586|P1|NOT COMPLETED|Overall Study||0
8158779|NCT02552810|20111585|P2|COMPLETED|Overall Study||15
8158780|NCT02552810|20111586|P1|COMPLETED|Overall Study||15
8158781|NCT02552810|20111585|P2|STARTED|Overall Study||15
8158782|NCT02552810|20111586|P1|STARTED|Overall Study||15
8158783|NCT02552732|20111602|P1|NOT COMPLETED|Overall Study||10
8158784|NCT02552732|20111602|P1|COMPLETED|Overall Study||19
8158785|NCT02552732|20111602|P1|Completed Day 1 and Day 31 Spirometry|Overall Study||12
8158786|NCT02552732|20111602|P1|Completed Week 4|Overall Study||19
8158787|NCT02552732|20111602|P1|Completed Week 3|Overall Study||19
8158788|NCT02552732|20111602|P1|Completed Week 2|Overall Study||20
8158789|NCT02552732|20111602|P1|Completed Week 1|Overall Study||21
8158790|NCT02552732|20111602|P1|Used Device|Overall Study||23
8158791|NCT02552732|20111602|P1|STARTED|Overall Study||29
8158792|NCT02552368|20111629|P1|NOT COMPLETED|Overall Study||13
8158793|NCT02552368|20111629|P1|COMPLETED|Overall Study||10
8158794|NCT02552368|20111629|P1|STARTED|Overall Study||23
8158795|NCT02552355|20111638|P4|NOT COMPLETED|Overall Study||1
8158796|NCT02552355|20111639|P3|NOT COMPLETED|Overall Study||2
8158797|NCT02552355|20111640|P2|NOT COMPLETED|Overall Study||2
8158798|NCT02552355|20111641|P1|NOT COMPLETED|Overall Study||0
8158799|NCT02552355|20111638|P4|COMPLETED|Overall Study||14
8158800|NCT02552355|20111639|P3|COMPLETED|Overall Study||12
8158801|NCT02552355|20111640|P2|COMPLETED|Overall Study||11
8158802|NCT02552355|20111641|P1|COMPLETED|Overall Study||14
8158803|NCT02552355|20111638|P4|STARTED|Overall Study||15
8158804|NCT02552355|20111639|P3|STARTED|Overall Study||14
8158805|NCT02552355|20111640|P2|STARTED|Overall Study||13
8158806|NCT02552355|20111641|P1|STARTED|Overall Study||14
8158807|NCT02552316|20111683|P1|NOT COMPLETED|Overall Study||2
8158808|NCT02552316|20111683|P1|COMPLETED|Overall Study||32
8158809|NCT02552316|20111683|P1|STARTED|Overall Study||34
8158810|NCT02552303|20111735|P4|NOT COMPLETED|Follow-Up||0
8158811|NCT02552303|20111736|P3|NOT COMPLETED|Follow-Up||1
8158812|NCT02552303|20111737|P2|NOT COMPLETED|Follow-Up||2
8158813|NCT02552303|20111738|P1|NOT COMPLETED|Follow-Up||0
8158814|NCT02552303|20111735|P4|COMPLETED|Follow-Up||10
8158815|NCT02552303|20111736|P3|COMPLETED|Follow-Up||6
8158816|NCT02552303|20111737|P2|COMPLETED|Follow-Up||6
8158817|NCT02552303|20111738|P1|COMPLETED|Follow-Up||7
8158818|NCT02552303|20111735|P4|STARTED|Follow-Up||10
8158819|NCT02552303|20111736|P3|STARTED|Follow-Up||7
8158820|NCT02552303|20111737|P2|STARTED|Follow-Up||8
8158821|NCT02552303|20111738|P1|STARTED|Follow-Up||7
8158822|NCT02552303|20111735|P4|NOT COMPLETED|Allocation||1
8158823|NCT02552303|20111736|P3|NOT COMPLETED|Allocation||1
8158824|NCT02552303|20111737|P2|NOT COMPLETED|Allocation||2
8158825|NCT02552303|20111738|P1|NOT COMPLETED|Allocation||3
8158826|NCT02552303|20111735|P4|COMPLETED|Allocation||10
8158827|NCT02552303|20111736|P3|COMPLETED|Allocation||7
8158828|NCT02552303|20111737|P2|COMPLETED|Allocation||8
8158829|NCT02552303|20111738|P1|COMPLETED|Allocation||7
8158830|NCT02552303|20111735|P4|STARTED|Allocation||11
8158831|NCT02552303|20111736|P3|STARTED|Allocation||8
8158832|NCT02552303|20111737|P2|STARTED|Allocation||10
8158833|NCT02552303|20111738|P1|STARTED|Allocation||10
8158834|NCT02552238|20111752|P1|NOT COMPLETED|Overall Study||2
8158835|NCT02552238|20111752|P1|COMPLETED|Overall Study||172
8158836|NCT02552238|20111752|P1|STARTED|Overall Study||174
8158837|NCT02552212|20111765|P2|NOT COMPLETED|Overall Study||17
8158838|NCT02552212|20111766|P1|NOT COMPLETED|Overall Study||15
8158839|NCT02552212|20111765|P2|COMPLETED|Overall Study||142
8158840|NCT02552212|20111766|P1|COMPLETED|Overall Study||143
8158841|NCT02552212|20111765|P2|Received OL-CZP|Overall Study||20
8158842|NCT02552212|20111766|P1|Received OL-CZP|Overall Study||96
8158843|NCT02552212|20111765|P2|STARTED|Overall Study||159
8158844|NCT02552212|20111766|P1|STARTED|Overall Study||158
8158845|NCT02552147|20111840|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8158846|NCT02552147|20111841|P1|NOT COMPLETED|Second Intervention (7 Days)||2
8158847|NCT02552147|20111840|P2|COMPLETED|Second Intervention (7 Days)||4
8158848|NCT02552147|20111841|P1|COMPLETED|Second Intervention (7 Days)||1
8158849|NCT02552147|20111840|P2|STARTED|Second Intervention (7 Days)||4
8158850|NCT02552147|20111841|P1|STARTED|Second Intervention (7 Days)||3
8158851|NCT02552147|20111840|P2|NOT COMPLETED|Washout (7 Days)||0
8158852|NCT02552147|20111841|P1|NOT COMPLETED|Washout (7 Days)||0
8158853|NCT02552147|20111840|P2|COMPLETED|Washout (7 Days)||4
8158854|NCT02552147|20111841|P1|COMPLETED|Washout (7 Days)||3
8158855|NCT02552147|20111840|P2|STARTED|Washout (7 Days)||4
8158856|NCT02552147|20111841|P1|STARTED|Washout (7 Days)||3
8158857|NCT02552147|20111840|P2|NOT COMPLETED|First Intervention (7 Days)||0
8158858|NCT02552147|20111841|P1|NOT COMPLETED|First Intervention (7 Days)||1
8158859|NCT02552147|20111840|P2|COMPLETED|First Intervention (7 Days)||4
8158860|NCT02552147|20111841|P1|COMPLETED|First Intervention (7 Days)||3
8158861|NCT02552147|20111840|P2|STARTED|First Intervention (7 Days)||4
8158862|NCT02552147|20111841|P1|STARTED|First Intervention (7 Days)||4
8158863|NCT02552121|20111875|P8|NOT COMPLETED|Part 2: Cohort Expansion||3
8158864|NCT02552121|20111876|P7|NOT COMPLETED|Part 2: Cohort Expansion||1
8158865|NCT02552121|20111877|P6|NOT COMPLETED|Part 2: Cohort Expansion||4
8158866|NCT02552121|20111878|P5|NOT COMPLETED|Part 2: Cohort Expansion||1
8158867|NCT02552121|20111879|P4|NOT COMPLETED|Part 2: Cohort Expansion||3
8158868|NCT02552121|20111880|P3|NOT COMPLETED|Part 2: Cohort Expansion||11
8158869|NCT02552121|20111881|P2|NOT COMPLETED|Part 2: Cohort Expansion||0
8158870|NCT02552121|20111882|P1|NOT COMPLETED|Part 2: Cohort Expansion||0
8158871|NCT02552121|20111875|P8|COMPLETED|Part 2: Cohort Expansion||0
8158872|NCT02552121|20111876|P7|COMPLETED|Part 2: Cohort Expansion||0
8158873|NCT02552121|20111877|P6|COMPLETED|Part 2: Cohort Expansion||1
8158874|NCT02552121|20111878|P5|COMPLETED|Part 2: Cohort Expansion||0
8158875|NCT02552121|20111879|P4|COMPLETED|Part 2: Cohort Expansion||0
8158876|NCT02552121|20111880|P3|COMPLETED|Part 2: Cohort Expansion||0
8158877|NCT02552121|20111881|P2|COMPLETED|Part 2: Cohort Expansion||0
8158878|NCT02552121|20111882|P1|COMPLETED|Part 2: Cohort Expansion||0
8158879|NCT02552121|20111875|P8|STARTED|Part 2: Cohort Expansion||3
8158880|NCT02552121|20111876|P7|STARTED|Part 2: Cohort Expansion||1
8158881|NCT02552121|20111877|P6|STARTED|Part 2: Cohort Expansion||5
8158882|NCT02552121|20111878|P5|STARTED|Part 2: Cohort Expansion||1
8158883|NCT02552121|20111879|P4|STARTED|Part 2: Cohort Expansion||3
8158884|NCT02552121|20111880|P3|STARTED|Part 2: Cohort Expansion||11
8158885|NCT02552121|20111881|P2|STARTED|Part 2: Cohort Expansion||0
8158886|NCT02552121|20111882|P1|STARTED|Part 2: Cohort Expansion||0
8158887|NCT02552121|20111875|P8|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158888|NCT02552121|20111876|P7|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158889|NCT02552121|20111877|P6|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158890|NCT02552121|20111878|P5|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158891|NCT02552121|20111879|P4|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158892|NCT02552121|20111880|P3|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158893|NCT02552121|20111881|P2|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
8158894|NCT02552121|20111882|P1|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158895|NCT02552121|20111875|P8|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158896|NCT02552121|20111876|P7|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158897|NCT02552121|20111877|P6|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158898|NCT02552121|20111878|P5|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158899|NCT02552121|20111879|P4|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158900|NCT02552121|20111880|P3|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158901|NCT02552121|20111881|P2|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158902|NCT02552121|20111882|P1|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8158903|NCT02552121|20111875|P8|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8158904|NCT02552121|20111876|P7|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8158905|NCT02552121|20111877|P6|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8158906|NCT02552121|20111878|P5|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8158907|NCT02552121|20111879|P4|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8158908|NCT02552121|20111880|P3|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8158909|NCT02552121|20111881|P2|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
8158910|NCT02552121|20111882|P1|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8158911|NCT02552121|20111875|P8|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158912|NCT02552121|20111876|P7|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158913|NCT02552121|20111877|P6|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158914|NCT02552121|20111878|P5|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158915|NCT02552121|20111879|P4|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158916|NCT02552121|20111880|P3|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158917|NCT02552121|20111881|P2|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158918|NCT02552121|20111882|P1|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
8158919|NCT02552121|20111875|P8|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158920|NCT02552121|20111876|P7|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158921|NCT02552121|20111877|P6|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158922|NCT02552121|20111878|P5|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158923|NCT02552121|20111879|P4|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158924|NCT02552121|20111880|P3|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158925|NCT02552121|20111881|P2|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158926|NCT02552121|20111882|P1|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158927|NCT02552121|20111875|P8|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158928|NCT02552121|20111876|P7|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158929|NCT02552121|20111877|P6|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158930|NCT02552121|20111878|P5|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158931|NCT02552121|20111879|P4|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158932|NCT02552121|20111880|P3|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158933|NCT02552121|20111881|P2|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8158934|NCT02552121|20111882|P1|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
8158935|NCT02551887|20112128|P3|NOT COMPLETED|Overall Study||0
8158936|NCT02551887|20112129|P2|NOT COMPLETED|Overall Study||0
8158937|NCT02551887|20112130|P1|NOT COMPLETED|Overall Study||0
8158938|NCT02551887|20112128|P3|COMPLETED|Overall Study||222
8158939|NCT02551887|20112129|P2|COMPLETED|Overall Study||124
8158940|NCT02551887|20112130|P1|COMPLETED|Overall Study||301
8158941|NCT02551887|20112128|P3|STARTED|Overall Study||222
8158942|NCT02551887|20112129|P2|STARTED|Overall Study||124
8158943|NCT02551887|20112130|P1|STARTED|Overall Study||301
8158944|NCT02551874|20112143|P2|NOT COMPLETED|Overall Study||39
8158945|NCT02551874|20112144|P1|NOT COMPLETED|Overall Study||28
8158946|NCT02551874|20112143|P2|COMPLETED|Overall Study||287
8158947|NCT02551874|20112144|P1|COMPLETED|Overall Study||296
8158948|NCT02551874|20112143|P2|Received Treatment in Long-term Study|Overall Study||284
8158949|NCT02551874|20112144|P1|Received Treatment in Long-term Study|Overall Study||295
8158950|NCT02551874|20112143|P2|Entered Long-term Study|Overall Study||294
8158951|NCT02551874|20112144|P1|Entered Long-term Study|Overall Study||306
8158952|NCT02551874|20112143|P2|Received Treatment in Short-term Study|Overall Study||319
8158953|NCT02551874|20112144|P1|Received Treatment in Short-term Study|Overall Study||324
8158954|NCT02551874|20112143|P2|STARTED|Overall Study||326
8158955|NCT02551874|20112144|P1|STARTED|Overall Study||324
8158956|NCT02551822|20112162|P2|NOT COMPLETED|Overall Study||2
8158957|NCT02551822|20112163|P1|NOT COMPLETED|Overall Study||2
8158958|NCT02551822|20112162|P2|COMPLETED|Overall Study||10
8158959|NCT02551822|20112163|P1|COMPLETED|Overall Study||9
8158960|NCT02551822|20112162|P2|STARTED|Overall Study||12
8158961|NCT02551822|20112163|P1|STARTED|Overall Study||11
8158962|NCT02551809|20112176|P3|NOT COMPLETED|Overall Study||1
8158963|NCT02551809|20112177|P2|NOT COMPLETED|Overall Study||1
8158964|NCT02551809|20112178|P1|NOT COMPLETED|Overall Study||0
8158965|NCT02551809|20112176|P3|COMPLETED|Overall Study||13
8158966|NCT02551809|20112177|P2|COMPLETED|Overall Study||14
8158967|NCT02551809|20112178|P1|COMPLETED|Overall Study||14
8158968|NCT02551809|20112176|P3|STARTED|Overall Study||14
8158969|NCT02551809|20112177|P2|STARTED|Overall Study||15
8158970|NCT02551809|20112178|P1|STARTED|Overall Study||14
8158971|NCT02551770|20112186|P2|NOT COMPLETED|Overall Study||3
8158972|NCT02551770|20112187|P1|NOT COMPLETED|Overall Study||3
8158973|NCT02551770|20112186|P2|COMPLETED|Overall Study||48
8158974|NCT02551770|20112187|P1|COMPLETED|Overall Study||48
8158975|NCT02551770|20112186|P2|STARTED|Overall Study||51
8158976|NCT02551770|20112187|P1|STARTED|Overall Study||51
8158977|NCT02551757|20112206|P2|NOT COMPLETED|Overall Study||3
8158978|NCT02551757|20112207|P1|NOT COMPLETED|Overall Study||7
8158979|NCT02551757|20112206|P2|COMPLETED|Overall Study||17
8158980|NCT02551757|20112207|P1|COMPLETED|Overall Study||13
8158981|NCT02551757|20112206|P2|STARTED|Overall Study||20
8158982|NCT02551757|20112207|P1|STARTED|Overall Study||20
8158983|NCT02551744|20112219|P2|NOT COMPLETED|Overall Study||0
8158984|NCT02551744|20112220|P1|NOT COMPLETED|Overall Study||0
8158985|NCT02551744|20112219|P2|COMPLETED|Overall Study||51
8158986|NCT02551744|20112220|P1|COMPLETED|Overall Study||50
8158987|NCT02551744|20112219|P2|STARTED|Overall Study||51
8158988|NCT02551744|20112220|P1|STARTED|Overall Study||50
8158989|NCT02551731|20112226|P1|NOT COMPLETED|Overall Study||2
8158990|NCT02551731|20112226|P1|COMPLETED|Overall Study||7
8158991|NCT02551731|20112226|P1|STARTED|Overall Study||9
8158992|NCT02551692|20112246|P3|NOT COMPLETED|Overall Study||5
8158993|NCT02551692|20112247|P2|NOT COMPLETED|Overall Study||1
8158994|NCT02551692|20112248|P1|NOT COMPLETED|Overall Study||1
8158995|NCT02551692|20112246|P3|COMPLETED|Overall Study||25
8158996|NCT02551692|20112247|P2|COMPLETED|Overall Study||26
8158997|NCT02551692|20112248|P1|COMPLETED|Overall Study||30
8158998|NCT02551692|20112246|P3|STARTED|Overall Study||30
8158999|NCT02551692|20112247|P2|STARTED|Overall Study||27
8159000|NCT02551692|20112248|P1|STARTED|Overall Study||31
8159001|NCT02551666|20112264|P2|NOT COMPLETED|Overall Study||3
8159002|NCT02551666|20112265|P1|NOT COMPLETED|Overall Study||1
8159003|NCT02551666|20112264|P2|COMPLETED|Overall Study||16
8159004|NCT02551666|20112265|P1|COMPLETED|Overall Study||15
8159005|NCT02551666|20112264|P2|STARTED|Overall Study||19
8159006|NCT02551666|20112265|P1|STARTED|Overall Study||16
8159007|NCT02551653|20112293|P2|NOT COMPLETED|Overall Study||0
8159008|NCT02551653|20112294|P1|NOT COMPLETED|Overall Study||0
8159009|NCT02551653|20112293|P2|COMPLETED|Overall Study||5
8159010|NCT02551653|20112294|P1|COMPLETED|Overall Study||5
8159011|NCT02551653|20112293|P2|STARTED|Overall Study||5
8159012|NCT02551653|20112294|P1|STARTED|Overall Study||5
8159013|NCT02551432|20112302|P1|NOT COMPLETED|Overall Study||0
8159014|NCT02551432|20112302|P1|COMPLETED|Overall Study||26
8159015|NCT02551432|20112302|P1|STARTED|Overall Study||26
8159016|NCT02551224|20112308|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
8159017|NCT02551224|20112309|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
8159018|NCT02551224|20112308|P2|COMPLETED|Second Intervention (5 Min After First )||50
8159019|NCT02551224|20112309|P1|COMPLETED|Second Intervention (5 Min After First )||50
8159020|NCT02551224|20112308|P2|STARTED|Second Intervention (5 Min After First )||50
8159021|NCT02551224|20112309|P1|STARTED|Second Intervention (5 Min After First )||50
8159022|NCT02551224|20112308|P2|NOT COMPLETED|First Intervention||0
8159023|NCT02551224|20112309|P1|NOT COMPLETED|First Intervention||0
8159024|NCT02551224|20112308|P2|COMPLETED|First Intervention||50
8159025|NCT02551224|20112309|P1|COMPLETED|First Intervention||50
8159026|NCT02551224|20112308|P2|STARTED|First Intervention||50
8159027|NCT02551224|20112309|P1|STARTED|First Intervention||50
8159028|NCT02551094|20112319|P2|NOT COMPLETED|Overall Study||147
8159029|NCT02551094|20112320|P1|NOT COMPLETED|Overall Study||140
8159030|NCT02551094|20112319|P2|COMPLETED|Overall Study||2232
8159031|NCT02551094|20112320|P1|COMPLETED|Overall Study||2226
8159032|NCT02551094|20112319|P2|STARTED|Overall Study||2379
8159033|NCT02551094|20112320|P1|STARTED|Overall Study||2366
8159034|NCT02551055|20112355|P8|NOT COMPLETED|Overall Study||0
8159035|NCT02551055|20112356|P7|NOT COMPLETED|Overall Study||3
8159036|NCT02551055|20112357|P6|NOT COMPLETED|Overall Study||1
8159037|NCT02551055|20112358|P5|NOT COMPLETED|Overall Study||7
8159038|NCT02551055|20112359|P4|NOT COMPLETED|Overall Study||5
8159039|NCT02551055|20112360|P3|NOT COMPLETED|Overall Study||2
8159040|NCT02551055|20112361|P2|NOT COMPLETED|Overall Study||6
8159041|NCT02551055|20112362|P1|NOT COMPLETED|Overall Study||4
8159042|NCT02551055|20112355|P8|COMPLETED|Overall Study||0
8159043|NCT02551055|20112356|P7|COMPLETED|Overall Study||1
8159044|NCT02551055|20112357|P6|COMPLETED|Overall Study||1
8159045|NCT02551055|20112358|P5|COMPLETED|Overall Study||0
8159046|NCT02551055|20112359|P4|COMPLETED|Overall Study||1
8159047|NCT02551055|20112360|P3|COMPLETED|Overall Study||1
8159048|NCT02551055|20112361|P2|COMPLETED|Overall Study||0
8159049|NCT02551055|20112362|P1|COMPLETED|Overall Study||0
8159050|NCT02551055|20112355|P8|STARTED|Overall Study||0
8159051|NCT02551055|20112356|P7|STARTED|Overall Study||4
8159052|NCT02551055|20112357|P6|STARTED|Overall Study||2
8159053|NCT02551055|20112358|P5|STARTED|Overall Study||7
8159054|NCT02551055|20112359|P4|STARTED|Overall Study||6
8159055|NCT02551055|20112360|P3|STARTED|Overall Study||3
8159056|NCT02551055|20112361|P2|STARTED|Overall Study||6
8159057|NCT02551055|20112362|P1|STARTED|Overall Study||4
8159058|NCT02550873|20112437|P3|NOT COMPLETED|Open Label Extension||111
8159059|NCT02550873|20112438|P2|NOT COMPLETED|Open Label Extension||0
8159060|NCT02550873|20112439|P1|NOT COMPLETED|Open Label Extension||0
8159061|NCT02550873|20112437|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
8159062|NCT02550873|20112438|P2|COMPLETED|Open Label Extension||0
8159063|NCT02550873|20112439|P1|COMPLETED|Open Label Extension||0
8159064|NCT02550873|20112437|P3|STARTED|Open Label Extension||111
8159065|NCT02550873|20112438|P2|STARTED|Open Label Extension||0
8159066|NCT02550873|20112439|P1|STARTED|Open Label Extension||0
8159067|NCT02550873|20112437|P3|NOT COMPLETED|Randomized Double Blind||0
8159068|NCT02550873|20112438|P2|NOT COMPLETED|Randomized Double Blind||2
8159069|NCT02550873|20112439|P1|NOT COMPLETED|Randomized Double Blind||4
8159070|NCT02550873|20112437|P3|COMPLETED|Randomized Double Blind||0
8159071|NCT02550873|20112438|P2|COMPLETED|Randomized Double Blind||37
8159072|NCT02550873|20112439|P1|COMPLETED|Randomized Double Blind||74
8159073|NCT02550873|20112437|P3|Continue to Open Label Extension|Randomized Double Blind||0
8159074|NCT02550873|20112438|P2|Continue to Open Label Extension|Randomized Double Blind||37
8159075|NCT02550873|20112439|P1|Continue to Open Label Extension|Randomized Double Blind||74
8159076|NCT02550873|20112437|P3|Received Treatment|Randomized Double Blind||0
8159077|NCT02550873|20112438|P2|Received Treatment|Randomized Double Blind||39
8159078|NCT02550873|20112439|P1|Received Treatment|Randomized Double Blind||77
8159079|NCT02550873|20112437|P3|STARTED|Randomized Double Blind||0
8159080|NCT02550873|20112438|P2|STARTED|Randomized Double Blind||39
8159081|NCT02550873|20112439|P1|STARTED|Randomized Double Blind||78
8159082|NCT02550795|20112520|P3|NOT COMPLETED|Overall Study||0
8159083|NCT02550795|20112521|P2|NOT COMPLETED|Overall Study||1
8159084|NCT02550795|20112522|P1|NOT COMPLETED|Overall Study||0
8159085|NCT02550795|20112520|P3|COMPLETED|Overall Study||50
8159086|NCT02550795|20112521|P2|COMPLETED|Overall Study||49
8159087|NCT02550795|20112522|P1|COMPLETED|Overall Study||50
8159088|NCT02550795|20112520|P3|STARTED|Overall Study||50
8159089|NCT02550795|20112521|P2|STARTED|Overall Study||50
8159090|NCT02550795|20112522|P1|STARTED|Overall Study||50
8159091|NCT02550652|20112538|P2|NOT COMPLETED|Overall Study||62
8159092|NCT02550652|20112539|P1|NOT COMPLETED|Overall Study||63
8159093|NCT02550652|20112538|P2|COMPLETED|Overall Study||0
8159094|NCT02550652|20112539|P1|COMPLETED|Overall Study||0
8159095|NCT02550652|20112538|P2|STARTED|Overall Study||62
8159096|NCT02550652|20112539|P1|STARTED|Overall Study||63
8159097|NCT02550288|20112586|P5|NOT COMPLETED|Overall Study||3
8159098|NCT02550288|20112587|P4|NOT COMPLETED|Overall Study||3
8159099|NCT02550288|20112588|P3|NOT COMPLETED|Overall Study||1
8159100|NCT02550288|20112589|P2|NOT COMPLETED|Overall Study||3
8159101|NCT02550288|20112590|P1|NOT COMPLETED|Overall Study||2
8159102|NCT02550288|20112586|P5|COMPLETED|Overall Study||66
8159103|NCT02550288|20112587|P4|COMPLETED|Overall Study||65
8159104|NCT02550288|20112588|P3|COMPLETED|Overall Study||68
8159105|NCT02550288|20112589|P2|COMPLETED|Overall Study||65
8159106|NCT02550288|20112590|P1|COMPLETED|Overall Study||33
8159107|NCT02550288|20112586|P5|STARTED|Overall Study||69
8159108|NCT02550288|20112587|P4|STARTED|Overall Study||68
8159109|NCT02550288|20112588|P3|STARTED|Overall Study||69
8159110|NCT02550288|20112589|P2|STARTED|Overall Study||68
8159111|NCT02550288|20112590|P1|STARTED|Overall Study||35
8159112|NCT02550210|20112687|P1|NOT COMPLETED|Overall Study||4
8159113|NCT02550210|20112687|P1|COMPLETED|Overall Study||19
8159114|NCT02550210|20112687|P1|STARTED|Overall Study||23
8159115|NCT02550197|20112696|P2|NOT COMPLETED|Overall Study||0
8159116|NCT02550197|20112697|P1|NOT COMPLETED|Overall Study||0
8159117|NCT02550197|20112696|P2|COMPLETED|Overall Study||100
8159118|NCT02550197|20112697|P1|COMPLETED|Overall Study||200
8159119|NCT02550197|20112696|P2|STARTED|Overall Study||100
8159120|NCT02550197|20112697|P1|STARTED|Overall Study||200
8159121|NCT02550132|20112715|P1|NOT COMPLETED|Overall Study||0
8159122|NCT02550132|20112715|P1|COMPLETED|Overall Study||25
8159123|NCT02550132|20112715|P1|STARTED|Overall Study||25
8159124|NCT02550106|20112746|P1|NOT COMPLETED|Overall Study||12
8159125|NCT02550106|20112746|P1|COMPLETED|Overall Study||124
8159126|NCT02550106|20112746|P1|STARTED|Overall Study||136
8159127|NCT02549859|20112770|P1|NOT COMPLETED|Visit 2||0
8159128|NCT02549859|20112770|P1|COMPLETED|Visit 2||10
8159129|NCT02549859|20112770|P1|STARTED|Visit 2||10
8159130|NCT02549859|20112770|P1|NOT COMPLETED|Long-term 60 Hz DBS||1
8159131|NCT02549859|20112770|P1|COMPLETED|Long-term 60 Hz DBS||10
8159132|NCT02549859|20112770|P1|STARTED|Long-term 60 Hz DBS||11
8159133|NCT02549859|20112770|P1|NOT COMPLETED|Visit 1||0
8159134|NCT02549859|20112770|P1|COMPLETED|Visit 1||11
8159135|NCT02549859|20112770|P1|STARTED|Visit 1||11
8159136|NCT02549755|20112835|P1|NOT COMPLETED|Overall Study||1
8159137|NCT02549755|20112835|P1|COMPLETED|Overall Study||0
8159138|NCT02549755|20112835|P1|STARTED|Overall Study||1
8159139|NCT02549716|20112841|P2|NOT COMPLETED|Overall Study||0
8159140|NCT02549716|20112842|P1|NOT COMPLETED|Overall Study||0
8159141|NCT02549716|20112841|P2|COMPLETED|Overall Study||2
8159142|NCT02549716|20112842|P1|COMPLETED|Overall Study||1
8159143|NCT02549716|20112841|P2|STARTED|Overall Study||2
8159144|NCT02549716|20112842|P1|STARTED|Overall Study||1
8159145|NCT02549573|20112856|P2|NOT COMPLETED|Overall Study||3
8159146|NCT02549573|20112857|P1|NOT COMPLETED|Overall Study||0
8159147|NCT02549573|20112856|P2|COMPLETED|Overall Study||4
8159148|NCT02549573|20112857|P1|COMPLETED|Overall Study||6
8159149|NCT02549573|20112856|P2|STARTED|Overall Study||7
8159150|NCT02549573|20112857|P1|STARTED|Overall Study||6
8159151|NCT02549508|20112901|P2|NOT COMPLETED|Overall Study||17
8159152|NCT02549508|20112902|P1|NOT COMPLETED|Overall Study||14
8159153|NCT02549508|20112901|P2|COMPLETED|Overall Study||21
8159154|NCT02549508|20112902|P1|COMPLETED|Overall Study||33
8159155|NCT02549508|20112901|P2|STARTED|Overall Study||38
8159156|NCT02549508|20112902|P1|STARTED|Overall Study||47
8159157|NCT02549365|20112914|P2|NOT COMPLETED|Overall Study||0
8159158|NCT02549365|20112915|P1|NOT COMPLETED|Overall Study||0
8159159|NCT02549365|20112914|P2|COMPLETED|Overall Study||112
8159160|NCT02549365|20112915|P1|COMPLETED|Overall Study||164
8159161|NCT02549365|20112914|P2|STARTED|Overall Study||112
8159162|NCT02549365|20112915|P1|STARTED|Overall Study||164
8159163|NCT02549352|20112924|P2|NOT COMPLETED|12-month Follow-up||12
8159164|NCT02549352|20112925|P1|NOT COMPLETED|12-month Follow-up||8
8159165|NCT02549352|20112924|P2|COMPLETED|12-month Follow-up||81
8159166|NCT02549352|20112925|P1|COMPLETED|12-month Follow-up||199
8159167|NCT02549352|20112924|P2|STARTED|12-month Follow-up||93
8159168|NCT02549352|20112925|P1|STARTED|12-month Follow-up||207
8159169|NCT02549352|20112924|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
8159170|NCT02549352|20112925|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
8159171|NCT02549352|20112924|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
8159172|NCT02549352|20112925|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
8159173|NCT02549352|20112924|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
8159174|NCT02549352|20112925|P1|Treated|3-day Treatment and 8-week Follow-up||209
8159175|NCT02549352|20112924|P2|STARTED|3-day Treatment and 8-week Follow-up||102
8159176|NCT02549352|20112925|P1|STARTED|3-day Treatment and 8-week Follow-up||209
8159177|NCT02549339|20112941|P2|NOT COMPLETED|12-month Follow-up||11
8159178|NCT02549339|20112942|P1|NOT COMPLETED|12-month Follow-up||9
8159179|NCT02549339|20112941|P2|COMPLETED|12-month Follow-up||87
8159180|NCT02549339|20112942|P1|COMPLETED|12-month Follow-up||192
8159181|NCT02549339|20112941|P2|STARTED|12-month Follow-up||98
8159182|NCT02549339|20112942|P1|STARTED|12-month Follow-up||201
8159183|NCT02549339|20112941|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
8159184|NCT02549339|20112942|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
8159185|NCT02549339|20112941|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
8159186|NCT02549339|20112942|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
8159187|NCT02549339|20112941|P2|Treated|3-day Treatment and 8-week Follow-up||104
8159188|NCT02549339|20112942|P1|Treated|3-day Treatment and 8-week Follow-up||202
8159189|NCT02549339|20112941|P2|STARTED|3-day Treatment and 8-week Follow-up||104
8159190|NCT02549339|20112942|P1|STARTED|3-day Treatment and 8-week Follow-up||205
8159191|NCT02549287|20112958|P2|NOT COMPLETED|Overall Study||32
8159192|NCT02549287|20112959|P1|NOT COMPLETED|Overall Study||80
8159193|NCT02549287|20112958|P2|COMPLETED|Overall Study||64
8159194|NCT02549287|20112959|P1|COMPLETED|Overall Study||113
8159195|NCT02549287|20112958|P2|STARTED|Overall Study||96
8159196|NCT02549287|20112959|P1|STARTED|Overall Study||193
8159197|NCT02549196|20112993|P4|NOT COMPLETED|Overall Study||1
8159198|NCT02549196|20112994|P3|NOT COMPLETED|Overall Study||1
8159199|NCT02549196|20112995|P2|NOT COMPLETED|Overall Study||0
8159200|NCT02549196|20112996|P1|NOT COMPLETED|Overall Study||1
8159201|NCT02549196|20112993|P4|COMPLETED|Overall Study||12
8159202|NCT02549196|20112994|P3|COMPLETED|Overall Study||5
8159203|NCT02549196|20112995|P2|COMPLETED|Overall Study||1
8159204|NCT02549196|20112996|P1|COMPLETED|Overall Study||7
8159205|NCT02549196|20112993|P4|STARTED|Overall Study||13
8159206|NCT02549196|20112994|P3|STARTED|Overall Study||6
8159207|NCT02549196|20112995|P2|STARTED|Overall Study||1
8159208|NCT02549196|20112996|P1|STARTED|Overall Study||8
8159209|NCT02549040|20113010|P1|NOT COMPLETED|Period 5||0
8159210|NCT02549040|20113010|P1|COMPLETED|Period 5||16
8159211|NCT02549040|20113010|P1|STARTED|Period 5||16
8159212|NCT02549040|20113010|P1|NOT COMPLETED|Period 4||0
8159213|NCT02549040|20113010|P1|COMPLETED|Period 4||16
8159214|NCT02549040|20113010|P1|STARTED|Period 4||16
8159215|NCT02549040|20113010|P1|NOT COMPLETED|Period 3||0
8159216|NCT02549040|20113010|P1|COMPLETED|Period 3||16
8159217|NCT02549040|20113010|P1|STARTED|Period 3||16
8159218|NCT02549040|20113010|P1|NOT COMPLETED|Period 2||0
8159219|NCT02549040|20113010|P1|COMPLETED|Period 2||16
8159220|NCT02549040|20113010|P1|STARTED|Period 2||16
8159221|NCT02549040|20113010|P1|NOT COMPLETED|Period 1||0
8159222|NCT02549040|20113010|P1|COMPLETED|Period 1||16
8159223|NCT02549040|20113010|P1|STARTED|Period 1||16
8159224|NCT02549027|20113052|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159225|NCT02549027|20113053|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
8159226|NCT02549027|20113054|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159227|NCT02549027|20113055|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159228|NCT02549027|20113056|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159229|NCT02549027|20113057|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159230|NCT02549027|20113052|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
8159231|NCT02549027|20113053|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
8159232|NCT02549027|20113054|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159233|NCT02549027|20113055|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159234|NCT02549027|20113056|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159235|NCT02549027|20113057|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159236|NCT02549027|20113052|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
8159237|NCT02549027|20113053|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
8159238|NCT02549027|20113054|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8159239|NCT02549027|20113055|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8159240|NCT02549027|20113056|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8159241|NCT02549027|20113057|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
8159242|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 4||0
8159243|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 4||0
8159244|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 4||1
8159245|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 4||1
8159246|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 4||1
8159247|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 4||0
8159248|NCT02549027|20113052|P6|COMPLETED|Washout After Period 4||0
8159249|NCT02549027|20113053|P5|COMPLETED|Washout After Period 4||0
8159250|NCT02549027|20113054|P4|COMPLETED|Washout After Period 4||4
8159251|NCT02549027|20113055|P3|COMPLETED|Washout After Period 4||4
8159252|NCT02549027|20113056|P2|COMPLETED|Washout After Period 4||4
8159253|NCT02549027|20113057|P1|COMPLETED|Washout After Period 4||5
8159254|NCT02549027|20113052|P6|STARTED|Washout After Period 4||0
8159255|NCT02549027|20113053|P5|STARTED|Washout After Period 4||0
8159256|NCT02549027|20113054|P4|STARTED|Washout After Period 4||5
8159257|NCT02549027|20113055|P3|STARTED|Washout After Period 4||5
8159258|NCT02549027|20113056|P2|STARTED|Washout After Period 4||5
8159259|NCT02549027|20113057|P1|STARTED|Washout After Period 4||5
8159260|NCT02549027|20113052|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159261|NCT02549027|20113053|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159262|NCT02549027|20113054|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159263|NCT02549027|20113055|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159264|NCT02549027|20113056|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159265|NCT02549027|20113057|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159266|NCT02549027|20113052|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
8159267|NCT02549027|20113053|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
8159268|NCT02549027|20113054|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159269|NCT02549027|20113055|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159270|NCT02549027|20113056|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159271|NCT02549027|20113057|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159272|NCT02549027|20113052|P6|STARTED|Period 4 - MK-1064 or Placebo||0
8159273|NCT02549027|20113053|P5|STARTED|Period 4 - MK-1064 or Placebo||0
8159274|NCT02549027|20113054|P4|STARTED|Period 4 - MK-1064 or Placebo||5
8159275|NCT02549027|20113055|P3|STARTED|Period 4 - MK-1064 or Placebo||5
8159276|NCT02549027|20113056|P2|STARTED|Period 4 - MK-1064 or Placebo||5
8159277|NCT02549027|20113057|P1|STARTED|Period 4 - MK-1064 or Placebo||5
8159278|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 3||0
8159279|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 3||0
8159280|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 3||0
8159281|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 3||0
8159282|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 3||0
8159283|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 3||0
8159284|NCT02549027|20113052|P6|COMPLETED|Washout After Period 3||0
8159285|NCT02549027|20113053|P5|COMPLETED|Washout After Period 3||0
8159286|NCT02549027|20113054|P4|COMPLETED|Washout After Period 3||5
8159287|NCT02549027|20113055|P3|COMPLETED|Washout After Period 3||5
8159288|NCT02549027|20113056|P2|COMPLETED|Washout After Period 3||5
8159289|NCT02549027|20113057|P1|COMPLETED|Washout After Period 3||5
8159290|NCT02549027|20113052|P6|STARTED|Washout After Period 3||0
8159291|NCT02549027|20113053|P5|STARTED|Washout After Period 3||0
8159292|NCT02549027|20113054|P4|STARTED|Washout After Period 3||5
8159293|NCT02549027|20113055|P3|STARTED|Washout After Period 3||5
8159294|NCT02549027|20113056|P2|STARTED|Washout After Period 3||5
8159295|NCT02549027|20113057|P1|STARTED|Washout After Period 3||5
8159296|NCT02549027|20113052|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159297|NCT02549027|20113053|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159298|NCT02549027|20113054|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159299|NCT02549027|20113055|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159300|NCT02549027|20113056|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159301|NCT02549027|20113057|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159302|NCT02549027|20113052|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
8159303|NCT02549027|20113053|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
8159304|NCT02549027|20113054|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159305|NCT02549027|20113055|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159306|NCT02549027|20113056|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159307|NCT02549027|20113057|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159308|NCT02549027|20113052|P6|STARTED|Period 3 - MK-1064 or Placebo||0
8159309|NCT02549027|20113053|P5|STARTED|Period 3 - MK-1064 or Placebo||0
8159310|NCT02549027|20113054|P4|STARTED|Period 3 - MK-1064 or Placebo||5
8159311|NCT02549027|20113055|P3|STARTED|Period 3 - MK-1064 or Placebo||5
8159312|NCT02549027|20113056|P2|STARTED|Period 3 - MK-1064 or Placebo||5
8159313|NCT02549027|20113057|P1|STARTED|Period 3 - MK-1064 or Placebo||5
8159314|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 2||0
8159315|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 2||0
8159316|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 2||0
8159317|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 2||0
8159318|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 2||0
8159319|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 2||0
8159320|NCT02549027|20113052|P6|COMPLETED|Washout After Period 2||0
8159321|NCT02549027|20113053|P5|COMPLETED|Washout After Period 2||0
8159322|NCT02549027|20113054|P4|COMPLETED|Washout After Period 2||5
8159323|NCT02549027|20113055|P3|COMPLETED|Washout After Period 2||5
8159324|NCT02549027|20113056|P2|COMPLETED|Washout After Period 2||5
8159325|NCT02549027|20113057|P1|COMPLETED|Washout After Period 2||5
8159326|NCT02549027|20113052|P6|STARTED|Washout After Period 2||0
8159327|NCT02549027|20113053|P5|STARTED|Washout After Period 2||0
8159328|NCT02549027|20113054|P4|STARTED|Washout After Period 2||5
8159329|NCT02549027|20113055|P3|STARTED|Washout After Period 2||5
8159330|NCT02549027|20113056|P2|STARTED|Washout After Period 2||5
8159331|NCT02549027|20113057|P1|STARTED|Washout After Period 2||5
8159332|NCT02549027|20113052|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159333|NCT02549027|20113053|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159334|NCT02549027|20113054|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159335|NCT02549027|20113055|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159336|NCT02549027|20113056|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159337|NCT02549027|20113057|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159338|NCT02549027|20113052|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
8159339|NCT02549027|20113053|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
8159340|NCT02549027|20113054|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159341|NCT02549027|20113055|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159342|NCT02549027|20113056|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159343|NCT02549027|20113057|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159344|NCT02549027|20113052|P6|STARTED|Period 2 - MK-1064 or Placebo||0
8159345|NCT02549027|20113053|P5|STARTED|Period 2 - MK-1064 or Placebo||0
8159346|NCT02549027|20113054|P4|STARTED|Period 2 - MK-1064 or Placebo||5
8159347|NCT02549027|20113055|P3|STARTED|Period 2 - MK-1064 or Placebo||5
8159348|NCT02549027|20113056|P2|STARTED|Period 2 - MK-1064 or Placebo||5
8159349|NCT02549027|20113057|P1|STARTED|Period 2 - MK-1064 or Placebo||5
8159350|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 1||0
8159351|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 1||0
8159352|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 1||0
8159353|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 1||0
8159354|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 1||0
8159355|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 1||0
8159356|NCT02549027|20113052|P6|COMPLETED|Washout After Period 1||0
8159357|NCT02549027|20113053|P5|COMPLETED|Washout After Period 1||0
8159358|NCT02549027|20113054|P4|COMPLETED|Washout After Period 1||5
8159359|NCT02549027|20113055|P3|COMPLETED|Washout After Period 1||5
8159360|NCT02549027|20113056|P2|COMPLETED|Washout After Period 1||5
8159361|NCT02549027|20113057|P1|COMPLETED|Washout After Period 1||5
8159362|NCT02549027|20113052|P6|STARTED|Washout After Period 1||0
8159363|NCT02549027|20113053|P5|STARTED|Washout After Period 1||0
8159364|NCT02549027|20113054|P4|STARTED|Washout After Period 1||5
8159365|NCT02549027|20113055|P3|STARTED|Washout After Period 1||5
8159366|NCT02549027|20113056|P2|STARTED|Washout After Period 1||5
8159367|NCT02549027|20113057|P1|STARTED|Washout After Period 1||5
8159368|NCT02549027|20113052|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159369|NCT02549027|20113053|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159370|NCT02549027|20113054|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159371|NCT02549027|20113055|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159372|NCT02549027|20113056|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159373|NCT02549027|20113057|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159374|NCT02549027|20113052|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
8159375|NCT02549027|20113053|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
8159376|NCT02549027|20113054|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159377|NCT02549027|20113055|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159378|NCT02549027|20113056|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159379|NCT02549027|20113057|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159380|NCT02549027|20113052|P6|STARTED|Period 1 - MK-1064 or Placebo||0
8159381|NCT02549027|20113053|P5|STARTED|Period 1 - MK-1064 or Placebo||0
8159382|NCT02549027|20113054|P4|STARTED|Period 1 - MK-1064 or Placebo||5
8159383|NCT02549027|20113055|P3|STARTED|Period 1 - MK-1064 or Placebo||5
8159384|NCT02549027|20113056|P2|STARTED|Period 1 - MK-1064 or Placebo||5
8159385|NCT02549027|20113057|P1|STARTED|Period 1 - MK-1064 or Placebo||5
8159386|NCT02549014|20113094|P2|NOT COMPLETED|Overall Study||0
8159387|NCT02549014|20113095|P1|NOT COMPLETED|Overall Study||0
8159388|NCT02549014|20113094|P2|COMPLETED|Overall Study||8
8159389|NCT02549014|20113095|P1|COMPLETED|Overall Study||8
8159390|NCT02549014|20113094|P2|STARTED|Overall Study||8
8159391|NCT02549014|20113095|P1|STARTED|Overall Study||8
8159392|NCT02548962|20113187|P2|NOT COMPLETED|Overall Study||0
8159393|NCT02548962|20113188|P1|NOT COMPLETED|Overall Study||1
8159394|NCT02548962|20113187|P2|COMPLETED|Overall Study||3
8159395|NCT02548962|20113188|P1|COMPLETED|Overall Study||7
8159396|NCT02548962|20113187|P2|STARTED|Overall Study||3
8159397|NCT02548962|20113188|P1|STARTED|Overall Study||8
8159398|NCT02548845|20113198|P1|NOT COMPLETED|Overall Study||0
8159399|NCT02548845|20113198|P1|COMPLETED|Overall Study||70
8159400|NCT02548845|20113198|P1|STARTED|Overall Study||70
8159401|NCT02548754|20113212|P2|NOT COMPLETED|Overall Study||4
8159402|NCT02548754|20113213|P1|NOT COMPLETED|Overall Study||2
8159403|NCT02548754|20113212|P2|COMPLETED|Overall Study||23
8159404|NCT02548754|20113213|P1|COMPLETED|Overall Study||24
8159405|NCT02548754|20113212|P2|STARTED|Overall Study||27
8159406|NCT02548754|20113213|P1|STARTED|Overall Study||26
8159407|NCT02548728|20113225|P2|NOT COMPLETED|Overall Study||0
8159408|NCT02548728|20113226|P1|NOT COMPLETED|Overall Study||0
8159409|NCT02548728|20113225|P2|COMPLETED|Overall Study||6
8159410|NCT02548728|20113226|P1|COMPLETED|Overall Study||6
8159411|NCT02548728|20113225|P2|STARTED|Overall Study||6
8159412|NCT02548728|20113226|P1|STARTED|Overall Study||6
8159413|NCT02548650|20113240|P2|NOT COMPLETED|Double Therapy||2
8159414|NCT02548650|20113241|P1|NOT COMPLETED|Double Therapy||1
8159415|NCT02548650|20113240|P2|COMPLETED|Double Therapy||30
8159416|NCT02548650|20113241|P1|COMPLETED|Double Therapy||28
8159417|NCT02548650|20113240|P2|STARTED|Double Therapy||32
8159418|NCT02548650|20113241|P1|STARTED|Double Therapy||29
8159419|NCT02548650|20113240|P2|NOT COMPLETED|Triple Therapy||4
8159420|NCT02548650|20113241|P1|NOT COMPLETED|Triple Therapy||1
8159421|NCT02548650|20113240|P2|COMPLETED|Triple Therapy||32
8159422|NCT02548650|20113241|P1|COMPLETED|Triple Therapy||29
8159423|NCT02548650|20113240|P2|STARTED|Triple Therapy||36
8159424|NCT02548650|20113241|P1|STARTED|Triple Therapy||30
8159425|NCT02548585|20113256|P7|NOT COMPLETED|Overall Study||1
8159426|NCT02548585|20113257|P6|NOT COMPLETED|Overall Study||2
8159427|NCT02548585|20113258|P5|NOT COMPLETED|Overall Study||3
8159428|NCT02548585|20113259|P4|NOT COMPLETED|Overall Study||2
8159429|NCT02548585|20113260|P3|NOT COMPLETED|Overall Study||0
8159430|NCT02548585|20113261|P2|NOT COMPLETED|Overall Study||0
8159431|NCT02548585|20113262|P1|NOT COMPLETED|Overall Study||2
8159432|NCT02548585|20113256|P7|COMPLETED|Overall Study||11
8159433|NCT02548585|20113257|P6|COMPLETED|Overall Study||10
8159434|NCT02548585|20113258|P5|COMPLETED|Overall Study||22
8159435|NCT02548585|20113259|P4|COMPLETED|Overall Study||5
8159436|NCT02548585|20113260|P3|COMPLETED|Overall Study||6
8159437|NCT02548585|20113261|P2|COMPLETED|Overall Study||6
8159438|NCT02548585|20113262|P1|COMPLETED|Overall Study||43
8159439|NCT02548585|20113256|P7|Treated|Overall Study||12
8159440|NCT02548585|20113257|P6|Treated|Overall Study||11
8159441|NCT02548585|20113258|P5|Treated|Overall Study||25
8159442|NCT02548585|20113259|P4|Treated|Overall Study||7
8159443|NCT02548585|20113260|P3|Treated|Overall Study||6
8159444|NCT02548585|20113261|P2|Treated|Overall Study||6
8159445|NCT02548585|20113262|P1|Treated|Overall Study||45
8159446|NCT02548585|20113256|P7|STARTED|Overall Study||12
8159447|NCT02548585|20113257|P6|STARTED|Overall Study||12
8159448|NCT02548585|20113258|P5|STARTED|Overall Study||25
8159449|NCT02548585|20113259|P4|STARTED|Overall Study||7
8159450|NCT02548585|20113260|P3|STARTED|Overall Study||6
8159451|NCT02548585|20113261|P2|STARTED|Overall Study||6
8159452|NCT02548585|20113262|P1|STARTED|Overall Study||45
8159453|NCT02548455|20113480|P1|NOT COMPLETED|Overall Study||240
8159454|NCT02548455|20113480|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
8159455|NCT02548455|20113480|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
8159456|NCT02548455|20113480|P1|Completed 6-Month Follow-up|Overall Study||259
8159457|NCT02548455|20113480|P1|Completed Pre-Discharge|Overall Study||484
8159458|NCT02548455|20113480|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
8159459|NCT02548312|20113492|P8|NOT COMPLETED|Overall Study||42
8159460|NCT02548312|20113493|P7|NOT COMPLETED|Overall Study||40
8159461|NCT02548312|20113494|P6|NOT COMPLETED|Overall Study||40
8159462|NCT02548312|20113495|P5|NOT COMPLETED|Overall Study||34
8159463|NCT02548312|20113496|P4|NOT COMPLETED|Overall Study||46
8159464|NCT02548312|20113497|P3|NOT COMPLETED|Overall Study||38
8159465|NCT02548312|20113498|P2|NOT COMPLETED|Overall Study||43
8159466|NCT02548312|20113499|P1|NOT COMPLETED|Overall Study||33
8159467|NCT02548312|20113492|P8|COMPLETED|Overall Study||91
8159468|NCT02548312|20113493|P7|COMPLETED|Overall Study||93
8159469|NCT02548312|20113494|P6|COMPLETED|Overall Study||93
8159470|NCT02548312|20113495|P5|COMPLETED|Overall Study||99
8159471|NCT02548312|20113496|P4|COMPLETED|Overall Study||87
8159472|NCT02548312|20113497|P3|COMPLETED|Overall Study||96
8159473|NCT02548312|20113498|P2|COMPLETED|Overall Study||90
8159474|NCT02548312|20113499|P1|COMPLETED|Overall Study||100
8159475|NCT02548312|20113492|P8|STARTED|Overall Study||133
8159476|NCT02548312|20113493|P7|STARTED|Overall Study||133
8159477|NCT02548312|20113494|P6|STARTED|Overall Study||133
8159478|NCT02548312|20113495|P5|STARTED|Overall Study||133
8159479|NCT02548312|20113496|P4|STARTED|Overall Study||133
8159480|NCT02548312|20113497|P3|STARTED|Overall Study||134
8159481|NCT02548312|20113498|P2|STARTED|Overall Study||133
8159482|NCT02548312|20113499|P1|STARTED|Overall Study||133
8159483|NCT02548156|20113541|P6|NOT COMPLETED|Period 3||0
8159484|NCT02548156|20113542|P5|NOT COMPLETED|Period 3||0
8159485|NCT02548156|20113543|P4|NOT COMPLETED|Period 3||0
8159486|NCT02548156|20113544|P3|NOT COMPLETED|Period 3||0
8159487|NCT02548156|20113545|P2|NOT COMPLETED|Period 3||0
8159488|NCT02548156|20113546|P1|NOT COMPLETED|Period 3||0
8159489|NCT02548156|20113541|P6|COMPLETED|Period 3||5
8159490|NCT02548156|20113542|P5|COMPLETED|Period 3||4
8159491|NCT02548156|20113543|P4|COMPLETED|Period 3||5
8159492|NCT02548156|20113544|P3|COMPLETED|Period 3||4
8159493|NCT02548156|20113545|P2|COMPLETED|Period 3||5
8159494|NCT02548156|20113546|P1|COMPLETED|Period 3||5
8159495|NCT02548156|20113541|P6|STARTED|Period 3||5
8159496|NCT02548156|20113542|P5|STARTED|Period 3||4
8159497|NCT02548156|20113543|P4|STARTED|Period 3||5
8159498|NCT02548156|20113544|P3|STARTED|Period 3||4
8159499|NCT02548156|20113545|P2|STARTED|Period 3||5
8159500|NCT02548156|20113546|P1|STARTED|Period 3||5
8159501|NCT02548156|20113541|P6|NOT COMPLETED|Washout Period 2||0
8159502|NCT02548156|20113542|P5|NOT COMPLETED|Washout Period 2||0
8159503|NCT02548156|20113543|P4|NOT COMPLETED|Washout Period 2||0
8159504|NCT02548156|20113544|P3|NOT COMPLETED|Washout Period 2||0
8159505|NCT02548156|20113545|P2|NOT COMPLETED|Washout Period 2||0
8159506|NCT02548156|20113546|P1|NOT COMPLETED|Washout Period 2||0
8159507|NCT02548156|20113541|P6|COMPLETED|Washout Period 2||5
8159508|NCT02548156|20113542|P5|COMPLETED|Washout Period 2||4
8159509|NCT02548156|20113543|P4|COMPLETED|Washout Period 2||5
8159510|NCT02548156|20113544|P3|COMPLETED|Washout Period 2||4
8159511|NCT02548156|20113545|P2|COMPLETED|Washout Period 2||5
8159512|NCT02548156|20113546|P1|COMPLETED|Washout Period 2||5
8159513|NCT02548156|20113541|P6|STARTED|Washout Period 2||5
8159514|NCT02548156|20113542|P5|STARTED|Washout Period 2||4
8159515|NCT02548156|20113543|P4|STARTED|Washout Period 2||5
8159516|NCT02548156|20113544|P3|STARTED|Washout Period 2||4
8159517|NCT02548156|20113545|P2|STARTED|Washout Period 2||5
8159518|NCT02548156|20113546|P1|STARTED|Washout Period 2||5
8159519|NCT02548156|20113541|P6|NOT COMPLETED|Period 2||0
8159520|NCT02548156|20113542|P5|NOT COMPLETED|Period 2||0
8159521|NCT02548156|20113543|P4|NOT COMPLETED|Period 2||0
8159522|NCT02548156|20113544|P3|NOT COMPLETED|Period 2||0
8159523|NCT02548156|20113545|P2|NOT COMPLETED|Period 2||0
8159524|NCT02548156|20113546|P1|NOT COMPLETED|Period 2||0
8159525|NCT02548156|20113541|P6|COMPLETED|Period 2||5
8159526|NCT02548156|20113542|P5|COMPLETED|Period 2||4
8159527|NCT02548156|20113543|P4|COMPLETED|Period 2||5
8159528|NCT02548156|20113544|P3|COMPLETED|Period 2||4
8159529|NCT02548156|20113545|P2|COMPLETED|Period 2||5
8159530|NCT02548156|20113546|P1|COMPLETED|Period 2||5
8159531|NCT02548156|20113541|P6|STARTED|Period 2||5
8159532|NCT02548156|20113542|P5|STARTED|Period 2||4
8159533|NCT02548156|20113543|P4|STARTED|Period 2||5
8159534|NCT02548156|20113544|P3|STARTED|Period 2||4
8159535|NCT02548156|20113545|P2|STARTED|Period 2||5
8159536|NCT02548156|20113546|P1|STARTED|Period 2||5
8159537|NCT02548156|20113541|P6|NOT COMPLETED|Washout Period 1||0
8159538|NCT02548156|20113542|P5|NOT COMPLETED|Washout Period 1||1
8159539|NCT02548156|20113543|P4|NOT COMPLETED|Washout Period 1||0
8159540|NCT02548156|20113544|P3|NOT COMPLETED|Washout Period 1||0
8159541|NCT02548156|20113545|P2|NOT COMPLETED|Washout Period 1||0
8159542|NCT02548156|20113546|P1|NOT COMPLETED|Washout Period 1||0
8159543|NCT02548156|20113541|P6|COMPLETED|Washout Period 1||5
8159544|NCT02548156|20113542|P5|COMPLETED|Washout Period 1||4
8159545|NCT02548156|20113543|P4|COMPLETED|Washout Period 1||5
8159546|NCT02548156|20113544|P3|COMPLETED|Washout Period 1||4
8159547|NCT02548156|20113545|P2|COMPLETED|Washout Period 1||5
8159548|NCT02548156|20113546|P1|COMPLETED|Washout Period 1||5
8159549|NCT02548156|20113541|P6|STARTED|Washout Period 1||5
8159550|NCT02548156|20113542|P5|STARTED|Washout Period 1||5
8159551|NCT02548156|20113543|P4|STARTED|Washout Period 1||5
8159552|NCT02548156|20113544|P3|STARTED|Washout Period 1||4
8159553|NCT02548156|20113545|P2|STARTED|Washout Period 1||5
8159554|NCT02548156|20113546|P1|STARTED|Washout Period 1||5
8159555|NCT02548156|20113541|P6|NOT COMPLETED|Period 1||0
8159556|NCT02548156|20113542|P5|NOT COMPLETED|Period 1||0
8159557|NCT02548156|20113543|P4|NOT COMPLETED|Period 1||0
8159558|NCT02548156|20113544|P3|NOT COMPLETED|Period 1||0
8159559|NCT02548156|20113545|P2|NOT COMPLETED|Period 1||0
8159560|NCT02548156|20113546|P1|NOT COMPLETED|Period 1||0
8159561|NCT02548156|20113541|P6|COMPLETED|Period 1||5
8159562|NCT02548156|20113542|P5|COMPLETED|Period 1||5
8159563|NCT02548156|20113543|P4|COMPLETED|Period 1||5
8159564|NCT02548156|20113544|P3|COMPLETED|Period 1||4
8159565|NCT02548156|20113545|P2|COMPLETED|Period 1||5
8159566|NCT02548156|20113546|P1|COMPLETED|Period 1||5
8159567|NCT02548156|20113541|P6|STARTED|Period 1||5
8159568|NCT02548156|20113542|P5|STARTED|Period 1||5
8159569|NCT02548156|20113543|P4|STARTED|Period 1||5
8159570|NCT02548156|20113544|P3|STARTED|Period 1||4
8159571|NCT02548156|20113545|P2|STARTED|Period 1||5
8159572|NCT02548156|20113546|P1|STARTED|Period 1||5
8159573|NCT02548143|20113565|P2|NOT COMPLETED|Overall Study||1
8159574|NCT02548143|20113566|P1|NOT COMPLETED|Overall Study||1
8159575|NCT02548143|20113565|P2|COMPLETED|Overall Study||5
8159576|NCT02548143|20113566|P1|COMPLETED|Overall Study||5
8159577|NCT02548143|20113565|P2|STARTED|Overall Study||6
8159578|NCT02548143|20113566|P1|STARTED|Overall Study||6
8159579|NCT02548078|20113578|P2|NOT COMPLETED|Overall Study||6
8159580|NCT02548078|20113579|P1|NOT COMPLETED|Overall Study||5
8159581|NCT02548078|20113578|P2|COMPLETED|Overall Study||294
8159582|NCT02548078|20113579|P1|COMPLETED|Overall Study||295
8159583|NCT02548078|20113578|P2|STARTED|Overall Study||300
8159584|NCT02548078|20113579|P1|STARTED|Overall Study||300
8159588|NCT02547974|20113775|P4|NOT COMPLETED|Overall Study||0
8159589|NCT02547974|20113776|P3|NOT COMPLETED|Overall Study||0
8159590|NCT02547974|20113777|P2|NOT COMPLETED|Overall Study||0
8159591|NCT02547974|20113778|P1|NOT COMPLETED|Overall Study||1
8159592|NCT02547974|20113775|P4|COMPLETED|Overall Study||44
8159593|NCT02547974|20113776|P3|COMPLETED|Overall Study||30
8159594|NCT02547974|20113777|P2|COMPLETED|Overall Study||31
8159595|NCT02547974|20113778|P1|COMPLETED|Overall Study||14
8159596|NCT02547974|20113775|P4|STARTED|Overall Study||44
8159597|NCT02547974|20113776|P3|STARTED|Overall Study||30
8159598|NCT02547974|20113777|P2|STARTED|Overall Study||31
8159599|NCT02547974|20113778|P1|STARTED|Overall Study||15
8159600|NCT02547935|20113865|P3|NOT COMPLETED|Overall Study||5
8159601|NCT02547935|20113866|P2|NOT COMPLETED|Overall Study||8
8159602|NCT02547935|20113867|P1|NOT COMPLETED|Overall Study||5
8159603|NCT02547935|20113865|P3|COMPLETED|Overall Study||143
8159604|NCT02547935|20113866|P2|COMPLETED|Overall Study||137
8159605|NCT02547935|20113867|P1|COMPLETED|Overall Study||150
8159606|NCT02547935|20113865|P3|Safety Analysis Set|Overall Study||148
8159607|NCT02547935|20113866|P2|Safety Analysis Set|Overall Study||145
8159608|NCT02547935|20113867|P1|Safety Analysis Set|Overall Study||152
8159609|NCT02547935|20113865|P3|Full Analysis Set|Overall Study||148
8159610|NCT02547935|20113866|P2|Full Analysis Set|Overall Study||144
8159611|NCT02547935|20113867|P1|Full Analysis Set|Overall Study||152
8159612|NCT02547935|20113865|P3|Received Treatment|Overall Study||148
8159613|NCT02547935|20113866|P2|Received Treatment|Overall Study||145
8159614|NCT02547935|20113867|P1|Received Treatment|Overall Study||152
8159615|NCT02547935|20113865|P3|STARTED|Overall Study||148
8159616|NCT02547935|20113866|P2|STARTED|Overall Study||145
8159617|NCT02547935|20113867|P1|STARTED|Overall Study||155
8159618|NCT02547779|20113896|P2|NOT COMPLETED|Overall Study||0
8159619|NCT02547779|20113897|P1|NOT COMPLETED|Overall Study||0
8159620|NCT02547779|20113896|P2|COMPLETED|Overall Study||5207
8159621|NCT02547779|20113897|P1|COMPLETED|Overall Study||5214
8159622|NCT02547779|20113896|P2|STARTED|Overall Study||5207
8159623|NCT02547779|20113897|P1|STARTED|Overall Study||5214
8159624|NCT02547766|20113905|P1|NOT COMPLETED|Overall Study||1
8159625|NCT02547766|20113905|P1|COMPLETED|Overall Study||9
8159626|NCT02547766|20113905|P1|STARTED|Overall Study||10
8159627|NCT02547714|20113912|P1|NOT COMPLETED|Overall Study||0
8159628|NCT02547714|20113912|P1|COMPLETED|Overall Study||34
8159629|NCT02547714|20113912|P1|STARTED|Overall Study||34
8159630|NCT02547649|20113925|P3|NOT COMPLETED|Overall Study||4
8159631|NCT02547649|20113926|P2|NOT COMPLETED|Overall Study||5
8159632|NCT02547649|20113927|P1|NOT COMPLETED|Overall Study||3
8159633|NCT02547649|20113925|P3|COMPLETED|Overall Study||224
8159634|NCT02547649|20113926|P2|COMPLETED|Overall Study||226
8159635|NCT02547649|20113927|P1|COMPLETED|Overall Study||228
8159636|NCT02547649|20113925|P3|Vaccinated|Overall Study||227
8159637|NCT02547649|20113926|P2|Vaccinated|Overall Study||231
8159638|NCT02547649|20113927|P1|Vaccinated|Overall Study||231
8159639|NCT02547649|20113925|P3|STARTED|Overall Study||228
8159640|NCT02547649|20113926|P2|STARTED|Overall Study||231
8159641|NCT02547649|20113927|P1|STARTED|Overall Study||231
8159642|NCT02547623|20113961|P2|NOT COMPLETED|Overall Study||3
8159643|NCT02547623|20113962|P1|NOT COMPLETED|Overall Study||4
8159644|NCT02547623|20113961|P2|COMPLETED|Overall Study||52
8159645|NCT02547623|20113962|P1|COMPLETED|Overall Study||122
8159646|NCT02547623|20113961|P2|STARTED|Overall Study||55
8159647|NCT02547623|20113962|P1|STARTED|Overall Study||126
8159648|NCT02547454|20113992|P1|NOT COMPLETED|Overall Study||172
8159649|NCT02547454|20113992|P1|COMPLETED|Overall Study||221
8159650|NCT02547454|20113992|P1|STARTED|Overall Study||393
8159651|NCT02547363|20114022|P2|NOT COMPLETED|12-month Follow-up||5
8159652|NCT02547363|20114023|P1|NOT COMPLETED|12-month Follow-up||10
8159653|NCT02547363|20114022|P2|COMPLETED|12-month Follow-up||81
8159654|NCT02547363|20114023|P1|COMPLETED|12-month Follow-up||194
8159655|NCT02547363|20114022|P2|STARTED|12-month Follow-up||86
8159656|NCT02547363|20114023|P1|STARTED|12-month Follow-up||204
8159657|NCT02547363|20114022|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
8159658|NCT02547363|20114023|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
8159659|NCT02547363|20114022|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
8159660|NCT02547363|20114023|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
8159661|NCT02547363|20114022|P2|Treated|3-day Treatment and 8-week Follow-up||104
8159662|NCT02547363|20114023|P1|Treated|3-day Treatment and 8-week Follow-up||209
8159663|NCT02547363|20114022|P2|STARTED|3-day Treatment and 8-week Follow-up||105
8159664|NCT02547363|20114023|P1|STARTED|3-day Treatment and 8-week Follow-up||211
8159665|NCT02547233|20114039|P2|NOT COMPLETED|12-month Follow-up||17
8159666|NCT02547233|20114040|P1|NOT COMPLETED|12-month Follow-up||14
8159667|NCT02547233|20114039|P2|COMPLETED|12-month Follow-up||67
8159668|NCT02547233|20114040|P1|COMPLETED|12-month Follow-up||185
8159669|NCT02547233|20114039|P2|STARTED|12-month Follow-up||84
8159670|NCT02547233|20114040|P1|STARTED|12-month Follow-up||199
8159671|NCT02547233|20114039|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
8159672|NCT02547233|20114040|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
8159673|NCT02547233|20114039|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
8159674|NCT02547233|20114040|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
8159675|NCT02547233|20114039|P2|Treated|3-day Treatment and 8-week Follow-up||100
8159676|NCT02547233|20114040|P1|Treated|3-day Treatment and 8-week Follow-up||205
8159677|NCT02547233|20114039|P2|STARTED|3-day Treatment and 8-week Follow-up||102
8159678|NCT02547233|20114040|P1|STARTED|3-day Treatment and 8-week Follow-up||205
8159679|NCT02547220|20114056|P2|NOT COMPLETED|Overall Study||20
8159680|NCT02547220|20114057|P1|NOT COMPLETED|Overall Study||19
8159681|NCT02547220|20114056|P2|COMPLETED|Overall Study||0
8159682|NCT02547220|20114057|P1|COMPLETED|Overall Study||0
8159683|NCT02547220|20114056|P2|STARTED|Overall Study||20
8159684|NCT02547220|20114057|P1|STARTED|Overall Study||19
8159685|NCT02547129|20114093|P2|NOT COMPLETED|Overall Study||0
8159686|NCT02547129|20114094|P1|NOT COMPLETED|Overall Study||1
8159687|NCT02547129|20114093|P2|COMPLETED|Overall Study||2
8159688|NCT02547129|20114094|P1|COMPLETED|Overall Study||1
8159689|NCT02547129|20114093|P2|STARTED|Overall Study||2
8159690|NCT02547129|20114094|P1|STARTED|Overall Study||2
8159691|NCT02547064|20114108|P2|NOT COMPLETED|Overall Study||2
8159692|NCT02547064|20114109|P1|NOT COMPLETED|Overall Study||3
8159693|NCT02547064|20114108|P2|COMPLETED|Overall Study||79
8159694|NCT02547064|20114109|P1|COMPLETED|Overall Study||78
8159695|NCT02547064|20114108|P2|STARTED|Overall Study||81
8159696|NCT02547064|20114109|P1|STARTED|Overall Study||81
8159697|NCT02547038|20114137|P2|NOT COMPLETED|Overall Study||2
8159698|NCT02547038|20114138|P1|NOT COMPLETED|Overall Study||3
8159699|NCT02547038|20114137|P2|COMPLETED|Overall Study||174
8159700|NCT02547038|20114138|P1|COMPLETED|Overall Study||173
8159701|NCT02547038|20114137|P2|STARTED|Overall Study||176
8159702|NCT02547038|20114138|P1|STARTED|Overall Study||176
8159703|NCT02547012|20114146|P2|NOT COMPLETED|Overall Study||0
8159704|NCT02547012|20114147|P1|NOT COMPLETED|Overall Study||0
8159705|NCT02547012|20114146|P2|COMPLETED|Overall Study||27
8159706|NCT02547012|20114147|P1|COMPLETED|Overall Study||24
8159707|NCT02547012|20114146|P2|STARTED|Overall Study||27
8159708|NCT02547012|20114147|P1|STARTED|Overall Study||24
8159709|NCT02546986|20114155|P2|NOT COMPLETED|Survival Follow-Up Phase||35
8159710|NCT02546986|20114156|P1|NOT COMPLETED|Survival Follow-Up Phase||36
8159711|NCT02546986|20114155|P2|COMPLETED|Survival Follow-Up Phase||0
8159712|NCT02546986|20114156|P1|COMPLETED|Survival Follow-Up Phase||0
8159713|NCT02546986|20114155|P2|STARTED|Survival Follow-Up Phase||35
8159714|NCT02546986|20114156|P1|STARTED|Survival Follow-Up Phase||36
8159715|NCT02546986|20114155|P2|NOT COMPLETED|Treatment Period||49
8159716|NCT02546986|20114156|P1|NOT COMPLETED|Treatment Period||51
8159717|NCT02546986|20114155|P2|COMPLETED|Treatment Period||0
8159718|NCT02546986|20114156|P1|COMPLETED|Treatment Period||0
8159719|NCT02546986|20114155|P2|STARTED|Treatment Period||49
8159720|NCT02546986|20114156|P1|STARTED|Treatment Period||51
8159721|NCT02546856|20114181|P2|NOT COMPLETED|6 Months Evaluation||7
8159722|NCT02546856|20114182|P1|NOT COMPLETED|6 Months Evaluation||8
8159723|NCT02546856|20114181|P2|COMPLETED|6 Months Evaluation||138
8159724|NCT02546856|20114182|P1|COMPLETED|6 Months Evaluation||136
8159725|NCT02546856|20114181|P2|STARTED|6 Months Evaluation||145
8159726|NCT02546856|20114182|P1|STARTED|6 Months Evaluation||144
8159727|NCT02546856|20114181|P2|NOT COMPLETED|4 Months Evaluation||11
8159728|NCT02546856|20114182|P1|NOT COMPLETED|4 Months Evaluation||20
8159729|NCT02546856|20114181|P2|COMPLETED|4 Months Evaluation||145
8159730|NCT02546856|20114182|P1|COMPLETED|4 Months Evaluation||144
8159731|NCT02546856|20114181|P2|STARTED|4 Months Evaluation||156
8159732|NCT02546856|20114182|P1|STARTED|4 Months Evaluation||164
8159733|NCT02546765|20114232|P4|NOT COMPLETED|Overall Study||0
8159734|NCT02546765|20114233|P3|NOT COMPLETED|Overall Study||0
8159735|NCT02546765|20114234|P2|NOT COMPLETED|Overall Study||1
8159736|NCT02546765|20114235|P1|NOT COMPLETED|Overall Study||0
8159737|NCT02546765|20114232|P4|COMPLETED|Overall Study||30
8159738|NCT02546765|20114233|P3|COMPLETED|Overall Study||30
8159739|NCT02546765|20114234|P2|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
8159740|NCT02546765|20114235|P1|COMPLETED|Overall Study||31
8159741|NCT02546765|20114232|P4|STARTED|Overall Study||30
8159742|NCT02546765|20114233|P3|STARTED|Overall Study||30
8159743|NCT02546765|20114234|P2|STARTED|Overall Study||30
8159744|NCT02546765|20114235|P1|STARTED|Overall Study||31
8159745|NCT02546609|20114276|P3|NOT COMPLETED|Overall Study||7
8159746|NCT02546609|20114277|P2|NOT COMPLETED|Overall Study||11
8159747|NCT02546609|20114278|P1|NOT COMPLETED|Overall Study||2
8159748|NCT02546609|20114276|P3|COMPLETED|Overall Study||25
8159749|NCT02546609|20114277|P2|COMPLETED|Overall Study||24
8159750|NCT02546609|20114278|P1|COMPLETED|Overall Study||22
8159751|NCT02546609|20114276|P3|STARTED|Overall Study||32
8159752|NCT02546609|20114277|P2|STARTED|Overall Study||35
8159753|NCT02546609|20114278|P1|STARTED|Overall Study||24
8159754|NCT02546570|20114321|P2|NOT COMPLETED|Overall Study||0
8159755|NCT02546570|20114322|P1|NOT COMPLETED|Overall Study||0
8159756|NCT02546570|20114321|P2|COMPLETED|Overall Study||2
8159757|NCT02546570|20114322|P1|COMPLETED|Overall Study||9
8159758|NCT02546570|20114321|P2|Crossover Order: Placebo, Oxytocin|Overall Study||0
8159759|NCT02546570|20114322|P1|Crossover Order: Placebo, Oxytocin|Overall Study||3
8159760|NCT02546570|20114321|P2|Crossover Order: Oxytocin, Placebo|Overall Study||2
8159761|NCT02546570|20114322|P1|Crossover Order: Oxytocin, Placebo|Overall Study||6
8159762|NCT02546570|20114321|P2|STARTED|Overall Study||2
8159763|NCT02546570|20114322|P1|STARTED|Overall Study||9
8159764|NCT02546544|20114358|P1|NOT COMPLETED|Overall Study||16
8159765|NCT02546544|20114358|P1|COMPLETED|Overall Study||0
8159766|NCT02546544|20114358|P1|Received Allocated Intervention|Overall Study||16
8159767|NCT02546544|20114358|P1|STARTED|Overall Study||16
8159768|NCT02546388|20114369|P2|NOT COMPLETED|Overall Study||0
8159769|NCT02546388|20114370|P1|NOT COMPLETED|Overall Study||0
8159770|NCT02546388|20114369|P2|COMPLETED|Overall Study||13
8159771|NCT02546388|20114370|P1|COMPLETED|Overall Study||4
8159772|NCT02546388|20114369|P2|STARTED|Overall Study||13
8159773|NCT02546388|20114370|P1|STARTED|Overall Study||4
8159774|NCT02546375|20114377|P1|NOT COMPLETED|Overall Study||0
8159775|NCT02546375|20114377|P1|COMPLETED|Overall Study||87
8159776|NCT02546375|20114377|P1|STARTED|Overall Study||87
8159777|NCT02546362|20114399|P1|NOT COMPLETED|12-week Treatment Period||9
8159778|NCT02546362|20114399|P1|COMPLETED|12-week Treatment Period||38
8159779|NCT02546362|20114399|P1|STARTED|12-week Treatment Period||47
8159780|NCT02546362|20114399|P1|NOT COMPLETED|4-week Treatment Period||3
8159781|NCT02546362|20114399|P1|COMPLETED|4-week Treatment Period||47
8159782|NCT02546362|20114399|P1|STARTED|4-week Treatment Period||50
8159783|NCT02546323|20114420|P2|NOT COMPLETED|Overall Study||66
8159784|NCT02546323|20114421|P1|NOT COMPLETED|Overall Study||60
8159785|NCT02546323|20114420|P2|COMPLETED|Overall Study||205
8159786|NCT02546323|20114421|P1|COMPLETED|Overall Study||212
8159787|NCT02546323|20114420|P2|Received Treatment|Overall Study||268
8159788|NCT02546323|20114421|P1|Received Treatment|Overall Study||272
8159789|NCT02546323|20114420|P2|STARTED|Overall Study||271
8159790|NCT02546323|20114421|P1|STARTED|Overall Study||272
8159791|NCT02546193|20114441|P4|NOT COMPLETED|Overall Study||0
8159792|NCT02546193|20114442|P3|NOT COMPLETED|Overall Study||2
8159793|NCT02546193|20114443|P2|NOT COMPLETED|Overall Study||6
8159794|NCT02546193|20114444|P1|NOT COMPLETED|Overall Study||6
8159795|NCT02546193|20114441|P4|COMPLETED|Overall Study||0
8159796|NCT02546193|20114442|P3|COMPLETED|Overall Study||0
8159797|NCT02546193|20114443|P2|COMPLETED|Overall Study||4
8159798|NCT02546193|20114444|P1|COMPLETED|Overall Study||4
8159799|NCT02546193|20114441|P4|STARTED|Overall Study||0
8159800|NCT02546193|20114442|P3|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
8159801|NCT02546193|20114443|P2|STARTED|Overall Study||10
8159802|NCT02546193|20114444|P1|STARTED|Overall Study||10
8159803|NCT02545933|20114481|P3|NOT COMPLETED|Overall Study||4
8159804|NCT02545933|20114482|P2|NOT COMPLETED|Overall Study||3
8159805|NCT02545933|20114483|P1|NOT COMPLETED|Overall Study||6
8159806|NCT02545933|20114481|P3|COMPLETED|Overall Study||39
8159807|NCT02545933|20114482|P2|COMPLETED|Overall Study||40
8159808|NCT02545933|20114483|P1|COMPLETED|Overall Study||38
8159809|NCT02545933|20114481|P3|STARTED|Overall Study||43
8159810|NCT02545933|20114482|P2|STARTED|Overall Study||43
8159811|NCT02545933|20114483|P1|STARTED|Overall Study||44
8159812|NCT02545868|20114494|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
8159813|NCT02545868|20114495|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
8159814|NCT02545868|20114496|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
8159815|NCT02545868|20114494|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
8159816|NCT02545868|20114495|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
8159817|NCT02545868|20114496|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
8159818|NCT02545868|20114494|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
8159819|NCT02545868|20114495|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
8159820|NCT02545868|20114496|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
8159821|NCT02545868|20114494|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
8159822|NCT02545868|20114495|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
8159823|NCT02545868|20114496|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
8159824|NCT02545868|20114494|P3|COMPLETED|Immunization Study Period (ISP)||34
8159825|NCT02545868|20114495|P2|COMPLETED|Immunization Study Period (ISP)||35
8159826|NCT02545868|20114496|P1|COMPLETED|Immunization Study Period (ISP)||33
8159827|NCT02545868|20114494|P3|STARTED|Immunization Study Period (ISP)||34
8159828|NCT02545868|20114495|P2|STARTED|Immunization Study Period (ISP)||35
8159829|NCT02545868|20114496|P1|STARTED|Immunization Study Period (ISP)||33
8159830|NCT02545608|20114569|P2|NOT COMPLETED|Overall Study||7
8159831|NCT02545608|20114570|P1|NOT COMPLETED|Overall Study||0
8159832|NCT02545608|20114569|P2|COMPLETED|Overall Study||93
8159833|NCT02545608|20114570|P1|COMPLETED|Overall Study||9
8159834|NCT02545608|20114569|P2|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
8159835|NCT02545608|20114570|P1|STARTED|Overall Study||9
8159836|NCT02545543|20114579|P2|NOT COMPLETED|Overall Study||34
8159837|NCT02545543|20114580|P1|NOT COMPLETED|Overall Study||81
8159838|NCT02545543|20114579|P2|COMPLETED|Overall Study||535
8159839|NCT02545543|20114580|P1|COMPLETED|Overall Study||1628
8159840|NCT02545543|20114579|P2|STARTED|Overall Study||569
8159841|NCT02545543|20114580|P1|STARTED|Overall Study||1709
8159842|NCT02545504|20114606|P2|NOT COMPLETED|Overall Study||214
8159843|NCT02545504|20114607|P1|NOT COMPLETED|Overall Study||218
8159844|NCT02545504|20114606|P2|COMPLETED|Overall Study||0
8159845|NCT02545504|20114607|P1|COMPLETED|Overall Study||0
8159846|NCT02545504|20114606|P2|STARTED|Overall Study||214
8159847|NCT02545504|20114607|P1|STARTED|Overall Study||218
8159848|NCT02545322|20114621|P1|NOT COMPLETED|Overall Study||3
8159849|NCT02545322|20114621|P1|COMPLETED|Overall Study||15
8159850|NCT02545322|20114621|P1|STARTED|Overall Study||18
8159851|NCT02545270|20114629|P3|NOT COMPLETED|Overall Study||2
8159852|NCT02545270|20114630|P2|NOT COMPLETED|Overall Study||1
8159853|NCT02545270|20114631|P1|NOT COMPLETED|Overall Study||0
8159854|NCT02545270|20114629|P3|COMPLETED|Overall Study||3
8159855|NCT02545270|20114630|P2|COMPLETED|Overall Study||4
8159856|NCT02545270|20114631|P1|COMPLETED|Overall Study||6
8159857|NCT02545270|20114629|P3|STARTED|Overall Study||5
8159858|NCT02545270|20114630|P2|STARTED|Overall Study||5
8159859|NCT02545270|20114631|P1|STARTED|Overall Study||6
8159860|NCT02545101|20114641|P1|NOT COMPLETED|Overall Study||0
8159861|NCT02545101|20114641|P1|COMPLETED|Overall Study||100
8159862|NCT02545101|20114641|P1|STARTED|Overall Study||100
8159863|NCT02545075|20114660|P2|NOT COMPLETED|Treatment||53
8159864|NCT02545075|20114661|P1|NOT COMPLETED|Treatment||122
8159865|NCT02545075|20114660|P2|COMPLETED|Treatment||0
8159866|NCT02545075|20114661|P1|COMPLETED|Treatment||0
8159867|NCT02545075|20114660|P2|STARTED|Treatment||53
8159868|NCT02545075|20114661|P1|STARTED|Treatment||122
8159869|NCT02545075|20114660|P2|NOT COMPLETED|Randomization||7
8159870|NCT02545075|20114661|P1|NOT COMPLETED|Randomization||0
8159871|NCT02545075|20114660|P2|COMPLETED|Randomization||53
8159872|NCT02545075|20114661|P1|COMPLETED|Randomization||122
8159873|NCT02545075|20114660|P2|STARTED|Randomization||60
8159874|NCT02545075|20114661|P1|STARTED|Randomization||122
8159875|NCT02544984|20114683|P2|NOT COMPLETED|Overall Study||2
8159876|NCT02544984|20114684|P1|NOT COMPLETED|Overall Study||2
8159877|NCT02544984|20114683|P2|COMPLETED|Overall Study||28
8159878|NCT02544984|20114684|P1|COMPLETED|Overall Study||28
8159879|NCT02544984|20114683|P2|STARTED|Overall Study||30
8159880|NCT02544984|20114684|P1|STARTED|Overall Study||30
8159881|NCT02544763|20114697|P3|NOT COMPLETED|Overall Study||1
8159882|NCT02544763|20114698|P2|NOT COMPLETED|Overall Study||12
8159883|NCT02544763|20114699|P1|NOT COMPLETED|Overall Study||10
8159884|NCT02544763|20114697|P3|COMPLETED|Overall Study||75
8159885|NCT02544763|20114698|P2|COMPLETED|Overall Study||61
8159886|NCT02544763|20114699|P1|COMPLETED|Overall Study||65
8159887|NCT02544763|20114697|P3|STARTED|Overall Study||76
8159888|NCT02544763|20114698|P2|STARTED|Overall Study||73
8159889|NCT02544763|20114699|P1|STARTED|Overall Study||75
8159890|NCT02544633|20114723|P4|NOT COMPLETED|Survival Follow-up Period||12
8159891|NCT02544633|20114724|P3|NOT COMPLETED|Survival Follow-up Period||7
8159892|NCT02544633|20114725|P2|NOT COMPLETED|Survival Follow-up Period||19
8159893|NCT02544633|20114726|P1|NOT COMPLETED|Survival Follow-up Period||28
8159894|NCT02544633|20114723|P4|COMPLETED|Survival Follow-up Period||0
8159895|NCT02544633|20114724|P3|COMPLETED|Survival Follow-up Period||0
8159896|NCT02544633|20114725|P2|COMPLETED|Survival Follow-up Period||0
8159897|NCT02544633|20114726|P1|COMPLETED|Survival Follow-up Period||0
8159898|NCT02544633|20114723|P4|STARTED|Survival Follow-up Period||12
8159899|NCT02544633|20114724|P3|STARTED|Survival Follow-up Period||7
8159900|NCT02544633|20114725|P2|STARTED|Survival Follow-up Period||19
8159901|NCT02544633|20114726|P1|STARTED|Survival Follow-up Period||28
8159902|NCT02544633|20114723|P4|NOT COMPLETED|Treatment Period||12
8159903|NCT02544633|20114724|P3|NOT COMPLETED|Treatment Period||8
8159904|NCT02544633|20114725|P2|NOT COMPLETED|Treatment Period||20
8159905|NCT02544633|20114726|P1|NOT COMPLETED|Treatment Period||28
8159906|NCT02544633|20114723|P4|COMPLETED|Treatment Period||0
8159907|NCT02544633|20114724|P3|COMPLETED|Treatment Period||0
8159908|NCT02544633|20114725|P2|COMPLETED|Treatment Period||0
8159909|NCT02544633|20114726|P1|COMPLETED|Treatment Period||0
8159910|NCT02544633|20114723|P4|STARTED|Treatment Period||12
8159911|NCT02544633|20114724|P3|STARTED|Treatment Period||8
8159912|NCT02544633|20114725|P2|STARTED|Treatment Period||20
8159913|NCT02544633|20114726|P1|STARTED|Treatment Period||28
8159914|NCT02544607|20114799|P1|NOT COMPLETED|Overall Study||0
8159915|NCT02544607|20114799|P1|COMPLETED|Overall Study||16
8159916|NCT02544607|20114799|P1|STARTED|Overall Study||16
8159917|NCT02544451|20114810|P3|NOT COMPLETED|Overall Study||1
8159918|NCT02544451|20114811|P2|NOT COMPLETED|Overall Study||12
8159919|NCT02544451|20114812|P1|NOT COMPLETED|Overall Study||14
8159920|NCT02544451|20114810|P3|COMPLETED|Overall Study||5
8159921|NCT02544451|20114811|P2|COMPLETED|Overall Study||84
8159922|NCT02544451|20114812|P1|COMPLETED|Overall Study||129
8159923|NCT02544451|20114810|P3|STARTED|Overall Study||6
8159924|NCT02544451|20114811|P2|STARTED|Overall Study||96
8159925|NCT02544451|20114812|P1|STARTED|Overall Study||143
8159926|NCT02544217|20114861|P6|NOT COMPLETED|Overall Study||0
8159927|NCT02544217|20114862|P5|NOT COMPLETED|Overall Study||0
8159928|NCT02544217|20114863|P4|NOT COMPLETED|Overall Study||0
8159929|NCT02544217|20114864|P3|NOT COMPLETED|Overall Study||0
8159930|NCT02544217|20114865|P2|NOT COMPLETED|Overall Study||1
8159931|NCT02544217|20114866|P1|NOT COMPLETED|Overall Study||1
8159932|NCT02544217|20114861|P6|COMPLETED|Overall Study||6
8159933|NCT02544217|20114862|P5|COMPLETED|Overall Study||4
8159934|NCT02544217|20114863|P4|COMPLETED|Overall Study||4
8159935|NCT02544217|20114864|P3|COMPLETED|Overall Study||4
8159936|NCT02544217|20114865|P2|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
8159937|NCT02544217|20114866|P1|COMPLETED|Overall Study||6
8159938|NCT02544217|20114861|P6|STARTED|Overall Study||6
8159939|NCT02544217|20114862|P5|STARTED|Overall Study||4
8159940|NCT02544217|20114863|P4|STARTED|Overall Study||4
8159941|NCT02544217|20114864|P3|STARTED|Overall Study||4
8159942|NCT02544217|20114865|P2|STARTED|Overall Study||7
8159943|NCT02544217|20114866|P1|STARTED|Overall Study||7
8159944|NCT02544152|20115661|P2|NOT COMPLETED|Overall Study||7
8159945|NCT02544152|20115662|P1|NOT COMPLETED|Overall Study||1
8159946|NCT02544152|20115661|P2|COMPLETED|Overall Study||30
8159947|NCT02544152|20115662|P1|COMPLETED|Overall Study||33
8159948|NCT02544152|20115661|P2|Safety Analysis Set (SAS)|Overall Study||37
8159949|NCT02544152|20115662|P1|Safety Analysis Set (SAS)|Overall Study||34
8159950|NCT02544152|20115661|P2|Modified Intent to Treat (mITT)|Overall Study||37
8159951|NCT02544152|20115662|P1|Modified Intent to Treat (mITT)|Overall Study||34
8159952|NCT02544152|20115661|P2|STARTED|Overall Study||37
8159953|NCT02544152|20115662|P1|STARTED|Overall Study||34
8159954|NCT02544074|20115705|P21|NOT COMPLETED|Overall Study||0
8159955|NCT02544074|20115706|P20|NOT COMPLETED|Overall Study||0
8159956|NCT02544074|20115707|P19|NOT COMPLETED|Overall Study||0
8159957|NCT02544074|20115708|P18|NOT COMPLETED|Overall Study||0
8159958|NCT02544074|20115709|P17|NOT COMPLETED|Overall Study||0
8159959|NCT02544074|20115710|P16|NOT COMPLETED|Overall Study||0
8159960|NCT02544074|20115711|P15|NOT COMPLETED|Overall Study||0
8159961|NCT02544074|20115712|P14|NOT COMPLETED|Overall Study||0
8159962|NCT02544074|20115713|P13|NOT COMPLETED|Overall Study||0
8159963|NCT02544074|20115714|P12|NOT COMPLETED|Overall Study||0
8159964|NCT02544074|20115715|P11|NOT COMPLETED|Overall Study||0
8159965|NCT02544074|20115716|P10|NOT COMPLETED|Overall Study||1
8159966|NCT02544074|20115717|P9|NOT COMPLETED|Overall Study||0
8159967|NCT02544074|20115718|P8|NOT COMPLETED|Overall Study||0
8159968|NCT02544074|20115719|P7|NOT COMPLETED|Overall Study||0
8159969|NCT02544074|20115720|P6|NOT COMPLETED|Overall Study||1
8159970|NCT02544074|20115721|P5|NOT COMPLETED|Overall Study||0
8159971|NCT02544074|20115722|P4|NOT COMPLETED|Overall Study||0
8159972|NCT02544074|20115723|P3|NOT COMPLETED|Overall Study||0
8159973|NCT02544074|20115724|P2|NOT COMPLETED|Overall Study||1
8159974|NCT02544074|20115725|P1|NOT COMPLETED|Overall Study||0
8159975|NCT02544074|20115705|P21|COMPLETED|Overall Study||3
8159976|NCT02544074|20115706|P20|COMPLETED|Overall Study||3
8159977|NCT02544074|20115707|P19|COMPLETED|Overall Study||4
8159978|NCT02544074|20115708|P18|COMPLETED|Overall Study||3
8159979|NCT02544074|20115709|P17|COMPLETED|Overall Study||6
8159980|NCT02544074|20115710|P16|COMPLETED|Overall Study||8
8159981|NCT02544074|20115711|P15|COMPLETED|Overall Study||5
8159982|NCT02544074|20115712|P14|COMPLETED|Overall Study||5
8159983|NCT02544074|20115713|P13|COMPLETED|Overall Study||4
8159984|NCT02544074|20115714|P12|COMPLETED|Overall Study||3
8159985|NCT02544074|20115715|P11|COMPLETED|Overall Study||2
8159986|NCT02544074|20115716|P10|COMPLETED|Overall Study||1
8159987|NCT02544074|20115717|P9|COMPLETED|Overall Study||6
8159988|NCT02544074|20115718|P8|COMPLETED|Overall Study||4
8159989|NCT02544074|20115719|P7|COMPLETED|Overall Study||2
8159990|NCT02544074|20115720|P6|COMPLETED|Overall Study||0
8159991|NCT02544074|20115721|P5|COMPLETED|Overall Study||4
8159992|NCT02544074|20115722|P4|COMPLETED|Overall Study||1
8159993|NCT02544074|20115723|P3|COMPLETED|Overall Study||1
8159994|NCT02544074|20115724|P2|COMPLETED|Overall Study||0
8159995|NCT02544074|20115725|P1|COMPLETED|Overall Study||1
8159996|NCT02544074|20115705|P21|STARTED|Overall Study||3
8159997|NCT02544074|20115706|P20|STARTED|Overall Study||3
8159998|NCT02544074|20115707|P19|STARTED|Overall Study||4
8159999|NCT02544074|20115708|P18|STARTED|Overall Study||3
8160000|NCT02544074|20115709|P17|STARTED|Overall Study||6
8160001|NCT02544074|20115710|P16|STARTED|Overall Study||8
8160002|NCT02544074|20115711|P15|STARTED|Overall Study||5
8160003|NCT02544074|20115712|P14|STARTED|Overall Study||5
8160004|NCT02544074|20115713|P13|STARTED|Overall Study||4
8160005|NCT02544074|20115714|P12|STARTED|Overall Study||3
8160006|NCT02544074|20115715|P11|STARTED|Overall Study||2
8160007|NCT02544074|20115716|P10|STARTED|Overall Study||2
8160008|NCT02544074|20115717|P9|STARTED|Overall Study||6
8160009|NCT02544074|20115718|P8|STARTED|Overall Study||4
8160010|NCT02544074|20115719|P7|STARTED|Overall Study||2
8160011|NCT02544074|20115720|P6|STARTED|Overall Study||1
8160012|NCT02544074|20115721|P5|STARTED|Overall Study||4
8160013|NCT02544074|20115722|P4|STARTED|Overall Study||1
8160014|NCT02544074|20115723|P3|STARTED|Overall Study||1
8160015|NCT02544074|20115724|P2|STARTED|Overall Study||1
8160016|NCT02544074|20115725|P1|STARTED|Overall Study||1
8160017|NCT02543918|20115761|P2|NOT COMPLETED|Overall Study||4
8160018|NCT02543918|20115762|P1|NOT COMPLETED|Overall Study||3
8160019|NCT02543918|20115761|P2|COMPLETED|Overall Study||39
8160020|NCT02543918|20115762|P1|COMPLETED|Overall Study||38
8160021|NCT02543918|20115761|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
8160022|NCT02543918|20115762|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
8160023|NCT02543918|20115761|P2|STARTED|Overall Study||43
8160024|NCT02543918|20115762|P1|STARTED|Overall Study||41
8160025|NCT02543892|20115776|P8|NOT COMPLETED|Had Immunology Data||0
8160026|NCT02543892|20115777|P7|NOT COMPLETED|Had Immunology Data||1
8160027|NCT02543892|20115778|P6|NOT COMPLETED|Had Immunology Data||0
8160028|NCT02543892|20115779|P5|NOT COMPLETED|Had Immunology Data||0
8160029|NCT02543892|20115780|P4|NOT COMPLETED|Had Immunology Data||0
8160030|NCT02543892|20115781|P3|NOT COMPLETED|Had Immunology Data||0
8160031|NCT02543892|20115782|P2|NOT COMPLETED|Had Immunology Data||0
8160032|NCT02543892|20115783|P1|NOT COMPLETED|Had Immunology Data||0
8160033|NCT02543892|20115776|P8|COMPLETED|Had Immunology Data||49
8160034|NCT02543892|20115777|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
8160035|NCT02543892|20115778|P6|COMPLETED|Had Immunology Data||49
8160036|NCT02543892|20115779|P5|COMPLETED|Had Immunology Data||50
8160037|NCT02543892|20115780|P4|COMPLETED|Had Immunology Data||12
8160038|NCT02543892|20115781|P3|COMPLETED|Had Immunology Data||12
8160039|NCT02543892|20115782|P2|COMPLETED|Had Immunology Data||11
8160040|NCT02543892|20115783|P1|COMPLETED|Had Immunology Data||11
8160041|NCT02543892|20115776|P8|STARTED|Had Immunology Data||49
8160042|NCT02543892|20115777|P7|STARTED|Had Immunology Data||50
8160043|NCT02543892|20115778|P6|STARTED|Had Immunology Data||49
8160044|NCT02543892|20115779|P5|STARTED|Had Immunology Data||50
8160045|NCT02543892|20115780|P4|STARTED|Had Immunology Data||12
8160046|NCT02543892|20115781|P3|STARTED|Had Immunology Data||12
8160047|NCT02543892|20115782|P2|STARTED|Had Immunology Data||11
8160048|NCT02543892|20115783|P1|STARTED|Had Immunology Data||11
8160049|NCT02543892|20115776|P8|NOT COMPLETED|Received Vaccination 2||1
8160050|NCT02543892|20115777|P7|NOT COMPLETED|Received Vaccination 2||0
8160051|NCT02543892|20115778|P6|NOT COMPLETED|Received Vaccination 2||1
8160052|NCT02543892|20115779|P5|NOT COMPLETED|Received Vaccination 2||0
8160053|NCT02543892|20115780|P4|NOT COMPLETED|Received Vaccination 2||0
8160054|NCT02543892|20115781|P3|NOT COMPLETED|Received Vaccination 2||0
8160055|NCT02543892|20115782|P2|NOT COMPLETED|Received Vaccination 2||1
8160056|NCT02543892|20115783|P1|NOT COMPLETED|Received Vaccination 2||1
8160057|NCT02543892|20115776|P8|COMPLETED|Received Vaccination 2||49
8160058|NCT02543892|20115777|P7|COMPLETED|Received Vaccination 2||50
8160059|NCT02543892|20115778|P6|COMPLETED|Received Vaccination 2||49
8160060|NCT02543892|20115779|P5|COMPLETED|Received Vaccination 2||50
8160061|NCT02543892|20115780|P4|COMPLETED|Received Vaccination 2||12
8160062|NCT02543892|20115781|P3|COMPLETED|Received Vaccination 2||12
8160063|NCT02543892|20115782|P2|COMPLETED|Received Vaccination 2||11
8160064|NCT02543892|20115783|P1|COMPLETED|Received Vaccination 2||11
8160065|NCT02543892|20115776|P8|STARTED|Received Vaccination 2||50
8160066|NCT02543892|20115777|P7|STARTED|Received Vaccination 2||50
8160067|NCT02543892|20115778|P6|STARTED|Received Vaccination 2||50
8160068|NCT02543892|20115779|P5|STARTED|Received Vaccination 2||50
8160069|NCT02543892|20115780|P4|STARTED|Received Vaccination 2||12
8160070|NCT02543892|20115781|P3|STARTED|Received Vaccination 2||12
8160071|NCT02543892|20115782|P2|STARTED|Received Vaccination 2||12
8160072|NCT02543892|20115783|P1|STARTED|Received Vaccination 2||12
8160073|NCT02543892|20115776|P8|NOT COMPLETED|Received Vaccination 1||0
8160074|NCT02543892|20115777|P7|NOT COMPLETED|Received Vaccination 1||0
8160075|NCT02543892|20115778|P6|NOT COMPLETED|Received Vaccination 1||0
8160076|NCT02543892|20115779|P5|NOT COMPLETED|Received Vaccination 1||0
8160077|NCT02543892|20115780|P4|NOT COMPLETED|Received Vaccination 1||0
8160078|NCT02543892|20115781|P3|NOT COMPLETED|Received Vaccination 1||0
8160079|NCT02543892|20115782|P2|NOT COMPLETED|Received Vaccination 1||0
8160080|NCT02543892|20115783|P1|NOT COMPLETED|Received Vaccination 1||0
8160081|NCT02543892|20115776|P8|COMPLETED|Received Vaccination 1||50
8160082|NCT02543892|20115777|P7|COMPLETED|Received Vaccination 1||50
8160083|NCT02543892|20115778|P6|COMPLETED|Received Vaccination 1||50
8160084|NCT02543892|20115779|P5|COMPLETED|Received Vaccination 1||50
8160085|NCT02543892|20115780|P4|COMPLETED|Received Vaccination 1||12
8160086|NCT02543892|20115781|P3|COMPLETED|Received Vaccination 1||12
8160087|NCT02543892|20115782|P2|COMPLETED|Received Vaccination 1||12
8160088|NCT02543892|20115783|P1|COMPLETED|Received Vaccination 1||12
8160089|NCT02543892|20115776|P8|STARTED|Received Vaccination 1||50
8160090|NCT02543892|20115777|P7|STARTED|Received Vaccination 1||50
8160091|NCT02543892|20115778|P6|STARTED|Received Vaccination 1||50
8160092|NCT02543892|20115779|P5|STARTED|Received Vaccination 1||50
8160093|NCT02543892|20115780|P4|STARTED|Received Vaccination 1||12
8160094|NCT02543892|20115781|P3|STARTED|Received Vaccination 1||12
8160095|NCT02543892|20115782|P2|STARTED|Received Vaccination 1||12
8160096|NCT02543892|20115783|P1|STARTED|Received Vaccination 1||12
8160097|NCT02543840|20115831|P2|NOT COMPLETED|Overall Study||0
8160098|NCT02543840|20115832|P1|NOT COMPLETED|Overall Study||0
8160099|NCT02543840|20115831|P2|COMPLETED|Overall Study||62
8160100|NCT02543840|20115832|P1|COMPLETED|Overall Study||1050
8160101|NCT02543840|20115831|P2|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
8160102|NCT02543840|20115832|P1|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
8160103|NCT02543840|20115831|P2|6 Month Timepoint (t6)|Overall Study||0
8160104|NCT02543840|20115832|P1|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
8160105|NCT02543840|20115831|P2|0 Month Timepoint (t0)|Overall Study||40
8160106|NCT02543840|20115832|P1|0 Month Timepoint (t0)|Overall Study||593
8160107|NCT02543840|20115831|P2|STARTED|Overall Study||62
8160108|NCT02543840|20115832|P1|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
8160109|NCT02543801|20115850|P4|NOT COMPLETED|Overall Study||0
8160110|NCT02543801|20115851|P3|NOT COMPLETED|Overall Study||0
8160111|NCT02543801|20115852|P2|NOT COMPLETED|Overall Study||2
8160112|NCT02543801|20115853|P1|NOT COMPLETED|Overall Study||1
8160113|NCT02543801|20115850|P4|COMPLETED|Overall Study||59
8160114|NCT02543801|20115851|P3|COMPLETED|Overall Study||59
8160115|NCT02543801|20115852|P2|COMPLETED|Overall Study||58
8160116|NCT02543801|20115853|P1|COMPLETED|Overall Study||60
8160117|NCT02543801|20115850|P4|STARTED|Overall Study||59
8160118|NCT02543801|20115851|P3|STARTED|Overall Study||59
8160119|NCT02543801|20115852|P2|STARTED|Overall Study||60
8160120|NCT02543801|20115853|P1|STARTED|Overall Study||61
8160121|NCT02543658|20115873|P2|NOT COMPLETED|Overall Study||4
8160122|NCT02543658|20115874|P1|NOT COMPLETED|Overall Study||0
8160123|NCT02543658|20115873|P2|COMPLETED|Overall Study||36
8160124|NCT02543658|20115874|P1|COMPLETED|Overall Study||40
8160125|NCT02543658|20115873|P2|STARTED|Overall Study||40
8160126|NCT02543658|20115874|P1|STARTED|Overall Study||40
8160127|NCT02543554|20115902|P2|NOT COMPLETED|Overall Study||0
8160128|NCT02543554|20115903|P1|NOT COMPLETED|Overall Study||0
8160129|NCT02543554|20115902|P2|COMPLETED|Overall Study||513
8160130|NCT02543554|20115903|P1|COMPLETED|Overall Study||1192
8160131|NCT02543554|20115902|P2|STARTED|Overall Study||513
8160132|NCT02543554|20115903|P1|STARTED|Overall Study||1192
8160133|NCT02543528|20115911|P5|NOT COMPLETED|Extended Wear Period||0
8160134|NCT02543528|20115912|P4|NOT COMPLETED|Extended Wear Period||12
8160135|NCT02543528|20115913|P3|NOT COMPLETED|Extended Wear Period||23
8160136|NCT02543528|20115914|P2|NOT COMPLETED|Extended Wear Period||21
8160137|NCT02543528|20115915|P1|NOT COMPLETED|Extended Wear Period||28
8160138|NCT02543528|20115911|P5|COMPLETED|Extended Wear Period||0
8160139|NCT02543528|20115912|P4|COMPLETED|Extended Wear Period||23
8160140|NCT02543528|20115913|P3|COMPLETED|Extended Wear Period||13
8160141|NCT02543528|20115914|P2|COMPLETED|Extended Wear Period||14
8160142|NCT02543528|20115915|P1|COMPLETED|Extended Wear Period||8
8160143|NCT02543528|20115911|P5|STARTED|Extended Wear Period||0
8160144|NCT02543528|20115912|P4|STARTED|Extended Wear Period||35
8160145|NCT02543528|20115913|P3|STARTED|Extended Wear Period||36
8160146|NCT02543528|20115914|P2|STARTED|Extended Wear Period||35
8160147|NCT02543528|20115915|P1|STARTED|Extended Wear Period||36
8160148|NCT02543528|20115911|P5|NOT COMPLETED|Adaptation Period||26
8160149|NCT02543528|20115912|P4|NOT COMPLETED|Adaptation Period||0
8160150|NCT02543528|20115913|P3|NOT COMPLETED|Adaptation Period||0
8160151|NCT02543528|20115914|P2|NOT COMPLETED|Adaptation Period||0
8160152|NCT02543528|20115915|P1|NOT COMPLETED|Adaptation Period||0
8160153|NCT02543528|20115911|P5|COMPLETED|Adaptation Period||142
8160154|NCT02543528|20115912|P4|COMPLETED|Adaptation Period||0
8160155|NCT02543528|20115913|P3|COMPLETED|Adaptation Period||0
8160156|NCT02543528|20115914|P2|COMPLETED|Adaptation Period||0
8160157|NCT02543528|20115915|P1|COMPLETED|Adaptation Period||0
8160158|NCT02543528|20115911|P5|STARTED|Adaptation Period||168
8160159|NCT02543528|20115912|P4|STARTED|Adaptation Period||0
8160160|NCT02543528|20115913|P3|STARTED|Adaptation Period||0
8160161|NCT02543528|20115914|P2|STARTED|Adaptation Period||0
8160162|NCT02543528|20115915|P1|STARTED|Adaptation Period||0
8160163|NCT02543437|20115934|P1|NOT COMPLETED|Overall Study||0
8160164|NCT02543437|20115934|P1|COMPLETED|Overall Study||117
8160165|NCT02543437|20115934|P1|STARTED|Overall Study||117
8160166|NCT02543398|20115941|P2|NOT COMPLETED|Overall Study||0
8160167|NCT02543398|20115942|P1|NOT COMPLETED|Overall Study||0
8160168|NCT02543398|20115941|P2|COMPLETED|Overall Study||20
8160169|NCT02543398|20115942|P1|COMPLETED|Overall Study||20
8160170|NCT02543398|20115941|P2|STARTED|Overall Study||20
8160171|NCT02543398|20115942|P1|STARTED|Overall Study||20
8160172|NCT02543346|20115948|P4|NOT COMPLETED|Second Treatment Visit||0
8160173|NCT02543346|20115949|P3|NOT COMPLETED|Second Treatment Visit||0
8160174|NCT02543346|20115950|P2|NOT COMPLETED|Second Treatment Visit||0
8160175|NCT02543346|20115951|P1|NOT COMPLETED|Second Treatment Visit||0
8160176|NCT02543346|20115948|P4|COMPLETED|Second Treatment Visit||21
8160177|NCT02543346|20115949|P3|COMPLETED|Second Treatment Visit||22
8160178|NCT02543346|20115950|P2|COMPLETED|Second Treatment Visit||23
8160179|NCT02543346|20115951|P1|COMPLETED|Second Treatment Visit||25
8160180|NCT02543346|20115948|P4|STARTED|Second Treatment Visit||21
8160181|NCT02543346|20115949|P3|STARTED|Second Treatment Visit||22
8160182|NCT02543346|20115950|P2|STARTED|Second Treatment Visit||23
8160183|NCT02543346|20115951|P1|STARTED|Second Treatment Visit||25
8160184|NCT02543346|20115948|P4|NOT COMPLETED|Second Priming Visit||2
8160185|NCT02543346|20115949|P3|NOT COMPLETED|Second Priming Visit||2
8160186|NCT02543346|20115950|P2|NOT COMPLETED|Second Priming Visit||2
8160187|NCT02543346|20115951|P1|NOT COMPLETED|Second Priming Visit||1
8160188|NCT02543346|20115948|P4|COMPLETED|Second Priming Visit||21
8160189|NCT02543346|20115949|P3|COMPLETED|Second Priming Visit||22
8160190|NCT02543346|20115950|P2|COMPLETED|Second Priming Visit||23
8160191|NCT02543346|20115951|P1|COMPLETED|Second Priming Visit||25
8160192|NCT02543346|20115948|P4|STARTED|Second Priming Visit||23
8160193|NCT02543346|20115949|P3|STARTED|Second Priming Visit||24
8160194|NCT02543346|20115950|P2|STARTED|Second Priming Visit||25
8160195|NCT02543346|20115951|P1|STARTED|Second Priming Visit||26
8160196|NCT02543346|20115948|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
8160197|NCT02543346|20115949|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
8160198|NCT02543346|20115950|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8160199|NCT02543346|20115951|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8160200|NCT02543346|20115948|P4|COMPLETED|Washout (at Least 14 Days)||23
8160201|NCT02543346|20115949|P3|COMPLETED|Washout (at Least 14 Days)||24
8160202|NCT02543346|20115950|P2|COMPLETED|Washout (at Least 14 Days)||25
8160203|NCT02543346|20115951|P1|COMPLETED|Washout (at Least 14 Days)||26
8160204|NCT02543346|20115948|P4|STARTED|Washout (at Least 14 Days)||23
8160205|NCT02543346|20115949|P3|STARTED|Washout (at Least 14 Days)||24
8160206|NCT02543346|20115950|P2|STARTED|Washout (at Least 14 Days)||25
8160207|NCT02543346|20115951|P1|STARTED|Washout (at Least 14 Days)||26
8160208|NCT02543346|20115948|P4|NOT COMPLETED|First Treatment Visit||0
8160209|NCT02543346|20115949|P3|NOT COMPLETED|First Treatment Visit||0
8160210|NCT02543346|20115950|P2|NOT COMPLETED|First Treatment Visit||0
8160211|NCT02543346|20115951|P1|NOT COMPLETED|First Treatment Visit||0
8160212|NCT02543346|20115948|P4|COMPLETED|First Treatment Visit||23
8160213|NCT02543346|20115949|P3|COMPLETED|First Treatment Visit||24
8160214|NCT02543346|20115950|P2|COMPLETED|First Treatment Visit||25
8160215|NCT02543346|20115951|P1|COMPLETED|First Treatment Visit||26
8160216|NCT02543346|20115948|P4|STARTED|First Treatment Visit||23
8160217|NCT02543346|20115949|P3|STARTED|First Treatment Visit||24
8160218|NCT02543346|20115950|P2|STARTED|First Treatment Visit||25
8160219|NCT02543346|20115951|P1|STARTED|First Treatment Visit||26
8160220|NCT02543346|20115948|P4|NOT COMPLETED|First Priming Visit||0
8160221|NCT02543346|20115949|P3|NOT COMPLETED|First Priming Visit||0
8160222|NCT02543346|20115950|P2|NOT COMPLETED|First Priming Visit||0
8160223|NCT02543346|20115951|P1|NOT COMPLETED|First Priming Visit||0
8160224|NCT02543346|20115948|P4|COMPLETED|First Priming Visit||23
8160225|NCT02543346|20115949|P3|COMPLETED|First Priming Visit||24
8160226|NCT02543346|20115950|P2|COMPLETED|First Priming Visit||25
8160227|NCT02543346|20115951|P1|COMPLETED|First Priming Visit||26
8160228|NCT02543346|20115948|P4|STARTED|First Priming Visit||23
8160229|NCT02543346|20115949|P3|STARTED|First Priming Visit||24
8160230|NCT02543346|20115950|P2|STARTED|First Priming Visit||25
8160231|NCT02543346|20115951|P1|STARTED|First Priming Visit||26
8160232|NCT02543294|20115977|P1|NOT COMPLETED|Overall Study||12
8160233|NCT02543294|20115977|P1|COMPLETED|Overall Study||8
8160234|NCT02543294|20115977|P1|STARTED|Overall Study||20
8160235|NCT02542943|20115985|P3|NOT COMPLETED|Overall Study||0
8160236|NCT02542943|20115986|P2|NOT COMPLETED|Overall Study||1
8160237|NCT02542943|20115987|P1|NOT COMPLETED|Overall Study||1
8160238|NCT02542943|20115985|P3|COMPLETED|Overall Study||81
8160239|NCT02542943|20115986|P2|COMPLETED|Overall Study||79
8160240|NCT02542943|20115987|P1|COMPLETED|Overall Study||78
8160241|NCT02542943|20115985|P3|STARTED|Overall Study||81
8160242|NCT02542943|20115986|P2|STARTED|Overall Study||80
8160243|NCT02542943|20115987|P1|STARTED|Overall Study||79
8160244|NCT02542865|20116014|P2|NOT COMPLETED|Overall Study||0
8160245|NCT02542865|20116015|P1|NOT COMPLETED|Overall Study||17
8160246|NCT02542865|20116014|P2|COMPLETED|Overall Study||462
8160247|NCT02542865|20116015|P1|COMPLETED|Overall Study||445
8160248|NCT02542865|20116014|P2|Treated|Overall Study||462
8160249|NCT02542865|20116015|P1|Treated|Overall Study||460
8160250|NCT02542865|20116014|P2|STARTED|Overall Study||462
8160251|NCT02542865|20116015|P1|STARTED|Overall Study||462
8160252|NCT02542761|20116059|P2|NOT COMPLETED|Second Intervention||0
8160253|NCT02542761|20116060|P1|NOT COMPLETED|Second Intervention||0
8160254|NCT02542761|20116059|P2|COMPLETED|Second Intervention||5
8160255|NCT02542761|20116060|P1|COMPLETED|Second Intervention||5
8160256|NCT02542761|20116059|P2|STARTED|Second Intervention||5
8160257|NCT02542761|20116060|P1|STARTED|Second Intervention||5
8160258|NCT02542761|20116059|P2|NOT COMPLETED|Acclimation Period 2||0
8160259|NCT02542761|20116060|P1|NOT COMPLETED|Acclimation Period 2||0
8160260|NCT02542761|20116059|P2|COMPLETED|Acclimation Period 2||5
8160261|NCT02542761|20116060|P1|COMPLETED|Acclimation Period 2||5
8160262|NCT02542761|20116059|P2|STARTED|Acclimation Period 2||5
8160263|NCT02542761|20116060|P1|STARTED|Acclimation Period 2||5
8160264|NCT02542761|20116059|P2|NOT COMPLETED|First Intervention||0
8160265|NCT02542761|20116060|P1|NOT COMPLETED|First Intervention||0
8160266|NCT02542761|20116059|P2|COMPLETED|First Intervention||5
8160267|NCT02542761|20116060|P1|COMPLETED|First Intervention||5
8160268|NCT02542761|20116059|P2|STARTED|First Intervention||5
8160269|NCT02542761|20116060|P1|STARTED|First Intervention||5
8160270|NCT02542761|20116059|P2|NOT COMPLETED|Acclimation Period 1||0
8160271|NCT02542761|20116060|P1|NOT COMPLETED|Acclimation Period 1||0
8160272|NCT02542761|20116059|P2|COMPLETED|Acclimation Period 1||5
8160273|NCT02542761|20116060|P1|COMPLETED|Acclimation Period 1||5
8160274|NCT02542761|20116059|P2|STARTED|Acclimation Period 1||5
8160275|NCT02542761|20116060|P1|STARTED|Acclimation Period 1||5
8160276|NCT02542631|20116078|P2|NOT COMPLETED|Overall Study||31
8160277|NCT02542631|20116079|P1|NOT COMPLETED|Overall Study||31
8160278|NCT02542631|20116078|P2|COMPLETED|Overall Study||108
8160279|NCT02542631|20116079|P1|COMPLETED|Overall Study||108
8160280|NCT02542631|20116078|P2|STARTED|Overall Study||139
8160281|NCT02542631|20116079|P1|STARTED|Overall Study||139
8160282|NCT02542605|20116101|P3|NOT COMPLETED|Part B: Randomization Phase||1
8160283|NCT02542605|20116102|P2|NOT COMPLETED|Part B: Randomization Phase||0
8160284|NCT02542605|20116103|P1|NOT COMPLETED|Part B: Randomization Phase||0
8160285|NCT02542605|20116101|P3|COMPLETED|Part B: Randomization Phase||7
8160286|NCT02542605|20116102|P2|COMPLETED|Part B: Randomization Phase||9
8160287|NCT02542605|20116103|P1|COMPLETED|Part B: Randomization Phase||0
8160288|NCT02542605|20116101|P3|Received Placebo/Erenumab|Part B: Randomization Phase||7
8160289|NCT02542605|20116102|P2|Received Placebo/Erenumab|Part B: Randomization Phase||9
8160290|NCT02542605|20116103|P1|Received Placebo/Erenumab|Part B: Randomization Phase||0
8160291|NCT02542605|20116101|P3|PACAP-38 naïve Participants|Part B: Randomization Phase||8
8160292|NCT02542605|20116102|P2|PACAP-38 naïve Participants|Part B: Randomization Phase||7
8160293|NCT02542605|20116103|P1|PACAP-38 naïve Participants|Part B: Randomization Phase||0
8160294|NCT02542605|20116101|P3|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
8160295|NCT02542605|20116102|P2|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
8160296|NCT02542605|20116103|P1|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
8160297|NCT02542605|20116101|P3|STARTED|Part B: Randomization Phase||8
8160298|NCT02542605|20116102|P2|STARTED|Part B: Randomization Phase||9
8160299|NCT02542605|20116103|P1|STARTED|Part B: Randomization Phase||0
8160300|NCT02542605|20116101|P3|NOT COMPLETED|Part B: Challenge Phase||0
8160301|NCT02542605|20116102|P2|NOT COMPLETED|Part B: Challenge Phase||0
8160302|NCT02542605|20116103|P1|NOT COMPLETED|Part B: Challenge Phase||1
8160303|NCT02542605|20116101|P3|COMPLETED|Part B: Challenge Phase||0
8160304|NCT02542605|20116102|P2|COMPLETED|Part B: Challenge Phase||0
8160305|NCT02542605|20116103|P1|COMPLETED|Part B: Challenge Phase||22
8160306|NCT02542605|20116101|P3|Proceeded to Randomization Phase|Part B: Challenge Phase||0
8160307|NCT02542605|20116102|P2|Proceeded to Randomization Phase|Part B: Challenge Phase||0
8160308|NCT02542605|20116103|P1|Proceeded to Randomization Phase|Part B: Challenge Phase||15
8160309|NCT02542605|20116101|P3|Received PACAP-38|Part B: Challenge Phase||0
8160310|NCT02542605|20116102|P2|Received PACAP-38|Part B: Challenge Phase||0
8160311|NCT02542605|20116103|P1|Received PACAP-38|Part B: Challenge Phase||23
8160312|NCT02542605|20116101|P3|STARTED|Part B: Challenge Phase||0
8160313|NCT02542605|20116102|P2|STARTED|Part B: Challenge Phase||0
8160314|NCT02542605|20116103|P1|STARTED|Part B: Challenge Phase||23
8160315|NCT02542605|20116101|P3|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160316|NCT02542605|20116102|P2|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160317|NCT02542605|20116103|P1|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160318|NCT02542605|20116101|P3|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160319|NCT02542605|20116102|P2|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160320|NCT02542605|20116103|P1|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
8160321|NCT02542605|20116101|P3|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
8160322|NCT02542605|20116102|P2|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
8160411|NCT02541669|20116355|P5|NOT COMPLETED|Open Label Treatment Period||0
8160323|NCT02542605|20116103|P1|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
8160324|NCT02542605|20116101|P3|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
8160325|NCT02542605|20116102|P2|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
8160326|NCT02542605|20116103|P1|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
8160327|NCT02542605|20116101|P3|STARTED|Part A: PACAP-38 Dose Selection Phase||0
8160328|NCT02542605|20116102|P2|STARTED|Part A: PACAP-38 Dose Selection Phase||0
8160329|NCT02542605|20116103|P1|STARTED|Part A: PACAP-38 Dose Selection Phase||12
8160330|NCT02542462|20116154|P4|NOT COMPLETED|Overall Study||1
8160331|NCT02542462|20116155|P3|NOT COMPLETED|Overall Study||0
8160332|NCT02542462|20116156|P2|NOT COMPLETED|Overall Study||0
8160333|NCT02542462|20116157|P1|NOT COMPLETED|Overall Study||0
8160334|NCT02542462|20116154|P4|COMPLETED|Overall Study||25
8160335|NCT02542462|20116155|P3|COMPLETED|Overall Study||25
8160336|NCT02542462|20116156|P2|COMPLETED|Overall Study||25
8160337|NCT02542462|20116157|P1|COMPLETED|Overall Study||25
8160338|NCT02542462|20116154|P4|STARTED|Overall Study||26
8160339|NCT02542462|20116155|P3|STARTED|Overall Study||25
8160340|NCT02542462|20116156|P2|STARTED|Overall Study||25
8160341|NCT02542462|20116157|P1|STARTED|Overall Study||25
8160342|NCT02542410|20116171|P2|NOT COMPLETED|Overall Study||1
8160343|NCT02542410|20116172|P1|NOT COMPLETED|Overall Study||2
8160344|NCT02542410|20116171|P2|COMPLETED|Overall Study||4
8160345|NCT02542410|20116172|P1|COMPLETED|Overall Study||3
8160346|NCT02542410|20116171|P2|STARTED|Overall Study||5
8160347|NCT02542410|20116172|P1|STARTED|Overall Study||5
8160348|NCT02542280|20116182|P2|NOT COMPLETED|Overall Study||8
8160349|NCT02542280|20116183|P1|NOT COMPLETED|Overall Study||12
8160350|NCT02542280|20116182|P2|COMPLETED|Overall Study||167
8160351|NCT02542280|20116183|P1|COMPLETED|Overall Study||162
8160352|NCT02542280|20116182|P2|STARTED|Overall Study||175
8160353|NCT02542280|20116183|P1|STARTED|Overall Study||174
8160354|NCT02542267|20116191|P1|NOT COMPLETED|Overall Study||77
8160355|NCT02542267|20116191|P1|COMPLETED|Overall Study||31
8160356|NCT02542267|20116191|P1|STARTED|Overall Study||108
8160357|NCT02542072|20116199|P2|NOT COMPLETED|Second Intervention (1 Month)||0
8160358|NCT02542072|20116200|P1|NOT COMPLETED|Second Intervention (1 Month)||2
8160359|NCT02542072|20116199|P2|COMPLETED|Second Intervention (1 Month)||43
8160360|NCT02542072|20116200|P1|COMPLETED|Second Intervention (1 Month)||37
8160361|NCT02542072|20116199|P2|STARTED|Second Intervention (1 Month)||43
8160362|NCT02542072|20116200|P1|STARTED|Second Intervention (1 Month)||39
8160363|NCT02542072|20116199|P2|NOT COMPLETED|First Intervention (1 Month)||3
8160364|NCT02542072|20116200|P1|NOT COMPLETED|First Intervention (1 Month)||5
8160365|NCT02542072|20116199|P2|COMPLETED|First Intervention (1 Month)||43
8160366|NCT02542072|20116200|P1|COMPLETED|First Intervention (1 Month)||39
8160367|NCT02542072|20116199|P2|STARTED|First Intervention (1 Month)||46
8160368|NCT02542072|20116200|P1|STARTED|First Intervention (1 Month)||44
8160369|NCT02542046|20116303|P3|NOT COMPLETED|Overall Study||0
8160370|NCT02542046|20116304|P2|NOT COMPLETED|Overall Study||0
8160371|NCT02542046|20116305|P1|NOT COMPLETED|Overall Study||0
8160372|NCT02542046|20116303|P3|COMPLETED|Overall Study||300
8160373|NCT02542046|20116304|P2|COMPLETED|Overall Study||300
8160374|NCT02542046|20116305|P1|COMPLETED|Overall Study||300
8160375|NCT02542046|20116303|P3|STARTED|Overall Study||300
8160376|NCT02542046|20116304|P2|STARTED|Overall Study||300
8160377|NCT02542046|20116305|P1|STARTED|Overall Study||300
8160378|NCT02541942|20116319|P1|NOT COMPLETED|Overall Study||0
8160379|NCT02541942|20116319|P1|COMPLETED|Overall Study||19
8160380|NCT02541942|20116319|P1|STARTED|Overall Study||19
8160381|NCT02541903|20116324|P1|NOT COMPLETED|Overall Study||1
8160382|NCT02541903|20116324|P1|COMPLETED|Overall Study||7
8160383|NCT02541903|20116324|P1|STARTED|Overall Study||8
8160384|NCT02541864|20116333|P2|NOT COMPLETED|Overall Study||0
8160385|NCT02541864|20116334|P1|NOT COMPLETED|Overall Study||0
8160386|NCT02541864|20116333|P2|COMPLETED|Overall Study||166
8160387|NCT02541864|20116334|P1|COMPLETED|Overall Study||164
8160388|NCT02541864|20116333|P2|STARTED|Overall Study||166
8160389|NCT02541864|20116334|P1|STARTED|Overall Study||164
8160390|NCT02541812|20116342|P2|NOT COMPLETED|Overall Study||0
8160391|NCT02541812|20116343|P1|NOT COMPLETED|Overall Study||0
8160392|NCT02541812|20116342|P2|COMPLETED|Overall Study||10
8160393|NCT02541812|20116343|P1|COMPLETED|Overall Study||10
8160394|NCT02541812|20116342|P2|STARTED|Overall Study||10
8160395|NCT02541812|20116343|P1|STARTED|Overall Study||10
8160396|NCT02541669|20116355|P5|NOT COMPLETED|Double-Blinded Treatment Period||1
8160397|NCT02541669|20116356|P4|NOT COMPLETED|Double-Blinded Treatment Period||0
8160398|NCT02541669|20116357|P3|NOT COMPLETED|Double-Blinded Treatment Period||1
8160399|NCT02541669|20116358|P2|NOT COMPLETED|Double-Blinded Treatment Period||0
8160400|NCT02541669|20116359|P1|NOT COMPLETED|Double-Blinded Treatment Period||0
8160401|NCT02541669|20116355|P5|COMPLETED|Double-Blinded Treatment Period||15
8160402|NCT02541669|20116356|P4|COMPLETED|Double-Blinded Treatment Period||16
8160403|NCT02541669|20116357|P3|COMPLETED|Double-Blinded Treatment Period||15
8160404|NCT02541669|20116358|P2|COMPLETED|Double-Blinded Treatment Period||0
8160405|NCT02541669|20116359|P1|COMPLETED|Double-Blinded Treatment Period||0
8160406|NCT02541669|20116355|P5|STARTED|Double-Blinded Treatment Period||16
8160407|NCT02541669|20116356|P4|STARTED|Double-Blinded Treatment Period||16
8160408|NCT02541669|20116357|P3|STARTED|Double-Blinded Treatment Period||16
8160409|NCT02541669|20116358|P2|STARTED|Double-Blinded Treatment Period||0
8160410|NCT02541669|20116359|P1|STARTED|Double-Blinded Treatment Period||0
8160412|NCT02541669|20116356|P4|NOT COMPLETED|Open Label Treatment Period||0
8160413|NCT02541669|20116357|P3|NOT COMPLETED|Open Label Treatment Period||0
8160414|NCT02541669|20116358|P2|NOT COMPLETED|Open Label Treatment Period||0
8160415|NCT02541669|20116359|P1|NOT COMPLETED|Open Label Treatment Period||0
8160416|NCT02541669|20116355|P5|COMPLETED|Open Label Treatment Period||0
8160417|NCT02541669|20116356|P4|COMPLETED|Open Label Treatment Period||0
8160418|NCT02541669|20116357|P3|COMPLETED|Open Label Treatment Period||0
8160419|NCT02541669|20116358|P2|COMPLETED|Open Label Treatment Period||8
8160420|NCT02541669|20116359|P1|COMPLETED|Open Label Treatment Period||8
8160421|NCT02541669|20116355|P5|STARTED|Open Label Treatment Period||0
8160422|NCT02541669|20116356|P4|STARTED|Open Label Treatment Period||0
8160423|NCT02541669|20116357|P3|STARTED|Open Label Treatment Period||0
8160424|NCT02541669|20116358|P2|STARTED|Open Label Treatment Period||8
8160425|NCT02541669|20116359|P1|STARTED|Open Label Treatment Period||8
8160426|NCT02541604|20116406|P12|NOT COMPLETED|Overall Study||3
8160427|NCT02541604|20116407|P11|NOT COMPLETED|Overall Study||2
8160428|NCT02541604|20116408|P10|NOT COMPLETED|Overall Study||4
8160429|NCT02541604|20116409|P9|NOT COMPLETED|Overall Study||4
8160430|NCT02541604|20116410|P8|NOT COMPLETED|Overall Study||10
8160431|NCT02541604|20116411|P7|NOT COMPLETED|Overall Study||10
8160432|NCT02541604|20116412|P6|NOT COMPLETED|Overall Study||10
8160433|NCT02541604|20116413|P5|NOT COMPLETED|Overall Study||10
8160434|NCT02541604|20116414|P4|NOT COMPLETED|Overall Study||3
8160435|NCT02541604|20116415|P3|NOT COMPLETED|Overall Study||11
8160436|NCT02541604|20116416|P2|NOT COMPLETED|Overall Study||9
8160437|NCT02541604|20116417|P1|NOT COMPLETED|Overall Study||11
8160438|NCT02541604|20116406|P12|COMPLETED|Overall Study||0
8160439|NCT02541604|20116407|P11|COMPLETED|Overall Study||0
8160440|NCT02541604|20116408|P10|COMPLETED|Overall Study||0
8160441|NCT02541604|20116409|P9|COMPLETED|Overall Study||0
8160442|NCT02541604|20116410|P8|COMPLETED|Overall Study||0
8160443|NCT02541604|20116411|P7|COMPLETED|Overall Study||0
8160444|NCT02541604|20116412|P6|COMPLETED|Overall Study||0
8160445|NCT02541604|20116413|P5|COMPLETED|Overall Study||0
8160446|NCT02541604|20116414|P4|COMPLETED|Overall Study||0
8160447|NCT02541604|20116415|P3|COMPLETED|Overall Study||0
8160448|NCT02541604|20116416|P2|COMPLETED|Overall Study||0
8160449|NCT02541604|20116417|P1|COMPLETED|Overall Study||0
8160450|NCT02541604|20116406|P12|STARTED|Overall Study||3
8160451|NCT02541604|20116407|P11|STARTED|Overall Study||2
8160452|NCT02541604|20116408|P10|STARTED|Overall Study||4
8160453|NCT02541604|20116409|P9|STARTED|Overall Study||4
8160454|NCT02541604|20116410|P8|STARTED|Overall Study||10
8160455|NCT02541604|20116411|P7|STARTED|Overall Study||10
8160456|NCT02541604|20116412|P6|STARTED|Overall Study||10
8160457|NCT02541604|20116413|P5|STARTED|Overall Study||10
8160458|NCT02541604|20116414|P4|STARTED|Overall Study||3
8160459|NCT02541604|20116415|P3|STARTED|Overall Study||11
8160460|NCT02541604|20116416|P2|STARTED|Overall Study||9
8160461|NCT02541604|20116417|P1|STARTED|Overall Study||11
8160462|NCT02541565|20116522|P1|NOT COMPLETED|Overall Study||3
8160463|NCT02541565|20116522|P1|COMPLETED|Overall Study||27
8160464|NCT02541565|20116522|P1|STARTED|Overall Study||30
8160465|NCT02541422|20116526|P2|NOT COMPLETED|Second Intervention||0
8160466|NCT02541422|20116527|P1|NOT COMPLETED|Second Intervention||0
8160467|NCT02541422|20116526|P2|COMPLETED|Second Intervention||26
8160468|NCT02541422|20116527|P1|COMPLETED|Second Intervention||23
8160469|NCT02541422|20116526|P2|STARTED|Second Intervention||26
8160470|NCT02541422|20116527|P1|STARTED|Second Intervention||23
8160471|NCT02541422|20116526|P2|NOT COMPLETED|First Intervention||0
8160472|NCT02541422|20116527|P1|NOT COMPLETED|First Intervention||0
8160473|NCT02541422|20116526|P2|COMPLETED|First Intervention||26
8160474|NCT02541422|20116527|P1|COMPLETED|First Intervention||23
8160475|NCT02541422|20116526|P2|STARTED|First Intervention||26
8160476|NCT02541422|20116527|P1|STARTED|First Intervention||23
8160477|NCT02540850|20116536|P3|NOT COMPLETED|Overall Study||34
8160478|NCT02540850|20116537|P2|NOT COMPLETED|Overall Study||66
8160479|NCT02540850|20116538|P1|NOT COMPLETED|Overall Study||69
8160480|NCT02540850|20116536|P3|COMPLETED|Overall Study||410
8160481|NCT02540850|20116537|P2|COMPLETED|Overall Study||330
8160482|NCT02540850|20116538|P1|COMPLETED|Overall Study||291
8160483|NCT02540850|20116536|P3|STARTED|Overall Study||444
8160484|NCT02540850|20116537|P2|STARTED|Overall Study||396
8160485|NCT02540850|20116538|P1|STARTED|Overall Study||360
8160486|NCT02540772|20116566|P2|NOT COMPLETED|Overall Study||0
8160487|NCT02540772|20116567|P1|NOT COMPLETED|Overall Study||0
8160488|NCT02540772|20116566|P2|COMPLETED|Overall Study||10
8160489|NCT02540772|20116567|P1|COMPLETED|Overall Study||10
8160490|NCT02540772|20116566|P2|STARTED|Overall Study||10
8160491|NCT02540772|20116567|P1|STARTED|Overall Study||10
8160492|NCT02540668|20116579|P2|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
8160493|NCT02540668|20116580|P1|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
8160494|NCT02540668|20116579|P2|COMPLETED|Period 2 - LY3314814 and Warfarin||14
8160495|NCT02540668|20116580|P1|COMPLETED|Period 2 - LY3314814 and Warfarin||0
8160496|NCT02540668|20116579|P2|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
8160497|NCT02540668|20116580|P1|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
8160498|NCT02540668|20116579|P2|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
8160499|NCT02540668|20116580|P1|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
8160500|NCT02540668|20116579|P2|COMPLETED|Period 1 - Warfarin Single Dose||0
8160501|NCT02540668|20116580|P1|COMPLETED|Period 1 - Warfarin Single Dose||15
8160502|NCT02540668|20116579|P2|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
8160503|NCT02540668|20116580|P1|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
8160504|NCT02540668|20116579|P2|STARTED|Period 1 - Warfarin Single Dose||0
8160505|NCT02540668|20116580|P1|STARTED|Period 1 - Warfarin Single Dose||15
8160506|NCT02540629|20116599|P2|NOT COMPLETED|Overall Study||0
8160507|NCT02540629|20116600|P1|NOT COMPLETED|Overall Study||0
8160508|NCT02540629|20116599|P2|COMPLETED|Overall Study||6469
8160509|NCT02540629|20116600|P1|COMPLETED|Overall Study||6201
8160510|NCT02540629|20116599|P2|STARTED|Overall Study||6469
8160511|NCT02540629|20116600|P1|STARTED|Overall Study||6201
8160512|NCT02540538|20116611|P3|NOT COMPLETED|Overall Study||0
8160513|NCT02540538|20116612|P2|NOT COMPLETED|Overall Study||1
8160514|NCT02540538|20116613|P1|NOT COMPLETED|Overall Study||0
8160515|NCT02540538|20116611|P3|COMPLETED|Overall Study||10
8160516|NCT02540538|20116612|P2|COMPLETED|Overall Study||11
8160517|NCT02540538|20116613|P1|COMPLETED|Overall Study||12
8160518|NCT02540538|20116611|P3|STARTED|Overall Study||10
8160519|NCT02540538|20116612|P2|STARTED|Overall Study||12
8160520|NCT02540538|20116613|P1|STARTED|Overall Study||12
8160521|NCT02540447|20116629|P2|NOT COMPLETED|Overall Study||0
8160522|NCT02540447|20116630|P1|NOT COMPLETED|Overall Study||0
8160523|NCT02540447|20116629|P2|COMPLETED|Overall Study||40
8160524|NCT02540447|20116630|P1|COMPLETED|Overall Study||40
8160525|NCT02540447|20116629|P2|STARTED|Overall Study||40
8160526|NCT02540447|20116630|P1|STARTED|Overall Study||40
8160527|NCT02540434|20116646|P2|NOT COMPLETED|Overall Study||0
8160528|NCT02540434|20116647|P1|NOT COMPLETED|Overall Study||0
8160529|NCT02540434|20116646|P2|COMPLETED|Overall Study||1
8160530|NCT02540434|20116647|P1|COMPLETED|Overall Study||1
8160531|NCT02540434|20116646|P2|STARTED|Overall Study||1
8160532|NCT02540434|20116647|P1|STARTED|Overall Study||1
8160533|NCT02540356|20116681|P2|NOT COMPLETED|Overall Study||0
8160534|NCT02540356|20116682|P1|NOT COMPLETED|Overall Study||1
8160535|NCT02540356|20116681|P2|COMPLETED|Overall Study||0
8160536|NCT02540356|20116682|P1|COMPLETED|Overall Study||0
8160537|NCT02540356|20116681|P2|STARTED|Overall Study||0
8160538|NCT02540356|20116682|P1|STARTED|Overall Study||1
8160539|NCT02540291|20116717|P4|NOT COMPLETED|Overall Study||7
8160540|NCT02540291|20116718|P3|NOT COMPLETED|Overall Study||7
8160541|NCT02540291|20116719|P2|NOT COMPLETED|Overall Study||8
8160542|NCT02540291|20116720|P1|NOT COMPLETED|Overall Study||8
8160543|NCT02540291|20116717|P4|COMPLETED|Overall Study||0
8160544|NCT02540291|20116718|P3|COMPLETED|Overall Study||0
8160545|NCT02540291|20116719|P2|COMPLETED|Overall Study||0
8160546|NCT02540291|20116720|P1|COMPLETED|Overall Study||0
8160547|NCT02540291|20116717|P4|STARTED|Overall Study||7
8160548|NCT02540291|20116718|P3|STARTED|Overall Study||7
8160549|NCT02540291|20116719|P2|STARTED|Overall Study||8
8160550|NCT02540291|20116720|P1|STARTED|Overall Study||8
8160551|NCT02540265|20116755|P3|NOT COMPLETED|Overall Study||1
8160552|NCT02540265|20116756|P2|NOT COMPLETED|Overall Study||0
8160553|NCT02540265|20116757|P1|NOT COMPLETED|Overall Study||0
8160554|NCT02540265|20116755|P3|COMPLETED|Overall Study||18
8160555|NCT02540265|20116756|P2|COMPLETED|Overall Study||20
8160556|NCT02540265|20116757|P1|COMPLETED|Overall Study||20
8160557|NCT02540265|20116755|P3|Treatment Completion|Overall Study||18
8160558|NCT02540265|20116756|P2|Treatment Completion|Overall Study||19
8160559|NCT02540265|20116757|P1|Treatment Completion|Overall Study||20
8160560|NCT02540265|20116755|P3|STARTED|Overall Study||19
8160561|NCT02540265|20116756|P2|STARTED|Overall Study||20
8160562|NCT02540265|20116757|P1|STARTED|Overall Study||20
8160563|NCT02540226|20116779|P2|NOT COMPLETED|Overall Study||1
8160564|NCT02540226|20116780|P1|NOT COMPLETED|Overall Study||2
8160565|NCT02540226|20116779|P2|COMPLETED|Overall Study||32
8160566|NCT02540226|20116780|P1|COMPLETED|Overall Study||31
8160567|NCT02540226|20116779|P2|STARTED|Overall Study||33
8160568|NCT02540226|20116780|P1|STARTED|Overall Study||33
8160569|NCT02540213|20116812|P1|NOT COMPLETED|Overall Study||39
8160570|NCT02540213|20116812|P1|COMPLETED|Overall Study||201
8160571|NCT02540213|20116812|P1|STARTED|Overall Study||240
8160572|NCT02540161|20116837|P4|NOT COMPLETED|Overall Study||0
8160573|NCT02540161|20116838|P3|NOT COMPLETED|Overall Study||0
8160574|NCT02540161|20116839|P2|NOT COMPLETED|Overall Study||0
8160575|NCT02540161|20116840|P1|NOT COMPLETED|Overall Study||0
8160576|NCT02540161|20116837|P4|COMPLETED|Overall Study||7
8160577|NCT02540161|20116838|P3|COMPLETED|Overall Study||5
8160578|NCT02540161|20116839|P2|COMPLETED|Overall Study||7
8160579|NCT02540161|20116840|P1|COMPLETED|Overall Study||20
8160580|NCT02540161|20116837|P4|STARTED|Overall Study||7
8160581|NCT02540161|20116838|P3|STARTED|Overall Study||5
8160582|NCT02540161|20116839|P2|STARTED|Overall Study||7
8160583|NCT02540161|20116840|P1|STARTED|Overall Study||20
8160584|NCT02540083|20116866|P1|NOT COMPLETED|Overall Study||16
8160585|NCT02540083|20116866|P1|COMPLETED|Overall Study||78
8160586|NCT02540083|20116866|P1|STARTED|Overall Study||94
8160587|NCT02539992|20116879|P3|NOT COMPLETED|Overall Study||4
8160588|NCT02539992|20116880|P2|NOT COMPLETED|Overall Study||4
8160589|NCT02539992|20116881|P1|NOT COMPLETED|Overall Study||0
8160590|NCT02539992|20116879|P3|COMPLETED|Overall Study||14
8160591|NCT02539992|20116880|P2|COMPLETED|Overall Study||7
8160592|NCT02539992|20116881|P1|COMPLETED|Overall Study||15
8160593|NCT02539992|20116879|P3|STARTED|Overall Study||18
8160594|NCT02539992|20116880|P2|STARTED|Overall Study||11
8160595|NCT02539992|20116881|P1|STARTED|Overall Study||15
8160596|NCT02539797|20116907|P3|NOT COMPLETED|Overall Study||0
8160597|NCT02539797|20116908|P2|NOT COMPLETED|Overall Study||1
8160598|NCT02539797|20116909|P1|NOT COMPLETED|Overall Study||0
8160599|NCT02539797|20116907|P3|COMPLETED|Overall Study||13
8160600|NCT02539797|20116908|P2|COMPLETED|Overall Study||12
8160601|NCT02539797|20116909|P1|COMPLETED|Overall Study||12
8160602|NCT02539797|20116907|P3|STARTED|Overall Study||13
8160603|NCT02539797|20116908|P2|STARTED|Overall Study||13
8160604|NCT02539797|20116909|P1|STARTED|Overall Study||12
8160605|NCT02539654|20116920|P1|NOT COMPLETED|Overall Study||0
8160606|NCT02539654|20116920|P1|COMPLETED|Overall Study||14
8160607|NCT02539654|20116920|P1|STARTED|Overall Study||14
8160608|NCT02539563|20116932|P2|NOT COMPLETED|Overall Study||14
8160609|NCT02539563|20116933|P1|NOT COMPLETED|Overall Study||6
8160610|NCT02539563|20116932|P2|COMPLETED|Overall Study||42
8160611|NCT02539563|20116933|P1|COMPLETED|Overall Study||39
8160612|NCT02539563|20116932|P2|STARTED|Overall Study||56
8160613|NCT02539563|20116933|P1|STARTED|Overall Study||45
8160614|NCT02539511|20116949|P2|NOT COMPLETED|Overall Study||0
8160615|NCT02539511|20116950|P1|NOT COMPLETED|Overall Study||6
8160616|NCT02539511|20116949|P2|COMPLETED|Overall Study||17
8160617|NCT02539511|20116950|P1|COMPLETED|Overall Study||17
8160618|NCT02539511|20116949|P2|STARTED|Overall Study||17
8160619|NCT02539511|20116950|P1|STARTED|Overall Study||23
8160620|NCT02539368|20116961|P5|NOT COMPLETED|Overall Study||14
8160621|NCT02539368|20116962|P4|NOT COMPLETED|Overall Study||7
8160622|NCT02539368|20116963|P3|NOT COMPLETED|Overall Study||67
8160623|NCT02539368|20116964|P2|NOT COMPLETED|Overall Study||101
8160624|NCT02539368|20116965|P1|NOT COMPLETED|Overall Study||405
8160625|NCT02539368|20116961|P5|COMPLETED|Overall Study||88
8160626|NCT02539368|20116962|P4|COMPLETED|Overall Study||60
8160627|NCT02539368|20116963|P3|COMPLETED|Overall Study||291
8160628|NCT02539368|20116964|P2|COMPLETED|Overall Study||393
8160629|NCT02539368|20116965|P1|COMPLETED|Overall Study||1117
8160630|NCT02539368|20116961|P5|STARTED|Overall Study||102
8160631|NCT02539368|20116962|P4|STARTED|Overall Study||67
8160632|NCT02539368|20116963|P3|STARTED|Overall Study||358
8160633|NCT02539368|20116964|P2|STARTED|Overall Study||494
8160634|NCT02539368|20116965|P1|STARTED|Overall Study||1522
8160635|NCT02539342|20117087|P2|NOT COMPLETED|Overall Study||0
8160636|NCT02539342|20117088|P1|NOT COMPLETED|Overall Study||0
8160637|NCT02539342|20117087|P2|COMPLETED|Overall Study||0
8160638|NCT02539342|20117088|P1|COMPLETED|Overall Study||1
8160639|NCT02539342|20117087|P2|STARTED|Overall Study||0
8160640|NCT02539342|20117088|P1|STARTED|Overall Study||1
8160641|NCT02539225|20117098|P2|NOT COMPLETED|Part B||16
8160642|NCT02539225|20117099|P1|NOT COMPLETED|Part B||4
8160643|NCT02539225|20117098|P2|COMPLETED|Part B||48
8160644|NCT02539225|20117099|P1|COMPLETED|Part B||54
8160645|NCT02539225|20117098|P2|STARTED|Part B||64
8160646|NCT02539225|20117099|P1|STARTED|Part B||58
8160647|NCT02539225|20117098|P2|NOT COMPLETED|Pre Treatment for Part B||2
8160648|NCT02539225|20117099|P1|NOT COMPLETED|Pre Treatment for Part B||5
8160649|NCT02539225|20117098|P2|COMPLETED|Pre Treatment for Part B||64
8160650|NCT02539225|20117099|P1|COMPLETED|Pre Treatment for Part B||58
8160651|NCT02539225|20117098|P2|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
8160652|NCT02539225|20117099|P1|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
8160653|NCT02539225|20117098|P2|NOT COMPLETED|Part A||16
8160654|NCT02539225|20117099|P1|NOT COMPLETED|Part A||20
8160655|NCT02539225|20117098|P2|COMPLETED|Part A||78
8160656|NCT02539225|20117099|P1|COMPLETED|Part A||77
8160657|NCT02539225|20117098|P2|Received Any Quantity of Study Drug|Part A||93
8160658|NCT02539225|20117099|P1|Received Any Quantity of Study Drug|Part A||96
8160659|NCT02539225|20117098|P2|STARTED|Part A||94
8160660|NCT02539225|20117099|P1|STARTED|Part A||97
8160661|NCT02539134|20117126|P6|NOT COMPLETED|Overall Study||0
8160662|NCT02539134|20117127|P5|NOT COMPLETED|Overall Study||0
8160663|NCT02539134|20117128|P4|NOT COMPLETED|Overall Study||0
8160664|NCT02539134|20117129|P3|NOT COMPLETED|Overall Study||0
8160665|NCT02539134|20117130|P2|NOT COMPLETED|Overall Study||0
8160666|NCT02539134|20117131|P1|NOT COMPLETED|Overall Study||1
8160667|NCT02539134|20117126|P6|COMPLETED|Overall Study||6
8160668|NCT02539134|20117127|P5|COMPLETED|Overall Study||6
8160669|NCT02539134|20117128|P4|COMPLETED|Overall Study||6
8160670|NCT02539134|20117129|P3|COMPLETED|Overall Study||6
8160671|NCT02539134|20117130|P2|COMPLETED|Overall Study||6
8160672|NCT02539134|20117131|P1|COMPLETED|Overall Study||9
8160673|NCT02539134|20117126|P6|STARTED|Overall Study||6
8160674|NCT02539134|20117127|P5|STARTED|Overall Study||6
8160675|NCT02539134|20117128|P4|STARTED|Overall Study||6
8160676|NCT02539134|20117129|P3|STARTED|Overall Study||6
8160677|NCT02539134|20117130|P2|STARTED|Overall Study||6
8160678|NCT02539134|20117131|P1|STARTED|Overall Study||10
8160679|NCT02539108|20117185|P2|NOT COMPLETED|Overall Study||0
8160680|NCT02539108|20117186|P1|NOT COMPLETED|Overall Study||0
8160681|NCT02539108|20117185|P2|COMPLETED|Overall Study||30
8160682|NCT02539108|20117186|P1|COMPLETED|Overall Study||30
8160683|NCT02539108|20117185|P2|STARTED|Overall Study||30
8160684|NCT02539108|20117186|P1|STARTED|Overall Study||30
8160685|NCT02538965|20117200|P1|NOT COMPLETED|Follow-Up Period||17
8160686|NCT02538965|20117200|P1|COMPLETED|Follow-Up Period||0
8160687|NCT02538965|20117200|P1|STARTED|Follow-Up Period||17
8160688|NCT02538965|20117200|P1|NOT COMPLETED|Treatment Period||17
8160689|NCT02538965|20117200|P1|COMPLETED|Treatment Period||0
8160690|NCT02538965|20117200|P1|STARTED|Treatment Period||17
8160691|NCT02538783|20117221|P2|NOT COMPLETED|Overall Study||1
8160692|NCT02538783|20117222|P1|NOT COMPLETED|Overall Study||0
8160693|NCT02538783|20117221|P2|COMPLETED|Overall Study||128
8160694|NCT02538783|20117222|P1|COMPLETED|Overall Study||130
8160695|NCT02538783|20117221|P2|STARTED|Overall Study||129
8160696|NCT02538783|20117222|P1|STARTED|Overall Study||130
8160697|NCT02538679|20117233|P3|NOT COMPLETED|Overall Study||8
8160698|NCT02538679|20117234|P2|NOT COMPLETED|Overall Study||9
8160699|NCT02538679|20117235|P1|NOT COMPLETED|Overall Study||3
8160700|NCT02538679|20117233|P3|COMPLETED|Overall Study||41
8160701|NCT02538679|20117234|P2|COMPLETED|Overall Study||45
8160702|NCT02538679|20117235|P1|COMPLETED|Overall Study||21
8160703|NCT02538679|20117233|P3|STARTED|Overall Study||49
8160704|NCT02538679|20117234|P2|STARTED|Overall Study||54
8160705|NCT02538679|20117235|P1|STARTED|Overall Study||24
8160706|NCT02538666|20117246|P3|NOT COMPLETED|Overall Study||1
8160707|NCT02538666|20117247|P2|NOT COMPLETED|Overall Study||1
8160708|NCT02538666|20117248|P1|NOT COMPLETED|Overall Study||2
8160709|NCT02538666|20117246|P3|COMPLETED|Overall Study||278
8160710|NCT02538666|20117247|P2|COMPLETED|Overall Study||279
8160711|NCT02538666|20117248|P1|COMPLETED|Overall Study||273
8160712|NCT02538666|20117246|P3|STARTED|Overall Study||279
8160713|NCT02538666|20117247|P2|STARTED|Overall Study||280
8160714|NCT02538666|20117248|P1|STARTED|Overall Study||275
8160715|NCT02538614|20117267|P1|NOT COMPLETED|Overall Study||2
8160716|NCT02538614|20117267|P1|COMPLETED|Overall Study||0
8160717|NCT02538614|20117267|P1|STARTED|Overall Study||2
8160718|NCT02538523|20117285|P2|NOT COMPLETED|Overall Study||0
8160719|NCT02538523|20117286|P1|NOT COMPLETED|Overall Study||0
8160720|NCT02538523|20117285|P2|COMPLETED|Overall Study||29
8160721|NCT02538523|20117286|P1|COMPLETED|Overall Study||29
8160722|NCT02538523|20117285|P2|STARTED|Overall Study||29
8160723|NCT02538523|20117286|P1|STARTED|Overall Study||29
8160724|NCT02538510|20117296|P2|NOT COMPLETED|Overall Study||0
8160725|NCT02538510|20117297|P1|NOT COMPLETED|Overall Study||0
8160726|NCT02538510|20117296|P2|COMPLETED|Overall Study||25
8160727|NCT02538510|20117297|P1|COMPLETED|Overall Study||25
8160728|NCT02538510|20117296|P2|STARTED|Overall Study||25
8160729|NCT02538510|20117297|P1|STARTED|Overall Study||25
8160730|NCT02538471|20117307|P1|NOT COMPLETED|Overall Study||2
8160731|NCT02538471|20117307|P1|COMPLETED|Overall Study||1
8160732|NCT02538471|20117307|P1|STARTED|Overall Study||3
8160733|NCT02538419|20117317|P2|NOT COMPLETED|Overall Study||0
8160734|NCT02538419|20117318|P1|NOT COMPLETED|Overall Study||0
8160735|NCT02538419|20117317|P2|COMPLETED|Overall Study||20
8160736|NCT02538419|20117318|P1|COMPLETED|Overall Study||20
8160737|NCT02538419|20117317|P2|STARTED|Overall Study||20
8160738|NCT02538419|20117318|P1|STARTED|Overall Study||20
8160739|NCT02538354|20117336|P2|NOT COMPLETED|Overall Study||0
8160740|NCT02538354|20117337|P1|NOT COMPLETED|Overall Study||0
8160741|NCT02538354|20117336|P2|COMPLETED|Overall Study||30
8160742|NCT02538354|20117337|P1|COMPLETED|Overall Study||40
8160743|NCT02538354|20117336|P2|STARTED|Overall Study||30
8160744|NCT02538354|20117337|P1|STARTED|Overall Study||40
8160745|NCT02538107|20117343|P1|NOT COMPLETED|Overall Study||110
8160746|NCT02538107|20117343|P1|COMPLETED|Overall Study||180
8160747|NCT02538107|20117343|P1|STARTED|Overall Study||290
8160748|NCT02538094|20117363|P2|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
8160749|NCT02538094|20117364|P1|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
8160750|NCT02538094|20117363|P2|COMPLETED|Intervention 2 (5 Days Per Participant)||3
8160751|NCT02538094|20117364|P1|COMPLETED|Intervention 2 (5 Days Per Participant)||2
8160752|NCT02538094|20117363|P2|STARTED|Intervention 2 (5 Days Per Participant)||3
8160753|NCT02538094|20117364|P1|STARTED|Intervention 2 (5 Days Per Participant)||2
8160754|NCT02538094|20117363|P2|NOT COMPLETED|Washout (4 Weeks)||1
8160755|NCT02538094|20117364|P1|NOT COMPLETED|Washout (4 Weeks)||0
8160756|NCT02538094|20117363|P2|COMPLETED|Washout (4 Weeks)||3
8160757|NCT02538094|20117364|P1|COMPLETED|Washout (4 Weeks)||2
8160758|NCT02538094|20117363|P2|STARTED|Washout (4 Weeks)||4
8160759|NCT02538094|20117364|P1|STARTED|Washout (4 Weeks)||2
8160760|NCT02538094|20117363|P2|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
8160761|NCT02538094|20117364|P1|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
8160762|NCT02538094|20117363|P2|COMPLETED|Intervention 1 (5 Days Per Participant)||4
8160763|NCT02538094|20117364|P1|COMPLETED|Intervention 1 (5 Days Per Participant)||2
8160764|NCT02538094|20117363|P2|STARTED|Intervention 1 (5 Days Per Participant)||5
8160765|NCT02538094|20117364|P1|STARTED|Intervention 1 (5 Days Per Participant)||2
8160766|NCT02538042|20117374|P2|NOT COMPLETED|Overall Study||11
8160767|NCT02538042|20117375|P1|NOT COMPLETED|Overall Study||11
8160768|NCT02538042|20117374|P2|COMPLETED|Overall Study||6
8160769|NCT02538042|20117375|P1|COMPLETED|Overall Study||6
8160770|NCT02538042|20117374|P2|Completed All Post-Quit Visits|Overall Study||12
8160771|NCT02538042|20117375|P1|Completed All Post-Quit Visits|Overall Study||12
8160772|NCT02538042|20117374|P2|Attended Post-Quit Visit|Overall Study||14
8160773|NCT02538042|20117375|P1|Attended Post-Quit Visit|Overall Study||15
8160774|NCT02538042|20117374|P2|Completed All MCE Sessions|Overall Study||15
8160775|NCT02538042|20117375|P1|Completed All MCE Sessions|Overall Study||15
8160776|NCT02538042|20117374|P2|STARTED|Overall Study||17
8160777|NCT02538042|20117375|P1|STARTED|Overall Study||17
8160778|NCT02538029|20117394|P3|NOT COMPLETED|Overall Study||1
8160779|NCT02538029|20117395|P2|NOT COMPLETED|Overall Study||0
8160780|NCT02538029|20117396|P1|NOT COMPLETED|Overall Study||1
8160781|NCT02538029|20117394|P3|COMPLETED|Overall Study||10
8160782|NCT02538029|20117395|P2|COMPLETED|Overall Study||10
8160783|NCT02538029|20117396|P1|COMPLETED|Overall Study||23
8160784|NCT02538029|20117394|P3|STARTED|Overall Study||11
8160785|NCT02538029|20117395|P2|STARTED|Overall Study||10
8160786|NCT02538029|20117396|P1|STARTED|Overall Study||24
8160787|NCT02538016|20117418|P1|NOT COMPLETED|Overall Study||0
8160788|NCT02538016|20117418|P1|COMPLETED|Overall Study||4
8160789|NCT02538016|20117418|P1|STARTED|Overall Study||4
8160790|NCT02537951|20117423|P1|NOT COMPLETED|Overall Study||0
8160791|NCT02537951|20117423|P1|COMPLETED|Overall Study||10
8160792|NCT02537951|20117423|P1|STARTED|Overall Study||10
8160793|NCT02537873|20117433|P2|NOT COMPLETED|Overall Study||4
8160794|NCT02537873|20117434|P1|NOT COMPLETED|Overall Study||8
8160795|NCT02537873|20117433|P2|COMPLETED|Overall Study||4
8160796|NCT02537873|20117434|P1|COMPLETED|Overall Study||9
8160797|NCT02537873|20117433|P2|STARTED|Overall Study||8
8160798|NCT02537873|20117434|P1|STARTED|Overall Study||17
8160799|NCT02537730|20117452|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8160800|NCT02537730|20117453|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8160801|NCT02537730|20117452|P2|COMPLETED|Second Intervention (7 Days)||16
8160802|NCT02537730|20117453|P1|COMPLETED|Second Intervention (7 Days)||17
8160803|NCT02537730|20117452|P2|STARTED|Second Intervention (7 Days)||16
8160804|NCT02537730|20117453|P1|STARTED|Second Intervention (7 Days)||17
8160805|NCT02537730|20117452|P2|NOT COMPLETED|First Intervention (7 Days)||0
8160806|NCT02537730|20117453|P1|NOT COMPLETED|First Intervention (7 Days)||0
8160807|NCT02537730|20117452|P2|COMPLETED|First Intervention (7 Days)||16
8160808|NCT02537730|20117453|P1|COMPLETED|First Intervention (7 Days)||17
8160809|NCT02537730|20117452|P2|STARTED|First Intervention (7 Days)||16
8160810|NCT02537730|20117453|P1|STARTED|First Intervention (7 Days)||17
8160811|NCT02537717|20117465|P1|NOT COMPLETED|Overall Study||0
8160812|NCT02537717|20117465|P1|COMPLETED|Overall Study||17
8160813|NCT02537717|20117465|P1|STARTED|Overall Study||17
8160814|NCT02537574|20117487|P3|NOT COMPLETED|Overall Study||108
8160815|NCT02537574|20117488|P2|NOT COMPLETED|Overall Study||103
8160816|NCT02537574|20117489|P1|NOT COMPLETED|Overall Study||99
8160817|NCT02537574|20117487|P3|COMPLETED|Overall Study||18
8160818|NCT02537574|20117488|P2|COMPLETED|Overall Study||23
8160819|NCT02537574|20117489|P1|COMPLETED|Overall Study||27
8160820|NCT02537574|20117487|P3|STARTED|Overall Study||126
8160821|NCT02537574|20117488|P2|STARTED|Overall Study||126
8160822|NCT02537574|20117489|P1|STARTED|Overall Study||126
8160823|NCT02537522|20117515|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160824|NCT02537522|20117516|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160825|NCT02537522|20117517|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160826|NCT02537522|20117518|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160827|NCT02537522|20117515|P4|COMPLETED|Phase II - Period 2 Bilateral||22
8160828|NCT02537522|20117516|P3|COMPLETED|Phase II - Period 2 Bilateral||23
8160829|NCT02537522|20117517|P2|COMPLETED|Phase II - Period 2 Bilateral||0
8160830|NCT02537522|20117518|P1|COMPLETED|Phase II - Period 2 Bilateral||0
8160831|NCT02537522|20117515|P4|STARTED|Phase II - Period 2 Bilateral||22
8160832|NCT02537522|20117516|P3|STARTED|Phase II - Period 2 Bilateral||23
8160833|NCT02537522|20117517|P2|STARTED|Phase II - Period 2 Bilateral||0
8160834|NCT02537522|20117518|P1|STARTED|Phase II - Period 2 Bilateral||0
8160835|NCT02537522|20117515|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
8160836|NCT02537522|20117516|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8160837|NCT02537522|20117517|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8160838|NCT02537522|20117518|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8160839|NCT02537522|20117515|P4|COMPLETED|Phase II - Period 1 Bilateral||22
8160840|NCT02537522|20117516|P3|COMPLETED|Phase II - Period 1 Bilateral||23
8160841|NCT02537522|20117517|P2|COMPLETED|Phase II - Period 1 Bilateral||0
8160842|NCT02537522|20117518|P1|COMPLETED|Phase II - Period 1 Bilateral||0
8160843|NCT02537522|20117515|P4|STARTED|Phase II - Period 1 Bilateral||23
8160844|NCT02537522|20117516|P3|STARTED|Phase II - Period 1 Bilateral||23
8160845|NCT02537522|20117517|P2|STARTED|Phase II - Period 1 Bilateral||0
8160846|NCT02537522|20117518|P1|STARTED|Phase II - Period 1 Bilateral||0
8160847|NCT02537522|20117515|P4|NOT COMPLETED|Phase I - Contralateral||0
8160848|NCT02537522|20117516|P3|NOT COMPLETED|Phase I - Contralateral||0
8160849|NCT02537522|20117517|P2|NOT COMPLETED|Phase I - Contralateral||10
8160850|NCT02537522|20117518|P1|NOT COMPLETED|Phase I - Contralateral||15
8160851|NCT02537522|20117515|P4|COMPLETED|Phase I - Contralateral||0
8160852|NCT02537522|20117516|P3|COMPLETED|Phase I - Contralateral||0
8160853|NCT02537522|20117517|P2|COMPLETED|Phase I - Contralateral||27
8160854|NCT02537522|20117518|P1|COMPLETED|Phase I - Contralateral||19
8160855|NCT02537522|20117515|P4|STARTED|Phase I - Contralateral||0
8160856|NCT02537522|20117516|P3|STARTED|Phase I - Contralateral||0
8160857|NCT02537522|20117517|P2|STARTED|Phase I - Contralateral||37
8160858|NCT02537522|20117518|P1|STARTED|Phase I - Contralateral||34
8160859|NCT02537444|20117528|P2|NOT COMPLETED|Overall Study||39
8160860|NCT02537444|20117529|P1|NOT COMPLETED|Overall Study||39
8160861|NCT02537444|20117528|P2|COMPLETED|Overall Study||0
8160862|NCT02537444|20117529|P1|COMPLETED|Overall Study||0
8160863|NCT02537444|20117528|P2|Discontinued Study|Overall Study||39
8160864|NCT02537444|20117529|P1|Discontinued Study|Overall Study||39
8160865|NCT02537444|20117528|P2|Received Study Medication|Overall Study||39
8160866|NCT02537444|20117529|P1|Received Study Medication|Overall Study||38
8160867|NCT02537444|20117528|P2|Enrolled|Overall Study||39
8160868|NCT02537444|20117529|P1|Enrolled|Overall Study||39
8160869|NCT02537444|20117528|P2|STARTED|Overall Study||39
8160870|NCT02537444|20117529|P1|STARTED|Overall Study||39
8160871|NCT02537431|20117535|P1|NOT COMPLETED|Treatment Extension Period II||0
8160872|NCT02537431|20117535|P1|COMPLETED|Treatment Extension Period II||8
8160873|NCT02537431|20117535|P1|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
8160874|NCT02537431|20117535|P1|NOT COMPLETED|Treatment Extension Period I||0
8160875|NCT02537431|20117535|P1|COMPLETED|Treatment Extension Period I||13
8160876|NCT02537431|20117535|P1|STARTED|Treatment Extension Period I||13
8160877|NCT02537431|20117535|P1|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
8160878|NCT02537431|20117535|P1|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
8160879|NCT02537431|20117535|P1|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
8160880|NCT02537015|20117564|P1|NOT COMPLETED|Overall Study||6
8160881|NCT02537015|20117564|P1|COMPLETED|Overall Study||75
8160882|NCT02537015|20117564|P1|STARTED|Overall Study||81
8160883|NCT02536976|20117570|P2|NOT COMPLETED|Overall Study||1
8160884|NCT02536976|20117571|P1|NOT COMPLETED|Overall Study||0
8160885|NCT02536976|20117570|P2|COMPLETED|Overall Study||1
8160886|NCT02536976|20117571|P1|COMPLETED|Overall Study||3
8160887|NCT02536976|20117570|P2|Washout|Overall Study||1
8160888|NCT02536976|20117571|P1|Washout|Overall Study||3
8160889|NCT02536976|20117570|P2|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
8160890|NCT02536976|20117571|P1|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
8160891|NCT02536976|20117570|P2|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
8160892|NCT02536976|20117571|P1|Randomization|Overall Study|2 weeks double blind mirabegron|3
8160893|NCT02536976|20117570|P2|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
8160894|NCT02536976|20117571|P1|STARTED|Overall Study|2 weeks single blind placebo run-in|3
8160895|NCT02536963|20117581|P1|NOT COMPLETED|Overall Study||18
8160896|NCT02536963|20117581|P1|COMPLETED|Overall Study||300
8160897|NCT02536963|20117581|P1|STARTED|Overall Study||318
8160898|NCT02536833|20117589|P4|NOT COMPLETED|Overall Study||19
8160899|NCT02536833|20117590|P3|NOT COMPLETED|Overall Study||15
8160900|NCT02536833|20117591|P2|NOT COMPLETED|Overall Study||10
8160901|NCT02536833|20117592|P1|NOT COMPLETED|Overall Study||9
8160902|NCT02536833|20117589|P4|COMPLETED|Overall Study||97
8160903|NCT02536833|20117590|P3|COMPLETED|Overall Study||95
8160904|NCT02536833|20117591|P2|COMPLETED|Overall Study||107
8160905|NCT02536833|20117592|P1|COMPLETED|Overall Study||103
8160906|NCT02536833|20117589|P4|STARTED|Overall Study||116
8160907|NCT02536833|20117590|P3|STARTED|Overall Study||110
8160908|NCT02536833|20117591|P2|STARTED|Overall Study||117
8160909|NCT02536833|20117592|P1|STARTED|Overall Study||112
8160910|NCT02536781|20117653|P2|NOT COMPLETED|Overall Study||0
8160911|NCT02536781|20117654|P1|NOT COMPLETED|Overall Study||2
8160912|NCT02536781|20117653|P2|COMPLETED|Overall Study||34
8160913|NCT02536781|20117654|P1|COMPLETED|Overall Study||34
8160914|NCT02536781|20117653|P2|STARTED|Overall Study||34
8160915|NCT02536781|20117654|P1|STARTED|Overall Study||36
8160916|NCT02536664|20117664|P2|NOT COMPLETED|Overall Study||80
8160917|NCT02536664|20117665|P1|NOT COMPLETED|Overall Study||107
8160918|NCT02536664|20117664|P2|COMPLETED|Overall Study||97
8160919|NCT02536664|20117665|P1|COMPLETED|Overall Study||205
8160920|NCT02536664|20117664|P2|STARTED|Overall Study||177
8160921|NCT02536664|20117665|P1|STARTED|Overall Study||312
8160922|NCT02536378|20117685|P2|NOT COMPLETED|Overall Study||7
8160923|NCT02536378|20117686|P1|NOT COMPLETED|Overall Study||7
8160924|NCT02536378|20117685|P2|COMPLETED|Overall Study||53
8160925|NCT02536378|20117686|P1|COMPLETED|Overall Study||625
8160926|NCT02536378|20117685|P2|STARTED|Overall Study||60
8160927|NCT02536378|20117686|P1|STARTED|Overall Study||632
8160932|NCT02536313|20117726|P2|NOT COMPLETED|Overall Study||1
8160933|NCT02536313|20117727|P1|NOT COMPLETED|Overall Study||0
8160934|NCT02536313|20117726|P2|COMPLETED|Overall Study||24
8160935|NCT02536313|20117727|P1|COMPLETED|Overall Study||24
8160936|NCT02536313|20117726|P2|STARTED|Overall Study||25
8160937|NCT02536313|20117727|P1|STARTED|Overall Study||24
8160938|NCT02536248|20117745|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8160939|NCT02536248|20117746|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8160940|NCT02536248|20117745|P2|COMPLETED|Second Intervention (6 Weeks)||10
8160941|NCT02536248|20117746|P1|COMPLETED|Second Intervention (6 Weeks)||10
8160942|NCT02536248|20117745|P2|STARTED|Second Intervention (6 Weeks)||10
8160943|NCT02536248|20117746|P1|STARTED|Second Intervention (6 Weeks)||10
8160944|NCT02536248|20117745|P2|NOT COMPLETED|Wash-out (14 Days)||0
8160945|NCT02536248|20117746|P1|NOT COMPLETED|Wash-out (14 Days)||0
8160946|NCT02536248|20117745|P2|COMPLETED|Wash-out (14 Days)||10
8160947|NCT02536248|20117746|P1|COMPLETED|Wash-out (14 Days)||10
8160948|NCT02536248|20117745|P2|STARTED|Wash-out (14 Days)||10
8160949|NCT02536248|20117746|P1|STARTED|Wash-out (14 Days)||10
8160950|NCT02536248|20117745|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8160951|NCT02536248|20117746|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8160952|NCT02536248|20117745|P2|COMPLETED|First Intervention (6 Weeks)||10
8160953|NCT02536248|20117746|P1|COMPLETED|First Intervention (6 Weeks)||10
8160954|NCT02536248|20117745|P2|STARTED|First Intervention (6 Weeks)||10
8160955|NCT02536248|20117746|P1|STARTED|First Intervention (6 Weeks)||10
8160956|NCT02536105|20117758|P1|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
8160957|NCT02536105|20117758|P1|COMPLETED|Methylphenidate HCl ER Suspension||72
8160958|NCT02536105|20117758|P1|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
8160959|NCT02536105|20117758|P1|STARTED|Methylphenidate HCl ER Suspension||74
8160960|NCT02536105|20117758|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
8160961|NCT02536105|20117758|P1|COMPLETED|Methylphenidate HCl ER Tablet 2||72
8160962|NCT02536105|20117758|P1|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
8160963|NCT02536105|20117758|P1|STARTED|Methylphenidate HCl ER Tablet 2||73
8160964|NCT02536105|20117758|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
8160965|NCT02536105|20117758|P1|COMPLETED|Methylphenidate HCl ER Tablet 1||72
8160966|NCT02536105|20117758|P1|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
8160967|NCT02536105|20117758|P1|STARTED|Methylphenidate HCl ER Tablet 1||72
8160968|NCT02536105|20117758|P1|NOT COMPLETED|Placebo||2
8160969|NCT02536105|20117758|P1|COMPLETED|Placebo||72
8160970|NCT02536105|20117758|P1|Completion of Placebo Day|Placebo||74
8160971|NCT02536105|20117758|P1|STARTED|Placebo||74
8160972|NCT02536105|20117758|P1|NOT COMPLETED|Concerta Open Label||8
8160973|NCT02536105|20117758|P1|COMPLETED|Concerta Open Label||72
8160974|NCT02536105|20117758|P1|Completion of Phase|Concerta Open Label||76
8160975|NCT02536105|20117758|P1|STARTED|Concerta Open Label||80
8160976|NCT02536040|20117782|P2|NOT COMPLETED|Overall Study||1
8160977|NCT02536040|20117783|P1|NOT COMPLETED|Overall Study||1
8160978|NCT02536040|20117782|P2|COMPLETED|Overall Study||35
8160979|NCT02536040|20117783|P1|COMPLETED|Overall Study||29
8160980|NCT02536040|20117782|P2|STARTED|Overall Study||36
8160981|NCT02536040|20117783|P1|STARTED|Overall Study||30
8160982|NCT02535806|20117789|P1|NOT COMPLETED|Overall Study||0
8160983|NCT02535806|20117789|P1|COMPLETED|Overall Study||2
8160984|NCT02535806|20117789|P1|STARTED|Overall Study||2
8160985|NCT02535741|20117796|P1|NOT COMPLETED|Overall Study||32
8160986|NCT02535741|20117796|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
8160987|NCT02535741|20117796|P1|STARTED|Overall Study||168
8160988|NCT02535715|20117804|P3|NOT COMPLETED|Overall Study||1
8160989|NCT02535715|20117805|P2|NOT COMPLETED|Overall Study||0
8160990|NCT02535715|20117806|P1|NOT COMPLETED|Overall Study||0
8160991|NCT02535715|20117804|P3|COMPLETED|Overall Study||2
8160992|NCT02535715|20117805|P2|COMPLETED|Overall Study||4
8160993|NCT02535715|20117806|P1|COMPLETED|Overall Study||4
8160994|NCT02535715|20117804|P3|STARTED|Overall Study||3
8160995|NCT02535715|20117805|P2|STARTED|Overall Study||4
8160996|NCT02535715|20117806|P1|STARTED|Overall Study||4
8160997|NCT02535611|20117828|P2|NOT COMPLETED|Overall Study||0
8160998|NCT02535611|20117829|P1|NOT COMPLETED|Overall Study||0
8160999|NCT02535611|20117828|P2|COMPLETED|Overall Study||20
8161000|NCT02535611|20117829|P1|COMPLETED|Overall Study||27
8161001|NCT02535611|20117828|P2|STARTED|Overall Study||20
8161002|NCT02535611|20117829|P1|STARTED|Overall Study||27
8161003|NCT02535481|20117843|P2|NOT COMPLETED|Overall Study||0
8161004|NCT02535481|20117844|P1|NOT COMPLETED|Overall Study||0
8161005|NCT02535481|20117843|P2|COMPLETED|Overall Study||22
8161006|NCT02535481|20117844|P1|COMPLETED|Overall Study||22
8161007|NCT02535481|20117843|P2|STARTED|Overall Study||22
8161008|NCT02535481|20117844|P1|STARTED|Overall Study||22
8161009|NCT02535416|20117869|P9|NOT COMPLETED|Overall Study||0
8161010|NCT02535416|20117870|P8|NOT COMPLETED|Overall Study||0
8161011|NCT02535416|20117871|P7|NOT COMPLETED|Overall Study||0
8161012|NCT02535416|20117872|P6|NOT COMPLETED|Overall Study||0
8161013|NCT02535416|20117873|P5|NOT COMPLETED|Overall Study||0
8161014|NCT02535416|20117874|P4|NOT COMPLETED|Overall Study||0
8161015|NCT02535416|20117875|P3|NOT COMPLETED|Overall Study||0
8161016|NCT02535416|20117876|P2|NOT COMPLETED|Overall Study||0
8161017|NCT02535416|20117877|P1|NOT COMPLETED|Overall Study||1
8161018|NCT02535416|20117869|P9|COMPLETED|Overall Study||6
8161019|NCT02535416|20117870|P8|COMPLETED|Overall Study||6
8161020|NCT02535416|20117871|P7|COMPLETED|Overall Study||6
8161021|NCT02535416|20117872|P6|COMPLETED|Overall Study||4
8161022|NCT02535416|20117873|P5|COMPLETED|Overall Study||4
8161023|NCT02535416|20117874|P4|COMPLETED|Overall Study||4
8161024|NCT02535416|20117875|P3|COMPLETED|Overall Study||4
8161025|NCT02535416|20117876|P2|COMPLETED|Overall Study||2
8161026|NCT02535416|20117877|P1|COMPLETED|Overall Study||3
8161027|NCT02535416|20117869|P9|STARTED|Overall Study||6
8161028|NCT02535416|20117870|P8|STARTED|Overall Study||6
8161029|NCT02535416|20117871|P7|STARTED|Overall Study||6
8161030|NCT02535416|20117872|P6|STARTED|Overall Study||4
8161031|NCT02535416|20117873|P5|STARTED|Overall Study||4
8161032|NCT02535416|20117874|P4|STARTED|Overall Study||4
8161033|NCT02535416|20117875|P3|STARTED|Overall Study||4
8161034|NCT02535416|20117876|P2|STARTED|Overall Study||2
8161035|NCT02535416|20117877|P1|STARTED|Overall Study||4
8161036|NCT02535364|20117929|P1|NOT COMPLETED|12-Month Follow-up Period||35
8161037|NCT02535364|20117929|P1|COMPLETED|12-Month Follow-up Period||3
8161038|NCT02535364|20117929|P1|STARTED|12-Month Follow-up Period||38
8161039|NCT02535364|20117929|P1|NOT COMPLETED|Study Treatment||2
8161040|NCT02535364|20117929|P1|COMPLETED|Study Treatment||38
8161041|NCT02535364|20117929|P1|STARTED|Study Treatment||40
8161042|NCT02535364|20117929|P1|NOT COMPLETED|Part B Screening||17
8161043|NCT02535364|20117929|P1|COMPLETED|Part B Screening||40
8161044|NCT02535364|20117929|P1|STARTED|Part B Screening||57
8161045|NCT02535364|20117929|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
8161046|NCT02535364|20117929|P1|COMPLETED|Part A Screening Through Leukapheresis||57
8161047|NCT02535364|20117929|P1|STARTED|Part A Screening Through Leukapheresis||82
8161053|NCT02535026|20117959|P1|NOT COMPLETED|Overall Study||0
8161054|NCT02535026|20117959|P1|COMPLETED|Overall Study||580
8161055|NCT02535026|20117959|P1|STARTED|Overall Study||580
8161056|NCT02535000|20118013|P2|NOT COMPLETED|Overall Study||2
8161057|NCT02535000|20118014|P1|NOT COMPLETED|Overall Study||1
8161058|NCT02535000|20118013|P2|COMPLETED|Overall Study||28
8161059|NCT02535000|20118014|P1|COMPLETED|Overall Study||29
8161060|NCT02535000|20118013|P2|STARTED|Overall Study||30
8161061|NCT02535000|20118014|P1|STARTED|Overall Study||30
8161062|NCT02534935|20118025|P3|NOT COMPLETED|Overall Study||5
8161063|NCT02534935|20118026|P2|NOT COMPLETED|Overall Study||10
8161064|NCT02534935|20118027|P1|NOT COMPLETED|Overall Study||0
8161065|NCT02534935|20118025|P3|COMPLETED|Overall Study||127
8161066|NCT02534935|20118026|P2|COMPLETED|Overall Study||210
8161067|NCT02534935|20118027|P1|COMPLETED|Overall Study||44
8161068|NCT02534935|20118025|P3|STARTED|Overall Study||132
8161069|NCT02534935|20118026|P2|STARTED|Overall Study||220
8161070|NCT02534935|20118027|P1|STARTED|Overall Study||44
8161071|NCT02534896|20118188|P3|NOT COMPLETED|Overall Study||1
8161072|NCT02534896|20118189|P2|NOT COMPLETED|Overall Study||1
8161073|NCT02534896|20118190|P1|NOT COMPLETED|Overall Study||4
8161074|NCT02534896|20118188|P3|COMPLETED|Overall Study||48
8161075|NCT02534896|20118189|P2|COMPLETED|Overall Study||51
8161076|NCT02534896|20118190|P1|COMPLETED|Overall Study||45
8161077|NCT02534896|20118188|P3|STARTED|Overall Study||49
8161078|NCT02534896|20118189|P2|STARTED|Overall Study||52
8161079|NCT02534896|20118190|P1|STARTED|Overall Study||49
8161080|NCT02534883|20118209|P2|NOT COMPLETED|Overall Study||3
8161081|NCT02534883|20118210|P1|NOT COMPLETED|Overall Study||8
8161082|NCT02534883|20118209|P2|COMPLETED|Overall Study||0
8161083|NCT02534883|20118210|P1|COMPLETED|Overall Study||0
8161084|NCT02534883|20118209|P2|STARTED|Overall Study||3
8161085|NCT02534883|20118210|P1|STARTED|Overall Study||8
8161086|NCT02534493|20118226|P1|NOT COMPLETED|Overall Study||2
8161087|NCT02534493|20118226|P1|COMPLETED|Overall Study||11
8161088|NCT02534493|20118226|P1|STARTED|Overall Study||13
8161089|NCT02534350|20118237|P2|NOT COMPLETED|Overall Study||0
8161090|NCT02534350|20118238|P1|NOT COMPLETED|Overall Study||4
8161091|NCT02534350|20118237|P2|COMPLETED|Overall Study||20
8161092|NCT02534350|20118238|P1|COMPLETED|Overall Study||37
8161093|NCT02534350|20118237|P2|STARTED|Overall Study||20
8161094|NCT02534350|20118238|P1|STARTED|Overall Study||41
8161095|NCT02534324|20118252|P2|NOT COMPLETED|Overall Study||8
8161096|NCT02534324|20118253|P1|NOT COMPLETED|Overall Study||25
8161097|NCT02534324|20118252|P2|COMPLETED|Overall Study||40
8161098|NCT02534324|20118253|P1|COMPLETED|Overall Study||73
8161099|NCT02534324|20118252|P2|STARTED|Overall Study||48
8161100|NCT02534324|20118253|P1|STARTED|Overall Study||98
8161101|NCT02534285|20118265|P2|NOT COMPLETED|Overall Study||0
8161102|NCT02534285|20118266|P1|NOT COMPLETED|Overall Study||0
8161103|NCT02534285|20118265|P2|COMPLETED|Overall Study||50
8161104|NCT02534285|20118266|P1|COMPLETED|Overall Study||50
8161105|NCT02534285|20118265|P2|STARTED|Overall Study||50
8161106|NCT02534285|20118266|P1|STARTED|Overall Study||50
8161107|NCT02534129|20118272|P2|NOT COMPLETED|Overall Study||0
8161108|NCT02534129|20118273|P1|NOT COMPLETED|Overall Study||0
8161109|NCT02534129|20118272|P2|COMPLETED|Overall Study||13
8161110|NCT02534129|20118273|P1|COMPLETED|Overall Study||13
8161111|NCT02534129|20118272|P2|STARTED|Overall Study||13
8161112|NCT02534129|20118273|P1|STARTED|Overall Study||13
8161113|NCT02534038|20118281|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
8161114|NCT02534038|20118282|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
8161115|NCT02534038|20118281|P2|COMPLETED|Period 2 (6 Weeks)||0
8161116|NCT02534038|20118282|P1|COMPLETED|Period 2 (6 Weeks)||1
8161117|NCT02534038|20118281|P2|STARTED|Period 2 (6 Weeks)||0
8161118|NCT02534038|20118282|P1|STARTED|Period 2 (6 Weeks)||1
8161119|NCT02534038|20118281|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
8161120|NCT02534038|20118282|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
8161121|NCT02534038|20118281|P2|COMPLETED|Period 1 (6 Weeks)||0
8161122|NCT02534038|20118282|P1|COMPLETED|Period 1 (6 Weeks)||1
8161123|NCT02534038|20118281|P2|STARTED|Period 1 (6 Weeks)||0
8161124|NCT02534038|20118282|P1|STARTED|Period 1 (6 Weeks)||1
8161125|NCT02533999|20118318|P2|NOT COMPLETED|Overall Study||7
8161126|NCT02533999|20118319|P1|NOT COMPLETED|Overall Study||6
8161127|NCT02533999|20118318|P2|COMPLETED|Overall Study||30
8161128|NCT02533999|20118319|P1|COMPLETED|Overall Study||32
8161129|NCT02533999|20118318|P2|STARTED|Overall Study||37
8161130|NCT02533999|20118319|P1|STARTED|Overall Study||38
8161131|NCT02533921|20118339|P2|NOT COMPLETED|Overall Study||11
8161132|NCT02533921|20118340|P1|NOT COMPLETED|Overall Study||16
8161133|NCT02533921|20118339|P2|COMPLETED|Overall Study||95
8161134|NCT02533921|20118340|P1|COMPLETED|Overall Study||88
8161135|NCT02533921|20118339|P2|STARTED|Overall Study||106
8161136|NCT02533921|20118340|P1|STARTED|Overall Study||104
8161137|NCT02533726|20118358|P2|NOT COMPLETED|Treatment||0
8161138|NCT02533726|20118359|P1|NOT COMPLETED|Treatment||0
8161139|NCT02533726|20118358|P2|COMPLETED|Treatment||603
8161140|NCT02533726|20118359|P1|COMPLETED|Treatment||709
8161141|NCT02533726|20118358|P2|Per Protocol Population|Treatment||555
8161142|NCT02533726|20118359|P1|Per Protocol Population|Treatment||671
8161143|NCT02533726|20118358|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
8161144|NCT02533726|20118359|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
8161145|NCT02533726|20118358|P2|NOT COMPLETED|Initial Allocation||0
8161146|NCT02533726|20118359|P1|NOT COMPLETED|Initial Allocation||0
8161147|NCT02533726|20118358|P2|COMPLETED|Initial Allocation||653
8161148|NCT02533726|20118359|P1|COMPLETED|Initial Allocation||659
8161149|NCT02533726|20118358|P2|STARTED|Initial Allocation||653
8161150|NCT02533726|20118359|P1|STARTED|Initial Allocation||659
8161151|NCT02533570|20118370|P3|NOT COMPLETED|Overall Study||1
8161152|NCT02533570|20118371|P2|NOT COMPLETED|Overall Study||1
8161153|NCT02533570|20118372|P1|NOT COMPLETED|Overall Study||0
8161154|NCT02533570|20118370|P3|COMPLETED|Overall Study||7
8161155|NCT02533570|20118371|P2|COMPLETED|Overall Study||7
8161156|NCT02533570|20118372|P1|COMPLETED|Overall Study||4
8161157|NCT02533570|20118370|P3|STARTED|Overall Study||8
8161158|NCT02533570|20118371|P2|STARTED|Overall Study||8
8161159|NCT02533570|20118372|P1|STARTED|Overall Study||4
8161160|NCT02533531|20118383|P1|NOT COMPLETED|Overall Study||1
8161161|NCT02533531|20118383|P1|COMPLETED|Overall Study||0
8161162|NCT02533531|20118383|P1|STARTED|Overall Study||1
8161163|NCT02533505|20118388|P2|NOT COMPLETED|Overall Study||1
8161164|NCT02533505|20118389|P1|NOT COMPLETED|Overall Study||3
8161165|NCT02533505|20118388|P2|COMPLETED|Overall Study||24
8161166|NCT02533505|20118389|P1|COMPLETED|Overall Study||23
8161167|NCT02533505|20118388|P2|STARTED|Overall Study||25
8161168|NCT02533505|20118389|P1|STARTED|Overall Study||26
8161169|NCT02533466|20118421|P2|NOT COMPLETED|Overall Study||0
8161170|NCT02533466|20118422|P1|NOT COMPLETED|Overall Study||0
8161171|NCT02533466|20118421|P2|COMPLETED|Overall Study||14
8161172|NCT02533466|20118422|P1|COMPLETED|Overall Study||16
8161173|NCT02533466|20118421|P2|STARTED|Overall Study||14
8161174|NCT02533466|20118422|P1|STARTED|Overall Study||16
8161175|NCT02533453|20118446|P1|NOT COMPLETED|Overall Study||9
8161176|NCT02533453|20118446|P1|COMPLETED|Overall Study||101
8161177|NCT02533453|20118446|P1|STARTED|Overall Study||110
8161178|NCT02533427|20118455|P1|NOT COMPLETED|Overall Study||0
8161179|NCT02533427|20118455|P1|COMPLETED|Overall Study||15
8161180|NCT02533427|20118455|P1|STARTED|Overall Study||15
8161181|NCT02533401|20118505|P1|NOT COMPLETED|Overall Study||11
8161182|NCT02533401|20118505|P1|COMPLETED|Overall Study||23
8161183|NCT02533401|20118505|P1|STARTED|Overall Study||34
8161184|NCT02533375|20118513|P1|NOT COMPLETED|Overall Study||5
8161185|NCT02533375|20118513|P1|COMPLETED|Overall Study||5
8161186|NCT02533375|20118513|P1|STARTED|Overall Study||10
8161187|NCT02533258|20118545|P1|NOT COMPLETED|Overall Study||8
8161188|NCT02533258|20118545|P1|COMPLETED|Overall Study||5
8161189|NCT02533258|20118545|P1|STARTED|Overall Study||13
8161190|NCT02533167|20118557|P1|NOT COMPLETED|Overall Study||15
8161191|NCT02533167|20118557|P1|COMPLETED|Overall Study||55
8161192|NCT02533167|20118557|P1|STARTED|Overall Study||70
8161193|NCT02533089|20118568|P2|NOT COMPLETED|Overall Study||114
8161194|NCT02533089|20118569|P1|NOT COMPLETED|Overall Study||241
8161195|NCT02533089|20118568|P2|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
8161196|NCT02533089|20118569|P1|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
8161197|NCT02533089|20118568|P2|STARTED|Overall Study||548
8161198|NCT02533089|20118569|P1|STARTED|Overall Study||605
8161199|NCT02533063|20118581|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||0
8161200|NCT02533063|20118582|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||0
8161201|NCT02533063|20118581|P2|COMPLETED|Intervention 2 (8 Weeks)||11
8161202|NCT02533063|20118582|P1|COMPLETED|Intervention 2 (8 Weeks)||14
8161203|NCT02533063|20118581|P2|STARTED|Intervention 2 (8 Weeks)||11
8161204|NCT02533063|20118582|P1|STARTED|Intervention 2 (8 Weeks)||14
8161205|NCT02533063|20118581|P2|NOT COMPLETED|Washout (4 Weeks)||0
8161206|NCT02533063|20118582|P1|NOT COMPLETED|Washout (4 Weeks)||0
8161207|NCT02533063|20118581|P2|COMPLETED|Washout (4 Weeks)||11
8161208|NCT02533063|20118582|P1|COMPLETED|Washout (4 Weeks)||14
8161209|NCT02533063|20118581|P2|STARTED|Washout (4 Weeks)||11
8161210|NCT02533063|20118582|P1|STARTED|Washout (4 Weeks)||14
8161211|NCT02533063|20118581|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||5
8161212|NCT02533063|20118582|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||2
8161213|NCT02533063|20118581|P2|COMPLETED|Intervention 1 (8 Weeks)||11
8161214|NCT02533063|20118582|P1|COMPLETED|Intervention 1 (8 Weeks)||14
8161215|NCT02533063|20118581|P2|STARTED|Intervention 1 (8 Weeks)||16
8161216|NCT02533063|20118582|P1|STARTED|Intervention 1 (8 Weeks)||16
8161217|NCT02532998|20118604|P1|NOT COMPLETED|Overall Study||0
8161218|NCT02532998|20118604|P1|COMPLETED|Overall Study||23
8161219|NCT02532998|20118604|P1|STARTED|Overall Study||23
8161220|NCT02532972|20118686|P1|NOT COMPLETED|Overall Study||1
8161221|NCT02532972|20118686|P1|COMPLETED|Overall Study||10
8161222|NCT02532972|20118686|P1|STARTED|Overall Study||11
8161223|NCT02532933|20118694|P2|NOT COMPLETED|Overall Study||6
8161224|NCT02532933|20118695|P1|NOT COMPLETED|Overall Study||6
8161225|NCT02532933|20118694|P2|COMPLETED|Overall Study||16
8161226|NCT02532933|20118695|P1|COMPLETED|Overall Study||16
8161227|NCT02532933|20118694|P2|STARTED|Overall Study||22
8161228|NCT02532933|20118695|P1|STARTED|Overall Study||22
8161229|NCT02532855|20118703|P2|NOT COMPLETED|Overall Study||11
8161230|NCT02532855|20118704|P1|NOT COMPLETED|Overall Study||8
8161231|NCT02532855|20118703|P2|COMPLETED|Overall Study||296
8161232|NCT02532855|20118704|P1|COMPLETED|Overall Study||299
8161233|NCT02532855|20118703|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
8161234|NCT02532855|20118704|P1|Treated|Overall Study||307
8161235|NCT02532855|20118703|P2|STARTED|Overall Study||307
8161236|NCT02532855|20118704|P1|STARTED|Overall Study||307
8161237|NCT02532764|20118738|P10|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8161238|NCT02532764|20118739|P9|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8161239|NCT02532764|20118740|P8|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8161240|NCT02532764|20118741|P7|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161241|NCT02532764|20118742|P6|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161242|NCT02532764|20118743|P5|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161243|NCT02532764|20118744|P4|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161244|NCT02532764|20118745|P3|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161245|NCT02532764|20118746|P2|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161246|NCT02532764|20118747|P1|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161247|NCT02532764|20118738|P10|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
8161248|NCT02532764|20118739|P9|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
8161249|NCT02532764|20118740|P8|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8161250|NCT02532764|20118741|P7|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8161251|NCT02532764|20118742|P6|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8161252|NCT02532764|20118743|P5|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161253|NCT02532764|20118744|P4|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161254|NCT02532764|20118745|P3|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161255|NCT02532764|20118746|P2|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161256|NCT02532764|20118747|P1|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161257|NCT02532764|20118738|P10|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
8161258|NCT02532764|20118739|P9|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8161259|NCT02532764|20118740|P8|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
8161260|NCT02532764|20118741|P7|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8161261|NCT02532764|20118742|P6|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8161262|NCT02532764|20118743|P5|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161263|NCT02532764|20118744|P4|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161264|NCT02532764|20118745|P3|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161265|NCT02532764|20118746|P2|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161266|NCT02532764|20118747|P1|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161267|NCT02532764|20118738|P10|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161268|NCT02532764|20118739|P9|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161269|NCT02532764|20118740|P8|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161270|NCT02532764|20118741|P7|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161271|NCT02532764|20118742|P6|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161272|NCT02532764|20118743|P5|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161273|NCT02532764|20118744|P4|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161274|NCT02532764|20118745|P3|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161275|NCT02532764|20118746|P2|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161276|NCT02532764|20118747|P1|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161277|NCT02532764|20118738|P10|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161278|NCT02532764|20118739|P9|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161279|NCT02532764|20118740|P8|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161280|NCT02532764|20118741|P7|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161281|NCT02532764|20118742|P6|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161282|NCT02532764|20118743|P5|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
8161283|NCT02532764|20118744|P4|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8161284|NCT02532764|20118745|P3|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
8161285|NCT02532764|20118746|P2|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8161286|NCT02532764|20118747|P1|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8161287|NCT02532764|20118738|P10|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161288|NCT02532764|20118739|P9|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161289|NCT02532764|20118740|P8|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161290|NCT02532764|20118741|P7|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161291|NCT02532764|20118742|P6|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161292|NCT02532764|20118743|P5|STARTED|Single Ascending Dose (SAD) Cohorts||9
8161293|NCT02532764|20118744|P4|STARTED|Single Ascending Dose (SAD) Cohorts||6
8161294|NCT02532764|20118745|P3|STARTED|Single Ascending Dose (SAD) Cohorts||9
8161295|NCT02532764|20118746|P2|STARTED|Single Ascending Dose (SAD) Cohorts||6
8161296|NCT02532764|20118747|P1|STARTED|Single Ascending Dose (SAD) Cohorts||6
8161297|NCT02532647|20118898|P3|NOT COMPLETED|Overall Study||1
8161298|NCT02532647|20118899|P2|NOT COMPLETED|Overall Study||0
8161299|NCT02532647|20118900|P1|NOT COMPLETED|Overall Study||1
8161300|NCT02532647|20118898|P3|COMPLETED|Overall Study||30
8161301|NCT02532647|20118899|P2|COMPLETED|Overall Study||16
8161302|NCT02532647|20118900|P1|COMPLETED|Overall Study||31
8161303|NCT02532647|20118898|P3|Safety Population|Overall Study||30
8161304|NCT02532647|20118899|P2|Safety Population|Overall Study||16
8161305|NCT02532647|20118900|P1|Safety Population|Overall Study||31
8161306|NCT02532647|20118898|P3|STARTED|Overall Study||31
8161307|NCT02532647|20118899|P2|STARTED|Overall Study||16
8161308|NCT02532647|20118900|P1|STARTED|Overall Study||32
8161309|NCT02532556|20118914|P1|NOT COMPLETED|Overall Study||0
8161310|NCT02532556|20118914|P1|COMPLETED|Overall Study||12
8161311|NCT02532556|20118914|P1|STARTED|Overall Study||12
8161312|NCT02532543|20118942|P4|NOT COMPLETED|Overall Study||0
8161313|NCT02532543|20118943|P3|NOT COMPLETED|Overall Study||1
8161314|NCT02532543|20118944|P2|NOT COMPLETED|Overall Study||0
8161315|NCT02532543|20118945|P1|NOT COMPLETED|Overall Study||0
8161316|NCT02532543|20118942|P4|COMPLETED|Overall Study||4
8161317|NCT02532543|20118943|P3|COMPLETED|Overall Study||4
8161318|NCT02532543|20118944|P2|COMPLETED|Overall Study||4
8161319|NCT02532543|20118945|P1|COMPLETED|Overall Study||3
8161320|NCT02532543|20118942|P4|STARTED|Overall Study||4
8161321|NCT02532543|20118943|P3|STARTED|Overall Study||5
8161322|NCT02532543|20118944|P2|STARTED|Overall Study||4
8161323|NCT02532543|20118945|P1|STARTED|Overall Study||3
8161324|NCT02532517|20118979|P1|NOT COMPLETED|Overall Study||17
8161325|NCT02532517|20118979|P1|COMPLETED|Overall Study||28
8161326|NCT02532517|20118979|P1|mITT Analysis Set|Overall Study||44
8161327|NCT02532517|20118979|P1|STARTED|Overall Study||45
8161328|NCT02532465|20118999|P2|NOT COMPLETED|Overall Study||1
8161329|NCT02532465|20119000|P1|NOT COMPLETED|Overall Study||1
8161330|NCT02532465|20118999|P2|COMPLETED|Overall Study||24
8161331|NCT02532465|20119000|P1|COMPLETED|Overall Study||24
8161332|NCT02532465|20118999|P2|STARTED|Overall Study||25
8161333|NCT02532465|20119000|P1|STARTED|Overall Study||25
8161334|NCT02532374|20119010|P1|NOT COMPLETED|Overall Study||2
8161335|NCT02532374|20119010|P1|COMPLETED|Overall Study||14
8161336|NCT02532374|20119010|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
8161337|NCT02532374|20119010|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
8161338|NCT02532374|20119010|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
8161339|NCT02532374|20119010|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
8161340|NCT02532374|20119010|P1|STARTED|Overall Study||16
8161341|NCT02532283|20119036|P2|NOT COMPLETED|Overall Study||5
8161342|NCT02532283|20119037|P1|NOT COMPLETED|Overall Study||9
8161343|NCT02532283|20119036|P2|COMPLETED|Overall Study||30
8161344|NCT02532283|20119037|P1|COMPLETED|Overall Study||55
8161345|NCT02532283|20119036|P2|Full Analysis Set|Overall Study||32
8161346|NCT02532283|20119037|P1|Full Analysis Set|Overall Study||63
8161347|NCT02532283|20119036|P2|STARTED|Overall Study||35
8161348|NCT02532283|20119037|P1|STARTED|Overall Study||64
8161349|NCT02532179|20119079|P1|NOT COMPLETED|Overall Study||3
8161350|NCT02532179|20119079|P1|COMPLETED|Overall Study||9
8161351|NCT02532179|20119079|P1|STARTED|Overall Study||12
8161352|NCT02532036|20119088|P2|NOT COMPLETED|Overall Study||0
8161353|NCT02532036|20119089|P1|NOT COMPLETED|Overall Study||0
8161354|NCT02532036|20119088|P2|COMPLETED|Overall Study||0
8161355|NCT02532036|20119089|P1|COMPLETED|Overall Study||2
8161356|NCT02532036|20119088|P2|STARTED|Overall Study||0
8161357|NCT02532036|20119089|P1|STARTED|Overall Study||2
8161358|NCT02532010|20119095|P2|NOT COMPLETED|Overall Study||4
8161359|NCT02532010|20119096|P1|NOT COMPLETED|Overall Study||9
8161360|NCT02532010|20119095|P2|COMPLETED|Overall Study||0
8161361|NCT02532010|20119096|P1|COMPLETED|Overall Study||0
8161362|NCT02532010|20119095|P2|STARTED|Overall Study||4
8161363|NCT02532010|20119096|P1|STARTED|Overall Study||9
8161364|NCT02531971|20119116|P2|NOT COMPLETED|Overall Study||0
8161365|NCT02531971|20119117|P1|NOT COMPLETED|Overall Study||0
8161366|NCT02531971|20119116|P2|COMPLETED|Overall Study||13
8161367|NCT02531971|20119117|P1|COMPLETED|Overall Study||11
8161368|NCT02531971|20119116|P2|STARTED|Overall Study||13
8161369|NCT02531971|20119117|P1|STARTED|Overall Study||11
8161370|NCT02531867|20119124|P1|NOT COMPLETED|Overall Study||0
8161371|NCT02531867|20119124|P1|COMPLETED|Overall Study||13
8161372|NCT02531867|20119124|P1|STARTED|Overall Study||13
8161373|NCT02531802|20119149|P21|NOT COMPLETED|Received Vaccination 2||1
8161374|NCT02531802|20119150|P20|NOT COMPLETED|Received Vaccination 2||1
8161375|NCT02531802|20119151|P19|NOT COMPLETED|Received Vaccination 2||3
8161376|NCT02531802|20119152|P18|NOT COMPLETED|Received Vaccination 2||4
8161377|NCT02531802|20119153|P17|NOT COMPLETED|Received Vaccination 2||0
8161378|NCT02531802|20119154|P16|NOT COMPLETED|Received Vaccination 2||0
8161379|NCT02531802|20119155|P15|NOT COMPLETED|Received Vaccination 2||1
8161380|NCT02531802|20119156|P14|NOT COMPLETED|Received Vaccination 2||2
8161381|NCT02531802|20119157|P13|NOT COMPLETED|Received Vaccination 2||2
8161382|NCT02531802|20119158|P12|NOT COMPLETED|Received Vaccination 2||0
8161383|NCT02531802|20119159|P11|NOT COMPLETED|Received Vaccination 2||2
8161384|NCT02531802|20119160|P10|NOT COMPLETED|Received Vaccination 2||3
8161385|NCT02531802|20119161|P9|NOT COMPLETED|Received Vaccination 2||0
8161386|NCT02531802|20119162|P8|NOT COMPLETED|Received Vaccination 2||0
8161387|NCT02531802|20119163|P7|NOT COMPLETED|Received Vaccination 2||0
8161388|NCT02531802|20119164|P6|NOT COMPLETED|Received Vaccination 2||3
8161389|NCT02531802|20119165|P5|NOT COMPLETED|Received Vaccination 2||0
8161390|NCT02531802|20119166|P4|NOT COMPLETED|Received Vaccination 2||0
8161391|NCT02531802|20119167|P3|NOT COMPLETED|Received Vaccination 2||1
8161392|NCT02531802|20119168|P2|NOT COMPLETED|Received Vaccination 2||0
8161393|NCT02531802|20119169|P1|NOT COMPLETED|Received Vaccination 2||0
8161394|NCT02531802|20119149|P21|COMPLETED|Received Vaccination 2||49
8161395|NCT02531802|20119150|P20|COMPLETED|Received Vaccination 2||29
8161396|NCT02531802|20119151|P19|COMPLETED|Received Vaccination 2||27
8161397|NCT02531802|20119152|P18|COMPLETED|Received Vaccination 2||26
8161398|NCT02531802|20119153|P17|COMPLETED|Received Vaccination 2||30
8161399|NCT02531802|20119154|P16|COMPLETED|Received Vaccination 2||30
8161400|NCT02531802|20119155|P15|COMPLETED|Received Vaccination 2||39
8161401|NCT02531802|20119156|P14|COMPLETED|Received Vaccination 2||13
8161402|NCT02531802|20119157|P13|COMPLETED|Received Vaccination 2||13
8161403|NCT02531802|20119158|P12|COMPLETED|Received Vaccination 2||15
8161404|NCT02531802|20119159|P11|COMPLETED|Received Vaccination 2||13
8161405|NCT02531802|20119160|P10|COMPLETED|Received Vaccination 2||49
8161406|NCT02531802|20119161|P9|COMPLETED|Received Vaccination 2||15
8161407|NCT02531802|20119162|P8|COMPLETED|Received Vaccination 2||15
8161408|NCT02531802|20119163|P7|COMPLETED|Received Vaccination 2||15
8161409|NCT02531802|20119164|P6|COMPLETED|Received Vaccination 2||0
8161410|NCT02531802|20119165|P5|COMPLETED|Received Vaccination 2||15
8161411|NCT02531802|20119166|P4|COMPLETED|Received Vaccination 2||15
8161412|NCT02531802|20119167|P3|COMPLETED|Received Vaccination 2||14
8161413|NCT02531802|20119168|P2|COMPLETED|Received Vaccination 2||15
8161414|NCT02531802|20119169|P1|COMPLETED|Received Vaccination 2||15
8161415|NCT02531802|20119149|P21|STARTED|Received Vaccination 2||50
8161416|NCT02531802|20119150|P20|STARTED|Received Vaccination 2||30
8161417|NCT02531802|20119151|P19|STARTED|Received Vaccination 2||30
8161418|NCT02531802|20119152|P18|STARTED|Received Vaccination 2||30
8161419|NCT02531802|20119153|P17|STARTED|Received Vaccination 2||30
8161420|NCT02531802|20119154|P16|STARTED|Received Vaccination 2||30
8161421|NCT02531802|20119155|P15|STARTED|Received Vaccination 2||40
8161422|NCT02531802|20119156|P14|STARTED|Received Vaccination 2||15
8161423|NCT02531802|20119157|P13|STARTED|Received Vaccination 2||15
8161424|NCT02531802|20119158|P12|STARTED|Received Vaccination 2||15
8161425|NCT02531802|20119159|P11|STARTED|Received Vaccination 2||15
8161426|NCT02531802|20119160|P10|STARTED|Received Vaccination 2||52
8161427|NCT02531802|20119161|P9|STARTED|Received Vaccination 2||15
8161428|NCT02531802|20119162|P8|STARTED|Received Vaccination 2||15
8161429|NCT02531802|20119163|P7|STARTED|Received Vaccination 2||15
8161430|NCT02531802|20119164|P6|STARTED|Received Vaccination 2||3
8161431|NCT02531802|20119165|P5|STARTED|Received Vaccination 2||15
8161432|NCT02531802|20119166|P4|STARTED|Received Vaccination 2||15
8161433|NCT02531802|20119167|P3|STARTED|Received Vaccination 2||15
8161434|NCT02531802|20119168|P2|STARTED|Received Vaccination 2||15
8161435|NCT02531802|20119169|P1|STARTED|Received Vaccination 2||15
8161436|NCT02531802|20119149|P21|NOT COMPLETED|Received Vaccination 1||0
8161437|NCT02531802|20119150|P20|NOT COMPLETED|Received Vaccination 1||0
8161438|NCT02531802|20119151|P19|NOT COMPLETED|Received Vaccination 1||0
8161439|NCT02531802|20119152|P18|NOT COMPLETED|Received Vaccination 1||0
8161440|NCT02531802|20119153|P17|NOT COMPLETED|Received Vaccination 1||0
8161441|NCT02531802|20119154|P16|NOT COMPLETED|Received Vaccination 1||0
8161442|NCT02531802|20119155|P15|NOT COMPLETED|Received Vaccination 1||0
8161443|NCT02531802|20119156|P14|NOT COMPLETED|Received Vaccination 1||0
8161444|NCT02531802|20119157|P13|NOT COMPLETED|Received Vaccination 1||0
8161445|NCT02531802|20119158|P12|NOT COMPLETED|Received Vaccination 1||0
8161446|NCT02531802|20119159|P11|NOT COMPLETED|Received Vaccination 1||0
8161447|NCT02531802|20119160|P10|NOT COMPLETED|Received Vaccination 1||0
8161448|NCT02531802|20119161|P9|NOT COMPLETED|Received Vaccination 1||0
8161449|NCT02531802|20119162|P8|NOT COMPLETED|Received Vaccination 1||0
8161450|NCT02531802|20119163|P7|NOT COMPLETED|Received Vaccination 1||0
8161451|NCT02531802|20119164|P6|NOT COMPLETED|Received Vaccination 1||0
8161452|NCT02531802|20119165|P5|NOT COMPLETED|Received Vaccination 1||0
8161453|NCT02531802|20119166|P4|NOT COMPLETED|Received Vaccination 1||0
8161454|NCT02531802|20119167|P3|NOT COMPLETED|Received Vaccination 1||0
8161455|NCT02531802|20119168|P2|NOT COMPLETED|Received Vaccination 1||0
8161456|NCT02531802|20119169|P1|NOT COMPLETED|Received Vaccination 1||0
8161457|NCT02531802|20119149|P21|COMPLETED|Received Vaccination 1||50
8161458|NCT02531802|20119150|P20|COMPLETED|Received Vaccination 1||30
8161459|NCT02531802|20119151|P19|COMPLETED|Received Vaccination 1||30
8161460|NCT02531802|20119152|P18|COMPLETED|Received Vaccination 1||30
8161461|NCT02531802|20119153|P17|COMPLETED|Received Vaccination 1||30
8161462|NCT02531802|20119154|P16|COMPLETED|Received Vaccination 1||30
8161463|NCT02531802|20119155|P15|COMPLETED|Received Vaccination 1||40
8161464|NCT02531802|20119156|P14|COMPLETED|Received Vaccination 1||15
8161465|NCT02531802|20119157|P13|COMPLETED|Received Vaccination 1||15
8161466|NCT02531802|20119158|P12|COMPLETED|Received Vaccination 1||15
8161467|NCT02531802|20119159|P11|COMPLETED|Received Vaccination 1||15
8161468|NCT02531802|20119160|P10|COMPLETED|Received Vaccination 1||52
8161469|NCT02531802|20119161|P9|COMPLETED|Received Vaccination 1||15
8161470|NCT02531802|20119162|P8|COMPLETED|Received Vaccination 1||15
8161471|NCT02531802|20119163|P7|COMPLETED|Received Vaccination 1||15
8161472|NCT02531802|20119164|P6|COMPLETED|Received Vaccination 1||3
8161473|NCT02531802|20119165|P5|COMPLETED|Received Vaccination 1||15
8161474|NCT02531802|20119166|P4|COMPLETED|Received Vaccination 1||15
8161475|NCT02531802|20119167|P3|COMPLETED|Received Vaccination 1||15
8161476|NCT02531802|20119168|P2|COMPLETED|Received Vaccination 1||15
8161477|NCT02531802|20119169|P1|COMPLETED|Received Vaccination 1||15
8161478|NCT02531802|20119149|P21|STARTED|Received Vaccination 1||50
8161479|NCT02531802|20119150|P20|STARTED|Received Vaccination 1||30
8161480|NCT02531802|20119151|P19|STARTED|Received Vaccination 1||30
8161481|NCT02531802|20119152|P18|STARTED|Received Vaccination 1||30
8161482|NCT02531802|20119153|P17|STARTED|Received Vaccination 1||30
8161483|NCT02531802|20119154|P16|STARTED|Received Vaccination 1||30
8161484|NCT02531802|20119155|P15|STARTED|Received Vaccination 1||40
8161485|NCT02531802|20119156|P14|STARTED|Received Vaccination 1||15
8161486|NCT02531802|20119157|P13|STARTED|Received Vaccination 1||15
8161487|NCT02531802|20119158|P12|STARTED|Received Vaccination 1||15
8161488|NCT02531802|20119159|P11|STARTED|Received Vaccination 1||15
8161489|NCT02531802|20119160|P10|STARTED|Received Vaccination 1||52
8161490|NCT02531802|20119161|P9|STARTED|Received Vaccination 1||15
8161491|NCT02531802|20119162|P8|STARTED|Received Vaccination 1||15
8161492|NCT02531802|20119163|P7|STARTED|Received Vaccination 1||15
8161493|NCT02531802|20119164|P6|STARTED|Received Vaccination 1||3
8161494|NCT02531802|20119165|P5|STARTED|Received Vaccination 1||15
8161495|NCT02531802|20119166|P4|STARTED|Received Vaccination 1||15
8161496|NCT02531802|20119167|P3|STARTED|Received Vaccination 1||15
8161497|NCT02531802|20119168|P2|STARTED|Received Vaccination 1||15
8161498|NCT02531802|20119169|P1|STARTED|Received Vaccination 1||15
8161499|NCT02531698|20119601|P2|NOT COMPLETED|Overall Study||2
8161500|NCT02531698|20119602|P1|NOT COMPLETED|Overall Study||11
8161501|NCT02531698|20119601|P2|COMPLETED|Overall Study||104
8161502|NCT02531698|20119602|P1|COMPLETED|Overall Study||283
8161503|NCT02531698|20119601|P2|STARTED|Overall Study||106
8161504|NCT02531698|20119602|P1|STARTED|Overall Study||294
8161505|NCT02531646|20119849|P3|NOT COMPLETED|Overall Study||0
8161506|NCT02531646|20119850|P2|NOT COMPLETED|Overall Study||1
8161507|NCT02531646|20119851|P1|NOT COMPLETED|Overall Study||5
8161508|NCT02531646|20119849|P3|COMPLETED|Overall Study||11
8161509|NCT02531646|20119850|P2|COMPLETED|Overall Study||17
8161510|NCT02531646|20119851|P1|COMPLETED|Overall Study||32
8161511|NCT02531646|20119849|P3|STARTED|Overall Study||11
8161512|NCT02531646|20119850|P2|STARTED|Overall Study||18
8161513|NCT02531646|20119851|P1|STARTED|Overall Study||37
8161514|NCT02531633|20119870|P10|NOT COMPLETED|Part B (104 Weeks)||4
8161515|NCT02531633|20119871|P9|NOT COMPLETED|Part B (104 Weeks)||5
8161516|NCT02531633|20119872|P8|NOT COMPLETED|Part B (104 Weeks)||4
8161517|NCT02531633|20119873|P7|NOT COMPLETED|Part B (104 Weeks)||5
8161518|NCT02531633|20119874|P6|NOT COMPLETED|Part B (104 Weeks)||8
8161519|NCT02531633|20119875|P5|NOT COMPLETED|Part B (104 Weeks)||0
8161520|NCT02531633|20119876|P4|NOT COMPLETED|Part B (104 Weeks)||0
8161521|NCT02531633|20119877|P3|NOT COMPLETED|Part B (104 Weeks)||0
8161522|NCT02531633|20119878|P2|NOT COMPLETED|Part B (104 Weeks)||0
8161523|NCT02531633|20119879|P1|NOT COMPLETED|Part B (104 Weeks)||0
8161524|NCT02531633|20119870|P10|COMPLETED|Part B (104 Weeks)||0
8161525|NCT02531633|20119871|P9|COMPLETED|Part B (104 Weeks)||0
8161526|NCT02531633|20119872|P8|COMPLETED|Part B (104 Weeks)||0
8161527|NCT02531633|20119873|P7|COMPLETED|Part B (104 Weeks)||0
8161528|NCT02531633|20119874|P6|COMPLETED|Part B (104 Weeks)||0
8161529|NCT02531633|20119875|P5|COMPLETED|Part B (104 Weeks)||0
8161530|NCT02531633|20119876|P4|COMPLETED|Part B (104 Weeks)||0
8161531|NCT02531633|20119877|P3|COMPLETED|Part B (104 Weeks)||0
8161532|NCT02531633|20119878|P2|COMPLETED|Part B (104 Weeks)||0
8161533|NCT02531633|20119879|P1|COMPLETED|Part B (104 Weeks)||0
8161534|NCT02531633|20119870|P10|STARTED|Part B (104 Weeks)||4
8161535|NCT02531633|20119871|P9|STARTED|Part B (104 Weeks)||5
8161536|NCT02531633|20119872|P8|STARTED|Part B (104 Weeks)||4
8161537|NCT02531633|20119873|P7|STARTED|Part B (104 Weeks)||5
8161538|NCT02531633|20119874|P6|STARTED|Part B (104 Weeks)||8
8161539|NCT02531633|20119875|P5|STARTED|Part B (104 Weeks)||0
8161540|NCT02531633|20119876|P4|STARTED|Part B (104 Weeks)||0
8161541|NCT02531633|20119877|P3|STARTED|Part B (104 Weeks)||0
8161542|NCT02531633|20119878|P2|STARTED|Part B (104 Weeks)||0
8161543|NCT02531633|20119879|P1|STARTED|Part B (104 Weeks)||0
8161544|NCT02531633|20119870|P10|NOT COMPLETED|Part A (52 Weeks)||0
8161545|NCT02531633|20119871|P9|NOT COMPLETED|Part A (52 Weeks)||0
8161546|NCT02531633|20119872|P8|NOT COMPLETED|Part A (52 Weeks)||0
8161547|NCT02531633|20119873|P7|NOT COMPLETED|Part A (52 Weeks)||0
8161548|NCT02531633|20119874|P6|NOT COMPLETED|Part A (52 Weeks)||0
8161549|NCT02531633|20119875|P5|NOT COMPLETED|Part A (52 Weeks)||23
8161550|NCT02531633|20119876|P4|NOT COMPLETED|Part A (52 Weeks)||22
8161551|NCT02531633|20119877|P3|NOT COMPLETED|Part A (52 Weeks)||22
8161552|NCT02531633|20119878|P2|NOT COMPLETED|Part A (52 Weeks)||34
8161553|NCT02531633|20119879|P1|NOT COMPLETED|Part A (52 Weeks)||34
8161554|NCT02531633|20119870|P10|COMPLETED|Part A (52 Weeks)||0
8161555|NCT02531633|20119871|P9|COMPLETED|Part A (52 Weeks)||0
8161556|NCT02531633|20119872|P8|COMPLETED|Part A (52 Weeks)||0
8161557|NCT02531633|20119873|P7|COMPLETED|Part A (52 Weeks)||0
8161558|NCT02531633|20119874|P6|COMPLETED|Part A (52 Weeks)||0
8161559|NCT02531633|20119875|P5|COMPLETED|Part A (52 Weeks)||4
8161560|NCT02531633|20119876|P4|COMPLETED|Part A (52 Weeks)||5
8161561|NCT02531633|20119877|P3|COMPLETED|Part A (52 Weeks)||4
8161562|NCT02531633|20119878|P2|COMPLETED|Part A (52 Weeks)||5
8161563|NCT02531633|20119879|P1|COMPLETED|Part A (52 Weeks)||8
8161564|NCT02531633|20119870|P10|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161565|NCT02531633|20119871|P9|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161566|NCT02531633|20119872|P8|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161567|NCT02531633|20119873|P7|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161568|NCT02531633|20119874|P6|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161569|NCT02531633|20119875|P5|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161570|NCT02531633|20119876|P4|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161571|NCT02531633|20119877|P3|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
8161572|NCT02531633|20119878|P2|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161573|NCT02531633|20119879|P1|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
8161574|NCT02531633|20119870|P10|STARTED|Part A (52 Weeks)||0
8161575|NCT02531633|20119871|P9|STARTED|Part A (52 Weeks)||0
8161576|NCT02531633|20119872|P8|STARTED|Part A (52 Weeks)||0
8161577|NCT02531633|20119873|P7|STARTED|Part A (52 Weeks)||0
8161578|NCT02531633|20119874|P6|STARTED|Part A (52 Weeks)||0
8161579|NCT02531633|20119875|P5|STARTED|Part A (52 Weeks)||27
8161580|NCT02531633|20119876|P4|STARTED|Part A (52 Weeks)||27
8161581|NCT02531633|20119877|P3|STARTED|Part A (52 Weeks)||26
8161582|NCT02531633|20119878|P2|STARTED|Part A (52 Weeks)||39
8161583|NCT02531633|20119879|P1|STARTED|Part A (52 Weeks)||42
8161584|NCT02531438|20120358|P2|NOT COMPLETED|Overall Study||26
8161585|NCT02531438|20120359|P1|NOT COMPLETED|Overall Study||30
8161586|NCT02531438|20120358|P2|COMPLETED|Overall Study||362
8161587|NCT02531438|20120359|P1|COMPLETED|Overall Study||356
8161588|NCT02531438|20120358|P2|STARTED|Overall Study||388
8161589|NCT02531438|20120359|P1|STARTED|Overall Study||386
8161590|NCT02531373|20120378|P9|NOT COMPLETED|Overall Study||9
8161591|NCT02531373|20120379|P8|NOT COMPLETED|Overall Study||9
8161592|NCT02531373|20120380|P7|NOT COMPLETED|Overall Study||11
8161593|NCT02531373|20120381|P6|NOT COMPLETED|Overall Study||9
8161594|NCT02531373|20120382|P5|NOT COMPLETED|Overall Study||8
8161595|NCT02531373|20120383|P4|NOT COMPLETED|Overall Study||0
8161596|NCT02531373|20120384|P3|NOT COMPLETED|Overall Study||0
8161597|NCT02531373|20120385|P2|NOT COMPLETED|Overall Study||0
8161598|NCT02531373|20120386|P1|NOT COMPLETED|Overall Study||0
8161599|NCT02531373|20120378|P9|COMPLETED|Overall Study||43
8161600|NCT02531373|20120379|P8|COMPLETED|Overall Study||43
8161601|NCT02531373|20120380|P7|COMPLETED|Overall Study||41
8161602|NCT02531373|20120381|P6|COMPLETED|Overall Study||42
8161603|NCT02531373|20120382|P5|COMPLETED|Overall Study||43
8161604|NCT02531373|20120383|P4|COMPLETED|Overall Study||20
8161605|NCT02531373|20120384|P3|COMPLETED|Overall Study||20
8161606|NCT02531373|20120385|P2|COMPLETED|Overall Study||20
8161607|NCT02531373|20120386|P1|COMPLETED|Overall Study||20
8161608|NCT02531373|20120378|P9|Vaccination 4|Overall Study||43
8161609|NCT02531373|20120379|P8|Vaccination 4|Overall Study||43
8161610|NCT02531373|20120380|P7|Vaccination 4|Overall Study||43
8161611|NCT02531373|20120381|P6|Vaccination 4|Overall Study||43
8161612|NCT02531373|20120382|P5|Vaccination 4|Overall Study||44
8161613|NCT02531373|20120383|P4|Vaccination 4|Overall Study||0
8161614|NCT02531373|20120384|P3|Vaccination 4|Overall Study||0
8161615|NCT02531373|20120385|P2|Vaccination 4|Overall Study||0
8161616|NCT02531373|20120386|P1|Vaccination 4|Overall Study||0
8161617|NCT02531373|20120378|P9|Vaccination 3|Overall Study||49
8161618|NCT02531373|20120379|P8|Vaccination 3|Overall Study||51
8161619|NCT02531373|20120380|P7|Vaccination 3|Overall Study||49
8161620|NCT02531373|20120381|P6|Vaccination 3|Overall Study||47
8161621|NCT02531373|20120382|P5|Vaccination 3|Overall Study||48
8161622|NCT02531373|20120383|P4|Vaccination 3|Overall Study||0
8161623|NCT02531373|20120384|P3|Vaccination 3|Overall Study||0
8161624|NCT02531373|20120385|P2|Vaccination 3|Overall Study||0
8161625|NCT02531373|20120386|P1|Vaccination 3|Overall Study||0
8161626|NCT02531373|20120378|P9|Vaccination 2|Overall Study||51
8161627|NCT02531373|20120379|P8|Vaccination 2|Overall Study||51
8161628|NCT02531373|20120380|P7|Vaccination 2|Overall Study||50
8161629|NCT02531373|20120381|P6|Vaccination 2|Overall Study||48
8161630|NCT02531373|20120382|P5|Vaccination 2|Overall Study||49
8161631|NCT02531373|20120383|P4|Vaccination 2|Overall Study||0
8161632|NCT02531373|20120384|P3|Vaccination 2|Overall Study||0
8161633|NCT02531373|20120385|P2|Vaccination 2|Overall Study||0
8161634|NCT02531373|20120386|P1|Vaccination 2|Overall Study||0
8161635|NCT02531373|20120378|P9|Vaccination 1|Overall Study||52
8161636|NCT02531373|20120379|P8|Vaccination 1|Overall Study||52
8161637|NCT02531373|20120380|P7|Vaccination 1|Overall Study||52
8161638|NCT02531373|20120381|P6|Vaccination 1|Overall Study||50
8161639|NCT02531373|20120382|P5|Vaccination 1|Overall Study||50
8161640|NCT02531373|20120383|P4|Vaccination 1|Overall Study||20
8161641|NCT02531373|20120384|P3|Vaccination 1|Overall Study||20
8161642|NCT02531373|20120385|P2|Vaccination 1|Overall Study||20
8161643|NCT02531373|20120386|P1|Vaccination 1|Overall Study||20
8161644|NCT02531373|20120378|P9|STARTED|Overall Study||52
8161645|NCT02531373|20120379|P8|STARTED|Overall Study||52
8161646|NCT02531373|20120380|P7|STARTED|Overall Study||52
8161647|NCT02531373|20120381|P6|STARTED|Overall Study||51
8161648|NCT02531373|20120382|P5|STARTED|Overall Study||51
8161649|NCT02531373|20120383|P4|STARTED|Overall Study||20
8161650|NCT02531373|20120384|P3|STARTED|Overall Study||20
8161651|NCT02531373|20120385|P2|STARTED|Overall Study||20
8161652|NCT02531373|20120386|P1|STARTED|Overall Study||20
8161653|NCT02531321|20120445|P2|NOT COMPLETED|Overall Study||0
8161654|NCT02531321|20120446|P1|NOT COMPLETED|Overall Study||2
8161655|NCT02531321|20120445|P2|COMPLETED|Overall Study||10
8161656|NCT02531321|20120446|P1|COMPLETED|Overall Study||5
8161657|NCT02531321|20120445|P2|STARTED|Overall Study||10
8161658|NCT02531321|20120446|P1|STARTED|Overall Study||7
8161659|NCT02531308|20120454|P1|NOT COMPLETED|Overall Study||3
8161660|NCT02531308|20120454|P1|COMPLETED|Overall Study||2
8161661|NCT02531308|20120454|P1|STARTED|Overall Study||5
8161662|NCT02531113|20120458|P1|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
8161663|NCT02531113|20120458|P1|COMPLETED|Extension Period: Week 12 up to Week 160||14
8161664|NCT02531113|20120458|P1|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
8161665|NCT02531113|20120458|P1|NOT COMPLETED|Induction Period: Week 0 to 12||11
8161666|NCT02531113|20120458|P1|COMPLETED|Induction Period: Week 0 to 12||58
8161667|NCT02531113|20120458|P1|STARTED|Induction Period: Week 0 to 12||69
8161668|NCT02531035|20120494|P2|NOT COMPLETED|Overall Study||95
8161669|NCT02531035|20120495|P1|NOT COMPLETED|Overall Study||81
8161670|NCT02531035|20120494|P2|COMPLETED|Overall Study||605
8161671|NCT02531035|20120495|P1|COMPLETED|Overall Study||624
8161672|NCT02531035|20120494|P2|Treated|Overall Study||699
8161673|NCT02531035|20120495|P1|Treated|Overall Study||703
8161674|NCT02531035|20120494|P2|STARTED|Overall Study||700
8161675|NCT02531035|20120495|P1|STARTED|Overall Study||705
8161676|NCT02531022|20120511|P2|NOT COMPLETED|Overall Study||2
8161677|NCT02531022|20120512|P1|NOT COMPLETED|Overall Study||0
8161678|NCT02531022|20120511|P2|COMPLETED|Overall Study||48
8161679|NCT02531022|20120512|P1|COMPLETED|Overall Study||55
8161680|NCT02531022|20120511|P2|STARTED|Overall Study||50
8161681|NCT02531022|20120512|P1|STARTED|Overall Study||55
8161682|NCT02530970|20120520|P1|NOT COMPLETED|Overall Study||134
8161683|NCT02530970|20120520|P1|COMPLETED|Overall Study||891
8161684|NCT02530970|20120520|P1|STARTED|Overall Study||1025
8161685|NCT02530671|20120527|P2|NOT COMPLETED|Overall Study||0
8161686|NCT02530671|20120528|P1|NOT COMPLETED|Overall Study||3
8161687|NCT02530671|20120527|P2|COMPLETED|Overall Study||55
8161688|NCT02530671|20120528|P1|COMPLETED|Overall Study||52
8161689|NCT02530671|20120527|P2|STARTED|Overall Study||55
8161690|NCT02530671|20120528|P1|STARTED|Overall Study||55
8161691|NCT02530619|20120544|P1|NOT COMPLETED|Follow-up Period (6 Months)||11
8161692|NCT02530619|20120544|P1|COMPLETED|Follow-up Period (6 Months)||10
8161693|NCT02530619|20120544|P1|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
8161694|NCT02530619|20120544|P1|NOT COMPLETED|Continued Treatment Cycle 7+||0
8161695|NCT02530619|20120544|P1|COMPLETED|Continued Treatment Cycle 7+||14
8161696|NCT02530619|20120544|P1|STARTED|Continued Treatment Cycle 7+||14
8161697|NCT02530619|20120544|P1|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
8161698|NCT02530619|20120544|P1|COMPLETED|Continued Treatment Cycles 2 Through 6||14
8161699|NCT02530619|20120544|P1|STARTED|Continued Treatment Cycles 2 Through 6||24
8161700|NCT02530619|20120544|P1|NOT COMPLETED|Completed 1st Cycle of Treatment||0
8161701|NCT02530619|20120544|P1|COMPLETED|Completed 1st Cycle of Treatment||24
8161702|NCT02530619|20120544|P1|STARTED|Completed 1st Cycle of Treatment||24
8161703|NCT02530619|20120544|P1|NOT COMPLETED|Registered for Study||2
8161704|NCT02530619|20120544|P1|COMPLETED|Registered for Study||24
8161705|NCT02530619|20120544|P1|Received 1st Dose of Alisertib|Registered for Study||24
8161706|NCT02530619|20120544|P1|Registered|Registered for Study||26
8161707|NCT02530619|20120544|P1|STARTED|Registered for Study||26
8161708|NCT02530554|20120548|P4|NOT COMPLETED|Overall Study||0
8161709|NCT02530554|20120549|P3|NOT COMPLETED|Overall Study||0
8161710|NCT02530554|20120550|P2|NOT COMPLETED|Overall Study||0
8161711|NCT02530554|20120551|P1|NOT COMPLETED|Overall Study||0
8161712|NCT02530554|20120548|P4|COMPLETED|Overall Study||14
8161713|NCT02530554|20120549|P3|COMPLETED|Overall Study||12
8161714|NCT02530554|20120550|P2|COMPLETED|Overall Study||14
8161715|NCT02530554|20120551|P1|COMPLETED|Overall Study||12
8161716|NCT02530554|20120548|P4|STARTED|Overall Study||14
8161717|NCT02530554|20120549|P3|STARTED|Overall Study||12
8161718|NCT02530554|20120550|P2|STARTED|Overall Study||14
8161719|NCT02530554|20120551|P1|STARTED|Overall Study||12
8161720|NCT02530515|20120561|P3|NOT COMPLETED|Overall Study||0
8161721|NCT02530515|20120562|P2|NOT COMPLETED|Overall Study||0
8161722|NCT02530515|20120563|P1|NOT COMPLETED|Overall Study||0
8161723|NCT02530515|20120561|P3|COMPLETED|Overall Study||8
8161724|NCT02530515|20120562|P2|COMPLETED|Overall Study||0
8161725|NCT02530515|20120563|P1|COMPLETED|Overall Study||0
8161726|NCT02530515|20120561|P3|STARTED|Overall Study||8
8161727|NCT02530515|20120562|P2|STARTED|Overall Study||0
8161728|NCT02530515|20120563|P1|STARTED|Overall Study||0
8161729|NCT02530476|20120584|P4|NOT COMPLETED|Overall Study||0
8161730|NCT02530476|20120585|P3|NOT COMPLETED|Overall Study||0
8161731|NCT02530476|20120586|P2|NOT COMPLETED|Overall Study||0
8161732|NCT02530476|20120587|P1|NOT COMPLETED|Overall Study||0
8161733|NCT02530476|20120584|P4|COMPLETED|Overall Study||3
8161734|NCT02530476|20120585|P3|COMPLETED|Overall Study||7
8161735|NCT02530476|20120586|P2|COMPLETED|Overall Study||3
8161736|NCT02530476|20120587|P1|COMPLETED|Overall Study||4
8161737|NCT02530476|20120584|P4|STARTED|Overall Study||3
8161738|NCT02530476|20120585|P3|STARTED|Overall Study||7
8161739|NCT02530476|20120586|P2|STARTED|Overall Study||3
8161740|NCT02530476|20120587|P1|STARTED|Overall Study||4
8161741|NCT02530450|20120611|P2|NOT COMPLETED|Overall Study||5
8161742|NCT02530450|20120612|P1|NOT COMPLETED|Overall Study||6
8161743|NCT02530450|20120611|P2|COMPLETED|Overall Study||9
8161744|NCT02530450|20120612|P1|COMPLETED|Overall Study||10
8161745|NCT02530450|20120611|P2|STARTED|Overall Study||14
8161746|NCT02530450|20120612|P1|STARTED|Overall Study||16
8161747|NCT02530385|20120620|P2|NOT COMPLETED|Overall Study||1
8161748|NCT02530385|20120621|P1|NOT COMPLETED|Overall Study||0
8161749|NCT02530385|20120620|P2|COMPLETED|Overall Study||11
8161750|NCT02530385|20120621|P1|COMPLETED|Overall Study||12
8161751|NCT02530385|20120620|P2|STARTED|Overall Study||12
8161752|NCT02530385|20120621|P1|STARTED|Overall Study||12
8161753|NCT02530294|20120637|P2|NOT COMPLETED|Overall Study||6
8161754|NCT02530294|20120638|P1|NOT COMPLETED|Overall Study||16
8161755|NCT02530294|20120637|P2|COMPLETED|Overall Study||113
8161756|NCT02530294|20120638|P1|COMPLETED|Overall Study||218
8161757|NCT02530294|20120637|P2|STARTED|Overall Study||119
8161758|NCT02530294|20120638|P1|STARTED|Overall Study||234
8161759|NCT02530281|20120654|P2|NOT COMPLETED|Overall Study||3
8161760|NCT02530281|20120655|P1|NOT COMPLETED|Overall Study||21
8161761|NCT02530281|20120654|P2|COMPLETED|Overall Study||112
8161762|NCT02530281|20120655|P1|COMPLETED|Overall Study||208
8161763|NCT02530281|20120654|P2|STARTED|Overall Study||115
8161764|NCT02530281|20120655|P1|STARTED|Overall Study||229
8161765|NCT02530242|20120673|P2|NOT COMPLETED|Overall Study||1
8161766|NCT02530242|20120674|P1|NOT COMPLETED|Overall Study||0
8161767|NCT02530242|20120673|P2|COMPLETED|Overall Study||15
8161768|NCT02530242|20120674|P1|COMPLETED|Overall Study||16
8161769|NCT02530242|20120673|P2|STARTED|Overall Study||16
8161770|NCT02530242|20120674|P1|STARTED|Overall Study||16
8161771|NCT02530151|20120682|P2|NOT COMPLETED|Overall Study||16
8161772|NCT02530151|20120683|P1|NOT COMPLETED|Overall Study||21
8161773|NCT02530151|20120682|P2|COMPLETED|Overall Study||17
8161774|NCT02530151|20120683|P1|COMPLETED|Overall Study||16
8161775|NCT02530151|20120682|P2|STARTED|Overall Study||33
8161776|NCT02530151|20120683|P1|STARTED|Overall Study||37
8161777|NCT02530125|20120693|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
8161778|NCT02530125|20120693|P1|COMPLETED|Followed for Survival for 2 Years||0
8161779|NCT02530125|20120693|P1|STARTED|Followed for Survival for 2 Years||3
8161780|NCT02530125|20120693|P1|NOT COMPLETED|Completed Treatment||1
8161781|NCT02530125|20120693|P1|COMPLETED|Completed Treatment||3
8161782|NCT02530125|20120693|P1|STARTED|Completed Treatment||4
8161783|NCT02529995|20120707|P2|NOT COMPLETED|Part B||12
8161784|NCT02529995|20120708|P1|NOT COMPLETED|Part B||6
8161785|NCT02529995|20120707|P2|COMPLETED|Part B||4
8161786|NCT02529995|20120708|P1|COMPLETED|Part B||9
8161787|NCT02529995|20120707|P2|STARTED|Part B||16
8161788|NCT02529995|20120708|P1|STARTED|Part B||15
8161789|NCT02529995|20120707|P2|NOT COMPLETED|Part A||16
8161790|NCT02529995|20120708|P1|NOT COMPLETED|Part A||15
8161791|NCT02529995|20120707|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
8161792|NCT02529995|20120708|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
8161793|NCT02529995|20120707|P2|STARTED|Part A||16
8161794|NCT02529995|20120708|P1|STARTED|Part A||15
8161795|NCT02529553|20120751|P9|NOT COMPLETED|Overall Study||3
8161796|NCT02529553|20120752|P8|NOT COMPLETED|Overall Study||6
8161797|NCT02529553|20120753|P7|NOT COMPLETED|Overall Study||3
8161798|NCT02529553|20120754|P6|NOT COMPLETED|Overall Study||4
8161799|NCT02529553|20120755|P5|NOT COMPLETED|Overall Study||3
8161800|NCT02529553|20120756|P4|NOT COMPLETED|Overall Study||3
8161801|NCT02529553|20120757|P3|NOT COMPLETED|Overall Study||1
8161802|NCT02529553|20120758|P2|NOT COMPLETED|Overall Study||1
8161803|NCT02529553|20120759|P1|NOT COMPLETED|Overall Study||1
8161804|NCT02529553|20120751|P9|COMPLETED|Overall Study||0
8161805|NCT02529553|20120752|P8|COMPLETED|Overall Study||0
8161806|NCT02529553|20120753|P7|COMPLETED|Overall Study||0
8161807|NCT02529553|20120754|P6|COMPLETED|Overall Study||0
8161808|NCT02529553|20120755|P5|COMPLETED|Overall Study||0
8161809|NCT02529553|20120756|P4|COMPLETED|Overall Study||0
8161810|NCT02529553|20120757|P3|COMPLETED|Overall Study||0
8161811|NCT02529553|20120758|P2|COMPLETED|Overall Study||0
8161812|NCT02529553|20120759|P1|COMPLETED|Overall Study||0
8161813|NCT02529553|20120751|P9|STARTED|Overall Study||3
8161814|NCT02529553|20120752|P8|STARTED|Overall Study||6
8161815|NCT02529553|20120753|P7|STARTED|Overall Study||3
8161816|NCT02529553|20120754|P6|STARTED|Overall Study||4
8161817|NCT02529553|20120755|P5|STARTED|Overall Study||3
8161818|NCT02529553|20120756|P4|STARTED|Overall Study||3
8161819|NCT02529553|20120757|P3|STARTED|Overall Study||1
8161820|NCT02529553|20120758|P2|STARTED|Overall Study||1
8161821|NCT02529553|20120759|P1|STARTED|Overall Study||1
8161822|NCT02529488|20120798|P1|NOT COMPLETED|Overall Study||4
8161823|NCT02529488|20120798|P1|COMPLETED|Overall Study||145
8161824|NCT02529488|20120798|P1|STARTED|Overall Study||149
8161825|NCT02529137|20120806|P1|NOT COMPLETED|Overall Study||8
8161826|NCT02529137|20120806|P1|COMPLETED|Overall Study||1992
8161827|NCT02529137|20120806|P1|STARTED|Overall Study||2000
8161828|NCT02529072|20120813|P2|NOT COMPLETED|Overall Study||0
8161829|NCT02529072|20120814|P1|NOT COMPLETED|Overall Study||0
8161830|NCT02529072|20120813|P2|COMPLETED|Overall Study||3
8161831|NCT02529072|20120814|P1|COMPLETED|Overall Study||3
8161832|NCT02529072|20120813|P2|STARTED|Overall Study||3
8161833|NCT02529072|20120814|P1|STARTED|Overall Study||3
8161834|NCT02528786|20120824|P1|NOT COMPLETED|Overall Study||0
8161835|NCT02528786|20120824|P1|COMPLETED|Overall Study||8
8161836|NCT02528786|20120824|P1|STARTED|Overall Study||8
8161837|NCT02528721|20120830|P2|NOT COMPLETED|Overall Study||3
8161838|NCT02528721|20120831|P1|NOT COMPLETED|Overall Study||7
8161839|NCT02528721|20120830|P2|COMPLETED|Overall Study||76
8161840|NCT02528721|20120831|P1|COMPLETED|Overall Study||196
8161841|NCT02528721|20120830|P2|STARTED|Overall Study||79
8161842|NCT02528721|20120831|P1|STARTED|Overall Study||203
8161843|NCT02528643|20120843|P2|NOT COMPLETED|Overall Study||85
8161844|NCT02528643|20120844|P1|NOT COMPLETED|Overall Study||39
8161845|NCT02528643|20120843|P2|COMPLETED|Overall Study||25
8161846|NCT02528643|20120844|P1|COMPLETED|Overall Study||16
8161847|NCT02528643|20120843|P2|Treated|Overall Study||107
8161848|NCT02528643|20120844|P1|Treated|Overall Study||55
8161849|NCT02528643|20120843|P2|STARTED|Overall Study||110
8161850|NCT02528643|20120844|P1|STARTED|Overall Study||55
8161851|NCT02528500|20120857|P1|NOT COMPLETED|Overall Study||0
8161852|NCT02528500|20120857|P1|COMPLETED|Overall Study||10
8161853|NCT02528500|20120857|P1|STARTED|Overall Study||10
8161854|NCT02528409|20120863|P2|NOT COMPLETED|Overall Study||16
8161855|NCT02528409|20120864|P1|NOT COMPLETED|Overall Study||22
8161856|NCT02528409|20120863|P2|COMPLETED|Overall Study||24
8161857|NCT02528409|20120864|P1|COMPLETED|Overall Study||18
8161858|NCT02528409|20120863|P2|STARTED|Overall Study||40
8161859|NCT02528409|20120864|P1|STARTED|Overall Study||40
8161860|NCT02528331|20120886|P1|NOT COMPLETED|Overall Study||2
8161861|NCT02528331|20120886|P1|COMPLETED|Overall Study||0
8161862|NCT02528331|20120886|P1|STARTED|Overall Study||2
8161863|NCT02528318|20120898|P5|NOT COMPLETED|Overall Study||0
8161864|NCT02528318|20120899|P4|NOT COMPLETED|Overall Study||0
8161865|NCT02528318|20120900|P3|NOT COMPLETED|Overall Study||0
8161866|NCT02528318|20120901|P2|NOT COMPLETED|Overall Study||0
8161867|NCT02528318|20120902|P1|NOT COMPLETED|Overall Study||0
8161868|NCT02528318|20120898|P5|COMPLETED|Overall Study||24
8161869|NCT02528318|20120899|P4|COMPLETED|Overall Study||0
8161870|NCT02528318|20120900|P3|COMPLETED|Overall Study||8
8161871|NCT02528318|20120901|P2|COMPLETED|Overall Study||8
8161872|NCT02528318|20120902|P1|COMPLETED|Overall Study||8
8161873|NCT02528318|20120898|P5|STARTED|Overall Study||24
8161874|NCT02528318|20120899|P4|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
8161875|NCT02528318|20120900|P3|STARTED|Overall Study||8
8161876|NCT02528318|20120901|P2|STARTED|Overall Study||8
8161877|NCT02528318|20120902|P1|STARTED|Overall Study||8
8161878|NCT02528305|20120954|P1|NOT COMPLETED|Overall Study||3
8161879|NCT02528305|20120954|P1|COMPLETED|Overall Study||9
8161880|NCT02528305|20120954|P1|End of Intervention Period Assessment|Overall Study||9
8161881|NCT02528305|20120954|P1|End of Control Period Assessment|Overall Study||11
8161882|NCT02528305|20120954|P1|STARTED|Overall Study||12
8161883|NCT02528253|20121001|P5|NOT COMPLETED|Overall Study||223
8161884|NCT02528253|20121002|P4|NOT COMPLETED|Overall Study||136
8161885|NCT02528253|20121003|P3|NOT COMPLETED|Overall Study||140
8161886|NCT02528253|20121004|P2|NOT COMPLETED|Overall Study||70
8161887|NCT02528253|20121005|P1|NOT COMPLETED|Overall Study||75
8161888|NCT02528253|20121001|P5|COMPLETED|Overall Study||379
8161889|NCT02528253|20121002|P4|COMPLETED|Overall Study||271
8161890|NCT02528253|20121003|P3|COMPLETED|Overall Study||267
8161891|NCT02528253|20121004|P2|COMPLETED|Overall Study||134
8161892|NCT02528253|20121005|P1|COMPLETED|Overall Study||130
8161893|NCT02528253|20121001|P5|Treated at Week 16|Overall Study||307
8161894|NCT02528253|20121002|P4|Treated at Week 16|Overall Study||242
8161895|NCT02528253|20121003|P3|Treated at Week 16|Overall Study||236
8161896|NCT02528253|20121004|P2|Treated at Week 16|Overall Study||95
8161897|NCT02528253|20121005|P1|Treated at Week 16|Overall Study||99
8161898|NCT02528253|20121001|P5|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
8161899|NCT02528253|20121002|P4|Intent to Treat Population|Overall Study||407
8161900|NCT02528253|20121003|P3|Intent to Treat Population|Overall Study||407
8161901|NCT02528253|20121004|P2|Intent to Treat Population|Overall Study||204
8161902|NCT02528253|20121005|P1|Intent to Treat Population|Overall Study||202
8161903|NCT02528253|20121001|P5|STARTED|Overall Study||602
8161904|NCT02528253|20121002|P4|STARTED|Overall Study||407
8161905|NCT02528253|20121003|P3|STARTED|Overall Study||407
8161906|NCT02528253|20121004|P2|STARTED|Overall Study||204
8161907|NCT02528253|20121005|P1|STARTED|Overall Study||205
8161908|NCT02528214|20121298|P2|NOT COMPLETED|Overall Study||3
8161909|NCT02528214|20121299|P1|NOT COMPLETED|Overall Study||0
8161910|NCT02528214|20121298|P2|COMPLETED|Overall Study||100
8161911|NCT02528214|20121299|P1|COMPLETED|Overall Study||107
8161912|NCT02528214|20121298|P2|Treated|Overall Study||103
8161913|NCT02528214|20121299|P1|Treated|Overall Study||107
8161914|NCT02528214|20121298|P2|STARTED|Overall Study||103
8161915|NCT02528214|20121299|P1|STARTED|Overall Study||107
8161916|NCT02528188|20121334|P3|NOT COMPLETED|Overall Study||251
8161917|NCT02528188|20121335|P2|NOT COMPLETED|Overall Study||276
8161918|NCT02528188|20121336|P1|NOT COMPLETED|Overall Study||267
8161919|NCT02528188|20121334|P3|COMPLETED|Overall Study||757
8161920|NCT02528188|20121335|P2|COMPLETED|Overall Study||729
8161921|NCT02528188|20121336|P1|COMPLETED|Overall Study||741
8161922|NCT02528188|20121334|P3|Treated|Overall Study||996
8161923|NCT02528188|20121335|P2|Treated|Overall Study||998
8161924|NCT02528188|20121336|P1|Treated|Overall Study||1002
8161925|NCT02528188|20121334|P3|STARTED|Overall Study||1008
8161926|NCT02528188|20121335|P2|STARTED|Overall Study||1005
8161927|NCT02528188|20121336|P1|STARTED|Overall Study||1008
8161928|NCT02528097|20121588|P2|NOT COMPLETED|Overall Study||0
8161929|NCT02528097|20121589|P1|NOT COMPLETED|Overall Study||0
8161930|NCT02528097|20121588|P2|COMPLETED|Overall Study||1
8161931|NCT02528097|20121589|P1|COMPLETED|Overall Study||1
8161932|NCT02528097|20121588|P2|STARTED|Overall Study||1
8161933|NCT02528097|20121589|P1|STARTED|Overall Study||1
8161934|NCT02527694|20121599|P2|NOT COMPLETED|Overall Study||8
8161935|NCT02527694|20121600|P1|NOT COMPLETED|Overall Study||10
8161936|NCT02527694|20121599|P2|COMPLETED|Overall Study||21
8161937|NCT02527694|20121600|P1|COMPLETED|Overall Study||10
8161938|NCT02527694|20121599|P2|STARTED|Overall Study||29
8161939|NCT02527694|20121600|P1|STARTED|Overall Study||20
8161940|NCT02527681|20121608|P1|NOT COMPLETED|Overall Study||0
8161941|NCT02527681|20121608|P1|COMPLETED|Overall Study||15
8161942|NCT02527681|20121608|P1|STARTED|Overall Study||15
8161943|NCT02527434|20121618|P3|NOT COMPLETED|Overall Study||20
8161944|NCT02527434|20121619|P2|NOT COMPLETED|Overall Study||11
8161945|NCT02527434|20121620|P1|NOT COMPLETED|Overall Study||28
8161946|NCT02527434|20121618|P3|COMPLETED|Overall Study||0
8161947|NCT02527434|20121619|P2|COMPLETED|Overall Study||1
8161948|NCT02527434|20121620|P1|COMPLETED|Overall Study||4
8161949|NCT02527434|20121618|P3|Started Retreatment Phase (MEDI)|Overall Study||1
8161950|NCT02527434|20121619|P2|Started Retreatment Phase (MEDI)|Overall Study||0
8161951|NCT02527434|20121620|P1|Started Retreatment Phase (MEDI)|Overall Study||4
8161952|NCT02527434|20121618|P3|Started Retreatment Phase (COMBO)|Overall Study||4
8161953|NCT02527434|20121619|P2|Started Retreatment Phase (COMBO)|Overall Study||5
8161954|NCT02527434|20121620|P1|Started Retreatment Phase (COMBO)|Overall Study||7
8161955|NCT02527434|20121618|P3|STARTED|Overall Study||20
8161956|NCT02527434|20121619|P2|STARTED|Overall Study||12
8161957|NCT02527434|20121620|P1|STARTED|Overall Study||32
8161958|NCT02527161|20121678|P1|NOT COMPLETED|Overall Study||132
8161959|NCT02527161|20121678|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
8161960|NCT02527161|20121678|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
8161961|NCT02527148|20121697|P2|NOT COMPLETED|Overall Study||0
8161962|NCT02527148|20121698|P1|NOT COMPLETED|Overall Study||1
8161963|NCT02527148|20121697|P2|COMPLETED|Overall Study||50
8161964|NCT02527148|20121698|P1|COMPLETED|Overall Study||49
8161965|NCT02527148|20121697|P2|STARTED|Overall Study||50
8161966|NCT02527148|20121698|P1|STARTED|Overall Study||50
8161967|NCT02526693|20121728|P2|NOT COMPLETED|Overall Study||1
8161968|NCT02526693|20121729|P1|NOT COMPLETED|Overall Study||3
8161969|NCT02526693|20121728|P2|COMPLETED|Overall Study||50
8161970|NCT02526693|20121729|P1|COMPLETED|Overall Study||50
8161971|NCT02526693|20121728|P2|STARTED|Overall Study||51
8161972|NCT02526693|20121729|P1|STARTED|Overall Study||53
8161973|NCT02526680|20121739|P1|NOT COMPLETED|Overall Study||0
8161974|NCT02526680|20121739|P1|COMPLETED|Overall Study||27
8161975|NCT02526680|20121739|P1|STARTED|Overall Study||27
8161976|NCT02526667|20121746|P3|NOT COMPLETED|Groin||0
8161977|NCT02526667|20121747|P2|NOT COMPLETED|Groin||0
8161978|NCT02526667|20121748|P1|NOT COMPLETED|Groin||0
8161979|NCT02526667|20121746|P3|COMPLETED|Groin||294
8161980|NCT02526667|20121747|P2|COMPLETED|Groin||56
8161981|NCT02526667|20121748|P1|COMPLETED|Groin||290
8161982|NCT02526667|20121746|P3|STARTED|Groin||294
8161983|NCT02526667|20121747|P2|STARTED|Groin||56
8161984|NCT02526667|20121748|P1|STARTED|Groin||290
8161985|NCT02526667|20121746|P3|NOT COMPLETED|Abdomen||0
8161986|NCT02526667|20121747|P2|NOT COMPLETED|Abdomen||0
8161987|NCT02526667|20121748|P1|NOT COMPLETED|Abdomen||0
8161988|NCT02526667|20121746|P3|COMPLETED|Abdomen||281
8161989|NCT02526667|20121747|P2|COMPLETED|Abdomen||56
8161990|NCT02526667|20121748|P1|COMPLETED|Abdomen||284
8161991|NCT02526667|20121746|P3|STARTED|Abdomen||281
8161992|NCT02526667|20121747|P2|STARTED|Abdomen||56
8161993|NCT02526667|20121748|P1|STARTED|Abdomen||284
8161994|NCT02526654|20121764|P2|NOT COMPLETED|Overall Study||0
8161995|NCT02526654|20121765|P1|NOT COMPLETED|Overall Study||0
8161996|NCT02526654|20121764|P2|COMPLETED|Overall Study||36
8161997|NCT02526654|20121765|P1|COMPLETED|Overall Study||79
8161998|NCT02526654|20121764|P2|STARTED|Overall Study||36
8161999|NCT02526654|20121765|P1|STARTED|Overall Study||79
8162000|NCT02526550|20121774|P1|NOT COMPLETED|Overall Study||1
8162001|NCT02526550|20121774|P1|COMPLETED|Overall Study||49
8162002|NCT02526550|20121774|P1|STARTED|Overall Study||50
8162003|NCT02526524|20121786|P6|NOT COMPLETED|Overall Study||21
8162004|NCT02526524|20121787|P5|NOT COMPLETED|Overall Study||24
8162005|NCT02526524|20121788|P4|NOT COMPLETED|Overall Study||7
8162006|NCT02526524|20121789|P3|NOT COMPLETED|Overall Study||26
8162007|NCT02526524|20121790|P2|NOT COMPLETED|Overall Study||9
8162008|NCT02526524|20121791|P1|NOT COMPLETED|Overall Study||12
8162009|NCT02526524|20121786|P6|COMPLETED|Overall Study||73
8162010|NCT02526524|20121787|P5|COMPLETED|Overall Study||72
8162011|NCT02526524|20121788|P4|COMPLETED|Overall Study||89
8162012|NCT02526524|20121789|P3|COMPLETED|Overall Study||70
8162013|NCT02526524|20121790|P2|COMPLETED|Overall Study||86
8162014|NCT02526524|20121791|P1|COMPLETED|Overall Study||82
8162015|NCT02526524|20121786|P6|STARTED|Overall Study||94
8162016|NCT02526524|20121787|P5|STARTED|Overall Study||96
8162017|NCT02526524|20121788|P4|STARTED|Overall Study||96
8162018|NCT02526524|20121789|P3|STARTED|Overall Study||96
8162019|NCT02526524|20121790|P2|STARTED|Overall Study||95
8162020|NCT02526524|20121791|P1|STARTED|Overall Study||94
8162021|NCT02526290|20121805|P1|NOT COMPLETED|Overall Study||8
8162022|NCT02526290|20121805|P1|COMPLETED|Overall Study||89
8162023|NCT02526290|20121805|P1|STARTED|Overall Study||97
8162024|NCT02526212|20121814|P2|NOT COMPLETED|Overall Study||1
8162025|NCT02526212|20121815|P1|NOT COMPLETED|Overall Study||2
8162026|NCT02526212|20121814|P2|COMPLETED|Overall Study||7
8162027|NCT02526212|20121815|P1|COMPLETED|Overall Study||8
8162028|NCT02526212|20121814|P2|STARTED|Overall Study||8
8162029|NCT02526212|20121815|P1|STARTED|Overall Study||10
8162030|NCT02525874|20121829|P1|NOT COMPLETED|Overall Study||60
8162031|NCT02525874|20121829|P1|COMPLETED|Overall Study||158
8162032|NCT02525874|20121829|P1|STARTED|Overall Study||218
8162033|NCT02525744|20121842|P4|NOT COMPLETED|Period 5||0
8162034|NCT02525744|20121843|P3|NOT COMPLETED|Period 5||0
8162035|NCT02525744|20121844|P2|NOT COMPLETED|Period 5||0
8162036|NCT02525744|20121845|P1|NOT COMPLETED|Period 5||1
8162037|NCT02525744|20121842|P4|COMPLETED|Period 5||6
8162038|NCT02525744|20121843|P3|COMPLETED|Period 5||5
8162039|NCT02525744|20121844|P2|COMPLETED|Period 5||5
8162040|NCT02525744|20121845|P1|COMPLETED|Period 5||4
8162041|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 5||6
8162042|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 5||5
8162043|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 5||5
8162044|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 5||4
8162045|NCT02525744|20121842|P4|STARTED|Period 5||6
8162046|NCT02525744|20121843|P3|STARTED|Period 5||5
8162047|NCT02525744|20121844|P2|STARTED|Period 5||5
8162048|NCT02525744|20121845|P1|STARTED|Period 5||5
8162049|NCT02525744|20121842|P4|NOT COMPLETED|Period 4||0
8162050|NCT02525744|20121843|P3|NOT COMPLETED|Period 4||0
8162051|NCT02525744|20121844|P2|NOT COMPLETED|Period 4||0
8162052|NCT02525744|20121845|P1|NOT COMPLETED|Period 4||1
8162053|NCT02525744|20121842|P4|COMPLETED|Period 4||6
8162054|NCT02525744|20121843|P3|COMPLETED|Period 4||5
8162055|NCT02525744|20121844|P2|COMPLETED|Period 4||5
8162056|NCT02525744|20121845|P1|COMPLETED|Period 4||5
8162057|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 4||6
8162058|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 4||5
8162059|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 4||5
8162060|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 4||6
8162061|NCT02525744|20121842|P4|STARTED|Period 4||6
8162062|NCT02525744|20121843|P3|STARTED|Period 4||5
8162063|NCT02525744|20121844|P2|STARTED|Period 4||5
8162064|NCT02525744|20121845|P1|STARTED|Period 4||6
8162065|NCT02525744|20121842|P4|NOT COMPLETED|Period 3||0
8162066|NCT02525744|20121843|P3|NOT COMPLETED|Period 3||0
8162067|NCT02525744|20121844|P2|NOT COMPLETED|Period 3||1
8162068|NCT02525744|20121845|P1|NOT COMPLETED|Period 3||0
8162069|NCT02525744|20121842|P4|COMPLETED|Period 3||6
8162070|NCT02525744|20121843|P3|COMPLETED|Period 3||5
8162071|NCT02525744|20121844|P2|COMPLETED|Period 3||5
8162072|NCT02525744|20121845|P1|COMPLETED|Period 3||6
8162073|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 3||6
8162074|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 3||5
8162075|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 3||6
8162076|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 3||6
8162077|NCT02525744|20121842|P4|STARTED|Period 3||6
8162078|NCT02525744|20121843|P3|STARTED|Period 3||5
8162079|NCT02525744|20121844|P2|STARTED|Period 3||6
8162080|NCT02525744|20121845|P1|STARTED|Period 3||6
8162081|NCT02525744|20121842|P4|NOT COMPLETED|Period 2||0
8162082|NCT02525744|20121843|P3|NOT COMPLETED|Period 2||0
8162083|NCT02525744|20121844|P2|NOT COMPLETED|Period 2||0
8162084|NCT02525744|20121845|P1|NOT COMPLETED|Period 2||0
8162085|NCT02525744|20121842|P4|COMPLETED|Period 2||6
8162086|NCT02525744|20121843|P3|COMPLETED|Period 2||5
8162087|NCT02525744|20121844|P2|COMPLETED|Period 2||6
8162088|NCT02525744|20121845|P1|COMPLETED|Period 2||6
8162089|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 2||6
8162090|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 2||5
8162091|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 2||6
8162092|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 2||6
8162093|NCT02525744|20121842|P4|STARTED|Period 2||6
8162094|NCT02525744|20121843|P3|STARTED|Period 2||5
8162095|NCT02525744|20121844|P2|STARTED|Period 2||6
8162096|NCT02525744|20121845|P1|STARTED|Period 2||6
8162097|NCT02525744|20121842|P4|NOT COMPLETED|Period 1||0
8162098|NCT02525744|20121843|P3|NOT COMPLETED|Period 1||1
8162099|NCT02525744|20121844|P2|NOT COMPLETED|Period 1||0
8162100|NCT02525744|20121845|P1|NOT COMPLETED|Period 1||0
8162101|NCT02525744|20121842|P4|COMPLETED|Period 1||6
8162102|NCT02525744|20121843|P3|COMPLETED|Period 1||5
8162103|NCT02525744|20121844|P2|COMPLETED|Period 1||6
8162104|NCT02525744|20121845|P1|COMPLETED|Period 1||6
8162105|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8162106|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 1||5
8162107|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8162108|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8162109|NCT02525744|20121842|P4|STARTED|Period 1||6
8162110|NCT02525744|20121843|P3|STARTED|Period 1||6
8162111|NCT02525744|20121844|P2|STARTED|Period 1||6
8162112|NCT02525744|20121845|P1|STARTED|Period 1||6
8162113|NCT02525718|20121861|P2|NOT COMPLETED|Overall Study||1
8162114|NCT02525718|20121862|P1|NOT COMPLETED|Overall Study||1
8162115|NCT02525718|20121861|P2|COMPLETED|Overall Study||23
8162116|NCT02525718|20121862|P1|COMPLETED|Overall Study||22
8162117|NCT02525718|20121861|P2|STARTED|Overall Study||24
8162118|NCT02525718|20121862|P1|STARTED|Overall Study||23
8162119|NCT02525653|20121874|P1|NOT COMPLETED|Overall Study||0
8162120|NCT02525653|20121874|P1|COMPLETED|Overall Study||40
8162121|NCT02525653|20121874|P1|STARTED|Overall Study||40
8162122|NCT02525627|20121881|P2|NOT COMPLETED|Overall Study||13
8162123|NCT02525627|20121882|P1|NOT COMPLETED|Overall Study||14
8162124|NCT02525627|20121881|P2|COMPLETED|Overall Study||5
8162125|NCT02525627|20121882|P1|COMPLETED|Overall Study||2
8162126|NCT02525627|20121881|P2|STARTED|Overall Study||18
8162127|NCT02525627|20121882|P1|STARTED|Overall Study||16
8162128|NCT02525588|20121894|P2|NOT COMPLETED|Overall Study||3
8162129|NCT02525588|20121895|P1|NOT COMPLETED|Overall Study||6
8162130|NCT02525588|20121894|P2|COMPLETED|Overall Study||45
8162131|NCT02525588|20121895|P1|COMPLETED|Overall Study||42
8162132|NCT02525588|20121894|P2|STARTED|Overall Study||48
8162133|NCT02525588|20121895|P1|STARTED|Overall Study||48
8162134|NCT02525575|20121911|P1|NOT COMPLETED|Overall Study||15
8162135|NCT02525575|20121911|P1|COMPLETED|Overall Study||22
8162136|NCT02525575|20121911|P1|STARTED|Overall Study||37
8162137|NCT02525549|20121921|P3|NOT COMPLETED|Overall Study||19
8162138|NCT02525549|20121922|P2|NOT COMPLETED|Overall Study||53
8162139|NCT02525549|20121923|P1|NOT COMPLETED|Overall Study||35
8162140|NCT02525549|20121921|P3|COMPLETED|Overall Study||159
8162141|NCT02525549|20121922|P2|COMPLETED|Overall Study||307
8162142|NCT02525549|20121923|P1|COMPLETED|Overall Study||330
8162143|NCT02525549|20121921|P3|STARTED|Overall Study||178
8162144|NCT02525549|20121922|P2|STARTED|Overall Study||360
8162145|NCT02525549|20121923|P1|STARTED|Overall Study||365
8162146|NCT02525536|20121937|P3|NOT COMPLETED|Overall Study||0
8162147|NCT02525536|20121938|P2|NOT COMPLETED|Overall Study||0
8162148|NCT02525536|20121939|P1|NOT COMPLETED|Overall Study||0
8162149|NCT02525536|20121937|P3|COMPLETED|Overall Study||6
8162150|NCT02525536|20121938|P2|COMPLETED|Overall Study||6
8162151|NCT02525536|20121939|P1|COMPLETED|Overall Study||6
8162152|NCT02525536|20121937|P3|STARTED|Overall Study||6
8162153|NCT02525536|20121938|P2|STARTED|Overall Study||6
8162154|NCT02525536|20121939|P1|STARTED|Overall Study||6
8162155|NCT02525523|20122012|P2|NOT COMPLETED|Overall Study||25
8162156|NCT02525523|20122013|P1|NOT COMPLETED|Overall Study||23
8162157|NCT02525523|20122012|P2|COMPLETED|Overall Study||44
8162158|NCT02525523|20122013|P1|COMPLETED|Overall Study||46
8162159|NCT02525523|20122012|P2|STARTED|Overall Study||69
8162160|NCT02525523|20122013|P1|STARTED|Overall Study||69
8162161|NCT02525133|20122023|P2|NOT COMPLETED|Overall Study||3
8162162|NCT02525133|20122024|P1|NOT COMPLETED|Overall Study||10
8162163|NCT02525133|20122023|P2|COMPLETED|Overall Study||103
8162164|NCT02525133|20122024|P1|COMPLETED|Overall Study||203
8162165|NCT02525133|20122023|P2|Randomized But Not Treated|Overall Study||0
8162166|NCT02525133|20122024|P1|Randomized But Not Treated|Overall Study||4
8162167|NCT02525133|20122023|P2|STARTED|Overall Study||106
8162168|NCT02525133|20122024|P1|STARTED|Overall Study||213
8162169|NCT02525094|20122042|P2|NOT COMPLETED|Overall Study||8
8162170|NCT02525094|20122043|P1|NOT COMPLETED|Overall Study||8
8162171|NCT02525094|20122042|P2|COMPLETED|Overall Study||48
8162172|NCT02525094|20122043|P1|COMPLETED|Overall Study||49
8162173|NCT02525094|20122042|P2|Treated|Overall Study||55
8162174|NCT02525094|20122043|P1|Treated|Overall Study||56
8162175|NCT02525094|20122042|P2|STARTED|Overall Study||56
8162176|NCT02525094|20122043|P1|STARTED|Overall Study||57
8162177|NCT02525055|20122076|P6|NOT COMPLETED|Overall Study||0
8162178|NCT02525055|20122077|P5|NOT COMPLETED|Overall Study||0
8162179|NCT02525055|20122078|P4|NOT COMPLETED|Overall Study||0
8162180|NCT02525055|20122079|P3|NOT COMPLETED|Overall Study||0
8162181|NCT02525055|20122080|P2|NOT COMPLETED|Overall Study||0
8162182|NCT02525055|20122081|P1|NOT COMPLETED|Overall Study||0
8162183|NCT02525055|20122076|P6|COMPLETED|Overall Study||16
8162184|NCT02525055|20122077|P5|COMPLETED|Overall Study||6
8162185|NCT02525055|20122078|P4|COMPLETED|Overall Study||6
8162186|NCT02525055|20122079|P3|COMPLETED|Overall Study||6
8162187|NCT02525055|20122080|P2|COMPLETED|Overall Study||6
8162188|NCT02525055|20122081|P1|COMPLETED|Overall Study||6
8162189|NCT02525055|20122076|P6|STARTED|Overall Study||16
8162190|NCT02525055|20122077|P5|STARTED|Overall Study||6
8162191|NCT02525055|20122078|P4|STARTED|Overall Study||6
8162192|NCT02525055|20122079|P3|STARTED|Overall Study||6
8162193|NCT02525055|20122080|P2|STARTED|Overall Study||6
8162194|NCT02525055|20122081|P1|STARTED|Overall Study||6
8162195|NCT02524977|20122097|P2|NOT COMPLETED|Overall Study||45
8162196|NCT02524977|20122098|P1|NOT COMPLETED|Overall Study||46
8162197|NCT02524977|20122097|P2|COMPLETED|Overall Study||801
8162198|NCT02524977|20122098|P1|COMPLETED|Overall Study||692
8162199|NCT02524977|20122097|P2|STARTED|Overall Study||846
8162200|NCT02524977|20122098|P1|STARTED|Overall Study||738
8162201|NCT02524847|20122106|P1|NOT COMPLETED|Overall Study||14
8162202|NCT02524847|20122106|P1|COMPLETED|Overall Study||15
8162203|NCT02524847|20122106|P1|Started Second Line Treatment|Overall Study||5
8162204|NCT02524847|20122106|P1|Completed Treatment Up to Week 12|Overall Study||14
8162205|NCT02524847|20122106|P1|STARTED|Overall Study||29
8162206|NCT02524665|20122118|P1|NOT COMPLETED|Overall Study||1
8162207|NCT02524665|20122118|P1|COMPLETED|Overall Study||19
8162208|NCT02524665|20122118|P1|STARTED|Overall Study||20
8162209|NCT02524561|20122136|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8162210|NCT02524561|20122137|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8162211|NCT02524561|20122138|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8162212|NCT02524561|20122136|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
8162213|NCT02524561|20122137|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
8162214|NCT02524561|20122138|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
8162215|NCT02524561|20122136|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
8162216|NCT02524561|20122137|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
8162217|NCT02524561|20122138|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
8162218|NCT02524561|20122136|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
8162219|NCT02524561|20122137|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
8162220|NCT02524561|20122138|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
8162221|NCT02524561|20122136|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8162222|NCT02524561|20122137|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8162223|NCT02524561|20122138|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8162224|NCT02524561|20122136|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
8162225|NCT02524561|20122137|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
8162226|NCT02524561|20122138|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
8162227|NCT02524561|20122136|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
8162228|NCT02524561|20122137|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
8162229|NCT02524561|20122138|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
8162230|NCT02524561|20122136|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
8162231|NCT02524561|20122137|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
8162232|NCT02524561|20122138|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
8162233|NCT02524561|20122136|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8162234|NCT02524561|20122137|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8162235|NCT02524561|20122138|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8162236|NCT02524561|20122136|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
8162237|NCT02524561|20122137|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
8162238|NCT02524561|20122138|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
8162239|NCT02524561|20122136|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
8162240|NCT02524561|20122137|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
8162241|NCT02524561|20122138|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
8162242|NCT02524561|20122136|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
8162243|NCT02524561|20122137|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
8162244|NCT02524561|20122138|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
8162245|NCT02524418|20122155|P1|NOT COMPLETED|Overall Study||13
8162246|NCT02524418|20122155|P1|COMPLETED|Overall Study||75
8162247|NCT02524418|20122155|P1|STARTED|Overall Study||88
8162252|NCT02524158|20122179|P2|NOT COMPLETED|6-month Assessment||21
8162253|NCT02524158|20122180|P1|NOT COMPLETED|6-month Assessment||22
8162254|NCT02524158|20122179|P2|COMPLETED|6-month Assessment||55
8162255|NCT02524158|20122180|P1|COMPLETED|6-month Assessment||54
8162256|NCT02524158|20122179|P2|STARTED|6-month Assessment||76
8162257|NCT02524158|20122180|P1|STARTED|6-month Assessment||76
8162258|NCT02524158|20122179|P2|NOT COMPLETED|12-weeks Assessment||13
8162259|NCT02524158|20122180|P1|NOT COMPLETED|12-weeks Assessment||19
8162260|NCT02524158|20122179|P2|COMPLETED|12-weeks Assessment||63
8162261|NCT02524158|20122180|P1|COMPLETED|12-weeks Assessment||57
8162262|NCT02524158|20122179|P2|STARTED|12-weeks Assessment||76
8162263|NCT02524158|20122180|P1|STARTED|12-weeks Assessment||76
8162264|NCT02524145|20122222|P3|NOT COMPLETED|Overall Study||3
8162265|NCT02524145|20122223|P2|NOT COMPLETED|Overall Study||2
8162266|NCT02524145|20122224|P1|NOT COMPLETED|Overall Study||2
8162267|NCT02524145|20122222|P3|COMPLETED|Overall Study||7
8162268|NCT02524145|20122223|P2|COMPLETED|Overall Study||13
8162269|NCT02524145|20122224|P1|COMPLETED|Overall Study||13
8162270|NCT02524145|20122222|P3|STARTED|Overall Study||10
8162271|NCT02524145|20122223|P2|STARTED|Overall Study||15
8162272|NCT02524145|20122224|P1|STARTED|Overall Study||15
8162273|NCT02524106|20122236|P2|NOT COMPLETED|Overall Study||0
8162274|NCT02524106|20122237|P1|NOT COMPLETED|Overall Study||0
8162275|NCT02524106|20122236|P2|COMPLETED|Overall Study||5
8162276|NCT02524106|20122237|P1|COMPLETED|Overall Study||6
8162277|NCT02524106|20122236|P2|STARTED|Overall Study||5
8162278|NCT02524106|20122237|P1|STARTED|Overall Study||6
8162279|NCT02524054|20122247|P3|NOT COMPLETED|Overall Study||0
8162280|NCT02524054|20122248|P2|NOT COMPLETED|Overall Study||0
8162281|NCT02524054|20122249|P1|NOT COMPLETED|Overall Study||0
8162282|NCT02524054|20122247|P3|COMPLETED|Overall Study||8
8162283|NCT02524054|20122248|P2|COMPLETED|Overall Study||9
8162284|NCT02524054|20122249|P1|COMPLETED|Overall Study||7
8162285|NCT02524054|20122247|P3|STARTED|Overall Study||8
8162286|NCT02524054|20122248|P2|STARTED|Overall Study||9
8162287|NCT02524054|20122249|P1|STARTED|Overall Study||7
8162288|NCT02523924|20122260|P1|NOT COMPLETED|Overall Study||0
8162289|NCT02523924|20122260|P1|COMPLETED|Overall Study||31
8162290|NCT02523924|20122260|P1|STARTED|Overall Study||31
8162291|NCT02523690|20122270|P2|NOT COMPLETED|Overall Study||0
8162292|NCT02523690|20122271|P1|NOT COMPLETED|Overall Study||0
8162293|NCT02523690|20122270|P2|COMPLETED|Overall Study||2
8162294|NCT02523690|20122271|P1|COMPLETED|Overall Study||3
8162295|NCT02523690|20122270|P2|STARTED|Overall Study||2
8162296|NCT02523690|20122271|P1|STARTED|Overall Study||3
8162297|NCT02523599|20122289|P2|NOT COMPLETED|Overall Study||1
8162298|NCT02523599|20122290|P1|NOT COMPLETED|Overall Study||8
8162299|NCT02523599|20122289|P2|COMPLETED|Overall Study||100
8162300|NCT02523599|20122290|P1|COMPLETED|Overall Study||196
8162301|NCT02523599|20122289|P2|Randomized But Not Treated|Overall Study||0
8162302|NCT02523599|20122290|P1|Randomized But Not Treated|Overall Study||1
8162303|NCT02523599|20122289|P2|STARTED|Overall Study||101
8162304|NCT02523599|20122290|P1|STARTED|Overall Study||204
8162305|NCT02523586|20122306|P1|NOT COMPLETED|Overall Study||4
8162306|NCT02523586|20122306|P1|COMPLETED|Overall Study||10
8162307|NCT02523586|20122306|P1|STARTED|Overall Study||14
8162308|NCT02523235|20122319|P2|NOT COMPLETED|Overall Study||0
8162309|NCT02523235|20122320|P1|NOT COMPLETED|Overall Study||0
8162310|NCT02523235|20122319|P2|COMPLETED|Overall Study||58
8162311|NCT02523235|20122320|P1|COMPLETED|Overall Study||56
8162312|NCT02523235|20122319|P2|STARTED|Overall Study||58
8162313|NCT02523235|20122320|P1|STARTED|Overall Study||56
8162314|NCT02522884|20122340|P1|NOT COMPLETED|Overall Study||18
8162315|NCT02522884|20122340|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|195
8162316|NCT02522884|20122340|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|213
8162317|NCT02522845|20122347|P2|NOT COMPLETED|Overall Study||35
8162318|NCT02522845|20122348|P1|NOT COMPLETED|Overall Study||37
8162319|NCT02522845|20122347|P2|COMPLETED|Overall Study||69
8162320|NCT02522845|20122348|P1|COMPLETED|Overall Study||63
8162321|NCT02522845|20122347|P2|STARTED|Overall Study||104
8162322|NCT02522845|20122348|P1|STARTED|Overall Study||100
8162323|NCT02522728|20122372|P2|NOT COMPLETED|Overall Study||11
8162324|NCT02522728|20122373|P1|NOT COMPLETED|Overall Study||12
8162325|NCT02522728|20122372|P2|COMPLETED|Overall Study||19
8162326|NCT02522728|20122373|P1|COMPLETED|Overall Study||16
8162327|NCT02522728|20122372|P2|STARTED|Overall Study||30
8162328|NCT02522728|20122373|P1|STARTED|Overall Study||28
8162329|NCT02522715|20122389|P2|NOT COMPLETED|Overall Study||0
8162330|NCT02522715|20122390|P1|NOT COMPLETED|Overall Study||0
8162331|NCT02522715|20122389|P2|COMPLETED|Overall Study||33
8162332|NCT02522715|20122390|P1|COMPLETED|Overall Study||3
8162333|NCT02522715|20122389|P2|STARTED|Overall Study|+1 early withdrawal|33
8162334|NCT02522715|20122390|P1|STARTED|Overall Study||3
8162335|NCT02522624|20122400|P2|NOT COMPLETED|Overall Study||0
8162336|NCT02522624|20122401|P1|NOT COMPLETED|Overall Study||1
8162337|NCT02522624|20122400|P2|COMPLETED|Overall Study||163
8162338|NCT02522624|20122401|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
8162339|NCT02522624|20122400|P2|STARTED|Overall Study||163
8162340|NCT02522624|20122401|P1|STARTED|Overall Study||165
8162341|NCT02522481|20122417|P1|NOT COMPLETED|Overall Study||2
8162342|NCT02522481|20122417|P1|COMPLETED|Overall Study||173
8162343|NCT02522481|20122417|P1|STARTED|Overall Study||175
8162344|NCT02522442|20122430|P2|NOT COMPLETED|Overall Study||0
8162345|NCT02522442|20122431|P1|NOT COMPLETED|Overall Study||0
8162346|NCT02522442|20122430|P2|COMPLETED|Overall Study||22
8162347|NCT02522442|20122431|P1|COMPLETED|Overall Study||26
8162348|NCT02522442|20122430|P2|STARTED|Overall Study||22
8162349|NCT02522442|20122431|P1|STARTED|Overall Study||26
8162350|NCT02522403|20122447|P2|NOT COMPLETED|Overall Study||6
8162351|NCT02522403|20122448|P1|NOT COMPLETED|Overall Study||4
8162352|NCT02522403|20122447|P2|COMPLETED|Overall Study||13
8162353|NCT02522403|20122448|P1|COMPLETED|Overall Study||13
8162354|NCT02522403|20122447|P2|STARTED|Overall Study||19
8162355|NCT02522403|20122448|P1|STARTED|Overall Study||17
8162356|NCT02522377|20122460|P2|NOT COMPLETED|Overall Study||0
8162357|NCT02522377|20122461|P1|NOT COMPLETED|Overall Study||4
8162358|NCT02522377|20122460|P2|COMPLETED|Overall Study||5
8162359|NCT02522377|20122461|P1|COMPLETED|Overall Study||3
8162360|NCT02522377|20122460|P2|STARTED|Overall Study||5
8162361|NCT02522377|20122461|P1|STARTED|Overall Study||7
8162362|NCT02522325|20122477|P2|NOT COMPLETED|Overall Study||1
8162363|NCT02522325|20122478|P1|NOT COMPLETED|Overall Study||0
8162364|NCT02522325|20122477|P2|COMPLETED|Overall Study||14
8162365|NCT02522325|20122478|P1|COMPLETED|Overall Study||15
8162366|NCT02522325|20122477|P2|STARTED|Overall Study||15
8162367|NCT02522325|20122478|P1|STARTED|Overall Study||15
8162368|NCT02522299|20122486|P2|NOT COMPLETED|Overall Study||1
8162369|NCT02522299|20122487|P1|NOT COMPLETED|Overall Study||4
8162370|NCT02522299|20122486|P2|COMPLETED|Overall Study||21
8162371|NCT02522299|20122487|P1|COMPLETED|Overall Study||18
8162372|NCT02522299|20122486|P2|STARTED|Overall Study||22
8162373|NCT02522299|20122487|P1|STARTED|Overall Study||22
8162374|NCT02522286|20122570|P4|NOT COMPLETED|Overall Study||3
8162375|NCT02522286|20122571|P3|NOT COMPLETED|Overall Study||0
8162376|NCT02522286|20122572|P2|NOT COMPLETED|Overall Study||0
8162377|NCT02522286|20122573|P1|NOT COMPLETED|Overall Study||3
8162378|NCT02522286|20122570|P4|COMPLETED|Overall Study||75
8162379|NCT02522286|20122571|P3|COMPLETED|Overall Study||75
8162380|NCT02522286|20122572|P2|COMPLETED|Overall Study||75
8162381|NCT02522286|20122573|P1|COMPLETED|Overall Study||75
8162382|NCT02522286|20122570|P4|STARTED|Overall Study||78
8162383|NCT02522286|20122571|P3|STARTED|Overall Study||75
8162384|NCT02522286|20122572|P2|STARTED|Overall Study||75
8162385|NCT02522286|20122573|P1|STARTED|Overall Study||78
8162386|NCT02521974|20122601|P2|NOT COMPLETED|Overall Study||4
8162387|NCT02521974|20122602|P1|NOT COMPLETED|Overall Study||3
8162388|NCT02521974|20122601|P2|COMPLETED|Overall Study||110
8162389|NCT02521974|20122602|P1|COMPLETED|Overall Study||47
8162390|NCT02521974|20122601|P2|STARTED|Overall Study||114
8162391|NCT02521974|20122602|P1|STARTED|Overall Study||50
8162392|NCT02521948|20122609|P1|NOT COMPLETED|Overall Study||13
8162393|NCT02521948|20122609|P1|COMPLETED|Overall Study||37
8162394|NCT02521948|20122609|P1|STARTED|Overall Study||50
8162395|NCT02521792|20122618|P1|NOT COMPLETED|Overall Study||6
8162396|NCT02521792|20122618|P1|COMPLETED|Overall Study||0
8162397|NCT02521792|20122618|P1|Received Treatment|Overall Study||4
8162398|NCT02521792|20122618|P1|STARTED|Overall Study||6
8162399|NCT02521766|20122633|P2|NOT COMPLETED|Overall Study||3
8162400|NCT02521766|20122634|P1|NOT COMPLETED|Overall Study||5
8162401|NCT02521766|20122633|P2|COMPLETED|Overall Study||62
8162402|NCT02521766|20122634|P1|COMPLETED|Overall Study||44
8162403|NCT02521766|20122633|P2|Per Protocol|Overall Study||65
8162404|NCT02521766|20122634|P1|Per Protocol|Overall Study||47
8162405|NCT02521766|20122633|P2|STARTED|Overall Study||65
8162406|NCT02521766|20122634|P1|STARTED|Overall Study||49
8162407|NCT02521376|20122668|P4|NOT COMPLETED|Overall Study||0
8162408|NCT02521376|20122669|P3|NOT COMPLETED|Overall Study||0
8162409|NCT02521376|20122670|P2|NOT COMPLETED|Overall Study||0
8162410|NCT02521376|20122671|P1|NOT COMPLETED|Overall Study||1
8162411|NCT02521376|20122668|P4|COMPLETED|Overall Study||20
8162412|NCT02521376|20122669|P3|COMPLETED|Overall Study||10
8162413|NCT02521376|20122670|P2|COMPLETED|Overall Study||18
8162414|NCT02521376|20122671|P1|COMPLETED|Overall Study||7
8162415|NCT02521376|20122668|P4|STARTED|Overall Study||20
8162416|NCT02521376|20122669|P3|STARTED|Overall Study||10
8162417|NCT02521376|20122670|P2|STARTED|Overall Study||18
8162418|NCT02521376|20122671|P1|STARTED|Overall Study||8
8162419|NCT02521259|20122703|P2|NOT COMPLETED|Overall Study||5
8162420|NCT02521259|20122704|P1|NOT COMPLETED|Overall Study||1
8162421|NCT02521259|20122703|P2|COMPLETED|Overall Study||28
8162422|NCT02521259|20122704|P1|COMPLETED|Overall Study||34
8162423|NCT02521259|20122703|P2|STARTED|Overall Study||33
8162424|NCT02521259|20122704|P1|STARTED|Overall Study||35
8162425|NCT02521181|20122713|P3|NOT COMPLETED|Overall Study||0
8162426|NCT02521181|20122714|P2|NOT COMPLETED|Overall Study||0
8162427|NCT02521181|20122715|P1|NOT COMPLETED|Overall Study||0
8162428|NCT02521181|20122713|P3|COMPLETED|Overall Study|All patients included in primary analysis|52
8162429|NCT02521181|20122714|P2|COMPLETED|Overall Study|All patients included in primary analysis|90
8162430|NCT02521181|20122715|P1|COMPLETED|Overall Study|All patients included in primary analysis|52
8162431|NCT02521181|20122713|P3|STARTED|Overall Study||52
8162432|NCT02521181|20122714|P2|STARTED|Overall Study||90
8162433|NCT02521181|20122715|P1|STARTED|Overall Study||52
8162434|NCT02520726|20122725|P2|NOT COMPLETED|Overall Study||2
8162435|NCT02520726|20122726|P1|NOT COMPLETED|Overall Study||3
8162436|NCT02520726|20122725|P2|COMPLETED|Overall Study||0
8162437|NCT02520726|20122726|P1|COMPLETED|Overall Study||0
8162438|NCT02520726|20122725|P2|STARTED|Overall Study||2
8162439|NCT02520726|20122726|P1|STARTED|Overall Study||3
8162440|NCT02520531|20122736|P2|NOT COMPLETED|Overall Study||6
8162441|NCT02520531|20122737|P1|NOT COMPLETED|Overall Study||6
8162442|NCT02520531|20122736|P2|COMPLETED|Overall Study||36
8162443|NCT02520531|20122737|P1|COMPLETED|Overall Study||36
8162444|NCT02520531|20122736|P2|STARTED|Overall Study||42
8162445|NCT02520531|20122737|P1|STARTED|Overall Study||42
8162446|NCT02520518|20122755|P4|NOT COMPLETED|Overall Study||1
8162447|NCT02520518|20122756|P3|NOT COMPLETED|Overall Study||2
8162448|NCT02520518|20122757|P2|NOT COMPLETED|Overall Study||0
8162449|NCT02520518|20122758|P1|NOT COMPLETED|Overall Study||0
8162450|NCT02520518|20122755|P4|COMPLETED|Overall Study||1
8162451|NCT02520518|20122756|P3|COMPLETED|Overall Study||1
8162452|NCT02520518|20122757|P2|COMPLETED|Overall Study||1
8162453|NCT02520518|20122758|P1|COMPLETED|Overall Study||3
8162454|NCT02520518|20122755|P4|STARTED|Overall Study||2
8162455|NCT02520518|20122756|P3|STARTED|Overall Study||3
8162456|NCT02520518|20122757|P2|STARTED|Overall Study||1
8162457|NCT02520518|20122758|P1|STARTED|Overall Study||3
8162458|NCT02520414|20122816|P1|NOT COMPLETED|Overall Study||0
8162459|NCT02520414|20122816|P1|COMPLETED|Overall Study||10
8162460|NCT02520414|20122816|P1|STARTED|Overall Study||10
8162461|NCT02520388|20122822|P2|NOT COMPLETED|Overall Study||16
8162462|NCT02520388|20122823|P1|NOT COMPLETED|Overall Study||9
8162463|NCT02520388|20122822|P2|COMPLETED|Overall Study||65
8162464|NCT02520388|20122823|P1|COMPLETED|Overall Study||73
8162465|NCT02520388|20122822|P2|Treated|Overall Study||80
8162466|NCT02520388|20122823|P1|Treated|Overall Study||81
8162467|NCT02520388|20122822|P2|STARTED|Overall Study||81
8162468|NCT02520388|20122823|P1|STARTED|Overall Study||82
8162484|NCT02520297|20123002|P1|NOT COMPLETED|Overall Study||0
8162485|NCT02520297|20123002|P1|COMPLETED|Overall Study||1
8162486|NCT02520297|20123002|P1|STARTED|Overall Study||1
8162487|NCT02520284|20123012|P3|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
8162488|NCT02520284|20123013|P2|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
8162489|NCT02520284|20123014|P1|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
8162490|NCT02520284|20123012|P3|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8162491|NCT02520284|20123013|P2|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8162492|NCT02520284|20123014|P1|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8162493|NCT02520284|20123012|P3|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
8162494|NCT02520284|20123013|P2|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
8162495|NCT02520284|20123014|P1|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
8162496|NCT02520284|20123012|P3|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
8162497|NCT02520284|20123013|P2|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
8162498|NCT02520284|20123014|P1|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
8162499|NCT02520284|20123012|P3|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8162500|NCT02520284|20123013|P2|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8162501|NCT02520284|20123014|P1|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8162502|NCT02520284|20123012|P3|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
8162503|NCT02520284|20123013|P2|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
8162504|NCT02520284|20123014|P1|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
8162505|NCT02520284|20123012|P3|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
8162506|NCT02520284|20123013|P2|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
8162507|NCT02520284|20123014|P1|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
8162508|NCT02520284|20123012|P3|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
8162509|NCT02520284|20123013|P2|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
8162510|NCT02520284|20123014|P1|COMPLETED|Blinded Induction Phase: Up to Week 8||52
8162511|NCT02520284|20123012|P3|STARTED|Blinded Induction Phase: Up to Week 8||55
8162512|NCT02520284|20123013|P2|STARTED|Blinded Induction Phase: Up to Week 8||56
8162513|NCT02520284|20123014|P1|STARTED|Blinded Induction Phase: Up to Week 8||54
8162514|NCT02520089|20123048|P2|NOT COMPLETED|Overall Study||4
8162515|NCT02520089|20123049|P1|NOT COMPLETED|Overall Study||3
8162516|NCT02520089|20123048|P2|COMPLETED|Overall Study||7
8162517|NCT02520089|20123049|P1|COMPLETED|Overall Study||9
8162518|NCT02520089|20123048|P2|STARTED|Overall Study||11
8162519|NCT02520089|20123049|P1|STARTED|Overall Study||12
8162520|NCT02519855|20123059|P2|NOT COMPLETED|Overall Study||4
8162521|NCT02519855|20123060|P1|NOT COMPLETED|Overall Study||3
8162522|NCT02519855|20123059|P2|COMPLETED|Overall Study||437
8162523|NCT02519855|20123060|P1|COMPLETED|Overall Study||438
8162524|NCT02519855|20123059|P2|Vaccinated at Week 4|Overall Study||424
8162525|NCT02519855|20123060|P1|Vaccinated at Week 4|Overall Study||432
8162526|NCT02519855|20123059|P2|Vaccinated on Day 1|Overall Study||441
8162527|NCT02519855|20123060|P1|Vaccinated on Day 1|Overall Study||440
8162528|NCT02519855|20123059|P2|STARTED|Overall Study|Participants are included as treated|441
8162529|NCT02519855|20123060|P1|STARTED|Overall Study|Participants are included as treated|441
8162530|NCT02519842|20123078|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
8162531|NCT02519842|20123079|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
8162532|NCT02519842|20123080|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
8162533|NCT02519842|20123078|P3|COMPLETED|Optional Extension: Cycles 2-6||26
8162534|NCT02519842|20123079|P2|COMPLETED|Optional Extension: Cycles 2-6||0
8162535|NCT02519842|20123080|P1|COMPLETED|Optional Extension: Cycles 2-6||0
8162536|NCT02519842|20123078|P3|Treated|Optional Extension: Cycles 2-6||55
8162537|NCT02519842|20123079|P2|Treated|Optional Extension: Cycles 2-6||0
8162538|NCT02519842|20123080|P1|Treated|Optional Extension: Cycles 2-6||0
8162539|NCT02519842|20123078|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
8162540|NCT02519842|20123079|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
8162541|NCT02519842|20123080|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
8162542|NCT02519842|20123078|P3|NOT COMPLETED|Base Study: Cycle 1||0
8162543|NCT02519842|20123079|P2|NOT COMPLETED|Base Study: Cycle 1||3
8162544|NCT02519842|20123080|P1|NOT COMPLETED|Base Study: Cycle 1||2
8162545|NCT02519842|20123078|P3|COMPLETED|Base Study: Cycle 1||0
8162546|NCT02519842|20123079|P2|COMPLETED|Base Study: Cycle 1||34
8162547|NCT02519842|20123080|P1|COMPLETED|Base Study: Cycle 1||36
8162548|NCT02519842|20123078|P3|Treated|Base Study: Cycle 1||0
8162549|NCT02519842|20123079|P2|Treated|Base Study: Cycle 1||34
8162550|NCT02519842|20123080|P1|Treated|Base Study: Cycle 1||37
8162551|NCT02519842|20123078|P3|STARTED|Base Study: Cycle 1||0
8162552|NCT02519842|20123079|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
8162553|NCT02519842|20123080|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
8162554|NCT02519712|20123099|P1|NOT COMPLETED|Overall Study||4
8162555|NCT02519712|20123099|P1|COMPLETED|Overall Study||0
8162556|NCT02519712|20123099|P1|STARTED|Overall Study||4
8162557|NCT02519621|20123106|P3|NOT COMPLETED|Overall Study||0
8162558|NCT02519621|20123107|P2|NOT COMPLETED|Overall Study||0
8162559|NCT02519621|20123108|P1|NOT COMPLETED|Overall Study||0
8162560|NCT02519621|20123106|P3|COMPLETED|Overall Study||30
8162561|NCT02519621|20123107|P2|COMPLETED|Overall Study||30
8162562|NCT02519621|20123108|P1|COMPLETED|Overall Study||30
8162563|NCT02519621|20123106|P3|STARTED|Overall Study||30
8162564|NCT02519621|20123107|P2|STARTED|Overall Study||30
8162565|NCT02519621|20123108|P1|STARTED|Overall Study||30
8162566|NCT02519595|20123128|P3|NOT COMPLETED|Overall Study||16
8162567|NCT02519595|20123129|P2|NOT COMPLETED|Overall Study||22
8162568|NCT02519595|20123130|P1|NOT COMPLETED|Overall Study||8
8162569|NCT02519595|20123128|P3|COMPLETED|Overall Study||40
8162570|NCT02519595|20123129|P2|COMPLETED|Overall Study||35
8162571|NCT02519595|20123130|P1|COMPLETED|Overall Study||50
8162572|NCT02519595|20123128|P3|STARTED|Overall Study||56
8162573|NCT02519595|20123129|P2|STARTED|Overall Study||57
8162574|NCT02519595|20123130|P1|STARTED|Overall Study||58
8162575|NCT02519504|20123155|P2|NOT COMPLETED|Overall Study||103
8162576|NCT02519504|20123156|P1|NOT COMPLETED|Overall Study||113
8162577|NCT02519504|20123155|P2|COMPLETED|Overall Study||144
8162578|NCT02519504|20123156|P1|COMPLETED|Overall Study||206
8162579|NCT02519504|20123155|P2|Attended Direct Testing|Overall Study||149
8162580|NCT02519504|20123156|P1|Attended Direct Testing|Overall Study||212
8162581|NCT02519504|20123155|P2|STARTED|Overall Study||247
8162582|NCT02519504|20123156|P1|STARTED|Overall Study||319
8162583|NCT02519387|20123216|P1|NOT COMPLETED|Overall Study||22
8162584|NCT02519387|20123216|P1|COMPLETED|Overall Study||56
8162585|NCT02519387|20123216|P1|STARTED|Overall Study||78
8162586|NCT02519244|20123224|P1|NOT COMPLETED|Overall Study||0
8162587|NCT02519244|20123224|P1|COMPLETED|Overall Study||10
8162588|NCT02519244|20123224|P1|STARTED|Overall Study||10
8162589|NCT02519231|20123255|P2|NOT COMPLETED|Overall Study||6
8162590|NCT02519231|20123256|P1|NOT COMPLETED|Overall Study||2
8162591|NCT02519231|20123255|P2|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
8162592|NCT02519231|20123256|P1|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
8162593|NCT02519231|20123255|P2|STARTED|Overall Study||14
8162594|NCT02519231|20123256|P1|STARTED|Overall Study||14
8162595|NCT02519036|20123270|P6|NOT COMPLETED|Overall Study||0
8162596|NCT02519036|20123271|P5|NOT COMPLETED|Overall Study||0
8162597|NCT02519036|20123272|P4|NOT COMPLETED|Overall Study||0
8162598|NCT02519036|20123273|P3|NOT COMPLETED|Overall Study||0
8162599|NCT02519036|20123274|P2|NOT COMPLETED|Overall Study||0
8162600|NCT02519036|20123275|P1|NOT COMPLETED|Overall Study||0
8162601|NCT02519036|20123270|P6|COMPLETED|Overall Study||10
8162602|NCT02519036|20123271|P5|COMPLETED|Overall Study||9
8162603|NCT02519036|20123272|P4|COMPLETED|Overall Study||6
8162604|NCT02519036|20123273|P3|COMPLETED|Overall Study||6
8162605|NCT02519036|20123274|P2|COMPLETED|Overall Study||3
8162606|NCT02519036|20123275|P1|COMPLETED|Overall Study||12
8162607|NCT02519036|20123270|P6|STARTED|Overall Study||10
8162608|NCT02519036|20123271|P5|STARTED|Overall Study||9
8162609|NCT02519036|20123272|P4|STARTED|Overall Study||6
8162610|NCT02519036|20123273|P3|STARTED|Overall Study||6
8162611|NCT02519036|20123274|P2|STARTED|Overall Study||3
8162612|NCT02519036|20123275|P1|STARTED|Overall Study||12
8162613|NCT02519023|20123330|P2|NOT COMPLETED|Overall Study||7
8162614|NCT02519023|20123331|P1|NOT COMPLETED|Overall Study||18
8162615|NCT02519023|20123330|P2|COMPLETED|Overall Study||31
8162616|NCT02519023|20123331|P1|COMPLETED|Overall Study||31
8162617|NCT02519023|20123330|P2|STARTED|Overall Study||38
8162618|NCT02519023|20123331|P1|STARTED|Overall Study||49
8162619|NCT02518997|20123363|P1|NOT COMPLETED|Overall Study||0
8162620|NCT02518997|20123363|P1|COMPLETED|Overall Study||18
8162621|NCT02518997|20123363|P1|STARTED|Overall Study||18
8162622|NCT02518971|20123372|P2|NOT COMPLETED|Overall Study||20
8162623|NCT02518971|20123373|P1|NOT COMPLETED|Overall Study||23
8162624|NCT02518971|20123372|P2|COMPLETED|Overall Study||67
8162625|NCT02518971|20123373|P1|COMPLETED|Overall Study||64
8162626|NCT02518971|20123372|P2|STARTED|Overall Study||87
8162627|NCT02518971|20123373|P1|STARTED|Overall Study||87
8162628|NCT02518919|20123393|P3|NOT COMPLETED|Overall Study||2
8162629|NCT02518919|20123394|P2|NOT COMPLETED|Overall Study||1
8162630|NCT02518919|20123395|P1|NOT COMPLETED|Overall Study||1
8162631|NCT02518919|20123393|P3|COMPLETED|Overall Study||19
8162632|NCT02518919|20123394|P2|COMPLETED|Overall Study||20
8162633|NCT02518919|20123395|P1|COMPLETED|Overall Study||20
8162634|NCT02518919|20123393|P3|STARTED|Overall Study||21
8162635|NCT02518919|20123394|P2|STARTED|Overall Study||21
8162636|NCT02518919|20123395|P1|STARTED|Overall Study||21
8162637|NCT02518750|20123415|P1|NOT COMPLETED|Overall Study||2
8162638|NCT02518750|20123415|P1|COMPLETED|Overall Study||1
8162639|NCT02518750|20123415|P1|STARTED|Overall Study||3
8162640|NCT02518685|20123425|P2|NOT COMPLETED|Overall Study||10
8162641|NCT02518685|20123426|P1|NOT COMPLETED|Overall Study||49
8162642|NCT02518685|20123425|P2|COMPLETED|Overall Study||79
8162643|NCT02518685|20123426|P1|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
8162644|NCT02518685|20123425|P2|Per Protocol Analysis|Overall Study||89
8162645|NCT02518685|20123426|P1|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
8162646|NCT02518685|20123425|P2|Enrolled|Overall Study||89
8162647|NCT02518685|20123426|P1|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
8162648|NCT02518685|20123425|P2|Randomized Cohort|Overall Study||89
8162649|NCT02518685|20123426|P1|Randomized Cohort|Overall Study||181
8162650|NCT02518685|20123425|P2|Safety Cohort|Overall Study||89
8162651|NCT02518685|20123426|P1|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
8162652|NCT02518685|20123425|P2|STARTED|Overall Study||89
8162653|NCT02518685|20123426|P1|STARTED|Overall Study||213
8162654|NCT02518620|20123435|P2|NOT COMPLETED|Overall Study||26
8162655|NCT02518620|20123436|P1|NOT COMPLETED|Overall Study||52
8162656|NCT02518620|20123435|P2|COMPLETED|Overall Study||123
8162657|NCT02518620|20123436|P1|COMPLETED|Overall Study||205
8162658|NCT02518620|20123435|P2|STARTED|Overall Study||149
8162659|NCT02518620|20123436|P1|STARTED|Overall Study||257
8162660|NCT02518490|20123459|P2|NOT COMPLETED|Overall Study||1
8162661|NCT02518490|20123460|P1|NOT COMPLETED|Overall Study||1
8162662|NCT02518490|20123459|P2|COMPLETED|Overall Study||17
8162663|NCT02518490|20123460|P1|COMPLETED|Overall Study||17
8162664|NCT02518490|20123459|P2|STARTED|Overall Study||18
8162665|NCT02518490|20123460|P1|STARTED|Overall Study||18
8162666|NCT02518464|20123478|P1|NOT COMPLETED|Overall Study||2
8162667|NCT02518464|20123478|P1|COMPLETED|Overall Study||38
8162668|NCT02518464|20123478|P1|STARTED|Overall Study||40
8162669|NCT02518139|20123485|P3|NOT COMPLETED|Overall Study||94
8162670|NCT02518139|20123486|P2|NOT COMPLETED|Overall Study||144
8162671|NCT02518139|20123487|P1|NOT COMPLETED|Overall Study||145
8162672|NCT02518139|20123485|P3|COMPLETED|Overall Study||262
8162673|NCT02518139|20123486|P2|COMPLETED|Overall Study||191
8162674|NCT02518139|20123487|P1|COMPLETED|Overall Study||219
8162675|NCT02518139|20123485|P3|STARTED|Overall Study||356
8162676|NCT02518139|20123486|P2|STARTED|Overall Study||335
8162677|NCT02518139|20123487|P1|STARTED|Overall Study||364
8162678|NCT02518113|20123499|P4|NOT COMPLETED|Overall Study||0
8162679|NCT02518113|20123500|P3|NOT COMPLETED|Overall Study||4
8162680|NCT02518113|20123501|P2|NOT COMPLETED|Overall Study||5
8162681|NCT02518113|20123502|P1|NOT COMPLETED|Overall Study||3
8162682|NCT02518113|20123499|P4|COMPLETED|Overall Study||3
8162683|NCT02518113|20123500|P3|COMPLETED|Overall Study||11
8162684|NCT02518113|20123501|P2|COMPLETED|Overall Study||7
8162685|NCT02518113|20123502|P1|COMPLETED|Overall Study||3
8162686|NCT02518113|20123499|P4|STARTED|Overall Study||3
8162687|NCT02518113|20123500|P3|STARTED|Overall Study||15
8162688|NCT02518113|20123501|P2|STARTED|Overall Study||12
8162689|NCT02518113|20123502|P1|STARTED|Overall Study||6
8162690|NCT02518048|20123543|P1|NOT COMPLETED|Overall Study||1
8162691|NCT02518048|20123543|P1|COMPLETED|Overall Study||34
8162692|NCT02518048|20123543|P1|STARTED|Overall Study||35
8162693|NCT02517996|20123556|P2|NOT COMPLETED|Overall Study||0
8162694|NCT02517996|20123557|P1|NOT COMPLETED|Overall Study||0
8162695|NCT02517996|20123556|P2|COMPLETED|Overall Study||9
8162696|NCT02517996|20123557|P1|COMPLETED|Overall Study||8
8162697|NCT02517996|20123556|P2|STARTED|Overall Study||9
8162698|NCT02517996|20123557|P1|STARTED|Overall Study||8
8162699|NCT02517905|20123571|P2|NOT COMPLETED|Overall Study||2
8162700|NCT02517905|20123572|P1|NOT COMPLETED|Overall Study||10
8162701|NCT02517905|20123571|P2|COMPLETED|Overall Study||57
8162702|NCT02517905|20123572|P1|COMPLETED|Overall Study||97
8162703|NCT02517905|20123571|P2|STARTED|Overall Study||59
8162704|NCT02517905|20123572|P1|STARTED|Overall Study||107
8162705|NCT02517866|20123588|P3|NOT COMPLETED|Overall Study||0
8162706|NCT02517866|20123589|P2|NOT COMPLETED|Overall Study||6
8162707|NCT02517866|20123590|P1|NOT COMPLETED|Overall Study||20
8162708|NCT02517866|20123588|P3|COMPLETED|Overall Study||1
8162709|NCT02517866|20123589|P2|COMPLETED|Overall Study||84
8162710|NCT02517866|20123590|P1|COMPLETED|Overall Study||269
8162711|NCT02517866|20123588|P3|STARTED|Overall Study||1
8162712|NCT02517866|20123589|P2|STARTED|Overall Study||90
8162713|NCT02517866|20123590|P1|STARTED|Overall Study||289
8162714|NCT02517658|20123635|P3|NOT COMPLETED|Overall Study||0
8162715|NCT02517658|20123636|P2|NOT COMPLETED|Overall Study||0
8162716|NCT02517658|20123637|P1|NOT COMPLETED|Overall Study||0
8162717|NCT02517658|20123635|P3|COMPLETED|Overall Study||33
8162718|NCT02517658|20123636|P2|COMPLETED|Overall Study||33
8162719|NCT02517658|20123637|P1|COMPLETED|Overall Study||33
8162720|NCT02517658|20123635|P3|STARTED|Overall Study||33
8162721|NCT02517658|20123636|P2|STARTED|Overall Study||33
8162722|NCT02517658|20123637|P1|STARTED|Overall Study||33
8162723|NCT02517580|20123645|P1|NOT COMPLETED|Overall Study||4
8162724|NCT02517580|20123645|P1|COMPLETED|Overall Study||56
8162725|NCT02517580|20123645|P1|STARTED|Overall Study||60
8162726|NCT02517567|20123649|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162727|NCT02517567|20123650|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162728|NCT02517567|20123651|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162729|NCT02517567|20123652|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162730|NCT02517567|20123649|P4|COMPLETED|Fourth Exposure (8 Hours)||8
8162731|NCT02517567|20123650|P3|COMPLETED|Fourth Exposure (8 Hours)||6
8162732|NCT02517567|20123651|P2|COMPLETED|Fourth Exposure (8 Hours)||8
8162733|NCT02517567|20123652|P1|COMPLETED|Fourth Exposure (8 Hours)||6
8162734|NCT02517567|20123649|P4|STARTED|Fourth Exposure (8 Hours)||8
8162735|NCT02517567|20123650|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
8162736|NCT02517567|20123651|P2|STARTED|Fourth Exposure (8 Hours)||8
8162737|NCT02517567|20123652|P1|STARTED|Fourth Exposure (8 Hours)||6
8162738|NCT02517567|20123649|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
8162739|NCT02517567|20123650|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
8162740|NCT02517567|20123651|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
8162741|NCT02517567|20123652|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
8162742|NCT02517567|20123649|P4|COMPLETED|Third Exposure (8 Hours)||8
8162743|NCT02517567|20123650|P3|COMPLETED|Third Exposure (8 Hours)||7
8162744|NCT02517567|20123651|P2|COMPLETED|Third Exposure (8 Hours)||8
8162745|NCT02517567|20123652|P1|COMPLETED|Third Exposure (8 Hours)||6
8162746|NCT02517567|20123649|P4|STARTED|Third Exposure (8 Hours)||8
8162747|NCT02517567|20123650|P3|STARTED|Third Exposure (8 Hours)||7
8162748|NCT02517567|20123651|P2|STARTED|Third Exposure (8 Hours)||8
8162749|NCT02517567|20123652|P1|STARTED|Third Exposure (8 Hours)||6
8162750|NCT02517567|20123649|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
8162751|NCT02517567|20123650|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
8162752|NCT02517567|20123651|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
8162753|NCT02517567|20123652|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
8162754|NCT02517567|20123649|P4|COMPLETED|Second Exposure (8 Hours)||8
8162755|NCT02517567|20123650|P3|COMPLETED|Second Exposure (8 Hours)||7
8162756|NCT02517567|20123651|P2|COMPLETED|Second Exposure (8 Hours)||8
8162757|NCT02517567|20123652|P1|COMPLETED|Second Exposure (8 Hours)||6
8162758|NCT02517567|20123649|P4|STARTED|Second Exposure (8 Hours)||8
8162759|NCT02517567|20123650|P3|STARTED|Second Exposure (8 Hours)||7
8162760|NCT02517567|20123651|P2|STARTED|Second Exposure (8 Hours)||8
8162761|NCT02517567|20123652|P1|STARTED|Second Exposure (8 Hours)||6
8162762|NCT02517567|20123649|P4|NOT COMPLETED|First Exposure (8 Hours)||0
8162763|NCT02517567|20123650|P3|NOT COMPLETED|First Exposure (8 Hours)||0
8162764|NCT02517567|20123651|P2|NOT COMPLETED|First Exposure (8 Hours)||0
8162765|NCT02517567|20123652|P1|NOT COMPLETED|First Exposure (8 Hours)||0
8162766|NCT02517567|20123649|P4|COMPLETED|First Exposure (8 Hours)||8
8162767|NCT02517567|20123650|P3|COMPLETED|First Exposure (8 Hours)||7
8162768|NCT02517567|20123651|P2|COMPLETED|First Exposure (8 Hours)||8
8162769|NCT02517567|20123652|P1|COMPLETED|First Exposure (8 Hours)||6
8162770|NCT02517567|20123649|P4|STARTED|First Exposure (8 Hours)||8
8162771|NCT02517567|20123650|P3|STARTED|First Exposure (8 Hours)||7
8162772|NCT02517567|20123651|P2|STARTED|First Exposure (8 Hours)||8
8162773|NCT02517567|20123652|P1|STARTED|First Exposure (8 Hours)||6
8162774|NCT02517541|20123661|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
8162775|NCT02517541|20123661|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
8162776|NCT02517541|20123661|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
8162777|NCT02517541|20123661|P1|NOT COMPLETED|Baseline Period (Own Product)||1
8162778|NCT02517541|20123661|P1|COMPLETED|Baseline Period (Own Product)||73
8162779|NCT02517541|20123661|P1|STARTED|Baseline Period (Own Product)||74
8162780|NCT02517528|20123667|P1|NOT COMPLETED|Overall Study||1
8162781|NCT02517528|20123667|P1|COMPLETED|Overall Study||103
8162782|NCT02517528|20123667|P1|STARTED|Overall Study||104
8162783|NCT02517515|20123677|P2|NOT COMPLETED|Overall Study||2
8162784|NCT02517515|20123678|P1|NOT COMPLETED|Overall Study||2
8162785|NCT02517515|20123677|P2|COMPLETED|Overall Study||323
8162786|NCT02517515|20123678|P1|COMPLETED|Overall Study||323
8162787|NCT02517515|20123677|P2|STARTED|Overall Study||325
8162788|NCT02517515|20123678|P1|STARTED|Overall Study||325
8162789|NCT02517463|20123695|P2|NOT COMPLETED|Overall Study||2
8162790|NCT02517463|20123696|P1|NOT COMPLETED|Overall Study||5
8162791|NCT02517463|20123695|P2|COMPLETED|Overall Study||329
8162792|NCT02517463|20123696|P1|COMPLETED|Overall Study||364
8162793|NCT02517463|20123695|P2|STARTED|Overall Study||331
8162794|NCT02517463|20123696|P1|STARTED|Overall Study||369
8162795|NCT02517268|20123708|P2|NOT COMPLETED|Overall Study||0
8162796|NCT02517268|20123709|P1|NOT COMPLETED|Overall Study||1
8162797|NCT02517268|20123708|P2|COMPLETED|Overall Study||37
8162798|NCT02517268|20123709|P1|COMPLETED|Overall Study||39
8162799|NCT02517268|20123708|P2|STARTED|Overall Study||37
8162800|NCT02517268|20123709|P1|STARTED|Overall Study||40
8162801|NCT02517047|20123723|P1|NOT COMPLETED|Overall Study||2
8162802|NCT02517047|20123723|P1|COMPLETED|Overall Study||24
8162803|NCT02517047|20123723|P1|STARTED|Overall Study||26
8162804|NCT02517021|20123732|P2|NOT COMPLETED|Overall Study||85
8162805|NCT02517021|20123733|P1|NOT COMPLETED|Overall Study||83
8162806|NCT02517021|20123732|P2|COMPLETED|Overall Study||117
8162807|NCT02517021|20123733|P1|COMPLETED|Overall Study||120
8162808|NCT02517021|20123732|P2|STARTED|Overall Study||202
8162809|NCT02517021|20123733|P1|STARTED|Overall Study||203
8162810|NCT02516982|20123761|P4|NOT COMPLETED|Overall Study||50
8162811|NCT02516982|20123762|P3|NOT COMPLETED|Overall Study||48
8162812|NCT02516982|20123763|P2|NOT COMPLETED|Overall Study||35
8162813|NCT02516982|20123764|P1|NOT COMPLETED|Overall Study||32
8162814|NCT02516982|20123761|P4|COMPLETED|Overall Study||125
8162815|NCT02516982|20123762|P3|COMPLETED|Overall Study||126
8162816|NCT02516982|20123763|P2|COMPLETED|Overall Study||257
8162817|NCT02516982|20123764|P1|COMPLETED|Overall Study||273
8162818|NCT02516982|20123761|P4|STARTED|Overall Study||175
8162819|NCT02516982|20123762|P3|STARTED|Overall Study||174
8162820|NCT02516982|20123763|P2|STARTED|Overall Study||292
8162821|NCT02516982|20123764|P1|STARTED|Overall Study||305
8162822|NCT02516605|20123791|P5|NOT COMPLETED|Overall Study||1
8162823|NCT02516605|20123792|P4|NOT COMPLETED|Overall Study||1
8162824|NCT02516605|20123793|P3|NOT COMPLETED|Overall Study||0
8162825|NCT02516605|20123794|P2|NOT COMPLETED|Overall Study||0
8162826|NCT02516605|20123795|P1|NOT COMPLETED|Overall Study||0
8162827|NCT02516605|20123791|P5|COMPLETED|Overall Study||20
8162828|NCT02516605|20123792|P4|COMPLETED|Overall Study||7
8162829|NCT02516605|20123793|P3|COMPLETED|Overall Study||12
8162830|NCT02516605|20123794|P2|COMPLETED|Overall Study||9
8162831|NCT02516605|20123795|P1|COMPLETED|Overall Study||11
8162832|NCT02516605|20123791|P5|STARTED|Overall Study||21
8162833|NCT02516605|20123792|P4|STARTED|Overall Study||8
8162834|NCT02516605|20123793|P3|STARTED|Overall Study||12
8162835|NCT02516605|20123794|P2|STARTED|Overall Study||9
8162836|NCT02516605|20123795|P1|STARTED|Overall Study||11
8162837|NCT02516592|20123866|P2|NOT COMPLETED|Overall Study||13
8162838|NCT02516592|20123867|P1|NOT COMPLETED|Overall Study||16
8162839|NCT02516592|20123866|P2|COMPLETED|Overall Study||238
8162840|NCT02516592|20123867|P1|COMPLETED|Overall Study||235
8162841|NCT02516592|20123866|P2|Full Analysis Set|Overall Study||250
8162842|NCT02516592|20123867|P1|Full Analysis Set|Overall Study||248
8162843|NCT02516592|20123866|P2|STARTED|Overall Study||251
8162844|NCT02516592|20123867|P1|STARTED|Overall Study||251
8162845|NCT02516579|20123881|P1|NOT COMPLETED|Overall Study||0
8162846|NCT02516579|20123881|P1|COMPLETED|Overall Study||1906
8162847|NCT02516579|20123881|P1|STARTED|Overall Study||1906
8162848|NCT02516410|20123889|P2|NOT COMPLETED|Overall Study||2
8162849|NCT02516410|20123890|P1|NOT COMPLETED|Overall Study||0
8162850|NCT02516410|20123889|P2|COMPLETED|Overall Study||81
8162851|NCT02516410|20123890|P1|COMPLETED|Overall Study||85
8162852|NCT02516410|20123889|P2|STARTED|Overall Study||83
8162853|NCT02516410|20123890|P1|STARTED|Overall Study||85
8162854|NCT02516306|20123919|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
8162855|NCT02516306|20123920|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
8162856|NCT02516306|20123919|P2|COMPLETED|Period 2: Day 8 - 91||23
8162857|NCT02516306|20123920|P1|COMPLETED|Period 2: Day 8 - 91||49
8162858|NCT02516306|20123919|P2|STARTED|Period 2: Day 8 - 91||25
8162859|NCT02516306|20123920|P1|STARTED|Period 2: Day 8 - 91||50
8162860|NCT02516306|20123919|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
8162861|NCT02516306|20123920|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
8162862|NCT02516306|20123919|P2|COMPLETED|Period 1: Day 1 - 7||25
8162863|NCT02516306|20123920|P1|COMPLETED|Period 1: Day 1 - 7||50
8162864|NCT02516306|20123919|P2|STARTED|Period 1: Day 1 - 7||25
8162865|NCT02516306|20123920|P1|STARTED|Period 1: Day 1 - 7||50
8162866|NCT02516228|20123926|P1|NOT COMPLETED|Overall Study||3
8162867|NCT02516228|20123926|P1|COMPLETED|Overall Study||3
8162868|NCT02516228|20123926|P1|STARTED|Overall Study||6
8162869|NCT02516202|20123937|P3|NOT COMPLETED|Overall Study||3
8162870|NCT02516202|20123938|P2|NOT COMPLETED|Overall Study||1
8162871|NCT02516202|20123939|P1|NOT COMPLETED|Overall Study||2
8162872|NCT02516202|20123937|P3|COMPLETED|Overall Study||97
8162873|NCT02516202|20123938|P2|COMPLETED|Overall Study||99
8162874|NCT02516202|20123939|P1|COMPLETED|Overall Study||100
8162875|NCT02516202|20123937|P3|STARTED|Overall Study||100
8162876|NCT02516202|20123938|P2|STARTED|Overall Study||100
8162877|NCT02516202|20123939|P1|STARTED|Overall Study||102
8162878|NCT02516163|20123965|P1|NOT COMPLETED|Overall Study||28
8162879|NCT02516163|20123965|P1|COMPLETED|Overall Study||24
8162880|NCT02516163|20123965|P1|STARTED|Overall Study||52
8162881|NCT02516150|20123969|P1|NOT COMPLETED|Overall Study||0
8162882|NCT02516150|20123969|P1|COMPLETED|Overall Study||15
8162883|NCT02516150|20123969|P1|STARTED|Overall Study||15
8162884|NCT02516098|20123979|P2|NOT COMPLETED|Washout After Period 2||0
8162885|NCT02516098|20123980|P1|NOT COMPLETED|Washout After Period 2||0
8162886|NCT02516098|20123979|P2|COMPLETED|Washout After Period 2||26
8162887|NCT02516098|20123980|P1|COMPLETED|Washout After Period 2||27
8162888|NCT02516098|20123979|P2|STARTED|Washout After Period 2||26
8162889|NCT02516098|20123980|P1|STARTED|Washout After Period 2||27
8162890|NCT02516098|20123979|P2|NOT COMPLETED|Period 2||1
8162891|NCT02516098|20123980|P1|NOT COMPLETED|Period 2||0
8162892|NCT02516098|20123979|P2|COMPLETED|Period 2||26
8162893|NCT02516098|20123980|P1|COMPLETED|Period 2||27
8162894|NCT02516098|20123979|P2|STARTED|Period 2||27
8162895|NCT02516098|20123980|P1|STARTED|Period 2||27
8162896|NCT02516098|20123979|P2|NOT COMPLETED|Washout After Period 1||1
8162897|NCT02516098|20123980|P1|NOT COMPLETED|Washout After Period 1||0
8162898|NCT02516098|20123979|P2|COMPLETED|Washout After Period 1||27
8162899|NCT02516098|20123980|P1|COMPLETED|Washout After Period 1||27
8162900|NCT02516098|20123979|P2|STARTED|Washout After Period 1||28
8162901|NCT02516098|20123980|P1|STARTED|Washout After Period 1||27
8162902|NCT02516098|20123979|P2|NOT COMPLETED|Period 1||0
8162903|NCT02516098|20123980|P1|NOT COMPLETED|Period 1||1
8162904|NCT02516098|20123979|P2|COMPLETED|Period 1||28
8162905|NCT02516098|20123980|P1|COMPLETED|Period 1||27
8162906|NCT02516098|20123979|P2|STARTED|Period 1||28
8162907|NCT02516098|20123980|P1|STARTED|Period 1||28
8162908|NCT02516046|20123992|P1|NOT COMPLETED|Overall Study||92
8162909|NCT02516046|20123992|P1|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
8162910|NCT02516046|20123992|P1|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
8162911|NCT02516046|20123992|P1|Died While on Study|Overall Study||73
8162912|NCT02516046|20123992|P1|STARTED|Overall Study|Total number of subjects scanned|156
8162913|NCT02515994|20124008|P2|NOT COMPLETED|Overall Study||7
8162914|NCT02515994|20124009|P1|NOT COMPLETED|Overall Study||10
8162915|NCT02515994|20124008|P2|COMPLETED|Overall Study||105
8162916|NCT02515994|20124009|P1|COMPLETED|Overall Study||99
8162917|NCT02515994|20124008|P2|STARTED|Overall Study||112
8162918|NCT02515994|20124009|P1|STARTED|Overall Study||109
8162919|NCT02515942|20124024|P3|NOT COMPLETED|Overall Study||4
8162920|NCT02515942|20124025|P2|NOT COMPLETED|Overall Study||3
8162921|NCT02515942|20124026|P1|NOT COMPLETED|Overall Study||7
8162922|NCT02515942|20124024|P3|COMPLETED|Overall Study||35
8162923|NCT02515942|20124025|P2|COMPLETED|Overall Study||36
8162924|NCT02515942|20124026|P1|COMPLETED|Overall Study||29
8162925|NCT02515942|20124024|P3|Completed Day 337|Overall Study||35
8162926|NCT02515942|20124025|P2|Completed Day 337|Overall Study||36
8162927|NCT02515942|20124026|P1|Completed Day 337|Overall Study||30
8162928|NCT02515942|20124024|P3|Completed Day 253|Overall Study||36
8162929|NCT02515942|20124025|P2|Completed Day 253|Overall Study||37
8162930|NCT02515942|20124026|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
8162931|NCT02515942|20124024|P3|Completed Day 169|Overall Study||37
8162932|NCT02515942|20124025|P2|Completed Day 169|Overall Study||37
8162933|NCT02515942|20124026|P1|Completed Day 169|Overall Study||32
8162934|NCT02515942|20124024|P3|Completed Day 85|Overall Study||37
8162935|NCT02515942|20124025|P2|Completed Day 85|Overall Study||38
8162936|NCT02515942|20124026|P1|Completed Day 85|Overall Study||35
8162937|NCT02515942|20124024|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
8162938|NCT02515942|20124025|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
8162939|NCT02515942|20124026|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
8162940|NCT02515942|20124024|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
8162941|NCT02515942|20124025|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
8162942|NCT02515942|20124026|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
8162943|NCT02515942|20124024|P3|Full Analysis Set (FAS)|Overall Study||38
8162944|NCT02515942|20124025|P2|Full Analysis Set (FAS)|Overall Study||37
8162945|NCT02515942|20124026|P1|Full Analysis Set (FAS)|Overall Study||35
8162946|NCT02515942|20124024|P3|Safety Analysis Set|Overall Study||39
8162947|NCT02515942|20124025|P2|Safety Analysis Set|Overall Study||39
8162948|NCT02515942|20124026|P1|Safety Analysis Set|Overall Study||36
8162949|NCT02515942|20124024|P3|STARTED|Overall Study||39
8162950|NCT02515942|20124025|P2|STARTED|Overall Study||39
8162951|NCT02515942|20124026|P1|STARTED|Overall Study||36
8162952|NCT02515890|20124078|P5|NOT COMPLETED|Overall Study||0
8162953|NCT02515890|20124079|P4|NOT COMPLETED|Overall Study||0
8162954|NCT02515890|20124080|P3|NOT COMPLETED|Overall Study||0
8162955|NCT02515890|20124081|P2|NOT COMPLETED|Overall Study||0
8162956|NCT02515890|20124082|P1|NOT COMPLETED|Overall Study||0
8162957|NCT02515890|20124078|P5|COMPLETED|Overall Study||8
8162958|NCT02515890|20124079|P4|COMPLETED|Overall Study||8
8162959|NCT02515890|20124080|P3|COMPLETED|Overall Study||5
8162960|NCT02515890|20124081|P2|COMPLETED|Overall Study||4
8162961|NCT02515890|20124082|P1|COMPLETED|Overall Study||7
8162962|NCT02515890|20124078|P5|STARTED|Overall Study||8
8162963|NCT02515890|20124079|P4|STARTED|Overall Study||8
8162964|NCT02515890|20124080|P3|STARTED|Overall Study||5
8162965|NCT02515890|20124081|P2|STARTED|Overall Study||4
8162966|NCT02515890|20124082|P1|STARTED|Overall Study||7
8162967|NCT02515851|20124095|P2|NOT COMPLETED|Overall Study||0
8162968|NCT02515851|20124096|P1|NOT COMPLETED|Overall Study||0
8162969|NCT02515851|20124095|P2|COMPLETED|Overall Study||15
8162970|NCT02515851|20124096|P1|COMPLETED|Overall Study||15
8162971|NCT02515851|20124095|P2|STARTED|Overall Study||15
8162972|NCT02515851|20124096|P1|STARTED|Overall Study||15
8162973|NCT02515669|20124112|P4|NOT COMPLETED|228 Week Open-Label Phase||26
8162974|NCT02515669|20124113|P3|NOT COMPLETED|228 Week Open-Label Phase||8
8162975|NCT02515669|20124114|P2|NOT COMPLETED|228 Week Open-Label Phase||9
8162976|NCT02515669|20124115|P1|NOT COMPLETED|228 Week Open-Label Phase||0
8162977|NCT02515669|20124112|P4|COMPLETED|228 Week Open-Label Phase||0
8162978|NCT02515669|20124113|P3|COMPLETED|228 Week Open-Label Phase||0
8162979|NCT02515669|20124114|P2|COMPLETED|228 Week Open-Label Phase||0
8162980|NCT02515669|20124115|P1|COMPLETED|228 Week Open-Label Phase||0
8162981|NCT02515669|20124112|P4|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
8162982|NCT02515669|20124113|P3|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
8162983|NCT02515669|20124114|P2|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
8162984|NCT02515669|20124115|P1|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
8162985|NCT02515669|20124112|P4|NOT COMPLETED|24 Week Double-Blind Phase||0
8162986|NCT02515669|20124113|P3|NOT COMPLETED|24 Week Double-Blind Phase||0
8162987|NCT02515669|20124114|P2|NOT COMPLETED|24 Week Double-Blind Phase||0
8162988|NCT02515669|20124115|P1|NOT COMPLETED|24 Week Double-Blind Phase||0
8162989|NCT02515669|20124112|P4|COMPLETED|24 Week Double-Blind Phase||19
8162990|NCT02515669|20124113|P3|COMPLETED|24 Week Double-Blind Phase||6
8162991|NCT02515669|20124114|P2|COMPLETED|24 Week Double-Blind Phase||7
8162992|NCT02515669|20124115|P1|COMPLETED|24 Week Double-Blind Phase||11
8162993|NCT02515669|20124112|P4|STARTED|24 Week Double-Blind Phase||19
8162994|NCT02515669|20124113|P3|STARTED|24 Week Double-Blind Phase||6
8162995|NCT02515669|20124114|P2|STARTED|24 Week Double-Blind Phase||7
8162996|NCT02515669|20124115|P1|STARTED|24 Week Double-Blind Phase||11
8162997|NCT02515656|20124193|P2|NOT COMPLETED|Overall Study||71
8162998|NCT02515656|20124194|P1|NOT COMPLETED|Overall Study||56
8162999|NCT02515656|20124193|P2|COMPLETED|Overall Study||261
8163000|NCT02515656|20124194|P1|COMPLETED|Overall Study||270
8163001|NCT02515656|20124193|P2|Safety Population|Overall Study||328
8163002|NCT02515656|20124194|P1|Safety Population|Overall Study||325
8163003|NCT02515656|20124193|P2|Per Protocol Set (PPS)|Overall Study||275
8163004|NCT02515656|20124194|P1|Per Protocol Set (PPS)|Overall Study||277
8163005|NCT02515656|20124193|P2|Full Analysis Set (FAS)|Overall Study||309
8163006|NCT02515656|20124194|P1|Full Analysis Set (FAS)|Overall Study||302
8163007|NCT02515656|20124193|P2|STARTED|Overall Study||332
8163008|NCT02515656|20124194|P1|STARTED|Overall Study||326
8163009|NCT02515630|20124212|P1|NOT COMPLETED|Overall Study||16
8163010|NCT02515630|20124212|P1|COMPLETED|Overall Study||25
8163011|NCT02515630|20124212|P1|STARTED|Overall Study||41
8163012|NCT02515331|20124285|P3|NOT COMPLETED|Overall Study||4
8163013|NCT02515331|20124286|P2|NOT COMPLETED|Overall Study||0
8163014|NCT02515331|20124287|P1|NOT COMPLETED|Overall Study||2
8163015|NCT02515331|20124285|P3|COMPLETED|Overall Study||28
8163016|NCT02515331|20124286|P2|COMPLETED|Overall Study||15
8163017|NCT02515331|20124287|P1|COMPLETED|Overall Study||15
8163018|NCT02515331|20124285|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8163019|NCT02515331|20124286|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
8163020|NCT02515331|20124287|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
8163021|NCT02515331|20124285|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
8163022|NCT02515331|20124286|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
8163023|NCT02515331|20124287|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
8163024|NCT02515331|20124285|P3|STARTED|Overall Study||32
8163025|NCT02515331|20124286|P2|STARTED|Overall Study||15
8163026|NCT02515331|20124287|P1|STARTED|Overall Study||17
8163027|NCT02515305|20124311|P3|NOT COMPLETED|Overall Study||14
8163028|NCT02515305|20124312|P2|NOT COMPLETED|Overall Study||35
8163029|NCT02515305|20124313|P1|NOT COMPLETED|Overall Study||29
8163030|NCT02515305|20124311|P3|COMPLETED|Overall Study||113
8163031|NCT02515305|20124312|P2|COMPLETED|Overall Study||343
8163032|NCT02515305|20124313|P1|COMPLETED|Overall Study||356
8163033|NCT02515305|20124311|P3|STARTED|Overall Study||127
8163034|NCT02515305|20124312|P2|STARTED|Overall Study||378
8163035|NCT02515305|20124313|P1|STARTED|Overall Study||385
8163036|NCT02515279|20124324|P1|NOT COMPLETED|Overall Study||104
8163037|NCT02515279|20124324|P1|COMPLETED|Overall Study||359
8163038|NCT02515279|20124324|P1|STARTED|Overall Study||463
8163039|NCT02515253|20124332|P2|NOT COMPLETED|Overall Study||8
8163040|NCT02515253|20124333|P1|NOT COMPLETED|Overall Study||7
8163041|NCT02515253|20124332|P2|COMPLETED|Overall Study||8
8163042|NCT02515253|20124333|P1|COMPLETED|Overall Study||10
8163043|NCT02515253|20124332|P2|STARTED|Overall Study||16
8163044|NCT02515253|20124333|P1|STARTED|Overall Study||17
8163045|NCT02515097|20124343|P2|NOT COMPLETED|Overall Study||6
8163046|NCT02515097|20124344|P1|NOT COMPLETED|Overall Study||7
8163047|NCT02515097|20124343|P2|COMPLETED|Overall Study||65
8163048|NCT02515097|20124344|P1|COMPLETED|Overall Study||135
8163049|NCT02515097|20124343|P2|Safety Population|Overall Study||70
8163050|NCT02515097|20124344|P1|Safety Population|Overall Study||142
8163051|NCT02515097|20124343|P2|Intent-to-Treat (ITT) Population|Overall Study||71
8163052|NCT02515097|20124344|P1|Intent-to-Treat (ITT) Population|Overall Study||142
8163053|NCT02515097|20124343|P2|STARTED|Overall Study||71
8163054|NCT02515097|20124344|P1|STARTED|Overall Study||142
8163055|NCT02515058|20124354|P2|NOT COMPLETED|Overall Study||2
8163056|NCT02515058|20124355|P1|NOT COMPLETED|Overall Study||3
8163057|NCT02515058|20124354|P2|COMPLETED|Overall Study||20
8163058|NCT02515058|20124355|P1|COMPLETED|Overall Study||18
8163059|NCT02515058|20124354|P2|STARTED|Overall Study||22
8163060|NCT02515058|20124355|P1|STARTED|Overall Study||21
8163061|NCT02515045|20124365|P3|NOT COMPLETED|Overall Study||4
8163062|NCT02515045|20124366|P2|NOT COMPLETED|Overall Study||4
8163063|NCT02515045|20124367|P1|NOT COMPLETED|Overall Study||0
8163064|NCT02515045|20124365|P3|COMPLETED|Overall Study||55
8163065|NCT02515045|20124366|P2|COMPLETED|Overall Study||26
8163066|NCT02515045|20124367|P1|COMPLETED|Overall Study||29
8163067|NCT02515045|20124365|P3|STARTED|Overall Study||59
8163068|NCT02515045|20124366|P2|STARTED|Overall Study||30
8163069|NCT02515045|20124367|P1|STARTED|Overall Study||29
8163070|NCT02514889|20124383|P2|NOT COMPLETED|Follow-up Assessment Participation||12
8163071|NCT02514889|20124384|P1|NOT COMPLETED|Follow-up Assessment Participation||10
8163072|NCT02514889|20124383|P2|COMPLETED|Follow-up Assessment Participation||86
8163073|NCT02514889|20124384|P1|COMPLETED|Follow-up Assessment Participation||92
8163074|NCT02514889|20124383|P2|STARTED|Follow-up Assessment Participation||98
8163075|NCT02514889|20124384|P1|STARTED|Follow-up Assessment Participation||102
8163076|NCT02514889|20124383|P2|NOT COMPLETED|Intervention Participation||8
8163077|NCT02514889|20124384|P1|NOT COMPLETED|Intervention Participation||9
8163078|NCT02514889|20124383|P2|COMPLETED|Intervention Participation||98
8163079|NCT02514889|20124384|P1|COMPLETED|Intervention Participation||102
8163080|NCT02514889|20124383|P2|STARTED|Intervention Participation||106
8163081|NCT02514889|20124384|P1|STARTED|Intervention Participation||111
8163082|NCT02514889|20124383|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
8163083|NCT02514889|20124384|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
8163084|NCT02514889|20124383|P2|COMPLETED|Randomization/Allocation to Condition||106
8163085|NCT02514889|20124384|P1|COMPLETED|Randomization/Allocation to Condition||111
8163086|NCT02514889|20124383|P2|STARTED|Randomization/Allocation to Condition||130
8163087|NCT02514889|20124384|P1|STARTED|Randomization/Allocation to Condition||131
8163088|NCT02514824|20124404|P4|NOT COMPLETED|Overall Study||0
8163089|NCT02514824|20124405|P3|NOT COMPLETED|Overall Study||0
8163090|NCT02514824|20124406|P2|NOT COMPLETED|Overall Study||1
8163091|NCT02514824|20124407|P1|NOT COMPLETED|Overall Study||1
8163092|NCT02514824|20124404|P4|COMPLETED|Overall Study||0
8163093|NCT02514824|20124405|P3|COMPLETED|Overall Study||0
8163094|NCT02514824|20124406|P2|COMPLETED|Overall Study||4
8163095|NCT02514824|20124407|P1|COMPLETED|Overall Study||3
8163096|NCT02514824|20124404|P4|Evaluable for Dose-limiting Toxicity|Overall Study||0
8163097|NCT02514824|20124405|P3|Evaluable for Dose-limiting Toxicity|Overall Study||0
8163098|NCT02514824|20124406|P2|Evaluable for Dose-limiting Toxicity|Overall Study||5
8163099|NCT02514824|20124407|P1|Evaluable for Dose-limiting Toxicity|Overall Study||3
8163100|NCT02514824|20124404|P4|STARTED|Overall Study||0
8163101|NCT02514824|20124405|P3|STARTED|Overall Study||0
8163102|NCT02514824|20124406|P2|STARTED|Overall Study||5
8163103|NCT02514824|20124407|P1|STARTED|Overall Study||4
8163104|NCT02514772|20124418|P2|NOT COMPLETED|Overall Study||2
8163105|NCT02514772|20124419|P1|NOT COMPLETED|Overall Study||3
8163106|NCT02514772|20124418|P2|COMPLETED|Overall Study||52
8163107|NCT02514772|20124419|P1|COMPLETED|Overall Study||50
8163108|NCT02514772|20124418|P2|STARTED|Overall Study||54
8163109|NCT02514772|20124419|P1|STARTED|Overall Study||53
8163110|NCT02514746|20124433|P2|NOT COMPLETED|Overall Study||15
8163111|NCT02514746|20124434|P1|NOT COMPLETED|Overall Study||22
8163112|NCT02514746|20124433|P2|COMPLETED|Overall Study||109
8163113|NCT02514746|20124434|P1|COMPLETED|Overall Study||415
8163114|NCT02514746|20124433|P2|Received CD-JEV Booster Vaccine|Overall Study||109
8163115|NCT02514746|20124434|P1|Received CD-JEV Booster Vaccine|Overall Study||424
8163116|NCT02514746|20124433|P2|Valid Serology 4 Years Post Primary Dose|Overall Study||109
8163117|NCT02514746|20124434|P1|Valid Serology 4 Years Post Primary Dose|Overall Study||424
8163118|NCT02514746|20124433|P2|Valid Serology 3 Years Post Primary Dose|Overall Study||123
8163119|NCT02514746|20124434|P1|Valid Serology 3 Years Post Primary Dose|Overall Study||437
8163120|NCT02514746|20124433|P2|STARTED|Overall Study||124
8163121|NCT02514746|20124434|P1|STARTED|Overall Study||437
8163122|NCT02514577|20124471|P2|NOT COMPLETED|Overall Study||13
8163123|NCT02514577|20124472|P1|NOT COMPLETED|Overall Study||14
8163124|NCT02514577|20124471|P2|COMPLETED|Overall Study||61
8163125|NCT02514577|20124472|P1|COMPLETED|Overall Study||129
8163126|NCT02514577|20124471|P2|Safety Population|Overall Study||72
8163127|NCT02514577|20124472|P1|Safety Population|Overall Study||142
8163128|NCT02514577|20124471|P2|Intent-to-Treat (ITT) Population|Overall Study||74
8163129|NCT02514577|20124472|P1|Intent-to-Treat (ITT) Population|Overall Study||143
8163130|NCT02514577|20124471|P2|STARTED|Overall Study||74
8163131|NCT02514577|20124472|P1|STARTED|Overall Study||143
8163132|NCT02514551|20124482|P2|NOT COMPLETED|Overall Study||3
8163133|NCT02514551|20124483|P1|NOT COMPLETED|Overall Study||0
8163134|NCT02514551|20124482|P2|COMPLETED|Overall Study||119
8163135|NCT02514551|20124483|P1|COMPLETED|Overall Study||123
8163136|NCT02514551|20124482|P2|Received at Least One Dose of Study Drug|Overall Study||120
8163137|NCT02514551|20124483|P1|Received at Least One Dose of Study Drug|Overall Study||123
8163138|NCT02514551|20124482|P2|STARTED|Overall Study||122
8163139|NCT02514551|20124483|P1|STARTED|Overall Study||123
8163140|NCT02514473|20124500|P2|NOT COMPLETED|Overall Study||5
8163141|NCT02514473|20124501|P1|NOT COMPLETED|Overall Study||3
8163142|NCT02514473|20124500|P2|COMPLETED|Overall Study||98
8163143|NCT02514473|20124501|P1|COMPLETED|Overall Study||98
8163144|NCT02514473|20124500|P2|STARTED|Overall Study||103
8163145|NCT02514473|20124501|P1|STARTED|Overall Study||101
8163146|NCT02514174|20124542|P1|NOT COMPLETED|Overall Study||25
8163147|NCT02514174|20124542|P1|COMPLETED|Overall Study||0
8163148|NCT02514174|20124542|P1|STARTED|Overall Study||25
8163149|NCT02514122|20124553|P2|NOT COMPLETED|Overall Study||0
8163150|NCT02514122|20124554|P1|NOT COMPLETED|Overall Study||2
8163151|NCT02514122|20124553|P2|COMPLETED|Overall Study||29
8163152|NCT02514122|20124554|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
8163153|NCT02514122|20124553|P2|STARTED|Overall Study||29
8163154|NCT02514122|20124554|P1|STARTED|Overall Study||32
8163155|NCT02514083|20124562|P1|NOT COMPLETED|Overall Study||1
8163156|NCT02514083|20124562|P1|COMPLETED|Overall Study||28
8163157|NCT02514083|20124562|P1|STARTED|Overall Study||29
8163158|NCT02514070|20124569|P2|NOT COMPLETED|Week 14 to Week 20||2
8163159|NCT02514070|20124570|P1|NOT COMPLETED|Week 14 to Week 20||1
8163160|NCT02514070|20124569|P2|COMPLETED|Week 14 to Week 20||14
8163161|NCT02514070|20124570|P1|COMPLETED|Week 14 to Week 20||16
8163162|NCT02514070|20124569|P2|STARTED|Week 14 to Week 20||16
8163163|NCT02514070|20124570|P1|STARTED|Week 14 to Week 20||17
8163164|NCT02514070|20124569|P2|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
8163165|NCT02514070|20124570|P1|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
8163166|NCT02514070|20124569|P2|COMPLETED|Week 6 to Week 14 - Washout Period||16
8163167|NCT02514070|20124570|P1|COMPLETED|Week 6 to Week 14 - Washout Period||17
8163168|NCT02514070|20124569|P2|STARTED|Week 6 to Week 14 - Washout Period||16
8163169|NCT02514070|20124570|P1|STARTED|Week 6 to Week 14 - Washout Period||17
8163170|NCT02514070|20124569|P2|NOT COMPLETED|Weeks 0 to Week 6||4
8163171|NCT02514070|20124570|P1|NOT COMPLETED|Weeks 0 to Week 6||2
8163172|NCT02514070|20124569|P2|COMPLETED|Weeks 0 to Week 6||16
8163173|NCT02514070|20124570|P1|COMPLETED|Weeks 0 to Week 6||17
8163174|NCT02514070|20124569|P2|STARTED|Weeks 0 to Week 6||20
8163175|NCT02514070|20124570|P1|STARTED|Weeks 0 to Week 6||19
8163176|NCT02514044|20124581|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
8163177|NCT02514044|20124581|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
8163178|NCT02514044|20124581|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
8163179|NCT02514044|20124581|P1|NOT COMPLETED|Washout (1 Week)||0
8163180|NCT02514044|20124581|P1|COMPLETED|Washout (1 Week)||10
8163181|NCT02514044|20124581|P1|STARTED|Washout (1 Week)||10
8163182|NCT02514044|20124581|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
8163183|NCT02514044|20124581|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
8163184|NCT02514044|20124581|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
8163185|NCT02513940|20124595|P6|NOT COMPLETED|Overall Study||0
8163186|NCT02513940|20124596|P5|NOT COMPLETED|Overall Study||0
8163187|NCT02513940|20124597|P4|NOT COMPLETED|Overall Study||0
8163188|NCT02513940|20124598|P3|NOT COMPLETED|Overall Study||0
8163189|NCT02513940|20124599|P2|NOT COMPLETED|Overall Study||0
8163190|NCT02513940|20124600|P1|NOT COMPLETED|Overall Study||0
8163191|NCT02513940|20124595|P6|COMPLETED|Overall Study||3
8163192|NCT02513940|20124596|P5|COMPLETED|Overall Study||2
8163193|NCT02513940|20124597|P4|COMPLETED|Overall Study||2
8163194|NCT02513940|20124598|P3|COMPLETED|Overall Study||2
8163195|NCT02513940|20124599|P2|COMPLETED|Overall Study||3
8163196|NCT02513940|20124600|P1|COMPLETED|Overall Study||2
8163197|NCT02513940|20124595|P6|STARTED|Overall Study||3
8163198|NCT02513940|20124596|P5|STARTED|Overall Study||2
8163199|NCT02513940|20124597|P4|STARTED|Overall Study||2
8163200|NCT02513940|20124598|P3|STARTED|Overall Study||2
8163201|NCT02513940|20124599|P2|STARTED|Overall Study||3
8163202|NCT02513940|20124600|P1|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
8163203|NCT02513823|20124620|P1|NOT COMPLETED|Overall Study||5
8163204|NCT02513823|20124620|P1|COMPLETED|Overall Study||22
8163205|NCT02513823|20124620|P1|STARTED|Overall Study||27
8163206|NCT02513771|20124627|P2|NOT COMPLETED|Overall Study||1
8163207|NCT02513771|20124628|P1|NOT COMPLETED|Overall Study||2
8163208|NCT02513771|20124627|P2|COMPLETED|Overall Study||44
8163209|NCT02513771|20124628|P1|COMPLETED|Overall Study||43
8163210|NCT02513771|20124627|P2|STARTED|Overall Study||45
8163211|NCT02513771|20124628|P1|STARTED|Overall Study||45
8163212|NCT02513745|20124666|P2|NOT COMPLETED|Overall Study||3
8163213|NCT02513745|20124667|P1|NOT COMPLETED|Overall Study||3
8163214|NCT02513745|20124666|P2|COMPLETED|Overall Study||39
8163215|NCT02513745|20124667|P1|COMPLETED|Overall Study||39
8163216|NCT02513745|20124666|P2|STARTED|Overall Study||42
8163217|NCT02513745|20124667|P1|STARTED|Overall Study||42
8163218|NCT02513732|20124677|P1|NOT COMPLETED|Overall Study||0
8163219|NCT02513732|20124677|P1|COMPLETED|Overall Study||100
8163220|NCT02513732|20124677|P1|STARTED|Overall Study||100
8163221|NCT02513719|20124807|P1|NOT COMPLETED|At 5 Years Clinical Follow-up||19
8163222|NCT02513719|20124807|P1|COMPLETED|At 5 Years Clinical Follow-up||254
8163223|NCT02513719|20124807|P1|STARTED|At 5 Years Clinical Follow-up||273
8163224|NCT02513719|20124807|P1|NOT COMPLETED|At 4 Years Clinical Follow-up||16
8163225|NCT02513719|20124807|P1|COMPLETED|At 4 Years Clinical Follow-up||273
8163226|NCT02513719|20124807|P1|STARTED|At 4 Years Clinical Follow-up||289
8163227|NCT02513719|20124807|P1|NOT COMPLETED|At 3 Years Clinical Follow-up||11
8163228|NCT02513719|20124807|P1|COMPLETED|At 3 Years Clinical Follow-up||289
8163229|NCT02513719|20124807|P1|STARTED|At 3 Years Clinical Follow-up||300
8163230|NCT02513719|20124807|P1|NOT COMPLETED|At 2 Years Clinical Follow-up||5
8163231|NCT02513719|20124807|P1|COMPLETED|At 2 Years Clinical Follow-up||300
8163232|NCT02513719|20124807|P1|STARTED|At 2 Years Clinical Follow-up||305
8163233|NCT02513719|20124807|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||7
8163234|NCT02513719|20124807|P1|COMPLETED|At 1 Year Clinical Follow-up||305
8163235|NCT02513719|20124807|P1|STARTED|At 1 Year Clinical Follow-up||312
8163236|NCT02513719|20124807|P1|NOT COMPLETED|At 8 Months Clinical Follow-up||0
8163237|NCT02513719|20124807|P1|COMPLETED|At 8 Months Clinical Follow-up||312
8163238|NCT02513719|20124807|P1|STARTED|At 8 Months Clinical Follow-up||312
8163239|NCT02513641|20124907|P1|NOT COMPLETED|Overall Study||0
8163240|NCT02513641|20124907|P1|COMPLETED|Overall Study||8
8163241|NCT02513641|20124907|P1|STARTED|Overall Study||8
8163242|NCT02513550|20124921|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
8163243|NCT02513550|20124922|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
8163244|NCT02513550|20124923|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
8163245|NCT02513550|20124924|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
8163246|NCT02513550|20124925|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
8163247|NCT02513550|20124926|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
8163248|NCT02513550|20124921|P6|COMPLETED|Post-Treatment Follow-up Period||15
8163249|NCT02513550|20124922|P5|COMPLETED|Post-Treatment Follow-up Period||4
8163250|NCT02513550|20124923|P4|COMPLETED|Post-Treatment Follow-up Period||9
8163251|NCT02513550|20124924|P3|COMPLETED|Post-Treatment Follow-up Period||496
8163252|NCT02513550|20124925|P2|COMPLETED|Post-Treatment Follow-up Period||244
8163253|NCT02513550|20124926|P1|COMPLETED|Post-Treatment Follow-up Period||254
8163254|NCT02513550|20124921|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
8163255|NCT02513550|20124922|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
8163256|NCT02513550|20124923|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
8163257|NCT02513550|20124924|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
8163258|NCT02513550|20124925|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
8163259|NCT02513550|20124926|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
8163260|NCT02513550|20124921|P6|NOT COMPLETED|Double Blind Treatment Period||1
8163261|NCT02513550|20124922|P5|NOT COMPLETED|Double Blind Treatment Period||1
8163262|NCT02513550|20124923|P4|NOT COMPLETED|Double Blind Treatment Period||0
8163263|NCT02513550|20124924|P3|NOT COMPLETED|Double Blind Treatment Period||74
8163264|NCT02513550|20124925|P2|NOT COMPLETED|Double Blind Treatment Period||38
8163265|NCT02513550|20124926|P1|NOT COMPLETED|Double Blind Treatment Period||36
8163266|NCT02513550|20124921|P6|COMPLETED|Double Blind Treatment Period||15
8163267|NCT02513550|20124922|P5|COMPLETED|Double Blind Treatment Period||4
8163268|NCT02513550|20124923|P4|COMPLETED|Double Blind Treatment Period||9
8163269|NCT02513550|20124924|P3|COMPLETED|Double Blind Treatment Period||537
8163270|NCT02513550|20124925|P2|COMPLETED|Double Blind Treatment Period||268
8163271|NCT02513550|20124926|P1|COMPLETED|Double Blind Treatment Period||274
8163272|NCT02513550|20124921|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
8163273|NCT02513550|20124922|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
8163274|NCT02513550|20124923|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
8163275|NCT02513550|20124924|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
8163276|NCT02513550|20124925|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
8163277|NCT02513550|20124926|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
8163278|NCT02513550|20124921|P6|STARTED|Double Blind Treatment Period||16
8163279|NCT02513550|20124922|P5|STARTED|Double Blind Treatment Period||5
8163280|NCT02513550|20124923|P4|STARTED|Double Blind Treatment Period||9
8163281|NCT02513550|20124924|P3|STARTED|Double Blind Treatment Period||611
8163282|NCT02513550|20124925|P2|STARTED|Double Blind Treatment Period||306
8163283|NCT02513550|20124926|P1|STARTED|Double Blind Treatment Period||310
8163284|NCT02513498|20124998|P1|NOT COMPLETED|Overall Study||24
8163285|NCT02513498|20124998|P1|COMPLETED|Overall Study||26
8163286|NCT02513498|20124998|P1|STARTED|Overall Study||50
8163287|NCT02513472|20125020|P2|NOT COMPLETED|Overall Study||93
8163288|NCT02513472|20125021|P1|NOT COMPLETED|Overall Study||65
8163289|NCT02513472|20125020|P2|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|8
8163290|NCT02513472|20125021|P1|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|1
8163291|NCT02513472|20125020|P2|Phase 2|Overall Study||97
8163292|NCT02513472|20125021|P1|Phase 2|Overall Study||63
8163293|NCT02513472|20125020|P2|Phase 1b Safety run-in|Overall Study||4
8163294|NCT02513472|20125021|P1|Phase 1b Safety run-in|Overall Study||3
8163295|NCT02513472|20125020|P2|STARTED|Overall Study||101
8163296|NCT02513472|20125021|P1|STARTED|Overall Study||66
8163297|NCT02513459|20125056|P1|NOT COMPLETED|Overall Study||21
8163298|NCT02513459|20125056|P1|COMPLETED|Overall Study||44
8163299|NCT02513459|20125056|P1|STARTED|Overall Study||65
8163300|NCT02513446|20125097|P2|NOT COMPLETED|Period 2||0
8163301|NCT02513446|20125098|P1|NOT COMPLETED|Period 2||0
8163302|NCT02513446|20125097|P2|COMPLETED|Period 2||8
8163303|NCT02513446|20125098|P1|COMPLETED|Period 2||8
8163304|NCT02513446|20125097|P2|STARTED|Period 2||8
8163305|NCT02513446|20125098|P1|STARTED|Period 2||8
8163306|NCT02513446|20125097|P2|NOT COMPLETED|Washout Period of 10 Days||0
8163307|NCT02513446|20125098|P1|NOT COMPLETED|Washout Period of 10 Days||0
8163308|NCT02513446|20125097|P2|COMPLETED|Washout Period of 10 Days||8
8163309|NCT02513446|20125098|P1|COMPLETED|Washout Period of 10 Days||8
8163310|NCT02513446|20125097|P2|STARTED|Washout Period of 10 Days||8
8163311|NCT02513446|20125098|P1|STARTED|Washout Period of 10 Days||8
8163312|NCT02513446|20125097|P2|NOT COMPLETED|Period 1||0
8163313|NCT02513446|20125098|P1|NOT COMPLETED|Period 1||0
8163314|NCT02513446|20125097|P2|COMPLETED|Period 1||8
8163315|NCT02513446|20125098|P1|COMPLETED|Period 1||8
8163316|NCT02513446|20125097|P2|STARTED|Period 1||8
8163317|NCT02513446|20125098|P1|STARTED|Period 1||8
8163318|NCT02513212|20125111|P2|NOT COMPLETED|Overall Study||0
8163319|NCT02513212|20125112|P1|NOT COMPLETED|Overall Study||1
8163320|NCT02513212|20125111|P2|COMPLETED|Overall Study||12
8163321|NCT02513212|20125112|P1|COMPLETED|Overall Study||11
8163322|NCT02513212|20125111|P2|STARTED|Overall Study||12
8163323|NCT02513212|20125112|P1|STARTED|Overall Study||12
8163324|NCT02513160|20125124|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
8163325|NCT02513160|20125125|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
8163326|NCT02513160|20125126|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
8163327|NCT02513160|20125127|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
8163328|NCT02513160|20125124|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
8163329|NCT02513160|20125125|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
8163330|NCT02513160|20125126|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
8163331|NCT02513160|20125127|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
8163332|NCT02513160|20125124|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
8163333|NCT02513160|20125125|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
8163334|NCT02513160|20125126|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
8163335|NCT02513160|20125127|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
8163336|NCT02513160|20125124|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163337|NCT02513160|20125125|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163338|NCT02513160|20125126|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163339|NCT02513160|20125127|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
8163340|NCT02513160|20125124|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163341|NCT02513160|20125125|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163342|NCT02513160|20125126|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163343|NCT02513160|20125127|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
8163344|NCT02513160|20125124|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
8163345|NCT02513160|20125125|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
8163346|NCT02513160|20125126|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
8163347|NCT02513160|20125127|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
8163348|NCT02513121|20125164|P2|NOT COMPLETED|Overall Study||0
8163349|NCT02513121|20125165|P1|NOT COMPLETED|Overall Study||0
8163350|NCT02513121|20125164|P2|COMPLETED|Overall Study||20
8163351|NCT02513121|20125165|P1|COMPLETED|Overall Study||20
8163352|NCT02513121|20125164|P2|STARTED|Overall Study||20
8163353|NCT02513121|20125165|P1|STARTED|Overall Study||20
8163354|NCT02513095|20125185|P2|NOT COMPLETED|Overall Study||16
8163355|NCT02513095|20125186|P1|NOT COMPLETED|Overall Study||14
8163356|NCT02513095|20125185|P2|COMPLETED|Overall Study||1
8163357|NCT02513095|20125186|P1|COMPLETED|Overall Study||3
8163358|NCT02513095|20125185|P2|STARTED|Overall Study||17
8163359|NCT02513095|20125186|P1|STARTED|Overall Study||17
8163360|NCT02512900|20125194|P2|NOT COMPLETED|Overall Study||0
8163361|NCT02512900|20125195|P1|NOT COMPLETED|Overall Study||0
8163362|NCT02512900|20125194|P2|COMPLETED|Overall Study||10
8163363|NCT02512900|20125195|P1|COMPLETED|Overall Study||11
8163364|NCT02512900|20125194|P2|STARTED|Overall Study||10
8163365|NCT02512900|20125195|P1|STARTED|Overall Study||11
8163366|NCT02512874|20125226|P1|NOT COMPLETED|Overall Study||2
8163367|NCT02512874|20125226|P1|COMPLETED|Overall Study||63
8163368|NCT02512874|20125226|P1|STARTED|Overall Study||65
8163369|NCT02512861|20125237|P2|NOT COMPLETED|Overall Study||9
8163370|NCT02512861|20125238|P1|NOT COMPLETED|Overall Study||6
8163371|NCT02512861|20125237|P2|COMPLETED|Overall Study||40
8163372|NCT02512861|20125238|P1|COMPLETED|Overall Study||38
8163373|NCT02512861|20125237|P2|STARTED|Overall Study||49
8163374|NCT02512861|20125238|P1|STARTED|Overall Study||44
8163375|NCT02512809|20125259|P1|NOT COMPLETED|Overall Study||0
8163376|NCT02512809|20125259|P1|COMPLETED|Overall Study||25
8163377|NCT02512809|20125259|P1|STARTED|Overall Study||25
8163378|NCT02512783|20125265|P2|NOT COMPLETED|Overall Study||0
8163379|NCT02512783|20125266|P1|NOT COMPLETED|Overall Study||0
8163380|NCT02512783|20125265|P2|COMPLETED|Overall Study||75
8163381|NCT02512783|20125266|P1|COMPLETED|Overall Study||96
8163382|NCT02512783|20125265|P2|STARTED|Overall Study||75
8163383|NCT02512783|20125266|P1|STARTED|Overall Study||96
8163384|NCT02512679|20125274|P2|NOT COMPLETED|Overall Study||0
8163385|NCT02512679|20125275|P1|NOT COMPLETED|Overall Study||0
8163386|NCT02512679|20125274|P2|COMPLETED|Overall Study||0
8163387|NCT02512679|20125275|P1|COMPLETED|Overall Study||20
8163388|NCT02512679|20125274|P2|STARTED|Overall Study||0
8163389|NCT02512679|20125275|P1|STARTED|Overall Study||20
8163390|NCT02512575|20125293|P10|NOT COMPLETED|Overall Study||0
8163391|NCT02512575|20125294|P9|NOT COMPLETED|Overall Study||0
8163392|NCT02512575|20125295|P8|NOT COMPLETED|Overall Study||0
8163393|NCT02512575|20125296|P7|NOT COMPLETED|Overall Study||0
8163394|NCT02512575|20125297|P6|NOT COMPLETED|Overall Study||0
8163395|NCT02512575|20125298|P5|NOT COMPLETED|Overall Study||0
8163396|NCT02512575|20125299|P4|NOT COMPLETED|Overall Study||0
8163397|NCT02512575|20125300|P3|NOT COMPLETED|Overall Study||0
8163398|NCT02512575|20125301|P2|NOT COMPLETED|Overall Study||0
8163399|NCT02512575|20125302|P1|NOT COMPLETED|Overall Study||0
8163400|NCT02512575|20125293|P10|COMPLETED|Overall Study||18
8163401|NCT02512575|20125294|P9|COMPLETED|Overall Study||6
8163402|NCT02512575|20125295|P8|COMPLETED|Overall Study||6
8163403|NCT02512575|20125296|P7|COMPLETED|Overall Study||6
8163404|NCT02512575|20125297|P6|COMPLETED|Overall Study||6
8163405|NCT02512575|20125298|P5|COMPLETED|Overall Study||6
8163406|NCT02512575|20125299|P4|COMPLETED|Overall Study||6
8163407|NCT02512575|20125300|P3|COMPLETED|Overall Study||6
8163408|NCT02512575|20125301|P2|COMPLETED|Overall Study||6
8163409|NCT02512575|20125302|P1|COMPLETED|Overall Study||6
8163410|NCT02512575|20125293|P10|STARTED|Overall Study||18
8163411|NCT02512575|20125294|P9|STARTED|Overall Study||6
8163412|NCT02512575|20125295|P8|STARTED|Overall Study||6
8163413|NCT02512575|20125296|P7|STARTED|Overall Study||6
8163414|NCT02512575|20125297|P6|STARTED|Overall Study||6
8163415|NCT02512575|20125298|P5|STARTED|Overall Study||6
8163416|NCT02512575|20125299|P4|STARTED|Overall Study||6
8163417|NCT02512575|20125300|P3|STARTED|Overall Study||6
8163418|NCT02512575|20125301|P2|STARTED|Overall Study||6
8163419|NCT02512575|20125302|P1|STARTED|Overall Study||6
8163420|NCT02512510|20125397|P3|NOT COMPLETED|Overall Study||52
8163421|NCT02512510|20125398|P2|NOT COMPLETED|Overall Study||35
8163422|NCT02512510|20125399|P1|NOT COMPLETED|Overall Study||42
8163423|NCT02512510|20125397|P3|COMPLETED|Overall Study||157
8163424|NCT02512510|20125398|P2|COMPLETED|Overall Study||162
8163425|NCT02512510|20125399|P1|COMPLETED|Overall Study||163
8163426|NCT02512510|20125397|P3|STARTED|Overall Study||209
8163427|NCT02512510|20125398|P2|STARTED|Overall Study||197
8163428|NCT02512510|20125399|P1|STARTED|Overall Study||205
8163429|NCT02512419|20125424|P2|NOT COMPLETED|Overall Study||0
8163430|NCT02512419|20125425|P1|NOT COMPLETED|Overall Study||2
8163431|NCT02512419|20125424|P2|COMPLETED|Overall Study||24
8163432|NCT02512419|20125425|P1|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
8163433|NCT02512419|20125424|P2|STARTED|Overall Study||24
8163434|NCT02512419|20125425|P1|STARTED|Overall Study||24
8163435|NCT02512393|20125435|P2|NOT COMPLETED|Overall Study||0
8163436|NCT02512393|20125436|P1|NOT COMPLETED|Overall Study||1
8163437|NCT02512393|20125435|P2|COMPLETED|Overall Study||20
8163438|NCT02512393|20125436|P1|COMPLETED|Overall Study||20
8163439|NCT02512393|20125435|P2|STARTED|Overall Study||20
8163440|NCT02512393|20125436|P1|STARTED|Overall Study||21
8163441|NCT02512302|20125516|P10|NOT COMPLETED|Period 5||0
8163442|NCT02512302|20125517|P9|NOT COMPLETED|Period 5||0
8163443|NCT02512302|20125518|P8|NOT COMPLETED|Period 5||0
8163444|NCT02512302|20125519|P7|NOT COMPLETED|Period 5||0
8163445|NCT02512302|20125520|P6|NOT COMPLETED|Period 5||0
8163446|NCT02512302|20125521|P5|NOT COMPLETED|Period 5||0
8163447|NCT02512302|20125522|P4|NOT COMPLETED|Period 5||0
8163448|NCT02512302|20125523|P3|NOT COMPLETED|Period 5||0
8163449|NCT02512302|20125524|P2|NOT COMPLETED|Period 5||0
8163450|NCT02512302|20125525|P1|NOT COMPLETED|Period 5||0
8163451|NCT02512302|20125516|P10|COMPLETED|Period 5||2
8163452|NCT02512302|20125517|P9|COMPLETED|Period 5||3
8163453|NCT02512302|20125518|P8|COMPLETED|Period 5||3
8163454|NCT02512302|20125519|P7|COMPLETED|Period 5||1
8163455|NCT02512302|20125520|P6|COMPLETED|Period 5||3
8163456|NCT02512302|20125521|P5|COMPLETED|Period 5||3
8163457|NCT02512302|20125522|P4|COMPLETED|Period 5||3
8163458|NCT02512302|20125523|P3|COMPLETED|Period 5||3
8163459|NCT02512302|20125524|P2|COMPLETED|Period 5||2
8163460|NCT02512302|20125525|P1|COMPLETED|Period 5||3
8163461|NCT02512302|20125516|P10|STARTED|Period 5||2
8163462|NCT02512302|20125517|P9|STARTED|Period 5||3
8163463|NCT02512302|20125518|P8|STARTED|Period 5||3
8163464|NCT02512302|20125519|P7|STARTED|Period 5||1
8163465|NCT02512302|20125520|P6|STARTED|Period 5||3
8163466|NCT02512302|20125521|P5|STARTED|Period 5||3
8163467|NCT02512302|20125522|P4|STARTED|Period 5||3
8163468|NCT02512302|20125523|P3|STARTED|Period 5||3
8163469|NCT02512302|20125524|P2|STARTED|Period 5||2
8163470|NCT02512302|20125525|P1|STARTED|Period 5||3
8163471|NCT02512302|20125516|P10|NOT COMPLETED|Period 4||0
8163472|NCT02512302|20125517|P9|NOT COMPLETED|Period 4||0
8163473|NCT02512302|20125518|P8|NOT COMPLETED|Period 4||0
8163474|NCT02512302|20125519|P7|NOT COMPLETED|Period 4||1
8163475|NCT02512302|20125520|P6|NOT COMPLETED|Period 4||0
8163476|NCT02512302|20125521|P5|NOT COMPLETED|Period 4||0
8163477|NCT02512302|20125522|P4|NOT COMPLETED|Period 4||0
8163478|NCT02512302|20125523|P3|NOT COMPLETED|Period 4||0
8163479|NCT02512302|20125524|P2|NOT COMPLETED|Period 4||0
8163480|NCT02512302|20125525|P1|NOT COMPLETED|Period 4||0
8163481|NCT02512302|20125516|P10|COMPLETED|Period 4||2
8163482|NCT02512302|20125517|P9|COMPLETED|Period 4||3
8163483|NCT02512302|20125518|P8|COMPLETED|Period 4||3
8163484|NCT02512302|20125519|P7|COMPLETED|Period 4||1
8163485|NCT02512302|20125520|P6|COMPLETED|Period 4||3
8163486|NCT02512302|20125521|P5|COMPLETED|Period 4||3
8163487|NCT02512302|20125522|P4|COMPLETED|Period 4||3
8163488|NCT02512302|20125523|P3|COMPLETED|Period 4||3
8163489|NCT02512302|20125524|P2|COMPLETED|Period 4||2
8163490|NCT02512302|20125525|P1|COMPLETED|Period 4||3
8163491|NCT02512302|20125516|P10|STARTED|Period 4||2
8163492|NCT02512302|20125517|P9|STARTED|Period 4||3
8163493|NCT02512302|20125518|P8|STARTED|Period 4||3
8163494|NCT02512302|20125519|P7|STARTED|Period 4||2
8163495|NCT02512302|20125520|P6|STARTED|Period 4||3
8163496|NCT02512302|20125521|P5|STARTED|Period 4||3
8163497|NCT02512302|20125522|P4|STARTED|Period 4||3
8163498|NCT02512302|20125523|P3|STARTED|Period 4||3
8163499|NCT02512302|20125524|P2|STARTED|Period 4||2
8163500|NCT02512302|20125525|P1|STARTED|Period 4||3
8163501|NCT02512302|20125516|P10|NOT COMPLETED|Period 3||0
8163502|NCT02512302|20125517|P9|NOT COMPLETED|Period 3||0
8163503|NCT02512302|20125518|P8|NOT COMPLETED|Period 3||0
8163504|NCT02512302|20125519|P7|NOT COMPLETED|Period 3||0
8163505|NCT02512302|20125520|P6|NOT COMPLETED|Period 3||0
8163506|NCT02512302|20125521|P5|NOT COMPLETED|Period 3||0
8163507|NCT02512302|20125522|P4|NOT COMPLETED|Period 3||0
8163508|NCT02512302|20125523|P3|NOT COMPLETED|Period 3||1
8163509|NCT02512302|20125524|P2|NOT COMPLETED|Period 3||0
8163510|NCT02512302|20125525|P1|NOT COMPLETED|Period 3||0
8163511|NCT02512302|20125516|P10|COMPLETED|Period 3||2
8163512|NCT02512302|20125517|P9|COMPLETED|Period 3||3
8163513|NCT02512302|20125518|P8|COMPLETED|Period 3||3
8163514|NCT02512302|20125519|P7|COMPLETED|Period 3||2
8163515|NCT02512302|20125520|P6|COMPLETED|Period 3||3
8163516|NCT02512302|20125521|P5|COMPLETED|Period 3||3
8163517|NCT02512302|20125522|P4|COMPLETED|Period 3||3
8163518|NCT02512302|20125523|P3|COMPLETED|Period 3||3
8163519|NCT02512302|20125524|P2|COMPLETED|Period 3||2
8163520|NCT02512302|20125525|P1|COMPLETED|Period 3||3
8163521|NCT02512302|20125516|P10|STARTED|Period 3||2
8163522|NCT02512302|20125517|P9|STARTED|Period 3||3
8163523|NCT02512302|20125518|P8|STARTED|Period 3||3
8163524|NCT02512302|20125519|P7|STARTED|Period 3||2
8163525|NCT02512302|20125520|P6|STARTED|Period 3||3
8163526|NCT02512302|20125521|P5|STARTED|Period 3||3
8163527|NCT02512302|20125522|P4|STARTED|Period 3||3
8163528|NCT02512302|20125523|P3|STARTED|Period 3||4
8163529|NCT02512302|20125524|P2|STARTED|Period 3||2
8163530|NCT02512302|20125525|P1|STARTED|Period 3||3
8163531|NCT02512302|20125516|P10|NOT COMPLETED|Period 2||1
8163532|NCT02512302|20125517|P9|NOT COMPLETED|Period 2||0
8163533|NCT02512302|20125518|P8|NOT COMPLETED|Period 2||0
8163534|NCT02512302|20125519|P7|NOT COMPLETED|Period 2||0
8163535|NCT02512302|20125520|P6|NOT COMPLETED|Period 2||0
8163536|NCT02512302|20125521|P5|NOT COMPLETED|Period 2||0
8163537|NCT02512302|20125522|P4|NOT COMPLETED|Period 2||0
8163538|NCT02512302|20125523|P3|NOT COMPLETED|Period 2||0
8163539|NCT02512302|20125524|P2|NOT COMPLETED|Period 2||0
8163540|NCT02512302|20125525|P1|NOT COMPLETED|Period 2||0
8163541|NCT02512302|20125516|P10|COMPLETED|Period 2||2
8163542|NCT02512302|20125517|P9|COMPLETED|Period 2||3
8163543|NCT02512302|20125518|P8|COMPLETED|Period 2||3
8163544|NCT02512302|20125519|P7|COMPLETED|Period 2||2
8163545|NCT02512302|20125520|P6|COMPLETED|Period 2||3
8163546|NCT02512302|20125521|P5|COMPLETED|Period 2||3
8163547|NCT02512302|20125522|P4|COMPLETED|Period 2||3
8163548|NCT02512302|20125523|P3|COMPLETED|Period 2||4
8163549|NCT02512302|20125524|P2|COMPLETED|Period 2||2
8163550|NCT02512302|20125525|P1|COMPLETED|Period 2||3
8163551|NCT02512302|20125516|P10|STARTED|Period 2||3
8163552|NCT02512302|20125517|P9|STARTED|Period 2||3
8163553|NCT02512302|20125518|P8|STARTED|Period 2||3
8163554|NCT02512302|20125519|P7|STARTED|Period 2||2
8163555|NCT02512302|20125520|P6|STARTED|Period 2||3
8163556|NCT02512302|20125521|P5|STARTED|Period 2||3
8163557|NCT02512302|20125522|P4|STARTED|Period 2||3
8163558|NCT02512302|20125523|P3|STARTED|Period 2||4
8163559|NCT02512302|20125524|P2|STARTED|Period 2||2
8163560|NCT02512302|20125525|P1|STARTED|Period 2||3
8163561|NCT02512302|20125516|P10|NOT COMPLETED|Period 1||0
8163562|NCT02512302|20125517|P9|NOT COMPLETED|Period 1||0
8163563|NCT02512302|20125518|P8|NOT COMPLETED|Period 1||0
8163564|NCT02512302|20125519|P7|NOT COMPLETED|Period 1||0
8163565|NCT02512302|20125520|P6|NOT COMPLETED|Period 1||0
8163566|NCT02512302|20125521|P5|NOT COMPLETED|Period 1||0
8163567|NCT02512302|20125522|P4|NOT COMPLETED|Period 1||0
8163568|NCT02512302|20125523|P3|NOT COMPLETED|Period 1||0
8163569|NCT02512302|20125524|P2|NOT COMPLETED|Period 1||1
8163570|NCT02512302|20125525|P1|NOT COMPLETED|Period 1||0
8163571|NCT02512302|20125516|P10|COMPLETED|Period 1||3
8163572|NCT02512302|20125517|P9|COMPLETED|Period 1||3
8163573|NCT02512302|20125518|P8|COMPLETED|Period 1||3
8163574|NCT02512302|20125519|P7|COMPLETED|Period 1||2
8163575|NCT02512302|20125520|P6|COMPLETED|Period 1||3
8163576|NCT02512302|20125521|P5|COMPLETED|Period 1||3
8163577|NCT02512302|20125522|P4|COMPLETED|Period 1||3
8163578|NCT02512302|20125523|P3|COMPLETED|Period 1||4
8163579|NCT02512302|20125524|P2|COMPLETED|Period 1||2
8163580|NCT02512302|20125525|P1|COMPLETED|Period 1||3
8163581|NCT02512302|20125516|P10|STARTED|Period 1||3
8163582|NCT02512302|20125517|P9|STARTED|Period 1||3
8163583|NCT02512302|20125518|P8|STARTED|Period 1||3
8163584|NCT02512302|20125519|P7|STARTED|Period 1||2
8163585|NCT02512302|20125520|P6|STARTED|Period 1||3
8163586|NCT02512302|20125521|P5|STARTED|Period 1||3
8163587|NCT02512302|20125522|P4|STARTED|Period 1||3
8163588|NCT02512302|20125523|P3|STARTED|Period 1||4
8163589|NCT02512302|20125524|P2|STARTED|Period 1||3
8163590|NCT02512302|20125525|P1|STARTED|Period 1||3
8163591|NCT02512276|20125599|P2|NOT COMPLETED|Overall Study||11
8163592|NCT02512276|20125600|P1|NOT COMPLETED|Overall Study||8
8163593|NCT02512276|20125599|P2|COMPLETED|Overall Study||2029
8163594|NCT02512276|20125600|P1|COMPLETED|Overall Study||2030
8163595|NCT02512276|20125599|P2|STARTED|Overall Study||2040
8163596|NCT02512276|20125600|P1|STARTED|Overall Study||2038
8163597|NCT02512224|20125618|P2|NOT COMPLETED|Overall Study||0
8163598|NCT02512224|20125619|P1|NOT COMPLETED|Overall Study||0
8163599|NCT02512224|20125618|P2|COMPLETED|Overall Study||2912
8163600|NCT02512224|20125619|P1|COMPLETED|Overall Study||2912
8163601|NCT02512224|20125618|P2|STARTED|Overall Study||2912
8163602|NCT02512224|20125619|P1|STARTED|Overall Study||2912
8163603|NCT02512094|20125635|P1|NOT COMPLETED|Overall Study||0
8163604|NCT02512094|20125635|P1|COMPLETED|Overall Study||53
8163605|NCT02512094|20125635|P1|STARTED|Overall Study||53
8163606|NCT02512068|20125641|P2|NOT COMPLETED|Overall Study||13
8163607|NCT02512068|20125642|P1|NOT COMPLETED|Overall Study||12
8163608|NCT02512068|20125641|P2|COMPLETED|Overall Study||39
8163609|NCT02512068|20125642|P1|COMPLETED|Overall Study||43
8163610|NCT02512068|20125641|P2|STARTED|Overall Study||52
8163611|NCT02512068|20125642|P1|STARTED|Overall Study||55
8163612|NCT02512042|20125668|P2|NOT COMPLETED|Overall Study||25
8163613|NCT02512042|20125669|P1|NOT COMPLETED|Overall Study||23
8163614|NCT02512042|20125668|P2|COMPLETED|Overall Study||453
8163615|NCT02512042|20125669|P1|COMPLETED|Overall Study||472
8163616|NCT02512042|20125668|P2|STARTED|Overall Study||478
8163617|NCT02512042|20125669|P1|STARTED|Overall Study||495
8163618|NCT02511782|20125678|P3|NOT COMPLETED|Overall Study||0
8163619|NCT02511782|20125679|P2|NOT COMPLETED|Overall Study||0
8163620|NCT02511782|20125680|P1|NOT COMPLETED|Overall Study||1
8163621|NCT02511782|20125678|P3|COMPLETED|Overall Study||10
8163622|NCT02511782|20125679|P2|COMPLETED|Overall Study||2
8163623|NCT02511782|20125680|P1|COMPLETED|Overall Study||50
8163624|NCT02511782|20125678|P3|STARTED|Overall Study||10
8163625|NCT02511782|20125679|P2|STARTED|Overall Study||2
8163626|NCT02511782|20125680|P1|STARTED|Overall Study||51
8163627|NCT02511730|20125690|P2|NOT COMPLETED|Session Reading Session||0
8163628|NCT02511730|20125691|P1|NOT COMPLETED|Session Reading Session||0
8163629|NCT02511730|20125690|P2|COMPLETED|Session Reading Session||50
8163630|NCT02511730|20125691|P1|COMPLETED|Session Reading Session||50
8163631|NCT02511730|20125690|P2|STARTED|Session Reading Session||50
8163632|NCT02511730|20125691|P1|STARTED|Session Reading Session||50
8163633|NCT02511730|20125690|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8163634|NCT02511730|20125691|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8163635|NCT02511730|20125690|P2|COMPLETED|4 Week Memory Washout Period||50
8163636|NCT02511730|20125691|P1|COMPLETED|4 Week Memory Washout Period||50
8163637|NCT02511730|20125690|P2|STARTED|4 Week Memory Washout Period||50
8163638|NCT02511730|20125691|P1|STARTED|4 Week Memory Washout Period||50
8163639|NCT02511730|20125690|P2|NOT COMPLETED|First Reading Session||0
8163640|NCT02511730|20125691|P1|NOT COMPLETED|First Reading Session||0
8163641|NCT02511730|20125690|P2|COMPLETED|First Reading Session||50
8163642|NCT02511730|20125691|P1|COMPLETED|First Reading Session||50
8163643|NCT02511730|20125690|P2|STARTED|First Reading Session||50
8163644|NCT02511730|20125691|P1|STARTED|First Reading Session||50
8163645|NCT02511717|20125699|P2|NOT COMPLETED|Overall Study||0
8163646|NCT02511717|20125700|P1|NOT COMPLETED|Overall Study||2
8163647|NCT02511717|20125699|P2|COMPLETED|Overall Study||10
8163648|NCT02511717|20125700|P1|COMPLETED|Overall Study||8
8163649|NCT02511717|20125699|P2|STARTED|Overall Study||10
8163650|NCT02511717|20125700|P1|STARTED|Overall Study||10
8163651|NCT02511678|20125706|P1|NOT COMPLETED|Overall Study||36
8163652|NCT02511678|20125706|P1|COMPLETED|Overall Study||37
8163653|NCT02511678|20125706|P1|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
8163654|NCT02511678|20125706|P1|Participants Discontinued Pre-Treatment|Overall Study||7
8163655|NCT02511678|20125706|P1|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
8163656|NCT02511678|20125706|P1|STARTED|Overall Study||73
8163657|NCT02511587|20125721|P2|NOT COMPLETED|Overall Study||0
8163658|NCT02511587|20125722|P1|NOT COMPLETED|Overall Study||0
8163659|NCT02511587|20125721|P2|COMPLETED|Overall Study||58
8163660|NCT02511587|20125722|P1|COMPLETED|Overall Study||58
8163661|NCT02511587|20125721|P2|STARTED|Overall Study||58
8163662|NCT02511587|20125722|P1|STARTED|Overall Study||58
8163663|NCT02511561|20125735|P3|NOT COMPLETED|Overall Study||0
8163664|NCT02511561|20125736|P2|NOT COMPLETED|Overall Study||0
8163665|NCT02511561|20125737|P1|NOT COMPLETED|Overall Study||0
8163666|NCT02511561|20125735|P3|COMPLETED|Overall Study||25
8163667|NCT02511561|20125736|P2|COMPLETED|Overall Study||25
8163668|NCT02511561|20125737|P1|COMPLETED|Overall Study||25
8163669|NCT02511561|20125735|P3|STARTED|Overall Study||25
8163670|NCT02511561|20125736|P2|STARTED|Overall Study||25
8163671|NCT02511561|20125737|P1|STARTED|Overall Study||25
8163672|NCT02511535|20125763|P3|NOT COMPLETED|Overall Study||0
8163673|NCT02511535|20125764|P2|NOT COMPLETED|Overall Study||0
8163674|NCT02511535|20125765|P1|NOT COMPLETED|Overall Study||0
8163675|NCT02511535|20125763|P3|COMPLETED|Overall Study||49
8163676|NCT02511535|20125764|P2|COMPLETED|Overall Study||21
8163677|NCT02511535|20125765|P1|COMPLETED|Overall Study||49
8163678|NCT02511535|20125763|P3|STARTED|Overall Study||49
8163679|NCT02511535|20125764|P2|STARTED|Overall Study||21
8163680|NCT02511535|20125765|P1|STARTED|Overall Study||49
8163681|NCT02511431|20125788|P6|NOT COMPLETED|Post-treatment Follow-up||0
8163682|NCT02511431|20125789|P5|NOT COMPLETED|Post-treatment Follow-up||0
8163683|NCT02511431|20125790|P4|NOT COMPLETED|Post-treatment Follow-up||0
8163684|NCT02511431|20125791|P3|NOT COMPLETED|Post-treatment Follow-up||0
8163685|NCT02511431|20125792|P2|NOT COMPLETED|Post-treatment Follow-up||0
8163686|NCT02511431|20125793|P1|NOT COMPLETED|Post-treatment Follow-up||0
8163687|NCT02511431|20125788|P6|COMPLETED|Post-treatment Follow-up||2
8163688|NCT02511431|20125789|P5|COMPLETED|Post-treatment Follow-up||3
8163689|NCT02511431|20125790|P4|COMPLETED|Post-treatment Follow-up||3
8163690|NCT02511431|20125791|P3|COMPLETED|Post-treatment Follow-up||3
8163691|NCT02511431|20125792|P2|COMPLETED|Post-treatment Follow-up||4
8163692|NCT02511431|20125793|P1|COMPLETED|Post-treatment Follow-up||4
8163693|NCT02511431|20125788|P6|STARTED|Post-treatment Follow-up||2
8163694|NCT02511431|20125789|P5|STARTED|Post-treatment Follow-up||3
8163695|NCT02511431|20125790|P4|STARTED|Post-treatment Follow-up||3
8163696|NCT02511431|20125791|P3|STARTED|Post-treatment Follow-up||3
8163697|NCT02511431|20125792|P2|STARTED|Post-treatment Follow-up||4
8163698|NCT02511431|20125793|P1|STARTED|Post-treatment Follow-up||4
8163699|NCT02511431|20125788|P6|NOT COMPLETED|Treatment||1
8163700|NCT02511431|20125789|P5|NOT COMPLETED|Treatment||0
8163701|NCT02511431|20125790|P4|NOT COMPLETED|Treatment||0
8163702|NCT02511431|20125791|P3|NOT COMPLETED|Treatment||1
8163703|NCT02511431|20125792|P2|NOT COMPLETED|Treatment||0
8163704|NCT02511431|20125793|P1|NOT COMPLETED|Treatment||0
8163705|NCT02511431|20125788|P6|COMPLETED|Treatment||2
8163706|NCT02511431|20125789|P5|COMPLETED|Treatment||3
8163707|NCT02511431|20125790|P4|COMPLETED|Treatment||3
8163708|NCT02511431|20125791|P3|COMPLETED|Treatment||3
8163709|NCT02511431|20125792|P2|COMPLETED|Treatment||4
8163710|NCT02511431|20125793|P1|COMPLETED|Treatment||4
8163711|NCT02511431|20125788|P6|STARTED|Treatment||3
8163712|NCT02511431|20125789|P5|STARTED|Treatment||3
8163713|NCT02511431|20125790|P4|STARTED|Treatment||3
8163714|NCT02511431|20125791|P3|STARTED|Treatment||4
8163715|NCT02511431|20125792|P2|STARTED|Treatment||4
8163716|NCT02511431|20125793|P1|STARTED|Treatment||4
8163717|NCT02511379|20125814|P1|NOT COMPLETED|Overall Study||0
8163718|NCT02511379|20125814|P1|COMPLETED|Overall Study||14
8163719|NCT02511379|20125814|P1|STARTED|Overall Study||14
8163720|NCT02511184|20125820|P2|NOT COMPLETED|Overall Study||7
8163721|NCT02511184|20125821|P1|NOT COMPLETED|Overall Study||2
8163722|NCT02511184|20125820|P2|COMPLETED|Overall Study||0
8163723|NCT02511184|20125821|P1|COMPLETED|Overall Study||0
8163724|NCT02511184|20125820|P2|STARTED|Overall Study||7
8163725|NCT02511184|20125821|P1|STARTED|Overall Study||2
8163726|NCT02510820|20125871|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8163727|NCT02510820|20125872|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8163728|NCT02510820|20125871|P2|COMPLETED|Second Intervention (4 Weeks)||26
8163729|NCT02510820|20125872|P1|COMPLETED|Second Intervention (4 Weeks)||20
8163730|NCT02510820|20125871|P2|STARTED|Second Intervention (4 Weeks)||26
8163731|NCT02510820|20125872|P1|STARTED|Second Intervention (4 Weeks)||21
8163732|NCT02510820|20125871|P2|NOT COMPLETED|Washout (1 Week)||0
8163733|NCT02510820|20125872|P1|NOT COMPLETED|Washout (1 Week)||0
8163734|NCT02510820|20125871|P2|COMPLETED|Washout (1 Week)||26
8163735|NCT02510820|20125872|P1|COMPLETED|Washout (1 Week)||21
8163736|NCT02510820|20125871|P2|STARTED|Washout (1 Week)||26
8163737|NCT02510820|20125872|P1|STARTED|Washout (1 Week)||21
8163738|NCT02510820|20125871|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8163739|NCT02510820|20125872|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8163740|NCT02510820|20125871|P2|COMPLETED|First Intervention (4 Weeks)||26
8163741|NCT02510820|20125872|P1|COMPLETED|First Intervention (4 Weeks)||21
8163742|NCT02510820|20125871|P2|STARTED|First Intervention (4 Weeks)||27
8163743|NCT02510820|20125872|P1|STARTED|First Intervention (4 Weeks)||21
8163744|NCT02510664|20125913|P3|NOT COMPLETED|Overall Study||0
8163745|NCT02510664|20125914|P2|NOT COMPLETED|Overall Study||20
8163746|NCT02510664|20125915|P1|NOT COMPLETED|Overall Study||20
8163747|NCT02510664|20125913|P3|COMPLETED|Overall Study||4
8163748|NCT02510664|20125914|P2|COMPLETED|Overall Study||64
8163749|NCT02510664|20125915|P1|COMPLETED|Overall Study||64
8163750|NCT02510664|20125913|P3|STARTED|Overall Study||4
8163751|NCT02510664|20125914|P2|STARTED|Overall Study||84
8163752|NCT02510664|20125915|P1|STARTED|Overall Study||84
8163753|NCT02510144|20125946|P2|NOT COMPLETED|Overall Study||0
8163754|NCT02510144|20125947|P1|NOT COMPLETED|Overall Study||0
8163755|NCT02510144|20125946|P2|COMPLETED|Overall Study||41
8163756|NCT02510144|20125947|P1|COMPLETED|Overall Study||39
8163757|NCT02510144|20125946|P2|STARTED|Overall Study||41
8163758|NCT02510144|20125947|P1|STARTED|Overall Study||39
8163759|NCT02510014|20125957|P2|NOT COMPLETED|Treatment Period||57
8163760|NCT02510014|20125958|P1|NOT COMPLETED|Treatment Period||206
8163761|NCT02510014|20125957|P2|COMPLETED|Treatment Period||200
8163762|NCT02510014|20125958|P1|COMPLETED|Treatment Period||206
8163763|NCT02510014|20125957|P2|STARTED|Treatment Period||257
8163764|NCT02510014|20125958|P1|STARTED|Treatment Period||412
8163765|NCT02510014|20125957|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
8163766|NCT02510014|20125958|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
8163767|NCT02510014|20125957|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
8163768|NCT02510014|20125958|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
8163769|NCT02510014|20125957|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
8163770|NCT02510014|20125958|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
8163771|NCT02509936|20125980|P2|NOT COMPLETED|Overall Study||16
8163772|NCT02509936|20125981|P1|NOT COMPLETED|Overall Study||12
8163773|NCT02509936|20125980|P2|COMPLETED|Overall Study||145
8163774|NCT02509936|20125981|P1|COMPLETED|Overall Study||151
8163775|NCT02509936|20125980|P2|STARTED|Overall Study||161
8163776|NCT02509936|20125981|P1|STARTED|Overall Study||163
8163777|NCT02509767|20126007|P2|NOT COMPLETED|Overall Study||41
8163778|NCT02509767|20126008|P1|NOT COMPLETED|Overall Study||44
8163779|NCT02509767|20126007|P2|COMPLETED|Overall Study||159
8163780|NCT02509767|20126008|P1|COMPLETED|Overall Study||157
8163781|NCT02509767|20126007|P2|STARTED|Overall Study||200
8163782|NCT02509767|20126008|P1|STARTED|Overall Study||201
8163783|NCT02509624|20126023|P4|NOT COMPLETED|Overall Study||0
8163784|NCT02509624|20126024|P3|NOT COMPLETED|Overall Study||0
8163785|NCT02509624|20126025|P2|NOT COMPLETED|Overall Study||0
8163786|NCT02509624|20126026|P1|NOT COMPLETED|Overall Study||0
8163787|NCT02509624|20126023|P4|COMPLETED|Overall Study||22
8163788|NCT02509624|20126024|P3|COMPLETED|Overall Study||10
8163789|NCT02509624|20126025|P2|COMPLETED|Overall Study||10
8163790|NCT02509624|20126026|P1|COMPLETED|Overall Study||10
8163791|NCT02509624|20126023|P4|STARTED|Overall Study||22
8163792|NCT02509624|20126024|P3|STARTED|Overall Study||10
8163793|NCT02509624|20126025|P2|STARTED|Overall Study||10
8163794|NCT02509624|20126026|P1|STARTED|Overall Study||10
8163795|NCT02509585|20126058|P1|NOT COMPLETED|Overall Study||0
8163796|NCT02509585|20126058|P1|COMPLETED|Overall Study||18
8163797|NCT02509585|20126058|P1|STARTED|Overall Study||18
8163798|NCT02509481|20126073|P2|NOT COMPLETED|Overall Study||0
8163799|NCT02509481|20126074|P1|NOT COMPLETED|Overall Study||0
8163800|NCT02509481|20126073|P2|COMPLETED|Overall Study||1447
8163801|NCT02509481|20126074|P1|COMPLETED|Overall Study||1265
8163802|NCT02509481|20126073|P2|STARTED|Overall Study||1447
8163803|NCT02509481|20126074|P1|STARTED|Overall Study||1265
8163804|NCT02509156|20126092|P2|NOT COMPLETED|Randomized Phase||1
8163805|NCT02509156|20126093|P1|NOT COMPLETED|Randomized Phase||2
8163806|NCT02509156|20126092|P2|COMPLETED|Randomized Phase||16
8163807|NCT02509156|20126093|P1|COMPLETED|Randomized Phase||12
8163808|NCT02509156|20126092|P2|STARTED|Randomized Phase||17
8163809|NCT02509156|20126093|P1|STARTED|Randomized Phase|Includes randomized participants only|14
8163810|NCT02509156|20126092|P2|NOT COMPLETED|Open-Label Lead-In Phase||0
8163811|NCT02509156|20126093|P1|NOT COMPLETED|Open-Label Lead-In Phase||0
8163812|NCT02509156|20126092|P2|COMPLETED|Open-Label Lead-In Phase||0
8163813|NCT02509156|20126093|P1|COMPLETED|Open-Label Lead-In Phase||6
8163814|NCT02509156|20126092|P2|STARTED|Open-Label Lead-In Phase||0
8163815|NCT02509156|20126093|P1|STARTED|Open-Label Lead-In Phase||6
8163816|NCT02509117|20126163|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163817|NCT02509117|20126164|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163818|NCT02509117|20126165|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163819|NCT02509117|20126166|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163820|NCT02509117|20126167|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163821|NCT02509117|20126168|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163822|NCT02509117|20126169|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163823|NCT02509117|20126170|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163824|NCT02509117|20126171|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163825|NCT02509117|20126172|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163826|NCT02509117|20126163|P10|COMPLETED|Period 4 -Part A: 4 Days||0
8163827|NCT02509117|20126164|P9|COMPLETED|Period 4 -Part A: 4 Days||0
8163828|NCT02509117|20126165|P8|COMPLETED|Period 4 -Part A: 4 Days||0
8163829|NCT02509117|20126166|P7|COMPLETED|Period 4 -Part A: 4 Days||0
8163830|NCT02509117|20126167|P6|COMPLETED|Period 4 -Part A: 4 Days||0
8163831|NCT02509117|20126168|P5|COMPLETED|Period 4 -Part A: 4 Days||0
8163832|NCT02509117|20126169|P4|COMPLETED|Period 4 -Part A: 4 Days||2
8163833|NCT02509117|20126170|P3|COMPLETED|Period 4 -Part A: 4 Days||2
8163834|NCT02509117|20126171|P2|COMPLETED|Period 4 -Part A: 4 Days||2
8163835|NCT02509117|20126172|P1|COMPLETED|Period 4 -Part A: 4 Days||2
8163836|NCT02509117|20126163|P10|STARTED|Period 4 -Part A: 4 Days||0
8163837|NCT02509117|20126164|P9|STARTED|Period 4 -Part A: 4 Days||0
8163838|NCT02509117|20126165|P8|STARTED|Period 4 -Part A: 4 Days||0
8163839|NCT02509117|20126166|P7|STARTED|Period 4 -Part A: 4 Days||0
8163840|NCT02509117|20126167|P6|STARTED|Period 4 -Part A: 4 Days||0
8163841|NCT02509117|20126168|P5|STARTED|Period 4 -Part A: 4 Days||0
8163842|NCT02509117|20126169|P4|STARTED|Period 4 -Part A: 4 Days||2
8163843|NCT02509117|20126170|P3|STARTED|Period 4 -Part A: 4 Days||2
8163844|NCT02509117|20126171|P2|STARTED|Period 4 -Part A: 4 Days||2
8163845|NCT02509117|20126172|P1|STARTED|Period 4 -Part A: 4 Days||2
8163846|NCT02509117|20126163|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163847|NCT02509117|20126164|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163848|NCT02509117|20126165|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163849|NCT02509117|20126166|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163850|NCT02509117|20126167|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163851|NCT02509117|20126168|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163852|NCT02509117|20126169|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163853|NCT02509117|20126170|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163854|NCT02509117|20126171|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163855|NCT02509117|20126172|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163856|NCT02509117|20126163|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163857|NCT02509117|20126164|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163858|NCT02509117|20126165|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163859|NCT02509117|20126166|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163860|NCT02509117|20126167|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163861|NCT02509117|20126168|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163862|NCT02509117|20126169|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163863|NCT02509117|20126170|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163864|NCT02509117|20126171|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163865|NCT02509117|20126172|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163866|NCT02509117|20126163|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163867|NCT02509117|20126164|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163868|NCT02509117|20126165|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163869|NCT02509117|20126166|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163870|NCT02509117|20126167|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163871|NCT02509117|20126168|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163872|NCT02509117|20126169|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163873|NCT02509117|20126170|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163874|NCT02509117|20126171|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163875|NCT02509117|20126172|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163876|NCT02509117|20126163|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163877|NCT02509117|20126164|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163878|NCT02509117|20126165|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163879|NCT02509117|20126166|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163880|NCT02509117|20126167|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163881|NCT02509117|20126168|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163882|NCT02509117|20126169|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163883|NCT02509117|20126170|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163884|NCT02509117|20126171|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163885|NCT02509117|20126172|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163886|NCT02509117|20126163|P10|COMPLETED|Period 3 -Part A: 4 Days||0
8163887|NCT02509117|20126164|P9|COMPLETED|Period 3 -Part A: 4 Days||0
8163888|NCT02509117|20126165|P8|COMPLETED|Period 3 -Part A: 4 Days||0
8163889|NCT02509117|20126166|P7|COMPLETED|Period 3 -Part A: 4 Days||0
8163890|NCT02509117|20126167|P6|COMPLETED|Period 3 -Part A: 4 Days||0
8163891|NCT02509117|20126168|P5|COMPLETED|Period 3 -Part A: 4 Days||0
8163892|NCT02509117|20126169|P4|COMPLETED|Period 3 -Part A: 4 Days||2
8163893|NCT02509117|20126170|P3|COMPLETED|Period 3 -Part A: 4 Days||2
8163894|NCT02509117|20126171|P2|COMPLETED|Period 3 -Part A: 4 Days||2
8163895|NCT02509117|20126172|P1|COMPLETED|Period 3 -Part A: 4 Days||2
8163896|NCT02509117|20126163|P10|STARTED|Period 3 -Part A: 4 Days||0
8163897|NCT02509117|20126164|P9|STARTED|Period 3 -Part A: 4 Days||0
8163898|NCT02509117|20126165|P8|STARTED|Period 3 -Part A: 4 Days||0
8163899|NCT02509117|20126166|P7|STARTED|Period 3 -Part A: 4 Days||0
8163900|NCT02509117|20126167|P6|STARTED|Period 3 -Part A: 4 Days||0
8163901|NCT02509117|20126168|P5|STARTED|Period 3 -Part A: 4 Days||0
8163902|NCT02509117|20126169|P4|STARTED|Period 3 -Part A: 4 Days||2
8163903|NCT02509117|20126170|P3|STARTED|Period 3 -Part A: 4 Days||2
8163904|NCT02509117|20126171|P2|STARTED|Period 3 -Part A: 4 Days||2
8163905|NCT02509117|20126172|P1|STARTED|Period 3 -Part A: 4 Days||2
8163906|NCT02509117|20126163|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163907|NCT02509117|20126164|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163908|NCT02509117|20126165|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163909|NCT02509117|20126166|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163910|NCT02509117|20126167|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163911|NCT02509117|20126168|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163912|NCT02509117|20126169|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163913|NCT02509117|20126170|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163914|NCT02509117|20126171|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163915|NCT02509117|20126172|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163916|NCT02509117|20126163|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163917|NCT02509117|20126164|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163918|NCT02509117|20126165|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163919|NCT02509117|20126166|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163920|NCT02509117|20126167|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163921|NCT02509117|20126168|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163922|NCT02509117|20126169|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163923|NCT02509117|20126170|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163924|NCT02509117|20126171|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163925|NCT02509117|20126172|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163926|NCT02509117|20126163|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163927|NCT02509117|20126164|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163928|NCT02509117|20126165|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163929|NCT02509117|20126166|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163930|NCT02509117|20126167|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163931|NCT02509117|20126168|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163932|NCT02509117|20126169|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163933|NCT02509117|20126170|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163934|NCT02509117|20126171|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163935|NCT02509117|20126172|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163936|NCT02509117|20126163|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163937|NCT02509117|20126164|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163938|NCT02509117|20126165|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163939|NCT02509117|20126166|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163940|NCT02509117|20126167|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163941|NCT02509117|20126168|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163942|NCT02509117|20126169|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163943|NCT02509117|20126170|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163944|NCT02509117|20126171|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163945|NCT02509117|20126172|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163946|NCT02509117|20126163|P10|COMPLETED|Period 2 -Part A: 4 Days||0
8163947|NCT02509117|20126164|P9|COMPLETED|Period 2 -Part A: 4 Days||0
8163948|NCT02509117|20126165|P8|COMPLETED|Period 2 -Part A: 4 Days||0
8163949|NCT02509117|20126166|P7|COMPLETED|Period 2 -Part A: 4 Days||0
8163950|NCT02509117|20126167|P6|COMPLETED|Period 2 -Part A: 4 Days||0
8163951|NCT02509117|20126168|P5|COMPLETED|Period 2 -Part A: 4 Days||0
8163952|NCT02509117|20126169|P4|COMPLETED|Period 2 -Part A: 4 Days||2
8163953|NCT02509117|20126170|P3|COMPLETED|Period 2 -Part A: 4 Days||2
8163954|NCT02509117|20126171|P2|COMPLETED|Period 2 -Part A: 4 Days||2
8163955|NCT02509117|20126172|P1|COMPLETED|Period 2 -Part A: 4 Days||2
8163956|NCT02509117|20126163|P10|Treated|Period 2 -Part A: 4 Days||0
8163957|NCT02509117|20126164|P9|Treated|Period 2 -Part A: 4 Days||0
8163958|NCT02509117|20126165|P8|Treated|Period 2 -Part A: 4 Days||0
8163959|NCT02509117|20126166|P7|Treated|Period 2 -Part A: 4 Days||0
8163960|NCT02509117|20126167|P6|Treated|Period 2 -Part A: 4 Days||0
8163961|NCT02509117|20126168|P5|Treated|Period 2 -Part A: 4 Days||0
8163962|NCT02509117|20126169|P4|Treated|Period 2 -Part A: 4 Days||2
8163963|NCT02509117|20126170|P3|Treated|Period 2 -Part A: 4 Days||2
8163964|NCT02509117|20126171|P2|Treated|Period 2 -Part A: 4 Days||2
8163965|NCT02509117|20126172|P1|Treated|Period 2 -Part A: 4 Days||2
8163966|NCT02509117|20126163|P10|STARTED|Period 2 -Part A: 4 Days||0
8163967|NCT02509117|20126164|P9|STARTED|Period 2 -Part A: 4 Days||0
8163968|NCT02509117|20126165|P8|STARTED|Period 2 -Part A: 4 Days||0
8163969|NCT02509117|20126166|P7|STARTED|Period 2 -Part A: 4 Days||0
8163970|NCT02509117|20126167|P6|STARTED|Period 2 -Part A: 4 Days||0
8163971|NCT02509117|20126168|P5|STARTED|Period 2 -Part A: 4 Days||0
8163972|NCT02509117|20126169|P4|STARTED|Period 2 -Part A: 4 Days||2
8163973|NCT02509117|20126170|P3|STARTED|Period 2 -Part A: 4 Days||2
8163974|NCT02509117|20126171|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
8163975|NCT02509117|20126172|P1|STARTED|Period 2 -Part A: 4 Days||2
8163976|NCT02509117|20126163|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163977|NCT02509117|20126164|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163978|NCT02509117|20126165|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163979|NCT02509117|20126166|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163980|NCT02509117|20126167|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163981|NCT02509117|20126168|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163982|NCT02509117|20126169|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163983|NCT02509117|20126170|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163984|NCT02509117|20126171|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163985|NCT02509117|20126172|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163986|NCT02509117|20126163|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163987|NCT02509117|20126164|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163988|NCT02509117|20126165|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163989|NCT02509117|20126166|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163990|NCT02509117|20126167|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163991|NCT02509117|20126168|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163992|NCT02509117|20126169|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8163993|NCT02509117|20126170|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8163994|NCT02509117|20126171|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
8163995|NCT02509117|20126172|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8163996|NCT02509117|20126163|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
8163997|NCT02509117|20126164|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
8163998|NCT02509117|20126165|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
8163999|NCT02509117|20126166|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
8164000|NCT02509117|20126167|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
8164001|NCT02509117|20126168|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
8164002|NCT02509117|20126169|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
8164003|NCT02509117|20126170|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
8164004|NCT02509117|20126171|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
8164005|NCT02509117|20126172|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
8164006|NCT02509117|20126163|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164007|NCT02509117|20126164|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164008|NCT02509117|20126165|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164009|NCT02509117|20126166|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164010|NCT02509117|20126167|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164011|NCT02509117|20126168|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164012|NCT02509117|20126169|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164013|NCT02509117|20126170|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164014|NCT02509117|20126171|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
8164015|NCT02509117|20126172|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164016|NCT02509117|20126163|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164017|NCT02509117|20126164|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
8164018|NCT02509117|20126165|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164019|NCT02509117|20126166|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164020|NCT02509117|20126167|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164021|NCT02509117|20126168|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164022|NCT02509117|20126169|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164023|NCT02509117|20126170|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164024|NCT02509117|20126171|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
8164025|NCT02509117|20126172|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164026|NCT02509117|20126163|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
8164027|NCT02509117|20126164|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
8164028|NCT02509117|20126165|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164029|NCT02509117|20126166|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164030|NCT02509117|20126167|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164031|NCT02509117|20126168|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164032|NCT02509117|20126169|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164033|NCT02509117|20126170|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164034|NCT02509117|20126171|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
8164035|NCT02509117|20126172|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164036|NCT02509117|20126163|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
8164037|NCT02509117|20126164|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
8164038|NCT02509117|20126165|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164039|NCT02509117|20126166|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164040|NCT02509117|20126167|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164041|NCT02509117|20126168|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164042|NCT02509117|20126169|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164043|NCT02509117|20126170|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164044|NCT02509117|20126171|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164045|NCT02509117|20126172|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164046|NCT02509078|20126383|P2|NOT COMPLETED|Overall Study||1
8164047|NCT02509078|20126384|P1|NOT COMPLETED|Overall Study||1
8164048|NCT02509078|20126383|P2|COMPLETED|Overall Study||505
8164049|NCT02509078|20126384|P1|COMPLETED|Overall Study||501
8164050|NCT02509078|20126383|P2|STARTED|Overall Study||506
8164051|NCT02509078|20126384|P1|STARTED|Overall Study||502
8164052|NCT02509065|20126420|P23|NOT COMPLETED|Overall Study||0
8164053|NCT02509065|20126421|P22|NOT COMPLETED|Overall Study||0
8164054|NCT02509065|20126422|P21|NOT COMPLETED|Overall Study||0
8164055|NCT02509065|20126423|P20|NOT COMPLETED|Overall Study||0
8164056|NCT02509065|20126424|P19|NOT COMPLETED|Overall Study||0
8164057|NCT02509065|20126425|P18|NOT COMPLETED|Overall Study||0
8164058|NCT02509065|20126426|P17|NOT COMPLETED|Overall Study||0
8164059|NCT02509065|20126427|P16|NOT COMPLETED|Overall Study||0
8164060|NCT02509065|20126428|P15|NOT COMPLETED|Overall Study||0
8164061|NCT02509065|20126429|P14|NOT COMPLETED|Overall Study||0
8164062|NCT02509065|20126430|P13|NOT COMPLETED|Overall Study||0
8164063|NCT02509065|20126431|P12|NOT COMPLETED|Overall Study||0
8164064|NCT02509065|20126432|P11|NOT COMPLETED|Overall Study||0
8164065|NCT02509065|20126433|P10|NOT COMPLETED|Overall Study||0
8164066|NCT02509065|20126434|P9|NOT COMPLETED|Overall Study||0
8164067|NCT02509065|20126435|P8|NOT COMPLETED|Overall Study||0
8164068|NCT02509065|20126436|P7|NOT COMPLETED|Overall Study||0
8164069|NCT02509065|20126437|P6|NOT COMPLETED|Overall Study||0
8164070|NCT02509065|20126438|P5|NOT COMPLETED|Overall Study||0
8164071|NCT02509065|20126439|P4|NOT COMPLETED|Overall Study||0
8164072|NCT02509065|20126440|P3|NOT COMPLETED|Overall Study||0
8164073|NCT02509065|20126441|P2|NOT COMPLETED|Overall Study||0
8164074|NCT02509065|20126442|P1|NOT COMPLETED|Overall Study||0
8164075|NCT02509065|20126420|P23|COMPLETED|Overall Study||1
8164076|NCT02509065|20126421|P22|COMPLETED|Overall Study||1
8164077|NCT02509065|20126422|P21|COMPLETED|Overall Study||1
8164078|NCT02509065|20126423|P20|COMPLETED|Overall Study||1
8164079|NCT02509065|20126424|P19|COMPLETED|Overall Study||1
8164080|NCT02509065|20126425|P18|COMPLETED|Overall Study||1
8164081|NCT02509065|20126426|P17|COMPLETED|Overall Study||1
8164082|NCT02509065|20126427|P16|COMPLETED|Overall Study||1
8164083|NCT02509065|20126428|P15|COMPLETED|Overall Study||1
8164084|NCT02509065|20126429|P14|COMPLETED|Overall Study||1
8164085|NCT02509065|20126430|P13|COMPLETED|Overall Study||1
8164086|NCT02509065|20126431|P12|COMPLETED|Overall Study||1
8164087|NCT02509065|20126432|P11|COMPLETED|Overall Study||1
8164088|NCT02509065|20126433|P10|COMPLETED|Overall Study||1
8164089|NCT02509065|20126434|P9|COMPLETED|Overall Study||1
8164090|NCT02509065|20126435|P8|COMPLETED|Overall Study||1
8164091|NCT02509065|20126436|P7|COMPLETED|Overall Study||1
8164092|NCT02509065|20126437|P6|COMPLETED|Overall Study||1
8164093|NCT02509065|20126438|P5|COMPLETED|Overall Study||1
8164094|NCT02509065|20126439|P4|COMPLETED|Overall Study||1
8164095|NCT02509065|20126440|P3|COMPLETED|Overall Study||2
8164096|NCT02509065|20126441|P2|COMPLETED|Overall Study||1
8164097|NCT02509065|20126442|P1|COMPLETED|Overall Study||1
8164098|NCT02509065|20126420|P23|STARTED|Overall Study||1
8164099|NCT02509065|20126421|P22|STARTED|Overall Study||1
8164100|NCT02509065|20126422|P21|STARTED|Overall Study||1
8164101|NCT02509065|20126423|P20|STARTED|Overall Study||1
8164102|NCT02509065|20126424|P19|STARTED|Overall Study||1
8164103|NCT02509065|20126425|P18|STARTED|Overall Study||1
8164104|NCT02509065|20126426|P17|STARTED|Overall Study||1
8164105|NCT02509065|20126427|P16|STARTED|Overall Study||1
8164106|NCT02509065|20126428|P15|STARTED|Overall Study||1
8164107|NCT02509065|20126429|P14|STARTED|Overall Study||1
8164108|NCT02509065|20126430|P13|STARTED|Overall Study||1
8164109|NCT02509065|20126431|P12|STARTED|Overall Study||1
8164110|NCT02509065|20126432|P11|STARTED|Overall Study||1
8164111|NCT02509065|20126433|P10|STARTED|Overall Study||1
8164112|NCT02509065|20126434|P9|STARTED|Overall Study||1
8164113|NCT02509065|20126435|P8|STARTED|Overall Study||1
8164114|NCT02509065|20126436|P7|STARTED|Overall Study||1
8164115|NCT02509065|20126437|P6|STARTED|Overall Study||1
8164116|NCT02509065|20126438|P5|STARTED|Overall Study||1
8164117|NCT02509065|20126439|P4|STARTED|Overall Study||1
8164118|NCT02509065|20126440|P3|STARTED|Overall Study||2
8164119|NCT02509065|20126441|P2|STARTED|Overall Study||1
8164120|NCT02509065|20126442|P1|STARTED|Overall Study||1
8164121|NCT02509026|20126527|P1|NOT COMPLETED|Retreatment Period (12 Weeks)||4
8164122|NCT02509026|20126527|P1|COMPLETED|Retreatment Period (12 Weeks)||84
8164123|NCT02509026|20126527|P1|Treated|Retreatment Period (12 Weeks)||87
8164124|NCT02509026|20126527|P1|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
8164125|NCT02509026|20126527|P1|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
8164126|NCT02509026|20126527|P1|COMPLETED|Withdrawal Period (40 Weeks)||112
8164127|NCT02509026|20126527|P1|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
8164128|NCT02509026|20126527|P1|NOT COMPLETED|Induction Period (24 Weeks)||22
8164129|NCT02509026|20126527|P1|COMPLETED|Induction Period (24 Weeks)||188
8164130|NCT02509026|20126527|P1|Treated|Induction Period (24 Weeks)||209
8164131|NCT02509026|20126527|P1|STARTED|Induction Period (24 Weeks)||210
8164132|NCT02508935|20126724|P1|NOT COMPLETED|Overall Study||23
8164133|NCT02508935|20126724|P1|COMPLETED|Overall Study||0
8164134|NCT02508935|20126724|P1|STARTED|Overall Study||23
8164135|NCT02508701|20126740|P4|NOT COMPLETED|Overall Study||3
8164136|NCT02508701|20126741|P3|NOT COMPLETED|Overall Study||5
8164137|NCT02508701|20126742|P2|NOT COMPLETED|Overall Study||5
8164138|NCT02508701|20126743|P1|NOT COMPLETED|Overall Study||9
8164139|NCT02508701|20126740|P4|COMPLETED|Overall Study||1
8164140|NCT02508701|20126741|P3|COMPLETED|Overall Study||0
8164141|NCT02508701|20126742|P2|COMPLETED|Overall Study||1
8164142|NCT02508701|20126743|P1|COMPLETED|Overall Study||0
8164143|NCT02508701|20126740|P4|STARTED|Overall Study||4
8164144|NCT02508701|20126741|P3|STARTED|Overall Study||5
8164145|NCT02508701|20126742|P2|STARTED|Overall Study||6
8164146|NCT02508701|20126743|P1|STARTED|Overall Study||9
8164147|NCT02508480|20126767|P2|NOT COMPLETED|Overall Study||4
8164148|NCT02508480|20126768|P1|NOT COMPLETED|Overall Study||5
8164149|NCT02508480|20126767|P2|COMPLETED|Overall Study||93
8164150|NCT02508480|20126768|P1|COMPLETED|Overall Study||90
8164151|NCT02508480|20126767|P2|Six-Month Follow-Up|Overall Study||86
8164152|NCT02508480|20126768|P1|Six-Month Follow-Up|Overall Study||84
8164153|NCT02508480|20126767|P2|Three Month Follow-up|Overall Study||86
8164154|NCT02508480|20126768|P1|Three Month Follow-up|Overall Study||84
8164155|NCT02508480|20126767|P2|Post-Treatment Assessment|Overall Study||89
8164156|NCT02508480|20126768|P1|Post-Treatment Assessment|Overall Study||87
8164157|NCT02508480|20126767|P2|STARTED|Overall Study||97
8164158|NCT02508480|20126768|P1|STARTED|Overall Study||95
8164159|NCT02508428|20126792|P2|NOT COMPLETED|Overall Study||67
8164160|NCT02508428|20126793|P1|NOT COMPLETED|Overall Study||52
8164161|NCT02508428|20126792|P2|COMPLETED|Overall Study||44
8164162|NCT02508428|20126793|P1|COMPLETED|Overall Study||62
8164163|NCT02508428|20126792|P2|STARTED|Overall Study||111
8164164|NCT02508428|20126793|P1|STARTED|Overall Study||114
8164165|NCT02508259|20126809|P2|NOT COMPLETED|Overall Study||0
8164166|NCT02508259|20126810|P1|NOT COMPLETED|Overall Study||0
8164167|NCT02508259|20126809|P2|COMPLETED|Overall Study||5
8164168|NCT02508259|20126810|P1|COMPLETED|Overall Study||5
8164169|NCT02508259|20126809|P2|STARTED|Overall Study||5
8164170|NCT02508259|20126810|P1|STARTED|Overall Study||5
8164171|NCT02508207|20126828|P2|NOT COMPLETED|Overall Study||0
8164172|NCT02508207|20126829|P1|NOT COMPLETED|Overall Study||0
8164173|NCT02508207|20126828|P2|COMPLETED|Overall Study||27
8164174|NCT02508207|20126829|P1|COMPLETED|Overall Study||7
8164175|NCT02508207|20126828|P2|STARTED|Overall Study||27
8164176|NCT02508207|20126829|P1|STARTED|Overall Study||7
8164177|NCT02508194|20126845|P2|NOT COMPLETED|Overall Study||44
8164178|NCT02508194|20126846|P1|NOT COMPLETED|Overall Study||52
8164179|NCT02508194|20126845|P2|COMPLETED|Overall Study||907
8164180|NCT02508194|20126846|P1|COMPLETED|Overall Study||897
8164181|NCT02508194|20126845|P2|STARTED|Overall Study||951
8164182|NCT02508194|20126846|P1|STARTED|Overall Study||949
8164183|NCT02508116|20126886|P2|NOT COMPLETED|Overall Study||7
8164184|NCT02508116|20126887|P1|NOT COMPLETED|Overall Study||8
8164185|NCT02508116|20126886|P2|COMPLETED|Overall Study||250
8164186|NCT02508116|20126887|P1|COMPLETED|Overall Study||244
8164187|NCT02508116|20126886|P2|Received Intervention as Randomized|Overall Study||255
8164188|NCT02508116|20126887|P1|Received Intervention as Randomized|Overall Study||249
8164189|NCT02508116|20126886|P2|STARTED|Overall Study||257
8164190|NCT02508116|20126887|P1|STARTED|Overall Study||252
8164191|NCT02508103|20126901|P2|NOT COMPLETED|Overall Study||0
8164192|NCT02508103|20126902|P1|NOT COMPLETED|Overall Study||0
8164193|NCT02508103|20126901|P2|COMPLETED|Overall Study||5
8164194|NCT02508103|20126902|P1|COMPLETED|Overall Study||5
8164195|NCT02508103|20126901|P2|STARTED|Overall Study||5
8164196|NCT02508103|20126902|P1|STARTED|Overall Study||5
8164197|NCT02508077|20126910|P1|NOT COMPLETED|Overall Study||0
8164198|NCT02508077|20126910|P1|COMPLETED|Overall Study||1
8164199|NCT02508077|20126910|P1|STARTED|Overall Study||1
8164200|NCT02507973|20126914|P1|NOT COMPLETED|Overall Study||1
8164201|NCT02507973|20126914|P1|COMPLETED|Overall Study||7
8164202|NCT02507973|20126914|P1|STARTED|Overall Study||8
8164203|NCT02507752|20126920|P1|NOT COMPLETED|Overall Study||17
8164204|NCT02507752|20126920|P1|COMPLETED|Overall Study||55
8164205|NCT02507752|20126920|P1|STARTED|Overall Study||72
8164206|NCT02507388|20126940|P2|NOT COMPLETED|Overall Study||0
8164207|NCT02507388|20126941|P1|NOT COMPLETED|Overall Study||0
8164208|NCT02507388|20126940|P2|COMPLETED|Overall Study||25
8164209|NCT02507388|20126941|P1|COMPLETED|Overall Study||25
8164210|NCT02507388|20126940|P2|STARTED|Overall Study||25
8164211|NCT02507388|20126941|P1|STARTED|Overall Study||25
8164212|NCT02507375|20126964|P2|NOT COMPLETED|Overall Study||8
8164213|NCT02507375|20126965|P1|NOT COMPLETED|Overall Study||4
8164214|NCT02507375|20126964|P2|COMPLETED|Overall Study||1
8164215|NCT02507375|20126965|P1|COMPLETED|Overall Study||2
8164216|NCT02507375|20126964|P2|Extension Period|Overall Study||1
8164217|NCT02507375|20126965|P1|Extension Period|Overall Study||2
8164218|NCT02507375|20126964|P2|Cycle 6|Overall Study||1
8164219|NCT02507375|20126965|P1|Cycle 6|Overall Study||3
8164220|NCT02507375|20126964|P2|Cycle 5|Overall Study||1
8164221|NCT02507375|20126965|P1|Cycle 5|Overall Study||3
8164222|NCT02507375|20126964|P2|Cycle 4|Overall Study||2
8164223|NCT02507375|20126965|P1|Cycle 4|Overall Study||4
8164224|NCT02507375|20126964|P2|Cycle 3|Overall Study||5
8164225|NCT02507375|20126965|P1|Cycle 3|Overall Study||4
8164226|NCT02507375|20126964|P2|Cycle 2|Overall Study||5
8164227|NCT02507375|20126965|P1|Cycle 2|Overall Study||5
8164228|NCT02507375|20126964|P2|Received Pertuzumab|Overall Study||6
8164229|NCT02507375|20126965|P1|Received Pertuzumab|Overall Study||6
8164230|NCT02507375|20126964|P2|Cycle 1|Overall Study||9
8164231|NCT02507375|20126965|P1|Cycle 1|Overall Study||6
8164232|NCT02507375|20126964|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
8164233|NCT02507375|20126965|P1|STARTED|Overall Study||6
8164234|NCT02507349|20126984|P2|NOT COMPLETED|Overall Study||161
8164235|NCT02507349|20126985|P1|NOT COMPLETED|Overall Study||187
8164236|NCT02507349|20126984|P2|COMPLETED|Overall Study||1050
8164237|NCT02507349|20126985|P1|COMPLETED|Overall Study||1045
8164238|NCT02507349|20126984|P2|STARTED|Overall Study||1211
8164239|NCT02507349|20126985|P1|STARTED|Overall Study||1232
8164240|NCT02507219|20127009|P6|NOT COMPLETED|Overall Study||0
8164241|NCT02507219|20127010|P5|NOT COMPLETED|Overall Study||1
8164242|NCT02507219|20127011|P4|NOT COMPLETED|Overall Study||0
8164243|NCT02507219|20127012|P3|NOT COMPLETED|Overall Study||0
8164244|NCT02507219|20127013|P2|NOT COMPLETED|Overall Study||0
8164245|NCT02507219|20127014|P1|NOT COMPLETED|Overall Study||1
8164246|NCT02507219|20127009|P6|COMPLETED|Overall Study||3
8164247|NCT02507219|20127010|P5|COMPLETED|Overall Study||3
8164248|NCT02507219|20127011|P4|COMPLETED|Overall Study||3
8164249|NCT02507219|20127012|P3|COMPLETED|Overall Study||3
8164250|NCT02507219|20127013|P2|COMPLETED|Overall Study||4
8164251|NCT02507219|20127014|P1|COMPLETED|Overall Study||4
8164252|NCT02507219|20127009|P6|STARTED|Overall Study||3
8164253|NCT02507219|20127010|P5|STARTED|Overall Study||4
8164254|NCT02507219|20127011|P4|STARTED|Overall Study||3
8164255|NCT02507219|20127012|P3|STARTED|Overall Study||3
8164256|NCT02507219|20127013|P2|STARTED|Overall Study||4
8164257|NCT02507219|20127014|P1|STARTED|Overall Study||5
8164258|NCT02507011|20127022|P2|NOT COMPLETED|Second Intervention||0
8164259|NCT02507011|20127023|P1|NOT COMPLETED|Second Intervention||0
8164260|NCT02507011|20127022|P2|COMPLETED|Second Intervention||1
8164261|NCT02507011|20127023|P1|COMPLETED|Second Intervention||1
8164262|NCT02507011|20127022|P2|STARTED|Second Intervention||1
8164263|NCT02507011|20127023|P1|STARTED|Second Intervention||1
8164264|NCT02507011|20127022|P2|NOT COMPLETED|First Intervention||0
8164265|NCT02507011|20127023|P1|NOT COMPLETED|First Intervention||0
8164266|NCT02507011|20127022|P2|COMPLETED|First Intervention||1
8164267|NCT02507011|20127023|P1|COMPLETED|First Intervention||1
8164268|NCT02507011|20127022|P2|STARTED|First Intervention||1
8164269|NCT02507011|20127023|P1|STARTED|First Intervention||1
8164270|NCT02506985|20127031|P2|NOT COMPLETED|Overall Study||0
8164271|NCT02506985|20127032|P1|NOT COMPLETED|Overall Study||0
8164272|NCT02506985|20127031|P2|COMPLETED|Overall Study||6
8164273|NCT02506985|20127032|P1|COMPLETED|Overall Study||4
8164274|NCT02506985|20127031|P2|STARTED|Overall Study||6
8164275|NCT02506985|20127032|P1|STARTED|Overall Study||4
8164276|NCT02506881|20127050|P4|NOT COMPLETED|Second Intervention (Day 1)||0
8164277|NCT02506881|20127051|P3|NOT COMPLETED|Second Intervention (Day 1)||0
8164278|NCT02506881|20127052|P2|NOT COMPLETED|Second Intervention (Day 1)||0
8164279|NCT02506881|20127053|P1|NOT COMPLETED|Second Intervention (Day 1)||0
8164280|NCT02506881|20127050|P4|COMPLETED|Second Intervention (Day 1)||12
8164281|NCT02506881|20127051|P3|COMPLETED|Second Intervention (Day 1)||12
8164282|NCT02506881|20127052|P2|COMPLETED|Second Intervention (Day 1)||12
8164283|NCT02506881|20127053|P1|COMPLETED|Second Intervention (Day 1)||12
8164284|NCT02506881|20127050|P4|STARTED|Second Intervention (Day 1)||12
8164285|NCT02506881|20127051|P3|STARTED|Second Intervention (Day 1)||12
8164286|NCT02506881|20127052|P2|STARTED|Second Intervention (Day 1)||12
8164287|NCT02506881|20127053|P1|STARTED|Second Intervention (Day 1)||12
8164288|NCT02506881|20127050|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
8164289|NCT02506881|20127051|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
8164290|NCT02506881|20127052|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
8164291|NCT02506881|20127053|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
8164292|NCT02506881|20127050|P4|COMPLETED|Washout (at Least 25 Days)||12
8164293|NCT02506881|20127051|P3|COMPLETED|Washout (at Least 25 Days)||12
8164294|NCT02506881|20127052|P2|COMPLETED|Washout (at Least 25 Days)||12
8164295|NCT02506881|20127053|P1|COMPLETED|Washout (at Least 25 Days)||12
8164296|NCT02506881|20127050|P4|STARTED|Washout (at Least 25 Days)||12
8164297|NCT02506881|20127051|P3|STARTED|Washout (at Least 25 Days)||12
8164298|NCT02506881|20127052|P2|STARTED|Washout (at Least 25 Days)||12
8164299|NCT02506881|20127053|P1|STARTED|Washout (at Least 25 Days)||12
8164300|NCT02506881|20127050|P4|NOT COMPLETED|First Intervention (Day 1)||12
8164301|NCT02506881|20127051|P3|NOT COMPLETED|First Intervention (Day 1)||13
8164302|NCT02506881|20127052|P2|NOT COMPLETED|First Intervention (Day 1)||0
8164303|NCT02506881|20127053|P1|NOT COMPLETED|First Intervention (Day 1)||1
8164304|NCT02506881|20127050|P4|COMPLETED|First Intervention (Day 1)||12
8164305|NCT02506881|20127051|P3|COMPLETED|First Intervention (Day 1)||12
8164306|NCT02506881|20127052|P2|COMPLETED|First Intervention (Day 1)||12
8164307|NCT02506881|20127053|P1|COMPLETED|First Intervention (Day 1)||12
8164308|NCT02506881|20127050|P4|STARTED|First Intervention (Day 1)||24
8164309|NCT02506881|20127051|P3|STARTED|First Intervention (Day 1)||25
8164310|NCT02506881|20127052|P2|STARTED|First Intervention (Day 1)||12
8164311|NCT02506881|20127053|P1|STARTED|First Intervention (Day 1)||13
8164312|NCT02506868|20127089|P2|NOT COMPLETED|Additional Period of Study (Until 52W)||5
8164313|NCT02506868|20127090|P1|NOT COMPLETED|Additional Period of Study (Until 52W)||3
8164314|NCT02506868|20127089|P2|COMPLETED|Additional Period of Study (Until 52W)||85
8164315|NCT02506868|20127090|P1|COMPLETED|Additional Period of Study (Until 52W)||83
8164316|NCT02506868|20127089|P2|STARTED|Additional Period of Study (Until 52W)||90
8164317|NCT02506868|20127090|P1|STARTED|Additional Period of Study (Until 52W)||86
8164318|NCT02506868|20127089|P2|NOT COMPLETED|Main Period of Study (24 Weeks)||8
8164319|NCT02506868|20127090|P1|NOT COMPLETED|Main Period of Study (24 Weeks)||12
8164320|NCT02506868|20127089|P2|COMPLETED|Main Period of Study (24 Weeks)||90
8164321|NCT02506868|20127090|P1|COMPLETED|Main Period of Study (24 Weeks)||86
8164322|NCT02506868|20127089|P2|Per Protocol Population|Main Period of Study (24 Weeks)||90
8164323|NCT02506868|20127090|P1|Per Protocol Population|Main Period of Study (24 Weeks)||86
8164324|NCT02506868|20127089|P2|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
8164325|NCT02506868|20127090|P1|mITT Population|Main Period of Study (24 Weeks)||98
8164326|NCT02506868|20127089|P2|STARTED|Main Period of Study (24 Weeks)||98
8164327|NCT02506868|20127090|P1|STARTED|Main Period of Study (24 Weeks)||98
8164328|NCT02506816|20127126|P1|NOT COMPLETED|Overall Study||3
8164329|NCT02506816|20127126|P1|COMPLETED|Overall Study||33
8164330|NCT02506816|20127126|P1|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
8164331|NCT02506816|20127126|P1|STARTED|Overall Study||36
8164332|NCT02506673|20127135|P2|NOT COMPLETED|Overall Study||0
8164333|NCT02506673|20127136|P1|NOT COMPLETED|Overall Study||0
8164334|NCT02506673|20127135|P2|COMPLETED|Overall Study||13
8164335|NCT02506673|20127136|P1|COMPLETED|Overall Study||13
8164336|NCT02506673|20127135|P2|STARTED|Overall Study||13
8164337|NCT02506673|20127136|P1|STARTED|Overall Study||13
8164338|NCT02506660|20127168|P2|NOT COMPLETED|Overall Study||1
8164339|NCT02506660|20127169|P1|NOT COMPLETED|Overall Study||2
8164340|NCT02506660|20127168|P2|COMPLETED|Overall Study||63
8164341|NCT02506660|20127169|P1|COMPLETED|Overall Study||62
8164342|NCT02506660|20127168|P2|STARTED|Overall Study||64
8164343|NCT02506660|20127169|P1|STARTED|Overall Study||64
8164344|NCT02506634|20127195|P1|NOT COMPLETED|Overall Study||17
8164345|NCT02506634|20127195|P1|COMPLETED|Overall Study||357
8164346|NCT02506634|20127195|P1|Participants Who Finished GERDQ|Overall Study||342
8164347|NCT02506634|20127195|P1|Participants Who Received PPI Treatment|Overall Study||357
8164348|NCT02506634|20127195|P1|Participants Who Were Diagnosed as GERD|Overall Study||154
8164349|NCT02506634|20127195|P1|STARTED|Overall Study||374
8164350|NCT02506309|20127235|P2|NOT COMPLETED|Overall Study||20
8164351|NCT02506309|20127236|P1|NOT COMPLETED|Overall Study||18
8164352|NCT02506309|20127235|P2|COMPLETED|Overall Study||64
8164353|NCT02506309|20127236|P1|COMPLETED|Overall Study||66
8164354|NCT02506309|20127235|P2|STARTED|Overall Study||84
8164355|NCT02506309|20127236|P1|STARTED|Overall Study||84
8164356|NCT02506257|20127252|P4|NOT COMPLETED|Overall Study||0
8164357|NCT02506257|20127253|P3|NOT COMPLETED|Overall Study||4
8164358|NCT02506257|20127254|P2|NOT COMPLETED|Overall Study||2
8164359|NCT02506257|20127255|P1|NOT COMPLETED|Overall Study||0
8164360|NCT02506257|20127252|P4|COMPLETED|Overall Study||9
8164361|NCT02506257|20127253|P3|COMPLETED|Overall Study||23
8164362|NCT02506257|20127254|P2|COMPLETED|Overall Study||26
8164363|NCT02506257|20127255|P1|COMPLETED|Overall Study||26
8164364|NCT02506257|20127252|P4|STARTED|Overall Study||9
8164365|NCT02506257|20127253|P3|STARTED|Overall Study||27
8164366|NCT02506257|20127254|P2|STARTED|Overall Study||28
8164367|NCT02506257|20127255|P1|STARTED|Overall Study||26
8164368|NCT02506101|20127287|P2|NOT COMPLETED|Overall Study||0
8164369|NCT02506101|20127288|P1|NOT COMPLETED|Overall Study||2
8164370|NCT02506101|20127287|P2|COMPLETED|Overall Study||0
8164371|NCT02506101|20127288|P1|COMPLETED|Overall Study||0
8164372|NCT02506101|20127287|P2|STARTED|Overall Study||0
8164373|NCT02506101|20127288|P1|STARTED|Overall Study||2
8164374|NCT02506036|20127304|P2|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
8164375|NCT02506036|20127305|P1|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
8164376|NCT02506036|20127304|P2|COMPLETED|Second Intervention (4-6 Weeks)||1
8164377|NCT02506036|20127305|P1|COMPLETED|Second Intervention (4-6 Weeks)||2
8164378|NCT02506036|20127304|P2|STARTED|Second Intervention (4-6 Weeks)||1
8164379|NCT02506036|20127305|P1|STARTED|Second Intervention (4-6 Weeks)||2
8164380|NCT02506036|20127304|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
8164381|NCT02506036|20127305|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
8164382|NCT02506036|20127304|P2|COMPLETED|Washout (1-2 Weeks)||1
8164383|NCT02506036|20127305|P1|COMPLETED|Washout (1-2 Weeks)||2
8164384|NCT02506036|20127304|P2|STARTED|Washout (1-2 Weeks)||1
8164385|NCT02506036|20127305|P1|STARTED|Washout (1-2 Weeks)||2
8164386|NCT02506036|20127304|P2|NOT COMPLETED|First Intervention (4-6 Weeks)||2
8164387|NCT02506036|20127305|P1|NOT COMPLETED|First Intervention (4-6 Weeks)||1
8164388|NCT02506036|20127304|P2|COMPLETED|First Intervention (4-6 Weeks)||1
8164389|NCT02506036|20127305|P1|COMPLETED|First Intervention (4-6 Weeks)||2
8164390|NCT02506036|20127304|P2|STARTED|First Intervention (4-6 Weeks)||3
8164391|NCT02506036|20127305|P1|STARTED|First Intervention (4-6 Weeks)||3
8164392|NCT02505945|20127313|P2|NOT COMPLETED|Overall Study||4
8164393|NCT02505945|20127314|P1|NOT COMPLETED|Overall Study||22
8164394|NCT02505945|20127313|P2|COMPLETED|Overall Study||46
8164395|NCT02505945|20127314|P1|COMPLETED|Overall Study||80
8164396|NCT02505945|20127313|P2|STARTED|Overall Study||50
8164397|NCT02505945|20127314|P1|STARTED|Overall Study||102
8164398|NCT02505919|20127324|P2|NOT COMPLETED|36 Months Follow-Up||5
8164399|NCT02505919|20127325|P1|NOT COMPLETED|36 Months Follow-Up||15
8164400|NCT02505919|20127324|P2|COMPLETED|36 Months Follow-Up||55
8164401|NCT02505919|20127325|P1|COMPLETED|36 Months Follow-Up||97
8164402|NCT02505919|20127324|P2|STARTED|36 Months Follow-Up||60
8164403|NCT02505919|20127325|P1|STARTED|36 Months Follow-Up||112
8164404|NCT02505919|20127324|P2|NOT COMPLETED|24 Months Follow-Up||1
8164405|NCT02505919|20127325|P1|NOT COMPLETED|24 Months Follow-Up||3
8164406|NCT02505919|20127324|P2|COMPLETED|24 Months Follow-Up||60
8164407|NCT02505919|20127325|P1|COMPLETED|24 Months Follow-Up||112
8164408|NCT02505919|20127324|P2|STARTED|24 Months Follow-Up||61
8164409|NCT02505919|20127325|P1|STARTED|24 Months Follow-Up||115
8164410|NCT02505919|20127324|P2|NOT COMPLETED|12 Months Follow-Up||2
8164411|NCT02505919|20127325|P1|NOT COMPLETED|12 Months Follow-Up||1
8164412|NCT02505919|20127324|P2|COMPLETED|12 Months Follow-Up||61
8164413|NCT02505919|20127325|P1|COMPLETED|12 Months Follow-Up||115
8164414|NCT02505919|20127324|P2|STARTED|12 Months Follow-Up||63
8164415|NCT02505919|20127325|P1|STARTED|12 Months Follow-Up||116
8164416|NCT02505919|20127324|P2|NOT COMPLETED|6 Months Follow-Up||2
8164417|NCT02505919|20127325|P1|NOT COMPLETED|6 Months Follow-Up||0
8164418|NCT02505919|20127324|P2|COMPLETED|6 Months Follow-Up||63
8164419|NCT02505919|20127325|P1|COMPLETED|6 Months Follow-Up||116
8164420|NCT02505919|20127324|P2|STARTED|6 Months Follow-Up||65
8164421|NCT02505919|20127325|P1|STARTED|6 Months Follow-Up||116
8164422|NCT02505919|20127324|P2|NOT COMPLETED|3 Months Follow-Up||0
8164423|NCT02505919|20127325|P1|NOT COMPLETED|3 Months Follow-Up||0
8164424|NCT02505919|20127324|P2|COMPLETED|3 Months Follow-Up||65
8164425|NCT02505919|20127325|P1|COMPLETED|3 Months Follow-Up||116
8164426|NCT02505919|20127324|P2|STARTED|3 Months Follow-Up||65
8164427|NCT02505919|20127325|P1|STARTED|3 Months Follow-Up||116
8164428|NCT02505919|20127324|P2|NOT COMPLETED|1 Month Follow-Up||0
8164429|NCT02505919|20127325|P1|NOT COMPLETED|1 Month Follow-Up||0
8164430|NCT02505919|20127324|P2|COMPLETED|1 Month Follow-Up||65
8164431|NCT02505919|20127325|P1|COMPLETED|1 Month Follow-Up||116
8164432|NCT02505919|20127324|P2|STARTED|1 Month Follow-Up||65
8164433|NCT02505919|20127325|P1|STARTED|1 Month Follow-Up||116
8164434|NCT02505919|20127324|P2|NOT COMPLETED|1 Week Follow-Up||0
8164435|NCT02505919|20127325|P1|NOT COMPLETED|1 Week Follow-Up||0
8164436|NCT02505919|20127324|P2|COMPLETED|1 Week Follow-Up||65
8164437|NCT02505919|20127325|P1|COMPLETED|1 Week Follow-Up||116
8164438|NCT02505919|20127324|P2|STARTED|1 Week Follow-Up||65
8164439|NCT02505919|20127325|P1|STARTED|1 Week Follow-Up||116
8164440|NCT02505919|20127324|P2|NOT COMPLETED|Treatment||2
8164441|NCT02505919|20127325|P1|NOT COMPLETED|Treatment||1
8164442|NCT02505919|20127324|P2|COMPLETED|Treatment||65
8164443|NCT02505919|20127325|P1|COMPLETED|Treatment||116
8164444|NCT02505919|20127324|P2|STARTED|Treatment||67
8164445|NCT02505919|20127325|P1|STARTED|Treatment||117
8164446|NCT02505867|20127335|P2|NOT COMPLETED|Overall Study||6
8164447|NCT02505867|20127336|P1|NOT COMPLETED|Overall Study||6
8164448|NCT02505867|20127335|P2|COMPLETED|Overall Study||0
8164449|NCT02505867|20127336|P1|COMPLETED|Overall Study||0
8164450|NCT02505867|20127335|P2|STARTED|Overall Study||6
8164451|NCT02505867|20127336|P1|STARTED|Overall Study||6
8164452|NCT02505542|20127342|P4|NOT COMPLETED|Part B: Double-Blind Period||7
8164453|NCT02505542|20127343|P3|NOT COMPLETED|Part B: Double-Blind Period||9
8164454|NCT02505542|20127344|P2|NOT COMPLETED|Part B: Double-Blind Period||12
8164455|NCT02505542|20127345|P1|NOT COMPLETED|Part B: Double-Blind Period||0
8164456|NCT02505542|20127342|P4|COMPLETED|Part B: Double-Blind Period||98
8164457|NCT02505542|20127343|P3|COMPLETED|Part B: Double-Blind Period||95
8164458|NCT02505542|20127344|P2|COMPLETED|Part B: Double-Blind Period||92
8164459|NCT02505542|20127345|P1|COMPLETED|Part B: Double-Blind Period||0
8164460|NCT02505542|20127342|P4|Started Escape Period|Part B: Double-Blind Period||15
8164461|NCT02505542|20127343|P3|Started Escape Period|Part B: Double-Blind Period||7
8164462|NCT02505542|20127344|P2|Started Escape Period|Part B: Double-Blind Period||73
8164463|NCT02505542|20127345|P1|Started Escape Period|Part B: Double-Blind Period||0
8164464|NCT02505542|20127342|P4|STARTED|Part B: Double-Blind Period||105
8164465|NCT02505542|20127343|P3|STARTED|Part B: Double-Blind Period||104
8164466|NCT02505542|20127344|P2|STARTED|Part B: Double-Blind Period||104
8164467|NCT02505542|20127345|P1|STARTED|Part B: Double-Blind Period||0
8164468|NCT02505542|20127342|P4|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8164469|NCT02505542|20127343|P3|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8164470|NCT02505542|20127344|P2|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8164471|NCT02505542|20127345|P1|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
8164472|NCT02505542|20127342|P4|COMPLETED|Completed Part A, Did Not Enter Part B||0
8164473|NCT02505542|20127343|P3|COMPLETED|Completed Part A, Did Not Enter Part B||0
8164474|NCT02505542|20127344|P2|COMPLETED|Completed Part A, Did Not Enter Part B||0
8164475|NCT02505542|20127345|P1|COMPLETED|Completed Part A, Did Not Enter Part B||313
8164476|NCT02505542|20127342|P4|STARTED|Completed Part A, Did Not Enter Part B||0
8164477|NCT02505542|20127343|P3|STARTED|Completed Part A, Did Not Enter Part B||0
8164478|NCT02505542|20127344|P2|STARTED|Completed Part A, Did Not Enter Part B||0
8164479|NCT02505542|20127345|P1|STARTED|Completed Part A, Did Not Enter Part B||659
8164480|NCT02505542|20127342|P4|NOT COMPLETED|Part A: Open-Label Period||0
8164481|NCT02505542|20127343|P3|NOT COMPLETED|Part A: Open-Label Period||0
8164482|NCT02505542|20127344|P2|NOT COMPLETED|Part A: Open-Label Period||0
8164483|NCT02505542|20127345|P1|NOT COMPLETED|Part A: Open-Label Period||77
8164484|NCT02505542|20127342|P4|COMPLETED|Part A: Open-Label Period||0
8164485|NCT02505542|20127343|P3|COMPLETED|Part A: Open-Label Period||0
8164486|NCT02505542|20127344|P2|COMPLETED|Part A: Open-Label Period||0
8164487|NCT02505542|20127345|P1|COMPLETED|Part A: Open-Label Period||659
8164488|NCT02505542|20127342|P4|STARTED|Part A: Open-Label Period||0
8164489|NCT02505542|20127343|P3|STARTED|Part A: Open-Label Period||0
8164490|NCT02505542|20127344|P2|STARTED|Part A: Open-Label Period||0
8164491|NCT02505542|20127345|P1|STARTED|Part A: Open-Label Period||736
8164492|NCT02505334|20127453|P2|NOT COMPLETED|Extension Treatment Period||0
8164493|NCT02505334|20127454|P1|NOT COMPLETED|Extension Treatment Period||18
8164494|NCT02505334|20127453|P2|COMPLETED|Extension Treatment Period||0
8164495|NCT02505334|20127454|P1|COMPLETED|Extension Treatment Period||194
8164496|NCT02505334|20127453|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
8164497|NCT02505334|20127454|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
8164498|NCT02505334|20127453|P2|NOT COMPLETED|Main Treatment Period||39
8164499|NCT02505334|20127454|P1|NOT COMPLETED|Main Treatment Period||15
8164500|NCT02505334|20127453|P2|COMPLETED|Main Treatment Period||194
8164501|NCT02505334|20127454|P1|COMPLETED|Main Treatment Period||218
8164502|NCT02505334|20127453|P2|STARTED|Main Treatment Period||233
8164503|NCT02505334|20127454|P1|STARTED|Main Treatment Period||233
8164504|NCT02505269|20127579|P1|NOT COMPLETED|Overall Study||0
8164505|NCT02505269|20127579|P1|COMPLETED|Overall Study||34
8164506|NCT02505269|20127579|P1|STARTED|Overall Study||34
8164507|NCT02505217|20127587|P2|NOT COMPLETED|Overall Study||2
8164508|NCT02505217|20127588|P1|NOT COMPLETED|Overall Study||1
8164509|NCT02505217|20127587|P2|COMPLETED|Overall Study||93
8164510|NCT02505217|20127588|P1|COMPLETED|Overall Study||104
8164511|NCT02505217|20127587|P2|STARTED|Overall Study||95
8164512|NCT02505217|20127588|P1|STARTED|Overall Study||105
8164513|NCT02504931|20127598|P2|NOT COMPLETED|Overall Study||10
8164514|NCT02504931|20127599|P1|NOT COMPLETED|Overall Study||12
8164515|NCT02504931|20127598|P2|COMPLETED|Overall Study||13
8164516|NCT02504931|20127599|P1|COMPLETED|Overall Study||14
8164517|NCT02504931|20127598|P2|STARTED|Overall Study||23
8164518|NCT02504931|20127599|P1|STARTED|Overall Study||26
8164519|NCT02504892|20127607|P1|NOT COMPLETED|Overall Study||2
8164520|NCT02504892|20127607|P1|COMPLETED|Overall Study||1
8164521|NCT02504892|20127607|P1|STARTED|Overall Study||3
8164522|NCT02504827|20127614|P1|NOT COMPLETED|Overall Study||1
8164523|NCT02504827|20127614|P1|COMPLETED|Overall Study||11
8164524|NCT02504827|20127614|P1|STARTED|Overall Study||12
8164525|NCT02504775|20127619|P2|NOT COMPLETED|Period 2||0
8164526|NCT02504775|20127620|P1|NOT COMPLETED|Period 2||0
8164527|NCT02504775|20127619|P2|COMPLETED|Period 2||14
8164528|NCT02504775|20127620|P1|COMPLETED|Period 2||14
8164529|NCT02504775|20127619|P2|STARTED|Period 2||14
8164530|NCT02504775|20127620|P1|STARTED|Period 2||14
8164531|NCT02504775|20127619|P2|NOT COMPLETED|Washout||0
8164532|NCT02504775|20127620|P1|NOT COMPLETED|Washout||0
8164533|NCT02504775|20127619|P2|COMPLETED|Washout||14
8164534|NCT02504775|20127620|P1|COMPLETED|Washout||14
8164535|NCT02504775|20127619|P2|STARTED|Washout||14
8164536|NCT02504775|20127620|P1|STARTED|Washout||14
8164537|NCT02504775|20127619|P2|NOT COMPLETED|Period 1||0
8164538|NCT02504775|20127620|P1|NOT COMPLETED|Period 1||0
8164539|NCT02504775|20127619|P2|COMPLETED|Period 1||14
8164540|NCT02504775|20127620|P1|COMPLETED|Period 1||14
8164541|NCT02504775|20127619|P2|STARTED|Period 1||14
8164542|NCT02504775|20127620|P1|STARTED|Period 1||14
8164543|NCT02504723|20127634|P2|NOT COMPLETED|Overall Study||0
8164544|NCT02504723|20127635|P1|NOT COMPLETED|Overall Study||0
8164545|NCT02504723|20127634|P2|COMPLETED|Overall Study||61
8164546|NCT02504723|20127635|P1|COMPLETED|Overall Study||60
8164547|NCT02504723|20127634|P2|STARTED|Overall Study||61
8164548|NCT02504723|20127635|P1|STARTED|Overall Study||60
8164549|NCT02504671|20127653|P6|NOT COMPLETED|Overall Study||14
8164550|NCT02504671|20127654|P5|NOT COMPLETED|Overall Study||12
8164551|NCT02504671|20127655|P4|NOT COMPLETED|Overall Study||10
8164552|NCT02504671|20127656|P3|NOT COMPLETED|Overall Study||10
8164553|NCT02504671|20127657|P2|NOT COMPLETED|Overall Study||14
8164554|NCT02504671|20127658|P1|NOT COMPLETED|Overall Study||12
8164555|NCT02504671|20127653|P6|COMPLETED|Overall Study||23
8164556|NCT02504671|20127654|P5|COMPLETED|Overall Study||25
8164557|NCT02504671|20127655|P4|COMPLETED|Overall Study||27
8164558|NCT02504671|20127656|P3|COMPLETED|Overall Study||27
8164559|NCT02504671|20127657|P2|COMPLETED|Overall Study||23
8164560|NCT02504671|20127658|P1|COMPLETED|Overall Study||25
8164561|NCT02504671|20127653|P6|STARTED|Overall Study||37
8164562|NCT02504671|20127654|P5|STARTED|Overall Study||37
8164563|NCT02504671|20127655|P4|STARTED|Overall Study||37
8164564|NCT02504671|20127656|P3|STARTED|Overall Study||37
8164565|NCT02504671|20127657|P2|STARTED|Overall Study||37
8164566|NCT02504671|20127658|P1|STARTED|Overall Study||37
8164567|NCT02504645|20127800|P2|NOT COMPLETED|Overall Study||25
8164568|NCT02504645|20127801|P1|NOT COMPLETED|Overall Study||24
8164569|NCT02504645|20127800|P2|COMPLETED|Overall Study||76
8164570|NCT02504645|20127801|P1|COMPLETED|Overall Study||77
8164571|NCT02504645|20127800|P2|STARTED|Overall Study||101
8164572|NCT02504645|20127801|P1|STARTED|Overall Study||101
8164573|NCT02504619|20127809|P1|NOT COMPLETED|Overall Study||0
8164574|NCT02504619|20127809|P1|COMPLETED|Overall Study||1
8164575|NCT02504619|20127809|P1|STARTED|Overall Study||1
8164576|NCT02504554|20127817|P2|NOT COMPLETED|Overall Study||0
8164577|NCT02504554|20127818|P1|NOT COMPLETED|Overall Study||0
8164578|NCT02504554|20127817|P2|COMPLETED|Overall Study||6
8164579|NCT02504554|20127818|P1|COMPLETED|Overall Study||12
8164580|NCT02504554|20127817|P2|STARTED|Overall Study||6
8164581|NCT02504554|20127818|P1|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
8164582|NCT02504541|20127830|P1|NOT COMPLETED|Overall Study||20
8164583|NCT02504541|20127830|P1|COMPLETED|Overall Study||113
8164584|NCT02504541|20127830|P1|STARTED|Overall Study||133
8164585|NCT02504502|20127836|P2|NOT COMPLETED|Crossover to Enhanced Report||0
8164586|NCT02504502|20127837|P1|NOT COMPLETED|Crossover to Enhanced Report||5
8164587|NCT02504502|20127836|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
8164588|NCT02504502|20127837|P1|COMPLETED|Crossover to Enhanced Report||15
8164589|NCT02504502|20127836|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
8164590|NCT02504502|20127837|P1|STARTED|Crossover to Enhanced Report||20
8164591|NCT02504502|20127836|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
8164592|NCT02504502|20127837|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
8164593|NCT02504502|20127836|P2|COMPLETED|Routine Care vs. Enhanced Report||21
8164594|NCT02504502|20127837|P1|COMPLETED|Routine Care vs. Enhanced Report||20
8164595|NCT02504502|20127836|P2|STARTED|Routine Care vs. Enhanced Report||28
8164596|NCT02504502|20127837|P1|STARTED|Routine Care vs. Enhanced Report||24
8164597|NCT02504424|20127843|P1|NOT COMPLETED|Overall Study||2
8164598|NCT02504424|20127843|P1|COMPLETED|Overall Study||48
8164599|NCT02504424|20127843|P1|STARTED|Overall Study||50
8164600|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 4||0
8164601|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 4||0
8164602|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 4||0
8164603|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 4||0
8164604|NCT02504320|20127852|P4|COMPLETED|Treatment Period 4||19
8164605|NCT02504320|20127853|P3|COMPLETED|Treatment Period 4||18
8164606|NCT02504320|20127854|P2|COMPLETED|Treatment Period 4||18
8164607|NCT02504320|20127855|P1|COMPLETED|Treatment Period 4||19
8164608|NCT02504320|20127852|P4|STARTED|Treatment Period 4||19
8164609|NCT02504320|20127853|P3|STARTED|Treatment Period 4||18
8164610|NCT02504320|20127854|P2|STARTED|Treatment Period 4||18
8164611|NCT02504320|20127855|P1|STARTED|Treatment Period 4||19
8164612|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 3||1
8164613|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 3||1
8164614|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 3||0
8164615|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 3||0
8164616|NCT02504320|20127852|P4|COMPLETED|Treatment Period 3||19
8164617|NCT02504320|20127853|P3|COMPLETED|Treatment Period 3||18
8164618|NCT02504320|20127854|P2|COMPLETED|Treatment Period 3||18
8164619|NCT02504320|20127855|P1|COMPLETED|Treatment Period 3||19
8164620|NCT02504320|20127852|P4|STARTED|Treatment Period 3||20
8164621|NCT02504320|20127853|P3|STARTED|Treatment Period 3||19
8164622|NCT02504320|20127854|P2|STARTED|Treatment Period 3||18
8164623|NCT02504320|20127855|P1|STARTED|Treatment Period 3||19
8164624|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 2||0
8164625|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 2||0
8164626|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 2||1
8164627|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 2||0
8164628|NCT02504320|20127852|P4|COMPLETED|Treatment Period 2||20
8164629|NCT02504320|20127853|P3|COMPLETED|Treatment Period 2||19
8164630|NCT02504320|20127854|P2|COMPLETED|Treatment Period 2||18
8164631|NCT02504320|20127855|P1|COMPLETED|Treatment Period 2||19
8164632|NCT02504320|20127852|P4|STARTED|Treatment Period 2||20
8164633|NCT02504320|20127853|P3|STARTED|Treatment Period 2||19
8164634|NCT02504320|20127854|P2|STARTED|Treatment Period 2||19
8164635|NCT02504320|20127855|P1|STARTED|Treatment Period 2||19
8164636|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 1||0
8164637|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 1||1
8164638|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 1||0
8164639|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 1||0
8164640|NCT02504320|20127852|P4|COMPLETED|Treatment Period 1||20
8164641|NCT02504320|20127853|P3|COMPLETED|Treatment Period 1||19
8164642|NCT02504320|20127854|P2|COMPLETED|Treatment Period 1||19
8164643|NCT02504320|20127855|P1|COMPLETED|Treatment Period 1||19
8164644|NCT02504320|20127852|P4|STARTED|Treatment Period 1||20
8164645|NCT02504320|20127853|P3|STARTED|Treatment Period 1||20
8164646|NCT02504320|20127854|P2|STARTED|Treatment Period 1||19
8164647|NCT02504320|20127855|P1|STARTED|Treatment Period 1||19
8164648|NCT02504294|20127875|P2|NOT COMPLETED|Overall Study||48
8164649|NCT02504294|20127876|P1|NOT COMPLETED|Overall Study||56
8164650|NCT02504294|20127875|P2|COMPLETED|Overall Study||158
8164651|NCT02504294|20127876|P1|COMPLETED|Overall Study||156
8164652|NCT02504294|20127875|P2|STARTED|Overall Study||206
8164653|NCT02504294|20127876|P1|STARTED|Overall Study||212
8164654|NCT02504268|20127886|P2|NOT COMPLETED|Overall Study||68
8164655|NCT02504268|20127887|P1|NOT COMPLETED|Overall Study||63
8164656|NCT02504268|20127886|P2|COMPLETED|Overall Study||233
8164657|NCT02504268|20127887|P1|COMPLETED|Overall Study||388
8164658|NCT02504268|20127886|P2|STARTED|Overall Study||301
8164659|NCT02504268|20127887|P1|STARTED|Overall Study||451
8164660|NCT02504216|20127903|P2|NOT COMPLETED|Overall Study||15
8164661|NCT02504216|20127904|P1|NOT COMPLETED|Overall Study||11
8164662|NCT02504216|20127903|P2|COMPLETED|Overall Study||3263
8164663|NCT02504216|20127904|P1|COMPLETED|Overall Study||3275
8164664|NCT02504216|20127903|P2|Received Treatment|Overall Study||3248
8164665|NCT02504216|20127904|P1|Received Treatment|Overall Study||3256
8164666|NCT02504216|20127903|P2|STARTED|Overall Study||3278
8164667|NCT02504216|20127904|P1|STARTED|Overall Study||3286
8164668|NCT02504099|20127930|P1|NOT COMPLETED|Overall Study||0
8164669|NCT02504099|20127930|P1|COMPLETED|Overall Study||3
8164670|NCT02504099|20127930|P1|STARTED|Overall Study||3
8164671|NCT02504073|20127938|P1|NOT COMPLETED|Overall Study||0
8164672|NCT02504073|20127938|P1|COMPLETED|Overall Study||54
8164673|NCT02504073|20127938|P1|STARTED|Overall Study||54
8164674|NCT02503982|20127944|P1|NOT COMPLETED|Overall Study||0
8164675|NCT02503982|20127944|P1|COMPLETED|Overall Study||13
8164676|NCT02503982|20127944|P1|STARTED|Overall Study||13
8164677|NCT02503865|20127951|P3|NOT COMPLETED|Overall Study||2
8164678|NCT02503865|20127952|P2|NOT COMPLETED|Overall Study||47
8164679|NCT02503865|20127953|P1|NOT COMPLETED|Overall Study||5
8164680|NCT02503865|20127951|P3|COMPLETED|Overall Study||64
8164681|NCT02503865|20127952|P2|COMPLETED|Overall Study||222
8164682|NCT02503865|20127953|P1|COMPLETED|Overall Study||65
8164683|NCT02503865|20127951|P3|STARTED|Overall Study||66
8164684|NCT02503865|20127952|P2|STARTED|Overall Study||269
8164685|NCT02503865|20127953|P1|STARTED|Overall Study||70
8164686|NCT02503852|20127977|P4|NOT COMPLETED|Overall Study||1
8164687|NCT02503852|20127978|P3|NOT COMPLETED|Overall Study||3
8164688|NCT02503852|20127979|P2|NOT COMPLETED|Overall Study||3
8164689|NCT02503852|20127980|P1|NOT COMPLETED|Overall Study||4
8164690|NCT02503852|20127977|P4|COMPLETED|Overall Study||8
8164691|NCT02503852|20127978|P3|COMPLETED|Overall Study||21
8164692|NCT02503852|20127979|P2|COMPLETED|Overall Study||19
8164693|NCT02503852|20127980|P1|COMPLETED|Overall Study||12
8164694|NCT02503852|20127977|P4|STARTED|Overall Study||9
8164695|NCT02503852|20127978|P3|STARTED|Overall Study||24
8164696|NCT02503852|20127979|P2|STARTED|Overall Study||22
8164697|NCT02503852|20127980|P1|STARTED|Overall Study||16
8164698|NCT02503787|20127998|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
8164699|NCT02503787|20127998|P1|COMPLETED|Implant to 3 Month Endpoint||29
8164700|NCT02503787|20127998|P1|STARTED|Implant to 3 Month Endpoint||32
8164701|NCT02503787|20127998|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
8164702|NCT02503787|20127998|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
8164703|NCT02503787|20127998|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
8164704|NCT02503787|20127998|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
8164705|NCT02503787|20127998|P1|COMPLETED|Device Trial (HD Programming Trial)||37
8164706|NCT02503787|20127998|P1|STARTED|Device Trial (HD Programming Trial)||44
8164707|NCT02503787|20127998|P1|NOT COMPLETED|Enrollment||20
8164708|NCT02503787|20127998|P1|COMPLETED|Enrollment||44
8164709|NCT02503787|20127998|P1|STARTED|Enrollment||64
8164710|NCT02503735|20128005|P1|NOT COMPLETED|Overall Study||0
8164711|NCT02503735|20128005|P1|COMPLETED|Overall Study||10
8164712|NCT02503735|20128005|P1|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
8164713|NCT02503735|20128005|P1|STARTED|Overall Study||10
8164714|NCT02503540|20128015|P1|NOT COMPLETED|Overall Study||3
8164715|NCT02503540|20128015|P1|COMPLETED|Overall Study||28
8164716|NCT02503540|20128015|P1|STARTED|Overall Study||31
8164717|NCT02503501|20128036|P2|NOT COMPLETED|Overall Study||3
8164718|NCT02503501|20128037|P1|NOT COMPLETED|Overall Study||1
8164719|NCT02503501|20128036|P2|COMPLETED|Overall Study||13
8164720|NCT02503501|20128037|P1|COMPLETED|Overall Study||18
8164721|NCT02503501|20128036|P2|STARTED|Overall Study||16
8164722|NCT02503501|20128037|P1|STARTED|Overall Study||19
8164723|NCT02503410|20128049|P2|NOT COMPLETED|Overall Study||0
8164724|NCT02503410|20128050|P1|NOT COMPLETED|Overall Study||0
8164725|NCT02503410|20128049|P2|COMPLETED|Overall Study||3
8164726|NCT02503410|20128050|P1|COMPLETED|Overall Study||4
8164727|NCT02503410|20128049|P2|STARTED|Overall Study||3
8164728|NCT02503410|20128050|P1|STARTED|Overall Study||4
8164729|NCT02503332|20128073|P4|NOT COMPLETED|Overall Study||4
8164730|NCT02503332|20128074|P3|NOT COMPLETED|Overall Study||8
8164731|NCT02503332|20128075|P2|NOT COMPLETED|Overall Study||19
8164732|NCT02503332|20128076|P1|NOT COMPLETED|Overall Study||34
8164733|NCT02503332|20128073|P4|COMPLETED|Overall Study||36
8164734|NCT02503332|20128074|P3|COMPLETED|Overall Study||33
8164735|NCT02503332|20128075|P2|COMPLETED|Overall Study||60
8164736|NCT02503332|20128076|P1|COMPLETED|Overall Study||52
8164737|NCT02503332|20128073|P4|STARTED|Overall Study||40
8164738|NCT02503332|20128074|P3|STARTED|Overall Study||41
8164739|NCT02503332|20128075|P2|STARTED|Overall Study||79
8164740|NCT02503332|20128076|P1|STARTED|Overall Study||86
8164741|NCT02503254|20128113|P2|NOT COMPLETED|Overall Study||0
8164742|NCT02503254|20128114|P1|NOT COMPLETED|Overall Study||0
8164743|NCT02503254|20128113|P2|COMPLETED|Overall Study||39
8164744|NCT02503254|20128114|P1|COMPLETED|Overall Study||41
8164745|NCT02503254|20128113|P2|STARTED|Overall Study||39
8164746|NCT02503254|20128114|P1|STARTED|Overall Study||41
8164747|NCT02503215|20128127|P1|NOT COMPLETED|Overall Study||3
8164748|NCT02503215|20128127|P1|COMPLETED|Overall Study||14
8164749|NCT02503215|20128127|P1|STARTED|Overall Study||17
8164750|NCT02503202|20128138|P5|NOT COMPLETED|Extension: Month 6 to 24||1
8164751|NCT02503202|20128139|P4|NOT COMPLETED|Extension: Month 6 to 24||18
8164752|NCT02503202|20128140|P3|NOT COMPLETED|Extension: Month 6 to 24||9
8164753|NCT02503202|20128141|P2|NOT COMPLETED|Extension: Month 6 to 24||16
8164754|NCT02503202|20128142|P1|NOT COMPLETED|Extension: Month 6 to 24||11
8164755|NCT02503202|20128138|P5|COMPLETED|Extension: Month 6 to 24||67
8164756|NCT02503202|20128139|P4|COMPLETED|Extension: Month 6 to 24||119
8164757|NCT02503202|20128140|P3|COMPLETED|Extension: Month 6 to 24||103
8164758|NCT02503202|20128141|P2|COMPLETED|Extension: Month 6 to 24||114
8164759|NCT02503202|20128142|P1|COMPLETED|Extension: Month 6 to 24||108
8164760|NCT02503202|20128138|P5|STARTED|Extension: Month 6 to 24||68
8164761|NCT02503202|20128139|P4|STARTED|Extension: Month 6 to 24||137
8164762|NCT02503202|20128140|P3|STARTED|Extension: Month 6 to 24||112
8164763|NCT02503202|20128141|P2|STARTED|Extension: Month 6 to 24||130
8164764|NCT02503202|20128142|P1|STARTED|Extension: Month 6 to 24||119
8164765|NCT02503202|20128138|P5|NOT COMPLETED|Base Study: Up to Month 6||3
8164766|NCT02503202|20128139|P4|NOT COMPLETED|Base Study: Up to Month 6||11
8164767|NCT02503202|20128140|P3|NOT COMPLETED|Base Study: Up to Month 6||15
8164768|NCT02503202|20128141|P2|NOT COMPLETED|Base Study: Up to Month 6||12
8164769|NCT02503202|20128142|P1|NOT COMPLETED|Base Study: Up to Month 6||18
8164770|NCT02503202|20128138|P5|COMPLETED|Base Study: Up to Month 6||130
8164771|NCT02503202|20128139|P4|COMPLETED|Base Study: Up to Month 6||255
8164772|NCT02503202|20128140|P3|COMPLETED|Base Study: Up to Month 6||252
8164773|NCT02503202|20128141|P2|COMPLETED|Base Study: Up to Month 6||253
8164774|NCT02503202|20128142|P1|COMPLETED|Base Study: Up to Month 6||248
8164775|NCT02503202|20128138|P5|Vaccinated|Base Study: Up to Month 6||133
8164776|NCT02503202|20128139|P4|Vaccinated|Base Study: Up to Month 6||264
8164777|NCT02503202|20128140|P3|Vaccinated|Base Study: Up to Month 6||266
8164778|NCT02503202|20128141|P2|Vaccinated|Base Study: Up to Month 6||265
8164779|NCT02503202|20128142|P1|Vaccinated|Base Study: Up to Month 6||266
8164780|NCT02503202|20128138|P5|STARTED|Base Study: Up to Month 6||133
8164781|NCT02503202|20128139|P4|STARTED|Base Study: Up to Month 6||266
8164782|NCT02503202|20128140|P3|STARTED|Base Study: Up to Month 6||267
8164783|NCT02503202|20128141|P2|STARTED|Base Study: Up to Month 6||265
8164784|NCT02503202|20128142|P1|STARTED|Base Study: Up to Month 6||266
8164785|NCT02503085|20128184|P4|NOT COMPLETED|Period 4||0
8164786|NCT02503085|20128185|P3|NOT COMPLETED|Period 4||0
8164787|NCT02503085|20128186|P2|NOT COMPLETED|Period 4||0
8164788|NCT02503085|20128187|P1|NOT COMPLETED|Period 4||0
8164789|NCT02503085|20128184|P4|COMPLETED|Period 4||7
8164790|NCT02503085|20128185|P3|COMPLETED|Period 4||6
8164791|NCT02503085|20128186|P2|COMPLETED|Period 4||7
8164792|NCT02503085|20128187|P1|COMPLETED|Period 4||6
8164793|NCT02503085|20128184|P4|STARTED|Period 4||7
8164794|NCT02503085|20128185|P3|STARTED|Period 4||6
8164795|NCT02503085|20128186|P2|STARTED|Period 4||7
8164796|NCT02503085|20128187|P1|STARTED|Period 4||6
8164797|NCT02503085|20128184|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164798|NCT02503085|20128185|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164799|NCT02503085|20128186|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164800|NCT02503085|20128187|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164801|NCT02503085|20128184|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
8164802|NCT02503085|20128185|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8164803|NCT02503085|20128186|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
8164804|NCT02503085|20128187|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8164805|NCT02503085|20128184|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
8164806|NCT02503085|20128185|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
8164807|NCT02503085|20128186|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
8164808|NCT02503085|20128187|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
8164809|NCT02503085|20128184|P4|NOT COMPLETED|Period 3||0
8164810|NCT02503085|20128185|P3|NOT COMPLETED|Period 3||0
8164811|NCT02503085|20128186|P2|NOT COMPLETED|Period 3||0
8164812|NCT02503085|20128187|P1|NOT COMPLETED|Period 3||0
8164813|NCT02503085|20128184|P4|COMPLETED|Period 3||7
8164814|NCT02503085|20128185|P3|COMPLETED|Period 3||6
8164815|NCT02503085|20128186|P2|COMPLETED|Period 3||7
8164816|NCT02503085|20128187|P1|COMPLETED|Period 3||6
8164817|NCT02503085|20128184|P4|STARTED|Period 3||7
8164818|NCT02503085|20128185|P3|STARTED|Period 3||6
8164819|NCT02503085|20128186|P2|STARTED|Period 3||7
8164820|NCT02503085|20128187|P1|STARTED|Period 3||6
8164821|NCT02503085|20128184|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8164822|NCT02503085|20128185|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
8164823|NCT02503085|20128186|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8164824|NCT02503085|20128187|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
8164825|NCT02503085|20128184|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
8164826|NCT02503085|20128185|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8164827|NCT02503085|20128186|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
8164828|NCT02503085|20128187|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8164829|NCT02503085|20128184|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
8164830|NCT02503085|20128185|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
8164831|NCT02503085|20128186|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
8164832|NCT02503085|20128187|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
8164833|NCT02503085|20128184|P4|NOT COMPLETED|Period 2||0
8164834|NCT02503085|20128185|P3|NOT COMPLETED|Period 2||0
8164835|NCT02503085|20128186|P2|NOT COMPLETED|Period 2||0
8164836|NCT02503085|20128187|P1|NOT COMPLETED|Period 2||0
8164837|NCT02503085|20128184|P4|COMPLETED|Period 2||7
8164838|NCT02503085|20128185|P3|COMPLETED|Period 2||7
8164839|NCT02503085|20128186|P2|COMPLETED|Period 2||7
8164840|NCT02503085|20128187|P1|COMPLETED|Period 2||7
8164841|NCT02503085|20128184|P4|STARTED|Period 2||7
8164842|NCT02503085|20128185|P3|STARTED|Period 2||7
8164843|NCT02503085|20128186|P2|STARTED|Period 2||7
8164844|NCT02503085|20128187|P1|STARTED|Period 2||7
8164845|NCT02503085|20128184|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164846|NCT02503085|20128185|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164847|NCT02503085|20128186|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164848|NCT02503085|20128187|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164849|NCT02503085|20128184|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164850|NCT02503085|20128185|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164851|NCT02503085|20128186|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164852|NCT02503085|20128187|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164853|NCT02503085|20128184|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
8164854|NCT02503085|20128185|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
8164855|NCT02503085|20128186|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
8164856|NCT02503085|20128187|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
8164857|NCT02503085|20128184|P4|NOT COMPLETED|Period 1||0
8164858|NCT02503085|20128185|P3|NOT COMPLETED|Period 1||0
8164859|NCT02503085|20128186|P2|NOT COMPLETED|Period 1||0
8164860|NCT02503085|20128187|P1|NOT COMPLETED|Period 1||0
8164861|NCT02503085|20128184|P4|COMPLETED|Period 1||7
8164862|NCT02503085|20128185|P3|COMPLETED|Period 1||7
8164863|NCT02503085|20128186|P2|COMPLETED|Period 1||7
8164864|NCT02503085|20128187|P1|COMPLETED|Period 1||7
8164865|NCT02503085|20128184|P4|STARTED|Period 1||7
8164866|NCT02503085|20128185|P3|STARTED|Period 1||7
8164867|NCT02503085|20128186|P2|STARTED|Period 1||7
8164868|NCT02503085|20128187|P1|STARTED|Period 1||7
8164869|NCT02502864|20128226|P1|NOT COMPLETED|Overall Study||1
8164870|NCT02502864|20128226|P1|COMPLETED|Overall Study||8
8164871|NCT02502864|20128226|P1|STARTED|Overall Study||9
8164872|NCT02502734|20128235|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
8164873|NCT02502734|20128236|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
8164874|NCT02502734|20128235|P2|COMPLETED|Double-blind Treatment Period 2||30
8164875|NCT02502734|20128236|P1|COMPLETED|Double-blind Treatment Period 2||28
8164876|NCT02502734|20128235|P2|STARTED|Double-blind Treatment Period 2||30
8164877|NCT02502734|20128236|P1|STARTED|Double-blind Treatment Period 2||28
8164878|NCT02502734|20128235|P2|NOT COMPLETED|Washout Period||0
8164879|NCT02502734|20128236|P1|NOT COMPLETED|Washout Period||1
8164880|NCT02502734|20128235|P2|COMPLETED|Washout Period||30
8164881|NCT02502734|20128236|P1|COMPLETED|Washout Period||28
8164882|NCT02502734|20128235|P2|STARTED|Washout Period||30
8164883|NCT02502734|20128236|P1|STARTED|Washout Period||29
8164884|NCT02502734|20128235|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
8164885|NCT02502734|20128236|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
8164886|NCT02502734|20128235|P2|COMPLETED|Double-blind Treatment Period 1||30
8164887|NCT02502734|20128236|P1|COMPLETED|Double-blind Treatment Period 1||29
8164888|NCT02502734|20128235|P2|STARTED|Double-blind Treatment Period 1||30
8164889|NCT02502734|20128236|P1|STARTED|Double-blind Treatment Period 1||30
8164890|NCT02502526|20128247|P3|NOT COMPLETED|Overall Study||6
8164891|NCT02502526|20128248|P2|NOT COMPLETED|Overall Study||4
8164892|NCT02502526|20128249|P1|NOT COMPLETED|Overall Study||6
8164893|NCT02502526|20128247|P3|COMPLETED|Overall Study||55
8164894|NCT02502526|20128248|P2|COMPLETED|Overall Study||55
8164895|NCT02502526|20128249|P1|COMPLETED|Overall Study||56
8164896|NCT02502526|20128247|P3|Intent-to-Treat (ITT)|Overall Study||59
8164897|NCT02502526|20128248|P2|Intent-to-Treat (ITT)|Overall Study||57
8164898|NCT02502526|20128249|P1|Intent-to-Treat (ITT)|Overall Study||57
8164899|NCT02502526|20128247|P3|STARTED|Overall Study||61
8164900|NCT02502526|20128248|P2|STARTED|Overall Study||59
8164901|NCT02502526|20128249|P1|STARTED|Overall Study||62
8164902|NCT02502487|20128265|P3|NOT COMPLETED|Overall Study||0
8164903|NCT02502487|20128266|P2|NOT COMPLETED|Overall Study||0
8164904|NCT02502487|20128267|P1|NOT COMPLETED|Overall Study||0
8164905|NCT02502487|20128265|P3|COMPLETED|Overall Study||86
8164906|NCT02502487|20128266|P2|COMPLETED|Overall Study||86
8164907|NCT02502487|20128267|P1|COMPLETED|Overall Study||86
8164908|NCT02502487|20128265|P3|STARTED|Overall Study||86
8164909|NCT02502487|20128266|P2|STARTED|Overall Study||86
8164910|NCT02502487|20128267|P1|STARTED|Overall Study||86
8164911|NCT02502461|20128337|P2|NOT COMPLETED|Overall Study||0
8164912|NCT02502461|20128338|P1|NOT COMPLETED|Overall Study||0
8164913|NCT02502461|20128337|P2|COMPLETED|Overall Study||44
8164914|NCT02502461|20128338|P1|COMPLETED|Overall Study||46
8164915|NCT02502461|20128337|P2|STARTED|Overall Study||44
8164916|NCT02502461|20128338|P1|STARTED|Overall Study||46
8164917|NCT02502149|20128346|P5|NOT COMPLETED|Treatment Period||0
8164918|NCT02502149|20128347|P4|NOT COMPLETED|Treatment Period||0
8164919|NCT02502149|20128348|P3|NOT COMPLETED|Treatment Period||0
8164920|NCT02502149|20128349|P2|NOT COMPLETED|Treatment Period||0
8164921|NCT02502149|20128350|P1|NOT COMPLETED|Treatment Period||0
8164922|NCT02502149|20128346|P5|COMPLETED|Treatment Period||12
8164923|NCT02502149|20128347|P4|COMPLETED|Treatment Period||11
8164924|NCT02502149|20128348|P3|COMPLETED|Treatment Period||0
8164925|NCT02502149|20128349|P2|COMPLETED|Treatment Period||0
8164926|NCT02502149|20128350|P1|COMPLETED|Treatment Period||0
8164927|NCT02502149|20128346|P5|STARTED|Treatment Period||12
8164928|NCT02502149|20128347|P4|STARTED|Treatment Period||11
8164929|NCT02502149|20128348|P3|STARTED|Treatment Period||0
8164930|NCT02502149|20128349|P2|STARTED|Treatment Period||0
8164931|NCT02502149|20128350|P1|STARTED|Treatment Period||0
8164932|NCT02502149|20128346|P5|NOT COMPLETED|PK2 Assessment Period||0
8164933|NCT02502149|20128347|P4|NOT COMPLETED|PK2 Assessment Period||0
8164934|NCT02502149|20128348|P3|NOT COMPLETED|PK2 Assessment Period||0
8164935|NCT02502149|20128349|P2|NOT COMPLETED|PK2 Assessment Period||0
8164936|NCT02502149|20128350|P1|NOT COMPLETED|PK2 Assessment Period||0
8164937|NCT02502149|20128346|P5|COMPLETED|PK2 Assessment Period||0
8164938|NCT02502149|20128347|P4|COMPLETED|PK2 Assessment Period||0
8164939|NCT02502149|20128348|P3|COMPLETED|PK2 Assessment Period||12
8164940|NCT02502149|20128349|P2|COMPLETED|PK2 Assessment Period||11
8164941|NCT02502149|20128350|P1|COMPLETED|PK2 Assessment Period||0
8164942|NCT02502149|20128346|P5|STARTED|PK2 Assessment Period||0
8164943|NCT02502149|20128347|P4|STARTED|PK2 Assessment Period||0
8164944|NCT02502149|20128348|P3|STARTED|PK2 Assessment Period||12
8164945|NCT02502149|20128349|P2|STARTED|PK2 Assessment Period||11
8164946|NCT02502149|20128350|P1|STARTED|PK2 Assessment Period||0
8164947|NCT02502149|20128346|P5|NOT COMPLETED|Intermediate||0
8164948|NCT02502149|20128347|P4|NOT COMPLETED|Intermediate||0
8164949|NCT02502149|20128348|P3|NOT COMPLETED|Intermediate||0
8164950|NCT02502149|20128349|P2|NOT COMPLETED|Intermediate||0
8164951|NCT02502149|20128350|P1|NOT COMPLETED|Intermediate||1
8164952|NCT02502149|20128346|P5|COMPLETED|Intermediate||0
8164953|NCT02502149|20128347|P4|COMPLETED|Intermediate||0
8164954|NCT02502149|20128348|P3|COMPLETED|Intermediate||0
8164955|NCT02502149|20128349|P2|COMPLETED|Intermediate||0
8164956|NCT02502149|20128350|P1|COMPLETED|Intermediate||23
8164957|NCT02502149|20128346|P5|STARTED|Intermediate||0
8164958|NCT02502149|20128347|P4|STARTED|Intermediate||0
8164959|NCT02502149|20128348|P3|STARTED|Intermediate||0
8164960|NCT02502149|20128349|P2|STARTED|Intermediate||0
8164961|NCT02502149|20128350|P1|STARTED|Intermediate||24
8164962|NCT02502149|20128346|P5|NOT COMPLETED|PK1 Assessment Period||0
8164963|NCT02502149|20128347|P4|NOT COMPLETED|PK1 Assessment Period||0
8164964|NCT02502149|20128348|P3|NOT COMPLETED|PK1 Assessment Period||0
8164965|NCT02502149|20128349|P2|NOT COMPLETED|PK1 Assessment Period||0
8164966|NCT02502149|20128350|P1|NOT COMPLETED|PK1 Assessment Period||0
8164967|NCT02502149|20128346|P5|COMPLETED|PK1 Assessment Period||0
8164968|NCT02502149|20128347|P4|COMPLETED|PK1 Assessment Period||0
8164969|NCT02502149|20128348|P3|COMPLETED|PK1 Assessment Period||0
8164970|NCT02502149|20128349|P2|COMPLETED|PK1 Assessment Period||0
8164971|NCT02502149|20128350|P1|COMPLETED|PK1 Assessment Period||24
8164972|NCT02502149|20128346|P5|STARTED|PK1 Assessment Period||0
8164973|NCT02502149|20128347|P4|STARTED|PK1 Assessment Period||0
8164974|NCT02502149|20128348|P3|STARTED|PK1 Assessment Period||0
8164975|NCT02502149|20128349|P2|STARTED|PK1 Assessment Period||0
8164976|NCT02502149|20128350|P1|STARTED|PK1 Assessment Period||24
8164977|NCT02502071|20128469|P1|NOT COMPLETED|Overall Study||0
8164978|NCT02502071|20128469|P1|COMPLETED|Overall Study||45
8164979|NCT02502071|20128469|P1|STARTED|Overall Study||45
8164980|NCT02502019|20128474|P1|NOT COMPLETED|Overall Study||0
8164981|NCT02502019|20128474|P1|COMPLETED|Overall Study||27
8164982|NCT02502019|20128474|P1|STARTED|Overall Study||27
8164983|NCT02501928|20128485|P6|NOT COMPLETED|Overall Study||0
8164984|NCT02501928|20128486|P5|NOT COMPLETED|Overall Study||1
8164985|NCT02501928|20128487|P4|NOT COMPLETED|Overall Study||0
8164986|NCT02501928|20128488|P3|NOT COMPLETED|Overall Study||0
8164987|NCT02501928|20128489|P2|NOT COMPLETED|Overall Study||0
8164988|NCT02501928|20128490|P1|NOT COMPLETED|Overall Study||0
8164989|NCT02501928|20128485|P6|COMPLETED|Overall Study||3
8164990|NCT02501928|20128486|P5|COMPLETED|Overall Study||6
8164991|NCT02501928|20128487|P4|COMPLETED|Overall Study||0
8164992|NCT02501928|20128488|P3|COMPLETED|Overall Study||0
8164993|NCT02501928|20128489|P2|COMPLETED|Overall Study||2
8164994|NCT02501928|20128490|P1|COMPLETED|Overall Study||0
8164995|NCT02501928|20128485|P6|STARTED|Overall Study||3
8164996|NCT02501928|20128486|P5|STARTED|Overall Study||7
8164997|NCT02501928|20128487|P4|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8164998|NCT02501928|20128488|P3|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8164999|NCT02501928|20128489|P2|STARTED|Overall Study||2
8165000|NCT02501928|20128490|P1|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8165001|NCT02501759|20128708|P1|NOT COMPLETED|Overall Study||1
8165002|NCT02501759|20128708|P1|COMPLETED|Overall Study||1
8165003|NCT02501759|20128708|P1|STARTED|Overall Study||2
8165004|NCT02501629|20128716|P2|NOT COMPLETED|Overall Study||7
8165005|NCT02501629|20128717|P1|NOT COMPLETED|Overall Study||5
8165006|NCT02501629|20128716|P2|COMPLETED|Overall Study||81
8165007|NCT02501629|20128717|P1|COMPLETED|Overall Study||84
8165008|NCT02501629|20128716|P2|STARTED|Overall Study||88
8165009|NCT02501629|20128717|P1|STARTED|Overall Study||89
8165010|NCT02501590|20128741|P2|NOT COMPLETED|Overall Study||0
8165011|NCT02501590|20128742|P1|NOT COMPLETED|Overall Study||0
8165012|NCT02501590|20128741|P2|COMPLETED|Overall Study||35
8165013|NCT02501590|20128742|P1|COMPLETED|Overall Study||13
8165014|NCT02501590|20128741|P2|STARTED|Overall Study||35
8165015|NCT02501590|20128742|P1|STARTED|Overall Study||13
8165016|NCT02501538|20128748|P1|NOT COMPLETED|Overall Study||3
8165017|NCT02501538|20128748|P1|COMPLETED|Overall Study||20
8165018|NCT02501538|20128748|P1|STARTED|Overall Study||23
8165019|NCT02501473|20128763|P8|NOT COMPLETED|Overall Study||0
8165020|NCT02501473|20128764|P7|NOT COMPLETED|Overall Study||1
8165021|NCT02501473|20128765|P6|NOT COMPLETED|Overall Study||14
8165022|NCT02501473|20128766|P5|NOT COMPLETED|Overall Study||4
8165023|NCT02501473|20128767|P4|NOT COMPLETED|Overall Study||14
8165024|NCT02501473|20128768|P3|NOT COMPLETED|Overall Study||13
8165025|NCT02501473|20128769|P2|NOT COMPLETED|Overall Study||3
8165026|NCT02501473|20128770|P1|NOT COMPLETED|Overall Study||3
8165027|NCT02501473|20128763|P8|COMPLETED|Overall Study||0
8165028|NCT02501473|20128764|P7|COMPLETED|Overall Study||0
8165029|NCT02501473|20128765|P6|COMPLETED|Overall Study||0
8165030|NCT02501473|20128766|P5|COMPLETED|Overall Study||0
8165031|NCT02501473|20128767|P4|COMPLETED|Overall Study||0
8165032|NCT02501473|20128768|P3|COMPLETED|Overall Study||0
8165033|NCT02501473|20128769|P2|COMPLETED|Overall Study||0
8165034|NCT02501473|20128770|P1|COMPLETED|Overall Study||0
8165035|NCT02501473|20128763|P8|Treated|Overall Study||0
8165036|NCT02501473|20128764|P7|Treated|Overall Study||1
8165037|NCT02501473|20128765|P6|Treated|Overall Study||14
8165038|NCT02501473|20128766|P5|Treated|Overall Study||4
8165039|NCT02501473|20128767|P4|Treated|Overall Study||13
8165040|NCT02501473|20128768|P3|Treated|Overall Study||13
8165041|NCT02501473|20128769|P2|Treated|Overall Study||3
8165042|NCT02501473|20128770|P1|Treated|Overall Study||3
8165043|NCT02501473|20128763|P8|STARTED|Overall Study||0
8165044|NCT02501473|20128764|P7|STARTED|Overall Study||1
8165045|NCT02501473|20128765|P6|STARTED|Overall Study||14
8165046|NCT02501473|20128766|P5|STARTED|Overall Study||4
8165047|NCT02501473|20128767|P4|STARTED|Overall Study||14
8165048|NCT02501473|20128768|P3|STARTED|Overall Study||13
8165049|NCT02501473|20128769|P2|STARTED|Overall Study||3
8165050|NCT02501473|20128770|P1|STARTED|Overall Study||3
8165051|NCT02501161|20128865|P2|NOT COMPLETED|Overall Study||25
8165052|NCT02501161|20128866|P1|NOT COMPLETED|Overall Study||22
8165053|NCT02501161|20128865|P2|COMPLETED|Overall Study||481
8165054|NCT02501161|20128866|P1|COMPLETED|Overall Study||484
8165055|NCT02501161|20128865|P2|Exposed|Overall Study||504
8165056|NCT02501161|20128866|P1|Exposed|Overall Study||506
8165057|NCT02501161|20128865|P2|STARTED|Overall Study||506
8165058|NCT02501161|20128866|P1|STARTED|Overall Study||506
8165059|NCT02501135|20128978|P1|NOT COMPLETED|Overall Study||0
8165060|NCT02501135|20128978|P1|COMPLETED|Overall Study||281
8165061|NCT02501135|20128978|P1|STARTED|Overall Study||281
8165062|NCT02500979|20128990|P2|NOT COMPLETED|Period 2||0
8165063|NCT02500979|20128991|P1|NOT COMPLETED|Period 2||1
8165064|NCT02500979|20128990|P2|COMPLETED|Period 2||16
8165065|NCT02500979|20128991|P1|COMPLETED|Period 2||11
8165066|NCT02500979|20128990|P2|STARTED|Period 2||16
8165067|NCT02500979|20128991|P1|STARTED|Period 2||12
8165068|NCT02500979|20128990|P2|NOT COMPLETED|Period 1||1
8165069|NCT02500979|20128991|P1|NOT COMPLETED|Period 1||4
8165070|NCT02500979|20128990|P2|COMPLETED|Period 1||16
8165071|NCT02500979|20128991|P1|COMPLETED|Period 1||12
8165072|NCT02500979|20128990|P2|STARTED|Period 1||17
8165073|NCT02500979|20128991|P1|STARTED|Period 1||16
8165074|NCT02500901|20129025|P1|NOT COMPLETED|Overall Study||2
8165075|NCT02500901|20129025|P1|COMPLETED|Overall Study||0
8165076|NCT02500901|20129025|P1|STARTED|Overall Study||2
8165077|NCT02500836|20129034|P3|NOT COMPLETED|Overall Study||1
8165078|NCT02500836|20129035|P2|NOT COMPLETED|Overall Study||5
8165079|NCT02500836|20129036|P1|NOT COMPLETED|Overall Study||3
8165080|NCT02500836|20129034|P3|COMPLETED|Overall Study||127
8165081|NCT02500836|20129035|P2|COMPLETED|Overall Study||254
8165082|NCT02500836|20129036|P1|COMPLETED|Overall Study||256
8165083|NCT02500836|20129034|P3|STARTED|Overall Study||128
8165084|NCT02500836|20129035|P2|STARTED|Overall Study||259
8165085|NCT02500836|20129036|P1|STARTED|Overall Study||259
8165118|NCT02500758|20129120|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
8165119|NCT02500758|20129121|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
8165120|NCT02500758|20129120|P2|COMPLETED|Second Intervention (2 Minutes)||10
8165121|NCT02500758|20129121|P1|COMPLETED|Second Intervention (2 Minutes)||10
8165122|NCT02500758|20129120|P2|STARTED|Second Intervention (2 Minutes)||12
8165123|NCT02500758|20129121|P1|STARTED|Second Intervention (2 Minutes)||13
8165124|NCT02500758|20129120|P2|NOT COMPLETED|Washout (1 Week)||2
8165125|NCT02500758|20129121|P1|NOT COMPLETED|Washout (1 Week)||2
8165126|NCT02500758|20129120|P2|COMPLETED|Washout (1 Week)||12
8165127|NCT02500758|20129121|P1|COMPLETED|Washout (1 Week)||13
8165128|NCT02500758|20129120|P2|STARTED|Washout (1 Week)||14
8165129|NCT02500758|20129121|P1|STARTED|Washout (1 Week)||15
8165130|NCT02500758|20129120|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
8165131|NCT02500758|20129121|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
8165132|NCT02500758|20129120|P2|COMPLETED|First Intervention (2 Minutes)||14
8165133|NCT02500758|20129121|P1|COMPLETED|First Intervention (2 Minutes)||15
8165134|NCT02500758|20129120|P2|STARTED|First Intervention (2 Minutes)||15
8165135|NCT02500758|20129121|P1|STARTED|First Intervention (2 Minutes)||15
8165136|NCT02500732|20129131|P2|NOT COMPLETED|Overall Study||1
8165137|NCT02500732|20129132|P1|NOT COMPLETED|Overall Study||0
8165138|NCT02500732|20129131|P2|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
8165139|NCT02500732|20129132|P1|COMPLETED|Overall Study||27
8165140|NCT02500732|20129131|P2|STARTED|Overall Study||30
8165141|NCT02500732|20129132|P1|STARTED|Overall Study||27
8165142|NCT02500706|20129149|P3|NOT COMPLETED|Overall Study||7
8165143|NCT02500706|20129150|P2|NOT COMPLETED|Overall Study||7
8165144|NCT02500706|20129151|P1|NOT COMPLETED|Overall Study||4
8165145|NCT02500706|20129149|P3|COMPLETED|Overall Study||335
8165146|NCT02500706|20129150|P2|COMPLETED|Overall Study||334
8165147|NCT02500706|20129151|P1|COMPLETED|Overall Study||338
8165148|NCT02500706|20129149|P3|Exposed|Overall Study||342
8165149|NCT02500706|20129150|P2|Exposed|Overall Study||341
8165150|NCT02500706|20129151|P1|Exposed|Overall Study||342
8165151|NCT02500706|20129149|P3|STARTED|Overall Study||342
8165152|NCT02500706|20129150|P2|STARTED|Overall Study||341
8165153|NCT02500706|20129151|P1|STARTED|Overall Study||342
8165154|NCT02500641|20129305|P2|NOT COMPLETED|Overall Study||12
8165155|NCT02500641|20129306|P1|NOT COMPLETED|Overall Study||10
8165156|NCT02500641|20129305|P2|COMPLETED|Overall Study||86
8165157|NCT02500641|20129306|P1|COMPLETED|Overall Study||88
8165158|NCT02500641|20129305|P2|STARTED|Overall Study||98
8165159|NCT02500641|20129306|P1|STARTED|Overall Study||98
8165160|NCT02500628|20129314|P2|NOT COMPLETED|Overall Study||0
8165161|NCT02500628|20129315|P1|NOT COMPLETED|Overall Study||0
8165162|NCT02500628|20129314|P2|COMPLETED|Overall Study||23
8165163|NCT02500628|20129315|P1|COMPLETED|Overall Study||38
8165164|NCT02500628|20129314|P2|STARTED|Overall Study||23
8165165|NCT02500628|20129315|P1|STARTED|Overall Study||38
8165166|NCT02500550|20129325|P1|NOT COMPLETED|Overall Study||7
8165167|NCT02500550|20129325|P1|COMPLETED|Overall Study||8
8165168|NCT02500550|20129325|P1|STARTED|Overall Study||15
8165169|NCT02500537|20129331|P2|NOT COMPLETED|Overall Study||1
8165170|NCT02500537|20129332|P1|NOT COMPLETED|Overall Study||3
8165171|NCT02500537|20129331|P2|COMPLETED|Overall Study||39
8165172|NCT02500537|20129332|P1|COMPLETED|Overall Study||57
8165173|NCT02500537|20129331|P2|STARTED|Overall Study||40
8165174|NCT02500537|20129332|P1|STARTED|Overall Study||60
8165175|NCT02500368|20129350|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8165176|NCT02500368|20129351|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8165177|NCT02500368|20129350|P2|COMPLETED|Second Intervention (1 Week)||20
8165178|NCT02500368|20129351|P1|COMPLETED|Second Intervention (1 Week)||20
8165179|NCT02500368|20129350|P2|STARTED|Second Intervention (1 Week)||20
8165180|NCT02500368|20129351|P1|STARTED|Second Intervention (1 Week)||20
8165181|NCT02500368|20129350|P2|NOT COMPLETED|First Intervention (1 Week)||0
8165182|NCT02500368|20129351|P1|NOT COMPLETED|First Intervention (1 Week)||0
8165183|NCT02500368|20129350|P2|COMPLETED|First Intervention (1 Week)||20
8165184|NCT02500368|20129351|P1|COMPLETED|First Intervention (1 Week)||20
8165185|NCT02500368|20129350|P2|STARTED|First Intervention (1 Week)||20
8165186|NCT02500368|20129351|P1|STARTED|First Intervention (1 Week)||20
8165187|NCT02500056|20129401|P2|NOT COMPLETED|Overall Study||8
8165188|NCT02500056|20129402|P1|NOT COMPLETED|Overall Study||7
8165189|NCT02500056|20129401|P2|COMPLETED|Overall Study||65
8165190|NCT02500056|20129402|P1|COMPLETED|Overall Study||63
8165191|NCT02500056|20129401|P2|STARTED|Overall Study||73
8165192|NCT02500056|20129402|P1|STARTED|Overall Study||70
8165193|NCT02499952|20129412|P1|NOT COMPLETED|Overall Study||10
8165194|NCT02499952|20129412|P1|COMPLETED|Overall Study||2
8165195|NCT02499952|20129412|P1|STARTED|Overall Study||12
8165196|NCT02499900|20129421|P2|NOT COMPLETED|Extension Study Period||20
8165197|NCT02499900|20129422|P1|NOT COMPLETED|Extension Study Period||12
8165198|NCT02499900|20129421|P2|COMPLETED|Extension Study Period||377
8165199|NCT02499900|20129422|P1|COMPLETED|Extension Study Period||380
8165200|NCT02499900|20129421|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
8165201|NCT02499900|20129422|P1|Safety Analysis Set|Extension Study Period||392
8165202|NCT02499900|20129421|P2|STARTED|Extension Study Period||397
8165203|NCT02499900|20129422|P1|STARTED|Extension Study Period||392
8165204|NCT02499900|20129421|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
8165205|NCT02499900|20129422|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
8165206|NCT02499900|20129421|P2|COMPLETED|Completed Core, Continued Into Extension||397
8165207|NCT02499900|20129422|P1|COMPLETED|Completed Core, Continued Into Extension||392
8165208|NCT02499900|20129421|P2|STARTED|Completed Core, Continued Into Extension||399
8165209|NCT02499900|20129422|P1|STARTED|Completed Core, Continued Into Extension||395
8165210|NCT02499900|20129421|P2|NOT COMPLETED|Core Study Period||32
8165211|NCT02499900|20129422|P1|NOT COMPLETED|Core Study Period||35
8165212|NCT02499900|20129421|P2|COMPLETED|Core Study Period||399
8165213|NCT02499900|20129422|P1|COMPLETED|Core Study Period||395
8165214|NCT02499900|20129421|P2|Safety Analysis Set|Core Study Period||430
8165215|NCT02499900|20129422|P1|Safety Analysis Set|Core Study Period||427
8165216|NCT02499900|20129421|P2|STARTED|Core Study Period||431
8165217|NCT02499900|20129422|P1|STARTED|Core Study Period||430
8165218|NCT02499887|20129444|P2|NOT COMPLETED|Overall Study||0
8165219|NCT02499887|20129445|P1|NOT COMPLETED|Overall Study||0
8165220|NCT02499887|20129444|P2|COMPLETED|Overall Study||3
8165221|NCT02499887|20129445|P1|COMPLETED|Overall Study||3
8165222|NCT02499887|20129444|P2|STARTED|Overall Study||3
8165223|NCT02499887|20129445|P1|STARTED|Overall Study||3
8165224|NCT02499783|20129453|P3|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
8165225|NCT02499783|20129454|P2|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
8165226|NCT02499783|20129455|P1|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
8165227|NCT02499783|20129453|P3|COMPLETED|Open Label Period: Weeks 8 to 26||159
8165228|NCT02499783|20129454|P2|COMPLETED|Open Label Period: Weeks 8 to 26||0
8165229|NCT02499783|20129455|P1|COMPLETED|Open Label Period: Weeks 8 to 26||0
8165230|NCT02499783|20129453|P3|STARTED|Open Label Period: Weeks 8 to 26||188
8165231|NCT02499783|20129454|P2|STARTED|Open Label Period: Weeks 8 to 26||0
8165232|NCT02499783|20129455|P1|STARTED|Open Label Period: Weeks 8 to 26||0
8165233|NCT02499783|20129453|P3|NOT COMPLETED|DB Period: Weeks 0-8||0
8165234|NCT02499783|20129454|P2|NOT COMPLETED|DB Period: Weeks 0-8||7
8165235|NCT02499783|20129455|P1|NOT COMPLETED|DB Period: Weeks 0-8||10
8165236|NCT02499783|20129453|P3|COMPLETED|DB Period: Weeks 0-8||0
8165237|NCT02499783|20129454|P2|COMPLETED|DB Period: Weeks 0-8||96
8165238|NCT02499783|20129455|P1|COMPLETED|DB Period: Weeks 0-8||92
8165239|NCT02499783|20129453|P3|STARTED|DB Period: Weeks 0-8||0
8165240|NCT02499783|20129454|P2|STARTED|DB Period: Weeks 0-8||103
8165241|NCT02499783|20129455|P1|STARTED|DB Period: Weeks 0-8||102
8165242|NCT02499783|20129453|P3|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
8165243|NCT02499783|20129454|P2|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
8165244|NCT02499783|20129455|P1|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
8165245|NCT02499783|20129453|P3|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
8165246|NCT02499783|20129454|P2|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
8165247|NCT02499783|20129455|P1|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
8165248|NCT02499783|20129453|P3|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
8165249|NCT02499783|20129454|P2|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
8165250|NCT02499783|20129455|P1|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
8165251|NCT02499770|20129504|P2|NOT COMPLETED|Overall Study||77
8165252|NCT02499770|20129505|P1|NOT COMPLETED|Overall Study||19
8165253|NCT02499770|20129504|P2|COMPLETED|Overall Study||0
8165254|NCT02499770|20129505|P1|COMPLETED|Overall Study||0
8165255|NCT02499770|20129504|P2|STARTED|Overall Study||77
8165256|NCT02499770|20129505|P1|STARTED|Overall Study||19
8165257|NCT02499692|20129614|P1|NOT COMPLETED|Overall Study||0
8165258|NCT02499692|20129614|P1|COMPLETED|Overall Study||103
8165259|NCT02499692|20129614|P1|STARTED|Overall Study||103
8165260|NCT02499575|20129625|P2|NOT COMPLETED|Overall Study||1
8165261|NCT02499575|20129626|P1|NOT COMPLETED|Overall Study||0
8165262|NCT02499575|20129625|P2|COMPLETED|Overall Study||0
8165263|NCT02499575|20129626|P1|COMPLETED|Overall Study||1
8165264|NCT02499575|20129625|P2|STARTED|Overall Study||1
8165265|NCT02499575|20129626|P1|STARTED|Overall Study||1
8165266|NCT02499406|20129636|P1|NOT COMPLETED|Overall Study||4
8165267|NCT02499406|20129636|P1|COMPLETED|Overall Study||13
8165268|NCT02499406|20129636|P1|STARTED|Overall Study||17
8165269|NCT02499380|20129652|P1|NOT COMPLETED|Overall Study||3
8165270|NCT02499380|20129652|P1|COMPLETED|Overall Study||17
8165271|NCT02499380|20129652|P1|STARTED|Overall Study||20
8165272|NCT02499263|20129657|P1|NOT COMPLETED|Overall Study||62
8165273|NCT02499263|20129657|P1|COMPLETED|Overall Study||84
8165274|NCT02499263|20129657|P1|STARTED|Overall Study||146
8165275|NCT02499172|20129694|P4|NOT COMPLETED|Overall Study||436
8165276|NCT02499172|20129695|P3|NOT COMPLETED|Overall Study||523
8165277|NCT02499172|20129696|P2|NOT COMPLETED|Overall Study||64
8165278|NCT02499172|20129697|P1|NOT COMPLETED|Overall Study||65
8165279|NCT02499172|20129694|P4|COMPLETED|Overall Study||0
8165280|NCT02499172|20129695|P3|COMPLETED|Overall Study||0
8165281|NCT02499172|20129696|P2|COMPLETED|Overall Study||835
8165282|NCT02499172|20129697|P1|COMPLETED|Overall Study||835
8165283|NCT02499172|20129694|P4|STARTED|Overall Study||436
8165284|NCT02499172|20129695|P3|STARTED|Overall Study||523
8165285|NCT02499172|20129696|P2|STARTED|Overall Study||899
8165286|NCT02499172|20129697|P1|STARTED|Overall Study||900
8165299|NCT02499146|20129734|P1|NOT COMPLETED|Overall Study||26
8165300|NCT02499146|20129734|P1|COMPLETED|Overall Study||0
8165301|NCT02499146|20129734|P1|STARTED|Overall Study||26
8165302|NCT02499120|20129774|P2|NOT COMPLETED|Overall Study||60
8165303|NCT02499120|20129775|P1|NOT COMPLETED|Overall Study||65
8165304|NCT02499120|20129774|P2|COMPLETED|Overall Study||0
8165305|NCT02499120|20129775|P1|COMPLETED|Overall Study||0
8165306|NCT02499120|20129774|P2|Received Treatment|Overall Study||60
8165307|NCT02499120|20129775|P1|Received Treatment|Overall Study||64
8165308|NCT02499120|20129774|P2|STARTED|Overall Study||60
8165309|NCT02499120|20129775|P1|STARTED|Overall Study||65
8165310|NCT02499029|20129806|P2|NOT COMPLETED|Overall Study||3
8165311|NCT02499029|20129807|P1|NOT COMPLETED|Overall Study||5
8165312|NCT02499029|20129806|P2|COMPLETED|Overall Study||14
8165313|NCT02499029|20129807|P1|COMPLETED|Overall Study||13
8165314|NCT02499029|20129806|P2|STARTED|Overall Study||17
8165315|NCT02499029|20129807|P1|STARTED|Overall Study||18
8165316|NCT02498834|20129821|P2|NOT COMPLETED|Overall Study||10
8165317|NCT02498834|20129822|P1|NOT COMPLETED|Overall Study||10
8165318|NCT02498834|20129821|P2|COMPLETED|Overall Study||164
8165319|NCT02498834|20129822|P1|COMPLETED|Overall Study||175
8165320|NCT02498834|20129821|P2|STARTED|Overall Study||174
8165321|NCT02498834|20129822|P1|STARTED|Overall Study||185
8165322|NCT02498821|20129834|P2|NOT COMPLETED|Overall Study||5
8165323|NCT02498821|20129835|P1|NOT COMPLETED|Overall Study||3
8165324|NCT02498821|20129834|P2|COMPLETED|Overall Study||60
8165325|NCT02498821|20129835|P1|COMPLETED|Overall Study||60
8165326|NCT02498821|20129834|P2|STARTED|Overall Study||65
8165327|NCT02498821|20129835|P1|STARTED|Overall Study||63
8165328|NCT02498769|20129864|P2|NOT COMPLETED|Overall Study||0
8165329|NCT02498769|20129865|P1|NOT COMPLETED|Overall Study||0
8165330|NCT02498769|20129864|P2|COMPLETED|Overall Study||67
8165331|NCT02498769|20129865|P1|COMPLETED|Overall Study||63
8165332|NCT02498769|20129864|P2|STARTED|Overall Study||67
8165333|NCT02498769|20129865|P1|STARTED|Overall Study||63
8165334|NCT02498678|20129879|P2|NOT COMPLETED|Overall Study||2
8165335|NCT02498678|20129880|P1|NOT COMPLETED|Overall Study||0
8165336|NCT02498678|20129879|P2|COMPLETED|Overall Study||23
8165337|NCT02498678|20129880|P1|COMPLETED|Overall Study||25
8165338|NCT02498678|20129879|P2|STARTED|Overall Study||25
8165339|NCT02498678|20129880|P1|STARTED|Overall Study||25
8165340|NCT02498652|20129896|P2|NOT COMPLETED|Overall Study||1
8165341|NCT02498652|20129897|P1|NOT COMPLETED|Overall Study||0
8165342|NCT02498652|20129896|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
8165343|NCT02498652|20129897|P1|COMPLETED|Overall Study||20
8165344|NCT02498652|20129896|P2|STARTED|Overall Study||21
8165345|NCT02498652|20129897|P1|STARTED|Overall Study||20
8165352|NCT02498522|20130013|P2|NOT COMPLETED|Overall Study||2
8165353|NCT02498522|20130014|P1|NOT COMPLETED|Overall Study||2
8165354|NCT02498522|20130013|P2|COMPLETED|Overall Study||83
8165355|NCT02498522|20130014|P1|COMPLETED|Overall Study||83
8165356|NCT02498522|20130013|P2|STARTED|Overall Study||85
8165357|NCT02498522|20130014|P1|STARTED|Overall Study||85
8165358|NCT02498483|20130022|P2|NOT COMPLETED|Overall Study||0
8165359|NCT02498483|20130023|P1|NOT COMPLETED|Overall Study||0
8165360|NCT02498483|20130022|P2|COMPLETED|Overall Study||5
8165361|NCT02498483|20130023|P1|COMPLETED|Overall Study||6
8165362|NCT02498483|20130022|P2|STARTED|Overall Study||5
8165363|NCT02498483|20130023|P1|STARTED|Overall Study||6
8165364|NCT02498418|20130040|P3|NOT COMPLETED|Overall Study||6
8165365|NCT02498418|20130041|P2|NOT COMPLETED|Overall Study||2
8165366|NCT02498418|20130042|P1|NOT COMPLETED|Overall Study||2
8165367|NCT02498418|20130040|P3|COMPLETED|Overall Study||238
8165368|NCT02498418|20130041|P2|COMPLETED|Overall Study||246
8165369|NCT02498418|20130042|P1|COMPLETED|Overall Study||245
8165370|NCT02498418|20130040|P3|Per-protocol Analysis Set|Overall Study||176
8165371|NCT02498418|20130041|P2|Per-protocol Analysis Set|Overall Study||181
8165372|NCT02498418|20130042|P1|Per-protocol Analysis Set|Overall Study||182
8165373|NCT02498418|20130040|P3|Modified Intent-to-treat Population|Overall Study||180
8165374|NCT02498418|20130041|P2|Modified Intent-to-treat Population|Overall Study||186
8165375|NCT02498418|20130042|P1|Modified Intent-to-treat Population|Overall Study||183
8165376|NCT02498418|20130040|P3|Safety Population|Overall Study||244
8165377|NCT02498418|20130041|P2|Safety Population|Overall Study||247
8165378|NCT02498418|20130042|P1|Safety Population|Overall Study||246
8165379|NCT02498418|20130040|P3|STARTED|Overall Study||244
8165380|NCT02498418|20130041|P2|STARTED|Overall Study||248
8165381|NCT02498418|20130042|P1|STARTED|Overall Study||247
8165382|NCT02498236|20130066|P8|NOT COMPLETED|Overall Study||1
8165383|NCT02498236|20130067|P7|NOT COMPLETED|Overall Study||1
8165384|NCT02498236|20130068|P6|NOT COMPLETED|Overall Study||0
8165385|NCT02498236|20130069|P5|NOT COMPLETED|Overall Study||1
8165386|NCT02498236|20130070|P4|NOT COMPLETED|Overall Study||0
8165387|NCT02498236|20130071|P3|NOT COMPLETED|Overall Study||0
8165388|NCT02498236|20130072|P2|NOT COMPLETED|Overall Study||0
8165389|NCT02498236|20130073|P1|NOT COMPLETED|Overall Study||1
8165390|NCT02498236|20130066|P8|COMPLETED|Overall Study||6
8165391|NCT02498236|20130067|P7|COMPLETED|Overall Study||6
8165392|NCT02498236|20130068|P6|COMPLETED|Overall Study||6
8165393|NCT02498236|20130069|P5|COMPLETED|Overall Study||6
8165394|NCT02498236|20130070|P4|COMPLETED|Overall Study||6
8165395|NCT02498236|20130071|P3|COMPLETED|Overall Study||6
8165396|NCT02498236|20130072|P2|COMPLETED|Overall Study||6
8165397|NCT02498236|20130073|P1|COMPLETED|Overall Study||5
8165398|NCT02498236|20130066|P8|Randomized|Overall Study||7
8165399|NCT02498236|20130067|P7|Randomized|Overall Study||7
8165400|NCT02498236|20130068|P6|Randomized|Overall Study||6
8165401|NCT02498236|20130069|P5|Randomized|Overall Study||7
8165402|NCT02498236|20130070|P4|Randomized|Overall Study||6
8165403|NCT02498236|20130071|P3|Randomized|Overall Study||6
8165404|NCT02498236|20130072|P2|Randomized|Overall Study||6
8165405|NCT02498236|20130073|P1|Randomized|Overall Study||6
8165406|NCT02498236|20130066|P8|STARTED|Overall Study||7
8165407|NCT02498236|20130067|P7|STARTED|Overall Study||7
8165408|NCT02498236|20130068|P6|STARTED|Overall Study||6
8165409|NCT02498236|20130069|P5|STARTED|Overall Study||7
8165410|NCT02498236|20130070|P4|STARTED|Overall Study||6
8165411|NCT02498236|20130071|P3|STARTED|Overall Study||6
8165412|NCT02498236|20130072|P2|STARTED|Overall Study||6
8165413|NCT02498236|20130073|P1|STARTED|Overall Study||6
8165414|NCT02498067|20130102|P1|NOT COMPLETED|Overall Study||33
8165415|NCT02498067|20130102|P1|COMPLETED|Overall Study||71
8165416|NCT02498067|20130102|P1|STARTED|Overall Study||104
8165417|NCT02497976|20130123|P2|NOT COMPLETED|Overall Study||1
8165418|NCT02497976|20130124|P1|NOT COMPLETED|Overall Study||2
8165419|NCT02497976|20130123|P2|COMPLETED|Overall Study||13
8165420|NCT02497976|20130124|P1|COMPLETED|Overall Study||26
8165421|NCT02497976|20130123|P2|STARTED|Overall Study||14
8165422|NCT02497976|20130124|P1|STARTED|Overall Study||28
8165423|NCT02497937|20130140|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
8165424|NCT02497937|20130141|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
8165425|NCT02497937|20130140|P2|COMPLETED|Period 2 (Up to 7 Days)||5
8165426|NCT02497937|20130141|P1|COMPLETED|Period 2 (Up to 7 Days)||6
8165427|NCT02497937|20130140|P2|STARTED|Period 2 (Up to 7 Days)||5
8165428|NCT02497937|20130141|P1|STARTED|Period 2 (Up to 7 Days)||6
8165429|NCT02497937|20130140|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8165430|NCT02497937|20130141|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8165431|NCT02497937|20130140|P2|COMPLETED|Washout Period (Up to 14 Days)||5
8165432|NCT02497937|20130141|P1|COMPLETED|Washout Period (Up to 14 Days)||6
8165433|NCT02497937|20130140|P2|STARTED|Washout Period (Up to 14 Days)||5
8165434|NCT02497937|20130141|P1|STARTED|Washout Period (Up to 14 Days)||6
8165435|NCT02497937|20130140|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
8165436|NCT02497937|20130141|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
8165437|NCT02497937|20130140|P2|COMPLETED|Period 1 (Up to 7 Days)||5
8165438|NCT02497937|20130141|P1|COMPLETED|Period 1 (Up to 7 Days)||6
8165439|NCT02497937|20130140|P2|STARTED|Period 1 (Up to 7 Days)||5
8165440|NCT02497937|20130141|P1|STARTED|Period 1 (Up to 7 Days)||6
8165441|NCT02497781|20130219|P2|NOT COMPLETED|Overall Study||3
8165442|NCT02497781|20130220|P1|NOT COMPLETED|Overall Study||4
8165443|NCT02497781|20130219|P2|COMPLETED|Overall Study||26
8165444|NCT02497781|20130220|P1|COMPLETED|Overall Study||64
8165445|NCT02497781|20130219|P2|Treated|Overall Study||28
8165446|NCT02497781|20130220|P1|Treated|Overall Study||67
8165447|NCT02497781|20130219|P2|STARTED|Overall Study||29
8165448|NCT02497781|20130220|P1|STARTED|Overall Study||68
8165449|NCT02497755|20130283|P2|NOT COMPLETED|Overall Study||0
8165450|NCT02497755|20130284|P1|NOT COMPLETED|Overall Study||1
8165451|NCT02497755|20130283|P2|COMPLETED|Overall Study||1
8165452|NCT02497755|20130284|P1|COMPLETED|Overall Study||17
8165453|NCT02497755|20130283|P2|STARTED|Overall Study||1
8165454|NCT02497755|20130284|P1|STARTED|Overall Study||18
8165455|NCT02497612|20130301|P4|NOT COMPLETED|Overall Study||47
8165456|NCT02497612|20130302|P3|NOT COMPLETED|Overall Study||49
8165457|NCT02497612|20130303|P2|NOT COMPLETED|Overall Study||57
8165458|NCT02497612|20130304|P1|NOT COMPLETED|Overall Study||66
8165459|NCT02497612|20130301|P4|COMPLETED|Overall Study||46
8165460|NCT02497612|20130302|P3|COMPLETED|Overall Study||48
8165461|NCT02497612|20130303|P2|COMPLETED|Overall Study||37
8165462|NCT02497612|20130304|P1|COMPLETED|Overall Study||27
8165463|NCT02497612|20130301|P4|Cohort 4: >6 Months to <=2 Years|Overall Study||7
8165464|NCT02497612|20130302|P3|Cohort 4: >6 Months to <=2 Years|Overall Study||6
8165465|NCT02497612|20130303|P2|Cohort 4: >6 Months to <=2 Years|Overall Study||8
8165466|NCT02497612|20130304|P1|Cohort 4: >6 Months to <=2 Years|Overall Study||7
8165467|NCT02497612|20130301|P4|Cohort 3: >2 Years to <=5 Years|Overall Study||65
8165468|NCT02497612|20130302|P3|Cohort 3: >2 Years to <=5 Years|Overall Study||67
8165469|NCT02497612|20130303|P2|Cohort 3: >2 Years to <=5 Years|Overall Study||66
8165470|NCT02497612|20130304|P1|Cohort 3: >2 Years to <=5 Years|Overall Study||66
8165471|NCT02497612|20130301|P4|Cohort 2: >5 Years to <=14 Years|Overall Study||5
8165472|NCT02497612|20130302|P3|Cohort 2: >5 Years to <=14 Years|Overall Study||6
8165473|NCT02497612|20130303|P2|Cohort 2: >5 Years to <=14 Years|Overall Study||5
8165474|NCT02497612|20130304|P1|Cohort 2: >5 Years to <=14 Years|Overall Study||6
8165475|NCT02497612|20130301|P4|Cohort 1: >14 Years to <70 Years|Overall Study||16
8165476|NCT02497612|20130302|P3|Cohort 1: >14 Years to <70 Years|Overall Study||18
8165477|NCT02497612|20130303|P2|Cohort 1: >14 Years to <70 Years|Overall Study||15
8165478|NCT02497612|20130304|P1|Cohort 1: >14 Years to <70 Years|Overall Study||14
8165479|NCT02497612|20130301|P4|Treated|Overall Study||91
8165480|NCT02497612|20130302|P3|Treated|Overall Study||96
8165481|NCT02497612|20130303|P2|Treated|Overall Study||94
8165482|NCT02497612|20130304|P1|Treated|Overall Study||92
8165483|NCT02497612|20130301|P4|STARTED|Overall Study||93
8165484|NCT02497612|20130302|P3|STARTED|Overall Study||97
8165485|NCT02497612|20130303|P2|STARTED|Overall Study||94
8165486|NCT02497612|20130304|P1|STARTED|Overall Study||93
8165487|NCT02497469|20130432|P2|NOT COMPLETED|Overall Study||115
8165488|NCT02497469|20130433|P1|NOT COMPLETED|Overall Study||169
8165489|NCT02497469|20130432|P2|COMPLETED|Overall Study||270
8165490|NCT02497469|20130433|P1|COMPLETED|Overall Study||217
8165491|NCT02497469|20130432|P2|Safety Analysis Set|Overall Study||383
8165492|NCT02497469|20130433|P1|Safety Analysis Set|Overall Study||386
8165493|NCT02497469|20130432|P2|STARTED|Overall Study||385
8165494|NCT02497469|20130433|P1|STARTED|Overall Study||386
8165495|NCT02497391|20130443|P6|NOT COMPLETED|Period 3 (14 Days)||0
8165496|NCT02497391|20130444|P5|NOT COMPLETED|Period 3 (14 Days)||1
8165497|NCT02497391|20130445|P4|NOT COMPLETED|Period 3 (14 Days)||0
8165498|NCT02497391|20130446|P3|NOT COMPLETED|Period 3 (14 Days)||1
8165499|NCT02497391|20130447|P2|NOT COMPLETED|Period 3 (14 Days)||1
8165500|NCT02497391|20130448|P1|NOT COMPLETED|Period 3 (14 Days)||0
8165501|NCT02497391|20130443|P6|COMPLETED|Period 3 (14 Days)||13
8165502|NCT02497391|20130444|P5|COMPLETED|Period 3 (14 Days)||13
8165503|NCT02497391|20130445|P4|COMPLETED|Period 3 (14 Days)||13
8165504|NCT02497391|20130446|P3|COMPLETED|Period 3 (14 Days)||12
8165505|NCT02497391|20130447|P2|COMPLETED|Period 3 (14 Days)||13
8165506|NCT02497391|20130448|P1|COMPLETED|Period 3 (14 Days)||12
8165507|NCT02497391|20130443|P6|STARTED|Period 3 (14 Days)||13
8165508|NCT02497391|20130444|P5|STARTED|Period 3 (14 Days)||14
8165509|NCT02497391|20130445|P4|STARTED|Period 3 (14 Days)||13
8165510|NCT02497391|20130446|P3|STARTED|Period 3 (14 Days)||13
8165511|NCT02497391|20130447|P2|STARTED|Period 3 (14 Days)||14
8165512|NCT02497391|20130448|P1|STARTED|Period 3 (14 Days)||12
8165513|NCT02497391|20130443|P6|NOT COMPLETED|Period 2 (14 Days)||3
8165514|NCT02497391|20130444|P5|NOT COMPLETED|Period 2 (14 Days)||2
8165515|NCT02497391|20130445|P4|NOT COMPLETED|Period 2 (14 Days)||3
8165516|NCT02497391|20130446|P3|NOT COMPLETED|Period 2 (14 Days)||3
8165517|NCT02497391|20130447|P2|NOT COMPLETED|Period 2 (14 Days)||1
8165518|NCT02497391|20130448|P1|NOT COMPLETED|Period 2 (14 Days)||4
8165519|NCT02497391|20130443|P6|COMPLETED|Period 2 (14 Days)||13
8165520|NCT02497391|20130444|P5|COMPLETED|Period 2 (14 Days)||14
8165521|NCT02497391|20130445|P4|COMPLETED|Period 2 (14 Days)||13
8165522|NCT02497391|20130446|P3|COMPLETED|Period 2 (14 Days)||13
8165523|NCT02497391|20130447|P2|COMPLETED|Period 2 (14 Days)||14
8165524|NCT02497391|20130448|P1|COMPLETED|Period 2 (14 Days)||12
8165525|NCT02497391|20130443|P6|STARTED|Period 2 (14 Days)||16
8165526|NCT02497391|20130444|P5|STARTED|Period 2 (14 Days)||16
8165527|NCT02497391|20130445|P4|STARTED|Period 2 (14 Days)||16
8165528|NCT02497391|20130446|P3|STARTED|Period 2 (14 Days)||16
8165529|NCT02497391|20130447|P2|STARTED|Period 2 (14 Days)||15
8165530|NCT02497391|20130448|P1|STARTED|Period 2 (14 Days)||16
8165531|NCT02497391|20130443|P6|NOT COMPLETED|Period 1 (14 Days)||0
8165532|NCT02497391|20130444|P5|NOT COMPLETED|Period 1 (14 Days)||0
8165533|NCT02497391|20130445|P4|NOT COMPLETED|Period 1 (14 Days)||0
8165534|NCT02497391|20130446|P3|NOT COMPLETED|Period 1 (14 Days)||0
8165535|NCT02497391|20130447|P2|NOT COMPLETED|Period 1 (14 Days)||0
8165536|NCT02497391|20130448|P1|NOT COMPLETED|Period 1 (14 Days)||0
8165537|NCT02497391|20130443|P6|COMPLETED|Period 1 (14 Days)||16
8165538|NCT02497391|20130444|P5|COMPLETED|Period 1 (14 Days)||16
8165539|NCT02497391|20130445|P4|COMPLETED|Period 1 (14 Days)||16
8165540|NCT02497391|20130446|P3|COMPLETED|Period 1 (14 Days)||16
8165541|NCT02497391|20130447|P2|COMPLETED|Period 1 (14 Days)||15
8165542|NCT02497391|20130448|P1|COMPLETED|Period 1 (14 Days)||16
8165543|NCT02497391|20130443|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165544|NCT02497391|20130444|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165545|NCT02497391|20130445|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165546|NCT02497391|20130446|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165547|NCT02497391|20130447|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
8165548|NCT02497391|20130448|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165549|NCT02497391|20130443|P6|STARTED|Period 1 (14 Days)||16
8165550|NCT02497391|20130444|P5|STARTED|Period 1 (14 Days)||16
8165551|NCT02497391|20130445|P4|STARTED|Period 1 (14 Days)||16
8165552|NCT02497391|20130446|P3|STARTED|Period 1 (14 Days)||16
8165553|NCT02497391|20130447|P2|STARTED|Period 1 (14 Days)||15
8165554|NCT02497391|20130448|P1|STARTED|Period 1 (14 Days)||16
8165555|NCT02497287|20130459|P1|NOT COMPLETED|Follow-up Phase (4 Week)||31
8165556|NCT02497287|20130459|P1|COMPLETED|Follow-up Phase (4 Week)||326
8165557|NCT02497287|20130459|P1|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
8165558|NCT02497287|20130459|P1|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
8165559|NCT02497287|20130459|P1|COMPLETED|Optimization/Maintenance (48 Weeks)||150
8165560|NCT02497287|20130459|P1|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
8165561|NCT02497287|20130459|P1|NOT COMPLETED|Induction Phase (4 Weeks)||199
8165562|NCT02497287|20130459|P1|COMPLETED|Induction Phase (4 Weeks)||580
8165563|NCT02497287|20130459|P1|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
8165564|NCT02497235|20130503|P5|NOT COMPLETED|Overall Study||0
8165565|NCT02497235|20130504|P4|NOT COMPLETED|Overall Study||0
8165566|NCT02497235|20130505|P3|NOT COMPLETED|Overall Study||0
8165567|NCT02497235|20130506|P2|NOT COMPLETED|Overall Study||0
8165568|NCT02497235|20130507|P1|NOT COMPLETED|Overall Study||0
8165569|NCT02497235|20130503|P5|COMPLETED|Overall Study||3
8165570|NCT02497235|20130504|P4|COMPLETED|Overall Study||2
8165571|NCT02497235|20130505|P3|COMPLETED|Overall Study||2
8165572|NCT02497235|20130506|P2|COMPLETED|Overall Study||2
8165573|NCT02497235|20130507|P1|COMPLETED|Overall Study||2
8165574|NCT02497235|20130503|P5|STARTED|Overall Study||3
8165575|NCT02497235|20130504|P4|STARTED|Overall Study||2
8165576|NCT02497235|20130505|P3|STARTED|Overall Study||2
8165577|NCT02497235|20130506|P2|STARTED|Overall Study||2
8165578|NCT02497235|20130507|P1|STARTED|Overall Study||2
8165579|NCT02497040|20130540|P3|NOT COMPLETED|Overall Study||0
8165580|NCT02497040|20130541|P2|NOT COMPLETED|Overall Study||0
8165581|NCT02497040|20130542|P1|NOT COMPLETED|Overall Study||0
8165582|NCT02497040|20130540|P3|COMPLETED|Overall Study||30
8165583|NCT02497040|20130541|P2|COMPLETED|Overall Study||30
8165584|NCT02497040|20130542|P1|COMPLETED|Overall Study||30
8165585|NCT02497040|20130540|P3|STARTED|Overall Study||30
8165586|NCT02497040|20130541|P2|STARTED|Overall Study||30
8165587|NCT02497040|20130542|P1|STARTED|Overall Study||30
8165588|NCT02497001|20130554|P4|NOT COMPLETED|Overall Study||41
8165589|NCT02497001|20130555|P3|NOT COMPLETED|Overall Study||50
8165590|NCT02497001|20130556|P2|NOT COMPLETED|Overall Study||103
8165591|NCT02497001|20130557|P1|NOT COMPLETED|Overall Study||74
8165592|NCT02497001|20130554|P4|COMPLETED|Overall Study||278
8165593|NCT02497001|20130555|P3|COMPLETED|Overall Study||266
8165594|NCT02497001|20130556|P2|COMPLETED|Overall Study||524
8165595|NCT02497001|20130557|P1|COMPLETED|Overall Study||566
8165596|NCT02497001|20130554|P4|STARTED|Overall Study||319
8165597|NCT02497001|20130555|P3|STARTED|Overall Study||316
8165598|NCT02497001|20130556|P2|STARTED|Overall Study||627
8165599|NCT02497001|20130557|P1|STARTED|Overall Study||640
8165600|NCT02496884|20130618|P4|NOT COMPLETED|Overall Study||0
8165601|NCT02496884|20130619|P3|NOT COMPLETED|Overall Study||0
8165602|NCT02496884|20130620|P2|NOT COMPLETED|Overall Study||3
8165603|NCT02496884|20130621|P1|NOT COMPLETED|Overall Study||2
8165604|NCT02496884|20130618|P4|COMPLETED|Overall Study||4
8165605|NCT02496884|20130619|P3|COMPLETED|Overall Study||1
8165606|NCT02496884|20130620|P2|COMPLETED|Overall Study||31
8165607|NCT02496884|20130621|P1|COMPLETED|Overall Study||15
8165608|NCT02496884|20130618|P4|Completed Treatment Per Protocol|Overall Study||3
8165609|NCT02496884|20130619|P3|Completed Treatment Per Protocol|Overall Study||1
8165610|NCT02496884|20130620|P2|Completed Treatment Per Protocol|Overall Study||27
8165611|NCT02496884|20130621|P1|Completed Treatment Per Protocol|Overall Study||16
8165612|NCT02496884|20130618|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8165613|NCT02496884|20130619|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8165614|NCT02496884|20130620|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||33
8165615|NCT02496884|20130621|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8165616|NCT02496884|20130618|P4|Modified Intent to Treat Set (mITT)|Overall Study||4
8165617|NCT02496884|20130619|P3|Modified Intent to Treat Set (mITT)|Overall Study||1
8165618|NCT02496884|20130620|P2|Modified Intent to Treat Set (mITT)|Overall Study||34
8165619|NCT02496884|20130621|P1|Modified Intent to Treat Set (mITT)|Overall Study||17
8165620|NCT02496884|20130618|P4|Safety Analysis Set|Overall Study||4
8165621|NCT02496884|20130619|P3|Safety Analysis Set|Overall Study||1
8165622|NCT02496884|20130620|P2|Safety Analysis Set|Overall Study||34
8165623|NCT02496884|20130621|P1|Safety Analysis Set|Overall Study||17
8165624|NCT02496884|20130618|P4|STARTED|Overall Study||4
8165625|NCT02496884|20130619|P3|STARTED|Overall Study||1
8165626|NCT02496884|20130620|P2|STARTED|Overall Study||34
8165627|NCT02496884|20130621|P1|STARTED|Overall Study||17
8165628|NCT02496767|20130647|P8|NOT COMPLETED|Double-blind, Withdrawal Phase||5
8165629|NCT02496767|20130648|P7|NOT COMPLETED|Double-blind, Withdrawal Phase||4
8165630|NCT02496767|20130649|P6|NOT COMPLETED|Double-blind, Withdrawal Phase||6
8165631|NCT02496767|20130650|P5|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165632|NCT02496767|20130651|P4|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165633|NCT02496767|20130652|P3|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165634|NCT02496767|20130653|P2|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165635|NCT02496767|20130654|P1|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165636|NCT02496767|20130647|P8|COMPLETED|Double-blind, Withdrawal Phase||96
8165637|NCT02496767|20130648|P7|COMPLETED|Double-blind, Withdrawal Phase||99
8165638|NCT02496767|20130649|P6|COMPLETED|Double-blind, Withdrawal Phase||126
8165639|NCT02496767|20130650|P5|COMPLETED|Double-blind, Withdrawal Phase||0
8165640|NCT02496767|20130651|P4|COMPLETED|Double-blind, Withdrawal Phase||0
8165641|NCT02496767|20130652|P3|COMPLETED|Double-blind, Withdrawal Phase||0
8165642|NCT02496767|20130653|P2|COMPLETED|Double-blind, Withdrawal Phase||0
8165643|NCT02496767|20130654|P1|COMPLETED|Double-blind, Withdrawal Phase||0
8165644|NCT02496767|20130647|P8|STARTED|Double-blind, Withdrawal Phase||101
8165645|NCT02496767|20130648|P7|STARTED|Double-blind, Withdrawal Phase||103
8165646|NCT02496767|20130649|P6|STARTED|Double-blind, Withdrawal Phase||132
8165647|NCT02496767|20130650|P5|STARTED|Double-blind, Withdrawal Phase||0
8165648|NCT02496767|20130651|P4|STARTED|Double-blind, Withdrawal Phase||0
8165649|NCT02496767|20130652|P3|STARTED|Double-blind, Withdrawal Phase||0
8165650|NCT02496767|20130653|P2|STARTED|Double-blind, Withdrawal Phase||0
8165651|NCT02496767|20130654|P1|STARTED|Double-blind, Withdrawal Phase||0
8165652|NCT02496767|20130647|P8|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165653|NCT02496767|20130648|P7|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165654|NCT02496767|20130649|P6|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165655|NCT02496767|20130650|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
8165656|NCT02496767|20130651|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
8165657|NCT02496767|20130652|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
8165658|NCT02496767|20130653|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
8165659|NCT02496767|20130654|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165660|NCT02496767|20130647|P8|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165661|NCT02496767|20130648|P7|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165662|NCT02496767|20130649|P6|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165663|NCT02496767|20130650|P5|COMPLETED|Double-blind, Placebo-controlled Phase||59
8165664|NCT02496767|20130651|P4|COMPLETED|Double-blind, Placebo-controlled Phase||65
8165665|NCT02496767|20130652|P3|COMPLETED|Double-blind, Placebo-controlled Phase||80
8165666|NCT02496767|20130653|P2|COMPLETED|Double-blind, Placebo-controlled Phase||132
8165667|NCT02496767|20130654|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165668|NCT02496767|20130647|P8|STARTED|Double-blind, Placebo-controlled Phase||0
8165669|NCT02496767|20130648|P7|STARTED|Double-blind, Placebo-controlled Phase||0
8165670|NCT02496767|20130649|P6|STARTED|Double-blind, Placebo-controlled Phase||0
8165671|NCT02496767|20130650|P5|STARTED|Double-blind, Placebo-controlled Phase||125
8165672|NCT02496767|20130651|P4|STARTED|Double-blind, Placebo-controlled Phase||126
8165673|NCT02496767|20130652|P3|STARTED|Double-blind, Placebo-controlled Phase||126
8165674|NCT02496767|20130653|P2|STARTED|Double-blind, Placebo-controlled Phase||188
8165675|NCT02496767|20130654|P1|STARTED|Double-blind, Placebo-controlled Phase||0
8165676|NCT02496767|20130647|P8|NOT COMPLETED|Open-label Lead-in Phase||0
8165677|NCT02496767|20130648|P7|NOT COMPLETED|Open-label Lead-in Phase||0
8165678|NCT02496767|20130649|P6|NOT COMPLETED|Open-label Lead-in Phase||0
8165679|NCT02496767|20130650|P5|NOT COMPLETED|Open-label Lead-in Phase||0
8165680|NCT02496767|20130651|P4|NOT COMPLETED|Open-label Lead-in Phase||0
8165681|NCT02496767|20130652|P3|NOT COMPLETED|Open-label Lead-in Phase||0
8165682|NCT02496767|20130653|P2|NOT COMPLETED|Open-label Lead-in Phase||0
8165683|NCT02496767|20130654|P1|NOT COMPLETED|Open-label Lead-in Phase||179
8165684|NCT02496767|20130647|P8|COMPLETED|Open-label Lead-in Phase||0
8165685|NCT02496767|20130648|P7|COMPLETED|Open-label Lead-in Phase||0
8165686|NCT02496767|20130649|P6|COMPLETED|Open-label Lead-in Phase||0
8165687|NCT02496767|20130650|P5|COMPLETED|Open-label Lead-in Phase||0
8165688|NCT02496767|20130651|P4|COMPLETED|Open-label Lead-in Phase||0
8165689|NCT02496767|20130652|P3|COMPLETED|Open-label Lead-in Phase||0
8165690|NCT02496767|20130653|P2|COMPLETED|Open-label Lead-in Phase||0
8165691|NCT02496767|20130654|P1|COMPLETED|Open-label Lead-in Phase||565
8165692|NCT02496767|20130647|P8|STARTED|Open-label Lead-in Phase||0
8165693|NCT02496767|20130648|P7|STARTED|Open-label Lead-in Phase||0
8165694|NCT02496767|20130649|P6|STARTED|Open-label Lead-in Phase||0
8165695|NCT02496767|20130650|P5|STARTED|Open-label Lead-in Phase||0
8165696|NCT02496767|20130651|P4|STARTED|Open-label Lead-in Phase||0
8165697|NCT02496767|20130652|P3|STARTED|Open-label Lead-in Phase||0
8165698|NCT02496767|20130653|P2|STARTED|Open-label Lead-in Phase||0
8165699|NCT02496767|20130654|P1|STARTED|Open-label Lead-in Phase||744
8165700|NCT02496702|20130694|P2|NOT COMPLETED|Overall Study||8
8165701|NCT02496702|20130695|P1|NOT COMPLETED|Overall Study||8
8165702|NCT02496702|20130694|P2|COMPLETED|Overall Study||22
8165703|NCT02496702|20130695|P1|COMPLETED|Overall Study||22
8165704|NCT02496702|20130694|P2|Did Not Receive Allocated Intervention|Overall Study||0
8165705|NCT02496702|20130695|P1|Did Not Receive Allocated Intervention|Overall Study||9
8165706|NCT02496702|20130694|P2|Received Allocated Intervention|Overall Study||0
8165707|NCT02496702|20130695|P1|Received Allocated Intervention|Overall Study||21
8165708|NCT02496702|20130694|P2|STARTED|Overall Study||30
8165709|NCT02496702|20130695|P1|STARTED|Overall Study||30
8165710|NCT02496533|20130717|P2|NOT COMPLETED|Overall Study||6
8165711|NCT02496533|20130718|P1|NOT COMPLETED|Overall Study||3
8165712|NCT02496533|20130717|P2|COMPLETED|Overall Study||106
8165713|NCT02496533|20130718|P1|COMPLETED|Overall Study||102
8165714|NCT02496533|20130717|P2|STARTED|Overall Study||112
8165715|NCT02496533|20130718|P1|STARTED|Overall Study||105
8165716|NCT02496221|20130730|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
8165717|NCT02496221|20130731|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
8165718|NCT02496221|20130730|P2|COMPLETED|Treatment Period 2 - 4 Days||9
8165719|NCT02496221|20130731|P1|COMPLETED|Treatment Period 2 - 4 Days||8
8165720|NCT02496221|20130730|P2|STARTED|Treatment Period 2 - 4 Days||10
8165721|NCT02496221|20130731|P1|STARTED|Treatment Period 2 - 4 Days||10
8165722|NCT02496221|20130730|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
8165723|NCT02496221|20130731|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
8165724|NCT02496221|20130730|P2|COMPLETED|Treatment Period 1 - 4 Days||10
8165725|NCT02496221|20130731|P1|COMPLETED|Treatment Period 1 - 4 Days||10
8165726|NCT02496221|20130730|P2|STARTED|Treatment Period 1 - 4 Days||10
8165727|NCT02496221|20130731|P1|STARTED|Treatment Period 1 - 4 Days||10
8165728|NCT02496091|20130765|P1|NOT COMPLETED|Overall Study||2
8165729|NCT02496091|20130765|P1|COMPLETED|Overall Study||142
8165730|NCT02496091|20130765|P1|STARTED|Overall Study||144
8165731|NCT02496039|20130774|P1|NOT COMPLETED|Overall Study||4
8165732|NCT02496039|20130774|P1|COMPLETED|Overall Study||1
8165733|NCT02496039|20130774|P1|STARTED|Overall Study||5
8165734|NCT02496000|20130789|P3|NOT COMPLETED|Overall Study||2
8165735|NCT02496000|20130790|P2|NOT COMPLETED|Overall Study||5
8165736|NCT02496000|20130791|P1|NOT COMPLETED|Overall Study||2
8165737|NCT02496000|20130789|P3|COMPLETED|Overall Study||61
8165738|NCT02496000|20130790|P2|COMPLETED|Overall Study||56
8165739|NCT02496000|20130791|P1|COMPLETED|Overall Study||62
8165740|NCT02496000|20130789|P3|STARTED|Overall Study||63
8165741|NCT02496000|20130790|P2|STARTED|Overall Study||61
8165742|NCT02496000|20130791|P1|STARTED|Overall Study||64
8165743|NCT02495948|20130812|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8165744|NCT02495948|20130813|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8165745|NCT02495948|20130812|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
8165746|NCT02495948|20130813|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
8165747|NCT02495948|20130812|P2|STARTED|Period 2, Second 30 Days of Wear||83
8165748|NCT02495948|20130813|P1|STARTED|Period 2, Second 30 Days of Wear||83
8165749|NCT02495948|20130812|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
8165750|NCT02495948|20130813|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8165751|NCT02495948|20130812|P2|COMPLETED|Period 1, First 30 Days of Wear||83
8165752|NCT02495948|20130813|P1|COMPLETED|Period 1, First 30 Days of Wear||83
8165753|NCT02495948|20130812|P2|STARTED|Period 1, First 30 Days of Wear||84
8165754|NCT02495948|20130813|P1|STARTED|Period 1, First 30 Days of Wear||83
8165755|NCT02495883|20130822|P2|NOT COMPLETED|Overall Study||0
8165756|NCT02495883|20130823|P1|NOT COMPLETED|Overall Study||1
8165757|NCT02495883|20130822|P2|COMPLETED|Overall Study||24
8165758|NCT02495883|20130823|P1|COMPLETED|Overall Study||31
8165759|NCT02495883|20130822|P2|STARTED|Overall Study||24
8165760|NCT02495883|20130823|P1|STARTED|Overall Study||32
8165761|NCT02495857|20130831|P3|NOT COMPLETED|Overall Study||18
8165762|NCT02495857|20130832|P2|NOT COMPLETED|Overall Study||16
8165763|NCT02495857|20130833|P1|NOT COMPLETED|Overall Study||22
8165764|NCT02495857|20130831|P3|COMPLETED|Overall Study||181
8165765|NCT02495857|20130832|P2|COMPLETED|Overall Study||184
8165766|NCT02495857|20130833|P1|COMPLETED|Overall Study||178
8165767|NCT02495857|20130831|P3|STARTED|Overall Study||199
8165768|NCT02495857|20130832|P2|STARTED|Overall Study||200
8165769|NCT02495857|20130833|P1|STARTED|Overall Study||200
8165770|NCT02495844|20130849|P2|NOT COMPLETED|Overall Study||4
8165771|NCT02495844|20130850|P1|NOT COMPLETED|Overall Study||1
8165772|NCT02495844|20130849|P2|COMPLETED|Overall Study||24
8165773|NCT02495844|20130850|P1|COMPLETED|Overall Study||26
8165774|NCT02495844|20130849|P2|STARTED|Overall Study||28
8165775|NCT02495844|20130850|P1|STARTED|Overall Study||27
8165776|NCT02495831|20130880|P2|NOT COMPLETED|Second Intervention||0
8165777|NCT02495831|20130881|P1|NOT COMPLETED|Second Intervention||0
8165778|NCT02495831|20130880|P2|COMPLETED|Second Intervention||10
8165779|NCT02495831|20130881|P1|COMPLETED|Second Intervention||12
8165780|NCT02495831|20130880|P2|STARTED|Second Intervention||10
8165781|NCT02495831|20130881|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
8165782|NCT02495831|20130880|P2|NOT COMPLETED|First Intervention||0
8165783|NCT02495831|20130881|P1|NOT COMPLETED|First Intervention||0
8165784|NCT02495831|20130880|P2|COMPLETED|First Intervention||10
8165785|NCT02495831|20130881|P1|COMPLETED|First Intervention||13
8165786|NCT02495831|20130880|P2|STARTED|First Intervention||10
8165787|NCT02495831|20130881|P1|STARTED|First Intervention||13
8165788|NCT02495779|20130895|P1|NOT COMPLETED|Overall Study||6
8165789|NCT02495779|20130895|P1|COMPLETED|Overall Study||48
8165790|NCT02495779|20130895|P1|STARTED|Overall Study||54
8165791|NCT02495623|20130902|P3|NOT COMPLETED|Overall Study||8
8165792|NCT02495623|20130903|P2|NOT COMPLETED|Overall Study||9
8165793|NCT02495623|20130904|P1|NOT COMPLETED|Overall Study||5
8165794|NCT02495623|20130902|P3|COMPLETED|Overall Study||20
8165795|NCT02495623|20130903|P2|COMPLETED|Overall Study||17
8165796|NCT02495623|20130904|P1|COMPLETED|Overall Study||20
8165797|NCT02495623|20130902|P3|Dosed|Overall Study||22
8165798|NCT02495623|20130903|P2|Dosed|Overall Study||19
8165799|NCT02495623|20130904|P1|Dosed|Overall Study||22
8165800|NCT02495623|20130902|P3|STARTED|Overall Study||28
8165801|NCT02495623|20130903|P2|STARTED|Overall Study||26
8165802|NCT02495623|20130904|P1|STARTED|Overall Study||25
8165803|NCT02495467|20130914|P2|NOT COMPLETED|Second Intervention (4 Weeks)||3
8165804|NCT02495467|20130915|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8165805|NCT02495467|20130914|P2|COMPLETED|Second Intervention (4 Weeks)||113
8165806|NCT02495467|20130915|P1|COMPLETED|Second Intervention (4 Weeks)||112
8165807|NCT02495467|20130914|P2|STARTED|Second Intervention (4 Weeks)||116
8165808|NCT02495467|20130915|P1|STARTED|Second Intervention (4 Weeks)||112
8165809|NCT02495467|20130914|P2|NOT COMPLETED|Washout (1 Week)||2
8165810|NCT02495467|20130915|P1|NOT COMPLETED|Washout (1 Week)||2
8165811|NCT02495467|20130914|P2|COMPLETED|Washout (1 Week)||116
8165812|NCT02495467|20130915|P1|COMPLETED|Washout (1 Week)||112
8165813|NCT02495467|20130914|P2|STARTED|Washout (1 Week)||118
8165814|NCT02495467|20130915|P1|STARTED|Washout (1 Week)||114
8165815|NCT02495467|20130914|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8165816|NCT02495467|20130915|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8165817|NCT02495467|20130914|P2|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
8165818|NCT02495467|20130915|P1|COMPLETED|First Intervention (4 Weeks)||114
8165819|NCT02495467|20130914|P2|STARTED|First Intervention (4 Weeks)||118
8165820|NCT02495467|20130915|P1|STARTED|First Intervention (4 Weeks)||114
8165821|NCT02495454|20130943|P1|NOT COMPLETED|Overall Study||1
8165822|NCT02495454|20130943|P1|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
8165823|NCT02495454|20130943|P1|STARTED|Overall Study||34
8165824|NCT02495389|20130952|P1|NOT COMPLETED|Overall Study||40
8165825|NCT02495389|20130952|P1|COMPLETED|Overall Study||44
8165826|NCT02495389|20130952|P1|STARTED|Overall Study||84
8165827|NCT02495259|20130963|P3|NOT COMPLETED|Overall Study||0
8165828|NCT02495259|20130964|P2|NOT COMPLETED|Overall Study||1
8165829|NCT02495259|20130965|P1|NOT COMPLETED|Overall Study||0
8165830|NCT02495259|20130963|P3|COMPLETED|Overall Study||8
8165831|NCT02495259|20130964|P2|COMPLETED|Overall Study||3
8165832|NCT02495259|20130965|P1|COMPLETED|Overall Study||7
8165833|NCT02495259|20130963|P3|STARTED|Overall Study||8
8165834|NCT02495259|20130964|P2|STARTED|Overall Study||4
8165835|NCT02495259|20130965|P1|STARTED|Overall Study||7
8165836|NCT02495233|20130990|P2|NOT COMPLETED|Overall Study||1
8165837|NCT02495233|20130991|P1|NOT COMPLETED|Overall Study||0
8165838|NCT02495233|20130990|P2|COMPLETED|Overall Study||6
8165839|NCT02495233|20130991|P1|COMPLETED|Overall Study||3
8165840|NCT02495233|20130990|P2|STARTED|Overall Study||7
8165841|NCT02495233|20130991|P1|STARTED|Overall Study||3
8165842|NCT02495168|20131020|P3|NOT COMPLETED|Overall Study||17
8165843|NCT02495168|20131021|P2|NOT COMPLETED|Overall Study||54
8165844|NCT02495168|20131022|P1|NOT COMPLETED|Overall Study||38
8165845|NCT02495168|20131020|P3|COMPLETED|Overall Study||110
8165846|NCT02495168|20131021|P2|COMPLETED|Overall Study||462
8165847|NCT02495168|20131022|P1|COMPLETED|Overall Study||466
8165848|NCT02495168|20131020|P3|Day 42 (D42PPS) Population|Overall Study||88
8165849|NCT02495168|20131021|P2|Day 42 (D42PPS) Population|Overall Study||383
8165850|NCT02495168|20131022|P1|Day 42 (D42PPS) Population|Overall Study||382
8165851|NCT02495168|20131020|P3|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
8165852|NCT02495168|20131021|P2|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
8165853|NCT02495168|20131022|P1|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
8165854|NCT02495168|20131020|P3|Modified Intent-to-Treat Population|Overall Study||111
8165855|NCT02495168|20131021|P2|Modified Intent-to-Treat Population|Overall Study||478
8165856|NCT02495168|20131022|P1|Modified Intent-to-Treat Population|Overall Study||468
8165857|NCT02495168|20131020|P3|Safety Population|Overall Study||126
8165858|NCT02495168|20131021|P2|Safety Population|Overall Study||514
8165859|NCT02495168|20131022|P1|Safety Population|Overall Study||501
8165860|NCT02495168|20131020|P3|STARTED|Overall Study||127
8165861|NCT02495168|20131021|P2|STARTED|Overall Study||516
8165862|NCT02495168|20131022|P1|STARTED|Overall Study||504
8165863|NCT02495103|20131041|P2|NOT COMPLETED|Overall Study||0
8165864|NCT02495103|20131042|P1|NOT COMPLETED|Overall Study||0
8165865|NCT02495103|20131041|P2|COMPLETED|Overall Study||4
8165866|NCT02495103|20131042|P1|COMPLETED|Overall Study||3
8165867|NCT02495103|20131041|P2|STARTED|Overall Study||4
8165868|NCT02495103|20131042|P1|STARTED|Overall Study||3
8165869|NCT02495038|20131057|P3|NOT COMPLETED|Overall Study||0
8165870|NCT02495038|20131058|P2|NOT COMPLETED|Overall Study||0
8165871|NCT02495038|20131059|P1|NOT COMPLETED|Overall Study||0
8165872|NCT02495038|20131057|P3|COMPLETED|Overall Study||27
8165873|NCT02495038|20131058|P2|COMPLETED|Overall Study||27
8165874|NCT02495038|20131059|P1|COMPLETED|Overall Study||27
8165875|NCT02495038|20131057|P3|STARTED|Overall Study||27
8165876|NCT02495038|20131058|P2|STARTED|Overall Study||27
8165877|NCT02495038|20131059|P1|STARTED|Overall Study||27
8165878|NCT02495025|20131096|P2|NOT COMPLETED|Overall Study||14
8165879|NCT02495025|20131097|P1|NOT COMPLETED|Overall Study||26
8165880|NCT02495025|20131096|P2|COMPLETED|Overall Study||61
8165881|NCT02495025|20131097|P1|COMPLETED|Overall Study||51
8165882|NCT02495025|20131096|P2|STARTED|Overall Study||75
8165883|NCT02495025|20131097|P1|STARTED|Overall Study||77
8165884|NCT02494817|20131111|P2|NOT COMPLETED|Overall Study||49
8165885|NCT02494817|20131112|P1|NOT COMPLETED|Overall Study||55
8165886|NCT02494817|20131111|P2|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
8165887|NCT02494817|20131112|P1|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
8165888|NCT02494817|20131111|P2|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
8165889|NCT02494817|20131112|P1|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
8165890|NCT02494817|20131111|P2|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
8165891|NCT02494817|20131112|P1|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
8165892|NCT02494817|20131111|P2|STARTED|Overall Study|representing 68 couples|136
8165893|NCT02494817|20131112|P1|STARTED|Overall Study|representing 81 couples|162
8165894|NCT02494713|20131132|P1|NOT COMPLETED|Overall Study||0
8165895|NCT02494713|20131132|P1|COMPLETED|Overall Study||4
8165896|NCT02494713|20131132|P1|STARTED|Overall Study||4
8165897|NCT02494596|20131149|P3|NOT COMPLETED|Overall Study||1
8165898|NCT02494596|20131150|P2|NOT COMPLETED|Overall Study||5
8165899|NCT02494596|20131151|P1|NOT COMPLETED|Overall Study||3
8165900|NCT02494596|20131149|P3|COMPLETED|Overall Study||6
8165901|NCT02494596|20131150|P2|COMPLETED|Overall Study||2
8165902|NCT02494596|20131151|P1|COMPLETED|Overall Study||2
8165903|NCT02494596|20131149|P3|STARTED|Overall Study||7
8165904|NCT02494596|20131150|P2|STARTED|Overall Study||7
8165905|NCT02494596|20131151|P1|STARTED|Overall Study||5
8165906|NCT02494583|20131179|P3|NOT COMPLETED|Overall Study||250
8165907|NCT02494583|20131180|P2|NOT COMPLETED|Overall Study||257
8165908|NCT02494583|20131181|P1|NOT COMPLETED|Overall Study||256
8165909|NCT02494583|20131179|P3|COMPLETED|Overall Study||0
8165910|NCT02494583|20131180|P2|COMPLETED|Overall Study||0
8165911|NCT02494583|20131181|P1|COMPLETED|Overall Study||0
8165912|NCT02494583|20131179|P3|Treated|Overall Study||244
8165913|NCT02494583|20131180|P2|Treated|Overall Study||250
8165914|NCT02494583|20131181|P1|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
8165915|NCT02494583|20131179|P3|STARTED|Overall Study||250
8165916|NCT02494583|20131180|P2|STARTED|Overall Study||257
8165917|NCT02494583|20131181|P1|STARTED|Overall Study||256
8165918|NCT02494518|20131237|P3|NOT COMPLETED|Overall Study||3
8165919|NCT02494518|20131238|P2|NOT COMPLETED|Overall Study||2
8165920|NCT02494518|20131239|P1|NOT COMPLETED|Overall Study||1
8165921|NCT02494518|20131237|P3|COMPLETED|Overall Study||8
8165922|NCT02494518|20131238|P2|COMPLETED|Overall Study||10
8165923|NCT02494518|20131239|P1|COMPLETED|Overall Study||10
8165924|NCT02494518|20131237|P3|STARTED|Overall Study||11
8165925|NCT02494518|20131238|P2|STARTED|Overall Study||12
8165926|NCT02494518|20131239|P1|STARTED|Overall Study||11
8165927|NCT02494440|20131271|P1|NOT COMPLETED|Overall Study||0
8165928|NCT02494440|20131271|P1|COMPLETED|Overall Study||90
8165929|NCT02494440|20131271|P1|STARTED|Overall Study||90
8165930|NCT02494401|20131279|P2|NOT COMPLETED|Overall Study||27
8165931|NCT02494401|20131280|P1|NOT COMPLETED|Overall Study||25
8165932|NCT02494401|20131279|P2|COMPLETED|Overall Study||106
8165933|NCT02494401|20131280|P1|COMPLETED|Overall Study||109
8165934|NCT02494401|20131279|P2|6 Month Follow up|Overall Study||106
8165935|NCT02494401|20131280|P1|6 Month Follow up|Overall Study||109
8165936|NCT02494401|20131279|P2|Week 16|Overall Study||124
8165937|NCT02494401|20131280|P1|Week 16|Overall Study||123
8165938|NCT02494401|20131279|P2|STARTED|Overall Study||133
8165939|NCT02494401|20131280|P1|STARTED|Overall Study||134
8165940|NCT02494336|20131320|P2|NOT COMPLETED|Overall Study||0
8165941|NCT02494336|20131321|P1|NOT COMPLETED|Overall Study||0
8165942|NCT02494336|20131320|P2|COMPLETED|Overall Study||24
8165943|NCT02494336|20131321|P1|COMPLETED|Overall Study||24
8165944|NCT02494336|20131320|P2|STARTED|Overall Study||24
8165945|NCT02494336|20131321|P1|STARTED|Overall Study||24
8165946|NCT02494323|20131339|P1|NOT COMPLETED|Overall Study||0
8165947|NCT02494323|20131339|P1|COMPLETED|Overall Study||70
8165948|NCT02494323|20131339|P1|STARTED|Overall Study||70
8165949|NCT02494206|20131344|P1|NOT COMPLETED|Overall Study||2
8165950|NCT02494206|20131344|P1|COMPLETED|Overall Study||7
8165951|NCT02494206|20131344|P1|STARTED|Overall Study||9
8165952|NCT02494180|20131350|P2|NOT COMPLETED|Overall Study||0
8165953|NCT02494180|20131351|P1|NOT COMPLETED|Overall Study||0
8165954|NCT02494180|20131350|P2|COMPLETED|Overall Study||85
8165955|NCT02494180|20131351|P1|COMPLETED|Overall Study||85
8165956|NCT02494180|20131350|P2|STARTED|Overall Study||85
8165957|NCT02494180|20131351|P1|STARTED|Overall Study||85
8165958|NCT02494102|20131373|P2|NOT COMPLETED|Overall Study||0
8165959|NCT02494102|20131374|P1|NOT COMPLETED|Overall Study||0
8165960|NCT02494102|20131373|P2|COMPLETED|Overall Study||47
8165961|NCT02494102|20131374|P1|COMPLETED|Overall Study||42
8165962|NCT02494102|20131373|P2|STARTED|Overall Study||47
8165963|NCT02494102|20131374|P1|STARTED|Overall Study||42
8165964|NCT02494076|20131384|P2|NOT COMPLETED|Overall Study||0
8165965|NCT02494076|20131385|P1|NOT COMPLETED|Overall Study||0
8165966|NCT02494076|20131384|P2|COMPLETED|Overall Study||26
8165967|NCT02494076|20131385|P1|COMPLETED|Overall Study||26
8165968|NCT02494076|20131384|P2|STARTED|Overall Study||26
8165969|NCT02494076|20131385|P1|STARTED|Overall Study||26
8165970|NCT02493946|20131398|P3|NOT COMPLETED|Open Label Period||86
8165971|NCT02493946|20131399|P2|NOT COMPLETED|Open Label Period||0
8165972|NCT02493946|20131400|P1|NOT COMPLETED|Open Label Period||0
8165973|NCT02493946|20131398|P3|COMPLETED|Open Label Period||509
8165974|NCT02493946|20131399|P2|COMPLETED|Open Label Period||0
8165975|NCT02493946|20131400|P1|COMPLETED|Open Label Period||0
8165976|NCT02493946|20131398|P3|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
8165977|NCT02493946|20131399|P2|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
8165978|NCT02493946|20131400|P1|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
8165979|NCT02493946|20131398|P3|NOT COMPLETED|DB Period||0
8165980|NCT02493946|20131399|P2|NOT COMPLETED|DB Period||5
8165981|NCT02493946|20131400|P1|NOT COMPLETED|DB Period||8
8165982|NCT02493946|20131398|P3|COMPLETED|DB Period||0
8165983|NCT02493946|20131399|P2|COMPLETED|DB Period||59
8165984|NCT02493946|20131400|P1|COMPLETED|DB Period||118
8165985|NCT02493946|20131398|P3|STARTED|DB Period||0
8165986|NCT02493946|20131399|P2|STARTED|DB Period||64
8165987|NCT02493946|20131400|P1|STARTED|DB Period||126
8165988|NCT02493868|20131433|P2|NOT COMPLETED|Follow-up Phase||2
8165989|NCT02493868|20131434|P1|NOT COMPLETED|Follow-up Phase||11
8165990|NCT02493868|20131433|P2|COMPLETED|Follow-up Phase||62
8165991|NCT02493868|20131434|P1|COMPLETED|Follow-up Phase||470
8165992|NCT02493868|20131433|P2|STARTED|Follow-up Phase||64
8165993|NCT02493868|20131434|P1|STARTED|Follow-up Phase||481
8165994|NCT02493868|20131433|P2|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
8165995|NCT02493868|20131434|P1|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
8165996|NCT02493868|20131433|P2|COMPLETED|Maintenance Phase: DE+TE Participants||177
8165997|NCT02493868|20131434|P1|COMPLETED|Maintenance Phase: DE+TE Participants||139
8165998|NCT02493868|20131433|P2|Stable Responders|Maintenance Phase: DE+TE Participants||59
8165999|NCT02493868|20131434|P1|Stable Responders|Maintenance Phase: DE+TE Participants||62
8166000|NCT02493868|20131433|P2|Stable Remitters|Maintenance Phase: DE+TE Participants||86
8166001|NCT02493868|20131434|P1|Stable Remitters|Maintenance Phase: DE+TE Participants||90
8166002|NCT02493868|20131433|P2|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
8166003|NCT02493868|20131434|P1|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
8166004|NCT02493868|20131433|P2|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
8166005|NCT02493868|20131434|P1|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
8166006|NCT02493868|20131433|P2|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
8166007|NCT02493868|20131434|P1|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
8166008|NCT02493868|20131433|P2|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
8166009|NCT02493868|20131434|P1|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
8166010|NCT02493868|20131433|P2|NOT COMPLETED|Induction Phase: DE Participants||0
8166011|NCT02493868|20131434|P1|NOT COMPLETED|Induction Phase: DE Participants||164
8166012|NCT02493868|20131433|P2|COMPLETED|Induction Phase: DE Participants||0
8166013|NCT02493868|20131434|P1|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
8166014|NCT02493868|20131433|P2|STARTED|Induction Phase: DE Participants||0
8166015|NCT02493868|20131434|P1|STARTED|Induction Phase: DE Participants||437
8166016|NCT02493855|20131483|P3|NOT COMPLETED|Overall Study||0
8166017|NCT02493855|20131484|P2|NOT COMPLETED|Overall Study||1
8166018|NCT02493855|20131485|P1|NOT COMPLETED|Overall Study||2
8166019|NCT02493855|20131483|P3|COMPLETED|Overall Study||6
8166020|NCT02493855|20131484|P2|COMPLETED|Overall Study||18
8166021|NCT02493855|20131485|P1|COMPLETED|Overall Study||19
8166022|NCT02493855|20131483|P3|STARTED|Overall Study||6
8166023|NCT02493855|20131484|P2|STARTED|Overall Study||19
8166024|NCT02493855|20131485|P1|STARTED|Overall Study||21
8166025|NCT02493777|20131495|P2|NOT COMPLETED|Overall Study||1
8166026|NCT02493777|20131496|P1|NOT COMPLETED|Overall Study||0
8166027|NCT02493777|20131495|P2|COMPLETED|Overall Study||53
8166028|NCT02493777|20131496|P1|COMPLETED|Overall Study||65
8166029|NCT02493777|20131495|P2|STARTED|Overall Study||54
8166030|NCT02493777|20131496|P1|STARTED|Overall Study||65
8166031|NCT02493764|20131506|P2|NOT COMPLETED|Overall Study||82
8166032|NCT02493764|20131507|P1|NOT COMPLETED|Overall Study||83
8166033|NCT02493764|20131506|P2|COMPLETED|Overall Study||187
8166034|NCT02493764|20131507|P1|COMPLETED|Overall Study||185
8166035|NCT02493764|20131506|P2|STARTED|Overall Study||269
8166036|NCT02493764|20131507|P1|STARTED|Overall Study||268
8166037|NCT02493751|20131557|P2|NOT COMPLETED|Overall Study||29
8166038|NCT02493751|20131558|P1|NOT COMPLETED|Overall Study||13
8166039|NCT02493751|20131557|P2|COMPLETED|Overall Study|Participants who died were considered as completed.|10
8166040|NCT02493751|20131558|P1|COMPLETED|Overall Study|Participants who died were considered as completed.|3
8166041|NCT02493751|20131557|P2|STARTED|Overall Study||39
8166042|NCT02493751|20131558|P1|STARTED|Overall Study||16
8166043|NCT02493712|20131566|P3|NOT COMPLETED|Overall Study||6
8166044|NCT02493712|20131567|P2|NOT COMPLETED|Overall Study||6
8166045|NCT02493712|20131568|P1|NOT COMPLETED|Overall Study||2
8166046|NCT02493712|20131566|P3|COMPLETED|Overall Study||11
8166047|NCT02493712|20131567|P2|COMPLETED|Overall Study||12
8166048|NCT02493712|20131568|P1|COMPLETED|Overall Study||14
8166049|NCT02493712|20131566|P3|STARTED|Overall Study||17
8166050|NCT02493712|20131567|P2|STARTED|Overall Study||18
8166051|NCT02493712|20131568|P1|STARTED|Overall Study||16
8166052|NCT02493621|20131581|P2|NOT COMPLETED|Overall Study||0
8166053|NCT02493621|20131582|P1|NOT COMPLETED|Overall Study||0
8166054|NCT02493621|20131581|P2|COMPLETED|Overall Study||58
8166055|NCT02493621|20131582|P1|COMPLETED|Overall Study||58
8166056|NCT02493621|20131581|P2|STARTED|Overall Study||58
8166057|NCT02493621|20131582|P1|STARTED|Overall Study||58
8166058|NCT02493608|20131592|P2|NOT COMPLETED|Overall Study||0
8166059|NCT02493608|20131593|P1|NOT COMPLETED|Overall Study||0
8166060|NCT02493608|20131592|P2|COMPLETED|Overall Study||48
8166061|NCT02493608|20131593|P1|COMPLETED|Overall Study||48
8166062|NCT02493608|20131592|P2|STARTED|Overall Study||48
8166063|NCT02493608|20131593|P1|STARTED|Overall Study||48
8166064|NCT02493517|20131605|P2|NOT COMPLETED|Overall Study||7
8166065|NCT02493517|20131606|P1|NOT COMPLETED|Overall Study||2
8166066|NCT02493517|20131605|P2|COMPLETED|Overall Study||57
8166067|NCT02493517|20131606|P1|COMPLETED|Overall Study||62
8166068|NCT02493517|20131605|P2|STARTED|Overall Study||64
8166069|NCT02493517|20131606|P1|STARTED|Overall Study||64
8166070|NCT02493452|20131631|P3|NOT COMPLETED|Overall Study||54
8166071|NCT02493452|20131632|P2|NOT COMPLETED|Overall Study||49
8166072|NCT02493452|20131633|P1|NOT COMPLETED|Overall Study||50
8166073|NCT02493452|20131631|P3|COMPLETED|Overall Study||325
8166074|NCT02493452|20131632|P2|COMPLETED|Overall Study||328
8166075|NCT02493452|20131633|P1|COMPLETED|Overall Study||329
8166076|NCT02493452|20131631|P3|STARTED|Overall Study||379
8166077|NCT02493452|20131632|P2|STARTED|Overall Study||377
8166078|NCT02493452|20131633|P1|STARTED|Overall Study||379
8166079|NCT02493361|20131665|P1|NOT COMPLETED|Overall Study||3
8166080|NCT02493361|20131665|P1|COMPLETED|Overall Study||21
8166081|NCT02493361|20131665|P1|Week 24 Assessment|Overall Study||21
8166082|NCT02493361|20131665|P1|STARTED|Overall Study||24
8166083|NCT02493257|20131677|P2|NOT COMPLETED|Overall Study||1
8166084|NCT02493257|20131678|P1|NOT COMPLETED|Overall Study||1
8166085|NCT02493257|20131677|P2|COMPLETED|Overall Study||10
8166086|NCT02493257|20131678|P1|COMPLETED|Overall Study||10
8166087|NCT02493257|20131677|P2|12 Week Follow up|Overall Study||10
8166088|NCT02493257|20131678|P1|12 Week Follow up|Overall Study||10
8166089|NCT02493257|20131677|P2|4 Week Follow up|Overall Study||11
8166090|NCT02493257|20131678|P1|4 Week Follow up|Overall Study||11
8166091|NCT02493257|20131677|P2|STARTED|Overall Study||11
8166092|NCT02493257|20131678|P1|STARTED|Overall Study||11
8166093|NCT02493127|20131692|P2|NOT COMPLETED|Overall Study||1
8166094|NCT02493127|20131693|P1|NOT COMPLETED|Overall Study||1
8166095|NCT02493127|20131692|P2|COMPLETED|Overall Study||60
8166096|NCT02493127|20131693|P1|COMPLETED|Overall Study||60
8166097|NCT02493127|20131692|P2|STARTED|Overall Study||61
8166098|NCT02493127|20131693|P1|STARTED|Overall Study||61
8166099|NCT02493088|20131705|P1|NOT COMPLETED|Overall Study||0
8166100|NCT02493088|20131705|P1|COMPLETED|Overall Study||11
8166101|NCT02493088|20131705|P1|STARTED|Overall Study||11
8166102|NCT02493062|20131711|P1|NOT COMPLETED|Overall Study||12
8166103|NCT02493062|20131711|P1|COMPLETED|Overall Study||23
8166104|NCT02493062|20131711|P1|STARTED|Overall Study||35
8166105|NCT02493036|20131722|P3|NOT COMPLETED|Overall Study||2
8166106|NCT02493036|20131723|P2|NOT COMPLETED|Overall Study||2
8166107|NCT02493036|20131724|P1|NOT COMPLETED|Overall Study||1
8166108|NCT02493036|20131722|P3|COMPLETED|Overall Study||15
8166109|NCT02493036|20131723|P2|COMPLETED|Overall Study||18
8166110|NCT02493036|20131724|P1|COMPLETED|Overall Study||16
8166111|NCT02493036|20131722|P3|STARTED|Overall Study||17
8166112|NCT02493036|20131723|P2|STARTED|Overall Study||20
8166113|NCT02493036|20131724|P1|STARTED|Overall Study||17
8166114|NCT02492997|20131734|P2|NOT COMPLETED|Overall Study||1
8166115|NCT02492997|20131735|P1|NOT COMPLETED|Overall Study||2
8166116|NCT02492997|20131734|P2|COMPLETED|Overall Study||20
8166117|NCT02492997|20131735|P1|COMPLETED|Overall Study||19
8166118|NCT02492997|20131734|P2|STARTED|Overall Study||21
8166119|NCT02492997|20131735|P1|STARTED|Overall Study||21
8166120|NCT02492984|20131745|P2|NOT COMPLETED|Overall Study||0
8166121|NCT02492984|20131746|P1|NOT COMPLETED|Overall Study||3
8166122|NCT02492984|20131745|P2|COMPLETED|Overall Study||14
8166123|NCT02492984|20131746|P1|COMPLETED|Overall Study||70
8166124|NCT02492984|20131745|P2|STARTED|Overall Study||14
8166125|NCT02492984|20131746|P1|STARTED|Overall Study||73
8166126|NCT02492958|20131770|P4|NOT COMPLETED|Overall Study||0
8166127|NCT02492958|20131771|P3|NOT COMPLETED|Overall Study||2
8166128|NCT02492958|20131772|P2|NOT COMPLETED|Overall Study||0
8166129|NCT02492958|20131773|P1|NOT COMPLETED|Overall Study||1
8166130|NCT02492958|20131770|P4|COMPLETED|Overall Study||34
8166131|NCT02492958|20131771|P3|COMPLETED|Overall Study||32
8166132|NCT02492958|20131772|P2|COMPLETED|Overall Study||34
8166133|NCT02492958|20131773|P1|COMPLETED|Overall Study||33
8166134|NCT02492958|20131770|P4|STARTED|Overall Study||34
8166135|NCT02492958|20131771|P3|STARTED|Overall Study||34
8166136|NCT02492958|20131772|P2|STARTED|Overall Study||34
8166137|NCT02492958|20131773|P1|STARTED|Overall Study||34
8166138|NCT02492880|20131859|P1|NOT COMPLETED|Overall Study||2
8166139|NCT02492880|20131859|P1|COMPLETED|Overall Study||13
8166140|NCT02492880|20131859|P1|STARTED|Overall Study||15
8166141|NCT02492841|20131866|P3|NOT COMPLETED|Overall Study||35
8166142|NCT02492841|20131867|P2|NOT COMPLETED|Overall Study||31
8166143|NCT02492841|20131868|P1|NOT COMPLETED|Overall Study||34
8166144|NCT02492841|20131866|P3|COMPLETED|Overall Study||25
8166145|NCT02492841|20131867|P2|COMPLETED|Overall Study||22
8166146|NCT02492841|20131868|P1|COMPLETED|Overall Study||22
8166147|NCT02492841|20131866|P3|STARTED|Overall Study||60
8166148|NCT02492841|20131867|P2|STARTED|Overall Study||53
8166149|NCT02492841|20131868|P1|STARTED|Overall Study||56
8166150|NCT02492802|20131879|P1|NOT COMPLETED|Overall Study||0
8166151|NCT02492802|20131879|P1|COMPLETED|Overall Study||64
8166152|NCT02492802|20131879|P1|STARTED|Overall Study||64
8166153|NCT02492763|20131887|P4|NOT COMPLETED|Overall Study||13
8166154|NCT02492763|20131888|P3|NOT COMPLETED|Overall Study||10
8166155|NCT02492763|20131889|P2|NOT COMPLETED|Overall Study||15
8166156|NCT02492763|20131890|P1|NOT COMPLETED|Overall Study||16
8166157|NCT02492763|20131887|P4|COMPLETED|Overall Study||30
8166158|NCT02492763|20131888|P3|COMPLETED|Overall Study||33
8166159|NCT02492763|20131889|P2|COMPLETED|Overall Study||29
8166160|NCT02492763|20131890|P1|COMPLETED|Overall Study||30
8166161|NCT02492763|20131887|P4|Treated|Overall Study||42
8166162|NCT02492763|20131888|P3|Treated|Overall Study||43
8166163|NCT02492763|20131889|P2|Treated|Overall Study||44
8166164|NCT02492763|20131890|P1|Treated|Overall Study||46
8166165|NCT02492763|20131887|P4|STARTED|Overall Study||43
8166166|NCT02492763|20131888|P3|STARTED|Overall Study||43
8166167|NCT02492763|20131889|P2|STARTED|Overall Study||44
8166168|NCT02492763|20131890|P1|STARTED|Overall Study||46
8166169|NCT02492750|20131947|P3|NOT COMPLETED|Overall Study||0
8166170|NCT02492750|20131948|P2|NOT COMPLETED|Overall Study||0
8166171|NCT02492750|20131949|P1|NOT COMPLETED|Overall Study||0
8166172|NCT02492750|20131947|P3|COMPLETED|Overall Study||6
8166173|NCT02492750|20131948|P2|COMPLETED|Overall Study||4
8166174|NCT02492750|20131949|P1|COMPLETED|Overall Study||4
8166175|NCT02492750|20131947|P3|STARTED|Overall Study||6
8166176|NCT02492750|20131948|P2|STARTED|Overall Study||4
8166177|NCT02492750|20131949|P1|STARTED|Overall Study||4
8166178|NCT02492451|20131966|P3|NOT COMPLETED|Overall Study||0
8166179|NCT02492451|20131967|P2|NOT COMPLETED|Overall Study||0
8166180|NCT02492451|20131968|P1|NOT COMPLETED|Overall Study||0
8166181|NCT02492451|20131966|P3|COMPLETED|Overall Study||39
8166182|NCT02492451|20131967|P2|COMPLETED|Overall Study||39
8166183|NCT02492451|20131968|P1|COMPLETED|Overall Study||40
8166184|NCT02492451|20131966|P3|STARTED|Overall Study||39
8166185|NCT02492451|20131967|P2|STARTED|Overall Study||39
8166186|NCT02492451|20131968|P1|STARTED|Overall Study||40
8166187|NCT02492295|20131976|P1|NOT COMPLETED|Overall Study||0
8166188|NCT02492295|20131976|P1|COMPLETED|Overall Study||0
8166189|NCT02492295|20131976|P1|STARTED|Overall Study||0
8166190|NCT02492165|20131995|P4|NOT COMPLETED|Overall Study||0
8166191|NCT02492165|20131996|P3|NOT COMPLETED|Overall Study||0
8166192|NCT02492165|20131997|P2|NOT COMPLETED|Overall Study||1
8166193|NCT02492165|20131998|P1|NOT COMPLETED|Overall Study||0
8166194|NCT02492165|20131995|P4|COMPLETED|Overall Study||30
8166195|NCT02492165|20131996|P3|COMPLETED|Overall Study||60
8166196|NCT02492165|20131997|P2|COMPLETED|Overall Study||59
8166197|NCT02492165|20131998|P1|COMPLETED|Overall Study||100
8166198|NCT02492165|20131995|P4|STARTED|Overall Study||30
8166199|NCT02492165|20131996|P3|STARTED|Overall Study||60
8166200|NCT02492165|20131997|P2|STARTED|Overall Study||60
8166201|NCT02492165|20131998|P1|STARTED|Overall Study||100
8166202|NCT02492100|20132020|P1|NOT COMPLETED|Overall Study||1
8166203|NCT02492100|20132020|P1|COMPLETED|Overall Study||46
8166204|NCT02492100|20132020|P1|STARTED|Overall Study||47
8166205|NCT02491944|20132027|P1|NOT COMPLETED|Overall Study||0
8166206|NCT02491944|20132027|P1|COMPLETED|Overall Study||10
8166207|NCT02491944|20132027|P1|STARTED|Overall Study||10
8166208|NCT02491892|20132049|P2|NOT COMPLETED|Overall Study||38
8166209|NCT02491892|20132050|P1|NOT COMPLETED|Overall Study||41
8166210|NCT02491892|20132049|P2|COMPLETED|Overall Study||0
8166211|NCT02491892|20132050|P1|COMPLETED|Overall Study||0
8166212|NCT02491892|20132049|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
8166213|NCT02491892|20132050|P1|Treated|Overall Study||41
8166214|NCT02491892|20132049|P2|STARTED|Overall Study||38
8166215|NCT02491892|20132050|P1|STARTED|Overall Study||41
8166216|NCT02491788|20132096|P2|NOT COMPLETED|Overall Study||0
8166217|NCT02491788|20132097|P1|NOT COMPLETED|Overall Study||0
8166218|NCT02491788|20132096|P2|COMPLETED|Overall Study||11
8166219|NCT02491788|20132097|P1|COMPLETED|Overall Study||8
8166220|NCT02491788|20132096|P2|STARTED|Overall Study||11
8166221|NCT02491788|20132097|P1|STARTED|Overall Study||8
8166222|NCT02491684|20132105|P2|NOT COMPLETED|Treatment Phase||3
8166223|NCT02491684|20132106|P1|NOT COMPLETED|Treatment Phase||3
8166224|NCT02491684|20132105|P2|COMPLETED|Treatment Phase||57
8166225|NCT02491684|20132106|P1|COMPLETED|Treatment Phase||58
8166226|NCT02491684|20132105|P2|STARTED|Treatment Phase||60
8166227|NCT02491684|20132106|P1|STARTED|Treatment Phase||61
8166228|NCT02491684|20132105|P2|NOT COMPLETED|Pre-treatment Phase||0
8166229|NCT02491684|20132106|P1|NOT COMPLETED|Pre-treatment Phase||0
8166230|NCT02491684|20132105|P2|COMPLETED|Pre-treatment Phase||60
8166231|NCT02491684|20132106|P1|COMPLETED|Pre-treatment Phase||61
8166232|NCT02491684|20132105|P2|STARTED|Pre-treatment Phase||60
8166233|NCT02491684|20132106|P1|STARTED|Pre-treatment Phase||61
8166234|NCT02491463|20132144|P4|NOT COMPLETED|Overall Study||1
8166235|NCT02491463|20132145|P3|NOT COMPLETED|Overall Study||4
8166236|NCT02491463|20132146|P2|NOT COMPLETED|Overall Study||10
8166237|NCT02491463|20132147|P1|NOT COMPLETED|Overall Study||2
8166238|NCT02491463|20132144|P4|COMPLETED|Overall Study||14
8166239|NCT02491463|20132145|P3|COMPLETED|Overall Study||15
8166240|NCT02491463|20132146|P2|COMPLETED|Overall Study||21
8166241|NCT02491463|20132147|P1|COMPLETED|Overall Study||5
8166242|NCT02491463|20132144|P4|STARTED|Overall Study||15
8166243|NCT02491463|20132145|P3|STARTED|Overall Study||19
8166244|NCT02491463|20132146|P2|STARTED|Overall Study||31
8166245|NCT02491463|20132147|P1|STARTED|Overall Study||7
8166246|NCT02491437|20132235|P2|NOT COMPLETED|Overall Study||357
8166247|NCT02491437|20132236|P1|NOT COMPLETED|Overall Study||352
8166248|NCT02491437|20132235|P2|COMPLETED|Overall Study||157
8166249|NCT02491437|20132236|P1|COMPLETED|Overall Study||168
8166250|NCT02491437|20132235|P2|Full Analysis Sample|Overall Study||489
8166251|NCT02491437|20132236|P1|Full Analysis Sample|Overall Study||494
8166252|NCT02491437|20132235|P2|Safety Sample|Overall Study||512
8166253|NCT02491437|20132236|P1|Safety Sample|Overall Study||518
8166254|NCT02491437|20132235|P2|STARTED|Overall Study||514
8166255|NCT02491437|20132236|P1|STARTED|Overall Study||520
8166256|NCT02491411|20132250|P1|NOT COMPLETED|Overall Study||4
8166257|NCT02491411|20132250|P1|COMPLETED|Overall Study||0
8166258|NCT02491411|20132250|P1|STARTED|Overall Study||4
8166259|NCT02491359|20132260|P1|NOT COMPLETED|Overall Study||16
8166260|NCT02491359|20132260|P1|COMPLETED|Overall Study||4
8166261|NCT02491359|20132260|P1|STARTED|Overall Study||20
8166262|NCT02491073|20132281|P2|NOT COMPLETED|Overall Study||0
8166263|NCT02491073|20132282|P1|NOT COMPLETED|Overall Study||1
8166264|NCT02491073|20132281|P2|COMPLETED|Overall Study||34
8166265|NCT02491073|20132282|P1|COMPLETED|Overall Study||36
8166266|NCT02491073|20132281|P2|STARTED|Overall Study||34
8166267|NCT02491073|20132282|P1|STARTED|Overall Study||37
8166268|NCT02490670|20132310|P2|NOT COMPLETED|Period 2 (19 Days)||0
8166269|NCT02490670|20132311|P1|NOT COMPLETED|Period 2 (19 Days)||0
8166270|NCT02490670|20132310|P2|COMPLETED|Period 2 (19 Days)||14
8166271|NCT02490670|20132311|P1|COMPLETED|Period 2 (19 Days)||14
8166272|NCT02490670|20132310|P2|STARTED|Period 2 (19 Days)||14
8166273|NCT02490670|20132311|P1|STARTED|Period 2 (19 Days)||14
8166274|NCT02490670|20132310|P2|NOT COMPLETED|Washout Period (7 Days)||0
8166275|NCT02490670|20132311|P1|NOT COMPLETED|Washout Period (7 Days)||0
8166276|NCT02490670|20132310|P2|COMPLETED|Washout Period (7 Days)||14
8166277|NCT02490670|20132311|P1|COMPLETED|Washout Period (7 Days)||14
8166278|NCT02490670|20132310|P2|STARTED|Washout Period (7 Days)||14
8166279|NCT02490670|20132311|P1|STARTED|Washout Period (7 Days)||14
8166280|NCT02490670|20132310|P2|NOT COMPLETED|Period 1 (19 Days)||0
8166281|NCT02490670|20132311|P1|NOT COMPLETED|Period 1 (19 Days)||0
8166282|NCT02490670|20132310|P2|COMPLETED|Period 1 (19 Days)||14
8166283|NCT02490670|20132311|P1|COMPLETED|Period 1 (19 Days)||14
8166284|NCT02490670|20132310|P2|STARTED|Period 1 (19 Days)||14
8166285|NCT02490670|20132311|P1|STARTED|Period 1 (19 Days)||14
8166286|NCT02490631|20132321|P2|NOT COMPLETED|Overall Study||3
8166287|NCT02490631|20132322|P1|NOT COMPLETED|Overall Study||3
8166288|NCT02490631|20132321|P2|COMPLETED|Overall Study||75
8166289|NCT02490631|20132322|P1|COMPLETED|Overall Study||76
8166290|NCT02490631|20132321|P2|STARTED|Overall Study||78
8166291|NCT02490631|20132322|P1|STARTED|Overall Study||79
8166292|NCT02490475|20132334|P4|NOT COMPLETED|Period 2: Extension Phase||1
8166293|NCT02490475|20132335|P3|NOT COMPLETED|Period 2: Extension Phase||3
8166294|NCT02490475|20132336|P2|NOT COMPLETED|Period 2: Extension Phase||0
8166295|NCT02490475|20132337|P1|NOT COMPLETED|Period 2: Extension Phase||1
8166296|NCT02490475|20132334|P4|COMPLETED|Period 2: Extension Phase||0
8166297|NCT02490475|20132335|P3|COMPLETED|Period 2: Extension Phase||0
8166298|NCT02490475|20132336|P2|COMPLETED|Period 2: Extension Phase||0
8166299|NCT02490475|20132337|P1|COMPLETED|Period 2: Extension Phase||0
8166300|NCT02490475|20132334|P4|STARTED|Period 2: Extension Phase||1
8166301|NCT02490475|20132335|P3|STARTED|Period 2: Extension Phase||3
8166302|NCT02490475|20132336|P2|STARTED|Period 2: Extension Phase||0
8166303|NCT02490475|20132337|P1|STARTED|Period 2: Extension Phase||1
8166304|NCT02490475|20132334|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
8166305|NCT02490475|20132335|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
8166306|NCT02490475|20132336|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
8166307|NCT02490475|20132337|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
8166308|NCT02490475|20132334|P4|COMPLETED|Period 1: First 6 Cycles||0
8166309|NCT02490475|20132335|P3|COMPLETED|Period 1: First 6 Cycles||0
8166310|NCT02490475|20132336|P2|COMPLETED|Period 1: First 6 Cycles||0
8166311|NCT02490475|20132337|P1|COMPLETED|Period 1: First 6 Cycles||0
8166312|NCT02490475|20132334|P4|STARTED|Period 1: First 6 Cycles||5
8166313|NCT02490475|20132335|P3|STARTED|Period 1: First 6 Cycles||6
8166314|NCT02490475|20132336|P2|STARTED|Period 1: First 6 Cycles||2
8166315|NCT02490475|20132337|P1|STARTED|Period 1: First 6 Cycles||6
8166316|NCT02490371|20132415|P2|NOT COMPLETED|Overall Study||1
8166317|NCT02490371|20132416|P1|NOT COMPLETED|Overall Study||1
8166318|NCT02490371|20132415|P2|COMPLETED|Overall Study||11
8166319|NCT02490371|20132416|P1|COMPLETED|Overall Study||11
8166320|NCT02490371|20132415|P2|STARTED|Overall Study||12
8166321|NCT02490371|20132416|P1|STARTED|Overall Study||12
8166322|NCT02490293|20132434|P2|NOT COMPLETED|Overall Study||3
8166323|NCT02490293|20132435|P1|NOT COMPLETED|Overall Study||2
8166324|NCT02490293|20132434|P2|COMPLETED|Overall Study||99
8166325|NCT02490293|20132435|P1|COMPLETED|Overall Study||94
8166326|NCT02490293|20132434|P2|STARTED|Overall Study||102
8166327|NCT02490293|20132435|P1|STARTED|Overall Study||96
8166328|NCT02489981|20132443|P1|NOT COMPLETED|Overall Study||127
8166329|NCT02489981|20132443|P1|COMPLETED|Overall Study||213
8166330|NCT02489981|20132443|P1|STARTED|Overall Study||340
8166331|NCT02489968|20132450|P6|NOT COMPLETED|Double-blind Treatment Period||8
8166332|NCT02489968|20132451|P5|NOT COMPLETED|Double-blind Treatment Period||6
8166333|NCT02489968|20132452|P4|NOT COMPLETED|Double-blind Treatment Period||8
8166334|NCT02489968|20132453|P3|NOT COMPLETED|Double-blind Treatment Period||2
8166335|NCT02489968|20132454|P2|NOT COMPLETED|Double-blind Treatment Period||0
8166336|NCT02489968|20132455|P1|NOT COMPLETED|Double-blind Treatment Period||0
8166337|NCT02489968|20132450|P6|COMPLETED|Double-blind Treatment Period||108
8166338|NCT02489968|20132451|P5|COMPLETED|Double-blind Treatment Period||110
8166339|NCT02489968|20132452|P4|COMPLETED|Double-blind Treatment Period||100
8166340|NCT02489968|20132453|P3|COMPLETED|Double-blind Treatment Period||105
8166341|NCT02489968|20132454|P2|COMPLETED|Double-blind Treatment Period||0
8166342|NCT02489968|20132455|P1|COMPLETED|Double-blind Treatment Period||0
8166343|NCT02489968|20132450|P6|STARTED|Double-blind Treatment Period||116
8166344|NCT02489968|20132451|P5|STARTED|Double-blind Treatment Period||116
8166345|NCT02489968|20132452|P4|STARTED|Double-blind Treatment Period||108
8166346|NCT02489968|20132453|P3|STARTED|Double-blind Treatment Period||107
8166347|NCT02489968|20132454|P2|STARTED|Double-blind Treatment Period||0
8166348|NCT02489968|20132455|P1|STARTED|Double-blind Treatment Period||0
8166349|NCT02489968|20132450|P6|NOT COMPLETED|Open-label Treatment Period||0
8166350|NCT02489968|20132451|P5|NOT COMPLETED|Open-label Treatment Period||0
8166351|NCT02489968|20132452|P4|NOT COMPLETED|Open-label Treatment Period||0
8166352|NCT02489968|20132453|P3|NOT COMPLETED|Open-label Treatment Period||0
8166353|NCT02489968|20132454|P2|NOT COMPLETED|Open-label Treatment Period||208
8166354|NCT02489968|20132455|P1|NOT COMPLETED|Open-label Treatment Period||224
8166355|NCT02489968|20132450|P6|COMPLETED|Open-label Treatment Period||0
8166356|NCT02489968|20132451|P5|COMPLETED|Open-label Treatment Period||0
8166357|NCT02489968|20132452|P4|COMPLETED|Open-label Treatment Period||0
8166358|NCT02489968|20132453|P3|COMPLETED|Open-label Treatment Period||0
8166359|NCT02489968|20132454|P2|COMPLETED|Open-label Treatment Period||232
8166360|NCT02489968|20132455|P1|COMPLETED|Open-label Treatment Period||215
8166361|NCT02489968|20132450|P6|STARTED|Open-label Treatment Period||0
8166362|NCT02489968|20132451|P5|STARTED|Open-label Treatment Period||0
8166363|NCT02489968|20132452|P4|STARTED|Open-label Treatment Period||0
8166364|NCT02489968|20132453|P3|STARTED|Open-label Treatment Period||0
8166365|NCT02489968|20132454|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
8166366|NCT02489968|20132455|P1|STARTED|Open-label Treatment Period||439
8166367|NCT02489799|20132469|P2|NOT COMPLETED|Overall Study||9
8166368|NCT02489799|20132470|P1|NOT COMPLETED|Overall Study||9
8166369|NCT02489799|20132469|P2|COMPLETED|Overall Study||38
8166370|NCT02489799|20132470|P1|COMPLETED|Overall Study||36
8166371|NCT02489799|20132469|P2|Postsurgical One Week Visit (V3)|Overall Study||39
8166372|NCT02489799|20132470|P1|Postsurgical One Week Visit (V3)|Overall Study||40
8166373|NCT02489799|20132469|P2|Presurgical Consent Visit (V2)|Overall Study||39
8166374|NCT02489799|20132470|P1|Presurgical Consent Visit (V2)|Overall Study||40
8166375|NCT02489799|20132469|P2|STARTED|Overall Study||47
8166376|NCT02489799|20132470|P1|STARTED|Overall Study||45
8166377|NCT02489773|20132496|P2|NOT COMPLETED|Overall Study||2
8166378|NCT02489773|20132497|P1|NOT COMPLETED|Overall Study||7
8166379|NCT02489773|20132496|P2|COMPLETED|Overall Study||50
8166380|NCT02489773|20132497|P1|COMPLETED|Overall Study||91
8166381|NCT02489773|20132496|P2|STARTED|Overall Study||52
8166382|NCT02489773|20132497|P1|STARTED|Overall Study||98
8166383|NCT02489500|20132507|P2|NOT COMPLETED|Overall Study||1
8166384|NCT02489500|20132508|P1|NOT COMPLETED|Overall Study||1
8166385|NCT02489500|20132507|P2|COMPLETED|Overall Study||0
8166386|NCT02489500|20132508|P1|COMPLETED|Overall Study||1
8166387|NCT02489500|20132507|P2|STARTED|Overall Study||1
8166388|NCT02489500|20132508|P1|STARTED|Overall Study||2
8166389|NCT02489357|20132520|P1|NOT COMPLETED|Overall Study||0
8166390|NCT02489357|20132520|P1|COMPLETED|Overall Study||12
8166391|NCT02489357|20132520|P1|STARTED|Overall Study||12
8166392|NCT02489344|20132526|P1|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
8166393|NCT02489344|20132526|P1|COMPLETED|LTS14116 (Extension Study): 31 Months||5
8166394|NCT02489344|20132526|P1|STARTED|LTS14116 (Extension Study): 31 Months||8
8166395|NCT02489344|20132526|P1|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
8166396|NCT02489344|20132526|P1|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
8166397|NCT02489344|20132526|P1|STARTED|ACT13739 (Initial Study): 26 Weeks||11
8166398|NCT02489279|20132568|P2|NOT COMPLETED|Overall Study||10
8166399|NCT02489279|20132569|P1|NOT COMPLETED|Overall Study||12
8166400|NCT02489279|20132568|P2|COMPLETED|Overall Study||31
8166401|NCT02489279|20132569|P1|COMPLETED|Overall Study||32
8166402|NCT02489279|20132568|P2|STARTED|Overall Study||41
8166403|NCT02489279|20132569|P1|STARTED|Overall Study||44
8166404|NCT02489227|20132584|P3|NOT COMPLETED|Overall Study||19
8166405|NCT02489227|20132585|P2|NOT COMPLETED|Overall Study||34
8166406|NCT02489227|20132586|P1|NOT COMPLETED|Overall Study||54
8166407|NCT02489227|20132584|P3|COMPLETED|Overall Study||117
8166408|NCT02489227|20132585|P2|COMPLETED|Overall Study||101
8166409|NCT02489227|20132586|P1|COMPLETED|Overall Study||220
8166410|NCT02489227|20132584|P3|STARTED|Overall Study||136
8166411|NCT02489227|20132585|P2|STARTED|Overall Study||135
8166412|NCT02489227|20132586|P1|STARTED|Overall Study||274
8166413|NCT02489110|20132598|P2|NOT COMPLETED|Overall Study||25
8166414|NCT02489110|20132599|P1|NOT COMPLETED|Overall Study||27
8166415|NCT02489110|20132598|P2|COMPLETED|Overall Study||50
8166416|NCT02489110|20132599|P1|COMPLETED|Overall Study||48
8166417|NCT02489110|20132598|P2|STARTED|Overall Study||75
8166418|NCT02489110|20132599|P1|STARTED|Overall Study||75
8166419|NCT02488980|20132610|P3|NOT COMPLETED|Overall Study||2
8166420|NCT02488980|20132611|P2|NOT COMPLETED|Overall Study||2
8166421|NCT02488980|20132612|P1|NOT COMPLETED|Overall Study||2
8166422|NCT02488980|20132610|P3|COMPLETED|Overall Study||99
8166423|NCT02488980|20132611|P2|COMPLETED|Overall Study||99
8166424|NCT02488980|20132612|P1|COMPLETED|Overall Study||102
8166425|NCT02488980|20132610|P3|STARTED|Overall Study||101
8166426|NCT02488980|20132611|P2|STARTED|Overall Study||101
8166427|NCT02488980|20132612|P1|STARTED|Overall Study||104
8166428|NCT02488915|20132629|P1|NOT COMPLETED|Overall Study||26
8166429|NCT02488915|20132629|P1|COMPLETED|Overall Study||202
8166430|NCT02488915|20132629|P1|STARTED|Overall Study||228
8166431|NCT02488824|20132647|P2|NOT COMPLETED|Overall Study||1
8166432|NCT02488824|20132648|P1|NOT COMPLETED|Overall Study||1
8166433|NCT02488824|20132647|P2|COMPLETED|Overall Study||19
8166434|NCT02488824|20132648|P1|COMPLETED|Overall Study||20
8166435|NCT02488824|20132647|P2|STARTED|Overall Study||20
8166436|NCT02488824|20132648|P1|STARTED|Overall Study||21
8166437|NCT02488681|20132662|P1|NOT COMPLETED|Overall Study||7
8166438|NCT02488681|20132662|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
8166439|NCT02488681|20132662|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
8166440|NCT02488330|20132666|P1|NOT COMPLETED|Overall Study||12
8166441|NCT02488330|20132666|P1|COMPLETED|Overall Study||0
8166442|NCT02488330|20132666|P1|STARTED|Overall Study||12
8166443|NCT02488317|20132672|P2|NOT COMPLETED|Overall Study||47
8166444|NCT02488317|20132673|P1|NOT COMPLETED|Overall Study||54
8166445|NCT02488317|20132672|P2|COMPLETED|Overall Study||70
8166446|NCT02488317|20132673|P1|COMPLETED|Overall Study||63
8166447|NCT02488317|20132672|P2|STARTED|Overall Study||117
8166448|NCT02488317|20132673|P1|STARTED|Overall Study||117
8166449|NCT02488239|20132687|P1|NOT COMPLETED|Overall Study||10
8166450|NCT02488239|20132687|P1|COMPLETED|Overall Study||54
8166451|NCT02488239|20132687|P1|STARTED|Overall Study||64
8166452|NCT02488070|20132692|P1|NOT COMPLETED|Overall Study||0
8166453|NCT02488070|20132692|P1|COMPLETED|Overall Study||10
8166454|NCT02488070|20132692|P1|STARTED|Overall Study||10
8166455|NCT02488018|20132700|P1|NOT COMPLETED|Overall Study||0
8166456|NCT02488018|20132700|P1|COMPLETED|Overall Study||10
8166457|NCT02488018|20132700|P1|STARTED|Overall Study||10
8166458|NCT02488005|20132704|P1|NOT COMPLETED|Overall Study||2
8166459|NCT02488005|20132704|P1|COMPLETED|Overall Study||13
8166460|NCT02488005|20132704|P1|STARTED|Overall Study||15
8166461|NCT02487979|20132714|P1|NOT COMPLETED|Overall Study||21
8166462|NCT02487979|20132714|P1|COMPLETED|Overall Study||1
8166463|NCT02487979|20132714|P1|STARTED|Overall Study||22
8166464|NCT02487810|20132726|P2|NOT COMPLETED|Overall Study||0
8166465|NCT02487810|20132727|P1|NOT COMPLETED|Overall Study||1
8166466|NCT02487810|20132726|P2|COMPLETED|Overall Study||102
8166467|NCT02487810|20132727|P1|COMPLETED|Overall Study||97
8166468|NCT02487810|20132726|P2|STARTED|Overall Study||102
8166469|NCT02487810|20132727|P1|STARTED|Overall Study||98
8166470|NCT02487771|20132759|P2|NOT COMPLETED|Overall Study||14
8166471|NCT02487771|20132760|P1|NOT COMPLETED|Overall Study||10
8166472|NCT02487771|20132759|P2|COMPLETED|Overall Study||85
8166473|NCT02487771|20132760|P1|COMPLETED|Overall Study||81
8166474|NCT02487771|20132759|P2|STARTED|Overall Study||99
8166475|NCT02487771|20132760|P1|STARTED|Overall Study||91
8166476|NCT02487563|20132913|P3|NOT COMPLETED|Overall Study||1
8166477|NCT02487563|20132914|P2|NOT COMPLETED|Overall Study||3
8166478|NCT02487563|20132915|P1|NOT COMPLETED|Overall Study||2
8166479|NCT02487563|20132913|P3|COMPLETED|Overall Study||31
8166480|NCT02487563|20132914|P2|COMPLETED|Overall Study||30
8166481|NCT02487563|20132915|P1|COMPLETED|Overall Study||30
8166482|NCT02487563|20132913|P3|STARTED|Overall Study||32
8166483|NCT02487563|20132914|P2|STARTED|Overall Study||33
8166484|NCT02487563|20132915|P1|STARTED|Overall Study||32
8166485|NCT02487498|20132926|P2|NOT COMPLETED|Period: Period 2||5
8166486|NCT02487498|20132927|P1|NOT COMPLETED|Period: Period 2||6
8166487|NCT02487498|20132926|P2|COMPLETED|Period: Period 2||154
8166488|NCT02487498|20132927|P1|COMPLETED|Period: Period 2||164
8166489|NCT02487498|20132926|P2|STARTED|Period: Period 2||159
8166490|NCT02487498|20132927|P1|STARTED|Period: Period 2||170
8166491|NCT02487498|20132926|P2|NOT COMPLETED|Period: Washout||7
8166492|NCT02487498|20132927|P1|NOT COMPLETED|Period: Washout||2
8166493|NCT02487498|20132926|P2|COMPLETED|Period: Washout||159
8166494|NCT02487498|20132927|P1|COMPLETED|Period: Washout||170
8166495|NCT02487498|20132926|P2|STARTED|Period: Washout||166
8166496|NCT02487498|20132927|P1|STARTED|Period: Washout||172
8166497|NCT02487498|20132926|P2|NOT COMPLETED|Period: Period 1||11
8166498|NCT02487498|20132927|P1|NOT COMPLETED|Period: Period 1||6
8166499|NCT02487498|20132926|P2|COMPLETED|Period: Period 1||166
8166500|NCT02487498|20132927|P1|COMPLETED|Period: Period 1||172
8166501|NCT02487498|20132926|P2|STARTED|Period: Period 1||177
8166502|NCT02487498|20132927|P1|STARTED|Period: Period 1||178
8166503|NCT02487485|20132952|P2|NOT COMPLETED|Overall Study||3
8166504|NCT02487485|20132953|P1|NOT COMPLETED|Overall Study||3
8166505|NCT02487485|20132952|P2|COMPLETED|Overall Study||8
8166506|NCT02487485|20132953|P1|COMPLETED|Overall Study||9
8166507|NCT02487485|20132952|P2|STARTED|Overall Study||11
8166508|NCT02487485|20132953|P1|STARTED|Overall Study||12
8166509|NCT02487472|20132971|P1|NOT COMPLETED|Overall Study||11
8166510|NCT02487472|20132971|P1|COMPLETED|Overall Study||90
8166511|NCT02487472|20132971|P1|STARTED|Overall Study||101
8166512|NCT02487446|20132987|P2|NOT COMPLETED|Period 2||5
8166513|NCT02487446|20132988|P1|NOT COMPLETED|Period 2||8
8166514|NCT02487446|20132987|P2|COMPLETED|Period 2||158
8166515|NCT02487446|20132988|P1|COMPLETED|Period 2||154
8166516|NCT02487446|20132987|P2|STARTED|Period 2||163
8166517|NCT02487446|20132988|P1|STARTED|Period 2||162
8166518|NCT02487446|20132987|P2|NOT COMPLETED|Washout||8
8166519|NCT02487446|20132988|P1|NOT COMPLETED|Washout||3
8166520|NCT02487446|20132987|P2|COMPLETED|Washout||163
8166521|NCT02487446|20132988|P1|COMPLETED|Washout||162
8166522|NCT02487446|20132987|P2|STARTED|Washout||171
8166523|NCT02487446|20132988|P1|STARTED|Washout||165
8166524|NCT02487446|20132987|P2|NOT COMPLETED|Period 1||8
8166525|NCT02487446|20132988|P1|NOT COMPLETED|Period 1||13
8166526|NCT02487446|20132987|P2|COMPLETED|Period 1||171
8166527|NCT02487446|20132988|P1|COMPLETED|Period 1||165
8166528|NCT02487446|20132987|P2|STARTED|Period 1||179
8166529|NCT02487446|20132988|P1|STARTED|Period 1||178
8166530|NCT02487303|20133014|P3|NOT COMPLETED|Overall Study||1
8166531|NCT02487303|20133015|P2|NOT COMPLETED|Overall Study||4
8166532|NCT02487303|20133016|P1|NOT COMPLETED|Overall Study||2
8166533|NCT02487303|20133014|P3|COMPLETED|Overall Study||47
8166534|NCT02487303|20133015|P2|COMPLETED|Overall Study||47
8166535|NCT02487303|20133016|P1|COMPLETED|Overall Study||47
8166536|NCT02487303|20133014|P3|STARTED|Overall Study||48
8166537|NCT02487303|20133015|P2|STARTED|Overall Study||51
8166538|NCT02487303|20133016|P1|STARTED|Overall Study||49
8166539|NCT02487277|20133035|P2|NOT COMPLETED|Overall Study||0
8166540|NCT02487277|20133036|P1|NOT COMPLETED|Overall Study||0
8166541|NCT02487277|20133035|P2|COMPLETED|Overall Study||0
8166542|NCT02487277|20133036|P1|COMPLETED|Overall Study||3
8166543|NCT02487277|20133035|P2|STARTED|Overall Study||0
8166544|NCT02487277|20133036|P1|STARTED|Overall Study||3
8166545|NCT02487225|20133053|P2|NOT COMPLETED|Overall Study||30
8166546|NCT02487225|20133054|P1|NOT COMPLETED|Overall Study||27
8166547|NCT02487225|20133053|P2|COMPLETED|Overall Study||8
8166548|NCT02487225|20133054|P1|COMPLETED|Overall Study||18
8166549|NCT02487225|20133053|P2|STARTED|Overall Study||38
8166550|NCT02487225|20133054|P1|STARTED|Overall Study||45
8166551|NCT02487199|20133068|P2|NOT COMPLETED|Overall Study||1
8166552|NCT02487199|20133069|P1|NOT COMPLETED|Overall Study||0
8166553|NCT02487199|20133068|P2|COMPLETED|Overall Study||4
8166554|NCT02487199|20133069|P1|COMPLETED|Overall Study||13
8166555|NCT02487199|20133068|P2|STARTED|Overall Study||5
8166556|NCT02487199|20133069|P1|STARTED|Overall Study||13
8166557|NCT02487056|20133081|P1|NOT COMPLETED|Overall Study||16
8166558|NCT02487056|20133081|P1|COMPLETED|Overall Study||1606
8166559|NCT02487056|20133081|P1|STARTED|Overall Study||1622
8166560|NCT02487030|20133094|P7|NOT COMPLETED|Overall Study||0
8166561|NCT02487030|20133095|P6|NOT COMPLETED|Overall Study||1
8166562|NCT02487030|20133096|P5|NOT COMPLETED|Overall Study||2
8166563|NCT02487030|20133097|P4|NOT COMPLETED|Overall Study||2
8166564|NCT02487030|20133098|P3|NOT COMPLETED|Overall Study||2
8166565|NCT02487030|20133099|P2|NOT COMPLETED|Overall Study||4
8166566|NCT02487030|20133100|P1|NOT COMPLETED|Overall Study||2
8166567|NCT02487030|20133094|P7|COMPLETED|Overall Study||11
8166568|NCT02487030|20133095|P6|COMPLETED|Overall Study||37
8166569|NCT02487030|20133096|P5|COMPLETED|Overall Study||34
8166570|NCT02487030|20133097|P4|COMPLETED|Overall Study||40
8166571|NCT02487030|20133098|P3|COMPLETED|Overall Study||41
8166572|NCT02487030|20133099|P2|COMPLETED|Overall Study||38
8166573|NCT02487030|20133100|P1|COMPLETED|Overall Study||41
8166574|NCT02487030|20133094|P7|STARTED|Overall Study||11
8166575|NCT02487030|20133095|P6|STARTED|Overall Study||38
8166576|NCT02487030|20133096|P5|STARTED|Overall Study||36
8166577|NCT02487030|20133097|P4|STARTED|Overall Study||42
8166578|NCT02487030|20133098|P3|STARTED|Overall Study||43
8166579|NCT02487030|20133099|P2|STARTED|Overall Study||42
8166580|NCT02487030|20133100|P1|STARTED|Overall Study||43
8166581|NCT02486952|20133131|P1|NOT COMPLETED|Overall Study||50
8166582|NCT02486952|20133131|P1|COMPLETED|Overall Study||104
8166583|NCT02486952|20133131|P1|Started Induction Therapy|Overall Study||151
8166584|NCT02486952|20133131|P1|STARTED|Overall Study||154
8166585|NCT02486939|20133138|P2|NOT COMPLETED|Overall Study||2
8166586|NCT02486939|20133139|P1|NOT COMPLETED|Overall Study||1
8166587|NCT02486939|20133138|P2|COMPLETED|Overall Study||132
8166588|NCT02486939|20133139|P1|COMPLETED|Overall Study||224
8166589|NCT02486939|20133138|P2|STARTED|Overall Study||134
8166590|NCT02486939|20133139|P1|STARTED|Overall Study||225
8166591|NCT02486796|20133149|P2|NOT COMPLETED|Overall Study||1
8166592|NCT02486796|20133150|P1|NOT COMPLETED|Overall Study||2
8166593|NCT02486796|20133149|P2|COMPLETED|Overall Study||1
8166594|NCT02486796|20133150|P1|COMPLETED|Overall Study||1
8166595|NCT02486796|20133149|P2|STARTED|Overall Study||2
8166596|NCT02486796|20133150|P1|STARTED|Overall Study||3
8166597|NCT02486757|20133162|P1|NOT COMPLETED|Overall Study||1
8166598|NCT02486757|20133162|P1|COMPLETED|Overall Study||5
8166599|NCT02486757|20133162|P1|STARTED|Overall Study||6
8166600|NCT02486692|20133168|P2|NOT COMPLETED|Overall Study||7
8166601|NCT02486692|20133169|P1|NOT COMPLETED|Overall Study||4
8166602|NCT02486692|20133168|P2|COMPLETED|Overall Study||23
8166603|NCT02486692|20133169|P1|COMPLETED|Overall Study||26
8166604|NCT02486692|20133168|P2|STARTED|Overall Study||30
8166605|NCT02486692|20133169|P1|STARTED|Overall Study||30
8166606|NCT02486653|20133181|P2|NOT COMPLETED|Overall Study||4
8166607|NCT02486653|20133182|P1|NOT COMPLETED|Overall Study||6
8166608|NCT02486653|20133181|P2|COMPLETED|Overall Study||71
8166609|NCT02486653|20133182|P1|COMPLETED|Overall Study||70
8166610|NCT02486653|20133181|P2|STARTED|Overall Study||75
8166611|NCT02486653|20133182|P1|STARTED|Overall Study||76
8166612|NCT02486627|20133206|P2|NOT COMPLETED|Overall Study||9
8166613|NCT02486627|20133207|P1|NOT COMPLETED|Overall Study||7
8166614|NCT02486627|20133206|P2|COMPLETED|Overall Study||294
8166615|NCT02486627|20133207|P1|COMPLETED|Overall Study||299
8166616|NCT02486627|20133206|P2|STARTED|Overall Study||303
8166617|NCT02486627|20133207|P1|STARTED|Overall Study||306
8166618|NCT02486588|20133230|P6|NOT COMPLETED|Overall Study||746
8166619|NCT02486588|20133231|P5|NOT COMPLETED|Overall Study||746
8166620|NCT02486588|20133232|P4|NOT COMPLETED|Overall Study||738
8166621|NCT02486588|20133233|P3|NOT COMPLETED|Overall Study||755
8166622|NCT02486588|20133234|P2|NOT COMPLETED|Overall Study||750
8166623|NCT02486588|20133235|P1|NOT COMPLETED|Overall Study||738
8166624|NCT02486588|20133230|P6|COMPLETED|Overall Study||459
8166625|NCT02486588|20133231|P5|COMPLETED|Overall Study||497
8166626|NCT02486588|20133232|P4|COMPLETED|Overall Study||468
8166627|NCT02486588|20133233|P3|COMPLETED|Overall Study||465
8166628|NCT02486588|20133234|P2|COMPLETED|Overall Study||502
8166629|NCT02486588|20133235|P1|COMPLETED|Overall Study||450
8166630|NCT02486588|20133230|P6|STARTED|Overall Study||1205
8166631|NCT02486588|20133231|P5|STARTED|Overall Study||1243
8166632|NCT02486588|20133232|P4|STARTED|Overall Study||1206
8166633|NCT02486588|20133233|P3|STARTED|Overall Study||1220
8166634|NCT02486588|20133234|P2|STARTED|Overall Study||1252
8166635|NCT02486588|20133235|P1|STARTED|Overall Study||1188
8166636|NCT02486328|20133293|P2|NOT COMPLETED|Overall Study||1
8166637|NCT02486328|20133294|P1|NOT COMPLETED|Overall Study||2
8166638|NCT02486328|20133293|P2|COMPLETED|Overall Study||50
8166639|NCT02486328|20133294|P1|COMPLETED|Overall Study||50
8166640|NCT02486328|20133293|P2|STARTED|Overall Study||51
8166641|NCT02486328|20133294|P1|STARTED|Overall Study||52
8166642|NCT02486302|20133310|P1|NOT COMPLETED|Overall Study||676
8166643|NCT02486302|20133310|P1|COMPLETED|Overall Study||858
8166644|NCT02486302|20133310|P1|Treated|Overall Study||1523
8166645|NCT02486302|20133310|P1|STARTED|Overall Study||1534
8166646|NCT02486263|20133367|P2|NOT COMPLETED|Overall Study||1
8166647|NCT02486263|20133368|P1|NOT COMPLETED|Overall Study||3
8166648|NCT02486263|20133367|P2|COMPLETED|Overall Study||35
8166649|NCT02486263|20133368|P1|COMPLETED|Overall Study||37
8166650|NCT02486263|20133367|P2|STARTED|Overall Study||36
8166651|NCT02486263|20133368|P1|STARTED|Overall Study||40
8166652|NCT02486211|20133384|P2|NOT COMPLETED|Overall Study||0
8166653|NCT02486211|20133385|P1|NOT COMPLETED|Overall Study||1
8166654|NCT02486211|20133384|P2|COMPLETED|Overall Study||7
8166655|NCT02486211|20133385|P1|COMPLETED|Overall Study||6
8166656|NCT02486211|20133384|P2|STARTED|Overall Study||7
8166657|NCT02486211|20133385|P1|STARTED|Overall Study||7
8166658|NCT02486016|20133399|P1|NOT COMPLETED|Overall Study||0
8166659|NCT02486016|20133399|P1|COMPLETED|Overall Study||10
8166660|NCT02486016|20133399|P1|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
8166661|NCT02485925|20133407|P1|NOT COMPLETED|Overall Study||15
8166662|NCT02485925|20133407|P1|COMPLETED|Overall Study||185
8166663|NCT02485925|20133407|P1|Per-Protocol Population|Overall Study||166
8166664|NCT02485925|20133407|P1|Intent to Treat (ITT) Population|Overall Study||193
8166665|NCT02485925|20133407|P1|Safety Population|Overall Study||200
8166666|NCT02485925|20133407|P1|STARTED|Overall Study||200
8166667|NCT02485912|20133417|P2|NOT COMPLETED|Overall Study||0
8166668|NCT02485912|20133418|P1|NOT COMPLETED|Overall Study||0
8166669|NCT02485912|20133417|P2|COMPLETED|Overall Study||20
8166670|NCT02485912|20133418|P1|COMPLETED|Overall Study||20
8166671|NCT02485912|20133417|P2|STARTED|Overall Study||20
8166672|NCT02485912|20133418|P1|STARTED|Overall Study||20
8166673|NCT02485834|20133426|P2|NOT COMPLETED|Overall Study||0
8166674|NCT02485834|20133427|P1|NOT COMPLETED|Overall Study||0
8166675|NCT02485834|20133426|P2|COMPLETED|Overall Study||2
8166676|NCT02485834|20133427|P1|COMPLETED|Overall Study||3
8166677|NCT02485834|20133426|P2|STARTED|Overall Study||2
8166678|NCT02485834|20133427|P1|STARTED|Overall Study||3
8166679|NCT02485717|20133439|P3|NOT COMPLETED|Overall Study||1
8166680|NCT02485717|20133440|P2|NOT COMPLETED|Overall Study||2
8166681|NCT02485717|20133441|P1|NOT COMPLETED|Overall Study||6
8166682|NCT02485717|20133439|P3|COMPLETED|Overall Study||19
8166683|NCT02485717|20133440|P2|COMPLETED|Overall Study||127
8166684|NCT02485717|20133441|P1|COMPLETED|Overall Study||136
8166685|NCT02485717|20133439|P3|STARTED|Overall Study||20
8166686|NCT02485717|20133440|P2|STARTED|Overall Study||129
8166687|NCT02485717|20133441|P1|STARTED|Overall Study||142
8166688|NCT02485704|20133456|P2|NOT COMPLETED|Overall Study||8
8166689|NCT02485704|20133457|P1|NOT COMPLETED|Overall Study||5
8166690|NCT02485704|20133456|P2|COMPLETED|Overall Study||118
8166691|NCT02485704|20133457|P1|COMPLETED|Overall Study||149
8166692|NCT02485704|20133456|P2|STARTED|Overall Study||126
8166693|NCT02485704|20133457|P1|STARTED|Overall Study||154
8166694|NCT02485561|20133466|P3|NOT COMPLETED|Overall Study||23
8166695|NCT02485561|20133467|P2|NOT COMPLETED|Overall Study||39
8166696|NCT02485561|20133468|P1|NOT COMPLETED|Overall Study||28
8166697|NCT02485561|20133466|P3|COMPLETED|Overall Study||136
8166698|NCT02485561|20133467|P2|COMPLETED|Overall Study||118
8166699|NCT02485561|20133468|P1|COMPLETED|Overall Study||133
8166700|NCT02485561|20133466|P3|Completed 1 mo Survey|Overall Study||144
8166701|NCT02485561|20133467|P2|Completed 1 mo Survey|Overall Study||138
8166702|NCT02485561|20133468|P1|Completed 1 mo Survey|Overall Study||145
8166703|NCT02485561|20133466|P3|STARTED|Overall Study||159
8166704|NCT02485561|20133467|P2|STARTED|Overall Study||157
8166705|NCT02485561|20133468|P1|STARTED|Overall Study||161
8166706|NCT02485483|20133505|P2|NOT COMPLETED|Overall Study||0
8166707|NCT02485483|20133506|P1|NOT COMPLETED|Overall Study||54
8166708|NCT02485483|20133505|P2|COMPLETED|Overall Study||1015
8166709|NCT02485483|20133506|P1|COMPLETED|Overall Study||223
8166710|NCT02485483|20133505|P2|STARTED|Overall Study||1015
8166711|NCT02485483|20133506|P1|STARTED|Overall Study||277
8166712|NCT02485353|20133521|P1|NOT COMPLETED|Overall Study||2
8166713|NCT02485353|20133521|P1|COMPLETED|Overall Study||0
8166714|NCT02485353|20133521|P1|STARTED|Overall Study||2
8166715|NCT02485301|20133528|P2|NOT COMPLETED|Overall Study||49
8166716|NCT02485301|20133529|P1|NOT COMPLETED|Overall Study||38
8166717|NCT02485301|20133528|P2|COMPLETED|Overall Study||1455
8166718|NCT02485301|20133529|P1|COMPLETED|Overall Study||1471
8166719|NCT02485301|20133528|P2|STARTED|Overall Study||1504
8166720|NCT02485301|20133529|P1|STARTED|Overall Study||1509
8166721|NCT02485158|20133579|P1|NOT COMPLETED|Overall Study||4
8166722|NCT02485158|20133579|P1|COMPLETED|Overall Study||24
8166723|NCT02485158|20133579|P1|STARTED|Overall Study||28
8166724|NCT02484911|20133668|P2|NOT COMPLETED|Overall Study||2
8166725|NCT02484911|20133669|P1|NOT COMPLETED|Overall Study||4
8166726|NCT02484911|20133668|P2|COMPLETED|Overall Study||58
8166727|NCT02484911|20133669|P1|COMPLETED|Overall Study||56
8166728|NCT02484911|20133668|P2|STARTED|Overall Study||60
8166729|NCT02484911|20133669|P1|STARTED|Overall Study||60
8166730|NCT02484898|20133697|P1|NOT COMPLETED|Overall Study||18
8166731|NCT02484898|20133697|P1|COMPLETED|Overall Study||182
8166732|NCT02484898|20133697|P1|STARTED|Overall Study||200
8166733|NCT02484859|20133703|P2|NOT COMPLETED|Overall Study||0
8166734|NCT02484859|20133704|P1|NOT COMPLETED|Overall Study||0
8166735|NCT02484859|20133703|P2|COMPLETED|Overall Study||44
8166736|NCT02484859|20133704|P1|COMPLETED|Overall Study||44
8166737|NCT02484859|20133703|P2|STARTED|Overall Study||44
8166738|NCT02484859|20133704|P1|STARTED|Overall Study||44
8166739|NCT02484807|20133724|P6|NOT COMPLETED|Overall Study||0
8166740|NCT02484807|20133725|P5|NOT COMPLETED|Overall Study||0
8166741|NCT02484807|20133726|P4|NOT COMPLETED|Overall Study||0
8166742|NCT02484807|20133727|P3|NOT COMPLETED|Overall Study||0
8166743|NCT02484807|20133728|P2|NOT COMPLETED|Overall Study||0
8166744|NCT02484807|20133729|P1|NOT COMPLETED|Overall Study||0
8166745|NCT02484807|20133724|P6|COMPLETED|Overall Study||6
8166746|NCT02484807|20133725|P5|COMPLETED|Overall Study||33
8166747|NCT02484807|20133726|P4|COMPLETED|Overall Study||21
8166748|NCT02484807|20133727|P3|COMPLETED|Overall Study||19
8166749|NCT02484807|20133728|P2|COMPLETED|Overall Study||7
8166750|NCT02484807|20133729|P1|COMPLETED|Overall Study||39
8166751|NCT02484807|20133724|P6|STARTED|Overall Study||6
8166752|NCT02484807|20133725|P5|STARTED|Overall Study||33
8166753|NCT02484807|20133726|P4|STARTED|Overall Study||21
8166754|NCT02484807|20133727|P3|STARTED|Overall Study||19
8166755|NCT02484807|20133728|P2|STARTED|Overall Study||7
8166756|NCT02484807|20133729|P1|STARTED|Overall Study||39
8166757|NCT02484729|20133759|P10|NOT COMPLETED|Overall Study||1
8166758|NCT02484729|20133760|P9|NOT COMPLETED|Overall Study||0
8166759|NCT02484729|20133761|P8|NOT COMPLETED|Overall Study||0
8166760|NCT02484729|20133762|P7|NOT COMPLETED|Overall Study||0
8166761|NCT02484729|20133763|P6|NOT COMPLETED|Overall Study||0
8166762|NCT02484729|20133764|P5|NOT COMPLETED|Overall Study||0
8166763|NCT02484729|20133765|P4|NOT COMPLETED|Overall Study||0
8166764|NCT02484729|20133766|P3|NOT COMPLETED|Overall Study||0
8166765|NCT02484729|20133767|P2|NOT COMPLETED|Overall Study||0
8166766|NCT02484729|20133768|P1|NOT COMPLETED|Overall Study||0
8166767|NCT02484729|20133759|P10|COMPLETED|Overall Study||7
8166768|NCT02484729|20133760|P9|COMPLETED|Overall Study||6
8166769|NCT02484729|20133761|P8|COMPLETED|Overall Study||6
8166770|NCT02484729|20133762|P7|COMPLETED|Overall Study||5
8166771|NCT02484729|20133763|P6|COMPLETED|Overall Study||6
8166772|NCT02484729|20133764|P5|COMPLETED|Overall Study||5
8166773|NCT02484729|20133765|P4|COMPLETED|Overall Study||6
8166774|NCT02484729|20133766|P3|COMPLETED|Overall Study||6
8166775|NCT02484729|20133767|P2|COMPLETED|Overall Study||6
8166776|NCT02484729|20133768|P1|COMPLETED|Overall Study||16
8166777|NCT02484729|20133759|P10|STARTED|Overall Study||8
8166778|NCT02484729|20133760|P9|STARTED|Overall Study||6
8166779|NCT02484729|20133761|P8|STARTED|Overall Study||6
8166780|NCT02484729|20133762|P7|STARTED|Overall Study||5
8166781|NCT02484729|20133763|P6|STARTED|Overall Study||6
8166782|NCT02484729|20133764|P5|STARTED|Overall Study||5
8166783|NCT02484729|20133765|P4|STARTED|Overall Study||6
8166784|NCT02484729|20133766|P3|STARTED|Overall Study||6
8166785|NCT02484729|20133767|P2|STARTED|Overall Study||6
8166786|NCT02484729|20133768|P1|STARTED|Overall Study||16
8166787|NCT02484690|20133969|P5|NOT COMPLETED|Overall Study||6
8166788|NCT02484690|20133970|P4|NOT COMPLETED|Overall Study||2
8166789|NCT02484690|20133971|P3|NOT COMPLETED|Overall Study||3
8166790|NCT02484690|20133972|P2|NOT COMPLETED|Overall Study||6
8166791|NCT02484690|20133973|P1|NOT COMPLETED|Overall Study||4
8166792|NCT02484690|20133969|P5|COMPLETED|Overall Study||58
8166793|NCT02484690|20133970|P4|COMPLETED|Overall Study||44
8166794|NCT02484690|20133971|P3|COMPLETED|Overall Study||36
8166795|NCT02484690|20133972|P2|COMPLETED|Overall Study||40
8166796|NCT02484690|20133973|P1|COMPLETED|Overall Study||64
8166797|NCT02484690|20133969|P5|Received at Least One Dose of Study Drug|Overall Study||64
8166798|NCT02484690|20133970|P4|Received at Least One Dose of Study Drug|Overall Study||46
8166799|NCT02484690|20133971|P3|Received at Least One Dose of Study Drug|Overall Study||39
8166800|NCT02484690|20133972|P2|Received at Least One Dose of Study Drug|Overall Study||46
8166801|NCT02484690|20133973|P1|Received at Least One Dose of Study Drug|Overall Study||67
8166802|NCT02484690|20133969|P5|STARTED|Overall Study||64
8166803|NCT02484690|20133970|P4|STARTED|Overall Study||46
8166804|NCT02484690|20133971|P3|STARTED|Overall Study||39
8166805|NCT02484690|20133972|P2|STARTED|Overall Study||46
8166806|NCT02484690|20133973|P1|STARTED|Overall Study||68
8166807|NCT02484651|20134117|P2|NOT COMPLETED|Overall Study||4
8166808|NCT02484651|20134118|P1|NOT COMPLETED|Overall Study||3
8166809|NCT02484651|20134117|P2|COMPLETED|Overall Study||31
8166810|NCT02484651|20134118|P1|COMPLETED|Overall Study||32
8166811|NCT02484651|20134117|P2|Data Analysis|Overall Study||31
8166812|NCT02484651|20134118|P1|Data Analysis|Overall Study||32
8166813|NCT02484651|20134117|P2|End of Clinical Study|Overall Study||35
8166814|NCT02484651|20134118|P1|End of Clinical Study|Overall Study||35
8166815|NCT02484651|20134117|P2|STARTED|Overall Study|35 patients were randomized|35
8166816|NCT02484651|20134118|P1|STARTED|Overall Study|35 patients were randomized|35
8166817|NCT02484222|20134130|P1|NOT COMPLETED|Overall Study||3
8166818|NCT02484222|20134130|P1|COMPLETED|Overall Study||77
8166819|NCT02484222|20134130|P1|STARTED|Overall Study||80
8166820|NCT02484092|20134137|P1|NOT COMPLETED|Overall Study||0
8166821|NCT02484092|20134137|P1|COMPLETED|Overall Study||15
8166822|NCT02484092|20134137|P1|STARTED|Overall Study||15
8166823|NCT02483975|20134152|P2|NOT COMPLETED|Overall Study||2
8166824|NCT02483975|20134153|P1|NOT COMPLETED|Overall Study||2
8166825|NCT02483975|20134152|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
8166826|NCT02483975|20134153|P1|COMPLETED|Overall Study||54
8166827|NCT02483975|20134152|P2|STARTED|Overall Study||55
8166828|NCT02483975|20134153|P1|STARTED|Overall Study||56
8166829|NCT02483676|20134169|P2|NOT COMPLETED|Overall Study||5
8166830|NCT02483676|20134170|P1|NOT COMPLETED|Overall Study||6
8166831|NCT02483676|20134169|P2|COMPLETED|Overall Study||17
8166832|NCT02483676|20134170|P1|COMPLETED|Overall Study||17
8166833|NCT02483676|20134169|P2|STARTED|Overall Study||22
8166834|NCT02483676|20134170|P1|STARTED|Overall Study||23
8166835|NCT02483611|20134191|P3|NOT COMPLETED|Overall Study||1
8166836|NCT02483611|20134192|P2|NOT COMPLETED|Overall Study||0
8166837|NCT02483611|20134193|P1|NOT COMPLETED|Overall Study||0
8166838|NCT02483611|20134191|P3|COMPLETED|Overall Study|One patient required decurarization|15
8166839|NCT02483611|20134192|P2|COMPLETED|Overall Study||16
8166840|NCT02483611|20134193|P1|COMPLETED|Overall Study||16
8166841|NCT02483611|20134191|P3|STARTED|Overall Study||16
8166842|NCT02483611|20134192|P2|STARTED|Overall Study||16
8166843|NCT02483611|20134193|P1|STARTED|Overall Study||16
8166844|NCT02483585|20134290|P2|NOT COMPLETED|Open-label Treatment Phase||25
8166845|NCT02483585|20134291|P1|NOT COMPLETED|Open-label Treatment Phase||27
8166846|NCT02483585|20134290|P2|COMPLETED|Open-label Treatment Phase||243
8166847|NCT02483585|20134291|P1|COMPLETED|Open-label Treatment Phase||243
8166848|NCT02483585|20134290|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
8166849|NCT02483585|20134291|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
8166850|NCT02483585|20134290|P2|NOT COMPLETED|Double-blind Treatment Phase||15
8166851|NCT02483585|20134291|P1|NOT COMPLETED|Double-blind Treatment Phase||16
8166852|NCT02483585|20134290|P2|COMPLETED|Double-blind Treatment Phase||271
8166853|NCT02483585|20134291|P1|COMPLETED|Double-blind Treatment Phase||275
8166854|NCT02483585|20134290|P2|Received Treatment|Double-blind Treatment Phase||283
8166855|NCT02483585|20134291|P1|Received Treatment|Double-blind Treatment Phase||289
8166856|NCT02483585|20134290|P2|STARTED|Double-blind Treatment Phase||286
8166857|NCT02483585|20134291|P1|STARTED|Double-blind Treatment Phase||291
8166858|NCT02483572|20134313|P2|NOT COMPLETED|Overall Study||1
8166859|NCT02483572|20134314|P1|NOT COMPLETED|Overall Study||2
8166860|NCT02483572|20134313|P2|COMPLETED|Overall Study||1
8166861|NCT02483572|20134314|P1|COMPLETED|Overall Study||0
8166862|NCT02483572|20134313|P2|STARTED|Overall Study||2
8166863|NCT02483572|20134314|P1|STARTED|Overall Study||2
8166864|NCT02483533|20134328|P2|NOT COMPLETED|Overall Study||50
8166865|NCT02483533|20134329|P1|NOT COMPLETED|Overall Study||50
8166866|NCT02483533|20134328|P2|COMPLETED|Overall Study||0
8166867|NCT02483533|20134329|P1|COMPLETED|Overall Study||0
8166868|NCT02483533|20134328|P2|STARTED|Overall Study||50
8166869|NCT02483533|20134329|P1|STARTED|Overall Study||50
8166870|NCT02483520|20134339|P2|NOT COMPLETED|Overall Study||24
8166871|NCT02483520|20134340|P1|NOT COMPLETED|Overall Study||11
8166872|NCT02483520|20134339|P2|COMPLETED|Overall Study||73
8166873|NCT02483520|20134340|P1|COMPLETED|Overall Study||81
8166874|NCT02483520|20134339|P2|Persons With Dementia|Overall Study||41
8166875|NCT02483520|20134340|P1|Persons With Dementia|Overall Study||42
8166876|NCT02483520|20134339|P2|Caregivers|Overall Study||56
8166877|NCT02483520|20134340|P1|Caregivers|Overall Study||50
8166878|NCT02483520|20134339|P2|STARTED|Overall Study||97
8166879|NCT02483520|20134340|P1|STARTED|Overall Study||92
8166880|NCT02483416|20134380|P2|NOT COMPLETED|Overall Study||1
8166881|NCT02483416|20134381|P1|NOT COMPLETED|Overall Study||3
8166882|NCT02483416|20134380|P2|COMPLETED|Overall Study||6
8166883|NCT02483416|20134381|P1|COMPLETED|Overall Study||18
8166884|NCT02483416|20134380|P2|STARTED|Overall Study||7
8166885|NCT02483416|20134381|P1|STARTED|Overall Study||21
8166886|NCT02483000|20134436|P1|NOT COMPLETED|Overall Study||0
8166887|NCT02483000|20134436|P1|COMPLETED|Overall Study||3
8166888|NCT02483000|20134436|P1|STARTED|Overall Study||3
8166889|NCT02482935|20134445|P2|NOT COMPLETED|Period 2||0
8166890|NCT02482935|20134446|P1|NOT COMPLETED|Period 2||0
8166891|NCT02482935|20134445|P2|COMPLETED|Period 2||15
8166892|NCT02482935|20134446|P1|COMPLETED|Period 2||14
8166893|NCT02482935|20134445|P2|Follow-up|Period 2||15
8166894|NCT02482935|20134446|P1|Follow-up|Period 2||14
8166895|NCT02482935|20134445|P2|Received Abemaciclib|Period 2||15
8166896|NCT02482935|20134446|P1|Received Abemaciclib|Period 2||14
8166897|NCT02482935|20134445|P2|STARTED|Period 2||15
8166898|NCT02482935|20134446|P1|STARTED|Period 2||14
8166899|NCT02482935|20134445|P2|NOT COMPLETED|Period 1||0
8166900|NCT02482935|20134446|P1|NOT COMPLETED|Period 1||1
8166901|NCT02482935|20134445|P2|COMPLETED|Period 1||15
8166902|NCT02482935|20134446|P1|COMPLETED|Period 1||14
8166903|NCT02482935|20134445|P2|Washout|Period 1||15
8166904|NCT02482935|20134446|P1|Washout|Period 1||15
8166905|NCT02482935|20134445|P2|Received Abemaciclib|Period 1||15
8166906|NCT02482935|20134446|P1|Received Abemaciclib|Period 1||15
8166907|NCT02482935|20134445|P2|STARTED|Period 1||15
8166908|NCT02482935|20134446|P1|STARTED|Period 1||15
8166909|NCT02482870|20134456|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
8166910|NCT02482870|20134457|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
8166911|NCT02482870|20134456|P2|COMPLETED|Period 2 - Rest of the Study||202
8166912|NCT02482870|20134457|P1|COMPLETED|Period 2 - Rest of the Study||186
8166913|NCT02482870|20134456|P2|STARTED|Period 2 - Rest of the Study||202
8166914|NCT02482870|20134457|P1|STARTED|Period 2 - Rest of the Study||186
8166915|NCT02482870|20134456|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
8166916|NCT02482870|20134457|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
8166917|NCT02482870|20134456|P2|COMPLETED|Period 1 - First 60 Patients||30
8166918|NCT02482870|20134457|P1|COMPLETED|Period 1 - First 60 Patients||30
8166919|NCT02482870|20134456|P2|STARTED|Period 1 - First 60 Patients||30
8166920|NCT02482870|20134457|P1|STARTED|Period 1 - First 60 Patients||30
8166921|NCT02482805|20134474|P3|NOT COMPLETED|Overall Study||0
8166922|NCT02482805|20134475|P2|NOT COMPLETED|Overall Study||4
8166923|NCT02482805|20134476|P1|NOT COMPLETED|Overall Study||4
8166924|NCT02482805|20134474|P3|COMPLETED|Overall Study||20
8166925|NCT02482805|20134475|P2|COMPLETED|Overall Study||23
8166926|NCT02482805|20134476|P1|COMPLETED|Overall Study||22
8166927|NCT02482805|20134474|P3|STARTED|Overall Study||20
8166928|NCT02482805|20134475|P2|STARTED|Overall Study||27
8166929|NCT02482805|20134476|P1|STARTED|Overall Study||26
8166930|NCT02482675|20134490|P23|NOT COMPLETED|Overall Study||0
8166931|NCT02482675|20134491|P22|NOT COMPLETED|Overall Study||0
8166932|NCT02482675|20134492|P21|NOT COMPLETED|Overall Study||0
8166933|NCT02482675|20134493|P20|NOT COMPLETED|Overall Study||0
8166934|NCT02482675|20134494|P19|NOT COMPLETED|Overall Study||0
8166935|NCT02482675|20134495|P18|NOT COMPLETED|Overall Study||0
8166936|NCT02482675|20134496|P17|NOT COMPLETED|Overall Study||0
8166937|NCT02482675|20134497|P16|NOT COMPLETED|Overall Study||0
8166938|NCT02482675|20134498|P15|NOT COMPLETED|Overall Study||0
8166939|NCT02482675|20134499|P14|NOT COMPLETED|Overall Study||0
8166940|NCT02482675|20134500|P13|NOT COMPLETED|Overall Study||0
8166941|NCT02482675|20134501|P12|NOT COMPLETED|Overall Study||0
8166942|NCT02482675|20134502|P11|NOT COMPLETED|Overall Study||0
8166943|NCT02482675|20134503|P10|NOT COMPLETED|Overall Study||0
8166944|NCT02482675|20134504|P9|NOT COMPLETED|Overall Study||0
8166945|NCT02482675|20134505|P8|NOT COMPLETED|Overall Study||0
8166946|NCT02482675|20134506|P7|NOT COMPLETED|Overall Study||0
8166947|NCT02482675|20134507|P6|NOT COMPLETED|Overall Study||0
8166948|NCT02482675|20134508|P5|NOT COMPLETED|Overall Study||0
8166949|NCT02482675|20134509|P4|NOT COMPLETED|Overall Study||0
8166950|NCT02482675|20134510|P3|NOT COMPLETED|Overall Study||0
8166951|NCT02482675|20134511|P2|NOT COMPLETED|Overall Study||0
8166952|NCT02482675|20134512|P1|NOT COMPLETED|Overall Study||0
8166953|NCT02482675|20134490|P23|COMPLETED|Overall Study||1
8166954|NCT02482675|20134491|P22|COMPLETED|Overall Study||1
8166955|NCT02482675|20134492|P21|COMPLETED|Overall Study||1
8166956|NCT02482675|20134493|P20|COMPLETED|Overall Study||1
8166957|NCT02482675|20134494|P19|COMPLETED|Overall Study||1
8166958|NCT02482675|20134495|P18|COMPLETED|Overall Study||1
8166959|NCT02482675|20134496|P17|COMPLETED|Overall Study||1
8166960|NCT02482675|20134497|P16|COMPLETED|Overall Study||1
8166961|NCT02482675|20134498|P15|COMPLETED|Overall Study||1
8166962|NCT02482675|20134499|P14|COMPLETED|Overall Study||1
8166963|NCT02482675|20134500|P13|COMPLETED|Overall Study||1
8166964|NCT02482675|20134501|P12|COMPLETED|Overall Study||1
8166965|NCT02482675|20134502|P11|COMPLETED|Overall Study||1
8166966|NCT02482675|20134503|P10|COMPLETED|Overall Study||1
8166967|NCT02482675|20134504|P9|COMPLETED|Overall Study||1
8166968|NCT02482675|20134505|P8|COMPLETED|Overall Study||1
8166969|NCT02482675|20134506|P7|COMPLETED|Overall Study||1
8166970|NCT02482675|20134507|P6|COMPLETED|Overall Study||1
8166971|NCT02482675|20134508|P5|COMPLETED|Overall Study||1
8166972|NCT02482675|20134509|P4|COMPLETED|Overall Study||1
8166973|NCT02482675|20134510|P3|COMPLETED|Overall Study||1
8166974|NCT02482675|20134511|P2|COMPLETED|Overall Study||1
8166975|NCT02482675|20134512|P1|COMPLETED|Overall Study||1
8166976|NCT02482675|20134490|P23|STARTED|Overall Study||1
8166977|NCT02482675|20134491|P22|STARTED|Overall Study||1
8166978|NCT02482675|20134492|P21|STARTED|Overall Study||1
8166979|NCT02482675|20134493|P20|STARTED|Overall Study||1
8166980|NCT02482675|20134494|P19|STARTED|Overall Study||1
8166981|NCT02482675|20134495|P18|STARTED|Overall Study||1
8166982|NCT02482675|20134496|P17|STARTED|Overall Study||1
8166983|NCT02482675|20134497|P16|STARTED|Overall Study||1
8166984|NCT02482675|20134498|P15|STARTED|Overall Study||1
8166985|NCT02482675|20134499|P14|STARTED|Overall Study||1
8166986|NCT02482675|20134500|P13|STARTED|Overall Study||1
8166987|NCT02482675|20134501|P12|STARTED|Overall Study||1
8166988|NCT02482675|20134502|P11|STARTED|Overall Study||1
8166989|NCT02482675|20134503|P10|STARTED|Overall Study||1
8166990|NCT02482675|20134504|P9|STARTED|Overall Study||1
8166991|NCT02482675|20134505|P8|STARTED|Overall Study||1
8166992|NCT02482675|20134506|P7|STARTED|Overall Study||1
8166993|NCT02482675|20134507|P6|STARTED|Overall Study||1
8166994|NCT02482675|20134508|P5|STARTED|Overall Study||1
8166995|NCT02482675|20134509|P4|STARTED|Overall Study||1
8166996|NCT02482675|20134510|P3|STARTED|Overall Study||1
8166997|NCT02482675|20134511|P2|STARTED|Overall Study||1
8166998|NCT02482675|20134512|P1|STARTED|Overall Study||1
8166999|NCT02482610|20134570|P6|NOT COMPLETED|Overall Study||0
8167000|NCT02482610|20134571|P5|NOT COMPLETED|Overall Study||0
8167001|NCT02482610|20134572|P4|NOT COMPLETED|Overall Study||0
8167002|NCT02482610|20134573|P3|NOT COMPLETED|Overall Study||0
8167003|NCT02482610|20134574|P2|NOT COMPLETED|Overall Study||0
8167004|NCT02482610|20134575|P1|NOT COMPLETED|Overall Study||0
8167005|NCT02482610|20134570|P6|COMPLETED|Overall Study||5
8167006|NCT02482610|20134571|P5|COMPLETED|Overall Study||3
8167007|NCT02482610|20134572|P4|COMPLETED|Overall Study||3
8167008|NCT02482610|20134573|P3|COMPLETED|Overall Study||2
8167009|NCT02482610|20134574|P2|COMPLETED|Overall Study||5
8167010|NCT02482610|20134575|P1|COMPLETED|Overall Study||4
8167011|NCT02482610|20134570|P6|STARTED|Overall Study||5
8167012|NCT02482610|20134571|P5|STARTED|Overall Study||3
8167013|NCT02482610|20134572|P4|STARTED|Overall Study||3
8167014|NCT02482610|20134573|P3|STARTED|Overall Study||2
8167015|NCT02482610|20134574|P2|STARTED|Overall Study||5
8167016|NCT02482610|20134575|P1|STARTED|Overall Study||4
8167017|NCT02482571|20134595|P1|NOT COMPLETED|Overall Study||8
8167018|NCT02482571|20134595|P1|COMPLETED|Overall Study||17
8167019|NCT02482571|20134595|P1|STARTED|Overall Study||25
8167020|NCT02482428|20134607|P5|NOT COMPLETED|Overall Study||7
8167021|NCT02482428|20134608|P4|NOT COMPLETED|Overall Study||2
8167022|NCT02482428|20134609|P3|NOT COMPLETED|Overall Study||1
8167023|NCT02482428|20134610|P2|NOT COMPLETED|Overall Study||12
8167024|NCT02482428|20134611|P1|NOT COMPLETED|Overall Study||9
8167025|NCT02482428|20134607|P5|COMPLETED|Overall Study||15
8167026|NCT02482428|20134608|P4|COMPLETED|Overall Study||8
8167027|NCT02482428|20134609|P3|COMPLETED|Overall Study||9
8167028|NCT02482428|20134610|P2|COMPLETED|Overall Study||10
8167029|NCT02482428|20134611|P1|COMPLETED|Overall Study||15
8167030|NCT02482428|20134607|P5|STARTED|Overall Study||22
8167031|NCT02482428|20134608|P4|STARTED|Overall Study||10
8167032|NCT02482428|20134609|P3|STARTED|Overall Study||10
8167033|NCT02482428|20134610|P2|STARTED|Overall Study||22
8167034|NCT02482428|20134611|P1|STARTED|Overall Study||24
8167035|NCT02482298|20134634|P3|NOT COMPLETED|Overall Study||3
8167036|NCT02482298|20134635|P2|NOT COMPLETED|Overall Study||3
8167037|NCT02482298|20134636|P1|NOT COMPLETED|Overall Study||2
8167038|NCT02482298|20134634|P3|COMPLETED|Overall Study||27
8167039|NCT02482298|20134635|P2|COMPLETED|Overall Study||24
8167040|NCT02482298|20134636|P1|COMPLETED|Overall Study||28
8167041|NCT02482298|20134634|P3|STARTED|Overall Study||30
8167042|NCT02482298|20134635|P2|STARTED|Overall Study||27
8167043|NCT02482298|20134636|P1|STARTED|Overall Study||30
8167044|NCT02482233|20134658|P2|NOT COMPLETED|Overall Study||1
8167045|NCT02482233|20134659|P1|NOT COMPLETED|Overall Study||1
8167046|NCT02482233|20134658|P2|COMPLETED|Overall Study||19
8167047|NCT02482233|20134659|P1|COMPLETED|Overall Study||9
8167048|NCT02482233|20134658|P2|STARTED|Overall Study||20
8167049|NCT02482233|20134659|P1|STARTED|Overall Study||10
8167050|NCT02482129|20134695|P2|NOT COMPLETED|Overall Study||2
8167051|NCT02482129|20134696|P1|NOT COMPLETED|Overall Study||6
8167052|NCT02482129|20134695|P2|COMPLETED|Overall Study||9
8167053|NCT02482129|20134696|P1|COMPLETED|Overall Study||26
8167054|NCT02482129|20134695|P2|Treated, as Randomized|Overall Study||9
8167055|NCT02482129|20134696|P1|Treated, as Randomized|Overall Study||30
8167056|NCT02482129|20134695|P2|STARTED|Overall Study||11
8167057|NCT02482129|20134696|P1|STARTED|Overall Study||32
8167058|NCT02482025|20134725|P2|NOT COMPLETED|Overall Study||0
8167059|NCT02482025|20134726|P1|NOT COMPLETED|Overall Study||0
8167060|NCT02482025|20134725|P2|COMPLETED|Overall Study||118
8167061|NCT02482025|20134726|P1|COMPLETED|Overall Study||122
8167062|NCT02482025|20134725|P2|STARTED|Overall Study||118
8167063|NCT02482025|20134726|P1|STARTED|Overall Study||122
8167064|NCT02481947|20134736|P2|NOT COMPLETED|Overall Study||36
8167065|NCT02481947|20134737|P1|NOT COMPLETED|Overall Study||46
8167066|NCT02481947|20134736|P2|COMPLETED|Overall Study||193
8167067|NCT02481947|20134737|P1|COMPLETED|Overall Study||184
8167068|NCT02481947|20134736|P2|STARTED|Overall Study||229
8167069|NCT02481947|20134737|P1|STARTED|Overall Study||230
8167070|NCT02481934|20134743|P1|NOT COMPLETED|Overall Study||2
8167071|NCT02481934|20134743|P1|COMPLETED|Overall Study||3
8167072|NCT02481934|20134743|P1|STARTED|Overall Study||5
8167073|NCT02481830|20134750|P2|NOT COMPLETED|Overall Study||20
8167074|NCT02481830|20134751|P1|NOT COMPLETED|Overall Study||2
8167075|NCT02481830|20134750|P2|COMPLETED|Overall Study||265
8167076|NCT02481830|20134751|P1|COMPLETED|Overall Study||282
8167077|NCT02481830|20134750|P2|STARTED|Overall Study||285
8167078|NCT02481830|20134751|P1|STARTED|Overall Study||284
8167079|NCT02481596|20134764|P3|NOT COMPLETED|Overall Study||8
8167080|NCT02481596|20134765|P2|NOT COMPLETED|Overall Study||1
8167081|NCT02481596|20134766|P1|NOT COMPLETED|Overall Study||3
8167082|NCT02481596|20134764|P3|COMPLETED|Overall Study||245
8167083|NCT02481596|20134765|P2|COMPLETED|Overall Study||126
8167084|NCT02481596|20134766|P1|COMPLETED|Overall Study||123
8167085|NCT02481596|20134764|P3|STARTED|Overall Study||253
8167086|NCT02481596|20134765|P2|STARTED|Overall Study||127
8167087|NCT02481596|20134766|P1|STARTED|Overall Study||126
8167088|NCT02481557|20134791|P2|NOT COMPLETED|Overall Study||0
8167089|NCT02481557|20134792|P1|NOT COMPLETED|Overall Study||0
8167090|NCT02481557|20134791|P2|COMPLETED|Overall Study||19
8167091|NCT02481557|20134792|P1|COMPLETED|Overall Study||17
8167092|NCT02481557|20134791|P2|STARTED|Overall Study||19
8167093|NCT02481557|20134792|P1|STARTED|Overall Study||17
8167094|NCT02481440|20134800|P1|NOT COMPLETED|Overall Study||61
8167095|NCT02481440|20134800|P1|COMPLETED|Overall Study||41
8167096|NCT02481440|20134800|P1|STARTED|Overall Study||102
8167097|NCT02481375|20134817|P4|NOT COMPLETED|Overall Study||14
8167098|NCT02481375|20134818|P3|NOT COMPLETED|Overall Study||10
8167099|NCT02481375|20134819|P2|NOT COMPLETED|Overall Study||11
8167100|NCT02481375|20134820|P1|NOT COMPLETED|Overall Study||14
8167101|NCT02481375|20134817|P4|COMPLETED|Overall Study||186
8167102|NCT02481375|20134818|P3|COMPLETED|Overall Study||191
8167103|NCT02481375|20134819|P2|COMPLETED|Overall Study||191
8167104|NCT02481375|20134820|P1|COMPLETED|Overall Study||192
8167105|NCT02481375|20134817|P4|STARTED|Overall Study||200
8167106|NCT02481375|20134818|P3|STARTED|Overall Study||201
8167107|NCT02481375|20134819|P2|STARTED|Overall Study||202
8167108|NCT02481375|20134820|P1|STARTED|Overall Study||206
8167109|NCT02481297|20134832|P2|NOT COMPLETED|Overall Study||0
8167110|NCT02481297|20134833|P1|NOT COMPLETED|Overall Study||0
8167111|NCT02481297|20134832|P2|COMPLETED|Overall Study||6
8167112|NCT02481297|20134833|P1|COMPLETED|Overall Study||1
8167113|NCT02481297|20134832|P2|STARTED|Overall Study||6
8167114|NCT02481297|20134833|P1|STARTED|Overall Study||1
8167115|NCT02481258|20134845|P2|NOT COMPLETED|Overall Study||0
8167116|NCT02481258|20134846|P1|NOT COMPLETED|Overall Study||0
8167117|NCT02481258|20134845|P2|COMPLETED|Overall Study||11
8167118|NCT02481258|20134846|P1|COMPLETED|Overall Study||12
8167119|NCT02481258|20134845|P2|STARTED|Overall Study||11
8167120|NCT02481258|20134846|P1|STARTED|Overall Study||12
8167121|NCT02481219|20134864|P2|NOT COMPLETED|Overall Study||1
8167122|NCT02481219|20134865|P1|NOT COMPLETED|Overall Study||2
8167123|NCT02481219|20134864|P2|COMPLETED|Overall Study||61
8167124|NCT02481219|20134865|P1|COMPLETED|Overall Study||58
8167125|NCT02481219|20134864|P2|STARTED|Overall Study||62
8167126|NCT02481219|20134865|P1|STARTED|Overall Study||60
8167127|NCT02481206|20134883|P2|NOT COMPLETED|Overall Study||1
8167128|NCT02481206|20134884|P1|NOT COMPLETED|Overall Study||5
8167129|NCT02481206|20134883|P2|COMPLETED|Overall Study||31
8167130|NCT02481206|20134884|P1|COMPLETED|Overall Study||29
8167131|NCT02481206|20134883|P2|STARTED|Overall Study||32
8167132|NCT02481206|20134884|P1|STARTED|Overall Study||34
8167133|NCT02481141|20134905|P2|NOT COMPLETED|Overall Study||5
8167134|NCT02481141|20134906|P1|NOT COMPLETED|Overall Study||9
8167135|NCT02481141|20134905|P2|COMPLETED|Overall Study||13
8167136|NCT02481141|20134906|P1|COMPLETED|Overall Study||26
8167137|NCT02481141|20134905|P2|STARTED|Overall Study||18
8167138|NCT02481141|20134906|P1|STARTED|Overall Study||35
8167139|NCT02481050|20134958|P1|NOT COMPLETED|Overall Study||58
8167140|NCT02481050|20134958|P1|COMPLETED|Overall Study||0
8167141|NCT02481050|20134958|P1|STARTED|Overall Study||58
8167142|NCT02480998|20134969|P2|NOT COMPLETED|Overall Study||0
8167143|NCT02480998|20134970|P1|NOT COMPLETED|Overall Study||0
8167144|NCT02480998|20134969|P2|COMPLETED|Overall Study||28
8167145|NCT02480998|20134970|P1|COMPLETED|Overall Study||56
8167146|NCT02480998|20134969|P2|STARTED|Overall Study||28
8167147|NCT02480998|20134970|P1|STARTED|Overall Study||56
8167148|NCT02480920|20134982|P1|NOT COMPLETED|Overall Study||0
8167149|NCT02480920|20134982|P1|COMPLETED|Overall Study||2738
8167150|NCT02480920|20134982|P1|STARTED|Overall Study||2738
8167151|NCT02480764|20134989|P3|NOT COMPLETED|Overall Study||21
8167152|NCT02480764|20134990|P2|NOT COMPLETED|Overall Study||20
8167153|NCT02480764|20134991|P1|NOT COMPLETED|Overall Study||10
8167154|NCT02480764|20134989|P3|COMPLETED|Overall Study||183
8167155|NCT02480764|20134990|P2|COMPLETED|Overall Study||189
8167156|NCT02480764|20134991|P1|COMPLETED|Overall Study||189
8167157|NCT02480764|20134989|P3|STARTED|Overall Study||204
8167158|NCT02480764|20134990|P2|STARTED|Overall Study||209
8167159|NCT02480764|20134991|P1|STARTED|Overall Study||199
8167160|NCT02480712|20135017|P1|NOT COMPLETED|Overall Study||11
8167161|NCT02480712|20135017|P1|COMPLETED|Overall Study||96
8167162|NCT02480712|20135017|P1|STARTED|Overall Study||107
8167163|NCT02480621|20135036|P2|NOT COMPLETED|Follow Up||2
8167164|NCT02480621|20135037|P1|NOT COMPLETED|Follow Up||4
8167165|NCT02480621|20135036|P2|COMPLETED|Follow Up||37
8167166|NCT02480621|20135037|P1|COMPLETED|Follow Up||39
8167167|NCT02480621|20135036|P2|STARTED|Follow Up||39
8167168|NCT02480621|20135037|P1|STARTED|Follow Up||43
8167169|NCT02480621|20135036|P2|NOT COMPLETED|Randomization||1
8167170|NCT02480621|20135037|P1|NOT COMPLETED|Randomization||1
8167171|NCT02480621|20135036|P2|COMPLETED|Randomization||39
8167172|NCT02480621|20135037|P1|COMPLETED|Randomization||43
8167173|NCT02480621|20135036|P2|STARTED|Randomization||40
8167174|NCT02480621|20135037|P1|STARTED|Randomization||44
8167175|NCT02480582|20135043|P6|NOT COMPLETED|Overall Study||0
8167176|NCT02480582|20135044|P5|NOT COMPLETED|Overall Study||0
8167177|NCT02480582|20135045|P4|NOT COMPLETED|Overall Study||0
8167178|NCT02480582|20135046|P3|NOT COMPLETED|Overall Study||0
8167179|NCT02480582|20135047|P2|NOT COMPLETED|Overall Study||0
8167180|NCT02480582|20135048|P1|NOT COMPLETED|Overall Study||0
8167181|NCT02480582|20135043|P6|COMPLETED|Overall Study||7
8167182|NCT02480582|20135044|P5|COMPLETED|Overall Study||7
8167183|NCT02480582|20135045|P4|COMPLETED|Overall Study||7
8167184|NCT02480582|20135046|P3|COMPLETED|Overall Study||7
8167185|NCT02480582|20135047|P2|COMPLETED|Overall Study||7
8167186|NCT02480582|20135048|P1|COMPLETED|Overall Study||7
8167187|NCT02480582|20135043|P6|STARTED|Overall Study||7
8167188|NCT02480582|20135044|P5|STARTED|Overall Study||7
8167189|NCT02480582|20135045|P4|STARTED|Overall Study||7
8167190|NCT02480582|20135046|P3|STARTED|Overall Study||7
8167191|NCT02480582|20135047|P2|STARTED|Overall Study||7
8167192|NCT02480582|20135048|P1|STARTED|Overall Study||7
8167193|NCT02480439|20135071|P3|NOT COMPLETED|Treatment Period 3||0
8167194|NCT02480439|20135072|P2|NOT COMPLETED|Treatment Period 3||0
8167195|NCT02480439|20135073|P1|NOT COMPLETED|Treatment Period 3||0
8167196|NCT02480439|20135071|P3|COMPLETED|Treatment Period 3||7
8167197|NCT02480439|20135072|P2|COMPLETED|Treatment Period 3||7
8167198|NCT02480439|20135073|P1|COMPLETED|Treatment Period 3||8
8167199|NCT02480439|20135071|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
8167200|NCT02480439|20135072|P2|STARTED|Treatment Period 3||7
8167201|NCT02480439|20135073|P1|STARTED|Treatment Period 3||8
8167202|NCT02480439|20135071|P3|NOT COMPLETED|Treatment Period 2||0
8167203|NCT02480439|20135072|P2|NOT COMPLETED|Treatment Period 2||0
8167204|NCT02480439|20135073|P1|NOT COMPLETED|Treatment Period 2||0
8167205|NCT02480439|20135071|P3|COMPLETED|Treatment Period 2||8
8167206|NCT02480439|20135072|P2|COMPLETED|Treatment Period 2||7
8167207|NCT02480439|20135073|P1|COMPLETED|Treatment Period 2||8
8167208|NCT02480439|20135071|P3|STARTED|Treatment Period 2||8
8167209|NCT02480439|20135072|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
8167210|NCT02480439|20135073|P1|STARTED|Treatment Period 2||8
8167211|NCT02480439|20135071|P3|NOT COMPLETED|Treatment Period 1||0
8167212|NCT02480439|20135072|P2|NOT COMPLETED|Treatment Period 1||0
8167213|NCT02480439|20135073|P1|NOT COMPLETED|Treatment Period 1||0
8167214|NCT02480439|20135071|P3|COMPLETED|Treatment Period 1||8
8167215|NCT02480439|20135072|P2|COMPLETED|Treatment Period 1||8
8167216|NCT02480439|20135073|P1|COMPLETED|Treatment Period 1||8
8167217|NCT02480439|20135071|P3|STARTED|Treatment Period 1||8
8167218|NCT02480439|20135072|P2|STARTED|Treatment Period 1||8
8167219|NCT02480439|20135073|P1|STARTED|Treatment Period 1||8
8167220|NCT02480166|20135099|P3|NOT COMPLETED|Overall Study||0
8167221|NCT02480166|20135100|P2|NOT COMPLETED|Overall Study||0
8167222|NCT02480166|20135101|P1|NOT COMPLETED|Overall Study||0
8167223|NCT02480166|20135099|P3|COMPLETED|Overall Study||4
8167224|NCT02480166|20135100|P2|COMPLETED|Overall Study||36
8167225|NCT02480166|20135101|P1|COMPLETED|Overall Study||20
8167226|NCT02480166|20135099|P3|STARTED|Overall Study||4
8167227|NCT02480166|20135100|P2|STARTED|Overall Study||36
8167228|NCT02480166|20135101|P1|STARTED|Overall Study||20
8167229|NCT02480153|20135114|P3|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
8167230|NCT02480153|20135115|P2|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
8167231|NCT02480153|20135116|P1|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
8167232|NCT02480153|20135114|P3|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
8167233|NCT02480153|20135115|P2|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
8167234|NCT02480153|20135116|P1|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
8167235|NCT02480153|20135114|P3|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
8167236|NCT02480153|20135115|P2|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
8167237|NCT02480153|20135116|P1|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
8167238|NCT02480153|20135114|P3|STARTED|Period 3: Week 52 Dosing to Week 78||127
8167239|NCT02480153|20135115|P2|STARTED|Period 3: Week 52 Dosing to Week 78||121
8167240|NCT02480153|20135116|P1|STARTED|Period 3: Week 52 Dosing to Week 78||259
8167241|NCT02480153|20135114|P3|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
8167242|NCT02480153|20135115|P2|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
8167243|NCT02480153|20135116|P1|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
8167244|NCT02480153|20135114|P3|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
8167245|NCT02480153|20135115|P2|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
8167246|NCT02480153|20135116|P1|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
8167247|NCT02480153|20135114|P3|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
8167248|NCT02480153|20135115|P2|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
8167249|NCT02480153|20135116|P1|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
8167250|NCT02480153|20135114|P3|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
8167251|NCT02480153|20135115|P2|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
8167252|NCT02480153|20135116|P1|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
8167253|NCT02480153|20135114|P3|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
8167254|NCT02480153|20135115|P2|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
8167255|NCT02480153|20135116|P1|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
8167256|NCT02480153|20135114|P3|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
8167257|NCT02480153|20135115|P2|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
8167258|NCT02480153|20135116|P1|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
8167259|NCT02480153|20135114|P3|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
8167260|NCT02480153|20135115|P2|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
8167261|NCT02480153|20135116|P1|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
8167262|NCT02480153|20135114|P3|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
8167263|NCT02480153|20135115|P2|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
8167264|NCT02480153|20135116|P1|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
8167271|NCT02480010|20135306|P2|NOT COMPLETED|Overall Study||33
8167272|NCT02480010|20135307|P1|NOT COMPLETED|Overall Study||35
8167273|NCT02480010|20135306|P2|COMPLETED|Overall Study||0
8167274|NCT02480010|20135307|P1|COMPLETED|Overall Study||0
8167275|NCT02480010|20135306|P2|STARTED|Overall Study||33
8167276|NCT02480010|20135307|P1|STARTED|Overall Study||35
8167277|NCT02479880|20135353|P2|NOT COMPLETED|Overall Study||13
8167278|NCT02479880|20135354|P1|NOT COMPLETED|Overall Study||13
8167279|NCT02479880|20135353|P2|COMPLETED|Overall Study||2
8167280|NCT02479880|20135354|P1|COMPLETED|Overall Study||2
8167281|NCT02479880|20135353|P2|STARTED|Overall Study||15
8167282|NCT02479880|20135354|P1|STARTED|Overall Study||15
8167283|NCT02479802|20135360|P1|NOT COMPLETED|Overall Study||2
8167284|NCT02479802|20135360|P1|COMPLETED|Overall Study||11
8167285|NCT02479802|20135360|P1|STARTED|Overall Study||13
8167286|NCT02479763|20135371|P2|NOT COMPLETED|Overall Study||3
8167287|NCT02479763|20135372|P1|NOT COMPLETED|Overall Study||3
8167288|NCT02479763|20135371|P2|COMPLETED|Overall Study||50
8167289|NCT02479763|20135372|P1|COMPLETED|Overall Study||50
8167290|NCT02479763|20135371|P2|STARTED|Overall Study||53
8167291|NCT02479763|20135372|P1|STARTED|Overall Study||53
8167292|NCT02479412|20135387|P9|NOT COMPLETED|Overall Study||1
8167293|NCT02479412|20135388|P8|NOT COMPLETED|Overall Study||1
8167294|NCT02479412|20135389|P7|NOT COMPLETED|Overall Study||0
8167295|NCT02479412|20135390|P6|NOT COMPLETED|Overall Study||0
8167296|NCT02479412|20135391|P5|NOT COMPLETED|Overall Study||1
8167297|NCT02479412|20135392|P4|NOT COMPLETED|Overall Study||1
8167298|NCT02479412|20135393|P3|NOT COMPLETED|Overall Study||2
8167299|NCT02479412|20135394|P2|NOT COMPLETED|Overall Study||0
8167300|NCT02479412|20135395|P1|NOT COMPLETED|Overall Study||0
8167301|NCT02479412|20135387|P9|COMPLETED|Overall Study||6
8167302|NCT02479412|20135388|P8|COMPLETED|Overall Study||4
8167303|NCT02479412|20135389|P7|COMPLETED|Overall Study||6
8167304|NCT02479412|20135390|P6|COMPLETED|Overall Study||5
8167305|NCT02479412|20135391|P5|COMPLETED|Overall Study||5
8167306|NCT02479412|20135392|P4|COMPLETED|Overall Study||6
8167307|NCT02479412|20135393|P3|COMPLETED|Overall Study||4
8167308|NCT02479412|20135394|P2|COMPLETED|Overall Study||6
8167309|NCT02479412|20135395|P1|COMPLETED|Overall Study||6
8167310|NCT02479412|20135387|P9|STARTED|Overall Study||7
8167311|NCT02479412|20135388|P8|STARTED|Overall Study||5
8167312|NCT02479412|20135389|P7|STARTED|Overall Study||6
8167313|NCT02479412|20135390|P6|STARTED|Overall Study||5
8167314|NCT02479412|20135391|P5|STARTED|Overall Study||6
8167315|NCT02479412|20135392|P4|STARTED|Overall Study||7
8167316|NCT02479412|20135393|P3|STARTED|Overall Study||6
8167317|NCT02479412|20135394|P2|STARTED|Overall Study||6
8167318|NCT02479412|20135395|P1|STARTED|Overall Study||6
8167319|NCT02479139|20135472|P6|NOT COMPLETED|Overall Study||6
8167320|NCT02479139|20135473|P5|NOT COMPLETED|Overall Study||5
8167321|NCT02479139|20135474|P4|NOT COMPLETED|Overall Study||7
8167322|NCT02479139|20135475|P3|NOT COMPLETED|Overall Study||7
8167323|NCT02479139|20135476|P2|NOT COMPLETED|Overall Study||10
8167324|NCT02479139|20135477|P1|NOT COMPLETED|Overall Study||8
8167325|NCT02479139|20135472|P6|COMPLETED|Overall Study||19
8167326|NCT02479139|20135473|P5|COMPLETED|Overall Study||17
8167327|NCT02479139|20135474|P4|COMPLETED|Overall Study||14
8167328|NCT02479139|20135475|P3|COMPLETED|Overall Study||21
8167329|NCT02479139|20135476|P2|COMPLETED|Overall Study||12
8167330|NCT02479139|20135477|P1|COMPLETED|Overall Study||19
8167331|NCT02479139|20135472|P6|STARTED|Overall Study||25
8167332|NCT02479139|20135473|P5|STARTED|Overall Study||22
8167333|NCT02479139|20135474|P4|STARTED|Overall Study||21
8167334|NCT02479139|20135475|P3|STARTED|Overall Study||28
8167335|NCT02479139|20135476|P2|STARTED|Overall Study||22
8167336|NCT02479139|20135477|P1|STARTED|Overall Study||27
8167337|NCT02478671|20135503|P1|NOT COMPLETED|Overall Study||0
8167338|NCT02478671|20135503|P1|COMPLETED|Overall Study||4
8167339|NCT02478671|20135503|P1|STARTED|Overall Study||4
8167340|NCT02478632|20135510|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
8167341|NCT02478632|20135511|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
8167342|NCT02478632|20135510|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
8167343|NCT02478632|20135511|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
8167344|NCT02478632|20135510|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||44
8167345|NCT02478632|20135511|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||49
8167346|NCT02478632|20135510|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
8167347|NCT02478632|20135511|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
8167348|NCT02478632|20135510|P2|COMPLETED|Early Switch Phase (Up to Week 52)||44
8167349|NCT02478632|20135511|P1|COMPLETED|Early Switch Phase (Up to Week 52)||49
8167350|NCT02478632|20135510|P2|STARTED|Early Switch Phase (Up to Week 52)||49
8167351|NCT02478632|20135511|P1|STARTED|Early Switch Phase (Up to Week 52)||53
8167352|NCT02478580|20135537|P2|NOT COMPLETED|Overall Study||0
8167353|NCT02478580|20135538|P1|NOT COMPLETED|Overall Study||0
8167354|NCT02478580|20135537|P2|COMPLETED|Overall Study||33
8167355|NCT02478580|20135538|P1|COMPLETED|Overall Study||34
8167356|NCT02478580|20135537|P2|STARTED|Overall Study||33
8167357|NCT02478580|20135538|P1|STARTED|Overall Study||34
8167358|NCT02478463|20135546|P1|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
8167359|NCT02478463|20135546|P1|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
8167360|NCT02478463|20135546|P1|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
8167361|NCT02478463|20135546|P1|NOT COMPLETED|Washout Period (Up to 42 Days)||1
8167362|NCT02478463|20135546|P1|COMPLETED|Washout Period (Up to 42 Days)||17
8167363|NCT02478463|20135546|P1|STARTED|Washout Period (Up to 42 Days)||18
8167364|NCT02478463|20135546|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
8167365|NCT02478463|20135546|P1|COMPLETED|Treatment Period 1 (Up to Day 29)||18
8167366|NCT02478463|20135546|P1|STARTED|Treatment Period 1 (Up to Day 29)||19
8167367|NCT02478398|20135663|P2|NOT COMPLETED|Overall Study||21
8167368|NCT02478398|20135664|P1|NOT COMPLETED|Overall Study||52
8167369|NCT02478398|20135663|P2|COMPLETED|Overall Study||491
8167370|NCT02478398|20135664|P1|COMPLETED|Overall Study||461
8167371|NCT02478398|20135663|P2|Treated|Overall Study||510
8167372|NCT02478398|20135664|P1|Treated|Overall Study||512
8167373|NCT02478398|20135663|P2|STARTED|Overall Study||512
8167374|NCT02478398|20135664|P1|STARTED|Overall Study||513
8167375|NCT02478372|20135684|P2|NOT COMPLETED|Overall Study||14
8167376|NCT02478372|20135685|P1|NOT COMPLETED|Overall Study||13
8167377|NCT02478372|20135684|P2|COMPLETED|Overall Study||107
8167378|NCT02478372|20135685|P1|COMPLETED|Overall Study||108
8167379|NCT02478372|20135684|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
8167380|NCT02478372|20135685|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
8167381|NCT02478372|20135684|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
8167382|NCT02478372|20135685|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
8167383|NCT02478372|20135684|P2|Recieved Allocation Intervention|Overall Study||113
8167384|NCT02478372|20135685|P1|Recieved Allocation Intervention|Overall Study||109
8167385|NCT02478372|20135684|P2|STARTED|Overall Study||121
8167386|NCT02478372|20135685|P1|STARTED|Overall Study||121
8167387|NCT02478359|20135709|P2|NOT COMPLETED|Overall Study||65
8167388|NCT02478359|20135710|P1|NOT COMPLETED|Overall Study||106
8167389|NCT02478359|20135709|P2|COMPLETED|Overall Study||1293
8167390|NCT02478359|20135710|P1|COMPLETED|Overall Study||1243
8167391|NCT02478359|20135709|P2|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
8167392|NCT02478359|20135710|P1|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
8167393|NCT02478359|20135709|P2|STARTED|Overall Study||1358
8167394|NCT02478359|20135710|P1|STARTED|Overall Study||1349
8167395|NCT02478164|20135782|P1|NOT COMPLETED|Overall Study||15
8167396|NCT02478164|20135782|P1|COMPLETED|Overall Study||0
8167397|NCT02478164|20135782|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
8167398|NCT02477709|20135789|P1|NOT COMPLETED|Overall Study||0
8167399|NCT02477709|20135789|P1|COMPLETED|Overall Study||6
8167400|NCT02477709|20135789|P1|STARTED|Overall Study||6
8167401|NCT02477670|20135795|P7|NOT COMPLETED|Stage 2||0
8167402|NCT02477670|20135796|P6|NOT COMPLETED|Stage 2||0
8167403|NCT02477670|20135797|P5|NOT COMPLETED|Stage 2||0
8167404|NCT02477670|20135798|P4|NOT COMPLETED|Stage 2||1
8167405|NCT02477670|20135799|P3|NOT COMPLETED|Stage 2||2
8167406|NCT02477670|20135800|P2|NOT COMPLETED|Stage 2||0
8167407|NCT02477670|20135801|P1|NOT COMPLETED|Stage 2||0
8167408|NCT02477670|20135795|P7|COMPLETED|Stage 2||42
8167409|NCT02477670|20135796|P6|COMPLETED|Stage 2||1
8167410|NCT02477670|20135797|P5|COMPLETED|Stage 2||2
8167411|NCT02477670|20135798|P4|COMPLETED|Stage 2||32
8167412|NCT02477670|20135799|P3|COMPLETED|Stage 2||28
8167413|NCT02477670|20135800|P2|COMPLETED|Stage 2||0
8167414|NCT02477670|20135801|P1|COMPLETED|Stage 2||0
8167415|NCT02477670|20135795|P7|STARTED|Stage 2||42
8167416|NCT02477670|20135796|P6|STARTED|Stage 2||1
8167417|NCT02477670|20135797|P5|STARTED|Stage 2||2
8167418|NCT02477670|20135798|P4|STARTED|Stage 2||33
8167419|NCT02477670|20135799|P3|STARTED|Stage 2||30
8167420|NCT02477670|20135800|P2|STARTED|Stage 2||0
8167421|NCT02477670|20135801|P1|STARTED|Stage 2||0
8167422|NCT02477670|20135795|P7|NOT COMPLETED|Stage 1||0
8167423|NCT02477670|20135796|P6|NOT COMPLETED|Stage 1||0
8167424|NCT02477670|20135797|P5|NOT COMPLETED|Stage 1||0
8167425|NCT02477670|20135798|P4|NOT COMPLETED|Stage 1||0
8167426|NCT02477670|20135799|P3|NOT COMPLETED|Stage 1||0
8167427|NCT02477670|20135800|P2|NOT COMPLETED|Stage 1||13
8167428|NCT02477670|20135801|P1|NOT COMPLETED|Stage 1||4
8167429|NCT02477670|20135795|P7|COMPLETED|Stage 1||0
8167430|NCT02477670|20135796|P6|COMPLETED|Stage 1||0
8167431|NCT02477670|20135797|P5|COMPLETED|Stage 1||0
8167432|NCT02477670|20135798|P4|COMPLETED|Stage 1||0
8167433|NCT02477670|20135799|P3|COMPLETED|Stage 1||0
8167434|NCT02477670|20135800|P2|COMPLETED|Stage 1||67
8167435|NCT02477670|20135801|P1|COMPLETED|Stage 1||43
8167436|NCT02477670|20135795|P7|STARTED|Stage 1||0
8167437|NCT02477670|20135796|P6|STARTED|Stage 1||0
8167438|NCT02477670|20135797|P5|STARTED|Stage 1||0
8167439|NCT02477670|20135798|P4|STARTED|Stage 1||0
8167440|NCT02477670|20135799|P3|STARTED|Stage 1||0
8167441|NCT02477670|20135800|P2|STARTED|Stage 1||80
8167442|NCT02477670|20135801|P1|STARTED|Stage 1||47
8167443|NCT02477618|20136017|P2|NOT COMPLETED|Overall Study||14
8167444|NCT02477618|20136018|P1|NOT COMPLETED|Overall Study||15
8167445|NCT02477618|20136017|P2|COMPLETED|Overall Study||53
8167446|NCT02477618|20136018|P1|COMPLETED|Overall Study||50
8167447|NCT02477618|20136017|P2|Intent-to-Treat Analysis Set|Overall Study||66
8167448|NCT02477618|20136018|P1|Intent-to-Treat Analysis Set|Overall Study||66
8167449|NCT02477618|20136017|P2|STARTED|Overall Study||67
8167450|NCT02477618|20136018|P1|STARTED|Overall Study||65
8167451|NCT02477605|20136042|P2|NOT COMPLETED|Overall Study||4
8167452|NCT02477605|20136043|P1|NOT COMPLETED|Overall Study||1
8167453|NCT02477605|20136042|P2|COMPLETED|Overall Study||64
8167454|NCT02477605|20136043|P1|COMPLETED|Overall Study||67
8167455|NCT02477605|20136042|P2|Randomized and Treated|Overall Study||68
8167456|NCT02477605|20136043|P1|Randomized and Treated|Overall Study||67
8167457|NCT02477605|20136042|P2|STARTED|Overall Study||68
8167458|NCT02477605|20136043|P1|STARTED|Overall Study||68
8167459|NCT02477553|20136059|P2|NOT COMPLETED|Overall Study||20
8167460|NCT02477553|20136060|P1|NOT COMPLETED|Overall Study||20
8167461|NCT02477553|20136059|P2|COMPLETED|Overall Study||344
8167462|NCT02477553|20136060|P1|COMPLETED|Overall Study||344
8167463|NCT02477553|20136059|P2|STARTED|Overall Study||364
8167464|NCT02477553|20136060|P1|STARTED|Overall Study||364
8167465|NCT02477527|20136080|P1|NOT COMPLETED|Overall Study||6
8167466|NCT02477527|20136080|P1|COMPLETED|Overall Study||21
8167467|NCT02477527|20136080|P1|STARTED|Overall Study||27
8167468|NCT02477423|20136090|P2|NOT COMPLETED|Overall Study||4
8167469|NCT02477423|20136091|P1|NOT COMPLETED|Overall Study||1
8167470|NCT02477423|20136090|P2|COMPLETED|Overall Study||11
8167471|NCT02477423|20136091|P1|COMPLETED|Overall Study||11
8167472|NCT02477423|20136090|P2|STARTED|Overall Study||15
8167473|NCT02477423|20136091|P1|STARTED|Overall Study||12
8167474|NCT02477332|20136115|P6|NOT COMPLETED|Overall Study||5
8167475|NCT02477332|20136116|P5|NOT COMPLETED|Overall Study||4
8167476|NCT02477332|20136117|P4|NOT COMPLETED|Overall Study||13
8167477|NCT02477332|20136118|P3|NOT COMPLETED|Overall Study||12
8167478|NCT02477332|20136119|P2|NOT COMPLETED|Overall Study||7
8167479|NCT02477332|20136120|P1|NOT COMPLETED|Overall Study||3
8167480|NCT02477332|20136115|P6|COMPLETED|Overall Study||37
8167481|NCT02477332|20136116|P5|COMPLETED|Overall Study||39
8167482|NCT02477332|20136117|P4|COMPLETED|Overall Study||72
8167483|NCT02477332|20136118|P3|COMPLETED|Overall Study||73
8167484|NCT02477332|20136119|P2|COMPLETED|Overall Study||77
8167485|NCT02477332|20136120|P1|COMPLETED|Overall Study||40
8167486|NCT02477332|20136115|P6|STARTED|Overall Study||42
8167487|NCT02477332|20136116|P5|STARTED|Overall Study||43
8167488|NCT02477332|20136117|P4|STARTED|Overall Study||85
8167489|NCT02477332|20136118|P3|STARTED|Overall Study||85
8167490|NCT02477332|20136119|P2|STARTED|Overall Study||84
8167491|NCT02477332|20136120|P1|STARTED|Overall Study||43
8167492|NCT02477319|20136198|P4|NOT COMPLETED|Overall Study||22
8167493|NCT02477319|20136199|P3|NOT COMPLETED|Overall Study||15
8167494|NCT02477319|20136200|P2|NOT COMPLETED|Overall Study||3
8167495|NCT02477319|20136201|P1|NOT COMPLETED|Overall Study||0
8167496|NCT02477319|20136198|P4|COMPLETED|Overall Study||171
8167497|NCT02477319|20136199|P3|COMPLETED|Overall Study||149
8167498|NCT02477319|20136200|P2|COMPLETED|Overall Study||37
8167499|NCT02477319|20136201|P1|COMPLETED|Overall Study||55
8167500|NCT02477319|20136198|P4|STARTED|Overall Study||193
8167501|NCT02477319|20136199|P3|STARTED|Overall Study||164
8167502|NCT02477319|20136200|P2|STARTED|Overall Study||40
8167503|NCT02477319|20136201|P1|STARTED|Overall Study||55
8167504|NCT02477215|20136212|P3|NOT COMPLETED|Fixed Dose Phase||0
8167505|NCT02477215|20136213|P2|NOT COMPLETED|Fixed Dose Phase||7
8167506|NCT02477215|20136214|P1|NOT COMPLETED|Fixed Dose Phase||0
8167507|NCT02477215|20136212|P3|COMPLETED|Fixed Dose Phase||0
8167508|NCT02477215|20136213|P2|COMPLETED|Fixed Dose Phase||13
8167509|NCT02477215|20136214|P1|COMPLETED|Fixed Dose Phase||0
8167510|NCT02477215|20136212|P3|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
8167511|NCT02477215|20136213|P2|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
8167512|NCT02477215|20136214|P1|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
8167513|NCT02477215|20136212|P3|NOT COMPLETED|Dose Escalation Phase||0
8167514|NCT02477215|20136213|P2|NOT COMPLETED|Dose Escalation Phase||2
8167515|NCT02477215|20136214|P1|NOT COMPLETED|Dose Escalation Phase||1
8167516|NCT02477215|20136212|P3|COMPLETED|Dose Escalation Phase||6
8167517|NCT02477215|20136213|P2|COMPLETED|Dose Escalation Phase||6
8167518|NCT02477215|20136214|P1|COMPLETED|Dose Escalation Phase||3
8167519|NCT02477215|20136212|P3|STARTED|Dose Escalation Phase||6
8167520|NCT02477215|20136213|P2|STARTED|Dose Escalation Phase||8
8167521|NCT02477215|20136214|P1|STARTED|Dose Escalation Phase||4
8167522|NCT02477020|20136230|P2|NOT COMPLETED|Overall Study||28
8167523|NCT02477020|20136231|P1|NOT COMPLETED|Overall Study||30
8167524|NCT02477020|20136230|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
8167525|NCT02477020|20136231|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
8167526|NCT02477020|20136230|P2|STARTED|Overall Study||83
8167527|NCT02477020|20136231|P1|STARTED|Overall Study||81
8167528|NCT02476994|20136261|P2|NOT COMPLETED|Overall Study||0
8167529|NCT02476994|20136262|P1|NOT COMPLETED|Overall Study||1
8167530|NCT02476994|20136261|P2|COMPLETED|Overall Study||0
8167531|NCT02476994|20136262|P1|COMPLETED|Overall Study||0
8167532|NCT02476994|20136261|P2|STARTED|Overall Study||0
8167533|NCT02476994|20136262|P1|STARTED|Overall Study||1
8167534|NCT02476890|20136292|P4|NOT COMPLETED|Overall Study||0
8167535|NCT02476890|20136293|P3|NOT COMPLETED|Overall Study||0
8167536|NCT02476890|20136294|P2|NOT COMPLETED|Overall Study||0
8167537|NCT02476890|20136295|P1|NOT COMPLETED|Overall Study||0
8167538|NCT02476890|20136292|P4|COMPLETED|Overall Study||12
8167539|NCT02476890|20136293|P3|COMPLETED|Overall Study||12
8167540|NCT02476890|20136294|P2|COMPLETED|Overall Study||6
8167541|NCT02476890|20136295|P1|COMPLETED|Overall Study||6
8167542|NCT02476890|20136292|P4|Washout|Overall Study||12
8167543|NCT02476890|20136293|P3|Washout|Overall Study||12
8167544|NCT02476890|20136294|P2|Washout|Overall Study||6
8167545|NCT02476890|20136295|P1|Washout|Overall Study||6
8167546|NCT02476890|20136292|P4|STARTED|Overall Study|Crossover study|12
8167547|NCT02476890|20136293|P3|STARTED|Overall Study|Crossover study|12
8167548|NCT02476890|20136294|P2|STARTED|Overall Study|Crossover study|6
8167549|NCT02476890|20136295|P1|STARTED|Overall Study|Crossover study|6
8167550|NCT02476617|20136331|P1|NOT COMPLETED|Overall Study||2
8167551|NCT02476617|20136331|P1|COMPLETED|Overall Study||23
8167552|NCT02476617|20136331|P1|STARTED|Overall Study||25
8167553|NCT02476578|20136337|P2|NOT COMPLETED|Overall Study||56
8167554|NCT02476578|20136338|P1|NOT COMPLETED|Overall Study||41
8167555|NCT02476578|20136337|P2|COMPLETED|Overall Study||4218
8167556|NCT02476578|20136338|P1|COMPLETED|Overall Study||4269
8167557|NCT02476578|20136337|P2|Left Before End of Trial|Overall Study||13
8167558|NCT02476578|20136338|P1|Left Before End of Trial|Overall Study||6
8167559|NCT02476578|20136337|P2|Died Before Email Was Sent|Overall Study||43
8167560|NCT02476578|20136338|P1|Died Before Email Was Sent|Overall Study||35
8167561|NCT02476578|20136337|P2|STARTED|Overall Study||4274
8167562|NCT02476578|20136338|P1|STARTED|Overall Study||4310
8167563|NCT02476565|20136352|P2|NOT COMPLETED|Overall Study||0
8167564|NCT02476565|20136353|P1|NOT COMPLETED|Overall Study||0
8167565|NCT02476565|20136352|P2|COMPLETED|Overall Study||19
8167566|NCT02476565|20136353|P1|COMPLETED|Overall Study||20
8167567|NCT02476565|20136352|P2|STARTED|Overall Study||19
8167568|NCT02476565|20136353|P1|STARTED|Overall Study||20
8167569|NCT02476448|20136377|P4|NOT COMPLETED|Overall Study||0
8167570|NCT02476448|20136378|P3|NOT COMPLETED|Overall Study||0
8167571|NCT02476448|20136379|P2|NOT COMPLETED|Overall Study||0
8167572|NCT02476448|20136380|P1|NOT COMPLETED|Overall Study||0
8167573|NCT02476448|20136377|P4|COMPLETED|Overall Study||44
8167574|NCT02476448|20136378|P3|COMPLETED|Overall Study||44
8167575|NCT02476448|20136379|P2|COMPLETED|Overall Study||44
8167576|NCT02476448|20136380|P1|COMPLETED|Overall Study||44
8167577|NCT02476448|20136377|P4|STARTED|Overall Study||44
8167578|NCT02476448|20136378|P3|STARTED|Overall Study||44
8167579|NCT02476448|20136379|P2|STARTED|Overall Study||44
8167580|NCT02476448|20136380|P1|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
8167581|NCT02476422|20136400|P2|NOT COMPLETED|Overall Study||1
8167582|NCT02476422|20136401|P1|NOT COMPLETED|Overall Study||0
8167583|NCT02476422|20136400|P2|COMPLETED|Overall Study||161
8167584|NCT02476422|20136401|P1|COMPLETED|Overall Study||166
8167585|NCT02476422|20136400|P2|STARTED|Overall Study||162
8167586|NCT02476422|20136401|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
8167587|NCT02476357|20136433|P2|NOT COMPLETED|Overall Study||0
8167588|NCT02476357|20136434|P1|NOT COMPLETED|Overall Study||0
8167589|NCT02476357|20136433|P2|COMPLETED|Overall Study||40
8167590|NCT02476357|20136434|P1|COMPLETED|Overall Study||40
8167591|NCT02476357|20136433|P2|STARTED|Overall Study||40
8167592|NCT02476357|20136434|P1|STARTED|Overall Study||40
8167593|NCT02476201|20136442|P1|NOT COMPLETED|Overall Study||26
8167594|NCT02476201|20136442|P1|COMPLETED|Overall Study||79
8167595|NCT02476201|20136442|P1|6 Months Visit|Overall Study||82
8167596|NCT02476201|20136442|P1|Sucessful Implants|Overall Study||102
8167597|NCT02476201|20136442|P1|Implant Attempts|Overall Study||103
8167598|NCT02476201|20136442|P1|STARTED|Overall Study||105
8167599|NCT02476175|20136450|P1|NOT COMPLETED|Overall Study||2
8167600|NCT02476175|20136450|P1|COMPLETED|Overall Study||33
8167601|NCT02476175|20136450|P1|STARTED|Overall Study||35
8167602|NCT02476032|20136461|P3|NOT COMPLETED|Overall Study||1
8167603|NCT02476032|20136462|P2|NOT COMPLETED|Overall Study||1
8167604|NCT02476032|20136463|P1|NOT COMPLETED|Overall Study||0
8167605|NCT02476032|20136461|P3|COMPLETED|Overall Study||19
8167606|NCT02476032|20136462|P2|COMPLETED|Overall Study||19
8167607|NCT02476032|20136463|P1|COMPLETED|Overall Study||20
8167608|NCT02476032|20136461|P3|STARTED|Overall Study||20
8167609|NCT02476032|20136462|P2|STARTED|Overall Study||20
8167610|NCT02476032|20136463|P1|STARTED|Overall Study||20
8167611|NCT02476006|20136474|P1|NOT COMPLETED|Overall Study||120
8167612|NCT02476006|20136474|P1|COMPLETED|Overall Study||878
8167613|NCT02476006|20136474|P1|Treated|Overall Study||994
8167614|NCT02476006|20136474|P1|STARTED|Overall Study||998
8167615|NCT02475980|20136488|P1|NOT COMPLETED|Overall Study||5
8167616|NCT02475980|20136488|P1|COMPLETED|Overall Study||8
8167617|NCT02475980|20136488|P1|STARTED|Overall Study||13
8167618|NCT02475837|20136499|P2|NOT COMPLETED|Overall Study||0
8167619|NCT02475837|20136500|P1|NOT COMPLETED|Overall Study||0
8167620|NCT02475837|20136499|P2|COMPLETED|Overall Study||7
8167621|NCT02475837|20136500|P1|COMPLETED|Overall Study||6
8167622|NCT02475837|20136499|P2|STARTED|Overall Study||7
8167623|NCT02475837|20136500|P1|STARTED|Overall Study||6
8167624|NCT02475733|20136514|P2|NOT COMPLETED|Overall Study||0
8167625|NCT02475733|20136515|P1|NOT COMPLETED|Overall Study||2
8167626|NCT02475733|20136514|P2|COMPLETED|Overall Study||22
8167627|NCT02475733|20136515|P1|COMPLETED|Overall Study||59
8167628|NCT02475733|20136514|P2|STARTED|Overall Study||22
8167629|NCT02475733|20136515|P1|STARTED|Overall Study||61
8167630|NCT02475655|20136572|P2|NOT COMPLETED|Overall Study||1
8167631|NCT02475655|20136573|P1|NOT COMPLETED|Overall Study||0
8167632|NCT02475655|20136572|P2|COMPLETED|Overall Study||19
8167633|NCT02475655|20136573|P1|COMPLETED|Overall Study||40
8167634|NCT02475655|20136572|P2|STARTED|Overall Study||20
8167635|NCT02475655|20136573|P1|STARTED|Overall Study||40
8167636|NCT02475629|20136725|P1|NOT COMPLETED|Overall Study||9
8167637|NCT02475629|20136725|P1|COMPLETED|Overall Study||31
8167638|NCT02475629|20136725|P1|STARTED|Overall Study||40
8167639|NCT02475564|20136748|P2|NOT COMPLETED|Overall Study||1
8167640|NCT02475564|20136749|P1|NOT COMPLETED|Overall Study||4
8167641|NCT02475564|20136748|P2|COMPLETED|Overall Study||21
8167642|NCT02475564|20136749|P1|COMPLETED|Overall Study||18
8167643|NCT02475564|20136748|P2|STARTED|Overall Study||22
8167644|NCT02475564|20136749|P1|STARTED|Overall Study||22
8167645|NCT02475395|20136761|P2|NOT COMPLETED|Overall Study||3
8167646|NCT02475395|20136762|P1|NOT COMPLETED|Overall Study||30
8167647|NCT02475395|20136761|P2|COMPLETED|Overall Study||11
8167648|NCT02475395|20136762|P1|COMPLETED|Overall Study||228
8167649|NCT02475395|20136761|P2|STARTED|Overall Study||14
8167650|NCT02475395|20136762|P1|STARTED|Overall Study||258
8167651|NCT02475278|20136772|P1|NOT COMPLETED|Overall Study||2
8167652|NCT02475278|20136772|P1|COMPLETED|Overall Study||48
8167653|NCT02475278|20136772|P1|STARTED|Overall Study||50
8167654|NCT02475265|20136783|P1|NOT COMPLETED|Overall Study||3
8167655|NCT02475265|20136783|P1|COMPLETED|Overall Study||8
8167656|NCT02475265|20136783|P1|STARTED|Overall Study||11
8167657|NCT02475070|20136789|P2|NOT COMPLETED|Overall Study||0
8167658|NCT02475070|20136790|P1|NOT COMPLETED|Overall Study||0
8167659|NCT02475070|20136789|P2|COMPLETED|Overall Study||11
8167660|NCT02475070|20136790|P1|COMPLETED|Overall Study||17
8167661|NCT02475070|20136789|P2|STARTED|Overall Study||11
8167662|NCT02475070|20136790|P1|STARTED|Overall Study||17
8167663|NCT02475031|20136800|P2|NOT COMPLETED|Overall Study||0
8167664|NCT02475031|20136801|P1|NOT COMPLETED|Overall Study||0
8167665|NCT02475031|20136800|P2|COMPLETED|Overall Study||35
8167666|NCT02475031|20136801|P1|COMPLETED|Overall Study||35
8167667|NCT02475031|20136800|P2|STARTED|Overall Study||35
8167668|NCT02475031|20136801|P1|STARTED|Overall Study||35
8167669|NCT02474901|20136817|P2|NOT COMPLETED|Overall Study||0
8167670|NCT02474901|20136818|P1|NOT COMPLETED|Overall Study||1
8167671|NCT02474901|20136817|P2|COMPLETED|Overall Study||56
8167672|NCT02474901|20136818|P1|COMPLETED|Overall Study||44
8167673|NCT02474901|20136817|P2|STARTED|Overall Study||56
8167674|NCT02474901|20136818|P1|STARTED|Overall Study||45
8167675|NCT02474589|20136834|P2|NOT COMPLETED|Overall Study||5
8167676|NCT02474589|20136835|P1|NOT COMPLETED|Overall Study||25
8167677|NCT02474589|20136834|P2|COMPLETED|Overall Study||85
8167678|NCT02474589|20136835|P1|COMPLETED|Overall Study||334
8167679|NCT02474589|20136834|P2|STARTED|Overall Study||90
8167680|NCT02474589|20136835|P1|STARTED|Overall Study||359
8167681|NCT02474498|20136844|P3|NOT COMPLETED|Overall Study||0
8167682|NCT02474498|20136845|P2|NOT COMPLETED|Overall Study||0
8167683|NCT02474498|20136846|P1|NOT COMPLETED|Overall Study||0
8167684|NCT02474498|20136844|P3|COMPLETED|Overall Study||14
8167685|NCT02474498|20136845|P2|COMPLETED|Overall Study||14
8167686|NCT02474498|20136846|P1|COMPLETED|Overall Study||13
8167687|NCT02474498|20136844|P3|STARTED|Overall Study||14
8167688|NCT02474498|20136845|P2|STARTED|Overall Study||14
8167689|NCT02474498|20136846|P1|STARTED|Overall Study||13
8167690|NCT02474407|20136863|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8167691|NCT02474407|20136864|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8167692|NCT02474407|20136863|P2|COMPLETED|Second Intervention (14 Days)||39
8167693|NCT02474407|20136864|P1|COMPLETED|Second Intervention (14 Days)||39
8167694|NCT02474407|20136863|P2|STARTED|Second Intervention (14 Days)||39
8167695|NCT02474407|20136864|P1|STARTED|Second Intervention (14 Days)||39
8167696|NCT02474407|20136863|P2|NOT COMPLETED|Washout (14 Days)||0
8167697|NCT02474407|20136864|P1|NOT COMPLETED|Washout (14 Days)||0
8167698|NCT02474407|20136863|P2|COMPLETED|Washout (14 Days)||39
8167699|NCT02474407|20136864|P1|COMPLETED|Washout (14 Days)||39
8167700|NCT02474407|20136863|P2|STARTED|Washout (14 Days)||39
8167701|NCT02474407|20136864|P1|STARTED|Washout (14 Days)||39
8167702|NCT02474407|20136863|P2|NOT COMPLETED|First Intervention (14 Days)||0
8167703|NCT02474407|20136864|P1|NOT COMPLETED|First Intervention (14 Days)||0
8167704|NCT02474407|20136863|P2|COMPLETED|First Intervention (14 Days)||39
8167705|NCT02474407|20136864|P1|COMPLETED|First Intervention (14 Days)||39
8167706|NCT02474407|20136863|P2|STARTED|First Intervention (14 Days)||39
8167707|NCT02474407|20136864|P1|STARTED|First Intervention (14 Days)||39
8167708|NCT02474082|20136894|P2|NOT COMPLETED|Overall Study||54
8167709|NCT02474082|20136895|P1|NOT COMPLETED|Overall Study||6
8167710|NCT02474082|20136894|P2|COMPLETED|Overall Study||43
8167711|NCT02474082|20136895|P1|COMPLETED|Overall Study||99
8167712|NCT02474082|20136894|P2|Full Analysis Set (FAS)|Overall Study||95
8167713|NCT02474082|20136895|P1|Full Analysis Set (FAS)|Overall Study||105
8167714|NCT02474082|20136894|P2|STARTED|Overall Study||97
8167715|NCT02474082|20136895|P1|STARTED|Overall Study||105
8167716|NCT02474069|20136929|P3|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
8167717|NCT02474069|20136930|P2|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
8167718|NCT02474069|20136931|P1|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
8167719|NCT02474069|20136929|P3|COMPLETED|Comparative Dosing Phase (CDP)||157
8167720|NCT02474069|20136930|P2|COMPLETED|Comparative Dosing Phase (CDP)||153
8167721|NCT02474069|20136931|P1|COMPLETED|Comparative Dosing Phase (CDP)||0
8167722|NCT02474069|20136929|P3|STARTED|Comparative Dosing Phase (CDP)||163
8167723|NCT02474069|20136930|P2|STARTED|Comparative Dosing Phase (CDP)||162
8167724|NCT02474069|20136931|P1|STARTED|Comparative Dosing Phase (CDP)||0
8167725|NCT02474069|20136929|P3|NOT COMPLETED|Selection Phase (SP)||0
8167726|NCT02474069|20136930|P2|NOT COMPLETED|Selection Phase (SP)||0
8167727|NCT02474069|20136931|P1|NOT COMPLETED|Selection Phase (SP)||23
8167728|NCT02474069|20136929|P3|COMPLETED|Selection Phase (SP)||0
8167729|NCT02474069|20136930|P2|COMPLETED|Selection Phase (SP)||0
8167730|NCT02474069|20136931|P1|COMPLETED|Selection Phase (SP)||749
8167731|NCT02474069|20136929|P3|STARTED|Selection Phase (SP)||0
8167732|NCT02474069|20136930|P2|STARTED|Selection Phase (SP)||0
8167733|NCT02474069|20136931|P1|STARTED|Selection Phase (SP)||772
8167734|NCT02473991|20136956|P1|NOT COMPLETED|Overall Study||0
8167735|NCT02473991|20136956|P1|COMPLETED|Overall Study||395
8167736|NCT02473991|20136956|P1|STARTED|Overall Study||395
8167737|NCT02473965|20136964|P2|NOT COMPLETED|Overall Study||10
8167738|NCT02473965|20136965|P1|NOT COMPLETED|Overall Study||12
8167739|NCT02473965|20136964|P2|COMPLETED|Overall Study||20
8167740|NCT02473965|20136965|P1|COMPLETED|Overall Study||18
8167741|NCT02473965|20136964|P2|STARTED|Overall Study||30
8167742|NCT02473965|20136965|P1|STARTED|Overall Study||30
8167743|NCT02473952|20136977|P2|NOT COMPLETED|Overall Study||8
8167744|NCT02473952|20136978|P1|NOT COMPLETED|Overall Study||2
8167745|NCT02473952|20136977|P2|COMPLETED|Overall Study||24
8167746|NCT02473952|20136978|P1|COMPLETED|Overall Study||28
8167747|NCT02473952|20136977|P2|STARTED|Overall Study||32
8167748|NCT02473952|20136978|P1|STARTED|Overall Study||30
8167749|NCT02473913|20136986|P2|NOT COMPLETED|Overall Study||3
8167750|NCT02473913|20136987|P1|NOT COMPLETED|Overall Study||3
8167751|NCT02473913|20136986|P2|COMPLETED|Overall Study||8
8167752|NCT02473913|20136987|P1|COMPLETED|Overall Study||8
8167753|NCT02473913|20136986|P2|STARTED|Overall Study||11
8167754|NCT02473913|20136987|P1|STARTED|Overall Study||11
8167755|NCT02473783|20137007|P2|NOT COMPLETED|Overall Study||0
8167756|NCT02473783|20137008|P1|NOT COMPLETED|Overall Study||0
8167757|NCT02473783|20137007|P2|COMPLETED|Overall Study||17
8167758|NCT02473783|20137008|P1|COMPLETED|Overall Study||20
8167759|NCT02473783|20137007|P2|STARTED|Overall Study||17
8167760|NCT02473783|20137008|P1|STARTED|Overall Study||20
8167761|NCT02473718|20137018|P2|NOT COMPLETED|Overall Study||0
8167762|NCT02473718|20137019|P1|NOT COMPLETED|Overall Study||0
8167763|NCT02473718|20137018|P2|COMPLETED|Overall Study||41
8167764|NCT02473718|20137019|P1|COMPLETED|Overall Study||41
8167765|NCT02473718|20137018|P2|STARTED|Overall Study||41
8167766|NCT02473718|20137019|P1|STARTED|Overall Study||41
8167767|NCT02473640|20137039|P1|NOT COMPLETED|Treatment Period 2||0
8167768|NCT02473640|20137039|P1|COMPLETED|Treatment Period 2||14
8167769|NCT02473640|20137039|P1|STARTED|Treatment Period 2||14
8167770|NCT02473640|20137039|P1|NOT COMPLETED|Run-in Phase||0
8167771|NCT02473640|20137039|P1|COMPLETED|Run-in Phase||14
8167772|NCT02473640|20137039|P1|STARTED|Run-in Phase||14
8167773|NCT02473640|20137039|P1|NOT COMPLETED|Treatment Period 1||1
8167774|NCT02473640|20137039|P1|COMPLETED|Treatment Period 1||14
8167775|NCT02473640|20137039|P1|STARTED|Treatment Period 1||15
8167776|NCT02473523|20137048|P1|NOT COMPLETED|Overall Study||2
8167777|NCT02473523|20137048|P1|COMPLETED|Overall Study||0
8167778|NCT02473523|20137048|P1|STARTED|Overall Study||2
8167779|NCT02473510|20137069|P2|NOT COMPLETED|Overall Study||2
8167780|NCT02473510|20137070|P1|NOT COMPLETED|Overall Study||1
8167781|NCT02473510|20137069|P2|COMPLETED|Overall Study||238
8167782|NCT02473510|20137070|P1|COMPLETED|Overall Study||59
8167783|NCT02473510|20137069|P2|STARTED|Overall Study||240
8167784|NCT02473510|20137070|P1|STARTED|Overall Study||60
8167785|NCT02473471|20137084|P1|NOT COMPLETED|Overall Study||3
8167786|NCT02473471|20137084|P1|COMPLETED|Overall Study||32
8167787|NCT02473471|20137084|P1|Randomized Not Treated|Overall Study||2
8167788|NCT02473471|20137084|P1|Received Allocated Intervention|Overall Study||33
8167789|NCT02473471|20137084|P1|STARTED|Overall Study||35
8167790|NCT02473445|20137115|P1|NOT COMPLETED|Overall Study||22
8167791|NCT02473445|20137115|P1|COMPLETED|Overall Study||0
8167792|NCT02473445|20137115|P1|STARTED|Overall Study||22
8167793|NCT02473367|20137121|P1|NOT COMPLETED|Period 4||1
8167794|NCT02473367|20137121|P1|COMPLETED|Period 4||18
8167795|NCT02473367|20137121|P1|STARTED|Period 4||19
8167796|NCT02473367|20137121|P1|NOT COMPLETED|Wait 3||0
8167797|NCT02473367|20137121|P1|COMPLETED|Wait 3||19
8167798|NCT02473367|20137121|P1|STARTED|Wait 3||19
8167799|NCT02473367|20137121|P1|NOT COMPLETED|Period 3||0
8167800|NCT02473367|20137121|P1|COMPLETED|Period 3||19
8167801|NCT02473367|20137121|P1|STARTED|Period 3||19
8167802|NCT02473367|20137121|P1|NOT COMPLETED|Wait 2||0
8167803|NCT02473367|20137121|P1|COMPLETED|Wait 2||19
8167804|NCT02473367|20137121|P1|STARTED|Wait 2||19
8167805|NCT02473367|20137121|P1|NOT COMPLETED|Period 2||0
8167806|NCT02473367|20137121|P1|COMPLETED|Period 2||19
8167807|NCT02473367|20137121|P1|STARTED|Period 2||19
8167808|NCT02473367|20137121|P1|NOT COMPLETED|Wait 1||1
8167809|NCT02473367|20137121|P1|COMPLETED|Wait 1||19
8167810|NCT02473367|20137121|P1|STARTED|Wait 1||20
8167811|NCT02473367|20137121|P1|NOT COMPLETED|Period 1||0
8167812|NCT02473367|20137121|P1|COMPLETED|Period 1||20
8167813|NCT02473367|20137121|P1|STARTED|Period 1||20
8167814|NCT02473289|20137141|P2|NOT COMPLETED|Overall Study||13
8167815|NCT02473289|20137142|P1|NOT COMPLETED|Overall Study||11
8167816|NCT02473289|20137141|P2|COMPLETED|Overall Study||81
8167817|NCT02473289|20137142|P1|COMPLETED|Overall Study||88
8167818|NCT02473289|20137141|P2|STARTED|Overall Study||94
8167819|NCT02473289|20137142|P1|STARTED|Overall Study||99
8167820|NCT02472977|20137167|P3|NOT COMPLETED|Overall Study||8
8167821|NCT02472977|20137168|P2|NOT COMPLETED|Overall Study||27
8167822|NCT02472977|20137169|P1|NOT COMPLETED|Overall Study||6
8167823|NCT02472977|20137167|P3|COMPLETED|Overall Study||0
8167824|NCT02472977|20137168|P2|COMPLETED|Overall Study||0
8167825|NCT02472977|20137169|P1|COMPLETED|Overall Study||0
8167826|NCT02472977|20137167|P3|STARTED|Overall Study||8
8167827|NCT02472977|20137168|P2|STARTED|Overall Study||27
8167828|NCT02472977|20137169|P1|STARTED|Overall Study||6
8167829|NCT02472964|20137194|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
8167830|NCT02472964|20137195|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
8167831|NCT02472964|20137194|P2|COMPLETED|Part 2 (Week 24-week 48)||116
8167832|NCT02472964|20137195|P1|COMPLETED|Part 2 (Week 24-week 48)||98
8167833|NCT02472964|20137194|P2|STARTED|Part 2 (Week 24-week 48)||179
8167834|NCT02472964|20137195|P1|STARTED|Part 2 (Week 24-week 48)||163
8167835|NCT02472964|20137194|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
8167836|NCT02472964|20137195|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
8167837|NCT02472964|20137194|P2|COMPLETED|Part 1 (up to Week 24)||185
8167838|NCT02472964|20137195|P1|COMPLETED|Part 1 (up to Week 24)||171
8167839|NCT02472964|20137194|P2|STARTED|Part 1 (up to Week 24)||247
8167840|NCT02472964|20137195|P1|STARTED|Part 1 (up to Week 24)||246
8167841|NCT02472886|20137204|P3|NOT COMPLETED|Overall Study||1
8167842|NCT02472886|20137205|P2|NOT COMPLETED|Overall Study||2
8167843|NCT02472886|20137206|P1|NOT COMPLETED|Overall Study||0
8167844|NCT02472886|20137204|P3|COMPLETED|Overall Study||26
8167845|NCT02472886|20137205|P2|COMPLETED|Overall Study||57
8167846|NCT02472886|20137206|P1|COMPLETED|Overall Study||67
8167847|NCT02472886|20137204|P3|STARTED|Overall Study||27
8167848|NCT02472886|20137205|P2|STARTED|Overall Study||59
8167849|NCT02472886|20137206|P1|STARTED|Overall Study||67
8167850|NCT02472847|20137234|P2|NOT COMPLETED|Overall Study||5
8167851|NCT02472847|20137235|P1|NOT COMPLETED|Overall Study||1
8167852|NCT02472847|20137234|P2|COMPLETED|Overall Study||21
8167853|NCT02472847|20137235|P1|COMPLETED|Overall Study||23
8167854|NCT02472847|20137234|P2|STARTED|Overall Study||26
8167855|NCT02472847|20137235|P1|STARTED|Overall Study||24
8167856|NCT02472795|20137246|P5|NOT COMPLETED|Overall Study||3
8167857|NCT02472795|20137247|P4|NOT COMPLETED|Overall Study||0
8167858|NCT02472795|20137248|P3|NOT COMPLETED|Overall Study||0
8167859|NCT02472795|20137249|P2|NOT COMPLETED|Overall Study||1
8167860|NCT02472795|20137250|P1|NOT COMPLETED|Overall Study||0
8167861|NCT02472795|20137246|P5|COMPLETED|Overall Study||14
8167862|NCT02472795|20137247|P4|COMPLETED|Overall Study||13
8167863|NCT02472795|20137248|P3|COMPLETED|Overall Study||13
8167864|NCT02472795|20137249|P2|COMPLETED|Overall Study||11
8167865|NCT02472795|20137250|P1|COMPLETED|Overall Study||12
8167866|NCT02472795|20137246|P5|Modified Pharmacodynamic Analysis Set|Overall Study||16
8167867|NCT02472795|20137247|P4|Modified Pharmacodynamic Analysis Set|Overall Study||9
8167868|NCT02472795|20137248|P3|Modified Pharmacodynamic Analysis Set|Overall Study||13
8167869|NCT02472795|20137249|P2|Modified Pharmacodynamic Analysis Set|Overall Study||10
8167870|NCT02472795|20137250|P1|Modified Pharmacodynamic Analysis Set|Overall Study||12
8167871|NCT02472795|20137246|P5|Pharmacodynamic Set|Overall Study||16
8167872|NCT02472795|20137247|P4|Pharmacodynamic Set|Overall Study||13
8167873|NCT02472795|20137248|P3|Pharmacodynamic Set|Overall Study||13
8167874|NCT02472795|20137249|P2|Pharmacodynamic Set|Overall Study||10
8167875|NCT02472795|20137250|P1|Pharmacodynamic Set|Overall Study||12
8167876|NCT02472795|20137246|P5|STARTED|Overall Study||17
8167877|NCT02472795|20137247|P4|STARTED|Overall Study||13
8167878|NCT02472795|20137248|P3|STARTED|Overall Study||13
8167879|NCT02472795|20137249|P2|STARTED|Overall Study||12
8167880|NCT02472795|20137250|P1|STARTED|Overall Study||12
8167881|NCT02472756|20137282|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
8167882|NCT02472756|20137282|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
8167883|NCT02472756|20137282|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
8167884|NCT02472756|20137282|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
8167885|NCT02472756|20137282|P1|COMPLETED|Induction (Approximately 6 Months)||39
8167886|NCT02472756|20137282|P1|Treated|Induction (Approximately 6 Months)||40
8167887|NCT02472756|20137282|P1|STARTED|Induction (Approximately 6 Months)||41
8167888|NCT02472730|20137290|P2|NOT COMPLETED|Overall Study||7
8167889|NCT02472730|20137291|P1|NOT COMPLETED|Overall Study||9
8167890|NCT02472730|20137290|P2|COMPLETED|Overall Study||102
8167891|NCT02472730|20137291|P1|COMPLETED|Overall Study||101
8167892|NCT02472730|20137290|P2|STARTED|Overall Study||109
8167893|NCT02472730|20137291|P1|STARTED|Overall Study||110
8167894|NCT02472652|20137303|P1|NOT COMPLETED|Overall Study||1
8167895|NCT02472652|20137303|P1|COMPLETED|Overall Study||1
8167896|NCT02472652|20137303|P1|STARTED|Overall Study||2
8167897|NCT02472639|20137310|P2|NOT COMPLETED|Overall Study||3
8167898|NCT02472639|20137311|P1|NOT COMPLETED|Overall Study||4
8167899|NCT02472639|20137310|P2|COMPLETED|Overall Study||0
8167900|NCT02472639|20137311|P1|COMPLETED|Overall Study||0
8167901|NCT02472639|20137310|P2|STARTED|Overall Study||3
8167902|NCT02472639|20137311|P1|STARTED|Overall Study||4
8167903|NCT02472522|20137327|P2|NOT COMPLETED|Overall Study||0
8167904|NCT02472522|20137328|P1|NOT COMPLETED|Overall Study||0
8167905|NCT02472522|20137327|P2|COMPLETED|Overall Study||50
8167906|NCT02472522|20137328|P1|COMPLETED|Overall Study||50
8167907|NCT02472522|20137327|P2|STARTED|Overall Study||50
8167908|NCT02472522|20137328|P1|STARTED|Overall Study||50
8167909|NCT02472457|20137360|P2|NOT COMPLETED|Overall Study||1
8167910|NCT02472457|20137361|P1|NOT COMPLETED|Overall Study||0
8167911|NCT02472457|20137360|P2|COMPLETED|Overall Study||10
8167912|NCT02472457|20137361|P1|COMPLETED|Overall Study||8
8167913|NCT02472457|20137360|P2|STARTED|Overall Study||11
8167914|NCT02472457|20137361|P1|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
8167915|NCT02472405|20137367|P1|NOT COMPLETED|Overall Study||10
8167916|NCT02472405|20137367|P1|COMPLETED|Overall Study||8
8167917|NCT02472405|20137367|P1|STARTED|Overall Study||18
8167918|NCT02472366|20137375|P2|NOT COMPLETED|Overall Study||0
8167919|NCT02472366|20137376|P1|NOT COMPLETED|Overall Study||1
8167920|NCT02472366|20137375|P2|COMPLETED|Overall Study||10
8167921|NCT02472366|20137376|P1|COMPLETED|Overall Study||5
8167922|NCT02472366|20137375|P2|STARTED|Overall Study||10
8167923|NCT02472366|20137376|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
8167924|NCT02472353|20137392|P2|NOT COMPLETED|Overall Study||6
8167925|NCT02472353|20137393|P1|NOT COMPLETED|Overall Study||4
8167926|NCT02472353|20137392|P2|COMPLETED|Overall Study||10
8167927|NCT02472353|20137393|P1|COMPLETED|Overall Study||10
8167928|NCT02472353|20137392|P2|STARTED|Overall Study||16
8167929|NCT02472353|20137393|P1|STARTED|Overall Study||14
8167930|NCT02472314|20137401|P2|NOT COMPLETED|Overall Study||0
8167931|NCT02472314|20137402|P1|NOT COMPLETED|Overall Study||0
8167932|NCT02472314|20137401|P2|COMPLETED|Overall Study||36
8167933|NCT02472314|20137402|P1|COMPLETED|Overall Study||34
8167934|NCT02472314|20137401|P2|STARTED|Overall Study||36
8167935|NCT02472314|20137402|P1|STARTED|Overall Study||34
8167936|NCT02472262|20137417|P3|NOT COMPLETED|Overall Study||25
8167937|NCT02472262|20137418|P2|NOT COMPLETED|Overall Study||21
8167938|NCT02472262|20137419|P1|NOT COMPLETED|Overall Study||18
8167939|NCT02472262|20137417|P3|COMPLETED|Overall Study||93
8167940|NCT02472262|20137418|P2|COMPLETED|Overall Study||99
8167941|NCT02472262|20137419|P1|COMPLETED|Overall Study||99
8167942|NCT02472262|20137417|P3|STARTED|Overall Study||118
8167943|NCT02472262|20137418|P2|STARTED|Overall Study||120
8167944|NCT02472262|20137419|P1|STARTED|Overall Study||117
8167945|NCT02472223|20137429|P2|NOT COMPLETED|Overall Study||5
8167946|NCT02472223|20137430|P1|NOT COMPLETED|Overall Study||6
8167947|NCT02472223|20137429|P2|COMPLETED|Overall Study||7
8167948|NCT02472223|20137430|P1|COMPLETED|Overall Study||10
8167949|NCT02472223|20137429|P2|STARTED|Overall Study||12
8167950|NCT02472223|20137430|P1|STARTED|Overall Study||16
8167951|NCT02472145|20137441|P3|NOT COMPLETED|Overall Study||157
8167952|NCT02472145|20137442|P2|NOT COMPLETED|Overall Study||159
8167953|NCT02472145|20137443|P1|NOT COMPLETED|Overall Study||10
8167954|NCT02472145|20137441|P3|COMPLETED|Overall Study||0
8167955|NCT02472145|20137442|P2|COMPLETED|Overall Study||0
8167956|NCT02472145|20137443|P1|COMPLETED|Overall Study||0
8167957|NCT02472145|20137441|P3|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
8167958|NCT02472145|20137442|P2|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
8167959|NCT02472145|20137443|P1|Safety|Overall Study||10
8167960|NCT02472145|20137441|P3|Treated|Overall Study||156
8167961|NCT02472145|20137442|P2|Treated|Overall Study||156
8167962|NCT02472145|20137443|P1|Treated|Overall Study||10
8167963|NCT02472145|20137441|P3|STARTED|Overall Study||157
8167964|NCT02472145|20137442|P2|STARTED|Overall Study||159
8167965|NCT02472145|20137443|P1|STARTED|Overall Study||10
8167966|NCT02471755|20137464|P2|NOT COMPLETED|Overall Study||1
8167967|NCT02471755|20137465|P1|NOT COMPLETED|Overall Study||1
8167968|NCT02471755|20137464|P2|COMPLETED|Overall Study||44
8167969|NCT02471755|20137465|P1|COMPLETED|Overall Study||44
8167970|NCT02471755|20137464|P2|STARTED|Overall Study||45
8167971|NCT02471755|20137465|P1|STARTED|Overall Study||45
8167972|NCT02471651|20137483|P2|NOT COMPLETED|Overall Study||5
8167973|NCT02471651|20137484|P1|NOT COMPLETED|Overall Study||5
8167974|NCT02471651|20137483|P2|COMPLETED|Overall Study||15
8167975|NCT02471651|20137484|P1|COMPLETED|Overall Study||15
8167976|NCT02471651|20137483|P2|STARTED|Overall Study||20
8167977|NCT02471651|20137484|P1|STARTED|Overall Study||20
8167978|NCT02471612|20137494|P1|NOT COMPLETED|Overall Study||2
8167979|NCT02471612|20137494|P1|COMPLETED|Overall Study||157
8167980|NCT02471612|20137494|P1|STARTED|Overall Study||159
8167981|NCT02471521|20137513|P2|NOT COMPLETED|Overall Study||8
8167982|NCT02471521|20137514|P1|NOT COMPLETED|Overall Study||0
8167983|NCT02471521|20137513|P2|COMPLETED|Overall Study||52
8167984|NCT02471521|20137514|P1|COMPLETED|Overall Study||60
8167985|NCT02471521|20137513|P2|STARTED|Overall Study||60
8167986|NCT02471521|20137514|P1|STARTED|Overall Study||60
8167987|NCT02471404|20137525|P3|NOT COMPLETED|Overall Study||25
8167988|NCT02471404|20137526|P2|NOT COMPLETED|Overall Study||14
8167989|NCT02471404|20137527|P1|NOT COMPLETED|Overall Study||33
8167990|NCT02471404|20137525|P3|COMPLETED|Overall Study||288
8167991|NCT02471404|20137526|P2|COMPLETED|Overall Study||298
8167992|NCT02471404|20137527|P1|COMPLETED|Overall Study||281
8167993|NCT02471404|20137525|P3|STARTED|Overall Study||313
8167994|NCT02471404|20137526|P2|STARTED|Overall Study||312
8167995|NCT02471404|20137527|P1|STARTED|Overall Study||314
8167996|NCT02471326|20137550|P1|NOT COMPLETED|Overall Study||1
8167997|NCT02471326|20137550|P1|COMPLETED|Overall Study||9
8167998|NCT02471326|20137550|P1|STARTED|Overall Study||10
8167999|NCT02471313|20137555|P1|NOT COMPLETED|Overall Study||0
8168000|NCT02471313|20137555|P1|COMPLETED|Overall Study||3
8168001|NCT02471313|20137555|P1|STARTED|Overall Study||3
8168002|NCT02471183|20137559|P1|NOT COMPLETED|Extended Treatment Period||1
8168003|NCT02471183|20137559|P1|COMPLETED|Extended Treatment Period||31
8168004|NCT02471183|20137559|P1|STARTED|Extended Treatment Period||32
8168005|NCT02471183|20137559|P1|NOT COMPLETED|Main Treatment Period||2
8168006|NCT02471183|20137559|P1|COMPLETED|Main Treatment Period||32
8168007|NCT02471183|20137559|P1|STARTED|Main Treatment Period||34
8168008|NCT02471014|20137576|P2|NOT COMPLETED|Overall Study||2
8168009|NCT02471014|20137577|P1|NOT COMPLETED|Overall Study||2
8168010|NCT02471014|20137576|P2|COMPLETED|Overall Study||23
8168011|NCT02471014|20137577|P1|COMPLETED|Overall Study||23
8168012|NCT02471014|20137576|P2|STARTED|Overall Study||25
8168013|NCT02471014|20137577|P1|STARTED|Overall Study||25
8168014|NCT02470949|20137583|P2|NOT COMPLETED|Second Intervention||0
8168015|NCT02470949|20137584|P1|NOT COMPLETED|Second Intervention||0
8168016|NCT02470949|20137583|P2|COMPLETED|Second Intervention||2
8168017|NCT02470949|20137584|P1|COMPLETED|Second Intervention||4
8168018|NCT02470949|20137583|P2|STARTED|Second Intervention||2
8168019|NCT02470949|20137584|P1|STARTED|Second Intervention||4
8168020|NCT02470949|20137583|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
8168021|NCT02470949|20137584|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
8168022|NCT02470949|20137583|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
8168023|NCT02470949|20137584|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
8168024|NCT02470949|20137583|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
8168025|NCT02470949|20137584|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
8168026|NCT02470949|20137583|P2|NOT COMPLETED|First Intervention||0
8168027|NCT02470949|20137584|P1|NOT COMPLETED|First Intervention||0
8168028|NCT02470949|20137583|P2|COMPLETED|First Intervention||5
8168029|NCT02470949|20137584|P1|COMPLETED|First Intervention||4
8168030|NCT02470949|20137583|P2|STARTED|First Intervention||5
8168031|NCT02470949|20137584|P1|STARTED|First Intervention||4
8168032|NCT02470910|20137594|P1|NOT COMPLETED|Overall Study||0
8168033|NCT02470910|20137594|P1|COMPLETED|Overall Study||15
8168034|NCT02470910|20137594|P1|STARTED|Overall Study||15
8168035|NCT02470806|20137603|P2|NOT COMPLETED|Overall Study||42
8168036|NCT02470806|20137604|P1|NOT COMPLETED|Overall Study||18
8168037|NCT02470806|20137603|P2|COMPLETED|Overall Study||42
8168038|NCT02470806|20137604|P1|COMPLETED|Overall Study||62
8168039|NCT02470806|20137603|P2|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
8168040|NCT02470806|20137604|P1|STARTED|Overall Study||80
8168041|NCT02470754|20137618|P2|NOT COMPLETED|Overall Study||0
8168042|NCT02470754|20137619|P1|NOT COMPLETED|Overall Study||2
8168043|NCT02470754|20137618|P2|COMPLETED|Overall Study||19
8168044|NCT02470754|20137619|P1|COMPLETED|Overall Study||17
8168045|NCT02470754|20137618|P2|STARTED|Overall Study||19
8168046|NCT02470754|20137619|P1|STARTED|Overall Study||19
8168047|NCT02470741|20137647|P2|NOT COMPLETED|Overall Study||2
8168048|NCT02470741|20137648|P1|NOT COMPLETED|Overall Study||3
8168049|NCT02470741|20137647|P2|COMPLETED|Overall Study||4
8168050|NCT02470741|20137648|P1|COMPLETED|Overall Study||3
8168051|NCT02470741|20137647|P2|STARTED|Overall Study||6
8168052|NCT02470741|20137648|P1|STARTED|Overall Study||6
8168053|NCT02470585|20137657|P3|NOT COMPLETED|Overall Study||125
8168054|NCT02470585|20137658|P2|NOT COMPLETED|Overall Study||117
8168055|NCT02470585|20137659|P1|NOT COMPLETED|Overall Study||107
8168056|NCT02470585|20137657|P3|COMPLETED|Overall Study||257
8168057|NCT02470585|20137658|P2|COMPLETED|Overall Study||266
8168058|NCT02470585|20137659|P1|COMPLETED|Overall Study||268
8168059|NCT02470585|20137657|P3|Received Study Drug|Overall Study||377
8168060|NCT02470585|20137658|P2|Received Study Drug|Overall Study||376
8168061|NCT02470585|20137659|P1|Received Study Drug|Overall Study||371
8168062|NCT02470585|20137657|P3|STARTED|Overall Study||382
8168063|NCT02470585|20137658|P2|STARTED|Overall Study||383
8168064|NCT02470585|20137659|P1|STARTED|Overall Study||375
8168065|NCT02470494|20137682|P1|NOT COMPLETED|Overall Study||5
8168066|NCT02470494|20137682|P1|COMPLETED|Overall Study||41
8168067|NCT02470494|20137682|P1|STARTED|Overall Study||46
8168068|NCT02470429|20137692|P2|NOT COMPLETED|Overall Study||0
8168069|NCT02470429|20137693|P1|NOT COMPLETED|Overall Study||2
8168070|NCT02470429|20137692|P2|COMPLETED|Overall Study||49
8168071|NCT02470429|20137693|P1|COMPLETED|Overall Study||48
8168072|NCT02470429|20137692|P2|STARTED|Overall Study||49
8168073|NCT02470429|20137693|P1|STARTED|Overall Study||50
8168074|NCT02470403|20137711|P5|NOT COMPLETED|Overall Study||0
8168075|NCT02470403|20137712|P4|NOT COMPLETED|Overall Study||4
8168076|NCT02470403|20137713|P3|NOT COMPLETED|Overall Study||0
8168077|NCT02470403|20137714|P2|NOT COMPLETED|Overall Study||1
8168078|NCT02470403|20137715|P1|NOT COMPLETED|Overall Study||2
8168079|NCT02470403|20137711|P5|COMPLETED|Overall Study||10
8168080|NCT02470403|20137712|P4|COMPLETED|Overall Study||39
8168081|NCT02470403|20137713|P3|COMPLETED|Overall Study||40
8168082|NCT02470403|20137714|P2|COMPLETED|Overall Study||43
8168083|NCT02470403|20137715|P1|COMPLETED|Overall Study||42
8168084|NCT02470403|20137711|P5|Normoglycemic|Overall Study||5
8168085|NCT02470403|20137712|P4|Normoglycemic|Overall Study||23
8168086|NCT02470403|20137713|P3|Normoglycemic|Overall Study||20
8168087|NCT02470403|20137714|P2|Normoglycemic|Overall Study||20
8168088|NCT02470403|20137715|P1|Normoglycemic|Overall Study||20
8168089|NCT02470403|20137711|P5|Dysglycemic|Overall Study||5
8168090|NCT02470403|20137712|P4|Dysglycemic|Overall Study||20
8168091|NCT02470403|20137713|P3|Dysglycemic|Overall Study||20
8168092|NCT02470403|20137714|P2|Dysglycemic|Overall Study||24
8168093|NCT02470403|20137715|P1|Dysglycemic|Overall Study||24
8168094|NCT02470403|20137711|P5|STARTED|Overall Study||10
8168095|NCT02470403|20137712|P4|STARTED|Overall Study||43
8168096|NCT02470403|20137713|P3|STARTED|Overall Study||40
8168097|NCT02470403|20137714|P2|STARTED|Overall Study||44
8168098|NCT02470403|20137715|P1|STARTED|Overall Study||44
8168099|NCT02470390|20137755|P2|NOT COMPLETED|Overall Study||1
8168100|NCT02470390|20137756|P1|NOT COMPLETED|Overall Study||0
8168101|NCT02470390|20137755|P2|COMPLETED|Overall Study||6
8168102|NCT02470390|20137756|P1|COMPLETED|Overall Study||6
8168103|NCT02470390|20137755|P2|STARTED|Overall Study||7
8168104|NCT02470390|20137756|P1|STARTED|Overall Study||6
8168105|NCT02470312|20137784|P2|NOT COMPLETED|Overall Study||12
8168106|NCT02470312|20137785|P1|NOT COMPLETED|Overall Study||5
8168107|NCT02470312|20137784|P2|COMPLETED|Overall Study||419
8168108|NCT02470312|20137785|P1|COMPLETED|Overall Study||142
8168109|NCT02470312|20137784|P2|STARTED|Overall Study||431
8168110|NCT02470312|20137785|P1|STARTED|Overall Study||147
8168111|NCT02469961|20137795|P2|NOT COMPLETED|Overall Study||1
8168112|NCT02469961|20137796|P1|NOT COMPLETED|Overall Study||4
8168113|NCT02469961|20137795|P2|COMPLETED|Overall Study||24
8168114|NCT02469961|20137796|P1|COMPLETED|Overall Study||21
8168115|NCT02469961|20137795|P2|STARTED|Overall Study||25
8168116|NCT02469961|20137796|P1|STARTED|Overall Study||25
8168117|NCT02469896|20137810|P2|NOT COMPLETED|Overall Study||0
8168118|NCT02469896|20137811|P1|NOT COMPLETED|Overall Study||2
8168119|NCT02469896|20137810|P2|COMPLETED|Overall Study||14
8168120|NCT02469896|20137811|P1|COMPLETED|Overall Study||6
8168121|NCT02469896|20137810|P2|STARTED|Overall Study||14
8168122|NCT02469896|20137811|P1|STARTED|Overall Study||8
8168123|NCT02469870|20137837|P2|NOT COMPLETED|Overall Study||7
8168124|NCT02469870|20137838|P1|NOT COMPLETED|Overall Study||4
8168125|NCT02469870|20137837|P2|COMPLETED|Overall Study||72
8168126|NCT02469870|20137838|P1|COMPLETED|Overall Study||73
8168127|NCT02469870|20137837|P2|STARTED|Overall Study||79
8168128|NCT02469870|20137838|P1|STARTED|Overall Study||77
8168129|NCT02469714|20137856|P2|NOT COMPLETED|Overall Study||5
8168130|NCT02469714|20137857|P1|NOT COMPLETED|Overall Study||8
8168131|NCT02469714|20137856|P2|COMPLETED|Overall Study||50
8168132|NCT02469714|20137857|P1|COMPLETED|Overall Study||47
8168133|NCT02469714|20137856|P2|8 Month Follow-Up|Overall Study||50
8168134|NCT02469714|20137857|P1|8 Month Follow-Up|Overall Study||49
8168135|NCT02469714|20137856|P2|4 Month Follow-Up|Overall Study||51
8168136|NCT02469714|20137857|P1|4 Month Follow-Up|Overall Study||50
8168137|NCT02469714|20137856|P2|STARTED|Overall Study||55
8168138|NCT02469714|20137857|P1|STARTED|Overall Study||55
8168139|NCT02469701|20137877|P1|NOT COMPLETED|Overall Study||0
8168140|NCT02469701|20137877|P1|COMPLETED|Overall Study||10
8168141|NCT02469701|20137877|P1|STARTED|Overall Study||10
8168142|NCT02469623|20137881|P1|NOT COMPLETED|Overall Study||13
8168143|NCT02469623|20137881|P1|COMPLETED|Overall Study||72
8168144|NCT02469623|20137881|P1|STARTED|Overall Study||85
8168145|NCT02469610|20137888|P2|NOT COMPLETED|Overall Study||1
8168146|NCT02469610|20137889|P1|NOT COMPLETED|Overall Study||4
8168147|NCT02469610|20137888|P2|COMPLETED|Overall Study||30
8168148|NCT02469610|20137889|P1|COMPLETED|Overall Study||30
8168149|NCT02469610|20137888|P2|STARTED|Overall Study||31
8168150|NCT02469610|20137889|P1|STARTED|Overall Study||34
8168151|NCT02469597|20137899|P2|NOT COMPLETED|Overall Study||0
8168152|NCT02469597|20137900|P1|NOT COMPLETED|Overall Study||0
8168153|NCT02469597|20137899|P2|COMPLETED|Overall Study||24
8168154|NCT02469597|20137900|P1|COMPLETED|Overall Study||22
8168155|NCT02469597|20137899|P2|STARTED|Overall Study||24
8168156|NCT02469597|20137900|P1|STARTED|Overall Study||22
8168157|NCT02469415|20137916|P1|NOT COMPLETED|Overall Study||3
8168158|NCT02469415|20137916|P1|COMPLETED|Overall Study||0
8168159|NCT02469415|20137916|P1|STARTED|Overall Study||3
8168160|NCT02469298|20137924|P4|NOT COMPLETED|Overall Study||2
8168161|NCT02469298|20137925|P3|NOT COMPLETED|Overall Study||2
8168162|NCT02469298|20137926|P2|NOT COMPLETED|Overall Study||1
8168163|NCT02469298|20137927|P1|NOT COMPLETED|Overall Study||1
8168164|NCT02469298|20137924|P4|COMPLETED|Overall Study||5
8168165|NCT02469298|20137925|P3|COMPLETED|Overall Study||14
8168166|NCT02469298|20137926|P2|COMPLETED|Overall Study||6
8168167|NCT02469298|20137927|P1|COMPLETED|Overall Study||14
8168168|NCT02469298|20137924|P4|STARTED|Overall Study||7
8168169|NCT02469298|20137925|P3|STARTED|Overall Study||16
8168170|NCT02469298|20137926|P2|STARTED|Overall Study||7
8168171|NCT02469298|20137927|P1|STARTED|Overall Study||15
8168172|NCT02469246|20138067|P2|NOT COMPLETED|Open-Label Extension (OLE)||0
8168173|NCT02469246|20138068|P1|NOT COMPLETED|Open-Label Extension (OLE)||0
8168174|NCT02469246|20138067|P2|COMPLETED|Open-Label Extension (OLE)||5
8168175|NCT02469246|20138068|P1|COMPLETED|Open-Label Extension (OLE)||6
8168176|NCT02469246|20138067|P2|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
8168177|NCT02469246|20138068|P1|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
8168178|NCT02469246|20138067|P2|NOT COMPLETED|Double-Blind Phase||56
8168179|NCT02469246|20138068|P1|NOT COMPLETED|Double-Blind Phase||67
8168180|NCT02469246|20138067|P2|COMPLETED|Double-Blind Phase||226
8168181|NCT02469246|20138068|P1|COMPLETED|Double-Blind Phase||218
8168182|NCT02469246|20138067|P2|STARTED|Double-Blind Phase||282
8168183|NCT02469246|20138068|P1|STARTED|Double-Blind Phase||285
8168184|NCT02469168|20138100|P2|NOT COMPLETED|Overall Study||0
8168185|NCT02469168|20138101|P1|NOT COMPLETED|Overall Study||1
8168186|NCT02469168|20138100|P2|COMPLETED|Overall Study||0
8168187|NCT02469168|20138101|P1|COMPLETED|Overall Study||0
8168188|NCT02469168|20138100|P2|STARTED|Overall Study||0
8168189|NCT02469168|20138101|P1|STARTED|Overall Study||1
8168190|NCT02469116|20138109|P1|NOT COMPLETED|Overall Study||0
8168191|NCT02469116|20138109|P1|COMPLETED|Overall Study||18
8168192|NCT02469116|20138109|P1|STARTED|Overall Study||18
8168193|NCT02469090|20138121|P3|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
8168194|NCT02469090|20138122|P2|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
8168195|NCT02469090|20138123|P1|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
8168196|NCT02469090|20138121|P3|COMPLETED|Period 2: Maintenance Treatment Phase||34
8168197|NCT02469090|20138122|P2|COMPLETED|Period 2: Maintenance Treatment Phase||46
8168198|NCT02469090|20138123|P1|COMPLETED|Period 2: Maintenance Treatment Phase||0
8168199|NCT02469090|20138121|P3|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
8168200|NCT02469090|20138122|P2|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
8168201|NCT02469090|20138123|P1|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
8168202|NCT02469090|20138121|P3|NOT COMPLETED|Period 1: Dose Titration Phase||0
8168203|NCT02469090|20138122|P2|NOT COMPLETED|Period 1: Dose Titration Phase||0
8168204|NCT02469090|20138123|P1|NOT COMPLETED|Period 1: Dose Titration Phase||32
8168205|NCT02469090|20138121|P3|COMPLETED|Period 1: Dose Titration Phase||0
8168206|NCT02469090|20138122|P2|COMPLETED|Period 1: Dose Titration Phase||0
8168207|NCT02469090|20138123|P1|COMPLETED|Period 1: Dose Titration Phase||109
8168208|NCT02469090|20138121|P3|STARTED|Period 1: Dose Titration Phase||0
8168209|NCT02469090|20138122|P2|STARTED|Period 1: Dose Titration Phase||0
8168210|NCT02469090|20138123|P1|STARTED|Period 1: Dose Titration Phase||141
8168211|NCT02469077|20138150|P2|NOT COMPLETED|Post Intervention /Followup||1
8168212|NCT02469077|20138151|P1|NOT COMPLETED|Post Intervention /Followup||2
8168213|NCT02469077|20138150|P2|COMPLETED|Post Intervention /Followup||44
8168214|NCT02469077|20138151|P1|COMPLETED|Post Intervention /Followup||38
8168215|NCT02469077|20138150|P2|Post Intervention Naloxone|Post Intervention /Followup||44
8168216|NCT02469077|20138151|P1|Post Intervention Naloxone|Post Intervention /Followup||39
8168217|NCT02469077|20138150|P2|Post Intervention Morphine|Post Intervention /Followup||45
8168218|NCT02469077|20138151|P1|Post Intervention Morphine|Post Intervention /Followup||40
8168219|NCT02469077|20138150|P2|Post Intervention Placebo|Post Intervention /Followup||45
8168220|NCT02469077|20138151|P1|Post Intervention Placebo|Post Intervention /Followup||39
8168221|NCT02469077|20138150|P2|STARTED|Post Intervention /Followup||45
8168222|NCT02469077|20138151|P1|STARTED|Post Intervention /Followup||40
8168223|NCT02469077|20138150|P2|NOT COMPLETED|Post Randomization/Intervention Period||4
8168224|NCT02469077|20138151|P1|NOT COMPLETED|Post Randomization/Intervention Period||4
8168225|NCT02469077|20138150|P2|COMPLETED|Post Randomization/Intervention Period||45
8168226|NCT02469077|20138151|P1|COMPLETED|Post Randomization/Intervention Period||40
8168227|NCT02469077|20138150|P2|STARTED|Post Randomization/Intervention Period||49
8168228|NCT02469077|20138151|P1|STARTED|Post Randomization/Intervention Period||44
8168229|NCT02469077|20138150|P2|NOT COMPLETED|Pre Randomization - Pre Intervention||0
8168230|NCT02469077|20138151|P1|NOT COMPLETED|Pre Randomization - Pre Intervention||0
8168231|NCT02469077|20138150|P2|COMPLETED|Pre Randomization - Pre Intervention||49
8168232|NCT02469077|20138151|P1|COMPLETED|Pre Randomization - Pre Intervention||44
8168233|NCT02469077|20138150|P2|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
8168234|NCT02469077|20138151|P1|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
8168235|NCT02469077|20138150|P2|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
8168236|NCT02469077|20138151|P1|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
8168237|NCT02469077|20138150|P2|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
8168238|NCT02469077|20138151|P1|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
8168239|NCT02469077|20138150|P2|STARTED|Pre Randomization - Pre Intervention||49
8168240|NCT02469077|20138151|P1|STARTED|Pre Randomization - Pre Intervention||44
8168241|NCT02469064|20138183|P2|NOT COMPLETED|Overall Study||3
8168242|NCT02469064|20138184|P1|NOT COMPLETED|Overall Study||1
8168243|NCT02469064|20138183|P2|COMPLETED|Overall Study||59
8168244|NCT02469064|20138184|P1|COMPLETED|Overall Study||63
8168245|NCT02469064|20138183|P2|STARTED|Overall Study||62
8168246|NCT02469064|20138184|P1|STARTED|Overall Study||64
8168247|NCT02469038|20138194|P2|NOT COMPLETED|Overall Study||5
8168248|NCT02469038|20138195|P1|NOT COMPLETED|Overall Study||4
8168249|NCT02469038|20138194|P2|COMPLETED|Overall Study||19
8168250|NCT02469038|20138195|P1|COMPLETED|Overall Study||22
8168251|NCT02469038|20138194|P2|STARTED|Overall Study||24
8168252|NCT02469038|20138195|P1|STARTED|Overall Study||26
8168253|NCT02468934|20138213|P1|NOT COMPLETED|Overall Study||7
8168254|NCT02468934|20138213|P1|COMPLETED|Overall Study||20
8168255|NCT02468934|20138213|P1|Underwent Total Knee Arthroplasty|Overall Study||20
8168256|NCT02468934|20138213|P1|Enrolled/Received Leads|Overall Study||24
8168257|NCT02468934|20138213|P1|STARTED|Overall Study||27
8168258|NCT02468830|20138232|P1|NOT COMPLETED|Overall Study||3
8168259|NCT02468830|20138232|P1|COMPLETED|Overall Study||55
8168260|NCT02468830|20138232|P1|STARTED|Overall Study||58
8168261|NCT02468700|20138242|P2|NOT COMPLETED|Overall Study||2
8168262|NCT02468700|20138243|P1|NOT COMPLETED|Overall Study||2
8168263|NCT02468700|20138242|P2|COMPLETED|Overall Study||19
8168264|NCT02468700|20138243|P1|COMPLETED|Overall Study||20
8168265|NCT02468700|20138242|P2|STARTED|Overall Study||21
8168266|NCT02468700|20138243|P1|STARTED|Overall Study||22
8168267|NCT02468674|20138264|P9|NOT COMPLETED|Overall Study||3
8168268|NCT02468674|20138265|P8|NOT COMPLETED|Overall Study||4
8168269|NCT02468674|20138266|P7|NOT COMPLETED|Overall Study||1
8168270|NCT02468674|20138267|P6|NOT COMPLETED|Overall Study||1
8168271|NCT02468674|20138268|P5|NOT COMPLETED|Overall Study||1
8168272|NCT02468674|20138269|P4|NOT COMPLETED|Overall Study||1
8168273|NCT02468674|20138270|P3|NOT COMPLETED|Overall Study||0
8168274|NCT02468674|20138271|P2|NOT COMPLETED|Overall Study||0
8168275|NCT02468674|20138272|P1|NOT COMPLETED|Overall Study||1
8168276|NCT02468674|20138264|P9|COMPLETED|Overall Study||40
8168277|NCT02468674|20138265|P8|COMPLETED|Overall Study||65
8168278|NCT02468674|20138266|P7|COMPLETED|Overall Study||14
8168279|NCT02468674|20138267|P6|COMPLETED|Overall Study||6
8168280|NCT02468674|20138268|P5|COMPLETED|Overall Study||6
8168281|NCT02468674|20138269|P4|COMPLETED|Overall Study||3
8168282|NCT02468674|20138270|P3|COMPLETED|Overall Study||5
8168283|NCT02468674|20138271|P2|COMPLETED|Overall Study||5
8168284|NCT02468674|20138272|P1|COMPLETED|Overall Study||4
8168285|NCT02468674|20138264|P9|STARTED|Overall Study||43
8168286|NCT02468674|20138265|P8|STARTED|Overall Study||69
8168287|NCT02468674|20138266|P7|STARTED|Overall Study||15
8168288|NCT02468674|20138267|P6|STARTED|Overall Study||7
8168289|NCT02468674|20138268|P5|STARTED|Overall Study||7
8168290|NCT02468674|20138269|P4|STARTED|Overall Study||4
8168291|NCT02468674|20138270|P3|STARTED|Overall Study||5
8168292|NCT02468674|20138271|P2|STARTED|Overall Study||5
8168293|NCT02468674|20138272|P1|STARTED|Overall Study||5
8168294|NCT02468648|20138328|P1|NOT COMPLETED|Overall Study||1
8168295|NCT02468648|20138328|P1|COMPLETED|Overall Study||71
8168296|NCT02468648|20138328|P1|STARTED|Overall Study||72
8168297|NCT02468583|20138337|P2|NOT COMPLETED|Overall Study||0
8168298|NCT02468583|20138338|P1|NOT COMPLETED|Overall Study||0
8168299|NCT02468583|20138337|P2|COMPLETED|Overall Study||3
8168300|NCT02468583|20138338|P1|COMPLETED|Overall Study||3
8168301|NCT02468583|20138337|P2|STARTED|Overall Study||3
8168302|NCT02468583|20138338|P1|STARTED|Overall Study||3
8168303|NCT02468570|20138376|P2|NOT COMPLETED|Overall Study||0
8168304|NCT02468570|20138377|P1|NOT COMPLETED|Overall Study||0
8168305|NCT02468570|20138376|P2|COMPLETED|Overall Study||3
8168306|NCT02468570|20138377|P1|COMPLETED|Overall Study||6
8168307|NCT02468570|20138376|P2|STARTED|Overall Study||3
8168308|NCT02468570|20138377|P1|STARTED|Overall Study||6
8168309|NCT02468414|20138395|P2|NOT COMPLETED|Overall Study||0
8168310|NCT02468414|20138396|P1|NOT COMPLETED|Overall Study||3
8168311|NCT02468414|20138395|P2|COMPLETED|Overall Study||0
8168312|NCT02468414|20138396|P1|COMPLETED|Overall Study||0
8168313|NCT02468414|20138395|P2|Safety Follow-up|Overall Study||0
8168314|NCT02468414|20138396|P1|Safety Follow-up|Overall Study||0
8168315|NCT02468414|20138395|P2|Implantation|Overall Study||0
8168316|NCT02468414|20138396|P1|Implantation|Overall Study||1
8168317|NCT02468414|20138395|P2|Harvesting|Overall Study||0
8168318|NCT02468414|20138396|P1|Harvesting|Overall Study||1
8168319|NCT02468414|20138395|P2|Successfully Screened|Overall Study||0
8168320|NCT02468414|20138396|P1|Successfully Screened|Overall Study||2
8168321|NCT02468414|20138395|P2|STARTED|Overall Study||0
8168322|NCT02468414|20138396|P1|STARTED|Overall Study||3
8168323|NCT02468193|20138402|P1|NOT COMPLETED|Overall Study||6
8168324|NCT02468193|20138402|P1|COMPLETED|Overall Study||3
8168325|NCT02468193|20138402|P1|Discontinued Study in Optional Ext. Per.|Overall Study||2
8168326|NCT02468193|20138402|P1|Completed Optional Extension Period|Overall Study||0
8168327|NCT02468193|20138402|P1|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
8168328|NCT02468193|20138402|P1|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
8168329|NCT02468193|20138402|P1|Discontinued at or Prior to Week48|Overall Study||2
8168330|NCT02468193|20138402|P1|Completed Week-48 (Study Period II)|Overall Study||2
8168331|NCT02468193|20138402|P1|Completed Week-12, Entered Study Per. II|Overall Study||4
8168332|NCT02468193|20138402|P1|Completed Week-12, Did Not Enter Per. II|Overall Study||3
8168333|NCT02468193|20138402|P1|Discontinued at or Prior to Week-12|Overall Study||2
8168334|NCT02468193|20138402|P1|Completed Week-12 (Study Period I)|Overall Study||7
8168335|NCT02468193|20138402|P1|STARTED|Overall Study||9
8168336|NCT02468154|20138496|P2|NOT COMPLETED|Overall Study||0
8168337|NCT02468154|20138497|P1|NOT COMPLETED|Overall Study||0
8168338|NCT02468154|20138496|P2|COMPLETED|Overall Study||28
8168339|NCT02468154|20138497|P1|COMPLETED|Overall Study||29
8168340|NCT02468154|20138496|P2|STARTED|Overall Study||28
8168341|NCT02468154|20138497|P1|STARTED|Overall Study||29
8168342|NCT02467842|20138512|P3|NOT COMPLETED|Overall Study||0
8168343|NCT02467842|20138513|P2|NOT COMPLETED|Overall Study||0
8168344|NCT02467842|20138514|P1|NOT COMPLETED|Overall Study||0
8168345|NCT02467842|20138512|P3|COMPLETED|Overall Study||378
8168346|NCT02467842|20138513|P2|COMPLETED|Overall Study||373
8168347|NCT02467842|20138514|P1|COMPLETED|Overall Study||752
8168348|NCT02467842|20138512|P3|STARTED|Overall Study||378
8168349|NCT02467842|20138513|P2|STARTED|Overall Study||373
8168350|NCT02467842|20138514|P1|STARTED|Overall Study||752
8168351|NCT02467777|20138539|P2|NOT COMPLETED|Overall Study||0
8168352|NCT02467777|20138540|P1|NOT COMPLETED|Overall Study||0
8168353|NCT02467777|20138539|P2|COMPLETED|Overall Study||27
8168354|NCT02467777|20138540|P1|COMPLETED|Overall Study||23
8168355|NCT02467777|20138539|P2|STARTED|Overall Study||27
8168356|NCT02467777|20138540|P1|STARTED|Overall Study||23
8168357|NCT02467621|20138548|P2|NOT COMPLETED|Overall Study||6
8168358|NCT02467621|20138549|P1|NOT COMPLETED|Overall Study||1
8168359|NCT02467621|20138548|P2|COMPLETED|Overall Study||1647
8168360|NCT02467621|20138549|P1|COMPLETED|Overall Study||1644
8168361|NCT02467621|20138548|P2|STARTED|Overall Study||1653
8168362|NCT02467621|20138549|P1|STARTED|Overall Study||1645
8168363|NCT02467504|20138569|P2|NOT COMPLETED|Overall Study||1
8168364|NCT02467504|20138570|P1|NOT COMPLETED|Overall Study||6
8168365|NCT02467504|20138569|P2|COMPLETED|Overall Study||23
8168366|NCT02467504|20138570|P1|COMPLETED|Overall Study||17
8168367|NCT02467504|20138569|P2|STARTED|Overall Study||24
8168368|NCT02467504|20138570|P1|STARTED|Overall Study||23
8168369|NCT02467491|20138614|P1|NOT COMPLETED|Overall Study||0
8168370|NCT02467491|20138614|P1|COMPLETED|Overall Study||12
8168371|NCT02467491|20138614|P1|STARTED|Overall Study||12
8168372|NCT02467465|20138625|P2|NOT COMPLETED|Overall Study||0
8168373|NCT02467465|20138626|P1|NOT COMPLETED|Overall Study||0
8168374|NCT02467465|20138625|P2|COMPLETED|Overall Study||15
8168375|NCT02467465|20138626|P1|COMPLETED|Overall Study||15
8168376|NCT02467465|20138625|P2|STARTED|Overall Study||15
8168377|NCT02467465|20138626|P1|STARTED|Overall Study||15
8168378|NCT02467387|20138670|P2|NOT COMPLETED|Second Intervention||0
8168379|NCT02467387|20138671|P1|NOT COMPLETED|Second Intervention||3
8168380|NCT02467387|20138670|P2|COMPLETED|Second Intervention||12
8168381|NCT02467387|20138671|P1|COMPLETED|Second Intervention||7
8168382|NCT02467387|20138670|P2|STARTED|Second Intervention||12
8168383|NCT02467387|20138671|P1|STARTED|Second Intervention||10
8168384|NCT02467387|20138670|P2|NOT COMPLETED|First Intervention||0
8168385|NCT02467387|20138671|P1|NOT COMPLETED|First Intervention||1
8168386|NCT02467387|20138670|P2|COMPLETED|First Intervention||12
8168387|NCT02467387|20138671|P1|COMPLETED|First Intervention||10
8168388|NCT02467387|20138670|P2|Received Treatment as Randomized|First Intervention||12
8168389|NCT02467387|20138671|P1|Received Treatment as Randomized|First Intervention||10
8168390|NCT02467387|20138670|P2|STARTED|First Intervention||12
8168391|NCT02467387|20138671|P1|STARTED|First Intervention||11
8168392|NCT02467179|20138681|P2|NOT COMPLETED|Overall Study||0
8168393|NCT02467179|20138682|P1|NOT COMPLETED|Overall Study||0
8168394|NCT02467179|20138681|P2|COMPLETED|Overall Study||25
8168395|NCT02467179|20138682|P1|COMPLETED|Overall Study||25
8168396|NCT02467179|20138681|P2|STARTED|Overall Study||25
8168397|NCT02467179|20138682|P1|STARTED|Overall Study||25
8168398|NCT02467075|20138692|P2|NOT COMPLETED|30 Day Follow-up||0
8168399|NCT02467075|20138693|P1|NOT COMPLETED|30 Day Follow-up||0
8168400|NCT02467075|20138692|P2|COMPLETED|30 Day Follow-up||1
8168401|NCT02467075|20138693|P1|COMPLETED|30 Day Follow-up||0
8168402|NCT02467075|20138692|P2|STARTED|30 Day Follow-up||1
8168403|NCT02467075|20138693|P1|STARTED|30 Day Follow-up||0
8168404|NCT02467075|20138692|P2|NOT COMPLETED|72 Hour Follow-up||0
8168405|NCT02467075|20138693|P1|NOT COMPLETED|72 Hour Follow-up||0
8168406|NCT02467075|20138692|P2|COMPLETED|72 Hour Follow-up||1
8168407|NCT02467075|20138693|P1|COMPLETED|72 Hour Follow-up||0
8168408|NCT02467075|20138692|P2|STARTED|72 Hour Follow-up||1
8168409|NCT02467075|20138693|P1|STARTED|72 Hour Follow-up||0
8168410|NCT02467075|20138692|P2|NOT COMPLETED|48 Hour Follow-up||0
8168411|NCT02467075|20138693|P1|NOT COMPLETED|48 Hour Follow-up||0
8168412|NCT02467075|20138692|P2|COMPLETED|48 Hour Follow-up||1
8168413|NCT02467075|20138693|P1|COMPLETED|48 Hour Follow-up||0
8168414|NCT02467075|20138692|P2|STARTED|48 Hour Follow-up||1
8168415|NCT02467075|20138693|P1|STARTED|48 Hour Follow-up||0
8168416|NCT02467075|20138692|P2|NOT COMPLETED|Initial CT Scan||0
8168417|NCT02467075|20138693|P1|NOT COMPLETED|Initial CT Scan||0
8168418|NCT02467075|20138692|P2|COMPLETED|Initial CT Scan||1
8168419|NCT02467075|20138693|P1|COMPLETED|Initial CT Scan||0
8168420|NCT02467075|20138692|P2|STARTED|Initial CT Scan||1
8168421|NCT02467075|20138693|P1|STARTED|Initial CT Scan||0
8168422|NCT02466958|20138711|P2|NOT COMPLETED|Overall Study||3
8168423|NCT02466958|20138712|P1|NOT COMPLETED|Overall Study||10
8168424|NCT02466958|20138711|P2|COMPLETED|Overall Study||9
8168425|NCT02466958|20138712|P1|COMPLETED|Overall Study||7
8168426|NCT02466958|20138711|P2|STARTED|Overall Study||12
8168427|NCT02466958|20138712|P1|STARTED|Overall Study||17
8168428|NCT02466659|20138724|P2|NOT COMPLETED|Overall Study||2
8168429|NCT02466659|20138725|P1|NOT COMPLETED|Overall Study||5
8168430|NCT02466659|20138724|P2|COMPLETED|Overall Study||1
8168431|NCT02466659|20138725|P1|COMPLETED|Overall Study||0
8168432|NCT02466659|20138724|P2|STARTED|Overall Study||3
8168433|NCT02466659|20138725|P1|STARTED|Overall Study||5
8168434|NCT02466646|20138736|P3|NOT COMPLETED|Overall Study||0
8168435|NCT02466646|20138737|P2|NOT COMPLETED|Overall Study||0
8168436|NCT02466646|20138738|P1|NOT COMPLETED|Overall Study||0
8168437|NCT02466646|20138736|P3|COMPLETED|Overall Study||14
8168438|NCT02466646|20138737|P2|COMPLETED|Overall Study||14
8168439|NCT02466646|20138738|P1|COMPLETED|Overall Study||14
8168440|NCT02466646|20138736|P3|STARTED|Overall Study||14
8168441|NCT02466646|20138737|P2|STARTED|Overall Study||14
8168442|NCT02466646|20138738|P1|STARTED|Overall Study||14
8168443|NCT02466555|20138779|P1|NOT COMPLETED|Overall Study||2
8168444|NCT02466555|20138779|P1|COMPLETED|Overall Study||28
8168445|NCT02466555|20138779|P1|STARTED|Overall Study||30
8168446|NCT02466516|20138791|P5|NOT COMPLETED|Overall Study||0
8168447|NCT02466516|20138792|P4|NOT COMPLETED|Overall Study||0
8168448|NCT02466516|20138793|P3|NOT COMPLETED|Overall Study||1
8168449|NCT02466516|20138794|P2|NOT COMPLETED|Overall Study||1
8168450|NCT02466516|20138795|P1|NOT COMPLETED|Overall Study||4
8168451|NCT02466516|20138791|P5|COMPLETED|Overall Study||10
8168452|NCT02466516|20138792|P4|COMPLETED|Overall Study||10
8168453|NCT02466516|20138793|P3|COMPLETED|Overall Study||9
8168454|NCT02466516|20138794|P2|COMPLETED|Overall Study||21
8168455|NCT02466516|20138795|P1|COMPLETED|Overall Study||16
8168456|NCT02466516|20138791|P5|STARTED|Overall Study||10
8168457|NCT02466516|20138792|P4|STARTED|Overall Study||10
8168458|NCT02466516|20138793|P3|STARTED|Overall Study||10
8168459|NCT02466516|20138794|P2|STARTED|Overall Study||22
8168460|NCT02466516|20138795|P1|STARTED|Overall Study||20
8168461|NCT02466425|20138814|P2|NOT COMPLETED|Overall Study||16
8168462|NCT02466425|20138815|P1|NOT COMPLETED|Overall Study||14
8168463|NCT02466425|20138814|P2|COMPLETED|Overall Study||116
8168464|NCT02466425|20138815|P1|COMPLETED|Overall Study||118
8168465|NCT02466425|20138814|P2|Treated|Overall Study||132
8168466|NCT02466425|20138815|P1|Treated|Overall Study||131
8168467|NCT02466425|20138814|P2|STARTED|Overall Study||132
8168468|NCT02466425|20138815|P1|STARTED|Overall Study||132
8168469|NCT02466412|20138825|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8168470|NCT02466412|20138826|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8168471|NCT02466412|20138825|P2|COMPLETED|Second Intervention (Day 3)||24
8168472|NCT02466412|20138826|P1|COMPLETED|Second Intervention (Day 3)||24
8168473|NCT02466412|20138825|P2|STARTED|Second Intervention (Day 3)||24
8168474|NCT02466412|20138826|P1|STARTED|Second Intervention (Day 3)||24
8168475|NCT02466412|20138825|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8168476|NCT02466412|20138826|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8168477|NCT02466412|20138825|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
8168478|NCT02466412|20138826|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
8168479|NCT02466412|20138825|P2|STARTED|Washout Period of 1 Day (Day 2)||24
8168480|NCT02466412|20138826|P1|STARTED|Washout Period of 1 Day (Day 2)||24
8168481|NCT02466412|20138825|P2|NOT COMPLETED|First Intervention (Day 1)||0
8168482|NCT02466412|20138826|P1|NOT COMPLETED|First Intervention (Day 1)||0
8168483|NCT02466412|20138825|P2|COMPLETED|First Intervention (Day 1)||24
8168484|NCT02466412|20138826|P1|COMPLETED|First Intervention (Day 1)||24
8168485|NCT02466412|20138825|P2|STARTED|First Intervention (Day 1)||24
8168486|NCT02466412|20138826|P1|STARTED|First Intervention (Day 1)||24
8168487|NCT02466412|20138825|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
8168488|NCT02466412|20138826|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
8168489|NCT02466412|20138825|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
8168490|NCT02466412|20138826|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
8168491|NCT02466412|20138825|P2|STARTED|Washout Period of 1 Day (Day -1)||24
8168492|NCT02466412|20138826|P1|STARTED|Washout Period of 1 Day (Day -1)||24
8168493|NCT02466399|20138837|P2|NOT COMPLETED|Overall Study||0
8168494|NCT02466399|20138838|P1|NOT COMPLETED|Overall Study||2
8168495|NCT02466399|20138837|P2|COMPLETED|Overall Study||27
8168496|NCT02466399|20138838|P1|COMPLETED|Overall Study||51
8168497|NCT02466399|20138837|P2|STARTED|Overall Study||27
8168498|NCT02466399|20138838|P1|STARTED|Overall Study||53
8168499|NCT02466230|20138844|P1|NOT COMPLETED|Overall Study||0
8168500|NCT02466230|20138844|P1|COMPLETED|Overall Study||28
8168501|NCT02466230|20138844|P1|STARTED|Overall Study||28
8168502|NCT02466087|20138849|P2|NOT COMPLETED|Second Intervention: Weeks 7-12||0
8168503|NCT02466087|20138850|P1|NOT COMPLETED|Second Intervention: Weeks 7-12||0
8168504|NCT02466087|20138849|P2|COMPLETED|Second Intervention: Weeks 7-12||57
8168505|NCT02466087|20138850|P1|COMPLETED|Second Intervention: Weeks 7-12||55
8168506|NCT02466087|20138849|P2|STARTED|Second Intervention: Weeks 7-12||57
8168507|NCT02466087|20138850|P1|STARTED|Second Intervention: Weeks 7-12||55
8168508|NCT02466087|20138849|P2|NOT COMPLETED|First Intervention: Weeks 1-6||7
8168509|NCT02466087|20138850|P1|NOT COMPLETED|First Intervention: Weeks 1-6||7
8168510|NCT02466087|20138849|P2|COMPLETED|First Intervention: Weeks 1-6||57
8168511|NCT02466087|20138850|P1|COMPLETED|First Intervention: Weeks 1-6||55
8168512|NCT02466087|20138849|P2|STARTED|First Intervention: Weeks 1-6||64
8168513|NCT02466087|20138850|P1|STARTED|First Intervention: Weeks 1-6||62
8168514|NCT02465931|20138862|P2|NOT COMPLETED|Overall Study||11
8168515|NCT02465931|20138863|P1|NOT COMPLETED|Overall Study||11
8168516|NCT02465931|20138862|P2|COMPLETED|Overall Study||45
8168517|NCT02465931|20138863|P1|COMPLETED|Overall Study||44
8168518|NCT02465931|20138862|P2|STARTED|Overall Study||56
8168519|NCT02465931|20138863|P1|STARTED|Overall Study||55
8168520|NCT02465866|20138869|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168521|NCT02465866|20138870|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168522|NCT02465866|20138871|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168523|NCT02465866|20138872|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168524|NCT02465866|20138869|P4|COMPLETED|Period 4: Washout (14 Days)||5
8168525|NCT02465866|20138870|P3|COMPLETED|Period 4: Washout (14 Days)||5
8168526|NCT02465866|20138871|P2|COMPLETED|Period 4: Washout (14 Days)||4
8168527|NCT02465866|20138872|P1|COMPLETED|Period 4: Washout (14 Days)||5
8168528|NCT02465866|20138869|P4|STARTED|Period 4: Washout (14 Days)||5
8168529|NCT02465866|20138870|P3|STARTED|Period 4: Washout (14 Days)||5
8168530|NCT02465866|20138871|P2|STARTED|Period 4: Washout (14 Days)||4
8168531|NCT02465866|20138872|P1|STARTED|Period 4: Washout (14 Days)||5
8168532|NCT02465866|20138869|P4|NOT COMPLETED|Period 4||0
8168533|NCT02465866|20138870|P3|NOT COMPLETED|Period 4||0
8168534|NCT02465866|20138871|P2|NOT COMPLETED|Period 4||0
8168535|NCT02465866|20138872|P1|NOT COMPLETED|Period 4||0
8168536|NCT02465866|20138869|P4|COMPLETED|Period 4||5
8168537|NCT02465866|20138870|P3|COMPLETED|Period 4||5
8168538|NCT02465866|20138871|P2|COMPLETED|Period 4||4
8168539|NCT02465866|20138872|P1|COMPLETED|Period 4||5
8168540|NCT02465866|20138869|P4|STARTED|Period 4||5
8168541|NCT02465866|20138870|P3|STARTED|Period 4||5
8168542|NCT02465866|20138871|P2|STARTED|Period 4||4
8168543|NCT02465866|20138872|P1|STARTED|Period 4||5
8168544|NCT02465866|20138869|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168545|NCT02465866|20138870|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168546|NCT02465866|20138871|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168547|NCT02465866|20138872|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168548|NCT02465866|20138869|P4|COMPLETED|Period 3: Washout (14 Days)||5
8168549|NCT02465866|20138870|P3|COMPLETED|Period 3: Washout (14 Days)||5
8168550|NCT02465866|20138871|P2|COMPLETED|Period 3: Washout (14 Days)||4
8168551|NCT02465866|20138872|P1|COMPLETED|Period 3: Washout (14 Days)||5
8168552|NCT02465866|20138869|P4|STARTED|Period 3: Washout (14 Days)||5
8168553|NCT02465866|20138870|P3|STARTED|Period 3: Washout (14 Days)||5
8168554|NCT02465866|20138871|P2|STARTED|Period 3: Washout (14 Days)||4
8168555|NCT02465866|20138872|P1|STARTED|Period 3: Washout (14 Days)||5
8168556|NCT02465866|20138869|P4|NOT COMPLETED|Period 3||0
8168557|NCT02465866|20138870|P3|NOT COMPLETED|Period 3||0
8168558|NCT02465866|20138871|P2|NOT COMPLETED|Period 3||1
8168559|NCT02465866|20138872|P1|NOT COMPLETED|Period 3||0
8168560|NCT02465866|20138869|P4|COMPLETED|Period 3||5
8168561|NCT02465866|20138870|P3|COMPLETED|Period 3||5
8168562|NCT02465866|20138871|P2|COMPLETED|Period 3||4
8168563|NCT02465866|20138872|P1|COMPLETED|Period 3||5
8168564|NCT02465866|20138869|P4|STARTED|Period 3||5
8168565|NCT02465866|20138870|P3|STARTED|Period 3||5
8168566|NCT02465866|20138871|P2|STARTED|Period 3||5
8168567|NCT02465866|20138872|P1|STARTED|Period 3||5
8168568|NCT02465866|20138869|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168569|NCT02465866|20138870|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168570|NCT02465866|20138871|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168571|NCT02465866|20138872|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168572|NCT02465866|20138869|P4|COMPLETED|Period 2: Washout (14 Days)||5
8168573|NCT02465866|20138870|P3|COMPLETED|Period 2: Washout (14 Days)||5
8168574|NCT02465866|20138871|P2|COMPLETED|Period 2: Washout (14 Days)||5
8168575|NCT02465866|20138872|P1|COMPLETED|Period 2: Washout (14 Days)||5
8168576|NCT02465866|20138869|P4|STARTED|Period 2: Washout (14 Days)||5
8168577|NCT02465866|20138870|P3|STARTED|Period 2: Washout (14 Days)||5
8168578|NCT02465866|20138871|P2|STARTED|Period 2: Washout (14 Days)||5
8168579|NCT02465866|20138872|P1|STARTED|Period 2: Washout (14 Days)||5
8168580|NCT02465866|20138869|P4|NOT COMPLETED|Period 2||0
8168581|NCT02465866|20138870|P3|NOT COMPLETED|Period 2||0
8168582|NCT02465866|20138871|P2|NOT COMPLETED|Period 2||0
8168583|NCT02465866|20138872|P1|NOT COMPLETED|Period 2||0
8168584|NCT02465866|20138869|P4|COMPLETED|Period 2||5
8168585|NCT02465866|20138870|P3|COMPLETED|Period 2||5
8168586|NCT02465866|20138871|P2|COMPLETED|Period 2||5
8168587|NCT02465866|20138872|P1|COMPLETED|Period 2||5
8168588|NCT02465866|20138869|P4|STARTED|Period 2||5
8168589|NCT02465866|20138870|P3|STARTED|Period 2||5
8168590|NCT02465866|20138871|P2|STARTED|Period 2||5
8168591|NCT02465866|20138872|P1|STARTED|Period 2||5
8168592|NCT02465866|20138869|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168593|NCT02465866|20138870|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168594|NCT02465866|20138871|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168595|NCT02465866|20138872|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168596|NCT02465866|20138869|P4|COMPLETED|Period 1: Washout (14 Days)||5
8168597|NCT02465866|20138870|P3|COMPLETED|Period 1: Washout (14 Days)||5
8168598|NCT02465866|20138871|P2|COMPLETED|Period 1: Washout (14 Days)||5
8168599|NCT02465866|20138872|P1|COMPLETED|Period 1: Washout (14 Days)||5
8168600|NCT02465866|20138869|P4|STARTED|Period 1: Washout (14 Days)||5
8168601|NCT02465866|20138870|P3|STARTED|Period 1: Washout (14 Days)||5
8168602|NCT02465866|20138871|P2|STARTED|Period 1: Washout (14 Days)||5
8168603|NCT02465866|20138872|P1|STARTED|Period 1: Washout (14 Days)||5
8168604|NCT02465866|20138869|P4|NOT COMPLETED|Period 1||0
8168605|NCT02465866|20138870|P3|NOT COMPLETED|Period 1||0
8168606|NCT02465866|20138871|P2|NOT COMPLETED|Period 1||0
8168607|NCT02465866|20138872|P1|NOT COMPLETED|Period 1||0
8168608|NCT02465866|20138869|P4|COMPLETED|Period 1||5
8168609|NCT02465866|20138870|P3|COMPLETED|Period 1||5
8168610|NCT02465866|20138871|P2|COMPLETED|Period 1||5
8168611|NCT02465866|20138872|P1|COMPLETED|Period 1||5
8168612|NCT02465866|20138869|P4|STARTED|Period 1||5
8168613|NCT02465866|20138870|P3|STARTED|Period 1||5
8168614|NCT02465866|20138871|P2|STARTED|Period 1||5
8168615|NCT02465866|20138872|P1|STARTED|Period 1||5
8168616|NCT02465632|20138945|P3|NOT COMPLETED|Overall Study||17
8168617|NCT02465632|20138946|P2|NOT COMPLETED|Overall Study||23
8168618|NCT02465632|20138947|P1|NOT COMPLETED|Overall Study||31
8168619|NCT02465632|20138945|P3|COMPLETED|Overall Study||203
8168620|NCT02465632|20138946|P2|COMPLETED|Overall Study||417
8168621|NCT02465632|20138947|P1|COMPLETED|Overall Study||409
8168622|NCT02465632|20138945|P3|STARTED|Overall Study||220
8168623|NCT02465632|20138946|P2|STARTED|Overall Study||440
8168624|NCT02465632|20138947|P1|STARTED|Overall Study||440
8168625|NCT02465528|20138962|P4|NOT COMPLETED|Overall Study||5
8168626|NCT02465528|20138963|P3|NOT COMPLETED|Overall Study||12
8168627|NCT02465528|20138964|P2|NOT COMPLETED|Overall Study||4
8168628|NCT02465528|20138965|P1|NOT COMPLETED|Overall Study||1
8168629|NCT02465528|20138962|P4|COMPLETED|Overall Study||0
8168630|NCT02465528|20138963|P3|COMPLETED|Overall Study||0
8168631|NCT02465528|20138964|P2|COMPLETED|Overall Study||0
8168632|NCT02465528|20138965|P1|COMPLETED|Overall Study||0
8168633|NCT02465528|20138962|P4|STARTED|Overall Study||5
8168634|NCT02465528|20138963|P3|STARTED|Overall Study||12
8168635|NCT02465528|20138964|P2|STARTED|Overall Study||4
8168636|NCT02465528|20138965|P1|STARTED|Overall Study||1
8168637|NCT02465515|20138998|P2|NOT COMPLETED|Overall Study||111
8168638|NCT02465515|20138999|P1|NOT COMPLETED|Overall Study||154
8168639|NCT02465515|20138998|P2|COMPLETED|Overall Study||4620
8168640|NCT02465515|20138999|P1|COMPLETED|Overall Study||4578
8168641|NCT02465515|20138998|P2|STARTED|Overall Study||4731
8168642|NCT02465515|20138999|P1|STARTED|Overall Study||4732
8168643|NCT02465489|20139045|P1|NOT COMPLETED|Overall Study||5
8168644|NCT02465489|20139045|P1|COMPLETED|Overall Study||15
8168645|NCT02465489|20139045|P1|STARTED|Overall Study||20
8168646|NCT02465463|20139074|P2|NOT COMPLETED|Overall Study||1
8168647|NCT02465463|20139075|P1|NOT COMPLETED|Overall Study||4
8168648|NCT02465463|20139074|P2|COMPLETED|Overall Study||4
8168649|NCT02465463|20139075|P1|COMPLETED|Overall Study||4
8168650|NCT02465463|20139074|P2|STARTED|Overall Study||5
8168651|NCT02465463|20139075|P1|STARTED|Overall Study||8
8168652|NCT02465450|20139094|P6|NOT COMPLETED|Treatment Period 2||0
8168653|NCT02465450|20139095|P5|NOT COMPLETED|Treatment Period 2||4
8168654|NCT02465450|20139096|P4|NOT COMPLETED|Treatment Period 2||3
8168655|NCT02465450|20139097|P3|NOT COMPLETED|Treatment Period 2||0
8168656|NCT02465450|20139098|P2|NOT COMPLETED|Treatment Period 2||0
8168657|NCT02465450|20139099|P1|NOT COMPLETED|Treatment Period 2||0
8168658|NCT02465450|20139094|P6|COMPLETED|Treatment Period 2||23
8168659|NCT02465450|20139095|P5|COMPLETED|Treatment Period 2||24
8168660|NCT02465450|20139096|P4|COMPLETED|Treatment Period 2||27
8168661|NCT02465450|20139097|P3|COMPLETED|Treatment Period 2||0
8168662|NCT02465450|20139098|P2|COMPLETED|Treatment Period 2||0
8168663|NCT02465450|20139099|P1|COMPLETED|Treatment Period 2||0
8168664|NCT02465450|20139094|P6|STARTED|Treatment Period 2||23
8168665|NCT02465450|20139095|P5|STARTED|Treatment Period 2||28
8168666|NCT02465450|20139096|P4|STARTED|Treatment Period 2||30
8168667|NCT02465450|20139097|P3|STARTED|Treatment Period 2||0
8168668|NCT02465450|20139098|P2|STARTED|Treatment Period 2||0
8168669|NCT02465450|20139099|P1|STARTED|Treatment Period 2||0
8168670|NCT02465450|20139094|P6|NOT COMPLETED|Treatment Period 1||0
8168671|NCT02465450|20139095|P5|NOT COMPLETED|Treatment Period 1||0
8168672|NCT02465450|20139096|P4|NOT COMPLETED|Treatment Period 1||0
8168673|NCT02465450|20139097|P3|NOT COMPLETED|Treatment Period 1||1
8168674|NCT02465450|20139098|P2|NOT COMPLETED|Treatment Period 1||1
8168675|NCT02465450|20139099|P1|NOT COMPLETED|Treatment Period 1||2
8168676|NCT02465450|20139094|P6|COMPLETED|Treatment Period 1||0
8168677|NCT02465450|20139095|P5|COMPLETED|Treatment Period 1||0
8168678|NCT02465450|20139096|P4|COMPLETED|Treatment Period 1||0
8168679|NCT02465450|20139097|P3|COMPLETED|Treatment Period 1||34
8168680|NCT02465450|20139098|P2|COMPLETED|Treatment Period 1||23
8168681|NCT02465450|20139099|P1|COMPLETED|Treatment Period 1||24
8168682|NCT02465450|20139094|P6|STARTED|Treatment Period 1||0
8168683|NCT02465450|20139095|P5|STARTED|Treatment Period 1||0
8168684|NCT02465450|20139096|P4|STARTED|Treatment Period 1||0
8168685|NCT02465450|20139097|P3|STARTED|Treatment Period 1||35
8168686|NCT02465450|20139098|P2|STARTED|Treatment Period 1||24
8168687|NCT02465450|20139099|P1|STARTED|Treatment Period 1||26
8168688|NCT02465437|20139123|P4|NOT COMPLETED|Overall Study||1
8168689|NCT02465437|20139124|P3|NOT COMPLETED|Overall Study||1
8168690|NCT02465437|20139125|P2|NOT COMPLETED|Overall Study||1
8168691|NCT02465437|20139126|P1|NOT COMPLETED|Overall Study||1
8168692|NCT02465437|20139123|P4|COMPLETED|Overall Study||14
8168693|NCT02465437|20139124|P3|COMPLETED|Overall Study||8
8168694|NCT02465437|20139125|P2|COMPLETED|Overall Study||8
8168695|NCT02465437|20139126|P1|COMPLETED|Overall Study||8
8168696|NCT02465437|20139123|P4|STARTED|Overall Study||15
8168697|NCT02465437|20139124|P3|STARTED|Overall Study||9
8168698|NCT02465437|20139125|P2|STARTED|Overall Study||9
8168699|NCT02465437|20139126|P1|STARTED|Overall Study||9
8168700|NCT02465372|20139146|P2|NOT COMPLETED|Overall Study||97
8168701|NCT02465372|20139147|P1|NOT COMPLETED|Overall Study||122
8168702|NCT02465372|20139146|P2|COMPLETED|Overall Study||153
8168703|NCT02465372|20139147|P1|COMPLETED|Overall Study||227
8168704|NCT02465372|20139146|P2|STARTED|Overall Study||250
8168705|NCT02465372|20139147|P1|STARTED|Overall Study||349
8168706|NCT02465216|20139162|P5|NOT COMPLETED|Overall Study||3
8168707|NCT02465216|20139163|P4|NOT COMPLETED|Overall Study||2
8168708|NCT02465216|20139164|P3|NOT COMPLETED|Overall Study||1
8168709|NCT02465216|20139165|P2|NOT COMPLETED|Overall Study||0
8168710|NCT02465216|20139166|P1|NOT COMPLETED|Overall Study||3
8168711|NCT02465216|20139162|P5|COMPLETED|Overall Study||9
8168712|NCT02465216|20139163|P4|COMPLETED|Overall Study||12
8168713|NCT02465216|20139164|P3|COMPLETED|Overall Study||13
8168714|NCT02465216|20139165|P2|COMPLETED|Overall Study||5
8168715|NCT02465216|20139166|P1|COMPLETED|Overall Study||12
8168716|NCT02465216|20139162|P5|STARTED|Overall Study||12
8168717|NCT02465216|20139163|P4|STARTED|Overall Study||14
8168718|NCT02465216|20139164|P3|STARTED|Overall Study||14
8168719|NCT02465216|20139165|P2|STARTED|Overall Study||5
8168720|NCT02465216|20139166|P1|STARTED|Overall Study||15
8168721|NCT02465203|20139186|P3|NOT COMPLETED|Overall Study||13
8168722|NCT02465203|20139187|P2|NOT COMPLETED|Overall Study||36
8168723|NCT02465203|20139188|P1|NOT COMPLETED|Overall Study||56
8168724|NCT02465203|20139186|P3|COMPLETED|Overall Study||0
8168725|NCT02465203|20139187|P2|COMPLETED|Overall Study||0
8168726|NCT02465203|20139188|P1|COMPLETED|Overall Study||0
8168727|NCT02465203|20139186|P3|STARTED|Overall Study||13
8168728|NCT02465203|20139187|P2|STARTED|Overall Study||36
8168729|NCT02465203|20139188|P1|STARTED|Overall Study||56
8168730|NCT02465099|20139201|P2|NOT COMPLETED|Overall Study||0
8168731|NCT02465099|20139202|P1|NOT COMPLETED|Overall Study||0
8168732|NCT02465099|20139201|P2|COMPLETED|Overall Study||19
8168733|NCT02465099|20139202|P1|COMPLETED|Overall Study||45
8168734|NCT02465099|20139201|P2|STARTED|Overall Study||19
8168735|NCT02465099|20139202|P1|STARTED|Overall Study||45
8168736|NCT02465073|20139211|P3|NOT COMPLETED|Overall Study||1
8168737|NCT02465073|20139212|P2|NOT COMPLETED|Overall Study||1
8168738|NCT02465073|20139213|P1|NOT COMPLETED|Overall Study||2
8168739|NCT02465073|20139211|P3|COMPLETED|Overall Study||15
8168740|NCT02465073|20139212|P2|COMPLETED|Overall Study||15
8168741|NCT02465073|20139213|P1|COMPLETED|Overall Study||15
8168742|NCT02465073|20139211|P3|STARTED|Overall Study||16
8168743|NCT02465073|20139212|P2|STARTED|Overall Study||16
8168744|NCT02465073|20139213|P1|STARTED|Overall Study||17
8168745|NCT02464917|20139223|P2|NOT COMPLETED|Overall Study||0
8168746|NCT02464917|20139224|P1|NOT COMPLETED|Overall Study||0
8168747|NCT02464917|20139223|P2|COMPLETED|Overall Study||35
8168748|NCT02464917|20139224|P1|COMPLETED|Overall Study||35
8168749|NCT02464917|20139223|P2|STARTED|Overall Study||35
8168750|NCT02464917|20139224|P1|STARTED|Overall Study||35
8168751|NCT02464540|20139250|P2|NOT COMPLETED|Overall Study||0
8168752|NCT02464540|20139251|P1|NOT COMPLETED|Overall Study||0
8168753|NCT02464540|20139250|P2|COMPLETED|Overall Study||11
8168754|NCT02464540|20139251|P1|COMPLETED|Overall Study||11
8168755|NCT02464540|20139250|P2|STARTED|Overall Study||11
8168756|NCT02464540|20139251|P1|STARTED|Overall Study||11
8168757|NCT02464176|20139260|P3|NOT COMPLETED|Overall Study||0
8168758|NCT02464176|20139261|P2|NOT COMPLETED|Overall Study||0
8168759|NCT02464176|20139262|P1|NOT COMPLETED|Overall Study||0
8168760|NCT02464176|20139260|P3|COMPLETED|Overall Study||15
8168761|NCT02464176|20139261|P2|COMPLETED|Overall Study||50
8168762|NCT02464176|20139262|P1|COMPLETED|Overall Study||50
8168763|NCT02464176|20139260|P3|STARTED|Overall Study||15
8168764|NCT02464176|20139261|P2|STARTED|Overall Study||50
8168765|NCT02464176|20139262|P1|STARTED|Overall Study||50
8168766|NCT02464163|20139283|P4|NOT COMPLETED|Overall Study||5
8168767|NCT02464163|20139284|P3|NOT COMPLETED|Overall Study||5
8168768|NCT02464163|20139285|P2|NOT COMPLETED|Overall Study||8
8168769|NCT02464163|20139286|P1|NOT COMPLETED|Overall Study||3
8168770|NCT02464163|20139283|P4|COMPLETED|Overall Study||96
8168771|NCT02464163|20139284|P3|COMPLETED|Overall Study||97
8168772|NCT02464163|20139285|P2|COMPLETED|Overall Study||94
8168773|NCT02464163|20139286|P1|COMPLETED|Overall Study||99
8168774|NCT02464163|20139283|P4|STARTED|Overall Study||101
8168775|NCT02464163|20139284|P3|STARTED|Overall Study||102
8168776|NCT02464163|20139285|P2|STARTED|Overall Study||102
8168777|NCT02464163|20139286|P1|STARTED|Overall Study||102
8168778|NCT02464059|20139308|P1|NOT COMPLETED|Overall Study||6
8168779|NCT02464059|20139308|P1|COMPLETED|Overall Study||17
8168780|NCT02464059|20139308|P1|STARTED|Overall Study||23
8168781|NCT02464033|20139314|P1|NOT COMPLETED|Overall Study||0
8168782|NCT02464033|20139314|P1|COMPLETED|Overall Study||20
8168783|NCT02464033|20139314|P1|STARTED|Overall Study||20
8168784|NCT02463981|20139345|P2|NOT COMPLETED|Overall Study||2
8168785|NCT02463981|20139346|P1|NOT COMPLETED|Overall Study||3
8168786|NCT02463981|20139345|P2|COMPLETED|Overall Study||14
8168787|NCT02463981|20139346|P1|COMPLETED|Overall Study||18
8168788|NCT02463981|20139345|P2|STARTED|Overall Study||16
8168789|NCT02463981|20139346|P1|STARTED|Overall Study||21
8168790|NCT02463487|20139356|P2|NOT COMPLETED|Overall Study||10
8168791|NCT02463487|20139357|P1|NOT COMPLETED|Overall Study||10
8168792|NCT02463487|20139356|P2|COMPLETED|Overall Study||65
8168793|NCT02463487|20139357|P1|COMPLETED|Overall Study||65
8168794|NCT02463487|20139356|P2|STARTED|Overall Study||75
8168795|NCT02463487|20139357|P1|STARTED|Overall Study||75
8168796|NCT02463409|20139367|P1|NOT COMPLETED|Overall Study||2
8168797|NCT02463409|20139367|P1|COMPLETED|Overall Study||4
8168798|NCT02463409|20139367|P1|STARTED|Overall Study||6
8168799|NCT02463331|20139375|P2|NOT COMPLETED|Overall Study||6
8168800|NCT02463331|20139376|P1|NOT COMPLETED|Overall Study||16
8168801|NCT02463331|20139375|P2|COMPLETED|Overall Study||25
8168802|NCT02463331|20139376|P1|COMPLETED|Overall Study||10
8168803|NCT02463331|20139375|P2|STARTED|Overall Study||31
8168804|NCT02463331|20139376|P1|STARTED|Overall Study||26
8168805|NCT02463227|20139384|P1|NOT COMPLETED|Overall Study||0
8168806|NCT02463227|20139384|P1|COMPLETED|Overall Study||14
8168807|NCT02463227|20139384|P1|STARTED|Overall Study||14
8168808|NCT02463097|20139392|P1|NOT COMPLETED|Overall Study||1
8168809|NCT02463097|20139392|P1|COMPLETED|Overall Study||123
8168810|NCT02463097|20139392|P1|STARTED|Overall Study||124
8168811|NCT02463071|20139401|P3|NOT COMPLETED|Overall Study||6
8168812|NCT02463071|20139402|P2|NOT COMPLETED|Overall Study||16
8168813|NCT02463071|20139403|P1|NOT COMPLETED|Overall Study||12
8168814|NCT02463071|20139401|P3|COMPLETED|Overall Study||71
8168815|NCT02463071|20139402|P2|COMPLETED|Overall Study||138
8168816|NCT02463071|20139403|P1|COMPLETED|Overall Study||140
8168817|NCT02463071|20139401|P3|STARTED|Overall Study||77
8168818|NCT02463071|20139402|P2|STARTED|Overall Study||154
8168819|NCT02463071|20139403|P1|STARTED|Overall Study||152
8168820|NCT02463032|20139431|P2|NOT COMPLETED|Overall Study||64
8168821|NCT02463032|20139432|P1|NOT COMPLETED|Overall Study||71
8168822|NCT02463032|20139431|P2|COMPLETED|Overall Study||0
8168823|NCT02463032|20139432|P1|COMPLETED|Overall Study||1
8168824|NCT02463032|20139431|P2|STARTED|Overall Study||64
8168825|NCT02463032|20139432|P1|STARTED|Overall Study||72
8168826|NCT02462967|20139453|P3|NOT COMPLETED|Overall Study||3
8168827|NCT02462967|20139454|P2|NOT COMPLETED|Overall Study||6
8168828|NCT02462967|20139455|P1|NOT COMPLETED|Overall Study||2
8168829|NCT02462967|20139453|P3|COMPLETED|Overall Study||51
8168830|NCT02462967|20139454|P2|COMPLETED|Overall Study||48
8168831|NCT02462967|20139455|P1|COMPLETED|Overall Study||52
8168832|NCT02462967|20139453|P3|STARTED|Overall Study||54
8168833|NCT02462967|20139454|P2|STARTED|Overall Study||54
8168834|NCT02462967|20139455|P1|STARTED|Overall Study||54
8168835|NCT02462928|20139484|P3|NOT COMPLETED|Overall Study||57
8168836|NCT02462928|20139485|P2|NOT COMPLETED|Overall Study||92
8168837|NCT02462928|20139486|P1|NOT COMPLETED|Overall Study||90
8168838|NCT02462928|20139484|P3|COMPLETED|Overall Study||255
8168839|NCT02462928|20139485|P2|COMPLETED|Overall Study||221
8168840|NCT02462928|20139486|P1|COMPLETED|Overall Study||224
8168841|NCT02462928|20139484|P3|STARTED|Overall Study||312
8168842|NCT02462928|20139485|P2|STARTED|Overall Study||313
8168843|NCT02462928|20139486|P1|STARTED|Overall Study||314
8168844|NCT02462876|20139506|P1|NOT COMPLETED|Overall Study||33
8168845|NCT02462876|20139506|P1|COMPLETED|Overall Study||27
8168846|NCT02462876|20139506|P1|STARTED|Overall Study||60
8168865|NCT02462720|20139566|P2|NOT COMPLETED|Part 2||1
8168866|NCT02462720|20139567|P1|NOT COMPLETED|Part 2||1
8168867|NCT02462720|20139566|P2|COMPLETED|Part 2||16
8168868|NCT02462720|20139567|P1|COMPLETED|Part 2||17
8168869|NCT02462720|20139566|P2|STARTED|Part 2||17
8168870|NCT02462720|20139567|P1|STARTED|Part 2||18
8168871|NCT02462720|20139566|P2|NOT COMPLETED|Part 1||0
8168872|NCT02462720|20139567|P1|NOT COMPLETED|Part 1||0
8168873|NCT02462720|20139566|P2|COMPLETED|Part 1||17
8168874|NCT02462720|20139567|P1|COMPLETED|Part 1||18
8168875|NCT02462720|20139566|P2|STARTED|Part 1||17
8168876|NCT02462720|20139567|P1|STARTED|Part 1||18
8168877|NCT02462486|20139580|P3|NOT COMPLETED|Overall Study||52
8168878|NCT02462486|20139581|P2|NOT COMPLETED|Overall Study||92
8168879|NCT02462486|20139582|P1|NOT COMPLETED|Overall Study||94
8168880|NCT02462486|20139580|P3|COMPLETED|Overall Study||266
8168881|NCT02462486|20139581|P2|COMPLETED|Overall Study||223
8168882|NCT02462486|20139582|P1|COMPLETED|Overall Study||222
8168883|NCT02462486|20139580|P3|STARTED|Overall Study||318
8168884|NCT02462486|20139581|P2|STARTED|Overall Study||315
8168885|NCT02462486|20139582|P1|STARTED|Overall Study||316
8168886|NCT02462473|20139602|P1|NOT COMPLETED|Overall Study||4
8168887|NCT02462473|20139602|P1|COMPLETED|Overall Study||5
8168888|NCT02462473|20139602|P1|STARTED|Overall Study||9
8168889|NCT02462382|20139615|P2|NOT COMPLETED|Overall Study||0
8168890|NCT02462382|20139616|P1|NOT COMPLETED|Overall Study||0
8168891|NCT02462382|20139615|P2|COMPLETED|Overall Study||27
8168892|NCT02462382|20139616|P1|COMPLETED|Overall Study||24
8168893|NCT02462382|20139615|P2|STARTED|Overall Study||27
8168894|NCT02462382|20139616|P1|STARTED|Overall Study||24
8168895|NCT02462291|20139630|P2|NOT COMPLETED|Overall Study||6
8168896|NCT02462291|20139631|P1|NOT COMPLETED|Overall Study||5
8168897|NCT02462291|20139630|P2|COMPLETED|Overall Study||75
8168898|NCT02462291|20139631|P1|COMPLETED|Overall Study||77
8168899|NCT02462291|20139630|P2|STARTED|Overall Study||81
8168900|NCT02462291|20139631|P1|STARTED|Overall Study||82
8168901|NCT02462148|20139672|P3|NOT COMPLETED|Overall Study||0
8168902|NCT02462148|20139673|P2|NOT COMPLETED|Overall Study||0
8168903|NCT02462148|20139674|P1|NOT COMPLETED|Overall Study||1
8168904|NCT02462148|20139672|P3|COMPLETED|Overall Study||12
8168905|NCT02462148|20139673|P2|COMPLETED|Overall Study||36
8168906|NCT02462148|20139674|P1|COMPLETED|Overall Study||36
8168907|NCT02462148|20139672|P3|STARTED|Overall Study||12
8168908|NCT02462148|20139673|P2|STARTED|Overall Study||36
8168909|NCT02462148|20139674|P1|STARTED|Overall Study||37
8168910|NCT02462122|20139699|P2|NOT COMPLETED|Overall Study||13
8168911|NCT02462122|20139700|P1|NOT COMPLETED|Overall Study||21
8168912|NCT02462122|20139699|P2|COMPLETED|Overall Study||61
8168913|NCT02462122|20139700|P1|COMPLETED|Overall Study||120
8168914|NCT02462122|20139699|P2|STARTED|Overall Study||74
8168915|NCT02462122|20139700|P1|STARTED|Overall Study||141
8168916|NCT02462083|20139708|P1|NOT COMPLETED|Overall Study||419
8168917|NCT02462083|20139708|P1|COMPLETED|Overall Study||136
8168918|NCT02462083|20139708|P1|Safety Population|Overall Study||550
8168919|NCT02462083|20139708|P1|STARTED|Overall Study||555
8168920|NCT02462070|20139714|P2|NOT COMPLETED|Overall Study||11
8168921|NCT02462070|20139715|P1|NOT COMPLETED|Overall Study||23
8168922|NCT02462070|20139714|P2|COMPLETED|Overall Study||57
8168923|NCT02462070|20139715|P1|COMPLETED|Overall Study||112
8168924|NCT02462070|20139714|P2|STARTED|Overall Study||68
8168925|NCT02462070|20139715|P1|STARTED|Overall Study||135
8168926|NCT02462057|20139728|P5|NOT COMPLETED|Overall Study||50
8168927|NCT02462057|20139729|P4|NOT COMPLETED|Overall Study||51
8168928|NCT02462057|20139730|P3|NOT COMPLETED|Overall Study||46
8168929|NCT02462057|20139731|P2|NOT COMPLETED|Overall Study||40
8168930|NCT02462057|20139732|P1|NOT COMPLETED|Overall Study||54
8168931|NCT02462057|20139728|P5|COMPLETED|Overall Study||708
8168932|NCT02462057|20139729|P4|COMPLETED|Overall Study||701
8168933|NCT02462057|20139730|P3|COMPLETED|Overall Study||766
8168934|NCT02462057|20139731|P2|COMPLETED|Overall Study||753
8168935|NCT02462057|20139732|P1|COMPLETED|Overall Study||737
8168936|NCT02462057|20139728|P5|STARTED|Overall Study||758
8168937|NCT02462057|20139729|P4|STARTED|Overall Study||752
8168938|NCT02462057|20139730|P3|STARTED|Overall Study||812
8168939|NCT02462057|20139731|P2|STARTED|Overall Study||793
8168940|NCT02462057|20139732|P1|STARTED|Overall Study||791
8168941|NCT02461992|20139744|P1|NOT COMPLETED|Overall Study||0
8168942|NCT02461992|20139744|P1|COMPLETED|Overall Study||13
8168943|NCT02461992|20139744|P1|STARTED|Overall Study||13
8168944|NCT02461966|20139764|P3|NOT COMPLETED|Overall Study||0
8168945|NCT02461966|20139765|P2|NOT COMPLETED|Overall Study||0
8168946|NCT02461966|20139766|P1|NOT COMPLETED|Overall Study||0
8168947|NCT02461966|20139764|P3|COMPLETED|Overall Study||60
8168948|NCT02461966|20139765|P2|COMPLETED|Overall Study||80
8168949|NCT02461966|20139766|P1|COMPLETED|Overall Study||160
8168950|NCT02461966|20139764|P3|STARTED|Overall Study||60
8168951|NCT02461966|20139765|P2|STARTED|Overall Study||80
8168952|NCT02461966|20139766|P1|STARTED|Overall Study||160
8168953|NCT02461771|20139777|P3|NOT COMPLETED|Overall Study||0
8168954|NCT02461771|20139778|P2|NOT COMPLETED|Overall Study||0
8168955|NCT02461771|20139779|P1|NOT COMPLETED|Overall Study||0
8168956|NCT02461771|20139777|P3|COMPLETED|Overall Study||7
8168957|NCT02461771|20139778|P2|COMPLETED|Overall Study||3
8168958|NCT02461771|20139779|P1|COMPLETED|Overall Study||3
8168959|NCT02461771|20139777|P3|STARTED|Overall Study||7
8168960|NCT02461771|20139778|P2|STARTED|Overall Study||3
8168961|NCT02461771|20139779|P1|STARTED|Overall Study||3
8168962|NCT02461758|20139818|P4|NOT COMPLETED|Overall Study||0
8168963|NCT02461758|20139819|P3|NOT COMPLETED|Overall Study||1
8168964|NCT02461758|20139820|P2|NOT COMPLETED|Overall Study||1
8168965|NCT02461758|20139821|P1|NOT COMPLETED|Overall Study||0
8168966|NCT02461758|20139818|P4|COMPLETED|Overall Study||15
8168967|NCT02461758|20139819|P3|COMPLETED|Overall Study||25
8168968|NCT02461758|20139820|P2|COMPLETED|Overall Study||19
8168969|NCT02461758|20139821|P1|COMPLETED|Overall Study||20
8168970|NCT02461758|20139818|P4|STARTED|Overall Study||15
8168971|NCT02461758|20139819|P3|STARTED|Overall Study||26
8168972|NCT02461758|20139820|P2|STARTED|Overall Study||20
8168973|NCT02461758|20139821|P1|STARTED|Overall Study||20
8168974|NCT02461745|20139847|P2|NOT COMPLETED|Overall Study||4
8168975|NCT02461745|20139848|P1|NOT COMPLETED|Overall Study||14
8168976|NCT02461745|20139847|P2|COMPLETED|Overall Study||66
8168977|NCT02461745|20139848|P1|COMPLETED|Overall Study||116
8168978|NCT02461745|20139847|P2|STARTED|Overall Study||70
8168979|NCT02461745|20139848|P1|STARTED|Overall Study||130
8168980|NCT02461693|20139858|P2|NOT COMPLETED|Overall Study||0
8168981|NCT02461693|20139859|P1|NOT COMPLETED|Overall Study||0
8168982|NCT02461693|20139858|P2|COMPLETED|Overall Study||102
8168983|NCT02461693|20139859|P1|COMPLETED|Overall Study||103
8168984|NCT02461693|20139858|P2|STARTED|Overall Study||102
8168985|NCT02461693|20139859|P1|STARTED|Overall Study||103
8168986|NCT02461628|20139873|P2|NOT COMPLETED|Overall Study||7
8168987|NCT02461628|20139874|P1|NOT COMPLETED|Overall Study||4
8168988|NCT02461628|20139873|P2|COMPLETED|Overall Study||3625
8168989|NCT02461628|20139874|P1|COMPLETED|Overall Study||3729
8168990|NCT02461628|20139873|P2|18 Month Survey|Overall Study||905
8168991|NCT02461628|20139874|P1|18 Month Survey|Overall Study||995
8168992|NCT02461628|20139873|P2|12 Month Survey|Overall Study||914
8168993|NCT02461628|20139874|P1|12 Month Survey|Overall Study||882
8168994|NCT02461628|20139873|P2|6 Month Survey|Overall Study||832
8168995|NCT02461628|20139874|P1|6 Month Survey|Overall Study||814
8168996|NCT02461628|20139873|P2|Baseline Survey|Overall Study||974
8168997|NCT02461628|20139874|P1|Baseline Survey|Overall Study||1038
8168998|NCT02461628|20139873|P2|STARTED|Overall Study||3632
8168999|NCT02461628|20139874|P1|STARTED|Overall Study||3733
8169000|NCT02461589|20139898|P10|NOT COMPLETED|Overall Study||5
8169001|NCT02461589|20139899|P9|NOT COMPLETED|Overall Study||6
8169002|NCT02461589|20139900|P8|NOT COMPLETED|Overall Study||5
8169003|NCT02461589|20139901|P7|NOT COMPLETED|Overall Study||6
8169004|NCT02461589|20139902|P6|NOT COMPLETED|Overall Study||3
8169005|NCT02461589|20139903|P5|NOT COMPLETED|Overall Study||2
8169006|NCT02461589|20139904|P4|NOT COMPLETED|Overall Study||5
8169007|NCT02461589|20139905|P3|NOT COMPLETED|Overall Study||5
8169008|NCT02461589|20139906|P2|NOT COMPLETED|Overall Study||2
8169009|NCT02461589|20139907|P1|NOT COMPLETED|Overall Study||6
8169010|NCT02461589|20139898|P10|COMPLETED|Overall Study||60
8169011|NCT02461589|20139899|P9|COMPLETED|Overall Study||123
8169012|NCT02461589|20139900|P8|COMPLETED|Overall Study||60
8169013|NCT02461589|20139901|P7|COMPLETED|Overall Study||58
8169014|NCT02461589|20139902|P6|COMPLETED|Overall Study||61
8169015|NCT02461589|20139903|P5|COMPLETED|Overall Study||62
8169016|NCT02461589|20139904|P4|COMPLETED|Overall Study||58
8169017|NCT02461589|20139905|P3|COMPLETED|Overall Study||60
8169018|NCT02461589|20139906|P2|COMPLETED|Overall Study||61
8169019|NCT02461589|20139907|P1|COMPLETED|Overall Study||58
8169020|NCT02461589|20139898|P10|Exposed|Overall Study||64
8169021|NCT02461589|20139899|P9|Exposed|Overall Study||129
8169022|NCT02461589|20139900|P8|Exposed|Overall Study||65
8169023|NCT02461589|20139901|P7|Exposed|Overall Study||64
8169024|NCT02461589|20139902|P6|Exposed|Overall Study||64
8169025|NCT02461589|20139903|P5|Exposed|Overall Study||64
8169026|NCT02461589|20139904|P4|Exposed|Overall Study||63
8169027|NCT02461589|20139905|P3|Exposed|Overall Study||65
8169028|NCT02461589|20139906|P2|Exposed|Overall Study||63
8169029|NCT02461589|20139907|P1|Exposed|Overall Study||64
8169030|NCT02461589|20139898|P10|STARTED|Overall Study||65
8169031|NCT02461589|20139899|P9|STARTED|Overall Study||129
8169032|NCT02461589|20139900|P8|STARTED|Overall Study||65
8169033|NCT02461589|20139901|P7|STARTED|Overall Study||64
8169034|NCT02461589|20139902|P6|STARTED|Overall Study||64
8169035|NCT02461589|20139903|P5|STARTED|Overall Study||64
8169036|NCT02461589|20139904|P4|STARTED|Overall Study||63
8169037|NCT02461589|20139905|P3|STARTED|Overall Study||65
8169038|NCT02461589|20139906|P2|STARTED|Overall Study||63
8169039|NCT02461589|20139907|P1|STARTED|Overall Study||64
8169040|NCT02461563|20139963|P4|NOT COMPLETED|Overall Study||0
8169041|NCT02461563|20139964|P3|NOT COMPLETED|Overall Study||0
8169042|NCT02461563|20139965|P2|NOT COMPLETED|Overall Study||0
8169043|NCT02461563|20139966|P1|NOT COMPLETED|Overall Study||0
8169044|NCT02461563|20139963|P4|COMPLETED|Overall Study||3
8169045|NCT02461563|20139964|P3|COMPLETED|Overall Study||3
8169046|NCT02461563|20139965|P2|COMPLETED|Overall Study||3
8169047|NCT02461563|20139966|P1|COMPLETED|Overall Study||3
8169048|NCT02461563|20139963|P4|STARTED|Overall Study||3
8169049|NCT02461563|20139964|P3|STARTED|Overall Study||3
8169050|NCT02461563|20139965|P2|STARTED|Overall Study||3
8169051|NCT02461563|20139966|P1|STARTED|Overall Study||3
8169052|NCT02461550|20140000|P1|NOT COMPLETED|Overall Study||0
8169053|NCT02461550|20140000|P1|COMPLETED|Overall Study||2
8169054|NCT02461550|20140000|P1|STARTED|Overall Study||2
8169055|NCT02461433|20140006|P2|NOT COMPLETED|Overall Study||0
8169056|NCT02461433|20140007|P1|NOT COMPLETED|Overall Study||0
8169057|NCT02461433|20140006|P2|COMPLETED|Overall Study||1
8169058|NCT02461433|20140007|P1|COMPLETED|Overall Study||1
8169059|NCT02461433|20140006|P2|STARTED|Overall Study||1
8169060|NCT02461433|20140007|P1|STARTED|Overall Study||1
8169061|NCT02461355|20140033|P1|NOT COMPLETED|Overall Study||0
8169062|NCT02461355|20140033|P1|COMPLETED|Overall Study||2
8169063|NCT02461355|20140033|P1|STARTED|Overall Study||2
8169064|NCT02461290|20140040|P1|NOT COMPLETED|Overall Study||10
8169065|NCT02461290|20140040|P1|COMPLETED|Overall Study||89
8169066|NCT02461290|20140040|P1|STARTED|Overall Study||99
8169067|NCT02461160|20140060|P13|NOT COMPLETED|Overall Study||0
8169068|NCT02461160|20140061|P12|NOT COMPLETED|Overall Study||0
8169069|NCT02461160|20140062|P11|NOT COMPLETED|Overall Study||0
8169070|NCT02461160|20140063|P10|NOT COMPLETED|Overall Study||0
8169071|NCT02461160|20140064|P9|NOT COMPLETED|Overall Study||0
8169072|NCT02461160|20140065|P8|NOT COMPLETED|Overall Study||1
8169073|NCT02461160|20140066|P7|NOT COMPLETED|Overall Study||0
8169074|NCT02461160|20140067|P6|NOT COMPLETED|Overall Study||0
8169075|NCT02461160|20140068|P5|NOT COMPLETED|Overall Study||0
8169076|NCT02461160|20140069|P4|NOT COMPLETED|Overall Study||0
8169077|NCT02461160|20140070|P3|NOT COMPLETED|Overall Study||0
8169078|NCT02461160|20140071|P2|NOT COMPLETED|Overall Study||0
8169079|NCT02461160|20140072|P1|NOT COMPLETED|Overall Study||0
8169080|NCT02461160|20140060|P13|COMPLETED|Overall Study||8
8169081|NCT02461160|20140061|P12|COMPLETED|Overall Study||4
8169082|NCT02461160|20140062|P11|COMPLETED|Overall Study||4
8169083|NCT02461160|20140063|P10|COMPLETED|Overall Study||4
8169084|NCT02461160|20140064|P9|COMPLETED|Overall Study||12
8169085|NCT02461160|20140065|P8|COMPLETED|Overall Study||5
8169086|NCT02461160|20140066|P7|COMPLETED|Overall Study||6
8169087|NCT02461160|20140067|P6|COMPLETED|Overall Study||6
8169088|NCT02461160|20140068|P5|COMPLETED|Overall Study||6
8169089|NCT02461160|20140069|P4|COMPLETED|Overall Study||12
8169090|NCT02461160|20140070|P3|COMPLETED|Overall Study||6
8169091|NCT02461160|20140071|P2|COMPLETED|Overall Study||6
8169092|NCT02461160|20140072|P1|COMPLETED|Overall Study||8
8169093|NCT02461160|20140060|P13|STARTED|Overall Study||8
8169094|NCT02461160|20140061|P12|STARTED|Overall Study||4
8169095|NCT02461160|20140062|P11|STARTED|Overall Study||4
8169096|NCT02461160|20140063|P10|STARTED|Overall Study||4
8169097|NCT02461160|20140064|P9|STARTED|Overall Study||12
8169098|NCT02461160|20140065|P8|STARTED|Overall Study||6
8169099|NCT02461160|20140066|P7|STARTED|Overall Study||6
8169100|NCT02461160|20140067|P6|STARTED|Overall Study||6
8169101|NCT02461160|20140068|P5|STARTED|Overall Study||6
8169102|NCT02461160|20140069|P4|STARTED|Overall Study||12
8169103|NCT02461160|20140070|P3|STARTED|Overall Study||6
8169104|NCT02461160|20140071|P2|STARTED|Overall Study||6
8169105|NCT02461160|20140072|P1|STARTED|Overall Study||8
8169106|NCT02461134|20140283|P1|NOT COMPLETED|Overall Study||1
8169107|NCT02461134|20140283|P1|COMPLETED|Overall Study||0
8169108|NCT02461134|20140283|P1|STARTED|Overall Study||1
8169115|NCT02460978|20140309|P3|NOT COMPLETED|Overall Study||33
8169116|NCT02460978|20140310|P2|NOT COMPLETED|Overall Study||25
8169117|NCT02460978|20140311|P1|NOT COMPLETED|Overall Study||27
8169118|NCT02460978|20140309|P3|COMPLETED|Overall Study||239
8169119|NCT02460978|20140310|P2|COMPLETED|Overall Study||245
8169120|NCT02460978|20140311|P1|COMPLETED|Overall Study||244
8169121|NCT02460978|20140309|P3|STARTED|Overall Study||272
8169122|NCT02460978|20140310|P2|STARTED|Overall Study||270
8169123|NCT02460978|20140311|P1|STARTED|Overall Study||271
8169124|NCT02460822|20140337|P1|NOT COMPLETED|Overall Study||1
8169125|NCT02460822|20140337|P1|COMPLETED|Overall Study||15
8169126|NCT02460822|20140337|P1|STARTED|Overall Study||16
8169127|NCT02460679|20140346|P1|NOT COMPLETED|Overall Study||5
8169128|NCT02460679|20140346|P1|COMPLETED|Overall Study||14
8169129|NCT02460679|20140346|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
8169130|NCT02460679|20140346|P1|STARTED|Overall Study||19
8169131|NCT02460575|20140371|P2|NOT COMPLETED|Overall Study||0
8169132|NCT02460575|20140372|P1|NOT COMPLETED|Overall Study||1
8169133|NCT02460575|20140371|P2|COMPLETED|Overall Study||20
8169134|NCT02460575|20140372|P1|COMPLETED|Overall Study||39
8169135|NCT02460575|20140371|P2|STARTED|Overall Study||20
8169136|NCT02460575|20140372|P1|STARTED|Overall Study||40
8169137|NCT02460562|20140382|P2|NOT COMPLETED|Overall Study||16
8169138|NCT02460562|20140383|P1|NOT COMPLETED|Overall Study||15
8169139|NCT02460562|20140382|P2|COMPLETED|Overall Study||60
8169140|NCT02460562|20140383|P1|COMPLETED|Overall Study||59
8169141|NCT02460562|20140382|P2|STARTED|Overall Study||76
8169142|NCT02460562|20140383|P1|STARTED|Overall Study||74
8169143|NCT02460458|20140391|P1|NOT COMPLETED|Second Prospective Phase||152
8169144|NCT02460458|20140391|P1|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
8169145|NCT02460458|20140391|P1|STARTED|Second Prospective Phase||152
8169146|NCT02460458|20140391|P1|NOT COMPLETED|Confirmation of Clinical Phase Data||9
8169147|NCT02460458|20140391|P1|COMPLETED|Confirmation of Clinical Phase Data||152
8169148|NCT02460458|20140391|P1|STARTED|Confirmation of Clinical Phase Data||161
8169149|NCT02460458|20140391|P1|NOT COMPLETED|First Prospective Phase||16
8169150|NCT02460458|20140391|P1|COMPLETED|First Prospective Phase||161
8169151|NCT02460458|20140391|P1|STARTED|First Prospective Phase||177
8169152|NCT02460458|20140391|P1|NOT COMPLETED|Confirmatory Phase||88
8169153|NCT02460458|20140391|P1|COMPLETED|Confirmatory Phase||177
8169154|NCT02460458|20140391|P1|STARTED|Confirmatory Phase||265
8169155|NCT02460458|20140391|P1|NOT COMPLETED|Retrospective Phase||0
8169156|NCT02460458|20140391|P1|COMPLETED|Retrospective Phase||265
8169157|NCT02460458|20140391|P1|STARTED|Retrospective Phase||265
8169158|NCT02460380|20140407|P2|NOT COMPLETED|Overall Study||5
8169159|NCT02460380|20140408|P1|NOT COMPLETED|Overall Study||10
8169160|NCT02460380|20140407|P2|COMPLETED|Overall Study||18
8169161|NCT02460380|20140408|P1|COMPLETED|Overall Study||35
8169162|NCT02460380|20140407|P2|STARTED|Overall Study||23
8169163|NCT02460380|20140408|P1|STARTED|Overall Study||45
8169164|NCT02460263|20140428|P1|NOT COMPLETED|In-Home Period||0
8169165|NCT02460263|20140428|P1|COMPLETED|In-Home Period||28
8169166|NCT02460263|20140428|P1|STARTED|In-Home Period||28
8169167|NCT02460263|20140428|P1|NOT COMPLETED|Transition Period||2
8169168|NCT02460263|20140428|P1|COMPLETED|Transition Period||28
8169169|NCT02460263|20140428|P1|STARTED|Transition Period||30
8169170|NCT02460263|20140428|P1|NOT COMPLETED|In-Center Period||0
8169171|NCT02460263|20140428|P1|COMPLETED|In-Center Period||30
8169172|NCT02460263|20140428|P1|STARTED|In-Center Period||30
8169179|NCT02460172|20140460|P1|NOT COMPLETED|Overall Study||0
8169180|NCT02460172|20140460|P1|COMPLETED|Overall Study||25
8169181|NCT02460172|20140460|P1|STARTED|Overall Study||25
8169182|NCT02460159|20140476|P2|NOT COMPLETED|Overall Study||1
8169183|NCT02460159|20140477|P1|NOT COMPLETED|Overall Study||6
8169184|NCT02460159|20140476|P2|COMPLETED|Overall Study||17
8169185|NCT02460159|20140477|P1|COMPLETED|Overall Study||111
8169186|NCT02460159|20140476|P2|STARTED|Overall Study||18
8169187|NCT02460159|20140477|P1|STARTED|Overall Study||117
8169188|NCT02459951|20140505|P1|NOT COMPLETED|Overall Study||1
8169189|NCT02459951|20140505|P1|COMPLETED|Overall Study||9
8169190|NCT02459951|20140505|P1|STARTED|Overall Study||10
8169191|NCT02459899|20140516|P4|NOT COMPLETED|Overall Study||2
8169192|NCT02459899|20140517|P3|NOT COMPLETED|Overall Study||0
8169193|NCT02459899|20140518|P2|NOT COMPLETED|Overall Study||6
8169194|NCT02459899|20140519|P1|NOT COMPLETED|Overall Study||3
8169195|NCT02459899|20140516|P4|COMPLETED|Overall Study||33
8169196|NCT02459899|20140517|P3|COMPLETED|Overall Study||35
8169197|NCT02459899|20140518|P2|COMPLETED|Overall Study||29
8169198|NCT02459899|20140519|P1|COMPLETED|Overall Study||33
8169199|NCT02459899|20140516|P4|STARTED|Overall Study||35
8169200|NCT02459899|20140517|P3|STARTED|Overall Study||35
8169201|NCT02459899|20140518|P2|STARTED|Overall Study||35
8169202|NCT02459899|20140519|P1|STARTED|Overall Study||36
8169203|NCT02459795|20140552|P3|NOT COMPLETED|Overall Study||1
8169204|NCT02459795|20140553|P2|NOT COMPLETED|Overall Study||3
8169205|NCT02459795|20140554|P1|NOT COMPLETED|Overall Study||6
8169206|NCT02459795|20140552|P3|COMPLETED|Overall Study||92
8169207|NCT02459795|20140553|P2|COMPLETED|Overall Study||186
8169208|NCT02459795|20140554|P1|COMPLETED|Overall Study||181
8169209|NCT02459795|20140552|P3|STARTED|Overall Study||93
8169210|NCT02459795|20140553|P2|STARTED|Overall Study||189
8169211|NCT02459795|20140554|P1|STARTED|Overall Study||187
8169212|NCT02459665|20140566|P4|NOT COMPLETED|Overall Study||2
8169213|NCT02459665|20140567|P3|NOT COMPLETED|Overall Study||1
8169214|NCT02459665|20140568|P2|NOT COMPLETED|Overall Study||1
8169215|NCT02459665|20140569|P1|NOT COMPLETED|Overall Study||0
8169216|NCT02459665|20140566|P4|COMPLETED|Overall Study||15
8169217|NCT02459665|20140567|P3|COMPLETED|Overall Study||16
8169218|NCT02459665|20140568|P2|COMPLETED|Overall Study||16
8169219|NCT02459665|20140569|P1|COMPLETED|Overall Study||17
8169220|NCT02459665|20140566|P4|Month 6 Visit|Overall Study||15
8169221|NCT02459665|20140567|P3|Month 6 Visit|Overall Study||16
8169222|NCT02459665|20140568|P2|Month 6 Visit|Overall Study||16
8169223|NCT02459665|20140569|P1|Month 6 Visit|Overall Study||17
8169224|NCT02459665|20140566|P4|Month 2 Visit|Overall Study||16
8169225|NCT02459665|20140567|P3|Month 2 Visit|Overall Study||17
8169226|NCT02459665|20140568|P2|Month 2 Visit|Overall Study||16
8169227|NCT02459665|20140569|P1|Month 2 Visit|Overall Study||17
8169228|NCT02459665|20140566|P4|Month 1 Visit|Overall Study||16
8169229|NCT02459665|20140567|P3|Month 1 Visit|Overall Study||17
8169230|NCT02459665|20140568|P2|Month 1 Visit|Overall Study||17
8169231|NCT02459665|20140569|P1|Month 1 Visit|Overall Study||17
8169232|NCT02459665|20140566|P4|Day 7 Visit|Overall Study||16
8169233|NCT02459665|20140567|P3|Day 7 Visit|Overall Study||17
8169234|NCT02459665|20140568|P2|Day 7 Visit|Overall Study||17
8169235|NCT02459665|20140569|P1|Day 7 Visit|Overall Study||17
8169236|NCT02459665|20140566|P4|STARTED|Overall Study||17
8169237|NCT02459665|20140567|P3|STARTED|Overall Study||17
8169238|NCT02459665|20140568|P2|STARTED|Overall Study||17
8169239|NCT02459665|20140569|P1|STARTED|Overall Study||17
8169240|NCT02459418|20140600|P2|NOT COMPLETED|Overall Study||6
8169241|NCT02459418|20140601|P1|NOT COMPLETED|Overall Study||8
8169242|NCT02459418|20140600|P2|COMPLETED|Overall Study||15
8169243|NCT02459418|20140601|P1|COMPLETED|Overall Study||13
8169244|NCT02459418|20140600|P2|Received Second Treatment|Overall Study||15
8169245|NCT02459418|20140601|P1|Received Second Treatment|Overall Study||13
8169246|NCT02459418|20140600|P2|Received First Treatment|Overall Study||21
8169247|NCT02459418|20140601|P1|Received First Treatment|Overall Study||21
8169248|NCT02459418|20140600|P2|STARTED|Overall Study||21
8169249|NCT02459418|20140601|P1|STARTED|Overall Study||21
8169250|NCT02459275|20140623|P2|NOT COMPLETED|Overall Study||0
8169251|NCT02459275|20140624|P1|NOT COMPLETED|Overall Study||0
8169252|NCT02459275|20140623|P2|COMPLETED|Overall Study||17
8169253|NCT02459275|20140624|P1|COMPLETED|Overall Study||19
8169254|NCT02459275|20140623|P2|STARTED|Overall Study||17
8169255|NCT02459275|20140624|P1|STARTED|Overall Study||19
8169256|NCT02459262|20140651|P11|NOT COMPLETED|Overall Study||0
8169257|NCT02459262|20140652|P10|NOT COMPLETED|Overall Study||1
8169258|NCT02459262|20140653|P9|NOT COMPLETED|Overall Study||0
8169259|NCT02459262|20140654|P8|NOT COMPLETED|Overall Study||0
8169260|NCT02459262|20140655|P7|NOT COMPLETED|Overall Study||0
8169261|NCT02459262|20140656|P6|NOT COMPLETED|Overall Study||0
8169262|NCT02459262|20140657|P5|NOT COMPLETED|Overall Study||0
8169263|NCT02459262|20140658|P4|NOT COMPLETED|Overall Study||0
8169264|NCT02459262|20140659|P3|NOT COMPLETED|Overall Study||0
8169265|NCT02459262|20140660|P2|NOT COMPLETED|Overall Study||0
8169266|NCT02459262|20140661|P1|NOT COMPLETED|Overall Study||0
8169267|NCT02459262|20140651|P11|COMPLETED|Overall Study||45
8169268|NCT02459262|20140652|P10|COMPLETED|Overall Study||44
8169269|NCT02459262|20140653|P9|COMPLETED|Overall Study||45
8169270|NCT02459262|20140654|P8|COMPLETED|Overall Study||45
8169271|NCT02459262|20140655|P7|COMPLETED|Overall Study||12
8169272|NCT02459262|20140656|P6|COMPLETED|Overall Study||8
8169273|NCT02459262|20140657|P5|COMPLETED|Overall Study||8
8169274|NCT02459262|20140658|P4|COMPLETED|Overall Study||8
8169275|NCT02459262|20140659|P3|COMPLETED|Overall Study||8
8169276|NCT02459262|20140660|P2|COMPLETED|Overall Study||8
8169277|NCT02459262|20140661|P1|COMPLETED|Overall Study||8
8169278|NCT02459262|20140651|P11|STARTED|Overall Study||45
8169279|NCT02459262|20140652|P10|STARTED|Overall Study||45
8169280|NCT02459262|20140653|P9|STARTED|Overall Study||45
8169281|NCT02459262|20140654|P8|STARTED|Overall Study||45
8169282|NCT02459262|20140655|P7|STARTED|Overall Study||12
8169283|NCT02459262|20140656|P6|STARTED|Overall Study||8
8169284|NCT02459262|20140657|P5|STARTED|Overall Study||8
8169285|NCT02459262|20140658|P4|STARTED|Overall Study||8
8169286|NCT02459262|20140659|P3|STARTED|Overall Study||8
8169287|NCT02459262|20140660|P2|STARTED|Overall Study||8
8169288|NCT02459262|20140661|P1|STARTED|Overall Study||8
8169289|NCT02459197|20140706|P2|NOT COMPLETED|Overall Study||1
8169290|NCT02459197|20140707|P1|NOT COMPLETED|Overall Study||0
8169291|NCT02459197|20140706|P2|COMPLETED|Overall Study||55
8169292|NCT02459197|20140707|P1|COMPLETED|Overall Study||58
8169293|NCT02459197|20140706|P2|STARTED|Overall Study||56
8169294|NCT02459197|20140707|P1|STARTED|Overall Study||58
8169295|NCT02459119|20140721|P1|NOT COMPLETED|Overall Study||0
8169296|NCT02459119|20140721|P1|COMPLETED|Overall Study||17
8169297|NCT02459119|20140721|P1|STARTED|Overall Study||17
8169298|NCT02459093|20140731|P2|NOT COMPLETED|Overall Study||18
8169299|NCT02459093|20140732|P1|NOT COMPLETED|Overall Study||12
8169300|NCT02459093|20140731|P2|COMPLETED|Overall Study||257
8169301|NCT02459093|20140732|P1|COMPLETED|Overall Study||263
8169302|NCT02459093|20140731|P2|STARTED|Overall Study||275
8169303|NCT02459093|20140732|P1|STARTED|Overall Study||275
8169304|NCT02459080|20140743|P3|NOT COMPLETED|Overall Study||58
8169305|NCT02459080|20140744|P2|NOT COMPLETED|Overall Study||40
8169306|NCT02459080|20140745|P1|NOT COMPLETED|Overall Study||44
8169307|NCT02459080|20140743|P3|COMPLETED|Overall Study||151
8169308|NCT02459080|20140744|P2|COMPLETED|Overall Study||158
8169309|NCT02459080|20140745|P1|COMPLETED|Overall Study||168
8169310|NCT02459080|20140743|P3|STARTED|Overall Study||209
8169311|NCT02459080|20140744|P2|STARTED|Overall Study||198
8169312|NCT02459080|20140745|P1|STARTED|Overall Study||212
8169313|NCT02458768|20140770|P2|NOT COMPLETED|Overall Study||5
8169314|NCT02458768|20140771|P1|NOT COMPLETED|Overall Study||7
8169315|NCT02458768|20140770|P2|COMPLETED|Overall Study||50
8169316|NCT02458768|20140771|P1|COMPLETED|Overall Study||50
8169317|NCT02458768|20140770|P2|STARTED|Overall Study||55
8169318|NCT02458768|20140771|P1|STARTED|Overall Study||57
8169319|NCT02458690|20140779|P2|NOT COMPLETED|Overall Study||9
8169320|NCT02458690|20140780|P1|NOT COMPLETED|Overall Study||8
8169321|NCT02458690|20140779|P2|COMPLETED|Overall Study||100
8169322|NCT02458690|20140780|P1|COMPLETED|Overall Study||99
8169323|NCT02458690|20140779|P2|STARTED|Overall Study||109
8169324|NCT02458690|20140780|P1|STARTED|Overall Study||107
8169325|NCT02458469|20140786|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
8169326|NCT02458469|20140787|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
8169327|NCT02458469|20140788|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
8169328|NCT02458469|20140789|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
8169329|NCT02458469|20140790|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
8169330|NCT02458469|20140791|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
8169331|NCT02458469|20140786|P6|COMPLETED|Third Intervention (2 Weeks)||1
8169332|NCT02458469|20140787|P5|COMPLETED|Third Intervention (2 Weeks)||1
8169333|NCT02458469|20140788|P4|COMPLETED|Third Intervention (2 Weeks)||0
8169334|NCT02458469|20140789|P3|COMPLETED|Third Intervention (2 Weeks)||2
8169335|NCT02458469|20140790|P2|COMPLETED|Third Intervention (2 Weeks)||2
8169336|NCT02458469|20140791|P1|COMPLETED|Third Intervention (2 Weeks)||2
8169337|NCT02458469|20140786|P6|STARTED|Third Intervention (2 Weeks)||1
8169338|NCT02458469|20140787|P5|STARTED|Third Intervention (2 Weeks)||1
8169339|NCT02458469|20140788|P4|STARTED|Third Intervention (2 Weeks)||0
8169340|NCT02458469|20140789|P3|STARTED|Third Intervention (2 Weeks)||2
8169341|NCT02458469|20140790|P2|STARTED|Third Intervention (2 Weeks)||2
8169342|NCT02458469|20140791|P1|STARTED|Third Intervention (2 Weeks)||2
8169343|NCT02458469|20140786|P6|NOT COMPLETED|Second Washout (2 Weeks)||0
8169344|NCT02458469|20140787|P5|NOT COMPLETED|Second Washout (2 Weeks)||0
8169345|NCT02458469|20140788|P4|NOT COMPLETED|Second Washout (2 Weeks)||0
8169346|NCT02458469|20140789|P3|NOT COMPLETED|Second Washout (2 Weeks)||0
8169347|NCT02458469|20140790|P2|NOT COMPLETED|Second Washout (2 Weeks)||0
8169348|NCT02458469|20140791|P1|NOT COMPLETED|Second Washout (2 Weeks)||0
8169349|NCT02458469|20140786|P6|COMPLETED|Second Washout (2 Weeks)||1
8169350|NCT02458469|20140787|P5|COMPLETED|Second Washout (2 Weeks)||1
8169351|NCT02458469|20140788|P4|COMPLETED|Second Washout (2 Weeks)||0
8169352|NCT02458469|20140789|P3|COMPLETED|Second Washout (2 Weeks)||2
8169353|NCT02458469|20140790|P2|COMPLETED|Second Washout (2 Weeks)||2
8169354|NCT02458469|20140791|P1|COMPLETED|Second Washout (2 Weeks)||2
8169355|NCT02458469|20140786|P6|STARTED|Second Washout (2 Weeks)||1
8169356|NCT02458469|20140787|P5|STARTED|Second Washout (2 Weeks)||1
8169357|NCT02458469|20140788|P4|STARTED|Second Washout (2 Weeks)||0
8169358|NCT02458469|20140789|P3|STARTED|Second Washout (2 Weeks)||2
8169359|NCT02458469|20140790|P2|STARTED|Second Washout (2 Weeks)||2
8169360|NCT02458469|20140791|P1|STARTED|Second Washout (2 Weeks)||2
8169361|NCT02458469|20140786|P6|NOT COMPLETED|Second Intervention (2 Weeks)||1
8169362|NCT02458469|20140787|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
8169363|NCT02458469|20140788|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
8169364|NCT02458469|20140789|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
8169365|NCT02458469|20140790|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8169366|NCT02458469|20140791|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8169367|NCT02458469|20140786|P6|COMPLETED|Second Intervention (2 Weeks)||1
8169368|NCT02458469|20140787|P5|COMPLETED|Second Intervention (2 Weeks)||1
8169369|NCT02458469|20140788|P4|COMPLETED|Second Intervention (2 Weeks)||0
8169370|NCT02458469|20140789|P3|COMPLETED|Second Intervention (2 Weeks)||2
8169371|NCT02458469|20140790|P2|COMPLETED|Second Intervention (2 Weeks)||2
8169372|NCT02458469|20140791|P1|COMPLETED|Second Intervention (2 Weeks)||2
8169373|NCT02458469|20140786|P6|STARTED|Second Intervention (2 Weeks)||2
8169374|NCT02458469|20140787|P5|STARTED|Second Intervention (2 Weeks)||1
8169375|NCT02458469|20140788|P4|STARTED|Second Intervention (2 Weeks)||0
8169376|NCT02458469|20140789|P3|STARTED|Second Intervention (2 Weeks)||2
8169377|NCT02458469|20140790|P2|STARTED|Second Intervention (2 Weeks)||2
8169378|NCT02458469|20140791|P1|STARTED|Second Intervention (2 Weeks)||2
8169379|NCT02458469|20140786|P6|NOT COMPLETED|First Washout (2 Weeks)||0
8169380|NCT02458469|20140787|P5|NOT COMPLETED|First Washout (2 Weeks)||0
8169381|NCT02458469|20140788|P4|NOT COMPLETED|First Washout (2 Weeks)||0
8169382|NCT02458469|20140789|P3|NOT COMPLETED|First Washout (2 Weeks)||0
8169383|NCT02458469|20140790|P2|NOT COMPLETED|First Washout (2 Weeks)||0
8169384|NCT02458469|20140791|P1|NOT COMPLETED|First Washout (2 Weeks)||0
8169385|NCT02458469|20140786|P6|COMPLETED|First Washout (2 Weeks)||2
8169386|NCT02458469|20140787|P5|COMPLETED|First Washout (2 Weeks)||1
8169387|NCT02458469|20140788|P4|COMPLETED|First Washout (2 Weeks)||0
8169388|NCT02458469|20140789|P3|COMPLETED|First Washout (2 Weeks)||2
8169389|NCT02458469|20140790|P2|COMPLETED|First Washout (2 Weeks)||2
8169390|NCT02458469|20140791|P1|COMPLETED|First Washout (2 Weeks)||2
8169391|NCT02458469|20140786|P6|STARTED|First Washout (2 Weeks)||2
8169392|NCT02458469|20140787|P5|STARTED|First Washout (2 Weeks)||1
8169393|NCT02458469|20140788|P4|STARTED|First Washout (2 Weeks)||0
8169394|NCT02458469|20140789|P3|STARTED|First Washout (2 Weeks)||2
8169395|NCT02458469|20140790|P2|STARTED|First Washout (2 Weeks)||2
8169396|NCT02458469|20140791|P1|STARTED|First Washout (2 Weeks)||2
8169397|NCT02458469|20140786|P6|NOT COMPLETED|First Intervention (2 Weeks)||0
8169398|NCT02458469|20140787|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
8169399|NCT02458469|20140788|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
8169400|NCT02458469|20140789|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
8169401|NCT02458469|20140790|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8169402|NCT02458469|20140791|P1|NOT COMPLETED|First Intervention (2 Weeks)||1
8169403|NCT02458469|20140786|P6|COMPLETED|First Intervention (2 Weeks)||2
8169404|NCT02458469|20140787|P5|COMPLETED|First Intervention (2 Weeks)||1
8169405|NCT02458469|20140788|P4|COMPLETED|First Intervention (2 Weeks)||0
8169406|NCT02458469|20140789|P3|COMPLETED|First Intervention (2 Weeks)||2
8169407|NCT02458469|20140790|P2|COMPLETED|First Intervention (2 Weeks)||2
8169408|NCT02458469|20140791|P1|COMPLETED|First Intervention (2 Weeks)||2
8169409|NCT02458469|20140786|P6|STARTED|First Intervention (2 Weeks)||2
8169410|NCT02458469|20140787|P5|STARTED|First Intervention (2 Weeks)||1
8169411|NCT02458469|20140788|P4|STARTED|First Intervention (2 Weeks)||0
8169412|NCT02458469|20140789|P3|STARTED|First Intervention (2 Weeks)||3
8169413|NCT02458469|20140790|P2|STARTED|First Intervention (2 Weeks)||2
8169414|NCT02458469|20140791|P1|STARTED|First Intervention (2 Weeks)||3
8169415|NCT02458365|20140804|P2|NOT COMPLETED|Overall Study||294
8169416|NCT02458365|20140805|P1|NOT COMPLETED|Overall Study||277
8169417|NCT02458365|20140804|P2|COMPLETED|Overall Study||1607
8169418|NCT02458365|20140805|P1|COMPLETED|Overall Study||1723
8169419|NCT02458365|20140804|P2|STARTED|Overall Study||1901
8169420|NCT02458365|20140805|P1|STARTED|Overall Study||2000
8169421|NCT02458352|20140825|P1|NOT COMPLETED|Overall Study||0
8169422|NCT02458352|20140825|P1|COMPLETED|Overall Study||105
8169423|NCT02458352|20140825|P1|STARTED|Overall Study||105
8169424|NCT02458287|20140837|P4|NOT COMPLETED|Overall Study||3
8169425|NCT02458287|20140838|P3|NOT COMPLETED|Overall Study||3
8169426|NCT02458287|20140839|P2|NOT COMPLETED|Overall Study||4
8169427|NCT02458287|20140840|P1|NOT COMPLETED|Overall Study||0
8169428|NCT02458287|20140837|P4|COMPLETED|Overall Study||97
8169429|NCT02458287|20140838|P3|COMPLETED|Overall Study||46
8169430|NCT02458287|20140839|P2|COMPLETED|Overall Study||96
8169431|NCT02458287|20140840|P1|COMPLETED|Overall Study||50
8169432|NCT02458287|20140837|P4|STARTED|Overall Study||100
8169433|NCT02458287|20140838|P3|STARTED|Overall Study||49
8169434|NCT02458287|20140839|P2|STARTED|Overall Study||100
8169435|NCT02458287|20140840|P1|STARTED|Overall Study||50
8169436|NCT02458235|20140885|P1|NOT COMPLETED|Overall Study||0
8169437|NCT02458235|20140885|P1|COMPLETED|Overall Study||17
8169438|NCT02458235|20140885|P1|STARTED|Overall Study||17
8169463|NCT02457897|20140939|P1|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
8169464|NCT02457897|20140939|P1|COMPLETED|Part 2 Long-term (6 Month) Study||5
8169465|NCT02457897|20140939|P1|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
8169466|NCT02457897|20140939|P1|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
8169467|NCT02457897|20140939|P1|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
8169468|NCT02457897|20140939|P1|STARTED|Part 1 Short-term (2 Weeks) Study||7
8169469|NCT02457819|20140946|P1|NOT COMPLETED|Overall Study||99
8169470|NCT02457819|20140946|P1|COMPLETED|Overall Study||138
8169471|NCT02457819|20140946|P1|Safety Population|Overall Study||236
8169472|NCT02457819|20140946|P1|STARTED|Overall Study||237
8169473|NCT02457793|20140958|P6|NOT COMPLETED|Overall Study||6
8169474|NCT02457793|20140959|P5|NOT COMPLETED|Overall Study||4
8169475|NCT02457793|20140960|P4|NOT COMPLETED|Overall Study||5
8169476|NCT02457793|20140961|P3|NOT COMPLETED|Overall Study||3
8169477|NCT02457793|20140962|P2|NOT COMPLETED|Overall Study||4
8169478|NCT02457793|20140963|P1|NOT COMPLETED|Overall Study||1
8169479|NCT02457793|20140958|P6|COMPLETED|Overall Study||0
8169480|NCT02457793|20140959|P5|COMPLETED|Overall Study||0
8169481|NCT02457793|20140960|P4|COMPLETED|Overall Study||0
8169482|NCT02457793|20140961|P3|COMPLETED|Overall Study||0
8169483|NCT02457793|20140962|P2|COMPLETED|Overall Study||1
8169484|NCT02457793|20140963|P1|COMPLETED|Overall Study||0
8169485|NCT02457793|20140958|P6|STARTED|Overall Study||6
8169486|NCT02457793|20140959|P5|STARTED|Overall Study||4
8169487|NCT02457793|20140960|P4|STARTED|Overall Study||5
8169488|NCT02457793|20140961|P3|STARTED|Overall Study||3
8169489|NCT02457793|20140962|P2|STARTED|Overall Study||5
8169490|NCT02457793|20140963|P1|STARTED|Overall Study||1
8169491|NCT02457728|20141103|P1|NOT COMPLETED|Overall Study||0
8169492|NCT02457728|20141103|P1|COMPLETED|Overall Study||34
8169493|NCT02457728|20141103|P1|STARTED|Overall Study||34
8169494|NCT02457637|20141107|P1|NOT COMPLETED|Clinic or Telephone Follow-up||71
8169495|NCT02457637|20141107|P1|COMPLETED|Clinic or Telephone Follow-up||2529
8169496|NCT02457637|20141107|P1|One-year Death|Clinic or Telephone Follow-up||475
8169497|NCT02457637|20141107|P1|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
8169498|NCT02457637|20141107|P1|STARTED|Clinic or Telephone Follow-up||2600
8169499|NCT02457637|20141107|P1|NOT COMPLETED|28-Days Hospitalization and Observation||0
8169500|NCT02457637|20141107|P1|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
8169501|NCT02457637|20141107|P1|Death|28-Days Hospitalization and Observation||74
8169502|NCT02457637|20141107|P1|Liver Transplantation|28-Days Hospitalization and Observation||124
8169503|NCT02457637|20141107|P1|STARTED|28-Days Hospitalization and Observation||2600
8169504|NCT02457637|20141107|P1|NOT COMPLETED|Recruitment||0
8169505|NCT02457637|20141107|P1|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
8169506|NCT02457637|20141107|P1|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
8169507|NCT02457611|20141115|P1|NOT COMPLETED|Overall Study||3
8169508|NCT02457611|20141115|P1|COMPLETED|Overall Study||23
8169509|NCT02457611|20141115|P1|STARTED|Overall Study||26
8169510|NCT02457546|20141129|P2|NOT COMPLETED|Overall Study||4
8169511|NCT02457546|20141130|P1|NOT COMPLETED|Overall Study||9
8169512|NCT02457546|20141129|P2|COMPLETED|Overall Study||116
8169513|NCT02457546|20141130|P1|COMPLETED|Overall Study||105
8169514|NCT02457546|20141129|P2|STARTED|Overall Study||120
8169515|NCT02457546|20141130|P1|STARTED|Overall Study||114
8169516|NCT02457403|20141140|P2|NOT COMPLETED|Overall Study||0
8169517|NCT02457403|20141141|P1|NOT COMPLETED|Overall Study||0
8169518|NCT02457403|20141140|P2|COMPLETED|Overall Study||34
8169519|NCT02457403|20141141|P1|COMPLETED|Overall Study||34
8169520|NCT02457403|20141140|P2|STARTED|Overall Study|34 historic controls|34
8169521|NCT02457403|20141141|P1|STARTED|Overall Study|34 participants|34
8169522|NCT02457325|20141151|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8169523|NCT02457325|20141152|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8169524|NCT02457325|20141151|P2|COMPLETED|Second Intervention (1 Day)||23
8169525|NCT02457325|20141152|P1|COMPLETED|Second Intervention (1 Day)||23
8169526|NCT02457325|20141151|P2|STARTED|Second Intervention (1 Day)||23
8169527|NCT02457325|20141152|P1|STARTED|Second Intervention (1 Day)||23
8169528|NCT02457325|20141151|P2|NOT COMPLETED|Washout (1-2 Months)||0
8169529|NCT02457325|20141152|P1|NOT COMPLETED|Washout (1-2 Months)||0
8169530|NCT02457325|20141151|P2|COMPLETED|Washout (1-2 Months)||23
8169531|NCT02457325|20141152|P1|COMPLETED|Washout (1-2 Months)||23
8169532|NCT02457325|20141151|P2|STARTED|Washout (1-2 Months)||23
8169533|NCT02457325|20141152|P1|STARTED|Washout (1-2 Months)||23
8169534|NCT02457325|20141151|P2|NOT COMPLETED|First Intervention (1 Day)||2
8169535|NCT02457325|20141152|P1|NOT COMPLETED|First Intervention (1 Day)||2
8169536|NCT02457325|20141151|P2|COMPLETED|First Intervention (1 Day)||23
8169537|NCT02457325|20141152|P1|COMPLETED|First Intervention (1 Day)||23
8169538|NCT02457325|20141151|P2|STARTED|First Intervention (1 Day)||25
8169539|NCT02457325|20141152|P1|STARTED|First Intervention (1 Day)||25
8169540|NCT02457260|20141181|P3|NOT COMPLETED|Overall Study||1
8169541|NCT02457260|20141182|P2|NOT COMPLETED|Overall Study||3
8169542|NCT02457260|20141183|P1|NOT COMPLETED|Overall Study||2
8169543|NCT02457260|20141181|P3|COMPLETED|Overall Study||1
8169544|NCT02457260|20141182|P2|COMPLETED|Overall Study||4
8169545|NCT02457260|20141183|P1|COMPLETED|Overall Study||10
8169546|NCT02457260|20141181|P3|STARTED|Overall Study||2
8169547|NCT02457260|20141182|P2|STARTED|Overall Study||7
8169548|NCT02457260|20141183|P1|STARTED|Overall Study||12
8169549|NCT02457247|20141225|P4|NOT COMPLETED|Period 2||0
8169550|NCT02457247|20141226|P3|NOT COMPLETED|Period 2||0
8169551|NCT02457247|20141227|P2|NOT COMPLETED|Period 2||3
8169552|NCT02457247|20141228|P1|NOT COMPLETED|Period 2||2
8169553|NCT02457247|20141225|P4|COMPLETED|Period 2||70
8169554|NCT02457247|20141226|P3|COMPLETED|Period 2||68
8169555|NCT02457247|20141227|P2|COMPLETED|Period 2||65
8169556|NCT02457247|20141228|P1|COMPLETED|Period 2||64
8169557|NCT02457247|20141225|P4|STARTED|Period 2||70
8169558|NCT02457247|20141226|P3|STARTED|Period 2||68
8169559|NCT02457247|20141227|P2|STARTED|Period 2||68
8169560|NCT02457247|20141228|P1|STARTED|Period 2||66
8169561|NCT02457247|20141225|P4|NOT COMPLETED|Period 1||0
8169562|NCT02457247|20141226|P3|NOT COMPLETED|Period 1||0
8169563|NCT02457247|20141227|P2|NOT COMPLETED|Period 1||2
8169564|NCT02457247|20141228|P1|NOT COMPLETED|Period 1||2
8169565|NCT02457247|20141225|P4|COMPLETED|Period 1||70
8169566|NCT02457247|20141226|P3|COMPLETED|Period 1||68
8169567|NCT02457247|20141227|P2|COMPLETED|Period 1||68
8169568|NCT02457247|20141228|P1|COMPLETED|Period 1||66
8169569|NCT02457247|20141225|P4|STARTED|Period 1||70
8169570|NCT02457247|20141226|P3|STARTED|Period 1||68
8169571|NCT02457247|20141227|P2|STARTED|Period 1||70
8169572|NCT02457247|20141228|P1|STARTED|Period 1||68
8169573|NCT02457195|20141248|P1|NOT COMPLETED|Overall Study||9
8169574|NCT02457195|20141248|P1|COMPLETED|Overall Study||41
8169575|NCT02457195|20141248|P1|STARTED|Overall Study||50
8169576|NCT02457182|20141254|P2|NOT COMPLETED|Overall Study||0
8169577|NCT02457182|20141255|P1|NOT COMPLETED|Overall Study||1
8169578|NCT02457182|20141254|P2|COMPLETED|Overall Study||11
8169579|NCT02457182|20141255|P1|COMPLETED|Overall Study||8
8169580|NCT02457182|20141254|P2|STARTED|Overall Study||11
8169581|NCT02457182|20141255|P1|STARTED|Overall Study||9
8169582|NCT02457065|20141273|P2|NOT COMPLETED|Overall Study||11
8169583|NCT02457065|20141274|P1|NOT COMPLETED|Overall Study||9
8169584|NCT02457065|20141273|P2|COMPLETED|Overall Study||16
8169585|NCT02457065|20141274|P1|COMPLETED|Overall Study||18
8169586|NCT02457065|20141273|P2|STARTED|Overall Study||27
8169587|NCT02457065|20141274|P1|STARTED|Overall Study||27
8169588|NCT02456896|20141284|P2|NOT COMPLETED|Overall Study||4
8169589|NCT02456896|20141285|P1|NOT COMPLETED|Overall Study||6
8169590|NCT02456896|20141284|P2|COMPLETED|Overall Study||21
8169591|NCT02456896|20141285|P1|COMPLETED|Overall Study||19
8169592|NCT02456896|20141284|P2|STARTED|Overall Study||25
8169593|NCT02456896|20141285|P1|STARTED|Overall Study||25
8169594|NCT02456740|20141296|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
8169595|NCT02456740|20141297|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
8169596|NCT02456740|20141298|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
8169597|NCT02456740|20141299|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
8169598|NCT02456740|20141300|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
8169599|NCT02456740|20141301|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
8169600|NCT02456740|20141302|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169601|NCT02456740|20141303|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169602|NCT02456740|20141304|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169603|NCT02456740|20141296|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
8169604|NCT02456740|20141297|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
8169605|NCT02456740|20141298|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
8169606|NCT02456740|20141299|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
8169607|NCT02456740|20141300|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
8169608|NCT02456740|20141301|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
8169609|NCT02456740|20141302|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169610|NCT02456740|20141303|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169611|NCT02456740|20141304|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169612|NCT02456740|20141296|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
8169613|NCT02456740|20141297|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8169614|NCT02456740|20141298|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8169615|NCT02456740|20141299|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
8169616|NCT02456740|20141300|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8169617|NCT02456740|20141301|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
8169618|NCT02456740|20141302|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8169619|NCT02456740|20141303|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8169620|NCT02456740|20141304|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8169621|NCT02456740|20141296|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169622|NCT02456740|20141297|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169623|NCT02456740|20141298|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169624|NCT02456740|20141299|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169625|NCT02456740|20141300|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169626|NCT02456740|20141301|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169627|NCT02456740|20141302|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
8169628|NCT02456740|20141303|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
8169629|NCT02456740|20141304|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
8169630|NCT02456740|20141296|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169631|NCT02456740|20141297|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169632|NCT02456740|20141298|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169633|NCT02456740|20141299|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169634|NCT02456740|20141300|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169635|NCT02456740|20141301|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169636|NCT02456740|20141302|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
8169637|NCT02456740|20141303|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
8169638|NCT02456740|20141304|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
8169639|NCT02456740|20141296|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169640|NCT02456740|20141297|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169641|NCT02456740|20141298|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169642|NCT02456740|20141299|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169643|NCT02456740|20141300|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169644|NCT02456740|20141301|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169645|NCT02456740|20141302|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
8169646|NCT02456740|20141303|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
8169647|NCT02456740|20141304|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
8169648|NCT02456740|20141296|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169649|NCT02456740|20141297|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169650|NCT02456740|20141298|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169651|NCT02456740|20141299|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169652|NCT02456740|20141300|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169653|NCT02456740|20141301|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169654|NCT02456740|20141302|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
8169655|NCT02456740|20141303|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
8169656|NCT02456740|20141304|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
8169657|NCT02456727|20141328|P2|NOT COMPLETED|Overall Study||106
8169658|NCT02456727|20141329|P1|NOT COMPLETED|Overall Study||109
8169659|NCT02456727|20141328|P2|COMPLETED|Overall Study||284
8169660|NCT02456727|20141329|P1|COMPLETED|Overall Study||280
8169661|NCT02456727|20141328|P2|24 Week|Overall Study||284
8169662|NCT02456727|20141329|P1|24 Week|Overall Study||280
8169663|NCT02456727|20141328|P2|12 Week|Overall Study||310
8169664|NCT02456727|20141329|P1|12 Week|Overall Study||295
8169665|NCT02456727|20141328|P2|6 Week|Overall Study||320
8169666|NCT02456727|20141329|P1|6 Week|Overall Study||298
8169667|NCT02456727|20141328|P2|Initiated Treatment|Overall Study||360
8169668|NCT02456727|20141329|P1|Initiated Treatment|Overall Study||346
8169669|NCT02456727|20141328|P2|STARTED|Overall Study||390
8169670|NCT02456727|20141329|P1|STARTED|Overall Study||389
8169671|NCT02456662|20141411|P2|NOT COMPLETED|Overall Study||1
8169672|NCT02456662|20141412|P1|NOT COMPLETED|Overall Study||2
8169673|NCT02456662|20141411|P2|COMPLETED|Overall Study||159
8169674|NCT02456662|20141412|P1|COMPLETED|Overall Study||157
8169675|NCT02456662|20141411|P2|STARTED|Overall Study||160
8169676|NCT02456662|20141412|P1|STARTED|Overall Study||159
8169677|NCT02456636|20141421|P3|NOT COMPLETED|Overall Study||75
8169678|NCT02456636|20141422|P2|NOT COMPLETED|Overall Study||69
8169679|NCT02456636|20141423|P1|NOT COMPLETED|Overall Study||68
8169680|NCT02456636|20141421|P3|COMPLETED|Overall Study||400
8169681|NCT02456636|20141422|P2|COMPLETED|Overall Study||410
8169682|NCT02456636|20141423|P1|COMPLETED|Overall Study||410
8169683|NCT02456636|20141421|P3|18 Month|Overall Study||461
8169684|NCT02456636|20141422|P2|18 Month|Overall Study||463
8169685|NCT02456636|20141423|P1|18 Month|Overall Study||467
8169686|NCT02456636|20141421|P3|6 Month|Overall Study||468
8169687|NCT02456636|20141422|P2|6 Month|Overall Study||474
8169688|NCT02456636|20141423|P1|6 Month|Overall Study||474
8169689|NCT02456636|20141421|P3|STARTED|Overall Study||475
8169690|NCT02456636|20141422|P2|STARTED|Overall Study||479
8169691|NCT02456636|20141423|P1|STARTED|Overall Study||478
8169692|NCT02456103|20141473|P1|NOT COMPLETED|Overall Study||246
8169693|NCT02456103|20141473|P1|COMPLETED|Overall Study||0
8169694|NCT02456103|20141473|P1|Intent-to-treat (ITT) Population|Overall Study||244
8169695|NCT02456103|20141473|P1|As-Treated Population|Overall Study||245
8169696|NCT02456103|20141473|P1|STARTED|Overall Study||246
8169697|NCT02455518|20141486|P4|NOT COMPLETED|Overall Study||3
8169698|NCT02455518|20141487|P3|NOT COMPLETED|Overall Study||1
8169699|NCT02455518|20141488|P2|NOT COMPLETED|Overall Study||1
8169700|NCT02455518|20141489|P1|NOT COMPLETED|Overall Study||0
8169701|NCT02455518|20141486|P4|COMPLETED|Overall Study||101
8169702|NCT02455518|20141487|P3|COMPLETED|Overall Study||103
8169703|NCT02455518|20141488|P2|COMPLETED|Overall Study||103
8169704|NCT02455518|20141489|P1|COMPLETED|Overall Study||104
8169705|NCT02455518|20141486|P4|STARTED|Overall Study||104
8169706|NCT02455518|20141487|P3|STARTED|Overall Study||104
8169707|NCT02455518|20141488|P2|STARTED|Overall Study||104
8169708|NCT02455518|20141489|P1|STARTED|Overall Study||104
8169709|NCT02455453|20141503|P1|NOT COMPLETED|Overall Study||0
8169710|NCT02455453|20141503|P1|COMPLETED|Overall Study||47
8169711|NCT02455453|20141503|P1|STARTED|Overall Study||47
8169712|NCT02455388|20141511|P3|NOT COMPLETED|Overall Study||11
8169713|NCT02455388|20141512|P2|NOT COMPLETED|Overall Study||0
8169714|NCT02455388|20141513|P1|NOT COMPLETED|Overall Study||1
8169715|NCT02455388|20141511|P3|COMPLETED|Overall Study||326
8169716|NCT02455388|20141512|P2|COMPLETED|Overall Study||15
8169717|NCT02455388|20141513|P1|COMPLETED|Overall Study||17
8169718|NCT02455388|20141511|P3|STARTED|Overall Study||337
8169719|NCT02455388|20141512|P2|STARTED|Overall Study||15
8169720|NCT02455388|20141513|P1|STARTED|Overall Study||18
8169721|NCT02455336|20141524|P2|NOT COMPLETED|Overall Study||2
8169722|NCT02455336|20141525|P1|NOT COMPLETED|Overall Study||5
8169723|NCT02455336|20141524|P2|COMPLETED|Overall Study||6
8169724|NCT02455336|20141525|P1|COMPLETED|Overall Study||10
8169725|NCT02455336|20141524|P2|STARTED|Overall Study||8
8169726|NCT02455336|20141525|P1|STARTED|Overall Study||15
8169727|NCT02455076|20141540|P5|NOT COMPLETED|Outpatient||12
8169728|NCT02455076|20141541|P4|NOT COMPLETED|Outpatient||6
8169729|NCT02455076|20141542|P3|NOT COMPLETED|Outpatient||0
8169730|NCT02455076|20141543|P2|NOT COMPLETED|Outpatient||0
8169731|NCT02455076|20141544|P1|NOT COMPLETED|Outpatient||0
8169732|NCT02455076|20141540|P5|COMPLETED|Outpatient||43
8169733|NCT02455076|20141541|P4|COMPLETED|Outpatient||42
8169734|NCT02455076|20141542|P3|COMPLETED|Outpatient||0
8169735|NCT02455076|20141543|P2|COMPLETED|Outpatient||0
8169736|NCT02455076|20141544|P1|COMPLETED|Outpatient||0
8169737|NCT02455076|20141540|P5|STARTED|Outpatient||55
8169738|NCT02455076|20141541|P4|STARTED|Outpatient||48
8169739|NCT02455076|20141542|P3|STARTED|Outpatient||0
8169740|NCT02455076|20141543|P2|STARTED|Outpatient||0
8169741|NCT02455076|20141544|P1|STARTED|Outpatient||0
8169742|NCT02455076|20141540|P5|NOT COMPLETED|Inpatient||0
8169743|NCT02455076|20141541|P4|NOT COMPLETED|Inpatient||0
8169744|NCT02455076|20141542|P3|NOT COMPLETED|Inpatient||0
8169745|NCT02455076|20141543|P2|NOT COMPLETED|Inpatient||1
8169746|NCT02455076|20141544|P1|NOT COMPLETED|Inpatient||4
8169747|NCT02455076|20141540|P5|COMPLETED|Inpatient||0
8169748|NCT02455076|20141541|P4|COMPLETED|Inpatient||0
8169749|NCT02455076|20141542|P3|COMPLETED|Inpatient||52
8169750|NCT02455076|20141543|P2|COMPLETED|Inpatient||50
8169751|NCT02455076|20141544|P1|COMPLETED|Inpatient||43
8169752|NCT02455076|20141540|P5|STARTED|Inpatient||0
8169753|NCT02455076|20141541|P4|STARTED|Inpatient||0
8169754|NCT02455076|20141542|P3|STARTED|Inpatient||52
8169755|NCT02455076|20141543|P2|STARTED|Inpatient||51
8169756|NCT02455076|20141544|P1|STARTED|Inpatient||47
8169757|NCT02455050|20141630|P4|NOT COMPLETED|Treatment Period 2||1
8169758|NCT02455050|20141631|P3|NOT COMPLETED|Treatment Period 2||2
8169759|NCT02455050|20141632|P2|NOT COMPLETED|Treatment Period 2||0
8169760|NCT02455050|20141633|P1|NOT COMPLETED|Treatment Period 2||1
8169761|NCT02455050|20141630|P4|COMPLETED|Treatment Period 2||17
8169762|NCT02455050|20141631|P3|COMPLETED|Treatment Period 2||17
8169763|NCT02455050|20141632|P2|COMPLETED|Treatment Period 2||18
8169764|NCT02455050|20141633|P1|COMPLETED|Treatment Period 2||18
8169765|NCT02455050|20141630|P4|STARTED|Treatment Period 2||18
8169766|NCT02455050|20141631|P3|STARTED|Treatment Period 2||19
8169767|NCT02455050|20141632|P2|STARTED|Treatment Period 2||18
8169768|NCT02455050|20141633|P1|STARTED|Treatment Period 2||19
8169769|NCT02455050|20141630|P4|NOT COMPLETED|Treatment Period 1||2
8169770|NCT02455050|20141631|P3|NOT COMPLETED|Treatment Period 1||1
8169771|NCT02455050|20141632|P2|NOT COMPLETED|Treatment Period 1||1
8169772|NCT02455050|20141633|P1|NOT COMPLETED|Treatment Period 1||1
8169773|NCT02455050|20141630|P4|COMPLETED|Treatment Period 1||18
8169774|NCT02455050|20141631|P3|COMPLETED|Treatment Period 1||19
8169775|NCT02455050|20141632|P2|COMPLETED|Treatment Period 1||18
8169776|NCT02455050|20141633|P1|COMPLETED|Treatment Period 1||19
8169777|NCT02455050|20141630|P4|STARTED|Treatment Period 1||20
8169778|NCT02455050|20141631|P3|STARTED|Treatment Period 1||20
8169779|NCT02455050|20141632|P2|STARTED|Treatment Period 1||19
8169780|NCT02455050|20141633|P1|STARTED|Treatment Period 1||20
8169781|NCT02454959|20141697|P1|NOT COMPLETED|Overall Study||9
8169782|NCT02454959|20141697|P1|COMPLETED|Overall Study||70
8169783|NCT02454959|20141697|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
8169784|NCT02454959|20141697|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
8169785|NCT02454959|20141697|P1|STARTED|Overall Study||79
8169794|NCT02454608|20141726|P3|NOT COMPLETED|Open Label Period||19
8169795|NCT02454608|20141727|P2|NOT COMPLETED|Open Label Period||0
8169796|NCT02454608|20141728|P1|NOT COMPLETED|Open Label Period||0
8169797|NCT02454608|20141726|P3|COMPLETED|Open Label Period||10
8169798|NCT02454608|20141727|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
8169799|NCT02454608|20141728|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
8169800|NCT02454608|20141726|P3|STARTED|Open Label Period||29
8169801|NCT02454608|20141727|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
8169802|NCT02454608|20141728|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
8169803|NCT02454608|20141726|P3|NOT COMPLETED|Double-Blind Period||0
8169804|NCT02454608|20141727|P2|NOT COMPLETED|Double-Blind Period||2
8169805|NCT02454608|20141728|P1|NOT COMPLETED|Double-Blind Period||0
8169806|NCT02454608|20141726|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
8169807|NCT02454608|20141727|P2|COMPLETED|Double-Blind Period||12
8169808|NCT02454608|20141728|P1|COMPLETED|Double-Blind Period||15
8169809|NCT02454608|20141726|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
8169810|NCT02454608|20141727|P2|STARTED|Double-Blind Period||14
8169811|NCT02454608|20141728|P1|STARTED|Double-Blind Period||15
8169812|NCT02454530|20141751|P2|NOT COMPLETED|Overall Study||127
8169813|NCT02454530|20141752|P1|NOT COMPLETED|Overall Study||70
8169814|NCT02454530|20141751|P2|COMPLETED|Overall Study||481
8169815|NCT02454530|20141752|P1|COMPLETED|Overall Study||482
8169816|NCT02454530|20141751|P2|STARTED|Overall Study||608
8169817|NCT02454530|20141752|P1|STARTED|Overall Study||552
8169818|NCT02454478|20141789|P1|NOT COMPLETED|Overall Study||1
8169819|NCT02454478|20141789|P1|COMPLETED|Overall Study||6
8169820|NCT02454478|20141789|P1|STARTED|Overall Study||7
8169821|NCT02454296|20141805|P2|NOT COMPLETED|Overall Study||0
8169822|NCT02454296|20141806|P1|NOT COMPLETED|Overall Study||0
8169823|NCT02454296|20141805|P2|COMPLETED|Overall Study||21
8169824|NCT02454296|20141806|P1|COMPLETED|Overall Study||20
8169825|NCT02454296|20141805|P2|STARTED|Overall Study||21
8169826|NCT02454296|20141806|P1|STARTED|Overall Study||20
8169827|NCT02454283|20141818|P2|NOT COMPLETED|Overall Study||0
8169828|NCT02454283|20141819|P1|NOT COMPLETED|Overall Study||0
8169829|NCT02454283|20141818|P2|COMPLETED|Overall Study||15
8169830|NCT02454283|20141819|P1|COMPLETED|Overall Study||26
8169831|NCT02454283|20141818|P2|STARTED|Overall Study||15
8169832|NCT02454283|20141819|P1|STARTED|Overall Study||26
8169833|NCT02454179|20141829|P2|NOT COMPLETED|Overall Study||39
8169834|NCT02454179|20141830|P1|NOT COMPLETED|Overall Study||39
8169835|NCT02454179|20141829|P2|COMPLETED|Overall Study||0
8169836|NCT02454179|20141830|P1|COMPLETED|Overall Study||0
8169837|NCT02454179|20141829|P2|Discontinue Study|Overall Study||39
8169838|NCT02454179|20141830|P1|Discontinue Study|Overall Study||39
8169839|NCT02454179|20141829|P2|Received Study Medication|Overall Study||37
8169840|NCT02454179|20141830|P1|Received Study Medication|Overall Study||39
8169841|NCT02454179|20141829|P2|Enrolled|Overall Study||39
8169842|NCT02454179|20141830|P1|Enrolled|Overall Study||39
8169843|NCT02454179|20141829|P2|STARTED|Overall Study||39
8169844|NCT02454179|20141830|P1|STARTED|Overall Study||39
8169845|NCT02454127|20141840|P4|NOT COMPLETED|Overall Study||20
8169846|NCT02454127|20141841|P3|NOT COMPLETED|Overall Study||14
8169847|NCT02454127|20141842|P2|NOT COMPLETED|Overall Study||14
8169848|NCT02454127|20141843|P1|NOT COMPLETED|Overall Study||19
8169849|NCT02454127|20141840|P4|COMPLETED|Overall Study||20
8169850|NCT02454127|20141841|P3|COMPLETED|Overall Study||26
8169851|NCT02454127|20141842|P2|COMPLETED|Overall Study||26
8169852|NCT02454127|20141843|P1|COMPLETED|Overall Study||21
8169853|NCT02454127|20141840|P4|STARTED|Overall Study||40
8169854|NCT02454127|20141841|P3|STARTED|Overall Study||40
8169855|NCT02454127|20141842|P2|STARTED|Overall Study||40
8169856|NCT02454127|20141843|P1|STARTED|Overall Study||40
8169857|NCT02454101|20141883|P2|NOT COMPLETED|Overall Study||7
8169858|NCT02454101|20141884|P1|NOT COMPLETED|Overall Study||5
8169859|NCT02454101|20141883|P2|COMPLETED|Overall Study||143
8169860|NCT02454101|20141884|P1|COMPLETED|Overall Study||145
8169861|NCT02454101|20141883|P2|STARTED|Overall Study||150
8169862|NCT02454101|20141884|P1|STARTED|Overall Study||150
8169863|NCT02453841|20141906|P1|NOT COMPLETED|Overall Study||3
8169864|NCT02453841|20141906|P1|COMPLETED|Overall Study||27
8169865|NCT02453841|20141906|P1|STARTED|Overall Study||30
8169866|NCT02453750|20141913|P1|NOT COMPLETED|Overall Study||0
8169867|NCT02453750|20141913|P1|COMPLETED|Overall Study||21
8169868|NCT02453750|20141913|P1|STARTED|Overall Study||21
8169869|NCT02453711|20141929|P9|NOT COMPLETED|Overall Study||13
8169870|NCT02453711|20141930|P8|NOT COMPLETED|Overall Study||7
8169871|NCT02453711|20141931|P7|NOT COMPLETED|Overall Study||3
8169872|NCT02453711|20141932|P6|NOT COMPLETED|Overall Study||6
8169873|NCT02453711|20141933|P5|NOT COMPLETED|Overall Study||2
8169874|NCT02453711|20141934|P4|NOT COMPLETED|Overall Study||7
8169875|NCT02453711|20141935|P3|NOT COMPLETED|Overall Study||9
8169876|NCT02453711|20141936|P2|NOT COMPLETED|Overall Study||7
8169877|NCT02453711|20141937|P1|NOT COMPLETED|Overall Study||11
8169878|NCT02453711|20141929|P9|COMPLETED|Overall Study||123
8169879|NCT02453711|20141930|P8|COMPLETED|Overall Study||96
8169880|NCT02453711|20141931|P7|COMPLETED|Overall Study||100
8169881|NCT02453711|20141932|P6|COMPLETED|Overall Study||96
8169882|NCT02453711|20141933|P5|COMPLETED|Overall Study||100
8169883|NCT02453711|20141934|P4|COMPLETED|Overall Study||96
8169884|NCT02453711|20141935|P3|COMPLETED|Overall Study||94
8169885|NCT02453711|20141936|P2|COMPLETED|Overall Study||95
8169886|NCT02453711|20141937|P1|COMPLETED|Overall Study||92
8169887|NCT02453711|20141929|P9|Safety Analysis Set|Overall Study||136
8169888|NCT02453711|20141930|P8|Safety Analysis Set|Overall Study||103
8169889|NCT02453711|20141931|P7|Safety Analysis Set|Overall Study||103
8169890|NCT02453711|20141932|P6|Safety Analysis Set|Overall Study||102
8169891|NCT02453711|20141933|P5|Safety Analysis Set|Overall Study||102
8169892|NCT02453711|20141934|P4|Safety Analysis Set|Overall Study||103
8169893|NCT02453711|20141935|P3|Safety Analysis Set|Overall Study||103
8169894|NCT02453711|20141936|P2|Safety Analysis Set|Overall Study||102
8169895|NCT02453711|20141937|P1|Safety Analysis Set|Overall Study||103
8169896|NCT02453711|20141929|P9|Full Analysis Set|Overall Study||136
8169897|NCT02453711|20141930|P8|Full Analysis Set|Overall Study||103
8169898|NCT02453711|20141931|P7|Full Analysis Set|Overall Study||103
8169899|NCT02453711|20141932|P6|Full Analysis Set|Overall Study||102
8169900|NCT02453711|20141933|P5|Full Analysis Set|Overall Study||102
8169901|NCT02453711|20141934|P4|Full Analysis Set|Overall Study||103
8169902|NCT02453711|20141935|P3|Full Analysis Set|Overall Study||103
8169903|NCT02453711|20141936|P2|Full Analysis Set|Overall Study||102
8169904|NCT02453711|20141937|P1|Full Analysis Set|Overall Study||103
8169905|NCT02453711|20141929|P9|STARTED|Overall Study||136
8169906|NCT02453711|20141930|P8|STARTED|Overall Study||103
8169907|NCT02453711|20141931|P7|STARTED|Overall Study||103
8169908|NCT02453711|20141932|P6|STARTED|Overall Study||102
8169909|NCT02453711|20141933|P5|STARTED|Overall Study||102
8169910|NCT02453711|20141934|P4|STARTED|Overall Study||103
8169911|NCT02453711|20141935|P3|STARTED|Overall Study||103
8169912|NCT02453711|20141936|P2|STARTED|Overall Study||102
8169913|NCT02453711|20141937|P1|STARTED|Overall Study||103
8169914|NCT02453685|20142281|P2|NOT COMPLETED|Overall Study||12
8169915|NCT02453685|20142282|P1|NOT COMPLETED|Overall Study||19
8169916|NCT02453685|20142281|P2|COMPLETED|Overall Study||155
8169917|NCT02453685|20142282|P1|COMPLETED|Overall Study||149
8169918|NCT02453685|20142281|P2|Exposed|Overall Study||166
8169919|NCT02453685|20142282|P1|Exposed|Overall Study||166
8169920|NCT02453685|20142281|P2|STARTED|Overall Study||167
8169921|NCT02453685|20142282|P1|STARTED|Overall Study||168
8169922|NCT02453672|20142297|P3|NOT COMPLETED|Overall Study||1
8169923|NCT02453672|20142298|P2|NOT COMPLETED|Overall Study||2
8169924|NCT02453672|20142299|P1|NOT COMPLETED|Overall Study||3
8169925|NCT02453672|20142297|P3|COMPLETED|Overall Study||38
8169926|NCT02453672|20142298|P2|COMPLETED|Overall Study||38
8169927|NCT02453672|20142299|P1|COMPLETED|Overall Study||37
8169928|NCT02453672|20142297|P3|STARTED|Overall Study||39
8169929|NCT02453672|20142298|P2|STARTED|Overall Study||40
8169930|NCT02453672|20142299|P1|STARTED|Overall Study||40
8169931|NCT02453581|20142316|P3|NOT COMPLETED|Overall Study||0
8169932|NCT02453581|20142317|P2|NOT COMPLETED|Overall Study||0
8169933|NCT02453581|20142318|P1|NOT COMPLETED|Overall Study||0
8169934|NCT02453581|20142316|P3|COMPLETED|Overall Study||8
8169935|NCT02453581|20142317|P2|COMPLETED|Overall Study||8
8169936|NCT02453581|20142318|P1|COMPLETED|Overall Study||8
8169937|NCT02453581|20142316|P3|STARTED|Overall Study||8
8169938|NCT02453581|20142317|P2|STARTED|Overall Study||8
8169939|NCT02453581|20142318|P1|STARTED|Overall Study||8
8169940|NCT02453555|20142340|P6|NOT COMPLETED|Extension Period||1
8169941|NCT02453555|20142341|P5|NOT COMPLETED|Extension Period||1
8169942|NCT02453555|20142342|P4|NOT COMPLETED|Extension Period||2
8169943|NCT02453555|20142343|P3|NOT COMPLETED|Extension Period||3
8169944|NCT02453555|20142344|P2|NOT COMPLETED|Extension Period||0
8169945|NCT02453555|20142345|P1|NOT COMPLETED|Extension Period||0
8169946|NCT02453555|20142340|P6|COMPLETED|Extension Period||5
8169947|NCT02453555|20142341|P5|COMPLETED|Extension Period||79
8169948|NCT02453555|20142342|P4|COMPLETED|Extension Period||49
8169949|NCT02453555|20142343|P3|COMPLETED|Extension Period||123
8169950|NCT02453555|20142344|P2|COMPLETED|Extension Period||0
8169951|NCT02453555|20142345|P1|COMPLETED|Extension Period||0
8169952|NCT02453555|20142340|P6|STARTED|Extension Period||6
8169953|NCT02453555|20142341|P5|STARTED|Extension Period||80
8169954|NCT02453555|20142342|P4|STARTED|Extension Period||51
8169955|NCT02453555|20142343|P3|STARTED|Extension Period||126
8169956|NCT02453555|20142344|P2|STARTED|Extension Period|This reporting group is not applicable in this period.|0
8169957|NCT02453555|20142345|P1|STARTED|Extension Period|This reporting group is not applicable in this period.|0
8169958|NCT02453555|20142340|P6|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169959|NCT02453555|20142341|P5|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169960|NCT02453555|20142342|P4|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169961|NCT02453555|20142343|P3|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169962|NCT02453555|20142344|P2|NOT COMPLETED|24-week Double-blind Treatment Period||7
8169963|NCT02453555|20142345|P1|NOT COMPLETED|24-week Double-blind Treatment Period||5
8169964|NCT02453555|20142340|P6|COMPLETED|24-week Double-blind Treatment Period||0
8169965|NCT02453555|20142341|P5|COMPLETED|24-week Double-blind Treatment Period||0
8169966|NCT02453555|20142342|P4|COMPLETED|24-week Double-blind Treatment Period||0
8169967|NCT02453555|20142343|P3|COMPLETED|24-week Double-blind Treatment Period||0
8169968|NCT02453555|20142344|P2|COMPLETED|24-week Double-blind Treatment Period||86
8169969|NCT02453555|20142345|P1|COMPLETED|24-week Double-blind Treatment Period||177
8169970|NCT02453555|20142340|P6|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169971|NCT02453555|20142341|P5|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169972|NCT02453555|20142342|P4|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169973|NCT02453555|20142343|P3|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169974|NCT02453555|20142344|P2|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
8169975|NCT02453555|20142345|P1|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
8169976|NCT02453386|20142361|P3|NOT COMPLETED|Overall Study||41
8169977|NCT02453386|20142362|P2|NOT COMPLETED|Overall Study||49
8169978|NCT02453386|20142363|P1|NOT COMPLETED|Overall Study||49
8169979|NCT02453386|20142361|P3|COMPLETED|Overall Study||108
8169980|NCT02453386|20142362|P2|COMPLETED|Overall Study||100
8169981|NCT02453386|20142363|P1|COMPLETED|Overall Study||102
8169982|NCT02453386|20142361|P3|STARTED|Overall Study||149
8169983|NCT02453386|20142362|P2|STARTED|Overall Study||149
8169984|NCT02453386|20142363|P1|STARTED|Overall Study||151
8169985|NCT02453360|20142389|P3|NOT COMPLETED|Overall Study||0
8169986|NCT02453360|20142390|P2|NOT COMPLETED|Overall Study||0
8169987|NCT02453360|20142391|P1|NOT COMPLETED|Overall Study||0
8169988|NCT02453360|20142389|P3|COMPLETED|Overall Study||20
8169989|NCT02453360|20142390|P2|COMPLETED|Overall Study||20
8169990|NCT02453360|20142391|P1|COMPLETED|Overall Study||20
8169991|NCT02453360|20142389|P3|STARTED|Overall Study||20
8169992|NCT02453360|20142390|P2|STARTED|Overall Study||20
8169993|NCT02453360|20142391|P1|STARTED|Overall Study||20
8169994|NCT02453347|20142411|P1|NOT COMPLETED|Overall Study||0
8169995|NCT02453347|20142411|P1|COMPLETED|Overall Study||6
8169996|NCT02453347|20142411|P1|STARTED|Overall Study||6
8169997|NCT02453321|20142427|P3|NOT COMPLETED|Overall Study||2
8169998|NCT02453321|20142428|P2|NOT COMPLETED|Overall Study||2
8169999|NCT02453321|20142429|P1|NOT COMPLETED|Overall Study||1
8170000|NCT02453321|20142427|P3|COMPLETED|Overall Study||19
8170001|NCT02453321|20142428|P2|COMPLETED|Overall Study||19
8170002|NCT02453321|20142429|P1|COMPLETED|Overall Study||19
8170003|NCT02453321|20142427|P3|STARTED|Overall Study||21
8170004|NCT02453321|20142428|P2|STARTED|Overall Study||21
8170005|NCT02453321|20142429|P1|STARTED|Overall Study||20
8170006|NCT02453282|20142449|P3|NOT COMPLETED|Overall Study||372
8170007|NCT02453282|20142450|P2|NOT COMPLETED|Overall Study||372
8170008|NCT02453282|20142451|P1|NOT COMPLETED|Overall Study||374
8170009|NCT02453282|20142449|P3|COMPLETED|Overall Study||0
8170010|NCT02453282|20142450|P2|COMPLETED|Overall Study||0
8170011|NCT02453282|20142451|P1|COMPLETED|Overall Study||0
8170012|NCT02453282|20142449|P3|Received Treatment|Overall Study||352
8170013|NCT02453282|20142450|P2|Received Treatment|Overall Study||371
8170014|NCT02453282|20142451|P1|Received Treatment|Overall Study||369
8170015|NCT02453282|20142449|P3|STARTED|Overall Study||372
8170016|NCT02453282|20142450|P2|STARTED|Overall Study||372
8170017|NCT02453282|20142451|P1|STARTED|Overall Study||374
8170018|NCT02453256|20142532|P2|NOT COMPLETED|Open Label Period||7
8170019|NCT02453256|20142533|P1|NOT COMPLETED|Open Label Period||7
8170020|NCT02453256|20142532|P2|COMPLETED|Open Label Period||85
8170021|NCT02453256|20142533|P1|COMPLETED|Open Label Period||82
8170022|NCT02453256|20142532|P2|STARTED|Open Label Period||92
8170023|NCT02453256|20142533|P1|STARTED|Open Label Period||89
8170024|NCT02453256|20142532|P2|NOT COMPLETED|Double Blind Period||9
8170025|NCT02453256|20142533|P1|NOT COMPLETED|Double Blind Period||13
8170026|NCT02453256|20142532|P2|COMPLETED|Double Blind Period||95
8170027|NCT02453256|20142533|P1|COMPLETED|Double Blind Period||93
8170028|NCT02453256|20142532|P2|STARTED|Double Blind Period||104
8170029|NCT02453256|20142533|P1|STARTED|Double Blind Period||106
8170030|NCT02453191|20142653|P1|NOT COMPLETED|Overall Study||1
8170031|NCT02453191|20142653|P1|COMPLETED|Overall Study||29
8170032|NCT02453191|20142653|P1|STARTED|Overall Study||30
8170033|NCT02453113|20142661|P1|NOT COMPLETED|Overall Study||0
8170034|NCT02453113|20142661|P1|COMPLETED|Overall Study||10
8170035|NCT02453113|20142661|P1|STARTED|Overall Study||10
8170036|NCT02453048|20142670|P5|NOT COMPLETED|Overall Study||6
8170037|NCT02453048|20142671|P4|NOT COMPLETED|Overall Study||0
8170038|NCT02453048|20142672|P3|NOT COMPLETED|Overall Study||2
8170039|NCT02453048|20142673|P2|NOT COMPLETED|Overall Study||1
8170040|NCT02453048|20142674|P1|NOT COMPLETED|Overall Study||0
8170041|NCT02453048|20142670|P5|COMPLETED|Overall Study||0
8170042|NCT02453048|20142671|P4|COMPLETED|Overall Study||12
8170043|NCT02453048|20142672|P3|COMPLETED|Overall Study||10
8170044|NCT02453048|20142673|P2|COMPLETED|Overall Study||11
8170045|NCT02453048|20142674|P1|COMPLETED|Overall Study||12
8170046|NCT02453048|20142670|P5|6-month Follow-up|Overall Study||6
8170047|NCT02453048|20142671|P4|6-month Follow-up|Overall Study||12
8170048|NCT02453048|20142672|P3|6-month Follow-up|Overall Study||12
8170049|NCT02453048|20142673|P2|6-month Follow-up|Overall Study||12
8170050|NCT02453048|20142674|P1|6-month Follow-up|Overall Study||12
8170051|NCT02453048|20142670|P5|STARTED|Overall Study||6
8170052|NCT02453048|20142671|P4|STARTED|Overall Study||12
8170053|NCT02453048|20142672|P3|STARTED|Overall Study||12
8170054|NCT02453048|20142673|P2|STARTED|Overall Study||12
8170055|NCT02453048|20142674|P1|STARTED|Overall Study||12
8170056|NCT02452944|20142698|P2|NOT COMPLETED|Overall Study||0
8170057|NCT02452944|20142699|P1|NOT COMPLETED|Overall Study||0
8170058|NCT02452944|20142698|P2|COMPLETED|Overall Study||31
8170059|NCT02452944|20142699|P1|COMPLETED|Overall Study||31
8170060|NCT02452944|20142698|P2|STARTED|Overall Study||31
8170061|NCT02452944|20142699|P1|STARTED|Overall Study||31
8170062|NCT02452931|20142707|P1|NOT COMPLETED|Overall Study||4
8170063|NCT02452931|20142707|P1|COMPLETED|Overall Study||60
8170064|NCT02452931|20142707|P1|STARTED|Overall Study||64
8170065|NCT02452892|20142734|P4|NOT COMPLETED|Follow-up||1
8170066|NCT02452892|20142735|P3|NOT COMPLETED|Follow-up||0
8170067|NCT02452892|20142736|P2|NOT COMPLETED|Follow-up||0
8170068|NCT02452892|20142737|P1|NOT COMPLETED|Follow-up||1
8170069|NCT02452892|20142734|P4|COMPLETED|Follow-up||38
8170070|NCT02452892|20142735|P3|COMPLETED|Follow-up||7
8170071|NCT02452892|20142736|P2|COMPLETED|Follow-up||7
8170072|NCT02452892|20142737|P1|COMPLETED|Follow-up||62
8170073|NCT02452892|20142734|P4|STARTED|Follow-up||39
8170074|NCT02452892|20142735|P3|STARTED|Follow-up||7
8170075|NCT02452892|20142736|P2|STARTED|Follow-up||7
8170076|NCT02452892|20142737|P1|STARTED|Follow-up||63
8170077|NCT02452892|20142734|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
8170078|NCT02452892|20142735|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
8170079|NCT02452892|20142736|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
8170080|NCT02452892|20142737|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
8170081|NCT02452892|20142734|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
8170082|NCT02452892|20142735|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
8170083|NCT02452892|20142736|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
8170084|NCT02452892|20142737|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
8170085|NCT02452892|20142734|P4|Responders|Week 2 Stratification & Re-Randomization||0
8170086|NCT02452892|20142735|P3|Responders|Week 2 Stratification & Re-Randomization||7
8170087|NCT02452892|20142736|P2|Responders|Week 2 Stratification & Re-Randomization||7
8170088|NCT02452892|20142737|P1|Responders|Week 2 Stratification & Re-Randomization||27
8170089|NCT02452892|20142734|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
8170090|NCT02452892|20142735|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
8170091|NCT02452892|20142736|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
8170092|NCT02452892|20142737|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
8170093|NCT02452892|20142734|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
8170094|NCT02452892|20142735|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
8170095|NCT02452892|20142736|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
8170096|NCT02452892|20142737|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
8170097|NCT02452892|20142734|P4|NOT COMPLETED|Week 1 Initial Randommization||0
8170098|NCT02452892|20142735|P3|NOT COMPLETED|Week 1 Initial Randommization||1
8170099|NCT02452892|20142736|P2|NOT COMPLETED|Week 1 Initial Randommization||0
8170100|NCT02452892|20142737|P1|NOT COMPLETED|Week 1 Initial Randommization||1
8170101|NCT02452892|20142734|P4|COMPLETED|Week 1 Initial Randommization||0
8170102|NCT02452892|20142735|P3|COMPLETED|Week 1 Initial Randommization||40
8170103|NCT02452892|20142736|P2|COMPLETED|Week 1 Initial Randommization||40
8170104|NCT02452892|20142737|P1|COMPLETED|Week 1 Initial Randommization||40
8170105|NCT02452892|20142734|P4|STARTED|Week 1 Initial Randommization||0
8170106|NCT02452892|20142735|P3|STARTED|Week 1 Initial Randommization||41
8170107|NCT02452892|20142736|P2|STARTED|Week 1 Initial Randommization||40
8170108|NCT02452892|20142737|P1|STARTED|Week 1 Initial Randommization||41
8170109|NCT02452554|20142772|P6|NOT COMPLETED|Overall Study||9
8170110|NCT02452554|20142773|P5|NOT COMPLETED|Overall Study||5
8170111|NCT02452554|20142774|P4|NOT COMPLETED|Overall Study||1
8170112|NCT02452554|20142775|P3|NOT COMPLETED|Overall Study||11
8170113|NCT02452554|20142776|P2|NOT COMPLETED|Overall Study||17
8170114|NCT02452554|20142777|P1|NOT COMPLETED|Overall Study||17
8170115|NCT02452554|20142772|P6|COMPLETED|Overall Study||1
8170116|NCT02452554|20142773|P5|COMPLETED|Overall Study||0
8170117|NCT02452554|20142774|P4|COMPLETED|Overall Study||0
8170118|NCT02452554|20142775|P3|COMPLETED|Overall Study||1
8170119|NCT02452554|20142776|P2|COMPLETED|Overall Study||0
8170120|NCT02452554|20142777|P1|COMPLETED|Overall Study||0
8170121|NCT02452554|20142772|P6|STARTED|Overall Study||10
8170122|NCT02452554|20142773|P5|STARTED|Overall Study||5
8170123|NCT02452554|20142774|P4|STARTED|Overall Study||1
8170124|NCT02452554|20142775|P3|STARTED|Overall Study||12
8170125|NCT02452554|20142776|P2|STARTED|Overall Study||17
8170126|NCT02452554|20142777|P1|STARTED|Overall Study||17
8170127|NCT02452528|20142794|P2|NOT COMPLETED|Overall Study||1
8170128|NCT02452528|20142795|P1|NOT COMPLETED|Overall Study||1
8170129|NCT02452528|20142794|P2|COMPLETED|Overall Study||1
8170130|NCT02452528|20142795|P1|COMPLETED|Overall Study||1
8170131|NCT02452528|20142794|P2|STARTED|Overall Study||2
8170132|NCT02452528|20142795|P1|STARTED|Overall Study||2
8170133|NCT02452463|20142830|P3|NOT COMPLETED|Overall Study||0
8170134|NCT02452463|20142831|P2|NOT COMPLETED|Overall Study||2
8170135|NCT02452463|20142832|P1|NOT COMPLETED|Overall Study||2
8170136|NCT02452463|20142830|P3|COMPLETED|Overall Study||0
8170137|NCT02452463|20142831|P2|COMPLETED|Overall Study||1
8170138|NCT02452463|20142832|P1|COMPLETED|Overall Study||3
8170139|NCT02452463|20142830|P3|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
8170140|NCT02452463|20142831|P2|STARTED|Overall Study||3
8170141|NCT02452463|20142832|P1|STARTED|Overall Study||5
8170142|NCT02452424|20142875|P11|NOT COMPLETED|Overall Study||2
8170143|NCT02452424|20142876|P10|NOT COMPLETED|Overall Study||2
8170144|NCT02452424|20142877|P9|NOT COMPLETED|Overall Study||6
8170145|NCT02452424|20142878|P8|NOT COMPLETED|Overall Study||4
8170146|NCT02452424|20142879|P7|NOT COMPLETED|Overall Study||10
8170147|NCT02452424|20142880|P6|NOT COMPLETED|Overall Study||1
8170148|NCT02452424|20142881|P5|NOT COMPLETED|Overall Study||2
8170149|NCT02452424|20142882|P4|NOT COMPLETED|Overall Study||8
8170150|NCT02452424|20142883|P3|NOT COMPLETED|Overall Study||7
8170151|NCT02452424|20142884|P2|NOT COMPLETED|Overall Study||3
8170152|NCT02452424|20142885|P1|NOT COMPLETED|Overall Study||2
8170153|NCT02452424|20142875|P11|COMPLETED|Overall Study||4
8170154|NCT02452424|20142876|P10|COMPLETED|Overall Study||1
8170155|NCT02452424|20142877|P9|COMPLETED|Overall Study||9
8170156|NCT02452424|20142878|P8|COMPLETED|Overall Study||4
8170157|NCT02452424|20142879|P7|COMPLETED|Overall Study||3
8170158|NCT02452424|20142880|P6|COMPLETED|Overall Study||5
8170159|NCT02452424|20142881|P5|COMPLETED|Overall Study||2
8170160|NCT02452424|20142882|P4|COMPLETED|Overall Study||1
8170161|NCT02452424|20142883|P3|COMPLETED|Overall Study||0
8170162|NCT02452424|20142884|P2|COMPLETED|Overall Study||0
8170163|NCT02452424|20142885|P1|COMPLETED|Overall Study||2
8170164|NCT02452424|20142875|P11|STARTED|Overall Study||6
8170165|NCT02452424|20142876|P10|STARTED|Overall Study||3
8170166|NCT02452424|20142877|P9|STARTED|Overall Study||15
8170167|NCT02452424|20142878|P8|STARTED|Overall Study||8
8170168|NCT02452424|20142879|P7|STARTED|Overall Study||13
8170169|NCT02452424|20142880|P6|STARTED|Overall Study||6
8170170|NCT02452424|20142881|P5|STARTED|Overall Study||4
8170171|NCT02452424|20142882|P4|STARTED|Overall Study||9
8170172|NCT02452424|20142883|P3|STARTED|Overall Study||7
8170173|NCT02452424|20142884|P2|STARTED|Overall Study||3
8170174|NCT02452424|20142885|P1|STARTED|Overall Study||4
8170175|NCT02452398|20142920|P1|NOT COMPLETED|Overall Study||41
8170176|NCT02452398|20142920|P1|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
8170177|NCT02452398|20142920|P1|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
8170178|NCT02452359|20142924|P1|NOT COMPLETED|Overall Study||21
8170179|NCT02452359|20142924|P1|COMPLETED|Overall Study||33
8170180|NCT02452359|20142924|P1|STARTED|Overall Study||54
8170181|NCT02452346|20142928|P1|NOT COMPLETED|Overall Study||9
8170182|NCT02452346|20142928|P1|COMPLETED|Overall Study||3
8170183|NCT02452346|20142928|P1|STARTED|Overall Study||12
8170184|NCT02452320|20142936|P2|NOT COMPLETED|Overall Study||1
8170185|NCT02452320|20142937|P1|NOT COMPLETED|Overall Study||0
8170186|NCT02452320|20142936|P2|COMPLETED|Overall Study||63
8170187|NCT02452320|20142937|P1|COMPLETED|Overall Study||64
8170188|NCT02452320|20142936|P2|STARTED|Overall Study||64
8170189|NCT02452320|20142937|P1|STARTED|Overall Study||64
8170190|NCT02452190|20142949|P2|NOT COMPLETED|Overall Study||24
8170191|NCT02452190|20142950|P1|NOT COMPLETED|Overall Study||35
8170192|NCT02452190|20142949|P2|COMPLETED|Overall Study||212
8170193|NCT02452190|20142950|P1|COMPLETED|Overall Study||197
8170194|NCT02452190|20142949|P2|Safety Population|Overall Study||237
8170195|NCT02452190|20142950|P1|Safety Population|Overall Study||231
8170196|NCT02452190|20142949|P2|Intent to Treat (ITT) Population|Overall Study||234
8170197|NCT02452190|20142950|P1|Intent to Treat (ITT) Population|Overall Study||230
8170198|NCT02452190|20142949|P2|STARTED|Overall Study||236
8170199|NCT02452190|20142950|P1|STARTED|Overall Study||232
8170200|NCT02452060|20142976|P2|NOT COMPLETED|Overall Study||0
8170201|NCT02452060|20142977|P1|NOT COMPLETED|Overall Study||0
8170202|NCT02452060|20142976|P2|COMPLETED|Overall Study||44
8170203|NCT02452060|20142977|P1|COMPLETED|Overall Study||46
8170204|NCT02452060|20142976|P2|STARTED|Overall Study||44
8170205|NCT02452060|20142977|P1|STARTED|Overall Study||46
8170206|NCT02452047|20142988|P3|NOT COMPLETED|Overall Study||2
8170207|NCT02452047|20142989|P2|NOT COMPLETED|Overall Study||5
8170208|NCT02452047|20142990|P1|NOT COMPLETED|Overall Study||4
8170209|NCT02452047|20142988|P3|COMPLETED|Overall Study||1
8170210|NCT02452047|20142989|P2|COMPLETED|Overall Study||11
8170211|NCT02452047|20142990|P1|COMPLETED|Overall Study||27
8170212|NCT02452047|20142988|P3|STARTED|Overall Study||3
8170213|NCT02452047|20142989|P2|STARTED|Overall Study||16
8170214|NCT02452047|20142990|P1|STARTED|Overall Study||31
8170215|NCT02452034|20143055|P6|NOT COMPLETED|Overall Study||3
8170216|NCT02452034|20143056|P5|NOT COMPLETED|Overall Study||1
8170217|NCT02452034|20143057|P4|NOT COMPLETED|Overall Study||1
8170218|NCT02452034|20143058|P3|NOT COMPLETED|Overall Study||1
8170219|NCT02452034|20143059|P2|NOT COMPLETED|Overall Study||1
8170220|NCT02452034|20143060|P1|NOT COMPLETED|Overall Study||2
8170221|NCT02452034|20143055|P6|COMPLETED|Overall Study||26
8170222|NCT02452034|20143056|P5|COMPLETED|Overall Study||19
8170223|NCT02452034|20143057|P4|COMPLETED|Overall Study||16
8170224|NCT02452034|20143058|P3|COMPLETED|Overall Study||14
8170225|NCT02452034|20143059|P2|COMPLETED|Overall Study||20
8170226|NCT02452034|20143060|P1|COMPLETED|Overall Study||14
8170227|NCT02452034|20143055|P6|Treated|Overall Study||29
8170228|NCT02452034|20143056|P5|Treated|Overall Study||20
8170229|NCT02452034|20143057|P4|Treated|Overall Study||16
8170230|NCT02452034|20143058|P3|Treated|Overall Study||15
8170231|NCT02452034|20143059|P2|Treated|Overall Study||21
8170232|NCT02452034|20143060|P1|Treated|Overall Study||14
8170233|NCT02452034|20143055|P6|STARTED|Overall Study||29
8170234|NCT02452034|20143056|P5|STARTED|Overall Study||20
8170235|NCT02452034|20143057|P4|STARTED|Overall Study||17
8170236|NCT02452034|20143058|P3|STARTED|Overall Study||15
8170237|NCT02452034|20143059|P2|STARTED|Overall Study||21
8170238|NCT02452034|20143060|P1|STARTED|Overall Study||16
8170239|NCT02451995|20143124|P2|NOT COMPLETED|Overall Study||0
8170240|NCT02451995|20143125|P1|NOT COMPLETED|Overall Study||0
8170241|NCT02451995|20143124|P2|COMPLETED|Overall Study||41
8170242|NCT02451995|20143125|P1|COMPLETED|Overall Study||42
8170243|NCT02451995|20143124|P2|STARTED|Overall Study||41
8170244|NCT02451995|20143125|P1|STARTED|Overall Study||42
8170245|NCT02451943|20143133|P2|NOT COMPLETED|Overall Study||24
8170246|NCT02451943|20143134|P1|NOT COMPLETED|Overall Study||20
8170247|NCT02451943|20143133|P2|COMPLETED|Overall Study||227
8170248|NCT02451943|20143134|P1|COMPLETED|Overall Study||238
8170249|NCT02451943|20143133|P2|Leiomyosarcoma (LMS) Population|Overall Study||115
8170250|NCT02451943|20143134|P1|Leiomyosarcoma (LMS) Population|Overall Study||119
8170251|NCT02451943|20143133|P2|Received at Least One Dose of Study Drug|Overall Study||249
8170252|NCT02451943|20143134|P1|Received at Least One Dose of Study Drug|Overall Study||257
8170253|NCT02451943|20143133|P2|STARTED|Overall Study||251
8170254|NCT02451943|20143134|P1|STARTED|Overall Study||258
8170255|NCT02451930|20143163|P2|NOT COMPLETED|Overall Study||30
8170256|NCT02451930|20143164|P1|NOT COMPLETED|Overall Study||2
8170257|NCT02451930|20143163|P2|COMPLETED|Overall Study||38
8170258|NCT02451930|20143164|P1|COMPLETED|Overall Study||1
8170259|NCT02451930|20143163|P2|Part C Participants|Overall Study||7
8170260|NCT02451930|20143164|P1|Part C Participants|Overall Study||0
8170261|NCT02451930|20143163|P2|Part B Participants|Overall Study||55
8170262|NCT02451930|20143164|P1|Part B Participants|Overall Study||0
8170263|NCT02451930|20143163|P2|Part A Cohort 2 Participants|Overall Study||6
8170264|NCT02451930|20143164|P1|Part A Cohort 2 Participants|Overall Study||0
8170265|NCT02451930|20143163|P2|Received at Least One Dose of Study Drug|Overall Study||68
8170266|NCT02451930|20143164|P1|Received at Least One Dose of Study Drug|Overall Study||3
8170267|NCT02451930|20143163|P2|STARTED|Overall Study||68
8170268|NCT02451930|20143164|P1|STARTED|Overall Study||3
8170269|NCT02451917|20143187|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
8170270|NCT02451917|20143188|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
8170271|NCT02451917|20143187|P2|COMPLETED|Second Intervention (24 Weeks)||15
8170272|NCT02451917|20143188|P1|COMPLETED|Second Intervention (24 Weeks)||14
8170273|NCT02451917|20143187|P2|STARTED|Second Intervention (24 Weeks)||15
8170274|NCT02451917|20143188|P1|STARTED|Second Intervention (24 Weeks)||14
8170275|NCT02451917|20143187|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
8170276|NCT02451917|20143188|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
8170277|NCT02451917|20143187|P2|COMPLETED|First Intervention (24 Weeks)||15
8170278|NCT02451917|20143188|P1|COMPLETED|First Intervention (24 Weeks)||14
8170279|NCT02451917|20143187|P2|STARTED|First Intervention (24 Weeks)||18
8170280|NCT02451917|20143188|P1|STARTED|First Intervention (24 Weeks)||16
8170281|NCT02451839|20143206|P3|NOT COMPLETED|Overall Study||7
8170282|NCT02451839|20143207|P2|NOT COMPLETED|Overall Study||19
8170283|NCT02451839|20143208|P1|NOT COMPLETED|Overall Study||28
8170284|NCT02451839|20143206|P3|COMPLETED|Overall Study||30
8170285|NCT02451839|20143207|P2|COMPLETED|Overall Study||40
8170286|NCT02451839|20143208|P1|COMPLETED|Overall Study||44
8170287|NCT02451839|20143206|P3|Baseline WHODAS Data Recorded|Overall Study||37
8170288|NCT02451839|20143207|P2|Baseline WHODAS Data Recorded|Overall Study||57
8170289|NCT02451839|20143208|P1|Baseline WHODAS Data Recorded|Overall Study||70
8170290|NCT02451839|20143206|P3|STARTED|Overall Study||37
8170291|NCT02451839|20143207|P2|STARTED|Overall Study||59
8170292|NCT02451839|20143208|P1|STARTED|Overall Study||72
8170293|NCT02451670|20143230|P2|NOT COMPLETED|Overall Study||696
8170294|NCT02451670|20143231|P1|NOT COMPLETED|Overall Study||714
8170295|NCT02451670|20143230|P2|COMPLETED|Overall Study||4387
8170296|NCT02451670|20143231|P1|COMPLETED|Overall Study||4550
8170297|NCT02451670|20143230|P2|STARTED|Overall Study||5083
8170298|NCT02451670|20143231|P1|STARTED|Overall Study||5264
8170299|NCT02451514|20143240|P3|NOT COMPLETED|Overall Study||0
8170300|NCT02451514|20143241|P2|NOT COMPLETED|Overall Study||0
8170301|NCT02451514|20143242|P1|NOT COMPLETED|Overall Study||0
8170302|NCT02451514|20143240|P3|COMPLETED|Overall Study||50
8170303|NCT02451514|20143241|P2|COMPLETED|Overall Study||46
8170304|NCT02451514|20143242|P1|COMPLETED|Overall Study||33
8170305|NCT02451514|20143240|P3|STARTED|Overall Study||50
8170306|NCT02451514|20143241|P2|STARTED|Overall Study||46
8170307|NCT02451514|20143242|P1|STARTED|Overall Study||33
8170308|NCT02451488|20143330|P2|NOT COMPLETED|Overall Study||0
8170309|NCT02451488|20143331|P1|NOT COMPLETED|Overall Study||0
8170310|NCT02451488|20143330|P2|COMPLETED|Overall Study||4
8170311|NCT02451488|20143331|P1|COMPLETED|Overall Study||4
8170312|NCT02451488|20143330|P2|STARTED|Overall Study||4
8170313|NCT02451488|20143331|P1|STARTED|Overall Study||4
8170314|NCT02451358|20143341|P4|NOT COMPLETED|Overall Study||0
8170315|NCT02451358|20143342|P3|NOT COMPLETED|Overall Study||1
8170316|NCT02451358|20143343|P2|NOT COMPLETED|Overall Study||2
8170317|NCT02451358|20143344|P1|NOT COMPLETED|Overall Study||1
8170318|NCT02451358|20143341|P4|COMPLETED|Overall Study||100
8170319|NCT02451358|20143342|P3|COMPLETED|Overall Study||99
8170320|NCT02451358|20143343|P2|COMPLETED|Overall Study||98
8170321|NCT02451358|20143344|P1|COMPLETED|Overall Study||99
8170322|NCT02451358|20143341|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
8170323|NCT02451358|20143342|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
8170324|NCT02451358|20143343|P2|Vaccinated at Day 28|Overall Study||98
8170325|NCT02451358|20143344|P1|Vaccinated at Day 28|Overall Study||99
8170326|NCT02451358|20143341|P4|Vaccinated at Day 0|Overall Study||100
8170327|NCT02451358|20143342|P3|Vaccinated at Day 0|Overall Study||100
8170328|NCT02451358|20143343|P2|Vaccinated at Day 0|Overall Study||100
8170329|NCT02451358|20143344|P1|Vaccinated at Day 0|Overall Study||100
8170330|NCT02451358|20143341|P4|STARTED|Overall Study||100
8170331|NCT02451358|20143342|P3|STARTED|Overall Study||100
8170332|NCT02451358|20143343|P2|STARTED|Overall Study||100
8170333|NCT02451358|20143344|P1|STARTED|Overall Study||100
8170334|NCT02451202|20143368|P2|NOT COMPLETED|Overall Study||3
8170335|NCT02451202|20143369|P1|NOT COMPLETED|Overall Study||2
8170336|NCT02451202|20143368|P2|COMPLETED|Overall Study||48
8170337|NCT02451202|20143369|P1|COMPLETED|Overall Study||49
8170338|NCT02451202|20143368|P2|STARTED|Overall Study||51
8170339|NCT02451202|20143369|P1|STARTED|Overall Study||51
8170340|NCT02451150|20143379|P2|NOT COMPLETED|Overall Study||0
8170341|NCT02451150|20143380|P1|NOT COMPLETED|Overall Study||0
8170342|NCT02451150|20143379|P2|COMPLETED|Overall Study||3
8170343|NCT02451150|20143380|P1|COMPLETED|Overall Study||3
8170344|NCT02451150|20143379|P2|STARTED|Overall Study||3
8170345|NCT02451150|20143380|P1|STARTED|Overall Study||3
8170346|NCT02451137|20143432|P2|NOT COMPLETED|Overall Study||298
8170347|NCT02451137|20143433|P1|NOT COMPLETED|Overall Study||246
8170348|NCT02451137|20143432|P2|COMPLETED|Overall Study||1355
8170349|NCT02451137|20143433|P1|COMPLETED|Overall Study||1405
8170350|NCT02451137|20143432|P2|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
8170351|NCT02451137|20143433|P1|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
8170352|NCT02451137|20143432|P2|Treated|Overall Study||1626
8170353|NCT02451137|20143433|P1|Treated|Overall Study||1632
8170354|NCT02451137|20143432|P2|STARTED|Overall Study||1653
8170355|NCT02451137|20143433|P1|STARTED|Overall Study||1651
8170356|NCT02451124|20143463|P1|NOT COMPLETED|Overall Study||1
8170357|NCT02451124|20143463|P1|COMPLETED|Overall Study||155
8170358|NCT02451124|20143463|P1|STARTED|Overall Study||156
8170359|NCT02451007|20143474|P1|NOT COMPLETED|Overall Study||7
8170360|NCT02451007|20143474|P1|COMPLETED|Overall Study||32
8170361|NCT02451007|20143474|P1|STARTED|Overall Study||39
8170367|NCT02450799|20143495|P3|NOT COMPLETED|Overall Study||0
8170368|NCT02450799|20143496|P2|NOT COMPLETED|Overall Study||0
8170369|NCT02450799|20143497|P1|NOT COMPLETED|Overall Study||0
8170370|NCT02450799|20143495|P3|COMPLETED|Overall Study||30
8170371|NCT02450799|20143496|P2|COMPLETED|Overall Study||37
8170372|NCT02450799|20143497|P1|COMPLETED|Overall Study||31
8170373|NCT02450799|20143495|P3|STARTED|Overall Study||30
8170374|NCT02450799|20143496|P2|STARTED|Overall Study||37
8170375|NCT02450799|20143497|P1|STARTED|Overall Study||31
8170376|NCT02450747|20143508|P1|NOT COMPLETED|Overall Study||0
8170377|NCT02450747|20143508|P1|COMPLETED|Overall Study||39
8170378|NCT02450747|20143508|P1|STARTED|Overall Study||39
8170379|NCT02450591|20143517|P1|NOT COMPLETED|Overall Study||0
8170380|NCT02450591|20143517|P1|COMPLETED|Overall Study||4
8170381|NCT02450591|20143517|P1|STARTED|Overall Study||4
8170382|NCT02450578|20143525|P4|NOT COMPLETED|Overall Study||0
8170383|NCT02450578|20143526|P3|NOT COMPLETED|Overall Study||0
8170384|NCT02450578|20143527|P2|NOT COMPLETED|Overall Study||0
8170385|NCT02450578|20143528|P1|NOT COMPLETED|Overall Study||1
8170386|NCT02450578|20143525|P4|COMPLETED|Overall Study||4
8170387|NCT02450578|20143526|P3|COMPLETED|Overall Study||6
8170388|NCT02450578|20143527|P2|COMPLETED|Overall Study||6
8170389|NCT02450578|20143528|P1|COMPLETED|Overall Study||5
8170390|NCT02450578|20143525|P4|STARTED|Overall Study||4
8170391|NCT02450578|20143526|P3|STARTED|Overall Study||6
8170392|NCT02450578|20143527|P2|STARTED|Overall Study||6
8170393|NCT02450578|20143528|P1|STARTED|Overall Study||6
8170394|NCT02450552|20143574|P3|NOT COMPLETED|Overall Study||5
8170395|NCT02450552|20143575|P2|NOT COMPLETED|Overall Study||0
8170396|NCT02450552|20143576|P1|NOT COMPLETED|Overall Study||5
8170397|NCT02450552|20143574|P3|COMPLETED|Overall Study||18
8170398|NCT02450552|20143575|P2|COMPLETED|Overall Study||23
8170399|NCT02450552|20143576|P1|COMPLETED|Overall Study||14
8170400|NCT02450552|20143574|P3|STARTED|Overall Study||23
8170401|NCT02450552|20143575|P2|STARTED|Overall Study||23
8170402|NCT02450552|20143576|P1|STARTED|Overall Study||19
8170403|NCT02450539|20143619|P2|NOT COMPLETED|Overall Study||33
8170404|NCT02450539|20143620|P1|NOT COMPLETED|Overall Study||50
8170405|NCT02450539|20143619|P2|COMPLETED|Overall Study||20
8170406|NCT02450539|20143620|P1|COMPLETED|Overall Study||56
8170407|NCT02450539|20143619|P2|Death|Overall Study||20
8170408|NCT02450539|20143620|P1|Death|Overall Study||56
8170409|NCT02450539|20143619|P2|Received at Least One Dose of Study Drug|Overall Study||52
8170410|NCT02450539|20143620|P1|Received at Least One Dose of Study Drug|Overall Study||106
8170411|NCT02450539|20143619|P2|STARTED|Overall Study||53
8170412|NCT02450539|20143620|P1|STARTED|Overall Study||106
8170413|NCT02450526|20143644|P5|NOT COMPLETED|OL Period (Cycles 2-5)||41
8170414|NCT02450526|20143645|P4|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170415|NCT02450526|20143646|P3|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170416|NCT02450526|20143647|P2|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170417|NCT02450526|20143648|P1|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170418|NCT02450526|20143644|P5|COMPLETED|OL Period (Cycles 2-5)||424
8170419|NCT02450526|20143645|P4|COMPLETED|OL Period (Cycles 2-5)||0
8170420|NCT02450526|20143646|P3|COMPLETED|OL Period (Cycles 2-5)||0
8170421|NCT02450526|20143647|P2|COMPLETED|OL Period (Cycles 2-5)||0
8170422|NCT02450526|20143648|P1|COMPLETED|OL Period (Cycles 2-5)||0
8170423|NCT02450526|20143644|P5|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170424|NCT02450526|20143645|P4|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170425|NCT02450526|20143646|P3|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170426|NCT02450526|20143647|P2|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170427|NCT02450526|20143648|P1|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170428|NCT02450526|20143644|P5|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
8170429|NCT02450526|20143645|P4|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170430|NCT02450526|20143646|P3|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170431|NCT02450526|20143647|P2|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170432|NCT02450526|20143648|P1|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170433|NCT02450526|20143644|P5|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
8170434|NCT02450526|20143645|P4|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170435|NCT02450526|20143646|P3|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170436|NCT02450526|20143647|P2|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170437|NCT02450526|20143648|P1|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170438|NCT02450526|20143644|P5|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
8170439|NCT02450526|20143645|P4|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170440|NCT02450526|20143646|P3|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170441|NCT02450526|20143647|P2|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170442|NCT02450526|20143648|P1|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170443|NCT02450526|20143644|P5|Safety Population|OL Period (Cycles 2-5)||465
8170444|NCT02450526|20143645|P4|Safety Population|OL Period (Cycles 2-5)||0
8170445|NCT02450526|20143646|P3|Safety Population|OL Period (Cycles 2-5)||0
8170446|NCT02450526|20143647|P2|Safety Population|OL Period (Cycles 2-5)||0
8170447|NCT02450526|20143648|P1|Safety Population|OL Period (Cycles 2-5)||0
8170448|NCT02450526|20143644|P5|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
8170449|NCT02450526|20143645|P4|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170450|NCT02450526|20143646|P3|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170451|NCT02450526|20143647|P2|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170452|NCT02450526|20143648|P1|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170453|NCT02450526|20143644|P5|NOT COMPLETED|DB Period (Cycle 1)||0
8170454|NCT02450526|20143645|P4|NOT COMPLETED|DB Period (Cycle 1)||2
8170455|NCT02450526|20143646|P3|NOT COMPLETED|DB Period (Cycle 1)||10
8170456|NCT02450526|20143647|P2|NOT COMPLETED|DB Period (Cycle 1)||3
8170457|NCT02450526|20143648|P1|NOT COMPLETED|DB Period (Cycle 1)||31
8170458|NCT02450526|20143644|P5|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
8170459|NCT02450526|20143645|P4|COMPLETED|DB Period (Cycle 1)||20
8170460|NCT02450526|20143646|P3|COMPLETED|DB Period (Cycle 1)||97
8170461|NCT02450526|20143647|P2|COMPLETED|DB Period (Cycle 1)||63
8170462|NCT02450526|20143648|P1|COMPLETED|DB Period (Cycle 1)||294
8170463|NCT02450526|20143644|P5|Safety Population|DB Period (Cycle 1)||0
8170464|NCT02450526|20143645|P4|Safety Population|DB Period (Cycle 1)||21
8170465|NCT02450526|20143646|P3|Safety Population|DB Period (Cycle 1)||107
8170466|NCT02450526|20143647|P2|Safety Population|DB Period (Cycle 1)||66
8170467|NCT02450526|20143648|P1|Safety Population|DB Period (Cycle 1)||326
8170468|NCT02450526|20143644|P5|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
8170469|NCT02450526|20143645|P4|STARTED|DB Period (Cycle 1)||22
8170470|NCT02450526|20143646|P3|STARTED|DB Period (Cycle 1)||107
8170471|NCT02450526|20143647|P2|STARTED|DB Period (Cycle 1)||66
8170472|NCT02450526|20143648|P1|STARTED|DB Period (Cycle 1)||325
8170473|NCT02450487|20143733|P1|NOT COMPLETED|Overall Study||3
8170474|NCT02450487|20143733|P1|COMPLETED|Overall Study||102
8170475|NCT02450487|20143733|P1|STARTED|Overall Study||105
8170476|NCT02450383|20143740|P2|NOT COMPLETED|Overall Study||0
8170477|NCT02450383|20143741|P1|NOT COMPLETED|Overall Study||0
8170478|NCT02450383|20143740|P2|COMPLETED|Overall Study||10
8170479|NCT02450383|20143741|P1|COMPLETED|Overall Study||10
8170480|NCT02450383|20143740|P2|STARTED|Overall Study||10
8170481|NCT02450383|20143741|P1|STARTED|Overall Study||10
8170482|NCT02450331|20143755|P2|NOT COMPLETED|Overall Study||406
8170483|NCT02450331|20143756|P1|NOT COMPLETED|Overall Study||403
8170484|NCT02450331|20143755|P2|COMPLETED|Overall Study||0
8170485|NCT02450331|20143756|P1|COMPLETED|Overall Study||0
8170486|NCT02450331|20143755|P2|STARTED|Overall Study||406
8170487|NCT02450331|20143756|P1|STARTED|Overall Study||403
8170488|NCT02449915|20143779|P2|NOT COMPLETED|Overall Study||4
8170489|NCT02449915|20143780|P1|NOT COMPLETED|Overall Study||2
8170490|NCT02449915|20143779|P2|COMPLETED|Overall Study||31
8170491|NCT02449915|20143780|P1|COMPLETED|Overall Study||33
8170492|NCT02449915|20143779|P2|STARTED|Overall Study||35
8170493|NCT02449915|20143780|P1|STARTED|Overall Study||35
8170494|NCT02449902|20143788|P2|NOT COMPLETED|Overall Study||2
8170495|NCT02449902|20143789|P1|NOT COMPLETED|Overall Study||0
8170496|NCT02449902|20143788|P2|COMPLETED|Overall Study||24
8170497|NCT02449902|20143789|P1|COMPLETED|Overall Study||24
8170498|NCT02449902|20143788|P2|STARTED|Overall Study||26
8170499|NCT02449902|20143789|P1|STARTED|Overall Study||24
8170500|NCT02449889|20143816|P3|NOT COMPLETED|Overall Study||1
8170501|NCT02449889|20143817|P2|NOT COMPLETED|Overall Study||6
8170502|NCT02449889|20143818|P1|NOT COMPLETED|Overall Study||1
8170503|NCT02449889|20143816|P3|COMPLETED|Overall Study||59
8170504|NCT02449889|20143817|P2|COMPLETED|Overall Study||52
8170505|NCT02449889|20143818|P1|COMPLETED|Overall Study||57
8170506|NCT02449889|20143816|P3|STARTED|Overall Study||60
8170507|NCT02449889|20143817|P2|STARTED|Overall Study||58
8170508|NCT02449889|20143818|P1|STARTED|Overall Study||58
8170509|NCT02449798|20143844|P1|NOT COMPLETED|Overall Study||0
8170510|NCT02449798|20143844|P1|COMPLETED|Overall Study||120
8170511|NCT02449798|20143844|P1|STARTED|Overall Study||120
8170512|NCT02449473|20143858|P2|NOT COMPLETED|Overall Study||0
8170513|NCT02449473|20143859|P1|NOT COMPLETED|Overall Study||0
8170514|NCT02449473|20143858|P2|COMPLETED|Overall Study||40
8170515|NCT02449473|20143859|P1|COMPLETED|Overall Study||39
8170516|NCT02449473|20143858|P2|STARTED|Overall Study||40
8170517|NCT02449473|20143859|P1|STARTED|Overall Study||39
8170518|NCT02449434|20143875|P2|NOT COMPLETED|Overall Study||0
8170519|NCT02449434|20143876|P1|NOT COMPLETED|Overall Study||0
8170520|NCT02449434|20143875|P2|COMPLETED|Overall Study||300
8170521|NCT02449434|20143876|P1|COMPLETED|Overall Study||300
8170522|NCT02449434|20143875|P2|STARTED|Overall Study||300
8170523|NCT02449434|20143876|P1|STARTED|Overall Study||300
8170524|NCT02449356|20143884|P2|NOT COMPLETED|Overall Study||0
8170525|NCT02449356|20143885|P1|NOT COMPLETED|Overall Study||0
8170526|NCT02449356|20143884|P2|COMPLETED|Overall Study||30
8170527|NCT02449356|20143885|P1|COMPLETED|Overall Study||30
8170528|NCT02449356|20143884|P2|STARTED|Overall Study||30
8170529|NCT02449356|20143885|P1|STARTED|Overall Study||30
8170530|NCT02449291|20143904|P3|NOT COMPLETED|Overall Study||1
8170531|NCT02449291|20143905|P2|NOT COMPLETED|Overall Study||2
8170532|NCT02449291|20143906|P1|NOT COMPLETED|Overall Study||5
8170533|NCT02449291|20143904|P3|COMPLETED|Overall Study||180
8170534|NCT02449291|20143905|P2|COMPLETED|Overall Study||186
8170535|NCT02449291|20143906|P1|COMPLETED|Overall Study||186
8170536|NCT02449291|20143904|P3|STARTED|Overall Study||181
8170537|NCT02449291|20143905|P2|STARTED|Overall Study||188
8170538|NCT02449291|20143906|P1|STARTED|Overall Study||191
8170539|NCT02449174|20143943|P2|NOT COMPLETED|Overall Study||0
8170540|NCT02449174|20143944|P1|NOT COMPLETED|Overall Study||0
8170541|NCT02449174|20143943|P2|COMPLETED|Overall Study||32
8170542|NCT02449174|20143944|P1|COMPLETED|Overall Study||36
8170543|NCT02449174|20143943|P2|STARTED|Overall Study||32
8170544|NCT02449174|20143944|P1|STARTED|Overall Study||36
8170545|NCT02449044|20143952|P1|NOT COMPLETED|Overall Study||64
8170546|NCT02449044|20143952|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
8170547|NCT02449044|20143952|P1|STARTED|Overall Study||111
8170548|NCT02449018|20143973|P2|NOT COMPLETED|Overall Study||2
8170549|NCT02449018|20143974|P1|NOT COMPLETED|Overall Study||12
8170550|NCT02449018|20143973|P2|COMPLETED|Overall Study||26
8170551|NCT02449018|20143974|P1|COMPLETED|Overall Study||52
8170552|NCT02449018|20143973|P2|STARTED|Overall Study||28
8170553|NCT02449018|20143974|P1|STARTED|Overall Study||64
8170554|NCT02448914|20144001|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8170555|NCT02448914|20144002|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8170556|NCT02448914|20144001|P2|COMPLETED|Second Intervention (1 Day)||5
8170557|NCT02448914|20144002|P1|COMPLETED|Second Intervention (1 Day)||6
8170558|NCT02448914|20144001|P2|STARTED|Second Intervention (1 Day)||5
8170559|NCT02448914|20144002|P1|STARTED|Second Intervention (1 Day)||6
8170560|NCT02448914|20144001|P2|NOT COMPLETED|First Intervention (1 Day)||0
8170561|NCT02448914|20144002|P1|NOT COMPLETED|First Intervention (1 Day)||0
8170562|NCT02448914|20144001|P2|COMPLETED|First Intervention (1 Day)||5
8170563|NCT02448914|20144002|P1|COMPLETED|First Intervention (1 Day)||6
8170564|NCT02448914|20144001|P2|STARTED|First Intervention (1 Day)||5
8170565|NCT02448914|20144002|P1|STARTED|First Intervention (1 Day)||6
8170566|NCT02448875|20144021|P3|NOT COMPLETED|Overall Study||1
8170567|NCT02448875|20144022|P2|NOT COMPLETED|Overall Study||1
8170568|NCT02448875|20144023|P1|NOT COMPLETED|Overall Study||7
8170569|NCT02448875|20144021|P3|COMPLETED|Overall Study||60
8170570|NCT02448875|20144022|P2|COMPLETED|Overall Study||20
8170571|NCT02448875|20144023|P1|COMPLETED|Overall Study||53
8170572|NCT02448875|20144021|P3|Safety Analysis Set|Overall Study||61
8170573|NCT02448875|20144022|P2|Safety Analysis Set|Overall Study||21
8170574|NCT02448875|20144023|P1|Safety Analysis Set|Overall Study||60
8170575|NCT02448875|20144021|P3|Full Analysis Set|Overall Study||61
8170576|NCT02448875|20144022|P2|Full Analysis Set|Overall Study||21
8170577|NCT02448875|20144023|P1|Full Analysis Set|Overall Study||60
8170578|NCT02448875|20144021|P3|Completed Dose Selection Phase|Overall Study||20
8170579|NCT02448875|20144022|P2|Completed Dose Selection Phase|Overall Study||21
8170580|NCT02448875|20144023|P1|Completed Dose Selection Phase|Overall Study||20
8170581|NCT02448875|20144021|P3|STARTED|Overall Study||61
8170582|NCT02448875|20144022|P2|STARTED|Overall Study||21
8170583|NCT02448875|20144023|P1|STARTED|Overall Study||60
8170584|NCT02448862|20144048|P2|NOT COMPLETED|Overall Study||0
8170585|NCT02448862|20144049|P1|NOT COMPLETED|Overall Study||0
8170586|NCT02448862|20144048|P2|COMPLETED|Overall Study||6050
8170587|NCT02448862|20144049|P1|COMPLETED|Overall Study||4525
8170588|NCT02448862|20144048|P2|STARTED|Overall Study||6050
8170589|NCT02448862|20144049|P1|STARTED|Overall Study||4525
8170590|NCT02448810|20144071|P8|NOT COMPLETED|Overall Study||8
8170591|NCT02448810|20144072|P7|NOT COMPLETED|Overall Study||18
8170592|NCT02448810|20144073|P6|NOT COMPLETED|Overall Study||16
8170593|NCT02448810|20144074|P5|NOT COMPLETED|Overall Study||31
8170594|NCT02448810|20144075|P4|NOT COMPLETED|Overall Study||3
8170595|NCT02448810|20144076|P3|NOT COMPLETED|Overall Study||3
8170596|NCT02448810|20144077|P2|NOT COMPLETED|Overall Study||3
8170597|NCT02448810|20144078|P1|NOT COMPLETED|Overall Study||3
8170598|NCT02448810|20144071|P8|COMPLETED|Overall Study||0
8170599|NCT02448810|20144072|P7|COMPLETED|Overall Study||0
8170600|NCT02448810|20144073|P6|COMPLETED|Overall Study||0
8170601|NCT02448810|20144074|P5|COMPLETED|Overall Study||0
8170602|NCT02448810|20144075|P4|COMPLETED|Overall Study||0
8170603|NCT02448810|20144076|P3|COMPLETED|Overall Study||0
8170604|NCT02448810|20144077|P2|COMPLETED|Overall Study||0
8170605|NCT02448810|20144078|P1|COMPLETED|Overall Study||0
8170606|NCT02448810|20144071|P8|Treated|Overall Study||7
8170607|NCT02448810|20144072|P7|Treated|Overall Study||18
8170608|NCT02448810|20144073|P6|Treated|Overall Study||13
8170609|NCT02448810|20144074|P5|Treated|Overall Study||29
8170610|NCT02448810|20144075|P4|Treated|Overall Study||3
8170611|NCT02448810|20144076|P3|Treated|Overall Study||3
8170612|NCT02448810|20144077|P2|Treated|Overall Study||3
8170613|NCT02448810|20144078|P1|Treated|Overall Study||3
8170614|NCT02448810|20144071|P8|STARTED|Overall Study||8
8170615|NCT02448810|20144072|P7|STARTED|Overall Study||18
8170616|NCT02448810|20144073|P6|STARTED|Overall Study||16
8170617|NCT02448810|20144074|P5|STARTED|Overall Study||31
8170618|NCT02448810|20144075|P4|STARTED|Overall Study||3
8170619|NCT02448810|20144076|P3|STARTED|Overall Study||3
8170620|NCT02448810|20144077|P2|STARTED|Overall Study||3
8170621|NCT02448810|20144078|P1|STARTED|Overall Study||3
8170622|NCT02448719|20144155|P11|NOT COMPLETED|Overall Study||0
8170623|NCT02448719|20144156|P10|NOT COMPLETED|Overall Study||0
8170624|NCT02448719|20144157|P9|NOT COMPLETED|Overall Study||0
8170625|NCT02448719|20144158|P8|NOT COMPLETED|Overall Study||0
8170626|NCT02448719|20144159|P7|NOT COMPLETED|Overall Study||0
8170627|NCT02448719|20144160|P6|NOT COMPLETED|Overall Study||0
8170628|NCT02448719|20144161|P5|NOT COMPLETED|Overall Study||1
8170629|NCT02448719|20144162|P4|NOT COMPLETED|Overall Study||0
8170630|NCT02448719|20144163|P3|NOT COMPLETED|Overall Study||0
8170631|NCT02448719|20144164|P2|NOT COMPLETED|Overall Study||0
8170632|NCT02448719|20144165|P1|NOT COMPLETED|Overall Study||0
8170633|NCT02448719|20144155|P11|COMPLETED|Overall Study||6
8170634|NCT02448719|20144156|P10|COMPLETED|Overall Study||6
8170635|NCT02448719|20144157|P9|COMPLETED|Overall Study||6
8170636|NCT02448719|20144158|P8|COMPLETED|Overall Study||6
8170637|NCT02448719|20144159|P7|COMPLETED|Overall Study||6
8170638|NCT02448719|20144160|P6|COMPLETED|Overall Study||6
8170639|NCT02448719|20144161|P5|COMPLETED|Overall Study||5
8170640|NCT02448719|20144162|P4|COMPLETED|Overall Study||6
8170641|NCT02448719|20144163|P3|COMPLETED|Overall Study||6
8170642|NCT02448719|20144164|P2|COMPLETED|Overall Study||6
8170643|NCT02448719|20144165|P1|COMPLETED|Overall Study||12
8170644|NCT02448719|20144155|P11|STARTED|Overall Study||6
8170645|NCT02448719|20144156|P10|STARTED|Overall Study||6
8170646|NCT02448719|20144157|P9|STARTED|Overall Study||6
8170647|NCT02448719|20144158|P8|STARTED|Overall Study||6
8170648|NCT02448719|20144159|P7|STARTED|Overall Study||6
8170649|NCT02448719|20144160|P6|STARTED|Overall Study||6
8170650|NCT02448719|20144161|P5|STARTED|Overall Study||6
8170651|NCT02448719|20144162|P4|STARTED|Overall Study||6
8170652|NCT02448719|20144163|P3|STARTED|Overall Study||6
8170653|NCT02448719|20144164|P2|STARTED|Overall Study||6
8170654|NCT02448719|20144165|P1|STARTED|Overall Study||12
8170655|NCT02448706|20144389|P2|NOT COMPLETED|Overall Study||4
8170656|NCT02448706|20144390|P1|NOT COMPLETED|Overall Study||5
8170657|NCT02448706|20144389|P2|COMPLETED|Overall Study||20
8170658|NCT02448706|20144390|P1|COMPLETED|Overall Study||20
8170659|NCT02448706|20144389|P2|Completed Baseline Testing|Overall Study||23
8170660|NCT02448706|20144390|P1|Completed Baseline Testing|Overall Study||24
8170661|NCT02448706|20144389|P2|Withdrew for Personal Reasons|Overall Study||1
8170662|NCT02448706|20144390|P1|Withdrew for Personal Reasons|Overall Study||1
8170663|NCT02448706|20144389|P2|STARTED|Overall Study||24
8170664|NCT02448706|20144390|P1|STARTED|Overall Study||25
8170665|NCT02448680|20144404|P2|NOT COMPLETED|Overall Study||3
8170666|NCT02448680|20144405|P1|NOT COMPLETED|Overall Study||1
8170667|NCT02448680|20144404|P2|COMPLETED|Overall Study||10
8170668|NCT02448680|20144405|P1|COMPLETED|Overall Study||11
8170669|NCT02448680|20144404|P2|STARTED|Overall Study||13
8170670|NCT02448680|20144405|P1|STARTED|Overall Study||12
8170671|NCT02448654|20144425|P2|NOT COMPLETED|Overall Study||4
8170672|NCT02448654|20144426|P1|NOT COMPLETED|Overall Study||3
8170673|NCT02448654|20144425|P2|COMPLETED|Overall Study||13
8170674|NCT02448654|20144426|P1|COMPLETED|Overall Study||16
8170675|NCT02448654|20144425|P2|Started Pills (Tolcapone or Placebo)|Overall Study||15
8170676|NCT02448654|20144426|P1|Started Pills (Tolcapone or Placebo)|Overall Study||17
8170677|NCT02448654|20144425|P2|STARTED|Overall Study||17
8170678|NCT02448654|20144426|P1|STARTED|Overall Study||19
8170679|NCT02448641|20144439|P3|NOT COMPLETED|Overall Study||4
8170680|NCT02448641|20144440|P2|NOT COMPLETED|Overall Study||5
8170681|NCT02448641|20144441|P1|NOT COMPLETED|Overall Study||1
8170682|NCT02448641|20144439|P3|COMPLETED|Overall Study||48
8170683|NCT02448641|20144440|P2|COMPLETED|Overall Study||51
8170684|NCT02448641|20144441|P1|COMPLETED|Overall Study||54
8170685|NCT02448641|20144439|P3|STARTED|Overall Study||52
8170686|NCT02448641|20144440|P2|STARTED|Overall Study||56
8170687|NCT02448641|20144441|P1|STARTED|Overall Study||55
8170688|NCT02448563|20144474|P2|NOT COMPLETED|Overall Study||11
8170689|NCT02448563|20144475|P1|NOT COMPLETED|Overall Study||16
8170690|NCT02448563|20144474|P2|COMPLETED|Overall Study||19
8170691|NCT02448563|20144475|P1|COMPLETED|Overall Study||16
8170692|NCT02448563|20144474|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
8170693|NCT02448563|20144475|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
8170694|NCT02448537|20144497|P3|NOT COMPLETED|Overall Study||1
8170695|NCT02448537|20144498|P2|NOT COMPLETED|Overall Study||1
8170696|NCT02448537|20144499|P1|NOT COMPLETED|Overall Study||1
8170697|NCT02448537|20144497|P3|COMPLETED|Overall Study||11
8170698|NCT02448537|20144498|P2|COMPLETED|Overall Study||9
8170699|NCT02448537|20144499|P1|COMPLETED|Overall Study||19
8170700|NCT02448537|20144497|P3|STARTED|Overall Study||12
8170701|NCT02448537|20144498|P2|STARTED|Overall Study||10
8170702|NCT02448537|20144499|P1|STARTED|Overall Study||20
8170703|NCT02448368|20144515|P13|NOT COMPLETED|Overall Study||0
8170704|NCT02448368|20144516|P12|NOT COMPLETED|Overall Study||0
8170705|NCT02448368|20144517|P11|NOT COMPLETED|Overall Study||0
8170706|NCT02448368|20144518|P10|NOT COMPLETED|Overall Study||0
8170707|NCT02448368|20144519|P9|NOT COMPLETED|Overall Study||0
8170708|NCT02448368|20144520|P8|NOT COMPLETED|Overall Study||0
8170709|NCT02448368|20144521|P7|NOT COMPLETED|Overall Study||0
8170710|NCT02448368|20144522|P6|NOT COMPLETED|Overall Study||0
8170711|NCT02448368|20144523|P5|NOT COMPLETED|Overall Study||0
8170712|NCT02448368|20144524|P4|NOT COMPLETED|Overall Study||0
8170713|NCT02448368|20144525|P3|NOT COMPLETED|Overall Study||0
8170714|NCT02448368|20144526|P2|NOT COMPLETED|Overall Study||0
8170715|NCT02448368|20144527|P1|NOT COMPLETED|Overall Study||0
8170716|NCT02448368|20144515|P13|COMPLETED|Overall Study||5
8170717|NCT02448368|20144516|P12|COMPLETED|Overall Study||5
8170718|NCT02448368|20144517|P11|COMPLETED|Overall Study||5
8170719|NCT02448368|20144518|P10|COMPLETED|Overall Study||2
8170720|NCT02448368|20144519|P9|COMPLETED|Overall Study||2
8170721|NCT02448368|20144520|P8|COMPLETED|Overall Study||2
8170722|NCT02448368|20144521|P7|COMPLETED|Overall Study||2
8170723|NCT02448368|20144522|P6|COMPLETED|Overall Study||2
8170724|NCT02448368|20144523|P5|COMPLETED|Overall Study||2
8170725|NCT02448368|20144524|P4|COMPLETED|Overall Study||2
8170726|NCT02448368|20144525|P3|COMPLETED|Overall Study||2
8170727|NCT02448368|20144526|P2|COMPLETED|Overall Study||2
8170728|NCT02448368|20144527|P1|COMPLETED|Overall Study||2
8170729|NCT02448368|20144515|P13|STARTED|Overall Study||5
8170730|NCT02448368|20144516|P12|STARTED|Overall Study||5
8170731|NCT02448368|20144517|P11|STARTED|Overall Study||5
8170732|NCT02448368|20144518|P10|STARTED|Overall Study||2
8170733|NCT02448368|20144519|P9|STARTED|Overall Study||2
8170734|NCT02448368|20144520|P8|STARTED|Overall Study||2
8170735|NCT02448368|20144521|P7|STARTED|Overall Study||2
8170736|NCT02448368|20144522|P6|STARTED|Overall Study||2
8170737|NCT02448368|20144523|P5|STARTED|Overall Study||2
8170738|NCT02448368|20144524|P4|STARTED|Overall Study||2
8170739|NCT02448368|20144525|P3|STARTED|Overall Study||2
8170740|NCT02448368|20144526|P2|STARTED|Overall Study||2
8170741|NCT02448368|20144527|P1|STARTED|Overall Study||2
8170742|NCT02448303|20144604|P2|NOT COMPLETED|Overall Study||36
8170743|NCT02448303|20144605|P1|NOT COMPLETED|Overall Study||38
8170744|NCT02448303|20144604|P2|COMPLETED|Overall Study||0
8170745|NCT02448303|20144605|P1|COMPLETED|Overall Study||0
8170746|NCT02448303|20144604|P2|Discontinued Study|Overall Study||36
8170747|NCT02448303|20144605|P1|Discontinued Study|Overall Study||38
8170748|NCT02448303|20144604|P2|Received Study Medication|Overall Study||35
8170749|NCT02448303|20144605|P1|Received Study Medication|Overall Study||33
8170750|NCT02448303|20144604|P2|Enrolled|Overall Study||36
8170751|NCT02448303|20144605|P1|Enrolled|Overall Study||38
8170752|NCT02448303|20144604|P2|STARTED|Overall Study||36
8170753|NCT02448303|20144605|P1|STARTED|Overall Study||38
8170754|NCT02448043|20144613|P2|NOT COMPLETED|Overall Study||4
8170755|NCT02448043|20144614|P1|NOT COMPLETED|Overall Study||3
8170756|NCT02448043|20144613|P2|COMPLETED|Overall Study||18
8170757|NCT02448043|20144614|P1|COMPLETED|Overall Study||20
8170758|NCT02448043|20144613|P2|STARTED|Overall Study||22
8170759|NCT02448043|20144614|P1|STARTED|Overall Study||23
8170760|NCT02447952|20144632|P1|NOT COMPLETED|Overall Study||7
8170761|NCT02447952|20144632|P1|COMPLETED|Overall Study||18
8170762|NCT02447952|20144632|P1|STARTED|Overall Study||25
8170763|NCT02447926|20144684|P1|NOT COMPLETED|Overall Study||0
8170764|NCT02447926|20144684|P1|COMPLETED|Overall Study||1
8170765|NCT02447926|20144684|P1|STARTED|Overall Study||1
8170766|NCT02447887|20144689|P1|NOT COMPLETED|Overall Study||3
8170767|NCT02447887|20144689|P1|COMPLETED|Overall Study||0
8170768|NCT02447887|20144689|P1|STARTED|Overall Study||3
8170769|NCT02447848|20144702|P1|NOT COMPLETED|Overall Study||11
8170770|NCT02447848|20144702|P1|COMPLETED|Overall Study||65
8170771|NCT02447848|20144702|P1|STARTED|Overall Study||76
8170772|NCT02447575|20144708|P1|NOT COMPLETED|Overall Study||0
8170773|NCT02447575|20144708|P1|COMPLETED|Overall Study||23
8170774|NCT02447575|20144708|P1|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
8170775|NCT02447497|20144716|P4|NOT COMPLETED|Overall Study||2
8170776|NCT02447497|20144717|P3|NOT COMPLETED|Overall Study||2
8170777|NCT02447497|20144718|P2|NOT COMPLETED|Overall Study||6
8170778|NCT02447497|20144719|P1|NOT COMPLETED|Overall Study||6
8170779|NCT02447497|20144716|P4|COMPLETED|Overall Study||21
8170780|NCT02447497|20144717|P3|COMPLETED|Overall Study||21
8170781|NCT02447497|20144718|P2|COMPLETED|Overall Study||19
8170782|NCT02447497|20144719|P1|COMPLETED|Overall Study||19
8170783|NCT02447497|20144716|P4|STARTED|Overall Study||23
8170784|NCT02447497|20144717|P3|STARTED|Overall Study||23
8170785|NCT02447497|20144718|P2|STARTED|Overall Study||25
8170786|NCT02447497|20144719|P1|STARTED|Overall Study||25
8170787|NCT02447458|20144743|P6|NOT COMPLETED|Overall Study||0
8170788|NCT02447458|20144744|P5|NOT COMPLETED|Overall Study||0
8170789|NCT02447458|20144745|P4|NOT COMPLETED|Overall Study||0
8170790|NCT02447458|20144746|P3|NOT COMPLETED|Overall Study||1
8170791|NCT02447458|20144747|P2|NOT COMPLETED|Overall Study||0
8170792|NCT02447458|20144748|P1|NOT COMPLETED|Overall Study||0
8170793|NCT02447458|20144743|P6|COMPLETED|Overall Study||10
8170794|NCT02447458|20144744|P5|COMPLETED|Overall Study||6
8170795|NCT02447458|20144745|P4|COMPLETED|Overall Study||6
8170796|NCT02447458|20144746|P3|COMPLETED|Overall Study||5
8170797|NCT02447458|20144747|P2|COMPLETED|Overall Study||6
8170798|NCT02447458|20144748|P1|COMPLETED|Overall Study||5
8170799|NCT02447458|20144743|P6|STARTED|Overall Study||10
8170800|NCT02447458|20144744|P5|STARTED|Overall Study||6
8170801|NCT02447458|20144745|P4|STARTED|Overall Study||6
8170802|NCT02447458|20144746|P3|STARTED|Overall Study||6
8170803|NCT02447458|20144747|P2|STARTED|Overall Study||6
8170804|NCT02447458|20144748|P1|STARTED|Overall Study||5
8170805|NCT02447432|20144846|P2|NOT COMPLETED|Epoch 002||0
8170806|NCT02447432|20144847|P1|NOT COMPLETED|Epoch 002||0
8170807|NCT02447432|20144846|P2|COMPLETED|Epoch 002||145
8170808|NCT02447432|20144847|P1|COMPLETED|Epoch 002||152
8170809|NCT02447432|20144846|P2|STARTED|Epoch 002||145
8170810|NCT02447432|20144847|P1|STARTED|Epoch 002||152
8170811|NCT02447432|20144846|P2|NOT COMPLETED|Epoch 001||13
8170812|NCT02447432|20144847|P1|NOT COMPLETED|Epoch 001||5
8170813|NCT02447432|20144846|P2|COMPLETED|Epoch 001||147
8170814|NCT02447432|20144847|P1|COMPLETED|Epoch 001||155
8170815|NCT02447432|20144846|P2|STARTED|Epoch 001||160
8170816|NCT02447432|20144847|P1|STARTED|Epoch 001||160
8170817|NCT02447328|20144879|P1|NOT COMPLETED|Overall Study||1
8170818|NCT02447328|20144879|P1|COMPLETED|Overall Study||82
8170819|NCT02447328|20144879|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
8170820|NCT02447250|20144883|P1|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
8170821|NCT02447250|20144883|P1|COMPLETED|Third Dose (360 mcg Albuterol)||8
8170822|NCT02447250|20144883|P1|STARTED|Third Dose (360 mcg Albuterol)||13
8170823|NCT02447250|20144883|P1|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
8170824|NCT02447250|20144883|P1|COMPLETED|Second Dose (270 mcg Albuterol)||13
8170825|NCT02447250|20144883|P1|STARTED|Second Dose (270 mcg Albuterol)||14
8170826|NCT02447250|20144883|P1|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
8170827|NCT02447250|20144883|P1|COMPLETED|First Dose (180 mcg Albuterol)||14
8170828|NCT02447250|20144883|P1|STARTED|First Dose (180 mcg Albuterol)||14
8170829|NCT02447133|20144894|P1|NOT COMPLETED|Overall Study||0
8170830|NCT02447133|20144894|P1|COMPLETED|Overall Study||12
8170831|NCT02447133|20144894|P1|STARTED|Overall Study||12
8170832|NCT02447081|20144900|P1|NOT COMPLETED|Overall Study||224
8170833|NCT02447081|20144900|P1|COMPLETED|Overall Study||864
8170834|NCT02447081|20144900|P1|STARTED|Overall Study||1088
8170835|NCT02447029|20144916|P2|NOT COMPLETED|Overall Study||2
8170836|NCT02447029|20144917|P1|NOT COMPLETED|Overall Study||3
8170837|NCT02447029|20144916|P2|COMPLETED|Overall Study||68
8170838|NCT02447029|20144917|P1|COMPLETED|Overall Study||69
8170839|NCT02447029|20144916|P2|Treated|Overall Study||68
8170840|NCT02447029|20144917|P1|Treated|Overall Study||69
8170841|NCT02447029|20144916|P2|STARTED|Overall Study||70
8170842|NCT02447029|20144917|P1|STARTED|Overall Study||72
8170843|NCT02447003|20144937|P2|NOT COMPLETED|Overall Study||84
8170844|NCT02447003|20144938|P1|NOT COMPLETED|Overall Study||170
8170845|NCT02447003|20144937|P2|COMPLETED|Overall Study||0
8170846|NCT02447003|20144938|P1|COMPLETED|Overall Study||0
8170847|NCT02447003|20144937|P2|STARTED|Overall Study||84
8170848|NCT02447003|20144938|P1|STARTED|Overall Study||170
8170849|NCT02446990|20144974|P2|NOT COMPLETED|Overall Study||658
8170850|NCT02446990|20144975|P1|NOT COMPLETED|Overall Study||720
8170851|NCT02446990|20144974|P2|COMPLETED|Overall Study||8894
8170852|NCT02446990|20144975|P1|COMPLETED|Overall Study||8830
8170853|NCT02446990|20144974|P2|STARTED|Overall Study||9552
8170854|NCT02446990|20144975|P1|STARTED|Overall Study||9550
8170855|NCT02446912|20145010|P3|NOT COMPLETED|Overall Study||35
8170856|NCT02446912|20145011|P2|NOT COMPLETED|Overall Study||35
8170857|NCT02446912|20145012|P1|NOT COMPLETED|Overall Study||18
8170858|NCT02446912|20145010|P3|COMPLETED|Overall Study||149
8170859|NCT02446912|20145011|P2|COMPLETED|Overall Study||145
8170860|NCT02446912|20145012|P1|COMPLETED|Overall Study||75
8170861|NCT02446912|20145010|P3|Participants Who Completed Week 52|Overall Study||157
8170862|NCT02446912|20145011|P2|Participants Who Completed Week 52|Overall Study||153
8170863|NCT02446912|20145012|P1|Participants Who Completed Week 52|Overall Study||80
8170864|NCT02446912|20145010|P3|STARTED|Overall Study||184
8170865|NCT02446912|20145011|P2|STARTED|Overall Study||180
8170866|NCT02446912|20145012|P1|STARTED|Overall Study||93
8170867|NCT02446899|20145085|P2|NOT COMPLETED|Overall Study||48
8170868|NCT02446899|20145086|P1|NOT COMPLETED|Overall Study||25
8170869|NCT02446899|20145085|P2|COMPLETED|Overall Study||136
8170870|NCT02446899|20145086|P1|COMPLETED|Overall Study||156
8170871|NCT02446899|20145085|P2|Received Study Drug|Overall Study||182
8170872|NCT02446899|20145086|P1|Received Study Drug|Overall Study||180
8170873|NCT02446899|20145085|P2|STARTED|Overall Study||184
8170874|NCT02446899|20145086|P1|STARTED|Overall Study||181
8170875|NCT02446886|20145112|P2|NOT COMPLETED|Overall Study||4
8170876|NCT02446886|20145113|P1|NOT COMPLETED|Overall Study||2
8170877|NCT02446886|20145112|P2|COMPLETED|Overall Study||3
8170878|NCT02446886|20145113|P1|COMPLETED|Overall Study||6
8170879|NCT02446886|20145112|P2|STARTED|Overall Study||7
8170880|NCT02446886|20145113|P1|STARTED|Overall Study||8
8170881|NCT02446847|20145131|P2|NOT COMPLETED|Overall Study||2
8170882|NCT02446847|20145132|P1|NOT COMPLETED|Overall Study||0
8170883|NCT02446847|20145131|P2|COMPLETED|Overall Study||6
8170884|NCT02446847|20145132|P1|COMPLETED|Overall Study||8
8170885|NCT02446847|20145131|P2|STARTED|Overall Study||8
8170886|NCT02446847|20145132|P1|STARTED|Overall Study||8
8170887|NCT02446769|20145142|P3|NOT COMPLETED|Study Period||0
8170888|NCT02446769|20145143|P2|NOT COMPLETED|Study Period||2
8170889|NCT02446769|20145144|P1|NOT COMPLETED|Study Period||0
8170890|NCT02446769|20145142|P3|COMPLETED|Study Period||3
8170891|NCT02446769|20145143|P2|COMPLETED|Study Period||2
8170892|NCT02446769|20145144|P1|COMPLETED|Study Period||0
8170893|NCT02446769|20145142|P3|STARTED|Study Period||3
8170894|NCT02446769|20145143|P2|STARTED|Study Period||4
8170895|NCT02446769|20145144|P1|STARTED|Study Period||0
8170896|NCT02446769|20145142|P3|NOT COMPLETED|Screening Period||0
8170897|NCT02446769|20145143|P2|NOT COMPLETED|Screening Period||0
8170898|NCT02446769|20145144|P1|NOT COMPLETED|Screening Period||11
8170899|NCT02446769|20145142|P3|COMPLETED|Screening Period||0
8170900|NCT02446769|20145143|P2|COMPLETED|Screening Period||0
8170901|NCT02446769|20145144|P1|COMPLETED|Screening Period||7
8170902|NCT02446769|20145142|P3|STARTED|Screening Period||0
8170903|NCT02446769|20145143|P2|STARTED|Screening Period||0
8170904|NCT02446769|20145144|P1|STARTED|Screening Period||18
8170905|NCT02446743|20145167|P2|NOT COMPLETED|Overall Study||5
8170906|NCT02446743|20145168|P1|NOT COMPLETED|Overall Study||5
8170907|NCT02446743|20145167|P2|COMPLETED|Overall Study||250
8170908|NCT02446743|20145168|P1|COMPLETED|Overall Study||271
8170909|NCT02446743|20145167|P2|STARTED|Overall Study||255
8170910|NCT02446743|20145168|P1|STARTED|Overall Study||276
8170911|NCT02446717|20145323|P5|NOT COMPLETED|Overall Study||1
8170912|NCT02446717|20145324|P4|NOT COMPLETED|Overall Study||1
8170913|NCT02446717|20145325|P3|NOT COMPLETED|Overall Study||2
8170914|NCT02446717|20145326|P2|NOT COMPLETED|Overall Study||1
8170915|NCT02446717|20145327|P1|NOT COMPLETED|Overall Study||0
8170916|NCT02446717|20145323|P5|COMPLETED|Overall Study||46
8170917|NCT02446717|20145324|P4|COMPLETED|Overall Study||43
8170918|NCT02446717|20145325|P3|COMPLETED|Overall Study||20
8170919|NCT02446717|20145326|P2|COMPLETED|Overall Study||21
8170920|NCT02446717|20145327|P1|COMPLETED|Overall Study||6
8170921|NCT02446717|20145323|P5|STARTED|Overall Study||47
8170922|NCT02446717|20145324|P4|STARTED|Overall Study||44
8170923|NCT02446717|20145325|P3|STARTED|Overall Study||22
8170924|NCT02446717|20145326|P2|STARTED|Overall Study||22
8170925|NCT02446717|20145327|P1|STARTED|Overall Study||6
8170926|NCT02446691|20145354|P1|NOT COMPLETED|Overall Study||11
8170927|NCT02446691|20145354|P1|COMPLETED|Overall Study||117
8170928|NCT02446691|20145354|P1|STARTED|Overall Study||128
8170929|NCT02446613|20145374|P2|NOT COMPLETED|Overall Study||0
8170930|NCT02446613|20145375|P1|NOT COMPLETED|Overall Study||0
8170931|NCT02446613|20145374|P2|COMPLETED|Overall Study||10
8170932|NCT02446613|20145375|P1|COMPLETED|Overall Study||6
8170933|NCT02446613|20145374|P2|STARTED|Overall Study||10
8170934|NCT02446613|20145375|P1|STARTED|Overall Study||6
8170935|NCT02446496|20145397|P1|NOT COMPLETED|Overall Study||0
8170936|NCT02446496|20145397|P1|COMPLETED|Overall Study||24
8170937|NCT02446496|20145397|P1|STARTED|Overall Study||24
8170938|NCT02446483|20145409|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
8170939|NCT02446483|20145410|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
8170940|NCT02446483|20145409|P2|COMPLETED|Period 3: Intervention Period 2||30
8170941|NCT02446483|20145410|P1|COMPLETED|Period 3: Intervention Period 2||30
8170942|NCT02446483|20145409|P2|STARTED|Period 3: Intervention Period 2||30
8170943|NCT02446483|20145410|P1|STARTED|Period 3: Intervention Period 2||30
8170944|NCT02446483|20145409|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8170945|NCT02446483|20145410|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8170946|NCT02446483|20145409|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
8170947|NCT02446483|20145410|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
8170948|NCT02446483|20145409|P2|STARTED|Period 2: Washout Period (7 Days)||30
8170949|NCT02446483|20145410|P1|STARTED|Period 2: Washout Period (7 Days)||30
8170950|NCT02446483|20145409|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
8170951|NCT02446483|20145410|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
8170952|NCT02446483|20145409|P2|COMPLETED|Period 1: Intervention Period 1||30
8170953|NCT02446483|20145410|P1|COMPLETED|Period 1: Intervention Period 1||30
8170954|NCT02446483|20145409|P2|STARTED|Period 1: Intervention Period 1||30
8170955|NCT02446483|20145410|P1|STARTED|Period 1: Intervention Period 1||30
8170956|NCT02446418|20145424|P2|NOT COMPLETED|Overall Study||16
8170957|NCT02446418|20145425|P1|NOT COMPLETED|Overall Study||18
8170958|NCT02446418|20145424|P2|COMPLETED|Overall Study||194
8170959|NCT02446418|20145425|P1|COMPLETED|Overall Study||192
8170960|NCT02446418|20145424|P2|STARTED|Overall Study||210
8170961|NCT02446418|20145425|P1|STARTED|Overall Study||210
8170962|NCT02446314|20145439|P4|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
8170963|NCT02446314|20145440|P3|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
8170964|NCT02446314|20145441|P2|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
8170965|NCT02446314|20145442|P1|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
8170966|NCT02446314|20145439|P4|COMPLETED|Thirteen to Twenty Four Weeks||28
8170967|NCT02446314|20145440|P3|COMPLETED|Thirteen to Twenty Four Weeks||29
8170968|NCT02446314|20145441|P2|COMPLETED|Thirteen to Twenty Four Weeks||28
8170969|NCT02446314|20145442|P1|COMPLETED|Thirteen to Twenty Four Weeks||27
8170970|NCT02446314|20145439|P4|STARTED|Thirteen to Twenty Four Weeks||29
8170971|NCT02446314|20145440|P3|STARTED|Thirteen to Twenty Four Weeks||31
8170972|NCT02446314|20145441|P2|STARTED|Thirteen to Twenty Four Weeks||29
8170973|NCT02446314|20145442|P1|STARTED|Thirteen to Twenty Four Weeks||27
8170974|NCT02446314|20145439|P4|NOT COMPLETED|Zero to Twelve Weeks.||2
8170975|NCT02446314|20145440|P3|NOT COMPLETED|Zero to Twelve Weeks.||0
8170976|NCT02446314|20145441|P2|NOT COMPLETED|Zero to Twelve Weeks.||1
8170977|NCT02446314|20145442|P1|NOT COMPLETED|Zero to Twelve Weeks.||3
8170978|NCT02446314|20145439|P4|COMPLETED|Zero to Twelve Weeks.||29
8170979|NCT02446314|20145440|P3|COMPLETED|Zero to Twelve Weeks.||31
8170980|NCT02446314|20145441|P2|COMPLETED|Zero to Twelve Weeks.||29
8170981|NCT02446314|20145442|P1|COMPLETED|Zero to Twelve Weeks.||27
8170982|NCT02446314|20145439|P4|STARTED|Zero to Twelve Weeks.||31
8170983|NCT02446314|20145440|P3|STARTED|Zero to Twelve Weeks.||31
8170984|NCT02446314|20145441|P2|STARTED|Zero to Twelve Weeks.||30
8170985|NCT02446314|20145442|P1|STARTED|Zero to Twelve Weeks.||30
8170986|NCT02446223|20145488|P1|NOT COMPLETED|Overall Study||1
8170987|NCT02446223|20145488|P1|COMPLETED|Overall Study||20
8170988|NCT02446223|20145488|P1|STARTED|Overall Study||21
8170989|NCT02446171|20145496|P4|NOT COMPLETED|Overall Study||0
8170990|NCT02446171|20145497|P3|NOT COMPLETED|Overall Study||2
8170991|NCT02446171|20145498|P2|NOT COMPLETED|Overall Study||0
8170992|NCT02446171|20145499|P1|NOT COMPLETED|Overall Study||0
8170993|NCT02446171|20145496|P4|COMPLETED|Overall Study||11
8170994|NCT02446171|20145497|P3|COMPLETED|Overall Study||9
8170995|NCT02446171|20145498|P2|COMPLETED|Overall Study||11
8170996|NCT02446171|20145499|P1|COMPLETED|Overall Study||11
8170997|NCT02446171|20145496|P4|STARTED|Overall Study||11
8170998|NCT02446171|20145497|P3|STARTED|Overall Study||11
8170999|NCT02446171|20145498|P2|STARTED|Overall Study||11
8171000|NCT02446171|20145499|P1|STARTED|Overall Study||11
8171001|NCT02446015|20145570|P2|NOT COMPLETED|Overall Study||1
8171002|NCT02446015|20145571|P1|NOT COMPLETED|Overall Study||1
8171003|NCT02446015|20145570|P2|COMPLETED|Overall Study||62
8171004|NCT02446015|20145571|P1|COMPLETED|Overall Study||33
8171005|NCT02446015|20145570|P2|STARTED|Overall Study||63
8171006|NCT02446015|20145571|P1|STARTED|Overall Study||34
8171019|NCT02445911|20145615|P4|NOT COMPLETED|Overall Study||0
8171020|NCT02445911|20145616|P3|NOT COMPLETED|Overall Study||0
8171021|NCT02445911|20145617|P2|NOT COMPLETED|Overall Study||0
8171022|NCT02445911|20145618|P1|NOT COMPLETED|Overall Study||0
8171023|NCT02445911|20145615|P4|COMPLETED|Overall Study||20
8171024|NCT02445911|20145616|P3|COMPLETED|Overall Study||21
8171025|NCT02445911|20145617|P2|COMPLETED|Overall Study||20
8171026|NCT02445911|20145618|P1|COMPLETED|Overall Study||20
8171027|NCT02445911|20145615|P4|STARTED|Overall Study||20
8171028|NCT02445911|20145616|P3|STARTED|Overall Study||21
8171029|NCT02445911|20145617|P2|STARTED|Overall Study||20
8171030|NCT02445911|20145618|P1|STARTED|Overall Study||20
8171031|NCT02445859|20145690|P2|NOT COMPLETED|Overall Study||3
8171032|NCT02445859|20145691|P1|NOT COMPLETED|Overall Study||2
8171033|NCT02445859|20145690|P2|COMPLETED|Overall Study||42
8171034|NCT02445859|20145691|P1|COMPLETED|Overall Study||43
8171035|NCT02445859|20145690|P2|STARTED|Overall Study||45
8171036|NCT02445859|20145691|P1|STARTED|Overall Study||45
8171037|NCT02445807|20145699|P2|NOT COMPLETED|Overall Study||0
8171038|NCT02445807|20145700|P1|NOT COMPLETED|Overall Study||0
8171039|NCT02445807|20145699|P2|COMPLETED|Overall Study||89
8171040|NCT02445807|20145700|P1|COMPLETED|Overall Study||176
8171041|NCT02445807|20145699|P2|STARTED|Overall Study||89
8171042|NCT02445807|20145700|P1|STARTED|Overall Study||176
8171043|NCT02445794|20145714|P4|NOT COMPLETED|Overall Study||0
8171044|NCT02445794|20145715|P3|NOT COMPLETED|Overall Study||2
8171045|NCT02445794|20145716|P2|NOT COMPLETED|Overall Study||0
8171046|NCT02445794|20145717|P1|NOT COMPLETED|Overall Study||0
8171047|NCT02445794|20145714|P4|COMPLETED|Overall Study||3
8171048|NCT02445794|20145715|P3|COMPLETED|Overall Study||5
8171049|NCT02445794|20145716|P2|COMPLETED|Overall Study||3
8171050|NCT02445794|20145717|P1|COMPLETED|Overall Study||6
8171051|NCT02445794|20145714|P4|STARTED|Overall Study||3
8171052|NCT02445794|20145715|P3|STARTED|Overall Study||7
8171053|NCT02445794|20145716|P2|STARTED|Overall Study||3
8171054|NCT02445794|20145717|P1|STARTED|Overall Study||6
8171055|NCT02445755|20145747|P1|NOT COMPLETED|Overall Study||13
8171056|NCT02445755|20145747|P1|COMPLETED|Overall Study||100
8171057|NCT02445755|20145747|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
8171058|NCT02445625|20145754|P1|NOT COMPLETED|Overall Study||0
8171059|NCT02445625|20145754|P1|COMPLETED|Overall Study||15
8171060|NCT02445625|20145754|P1|STARTED|Overall Study||15
8171061|NCT02445586|20145761|P1|NOT COMPLETED|Overall Study||39
8171062|NCT02445586|20145761|P1|COMPLETED|Overall Study||13
8171063|NCT02445586|20145761|P1|Received at Least One Dose of Study Drug|Overall Study||52
8171064|NCT02445586|20145761|P1|STARTED|Overall Study||52
8171065|NCT02445573|20145801|P2|NOT COMPLETED|Overall Study||2
8171066|NCT02445573|20145802|P1|NOT COMPLETED|Overall Study||1
8171067|NCT02445573|20145801|P2|COMPLETED|Overall Study||38
8171068|NCT02445573|20145802|P1|COMPLETED|Overall Study||39
8171069|NCT02445573|20145801|P2|STARTED|Overall Study||40
8171070|NCT02445573|20145802|P1|STARTED|Overall Study||40
8171071|NCT02445326|20145818|P2|NOT COMPLETED|Overall Study||1
8171072|NCT02445326|20145819|P1|NOT COMPLETED|Overall Study||2
8171073|NCT02445326|20145818|P2|COMPLETED|Overall Study||37
8171074|NCT02445326|20145819|P1|COMPLETED|Overall Study||33
8171075|NCT02445326|20145818|P2|STARTED|Overall Study||38
8171076|NCT02445326|20145819|P1|STARTED|Overall Study||35
8171077|NCT02445287|20145837|P2|NOT COMPLETED|Overall Study||0
8171078|NCT02445287|20145838|P1|NOT COMPLETED|Overall Study||0
8171079|NCT02445287|20145837|P2|COMPLETED|Overall Study||13
8171080|NCT02445287|20145838|P1|COMPLETED|Overall Study||35
8171081|NCT02445287|20145837|P2|STARTED|Overall Study||13
8171082|NCT02445287|20145838|P1|STARTED|Overall Study||35
8171083|NCT02445196|20145853|P2|NOT COMPLETED|Overall Study||6
8171084|NCT02445196|20145854|P1|NOT COMPLETED|Overall Study||11
8171085|NCT02445196|20145853|P2|COMPLETED|Overall Study||52
8171086|NCT02445196|20145854|P1|COMPLETED|Overall Study||51
8171087|NCT02445196|20145853|P2|STARTED|Overall Study||58
8171088|NCT02445196|20145854|P1|STARTED|Overall Study||62
8171089|NCT02445027|20145867|P1|NOT COMPLETED|Overall Study||15
8171090|NCT02445027|20145867|P1|COMPLETED|Overall Study||45
8171091|NCT02445027|20145867|P1|STARTED|Overall Study||60
8171092|NCT02445014|20145871|P1|NOT COMPLETED|Overall Study||0
8171093|NCT02445014|20145871|P1|COMPLETED|Overall Study||3
8171094|NCT02445014|20145871|P1|STARTED|Overall Study||3
8171095|NCT02444988|20145877|P2|NOT COMPLETED|Overall Study||0
8171096|NCT02444988|20145878|P1|NOT COMPLETED|Overall Study||0
8171097|NCT02444988|20145877|P2|COMPLETED|Overall Study||2735
8171098|NCT02444988|20145878|P1|COMPLETED|Overall Study||2646
8171099|NCT02444988|20145877|P2|STARTED|Overall Study||2735
8171100|NCT02444988|20145878|P1|STARTED|Overall Study||2646
8171101|NCT02444936|20145888|P2|NOT COMPLETED|Overall Study||0
8171102|NCT02444936|20145889|P1|NOT COMPLETED|Overall Study||0
8171103|NCT02444936|20145888|P2|COMPLETED|Overall Study||12
8171104|NCT02444936|20145889|P1|COMPLETED|Overall Study||10
8171105|NCT02444936|20145888|P2|STARTED|Overall Study||12
8171106|NCT02444936|20145889|P1|STARTED|Overall Study||10
8171107|NCT02444793|20145899|P4|NOT COMPLETED|Overall Study||3
8171108|NCT02444793|20145900|P3|NOT COMPLETED|Overall Study||4
8171109|NCT02444793|20145901|P2|NOT COMPLETED|Overall Study||6
8171110|NCT02444793|20145902|P1|NOT COMPLETED|Overall Study||11
8171111|NCT02444793|20145899|P4|COMPLETED|Overall Study||0
8171112|NCT02444793|20145900|P3|COMPLETED|Overall Study||0
8171113|NCT02444793|20145901|P2|COMPLETED|Overall Study||0
8171114|NCT02444793|20145902|P1|COMPLETED|Overall Study||0
8171115|NCT02444793|20145899|P4|STARTED|Overall Study||3
8171116|NCT02444793|20145900|P3|STARTED|Overall Study||4
8171117|NCT02444793|20145901|P2|STARTED|Overall Study||6
8171118|NCT02444793|20145902|P1|STARTED|Overall Study||11
8171119|NCT02444715|20146029|P2|NOT COMPLETED|Overall Study||16
8171120|NCT02444715|20146030|P1|NOT COMPLETED|Overall Study||10
8171121|NCT02444715|20146029|P2|COMPLETED|Overall Study||32
8171122|NCT02444715|20146030|P1|COMPLETED|Overall Study||36
8171123|NCT02444715|20146029|P2|STARTED|Overall Study||48
8171124|NCT02444715|20146030|P1|STARTED|Overall Study||46
8171125|NCT02444533|20146061|P2|NOT COMPLETED|Overall Study||4
8171126|NCT02444533|20146062|P1|NOT COMPLETED|Overall Study||2
8171127|NCT02444533|20146061|P2|COMPLETED|Overall Study||18
8171128|NCT02444533|20146062|P1|COMPLETED|Overall Study||15
8171129|NCT02444533|20146061|P2|STARTED|Overall Study||22
8171130|NCT02444533|20146062|P1|STARTED|Overall Study||17
8171131|NCT02444234|20146076|P2|NOT COMPLETED|Second Intervention (3 Days)||0
8171132|NCT02444234|20146077|P1|NOT COMPLETED|Second Intervention (3 Days)||0
8171133|NCT02444234|20146076|P2|COMPLETED|Second Intervention (3 Days)||5
8171134|NCT02444234|20146077|P1|COMPLETED|Second Intervention (3 Days)||6
8171135|NCT02444234|20146076|P2|STARTED|Second Intervention (3 Days)||5
8171136|NCT02444234|20146077|P1|STARTED|Second Intervention (3 Days)||6
8171137|NCT02444234|20146076|P2|NOT COMPLETED|Washout (2 Day Minimum)||0
8171138|NCT02444234|20146077|P1|NOT COMPLETED|Washout (2 Day Minimum)||0
8171139|NCT02444234|20146076|P2|COMPLETED|Washout (2 Day Minimum)||5
8171140|NCT02444234|20146077|P1|COMPLETED|Washout (2 Day Minimum)||6
8171141|NCT02444234|20146076|P2|STARTED|Washout (2 Day Minimum)||5
8171142|NCT02444234|20146077|P1|STARTED|Washout (2 Day Minimum)||6
8171143|NCT02444234|20146076|P2|NOT COMPLETED|First Intervention (3 Days)||0
8171144|NCT02444234|20146077|P1|NOT COMPLETED|First Intervention (3 Days)||0
8171145|NCT02444234|20146076|P2|COMPLETED|First Intervention (3 Days)||5
8171146|NCT02444234|20146077|P1|COMPLETED|First Intervention (3 Days)||6
8171147|NCT02444234|20146076|P2|STARTED|First Intervention (3 Days)||5
8171148|NCT02444234|20146077|P1|STARTED|First Intervention (3 Days)||6
8171149|NCT02444182|20146095|P2|NOT COMPLETED|Overall Study||5
8171150|NCT02444182|20146096|P1|NOT COMPLETED|Overall Study||2
8171151|NCT02444182|20146095|P2|COMPLETED|Overall Study||49
8171152|NCT02444182|20146096|P1|COMPLETED|Overall Study||52
8171153|NCT02444182|20146095|P2|STARTED|Overall Study||54
8171154|NCT02444182|20146096|P1|STARTED|Overall Study||54
8171155|NCT02444143|20146106|P2|NOT COMPLETED|Overall Study||1
8171156|NCT02444143|20146107|P1|NOT COMPLETED|Overall Study||0
8171157|NCT02444143|20146106|P2|COMPLETED|Overall Study|1 patient withdrawal|9
8171158|NCT02444143|20146107|P1|COMPLETED|Overall Study||10
8171159|NCT02444143|20146106|P2|STARTED|Overall Study||10
8171160|NCT02444143|20146107|P1|STARTED|Overall Study||10
8171161|NCT02443883|20146119|P4|NOT COMPLETED|Overall Study||5
8171162|NCT02443883|20146120|P3|NOT COMPLETED|Overall Study||1
8171163|NCT02443883|20146121|P2|NOT COMPLETED|Overall Study||4
8171164|NCT02443883|20146122|P1|NOT COMPLETED|Overall Study||6
8171165|NCT02443883|20146119|P4|COMPLETED|Overall Study||36
8171166|NCT02443883|20146120|P3|COMPLETED|Overall Study||40
8171167|NCT02443883|20146121|P2|COMPLETED|Overall Study||38
8171168|NCT02443883|20146122|P1|COMPLETED|Overall Study||34
8171169|NCT02443883|20146119|P4|Received at Least One Dose of Study Drug|Overall Study||40
8171170|NCT02443883|20146120|P3|Received at Least One Dose of Study Drug|Overall Study||41
8171171|NCT02443883|20146121|P2|Received at Least One Dose of Study Drug|Overall Study||42
8171172|NCT02443883|20146122|P1|Received at Least One Dose of Study Drug|Overall Study||38
8171173|NCT02443883|20146119|P4|STARTED|Overall Study||41
8171174|NCT02443883|20146120|P3|STARTED|Overall Study||41
8171175|NCT02443883|20146121|P2|STARTED|Overall Study||42
8171176|NCT02443883|20146122|P1|STARTED|Overall Study||40
8171177|NCT02443805|20146142|P2|NOT COMPLETED|Overall Study||127
8171178|NCT02443805|20146143|P1|NOT COMPLETED|Overall Study||213
8171179|NCT02443805|20146142|P2|COMPLETED|Overall Study||678
8171180|NCT02443805|20146143|P1|COMPLETED|Overall Study||589
8171181|NCT02443805|20146142|P2|STARTED|Overall Study||805
8171182|NCT02443805|20146143|P1|STARTED|Overall Study||802
8171183|NCT02443792|20146155|P2|NOT COMPLETED|Overall Study||2
8171184|NCT02443792|20146156|P1|NOT COMPLETED|Overall Study||7
8171185|NCT02443792|20146155|P2|COMPLETED|Overall Study||23
8171186|NCT02443792|20146156|P1|COMPLETED|Overall Study||43
8171187|NCT02443792|20146155|P2|STARTED|Overall Study||25
8171188|NCT02443792|20146156|P1|STARTED|Overall Study||50
8171420|NCT02443688|20146366|P3|NOT COMPLETED|Overall Study||12
8171421|NCT02443688|20146367|P2|NOT COMPLETED|Overall Study||9
8171422|NCT02443688|20146368|P1|NOT COMPLETED|Overall Study||12
8171423|NCT02443688|20146366|P3|COMPLETED|Overall Study||55
8171424|NCT02443688|20146367|P2|COMPLETED|Overall Study||58
8171425|NCT02443688|20146368|P1|COMPLETED|Overall Study||54
8171426|NCT02443688|20146366|P3|STARTED|Overall Study||67
8171427|NCT02443688|20146367|P2|STARTED|Overall Study||67
8171428|NCT02443688|20146368|P1|STARTED|Overall Study||66
8171429|NCT02443571|20146433|P3|NOT COMPLETED|Overall Study||0
8171430|NCT02443571|20146434|P2|NOT COMPLETED|Overall Study||0
8171431|NCT02443571|20146435|P1|NOT COMPLETED|Overall Study||0
8171432|NCT02443571|20146433|P3|COMPLETED|Overall Study||23
8171433|NCT02443571|20146434|P2|COMPLETED|Overall Study||95
8171434|NCT02443571|20146435|P1|COMPLETED|Overall Study||596
8171435|NCT02443571|20146433|P3|STARTED|Overall Study||23
8171436|NCT02443571|20146434|P2|STARTED|Overall Study||95
8171437|NCT02443571|20146435|P1|STARTED|Overall Study||596
8171438|NCT02443519|20146447|P2|NOT COMPLETED|Overall Study||3
8171439|NCT02443519|20146448|P1|NOT COMPLETED|Overall Study||2
8171440|NCT02443519|20146447|P2|COMPLETED|Overall Study||26
8171441|NCT02443519|20146448|P1|COMPLETED|Overall Study||29
8171442|NCT02443519|20146447|P2|STARTED|Overall Study||29
8171443|NCT02443519|20146448|P1|STARTED|Overall Study||31
8171444|NCT02443402|20146478|P2|NOT COMPLETED|Overall Study||3
8171445|NCT02443402|20146479|P1|NOT COMPLETED|Overall Study||4
8171446|NCT02443402|20146478|P2|COMPLETED|Overall Study||28
8171447|NCT02443402|20146479|P1|COMPLETED|Overall Study||32
8171448|NCT02443402|20146478|P2|STARTED|Overall Study||31
8171449|NCT02443402|20146479|P1|STARTED|Overall Study||36
8171450|NCT02443337|20146541|P2|NOT COMPLETED|Overall Study||2
8171451|NCT02443337|20146542|P1|NOT COMPLETED|Overall Study||5
8171452|NCT02443337|20146541|P2|COMPLETED|Overall Study||14
8171453|NCT02443337|20146542|P1|COMPLETED|Overall Study||10
8171454|NCT02443337|20146541|P2|Received at Least One Dose of Study Drug|Overall Study||16
8171455|NCT02443337|20146542|P1|Received at Least One Dose of Study Drug|Overall Study||15
8171456|NCT02443337|20146541|P2|STARTED|Overall Study||16
8171457|NCT02443337|20146542|P1|STARTED|Overall Study||15
8171458|NCT02443298|20146560|P2|NOT COMPLETED|Overall Study||5
8171459|NCT02443298|20146561|P1|NOT COMPLETED|Overall Study||4
8171460|NCT02443298|20146560|P2|COMPLETED|Overall Study||104
8171461|NCT02443298|20146561|P1|COMPLETED|Overall Study||101
8171462|NCT02443298|20146560|P2|STARTED|Overall Study||109
8171463|NCT02443298|20146561|P1|STARTED|Overall Study||105
8171488|NCT02443103|20147032|P1|NOT COMPLETED|Overall Study||3
8171489|NCT02443103|20147032|P1|COMPLETED|Overall Study||1
8171490|NCT02443103|20147032|P1|STARTED|Overall Study||4
8171491|NCT02442856|20147037|P1|NOT COMPLETED|Overall Study||0
8171492|NCT02442856|20147037|P1|COMPLETED|Overall Study||21
8171493|NCT02442856|20147037|P1|STARTED|Overall Study||21
8171494|NCT02442830|20147045|P2|NOT COMPLETED|Overall Study||1
8171495|NCT02442830|20147046|P1|NOT COMPLETED|Overall Study||0
8171496|NCT02442830|20147045|P2|COMPLETED|Overall Study||44
8171497|NCT02442830|20147046|P1|COMPLETED|Overall Study||42
8171498|NCT02442830|20147045|P2|STARTED|Overall Study||45
8171499|NCT02442830|20147046|P1|STARTED|Overall Study||42
8171500|NCT02442804|20147056|P2|NOT COMPLETED|Overall Study||1
8171501|NCT02442804|20147057|P1|NOT COMPLETED|Overall Study||1
8171502|NCT02442804|20147056|P2|COMPLETED|Overall Study||7
8171503|NCT02442804|20147057|P1|COMPLETED|Overall Study||7
8171504|NCT02442804|20147056|P2|STARTED|Overall Study||8
8171505|NCT02442804|20147057|P1|STARTED|Overall Study||8
8171506|NCT02442700|20147087|P2|NOT COMPLETED|Later 12 Weeks||0
8171507|NCT02442700|20147088|P1|NOT COMPLETED|Later 12 Weeks||0
8171508|NCT02442700|20147087|P2|COMPLETED|Later 12 Weeks||12
8171509|NCT02442700|20147088|P1|COMPLETED|Later 12 Weeks||12
8171510|NCT02442700|20147087|P2|STARTED|Later 12 Weeks||12
8171511|NCT02442700|20147088|P1|STARTED|Later 12 Weeks||12
8171512|NCT02442700|20147087|P2|NOT COMPLETED|First 12 Weeks||0
8171513|NCT02442700|20147088|P1|NOT COMPLETED|First 12 Weeks||0
8171514|NCT02442700|20147087|P2|COMPLETED|First 12 Weeks||12
8171515|NCT02442700|20147088|P1|COMPLETED|First 12 Weeks||12
8171516|NCT02442700|20147087|P2|STARTED|First 12 Weeks||12
8171517|NCT02442700|20147088|P1|STARTED|First 12 Weeks||12
8171518|NCT02442687|20147099|P3|NOT COMPLETED|Overall Study||3
8171519|NCT02442687|20147100|P2|NOT COMPLETED|Overall Study||11
8171520|NCT02442687|20147101|P1|NOT COMPLETED|Overall Study||8
8171521|NCT02442687|20147099|P3|COMPLETED|Overall Study||19
8171522|NCT02442687|20147100|P2|COMPLETED|Overall Study||11
8171523|NCT02442687|20147101|P1|COMPLETED|Overall Study||13
8171524|NCT02442687|20147099|P3|STARTED|Overall Study||22
8171525|NCT02442687|20147100|P2|STARTED|Overall Study||22
8171526|NCT02442687|20147101|P1|STARTED|Overall Study||21
8171527|NCT02442622|20147164|P2|NOT COMPLETED|Overall Study||1
8171528|NCT02442622|20147165|P1|NOT COMPLETED|Overall Study||3
8171529|NCT02442622|20147164|P2|COMPLETED|Overall Study||16
8171530|NCT02442622|20147165|P1|COMPLETED|Overall Study||12
8171531|NCT02442622|20147164|P2|STARTED|Overall Study||17
8171532|NCT02442622|20147165|P1|STARTED|Overall Study||15
8171533|NCT02442349|20147175|P1|NOT COMPLETED|Overall Study||171
8171534|NCT02442349|20147175|P1|COMPLETED|Overall Study||0
8171535|NCT02442349|20147175|P1|STARTED|Overall Study||171
8171536|NCT02442336|20147180|P1|NOT COMPLETED|Overall Study||36
8171537|NCT02442336|20147180|P1|COMPLETED|Overall Study||44
8171538|NCT02442336|20147180|P1|Provided Access to Intervention|Overall Study||55
8171539|NCT02442336|20147180|P1|Evaluation Phase|Overall Study||74
8171540|NCT02442336|20147180|P1|Developmental Phase|Overall Study||6
8171541|NCT02442336|20147180|P1|STARTED|Overall Study||80
8171542|NCT02442310|20147184|P1|NOT COMPLETED|Overall Study||3
8171543|NCT02442310|20147184|P1|COMPLETED|Overall Study||17
8171544|NCT02442310|20147184|P1|STARTED|Overall Study||20
8171545|NCT02442284|20147206|P1|NOT COMPLETED|Overall Study||7
8171546|NCT02442284|20147206|P1|COMPLETED|Overall Study||92
8171547|NCT02442284|20147206|P1|STARTED|Overall Study||99
8171548|NCT02442271|20147213|P1|NOT COMPLETED|Overall Study||4
8171549|NCT02442271|20147213|P1|COMPLETED|Overall Study||218
8171550|NCT02442271|20147213|P1|STARTED|Overall Study||222
8171551|NCT02442206|20147239|P2|NOT COMPLETED|Period 2||0
8171552|NCT02442206|20147240|P1|NOT COMPLETED|Period 2||1
8171553|NCT02442206|20147239|P2|COMPLETED|Period 2||29
8171554|NCT02442206|20147240|P1|COMPLETED|Period 2||28
8171555|NCT02442206|20147239|P2|STARTED|Period 2||29
8171556|NCT02442206|20147240|P1|STARTED|Period 2||29
8171557|NCT02442206|20147239|P2|NOT COMPLETED|Period 1||3
8171558|NCT02442206|20147240|P1|NOT COMPLETED|Period 1||1
8171559|NCT02442206|20147239|P2|COMPLETED|Period 1||29
8171560|NCT02442206|20147240|P1|COMPLETED|Period 1||29
8171561|NCT02442206|20147239|P2|STARTED|Period 1||32
8171562|NCT02442206|20147240|P1|STARTED|Period 1||30
8171563|NCT02441946|20147272|P3|NOT COMPLETED|Extension Period (8 Weeks)||0
8171564|NCT02441946|20147273|P2|NOT COMPLETED|Extension Period (8 Weeks)||0
8171565|NCT02441946|20147274|P1|NOT COMPLETED|Extension Period (8 Weeks)||2
8171566|NCT02441946|20147272|P3|COMPLETED|Extension Period (8 Weeks)||0
8171567|NCT02441946|20147273|P2|COMPLETED|Extension Period (8 Weeks)||0
8171568|NCT02441946|20147274|P1|COMPLETED|Extension Period (8 Weeks)||40
8171569|NCT02441946|20147272|P3|STARTED|Extension Period (8 Weeks)||0
8171570|NCT02441946|20147273|P2|STARTED|Extension Period (8 Weeks)||0
8171571|NCT02441946|20147274|P1|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
8171572|NCT02441946|20147272|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171573|NCT02441946|20147273|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171574|NCT02441946|20147274|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
8171575|NCT02441946|20147272|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171576|NCT02441946|20147273|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171577|NCT02441946|20147274|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
8171578|NCT02441946|20147272|P3|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
8171579|NCT02441946|20147273|P2|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
8171580|NCT02441946|20147274|P1|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
8171581|NCT02441946|20147272|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
8171582|NCT02441946|20147273|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
8171583|NCT02441946|20147274|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
8171584|NCT02441946|20147272|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
8171585|NCT02441946|20147273|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
8171586|NCT02441946|20147274|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
8171587|NCT02441946|20147272|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8171588|NCT02441946|20147273|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
8171589|NCT02441946|20147274|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
8171590|NCT02441946|20147272|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
8171591|NCT02441946|20147273|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
8171592|NCT02441946|20147274|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
8171593|NCT02441946|20147272|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
8171594|NCT02441946|20147273|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
8171595|NCT02441946|20147274|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
8171596|NCT02441946|20147272|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
8171597|NCT02441946|20147273|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
8171598|NCT02441946|20147274|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
8171599|NCT02441517|20147295|P1|NOT COMPLETED|Overall Study||4
8171600|NCT02441517|20147295|P1|COMPLETED|Overall Study||0
8171601|NCT02441517|20147295|P1|Received Treatment|Overall Study||4
8171602|NCT02441517|20147295|P1|STARTED|Overall Study||4
8171603|NCT02441309|20147308|P3|NOT COMPLETED|Overall Study||3
8171604|NCT02441309|20147309|P2|NOT COMPLETED|Overall Study||2
8171605|NCT02441309|20147310|P1|NOT COMPLETED|Overall Study||3
8171606|NCT02441309|20147308|P3|COMPLETED|Overall Study||0
8171607|NCT02441309|20147309|P2|COMPLETED|Overall Study||0
8171608|NCT02441309|20147310|P1|COMPLETED|Overall Study||0
8171609|NCT02441309|20147308|P3|Received Allocated Intervention|Overall Study||3
8171610|NCT02441309|20147309|P2|Received Allocated Intervention|Overall Study||2
8171611|NCT02441309|20147310|P1|Received Allocated Intervention|Overall Study||1
8171612|NCT02441309|20147308|P3|STARTED|Overall Study||3
8171613|NCT02441309|20147309|P2|STARTED|Overall Study||2
8171614|NCT02441309|20147310|P1|STARTED|Overall Study||3
8171615|NCT02441283|20147339|P1|NOT COMPLETED|Overall Study||90
8171616|NCT02441283|20147339|P1|COMPLETED|Overall Study||287
8171617|NCT02441283|20147339|P1|STARTED|Overall Study||377
8171618|NCT02441218|20147352|P2|NOT COMPLETED|Overall Study||612
8171619|NCT02441218|20147353|P1|NOT COMPLETED|Overall Study||578
8171620|NCT02441218|20147352|P2|COMPLETED|Overall Study||2652
8171621|NCT02441218|20147353|P1|COMPLETED|Overall Study||2663
8171622|NCT02441218|20147352|P2|STARTED|Overall Study||3264
8171623|NCT02441218|20147353|P1|STARTED|Overall Study||3241
8171624|NCT02441179|20147379|P2|NOT COMPLETED|Overall Study||1
8171625|NCT02441179|20147380|P1|NOT COMPLETED|Overall Study||1
8171626|NCT02441179|20147379|P2|COMPLETED|Overall Study||16
8171627|NCT02441179|20147380|P1|COMPLETED|Overall Study||17
8171628|NCT02441179|20147379|P2|STARTED|Overall Study||17
8171629|NCT02441179|20147380|P1|STARTED|Overall Study||18
8171630|NCT02441114|20147398|P1|NOT COMPLETED|Period3||0
8171631|NCT02441114|20147398|P1|COMPLETED|Period3||6
8171632|NCT02441114|20147398|P1|STARTED|Period3||6
8171633|NCT02441114|20147398|P1|NOT COMPLETED|Washout2||4
8171634|NCT02441114|20147398|P1|COMPLETED|Washout2||6
8171635|NCT02441114|20147398|P1|STARTED|Washout2||10
8171636|NCT02441114|20147398|P1|NOT COMPLETED|Period2||0
8171637|NCT02441114|20147398|P1|COMPLETED|Period2||10
8171638|NCT02441114|20147398|P1|STARTED|Period2||10
8171639|NCT02441114|20147398|P1|NOT COMPLETED|Washout1||0
8171640|NCT02441114|20147398|P1|COMPLETED|Washout1||10
8171641|NCT02441114|20147398|P1|STARTED|Washout1||10
8171642|NCT02441114|20147398|P1|NOT COMPLETED|Period1||0
8171643|NCT02441114|20147398|P1|COMPLETED|Period1||10
8171644|NCT02441114|20147398|P1|STARTED|Period1||10
8171645|NCT02441062|20147404|P1|NOT COMPLETED|Overall Study||0
8171646|NCT02441062|20147404|P1|COMPLETED|Overall Study||122
8171647|NCT02441062|20147404|P1|STARTED|Overall Study||122
8171648|NCT02441036|20147413|P5|NOT COMPLETED|Overall Study||0
8171649|NCT02441036|20147414|P4|NOT COMPLETED|Overall Study||1
8171650|NCT02441036|20147415|P3|NOT COMPLETED|Overall Study||0
8171651|NCT02441036|20147416|P2|NOT COMPLETED|Overall Study||1
8171652|NCT02441036|20147417|P1|NOT COMPLETED|Overall Study||0
8171653|NCT02441036|20147413|P5|COMPLETED|Overall Study||1
8171654|NCT02441036|20147414|P4|COMPLETED|Overall Study||3
8171655|NCT02441036|20147415|P3|COMPLETED|Overall Study||3
8171656|NCT02441036|20147416|P2|COMPLETED|Overall Study||4
8171657|NCT02441036|20147417|P1|COMPLETED|Overall Study||3
8171658|NCT02441036|20147413|P5|Tissue Resected|Overall Study||1
8171659|NCT02441036|20147414|P4|Tissue Resected|Overall Study||3
8171660|NCT02441036|20147415|P3|Tissue Resected|Overall Study||3
8171661|NCT02441036|20147416|P2|Tissue Resected|Overall Study||4
8171662|NCT02441036|20147417|P1|Tissue Resected|Overall Study||3
8171663|NCT02441036|20147413|P5|Treated|Overall Study||1
8171664|NCT02441036|20147414|P4|Treated|Overall Study||4
8171665|NCT02441036|20147415|P3|Treated|Overall Study||3
8171666|NCT02441036|20147416|P2|Treated|Overall Study||5
8171667|NCT02441036|20147417|P1|Treated|Overall Study||3
8171668|NCT02441036|20147413|P5|STARTED|Overall Study||1
8171669|NCT02441036|20147414|P4|STARTED|Overall Study||4
8171670|NCT02441036|20147415|P3|STARTED|Overall Study||3
8171671|NCT02441036|20147416|P2|STARTED|Overall Study||5
8171672|NCT02441036|20147417|P1|STARTED|Overall Study||3
8171673|NCT02440789|20147444|P1|NOT COMPLETED|Overall Study||4
8171674|NCT02440789|20147444|P1|COMPLETED|Overall Study||28
8171675|NCT02440789|20147444|P1|Completed 20 Weeks of Sirolimus|Overall Study||16
8171676|NCT02440789|20147444|P1|Initiated Sirolimus|Overall Study||30
8171677|NCT02440789|20147444|P1|STARTED|Overall Study||32
8171678|NCT02440659|20147495|P2|NOT COMPLETED|Overall Study||335
8171679|NCT02440659|20147496|P1|NOT COMPLETED|Overall Study||651
8171680|NCT02440659|20147495|P2|COMPLETED|Overall Study||614
8171681|NCT02440659|20147496|P1|COMPLETED|Overall Study||1346
8171682|NCT02440659|20147495|P2|STARTED|Overall Study||949
8171683|NCT02440659|20147496|P1|STARTED|Overall Study||1997
8171684|NCT02440633|20147502|P1|NOT COMPLETED|Overall Study||0
8171685|NCT02440633|20147502|P1|COMPLETED|Overall Study||8
8171686|NCT02440633|20147502|P1|STARTED|Overall Study||8
8171687|NCT02440594|20147519|P8|NOT COMPLETED|Overall Study||56
8171688|NCT02440594|20147520|P7|NOT COMPLETED|Overall Study||37
8171689|NCT02440594|20147521|P6|NOT COMPLETED|Overall Study||7
8171690|NCT02440594|20147522|P5|NOT COMPLETED|Overall Study||9
8171691|NCT02440594|20147523|P4|NOT COMPLETED|Overall Study||89
8171692|NCT02440594|20147524|P3|NOT COMPLETED|Overall Study||117
8171693|NCT02440594|20147525|P2|NOT COMPLETED|Overall Study||108
8171694|NCT02440594|20147526|P1|NOT COMPLETED|Overall Study||132
8171695|NCT02440594|20147519|P8|COMPLETED|Overall Study||234
8171696|NCT02440594|20147520|P7|COMPLETED|Overall Study||113
8171697|NCT02440594|20147521|P6|COMPLETED|Overall Study||47
8171698|NCT02440594|20147522|P5|COMPLETED|Overall Study||46
8171699|NCT02440594|20147523|P4|COMPLETED|Overall Study||340
8171700|NCT02440594|20147524|P3|COMPLETED|Overall Study||319
8171701|NCT02440594|20147525|P2|COMPLETED|Overall Study||401
8171702|NCT02440594|20147526|P1|COMPLETED|Overall Study||377
8171703|NCT02440594|20147519|P8|STARTED|Overall Study||290
8171704|NCT02440594|20147520|P7|STARTED|Overall Study||150
8171705|NCT02440594|20147521|P6|STARTED|Overall Study||54
8171706|NCT02440594|20147522|P5|STARTED|Overall Study||55
8171707|NCT02440594|20147523|P4|STARTED|Overall Study||429
8171708|NCT02440594|20147524|P3|STARTED|Overall Study||436
8171709|NCT02440594|20147525|P2|STARTED|Overall Study||509
8171710|NCT02440594|20147526|P1|STARTED|Overall Study||509
8171711|NCT02440451|20147558|P1|NOT COMPLETED|Overall Study||0
8171712|NCT02440451|20147558|P1|COMPLETED|Overall Study||15
8171713|NCT02440451|20147558|P1|STARTED|Overall Study||15
8171714|NCT02440334|20147564|P1|NOT COMPLETED|Overall Study||0
8171715|NCT02440334|20147564|P1|COMPLETED|Overall Study||53
8171716|NCT02440334|20147564|P1|STARTED|Overall Study||53
8171717|NCT02440308|20147568|P1|NOT COMPLETED|Overall Study||0
8171718|NCT02440308|20147568|P1|COMPLETED|Overall Study||10
8171719|NCT02440308|20147568|P1|STARTED|Overall Study||10
8171720|NCT02440204|20147576|P3|NOT COMPLETED|Overall Study||0
8171721|NCT02440204|20147577|P2|NOT COMPLETED|Overall Study||0
8171722|NCT02440204|20147578|P1|NOT COMPLETED|Overall Study||0
8171723|NCT02440204|20147576|P3|COMPLETED|Overall Study||22
8171724|NCT02440204|20147577|P2|COMPLETED|Overall Study||24
8171725|NCT02440204|20147578|P1|COMPLETED|Overall Study||22
8171726|NCT02440204|20147576|P3|STARTED|Overall Study||22
8171727|NCT02440204|20147577|P2|STARTED|Overall Study||24
8171728|NCT02440204|20147578|P1|STARTED|Overall Study||22
8171729|NCT02440022|20147591|P2|NOT COMPLETED|Overall Study||13
8171730|NCT02440022|20147592|P1|NOT COMPLETED|Overall Study||27
8171731|NCT02440022|20147591|P2|COMPLETED|Overall Study||131
8171732|NCT02440022|20147592|P1|COMPLETED|Overall Study||114
8171733|NCT02440022|20147591|P2|STARTED|Overall Study||144
8171734|NCT02440022|20147592|P1|STARTED|Overall Study||141
8171735|NCT02439879|20147618|P2|NOT COMPLETED|Overall Study||0
8171736|NCT02439879|20147619|P1|NOT COMPLETED|Overall Study||0
8171737|NCT02439879|20147618|P2|COMPLETED|Overall Study||17
8171738|NCT02439879|20147619|P1|COMPLETED|Overall Study||16
8171739|NCT02439879|20147618|P2|STARTED|Overall Study||17
8171740|NCT02439879|20147619|P1|STARTED|Overall Study||16
8171741|NCT02439814|20147627|P2|NOT COMPLETED|Overall Study||0
8171742|NCT02439814|20147628|P1|NOT COMPLETED|Overall Study||0
8171743|NCT02439814|20147627|P2|COMPLETED|Overall Study||10
8171744|NCT02439814|20147628|P1|COMPLETED|Overall Study||11
8171745|NCT02439814|20147627|P2|STARTED|Overall Study||10
8171746|NCT02439814|20147628|P1|STARTED|Overall Study||11
8171747|NCT02439710|20147634|P1|NOT COMPLETED|Overall Study||0
8171748|NCT02439710|20147634|P1|COMPLETED|Overall Study||656
8171749|NCT02439710|20147634|P1|STARTED|Overall Study||656
8171750|NCT02439320|20147643|P3|NOT COMPLETED|Overall Study||99
8171751|NCT02439320|20147644|P2|NOT COMPLETED|Overall Study||114
8171752|NCT02439320|20147645|P1|NOT COMPLETED|Overall Study||96
8171753|NCT02439320|20147643|P3|COMPLETED|Overall Study||643
8171754|NCT02439320|20147644|P2|COMPLETED|Overall Study||631
8171755|NCT02439320|20147645|P1|COMPLETED|Overall Study||648
8171756|NCT02439320|20147643|P3|2nd Dose (After 2 Hour Assessment)|Overall Study||401
8171757|NCT02439320|20147644|P2|2nd Dose (After 2 Hour Assessment)|Overall Study||238
8171758|NCT02439320|20147645|P1|2nd Dose (After 2 Hour Assessment)|Overall Study||289
8171759|NCT02439320|20147643|P3|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
8171760|NCT02439320|20147644|P2|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
8171761|NCT02439320|20147645|P1|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
8171762|NCT02439320|20147643|P3|Confirmed Eligibility|Overall Study||705
8171763|NCT02439320|20147644|P2|Confirmed Eligibility|Overall Study||695
8171764|NCT02439320|20147645|P1|Confirmed Eligibility|Overall Study||710
8171765|NCT02439320|20147643|P3|STARTED|Overall Study||742
8171766|NCT02439320|20147644|P2|STARTED|Overall Study||745
8171767|NCT02439320|20147645|P1|STARTED|Overall Study||744
8171768|NCT02439281|20147690|P2|NOT COMPLETED|Overall Study||0
8171769|NCT02439281|20147691|P1|NOT COMPLETED|Overall Study||0
8171770|NCT02439281|20147690|P2|COMPLETED|Overall Study||26
8171771|NCT02439281|20147691|P1|COMPLETED|Overall Study||24
8171772|NCT02439281|20147690|P2|STARTED|Overall Study||26
8171773|NCT02439281|20147691|P1|STARTED|Overall Study||24
8171774|NCT02439164|20147711|P2|NOT COMPLETED|Overall Study||0
8171775|NCT02439164|20147712|P1|NOT COMPLETED|Overall Study||0
8171776|NCT02439164|20147711|P2|COMPLETED|Overall Study||18
8171777|NCT02439164|20147712|P1|COMPLETED|Overall Study||18
8171778|NCT02439164|20147711|P2|STARTED|Overall Study||18
8171779|NCT02439164|20147712|P1|STARTED|Overall Study||18
8171780|NCT02439138|20147725|P1|NOT COMPLETED|Overall Study||3
8171781|NCT02439138|20147725|P1|COMPLETED|Overall Study||2
8171782|NCT02439138|20147725|P1|STARTED|Overall Study||5
8171783|NCT02438826|20147738|P4|NOT COMPLETED|Post-Treatment Phase||0
8171784|NCT02438826|20147739|P3|NOT COMPLETED|Post-Treatment Phase||0
8171785|NCT02438826|20147740|P2|NOT COMPLETED|Post-Treatment Phase||1
8171786|NCT02438826|20147741|P1|NOT COMPLETED|Post-Treatment Phase||9
8171787|NCT02438826|20147738|P4|COMPLETED|Post-Treatment Phase||4
8171788|NCT02438826|20147739|P3|COMPLETED|Post-Treatment Phase||2
8171789|NCT02438826|20147740|P2|COMPLETED|Post-Treatment Phase||92
8171790|NCT02438826|20147741|P1|COMPLETED|Post-Treatment Phase||84
8171791|NCT02438826|20147738|P4|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
8171792|NCT02438826|20147739|P3|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
8171793|NCT02438826|20147740|P2|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
8171794|NCT02438826|20147741|P1|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
8171795|NCT02438826|20147738|P4|NOT COMPLETED|Open-Label Treatment Phase||0
8171796|NCT02438826|20147739|P3|NOT COMPLETED|Open-Label Treatment Phase||0
8171797|NCT02438826|20147740|P2|NOT COMPLETED|Open-Label Treatment Phase||33
8171798|NCT02438826|20147741|P1|NOT COMPLETED|Open-Label Treatment Phase||44
8171799|NCT02438826|20147738|P4|COMPLETED|Open-Label Treatment Phase||0
8171800|NCT02438826|20147739|P3|COMPLETED|Open-Label Treatment Phase||0
8171801|NCT02438826|20147740|P2|COMPLETED|Open-Label Treatment Phase||80
8171802|NCT02438826|20147741|P1|COMPLETED|Open-Label Treatment Phase||72
8171803|NCT02438826|20147738|P4|STARTED|Open-Label Treatment Phase||0
8171804|NCT02438826|20147739|P3|STARTED|Open-Label Treatment Phase||0
8171805|NCT02438826|20147740|P2|STARTED|Open-Label Treatment Phase||113
8171806|NCT02438826|20147741|P1|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
8171807|NCT02438826|20147738|P4|NOT COMPLETED|Double-Blind Treatment Phase||0
8171808|NCT02438826|20147739|P3|NOT COMPLETED|Double-Blind Treatment Phase||0
8171809|NCT02438826|20147740|P2|NOT COMPLETED|Double-Blind Treatment Phase||4
8171810|NCT02438826|20147741|P1|NOT COMPLETED|Double-Blind Treatment Phase||6
8171811|NCT02438826|20147738|P4|COMPLETED|Double-Blind Treatment Phase||0
8171812|NCT02438826|20147739|P3|COMPLETED|Double-Blind Treatment Phase||0
8171813|NCT02438826|20147740|P2|COMPLETED|Double-Blind Treatment Phase||113
8171814|NCT02438826|20147741|P1|COMPLETED|Double-Blind Treatment Phase||117
8171815|NCT02438826|20147738|P4|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
8171816|NCT02438826|20147739|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
8171817|NCT02438826|20147740|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
8171818|NCT02438826|20147741|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
8171819|NCT02438826|20147738|P4|STARTED|Double-Blind Treatment Phase||0
8171820|NCT02438826|20147739|P3|STARTED|Double-Blind Treatment Phase||0
8171821|NCT02438826|20147740|P2|STARTED|Double-Blind Treatment Phase||117
8171822|NCT02438826|20147741|P1|STARTED|Double-Blind Treatment Phase||123
8171823|NCT02438813|20147775|P1|NOT COMPLETED|Overall Study||525
8171824|NCT02438813|20147775|P1|COMPLETED|Overall Study||504
8171825|NCT02438813|20147775|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
8171826|NCT02438813|20147775|P1|Received Treatment for SMF|Overall Study||676
8171827|NCT02438813|20147775|P1|STARTED|Overall Study||1029
8171828|NCT02438787|20147827|P3|NOT COMPLETED|Overall Study||83
8171829|NCT02438787|20147828|P2|NOT COMPLETED|Overall Study||83
8171830|NCT02438787|20147829|P1|NOT COMPLETED|Overall Study||81
8171831|NCT02438787|20147827|P3|COMPLETED|Overall Study||22
8171832|NCT02438787|20147828|P2|COMPLETED|Overall Study||23
8171833|NCT02438787|20147829|P1|COMPLETED|Overall Study||23
8171834|NCT02438787|20147827|P3|Cross Over at Week 24|Overall Study||0
8171835|NCT02438787|20147828|P2|Cross Over at Week 24|Overall Study||0
8171836|NCT02438787|20147829|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
8171837|NCT02438787|20147827|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
8171838|NCT02438787|20147828|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8171839|NCT02438787|20147829|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8171840|NCT02438787|20147827|P3|STARTED|Overall Study||105
8171841|NCT02438787|20147828|P2|STARTED|Overall Study||106
8171842|NCT02438787|20147829|P1|STARTED|Overall Study||104
8171843|NCT02438540|20147874|P2|NOT COMPLETED|Overall Study||0
8171844|NCT02438540|20147875|P1|NOT COMPLETED|Overall Study||0
8171845|NCT02438540|20147874|P2|COMPLETED|Overall Study||20
8171846|NCT02438540|20147875|P1|COMPLETED|Overall Study||19
8171847|NCT02438540|20147874|P2|STARTED|Overall Study||20
8171848|NCT02438540|20147875|P1|STARTED|Overall Study||19
8171849|NCT02438475|20147917|P2|NOT COMPLETED|Overall Study||0
8171850|NCT02438475|20147918|P1|NOT COMPLETED|Overall Study||2
8171851|NCT02438475|20147917|P2|COMPLETED|Overall Study||104
8171852|NCT02438475|20147918|P1|COMPLETED|Overall Study||102
8171853|NCT02438475|20147917|P2|STARTED|Overall Study||104
8171854|NCT02438475|20147918|P1|STARTED|Overall Study||104
8171855|NCT02438423|20147932|P4|NOT COMPLETED|Overall Study||0
8171856|NCT02438423|20147933|P3|NOT COMPLETED|Overall Study||0
8171857|NCT02438423|20147934|P2|NOT COMPLETED|Overall Study||0
8171858|NCT02438423|20147935|P1|NOT COMPLETED|Overall Study||0
8171859|NCT02438423|20147932|P4|COMPLETED|Overall Study||25
8171860|NCT02438423|20147933|P3|COMPLETED|Overall Study||25
8171861|NCT02438423|20147934|P2|COMPLETED|Overall Study||25
8171862|NCT02438423|20147935|P1|COMPLETED|Overall Study||25
8171863|NCT02438423|20147932|P4|STARTED|Overall Study||25
8171864|NCT02438423|20147933|P3|STARTED|Overall Study||25
8171865|NCT02438423|20147934|P2|STARTED|Overall Study||25
8171866|NCT02438423|20147935|P1|STARTED|Overall Study||25
8171867|NCT02438384|20147962|P3|NOT COMPLETED|Overall Study||4
8171868|NCT02438384|20147963|P2|NOT COMPLETED|Overall Study||6
8171869|NCT02438384|20147964|P1|NOT COMPLETED|Overall Study||8
8171870|NCT02438384|20147962|P3|COMPLETED|Overall Study||21
8171871|NCT02438384|20147963|P2|COMPLETED|Overall Study||19
8171872|NCT02438384|20147964|P1|COMPLETED|Overall Study||17
8171873|NCT02438384|20147962|P3|STARTED|Overall Study||25
8171874|NCT02438384|20147963|P2|STARTED|Overall Study||25
8171875|NCT02438384|20147964|P1|STARTED|Overall Study||25
8171876|NCT02438280|20147983|P2|NOT COMPLETED|Overall Study||0
8171877|NCT02438280|20147984|P1|NOT COMPLETED|Overall Study||1
8171878|NCT02438280|20147983|P2|COMPLETED|Overall Study||13
8171879|NCT02438280|20147984|P1|COMPLETED|Overall Study||13
8171880|NCT02438280|20147983|P2|STARTED|Overall Study||13
8171881|NCT02438280|20147984|P1|STARTED|Overall Study||14
8171882|NCT02438137|20147994|P2|NOT COMPLETED|Overall Study||6
8171883|NCT02438137|20147995|P1|NOT COMPLETED|Overall Study||8
8171884|NCT02438137|20147994|P2|COMPLETED|Overall Study||15
8171885|NCT02438137|20147995|P1|COMPLETED|Overall Study||36
8171886|NCT02438137|20147994|P2|STARTED|Overall Study||21
8171887|NCT02438137|20147995|P1|STARTED|Overall Study||44
8171888|NCT02437903|20148003|P1|NOT COMPLETED|Overall Study||5
8171889|NCT02437903|20148003|P1|COMPLETED|Overall Study||25
8171890|NCT02437903|20148003|P1|STARTED|Overall Study||30
8171891|NCT02437890|20148016|P5|NOT COMPLETED|Overall Study||16
8171892|NCT02437890|20148017|P4|NOT COMPLETED|Overall Study||22
8171893|NCT02437890|20148018|P3|NOT COMPLETED|Overall Study||15
8171894|NCT02437890|20148019|P2|NOT COMPLETED|Overall Study||16
8171895|NCT02437890|20148020|P1|NOT COMPLETED|Overall Study||8
8171896|NCT02437890|20148016|P5|COMPLETED|Overall Study||46
8171897|NCT02437890|20148017|P4|COMPLETED|Overall Study||40
8171898|NCT02437890|20148018|P3|COMPLETED|Overall Study||47
8171899|NCT02437890|20148019|P2|COMPLETED|Overall Study||48
8171900|NCT02437890|20148020|P1|COMPLETED|Overall Study||54
8171901|NCT02437890|20148016|P5|STARTED|Overall Study||62
8171902|NCT02437890|20148017|P4|STARTED|Overall Study||62
8171903|NCT02437890|20148018|P3|STARTED|Overall Study||62
8171904|NCT02437890|20148019|P2|STARTED|Overall Study||64
8171905|NCT02437890|20148020|P1|STARTED|Overall Study||62
8171906|NCT02437864|20148233|P2|NOT COMPLETED|Overall Study||0
8171907|NCT02437864|20148234|P1|NOT COMPLETED|Overall Study||4
8171908|NCT02437864|20148233|P2|COMPLETED|Overall Study||160
8171909|NCT02437864|20148234|P1|COMPLETED|Overall Study||196
8171910|NCT02437864|20148233|P2|STARTED|Overall Study||160
8171911|NCT02437864|20148234|P1|STARTED|Overall Study||200
8171912|NCT02437669|20148248|P1|NOT COMPLETED|Overall Study||0
8171913|NCT02437669|20148248|P1|COMPLETED|Overall Study||35
8171914|NCT02437669|20148248|P1|STARTED|Overall Study||35
8171915|NCT02437513|20148255|P1|NOT COMPLETED|Overall Study||2
8171916|NCT02437513|20148255|P1|COMPLETED|Overall Study||0
8171917|NCT02437513|20148255|P1|STARTED|Overall Study||2
8171918|NCT02437487|20148265|P2|NOT COMPLETED|Overall Study||14
8171919|NCT02437487|20148266|P1|NOT COMPLETED|Overall Study||27
8171920|NCT02437487|20148265|P2|COMPLETED|Overall Study||16
8171921|NCT02437487|20148266|P1|COMPLETED|Overall Study||32
8171922|NCT02437487|20148265|P2|Intention-to-Treat Population|Overall Study||30
8171923|NCT02437487|20148266|P1|Intention-to-Treat Population|Overall Study||59
8171924|NCT02437487|20148265|P2|Actual Treatment Received|Overall Study||29
8171925|NCT02437487|20148266|P1|Actual Treatment Received|Overall Study||60
8171926|NCT02437487|20148265|P2|STARTED|Overall Study||30
8171927|NCT02437487|20148266|P1|STARTED|Overall Study||59
8171928|NCT02437409|20148280|P1|NOT COMPLETED|Overall Study||15
8171929|NCT02437409|20148280|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
8171930|NCT02437409|20148280|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
8171931|NCT02437383|20148291|P2|NOT COMPLETED|Overall Study||13
8171932|NCT02437383|20148292|P1|NOT COMPLETED|Overall Study||13
8171933|NCT02437383|20148291|P2|COMPLETED|Overall Study||87
8171934|NCT02437383|20148292|P1|COMPLETED|Overall Study||87
8171935|NCT02437383|20148291|P2|STARTED|Overall Study||100
8171936|NCT02437383|20148292|P1|STARTED|Overall Study||100
8171937|NCT02437344|20148366|P1|NOT COMPLETED|Overall Study||1
8171938|NCT02437344|20148366|P1|COMPLETED|Overall Study||15
8171939|NCT02437344|20148366|P1|STARTED|Overall Study||16
8171940|NCT02437318|20148373|P2|NOT COMPLETED|Overall Study||242
8171941|NCT02437318|20148374|P1|NOT COMPLETED|Overall Study||229
8171942|NCT02437318|20148373|P2|COMPLETED|Overall Study||46
8171943|NCT02437318|20148374|P1|COMPLETED|Overall Study||55
8171944|NCT02437318|20148373|P2|Untreated (Protocol Deviation)|Overall Study||1
8171945|NCT02437318|20148374|P1|Untreated (Protocol Deviation)|Overall Study||0
8171946|NCT02437318|20148373|P2|End of Treatment (Didn't Complete)|Overall Study||241
8171947|NCT02437318|20148374|P1|End of Treatment (Didn't Complete)|Overall Study||229
8171948|NCT02437318|20148373|P2|STARTED|Overall Study||288
8171949|NCT02437318|20148374|P1|STARTED|Overall Study||284
8171950|NCT02437305|20148382|P2|NOT COMPLETED|Overall Study||12
8171951|NCT02437305|20148383|P1|NOT COMPLETED|Overall Study||18
8171952|NCT02437305|20148382|P2|COMPLETED|Overall Study||38
8171953|NCT02437305|20148383|P1|COMPLETED|Overall Study||32
8171954|NCT02437305|20148382|P2|STARTED|Overall Study||50
8171955|NCT02437305|20148383|P1|STARTED|Overall Study||50
8171956|NCT02437253|20148393|P2|NOT COMPLETED|Overall Study||0
8171957|NCT02437253|20148394|P1|NOT COMPLETED|Overall Study||0
8171958|NCT02437253|20148393|P2|COMPLETED|Overall Study||1
8171959|NCT02437253|20148394|P1|COMPLETED|Overall Study||1
8171960|NCT02437253|20148393|P2|STARTED|Overall Study||1
8171961|NCT02437253|20148394|P1|STARTED|Overall Study||1
8171962|NCT02437188|20148410|P2|NOT COMPLETED|Overall Study||9
8171963|NCT02437188|20148411|P1|NOT COMPLETED|Overall Study||4
8171964|NCT02437188|20148410|P2|COMPLETED|Overall Study||35
8171965|NCT02437188|20148411|P1|COMPLETED|Overall Study||40
8171966|NCT02437188|20148410|P2|STARTED|Overall Study||44
8171967|NCT02437188|20148411|P1|STARTED|Overall Study||44
8171968|NCT02437162|20148428|P3|NOT COMPLETED|Overall Study||109
8171969|NCT02437162|20148429|P2|NOT COMPLETED|Overall Study||108
8171970|NCT02437162|20148430|P1|NOT COMPLETED|Overall Study||107
8171971|NCT02437162|20148428|P3|COMPLETED|Overall Study||6
8171972|NCT02437162|20148429|P2|COMPLETED|Overall Study||8
8171973|NCT02437162|20148430|P1|COMPLETED|Overall Study||9
8171974|NCT02437162|20148428|P3|Cross Over at Week 24|Overall Study||0
8171975|NCT02437162|20148429|P2|Cross Over at Week 24|Overall Study||0
8171976|NCT02437162|20148430|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
8171977|NCT02437162|20148428|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
8171978|NCT02437162|20148429|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8171979|NCT02437162|20148430|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
8171980|NCT02437162|20148428|P3|Treated|Overall Study||114
8171981|NCT02437162|20148429|P2|Treated|Overall Study||116
8171982|NCT02437162|20148430|P1|Treated|Overall Study||116
8171983|NCT02437162|20148428|P3|STARTED|Overall Study||115
8171984|NCT02437162|20148429|P2|STARTED|Overall Study||116
8171985|NCT02437162|20148430|P1|STARTED|Overall Study||116
8171986|NCT02436915|20148550|P2|NOT COMPLETED|Overall Study||1
8171987|NCT02436915|20148551|P1|NOT COMPLETED|Overall Study||0
8171988|NCT02436915|20148550|P2|COMPLETED|Overall Study||9
8171989|NCT02436915|20148551|P1|COMPLETED|Overall Study||9
8171990|NCT02436915|20148550|P2|STARTED|Overall Study||10
8171991|NCT02436915|20148551|P1|STARTED|Overall Study||9
8171992|NCT02436889|20148573|P2|NOT COMPLETED|Overall Study||1
8171993|NCT02436889|20148574|P1|NOT COMPLETED|Overall Study||1
8171994|NCT02436889|20148573|P2|COMPLETED|Overall Study||10
8171995|NCT02436889|20148574|P1|COMPLETED|Overall Study||11
8171996|NCT02436889|20148573|P2|STARTED|Overall Study||11
8171997|NCT02436889|20148574|P1|STARTED|Overall Study||12
8171998|NCT02436811|20148593|P3|NOT COMPLETED|Overall Study||7
8171999|NCT02436811|20148594|P2|NOT COMPLETED|Overall Study||9
8172000|NCT02436811|20148595|P1|NOT COMPLETED|Overall Study||2
8172001|NCT02436811|20148593|P3|COMPLETED|Overall Study||53
8172002|NCT02436811|20148594|P2|COMPLETED|Overall Study||51
8172003|NCT02436811|20148595|P1|COMPLETED|Overall Study||58
8172004|NCT02436811|20148593|P3|STARTED|Overall Study||60
8172005|NCT02436811|20148594|P2|STARTED|Overall Study||60
8172006|NCT02436811|20148595|P1|STARTED|Overall Study||60
8172007|NCT02436759|20148605|P2|NOT COMPLETED|Overall Study||1
8172008|NCT02436759|20148606|P1|NOT COMPLETED|Overall Study||4
8172009|NCT02436759|20148605|P2|COMPLETED|Overall Study||45
8172010|NCT02436759|20148606|P1|COMPLETED|Overall Study||90
8172011|NCT02436759|20148605|P2|Subjects Treated|Overall Study||46
8172012|NCT02436759|20148606|P1|Subjects Treated|Overall Study||94
8172013|NCT02436759|20148605|P2|Subjects Randomized|Overall Study||46
8172014|NCT02436759|20148606|P1|Subjects Randomized|Overall Study||94
8172015|NCT02436759|20148605|P2|STARTED|Overall Study||46
8172016|NCT02436759|20148606|P1|STARTED|Overall Study||94
8172017|NCT02436681|20148614|P1|NOT COMPLETED|Overall Study||14
8172018|NCT02436681|20148614|P1|COMPLETED|Overall Study||27
8172019|NCT02436681|20148614|P1|STARTED|Overall Study||41
8172020|NCT02436668|20148627|P2|NOT COMPLETED|Overall Study||4
8172021|NCT02436668|20148628|P1|NOT COMPLETED|Overall Study||1
8172022|NCT02436668|20148627|P2|COMPLETED|Overall Study||207
8172023|NCT02436668|20148628|P1|COMPLETED|Overall Study||212
8172024|NCT02436668|20148627|P2|STARTED|Overall Study||211
8172025|NCT02436668|20148628|P1|STARTED|Overall Study||213
8172026|NCT02436577|20148654|P6|NOT COMPLETED|Overall Study||0
8172027|NCT02436577|20148655|P5|NOT COMPLETED|Overall Study||0
8172028|NCT02436577|20148656|P4|NOT COMPLETED|Overall Study||0
8172029|NCT02436577|20148657|P3|NOT COMPLETED|Overall Study||0
8172030|NCT02436577|20148658|P2|NOT COMPLETED|Overall Study||1
8172031|NCT02436577|20148659|P1|NOT COMPLETED|Overall Study||0
8172032|NCT02436577|20148654|P6|COMPLETED|Overall Study||7
8172033|NCT02436577|20148655|P5|COMPLETED|Overall Study||7
8172034|NCT02436577|20148656|P4|COMPLETED|Overall Study||7
8172035|NCT02436577|20148657|P3|COMPLETED|Overall Study||7
8172036|NCT02436577|20148658|P2|COMPLETED|Overall Study||6
8172037|NCT02436577|20148659|P1|COMPLETED|Overall Study||7
8172038|NCT02436577|20148654|P6|STARTED|Overall Study||7
8172039|NCT02436577|20148655|P5|STARTED|Overall Study||7
8172040|NCT02436577|20148656|P4|STARTED|Overall Study||7
8172041|NCT02436577|20148657|P3|STARTED|Overall Study||7
8172042|NCT02436577|20148658|P2|STARTED|Overall Study||7
8172043|NCT02436577|20148659|P1|STARTED|Overall Study||7
8172044|NCT02436356|20148715|P3|NOT COMPLETED|Overall Study||2
8172045|NCT02436356|20148716|P2|NOT COMPLETED|Overall Study||1
8172046|NCT02436356|20148717|P1|NOT COMPLETED|Overall Study||5
8172047|NCT02436356|20148715|P3|COMPLETED|Overall Study||2
8172048|NCT02436356|20148716|P2|COMPLETED|Overall Study||10
8172049|NCT02436356|20148717|P1|COMPLETED|Overall Study||28
8172050|NCT02436356|20148715|P3|Low Energy Fracture|Overall Study||0
8172051|NCT02436356|20148716|P2|Low Energy Fracture|Overall Study||0
8172052|NCT02436356|20148717|P1|Low Energy Fracture|Overall Study||19
8172053|NCT02436356|20148715|P3|High Energy Fracture|Overall Study||4
8172054|NCT02436356|20148716|P2|High Energy Fracture|Overall Study||0
8172055|NCT02436356|20148717|P1|High Energy Fracture|Overall Study||14
8172056|NCT02436356|20148715|P3|STARTED|Overall Study||4
8172057|NCT02436356|20148716|P2|STARTED|Overall Study||11
8172058|NCT02436356|20148717|P1|STARTED|Overall Study||33
8172059|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 6||1
8172060|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 6||3
8172061|NCT02436330|20148748|P2|COMPLETED|Cohort 6||4
8172062|NCT02436330|20148749|P1|COMPLETED|Cohort 6||1
8172063|NCT02436330|20148748|P2|STARTED|Cohort 6||5
8172064|NCT02436330|20148749|P1|STARTED|Cohort 6||4
8172065|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 5||4
8172066|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 5||6
8172067|NCT02436330|20148748|P2|COMPLETED|Cohort 5||1
8172068|NCT02436330|20148749|P1|COMPLETED|Cohort 5||4
8172069|NCT02436330|20148748|P2|STARTED|Cohort 5||5
8172070|NCT02436330|20148749|P1|STARTED|Cohort 5||10
8172071|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 4||0
8172072|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 4||2
8172073|NCT02436330|20148748|P2|COMPLETED|Cohort 4||0
8172074|NCT02436330|20148749|P1|COMPLETED|Cohort 4||4
8172075|NCT02436330|20148748|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
8172076|NCT02436330|20148749|P1|STARTED|Cohort 4||6
8172077|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 3||0
8172078|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 3||5
8172079|NCT02436330|20148748|P2|COMPLETED|Cohort 3||0
8172080|NCT02436330|20148749|P1|COMPLETED|Cohort 3||7
8172081|NCT02436330|20148748|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
8172082|NCT02436330|20148749|P1|STARTED|Cohort 3||12
8172083|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 2||3
8172084|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 2||4
8172085|NCT02436330|20148748|P2|COMPLETED|Cohort 2||7
8172086|NCT02436330|20148749|P1|COMPLETED|Cohort 2||10
8172087|NCT02436330|20148748|P2|STARTED|Cohort 2||10
8172088|NCT02436330|20148749|P1|STARTED|Cohort 2||14
8172089|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 1||3
8172090|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 1||5
8172091|NCT02436330|20148748|P2|COMPLETED|Cohort 1||1
8172092|NCT02436330|20148749|P1|COMPLETED|Cohort 1||9
8172093|NCT02436330|20148748|P2|STARTED|Cohort 1||4
8172094|NCT02436330|20148749|P1|STARTED|Cohort 1||14
8172095|NCT02436304|20148794|P3|NOT COMPLETED|Overall Study||1
8172096|NCT02436304|20148795|P2|NOT COMPLETED|Overall Study||2
8172097|NCT02436304|20148796|P1|NOT COMPLETED|Overall Study||0
8172098|NCT02436304|20148794|P3|COMPLETED|Overall Study||100
8172099|NCT02436304|20148795|P2|COMPLETED|Overall Study||100
8172100|NCT02436304|20148796|P1|COMPLETED|Overall Study||153
8172101|NCT02436304|20148794|P3|STARTED|Overall Study||101
8172102|NCT02436304|20148795|P2|STARTED|Overall Study||102
8172103|NCT02436304|20148796|P1|STARTED|Overall Study||153
8172104|NCT02436239|20148815|P4|NOT COMPLETED|Down-Taper Period||2
8172105|NCT02436239|20148816|P3|NOT COMPLETED|Down-Taper Period||1
8172106|NCT02436239|20148817|P2|NOT COMPLETED|Down-Taper Period||4
8172107|NCT02436239|20148818|P1|NOT COMPLETED|Down-Taper Period||4
8172108|NCT02436239|20148815|P4|COMPLETED|Down-Taper Period||4
8172109|NCT02436239|20148816|P3|COMPLETED|Down-Taper Period||43
8172110|NCT02436239|20148817|P2|COMPLETED|Down-Taper Period||99
8172111|NCT02436239|20148818|P1|COMPLETED|Down-Taper Period||86
8172112|NCT02436239|20148815|P4|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
8172113|NCT02436239|20148816|P3|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
8172114|NCT02436239|20148817|P2|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
8172115|NCT02436239|20148818|P1|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
8172116|NCT02436239|20148815|P4|NOT COMPLETED|Open-Lable Treatment Period||5
8172117|NCT02436239|20148816|P3|NOT COMPLETED|Open-Lable Treatment Period||27
8172118|NCT02436239|20148817|P2|NOT COMPLETED|Open-Lable Treatment Period||34
8172119|NCT02436239|20148818|P1|NOT COMPLETED|Open-Lable Treatment Period||33
8172120|NCT02436239|20148815|P4|COMPLETED|Open-Lable Treatment Period||7
8172121|NCT02436239|20148816|P3|COMPLETED|Open-Lable Treatment Period||38
8172122|NCT02436239|20148817|P2|COMPLETED|Open-Lable Treatment Period||97
8172123|NCT02436239|20148818|P1|COMPLETED|Open-Lable Treatment Period||89
8172124|NCT02436239|20148815|P4|STARTED|Open-Lable Treatment Period||12
8172125|NCT02436239|20148816|P3|STARTED|Open-Lable Treatment Period||65
8172126|NCT02436239|20148817|P2|STARTED|Open-Lable Treatment Period||131
8172127|NCT02436239|20148818|P1|STARTED|Open-Lable Treatment Period||122
8172128|NCT02436200|20148840|P1|NOT COMPLETED|Overall Study||1
8172129|NCT02436200|20148840|P1|COMPLETED|Overall Study||20
8172130|NCT02436200|20148840|P1|STARTED|Overall Study||21
8172131|NCT02436135|20148847|P2|NOT COMPLETED|Overall Study||4
8172132|NCT02436135|20148848|P1|NOT COMPLETED|Overall Study||6
8172133|NCT02436135|20148847|P2|COMPLETED|Overall Study||0
8172134|NCT02436135|20148848|P1|COMPLETED|Overall Study||0
8172135|NCT02436135|20148847|P2|STARTED|Overall Study||4
8172136|NCT02436135|20148848|P1|STARTED|Overall Study||6
8172137|NCT02436031|20148872|P2|NOT COMPLETED|Second Study Night||0
8172138|NCT02436031|20148873|P1|NOT COMPLETED|Second Study Night||0
8172139|NCT02436031|20148872|P2|COMPLETED|Second Study Night||8
8172140|NCT02436031|20148873|P1|COMPLETED|Second Study Night||7
8172141|NCT02436031|20148872|P2|STARTED|Second Study Night||8
8172142|NCT02436031|20148873|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
8172143|NCT02436031|20148872|P2|NOT COMPLETED|First Study Night||0
8172144|NCT02436031|20148873|P1|NOT COMPLETED|First Study Night||0
8172145|NCT02436031|20148872|P2|COMPLETED|First Study Night||8
8172146|NCT02436031|20148873|P1|COMPLETED|First Study Night||8
8172147|NCT02436031|20148872|P2|STARTED|First Study Night||8
8172148|NCT02436031|20148873|P1|STARTED|First Study Night||8
8172149|NCT02436005|20148883|P2|NOT COMPLETED|Second Intervention||1
8172150|NCT02436005|20148884|P1|NOT COMPLETED|Second Intervention||0
8172151|NCT02436005|20148883|P2|COMPLETED|Second Intervention||12
8172152|NCT02436005|20148884|P1|COMPLETED|Second Intervention||12
8172153|NCT02436005|20148883|P2|STARTED|Second Intervention||13
8172154|NCT02436005|20148884|P1|STARTED|Second Intervention||12
8172155|NCT02436005|20148883|P2|NOT COMPLETED|First Intervention||0
8172156|NCT02436005|20148884|P1|NOT COMPLETED|First Intervention||0
8172157|NCT02436005|20148883|P2|COMPLETED|First Intervention||13
8172158|NCT02436005|20148884|P1|COMPLETED|First Intervention||12
8172159|NCT02436005|20148883|P2|STARTED|First Intervention||13
8172160|NCT02436005|20148884|P1|STARTED|First Intervention||12
8172161|NCT02435966|20148949|P3|NOT COMPLETED|Overall Study||0
8172162|NCT02435966|20148950|P2|NOT COMPLETED|Overall Study||1
8172163|NCT02435966|20148951|P1|NOT COMPLETED|Overall Study||0
8172164|NCT02435966|20148949|P3|COMPLETED|Overall Study||30
8172165|NCT02435966|20148950|P2|COMPLETED|Overall Study||53
8172166|NCT02435966|20148951|P1|COMPLETED|Overall Study||47
8172167|NCT02435966|20148949|P3|Follow-up|Overall Study||30
8172168|NCT02435966|20148950|P2|Follow-up|Overall Study||53
8172169|NCT02435966|20148951|P1|Follow-up|Overall Study||47
8172170|NCT02435966|20148949|P3|Second Intervention|Overall Study||30
8172171|NCT02435966|20148950|P2|Second Intervention|Overall Study||53
8172172|NCT02435966|20148951|P1|Second Intervention|Overall Study||47
8172173|NCT02435966|20148949|P3|First Intervention|Overall Study||30
8172174|NCT02435966|20148950|P2|First Intervention|Overall Study||54
8172175|NCT02435966|20148951|P1|First Intervention|Overall Study||47
8172176|NCT02435966|20148949|P3|STARTED|Overall Study||30
8172177|NCT02435966|20148950|P2|STARTED|Overall Study||54
8172178|NCT02435966|20148951|P1|STARTED|Overall Study||47
8172179|NCT02435914|20148963|P4|NOT COMPLETED|Overall Study||0
8172180|NCT02435914|20148964|P3|NOT COMPLETED|Overall Study||1
8172181|NCT02435914|20148965|P2|NOT COMPLETED|Overall Study||1
8172182|NCT02435914|20148966|P1|NOT COMPLETED|Overall Study||1
8172183|NCT02435914|20148963|P4|COMPLETED|Overall Study||59
8172184|NCT02435914|20148964|P3|COMPLETED|Overall Study||59
8172185|NCT02435914|20148965|P2|COMPLETED|Overall Study||58
8172186|NCT02435914|20148966|P1|COMPLETED|Overall Study||57
8172187|NCT02435914|20148963|P4|STARTED|Overall Study||59
8172188|NCT02435914|20148964|P3|STARTED|Overall Study||60
8172189|NCT02435914|20148965|P2|STARTED|Overall Study||59
8172190|NCT02435914|20148966|P1|STARTED|Overall Study||58
8172191|NCT02435901|20148988|P1|NOT COMPLETED|Overall Study||0
8172192|NCT02435901|20148988|P1|COMPLETED|Overall Study||29
8172193|NCT02435901|20148988|P1|STARTED|Overall Study||29
8172194|NCT02435836|20148994|P1|NOT COMPLETED|Overall Study||631
8172195|NCT02435836|20148994|P1|COMPLETED|Overall Study||0
8172196|NCT02435836|20148994|P1|STARTED|Overall Study||631
8172197|NCT02435706|20149012|P2|NOT COMPLETED|Overall Study||1
8172198|NCT02435706|20149013|P1|NOT COMPLETED|Overall Study||2
8172199|NCT02435706|20149012|P2|COMPLETED|Overall Study||20
8172200|NCT02435706|20149013|P1|COMPLETED|Overall Study||16
8172201|NCT02435706|20149012|P2|STARTED|Overall Study||21
8172202|NCT02435706|20149013|P1|STARTED|Overall Study||18
8172203|NCT02435524|20149027|P2|NOT COMPLETED|Endline Survey||0
8172204|NCT02435524|20149028|P1|NOT COMPLETED|Endline Survey||0
8172205|NCT02435524|20149027|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
8172206|NCT02435524|20149028|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
8172207|NCT02435524|20149027|P2|STARTED|Endline Survey||1161
8172208|NCT02435524|20149028|P1|STARTED|Endline Survey||1092
8172209|NCT02435524|20149027|P2|NOT COMPLETED|Baseline Survey||0
8172210|NCT02435524|20149028|P1|NOT COMPLETED|Baseline Survey||0
8172211|NCT02435524|20149027|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
8172212|NCT02435524|20149028|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
8172213|NCT02435524|20149027|P2|STARTED|Baseline Survey||1177
8172214|NCT02435524|20149028|P1|STARTED|Baseline Survey||1111
8172215|NCT02435511|20149036|P2|NOT COMPLETED|Overall Study||35
8172216|NCT02435511|20149037|P1|NOT COMPLETED|Overall Study||44
8172217|NCT02435511|20149036|P2|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
8172218|NCT02435511|20149037|P1|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
8172219|NCT02435511|20149036|P2|STARTED|Overall Study|Defined as enrolled and completed baseline|209
8172220|NCT02435511|20149037|P1|STARTED|Overall Study|Defined as enrolled and completed baseline|202
8172221|NCT02435433|20149053|P5|NOT COMPLETED|Overall Study||0
8172222|NCT02435433|20149054|P4|NOT COMPLETED|Overall Study||0
8172223|NCT02435433|20149055|P3|NOT COMPLETED|Overall Study||0
8172224|NCT02435433|20149056|P2|NOT COMPLETED|Overall Study||5
8172225|NCT02435433|20149057|P1|NOT COMPLETED|Overall Study||15
8172226|NCT02435433|20149053|P5|COMPLETED|Overall Study||0
8172227|NCT02435433|20149054|P4|COMPLETED|Overall Study||0
8172228|NCT02435433|20149055|P3|COMPLETED|Overall Study||0
8172229|NCT02435433|20149056|P2|COMPLETED|Overall Study||90
8172230|NCT02435433|20149057|P1|COMPLETED|Overall Study||182
8172231|NCT02435433|20149053|P5|Participants Who Received Study Drug|Overall Study||0
8172232|NCT02435433|20149054|P4|Participants Who Received Study Drug|Overall Study||0
8172233|NCT02435433|20149055|P3|Participants Who Received Study Drug|Overall Study||0
8172234|NCT02435433|20149056|P2|Participants Who Received Study Drug|Overall Study||95
8172235|NCT02435433|20149057|P1|Participants Who Received Study Drug|Overall Study||197
8172236|NCT02435433|20149053|P5|STARTED|Overall Study||0
8172237|NCT02435433|20149054|P4|STARTED|Overall Study||0
8172238|NCT02435433|20149055|P3|STARTED|Overall Study||0
8172239|NCT02435433|20149056|P2|STARTED|Overall Study||95
8172240|NCT02435433|20149057|P1|STARTED|Overall Study||197
8172241|NCT02435277|20149083|P4|NOT COMPLETED|Overall Study||0
8172242|NCT02435277|20149084|P3|NOT COMPLETED|Overall Study||0
8172243|NCT02435277|20149085|P2|NOT COMPLETED|Overall Study||1
8172244|NCT02435277|20149086|P1|NOT COMPLETED|Overall Study||2
8172245|NCT02435277|20149083|P4|COMPLETED|Overall Study||11
8172246|NCT02435277|20149084|P3|COMPLETED|Overall Study||11
8172247|NCT02435277|20149085|P2|COMPLETED|Overall Study||15
8172248|NCT02435277|20149086|P1|COMPLETED|Overall Study||10
8172249|NCT02435277|20149083|P4|STARTED|Overall Study||11
8172250|NCT02435277|20149084|P3|STARTED|Overall Study||11
8172251|NCT02435277|20149085|P2|STARTED|Overall Study||16
8172252|NCT02435277|20149086|P1|STARTED|Overall Study||12
8172253|NCT02435147|20149100|P1|NOT COMPLETED|Overall Study||11
8172254|NCT02435147|20149100|P1|COMPLETED|Overall Study||75
8172255|NCT02435147|20149100|P1|STARTED|Overall Study||86
8172256|NCT02435069|20149105|P5|NOT COMPLETED|Effectiveness - Second Intervention||1
8172257|NCT02435069|20149106|P4|NOT COMPLETED|Effectiveness - Second Intervention||0
8172258|NCT02435069|20149107|P3|NOT COMPLETED|Effectiveness - Second Intervention||0
8172259|NCT02435069|20149108|P2|NOT COMPLETED|Effectiveness - Second Intervention||0
8172260|NCT02435069|20149109|P1|NOT COMPLETED|Effectiveness - Second Intervention||0
8172261|NCT02435069|20149105|P5|COMPLETED|Effectiveness - Second Intervention||0
8172262|NCT02435069|20149106|P4|COMPLETED|Effectiveness - Second Intervention||1
8172263|NCT02435069|20149107|P3|COMPLETED|Effectiveness - Second Intervention||0
8172264|NCT02435069|20149108|P2|COMPLETED|Effectiveness - Second Intervention||0
8172265|NCT02435069|20149109|P1|COMPLETED|Effectiveness - Second Intervention||0
8172266|NCT02435069|20149105|P5|STARTED|Effectiveness - Second Intervention||1
8172267|NCT02435069|20149106|P4|STARTED|Effectiveness - Second Intervention||1
8172268|NCT02435069|20149107|P3|STARTED|Effectiveness - Second Intervention||0
8172269|NCT02435069|20149108|P2|STARTED|Effectiveness - Second Intervention||0
8172270|NCT02435069|20149109|P1|STARTED|Effectiveness - Second Intervention||0
8172271|NCT02435069|20149105|P5|NOT COMPLETED|Dose Response - First Intervention||0
8172272|NCT02435069|20149106|P4|NOT COMPLETED|Dose Response - First Intervention||0
8172273|NCT02435069|20149107|P3|NOT COMPLETED|Dose Response - First Intervention||1
8172274|NCT02435069|20149108|P2|NOT COMPLETED|Dose Response - First Intervention||1
8172275|NCT02435069|20149109|P1|NOT COMPLETED|Dose Response - First Intervention||0
8172276|NCT02435069|20149105|P5|COMPLETED|Dose Response - First Intervention||0
8172277|NCT02435069|20149106|P4|COMPLETED|Dose Response - First Intervention||0
8172278|NCT02435069|20149107|P3|COMPLETED|Dose Response - First Intervention||1
8172279|NCT02435069|20149108|P2|COMPLETED|Dose Response - First Intervention||2
8172280|NCT02435069|20149109|P1|COMPLETED|Dose Response - First Intervention||0
8172281|NCT02435069|20149105|P5|STARTED|Dose Response - First Intervention||0
8172282|NCT02435069|20149106|P4|STARTED|Dose Response - First Intervention||0
8172283|NCT02435069|20149107|P3|STARTED|Dose Response - First Intervention||2
8172284|NCT02435069|20149108|P2|STARTED|Dose Response - First Intervention||3
8172285|NCT02435069|20149109|P1|STARTED|Dose Response - First Intervention||0
8172286|NCT02435069|20149105|P5|NOT COMPLETED|Preoperative Baseline Phase||0
8172287|NCT02435069|20149106|P4|NOT COMPLETED|Preoperative Baseline Phase||0
8172288|NCT02435069|20149107|P3|NOT COMPLETED|Preoperative Baseline Phase||0
8172289|NCT02435069|20149108|P2|NOT COMPLETED|Preoperative Baseline Phase||0
8172290|NCT02435069|20149109|P1|NOT COMPLETED|Preoperative Baseline Phase||0
8172291|NCT02435069|20149105|P5|COMPLETED|Preoperative Baseline Phase||0
8172292|NCT02435069|20149106|P4|COMPLETED|Preoperative Baseline Phase||0
8172293|NCT02435069|20149107|P3|COMPLETED|Preoperative Baseline Phase||0
8172294|NCT02435069|20149108|P2|COMPLETED|Preoperative Baseline Phase||0
8172295|NCT02435069|20149109|P1|COMPLETED|Preoperative Baseline Phase||5
8172296|NCT02435069|20149105|P5|STARTED|Preoperative Baseline Phase||0
8172297|NCT02435069|20149106|P4|STARTED|Preoperative Baseline Phase||0
8172298|NCT02435069|20149107|P3|STARTED|Preoperative Baseline Phase||0
8172299|NCT02435069|20149108|P2|STARTED|Preoperative Baseline Phase||0
8172300|NCT02435069|20149109|P1|STARTED|Preoperative Baseline Phase||5
8172301|NCT02434939|20149131|P2|NOT COMPLETED|Overall Study||49
8172302|NCT02434939|20149132|P1|NOT COMPLETED|Overall Study||37
8172303|NCT02434939|20149131|P2|COMPLETED|Overall Study||71
8172304|NCT02434939|20149132|P1|COMPLETED|Overall Study||83
8172305|NCT02434939|20149131|P2|STARTED|Overall Study||120
8172306|NCT02434939|20149132|P1|STARTED|Overall Study||120
8172307|NCT02434770|20149147|P3|NOT COMPLETED|Week 18 to Week||6
8172308|NCT02434770|20149148|P2|NOT COMPLETED|Week 18 to Week||8
8172309|NCT02434770|20149149|P1|NOT COMPLETED|Week 18 to Week||8
8172310|NCT02434770|20149147|P3|COMPLETED|Week 18 to Week||227
8172311|NCT02434770|20149148|P2|COMPLETED|Week 18 to Week||220
8172312|NCT02434770|20149149|P1|COMPLETED|Week 18 to Week||227
8172313|NCT02434770|20149147|P3|STARTED|Week 18 to Week||233
8172314|NCT02434770|20149148|P2|STARTED|Week 18 to Week||228
8172315|NCT02434770|20149149|P1|STARTED|Week 18 to Week||235
8172316|NCT02434770|20149147|P3|NOT COMPLETED|Week 1 to Week 18||17
8172317|NCT02434770|20149148|P2|NOT COMPLETED|Week 1 to Week 18||22
8172318|NCT02434770|20149149|P1|NOT COMPLETED|Week 1 to Week 18||15
8172319|NCT02434770|20149147|P3|COMPLETED|Week 1 to Week 18||233
8172320|NCT02434770|20149148|P2|COMPLETED|Week 1 to Week 18||228
8172321|NCT02434770|20149149|P1|COMPLETED|Week 1 to Week 18||235
8172322|NCT02434770|20149147|P3|Received at Least One Vaccination|Week 1 to Week 18||250
8172323|NCT02434770|20149148|P2|Received at Least One Vaccination|Week 1 to Week 18||250
8172324|NCT02434770|20149149|P1|Received at Least One Vaccination|Week 1 to Week 18||249
8172325|NCT02434770|20149147|P3|STARTED|Week 1 to Week 18||250
8172326|NCT02434770|20149148|P2|STARTED|Week 1 to Week 18||250
8172327|NCT02434770|20149149|P1|STARTED|Week 1 to Week 18||250
8172328|NCT02434523|20149186|P2|NOT COMPLETED|Overall Study||6
8172329|NCT02434523|20149187|P1|NOT COMPLETED|Overall Study||5
8172330|NCT02434523|20149186|P2|COMPLETED|Overall Study||9
8172331|NCT02434523|20149187|P1|COMPLETED|Overall Study||10
8172332|NCT02434523|20149186|P2|STARTED|Overall Study||15
8172333|NCT02434523|20149187|P1|STARTED|Overall Study||15
8172334|NCT02434497|20149199|P1|NOT COMPLETED|Overall Study||5
8172335|NCT02434497|20149199|P1|COMPLETED|Overall Study||4
8172336|NCT02434497|20149199|P1|STARTED|Overall Study||9
8172337|NCT02434471|20149299|P1|NOT COMPLETED|Overall Study||9
8172338|NCT02434471|20149299|P1|COMPLETED|Overall Study||25
8172339|NCT02434471|20149299|P1|STARTED|Overall Study||34
8172340|NCT02434354|20149306|P1|NOT COMPLETED|Overall Study||3
8172341|NCT02434354|20149306|P1|COMPLETED|Overall Study||30
8172342|NCT02434354|20149306|P1|Post Consent Screening|Overall Study||30
8172343|NCT02434354|20149306|P1|STARTED|Overall Study|Consented|33
8172344|NCT02434328|20149312|P2|NOT COMPLETED|Overall Study||42
8172345|NCT02434328|20149313|P1|NOT COMPLETED|Overall Study||30
8172346|NCT02434328|20149312|P2|COMPLETED|Overall Study||329
8172347|NCT02434328|20149313|P1|COMPLETED|Overall Study||342
8172348|NCT02434328|20149312|P2|Randomized and Treated|Overall Study||369
8172349|NCT02434328|20149313|P1|Randomized and Treated|Overall Study||370
8172350|NCT02434328|20149312|P2|STARTED|Overall Study||371
8172351|NCT02434328|20149313|P1|STARTED|Overall Study||372
8172352|NCT02434146|20149376|P1|NOT COMPLETED|Overall Study||0
8172353|NCT02434146|20149376|P1|COMPLETED|Overall Study||3
8172354|NCT02434146|20149376|P1|STARTED|Overall Study||3
8172355|NCT02433834|20149388|P1|NOT COMPLETED|Overall Study||37
8172356|NCT02433834|20149388|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
8172357|NCT02433834|20149388|P1|SAL 50 µg|Overall Study||167
8172358|NCT02433834|20149388|P1|Placebo MDI|Overall Study||174
8172359|NCT02433834|20149388|P1|GP MDI 1.9 µg|Overall Study||107
8172360|NCT02433834|20149388|P1|GP MDI 3.6 µg|Overall Study||118
8172361|NCT02433834|20149388|P1|GP MDI 7.2 µg|Overall Study||228
8172362|NCT02433834|20149388|P1|GP MDI 14.4 µg|Overall Study||230
8172363|NCT02433834|20149388|P1|GP MDI 28.8 µg|Overall Study||112
8172364|NCT02433834|20149388|P1|STARTED|Overall Study||248
8172365|NCT02433678|20149448|P2|NOT COMPLETED|Overall Study||2
8172366|NCT02433678|20149449|P1|NOT COMPLETED|Overall Study||1
8172367|NCT02433678|20149448|P2|COMPLETED|Overall Study||24
8172368|NCT02433678|20149449|P1|COMPLETED|Overall Study||25
8172369|NCT02433678|20149448|P2|STARTED|Overall Study||26
8172370|NCT02433678|20149449|P1|STARTED|Overall Study||26
8172371|NCT02433665|20149483|P2|NOT COMPLETED|Overall Study||0
8172372|NCT02433665|20149484|P1|NOT COMPLETED|Overall Study||0
8172373|NCT02433665|20149483|P2|COMPLETED|Overall Study||79
8172374|NCT02433665|20149484|P1|COMPLETED|Overall Study||77
8172375|NCT02433665|20149483|P2|STARTED|Overall Study||79
8172376|NCT02433665|20149484|P1|STARTED|Overall Study||77
8172377|NCT02433613|20149490|P1|NOT COMPLETED|Overall Study||17
8172378|NCT02433613|20149490|P1|COMPLETED|Overall Study||1054
8172379|NCT02433613|20149490|P1|STARTED|Overall Study||1071
8172380|NCT02433496|20149510|P3|NOT COMPLETED|Overall Study||0
8172381|NCT02433496|20149511|P2|NOT COMPLETED|Overall Study||0
8172382|NCT02433496|20149512|P1|NOT COMPLETED|Overall Study||0
8172383|NCT02433496|20149510|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
8172384|NCT02433496|20149511|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
8172385|NCT02433496|20149512|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
8172386|NCT02433496|20149510|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
8172387|NCT02433496|20149511|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
8172388|NCT02433496|20149512|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
8172389|NCT02433483|20149542|P1|NOT COMPLETED|Overall Study||2
8172390|NCT02433483|20149542|P1|COMPLETED|Overall Study||0
8172391|NCT02433483|20149542|P1|STARTED|Overall Study||2
8172392|NCT02433379|20149554|P1|NOT COMPLETED|Overall Study||321
8172393|NCT02433379|20149554|P1|COMPLETED|Overall Study||852
8172394|NCT02433379|20149554|P1|STARTED|Overall Study||1173
8172395|NCT02433366|20149564|P2|NOT COMPLETED|Overall Study||0
8172396|NCT02433366|20149565|P1|NOT COMPLETED|Overall Study||0
8172397|NCT02433366|20149564|P2|COMPLETED|Overall Study||802
8172398|NCT02433366|20149565|P1|COMPLETED|Overall Study||411
8172399|NCT02433366|20149564|P2|STARTED|Overall Study||802
8172400|NCT02433366|20149565|P1|STARTED|Overall Study||411
8172401|NCT02433340|20149577|P4|NOT COMPLETED|Overall Study||2
8172402|NCT02433340|20149578|P3|NOT COMPLETED|Overall Study||2
8172403|NCT02433340|20149579|P2|NOT COMPLETED|Overall Study||2
8172404|NCT02433340|20149580|P1|NOT COMPLETED|Overall Study||2
8172405|NCT02433340|20149577|P4|COMPLETED|Overall Study||38
8172406|NCT02433340|20149578|P3|COMPLETED|Overall Study||37
8172407|NCT02433340|20149579|P2|COMPLETED|Overall Study||35
8172408|NCT02433340|20149580|P1|COMPLETED|Overall Study||40
8172409|NCT02433340|20149577|P4|STARTED|Overall Study||40
8172410|NCT02433340|20149578|P3|STARTED|Overall Study||39
8172411|NCT02433340|20149579|P2|STARTED|Overall Study||37
8172412|NCT02433340|20149580|P1|STARTED|Overall Study||42
8172413|NCT02433288|20150474|P2|NOT COMPLETED|Overall Study||126
8172414|NCT02433288|20150475|P1|NOT COMPLETED|Overall Study||123
8172415|NCT02433288|20150474|P2|COMPLETED|Overall Study||316
8172416|NCT02433288|20150475|P1|COMPLETED|Overall Study||320
8172417|NCT02433288|20150474|P2|STARTED|Overall Study||442
8172418|NCT02433288|20150475|P1|STARTED|Overall Study||443
8172419|NCT02433080|20150491|P2|NOT COMPLETED|Overall Study||4
8172420|NCT02433080|20150492|P1|NOT COMPLETED|Overall Study||1
8172421|NCT02433080|20150491|P2|COMPLETED|Overall Study||24
8172422|NCT02433080|20150492|P1|COMPLETED|Overall Study||25
8172423|NCT02433080|20150491|P2|8 Weeks|Overall Study||24
8172424|NCT02433080|20150492|P1|8 Weeks|Overall Study||25
8172425|NCT02433080|20150491|P2|STARTED|Overall Study||28
8172426|NCT02433080|20150492|P1|STARTED|Overall Study||26
8172427|NCT02432742|20150518|P1|NOT COMPLETED|Overall Study||5
8172428|NCT02432742|20150518|P1|COMPLETED|Overall Study||95
8172429|NCT02432742|20150518|P1|STARTED|Overall Study||100
8172430|NCT02432729|20150523|P1|NOT COMPLETED|Month 12 Visit||196
8172431|NCT02432729|20150523|P1|COMPLETED|Month 12 Visit||436
8172432|NCT02432729|20150523|P1|STARTED|Month 12 Visit||632
8172433|NCT02432729|20150523|P1|NOT COMPLETED|Month 6 Visit||86
8172434|NCT02432729|20150523|P1|COMPLETED|Month 6 Visit||632
8172435|NCT02432729|20150523|P1|STARTED|Month 6 Visit||718
8172436|NCT02432729|20150523|P1|NOT COMPLETED|Month 3 Visit||2
8172437|NCT02432729|20150523|P1|COMPLETED|Month 3 Visit||718
8172438|NCT02432729|20150523|P1|STARTED|Month 3 Visit||720
8172439|NCT02432716|20150551|P2|NOT COMPLETED|Overall Study||0
8172440|NCT02432716|20150552|P1|NOT COMPLETED|Overall Study||0
8172441|NCT02432716|20150551|P2|COMPLETED|Overall Study||6
8172442|NCT02432716|20150552|P1|COMPLETED|Overall Study||6
8172443|NCT02432716|20150551|P2|STARTED|Overall Study||6
8172444|NCT02432716|20150552|P1|STARTED|Overall Study||6
8172445|NCT02432456|20150568|P2|NOT COMPLETED|Overall Study||0
8172446|NCT02432456|20150569|P1|NOT COMPLETED|Overall Study||0
8172447|NCT02432456|20150568|P2|COMPLETED|Overall Study||75
8172448|NCT02432456|20150569|P1|COMPLETED|Overall Study||75
8172449|NCT02432456|20150568|P2|STARTED|Overall Study||75
8172450|NCT02432456|20150569|P1|STARTED|Overall Study||75
8172451|NCT02432300|20150591|P1|NOT COMPLETED|Overall Study||4
8172452|NCT02432300|20150591|P1|COMPLETED|Overall Study||13
8172453|NCT02432300|20150591|P1|STARTED|Overall Study||17
8172454|NCT02432287|20150600|P2|NOT COMPLETED|Second Intervention||0
8172455|NCT02432287|20150601|P1|NOT COMPLETED|Second Intervention||0
8172456|NCT02432287|20150600|P2|COMPLETED|Second Intervention||7
8172457|NCT02432287|20150601|P1|COMPLETED|Second Intervention||7
8172458|NCT02432287|20150600|P2|STARTED|Second Intervention||7
8172459|NCT02432287|20150601|P1|STARTED|Second Intervention||7
8172460|NCT02432287|20150600|P2|NOT COMPLETED|Washout Period||0
8172461|NCT02432287|20150601|P1|NOT COMPLETED|Washout Period||0
8172462|NCT02432287|20150600|P2|COMPLETED|Washout Period||7
8172463|NCT02432287|20150601|P1|COMPLETED|Washout Period||7
8172464|NCT02432287|20150600|P2|STARTED|Washout Period||7
8172465|NCT02432287|20150601|P1|STARTED|Washout Period||7
8172466|NCT02432287|20150600|P2|NOT COMPLETED|First Intervention||1
8172467|NCT02432287|20150601|P1|NOT COMPLETED|First Intervention||0
8172468|NCT02432287|20150600|P2|COMPLETED|First Intervention||7
8172469|NCT02432287|20150601|P1|COMPLETED|First Intervention||8
8172470|NCT02432287|20150600|P2|STARTED|First Intervention||8
8172471|NCT02432287|20150601|P1|STARTED|First Intervention||8
8172512|NCT02432196|20150737|P1|NOT COMPLETED|Overall Study||26
8172513|NCT02432196|20150737|P1|COMPLETED|Overall Study||0
8172514|NCT02432196|20150737|P1|Implanted With Device|Overall Study||25
8172515|NCT02432196|20150737|P1|STARTED|Overall Study||26
8172516|NCT02432144|20150745|P1|NOT COMPLETED|Overall Study||1
8172517|NCT02432144|20150745|P1|COMPLETED|Overall Study||11
8172518|NCT02432144|20150745|P1|STARTED|Overall Study||12
8172519|NCT02432105|20150753|P3|NOT COMPLETED|Overall Study||3
8172520|NCT02432105|20150754|P2|NOT COMPLETED|Overall Study||2
8172521|NCT02432105|20150755|P1|NOT COMPLETED|Overall Study||2
8172522|NCT02432105|20150753|P3|COMPLETED|Overall Study||108
8172523|NCT02432105|20150754|P2|COMPLETED|Overall Study||108
8172524|NCT02432105|20150755|P1|COMPLETED|Overall Study||162
8172525|NCT02432105|20150753|P3|STARTED|Overall Study||111
8172526|NCT02432105|20150754|P2|STARTED|Overall Study||110
8172527|NCT02432105|20150755|P1|STARTED|Overall Study||164
8172528|NCT02432040|20150772|P2|NOT COMPLETED|Overall Study||6
8172529|NCT02432040|20150773|P1|NOT COMPLETED|Overall Study||8
8172530|NCT02432040|20150772|P2|COMPLETED|Overall Study||8
8172531|NCT02432040|20150773|P1|COMPLETED|Overall Study||6
8172532|NCT02432040|20150772|P2|STARTED|Overall Study||14
8172533|NCT02432040|20150773|P1|STARTED|Overall Study||14
8172534|NCT02431806|20150797|P4|NOT COMPLETED|Double-blind Down-taper Period||0
8172535|NCT02431806|20150798|P3|NOT COMPLETED|Double-blind Down-taper Period||0
8172536|NCT02431806|20150799|P2|NOT COMPLETED|Double-blind Down-taper Period||0
8172537|NCT02431806|20150800|P1|NOT COMPLETED|Double-blind Down-taper Period||0
8172538|NCT02431806|20150797|P4|COMPLETED|Double-blind Down-taper Period||107
8172539|NCT02431806|20150798|P3|COMPLETED|Double-blind Down-taper Period||104
8172540|NCT02431806|20150799|P2|COMPLETED|Double-blind Down-taper Period||109
8172541|NCT02431806|20150800|P1|COMPLETED|Double-blind Down-taper Period||111
8172542|NCT02431806|20150797|P4|STARTED|Double-blind Down-taper Period||107
8172543|NCT02431806|20150798|P3|STARTED|Double-blind Down-taper Period||104
8172544|NCT02431806|20150799|P2|STARTED|Double-blind Down-taper Period||109
8172545|NCT02431806|20150800|P1|STARTED|Double-blind Down-taper Period||111
8172546|NCT02431806|20150797|P4|NOT COMPLETED|Double-blind Treatment Period||26
8172547|NCT02431806|20150798|P3|NOT COMPLETED|Double-blind Treatment Period||32
8172548|NCT02431806|20150799|P2|NOT COMPLETED|Double-blind Treatment Period||21
8172549|NCT02431806|20150800|P1|NOT COMPLETED|Double-blind Treatment Period||25
8172550|NCT02431806|20150797|P4|COMPLETED|Double-blind Treatment Period||109
8172551|NCT02431806|20150798|P3|COMPLETED|Double-blind Treatment Period||107
8172552|NCT02431806|20150799|P2|COMPLETED|Double-blind Treatment Period||115
8172553|NCT02431806|20150800|P1|COMPLETED|Double-blind Treatment Period||117
8172554|NCT02431806|20150797|P4|Safety Population|Double-blind Treatment Period||134
8172555|NCT02431806|20150798|P3|Safety Population|Double-blind Treatment Period||138
8172556|NCT02431806|20150799|P2|Safety Population|Double-blind Treatment Period||134
8172557|NCT02431806|20150800|P1|Safety Population|Double-blind Treatment Period||141
8172558|NCT02431806|20150797|P4|STARTED|Double-blind Treatment Period||135
8172559|NCT02431806|20150798|P3|STARTED|Double-blind Treatment Period||139
8172560|NCT02431806|20150799|P2|STARTED|Double-blind Treatment Period||136
8172561|NCT02431806|20150800|P1|STARTED|Double-blind Treatment Period||142
8172562|NCT02431793|20150817|P3|NOT COMPLETED|Overall Study||117
8172563|NCT02431793|20150818|P2|NOT COMPLETED|Overall Study||134
8172564|NCT02431793|20150819|P1|NOT COMPLETED|Overall Study||119
8172565|NCT02431793|20150817|P3|COMPLETED|Overall Study||90
8172566|NCT02431793|20150818|P2|COMPLETED|Overall Study||109
8172567|NCT02431793|20150819|P1|COMPLETED|Overall Study||83
8172568|NCT02431793|20150817|P3|Completed T3 (30 Days Post Enrollment)|Overall Study||93
8172569|NCT02431793|20150818|P2|Completed T3 (30 Days Post Enrollment)|Overall Study||113
8172570|NCT02431793|20150819|P1|Completed T3 (30 Days Post Enrollment)|Overall Study||85
8172571|NCT02431793|20150817|P3|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
8172572|NCT02431793|20150818|P2|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
8172573|NCT02431793|20150819|P1|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
8172574|NCT02431793|20150817|P3|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
8172575|NCT02431793|20150818|P2|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
8172576|NCT02431793|20150819|P1|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
8172577|NCT02431793|20150817|P3|STARTED|Overall Study||207
8172578|NCT02431793|20150818|P2|STARTED|Overall Study||243
8172579|NCT02431793|20150819|P1|STARTED|Overall Study||202
8172580|NCT02431754|20150841|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
8172581|NCT02431754|20150842|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
8172582|NCT02431754|20150841|P2|COMPLETED|Period 2 (8 Weeks)||78
8172583|NCT02431754|20150842|P1|COMPLETED|Period 2 (8 Weeks)||74
8172584|NCT02431754|20150841|P2|STARTED|Period 2 (8 Weeks)||82
8172585|NCT02431754|20150842|P1|STARTED|Period 2 (8 Weeks)||75
8172586|NCT02431754|20150841|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
8172587|NCT02431754|20150842|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
8172588|NCT02431754|20150841|P2|COMPLETED|Wash-out Period (4 Weeks)||82
8172589|NCT02431754|20150842|P1|COMPLETED|Wash-out Period (4 Weeks)||75
8172590|NCT02431754|20150841|P2|STARTED|Wash-out Period (4 Weeks)||82
8172591|NCT02431754|20150842|P1|STARTED|Wash-out Period (4 Weeks)||79
8172592|NCT02431754|20150841|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
8172593|NCT02431754|20150842|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
8172594|NCT02431754|20150841|P2|COMPLETED|Period 1 (8 Weeks)||82
8172595|NCT02431754|20150842|P1|COMPLETED|Period 1 (8 Weeks)||79
8172596|NCT02431754|20150841|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
8172597|NCT02431754|20150842|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
8172598|NCT02431754|20150841|P2|STARTED|Period 1 (8 Weeks)||86
8172599|NCT02431754|20150842|P1|STARTED|Period 1 (8 Weeks)||85
8172600|NCT02431741|20150860|P1|NOT COMPLETED|Overall Study||0
8172601|NCT02431741|20150860|P1|COMPLETED|Overall Study||14
8172602|NCT02431741|20150860|P1|STARTED|Overall Study||14
8172603|NCT02431702|20150864|P7|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172604|NCT02431702|20150865|P6|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
8172605|NCT02431702|20150866|P5|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
8172606|NCT02431702|20150867|P4|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
8172607|NCT02431702|20150868|P3|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172608|NCT02431702|20150869|P2|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172609|NCT02431702|20150870|P1|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172610|NCT02431702|20150864|P7|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172611|NCT02431702|20150865|P6|COMPLETED|Part 3: 9 Month of Additional Treatment||46
8172612|NCT02431702|20150866|P5|COMPLETED|Part 3: 9 Month of Additional Treatment||47
8172613|NCT02431702|20150867|P4|COMPLETED|Part 3: 9 Month of Additional Treatment||40
8172614|NCT02431702|20150868|P3|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172615|NCT02431702|20150869|P2|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172616|NCT02431702|20150870|P1|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172617|NCT02431702|20150864|P7|STARTED|Part 3: 9 Month of Additional Treatment||0
8172618|NCT02431702|20150865|P6|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
8172619|NCT02431702|20150866|P5|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
8172620|NCT02431702|20150867|P4|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
8172621|NCT02431702|20150868|P3|STARTED|Part 3: 9 Month of Additional Treatment||0
8172622|NCT02431702|20150869|P2|STARTED|Part 3: 9 Month of Additional Treatment||0
8172623|NCT02431702|20150870|P1|STARTED|Part 3: 9 Month of Additional Treatment||0
8172624|NCT02431702|20150864|P7|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172625|NCT02431702|20150865|P6|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172626|NCT02431702|20150866|P5|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172627|NCT02431702|20150867|P4|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172628|NCT02431702|20150868|P3|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
8172629|NCT02431702|20150869|P2|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
8172630|NCT02431702|20150870|P1|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172631|NCT02431702|20150864|P7|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172632|NCT02431702|20150865|P6|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172633|NCT02431702|20150866|P5|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172634|NCT02431702|20150867|P4|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172635|NCT02431702|20150868|P3|COMPLETED|Part 2: 9Month Disease Progression Phase||128
8172636|NCT02431702|20150869|P2|COMPLETED|Part 2: 9Month Disease Progression Phase||52
8172637|NCT02431702|20150870|P1|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172638|NCT02431702|20150864|P7|STARTED|Part 2: 9Month Disease Progression Phase||0
8172639|NCT02431702|20150865|P6|STARTED|Part 2: 9Month Disease Progression Phase||0
8172640|NCT02431702|20150866|P5|STARTED|Part 2: 9Month Disease Progression Phase||0
8172641|NCT02431702|20150867|P4|STARTED|Part 2: 9Month Disease Progression Phase||0
8172642|NCT02431702|20150868|P3|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
8172643|NCT02431702|20150869|P2|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
8172644|NCT02431702|20150870|P1|STARTED|Part 2: 9Month Disease Progression Phase||0
8172645|NCT02431702|20150864|P7|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
8172646|NCT02431702|20150865|P6|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172647|NCT02431702|20150866|P5|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172648|NCT02431702|20150867|P4|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172649|NCT02431702|20150868|P3|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172650|NCT02431702|20150869|P2|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172651|NCT02431702|20150870|P1|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
8172652|NCT02431702|20150864|P7|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
8172653|NCT02431702|20150865|P6|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172654|NCT02431702|20150866|P5|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172655|NCT02431702|20150867|P4|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172656|NCT02431702|20150868|P3|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172657|NCT02431702|20150869|P2|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172658|NCT02431702|20150870|P1|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
8172659|NCT02431702|20150864|P7|STARTED|Part 1: 2-Month Oral Run-in Phase||64
8172660|NCT02431702|20150865|P6|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172661|NCT02431702|20150866|P5|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172662|NCT02431702|20150867|P4|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172663|NCT02431702|20150868|P3|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172664|NCT02431702|20150869|P2|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172665|NCT02431702|20150870|P1|STARTED|Part 1: 2-Month Oral Run-in Phase||273
8172666|NCT02431676|20150946|P3|NOT COMPLETED|Overall Study||2
8172667|NCT02431676|20150947|P2|NOT COMPLETED|Overall Study||1
8172668|NCT02431676|20150948|P1|NOT COMPLETED|Overall Study||0
8172669|NCT02431676|20150946|P3|COMPLETED|Overall Study||40
8172670|NCT02431676|20150947|P2|COMPLETED|Overall Study||38
8172671|NCT02431676|20150948|P1|COMPLETED|Overall Study||40
8172672|NCT02431676|20150946|P3|STARTED|Overall Study||42
8172673|NCT02431676|20150947|P2|STARTED|Overall Study||39
8172674|NCT02431676|20150948|P1|STARTED|Overall Study||40
8172675|NCT02431650|20150964|P2|NOT COMPLETED|Overall Study||0
8172676|NCT02431650|20150965|P1|NOT COMPLETED|Overall Study||0
8172677|NCT02431650|20150964|P2|COMPLETED|Overall Study||6
8172678|NCT02431650|20150965|P1|COMPLETED|Overall Study||5
8172679|NCT02431650|20150964|P2|STARTED|Overall Study||6
8172680|NCT02431650|20150965|P1|STARTED|Overall Study||5
8172681|NCT02431637|20150973|P1|NOT COMPLETED|Overall Study||0
8172682|NCT02431637|20150973|P1|COMPLETED|Overall Study||6
8172683|NCT02431637|20150973|P1|STARTED|Overall Study||6
8172684|NCT02431598|20150978|P6|NOT COMPLETED|Overall Study||0
8172685|NCT02431598|20150979|P5|NOT COMPLETED|Overall Study||0
8172686|NCT02431598|20150980|P4|NOT COMPLETED|Overall Study||0
8172687|NCT02431598|20150981|P3|NOT COMPLETED|Overall Study||0
8172688|NCT02431598|20150982|P2|NOT COMPLETED|Overall Study||0
8172689|NCT02431598|20150983|P1|NOT COMPLETED|Overall Study||0
8172690|NCT02431598|20150978|P6|COMPLETED|Overall Study||6
8172691|NCT02431598|20150979|P5|COMPLETED|Overall Study||7
8172692|NCT02431598|20150980|P4|COMPLETED|Overall Study||7
8172693|NCT02431598|20150981|P3|COMPLETED|Overall Study||9
8172694|NCT02431598|20150982|P2|COMPLETED|Overall Study||9
8172695|NCT02431598|20150983|P1|COMPLETED|Overall Study||6
8172696|NCT02431598|20150978|P6|STARTED|Overall Study||6
8172697|NCT02431598|20150979|P5|STARTED|Overall Study||7
8172698|NCT02431598|20150980|P4|STARTED|Overall Study||7
8172699|NCT02431598|20150981|P3|STARTED|Overall Study||9
8172700|NCT02431598|20150982|P2|STARTED|Overall Study||9
8172701|NCT02431598|20150983|P1|STARTED|Overall Study||6
8172702|NCT02431572|20151010|P3|NOT COMPLETED|Overall Study||0
8172703|NCT02431572|20151011|P2|NOT COMPLETED|Overall Study||0
8172704|NCT02431572|20151012|P1|NOT COMPLETED|Overall Study||1
8172705|NCT02431572|20151010|P3|COMPLETED|Overall Study||9
8172706|NCT02431572|20151011|P2|COMPLETED|Overall Study||1
8172707|NCT02431572|20151012|P1|COMPLETED|Overall Study||0
8172708|NCT02431572|20151010|P3|STARTED|Overall Study||9
8172709|NCT02431572|20151011|P2|STARTED|Overall Study||1
8172710|NCT02431572|20151012|P1|STARTED|Overall Study||1
8172711|NCT02431559|20151024|P4|NOT COMPLETED|Overall Study||31
8172712|NCT02431559|20151025|P3|NOT COMPLETED|Overall Study||4
8172713|NCT02431559|20151026|P2|NOT COMPLETED|Overall Study||3
8172714|NCT02431559|20151027|P1|NOT COMPLETED|Overall Study||2
8172715|NCT02431559|20151024|P4|COMPLETED|Overall Study||9
8172716|NCT02431559|20151025|P3|COMPLETED|Overall Study||2
8172717|NCT02431559|20151026|P2|COMPLETED|Overall Study||1
8172718|NCT02431559|20151027|P1|COMPLETED|Overall Study||1
8172719|NCT02431559|20151024|P4|STARTED|Overall Study||40
8172720|NCT02431559|20151025|P3|STARTED|Overall Study||6
8172721|NCT02431559|20151026|P2|STARTED|Overall Study||4
8172722|NCT02431559|20151027|P1|STARTED|Overall Study||3
8172723|NCT02431533|20151051|P2|NOT COMPLETED|Overall Study||3
8172724|NCT02431533|20151052|P1|NOT COMPLETED|Overall Study||2
8172725|NCT02431533|20151051|P2|COMPLETED|Overall Study||22
8172726|NCT02431533|20151052|P1|COMPLETED|Overall Study||23
8172727|NCT02431533|20151051|P2|STARTED|Overall Study||25
8172728|NCT02431533|20151052|P1|STARTED|Overall Study||25
8172729|NCT02431494|20151087|P3|NOT COMPLETED|Overall Study||0
8172730|NCT02431494|20151088|P2|NOT COMPLETED|Overall Study||0
8172731|NCT02431494|20151089|P1|NOT COMPLETED|Overall Study||0
8172732|NCT02431494|20151087|P3|COMPLETED|Overall Study||0
8172733|NCT02431494|20151088|P2|COMPLETED|Overall Study||0
8172734|NCT02431494|20151089|P1|COMPLETED|Overall Study||0
8172735|NCT02431494|20151087|P3|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
8172736|NCT02431494|20151088|P2|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
8172737|NCT02431494|20151089|P1|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
8172738|NCT02431468|20151118|P3|NOT COMPLETED|Overall Study||9
8172739|NCT02431468|20151119|P2|NOT COMPLETED|Overall Study||18
8172740|NCT02431468|20151120|P1|NOT COMPLETED|Overall Study||8
8172741|NCT02431468|20151118|P3|COMPLETED|Overall Study||39
8172742|NCT02431468|20151119|P2|COMPLETED|Overall Study||29
8172743|NCT02431468|20151120|P1|COMPLETED|Overall Study||38
8172744|NCT02431468|20151118|P3|STARTED|Overall Study||48
8172745|NCT02431468|20151119|P2|STARTED|Overall Study||47
8172746|NCT02431468|20151120|P1|STARTED|Overall Study||46
8172747|NCT02431455|20151142|P2|NOT COMPLETED|Overall Study||0
8172748|NCT02431455|20151143|P1|NOT COMPLETED|Overall Study||0
8172749|NCT02431455|20151142|P2|COMPLETED|Overall Study||112
8172750|NCT02431455|20151143|P1|COMPLETED|Overall Study||112
8172751|NCT02431455|20151142|P2|STARTED|Overall Study||112
8172752|NCT02431455|20151143|P1|STARTED|Overall Study||112
8172753|NCT02431299|20151157|P2|NOT COMPLETED|Overall Study||1
8172754|NCT02431299|20151158|P1|NOT COMPLETED|Overall Study||53
8172755|NCT02431299|20151157|P2|COMPLETED|Overall Study||62
8172756|NCT02431299|20151158|P1|COMPLETED|Overall Study||183
8172757|NCT02431299|20151157|P2|STARTED|Overall Study||63
8172758|NCT02431299|20151158|P1|STARTED|Overall Study||236
8172759|NCT02431273|20151171|P1|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
8172760|NCT02431273|20151171|P1|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
8172761|NCT02431273|20151171|P1|STARTED|TDF-FTC-MVC (Triple IVR)||6
8172762|NCT02431273|20151171|P1|NOT COMPLETED|TDF-FTC (Dual IVR)||0
8172763|NCT02431273|20151171|P1|COMPLETED|TDF-FTC (Dual IVR)||6
8172764|NCT02431273|20151171|P1|STARTED|TDF-FTC (Dual IVR)||6
8172765|NCT02431273|20151171|P1|NOT COMPLETED|TDF (Single IVR)||0
8172766|NCT02431273|20151171|P1|COMPLETED|TDF (Single IVR)||6
8172767|NCT02431273|20151171|P1|STARTED|TDF (Single IVR)||6
8172768|NCT02431260|20151211|P14|NOT COMPLETED|Overall Study||1
8172769|NCT02431260|20151212|P13|NOT COMPLETED|Overall Study||10
8172770|NCT02431260|20151213|P12|NOT COMPLETED|Overall Study||4
8172771|NCT02431260|20151214|P11|NOT COMPLETED|Overall Study||4
8172772|NCT02431260|20151215|P10|NOT COMPLETED|Overall Study||8
8172773|NCT02431260|20151216|P9|NOT COMPLETED|Overall Study||8
8172774|NCT02431260|20151217|P8|NOT COMPLETED|Overall Study||3
8172775|NCT02431260|20151218|P7|NOT COMPLETED|Overall Study||4
8172776|NCT02431260|20151219|P6|NOT COMPLETED|Overall Study||4
8172777|NCT02431260|20151220|P5|NOT COMPLETED|Overall Study||3
8172778|NCT02431260|20151221|P4|NOT COMPLETED|Overall Study||5
8172779|NCT02431260|20151222|P3|NOT COMPLETED|Overall Study||6
8172780|NCT02431260|20151223|P2|NOT COMPLETED|Overall Study||5
8172781|NCT02431260|20151224|P1|NOT COMPLETED|Overall Study||4
8172782|NCT02431260|20151211|P14|COMPLETED|Overall Study||0
8172783|NCT02431260|20151212|P13|COMPLETED|Overall Study||0
8172784|NCT02431260|20151213|P12|COMPLETED|Overall Study||0
8172785|NCT02431260|20151214|P11|COMPLETED|Overall Study||0
8172786|NCT02431260|20151215|P10|COMPLETED|Overall Study||0
8172787|NCT02431260|20151216|P9|COMPLETED|Overall Study||0
8172788|NCT02431260|20151217|P8|COMPLETED|Overall Study||0
8172789|NCT02431260|20151218|P7|COMPLETED|Overall Study||0
8172790|NCT02431260|20151219|P6|COMPLETED|Overall Study||0
8172791|NCT02431260|20151220|P5|COMPLETED|Overall Study||0
8172792|NCT02431260|20151221|P4|COMPLETED|Overall Study||0
8172793|NCT02431260|20151222|P3|COMPLETED|Overall Study||0
8172794|NCT02431260|20151223|P2|COMPLETED|Overall Study||0
8172795|NCT02431260|20151224|P1|COMPLETED|Overall Study||0
8172796|NCT02431260|20151211|P14|STARTED|Overall Study||1
8172797|NCT02431260|20151212|P13|STARTED|Overall Study||10
8172798|NCT02431260|20151213|P12|STARTED|Overall Study||4
8172799|NCT02431260|20151214|P11|STARTED|Overall Study||4
8172800|NCT02431260|20151215|P10|STARTED|Overall Study||8
8172801|NCT02431260|20151216|P9|STARTED|Overall Study||8
8172802|NCT02431260|20151217|P8|STARTED|Overall Study||3
8172803|NCT02431260|20151218|P7|STARTED|Overall Study||4
8172804|NCT02431260|20151219|P6|STARTED|Overall Study||4
8172805|NCT02431260|20151220|P5|STARTED|Overall Study||3
8172806|NCT02431260|20151221|P4|STARTED|Overall Study||5
8172807|NCT02431260|20151222|P3|STARTED|Overall Study||6
8172808|NCT02431260|20151223|P2|STARTED|Overall Study||5
8172809|NCT02431260|20151224|P1|STARTED|Overall Study||4
8172810|NCT02431247|20151317|P2|NOT COMPLETED|Overall Study||363
8172811|NCT02431247|20151318|P1|NOT COMPLETED|Overall Study||362
8172812|NCT02431247|20151317|P2|COMPLETED|Overall Study||0
8172813|NCT02431247|20151318|P1|COMPLETED|Overall Study||0
8172814|NCT02431247|20151317|P2|STARTED|Overall Study||363
8172815|NCT02431247|20151318|P1|STARTED|Overall Study||362
8172816|NCT02431052|20151377|P5|NOT COMPLETED|Overall Study||15
8172817|NCT02431052|20151378|P4|NOT COMPLETED|Overall Study||16
8172818|NCT02431052|20151379|P3|NOT COMPLETED|Overall Study||12
8172819|NCT02431052|20151380|P2|NOT COMPLETED|Overall Study||4
8172820|NCT02431052|20151381|P1|NOT COMPLETED|Overall Study||11
8172821|NCT02431052|20151377|P5|COMPLETED|Overall Study||86
8172822|NCT02431052|20151378|P4|COMPLETED|Overall Study||94
8172823|NCT02431052|20151379|P3|COMPLETED|Overall Study||94
8172824|NCT02431052|20151380|P2|COMPLETED|Overall Study||46
8172825|NCT02431052|20151381|P1|COMPLETED|Overall Study||42
8172826|NCT02431052|20151377|P5|STARTED|Overall Study||101
8172827|NCT02431052|20151378|P4|STARTED|Overall Study||110
8172828|NCT02431052|20151379|P3|STARTED|Overall Study||106
8172829|NCT02431052|20151380|P2|STARTED|Overall Study||50
8172830|NCT02431052|20151381|P1|STARTED|Overall Study||53
8172831|NCT02430870|20151411|P8|NOT COMPLETED|Part 2||1
8172832|NCT02430870|20151412|P7|NOT COMPLETED|Part 2||1
8172833|NCT02430870|20151413|P6|NOT COMPLETED|Part 2||0
8172834|NCT02430870|20151414|P5|NOT COMPLETED|Part 2||0
8172835|NCT02430870|20151415|P4|NOT COMPLETED|Part 2||0
8172836|NCT02430870|20151416|P3|NOT COMPLETED|Part 2||0
8172837|NCT02430870|20151417|P2|NOT COMPLETED|Part 2||0
8172838|NCT02430870|20151418|P1|NOT COMPLETED|Part 2||0
8172839|NCT02430870|20151411|P8|COMPLETED|Part 2||7
8172840|NCT02430870|20151412|P7|COMPLETED|Part 2||5
8172841|NCT02430870|20151413|P6|COMPLETED|Part 2||6
8172842|NCT02430870|20151414|P5|COMPLETED|Part 2||6
8172843|NCT02430870|20151415|P4|COMPLETED|Part 2||6
8172844|NCT02430870|20151416|P3|COMPLETED|Part 2||0
8172845|NCT02430870|20151417|P2|COMPLETED|Part 2||0
8172846|NCT02430870|20151418|P1|COMPLETED|Part 2||0
8172847|NCT02430870|20151411|P8|STARTED|Part 2||8
8172848|NCT02430870|20151412|P7|STARTED|Part 2||6
8172849|NCT02430870|20151413|P6|STARTED|Part 2||6
8172850|NCT02430870|20151414|P5|STARTED|Part 2||6
8172851|NCT02430870|20151415|P4|STARTED|Part 2||6
8172852|NCT02430870|20151416|P3|STARTED|Part 2||0
8172853|NCT02430870|20151417|P2|STARTED|Part 2||0
8172854|NCT02430870|20151418|P1|STARTED|Part 2||0
8172855|NCT02430870|20151411|P8|NOT COMPLETED|Part 1||0
8172856|NCT02430870|20151412|P7|NOT COMPLETED|Part 1||0
8172857|NCT02430870|20151413|P6|NOT COMPLETED|Part 1||0
8172858|NCT02430870|20151414|P5|NOT COMPLETED|Part 1||0
8172859|NCT02430870|20151415|P4|NOT COMPLETED|Part 1||0
8172860|NCT02430870|20151416|P3|NOT COMPLETED|Part 1||0
8172861|NCT02430870|20151417|P2|NOT COMPLETED|Part 1||0
8172862|NCT02430870|20151418|P1|NOT COMPLETED|Part 1||0
8172863|NCT02430870|20151411|P8|COMPLETED|Part 1||0
8172864|NCT02430870|20151412|P7|COMPLETED|Part 1||0
8172865|NCT02430870|20151413|P6|COMPLETED|Part 1||0
8172866|NCT02430870|20151414|P5|COMPLETED|Part 1||0
8172867|NCT02430870|20151415|P4|COMPLETED|Part 1||0
8172868|NCT02430870|20151416|P3|COMPLETED|Part 1||4
8172869|NCT02430870|20151417|P2|COMPLETED|Part 1||6
8172870|NCT02430870|20151418|P1|COMPLETED|Part 1||6
8172871|NCT02430870|20151411|P8|STARTED|Part 1||0
8172872|NCT02430870|20151412|P7|STARTED|Part 1||0
8172873|NCT02430870|20151413|P6|STARTED|Part 1||0
8172874|NCT02430870|20151414|P5|STARTED|Part 1||0
8172875|NCT02430870|20151415|P4|STARTED|Part 1||0
8172876|NCT02430870|20151416|P3|STARTED|Part 1||4
8172877|NCT02430870|20151417|P2|STARTED|Part 1||6
8172878|NCT02430870|20151418|P1|STARTED|Part 1||6
8172879|NCT02430818|20151492|P2|NOT COMPLETED|Overall Study||0
8172880|NCT02430818|20151493|P1|NOT COMPLETED|Overall Study||0
8172881|NCT02430818|20151492|P2|COMPLETED|Overall Study||6
8172882|NCT02430818|20151493|P1|COMPLETED|Overall Study||7
8172883|NCT02430818|20151492|P2|STARTED|Overall Study||6
8172884|NCT02430818|20151493|P1|STARTED|Overall Study||7
8172885|NCT02430532|20151505|P2|NOT COMPLETED|Overall Study||28
8172886|NCT02430532|20151506|P1|NOT COMPLETED|Overall Study||30
8172887|NCT02430532|20151505|P2|COMPLETED|Overall Study||0
8172888|NCT02430532|20151506|P1|COMPLETED|Overall Study||0
8172889|NCT02430532|20151505|P2|STARTED|Overall Study||28
8172890|NCT02430532|20151506|P1|STARTED|Overall Study||30
8172891|NCT02430480|20151520|P1|NOT COMPLETED|Overall Study||3
8172892|NCT02430480|20151520|P1|COMPLETED|Overall Study||36
8172893|NCT02430480|20151520|P1|STARTED|Overall Study||39
8172894|NCT02430389|20151538|P2|NOT COMPLETED|Overall Study||0
8172895|NCT02430389|20151539|P1|NOT COMPLETED|Overall Study||0
8172896|NCT02430389|20151538|P2|COMPLETED|Overall Study||10
8172897|NCT02430389|20151539|P1|COMPLETED|Overall Study||10
8172898|NCT02430389|20151538|P2|STARTED|Overall Study||10
8172899|NCT02430389|20151539|P1|STARTED|Overall Study||10
8172900|NCT02430337|20151549|P2|NOT COMPLETED|Overall Study||0
8172901|NCT02430337|20151550|P1|NOT COMPLETED|Overall Study||0
8172902|NCT02430337|20151549|P2|COMPLETED|Overall Study||20
8172903|NCT02430337|20151550|P1|COMPLETED|Overall Study||11
8172904|NCT02430337|20151549|P2|STARTED|Overall Study||20
8172905|NCT02430337|20151550|P1|STARTED|Overall Study||11
8172906|NCT02430311|20151563|P2|NOT COMPLETED|Part B||8
8172907|NCT02430311|20151564|P1|NOT COMPLETED|Part B||10
8172908|NCT02430311|20151563|P2|COMPLETED|Part B||7
8172909|NCT02430311|20151564|P1|COMPLETED|Part B||9
8172910|NCT02430311|20151563|P2|Received Paclitaxel|Part B||14
8172911|NCT02430311|20151564|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
8172912|NCT02430311|20151563|P2|Received Olaparib|Part B||15
8172913|NCT02430311|20151564|P1|Received Olaparib|Part B||19
8172914|NCT02430311|20151563|P2|STARTED|Part B||15
8172915|NCT02430311|20151564|P1|STARTED|Part B||19
8172916|NCT02430311|20151563|P2|NOT COMPLETED|Part A||1
8172917|NCT02430311|20151564|P1|NOT COMPLETED|Part A||1
8172918|NCT02430311|20151563|P2|COMPLETED|Part A||15
8172919|NCT02430311|20151564|P1|COMPLETED|Part A||19
8172920|NCT02430311|20151563|P2|Received Paclitaxel|Part A||16
8172921|NCT02430311|20151564|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
8172922|NCT02430311|20151563|P2|Received Olaparib|Part A||16
8172923|NCT02430311|20151564|P1|Received Olaparib|Part A||20
8172924|NCT02430311|20151563|P2|STARTED|Part A||16
8172925|NCT02430311|20151564|P1|STARTED|Part A||20
8172926|NCT02430090|20151600|P3|NOT COMPLETED|Overall Study||0
8172927|NCT02430090|20151601|P2|NOT COMPLETED|Overall Study||0
8172928|NCT02430090|20151602|P1|NOT COMPLETED|Overall Study||0
8172929|NCT02430090|20151600|P3|COMPLETED|Overall Study||15
8172930|NCT02430090|20151601|P2|COMPLETED|Overall Study||15
8172931|NCT02430090|20151602|P1|COMPLETED|Overall Study||15
8172932|NCT02430090|20151600|P3|STARTED|Overall Study||15
8172933|NCT02430090|20151601|P2|STARTED|Overall Study||15
8172934|NCT02430090|20151602|P1|STARTED|Overall Study||15
8172935|NCT02429869|20151610|P1|NOT COMPLETED|Overall Study||0
8172936|NCT02429869|20151610|P1|COMPLETED|Overall Study||10
8172937|NCT02429869|20151610|P1|STARTED|Overall Study||10
8172938|NCT02429856|20151618|P2|NOT COMPLETED|Overall Study||19
8172939|NCT02429856|20151619|P1|NOT COMPLETED|Overall Study||19
8172940|NCT02429856|20151618|P2|COMPLETED|Overall Study||32
8172941|NCT02429856|20151619|P1|COMPLETED|Overall Study||30
8172942|NCT02429856|20151618|P2|STARTED|Overall Study||51
8172943|NCT02429856|20151619|P1|STARTED|Overall Study||49
8172944|NCT02429791|20151637|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
8172945|NCT02429791|20151638|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
8172946|NCT02429791|20151637|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
8172947|NCT02429791|20151638|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
8172948|NCT02429791|20151637|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||238
8172949|NCT02429791|20151638|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||239
8172950|NCT02429791|20151637|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
8172951|NCT02429791|20151638|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
8172952|NCT02429791|20151637|P2|COMPLETED|Early Switch Phase (Up to Week 52)||238
8172953|NCT02429791|20151638|P1|COMPLETED|Early Switch Phase (Up to Week 52)||239
8172954|NCT02429791|20151637|P2|STARTED|Early Switch Phase (Up to Week 52)||256
8172955|NCT02429791|20151638|P1|STARTED|Early Switch Phase (Up to Week 52)||252
8172956|NCT02429778|20151726|P2|NOT COMPLETED|Overall Study||0
8172957|NCT02429778|20151727|P1|NOT COMPLETED|Overall Study||7
8172958|NCT02429778|20151726|P2|COMPLETED|Overall Study||20
8172959|NCT02429778|20151727|P1|COMPLETED|Overall Study||13
8172960|NCT02429778|20151726|P2|STARTED|Overall Study||20
8172961|NCT02429778|20151727|P1|STARTED|Overall Study||20
8172962|NCT02429583|20151741|P2|NOT COMPLETED|Overall Study||20
8172963|NCT02429583|20151742|P1|NOT COMPLETED|Overall Study||0
8172964|NCT02429583|20151741|P2|COMPLETED|Overall Study||3
8172965|NCT02429583|20151742|P1|COMPLETED|Overall Study||1
8172966|NCT02429583|20151741|P2|STARTED|Overall Study||23
8172967|NCT02429583|20151742|P1|STARTED|Overall Study||1
8172968|NCT02429427|20151758|P2|NOT COMPLETED|Overall Study||179
8172969|NCT02429427|20151759|P1|NOT COMPLETED|Overall Study||371
8172970|NCT02429427|20151758|P2|COMPLETED|Overall Study||697
8172971|NCT02429427|20151759|P1|COMPLETED|Overall Study||1392
8172972|NCT02429427|20151758|P2|STARTED|Overall Study||876
8172973|NCT02429427|20151759|P1|STARTED|Overall Study||1763
8172974|NCT02429310|20151773|P2|NOT COMPLETED|Overall Study||3
8172975|NCT02429310|20151774|P1|NOT COMPLETED|Overall Study||2
8172976|NCT02429310|20151773|P2|COMPLETED|Overall Study||17
8172977|NCT02429310|20151774|P1|COMPLETED|Overall Study||20
8172978|NCT02429310|20151773|P2|STARTED|Overall Study||20
8172979|NCT02429310|20151774|P1|STARTED|Overall Study||22
8172980|NCT02429258|20151784|P2|NOT COMPLETED|Overall Study||1
8172981|NCT02429258|20151785|P1|NOT COMPLETED|Overall Study||2
8172982|NCT02429258|20151784|P2|COMPLETED|Overall Study||49
8172983|NCT02429258|20151785|P1|COMPLETED|Overall Study||48
8172984|NCT02429258|20151784|P2|STARTED|Overall Study||50
8172985|NCT02429258|20151785|P1|STARTED|Overall Study||50
8172986|NCT02429115|20151817|P6|NOT COMPLETED|Overall Study||1
8172987|NCT02429115|20151818|P5|NOT COMPLETED|Overall Study||7
8172988|NCT02429115|20151819|P4|NOT COMPLETED|Overall Study||8
8172989|NCT02429115|20151820|P3|NOT COMPLETED|Overall Study||16
8172990|NCT02429115|20151821|P2|NOT COMPLETED|Overall Study||10
8172991|NCT02429115|20151822|P1|NOT COMPLETED|Overall Study||12
8172992|NCT02429115|20151817|P6|COMPLETED|Overall Study||27
8172993|NCT02429115|20151818|P5|COMPLETED|Overall Study||22
8172994|NCT02429115|20151819|P4|COMPLETED|Overall Study||21
8172995|NCT02429115|20151820|P3|COMPLETED|Overall Study||35
8172996|NCT02429115|20151821|P2|COMPLETED|Overall Study||42
8172997|NCT02429115|20151822|P1|COMPLETED|Overall Study||40
8172998|NCT02429115|20151817|P6|STARTED|Overall Study||28
8172999|NCT02429115|20151818|P5|STARTED|Overall Study||29
8173000|NCT02429115|20151819|P4|STARTED|Overall Study||29
8173001|NCT02429115|20151820|P3|STARTED|Overall Study||51
8173002|NCT02429115|20151821|P2|STARTED|Overall Study||52
8173003|NCT02429115|20151822|P1|STARTED|Overall Study||52
8173004|NCT02428855|20151839|P1|NOT COMPLETED|Overall Study||2
8173005|NCT02428855|20151839|P1|COMPLETED|Overall Study||6
8173006|NCT02428855|20151839|P1|STARTED|Overall Study||8
8173007|NCT02428699|20151846|P2|NOT COMPLETED|Period 2||0
8173008|NCT02428699|20151847|P1|NOT COMPLETED|Period 2||0
8173009|NCT02428699|20151846|P2|COMPLETED|Period 2||23
8173010|NCT02428699|20151847|P1|COMPLETED|Period 2||24
8173011|NCT02428699|20151846|P2|STARTED|Period 2||23
8173012|NCT02428699|20151847|P1|STARTED|Period 2||24
8173013|NCT02428699|20151846|P2|NOT COMPLETED|Washout Period 1||2
8173014|NCT02428699|20151847|P1|NOT COMPLETED|Washout Period 1||1
8173015|NCT02428699|20151846|P2|COMPLETED|Washout Period 1||23
8173016|NCT02428699|20151847|P1|COMPLETED|Washout Period 1||24
8173017|NCT02428699|20151846|P2|STARTED|Washout Period 1||25
8173018|NCT02428699|20151847|P1|STARTED|Washout Period 1||25
8173019|NCT02428699|20151846|P2|NOT COMPLETED|Period 1||0
8173020|NCT02428699|20151847|P1|NOT COMPLETED|Period 1||0
8173021|NCT02428699|20151846|P2|COMPLETED|Period 1||25
8173022|NCT02428699|20151847|P1|COMPLETED|Period 1||25
8173023|NCT02428699|20151846|P2|STARTED|Period 1||25
8173024|NCT02428699|20151847|P1|STARTED|Period 1||25
8173025|NCT02428608|20151875|P1|NOT COMPLETED|Overall Study||83
8173026|NCT02428608|20151875|P1|COMPLETED|Overall Study||487
8173027|NCT02428608|20151875|P1|STARTED|Overall Study||570
8173028|NCT02428595|20151880|P1|NOT COMPLETED|Treatment||19
8173029|NCT02428595|20151880|P1|COMPLETED|Treatment||54
8173030|NCT02428595|20151880|P1|STARTED|Treatment||73
8173031|NCT02428595|20151880|P1|NOT COMPLETED|Fitting||64
8173032|NCT02428595|20151880|P1|COMPLETED|Fitting||73
8173033|NCT02428595|20151880|P1|STARTED|Fitting||137
8173034|NCT02428478|20151896|P2|NOT COMPLETED|Second Study Night||0
8173035|NCT02428478|20151897|P1|NOT COMPLETED|Second Study Night||0
8173036|NCT02428478|20151896|P2|COMPLETED|Second Study Night||6
8173037|NCT02428478|20151897|P1|COMPLETED|Second Study Night||8
8173038|NCT02428478|20151896|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
8173039|NCT02428478|20151897|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
8173040|NCT02428478|20151896|P2|NOT COMPLETED|First Study Night||0
8173041|NCT02428478|20151897|P1|NOT COMPLETED|First Study Night||0
8173042|NCT02428478|20151896|P2|COMPLETED|First Study Night||8
8173043|NCT02428478|20151897|P1|COMPLETED|First Study Night||9
8173044|NCT02428478|20151896|P2|STARTED|First Study Night||8
8173045|NCT02428478|20151897|P1|STARTED|First Study Night||9
8173046|NCT02428413|20151907|P2|NOT COMPLETED|Overall Study||9
8173047|NCT02428413|20151908|P1|NOT COMPLETED|Overall Study||8
8173048|NCT02428413|20151907|P2|COMPLETED|Overall Study||52
8173049|NCT02428413|20151908|P1|COMPLETED|Overall Study||56
8173050|NCT02428413|20151907|P2|STARTED|Overall Study||61
8173051|NCT02428413|20151908|P1|STARTED|Overall Study||64
8173052|NCT02428309|20151920|P1|NOT COMPLETED|Overall Study||0
8173053|NCT02428309|20151920|P1|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
8173054|NCT02428309|20151920|P1|STARTED|Overall Study||1
8173055|NCT02428296|20151943|P1|NOT COMPLETED|Overall Study||9
8173056|NCT02428296|20151943|P1|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
8173057|NCT02428296|20151943|P1|Treated|Overall Study||39
8173058|NCT02428296|20151943|P1|STARTED|Overall Study||39
8173059|NCT02428231|20151955|P2|NOT COMPLETED|Overall Study||17
8173060|NCT02428231|20151956|P1|NOT COMPLETED|Overall Study||13
8173061|NCT02428231|20151955|P2|COMPLETED|Overall Study||15
8173062|NCT02428231|20151956|P1|COMPLETED|Overall Study||17
8173063|NCT02428231|20151955|P2|STARTED|Overall Study||32
8173064|NCT02428231|20151956|P1|STARTED|Overall Study||30
8173071|NCT02427984|20151988|P3|NOT COMPLETED|Overall Study||18
8173072|NCT02427984|20151989|P2|NOT COMPLETED|Overall Study||5
8173073|NCT02427984|20151990|P1|NOT COMPLETED|Overall Study||13
8173074|NCT02427984|20151988|P3|COMPLETED|Overall Study||32
8173075|NCT02427984|20151989|P2|COMPLETED|Overall Study||40
8173076|NCT02427984|20151990|P1|COMPLETED|Overall Study||40
8173077|NCT02427984|20151988|P3|STARTED|Overall Study||50
8173078|NCT02427984|20151989|P2|STARTED|Overall Study||45
8173079|NCT02427984|20151990|P1|STARTED|Overall Study||53
8173080|NCT02427958|20152004|P1|NOT COMPLETED|Overall Study||24
8173081|NCT02427958|20152004|P1|COMPLETED|Overall Study||283
8173082|NCT02427958|20152004|P1|STARTED|Overall Study||307
8173083|NCT02427841|20152009|P1|NOT COMPLETED|Overall Study||8
8173084|NCT02427841|20152009|P1|COMPLETED|Overall Study||11
8173085|NCT02427841|20152009|P1|STARTED|Overall Study||19
8173086|NCT02427750|20152015|P2|NOT COMPLETED|Overall Study||0
8173087|NCT02427750|20152016|P1|NOT COMPLETED|Overall Study||0
8173088|NCT02427750|20152015|P2|COMPLETED|Overall Study||63
8173089|NCT02427750|20152016|P1|COMPLETED|Overall Study||63
8173090|NCT02427750|20152015|P2|STARTED|Overall Study||63
8173091|NCT02427750|20152016|P1|STARTED|Overall Study||63
8173092|NCT02427737|20152041|P2|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
8173093|NCT02427737|20152042|P1|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
8173094|NCT02427737|20152041|P2|COMPLETED|Duke Pre- and Post-Training Groups||4051
8173095|NCT02427737|20152042|P1|COMPLETED|Duke Pre- and Post-Training Groups||8879
8173096|NCT02427737|20152041|P2|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
8173097|NCT02427737|20152042|P1|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
8173098|NCT02427737|20152041|P2|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
8173099|NCT02427737|20152042|P1|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
8173100|NCT02427737|20152041|P2|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
8173101|NCT02427737|20152042|P1|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
8173102|NCT02427737|20152041|P2|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
8173103|NCT02427737|20152042|P1|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
8173104|NCT02427737|20152041|P2|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
8173105|NCT02427737|20152042|P1|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
8173106|NCT02427737|20152041|P2|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
8173107|NCT02427737|20152042|P1|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
8173108|NCT02427737|20152041|P2|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
8173109|NCT02427737|20152042|P1|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
8173110|NCT02427737|20152041|P2|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
8173111|NCT02427737|20152042|P1|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
8173112|NCT02427737|20152041|P2|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
8173113|NCT02427737|20152042|P1|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
8173114|NCT02427737|20152041|P2|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
8173115|NCT02427737|20152042|P1|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
8173116|NCT02427737|20152041|P2|NOT COMPLETED|OSU Baseline Q4FY15||216
8173117|NCT02427737|20152042|P1|NOT COMPLETED|OSU Baseline Q4FY15||218
8173118|NCT02427737|20152041|P2|COMPLETED|OSU Baseline Q4FY15||3230
8173119|NCT02427737|20152042|P1|COMPLETED|OSU Baseline Q4FY15||3940
8173120|NCT02427737|20152041|P2|STARTED|OSU Baseline Q4FY15||3446
8173121|NCT02427737|20152042|P1|STARTED|OSU Baseline Q4FY15||4158
8173122|NCT02427672|20152090|P2|NOT COMPLETED|Overall Study||2
8173123|NCT02427672|20152091|P1|NOT COMPLETED|Overall Study||1
8173124|NCT02427672|20152090|P2|COMPLETED|Overall Study||42
8173125|NCT02427672|20152091|P1|COMPLETED|Overall Study||39
8173126|NCT02427672|20152090|P2|STARTED|Overall Study||44
8173127|NCT02427672|20152091|P1|STARTED|Overall Study||40
8173128|NCT02427646|20152101|P2|NOT COMPLETED|Overall Study||14
8173129|NCT02427646|20152102|P1|NOT COMPLETED|Overall Study||8
8173130|NCT02427646|20152101|P2|COMPLETED|Overall Study||14
8173131|NCT02427646|20152102|P1|COMPLETED|Overall Study||16
8173132|NCT02427646|20152101|P2|STARTED|Overall Study||28
8173133|NCT02427646|20152102|P1|STARTED|Overall Study||24
8173134|NCT02427607|20152110|P1|NOT COMPLETED|Overall Study||1
8173135|NCT02427607|20152110|P1|COMPLETED|Overall Study||6
8173136|NCT02427607|20152110|P1|STARTED|Overall Study||7
8173137|NCT02427477|20152116|P2|NOT COMPLETED|Period 3||0
8173138|NCT02427477|20152117|P1|NOT COMPLETED|Period 3||0
8173139|NCT02427477|20152116|P2|COMPLETED|Period 3||60
8173140|NCT02427477|20152117|P1|COMPLETED|Period 3||59
8173141|NCT02427477|20152116|P2|STARTED|Period 3||60
8173142|NCT02427477|20152117|P1|STARTED|Period 3||59
8173143|NCT02427477|20152116|P2|NOT COMPLETED|Period 2||0
8173144|NCT02427477|20152117|P1|NOT COMPLETED|Period 2||0
8173145|NCT02427477|20152116|P2|COMPLETED|Period 2||60
8173146|NCT02427477|20152117|P1|COMPLETED|Period 2||59
8173147|NCT02427477|20152116|P2|STARTED|Period 2||60
8173148|NCT02427477|20152117|P1|STARTED|Period 2||59
8173149|NCT02427477|20152116|P2|NOT COMPLETED|Period 1||0
8173150|NCT02427477|20152117|P1|NOT COMPLETED|Period 1||1
8173151|NCT02427477|20152116|P2|COMPLETED|Period 1||60
8173152|NCT02427477|20152117|P1|COMPLETED|Period 1||59
8173153|NCT02427477|20152116|P2|STARTED|Period 1||60
8173154|NCT02427477|20152117|P1|STARTED|Period 1||60
8173155|NCT02427399|20152130|P5|NOT COMPLETED|Overall Study||15
8173156|NCT02427399|20152131|P4|NOT COMPLETED|Overall Study||18
8173157|NCT02427399|20152132|P3|NOT COMPLETED|Overall Study||12
8173158|NCT02427399|20152133|P2|NOT COMPLETED|Overall Study||16
8173159|NCT02427399|20152134|P1|NOT COMPLETED|Overall Study||14
8173160|NCT02427399|20152130|P5|COMPLETED|Overall Study||205
8173161|NCT02427399|20152131|P4|COMPLETED|Overall Study||202
8173162|NCT02427399|20152132|P3|COMPLETED|Overall Study||208
8173163|NCT02427399|20152133|P2|COMPLETED|Overall Study||204
8173164|NCT02427399|20152134|P1|COMPLETED|Overall Study||206
8173165|NCT02427399|20152130|P5|STARTED|Overall Study||220
8173166|NCT02427399|20152131|P4|STARTED|Overall Study||220
8173167|NCT02427399|20152132|P3|STARTED|Overall Study||220
8173168|NCT02427399|20152133|P2|STARTED|Overall Study||220
8173169|NCT02427399|20152134|P1|STARTED|Overall Study||220
8173170|NCT02427100|20152158|P2|NOT COMPLETED|Overall Study||2
8173171|NCT02427100|20152159|P1|NOT COMPLETED|Overall Study||0
8173172|NCT02427100|20152158|P2|COMPLETED|Overall Study||15
8173173|NCT02427100|20152159|P1|COMPLETED|Overall Study||15
8173174|NCT02427100|20152158|P2|STARTED|Overall Study||17
8173175|NCT02427100|20152159|P1|STARTED|Overall Study||15
8173176|NCT02426918|20152170|P3|NOT COMPLETED|Overall Study||14
8173177|NCT02426918|20152171|P2|NOT COMPLETED|Overall Study||19
8173178|NCT02426918|20152172|P1|NOT COMPLETED|Overall Study||17
8173179|NCT02426918|20152170|P3|COMPLETED|Overall Study||97
8173180|NCT02426918|20152171|P2|COMPLETED|Overall Study||90
8173181|NCT02426918|20152172|P1|COMPLETED|Overall Study||93
8173182|NCT02426918|20152170|P3|Safety Population|Overall Study||107
8173183|NCT02426918|20152171|P2|Safety Population|Overall Study||107
8173184|NCT02426918|20152172|P1|Safety Population|Overall Study||110
8173185|NCT02426918|20152170|P3|STARTED|Overall Study||111
8173186|NCT02426918|20152171|P2|STARTED|Overall Study||109
8173187|NCT02426918|20152172|P1|STARTED|Overall Study||110
8173188|NCT02426749|20152194|P2|NOT COMPLETED|Overall Study||1
8173189|NCT02426749|20152195|P1|NOT COMPLETED|Overall Study||3
8173190|NCT02426749|20152194|P2|COMPLETED|Overall Study||9
8173191|NCT02426749|20152195|P1|COMPLETED|Overall Study||9
8173192|NCT02426749|20152194|P2|STARTED|Overall Study||10
8173193|NCT02426749|20152195|P1|STARTED|Overall Study||12
8173194|NCT02426658|20152207|P1|NOT COMPLETED|Overall Study||3
8173195|NCT02426658|20152207|P1|COMPLETED|Overall Study||13
8173196|NCT02426658|20152207|P1|STARTED|Overall Study||16
8173197|NCT02426580|20152214|P2|NOT COMPLETED|Overall Study||16
8173198|NCT02426580|20152215|P1|NOT COMPLETED|Overall Study||11
8173199|NCT02426580|20152214|P2|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
8173200|NCT02426580|20152215|P1|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
8173201|NCT02426580|20152214|P2|STARTED|Overall Study|January 2014|70
8173202|NCT02426580|20152215|P1|STARTED|Overall Study|April 2015|70
8173203|NCT02426541|20152223|P2|NOT COMPLETED|Overall Study||0
8173204|NCT02426541|20152224|P1|NOT COMPLETED|Overall Study||1
8173205|NCT02426541|20152223|P2|COMPLETED|Overall Study||16
8173206|NCT02426541|20152224|P1|COMPLETED|Overall Study||15
8173207|NCT02426541|20152223|P2|STARTED|Overall Study||16
8173208|NCT02426541|20152224|P1|STARTED|Overall Study||16
8173209|NCT02426138|20152236|P2|NOT COMPLETED|Intent to Treat Population Milestone||0
8173210|NCT02426138|20152237|P1|NOT COMPLETED|Intent to Treat Population Milestone||0
8173211|NCT02426138|20152236|P2|COMPLETED|Intent to Treat Population Milestone||22
8173212|NCT02426138|20152237|P1|COMPLETED|Intent to Treat Population Milestone||20
8173213|NCT02426138|20152236|P2|STARTED|Intent to Treat Population Milestone||22
8173214|NCT02426138|20152237|P1|STARTED|Intent to Treat Population Milestone||20
8173215|NCT02426138|20152236|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8173216|NCT02426138|20152237|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8173217|NCT02426138|20152236|P2|COMPLETED|Second Intervention (12 Weeks)||22
8173218|NCT02426138|20152237|P1|COMPLETED|Second Intervention (12 Weeks)||20
8173219|NCT02426138|20152236|P2|STARTED|Second Intervention (12 Weeks)||22
8173220|NCT02426138|20152237|P1|STARTED|Second Intervention (12 Weeks)||20
8173221|NCT02426138|20152236|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8173222|NCT02426138|20152237|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
8173223|NCT02426138|20152236|P2|COMPLETED|First Intervention (12 Weeks)||22
8173224|NCT02426138|20152237|P1|COMPLETED|First Intervention (12 Weeks)||20
8173225|NCT02426138|20152236|P2|STARTED|First Intervention (12 Weeks)||23
8173226|NCT02426138|20152237|P1|STARTED|First Intervention (12 Weeks)||21
8173227|NCT02426125|20152277|P2|NOT COMPLETED|Overall Study||26
8173228|NCT02426125|20152278|P1|NOT COMPLETED|Overall Study||29
8173229|NCT02426125|20152277|P2|COMPLETED|Overall Study||241
8173230|NCT02426125|20152278|P1|COMPLETED|Overall Study||234
8173231|NCT02426125|20152277|P2|First Randomized Participants|Overall Study||221
8173232|NCT02426125|20152278|P1|First Randomized Participants|Overall Study||216
8173233|NCT02426125|20152277|P2|Received at Least One Dose of Study Drug|Overall Study||265
8173234|NCT02426125|20152278|P1|Received at Least One Dose of Study Drug|Overall Study||258
8173235|NCT02426125|20152277|P2|STARTED|Overall Study||267
8173236|NCT02426125|20152278|P1|STARTED|Overall Study||263
8173237|NCT02425956|20152302|P1|NOT COMPLETED|Overall Study||0
8173238|NCT02425956|20152302|P1|COMPLETED|Overall Study||21
8173239|NCT02425956|20152302|P1|STARTED|Overall Study||21
8173240|NCT02425826|20152309|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
8173241|NCT02425826|20152310|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
8173242|NCT02425826|20152311|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
8173243|NCT02425826|20152309|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
8173244|NCT02425826|20152310|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
8173245|NCT02425826|20152311|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
8173246|NCT02425826|20152309|P3|STARTED|Post-Treatment Observational Follow-Up||49
8173247|NCT02425826|20152310|P2|STARTED|Post-Treatment Observational Follow-Up||0
8173248|NCT02425826|20152311|P1|STARTED|Post-Treatment Observational Follow-Up||81
8173249|NCT02425826|20152309|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
8173250|NCT02425826|20152310|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
8173251|NCT02425826|20152311|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
8173252|NCT02425826|20152309|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
8173253|NCT02425826|20152310|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
8173254|NCT02425826|20152311|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
8173255|NCT02425826|20152309|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
8173256|NCT02425826|20152310|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
8173257|NCT02425826|20152311|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
8173258|NCT02425826|20152309|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
8173259|NCT02425826|20152310|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
8173260|NCT02425826|20152311|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
8173261|NCT02425826|20152309|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
8173262|NCT02425826|20152310|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
8173263|NCT02425826|20152311|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
8173264|NCT02425826|20152309|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
8173265|NCT02425826|20152310|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
8173266|NCT02425826|20152311|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
8173267|NCT02425826|20152309|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
8173268|NCT02425826|20152310|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
8173269|NCT02425826|20152311|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
8173270|NCT02425826|20152309|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
8173271|NCT02425826|20152310|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
8173272|NCT02425826|20152311|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
8173273|NCT02425449|20152349|P5|NOT COMPLETED|Overall Study||0
8173274|NCT02425449|20152350|P4|NOT COMPLETED|Overall Study||0
8173275|NCT02425449|20152351|P3|NOT COMPLETED|Overall Study||0
8173276|NCT02425449|20152352|P2|NOT COMPLETED|Overall Study||0
8173277|NCT02425449|20152353|P1|NOT COMPLETED|Overall Study||0
8173278|NCT02425449|20152349|P5|COMPLETED|Overall Study||5
8173279|NCT02425449|20152350|P4|COMPLETED|Overall Study||5
8173280|NCT02425449|20152351|P3|COMPLETED|Overall Study||5
8173281|NCT02425449|20152352|P2|COMPLETED|Overall Study||4
8173282|NCT02425449|20152353|P1|COMPLETED|Overall Study||0
8173283|NCT02425449|20152349|P5|STARTED|Overall Study||5
8173284|NCT02425449|20152350|P4|STARTED|Overall Study||5
8173285|NCT02425449|20152351|P3|STARTED|Overall Study||5
8173286|NCT02425449|20152352|P2|STARTED|Overall Study||4
8173287|NCT02425449|20152353|P1|STARTED|Overall Study||0
8173288|NCT02425111|20152365|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
8173289|NCT02425111|20152365|P1|COMPLETED|Part B: Treatment Extension Period||46
8173290|NCT02425111|20152365|P1|STARTED|Part B: Treatment Extension Period||56
8173291|NCT02425111|20152365|P1|NOT COMPLETED|Part A: Treatment Period||23
8173292|NCT02425111|20152365|P1|COMPLETED|Part A: Treatment Period||78
8173293|NCT02425111|20152365|P1|STARTED|Part A: Treatment Period||101
8173294|NCT02425098|20152386|P2|NOT COMPLETED|Overall Study||16
8173295|NCT02425098|20152387|P1|NOT COMPLETED|Overall Study||13
8173296|NCT02425098|20152386|P2|COMPLETED|Overall Study||159
8173297|NCT02425098|20152387|P1|COMPLETED|Overall Study||163
8173298|NCT02425098|20152386|P2|STARTED|Overall Study||175
8173299|NCT02425098|20152387|P1|STARTED|Overall Study||176
8173300|NCT02424799|20152435|P6|NOT COMPLETED|Part C (Up to Day 23)||0
8173301|NCT02424799|20152436|P5|NOT COMPLETED|Part C (Up to Day 23)||0
8173302|NCT02424799|20152437|P4|NOT COMPLETED|Part C (Up to Day 23)||0
8173303|NCT02424799|20152438|P3|NOT COMPLETED|Part C (Up to Day 23)||0
8173304|NCT02424799|20152439|P2|NOT COMPLETED|Part C (Up to Day 23)||0
8173305|NCT02424799|20152440|P1|NOT COMPLETED|Part C (Up to Day 23)||0
8173306|NCT02424799|20152435|P6|COMPLETED|Part C (Up to Day 23)||4
8173307|NCT02424799|20152436|P5|COMPLETED|Part C (Up to Day 23)||1
8173308|NCT02424799|20152437|P4|COMPLETED|Part C (Up to Day 23)||0
8173309|NCT02424799|20152438|P3|COMPLETED|Part C (Up to Day 23)||0
8173310|NCT02424799|20152439|P2|COMPLETED|Part C (Up to Day 23)||0
8173311|NCT02424799|20152440|P1|COMPLETED|Part C (Up to Day 23)||0
8173312|NCT02424799|20152435|P6|STARTED|Part C (Up to Day 23)||4
8173313|NCT02424799|20152436|P5|STARTED|Part C (Up to Day 23)||1
8173314|NCT02424799|20152437|P4|STARTED|Part C (Up to Day 23)||0
8173315|NCT02424799|20152438|P3|STARTED|Part C (Up to Day 23)||0
8173316|NCT02424799|20152439|P2|STARTED|Part C (Up to Day 23)||0
8173317|NCT02424799|20152440|P1|STARTED|Part C (Up to Day 23)||0
8173318|NCT02424799|20152435|P6|NOT COMPLETED|Part B (Up to Day 19)||0
8173319|NCT02424799|20152436|P5|NOT COMPLETED|Part B (Up to Day 19)||0
8173320|NCT02424799|20152437|P4|NOT COMPLETED|Part B (Up to Day 19)||0
8173321|NCT02424799|20152438|P3|NOT COMPLETED|Part B (Up to Day 19)||0
8173322|NCT02424799|20152439|P2|NOT COMPLETED|Part B (Up to Day 19)||0
8173323|NCT02424799|20152440|P1|NOT COMPLETED|Part B (Up to Day 19)||0
8173324|NCT02424799|20152435|P6|COMPLETED|Part B (Up to Day 19)||0
8173325|NCT02424799|20152436|P5|COMPLETED|Part B (Up to Day 19)||0
8173326|NCT02424799|20152437|P4|COMPLETED|Part B (Up to Day 19)||9
8173327|NCT02424799|20152438|P3|COMPLETED|Part B (Up to Day 19)||3
8173328|NCT02424799|20152439|P2|COMPLETED|Part B (Up to Day 19)||0
8173329|NCT02424799|20152440|P1|COMPLETED|Part B (Up to Day 19)||0
8173330|NCT02424799|20152435|P6|STARTED|Part B (Up to Day 19)||0
8173331|NCT02424799|20152436|P5|STARTED|Part B (Up to Day 19)||0
8173332|NCT02424799|20152437|P4|STARTED|Part B (Up to Day 19)||9
8173333|NCT02424799|20152438|P3|STARTED|Part B (Up to Day 19)||3
8173334|NCT02424799|20152439|P2|STARTED|Part B (Up to Day 19)||0
8173335|NCT02424799|20152440|P1|STARTED|Part B (Up to Day 19)||0
8173336|NCT02424799|20152435|P6|NOT COMPLETED|Part A (Up to Day 11)||0
8173337|NCT02424799|20152436|P5|NOT COMPLETED|Part A (Up to Day 11)||0
8173338|NCT02424799|20152437|P4|NOT COMPLETED|Part A (Up to Day 11)||0
8173339|NCT02424799|20152438|P3|NOT COMPLETED|Part A (Up to Day 11)||0
8173340|NCT02424799|20152439|P2|NOT COMPLETED|Part A (Up to Day 11)||0
8173341|NCT02424799|20152440|P1|NOT COMPLETED|Part A (Up to Day 11)||0
8173342|NCT02424799|20152435|P6|COMPLETED|Part A (Up to Day 11)||0
8173343|NCT02424799|20152436|P5|COMPLETED|Part A (Up to Day 11)||0
8173344|NCT02424799|20152437|P4|COMPLETED|Part A (Up to Day 11)||0
8173345|NCT02424799|20152438|P3|COMPLETED|Part A (Up to Day 11)||0
8173346|NCT02424799|20152439|P2|COMPLETED|Part A (Up to Day 11)||8
8173347|NCT02424799|20152440|P1|COMPLETED|Part A (Up to Day 11)||9
8173348|NCT02424799|20152435|P6|STARTED|Part A (Up to Day 11)||0
8173349|NCT02424799|20152436|P5|STARTED|Part A (Up to Day 11)||0
8173350|NCT02424799|20152437|P4|STARTED|Part A (Up to Day 11)||0
8173351|NCT02424799|20152438|P3|STARTED|Part A (Up to Day 11)||0
8173352|NCT02424799|20152439|P2|STARTED|Part A (Up to Day 11)||8
8173353|NCT02424799|20152440|P1|STARTED|Part A (Up to Day 11)||9
8173354|NCT02424734|20152539|P3|NOT COMPLETED|Overall Study||0
8173355|NCT02424734|20152540|P2|NOT COMPLETED|Overall Study||2
8173356|NCT02424734|20152541|P1|NOT COMPLETED|Overall Study||2
8173357|NCT02424734|20152539|P3|COMPLETED|Overall Study||2
8173358|NCT02424734|20152540|P2|COMPLETED|Overall Study||3
8173359|NCT02424734|20152541|P1|COMPLETED|Overall Study||2
8173360|NCT02424734|20152539|P3|Treated|Overall Study||2
8173361|NCT02424734|20152540|P2|Treated|Overall Study||5
8173362|NCT02424734|20152541|P1|Treated|Overall Study||4
8173363|NCT02424734|20152539|P3|STARTED|Overall Study||2
8173364|NCT02424734|20152540|P2|STARTED|Overall Study||5
8173365|NCT02424734|20152541|P1|STARTED|Overall Study||4
8173366|NCT02424630|20152560|P2|NOT COMPLETED|Overall Study||3
8173367|NCT02424630|20152561|P1|NOT COMPLETED|Overall Study||1
8173368|NCT02424630|20152560|P2|COMPLETED|Overall Study||24
8173369|NCT02424630|20152561|P1|COMPLETED|Overall Study||24
8173370|NCT02424630|20152560|P2|STARTED|Overall Study||27
8173371|NCT02424630|20152561|P1|STARTED|Overall Study||25
8173372|NCT02424591|20152571|P2|NOT COMPLETED|Overall Study||3
8173373|NCT02424591|20152572|P1|NOT COMPLETED|Overall Study||2
8173374|NCT02424591|20152571|P2|COMPLETED|Overall Study||20
8173375|NCT02424591|20152572|P1|COMPLETED|Overall Study||20
8173376|NCT02424591|20152571|P2|STARTED|Overall Study||23
8173377|NCT02424591|20152572|P1|STARTED|Overall Study||22
8173378|NCT02424578|20152584|P2|NOT COMPLETED|Overall Study||1
8173379|NCT02424578|20152585|P1|NOT COMPLETED|Overall Study||0
8173380|NCT02424578|20152584|P2|COMPLETED|Overall Study||14
8173381|NCT02424578|20152585|P1|COMPLETED|Overall Study||15
8173382|NCT02424578|20152584|P2|STARTED|Overall Study||15
8173383|NCT02424578|20152585|P1|STARTED|Overall Study||15
8173384|NCT02424565|20152591|P2|NOT COMPLETED|Period 2 (D3)||0
8173385|NCT02424565|20152592|P1|NOT COMPLETED|Period 2 (D3)||0
8173386|NCT02424565|20152591|P2|COMPLETED|Period 2 (D3)||6
8173387|NCT02424565|20152592|P1|COMPLETED|Period 2 (D3)||8
8173388|NCT02424565|20152591|P2|STARTED|Period 2 (D3)||6
8173389|NCT02424565|20152592|P1|STARTED|Period 2 (D3)||8
8173390|NCT02424565|20152591|P2|NOT COMPLETED|Washout Period||0
8173391|NCT02424565|20152592|P1|NOT COMPLETED|Washout Period||0
8173392|NCT02424565|20152591|P2|COMPLETED|Washout Period||6
8173393|NCT02424565|20152592|P1|COMPLETED|Washout Period||8
8173394|NCT02424565|20152591|P2|STARTED|Washout Period||6
8173395|NCT02424565|20152592|P1|STARTED|Washout Period||8
8173396|NCT02424565|20152591|P2|NOT COMPLETED|Period 1 (D0)||1
8173397|NCT02424565|20152592|P1|NOT COMPLETED|Period 1 (D0)||0
8173398|NCT02424565|20152591|P2|COMPLETED|Period 1 (D0)||6
8173399|NCT02424565|20152592|P1|COMPLETED|Period 1 (D0)||8
8173400|NCT02424565|20152591|P2|STARTED|Period 1 (D0)||7
8173401|NCT02424565|20152592|P1|STARTED|Period 1 (D0)||8
8173402|NCT02424539|20152601|P3|NOT COMPLETED|Overall Study||8
8173403|NCT02424539|20152602|P2|NOT COMPLETED|Overall Study||8
8173404|NCT02424539|20152603|P1|NOT COMPLETED|Overall Study||14
8173405|NCT02424539|20152601|P3|COMPLETED|Overall Study||111
8173406|NCT02424539|20152602|P2|COMPLETED|Overall Study||111
8173407|NCT02424539|20152603|P1|COMPLETED|Overall Study||106
8173408|NCT02424539|20152601|P3|STARTED|Overall Study||119
8173409|NCT02424539|20152602|P2|STARTED|Overall Study||119
8173410|NCT02424539|20152603|P1|STARTED|Overall Study||120
8173411|NCT02424526|20152667|P2|NOT COMPLETED|Overall Study||0
8173412|NCT02424526|20152668|P1|NOT COMPLETED|Overall Study||0
8173413|NCT02424526|20152667|P2|COMPLETED|Overall Study||10
8173414|NCT02424526|20152668|P1|COMPLETED|Overall Study||9
8173415|NCT02424526|20152667|P2|STARTED|Overall Study||10
8173416|NCT02424526|20152668|P1|STARTED|Overall Study||9
8173417|NCT02424383|20152686|P1|NOT COMPLETED|Overall Study||376
8173418|NCT02424383|20152686|P1|COMPLETED|Overall Study||629
8173419|NCT02424383|20152686|P1|Per-Protocol Population|Overall Study||966
8173420|NCT02424383|20152686|P1|STARTED|Overall Study||1005
8173421|NCT02424357|20152699|P2|NOT COMPLETED|Overall Study||0
8173422|NCT02424357|20152700|P1|NOT COMPLETED|Overall Study||0
8173423|NCT02424357|20152699|P2|COMPLETED|Overall Study||30
8173424|NCT02424357|20152700|P1|COMPLETED|Overall Study||35
8173425|NCT02424357|20152699|P2|STARTED|Overall Study||30
8173426|NCT02424357|20152700|P1|STARTED|Overall Study||35
8173427|NCT02424344|20152710|P2|NOT COMPLETED|Overall Study||10
8173428|NCT02424344|20152711|P1|NOT COMPLETED|Overall Study||7
8173429|NCT02424344|20152710|P2|COMPLETED|Overall Study||123
8173430|NCT02424344|20152711|P1|COMPLETED|Overall Study||127
8173431|NCT02424344|20152710|P2|STARTED|Overall Study||133
8173432|NCT02424344|20152711|P1|STARTED|Overall Study||134
8173433|NCT02424175|20152721|P1|NOT COMPLETED|Overall Study||0
8173434|NCT02424175|20152721|P1|COMPLETED|Overall Study||10
8173435|NCT02424175|20152721|P1|STARTED|Overall Study||10
8173436|NCT02424149|20152729|P2|NOT COMPLETED|Overall Study||1
8173437|NCT02424149|20152730|P1|NOT COMPLETED|Overall Study||2
8173438|NCT02424149|20152729|P2|COMPLETED|Overall Study||52
8173439|NCT02424149|20152730|P1|COMPLETED|Overall Study||52
8173440|NCT02424149|20152729|P2|STARTED|Overall Study||53
8173441|NCT02424149|20152730|P1|STARTED|Overall Study||54
8173442|NCT02424097|20152746|P2|NOT COMPLETED|Overall Study||2
8173443|NCT02424097|20152747|P1|NOT COMPLETED|Overall Study||1
8173444|NCT02424097|20152746|P2|COMPLETED|Overall Study||18
8173445|NCT02424097|20152747|P1|COMPLETED|Overall Study||19
8173446|NCT02424097|20152746|P2|STARTED|Overall Study||20
8173447|NCT02424097|20152747|P1|STARTED|Overall Study||20
8173448|NCT02423993|20152759|P4|NOT COMPLETED|Overall Study||0
8173449|NCT02423993|20152760|P3|NOT COMPLETED|Overall Study||0
8173450|NCT02423993|20152761|P2|NOT COMPLETED|Overall Study||0
8173451|NCT02423993|20152762|P1|NOT COMPLETED|Overall Study||0
8173452|NCT02423993|20152759|P4|COMPLETED|Overall Study||19
8173453|NCT02423993|20152760|P3|COMPLETED|Overall Study||23
8173454|NCT02423993|20152761|P2|COMPLETED|Overall Study||16
8173455|NCT02423993|20152762|P1|COMPLETED|Overall Study||19
8173456|NCT02423993|20152759|P4|STARTED|Overall Study||19
8173457|NCT02423993|20152760|P3|STARTED|Overall Study||23
8173458|NCT02423993|20152761|P2|STARTED|Overall Study||16
8173459|NCT02423993|20152762|P1|STARTED|Overall Study||19
8173460|NCT02423980|20152792|P1|NOT COMPLETED|Overall Study||0
8173461|NCT02423980|20152792|P1|COMPLETED|Overall Study||7
8173462|NCT02423980|20152792|P1|STARTED|Overall Study||7
8173463|NCT02423798|20152802|P1|NOT COMPLETED|Overall Study||3
8173464|NCT02423798|20152802|P1|COMPLETED|Overall Study||21
8173465|NCT02423798|20152802|P1|STARTED|Overall Study||24
8173466|NCT02423577|20152810|P2|NOT COMPLETED|Overall Study||0
8173467|NCT02423577|20152811|P1|NOT COMPLETED|Overall Study||0
8173468|NCT02423577|20152810|P2|COMPLETED|Overall Study||26
8173469|NCT02423577|20152811|P1|COMPLETED|Overall Study||53
8173470|NCT02423577|20152810|P2|STARTED|Overall Study||26
8173471|NCT02423577|20152811|P1|STARTED|Overall Study||53
8173472|NCT02423447|20152817|P2|NOT COMPLETED|Overall Study||0
8173473|NCT02423447|20152818|P1|NOT COMPLETED|Overall Study||0
8173474|NCT02423447|20152817|P2|COMPLETED|Overall Study||12
8173475|NCT02423447|20152818|P1|COMPLETED|Overall Study||13
8173476|NCT02423447|20152817|P2|STARTED|Overall Study||12
8173477|NCT02423447|20152818|P1|STARTED|Overall Study||13
8173478|NCT02423408|20152834|P2|NOT COMPLETED|Overall Study||2
8173479|NCT02423408|20152835|P1|NOT COMPLETED|Overall Study||1
8173480|NCT02423408|20152834|P2|COMPLETED|Overall Study||80
8173481|NCT02423408|20152835|P1|COMPLETED|Overall Study||82
8173482|NCT02423408|20152834|P2|STARTED|Overall Study||82
8173483|NCT02423408|20152835|P1|STARTED|Overall Study||83
8173484|NCT02423317|20152849|P2|NOT COMPLETED|Overall Study||0
8173485|NCT02423317|20152850|P1|NOT COMPLETED|Overall Study||0
8173486|NCT02423317|20152849|P2|COMPLETED|Overall Study||30
8173487|NCT02423317|20152850|P1|COMPLETED|Overall Study||30
8173488|NCT02423317|20152849|P2|STARTED|Overall Study||30
8173489|NCT02423317|20152850|P1|STARTED|Overall Study||30
8173490|NCT02423291|20152868|P1|NOT COMPLETED|Overall Study||15
8173491|NCT02423291|20152868|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
8173492|NCT02423291|20152868|P1|STARTED|Overall Study|Patients enrolled|15
8173493|NCT02423200|20152874|P2|NOT COMPLETED|Overall Study||0
8173494|NCT02423200|20152875|P1|NOT COMPLETED|Overall Study||1
8173495|NCT02423200|20152874|P2|COMPLETED|Overall Study||1
8173496|NCT02423200|20152875|P1|COMPLETED|Overall Study||7
8173497|NCT02423200|20152874|P2|STARTED|Overall Study||1
8173498|NCT02423200|20152875|P1|STARTED|Overall Study||8
8173499|NCT02423122|20152885|P2|NOT COMPLETED|Overall Study||0
8173500|NCT02423122|20152886|P1|NOT COMPLETED|Overall Study||0
8173501|NCT02423122|20152885|P2|COMPLETED|Overall Study||7
8173502|NCT02423122|20152886|P1|COMPLETED|Overall Study||9
8173503|NCT02423122|20152885|P2|STARTED|Overall Study||7
8173504|NCT02423122|20152886|P1|STARTED|Overall Study||9
8173505|NCT02423109|20152898|P2|NOT COMPLETED|Lens 2||0
8173506|NCT02423109|20152899|P1|NOT COMPLETED|Lens 2||0
8173507|NCT02423109|20152898|P2|COMPLETED|Lens 2||14
8173508|NCT02423109|20152899|P1|COMPLETED|Lens 2||18
8173509|NCT02423109|20152898|P2|STARTED|Lens 2||14
8173510|NCT02423109|20152899|P1|STARTED|Lens 2||18
8173511|NCT02423109|20152898|P2|NOT COMPLETED|Lens 1||0
8173512|NCT02423109|20152899|P1|NOT COMPLETED|Lens 1||1
8173513|NCT02423109|20152898|P2|COMPLETED|Lens 1||14
8173514|NCT02423109|20152899|P1|COMPLETED|Lens 1||18
8173515|NCT02423109|20152898|P2|STARTED|Lens 1||14
8173516|NCT02423109|20152899|P1|STARTED|Lens 1||19
8173517|NCT02422940|20152909|P2|NOT COMPLETED|Overall Study||121
8173518|NCT02422940|20152910|P1|NOT COMPLETED|Overall Study||121
8173519|NCT02422940|20152909|P2|COMPLETED|Overall Study||21
8173520|NCT02422940|20152910|P1|COMPLETED|Overall Study||31
8173521|NCT02422940|20152909|P2|STARTED|Overall Study||142
8173522|NCT02422940|20152910|P1|STARTED|Overall Study||152
8173523|NCT02422797|20152932|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
8173524|NCT02422797|20152933|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
8173525|NCT02422797|20152932|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
8173526|NCT02422797|20152933|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
8173527|NCT02422797|20152932|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||239
8173528|NCT02422797|20152933|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||245
8173529|NCT02422797|20152932|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
8173530|NCT02422797|20152933|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
8173531|NCT02422797|20152932|P2|COMPLETED|Early Switch Phase (Up to Week 52)||239
8173532|NCT02422797|20152933|P1|COMPLETED|Early Switch Phase (Up to Week 52)||245
8173533|NCT02422797|20152932|P2|STARTED|Early Switch Phase (Up to Week 52)||255
8173534|NCT02422797|20152933|P1|STARTED|Early Switch Phase (Up to Week 52)||261
8173535|NCT02422615|20153021|P2|NOT COMPLETED|Overall Study||166
8173536|NCT02422615|20153022|P1|NOT COMPLETED|Overall Study||280
8173537|NCT02422615|20153021|P2|COMPLETED|Overall Study||76
8173538|NCT02422615|20153022|P1|COMPLETED|Overall Study||204
8173539|NCT02422615|20153021|P2|Untreated|Overall Study||1
8173540|NCT02422615|20153022|P1|Untreated|Overall Study||1
8173541|NCT02422615|20153021|P2|STARTED|Overall Study||242
8173542|NCT02422615|20153022|P1|STARTED|Overall Study||484
8173543|NCT02422446|20153030|P2|NOT COMPLETED|Overall Study||0
8173544|NCT02422446|20153031|P1|NOT COMPLETED|Overall Study||0
8173545|NCT02422446|20153030|P2|COMPLETED|Overall Study||1
8173546|NCT02422446|20153031|P1|COMPLETED|Overall Study||1
8173547|NCT02422446|20153030|P2|STARTED|Overall Study||1
8173548|NCT02422446|20153031|P1|STARTED|Overall Study||1
8173549|NCT02422303|20153039|P2|NOT COMPLETED|Overall Study||1
8173550|NCT02422303|20153040|P1|NOT COMPLETED|Overall Study||1
8173551|NCT02422303|20153039|P2|COMPLETED|Overall Study||5
8173552|NCT02422303|20153040|P1|COMPLETED|Overall Study||5
8173553|NCT02422303|20153039|P2|STARTED|Overall Study||6
8173554|NCT02422303|20153040|P1|STARTED|Overall Study||6
8173555|NCT02422290|20153046|P1|NOT COMPLETED|Overall Study||0
8173556|NCT02422290|20153046|P1|COMPLETED|Overall Study||5
8173557|NCT02422290|20153046|P1|STARTED|Overall Study||5
8173558|NCT02422264|20153055|P2|NOT COMPLETED|Overall Study||4
8173559|NCT02422264|20153056|P1|NOT COMPLETED|Overall Study||5
8173560|NCT02422264|20153055|P2|COMPLETED|Overall Study||301
8173561|NCT02422264|20153056|P1|COMPLETED|Overall Study||291
8173562|NCT02422264|20153055|P2|STARTED|Overall Study||305
8173563|NCT02422264|20153056|P1|STARTED|Overall Study||296
8173564|NCT02422186|20153102|P2|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
8173565|NCT02422186|20153103|P1|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
8173566|NCT02422186|20153102|P2|COMPLETED|Follow-up Phase (2 Weeks)||3
8173567|NCT02422186|20153103|P1|COMPLETED|Follow-up Phase (2 Weeks)||8
8173568|NCT02422186|20153102|P2|STARTED|Follow-up Phase (2 Weeks)||3
8173569|NCT02422186|20153103|P1|STARTED|Follow-up Phase (2 Weeks)||12
8173570|NCT02422186|20153102|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8173571|NCT02422186|20153103|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
8173572|NCT02422186|20153102|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
8173573|NCT02422186|20153103|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
8173574|NCT02422186|20153102|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
8173575|NCT02422186|20153103|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
8173576|NCT02422186|20153102|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
8173577|NCT02422186|20153103|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
8173578|NCT02422186|20153102|P2|STARTED|Double-blind Induction Phase (4 Weeks)||66
8173579|NCT02422186|20153103|P1|STARTED|Double-blind Induction Phase (4 Weeks)||72
8173580|NCT02421952|20153125|P1|NOT COMPLETED|Overall Study||109
8173581|NCT02421952|20153125|P1|COMPLETED|Overall Study||99
8173582|NCT02421952|20153125|P1|Included in PACU Analysis|Overall Study||192
8173583|NCT02421952|20153125|P1|Excluded From PACU and Post-Analysis|Overall Study||16
8173584|NCT02421952|20153125|P1|STARTED|Overall Study||208
8173585|NCT02421939|20153134|P2|NOT COMPLETED|Overall Study||124
8173586|NCT02421939|20153135|P1|NOT COMPLETED|Overall Study||209
8173587|NCT02421939|20153134|P2|COMPLETED|Overall Study||0
8173588|NCT02421939|20153135|P1|COMPLETED|Overall Study||38
8173589|NCT02421939|20153134|P2|Treated|Overall Study||109
8173590|NCT02421939|20153135|P1|Treated|Overall Study||246
8173591|NCT02421939|20153134|P2|STARTED|Overall Study||124
8173592|NCT02421939|20153135|P1|STARTED|Overall Study||247
8173593|NCT02421887|20153163|P2|NOT COMPLETED|Overall Study||9
8173594|NCT02421887|20153164|P1|NOT COMPLETED|Overall Study||17
8173595|NCT02421887|20153163|P2|COMPLETED|Overall Study||77
8173596|NCT02421887|20153164|P1|COMPLETED|Overall Study||68
8173597|NCT02421887|20153163|P2|STARTED|Overall Study||86
8173598|NCT02421887|20153164|P1|STARTED|Overall Study||85
8173599|NCT02421666|20153190|P2|NOT COMPLETED|12-month Follow-up||16
8173600|NCT02421666|20153191|P1|NOT COMPLETED|12-month Follow-up||11
8173601|NCT02421666|20153190|P2|COMPLETED|12-month Follow-up||231
8173602|NCT02421666|20153191|P1|COMPLETED|12-month Follow-up||248
8173603|NCT02421666|20153190|P2|STARTED|12-month Follow-up||247
8173604|NCT02421666|20153191|P1|STARTED|12-month Follow-up||259
8173605|NCT02421666|20153190|P2|NOT COMPLETED|6-month Follow-up||13
8173606|NCT02421666|20153191|P1|NOT COMPLETED|6-month Follow-up||13
8173607|NCT02421666|20153190|P2|COMPLETED|6-month Follow-up||247
8173608|NCT02421666|20153191|P1|COMPLETED|6-month Follow-up||259
8173609|NCT02421666|20153190|P2|STARTED|6-month Follow-up||260
8173610|NCT02421666|20153191|P1|STARTED|6-month Follow-up||272
8173611|NCT02421666|20153190|P2|NOT COMPLETED|Overall Study Baseline||0
8173612|NCT02421666|20153191|P1|NOT COMPLETED|Overall Study Baseline||0
8173613|NCT02421666|20153190|P2|COMPLETED|Overall Study Baseline||260
8173614|NCT02421666|20153191|P1|COMPLETED|Overall Study Baseline||272
8173615|NCT02421666|20153190|P2|STARTED|Overall Study Baseline||260
8173616|NCT02421666|20153191|P1|STARTED|Overall Study Baseline||272
8173617|NCT02421588|20153199|P2|NOT COMPLETED|Overall Study||221
8173618|NCT02421588|20153200|P1|NOT COMPLETED|Overall Study||221
8173619|NCT02421588|20153199|P2|COMPLETED|Overall Study||0
8173620|NCT02421588|20153200|P1|COMPLETED|Overall Study||0
8173621|NCT02421588|20153199|P2|STARTED|Overall Study||221
8173622|NCT02421588|20153200|P1|STARTED|Overall Study||221
8173623|NCT02421510|20153223|P3|NOT COMPLETED|Overall Study||36
8173624|NCT02421510|20153224|P2|NOT COMPLETED|Overall Study||35
8173625|NCT02421510|20153225|P1|NOT COMPLETED|Overall Study||33
8173626|NCT02421510|20153223|P3|COMPLETED|Overall Study||227
8173627|NCT02421510|20153224|P2|COMPLETED|Overall Study||226
8173628|NCT02421510|20153225|P1|COMPLETED|Overall Study||225
8173629|NCT02421510|20153223|P3|Completed the 24 Week Treatment Period|Overall Study||240
8173630|NCT02421510|20153224|P2|Completed the 24 Week Treatment Period|Overall Study||239
8173631|NCT02421510|20153225|P1|Completed the 24 Week Treatment Period|Overall Study||236
8173632|NCT02421510|20153223|P3|STARTED|Overall Study||263
8173633|NCT02421510|20153224|P2|STARTED|Overall Study||261
8173634|NCT02421510|20153225|P1|STARTED|Overall Study||258
8173635|NCT02421419|20153257|P3|NOT COMPLETED|Overall Study||1
8173636|NCT02421419|20153258|P2|NOT COMPLETED|Overall Study||0
8173637|NCT02421419|20153259|P1|NOT COMPLETED|Overall Study||0
8173638|NCT02421419|20153257|P3|COMPLETED|Overall Study||8
8173639|NCT02421419|20153258|P2|COMPLETED|Overall Study||11
8173640|NCT02421419|20153259|P1|COMPLETED|Overall Study||6
8173641|NCT02421419|20153257|P3|STARTED|Overall Study||9
8173642|NCT02421419|20153258|P2|STARTED|Overall Study||11
8173643|NCT02421419|20153259|P1|STARTED|Overall Study||6
8173644|NCT02421354|20153276|P1|NOT COMPLETED|Overall Study||0
8173645|NCT02421354|20153276|P1|COMPLETED|Overall Study||8
8173646|NCT02421354|20153276|P1|STARTED|Overall Study||8
8173647|NCT02421224|20153289|P9|NOT COMPLETED|Overall Study||1
8173648|NCT02421224|20153290|P8|NOT COMPLETED|Overall Study||2
8173649|NCT02421224|20153291|P7|NOT COMPLETED|Overall Study||0
8173650|NCT02421224|20153292|P6|NOT COMPLETED|Overall Study||2
8173651|NCT02421224|20153293|P5|NOT COMPLETED|Overall Study||4
8173652|NCT02421224|20153294|P4|NOT COMPLETED|Overall Study||3
8173653|NCT02421224|20153295|P3|NOT COMPLETED|Overall Study||1
8173654|NCT02421224|20153296|P2|NOT COMPLETED|Overall Study||3
8173655|NCT02421224|20153297|P1|NOT COMPLETED|Overall Study||2
8173656|NCT02421224|20153289|P9|COMPLETED|Overall Study||495
8173657|NCT02421224|20153290|P8|COMPLETED|Overall Study||362
8173658|NCT02421224|20153291|P7|COMPLETED|Overall Study||489
8173659|NCT02421224|20153292|P6|COMPLETED|Overall Study||513
8173660|NCT02421224|20153293|P5|COMPLETED|Overall Study||491
8173661|NCT02421224|20153294|P4|COMPLETED|Overall Study||479
8173662|NCT02421224|20153295|P3|COMPLETED|Overall Study||507
8173663|NCT02421224|20153296|P2|COMPLETED|Overall Study||394
8173664|NCT02421224|20153297|P1|COMPLETED|Overall Study||442
8173665|NCT02421224|20153289|P9|STARTED|Overall Study||496
8173666|NCT02421224|20153290|P8|STARTED|Overall Study||364
8173667|NCT02421224|20153291|P7|STARTED|Overall Study||489
8173668|NCT02421224|20153292|P6|STARTED|Overall Study||515
8173669|NCT02421224|20153293|P5|STARTED|Overall Study||495
8173670|NCT02421224|20153294|P4|STARTED|Overall Study||482
8173671|NCT02421224|20153295|P3|STARTED|Overall Study||508
8173672|NCT02421224|20153296|P2|STARTED|Overall Study||397
8173673|NCT02421224|20153297|P1|STARTED|Overall Study||444
8173674|NCT02421211|20153346|P2|NOT COMPLETED|Overall Study||0
8173675|NCT02421211|20153347|P1|NOT COMPLETED|Overall Study||0
8173676|NCT02421211|20153346|P2|COMPLETED|Overall Study||20
8173677|NCT02421211|20153347|P1|COMPLETED|Overall Study||20
8173678|NCT02421211|20153346|P2|STARTED|Overall Study||20
8173679|NCT02421211|20153347|P1|STARTED|Overall Study||20
8173680|NCT02421172|20153393|P5|NOT COMPLETED|Period 2||1
8173681|NCT02421172|20153394|P4|NOT COMPLETED|Period 2||3
8173682|NCT02421172|20153395|P3|NOT COMPLETED|Period 2||7
8173683|NCT02421172|20153396|P2|NOT COMPLETED|Period 2||0
8173684|NCT02421172|20153397|P1|NOT COMPLETED|Period 2||0
8173685|NCT02421172|20153393|P5|COMPLETED|Period 2||14
8173686|NCT02421172|20153394|P4|COMPLETED|Period 2||13
8173687|NCT02421172|20153395|P3|COMPLETED|Period 2||22
8173688|NCT02421172|20153396|P2|COMPLETED|Period 2||0
8173689|NCT02421172|20153397|P1|COMPLETED|Period 2||0
8173690|NCT02421172|20153393|P5|STARTED|Period 2||15
8173691|NCT02421172|20153394|P4|STARTED|Period 2||16
8173692|NCT02421172|20153395|P3|STARTED|Period 2||29
8173693|NCT02421172|20153396|P2|STARTED|Period 2||0
8173694|NCT02421172|20153397|P1|STARTED|Period 2||0
8173695|NCT02421172|20153393|P5|NOT COMPLETED|Period 1||0
8173696|NCT02421172|20153394|P4|NOT COMPLETED|Period 1||0
8173697|NCT02421172|20153395|P3|NOT COMPLETED|Period 1||0
8173698|NCT02421172|20153396|P2|NOT COMPLETED|Period 1||2
8173699|NCT02421172|20153397|P1|NOT COMPLETED|Period 1||4
8173700|NCT02421172|20153393|P5|COMPLETED|Period 1||0
8173701|NCT02421172|20153394|P4|COMPLETED|Period 1||0
8173702|NCT02421172|20153395|P3|COMPLETED|Period 1||0
8173703|NCT02421172|20153396|P2|COMPLETED|Period 1||31
8173704|NCT02421172|20153397|P1|COMPLETED|Period 1||29
8173705|NCT02421172|20153393|P5|PK Analysis Set Period 1|Period 1||0
8173706|NCT02421172|20153394|P4|PK Analysis Set Period 1|Period 1||0
8173707|NCT02421172|20153395|P3|PK Analysis Set Period 1|Period 1||0
8173708|NCT02421172|20153396|P2|PK Analysis Set Period 1|Period 1||0
8173709|NCT02421172|20153397|P1|PK Analysis Set Period 1|Period 1||33
8173710|NCT02421172|20153393|P5|PD Analysis Set Period 1|Period 1||0
8173711|NCT02421172|20153394|P4|PD Analysis Set Period 1|Period 1||0
8173712|NCT02421172|20153395|P3|PD Analysis Set Period 1|Period 1||0
8173713|NCT02421172|20153396|P2|PD Analysis Set Period 1|Period 1||33
8173714|NCT02421172|20153397|P1|PD Analysis Set Period 1|Period 1||31
8173715|NCT02421172|20153393|P5|STARTED|Period 1||0
8173716|NCT02421172|20153394|P4|STARTED|Period 1||0
8173717|NCT02421172|20153395|P3|STARTED|Period 1||0
8173718|NCT02421172|20153396|P2|STARTED|Period 1||33
8173719|NCT02421172|20153397|P1|STARTED|Period 1||33
8173720|NCT02421146|20153424|P4|NOT COMPLETED|Overall Study||0
8173721|NCT02421146|20153425|P3|NOT COMPLETED|Overall Study||0
8173722|NCT02421146|20153426|P2|NOT COMPLETED|Overall Study||0
8173723|NCT02421146|20153427|P1|NOT COMPLETED|Overall Study||0
8173724|NCT02421146|20153424|P4|COMPLETED|Overall Study||3
8173725|NCT02421146|20153425|P3|COMPLETED|Overall Study||3
8173726|NCT02421146|20153426|P2|COMPLETED|Overall Study||4
8173727|NCT02421146|20153427|P1|COMPLETED|Overall Study||2
8173728|NCT02421146|20153424|P4|STARTED|Overall Study||3
8173729|NCT02421146|20153425|P3|STARTED|Overall Study||3
8173730|NCT02421146|20153426|P2|STARTED|Overall Study||4
8173731|NCT02421146|20153427|P1|STARTED|Overall Study||2
8173732|NCT02421120|20153441|P1|NOT COMPLETED|Overall Study||1
8173733|NCT02421120|20153441|P1|COMPLETED|Overall Study||20
8173734|NCT02421120|20153441|P1|STARTED|Overall Study||21
8173735|NCT02421094|20153451|P2|NOT COMPLETED|Overall Study||0
8173736|NCT02421094|20153452|P1|NOT COMPLETED|Overall Study||0
8173737|NCT02421094|20153451|P2|COMPLETED|Overall Study||15
8173738|NCT02421094|20153452|P1|COMPLETED|Overall Study||15
8173739|NCT02421094|20153451|P2|STARTED|Overall Study||15
8173740|NCT02421094|20153452|P1|STARTED|Overall Study||15
8173741|NCT02421055|20153464|P3|NOT COMPLETED|Overall Study||0
8173742|NCT02421055|20153465|P2|NOT COMPLETED|Overall Study||0
8173743|NCT02421055|20153466|P1|NOT COMPLETED|Overall Study||34
8173744|NCT02421055|20153464|P3|COMPLETED|Overall Study||74
8173745|NCT02421055|20153465|P2|COMPLETED|Overall Study||50
8173746|NCT02421055|20153466|P1|COMPLETED|Overall Study||0
8173747|NCT02421055|20153464|P3|Post-operative Complete Sample Set|Overall Study||14
8173748|NCT02421055|20153465|P2|Post-operative Complete Sample Set|Overall Study||13
8173749|NCT02421055|20153466|P1|Post-operative Complete Sample Set|Overall Study||0
8173750|NCT02421055|20153464|P3|Post-operative Serum Sample (Minimum)|Overall Study||26
8173751|NCT02421055|20153465|P2|Post-operative Serum Sample (Minimum)|Overall Study||23
8173752|NCT02421055|20153466|P1|Post-operative Serum Sample (Minimum)|Overall Study||0
8173753|NCT02421055|20153464|P3|Pre-operative Complete Sample Set|Overall Study||36
8173754|NCT02421055|20153465|P2|Pre-operative Complete Sample Set|Overall Study||22
8173755|NCT02421055|20153466|P1|Pre-operative Complete Sample Set|Overall Study||23
8173756|NCT02421055|20153464|P3|Pre-operative Serum Sample (Minimum)|Overall Study||74
8173757|NCT02421055|20153465|P2|Pre-operative Serum Sample (Minimum)|Overall Study||50
8173758|NCT02421055|20153466|P1|Pre-operative Serum Sample (Minimum)|Overall Study||34
8173759|NCT02421055|20153464|P3|STARTED|Overall Study||74
8173760|NCT02421055|20153465|P2|STARTED|Overall Study||50
8173761|NCT02421055|20153466|P1|STARTED|Overall Study||34
8173762|NCT02420951|20153493|P2|NOT COMPLETED|Overall Study||0
8173763|NCT02420951|20153494|P1|NOT COMPLETED|Overall Study||0
8173764|NCT02420951|20153493|P2|COMPLETED|Overall Study||25
8173765|NCT02420951|20153494|P1|COMPLETED|Overall Study||25
8173766|NCT02420951|20153493|P2|STARTED|Overall Study||25
8173767|NCT02420951|20153494|P1|STARTED|Overall Study||25
8173768|NCT02420873|20153513|P3|NOT COMPLETED|Overall Study||0
8173769|NCT02420873|20153514|P2|NOT COMPLETED|Overall Study||0
8173770|NCT02420873|20153515|P1|NOT COMPLETED|Overall Study||0
8173771|NCT02420873|20153513|P3|COMPLETED|Overall Study||0
8173772|NCT02420873|20153514|P2|COMPLETED|Overall Study||0
8173773|NCT02420873|20153515|P1|COMPLETED|Overall Study||9
8173774|NCT02420873|20153513|P3|STARTED|Overall Study||0
8173775|NCT02420873|20153514|P2|STARTED|Overall Study||0
8173776|NCT02420873|20153515|P1|STARTED|Overall Study||9
8173783|NCT02420691|20153594|P1|NOT COMPLETED|Overall Study||6
8173784|NCT02420691|20153594|P1|COMPLETED|Overall Study||14
8173785|NCT02420691|20153594|P1|STARTED|Overall Study||20
8173786|NCT02420379|20153604|P2|NOT COMPLETED|Overall Study||4
8173787|NCT02420379|20153605|P1|NOT COMPLETED|Overall Study||1
8173788|NCT02420379|20153604|P2|COMPLETED|Overall Study||3
8173789|NCT02420379|20153605|P1|COMPLETED|Overall Study||25
8173790|NCT02420379|20153604|P2|STARTED|Overall Study||7
8173791|NCT02420379|20153605|P1|STARTED|Overall Study||26
8173792|NCT02420353|20153625|P2|NOT COMPLETED|Overall Study||1
8173793|NCT02420353|20153626|P1|NOT COMPLETED|Overall Study||0
8173794|NCT02420353|20153625|P2|COMPLETED|Overall Study||9
8173795|NCT02420353|20153626|P1|COMPLETED|Overall Study||10
8173796|NCT02420353|20153625|P2|Allocation to Intervention|Overall Study||10
8173797|NCT02420353|20153626|P1|Allocation to Intervention|Overall Study||10
8173798|NCT02420353|20153625|P2|STARTED|Overall Study||10
8173799|NCT02420353|20153626|P1|STARTED|Overall Study||10
8173800|NCT02420327|20153718|P1|NOT COMPLETED|Overall Study||16
8173801|NCT02420327|20153718|P1|COMPLETED|Overall Study||27
8173802|NCT02420327|20153718|P1|STARTED|Overall Study||43
8173803|NCT02420262|20153754|P2|NOT COMPLETED|Overall Study||5
8173804|NCT02420262|20153755|P1|NOT COMPLETED|Overall Study||2
8173805|NCT02420262|20153754|P2|COMPLETED|Overall Study||249
8173806|NCT02420262|20153755|P1|COMPLETED|Overall Study||250
8173807|NCT02420262|20153754|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
8173808|NCT02420262|20153755|P1|Exposed|Overall Study||252
8173809|NCT02420262|20153754|P2|STARTED|Overall Study||254
8173810|NCT02420262|20153755|P1|STARTED|Overall Study||252
8173811|NCT02420210|20153769|P1|NOT COMPLETED|Overall Study||0
8173812|NCT02420210|20153769|P1|COMPLETED|Overall Study||2
8173813|NCT02420210|20153769|P1|STARTED|Overall Study||2
8173814|NCT02420093|20153781|P2|NOT COMPLETED|Overall Study||1
8173815|NCT02420093|20153782|P1|NOT COMPLETED|Overall Study||1
8173816|NCT02420093|20153781|P2|COMPLETED|Overall Study||7
8173817|NCT02420093|20153782|P1|COMPLETED|Overall Study||8
8173818|NCT02420093|20153781|P2|STARTED|Overall Study||8
8173819|NCT02420093|20153782|P1|STARTED|Overall Study||9
8173820|NCT02420041|20153798|P2|NOT COMPLETED|Overall Study||0
8173821|NCT02420041|20153799|P1|NOT COMPLETED|Overall Study||0
8173822|NCT02420041|20153798|P2|COMPLETED|Overall Study||14
8173823|NCT02420041|20153799|P1|COMPLETED|Overall Study||14
8173824|NCT02420041|20153798|P2|STARTED|Overall Study||14
8173825|NCT02420041|20153799|P1|STARTED|Overall Study||14
8173826|NCT02420015|20153825|P2|NOT COMPLETED|Overall Study||0
8173827|NCT02420015|20153826|P1|NOT COMPLETED|Overall Study||0
8173828|NCT02420015|20153825|P2|COMPLETED|Overall Study||13
8173829|NCT02420015|20153826|P1|COMPLETED|Overall Study||21
8173830|NCT02420015|20153825|P2|STARTED|Overall Study||13
8173831|NCT02420015|20153826|P1|STARTED|Overall Study||21
8173832|NCT02419937|20153844|P2|NOT COMPLETED|Overall Study||0
8173833|NCT02419937|20153845|P1|NOT COMPLETED|Overall Study||1
8173834|NCT02419937|20153844|P2|COMPLETED|Overall Study||16
8173835|NCT02419937|20153845|P1|COMPLETED|Overall Study||11
8173836|NCT02419937|20153844|P2|STARTED|Overall Study||16
8173837|NCT02419937|20153845|P1|STARTED|Overall Study||12
8173838|NCT02419924|20153851|P1|NOT COMPLETED|Overall Study||0
8173839|NCT02419924|20153851|P1|COMPLETED|Overall Study||12
8173840|NCT02419924|20153851|P1|STARTED|Overall Study||12
8173841|NCT02419807|20153858|P1|NOT COMPLETED|Overall Study||10
8173842|NCT02419807|20153858|P1|COMPLETED|Overall Study||92
8173843|NCT02419807|20153858|P1|STARTED|Overall Study||102
8173844|NCT02419755|20153864|P2|NOT COMPLETED|Overall Study||4
8173845|NCT02419755|20153865|P1|NOT COMPLETED|Overall Study||3
8173846|NCT02419755|20153864|P2|COMPLETED|Overall Study||2
8173847|NCT02419755|20153865|P1|COMPLETED|Overall Study||3
8173848|NCT02419755|20153864|P2|STARTED|Overall Study||6
8173849|NCT02419755|20153865|P1|STARTED|Overall Study||6
8173850|NCT02419690|20153891|P2|NOT COMPLETED|Overall Study||0
8173851|NCT02419690|20153892|P1|NOT COMPLETED|Overall Study||0
8173852|NCT02419690|20153891|P2|COMPLETED|Overall Study||122
8173853|NCT02419690|20153892|P1|COMPLETED|Overall Study||122
8173854|NCT02419690|20153891|P2|STARTED|Overall Study||122
8173855|NCT02419690|20153892|P1|STARTED|Overall Study||122
8173856|NCT02419612|20153906|P2|NOT COMPLETED|Long-term Treatment Period||22
8173857|NCT02419612|20153907|P1|NOT COMPLETED|Long-term Treatment Period||22
8173858|NCT02419612|20153906|P2|COMPLETED|Long-term Treatment Period||164
8173859|NCT02419612|20153907|P1|COMPLETED|Long-term Treatment Period||174
8173860|NCT02419612|20153906|P2|Received Treatment|Long-term Treatment Period||183
8173861|NCT02419612|20153907|P1|Received Treatment|Long-term Treatment Period||196
8173862|NCT02419612|20153906|P2|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
8173863|NCT02419612|20153907|P1|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
8173864|NCT02419612|20153906|P2|NOT COMPLETED|Short-term Treatment Period||23
8173865|NCT02419612|20153907|P1|NOT COMPLETED|Short-term Treatment Period||17
8173866|NCT02419612|20153906|P2|COMPLETED|Short-term Treatment Period||194
8173867|NCT02419612|20153907|P1|COMPLETED|Short-term Treatment Period||210
8173868|NCT02419612|20153906|P2|Recevied Treatment|Short-term Treatment Period||216
8173869|NCT02419612|20153907|P1|Recevied Treatment|Short-term Treatment Period||227
8173870|NCT02419612|20153906|P2|STARTED|Short-term Treatment Period||217
8173871|NCT02419612|20153907|P1|STARTED|Short-term Treatment Period||227
8173872|NCT02419573|20153929|P2|NOT COMPLETED|Overall Study||0
8173873|NCT02419573|20153930|P1|NOT COMPLETED|Overall Study||4
8173874|NCT02419573|20153929|P2|COMPLETED|Overall Study||1505
8173875|NCT02419573|20153930|P1|COMPLETED|Overall Study||1495
8173876|NCT02419573|20153929|P2|STARTED|Overall Study||1505
8173877|NCT02419573|20153930|P1|STARTED|Overall Study||1499
8173878|NCT02419547|20153942|P1|NOT COMPLETED|Overall Study||0
8173879|NCT02419547|20153942|P1|COMPLETED|Overall Study||11
8173880|NCT02419547|20153942|P1|STARTED|Overall Study||11
8173881|NCT02419521|20153946|P1|NOT COMPLETED|Overall Study||1
8173882|NCT02419521|20153946|P1|COMPLETED|Overall Study||74
8173883|NCT02419521|20153946|P1|STARTED|Overall Study||75
8173884|NCT02419508|20153960|P2|NOT COMPLETED|Overall Study||4
8173885|NCT02419508|20153961|P1|NOT COMPLETED|Overall Study||10
8173886|NCT02419508|20153960|P2|COMPLETED|Overall Study||88
8173887|NCT02419508|20153961|P1|COMPLETED|Overall Study||86
8173888|NCT02419508|20153960|P2|Safety Analysis Set|Overall Study||92
8173889|NCT02419508|20153961|P1|Safety Analysis Set|Overall Study||95
8173890|NCT02419508|20153960|P2|Full Analysis Set|Overall Study||92
8173891|NCT02419508|20153961|P1|Full Analysis Set|Overall Study||95
8173892|NCT02419508|20153960|P2|STARTED|Overall Study||92
8173893|NCT02419508|20153961|P1|STARTED|Overall Study||96
8173894|NCT02419469|20153979|P1|NOT COMPLETED|Overall Study||1
8173895|NCT02419469|20153979|P1|COMPLETED|Overall Study||0
8173896|NCT02419469|20153979|P1|STARTED|Overall Study||1
8173897|NCT02419313|20153983|P2|NOT COMPLETED|Second Intervention||0
8173898|NCT02419313|20153984|P1|NOT COMPLETED|Second Intervention||1
8173899|NCT02419313|20153983|P2|COMPLETED|Second Intervention||15
8173900|NCT02419313|20153984|P1|COMPLETED|Second Intervention||15
8173901|NCT02419313|20153983|P2|STARTED|Second Intervention||15
8173902|NCT02419313|20153984|P1|STARTED|Second Intervention||16
8173903|NCT02419313|20153983|P2|NOT COMPLETED|First Intervention||0
8173904|NCT02419313|20153984|P1|NOT COMPLETED|First Intervention||2
8173905|NCT02419313|20153983|P2|COMPLETED|First Intervention||15
8173906|NCT02419313|20153984|P1|COMPLETED|First Intervention||16
8173907|NCT02419313|20153983|P2|STARTED|First Intervention||15
8173908|NCT02419313|20153984|P1|STARTED|First Intervention||18
8173909|NCT02419001|20153996|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
8173910|NCT02419001|20153997|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
8173911|NCT02419001|20153996|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
8173912|NCT02419001|20153997|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
8173913|NCT02419001|20153996|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
8173914|NCT02419001|20153997|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
8173915|NCT02419001|20153996|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
8173916|NCT02419001|20153997|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
8173917|NCT02419001|20153996|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
8173918|NCT02419001|20153997|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
8173919|NCT02419001|20153996|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
8173920|NCT02419001|20153997|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
8173921|NCT02418910|20154007|P1|NOT COMPLETED|Overall Study||7
8173922|NCT02418910|20154007|P1|COMPLETED|Overall Study||43
8173923|NCT02418910|20154007|P1|STARTED|Overall Study||50
8173924|NCT02418819|20154015|P4|NOT COMPLETED|Overall Study||1
8173925|NCT02418819|20154016|P3|NOT COMPLETED|Overall Study||4
8173926|NCT02418819|20154017|P2|NOT COMPLETED|Overall Study||0
8173927|NCT02418819|20154018|P1|NOT COMPLETED|Overall Study||1
8173928|NCT02418819|20154015|P4|COMPLETED|Overall Study||28
8173929|NCT02418819|20154016|P3|COMPLETED|Overall Study||29
8173930|NCT02418819|20154017|P2|COMPLETED|Overall Study||16
8173931|NCT02418819|20154018|P1|COMPLETED|Overall Study||21
8173932|NCT02418819|20154015|P4|STARTED|Overall Study||29
8173933|NCT02418819|20154016|P3|STARTED|Overall Study||33
8173934|NCT02418819|20154017|P2|STARTED|Overall Study||16
8173935|NCT02418819|20154018|P1|STARTED|Overall Study||22
8173936|NCT02418754|20154061|P5|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
8173937|NCT02418754|20154062|P4|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
8173938|NCT02418754|20154063|P3|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
8173939|NCT02418754|20154064|P2|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
8173940|NCT02418754|20154065|P1|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
8173941|NCT02418754|20154061|P5|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
8173942|NCT02418754|20154062|P4|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
8173943|NCT02418754|20154063|P3|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
8173944|NCT02418754|20154064|P2|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
8173945|NCT02418754|20154065|P1|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
8173946|NCT02418754|20154061|P5|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
8173947|NCT02418754|20154062|P4|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
8173948|NCT02418754|20154063|P3|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
8173949|NCT02418754|20154064|P2|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
8173950|NCT02418754|20154065|P1|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
8173951|NCT02418754|20154061|P5|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
8173952|NCT02418754|20154062|P4|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
8173953|NCT02418754|20154063|P3|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
8173954|NCT02418754|20154064|P2|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
8173955|NCT02418754|20154065|P1|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
8173956|NCT02418754|20154061|P5|COMPLETED|Period 1 (Day 1 to Week 12)||0
8173957|NCT02418754|20154062|P4|COMPLETED|Period 1 (Day 1 to Week 12)||0
8173958|NCT02418754|20154063|P3|COMPLETED|Period 1 (Day 1 to Week 12)||200
8173959|NCT02418754|20154064|P2|COMPLETED|Period 1 (Day 1 to Week 12)||196
8173960|NCT02418754|20154065|P1|COMPLETED|Period 1 (Day 1 to Week 12)||101
8173961|NCT02418754|20154061|P5|STARTED|Period 1 (Day 1 to Week 12)||0
8173962|NCT02418754|20154062|P4|STARTED|Period 1 (Day 1 to Week 12)||0
8173963|NCT02418754|20154063|P3|STARTED|Period 1 (Day 1 to Week 12)||202
8173964|NCT02418754|20154064|P2|STARTED|Period 1 (Day 1 to Week 12)||200
8173965|NCT02418754|20154065|P1|STARTED|Period 1 (Day 1 to Week 12)||103
8173966|NCT02418676|20154099|P3|NOT COMPLETED|Overall Study||0
8173967|NCT02418676|20154100|P2|NOT COMPLETED|Overall Study||0
8173968|NCT02418676|20154101|P1|NOT COMPLETED|Overall Study||0
8173969|NCT02418676|20154099|P3|COMPLETED|Overall Study||5
8173970|NCT02418676|20154100|P2|COMPLETED|Overall Study||5
8173971|NCT02418676|20154101|P1|COMPLETED|Overall Study||5
8173972|NCT02418676|20154099|P3|STARTED|Overall Study||5
8173973|NCT02418676|20154100|P2|STARTED|Overall Study||5
8173974|NCT02418676|20154101|P1|STARTED|Overall Study||5
8173975|NCT02418585|20154114|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
8173976|NCT02418585|20154115|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
8173977|NCT02418585|20154114|P2|COMPLETED|Follow-up Phase (24 Weeks)||27
8173978|NCT02418585|20154115|P1|COMPLETED|Follow-up Phase (24 Weeks)||16
8173979|NCT02418585|20154114|P2|STARTED|Follow-up Phase (24 Weeks)||52
8173980|NCT02418585|20154115|P1|STARTED|Follow-up Phase (24 Weeks)||34
8173981|NCT02418585|20154114|P2|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
8173982|NCT02418585|20154115|P1|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
8173983|NCT02418585|20154114|P2|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
8173984|NCT02418585|20154115|P1|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
8173985|NCT02418585|20154114|P2|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
8173986|NCT02418585|20154115|P1|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
8173987|NCT02418585|20154114|P2|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
8173988|NCT02418585|20154115|P1|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
8173989|NCT02418585|20154114|P2|STARTED|Double Blind (DB) Phase (4 Weeks)||111
8173990|NCT02418585|20154115|P1|STARTED|Double Blind (DB) Phase (4 Weeks)||116
8173991|NCT02418546|20154156|P3|NOT COMPLETED|Overall Study||3
8173992|NCT02418546|20154157|P2|NOT COMPLETED|Overall Study||6
8173993|NCT02418546|20154158|P1|NOT COMPLETED|Overall Study||7
8173994|NCT02418546|20154156|P3|COMPLETED|Overall Study||23
8173995|NCT02418546|20154157|P2|COMPLETED|Overall Study||20
8173996|NCT02418546|20154158|P1|COMPLETED|Overall Study||19
8173997|NCT02418546|20154156|P3|STARTED|Overall Study||26
8173998|NCT02418546|20154157|P2|STARTED|Overall Study||26
8173999|NCT02418546|20154158|P1|STARTED|Overall Study||26
8174000|NCT02418468|20154171|P2|NOT COMPLETED|Overall Study||1
8174001|NCT02418468|20154172|P1|NOT COMPLETED|Overall Study||2
8174002|NCT02418468|20154171|P2|COMPLETED|Overall Study||10
8174003|NCT02418468|20154172|P1|COMPLETED|Overall Study||11
8174004|NCT02418468|20154171|P2|STARTED|Overall Study||11
8174005|NCT02418468|20154172|P1|STARTED|Overall Study||13
8174006|NCT02418455|20154178|P1|NOT COMPLETED|Continuation Period||7
8174007|NCT02418455|20154178|P1|COMPLETED|Continuation Period||0
8174008|NCT02418455|20154178|P1|STARTED|Continuation Period||7
8174009|NCT02418455|20154178|P1|NOT COMPLETED|48-Week Treatment Period||1
8174010|NCT02418455|20154178|P1|COMPLETED|48-Week Treatment Period||7
8174011|NCT02418455|20154178|P1|Emergency IND (eIND)|48-Week Treatment Period||1
8174012|NCT02418455|20154178|P1|STARTED|48-Week Treatment Period||8
8174013|NCT02418312|20154201|P2|NOT COMPLETED|Overall Study||0
8174014|NCT02418312|20154202|P1|NOT COMPLETED|Overall Study||0
8174015|NCT02418312|20154201|P2|COMPLETED|Overall Study||114
8174016|NCT02418312|20154202|P1|COMPLETED|Overall Study||114
8174017|NCT02418312|20154201|P2|STARTED|Overall Study||114
8174018|NCT02418312|20154202|P1|STARTED|Overall Study||114
8174019|NCT02418234|20154208|P1|NOT COMPLETED|Overall Study||0
8174020|NCT02418234|20154208|P1|COMPLETED|Overall Study||314
8174021|NCT02418234|20154208|P1|STARTED|Overall Study||314
8174022|NCT02418182|20154221|P2|NOT COMPLETED|Overall Study||17
8174023|NCT02418182|20154222|P1|NOT COMPLETED|Overall Study||18
8174024|NCT02418182|20154221|P2|COMPLETED|Overall Study||33
8174025|NCT02418182|20154222|P1|COMPLETED|Overall Study||31
8174026|NCT02418182|20154221|P2|STARTED|Overall Study||50
8174027|NCT02418182|20154222|P1|STARTED|Overall Study||49
8174028|NCT02418156|20154234|P1|NOT COMPLETED|Overall Study||17
8174029|NCT02418156|20154234|P1|COMPLETED|Overall Study||21
8174030|NCT02418156|20154234|P1|STARTED|Overall Study||38
8174031|NCT02418026|20154240|P2|NOT COMPLETED|Overall Study||0
8174032|NCT02418026|20154241|P1|NOT COMPLETED|Overall Study||0
8174033|NCT02418026|20154240|P2|COMPLETED|Overall Study||35
8174034|NCT02418026|20154241|P1|COMPLETED|Overall Study||44
8174035|NCT02418026|20154240|P2|STARTED|Overall Study||35
8174036|NCT02418026|20154241|P1|STARTED|Overall Study||44
8174037|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
8174038|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174039|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174040|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174041|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174042|NCT02418000|20154276|P5|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174043|NCT02418000|20154277|P4|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174044|NCT02418000|20154278|P3|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174045|NCT02418000|20154279|P2|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174046|NCT02418000|20154280|P1|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174047|NCT02418000|20154276|P5|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
8174048|NCT02418000|20154277|P4|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174049|NCT02418000|20154278|P3|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174050|NCT02418000|20154279|P2|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174051|NCT02418000|20154280|P1|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174052|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174053|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
8174054|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174055|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174056|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174057|NCT02418000|20154276|P5|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174058|NCT02418000|20154277|P4|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174059|NCT02418000|20154278|P3|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174060|NCT02418000|20154279|P2|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174061|NCT02418000|20154280|P1|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174062|NCT02418000|20154276|P5|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174063|NCT02418000|20154277|P4|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
8174064|NCT02418000|20154278|P3|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174065|NCT02418000|20154279|P2|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174066|NCT02418000|20154280|P1|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174067|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174068|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174069|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
8174070|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174071|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174072|NCT02418000|20154276|P5|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174073|NCT02418000|20154277|P4|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174074|NCT02418000|20154278|P3|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174075|NCT02418000|20154279|P2|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174076|NCT02418000|20154280|P1|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174077|NCT02418000|20154276|P5|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174078|NCT02418000|20154277|P4|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174079|NCT02418000|20154278|P3|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
8174080|NCT02418000|20154279|P2|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174081|NCT02418000|20154280|P1|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174082|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174083|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174084|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174085|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
8174086|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174087|NCT02418000|20154276|P5|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174088|NCT02418000|20154277|P4|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174089|NCT02418000|20154278|P3|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174090|NCT02418000|20154279|P2|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174091|NCT02418000|20154280|P1|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174092|NCT02418000|20154276|P5|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174093|NCT02418000|20154277|P4|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174094|NCT02418000|20154278|P3|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174095|NCT02418000|20154279|P2|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
8174096|NCT02418000|20154280|P1|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174097|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174098|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174099|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174100|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174101|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
8174102|NCT02418000|20154276|P5|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174103|NCT02418000|20154277|P4|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174104|NCT02418000|20154278|P3|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174105|NCT02418000|20154279|P2|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174106|NCT02418000|20154280|P1|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174107|NCT02418000|20154276|P5|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174108|NCT02418000|20154277|P4|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174109|NCT02418000|20154278|P3|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174110|NCT02418000|20154279|P2|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174111|NCT02418000|20154280|P1|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
8174112|NCT02417961|20154398|P1|NOT COMPLETED|Overall Study||4
8174113|NCT02417961|20154398|P1|COMPLETED|Overall Study||112
8174114|NCT02417961|20154398|P1|STARTED|Overall Study||116
8174115|NCT02417935|20154410|P2|NOT COMPLETED|Tapering Period||0
8174116|NCT02417935|20154411|P1|NOT COMPLETED|Tapering Period||0
8174117|NCT02417935|20154410|P2|COMPLETED|Tapering Period||142
8174118|NCT02417935|20154411|P1|COMPLETED|Tapering Period||134
8174119|NCT02417935|20154410|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
8174120|NCT02417935|20154411|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
8174121|NCT02417935|20154410|P2|NOT COMPLETED|Treatment Period||16
8174122|NCT02417935|20154411|P1|NOT COMPLETED|Treatment Period||21
8174123|NCT02417935|20154410|P2|COMPLETED|Treatment Period||137
8174124|NCT02417935|20154411|P1|COMPLETED|Treatment Period||130
8174125|NCT02417935|20154410|P2|Received at Least One Dose of Study Drug|Treatment Period||152
8174126|NCT02417935|20154411|P1|Received at Least One Dose of Study Drug|Treatment Period||151
8174127|NCT02417935|20154410|P2|STARTED|Treatment Period||153
8174128|NCT02417935|20154411|P1|STARTED|Treatment Period||151
8174129|NCT02417844|20154435|P2|NOT COMPLETED|Overall Study||0
8174130|NCT02417844|20154436|P1|NOT COMPLETED|Overall Study||0
8174131|NCT02417844|20154435|P2|COMPLETED|Overall Study||17
8174132|NCT02417844|20154436|P1|COMPLETED|Overall Study||17
8174133|NCT02417844|20154435|P2|STARTED|Overall Study||17
8174134|NCT02417844|20154436|P1|STARTED|Overall Study||17
8174135|NCT02417831|20154452|P2|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
8174136|NCT02417831|20154453|P1|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
8174137|NCT02417831|20154452|P2|COMPLETED|Period 2: Treatment Period 2 + Washout||17
8174138|NCT02417831|20154453|P1|COMPLETED|Period 2: Treatment Period 2 + Washout||17
8174139|NCT02417831|20154452|P2|STARTED|Period 2: Treatment Period 2 + Washout||17
8174140|NCT02417831|20154453|P1|STARTED|Period 2: Treatment Period 2 + Washout||17
8174141|NCT02417831|20154452|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8174142|NCT02417831|20154453|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8174143|NCT02417831|20154452|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||17
8174144|NCT02417831|20154453|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||17
8174145|NCT02417831|20154452|P2|STARTED|Period 1: Treatment Period 1 + Washout||17
8174146|NCT02417831|20154453|P1|STARTED|Period 1: Treatment Period 1 + Washout||17
8174147|NCT02417753|20154469|P1|NOT COMPLETED|Overall Study||1
8174148|NCT02417753|20154469|P1|COMPLETED|Overall Study||0
8174149|NCT02417753|20154469|P1|STARTED|Overall Study||1
8174150|NCT02417532|20154479|P1|NOT COMPLETED|Overall Study||0
8174151|NCT02417532|20154479|P1|COMPLETED|Overall Study||56
8174152|NCT02417532|20154479|P1|STARTED|Overall Study||56
8174153|NCT02417441|20154489|P2|NOT COMPLETED|Overall Study||19
8174154|NCT02417441|20154490|P1|NOT COMPLETED|Overall Study||52
8174155|NCT02417441|20154489|P2|COMPLETED|Overall Study||306
8174156|NCT02417441|20154490|P1|COMPLETED|Overall Study||593
8174157|NCT02417441|20154489|P2|STARTED|Overall Study||325
8174158|NCT02417441|20154490|P1|STARTED|Overall Study||645
8174159|NCT02417376|20154511|P2|NOT COMPLETED|Overall Study||10
8174160|NCT02417376|20154512|P1|NOT COMPLETED|Overall Study||5
8174161|NCT02417376|20154511|P2|COMPLETED|Overall Study||25
8174162|NCT02417376|20154512|P1|COMPLETED|Overall Study||30
8174163|NCT02417376|20154511|P2|STARTED|Overall Study||35
8174164|NCT02417376|20154512|P1|STARTED|Overall Study||35
8174165|NCT02417246|20154558|P2|NOT COMPLETED|Phase 4 2nd Generic Administered||0
8174166|NCT02417246|20154559|P1|NOT COMPLETED|Phase 4 2nd Generic Administered||0
8174167|NCT02417246|20154558|P2|COMPLETED|Phase 4 2nd Generic Administered||20
8174168|NCT02417246|20154559|P1|COMPLETED|Phase 4 2nd Generic Administered||18
8174169|NCT02417246|20154558|P2|STARTED|Phase 4 2nd Generic Administered||20
8174170|NCT02417246|20154559|P1|STARTED|Phase 4 2nd Generic Administered||18
8174171|NCT02417246|20154558|P2|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
8174172|NCT02417246|20154559|P1|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
8174173|NCT02417246|20154558|P2|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
8174174|NCT02417246|20154559|P1|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
8174175|NCT02417246|20154558|P2|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
8174176|NCT02417246|20154559|P1|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
8174177|NCT02417246|20154558|P2|NOT COMPLETED|Phase 2 1st Generic Administered||0
8174178|NCT02417246|20154559|P1|NOT COMPLETED|Phase 2 1st Generic Administered||1
8174179|NCT02417246|20154558|P2|COMPLETED|Phase 2 1st Generic Administered||20
8174180|NCT02417246|20154559|P1|COMPLETED|Phase 2 1st Generic Administered||19
8174181|NCT02417246|20154558|P2|STARTED|Phase 2 1st Generic Administered||20
8174182|NCT02417246|20154559|P1|STARTED|Phase 2 1st Generic Administered||20
8174183|NCT02417246|20154558|P2|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
8174184|NCT02417246|20154559|P1|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
8174185|NCT02417246|20154558|P2|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
8174186|NCT02417246|20154559|P1|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
8174187|NCT02417246|20154558|P2|STARTED|Phase 1 Brand Name Metoprolol ER||24
8174188|NCT02417246|20154559|P1|STARTED|Phase 1 Brand Name Metoprolol ER||24
8174189|NCT02417233|20154582|P3|NOT COMPLETED|Overall Study||59
8174190|NCT02417233|20154583|P2|NOT COMPLETED|Overall Study||51
8174191|NCT02417233|20154584|P1|NOT COMPLETED|Overall Study||36
8174192|NCT02417233|20154582|P3|COMPLETED|Overall Study||239
8174193|NCT02417233|20154583|P2|COMPLETED|Overall Study||238
8174194|NCT02417233|20154584|P1|COMPLETED|Overall Study||133
8174195|NCT02417233|20154582|P3|STARTED|Overall Study||298
8174196|NCT02417233|20154583|P2|STARTED|Overall Study||289
8174197|NCT02417233|20154584|P1|STARTED|Overall Study||169
8174198|NCT02417129|20154607|P2|NOT COMPLETED|Overall Study||0
8174199|NCT02417129|20154608|P1|NOT COMPLETED|Overall Study||0
8174200|NCT02417129|20154607|P2|COMPLETED|Overall Study||0
8174201|NCT02417129|20154608|P1|COMPLETED|Overall Study||2
8174202|NCT02417129|20154607|P2|STARTED|Overall Study||0
8174203|NCT02417129|20154608|P1|STARTED|Overall Study||2
8174204|NCT02417064|20154621|P3|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
8174205|NCT02417064|20154622|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
8174206|NCT02417064|20154623|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
8174207|NCT02417064|20154621|P3|COMPLETED|Follow-up Phase (24 Weeks)||18
8174208|NCT02417064|20154622|P2|COMPLETED|Follow-up Phase (24 Weeks)||10
8174209|NCT02417064|20154623|P1|COMPLETED|Follow-up Phase (24 Weeks)||8
8174210|NCT02417064|20154621|P3|STARTED|Follow-up Phase (24 Weeks)||69
8174211|NCT02417064|20154622|P2|STARTED|Follow-up Phase (24 Weeks)||52
8174212|NCT02417064|20154623|P1|STARTED|Follow-up Phase (24 Weeks)||47
8174213|NCT02417064|20154621|P3|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8174214|NCT02417064|20154622|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
8174215|NCT02417064|20154623|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8174216|NCT02417064|20154621|P3|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
8174217|NCT02417064|20154622|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
8174218|NCT02417064|20154623|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
8174219|NCT02417064|20154621|P3|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
8174220|NCT02417064|20154622|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
8174221|NCT02417064|20154623|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
8174222|NCT02417064|20154621|P3|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
8174223|NCT02417064|20154622|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
8174224|NCT02417064|20154623|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
8174225|NCT02417064|20154621|P3|STARTED|Double-blind Induction Phase (4 Weeks)||113
8174226|NCT02417064|20154622|P2|STARTED|Double-blind Induction Phase (4 Weeks)||116
8174227|NCT02417064|20154623|P1|STARTED|Double-blind Induction Phase (4 Weeks)||117
8174228|NCT02416973|20154682|P3|NOT COMPLETED|Overall Study||1
8174229|NCT02416973|20154683|P2|NOT COMPLETED|Overall Study||3
8174230|NCT02416973|20154684|P1|NOT COMPLETED|Overall Study||1
8174231|NCT02416973|20154682|P3|COMPLETED|Overall Study||13
8174232|NCT02416973|20154683|P2|COMPLETED|Overall Study||10
8174233|NCT02416973|20154684|P1|COMPLETED|Overall Study||13
8174234|NCT02416973|20154682|P3|STARTED|Overall Study||14
8174235|NCT02416973|20154683|P2|STARTED|Overall Study||13
8174236|NCT02416973|20154684|P1|STARTED|Overall Study||14
8174237|NCT02416934|20154694|P2|NOT COMPLETED|Overall Study||7
8174238|NCT02416934|20154695|P1|NOT COMPLETED|Overall Study||3
8174239|NCT02416934|20154694|P2|COMPLETED|Overall Study||31
8174240|NCT02416934|20154695|P1|COMPLETED|Overall Study||33
8174241|NCT02416934|20154694|P2|Last Participant Completed 1 yr|Overall Study||31
8174242|NCT02416934|20154695|P1|Last Participant Completed 1 yr|Overall Study||33
8174243|NCT02416934|20154694|P2|Double Blind (0-52 Weeks)|Overall Study||38
8174244|NCT02416934|20154695|P1|Double Blind (0-52 Weeks)|Overall Study||36
8174245|NCT02416934|20154694|P2|STARTED|Overall Study||38
8174246|NCT02416934|20154695|P1|STARTED|Overall Study||36
8174247|NCT02416908|20154710|P4|NOT COMPLETED|Maintenance Phase||0
8174248|NCT02416908|20154711|P3|NOT COMPLETED|Maintenance Phase||0
8174249|NCT02416908|20154712|P2|NOT COMPLETED|Maintenance Phase||0
8174250|NCT02416908|20154713|P1|NOT COMPLETED|Maintenance Phase||0
8174251|NCT02416908|20154710|P4|COMPLETED|Maintenance Phase||2
8174252|NCT02416908|20154711|P3|COMPLETED|Maintenance Phase||0
8174253|NCT02416908|20154712|P2|COMPLETED|Maintenance Phase||0
8174254|NCT02416908|20154713|P1|COMPLETED|Maintenance Phase||0
8174255|NCT02416908|20154710|P4|STARTED|Maintenance Phase||2
8174256|NCT02416908|20154711|P3|STARTED|Maintenance Phase||0
8174257|NCT02416908|20154712|P2|STARTED|Maintenance Phase||0
8174258|NCT02416908|20154713|P1|STARTED|Maintenance Phase||0
8174259|NCT02416908|20154710|P4|NOT COMPLETED|Dose Escalation Phase||0
8174260|NCT02416908|20154711|P3|NOT COMPLETED|Dose Escalation Phase||4
8174261|NCT02416908|20154712|P2|NOT COMPLETED|Dose Escalation Phase||0
8174262|NCT02416908|20154713|P1|NOT COMPLETED|Dose Escalation Phase||0
8174263|NCT02416908|20154710|P4|COMPLETED|Dose Escalation Phase||0
8174264|NCT02416908|20154711|P3|COMPLETED|Dose Escalation Phase||30
8174265|NCT02416908|20154712|P2|COMPLETED|Dose Escalation Phase||0
8174266|NCT02416908|20154713|P1|COMPLETED|Dose Escalation Phase||6
8174267|NCT02416908|20154710|P4|STARTED|Dose Escalation Phase||0
8174268|NCT02416908|20154711|P3|STARTED|Dose Escalation Phase||34
8174269|NCT02416908|20154712|P2|STARTED|Dose Escalation Phase||0
8174270|NCT02416908|20154713|P1|STARTED|Dose Escalation Phase||6
8174271|NCT02416791|20154731|P3|NOT COMPLETED|6 Months||1
8174272|NCT02416791|20154732|P2|NOT COMPLETED|6 Months||0
8174273|NCT02416791|20154733|P1|NOT COMPLETED|6 Months||0
8174274|NCT02416791|20154731|P3|COMPLETED|6 Months||2
8174275|NCT02416791|20154732|P2|COMPLETED|6 Months||3
8174276|NCT02416791|20154733|P1|COMPLETED|6 Months||3
8174277|NCT02416791|20154731|P3|STARTED|6 Months||3
8174278|NCT02416791|20154732|P2|STARTED|6 Months||3
8174279|NCT02416791|20154733|P1|STARTED|6 Months||3
8174280|NCT02416791|20154731|P3|NOT COMPLETED|6 Weeks||0
8174281|NCT02416791|20154732|P2|NOT COMPLETED|6 Weeks||0
8174282|NCT02416791|20154733|P1|NOT COMPLETED|6 Weeks||0
8174283|NCT02416791|20154731|P3|COMPLETED|6 Weeks||3
8174284|NCT02416791|20154732|P2|COMPLETED|6 Weeks||3
8174285|NCT02416791|20154733|P1|COMPLETED|6 Weeks||3
8174286|NCT02416791|20154731|P3|STARTED|6 Weeks||3
8174287|NCT02416791|20154732|P2|STARTED|6 Weeks||3
8174288|NCT02416791|20154733|P1|STARTED|6 Weeks||3
8174289|NCT02416713|20154775|P4|NOT COMPLETED|Overall Study||0
8174290|NCT02416713|20154776|P3|NOT COMPLETED|Overall Study||0
8174291|NCT02416713|20154777|P2|NOT COMPLETED|Overall Study||0
8174292|NCT02416713|20154778|P1|NOT COMPLETED|Overall Study||0
8174293|NCT02416713|20154775|P4|COMPLETED|Overall Study||10
8174294|NCT02416713|20154776|P3|COMPLETED|Overall Study||8
8174295|NCT02416713|20154777|P2|COMPLETED|Overall Study||9
8174296|NCT02416713|20154778|P1|COMPLETED|Overall Study||8
8174297|NCT02416713|20154775|P4|STARTED|Overall Study||10
8174298|NCT02416713|20154776|P3|STARTED|Overall Study||8
8174299|NCT02416713|20154777|P2|STARTED|Overall Study||9
8174300|NCT02416713|20154778|P1|STARTED|Overall Study||8
8174301|NCT02416622|20154791|P3|NOT COMPLETED|Overall Study||13
8174302|NCT02416622|20154792|P2|NOT COMPLETED|Overall Study||8
8174303|NCT02416622|20154793|P1|NOT COMPLETED|Overall Study||6
8174304|NCT02416622|20154791|P3|COMPLETED|Overall Study||0
8174305|NCT02416622|20154792|P2|COMPLETED|Overall Study||0
8174306|NCT02416622|20154793|P1|COMPLETED|Overall Study||0
8174307|NCT02416622|20154791|P3|Started Long-Term Follow-Up|Overall Study||13
8174308|NCT02416622|20154792|P2|Started Long-Term Follow-Up|Overall Study||8
8174309|NCT02416622|20154793|P1|Started Long-Term Follow-Up|Overall Study||6
8174310|NCT02416622|20154791|P3|Completed Month 12|Overall Study||13
8174311|NCT02416622|20154792|P2|Completed Month 12|Overall Study||8
8174312|NCT02416622|20154793|P1|Completed Month 12|Overall Study||6
8174313|NCT02416622|20154791|P3|STARTED|Overall Study||13
8174314|NCT02416622|20154792|P2|STARTED|Overall Study||8
8174315|NCT02416622|20154793|P1|STARTED|Overall Study||6
8174316|NCT02416193|20154812|P2|NOT COMPLETED|Overall Study||0
8174317|NCT02416193|20154813|P1|NOT COMPLETED|Overall Study||0
8174318|NCT02416193|20154812|P2|COMPLETED|Overall Study||15
8174319|NCT02416193|20154813|P1|COMPLETED|Overall Study||15
8174320|NCT02416193|20154812|P2|STARTED|Overall Study||15
8174321|NCT02416193|20154813|P1|STARTED|Overall Study||15
8174322|NCT02416180|20154831|P1|NOT COMPLETED|Overall Study||1
8174323|NCT02416180|20154831|P1|COMPLETED|Overall Study||110
8174324|NCT02416180|20154831|P1|STARTED|Overall Study||111
8174325|NCT02416102|20154841|P3|NOT COMPLETED|Overall Study||0
8174326|NCT02416102|20154842|P2|NOT COMPLETED|Overall Study||8
8174327|NCT02416102|20154843|P1|NOT COMPLETED|Overall Study||9
8174328|NCT02416102|20154841|P3|COMPLETED|Overall Study||0
8174329|NCT02416102|20154842|P2|COMPLETED|Overall Study||7
8174330|NCT02416102|20154843|P1|COMPLETED|Overall Study||7
8174331|NCT02416102|20154841|P3|STARTED|Overall Study||0
8174332|NCT02416102|20154842|P2|STARTED|Overall Study||15
8174333|NCT02416102|20154843|P1|STARTED|Overall Study||16
8174334|NCT02416011|20154860|P3|NOT COMPLETED|Overall Study||53
8174335|NCT02416011|20154861|P2|NOT COMPLETED|Overall Study||53
8174336|NCT02416011|20154862|P1|NOT COMPLETED|Overall Study||14
8174337|NCT02416011|20154860|P3|COMPLETED|Overall Study||1114
8174338|NCT02416011|20154861|P2|COMPLETED|Overall Study||1101
8174339|NCT02416011|20154862|P1|COMPLETED|Overall Study||561
8174340|NCT02416011|20154860|P3|STARTED|Overall Study||1167
8174341|NCT02416011|20154861|P2|STARTED|Overall Study||1154
8174342|NCT02416011|20154862|P1|STARTED|Overall Study||575
8174343|NCT02415998|20154883|P1|NOT COMPLETED|Overall Study||5
8174344|NCT02415998|20154883|P1|COMPLETED|Overall Study||20
8174345|NCT02415998|20154883|P1|STARTED|Overall Study||25
8174346|NCT02415959|20154892|P5|NOT COMPLETED|Overall Study||0
8174347|NCT02415959|20154893|P4|NOT COMPLETED|Overall Study||1
8174348|NCT02415959|20154894|P3|NOT COMPLETED|Overall Study||0
8174349|NCT02415959|20154895|P2|NOT COMPLETED|Overall Study||1
8174350|NCT02415959|20154896|P1|NOT COMPLETED|Overall Study||0
8174351|NCT02415959|20154892|P5|COMPLETED|Overall Study||14
8174352|NCT02415959|20154893|P4|COMPLETED|Overall Study||13
8174353|NCT02415959|20154894|P3|COMPLETED|Overall Study||14
8174354|NCT02415959|20154895|P2|COMPLETED|Overall Study||13
8174355|NCT02415959|20154896|P1|COMPLETED|Overall Study||14
8174356|NCT02415959|20154892|P5|STARTED|Overall Study||14
8174357|NCT02415959|20154893|P4|STARTED|Overall Study||14
8174358|NCT02415959|20154894|P3|STARTED|Overall Study||14
8174359|NCT02415959|20154895|P2|STARTED|Overall Study||14
8174360|NCT02415959|20154896|P1|STARTED|Overall Study||14
8174361|NCT02415855|20154930|P2|NOT COMPLETED|Overall Study||2
8174362|NCT02415855|20154931|P1|NOT COMPLETED|Overall Study||3
8174363|NCT02415855|20154930|P2|COMPLETED|Overall Study||62
8174364|NCT02415855|20154931|P1|COMPLETED|Overall Study||34
8174365|NCT02415855|20154930|P2|STARTED|Overall Study||64
8174366|NCT02415855|20154931|P1|STARTED|Overall Study||37
8174367|NCT02415842|20154958|P13|NOT COMPLETED|Overall Study||0
8174368|NCT02415842|20154959|P12|NOT COMPLETED|Overall Study||0
8174369|NCT02415842|20154960|P11|NOT COMPLETED|Overall Study||0
8174370|NCT02415842|20154961|P10|NOT COMPLETED|Overall Study||0
8174371|NCT02415842|20154962|P9|NOT COMPLETED|Overall Study||0
8174372|NCT02415842|20154963|P8|NOT COMPLETED|Overall Study||0
8174373|NCT02415842|20154964|P7|NOT COMPLETED|Overall Study||0
8174374|NCT02415842|20154965|P6|NOT COMPLETED|Overall Study||0
8174375|NCT02415842|20154966|P5|NOT COMPLETED|Overall Study||0
8174376|NCT02415842|20154967|P4|NOT COMPLETED|Overall Study||0
8174377|NCT02415842|20154968|P3|NOT COMPLETED|Overall Study||0
8174378|NCT02415842|20154969|P2|NOT COMPLETED|Overall Study||0
8174379|NCT02415842|20154970|P1|NOT COMPLETED|Overall Study||0
8174380|NCT02415842|20154958|P13|COMPLETED|Overall Study||20
8174381|NCT02415842|20154959|P12|COMPLETED|Overall Study||33
8174382|NCT02415842|20154960|P11|COMPLETED|Overall Study||49
8174383|NCT02415842|20154961|P10|COMPLETED|Overall Study||53
8174384|NCT02415842|20154962|P9|COMPLETED|Overall Study||29
8174385|NCT02415842|20154963|P8|COMPLETED|Overall Study||26
8174386|NCT02415842|20154964|P7|COMPLETED|Overall Study||30
8174387|NCT02415842|20154965|P6|COMPLETED|Overall Study||30
8174388|NCT02415842|20154966|P5|COMPLETED|Overall Study||30
8174389|NCT02415842|20154967|P4|COMPLETED|Overall Study||27
8174390|NCT02415842|20154968|P3|COMPLETED|Overall Study||29
8174391|NCT02415842|20154969|P2|COMPLETED|Overall Study||29
8174392|NCT02415842|20154970|P1|COMPLETED|Overall Study||29
8174393|NCT02415842|20154958|P13|STARTED|Overall Study||20
8174394|NCT02415842|20154959|P12|STARTED|Overall Study||33
8174395|NCT02415842|20154960|P11|STARTED|Overall Study||49
8174396|NCT02415842|20154961|P10|STARTED|Overall Study||53
8174397|NCT02415842|20154962|P9|STARTED|Overall Study||29
8174398|NCT02415842|20154963|P8|STARTED|Overall Study||26
8174399|NCT02415842|20154964|P7|STARTED|Overall Study||30
8174400|NCT02415842|20154965|P6|STARTED|Overall Study||30
8174401|NCT02415842|20154966|P5|STARTED|Overall Study||30
8174402|NCT02415842|20154967|P4|STARTED|Overall Study||27
8174403|NCT02415842|20154968|P3|STARTED|Overall Study||29
8174404|NCT02415842|20154969|P2|STARTED|Overall Study||29
8174405|NCT02415842|20154970|P1|STARTED|Overall Study||29
8174406|NCT02415608|20155311|P2|NOT COMPLETED|Overall Study||0
8174407|NCT02415608|20155312|P1|NOT COMPLETED|Overall Study||0
8174408|NCT02415608|20155311|P2|COMPLETED|Overall Study||1
8174409|NCT02415608|20155312|P1|COMPLETED|Overall Study||3
8174410|NCT02415608|20155311|P2|STARTED|Overall Study||1
8174411|NCT02415608|20155312|P1|STARTED|Overall Study||3
8174412|NCT02415595|20155342|P4|NOT COMPLETED|Overall Study||53
8174413|NCT02415595|20155343|P3|NOT COMPLETED|Overall Study||51
8174414|NCT02415595|20155344|P2|NOT COMPLETED|Overall Study||52
8174415|NCT02415595|20155345|P1|NOT COMPLETED|Overall Study||50
8174416|NCT02415595|20155342|P4|COMPLETED|Overall Study||0
8174417|NCT02415595|20155343|P3|COMPLETED|Overall Study||0
8174418|NCT02415595|20155344|P2|COMPLETED|Overall Study||0
8174419|NCT02415595|20155345|P1|COMPLETED|Overall Study||0
8174420|NCT02415595|20155342|P4|STARTED|Overall Study||53
8174421|NCT02415595|20155343|P3|STARTED|Overall Study||51
8174422|NCT02415595|20155344|P2|STARTED|Overall Study||52
8174423|NCT02415595|20155345|P1|STARTED|Overall Study||50
8174424|NCT02415439|20155417|P13|NOT COMPLETED|Overall Study||0
8174425|NCT02415439|20155418|P12|NOT COMPLETED|Overall Study||0
8174426|NCT02415439|20155419|P11|NOT COMPLETED|Overall Study||0
8174427|NCT02415439|20155420|P10|NOT COMPLETED|Overall Study||0
8174428|NCT02415439|20155421|P9|NOT COMPLETED|Overall Study||1
8174429|NCT02415439|20155422|P8|NOT COMPLETED|Overall Study||0
8174430|NCT02415439|20155423|P7|NOT COMPLETED|Overall Study||0
8174431|NCT02415439|20155424|P6|NOT COMPLETED|Overall Study||0
8174432|NCT02415439|20155425|P5|NOT COMPLETED|Overall Study||0
8174433|NCT02415439|20155426|P4|NOT COMPLETED|Overall Study||0
8174434|NCT02415439|20155427|P3|NOT COMPLETED|Overall Study||0
8174435|NCT02415439|20155428|P2|NOT COMPLETED|Overall Study||0
8174436|NCT02415439|20155429|P1|NOT COMPLETED|Overall Study||0
8174437|NCT02415439|20155417|P13|COMPLETED|Overall Study||8
8174438|NCT02415439|20155418|P12|COMPLETED|Overall Study||6
8174439|NCT02415439|20155419|P11|COMPLETED|Overall Study||6
8174440|NCT02415439|20155420|P10|COMPLETED|Overall Study||6
8174441|NCT02415439|20155421|P9|COMPLETED|Overall Study||5
8174442|NCT02415439|20155422|P8|COMPLETED|Overall Study||12
8174443|NCT02415439|20155423|P7|COMPLETED|Overall Study||6
8174444|NCT02415439|20155424|P6|COMPLETED|Overall Study||6
8174445|NCT02415439|20155425|P5|COMPLETED|Overall Study||6
8174446|NCT02415439|20155426|P4|COMPLETED|Overall Study||6
8174447|NCT02415439|20155427|P3|COMPLETED|Overall Study||6
8174448|NCT02415439|20155428|P2|COMPLETED|Overall Study||6
8174449|NCT02415439|20155429|P1|COMPLETED|Overall Study||6
8174450|NCT02415439|20155417|P13|STARTED|Overall Study||8
8174451|NCT02415439|20155418|P12|STARTED|Overall Study||6
8174452|NCT02415439|20155419|P11|STARTED|Overall Study||6
8174453|NCT02415439|20155420|P10|STARTED|Overall Study||6
8174454|NCT02415439|20155421|P9|STARTED|Overall Study||6
8174455|NCT02415439|20155422|P8|STARTED|Overall Study||12
8174456|NCT02415439|20155423|P7|STARTED|Overall Study||6
8174457|NCT02415439|20155424|P6|STARTED|Overall Study||6
8174458|NCT02415439|20155425|P5|STARTED|Overall Study||6
8174459|NCT02415439|20155426|P4|STARTED|Overall Study||6
8174460|NCT02415439|20155427|P3|STARTED|Overall Study||6
8174461|NCT02415439|20155428|P2|STARTED|Overall Study||6
8174462|NCT02415439|20155429|P1|STARTED|Overall Study||6
8174463|NCT02415400|20155487|P4|NOT COMPLETED|Overall Study||83
8174464|NCT02415400|20155488|P3|NOT COMPLETED|Overall Study||85
8174465|NCT02415400|20155489|P2|NOT COMPLETED|Overall Study||62
8174466|NCT02415400|20155490|P1|NOT COMPLETED|Overall Study||66
8174467|NCT02415400|20155487|P4|COMPLETED|Overall Study||1071
8174468|NCT02415400|20155488|P3|COMPLETED|Overall Study||1069
8174469|NCT02415400|20155489|P2|COMPLETED|Overall Study||1091
8174470|NCT02415400|20155490|P1|COMPLETED|Overall Study||1087
8174471|NCT02415400|20155487|P4|STARTED|Overall Study||1154
8174472|NCT02415400|20155488|P3|STARTED|Overall Study||1154
8174473|NCT02415400|20155489|P2|STARTED|Overall Study||1153
8174474|NCT02415400|20155490|P1|STARTED|Overall Study||1153
8174475|NCT02415244|20155516|P2|NOT COMPLETED|Overall Study||0
8174476|NCT02415244|20155517|P1|NOT COMPLETED|Overall Study||0
8174477|NCT02415244|20155516|P2|COMPLETED|Overall Study||25
8174478|NCT02415244|20155517|P1|COMPLETED|Overall Study||50
8174479|NCT02415244|20155516|P2|STARTED|Overall Study||25
8174480|NCT02415244|20155517|P1|STARTED|Overall Study||50
8174481|NCT02415166|20155527|P4|NOT COMPLETED|Overall Study||0
8174482|NCT02415166|20155528|P3|NOT COMPLETED|Overall Study||0
8174483|NCT02415166|20155529|P2|NOT COMPLETED|Overall Study||0
8174484|NCT02415166|20155530|P1|NOT COMPLETED|Overall Study||0
8174485|NCT02415166|20155527|P4|COMPLETED|Overall Study||0
8174486|NCT02415166|20155528|P3|COMPLETED|Overall Study||0
8174487|NCT02415166|20155529|P2|COMPLETED|Overall Study||0
8174488|NCT02415166|20155530|P1|COMPLETED|Overall Study||6
8174489|NCT02415166|20155527|P4|STARTED|Overall Study||0
8174490|NCT02415166|20155528|P3|STARTED|Overall Study||0
8174491|NCT02415166|20155529|P2|STARTED|Overall Study||0
8174492|NCT02415166|20155530|P1|STARTED|Overall Study||6
8174493|NCT02415127|20155558|P2|NOT COMPLETED|Overall Study||0
8174494|NCT02415127|20155559|P1|NOT COMPLETED|Overall Study||1
8174495|NCT02415127|20155558|P2|COMPLETED|Overall Study||45
8174496|NCT02415127|20155559|P1|COMPLETED|Overall Study||46
8174497|NCT02415127|20155558|P2|STARTED|Overall Study||45
8174498|NCT02415127|20155559|P1|STARTED|Overall Study||47
8174499|NCT02414958|20155576|P3|NOT COMPLETED|Overall Study||14
8174500|NCT02414958|20155577|P2|NOT COMPLETED|Overall Study||20
8174501|NCT02414958|20155578|P1|NOT COMPLETED|Overall Study||32
8174502|NCT02414958|20155576|P3|COMPLETED|Overall Study||230
8174503|NCT02414958|20155577|P2|COMPLETED|Overall Study||223
8174504|NCT02414958|20155578|P1|COMPLETED|Overall Study||211
8174505|NCT02414958|20155576|P3|STARTED|Overall Study||244
8174506|NCT02414958|20155577|P2|STARTED|Overall Study||243
8174507|NCT02414958|20155578|P1|STARTED|Overall Study||243
8174508|NCT02414854|20155611|P4|NOT COMPLETED|Overall Study||51
8174509|NCT02414854|20155612|P3|NOT COMPLETED|Overall Study||20
8174510|NCT02414854|20155613|P2|NOT COMPLETED|Overall Study||45
8174511|NCT02414854|20155614|P1|NOT COMPLETED|Overall Study||22
8174512|NCT02414854|20155611|P4|COMPLETED|Overall Study||582
8174513|NCT02414854|20155612|P3|COMPLETED|Overall Study||301
8174514|NCT02414854|20155613|P2|COMPLETED|Overall Study||586
8174515|NCT02414854|20155614|P1|COMPLETED|Overall Study||295
8174516|NCT02414854|20155611|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
8174517|NCT02414854|20155612|P3|Treated|Overall Study||321
8174518|NCT02414854|20155613|P2|Treated|Overall Study||629
8174519|NCT02414854|20155614|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
8174520|NCT02414854|20155611|P4|STARTED|Overall Study||633
8174521|NCT02414854|20155612|P3|STARTED|Overall Study||321
8174522|NCT02414854|20155613|P2|STARTED|Overall Study||631
8174523|NCT02414854|20155614|P1|STARTED|Overall Study||317
8174524|NCT02414841|20155778|P2|NOT COMPLETED|Overall Study||33
8174525|NCT02414841|20155779|P1|NOT COMPLETED|Overall Study||56
8174526|NCT02414841|20155778|P2|COMPLETED|Overall Study||175
8174527|NCT02414841|20155779|P1|COMPLETED|Overall Study||349
8174528|NCT02414841|20155778|P2|STARTED|Overall Study||208
8174529|NCT02414841|20155779|P1|STARTED|Overall Study||405
8174530|NCT02414828|20155791|P4|NOT COMPLETED|Overall Study||2
8174531|NCT02414828|20155792|P3|NOT COMPLETED|Overall Study||1
8174532|NCT02414828|20155793|P2|NOT COMPLETED|Overall Study||1
8174533|NCT02414828|20155794|P1|NOT COMPLETED|Overall Study||0
8174534|NCT02414828|20155791|P4|COMPLETED|Overall Study||29
8174535|NCT02414828|20155792|P3|COMPLETED|Overall Study||19
8174536|NCT02414828|20155793|P2|COMPLETED|Overall Study||9
8174537|NCT02414828|20155794|P1|COMPLETED|Overall Study||11
8174538|NCT02414828|20155791|P4|STARTED|Overall Study||31
8174539|NCT02414828|20155792|P3|STARTED|Overall Study||20
8174540|NCT02414828|20155793|P2|STARTED|Overall Study||10
8174541|NCT02414828|20155794|P1|STARTED|Overall Study||11
8174542|NCT02414698|20155834|P2|NOT COMPLETED|Overall Study||0
8174543|NCT02414698|20155835|P1|NOT COMPLETED|Overall Study||0
8174544|NCT02414698|20155834|P2|COMPLETED|Overall Study||1
8174545|NCT02414698|20155835|P1|COMPLETED|Overall Study||3
8174546|NCT02414698|20155834|P2|STARTED|Overall Study||1
8174547|NCT02414698|20155835|P1|STARTED|Overall Study||3
8174548|NCT02414633|20155845|P1|NOT COMPLETED|Overall Study||0
8174549|NCT02414633|20155845|P1|COMPLETED|Overall Study||148
8174550|NCT02414633|20155845|P1|STARTED|Overall Study||148
8174551|NCT02414243|20155868|P2|NOT COMPLETED|Overall Study||4
8174552|NCT02414243|20155869|P1|NOT COMPLETED|Overall Study||6
8174553|NCT02414243|20155868|P2|COMPLETED|Overall Study||17
8174554|NCT02414243|20155869|P1|COMPLETED|Overall Study||13
8174555|NCT02414243|20155868|P2|Entered Open Challenge at Home|Overall Study||20
8174556|NCT02414243|20155869|P1|Entered Open Challenge at Home|Overall Study||17
8174557|NCT02414243|20155868|P2|Moved to the Other Group|Overall Study||20
8174558|NCT02414243|20155869|P1|Moved to the Other Group|Overall Study||17
8174559|NCT02414243|20155868|P2|STARTED|Overall Study||21
8174560|NCT02414243|20155869|P1|STARTED|Overall Study||19
8174561|NCT02414204|20155878|P2|NOT COMPLETED|Overall Study||0
8174562|NCT02414204|20155879|P1|NOT COMPLETED|Overall Study||0
8174563|NCT02414204|20155878|P2|COMPLETED|Overall Study||2
8174564|NCT02414204|20155879|P1|COMPLETED|Overall Study||2
8174565|NCT02414204|20155878|P2|STARTED|Overall Study||2
8174566|NCT02414204|20155879|P1|STARTED|Overall Study||2
8174567|NCT02414152|20155887|P1|NOT COMPLETED|Overall Study||2
8174568|NCT02414152|20155887|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
8174569|NCT02414152|20155887|P1|STARTED|Overall Study||2
8174570|NCT02413996|20155893|P2|NOT COMPLETED|Overall Study||2
8174571|NCT02413996|20155894|P1|NOT COMPLETED|Overall Study||9
8174572|NCT02413996|20155893|P2|COMPLETED|Overall Study||39
8174573|NCT02413996|20155894|P1|COMPLETED|Overall Study||35
8174574|NCT02413996|20155893|P2|STARTED|Overall Study||41
8174575|NCT02413996|20155894|P1|STARTED|Overall Study||44
8174576|NCT02413918|20155916|P1|NOT COMPLETED|Overall Study||25
8174577|NCT02413918|20155916|P1|COMPLETED|Overall Study||16
8174578|NCT02413918|20155916|P1|STARTED|Overall Study||41
8174579|NCT02413879|20155923|P1|NOT COMPLETED|Overall Study||0
8174580|NCT02413879|20155923|P1|COMPLETED|Overall Study||86
8174581|NCT02413879|20155923|P1|STARTED|Overall Study||86
8174582|NCT02413684|20155929|P1|NOT COMPLETED|Overall Study||13
8174583|NCT02413684|20155929|P1|COMPLETED|Overall Study||40
8174584|NCT02413684|20155929|P1|STARTED|Overall Study||53
8174585|NCT02413593|20155939|P1|NOT COMPLETED|Overall Study||4
8174586|NCT02413593|20155939|P1|COMPLETED|Overall Study||107
8174587|NCT02413593|20155939|P1|STARTED|Overall Study||111
8174588|NCT02413580|20155948|P1|NOT COMPLETED|Overall Study||3
8174589|NCT02413580|20155948|P1|COMPLETED|Overall Study||46
8174590|NCT02413580|20155948|P1|STARTED|Overall Study||49
8174591|NCT02413489|20155958|P3|NOT COMPLETED|Overall Study||5
8174592|NCT02413489|20155959|P2|NOT COMPLETED|Overall Study||16
8174593|NCT02413489|20155960|P1|NOT COMPLETED|Overall Study||15
8174594|NCT02413489|20155958|P3|COMPLETED|Overall Study||0
8174595|NCT02413489|20155959|P2|COMPLETED|Overall Study||0
8174596|NCT02413489|20155960|P1|COMPLETED|Overall Study||0
8174597|NCT02413489|20155958|P3|STARTED|Overall Study||5
8174598|NCT02413489|20155959|P2|STARTED|Overall Study||16
8174599|NCT02413489|20155960|P1|STARTED|Overall Study||15
8174600|NCT02413463|20155982|P2|NOT COMPLETED|Overall Study||2
8174601|NCT02413463|20155983|P1|NOT COMPLETED|Overall Study||5
8174602|NCT02413463|20155982|P2|COMPLETED|Overall Study||28
8174603|NCT02413463|20155983|P1|COMPLETED|Overall Study||25
8174604|NCT02413463|20155982|P2|STARTED|Overall Study||30
8174605|NCT02413463|20155983|P1|STARTED|Overall Study||30
8174606|NCT02413398|20156001|P2|NOT COMPLETED|Overall Study||7
8174607|NCT02413398|20156002|P1|NOT COMPLETED|Overall Study||4
8174608|NCT02413398|20156001|P2|COMPLETED|Overall Study||154
8174609|NCT02413398|20156002|P1|COMPLETED|Overall Study||156
8174610|NCT02413398|20156001|P2|STARTED|Overall Study||161
8174611|NCT02413398|20156002|P1|STARTED|Overall Study||160
8174630|NCT02413346|20156068|P2|NOT COMPLETED|Overall Study||70
8174631|NCT02413346|20156069|P1|NOT COMPLETED|Overall Study||59
8174632|NCT02413346|20156068|P2|COMPLETED|Overall Study||177
8174633|NCT02413346|20156069|P1|COMPLETED|Overall Study||177
8174634|NCT02413346|20156068|P2|STARTED|Overall Study||247
8174635|NCT02413346|20156069|P1|STARTED|Overall Study||236
8174636|NCT02413333|20156079|P2|NOT COMPLETED|Period 2||0
8174637|NCT02413333|20156080|P1|NOT COMPLETED|Period 2||1
8174638|NCT02413333|20156079|P2|COMPLETED|Period 2||65
8174639|NCT02413333|20156080|P1|COMPLETED|Period 2||64
8174640|NCT02413333|20156079|P2|STARTED|Period 2||65
8174641|NCT02413333|20156080|P1|STARTED|Period 2||65
8174642|NCT02413333|20156079|P2|NOT COMPLETED|Period 1||1
8174643|NCT02413333|20156080|P1|NOT COMPLETED|Period 1||1
8174644|NCT02413333|20156079|P2|COMPLETED|Period 1||65
8174645|NCT02413333|20156080|P1|COMPLETED|Period 1||65
8174646|NCT02413333|20156079|P2|Randomized and Treated|Period 1||66
8174647|NCT02413333|20156080|P1|Randomized and Treated|Period 1||66
8174648|NCT02413333|20156079|P2|STARTED|Period 1||66
8174649|NCT02413333|20156080|P1|STARTED|Period 1||66
8174650|NCT02413294|20156088|P1|NOT COMPLETED|Overall Study||1
8174651|NCT02413294|20156088|P1|COMPLETED|Overall Study||11
8174652|NCT02413294|20156088|P1|STARTED|Overall Study||12
8174653|NCT02413255|20156123|P17|NOT COMPLETED|Overall Study||0
8174654|NCT02413255|20156124|P16|NOT COMPLETED|Overall Study||0
8174655|NCT02413255|20156125|P15|NOT COMPLETED|Overall Study||1
8174656|NCT02413255|20156126|P14|NOT COMPLETED|Overall Study||0
8174657|NCT02413255|20156127|P13|NOT COMPLETED|Overall Study||0
8174658|NCT02413255|20156128|P12|NOT COMPLETED|Overall Study||0
8174659|NCT02413255|20156129|P11|NOT COMPLETED|Overall Study||0
8174660|NCT02413255|20156130|P10|NOT COMPLETED|Overall Study||0
8174661|NCT02413255|20156131|P9|NOT COMPLETED|Overall Study||0
8174662|NCT02413255|20156132|P8|NOT COMPLETED|Overall Study||0
8174663|NCT02413255|20156133|P7|NOT COMPLETED|Overall Study||0
8174664|NCT02413255|20156134|P6|NOT COMPLETED|Overall Study||0
8174665|NCT02413255|20156135|P5|NOT COMPLETED|Overall Study||0
8174666|NCT02413255|20156136|P4|NOT COMPLETED|Overall Study||0
8174667|NCT02413255|20156137|P3|NOT COMPLETED|Overall Study||0
8174668|NCT02413255|20156138|P2|NOT COMPLETED|Overall Study||0
8174669|NCT02413255|20156139|P1|NOT COMPLETED|Overall Study||0
8174670|NCT02413255|20156123|P17|COMPLETED|Overall Study||6
8174671|NCT02413255|20156124|P16|COMPLETED|Overall Study||6
8174672|NCT02413255|20156125|P15|COMPLETED|Overall Study||5
8174673|NCT02413255|20156126|P14|COMPLETED|Overall Study||6
8174674|NCT02413255|20156127|P13|COMPLETED|Overall Study||6
8174675|NCT02413255|20156128|P12|COMPLETED|Overall Study||6
8174676|NCT02413255|20156129|P11|COMPLETED|Overall Study||12
8174677|NCT02413255|20156130|P10|COMPLETED|Overall Study||6
8174678|NCT02413255|20156131|P9|COMPLETED|Overall Study||6
8174679|NCT02413255|20156132|P8|COMPLETED|Overall Study||6
8174680|NCT02413255|20156133|P7|COMPLETED|Overall Study||6
8174681|NCT02413255|20156134|P6|COMPLETED|Overall Study||6
8174682|NCT02413255|20156135|P5|COMPLETED|Overall Study||6
8174683|NCT02413255|20156136|P4|COMPLETED|Overall Study||6
8174684|NCT02413255|20156137|P3|COMPLETED|Overall Study||6
8174685|NCT02413255|20156138|P2|COMPLETED|Overall Study||6
8174686|NCT02413255|20156139|P1|COMPLETED|Overall Study||18
8174687|NCT02413255|20156123|P17|STARTED|Overall Study||6
8174688|NCT02413255|20156124|P16|STARTED|Overall Study||6
8174689|NCT02413255|20156125|P15|STARTED|Overall Study||6
8174690|NCT02413255|20156126|P14|STARTED|Overall Study||6
8174691|NCT02413255|20156127|P13|STARTED|Overall Study||6
8174692|NCT02413255|20156128|P12|STARTED|Overall Study||6
8174693|NCT02413255|20156129|P11|STARTED|Overall Study||12
8174694|NCT02413255|20156130|P10|STARTED|Overall Study||6
8174695|NCT02413255|20156131|P9|STARTED|Overall Study||6
8174696|NCT02413255|20156132|P8|STARTED|Overall Study||6
8174697|NCT02413255|20156133|P7|STARTED|Overall Study||6
8174698|NCT02413255|20156134|P6|STARTED|Overall Study||6
8174699|NCT02413255|20156135|P5|STARTED|Overall Study||6
8174700|NCT02413255|20156136|P4|STARTED|Overall Study||6
8174701|NCT02413255|20156137|P3|STARTED|Overall Study||6
8174702|NCT02413255|20156138|P2|STARTED|Overall Study||6
8174703|NCT02413255|20156139|P1|STARTED|Overall Study||18
8174704|NCT02413229|20156495|P8|NOT COMPLETED|Overall Study||4
8174705|NCT02413229|20156496|P7|NOT COMPLETED|Overall Study||0
8174706|NCT02413229|20156497|P6|NOT COMPLETED|Overall Study||0
8174707|NCT02413229|20156498|P5|NOT COMPLETED|Overall Study||3
8174708|NCT02413229|20156499|P4|NOT COMPLETED|Overall Study||1
8174709|NCT02413229|20156500|P3|NOT COMPLETED|Overall Study||1
8174710|NCT02413229|20156501|P2|NOT COMPLETED|Overall Study||1
8174711|NCT02413229|20156502|P1|NOT COMPLETED|Overall Study||1
8174712|NCT02413229|20156495|P8|COMPLETED|Overall Study||11
8174713|NCT02413229|20156496|P7|COMPLETED|Overall Study||25
8174714|NCT02413229|20156497|P6|COMPLETED|Overall Study||12
8174715|NCT02413229|20156498|P5|COMPLETED|Overall Study||21
8174716|NCT02413229|20156499|P4|COMPLETED|Overall Study||11
8174717|NCT02413229|20156500|P3|COMPLETED|Overall Study||25
8174718|NCT02413229|20156501|P2|COMPLETED|Overall Study||11
8174719|NCT02413229|20156502|P1|COMPLETED|Overall Study||24
8174720|NCT02413229|20156495|P8|STARTED|Overall Study||15
8174721|NCT02413229|20156496|P7|STARTED|Overall Study||25
8174722|NCT02413229|20156497|P6|STARTED|Overall Study||12
8174723|NCT02413229|20156498|P5|STARTED|Overall Study||24
8174724|NCT02413229|20156499|P4|STARTED|Overall Study||12
8174725|NCT02413229|20156500|P3|STARTED|Overall Study||26
8174726|NCT02413229|20156501|P2|STARTED|Overall Study||12
8174727|NCT02413229|20156502|P1|STARTED|Overall Study||25
8174728|NCT02413203|20156522|P2|NOT COMPLETED|Overall Study||0
8174729|NCT02413203|20156523|P1|NOT COMPLETED|Overall Study||0
8174730|NCT02413203|20156522|P2|COMPLETED|Overall Study||10
8174731|NCT02413203|20156523|P1|COMPLETED|Overall Study||10
8174732|NCT02413203|20156522|P2|STARTED|Overall Study||10
8174733|NCT02413203|20156523|P1|STARTED|Overall Study||10
8174734|NCT02413190|20156543|P1|NOT COMPLETED|Overall Study||0
8174735|NCT02413190|20156543|P1|COMPLETED|Overall Study||94
8174736|NCT02413190|20156543|P1|STARTED|Overall Study||94
8174737|NCT02413151|20156549|P2|NOT COMPLETED|Overall Study||2
8174738|NCT02413151|20156550|P1|NOT COMPLETED|Overall Study||10
8174739|NCT02413151|20156549|P2|COMPLETED|Overall Study||28
8174740|NCT02413151|20156550|P1|COMPLETED|Overall Study||22
8174741|NCT02413151|20156549|P2|STARTED|Overall Study||30
8174742|NCT02413151|20156550|P1|STARTED|Overall Study||32
8174743|NCT02413047|20156578|P1|NOT COMPLETED|Overall Study||0
8174744|NCT02413047|20156578|P1|COMPLETED|Overall Study||3
8174745|NCT02413047|20156578|P1|Participants on Adalimumab|Overall Study||1
8174746|NCT02413047|20156578|P1|Participants on Infliximab|Overall Study||2
8174747|NCT02413047|20156578|P1|STARTED|Overall Study||3
8174748|NCT02413034|20156591|P2|NOT COMPLETED|Overall Study||0
8174749|NCT02413034|20156592|P1|NOT COMPLETED|Overall Study||0
8174750|NCT02413034|20156591|P2|COMPLETED|Overall Study||14
8174751|NCT02413034|20156592|P1|COMPLETED|Overall Study||14
8174752|NCT02413034|20156591|P2|STARTED|Overall Study||14
8174753|NCT02413034|20156592|P1|STARTED|Overall Study||14
8174754|NCT02413008|20156602|P2|NOT COMPLETED|Overall Study||2
8174755|NCT02413008|20156603|P1|NOT COMPLETED|Overall Study||7
8174756|NCT02413008|20156602|P2|COMPLETED|Overall Study||9
8174757|NCT02413008|20156603|P1|COMPLETED|Overall Study||43
8174758|NCT02413008|20156602|P2|STARTED|Overall Study||11
8174759|NCT02413008|20156603|P1|STARTED|Overall Study||50
8174760|NCT02412878|20156641|P2|NOT COMPLETED|Overall Study||13
8174761|NCT02412878|20156642|P1|NOT COMPLETED|Overall Study||21
8174762|NCT02412878|20156641|P2|COMPLETED|Overall Study||227
8174763|NCT02412878|20156642|P1|COMPLETED|Overall Study||217
8174764|NCT02412878|20156641|P2|Received Carfilzomib|Overall Study||238
8174765|NCT02412878|20156642|P1|Received Carfilzomib|Overall Study||235
8174766|NCT02412878|20156641|P2|STARTED|Overall Study||240
8174767|NCT02412878|20156642|P1|STARTED|Overall Study||238
8174768|NCT02412852|20156660|P4|NOT COMPLETED|Overall Study||1
8174769|NCT02412852|20156661|P3|NOT COMPLETED|Overall Study||0
8174770|NCT02412852|20156662|P2|NOT COMPLETED|Overall Study||1
8174771|NCT02412852|20156663|P1|NOT COMPLETED|Overall Study||0
8174772|NCT02412852|20156660|P4|COMPLETED|Overall Study||8
8174773|NCT02412852|20156661|P3|COMPLETED|Overall Study||5
8174774|NCT02412852|20156662|P2|COMPLETED|Overall Study||7
8174775|NCT02412852|20156663|P1|COMPLETED|Overall Study||4
8174776|NCT02412852|20156660|P4|STARTED|Overall Study||9
8174777|NCT02412852|20156661|P3|STARTED|Overall Study||5
8174778|NCT02412852|20156662|P2|STARTED|Overall Study||8
8174779|NCT02412852|20156663|P1|STARTED|Overall Study||4
8174780|NCT02412761|20156689|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174781|NCT02412761|20156690|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174782|NCT02412761|20156691|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174783|NCT02412761|20156692|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174784|NCT02412761|20156693|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174785|NCT02412761|20156694|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174786|NCT02412761|20156689|P6|COMPLETED|Third Intervention (2 Weeks)||6
8174787|NCT02412761|20156690|P5|COMPLETED|Third Intervention (2 Weeks)||4
8174788|NCT02412761|20156691|P4|COMPLETED|Third Intervention (2 Weeks)||8
8174789|NCT02412761|20156692|P3|COMPLETED|Third Intervention (2 Weeks)||4
8174790|NCT02412761|20156693|P2|COMPLETED|Third Intervention (2 Weeks)||5
8174791|NCT02412761|20156694|P1|COMPLETED|Third Intervention (2 Weeks)||5
8174792|NCT02412761|20156689|P6|STARTED|Third Intervention (2 Weeks)||6
8174793|NCT02412761|20156690|P5|STARTED|Third Intervention (2 Weeks)||4
8174794|NCT02412761|20156691|P4|STARTED|Third Intervention (2 Weeks)||8
8174795|NCT02412761|20156692|P3|STARTED|Third Intervention (2 Weeks)||4
8174796|NCT02412761|20156693|P2|STARTED|Third Intervention (2 Weeks)||5
8174797|NCT02412761|20156694|P1|STARTED|Third Intervention (2 Weeks)||5
8174798|NCT02412761|20156689|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174799|NCT02412761|20156690|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174800|NCT02412761|20156691|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174801|NCT02412761|20156692|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174802|NCT02412761|20156693|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174803|NCT02412761|20156694|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174804|NCT02412761|20156689|P6|COMPLETED|Second Intervention (2 Weeks)||6
8174805|NCT02412761|20156690|P5|COMPLETED|Second Intervention (2 Weeks)||4
8174806|NCT02412761|20156691|P4|COMPLETED|Second Intervention (2 Weeks)||8
8174807|NCT02412761|20156692|P3|COMPLETED|Second Intervention (2 Weeks)||4
8174808|NCT02412761|20156693|P2|COMPLETED|Second Intervention (2 Weeks)||5
8174809|NCT02412761|20156694|P1|COMPLETED|Second Intervention (2 Weeks)||5
8174810|NCT02412761|20156689|P6|STARTED|Second Intervention (2 Weeks)||6
8174811|NCT02412761|20156690|P5|STARTED|Second Intervention (2 Weeks)||4
8174812|NCT02412761|20156691|P4|STARTED|Second Intervention (2 Weeks)||8
8174813|NCT02412761|20156692|P3|STARTED|Second Intervention (2 Weeks)||4
8174814|NCT02412761|20156693|P2|STARTED|Second Intervention (2 Weeks)||5
8174815|NCT02412761|20156694|P1|STARTED|Second Intervention (2 Weeks)||5
8174816|NCT02412761|20156689|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
8174817|NCT02412761|20156690|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
8174818|NCT02412761|20156691|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
8174819|NCT02412761|20156692|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
8174820|NCT02412761|20156693|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
8174821|NCT02412761|20156694|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8174822|NCT02412761|20156689|P6|COMPLETED|First Intervention (2 Weeks)||6
8174823|NCT02412761|20156690|P5|COMPLETED|First Intervention (2 Weeks)||4
8174824|NCT02412761|20156691|P4|COMPLETED|First Intervention (2 Weeks)||8
8174825|NCT02412761|20156692|P3|COMPLETED|First Intervention (2 Weeks)||4
8174826|NCT02412761|20156693|P2|COMPLETED|First Intervention (2 Weeks)||5
8174827|NCT02412761|20156694|P1|COMPLETED|First Intervention (2 Weeks)||5
8174828|NCT02412761|20156689|P6|STARTED|First Intervention (2 Weeks)||7
8174829|NCT02412761|20156690|P5|STARTED|First Intervention (2 Weeks)||4
8174830|NCT02412761|20156691|P4|STARTED|First Intervention (2 Weeks)||8
8174831|NCT02412761|20156692|P3|STARTED|First Intervention (2 Weeks)||5
8174832|NCT02412761|20156693|P2|STARTED|First Intervention (2 Weeks)||6
8174833|NCT02412761|20156694|P1|STARTED|First Intervention (2 Weeks)||5
8174834|NCT02412722|20156708|P6|NOT COMPLETED|Overall Study||13
8174835|NCT02412722|20156709|P5|NOT COMPLETED|Overall Study||7
8174836|NCT02412722|20156710|P4|NOT COMPLETED|Overall Study||15
8174837|NCT02412722|20156711|P3|NOT COMPLETED|Overall Study||7
8174838|NCT02412722|20156712|P2|NOT COMPLETED|Overall Study||8
8174839|NCT02412722|20156713|P1|NOT COMPLETED|Overall Study||11
8174840|NCT02412722|20156708|P6|COMPLETED|Overall Study||0
8174841|NCT02412722|20156709|P5|COMPLETED|Overall Study||0
8174842|NCT02412722|20156710|P4|COMPLETED|Overall Study||0
8174843|NCT02412722|20156711|P3|COMPLETED|Overall Study||0
8174844|NCT02412722|20156712|P2|COMPLETED|Overall Study||0
8174845|NCT02412722|20156713|P1|COMPLETED|Overall Study||0
8174846|NCT02412722|20156708|P6|Safety Population|Overall Study||13
8174847|NCT02412722|20156709|P5|Safety Population|Overall Study||7
8174848|NCT02412722|20156710|P4|Safety Population|Overall Study||15
8174849|NCT02412722|20156711|P3|Safety Population|Overall Study||7
8174850|NCT02412722|20156712|P2|Safety Population|Overall Study||6
8174851|NCT02412722|20156713|P1|Safety Population|Overall Study||11
8174852|NCT02412722|20156708|P6|STARTED|Overall Study||13
8174853|NCT02412722|20156709|P5|STARTED|Overall Study||7
8174854|NCT02412722|20156710|P4|STARTED|Overall Study||15
8174855|NCT02412722|20156711|P3|STARTED|Overall Study||7
8174856|NCT02412722|20156712|P2|STARTED|Overall Study||8
8174857|NCT02412722|20156713|P1|STARTED|Overall Study||11
8174858|NCT02412670|20156783|P2|NOT COMPLETED|Overall Study||1
8174859|NCT02412670|20156784|P1|NOT COMPLETED|Overall Study||7
8174860|NCT02412670|20156783|P2|COMPLETED|Overall Study||5
8174861|NCT02412670|20156784|P1|COMPLETED|Overall Study||23
8174862|NCT02412670|20156783|P2|Eligible and Treated|Overall Study||6
8174863|NCT02412670|20156784|P1|Eligible and Treated|Overall Study||29
8174864|NCT02412670|20156783|P2|STARTED|Overall Study||6
8174865|NCT02412670|20156784|P1|STARTED|Overall Study||30
8174866|NCT02412657|20156805|P3|NOT COMPLETED|Overall Study||3
8174867|NCT02412657|20156806|P2|NOT COMPLETED|Overall Study||2
8174868|NCT02412657|20156807|P1|NOT COMPLETED|Overall Study||1
8174869|NCT02412657|20156805|P3|COMPLETED|Overall Study||22
8174870|NCT02412657|20156806|P2|COMPLETED|Overall Study||23
8174871|NCT02412657|20156807|P1|COMPLETED|Overall Study||24
8174872|NCT02412657|20156805|P3|STARTED|Overall Study||25
8174873|NCT02412657|20156806|P2|STARTED|Overall Study||25
8174874|NCT02412657|20156807|P1|STARTED|Overall Study||25
8174875|NCT02412644|20156817|P2|NOT COMPLETED|Overall Study||4
8174876|NCT02412644|20156818|P1|NOT COMPLETED|Overall Study||15
8174877|NCT02412644|20156817|P2|COMPLETED|Overall Study||4
8174878|NCT02412644|20156818|P1|COMPLETED|Overall Study||6
8174879|NCT02412644|20156817|P2|STARTED|Overall Study||8
8174880|NCT02412644|20156818|P1|STARTED|Overall Study||21
8174881|NCT02412501|20156830|P1|NOT COMPLETED|Overall Study||0
8174882|NCT02412501|20156830|P1|COMPLETED|Overall Study||101
8174883|NCT02412501|20156830|P1|STARTED|Overall Study||101
8174884|NCT02412488|20156851|P1|NOT COMPLETED|Overall Study||18
8174885|NCT02412488|20156851|P1|COMPLETED|Overall Study||174
8174886|NCT02412488|20156851|P1|Reveal LINQ Implanted|Overall Study||191
8174887|NCT02412488|20156851|P1|STARTED|Overall Study||192
8174888|NCT02412436|20156855|P1|NOT COMPLETED|Overall Study||18
8174889|NCT02412436|20156855|P1|COMPLETED|Overall Study||44
8174890|NCT02412436|20156855|P1|STARTED|Overall Study||62
8174891|NCT02412371|20156875|P6|NOT COMPLETED|Overall Study||5
8174892|NCT02412371|20156876|P5|NOT COMPLETED|Overall Study||12
8174893|NCT02412371|20156877|P4|NOT COMPLETED|Overall Study||8
8174894|NCT02412371|20156878|P3|NOT COMPLETED|Overall Study||7
8174895|NCT02412371|20156879|P2|NOT COMPLETED|Overall Study||9
8174896|NCT02412371|20156880|P1|NOT COMPLETED|Overall Study||7
8174897|NCT02412371|20156875|P6|COMPLETED|Overall Study||0
8174898|NCT02412371|20156876|P5|COMPLETED|Overall Study||0
8174899|NCT02412371|20156877|P4|COMPLETED|Overall Study||0
8174900|NCT02412371|20156878|P3|COMPLETED|Overall Study||0
8174901|NCT02412371|20156879|P2|COMPLETED|Overall Study||0
8174902|NCT02412371|20156880|P1|COMPLETED|Overall Study||0
8174903|NCT02412371|20156875|P6|STARTED|Overall Study||5
8174904|NCT02412371|20156876|P5|STARTED|Overall Study||12
8174905|NCT02412371|20156877|P4|STARTED|Overall Study||8
8174906|NCT02412371|20156878|P3|STARTED|Overall Study||7
8174907|NCT02412371|20156879|P2|STARTED|Overall Study||9
8174908|NCT02412371|20156880|P1|STARTED|Overall Study||7
8174909|NCT02412306|20156908|P5|NOT COMPLETED|Overall Study||2
8174910|NCT02412306|20156909|P4|NOT COMPLETED|Overall Study||0
8174911|NCT02412306|20156910|P3|NOT COMPLETED|Overall Study||16
8174912|NCT02412306|20156911|P2|NOT COMPLETED|Overall Study||8
8174913|NCT02412306|20156912|P1|NOT COMPLETED|Overall Study||5
8174914|NCT02412306|20156908|P5|COMPLETED|Overall Study||15
8174915|NCT02412306|20156909|P4|COMPLETED|Overall Study||14
8174916|NCT02412306|20156910|P3|COMPLETED|Overall Study||5
8174917|NCT02412306|20156911|P2|COMPLETED|Overall Study||1
8174918|NCT02412306|20156912|P1|COMPLETED|Overall Study||0
8174919|NCT02412306|20156908|P5|STARTED|Overall Study||17
8174920|NCT02412306|20156909|P4|STARTED|Overall Study||14
8174921|NCT02412306|20156910|P3|STARTED|Overall Study||21
8174922|NCT02412306|20156911|P2|STARTED|Overall Study||9
8174923|NCT02412306|20156912|P1|STARTED|Overall Study||5
8174924|NCT02412111|20156974|P3|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
8174925|NCT02412111|20156975|P2|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
8174926|NCT02412111|20156976|P1|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
8174927|NCT02412111|20156974|P3|COMPLETED|Active Comparator Period (8 Weeks)||69
8174928|NCT02412111|20156975|P2|COMPLETED|Active Comparator Period (8 Weeks)||75
8174929|NCT02412111|20156976|P1|COMPLETED|Active Comparator Period (8 Weeks)||0
8174930|NCT02412111|20156974|P3|Full Analysis Set|Active Comparator Period (8 Weeks)||74
8174931|NCT02412111|20156975|P2|Full Analysis Set|Active Comparator Period (8 Weeks)||76
8174932|NCT02412111|20156976|P1|Full Analysis Set|Active Comparator Period (8 Weeks)||0
8174933|NCT02412111|20156974|P3|STARTED|Active Comparator Period (8 Weeks)||75
8174934|NCT02412111|20156975|P2|STARTED|Active Comparator Period (8 Weeks)||76
8174935|NCT02412111|20156976|P1|STARTED|Active Comparator Period (8 Weeks)||0
8174936|NCT02412111|20156974|P3|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174937|NCT02412111|20156975|P2|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174938|NCT02412111|20156976|P1|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
8174939|NCT02412111|20156974|P3|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174940|NCT02412111|20156975|P2|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174941|NCT02412111|20156976|P1|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
8174942|NCT02412111|20156974|P3|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
8174943|NCT02412111|20156975|P2|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
8174944|NCT02412111|20156976|P1|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
8174945|NCT02412098|20156998|P3|NOT COMPLETED|Overall Study||0
8174946|NCT02412098|20156999|P2|NOT COMPLETED|Overall Study||0
8174947|NCT02412098|20157000|P1|NOT COMPLETED|Overall Study||0
8174948|NCT02412098|20156998|P3|COMPLETED|Overall Study||21
8174949|NCT02412098|20156999|P2|COMPLETED|Overall Study||14
8174950|NCT02412098|20157000|P1|COMPLETED|Overall Study||14
8174951|NCT02412098|20156998|P3|STARTED|Overall Study||21
8174952|NCT02412098|20156999|P2|STARTED|Overall Study||14
8174953|NCT02412098|20157000|P1|STARTED|Overall Study||14
8174954|NCT02411929|20157027|P1|NOT COMPLETED|Period 2||0
8174955|NCT02411929|20157027|P1|COMPLETED|Period 2||8
8174956|NCT02411929|20157027|P1|STARTED|Period 2||8
8174957|NCT02411929|20157027|P1|NOT COMPLETED|Washout Period||0
8174958|NCT02411929|20157027|P1|COMPLETED|Washout Period||8
8174959|NCT02411929|20157027|P1|STARTED|Washout Period||8
8174960|NCT02411929|20157027|P1|NOT COMPLETED|Period 1||0
8174961|NCT02411929|20157027|P1|COMPLETED|Period 1||8
8174962|NCT02411929|20157027|P1|STARTED|Period 1||8
8174963|NCT02411747|20157059|P2|NOT COMPLETED|Overall Study||4
8174964|NCT02411747|20157060|P1|NOT COMPLETED|Overall Study||3
8174965|NCT02411747|20157059|P2|COMPLETED|Overall Study||12
8174966|NCT02411747|20157060|P1|COMPLETED|Overall Study||13
8174967|NCT02411747|20157059|P2|Simulation Training Completed|Overall Study||16
8174968|NCT02411747|20157060|P1|Simulation Training Completed|Overall Study||16
8174969|NCT02411747|20157059|P2|STARTED|Overall Study||16
8174970|NCT02411747|20157060|P1|STARTED|Overall Study||16
8174971|NCT02411643|20157066|P1|NOT COMPLETED|Overall Study||0
8174972|NCT02411643|20157066|P1|COMPLETED|Overall Study||2
8174973|NCT02411643|20157066|P1|STARTED|Overall Study||2
8174974|NCT02411591|20157076|P3|NOT COMPLETED|Overall Study||3
8174975|NCT02411591|20157077|P2|NOT COMPLETED|Overall Study||10
8174976|NCT02411591|20157078|P1|NOT COMPLETED|Overall Study||0
8174977|NCT02411591|20157076|P3|COMPLETED|Overall Study||3
8174978|NCT02411591|20157077|P2|COMPLETED|Overall Study||47
8174979|NCT02411591|20157078|P1|COMPLETED|Overall Study||3
8174980|NCT02411591|20157076|P3|Death|Overall Study||0
8174981|NCT02411591|20157077|P2|Death|Overall Study||2
8174982|NCT02411591|20157078|P1|Death|Overall Study||0
8174983|NCT02411591|20157076|P3|Progressive Disease|Overall Study||3
8174984|NCT02411591|20157077|P2|Progressive Disease|Overall Study||42
8174985|NCT02411591|20157078|P1|Progressive Disease|Overall Study||3
8174986|NCT02411591|20157076|P3|Expansion Cohort Part B|Overall Study||0
8174987|NCT02411591|20157077|P2|Expansion Cohort Part B|Overall Study||51
8174988|NCT02411591|20157078|P1|Expansion Cohort Part B|Overall Study||0
8174989|NCT02411591|20157076|P3|Part A|Overall Study||6
8174990|NCT02411591|20157077|P2|Part A|Overall Study||6
8174991|NCT02411591|20157078|P1|Part A|Overall Study||3
8174992|NCT02411591|20157076|P3|STARTED|Overall Study||6
8174993|NCT02411591|20157077|P2|STARTED|Overall Study||57
8174994|NCT02411591|20157078|P1|STARTED|Overall Study||3
8174995|NCT02411578|20157110|P2|NOT COMPLETED|Extension Phase||0
8174996|NCT02411578|20157111|P1|NOT COMPLETED|Extension Phase||0
8174997|NCT02411578|20157110|P2|COMPLETED|Extension Phase||9
8174998|NCT02411578|20157111|P1|COMPLETED|Extension Phase||8
8174999|NCT02411578|20157110|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
8175000|NCT02411578|20157111|P1|STARTED|Extension Phase||8
8175001|NCT02411578|20157110|P2|NOT COMPLETED|Crossover Trial Phase||1
8175002|NCT02411578|20157111|P1|NOT COMPLETED|Crossover Trial Phase||0
8175003|NCT02411578|20157110|P2|COMPLETED|Crossover Trial Phase||11
8175004|NCT02411578|20157111|P1|COMPLETED|Crossover Trial Phase||8
8175005|NCT02411578|20157110|P2|STARTED|Crossover Trial Phase||12
8175006|NCT02411578|20157111|P1|STARTED|Crossover Trial Phase||8
8175007|NCT02411565|20157153|P2|NOT COMPLETED|Overall Study||0
8175008|NCT02411565|20157154|P1|NOT COMPLETED|Overall Study||0
8175009|NCT02411565|20157153|P2|COMPLETED|Overall Study||2
8175010|NCT02411565|20157154|P1|COMPLETED|Overall Study||1
8175011|NCT02411565|20157153|P2|STARTED|Overall Study||2
8175012|NCT02411565|20157154|P1|STARTED|Overall Study||1
8175013|NCT02411539|20157168|P2|NOT COMPLETED|Overall Study||1
8175014|NCT02411539|20157169|P1|NOT COMPLETED|Overall Study||2
8175015|NCT02411539|20157168|P2|COMPLETED|Overall Study||19
8175016|NCT02411539|20157169|P1|COMPLETED|Overall Study||18
8175017|NCT02411539|20157168|P2|STARTED|Overall Study||20
8175018|NCT02411539|20157169|P1|STARTED|Overall Study||20
8175019|NCT02411461|20157247|P3|NOT COMPLETED|Overall Study||0
8175020|NCT02411461|20157248|P2|NOT COMPLETED|Overall Study||0
8175021|NCT02411461|20157249|P1|NOT COMPLETED|Overall Study||0
8175022|NCT02411461|20157247|P3|COMPLETED|Overall Study||15
8175023|NCT02411461|20157248|P2|COMPLETED|Overall Study||8
8175024|NCT02411461|20157249|P1|COMPLETED|Overall Study||16
8175025|NCT02411461|20157247|P3|STARTED|Overall Study||15
8175026|NCT02411461|20157248|P2|STARTED|Overall Study||8
8175027|NCT02411461|20157249|P1|STARTED|Overall Study||16
8175028|NCT02411448|20157260|P3|NOT COMPLETED|Overall Study||52
8175029|NCT02411448|20157261|P2|NOT COMPLETED|Overall Study||83
8175030|NCT02411448|20157262|P1|NOT COMPLETED|Overall Study||4
8175031|NCT02411448|20157260|P3|COMPLETED|Overall Study||173
8175032|NCT02411448|20157261|P2|COMPLETED|Overall Study||141
8175033|NCT02411448|20157262|P1|COMPLETED|Overall Study||10
8175034|NCT02411448|20157260|P3|Received at Least One Dose of Study Drug|Overall Study||225
8175035|NCT02411448|20157261|P2|Received at Least One Dose of Study Drug|Overall Study||221
8175036|NCT02411448|20157262|P1|Received at Least One Dose of Study Drug|Overall Study||14
8175037|NCT02411448|20157260|P3|STARTED|Overall Study||225
8175038|NCT02411448|20157261|P2|STARTED|Overall Study||224
8175039|NCT02411448|20157262|P1|STARTED|Overall Study||14
8175040|NCT02411396|20157291|P1|NOT COMPLETED|Overall Study||41
8175041|NCT02411396|20157291|P1|COMPLETED|Overall Study||442
8175042|NCT02411396|20157291|P1|STARTED|Overall Study||483
8175043|NCT02411292|20157304|P1|NOT COMPLETED|Overall Study||21
8175044|NCT02411292|20157304|P1|COMPLETED|Overall Study||89
8175045|NCT02411292|20157304|P1|STARTED|Overall Study||110
8175046|NCT02411201|20157310|P1|NOT COMPLETED|Overall Study||6
8175047|NCT02411201|20157310|P1|COMPLETED|Overall Study||45
8175048|NCT02411201|20157310|P1|STARTED|Overall Study||51
8175049|NCT02411110|20157323|P2|NOT COMPLETED|Treatment Period 2||4
8175050|NCT02411110|20157324|P1|NOT COMPLETED|Treatment Period 2||1
8175051|NCT02411110|20157323|P2|COMPLETED|Treatment Period 2||44
8175052|NCT02411110|20157324|P1|COMPLETED|Treatment Period 2||49
8175053|NCT02411110|20157323|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
8175054|NCT02411110|20157324|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
8175055|NCT02411110|20157323|P2|NOT COMPLETED|Treatment Period 1||7
8175056|NCT02411110|20157324|P1|NOT COMPLETED|Treatment Period 1||9
8175057|NCT02411110|20157323|P2|COMPLETED|Treatment Period 1||59
8175058|NCT02411110|20157324|P1|COMPLETED|Treatment Period 1||56
8175059|NCT02411110|20157323|P2|STARTED|Treatment Period 1||66
8175060|NCT02411110|20157324|P1|STARTED|Treatment Period 1||65
8175061|NCT02411084|20157334|P2|NOT COMPLETED|Overall Study||13
8175062|NCT02411084|20157335|P1|NOT COMPLETED|Overall Study||13
8175063|NCT02411084|20157334|P2|COMPLETED|Overall Study||5
8175064|NCT02411084|20157335|P1|COMPLETED|Overall Study||5
8175065|NCT02411084|20157334|P2|STARTED|Overall Study||18
8175066|NCT02411084|20157335|P1|STARTED|Overall Study||18
8175067|NCT02410967|20157350|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
8175068|NCT02410967|20157351|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
8175069|NCT02410967|20157350|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
8175070|NCT02410967|20157351|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
8175071|NCT02410967|20157350|P2|STARTED|Follow-up Phase (8 Weeks)||22
8175072|NCT02410967|20157351|P1|STARTED|Follow-up Phase (8 Weeks)||26
8175073|NCT02410967|20157350|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
8175074|NCT02410967|20157351|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
8175075|NCT02410967|20157350|P2|COMPLETED|Treatment Phase (4 Weeks)||22
8175076|NCT02410967|20157351|P1|COMPLETED|Treatment Phase (4 Weeks)||26
8175077|NCT02410967|20157350|P2|STARTED|Treatment Phase (4 Weeks)||26
8175078|NCT02410967|20157351|P1|STARTED|Treatment Phase (4 Weeks)||27
8175079|NCT02410824|20157367|P2|NOT COMPLETED|Second Intervention (One Week)||0
8175080|NCT02410824|20157368|P1|NOT COMPLETED|Second Intervention (One Week)||0
8175081|NCT02410824|20157367|P2|COMPLETED|Second Intervention (One Week)||22
8175082|NCT02410824|20157368|P1|COMPLETED|Second Intervention (One Week)||22
8175083|NCT02410824|20157367|P2|STARTED|Second Intervention (One Week)||22
8175084|NCT02410824|20157368|P1|STARTED|Second Intervention (One Week)||22
8175085|NCT02410824|20157367|P2|NOT COMPLETED|First Intervention (One Week)||1
8175086|NCT02410824|20157368|P1|NOT COMPLETED|First Intervention (One Week)||0
8175087|NCT02410824|20157367|P2|COMPLETED|First Intervention (One Week)||22
8175088|NCT02410824|20157368|P1|COMPLETED|First Intervention (One Week)||22
8175089|NCT02410824|20157367|P2|STARTED|First Intervention (One Week)||23
8175090|NCT02410824|20157368|P1|STARTED|First Intervention (One Week)||22
8175091|NCT02410811|20157404|P4|NOT COMPLETED|Overall Study||0
8175092|NCT02410811|20157405|P3|NOT COMPLETED|Overall Study||1
8175093|NCT02410811|20157406|P2|NOT COMPLETED|Overall Study||0
8175094|NCT02410811|20157407|P1|NOT COMPLETED|Overall Study||0
8175095|NCT02410811|20157404|P4|COMPLETED|Overall Study||7
8175096|NCT02410811|20157405|P3|COMPLETED|Overall Study||10
8175097|NCT02410811|20157406|P2|COMPLETED|Overall Study||10
8175098|NCT02410811|20157407|P1|COMPLETED|Overall Study||5
8175099|NCT02410811|20157404|P4|STARTED|Overall Study||7
8175100|NCT02410811|20157405|P3|STARTED|Overall Study||11
8175101|NCT02410811|20157406|P2|STARTED|Overall Study||10
8175102|NCT02410811|20157407|P1|STARTED|Overall Study||5
8175103|NCT02410707|20157421|P1|NOT COMPLETED|Overall Study||0
8175104|NCT02410707|20157421|P1|COMPLETED|Overall Study||43
8175105|NCT02410707|20157421|P1|STARTED|Overall Study||43
8175106|NCT02410629|20157434|P2|NOT COMPLETED|Overall Study||3
8175107|NCT02410629|20157435|P1|NOT COMPLETED|Overall Study||3
8175108|NCT02410629|20157434|P2|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
8175109|NCT02410629|20157435|P1|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
8175110|NCT02410629|20157434|P2|STARTED|Overall Study||9
8175111|NCT02410629|20157435|P1|STARTED|Overall Study||8
8175112|NCT02410577|20157447|P1|NOT COMPLETED|Overall Study||0
8175113|NCT02410577|20157447|P1|COMPLETED|Overall Study||2
8175114|NCT02410577|20157447|P1|STARTED|Overall Study||2
8175115|NCT02410551|20157451|P1|NOT COMPLETED|Overall Study||4
8175116|NCT02410551|20157451|P1|COMPLETED|Overall Study||0
8175117|NCT02410551|20157451|P1|STARTED|Overall Study||4
8175118|NCT02410382|20157458|P2|NOT COMPLETED|Overall Study||0
8175119|NCT02410382|20157459|P1|NOT COMPLETED|Overall Study||0
8175120|NCT02410382|20157458|P2|COMPLETED|Overall Study||0
8175121|NCT02410382|20157459|P1|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
8175122|NCT02410382|20157458|P2|STARTED|Overall Study||0
8175123|NCT02410382|20157459|P1|STARTED|Overall Study||0
8175124|NCT02410343|20157469|P2|NOT COMPLETED|Extension Period (12 Months)||1
8175125|NCT02410343|20157470|P1|NOT COMPLETED|Extension Period (12 Months)||1
8175126|NCT02410343|20157469|P2|COMPLETED|Extension Period (12 Months)||0
8175127|NCT02410343|20157470|P1|COMPLETED|Extension Period (12 Months)||0
8175128|NCT02410343|20157469|P2|STARTED|Extension Period (12 Months)||1
8175129|NCT02410343|20157470|P1|STARTED|Extension Period (12 Months)||1
8175130|NCT02410343|20157469|P2|NOT COMPLETED|Core Period (24 Weeks)||7
8175131|NCT02410343|20157470|P1|NOT COMPLETED|Core Period (24 Weeks)||5
8175132|NCT02410343|20157469|P2|COMPLETED|Core Period (24 Weeks)||1
8175133|NCT02410343|20157470|P1|COMPLETED|Core Period (24 Weeks)||1
8175134|NCT02410343|20157469|P2|STARTED|Core Period (24 Weeks)||8
8175135|NCT02410343|20157470|P1|STARTED|Core Period (24 Weeks)||6
8175136|NCT02410291|20157507|P2|NOT COMPLETED|Overall Study||0
8175137|NCT02410291|20157508|P1|NOT COMPLETED|Overall Study||0
8175138|NCT02410291|20157507|P2|COMPLETED|Overall Study||29
8175139|NCT02410291|20157508|P1|COMPLETED|Overall Study||29
8175140|NCT02410291|20157507|P2|STARTED|Overall Study||29
8175141|NCT02410291|20157508|P1|STARTED|Overall Study||29
8175142|NCT02410278|20157516|P3|NOT COMPLETED|Study Treatment Period||4
8175143|NCT02410278|20157517|P2|NOT COMPLETED|Study Treatment Period||11
8175144|NCT02410278|20157518|P1|NOT COMPLETED|Study Treatment Period||0
8175145|NCT02410278|20157516|P3|COMPLETED|Study Treatment Period||29
8175146|NCT02410278|20157517|P2|COMPLETED|Study Treatment Period||20
8175147|NCT02410278|20157518|P1|COMPLETED|Study Treatment Period||0
8175148|NCT02410278|20157516|P3|Completed Randomized Study Treatment|Study Treatment Period||29
8175149|NCT02410278|20157517|P2|Completed Randomized Study Treatment|Study Treatment Period||20
8175150|NCT02410278|20157518|P1|Completed Randomized Study Treatment|Study Treatment Period||0
8175151|NCT02410278|20157516|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
8175152|NCT02410278|20157517|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
8175153|NCT02410278|20157518|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
8175154|NCT02410278|20157516|P3|STARTED|Study Treatment Period||33
8175155|NCT02410278|20157517|P2|STARTED|Study Treatment Period||31
8175156|NCT02410278|20157518|P1|STARTED|Study Treatment Period||0
8175157|NCT02410278|20157516|P3|NOT COMPLETED|Run-in Period||0
8175158|NCT02410278|20157517|P2|NOT COMPLETED|Run-in Period||0
8175159|NCT02410278|20157518|P1|NOT COMPLETED|Run-in Period||38
8175160|NCT02410278|20157516|P3|COMPLETED|Run-in Period||0
8175161|NCT02410278|20157517|P2|COMPLETED|Run-in Period||0
8175162|NCT02410278|20157518|P1|COMPLETED|Run-in Period||64
8175163|NCT02410278|20157516|P3|Received at Least 1 Dose of DMF|Run-in Period||0
8175164|NCT02410278|20157517|P2|Received at Least 1 Dose of DMF|Run-in Period||0
8175165|NCT02410278|20157518|P1|Received at Least 1 Dose of DMF|Run-in Period||98
8175166|NCT02410278|20157516|P3|STARTED|Run-in Period||0
8175167|NCT02410278|20157517|P2|STARTED|Run-in Period||0
8175168|NCT02410278|20157518|P1|STARTED|Run-in Period||102
8175169|NCT02410252|20157543|P1|NOT COMPLETED|Overall Study||6
8175170|NCT02410252|20157543|P1|COMPLETED|Overall Study||19
8175171|NCT02410252|20157543|P1|STARTED|Overall Study||25
8175172|NCT02410213|20157549|P2|NOT COMPLETED|Overall Study||0
8175173|NCT02410213|20157550|P1|NOT COMPLETED|Overall Study||0
8175174|NCT02410213|20157549|P2|COMPLETED|Overall Study||19
8175175|NCT02410213|20157550|P1|COMPLETED|Overall Study||16
8175176|NCT02410213|20157549|P2|STARTED|Overall Study||19
8175177|NCT02410213|20157550|P1|STARTED|Overall Study||16
8175178|NCT02410200|20157556|P1|NOT COMPLETED|Overall Study||2
8175179|NCT02410200|20157556|P1|COMPLETED|Overall Study||20
8175180|NCT02410200|20157556|P1|STARTED|Overall Study||22
8175181|NCT02410161|20157569|P2|NOT COMPLETED|Overall Study||0
8175182|NCT02410161|20157570|P1|NOT COMPLETED|Overall Study||0
8175183|NCT02410161|20157569|P2|COMPLETED|Overall Study||10
8175184|NCT02410161|20157570|P1|COMPLETED|Overall Study||10
8175185|NCT02410161|20157569|P2|STARTED|Overall Study||10
8175186|NCT02410161|20157570|P1|STARTED|Overall Study||10
8175187|NCT02410018|20157586|P2|NOT COMPLETED|Overall Study||0
8175188|NCT02410018|20157587|P1|NOT COMPLETED|Overall Study||0
8175189|NCT02410018|20157586|P2|COMPLETED|Overall Study||1
8175190|NCT02410018|20157587|P1|COMPLETED|Overall Study||2
8175191|NCT02410018|20157586|P2|STARTED|Overall Study||1
8175192|NCT02410018|20157587|P1|STARTED|Overall Study||2
8175193|NCT02409927|20157607|P1|NOT COMPLETED|Overall Study||0
8175194|NCT02409927|20157607|P1|COMPLETED|Overall Study||10
8175195|NCT02409927|20157607|P1|STARTED|Overall Study||10
8175196|NCT02409914|20157615|P1|NOT COMPLETED|Overall Study||0
8175197|NCT02409914|20157615|P1|COMPLETED|Overall Study||7
8175198|NCT02409914|20157615|P1|STARTED|Overall Study||7
8175199|NCT02409784|20157621|P1|NOT COMPLETED|Overall Study||0
8175200|NCT02409784|20157621|P1|COMPLETED|Overall Study||10
8175201|NCT02409784|20157621|P1|STARTED|Overall Study||10
8175202|NCT02409732|20157626|P1|NOT COMPLETED|Overall Study||6
8175203|NCT02409732|20157626|P1|COMPLETED|Overall Study||14
8175204|NCT02409732|20157626|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
8175205|NCT02409719|20157636|P2|NOT COMPLETED|Overall Study||3
8175206|NCT02409719|20157637|P1|NOT COMPLETED|Overall Study||3
8175207|NCT02409719|20157636|P2|COMPLETED|Overall Study||42
8175208|NCT02409719|20157637|P1|COMPLETED|Overall Study||28
8175209|NCT02409719|20157636|P2|12 Months|Overall Study||42
8175210|NCT02409719|20157637|P1|12 Months|Overall Study||28
8175211|NCT02409719|20157636|P2|6 Months|Overall Study||42
8175212|NCT02409719|20157637|P1|6 Months|Overall Study||28
8175213|NCT02409719|20157636|P2|3 Months|Overall Study||42
8175214|NCT02409719|20157637|P1|3 Months|Overall Study||28
8175215|NCT02409719|20157636|P2|6 Weeks|Overall Study||42
8175216|NCT02409719|20157637|P1|6 Weeks|Overall Study||28
8175217|NCT02409719|20157636|P2|4 Weeks|Overall Study||42
8175218|NCT02409719|20157637|P1|4 Weeks|Overall Study||28
8175219|NCT02409719|20157636|P2|2 Weeks|Overall Study||42
8175220|NCT02409719|20157637|P1|2 Weeks|Overall Study||28
8175221|NCT02409719|20157636|P2|STARTED|Overall Study||45
8175222|NCT02409719|20157637|P1|STARTED|Overall Study||31
8175223|NCT02409667|20157647|P5|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
8175224|NCT02409667|20157648|P4|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
8175225|NCT02409667|20157649|P3|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
8175226|NCT02409667|20157650|P2|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
8175227|NCT02409667|20157651|P1|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
8175228|NCT02409667|20157647|P5|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
8175229|NCT02409667|20157648|P4|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
8175230|NCT02409667|20157649|P3|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
8175231|NCT02409667|20157650|P2|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
8175232|NCT02409667|20157651|P1|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
8175233|NCT02409667|20157647|P5|STARTED|Treatment Period 2, Week 24 to Week 52)||93
8175234|NCT02409667|20157648|P4|STARTED|Treatment Period 2, Week 24 to Week 52)||114
8175235|NCT02409667|20157649|P3|STARTED|Treatment Period 2, Week 24 to Week 52)||662
8175236|NCT02409667|20157650|P2|STARTED|Treatment Period 2, Week 24 to Week 52)||644
8175237|NCT02409667|20157651|P1|STARTED|Treatment Period 2, Week 24 to Week 52)||0
8175238|NCT02409667|20157647|P5|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175239|NCT02409667|20157648|P4|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175240|NCT02409667|20157649|P3|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175241|NCT02409667|20157650|P2|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175242|NCT02409667|20157651|P1|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
8175243|NCT02409667|20157647|P5|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175244|NCT02409667|20157648|P4|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175245|NCT02409667|20157649|P3|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175246|NCT02409667|20157650|P2|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175247|NCT02409667|20157651|P1|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
8175248|NCT02409667|20157647|P5|STARTED|Treatment Period 1, Baseline to Week 24||0
8175249|NCT02409667|20157648|P4|STARTED|Treatment Period 1, Baseline to Week 24||0
8175250|NCT02409667|20157649|P3|STARTED|Treatment Period 1, Baseline to Week 24||0
8175251|NCT02409667|20157650|P2|STARTED|Treatment Period 1, Baseline to Week 24||0
8175252|NCT02409667|20157651|P1|STARTED|Treatment Period 1, Baseline to Week 24||1647
8175253|NCT02409459|20157692|P2|NOT COMPLETED|Overall Study||1
8175254|NCT02409459|20157693|P1|NOT COMPLETED|Overall Study||1
8175255|NCT02409459|20157692|P2|COMPLETED|Overall Study||39
8175256|NCT02409459|20157693|P1|COMPLETED|Overall Study||40
8175257|NCT02409459|20157692|P2|STARTED|Overall Study||40
8175258|NCT02409459|20157693|P1|STARTED|Overall Study||41
8175259|NCT02409355|20157713|P2|NOT COMPLETED|Overall Study||4
8175260|NCT02409355|20157714|P1|NOT COMPLETED|Overall Study||4
8175261|NCT02409355|20157713|P2|COMPLETED|Overall Study||0
8175262|NCT02409355|20157714|P1|COMPLETED|Overall Study||0
8175263|NCT02409355|20157713|P2|STARTED|Overall Study||4
8175264|NCT02409355|20157714|P1|STARTED|Overall Study||4
8175265|NCT02409329|20157723|P3|NOT COMPLETED|Overall Study||9
8175266|NCT02409329|20157724|P2|NOT COMPLETED|Overall Study||6
8175267|NCT02409329|20157725|P1|NOT COMPLETED|Overall Study||5
8175268|NCT02409329|20157723|P3|COMPLETED|Overall Study||244
8175269|NCT02409329|20157724|P2|COMPLETED|Overall Study||120
8175270|NCT02409329|20157725|P1|COMPLETED|Overall Study||122
8175271|NCT02409329|20157723|P3|STARTED|Overall Study||253
8175272|NCT02409329|20157724|P2|STARTED|Overall Study||126
8175273|NCT02409329|20157725|P1|STARTED|Overall Study||127
8175274|NCT02409277|20157748|P3|NOT COMPLETED|Overall Study||0
8175275|NCT02409277|20157749|P2|NOT COMPLETED|Overall Study||17
8175276|NCT02409277|20157750|P1|NOT COMPLETED|Overall Study||100
8175277|NCT02409277|20157748|P3|COMPLETED|Overall Study||599
8175278|NCT02409277|20157749|P2|COMPLETED|Overall Study||43
8175279|NCT02409277|20157750|P1|COMPLETED|Overall Study||167
8175280|NCT02409277|20157748|P3|12 Months Follow-up|Overall Study||599
8175281|NCT02409277|20157749|P2|12 Months Follow-up|Overall Study||43
8175282|NCT02409277|20157750|P1|12 Months Follow-up|Overall Study||167
8175283|NCT02409277|20157748|P3|6 Months Follow-up|Overall Study||599
8175284|NCT02409277|20157749|P2|6 Months Follow-up|Overall Study||42
8175285|NCT02409277|20157750|P1|6 Months Follow-up|Overall Study||182
8175286|NCT02409277|20157748|P3|3 Months Follow-up|Overall Study||599
8175287|NCT02409277|20157749|P2|3 Months Follow-up|Overall Study||40
8175288|NCT02409277|20157750|P1|3 Months Follow-up|Overall Study||178
8175289|NCT02409277|20157748|P3|STARTED|Overall Study||599
8175290|NCT02409277|20157749|P2|STARTED|Overall Study||60
8175291|NCT02409277|20157750|P1|STARTED|Overall Study||267
8175292|NCT02408965|20157790|P2|NOT COMPLETED|Overall Study||0
8175293|NCT02408965|20157791|P1|NOT COMPLETED|Overall Study||0
8175294|NCT02408965|20157790|P2|COMPLETED|Overall Study||144
8175295|NCT02408965|20157791|P1|COMPLETED|Overall Study||140
8175296|NCT02408965|20157790|P2|STARTED|Overall Study||144
8175297|NCT02408965|20157791|P1|STARTED|Overall Study||140
8175298|NCT02408796|20157813|P1|NOT COMPLETED|Overall Study||0
8175299|NCT02408796|20157813|P1|COMPLETED|Overall Study||39
8175300|NCT02408796|20157813|P1|STARTED|Overall Study||39
8175301|NCT02408692|20157822|P3|NOT COMPLETED|Overall Study||0
8175302|NCT02408692|20157823|P2|NOT COMPLETED|Overall Study||0
8175303|NCT02408692|20157824|P1|NOT COMPLETED|Overall Study||0
8175304|NCT02408692|20157822|P3|COMPLETED|Overall Study||5
8175305|NCT02408692|20157823|P2|COMPLETED|Overall Study||5
8175306|NCT02408692|20157824|P1|COMPLETED|Overall Study||5
8175307|NCT02408692|20157822|P3|STARTED|Overall Study||5
8175308|NCT02408692|20157823|P2|STARTED|Overall Study||5
8175309|NCT02408692|20157824|P1|STARTED|Overall Study||5
8175310|NCT02408523|20157837|P2|NOT COMPLETED|Overall Study||18
8175311|NCT02408523|20157838|P1|NOT COMPLETED|Overall Study||11
8175312|NCT02408523|20157837|P2|COMPLETED|Overall Study||103
8175313|NCT02408523|20157838|P1|COMPLETED|Overall Study||110
8175314|NCT02408523|20157837|P2|Enrolled Safety Folllow-up Period|Overall Study||11
8175315|NCT02408523|20157838|P1|Enrolled Safety Folllow-up Period|Overall Study||10
8175316|NCT02408523|20157837|P2|Enrolled Taper Period|Overall Study||9
8175317|NCT02408523|20157838|P1|Enrolled Taper Period|Overall Study||7
8175318|NCT02408523|20157837|P2|Enrolled Transition Period|Overall Study||101
8175319|NCT02408523|20157838|P1|Enrolled Transition Period|Overall Study||108
8175320|NCT02408523|20157837|P2|Completed Treatment Period|Overall Study||103
8175321|NCT02408523|20157838|P1|Completed Treatment Period|Overall Study||110
8175322|NCT02408523|20157837|P2|STARTED|Overall Study||121
8175323|NCT02408523|20157838|P1|STARTED|Overall Study||121
8175324|NCT02408484|20157858|P1|NOT COMPLETED|Overall Study||4
8175325|NCT02408484|20157858|P1|COMPLETED|Overall Study||11
8175326|NCT02408484|20157858|P1|SURG Population|Overall Study||3
8175327|NCT02408484|20157858|P1|BLEED Population|Overall Study||8
8175328|NCT02408484|20157858|P1|firstBLEED Population|Overall Study||8
8175329|NCT02408484|20157858|P1|PK Population|Overall Study||13
8175330|NCT02408484|20157858|P1|FAS Population|Overall Study||14
8175331|NCT02408484|20157858|P1|SAF Population|Overall Study||14
8175332|NCT02408484|20157858|P1|STARTED|Overall Study||15
8175333|NCT02408445|20157892|P2|NOT COMPLETED|Overall Study||0
8175334|NCT02408445|20157893|P1|NOT COMPLETED|Overall Study||0
8175335|NCT02408445|20157892|P2|COMPLETED|Overall Study||10
8175336|NCT02408445|20157893|P1|COMPLETED|Overall Study||10
8175337|NCT02408445|20157892|P2|STARTED|Overall Study||10
8175338|NCT02408445|20157893|P1|STARTED|Overall Study||10
8175339|NCT02408315|20157922|P2|NOT COMPLETED|Overall Study||0
8175340|NCT02408315|20157923|P1|NOT COMPLETED|Overall Study||0
8175341|NCT02408315|20157922|P2|COMPLETED|Overall Study||152
8175342|NCT02408315|20157923|P1|COMPLETED|Overall Study||148
8175343|NCT02408315|20157922|P2|STARTED|Overall Study||152
8175344|NCT02408315|20157923|P1|STARTED|Overall Study||148
8175345|NCT02408263|20157945|P2|NOT COMPLETED|Overall Study||0
8175346|NCT02408263|20157946|P1|NOT COMPLETED|Overall Study||0
8175347|NCT02408263|20157945|P2|COMPLETED|Overall Study||25
8175348|NCT02408263|20157946|P1|COMPLETED|Overall Study||25
8175349|NCT02408263|20157945|P2|STARTED|Overall Study||25
8175350|NCT02408263|20157946|P1|STARTED|Overall Study||25
8175351|NCT02408198|20157954|P2|NOT COMPLETED|Overall Study||0
8175352|NCT02408198|20157955|P1|NOT COMPLETED|Overall Study||3
8175353|NCT02408198|20157954|P2|COMPLETED|Overall Study||5
8175354|NCT02408198|20157955|P1|COMPLETED|Overall Study||10
8175355|NCT02408198|20157954|P2|STARTED|Overall Study||5
8175356|NCT02408198|20157955|P1|STARTED|Overall Study||13
8175357|NCT02408120|20157963|P2|NOT COMPLETED|Overall Study||5
8175358|NCT02408120|20157964|P1|NOT COMPLETED|Overall Study||4
8175359|NCT02408120|20157963|P2|COMPLETED|Overall Study||107
8175360|NCT02408120|20157964|P1|COMPLETED|Overall Study||108
8175361|NCT02408120|20157963|P2|STARTED|Overall Study||112
8175362|NCT02408120|20157964|P1|STARTED|Overall Study||112
8175363|NCT02408068|20157990|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175364|NCT02408068|20157991|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175365|NCT02408068|20157992|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175366|NCT02408068|20157993|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
8175367|NCT02408068|20157994|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175368|NCT02408068|20157995|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175369|NCT02408068|20157990|P6|COMPLETED|Treatment 3 (1.5 Days)||3
8175370|NCT02408068|20157991|P5|COMPLETED|Treatment 3 (1.5 Days)||3
8175371|NCT02408068|20157992|P4|COMPLETED|Treatment 3 (1.5 Days)||3
8175372|NCT02408068|20157993|P3|COMPLETED|Treatment 3 (1.5 Days)||2
8175373|NCT02408068|20157994|P2|COMPLETED|Treatment 3 (1.5 Days)||3
8175374|NCT02408068|20157995|P1|COMPLETED|Treatment 3 (1.5 Days)||3
8175375|NCT02408068|20157990|P6|STARTED|Treatment 3 (1.5 Days)||3
8175376|NCT02408068|20157991|P5|STARTED|Treatment 3 (1.5 Days)||3
8175377|NCT02408068|20157992|P4|STARTED|Treatment 3 (1.5 Days)||3
8175378|NCT02408068|20157993|P3|STARTED|Treatment 3 (1.5 Days)||3
8175379|NCT02408068|20157994|P2|STARTED|Treatment 3 (1.5 Days)||3
8175380|NCT02408068|20157995|P1|STARTED|Treatment 3 (1.5 Days)||3
8175381|NCT02408068|20157990|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175382|NCT02408068|20157991|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175383|NCT02408068|20157992|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175384|NCT02408068|20157993|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175385|NCT02408068|20157994|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175386|NCT02408068|20157995|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175387|NCT02408068|20157990|P6|COMPLETED|Washout Period 2 (7 Days)||3
8175388|NCT02408068|20157991|P5|COMPLETED|Washout Period 2 (7 Days)||3
8175389|NCT02408068|20157992|P4|COMPLETED|Washout Period 2 (7 Days)||3
8175390|NCT02408068|20157993|P3|COMPLETED|Washout Period 2 (7 Days)||3
8175391|NCT02408068|20157994|P2|COMPLETED|Washout Period 2 (7 Days)||3
8175392|NCT02408068|20157995|P1|COMPLETED|Washout Period 2 (7 Days)||3
8175393|NCT02408068|20157990|P6|STARTED|Washout Period 2 (7 Days)||3
8175394|NCT02408068|20157991|P5|STARTED|Washout Period 2 (7 Days)||3
8175395|NCT02408068|20157992|P4|STARTED|Washout Period 2 (7 Days)||3
8175396|NCT02408068|20157993|P3|STARTED|Washout Period 2 (7 Days)||3
8175397|NCT02408068|20157994|P2|STARTED|Washout Period 2 (7 Days)||3
8175398|NCT02408068|20157995|P1|STARTED|Washout Period 2 (7 Days)||3
8175399|NCT02408068|20157990|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175400|NCT02408068|20157991|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175401|NCT02408068|20157992|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175402|NCT02408068|20157993|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175403|NCT02408068|20157994|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175404|NCT02408068|20157995|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175405|NCT02408068|20157990|P6|COMPLETED|Treatment 2 (1.5 Days)||3
8175406|NCT02408068|20157991|P5|COMPLETED|Treatment 2 (1.5 Days)||3
8175407|NCT02408068|20157992|P4|COMPLETED|Treatment 2 (1.5 Days)||3
8175408|NCT02408068|20157993|P3|COMPLETED|Treatment 2 (1.5 Days)||3
8175409|NCT02408068|20157994|P2|COMPLETED|Treatment 2 (1.5 Days)||3
8175410|NCT02408068|20157995|P1|COMPLETED|Treatment 2 (1.5 Days)||3
8175411|NCT02408068|20157990|P6|STARTED|Treatment 2 (1.5 Days)||3
8175412|NCT02408068|20157991|P5|STARTED|Treatment 2 (1.5 Days)||3
8175413|NCT02408068|20157992|P4|STARTED|Treatment 2 (1.5 Days)||3
8175414|NCT02408068|20157993|P3|STARTED|Treatment 2 (1.5 Days)||3
8175415|NCT02408068|20157994|P2|STARTED|Treatment 2 (1.5 Days)||3
8175416|NCT02408068|20157995|P1|STARTED|Treatment 2 (1.5 Days)||3
8175417|NCT02408068|20157990|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175418|NCT02408068|20157991|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175419|NCT02408068|20157992|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175420|NCT02408068|20157993|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175421|NCT02408068|20157994|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175422|NCT02408068|20157995|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175423|NCT02408068|20157990|P6|COMPLETED|Washout Period 1 (7 Days)||3
8175424|NCT02408068|20157991|P5|COMPLETED|Washout Period 1 (7 Days)||3
8175425|NCT02408068|20157992|P4|COMPLETED|Washout Period 1 (7 Days)||3
8175426|NCT02408068|20157993|P3|COMPLETED|Washout Period 1 (7 Days)||3
8175427|NCT02408068|20157994|P2|COMPLETED|Washout Period 1 (7 Days)||3
8175428|NCT02408068|20157995|P1|COMPLETED|Washout Period 1 (7 Days)||3
8175429|NCT02408068|20157990|P6|STARTED|Washout Period 1 (7 Days)||3
8175430|NCT02408068|20157991|P5|STARTED|Washout Period 1 (7 Days)||3
8175431|NCT02408068|20157992|P4|STARTED|Washout Period 1 (7 Days)||3
8175432|NCT02408068|20157993|P3|STARTED|Washout Period 1 (7 Days)||3
8175433|NCT02408068|20157994|P2|STARTED|Washout Period 1 (7 Days)||3
8175434|NCT02408068|20157995|P1|STARTED|Washout Period 1 (7 Days)||3
8175435|NCT02408068|20157990|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175436|NCT02408068|20157991|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175437|NCT02408068|20157992|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175438|NCT02408068|20157993|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175439|NCT02408068|20157994|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175440|NCT02408068|20157995|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175441|NCT02408068|20157990|P6|COMPLETED|Treatment 1 (1.5 Days)||3
8175442|NCT02408068|20157991|P5|COMPLETED|Treatment 1 (1.5 Days)||3
8175443|NCT02408068|20157992|P4|COMPLETED|Treatment 1 (1.5 Days)||3
8175444|NCT02408068|20157993|P3|COMPLETED|Treatment 1 (1.5 Days)||3
8175445|NCT02408068|20157994|P2|COMPLETED|Treatment 1 (1.5 Days)||3
8175446|NCT02408068|20157995|P1|COMPLETED|Treatment 1 (1.5 Days)||3
8175447|NCT02408068|20157990|P6|STARTED|Treatment 1 (1.5 Days)||3
8175448|NCT02408068|20157991|P5|STARTED|Treatment 1 (1.5 Days)||3
8175449|NCT02408068|20157992|P4|STARTED|Treatment 1 (1.5 Days)||3
8175450|NCT02408068|20157993|P3|STARTED|Treatment 1 (1.5 Days)||3
8175451|NCT02408068|20157994|P2|STARTED|Treatment 1 (1.5 Days)||3
8175452|NCT02408068|20157995|P1|STARTED|Treatment 1 (1.5 Days)||3
8175453|NCT02407756|20158022|P4|NOT COMPLETED|Overall Study||0
8175454|NCT02407756|20158023|P3|NOT COMPLETED|Overall Study||0
8175455|NCT02407756|20158024|P2|NOT COMPLETED|Overall Study||0
8175456|NCT02407756|20158025|P1|NOT COMPLETED|Overall Study||0
8175457|NCT02407756|20158022|P4|COMPLETED|Overall Study||19
8175458|NCT02407756|20158023|P3|COMPLETED|Overall Study||20
8175459|NCT02407756|20158024|P2|COMPLETED|Overall Study||18
8175460|NCT02407756|20158025|P1|COMPLETED|Overall Study||20
8175461|NCT02407756|20158022|P4|Treated|Overall Study||19
8175462|NCT02407756|20158023|P3|Treated|Overall Study||20
8175463|NCT02407756|20158024|P2|Treated|Overall Study||18
8175464|NCT02407756|20158025|P1|Treated|Overall Study||20
8175465|NCT02407756|20158022|P4|STARTED|Overall Study||19
8175466|NCT02407756|20158023|P3|STARTED|Overall Study||20
8175467|NCT02407756|20158024|P2|STARTED|Overall Study||18
8175468|NCT02407756|20158025|P1|STARTED|Overall Study||20
8175469|NCT02407704|20158067|P4|NOT COMPLETED|Overall Study||3
8175470|NCT02407704|20158068|P3|NOT COMPLETED|Overall Study||1
8175471|NCT02407704|20158069|P2|NOT COMPLETED|Overall Study||0
8175472|NCT02407704|20158070|P1|NOT COMPLETED|Overall Study||0
8175473|NCT02407704|20158067|P4|COMPLETED|Overall Study||2
8175474|NCT02407704|20158068|P3|COMPLETED|Overall Study||4
8175475|NCT02407704|20158069|P2|COMPLETED|Overall Study||3
8175476|NCT02407704|20158070|P1|COMPLETED|Overall Study||2
8175477|NCT02407704|20158067|P4|STARTED|Overall Study||5
8175478|NCT02407704|20158068|P3|STARTED|Overall Study||5
8175479|NCT02407704|20158069|P2|STARTED|Overall Study||3
8175480|NCT02407704|20158070|P1|STARTED|Overall Study||2
8175481|NCT02407457|20158106|P2|NOT COMPLETED|5-year||63
8175482|NCT02407457|20158107|P1|NOT COMPLETED|5-year||71
8175483|NCT02407457|20158106|P2|COMPLETED|5-year||0
8175484|NCT02407457|20158107|P1|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|0
8175485|NCT02407457|20158106|P2|STARTED|5-year||63
8175486|NCT02407457|20158107|P1|STARTED|5-year||71
8175487|NCT02407457|20158106|P2|NOT COMPLETED|4-year||77
8175488|NCT02407457|20158107|P1|NOT COMPLETED|4-year||86
8175489|NCT02407457|20158106|P2|COMPLETED|4-year||63
8175490|NCT02407457|20158107|P1|COMPLETED|4-year||71
8175491|NCT02407457|20158106|P2|STARTED|4-year||140
8175492|NCT02407457|20158107|P1|STARTED|4-year||157
8175493|NCT02407457|20158106|P2|NOT COMPLETED|3-year||42
8175494|NCT02407457|20158107|P1|NOT COMPLETED|3-year||48
8175495|NCT02407457|20158106|P2|COMPLETED|3-year||140
8175496|NCT02407457|20158107|P1|COMPLETED|3-year||157
8175497|NCT02407457|20158106|P2|STARTED|3-year||182
8175498|NCT02407457|20158107|P1|STARTED|3-year||205
8175499|NCT02407457|20158106|P2|NOT COMPLETED|2-year||14
8175500|NCT02407457|20158107|P1|NOT COMPLETED|2-year||15
8175501|NCT02407457|20158106|P2|COMPLETED|2-year||182
8175502|NCT02407457|20158107|P1|COMPLETED|2-year||205
8175503|NCT02407457|20158106|P2|STARTED|2-year||196
8175504|NCT02407457|20158107|P1|STARTED|2-year||220
8175505|NCT02407457|20158106|P2|NOT COMPLETED|1 Year||24
8175506|NCT02407457|20158107|P1|NOT COMPLETED|1 Year||15
8175507|NCT02407457|20158106|P2|COMPLETED|1 Year||196
8175508|NCT02407457|20158107|P1|COMPLETED|1 Year||220
8175509|NCT02407457|20158106|P2|STARTED|1 Year||220
8175510|NCT02407457|20158107|P1|STARTED|1 Year||235
8175511|NCT02407249|20158113|P1|NOT COMPLETED|Overall Study||26
8175512|NCT02407249|20158113|P1|COMPLETED|Overall Study||47
8175513|NCT02407249|20158113|P1|Treated|Overall Study||60
8175514|NCT02407249|20158113|P1|STARTED|Overall Study||73
8175515|NCT02407236|20158129|P8|NOT COMPLETED|Maintenance Study (44 Weeks)||8
8175516|NCT02407236|20158130|P7|NOT COMPLETED|Maintenance Study (44 Weeks)||9
8175517|NCT02407236|20158131|P6|NOT COMPLETED|Maintenance Study (44 Weeks)||8
8175518|NCT02407236|20158132|P5|NOT COMPLETED|Maintenance Study (44 Weeks)||11
8175519|NCT02407236|20158133|P4|NOT COMPLETED|Maintenance Study (44 Weeks)||10
8175520|NCT02407236|20158134|P3|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8175521|NCT02407236|20158135|P2|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8175522|NCT02407236|20158136|P1|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8175523|NCT02407236|20158129|P8|COMPLETED|Maintenance Study (44 Weeks)||149
8175524|NCT02407236|20158130|P7|COMPLETED|Maintenance Study (44 Weeks)||94
8175525|NCT02407236|20158131|P6|COMPLETED|Maintenance Study (44 Weeks)||168
8175526|NCT02407236|20158132|P5|COMPLETED|Maintenance Study (44 Weeks)||161
8175527|NCT02407236|20158133|P4|COMPLETED|Maintenance Study (44 Weeks)||165
8175528|NCT02407236|20158134|P3|COMPLETED|Maintenance Study (44 Weeks)||0
8175529|NCT02407236|20158135|P2|COMPLETED|Maintenance Study (44 Weeks)||0
8175530|NCT02407236|20158136|P1|COMPLETED|Maintenance Study (44 Weeks)||0
8175531|NCT02407236|20158129|P8|STARTED|Maintenance Study (44 Weeks)||157
8175532|NCT02407236|20158130|P7|STARTED|Maintenance Study (44 Weeks)||103
8175533|NCT02407236|20158131|P6|STARTED|Maintenance Study (44 Weeks)||176
8175534|NCT02407236|20158132|P5|STARTED|Maintenance Study (44 Weeks)||172
8175535|NCT02407236|20158133|P4|STARTED|Maintenance Study (44 Weeks)||175
8175536|NCT02407236|20158134|P3|STARTED|Maintenance Study (44 Weeks)||0
8175537|NCT02407236|20158135|P2|STARTED|Maintenance Study (44 Weeks)||0
8175538|NCT02407236|20158136|P1|STARTED|Maintenance Study (44 Weeks)||0
8175539|NCT02407236|20158129|P8|NOT COMPLETED|Induction Study (8 Weeks)||0
8175540|NCT02407236|20158130|P7|NOT COMPLETED|Induction Study (8 Weeks)||0
8175541|NCT02407236|20158131|P6|NOT COMPLETED|Induction Study (8 Weeks)||0
8175542|NCT02407236|20158132|P5|NOT COMPLETED|Induction Study (8 Weeks)||0
8175543|NCT02407236|20158133|P4|NOT COMPLETED|Induction Study (8 Weeks)||0
8175544|NCT02407236|20158134|P3|NOT COMPLETED|Induction Study (8 Weeks)||15
8175545|NCT02407236|20158135|P2|NOT COMPLETED|Induction Study (8 Weeks)||11
8175546|NCT02407236|20158136|P1|NOT COMPLETED|Induction Study (8 Weeks)||23
8175547|NCT02407236|20158129|P8|COMPLETED|Induction Study (8 Weeks)||0
8175548|NCT02407236|20158130|P7|COMPLETED|Induction Study (8 Weeks)||0
8175549|NCT02407236|20158131|P6|COMPLETED|Induction Study (8 Weeks)||0
8175550|NCT02407236|20158132|P5|COMPLETED|Induction Study (8 Weeks)||0
8175551|NCT02407236|20158133|P4|COMPLETED|Induction Study (8 Weeks)||0
8175552|NCT02407236|20158134|P3|COMPLETED|Induction Study (8 Weeks)||307
8175553|NCT02407236|20158135|P2|COMPLETED|Induction Study (8 Weeks)||309
8175554|NCT02407236|20158136|P1|COMPLETED|Induction Study (8 Weeks)||296
8175555|NCT02407236|20158129|P8|Non-responders at Week 8|Induction Study (8 Weeks)||0
8175556|NCT02407236|20158130|P7|Non-responders at Week 8|Induction Study (8 Weeks)||0
8175557|NCT02407236|20158131|P6|Non-responders at Week 8|Induction Study (8 Weeks)||0
8175558|NCT02407236|20158132|P5|Non-responders at Week 8|Induction Study (8 Weeks)||0
8175559|NCT02407236|20158133|P4|Non-responders at Week 8|Induction Study (8 Weeks)||0
8175560|NCT02407236|20158134|P3|Non-responders at Week 8|Induction Study (8 Weeks)||101
8175561|NCT02407236|20158135|P2|Non-responders at Week 8|Induction Study (8 Weeks)||132
8175562|NCT02407236|20158136|P1|Non-responders at Week 8|Induction Study (8 Weeks)||184
8175563|NCT02407236|20158129|P8|Safety Analysis Set|Induction Study (8 Weeks)||0
8175564|NCT02407236|20158130|P7|Safety Analysis Set|Induction Study (8 Weeks)||0
8175565|NCT02407236|20158131|P6|Safety Analysis Set|Induction Study (8 Weeks)||0
8175566|NCT02407236|20158132|P5|Safety Analysis Set|Induction Study (8 Weeks)||0
8175567|NCT02407236|20158133|P4|Safety Analysis Set|Induction Study (8 Weeks)||0
8175568|NCT02407236|20158134|P3|Safety Analysis Set|Induction Study (8 Weeks)||320
8175569|NCT02407236|20158135|P2|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
8175570|NCT02407236|20158136|P1|Safety Analysis Set|Induction Study (8 Weeks)||319
8175571|NCT02407236|20158129|P8|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8175572|NCT02407236|20158130|P7|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8175573|NCT02407236|20158131|P6|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8175574|NCT02407236|20158132|P5|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8175575|NCT02407236|20158133|P4|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8175576|NCT02407236|20158134|P3|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
8175577|NCT02407236|20158135|P2|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
8175578|NCT02407236|20158136|P1|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
8175579|NCT02407236|20158129|P8|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8175580|NCT02407236|20158130|P7|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8175581|NCT02407236|20158131|P6|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8175582|NCT02407236|20158132|P5|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8175583|NCT02407236|20158133|P4|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8175584|NCT02407236|20158134|P3|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
8175585|NCT02407236|20158135|P2|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
8175586|NCT02407236|20158136|P1|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
8175587|NCT02407236|20158129|P8|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8175588|NCT02407236|20158130|P7|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8175589|NCT02407236|20158131|P6|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8175590|NCT02407236|20158132|P5|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8175591|NCT02407236|20158133|P4|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8175592|NCT02407236|20158134|P3|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
8175593|NCT02407236|20158135|P2|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
8175594|NCT02407236|20158136|P1|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
8175595|NCT02407236|20158129|P8|STARTED|Induction Study (8 Weeks)||0
8175596|NCT02407236|20158130|P7|STARTED|Induction Study (8 Weeks)||0
8175597|NCT02407236|20158131|P6|STARTED|Induction Study (8 Weeks)||0
8175598|NCT02407236|20158132|P5|STARTED|Induction Study (8 Weeks)||0
8175599|NCT02407236|20158133|P4|STARTED|Induction Study (8 Weeks)||0
8175600|NCT02407236|20158134|P3|STARTED|Induction Study (8 Weeks)||322
8175601|NCT02407236|20158135|P2|STARTED|Induction Study (8 Weeks)||320
8175602|NCT02407236|20158136|P1|STARTED|Induction Study (8 Weeks)||319
8175603|NCT02407223|20158376|P3|NOT COMPLETED|Overall Study||122
8175604|NCT02407223|20158377|P2|NOT COMPLETED|Overall Study||118
8175605|NCT02407223|20158378|P1|NOT COMPLETED|Overall Study||116
8175606|NCT02407223|20158376|P3|COMPLETED|Overall Study||0
8175607|NCT02407223|20158377|P2|COMPLETED|Overall Study||0
8175608|NCT02407223|20158378|P1|COMPLETED|Overall Study||0
8175609|NCT02407223|20158376|P3|Qualified Re-randomization at Week 52|Overall Study||2
8175610|NCT02407223|20158377|P2|Qualified Re-randomization at Week 52|Overall Study||3
8175611|NCT02407223|20158378|P1|Qualified Re-randomization at Week 52|Overall Study||0
8175612|NCT02407223|20158376|P3|Cross Over at Week 24|Overall Study||0
8175613|NCT02407223|20158377|P2|Cross Over at Week 24|Overall Study||0
8175614|NCT02407223|20158378|P1|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
8175615|NCT02407223|20158376|P3|Early Escape at Week 16|Overall Study||0
8175616|NCT02407223|20158377|P2|Early Escape at Week 16|Overall Study||0
8175617|NCT02407223|20158378|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
8175618|NCT02407223|20158376|P3|STARTED|Overall Study||122
8175619|NCT02407223|20158377|P2|STARTED|Overall Study||118
8175620|NCT02407223|20158378|P1|STARTED|Overall Study||116
8175621|NCT02407132|20158423|P2|NOT COMPLETED|12 Months Post-intervention||2
8175622|NCT02407132|20158424|P1|NOT COMPLETED|12 Months Post-intervention||13
8175623|NCT02407132|20158423|P2|COMPLETED|12 Months Post-intervention||90
8175624|NCT02407132|20158424|P1|COMPLETED|12 Months Post-intervention||83
8175625|NCT02407132|20158423|P2|STARTED|12 Months Post-intervention||92
8175626|NCT02407132|20158424|P1|STARTED|12 Months Post-intervention||96
8175627|NCT02407132|20158423|P2|NOT COMPLETED|6 Months Post-intervention||9
8175628|NCT02407132|20158424|P1|NOT COMPLETED|6 Months Post-intervention||11
8175629|NCT02407132|20158423|P2|COMPLETED|6 Months Post-intervention||92
8175630|NCT02407132|20158424|P1|COMPLETED|6 Months Post-intervention||96
8175631|NCT02407132|20158423|P2|STARTED|6 Months Post-intervention||101
8175632|NCT02407132|20158424|P1|STARTED|6 Months Post-intervention||107
8175633|NCT02407132|20158423|P2|NOT COMPLETED|Immediate Post-intervention||10
8175634|NCT02407132|20158424|P1|NOT COMPLETED|Immediate Post-intervention||3
8175635|NCT02407132|20158423|P2|COMPLETED|Immediate Post-intervention||101
8175636|NCT02407132|20158424|P1|COMPLETED|Immediate Post-intervention||107
8175637|NCT02407132|20158423|P2|STARTED|Immediate Post-intervention||111
8175638|NCT02407132|20158424|P1|STARTED|Immediate Post-intervention||110
8175639|NCT02407041|20158448|P1|NOT COMPLETED|Overall Study||0
8175640|NCT02407041|20158448|P1|COMPLETED|Overall Study||5
8175641|NCT02407041|20158448|P1|STARTED|Overall Study||5
8175642|NCT02406937|20158455|P3|NOT COMPLETED|Overall Study||2
8175643|NCT02406937|20158456|P2|NOT COMPLETED|Overall Study||1
8175644|NCT02406937|20158457|P1|NOT COMPLETED|Overall Study||1
8175645|NCT02406937|20158455|P3|COMPLETED|Overall Study||58
8175646|NCT02406937|20158456|P2|COMPLETED|Overall Study||59
8175647|NCT02406937|20158457|P1|COMPLETED|Overall Study||59
8175648|NCT02406937|20158455|P3|STARTED|Overall Study||60
8175649|NCT02406937|20158456|P2|STARTED|Overall Study||60
8175650|NCT02406937|20158457|P1|STARTED|Overall Study||60
8175651|NCT02406885|20158515|P2|NOT COMPLETED|Overall Study||2
8175652|NCT02406885|20158516|P1|NOT COMPLETED|Overall Study||3
8175653|NCT02406885|20158515|P2|COMPLETED|Overall Study||14
8175654|NCT02406885|20158516|P1|COMPLETED|Overall Study||14
8175655|NCT02406885|20158515|P2|STARTED|Overall Study||16
8175656|NCT02406885|20158516|P1|STARTED|Overall Study||17
8175657|NCT02406677|20158530|P2|NOT COMPLETED|Overall Study||598
8175658|NCT02406677|20158531|P1|NOT COMPLETED|Overall Study||301
8175659|NCT02406677|20158530|P2|COMPLETED|Overall Study||3967
8175660|NCT02406677|20158531|P1|COMPLETED|Overall Study||6135
8175661|NCT02406677|20158530|P2|STARTED|Overall Study||4565
8175662|NCT02406677|20158531|P1|STARTED|Overall Study||6436
8175663|NCT02406612|20158545|P2|NOT COMPLETED|Overall Study||4
8175664|NCT02406612|20158546|P1|NOT COMPLETED|Overall Study||4
8175665|NCT02406612|20158545|P2|COMPLETED|Overall Study||17
8175666|NCT02406612|20158546|P1|COMPLETED|Overall Study||22
8175667|NCT02406612|20158545|P2|STARTED|Overall Study||21
8175668|NCT02406612|20158546|P1|STARTED|Overall Study||26
8175669|NCT02406586|20158561|P3|NOT COMPLETED|Overall Study||2
8175670|NCT02406586|20158562|P2|NOT COMPLETED|Overall Study||4
8175671|NCT02406586|20158563|P1|NOT COMPLETED|Overall Study||1
8175672|NCT02406586|20158561|P3|COMPLETED|Overall Study||10
8175673|NCT02406586|20158562|P2|COMPLETED|Overall Study||8
8175674|NCT02406586|20158563|P1|COMPLETED|Overall Study||11
8175675|NCT02406586|20158561|P3|STARTED|Overall Study||12
8175676|NCT02406586|20158562|P2|STARTED|Overall Study||12
8175677|NCT02406586|20158563|P1|STARTED|Overall Study||12
8175678|NCT02406573|20158637|P1|NOT COMPLETED|Overall Study||0
8175679|NCT02406573|20158637|P1|COMPLETED|Overall Study||30
8175680|NCT02406573|20158637|P1|STARTED|Overall Study||30
8175681|NCT02406495|20158643|P1|NOT COMPLETED|Overall Study||0
8175682|NCT02406495|20158643|P1|COMPLETED|Overall Study||40
8175683|NCT02406495|20158643|P1|STARTED|Overall Study||40
8175684|NCT02406443|20158684|P2|NOT COMPLETED|Overall Study||2
8175685|NCT02406443|20158685|P1|NOT COMPLETED|Overall Study||2
8175686|NCT02406443|20158684|P2|COMPLETED|Overall Study||16
8175687|NCT02406443|20158685|P1|COMPLETED|Overall Study||16
8175688|NCT02406443|20158684|P2|STARTED|Overall Study||18
8175689|NCT02406443|20158685|P1|STARTED|Overall Study||18
8175690|NCT02406261|20158705|P2|NOT COMPLETED|Period 2||3
8175691|NCT02406261|20158706|P1|NOT COMPLETED|Period 2||0
8175692|NCT02406261|20158705|P2|COMPLETED|Period 2||29
8175693|NCT02406261|20158706|P1|COMPLETED|Period 2||0
8175694|NCT02406261|20158705|P2|STARTED|Period 2||32
8175695|NCT02406261|20158706|P1|STARTED|Period 2|Cohort A participated in Period 1 only|0
8175696|NCT02406261|20158705|P2|NOT COMPLETED|Period 1||0
8175697|NCT02406261|20158706|P1|NOT COMPLETED|Period 1||3
8175698|NCT02406261|20158705|P2|COMPLETED|Period 1||32
8175699|NCT02406261|20158706|P1|COMPLETED|Period 1||47
8175700|NCT02406261|20158705|P2|Received at Least One Dose of Study Drug|Period 1||32
8175701|NCT02406261|20158706|P1|Received at Least One Dose of Study Drug|Period 1||50
8175702|NCT02406261|20158705|P2|STARTED|Period 1||32
8175703|NCT02406261|20158706|P1|STARTED|Period 1||50
8175704|NCT02406248|20158718|P1|NOT COMPLETED|Overall Study||9
8175705|NCT02406248|20158718|P1|COMPLETED|Overall Study||99
8175706|NCT02406248|20158718|P1|STARTED|Overall Study||108
8175707|NCT02406027|20158729|P7|NOT COMPLETED|Open-label Phase (Period 2)||22
8175708|NCT02406027|20158730|P6|NOT COMPLETED|Open-label Phase (Period 2)||26
8175709|NCT02406027|20158731|P5|NOT COMPLETED|Open-label Phase (Period 2)||14
8175710|NCT02406027|20158732|P4|NOT COMPLETED|Open-label Phase (Period 2)||15
8175711|NCT02406027|20158733|P3|NOT COMPLETED|Open-label Phase (Period 2)||0
8175712|NCT02406027|20158734|P2|NOT COMPLETED|Open-label Phase (Period 2)||0
8175713|NCT02406027|20158735|P1|NOT COMPLETED|Open-label Phase (Period 2)||0
8175714|NCT02406027|20158729|P7|COMPLETED|Open-label Phase (Period 2)||0
8175715|NCT02406027|20158730|P6|COMPLETED|Open-label Phase (Period 2)||0
8175716|NCT02406027|20158731|P5|COMPLETED|Open-label Phase (Period 2)||0
8175717|NCT02406027|20158732|P4|COMPLETED|Open-label Phase (Period 2)||0
8175718|NCT02406027|20158733|P3|COMPLETED|Open-label Phase (Period 2)||0
8175719|NCT02406027|20158734|P2|COMPLETED|Open-label Phase (Period 2)||0
8175720|NCT02406027|20158735|P1|COMPLETED|Open-label Phase (Period 2)||0
8175721|NCT02406027|20158729|P7|STARTED|Open-label Phase (Period 2)||22
8175722|NCT02406027|20158730|P6|STARTED|Open-label Phase (Period 2)||26
8175723|NCT02406027|20158731|P5|STARTED|Open-label Phase (Period 2)||14
8175724|NCT02406027|20158732|P4|STARTED|Open-label Phase (Period 2)||15
8175725|NCT02406027|20158733|P3|STARTED|Open-label Phase (Period 2)||0
8175726|NCT02406027|20158734|P2|STARTED|Open-label Phase (Period 2)||0
8175727|NCT02406027|20158735|P1|STARTED|Open-label Phase (Period 2)||0
8175728|NCT02406027|20158729|P7|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175729|NCT02406027|20158730|P6|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175730|NCT02406027|20158731|P5|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175731|NCT02406027|20158732|P4|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175732|NCT02406027|20158733|P3|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
8175733|NCT02406027|20158734|P2|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
8175734|NCT02406027|20158735|P1|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
8175735|NCT02406027|20158729|P7|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175736|NCT02406027|20158730|P6|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175737|NCT02406027|20158731|P5|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175738|NCT02406027|20158732|P4|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175739|NCT02406027|20158733|P3|COMPLETED|Double-blind Treatment Phase (Period 1)||22
8175740|NCT02406027|20158734|P2|COMPLETED|Double-blind Treatment Phase (Period 1)||26
8175741|NCT02406027|20158735|P1|COMPLETED|Double-blind Treatment Phase (Period 1)||29
8175742|NCT02406027|20158729|P7|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175743|NCT02406027|20158730|P6|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175744|NCT02406027|20158731|P5|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175745|NCT02406027|20158732|P4|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175746|NCT02406027|20158733|P3|Prodromal|Double-blind Treatment Phase (Period 1)||20
8175747|NCT02406027|20158734|P2|Prodromal|Double-blind Treatment Phase (Period 1)||21
8175748|NCT02406027|20158735|P1|Prodromal|Double-blind Treatment Phase (Period 1)||29
8175749|NCT02406027|20158729|P7|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175750|NCT02406027|20158730|P6|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175751|NCT02406027|20158731|P5|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175752|NCT02406027|20158732|P4|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175753|NCT02406027|20158733|P3|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
8175754|NCT02406027|20158734|P2|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
8175755|NCT02406027|20158735|P1|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
8175756|NCT02406027|20158729|P7|STARTED|Double-blind Treatment Phase (Period 1)||0
8175757|NCT02406027|20158730|P6|STARTED|Double-blind Treatment Phase (Period 1)||0
8175758|NCT02406027|20158731|P5|STARTED|Double-blind Treatment Phase (Period 1)||0
8175759|NCT02406027|20158732|P4|STARTED|Double-blind Treatment Phase (Period 1)||0
8175760|NCT02406027|20158733|P3|STARTED|Double-blind Treatment Phase (Period 1)||26
8175761|NCT02406027|20158734|P2|STARTED|Double-blind Treatment Phase (Period 1)||29
8175762|NCT02406027|20158735|P1|STARTED|Double-blind Treatment Phase (Period 1)||35
8175763|NCT02405962|20158765|P2|NOT COMPLETED|Overall Study||5
8175764|NCT02405962|20158766|P1|NOT COMPLETED|Overall Study||1
8175765|NCT02405962|20158765|P2|COMPLETED|Overall Study||79
8175766|NCT02405962|20158766|P1|COMPLETED|Overall Study||83
8175767|NCT02405962|20158765|P2|3 Months After the Intervention|Overall Study||79
8175768|NCT02405962|20158766|P1|3 Months After the Intervention|Overall Study||80
8175769|NCT02405962|20158765|P2|Post-intervention|Overall Study||81
8175770|NCT02405962|20158766|P1|Post-intervention|Overall Study||80
8175771|NCT02405962|20158765|P2|STARTED|Overall Study||84
8175772|NCT02405962|20158766|P1|STARTED|Overall Study||84
8175773|NCT02405780|20158804|P4|NOT COMPLETED|Period II||18
8175774|NCT02405780|20158805|P3|NOT COMPLETED|Period II||12
8175775|NCT02405780|20158806|P2|NOT COMPLETED|Period II||12
8175776|NCT02405780|20158807|P1|NOT COMPLETED|Period II||15
8175777|NCT02405780|20158804|P4|COMPLETED|Period II||172
8175778|NCT02405780|20158805|P3|COMPLETED|Period II||81
8175779|NCT02405780|20158806|P2|COMPLETED|Period II||88
8175780|NCT02405780|20158807|P1|COMPLETED|Period II||174
8175781|NCT02405780|20158804|P4|STARTED|Period II||190
8175782|NCT02405780|20158805|P3|STARTED|Period II||93
8175783|NCT02405780|20158806|P2|STARTED|Period II||100
8175784|NCT02405780|20158807|P1|STARTED|Period II||189
8175785|NCT02405780|20158804|P4|NOT COMPLETED|Period I||23
8175786|NCT02405780|20158805|P3|NOT COMPLETED|Period I||15
8175787|NCT02405780|20158806|P2|NOT COMPLETED|Period I||8
8175788|NCT02405780|20158807|P1|NOT COMPLETED|Period I||27
8175789|NCT02405780|20158804|P4|COMPLETED|Period I||190
8175790|NCT02405780|20158805|P3|COMPLETED|Period I||93
8175791|NCT02405780|20158806|P2|COMPLETED|Period I||100
8175792|NCT02405780|20158807|P1|COMPLETED|Period I||189
8175793|NCT02405780|20158804|P4|STARTED|Period I||213
8175794|NCT02405780|20158805|P3|STARTED|Period I||108
8175795|NCT02405780|20158806|P2|STARTED|Period I||108
8175796|NCT02405780|20158807|P1|STARTED|Period I||216
8175797|NCT02405442|20158870|P4|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8175798|NCT02405442|20158871|P3|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8175799|NCT02405442|20158872|P2|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8175800|NCT02405442|20158873|P1|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
8175801|NCT02405442|20158870|P4|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175802|NCT02405442|20158871|P3|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175803|NCT02405442|20158872|P2|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175804|NCT02405442|20158873|P1|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175805|NCT02405442|20158870|P4|STARTED|Extended Treatment Phase(up to Week 208)||2
8175806|NCT02405442|20158871|P3|STARTED|Extended Treatment Phase(up to Week 208)||2
8175807|NCT02405442|20158872|P2|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
8175808|NCT02405442|20158873|P1|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
8175809|NCT02405442|20158870|P4|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
8175810|NCT02405442|20158871|P3|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
8175811|NCT02405442|20158872|P2|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
8175812|NCT02405442|20158873|P1|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
8175813|NCT02405442|20158870|P4|COMPLETED|Open-Label Phase (up to Week 52)||2
8175814|NCT02405442|20158871|P3|COMPLETED|Open-Label Phase (up to Week 52)||2
8175815|NCT02405442|20158872|P2|COMPLETED|Open-Label Phase (up to Week 52)||3
8175816|NCT02405442|20158873|P1|COMPLETED|Open-Label Phase (up to Week 52)||4
8175817|NCT02405442|20158870|P4|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
8175818|NCT02405442|20158871|P3|STARTED|Open-Label Phase (up to Week 52)||47
8175819|NCT02405442|20158872|P2|STARTED|Open-Label Phase (up to Week 52)||48
8175820|NCT02405442|20158873|P1|STARTED|Open-Label Phase (up to Week 52)||52
8175821|NCT02405442|20158870|P4|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
8175822|NCT02405442|20158871|P3|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
8175823|NCT02405442|20158872|P2|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
8175824|NCT02405442|20158873|P1|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
8175825|NCT02405442|20158870|P4|COMPLETED|Double-Blind Phase (up to Week 8)||27
8175826|NCT02405442|20158871|P3|COMPLETED|Double-Blind Phase (up to Week 8)||47
8175827|NCT02405442|20158872|P2|COMPLETED|Double-Blind Phase (up to Week 8)||48
8175828|NCT02405442|20158873|P1|COMPLETED|Double-Blind Phase (up to Week 8)||52
8175829|NCT02405442|20158870|P4|STARTED|Double-Blind Phase (up to Week 8)||28
8175830|NCT02405442|20158871|P3|STARTED|Double-Blind Phase (up to Week 8)||53
8175831|NCT02405442|20158872|P2|STARTED|Double-Blind Phase (up to Week 8)||53
8175832|NCT02405442|20158873|P1|STARTED|Double-Blind Phase (up to Week 8)||53
8175833|NCT02405429|20158899|P1|NOT COMPLETED|Overall Study||0
8175834|NCT02405429|20158899|P1|COMPLETED|Overall Study||49
8175835|NCT02405429|20158899|P1|STARTED|Overall Study||49
8175836|NCT02405390|20158909|P2|NOT COMPLETED|Overall Study||0
8175837|NCT02405390|20158910|P1|NOT COMPLETED|Overall Study||0
8175838|NCT02405390|20158909|P2|COMPLETED|Overall Study||46
8175839|NCT02405390|20158910|P1|COMPLETED|Overall Study||46
8175840|NCT02405390|20158909|P2|STARTED|Overall Study||46
8175841|NCT02405390|20158910|P1|STARTED|Overall Study||46
8175842|NCT02405195|20158918|P1|NOT COMPLETED|Overall Study||0
8175843|NCT02405195|20158918|P1|COMPLETED|Overall Study||18
8175844|NCT02405195|20158918|P1|STARTED|Overall Study||18
8175845|NCT02405091|20158927|P3|NOT COMPLETED|Overall Study||2
8175846|NCT02405091|20158928|P2|NOT COMPLETED|Overall Study||33
8175847|NCT02405091|20158929|P1|NOT COMPLETED|Overall Study||29
8175848|NCT02405091|20158927|P3|COMPLETED|Overall Study||9
8175849|NCT02405091|20158928|P2|COMPLETED|Overall Study||74
8175850|NCT02405091|20158929|P1|COMPLETED|Overall Study||20
8175851|NCT02405091|20158927|P3|STARTED|Overall Study||11
8175852|NCT02405091|20158928|P2|STARTED|Overall Study||107
8175853|NCT02405091|20158929|P1|STARTED|Overall Study||49
8175854|NCT02404792|20158952|P2|NOT COMPLETED|Overall Study||8
8175855|NCT02404792|20158953|P1|NOT COMPLETED|Overall Study||5
8175856|NCT02404792|20158952|P2|COMPLETED|Overall Study||29
8175857|NCT02404792|20158953|P1|COMPLETED|Overall Study||27
8175858|NCT02404792|20158952|P2|STARTED|Overall Study||37
8175859|NCT02404792|20158953|P1|STARTED|Overall Study||32
8175860|NCT02404649|20158965|P2|NOT COMPLETED|Overall Study||2
8175861|NCT02404649|20158966|P1|NOT COMPLETED|Overall Study||1
8175862|NCT02404649|20158965|P2|COMPLETED|Overall Study||14
8175863|NCT02404649|20158966|P1|COMPLETED|Overall Study||16
8175864|NCT02404649|20158965|P2|STARTED|Overall Study||16
8175865|NCT02404649|20158966|P1|STARTED|Overall Study||17
8175866|NCT02404610|20158976|P2|NOT COMPLETED|Overall Study||0
8175867|NCT02404610|20158977|P1|NOT COMPLETED|Overall Study||0
8175868|NCT02404610|20158976|P2|COMPLETED|Overall Study||53
8175869|NCT02404610|20158977|P1|COMPLETED|Overall Study||54
8175870|NCT02404610|20158976|P2|STARTED|Overall Study||53
8175871|NCT02404610|20158977|P1|STARTED|Overall Study||54
8175872|NCT02404545|20158985|P2|NOT COMPLETED|Overall Study||6
8175873|NCT02404545|20158986|P1|NOT COMPLETED|Overall Study||6
8175874|NCT02404545|20158985|P2|COMPLETED|Overall Study||0
8175875|NCT02404545|20158986|P1|COMPLETED|Overall Study||0
8175876|NCT02404545|20158985|P2|STARTED|Overall Study||6
8175877|NCT02404545|20158986|P1|STARTED|Overall Study||6
8175878|NCT02404532|20158993|P1|NOT COMPLETED|Overall Study||0
8175879|NCT02404532|20158993|P1|COMPLETED|Overall Study||29
8175880|NCT02404532|20158993|P1|STARTED|Overall Study||29
8175881|NCT02404493|20159005|P2|NOT COMPLETED|Overall Study||1
8175882|NCT02404493|20159006|P1|NOT COMPLETED|Overall Study||1
8175883|NCT02404493|20159005|P2|COMPLETED|Overall Study||5
8175884|NCT02404493|20159006|P1|COMPLETED|Overall Study||16
8175885|NCT02404493|20159005|P2|STARTED|Overall Study||6
8175886|NCT02404493|20159006|P1|STARTED|Overall Study||17
8175887|NCT02404389|20159251|P5|NOT COMPLETED|Overall Study||3
8175888|NCT02404389|20159252|P4|NOT COMPLETED|Overall Study||1
8175889|NCT02404389|20159253|P3|NOT COMPLETED|Overall Study||1
8175890|NCT02404389|20159254|P2|NOT COMPLETED|Overall Study||0
8175891|NCT02404389|20159255|P1|NOT COMPLETED|Overall Study||2
8175892|NCT02404389|20159251|P5|COMPLETED|Overall Study||18
8175893|NCT02404389|20159252|P4|COMPLETED|Overall Study||9
8175894|NCT02404389|20159253|P3|COMPLETED|Overall Study||10
8175895|NCT02404389|20159254|P2|COMPLETED|Overall Study||20
8175896|NCT02404389|20159255|P1|COMPLETED|Overall Study||18
8175897|NCT02404389|20159251|P5|STARTED|Overall Study||21
8175898|NCT02404389|20159252|P4|STARTED|Overall Study||10
8175899|NCT02404389|20159253|P3|STARTED|Overall Study||11
8175900|NCT02404389|20159254|P2|STARTED|Overall Study||20
8175901|NCT02404389|20159255|P1|STARTED|Overall Study||20
8175902|NCT02404350|20159295|P4|NOT COMPLETED|Overall Study||37
8175903|NCT02404350|20159296|P3|NOT COMPLETED|Overall Study||6
8175904|NCT02404350|20159297|P2|NOT COMPLETED|Overall Study||6
8175905|NCT02404350|20159298|P1|NOT COMPLETED|Overall Study||15
8175906|NCT02404350|20159295|P4|COMPLETED|Overall Study||295
8175907|NCT02404350|20159296|P3|COMPLETED|Overall Study||216
8175908|NCT02404350|20159297|P2|COMPLETED|Overall Study||214
8175909|NCT02404350|20159298|P1|COMPLETED|Overall Study||207
8175910|NCT02404350|20159295|P4|STARTED|Overall Study||332
8175911|NCT02404350|20159296|P3|STARTED|Overall Study||222
8175912|NCT02404350|20159297|P2|STARTED|Overall Study||220
8175913|NCT02404350|20159298|P1|STARTED|Overall Study||222
8175914|NCT02404311|20159346|P5|NOT COMPLETED|Part B: Month 30-36||0
8175915|NCT02404311|20159347|P4|NOT COMPLETED|Part B: Month 30-36||0
8175916|NCT02404311|20159348|P3|NOT COMPLETED|Part B: Month 30-36||0
8175917|NCT02404311|20159349|P2|NOT COMPLETED|Part B: Month 30-36||0
8175918|NCT02404311|20159350|P1|NOT COMPLETED|Part B: Month 30-36||0
8175919|NCT02404311|20159346|P5|COMPLETED|Part B: Month 30-36||7
8175920|NCT02404311|20159347|P4|COMPLETED|Part B: Month 30-36||31
8175921|NCT02404311|20159348|P3|COMPLETED|Part B: Month 30-36||32
8175922|NCT02404311|20159349|P2|COMPLETED|Part B: Month 30-36||0
8175923|NCT02404311|20159350|P1|COMPLETED|Part B: Month 30-36||0
8175924|NCT02404311|20159346|P5|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
8175925|NCT02404311|20159347|P4|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
8176110|NCT02402933|20159839|P1|COMPLETED|Overall Study||12
8175926|NCT02404311|20159348|P3|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
8175927|NCT02404311|20159349|P2|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
8175928|NCT02404311|20159350|P1|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
8175929|NCT02404311|20159346|P5|STARTED|Part B: Month 30-36||7
8175930|NCT02404311|20159347|P4|STARTED|Part B: Month 30-36||31
8175931|NCT02404311|20159348|P3|STARTED|Part B: Month 30-36||32
8175932|NCT02404311|20159349|P2|STARTED|Part B: Month 30-36||0
8175933|NCT02404311|20159350|P1|STARTED|Part B: Month 30-36||0
8175934|NCT02404311|20159346|P5|NOT COMPLETED|Part A: Month 0-18||0
8175935|NCT02404311|20159347|P4|NOT COMPLETED|Part A: Month 0-18||0
8175936|NCT02404311|20159348|P3|NOT COMPLETED|Part A: Month 0-18||0
8175937|NCT02404311|20159349|P2|NOT COMPLETED|Part A: Month 0-18||6
8175938|NCT02404311|20159350|P1|NOT COMPLETED|Part A: Month 0-18||26
8175939|NCT02404311|20159346|P5|COMPLETED|Part A: Month 0-18||0
8175940|NCT02404311|20159347|P4|COMPLETED|Part A: Month 0-18||0
8175941|NCT02404311|20159348|P3|COMPLETED|Part A: Month 0-18||0
8175942|NCT02404311|20159349|P2|COMPLETED|Part A: Month 0-18||36
8175943|NCT02404311|20159350|P1|COMPLETED|Part A: Month 0-18||184
8175944|NCT02404311|20159346|P5|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175945|NCT02404311|20159347|P4|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175946|NCT02404311|20159348|P3|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175947|NCT02404311|20159349|P2|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
8175948|NCT02404311|20159350|P1|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
8175949|NCT02404311|20159346|P5|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175950|NCT02404311|20159347|P4|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175951|NCT02404311|20159348|P3|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175952|NCT02404311|20159349|P2|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
8175953|NCT02404311|20159350|P1|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
8175954|NCT02404311|20159346|P5|Per Protocol|Part A: Month 0-18||0
8175955|NCT02404311|20159347|P4|Per Protocol|Part A: Month 0-18||0
8175956|NCT02404311|20159348|P3|Per Protocol|Part A: Month 0-18||0
8175957|NCT02404311|20159349|P2|Per Protocol|Part A: Month 0-18||37
8175958|NCT02404311|20159350|P1|Per Protocol|Part A: Month 0-18||185
8175959|NCT02404311|20159346|P5|STARTED|Part A: Month 0-18||0
8175960|NCT02404311|20159347|P4|STARTED|Part A: Month 0-18||0
8175961|NCT02404311|20159348|P3|STARTED|Part A: Month 0-18||0
8175962|NCT02404311|20159349|P2|STARTED|Part A: Month 0-18||42
8175963|NCT02404311|20159350|P1|STARTED|Part A: Month 0-18||210
8175964|NCT02404285|20159454|P2|NOT COMPLETED|Overall Study||2
8175965|NCT02404285|20159455|P1|NOT COMPLETED|Overall Study||2
8175966|NCT02404285|20159454|P2|COMPLETED|Overall Study||33
8175967|NCT02404285|20159455|P1|COMPLETED|Overall Study||31
8175968|NCT02404285|20159454|P2|STARTED|Overall Study||35
8175969|NCT02404285|20159455|P1|STARTED|Overall Study||33
8175970|NCT02404220|20159491|P4|NOT COMPLETED|Overall Study||10
8175971|NCT02404220|20159492|P3|NOT COMPLETED|Overall Study||7
8175972|NCT02404220|20159493|P2|NOT COMPLETED|Overall Study||8
8175973|NCT02404220|20159494|P1|NOT COMPLETED|Overall Study||5
8175974|NCT02404220|20159491|P4|COMPLETED|Overall Study||0
8175975|NCT02404220|20159492|P3|COMPLETED|Overall Study||0
8175976|NCT02404220|20159493|P2|COMPLETED|Overall Study||0
8175977|NCT02404220|20159494|P1|COMPLETED|Overall Study||0
8175978|NCT02404220|20159491|P4|STARTED|Overall Study||10
8175979|NCT02404220|20159492|P3|STARTED|Overall Study||7
8175980|NCT02404220|20159493|P2|STARTED|Overall Study||8
8175981|NCT02404220|20159494|P1|STARTED|Overall Study||5
8175982|NCT02404168|20159520|P1|NOT COMPLETED|Overall Study||0
8175983|NCT02404168|20159520|P1|COMPLETED|Overall Study||4
8175984|NCT02404168|20159520|P1|STARTED|Overall Study||4
8175985|NCT02404103|20159530|P2|NOT COMPLETED|Overall Study||3
8175986|NCT02404103|20159531|P1|NOT COMPLETED|Overall Study||4
8175987|NCT02404103|20159530|P2|COMPLETED|Overall Study||9
8175988|NCT02404103|20159531|P1|COMPLETED|Overall Study||10
8175989|NCT02404103|20159530|P2|STARTED|Overall Study||12
8175990|NCT02404103|20159531|P1|STARTED|Overall Study||14
8175991|NCT02404025|20159551|P1|NOT COMPLETED|Overall Study||4
8175992|NCT02404025|20159551|P1|COMPLETED|Overall Study||6
8175993|NCT02404025|20159551|P1|STARTED|Overall Study||10
8175994|NCT02403999|20159583|P3|NOT COMPLETED|Overall Study||0
8175995|NCT02403999|20159584|P2|NOT COMPLETED|Overall Study||0
8175996|NCT02403999|20159585|P1|NOT COMPLETED|Overall Study||0
8175997|NCT02403999|20159583|P3|COMPLETED|Overall Study||11
8175998|NCT02403999|20159584|P2|COMPLETED|Overall Study||10
8175999|NCT02403999|20159585|P1|COMPLETED|Overall Study||10
8176000|NCT02403999|20159583|P3|STARTED|Overall Study||11
8176001|NCT02403999|20159584|P2|STARTED|Overall Study||10
8176002|NCT02403999|20159585|P1|STARTED|Overall Study||10
8176003|NCT02403986|20159598|P2|NOT COMPLETED|Overall Study||4
8176004|NCT02403986|20159599|P1|NOT COMPLETED|Overall Study||5
8176005|NCT02403986|20159598|P2|COMPLETED|Overall Study||23
8176006|NCT02403986|20159599|P1|COMPLETED|Overall Study||21
8176007|NCT02403986|20159598|P2|STARTED|Overall Study||27
8176008|NCT02403986|20159599|P1|STARTED|Overall Study||26
8176009|NCT02403895|20159607|P1|NOT COMPLETED|Overall Study||0
8176010|NCT02403895|20159607|P1|COMPLETED|Overall Study||11
8176011|NCT02403895|20159607|P1|STARTED|Overall Study||11
8176012|NCT02403830|20159620|P2|NOT COMPLETED|Visit 2||0
8176013|NCT02403830|20159621|P1|NOT COMPLETED|Visit 2||0
8176014|NCT02403830|20159620|P2|COMPLETED|Visit 2||15
8176015|NCT02403830|20159621|P1|COMPLETED|Visit 2||14
8176016|NCT02403830|20159620|P2|STARTED|Visit 2||15
8176017|NCT02403830|20159621|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
8176018|NCT02403830|20159620|P2|NOT COMPLETED|Visit 1||0
8176019|NCT02403830|20159621|P1|NOT COMPLETED|Visit 1||0
8176020|NCT02403830|20159620|P2|COMPLETED|Visit 1||15
8176021|NCT02403830|20159621|P1|COMPLETED|Visit 1||15
8176022|NCT02403830|20159620|P2|STARTED|Visit 1||15
8176023|NCT02403830|20159621|P1|STARTED|Visit 1||15
8176024|NCT02403817|20159633|P2|NOT COMPLETED|Overall Study||0
8176025|NCT02403817|20159634|P1|NOT COMPLETED|Overall Study||5
8176026|NCT02403817|20159633|P2|COMPLETED|Overall Study||2
8176027|NCT02403817|20159634|P1|COMPLETED|Overall Study||23
8176028|NCT02403817|20159633|P2|STARTED|Overall Study||2
8176029|NCT02403817|20159634|P1|STARTED|Overall Study||28
8176030|NCT02403778|20159648|P2|NOT COMPLETED|Overall Study||0
8176031|NCT02403778|20159649|P1|NOT COMPLETED|Overall Study||0
8176032|NCT02403778|20159648|P2|COMPLETED|Overall Study||4
8176033|NCT02403778|20159649|P1|COMPLETED|Overall Study||6
8176034|NCT02403778|20159648|P2|STARTED|Overall Study||4
8176035|NCT02403778|20159649|P1|STARTED|Overall Study||6
8176036|NCT02403674|20159665|P2|NOT COMPLETED|Overall Study||63
8176037|NCT02403674|20159666|P1|NOT COMPLETED|Overall Study||55
8176038|NCT02403674|20159665|P2|COMPLETED|Overall Study||303
8176039|NCT02403674|20159666|P1|COMPLETED|Overall Study||313
8176040|NCT02403674|20159665|P2|Treated|Overall Study||364
8176041|NCT02403674|20159666|P1|Treated|Overall Study||364
8176042|NCT02403674|20159665|P2|STARTED|Overall Study||366
8176043|NCT02403674|20159666|P1|STARTED|Overall Study||368
8176044|NCT02403635|20159705|P1|NOT COMPLETED|Overall Study||9
8176045|NCT02403635|20159705|P1|COMPLETED|Overall Study||18
8176046|NCT02403635|20159705|P1|Received the First Dose|Overall Study||18
8176047|NCT02403635|20159705|P1|Screening (28 Days)|Overall Study||27
8176048|NCT02403635|20159705|P1|STARTED|Overall Study||27
8176049|NCT02403479|20159773|P2|NOT COMPLETED|Overall Study||0
8176050|NCT02403479|20159774|P1|NOT COMPLETED|Overall Study||2
8176051|NCT02403479|20159773|P2|COMPLETED|Overall Study||12
8176052|NCT02403479|20159774|P1|COMPLETED|Overall Study||8
8176053|NCT02403479|20159773|P2|STARTED|Overall Study||12
8176054|NCT02403479|20159774|P1|STARTED|Overall Study||10
8176055|NCT02403271|20159782|P2|NOT COMPLETED|Period 2||124
8176056|NCT02403271|20159783|P1|NOT COMPLETED|Period 2||0
8176057|NCT02403271|20159782|P2|COMPLETED|Period 2||0
8176058|NCT02403271|20159783|P1|COMPLETED|Period 2||0
8176059|NCT02403271|20159782|P2|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
8176060|NCT02403271|20159783|P1|STARTED|Period 2||0
8176061|NCT02403271|20159782|P2|NOT COMPLETED|Period 1||0
8176062|NCT02403271|20159783|P1|NOT COMPLETED|Period 1||1
8176063|NCT02403271|20159782|P2|COMPLETED|Period 1||0
8176064|NCT02403271|20159783|P1|COMPLETED|Period 1||6
8176065|NCT02403271|20159782|P2|STARTED|Period 1||0
8176066|NCT02403271|20159783|P1|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
8176067|NCT02403206|20159797|P2|NOT COMPLETED|Overall Study||10
8176068|NCT02403206|20159798|P1|NOT COMPLETED|Overall Study||11
8176069|NCT02403206|20159797|P2|COMPLETED|Overall Study||186
8176070|NCT02403206|20159798|P1|COMPLETED|Overall Study||183
8176071|NCT02403206|20159797|P2|Randomized and Treated|Overall Study||190
8176072|NCT02403206|20159798|P1|Randomized and Treated|Overall Study||188
8176073|NCT02403206|20159797|P2|Treated Prior to Randomization|Overall Study||1
8176074|NCT02403206|20159798|P1|Treated Prior to Randomization|Overall Study||0
8176075|NCT02403206|20159797|P2|STARTED|Overall Study||196
8176076|NCT02403206|20159798|P1|STARTED|Overall Study||194
8176077|NCT02403180|20159809|P2|NOT COMPLETED|Period 2 (5 Days)||1
8176078|NCT02403180|20159810|P1|NOT COMPLETED|Period 2 (5 Days)||0
8176079|NCT02403180|20159809|P2|COMPLETED|Period 2 (5 Days)||32
8176080|NCT02403180|20159810|P1|COMPLETED|Period 2 (5 Days)||36
8176081|NCT02403180|20159809|P2|STARTED|Period 2 (5 Days)||33
8176082|NCT02403180|20159810|P1|STARTED|Period 2 (5 Days)||36
8176083|NCT02403180|20159809|P2|NOT COMPLETED|Period 1 (5 Days)||0
8176084|NCT02403180|20159810|P1|NOT COMPLETED|Period 1 (5 Days)||0
8176085|NCT02403180|20159809|P2|COMPLETED|Period 1 (5 Days)||33
8176086|NCT02403180|20159810|P1|COMPLETED|Period 1 (5 Days)||36
8176087|NCT02403180|20159809|P2|Randomized|Period 1 (5 Days)||33
8176088|NCT02403180|20159810|P1|Randomized|Period 1 (5 Days)||36
8176089|NCT02403180|20159809|P2|STARTED|Period 1 (5 Days)||33
8176090|NCT02403180|20159810|P1|STARTED|Period 1 (5 Days)||36
8176091|NCT02403180|20159809|P2|NOT COMPLETED|Pre-Treatment Period||1
8176092|NCT02403180|20159810|P1|NOT COMPLETED|Pre-Treatment Period||0
8176093|NCT02403180|20159809|P2|COMPLETED|Pre-Treatment Period||33
8176094|NCT02403180|20159810|P1|COMPLETED|Pre-Treatment Period||36
8176095|NCT02403180|20159809|P2|STARTED|Pre-Treatment Period||34
8176096|NCT02403180|20159810|P1|STARTED|Pre-Treatment Period||36
8176097|NCT02403154|20159822|P4|NOT COMPLETED|Overall Study||1
8176098|NCT02403154|20159823|P3|NOT COMPLETED|Overall Study||1
8176099|NCT02403154|20159824|P2|NOT COMPLETED|Overall Study||0
8176100|NCT02403154|20159825|P1|NOT COMPLETED|Overall Study||2
8176101|NCT02403154|20159822|P4|COMPLETED|Overall Study||0
8176102|NCT02403154|20159823|P3|COMPLETED|Overall Study||0
8176103|NCT02403154|20159824|P2|COMPLETED|Overall Study||0
8176104|NCT02403154|20159825|P1|COMPLETED|Overall Study||0
8176105|NCT02403154|20159822|P4|STARTED|Overall Study||1
8176106|NCT02403154|20159823|P3|STARTED|Overall Study||1
8176107|NCT02403154|20159824|P2|STARTED|Overall Study||0
8176108|NCT02403154|20159825|P1|STARTED|Overall Study||2
8176109|NCT02402933|20159839|P1|NOT COMPLETED|Overall Study||14
8176111|NCT02402933|20159839|P1|Received at Least One Dose of Study Drug|Overall Study||22
8176112|NCT02402933|20159839|P1|STARTED|Overall Study||26
8176113|NCT02402907|20159848|P2|NOT COMPLETED|Overall Study||27
8176114|NCT02402907|20159849|P1|NOT COMPLETED|Overall Study||20
8176115|NCT02402907|20159848|P2|COMPLETED|Overall Study||647
8176116|NCT02402907|20159849|P1|COMPLETED|Overall Study||662
8176117|NCT02402907|20159848|P2|STARTED|Overall Study||674
8176118|NCT02402907|20159849|P1|STARTED|Overall Study||682
8176119|NCT02402881|20159869|P2|NOT COMPLETED|Post-Intervention Study Period||0
8176120|NCT02402881|20159870|P1|NOT COMPLETED|Post-Intervention Study Period||0
8176121|NCT02402881|20159869|P2|COMPLETED|Post-Intervention Study Period||8662
8176122|NCT02402881|20159870|P1|COMPLETED|Post-Intervention Study Period||3111
8176123|NCT02402881|20159869|P2|STARTED|Post-Intervention Study Period||8662
8176124|NCT02402881|20159870|P1|STARTED|Post-Intervention Study Period||3111
8176125|NCT02402881|20159869|P2|NOT COMPLETED|Pre-Intervention Study Period||0
8176126|NCT02402881|20159870|P1|NOT COMPLETED|Pre-Intervention Study Period||0
8176127|NCT02402881|20159869|P2|COMPLETED|Pre-Intervention Study Period||5657
8176128|NCT02402881|20159870|P1|COMPLETED|Pre-Intervention Study Period||2222
8176129|NCT02402881|20159869|P2|STARTED|Pre-Intervention Study Period||5657
8176130|NCT02402881|20159870|P1|STARTED|Pre-Intervention Study Period||2222
8176131|NCT02402764|20159878|P1|NOT COMPLETED|Overall Study||0
8176132|NCT02402764|20159878|P1|COMPLETED|Overall Study||10
8176133|NCT02402764|20159878|P1|STARTED|Overall Study||10
8176134|NCT02402452|20159888|P2|NOT COMPLETED|Overall Study||0
8176135|NCT02402452|20159889|P1|NOT COMPLETED|Overall Study||0
8176136|NCT02402452|20159888|P2|COMPLETED|Overall Study||10
8176137|NCT02402452|20159889|P1|COMPLETED|Overall Study||10
8176138|NCT02402452|20159888|P2|STARTED|Overall Study||10
8176139|NCT02402452|20159889|P1|STARTED|Overall Study||10
8176140|NCT02402322|20159904|P3|NOT COMPLETED|Follow-up||24
8176141|NCT02402322|20159905|P2|NOT COMPLETED|Follow-up||3
8176142|NCT02402322|20159906|P1|NOT COMPLETED|Follow-up||6
8176143|NCT02402322|20159904|P3|COMPLETED|Follow-up||0
8176144|NCT02402322|20159905|P2|COMPLETED|Follow-up||21
8176145|NCT02402322|20159906|P1|COMPLETED|Follow-up||18
8176146|NCT02402322|20159904|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
8176147|NCT02402322|20159905|P2|STARTED|Follow-up||24
8176148|NCT02402322|20159906|P1|STARTED|Follow-up||24
8176149|NCT02402322|20159904|P3|NOT COMPLETED|Pretreatment||1
8176150|NCT02402322|20159905|P2|NOT COMPLETED|Pretreatment||1
8176151|NCT02402322|20159906|P1|NOT COMPLETED|Pretreatment||3
8176152|NCT02402322|20159904|P3|COMPLETED|Pretreatment||24
8176153|NCT02402322|20159905|P2|COMPLETED|Pretreatment||24
8176154|NCT02402322|20159906|P1|COMPLETED|Pretreatment||24
8176155|NCT02402322|20159904|P3|Posttreatment Measures|Pretreatment||24
8176156|NCT02402322|20159905|P2|Posttreatment Measures|Pretreatment||24
8176157|NCT02402322|20159906|P1|Posttreatment Measures|Pretreatment||24
8176158|NCT02402322|20159904|P3|STARTED|Pretreatment||25
8176159|NCT02402322|20159905|P2|STARTED|Pretreatment||25
8176160|NCT02402322|20159906|P1|STARTED|Pretreatment||27
8176161|NCT02402296|20159940|P2|NOT COMPLETED|Overall Study||0
8176162|NCT02402296|20159941|P1|NOT COMPLETED|Overall Study||0
8176163|NCT02402296|20159940|P2|COMPLETED|Overall Study||15
8176164|NCT02402296|20159941|P1|COMPLETED|Overall Study||15
8176165|NCT02402296|20159940|P2|STARTED|Overall Study||15
8176166|NCT02402296|20159941|P1|STARTED|Overall Study||15
8176167|NCT02402218|20159956|P3|NOT COMPLETED|Overall Study||17
8176168|NCT02402218|20159957|P2|NOT COMPLETED|Overall Study||13
8176169|NCT02402218|20159958|P1|NOT COMPLETED|Overall Study||14
8176170|NCT02402218|20159956|P3|COMPLETED|Overall Study||37
8176171|NCT02402218|20159957|P2|COMPLETED|Overall Study||41
8176172|NCT02402218|20159958|P1|COMPLETED|Overall Study||22
8176173|NCT02402218|20159956|P3|Achieved Sustained Virologic Response|Overall Study||37
8176174|NCT02402218|20159957|P2|Achieved Sustained Virologic Response|Overall Study||41
8176175|NCT02402218|20159958|P1|Achieved Sustained Virologic Response|Overall Study||22
8176176|NCT02402218|20159956|P3|Completed Treatment With LDV/SOF|Overall Study||39
8176177|NCT02402218|20159957|P2|Completed Treatment With LDV/SOF|Overall Study||42
8176178|NCT02402218|20159958|P1|Completed Treatment With LDV/SOF|Overall Study||23
8176179|NCT02402218|20159956|P3|Initiated Treatment With LDV/SOF|Overall Study||41
8176180|NCT02402218|20159957|P2|Initiated Treatment With LDV/SOF|Overall Study||45
8176181|NCT02402218|20159958|P1|Initiated Treatment With LDV/SOF|Overall Study||24
8176182|NCT02402218|20159956|P3|STARTED|Overall Study||54
8176183|NCT02402218|20159957|P2|STARTED|Overall Study||54
8176184|NCT02402218|20159958|P1|STARTED|Overall Study||36
8176185|NCT02402166|20159981|P1|NOT COMPLETED|Overall Study||5
8176186|NCT02402166|20159981|P1|COMPLETED|Overall Study||19
8176187|NCT02402166|20159981|P1|STARTED|Overall Study||24
8176188|NCT02402153|20160002|P1|NOT COMPLETED|Overall Study||0
8176189|NCT02402153|20160002|P1|COMPLETED|Overall Study||18
8176190|NCT02402153|20160002|P1|STARTED|Overall Study||18
8176191|NCT02402127|20160018|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
8176192|NCT02402127|20160019|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
8176193|NCT02402127|20160020|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
8176194|NCT02402127|20160021|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
8176195|NCT02402127|20160022|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
8176196|NCT02402127|20160023|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
8176197|NCT02402127|20160018|P6|COMPLETED|Third Wear Period (1 Day)||4
8176198|NCT02402127|20160019|P5|COMPLETED|Third Wear Period (1 Day)||4
8176199|NCT02402127|20160020|P4|COMPLETED|Third Wear Period (1 Day)||4
8176200|NCT02402127|20160021|P3|COMPLETED|Third Wear Period (1 Day)||4
8176201|NCT02402127|20160022|P2|COMPLETED|Third Wear Period (1 Day)||4
8176202|NCT02402127|20160023|P1|COMPLETED|Third Wear Period (1 Day)||4
8176203|NCT02402127|20160018|P6|STARTED|Third Wear Period (1 Day)||4
8176204|NCT02402127|20160019|P5|STARTED|Third Wear Period (1 Day)||4
8176205|NCT02402127|20160020|P4|STARTED|Third Wear Period (1 Day)||4
8176206|NCT02402127|20160021|P3|STARTED|Third Wear Period (1 Day)||4
8176207|NCT02402127|20160022|P2|STARTED|Third Wear Period (1 Day)||4
8176208|NCT02402127|20160023|P1|STARTED|Third Wear Period (1 Day)||4
8176209|NCT02402127|20160018|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
8176210|NCT02402127|20160019|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
8176211|NCT02402127|20160020|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
8176212|NCT02402127|20160021|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
8176213|NCT02402127|20160022|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
8176214|NCT02402127|20160023|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
8176215|NCT02402127|20160018|P6|COMPLETED|Second Wear Period (1 Day)||4
8176216|NCT02402127|20160019|P5|COMPLETED|Second Wear Period (1 Day)||4
8176217|NCT02402127|20160020|P4|COMPLETED|Second Wear Period (1 Day)||4
8176218|NCT02402127|20160021|P3|COMPLETED|Second Wear Period (1 Day)||4
8176219|NCT02402127|20160022|P2|COMPLETED|Second Wear Period (1 Day)||4
8176220|NCT02402127|20160023|P1|COMPLETED|Second Wear Period (1 Day)||4
8176221|NCT02402127|20160018|P6|STARTED|Second Wear Period (1 Day)||4
8176222|NCT02402127|20160019|P5|STARTED|Second Wear Period (1 Day)||4
8176223|NCT02402127|20160020|P4|STARTED|Second Wear Period (1 Day)||4
8176224|NCT02402127|20160021|P3|STARTED|Second Wear Period (1 Day)||4
8176225|NCT02402127|20160022|P2|STARTED|Second Wear Period (1 Day)||4
8176226|NCT02402127|20160023|P1|STARTED|Second Wear Period (1 Day)||4
8176227|NCT02402127|20160018|P6|NOT COMPLETED|First Wear Period (1 Day)||0
8176228|NCT02402127|20160019|P5|NOT COMPLETED|First Wear Period (1 Day)||0
8176229|NCT02402127|20160020|P4|NOT COMPLETED|First Wear Period (1 Day)||0
8176230|NCT02402127|20160021|P3|NOT COMPLETED|First Wear Period (1 Day)||0
8176231|NCT02402127|20160022|P2|NOT COMPLETED|First Wear Period (1 Day)||0
8176232|NCT02402127|20160023|P1|NOT COMPLETED|First Wear Period (1 Day)||0
8176233|NCT02402127|20160018|P6|COMPLETED|First Wear Period (1 Day)||4
8176234|NCT02402127|20160019|P5|COMPLETED|First Wear Period (1 Day)||4
8176235|NCT02402127|20160020|P4|COMPLETED|First Wear Period (1 Day)||4
8176236|NCT02402127|20160021|P3|COMPLETED|First Wear Period (1 Day)||4
8176237|NCT02402127|20160022|P2|COMPLETED|First Wear Period (1 Day)||4
8176238|NCT02402127|20160023|P1|COMPLETED|First Wear Period (1 Day)||4
8176239|NCT02402127|20160018|P6|Randomized and Treated|First Wear Period (1 Day)||4
8176240|NCT02402127|20160019|P5|Randomized and Treated|First Wear Period (1 Day)||4
8176241|NCT02402127|20160020|P4|Randomized and Treated|First Wear Period (1 Day)||4
8176242|NCT02402127|20160021|P3|Randomized and Treated|First Wear Period (1 Day)||4
8176243|NCT02402127|20160022|P2|Randomized and Treated|First Wear Period (1 Day)||4
8176244|NCT02402127|20160023|P1|Randomized and Treated|First Wear Period (1 Day)||4
8176245|NCT02402127|20160018|P6|STARTED|First Wear Period (1 Day)||4
8176246|NCT02402127|20160019|P5|STARTED|First Wear Period (1 Day)||4
8176247|NCT02402127|20160020|P4|STARTED|First Wear Period (1 Day)||4
8176248|NCT02402127|20160021|P3|STARTED|First Wear Period (1 Day)||4
8176249|NCT02402127|20160022|P2|STARTED|First Wear Period (1 Day)||4
8176250|NCT02402127|20160023|P1|STARTED|First Wear Period (1 Day)||4
8176251|NCT02402062|20160034|P1|NOT COMPLETED|Overall Study||0
8176252|NCT02402062|20160034|P1|COMPLETED|Overall Study||17
8176253|NCT02402062|20160034|P1|STARTED|Overall Study||17
8176254|NCT02402036|20160044|P1|NOT COMPLETED|Overall Study||0
8176255|NCT02402036|20160044|P1|COMPLETED|Overall Study||10
8176256|NCT02402036|20160044|P1|STARTED|Overall Study||10
8176257|NCT02401867|20160048|P1|NOT COMPLETED|Analysis||9
8176258|NCT02401867|20160048|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
8176259|NCT02401867|20160048|P1|STARTED|Analysis||140
8176260|NCT02401867|20160048|P1|NOT COMPLETED|Specimen Collection||10
8176261|NCT02401867|20160048|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
8176262|NCT02401867|20160048|P1|STARTED|Specimen Collection||150
8176263|NCT02401867|20160048|P1|NOT COMPLETED|Enrolled||0
8176264|NCT02401867|20160048|P1|COMPLETED|Enrolled||150
8176265|NCT02401867|20160048|P1|STARTED|Enrolled||150
8176266|NCT02401672|20160055|P2|NOT COMPLETED|Overall Study||3
8176267|NCT02401672|20160056|P1|NOT COMPLETED|Overall Study||1
8176268|NCT02401672|20160055|P2|COMPLETED|Overall Study||17
8176269|NCT02401672|20160056|P1|COMPLETED|Overall Study||21
8176270|NCT02401672|20160055|P2|STARTED|Overall Study||20
8176271|NCT02401672|20160056|P1|STARTED|Overall Study||22
8176272|NCT02401555|20160071|P3|NOT COMPLETED|Overall Study||0
8176273|NCT02401555|20160072|P2|NOT COMPLETED|Overall Study||0
8176274|NCT02401555|20160073|P1|NOT COMPLETED|Overall Study||0
8176275|NCT02401555|20160071|P3|COMPLETED|Overall Study||120
8176276|NCT02401555|20160072|P2|COMPLETED|Overall Study||212
8176277|NCT02401555|20160073|P1|COMPLETED|Overall Study||87
8176278|NCT02401555|20160071|P3|STARTED|Overall Study||120
8176279|NCT02401555|20160072|P2|STARTED|Overall Study||212
8176280|NCT02401555|20160073|P1|STARTED|Overall Study||87
8176281|NCT02401542|20160084|P3|NOT COMPLETED|Overall Study||0
8176282|NCT02401542|20160085|P2|NOT COMPLETED|Overall Study||0
8176283|NCT02401542|20160086|P1|NOT COMPLETED|Overall Study||1
8176284|NCT02401542|20160084|P3|COMPLETED|Overall Study||0
8176285|NCT02401542|20160085|P2|COMPLETED|Overall Study||30
8176286|NCT02401542|20160086|P1|COMPLETED|Overall Study||40
8176287|NCT02401542|20160084|P3|STARTED|Overall Study||0
8176288|NCT02401542|20160085|P2|STARTED|Overall Study||30
8176289|NCT02401542|20160086|P1|STARTED|Overall Study||41
8176290|NCT02401529|20160098|P2|NOT COMPLETED|Overall Study||7
8176291|NCT02401529|20160099|P1|NOT COMPLETED|Overall Study||9
8176292|NCT02401529|20160098|P2|COMPLETED|Overall Study||50
8176293|NCT02401529|20160099|P1|COMPLETED|Overall Study||50
8176294|NCT02401529|20160098|P2|STARTED|Overall Study||57
8176295|NCT02401529|20160099|P1|STARTED|Overall Study||59
8176296|NCT02401464|20160127|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176297|NCT02401464|20160128|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176298|NCT02401464|20160129|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176299|NCT02401464|20160130|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176300|NCT02401464|20160127|P4|COMPLETED|Intervention Period 2 (6 Days)||13
8176301|NCT02401464|20160128|P3|COMPLETED|Intervention Period 2 (6 Days)||13
8176302|NCT02401464|20160129|P2|COMPLETED|Intervention Period 2 (6 Days)||13
8176303|NCT02401464|20160130|P1|COMPLETED|Intervention Period 2 (6 Days)||13
8176304|NCT02401464|20160127|P4|STARTED|Intervention Period 2 (6 Days)||13
8176305|NCT02401464|20160128|P3|STARTED|Intervention Period 2 (6 Days)||13
8176306|NCT02401464|20160129|P2|STARTED|Intervention Period 2 (6 Days)||13
8176307|NCT02401464|20160130|P1|STARTED|Intervention Period 2 (6 Days)||13
8176308|NCT02401464|20160127|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176309|NCT02401464|20160128|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176310|NCT02401464|20160129|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176311|NCT02401464|20160130|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176312|NCT02401464|20160127|P4|COMPLETED|Washout Period (At Least 6 Days)||13
8176313|NCT02401464|20160128|P3|COMPLETED|Washout Period (At Least 6 Days)||13
8176314|NCT02401464|20160129|P2|COMPLETED|Washout Period (At Least 6 Days)||13
8176315|NCT02401464|20160130|P1|COMPLETED|Washout Period (At Least 6 Days)||13
8176316|NCT02401464|20160127|P4|STARTED|Washout Period (At Least 6 Days)||13
8176317|NCT02401464|20160128|P3|STARTED|Washout Period (At Least 6 Days)||13
8176318|NCT02401464|20160129|P2|STARTED|Washout Period (At Least 6 Days)||13
8176319|NCT02401464|20160130|P1|STARTED|Washout Period (At Least 6 Days)||13
8176320|NCT02401464|20160127|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176321|NCT02401464|20160128|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176322|NCT02401464|20160129|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176323|NCT02401464|20160130|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176324|NCT02401464|20160127|P4|COMPLETED|Intervention Period 1 (6 Days)||13
8176325|NCT02401464|20160128|P3|COMPLETED|Intervention Period 1 (6 Days)||13
8176326|NCT02401464|20160129|P2|COMPLETED|Intervention Period 1 (6 Days)||13
8176327|NCT02401464|20160130|P1|COMPLETED|Intervention Period 1 (6 Days)||13
8176328|NCT02401464|20160127|P4|STARTED|Intervention Period 1 (6 Days)||13
8176329|NCT02401464|20160128|P3|STARTED|Intervention Period 1 (6 Days)||13
8176330|NCT02401464|20160129|P2|STARTED|Intervention Period 1 (6 Days)||13
8176331|NCT02401464|20160130|P1|STARTED|Intervention Period 1 (6 Days)||13
8176332|NCT02401412|20160166|P2|NOT COMPLETED|Overall Study||32
8176333|NCT02401412|20160167|P1|NOT COMPLETED|Overall Study||30
8176334|NCT02401412|20160166|P2|COMPLETED|Overall Study||49
8176335|NCT02401412|20160167|P1|COMPLETED|Overall Study||59
8176336|NCT02401412|20160166|P2|Received Study Device|Overall Study||80
8176337|NCT02401412|20160167|P1|Received Study Device|Overall Study||89
8176338|NCT02401412|20160166|P2|STARTED|Overall Study||81
8176339|NCT02401412|20160167|P1|STARTED|Overall Study||89
8176340|NCT02401256|20160175|P1|NOT COMPLETED|Overall Study||17
8176341|NCT02401256|20160175|P1|COMPLETED|Overall Study||53
8176342|NCT02401256|20160175|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
8176343|NCT02401256|20160175|P1|Finished Phase 3|Overall Study||53
8176344|NCT02401256|20160175|P1|Finished Phase 2|Overall Study||58
8176345|NCT02401256|20160175|P1|Finished Phase 1|Overall Study||64
8176346|NCT02401256|20160175|P1|STARTED|Overall Study||70
8176347|NCT02401230|20160184|P3|NOT COMPLETED|Overall Study||4
8176348|NCT02401230|20160185|P2|NOT COMPLETED|Overall Study||6
8176349|NCT02401230|20160186|P1|NOT COMPLETED|Overall Study||6
8176350|NCT02401230|20160184|P3|COMPLETED|Overall Study||21
8176351|NCT02401230|20160185|P2|COMPLETED|Overall Study||19
8176352|NCT02401230|20160186|P1|COMPLETED|Overall Study||20
8176353|NCT02401230|20160184|P3|STARTED|Overall Study||25
8176354|NCT02401230|20160185|P2|STARTED|Overall Study||25
8176355|NCT02401230|20160186|P1|STARTED|Overall Study||26
8176356|NCT02401048|20160221|P2|NOT COMPLETED|Overall Study||30
8176357|NCT02401048|20160222|P1|NOT COMPLETED|Overall Study||22
8176358|NCT02401048|20160221|P2|COMPLETED|Overall Study||4
8176359|NCT02401048|20160222|P1|COMPLETED|Overall Study||5
8176360|NCT02401048|20160221|P2|STARTED|Overall Study||34
8176361|NCT02401048|20160222|P1|STARTED|Overall Study||27
8176362|NCT02401022|20160254|P2|NOT COMPLETED|Overall Study||20
8176363|NCT02401022|20160255|P1|NOT COMPLETED|Overall Study||15
8176364|NCT02401022|20160254|P2|COMPLETED|Overall Study||90
8176365|NCT02401022|20160255|P1|COMPLETED|Overall Study||89
8176366|NCT02401022|20160254|P2|STARTED|Overall Study||110
8176367|NCT02401022|20160255|P1|STARTED|Overall Study||104
8176368|NCT02400996|20160261|P1|NOT COMPLETED|Overall Study||0
8176369|NCT02400996|20160261|P1|COMPLETED|Overall Study||40
8176370|NCT02400996|20160261|P1|STARTED|Overall Study||40
8176371|NCT02400905|20160265|P1|NOT COMPLETED|Overall Study||271
8176372|NCT02400905|20160265|P1|COMPLETED|Overall Study||0
8176373|NCT02400905|20160265|P1|12-month Follow-up|Overall Study||256
8176374|NCT02400905|20160265|P1|STARTED|Overall Study||271
8176375|NCT02400749|20160275|P2|NOT COMPLETED|Week 17 - 32||3
8176376|NCT02400749|20160276|P1|NOT COMPLETED|Week 17 - 32||5
8176377|NCT02400749|20160275|P2|COMPLETED|Week 17 - 32||41
8176378|NCT02400749|20160276|P1|COMPLETED|Week 17 - 32||34
8176379|NCT02400749|20160275|P2|STARTED|Week 17 - 32||44
8176380|NCT02400749|20160276|P1|STARTED|Week 17 - 32||39
8176381|NCT02400749|20160275|P2|NOT COMPLETED|Week 0 -16||6
8176382|NCT02400749|20160276|P1|NOT COMPLETED|Week 0 -16||11
8176383|NCT02400749|20160275|P2|COMPLETED|Week 0 -16||44
8176384|NCT02400749|20160276|P1|COMPLETED|Week 0 -16||39
8176385|NCT02400749|20160275|P2|STARTED|Week 0 -16||50
8176386|NCT02400749|20160276|P1|STARTED|Week 0 -16||50
8176387|NCT02400710|20160292|P2|NOT COMPLETED|Overall Study||0
8176388|NCT02400710|20160293|P1|NOT COMPLETED|Overall Study||0
8176389|NCT02400710|20160292|P2|COMPLETED|Overall Study||10
8176390|NCT02400710|20160293|P1|COMPLETED|Overall Study||10
8176391|NCT02400710|20160292|P2|STARTED|Overall Study||10
8176392|NCT02400710|20160293|P1|STARTED|Overall Study||10
8176393|NCT02400580|20160303|P2|NOT COMPLETED|Overall Study||1
8176394|NCT02400580|20160304|P1|NOT COMPLETED|Overall Study||2
8176395|NCT02400580|20160303|P2|COMPLETED|Overall Study||91
8176396|NCT02400580|20160304|P1|COMPLETED|Overall Study||89
8176397|NCT02400580|20160303|P2|STARTED|Overall Study||92
8176398|NCT02400580|20160304|P1|STARTED|Overall Study||91
8176399|NCT02400463|20160320|P1|NOT COMPLETED|Overall Study||0
8176400|NCT02400463|20160320|P1|COMPLETED|Overall Study||6
8176401|NCT02400463|20160320|P1|STARTED|Overall Study||6
8176402|NCT02400437|20160328|P1|NOT COMPLETED|Overall Study||0
8176403|NCT02400437|20160328|P1|COMPLETED|Overall Study||26
8176404|NCT02400437|20160328|P1|STARTED|Overall Study||26
8176405|NCT02400346|20160339|P1|NOT COMPLETED|Overall Study||44
8176406|NCT02400346|20160339|P1|COMPLETED|Overall Study||88
8176407|NCT02400346|20160339|P1|STARTED|Overall Study||132
8176408|NCT02400333|20160347|P4|NOT COMPLETED|Overall Study||2
8176409|NCT02400333|20160348|P3|NOT COMPLETED|Overall Study||2
8176410|NCT02400333|20160349|P2|NOT COMPLETED|Overall Study||1
8176411|NCT02400333|20160350|P1|NOT COMPLETED|Overall Study||1
8176412|NCT02400333|20160347|P4|COMPLETED|Overall Study||7
8176413|NCT02400333|20160348|P3|COMPLETED|Overall Study||7
8176414|NCT02400333|20160349|P2|COMPLETED|Overall Study||8
8176415|NCT02400333|20160350|P1|COMPLETED|Overall Study||8
8176416|NCT02400333|20160347|P4|STARTED|Overall Study||9
8176417|NCT02400333|20160348|P3|STARTED|Overall Study||9
8176418|NCT02400333|20160349|P2|STARTED|Overall Study||9
8176419|NCT02400333|20160350|P1|STARTED|Overall Study||9
8176420|NCT02400307|20160410|P2|NOT COMPLETED|Overall Study||0
8176421|NCT02400307|20160411|P1|NOT COMPLETED|Overall Study||1
8176422|NCT02400307|20160410|P2|COMPLETED|Overall Study||8
8176423|NCT02400307|20160411|P1|COMPLETED|Overall Study||10
8176424|NCT02400307|20160410|P2|STARTED|Overall Study||8
8176425|NCT02400307|20160411|P1|STARTED|Overall Study||11
8176426|NCT02400073|20160431|P1|NOT COMPLETED|Overall Study||11
8176427|NCT02400073|20160431|P1|COMPLETED|Overall Study||111
8176428|NCT02400073|20160431|P1|STARTED|Overall Study||122
8176429|NCT02399917|20160439|P3|NOT COMPLETED|Overall Study||0
8176430|NCT02399917|20160440|P2|NOT COMPLETED|Overall Study||0
8176431|NCT02399917|20160441|P1|NOT COMPLETED|Overall Study||0
8176432|NCT02399917|20160439|P3|COMPLETED|Overall Study||24
8176433|NCT02399917|20160440|P2|COMPLETED|Overall Study||6
8176434|NCT02399917|20160441|P1|COMPLETED|Overall Study||6
8176435|NCT02399917|20160439|P3|STARTED|Overall Study||24
8176436|NCT02399917|20160440|P2|STARTED|Overall Study||6
8176437|NCT02399917|20160441|P1|STARTED|Overall Study||6
8176438|NCT02399345|20160459|P1|NOT COMPLETED|Overall Study||0
8176439|NCT02399345|20160459|P1|COMPLETED|Overall Study||10
8176440|NCT02399345|20160459|P1|STARTED|Overall Study||10
8176441|NCT02399254|20160465|P1|NOT COMPLETED|Overall Study||2
8176442|NCT02399254|20160465|P1|COMPLETED|Overall Study||19
8176443|NCT02399254|20160465|P1|STARTED|Overall Study||21
8176444|NCT02399163|20160472|P1|NOT COMPLETED|Overall Study||9
8176445|NCT02399163|20160472|P1|COMPLETED|Overall Study||53
8176446|NCT02399163|20160472|P1|STARTED|Overall Study||62
8176447|NCT02399111|20160500|P4|NOT COMPLETED|Overall Study||0
8176448|NCT02399111|20160501|P3|NOT COMPLETED|Overall Study||0
8176449|NCT02399111|20160502|P2|NOT COMPLETED|Overall Study||0
8176450|NCT02399111|20160503|P1|NOT COMPLETED|Overall Study||0
8176451|NCT02399111|20160500|P4|COMPLETED|Overall Study||0
8176452|NCT02399111|20160501|P3|COMPLETED|Overall Study||4
8176453|NCT02399111|20160502|P2|COMPLETED|Overall Study||1
8176454|NCT02399111|20160503|P1|COMPLETED|Overall Study||4
8176455|NCT02399111|20160500|P4|STARTED|Overall Study||0
8176456|NCT02399111|20160501|P3|STARTED|Overall Study||4
8176457|NCT02399111|20160502|P2|STARTED|Overall Study||1
8176458|NCT02399111|20160503|P1|STARTED|Overall Study||4
8176459|NCT02399085|20160517|P1|NOT COMPLETED|Overall Study||51
8176460|NCT02399085|20160517|P1|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
8176461|NCT02399085|20160517|P1|STARTED|Overall Study||81
8176462|NCT02398409|20160527|P2|NOT COMPLETED|Overall Study||5
8176463|NCT02398409|20160528|P1|NOT COMPLETED|Overall Study||2
8176464|NCT02398409|20160527|P2|COMPLETED|Overall Study||63
8176465|NCT02398409|20160528|P1|COMPLETED|Overall Study||67
8176466|NCT02398409|20160527|P2|STARTED|Overall Study||68
8176467|NCT02398409|20160528|P1|STARTED|Overall Study||69
8176468|NCT02398227|20160542|P2|NOT COMPLETED|Overall Study||18
8176469|NCT02398227|20160543|P1|NOT COMPLETED|Overall Study||27
8176470|NCT02398227|20160542|P2|COMPLETED|Overall Study||71
8176471|NCT02398227|20160543|P1|COMPLETED|Overall Study||56
8176472|NCT02398227|20160542|P2|STARTED|Overall Study||89
8176473|NCT02398227|20160543|P1|STARTED|Overall Study||83
8176474|NCT02398188|20160553|P2|NOT COMPLETED|Overall Study||34
8176475|NCT02398188|20160554|P1|NOT COMPLETED|Overall Study||27
8176476|NCT02398188|20160553|P2|COMPLETED|Overall Study||361
8176477|NCT02398188|20160554|P1|COMPLETED|Overall Study||371
8176478|NCT02398188|20160553|P2|STARTED|Overall Study||395
8176479|NCT02398188|20160554|P1|STARTED|Overall Study||398
8176480|NCT02397954|20160564|P1|NOT COMPLETED|Overall Study||0
8176481|NCT02397954|20160564|P1|COMPLETED|Overall Study||4
8176482|NCT02397954|20160564|P1|STARTED|Overall Study||4
8176483|NCT02397915|20160572|P4|NOT COMPLETED|Period 2||0
8176484|NCT02397915|20160573|P3|NOT COMPLETED|Period 2||0
8176485|NCT02397915|20160574|P2|NOT COMPLETED|Period 2||0
8176486|NCT02397915|20160575|P1|NOT COMPLETED|Period 2||0
8176487|NCT02397915|20160572|P4|COMPLETED|Period 2||149
8176488|NCT02397915|20160573|P3|COMPLETED|Period 2||149
8176489|NCT02397915|20160574|P2|COMPLETED|Period 2||0
8176490|NCT02397915|20160575|P1|COMPLETED|Period 2||0
8176491|NCT02397915|20160572|P4|STARTED|Period 2||149
8176492|NCT02397915|20160573|P3|STARTED|Period 2||149
8176493|NCT02397915|20160574|P2|STARTED|Period 2||0
8176494|NCT02397915|20160575|P1|STARTED|Period 2||0
8176495|NCT02397915|20160572|P4|NOT COMPLETED|Period 1||0
8176496|NCT02397915|20160573|P3|NOT COMPLETED|Period 1||0
8176497|NCT02397915|20160574|P2|NOT COMPLETED|Period 1||1
8176498|NCT02397915|20160575|P1|NOT COMPLETED|Period 1||1
8176499|NCT02397915|20160572|P4|COMPLETED|Period 1||0
8176500|NCT02397915|20160573|P3|COMPLETED|Period 1||0
8176501|NCT02397915|20160574|P2|COMPLETED|Period 1||149
8176502|NCT02397915|20160575|P1|COMPLETED|Period 1||149
8176503|NCT02397915|20160572|P4|STARTED|Period 1||0
8176504|NCT02397915|20160573|P3|STARTED|Period 1||0
8176505|NCT02397915|20160574|P2|STARTED|Period 1||150
8176506|NCT02397915|20160575|P1|STARTED|Period 1||150
8176507|NCT02397837|20160627|P2|NOT COMPLETED|Overall Study||6
8176508|NCT02397837|20160628|P1|NOT COMPLETED|Overall Study||7
8176509|NCT02397837|20160627|P2|COMPLETED|Overall Study||24
8176510|NCT02397837|20160628|P1|COMPLETED|Overall Study||26
8176511|NCT02397837|20160627|P2|STARTED|Overall Study||30
8176512|NCT02397837|20160628|P1|STARTED|Overall Study||33
8176513|NCT02397785|20160654|P2|NOT COMPLETED|Overall Study||9
8176514|NCT02397785|20160655|P1|NOT COMPLETED|Overall Study||2
8176515|NCT02397785|20160654|P2|COMPLETED|Overall Study||25
8176516|NCT02397785|20160655|P1|COMPLETED|Overall Study||22
8176517|NCT02397785|20160654|P2|STARTED|Overall Study||34
8176518|NCT02397785|20160655|P1|STARTED|Overall Study||24
8176519|NCT02397707|20160702|P3|NOT COMPLETED|Overall Study||0
8176520|NCT02397707|20160703|P2|NOT COMPLETED|Overall Study||0
8176521|NCT02397707|20160704|P1|NOT COMPLETED|Overall Study||0
8176522|NCT02397707|20160702|P3|COMPLETED|Overall Study||9
8176523|NCT02397707|20160703|P2|COMPLETED|Overall Study||10
8176524|NCT02397707|20160704|P1|COMPLETED|Overall Study||14
8176525|NCT02397707|20160702|P3|STARTED|Overall Study||9
8176526|NCT02397707|20160703|P2|STARTED|Overall Study||10
8176527|NCT02397707|20160704|P1|STARTED|Overall Study||14
8176528|NCT02397694|20160723|P2|NOT COMPLETED|Open Label Extension Phase||1
8176529|NCT02397694|20160724|P1|NOT COMPLETED|Open Label Extension Phase||8
8176530|NCT02397694|20160723|P2|COMPLETED|Open Label Extension Phase||29
8176531|NCT02397694|20160724|P1|COMPLETED|Open Label Extension Phase||54
8176532|NCT02397694|20160723|P2|STARTED|Open Label Extension Phase||30
8176533|NCT02397694|20160724|P1|STARTED|Open Label Extension Phase||62
8176534|NCT02397694|20160723|P2|NOT COMPLETED|Double-Blinded Phase||3
8176535|NCT02397694|20160724|P1|NOT COMPLETED|Double-Blinded Phase||3
8176536|NCT02397694|20160723|P2|COMPLETED|Double-Blinded Phase||30
8176537|NCT02397694|20160724|P1|COMPLETED|Double-Blinded Phase||62
8176538|NCT02397694|20160723|P2|STARTED|Double-Blinded Phase||33
8176539|NCT02397694|20160724|P1|STARTED|Double-Blinded Phase||65
8176540|NCT02397655|20160762|P1|NOT COMPLETED|Overall Study||1301
8176541|NCT02397655|20160762|P1|COMPLETED|Overall Study||10711
8176542|NCT02397655|20160762|P1|STARTED|Overall Study||12012
8176543|NCT02397564|20160766|P1|NOT COMPLETED|Overall Study||4
8176544|NCT02397564|20160766|P1|COMPLETED|Overall Study||16
8176545|NCT02397564|20160766|P1|STARTED|Overall Study||20
8176546|NCT02397473|20160773|P2|NOT COMPLETED|Post Treatment Follow-up Phase||2
8176547|NCT02397473|20160774|P1|NOT COMPLETED|Post Treatment Follow-up Phase||3
8176548|NCT02397473|20160773|P2|COMPLETED|Post Treatment Follow-up Phase||45
8176549|NCT02397473|20160774|P1|COMPLETED|Post Treatment Follow-up Phase||47
8176550|NCT02397473|20160773|P2|STARTED|Post Treatment Follow-up Phase||47
8176551|NCT02397473|20160774|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
8176552|NCT02397473|20160773|P2|NOT COMPLETED|Treatment Phase||7
8176553|NCT02397473|20160774|P1|NOT COMPLETED|Treatment Phase||12
8176554|NCT02397473|20160773|P2|COMPLETED|Treatment Phase||45
8176555|NCT02397473|20160774|P1|COMPLETED|Treatment Phase||45
8176556|NCT02397473|20160773|P2|Received at Least One Dose of Study Drug|Treatment Phase||49
8176557|NCT02397473|20160774|P1|Received at Least One Dose of Study Drug|Treatment Phase||57
8176558|NCT02397473|20160773|P2|STARTED|Treatment Phase||52
8176559|NCT02397473|20160774|P1|STARTED|Treatment Phase||57
8176560|NCT02397447|20160804|P2|NOT COMPLETED|Overall Study||2
8176561|NCT02397447|20160805|P1|NOT COMPLETED|Overall Study||2
8176562|NCT02397447|20160804|P2|COMPLETED|Overall Study||10
8176563|NCT02397447|20160805|P1|COMPLETED|Overall Study||10
8176564|NCT02397447|20160804|P2|STARTED|Overall Study||12
8176565|NCT02397447|20160805|P1|STARTED|Overall Study||12
8176566|NCT02397408|20160851|P1|NOT COMPLETED|Overall Study||6
8176567|NCT02397408|20160851|P1|COMPLETED|Overall Study||12
8176568|NCT02397408|20160851|P1|Completed Surgery Per Protocol|Overall Study||16
8176569|NCT02397408|20160851|P1|STARTED|Overall Study||18
8176570|NCT02397265|20160869|P3|NOT COMPLETED|Third Intervention of Three||0
8176571|NCT02397265|20160870|P2|NOT COMPLETED|Third Intervention of Three||0
8176572|NCT02397265|20160871|P1|NOT COMPLETED|Third Intervention of Three||0
8176573|NCT02397265|20160869|P3|COMPLETED|Third Intervention of Three||2
8176574|NCT02397265|20160870|P2|COMPLETED|Third Intervention of Three||2
8176575|NCT02397265|20160871|P1|COMPLETED|Third Intervention of Three||2
8176576|NCT02397265|20160869|P3|STARTED|Third Intervention of Three||2
8176577|NCT02397265|20160870|P2|STARTED|Third Intervention of Three||2
8176578|NCT02397265|20160871|P1|STARTED|Third Intervention of Three||2
8176579|NCT02397265|20160869|P3|NOT COMPLETED|Second Intervention of Three||0
8176580|NCT02397265|20160870|P2|NOT COMPLETED|Second Intervention of Three||0
8176581|NCT02397265|20160871|P1|NOT COMPLETED|Second Intervention of Three||0
8176582|NCT02397265|20160869|P3|COMPLETED|Second Intervention of Three||2
8176583|NCT02397265|20160870|P2|COMPLETED|Second Intervention of Three||2
8176584|NCT02397265|20160871|P1|COMPLETED|Second Intervention of Three||2
8176585|NCT02397265|20160869|P3|STARTED|Second Intervention of Three||2
8176586|NCT02397265|20160870|P2|STARTED|Second Intervention of Three||2
8176587|NCT02397265|20160871|P1|STARTED|Second Intervention of Three||2
8176588|NCT02397265|20160869|P3|NOT COMPLETED|First Intervention of Three||0
8176589|NCT02397265|20160870|P2|NOT COMPLETED|First Intervention of Three||0
8176590|NCT02397265|20160871|P1|NOT COMPLETED|First Intervention of Three||0
8176591|NCT02397265|20160869|P3|COMPLETED|First Intervention of Three||2
8176592|NCT02397265|20160870|P2|COMPLETED|First Intervention of Three||2
8176593|NCT02397265|20160871|P1|COMPLETED|First Intervention of Three||2
8176594|NCT02397265|20160869|P3|STARTED|First Intervention of Three||2
8176595|NCT02397265|20160870|P2|STARTED|First Intervention of Three||2
8176596|NCT02397265|20160871|P1|STARTED|First Intervention of Three||2
8176597|NCT02397122|20160881|P2|NOT COMPLETED|Overall Study||0
8176598|NCT02397122|20160882|P1|NOT COMPLETED|Overall Study||0
8176599|NCT02397122|20160881|P2|COMPLETED|Overall Study||20
8176600|NCT02397122|20160882|P1|COMPLETED|Overall Study||20
8176601|NCT02397122|20160881|P2|STARTED|Overall Study||20
8176602|NCT02397122|20160882|P1|STARTED|Overall Study||20
8176603|NCT02397096|20160900|P2|NOT COMPLETED|Study Extensions||202
8176604|NCT02397096|20160901|P1|NOT COMPLETED|Study Extensions||399
8176605|NCT02397096|20160900|P2|COMPLETED|Study Extensions|The extension study is ongoing.|0
8176606|NCT02397096|20160901|P1|COMPLETED|Study Extensions|The extension study is ongoing.|0
8176607|NCT02397096|20160900|P2|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
8176608|NCT02397096|20160901|P1|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
8176609|NCT02397096|20160900|P2|NOT COMPLETED|Week 24 to Week 48||7
8176610|NCT02397096|20160901|P1|NOT COMPLETED|Week 24 to Week 48||20
8176611|NCT02397096|20160900|P2|COMPLETED|Week 24 to Week 48||202
8176612|NCT02397096|20160901|P1|COMPLETED|Week 24 to Week 48||407
8176613|NCT02397096|20160900|P2|STARTED|Week 24 to Week 48||209
8176614|NCT02397096|20160901|P1|STARTED|Week 24 to Week 48||427
8176615|NCT02397096|20160900|P2|NOT COMPLETED|Day 1 to Week 24||14
8176616|NCT02397096|20160901|P1|NOT COMPLETED|Day 1 to Week 24||20
8176617|NCT02397096|20160900|P2|COMPLETED|Day 1 to Week 24||209
8176618|NCT02397096|20160901|P1|COMPLETED|Day 1 to Week 24||427
8176619|NCT02397096|20160900|P2|STARTED|Day 1 to Week 24||223
8176620|NCT02397096|20160901|P1|STARTED|Day 1 to Week 24||447
8176621|NCT02396953|20160934|P3|NOT COMPLETED|Overall Study||3
8176622|NCT02396953|20160935|P2|NOT COMPLETED|Overall Study||3
8176623|NCT02396953|20160936|P1|NOT COMPLETED|Overall Study||4
8176624|NCT02396953|20160934|P3|COMPLETED|Overall Study||7
8176625|NCT02396953|20160935|P2|COMPLETED|Overall Study||6
8176626|NCT02396953|20160936|P1|COMPLETED|Overall Study||5
8176627|NCT02396953|20160934|P3|STARTED|Overall Study||10
8176628|NCT02396953|20160935|P2|STARTED|Overall Study||9
8176629|NCT02396953|20160936|P1|STARTED|Overall Study||9
8176630|NCT02396745|20160986|P1|NOT COMPLETED|Overall Study||0
8176631|NCT02396745|20160986|P1|COMPLETED|Overall Study||1
8176632|NCT02396745|20160986|P1|STARTED|Overall Study||1
8176633|NCT02396732|20160998|P2|NOT COMPLETED|Overall Study||0
8176634|NCT02396732|20160999|P1|NOT COMPLETED|Overall Study||0
8176635|NCT02396732|20160998|P2|COMPLETED|Overall Study||17
8176636|NCT02396732|20160999|P1|COMPLETED|Overall Study||14
8176637|NCT02396732|20160998|P2|STARTED|Overall Study||17
8176638|NCT02396732|20160999|P1|STARTED|Overall Study||14
8176639|NCT02396537|20161011|P2|NOT COMPLETED|Overall Study||1
8176640|NCT02396537|20161012|P1|NOT COMPLETED|Overall Study||0
8176641|NCT02396537|20161011|P2|COMPLETED|Overall Study||36
8176642|NCT02396537|20161012|P1|COMPLETED|Overall Study||40
8176643|NCT02396537|20161011|P2|STARTED|Overall Study||37
8176644|NCT02396537|20161012|P1|STARTED|Overall Study||40
8176645|NCT02396511|20161018|P1|NOT COMPLETED|Overall Study||0
8176646|NCT02396511|20161018|P1|COMPLETED|Overall Study||2
8176647|NCT02396511|20161018|P1|STARTED|Overall Study||2
8176648|NCT02396420|20161024|P1|NOT COMPLETED|Overall Study||1
8176649|NCT02396420|20161024|P1|COMPLETED|Overall Study||1
8176650|NCT02396420|20161024|P1|6 Months Post PAE|Overall Study||2
8176651|NCT02396420|20161024|P1|3 Months Post PAE|Overall Study||2
8176652|NCT02396420|20161024|P1|1 Month Post PAE|Overall Study||2
8176653|NCT02396420|20161024|P1|STARTED|Overall Study||2
8176654|NCT02396381|20161048|P2|NOT COMPLETED|Overall Study||74
8176655|NCT02396381|20161049|P1|NOT COMPLETED|Overall Study||107
8176656|NCT02396381|20161048|P2|COMPLETED|Overall Study||422
8176657|NCT02396381|20161049|P1|COMPLETED|Overall Study||381
8176658|NCT02396381|20161048|P2|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
8176659|NCT02396381|20161049|P1|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
8176660|NCT02396381|20161048|P2|STARTED|Overall Study||496
8176661|NCT02396381|20161049|P1|STARTED|Overall Study||488
8176662|NCT02396316|20161088|P2|NOT COMPLETED|Overall Study||5
8176663|NCT02396316|20161089|P1|NOT COMPLETED|Overall Study||7
8176664|NCT02396316|20161088|P2|COMPLETED|Overall Study||22
8176665|NCT02396316|20161089|P1|COMPLETED|Overall Study||20
8176666|NCT02396316|20161088|P2|Received Active Injection at Week 9|Overall Study||1
8176667|NCT02396316|20161089|P1|Received Active Injection at Week 9|Overall Study||2
8176668|NCT02396316|20161088|P2|Received Active Injection at Week 5|Overall Study||4
8176669|NCT02396316|20161089|P1|Received Active Injection at Week 5|Overall Study||4
8176670|NCT02396316|20161088|P2|Received AFL Injection at Week 1|Overall Study||22
8176671|NCT02396316|20161089|P1|Received AFL Injection at Week 1|Overall Study||0
8176672|NCT02396316|20161088|P2|Received Sham Injection at Week 1|Overall Study||0
8176673|NCT02396316|20161089|P1|Received Sham Injection at Week 1|Overall Study||10
8176674|NCT02396316|20161088|P2|Treated|Overall Study||27
8176675|NCT02396316|20161089|P1|Treated|Overall Study||27
8176676|NCT02396316|20161088|P2|STARTED|Overall Study||27
8176677|NCT02396316|20161089|P1|STARTED|Overall Study||27
8176678|NCT02396251|20161101|P2|NOT COMPLETED|Overall Study||5
8176679|NCT02396251|20161102|P1|NOT COMPLETED|Overall Study||13
8176680|NCT02396251|20161101|P2|COMPLETED|Overall Study||7
8176681|NCT02396251|20161102|P1|COMPLETED|Overall Study||23
8176682|NCT02396251|20161101|P2|STARTED|Overall Study||12
8176683|NCT02396251|20161102|P1|STARTED|Overall Study||36
8176684|NCT02396212|20161108|P1|NOT COMPLETED|Overall Study||3
8176685|NCT02396212|20161108|P1|COMPLETED|Overall Study||16
8176686|NCT02396212|20161108|P1|STARTED|Overall Study||19
8176687|NCT02396160|20161129|P2|NOT COMPLETED|Overall Study||2
8176688|NCT02396160|20161130|P1|NOT COMPLETED|Overall Study||6
8176689|NCT02396160|20161129|P2|COMPLETED|Overall Study||73
8176690|NCT02396160|20161130|P1|COMPLETED|Overall Study||69
8176691|NCT02396160|20161129|P2|STARTED|Overall Study||75
8176692|NCT02396160|20161130|P1|STARTED|Overall Study||75
8176693|NCT02396147|20161146|P2|NOT COMPLETED|Period 3||0
8176694|NCT02396147|20161147|P1|NOT COMPLETED|Period 3||0
8176695|NCT02396147|20161146|P2|COMPLETED|Period 3||27
8176696|NCT02396147|20161147|P1|COMPLETED|Period 3||27
8176697|NCT02396147|20161146|P2|STARTED|Period 3||27
8176698|NCT02396147|20161147|P1|STARTED|Period 3||27
8176699|NCT02396147|20161146|P2|NOT COMPLETED|Period 2||0
8176700|NCT02396147|20161147|P1|NOT COMPLETED|Period 2||0
8176701|NCT02396147|20161146|P2|COMPLETED|Period 2||27
8176702|NCT02396147|20161147|P1|COMPLETED|Period 2||27
8176703|NCT02396147|20161146|P2|STARTED|Period 2||27
8176704|NCT02396147|20161147|P1|STARTED|Period 2||27
8176705|NCT02396147|20161146|P2|NOT COMPLETED|Period 1||0
8176706|NCT02396147|20161147|P1|NOT COMPLETED|Period 1||0
8176707|NCT02396147|20161146|P2|COMPLETED|Period 1||27
8176708|NCT02396147|20161147|P1|COMPLETED|Period 1||27
8176709|NCT02396147|20161146|P2|STARTED|Period 1||27
8176710|NCT02396147|20161147|P1|STARTED|Period 1||27
8176711|NCT02395978|20161220|P5|NOT COMPLETED|Overall Study||5
8176712|NCT02395978|20161221|P4|NOT COMPLETED|Overall Study||5
8176713|NCT02395978|20161222|P3|NOT COMPLETED|Overall Study||2
8176714|NCT02395978|20161223|P2|NOT COMPLETED|Overall Study||0
8176715|NCT02395978|20161224|P1|NOT COMPLETED|Overall Study||0
8176716|NCT02395978|20161220|P5|COMPLETED|Overall Study||15
8176717|NCT02395978|20161221|P4|COMPLETED|Overall Study||14
8176718|NCT02395978|20161222|P3|COMPLETED|Overall Study||19
8176719|NCT02395978|20161223|P2|COMPLETED|Overall Study||6
8176720|NCT02395978|20161224|P1|COMPLETED|Overall Study||6
8176721|NCT02395978|20161220|P5|STARTED|Overall Study||20
8176722|NCT02395978|20161221|P4|STARTED|Overall Study||19
8176723|NCT02395978|20161222|P3|STARTED|Overall Study||21
8176724|NCT02395978|20161223|P2|STARTED|Overall Study||6
8176725|NCT02395978|20161224|P1|STARTED|Overall Study||6
8176726|NCT02395822|20161261|P1|NOT COMPLETED|Overall Study||2
8176727|NCT02395822|20161261|P1|COMPLETED|Overall Study||15
8176728|NCT02395822|20161261|P1|STARTED|Overall Study||17
8176729|NCT02395692|20161269|P2|NOT COMPLETED|Overall Study||0
8176730|NCT02395692|20161270|P1|NOT COMPLETED|Overall Study||0
8176731|NCT02395692|20161269|P2|COMPLETED|Overall Study||0
8176732|NCT02395692|20161270|P1|COMPLETED|Overall Study||19
8176733|NCT02395692|20161269|P2|STARTED|Overall Study||0
8176734|NCT02395692|20161270|P1|STARTED|Overall Study||19
8176735|NCT02395666|20161282|P2|NOT COMPLETED|Overall Study||1
8176736|NCT02395666|20161283|P1|NOT COMPLETED|Overall Study||6
8176737|NCT02395666|20161282|P2|COMPLETED|Overall Study||38
8176738|NCT02395666|20161283|P1|COMPLETED|Overall Study||95
8176739|NCT02395666|20161282|P2|STARTED|Overall Study||39
8176740|NCT02395666|20161283|P1|STARTED|Overall Study||101
8176741|NCT02395653|20161297|P1|NOT COMPLETED|Overall Study||12
8176742|NCT02395653|20161297|P1|COMPLETED|Overall Study||59
8176743|NCT02395653|20161297|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
8176744|NCT02395653|20161297|P1|STARTED|Overall Study||71
8176745|NCT02395627|20161307|P3|NOT COMPLETED|Overall Study||0
8176746|NCT02395627|20161308|P2|NOT COMPLETED|Overall Study||3
8176747|NCT02395627|20161309|P1|NOT COMPLETED|Overall Study||3
8176748|NCT02395627|20161307|P3|COMPLETED|Overall Study||4
8176749|NCT02395627|20161308|P2|COMPLETED|Overall Study||13
8176750|NCT02395627|20161309|P1|COMPLETED|Overall Study||15
8176751|NCT02395627|20161307|P3|STARTED|Overall Study||4
8176752|NCT02395627|20161308|P2|STARTED|Overall Study||16
8176753|NCT02395627|20161309|P1|STARTED|Overall Study||18
8176754|NCT02395536|20161337|P2|NOT COMPLETED|Overall Study||30
8176755|NCT02395536|20161338|P1|NOT COMPLETED|Overall Study||20
8176756|NCT02395536|20161337|P2|COMPLETED|Overall Study||227
8176757|NCT02395536|20161338|P1|COMPLETED|Overall Study||244
8176758|NCT02395536|20161337|P2|REVEAL LINQ Insertion|Overall Study||231
8176759|NCT02395536|20161338|P1|REVEAL LINQ Insertion|Overall Study||251
8176760|NCT02395536|20161337|P2|STARTED|Overall Study||257
8176761|NCT02395536|20161338|P1|STARTED|Overall Study||264
8176762|NCT02395471|20161346|P2|NOT COMPLETED|Overall Study||3
8176763|NCT02395471|20161347|P1|NOT COMPLETED|Overall Study||7
8176764|NCT02395471|20161346|P2|COMPLETED|Overall Study||59
8176765|NCT02395471|20161347|P1|COMPLETED|Overall Study||122
8176766|NCT02395471|20161346|P2|STARTED|Overall Study||62
8176767|NCT02395471|20161347|P1|STARTED|Overall Study||129
8176768|NCT02395302|20161362|P1|NOT COMPLETED|Overall Study||14
8176769|NCT02395302|20161362|P1|COMPLETED|Overall Study||14
8176770|NCT02395302|20161362|P1|STARTED|Overall Study||28
8176771|NCT02395185|20161366|P1|NOT COMPLETED|Overall Study||0
8176772|NCT02395185|20161366|P1|COMPLETED|Overall Study||33
8176773|NCT02395185|20161366|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
8176774|NCT02395185|20161366|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
8176775|NCT02395185|20161366|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
8176776|NCT02395185|20161366|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
8176777|NCT02395185|20161366|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
8176778|NCT02395185|20161366|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
8176779|NCT02395185|20161366|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
8176780|NCT02395185|20161366|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
8176781|NCT02395185|20161366|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
8176782|NCT02395185|20161366|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
8176783|NCT02395185|20161366|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
8176784|NCT02395185|20161366|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
8176785|NCT02395185|20161366|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
8176786|NCT02395185|20161366|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
8176787|NCT02395185|20161366|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
8176788|NCT02395185|20161366|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
8176789|NCT02395185|20161366|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
8176790|NCT02395185|20161366|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
8176791|NCT02395185|20161366|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
8176792|NCT02395172|20161382|P2|NOT COMPLETED|Overall Study||31
8176793|NCT02395172|20161383|P1|NOT COMPLETED|Overall Study||3
8176794|NCT02395172|20161382|P2|COMPLETED|Overall Study||365
8176795|NCT02395172|20161383|P1|COMPLETED|Overall Study||393
8176796|NCT02395172|20161382|P2|Treated|Overall Study||365
8176797|NCT02395172|20161383|P1|Treated|Overall Study||393
8176798|NCT02395172|20161382|P2|STARTED|Overall Study||396
8176799|NCT02395172|20161383|P1|STARTED|Overall Study||396
8176800|NCT02395133|20161422|P4|NOT COMPLETED|Overall Study||14
8176801|NCT02395133|20161423|P3|NOT COMPLETED|Overall Study||10
8176802|NCT02395133|20161424|P2|NOT COMPLETED|Overall Study||9
8176803|NCT02395133|20161425|P1|NOT COMPLETED|Overall Study||14
8176804|NCT02395133|20161422|P4|COMPLETED|Overall Study||155
8176805|NCT02395133|20161423|P3|COMPLETED|Overall Study||76
8176806|NCT02395133|20161424|P2|COMPLETED|Overall Study||75
8176807|NCT02395133|20161425|P1|COMPLETED|Overall Study||69
8176808|NCT02395133|20161422|P4|STARTED|Overall Study||169
8176809|NCT02395133|20161423|P3|STARTED|Overall Study||86
8176810|NCT02395133|20161424|P2|STARTED|Overall Study||84
8176811|NCT02395133|20161425|P1|STARTED|Overall Study||83
8176812|NCT02395055|20161513|P2|NOT COMPLETED|Overall Study||3
8176813|NCT02395055|20161514|P1|NOT COMPLETED|Overall Study||7
8176814|NCT02395055|20161513|P2|COMPLETED|Overall Study||44
8176815|NCT02395055|20161514|P1|COMPLETED|Overall Study||40
8176816|NCT02395055|20161513|P2|STARTED|Overall Study||47
8176817|NCT02395055|20161514|P1|STARTED|Overall Study||47
8176818|NCT02395042|20161527|P3|NOT COMPLETED|Treatment 2 Period||0
8176819|NCT02395042|20161528|P2|NOT COMPLETED|Treatment 2 Period||1
8176820|NCT02395042|20161529|P1|NOT COMPLETED|Treatment 2 Period||1
8176821|NCT02395042|20161527|P3|COMPLETED|Treatment 2 Period||13
8176822|NCT02395042|20161528|P2|COMPLETED|Treatment 2 Period||23
8176823|NCT02395042|20161529|P1|COMPLETED|Treatment 2 Period||9
8176824|NCT02395042|20161527|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
8176825|NCT02395042|20161528|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
8176826|NCT02395042|20161529|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
8176827|NCT02395042|20161527|P3|NOT COMPLETED|Treatment 1 Period||2
8176828|NCT02395042|20161528|P2|NOT COMPLETED|Treatment 1 Period||6
8176829|NCT02395042|20161529|P1|NOT COMPLETED|Treatment 1 Period||3
8176830|NCT02395042|20161527|P3|COMPLETED|Treatment 1 Period||14
8176831|NCT02395042|20161528|P2|COMPLETED|Treatment 1 Period||25
8176832|NCT02395042|20161529|P1|COMPLETED|Treatment 1 Period||9
8176833|NCT02395042|20161527|P3|STARTED|Treatment 1 Period||16
8176834|NCT02395042|20161528|P2|STARTED|Treatment 1 Period||31
8176835|NCT02395042|20161529|P1|STARTED|Treatment 1 Period||12
8176836|NCT02394951|20161548|P2|NOT COMPLETED|Period II||4
8176837|NCT02394951|20161549|P1|NOT COMPLETED|Period II||0
8176838|NCT02394951|20161548|P2|COMPLETED|Period II||9
8176839|NCT02394951|20161549|P1|COMPLETED|Period II||11
8176840|NCT02394951|20161548|P2|STARTED|Period II||13
8176841|NCT02394951|20161549|P1|STARTED|Period II||11
8176842|NCT02394951|20161548|P2|NOT COMPLETED|Period I||1
8176843|NCT02394951|20161549|P1|NOT COMPLETED|Period I||1
8176844|NCT02394951|20161548|P2|COMPLETED|Period I||13
8176845|NCT02394951|20161549|P1|COMPLETED|Period I||11
8176846|NCT02394951|20161548|P2|STARTED|Period I||14
8176847|NCT02394951|20161549|P1|STARTED|Period I||12
8176848|NCT02394925|20161567|P1|NOT COMPLETED|Overall Study||29
8176849|NCT02394925|20161567|P1|COMPLETED|Overall Study||79
8176850|NCT02394925|20161567|P1|STARTED|Overall Study||108
8176851|NCT02394912|20161571|P1|NOT COMPLETED|Overall Study||0
8176852|NCT02394912|20161571|P1|COMPLETED|Overall Study||21
8176853|NCT02394912|20161571|P1|STARTED|Overall Study||21
8176854|NCT02394808|20161577|P2|NOT COMPLETED|Period 2||0
8176855|NCT02394808|20161578|P1|NOT COMPLETED|Period 2||1
8176856|NCT02394808|20161577|P2|COMPLETED|Period 2||28
8176857|NCT02394808|20161578|P1|COMPLETED|Period 2||24
8176858|NCT02394808|20161577|P2|STARTED|Period 2||28
8176859|NCT02394808|20161578|P1|STARTED|Period 2||25
8176860|NCT02394808|20161577|P2|NOT COMPLETED|Period 1||1
8176861|NCT02394808|20161578|P1|NOT COMPLETED|Period 1||0
8176862|NCT02394808|20161577|P2|COMPLETED|Period 1||28
8176863|NCT02394808|20161578|P1|COMPLETED|Period 1||25
8176864|NCT02394808|20161577|P2|STARTED|Period 1||29
8176865|NCT02394808|20161578|P1|STARTED|Period 1||25
8176866|NCT02394756|20161586|P6|NOT COMPLETED|Period 3||0
8176867|NCT02394756|20161587|P5|NOT COMPLETED|Period 3||0
8176868|NCT02394756|20161588|P4|NOT COMPLETED|Period 3||0
8176869|NCT02394756|20161589|P3|NOT COMPLETED|Period 3||0
8176870|NCT02394756|20161590|P2|NOT COMPLETED|Period 3||0
8176871|NCT02394756|20161591|P1|NOT COMPLETED|Period 3||0
8176872|NCT02394756|20161586|P6|COMPLETED|Period 3||6
8176873|NCT02394756|20161587|P5|COMPLETED|Period 3||6
8176874|NCT02394756|20161588|P4|COMPLETED|Period 3||6
8176875|NCT02394756|20161589|P3|COMPLETED|Period 3||6
8176876|NCT02394756|20161590|P2|COMPLETED|Period 3||6
8176877|NCT02394756|20161591|P1|COMPLETED|Period 3||7
8176878|NCT02394756|20161586|P6|STARTED|Period 3||6
8176879|NCT02394756|20161587|P5|STARTED|Period 3||6
8176880|NCT02394756|20161588|P4|STARTED|Period 3||6
8176881|NCT02394756|20161589|P3|STARTED|Period 3||6
8176882|NCT02394756|20161590|P2|STARTED|Period 3||6
8176883|NCT02394756|20161591|P1|STARTED|Period 3||7
8176884|NCT02394756|20161586|P6|NOT COMPLETED|Period 2||0
8176885|NCT02394756|20161587|P5|NOT COMPLETED|Period 2||1
8176886|NCT02394756|20161588|P4|NOT COMPLETED|Period 2||0
8176887|NCT02394756|20161589|P3|NOT COMPLETED|Period 2||0
8176888|NCT02394756|20161590|P2|NOT COMPLETED|Period 2||0
8176889|NCT02394756|20161591|P1|NOT COMPLETED|Period 2||0
8176890|NCT02394756|20161586|P6|COMPLETED|Period 2||6
8176891|NCT02394756|20161587|P5|COMPLETED|Period 2||6
8176892|NCT02394756|20161588|P4|COMPLETED|Period 2||6
8176893|NCT02394756|20161589|P3|COMPLETED|Period 2||6
8176894|NCT02394756|20161590|P2|COMPLETED|Period 2||6
8176895|NCT02394756|20161591|P1|COMPLETED|Period 2||7
8176896|NCT02394756|20161586|P6|STARTED|Period 2||6
8176897|NCT02394756|20161587|P5|STARTED|Period 2||7
8176898|NCT02394756|20161588|P4|STARTED|Period 2||6
8176899|NCT02394756|20161589|P3|STARTED|Period 2||6
8176900|NCT02394756|20161590|P2|STARTED|Period 2||6
8176901|NCT02394756|20161591|P1|STARTED|Period 2||7
8176902|NCT02394756|20161586|P6|NOT COMPLETED|Period 1||1
8176903|NCT02394756|20161587|P5|NOT COMPLETED|Period 1||0
8176904|NCT02394756|20161588|P4|NOT COMPLETED|Period 1||1
8176905|NCT02394756|20161589|P3|NOT COMPLETED|Period 1||1
8176906|NCT02394756|20161590|P2|NOT COMPLETED|Period 1||1
8176907|NCT02394756|20161591|P1|NOT COMPLETED|Period 1||0
8176908|NCT02394756|20161586|P6|COMPLETED|Period 1||6
8176909|NCT02394756|20161587|P5|COMPLETED|Period 1||7
8176910|NCT02394756|20161588|P4|COMPLETED|Period 1||6
8176911|NCT02394756|20161589|P3|COMPLETED|Period 1||6
8176912|NCT02394756|20161590|P2|COMPLETED|Period 1||6
8176913|NCT02394756|20161591|P1|COMPLETED|Period 1||7
8176914|NCT02394756|20161586|P6|STARTED|Period 1||7
8176915|NCT02394756|20161587|P5|STARTED|Period 1||7
8176916|NCT02394756|20161588|P4|STARTED|Period 1||7
8176917|NCT02394756|20161589|P3|STARTED|Period 1||7
8176918|NCT02394756|20161590|P2|STARTED|Period 1||7
8176919|NCT02394756|20161591|P1|STARTED|Period 1||7
8176920|NCT02394730|20161604|P2|NOT COMPLETED|Overall Study||1
8176921|NCT02394730|20161605|P1|NOT COMPLETED|Overall Study||1
8176922|NCT02394730|20161604|P2|COMPLETED|Overall Study||30
8176923|NCT02394730|20161605|P1|COMPLETED|Overall Study||33
8176924|NCT02394730|20161604|P2|STARTED|Overall Study||31
8176925|NCT02394730|20161605|P1|STARTED|Overall Study||34
8176926|NCT02394665|20161642|P3|NOT COMPLETED|Overall Study||0
8176927|NCT02394665|20161643|P2|NOT COMPLETED|Overall Study||0
8176928|NCT02394665|20161644|P1|NOT COMPLETED|Overall Study||1
8176929|NCT02394665|20161642|P3|COMPLETED|Overall Study||0
8176930|NCT02394665|20161643|P2|COMPLETED|Overall Study||0
8176931|NCT02394665|20161644|P1|COMPLETED|Overall Study||0
8176932|NCT02394665|20161642|P3|STARTED|Overall Study||0
8176933|NCT02394665|20161643|P2|STARTED|Overall Study||0
8176934|NCT02394665|20161644|P1|STARTED|Overall Study||1
8176935|NCT02394600|20161666|P2|NOT COMPLETED|Overall Study||2
8176936|NCT02394600|20161667|P1|NOT COMPLETED|Overall Study||4
8176937|NCT02394600|20161666|P2|COMPLETED|Overall Study||44
8176938|NCT02394600|20161667|P1|COMPLETED|Overall Study||43
8176939|NCT02394600|20161666|P2|STARTED|Overall Study||46
8176940|NCT02394600|20161667|P1|STARTED|Overall Study||47
8176941|NCT02394561|20161677|P2|NOT COMPLETED|Extension Phase||12
8176942|NCT02394561|20161678|P1|NOT COMPLETED|Extension Phase||11
8176943|NCT02394561|20161677|P2|COMPLETED|Extension Phase||207
8176944|NCT02394561|20161678|P1|COMPLETED|Extension Phase||151
8176945|NCT02394561|20161677|P2|STARTED|Extension Phase||219
8176946|NCT02394561|20161678|P1|STARTED|Extension Phase||162
8176947|NCT02394561|20161677|P2|NOT COMPLETED|CORE Phase||19
8176948|NCT02394561|20161678|P1|NOT COMPLETED|CORE Phase||13
8176949|NCT02394561|20161677|P2|COMPLETED|CORE Phase||227
8176950|NCT02394561|20161678|P1|COMPLETED|CORE Phase||172
8176951|NCT02394561|20161677|P2|ITT Set|CORE Phase||246
8176952|NCT02394561|20161678|P1|ITT Set|CORE Phase||184
8176953|NCT02394561|20161677|P2|Safety Set|CORE Phase||246
8176954|NCT02394561|20161678|P1|Safety Set|CORE Phase||185
8176955|NCT02394561|20161677|P2|Full Analysis Set|CORE Phase||246
8176956|NCT02394561|20161678|P1|Full Analysis Set|CORE Phase||185
8176957|NCT02394561|20161677|P2|STARTED|CORE Phase||246
8176958|NCT02394561|20161678|P1|STARTED|CORE Phase||185
8176962|NCT02394457|20161708|P2|NOT COMPLETED|Overall Study||0
8176963|NCT02394457|20161709|P1|NOT COMPLETED|Overall Study||0
8176964|NCT02394457|20161708|P2|COMPLETED|Overall Study||13
8176965|NCT02394457|20161709|P1|COMPLETED|Overall Study||15
8176966|NCT02394457|20161708|P2|STARTED|Overall Study||13
8176967|NCT02394457|20161709|P1|STARTED|Overall Study||15
8176968|NCT02394340|20161725|P1|NOT COMPLETED|Overall Study||2
8176969|NCT02394340|20161725|P1|COMPLETED|Overall Study||18
8176970|NCT02394340|20161725|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
8176971|NCT02394340|20161725|P1|STARTED|Overall Study||20
8176972|NCT02393950|20161732|P2|NOT COMPLETED|Overall Study||1
8176973|NCT02393950|20161733|P1|NOT COMPLETED|Overall Study||1
8176974|NCT02393950|20161732|P2|COMPLETED|Overall Study||8
8176975|NCT02393950|20161733|P1|COMPLETED|Overall Study||8
8176976|NCT02393950|20161732|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
8176977|NCT02393950|20161733|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
8176978|NCT02393950|20161732|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
8176979|NCT02393950|20161733|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
8176980|NCT02393950|20161732|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
8176981|NCT02393950|20161733|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
8176982|NCT02393950|20161732|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
8176983|NCT02393950|20161733|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
8176984|NCT02393950|20161732|P2|STARTED|Overall Study||9
8176985|NCT02393950|20161733|P1|STARTED|Overall Study||9
8176986|NCT02393859|20161800|P2|NOT COMPLETED|Overall Study||54
8176987|NCT02393859|20161801|P1|NOT COMPLETED|Overall Study||54
8176988|NCT02393859|20161800|P2|COMPLETED|Overall Study||0
8176989|NCT02393859|20161801|P1|COMPLETED|Overall Study||0
8176990|NCT02393859|20161800|P2|STARTED|Overall Study||54
8176991|NCT02393859|20161801|P1|STARTED|Overall Study||54
8176992|NCT02393755|20161826|P2|NOT COMPLETED|Overall Study||7
8176993|NCT02393755|20161827|P1|NOT COMPLETED|Overall Study||0
8176994|NCT02393755|20161826|P2|COMPLETED|Overall Study||32
8176995|NCT02393755|20161827|P1|COMPLETED|Overall Study||3
8176996|NCT02393755|20161826|P2|STARTED|Overall Study||39
8176997|NCT02393755|20161827|P1|STARTED|Overall Study||3
8176998|NCT02393677|20161839|P2|NOT COMPLETED|Overall Study||0
8176999|NCT02393677|20161840|P1|NOT COMPLETED|Overall Study||0
8177000|NCT02393677|20161839|P2|COMPLETED|Overall Study||40
8177001|NCT02393677|20161840|P1|COMPLETED|Overall Study||40
8177002|NCT02393677|20161839|P2|STARTED|Overall Study||40
8177003|NCT02393677|20161840|P1|STARTED|Overall Study||40
8177004|NCT02393547|20161846|P1|NOT COMPLETED|Overall Study||6
8177005|NCT02393547|20161846|P1|COMPLETED|Overall Study||14
8177006|NCT02393547|20161846|P1|STARTED|Overall Study||20
8177007|NCT02393417|20161857|P4|NOT COMPLETED|Overall Study||12
8177008|NCT02393417|20161858|P3|NOT COMPLETED|Overall Study||10
8177009|NCT02393417|20161859|P2|NOT COMPLETED|Overall Study||13
8177010|NCT02393417|20161860|P1|NOT COMPLETED|Overall Study||15
8177011|NCT02393417|20161857|P4|COMPLETED|Overall Study||29
8177012|NCT02393417|20161858|P3|COMPLETED|Overall Study||30
8177013|NCT02393417|20161859|P2|COMPLETED|Overall Study||32
8177014|NCT02393417|20161860|P1|COMPLETED|Overall Study||28
8177015|NCT02393417|20161857|P4|Completed Treatment|Overall Study||30
8177016|NCT02393417|20161858|P3|Completed Treatment|Overall Study||32
8177017|NCT02393417|20161859|P2|Completed Treatment|Overall Study||34
8177018|NCT02393417|20161860|P1|Completed Treatment|Overall Study||30
8177019|NCT02393417|20161857|P4|STARTED|Overall Study||41
8177020|NCT02393417|20161858|P3|STARTED|Overall Study||40
8177021|NCT02393417|20161859|P2|STARTED|Overall Study||45
8177022|NCT02393417|20161860|P1|STARTED|Overall Study||43
8177023|NCT02393378|20161918|P2|NOT COMPLETED|Overall Study||0
8177024|NCT02393378|20161919|P1|NOT COMPLETED|Overall Study||0
8177025|NCT02393378|20161918|P2|COMPLETED|Overall Study||4
8177026|NCT02393378|20161919|P1|COMPLETED|Overall Study||3
8177027|NCT02393378|20161918|P2|STARTED|Overall Study||4
8177028|NCT02393378|20161919|P1|STARTED|Overall Study||3
8177029|NCT02393209|20161937|P4|NOT COMPLETED|Overall Study||0
8177030|NCT02393209|20161938|P3|NOT COMPLETED|Overall Study||0
8177031|NCT02393209|20161939|P2|NOT COMPLETED|Overall Study||8
8177032|NCT02393209|20161940|P1|NOT COMPLETED|Overall Study||6
8177033|NCT02393209|20161937|P4|COMPLETED|Overall Study||0
8177034|NCT02393209|20161938|P3|COMPLETED|Overall Study||0
8177035|NCT02393209|20161939|P2|COMPLETED|Overall Study||0
8177036|NCT02393209|20161940|P1|COMPLETED|Overall Study||0
8177037|NCT02393209|20161937|P4|STARTED|Overall Study||0
8177038|NCT02393209|20161938|P3|STARTED|Overall Study||0
8177039|NCT02393209|20161939|P2|STARTED|Overall Study||8
8177040|NCT02393209|20161940|P1|STARTED|Overall Study||6
8177041|NCT02392806|20161998|P2|NOT COMPLETED|Overall Study||0
8177042|NCT02392806|20161999|P1|NOT COMPLETED|Overall Study||0
8177043|NCT02392806|20161998|P2|COMPLETED|Overall Study||21
8177044|NCT02392806|20161999|P1|COMPLETED|Overall Study||22
8177045|NCT02392806|20161998|P2|STARTED|Overall Study||21
8177046|NCT02392806|20161999|P1|STARTED|Overall Study||22
8177047|NCT02392767|20162009|P2|NOT COMPLETED|Overall Study||0
8177048|NCT02392767|20162010|P1|NOT COMPLETED|Overall Study||0
8177049|NCT02392767|20162009|P2|COMPLETED|Overall Study||13
8177050|NCT02392767|20162010|P1|COMPLETED|Overall Study||12
8177051|NCT02392767|20162009|P2|STARTED|Overall Study||13
8177052|NCT02392767|20162010|P1|STARTED|Overall Study||12
8177053|NCT02392624|20162029|P3|NOT COMPLETED|Overall Study||13
8177054|NCT02392624|20162030|P2|NOT COMPLETED|Overall Study||15
8177055|NCT02392624|20162031|P1|NOT COMPLETED|Overall Study||71
8177056|NCT02392624|20162029|P3|COMPLETED|Overall Study||40
8177057|NCT02392624|20162030|P2|COMPLETED|Overall Study||66
8177058|NCT02392624|20162031|P1|COMPLETED|Overall Study||0
8177059|NCT02392624|20162029|P3|STARTED|Overall Study||53
8177060|NCT02392624|20162030|P2|STARTED|Overall Study||81
8177061|NCT02392624|20162031|P1|STARTED|Overall Study||71
8177062|NCT02392611|20162053|P9|NOT COMPLETED|Overall Study||0
8177063|NCT02392611|20162054|P8|NOT COMPLETED|Overall Study||0
8177064|NCT02392611|20162055|P7|NOT COMPLETED|Overall Study||1
8177065|NCT02392611|20162056|P6|NOT COMPLETED|Overall Study||1
8177066|NCT02392611|20162057|P5|NOT COMPLETED|Overall Study||1
8177067|NCT02392611|20162058|P4|NOT COMPLETED|Overall Study||6
8177068|NCT02392611|20162059|P3|NOT COMPLETED|Overall Study||0
8177069|NCT02392611|20162060|P2|NOT COMPLETED|Overall Study||0
8177070|NCT02392611|20162061|P1|NOT COMPLETED|Overall Study||1
8177071|NCT02392611|20162053|P9|COMPLETED|Overall Study||3
8177072|NCT02392611|20162054|P8|COMPLETED|Overall Study||3
8177073|NCT02392611|20162055|P7|COMPLETED|Overall Study||3
8177074|NCT02392611|20162056|P6|COMPLETED|Overall Study||3
8177075|NCT02392611|20162057|P5|COMPLETED|Overall Study||5
8177076|NCT02392611|20162058|P4|COMPLETED|Overall Study||3
8177077|NCT02392611|20162059|P3|COMPLETED|Overall Study||1
8177078|NCT02392611|20162060|P2|COMPLETED|Overall Study||1
8177079|NCT02392611|20162061|P1|COMPLETED|Overall Study||1
8177080|NCT02392611|20162053|P9|STARTED|Overall Study||3
8177081|NCT02392611|20162054|P8|STARTED|Overall Study||3
8177082|NCT02392611|20162055|P7|STARTED|Overall Study||4
8177083|NCT02392611|20162056|P6|STARTED|Overall Study||4
8177084|NCT02392611|20162057|P5|STARTED|Overall Study||6
8177085|NCT02392611|20162058|P4|STARTED|Overall Study||9
8177086|NCT02392611|20162059|P3|STARTED|Overall Study||1
8177087|NCT02392611|20162060|P2|STARTED|Overall Study||1
8177088|NCT02392611|20162061|P1|STARTED|Overall Study||2
8177089|NCT02392559|20162137|P2|NOT COMPLETED|Overall Study||1
8177090|NCT02392559|20162138|P1|NOT COMPLETED|Overall Study||0
8177091|NCT02392559|20162137|P2|COMPLETED|Overall Study||104
8177092|NCT02392559|20162138|P1|COMPLETED|Overall Study||53
8177093|NCT02392559|20162137|P2|Randomized and Dosed|Overall Study||104
8177094|NCT02392559|20162138|P1|Randomized and Dosed|Overall Study||53
8177095|NCT02392559|20162137|P2|STARTED|Overall Study||105
8177096|NCT02392559|20162138|P1|STARTED|Overall Study||53
8177097|NCT02392507|20162169|P1|NOT COMPLETED|Maintenance Regimen||2
8177098|NCT02392507|20162169|P1|COMPLETED|Maintenance Regimen||32
8177099|NCT02392507|20162169|P1|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
8177100|NCT02392507|20162169|P1|NOT COMPLETED|Induction Regimen||7
8177101|NCT02392507|20162169|P1|COMPLETED|Induction Regimen||47
8177102|NCT02392507|20162169|P1|Received at Least 1 Dose of Study Drug|Induction Regimen||54
8177103|NCT02392507|20162169|P1|STARTED|Induction Regimen||54
8177104|NCT02392494|20162187|P4|NOT COMPLETED|Overall Study||0
8177105|NCT02392494|20162188|P3|NOT COMPLETED|Overall Study||0
8177106|NCT02392494|20162189|P2|NOT COMPLETED|Overall Study||0
8177107|NCT02392494|20162190|P1|NOT COMPLETED|Overall Study||0
8177108|NCT02392494|20162187|P4|COMPLETED|Overall Study||0
8177109|NCT02392494|20162188|P3|COMPLETED|Overall Study||3
8177110|NCT02392494|20162189|P2|COMPLETED|Overall Study||3
8177111|NCT02392494|20162190|P1|COMPLETED|Overall Study||3
8177112|NCT02392494|20162187|P4|STARTED|Overall Study||0
8177113|NCT02392494|20162188|P3|STARTED|Overall Study||3
8177114|NCT02392494|20162189|P2|STARTED|Overall Study||3
8177115|NCT02392494|20162190|P1|STARTED|Overall Study||3
8177116|NCT02392481|20162208|P4|NOT COMPLETED|Overall Study||2
8177117|NCT02392481|20162209|P3|NOT COMPLETED|Overall Study||2
8177118|NCT02392481|20162210|P2|NOT COMPLETED|Overall Study||0
8177119|NCT02392481|20162211|P1|NOT COMPLETED|Overall Study||0
8177120|NCT02392481|20162208|P4|COMPLETED|Overall Study||25
8177121|NCT02392481|20162209|P3|COMPLETED|Overall Study||18
8177122|NCT02392481|20162210|P2|COMPLETED|Overall Study||12
8177123|NCT02392481|20162211|P1|COMPLETED|Overall Study||10
8177124|NCT02392481|20162208|P4|STARTED|Overall Study||27
8177125|NCT02392481|20162209|P3|STARTED|Overall Study||20
8177126|NCT02392481|20162210|P2|STARTED|Overall Study||12
8177127|NCT02392481|20162211|P1|STARTED|Overall Study||10
8177128|NCT02392403|20162233|P1|NOT COMPLETED|Overall Study||3
8177129|NCT02392403|20162233|P1|COMPLETED|Overall Study||42
8177130|NCT02392403|20162233|P1|STARTED|Overall Study||45
8177131|NCT02392377|20162247|P2|NOT COMPLETED|Overall Study||1
8177132|NCT02392377|20162248|P1|NOT COMPLETED|Overall Study||0
8177133|NCT02392377|20162247|P2|COMPLETED|Overall Study||0
8177134|NCT02392377|20162248|P1|COMPLETED|Overall Study||0
8177135|NCT02392377|20162247|P2|STARTED|Overall Study||1
8177136|NCT02392377|20162248|P1|STARTED|Overall Study||0
8177143|NCT02392286|20162323|P2|NOT COMPLETED|Overall Study||2
8177144|NCT02392286|20162324|P1|NOT COMPLETED|Overall Study||3
8177145|NCT02392286|20162323|P2|COMPLETED|Overall Study||6
8177146|NCT02392286|20162324|P1|COMPLETED|Overall Study||4
8177147|NCT02392286|20162323|P2|STARTED|Overall Study||8
8177148|NCT02392286|20162324|P1|STARTED|Overall Study||7
8177149|NCT02392247|20162340|P1|NOT COMPLETED|Overall Study||2
8177150|NCT02392247|20162340|P1|COMPLETED|Overall Study||50
8177151|NCT02392247|20162340|P1|STARTED|Overall Study||52
8177152|NCT02392234|20162351|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177153|NCT02392234|20162352|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177154|NCT02392234|20162353|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177155|NCT02392234|20162354|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177156|NCT02392234|20162355|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177157|NCT02392234|20162356|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
8177158|NCT02392234|20162351|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
8177159|NCT02392234|20162352|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
8177160|NCT02392234|20162353|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
8177161|NCT02392234|20162354|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
8177162|NCT02392234|20162355|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
8177163|NCT02392234|20162356|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
8177164|NCT02392234|20162351|P6|STARTED|Treatment Period 2 (8 Weeks)||38
8177165|NCT02392234|20162352|P5|STARTED|Treatment Period 2 (8 Weeks)||37
8177166|NCT02392234|20162353|P4|STARTED|Treatment Period 2 (8 Weeks)||41
8177167|NCT02392234|20162354|P3|STARTED|Treatment Period 2 (8 Weeks)||38
8177168|NCT02392234|20162355|P2|STARTED|Treatment Period 2 (8 Weeks)||43
8177169|NCT02392234|20162356|P1|STARTED|Treatment Period 2 (8 Weeks)||38
8177170|NCT02392234|20162351|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
8177171|NCT02392234|20162352|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
8177172|NCT02392234|20162353|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
8177173|NCT02392234|20162354|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
8177174|NCT02392234|20162355|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
8177175|NCT02392234|20162356|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
8177176|NCT02392234|20162351|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
8177177|NCT02392234|20162352|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
8177178|NCT02392234|20162353|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
8177179|NCT02392234|20162354|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
8177180|NCT02392234|20162355|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
8177181|NCT02392234|20162356|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
8177182|NCT02392234|20162351|P6|Treated|Treatment Period 1 (8 Weeks)||41
8177183|NCT02392234|20162352|P5|Treated|Treatment Period 1 (8 Weeks)||40
8177184|NCT02392234|20162353|P4|Treated|Treatment Period 1 (8 Weeks)||42
8177185|NCT02392234|20162354|P3|Treated|Treatment Period 1 (8 Weeks)||39
8177186|NCT02392234|20162355|P2|Treated|Treatment Period 1 (8 Weeks)||43
8177187|NCT02392234|20162356|P1|Treated|Treatment Period 1 (8 Weeks)||41
8177188|NCT02392234|20162351|P6|STARTED|Treatment Period 1 (8 Weeks)||41
8177189|NCT02392234|20162352|P5|STARTED|Treatment Period 1 (8 Weeks)||41
8177190|NCT02392234|20162353|P4|STARTED|Treatment Period 1 (8 Weeks)||42
8177191|NCT02392234|20162354|P3|STARTED|Treatment Period 1 (8 Weeks)||40
8177192|NCT02392234|20162355|P2|STARTED|Treatment Period 1 (8 Weeks)||43
8177193|NCT02392234|20162356|P1|STARTED|Treatment Period 1 (8 Weeks)||41
8177194|NCT02392208|20162378|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
8177195|NCT02392208|20162378|P1|COMPLETED|Telavancin After Hemodialysis||8
8177196|NCT02392208|20162378|P1|STARTED|Telavancin After Hemodialysis||8
8177197|NCT02392208|20162378|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
8177198|NCT02392208|20162378|P1|COMPLETED|Telavancin Before Hemodialysis||8
8177199|NCT02392208|20162378|P1|STARTED|Telavancin Before Hemodialysis||8
8177200|NCT02392195|20162388|P1|NOT COMPLETED|Overall Study||8
8177201|NCT02392195|20162388|P1|COMPLETED|Overall Study||2
8177202|NCT02392195|20162388|P1|STARTED|Overall Study||10
8177203|NCT02392104|20162394|P1|NOT COMPLETED|Overall Study||11
8177204|NCT02392104|20162394|P1|COMPLETED|Overall Study||39
8177205|NCT02392104|20162394|P1|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
8177206|NCT02392000|20162405|P1|NOT COMPLETED|Overall Study||27
8177207|NCT02392000|20162405|P1|COMPLETED|Overall Study||11
8177208|NCT02392000|20162405|P1|STARTED|Overall Study||38
8177209|NCT02391987|20162415|P2|NOT COMPLETED|Overall Study||0
8177210|NCT02391987|20162416|P1|NOT COMPLETED|Overall Study||0
8177211|NCT02391987|20162415|P2|COMPLETED|Overall Study||58
8177212|NCT02391987|20162416|P1|COMPLETED|Overall Study||54
8177213|NCT02391987|20162415|P2|STARTED|Overall Study||58
8177214|NCT02391987|20162416|P1|STARTED|Overall Study||54
8177215|NCT02391961|20162428|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8177216|NCT02391961|20162429|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8177217|NCT02391961|20162428|P2|COMPLETED|Second Intervention (4 Weeks)||7
8177218|NCT02391961|20162429|P1|COMPLETED|Second Intervention (4 Weeks)||6
8177219|NCT02391961|20162428|P2|STARTED|Second Intervention (4 Weeks)||8
8177220|NCT02391961|20162429|P1|STARTED|Second Intervention (4 Weeks)||7
8177221|NCT02391961|20162428|P2|NOT COMPLETED|Washout (2 Weeks)||1
8177222|NCT02391961|20162429|P1|NOT COMPLETED|Washout (2 Weeks)||1
8177223|NCT02391961|20162428|P2|COMPLETED|Washout (2 Weeks)||8
8177224|NCT02391961|20162429|P1|COMPLETED|Washout (2 Weeks)||7
8177225|NCT02391961|20162428|P2|STARTED|Washout (2 Weeks)||9
8177226|NCT02391961|20162429|P1|STARTED|Washout (2 Weeks)||8
8177227|NCT02391961|20162428|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8177228|NCT02391961|20162429|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8177229|NCT02391961|20162428|P2|COMPLETED|First Intervention (4 Weeks)||9
8177230|NCT02391961|20162429|P1|COMPLETED|First Intervention (4 Weeks)||8
8177231|NCT02391961|20162428|P2|STARTED|First Intervention (4 Weeks)||9
8177232|NCT02391961|20162429|P1|STARTED|First Intervention (4 Weeks)||10
8177233|NCT02391948|20162452|P5|NOT COMPLETED|24-month Assessment||10
8177234|NCT02391948|20162453|P4|NOT COMPLETED|24-month Assessment||9
8177235|NCT02391948|20162454|P3|NOT COMPLETED|24-month Assessment||3
8177236|NCT02391948|20162455|P2|NOT COMPLETED|24-month Assessment||10
8177237|NCT02391948|20162456|P1|NOT COMPLETED|24-month Assessment||14
8177238|NCT02391948|20162452|P5|COMPLETED|24-month Assessment||69
8177239|NCT02391948|20162453|P4|COMPLETED|24-month Assessment||75
8177240|NCT02391948|20162454|P3|COMPLETED|24-month Assessment||48
8177241|NCT02391948|20162455|P2|COMPLETED|24-month Assessment||97
8177242|NCT02391948|20162456|P1|COMPLETED|24-month Assessment||135
8177243|NCT02391948|20162452|P5|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
8177244|NCT02391948|20162453|P4|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
8177245|NCT02391948|20162454|P3|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
8177246|NCT02391948|20162455|P2|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
8177247|NCT02391948|20162456|P1|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
8177248|NCT02391948|20162452|P5|NOT COMPLETED|18-month Assessment||30
8177249|NCT02391948|20162453|P4|NOT COMPLETED|18-month Assessment||36
8177250|NCT02391948|20162454|P3|NOT COMPLETED|18-month Assessment||26
8177251|NCT02391948|20162455|P2|NOT COMPLETED|18-month Assessment||50
8177252|NCT02391948|20162456|P1|NOT COMPLETED|18-month Assessment||72
8177253|NCT02391948|20162452|P5|COMPLETED|18-month Assessment||75
8177254|NCT02391948|20162453|P4|COMPLETED|18-month Assessment||83
8177255|NCT02391948|20162454|P3|COMPLETED|18-month Assessment||48
8177256|NCT02391948|20162455|P2|COMPLETED|18-month Assessment||101
8177257|NCT02391948|20162456|P1|COMPLETED|18-month Assessment||147
8177258|NCT02391948|20162452|P5|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
8177259|NCT02391948|20162453|P4|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
8177260|NCT02391948|20162454|P3|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
8177261|NCT02391948|20162455|P2|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
8177262|NCT02391948|20162456|P1|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
8177263|NCT02391948|20162452|P5|NOT COMPLETED|12-month Assessment||6
8177264|NCT02391948|20162453|P4|NOT COMPLETED|12-month Assessment||9
8177265|NCT02391948|20162454|P3|NOT COMPLETED|12-month Assessment||4
8177266|NCT02391948|20162455|P2|NOT COMPLETED|12-month Assessment||9
8177267|NCT02391948|20162456|P1|NOT COMPLETED|12-month Assessment||8
8177268|NCT02391948|20162452|P5|COMPLETED|12-month Assessment||103
8177269|NCT02391948|20162453|P4|COMPLETED|12-month Assessment||116
8177270|NCT02391948|20162454|P3|COMPLETED|12-month Assessment||73
8177271|NCT02391948|20162455|P2|COMPLETED|12-month Assessment||147
8177272|NCT02391948|20162456|P1|COMPLETED|12-month Assessment||217
8177273|NCT02391948|20162452|P5|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
8177274|NCT02391948|20162453|P4|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
8177275|NCT02391948|20162454|P3|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
8177276|NCT02391948|20162455|P2|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
8177277|NCT02391948|20162456|P1|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
8177278|NCT02391948|20162452|P5|NOT COMPLETED|6-month Assessment||26
8177279|NCT02391948|20162453|P4|NOT COMPLETED|6-month Assessment||45
8177280|NCT02391948|20162454|P3|NOT COMPLETED|6-month Assessment||31
8177281|NCT02391948|20162455|P2|NOT COMPLETED|6-month Assessment||56
8177282|NCT02391948|20162456|P1|NOT COMPLETED|6-month Assessment||79
8177283|NCT02391948|20162452|P5|COMPLETED|6-month Assessment||85
8177284|NCT02391948|20162453|P4|COMPLETED|6-month Assessment||84
8177285|NCT02391948|20162454|P3|COMPLETED|6-month Assessment||49
8177286|NCT02391948|20162455|P2|COMPLETED|6-month Assessment||105
8177287|NCT02391948|20162456|P1|COMPLETED|6-month Assessment||148
8177288|NCT02391948|20162452|P5|STARTED|6-month Assessment||111
8177289|NCT02391948|20162453|P4|STARTED|6-month Assessment||129
8177290|NCT02391948|20162454|P3|STARTED|6-month Assessment||80
8177291|NCT02391948|20162455|P2|STARTED|6-month Assessment||161
8177292|NCT02391948|20162456|P1|STARTED|6-month Assessment||227
8177293|NCT02391948|20162452|P5|NOT COMPLETED|Baseline||0
8177294|NCT02391948|20162453|P4|NOT COMPLETED|Baseline||0
8177295|NCT02391948|20162454|P3|NOT COMPLETED|Baseline||0
8177296|NCT02391948|20162455|P2|NOT COMPLETED|Baseline||0
8177297|NCT02391948|20162456|P1|NOT COMPLETED|Baseline||0
8177298|NCT02391948|20162452|P5|COMPLETED|Baseline||111
8177299|NCT02391948|20162453|P4|COMPLETED|Baseline||129
8177300|NCT02391948|20162454|P3|COMPLETED|Baseline||80
8177301|NCT02391948|20162455|P2|COMPLETED|Baseline||161
8177302|NCT02391948|20162456|P1|COMPLETED|Baseline||227
8177303|NCT02391948|20162452|P5|STARTED|Baseline||111
8177304|NCT02391948|20162453|P4|STARTED|Baseline||129
8177305|NCT02391948|20162454|P3|STARTED|Baseline||80
8177306|NCT02391948|20162455|P2|STARTED|Baseline||161
8177307|NCT02391948|20162456|P1|STARTED|Baseline||227
8177308|NCT02391714|20162550|P2|NOT COMPLETED|Overall Study||0
8177309|NCT02391714|20162551|P1|NOT COMPLETED|Overall Study||0
8177310|NCT02391714|20162550|P2|COMPLETED|Overall Study||40
8177311|NCT02391714|20162551|P1|COMPLETED|Overall Study||40
8177312|NCT02391714|20162550|P2|STARTED|Overall Study||40
8177313|NCT02391714|20162551|P1|STARTED|Overall Study||40
8177314|NCT02391701|20162563|P2|NOT COMPLETED|Overall Study||38
8177315|NCT02391701|20162564|P1|NOT COMPLETED|Overall Study||21
8177316|NCT02391701|20162563|P2|COMPLETED|Overall Study||315
8177317|NCT02391701|20162564|P1|COMPLETED|Overall Study||346
8177318|NCT02391701|20162563|P2|STARTED|Overall Study||353
8177319|NCT02391701|20162564|P1|STARTED|Overall Study||367
8177320|NCT02391584|20162580|P2|NOT COMPLETED|12 Month (End of Study)||0
8177321|NCT02391584|20162581|P1|NOT COMPLETED|12 Month (End of Study)||2
8177322|NCT02391584|20162580|P2|COMPLETED|12 Month (End of Study)||0
8177323|NCT02391584|20162581|P1|COMPLETED|12 Month (End of Study)||49
8177324|NCT02391584|20162580|P2|STARTED|12 Month (End of Study)||0
8177325|NCT02391584|20162581|P1|STARTED|12 Month (End of Study)||51
8177326|NCT02391584|20162580|P2|NOT COMPLETED|6 Month||0
8177327|NCT02391584|20162581|P1|NOT COMPLETED|6 Month||1
8177328|NCT02391584|20162580|P2|COMPLETED|6 Month||0
8177329|NCT02391584|20162581|P1|COMPLETED|6 Month||51
8177330|NCT02391584|20162580|P2|STARTED|6 Month||0
8177331|NCT02391584|20162581|P1|STARTED|6 Month||52
8177332|NCT02391584|20162580|P2|NOT COMPLETED|3 Month||0
8177333|NCT02391584|20162581|P1|NOT COMPLETED|3 Month||1
8177334|NCT02391584|20162580|P2|COMPLETED|3 Month||0
8177335|NCT02391584|20162581|P1|COMPLETED|3 Month||52
8177336|NCT02391584|20162580|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
8177337|NCT02391584|20162581|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
8177338|NCT02391584|20162580|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
8177339|NCT02391584|20162581|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
8177340|NCT02391584|20162580|P2|COMPLETED|Primary Endpoint (6-weeks)||27
8177341|NCT02391584|20162581|P1|COMPLETED|Primary Endpoint (6-weeks)||29
8177342|NCT02391584|20162580|P2|STARTED|Primary Endpoint (6-weeks)||29
8177343|NCT02391584|20162581|P1|STARTED|Primary Endpoint (6-weeks)||31
8177344|NCT02391545|20162598|P2|NOT COMPLETED|Overall Study||28
8177345|NCT02391545|20162599|P1|NOT COMPLETED|Overall Study||26
8177346|NCT02391545|20162598|P2|COMPLETED|Overall Study||0
8177347|NCT02391545|20162599|P1|COMPLETED|Overall Study||1
8177348|NCT02391545|20162598|P2|STARTED|Overall Study||28
8177349|NCT02391545|20162599|P1|STARTED|Overall Study||27
8177350|NCT02391363|20162619|P2|NOT COMPLETED|Overall Study||8
8177351|NCT02391363|20162620|P1|NOT COMPLETED|Overall Study||11
8177352|NCT02391363|20162619|P2|COMPLETED|Overall Study||56
8177353|NCT02391363|20162620|P1|COMPLETED|Overall Study||59
8177354|NCT02391363|20162619|P2|STARTED|Overall Study||64
8177355|NCT02391363|20162620|P1|STARTED|Overall Study||70
8177356|NCT02391350|20162686|P2|NOT COMPLETED|Overall Study||17
8177357|NCT02391350|20162687|P1|NOT COMPLETED|Overall Study||12
8177358|NCT02391350|20162686|P2|COMPLETED|Overall Study||93
8177359|NCT02391350|20162687|P1|COMPLETED|Overall Study||98
8177360|NCT02391350|20162686|P2|6-month Follow-up|Overall Study||96
8177361|NCT02391350|20162687|P1|6-month Follow-up|Overall Study||100
8177362|NCT02391350|20162686|P2|4-week Follow-up|Overall Study||105
8177363|NCT02391350|20162687|P1|4-week Follow-up|Overall Study||106
8177364|NCT02391350|20162686|P2|STARTED|Overall Study||110
8177365|NCT02391350|20162687|P1|STARTED|Overall Study||110
8177366|NCT02391311|20162705|P2|NOT COMPLETED|Overall Study||2
8177367|NCT02391311|20162706|P1|NOT COMPLETED|Overall Study||3
8177368|NCT02391311|20162705|P2|COMPLETED|Overall Study||19
8177369|NCT02391311|20162706|P1|COMPLETED|Overall Study||18
8177370|NCT02391311|20162705|P2|STARTED|Overall Study||21
8177371|NCT02391311|20162706|P1|STARTED|Overall Study||21
8177372|NCT02391116|20162714|P1|NOT COMPLETED|Survival Follow-up||4
8177373|NCT02391116|20162714|P1|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
8177374|NCT02391116|20162714|P1|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
8177375|NCT02391116|20162714|P1|NOT COMPLETED|Active Follow-up||3
8177376|NCT02391116|20162714|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
8177377|NCT02391116|20162714|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
8177378|NCT02391116|20162714|P1|NOT COMPLETED|Safety Follow-up||13
8177379|NCT02391116|20162714|P1|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
8177380|NCT02391116|20162714|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
8177381|NCT02391116|20162714|P1|NOT COMPLETED|Treatment||14
8177382|NCT02391116|20162714|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
8177383|NCT02391116|20162714|P1|Included in Per Protocol Set|Treatment||40
8177384|NCT02391116|20162714|P1|STARTED|Treatment||67
8177385|NCT02391038|20162768|P3|NOT COMPLETED|Overall Study||6
8177386|NCT02391038|20162769|P2|NOT COMPLETED|Overall Study||3
8177387|NCT02391038|20162770|P1|NOT COMPLETED|Overall Study||3
8177388|NCT02391038|20162768|P3|COMPLETED|Overall Study||0
8177389|NCT02391038|20162769|P2|COMPLETED|Overall Study||0
8177390|NCT02391038|20162770|P1|COMPLETED|Overall Study||0
8177391|NCT02391038|20162768|P3|STARTED|Overall Study||6
8177392|NCT02391038|20162769|P2|STARTED|Overall Study||3
8177393|NCT02391038|20162770|P1|STARTED|Overall Study||3
8177394|NCT02390791|20162886|P2|NOT COMPLETED|Overall Study||0
8177395|NCT02390791|20162887|P1|NOT COMPLETED|Overall Study||0
8177396|NCT02390791|20162886|P2|COMPLETED|Overall Study||45
8177397|NCT02390791|20162887|P1|COMPLETED|Overall Study||40
8177398|NCT02390791|20162886|P2|STARTED|Overall Study||45
8177399|NCT02390791|20162887|P1|STARTED|Overall Study||40
8177400|NCT02390557|20162914|P3|NOT COMPLETED|Wave 2||23
8177401|NCT02390557|20162915|P2|NOT COMPLETED|Wave 2||41
8177402|NCT02390557|20162916|P1|NOT COMPLETED|Wave 2||72
8177403|NCT02390557|20162914|P3|COMPLETED|Wave 2||112
8177404|NCT02390557|20162915|P2|COMPLETED|Wave 2||115
8177405|NCT02390557|20162916|P1|COMPLETED|Wave 2||88
8177406|NCT02390557|20162914|P3|STARTED|Wave 2||135
8177407|NCT02390557|20162915|P2|STARTED|Wave 2||156
8177408|NCT02390557|20162916|P1|STARTED|Wave 2||160
8177409|NCT02390557|20162914|P3|NOT COMPLETED|Wave 1||0
8177410|NCT02390557|20162915|P2|NOT COMPLETED|Wave 1||0
8177411|NCT02390557|20162916|P1|NOT COMPLETED|Wave 1||0
8177412|NCT02390557|20162914|P3|COMPLETED|Wave 1||135
8177413|NCT02390557|20162915|P2|COMPLETED|Wave 1||156
8177414|NCT02390557|20162916|P1|COMPLETED|Wave 1||160
8177415|NCT02390557|20162914|P3|STARTED|Wave 1||135
8177416|NCT02390557|20162915|P2|STARTED|Wave 1||156
8177417|NCT02390557|20162916|P1|STARTED|Wave 1||160
8177418|NCT02390362|20162926|P2|NOT COMPLETED|Overall Study||1
8177419|NCT02390362|20162927|P1|NOT COMPLETED|Overall Study||0
8177420|NCT02390362|20162926|P2|COMPLETED|Overall Study||1
8177421|NCT02390362|20162927|P1|COMPLETED|Overall Study||1
8177422|NCT02390362|20162926|P2|STARTED|Overall Study||2
8177423|NCT02390362|20162927|P1|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
8177424|NCT02390219|20162935|P1|NOT COMPLETED|Overall Study||13
8177425|NCT02390219|20162935|P1|COMPLETED|Overall Study||33
8177426|NCT02390219|20162935|P1|STARTED|Overall Study||46
8177427|NCT02390167|20162945|P1|NOT COMPLETED|Overall Study||1
8177428|NCT02390167|20162945|P1|COMPLETED|Overall Study||375
8177429|NCT02390167|20162945|P1|Without Diabetes|Overall Study||43
8177430|NCT02390167|20162945|P1|With Diabetes|Overall Study||333
8177431|NCT02390167|20162945|P1|STARTED|Overall Study||376
8177432|NCT02390076|20162967|P3|NOT COMPLETED|Overall Study||4
8177433|NCT02390076|20162968|P2|NOT COMPLETED|Overall Study||1
8177434|NCT02390076|20162969|P1|NOT COMPLETED|Overall Study||2
8177435|NCT02390076|20162967|P3|COMPLETED|Overall Study||11
8177436|NCT02390076|20162968|P2|COMPLETED|Overall Study||17
8177437|NCT02390076|20162969|P1|COMPLETED|Overall Study||16
8177438|NCT02390076|20162967|P3|STARTED|Overall Study||15
8177439|NCT02390076|20162968|P2|STARTED|Overall Study||18
8177440|NCT02390076|20162969|P1|STARTED|Overall Study||18
8177441|NCT02389946|20162982|P2|NOT COMPLETED|Overall Study||15
8177442|NCT02389946|20162983|P1|NOT COMPLETED|Overall Study||24
8177443|NCT02389946|20162982|P2|COMPLETED|Overall Study||435
8177444|NCT02389946|20162983|P1|COMPLETED|Overall Study||860
8177445|NCT02389946|20162982|P2|STARTED|Overall Study||450
8177446|NCT02389946|20162983|P1|STARTED|Overall Study||884
8177447|NCT02389894|20162998|P3|NOT COMPLETED|Overall Study||9
8177448|NCT02389894|20162999|P2|NOT COMPLETED|Overall Study||10
8177449|NCT02389894|20163000|P1|NOT COMPLETED|Overall Study||8
8177450|NCT02389894|20162998|P3|COMPLETED|Overall Study||123
8177451|NCT02389894|20162999|P2|COMPLETED|Overall Study||108
8177452|NCT02389894|20163000|P1|COMPLETED|Overall Study||125
8177453|NCT02389894|20162998|P3|STARTED|Overall Study||132
8177454|NCT02389894|20162999|P2|STARTED|Overall Study||118
8177455|NCT02389894|20163000|P1|STARTED|Overall Study||133
8177456|NCT02389881|20163075|P7|NOT COMPLETED|Overall Study||0
8177457|NCT02389881|20163076|P6|NOT COMPLETED|Overall Study||0
8177458|NCT02389881|20163077|P5|NOT COMPLETED|Overall Study||0
8177459|NCT02389881|20163078|P4|NOT COMPLETED|Overall Study||0
8177460|NCT02389881|20163079|P3|NOT COMPLETED|Overall Study||0
8177461|NCT02389881|20163080|P2|NOT COMPLETED|Overall Study||0
8177462|NCT02389881|20163081|P1|NOT COMPLETED|Overall Study||0
8177463|NCT02389881|20163075|P7|COMPLETED|Overall Study||2
8177464|NCT02389881|20163076|P6|COMPLETED|Overall Study||8
8177465|NCT02389881|20163077|P5|COMPLETED|Overall Study||6
8177466|NCT02389881|20163078|P4|COMPLETED|Overall Study||6
8177467|NCT02389881|20163079|P3|COMPLETED|Overall Study||6
8177468|NCT02389881|20163080|P2|COMPLETED|Overall Study||6
8177469|NCT02389881|20163081|P1|COMPLETED|Overall Study||6
8177470|NCT02389881|20163075|P7|STARTED|Overall Study||2
8177471|NCT02389881|20163076|P6|STARTED|Overall Study||8
8177472|NCT02389881|20163077|P5|STARTED|Overall Study||6
8177473|NCT02389881|20163078|P4|STARTED|Overall Study||6
8177474|NCT02389881|20163079|P3|STARTED|Overall Study||6
8177475|NCT02389881|20163080|P2|STARTED|Overall Study||6
8177476|NCT02389881|20163081|P1|STARTED|Overall Study||6
8177477|NCT02389829|20163132|P2|NOT COMPLETED|Overall Study||1
8177478|NCT02389829|20163133|P1|NOT COMPLETED|Overall Study||0
8177479|NCT02389829|20163132|P2|COMPLETED|Overall Study||62
8177480|NCT02389829|20163133|P1|COMPLETED|Overall Study||64
8177481|NCT02389829|20163132|P2|STARTED|Overall Study||63
8177482|NCT02389829|20163133|P1|STARTED|Overall Study||64
8177483|NCT02389816|20163148|P3|NOT COMPLETED|Overall Study||12
8177484|NCT02389816|20163149|P2|NOT COMPLETED|Overall Study||13
8177485|NCT02389816|20163150|P1|NOT COMPLETED|Overall Study||15
8177486|NCT02389816|20163148|P3|COMPLETED|Overall Study||152
8177487|NCT02389816|20163149|P2|COMPLETED|Overall Study||152
8177488|NCT02389816|20163150|P1|COMPLETED|Overall Study||149
8177489|NCT02389816|20163148|P3|STARTED|Overall Study||164
8177490|NCT02389816|20163149|P2|STARTED|Overall Study||165
8177491|NCT02389816|20163150|P1|STARTED|Overall Study||164
8177492|NCT02389764|20163182|P1|NOT COMPLETED|Overall Study||9
8177493|NCT02389764|20163182|P1|COMPLETED|Overall Study||0
8177494|NCT02389764|20163182|P1|STARTED|Overall Study||9
8177495|NCT02389738|20163187|P1|NOT COMPLETED|Overall Study||1
8177496|NCT02389738|20163187|P1|COMPLETED|Overall Study||5
8177497|NCT02389738|20163187|P1|STARTED|Overall Study||6
8177498|NCT02389725|20163193|P2|NOT COMPLETED|Overall Study||0
8177499|NCT02389725|20163194|P1|NOT COMPLETED|Overall Study||0
8177500|NCT02389725|20163193|P2|COMPLETED|Overall Study||60
8177501|NCT02389725|20163194|P1|COMPLETED|Overall Study||59
8177502|NCT02389725|20163193|P2|STARTED|Overall Study||60
8177503|NCT02389725|20163194|P1|STARTED|Overall Study||59
8177504|NCT02389712|20163208|P2|NOT COMPLETED|Overall Study||0
8177505|NCT02389712|20163209|P1|NOT COMPLETED|Overall Study||0
8177506|NCT02389712|20163208|P2|COMPLETED|Overall Study||1
8177507|NCT02389712|20163209|P1|COMPLETED|Overall Study||1
8177508|NCT02389712|20163208|P2|STARTED|Overall Study||1
8177509|NCT02389712|20163209|P1|STARTED|Overall Study||1
8177510|NCT02389621|20163217|P2|NOT COMPLETED|Posttreatment Period||4
8177511|NCT02389621|20163218|P1|NOT COMPLETED|Posttreatment Period||9
8177512|NCT02389621|20163217|P2|COMPLETED|Posttreatment Period||102
8177513|NCT02389621|20163218|P1|COMPLETED|Posttreatment Period||98
8177514|NCT02389621|20163217|P2|STARTED|Posttreatment Period||106
8177515|NCT02389621|20163218|P1|STARTED|Posttreatment Period||107
8177516|NCT02389621|20163217|P2|NOT COMPLETED|Treatment Period||1
8177517|NCT02389621|20163218|P1|NOT COMPLETED|Treatment Period||1
8177518|NCT02389621|20163217|P2|COMPLETED|Treatment Period||106
8177519|NCT02389621|20163218|P1|COMPLETED|Treatment Period||107
8177520|NCT02389621|20163217|P2|Received Study Drug|Treatment Period||107
8177521|NCT02389621|20163218|P1|Received Study Drug|Treatment Period||107
8177522|NCT02389621|20163217|P2|STARTED|Treatment Period||107
8177523|NCT02389621|20163218|P1|STARTED|Treatment Period||108
8177524|NCT02389452|20163248|P1|NOT COMPLETED|Overall Study||25
8177525|NCT02389452|20163248|P1|COMPLETED|Overall Study||369
8177526|NCT02389452|20163248|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
8177527|NCT02389452|20163248|P1|STARTED|Overall Study||394
8177528|NCT02389374|20163269|P3|NOT COMPLETED|Overall Study||1
8177529|NCT02389374|20163270|P2|NOT COMPLETED|Overall Study||28
8177530|NCT02389374|20163271|P1|NOT COMPLETED|Overall Study||9
8177531|NCT02389374|20163269|P3|COMPLETED|Overall Study||10
8177532|NCT02389374|20163270|P2|COMPLETED|Overall Study||87
8177533|NCT02389374|20163271|P1|COMPLETED|Overall Study||46
8177534|NCT02389374|20163269|P3|STARTED|Overall Study||11
8177535|NCT02389374|20163270|P2|STARTED|Overall Study||115
8177536|NCT02389374|20163271|P1|STARTED|Overall Study||55
8177537|NCT02389361|20163303|P2|NOT COMPLETED|Overall Study||0
8177538|NCT02389361|20163304|P1|NOT COMPLETED|Overall Study||0
8177539|NCT02389361|20163303|P2|COMPLETED|Overall Study||27
8177540|NCT02389361|20163304|P1|COMPLETED|Overall Study||24
8177541|NCT02389361|20163303|P2|STARTED|Overall Study||27
8177542|NCT02389361|20163304|P1|STARTED|Overall Study||24
8177543|NCT02389101|20163310|P1|NOT COMPLETED|Overall Study||0
8177544|NCT02389101|20163310|P1|COMPLETED|Overall Study||21
8177545|NCT02389101|20163310|P1|STARTED|Overall Study||21
8177546|NCT02389088|20163314|P1|NOT COMPLETED|Phase II - All Study Participants||0
8177547|NCT02389088|20163314|P1|COMPLETED|Phase II - All Study Participants||9
8177548|NCT02389088|20163314|P1|STARTED|Phase II - All Study Participants||9
8177549|NCT02389088|20163314|P1|NOT COMPLETED|Overall Study - Phase I||0
8177550|NCT02389088|20163314|P1|COMPLETED|Overall Study - Phase I||9
8177551|NCT02389088|20163314|P1|STARTED|Overall Study - Phase I||9
8177552|NCT02388997|20163360|P2|NOT COMPLETED|Overall Study||6
8177553|NCT02388997|20163361|P1|NOT COMPLETED|Overall Study||3
8177554|NCT02388997|20163360|P2|COMPLETED|Overall Study||10
8177555|NCT02388997|20163361|P1|COMPLETED|Overall Study||12
8177556|NCT02388997|20163360|P2|STARTED|Overall Study||16
8177557|NCT02388997|20163361|P1|STARTED|Overall Study||15
8177558|NCT02388932|20163379|P1|NOT COMPLETED|Overall Study||1
8177559|NCT02388932|20163379|P1|COMPLETED|Overall Study||2
8177560|NCT02388932|20163379|P1|STARTED|Overall Study||3
8177561|NCT02388880|20163389|P1|NOT COMPLETED|Overall Study||0
8177562|NCT02388880|20163389|P1|COMPLETED|Overall Study||3
8177563|NCT02388880|20163389|P1|STARTED|Overall Study||3
8177564|NCT02388815|20163396|P1|NOT COMPLETED|Overall Study||4
8177565|NCT02388815|20163396|P1|COMPLETED|Overall Study||85
8177566|NCT02388815|20163396|P1|STARTED|Overall Study||89
8177567|NCT02388776|20163400|P1|NOT COMPLETED|Overall Study||2
8177568|NCT02388776|20163400|P1|COMPLETED|Overall Study||0
8177569|NCT02388776|20163400|P1|STARTED|Overall Study||2
8177570|NCT02388763|20163405|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
8177571|NCT02388763|20163406|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
8177572|NCT02388763|20163405|P2|COMPLETED|Period 2, 10 Days of Wear||30
8177573|NCT02388763|20163406|P1|COMPLETED|Period 2, 10 Days of Wear||30
8177574|NCT02388763|20163405|P2|STARTED|Period 2, 10 Days of Wear||30
8177575|NCT02388763|20163406|P1|STARTED|Period 2, 10 Days of Wear||30
8177576|NCT02388763|20163405|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
8177577|NCT02388763|20163406|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
8177578|NCT02388763|20163405|P2|COMPLETED|Period 1, 10 Days of Wear||30
8177579|NCT02388763|20163406|P1|COMPLETED|Period 1, 10 Days of Wear||30
8177580|NCT02388763|20163405|P2|STARTED|Period 1, 10 Days of Wear||31
8177581|NCT02388763|20163406|P1|STARTED|Period 1, 10 Days of Wear||31
8177582|NCT02388763|20163405|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
8177583|NCT02388763|20163406|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
8177584|NCT02388763|20163405|P2|COMPLETED|Habitual, 10 Days of Wear||31
8177585|NCT02388763|20163406|P1|COMPLETED|Habitual, 10 Days of Wear||31
8177586|NCT02388763|20163405|P2|STARTED|Habitual, 10 Days of Wear||32
8177587|NCT02388763|20163406|P1|STARTED|Habitual, 10 Days of Wear||32
8177588|NCT02388737|20163420|P3|NOT COMPLETED|Overall Study||62
8177589|NCT02388737|20163421|P2|NOT COMPLETED|Overall Study||60
8177590|NCT02388737|20163422|P1|NOT COMPLETED|Overall Study||54
8177591|NCT02388737|20163420|P3|COMPLETED|Overall Study||180
8177592|NCT02388737|20163421|P2|COMPLETED|Overall Study||166
8177593|NCT02388737|20163422|P1|COMPLETED|Overall Study||181
8177594|NCT02388737|20163420|P3|STARTED|Overall Study||242
8177595|NCT02388737|20163421|P2|STARTED|Overall Study||226
8177596|NCT02388737|20163422|P1|STARTED|Overall Study||235
8177597|NCT02388724|20163456|P2|NOT COMPLETED|Overall Study||13
8177598|NCT02388724|20163457|P1|NOT COMPLETED|Overall Study||12
8177599|NCT02388724|20163456|P2|COMPLETED|Overall Study||224
8177600|NCT02388724|20163457|P1|COMPLETED|Overall Study||232
8177601|NCT02388724|20163456|P2|Safety Set: Randomized But Not Treated|Overall Study||2
8177602|NCT02388724|20163457|P1|Safety Set: Randomized But Not Treated|Overall Study||0
8177603|NCT02388724|20163456|P2|STARTED|Overall Study||237
8177604|NCT02388724|20163457|P1|STARTED|Overall Study||244
8177605|NCT02388568|20163481|P2|NOT COMPLETED|Overall Study||15
8177606|NCT02388568|20163482|P1|NOT COMPLETED|Overall Study||10
8177607|NCT02388568|20163481|P2|COMPLETED|Overall Study||53
8177608|NCT02388568|20163482|P1|COMPLETED|Overall Study||59
8177609|NCT02388568|20163481|P2|STARTED|Overall Study||68
8177610|NCT02388568|20163482|P1|STARTED|Overall Study||69
8177611|NCT02388386|20163498|P1|NOT COMPLETED|Overall Study||0
8177612|NCT02388386|20163498|P1|COMPLETED|Overall Study||10
8177613|NCT02388386|20163498|P1|STARTED|Overall Study||10
8177614|NCT02388347|20163511|P5|NOT COMPLETED|Overall Study||0
8177615|NCT02388347|20163512|P4|NOT COMPLETED|Overall Study||0
8177616|NCT02388347|20163513|P3|NOT COMPLETED|Overall Study||1
8177617|NCT02388347|20163514|P2|NOT COMPLETED|Overall Study||0
8177618|NCT02388347|20163515|P1|NOT COMPLETED|Overall Study||0
8177619|NCT02388347|20163511|P5|COMPLETED|Overall Study||6
8177620|NCT02388347|20163512|P4|COMPLETED|Overall Study||6
8177621|NCT02388347|20163513|P3|COMPLETED|Overall Study||5
8177622|NCT02388347|20163514|P2|COMPLETED|Overall Study||6
8177623|NCT02388347|20163515|P1|COMPLETED|Overall Study||8
8177624|NCT02388347|20163511|P5|STARTED|Overall Study||6
8177625|NCT02388347|20163512|P4|STARTED|Overall Study||6
8177626|NCT02388347|20163513|P3|STARTED|Overall Study||6
8177627|NCT02388347|20163514|P2|STARTED|Overall Study||6
8177628|NCT02388347|20163515|P1|STARTED|Overall Study||8
8177629|NCT02388321|20163582|P2|NOT COMPLETED|Overall Study||0
8177630|NCT02388321|20163583|P1|NOT COMPLETED|Overall Study||0
8177631|NCT02388321|20163582|P2|COMPLETED|Overall Study||11
8177632|NCT02388321|20163583|P1|COMPLETED|Overall Study||11
8177633|NCT02388321|20163582|P2|STARTED|Overall Study||11
8177634|NCT02388321|20163583|P1|STARTED|Overall Study||11
8177635|NCT02388295|20163594|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
8177636|NCT02388295|20163595|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
8177637|NCT02388295|20163596|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
8177638|NCT02388295|20163594|P3|COMPLETED|Treatment Weeks 3 to 12||17
8177639|NCT02388295|20163595|P2|COMPLETED|Treatment Weeks 3 to 12||13
8177640|NCT02388295|20163596|P1|COMPLETED|Treatment Weeks 3 to 12||15
8177641|NCT02388295|20163594|P3|STARTED|Treatment Weeks 3 to 12||17
8177642|NCT02388295|20163595|P2|STARTED|Treatment Weeks 3 to 12||14
8177643|NCT02388295|20163596|P1|STARTED|Treatment Weeks 3 to 12||16
8177644|NCT02388295|20163594|P3|NOT COMPLETED|Dose Escalation Week 2||1
8177645|NCT02388295|20163595|P2|NOT COMPLETED|Dose Escalation Week 2||2
8177646|NCT02388295|20163596|P1|NOT COMPLETED|Dose Escalation Week 2||1
8177647|NCT02388295|20163594|P3|COMPLETED|Dose Escalation Week 2||17
8177648|NCT02388295|20163595|P2|COMPLETED|Dose Escalation Week 2||14
8177649|NCT02388295|20163596|P1|COMPLETED|Dose Escalation Week 2||16
8177650|NCT02388295|20163594|P3|STARTED|Dose Escalation Week 2||18
8177651|NCT02388295|20163595|P2|STARTED|Dose Escalation Week 2||16
8177652|NCT02388295|20163596|P1|STARTED|Dose Escalation Week 2||17
8177653|NCT02388295|20163594|P3|NOT COMPLETED|Dose Escalation Week 1||2
8177654|NCT02388295|20163595|P2|NOT COMPLETED|Dose Escalation Week 1||3
8177655|NCT02388295|20163596|P1|NOT COMPLETED|Dose Escalation Week 1||2
8177656|NCT02388295|20163594|P3|COMPLETED|Dose Escalation Week 1||18
8177657|NCT02388295|20163595|P2|COMPLETED|Dose Escalation Week 1||16
8177658|NCT02388295|20163596|P1|COMPLETED|Dose Escalation Week 1||17
8177659|NCT02388295|20163594|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
8177660|NCT02388295|20163595|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
8177661|NCT02388295|20163596|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
8177662|NCT02388269|20163614|P3|NOT COMPLETED|Overall Study||10
8177663|NCT02388269|20163615|P2|NOT COMPLETED|Overall Study||2
8177664|NCT02388269|20163616|P1|NOT COMPLETED|Overall Study||9
8177665|NCT02388269|20163614|P3|COMPLETED|Overall Study||0
8177666|NCT02388269|20163615|P2|COMPLETED|Overall Study||38
8177667|NCT02388269|20163616|P1|COMPLETED|Overall Study||32
8177668|NCT02388269|20163614|P3|Open Label|Overall Study||0
8177669|NCT02388269|20163615|P2|Open Label|Overall Study||38
8177670|NCT02388269|20163616|P1|Open Label|Overall Study||37
8177671|NCT02388269|20163614|P3|Randomised Period|Overall Study||0
8177672|NCT02388269|20163615|P2|Randomised Period|Overall Study||40
8177673|NCT02388269|20163616|P1|Randomised Period|Overall Study||41
8177674|NCT02388269|20163614|P3|STARTED|Overall Study||10
8177675|NCT02388269|20163615|P2|STARTED|Overall Study||40
8177676|NCT02388269|20163616|P1|STARTED|Overall Study||41
8177677|NCT02388191|20163648|P2|NOT COMPLETED|Overall Study||0
8177678|NCT02388191|20163649|P1|NOT COMPLETED|Overall Study||1
8177679|NCT02388191|20163648|P2|COMPLETED|Overall Study||60
8177680|NCT02388191|20163649|P1|COMPLETED|Overall Study||58
8177681|NCT02388191|20163648|P2|STARTED|Overall Study||60
8177682|NCT02388191|20163649|P1|STARTED|Overall Study||59
8177683|NCT02388165|20163665|P2|NOT COMPLETED|Overall Study||130
8177684|NCT02388165|20163666|P1|NOT COMPLETED|Overall Study||127
8177685|NCT02388165|20163665|P2|COMPLETED|Overall Study||1594
8177686|NCT02388165|20163666|P1|COMPLETED|Overall Study||1599
8177687|NCT02388165|20163665|P2|Vaccinated (Safety Population)|Overall Study||1709
8177688|NCT02388165|20163666|P1|Vaccinated (Safety Population)|Overall Study||1708
8177689|NCT02388165|20163665|P2|STARTED|Overall Study||1724
8177690|NCT02388165|20163666|P1|STARTED|Overall Study||1726
8177691|NCT02388074|20163696|P1|NOT COMPLETED|Overall Study||3
8177692|NCT02388074|20163696|P1|COMPLETED|Overall Study||22
8177693|NCT02388074|20163696|P1|STARTED|Overall Study||25
8177694|NCT02387996|20163700|P1|NOT COMPLETED|Overall Study||204
8177695|NCT02387996|20163700|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
8177696|NCT02387996|20163700|P1|STARTED|Overall Study||270
8177697|NCT02387983|20163711|P1|NOT COMPLETED|Overall Study||7
8177698|NCT02387983|20163711|P1|COMPLETED|Overall Study||58
8177699|NCT02387983|20163711|P1|STARTED|Overall Study||65
8177700|NCT02387970|20163725|P2|NOT COMPLETED|Overall Study||2
8177701|NCT02387970|20163726|P1|NOT COMPLETED|Overall Study||1
8177702|NCT02387970|20163725|P2|COMPLETED|Overall Study||23
8177703|NCT02387970|20163726|P1|COMPLETED|Overall Study||26
8177704|NCT02387970|20163725|P2|STARTED|Overall Study||25
8177705|NCT02387970|20163726|P1|STARTED|Overall Study||27
8177706|NCT02387957|20163747|P3|NOT COMPLETED|Overall Study||20
8177707|NCT02387957|20163748|P2|NOT COMPLETED|Overall Study||21
8177708|NCT02387957|20163749|P1|NOT COMPLETED|Overall Study||21
8177709|NCT02387957|20163747|P3|COMPLETED|Overall Study|The study was discontinued|1
8177710|NCT02387957|20163748|P2|COMPLETED|Overall Study|The study was discontinued|0
8177711|NCT02387957|20163749|P1|COMPLETED|Overall Study|The study was discontinued|0
8177712|NCT02387957|20163747|P3|STARTED|Overall Study||21
8177713|NCT02387957|20163748|P2|STARTED|Overall Study||21
8177714|NCT02387957|20163749|P1|STARTED|Overall Study||21
8177715|NCT02387853|20163760|P1|NOT COMPLETED|Overall Study||3
8177716|NCT02387853|20163760|P1|COMPLETED|Overall Study||103
8177717|NCT02387853|20163760|P1|STARTED|Overall Study||106
8177718|NCT02387840|20163782|P6|NOT COMPLETED|Overall Study||1
8177719|NCT02387840|20163783|P5|NOT COMPLETED|Overall Study||0
8177720|NCT02387840|20163784|P4|NOT COMPLETED|Overall Study||0
8177721|NCT02387840|20163785|P3|NOT COMPLETED|Overall Study||0
8177722|NCT02387840|20163786|P2|NOT COMPLETED|Overall Study||0
8177723|NCT02387840|20163787|P1|NOT COMPLETED|Overall Study||0
8177724|NCT02387840|20163782|P6|COMPLETED|Overall Study||5
8177725|NCT02387840|20163783|P5|COMPLETED|Overall Study||4
8177726|NCT02387840|20163784|P4|COMPLETED|Overall Study||8
8177727|NCT02387840|20163785|P3|COMPLETED|Overall Study||6
8177728|NCT02387840|20163786|P2|COMPLETED|Overall Study||6
8177729|NCT02387840|20163787|P1|COMPLETED|Overall Study||4
8177730|NCT02387840|20163782|P6|STARTED|Overall Study||6
8177731|NCT02387840|20163783|P5|STARTED|Overall Study||4
8177732|NCT02387840|20163784|P4|STARTED|Overall Study||8
8177733|NCT02387840|20163785|P3|STARTED|Overall Study||6
8177734|NCT02387840|20163786|P2|STARTED|Overall Study||6
8177735|NCT02387840|20163787|P1|STARTED|Overall Study||4
8177736|NCT02387814|20163817|P4|NOT COMPLETED|Overall Study||0
8177737|NCT02387814|20163818|P3|NOT COMPLETED|Overall Study||0
8177738|NCT02387814|20163819|P2|NOT COMPLETED|Overall Study||0
8177739|NCT02387814|20163820|P1|NOT COMPLETED|Overall Study||0
8177740|NCT02387814|20163817|P4|COMPLETED|Overall Study||6
8177741|NCT02387814|20163818|P3|COMPLETED|Overall Study||10
8177742|NCT02387814|20163819|P2|COMPLETED|Overall Study||9
8177743|NCT02387814|20163820|P1|COMPLETED|Overall Study||10
8177744|NCT02387814|20163817|P4|Received Abemaciclib|Overall Study||6
8177745|NCT02387814|20163818|P3|Received Abemaciclib|Overall Study||10
8177746|NCT02387814|20163819|P2|Received Abemaciclib|Overall Study||9
8177747|NCT02387814|20163820|P1|Received Abemaciclib|Overall Study||10
8177748|NCT02387814|20163817|P4|STARTED|Overall Study||6
8177749|NCT02387814|20163818|P3|STARTED|Overall Study||10
8177750|NCT02387814|20163819|P2|STARTED|Overall Study||9
8177751|NCT02387814|20163820|P1|STARTED|Overall Study||10
8177752|NCT02387801|20163836|P2|NOT COMPLETED|Post-Treatment Follow-up||0
8177753|NCT02387801|20163837|P1|NOT COMPLETED|Post-Treatment Follow-up||0
8177754|NCT02387801|20163836|P2|COMPLETED|Post-Treatment Follow-up||12
8177755|NCT02387801|20163837|P1|COMPLETED|Post-Treatment Follow-up||0
8177756|NCT02387801|20163836|P2|STARTED|Post-Treatment Follow-up||12
8177757|NCT02387801|20163837|P1|STARTED|Post-Treatment Follow-up||0
8177758|NCT02387801|20163836|P2|NOT COMPLETED|Maintenance Dosing Period||0
8177759|NCT02387801|20163837|P1|NOT COMPLETED|Maintenance Dosing Period||0
8177760|NCT02387801|20163836|P2|COMPLETED|Maintenance Dosing Period||12
8177761|NCT02387801|20163837|P1|COMPLETED|Maintenance Dosing Period||0
8177762|NCT02387801|20163836|P2|STARTED|Maintenance Dosing Period||12
8177763|NCT02387801|20163837|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
8177764|NCT02387801|20163836|P2|NOT COMPLETED|Induction Dosing Period||0
8177765|NCT02387801|20163837|P1|NOT COMPLETED|Induction Dosing Period||0
8177766|NCT02387801|20163836|P2|COMPLETED|Induction Dosing Period||6
8177767|NCT02387801|20163837|P1|COMPLETED|Induction Dosing Period||6
8177768|NCT02387801|20163836|P2|STARTED|Induction Dosing Period||6
8177769|NCT02387801|20163837|P1|STARTED|Induction Dosing Period||6
8177770|NCT02387762|20163857|P2|NOT COMPLETED|Overall Study||0
8177771|NCT02387762|20163858|P1|NOT COMPLETED|Overall Study||1
8177772|NCT02387762|20163857|P2|COMPLETED|Overall Study||15
8177773|NCT02387762|20163858|P1|COMPLETED|Overall Study||15
8177774|NCT02387762|20163857|P2|STARTED|Overall Study||15
8177775|NCT02387762|20163858|P1|STARTED|Overall Study||16
8177776|NCT02387749|20163864|P1|NOT COMPLETED|Overall Study||0
8177777|NCT02387749|20163864|P1|COMPLETED|Overall Study||10
8177778|NCT02387749|20163864|P1|STARTED|Overall Study||10
8177779|NCT02387710|20163873|P2|NOT COMPLETED|Second Study Night||0
8177780|NCT02387710|20163874|P1|NOT COMPLETED|Second Study Night||0
8177781|NCT02387710|20163873|P2|COMPLETED|Second Study Night||7
8177782|NCT02387710|20163874|P1|COMPLETED|Second Study Night||9
8177783|NCT02387710|20163873|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
8177784|NCT02387710|20163874|P1|STARTED|Second Study Night||9
8177785|NCT02387710|20163873|P2|NOT COMPLETED|First Study Night||0
8177786|NCT02387710|20163874|P1|NOT COMPLETED|First Study Night||0
8177787|NCT02387710|20163873|P2|COMPLETED|First Study Night||9
8177788|NCT02387710|20163874|P1|COMPLETED|First Study Night||9
8177789|NCT02387710|20163873|P2|STARTED|First Study Night||9
8177790|NCT02387710|20163874|P1|STARTED|First Study Night||9
8177791|NCT02387580|20163890|P6|NOT COMPLETED|Overall Study||0
8177792|NCT02387580|20163891|P5|NOT COMPLETED|Overall Study||0
8177793|NCT02387580|20163892|P4|NOT COMPLETED|Overall Study||1
8177794|NCT02387580|20163893|P3|NOT COMPLETED|Overall Study||0
8177795|NCT02387580|20163894|P2|NOT COMPLETED|Overall Study||0
8177796|NCT02387580|20163895|P1|NOT COMPLETED|Overall Study||0
8177797|NCT02387580|20163890|P6|COMPLETED|Overall Study||8
8177798|NCT02387580|20163891|P5|COMPLETED|Overall Study||8
8177799|NCT02387580|20163892|P4|COMPLETED|Overall Study||7
8177800|NCT02387580|20163893|P3|COMPLETED|Overall Study||8
8177801|NCT02387580|20163894|P2|COMPLETED|Overall Study||8
8177802|NCT02387580|20163895|P1|COMPLETED|Overall Study||8
8177803|NCT02387580|20163890|P6|STARTED|Overall Study||8
8177804|NCT02387580|20163891|P5|STARTED|Overall Study||8
8177805|NCT02387580|20163892|P4|STARTED|Overall Study||8
8177806|NCT02387580|20163893|P3|STARTED|Overall Study||8
8177807|NCT02387580|20163894|P2|STARTED|Overall Study||8
8177808|NCT02387580|20163895|P1|STARTED|Overall Study||8
8177809|NCT02387554|20163931|P4|NOT COMPLETED|Overall Study||2
8177810|NCT02387554|20163932|P3|NOT COMPLETED|Overall Study||2
8177811|NCT02387554|20163933|P2|NOT COMPLETED|Overall Study||0
8177812|NCT02387554|20163934|P1|NOT COMPLETED|Overall Study||3
8177813|NCT02387554|20163931|P4|COMPLETED|Overall Study||6
8177814|NCT02387554|20163932|P3|COMPLETED|Overall Study||6
8177815|NCT02387554|20163933|P2|COMPLETED|Overall Study||7
8177816|NCT02387554|20163934|P1|COMPLETED|Overall Study||7
8177817|NCT02387554|20163931|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
8177818|NCT02387554|20163932|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
8177819|NCT02387554|20163933|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
8177820|NCT02387554|20163934|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
8177821|NCT02387502|20163947|P3|NOT COMPLETED|Overall Study||0
8177822|NCT02387502|20163948|P2|NOT COMPLETED|Overall Study||0
8177823|NCT02387502|20163949|P1|NOT COMPLETED|Overall Study||0
8177824|NCT02387502|20163947|P3|COMPLETED|Overall Study||40
8177825|NCT02387502|20163948|P2|COMPLETED|Overall Study||40
8177826|NCT02387502|20163949|P1|COMPLETED|Overall Study||40
8177827|NCT02387502|20163947|P3|STARTED|Overall Study||40
8177828|NCT02387502|20163948|P2|STARTED|Overall Study||40
8177829|NCT02387502|20163949|P1|STARTED|Overall Study||40
8177830|NCT02387476|20163959|P2|NOT COMPLETED|Overall Study||5
8177831|NCT02387476|20163960|P1|NOT COMPLETED|Overall Study||6
8177832|NCT02387476|20163959|P2|COMPLETED|Overall Study||17
8177833|NCT02387476|20163960|P1|COMPLETED|Overall Study||19
8177834|NCT02387476|20163959|P2|STARTED|Overall Study||22
8177835|NCT02387476|20163960|P1|STARTED|Overall Study||25
8177836|NCT02387372|20163988|P2|NOT COMPLETED|Overall Study||0
8177837|NCT02387372|20163989|P1|NOT COMPLETED|Overall Study||1
8177838|NCT02387372|20163988|P2|COMPLETED|Overall Study||10
8177839|NCT02387372|20163989|P1|COMPLETED|Overall Study||26
8177840|NCT02387372|20163988|P2|Treated|Overall Study||10
8177841|NCT02387372|20163989|P1|Treated|Overall Study||26
8177842|NCT02387372|20163988|P2|STARTED|Overall Study||10
8177843|NCT02387372|20163989|P1|STARTED|Overall Study||27
8177844|NCT02387359|20164038|P3|NOT COMPLETED|Overall Study||56
8177845|NCT02387359|20164039|P2|NOT COMPLETED|Overall Study||42
8177846|NCT02387359|20164040|P1|NOT COMPLETED|Overall Study||59
8177847|NCT02387359|20164038|P3|COMPLETED|Overall Study||293
8177848|NCT02387359|20164039|P2|COMPLETED|Overall Study||309
8177849|NCT02387359|20164040|P1|COMPLETED|Overall Study||295
8177850|NCT02387359|20164038|P3|STARTED|Overall Study||349
8177851|NCT02387359|20164039|P2|STARTED|Overall Study||351
8177852|NCT02387359|20164040|P1|STARTED|Overall Study||354
8177853|NCT02387268|20164072|P1|NOT COMPLETED|Overall Study||1
8177854|NCT02387268|20164072|P1|COMPLETED|Overall Study||9
8177855|NCT02387268|20164072|P1|STARTED|Overall Study||10
8177856|NCT02387164|20164079|P2|NOT COMPLETED|Overall Study||2
8177857|NCT02387164|20164080|P1|NOT COMPLETED|Overall Study||3
8177858|NCT02387164|20164079|P2|COMPLETED|Overall Study||11
8177859|NCT02387164|20164080|P1|COMPLETED|Overall Study||10
8177860|NCT02387164|20164079|P2|STARTED|Overall Study||13
8177861|NCT02387164|20164080|P1|STARTED|Overall Study||13
8177862|NCT02387008|20164105|P3|NOT COMPLETED|Overall Study||0
8177863|NCT02387008|20164106|P2|NOT COMPLETED|Overall Study||0
8177864|NCT02387008|20164107|P1|NOT COMPLETED|Overall Study||0
8177865|NCT02387008|20164105|P3|COMPLETED|Overall Study||4
8177866|NCT02387008|20164106|P2|COMPLETED|Overall Study||0
8177867|NCT02387008|20164107|P1|COMPLETED|Overall Study||2
8177868|NCT02387008|20164105|P3|STARTED|Overall Study||4
8177869|NCT02387008|20164106|P2|STARTED|Overall Study||0
8177870|NCT02387008|20164107|P1|STARTED|Overall Study||2
8177871|NCT02386995|20164124|P1|NOT COMPLETED|Overall Study||0
8177872|NCT02386995|20164124|P1|COMPLETED|Overall Study||30
8177873|NCT02386995|20164124|P1|STARTED|Overall Study||30
8177874|NCT02386345|20164129|P1|NOT COMPLETED|Overall Study||102
8177875|NCT02386345|20164129|P1|COMPLETED|Overall Study||197
8177876|NCT02386345|20164129|P1|STARTED|Overall Study||299
8177877|NCT02386189|20164139|P2|NOT COMPLETED|Overall Study||3
8177878|NCT02386189|20164140|P1|NOT COMPLETED|Overall Study||4
8177879|NCT02386189|20164139|P2|COMPLETED|Overall Study||30
8177880|NCT02386189|20164140|P1|COMPLETED|Overall Study||26
8177881|NCT02386189|20164139|P2|STARTED|Overall Study||33
8177882|NCT02386189|20164140|P1|STARTED|Overall Study||30
8177883|NCT02386098|20164163|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177884|NCT02386098|20164164|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177885|NCT02386098|20164165|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177886|NCT02386098|20164166|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177887|NCT02386098|20164167|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177888|NCT02386098|20164163|P5|COMPLETED|Stage 2 (96 Weeks)||0
8177889|NCT02386098|20164164|P4|COMPLETED|Stage 2 (96 Weeks)||0
8177890|NCT02386098|20164165|P3|COMPLETED|Stage 2 (96 Weeks)||0
8177891|NCT02386098|20164166|P2|COMPLETED|Stage 2 (96 Weeks)||0
8177892|NCT02386098|20164167|P1|COMPLETED|Stage 2 (96 Weeks)||0
8177893|NCT02386098|20164163|P5|STARTED|Stage 2 (96 Weeks)||0
8177894|NCT02386098|20164164|P4|STARTED|Stage 2 (96 Weeks)||0
8177895|NCT02386098|20164165|P3|STARTED|Stage 2 (96 Weeks)||0
8177896|NCT02386098|20164166|P2|STARTED|Stage 2 (96 Weeks)||0
8177897|NCT02386098|20164167|P1|STARTED|Stage 2 (96 Weeks)||0
8177898|NCT02386098|20164163|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
8177899|NCT02386098|20164164|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
8177900|NCT02386098|20164165|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
8177901|NCT02386098|20164166|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
8177902|NCT02386098|20164167|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
8177903|NCT02386098|20164163|P5|COMPLETED|Stage 1 (96 Weeks)||0
8177904|NCT02386098|20164164|P4|COMPLETED|Stage 1 (96 Weeks)||0
8177905|NCT02386098|20164165|P3|COMPLETED|Stage 1 (96 Weeks)||0
8177906|NCT02386098|20164166|P2|COMPLETED|Stage 1 (96 Weeks)||0
8177907|NCT02386098|20164167|P1|COMPLETED|Stage 1 (96 Weeks)||0
8177908|NCT02386098|20164163|P5|STARTED|Stage 1 (96 Weeks)||0
8177909|NCT02386098|20164164|P4|STARTED|Stage 1 (96 Weeks)||0
8177910|NCT02386098|20164165|P3|STARTED|Stage 1 (96 Weeks)||0
8177911|NCT02386098|20164166|P2|STARTED|Stage 1 (96 Weeks)||43
8177912|NCT02386098|20164167|P1|STARTED|Stage 1 (96 Weeks)||43
8177913|NCT02385799|20164246|P2|NOT COMPLETED|Overall Study||8
8177914|NCT02385799|20164247|P1|NOT COMPLETED|Overall Study||5
8177915|NCT02385799|20164246|P2|COMPLETED|Overall Study||24
8177916|NCT02385799|20164247|P1|COMPLETED|Overall Study||21
8177917|NCT02385799|20164246|P2|Completed End-of-Treatment Visit|Overall Study||26
8177918|NCT02385799|20164247|P1|Completed End-of-Treatment Visit|Overall Study||21
8177919|NCT02385799|20164246|P2|STARTED|Overall Study||32
8177920|NCT02385799|20164247|P1|STARTED|Overall Study||26
8177921|NCT02385721|20164281|P1|NOT COMPLETED|Overall Study||230
8177922|NCT02385721|20164281|P1|COMPLETED|Overall Study||371
8177923|NCT02385721|20164281|P1|STARTED|Overall Study||601
8177924|NCT02385708|20164288|P2|NOT COMPLETED|Overall Study||15
8177925|NCT02385708|20164289|P1|NOT COMPLETED|Overall Study||8
8177926|NCT02385708|20164288|P2|COMPLETED|Overall Study||67
8177927|NCT02385708|20164289|P1|COMPLETED|Overall Study||73
8177928|NCT02385708|20164288|P2|Intervention Started|Overall Study||82
8177929|NCT02385708|20164289|P1|Intervention Started|Overall Study||81
8177930|NCT02385708|20164288|P2|STARTED|Overall Study||82
8177931|NCT02385708|20164289|P1|STARTED|Overall Study||81
8177932|NCT02385669|20164295|P1|NOT COMPLETED|Overall Study||2
8177933|NCT02385669|20164295|P1|COMPLETED|Overall Study||1
8177934|NCT02385669|20164295|P1|STARTED|Overall Study||3
8177935|NCT02385526|20164303|P3|NOT COMPLETED|Overall Study||0
8177936|NCT02385526|20164304|P2|NOT COMPLETED|Overall Study||3
8177937|NCT02385526|20164305|P1|NOT COMPLETED|Overall Study||2
8177938|NCT02385526|20164303|P3|COMPLETED|Overall Study||20
8177939|NCT02385526|20164304|P2|COMPLETED|Overall Study||17
8177940|NCT02385526|20164305|P1|COMPLETED|Overall Study||20
8177941|NCT02385526|20164303|P3|STARTED|Overall Study||20
8177942|NCT02385526|20164304|P2|STARTED|Overall Study||20
8177943|NCT02385526|20164305|P1|STARTED|Overall Study||22
8177953|NCT02385240|20164329|P3|NOT COMPLETED|Overall Study||1
8177954|NCT02385240|20164330|P2|NOT COMPLETED|Overall Study||6
8177955|NCT02385240|20164331|P1|NOT COMPLETED|Overall Study||1
8177956|NCT02385240|20164329|P3|COMPLETED|Overall Study||184
8177957|NCT02385240|20164330|P2|COMPLETED|Overall Study||178
8177958|NCT02385240|20164331|P1|COMPLETED|Overall Study||182
8177959|NCT02385240|20164329|P3|STARTED|Overall Study||185
8177960|NCT02385240|20164330|P2|STARTED|Overall Study||184
8177961|NCT02385240|20164331|P1|STARTED|Overall Study||183
8177962|NCT02385084|20164345|P6|NOT COMPLETED|Period 3||0
8177963|NCT02385084|20164346|P5|NOT COMPLETED|Period 3||0
8177964|NCT02385084|20164347|P4|NOT COMPLETED|Period 3||0
8177965|NCT02385084|20164348|P3|NOT COMPLETED|Period 3||0
8177966|NCT02385084|20164349|P2|NOT COMPLETED|Period 3||0
8177967|NCT02385084|20164350|P1|NOT COMPLETED|Period 3||0
8177968|NCT02385084|20164345|P6|COMPLETED|Period 3||3
8177969|NCT02385084|20164346|P5|COMPLETED|Period 3||2
8177970|NCT02385084|20164347|P4|COMPLETED|Period 3||3
8177971|NCT02385084|20164348|P3|COMPLETED|Period 3||1
8177972|NCT02385084|20164349|P2|COMPLETED|Period 3||3
8177973|NCT02385084|20164350|P1|COMPLETED|Period 3||2
8177974|NCT02385084|20164345|P6|Washout|Period 3||3
8177975|NCT02385084|20164346|P5|Washout|Period 3||2
8177976|NCT02385084|20164347|P4|Washout|Period 3||3
8177977|NCT02385084|20164348|P3|Washout|Period 3||1
8177978|NCT02385084|20164349|P2|Washout|Period 3||3
8177979|NCT02385084|20164350|P1|Washout|Period 3||2
8177980|NCT02385084|20164345|P6|Received LY2409021|Period 3||3
8177981|NCT02385084|20164346|P5|Received LY2409021|Period 3||2
8177982|NCT02385084|20164347|P4|Received LY2409021|Period 3||3
8177983|NCT02385084|20164348|P3|Received LY2409021|Period 3||1
8177984|NCT02385084|20164349|P2|Received LY2409021|Period 3||3
8177985|NCT02385084|20164350|P1|Received LY2409021|Period 3||2
8177986|NCT02385084|20164345|P6|STARTED|Period 3||3
8177987|NCT02385084|20164346|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
8177988|NCT02385084|20164347|P4|STARTED|Period 3||3
8177989|NCT02385084|20164348|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
8177990|NCT02385084|20164349|P2|STARTED|Period 3||3
8177991|NCT02385084|20164350|P1|STARTED|Period 3||2
8177992|NCT02385084|20164345|P6|NOT COMPLETED|Period 2||0
8177993|NCT02385084|20164346|P5|NOT COMPLETED|Period 2||0
8177994|NCT02385084|20164347|P4|NOT COMPLETED|Period 2||0
8177995|NCT02385084|20164348|P3|NOT COMPLETED|Period 2||1
8177996|NCT02385084|20164349|P2|NOT COMPLETED|Period 2||0
8177997|NCT02385084|20164350|P1|NOT COMPLETED|Period 2||0
8177998|NCT02385084|20164345|P6|COMPLETED|Period 2||3
8177999|NCT02385084|20164346|P5|COMPLETED|Period 2||3
8178000|NCT02385084|20164347|P4|COMPLETED|Period 2||3
8178001|NCT02385084|20164348|P3|COMPLETED|Period 2||2
8178002|NCT02385084|20164349|P2|COMPLETED|Period 2||3
8178003|NCT02385084|20164350|P1|COMPLETED|Period 2||2
8178004|NCT02385084|20164345|P6|Washout|Period 2||3
8178005|NCT02385084|20164346|P5|Washout|Period 2||3
8178006|NCT02385084|20164347|P4|Washout|Period 2||3
8178007|NCT02385084|20164348|P3|Washout|Period 2||3
8178008|NCT02385084|20164349|P2|Washout|Period 2||3
8178009|NCT02385084|20164350|P1|Washout|Period 2||2
8178010|NCT02385084|20164345|P6|Received LY2409021|Period 2||3
8178011|NCT02385084|20164346|P5|Received LY2409021|Period 2||3
8178012|NCT02385084|20164347|P4|Received LY2409021|Period 2||3
8178013|NCT02385084|20164348|P3|Received LY2409021|Period 2||3
8178014|NCT02385084|20164349|P2|Received LY2409021|Period 2||3
8178015|NCT02385084|20164350|P1|Received LY2409021|Period 2||2
8178016|NCT02385084|20164345|P6|STARTED|Period 2||3
8178017|NCT02385084|20164346|P5|STARTED|Period 2||3
8178018|NCT02385084|20164347|P4|STARTED|Period 2||3
8178019|NCT02385084|20164348|P3|STARTED|Period 2||3
8178020|NCT02385084|20164349|P2|STARTED|Period 2||3
8178021|NCT02385084|20164350|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
8178022|NCT02385084|20164345|P6|NOT COMPLETED|Period 1||0
8178023|NCT02385084|20164346|P5|NOT COMPLETED|Period 1||0
8178024|NCT02385084|20164347|P4|NOT COMPLETED|Period 1||0
8178025|NCT02385084|20164348|P3|NOT COMPLETED|Period 1||0
8178026|NCT02385084|20164349|P2|NOT COMPLETED|Period 1||0
8178027|NCT02385084|20164350|P1|NOT COMPLETED|Period 1||0
8178028|NCT02385084|20164345|P6|COMPLETED|Period 1||3
8178029|NCT02385084|20164346|P5|COMPLETED|Period 1||3
8178030|NCT02385084|20164347|P4|COMPLETED|Period 1||3
8178031|NCT02385084|20164348|P3|COMPLETED|Period 1||3
8178032|NCT02385084|20164349|P2|COMPLETED|Period 1||3
8178033|NCT02385084|20164350|P1|COMPLETED|Period 1||3
8178034|NCT02385084|20164345|P6|Washout|Period 1||3
8178035|NCT02385084|20164346|P5|Washout|Period 1||3
8178036|NCT02385084|20164347|P4|Washout|Period 1||3
8178037|NCT02385084|20164348|P3|Washout|Period 1||3
8178038|NCT02385084|20164349|P2|Washout|Period 1||3
8178039|NCT02385084|20164350|P1|Washout|Period 1||3
8178040|NCT02385084|20164345|P6|Received LY2409021|Period 1||3
8178041|NCT02385084|20164346|P5|Received LY2409021|Period 1||3
8178042|NCT02385084|20164347|P4|Received LY2409021|Period 1||3
8178043|NCT02385084|20164348|P3|Received LY2409021|Period 1||3
8178044|NCT02385084|20164349|P2|Received LY2409021|Period 1||3
8178045|NCT02385084|20164350|P1|Received LY2409021|Period 1||3
8178046|NCT02385084|20164345|P6|STARTED|Period 1||3
8178047|NCT02385084|20164346|P5|STARTED|Period 1||3
8178048|NCT02385084|20164347|P4|STARTED|Period 1||3
8178049|NCT02385084|20164348|P3|STARTED|Period 1||3
8178050|NCT02385084|20164349|P2|STARTED|Period 1||3
8178051|NCT02385084|20164350|P1|STARTED|Period 1||3
8178052|NCT02384993|20164363|P2|NOT COMPLETED|Overall Study||1
8178053|NCT02384993|20164364|P1|NOT COMPLETED|Overall Study||0
8178054|NCT02384993|20164363|P2|COMPLETED|Overall Study||11
8178055|NCT02384993|20164364|P1|COMPLETED|Overall Study||12
8178056|NCT02384993|20164363|P2|STARTED|Overall Study||12
8178057|NCT02384993|20164364|P1|STARTED|Overall Study||12
8178058|NCT02384941|20164390|P3|NOT COMPLETED|Overall Study||41
8178059|NCT02384941|20164391|P2|NOT COMPLETED|Overall Study||35
8178060|NCT02384941|20164392|P1|NOT COMPLETED|Overall Study||50
8178061|NCT02384941|20164390|P3|COMPLETED|Overall Study||221
8178062|NCT02384941|20164391|P2|COMPLETED|Overall Study||228
8178063|NCT02384941|20164392|P1|COMPLETED|Overall Study||218
8178064|NCT02384941|20164390|P3|STARTED|Overall Study||262
8178065|NCT02384941|20164391|P2|STARTED|Overall Study||263
8178066|NCT02384941|20164392|P1|STARTED|Overall Study||268
8178067|NCT02384538|20164423|P2|NOT COMPLETED|Overall Study||15
8178068|NCT02384538|20164424|P1|NOT COMPLETED|Overall Study||6
8178069|NCT02384538|20164423|P2|COMPLETED|Overall Study||49
8178070|NCT02384538|20164424|P1|COMPLETED|Overall Study||61
8178071|NCT02384538|20164423|P2|STARTED|Overall Study||64
8178072|NCT02384538|20164424|P1|STARTED|Overall Study||67
8178073|NCT02384460|20164444|P2|NOT COMPLETED|Overall Study||7
8178074|NCT02384460|20164445|P1|NOT COMPLETED|Overall Study||7
8178075|NCT02384460|20164444|P2|COMPLETED|Overall Study||80
8178076|NCT02384460|20164445|P1|COMPLETED|Overall Study||75
8178077|NCT02384460|20164444|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
8178078|NCT02384460|20164445|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
8178079|NCT02384460|20164444|P2|STARTED|Overall Study||87
8178080|NCT02384460|20164445|P1|STARTED|Overall Study||82
8178081|NCT02384382|20164463|P1|NOT COMPLETED|Overall Study||23
8178082|NCT02384382|20164463|P1|COMPLETED|Overall Study||0
8178083|NCT02384382|20164463|P1|STARTED|Overall Study||23
8178084|NCT02384200|20164470|P2|NOT COMPLETED|Overall Study||0
8178085|NCT02384200|20164471|P1|NOT COMPLETED|Overall Study||0
8178086|NCT02384200|20164470|P2|COMPLETED|Overall Study||43
8178087|NCT02384200|20164471|P1|COMPLETED|Overall Study||43
8178088|NCT02384200|20164470|P2|STARTED|Overall Study||43
8178089|NCT02384200|20164471|P1|STARTED|Overall Study||43
8178090|NCT02384096|20164497|P2|NOT COMPLETED|Second Intervention (7 Days)||1
8178091|NCT02384096|20164498|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8178092|NCT02384096|20164497|P2|COMPLETED|Second Intervention (7 Days)||6
8178093|NCT02384096|20164498|P1|COMPLETED|Second Intervention (7 Days)||4
8178094|NCT02384096|20164497|P2|STARTED|Second Intervention (7 Days)||7
8178095|NCT02384096|20164498|P1|STARTED|Second Intervention (7 Days)||4
8178096|NCT02384096|20164497|P2|NOT COMPLETED|First Intervention (7 Days)||0
8178097|NCT02384096|20164498|P1|NOT COMPLETED|First Intervention (7 Days)||1
8178098|NCT02384096|20164497|P2|COMPLETED|First Intervention (7 Days)||7
8178099|NCT02384096|20164498|P1|COMPLETED|First Intervention (7 Days)||4
8178100|NCT02384096|20164497|P2|STARTED|First Intervention (7 Days)||7
8178101|NCT02384096|20164498|P1|STARTED|First Intervention (7 Days)||5
8178102|NCT02384070|20164506|P3|NOT COMPLETED|Overall Study||0
8178103|NCT02384070|20164507|P2|NOT COMPLETED|Overall Study||0
8178104|NCT02384070|20164508|P1|NOT COMPLETED|Overall Study||0
8178105|NCT02384070|20164506|P3|COMPLETED|Overall Study||100
8178106|NCT02384070|20164507|P2|COMPLETED|Overall Study||100
8178107|NCT02384070|20164508|P1|COMPLETED|Overall Study||100
8178108|NCT02384070|20164506|P3|STARTED|Overall Study||100
8178109|NCT02384070|20164507|P2|STARTED|Overall Study||100
8178110|NCT02384070|20164508|P1|STARTED|Overall Study||100
8178111|NCT02384044|20164524|P2|NOT COMPLETED|Overall Study||0
8178112|NCT02384044|20164525|P1|NOT COMPLETED|Overall Study||0
8178113|NCT02384044|20164524|P2|COMPLETED|Overall Study||15
8178114|NCT02384044|20164525|P1|COMPLETED|Overall Study||15
8178115|NCT02384044|20164524|P2|STARTED|Overall Study||15
8178116|NCT02384044|20164525|P1|STARTED|Overall Study||15
8178117|NCT02383966|20164535|P2|NOT COMPLETED|Overall Study||7
8178118|NCT02383966|20164536|P1|NOT COMPLETED|Overall Study||26
8178119|NCT02383966|20164535|P2|COMPLETED|Overall Study||72
8178120|NCT02383966|20164536|P1|COMPLETED|Overall Study||138
8178121|NCT02383966|20164535|P2|STARTED|Overall Study||79
8178122|NCT02383966|20164536|P1|STARTED|Overall Study||164
8178123|NCT02383940|20164556|P2|NOT COMPLETED|Overall Study||3
8178124|NCT02383940|20164557|P1|NOT COMPLETED|Overall Study||9
8178125|NCT02383940|20164556|P2|COMPLETED|Overall Study||40
8178126|NCT02383940|20164557|P1|COMPLETED|Overall Study||35
8178127|NCT02383940|20164556|P2|Treated|Overall Study||43
8178128|NCT02383940|20164557|P1|Treated|Overall Study||42
8178129|NCT02383940|20164556|P2|STARTED|Overall Study||43
8178130|NCT02383940|20164557|P1|STARTED|Overall Study||44
8178131|NCT02383862|20164573|P2|NOT COMPLETED|3 Month Follow up||21
8178132|NCT02383862|20164574|P1|NOT COMPLETED|3 Month Follow up||23
8178133|NCT02383862|20164573|P2|COMPLETED|3 Month Follow up||128
8178134|NCT02383862|20164574|P1|COMPLETED|3 Month Follow up||128
8178135|NCT02383862|20164573|P2|STARTED|3 Month Follow up||149
8178136|NCT02383862|20164574|P1|STARTED|3 Month Follow up||151
8178137|NCT02383862|20164573|P2|NOT COMPLETED|Baseline||0
8178138|NCT02383862|20164574|P1|NOT COMPLETED|Baseline||0
8178139|NCT02383862|20164573|P2|COMPLETED|Baseline||149
8178140|NCT02383862|20164574|P1|COMPLETED|Baseline||151
8178141|NCT02383862|20164573|P2|STARTED|Baseline||149
8178142|NCT02383862|20164574|P1|STARTED|Baseline||151
8178143|NCT02383758|20164607|P2|NOT COMPLETED|Overall Study||2
8178144|NCT02383758|20164608|P1|NOT COMPLETED|Overall Study||0
8178145|NCT02383758|20164607|P2|COMPLETED|Overall Study||8
8178146|NCT02383758|20164608|P1|COMPLETED|Overall Study||10
8178147|NCT02383758|20164607|P2|STARTED|Overall Study||10
8178148|NCT02383758|20164608|P1|STARTED|Overall Study||10
8178149|NCT02383719|20164620|P1|NOT COMPLETED|Overall Study||0
8178150|NCT02383719|20164620|P1|COMPLETED|Overall Study||18
8178151|NCT02383719|20164620|P1|STARTED|Overall Study||18
8178152|NCT02383706|20164624|P1|NOT COMPLETED|Overall Study||28
8178153|NCT02383706|20164624|P1|COMPLETED|Overall Study||80
8178154|NCT02383706|20164624|P1|STARTED|Overall Study||108
8178155|NCT02383667|20164630|P1|NOT COMPLETED|Overall Study||0
8178156|NCT02383667|20164630|P1|COMPLETED|Overall Study||20
8178157|NCT02383667|20164630|P1|STARTED|Overall Study||20
8178158|NCT02383589|20164636|P2|NOT COMPLETED|Safety Follow-up (SFU)||5
8178159|NCT02383589|20164637|P1|NOT COMPLETED|Safety Follow-up (SFU)||7
8178160|NCT02383589|20164636|P2|COMPLETED|Safety Follow-up (SFU)||53
8178161|NCT02383589|20164637|P1|COMPLETED|Safety Follow-up (SFU)||59
8178162|NCT02383589|20164636|P2|STARTED|Safety Follow-up (SFU)||58
8178163|NCT02383589|20164637|P1|STARTED|Safety Follow-up (SFU)||66
8178164|NCT02383589|20164636|P2|NOT COMPLETED|Treatment Period||10
8178165|NCT02383589|20164637|P1|NOT COMPLETED|Treatment Period||1
8178166|NCT02383589|20164636|P2|COMPLETED|Treatment Period||58
8178167|NCT02383589|20164637|P1|COMPLETED|Treatment Period||66
8178168|NCT02383589|20164636|P2|STARTED|Treatment Period||68
8178169|NCT02383589|20164637|P1|STARTED|Treatment Period||67
8178170|NCT02383576|20164662|P2|NOT COMPLETED|Overall Study||45
8178171|NCT02383576|20164663|P1|NOT COMPLETED|Overall Study||63
8178172|NCT02383576|20164662|P2|COMPLETED|Overall Study||46
8178173|NCT02383576|20164663|P1|COMPLETED|Overall Study||31
8178174|NCT02383576|20164662|P2|STARTED|Overall Study||91
8178175|NCT02383576|20164663|P1|STARTED|Overall Study||94
8178176|NCT02383472|20164679|P2|NOT COMPLETED|Overall Study||1
8178177|NCT02383472|20164680|P1|NOT COMPLETED|Overall Study||1
8178178|NCT02383472|20164679|P2|COMPLETED|Overall Study||29
8178179|NCT02383472|20164680|P1|COMPLETED|Overall Study||22
8178180|NCT02383472|20164679|P2|STARTED|Overall Study||30
8178181|NCT02383472|20164680|P1|STARTED|Overall Study||23
8178182|NCT02383433|20164694|P1|NOT COMPLETED|Overall Study||2
8178183|NCT02383433|20164694|P1|COMPLETED|Overall Study||0
8178184|NCT02383433|20164694|P1|STARTED|Overall Study||2
8178185|NCT02383420|20164701|P3|NOT COMPLETED|Overall Study||0
8178186|NCT02383420|20164702|P2|NOT COMPLETED|Overall Study||0
8178187|NCT02383420|20164703|P1|NOT COMPLETED|Overall Study||2
8178188|NCT02383420|20164701|P3|COMPLETED|Overall Study||3
8178189|NCT02383420|20164702|P2|COMPLETED|Overall Study||10
8178190|NCT02383420|20164703|P1|COMPLETED|Overall Study||8
8178191|NCT02383420|20164701|P3|STARTED|Overall Study||3
8178192|NCT02383420|20164702|P2|STARTED|Overall Study||10
8178193|NCT02383420|20164703|P1|STARTED|Overall Study||10
8178194|NCT02383355|20164713|P2|NOT COMPLETED|Overall Study||0
8178195|NCT02383355|20164714|P1|NOT COMPLETED|Overall Study||2
8178196|NCT02383355|20164713|P2|COMPLETED|Overall Study||21
8178197|NCT02383355|20164714|P1|COMPLETED|Overall Study||17
8178198|NCT02383355|20164713|P2|STARTED|Overall Study||21
8178199|NCT02383355|20164714|P1|STARTED|Overall Study||19
8178200|NCT02383173|20164730|P2|NOT COMPLETED|Overall Study||2
8178201|NCT02383173|20164731|P1|NOT COMPLETED|Overall Study||0
8178202|NCT02383173|20164730|P2|COMPLETED|Overall Study||44
8178203|NCT02383173|20164731|P1|COMPLETED|Overall Study||88
8178204|NCT02383173|20164730|P2|STARTED|Overall Study||46
8178205|NCT02383173|20164731|P1|STARTED|Overall Study||88
8178206|NCT02383056|20164755|P2|NOT COMPLETED|Overall Study||2
8178207|NCT02383056|20164756|P1|NOT COMPLETED|Overall Study||1
8178208|NCT02383056|20164755|P2|COMPLETED|Overall Study||5
8178209|NCT02383056|20164756|P1|COMPLETED|Overall Study||6
8178210|NCT02383056|20164755|P2|STARTED|Overall Study||7
8178211|NCT02383056|20164756|P1|STARTED|Overall Study||7
8178212|NCT02383043|20164769|P3|NOT COMPLETED|Overall Study||0
8178213|NCT02383043|20164770|P2|NOT COMPLETED|Overall Study||0
8178214|NCT02383043|20164771|P1|NOT COMPLETED|Overall Study||2
8178215|NCT02383043|20164769|P3|COMPLETED|Overall Study||4
8178216|NCT02383043|20164770|P2|COMPLETED|Overall Study||5
8178217|NCT02383043|20164771|P1|COMPLETED|Overall Study||7
8178218|NCT02383043|20164769|P3|STARTED|Overall Study||4
8178219|NCT02383043|20164770|P2|STARTED|Overall Study||5
8178220|NCT02383043|20164771|P1|STARTED|Overall Study||9
8178221|NCT02383017|20164782|P2|NOT COMPLETED|Overall Study||2
8178222|NCT02383017|20164783|P1|NOT COMPLETED|Overall Study||5
8178223|NCT02383017|20164782|P2|COMPLETED|Overall Study||11
8178224|NCT02383017|20164783|P1|COMPLETED|Overall Study||10
8178225|NCT02383017|20164782|P2|STARTED|Overall Study||13
8178226|NCT02383017|20164783|P1|STARTED|Overall Study||15
8178227|NCT02382991|20164807|P2|NOT COMPLETED|Overall Study||3
8178228|NCT02382991|20164808|P1|NOT COMPLETED|Overall Study||2
8178229|NCT02382991|20164807|P2|COMPLETED|Overall Study||15
8178230|NCT02382991|20164808|P1|COMPLETED|Overall Study||15
8178231|NCT02382991|20164807|P2|STARTED|Overall Study||18
8178232|NCT02382991|20164808|P1|STARTED|Overall Study||17
8178233|NCT02382939|20164820|P2|NOT COMPLETED|Overall Study||3
8178234|NCT02382939|20164821|P1|NOT COMPLETED|Overall Study||3
8178235|NCT02382939|20164820|P2|COMPLETED|Overall Study||58
8178236|NCT02382939|20164821|P1|COMPLETED|Overall Study||28
8178237|NCT02382939|20164820|P2|Exposed|Overall Study||61
8178238|NCT02382939|20164821|P1|Exposed|Overall Study||31
8178239|NCT02382939|20164820|P2|STARTED|Overall Study||61
8178240|NCT02382939|20164821|P1|STARTED|Overall Study||31
8178241|NCT02382913|20164842|P10|NOT COMPLETED|Overall Study||0
8178242|NCT02382913|20164843|P9|NOT COMPLETED|Overall Study||0
8178243|NCT02382913|20164844|P8|NOT COMPLETED|Overall Study||0
8178244|NCT02382913|20164845|P7|NOT COMPLETED|Overall Study||0
8178245|NCT02382913|20164846|P6|NOT COMPLETED|Overall Study||0
8178246|NCT02382913|20164847|P5|NOT COMPLETED|Overall Study||0
8178247|NCT02382913|20164848|P4|NOT COMPLETED|Overall Study||0
8178248|NCT02382913|20164849|P3|NOT COMPLETED|Overall Study||0
8178249|NCT02382913|20164850|P2|NOT COMPLETED|Overall Study||0
8178250|NCT02382913|20164851|P1|NOT COMPLETED|Overall Study||0
8178251|NCT02382913|20164842|P10|COMPLETED|Overall Study||33
8178252|NCT02382913|20164843|P9|COMPLETED|Overall Study||30
8178253|NCT02382913|20164844|P8|COMPLETED|Overall Study||30
8178254|NCT02382913|20164845|P7|COMPLETED|Overall Study||37
8178255|NCT02382913|20164846|P6|COMPLETED|Overall Study||30
8178256|NCT02382913|20164847|P5|COMPLETED|Overall Study||33
8178257|NCT02382913|20164848|P4|COMPLETED|Overall Study||27
8178258|NCT02382913|20164849|P3|COMPLETED|Overall Study||32
8178259|NCT02382913|20164850|P2|COMPLETED|Overall Study||36
8178260|NCT02382913|20164851|P1|COMPLETED|Overall Study||27
8178261|NCT02382913|20164842|P10|STARTED|Overall Study||33
8178262|NCT02382913|20164843|P9|STARTED|Overall Study||30
8178263|NCT02382913|20164844|P8|STARTED|Overall Study||30
8178264|NCT02382913|20164845|P7|STARTED|Overall Study||37
8178265|NCT02382913|20164846|P6|STARTED|Overall Study||30
8178266|NCT02382913|20164847|P5|STARTED|Overall Study||33
8178267|NCT02382913|20164848|P4|STARTED|Overall Study||27
8178268|NCT02382913|20164849|P3|STARTED|Overall Study||32
8178269|NCT02382913|20164850|P2|STARTED|Overall Study||36
8178270|NCT02382913|20164851|P1|STARTED|Overall Study||27
8178271|NCT02382848|20164887|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8178272|NCT02382848|20164888|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8178273|NCT02382848|20164887|P2|COMPLETED|Second Intervention (3 Weeks)||5
8178274|NCT02382848|20164888|P1|COMPLETED|Second Intervention (3 Weeks)||3
8178275|NCT02382848|20164887|P2|STARTED|Second Intervention (3 Weeks)||5
8178276|NCT02382848|20164888|P1|STARTED|Second Intervention (3 Weeks)||3
8178277|NCT02382848|20164887|P2|NOT COMPLETED|Washout (1 Week)||0
8178278|NCT02382848|20164888|P1|NOT COMPLETED|Washout (1 Week)||0
8178279|NCT02382848|20164887|P2|COMPLETED|Washout (1 Week)||5
8178280|NCT02382848|20164888|P1|COMPLETED|Washout (1 Week)||3
8178281|NCT02382848|20164887|P2|STARTED|Washout (1 Week)||5
8178282|NCT02382848|20164888|P1|STARTED|Washout (1 Week)||3
8178283|NCT02382848|20164887|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8178284|NCT02382848|20164888|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8178285|NCT02382848|20164887|P2|COMPLETED|First Intervention (3 Weeks)||5
8178286|NCT02382848|20164888|P1|COMPLETED|First Intervention (3 Weeks)||3
8178287|NCT02382848|20164887|P2|STARTED|First Intervention (3 Weeks)||5
8178288|NCT02382848|20164888|P1|STARTED|First Intervention (3 Weeks)||3
8178289|NCT02382796|20164904|P1|NOT COMPLETED|Overall Study||7
8178290|NCT02382796|20164904|P1|COMPLETED|Overall Study||0
8178291|NCT02382796|20164904|P1|STARTED|Overall Study||7
8178292|NCT02382744|20164911|P2|NOT COMPLETED|Overall Study||0
8178293|NCT02382744|20164912|P1|NOT COMPLETED|Overall Study||0
8178294|NCT02382744|20164911|P2|COMPLETED|Overall Study||40
8178295|NCT02382744|20164912|P1|COMPLETED|Overall Study||40
8178296|NCT02382744|20164911|P2|Analyzed|Overall Study||40
8178297|NCT02382744|20164912|P1|Analyzed|Overall Study||40
8178298|NCT02382744|20164911|P2|Allocated|Overall Study||40
8178299|NCT02382744|20164912|P1|Allocated|Overall Study||40
8178300|NCT02382744|20164911|P2|STARTED|Overall Study||40
8178301|NCT02382744|20164912|P1|STARTED|Overall Study||40
8178302|NCT02382705|20164943|P1|NOT COMPLETED|Overall Study||24
8178303|NCT02382705|20164943|P1|COMPLETED|Overall Study||33
8178304|NCT02382705|20164943|P1|STARTED|Overall Study||57
8178305|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8178306|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8178307|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8178308|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
8178309|NCT02382640|20164954|P4|COMPLETED|Intervention Period 4 (3 Days)||9
8178310|NCT02382640|20164955|P3|COMPLETED|Intervention Period 4 (3 Days)||9
8178311|NCT02382640|20164956|P2|COMPLETED|Intervention Period 4 (3 Days)||9
8178312|NCT02382640|20164957|P1|COMPLETED|Intervention Period 4 (3 Days)||8
8178313|NCT02382640|20164954|P4|STARTED|Intervention Period 4 (3 Days)||9
8178314|NCT02382640|20164955|P3|STARTED|Intervention Period 4 (3 Days)||9
8178315|NCT02382640|20164956|P2|STARTED|Intervention Period 4 (3 Days)||9
8178316|NCT02382640|20164957|P1|STARTED|Intervention Period 4 (3 Days)||9
8178317|NCT02382640|20164954|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178318|NCT02382640|20164955|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178319|NCT02382640|20164956|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178320|NCT02382640|20164957|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178321|NCT02382640|20164954|P4|COMPLETED|Washout Period 3 (7 Days)||9
8178322|NCT02382640|20164955|P3|COMPLETED|Washout Period 3 (7 Days)||9
8178323|NCT02382640|20164956|P2|COMPLETED|Washout Period 3 (7 Days)||9
8178324|NCT02382640|20164957|P1|COMPLETED|Washout Period 3 (7 Days)||9
8178325|NCT02382640|20164954|P4|STARTED|Washout Period 3 (7 Days)||9
8178326|NCT02382640|20164955|P3|STARTED|Washout Period 3 (7 Days)||9
8178327|NCT02382640|20164956|P2|STARTED|Washout Period 3 (7 Days)||9
8178328|NCT02382640|20164957|P1|STARTED|Washout Period 3 (7 Days)||9
8178329|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178330|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178331|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178332|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178333|NCT02382640|20164954|P4|COMPLETED|Intervention Period 3 (3 Days)||9
8178334|NCT02382640|20164955|P3|COMPLETED|Intervention Period 3 (3 Days)||9
8178335|NCT02382640|20164956|P2|COMPLETED|Intervention Period 3 (3 Days)||9
8178336|NCT02382640|20164957|P1|COMPLETED|Intervention Period 3 (3 Days)||9
8178337|NCT02382640|20164954|P4|STARTED|Intervention Period 3 (3 Days)||9
8178338|NCT02382640|20164955|P3|STARTED|Intervention Period 3 (3 Days)||9
8178339|NCT02382640|20164956|P2|STARTED|Intervention Period 3 (3 Days)||9
8178340|NCT02382640|20164957|P1|STARTED|Intervention Period 3 (3 Days)||9
8178341|NCT02382640|20164954|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178342|NCT02382640|20164955|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178343|NCT02382640|20164956|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178344|NCT02382640|20164957|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178345|NCT02382640|20164954|P4|COMPLETED|Washout Period 2 (7 Days)||9
8178346|NCT02382640|20164955|P3|COMPLETED|Washout Period 2 (7 Days)||9
8178347|NCT02382640|20164956|P2|COMPLETED|Washout Period 2 (7 Days)||9
8178348|NCT02382640|20164957|P1|COMPLETED|Washout Period 2 (7 Days)||9
8178349|NCT02382640|20164954|P4|STARTED|Washout Period 2 (7 Days)||9
8178350|NCT02382640|20164955|P3|STARTED|Washout Period 2 (7 Days)||9
8178351|NCT02382640|20164956|P2|STARTED|Washout Period 2 (7 Days)||9
8178352|NCT02382640|20164957|P1|STARTED|Washout Period 2 (7 Days)||9
8178353|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178354|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178355|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178356|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178357|NCT02382640|20164954|P4|COMPLETED|Intervention Period 2 (3 Days)||9
8178358|NCT02382640|20164955|P3|COMPLETED|Intervention Period 2 (3 Days)||9
8178359|NCT02382640|20164956|P2|COMPLETED|Intervention Period 2 (3 Days)||9
8178360|NCT02382640|20164957|P1|COMPLETED|Intervention Period 2 (3 Days)||9
8178361|NCT02382640|20164954|P4|STARTED|Intervention Period 2 (3 Days)||9
8178362|NCT02382640|20164955|P3|STARTED|Intervention Period 2 (3 Days)||9
8178363|NCT02382640|20164956|P2|STARTED|Intervention Period 2 (3 Days)||9
8178364|NCT02382640|20164957|P1|STARTED|Intervention Period 2 (3 Days)||9
8178365|NCT02382640|20164954|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178366|NCT02382640|20164955|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178367|NCT02382640|20164956|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178368|NCT02382640|20164957|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178369|NCT02382640|20164954|P4|COMPLETED|Washout Period 1 (7 Days)||9
8178370|NCT02382640|20164955|P3|COMPLETED|Washout Period 1 (7 Days)||9
8178371|NCT02382640|20164956|P2|COMPLETED|Washout Period 1 (7 Days)||9
8178372|NCT02382640|20164957|P1|COMPLETED|Washout Period 1 (7 Days)||9
8178373|NCT02382640|20164954|P4|STARTED|Washout Period 1 (7 Days)||9
8178374|NCT02382640|20164955|P3|STARTED|Washout Period 1 (7 Days)||9
8178375|NCT02382640|20164956|P2|STARTED|Washout Period 1 (7 Days)||9
8178376|NCT02382640|20164957|P1|STARTED|Washout Period 1 (7 Days)||9
8178377|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178378|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178379|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178380|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178381|NCT02382640|20164954|P4|COMPLETED|Intervention Period 1 (3 Days)||9
8178382|NCT02382640|20164955|P3|COMPLETED|Intervention Period 1 (3 Days)||9
8178383|NCT02382640|20164956|P2|COMPLETED|Intervention Period 1 (3 Days)||9
8178384|NCT02382640|20164957|P1|COMPLETED|Intervention Period 1 (3 Days)||9
8178385|NCT02382640|20164954|P4|STARTED|Intervention Period 1 (3 Days)||9
8178386|NCT02382640|20164955|P3|STARTED|Intervention Period 1 (3 Days)||9
8178387|NCT02382640|20164956|P2|STARTED|Intervention Period 1 (3 Days)||9
8178388|NCT02382640|20164957|P1|STARTED|Intervention Period 1 (3 Days)||9
8178389|NCT02382276|20164998|P3|NOT COMPLETED|Overall Study||39
8178390|NCT02382276|20164999|P2|NOT COMPLETED|Overall Study||10
8178391|NCT02382276|20165000|P1|NOT COMPLETED|Overall Study||11
8178392|NCT02382276|20164998|P3|COMPLETED|Overall Study||133
8178393|NCT02382276|20164999|P2|COMPLETED|Overall Study||84
8178394|NCT02382276|20165000|P1|COMPLETED|Overall Study||126
8178395|NCT02382276|20164998|P3|STARTED|Overall Study||172
8178396|NCT02382276|20164999|P2|STARTED|Overall Study||94
8178397|NCT02382276|20165000|P1|STARTED|Overall Study||137
8178398|NCT02382133|20165012|P1|NOT COMPLETED|Overall Study||33
8178399|NCT02382133|20165012|P1|COMPLETED|Overall Study||10
8178400|NCT02382133|20165012|P1|STARTED|Overall Study||43
8178401|NCT02382016|20165019|P2|NOT COMPLETED|OL Extension Period||0
8178402|NCT02382016|20165020|P1|NOT COMPLETED|OL Extension Period||6
8178403|NCT02382016|20165019|P2|COMPLETED|OL Extension Period||0
8178404|NCT02382016|20165020|P1|COMPLETED|OL Extension Period||27
8178405|NCT02382016|20165019|P2|STARTED|OL Extension Period||0
8178406|NCT02382016|20165020|P1|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
8178407|NCT02382016|20165019|P2|NOT COMPLETED|Open-label (OL) Treatment Period||0
8178408|NCT02382016|20165020|P1|NOT COMPLETED|Open-label (OL) Treatment Period||9
8178409|NCT02382016|20165019|P2|COMPLETED|Open-label (OL) Treatment Period||0
8178410|NCT02382016|20165020|P1|COMPLETED|Open-label (OL) Treatment Period||71
8178411|NCT02382016|20165019|P2|STARTED|Open-label (OL) Treatment Period||0
8178412|NCT02382016|20165020|P1|STARTED|Open-label (OL) Treatment Period||80
8178413|NCT02382016|20165019|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||1
8178414|NCT02382016|20165020|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||4
8178415|NCT02382016|20165019|P2|COMPLETED|Double-blind (DB) Treatment Period||41
8178416|NCT02382016|20165020|P1|COMPLETED|Double-blind (DB) Treatment Period||39
8178417|NCT02382016|20165019|P2|STARTED|Double-blind (DB) Treatment Period||42
8178418|NCT02382016|20165020|P1|STARTED|Double-blind (DB) Treatment Period||43
8178419|NCT02381795|20165044|P1|NOT COMPLETED|Overall Study||3
8178420|NCT02381795|20165044|P1|COMPLETED|Overall Study||7
8178421|NCT02381795|20165044|P1|STARTED|Overall Study||10
8178422|NCT02381678|20165048|P3|NOT COMPLETED|Overall Study||0
8178423|NCT02381678|20165049|P2|NOT COMPLETED|Overall Study||0
8178424|NCT02381678|20165050|P1|NOT COMPLETED|Overall Study||0
8178425|NCT02381678|20165048|P3|COMPLETED|Overall Study||32
8178426|NCT02381678|20165049|P2|COMPLETED|Overall Study||139
8178427|NCT02381678|20165050|P1|COMPLETED|Overall Study||54
8178428|NCT02381678|20165048|P3|STARTED|Overall Study||32
8178429|NCT02381678|20165049|P2|STARTED|Overall Study||139
8178430|NCT02381678|20165050|P1|STARTED|Overall Study||54
8178431|NCT02381652|20165059|P3|NOT COMPLETED|Overall Study||1
8178432|NCT02381652|20165060|P2|NOT COMPLETED|Overall Study||0
8178433|NCT02381652|20165061|P1|NOT COMPLETED|Overall Study||0
8178434|NCT02381652|20165059|P3|COMPLETED|Overall Study||49
8178435|NCT02381652|20165060|P2|COMPLETED|Overall Study||98
8178436|NCT02381652|20165061|P1|COMPLETED|Overall Study||94
8178437|NCT02381652|20165059|P3|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
8178438|NCT02381652|20165060|P2|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
8178439|NCT02381652|20165061|P1|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
8178440|NCT02381418|20165068|P1|NOT COMPLETED|Overall Study||0
8178441|NCT02381418|20165068|P1|COMPLETED|Overall Study||120
8178442|NCT02381418|20165068|P1|STARTED|Overall Study||120
8178443|NCT02381392|20165076|P2|NOT COMPLETED|Overall Study||0
8178444|NCT02381392|20165077|P1|NOT COMPLETED|Overall Study||0
8178445|NCT02381392|20165076|P2|COMPLETED|Overall Study||12
8178446|NCT02381392|20165077|P1|COMPLETED|Overall Study||11
8178447|NCT02381392|20165076|P2|STARTED|Overall Study||12
8178448|NCT02381392|20165077|P1|STARTED|Overall Study||11
8178449|NCT02381288|20165095|P4|NOT COMPLETED|Overall Study||0
8178450|NCT02381288|20165096|P3|NOT COMPLETED|Overall Study||0
8178451|NCT02381288|20165097|P2|NOT COMPLETED|Overall Study||0
8178452|NCT02381288|20165098|P1|NOT COMPLETED|Overall Study||0
8178453|NCT02381288|20165095|P4|COMPLETED|Overall Study||5
8178454|NCT02381288|20165096|P3|COMPLETED|Overall Study||5
8178455|NCT02381288|20165097|P2|COMPLETED|Overall Study||2
8178456|NCT02381288|20165098|P1|COMPLETED|Overall Study||5
8178457|NCT02381288|20165095|P4|STARTED|Overall Study||5
8178458|NCT02381288|20165096|P3|STARTED|Overall Study||5
8178459|NCT02381288|20165097|P2|STARTED|Overall Study||2
8178460|NCT02381288|20165098|P1|STARTED|Overall Study||5
8178461|NCT02381015|20165129|P4|NOT COMPLETED|Year 3 Chart Review||51
8178462|NCT02381015|20165130|P3|NOT COMPLETED|Year 3 Chart Review||58
8178463|NCT02381015|20165131|P2|NOT COMPLETED|Year 3 Chart Review||34
8178464|NCT02381015|20165132|P1|NOT COMPLETED|Year 3 Chart Review||47
8178465|NCT02381015|20165129|P4|COMPLETED|Year 3 Chart Review||118
8178466|NCT02381015|20165130|P3|COMPLETED|Year 3 Chart Review||115
8178467|NCT02381015|20165131|P2|COMPLETED|Year 3 Chart Review||134
8178468|NCT02381015|20165132|P1|COMPLETED|Year 3 Chart Review||125
8178469|NCT02381015|20165129|P4|STARTED|Year 3 Chart Review||169
8178470|NCT02381015|20165130|P3|STARTED|Year 3 Chart Review||173
8178471|NCT02381015|20165131|P2|STARTED|Year 3 Chart Review||168
8178472|NCT02381015|20165132|P1|STARTED|Year 3 Chart Review||172
8178473|NCT02381015|20165129|P4|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178474|NCT02381015|20165130|P3|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178475|NCT02381015|20165131|P2|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178476|NCT02381015|20165132|P1|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178477|NCT02381015|20165129|P4|COMPLETED|Visit 3 - 3 Months Followup||169
8178478|NCT02381015|20165130|P3|COMPLETED|Visit 3 - 3 Months Followup||173
8178479|NCT02381015|20165131|P2|COMPLETED|Visit 3 - 3 Months Followup||168
8178480|NCT02381015|20165132|P1|COMPLETED|Visit 3 - 3 Months Followup||172
8178481|NCT02381015|20165129|P4|STARTED|Visit 3 - 3 Months Followup||169
8178482|NCT02381015|20165130|P3|STARTED|Visit 3 - 3 Months Followup||173
8178483|NCT02381015|20165131|P2|STARTED|Visit 3 - 3 Months Followup||168
8178484|NCT02381015|20165132|P1|STARTED|Visit 3 - 3 Months Followup||172
8178485|NCT02381015|20165129|P4|NOT COMPLETED|Visit 2 - Results DIsclosure||3
8178486|NCT02381015|20165130|P3|NOT COMPLETED|Visit 2 - Results DIsclosure||2
8178487|NCT02381015|20165131|P2|NOT COMPLETED|Visit 2 - Results DIsclosure||5
8178488|NCT02381015|20165132|P1|NOT COMPLETED|Visit 2 - Results DIsclosure||3
8178489|NCT02381015|20165129|P4|COMPLETED|Visit 2 - Results DIsclosure||169
8178490|NCT02381015|20165130|P3|COMPLETED|Visit 2 - Results DIsclosure||173
8178491|NCT02381015|20165131|P2|COMPLETED|Visit 2 - Results DIsclosure||168
8178492|NCT02381015|20165132|P1|COMPLETED|Visit 2 - Results DIsclosure||172
8178493|NCT02381015|20165129|P4|STARTED|Visit 2 - Results DIsclosure||172
8178494|NCT02381015|20165130|P3|STARTED|Visit 2 - Results DIsclosure||175
8178495|NCT02381015|20165131|P2|STARTED|Visit 2 - Results DIsclosure||173
8178496|NCT02381015|20165132|P1|STARTED|Visit 2 - Results DIsclosure||175
8178497|NCT02381015|20165129|P4|NOT COMPLETED|Visit 1 - Enrollment||3
8178498|NCT02381015|20165130|P3|NOT COMPLETED|Visit 1 - Enrollment||0
8178499|NCT02381015|20165131|P2|NOT COMPLETED|Visit 1 - Enrollment||2
8178500|NCT02381015|20165132|P1|NOT COMPLETED|Visit 1 - Enrollment||0
8178501|NCT02381015|20165129|P4|COMPLETED|Visit 1 - Enrollment||172
8178502|NCT02381015|20165130|P3|COMPLETED|Visit 1 - Enrollment||175
8178503|NCT02381015|20165131|P2|COMPLETED|Visit 1 - Enrollment||173
8178504|NCT02381015|20165132|P1|COMPLETED|Visit 1 - Enrollment||175
8178505|NCT02381015|20165129|P4|STARTED|Visit 1 - Enrollment||175
8178506|NCT02381015|20165130|P3|STARTED|Visit 1 - Enrollment||175
8178507|NCT02381015|20165131|P2|STARTED|Visit 1 - Enrollment||175
8178508|NCT02381015|20165132|P1|STARTED|Visit 1 - Enrollment||175
8178509|NCT02380859|20165164|P2|NOT COMPLETED|Overall Study||0
8178510|NCT02380859|20165165|P1|NOT COMPLETED|Overall Study||2
8178511|NCT02380859|20165164|P2|COMPLETED|Overall Study||13
8178512|NCT02380859|20165165|P1|COMPLETED|Overall Study||17
8178513|NCT02380859|20165164|P2|STARTED|Overall Study||13
8178514|NCT02380859|20165165|P1|STARTED|Overall Study||19
8178515|NCT02380742|20165201|P2|NOT COMPLETED|Overall Study||0
8178516|NCT02380742|20165202|P1|NOT COMPLETED|Overall Study||1
8178517|NCT02380742|20165201|P2|COMPLETED|Overall Study||26
8178518|NCT02380742|20165202|P1|COMPLETED|Overall Study||27
8178519|NCT02380742|20165201|P2|STARTED|Overall Study||26
8178520|NCT02380742|20165202|P1|STARTED|Overall Study||28
8178521|NCT02380703|20165216|P2|NOT COMPLETED|Overall Study||36
8178522|NCT02380703|20165217|P1|NOT COMPLETED|Overall Study||36
8178523|NCT02380703|20165216|P2|COMPLETED|Overall Study||78
8178524|NCT02380703|20165217|P1|COMPLETED|Overall Study||78
8178525|NCT02380703|20165216|P2|Month 12|Overall Study||100
8178526|NCT02380703|20165217|P1|Month 12|Overall Study||99
8178527|NCT02380703|20165216|P2|Month 6|Overall Study||107
8178528|NCT02380703|20165217|P1|Month 6|Overall Study||102
8178529|NCT02380703|20165216|P2|Month 3|Overall Study||109
8178530|NCT02380703|20165217|P1|Month 3|Overall Study||104
8178531|NCT02380703|20165216|P2|STARTED|Overall Study||114
8178532|NCT02380703|20165217|P1|STARTED|Overall Study||114
8178533|NCT02380690|20165239|P2|NOT COMPLETED|Overall Study||12
8178534|NCT02380690|20165240|P1|NOT COMPLETED|Overall Study||34
8178535|NCT02380690|20165239|P2|COMPLETED|Overall Study||82
8178536|NCT02380690|20165240|P1|COMPLETED|Overall Study||85
8178537|NCT02380690|20165239|P2|STARTED|Overall Study||94
8178538|NCT02380690|20165240|P1|STARTED|Overall Study||119
8178539|NCT02380677|20165288|P12|NOT COMPLETED|Overall Study||5
8178540|NCT02380677|20165289|P11|NOT COMPLETED|Overall Study||4
8178541|NCT02380677|20165290|P10|NOT COMPLETED|Overall Study||2
8178542|NCT02380677|20165291|P9|NOT COMPLETED|Overall Study||4
8178543|NCT02380677|20165292|P8|NOT COMPLETED|Overall Study||4
8178544|NCT02380677|20165293|P7|NOT COMPLETED|Overall Study||3
8178545|NCT02380677|20165294|P6|NOT COMPLETED|Overall Study||6
8178546|NCT02380677|20165295|P5|NOT COMPLETED|Overall Study||6
8178547|NCT02380677|20165296|P4|NOT COMPLETED|Overall Study||3
8178548|NCT02380677|20165297|P3|NOT COMPLETED|Overall Study||3
8178549|NCT02380677|20165298|P2|NOT COMPLETED|Overall Study||1
8178550|NCT02380677|20165299|P1|NOT COMPLETED|Overall Study||1
8178551|NCT02380677|20165288|P12|COMPLETED|Overall Study||0
8178552|NCT02380677|20165289|P11|COMPLETED|Overall Study||0
8178553|NCT02380677|20165290|P10|COMPLETED|Overall Study||0
8178554|NCT02380677|20165291|P9|COMPLETED|Overall Study||0
8178555|NCT02380677|20165292|P8|COMPLETED|Overall Study||0
8178556|NCT02380677|20165293|P7|COMPLETED|Overall Study||0
8178557|NCT02380677|20165294|P6|COMPLETED|Overall Study||0
8178558|NCT02380677|20165295|P5|COMPLETED|Overall Study||0
8178559|NCT02380677|20165296|P4|COMPLETED|Overall Study||0
8178560|NCT02380677|20165297|P3|COMPLETED|Overall Study||0
8178561|NCT02380677|20165298|P2|COMPLETED|Overall Study||0
8178562|NCT02380677|20165299|P1|COMPLETED|Overall Study||0
8178563|NCT02380677|20165288|P12|STARTED|Overall Study||5
8178564|NCT02380677|20165289|P11|STARTED|Overall Study||4
8178565|NCT02380677|20165290|P10|STARTED|Overall Study||2
8178566|NCT02380677|20165291|P9|STARTED|Overall Study||4
8178567|NCT02380677|20165292|P8|STARTED|Overall Study||4
8178568|NCT02380677|20165293|P7|STARTED|Overall Study||3
8178569|NCT02380677|20165294|P6|STARTED|Overall Study||6
8178570|NCT02380677|20165295|P5|STARTED|Overall Study||6
8178571|NCT02380677|20165296|P4|STARTED|Overall Study||3
8178572|NCT02380677|20165297|P3|STARTED|Overall Study||3
8178573|NCT02380677|20165298|P2|STARTED|Overall Study||1
8178574|NCT02380677|20165299|P1|STARTED|Overall Study||1
8178575|NCT02380287|20165355|P8|NOT COMPLETED|Overall Study||0
8178576|NCT02380287|20165356|P7|NOT COMPLETED|Overall Study||0
8178577|NCT02380287|20165357|P6|NOT COMPLETED|Overall Study||0
8178578|NCT02380287|20165358|P5|NOT COMPLETED|Overall Study||0
8178579|NCT02380287|20165359|P4|NOT COMPLETED|Overall Study||0
8178580|NCT02380287|20165360|P3|NOT COMPLETED|Overall Study||1
8178581|NCT02380287|20165361|P2|NOT COMPLETED|Overall Study||0
8178582|NCT02380287|20165362|P1|NOT COMPLETED|Overall Study||0
8178583|NCT02380287|20165355|P8|COMPLETED|Overall Study||3
8178584|NCT02380287|20165356|P7|COMPLETED|Overall Study||3
8178585|NCT02380287|20165357|P6|COMPLETED|Overall Study||3
8178586|NCT02380287|20165358|P5|COMPLETED|Overall Study||3
8178587|NCT02380287|20165359|P4|COMPLETED|Overall Study||3
8178588|NCT02380287|20165360|P3|COMPLETED|Overall Study||2
8178589|NCT02380287|20165361|P2|COMPLETED|Overall Study||3
8178590|NCT02380287|20165362|P1|COMPLETED|Overall Study||1
8178591|NCT02380287|20165355|P8|STARTED|Overall Study||3
8178592|NCT02380287|20165356|P7|STARTED|Overall Study||3
8178593|NCT02380287|20165357|P6|STARTED|Overall Study||3
8178594|NCT02380287|20165358|P5|STARTED|Overall Study||3
8178595|NCT02380287|20165359|P4|STARTED|Overall Study||3
8178596|NCT02380287|20165360|P3|STARTED|Overall Study||3
8178597|NCT02380287|20165361|P2|STARTED|Overall Study||3
8178598|NCT02380287|20165362|P1|STARTED|Overall Study||1
8178599|NCT02380261|20165373|P1|NOT COMPLETED|Overall Study||0
8178600|NCT02380261|20165373|P1|COMPLETED|Overall Study||35
8178601|NCT02380261|20165373|P1|STARTED|Overall Study||35
8178602|NCT02380248|20165378|P1|NOT COMPLETED|Overall Study||14
8178603|NCT02380248|20165378|P1|COMPLETED|Overall Study||186
8178604|NCT02380248|20165378|P1|STARTED|Overall Study||200
8178605|NCT02380183|20165385|P2|NOT COMPLETED|Overall Study||0
8178606|NCT02380183|20165386|P1|NOT COMPLETED|Overall Study||0
8178607|NCT02380183|20165385|P2|COMPLETED|Overall Study||34
8178608|NCT02380183|20165386|P1|COMPLETED|Overall Study||36
8178609|NCT02380183|20165385|P2|STARTED|Overall Study||34
8178610|NCT02380183|20165386|P1|STARTED|Overall Study||36
8178611|NCT02379923|20165394|P1|NOT COMPLETED|Overall Study||5
8178612|NCT02379923|20165394|P1|COMPLETED|Overall Study||158
8178613|NCT02379923|20165394|P1|STARTED|Overall Study||163
8178614|NCT02379858|20165410|P2|NOT COMPLETED|Overall Study||0
8178615|NCT02379858|20165411|P1|NOT COMPLETED|Overall Study||0
8178616|NCT02379858|20165410|P2|COMPLETED|Overall Study||4
8178617|NCT02379858|20165411|P1|COMPLETED|Overall Study||6
8178618|NCT02379858|20165410|P2|STARTED|Overall Study||4
8178619|NCT02379858|20165411|P1|STARTED|Overall Study||6
8178620|NCT02379728|20165423|P4|NOT COMPLETED|Overall Study||3
8178621|NCT02379728|20165424|P3|NOT COMPLETED|Overall Study||10
8178622|NCT02379728|20165425|P2|NOT COMPLETED|Overall Study||0
8178623|NCT02379728|20165426|P1|NOT COMPLETED|Overall Study||6
8178624|NCT02379728|20165423|P4|COMPLETED|Overall Study||13
8178625|NCT02379728|20165424|P3|COMPLETED|Overall Study||74
8178626|NCT02379728|20165425|P2|COMPLETED|Overall Study||16
8178627|NCT02379728|20165426|P1|COMPLETED|Overall Study||78
8178628|NCT02379728|20165423|P4|STARTED|Overall Study||16
8178629|NCT02379728|20165424|P3|STARTED|Overall Study||84
8178630|NCT02379728|20165425|P2|STARTED|Overall Study||16
8178631|NCT02379728|20165426|P1|STARTED|Overall Study||84
8178632|NCT02379637|20165482|P2|NOT COMPLETED|Overall Study||1
8178633|NCT02379637|20165483|P1|NOT COMPLETED|Overall Study||2
8178634|NCT02379637|20165482|P2|COMPLETED|Overall Study||34
8178635|NCT02379637|20165483|P1|COMPLETED|Overall Study||33
8178636|NCT02379637|20165482|P2|STARTED|Overall Study||35
8178637|NCT02379637|20165483|P1|STARTED|Overall Study||35
8178638|NCT02379585|20165493|P2|NOT COMPLETED|Overall Study||5
8178639|NCT02379585|20165494|P1|NOT COMPLETED|Overall Study||3
8178640|NCT02379585|20165493|P2|COMPLETED|Overall Study||0
8178641|NCT02379585|20165494|P1|COMPLETED|Overall Study||0
8178642|NCT02379585|20165493|P2|STARTED|Overall Study||5
8178643|NCT02379585|20165494|P1|STARTED|Overall Study||3
8178644|NCT02379442|20165516|P1|NOT COMPLETED|Overall Study||0
8178645|NCT02379442|20165516|P1|COMPLETED|Overall Study||1
8178646|NCT02379442|20165516|P1|STARTED|Overall Study||1
8178647|NCT02379390|20165522|P2|NOT COMPLETED|Overall Study||2
8178648|NCT02379390|20165523|P1|NOT COMPLETED|Overall Study||2
8178649|NCT02379390|20165522|P2|COMPLETED|Overall Study||2
8178650|NCT02379390|20165523|P1|COMPLETED|Overall Study||2
8178651|NCT02379390|20165522|P2|STARTED|Overall Study||4
8178652|NCT02379390|20165523|P1|STARTED|Overall Study||4
8178653|NCT02379221|20165551|P1|NOT COMPLETED|Overall Study||1
8178654|NCT02379221|20165551|P1|COMPLETED|Overall Study||48
8178655|NCT02379221|20165551|P1|STARTED|Overall Study||49
8178656|NCT02379195|20165566|P1|NOT COMPLETED|Overall Study||0
8178657|NCT02379195|20165566|P1|COMPLETED|Overall Study||12
8178658|NCT02379195|20165566|P1|STARTED|Overall Study||12
8178659|NCT02379117|20165576|P2|NOT COMPLETED|Overall Study||0
8178660|NCT02379117|20165577|P1|NOT COMPLETED|Overall Study||0
8178661|NCT02379117|20165576|P2|COMPLETED|Overall Study||31
8178662|NCT02379117|20165577|P1|COMPLETED|Overall Study||30
8178663|NCT02379117|20165576|P2|STARTED|Overall Study||31
8178664|NCT02379117|20165577|P1|STARTED|Overall Study||30
8178665|NCT02379091|20165587|P4|NOT COMPLETED|Overall Study||14
8178666|NCT02379091|20165588|P3|NOT COMPLETED|Overall Study||7
8178667|NCT02379091|20165589|P2|NOT COMPLETED|Overall Study||10
8178668|NCT02379091|20165590|P1|NOT COMPLETED|Overall Study||12
8178669|NCT02379091|20165587|P4|COMPLETED|Overall Study||14
8178670|NCT02379091|20165588|P3|COMPLETED|Overall Study||18
8178671|NCT02379091|20165589|P2|COMPLETED|Overall Study||18
8178672|NCT02379091|20165590|P1|COMPLETED|Overall Study||15
8178673|NCT02379091|20165587|P4|Full Analysis Set|Overall Study||28
8178674|NCT02379091|20165588|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
8178675|NCT02379091|20165589|P2|Full Analysis Set|Overall Study||28
8178676|NCT02379091|20165590|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
8178677|NCT02379091|20165587|P4|STARTED|Overall Study||28
8178678|NCT02379091|20165588|P3|STARTED|Overall Study||25
8178679|NCT02379091|20165589|P2|STARTED|Overall Study||28
8178680|NCT02379091|20165590|P1|STARTED|Overall Study||27
8178681|NCT02379078|20165628|P2|NOT COMPLETED|Overall Study||35
8178682|NCT02379078|20165629|P1|NOT COMPLETED|Overall Study||39
8178683|NCT02379078|20165628|P2|COMPLETED|Overall Study||79
8178684|NCT02379078|20165629|P1|COMPLETED|Overall Study||72
8178685|NCT02379078|20165628|P2|STARTED|Overall Study||114
8178686|NCT02379078|20165629|P1|STARTED|Overall Study||111
8178687|NCT02379052|20165645|P2|NOT COMPLETED|Overall Study||5
8178688|NCT02379052|20165646|P1|NOT COMPLETED|Overall Study||6
8178689|NCT02379052|20165645|P2|COMPLETED|Overall Study||18
8178690|NCT02379052|20165646|P1|COMPLETED|Overall Study||18
8178691|NCT02379052|20165645|P2|STARTED|Overall Study||23
8178692|NCT02379052|20165646|P1|STARTED|Overall Study||24
8178693|NCT02378961|20165688|P4|NOT COMPLETED|Overall Study||1
8178694|NCT02378961|20165689|P3|NOT COMPLETED|Overall Study||1
8178695|NCT02378961|20165690|P2|NOT COMPLETED|Overall Study||2
8178696|NCT02378961|20165691|P1|NOT COMPLETED|Overall Study||4
8178697|NCT02378961|20165688|P4|COMPLETED|Overall Study||28
8178698|NCT02378961|20165689|P3|COMPLETED|Overall Study||35
8178699|NCT02378961|20165690|P2|COMPLETED|Overall Study||28
8178700|NCT02378961|20165691|P1|COMPLETED|Overall Study||29
8178701|NCT02378961|20165688|P4|STARTED|Overall Study||29
8178702|NCT02378961|20165689|P3|STARTED|Overall Study||36
8178703|NCT02378961|20165690|P2|STARTED|Overall Study||30
8178704|NCT02378961|20165691|P1|STARTED|Overall Study||33
8178705|NCT02378935|20165728|P7|NOT COMPLETED|Overall Study||0
8178706|NCT02378935|20165729|P6|NOT COMPLETED|Overall Study||0
8178707|NCT02378935|20165730|P5|NOT COMPLETED|Overall Study||0
8178708|NCT02378935|20165731|P4|NOT COMPLETED|Overall Study||6
8178709|NCT02378935|20165732|P3|NOT COMPLETED|Overall Study||3
8178710|NCT02378935|20165733|P2|NOT COMPLETED|Overall Study||0
8178711|NCT02378935|20165734|P1|NOT COMPLETED|Overall Study||10
8178712|NCT02378935|20165728|P7|COMPLETED|Overall Study||8
8178713|NCT02378935|20165729|P6|COMPLETED|Overall Study||32
8178714|NCT02378935|20165730|P5|COMPLETED|Overall Study||31
8178715|NCT02378935|20165731|P4|COMPLETED|Overall Study||25
8178716|NCT02378935|20165732|P3|COMPLETED|Overall Study||30
8178717|NCT02378935|20165733|P2|COMPLETED|Overall Study||36
8178718|NCT02378935|20165734|P1|COMPLETED|Overall Study||24
8178719|NCT02378935|20165728|P7|STARTED|Overall Study||8
8178720|NCT02378935|20165729|P6|STARTED|Overall Study||32
8178721|NCT02378935|20165730|P5|STARTED|Overall Study||31
8178722|NCT02378935|20165731|P4|STARTED|Overall Study||31
8178723|NCT02378935|20165732|P3|STARTED|Overall Study||33
8178724|NCT02378935|20165733|P2|STARTED|Overall Study||36
8178725|NCT02378935|20165734|P1|STARTED|Overall Study||34
8178726|NCT02378883|20165785|P1|NOT COMPLETED|12 Months Follow-Up||5
8178727|NCT02378883|20165785|P1|COMPLETED|12 Months Follow-Up||41
8178728|NCT02378883|20165785|P1|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
8178729|NCT02378883|20165785|P1|NOT COMPLETED|30 Day Follow-Up||6
8178730|NCT02378883|20165785|P1|COMPLETED|30 Day Follow-Up||106
8178731|NCT02378883|20165785|P1|STARTED|30 Day Follow-Up||112
8178732|NCT02378883|20165785|P1|NOT COMPLETED|Discharge||0
8178733|NCT02378883|20165785|P1|COMPLETED|Discharge||112
8178734|NCT02378883|20165785|P1|STARTED|Discharge||112
8178735|NCT02378883|20165785|P1|NOT COMPLETED|Enrollment||9
8178736|NCT02378883|20165785|P1|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
8178737|NCT02378883|20165785|P1|STARTED|Enrollment|Participants consented and assessed for eligibility|121
8178738|NCT02378844|20165798|P3|NOT COMPLETED|Open Label Period||0
8178739|NCT02378844|20165799|P2|NOT COMPLETED|Open Label Period||48
8178740|NCT02378844|20165800|P1|NOT COMPLETED|Open Label Period||43
8178741|NCT02378844|20165798|P3|COMPLETED|Open Label Period||0
8178742|NCT02378844|20165799|P2|COMPLETED|Open Label Period||87
8178743|NCT02378844|20165800|P1|COMPLETED|Open Label Period||99
8178744|NCT02378844|20165798|P3|STARTED|Open Label Period||0
8178745|NCT02378844|20165799|P2|STARTED|Open Label Period||135
8178746|NCT02378844|20165800|P1|STARTED|Open Label Period||142
8178747|NCT02378844|20165798|P3|NOT COMPLETED|Randomized Period (Double Blind)||0
8178748|NCT02378844|20165799|P2|NOT COMPLETED|Randomized Period (Double Blind)||32
8178749|NCT02378844|20165800|P1|NOT COMPLETED|Randomized Period (Double Blind)||23
8178750|NCT02378844|20165798|P3|COMPLETED|Randomized Period (Double Blind)||0
8178751|NCT02378844|20165799|P2|COMPLETED|Randomized Period (Double Blind)||135
8178752|NCT02378844|20165800|P1|COMPLETED|Randomized Period (Double Blind)||142
8178753|NCT02378844|20165798|P3|STARTED|Randomized Period (Double Blind)||0
8178754|NCT02378844|20165799|P2|STARTED|Randomized Period (Double Blind)||167
8178755|NCT02378844|20165800|P1|STARTED|Randomized Period (Double Blind)||165
8178756|NCT02378844|20165798|P3|NOT COMPLETED|Run-in Period||136
8178757|NCT02378844|20165799|P2|NOT COMPLETED|Run-in Period||5
8178758|NCT02378844|20165800|P1|NOT COMPLETED|Run-in Period||4
8178759|NCT02378844|20165798|P3|COMPLETED|Run-in Period||0
8178760|NCT02378844|20165799|P2|COMPLETED|Run-in Period||167
8178761|NCT02378844|20165800|P1|COMPLETED|Run-in Period||165
8178762|NCT02378844|20165798|P3|STARTED|Run-in Period||136
8178763|NCT02378844|20165799|P2|STARTED|Run-in Period||172
8178764|NCT02378844|20165800|P1|STARTED|Run-in Period||169
8178765|NCT02378753|20165830|P2|NOT COMPLETED|Overall Study||695
8178766|NCT02378753|20165831|P1|NOT COMPLETED|Overall Study||218
8178767|NCT02378753|20165830|P2|COMPLETED|Overall Study||3637
8178768|NCT02378753|20165831|P1|COMPLETED|Overall Study||4101
8178769|NCT02378753|20165830|P2|STARTED|Overall Study||4332
8178770|NCT02378753|20165831|P1|STARTED|Overall Study||4319
8178771|NCT02378662|20165851|P2|NOT COMPLETED|Overall Study||0
8178772|NCT02378662|20165852|P1|NOT COMPLETED|Overall Study||2
8178773|NCT02378662|20165851|P2|COMPLETED|Overall Study||0
8178774|NCT02378662|20165852|P1|COMPLETED|Overall Study||0
8178775|NCT02378662|20165851|P2|Implantation|Overall Study||0
8178776|NCT02378662|20165852|P1|Implantation|Overall Study||2
8178777|NCT02378662|20165851|P2|Harvesting|Overall Study||0
8178778|NCT02378662|20165852|P1|Harvesting|Overall Study||2
8178779|NCT02378662|20165851|P2|STARTED|Overall Study||0
8178780|NCT02378662|20165852|P1|STARTED|Overall Study||2
8178781|NCT02378506|20165858|P1|NOT COMPLETED|Overall Study||25
8178782|NCT02378506|20165858|P1|COMPLETED|Overall Study||163
8178783|NCT02378506|20165858|P1|Treated|Overall Study||187
8178784|NCT02378506|20165858|P1|STARTED|Overall Study||188
8178785|NCT02378480|20165877|P2|NOT COMPLETED|Overall Study||32
8178786|NCT02378480|20165878|P1|NOT COMPLETED|Overall Study||28
8178787|NCT02378480|20165877|P2|COMPLETED|Overall Study||294
8178788|NCT02378480|20165878|P1|COMPLETED|Overall Study||301
8178789|NCT02378480|20165877|P2|STARTED|Overall Study||326
8178790|NCT02378480|20165878|P1|STARTED|Overall Study||329
8178791|NCT02378402|20165893|P3|NOT COMPLETED|Overall Study||0
8178792|NCT02378402|20165894|P2|NOT COMPLETED|Overall Study||2
8178793|NCT02378402|20165895|P1|NOT COMPLETED|Overall Study||0
8178794|NCT02378402|20165893|P3|COMPLETED|Overall Study||21
8178795|NCT02378402|20165894|P2|COMPLETED|Overall Study||23
8178796|NCT02378402|20165895|P1|COMPLETED|Overall Study||25
8178797|NCT02378402|20165893|P3|STARTED|Overall Study||21
8178798|NCT02378402|20165894|P2|STARTED|Overall Study||25
8178799|NCT02378402|20165895|P1|STARTED|Overall Study||25
8178800|NCT02378220|20165905|P2|NOT COMPLETED|Overall Study||1
8178801|NCT02378220|20165906|P1|NOT COMPLETED|Overall Study||6
8178802|NCT02378220|20165905|P2|COMPLETED|Overall Study||56
8178803|NCT02378220|20165906|P1|COMPLETED|Overall Study||47
8178804|NCT02378220|20165905|P2|STARTED|Overall Study||57
8178805|NCT02378220|20165906|P1|STARTED|Overall Study||53
8178806|NCT02378207|20165940|P4|NOT COMPLETED|Overall Study||1
8178807|NCT02378207|20165941|P3|NOT COMPLETED|Overall Study||2
8178808|NCT02378207|20165942|P2|NOT COMPLETED|Overall Study||3
8178809|NCT02378207|20165943|P1|NOT COMPLETED|Overall Study||0
8178810|NCT02378207|20165940|P4|COMPLETED|Overall Study||11
8178811|NCT02378207|20165941|P3|COMPLETED|Overall Study||22
8178812|NCT02378207|20165942|P2|COMPLETED|Overall Study||21
8178813|NCT02378207|20165943|P1|COMPLETED|Overall Study||24
8178814|NCT02378207|20165940|P4|STARTED|Overall Study||12
8178815|NCT02378207|20165941|P3|STARTED|Overall Study||24
8178816|NCT02378207|20165942|P2|STARTED|Overall Study||24
8178817|NCT02378207|20165943|P1|STARTED|Overall Study||24
8178818|NCT02378038|20165957|P1|NOT COMPLETED|Overall Study||5
8178819|NCT02378038|20165957|P1|COMPLETED|Overall Study||0
8178820|NCT02378038|20165957|P1|STARTED|Overall Study||5
8178821|NCT02378025|20165969|P2|NOT COMPLETED|Overall Study||21
8178822|NCT02378025|20165970|P1|NOT COMPLETED|Overall Study||13
8178823|NCT02378025|20165969|P2|COMPLETED|Overall Study||15
8178824|NCT02378025|20165970|P1|COMPLETED|Overall Study||26
8178825|NCT02378025|20165969|P2|STARTED|Overall Study||36
8178826|NCT02378025|20165970|P1|STARTED|Overall Study||39
8178827|NCT02377986|20165986|P1|NOT COMPLETED|Overall Study||0
8178828|NCT02377986|20165986|P1|COMPLETED|Overall Study||5
8178829|NCT02377986|20165986|P1|STARTED|Overall Study||5
8178830|NCT02377947|20165991|P1|NOT COMPLETED|Overall Study||0
8178831|NCT02377947|20165991|P1|COMPLETED|Overall Study||50
8178832|NCT02377947|20165991|P1|STARTED|Overall Study||50
8178833|NCT02377921|20166004|P2|NOT COMPLETED|Overall Study||1
8178834|NCT02377921|20166005|P1|NOT COMPLETED|Overall Study||1
8178835|NCT02377921|20166004|P2|COMPLETED|Overall Study||43
8178836|NCT02377921|20166005|P1|COMPLETED|Overall Study||44
8178837|NCT02377921|20166004|P2|STARTED|Overall Study||44
8178838|NCT02377921|20166005|P1|STARTED|Overall Study||45
8178839|NCT02377817|20166029|P2|NOT COMPLETED|Overall Study||0
8178840|NCT02377817|20166030|P1|NOT COMPLETED|Overall Study||3
8178841|NCT02377817|20166029|P2|COMPLETED|Overall Study||10
8178842|NCT02377817|20166030|P1|COMPLETED|Overall Study||10
8178843|NCT02377817|20166029|P2|STARTED|Overall Study||10
8178844|NCT02377817|20166030|P1|STARTED|Overall Study||13
8178845|NCT02377700|20166092|P1|NOT COMPLETED|Overall Study||0
8178846|NCT02377700|20166092|P1|COMPLETED|Overall Study||5
8178847|NCT02377700|20166092|P1|STARTED|Overall Study||5
8178848|NCT02377674|20166098|P1|NOT COMPLETED|Overall Study||0
8178849|NCT02377674|20166098|P1|COMPLETED|Overall Study||5
8178850|NCT02377674|20166098|P1|STARTED|Overall Study||5
8178851|NCT02377466|20166105|P2|NOT COMPLETED|Overall Study||2
8178852|NCT02377466|20166106|P1|NOT COMPLETED|Overall Study||0
8178853|NCT02377466|20166105|P2|COMPLETED|Overall Study||10
8178854|NCT02377466|20166106|P1|COMPLETED|Overall Study||13
8178855|NCT02377466|20166105|P2|Treated|Overall Study||10
8178856|NCT02377466|20166106|P1|Treated|Overall Study||13
8178857|NCT02377466|20166105|P2|STARTED|Overall Study||12
8178858|NCT02377466|20166106|P1|STARTED|Overall Study||13
8178859|NCT02377427|20166224|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178860|NCT02377427|20166225|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178861|NCT02377427|20166226|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
8178862|NCT02377427|20166227|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178863|NCT02377427|20166228|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178864|NCT02377427|20166224|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
8178865|NCT02377427|20166225|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
8178866|NCT02377427|20166226|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
8178867|NCT02377427|20166227|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178868|NCT02377427|20166228|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178869|NCT02377427|20166224|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
8178870|NCT02377427|20166225|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
8178871|NCT02377427|20166226|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
8178872|NCT02377427|20166227|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
8178873|NCT02377427|20166228|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
8178874|NCT02377427|20166224|P5|NOT COMPLETED|Part A (Up to Week 20)||0
8178875|NCT02377427|20166225|P4|NOT COMPLETED|Part A (Up to Week 20)||0
8178876|NCT02377427|20166226|P3|NOT COMPLETED|Part A (Up to Week 20)||0
8178877|NCT02377427|20166227|P2|NOT COMPLETED|Part A (Up to Week 20)||0
8178878|NCT02377427|20166228|P1|NOT COMPLETED|Part A (Up to Week 20)||4
8178879|NCT02377427|20166224|P5|COMPLETED|Part A (Up to Week 20)||0
8178880|NCT02377427|20166225|P4|COMPLETED|Part A (Up to Week 20)||0
8178881|NCT02377427|20166226|P3|COMPLETED|Part A (Up to Week 20)||0
8178882|NCT02377427|20166227|P2|COMPLETED|Part A (Up to Week 20)||10
8178883|NCT02377427|20166228|P1|COMPLETED|Part A (Up to Week 20)||22
8178884|NCT02377427|20166224|P5|STARTED|Part A (Up to Week 20)||0
8178885|NCT02377427|20166225|P4|STARTED|Part A (Up to Week 20)||0
8178886|NCT02377427|20166226|P3|STARTED|Part A (Up to Week 20)||0
8178887|NCT02377427|20166227|P2|STARTED|Part A (Up to Week 20)||10
8178888|NCT02377427|20166228|P1|STARTED|Part A (Up to Week 20)||26
8178889|NCT02377362|20166301|P13|NOT COMPLETED|Part B Overall||0
8178890|NCT02377362|20166302|P12|NOT COMPLETED|Part B Overall||1
8178891|NCT02377362|20166303|P11|NOT COMPLETED|Part B Overall||0
8178892|NCT02377362|20166304|P10|NOT COMPLETED|Part B Overall||1
8178893|NCT02377362|20166305|P9|NOT COMPLETED|Part B Overall||0
8178894|NCT02377362|20166306|P8|NOT COMPLETED|Part B Overall||1
8178895|NCT02377362|20166307|P7|NOT COMPLETED|Part B Overall||2
8178896|NCT02377362|20166308|P6|NOT COMPLETED|Part B Overall||0
8178897|NCT02377362|20166309|P5|NOT COMPLETED|Part B Overall||0
8178898|NCT02377362|20166310|P4|NOT COMPLETED|Part B Overall||0
8178899|NCT02377362|20166311|P3|NOT COMPLETED|Part B Overall||0
8178900|NCT02377362|20166312|P2|NOT COMPLETED|Part B Overall||0
8178901|NCT02377362|20166313|P1|NOT COMPLETED|Part B Overall||0
8178902|NCT02377362|20166301|P13|COMPLETED|Part B Overall||12
8178903|NCT02377362|20166302|P12|COMPLETED|Part B Overall||6
8178904|NCT02377362|20166303|P11|COMPLETED|Part B Overall||6
8178905|NCT02377362|20166304|P10|COMPLETED|Part B Overall||6
8178906|NCT02377362|20166305|P9|COMPLETED|Part B Overall||6
8178907|NCT02377362|20166306|P8|COMPLETED|Part B Overall||5
8178908|NCT02377362|20166307|P7|COMPLETED|Part B Overall||4
8178909|NCT02377362|20166308|P6|COMPLETED|Part B Overall||0
8178910|NCT02377362|20166309|P5|COMPLETED|Part B Overall||0
8178911|NCT02377362|20166310|P4|COMPLETED|Part B Overall||0
8178912|NCT02377362|20166311|P3|COMPLETED|Part B Overall||0
8178913|NCT02377362|20166312|P2|COMPLETED|Part B Overall||0
8178914|NCT02377362|20166313|P1|COMPLETED|Part B Overall||0
8178915|NCT02377362|20166301|P13|STARTED|Part B Overall||12
8178916|NCT02377362|20166302|P12|STARTED|Part B Overall||7
8178917|NCT02377362|20166303|P11|STARTED|Part B Overall||6
8178918|NCT02377362|20166304|P10|STARTED|Part B Overall||7
8178919|NCT02377362|20166305|P9|STARTED|Part B Overall||6
8178920|NCT02377362|20166306|P8|STARTED|Part B Overall||6
8178921|NCT02377362|20166307|P7|STARTED|Part B Overall||6
8178922|NCT02377362|20166308|P6|STARTED|Part B Overall||0
8178923|NCT02377362|20166309|P5|STARTED|Part B Overall||0
8178924|NCT02377362|20166310|P4|STARTED|Part B Overall||0
8178925|NCT02377362|20166311|P3|STARTED|Part B Overall||0
8178926|NCT02377362|20166312|P2|STARTED|Part B Overall||0
8178927|NCT02377362|20166313|P1|STARTED|Part B Overall||0
8178928|NCT02377362|20166301|P13|NOT COMPLETED|Part A Third Treatment||0
8178929|NCT02377362|20166302|P12|NOT COMPLETED|Part A Third Treatment||0
8178930|NCT02377362|20166303|P11|NOT COMPLETED|Part A Third Treatment||0
8178931|NCT02377362|20166304|P10|NOT COMPLETED|Part A Third Treatment||0
8178932|NCT02377362|20166305|P9|NOT COMPLETED|Part A Third Treatment||0
8178933|NCT02377362|20166306|P8|NOT COMPLETED|Part A Third Treatment||0
8178934|NCT02377362|20166307|P7|NOT COMPLETED|Part A Third Treatment||0
8178935|NCT02377362|20166308|P6|NOT COMPLETED|Part A Third Treatment||4
8178936|NCT02377362|20166309|P5|NOT COMPLETED|Part A Third Treatment||3
8178937|NCT02377362|20166310|P4|NOT COMPLETED|Part A Third Treatment||4
8178938|NCT02377362|20166311|P3|NOT COMPLETED|Part A Third Treatment||0
8178939|NCT02377362|20166312|P2|NOT COMPLETED|Part A Third Treatment||0
8178940|NCT02377362|20166313|P1|NOT COMPLETED|Part A Third Treatment||0
8178941|NCT02377362|20166301|P13|COMPLETED|Part A Third Treatment||0
8178942|NCT02377362|20166302|P12|COMPLETED|Part A Third Treatment||0
8178943|NCT02377362|20166303|P11|COMPLETED|Part A Third Treatment||0
8178944|NCT02377362|20166304|P10|COMPLETED|Part A Third Treatment||0
8178945|NCT02377362|20166305|P9|COMPLETED|Part A Third Treatment||0
8178946|NCT02377362|20166306|P8|COMPLETED|Part A Third Treatment||0
8178947|NCT02377362|20166307|P7|COMPLETED|Part A Third Treatment||0
8178948|NCT02377362|20166308|P6|COMPLETED|Part A Third Treatment||0
8178949|NCT02377362|20166309|P5|COMPLETED|Part A Third Treatment||0
8178950|NCT02377362|20166310|P4|COMPLETED|Part A Third Treatment||0
8178951|NCT02377362|20166311|P3|COMPLETED|Part A Third Treatment||4
8178952|NCT02377362|20166312|P2|COMPLETED|Part A Third Treatment||4
8178953|NCT02377362|20166313|P1|COMPLETED|Part A Third Treatment||4
8178954|NCT02377362|20166301|P13|STARTED|Part A Third Treatment||0
8178955|NCT02377362|20166302|P12|STARTED|Part A Third Treatment||0
8178956|NCT02377362|20166303|P11|STARTED|Part A Third Treatment||0
8178957|NCT02377362|20166304|P10|STARTED|Part A Third Treatment||0
8178958|NCT02377362|20166305|P9|STARTED|Part A Third Treatment||0
8178959|NCT02377362|20166306|P8|STARTED|Part A Third Treatment||0
8178960|NCT02377362|20166307|P7|STARTED|Part A Third Treatment||0
8178961|NCT02377362|20166308|P6|STARTED|Part A Third Treatment||4
8178962|NCT02377362|20166309|P5|STARTED|Part A Third Treatment||3
8178963|NCT02377362|20166310|P4|STARTED|Part A Third Treatment||4
8178964|NCT02377362|20166311|P3|STARTED|Part A Third Treatment||4
8178965|NCT02377362|20166312|P2|STARTED|Part A Third Treatment||4
8178966|NCT02377362|20166313|P1|STARTED|Part A Third Treatment||4
8178967|NCT02377362|20166301|P13|NOT COMPLETED|Part A Second Treatment||0
8178968|NCT02377362|20166302|P12|NOT COMPLETED|Part A Second Treatment||0
8178969|NCT02377362|20166303|P11|NOT COMPLETED|Part A Second Treatment||0
8178970|NCT02377362|20166304|P10|NOT COMPLETED|Part A Second Treatment||0
8178971|NCT02377362|20166305|P9|NOT COMPLETED|Part A Second Treatment||0
8178972|NCT02377362|20166306|P8|NOT COMPLETED|Part A Second Treatment||0
8178973|NCT02377362|20166307|P7|NOT COMPLETED|Part A Second Treatment||0
8178974|NCT02377362|20166308|P6|NOT COMPLETED|Part A Second Treatment||0
8178975|NCT02377362|20166309|P5|NOT COMPLETED|Part A Second Treatment||1
8178976|NCT02377362|20166310|P4|NOT COMPLETED|Part A Second Treatment||0
8178977|NCT02377362|20166311|P3|NOT COMPLETED|Part A Second Treatment||0
8178978|NCT02377362|20166312|P2|NOT COMPLETED|Part A Second Treatment||0
8178979|NCT02377362|20166313|P1|NOT COMPLETED|Part A Second Treatment||0
8178980|NCT02377362|20166301|P13|COMPLETED|Part A Second Treatment||0
8178981|NCT02377362|20166302|P12|COMPLETED|Part A Second Treatment||0
8178982|NCT02377362|20166303|P11|COMPLETED|Part A Second Treatment||0
8178983|NCT02377362|20166304|P10|COMPLETED|Part A Second Treatment||0
8178984|NCT02377362|20166305|P9|COMPLETED|Part A Second Treatment||0
8178985|NCT02377362|20166306|P8|COMPLETED|Part A Second Treatment||0
8178986|NCT02377362|20166307|P7|COMPLETED|Part A Second Treatment||0
8178987|NCT02377362|20166308|P6|COMPLETED|Part A Second Treatment||4
8178988|NCT02377362|20166309|P5|COMPLETED|Part A Second Treatment||3
8178989|NCT02377362|20166310|P4|COMPLETED|Part A Second Treatment||4
8178990|NCT02377362|20166311|P3|COMPLETED|Part A Second Treatment||4
8178991|NCT02377362|20166312|P2|COMPLETED|Part A Second Treatment||4
8178992|NCT02377362|20166313|P1|COMPLETED|Part A Second Treatment||4
8178993|NCT02377362|20166301|P13|STARTED|Part A Second Treatment||0
8178994|NCT02377362|20166302|P12|STARTED|Part A Second Treatment||0
8178995|NCT02377362|20166303|P11|STARTED|Part A Second Treatment||0
8178996|NCT02377362|20166304|P10|STARTED|Part A Second Treatment||0
8178997|NCT02377362|20166305|P9|STARTED|Part A Second Treatment||0
8178998|NCT02377362|20166306|P8|STARTED|Part A Second Treatment||0
8178999|NCT02377362|20166307|P7|STARTED|Part A Second Treatment||0
8179000|NCT02377362|20166308|P6|STARTED|Part A Second Treatment||4
8179001|NCT02377362|20166309|P5|STARTED|Part A Second Treatment||4
8179002|NCT02377362|20166310|P4|STARTED|Part A Second Treatment||4
8179003|NCT02377362|20166311|P3|STARTED|Part A Second Treatment||4
8179004|NCT02377362|20166312|P2|STARTED|Part A Second Treatment||4
8179005|NCT02377362|20166313|P1|STARTED|Part A Second Treatment||4
8179006|NCT02377362|20166301|P13|NOT COMPLETED|Part A First Treatment||0
8179007|NCT02377362|20166302|P12|NOT COMPLETED|Part A First Treatment||0
8179008|NCT02377362|20166303|P11|NOT COMPLETED|Part A First Treatment||0
8179009|NCT02377362|20166304|P10|NOT COMPLETED|Part A First Treatment||0
8179010|NCT02377362|20166305|P9|NOT COMPLETED|Part A First Treatment||0
8179011|NCT02377362|20166306|P8|NOT COMPLETED|Part A First Treatment||0
8179012|NCT02377362|20166307|P7|NOT COMPLETED|Part A First Treatment||0
8179013|NCT02377362|20166308|P6|NOT COMPLETED|Part A First Treatment||0
8179014|NCT02377362|20166309|P5|NOT COMPLETED|Part A First Treatment||0
8179015|NCT02377362|20166310|P4|NOT COMPLETED|Part A First Treatment||0
8179016|NCT02377362|20166311|P3|NOT COMPLETED|Part A First Treatment||0
8179017|NCT02377362|20166312|P2|NOT COMPLETED|Part A First Treatment||0
8179018|NCT02377362|20166313|P1|NOT COMPLETED|Part A First Treatment||0
8179019|NCT02377362|20166301|P13|COMPLETED|Part A First Treatment||0
8179020|NCT02377362|20166302|P12|COMPLETED|Part A First Treatment||0
8179021|NCT02377362|20166303|P11|COMPLETED|Part A First Treatment||0
8179022|NCT02377362|20166304|P10|COMPLETED|Part A First Treatment||0
8179023|NCT02377362|20166305|P9|COMPLETED|Part A First Treatment||0
8179024|NCT02377362|20166306|P8|COMPLETED|Part A First Treatment||0
8179025|NCT02377362|20166307|P7|COMPLETED|Part A First Treatment||0
8179026|NCT02377362|20166308|P6|COMPLETED|Part A First Treatment||4
8179027|NCT02377362|20166309|P5|COMPLETED|Part A First Treatment||4
8179028|NCT02377362|20166310|P4|COMPLETED|Part A First Treatment||4
8179029|NCT02377362|20166311|P3|COMPLETED|Part A First Treatment||4
8179030|NCT02377362|20166312|P2|COMPLETED|Part A First Treatment||4
8179031|NCT02377362|20166313|P1|COMPLETED|Part A First Treatment||4
8179032|NCT02377362|20166301|P13|STARTED|Part A First Treatment||0
8179033|NCT02377362|20166302|P12|STARTED|Part A First Treatment||0
8179034|NCT02377362|20166303|P11|STARTED|Part A First Treatment||0
8179035|NCT02377362|20166304|P10|STARTED|Part A First Treatment||0
8179036|NCT02377362|20166305|P9|STARTED|Part A First Treatment||0
8179037|NCT02377362|20166306|P8|STARTED|Part A First Treatment||0
8179038|NCT02377362|20166307|P7|STARTED|Part A First Treatment||0
8179039|NCT02377362|20166308|P6|STARTED|Part A First Treatment||4
8179040|NCT02377362|20166309|P5|STARTED|Part A First Treatment||4
8179041|NCT02377362|20166310|P4|STARTED|Part A First Treatment||4
8179042|NCT02377362|20166311|P3|STARTED|Part A First Treatment||4
8179043|NCT02377362|20166312|P2|STARTED|Part A First Treatment||4
8179044|NCT02377362|20166313|P1|STARTED|Part A First Treatment||4
8179045|NCT02377349|20166522|P2|NOT COMPLETED|Overall Study||11
8179046|NCT02377349|20166523|P1|NOT COMPLETED|Overall Study||16
8179047|NCT02377349|20166522|P2|COMPLETED|Overall Study||335
8179048|NCT02377349|20166523|P1|COMPLETED|Overall Study||325
8179049|NCT02377349|20166522|P2|STARTED|Overall Study||346
8179050|NCT02377349|20166523|P1|STARTED|Overall Study||341
8179051|NCT02377063|20166561|P1|NOT COMPLETED|Overall Study||5
8179052|NCT02377063|20166561|P1|COMPLETED|Overall Study||20
8179053|NCT02377063|20166561|P1|STARTED|Overall Study||25
8179054|NCT02376998|20166565|P1|NOT COMPLETED|Overall Study||9
8179055|NCT02376998|20166565|P1|COMPLETED|Overall Study||11
8179056|NCT02376998|20166565|P1|STARTED|Overall Study||20
8179057|NCT02376933|20166569|P1|NOT COMPLETED|Overall Study||2
8179058|NCT02376933|20166569|P1|COMPLETED|Overall Study||8
8179059|NCT02376933|20166569|P1|STARTED|Overall Study||10
8179072|NCT02376530|20166701|P4|NOT COMPLETED|Overall Study||0
8179073|NCT02376530|20166702|P3|NOT COMPLETED|Overall Study||0
8179074|NCT02376530|20166703|P2|NOT COMPLETED|Overall Study||0
8179075|NCT02376530|20166704|P1|NOT COMPLETED|Overall Study||0
8179076|NCT02376530|20166701|P4|COMPLETED|Overall Study||197
8179077|NCT02376530|20166702|P3|COMPLETED|Overall Study||197
8179078|NCT02376530|20166703|P2|COMPLETED|Overall Study||198
8179079|NCT02376530|20166704|P1|COMPLETED|Overall Study||196
8179080|NCT02376530|20166701|P4|STARTED|Overall Study||197
8179081|NCT02376530|20166702|P3|STARTED|Overall Study||197
8179082|NCT02376530|20166703|P2|STARTED|Overall Study||198
8179083|NCT02376530|20166704|P1|STARTED|Overall Study||196
8179084|NCT02376283|20166717|P3|NOT COMPLETED|Overall Study||0
8179085|NCT02376283|20166718|P2|NOT COMPLETED|Overall Study||0
8179086|NCT02376283|20166719|P1|NOT COMPLETED|Overall Study||0
8179087|NCT02376283|20166717|P3|COMPLETED|Overall Study||30
8179088|NCT02376283|20166718|P2|COMPLETED|Overall Study||30
8179089|NCT02376283|20166719|P1|COMPLETED|Overall Study||27
8179090|NCT02376283|20166717|P3|STARTED|Overall Study||30
8179091|NCT02376283|20166718|P2|STARTED|Overall Study||30
8179092|NCT02376283|20166719|P1|STARTED|Overall Study||27
8179093|NCT02376257|20166737|P3|NOT COMPLETED|Overall Study||0
8179094|NCT02376257|20166738|P2|NOT COMPLETED|Overall Study||0
8179095|NCT02376257|20166739|P1|NOT COMPLETED|Overall Study||0
8179096|NCT02376257|20166737|P3|COMPLETED|Overall Study||11
8179097|NCT02376257|20166738|P2|COMPLETED|Overall Study||12
8179098|NCT02376257|20166739|P1|COMPLETED|Overall Study||13
8179099|NCT02376257|20166737|P3|STARTED|Overall Study||11
8179100|NCT02376257|20166738|P2|STARTED|Overall Study||12
8179101|NCT02376257|20166739|P1|STARTED|Overall Study||13
8179102|NCT02376179|20166768|P1|NOT COMPLETED|Overall Study||0
8179103|NCT02376179|20166768|P1|COMPLETED|Overall Study||84
8179104|NCT02376179|20166768|P1|STARTED|Overall Study||84
8179105|NCT02376166|20166772|P1|NOT COMPLETED|Overall Study||3
8179106|NCT02376166|20166772|P1|COMPLETED|Overall Study||12
8179107|NCT02376166|20166772|P1|STARTED|Overall Study||15
8179108|NCT02375971|20166800|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
8179109|NCT02375971|20166801|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
8179110|NCT02375971|20166802|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
8179111|NCT02375971|20166800|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
8179112|NCT02375971|20166801|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
8179113|NCT02375971|20166802|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
8179114|NCT02375971|20166800|P3|STARTED|Follow-Up Phase (up to Day 169)||69
8179115|NCT02375971|20166801|P2|STARTED|Follow-Up Phase (up to Day 169)||76
8179116|NCT02375971|20166802|P1|STARTED|Follow-Up Phase (up to Day 169)||73
8179117|NCT02375971|20166800|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
8179118|NCT02375971|20166801|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
8179119|NCT02375971|20166802|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
8179120|NCT02375971|20166800|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
8179121|NCT02375971|20166801|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
8179122|NCT02375971|20166802|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
8179123|NCT02375971|20166800|P3|PK Set|Treatment (Day 1 - Baseline)||0
8179124|NCT02375971|20166801|P2|PK Set|Treatment (Day 1 - Baseline)||46
8179125|NCT02375971|20166802|P1|PK Set|Treatment (Day 1 - Baseline)||49
8179126|NCT02375971|20166800|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
8179127|NCT02375971|20166801|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
8179128|NCT02375971|20166802|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
8179129|NCT02375971|20166800|P3|Safety Set|Treatment (Day 1 - Baseline)||69
8179130|NCT02375971|20166801|P2|Safety Set|Treatment (Day 1 - Baseline)||76
8179131|NCT02375971|20166802|P1|Safety Set|Treatment (Day 1 - Baseline)||73
8179132|NCT02375971|20166800|P3|STARTED|Treatment (Day 1 - Baseline)||74
8179133|NCT02375971|20166801|P2|STARTED|Treatment (Day 1 - Baseline)||77
8179134|NCT02375971|20166802|P1|STARTED|Treatment (Day 1 - Baseline)||74
8179135|NCT02375724|20166844|P2|NOT COMPLETED|Overall Study||6
8179136|NCT02375724|20166845|P1|NOT COMPLETED|Overall Study||6
8179137|NCT02375724|20166844|P2|COMPLETED|Overall Study||128
8179138|NCT02375724|20166845|P1|COMPLETED|Overall Study||129
8179139|NCT02375724|20166844|P2|STARTED|Overall Study||134
8179140|NCT02375724|20166845|P1|STARTED|Overall Study||135
8179141|NCT02375698|20166857|P2|NOT COMPLETED|Overall Study||2
8179142|NCT02375698|20166858|P1|NOT COMPLETED|Overall Study||2
8179143|NCT02375698|20166857|P2|COMPLETED|Overall Study||4
8179144|NCT02375698|20166858|P1|COMPLETED|Overall Study||14
8179145|NCT02375698|20166857|P2|STARTED|Overall Study||6
8179146|NCT02375698|20166858|P1|STARTED|Overall Study||16
8179147|NCT02375373|20166866|P1|NOT COMPLETED|Overall Study||11
8179148|NCT02375373|20166866|P1|COMPLETED|Overall Study||1
8179149|NCT02375373|20166866|P1|STARTED|Overall Study||12
8179150|NCT02375347|20166870|P1|NOT COMPLETED|Overall Study||1
8179151|NCT02375347|20166870|P1|COMPLETED|Overall Study||12
8179152|NCT02375347|20166870|P1|STARTED|Overall Study||13
8179153|NCT02374957|20166876|P2|NOT COMPLETED|Overall Study||0
8179154|NCT02374957|20166877|P1|NOT COMPLETED|Overall Study||1
8179155|NCT02374957|20166876|P2|COMPLETED|Overall Study||9
8179156|NCT02374957|20166877|P1|COMPLETED|Overall Study||10
8179157|NCT02374957|20166876|P2|STARTED|Overall Study||9
8179158|NCT02374957|20166877|P1|STARTED|Overall Study||11
8179159|NCT02374671|20166906|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
8179160|NCT02374671|20166907|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8179161|NCT02374671|20166908|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
8179162|NCT02374671|20166906|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
8179163|NCT02374671|20166907|P2|COMPLETED|Implantation- Nonrandomized & Randomized||27
8179164|NCT02374671|20166908|P1|COMPLETED|Implantation- Nonrandomized & Randomized||281
8179165|NCT02374671|20166906|P3|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
8179166|NCT02374671|20166907|P2|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
8179167|NCT02374671|20166908|P1|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
8179168|NCT02374671|20166906|P3|NOT COMPLETED|Observation (Deferred Implantation)||5
8179169|NCT02374671|20166907|P2|NOT COMPLETED|Observation (Deferred Implantation)||0
8179170|NCT02374671|20166908|P1|NOT COMPLETED|Observation (Deferred Implantation)||0
8179171|NCT02374671|20166906|P3|COMPLETED|Observation (Deferred Implantation)||26
8179172|NCT02374671|20166907|P2|COMPLETED|Observation (Deferred Implantation)||0
8179173|NCT02374671|20166908|P1|COMPLETED|Observation (Deferred Implantation)||0
8179174|NCT02374671|20166906|P3|STARTED|Observation (Deferred Implantation)||31
8179175|NCT02374671|20166907|P2|STARTED|Observation (Deferred Implantation)||0
8179176|NCT02374671|20166908|P1|STARTED|Observation (Deferred Implantation)||0
8179177|NCT02374593|20166916|P2|NOT COMPLETED|Overall Study||0
8179178|NCT02374593|20166917|P1|NOT COMPLETED|Overall Study||2
8179179|NCT02374593|20166916|P2|COMPLETED|Overall Study||44
8179180|NCT02374593|20166917|P1|COMPLETED|Overall Study||22
8179181|NCT02374593|20166916|P2|STARTED|Overall Study||44
8179182|NCT02374593|20166917|P1|STARTED|Overall Study||24
8179183|NCT02374463|20166929|P2|NOT COMPLETED|Overall Study||3
8179184|NCT02374463|20166930|P1|NOT COMPLETED|Overall Study||3
8179185|NCT02374463|20166929|P2|COMPLETED|Overall Study||9
8179186|NCT02374463|20166930|P1|COMPLETED|Overall Study||12
8179187|NCT02374463|20166929|P2|STARTED|Overall Study||12
8179188|NCT02374463|20166930|P1|STARTED|Overall Study||15
8179189|NCT02374398|20166950|P4|NOT COMPLETED|Overall Study||0
8179190|NCT02374398|20166951|P3|NOT COMPLETED|Overall Study||3
8179191|NCT02374398|20166952|P2|NOT COMPLETED|Overall Study||1
8179192|NCT02374398|20166953|P1|NOT COMPLETED|Overall Study||2
8179193|NCT02374398|20166950|P4|COMPLETED|Overall Study||32
8179194|NCT02374398|20166951|P3|COMPLETED|Overall Study||29
8179195|NCT02374398|20166952|P2|COMPLETED|Overall Study||31
8179196|NCT02374398|20166953|P1|COMPLETED|Overall Study||29
8179197|NCT02374398|20166950|P4|STARTED|Overall Study||32
8179198|NCT02374398|20166951|P3|STARTED|Overall Study||32
8179199|NCT02374398|20166952|P2|STARTED|Overall Study||32
8179200|NCT02374398|20166953|P1|STARTED|Overall Study||31
8179201|NCT02374346|20166979|P1|NOT COMPLETED|Overall Study||48
8179202|NCT02374346|20166979|P1|COMPLETED|Overall Study||446
8179203|NCT02374346|20166979|P1|STARTED|Overall Study||494
8179204|NCT02374307|20166987|P2|NOT COMPLETED|6-months Follow-up||6
8179205|NCT02374307|20166988|P1|NOT COMPLETED|6-months Follow-up||3
8179206|NCT02374307|20166987|P2|COMPLETED|6-months Follow-up||64
8179207|NCT02374307|20166988|P1|COMPLETED|6-months Follow-up||71
8179208|NCT02374307|20166987|P2|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
8179209|NCT02374307|20166988|P1|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
8179210|NCT02374307|20166987|P2|NOT COMPLETED|3-months Follow-up||9
8179211|NCT02374307|20166988|P1|NOT COMPLETED|3-months Follow-up||8
8179212|NCT02374307|20166987|P2|COMPLETED|3-months Follow-up||69
8179213|NCT02374307|20166988|P1|COMPLETED|3-months Follow-up||69
8179214|NCT02374307|20166987|P2|STARTED|3-months Follow-up||78
8179215|NCT02374307|20166988|P1|STARTED|3-months Follow-up||77
8179216|NCT02374255|20167019|P4|NOT COMPLETED|Overall Study||0
8179217|NCT02374255|20167020|P3|NOT COMPLETED|Overall Study||0
8179218|NCT02374255|20167021|P2|NOT COMPLETED|Overall Study||0
8179219|NCT02374255|20167022|P1|NOT COMPLETED|Overall Study||2
8179220|NCT02374255|20167019|P4|COMPLETED|Overall Study||11
8179221|NCT02374255|20167020|P3|COMPLETED|Overall Study||11
8179222|NCT02374255|20167021|P2|COMPLETED|Overall Study||110
8179223|NCT02374255|20167022|P1|COMPLETED|Overall Study||153
8179224|NCT02374255|20167019|P4|STARTED|Overall Study||11
8179225|NCT02374255|20167020|P3|STARTED|Overall Study||11
8179226|NCT02374255|20167021|P2|STARTED|Overall Study||110
8179227|NCT02374255|20167022|P1|STARTED|Overall Study||155
8179228|NCT02374164|20167043|P3|NOT COMPLETED|Treatment Period 3||0
8179229|NCT02374164|20167044|P2|NOT COMPLETED|Treatment Period 3||0
8179230|NCT02374164|20167045|P1|NOT COMPLETED|Treatment Period 3||0
8179231|NCT02374164|20167043|P3|COMPLETED|Treatment Period 3||12
8179232|NCT02374164|20167044|P2|COMPLETED|Treatment Period 3||11
8179233|NCT02374164|20167045|P1|COMPLETED|Treatment Period 3||12
8179234|NCT02374164|20167043|P3|STARTED|Treatment Period 3||12
8179235|NCT02374164|20167044|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
8179236|NCT02374164|20167045|P1|STARTED|Treatment Period 3||12
8179237|NCT02374164|20167043|P3|NOT COMPLETED|Treatment Period 2||0
8179238|NCT02374164|20167044|P2|NOT COMPLETED|Treatment Period 2||0
8179239|NCT02374164|20167045|P1|NOT COMPLETED|Treatment Period 2||0
8179240|NCT02374164|20167043|P3|COMPLETED|Treatment Period 2||12
8179241|NCT02374164|20167044|P2|COMPLETED|Treatment Period 2||12
8179242|NCT02374164|20167045|P1|COMPLETED|Treatment Period 2||12
8179243|NCT02374164|20167043|P3|STARTED|Treatment Period 2||12
8179244|NCT02374164|20167044|P2|STARTED|Treatment Period 2||12
8179245|NCT02374164|20167045|P1|STARTED|Treatment Period 2||12
8179246|NCT02374164|20167043|P3|NOT COMPLETED|Treatment Period 1||0
8179247|NCT02374164|20167044|P2|NOT COMPLETED|Treatment Period 1||0
8179248|NCT02374164|20167045|P1|NOT COMPLETED|Treatment Period 1||0
8179249|NCT02374164|20167043|P3|COMPLETED|Treatment Period 1||12
8179250|NCT02374164|20167044|P2|COMPLETED|Treatment Period 1||12
8179251|NCT02374164|20167045|P1|COMPLETED|Treatment Period 1||12
8179252|NCT02374164|20167043|P3|STARTED|Treatment Period 1||12
8179253|NCT02374164|20167044|P2|STARTED|Treatment Period 1||12
8179254|NCT02374164|20167045|P1|STARTED|Treatment Period 1||12
8179255|NCT02374138|20167064|P2|NOT COMPLETED|Twelve Month FollowUp||12
8179256|NCT02374138|20167065|P1|NOT COMPLETED|Twelve Month FollowUp||9
8179257|NCT02374138|20167064|P2|COMPLETED|Twelve Month FollowUp||95
8179258|NCT02374138|20167065|P1|COMPLETED|Twelve Month FollowUp||101
8179259|NCT02374138|20167064|P2|STARTED|Twelve Month FollowUp||107
8179260|NCT02374138|20167065|P1|STARTED|Twelve Month FollowUp||110
8179261|NCT02374138|20167064|P2|NOT COMPLETED|Six Month Follow Up||14
8179262|NCT02374138|20167065|P1|NOT COMPLETED|Six Month Follow Up||8
8179263|NCT02374138|20167064|P2|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
8179264|NCT02374138|20167065|P1|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
8179265|NCT02374138|20167064|P2|STARTED|Six Month Follow Up||107
8179266|NCT02374138|20167065|P1|STARTED|Six Month Follow Up||110
8179267|NCT02374099|20167123|P2|NOT COMPLETED|Overall Study||49
8179268|NCT02374099|20167124|P1|NOT COMPLETED|Overall Study||48
8179269|NCT02374099|20167123|P2|COMPLETED|Overall Study||0
8179270|NCT02374099|20167124|P1|COMPLETED|Overall Study||0
8179271|NCT02374099|20167123|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
8179272|NCT02374099|20167124|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
8179273|NCT02374099|20167123|P2|STARTED|Overall Study||49
8179274|NCT02374099|20167124|P1|STARTED|Overall Study||48
8179275|NCT02374060|20167143|P3|NOT COMPLETED|Overall Study||3
8179276|NCT02374060|20167144|P2|NOT COMPLETED|Overall Study||1
8179277|NCT02374060|20167145|P1|NOT COMPLETED|Overall Study||2
8179278|NCT02374060|20167143|P3|COMPLETED|Overall Study||61
8179279|NCT02374060|20167144|P2|COMPLETED|Overall Study||62
8179280|NCT02374060|20167145|P1|COMPLETED|Overall Study||63
8179281|NCT02374060|20167143|P3|STARTED|Overall Study||64
8179282|NCT02374060|20167144|P2|STARTED|Overall Study||63
8179283|NCT02374060|20167145|P1|STARTED|Overall Study||65
8179284|NCT02373865|20167197|P2|NOT COMPLETED|Overall Study||0
8179285|NCT02373865|20167198|P1|NOT COMPLETED|Overall Study||0
8179286|NCT02373865|20167197|P2|COMPLETED|Overall Study||2
8179287|NCT02373865|20167198|P1|COMPLETED|Overall Study||2
8179288|NCT02373865|20167197|P2|STARTED|Overall Study||2
8179289|NCT02373865|20167198|P1|STARTED|Overall Study||2
8179290|NCT02373852|20167208|P1|NOT COMPLETED|Overall Study||1
8179291|NCT02373852|20167208|P1|COMPLETED|Overall Study||11
8179292|NCT02373852|20167208|P1|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
8179293|NCT02373813|20167216|P4|NOT COMPLETED|Double-Blind Treatment Period||4
8179294|NCT02373813|20167217|P3|NOT COMPLETED|Double-Blind Treatment Period||9
8179295|NCT02373813|20167218|P2|NOT COMPLETED|Double-Blind Treatment Period||13
8179296|NCT02373813|20167219|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8179297|NCT02373813|20167216|P4|COMPLETED|Double-Blind Treatment Period||47
8179298|NCT02373813|20167217|P3|COMPLETED|Double-Blind Treatment Period||92
8179299|NCT02373813|20167218|P2|COMPLETED|Double-Blind Treatment Period||88
8179300|NCT02373813|20167219|P1|COMPLETED|Double-Blind Treatment Period||0
8179301|NCT02373813|20167216|P4|Received Rescue Treatment|Double-Blind Treatment Period||15
8179302|NCT02373813|20167217|P3|Received Rescue Treatment|Double-Blind Treatment Period||36
8179303|NCT02373813|20167218|P2|Received Rescue Treatment|Double-Blind Treatment Period||52
8179304|NCT02373813|20167219|P1|Received Rescue Treatment|Double-Blind Treatment Period||0
8179305|NCT02373813|20167216|P4|Received Investigational Product (IP)|Double-Blind Treatment Period||51
8179306|NCT02373813|20167217|P3|Received Investigational Product (IP)|Double-Blind Treatment Period||100
8179307|NCT02373813|20167218|P2|Received Investigational Product (IP)|Double-Blind Treatment Period||101
8179308|NCT02373813|20167219|P1|Received Investigational Product (IP)|Double-Blind Treatment Period||0
8179309|NCT02373813|20167216|P4|STARTED|Double-Blind Treatment Period||51
8179310|NCT02373813|20167217|P3|STARTED|Double-Blind Treatment Period||101
8179311|NCT02373813|20167218|P2|STARTED|Double-Blind Treatment Period||101
8179312|NCT02373813|20167219|P1|STARTED|Double-Blind Treatment Period||0
8179313|NCT02373813|20167216|P4|NOT COMPLETED|Run-In Period||0
8179314|NCT02373813|20167217|P3|NOT COMPLETED|Run-In Period||0
8179315|NCT02373813|20167218|P2|NOT COMPLETED|Run-In Period||0
8179316|NCT02373813|20167219|P1|NOT COMPLETED|Run-In Period||116
8179317|NCT02373813|20167216|P4|COMPLETED|Run-In Period||0
8179318|NCT02373813|20167217|P3|COMPLETED|Run-In Period||0
8179319|NCT02373813|20167218|P2|COMPLETED|Run-In Period||0
8179320|NCT02373813|20167219|P1|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
8179321|NCT02373813|20167216|P4|Treated|Run-In Period||0
8179322|NCT02373813|20167217|P3|Treated|Run-In Period||0
8179323|NCT02373813|20167218|P2|Treated|Run-In Period||0
8179324|NCT02373813|20167219|P1|Treated|Run-In Period||368
8179325|NCT02373813|20167216|P4|STARTED|Run-In Period||0
8179326|NCT02373813|20167217|P3|STARTED|Run-In Period||0
8179327|NCT02373813|20167218|P2|STARTED|Run-In Period||0
8179328|NCT02373813|20167219|P1|STARTED|Run-In Period||371
8179329|NCT02373371|20167274|P2|NOT COMPLETED|Overall Study||0
8179330|NCT02373371|20167275|P1|NOT COMPLETED|Overall Study||0
8179331|NCT02373371|20167274|P2|COMPLETED|Overall Study||13
8179332|NCT02373371|20167275|P1|COMPLETED|Overall Study||13
8179333|NCT02373371|20167274|P2|STARTED|Overall Study||13
8179334|NCT02373371|20167275|P1|STARTED|Overall Study||13
8179335|NCT02373202|20167291|P4|NOT COMPLETED|Overall Study||1
8179336|NCT02373202|20167292|P3|NOT COMPLETED|Overall Study||3
8179337|NCT02373202|20167293|P2|NOT COMPLETED|Overall Study||6
8179338|NCT02373202|20167294|P1|NOT COMPLETED|Overall Study||2
8179339|NCT02373202|20167291|P4|COMPLETED|Overall Study||30
8179340|NCT02373202|20167292|P3|COMPLETED|Overall Study||27
8179341|NCT02373202|20167293|P2|COMPLETED|Overall Study||9
8179342|NCT02373202|20167294|P1|COMPLETED|Overall Study||13
8179343|NCT02373202|20167291|P4|STARTED|Overall Study||31
8179344|NCT02373202|20167292|P3|STARTED|Overall Study||30
8179345|NCT02373202|20167293|P2|STARTED|Overall Study||15
8179346|NCT02373202|20167294|P1|STARTED|Overall Study||15
8179347|NCT02373137|20167346|P2|NOT COMPLETED|Overall Study||1
8179348|NCT02373137|20167347|P1|NOT COMPLETED|Overall Study||1
8179349|NCT02373137|20167346|P2|COMPLETED|Overall Study||18
8179350|NCT02373137|20167347|P1|COMPLETED|Overall Study||18
8179351|NCT02373137|20167346|P2|12-Month Follow-Up|Overall Study||19
8179352|NCT02373137|20167347|P1|12-Month Follow-Up|Overall Study||19
8179353|NCT02373137|20167346|P2|6-Month Follow-Up|Overall Study||18
8179354|NCT02373137|20167347|P1|6-Month Follow-Up|Overall Study||19
8179355|NCT02373137|20167346|P2|3-Month Follow-Up|Overall Study||19
8179356|NCT02373137|20167347|P1|3-Month Follow-Up|Overall Study||19
8179357|NCT02373137|20167346|P2|STARTED|Overall Study||19
8179358|NCT02373137|20167347|P1|STARTED|Overall Study||19
8179359|NCT02373124|20167379|P1|NOT COMPLETED|Overall Study||1
8179360|NCT02373124|20167379|P1|COMPLETED|Overall Study||3
8179361|NCT02373124|20167379|P1|STARTED|Overall Study||4
8179362|NCT02373098|20167385|P2|NOT COMPLETED|Overall Study||0
8179363|NCT02373098|20167386|P1|NOT COMPLETED|Overall Study||12
8179364|NCT02373098|20167385|P2|COMPLETED|Overall Study||60
8179365|NCT02373098|20167386|P1|COMPLETED|Overall Study||54
8179366|NCT02373098|20167385|P2|STARTED|Overall Study||60
8179367|NCT02373098|20167386|P1|STARTED|Overall Study||66
8179368|NCT02372799|20167414|P3|NOT COMPLETED|Down-taper Period||2
8179369|NCT02372799|20167415|P2|NOT COMPLETED|Down-taper Period||2
8179370|NCT02372799|20167416|P1|NOT COMPLETED|Down-taper Period||1
8179371|NCT02372799|20167414|P3|COMPLETED|Down-taper Period||80
8179372|NCT02372799|20167415|P2|COMPLETED|Down-taper Period||157
8179373|NCT02372799|20167416|P1|COMPLETED|Down-taper Period||151
8179374|NCT02372799|20167414|P3|STARTED|Down-taper Period||82
8179375|NCT02372799|20167415|P2|STARTED|Down-taper Period||159
8179376|NCT02372799|20167416|P1|STARTED|Down-taper Period||152
8179377|NCT02372799|20167414|P3|NOT COMPLETED|Treatment Period||15
8179378|NCT02372799|20167415|P2|NOT COMPLETED|Treatment Period||32
8179379|NCT02372799|20167416|P1|NOT COMPLETED|Treatment Period||34
8179380|NCT02372799|20167414|P3|COMPLETED|Treatment Period||82
8179381|NCT02372799|20167415|P2|COMPLETED|Treatment Period||155
8179382|NCT02372799|20167416|P1|COMPLETED|Treatment Period||152
8179383|NCT02372799|20167414|P3|STARTED|Treatment Period||97
8179384|NCT02372799|20167415|P2|STARTED|Treatment Period||187
8179385|NCT02372799|20167416|P1|STARTED|Treatment Period||186
8179386|NCT02372682|20167429|P2|NOT COMPLETED|Overall Study||14
8179387|NCT02372682|20167430|P1|NOT COMPLETED|Overall Study||8
8179388|NCT02372682|20167429|P2|COMPLETED|Overall Study||79
8179389|NCT02372682|20167430|P1|COMPLETED|Overall Study||70
8179390|NCT02372682|20167429|P2|STARTED|Overall Study||93
8179391|NCT02372682|20167430|P1|STARTED|Overall Study||78
8179392|NCT02372396|20167445|P2|NOT COMPLETED|Overall Study||9
8179393|NCT02372396|20167446|P1|NOT COMPLETED|Overall Study||7
8179394|NCT02372396|20167445|P2|COMPLETED|Overall Study||11
8179395|NCT02372396|20167446|P1|COMPLETED|Overall Study||10
8179396|NCT02372396|20167445|P2|Began Intervention|Overall Study||14
8179397|NCT02372396|20167446|P1|Began Intervention|Overall Study||14
8179398|NCT02372396|20167445|P2|STARTED|Overall Study||20
8179399|NCT02372396|20167446|P1|STARTED|Overall Study||17
8179400|NCT02372344|20167452|P3|NOT COMPLETED|Period 3 (Visit 4)||0
8179401|NCT02372344|20167453|P2|NOT COMPLETED|Period 3 (Visit 4)||0
8179402|NCT02372344|20167454|P1|NOT COMPLETED|Period 3 (Visit 4)||0
8179403|NCT02372344|20167452|P3|COMPLETED|Period 3 (Visit 4)||14
8179404|NCT02372344|20167453|P2|COMPLETED|Period 3 (Visit 4)||14
8179405|NCT02372344|20167454|P1|COMPLETED|Period 3 (Visit 4)||14
8179406|NCT02372344|20167452|P3|STARTED|Period 3 (Visit 4)||14
8179407|NCT02372344|20167453|P2|STARTED|Period 3 (Visit 4)||14
8179408|NCT02372344|20167454|P1|STARTED|Period 3 (Visit 4)||14
8179409|NCT02372344|20167452|P3|NOT COMPLETED|Period 2 (Visit 3)||0
8179410|NCT02372344|20167453|P2|NOT COMPLETED|Period 2 (Visit 3)||0
8179411|NCT02372344|20167454|P1|NOT COMPLETED|Period 2 (Visit 3)||0
8179412|NCT02372344|20167452|P3|COMPLETED|Period 2 (Visit 3)||14
8179413|NCT02372344|20167453|P2|COMPLETED|Period 2 (Visit 3)||14
8179414|NCT02372344|20167454|P1|COMPLETED|Period 2 (Visit 3)||14
8179415|NCT02372344|20167452|P3|STARTED|Period 2 (Visit 3)||14
8179416|NCT02372344|20167453|P2|STARTED|Period 2 (Visit 3)||14
8179417|NCT02372344|20167454|P1|STARTED|Period 2 (Visit 3)||14
8179418|NCT02372344|20167452|P3|NOT COMPLETED|Period 1 (Visit 2)||0
8179419|NCT02372344|20167453|P2|NOT COMPLETED|Period 1 (Visit 2)||0
8179420|NCT02372344|20167454|P1|NOT COMPLETED|Period 1 (Visit 2)||0
8179421|NCT02372344|20167452|P3|COMPLETED|Period 1 (Visit 2)||14
8179422|NCT02372344|20167453|P2|COMPLETED|Period 1 (Visit 2)||14
8179423|NCT02372344|20167454|P1|COMPLETED|Period 1 (Visit 2)||14
8179424|NCT02372344|20167452|P3|STARTED|Period 1 (Visit 2)||14
8179425|NCT02372344|20167453|P2|STARTED|Period 1 (Visit 2)||14
8179426|NCT02372344|20167454|P1|STARTED|Period 1 (Visit 2)||14
8179427|NCT02372253|20167470|P2|NOT COMPLETED|Overall Study||0
8179428|NCT02372253|20167471|P1|NOT COMPLETED|Overall Study||2
8179429|NCT02372253|20167470|P2|COMPLETED|Overall Study||13
8179430|NCT02372253|20167471|P1|COMPLETED|Overall Study||11
8179431|NCT02372253|20167470|P2|STARTED|Overall Study||13
8179432|NCT02372253|20167471|P1|STARTED|Overall Study||13
8179433|NCT02372097|20167489|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
8179434|NCT02372097|20167490|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
8179435|NCT02372097|20167489|P2|COMPLETED|Second Intervention Period (8 Days)||12
8179436|NCT02372097|20167490|P1|COMPLETED|Second Intervention Period (8 Days)||12
8179437|NCT02372097|20167489|P2|STARTED|Second Intervention Period (8 Days)||12
8179438|NCT02372097|20167490|P1|STARTED|Second Intervention Period (8 Days)||12
8179439|NCT02372097|20167489|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
8179440|NCT02372097|20167490|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
8179441|NCT02372097|20167489|P2|COMPLETED|Wash Out Period (13 Days)||12
8179442|NCT02372097|20167490|P1|COMPLETED|Wash Out Period (13 Days)||12
8179443|NCT02372097|20167489|P2|STARTED|Wash Out Period (13 Days)||12
8179444|NCT02372097|20167490|P1|STARTED|Wash Out Period (13 Days)||12
8179445|NCT02372097|20167489|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
8179446|NCT02372097|20167490|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
8179447|NCT02372097|20167489|P2|COMPLETED|First Intervention Period (8 Days)||12
8179448|NCT02372097|20167490|P1|COMPLETED|First Intervention Period (8 Days)||12
8179449|NCT02372097|20167489|P2|STARTED|First Intervention Period (8 Days)||12
8179450|NCT02372097|20167490|P1|STARTED|First Intervention Period (8 Days)||12
8179451|NCT02372071|20167516|P1|NOT COMPLETED|Overall Study||18
8179452|NCT02372071|20167516|P1|COMPLETED|Overall Study||93
8179453|NCT02372071|20167516|P1|STARTED|Overall Study||111
8179454|NCT02372058|20167521|P1|NOT COMPLETED|Overall Study||3
8179455|NCT02372058|20167521|P1|COMPLETED|Overall Study||100
8179456|NCT02372058|20167521|P1|STARTED|Overall Study||103
8179457|NCT02371980|20167527|P5|NOT COMPLETED|Double-blind Period||58
8179458|NCT02371980|20167528|P4|NOT COMPLETED|Double-blind Period||49
8179459|NCT02371980|20167529|P3|NOT COMPLETED|Double-blind Period||56
8179460|NCT02371980|20167530|P2|NOT COMPLETED|Double-blind Period||81
8179461|NCT02371980|20167531|P1|NOT COMPLETED|Double-blind Period||0
8179462|NCT02371980|20167527|P5|COMPLETED|Double-blind Period||86
8179463|NCT02371980|20167528|P4|COMPLETED|Double-blind Period||96
8179464|NCT02371980|20167529|P3|COMPLETED|Double-blind Period||84
8179465|NCT02371980|20167530|P2|COMPLETED|Double-blind Period||70
8179466|NCT02371980|20167531|P1|COMPLETED|Double-blind Period||0
8179467|NCT02371980|20167527|P5|STARTED|Double-blind Period||144
8179468|NCT02371980|20167528|P4|STARTED|Double-blind Period||145
8179469|NCT02371980|20167529|P3|STARTED|Double-blind Period||140
8179470|NCT02371980|20167530|P2|STARTED|Double-blind Period||151
8179471|NCT02371980|20167531|P1|STARTED|Double-blind Period||0
8179472|NCT02371980|20167527|P5|NOT COMPLETED|Open-label Period||0
8179473|NCT02371980|20167528|P4|NOT COMPLETED|Open-label Period||0
8179474|NCT02371980|20167529|P3|NOT COMPLETED|Open-label Period||0
8179475|NCT02371980|20167530|P2|NOT COMPLETED|Open-label Period||0
8179476|NCT02371980|20167531|P1|NOT COMPLETED|Open-label Period||526
8179477|NCT02371980|20167527|P5|COMPLETED|Open-label Period||0
8179478|NCT02371980|20167528|P4|COMPLETED|Open-label Period||0
8179479|NCT02371980|20167529|P3|COMPLETED|Open-label Period||0
8179480|NCT02371980|20167530|P2|COMPLETED|Open-label Period||0
8179481|NCT02371980|20167531|P1|COMPLETED|Open-label Period||580
8179482|NCT02371980|20167527|P5|STARTED|Open-label Period||0
8179483|NCT02371980|20167528|P4|STARTED|Open-label Period||0
8179484|NCT02371980|20167529|P3|STARTED|Open-label Period||0
8179485|NCT02371980|20167530|P2|STARTED|Open-label Period||0
8179486|NCT02371980|20167531|P1|STARTED|Open-label Period||1106
8179487|NCT02371876|20167558|P1|NOT COMPLETED|Overall Study||0
8179488|NCT02371876|20167558|P1|COMPLETED|Overall Study||134
8179489|NCT02371876|20167558|P1|STARTED|Overall Study||134
8179490|NCT02371850|20167568|P1|NOT COMPLETED|Overall Study||0
8179491|NCT02371850|20167568|P1|COMPLETED|Overall Study||10
8179492|NCT02371850|20167568|P1|STARTED|Overall Study||10
8179493|NCT02371785|20167573|P1|NOT COMPLETED|Overall Study||0
8179494|NCT02371785|20167573|P1|COMPLETED|Overall Study||20
8179495|NCT02371785|20167573|P1|STARTED|Overall Study||20
8179496|NCT02371759|20167591|P8|NOT COMPLETED|Overall Study||4
8179497|NCT02371759|20167592|P7|NOT COMPLETED|Overall Study||0
8179498|NCT02371759|20167593|P6|NOT COMPLETED|Overall Study||1
8179499|NCT02371759|20167594|P5|NOT COMPLETED|Overall Study||3
8179500|NCT02371759|20167595|P4|NOT COMPLETED|Overall Study||0
8179501|NCT02371759|20167596|P3|NOT COMPLETED|Overall Study||1
8179502|NCT02371759|20167597|P2|NOT COMPLETED|Overall Study||1
8179503|NCT02371759|20167598|P1|NOT COMPLETED|Overall Study||3
8179504|NCT02371759|20167591|P8|COMPLETED|Overall Study||24
8179505|NCT02371759|20167592|P7|COMPLETED|Overall Study||25
8179506|NCT02371759|20167593|P6|COMPLETED|Overall Study||25
8179507|NCT02371759|20167594|P5|COMPLETED|Overall Study||24
8179508|NCT02371759|20167595|P4|COMPLETED|Overall Study||31
8179509|NCT02371759|20167596|P3|COMPLETED|Overall Study||32
8179510|NCT02371759|20167597|P2|COMPLETED|Overall Study||30
8179511|NCT02371759|20167598|P1|COMPLETED|Overall Study||29
8179512|NCT02371759|20167591|P8|STARTED|Overall Study||28
8179513|NCT02371759|20167592|P7|STARTED|Overall Study||25
8179514|NCT02371759|20167593|P6|STARTED|Overall Study||26
8179515|NCT02371759|20167594|P5|STARTED|Overall Study||27
8179516|NCT02371759|20167595|P4|STARTED|Overall Study||31
8179517|NCT02371759|20167596|P3|STARTED|Overall Study||33
8179518|NCT02371759|20167597|P2|STARTED|Overall Study||31
8179519|NCT02371759|20167598|P1|STARTED|Overall Study||32
8179520|NCT02371746|20167815|P7|NOT COMPLETED|Overall Study||1
8179521|NCT02371746|20167816|P6|NOT COMPLETED|Overall Study||0
8179522|NCT02371746|20167817|P5|NOT COMPLETED|Overall Study||0
8179523|NCT02371746|20167818|P4|NOT COMPLETED|Overall Study||0
8179524|NCT02371746|20167819|P3|NOT COMPLETED|Overall Study||0
8179525|NCT02371746|20167820|P2|NOT COMPLETED|Overall Study||0
8179526|NCT02371746|20167821|P1|NOT COMPLETED|Overall Study||0
8179527|NCT02371746|20167815|P7|COMPLETED|Overall Study||8
8179528|NCT02371746|20167816|P6|COMPLETED|Overall Study||6
8179529|NCT02371746|20167817|P5|COMPLETED|Overall Study||5
8179530|NCT02371746|20167818|P4|COMPLETED|Overall Study||2
8179531|NCT02371746|20167819|P3|COMPLETED|Overall Study||2
8179532|NCT02371746|20167820|P2|COMPLETED|Overall Study||10
8179533|NCT02371746|20167821|P1|COMPLETED|Overall Study||7
8179534|NCT02371746|20167815|P7|STARTED|Overall Study||9
8179535|NCT02371746|20167816|P6|STARTED|Overall Study||6
8179536|NCT02371746|20167817|P5|STARTED|Overall Study||5
8179537|NCT02371746|20167818|P4|STARTED|Overall Study||2
8179538|NCT02371746|20167819|P3|STARTED|Overall Study||2
8179539|NCT02371746|20167820|P2|STARTED|Overall Study||10
8179540|NCT02371746|20167821|P1|STARTED|Overall Study||7
8179541|NCT02371668|20167839|P2|NOT COMPLETED|Overall Study||0
8179542|NCT02371668|20167840|P1|NOT COMPLETED|Overall Study||0
8179543|NCT02371668|20167839|P2|COMPLETED|Overall Study||42
8179544|NCT02371668|20167840|P1|COMPLETED|Overall Study||49
8179545|NCT02371668|20167839|P2|STARTED|Overall Study||42
8179546|NCT02371668|20167840|P1|STARTED|Overall Study||49
8179547|NCT02371629|20167864|P2|NOT COMPLETED|Overall Study||25
8179548|NCT02371629|20167865|P1|NOT COMPLETED|Overall Study||26
8179549|NCT02371629|20167864|P2|COMPLETED|Overall Study||363
8179550|NCT02371629|20167865|P1|COMPLETED|Overall Study||362
8179551|NCT02371629|20167864|P2|STARTED|Overall Study||388
8179552|NCT02371629|20167865|P1|STARTED|Overall Study||388
8179553|NCT02371616|20167901|P2|NOT COMPLETED|Overall Study||7
8179554|NCT02371616|20167902|P1|NOT COMPLETED|Overall Study||4
8179555|NCT02371616|20167901|P2|COMPLETED|Overall Study||147
8179556|NCT02371616|20167902|P1|COMPLETED|Overall Study||146
8179557|NCT02371616|20167901|P2|STARTED|Overall Study||154
8179558|NCT02371616|20167902|P1|STARTED|Overall Study||150
8179559|NCT02371395|20167914|P1|NOT COMPLETED|Overall Study||0
8179560|NCT02371395|20167914|P1|COMPLETED|Overall Study||1000
8179561|NCT02371395|20167914|P1|STARTED|Overall Study||1000
8179562|NCT02371356|20167923|P5|NOT COMPLETED|Overall Study||0
8179563|NCT02371356|20167924|P4|NOT COMPLETED|Overall Study||0
8179564|NCT02371356|20167925|P3|NOT COMPLETED|Overall Study||0
8179565|NCT02371356|20167926|P2|NOT COMPLETED|Overall Study||0
8179566|NCT02371356|20167927|P1|NOT COMPLETED|Overall Study||0
8179567|NCT02371356|20167923|P5|COMPLETED|Overall Study||72183
8179568|NCT02371356|20167924|P4|COMPLETED|Overall Study||7423
8179569|NCT02371356|20167925|P3|COMPLETED|Overall Study||2804
8179570|NCT02371356|20167926|P2|COMPLETED|Overall Study||7354
8179571|NCT02371356|20167927|P1|COMPLETED|Overall Study||1320
8179572|NCT02371356|20167923|P5|STARTED|Overall Study||72183
8179573|NCT02371356|20167924|P4|STARTED|Overall Study||7423
8179574|NCT02371356|20167925|P3|STARTED|Overall Study||2804
8179575|NCT02371356|20167926|P2|STARTED|Overall Study||7354
8179576|NCT02371356|20167927|P1|STARTED|Overall Study||1320
8179577|NCT02371187|20167946|P2|NOT COMPLETED|Overall Study||4
8179578|NCT02371187|20167947|P1|NOT COMPLETED|Overall Study||3
8179579|NCT02371187|20167946|P2|COMPLETED|Overall Study||15
8179580|NCT02371187|20167947|P1|COMPLETED|Overall Study||15
8179581|NCT02371187|20167946|P2|STARTED|Overall Study||19
8179582|NCT02371187|20167947|P1|STARTED|Overall Study||18
8179583|NCT02370914|20167961|P1|NOT COMPLETED|Overall Study||2
8179584|NCT02370914|20167961|P1|COMPLETED|Overall Study||82
8179585|NCT02370914|20167961|P1|STARTED|Overall Study||84
8179586|NCT02370888|20167969|P1|NOT COMPLETED|Overall Study||8
8179587|NCT02370888|20167969|P1|COMPLETED|Overall Study||1
8179588|NCT02370888|20167969|P1|Proceed to Treatment|Overall Study||3
8179589|NCT02370888|20167969|P1|STARTED|Overall Study||9
8179590|NCT02370784|20167979|P2|NOT COMPLETED|Overall Study||1
8179591|NCT02370784|20167980|P1|NOT COMPLETED|Overall Study||0
8179592|NCT02370784|20167979|P2|COMPLETED|Overall Study||13
8179593|NCT02370784|20167980|P1|COMPLETED|Overall Study||10
8179594|NCT02370784|20167979|P2|STARTED|Overall Study||14
8179595|NCT02370784|20167980|P1|STARTED|Overall Study||10
8179596|NCT02370667|20167995|P3|NOT COMPLETED|Overall Study||0
8179597|NCT02370667|20167996|P2|NOT COMPLETED|Overall Study||1
8179598|NCT02370667|20167997|P1|NOT COMPLETED|Overall Study||0
8179599|NCT02370667|20167995|P3|COMPLETED|Overall Study||10
8179600|NCT02370667|20167996|P2|COMPLETED|Overall Study||10
8179601|NCT02370667|20167997|P1|COMPLETED|Overall Study||10
8179602|NCT02370667|20167995|P3|STARTED|Overall Study||10
8179603|NCT02370667|20167996|P2|STARTED|Overall Study||11
8179604|NCT02370667|20167997|P1|STARTED|Overall Study||10
8179605|NCT02370641|20168061|P2|NOT COMPLETED|Overall Study||2
8179606|NCT02370641|20168062|P1|NOT COMPLETED|Overall Study||4
8179607|NCT02370641|20168061|P2|COMPLETED|Overall Study||6
8179608|NCT02370641|20168062|P1|COMPLETED|Overall Study||14
8179609|NCT02370641|20168061|P2|STARTED|Overall Study||8
8179610|NCT02370641|20168062|P1|STARTED|Overall Study||18
8179611|NCT02370615|20168070|P2|NOT COMPLETED|Overall Study||0
8179612|NCT02370615|20168071|P1|NOT COMPLETED|Overall Study||1
8179613|NCT02370615|20168070|P2|COMPLETED|Overall Study||18
8179614|NCT02370615|20168071|P1|COMPLETED|Overall Study||15
8179615|NCT02370615|20168070|P2|STARTED|Overall Study||18
8179616|NCT02370615|20168071|P1|STARTED|Overall Study||16
8179617|NCT02370602|20168114|P6|NOT COMPLETED|Overall Study||0
8179618|NCT02370602|20168115|P5|NOT COMPLETED|Overall Study||0
8179619|NCT02370602|20168116|P4|NOT COMPLETED|Overall Study||0
8179620|NCT02370602|20168117|P3|NOT COMPLETED|Overall Study||0
8179621|NCT02370602|20168118|P2|NOT COMPLETED|Overall Study||0
8179622|NCT02370602|20168119|P1|NOT COMPLETED|Overall Study||1
8179623|NCT02370602|20168114|P6|COMPLETED|Overall Study||2
8179624|NCT02370602|20168115|P5|COMPLETED|Overall Study||3
8179625|NCT02370602|20168116|P4|COMPLETED|Overall Study||3
8179626|NCT02370602|20168117|P3|COMPLETED|Overall Study||2
8179627|NCT02370602|20168118|P2|COMPLETED|Overall Study||2
8179628|NCT02370602|20168119|P1|COMPLETED|Overall Study||0
8179629|NCT02370602|20168114|P6|STARTED|Overall Study||2
8179630|NCT02370602|20168115|P5|STARTED|Overall Study||3
8179631|NCT02370602|20168116|P4|STARTED|Overall Study||3
8179632|NCT02370602|20168117|P3|STARTED|Overall Study||2
8179633|NCT02370602|20168118|P2|STARTED|Overall Study||2
8179634|NCT02370602|20168119|P1|STARTED|Overall Study||1
8179635|NCT02370537|20168213|P3|NOT COMPLETED|Part B||259
8179636|NCT02370537|20168214|P2|NOT COMPLETED|Part B||3
8179637|NCT02370537|20168215|P1|NOT COMPLETED|Part B||1
8179638|NCT02370537|20168213|P3|COMPLETED|Part B||23
8179639|NCT02370537|20168214|P2|COMPLETED|Part B||12
8179640|NCT02370537|20168215|P1|COMPLETED|Part B||15
8179641|NCT02370537|20168213|P3|Period 2 Sequence BA|Part B||12
8179642|NCT02370537|20168214|P2|Period 2 Sequence BA|Part B||7
8179643|NCT02370537|20168215|P1|Period 2 Sequence BA|Part B||7
8179644|NCT02370537|20168213|P3|Period 2 Sequence AB|Part B||11
8179645|NCT02370537|20168214|P2|Period 2 Sequence AB|Part B||5
8179646|NCT02370537|20168215|P1|Period 2 Sequence AB|Part B||8
8179647|NCT02370537|20168213|P3|Period 1 Sequence BA|Part B||12
8179648|NCT02370537|20168214|P2|Period 1 Sequence BA|Part B||7
8179649|NCT02370537|20168215|P1|Period 1 Sequence BA|Part B||7
8179650|NCT02370537|20168213|P3|Period 1 Sequence AB|Part B||11
8179651|NCT02370537|20168214|P2|Period 1 Sequence AB|Part B||6
8179652|NCT02370537|20168215|P1|Period 1 Sequence AB|Part B||8
8179653|NCT02370537|20168213|P3|Eligible for Randomisation|Part B||23
8179654|NCT02370537|20168214|P2|Eligible for Randomisation|Part B||13
8179655|NCT02370537|20168215|P1|Eligible for Randomisation|Part B||15
8179656|NCT02370537|20168213|P3|STARTED|Part B||282
8179657|NCT02370537|20168214|P2|STARTED|Part B||15
8179658|NCT02370537|20168215|P1|STARTED|Part B||16
8179659|NCT02370537|20168213|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
8179660|NCT02370537|20168214|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
8179661|NCT02370537|20168215|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
8179662|NCT02370537|20168213|P3|COMPLETED|Part A (Open-label Recruitment)||282
8179663|NCT02370537|20168214|P2|COMPLETED|Part A (Open-label Recruitment)||15
8179664|NCT02370537|20168215|P1|COMPLETED|Part A (Open-label Recruitment)||16
8179665|NCT02370537|20168213|P3|STARTED|Part A (Open-label Recruitment)||283
8179666|NCT02370537|20168214|P2|STARTED|Part A (Open-label Recruitment)||16
8179667|NCT02370537|20168215|P1|STARTED|Part A (Open-label Recruitment)||16
8179668|NCT02370498|20168264|P2|NOT COMPLETED|Overall Study||296
8179669|NCT02370498|20168265|P1|NOT COMPLETED|Overall Study||296
8179670|NCT02370498|20168264|P2|COMPLETED|Overall Study||0
8179671|NCT02370498|20168265|P1|COMPLETED|Overall Study||0
8179672|NCT02370498|20168264|P2|PD-L1 Positive Participants|Overall Study||199
8179673|NCT02370498|20168265|P1|PD-L1 Positive Participants|Overall Study||196
8179674|NCT02370498|20168264|P2|Treated|Overall Study||276
8179675|NCT02370498|20168265|P1|Treated|Overall Study||294
8179676|NCT02370498|20168264|P2|STARTED|Overall Study||296
8179677|NCT02370498|20168265|P1|STARTED|Overall Study||296
8179678|NCT02370420|20168319|P2|NOT COMPLETED|Overall Study||12
8179679|NCT02370420|20168320|P1|NOT COMPLETED|Overall Study||14
8179680|NCT02370420|20168319|P2|COMPLETED|Overall Study||15
8179681|NCT02370420|20168320|P1|COMPLETED|Overall Study||15
8179682|NCT02370420|20168319|P2|STARTED|Overall Study||27
8179683|NCT02370420|20168320|P1|STARTED|Overall Study||29
8179684|NCT02370407|20168332|P2|NOT COMPLETED|Overall Study||0
8179685|NCT02370407|20168333|P1|NOT COMPLETED|Overall Study||0
8179686|NCT02370407|20168332|P2|COMPLETED|Overall Study||20
8179687|NCT02370407|20168333|P1|COMPLETED|Overall Study||20
8179688|NCT02370407|20168332|P2|STARTED|Overall Study||20
8179689|NCT02370407|20168333|P1|STARTED|Overall Study||20
8179690|NCT02370394|20168357|P2|NOT COMPLETED|Overall Study||2
8179691|NCT02370394|20168358|P1|NOT COMPLETED|Overall Study||2
8179692|NCT02370394|20168357|P2|COMPLETED|Overall Study||23
8179693|NCT02370394|20168358|P1|COMPLETED|Overall Study||26
8179694|NCT02370394|20168357|P2|STARTED|Overall Study||25
8179695|NCT02370394|20168358|P1|STARTED|Overall Study||28
8179696|NCT02370368|20168374|P2|NOT COMPLETED|Overall Study||6
8179697|NCT02370368|20168375|P1|NOT COMPLETED|Overall Study||6
8179698|NCT02370368|20168374|P2|COMPLETED|Overall Study||7
8179699|NCT02370368|20168375|P1|COMPLETED|Overall Study||8
8179700|NCT02370368|20168374|P2|STARTED|Overall Study||13
8179701|NCT02370368|20168375|P1|STARTED|Overall Study||14
8179702|NCT02370251|20168385|P1|NOT COMPLETED|Overall Study||11
8179703|NCT02370251|20168385|P1|COMPLETED|Overall Study||52
8179704|NCT02370251|20168385|P1|STARTED|Overall Study||63
8179705|NCT02370160|20168391|P3|NOT COMPLETED|Overall Study||1
8179706|NCT02370160|20168392|P2|NOT COMPLETED|Overall Study||4
8179707|NCT02370160|20168393|P1|NOT COMPLETED|Overall Study||3
8179708|NCT02370160|20168391|P3|COMPLETED|Overall Study||2
8179709|NCT02370160|20168392|P2|COMPLETED|Overall Study||2
8179710|NCT02370160|20168393|P1|COMPLETED|Overall Study||6
8179711|NCT02370160|20168391|P3|STARTED|Overall Study||3
8179712|NCT02370160|20168392|P2|STARTED|Overall Study||6
8179713|NCT02370160|20168393|P1|STARTED|Overall Study||9
8179714|NCT02370121|20168417|P2|NOT COMPLETED|Overall Study||1
8179715|NCT02370121|20168418|P1|NOT COMPLETED|Overall Study||1
8179716|NCT02370121|20168417|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8179717|NCT02370121|20168418|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8179718|NCT02370121|20168417|P2|STARTED|Overall Study||12
8179719|NCT02370121|20168418|P1|STARTED|Overall Study||12
8179720|NCT02370095|20168458|P2|NOT COMPLETED|Overall Study||1
8179721|NCT02370095|20168459|P1|NOT COMPLETED|Overall Study||0
8179722|NCT02370095|20168458|P2|COMPLETED|Overall Study||3
8179723|NCT02370095|20168459|P1|COMPLETED|Overall Study||10
8179724|NCT02370095|20168458|P2|STARTED|Overall Study||4
8179725|NCT02370095|20168459|P1|STARTED|Overall Study||10
8179726|NCT02370056|20168491|P2|NOT COMPLETED|Overall Study||0
8179727|NCT02370056|20168492|P1|NOT COMPLETED|Overall Study||0
8179728|NCT02370056|20168491|P2|COMPLETED|Overall Study||26
8179729|NCT02370056|20168492|P1|COMPLETED|Overall Study||27
8179730|NCT02370056|20168491|P2|STARTED|Overall Study||26
8179731|NCT02370056|20168492|P1|STARTED|Overall Study||27
8179732|NCT02370043|20168500|P6|NOT COMPLETED|Overall Study||1
8179733|NCT02370043|20168501|P5|NOT COMPLETED|Overall Study||1
8179734|NCT02370043|20168502|P4|NOT COMPLETED|Overall Study||0
8179735|NCT02370043|20168503|P3|NOT COMPLETED|Overall Study||0
8179736|NCT02370043|20168504|P2|NOT COMPLETED|Overall Study||0
8179737|NCT02370043|20168505|P1|NOT COMPLETED|Overall Study||0
8179738|NCT02370043|20168500|P6|COMPLETED|Overall Study||3
8179739|NCT02370043|20168501|P5|COMPLETED|Overall Study||2
8179740|NCT02370043|20168502|P4|COMPLETED|Overall Study||3
8179741|NCT02370043|20168503|P3|COMPLETED|Overall Study||3
8179742|NCT02370043|20168504|P2|COMPLETED|Overall Study||3
8179743|NCT02370043|20168505|P1|COMPLETED|Overall Study||3
8179744|NCT02370043|20168500|P6|STARTED|Overall Study||4
8179745|NCT02370043|20168501|P5|STARTED|Overall Study||3
8179746|NCT02370043|20168502|P4|STARTED|Overall Study||3
8179747|NCT02370043|20168503|P3|STARTED|Overall Study||3
8179748|NCT02370043|20168504|P2|STARTED|Overall Study||3
8179749|NCT02370043|20168505|P1|STARTED|Overall Study||3
8179750|NCT02370004|20168634|P1|NOT COMPLETED|Overall Study||1
8179751|NCT02370004|20168634|P1|COMPLETED|Overall Study||10
8179752|NCT02370004|20168634|P1|STARTED|Overall Study||11
8179765|NCT02369848|20168695|P1|NOT COMPLETED|Overall Study||4
8179766|NCT02369848|20168695|P1|COMPLETED|Overall Study||56
8179767|NCT02369848|20168695|P1|12 Month Primary Endpoint|Overall Study||30
8179768|NCT02369848|20168695|P1|30 Day Primary Safety Endpoint|Overall Study||58
8179769|NCT02369848|20168695|P1|STARTED|Overall Study||60
8179770|NCT02369835|20168711|P2|NOT COMPLETED|Overall Study||13
8179771|NCT02369835|20168712|P1|NOT COMPLETED|Overall Study||11
8179772|NCT02369835|20168711|P2|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
8179773|NCT02369835|20168712|P1|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
8179774|NCT02369835|20168711|P2|STARTED|Overall Study||68
8179775|NCT02369835|20168712|P1|STARTED|Overall Study||64
8179776|NCT02369796|20168727|P5|NOT COMPLETED|Overall Study||0
8179777|NCT02369796|20168728|P4|NOT COMPLETED|Overall Study||0
8179778|NCT02369796|20168729|P3|NOT COMPLETED|Overall Study||0
8179779|NCT02369796|20168730|P2|NOT COMPLETED|Overall Study||0
8179780|NCT02369796|20168731|P1|NOT COMPLETED|Overall Study||0
8179781|NCT02369796|20168727|P5|COMPLETED|Overall Study||3
8179782|NCT02369796|20168728|P4|COMPLETED|Overall Study||3
8179783|NCT02369796|20168729|P3|COMPLETED|Overall Study||3
8179784|NCT02369796|20168730|P2|COMPLETED|Overall Study||3
8179785|NCT02369796|20168731|P1|COMPLETED|Overall Study||3
8179786|NCT02369796|20168727|P5|STARTED|Overall Study||3
8179787|NCT02369796|20168728|P4|STARTED|Overall Study||3
8179788|NCT02369796|20168729|P3|STARTED|Overall Study||3
8179789|NCT02369796|20168730|P2|STARTED|Overall Study||3
8179790|NCT02369796|20168731|P1|STARTED|Overall Study||3
8179791|NCT02369744|20168772|P2|NOT COMPLETED|Overall Study||0
8179792|NCT02369744|20168773|P1|NOT COMPLETED|Overall Study||0
8179793|NCT02369744|20168772|P2|COMPLETED|Overall Study||0
8179794|NCT02369744|20168773|P1|COMPLETED|Overall Study||0
8179795|NCT02369744|20168772|P2|STARTED|Overall Study||0
8179796|NCT02369744|20168773|P1|STARTED|Overall Study||0
8179797|NCT02369510|20168788|P3|NOT COMPLETED|Overall Study||6
8179798|NCT02369510|20168789|P2|NOT COMPLETED|Overall Study||3
8179799|NCT02369510|20168790|P1|NOT COMPLETED|Overall Study||2
8179800|NCT02369510|20168788|P3|COMPLETED|Overall Study||17
8179801|NCT02369510|20168789|P2|COMPLETED|Overall Study||19
8179802|NCT02369510|20168790|P1|COMPLETED|Overall Study||21
8179803|NCT02369510|20168788|P3|STARTED|Overall Study||23
8179804|NCT02369510|20168789|P2|STARTED|Overall Study||22
8179805|NCT02369510|20168790|P1|STARTED|Overall Study||23
8179806|NCT02369484|20168819|P1|NOT COMPLETED|Overall Study||0
8179807|NCT02369484|20168819|P1|COMPLETED|Overall Study||13
8179808|NCT02369484|20168819|P1|STARTED|Overall Study||13
8179809|NCT02369341|20168829|P2|NOT COMPLETED|Overall Study||0
8179810|NCT02369341|20168830|P1|NOT COMPLETED|Overall Study||1
8179811|NCT02369341|20168829|P2|COMPLETED|Overall Study||57
8179812|NCT02369341|20168830|P1|COMPLETED|Overall Study||62
8179813|NCT02369341|20168829|P2|STARTED|Overall Study||57
8179814|NCT02369341|20168830|P1|STARTED|Overall Study||63
8179815|NCT02369211|20168886|P2|NOT COMPLETED|Overall Study||2
8179816|NCT02369211|20168887|P1|NOT COMPLETED|Overall Study||0
8179817|NCT02369211|20168886|P2|COMPLETED|Overall Study||41
8179818|NCT02369211|20168887|P1|COMPLETED|Overall Study||43
8179819|NCT02369211|20168886|P2|STARTED|Overall Study||43
8179820|NCT02369211|20168887|P1|STARTED|Overall Study||43
8179821|NCT02369172|20168899|P1|NOT COMPLETED|Overall Study||0
8179822|NCT02369172|20168899|P1|COMPLETED|Overall Study||24
8179823|NCT02369172|20168899|P1|STARTED|Overall Study||24
8179824|NCT02369068|20168973|P2|NOT COMPLETED|6 Months||1
8179825|NCT02369068|20168974|P1|NOT COMPLETED|6 Months||0
8179826|NCT02369068|20168973|P2|COMPLETED|6 Months||7
8179827|NCT02369068|20168974|P1|COMPLETED|6 Months||9
8179828|NCT02369068|20168973|P2|STARTED|6 Months||8
8179829|NCT02369068|20168974|P1|STARTED|6 Months||9
8179830|NCT02369068|20168973|P2|NOT COMPLETED|3 Months||2
8179831|NCT02369068|20168974|P1|NOT COMPLETED|3 Months||0
8179832|NCT02369068|20168973|P2|COMPLETED|3 Months||8
8179833|NCT02369068|20168974|P1|COMPLETED|3 Months||9
8179834|NCT02369068|20168973|P2|STARTED|3 Months||10
8179835|NCT02369068|20168974|P1|STARTED|3 Months||9
8179836|NCT02369068|20168973|P2|NOT COMPLETED|1 Month||1
8179837|NCT02369068|20168974|P1|NOT COMPLETED|1 Month||1
8179838|NCT02369068|20168973|P2|COMPLETED|1 Month||10
8179839|NCT02369068|20168974|P1|COMPLETED|1 Month||9
8179840|NCT02369068|20168973|P2|STARTED|1 Month||11
8179841|NCT02369068|20168974|P1|STARTED|1 Month||10
8179842|NCT02368886|20169006|P4|NOT COMPLETED|Overall Study||4
8179843|NCT02368886|20169007|P3|NOT COMPLETED|Overall Study||1
8179844|NCT02368886|20169008|P2|NOT COMPLETED|Overall Study||1
8179845|NCT02368886|20169009|P1|NOT COMPLETED|Overall Study||1
8179846|NCT02368886|20169006|P4|COMPLETED|Overall Study||29
8179847|NCT02368886|20169007|P3|COMPLETED|Overall Study||33
8179848|NCT02368886|20169008|P2|COMPLETED|Overall Study||26
8179849|NCT02368886|20169009|P1|COMPLETED|Overall Study||28
8179850|NCT02368886|20169006|P4|STARTED|Overall Study||33
8179851|NCT02368886|20169007|P3|STARTED|Overall Study||34
8179852|NCT02368886|20169008|P2|STARTED|Overall Study||27
8179853|NCT02368886|20169009|P1|STARTED|Overall Study||29
8179854|NCT02368691|20169027|P1|NOT COMPLETED|Overall Study||32
8179855|NCT02368691|20169027|P1|COMPLETED|Overall Study||0
8179856|NCT02368691|20169027|P1|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
8179857|NCT02368457|20169040|P2|NOT COMPLETED|Overall Study||0
8179858|NCT02368457|20169041|P1|NOT COMPLETED|Overall Study||0
8179859|NCT02368457|20169040|P2|COMPLETED|Overall Study||12
8179860|NCT02368457|20169041|P1|COMPLETED|Overall Study||12
8179861|NCT02368457|20169040|P2|STARTED|Overall Study||12
8179862|NCT02368457|20169041|P1|STARTED|Overall Study||12
8179863|NCT02368431|20169051|P2|NOT COMPLETED|Overall Study||19
8179864|NCT02368431|20169052|P1|NOT COMPLETED|Overall Study||24
8179865|NCT02368431|20169051|P2|COMPLETED|Overall Study||27
8179866|NCT02368431|20169052|P1|COMPLETED|Overall Study||22
8179867|NCT02368431|20169051|P2|STARTED|Overall Study||46
8179868|NCT02368431|20169052|P1|STARTED|Overall Study||46
8179869|NCT02368314|20169072|P2|NOT COMPLETED|Overall Study||3
8179870|NCT02368314|20169073|P1|NOT COMPLETED|Overall Study||3
8179871|NCT02368314|20169072|P2|COMPLETED|Overall Study||57
8179872|NCT02368314|20169073|P1|COMPLETED|Overall Study||61
8179873|NCT02368314|20169072|P2|STARTED|Overall Study||60
8179874|NCT02368314|20169073|P1|STARTED|Overall Study||64
8179875|NCT02368210|20169085|P2|NOT COMPLETED|Overall Study||1
8179876|NCT02368210|20169086|P1|NOT COMPLETED|Overall Study||1
8179877|NCT02368210|20169085|P2|COMPLETED|Overall Study||75
8179878|NCT02368210|20169086|P1|COMPLETED|Overall Study||74
8179879|NCT02368210|20169085|P2|STARTED|Overall Study||76
8179880|NCT02368210|20169086|P1|STARTED|Overall Study||75
8179881|NCT02368093|20169104|P2|NOT COMPLETED|Overall Study||0
8179882|NCT02368093|20169105|P1|NOT COMPLETED|Overall Study||0
8179883|NCT02368093|20169104|P2|COMPLETED|Overall Study||24
8179884|NCT02368093|20169105|P1|COMPLETED|Overall Study||24
8179885|NCT02368093|20169104|P2|STARTED|Overall Study||24
8179886|NCT02368093|20169105|P1|STARTED|Overall Study||24
8179887|NCT02367911|20169113|P2|NOT COMPLETED|Overall Study||4
8179888|NCT02367911|20169114|P1|NOT COMPLETED|Overall Study||5
8179889|NCT02367911|20169113|P2|COMPLETED|Overall Study||69
8179890|NCT02367911|20169114|P1|COMPLETED|Overall Study||66
8179891|NCT02367911|20169113|P2|STARTED|Overall Study||73
8179892|NCT02367911|20169114|P1|STARTED|Overall Study||71
8179893|NCT02367885|20169125|P3|NOT COMPLETED|Overall Study||0
8179894|NCT02367885|20169126|P2|NOT COMPLETED|Overall Study||0
8179895|NCT02367885|20169127|P1|NOT COMPLETED|Overall Study||2
8179896|NCT02367885|20169125|P3|COMPLETED|Overall Study||33
8179897|NCT02367885|20169126|P2|COMPLETED|Overall Study||33
8179898|NCT02367885|20169127|P1|COMPLETED|Overall Study||31
8179899|NCT02367885|20169125|P3|STARTED|Overall Study||33
8179900|NCT02367885|20169126|P2|STARTED|Overall Study||33
8179901|NCT02367885|20169127|P1|STARTED|Overall Study||33
8179902|NCT02367872|20169200|P8|NOT COMPLETED|Overall Study||0
8179903|NCT02367872|20169201|P7|NOT COMPLETED|Overall Study||0
8179904|NCT02367872|20169202|P6|NOT COMPLETED|Overall Study||0
8179905|NCT02367872|20169203|P5|NOT COMPLETED|Overall Study||0
8179906|NCT02367872|20169204|P4|NOT COMPLETED|Overall Study||0
8179907|NCT02367872|20169205|P3|NOT COMPLETED|Overall Study||0
8179908|NCT02367872|20169206|P2|NOT COMPLETED|Overall Study||0
8179909|NCT02367872|20169207|P1|NOT COMPLETED|Overall Study||0
8179910|NCT02367872|20169200|P8|COMPLETED|Overall Study||6
8179911|NCT02367872|20169201|P7|COMPLETED|Overall Study||6
8179912|NCT02367872|20169202|P6|COMPLETED|Overall Study||6
8179913|NCT02367872|20169203|P5|COMPLETED|Overall Study||6
8179914|NCT02367872|20169204|P4|COMPLETED|Overall Study||6
8179915|NCT02367872|20169205|P3|COMPLETED|Overall Study||6
8179916|NCT02367872|20169206|P2|COMPLETED|Overall Study||6
8179917|NCT02367872|20169207|P1|COMPLETED|Overall Study||6
8179918|NCT02367872|20169200|P8|STARTED|Overall Study||6
8179919|NCT02367872|20169201|P7|STARTED|Overall Study||6
8179920|NCT02367872|20169202|P6|STARTED|Overall Study||6
8179921|NCT02367872|20169203|P5|STARTED|Overall Study||6
8179922|NCT02367872|20169204|P4|STARTED|Overall Study||6
8179923|NCT02367872|20169205|P3|STARTED|Overall Study||6
8179924|NCT02367872|20169206|P2|STARTED|Overall Study||6
8179925|NCT02367872|20169207|P1|STARTED|Overall Study||6
8179926|NCT02367859|20169360|P1|NOT COMPLETED|Overall Study||0
8179927|NCT02367859|20169360|P1|COMPLETED|Overall Study||1
8179928|NCT02367859|20169360|P1|STARTED|Overall Study||1
8179929|NCT02367833|20169370|P3|NOT COMPLETED|Overall Study||0
8179930|NCT02367833|20169371|P2|NOT COMPLETED|Overall Study||1
8179931|NCT02367833|20169372|P1|NOT COMPLETED|Overall Study||1
8179932|NCT02367833|20169370|P3|COMPLETED|Overall Study||8
8179933|NCT02367833|20169371|P2|COMPLETED|Overall Study||8
8179934|NCT02367833|20169372|P1|COMPLETED|Overall Study||8
8179935|NCT02367833|20169370|P3|STARTED|Overall Study||8
8179936|NCT02367833|20169371|P2|STARTED|Overall Study||9
8179937|NCT02367833|20169372|P1|STARTED|Overall Study||9
8179938|NCT02367820|20169390|P1|NOT COMPLETED|Overall Study||236
8179939|NCT02367820|20169390|P1|COMPLETED|Overall Study||402
8179940|NCT02367820|20169390|P1|STARTED|Overall Study||638
8179941|NCT02367794|20169411|P3|NOT COMPLETED|Overall Study||249
8179942|NCT02367794|20169412|P2|NOT COMPLETED|Overall Study||240
8179943|NCT02367794|20169413|P1|NOT COMPLETED|Overall Study||258
8179944|NCT02367794|20169411|P3|COMPLETED|Overall Study||89
8179945|NCT02367794|20169412|P2|COMPLETED|Overall Study||103
8179946|NCT02367794|20169413|P1|COMPLETED|Overall Study||82
8179947|NCT02367794|20169411|P3|STARTED|Overall Study||338
8179948|NCT02367794|20169412|P2|STARTED|Overall Study||343
8179949|NCT02367794|20169413|P1|STARTED|Overall Study||340
8179950|NCT02367781|20169426|P2|NOT COMPLETED|Overall Study||240
8179951|NCT02367781|20169427|P1|NOT COMPLETED|Overall Study||483
8179952|NCT02367781|20169426|P2|COMPLETED|Overall Study||0
8179953|NCT02367781|20169427|P1|COMPLETED|Overall Study||0
8179954|NCT02367781|20169426|P2|STARTED|Overall Study||240
8179955|NCT02367781|20169427|P1|STARTED|Overall Study||483
8179956|NCT02367729|20169437|P2|NOT COMPLETED|Overall Study||8
8179957|NCT02367729|20169438|P1|NOT COMPLETED|Overall Study||3
8179958|NCT02367729|20169437|P2|COMPLETED|Overall Study||47
8179959|NCT02367729|20169438|P1|COMPLETED|Overall Study||57
8179960|NCT02367729|20169437|P2|STARTED|Overall Study||55
8179961|NCT02367729|20169438|P1|STARTED|Overall Study||60
8179962|NCT02367716|20169454|P1|NOT COMPLETED|Overall Study||1
8179963|NCT02367716|20169454|P1|COMPLETED|Overall Study||120
8179964|NCT02367716|20169454|P1|STARTED|Overall Study||121
8179965|NCT02367599|20169463|P2|NOT COMPLETED|Overall Study||0
8179966|NCT02367599|20169464|P1|NOT COMPLETED|Overall Study||0
8179967|NCT02367599|20169463|P2|COMPLETED|Overall Study||48
8179968|NCT02367599|20169464|P1|COMPLETED|Overall Study||48
8179969|NCT02367599|20169463|P2|STARTED|Overall Study||48
8179970|NCT02367599|20169464|P1|STARTED|Overall Study||48
8179971|NCT02367521|20169478|P2|NOT COMPLETED|Overall Study||0
8179972|NCT02367521|20169479|P1|NOT COMPLETED|Overall Study||4
8179973|NCT02367521|20169478|P2|COMPLETED|Overall Study||17
8179974|NCT02367521|20169479|P1|COMPLETED|Overall Study||13
8179975|NCT02367521|20169478|P2|STARTED|Overall Study||17
8179976|NCT02367521|20169479|P1|STARTED|Overall Study||17
8179977|NCT02367430|20169531|P1|NOT COMPLETED|Overall Study||3
8179978|NCT02367430|20169531|P1|COMPLETED|Overall Study||11
8179979|NCT02367430|20169531|P1|STARTED|Overall Study||14
8179980|NCT02367391|20169538|P2|NOT COMPLETED|Overall Study||0
8179981|NCT02367391|20169539|P1|NOT COMPLETED|Overall Study||2
8179982|NCT02367391|20169538|P2|COMPLETED|Overall Study||76
8179983|NCT02367391|20169539|P1|COMPLETED|Overall Study||74
8179984|NCT02367391|20169538|P2|STARTED|Overall Study||76
8179985|NCT02367391|20169539|P1|STARTED|Overall Study||76
8179986|NCT02367352|20169557|P3|NOT COMPLETED|Overall Study||0
8179987|NCT02367352|20169558|P2|NOT COMPLETED|Overall Study||0
8179988|NCT02367352|20169559|P1|NOT COMPLETED|Overall Study||9
8179989|NCT02367352|20169557|P3|COMPLETED|Overall Study||0
8179990|NCT02367352|20169558|P2|COMPLETED|Overall Study||0
8179991|NCT02367352|20169559|P1|COMPLETED|Overall Study||0
8179992|NCT02367352|20169557|P3|STARTED|Overall Study||0
8179993|NCT02367352|20169558|P2|STARTED|Overall Study||0
8179994|NCT02367352|20169559|P1|STARTED|Overall Study||9
8179995|NCT02367170|20169598|P2|NOT COMPLETED|Overall Study||0
8179996|NCT02367170|20169599|P1|NOT COMPLETED|Overall Study||0
8179997|NCT02367170|20169598|P2|COMPLETED|Overall Study||0
8179998|NCT02367170|20169599|P1|COMPLETED|Overall Study||1
8179999|NCT02367170|20169598|P2|STARTED|Overall Study||0
8180000|NCT02367170|20169599|P1|STARTED|Overall Study||1
8180001|NCT02367131|20169609|P1|NOT COMPLETED|Overall Study||222
8180002|NCT02367131|20169609|P1|COMPLETED|Overall Study||201
8180003|NCT02367131|20169609|P1|STARTED|Overall Study|Started are the treated patients|423
8180010|NCT02367066|20169686|P2|NOT COMPLETED|Overall Study||0
8180011|NCT02367066|20169687|P1|NOT COMPLETED|Overall Study||0
8180012|NCT02367066|20169686|P2|COMPLETED|Overall Study||10
8180013|NCT02367066|20169687|P1|COMPLETED|Overall Study||10
8180014|NCT02367066|20169686|P2|STARTED|Overall Study||10
8180015|NCT02367066|20169687|P1|STARTED|Overall Study||10
8180016|NCT02367014|20169749|P4|NOT COMPLETED|Overall Study||0
8180017|NCT02367014|20169750|P3|NOT COMPLETED|Overall Study||0
8180018|NCT02367014|20169751|P2|NOT COMPLETED|Overall Study||0
8180019|NCT02367014|20169752|P1|NOT COMPLETED|Overall Study||0
8180020|NCT02367014|20169749|P4|COMPLETED|Overall Study||9
8180021|NCT02367014|20169750|P3|COMPLETED|Overall Study||9
8180022|NCT02367014|20169751|P2|COMPLETED|Overall Study||9
8180023|NCT02367014|20169752|P1|COMPLETED|Overall Study||9
8180024|NCT02367014|20169749|P4|STARTED|Overall Study||9
8180025|NCT02367014|20169750|P3|STARTED|Overall Study||9
8180026|NCT02367014|20169751|P2|STARTED|Overall Study||9
8180027|NCT02367014|20169752|P1|STARTED|Overall Study||9
8180028|NCT02366936|20169870|P1|NOT COMPLETED|Overall Study||8
8180029|NCT02366936|20169870|P1|COMPLETED|Overall Study||24
8180030|NCT02366936|20169870|P1|STARTED|Overall Study||32
8180031|NCT02366923|20169875|P1|NOT COMPLETED|Overall Study||6
8180032|NCT02366923|20169875|P1|COMPLETED|Overall Study||22
8180033|NCT02366923|20169875|P1|STARTED|Overall Study||28
8180034|NCT02366910|20169888|P1|NOT COMPLETED|Overall Study||5
8180035|NCT02366910|20169888|P1|COMPLETED|Overall Study||21
8180036|NCT02366910|20169888|P1|STARTED|Overall Study||26
8180037|NCT02366871|20169902|P2|NOT COMPLETED|Overall Study||0
8180038|NCT02366871|20169903|P1|NOT COMPLETED|Overall Study||0
8180039|NCT02366871|20169902|P2|COMPLETED|Overall Study||196
8180040|NCT02366871|20169903|P1|COMPLETED|Overall Study||204
8180041|NCT02366871|20169902|P2|STARTED|Overall Study||196
8180042|NCT02366871|20169903|P1|STARTED|Overall Study||204
8180043|NCT02366845|20169921|P2|NOT COMPLETED|Overall Study||0
8180044|NCT02366845|20169922|P1|NOT COMPLETED|Overall Study||0
8180045|NCT02366845|20169921|P2|COMPLETED|Overall Study||25
8180046|NCT02366845|20169922|P1|COMPLETED|Overall Study||25
8180047|NCT02366845|20169921|P2|STARTED|Overall Study||25
8180048|NCT02366845|20169922|P1|STARTED|Overall Study||25
8180049|NCT02366767|20169936|P2|NOT COMPLETED|Overall Study||0
8180050|NCT02366767|20169937|P1|NOT COMPLETED|Overall Study||1
8180051|NCT02366767|20169936|P2|COMPLETED|Overall Study||10
8180052|NCT02366767|20169937|P1|COMPLETED|Overall Study||10
8180053|NCT02366767|20169936|P2|STARTED|Overall Study||10
8180054|NCT02366767|20169937|P1|STARTED|Overall Study||11
8180055|NCT02366689|20169950|P3|NOT COMPLETED|Overall Study||2
8180056|NCT02366689|20169951|P2|NOT COMPLETED|Overall Study||3
8180057|NCT02366689|20169952|P1|NOT COMPLETED|Overall Study||4
8180058|NCT02366689|20169950|P3|COMPLETED|Overall Study||59
8180059|NCT02366689|20169951|P2|COMPLETED|Overall Study||55
8180060|NCT02366689|20169952|P1|COMPLETED|Overall Study||56
8180061|NCT02366689|20169950|P3|STARTED|Overall Study||61
8180062|NCT02366689|20169951|P2|STARTED|Overall Study||58
8180063|NCT02366689|20169952|P1|STARTED|Overall Study||60
8180064|NCT02366663|20169977|P2|NOT COMPLETED|Overall Study||0
8180065|NCT02366663|20169978|P1|NOT COMPLETED|Overall Study||0
8180066|NCT02366663|20169977|P2|COMPLETED|Overall Study||1
8180067|NCT02366663|20169978|P1|COMPLETED|Overall Study||2
8180068|NCT02366663|20169977|P2|STARTED|Overall Study||1
8180069|NCT02366663|20169978|P1|STARTED|Overall Study||2
8180070|NCT02366637|20170004|P2|NOT COMPLETED|Second Intervention Period||1
8180071|NCT02366637|20170005|P1|NOT COMPLETED|Second Intervention Period||1
8180072|NCT02366637|20170004|P2|COMPLETED|Second Intervention Period||0
8180073|NCT02366637|20170005|P1|COMPLETED|Second Intervention Period||0
8180074|NCT02366637|20170004|P2|STARTED|Second Intervention Period||1
8180075|NCT02366637|20170005|P1|STARTED|Second Intervention Period||1
8180076|NCT02366637|20170004|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
8180077|NCT02366637|20170005|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
8180078|NCT02366637|20170004|P2|COMPLETED|Washout Period 28 to 49 Days||1
8180079|NCT02366637|20170005|P1|COMPLETED|Washout Period 28 to 49 Days||1
8180080|NCT02366637|20170004|P2|STARTED|Washout Period 28 to 49 Days||1
8180081|NCT02366637|20170005|P1|STARTED|Washout Period 28 to 49 Days||1
8180082|NCT02366637|20170004|P2|NOT COMPLETED|First Intervention Period||5
8180083|NCT02366637|20170005|P1|NOT COMPLETED|First Intervention Period||6
8180084|NCT02366637|20170004|P2|COMPLETED|First Intervention Period||1
8180085|NCT02366637|20170005|P1|COMPLETED|First Intervention Period||1
8180086|NCT02366637|20170004|P2|STARTED|First Intervention Period||6
8180087|NCT02366637|20170005|P1|STARTED|First Intervention Period||7
8180088|NCT02366611|20170031|P2|NOT COMPLETED|Overall Study||0
8180089|NCT02366611|20170032|P1|NOT COMPLETED|Overall Study||2
8180090|NCT02366611|20170031|P2|COMPLETED|Overall Study||1
8180091|NCT02366611|20170032|P1|COMPLETED|Overall Study||8
8180092|NCT02366611|20170031|P2|STARTED|Overall Study||1
8180093|NCT02366611|20170032|P1|STARTED|Overall Study||10
8180094|NCT02366468|20170053|P2|NOT COMPLETED|Overall Study||9
8180095|NCT02366468|20170054|P1|NOT COMPLETED|Overall Study||6
8180096|NCT02366468|20170053|P2|COMPLETED|Overall Study||58
8180097|NCT02366468|20170054|P1|COMPLETED|Overall Study||62
8180098|NCT02366468|20170053|P2|Per Protocol Set (PPS)|Overall Study||61
8180099|NCT02366468|20170054|P1|Per Protocol Set (PPS)|Overall Study||62
8180100|NCT02366468|20170053|P2|Full Analysis Set (FAS)|Overall Study||66
8180101|NCT02366468|20170054|P1|Full Analysis Set (FAS)|Overall Study||67
8180102|NCT02366468|20170053|P2|STARTED|Overall Study||67
8180103|NCT02366468|20170054|P1|STARTED|Overall Study||68
8180104|NCT02366338|20170075|P3|NOT COMPLETED|Overall Study||0
8180105|NCT02366338|20170076|P2|NOT COMPLETED|Overall Study||0
8180106|NCT02366338|20170077|P1|NOT COMPLETED|Overall Study||0
8180107|NCT02366338|20170075|P3|COMPLETED|Overall Study||36
8180108|NCT02366338|20170076|P2|COMPLETED|Overall Study||39
8180109|NCT02366338|20170077|P1|COMPLETED|Overall Study||73
8180110|NCT02366338|20170075|P3|STARTED|Overall Study||36
8180111|NCT02366338|20170076|P2|STARTED|Overall Study||39
8180112|NCT02366338|20170077|P1|STARTED|Overall Study||73
8180113|NCT02366195|20170085|P1|NOT COMPLETED|Overall Study||112
8180114|NCT02366195|20170085|P1|COMPLETED|Overall Study||0
8180115|NCT02366195|20170085|P1|Received Study Drug|Overall Study||111
8180116|NCT02366195|20170085|P1|STARTED|Overall Study||112
8180117|NCT02366143|20170106|P3|NOT COMPLETED|Overall Study||400
8180118|NCT02366143|20170107|P2|NOT COMPLETED|Overall Study||402
8180119|NCT02366143|20170108|P1|NOT COMPLETED|Overall Study||400
8180120|NCT02366143|20170106|P3|COMPLETED|Overall Study||0
8180121|NCT02366143|20170107|P2|COMPLETED|Overall Study||0
8180122|NCT02366143|20170108|P1|COMPLETED|Overall Study||0
8180123|NCT02366143|20170106|P3|STARTED|Overall Study||400
8180124|NCT02366143|20170107|P2|STARTED|Overall Study||402
8180125|NCT02366143|20170108|P1|STARTED|Overall Study||400
8180126|NCT02365961|20170173|P2|NOT COMPLETED|Overall Study||0
8180127|NCT02365961|20170174|P1|NOT COMPLETED|Overall Study||0
8180128|NCT02365961|20170173|P2|COMPLETED|Overall Study||43
8180129|NCT02365961|20170174|P1|COMPLETED|Overall Study||41
8180130|NCT02365961|20170173|P2|STARTED|Overall Study||43
8180131|NCT02365961|20170174|P1|STARTED|Overall Study||41
8180132|NCT02365870|20170190|P2|NOT COMPLETED|Overall Study||0
8180133|NCT02365870|20170191|P1|NOT COMPLETED|Overall Study||0
8180134|NCT02365870|20170190|P2|COMPLETED|Overall Study||3
8180135|NCT02365870|20170191|P1|COMPLETED|Overall Study||1
8180136|NCT02365870|20170190|P2|STARTED|Overall Study||3
8180137|NCT02365870|20170191|P1|STARTED|Overall Study||1
8180138|NCT02365714|20170199|P1|NOT COMPLETED|Overall Study||0
8180139|NCT02365714|20170199|P1|COMPLETED|Overall Study||2
8180140|NCT02365714|20170199|P1|STARTED|Overall Study||2
8180141|NCT02365688|20170205|P1|NOT COMPLETED|Overall Study||0
8180142|NCT02365688|20170205|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
8180143|NCT02365688|20170205|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
8180144|NCT02365636|20170212|P3|NOT COMPLETED|Overall Study||3
8180145|NCT02365636|20170213|P2|NOT COMPLETED|Overall Study||7
8180146|NCT02365636|20170214|P1|NOT COMPLETED|Overall Study||6
8180147|NCT02365636|20170212|P3|COMPLETED|Overall Study||97
8180148|NCT02365636|20170213|P2|COMPLETED|Overall Study||93
8180149|NCT02365636|20170214|P1|COMPLETED|Overall Study||94
8180150|NCT02365636|20170212|P3|Full Analysis Set|Overall Study||100
8180151|NCT02365636|20170213|P2|Full Analysis Set|Overall Study||98
8180152|NCT02365636|20170214|P1|Full Analysis Set|Overall Study||100
8180153|NCT02365636|20170212|P3|Safety Population|Overall Study||100
8180154|NCT02365636|20170213|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
8180155|NCT02365636|20170214|P1|Safety Population|Overall Study||100
8180156|NCT02365636|20170212|P3|STARTED|Overall Study||100
8180157|NCT02365636|20170213|P2|STARTED|Overall Study||100
8180158|NCT02365636|20170214|P1|STARTED|Overall Study||100
8180159|NCT02365584|20170260|P2|NOT COMPLETED|Overall Study||14
8180160|NCT02365584|20170261|P1|NOT COMPLETED|Overall Study||12
8180161|NCT02365584|20170260|P2|COMPLETED|Overall Study||8
8180162|NCT02365584|20170261|P1|COMPLETED|Overall Study||9
8180163|NCT02365584|20170260|P2|STARTED|Overall Study||22
8180164|NCT02365584|20170261|P1|STARTED|Overall Study||21
8180165|NCT02365558|20170285|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
8180166|NCT02365558|20170286|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
8180167|NCT02365558|20170285|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
8180168|NCT02365558|20170286|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
8180169|NCT02365558|20170285|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
8180170|NCT02365558|20170286|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
8180171|NCT02365558|20170285|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
8180172|NCT02365558|20170286|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
8180173|NCT02365558|20170285|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
8180174|NCT02365558|20170286|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
8180175|NCT02365558|20170285|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
8180176|NCT02365558|20170286|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
8180177|NCT02365558|20170285|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
8180178|NCT02365558|20170286|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
8180179|NCT02365519|20170299|P3|NOT COMPLETED|Randomized and Treated||1
8180180|NCT02365519|20170300|P2|NOT COMPLETED|Randomized and Treated||2
8180181|NCT02365519|20170301|P1|NOT COMPLETED|Randomized and Treated||0
8180182|NCT02365519|20170299|P3|COMPLETED|Randomized and Treated||64
8180183|NCT02365519|20170300|P2|COMPLETED|Randomized and Treated||67
8180184|NCT02365519|20170301|P1|COMPLETED|Randomized and Treated||0
8180185|NCT02365519|20170299|P3|STARTED|Randomized and Treated||65
8180186|NCT02365519|20170300|P2|STARTED|Randomized and Treated||69
8180187|NCT02365519|20170301|P1|STARTED|Randomized and Treated||0
8180188|NCT02365519|20170299|P3|NOT COMPLETED|Vehicle Run-In||0
8180189|NCT02365519|20170300|P2|NOT COMPLETED|Vehicle Run-In||0
8180190|NCT02365519|20170301|P1|NOT COMPLETED|Vehicle Run-In||79
8180191|NCT02365519|20170299|P3|COMPLETED|Vehicle Run-In||0
8180192|NCT02365519|20170300|P2|COMPLETED|Vehicle Run-In||0
8180193|NCT02365519|20170301|P1|COMPLETED|Vehicle Run-In||134
8180194|NCT02365519|20170299|P3|STARTED|Vehicle Run-In||0
8180195|NCT02365519|20170300|P2|STARTED|Vehicle Run-In||0
8180196|NCT02365519|20170301|P1|STARTED|Vehicle Run-In||213
8180197|NCT02365506|20170325|P3|NOT COMPLETED|Overall Study||1
8180198|NCT02365506|20170326|P2|NOT COMPLETED|Overall Study||0
8180199|NCT02365506|20170327|P1|NOT COMPLETED|Overall Study||0
8180200|NCT02365506|20170325|P3|COMPLETED|Overall Study||4
8180201|NCT02365506|20170326|P2|COMPLETED|Overall Study||4
8180202|NCT02365506|20170327|P1|COMPLETED|Overall Study||4
8180203|NCT02365506|20170325|P3|STARTED|Overall Study||5
8180204|NCT02365506|20170326|P2|STARTED|Overall Study||4
8180205|NCT02365506|20170327|P1|STARTED|Overall Study||4
8180206|NCT02365298|20170356|P2|NOT COMPLETED|Period 2||2
8180207|NCT02365298|20170357|P1|NOT COMPLETED|Period 2||2
8180208|NCT02365298|20170356|P2|COMPLETED|Period 2||12
8180209|NCT02365298|20170357|P1|COMPLETED|Period 2||12
8180210|NCT02365298|20170356|P2|STARTED|Period 2||14
8180211|NCT02365298|20170357|P1|STARTED|Period 2||14
8180212|NCT02365298|20170356|P2|NOT COMPLETED|Period 1||0
8180213|NCT02365298|20170357|P1|NOT COMPLETED|Period 1||0
8180214|NCT02365298|20170356|P2|COMPLETED|Period 1||14
8180215|NCT02365298|20170357|P1|COMPLETED|Period 1||14
8180216|NCT02365298|20170356|P2|STARTED|Period 1||14
8180217|NCT02365298|20170357|P1|STARTED|Period 1||14
8180218|NCT02365285|20170377|P4|NOT COMPLETED|Overall Study||2
8180219|NCT02365285|20170378|P3|NOT COMPLETED|Overall Study||1
8180220|NCT02365285|20170379|P2|NOT COMPLETED|Overall Study||1
8180221|NCT02365285|20170380|P1|NOT COMPLETED|Overall Study||0
8180222|NCT02365285|20170377|P4|COMPLETED|Overall Study||1
8180223|NCT02365285|20170378|P3|COMPLETED|Overall Study||6
8180224|NCT02365285|20170379|P2|COMPLETED|Overall Study||5
8180225|NCT02365285|20170380|P1|COMPLETED|Overall Study||7
8180226|NCT02365285|20170377|P4|STARTED|Overall Study||3
8180227|NCT02365285|20170378|P3|STARTED|Overall Study||7
8180228|NCT02365285|20170379|P2|STARTED|Overall Study||6
8180229|NCT02365285|20170380|P1|STARTED|Overall Study||7
8180230|NCT02365233|20170397|P3|NOT COMPLETED|Overall Study||2
8180231|NCT02365233|20170398|P2|NOT COMPLETED|Overall Study||2
8180232|NCT02365233|20170399|P1|NOT COMPLETED|Overall Study||1
8180233|NCT02365233|20170397|P3|COMPLETED|Overall Study||0
8180234|NCT02365233|20170398|P2|COMPLETED|Overall Study||0
8180235|NCT02365233|20170399|P1|COMPLETED|Overall Study||0
8180236|NCT02365233|20170397|P3|STARTED|Overall Study||2
8180237|NCT02365233|20170398|P2|STARTED|Overall Study||2
8180238|NCT02365233|20170399|P1|STARTED|Overall Study||1
8180239|NCT02365207|20170407|P1|NOT COMPLETED|Overall Study||2
8180240|NCT02365207|20170407|P1|COMPLETED|Overall Study||4
8180241|NCT02365207|20170407|P1|STARTED|Overall Study||6
8180242|NCT02364999|20170413|P2|NOT COMPLETED|Overall Study||173
8180243|NCT02364999|20170414|P1|NOT COMPLETED|Overall Study||165
8180244|NCT02364999|20170413|P2|COMPLETED|Overall Study||188
8180245|NCT02364999|20170414|P1|COMPLETED|Overall Study||193
8180246|NCT02364999|20170413|P2|Received Treatment|Overall Study||358
8180247|NCT02364999|20170414|P1|Received Treatment|Overall Study||356
8180248|NCT02364999|20170413|P2|STARTED|Overall Study||361
8180249|NCT02364999|20170414|P1|STARTED|Overall Study||358
8180250|NCT02364947|20170440|P3|NOT COMPLETED|Overall Study||26
8180251|NCT02364947|20170441|P2|NOT COMPLETED|Overall Study||45
8180252|NCT02364947|20170442|P1|NOT COMPLETED|Overall Study||59
8180253|NCT02364947|20170440|P3|COMPLETED|Overall Study||219
8180254|NCT02364947|20170441|P2|COMPLETED|Overall Study||139
8180255|NCT02364947|20170442|P1|COMPLETED|Overall Study||189
8180256|NCT02364947|20170440|P3|STARTED|Overall Study||245
8180257|NCT02364947|20170441|P2|STARTED|Overall Study||184
8180258|NCT02364947|20170442|P1|STARTED|Overall Study||248
8180259|NCT02364778|20170509|P1|NOT COMPLETED|Overall Study||0
8180260|NCT02364778|20170509|P1|COMPLETED|Overall Study||30
8180261|NCT02364778|20170509|P1|STARTED|Overall Study||30
8180262|NCT02364700|20170521|P1|NOT COMPLETED|Overall Study||0
8180263|NCT02364700|20170521|P1|COMPLETED|Overall Study||12
8180264|NCT02364700|20170521|P1|STARTED|Overall Study||12
8180265|NCT02364570|20170530|P16|NOT COMPLETED|Overall Study||0
8180266|NCT02364570|20170531|P15|NOT COMPLETED|Overall Study||0
8180267|NCT02364570|20170532|P14|NOT COMPLETED|Overall Study||0
8180268|NCT02364570|20170533|P13|NOT COMPLETED|Overall Study||0
8180269|NCT02364570|20170534|P12|NOT COMPLETED|Overall Study||0
8180270|NCT02364570|20170535|P11|NOT COMPLETED|Overall Study||0
8180271|NCT02364570|20170536|P10|NOT COMPLETED|Overall Study||0
8180272|NCT02364570|20170537|P9|NOT COMPLETED|Overall Study||0
8180273|NCT02364570|20170538|P8|NOT COMPLETED|Overall Study||0
8180274|NCT02364570|20170539|P7|NOT COMPLETED|Overall Study||0
8180275|NCT02364570|20170540|P6|NOT COMPLETED|Overall Study||0
8180276|NCT02364570|20170541|P5|NOT COMPLETED|Overall Study||0
8180277|NCT02364570|20170542|P4|NOT COMPLETED|Overall Study||0
8180278|NCT02364570|20170543|P3|NOT COMPLETED|Overall Study||0
8180279|NCT02364570|20170544|P2|NOT COMPLETED|Overall Study||0
8180280|NCT02364570|20170545|P1|NOT COMPLETED|Overall Study||0
8180281|NCT02364570|20170530|P16|COMPLETED|Overall Study||1
8180282|NCT02364570|20170531|P15|COMPLETED|Overall Study||1
8180283|NCT02364570|20170532|P14|COMPLETED|Overall Study||2
8180284|NCT02364570|20170533|P13|COMPLETED|Overall Study||1
8180285|NCT02364570|20170534|P12|COMPLETED|Overall Study||1
8180286|NCT02364570|20170535|P11|COMPLETED|Overall Study||1
8180287|NCT02364570|20170536|P10|COMPLETED|Overall Study||1
8180288|NCT02364570|20170537|P9|COMPLETED|Overall Study||2
8180289|NCT02364570|20170538|P8|COMPLETED|Overall Study||1
8180290|NCT02364570|20170539|P7|COMPLETED|Overall Study||2
8180291|NCT02364570|20170540|P6|COMPLETED|Overall Study||1
8180292|NCT02364570|20170541|P5|COMPLETED|Overall Study||1
8180293|NCT02364570|20170542|P4|COMPLETED|Overall Study||1
8180294|NCT02364570|20170543|P3|COMPLETED|Overall Study||2
8180295|NCT02364570|20170544|P2|COMPLETED|Overall Study||1
8180296|NCT02364570|20170545|P1|COMPLETED|Overall Study||1
8180297|NCT02364570|20170530|P16|STARTED|Overall Study||1
8180298|NCT02364570|20170531|P15|STARTED|Overall Study||1
8180299|NCT02364570|20170532|P14|STARTED|Overall Study||2
8180300|NCT02364570|20170533|P13|STARTED|Overall Study||1
8180301|NCT02364570|20170534|P12|STARTED|Overall Study||1
8180302|NCT02364570|20170535|P11|STARTED|Overall Study||1
8180303|NCT02364570|20170536|P10|STARTED|Overall Study||1
8180304|NCT02364570|20170537|P9|STARTED|Overall Study||2
8180305|NCT02364570|20170538|P8|STARTED|Overall Study||1
8180306|NCT02364570|20170539|P7|STARTED|Overall Study||2
8180307|NCT02364570|20170540|P6|STARTED|Overall Study||1
8180308|NCT02364570|20170541|P5|STARTED|Overall Study||1
8180309|NCT02364570|20170542|P4|STARTED|Overall Study||1
8180310|NCT02364570|20170543|P3|STARTED|Overall Study||2
8180311|NCT02364570|20170544|P2|STARTED|Overall Study||1
8180312|NCT02364570|20170545|P1|STARTED|Overall Study||1
8180313|NCT02364388|20170611|P1|NOT COMPLETED|Overall Study||8
8180314|NCT02364388|20170611|P1|COMPLETED|Overall Study||209
8180315|NCT02364388|20170611|P1|Excluded|Overall Study||8
8180316|NCT02364388|20170611|P1|Biopsied|Overall Study||209
8180317|NCT02364388|20170611|P1|STARTED|Overall Study||217
8180318|NCT02364336|20170618|P2|NOT COMPLETED|Overall Study||1
8180319|NCT02364336|20170619|P1|NOT COMPLETED|Overall Study||0
8180320|NCT02364336|20170618|P2|COMPLETED|Overall Study||11
8180321|NCT02364336|20170619|P1|COMPLETED|Overall Study||1
8180322|NCT02364336|20170618|P2|48 Weeks After End of Peginterferon|Overall Study||10
8180323|NCT02364336|20170619|P1|48 Weeks After End of Peginterferon|Overall Study||1
8180324|NCT02364336|20170618|P2|24 Weeks After End of Peginterferon|Overall Study||11
8180325|NCT02364336|20170619|P1|24 Weeks After End of Peginterferon|Overall Study||1
8180326|NCT02364336|20170618|P2|End of Peginterferon Treatment|Overall Study||11
8180327|NCT02364336|20170619|P1|End of Peginterferon Treatment|Overall Study||1
8180328|NCT02364336|20170618|P2|6 Hours Post First Peginterferon Inject|Overall Study||12
8180329|NCT02364336|20170619|P1|6 Hours Post First Peginterferon Inject|Overall Study||1
8180330|NCT02364336|20170618|P2|STARTED|Overall Study||12
8180331|NCT02364336|20170619|P1|STARTED|Overall Study||1
8180332|NCT02364180|20170632|P1|NOT COMPLETED|Overall Study||1
8180333|NCT02364180|20170632|P1|COMPLETED|Overall Study||10
8180334|NCT02364180|20170632|P1|STARTED|Overall Study||11
8180335|NCT02364076|20170636|P1|NOT COMPLETED|Overall Study||5
8180336|NCT02364076|20170636|P1|COMPLETED|Overall Study||40
8180337|NCT02364076|20170636|P1|STARTED|Overall Study||45
8180338|NCT02364037|20170645|P2|NOT COMPLETED|Overall Study||53
8180339|NCT02364037|20170646|P1|NOT COMPLETED|Overall Study||44
8180340|NCT02364037|20170645|P2|COMPLETED|Overall Study||453
8180341|NCT02364037|20170646|P1|COMPLETED|Overall Study||458
8180342|NCT02364037|20170645|P2|STARTED|Overall Study||506
8180343|NCT02364037|20170646|P1|STARTED|Overall Study||502
8180347|NCT02363959|20170679|P2|NOT COMPLETED|Overall Study||0
8180348|NCT02363959|20170680|P1|NOT COMPLETED|Overall Study||1
8180349|NCT02363959|20170679|P2|COMPLETED|Overall Study||10
8180350|NCT02363959|20170680|P1|COMPLETED|Overall Study||9
8180351|NCT02363959|20170679|P2|STARTED|Overall Study||10
8180352|NCT02363959|20170680|P1|STARTED|Overall Study||10
8180353|NCT02363946|20170709|P13|NOT COMPLETED|Overall Study||0
8180354|NCT02363946|20170710|P12|NOT COMPLETED|Overall Study||0
8180355|NCT02363946|20170711|P11|NOT COMPLETED|Overall Study||0
8180356|NCT02363946|20170712|P10|NOT COMPLETED|Overall Study||0
8180357|NCT02363946|20170713|P9|NOT COMPLETED|Overall Study||0
8180358|NCT02363946|20170714|P8|NOT COMPLETED|Overall Study||1
8180359|NCT02363946|20170715|P7|NOT COMPLETED|Overall Study||0
8180360|NCT02363946|20170716|P6|NOT COMPLETED|Overall Study||0
8180361|NCT02363946|20170717|P5|NOT COMPLETED|Overall Study||0
8180362|NCT02363946|20170718|P4|NOT COMPLETED|Overall Study||0
8180363|NCT02363946|20170719|P3|NOT COMPLETED|Overall Study||0
8180364|NCT02363946|20170720|P2|NOT COMPLETED|Overall Study||0
8180365|NCT02363946|20170721|P1|NOT COMPLETED|Overall Study||0
8180366|NCT02363946|20170709|P13|COMPLETED|Overall Study||4
8180367|NCT02363946|20170710|P12|COMPLETED|Overall Study||3
8180368|NCT02363946|20170711|P11|COMPLETED|Overall Study||4
8180369|NCT02363946|20170712|P10|COMPLETED|Overall Study||18
8180370|NCT02363946|20170713|P9|COMPLETED|Overall Study||4
8180371|NCT02363946|20170714|P8|COMPLETED|Overall Study||3
8180372|NCT02363946|20170715|P7|COMPLETED|Overall Study||4
8180373|NCT02363946|20170716|P6|COMPLETED|Overall Study||4
8180374|NCT02363946|20170717|P5|COMPLETED|Overall Study||4
8180375|NCT02363946|20170718|P4|COMPLETED|Overall Study||4
8180376|NCT02363946|20170719|P3|COMPLETED|Overall Study||4
8180377|NCT02363946|20170720|P2|COMPLETED|Overall Study||4
8180378|NCT02363946|20170721|P1|COMPLETED|Overall Study||4
8180379|NCT02363946|20170709|P13|STARTED|Overall Study||4
8180380|NCT02363946|20170710|P12|STARTED|Overall Study||3
8180381|NCT02363946|20170711|P11|STARTED|Overall Study||4
8180382|NCT02363946|20170712|P10|STARTED|Overall Study||18
8180383|NCT02363946|20170713|P9|STARTED|Overall Study||4
8180384|NCT02363946|20170714|P8|STARTED|Overall Study||4
8180385|NCT02363946|20170715|P7|STARTED|Overall Study||4
8180386|NCT02363946|20170716|P6|STARTED|Overall Study||4
8180387|NCT02363946|20170717|P5|STARTED|Overall Study||4
8180388|NCT02363946|20170718|P4|STARTED|Overall Study||4
8180389|NCT02363946|20170719|P3|STARTED|Overall Study||4
8180390|NCT02363946|20170720|P2|STARTED|Overall Study||4
8180391|NCT02363946|20170721|P1|STARTED|Overall Study||4
8180392|NCT02363933|20170907|P1|NOT COMPLETED|Overall Study||6
8180393|NCT02363933|20170907|P1|COMPLETED|Overall Study||2
8180394|NCT02363933|20170907|P1|STARTED|Overall Study||8
8180395|NCT02363907|20170912|P1|NOT COMPLETED|Overall Study||0
8180396|NCT02363907|20170912|P1|COMPLETED|Overall Study||30
8180397|NCT02363907|20170912|P1|STARTED|Overall Study||30
8180398|NCT02363803|20170918|P2|NOT COMPLETED|Period 2||0
8180399|NCT02363803|20170919|P1|NOT COMPLETED|Period 2||0
8180400|NCT02363803|20170918|P2|COMPLETED|Period 2||16
8180401|NCT02363803|20170919|P1|COMPLETED|Period 2||17
8180402|NCT02363803|20170918|P2|STARTED|Period 2|One participant did not return for Period 2 treatment|16
8180403|NCT02363803|20170919|P1|STARTED|Period 2||17
8180404|NCT02363803|20170918|P2|NOT COMPLETED|Period 1||0
8180405|NCT02363803|20170919|P1|NOT COMPLETED|Period 1||0
8180406|NCT02363803|20170918|P2|COMPLETED|Period 1||17
8180407|NCT02363803|20170919|P1|COMPLETED|Period 1||17
8180408|NCT02363803|20170918|P2|STARTED|Period 1||17
8180409|NCT02363803|20170919|P1|STARTED|Period 1||17
8180410|NCT02363621|20170939|P2|NOT COMPLETED|Overall Study||0
8180411|NCT02363621|20170940|P1|NOT COMPLETED|Overall Study||1
8180412|NCT02363621|20170939|P2|COMPLETED|Overall Study||50
8180413|NCT02363621|20170940|P1|COMPLETED|Overall Study||50
8180414|NCT02363621|20170939|P2|STARTED|Overall Study||50
8180415|NCT02363621|20170940|P1|STARTED|Overall Study||51
8180416|NCT02363478|20170950|P1|NOT COMPLETED|Overall Study||8
8180417|NCT02363478|20170950|P1|COMPLETED|Overall Study||22
8180418|NCT02363478|20170950|P1|STARTED|Overall Study||30
8180419|NCT02363439|20170957|P1|NOT COMPLETED|Overall Study||4
8180420|NCT02363439|20170957|P1|COMPLETED|Overall Study||1
8180421|NCT02363439|20170957|P1|STARTED|Overall Study||5
8180422|NCT02363322|20170963|P2|NOT COMPLETED|Overall Study||0
8180423|NCT02363322|20170964|P1|NOT COMPLETED|Overall Study||1
8180424|NCT02363322|20170963|P2|COMPLETED|Overall Study||36
8180425|NCT02363322|20170964|P1|COMPLETED|Overall Study||35
8180426|NCT02363322|20170963|P2|STARTED|Overall Study||36
8180427|NCT02363322|20170964|P1|STARTED|Overall Study||36
8180428|NCT02363283|20170974|P1|NOT COMPLETED|Overall Study||2
8180429|NCT02363283|20170974|P1|COMPLETED|Overall Study||35
8180430|NCT02363283|20170974|P1|STARTED|Overall Study||37
8180431|NCT02363270|20170984|P2|NOT COMPLETED|Overall Study||0
8180432|NCT02363270|20170985|P1|NOT COMPLETED|Overall Study||0
8180433|NCT02363270|20170984|P2|COMPLETED|Overall Study||24
8180434|NCT02363270|20170985|P1|COMPLETED|Overall Study||24
8180435|NCT02363270|20170984|P2|STARTED|Overall Study||24
8180436|NCT02363270|20170985|P1|STARTED|Overall Study||24
8180437|NCT02362789|20170993|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
8180438|NCT02362789|20170994|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
8180439|NCT02362789|20170995|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
8180440|NCT02362789|20170993|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
8180441|NCT02362789|20170994|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
8180442|NCT02362789|20170995|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
8180443|NCT02362789|20170993|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
8180444|NCT02362789|20170994|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
8180445|NCT02362789|20170995|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
8180446|NCT02362789|20170993|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
8180447|NCT02362789|20170994|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
8180448|NCT02362789|20170995|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
8180449|NCT02362789|20170993|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
8180450|NCT02362789|20170994|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
8180451|NCT02362789|20170995|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
8180452|NCT02362789|20170993|P3|STARTED|Run-in Phase (Week 0 to 16)||0
8180453|NCT02362789|20170994|P2|STARTED|Run-in Phase (Week 0 to 16)||0
8180454|NCT02362789|20170995|P1|STARTED|Run-in Phase (Week 0 to 16)||130
8180455|NCT02362724|20171004|P2|NOT COMPLETED|Overall Study||1
8180456|NCT02362724|20171005|P1|NOT COMPLETED|Overall Study||6
8180457|NCT02362724|20171004|P2|COMPLETED|Overall Study||29
8180458|NCT02362724|20171005|P1|COMPLETED|Overall Study||53
8180459|NCT02362724|20171004|P2|STARTED|Overall Study||30
8180460|NCT02362724|20171005|P1|STARTED|Overall Study||59
8180461|NCT02362672|20171043|P3|NOT COMPLETED|Double-blind Maintenance Phase||59
8180462|NCT02362672|20171044|P2|NOT COMPLETED|Double-blind Maintenance Phase||60
8180463|NCT02362672|20171045|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
8180464|NCT02362672|20171043|P3|COMPLETED|Double-blind Maintenance Phase||242
8180465|NCT02362672|20171044|P2|COMPLETED|Double-blind Maintenance Phase||249
8180466|NCT02362672|20171045|P1|COMPLETED|Double-blind Maintenance Phase||0
8180467|NCT02362672|20171043|P3|STARTED|Double-blind Maintenance Phase||301
8180468|NCT02362672|20171044|P2|STARTED|Double-blind Maintenance Phase||309
8180469|NCT02362672|20171045|P1|STARTED|Double-blind Maintenance Phase||0
8180470|NCT02362672|20171043|P3|NOT COMPLETED|Titration Phase||0
8180471|NCT02362672|20171044|P2|NOT COMPLETED|Titration Phase||0
8180472|NCT02362672|20171045|P1|NOT COMPLETED|Titration Phase||579
8180473|NCT02362672|20171043|P3|COMPLETED|Titration Phase||0
8180474|NCT02362672|20171044|P2|COMPLETED|Titration Phase||0
8180475|NCT02362672|20171045|P1|COMPLETED|Titration Phase||610
8180476|NCT02362672|20171043|P3|STARTED|Titration Phase||0
8180477|NCT02362672|20171044|P2|STARTED|Titration Phase||0
8180478|NCT02362672|20171045|P1|STARTED|Titration Phase||1189
8180479|NCT02362646|20171064|P2|NOT COMPLETED|Overall Study||24
8180480|NCT02362646|20171065|P1|NOT COMPLETED|Overall Study||38
8180481|NCT02362646|20171064|P2|COMPLETED|Overall Study||29
8180482|NCT02362646|20171065|P1|COMPLETED|Overall Study||68
8180483|NCT02362646|20171064|P2|STARTED|Overall Study||53
8180484|NCT02362646|20171065|P1|STARTED|Overall Study||106
8180485|NCT02362594|20171075|P2|NOT COMPLETED|Overall Study||225
8180486|NCT02362594|20171076|P1|NOT COMPLETED|Overall Study||250
8180487|NCT02362594|20171075|P2|COMPLETED|Overall Study||280
8180488|NCT02362594|20171076|P1|COMPLETED|Overall Study||264
8180489|NCT02362594|20171075|P2|Continuing Part 1 Adjuvant Therapy|Overall Study||21
8180490|NCT02362594|20171076|P1|Continuing Part 1 Adjuvant Therapy|Overall Study||41
8180491|NCT02362594|20171075|P2|Treated|Overall Study||502
8180492|NCT02362594|20171076|P1|Treated|Overall Study||509
8180493|NCT02362594|20171075|P2|STARTED|Overall Study||505
8180494|NCT02362594|20171076|P1|STARTED|Overall Study||514
8180495|NCT02362503|20171097|P3|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||99
8180496|NCT02362503|20171098|P2|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||198
8180497|NCT02362503|20171099|P1|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||68
8180498|NCT02362503|20171097|P3|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
8180499|NCT02362503|20171098|P2|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
8180500|NCT02362503|20171099|P1|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
8180501|NCT02362503|20171097|P3|STARTED|Open Label Period-Up to Atleast 96 Weeks||99
8180502|NCT02362503|20171098|P2|STARTED|Open Label Period-Up to Atleast 96 Weeks|Subject withdrawn due to progression of disease died during study due to squamous cell carcinoma.|198
8180503|NCT02362503|20171099|P1|STARTED|Open Label Period-Up to Atleast 96 Weeks||68
8180504|NCT02362503|20171097|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
8180505|NCT02362503|20171098|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||5
8180506|NCT02362503|20171099|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
8180507|NCT02362503|20171097|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
8180508|NCT02362503|20171098|P2|COMPLETED|Double-blind Period-Up to 8 Days||198
8180509|NCT02362503|20171099|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
8180510|NCT02362503|20171097|P3|STARTED|Double-blind Period-Up to 8 Days||0
8180511|NCT02362503|20171098|P2|STARTED|Double-blind Period-Up to 8 Days||203
8180512|NCT02362503|20171099|P1|STARTED|Double-blind Period-Up to 8 Days||69
8180513|NCT02362425|20171128|P4|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
8180514|NCT02362425|20171129|P3|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
8180515|NCT02362425|20171130|P2|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180516|NCT02362425|20171131|P1|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180517|NCT02362425|20171128|P4|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
8180518|NCT02362425|20171129|P3|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
8180519|NCT02362425|20171130|P2|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180520|NCT02362425|20171131|P1|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180521|NCT02362425|20171128|P4|STARTED|Phase 2 (up to 6 Months, Randomized)||17
8180522|NCT02362425|20171129|P3|STARTED|Phase 2 (up to 6 Months, Randomized)||16
8180523|NCT02362425|20171130|P2|STARTED|Phase 2 (up to 6 Months, Randomized)||0
8180524|NCT02362425|20171131|P1|STARTED|Phase 2 (up to 6 Months, Randomized)||0
8180525|NCT02362425|20171128|P4|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8180526|NCT02362425|20171129|P3|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8180527|NCT02362425|20171130|P2|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8180528|NCT02362425|20171131|P1|NOT COMPLETED|Phase 1 (up to 6 Months)||16
8180529|NCT02362425|20171128|P4|COMPLETED|Phase 1 (up to 6 Months)||0
8180530|NCT02362425|20171129|P3|COMPLETED|Phase 1 (up to 6 Months)||0
8180531|NCT02362425|20171130|P2|COMPLETED|Phase 1 (up to 6 Months)||10
8180532|NCT02362425|20171131|P1|COMPLETED|Phase 1 (up to 6 Months)||37
8180533|NCT02362425|20171128|P4|STARTED|Phase 1 (up to 6 Months)||0
8180534|NCT02362425|20171129|P3|STARTED|Phase 1 (up to 6 Months)||0
8180535|NCT02362425|20171130|P2|STARTED|Phase 1 (up to 6 Months)||10
8180536|NCT02362425|20171131|P1|STARTED|Phase 1 (up to 6 Months)||53
8180537|NCT02362412|20171249|P2|NOT COMPLETED|Treatment Period III||1
8180538|NCT02362412|20171250|P1|NOT COMPLETED|Treatment Period III||0
8180539|NCT02362412|20171249|P2|COMPLETED|Treatment Period III||10
8180540|NCT02362412|20171250|P1|COMPLETED|Treatment Period III||9
8180541|NCT02362412|20171249|P2|TREATED|Treatment Period III||11
8180542|NCT02362412|20171250|P1|TREATED|Treatment Period III||9
8180543|NCT02362412|20171249|P2|STARTED|Treatment Period III||11
8180544|NCT02362412|20171250|P1|STARTED|Treatment Period III||9
8180545|NCT02362412|20171249|P2|NOT COMPLETED|Treatment Period II||0
8180546|NCT02362412|20171250|P1|NOT COMPLETED|Treatment Period II||0
8180547|NCT02362412|20171249|P2|COMPLETED|Treatment Period II||11
8180548|NCT02362412|20171250|P1|COMPLETED|Treatment Period II||9
8180549|NCT02362412|20171249|P2|TREATED|Treatment Period II||11
8180550|NCT02362412|20171250|P1|TREATED|Treatment Period II||9
8180551|NCT02362412|20171249|P2|STARTED|Treatment Period II||11
8180552|NCT02362412|20171250|P1|STARTED|Treatment Period II||9
8180553|NCT02362373|20171276|P1|NOT COMPLETED|Overall Study||0
8180554|NCT02362373|20171276|P1|COMPLETED|Overall Study||20
8180555|NCT02362373|20171276|P1|STARTED|Overall Study||20
8180556|NCT02362360|20171284|P2|NOT COMPLETED|Period 2||0
8180557|NCT02362360|20171285|P1|NOT COMPLETED|Period 2||0
8180558|NCT02362360|20171284|P2|COMPLETED|Period 2||25
8180559|NCT02362360|20171285|P1|COMPLETED|Period 2||23
8180560|NCT02362360|20171284|P2|STARTED|Period 2||25
8180561|NCT02362360|20171285|P1|STARTED|Period 2||23
8180562|NCT02362360|20171284|P2|NOT COMPLETED|Period 1||1
8180563|NCT02362360|20171285|P1|NOT COMPLETED|Period 1||3
8180564|NCT02362360|20171284|P2|COMPLETED|Period 1||25
8180565|NCT02362360|20171285|P1|COMPLETED|Period 1||23
8180566|NCT02362360|20171284|P2|STARTED|Period 1||26
8180567|NCT02362360|20171285|P1|STARTED|Period 1||26
8180568|NCT02362321|20171293|P2|NOT COMPLETED|Overall Study||0
8180569|NCT02362321|20171294|P1|NOT COMPLETED|Overall Study||4
8180570|NCT02362321|20171293|P2|COMPLETED|Overall Study||10
8180571|NCT02362321|20171294|P1|COMPLETED|Overall Study||6
8180572|NCT02362321|20171293|P2|STARTED|Overall Study||10
8180573|NCT02362321|20171294|P1|STARTED|Overall Study||10
8180574|NCT02362282|20171302|P2|NOT COMPLETED|Overall Study||0
8180575|NCT02362282|20171303|P1|NOT COMPLETED|Overall Study||1
8180576|NCT02362282|20171302|P2|COMPLETED|Overall Study||7
8180577|NCT02362282|20171303|P1|COMPLETED|Overall Study||4
8180578|NCT02362282|20171302|P2|STARTED|Overall Study||7
8180579|NCT02362282|20171303|P1|STARTED|Overall Study||5
8180580|NCT02362269|20171311|P2|NOT COMPLETED|Overall Study||6
8180581|NCT02362269|20171312|P1|NOT COMPLETED|Overall Study||1
8180582|NCT02362269|20171311|P2|COMPLETED|Overall Study||80
8180583|NCT02362269|20171312|P1|COMPLETED|Overall Study||82
8180584|NCT02362269|20171311|P2|STARTED|Overall Study||86
8180585|NCT02362269|20171312|P1|STARTED|Overall Study||83
8180586|NCT02362191|20171318|P1|NOT COMPLETED|Overall Study||2
8180587|NCT02362191|20171318|P1|COMPLETED|Overall Study||3
8180588|NCT02362191|20171318|P1|STARTED|Overall Study||5
8180589|NCT02362048|20171325|P2|NOT COMPLETED|Overall Study||40
8180590|NCT02362048|20171326|P1|NOT COMPLETED|Overall Study||37
8180591|NCT02362048|20171325|P2|COMPLETED|Overall Study||0
8180592|NCT02362048|20171326|P1|COMPLETED|Overall Study||0
8180593|NCT02362048|20171325|P2|Discontinued Study|Overall Study||40
8180594|NCT02362048|20171326|P1|Discontinued Study|Overall Study||37
8180595|NCT02362048|20171325|P2|Received Study Medication|Overall Study||38
8180596|NCT02362048|20171326|P1|Received Study Medication|Overall Study||35
8180597|NCT02362048|20171325|P2|Enrolled|Overall Study||40
8180598|NCT02362048|20171326|P1|Enrolled|Overall Study||37
8180599|NCT02362048|20171325|P2|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
8180600|NCT02362048|20171326|P1|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
8180601|NCT02361762|20171334|P2|NOT COMPLETED|Overall Study||2
8180602|NCT02361762|20171335|P1|NOT COMPLETED|Overall Study||0
8180603|NCT02361762|20171334|P2|COMPLETED|Overall Study||33
8180604|NCT02361762|20171335|P1|COMPLETED|Overall Study||35
8180605|NCT02361762|20171334|P2|STARTED|Overall Study||35
8180606|NCT02361762|20171335|P1|STARTED|Overall Study||35
8180607|NCT02361736|20171365|P2|NOT COMPLETED|Overall Study||1
8180608|NCT02361736|20171366|P1|NOT COMPLETED|Overall Study||1
8180609|NCT02361736|20171365|P2|COMPLETED|Overall Study||59
8180610|NCT02361736|20171366|P1|COMPLETED|Overall Study||59
8180611|NCT02361736|20171365|P2|STARTED|Overall Study||60
8180612|NCT02361736|20171366|P1|STARTED|Overall Study||60
8180613|NCT02361580|20171386|P2|NOT COMPLETED|Overall Study||3
8180614|NCT02361580|20171387|P1|NOT COMPLETED|Overall Study||6
8180615|NCT02361580|20171386|P2|COMPLETED|Overall Study||0
8180616|NCT02361580|20171387|P1|COMPLETED|Overall Study||0
8180617|NCT02361580|20171386|P2|STARTED|Overall Study||3
8180618|NCT02361580|20171387|P1|STARTED|Overall Study||6
8180619|NCT02361476|20171399|P2|NOT COMPLETED|Overall Study||0
8180620|NCT02361476|20171400|P1|NOT COMPLETED|Overall Study||0
8180621|NCT02361476|20171399|P2|COMPLETED|Overall Study||188
8180622|NCT02361476|20171400|P1|COMPLETED|Overall Study||191
8180623|NCT02361476|20171399|P2|STARTED|Overall Study||188
8180624|NCT02361476|20171400|P1|STARTED|Overall Study||191
8180625|NCT02361216|20171416|P2|NOT COMPLETED|12-month Follow-up||27
8180626|NCT02361216|20171417|P1|NOT COMPLETED|12-month Follow-up||52
8180627|NCT02361216|20171416|P2|COMPLETED|12-month Follow-up||130
8180628|NCT02361216|20171417|P1|COMPLETED|12-month Follow-up||489
8180629|NCT02361216|20171416|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
8180630|NCT02361216|20171417|P1|STARTED|12-month Follow-up||541
8180631|NCT02361216|20171416|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
8180632|NCT02361216|20171417|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
8180633|NCT02361216|20171416|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
8180634|NCT02361216|20171417|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
8180635|NCT02361216|20171416|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
8180636|NCT02361216|20171417|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
8180637|NCT02360995|20171432|P3|NOT COMPLETED|Overall Study||2
8180638|NCT02360995|20171433|P2|NOT COMPLETED|Overall Study||1
8180639|NCT02360995|20171434|P1|NOT COMPLETED|Overall Study||2
8180640|NCT02360995|20171432|P3|COMPLETED|Overall Study||41
8180641|NCT02360995|20171433|P2|COMPLETED|Overall Study||42
8180642|NCT02360995|20171434|P1|COMPLETED|Overall Study||41
8180643|NCT02360995|20171432|P3|STARTED|Overall Study||43
8180644|NCT02360995|20171433|P2|STARTED|Overall Study||43
8180645|NCT02360995|20171434|P1|STARTED|Overall Study||43
8180646|NCT02360774|20171459|P2|NOT COMPLETED|Overall Study||2
8180647|NCT02360774|20171460|P1|NOT COMPLETED|Overall Study||3
8180648|NCT02360774|20171459|P2|COMPLETED|Overall Study||13
8180649|NCT02360774|20171460|P1|COMPLETED|Overall Study||12
8180650|NCT02360774|20171459|P2|STARTED|Overall Study||15
8180651|NCT02360774|20171460|P1|STARTED|Overall Study||15
8180652|NCT02360631|20171474|P2|NOT COMPLETED|Overall Study||26
8180653|NCT02360631|20171475|P1|NOT COMPLETED|Overall Study||33
8180654|NCT02360631|20171474|P2|COMPLETED|Overall Study||174
8180655|NCT02360631|20171475|P1|COMPLETED|Overall Study||267
8180656|NCT02360631|20171474|P2|Week 12|Overall Study||165
8180657|NCT02360631|20171475|P1|Week 12|Overall Study||249
8180658|NCT02360631|20171474|P2|STARTED|Overall Study||200
8180659|NCT02360631|20171475|P1|STARTED|Overall Study||300
8180660|NCT02360488|20171487|P2|NOT COMPLETED|Overall Study||7
8180661|NCT02360488|20171488|P1|NOT COMPLETED|Overall Study||3
8180662|NCT02360488|20171487|P2|COMPLETED|Overall Study||55
8180663|NCT02360488|20171488|P1|COMPLETED|Overall Study||59
8180664|NCT02360488|20171487|P2|STARTED|Overall Study||62
8180665|NCT02360488|20171488|P1|STARTED|Overall Study||62
8180666|NCT02360475|20171498|P4|NOT COMPLETED|Overall Study||5
8180667|NCT02360475|20171499|P3|NOT COMPLETED|Overall Study||8
8180668|NCT02360475|20171500|P2|NOT COMPLETED|Overall Study||13
8180669|NCT02360475|20171501|P1|NOT COMPLETED|Overall Study||4
8180670|NCT02360475|20171498|P4|COMPLETED|Overall Study||120
8180671|NCT02360475|20171499|P3|COMPLETED|Overall Study||117
8180672|NCT02360475|20171500|P2|COMPLETED|Overall Study||111
8180673|NCT02360475|20171501|P1|COMPLETED|Overall Study||122
8180674|NCT02360475|20171498|P4|STARTED|Overall Study||125
8180675|NCT02360475|20171499|P3|STARTED|Overall Study||125
8180676|NCT02360475|20171500|P2|STARTED|Overall Study||124
8180677|NCT02360475|20171501|P1|STARTED|Overall Study||126
8180678|NCT02360397|20171559|P1|NOT COMPLETED|Overall Study||4
8180679|NCT02360397|20171559|P1|COMPLETED|Overall Study||2
8180680|NCT02360397|20171559|P1|STARTED|Overall Study||6
8180681|NCT02360319|20171568|P2|NOT COMPLETED|Overall Study||61
8180682|NCT02360319|20171569|P1|NOT COMPLETED|Overall Study||88
8180683|NCT02360319|20171568|P2|COMPLETED|Overall Study||173
8180684|NCT02360319|20171569|P1|COMPLETED|Overall Study||167
8180685|NCT02360319|20171568|P2|STARTED|Overall Study||234
8180686|NCT02360319|20171569|P1|STARTED|Overall Study||255
8180687|NCT02360293|20171585|P2|NOT COMPLETED|Overall Study||96
8180688|NCT02360293|20171586|P1|NOT COMPLETED|Overall Study||76
8180689|NCT02360293|20171585|P2|COMPLETED|Overall Study||83
8180690|NCT02360293|20171586|P1|COMPLETED|Overall Study||102
8180691|NCT02360293|20171585|P2|12month Physical Activity|Overall Study||59
8180692|NCT02360293|20171586|P1|12month Physical Activity|Overall Study||68
8180693|NCT02360293|20171585|P2|12month f/u Survey|Overall Study||83
8180694|NCT02360293|20171586|P1|12month f/u Survey|Overall Study||102
8180695|NCT02360293|20171585|P2|6month Physical Activity|Overall Study||108
8180696|NCT02360293|20171586|P1|6month Physical Activity|Overall Study||122
8180697|NCT02360293|20171585|P2|6month f/u Survey|Overall Study||105
8180698|NCT02360293|20171586|P1|6month f/u Survey|Overall Study||110
8180699|NCT02360293|20171585|P2|STARTED|Overall Study||179
8180700|NCT02360293|20171586|P1|STARTED|Overall Study||178
8180701|NCT02360280|20171600|P2|NOT COMPLETED|Overall Study||1
8180702|NCT02360280|20171601|P1|NOT COMPLETED|Overall Study||3
8180703|NCT02360280|20171600|P2|COMPLETED|Overall Study||29
8180704|NCT02360280|20171601|P1|COMPLETED|Overall Study||25
8180705|NCT02360280|20171600|P2|STARTED|Overall Study||30
8180706|NCT02360280|20171601|P1|STARTED|Overall Study||28
8180707|NCT02360228|20171616|P3|NOT COMPLETED|Overall Study||1
8180708|NCT02360228|20171617|P2|NOT COMPLETED|Overall Study||1
8180709|NCT02360228|20171618|P1|NOT COMPLETED|Overall Study||1
8180710|NCT02360228|20171616|P3|COMPLETED|Overall Study||7
8180711|NCT02360228|20171617|P2|COMPLETED|Overall Study||7
8180712|NCT02360228|20171618|P1|COMPLETED|Overall Study||8
8180713|NCT02360228|20171616|P3|STARTED|Overall Study||8
8180714|NCT02360228|20171617|P2|STARTED|Overall Study||8
8180715|NCT02360228|20171618|P1|STARTED|Overall Study||9
8180716|NCT02360215|20171646|P2|NOT COMPLETED|Overall Study||0
8180717|NCT02360215|20171647|P1|NOT COMPLETED|Overall Study||0
8180718|NCT02360215|20171646|P2|COMPLETED|Overall Study||261
8180719|NCT02360215|20171647|P1|COMPLETED|Overall Study||257
8180720|NCT02360215|20171646|P2|EQ-5D-5L VAS at 12 Months|Overall Study||48
8180721|NCT02360215|20171647|P1|EQ-5D-5L VAS at 12 Months|Overall Study||57
8180722|NCT02360215|20171646|P2|EQ-5D-5L VAS at 6 Months|Overall Study||69
8180723|NCT02360215|20171647|P1|EQ-5D-5L VAS at 6 Months|Overall Study||76
8180724|NCT02360215|20171646|P2|EQ-5D-5L VAS at 4 Months|Overall Study||193
8180725|NCT02360215|20171647|P1|EQ-5D-5L VAS at 4 Months|Overall Study||104
8180726|NCT02360215|20171646|P2|EQ-5D-5L VAS at 2 Months|Overall Study||123
8180727|NCT02360215|20171647|P1|EQ-5D-5L VAS at 2 Months|Overall Study||139
8180728|NCT02360215|20171646|P2|EQ-5D-5L Index at 12 Months|Overall Study||45
8180729|NCT02360215|20171647|P1|EQ-5D-5L Index at 12 Months|Overall Study||56
8180730|NCT02360215|20171646|P2|EQ-5D-5L Index at 6 Months|Overall Study||70
8180731|NCT02360215|20171647|P1|EQ-5D-5L Index at 6 Months|Overall Study||79
8180732|NCT02360215|20171646|P2|EQ-5D-5L Index at 4 Months|Overall Study||96
8180733|NCT02360215|20171647|P1|EQ-5D-5L Index at 4 Months|Overall Study||110
8180734|NCT02360215|20171646|P2|EQ-5D-5L Index at 2 Months|Overall Study||125
8180735|NCT02360215|20171647|P1|EQ-5D-5L Index at 2 Months|Overall Study||142
8180736|NCT02360215|20171646|P2|Clinical Trial Battery Composite Score|Overall Study||259
8180737|NCT02360215|20171647|P1|Clinical Trial Battery Composite Score|Overall Study||255
8180738|NCT02360215|20171646|P2|Controlled Oral Word Association (COWA)|Overall Study||261
8180739|NCT02360215|20171647|P1|Controlled Oral Word Association (COWA)|Overall Study||257
8180740|NCT02360215|20171646|P2|TMT Part B|Overall Study||257
8180741|NCT02360215|20171647|P1|TMT Part B|Overall Study||250
8180742|NCT02360215|20171646|P2|Trail Making Test (TMT) Part A|Overall Study||260
8180743|NCT02360215|20171647|P1|Trail Making Test (TMT) Part A|Overall Study||256
8180744|NCT02360215|20171646|P2|HVLT-R Recognition|Overall Study||259
8180745|NCT02360215|20171647|P1|HVLT-R Recognition|Overall Study||255
8180746|NCT02360215|20171646|P2|HVLT-R Delayed Recall|Overall Study||259
8180747|NCT02360215|20171647|P1|HVLT-R Delayed Recall|Overall Study||256
8180748|NCT02360215|20171646|P2|HVLT-R Total Recall|Overall Study||259
8180749|NCT02360215|20171647|P1|HVLT-R Total Recall|Overall Study||256
8180750|NCT02360215|20171646|P2|MDASI-BT Neurologic Factor Score|Overall Study||251
8180751|NCT02360215|20171647|P1|MDASI-BT Neurologic Factor Score|Overall Study||249
8180752|NCT02360215|20171646|P2|MDASI-BT Cognitive Factor Score|Overall Study||251
8180753|NCT02360215|20171647|P1|MDASI-BT Cognitive Factor Score|Overall Study||249
8180754|NCT02360215|20171646|P2|MDASI-BT Intererence Score|Overall Study||251
8180755|NCT02360215|20171647|P1|MDASI-BT Intererence Score|Overall Study||248
8180756|NCT02360215|20171646|P2|MDASI-BT Symptom Score|Overall Study||251
8180757|NCT02360215|20171647|P1|MDASI-BT Symptom Score|Overall Study||249
8180758|NCT02360215|20171646|P2|Started Protocol Treatment|Overall Study||223
8180759|NCT02360215|20171647|P1|Started Protocol Treatment|Overall Study||232
8180760|NCT02360215|20171646|P2|All Randomized Participants|Overall Study||261
8180761|NCT02360215|20171647|P1|All Randomized Participants|Overall Study||257
8180762|NCT02360215|20171646|P2|STARTED|Overall Study||261
8180763|NCT02360215|20171647|P1|STARTED|Overall Study||257
8180764|NCT02360124|20171700|P3|NOT COMPLETED|Overall Study||26
8180765|NCT02360124|20171701|P2|NOT COMPLETED|Overall Study||12
8180766|NCT02360124|20171702|P1|NOT COMPLETED|Overall Study||28
8180767|NCT02360124|20171700|P3|COMPLETED|Overall Study||82
8180768|NCT02360124|20171701|P2|COMPLETED|Overall Study||95
8180769|NCT02360124|20171702|P1|COMPLETED|Overall Study||80
8180770|NCT02360124|20171700|P3|STARTED|Overall Study||108
8180771|NCT02360124|20171701|P2|STARTED|Overall Study||107
8180772|NCT02360124|20171702|P1|STARTED|Overall Study||108
8180773|NCT02360111|20171713|P1|NOT COMPLETED|Overall Study||2
8180774|NCT02360111|20171713|P1|COMPLETED|Overall Study||1
8180775|NCT02360111|20171713|P1|STARTED|Overall Study||3
8180776|NCT02360098|20171723|P1|NOT COMPLETED|Overall Study||7
8180777|NCT02360098|20171723|P1|COMPLETED|Overall Study||29
8180778|NCT02360098|20171723|P1|STARTED|Overall Study||36
8180779|NCT02360085|20171728|P1|NOT COMPLETED|Overall Study||16
8180780|NCT02360085|20171728|P1|COMPLETED|Overall Study||49
8180781|NCT02360085|20171728|P1|STARTED|Overall Study||65
8180782|NCT02360059|20171741|P2|NOT COMPLETED|Overall Study||0
8180783|NCT02360059|20171742|P1|NOT COMPLETED|Overall Study||0
8180784|NCT02360059|20171741|P2|COMPLETED|Overall Study||0
8180785|NCT02360059|20171742|P1|COMPLETED|Overall Study||1
8180786|NCT02360059|20171741|P2|STARTED|Overall Study||0
8180787|NCT02360059|20171742|P1|STARTED|Overall Study||1
8180788|NCT02359955|20171750|P2|NOT COMPLETED|Overall Study||0
8180789|NCT02359955|20171751|P1|NOT COMPLETED|Overall Study||0
8180790|NCT02359955|20171750|P2|COMPLETED|Overall Study||10
8180791|NCT02359955|20171751|P1|COMPLETED|Overall Study||10
8180792|NCT02359955|20171750|P2|STARTED|Overall Study||10
8180793|NCT02359955|20171751|P1|STARTED|Overall Study||10
8180794|NCT02359916|20171774|P7|NOT COMPLETED|Overall Study||0
8180795|NCT02359916|20171775|P6|NOT COMPLETED|Overall Study||0
8180796|NCT02359916|20171776|P5|NOT COMPLETED|Overall Study||0
8180797|NCT02359916|20171777|P4|NOT COMPLETED|Overall Study||0
8180798|NCT02359916|20171778|P3|NOT COMPLETED|Overall Study||0
8180799|NCT02359916|20171779|P2|NOT COMPLETED|Overall Study||0
8180800|NCT02359916|20171780|P1|NOT COMPLETED|Overall Study||0
8180801|NCT02359916|20171774|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180802|NCT02359916|20171775|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180803|NCT02359916|20171776|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180804|NCT02359916|20171777|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180805|NCT02359916|20171778|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180806|NCT02359916|20171779|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180807|NCT02359916|20171780|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180808|NCT02359916|20171774|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180809|NCT02359916|20171775|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180810|NCT02359916|20171776|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180811|NCT02359916|20171777|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180812|NCT02359916|20171778|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180813|NCT02359916|20171779|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180814|NCT02359916|20171780|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180815|NCT02359903|20171802|P2|NOT COMPLETED|Overall Study||2
8180816|NCT02359903|20171803|P1|NOT COMPLETED|Overall Study||0
8180817|NCT02359903|20171802|P2|COMPLETED|Overall Study||43
8180818|NCT02359903|20171803|P1|COMPLETED|Overall Study||45
8180819|NCT02359903|20171802|P2|STARTED|Overall Study||45
8180820|NCT02359903|20171803|P1|STARTED|Overall Study||45
8180821|NCT02359890|20171811|P1|NOT COMPLETED|Overall Study||10
8180822|NCT02359890|20171811|P1|COMPLETED|Overall Study||155
8180823|NCT02359890|20171811|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
8180824|NCT02359890|20171811|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
8180825|NCT02359890|20171811|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
8180826|NCT02359890|20171811|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
8180827|NCT02359877|20171822|P4|NOT COMPLETED|Overall Study||3
8180828|NCT02359877|20171823|P3|NOT COMPLETED|Overall Study||0
8180829|NCT02359877|20171824|P2|NOT COMPLETED|Overall Study||0
8180830|NCT02359877|20171825|P1|NOT COMPLETED|Overall Study||1
8180831|NCT02359877|20171822|P4|COMPLETED|Overall Study||11
8180832|NCT02359877|20171823|P3|COMPLETED|Overall Study||6
8180833|NCT02359877|20171824|P2|COMPLETED|Overall Study||6
8180834|NCT02359877|20171825|P1|COMPLETED|Overall Study||33
8180835|NCT02359877|20171822|P4|STARTED|Overall Study||14
8180836|NCT02359877|20171823|P3|STARTED|Overall Study||6
8180837|NCT02359877|20171824|P2|STARTED|Overall Study||6
8180838|NCT02359877|20171825|P1|STARTED|Overall Study||34
8180839|NCT02359851|20171875|P1|NOT COMPLETED|Overall Study||2
8180840|NCT02359851|20171875|P1|COMPLETED|Overall Study||3
8180841|NCT02359851|20171875|P1|STARTED|Overall Study||5
8180842|NCT02359552|20171885|P2|NOT COMPLETED|Overall Study||4
8180843|NCT02359552|20171886|P1|NOT COMPLETED|Overall Study||3
8180844|NCT02359552|20171885|P2|COMPLETED|Overall Study||21
8180845|NCT02359552|20171886|P1|COMPLETED|Overall Study||22
8180846|NCT02359552|20171885|P2|STARTED|Overall Study||25
8180847|NCT02359552|20171886|P1|STARTED|Overall Study||25
8180848|NCT02359435|20171908|P2|NOT COMPLETED|Overall Study||4
8180849|NCT02359435|20171909|P1|NOT COMPLETED|Overall Study||4
8180850|NCT02359435|20171908|P2|COMPLETED|Overall Study||216
8180851|NCT02359435|20171909|P1|COMPLETED|Overall Study||216
8180852|NCT02359435|20171908|P2|STARTED|Overall Study||220
8180853|NCT02359435|20171909|P1|STARTED|Overall Study||220
8180854|NCT02359305|20171917|P2|NOT COMPLETED|Overall Study||0
8180855|NCT02359305|20171918|P1|NOT COMPLETED|Overall Study||0
8180856|NCT02359305|20171917|P2|COMPLETED|Overall Study||34
8180857|NCT02359305|20171918|P1|COMPLETED|Overall Study||34
8180858|NCT02359305|20171917|P2|STARTED|Overall Study||34
8180859|NCT02359305|20171918|P1|STARTED|Overall Study||34
8180860|NCT02359110|20171930|P2|NOT COMPLETED|Overall Study||0
8180861|NCT02359110|20171931|P1|NOT COMPLETED|Overall Study||0
8180862|NCT02359110|20171930|P2|COMPLETED|Overall Study||54
8180863|NCT02359110|20171931|P1|COMPLETED|Overall Study||55
8180864|NCT02359110|20171930|P2|STARTED|Overall Study||54
8180865|NCT02359110|20171931|P1|STARTED|Overall Study||55
8180866|NCT02359058|20171944|P3|NOT COMPLETED|Overall Study||0
8180867|NCT02359058|20171945|P2|NOT COMPLETED|Overall Study||0
8180868|NCT02359058|20171946|P1|NOT COMPLETED|Overall Study||0
8180869|NCT02359058|20171944|P3|COMPLETED|Overall Study||6
8180870|NCT02359058|20171945|P2|COMPLETED|Overall Study||6
8180871|NCT02359058|20171946|P1|COMPLETED|Overall Study||6
8180872|NCT02359058|20171944|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8180873|NCT02359058|20171945|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8180874|NCT02359058|20171946|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8180875|NCT02359058|20171944|P3|STARTED|Overall Study||6
8180876|NCT02359058|20171945|P2|STARTED|Overall Study||6
8180877|NCT02359058|20171946|P1|STARTED|Overall Study||6
8180878|NCT02359045|20171969|P2|NOT COMPLETED|Overall Study||3
8180879|NCT02359045|20171970|P1|NOT COMPLETED|Overall Study||4
8180880|NCT02359045|20171969|P2|COMPLETED|Overall Study||39
8180881|NCT02359045|20171970|P1|COMPLETED|Overall Study||36
8180882|NCT02359045|20171969|P2|STARTED|Overall Study||42
8180883|NCT02359045|20171970|P1|STARTED|Overall Study||40
8180884|NCT02359019|20172203|P1|NOT COMPLETED|Overall Study||0
8180885|NCT02359019|20172203|P1|COMPLETED|Overall Study||45
8180886|NCT02359019|20172203|P1|STARTED|Overall Study||45
8180887|NCT02359006|20172211|P2|NOT COMPLETED|Overall Study||3
8180888|NCT02359006|20172212|P1|NOT COMPLETED|Overall Study||4
8180889|NCT02359006|20172211|P2|COMPLETED|Overall Study||10
8180890|NCT02359006|20172212|P1|COMPLETED|Overall Study||10
8180891|NCT02359006|20172211|P2|STARTED|Overall Study||13
8180892|NCT02359006|20172212|P1|STARTED|Overall Study||14
8180893|NCT02358889|20172255|P3|NOT COMPLETED|Overall Study||1
8180894|NCT02358889|20172256|P2|NOT COMPLETED|Overall Study||2
8180895|NCT02358889|20172257|P1|NOT COMPLETED|Overall Study||0
8180896|NCT02358889|20172255|P3|COMPLETED|Overall Study||27
8180897|NCT02358889|20172256|P2|COMPLETED|Overall Study||28
8180898|NCT02358889|20172257|P1|COMPLETED|Overall Study||30
8180899|NCT02358889|20172255|P3|STARTED|Overall Study||28
8180900|NCT02358889|20172256|P2|STARTED|Overall Study||30
8180901|NCT02358889|20172257|P1|STARTED|Overall Study||30
8180902|NCT02358876|20172274|P1|NOT COMPLETED|Overall Study||2
8180903|NCT02358876|20172274|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
8180904|NCT02358876|20172274|P1|STARTED|Overall Study||32
8180905|NCT02358863|20172278|P1|NOT COMPLETED|Overall Study||3
8180906|NCT02358863|20172278|P1|COMPLETED|Overall Study||10
8180907|NCT02358863|20172278|P1|STARTED|Overall Study||13
8180908|NCT02358668|20172285|P3|NOT COMPLETED|Overall Study||0
8180909|NCT02358668|20172286|P2|NOT COMPLETED|Overall Study||1
8180910|NCT02358668|20172287|P1|NOT COMPLETED|Overall Study||2
8180911|NCT02358668|20172285|P3|COMPLETED|Overall Study||12
8180912|NCT02358668|20172286|P2|COMPLETED|Overall Study||23
8180913|NCT02358668|20172287|P1|COMPLETED|Overall Study||22
8180914|NCT02358668|20172285|P3|STARTED|Overall Study||12
8180915|NCT02358668|20172286|P2|STARTED|Overall Study||24
8180916|NCT02358668|20172287|P1|STARTED|Overall Study||24
8180917|NCT02358603|20172429|P2|NOT COMPLETED|Overall Study||0
8180918|NCT02358603|20172430|P1|NOT COMPLETED|Overall Study||0
8180919|NCT02358603|20172429|P2|COMPLETED|Overall Study||8
8180920|NCT02358603|20172430|P1|COMPLETED|Overall Study||40
8180921|NCT02358603|20172429|P2|STARTED|Overall Study||8
8180922|NCT02358603|20172430|P1|STARTED|Overall Study||40
8180923|NCT02358473|20172436|P1|NOT COMPLETED|Overall Study||13
8180924|NCT02358473|20172436|P1|COMPLETED|Overall Study||0
8180925|NCT02358473|20172436|P1|STARTED|Overall Study||13
8180926|NCT02358369|20172448|P5|NOT COMPLETED|Treatment Period C||7
8180927|NCT02358369|20172449|P4|NOT COMPLETED|Treatment Period C||0
8180928|NCT02358369|20172450|P3|NOT COMPLETED|Treatment Period C||0
8180929|NCT02358369|20172451|P2|NOT COMPLETED|Treatment Period C||0
8180930|NCT02358369|20172452|P1|NOT COMPLETED|Treatment Period C||0
8180931|NCT02358369|20172448|P5|COMPLETED|Treatment Period C||106
8180932|NCT02358369|20172449|P4|COMPLETED|Treatment Period C||0
8180933|NCT02358369|20172450|P3|COMPLETED|Treatment Period C||0
8180934|NCT02358369|20172451|P2|COMPLETED|Treatment Period C||0
8180935|NCT02358369|20172452|P1|COMPLETED|Treatment Period C||0
8180936|NCT02358369|20172448|P5|STARTED|Treatment Period C||113
8180937|NCT02358369|20172449|P4|STARTED|Treatment Period C||0
8180938|NCT02358369|20172450|P3|STARTED|Treatment Period C||0
8180939|NCT02358369|20172451|P2|STARTED|Treatment Period C||0
8180940|NCT02358369|20172452|P1|STARTED|Treatment Period C||0
8180941|NCT02358369|20172448|P5|NOT COMPLETED|Treatment Period A/B||0
8180942|NCT02358369|20172449|P4|NOT COMPLETED|Treatment Period A/B||4
8180943|NCT02358369|20172450|P3|NOT COMPLETED|Treatment Period A/B||2
8180944|NCT02358369|20172451|P2|NOT COMPLETED|Treatment Period A/B||2
8180945|NCT02358369|20172452|P1|NOT COMPLETED|Treatment Period A/B||0
8180946|NCT02358369|20172448|P5|COMPLETED|Treatment Period A/B||0
8180947|NCT02358369|20172449|P4|COMPLETED|Treatment Period A/B||37
8180948|NCT02358369|20172450|P3|COMPLETED|Treatment Period A/B||38
8180949|NCT02358369|20172451|P2|COMPLETED|Treatment Period A/B||38
8180950|NCT02358369|20172452|P1|COMPLETED|Treatment Period A/B||0
8180951|NCT02358369|20172448|P5|STARTED|Treatment Period A/B||0
8180952|NCT02358369|20172449|P4|STARTED|Treatment Period A/B||41
8180953|NCT02358369|20172450|P3|STARTED|Treatment Period A/B||40
8180954|NCT02358369|20172451|P2|STARTED|Treatment Period A/B||40
8180955|NCT02358369|20172452|P1|STARTED|Treatment Period A/B||0
8180956|NCT02358369|20172448|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
8180957|NCT02358369|20172449|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
8180958|NCT02358369|20172450|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
8180959|NCT02358369|20172451|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
8180960|NCT02358369|20172452|P1|NOT COMPLETED|Pre-Randomization Washout Period||35
8180961|NCT02358369|20172448|P5|COMPLETED|Pre-Randomization Washout Period||0
8180962|NCT02358369|20172449|P4|COMPLETED|Pre-Randomization Washout Period||0
8180963|NCT02358369|20172450|P3|COMPLETED|Pre-Randomization Washout Period||0
8180964|NCT02358369|20172451|P2|COMPLETED|Pre-Randomization Washout Period||0
8180965|NCT02358369|20172452|P1|COMPLETED|Pre-Randomization Washout Period||121
8180966|NCT02358369|20172448|P5|STARTED|Pre-Randomization Washout Period||0
8180967|NCT02358369|20172449|P4|STARTED|Pre-Randomization Washout Period||0
8180968|NCT02358369|20172450|P3|STARTED|Pre-Randomization Washout Period||0
8180969|NCT02358369|20172451|P2|STARTED|Pre-Randomization Washout Period||0
8180970|NCT02358369|20172452|P1|STARTED|Pre-Randomization Washout Period||156
8180971|NCT02358343|20172498|P5|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
8180972|NCT02358343|20172499|P4|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
8180973|NCT02358343|20172500|P3|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
8180974|NCT02358343|20172501|P2|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
8180975|NCT02358343|20172502|P1|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
8180976|NCT02358343|20172498|P5|COMPLETED|Comparative Efficacy Trial / Observation||18
8180977|NCT02358343|20172499|P4|COMPLETED|Comparative Efficacy Trial / Observation||58
8180978|NCT02358343|20172500|P3|COMPLETED|Comparative Efficacy Trial / Observation||55
8180979|NCT02358343|20172501|P2|COMPLETED|Comparative Efficacy Trial / Observation||0
8180980|NCT02358343|20172502|P1|COMPLETED|Comparative Efficacy Trial / Observation||0
8180981|NCT02358343|20172498|P5|STARTED|Comparative Efficacy Trial / Observation||20
8180982|NCT02358343|20172499|P4|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
8180983|NCT02358343|20172500|P3|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
8180984|NCT02358343|20172501|P2|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
8180985|NCT02358343|20172502|P1|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
8180986|NCT02358343|20172498|P5|NOT COMPLETED|Screening Intervention||0
8180987|NCT02358343|20172499|P4|NOT COMPLETED|Screening Intervention||0
8180988|NCT02358343|20172500|P3|NOT COMPLETED|Screening Intervention||0
8180989|NCT02358343|20172501|P2|NOT COMPLETED|Screening Intervention||8
8180990|NCT02358343|20172502|P1|NOT COMPLETED|Screening Intervention||6
8180991|NCT02358343|20172498|P5|COMPLETED|Screening Intervention||0
8180992|NCT02358343|20172499|P4|COMPLETED|Screening Intervention||0
8180993|NCT02358343|20172500|P3|COMPLETED|Screening Intervention||0
8180994|NCT02358343|20172501|P2|COMPLETED|Screening Intervention||84
8180995|NCT02358343|20172502|P1|COMPLETED|Screening Intervention||86
8180996|NCT02358343|20172498|P5|STARTED|Screening Intervention||0
8180997|NCT02358343|20172499|P4|STARTED|Screening Intervention||0
8180998|NCT02358343|20172500|P3|STARTED|Screening Intervention||0
8180999|NCT02358343|20172501|P2|STARTED|Screening Intervention|89 completed control visit|92
8181000|NCT02358343|20172502|P1|STARTED|Screening Intervention|90 completed engagement interview|92
8181001|NCT02358135|20172539|P2|NOT COMPLETED|Overall Study||19
8181002|NCT02358135|20172540|P1|NOT COMPLETED|Overall Study||15
8181003|NCT02358135|20172539|P2|COMPLETED|Overall Study||131
8181004|NCT02358135|20172540|P1|COMPLETED|Overall Study||135
8181005|NCT02358135|20172539|P2|Randomized|Overall Study||148
8181006|NCT02358135|20172540|P1|Randomized|Overall Study||148
8181007|NCT02358135|20172539|P2|STARTED|Overall Study||150
8181008|NCT02358135|20172540|P1|STARTED|Overall Study||150
8181009|NCT02358044|20172558|P2|NOT COMPLETED|Overall Study||7
8181010|NCT02358044|20172559|P1|NOT COMPLETED|Overall Study||2
8181011|NCT02358044|20172558|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
8181012|NCT02358044|20172559|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
8181013|NCT02358044|20172558|P2|Treated|Overall Study||126
8181014|NCT02358044|20172559|P1|Treated|Overall Study||129
8181015|NCT02358044|20172558|P2|STARTED|Overall Study||128
8181016|NCT02358044|20172559|P1|STARTED|Overall Study||129
8181017|NCT02358031|20172578|P3|NOT COMPLETED|Overall Study||300
8181018|NCT02358031|20172579|P2|NOT COMPLETED|Overall Study||281
8181019|NCT02358031|20172580|P1|NOT COMPLETED|Overall Study||301
8181020|NCT02358031|20172578|P3|COMPLETED|Overall Study||0
8181021|NCT02358031|20172579|P2|COMPLETED|Overall Study||0
8181022|NCT02358031|20172580|P1|COMPLETED|Overall Study||0
8181023|NCT02358031|20172578|P3|Pembro Combo v Control Efficacy Analyses|Overall Study||278
8181024|NCT02358031|20172579|P2|Pembro Combo v Control Efficacy Analyses|Overall Study||281
8181025|NCT02358031|20172580|P1|Pembro Combo v Control Efficacy Analyses|Overall Study||0
8181026|NCT02358031|20172578|P3|Pembro Mono v Control Efficacy Analyses|Overall Study||300
8181027|NCT02358031|20172579|P2|Pembro Mono v Control Efficacy Analyses|Overall Study||0
8181028|NCT02358031|20172580|P1|Pembro Mono v Control Efficacy Analyses|Overall Study||301
8181029|NCT02358031|20172578|P3|Treated|Overall Study||287
8181030|NCT02358031|20172579|P2|Treated|Overall Study||276
8181031|NCT02358031|20172580|P1|Treated|Overall Study||300
8181032|NCT02358031|20172578|P3|STARTED|Overall Study||300
8181033|NCT02358031|20172579|P2|STARTED|Overall Study||281
8181034|NCT02358031|20172580|P1|STARTED|Overall Study||301
8181035|NCT02357940|20172707|P2|NOT COMPLETED|Overall Study||2
8181036|NCT02357940|20172708|P1|NOT COMPLETED|Overall Study||0
8181037|NCT02357940|20172707|P2|COMPLETED|Overall Study||30
8181038|NCT02357940|20172708|P1|COMPLETED|Overall Study||9
8181039|NCT02357940|20172707|P2|STARTED|Overall Study||32
8181040|NCT02357940|20172708|P1|STARTED|Overall Study||9
8181041|NCT02357901|20172835|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
8181042|NCT02357901|20172836|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
8181043|NCT02357901|20172837|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
8181044|NCT02357901|20172838|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
8181045|NCT02357901|20172835|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
8181046|NCT02357901|20172836|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
8181047|NCT02357901|20172837|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
8181048|NCT02357901|20172838|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
8181049|NCT02357901|20172835|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
8181050|NCT02357901|20172836|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
8181051|NCT02357901|20172837|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
8181052|NCT02357901|20172838|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
8181053|NCT02357901|20172835|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
8181054|NCT02357901|20172836|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
8181055|NCT02357901|20172837|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
8181056|NCT02357901|20172838|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
8181057|NCT02357901|20172835|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
8181058|NCT02357901|20172836|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
8181059|NCT02357901|20172837|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
8181060|NCT02357901|20172838|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
8181061|NCT02357901|20172835|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181062|NCT02357901|20172836|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181063|NCT02357901|20172837|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181064|NCT02357901|20172838|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
8181065|NCT02357901|20172835|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181066|NCT02357901|20172836|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181067|NCT02357901|20172837|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181068|NCT02357901|20172838|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
8181069|NCT02357901|20172835|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
8181070|NCT02357901|20172836|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
8181071|NCT02357901|20172837|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
8181072|NCT02357901|20172838|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
8181073|NCT02357810|20172888|P1|NOT COMPLETED|Follow-up at Treatment Discontinuation||18
8181074|NCT02357810|20172888|P1|COMPLETED|Follow-up at Treatment Discontinuation||133
8181075|NCT02357810|20172888|P1|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
8181076|NCT02357810|20172888|P1|NOT COMPLETED|12 Week Response and Further Treatment||22
8181077|NCT02357810|20172888|P1|COMPLETED|12 Week Response and Further Treatment||73
8181078|NCT02357810|20172888|P1|Went on to be Treated After Response|12 Week Response and Further Treatment||73
8181079|NCT02357810|20172888|P1|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
8181080|NCT02357810|20172888|P1|STARTED|12 Week Response and Further Treatment||95
8181081|NCT02357810|20172888|P1|NOT COMPLETED|Reached 12 Weeks Response||56
8181082|NCT02357810|20172888|P1|COMPLETED|Reached 12 Weeks Response||95
8181083|NCT02357810|20172888|P1|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
8181084|NCT02357810|20172888|P1|Reached 6 Week Response|Reached 12 Weeks Response||129
8181085|NCT02357810|20172888|P1|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
8181086|NCT02357810|20172888|P1|STARTED|Reached 12 Weeks Response||151
8181087|NCT02357810|20172888|P1|NOT COMPLETED|Registered and Started Treatment||27
8181088|NCT02357810|20172888|P1|COMPLETED|Registered and Started Treatment||151
8181089|NCT02357810|20172888|P1|Initiated Treatment on Study|Registered and Started Treatment||151
8181090|NCT02357810|20172888|P1|Registered to Study|Registered and Started Treatment||152
8181091|NCT02357810|20172888|P1|Signed Consent|Registered and Started Treatment||178
8181092|NCT02357810|20172888|P1|STARTED|Registered and Started Treatment||178
8181093|NCT02357758|20172903|P3|NOT COMPLETED|Overall Study||7
8181094|NCT02357758|20172904|P2|NOT COMPLETED|Overall Study||0
8181095|NCT02357758|20172905|P1|NOT COMPLETED|Overall Study||16
8181096|NCT02357758|20172903|P3|COMPLETED|Overall Study||5
8181097|NCT02357758|20172904|P2|COMPLETED|Overall Study||20
8181098|NCT02357758|20172905|P1|COMPLETED|Overall Study||9
8181099|NCT02357758|20172903|P3|STARTED|Overall Study||12
8181100|NCT02357758|20172904|P2|STARTED|Overall Study||20
8181101|NCT02357758|20172905|P1|STARTED|Overall Study||25
8181102|NCT02357706|20172913|P2|NOT COMPLETED|Overall Study||0
8181103|NCT02357706|20172914|P1|NOT COMPLETED|Overall Study||0
8181104|NCT02357706|20172913|P2|COMPLETED|Overall Study||10
8181105|NCT02357706|20172914|P1|COMPLETED|Overall Study||10
8181106|NCT02357706|20172913|P2|STARTED|Overall Study||10
8181107|NCT02357706|20172914|P1|STARTED|Overall Study||10
8181108|NCT02357576|20172938|P2|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
8181109|NCT02357576|20172939|P1|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
8181110|NCT02357576|20172938|P2|COMPLETED|Neurodevelopmental Outcome Follow Up||2
8181111|NCT02357576|20172939|P1|COMPLETED|Neurodevelopmental Outcome Follow Up||6
8181112|NCT02357576|20172938|P2|STARTED|Neurodevelopmental Outcome Follow Up||7
8181113|NCT02357576|20172939|P1|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
8181114|NCT02357576|20172938|P2|NOT COMPLETED|Treatment Period||2
8181115|NCT02357576|20172939|P1|NOT COMPLETED|Treatment Period||0
8181116|NCT02357576|20172938|P2|COMPLETED|Treatment Period||7
8181117|NCT02357576|20172939|P1|COMPLETED|Treatment Period||12
8181118|NCT02357576|20172938|P2|STARTED|Treatment Period||9
8181119|NCT02357576|20172939|P1|STARTED|Treatment Period||12
8181120|NCT02357485|20172983|P1|NOT COMPLETED|Overall Study||0
8181121|NCT02357485|20172983|P1|COMPLETED|Overall Study||6
8181122|NCT02357485|20172983|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
8181123|NCT02357459|20172994|P3|NOT COMPLETED|Overall Study||12
8181124|NCT02357459|20172995|P2|NOT COMPLETED|Overall Study||14
8181125|NCT02357459|20172996|P1|NOT COMPLETED|Overall Study||17
8181126|NCT02357459|20172994|P3|COMPLETED|Overall Study||150
8181127|NCT02357459|20172995|P2|COMPLETED|Overall Study||149
8181128|NCT02357459|20172996|P1|COMPLETED|Overall Study||144
8181129|NCT02357459|20172994|P3|STARTED|Overall Study||162
8181130|NCT02357459|20172995|P2|STARTED|Overall Study||163
8181131|NCT02357459|20172996|P1|STARTED|Overall Study||161
8181132|NCT02357420|20173042|P4|NOT COMPLETED|Overall Study||19
8181133|NCT02357420|20173043|P3|NOT COMPLETED|Overall Study||16
8181134|NCT02357420|20173044|P2|NOT COMPLETED|Overall Study||12
8181135|NCT02357420|20173045|P1|NOT COMPLETED|Overall Study||12
8181136|NCT02357420|20173042|P4|COMPLETED|Overall Study||63
8181137|NCT02357420|20173043|P3|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
8181138|NCT02357420|20173044|P2|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
8181139|NCT02357420|20173045|P1|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
8181140|NCT02357420|20173042|P4|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
8181141|NCT02357420|20173043|P3|Full Analysis Set (FAS)|Overall Study||109
8181142|NCT02357420|20173044|P2|Full Analysis Set (FAS)|Overall Study||98
8181143|NCT02357420|20173045|P1|Full Analysis Set (FAS)|Overall Study||104
8181144|NCT02357420|20173042|P4|STARTED|Overall Study||82
8181145|NCT02357420|20173043|P3|STARTED|Overall Study||109
8181146|NCT02357420|20173044|P2|STARTED|Overall Study||98
8181147|NCT02357420|20173045|P1|STARTED|Overall Study||104
8181148|NCT02357394|20173065|P2|NOT COMPLETED|Overall Study||0
8181149|NCT02357394|20173066|P1|NOT COMPLETED|Overall Study||0
8181150|NCT02357394|20173065|P2|COMPLETED|Overall Study||3
8181151|NCT02357394|20173066|P1|COMPLETED|Overall Study||4
8181152|NCT02357394|20173065|P2|STARTED|Overall Study||3
8181153|NCT02357394|20173066|P1|STARTED|Overall Study||4
8181154|NCT02357368|20173108|P4|NOT COMPLETED|Overall Study||3
8181155|NCT02357368|20173109|P3|NOT COMPLETED|Overall Study||1
8181156|NCT02357368|20173110|P2|NOT COMPLETED|Overall Study||3
8181157|NCT02357368|20173111|P1|NOT COMPLETED|Overall Study||6
8181158|NCT02357368|20173108|P4|COMPLETED|Overall Study||5
8181159|NCT02357368|20173109|P3|COMPLETED|Overall Study||13
8181160|NCT02357368|20173110|P2|COMPLETED|Overall Study||15
8181161|NCT02357368|20173111|P1|COMPLETED|Overall Study||13
8181162|NCT02357368|20173108|P4|STARTED|Overall Study||8
8181163|NCT02357368|20173109|P3|STARTED|Overall Study||14
8181164|NCT02357368|20173110|P2|STARTED|Overall Study||18
8181165|NCT02357368|20173111|P1|STARTED|Overall Study||19
8181166|NCT02357342|20173135|P2|NOT COMPLETED|Extension Study||0
8181167|NCT02357342|20173136|P1|NOT COMPLETED|Extension Study||0
8181168|NCT02357342|20173135|P2|COMPLETED|Extension Study||9
8181169|NCT02357342|20173136|P1|COMPLETED|Extension Study||4
8181170|NCT02357342|20173135|P2|STARTED|Extension Study||9
8181171|NCT02357342|20173136|P1|STARTED|Extension Study||4
8181172|NCT02357342|20173135|P2|NOT COMPLETED|First 6 Months||0
8181173|NCT02357342|20173136|P1|NOT COMPLETED|First 6 Months||2
8181174|NCT02357342|20173135|P2|COMPLETED|First 6 Months||20
8181175|NCT02357342|20173136|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
8181176|NCT02357342|20173135|P2|STARTED|First 6 Months||20
8181177|NCT02357342|20173136|P1|STARTED|First 6 Months||20
8181178|NCT02357290|20173146|P1|NOT COMPLETED|Overall Study||26
8181179|NCT02357290|20173146|P1|COMPLETED|Overall Study||14
8181180|NCT02357290|20173146|P1|Exposed|Overall Study||26
8181181|NCT02357290|20173146|P1|STARTED|Overall Study||40
8181182|NCT02357264|20173153|P2|NOT COMPLETED|Overall Study||0
8181183|NCT02357264|20173154|P1|NOT COMPLETED|Overall Study||0
8181184|NCT02357264|20173153|P2|COMPLETED|Overall Study||130
8181185|NCT02357264|20173154|P1|COMPLETED|Overall Study||56
8181186|NCT02357264|20173153|P2|STARTED|Overall Study||130
8181187|NCT02357264|20173154|P1|STARTED|Overall Study||56
8181188|NCT02357173|20173163|P3|NOT COMPLETED|Overall Study||6
8181189|NCT02357173|20173164|P2|NOT COMPLETED|Overall Study||6
8181190|NCT02357173|20173165|P1|NOT COMPLETED|Overall Study||6
8181191|NCT02357173|20173163|P3|COMPLETED|Overall Study||16
8181192|NCT02357173|20173164|P2|COMPLETED|Overall Study||15
8181193|NCT02357173|20173165|P1|COMPLETED|Overall Study||19
8181194|NCT02357173|20173163|P3|STARTED|Overall Study||22
8181195|NCT02357173|20173164|P2|STARTED|Overall Study||21
8181196|NCT02357173|20173165|P1|STARTED|Overall Study||25
8181197|NCT02357147|20173184|P2|NOT COMPLETED|Maintenance Treatment Phase||29
8181198|NCT02357147|20173185|P1|NOT COMPLETED|Maintenance Treatment Phase||26
8181199|NCT02357147|20173184|P2|COMPLETED|Maintenance Treatment Phase||0
8181200|NCT02357147|20173185|P1|COMPLETED|Maintenance Treatment Phase||0
8181201|NCT02357147|20173184|P2|Treated|Maintenance Treatment Phase||29
8181202|NCT02357147|20173185|P1|Treated|Maintenance Treatment Phase||25
8181203|NCT02357147|20173184|P2|STARTED|Maintenance Treatment Phase||29
8181204|NCT02357147|20173185|P1|STARTED|Maintenance Treatment Phase||26
8181205|NCT02357147|20173184|P2|NOT COMPLETED|Combination Treatment Phase||27
8181206|NCT02357147|20173185|P1|NOT COMPLETED|Combination Treatment Phase||26
8181207|NCT02357147|20173184|P2|COMPLETED|Combination Treatment Phase||29
8181208|NCT02357147|20173185|P1|COMPLETED|Combination Treatment Phase||26
8181209|NCT02357147|20173184|P2|Treated|Combination Treatment Phase||54
8181210|NCT02357147|20173185|P1|Treated|Combination Treatment Phase||52
8181211|NCT02357147|20173184|P2|STARTED|Combination Treatment Phase||56
8181212|NCT02357147|20173185|P1|STARTED|Combination Treatment Phase||52
8181213|NCT02356900|20173197|P2|NOT COMPLETED|Overall Study||0
8181214|NCT02356900|20173198|P1|NOT COMPLETED|Overall Study||0
8181215|NCT02356900|20173197|P2|COMPLETED|Overall Study||10
8181216|NCT02356900|20173198|P1|COMPLETED|Overall Study||11
8181217|NCT02356900|20173197|P2|STARTED|Overall Study||10
8181218|NCT02356900|20173198|P1|STARTED|Overall Study||11
8181219|NCT02356887|20173216|P1|NOT COMPLETED|Overall Study||2
8181220|NCT02356887|20173216|P1|COMPLETED|Overall Study||10
8181221|NCT02356887|20173216|P1|STARTED|Overall Study||12
8181222|NCT02356783|20173233|P2|NOT COMPLETED|Overall Study||3
8181223|NCT02356783|20173234|P1|NOT COMPLETED|Overall Study||1
8181224|NCT02356783|20173233|P2|COMPLETED|Overall Study||14
8181225|NCT02356783|20173234|P1|COMPLETED|Overall Study||15
8181226|NCT02356783|20173233|P2|STARTED|Overall Study||17
8181227|NCT02356783|20173234|P1|STARTED|Overall Study||16
8181228|NCT02356692|20173242|P2|NOT COMPLETED|Overall Study||0
8181229|NCT02356692|20173243|P1|NOT COMPLETED|Overall Study||0
8181230|NCT02356692|20173242|P2|COMPLETED|Overall Study||60
8181231|NCT02356692|20173243|P1|COMPLETED|Overall Study||60
8181232|NCT02356692|20173242|P2|STARTED|Overall Study||60
8181233|NCT02356692|20173243|P1|STARTED|Overall Study||60
8181234|NCT02356588|20173255|P2|NOT COMPLETED|Overall Study||13
8181235|NCT02356588|20173256|P1|NOT COMPLETED|Overall Study||5
8181236|NCT02356588|20173255|P2|COMPLETED|Overall Study||41
8181237|NCT02356588|20173256|P1|COMPLETED|Overall Study||102
8181238|NCT02356588|20173255|P2|STARTED|Overall Study||54
8181239|NCT02356588|20173256|P1|STARTED|Overall Study||107
8181240|NCT02356575|20173290|P2|NOT COMPLETED|Overall Study||0
8181241|NCT02356575|20173291|P1|NOT COMPLETED|Overall Study||0
8181242|NCT02356575|20173290|P2|COMPLETED|Overall Study||80
8181243|NCT02356575|20173291|P1|COMPLETED|Overall Study||80
8181244|NCT02356575|20173290|P2|STARTED|Overall Study||80
8181245|NCT02356575|20173291|P1|STARTED|Overall Study||80
8181246|NCT02356562|20173373|P2|NOT COMPLETED|Overall Study||1
8181247|NCT02356562|20173374|P1|NOT COMPLETED|Overall Study||2
8181248|NCT02356562|20173373|P2|COMPLETED|Overall Study||6
8181249|NCT02356562|20173374|P1|COMPLETED|Overall Study||20
8181250|NCT02356562|20173373|P2|STARTED|Overall Study||7
8181251|NCT02356562|20173374|P1|STARTED|Overall Study||22
8181252|NCT02356484|20173384|P1|NOT COMPLETED|Overall Study||0
8181253|NCT02356484|20173384|P1|COMPLETED|Overall Study||138
8181254|NCT02356484|20173384|P1|STARTED|Overall Study||138
8181255|NCT02356471|20173388|P1|NOT COMPLETED|Overall Study||6
8181256|NCT02356471|20173388|P1|COMPLETED|Overall Study||28
8181257|NCT02356471|20173388|P1|STARTED|Overall Study||34
8181258|NCT02356211|20173403|P2|NOT COMPLETED|Overall Study||10
8181259|NCT02356211|20173404|P1|NOT COMPLETED|Overall Study||3
8181260|NCT02356211|20173403|P2|COMPLETED|Overall Study||42
8181261|NCT02356211|20173404|P1|COMPLETED|Overall Study||54
8181262|NCT02356211|20173403|P2|STARTED|Overall Study||52
8181263|NCT02356211|20173404|P1|STARTED|Overall Study||57
8181264|NCT02356198|20173412|P2|NOT COMPLETED|Overall Study||7
8181265|NCT02356198|20173413|P1|NOT COMPLETED|Overall Study||2
8181266|NCT02356198|20173412|P2|COMPLETED|Overall Study||98
8181267|NCT02356198|20173413|P1|COMPLETED|Overall Study||102
8181268|NCT02356198|20173412|P2|STARTED|Overall Study||105
8181269|NCT02356198|20173413|P1|STARTED|Overall Study||104
8181270|NCT02356107|20173427|P1|NOT COMPLETED|Overall Study||3
8181271|NCT02356107|20173427|P1|COMPLETED|Overall Study||12
8181272|NCT02356107|20173427|P1|STARTED|Overall Study||15
8181273|NCT02356003|20173431|P1|NOT COMPLETED|Overall Study||0
8181274|NCT02356003|20173431|P1|COMPLETED|Overall Study||10
8181275|NCT02356003|20173431|P1|STARTED|Overall Study||10
8181276|NCT02355977|20173440|P3|NOT COMPLETED|Overall Study||0
8181277|NCT02355977|20173441|P2|NOT COMPLETED|Overall Study||0
8181278|NCT02355977|20173442|P1|NOT COMPLETED|Overall Study||0
8181279|NCT02355977|20173440|P3|COMPLETED|Overall Study||23
8181280|NCT02355977|20173441|P2|COMPLETED|Overall Study||26
8181281|NCT02355977|20173442|P1|COMPLETED|Overall Study||21
8181282|NCT02355977|20173440|P3|STARTED|Overall Study||23
8181283|NCT02355977|20173441|P2|STARTED|Overall Study||26
8181284|NCT02355977|20173442|P1|STARTED|Overall Study||21
8181285|NCT02355886|20173458|P2|NOT COMPLETED|Overall Study||0
8181286|NCT02355886|20173459|P1|NOT COMPLETED|Overall Study||0
8181287|NCT02355886|20173458|P2|COMPLETED|Overall Study||12
8181288|NCT02355886|20173459|P1|COMPLETED|Overall Study||13
8181289|NCT02355886|20173458|P2|STARTED|Overall Study||12
8181290|NCT02355886|20173459|P1|STARTED|Overall Study||13
8181291|NCT02355743|20173469|P1|NOT COMPLETED|Overall Study||2
8181292|NCT02355743|20173469|P1|COMPLETED|Overall Study||6
8181293|NCT02355743|20173469|P1|STARTED|Overall Study||8
8181294|NCT02355691|20173477|P2|NOT COMPLETED|Overall Study||9
8181295|NCT02355691|20173478|P1|NOT COMPLETED|Overall Study||7
8181296|NCT02355691|20173477|P2|COMPLETED|Overall Study||0
8181297|NCT02355691|20173478|P1|COMPLETED|Overall Study||0
8181298|NCT02355691|20173477|P2|2nd Postop Visit|Overall Study||9
8181299|NCT02355691|20173478|P1|2nd Postop Visit|Overall Study||7
8181300|NCT02355691|20173477|P2|1st Postop Visit|Overall Study||9
8181301|NCT02355691|20173478|P1|1st Postop Visit|Overall Study||7
8181302|NCT02355691|20173477|P2|STARTED|Overall Study||9
8181303|NCT02355691|20173478|P1|STARTED|Overall Study||7
8181304|NCT02355665|20173488|P2|NOT COMPLETED|Overall Study||232
8181305|NCT02355665|20173489|P1|NOT COMPLETED|Overall Study||249
8181306|NCT02355665|20173488|P2|COMPLETED|Overall Study||365
8181307|NCT02355665|20173489|P1|COMPLETED|Overall Study||352
8181308|NCT02355665|20173488|P2|STARTED|Overall Study||597
8181309|NCT02355665|20173489|P1|STARTED|Overall Study||601
8181310|NCT02355275|20173921|P1|NOT COMPLETED|Overall Study||8
8181311|NCT02355275|20173921|P1|COMPLETED|Overall Study||14
8181312|NCT02355275|20173921|P1|STARTED|Overall Study||22
8181313|NCT02355158|20173926|P1|NOT COMPLETED|Overall Study||150
8181314|NCT02355158|20173926|P1|COMPLETED|Overall Study||47
8181315|NCT02355158|20173926|P1|STARTED|Overall Study||197
8181316|NCT02355067|20173932|P2|NOT COMPLETED|Overall Study||8
8181317|NCT02355067|20173933|P1|NOT COMPLETED|Overall Study||8
8181318|NCT02355067|20173932|P2|COMPLETED|Overall Study||12
8181319|NCT02355067|20173933|P1|COMPLETED|Overall Study||12
8181320|NCT02355067|20173932|P2|STARTED|Overall Study||20
8181321|NCT02355067|20173933|P1|STARTED|Overall Study||20
8181322|NCT02355028|20173947|P2|NOT COMPLETED|Overall Study||5
8181323|NCT02355028|20173948|P1|NOT COMPLETED|Overall Study||11
8181324|NCT02355028|20173947|P2|COMPLETED|Overall Study||41
8181325|NCT02355028|20173948|P1|COMPLETED|Overall Study||36
8181326|NCT02355028|20173947|P2|Treated|Overall Study||45
8181327|NCT02355028|20173948|P1|Treated|Overall Study||46
8181328|NCT02355028|20173947|P2|STARTED|Overall Study||46
8181329|NCT02355028|20173948|P1|STARTED|Overall Study||47
8181330|NCT02354976|20173984|P3|NOT COMPLETED|Overall Study||3
8181331|NCT02354976|20173985|P2|NOT COMPLETED|Overall Study||1
8181332|NCT02354976|20173986|P1|NOT COMPLETED|Overall Study||2
8181333|NCT02354976|20173984|P3|COMPLETED|Overall Study||23
8181334|NCT02354976|20173985|P2|COMPLETED|Overall Study||26
8181335|NCT02354976|20173986|P1|COMPLETED|Overall Study||23
8181336|NCT02354976|20173984|P3|STARTED|Overall Study||26
8181337|NCT02354976|20173985|P2|STARTED|Overall Study||27
8181338|NCT02354976|20173986|P1|STARTED|Overall Study||25
8181339|NCT02354924|20173997|P2|NOT COMPLETED|Overall Study||0
8181340|NCT02354924|20173998|P1|NOT COMPLETED|Overall Study||0
8181341|NCT02354924|20173997|P2|COMPLETED|Overall Study||20
8181342|NCT02354924|20173998|P1|COMPLETED|Overall Study||40
8181343|NCT02354924|20173997|P2|STARTED|Overall Study||20
8181344|NCT02354924|20173998|P1|STARTED|Overall Study||40
8181345|NCT02354859|20174010|P2|NOT COMPLETED|Overall Study||2
8181346|NCT02354859|20174011|P1|NOT COMPLETED|Overall Study||0
8181347|NCT02354859|20174010|P2|COMPLETED|Overall Study||57
8181348|NCT02354859|20174011|P1|COMPLETED|Overall Study||60
8181349|NCT02354859|20174010|P2|STARTED|Overall Study||59
8181350|NCT02354859|20174011|P1|STARTED|Overall Study||60
8181351|NCT02354833|20174029|P2|NOT COMPLETED|Overall Study||0
8181352|NCT02354833|20174030|P1|NOT COMPLETED|Overall Study||0
8181353|NCT02354833|20174029|P2|COMPLETED|Overall Study||43
8181354|NCT02354833|20174030|P1|COMPLETED|Overall Study||38
8181355|NCT02354833|20174029|P2|STARTED|Overall Study||43
8181356|NCT02354833|20174030|P1|STARTED|Overall Study||38
8181357|NCT02354781|20174042|P1|NOT COMPLETED|Overall Study||0
8181358|NCT02354781|20174042|P1|COMPLETED|Overall Study||3
8181359|NCT02354781|20174042|P1|STARTED|Overall Study||3
8181360|NCT02354690|20174049|P1|NOT COMPLETED|Overall Study||1
8181361|NCT02354690|20174049|P1|COMPLETED|Overall Study||12
8181362|NCT02354690|20174049|P1|STARTED|Overall Study||13
8181363|NCT02354599|20174063|P6|NOT COMPLETED|Overall Study||1
8181364|NCT02354599|20174064|P5|NOT COMPLETED|Overall Study||0
8181365|NCT02354599|20174065|P4|NOT COMPLETED|Overall Study||0
8181366|NCT02354599|20174066|P3|NOT COMPLETED|Overall Study||0
8181367|NCT02354599|20174067|P2|NOT COMPLETED|Overall Study||1
8181368|NCT02354599|20174068|P1|NOT COMPLETED|Overall Study||1
8181369|NCT02354599|20174063|P6|COMPLETED|Overall Study||5
8181370|NCT02354599|20174064|P5|COMPLETED|Overall Study||2
8181371|NCT02354599|20174065|P4|COMPLETED|Overall Study||6
8181372|NCT02354599|20174066|P3|COMPLETED|Overall Study||6
8181373|NCT02354599|20174067|P2|COMPLETED|Overall Study||5
8181374|NCT02354599|20174068|P1|COMPLETED|Overall Study||5
8181375|NCT02354599|20174063|P6|STARTED|Overall Study||6
8181376|NCT02354599|20174064|P5|STARTED|Overall Study||2
8181377|NCT02354599|20174065|P4|STARTED|Overall Study||6
8181378|NCT02354599|20174066|P3|STARTED|Overall Study||6
8181379|NCT02354599|20174067|P2|STARTED|Overall Study||6
8181380|NCT02354599|20174068|P1|STARTED|Overall Study||6
8181381|NCT02354586|20174138|P1|NOT COMPLETED|Overall Study||341
8181382|NCT02354586|20174138|P1|COMPLETED|Overall Study||122
8181383|NCT02354586|20174138|P1|Ongoing in Study|Overall Study||21
8181384|NCT02354586|20174138|P1|STARTED|Overall Study||463
8181385|NCT02354508|20174157|P3|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
8181386|NCT02354508|20174158|P2|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
8181387|NCT02354508|20174159|P1|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
8181388|NCT02354508|20174157|P3|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
8181389|NCT02354508|20174158|P2|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
8181390|NCT02354508|20174159|P1|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
8181391|NCT02354508|20174157|P3|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
8181392|NCT02354508|20174158|P2|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
8181393|NCT02354508|20174159|P1|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
8181394|NCT02354508|20174157|P3|STARTED|Period 3: Post-treatment Follow up Phase||39
8181395|NCT02354508|20174158|P2|STARTED|Period 3: Post-treatment Follow up Phase||23
8181396|NCT02354508|20174159|P1|STARTED|Period 3: Post-treatment Follow up Phase||26
8181397|NCT02354508|20174157|P3|NOT COMPLETED|Period 2: Extension Phase||3
8181398|NCT02354508|20174158|P2|NOT COMPLETED|Period 2: Extension Phase||4
8181399|NCT02354508|20174159|P1|NOT COMPLETED|Period 2: Extension Phase||6
8181400|NCT02354508|20174157|P3|COMPLETED|Period 2: Extension Phase||36
8181401|NCT02354508|20174158|P2|COMPLETED|Period 2: Extension Phase||19
8181402|NCT02354508|20174159|P1|COMPLETED|Period 2: Extension Phase||20
8181403|NCT02354508|20174157|P3|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
8181404|NCT02354508|20174158|P2|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
8181405|NCT02354508|20174159|P1|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
8181406|NCT02354508|20174157|P3|NOT COMPLETED|Period 1: Core Phase||6
8181407|NCT02354508|20174158|P2|NOT COMPLETED|Period 1: Core Phase||2
8181408|NCT02354508|20174159|P1|NOT COMPLETED|Period 1: Core Phase||2
8181409|NCT02354508|20174157|P3|COMPLETED|Period 1: Core Phase||47
8181410|NCT02354508|20174158|P2|COMPLETED|Period 1: Core Phase||27
8181411|NCT02354508|20174159|P1|COMPLETED|Period 1: Core Phase||39
8181412|NCT02354508|20174157|P3|STARTED|Period 1: Core Phase||53
8181413|NCT02354508|20174158|P2|STARTED|Period 1: Core Phase||29
8181414|NCT02354508|20174159|P1|STARTED|Period 1: Core Phase||41
8181415|NCT02354482|20174237|P1|NOT COMPLETED|Reference||0
8181416|NCT02354482|20174237|P1|COMPLETED|Reference||2042
8181417|NCT02354482|20174237|P1|STARTED|Reference||2042
8181418|NCT02354482|20174237|P1|NOT COMPLETED|Assessment and Teach Back||0
8181419|NCT02354482|20174237|P1|COMPLETED|Assessment and Teach Back||508
8181420|NCT02354482|20174237|P1|STARTED|Assessment and Teach Back||508
8181421|NCT02354482|20174237|P1|NOT COMPLETED|Patient/Family Caregiver Assessment||0
8181422|NCT02354482|20174237|P1|COMPLETED|Patient/Family Caregiver Assessment||3093
8181423|NCT02354482|20174237|P1|STARTED|Patient/Family Caregiver Assessment||3093
8181424|NCT02354482|20174237|P1|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
8181425|NCT02354482|20174237|P1|COMPLETED|Hospital-Based Trust and Plain Language||2090
8181426|NCT02354482|20174237|P1|STARTED|Hospital-Based Trust and Plain Language||2090
8181427|NCT02354482|20174237|P1|NOT COMPLETED|Home-Based Trust and Plain Language||0
8181428|NCT02354482|20174237|P1|COMPLETED|Home-Based Trust and Plain Language||1979
8181429|NCT02354482|20174237|P1|STARTED|Home-Based Trust and Plain Language||1979
8181430|NCT02354482|20174237|P1|NOT COMPLETED|Patient Communication and Care||0
8181431|NCT02354482|20174237|P1|COMPLETED|Patient Communication and Care||2158
8181432|NCT02354482|20174237|P1|STARTED|Patient Communication and Care||2158
8181433|NCT02354443|20174257|P1|NOT COMPLETED|Overall Study||0
8181434|NCT02354443|20174257|P1|COMPLETED|Overall Study||1
8181435|NCT02354443|20174257|P1|STARTED|Overall Study||1
8181436|NCT02354417|20174261|P1|NOT COMPLETED|Overall Study||1
8181437|NCT02354417|20174261|P1|COMPLETED|Overall Study||2
8181438|NCT02354417|20174261|P1|STARTED|Overall Study||3
8181439|NCT02354378|20174267|P2|NOT COMPLETED|Overall Study||4
8181440|NCT02354378|20174268|P1|NOT COMPLETED|Overall Study||34
8181441|NCT02354378|20174267|P2|COMPLETED|Overall Study||16
8181442|NCT02354378|20174268|P1|COMPLETED|Overall Study||30
8181443|NCT02354378|20174267|P2|STARTED|Overall Study||20
8181444|NCT02354378|20174268|P1|STARTED|Overall Study||64
8181445|NCT02354352|20174278|P2|NOT COMPLETED|Overall Study||3
8181446|NCT02354352|20174279|P1|NOT COMPLETED|Overall Study||3
8181447|NCT02354352|20174278|P2|COMPLETED|Overall Study||23
8181448|NCT02354352|20174279|P1|COMPLETED|Overall Study||23
8181449|NCT02354352|20174278|P2|9 Months|Overall Study||23
8181450|NCT02354352|20174279|P1|9 Months|Overall Study||25
8181451|NCT02354352|20174278|P2|6 Months|Overall Study||23
8181452|NCT02354352|20174279|P1|6 Months|Overall Study||25
8181453|NCT02354352|20174278|P2|3 Months|Overall Study||23
8181454|NCT02354352|20174279|P1|3 Months|Overall Study||25
8181455|NCT02354352|20174278|P2|2 Months|Overall Study||22
8181456|NCT02354352|20174279|P1|2 Months|Overall Study||24
8181457|NCT02354352|20174278|P2|1 Month|Overall Study||23
8181458|NCT02354352|20174279|P1|1 Month|Overall Study||24
8181459|NCT02354352|20174278|P2|2 Weeks|Overall Study||25
8181460|NCT02354352|20174279|P1|2 Weeks|Overall Study||26
8181461|NCT02354352|20174278|P2|STARTED|Overall Study||26
8181462|NCT02354352|20174279|P1|STARTED|Overall Study||26
8181463|NCT02354339|20174287|P2|NOT COMPLETED|Overall Study||0
8181464|NCT02354339|20174288|P1|NOT COMPLETED|Overall Study||0
8181465|NCT02354339|20174287|P2|COMPLETED|Overall Study||12
8181466|NCT02354339|20174288|P1|COMPLETED|Overall Study||12
8181467|NCT02354339|20174287|P2|STARTED|Overall Study||12
8181468|NCT02354339|20174288|P1|STARTED|Overall Study||12
8181469|NCT02354235|20174328|P2|NOT COMPLETED|Overall Study||7
8181470|NCT02354235|20174329|P1|NOT COMPLETED|Overall Study||3
8181471|NCT02354235|20174328|P2|COMPLETED|Overall Study||61
8181472|NCT02354235|20174329|P1|COMPLETED|Overall Study||67
8181473|NCT02354235|20174328|P2|STARTED|Overall Study||68
8181474|NCT02354235|20174329|P1|STARTED|Overall Study||70
8181475|NCT02354222|20174345|P2|NOT COMPLETED|Overall Study||11
8181476|NCT02354222|20174346|P1|NOT COMPLETED|Overall Study||4
8181477|NCT02354222|20174345|P2|COMPLETED|Overall Study||66
8181478|NCT02354222|20174346|P1|COMPLETED|Overall Study||73
8181479|NCT02354222|20174345|P2|STARTED|Overall Study||77
8181480|NCT02354222|20174346|P1|STARTED|Overall Study||77
8181481|NCT02354092|20174362|P2|NOT COMPLETED|Overall Study||0
8181482|NCT02354092|20174363|P1|NOT COMPLETED|Overall Study||0
8181483|NCT02354092|20174362|P2|COMPLETED|Overall Study||7
8181484|NCT02354092|20174363|P1|COMPLETED|Overall Study||7
8181485|NCT02354092|20174362|P2|STARTED|Overall Study||7
8181486|NCT02354092|20174363|P1|STARTED|Overall Study||7
8181487|NCT02353871|20174377|P2|NOT COMPLETED|Overall Study||9
8181488|NCT02353871|20174378|P1|NOT COMPLETED|Overall Study||3
8181489|NCT02353871|20174377|P2|COMPLETED|Overall Study||51
8181490|NCT02353871|20174378|P1|COMPLETED|Overall Study||122
8181491|NCT02353871|20174377|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
8181492|NCT02353871|20174378|P1|STARTED|Overall Study|Randomised.|125
8181493|NCT02353832|20174398|P1|NOT COMPLETED|Overall Study||0
8181494|NCT02353832|20174398|P1|COMPLETED|Overall Study||44
8181495|NCT02353832|20174398|P1|STARTED|Overall Study||44
8181496|NCT02353806|20174403|P1|NOT COMPLETED|Overall Study||10
8181497|NCT02353806|20174403|P1|COMPLETED|Overall Study||6
8181498|NCT02353806|20174403|P1|STARTED|Overall Study||16
8181499|NCT02353780|20174421|P3|NOT COMPLETED|Overall Study||0
8181500|NCT02353780|20174422|P2|NOT COMPLETED|Overall Study||0
8181501|NCT02353780|20174423|P1|NOT COMPLETED|Overall Study||0
8181502|NCT02353780|20174421|P3|COMPLETED|Overall Study||3
8181503|NCT02353780|20174422|P2|COMPLETED|Overall Study||3
8181504|NCT02353780|20174423|P1|COMPLETED|Overall Study||3
8181505|NCT02353780|20174421|P3|STARTED|Overall Study||3
8181506|NCT02353780|20174422|P2|STARTED|Overall Study||3
8181507|NCT02353780|20174423|P1|STARTED|Overall Study||3
8181508|NCT02353754|20174460|P2|NOT COMPLETED|Overall Study||0
8181509|NCT02353754|20174461|P1|NOT COMPLETED|Overall Study||2
8181510|NCT02353754|20174460|P2|COMPLETED|Overall Study||0
8181511|NCT02353754|20174461|P1|COMPLETED|Overall Study||10
8181512|NCT02353754|20174460|P2|STARTED|Overall Study||0
8181513|NCT02353754|20174461|P1|STARTED|Overall Study||12
8181514|NCT02353572|20174471|P1|NOT COMPLETED|Overall Study||3
8181515|NCT02353572|20174471|P1|COMPLETED|Overall Study||0
8181516|NCT02353572|20174471|P1|STARTED|Overall Study||3
8181517|NCT02353468|20174475|P1|NOT COMPLETED|Overall Study||3
8181518|NCT02353468|20174475|P1|COMPLETED|Overall Study||0
8181519|NCT02353468|20174475|P1|STARTED|Overall Study||3
8181520|NCT02353442|20174481|P2|NOT COMPLETED|Overall Study||4
8181521|NCT02353442|20174482|P1|NOT COMPLETED|Overall Study||3
8181522|NCT02353442|20174481|P2|COMPLETED|Overall Study||27
8181523|NCT02353442|20174482|P1|COMPLETED|Overall Study||25
8181524|NCT02353442|20174481|P2|STARTED|Overall Study||31
8181525|NCT02353442|20174482|P1|STARTED|Overall Study||28
8181526|NCT02353299|20174496|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181527|NCT02353299|20174497|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181528|NCT02353299|20174498|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181529|NCT02353299|20174499|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181530|NCT02353299|20174496|P4|COMPLETED|Fourth Intervention (1 Night)||13
8181531|NCT02353299|20174497|P3|COMPLETED|Fourth Intervention (1 Night)||13
8181532|NCT02353299|20174498|P2|COMPLETED|Fourth Intervention (1 Night)||12
8181533|NCT02353299|20174499|P1|COMPLETED|Fourth Intervention (1 Night)||13
8181534|NCT02353299|20174496|P4|STARTED|Fourth Intervention (1 Night)||13
8181535|NCT02353299|20174497|P3|STARTED|Fourth Intervention (1 Night)||13
8181536|NCT02353299|20174498|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
8181537|NCT02353299|20174499|P1|STARTED|Fourth Intervention (1 Night)||13
8181538|NCT02353299|20174496|P4|NOT COMPLETED|Third Intervention (1 Night)||0
8181539|NCT02353299|20174497|P3|NOT COMPLETED|Third Intervention (1 Night)||0
8181540|NCT02353299|20174498|P2|NOT COMPLETED|Third Intervention (1 Night)||0
8181541|NCT02353299|20174499|P1|NOT COMPLETED|Third Intervention (1 Night)||0
8181542|NCT02353299|20174496|P4|COMPLETED|Third Intervention (1 Night)||13
8181543|NCT02353299|20174497|P3|COMPLETED|Third Intervention (1 Night)||13
8181544|NCT02353299|20174498|P2|COMPLETED|Third Intervention (1 Night)||13
8181545|NCT02353299|20174499|P1|COMPLETED|Third Intervention (1 Night)||13
8181546|NCT02353299|20174496|P4|STARTED|Third Intervention (1 Night)||13
8181547|NCT02353299|20174497|P3|STARTED|Third Intervention (1 Night)||13
8181548|NCT02353299|20174498|P2|STARTED|Third Intervention (1 Night)||13
8181549|NCT02353299|20174499|P1|STARTED|Third Intervention (1 Night)||13
8181550|NCT02353299|20174496|P4|NOT COMPLETED|Second Intervention (1 Night)||0
8181551|NCT02353299|20174497|P3|NOT COMPLETED|Second Intervention (1 Night)||0
8181552|NCT02353299|20174498|P2|NOT COMPLETED|Second Intervention (1 Night)||0
8181553|NCT02353299|20174499|P1|NOT COMPLETED|Second Intervention (1 Night)||0
8181554|NCT02353299|20174496|P4|COMPLETED|Second Intervention (1 Night)||13
8181555|NCT02353299|20174497|P3|COMPLETED|Second Intervention (1 Night)||13
8181556|NCT02353299|20174498|P2|COMPLETED|Second Intervention (1 Night)||13
8181557|NCT02353299|20174499|P1|COMPLETED|Second Intervention (1 Night)||13
8181558|NCT02353299|20174496|P4|STARTED|Second Intervention (1 Night)||13
8181559|NCT02353299|20174497|P3|STARTED|Second Intervention (1 Night)||13
8181560|NCT02353299|20174498|P2|STARTED|Second Intervention (1 Night)||13
8181561|NCT02353299|20174499|P1|STARTED|Second Intervention (1 Night)||13
8181562|NCT02353299|20174496|P4|NOT COMPLETED|First Intervention (1 Night)||0
8181563|NCT02353299|20174497|P3|NOT COMPLETED|First Intervention (1 Night)||0
8181564|NCT02353299|20174498|P2|NOT COMPLETED|First Intervention (1 Night)||0
8181565|NCT02353299|20174499|P1|NOT COMPLETED|First Intervention (1 Night)||0
8181566|NCT02353299|20174496|P4|COMPLETED|First Intervention (1 Night)||13
8181567|NCT02353299|20174497|P3|COMPLETED|First Intervention (1 Night)||13
8181568|NCT02353299|20174498|P2|COMPLETED|First Intervention (1 Night)||13
8181569|NCT02353299|20174499|P1|COMPLETED|First Intervention (1 Night)||13
8181570|NCT02353299|20174496|P4|STARTED|First Intervention (1 Night)||13
8181571|NCT02353299|20174497|P3|STARTED|First Intervention (1 Night)||13
8181572|NCT02353299|20174498|P2|STARTED|First Intervention (1 Night)||13
8181573|NCT02353299|20174499|P1|STARTED|First Intervention (1 Night)||13
8181574|NCT02353169|20174537|P4|NOT COMPLETED|Overall Study||3
8181575|NCT02353169|20174538|P3|NOT COMPLETED|Overall Study||4
8181576|NCT02353169|20174539|P2|NOT COMPLETED|Overall Study||6
8181577|NCT02353169|20174540|P1|NOT COMPLETED|Overall Study||3
8181578|NCT02353169|20174537|P4|COMPLETED|Overall Study||12
8181579|NCT02353169|20174538|P3|COMPLETED|Overall Study||12
8181580|NCT02353169|20174539|P2|COMPLETED|Overall Study||12
8181581|NCT02353169|20174540|P1|COMPLETED|Overall Study||12
8181582|NCT02353169|20174537|P4|STARTED|Overall Study||15
8181583|NCT02353169|20174538|P3|STARTED|Overall Study||16
8181584|NCT02353169|20174539|P2|STARTED|Overall Study||18
8181585|NCT02353169|20174540|P1|STARTED|Overall Study||15
8181586|NCT02353091|20174560|P2|NOT COMPLETED|Overall Study||0
8181587|NCT02353091|20174561|P1|NOT COMPLETED|Overall Study||0
8181588|NCT02353091|20174560|P2|COMPLETED|Overall Study||13
8181589|NCT02353091|20174561|P1|COMPLETED|Overall Study||13
8181590|NCT02353091|20174560|P2|STARTED|Overall Study||13
8181591|NCT02353091|20174561|P1|STARTED|Overall Study||13
8181592|NCT02352974|20174599|P1|NOT COMPLETED|Extension||0
8181593|NCT02352974|20174599|P1|COMPLETED|Extension||3
8181594|NCT02352974|20174599|P1|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
8181595|NCT02352974|20174599|P1|NOT COMPLETED|Main Study||0
8181596|NCT02352974|20174599|P1|COMPLETED|Main Study||12
8181597|NCT02352974|20174599|P1|STARTED|Main Study||12
8181628|NCT02352922|20174695|P2|NOT COMPLETED|Overall Study||4
8181629|NCT02352922|20174696|P1|NOT COMPLETED|Overall Study||4
8181630|NCT02352922|20174695|P2|COMPLETED|Overall Study|Completed POD14 survey|28
8181631|NCT02352922|20174696|P1|COMPLETED|Overall Study|completed POD14 Survey|28
8181632|NCT02352922|20174695|P2|STARTED|Overall Study||32
8181633|NCT02352922|20174696|P1|STARTED|Overall Study||32
8181634|NCT02352844|20174730|P1|NOT COMPLETED|Overall Study||0
8181635|NCT02352844|20174730|P1|COMPLETED|Overall Study||12
8181636|NCT02352844|20174730|P1|STARTED|Overall Study||12
8181637|NCT02352831|20174738|P2|NOT COMPLETED|Overall Study||0
8181638|NCT02352831|20174739|P1|NOT COMPLETED|Overall Study||0
8181639|NCT02352831|20174738|P2|COMPLETED|Overall Study||10
8181640|NCT02352831|20174739|P1|COMPLETED|Overall Study||6
8181641|NCT02352831|20174738|P2|STARTED|Overall Study||10
8181642|NCT02352831|20174739|P1|STARTED|Overall Study||6
8181643|NCT02352779|20174762|P3|NOT COMPLETED|Overall Study||2
8181644|NCT02352779|20174763|P2|NOT COMPLETED|Overall Study||1
8181645|NCT02352779|20174764|P1|NOT COMPLETED|Overall Study||8
8181646|NCT02352779|20174762|P3|COMPLETED|Overall Study||33
8181647|NCT02352779|20174763|P2|COMPLETED|Overall Study||35
8181648|NCT02352779|20174764|P1|COMPLETED|Overall Study||29
8181649|NCT02352779|20174762|P3|STARTED|Overall Study||35
8181650|NCT02352779|20174763|P2|STARTED|Overall Study||36
8181651|NCT02352779|20174764|P1|STARTED|Overall Study||37
8181652|NCT02352493|20174790|P18|NOT COMPLETED|Overall Study||0
8181653|NCT02352493|20174791|P17|NOT COMPLETED|Overall Study||0
8181654|NCT02352493|20174792|P16|NOT COMPLETED|Overall Study||0
8181655|NCT02352493|20174793|P15|NOT COMPLETED|Overall Study||1
8181656|NCT02352493|20174794|P14|NOT COMPLETED|Overall Study||2
8181657|NCT02352493|20174795|P13|NOT COMPLETED|Overall Study||1
8181658|NCT02352493|20174796|P12|NOT COMPLETED|Overall Study||0
8181659|NCT02352493|20174797|P11|NOT COMPLETED|Overall Study||0
8181660|NCT02352493|20174798|P10|NOT COMPLETED|Overall Study||1
8181661|NCT02352493|20174799|P9|NOT COMPLETED|Overall Study||2
8181662|NCT02352493|20174800|P8|NOT COMPLETED|Overall Study||0
8181663|NCT02352493|20174801|P7|NOT COMPLETED|Overall Study||1
8181664|NCT02352493|20174802|P6|NOT COMPLETED|Overall Study||0
8181665|NCT02352493|20174803|P5|NOT COMPLETED|Overall Study||0
8181666|NCT02352493|20174804|P4|NOT COMPLETED|Overall Study||0
8181667|NCT02352493|20174805|P3|NOT COMPLETED|Overall Study||0
8181668|NCT02352493|20174806|P2|NOT COMPLETED|Overall Study||0
8181669|NCT02352493|20174807|P1|NOT COMPLETED|Overall Study||0
8181670|NCT02352493|20174790|P18|COMPLETED|Overall Study||3
8181671|NCT02352493|20174791|P17|COMPLETED|Overall Study||3
8181672|NCT02352493|20174792|P16|COMPLETED|Overall Study||3
8181673|NCT02352493|20174793|P15|COMPLETED|Overall Study||2
8181674|NCT02352493|20174794|P14|COMPLETED|Overall Study||1
8181675|NCT02352493|20174795|P13|COMPLETED|Overall Study||2
8181676|NCT02352493|20174796|P12|COMPLETED|Overall Study||3
8181677|NCT02352493|20174797|P11|COMPLETED|Overall Study||3
8181678|NCT02352493|20174798|P10|COMPLETED|Overall Study||5
8181679|NCT02352493|20174799|P9|COMPLETED|Overall Study||1
8181680|NCT02352493|20174800|P8|COMPLETED|Overall Study||3
8181681|NCT02352493|20174801|P7|COMPLETED|Overall Study||2
8181682|NCT02352493|20174802|P6|COMPLETED|Overall Study||3
8181683|NCT02352493|20174803|P5|COMPLETED|Overall Study||3
8181684|NCT02352493|20174804|P4|COMPLETED|Overall Study||3
8181685|NCT02352493|20174805|P3|COMPLETED|Overall Study||3
8181686|NCT02352493|20174806|P2|COMPLETED|Overall Study||3
8181687|NCT02352493|20174807|P1|COMPLETED|Overall Study||8
8181688|NCT02352493|20174790|P18|STARTED|Overall Study||3
8181689|NCT02352493|20174791|P17|STARTED|Overall Study||3
8181690|NCT02352493|20174792|P16|STARTED|Overall Study||3
8181691|NCT02352493|20174793|P15|STARTED|Overall Study||3
8181692|NCT02352493|20174794|P14|STARTED|Overall Study||3
8181693|NCT02352493|20174795|P13|STARTED|Overall Study||3
8181694|NCT02352493|20174796|P12|STARTED|Overall Study||3
8181695|NCT02352493|20174797|P11|STARTED|Overall Study||3
8181696|NCT02352493|20174798|P10|STARTED|Overall Study||6
8181697|NCT02352493|20174799|P9|STARTED|Overall Study||3
8181698|NCT02352493|20174800|P8|STARTED|Overall Study||3
8181699|NCT02352493|20174801|P7|STARTED|Overall Study||3
8181700|NCT02352493|20174802|P6|STARTED|Overall Study||3
8181701|NCT02352493|20174803|P5|STARTED|Overall Study||3
8181702|NCT02352493|20174804|P4|STARTED|Overall Study||3
8181703|NCT02352493|20174805|P3|STARTED|Overall Study||3
8181704|NCT02352493|20174806|P2|STARTED|Overall Study||3
8181705|NCT02352493|20174807|P1|STARTED|Overall Study||8
8181706|NCT02352363|20174997|P2|NOT COMPLETED|Overall Study||3
8181707|NCT02352363|20174998|P1|NOT COMPLETED|Overall Study||7
8181708|NCT02352363|20174997|P2|COMPLETED|Overall Study||127
8181709|NCT02352363|20174998|P1|COMPLETED|Overall Study||271
8181710|NCT02352363|20174997|P2|STARTED|Overall Study||130
8181711|NCT02352363|20174998|P1|STARTED|Overall Study||278
8181712|NCT02352298|20175010|P1|NOT COMPLETED|Overall Study||0
8181713|NCT02352298|20175010|P1|COMPLETED|Overall Study||52
8181714|NCT02352298|20175010|P1|STARTED|Overall Study||52
8181715|NCT02352103|20175017|P2|NOT COMPLETED|Overall Study||1
8181716|NCT02352103|20175018|P1|NOT COMPLETED|Overall Study||0
8181717|NCT02352103|20175017|P2|COMPLETED|Overall Study||59
8181718|NCT02352103|20175018|P1|COMPLETED|Overall Study||60
8181719|NCT02352103|20175017|P2|STARTED|Overall Study||60
8181720|NCT02352103|20175018|P1|STARTED|Overall Study||60
8181721|NCT02351960|20175040|P2|NOT COMPLETED|Overall Study||12
8181722|NCT02351960|20175041|P1|NOT COMPLETED|Overall Study||11
8181723|NCT02351960|20175040|P2|COMPLETED|Overall Study||76
8181724|NCT02351960|20175041|P1|COMPLETED|Overall Study||197
8181725|NCT02351960|20175040|P2|STARTED|Overall Study||88
8181726|NCT02351960|20175041|P1|STARTED|Overall Study||208
8181727|NCT02351934|20175062|P2|NOT COMPLETED|Follow-Up||10
8181728|NCT02351934|20175063|P1|NOT COMPLETED|Follow-Up||12
8181729|NCT02351934|20175062|P2|COMPLETED|Follow-Up||51
8181730|NCT02351934|20175063|P1|COMPLETED|Follow-Up||44
8181731|NCT02351934|20175062|P2|STARTED|Follow-Up||61
8181732|NCT02351934|20175063|P1|STARTED|Follow-Up||56
8181733|NCT02351934|20175062|P2|NOT COMPLETED|Allocation||0
8181734|NCT02351934|20175063|P1|NOT COMPLETED|Allocation||6
8181735|NCT02351934|20175062|P2|COMPLETED|Allocation||61
8181736|NCT02351934|20175063|P1|COMPLETED|Allocation||56
8181737|NCT02351934|20175062|P2|Received Allocation|Allocation||61
8181738|NCT02351934|20175063|P1|Received Allocation|Allocation||56
8181739|NCT02351934|20175062|P2|STARTED|Allocation||61
8181740|NCT02351934|20175063|P1|STARTED|Allocation||62
8181741|NCT02351817|20175079|P2|NOT COMPLETED|Period 2||2
8181742|NCT02351817|20175080|P1|NOT COMPLETED|Period 2||1
8181743|NCT02351817|20175079|P2|COMPLETED|Period 2||3
8181744|NCT02351817|20175080|P1|COMPLETED|Period 2||4
8181745|NCT02351817|20175079|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8181746|NCT02351817|20175080|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8181747|NCT02351817|20175079|P2|NOT COMPLETED|Period 1||3
8181748|NCT02351817|20175080|P1|NOT COMPLETED|Period 1||1
8181749|NCT02351817|20175079|P2|COMPLETED|Period 1||2
8181750|NCT02351817|20175080|P1|COMPLETED|Period 1||4
8181751|NCT02351817|20175079|P2|STARTED|Period 1||5
8181752|NCT02351817|20175080|P1|STARTED|Period 1||5
8181753|NCT02351817|20175079|P2|NOT COMPLETED|Baseline Period||0
8181754|NCT02351817|20175080|P1|NOT COMPLETED|Baseline Period||0
8181755|NCT02351817|20175079|P2|COMPLETED|Baseline Period||5
8181756|NCT02351817|20175080|P1|COMPLETED|Baseline Period||5
8181757|NCT02351817|20175079|P2|STARTED|Baseline Period||5
8181758|NCT02351817|20175080|P1|STARTED|Baseline Period||5
8181759|NCT02351739|20175089|P2|NOT COMPLETED|Overall Study||40
8181760|NCT02351739|20175090|P1|NOT COMPLETED|Overall Study||38
8181761|NCT02351739|20175089|P2|COMPLETED|Overall Study||0
8181762|NCT02351739|20175090|P1|COMPLETED|Overall Study||0
8181763|NCT02351739|20175089|P2|Discontinued Study|Overall Study||40
8181764|NCT02351739|20175090|P1|Discontinued Study|Overall Study||38
8181765|NCT02351739|20175089|P2|Received Study Medication|Overall Study||40
8181766|NCT02351739|20175090|P1|Received Study Medication|Overall Study||35
8181767|NCT02351739|20175089|P2|Enrolled|Overall Study||40
8181768|NCT02351739|20175090|P1|Enrolled|Overall Study||38
8181769|NCT02351739|20175089|P2|STARTED|Overall Study||40
8181770|NCT02351739|20175090|P1|STARTED|Overall Study||38
8181771|NCT02351505|20175096|P1|NOT COMPLETED|Overall Study||0
8181772|NCT02351505|20175096|P1|COMPLETED|Overall Study||1
8181773|NCT02351505|20175096|P1|STARTED|Overall Study||1
8181774|NCT02351271|20175109|P2|NOT COMPLETED|Overall Study||0
8181775|NCT02351271|20175110|P1|NOT COMPLETED|Overall Study||0
8181776|NCT02351271|20175109|P2|COMPLETED|Overall Study||62
8181777|NCT02351271|20175110|P1|COMPLETED|Overall Study||68
8181778|NCT02351271|20175109|P2|STARTED|Overall Study||62
8181779|NCT02351271|20175110|P1|STARTED|Overall Study||68
8181780|NCT02351258|20175122|P2|NOT COMPLETED|Intervention 2 (12 Months)||0
8181781|NCT02351258|20175123|P1|NOT COMPLETED|Intervention 2 (12 Months)||0
8181782|NCT02351258|20175122|P2|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181783|NCT02351258|20175123|P1|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181784|NCT02351258|20175122|P2|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181785|NCT02351258|20175123|P1|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181786|NCT02351258|20175122|P2|NOT COMPLETED|Washout (2-3 Months)||0
8181787|NCT02351258|20175123|P1|NOT COMPLETED|Washout (2-3 Months)||0
8181788|NCT02351258|20175122|P2|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181789|NCT02351258|20175123|P1|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181790|NCT02351258|20175122|P2|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181791|NCT02351258|20175123|P1|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181792|NCT02351258|20175122|P2|NOT COMPLETED|Intervention 1 (12 Months)||0
8181793|NCT02351258|20175123|P1|NOT COMPLETED|Intervention 1 (12 Months)||0
8181794|NCT02351258|20175122|P2|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181795|NCT02351258|20175123|P1|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181796|NCT02351258|20175122|P2|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181797|NCT02351258|20175123|P1|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181798|NCT02351167|20175141|P3|NOT COMPLETED|Overall Study||21
8181799|NCT02351167|20175142|P2|NOT COMPLETED|Overall Study||18
8181800|NCT02351167|20175143|P1|NOT COMPLETED|Overall Study||19
8181801|NCT02351167|20175141|P3|COMPLETED|Overall Study||252
8181802|NCT02351167|20175142|P2|COMPLETED|Overall Study||256
8181803|NCT02351167|20175143|P1|COMPLETED|Overall Study||256
8181804|NCT02351167|20175141|P3|STARTED|Overall Study||273
8181805|NCT02351167|20175142|P2|STARTED|Overall Study||274
8181806|NCT02351167|20175143|P1|STARTED|Overall Study||275
8181807|NCT02351063|20175185|P1|NOT COMPLETED|Overall Study||0
8181808|NCT02351063|20175185|P1|COMPLETED|Overall Study|Study terminated. No study data collected.|1
8181809|NCT02351063|20175185|P1|STARTED|Overall Study||1
8181810|NCT02351037|20175192|P3|NOT COMPLETED|Overall Study||0
8181811|NCT02351037|20175193|P2|NOT COMPLETED|Overall Study||0
8181812|NCT02351037|20175194|P1|NOT COMPLETED|Overall Study||0
8181813|NCT02351037|20175192|P3|COMPLETED|Overall Study||8
8181814|NCT02351037|20175193|P2|COMPLETED|Overall Study||21
8181815|NCT02351037|20175194|P1|COMPLETED|Overall Study||7
8181816|NCT02351037|20175192|P3|STARTED|Overall Study||8
8181817|NCT02351037|20175193|P2|STARTED|Overall Study||21
8181818|NCT02351037|20175194|P1|STARTED|Overall Study||7
8181819|NCT02350998|20175202|P1|NOT COMPLETED|Overall Study||0
8181820|NCT02350998|20175202|P1|COMPLETED|Overall Study||33
8181821|NCT02350998|20175202|P1|STARTED|Overall Study||33
8181822|NCT02350881|20175209|P1|NOT COMPLETED|Overall Study||0
8181823|NCT02350881|20175209|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
8181824|NCT02350881|20175209|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
8181825|NCT02350816|20175241|P4|NOT COMPLETED|Overall Study||0
8181826|NCT02350816|20175242|P3|NOT COMPLETED|Overall Study||0
8181827|NCT02350816|20175243|P2|NOT COMPLETED|Overall Study||0
8181828|NCT02350816|20175244|P1|NOT COMPLETED|Overall Study||0
8181829|NCT02350816|20175241|P4|COMPLETED|Overall Study||2
8181830|NCT02350816|20175242|P3|COMPLETED|Overall Study||2
8181831|NCT02350816|20175243|P2|COMPLETED|Overall Study||6
8181832|NCT02350816|20175244|P1|COMPLETED|Overall Study||7
8181833|NCT02350816|20175241|P4|STARTED|Overall Study||2
8181834|NCT02350816|20175242|P3|STARTED|Overall Study||2
8181835|NCT02350816|20175243|P2|STARTED|Overall Study||6
8181836|NCT02350816|20175244|P1|STARTED|Overall Study||7
8181837|NCT02350777|20175288|P2|NOT COMPLETED|Overall Study||0
8181838|NCT02350777|20175289|P1|NOT COMPLETED|Overall Study||0
8181839|NCT02350777|20175288|P2|COMPLETED|Overall Study||2
8181840|NCT02350777|20175289|P1|COMPLETED|Overall Study||2
8181841|NCT02350777|20175288|P2|STARTED|Overall Study||2
8181842|NCT02350777|20175289|P1|STARTED|Overall Study||2
8181843|NCT02350660|20175297|P2|NOT COMPLETED|Overall Study||0
8181844|NCT02350660|20175298|P1|NOT COMPLETED|Overall Study||0
8181845|NCT02350660|20175297|P2|COMPLETED|Overall Study||17
8181846|NCT02350660|20175298|P1|COMPLETED|Overall Study||7
8181847|NCT02350660|20175297|P2|STARTED|Overall Study||17
8181848|NCT02350660|20175298|P1|STARTED|Overall Study||7
8181849|NCT02350647|20175306|P2|NOT COMPLETED|Overall Study||6
8181850|NCT02350647|20175307|P1|NOT COMPLETED|Overall Study||6
8181851|NCT02350647|20175306|P2|COMPLETED|Overall Study||26
8181852|NCT02350647|20175307|P1|COMPLETED|Overall Study||26
8181853|NCT02350647|20175306|P2|STARTED|Overall Study||32
8181854|NCT02350647|20175307|P1|STARTED|Overall Study||32
8181855|NCT02350569|20175319|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
8181856|NCT02350569|20175319|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
8181857|NCT02350569|20175319|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
8181858|NCT02350569|20175319|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
8181859|NCT02350569|20175319|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
8181860|NCT02350569|20175319|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
8181861|NCT02350478|20175331|P2|NOT COMPLETED|Overall Study||1
8181862|NCT02350478|20175332|P1|NOT COMPLETED|Overall Study||5
8181863|NCT02350478|20175331|P2|COMPLETED|Overall Study||23
8181864|NCT02350478|20175332|P1|COMPLETED|Overall Study||20
8181865|NCT02350478|20175331|P2|STARTED|Overall Study||24
8181866|NCT02350478|20175332|P1|STARTED|Overall Study||25
8181867|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||1
8181868|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181869|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181870|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181871|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181872|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181873|NCT02350309|20175354|P6|COMPLETED|Treatment Period 4 (2 Days)||11
8181874|NCT02350309|20175355|P5|COMPLETED|Treatment Period 4 (2 Days)||12
8181875|NCT02350309|20175356|P4|COMPLETED|Treatment Period 4 (2 Days)||11
8181876|NCT02350309|20175357|P3|COMPLETED|Treatment Period 4 (2 Days)||10
8181877|NCT02350309|20175358|P2|COMPLETED|Treatment Period 4 (2 Days)||11
8181878|NCT02350309|20175359|P1|COMPLETED|Treatment Period 4 (2 Days)||12
8181879|NCT02350309|20175354|P6|STARTED|Treatment Period 4 (2 Days)||12
8181880|NCT02350309|20175355|P5|STARTED|Treatment Period 4 (2 Days)||12
8181881|NCT02350309|20175356|P4|STARTED|Treatment Period 4 (2 Days)||11
8181882|NCT02350309|20175357|P3|STARTED|Treatment Period 4 (2 Days)||10
8181883|NCT02350309|20175358|P2|STARTED|Treatment Period 4 (2 Days)||11
8181884|NCT02350309|20175359|P1|STARTED|Treatment Period 4 (2 Days)||12
8181885|NCT02350309|20175354|P6|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181886|NCT02350309|20175355|P5|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181887|NCT02350309|20175356|P4|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181888|NCT02350309|20175357|P3|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181889|NCT02350309|20175358|P2|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181890|NCT02350309|20175359|P1|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181891|NCT02350309|20175354|P6|COMPLETED|Washout Period 3 (12-16 Days)||12
8181892|NCT02350309|20175355|P5|COMPLETED|Washout Period 3 (12-16 Days)||12
8181893|NCT02350309|20175356|P4|COMPLETED|Washout Period 3 (12-16 Days)||11
8181894|NCT02350309|20175357|P3|COMPLETED|Washout Period 3 (12-16 Days)||10
8181895|NCT02350309|20175358|P2|COMPLETED|Washout Period 3 (12-16 Days)||11
8181896|NCT02350309|20175359|P1|COMPLETED|Washout Period 3 (12-16 Days)||12
8181897|NCT02350309|20175354|P6|STARTED|Washout Period 3 (12-16 Days)||12
8181898|NCT02350309|20175355|P5|STARTED|Washout Period 3 (12-16 Days)||12
8181899|NCT02350309|20175356|P4|STARTED|Washout Period 3 (12-16 Days)||11
8181900|NCT02350309|20175357|P3|STARTED|Washout Period 3 (12-16 Days)||10
8181901|NCT02350309|20175358|P2|STARTED|Washout Period 3 (12-16 Days)||11
8181902|NCT02350309|20175359|P1|STARTED|Washout Period 3 (12-16 Days)||12
8181903|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181904|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181905|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181906|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181907|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181908|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181909|NCT02350309|20175354|P6|COMPLETED|Treatment Period 3 (2 Days)||12
8181910|NCT02350309|20175355|P5|COMPLETED|Treatment Period 3 (2 Days)||12
8181911|NCT02350309|20175356|P4|COMPLETED|Treatment Period 3 (2 Days)||11
8181912|NCT02350309|20175357|P3|COMPLETED|Treatment Period 3 (2 Days)||10
8181913|NCT02350309|20175358|P2|COMPLETED|Treatment Period 3 (2 Days)||11
8181914|NCT02350309|20175359|P1|COMPLETED|Treatment Period 3 (2 Days)||12
8181915|NCT02350309|20175354|P6|STARTED|Treatment Period 3 (2 Days)||12
8181916|NCT02350309|20175355|P5|STARTED|Treatment Period 3 (2 Days)||12
8181917|NCT02350309|20175356|P4|STARTED|Treatment Period 3 (2 Days)||11
8181918|NCT02350309|20175357|P3|STARTED|Treatment Period 3 (2 Days)||10
8181919|NCT02350309|20175358|P2|STARTED|Treatment Period 3 (2 Days)||11
8181920|NCT02350309|20175359|P1|STARTED|Treatment Period 3 (2 Days)||12
8181921|NCT02350309|20175354|P6|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181922|NCT02350309|20175355|P5|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181923|NCT02350309|20175356|P4|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181924|NCT02350309|20175357|P3|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181925|NCT02350309|20175358|P2|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181926|NCT02350309|20175359|P1|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181927|NCT02350309|20175354|P6|COMPLETED|Washout Period 2 (12-16 Days)||12
8181928|NCT02350309|20175355|P5|COMPLETED|Washout Period 2 (12-16 Days)||12
8181929|NCT02350309|20175356|P4|COMPLETED|Washout Period 2 (12-16 Days)||11
8181930|NCT02350309|20175357|P3|COMPLETED|Washout Period 2 (12-16 Days)||10
8181931|NCT02350309|20175358|P2|COMPLETED|Washout Period 2 (12-16 Days)||11
8181932|NCT02350309|20175359|P1|COMPLETED|Washout Period 2 (12-16 Days)||12
8181933|NCT02350309|20175354|P6|STARTED|Washout Period 2 (12-16 Days)||12
8181934|NCT02350309|20175355|P5|STARTED|Washout Period 2 (12-16 Days)||12
8181935|NCT02350309|20175356|P4|STARTED|Washout Period 2 (12-16 Days)||11
8181936|NCT02350309|20175357|P3|STARTED|Washout Period 2 (12-16 Days)||10
8181937|NCT02350309|20175358|P2|STARTED|Washout Period 2 (12-16 Days)||11
8181938|NCT02350309|20175359|P1|STARTED|Washout Period 2 (12-16 Days)||12
8181939|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181940|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181941|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181942|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181943|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181944|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181945|NCT02350309|20175354|P6|COMPLETED|Treatment Period 2 (2 Days)||12
8181946|NCT02350309|20175355|P5|COMPLETED|Treatment Period 2 (2 Days)||12
8181947|NCT02350309|20175356|P4|COMPLETED|Treatment Period 2 (2 Days)||11
8181948|NCT02350309|20175357|P3|COMPLETED|Treatment Period 2 (2 Days)||10
8181949|NCT02350309|20175358|P2|COMPLETED|Treatment Period 2 (2 Days)||11
8181950|NCT02350309|20175359|P1|COMPLETED|Treatment Period 2 (2 Days)||12
8181951|NCT02350309|20175354|P6|STARTED|Treatment Period 2 (2 Days)||12
8181952|NCT02350309|20175355|P5|STARTED|Treatment Period 2 (2 Days)||12
8181953|NCT02350309|20175356|P4|STARTED|Treatment Period 2 (2 Days)||11
8181954|NCT02350309|20175357|P3|STARTED|Treatment Period 2 (2 Days)||10
8181955|NCT02350309|20175358|P2|STARTED|Treatment Period 2 (2 Days)||11
8181956|NCT02350309|20175359|P1|STARTED|Treatment Period 2 (2 Days)||12
8181957|NCT02350309|20175354|P6|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181958|NCT02350309|20175355|P5|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181959|NCT02350309|20175356|P4|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181960|NCT02350309|20175357|P3|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181961|NCT02350309|20175358|P2|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181962|NCT02350309|20175359|P1|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181963|NCT02350309|20175354|P6|COMPLETED|Washout Period 1 (12-16 Days)||12
8181964|NCT02350309|20175355|P5|COMPLETED|Washout Period 1 (12-16 Days)||12
8181965|NCT02350309|20175356|P4|COMPLETED|Washout Period 1 (12-16 Days)||11
8181966|NCT02350309|20175357|P3|COMPLETED|Washout Period 1 (12-16 Days)||10
8181967|NCT02350309|20175358|P2|COMPLETED|Washout Period 1 (12-16 Days)||11
8181968|NCT02350309|20175359|P1|COMPLETED|Washout Period 1 (12-16 Days)||12
8181969|NCT02350309|20175354|P6|STARTED|Washout Period 1 (12-16 Days)||12
8181970|NCT02350309|20175355|P5|STARTED|Washout Period 1 (12-16 Days)||12
8181971|NCT02350309|20175356|P4|STARTED|Washout Period 1 (12-16 Days)||11
8181972|NCT02350309|20175357|P3|STARTED|Washout Period 1 (12-16 Days)||10
8181973|NCT02350309|20175358|P2|STARTED|Washout Period 1 (12-16 Days)||11
8181974|NCT02350309|20175359|P1|STARTED|Washout Period 1 (12-16 Days)||12
8181975|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181976|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181977|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181978|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||1
8181979|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181980|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181981|NCT02350309|20175354|P6|COMPLETED|Treatment Period 1 (2 Days)||12
8181982|NCT02350309|20175355|P5|COMPLETED|Treatment Period 1 (2 Days)||12
8181983|NCT02350309|20175356|P4|COMPLETED|Treatment Period 1 (2 Days)||11
8181984|NCT02350309|20175357|P3|COMPLETED|Treatment Period 1 (2 Days)||10
8181985|NCT02350309|20175358|P2|COMPLETED|Treatment Period 1 (2 Days)||11
8181986|NCT02350309|20175359|P1|COMPLETED|Treatment Period 1 (2 Days)||12
8181987|NCT02350309|20175354|P6|STARTED|Treatment Period 1 (2 Days)||12
8181988|NCT02350309|20175355|P5|STARTED|Treatment Period 1 (2 Days)||12
8181989|NCT02350309|20175356|P4|STARTED|Treatment Period 1 (2 Days)||11
8181990|NCT02350309|20175357|P3|STARTED|Treatment Period 1 (2 Days)||11
8181991|NCT02350309|20175358|P2|STARTED|Treatment Period 1 (2 Days)||11
8181992|NCT02350309|20175359|P1|STARTED|Treatment Period 1 (2 Days)||12
8181993|NCT02350127|20175400|P2|NOT COMPLETED|8-Month Assessment||9
8181994|NCT02350127|20175401|P1|NOT COMPLETED|8-Month Assessment||6
8181995|NCT02350127|20175400|P2|COMPLETED|8-Month Assessment||26
8181996|NCT02350127|20175401|P1|COMPLETED|8-Month Assessment||27
8181997|NCT02350127|20175400|P2|STARTED|8-Month Assessment||35
8181998|NCT02350127|20175401|P1|STARTED|8-Month Assessment||33
8181999|NCT02350127|20175400|P2|NOT COMPLETED|4-Month Assessment||9
8182000|NCT02350127|20175401|P1|NOT COMPLETED|4-Month Assessment||11
8182001|NCT02350127|20175400|P2|COMPLETED|4-Month Assessment||35
8182002|NCT02350127|20175401|P1|COMPLETED|4-Month Assessment||33
8182003|NCT02350127|20175400|P2|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
8182004|NCT02350127|20175401|P1|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
8182005|NCT02350127|20175400|P2|STARTED|4-Month Assessment||44
8182006|NCT02350127|20175401|P1|STARTED|4-Month Assessment||44
8182007|NCT02349789|20175440|P1|NOT COMPLETED|Overall Study||2
8182008|NCT02349789|20175440|P1|COMPLETED|Overall Study||9
8182009|NCT02349789|20175440|P1|STARTED|Overall Study||11
8182010|NCT02349711|20175451|P2|NOT COMPLETED|Overall Study||2
8182011|NCT02349711|20175452|P1|NOT COMPLETED|Overall Study||3
8182012|NCT02349711|20175451|P2|COMPLETED|Overall Study||84
8182013|NCT02349711|20175452|P1|COMPLETED|Overall Study||84
8182014|NCT02349711|20175451|P2|STARTED|Overall Study||86
8182015|NCT02349711|20175452|P1|STARTED|Overall Study||87
8182016|NCT02349685|20175467|P3|NOT COMPLETED|Overall Study||4
8182017|NCT02349685|20175468|P2|NOT COMPLETED|Overall Study||2
8182018|NCT02349685|20175469|P1|NOT COMPLETED|Overall Study||5
8182019|NCT02349685|20175467|P3|COMPLETED|Overall Study||37
8182020|NCT02349685|20175468|P2|COMPLETED|Overall Study||87
8182021|NCT02349685|20175469|P1|COMPLETED|Overall Study||84
8182022|NCT02349685|20175467|P3|STARTED|Overall Study||41
8182023|NCT02349685|20175468|P2|STARTED|Overall Study||89
8182024|NCT02349685|20175469|P1|STARTED|Overall Study||89
8182025|NCT02349646|20175480|P1|NOT COMPLETED|Overall Study||17
8182026|NCT02349646|20175480|P1|COMPLETED|Overall Study||16
8182027|NCT02349646|20175480|P1|Receive Permanent System|Overall Study||27
8182028|NCT02349646|20175480|P1|Received Trial System|Overall Study||24
8182029|NCT02349646|20175480|P1|STARTED|Overall Study||33
8182030|NCT02349542|20175485|P1|NOT COMPLETED|Overall Study||5
8182031|NCT02349542|20175485|P1|COMPLETED|Overall Study||15
8182032|NCT02349542|20175485|P1|STARTED|Overall Study||20
8182033|NCT02349477|20175492|P2|NOT COMPLETED|Overall Study||18
8182034|NCT02349477|20175493|P1|NOT COMPLETED|Overall Study||13
8182035|NCT02349477|20175492|P2|COMPLETED|Overall Study||28
8182036|NCT02349477|20175493|P1|COMPLETED|Overall Study||31
8182037|NCT02349477|20175492|P2|STARTED|Overall Study||46
8182038|NCT02349477|20175493|P1|STARTED|Overall Study||44
8182039|NCT02349451|20175509|P4|NOT COMPLETED|Overall Study||1
8182040|NCT02349451|20175510|P3|NOT COMPLETED|Overall Study||2
8182041|NCT02349451|20175511|P2|NOT COMPLETED|Overall Study||1
8182042|NCT02349451|20175512|P1|NOT COMPLETED|Overall Study||0
8182043|NCT02349451|20175509|P4|COMPLETED|Overall Study||72
8182044|NCT02349451|20175510|P3|COMPLETED|Overall Study||69
8182045|NCT02349451|20175511|P2|COMPLETED|Overall Study||71
8182046|NCT02349451|20175512|P1|COMPLETED|Overall Study||24
8182047|NCT02349451|20175509|P4|STARTED|Overall Study||73
8182048|NCT02349451|20175510|P3|STARTED|Overall Study||71
8182049|NCT02349451|20175511|P2|STARTED|Overall Study||72
8182050|NCT02349451|20175512|P1|STARTED|Overall Study||24
8182051|NCT02349438|20175548|P2|NOT COMPLETED|Period 2||0
8182052|NCT02349438|20175549|P1|NOT COMPLETED|Period 2||0
8182053|NCT02349438|20175548|P2|COMPLETED|Period 2||10
8182054|NCT02349438|20175549|P1|COMPLETED|Period 2||11
8182055|NCT02349438|20175548|P2|STARTED|Period 2||10
8182056|NCT02349438|20175549|P1|STARTED|Period 2||11
8182057|NCT02349438|20175548|P2|NOT COMPLETED|Period 1||0
8182058|NCT02349438|20175549|P1|NOT COMPLETED|Period 1||0
8182059|NCT02349438|20175548|P2|COMPLETED|Period 1||10
8182060|NCT02349438|20175549|P1|COMPLETED|Period 1||11
8182061|NCT02349438|20175548|P2|STARTED|Period 1||10
8182062|NCT02349438|20175549|P1|STARTED|Period 1||11
8182063|NCT02349425|20175563|P4|NOT COMPLETED|Period 2||0
8182064|NCT02349425|20175564|P3|NOT COMPLETED|Period 2||1
8182065|NCT02349425|20175565|P2|NOT COMPLETED|Period 2||1
8182066|NCT02349425|20175566|P1|NOT COMPLETED|Period 2||0
8182067|NCT02349425|20175563|P4|COMPLETED|Period 2||15
8182068|NCT02349425|20175564|P3|COMPLETED|Period 2||14
8182069|NCT02349425|20175565|P2|COMPLETED|Period 2||12
8182070|NCT02349425|20175566|P1|COMPLETED|Period 2||14
8182071|NCT02349425|20175563|P4|STARTED|Period 2||15
8182072|NCT02349425|20175564|P3|STARTED|Period 2||15
8182073|NCT02349425|20175565|P2|STARTED|Period 2||13
8182074|NCT02349425|20175566|P1|STARTED|Period 2||14
8182075|NCT02349425|20175563|P4|NOT COMPLETED|Period 1||0
8182076|NCT02349425|20175564|P3|NOT COMPLETED|Period 1||0
8182077|NCT02349425|20175565|P2|NOT COMPLETED|Period 1||1
8182078|NCT02349425|20175566|P1|NOT COMPLETED|Period 1||1
8182079|NCT02349425|20175563|P4|COMPLETED|Period 1||15
8182080|NCT02349425|20175564|P3|COMPLETED|Period 1||15
8182081|NCT02349425|20175565|P2|COMPLETED|Period 1||13
8182082|NCT02349425|20175566|P1|COMPLETED|Period 1||14
8182083|NCT02349425|20175563|P4|STARTED|Period 1||15
8182084|NCT02349425|20175564|P3|STARTED|Period 1||15
8182085|NCT02349425|20175565|P2|STARTED|Period 1||14
8182086|NCT02349425|20175566|P1|STARTED|Period 1||15
8182087|NCT02349412|20175740|P2|NOT COMPLETED|Overall Study||7
8182088|NCT02349412|20175741|P1|NOT COMPLETED|Overall Study||7
8182089|NCT02349412|20175740|P2|COMPLETED|Overall Study||196
8182090|NCT02349412|20175741|P1|COMPLETED|Overall Study||195
8182091|NCT02349412|20175740|P2|Completed Week-24 QOL Assessment Measure|Overall Study||80
8182092|NCT02349412|20175741|P1|Completed Week-24 QOL Assessment Measure|Overall Study||68
8182093|NCT02349412|20175740|P2|Completed Week-12 QOL Assessment Measure|Overall Study||101
8182094|NCT02349412|20175741|P1|Completed Week-12 QOL Assessment Measure|Overall Study||92
8182095|NCT02349412|20175740|P2|STARTED|Overall Study||203
8182096|NCT02349412|20175741|P1|STARTED|Overall Study||202
8182097|NCT02349360|20175757|P2|NOT COMPLETED|Overall Study||1
8182098|NCT02349360|20175758|P1|NOT COMPLETED|Overall Study||0
8182099|NCT02349360|20175757|P2|COMPLETED|Overall Study||20
8182100|NCT02349360|20175758|P1|COMPLETED|Overall Study||21
8182101|NCT02349360|20175757|P2|STARTED|Overall Study||21
8182102|NCT02349360|20175758|P1|STARTED|Overall Study||21
8182103|NCT02349295|20175769|P14|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
8182104|NCT02349295|20175770|P13|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
8182105|NCT02349295|20175771|P12|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
8182106|NCT02349295|20175772|P11|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182107|NCT02349295|20175773|P10|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182108|NCT02349295|20175774|P9|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182109|NCT02349295|20175775|P8|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182110|NCT02349295|20175776|P7|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182111|NCT02349295|20175777|P6|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182112|NCT02349295|20175778|P5|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182113|NCT02349295|20175779|P4|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182114|NCT02349295|20175780|P3|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182115|NCT02349295|20175781|P2|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182116|NCT02349295|20175782|P1|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182117|NCT02349295|20175769|P14|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
8182118|NCT02349295|20175770|P13|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
8182119|NCT02349295|20175771|P12|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
8182120|NCT02349295|20175772|P11|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182121|NCT02349295|20175773|P10|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182122|NCT02349295|20175774|P9|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182123|NCT02349295|20175775|P8|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182124|NCT02349295|20175776|P7|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182125|NCT02349295|20175777|P6|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182126|NCT02349295|20175778|P5|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182127|NCT02349295|20175779|P4|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182128|NCT02349295|20175780|P3|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182129|NCT02349295|20175781|P2|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182130|NCT02349295|20175782|P1|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182131|NCT02349295|20175769|P14|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
8182132|NCT02349295|20175770|P13|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
8182133|NCT02349295|20175771|P12|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
8182134|NCT02349295|20175772|P11|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182135|NCT02349295|20175773|P10|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182136|NCT02349295|20175774|P9|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182137|NCT02349295|20175775|P8|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182138|NCT02349295|20175776|P7|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182139|NCT02349295|20175777|P6|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182140|NCT02349295|20175778|P5|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182141|NCT02349295|20175779|P4|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182142|NCT02349295|20175780|P3|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182143|NCT02349295|20175781|P2|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182144|NCT02349295|20175782|P1|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182145|NCT02349295|20175769|P14|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182146|NCT02349295|20175770|P13|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182147|NCT02349295|20175771|P12|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182148|NCT02349295|20175772|P11|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
8182149|NCT02349295|20175773|P10|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
8182150|NCT02349295|20175774|P9|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
8182151|NCT02349295|20175775|P8|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
8182152|NCT02349295|20175776|P7|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182153|NCT02349295|20175777|P6|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182154|NCT02349295|20175778|P5|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182155|NCT02349295|20175779|P4|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182156|NCT02349295|20175780|P3|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182157|NCT02349295|20175781|P2|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182158|NCT02349295|20175782|P1|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182159|NCT02349295|20175769|P14|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182160|NCT02349295|20175770|P13|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182161|NCT02349295|20175771|P12|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182162|NCT02349295|20175772|P11|COMPLETED|Long-Term Extension Period (Week 24-156)||23
8182163|NCT02349295|20175773|P10|COMPLETED|Long-Term Extension Period (Week 24-156)||20
8182164|NCT02349295|20175774|P9|COMPLETED|Long-Term Extension Period (Week 24-156)||70
8182165|NCT02349295|20175775|P8|COMPLETED|Long-Term Extension Period (Week 24-156)||55
8182166|NCT02349295|20175776|P7|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182167|NCT02349295|20175777|P6|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182168|NCT02349295|20175778|P5|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182169|NCT02349295|20175779|P4|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182170|NCT02349295|20175780|P3|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182171|NCT02349295|20175781|P2|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182172|NCT02349295|20175782|P1|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182173|NCT02349295|20175769|P14|STARTED|Long-Term Extension Period (Week 24-156)||0
8182174|NCT02349295|20175770|P13|STARTED|Long-Term Extension Period (Week 24-156)||0
8182175|NCT02349295|20175771|P12|STARTED|Long-Term Extension Period (Week 24-156)||0
8182176|NCT02349295|20175772|P11|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
8182177|NCT02349295|20175773|P10|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
8182178|NCT02349295|20175774|P9|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
8182179|NCT02349295|20175775|P8|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
8182180|NCT02349295|20175776|P7|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182181|NCT02349295|20175777|P6|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182182|NCT02349295|20175778|P5|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182183|NCT02349295|20175779|P4|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182184|NCT02349295|20175780|P3|STARTED|Long-Term Extension Period (Week 24-156)||0
8182185|NCT02349295|20175781|P2|STARTED|Long-Term Extension Period (Week 24-156)||0
8182186|NCT02349295|20175782|P1|STARTED|Long-Term Extension Period (Week 24-156)||0
8182187|NCT02349295|20175769|P14|NOT COMPLETED|IR (Week 16-24)||0
8182188|NCT02349295|20175770|P13|NOT COMPLETED|IR (Week 16-24)||0
8182189|NCT02349295|20175771|P12|NOT COMPLETED|IR (Week 16-24)||0
8182190|NCT02349295|20175772|P11|NOT COMPLETED|IR (Week 16-24)||0
8182191|NCT02349295|20175773|P10|NOT COMPLETED|IR (Week 16-24)||0
8182192|NCT02349295|20175774|P9|NOT COMPLETED|IR (Week 16-24)||0
8182193|NCT02349295|20175775|P8|NOT COMPLETED|IR (Week 16-24)||0
8182194|NCT02349295|20175776|P7|NOT COMPLETED|IR (Week 16-24)||0
8182195|NCT02349295|20175777|P6|NOT COMPLETED|IR (Week 16-24)||0
8182196|NCT02349295|20175778|P5|NOT COMPLETED|IR (Week 16-24)||0
8182197|NCT02349295|20175779|P4|NOT COMPLETED|IR (Week 16-24)||1
8182198|NCT02349295|20175780|P3|NOT COMPLETED|IR (Week 16-24)||0
8182199|NCT02349295|20175781|P2|NOT COMPLETED|IR (Week 16-24)||0
8182200|NCT02349295|20175782|P1|NOT COMPLETED|IR (Week 16-24)||0
8182201|NCT02349295|20175769|P14|COMPLETED|IR (Week 16-24)||0
8182202|NCT02349295|20175770|P13|COMPLETED|IR (Week 16-24)||0
8182203|NCT02349295|20175771|P12|COMPLETED|IR (Week 16-24)||0
8182204|NCT02349295|20175772|P11|COMPLETED|IR (Week 16-24)||0
8182205|NCT02349295|20175773|P10|COMPLETED|IR (Week 16-24)||0
8182206|NCT02349295|20175774|P9|COMPLETED|IR (Week 16-24)||0
8182207|NCT02349295|20175775|P8|COMPLETED|IR (Week 16-24)||0
8182208|NCT02349295|20175776|P7|COMPLETED|IR (Week 16-24)||16
8182209|NCT02349295|20175777|P6|COMPLETED|IR (Week 16-24)||16
8182210|NCT02349295|20175778|P5|COMPLETED|IR (Week 16-24)||15
8182211|NCT02349295|20175779|P4|COMPLETED|IR (Week 16-24)||16
8182212|NCT02349295|20175780|P3|COMPLETED|IR (Week 16-24)||0
8182213|NCT02349295|20175781|P2|COMPLETED|IR (Week 16-24)||0
8182214|NCT02349295|20175782|P1|COMPLETED|IR (Week 16-24)||0
8182215|NCT02349295|20175769|P14|STARTED|IR (Week 16-24)||0
8182216|NCT02349295|20175770|P13|STARTED|IR (Week 16-24)||0
8182217|NCT02349295|20175771|P12|STARTED|IR (Week 16-24)||0
8182218|NCT02349295|20175772|P11|STARTED|IR (Week 16-24)||0
8182219|NCT02349295|20175773|P10|STARTED|IR (Week 16-24)||0
8182220|NCT02349295|20175774|P9|STARTED|IR (Week 16-24)||0
8182221|NCT02349295|20175775|P8|STARTED|IR (Week 16-24)||0
8182222|NCT02349295|20175776|P7|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
8182223|NCT02349295|20175777|P6|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
8182224|NCT02349295|20175778|P5|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
8182225|NCT02349295|20175779|P4|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
8182226|NCT02349295|20175780|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8182227|NCT02349295|20175781|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8182228|NCT02349295|20175782|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8182229|NCT02349295|20175769|P14|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182230|NCT02349295|20175770|P13|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182231|NCT02349295|20175771|P12|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182232|NCT02349295|20175772|P11|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182233|NCT02349295|20175773|P10|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182234|NCT02349295|20175774|P9|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182235|NCT02349295|20175775|P8|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182236|NCT02349295|20175776|P7|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182237|NCT02349295|20175777|P6|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182238|NCT02349295|20175778|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182239|NCT02349295|20175779|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182240|NCT02349295|20175780|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
8182241|NCT02349295|20175781|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
8182242|NCT02349295|20175782|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
8182243|NCT02349295|20175769|P14|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182244|NCT02349295|20175770|P13|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182245|NCT02349295|20175771|P12|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182246|NCT02349295|20175772|P11|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182247|NCT02349295|20175773|P10|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182248|NCT02349295|20175774|P9|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182249|NCT02349295|20175775|P8|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182250|NCT02349295|20175776|P7|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182251|NCT02349295|20175777|P6|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182252|NCT02349295|20175778|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182253|NCT02349295|20175779|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182254|NCT02349295|20175780|P3|COMPLETED|Double Blind Treatment (Week 0-24)||94
8182255|NCT02349295|20175781|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
8182256|NCT02349295|20175782|P1|COMPLETED|Double Blind Treatment (Week 0-24)||109
8182257|NCT02349295|20175769|P14|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182258|NCT02349295|20175770|P13|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182259|NCT02349295|20175771|P12|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182260|NCT02349295|20175772|P11|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182261|NCT02349295|20175773|P10|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182262|NCT02349295|20175774|P9|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182263|NCT02349295|20175775|P8|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182264|NCT02349295|20175776|P7|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182265|NCT02349295|20175777|P6|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182266|NCT02349295|20175778|P5|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182267|NCT02349295|20175779|P4|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182268|NCT02349295|20175780|P3|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
8182269|NCT02349295|20175781|P2|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
8182270|NCT02349295|20175782|P1|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
8182271|NCT02349295|20175769|P14|STARTED|Double Blind Treatment (Week 0-24)||0
8182272|NCT02349295|20175770|P13|STARTED|Double Blind Treatment (Week 0-24)||0
8182273|NCT02349295|20175771|P12|STARTED|Double Blind Treatment (Week 0-24)||0
8182274|NCT02349295|20175772|P11|STARTED|Double Blind Treatment (Week 0-24)||0
8182275|NCT02349295|20175773|P10|STARTED|Double Blind Treatment (Week 0-24)||0
8182276|NCT02349295|20175774|P9|STARTED|Double Blind Treatment (Week 0-24)||0
8182277|NCT02349295|20175775|P8|STARTED|Double Blind Treatment (Week 0-24)||0
8182278|NCT02349295|20175776|P7|STARTED|Double Blind Treatment (Week 0-24)||0
8182279|NCT02349295|20175777|P6|STARTED|Double Blind Treatment (Week 0-24)||0
8182280|NCT02349295|20175778|P5|STARTED|Double Blind Treatment (Week 0-24)||0
8182281|NCT02349295|20175779|P4|STARTED|Double Blind Treatment (Week 0-24)||0
8182282|NCT02349295|20175780|P3|STARTED|Double Blind Treatment (Week 0-24)||118
8182283|NCT02349295|20175781|P2|STARTED|Double Blind Treatment (Week 0-24)||122
8182284|NCT02349295|20175782|P1|STARTED|Double Blind Treatment (Week 0-24)||123
8182285|NCT02349178|20175877|P1|NOT COMPLETED|Overall Study||0
8182286|NCT02349178|20175877|P1|COMPLETED|Overall Study||6
8182287|NCT02349178|20175877|P1|STARTED|Overall Study||6
8182288|NCT02349152|20175883|P2|NOT COMPLETED|Overall Study||4
8182289|NCT02349152|20175884|P1|NOT COMPLETED|Overall Study||6
8182290|NCT02349152|20175883|P2|COMPLETED|Overall Study||52
8182291|NCT02349152|20175884|P1|COMPLETED|Overall Study||54
8182292|NCT02349152|20175883|P2|STARTED|Overall Study||56
8182293|NCT02349152|20175884|P1|STARTED|Overall Study||60
8182294|NCT02349061|20175922|P3|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
8182295|NCT02349061|20175923|P2|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
8182296|NCT02349061|20175924|P1|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
8182297|NCT02349061|20175922|P3|COMPLETED|Study Extension (Week 56 to Week 120)||14
8182298|NCT02349061|20175923|P2|COMPLETED|Study Extension (Week 56 to Week 120)||24
8182299|NCT02349061|20175924|P1|COMPLETED|Study Extension (Week 56 to Week 120)||0
8182389|NCT02348658|20176040|P2|COMPLETED|Period 1 (7 Days)||6
8182300|NCT02349061|20175922|P3|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
8182301|NCT02349061|20175923|P2|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
8182302|NCT02349061|20175924|P1|STARTED|Study Extension (Week 56 to Week 120)||0
8182303|NCT02349061|20175922|P3|NOT COMPLETED|Main Study: Week 24 to 56||3
8182304|NCT02349061|20175923|P2|NOT COMPLETED|Main Study: Week 24 to 56||3
8182305|NCT02349061|20175924|P1|NOT COMPLETED|Main Study: Week 24 to 56||0
8182306|NCT02349061|20175922|P3|COMPLETED|Main Study: Week 24 to 56||30
8182307|NCT02349061|20175923|P2|COMPLETED|Main Study: Week 24 to 56||53
8182308|NCT02349061|20175924|P1|COMPLETED|Main Study: Week 24 to 56||0
8182309|NCT02349061|20175922|P3|STARTED|Main Study: Week 24 to 56||33
8182310|NCT02349061|20175923|P2|STARTED|Main Study: Week 24 to 56||56
8182311|NCT02349061|20175924|P1|STARTED|Main Study: Week 24 to 56||0
8182312|NCT02349061|20175922|P3|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
8182313|NCT02349061|20175923|P2|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
8182314|NCT02349061|20175924|P1|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
8182315|NCT02349061|20175922|P3|COMPLETED|Main Study: PCP (Up to Week 24)||0
8182316|NCT02349061|20175923|P2|COMPLETED|Main Study: PCP (Up to Week 24)||56
8182317|NCT02349061|20175924|P1|COMPLETED|Main Study: PCP (Up to Week 24)||33
8182318|NCT02349061|20175922|P3|STARTED|Main Study: PCP (Up to Week 24)||0
8182319|NCT02349061|20175923|P2|STARTED|Main Study: PCP (Up to Week 24)||60
8182320|NCT02349061|20175924|P1|STARTED|Main Study: PCP (Up to Week 24)||42
8182321|NCT02349048|20175944|P2|NOT COMPLETED|Overall Study||0
8182322|NCT02349048|20175945|P1|NOT COMPLETED|Overall Study||5
8182323|NCT02349048|20175944|P2|COMPLETED|Overall Study||9
8182324|NCT02349048|20175945|P1|COMPLETED|Overall Study||54
8182325|NCT02349048|20175944|P2|STARTED|Overall Study||9
8182326|NCT02349048|20175945|P1|STARTED|Overall Study||59
8182327|NCT02348918|20175974|P9|NOT COMPLETED|Overall Study||0
8182328|NCT02348918|20175975|P8|NOT COMPLETED|Overall Study||0
8182329|NCT02348918|20175976|P7|NOT COMPLETED|Overall Study||0
8182330|NCT02348918|20175977|P6|NOT COMPLETED|Overall Study||0
8182331|NCT02348918|20175978|P5|NOT COMPLETED|Overall Study||0
8182332|NCT02348918|20175979|P4|NOT COMPLETED|Overall Study||0
8182333|NCT02348918|20175980|P3|NOT COMPLETED|Overall Study||0
8182334|NCT02348918|20175981|P2|NOT COMPLETED|Overall Study||0
8182335|NCT02348918|20175982|P1|NOT COMPLETED|Overall Study||0
8182336|NCT02348918|20175974|P9|COMPLETED|Overall Study||15
8182337|NCT02348918|20175975|P8|COMPLETED|Overall Study||16
8182338|NCT02348918|20175976|P7|COMPLETED|Overall Study||13
8182339|NCT02348918|20175977|P6|COMPLETED|Overall Study||17
8182340|NCT02348918|20175978|P5|COMPLETED|Overall Study||19
8182341|NCT02348918|20175979|P4|COMPLETED|Overall Study||24
8182342|NCT02348918|20175980|P3|COMPLETED|Overall Study||42
8182343|NCT02348918|20175981|P2|COMPLETED|Overall Study||33
8182344|NCT02348918|20175982|P1|COMPLETED|Overall Study||39
8182345|NCT02348918|20175974|P9|STARTED|Overall Study||15
8182346|NCT02348918|20175975|P8|STARTED|Overall Study||16
8182347|NCT02348918|20175976|P7|STARTED|Overall Study||13
8182348|NCT02348918|20175977|P6|STARTED|Overall Study||17
8182349|NCT02348918|20175978|P5|STARTED|Overall Study||19
8182350|NCT02348918|20175979|P4|STARTED|Overall Study||24
8182351|NCT02348918|20175980|P3|STARTED|Overall Study||42
8182352|NCT02348918|20175981|P2|STARTED|Overall Study||33
8182353|NCT02348918|20175982|P1|STARTED|Overall Study||39
8182354|NCT02348840|20176006|P4|NOT COMPLETED|Overall Study||0
8182355|NCT02348840|20176007|P3|NOT COMPLETED|Overall Study||0
8182356|NCT02348840|20176008|P2|NOT COMPLETED|Overall Study||1
8182357|NCT02348840|20176009|P1|NOT COMPLETED|Overall Study||2
8182358|NCT02348840|20176006|P4|COMPLETED|Overall Study||374
8182359|NCT02348840|20176007|P3|COMPLETED|Overall Study||425
8182360|NCT02348840|20176008|P2|COMPLETED|Overall Study||20
8182361|NCT02348840|20176009|P1|COMPLETED|Overall Study||21
8182362|NCT02348840|20176006|P4|STARTED|Overall Study||374
8182363|NCT02348840|20176007|P3|STARTED|Overall Study||425
8182364|NCT02348840|20176008|P2|STARTED|Overall Study||21
8182365|NCT02348840|20176009|P1|STARTED|Overall Study||23
8182366|NCT02348723|20176023|P2|NOT COMPLETED|Overall Study||26
8182367|NCT02348723|20176024|P1|NOT COMPLETED|Overall Study||28
8182368|NCT02348723|20176023|P2|COMPLETED|Overall Study||312
8182369|NCT02348723|20176024|P1|COMPLETED|Overall Study||310
8182370|NCT02348723|20176023|P2|STARTED|Overall Study||338
8182371|NCT02348723|20176024|P1|STARTED|Overall Study||338
8182372|NCT02348684|20176036|P1|NOT COMPLETED|Overall Study||0
8182373|NCT02348684|20176036|P1|COMPLETED|Overall Study||20
8182374|NCT02348684|20176036|P1|STARTED|Overall Study||20
8182375|NCT02348658|20176040|P2|NOT COMPLETED|Period 2 (7 Days)||0
8182376|NCT02348658|20176041|P1|NOT COMPLETED|Period 2 (7 Days)||0
8182377|NCT02348658|20176040|P2|COMPLETED|Period 2 (7 Days)||6
8182378|NCT02348658|20176041|P1|COMPLETED|Period 2 (7 Days)||6
8182379|NCT02348658|20176040|P2|STARTED|Period 2 (7 Days)||6
8182380|NCT02348658|20176041|P1|STARTED|Period 2 (7 Days)||6
8182381|NCT02348658|20176040|P2|NOT COMPLETED|Washout Period (22 Days)||0
8182382|NCT02348658|20176041|P1|NOT COMPLETED|Washout Period (22 Days)||0
8182383|NCT02348658|20176040|P2|COMPLETED|Washout Period (22 Days)||6
8182384|NCT02348658|20176041|P1|COMPLETED|Washout Period (22 Days)||6
8182385|NCT02348658|20176040|P2|STARTED|Washout Period (22 Days)||6
8182386|NCT02348658|20176041|P1|STARTED|Washout Period (22 Days)||6
8182387|NCT02348658|20176040|P2|NOT COMPLETED|Period 1 (7 Days)||0
8182388|NCT02348658|20176041|P1|NOT COMPLETED|Period 1 (7 Days)||0
8182390|NCT02348658|20176041|P1|COMPLETED|Period 1 (7 Days)||6
8182391|NCT02348658|20176040|P2|STARTED|Period 1 (7 Days)||6
8182392|NCT02348658|20176041|P1|STARTED|Period 1 (7 Days)||6
8182393|NCT02348632|20176075|P2|NOT COMPLETED|Randomized Withdrawal Period||1
8182394|NCT02348632|20176076|P1|NOT COMPLETED|Randomized Withdrawal Period||3
8182395|NCT02348632|20176075|P2|COMPLETED|Randomized Withdrawal Period||141
8182396|NCT02348632|20176076|P1|COMPLETED|Randomized Withdrawal Period||137
8182397|NCT02348632|20176075|P2|STARTED|Randomized Withdrawal Period||142
8182398|NCT02348632|20176076|P1|STARTED|Randomized Withdrawal Period||140
8182399|NCT02348632|20176075|P2|NOT COMPLETED|Open-label Period||0
8182400|NCT02348632|20176076|P1|NOT COMPLETED|Open-label Period||185
8182401|NCT02348632|20176075|P2|COMPLETED|Open-label Period||0
8182402|NCT02348632|20176076|P1|COMPLETED|Open-label Period||458
8182403|NCT02348632|20176075|P2|STARTED|Open-label Period||0
8182404|NCT02348632|20176076|P1|STARTED|Open-label Period||643
8182405|NCT02348619|20176086|P2|NOT COMPLETED|Double-Blind Withdrawal Phase||0
8182406|NCT02348619|20176087|P1|NOT COMPLETED|Double-Blind Withdrawal Phase||2
8182407|NCT02348619|20176086|P2|COMPLETED|Double-Blind Withdrawal Phase||62
8182408|NCT02348619|20176087|P1|COMPLETED|Double-Blind Withdrawal Phase||60
8182409|NCT02348619|20176086|P2|STARTED|Double-Blind Withdrawal Phase||62
8182410|NCT02348619|20176087|P1|STARTED|Double-Blind Withdrawal Phase||62
8182411|NCT02348619|20176086|P2|NOT COMPLETED|Stable-Dose Phase||0
8182412|NCT02348619|20176087|P1|NOT COMPLETED|Stable-Dose Phase||33
8182413|NCT02348619|20176086|P2|COMPLETED|Stable-Dose Phase||0
8182414|NCT02348619|20176087|P1|COMPLETED|Stable-Dose Phase||124
8182415|NCT02348619|20176086|P2|STARTED|Stable-Dose Phase||0
8182416|NCT02348619|20176087|P1|STARTED|Stable-Dose Phase||157
8182417|NCT02348619|20176086|P2|NOT COMPLETED|Titration Phase||0
8182418|NCT02348619|20176087|P1|NOT COMPLETED|Titration Phase||17
8182419|NCT02348619|20176086|P2|COMPLETED|Titration Phase||0
8182420|NCT02348619|20176087|P1|COMPLETED|Titration Phase||157
8182421|NCT02348619|20176086|P2|STARTED|Titration Phase||0
8182422|NCT02348619|20176087|P1|STARTED|Titration Phase||174
8182423|NCT02348606|20176106|P5|NOT COMPLETED|Overall Study||18
8182424|NCT02348606|20176107|P4|NOT COMPLETED|Overall Study||24
8182425|NCT02348606|20176108|P3|NOT COMPLETED|Overall Study||11
8182426|NCT02348606|20176109|P2|NOT COMPLETED|Overall Study||8
8182427|NCT02348606|20176110|P1|NOT COMPLETED|Overall Study||9
8182428|NCT02348606|20176106|P5|COMPLETED|Overall Study||101
8182429|NCT02348606|20176107|P4|COMPLETED|Overall Study||94
8182430|NCT02348606|20176108|P3|COMPLETED|Overall Study||106
8182431|NCT02348606|20176109|P2|COMPLETED|Overall Study||54
8182432|NCT02348606|20176110|P1|COMPLETED|Overall Study||49
8182433|NCT02348606|20176106|P5|STARTED|Overall Study||119
8182434|NCT02348606|20176107|P4|STARTED|Overall Study||118
8182435|NCT02348606|20176108|P3|STARTED|Overall Study||117
8182436|NCT02348606|20176109|P2|STARTED|Overall Study||62
8182437|NCT02348606|20176110|P1|STARTED|Overall Study||58
8182438|NCT02348593|20176166|P4|NOT COMPLETED|Overall Study||7
8182439|NCT02348593|20176167|P3|NOT COMPLETED|Overall Study||16
8182440|NCT02348593|20176168|P2|NOT COMPLETED|Overall Study||8
8182441|NCT02348593|20176169|P1|NOT COMPLETED|Overall Study||10
8182442|NCT02348593|20176166|P4|COMPLETED|Overall Study||52
8182443|NCT02348593|20176167|P3|COMPLETED|Overall Study||43
8182444|NCT02348593|20176168|P2|COMPLETED|Overall Study||51
8182445|NCT02348593|20176169|P1|COMPLETED|Overall Study||49
8182446|NCT02348593|20176166|P4|STARTED|Overall Study||59
8182447|NCT02348593|20176167|P3|STARTED|Overall Study||59
8182448|NCT02348593|20176168|P2|STARTED|Overall Study||59
8182449|NCT02348593|20176169|P1|STARTED|Overall Study||59
8182450|NCT02348489|20176213|P2|NOT COMPLETED|Overall Study||367
8182451|NCT02348489|20176214|P1|NOT COMPLETED|Overall Study||353
8182452|NCT02348489|20176213|P2|COMPLETED|Overall Study||40
8182453|NCT02348489|20176214|P1|COMPLETED|Overall Study||55
8182454|NCT02348489|20176213|P2|STARTED|Overall Study||407
8182455|NCT02348489|20176214|P1|STARTED|Overall Study||408
8182456|NCT02348385|20176238|P2|NOT COMPLETED|Overall Study||0
8182457|NCT02348385|20176239|P1|NOT COMPLETED|Overall Study||0
8182458|NCT02348385|20176238|P2|COMPLETED|Overall Study||25
8182459|NCT02348385|20176239|P1|COMPLETED|Overall Study||24
8182460|NCT02348385|20176238|P2|STARTED|Overall Study||25
8182461|NCT02348385|20176239|P1|STARTED|Overall Study||24
8182462|NCT02348359|20176251|P4|NOT COMPLETED|Overall Study||12
8182463|NCT02348359|20176252|P3|NOT COMPLETED|Overall Study||14
8182464|NCT02348359|20176253|P2|NOT COMPLETED|Overall Study||17
8182465|NCT02348359|20176254|P1|NOT COMPLETED|Overall Study||11
8182466|NCT02348359|20176251|P4|COMPLETED|Overall Study||27
8182467|NCT02348359|20176252|P3|COMPLETED|Overall Study||25
8182468|NCT02348359|20176253|P2|COMPLETED|Overall Study||22
8182469|NCT02348359|20176254|P1|COMPLETED|Overall Study||29
8182470|NCT02348359|20176251|P4|STARTED|Overall Study||39
8182471|NCT02348359|20176252|P3|STARTED|Overall Study||39
8182472|NCT02348359|20176253|P2|STARTED|Overall Study||39
8182473|NCT02348359|20176254|P1|STARTED|Overall Study||40
8182474|NCT02348203|20176266|P2|NOT COMPLETED|Overall Study||10
8182475|NCT02348203|20176267|P1|NOT COMPLETED|Overall Study||10
8182476|NCT02348203|20176266|P2|COMPLETED|Overall Study||22
8182477|NCT02348203|20176267|P1|COMPLETED|Overall Study||21
8182478|NCT02348203|20176266|P2|STARTED|Overall Study||32
8182479|NCT02348203|20176267|P1|STARTED|Overall Study||31
8182480|NCT02348008|20176275|P3|NOT COMPLETED|Overall Study||19
8182481|NCT02348008|20176276|P2|NOT COMPLETED|Overall Study||10
8182482|NCT02348008|20176277|P1|NOT COMPLETED|Overall Study||3
8182483|NCT02348008|20176275|P3|COMPLETED|Overall Study||29
8182484|NCT02348008|20176276|P2|COMPLETED|Overall Study||0
8182485|NCT02348008|20176277|P1|COMPLETED|Overall Study||0
8182486|NCT02348008|20176275|P3|STARTED|Overall Study||48
8182487|NCT02348008|20176276|P2|STARTED|Overall Study||10
8182488|NCT02348008|20176277|P1|STARTED|Overall Study||3
8182489|NCT02347943|20176293|P3|NOT COMPLETED|Overall Study||45
8182490|NCT02347943|20176294|P2|NOT COMPLETED|Overall Study||67
8182491|NCT02347943|20176295|P1|NOT COMPLETED|Overall Study||140
8182492|NCT02347943|20176293|P3|COMPLETED|Overall Study||0
8182493|NCT02347943|20176294|P2|COMPLETED|Overall Study||0
8182494|NCT02347943|20176295|P1|COMPLETED|Overall Study||0
8182495|NCT02347943|20176293|P3|STARTED|Overall Study||45
8182496|NCT02347943|20176294|P2|STARTED|Overall Study||67
8182497|NCT02347943|20176295|P1|STARTED|Overall Study||140
8182498|NCT02347813|20176305|P2|NOT COMPLETED|Second Intervention, 24 Weeks||0
8182499|NCT02347813|20176306|P1|NOT COMPLETED|Second Intervention, 24 Weeks||0
8182500|NCT02347813|20176305|P2|COMPLETED|Second Intervention, 24 Weeks||4
8182501|NCT02347813|20176306|P1|COMPLETED|Second Intervention, 24 Weeks||4
8182502|NCT02347813|20176305|P2|STARTED|Second Intervention, 24 Weeks||4
8182503|NCT02347813|20176306|P1|STARTED|Second Intervention, 24 Weeks||4
8182504|NCT02347813|20176305|P2|NOT COMPLETED|First Intervention, 24 Weeks||2
8182505|NCT02347813|20176306|P1|NOT COMPLETED|First Intervention, 24 Weeks||2
8182506|NCT02347813|20176305|P2|COMPLETED|First Intervention, 24 Weeks||4
8182507|NCT02347813|20176306|P1|COMPLETED|First Intervention, 24 Weeks||4
8182508|NCT02347813|20176305|P2|STARTED|First Intervention, 24 Weeks||6
8182509|NCT02347813|20176306|P1|STARTED|First Intervention, 24 Weeks||6
8182510|NCT02347787|20176316|P2|NOT COMPLETED|9 Month Follow-Up||71
8182511|NCT02347787|20176317|P1|NOT COMPLETED|9 Month Follow-Up||61
8182512|NCT02347787|20176316|P2|COMPLETED|9 Month Follow-Up||233
8182513|NCT02347787|20176317|P1|COMPLETED|9 Month Follow-Up||227
8182514|NCT02347787|20176316|P2|STARTED|9 Month Follow-Up||304
8182515|NCT02347787|20176317|P1|STARTED|9 Month Follow-Up||288
8182516|NCT02347787|20176316|P2|NOT COMPLETED|6 Month Follow-Up||56
8182517|NCT02347787|20176317|P1|NOT COMPLETED|6 Month Follow-Up||66
8182518|NCT02347787|20176316|P2|COMPLETED|6 Month Follow-Up||248
8182519|NCT02347787|20176317|P1|COMPLETED|6 Month Follow-Up||222
8182520|NCT02347787|20176316|P2|STARTED|6 Month Follow-Up||304
8182521|NCT02347787|20176317|P1|STARTED|6 Month Follow-Up||288
8182522|NCT02347774|20176379|P3|NOT COMPLETED|On Study Treatment||36
8182523|NCT02347774|20176380|P2|NOT COMPLETED|On Study Treatment||31
8182524|NCT02347774|20176381|P1|NOT COMPLETED|On Study Treatment||24
8182525|NCT02347774|20176379|P3|COMPLETED|On Study Treatment||177
8182526|NCT02347774|20176380|P2|COMPLETED|On Study Treatment||183
8182527|NCT02347774|20176381|P1|COMPLETED|On Study Treatment||190
8182528|NCT02347774|20176379|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
8182529|NCT02347774|20176380|P2|STARTED|On Study Treatment||214
8182530|NCT02347774|20176381|P1|STARTED|On Study Treatment||214
8182531|NCT02347774|20176379|P3|NOT COMPLETED|Study Participation||25
8182532|NCT02347774|20176380|P2|NOT COMPLETED|Study Participation||21
8182533|NCT02347774|20176381|P1|NOT COMPLETED|Study Participation||15
8182534|NCT02347774|20176379|P3|COMPLETED|Study Participation||188
8182535|NCT02347774|20176380|P2|COMPLETED|Study Participation||193
8182536|NCT02347774|20176381|P1|COMPLETED|Study Participation||199
8182537|NCT02347774|20176379|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
8182538|NCT02347774|20176380|P2|STARTED|Study Participation||214
8182539|NCT02347774|20176381|P1|STARTED|Study Participation||214
8182540|NCT02347761|20176437|P3|NOT COMPLETED|On Study Treatment||42
8182541|NCT02347761|20176438|P2|NOT COMPLETED|On Study Treatment||23
8182542|NCT02347761|20176439|P1|NOT COMPLETED|On Study Treatment||27
8182543|NCT02347761|20176437|P3|COMPLETED|On Study Treatment||176
8182544|NCT02347761|20176438|P2|COMPLETED|On Study Treatment||194
8182545|NCT02347761|20176439|P1|COMPLETED|On Study Treatment||191
8182546|NCT02347761|20176437|P3|STARTED|On Study Treatment||218
8182547|NCT02347761|20176438|P2|STARTED|On Study Treatment||217
8182548|NCT02347761|20176439|P1|STARTED|On Study Treatment||218
8182549|NCT02347761|20176437|P3|NOT COMPLETED|All Collected||27
8182550|NCT02347761|20176438|P2|NOT COMPLETED|All Collected||14
8182551|NCT02347761|20176439|P1|NOT COMPLETED|All Collected||17
8182552|NCT02347761|20176437|P3|COMPLETED|All Collected||191
8182553|NCT02347761|20176438|P2|COMPLETED|All Collected||203
8182554|NCT02347761|20176439|P1|COMPLETED|All Collected||201
8182555|NCT02347761|20176437|P3|STARTED|All Collected||218
8182556|NCT02347761|20176438|P2|STARTED|All Collected||217
8182557|NCT02347761|20176439|P1|STARTED|All Collected||218
8182558|NCT02347657|20176500|P2|NOT COMPLETED|Overall Study||15
8182559|NCT02347657|20176501|P1|NOT COMPLETED|Overall Study||18
8182560|NCT02347657|20176500|P2|COMPLETED|Overall Study||236
8182561|NCT02347657|20176501|P1|COMPLETED|Overall Study||241
8182562|NCT02347657|20176500|P2|Treated|Overall Study||251
8182563|NCT02347657|20176501|P1|Treated|Overall Study||258
8182564|NCT02347657|20176500|P2|STARTED|Overall Study||251
8182565|NCT02347657|20176501|P1|STARTED|Overall Study||259
8182566|NCT02347631|20176528|P2|NOT COMPLETED|Second Intervention (2 Months)||4
8182567|NCT02347631|20176529|P1|NOT COMPLETED|Second Intervention (2 Months)||13
8182568|NCT02347631|20176528|P2|COMPLETED|Second Intervention (2 Months)||44
8182569|NCT02347631|20176529|P1|COMPLETED|Second Intervention (2 Months)||39
8182570|NCT02347631|20176528|P2|STARTED|Second Intervention (2 Months)||48
8182571|NCT02347631|20176529|P1|STARTED|Second Intervention (2 Months)||52
8182572|NCT02347631|20176528|P2|NOT COMPLETED|Washout 2 (1 Month)||3
8182573|NCT02347631|20176529|P1|NOT COMPLETED|Washout 2 (1 Month)||2
8182574|NCT02347631|20176528|P2|COMPLETED|Washout 2 (1 Month)||48
8182575|NCT02347631|20176529|P1|COMPLETED|Washout 2 (1 Month)||52
8182576|NCT02347631|20176528|P2|STARTED|Washout 2 (1 Month)||51
8182577|NCT02347631|20176529|P1|STARTED|Washout 2 (1 Month)||54
8182578|NCT02347631|20176528|P2|NOT COMPLETED|First Intervention (2 Months)||6
8182579|NCT02347631|20176529|P1|NOT COMPLETED|First Intervention (2 Months)||7
8182580|NCT02347631|20176528|P2|COMPLETED|First Intervention (2 Months)||51
8182581|NCT02347631|20176529|P1|COMPLETED|First Intervention (2 Months)||54
8182582|NCT02347631|20176528|P2|STARTED|First Intervention (2 Months)||57
8182583|NCT02347631|20176529|P1|STARTED|First Intervention (2 Months)||61
8182584|NCT02347631|20176528|P2|NOT COMPLETED|Washout 1 (1 Month)||0
8182585|NCT02347631|20176529|P1|NOT COMPLETED|Washout 1 (1 Month)||0
8182586|NCT02347631|20176528|P2|COMPLETED|Washout 1 (1 Month)||57
8182587|NCT02347631|20176529|P1|COMPLETED|Washout 1 (1 Month)||61
8182588|NCT02347631|20176528|P2|STARTED|Washout 1 (1 Month)||57
8182589|NCT02347631|20176529|P1|STARTED|Washout 1 (1 Month)||61
8182590|NCT02347605|20176543|P6|NOT COMPLETED|Overall Study||2
8182591|NCT02347605|20176544|P5|NOT COMPLETED|Overall Study||3
8182592|NCT02347605|20176545|P4|NOT COMPLETED|Overall Study||4
8182593|NCT02347605|20176546|P3|NOT COMPLETED|Overall Study||1
8182594|NCT02347605|20176547|P2|NOT COMPLETED|Overall Study||3
8182595|NCT02347605|20176548|P1|NOT COMPLETED|Overall Study||3
8182596|NCT02347605|20176543|P6|COMPLETED|Overall Study||7
8182597|NCT02347605|20176544|P5|COMPLETED|Overall Study||6
8182598|NCT02347605|20176545|P4|COMPLETED|Overall Study||6
8182599|NCT02347605|20176546|P3|COMPLETED|Overall Study||7
8182600|NCT02347605|20176547|P2|COMPLETED|Overall Study||7
8182601|NCT02347605|20176548|P1|COMPLETED|Overall Study||7
8182602|NCT02347605|20176543|P6|Completed Lab 2|Overall Study||8
8182603|NCT02347605|20176544|P5|Completed Lab 2|Overall Study||6
8182604|NCT02347605|20176545|P4|Completed Lab 2|Overall Study||7
8182605|NCT02347605|20176546|P3|Completed Lab 2|Overall Study||7
8182606|NCT02347605|20176547|P2|Completed Lab 2|Overall Study||7
8182607|NCT02347605|20176548|P1|Completed Lab 2|Overall Study||7
8182608|NCT02347605|20176543|P6|Completed Lab 1|Overall Study||9
8182609|NCT02347605|20176544|P5|Completed Lab 1|Overall Study||8
8182610|NCT02347605|20176545|P4|Completed Lab 1|Overall Study||10
8182611|NCT02347605|20176546|P3|Completed Lab 1|Overall Study||8
8182612|NCT02347605|20176547|P2|Completed Lab 1|Overall Study||10
8182613|NCT02347605|20176548|P1|Completed Lab 1|Overall Study||10
8182614|NCT02347605|20176543|P6|STARTED|Overall Study||9
8182615|NCT02347605|20176544|P5|STARTED|Overall Study||9
8182616|NCT02347605|20176545|P4|STARTED|Overall Study||10
8182617|NCT02347605|20176546|P3|STARTED|Overall Study||8
8182618|NCT02347605|20176547|P2|STARTED|Overall Study||10
8182619|NCT02347605|20176548|P1|STARTED|Overall Study||10
8182620|NCT02347488|20176559|P1|NOT COMPLETED|Overall Study||0
8182621|NCT02347488|20176559|P1|COMPLETED|Overall Study||30
8182622|NCT02347488|20176559|P1|STARTED|Overall Study||30
8182623|NCT02347345|20176572|P3|NOT COMPLETED|Overall Study||0
8182624|NCT02347345|20176573|P2|NOT COMPLETED|Overall Study||0
8182625|NCT02347345|20176574|P1|NOT COMPLETED|Overall Study||0
8182626|NCT02347345|20176572|P3|COMPLETED|Overall Study||12
8182627|NCT02347345|20176573|P2|COMPLETED|Overall Study||12
8182628|NCT02347345|20176574|P1|COMPLETED|Overall Study||10
8182629|NCT02347345|20176572|P3|STARTED|Overall Study||12
8182630|NCT02347345|20176573|P2|STARTED|Overall Study||12
8182631|NCT02347345|20176574|P1|STARTED|Overall Study||10
8182632|NCT02347332|20176590|P2|NOT COMPLETED|Overall Study||229
8182633|NCT02347332|20176591|P1|NOT COMPLETED|Overall Study||230
8182634|NCT02347332|20176590|P2|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
8182635|NCT02347332|20176591|P1|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
8182636|NCT02347332|20176590|P2|STARTED|Overall Study||229
8182637|NCT02347332|20176591|P1|STARTED|Overall Study||230
8182638|NCT02347189|20176605|P1|NOT COMPLETED|Overall Study||11
8182639|NCT02347189|20176605|P1|COMPLETED|Overall Study||28
8182640|NCT02347189|20176605|P1|Implanted > 24 Hours|Overall Study||30
8182641|NCT02347189|20176605|P1|Implanted|Overall Study||30
8182642|NCT02347189|20176605|P1|Catheterized|Overall Study||39
8182643|NCT02347189|20176605|P1|STARTED|Overall Study||39
8182644|NCT02347176|20176624|P4|NOT COMPLETED|Overall Study||4
8182645|NCT02347176|20176625|P3|NOT COMPLETED|Overall Study||8
8182646|NCT02347176|20176626|P2|NOT COMPLETED|Overall Study||10
8182647|NCT02347176|20176627|P1|NOT COMPLETED|Overall Study||12
8182648|NCT02347176|20176624|P4|COMPLETED|Overall Study||48
8182649|NCT02347176|20176625|P3|COMPLETED|Overall Study||43
8182650|NCT02347176|20176626|P2|COMPLETED|Overall Study||40
8182651|NCT02347176|20176627|P1|COMPLETED|Overall Study||39
8182652|NCT02347176|20176624|P4|STARTED|Overall Study||52
8182653|NCT02347176|20176625|P3|STARTED|Overall Study||51
8182654|NCT02347176|20176626|P2|STARTED|Overall Study||50
8182655|NCT02347176|20176627|P1|STARTED|Overall Study||51
8182656|NCT02347124|20176675|P2|NOT COMPLETED|Overall Study||99
8182657|NCT02347124|20176676|P1|NOT COMPLETED|Overall Study||93
8182658|NCT02347124|20176675|P2|COMPLETED|Overall Study||259
8182659|NCT02347124|20176676|P1|COMPLETED|Overall Study||267
8182660|NCT02347124|20176675|P2|2 Month Follow-up|Overall Study||275
8182661|NCT02347124|20176676|P1|2 Month Follow-up|Overall Study||298
8182662|NCT02347124|20176675|P2|STARTED|Overall Study||358
8182663|NCT02347124|20176676|P1|STARTED|Overall Study||360
8182664|NCT02347098|20176712|P2|NOT COMPLETED|Overall Study||8
8182665|NCT02347098|20176713|P1|NOT COMPLETED|Overall Study||7
8182666|NCT02347098|20176712|P2|COMPLETED|Overall Study||58
8182667|NCT02347098|20176713|P1|COMPLETED|Overall Study||56
8182668|NCT02347098|20176712|P2|STARTED|Overall Study||66
8182669|NCT02347098|20176713|P1|STARTED|Overall Study||63
8182670|NCT02347085|20176725|P1|NOT COMPLETED|Overall Study||10
8182671|NCT02347085|20176725|P1|COMPLETED|Overall Study||33
8182672|NCT02347085|20176725|P1|Placebo MDI|Overall Study||40
8182673|NCT02347085|20176725|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
8182674|NCT02347085|20176725|P1|STARTED|Overall Study||43
8182675|NCT02347072|20176747|P1|NOT COMPLETED|Overall Study||18
8182676|NCT02347072|20176747|P1|COMPLETED|Overall Study||62
8182677|NCT02347072|20176747|P1|Spiriva Respimat 5 µg|Overall Study||73
8182678|NCT02347072|20176747|P1|Placebo MDI|Overall Study||72
8182679|NCT02347072|20176747|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
8182680|NCT02347072|20176747|P1|STARTED|Overall Study||80
8182681|NCT02346877|20176781|P2|NOT COMPLETED|Overall Study||0
8182682|NCT02346877|20176782|P1|NOT COMPLETED|Overall Study||19
8182683|NCT02346877|20176781|P2|COMPLETED|Overall Study||0
8182684|NCT02346877|20176782|P1|COMPLETED|Overall Study||0
8182685|NCT02346877|20176781|P2|STARTED|Overall Study||0
8182686|NCT02346877|20176782|P1|STARTED|Overall Study||19
8182687|NCT02346721|20176792|P1|NOT COMPLETED|Overall Study||4
8182688|NCT02346721|20176792|P1|COMPLETED|Overall Study||107
8182689|NCT02346721|20176792|P1|STARTED|Overall Study||111
8182696|NCT02346643|20176812|P1|NOT COMPLETED|Overall Study||35
8182697|NCT02346643|20176812|P1|COMPLETED|Overall Study||6
8182698|NCT02346643|20176812|P1|Received Permanent System|Overall Study||31
8182699|NCT02346643|20176812|P1|Received Trial System|Overall Study||29
8182700|NCT02346643|20176812|P1|STARTED|Overall Study||41
8182701|NCT02346461|20176819|P2|NOT COMPLETED|Overall Study||0
8182702|NCT02346461|20176820|P1|NOT COMPLETED|Overall Study||0
8182703|NCT02346461|20176819|P2|COMPLETED|Overall Study||6
8182704|NCT02346461|20176820|P1|COMPLETED|Overall Study||6
8182705|NCT02346461|20176819|P2|STARTED|Overall Study||6
8182706|NCT02346461|20176820|P1|STARTED|Overall Study||6
8182707|NCT02346370|20176842|P3|NOT COMPLETED|Overall Study||4
8182708|NCT02346370|20176843|P2|NOT COMPLETED|Overall Study||4
8182709|NCT02346370|20176844|P1|NOT COMPLETED|Overall Study||8
8182710|NCT02346370|20176842|P3|COMPLETED|Overall Study||0
8182711|NCT02346370|20176843|P2|COMPLETED|Overall Study||0
8182712|NCT02346370|20176844|P1|COMPLETED|Overall Study||0
8182713|NCT02346370|20176842|P3|STARTED|Overall Study||4
8182714|NCT02346370|20176843|P2|STARTED|Overall Study||4
8182715|NCT02346370|20176844|P1|STARTED|Overall Study||8
8182716|NCT02346240|20176893|P24|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
8182717|NCT02346240|20176894|P23|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
8182718|NCT02346240|20176895|P22|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
8182719|NCT02346240|20176896|P21|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
8182720|NCT02346240|20176897|P20|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
8182721|NCT02346240|20176898|P19|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
8182722|NCT02346240|20176899|P18|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
8182723|NCT02346240|20176900|P17|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182724|NCT02346240|20176901|P16|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182725|NCT02346240|20176902|P15|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182726|NCT02346240|20176903|P14|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182727|NCT02346240|20176904|P13|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182728|NCT02346240|20176905|P12|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182729|NCT02346240|20176906|P11|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182730|NCT02346240|20176907|P10|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182731|NCT02346240|20176908|P9|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182732|NCT02346240|20176909|P8|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182733|NCT02346240|20176910|P7|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182734|NCT02346240|20176911|P6|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182735|NCT02346240|20176912|P5|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182736|NCT02346240|20176913|P4|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182737|NCT02346240|20176914|P3|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182738|NCT02346240|20176915|P2|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182739|NCT02346240|20176916|P1|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182740|NCT02346240|20176893|P24|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
8182741|NCT02346240|20176894|P23|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
8182742|NCT02346240|20176895|P22|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
8182743|NCT02346240|20176896|P21|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
8182744|NCT02346240|20176897|P20|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
8182745|NCT02346240|20176898|P19|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
8182746|NCT02346240|20176899|P18|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
8182747|NCT02346240|20176900|P17|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182748|NCT02346240|20176901|P16|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182749|NCT02346240|20176902|P15|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182750|NCT02346240|20176903|P14|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182751|NCT02346240|20176904|P13|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182752|NCT02346240|20176905|P12|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182753|NCT02346240|20176906|P11|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182754|NCT02346240|20176907|P10|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182755|NCT02346240|20176908|P9|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182756|NCT02346240|20176909|P8|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182757|NCT02346240|20176910|P7|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182758|NCT02346240|20176911|P6|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182759|NCT02346240|20176912|P5|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182760|NCT02346240|20176913|P4|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182761|NCT02346240|20176914|P3|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182762|NCT02346240|20176915|P2|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182763|NCT02346240|20176916|P1|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8182764|NCT02346240|20176893|P24|STARTED|Open-Label Period (Week 48 to Week 144)||16
8182765|NCT02346240|20176894|P23|STARTED|Open-Label Period (Week 48 to Week 144)||34
8182766|NCT02346240|20176895|P22|STARTED|Open-Label Period (Week 48 to Week 144)||177
8182767|NCT02346240|20176896|P21|STARTED|Open-Label Period (Week 48 to Week 144)||48
8182768|NCT02346240|20176897|P20|STARTED|Open-Label Period (Week 48 to Week 144)||41
8182769|NCT02346240|20176898|P19|STARTED|Open-Label Period (Week 48 to Week 144)||122
8182770|NCT02346240|20176899|P18|STARTED|Open-Label Period (Week 48 to Week 144)||34
8182771|NCT02346240|20176900|P17|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182772|NCT02346240|20176901|P16|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182773|NCT02346240|20176902|P15|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182774|NCT02346240|20176903|P14|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182775|NCT02346240|20176904|P13|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182776|NCT02346240|20176905|P12|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182777|NCT02346240|20176906|P11|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182778|NCT02346240|20176907|P10|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182779|NCT02346240|20176908|P9|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182780|NCT02346240|20176909|P8|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182781|NCT02346240|20176910|P7|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182782|NCT02346240|20176911|P6|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182783|NCT02346240|20176912|P5|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182784|NCT02346240|20176913|P4|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182785|NCT02346240|20176914|P3|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182786|NCT02346240|20176915|P2|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182787|NCT02346240|20176916|P1|STARTED|Open-Label Period (Week 48 to Week 144)||0
8182788|NCT02346240|20176893|P24|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182789|NCT02346240|20176894|P23|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182790|NCT02346240|20176895|P22|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182791|NCT02346240|20176896|P21|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182792|NCT02346240|20176897|P20|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182793|NCT02346240|20176898|P19|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182794|NCT02346240|20176899|P18|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182795|NCT02346240|20176900|P17|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8182796|NCT02346240|20176901|P16|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
8182797|NCT02346240|20176902|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
8182798|NCT02346240|20176903|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
8182799|NCT02346240|20176904|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182800|NCT02346240|20176905|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8182801|NCT02346240|20176906|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8182802|NCT02346240|20176907|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8182803|NCT02346240|20176908|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
8182804|NCT02346240|20176909|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8182805|NCT02346240|20176910|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8182806|NCT02346240|20176911|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8182807|NCT02346240|20176912|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182808|NCT02346240|20176913|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182809|NCT02346240|20176914|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182810|NCT02346240|20176915|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182811|NCT02346240|20176916|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182812|NCT02346240|20176893|P24|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182813|NCT02346240|20176894|P23|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182814|NCT02346240|20176895|P22|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182815|NCT02346240|20176896|P21|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182816|NCT02346240|20176897|P20|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182817|NCT02346240|20176898|P19|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182818|NCT02346240|20176899|P18|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182819|NCT02346240|20176900|P17|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
8182820|NCT02346240|20176901|P16|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
8182821|NCT02346240|20176902|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
8182822|NCT02346240|20176903|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
8182823|NCT02346240|20176904|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
8182824|NCT02346240|20176905|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
8182825|NCT02346240|20176906|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
8182826|NCT02346240|20176907|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
8182827|NCT02346240|20176908|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
8182828|NCT02346240|20176909|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
8182829|NCT02346240|20176910|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
8182830|NCT02346240|20176911|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
8182831|NCT02346240|20176912|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8182832|NCT02346240|20176913|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182833|NCT02346240|20176914|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182834|NCT02346240|20176915|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182835|NCT02346240|20176916|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8182836|NCT02346240|20176893|P24|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182837|NCT02346240|20176894|P23|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182838|NCT02346240|20176895|P22|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182839|NCT02346240|20176896|P21|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182840|NCT02346240|20176897|P20|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182841|NCT02346240|20176898|P19|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182842|NCT02346240|20176899|P18|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182843|NCT02346240|20176900|P17|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
8182844|NCT02346240|20176901|P16|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
8182845|NCT02346240|20176902|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
8182846|NCT02346240|20176903|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
8182847|NCT02346240|20176904|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
8182848|NCT02346240|20176905|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
8182849|NCT02346240|20176906|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
8182850|NCT02346240|20176907|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
8182851|NCT02346240|20176908|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
8182852|NCT02346240|20176909|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
8182853|NCT02346240|20176910|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
8182854|NCT02346240|20176911|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
8182855|NCT02346240|20176912|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
8182856|NCT02346240|20176913|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182857|NCT02346240|20176914|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182858|NCT02346240|20176915|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182859|NCT02346240|20176916|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8182860|NCT02346240|20176893|P24|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182861|NCT02346240|20176894|P23|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182862|NCT02346240|20176895|P22|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182863|NCT02346240|20176896|P21|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182864|NCT02346240|20176897|P20|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182865|NCT02346240|20176898|P19|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182866|NCT02346240|20176899|P18|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182867|NCT02346240|20176900|P17|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
8182868|NCT02346240|20176901|P16|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
8182869|NCT02346240|20176902|P15|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
8182870|NCT02346240|20176903|P14|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
8182871|NCT02346240|20176904|P13|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
8182872|NCT02346240|20176905|P12|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
8182873|NCT02346240|20176906|P11|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
8182874|NCT02346240|20176907|P10|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
8182875|NCT02346240|20176908|P9|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
8182876|NCT02346240|20176909|P8|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
8182877|NCT02346240|20176910|P7|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
8182878|NCT02346240|20176911|P6|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
8182879|NCT02346240|20176912|P5|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
8182880|NCT02346240|20176913|P4|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182881|NCT02346240|20176914|P3|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8183109|NCT02345226|20177248|P2|NOT COMPLETED|Double-Blind Phase||71
8182882|NCT02346240|20176915|P2|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182883|NCT02346240|20176916|P1|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8182884|NCT02346240|20176893|P24|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182885|NCT02346240|20176894|P23|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182886|NCT02346240|20176895|P22|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182887|NCT02346240|20176896|P21|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182888|NCT02346240|20176897|P20|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182889|NCT02346240|20176898|P19|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182890|NCT02346240|20176899|P18|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182891|NCT02346240|20176900|P17|STARTED|Maintenance Period (Week 16 to Week 48)||36
8182892|NCT02346240|20176901|P16|STARTED|Maintenance Period (Week 16 to Week 48)||49
8182893|NCT02346240|20176902|P15|STARTED|Maintenance Period (Week 16 to Week 48)||85
8182894|NCT02346240|20176903|P14|STARTED|Maintenance Period (Week 16 to Week 48)||53
8182895|NCT02346240|20176904|P13|STARTED|Maintenance Period (Week 16 to Week 48)||49
8182896|NCT02346240|20176905|P12|STARTED|Maintenance Period (Week 16 to Week 48)||50
8182897|NCT02346240|20176906|P11|STARTED|Maintenance Period (Week 16 to Week 48)||25
8182898|NCT02346240|20176907|P10|STARTED|Maintenance Period (Week 16 to Week 48)||44
8182899|NCT02346240|20176908|P9|STARTED|Maintenance Period (Week 16 to Week 48)||44
8182900|NCT02346240|20176909|P8|STARTED|Maintenance Period (Week 16 to Week 48)||22
8182901|NCT02346240|20176910|P7|STARTED|Maintenance Period (Week 16 to Week 48)||50
8182902|NCT02346240|20176911|P6|STARTED|Maintenance Period (Week 16 to Week 48)||24
8182903|NCT02346240|20176912|P5|STARTED|Maintenance Period (Week 16 to Week 48)||2
8182904|NCT02346240|20176913|P4|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182905|NCT02346240|20176914|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182906|NCT02346240|20176915|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182907|NCT02346240|20176916|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
8182908|NCT02346240|20176893|P24|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182909|NCT02346240|20176894|P23|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182910|NCT02346240|20176895|P22|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182911|NCT02346240|20176896|P21|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182912|NCT02346240|20176897|P20|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182913|NCT02346240|20176898|P19|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182914|NCT02346240|20176899|P18|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182915|NCT02346240|20176900|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182916|NCT02346240|20176901|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182917|NCT02346240|20176902|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182918|NCT02346240|20176903|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182919|NCT02346240|20176904|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182920|NCT02346240|20176905|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182921|NCT02346240|20176906|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182922|NCT02346240|20176907|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182923|NCT02346240|20176908|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182924|NCT02346240|20176909|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182925|NCT02346240|20176910|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182926|NCT02346240|20176911|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182927|NCT02346240|20176912|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8182928|NCT02346240|20176913|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
8182929|NCT02346240|20176914|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
8182930|NCT02346240|20176915|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
8182931|NCT02346240|20176916|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
8182932|NCT02346240|20176893|P24|COMPLETED|Initial Period (Baseline to Week 16)||0
8182933|NCT02346240|20176894|P23|COMPLETED|Initial Period (Baseline to Week 16)||0
8182934|NCT02346240|20176895|P22|COMPLETED|Initial Period (Baseline to Week 16)||0
8182935|NCT02346240|20176896|P21|COMPLETED|Initial Period (Baseline to Week 16)||0
8182936|NCT02346240|20176897|P20|COMPLETED|Initial Period (Baseline to Week 16)||0
8182937|NCT02346240|20176898|P19|COMPLETED|Initial Period (Baseline to Week 16)||0
8182938|NCT02346240|20176899|P18|COMPLETED|Initial Period (Baseline to Week 16)||0
8182939|NCT02346240|20176900|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
8182940|NCT02346240|20176901|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
8182941|NCT02346240|20176902|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
8182942|NCT02346240|20176903|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
8182943|NCT02346240|20176904|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
8182944|NCT02346240|20176905|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
8182945|NCT02346240|20176906|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
8182946|NCT02346240|20176907|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
8182947|NCT02346240|20176908|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
8182948|NCT02346240|20176909|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
8182949|NCT02346240|20176910|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
8182950|NCT02346240|20176911|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
8182951|NCT02346240|20176912|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
8182952|NCT02346240|20176913|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
8182953|NCT02346240|20176914|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
8182954|NCT02346240|20176915|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
8182955|NCT02346240|20176916|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
8183110|NCT02345226|20177249|P1|NOT COMPLETED|Double-Blind Phase||69
8182956|NCT02346240|20176893|P24|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182957|NCT02346240|20176894|P23|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182958|NCT02346240|20176895|P22|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182959|NCT02346240|20176896|P21|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182960|NCT02346240|20176897|P20|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182961|NCT02346240|20176898|P19|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182962|NCT02346240|20176899|P18|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182963|NCT02346240|20176900|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182964|NCT02346240|20176901|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182965|NCT02346240|20176902|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182966|NCT02346240|20176903|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182967|NCT02346240|20176904|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182968|NCT02346240|20176905|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182969|NCT02346240|20176906|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182970|NCT02346240|20176907|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182971|NCT02346240|20176908|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182972|NCT02346240|20176909|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182973|NCT02346240|20176910|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182974|NCT02346240|20176911|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182975|NCT02346240|20176912|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8182976|NCT02346240|20176913|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
8182977|NCT02346240|20176914|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
8182978|NCT02346240|20176915|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
8182979|NCT02346240|20176916|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
8182980|NCT02346240|20176893|P24|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182981|NCT02346240|20176894|P23|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182982|NCT02346240|20176895|P22|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182983|NCT02346240|20176896|P21|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182984|NCT02346240|20176897|P20|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182985|NCT02346240|20176898|P19|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182986|NCT02346240|20176899|P18|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182987|NCT02346240|20176900|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182988|NCT02346240|20176901|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182989|NCT02346240|20176902|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182990|NCT02346240|20176903|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182991|NCT02346240|20176904|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182992|NCT02346240|20176905|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182993|NCT02346240|20176906|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182994|NCT02346240|20176907|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182995|NCT02346240|20176908|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182996|NCT02346240|20176909|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182997|NCT02346240|20176910|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182998|NCT02346240|20176911|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
8182999|NCT02346240|20176912|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
8183000|NCT02346240|20176913|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
8183001|NCT02346240|20176914|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
8183002|NCT02346240|20176915|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
8183003|NCT02346240|20176916|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
8183004|NCT02346240|20176893|P24|STARTED|Initial Period (Baseline to Week 16)||0
8183005|NCT02346240|20176894|P23|STARTED|Initial Period (Baseline to Week 16)||0
8183006|NCT02346240|20176895|P22|STARTED|Initial Period (Baseline to Week 16)||0
8183007|NCT02346240|20176896|P21|STARTED|Initial Period (Baseline to Week 16)||0
8183008|NCT02346240|20176897|P20|STARTED|Initial Period (Baseline to Week 16)||0
8183009|NCT02346240|20176898|P19|STARTED|Initial Period (Baseline to Week 16)||0
8183010|NCT02346240|20176899|P18|STARTED|Initial Period (Baseline to Week 16)||0
8183011|NCT02346240|20176900|P17|STARTED|Initial Period (Baseline to Week 16)||0
8183012|NCT02346240|20176901|P16|STARTED|Initial Period (Baseline to Week 16)||0
8183013|NCT02346240|20176902|P15|STARTED|Initial Period (Baseline to Week 16)||0
8183014|NCT02346240|20176903|P14|STARTED|Initial Period (Baseline to Week 16)||0
8183015|NCT02346240|20176904|P13|STARTED|Initial Period (Baseline to Week 16)||0
8183016|NCT02346240|20176905|P12|STARTED|Initial Period (Baseline to Week 16)||0
8183017|NCT02346240|20176906|P11|STARTED|Initial Period (Baseline to Week 16)||0
8183018|NCT02346240|20176907|P10|STARTED|Initial Period (Baseline to Week 16)||0
8183019|NCT02346240|20176908|P9|STARTED|Initial Period (Baseline to Week 16)||0
8183020|NCT02346240|20176909|P8|STARTED|Initial Period (Baseline to Week 16)||0
8183021|NCT02346240|20176910|P7|STARTED|Initial Period (Baseline to Week 16)||0
8183022|NCT02346240|20176911|P6|STARTED|Initial Period (Baseline to Week 16)||0
8183023|NCT02346240|20176912|P5|STARTED|Initial Period (Baseline to Week 16)||0
8183024|NCT02346240|20176913|P4|STARTED|Initial Period (Baseline to Week 16)||167
8183025|NCT02346240|20176914|P3|STARTED|Initial Period (Baseline to Week 16)||165
8183026|NCT02346240|20176915|P2|STARTED|Initial Period (Baseline to Week 16)||170
8183027|NCT02346240|20176916|P1|STARTED|Initial Period (Baseline to Week 16)||57
8183028|NCT02346136|20176955|P2|NOT COMPLETED|Overall Study||23
8183029|NCT02346136|20176956|P1|NOT COMPLETED|Overall Study||22
8183030|NCT02346136|20176955|P2|COMPLETED|Overall Study||64
8183031|NCT02346136|20176956|P1|COMPLETED|Overall Study||71
8183032|NCT02346136|20176955|P2|STARTED|Overall Study||87
8183033|NCT02346136|20176956|P1|STARTED|Overall Study||93
8183034|NCT02345889|20176992|P4|NOT COMPLETED|Overall Study||16
8183035|NCT02345889|20176993|P3|NOT COMPLETED|Overall Study||20
8183036|NCT02345889|20176994|P2|NOT COMPLETED|Overall Study||17
8183037|NCT02345889|20176995|P1|NOT COMPLETED|Overall Study||21
8183038|NCT02345889|20176992|P4|COMPLETED|Overall Study||299
8183039|NCT02345889|20176993|P3|COMPLETED|Overall Study||295
8183040|NCT02345889|20176994|P2|COMPLETED|Overall Study||299
8183041|NCT02345889|20176995|P1|COMPLETED|Overall Study||295
8183042|NCT02345889|20176992|P4|STARTED|Overall Study||315
8183043|NCT02345889|20176993|P3|STARTED|Overall Study||315
8183044|NCT02345889|20176994|P2|STARTED|Overall Study||316
8183045|NCT02345889|20176995|P1|STARTED|Overall Study||316
8183046|NCT02345811|20177061|P2|NOT COMPLETED|Second Intervention||0
8183047|NCT02345811|20177062|P1|NOT COMPLETED|Second Intervention||0
8183048|NCT02345811|20177061|P2|COMPLETED|Second Intervention||16
8183049|NCT02345811|20177062|P1|COMPLETED|Second Intervention||16
8183050|NCT02345811|20177061|P2|STARTED|Second Intervention||16
8183051|NCT02345811|20177062|P1|STARTED|Second Intervention||16
8183052|NCT02345811|20177061|P2|NOT COMPLETED|First Intervention||1
8183053|NCT02345811|20177062|P1|NOT COMPLETED|First Intervention||1
8183054|NCT02345811|20177061|P2|COMPLETED|First Intervention||16
8183055|NCT02345811|20177062|P1|COMPLETED|First Intervention||16
8183056|NCT02345811|20177061|P2|STARTED|First Intervention||17
8183057|NCT02345811|20177062|P1|STARTED|First Intervention||17
8183058|NCT02345772|20177092|P1|NOT COMPLETED|Overall Study||4
8183059|NCT02345772|20177092|P1|COMPLETED|Overall Study||0
8183060|NCT02345772|20177092|P1|STARTED|Overall Study||4
8183061|NCT02345720|20177098|P1|NOT COMPLETED|Overall Study||0
8183062|NCT02345720|20177098|P1|COMPLETED|Overall Study||20
8183063|NCT02345720|20177098|P1|STARTED|Overall Study||20
8183064|NCT02345642|20177106|P2|NOT COMPLETED|Overall Study||0
8183065|NCT02345642|20177107|P1|NOT COMPLETED|Overall Study||0
8183066|NCT02345642|20177106|P2|COMPLETED|Overall Study||10
8183067|NCT02345642|20177107|P1|COMPLETED|Overall Study||10
8183068|NCT02345642|20177106|P2|STARTED|Overall Study||10
8183069|NCT02345642|20177107|P1|STARTED|Overall Study||10
8183070|NCT02345512|20177113|P1|NOT COMPLETED|Overall Study||2
8183071|NCT02345512|20177113|P1|COMPLETED|Overall Study||9
8183072|NCT02345512|20177113|P1|STARTED|Overall Study||11
8183073|NCT02345486|20177134|P2|NOT COMPLETED|Overall Study||0
8183074|NCT02345486|20177135|P1|NOT COMPLETED|Overall Study||0
8183075|NCT02345486|20177134|P2|COMPLETED|Overall Study||520
8183076|NCT02345486|20177135|P1|COMPLETED|Overall Study||454
8183077|NCT02345486|20177134|P2|STARTED|Overall Study||520
8183078|NCT02345486|20177135|P1|STARTED|Overall Study||454
8183079|NCT02345460|20177183|P1|NOT COMPLETED|Overall Study||0
8183080|NCT02345460|20177183|P1|COMPLETED|Overall Study||1
8183081|NCT02345460|20177183|P1|STARTED|Overall Study||1
8183082|NCT02345369|20177196|P2|NOT COMPLETED|Overall Study||0
8183083|NCT02345369|20177197|P1|NOT COMPLETED|Overall Study||0
8183084|NCT02345369|20177196|P2|COMPLETED|Overall Study||0
8183085|NCT02345369|20177197|P1|COMPLETED|Overall Study||0
8183086|NCT02345369|20177196|P2|STARTED|Overall Study||0
8183087|NCT02345369|20177197|P1|STARTED|Overall Study||0
8183088|NCT02345330|20177207|P1|NOT COMPLETED|Overall Study||3
8183089|NCT02345330|20177207|P1|COMPLETED|Overall Study||1
8183090|NCT02345330|20177207|P1|STARTED|Overall Study||4
8183091|NCT02345252|20177219|P2|NOT COMPLETED|Open-Label Extension Phase||0
8183092|NCT02345252|20177220|P1|NOT COMPLETED|Open-Label Extension Phase||0
8183093|NCT02345252|20177219|P2|COMPLETED|Open-Label Extension Phase||17
8183094|NCT02345252|20177220|P1|COMPLETED|Open-Label Extension Phase||19
8183095|NCT02345252|20177219|P2|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
8183096|NCT02345252|20177220|P1|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
8183097|NCT02345252|20177219|P2|NOT COMPLETED|Double-Blind Phase||49
8183098|NCT02345252|20177220|P1|NOT COMPLETED|Double-Blind Phase||40
8183099|NCT02345252|20177219|P2|COMPLETED|Double-Blind Phase||267
8183100|NCT02345252|20177220|P1|COMPLETED|Double-Blind Phase||276
8183101|NCT02345252|20177219|P2|STARTED|Double-Blind Phase||316
8183102|NCT02345252|20177220|P1|STARTED|Double-Blind Phase||316
8183103|NCT02345226|20177248|P2|NOT COMPLETED|Open-Label Extension Phase||1
8183104|NCT02345226|20177249|P1|NOT COMPLETED|Open-Label Extension Phase||0
8183105|NCT02345226|20177248|P2|COMPLETED|Open-Label Extension Phase||20
8183106|NCT02345226|20177249|P1|COMPLETED|Open-Label Extension Phase||25
8183107|NCT02345226|20177248|P2|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
8183108|NCT02345226|20177249|P1|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
8183111|NCT02345226|20177248|P2|COMPLETED|Double-Blind Phase||370
8183112|NCT02345226|20177249|P1|COMPLETED|Double-Blind Phase||371
8183113|NCT02345226|20177248|P2|STARTED|Double-Blind Phase||441
8183114|NCT02345226|20177249|P1|STARTED|Double-Blind Phase||440
8183115|NCT02345161|20177281|P2|NOT COMPLETED|Overall Study||57
8183116|NCT02345161|20177282|P1|NOT COMPLETED|Overall Study||45
8183117|NCT02345161|20177281|P2|COMPLETED|Overall Study||842
8183118|NCT02345161|20177282|P1|COMPLETED|Overall Study||866
8183119|NCT02345161|20177281|P2|STARTED|Overall Study||899
8183120|NCT02345161|20177282|P1|STARTED|Overall Study||911
8183121|NCT02345070|20177387|P3|NOT COMPLETED|Overall Study||23
8183122|NCT02345070|20177388|P2|NOT COMPLETED|Overall Study||11
8183123|NCT02345070|20177389|P1|NOT COMPLETED|Overall Study||20
8183124|NCT02345070|20177387|P3|COMPLETED|Overall Study||85
8183125|NCT02345070|20177388|P2|COMPLETED|Overall Study||98
8183126|NCT02345070|20177389|P1|COMPLETED|Overall Study||90
8183127|NCT02345070|20177387|P3|Treated|Overall Study||108
8183128|NCT02345070|20177388|P2|Treated|Overall Study||108
8183129|NCT02345070|20177389|P1|Treated|Overall Study||109
8183130|NCT02345070|20177387|P3|STARTED|Overall Study||108
8183131|NCT02345070|20177388|P2|STARTED|Overall Study||109
8183132|NCT02345070|20177389|P1|STARTED|Overall Study||110
8183133|NCT02345031|20177405|P2|NOT COMPLETED|Overall Study||1
8183134|NCT02345031|20177406|P1|NOT COMPLETED|Overall Study||1
8183135|NCT02345031|20177405|P2|COMPLETED|Overall Study||39
8183136|NCT02345031|20177406|P1|COMPLETED|Overall Study||37
8183137|NCT02345031|20177405|P2|STARTED|Overall Study||40
8183138|NCT02345031|20177406|P1|STARTED|Overall Study||38
8183139|NCT02344745|20177422|P2|NOT COMPLETED|Overall Study||0
8183140|NCT02344745|20177423|P1|NOT COMPLETED|Overall Study||2
8183141|NCT02344745|20177422|P2|COMPLETED|Overall Study||40
8183142|NCT02344745|20177423|P1|COMPLETED|Overall Study||38
8183143|NCT02344745|20177422|P2|STARTED|Overall Study||40
8183144|NCT02344745|20177423|P1|STARTED|Overall Study||40
8183145|NCT02344628|20177437|P2|NOT COMPLETED|Overall Study||86
8183146|NCT02344628|20177438|P1|NOT COMPLETED|Overall Study||91
8183147|NCT02344628|20177437|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
8183148|NCT02344628|20177438|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
8183149|NCT02344628|20177437|P2|STARTED|Overall Study||292
8183150|NCT02344628|20177438|P1|STARTED|Overall Study||291
8183151|NCT02344576|20177452|P4|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183152|NCT02344576|20177453|P3|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183153|NCT02344576|20177454|P2|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183154|NCT02344576|20177455|P1|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183155|NCT02344576|20177452|P4|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
8183156|NCT02344576|20177453|P3|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
8183157|NCT02344576|20177454|P2|COMPLETED|12-Month Medical Record Follow-Up||67
8183158|NCT02344576|20177455|P1|COMPLETED|12-Month Medical Record Follow-Up||98
8183159|NCT02344576|20177452|P4|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
8183160|NCT02344576|20177453|P3|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
8183161|NCT02344576|20177454|P2|STARTED|12-Month Medical Record Follow-Up||67
8183162|NCT02344576|20177455|P1|STARTED|12-Month Medical Record Follow-Up||98
8183163|NCT02344576|20177452|P4|NOT COMPLETED|6-Month Follow-Up||8
8183164|NCT02344576|20177453|P3|NOT COMPLETED|6-Month Follow-Up||14
8183165|NCT02344576|20177454|P2|NOT COMPLETED|6-Month Follow-Up||19
8183166|NCT02344576|20177455|P1|NOT COMPLETED|6-Month Follow-Up||19
8183167|NCT02344576|20177452|P4|COMPLETED|6-Month Follow-Up||50
8183168|NCT02344576|20177453|P3|COMPLETED|6-Month Follow-Up||78
8183169|NCT02344576|20177454|P2|COMPLETED|6-Month Follow-Up||67
8183170|NCT02344576|20177455|P1|COMPLETED|6-Month Follow-Up||98
8183171|NCT02344576|20177452|P4|Completed 6-Month Survey|6-Month Follow-Up||50
8183172|NCT02344576|20177453|P3|Completed 6-Month Survey|6-Month Follow-Up||78
8183173|NCT02344576|20177454|P2|Completed 6-Month Survey|6-Month Follow-Up||67
8183174|NCT02344576|20177455|P1|Completed 6-Month Survey|6-Month Follow-Up||98
8183175|NCT02344576|20177452|P4|STARTED|6-Month Follow-Up||58
8183176|NCT02344576|20177453|P3|STARTED|6-Month Follow-Up||92
8183177|NCT02344576|20177454|P2|STARTED|6-Month Follow-Up||86
8183178|NCT02344576|20177455|P1|STARTED|6-Month Follow-Up||117
8183179|NCT02344576|20177452|P4|NOT COMPLETED|1-Month Follow-Up||13
8183180|NCT02344576|20177453|P3|NOT COMPLETED|1-Month Follow-Up||19
8183181|NCT02344576|20177454|P2|NOT COMPLETED|1-Month Follow-Up||27
8183182|NCT02344576|20177455|P1|NOT COMPLETED|1-Month Follow-Up||18
8183183|NCT02344576|20177452|P4|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
8183184|NCT02344576|20177453|P3|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
8183185|NCT02344576|20177454|P2|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
8183186|NCT02344576|20177455|P1|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
8183187|NCT02344576|20177452|P4|Completed 1-Month Survey|1-Month Follow-Up||53
8183188|NCT02344576|20177453|P3|Completed 1-Month Survey|1-Month Follow-Up||89
8183189|NCT02344576|20177454|P2|Completed 1-Month Survey|1-Month Follow-Up||79
8183190|NCT02344576|20177455|P1|Completed 1-Month Survey|1-Month Follow-Up||104
8183191|NCT02344576|20177452|P4|STARTED|1-Month Follow-Up||71
8183192|NCT02344576|20177453|P3|STARTED|1-Month Follow-Up||111
8183193|NCT02344576|20177454|P2|STARTED|1-Month Follow-Up||113
8183194|NCT02344576|20177455|P1|STARTED|1-Month Follow-Up||135
8183195|NCT02344576|20177452|P4|NOT COMPLETED|Enrollment||0
8183196|NCT02344576|20177453|P3|NOT COMPLETED|Enrollment||0
8183197|NCT02344576|20177454|P2|NOT COMPLETED|Enrollment||8
8183198|NCT02344576|20177455|P1|NOT COMPLETED|Enrollment||7
8183199|NCT02344576|20177452|P4|COMPLETED|Enrollment||71
8183200|NCT02344576|20177453|P3|COMPLETED|Enrollment||111
8183201|NCT02344576|20177454|P2|COMPLETED|Enrollment||113
8183202|NCT02344576|20177455|P1|COMPLETED|Enrollment||135
8183203|NCT02344576|20177452|P4|Agreed to Survey Data Collection|Enrollment||71
8183204|NCT02344576|20177453|P3|Agreed to Survey Data Collection|Enrollment||111
8183205|NCT02344576|20177454|P2|Agreed to Survey Data Collection|Enrollment||113
8183206|NCT02344576|20177455|P1|Agreed to Survey Data Collection|Enrollment||135
8183207|NCT02344576|20177452|P4|STARTED|Enrollment||71
8183208|NCT02344576|20177453|P3|STARTED|Enrollment||111
8183209|NCT02344576|20177454|P2|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
8183210|NCT02344576|20177455|P1|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
8183211|NCT02344407|20177501|P3|NOT COMPLETED|Overall Study||6
8183212|NCT02344407|20177502|P2|NOT COMPLETED|Overall Study||9
8183213|NCT02344407|20177503|P1|NOT COMPLETED|Overall Study||8
8183214|NCT02344407|20177501|P3|COMPLETED|Overall Study||494
8183215|NCT02344407|20177502|P2|COMPLETED|Overall Study||491
8183216|NCT02344407|20177503|P1|COMPLETED|Overall Study||492
8183217|NCT02344407|20177501|P3|STARTED|Overall Study||500
8183218|NCT02344407|20177502|P2|STARTED|Overall Study||500
8183219|NCT02344407|20177503|P1|STARTED|Overall Study||500
8183220|NCT02344342|20177518|P4|NOT COMPLETED|Overall Study||10
8183221|NCT02344342|20177519|P3|NOT COMPLETED|Overall Study||14
8183222|NCT02344342|20177520|P2|NOT COMPLETED|Overall Study||9
8183223|NCT02344342|20177521|P1|NOT COMPLETED|Overall Study||11
8183224|NCT02344342|20177518|P4|COMPLETED|Overall Study||3
8183225|NCT02344342|20177519|P3|COMPLETED|Overall Study||0
8183226|NCT02344342|20177520|P2|COMPLETED|Overall Study||2
8183227|NCT02344342|20177521|P1|COMPLETED|Overall Study||2
8183228|NCT02344342|20177518|P4|STARTED|Overall Study||13
8183229|NCT02344342|20177519|P3|STARTED|Overall Study||14
8183230|NCT02344342|20177520|P2|STARTED|Overall Study||11
8183231|NCT02344342|20177521|P1|STARTED|Overall Study||13
8183232|NCT02344251|20177545|P2|NOT COMPLETED|Overall Study||0
8183233|NCT02344251|20177546|P1|NOT COMPLETED|Overall Study||0
8183234|NCT02344251|20177545|P2|COMPLETED|Overall Study||20
8183235|NCT02344251|20177546|P1|COMPLETED|Overall Study||20
8183236|NCT02344251|20177545|P2|STARTED|Overall Study||20
8183237|NCT02344251|20177546|P1|STARTED|Overall Study||20
8183238|NCT02344238|20177557|P3|NOT COMPLETED|Overall Study||0
8183239|NCT02344238|20177558|P2|NOT COMPLETED|Overall Study||0
8183240|NCT02344238|20177559|P1|NOT COMPLETED|Overall Study||0
8183241|NCT02344238|20177557|P3|COMPLETED|Overall Study||20
8183242|NCT02344238|20177558|P2|COMPLETED|Overall Study||20
8183243|NCT02344238|20177559|P1|COMPLETED|Overall Study||20
8183244|NCT02344238|20177557|P3|STARTED|Overall Study||20
8183245|NCT02344238|20177558|P2|STARTED|Overall Study||20
8183246|NCT02344238|20177559|P1|STARTED|Overall Study||20
8183247|NCT02344225|20177571|P3|NOT COMPLETED|Overall Study||0
8183248|NCT02344225|20177572|P2|NOT COMPLETED|Overall Study||0
8183249|NCT02344225|20177573|P1|NOT COMPLETED|Overall Study||0
8183250|NCT02344225|20177571|P3|COMPLETED|Overall Study||5
8183251|NCT02344225|20177572|P2|COMPLETED|Overall Study||3
8183252|NCT02344225|20177573|P1|COMPLETED|Overall Study||6
8183253|NCT02344225|20177571|P3|STARTED|Overall Study||5
8183254|NCT02344225|20177572|P2|STARTED|Overall Study||3
8183255|NCT02344225|20177573|P1|STARTED|Overall Study||6
8183256|NCT02344173|20177587|P1|NOT COMPLETED|12-month Visit||96
8183257|NCT02344173|20177587|P1|COMPLETED|12-month Visit||1932
8183258|NCT02344173|20177587|P1|STARTED|12-month Visit||2028
8183259|NCT02344173|20177587|P1|NOT COMPLETED|Procedure||7
8183260|NCT02344173|20177587|P1|COMPLETED|Procedure||2028
8183261|NCT02344173|20177587|P1|STARTED|Procedure||2035
8183262|NCT02344173|20177587|P1|NOT COMPLETED|Enrollment||0
8183263|NCT02344173|20177587|P1|COMPLETED|Enrollment||2035
8183264|NCT02344173|20177587|P1|STARTED|Enrollment||2035
8183265|NCT02344004|20177595|P2|NOT COMPLETED|Overall Study||14
8183266|NCT02344004|20177596|P1|NOT COMPLETED|Overall Study||61
8183267|NCT02344004|20177595|P2|COMPLETED|Overall Study||98
8183268|NCT02344004|20177596|P1|COMPLETED|Overall Study||163
8183269|NCT02344004|20177595|P2|STARTED|Overall Study||112
8183270|NCT02344004|20177596|P1|STARTED|Overall Study||224
8183271|NCT02343939|20177623|P9|NOT COMPLETED|Overall Study||7
8183272|NCT02343939|20177624|P8|NOT COMPLETED|Overall Study||37
8183273|NCT02343939|20177625|P7|NOT COMPLETED|Overall Study||15
8183274|NCT02343939|20177626|P6|NOT COMPLETED|Overall Study||17
8183275|NCT02343939|20177627|P5|NOT COMPLETED|Overall Study||8
8183276|NCT02343939|20177628|P4|NOT COMPLETED|Overall Study||6
8183277|NCT02343939|20177629|P3|NOT COMPLETED|Overall Study||5
8183278|NCT02343939|20177630|P2|NOT COMPLETED|Overall Study||48
8183279|NCT02343939|20177631|P1|NOT COMPLETED|Overall Study||3
8183280|NCT02343939|20177623|P9|COMPLETED|Overall Study||0
8183281|NCT02343939|20177624|P8|COMPLETED|Overall Study||0
8183282|NCT02343939|20177625|P7|COMPLETED|Overall Study||0
8183283|NCT02343939|20177626|P6|COMPLETED|Overall Study||0
8183284|NCT02343939|20177627|P5|COMPLETED|Overall Study||0
8183285|NCT02343939|20177628|P4|COMPLETED|Overall Study||0
8183286|NCT02343939|20177629|P3|COMPLETED|Overall Study||0
8183287|NCT02343939|20177630|P2|COMPLETED|Overall Study||2
8183288|NCT02343939|20177631|P1|COMPLETED|Overall Study||0
8183289|NCT02343939|20177623|P9|STARTED|Overall Study||7
8183290|NCT02343939|20177624|P8|STARTED|Overall Study||37
8183291|NCT02343939|20177625|P7|STARTED|Overall Study||15
8183292|NCT02343939|20177626|P6|STARTED|Overall Study||17
8183293|NCT02343939|20177627|P5|STARTED|Overall Study||8
8183294|NCT02343939|20177628|P4|STARTED|Overall Study||6
8183295|NCT02343939|20177629|P3|STARTED|Overall Study||5
8183296|NCT02343939|20177630|P2|STARTED|Overall Study||50
8183297|NCT02343939|20177631|P1|STARTED|Overall Study||3
8183298|NCT02343627|20177743|P2|NOT COMPLETED|Overall Study||1
8183299|NCT02343627|20177744|P1|NOT COMPLETED|Overall Study||12
8183300|NCT02343627|20177743|P2|COMPLETED|Overall Study||11
8183301|NCT02343627|20177744|P1|COMPLETED|Overall Study||23
8183302|NCT02343627|20177743|P2|STARTED|Overall Study||12
8183303|NCT02343627|20177744|P1|STARTED|Overall Study||35
8183304|NCT02343575|20177752|P2|NOT COMPLETED|Overall Study||0
8183305|NCT02343575|20177753|P1|NOT COMPLETED|Overall Study||0
8183306|NCT02343575|20177752|P2|COMPLETED|Overall Study||2
8183307|NCT02343575|20177753|P1|COMPLETED|Overall Study||1
8183308|NCT02343575|20177752|P2|STARTED|Overall Study||2
8183309|NCT02343575|20177753|P1|STARTED|Overall Study||1
8183310|NCT02343458|20177773|P4|NOT COMPLETED|Overall Study||38
8183311|NCT02343458|20177774|P3|NOT COMPLETED|Overall Study||63
8183312|NCT02343458|20177775|P2|NOT COMPLETED|Overall Study||66
8183313|NCT02343458|20177776|P1|NOT COMPLETED|Overall Study||61
8183314|NCT02343458|20177773|P4|COMPLETED|Overall Study||200
8183315|NCT02343458|20177774|P3|COMPLETED|Overall Study||417
8183316|NCT02343458|20177775|P2|COMPLETED|Overall Study||417
8183317|NCT02343458|20177776|P1|COMPLETED|Overall Study||494
8183318|NCT02343458|20177773|P4|STARTED|Overall Study||238
8183319|NCT02343458|20177774|P3|STARTED|Overall Study||480
8183320|NCT02343458|20177775|P2|STARTED|Overall Study||483
8183321|NCT02343458|20177776|P1|STARTED|Overall Study||555
8183322|NCT02343406|20177855|P5|NOT COMPLETED|Overall Study||5
8183323|NCT02343406|20177856|P4|NOT COMPLETED|Overall Study||26
8183324|NCT02343406|20177857|P3|NOT COMPLETED|Overall Study||58
8183325|NCT02343406|20177858|P2|NOT COMPLETED|Overall Study||86
8183326|NCT02343406|20177859|P1|NOT COMPLETED|Overall Study||88
8183327|NCT02343406|20177855|P5|COMPLETED|Overall Study||1
8183328|NCT02343406|20177856|P4|COMPLETED|Overall Study||0
8183329|NCT02343406|20177857|P3|COMPLETED|Overall Study||2
8183330|NCT02343406|20177858|P2|COMPLETED|Overall Study||0
8183331|NCT02343406|20177859|P1|COMPLETED|Overall Study||0
8183332|NCT02343406|20177855|P5|STARTED|Overall Study||6
8183333|NCT02343406|20177856|P4|STARTED|Overall Study||26
8183334|NCT02343406|20177857|P3|STARTED|Overall Study||60
8183335|NCT02343406|20177858|P2|STARTED|Overall Study||86
8183336|NCT02343406|20177859|P1|STARTED|Overall Study||88
8183337|NCT02343380|20177894|P2|NOT COMPLETED|Overall Study||0
8183338|NCT02343380|20177895|P1|NOT COMPLETED|Overall Study||0
8183339|NCT02343380|20177894|P2|COMPLETED|Overall Study|Morning test (second week)|10
8183340|NCT02343380|20177895|P1|COMPLETED|Overall Study|Evening test (second week)|10
8183341|NCT02343380|20177894|P2|STARTED|Overall Study|Evening test (first week)|10
8183342|NCT02343380|20177895|P1|STARTED|Overall Study|Morning test (first week)|10
8183343|NCT02343276|20177913|P2|NOT COMPLETED|Overall Study||0
8183344|NCT02343276|20177914|P1|NOT COMPLETED|Overall Study||0
8183345|NCT02343276|20177913|P2|COMPLETED|Overall Study||164
8183346|NCT02343276|20177914|P1|COMPLETED|Overall Study||164
8183347|NCT02343276|20177913|P2|STARTED|Overall Study||164
8183348|NCT02343276|20177914|P1|STARTED|Overall Study||164
8183349|NCT02343263|20177927|P3|NOT COMPLETED|Overall Study||1
8183350|NCT02343263|20177928|P2|NOT COMPLETED|Overall Study||3
8183351|NCT02343263|20177929|P1|NOT COMPLETED|Overall Study||5
8183352|NCT02343263|20177927|P3|COMPLETED|Overall Study||0
8183353|NCT02343263|20177928|P2|COMPLETED|Overall Study||0
8183354|NCT02343263|20177929|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
8183355|NCT02343263|20177927|P3|STARTED|Overall Study||1
8183356|NCT02343263|20177928|P2|STARTED|Overall Study||3
8183357|NCT02343263|20177929|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
8183358|NCT02343159|20177958|P3|NOT COMPLETED|Overall Study||30
8183359|NCT02343159|20177959|P2|NOT COMPLETED|Overall Study||26
8183360|NCT02343159|20177960|P1|NOT COMPLETED|Overall Study||26
8183361|NCT02343159|20177958|P3|COMPLETED|Overall Study||0
8183362|NCT02343159|20177959|P2|COMPLETED|Overall Study||1
8183363|NCT02343159|20177960|P1|COMPLETED|Overall Study||1
8183364|NCT02343159|20177958|P3|STARTED|Overall Study||30
8183365|NCT02343159|20177959|P2|STARTED|Overall Study||27
8183366|NCT02343159|20177960|P1|STARTED|Overall Study||27
8183367|NCT02343081|20177987|P2|NOT COMPLETED|Second Intervention (Day 4)||0
8183368|NCT02343081|20177988|P1|NOT COMPLETED|Second Intervention (Day 4)||0
8183369|NCT02343081|20177987|P2|COMPLETED|Second Intervention (Day 4)||8
8183370|NCT02343081|20177988|P1|COMPLETED|Second Intervention (Day 4)||8
8183371|NCT02343081|20177987|P2|Received Intervention|Second Intervention (Day 4)||8
8183372|NCT02343081|20177988|P1|Received Intervention|Second Intervention (Day 4)||8
8183373|NCT02343081|20177987|P2|STARTED|Second Intervention (Day 4)||8
8183374|NCT02343081|20177988|P1|STARTED|Second Intervention (Day 4)||8
8183375|NCT02343081|20177987|P2|NOT COMPLETED|Washout (10 Hours)||0
8183376|NCT02343081|20177988|P1|NOT COMPLETED|Washout (10 Hours)||0
8183377|NCT02343081|20177987|P2|COMPLETED|Washout (10 Hours)||8
8183378|NCT02343081|20177988|P1|COMPLETED|Washout (10 Hours)||8
8183379|NCT02343081|20177987|P2|STARTED|Washout (10 Hours)||8
8183380|NCT02343081|20177988|P1|STARTED|Washout (10 Hours)||8
8183381|NCT02343081|20177987|P2|NOT COMPLETED|First Intervention (Day 3)||0
8183382|NCT02343081|20177988|P1|NOT COMPLETED|First Intervention (Day 3)||0
8183383|NCT02343081|20177987|P2|COMPLETED|First Intervention (Day 3)||8
8183384|NCT02343081|20177988|P1|COMPLETED|First Intervention (Day 3)||8
8183385|NCT02343081|20177987|P2|Received Intervention|First Intervention (Day 3)||8
8183386|NCT02343081|20177988|P1|Received Intervention|First Intervention (Day 3)||8
8183387|NCT02343081|20177987|P2|STARTED|First Intervention (Day 3)||8
8183388|NCT02343081|20177988|P1|STARTED|First Intervention (Day 3)||8
8183389|NCT02343003|20178004|P2|NOT COMPLETED|Overall Study||7
8183390|NCT02343003|20178005|P1|NOT COMPLETED|Overall Study||18
8183391|NCT02343003|20178004|P2|COMPLETED|Overall Study||68
8183392|NCT02343003|20178005|P1|COMPLETED|Overall Study||58
8183393|NCT02343003|20178004|P2|STARTED|Overall Study||75
8183394|NCT02343003|20178005|P1|STARTED|Overall Study||76
8183395|NCT02342886|20178026|P5|NOT COMPLETED|Overall Study||3
8183396|NCT02342886|20178027|P4|NOT COMPLETED|Overall Study||9
8183397|NCT02342886|20178028|P3|NOT COMPLETED|Overall Study||15
8183398|NCT02342886|20178029|P2|NOT COMPLETED|Overall Study||8
8183399|NCT02342886|20178030|P1|NOT COMPLETED|Overall Study||8
8183400|NCT02342886|20178026|P5|COMPLETED|Overall Study||10
8183401|NCT02342886|20178027|P4|COMPLETED|Overall Study||59
8183402|NCT02342886|20178028|P3|COMPLETED|Overall Study||52
8183403|NCT02342886|20178029|P2|COMPLETED|Overall Study||63
8183404|NCT02342886|20178030|P1|COMPLETED|Overall Study||57
8183405|NCT02342886|20178026|P5|Completed Month 24 Follow-Up|Overall Study||10
8183406|NCT02342886|20178027|P4|Completed Month 24 Follow-Up|Overall Study||53
8183407|NCT02342886|20178028|P3|Completed Month 24 Follow-Up|Overall Study||46
8183408|NCT02342886|20178029|P2|Completed Month 24 Follow-Up|Overall Study||47
8183409|NCT02342886|20178030|P1|Completed Month 24 Follow-Up|Overall Study||40
8183410|NCT02342886|20178026|P5|Completed Month 12 Follow-Up|Overall Study||10
8183411|NCT02342886|20178027|P4|Completed Month 12 Follow-Up|Overall Study||57
8183412|NCT02342886|20178028|P3|Completed Month 12 Follow-Up|Overall Study||49
8183413|NCT02342886|20178029|P2|Completed Month 12 Follow-Up|Overall Study||52
8183414|NCT02342886|20178030|P1|Completed Month 12 Follow-Up|Overall Study||43
8183415|NCT02342886|20178026|P5|STARTED|Overall Study||13
8183416|NCT02342886|20178027|P4|STARTED|Overall Study||68
8183417|NCT02342886|20178028|P3|STARTED|Overall Study||67
8183418|NCT02342886|20178029|P2|STARTED|Overall Study||71
8183419|NCT02342886|20178030|P1|STARTED|Overall Study||65
8183420|NCT02342743|20178047|P1|NOT COMPLETED|Treatment Period||11
8183421|NCT02342743|20178047|P1|COMPLETED|Treatment Period||47
8183422|NCT02342743|20178047|P1|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
8183423|NCT02342743|20178047|P1|NOT COMPLETED|Baseline Period||15
8183424|NCT02342743|20178047|P1|COMPLETED|Baseline Period||58
8183425|NCT02342743|20178047|P1|STARTED|Baseline Period||73
8183426|NCT02342704|20178060|P2|NOT COMPLETED|Overall Study||51
8183427|NCT02342704|20178061|P1|NOT COMPLETED|Overall Study||53
8183428|NCT02342704|20178060|P2|COMPLETED|Overall Study||3
8183429|NCT02342704|20178061|P1|COMPLETED|Overall Study||1
8183430|NCT02342704|20178060|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8183431|NCT02342704|20178061|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8183432|NCT02342678|20178089|P2|NOT COMPLETED|Overall Study||5
8183433|NCT02342678|20178090|P1|NOT COMPLETED|Overall Study||1
8183434|NCT02342678|20178089|P2|COMPLETED|Overall Study||23
8183435|NCT02342678|20178090|P1|COMPLETED|Overall Study||27
8183436|NCT02342678|20178089|P2|STARTED|Overall Study||28
8183437|NCT02342678|20178090|P1|STARTED|Overall Study||28
8183438|NCT02342561|20178110|P1|NOT COMPLETED|Overall Study||0
8183439|NCT02342561|20178110|P1|COMPLETED|Overall Study||20
8183440|NCT02342561|20178110|P1|STARTED|Overall Study||20
8183441|NCT02342548|20178121|P3|NOT COMPLETED|Overall Study||43
8183442|NCT02342548|20178122|P2|NOT COMPLETED|Overall Study||62
8183443|NCT02342548|20178123|P1|NOT COMPLETED|Overall Study||34
8183444|NCT02342548|20178121|P3|COMPLETED|Overall Study||23
8183445|NCT02342548|20178122|P2|COMPLETED|Overall Study||9
8183446|NCT02342548|20178123|P1|COMPLETED|Overall Study||17
8183447|NCT02342548|20178121|P3|STARTED|Overall Study||66
8183448|NCT02342548|20178122|P2|STARTED|Overall Study||71
8183449|NCT02342548|20178123|P1|STARTED|Overall Study||51
8183450|NCT02342535|20178161|P1|NOT COMPLETED|Overall Study||0
8183451|NCT02342535|20178161|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
8183452|NCT02342535|20178161|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
8183453|NCT02342418|20178167|P2|NOT COMPLETED|Overall Study||1
8183454|NCT02342418|20178168|P1|NOT COMPLETED|Overall Study||0
8183455|NCT02342418|20178167|P2|COMPLETED|Overall Study||9
8183456|NCT02342418|20178168|P1|COMPLETED|Overall Study||9
8183457|NCT02342418|20178167|P2|STARTED|Overall Study||10
8183458|NCT02342418|20178168|P1|STARTED|Overall Study||9
8183459|NCT02342379|20178176|P1|NOT COMPLETED|Overall Study||0
8183460|NCT02342379|20178176|P1|COMPLETED|Overall Study||35
8183461|NCT02342379|20178176|P1|STARTED|Overall Study||35
8183462|NCT02342314|20178183|P17|NOT COMPLETED|Part B||0
8183463|NCT02342314|20178184|P16|NOT COMPLETED|Part B||0
8183464|NCT02342314|20178185|P15|NOT COMPLETED|Part B||0
8183465|NCT02342314|20178186|P14|NOT COMPLETED|Part B||0
8183466|NCT02342314|20178187|P13|NOT COMPLETED|Part B||0
8183467|NCT02342314|20178188|P12|NOT COMPLETED|Part B||0
8183468|NCT02342314|20178189|P11|NOT COMPLETED|Part B||0
8183469|NCT02342314|20178190|P10|NOT COMPLETED|Part B||0
8183470|NCT02342314|20178191|P9|NOT COMPLETED|Part B||0
8183471|NCT02342314|20178192|P8|NOT COMPLETED|Part B||0
8183472|NCT02342314|20178193|P7|NOT COMPLETED|Part B||0
8183473|NCT02342314|20178194|P6|NOT COMPLETED|Part B||0
8183474|NCT02342314|20178195|P5|NOT COMPLETED|Part B||0
8183475|NCT02342314|20178196|P4|NOT COMPLETED|Part B||0
8183476|NCT02342314|20178197|P3|NOT COMPLETED|Part B||0
8183477|NCT02342314|20178198|P2|NOT COMPLETED|Part B||0
8183478|NCT02342314|20178199|P1|NOT COMPLETED|Part B||0
8183479|NCT02342314|20178183|P17|COMPLETED|Part B||6
8183480|NCT02342314|20178184|P16|COMPLETED|Part B||3
8183481|NCT02342314|20178185|P15|COMPLETED|Part B||3
8183482|NCT02342314|20178186|P14|COMPLETED|Part B||3
8183483|NCT02342314|20178187|P13|COMPLETED|Part B||3
8183484|NCT02342314|20178188|P12|COMPLETED|Part B||3
8183485|NCT02342314|20178189|P11|COMPLETED|Part B||3
8183486|NCT02342314|20178190|P10|COMPLETED|Part B||3
8183487|NCT02342314|20178191|P9|COMPLETED|Part B||3
8183488|NCT02342314|20178192|P8|COMPLETED|Part B||3
8183489|NCT02342314|20178193|P7|COMPLETED|Part B||11
8183490|NCT02342314|20178194|P6|COMPLETED|Part B||0
8183491|NCT02342314|20178195|P5|COMPLETED|Part B||0
8183492|NCT02342314|20178196|P4|COMPLETED|Part B||0
8183493|NCT02342314|20178197|P3|COMPLETED|Part B||0
8183494|NCT02342314|20178198|P2|COMPLETED|Part B||0
8183495|NCT02342314|20178199|P1|COMPLETED|Part B||0
8183496|NCT02342314|20178183|P17|STARTED|Part B|Participants received rGlucagon in Part B.|6
8183497|NCT02342314|20178184|P16|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183498|NCT02342314|20178185|P15|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183499|NCT02342314|20178186|P14|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183500|NCT02342314|20178187|P13|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183501|NCT02342314|20178188|P12|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183502|NCT02342314|20178189|P11|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183503|NCT02342314|20178190|P10|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183504|NCT02342314|20178191|P9|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183505|NCT02342314|20178192|P8|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183506|NCT02342314|20178193|P7|STARTED|Part B|Participants received placebo in Part B.|11
8183507|NCT02342314|20178194|P6|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183508|NCT02342314|20178195|P5|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183509|NCT02342314|20178196|P4|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183510|NCT02342314|20178197|P3|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183511|NCT02342314|20178198|P2|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183512|NCT02342314|20178199|P1|STARTED|Part B|Participants received placebo in Part A.|0
8183513|NCT02342314|20178183|P17|NOT COMPLETED|Part A||0
8183514|NCT02342314|20178184|P16|NOT COMPLETED|Part A||0
8183515|NCT02342314|20178185|P15|NOT COMPLETED|Part A||0
8183516|NCT02342314|20178186|P14|NOT COMPLETED|Part A||0
8183517|NCT02342314|20178187|P13|NOT COMPLETED|Part A||0
8183518|NCT02342314|20178188|P12|NOT COMPLETED|Part A||0
8183519|NCT02342314|20178189|P11|NOT COMPLETED|Part A||0
8183520|NCT02342314|20178190|P10|NOT COMPLETED|Part A||0
8183521|NCT02342314|20178191|P9|NOT COMPLETED|Part A||0
8183522|NCT02342314|20178192|P8|NOT COMPLETED|Part A||0
8183523|NCT02342314|20178193|P7|NOT COMPLETED|Part A||0
8183524|NCT02342314|20178194|P6|NOT COMPLETED|Part A||0
8183525|NCT02342314|20178195|P5|NOT COMPLETED|Part A||0
8183526|NCT02342314|20178196|P4|NOT COMPLETED|Part A||0
8183527|NCT02342314|20178197|P3|NOT COMPLETED|Part A||0
8183528|NCT02342314|20178198|P2|NOT COMPLETED|Part A||0
8183529|NCT02342314|20178199|P1|NOT COMPLETED|Part A||0
8183530|NCT02342314|20178183|P17|COMPLETED|Part A||0
8183531|NCT02342314|20178184|P16|COMPLETED|Part A||0
8183532|NCT02342314|20178185|P15|COMPLETED|Part A||0
8183533|NCT02342314|20178186|P14|COMPLETED|Part A||0
8183534|NCT02342314|20178187|P13|COMPLETED|Part A||0
8183535|NCT02342314|20178188|P12|COMPLETED|Part A||0
8183536|NCT02342314|20178189|P11|COMPLETED|Part A||0
8183537|NCT02342314|20178190|P10|COMPLETED|Part A||0
8183538|NCT02342314|20178191|P9|COMPLETED|Part A||0
8183539|NCT02342314|20178192|P8|COMPLETED|Part A||0
8183540|NCT02342314|20178193|P7|COMPLETED|Part A||0
8183541|NCT02342314|20178194|P6|COMPLETED|Part A||3
8183542|NCT02342314|20178195|P5|COMPLETED|Part A||6
8183543|NCT02342314|20178196|P4|COMPLETED|Part A||3
8183544|NCT02342314|20178197|P3|COMPLETED|Part A||3
8183545|NCT02342314|20178198|P2|COMPLETED|Part A||3
8183546|NCT02342314|20178199|P1|COMPLETED|Part A||6
8183547|NCT02342314|20178183|P17|STARTED|Part A||0
8183548|NCT02342314|20178184|P16|STARTED|Part A||0
8183549|NCT02342314|20178185|P15|STARTED|Part A||0
8183550|NCT02342314|20178186|P14|STARTED|Part A||0
8183551|NCT02342314|20178187|P13|STARTED|Part A||0
8183552|NCT02342314|20178188|P12|STARTED|Part A||0
8183553|NCT02342314|20178189|P11|STARTED|Part A||0
8183554|NCT02342314|20178190|P10|STARTED|Part A||0
8183555|NCT02342314|20178191|P9|STARTED|Part A||0
8183556|NCT02342314|20178192|P8|STARTED|Part A||0
8183557|NCT02342314|20178193|P7|STARTED|Part A||0
8183558|NCT02342314|20178194|P6|STARTED|Part A||3
8183559|NCT02342314|20178195|P5|STARTED|Part A||6
8183560|NCT02342314|20178196|P4|STARTED|Part A||3
8183561|NCT02342314|20178197|P3|STARTED|Part A||3
8183562|NCT02342314|20178198|P2|STARTED|Part A||3
8183563|NCT02342314|20178199|P1|STARTED|Part A||6
8183564|NCT02342288|20178347|P2|NOT COMPLETED|Overall Study||6
8183565|NCT02342288|20178348|P1|NOT COMPLETED|Overall Study||5
8183566|NCT02342288|20178347|P2|COMPLETED|Overall Study||27
8183567|NCT02342288|20178348|P1|COMPLETED|Overall Study||25
8183568|NCT02342288|20178347|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
8183569|NCT02342288|20178348|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
8183570|NCT02342223|20178354|P1|NOT COMPLETED|Overall Study||1
8183571|NCT02342223|20178354|P1|COMPLETED|Overall Study||19
8183572|NCT02342223|20178354|P1|STARTED|Overall Study||20
8183573|NCT02342197|20178365|P2|NOT COMPLETED|Overall Study||2
8183574|NCT02342197|20178366|P1|NOT COMPLETED|Overall Study||3
8183575|NCT02342197|20178365|P2|COMPLETED|Overall Study||28
8183576|NCT02342197|20178366|P1|COMPLETED|Overall Study||27
8183577|NCT02342197|20178365|P2|STARTED|Overall Study||30
8183578|NCT02342197|20178366|P1|STARTED|Overall Study||30
8183579|NCT02342171|20178374|P2|NOT COMPLETED|Overall Study||89
8183580|NCT02342171|20178375|P1|NOT COMPLETED|Overall Study||15
8183581|NCT02342171|20178374|P2|COMPLETED|Overall Study||418
8183582|NCT02342171|20178375|P1|COMPLETED|Overall Study||84
8183583|NCT02342171|20178374|P2|STARTED|Overall Study||507
8183584|NCT02342171|20178375|P1|STARTED|Overall Study||99
8183585|NCT02341859|20178391|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8183586|NCT02341859|20178392|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8183587|NCT02341859|20178391|P2|COMPLETED|Second Intervention (1 Day)||9
8183588|NCT02341859|20178392|P1|COMPLETED|Second Intervention (1 Day)||10
8183589|NCT02341859|20178391|P2|STARTED|Second Intervention (1 Day)||9
8183590|NCT02341859|20178392|P1|STARTED|Second Intervention (1 Day)||10
8183591|NCT02341859|20178391|P2|NOT COMPLETED|First Intervention (1 Day)||0
8183592|NCT02341859|20178392|P1|NOT COMPLETED|First Intervention (1 Day)||0
8183593|NCT02341859|20178391|P2|COMPLETED|First Intervention (1 Day)||9
8183594|NCT02341859|20178392|P1|COMPLETED|First Intervention (1 Day)||10
8183595|NCT02341859|20178391|P2|STARTED|First Intervention (1 Day)||9
8183596|NCT02341859|20178392|P1|STARTED|First Intervention (1 Day)||10
8183597|NCT02341599|20178550|P5|NOT COMPLETED|Overall Study||0
8183598|NCT02341599|20178551|P4|NOT COMPLETED|Overall Study||0
8183599|NCT02341599|20178552|P3|NOT COMPLETED|Overall Study||0
8183600|NCT02341599|20178553|P2|NOT COMPLETED|Overall Study||0
8183601|NCT02341599|20178554|P1|NOT COMPLETED|Overall Study||0
8183602|NCT02341599|20178550|P5|COMPLETED|Overall Study||8
8183603|NCT02341599|20178551|P4|COMPLETED|Overall Study||8
8183604|NCT02341599|20178552|P3|COMPLETED|Overall Study||8
8183605|NCT02341599|20178553|P2|COMPLETED|Overall Study||8
8183606|NCT02341599|20178554|P1|COMPLETED|Overall Study||8
8183607|NCT02341599|20178550|P5|STARTED|Overall Study||8
8183608|NCT02341599|20178551|P4|STARTED|Overall Study||8
8183609|NCT02341599|20178552|P3|STARTED|Overall Study||8
8183610|NCT02341599|20178553|P2|STARTED|Overall Study||8
8183611|NCT02341599|20178554|P1|STARTED|Overall Study||8
8183612|NCT02341495|20178622|P1|NOT COMPLETED|Overall Study||0
8183613|NCT02341495|20178622|P1|COMPLETED|Overall Study||4
8183614|NCT02341495|20178622|P1|STARTED|Overall Study||4
8183615|NCT02341482|20178629|P1|NOT COMPLETED|Overall Study||1
8183616|NCT02341482|20178629|P1|COMPLETED|Overall Study||12
8183617|NCT02341482|20178629|P1|STARTED|Overall Study||13
8183618|NCT02341456|20178658|P3|NOT COMPLETED|Overall Study||4
8183619|NCT02341456|20178659|P2|NOT COMPLETED|Overall Study||6
8183620|NCT02341456|20178660|P1|NOT COMPLETED|Overall Study||4
8183621|NCT02341456|20178658|P3|COMPLETED|Overall Study||2
8183622|NCT02341456|20178659|P2|COMPLETED|Overall Study||0
8183623|NCT02341456|20178660|P1|COMPLETED|Overall Study||3
8183624|NCT02341456|20178658|P3|STARTED|Overall Study||6
8183625|NCT02341456|20178659|P2|STARTED|Overall Study||6
8183626|NCT02341456|20178660|P1|STARTED|Overall Study||7
8183627|NCT02341417|20178785|P3|NOT COMPLETED|Overall Study||1
8183628|NCT02341417|20178786|P2|NOT COMPLETED|Overall Study||2
8183629|NCT02341417|20178787|P1|NOT COMPLETED|Overall Study||2
8183630|NCT02341417|20178785|P3|COMPLETED|Overall Study||0
8183631|NCT02341417|20178786|P2|COMPLETED|Overall Study||12
8183632|NCT02341417|20178787|P1|COMPLETED|Overall Study||11
8183633|NCT02341417|20178785|P3|STARTED|Overall Study||1
8183634|NCT02341417|20178786|P2|STARTED|Overall Study||14
8183635|NCT02341417|20178787|P1|STARTED|Overall Study||13
8183636|NCT02341144|20178831|P2|NOT COMPLETED|Overall Study||1
8183637|NCT02341144|20178832|P1|NOT COMPLETED|Overall Study||2
8183638|NCT02341144|20178831|P2|COMPLETED|Overall Study||30
8183639|NCT02341144|20178832|P1|COMPLETED|Overall Study||28
8183640|NCT02341144|20178831|P2|STARTED|Overall Study||31
8183641|NCT02341144|20178832|P1|STARTED|Overall Study||30
8183642|NCT02340975|20178852|P6|NOT COMPLETED|Overall Study||19
8183643|NCT02340975|20178853|P5|NOT COMPLETED|Overall Study||25
8183644|NCT02340975|20178854|P4|NOT COMPLETED|Overall Study||12
8183645|NCT02340975|20178855|P3|NOT COMPLETED|Overall Study||24
8183646|NCT02340975|20178856|P2|NOT COMPLETED|Overall Study||27
8183647|NCT02340975|20178857|P1|NOT COMPLETED|Overall Study||6
8183648|NCT02340975|20178852|P6|COMPLETED|Overall Study||0
8183649|NCT02340975|20178853|P5|COMPLETED|Overall Study||0
8183650|NCT02340975|20178854|P4|COMPLETED|Overall Study||0
8183651|NCT02340975|20178855|P3|COMPLETED|Overall Study||0
8183652|NCT02340975|20178856|P2|COMPLETED|Overall Study||0
8183653|NCT02340975|20178857|P1|COMPLETED|Overall Study||0
8183654|NCT02340975|20178852|P6|STARTED|Overall Study||19
8183655|NCT02340975|20178853|P5|STARTED|Overall Study||25
8183656|NCT02340975|20178854|P4|STARTED|Overall Study||12
8183657|NCT02340975|20178855|P3|STARTED|Overall Study||24
8183658|NCT02340975|20178856|P2|STARTED|Overall Study||27
8183659|NCT02340975|20178857|P1|STARTED|Overall Study||6
8183660|NCT02340962|20178971|P2|NOT COMPLETED|Overall Study||0
8183661|NCT02340962|20178972|P1|NOT COMPLETED|Overall Study||1
8183662|NCT02340962|20178971|P2|COMPLETED|Overall Study||12
8183663|NCT02340962|20178972|P1|COMPLETED|Overall Study||12
8183664|NCT02340962|20178971|P2|STARTED|Overall Study||12
8183665|NCT02340962|20178972|P1|STARTED|Overall Study||13
8183666|NCT02340819|20178992|P1|NOT COMPLETED|Overall Study||4
8183667|NCT02340819|20178992|P1|COMPLETED|Overall Study||7
8183668|NCT02340819|20178992|P1|Completed Stage 4|Overall Study||7
8183669|NCT02340819|20178992|P1|Started Stage 4|Overall Study||7
8183670|NCT02340819|20178992|P1|Completed Stage 3|Overall Study||7
8183671|NCT02340819|20178992|P1|Started Stage 3|Overall Study||8
8183672|NCT02340819|20178992|P1|Completed Stage 2|Overall Study||9
8183673|NCT02340819|20178992|P1|Started Stage 2|Overall Study||11
8183674|NCT02340819|20178992|P1|STARTED|Overall Study||11
8183675|NCT02340806|20179021|P2|NOT COMPLETED|Overall Study||4
8183676|NCT02340806|20179022|P1|NOT COMPLETED|Overall Study||6
8183677|NCT02340806|20179021|P2|COMPLETED|Overall Study||108
8183678|NCT02340806|20179022|P1|COMPLETED|Overall Study||102
8183679|NCT02340806|20179021|P2|STARTED|Overall Study||112
8183680|NCT02340806|20179022|P1|STARTED|Overall Study||108
8183681|NCT02340780|20179048|P1|NOT COMPLETED|Overall Study||1
8183682|NCT02340780|20179048|P1|COMPLETED|Overall Study||13
8183683|NCT02340780|20179048|P1|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
8183684|NCT02340767|20179062|P9|NOT COMPLETED|Overall Study||0
8183685|NCT02340767|20179063|P8|NOT COMPLETED|Overall Study||0
8183686|NCT02340767|20179064|P7|NOT COMPLETED|Overall Study||0
8183687|NCT02340767|20179065|P6|NOT COMPLETED|Overall Study||0
8183688|NCT02340767|20179066|P5|NOT COMPLETED|Overall Study||0
8183689|NCT02340767|20179067|P4|NOT COMPLETED|Overall Study||0
8183690|NCT02340767|20179068|P3|NOT COMPLETED|Overall Study||0
8183691|NCT02340767|20179069|P2|NOT COMPLETED|Overall Study||0
8183692|NCT02340767|20179070|P1|NOT COMPLETED|Overall Study||0
8183693|NCT02340767|20179062|P9|COMPLETED|Overall Study||531
8183694|NCT02340767|20179063|P8|COMPLETED|Overall Study||444
8183695|NCT02340767|20179064|P7|COMPLETED|Overall Study||525
8183696|NCT02340767|20179065|P6|COMPLETED|Overall Study||526
8183697|NCT02340767|20179066|P5|COMPLETED|Overall Study||474
8183698|NCT02340767|20179067|P4|COMPLETED|Overall Study||500
8183699|NCT02340767|20179068|P3|COMPLETED|Overall Study||29
8183700|NCT02340767|20179069|P2|COMPLETED|Overall Study||28
8183701|NCT02340767|20179070|P1|COMPLETED|Overall Study||28
8183702|NCT02340767|20179062|P9|STARTED|Overall Study||531
8183703|NCT02340767|20179063|P8|STARTED|Overall Study||444
8183704|NCT02340767|20179064|P7|STARTED|Overall Study||525
8183705|NCT02340767|20179065|P6|STARTED|Overall Study||526
8183706|NCT02340767|20179066|P5|STARTED|Overall Study||474
8183707|NCT02340767|20179067|P4|STARTED|Overall Study||500
8183708|NCT02340767|20179068|P3|STARTED|Overall Study||29
8183709|NCT02340767|20179069|P2|STARTED|Overall Study||28
8183710|NCT02340767|20179070|P1|STARTED|Overall Study||28
8183711|NCT02340728|20179088|P2|NOT COMPLETED|Overall Study||0
8183712|NCT02340728|20179089|P1|NOT COMPLETED|Overall Study||0
8183713|NCT02340728|20179088|P2|COMPLETED|Overall Study||11
8183714|NCT02340728|20179089|P1|COMPLETED|Overall Study||13
8183715|NCT02340728|20179088|P2|STARTED|Overall Study||11
8183716|NCT02340728|20179089|P1|STARTED|Overall Study||13
8183717|NCT02340715|20179099|P1|NOT COMPLETED|Overall Study||0
8183718|NCT02340715|20179099|P1|COMPLETED|Overall Study|158|158
8183719|NCT02340715|20179099|P1|STARTED|Overall Study|158|158
8183720|NCT02340663|20179105|P2|NOT COMPLETED|Overall Study||1
8183721|NCT02340663|20179106|P1|NOT COMPLETED|Overall Study||5
8183722|NCT02340663|20179105|P2|COMPLETED|Overall Study||31
8183723|NCT02340663|20179106|P1|COMPLETED|Overall Study||30
8183724|NCT02340663|20179105|P2|4 Month Follow-up, Assessments|Overall Study||31
8183725|NCT02340663|20179106|P1|4 Month Follow-up, Assessments|Overall Study||30
8183726|NCT02340663|20179105|P2|1 Week Follow-up, Assessments|Overall Study||31
8183727|NCT02340663|20179106|P1|1 Week Follow-up, Assessments|Overall Study||33
8183728|NCT02340663|20179105|P2|Splint Delivery, Assessments|Overall Study||31
8183729|NCT02340663|20179106|P1|Splint Delivery, Assessments|Overall Study||33
8183730|NCT02340663|20179105|P2|Clinical Exam, Impressions|Overall Study||32
8183731|NCT02340663|20179106|P1|Clinical Exam, Impressions|Overall Study||35
8183732|NCT02340663|20179105|P2|STARTED|Overall Study||32
8183733|NCT02340663|20179106|P1|STARTED|Overall Study||35
8183734|NCT02340520|20179162|P1|NOT COMPLETED|Overall Study||3
8183735|NCT02340520|20179162|P1|COMPLETED|Overall Study||8
8183736|NCT02340520|20179162|P1|STARTED|Overall Study||11
8183737|NCT02340338|20179174|P7|NOT COMPLETED|Overall Study||0
8183738|NCT02340338|20179175|P6|NOT COMPLETED|Overall Study||0
8183739|NCT02340338|20179176|P5|NOT COMPLETED|Overall Study||0
8183740|NCT02340338|20179177|P4|NOT COMPLETED|Overall Study||0
8183741|NCT02340338|20179178|P3|NOT COMPLETED|Overall Study||0
8183742|NCT02340338|20179179|P2|NOT COMPLETED|Overall Study||0
8183743|NCT02340338|20179180|P1|NOT COMPLETED|Overall Study||0
8183744|NCT02340338|20179174|P7|COMPLETED|Overall Study||12
8183745|NCT02340338|20179175|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
8183746|NCT02340338|20179176|P5|COMPLETED|Overall Study||9
8183747|NCT02340338|20179177|P4|COMPLETED|Overall Study||9
8183748|NCT02340338|20179178|P3|COMPLETED|Overall Study||3
8183749|NCT02340338|20179179|P2|COMPLETED|Overall Study||2
8183750|NCT02340338|20179180|P1|COMPLETED|Overall Study||2
8183751|NCT02340338|20179174|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
8183752|NCT02340338|20179175|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
8183753|NCT02340338|20179176|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
8183754|NCT02340338|20179177|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
8183755|NCT02340338|20179178|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
8183756|NCT02340338|20179179|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
8183757|NCT02340338|20179180|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
8183758|NCT02340299|20179205|P2|NOT COMPLETED|Overall Study||0
8183759|NCT02340299|20179206|P1|NOT COMPLETED|Overall Study||0
8183760|NCT02340299|20179205|P2|COMPLETED|Overall Study||2
8183761|NCT02340299|20179206|P1|COMPLETED|Overall Study||4
8183762|NCT02340299|20179205|P2|STARTED|Overall Study||2
8183763|NCT02340299|20179206|P1|STARTED|Overall Study||4
8183770|NCT02340104|20179239|P1|NOT COMPLETED|Overall Study||0
8183771|NCT02340104|20179239|P1|COMPLETED|Overall Study||8
8183772|NCT02340104|20179239|P1|STARTED|Overall Study||8
8183773|NCT02340091|20179244|P1|NOT COMPLETED|Overall Study||2
8183774|NCT02340091|20179244|P1|COMPLETED|Overall Study||60
8183775|NCT02340091|20179244|P1|STARTED|Overall Study|All Study Participants|62
8183776|NCT02340078|20179249|P1|NOT COMPLETED|Overall Study||1
8183777|NCT02340078|20179249|P1|COMPLETED|Overall Study||61
8183778|NCT02340078|20179249|P1|STARTED|Overall Study||62
8183779|NCT02340000|20179256|P2|NOT COMPLETED|Time Period 2||15
8183780|NCT02340000|20179257|P1|NOT COMPLETED|Time Period 2||19
8183781|NCT02340000|20179256|P2|COMPLETED|Time Period 2||52
8183782|NCT02340000|20179257|P1|COMPLETED|Time Period 2||50
8183783|NCT02340000|20179256|P2|STARTED|Time Period 2||67
8183784|NCT02340000|20179257|P1|STARTED|Time Period 2||69
8183785|NCT02340000|20179256|P2|NOT COMPLETED|Time Period 1||15
8183786|NCT02340000|20179257|P1|NOT COMPLETED|Time Period 1||12
8183787|NCT02340000|20179256|P2|COMPLETED|Time Period 1||74
8183788|NCT02340000|20179257|P1|COMPLETED|Time Period 1||78
8183789|NCT02340000|20179256|P2|STARTED|Time Period 1||89
8183790|NCT02340000|20179257|P1|STARTED|Time Period 1||90
8183791|NCT02339909|20179287|P3|NOT COMPLETED|Overall Study||71
8183792|NCT02339909|20179288|P2|NOT COMPLETED|Overall Study||63
8183793|NCT02339909|20179289|P1|NOT COMPLETED|Overall Study||89
8183794|NCT02339909|20179287|P3|COMPLETED|Overall Study||304
8183795|NCT02339909|20179288|P2|COMPLETED|Overall Study||312
8183796|NCT02339909|20179289|P1|COMPLETED|Overall Study||435
8183797|NCT02339909|20179287|P3|STARTED|Overall Study||375
8183798|NCT02339909|20179288|P2|STARTED|Overall Study||375
8183799|NCT02339909|20179289|P1|STARTED|Overall Study||524
8183800|NCT02339831|20179302|P2|NOT COMPLETED|Overall Study||7
8183801|NCT02339831|20179303|P1|NOT COMPLETED|Overall Study||20
8183802|NCT02339831|20179302|P2|COMPLETED|Overall Study||45
8183803|NCT02339831|20179303|P1|COMPLETED|Overall Study||38
8183804|NCT02339831|20179302|P2|Lost to Follow Up|Overall Study||7
8183805|NCT02339831|20179303|P1|Lost to Follow Up|Overall Study||20
8183806|NCT02339831|20179302|P2|STARTED|Overall Study||52
8183807|NCT02339831|20179303|P1|STARTED|Overall Study||58
8183808|NCT02339584|20179327|P2|NOT COMPLETED|Overall Study||15
8183809|NCT02339584|20179328|P1|NOT COMPLETED|Overall Study||15
8183810|NCT02339584|20179327|P2|COMPLETED|Overall Study||176
8183811|NCT02339584|20179328|P1|COMPLETED|Overall Study||173
8183812|NCT02339584|20179327|P2|STARTED|Overall Study||191
8183813|NCT02339584|20179328|P1|STARTED|Overall Study||188
8183814|NCT02339558|20179334|P1|NOT COMPLETED|Overall Study||0
8183815|NCT02339558|20179334|P1|COMPLETED|Overall Study||45
8183816|NCT02339558|20179334|P1|STARTED|Overall Study||45
8183817|NCT02339545|20179343|P1|NOT COMPLETED|Overall Study||0
8183818|NCT02339545|20179343|P1|COMPLETED|Overall Study||15
8183819|NCT02339545|20179343|P1|STARTED|Overall Study||15
8183820|NCT02339506|20179348|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
8183821|NCT02339506|20179349|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
8183822|NCT02339506|20179348|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
8183823|NCT02339506|20179349|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
8183824|NCT02339506|20179348|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
8183825|NCT02339506|20179349|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
8183826|NCT02339506|20179348|P2|NOT COMPLETED|Washout (Period 2)||0
8183827|NCT02339506|20179349|P1|NOT COMPLETED|Washout (Period 2)||2
8183828|NCT02339506|20179348|P2|COMPLETED|Washout (Period 2)||10
8183829|NCT02339506|20179349|P1|COMPLETED|Washout (Period 2)||10
8183830|NCT02339506|20179348|P2|STARTED|Washout (Period 2)||10
8183831|NCT02339506|20179349|P1|STARTED|Washout (Period 2)||12
8183832|NCT02339506|20179348|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
8183833|NCT02339506|20179349|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
8183834|NCT02339506|20179348|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
8183835|NCT02339506|20179349|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
8183836|NCT02339506|20179348|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
8183837|NCT02339506|20179349|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
8183838|NCT02339415|20179359|P2|NOT COMPLETED|Second Period||2
8183839|NCT02339415|20179360|P1|NOT COMPLETED|Second Period||1
8183840|NCT02339415|20179359|P2|COMPLETED|Second Period||18
8183841|NCT02339415|20179360|P1|COMPLETED|Second Period||19
8183842|NCT02339415|20179359|P2|STARTED|Second Period||20
8183843|NCT02339415|20179360|P1|STARTED|Second Period||20
8183844|NCT02339415|20179359|P2|NOT COMPLETED|Washout||0
8183845|NCT02339415|20179360|P1|NOT COMPLETED|Washout||0
8183846|NCT02339415|20179359|P2|COMPLETED|Washout||20
8183847|NCT02339415|20179360|P1|COMPLETED|Washout||20
8183848|NCT02339415|20179359|P2|STARTED|Washout||20
8183849|NCT02339415|20179360|P1|STARTED|Washout||20
8183850|NCT02339415|20179359|P2|NOT COMPLETED|First Period||2
8183851|NCT02339415|20179360|P1|NOT COMPLETED|First Period||2
8183852|NCT02339415|20179359|P2|COMPLETED|First Period||20
8183853|NCT02339415|20179360|P1|COMPLETED|First Period||20
8183854|NCT02339415|20179359|P2|Received at Least One Dose|First Period||20
8183855|NCT02339415|20179360|P1|Received at Least One Dose|First Period||21
8183856|NCT02339415|20179359|P2|STARTED|First Period||22
8183857|NCT02339415|20179360|P1|STARTED|First Period||22
8183858|NCT02339389|20179370|P1|NOT COMPLETED|Overall Study||16
8183859|NCT02339389|20179370|P1|COMPLETED|Overall Study||41
8183860|NCT02339389|20179370|P1|STARTED|Overall Study||57
8183861|NCT02339285|20179378|P3|NOT COMPLETED|Overall Study||2
8183862|NCT02339285|20179379|P2|NOT COMPLETED|Overall Study||3
8183863|NCT02339285|20179380|P1|NOT COMPLETED|Overall Study||1
8183864|NCT02339285|20179378|P3|COMPLETED|Overall Study||9
8183865|NCT02339285|20179379|P2|COMPLETED|Overall Study||8
8183866|NCT02339285|20179380|P1|COMPLETED|Overall Study||9
8183867|NCT02339285|20179378|P3|4 Week Follow-up Visit|Overall Study||9
8183868|NCT02339285|20179379|P2|4 Week Follow-up Visit|Overall Study||8
8183869|NCT02339285|20179380|P1|4 Week Follow-up Visit|Overall Study||9
8183870|NCT02339285|20179378|P3|2 Week Follow-up|Overall Study||10
8183871|NCT02339285|20179379|P2|2 Week Follow-up|Overall Study||10
8183872|NCT02339285|20179380|P1|2 Week Follow-up|Overall Study||9
8183873|NCT02339285|20179378|P3|Completed Intervention|Overall Study||10
8183874|NCT02339285|20179379|P2|Completed Intervention|Overall Study||10
8183875|NCT02339285|20179380|P1|Completed Intervention|Overall Study||10
8183876|NCT02339285|20179378|P3|STARTED|Overall Study||11
8183877|NCT02339285|20179379|P2|STARTED|Overall Study||11
8183878|NCT02339285|20179380|P1|STARTED|Overall Study||10
8183879|NCT02339246|20179408|P3|NOT COMPLETED|Third Period (7 Days)||0
8183880|NCT02339246|20179409|P2|NOT COMPLETED|Third Period (7 Days)||0
8183881|NCT02339246|20179410|P1|NOT COMPLETED|Third Period (7 Days)||0
8183882|NCT02339246|20179408|P3|COMPLETED|Third Period (7 Days)||0
8183883|NCT02339246|20179409|P2|COMPLETED|Third Period (7 Days)||16
8183884|NCT02339246|20179410|P1|COMPLETED|Third Period (7 Days)||15
8183885|NCT02339246|20179408|P3|STARTED|Third Period (7 Days)||0
8183886|NCT02339246|20179409|P2|STARTED|Third Period (7 Days)||16
8183887|NCT02339246|20179410|P1|STARTED|Third Period (7 Days)||15
8183888|NCT02339246|20179408|P3|NOT COMPLETED|Second Intervention (7 Days)||0
8183889|NCT02339246|20179409|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8183890|NCT02339246|20179410|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8183891|NCT02339246|20179408|P3|COMPLETED|Second Intervention (7 Days)||0
8183892|NCT02339246|20179409|P2|COMPLETED|Second Intervention (7 Days)||15
8183893|NCT02339246|20179410|P1|COMPLETED|Second Intervention (7 Days)||16
8183894|NCT02339246|20179408|P3|STARTED|Second Intervention (7 Days)||0
8183895|NCT02339246|20179409|P2|STARTED|Second Intervention (7 Days)||15
8183896|NCT02339246|20179410|P1|STARTED|Second Intervention (7 Days)||16
8183897|NCT02339246|20179408|P3|NOT COMPLETED|First Intervention (7 Days)||0
8183898|NCT02339246|20179409|P2|NOT COMPLETED|First Intervention (7 Days)||0
8183899|NCT02339246|20179410|P1|NOT COMPLETED|First Intervention (7 Days)||0
8183900|NCT02339246|20179408|P3|COMPLETED|First Intervention (7 Days)||31
8183901|NCT02339246|20179409|P2|COMPLETED|First Intervention (7 Days)||0
8183902|NCT02339246|20179410|P1|COMPLETED|First Intervention (7 Days)||0
8183903|NCT02339246|20179408|P3|STARTED|First Intervention (7 Days)||31
8183904|NCT02339246|20179409|P2|STARTED|First Intervention (7 Days)||0
8183905|NCT02339246|20179410|P1|STARTED|First Intervention (7 Days)||0
8183906|NCT02339155|20179426|P2|NOT COMPLETED|Overall Study||21
8183907|NCT02339155|20179427|P1|NOT COMPLETED|Overall Study||15
8183908|NCT02339155|20179426|P2|COMPLETED|Overall Study||266
8183909|NCT02339155|20179427|P1|COMPLETED|Overall Study||271
8183910|NCT02339155|20179426|P2|Received Study Treatment|Overall Study||281
8183911|NCT02339155|20179427|P1|Received Study Treatment|Overall Study||285
8183912|NCT02339155|20179426|P2|STARTED|Overall Study||287
8183913|NCT02339155|20179427|P1|STARTED|Overall Study||286
8183914|NCT02339038|20179453|P1|NOT COMPLETED|Overall Study||600
8183915|NCT02339038|20179453|P1|COMPLETED|Overall Study||0
8183916|NCT02339038|20179453|P1|STARTED|Overall Study||600
8183917|NCT02338973|20179457|P1|NOT COMPLETED|Overall Study||0
8183918|NCT02338973|20179457|P1|COMPLETED|Overall Study||4
8183919|NCT02338973|20179457|P1|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
8183920|NCT02338973|20179457|P1|Rod-cone Dystrophy (RCD)|Overall Study||2
8183921|NCT02338973|20179457|P1|STARTED|Overall Study||4
8183922|NCT02338882|20179633|P2|NOT COMPLETED|Overall Study||3
8183923|NCT02338882|20179634|P1|NOT COMPLETED|Overall Study||7
8183924|NCT02338882|20179633|P2|COMPLETED|Overall Study||47
8183925|NCT02338882|20179634|P1|COMPLETED|Overall Study||43
8183926|NCT02338882|20179633|P2|STARTED|Overall Study||50
8183927|NCT02338882|20179634|P1|STARTED|Overall Study||50
8183928|NCT02338843|20179672|P2|NOT COMPLETED|Overall Study||58
8183929|NCT02338843|20179673|P1|NOT COMPLETED|Overall Study||44
8183930|NCT02338843|20179672|P2|COMPLETED|Overall Study||100
8183931|NCT02338843|20179673|P1|COMPLETED|Overall Study||119
8183932|NCT02338843|20179672|P2|STARTED|Overall Study||158
8183933|NCT02338843|20179673|P1|STARTED|Overall Study||163
8183934|NCT02338713|20179679|P1|NOT COMPLETED|Overall Study||0
8183935|NCT02338713|20179679|P1|COMPLETED|Overall Study||27
8183936|NCT02338713|20179679|P1|STARTED|Overall Study||27
8183937|NCT02338492|20179701|P1|NOT COMPLETED|Overall Study||45
8183938|NCT02338492|20179701|P1|COMPLETED|Overall Study||36
8183939|NCT02338492|20179701|P1|Treatment Failure|Overall Study||2
8183940|NCT02338492|20179701|P1|Device Implanted|Overall Study||79
8183941|NCT02338492|20179701|P1|Enrolled|Overall Study||81
8183942|NCT02338492|20179701|P1|STARTED|Overall Study||81
8183943|NCT02338362|20179717|P2|NOT COMPLETED|Overall Study||1
8183944|NCT02338362|20179718|P1|NOT COMPLETED|Overall Study||1
8183945|NCT02338362|20179717|P2|COMPLETED|Overall Study||10
8183946|NCT02338362|20179718|P1|COMPLETED|Overall Study||10
8183947|NCT02338362|20179717|P2|STARTED|Overall Study||11
8183948|NCT02338362|20179718|P1|STARTED|Overall Study||11
8183949|NCT02338336|20179734|P4|NOT COMPLETED|Overall Study||0
8183950|NCT02338336|20179735|P3|NOT COMPLETED|Overall Study||0
8183951|NCT02338336|20179736|P2|NOT COMPLETED|Overall Study||0
8183952|NCT02338336|20179737|P1|NOT COMPLETED|Overall Study||2
8183953|NCT02338336|20179734|P4|COMPLETED|Overall Study||4
8183954|NCT02338336|20179735|P3|COMPLETED|Overall Study||7
8183955|NCT02338336|20179736|P2|COMPLETED|Overall Study||17
8183956|NCT02338336|20179737|P1|COMPLETED|Overall Study||24
8183957|NCT02338336|20179734|P4|STARTED|Overall Study||4
8183958|NCT02338336|20179735|P3|STARTED|Overall Study||7
8183959|NCT02338336|20179736|P2|STARTED|Overall Study||17
8183960|NCT02338336|20179737|P1|STARTED|Overall Study||26
8183961|NCT02338193|20179748|P3|NOT COMPLETED|Overall Study||10
8183962|NCT02338193|20179749|P2|NOT COMPLETED|Overall Study||4
8183963|NCT02338193|20179750|P1|NOT COMPLETED|Overall Study||3
8183964|NCT02338193|20179748|P3|COMPLETED|Overall Study||15
8183965|NCT02338193|20179749|P2|COMPLETED|Overall Study||17
8183966|NCT02338193|20179750|P1|COMPLETED|Overall Study||17
8183967|NCT02338193|20179748|P3|STARTED|Overall Study||25
8183968|NCT02338193|20179749|P2|STARTED|Overall Study||21
8183969|NCT02338193|20179750|P1|STARTED|Overall Study||20
8183970|NCT02338154|20179803|P1|NOT COMPLETED|Overall Study||143
8183971|NCT02338154|20179803|P1|COMPLETED|Overall Study||373
8183972|NCT02338154|20179803|P1|INTUITY (Study Valve Cohort)|Overall Study||493
8183973|NCT02338154|20179803|P1|Enrolled Cohort (Intent to Treat)|Overall Study||516
8183974|NCT02338154|20179803|P1|STARTED|Overall Study||516
8183975|NCT02338076|20179899|P1|NOT COMPLETED|Overall Study||0
8183976|NCT02338076|20179899|P1|COMPLETED|Overall Study||20
8183977|NCT02338076|20179899|P1|STARTED|Overall Study||20
8183978|NCT02337959|20179917|P3|NOT COMPLETED|Overall Study||0
8183979|NCT02337959|20179918|P2|NOT COMPLETED|Overall Study||3
8183980|NCT02337959|20179919|P1|NOT COMPLETED|Overall Study||0
8183981|NCT02337959|20179917|P3|COMPLETED|Overall Study||7
8183982|NCT02337959|20179918|P2|COMPLETED|Overall Study||7
8183983|NCT02337959|20179919|P1|COMPLETED|Overall Study||10
8183984|NCT02337959|20179917|P3|STARTED|Overall Study||7
8183985|NCT02337959|20179918|P2|STARTED|Overall Study||10
8183986|NCT02337959|20179919|P1|STARTED|Overall Study||10
8183987|NCT02337946|20179927|P3|NOT COMPLETED|Protocol Treatment 2 Period||50
8183988|NCT02337946|20179928|P2|NOT COMPLETED|Protocol Treatment 2 Period||51
8183989|NCT02337946|20179929|P1|NOT COMPLETED|Protocol Treatment 2 Period||0
8183990|NCT02337946|20179927|P3|COMPLETED|Protocol Treatment 2 Period||7
8183991|NCT02337946|20179928|P2|COMPLETED|Protocol Treatment 2 Period||5
8183992|NCT02337946|20179929|P1|COMPLETED|Protocol Treatment 2 Period||0
8183993|NCT02337946|20179927|P3|Safety Population|Protocol Treatment 2 Period||54
8183994|NCT02337946|20179928|P2|Safety Population|Protocol Treatment 2 Period||56
8183995|NCT02337946|20179929|P1|Safety Population|Protocol Treatment 2 Period||0
8183996|NCT02337946|20179927|P3|STARTED|Protocol Treatment 2 Period||57
8183997|NCT02337946|20179928|P2|STARTED|Protocol Treatment 2 Period||56
8183998|NCT02337946|20179929|P1|STARTED|Protocol Treatment 2 Period||0
8183999|NCT02337946|20179927|P3|NOT COMPLETED|In-between Period||0
8184000|NCT02337946|20179928|P2|NOT COMPLETED|In-between Period||0
8184001|NCT02337946|20179929|P1|NOT COMPLETED|In-between Period||1
8184002|NCT02337946|20179927|P3|COMPLETED|In-between Period||0
8184003|NCT02337946|20179928|P2|COMPLETED|In-between Period||0
8184004|NCT02337946|20179929|P1|COMPLETED|In-between Period||113
8184005|NCT02337946|20179927|P3|STARTED|In-between Period||0
8184006|NCT02337946|20179928|P2|STARTED|In-between Period||0
8184007|NCT02337946|20179929|P1|STARTED|In-between Period||114
8184008|NCT02337946|20179927|P3|NOT COMPLETED|Protocol Treatment 1 Period||0
8184009|NCT02337946|20179928|P2|NOT COMPLETED|Protocol Treatment 1 Period||0
8184010|NCT02337946|20179929|P1|NOT COMPLETED|Protocol Treatment 1 Period||50
8184011|NCT02337946|20179927|P3|COMPLETED|Protocol Treatment 1 Period||0
8184012|NCT02337946|20179928|P2|COMPLETED|Protocol Treatment 1 Period||0
8184013|NCT02337946|20179929|P1|COMPLETED|Protocol Treatment 1 Period||114
8184014|NCT02337946|20179927|P3|STARTED|Protocol Treatment 1 Period||0
8184015|NCT02337946|20179928|P2|STARTED|Protocol Treatment 1 Period||0
8184016|NCT02337946|20179929|P1|STARTED|Protocol Treatment 1 Period||164
8184017|NCT02337933|20179953|P2|NOT COMPLETED|Overall Study||0
8184018|NCT02337933|20179954|P1|NOT COMPLETED|Overall Study||0
8184019|NCT02337933|20179953|P2|COMPLETED|Overall Study||12
8184020|NCT02337933|20179954|P1|COMPLETED|Overall Study||12
8184021|NCT02337933|20179953|P2|STARTED|Overall Study||12
8184022|NCT02337933|20179954|P1|STARTED|Overall Study||12
8184023|NCT02337907|20179990|P6|NOT COMPLETED|Overall Study||1
8184024|NCT02337907|20179991|P5|NOT COMPLETED|Overall Study||10
8184025|NCT02337907|20179992|P4|NOT COMPLETED|Overall Study||4
8184026|NCT02337907|20179993|P3|NOT COMPLETED|Overall Study||1
8184027|NCT02337907|20179994|P2|NOT COMPLETED|Overall Study||4
8184028|NCT02337907|20179995|P1|NOT COMPLETED|Overall Study||4
8184029|NCT02337907|20179990|P6|COMPLETED|Overall Study||4
8184030|NCT02337907|20179991|P5|COMPLETED|Overall Study||96
8184031|NCT02337907|20179992|P4|COMPLETED|Overall Study||51
8184032|NCT02337907|20179993|P3|COMPLETED|Overall Study||54
8184033|NCT02337907|20179994|P2|COMPLETED|Overall Study||49
8184034|NCT02337907|20179995|P1|COMPLETED|Overall Study||51
8184035|NCT02337907|20179990|P6|STARTED|Overall Study||5
8184036|NCT02337907|20179991|P5|STARTED|Overall Study||106
8184037|NCT02337907|20179992|P4|STARTED|Overall Study||55
8184038|NCT02337907|20179993|P3|STARTED|Overall Study||55
8184039|NCT02337907|20179994|P2|STARTED|Overall Study||53
8184040|NCT02337907|20179995|P1|STARTED|Overall Study||55
8184041|NCT02337764|20180030|P1|NOT COMPLETED|Overall Study||60
8184042|NCT02337764|20180030|P1|COMPLETED|Overall Study||162
8184043|NCT02337764|20180030|P1|STARTED|Overall Study||222
8184044|NCT02337751|20180043|P2|NOT COMPLETED|Overall Study||16
8184045|NCT02337751|20180044|P1|NOT COMPLETED|Overall Study||11
8184046|NCT02337751|20180043|P2|COMPLETED|Overall Study||87
8184047|NCT02337751|20180044|P1|COMPLETED|Overall Study||84
8184048|NCT02337751|20180043|P2|STARTED|Overall Study||103
8184049|NCT02337751|20180044|P1|STARTED|Overall Study||95
8184050|NCT02337738|20180063|P3|NOT COMPLETED|Overall Study||26
8184051|NCT02337738|20180064|P2|NOT COMPLETED|Overall Study||30
8184052|NCT02337738|20180065|P1|NOT COMPLETED|Overall Study||22
8184053|NCT02337738|20180063|P3|COMPLETED|Overall Study||103
8184054|NCT02337738|20180064|P2|COMPLETED|Overall Study||104
8184055|NCT02337738|20180065|P1|COMPLETED|Overall Study||119
8184056|NCT02337738|20180063|P3|STARTED|Overall Study||129
8184057|NCT02337738|20180064|P2|STARTED|Overall Study||134
8184058|NCT02337738|20180065|P1|STARTED|Overall Study||141
8184059|NCT02337725|20180105|P2|NOT COMPLETED|Overall Study||8
8184060|NCT02337725|20180106|P1|NOT COMPLETED|Overall Study||26
8184061|NCT02337725|20180105|P2|COMPLETED|Overall Study||110
8184062|NCT02337725|20180106|P1|COMPLETED|Overall Study||100
8184063|NCT02337725|20180105|P2|STARTED|Overall Study||118
8184064|NCT02337725|20180106|P1|STARTED|Overall Study||126
8184065|NCT02337491|20180130|P2|NOT COMPLETED|Overall Study||30
8184066|NCT02337491|20180131|P1|NOT COMPLETED|Overall Study||50
8184067|NCT02337491|20180130|P2|COMPLETED|Overall Study||0
8184068|NCT02337491|20180131|P1|COMPLETED|Overall Study||0
8184069|NCT02337491|20180130|P2|STARTED|Overall Study||30
8184070|NCT02337491|20180131|P1|STARTED|Overall Study||50
8184071|NCT02337478|20180145|P1|NOT COMPLETED|Overall Study||5
8184072|NCT02337478|20180145|P1|COMPLETED|Overall Study||0
8184073|NCT02337478|20180145|P1|STARTED|Overall Study||5
8184074|NCT02337387|20180155|P4|NOT COMPLETED|Overall Study||3
8184075|NCT02337387|20180156|P3|NOT COMPLETED|Overall Study||3
8184076|NCT02337387|20180157|P2|NOT COMPLETED|Overall Study||8
8184077|NCT02337387|20180158|P1|NOT COMPLETED|Overall Study||14
8184078|NCT02337387|20180155|P4|COMPLETED|Overall Study||0
8184079|NCT02337387|20180156|P3|COMPLETED|Overall Study||0
8184080|NCT02337387|20180157|P2|COMPLETED|Overall Study||0
8184081|NCT02337387|20180158|P1|COMPLETED|Overall Study||0
8184082|NCT02337387|20180155|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8184083|NCT02337387|20180156|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8184084|NCT02337387|20180157|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8184085|NCT02337387|20180158|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
8184086|NCT02337387|20180155|P4|STARTED|Overall Study||3
8184087|NCT02337387|20180156|P3|STARTED|Overall Study||3
8184088|NCT02337387|20180157|P2|STARTED|Overall Study||8
8184089|NCT02337387|20180158|P1|STARTED|Overall Study||14
8184090|NCT02337361|20180176|P2|NOT COMPLETED|6-month Follow-up||4
8184091|NCT02337361|20180177|P1|NOT COMPLETED|6-month Follow-up||2
8184092|NCT02337361|20180176|P2|COMPLETED|6-month Follow-up||68
8184093|NCT02337361|20180177|P1|COMPLETED|6-month Follow-up||78
8184094|NCT02337361|20180176|P2|STARTED|6-month Follow-up||72
8184095|NCT02337361|20180177|P1|STARTED|6-month Follow-up||80
8184096|NCT02337361|20180176|P2|NOT COMPLETED|3-month Follow-up||14
8184097|NCT02337361|20180177|P1|NOT COMPLETED|3-month Follow-up||19
8184098|NCT02337361|20180176|P2|COMPLETED|3-month Follow-up||72
8184099|NCT02337361|20180177|P1|COMPLETED|3-month Follow-up||80
8184100|NCT02337361|20180176|P2|STARTED|3-month Follow-up||86
8184101|NCT02337361|20180177|P1|STARTED|3-month Follow-up||99
8184102|NCT02337361|20180176|P2|NOT COMPLETED|Baseline Assessment||0
8184103|NCT02337361|20180177|P1|NOT COMPLETED|Baseline Assessment||0
8184104|NCT02337361|20180176|P2|COMPLETED|Baseline Assessment||86
8184105|NCT02337361|20180177|P1|COMPLETED|Baseline Assessment||99
8184106|NCT02337361|20180176|P2|STARTED|Baseline Assessment||86
8184107|NCT02337361|20180177|P1|STARTED|Baseline Assessment||99
8184108|NCT02337218|20180197|P2|NOT COMPLETED|Overall Study||0
8184109|NCT02337218|20180198|P1|NOT COMPLETED|Overall Study||0
8184110|NCT02337218|20180197|P2|COMPLETED|Overall Study||11
8184111|NCT02337218|20180198|P1|COMPLETED|Overall Study||17
8184112|NCT02337218|20180197|P2|STARTED|Overall Study||11
8184113|NCT02337218|20180198|P1|STARTED|Overall Study||17
8184114|NCT02337062|20180210|P2|NOT COMPLETED|Overall Study||19
8184115|NCT02337062|20180211|P1|NOT COMPLETED|Overall Study||17
8184116|NCT02337062|20180210|P2|COMPLETED|Overall Study||556
8184117|NCT02337062|20180211|P1|COMPLETED|Overall Study||555
8184118|NCT02337062|20180210|P2|STARTED|Overall Study||575
8184119|NCT02337062|20180211|P1|STARTED|Overall Study||572
8184120|NCT02336958|20180229|P2|NOT COMPLETED|Overall Study||0
8184121|NCT02336958|20180230|P1|NOT COMPLETED|Overall Study||0
8184122|NCT02336958|20180229|P2|COMPLETED|Overall Study||20
8184123|NCT02336958|20180230|P1|COMPLETED|Overall Study||20
8184124|NCT02336958|20180229|P2|STARTED|Overall Study||20
8184125|NCT02336958|20180230|P1|STARTED|Overall Study||20
8184126|NCT02336815|20180240|P2|NOT COMPLETED|Overall Study||123
8184127|NCT02336815|20180241|P1|NOT COMPLETED|Overall Study||79
8184128|NCT02336815|20180240|P2|COMPLETED|Overall Study||0
8184129|NCT02336815|20180241|P1|COMPLETED|Overall Study||0
8184130|NCT02336815|20180240|P2|STARTED|Overall Study||123
8184131|NCT02336815|20180241|P1|STARTED|Overall Study||79
8184132|NCT02336763|20180268|P1|NOT COMPLETED|Overall Study||0
8184133|NCT02336763|20180268|P1|COMPLETED|Overall Study||2
8184134|NCT02336763|20180268|P1|STARTED|Overall Study||2
8184135|NCT02336737|20180278|P1|NOT COMPLETED|Overall Study||13
8184136|NCT02336737|20180278|P1|COMPLETED|Overall Study||147
8184137|NCT02336737|20180278|P1|STARTED|Overall Study||160
8184138|NCT02336607|20180289|P4|NOT COMPLETED|Overall Study||87
8184139|NCT02336607|20180290|P3|NOT COMPLETED|Overall Study||6
8184140|NCT02336607|20180291|P2|NOT COMPLETED|Overall Study||10
8184141|NCT02336607|20180292|P1|NOT COMPLETED|Overall Study||4
8184142|NCT02336607|20180289|P4|COMPLETED|Overall Study||180
8184143|NCT02336607|20180290|P3|COMPLETED|Overall Study||86
8184144|NCT02336607|20180291|P2|COMPLETED|Overall Study||75
8184145|NCT02336607|20180292|P1|COMPLETED|Overall Study||81
8184146|NCT02336607|20180289|P4|Patients Included in Safety Population|Overall Study||260
8184147|NCT02336607|20180290|P3|Patients Included in Safety Population|Overall Study||92
8184148|NCT02336607|20180291|P2|Patients Included in Safety Population|Overall Study||85
8184149|NCT02336607|20180292|P1|Patients Included in Safety Population|Overall Study||85
8184150|NCT02336607|20180289|P4|Patients Included in PP Population|Overall Study||162
8184151|NCT02336607|20180290|P3|Patients Included in PP Population|Overall Study||75
8184152|NCT02336607|20180291|P2|Patients Included in PP Population|Overall Study||75
8184153|NCT02336607|20180292|P1|Patients Included in PP Population|Overall Study||78
8184154|NCT02336607|20180289|P4|Patients Included in ITT Population|Overall Study||222
8184155|NCT02336607|20180290|P3|Patients Included in ITT Population|Overall Study||91
8184156|NCT02336607|20180291|P2|Patients Included in ITT Population|Overall Study||84
8184157|NCT02336607|20180292|P1|Patients Included in ITT Population|Overall Study||84
8184158|NCT02336607|20180289|P4|STARTED|Overall Study||267
8184159|NCT02336607|20180290|P3|STARTED|Overall Study||92
8184160|NCT02336607|20180291|P2|STARTED|Overall Study||85
8184161|NCT02336607|20180292|P1|STARTED|Overall Study||85
8184162|NCT02336594|20180350|P4|NOT COMPLETED|Overall Study||0
8184163|NCT02336594|20180351|P3|NOT COMPLETED|Overall Study||0
8184164|NCT02336594|20180352|P2|NOT COMPLETED|Overall Study||0
8184165|NCT02336594|20180353|P1|NOT COMPLETED|Overall Study||0
8184166|NCT02336594|20180350|P4|COMPLETED|Overall Study||4
8184167|NCT02336594|20180351|P3|COMPLETED|Overall Study||4
8184168|NCT02336594|20180352|P2|COMPLETED|Overall Study||4
8184169|NCT02336594|20180353|P1|COMPLETED|Overall Study||3
8184170|NCT02336594|20180350|P4|STARTED|Overall Study||4
8184171|NCT02336594|20180351|P3|STARTED|Overall Study||4
8184172|NCT02336594|20180352|P2|STARTED|Overall Study||4
8184173|NCT02336594|20180353|P1|STARTED|Overall Study||3
8184174|NCT02336555|20180395|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8184175|NCT02336555|20180396|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8184176|NCT02336555|20180395|P2|COMPLETED|Treatment Period 2 (28 Days)||15
8184177|NCT02336555|20180396|P1|COMPLETED|Treatment Period 2 (28 Days)||16
8184178|NCT02336555|20180395|P2|STARTED|Treatment Period 2 (28 Days)||16
8184179|NCT02336555|20180396|P1|STARTED|Treatment Period 2 (28 Days)||16
8184180|NCT02336555|20180395|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8184181|NCT02336555|20180396|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||2
8184182|NCT02336555|20180395|P2|COMPLETED|Treatment Period 1 (28 Days)||16
8184183|NCT02336555|20180396|P1|COMPLETED|Treatment Period 1 (28 Days)||16
8184184|NCT02336555|20180395|P2|STARTED|Treatment Period 1 (28 Days)||17
8184185|NCT02336555|20180396|P1|STARTED|Treatment Period 1 (28 Days)||18
8184186|NCT02336451|20180409|P5|NOT COMPLETED|Overall Study||18
8184187|NCT02336451|20180410|P4|NOT COMPLETED|Overall Study||44
8184188|NCT02336451|20180411|P3|NOT COMPLETED|Overall Study||12
8184189|NCT02336451|20180412|P2|NOT COMPLETED|Overall Study||40
8184190|NCT02336451|20180413|P1|NOT COMPLETED|Overall Study||42
8184191|NCT02336451|20180409|P5|COMPLETED|Overall Study||0
8184192|NCT02336451|20180410|P4|COMPLETED|Overall Study||0
8184193|NCT02336451|20180411|P3|COMPLETED|Overall Study||0
8184194|NCT02336451|20180412|P2|COMPLETED|Overall Study||0
8184195|NCT02336451|20180413|P1|COMPLETED|Overall Study||0
8184196|NCT02336451|20180409|P5|STARTED|Overall Study||18
8184197|NCT02336451|20180410|P4|STARTED|Overall Study||44
8184198|NCT02336451|20180411|P3|STARTED|Overall Study||12
8184199|NCT02336451|20180412|P2|STARTED|Overall Study||40
8184200|NCT02336451|20180413|P1|STARTED|Overall Study||42
8184201|NCT02336438|20180557|P1|NOT COMPLETED|Overall Study||1
8184202|NCT02336438|20180557|P1|COMPLETED|Overall Study||10
8184203|NCT02336438|20180557|P1|STARTED|Overall Study||11
8184204|NCT02336425|20180570|P4|NOT COMPLETED|Overall Study||3
8184205|NCT02336425|20180571|P3|NOT COMPLETED|Overall Study||3
8184206|NCT02336425|20180572|P2|NOT COMPLETED|Overall Study||2
8184207|NCT02336425|20180573|P1|NOT COMPLETED|Overall Study||2
8184208|NCT02336425|20180570|P4|COMPLETED|Overall Study||0
8184209|NCT02336425|20180571|P3|COMPLETED|Overall Study||0
8184210|NCT02336425|20180572|P2|COMPLETED|Overall Study||0
8184211|NCT02336425|20180573|P1|COMPLETED|Overall Study||0
8184212|NCT02336425|20180570|P4|STARTED|Overall Study||3
8184213|NCT02336425|20180571|P3|STARTED|Overall Study||3
8184214|NCT02336425|20180572|P2|STARTED|Overall Study||2
8184215|NCT02336425|20180573|P1|STARTED|Overall Study||2
8184216|NCT02336373|20180623|P1|NOT COMPLETED|Overall Study||18
8184217|NCT02336373|20180623|P1|COMPLETED|Overall Study||14
8184218|NCT02336373|20180623|P1|STARTED|Overall Study||32
8184219|NCT02336360|20180638|P1|NOT COMPLETED|Overall Study||0
8184220|NCT02336360|20180638|P1|COMPLETED|Overall Study||6
8184221|NCT02336360|20180638|P1|STARTED|Overall Study||6
8184222|NCT02336282|20180642|P1|NOT COMPLETED|Overall Study||5
8184223|NCT02336282|20180642|P1|COMPLETED|Overall Study||28
8184224|NCT02336282|20180642|P1|STARTED|Overall Study||33
8184225|NCT02336178|20180666|P1|NOT COMPLETED|Overall Study||4
8184226|NCT02336178|20180666|P1|COMPLETED|Overall Study||66
8184227|NCT02336178|20180666|P1|STARTED|Overall Study||70
8184243|NCT02336074|20180795|P2|NOT COMPLETED|Overall Study||2
8184244|NCT02336074|20180796|P1|NOT COMPLETED|Overall Study||0
8184245|NCT02336074|20180795|P2|COMPLETED|Overall Study||28
8184246|NCT02336074|20180796|P1|COMPLETED|Overall Study||30
8184247|NCT02336074|20180795|P2|STARTED|Overall Study||30
8184248|NCT02336074|20180796|P1|STARTED|Overall Study||30
8184249|NCT02335983|20180819|P6|NOT COMPLETED|Overall Study||32
8184250|NCT02335983|20180820|P5|NOT COMPLETED|Overall Study||8
8184251|NCT02335983|20180821|P4|NOT COMPLETED|Overall Study||9
8184252|NCT02335983|20180822|P3|NOT COMPLETED|Overall Study||32
8184253|NCT02335983|20180823|P2|NOT COMPLETED|Overall Study||9
8184254|NCT02335983|20180824|P1|NOT COMPLETED|Overall Study||8
8184255|NCT02335983|20180819|P6|COMPLETED|Overall Study||1
8184256|NCT02335983|20180820|P5|COMPLETED|Overall Study||1
8184257|NCT02335983|20180821|P4|COMPLETED|Overall Study||0
8184258|NCT02335983|20180822|P3|COMPLETED|Overall Study||2
8184259|NCT02335983|20180823|P2|COMPLETED|Overall Study||3
8184260|NCT02335983|20180824|P1|COMPLETED|Overall Study||2
8184261|NCT02335983|20180819|P6|STARTED|Overall Study||33
8184262|NCT02335983|20180820|P5|STARTED|Overall Study||9
8184263|NCT02335983|20180821|P4|STARTED|Overall Study||9
8184264|NCT02335983|20180822|P3|STARTED|Overall Study||34
8184265|NCT02335983|20180823|P2|STARTED|Overall Study||12
8184266|NCT02335983|20180824|P1|STARTED|Overall Study||10
8184267|NCT02335710|20180908|P2|NOT COMPLETED|Overall Study||0
8184268|NCT02335710|20180909|P1|NOT COMPLETED|Overall Study||0
8184269|NCT02335710|20180908|P2|COMPLETED|Overall Study||10
8184270|NCT02335710|20180909|P1|COMPLETED|Overall Study||40
8184271|NCT02335710|20180908|P2|STARTED|Overall Study||10
8184272|NCT02335710|20180909|P1|STARTED|Overall Study||40
8184273|NCT02335658|20180931|P2|NOT COMPLETED|Overall Study||44
8184274|NCT02335658|20180932|P1|NOT COMPLETED|Overall Study||40
8184275|NCT02335658|20180931|P2|COMPLETED|Overall Study||59
8184276|NCT02335658|20180932|P1|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
8184277|NCT02335658|20180931|P2|STARTED|Overall Study||103
8184278|NCT02335658|20180932|P1|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
8184279|NCT02335502|20180942|P1|NOT COMPLETED|Overall Study||17
8184280|NCT02335502|20180942|P1|COMPLETED|Overall Study||49
8184281|NCT02335502|20180942|P1|Receiving Permanent System|Overall Study||56
8184282|NCT02335502|20180942|P1|Received Trial System|Overall Study||65
8184283|NCT02335502|20180942|P1|STARTED|Overall Study||66
8184284|NCT02335489|20180947|P1|NOT COMPLETED|Overall Study||10
8184285|NCT02335489|20180947|P1|COMPLETED|Overall Study||0
8184286|NCT02335489|20180947|P1|Receiving Permanent System|Overall Study||8
8184287|NCT02335489|20180947|P1|Received Trial System|Overall Study||9
8184288|NCT02335489|20180947|P1|STARTED|Overall Study||10
8184289|NCT02335450|20180951|P1|NOT COMPLETED|Overall Study||1
8184290|NCT02335450|20180951|P1|COMPLETED|Overall Study||4
8184291|NCT02335450|20180951|P1|STARTED|Overall Study||5
8184292|NCT02335424|20180955|P1|NOT COMPLETED|Overall Study||374
8184293|NCT02335424|20180955|P1|COMPLETED|Overall Study||0
8184294|NCT02335424|20180955|P1|Treated|Overall Study||370
8184295|NCT02335424|20180955|P1|STARTED|Overall Study||374
8184296|NCT02335346|20180988|P1|NOT COMPLETED|Overall Study||12
8184297|NCT02335346|20180988|P1|COMPLETED|Overall Study||81
8184298|NCT02335346|20180988|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
8184299|NCT02335346|20180988|P1|STARTED|Overall Study||93
8184300|NCT02335294|20181006|P6|NOT COMPLETED|Overall Study||1
8184301|NCT02335294|20181007|P5|NOT COMPLETED|Overall Study||2
8184302|NCT02335294|20181008|P4|NOT COMPLETED|Overall Study||3
8184303|NCT02335294|20181009|P3|NOT COMPLETED|Overall Study||1
8184304|NCT02335294|20181010|P2|NOT COMPLETED|Overall Study||4
8184305|NCT02335294|20181011|P1|NOT COMPLETED|Overall Study||3
8184306|NCT02335294|20181006|P6|COMPLETED|Overall Study||19
8184307|NCT02335294|20181007|P5|COMPLETED|Overall Study||39
8184308|NCT02335294|20181008|P4|COMPLETED|Overall Study||36
8184309|NCT02335294|20181009|P3|COMPLETED|Overall Study||18
8184310|NCT02335294|20181010|P2|COMPLETED|Overall Study||38
8184311|NCT02335294|20181011|P1|COMPLETED|Overall Study||36
8184312|NCT02335294|20181006|P6|STARTED|Overall Study||20
8184313|NCT02335294|20181007|P5|STARTED|Overall Study||41
8184314|NCT02335294|20181008|P4|STARTED|Overall Study||39
8184315|NCT02335294|20181009|P3|STARTED|Overall Study||19
8184316|NCT02335294|20181010|P2|STARTED|Overall Study||42
8184317|NCT02335294|20181011|P1|STARTED|Overall Study||39
8184318|NCT02335229|20181027|P1|NOT COMPLETED|Overall Study||7
8184319|NCT02335229|20181027|P1|COMPLETED|Overall Study||23
8184320|NCT02335229|20181027|P1|Received Permanent System|Overall Study||26
8184321|NCT02335229|20181027|P1|Received Trial System|Overall Study||10
8184322|NCT02335229|20181027|P1|STARTED|Overall Study||30
8184323|NCT02335216|20181032|P1|NOT COMPLETED|Overall Study||13
8184324|NCT02335216|20181032|P1|COMPLETED|Overall Study||9
8184325|NCT02335216|20181032|P1|Received Permanent System|Overall Study||13
8184326|NCT02335216|20181032|P1|Received Trial System|Overall Study||16
8184327|NCT02335216|20181032|P1|STARTED|Overall Study||22
8184328|NCT02335125|20181039|P2|NOT COMPLETED|Overall Study||0
8184329|NCT02335125|20181040|P1|NOT COMPLETED|Overall Study||0
8184330|NCT02335125|20181039|P2|COMPLETED|Overall Study||20
8184331|NCT02335125|20181040|P1|COMPLETED|Overall Study||20
8184332|NCT02335125|20181039|P2|STARTED|Overall Study||20
8184333|NCT02335125|20181040|P1|STARTED|Overall Study||20
8184334|NCT02334982|20181065|P7|NOT COMPLETED|Overall Study||0
8184335|NCT02334982|20181066|P6|NOT COMPLETED|Overall Study||0
8184336|NCT02334982|20181067|P5|NOT COMPLETED|Overall Study||0
8184337|NCT02334982|20181068|P4|NOT COMPLETED|Overall Study||0
8184338|NCT02334982|20181069|P3|NOT COMPLETED|Overall Study||0
8184339|NCT02334982|20181070|P2|NOT COMPLETED|Overall Study||0
8184340|NCT02334982|20181071|P1|NOT COMPLETED|Overall Study||0
8184341|NCT02334982|20181065|P7|COMPLETED|Overall Study||12
8184342|NCT02334982|20181066|P6|COMPLETED|Overall Study||6
8184343|NCT02334982|20181067|P5|COMPLETED|Overall Study||6
8184344|NCT02334982|20181068|P4|COMPLETED|Overall Study||6
8184345|NCT02334982|20181069|P3|COMPLETED|Overall Study||6
8184346|NCT02334982|20181070|P2|COMPLETED|Overall Study||5
8184347|NCT02334982|20181071|P1|COMPLETED|Overall Study||6
8184348|NCT02334982|20181065|P7|STARTED|Overall Study||12
8184349|NCT02334982|20181066|P6|STARTED|Overall Study||6
8184350|NCT02334982|20181067|P5|STARTED|Overall Study||6
8184351|NCT02334982|20181068|P4|STARTED|Overall Study||6
8184352|NCT02334982|20181069|P3|STARTED|Overall Study||6
8184353|NCT02334982|20181070|P2|STARTED|Overall Study||5
8184354|NCT02334982|20181071|P1|STARTED|Overall Study||6
8184355|NCT02334813|20181177|P2|NOT COMPLETED|Overall Study||1
8184356|NCT02334813|20181178|P1|NOT COMPLETED|Overall Study||3
8184357|NCT02334813|20181177|P2|COMPLETED|Overall Study||13
8184358|NCT02334813|20181178|P1|COMPLETED|Overall Study||9
8184359|NCT02334813|20181177|P2|STARTED|Overall Study||14
8184360|NCT02334813|20181178|P1|STARTED|Overall Study||12
8184361|NCT02334800|20181188|P4|NOT COMPLETED|Overall Study||0
8184362|NCT02334800|20181189|P3|NOT COMPLETED|Overall Study||0
8184363|NCT02334800|20181190|P2|NOT COMPLETED|Overall Study||0
8184364|NCT02334800|20181191|P1|NOT COMPLETED|Overall Study||0
8184365|NCT02334800|20181188|P4|COMPLETED|Overall Study||7
8184366|NCT02334800|20181189|P3|COMPLETED|Overall Study||7
8184367|NCT02334800|20181190|P2|COMPLETED|Overall Study||7
8184368|NCT02334800|20181191|P1|COMPLETED|Overall Study||7
8184369|NCT02334800|20181188|P4|Received Treatment|Overall Study||7
8184370|NCT02334800|20181189|P3|Received Treatment|Overall Study||7
8184371|NCT02334800|20181190|P2|Received Treatment|Overall Study||7
8184372|NCT02334800|20181191|P1|Received Treatment|Overall Study||7
8184373|NCT02334800|20181188|P4|STARTED|Overall Study||7
8184374|NCT02334800|20181189|P3|STARTED|Overall Study||7
8184375|NCT02334800|20181190|P2|STARTED|Overall Study||7
8184376|NCT02334800|20181191|P1|STARTED|Overall Study||7
8184377|NCT02334787|20181285|P4|NOT COMPLETED|Overall Study||0
8184378|NCT02334787|20181286|P3|NOT COMPLETED|Overall Study||0
8184379|NCT02334787|20181287|P2|NOT COMPLETED|Overall Study||0
8184380|NCT02334787|20181288|P1|NOT COMPLETED|Overall Study||0
8184381|NCT02334787|20181285|P4|COMPLETED|Overall Study||8
8184382|NCT02334787|20181286|P3|COMPLETED|Overall Study||8
8184383|NCT02334787|20181287|P2|COMPLETED|Overall Study||8
8184384|NCT02334787|20181288|P1|COMPLETED|Overall Study||8
8184385|NCT02334787|20181285|P4|STARTED|Overall Study||8
8184386|NCT02334787|20181286|P3|STARTED|Overall Study||8
8184387|NCT02334787|20181287|P2|STARTED|Overall Study||8
8184388|NCT02334787|20181288|P1|STARTED|Overall Study||8
8184389|NCT02334748|20181310|P1|NOT COMPLETED|Overall Study||8
8184390|NCT02334748|20181310|P1|COMPLETED|Overall Study||23
8184391|NCT02334748|20181310|P1|STARTED|Overall Study||31
8184392|NCT02334527|20181315|P1|NOT COMPLETED|Overall Study||0
8184393|NCT02334527|20181315|P1|COMPLETED|Overall Study||12
8184394|NCT02334527|20181315|P1|STARTED|Overall Study||12
8184395|NCT02334436|20181326|P2|NOT COMPLETED|Overall Study||1
8184396|NCT02334436|20181327|P1|NOT COMPLETED|Overall Study||9
8184397|NCT02334436|20181326|P2|COMPLETED|Overall Study||77
8184398|NCT02334436|20181327|P1|COMPLETED|Overall Study||237
8184399|NCT02334436|20181326|P2|STARTED|Overall Study||78
8184400|NCT02334436|20181327|P1|STARTED|Overall Study||246
8184401|NCT02334423|20181341|P2|NOT COMPLETED|Overall Study||3
8184402|NCT02334423|20181342|P1|NOT COMPLETED|Overall Study||10
8184403|NCT02334423|20181341|P2|COMPLETED|Overall Study||81
8184404|NCT02334423|20181342|P1|COMPLETED|Overall Study||236
8184405|NCT02334423|20181341|P2|STARTED|Overall Study||84
8184406|NCT02334423|20181342|P1|STARTED|Overall Study||246
8184407|NCT02334384|20181356|P2|NOT COMPLETED|Overall Study||1
8184408|NCT02334384|20181357|P1|NOT COMPLETED|Overall Study||1
8184409|NCT02334384|20181356|P2|COMPLETED|Overall Study||1
8184410|NCT02334384|20181357|P1|COMPLETED|Overall Study||3
8184411|NCT02334384|20181356|P2|STARTED|Overall Study||2
8184412|NCT02334384|20181357|P1|STARTED|Overall Study||4
8184413|NCT02334358|20181363|P1|NOT COMPLETED|Overall Study||9
8184414|NCT02334358|20181363|P1|COMPLETED|Overall Study||494
8184415|NCT02334358|20181363|P1|STARTED|Overall Study||503
8184416|NCT02334306|20181369|P2|NOT COMPLETED|Open-label Period||0
8184417|NCT02334306|20181370|P1|NOT COMPLETED|Open-label Period||0
8184418|NCT02334306|20181369|P2|COMPLETED|Open-label Period||14
8184419|NCT02334306|20181370|P1|COMPLETED|Open-label Period||15
8184420|NCT02334306|20181369|P2|STARTED|Open-label Period||14
8184421|NCT02334306|20181370|P1|STARTED|Open-label Period||15
8184422|NCT02334306|20181369|P2|NOT COMPLETED|Double-blind Period||2
8184423|NCT02334306|20181370|P1|NOT COMPLETED|Double-blind Period||1
8184424|NCT02334306|20181369|P2|COMPLETED|Double-blind Period||14
8184425|NCT02334306|20181370|P1|COMPLETED|Double-blind Period||15
8184426|NCT02334306|20181369|P2|STARTED|Double-blind Period||16
8184427|NCT02334306|20181370|P1|STARTED|Double-blind Period||16
8184428|NCT02334267|20181392|P2|NOT COMPLETED|Overall Study||0
8184429|NCT02334267|20181393|P1|NOT COMPLETED|Overall Study||1
8184430|NCT02334267|20181392|P2|COMPLETED|Overall Study||5
8184431|NCT02334267|20181393|P1|COMPLETED|Overall Study||5
8184432|NCT02334267|20181392|P2|STARTED|Overall Study||5
8184433|NCT02334267|20181393|P1|STARTED|Overall Study||6
8184434|NCT02334215|20181408|P3|NOT COMPLETED|Overall Study||15
8184435|NCT02334215|20181409|P2|NOT COMPLETED|Overall Study||6
8184436|NCT02334215|20181410|P1|NOT COMPLETED|Overall Study||7
8184437|NCT02334215|20181408|P3|COMPLETED|Overall Study||61
8184438|NCT02334215|20181409|P2|COMPLETED|Overall Study||68
8184439|NCT02334215|20181410|P1|COMPLETED|Overall Study||68
8184440|NCT02334215|20181408|P3|STARTED|Overall Study||76
8184441|NCT02334215|20181409|P2|STARTED|Overall Study||74
8184442|NCT02334215|20181410|P1|STARTED|Overall Study||75
8184443|NCT02334059|20181472|P3|NOT COMPLETED|Overall Study||0
8184444|NCT02334059|20181473|P2|NOT COMPLETED|Overall Study||0
8184445|NCT02334059|20181474|P1|NOT COMPLETED|Overall Study||0
8184446|NCT02334059|20181472|P3|COMPLETED|Overall Study||37
8184447|NCT02334059|20181473|P2|COMPLETED|Overall Study||34
8184448|NCT02334059|20181474|P1|COMPLETED|Overall Study||37
8184449|NCT02334059|20181472|P3|STARTED|Overall Study||37
8184450|NCT02334059|20181473|P2|STARTED|Overall Study||34
8184451|NCT02334059|20181474|P1|STARTED|Overall Study||37
8184452|NCT02333630|20181490|P2|NOT COMPLETED|Overall Study||2
8184453|NCT02333630|20181491|P1|NOT COMPLETED|Overall Study||5
8184454|NCT02333630|20181490|P2|COMPLETED|Overall Study||98
8184455|NCT02333630|20181491|P1|COMPLETED|Overall Study||95
8184456|NCT02333630|20181490|P2|STARTED|Overall Study||100
8184457|NCT02333630|20181491|P1|STARTED|Overall Study||100
8184458|NCT02333487|20181506|P3|NOT COMPLETED|Overall Study||0
8184459|NCT02333487|20181507|P2|NOT COMPLETED|Overall Study||2
8184460|NCT02333487|20181508|P1|NOT COMPLETED|Overall Study||0
8184461|NCT02333487|20181506|P3|COMPLETED|Overall Study||8
8184462|NCT02333487|20181507|P2|COMPLETED|Overall Study||6
8184463|NCT02333487|20181508|P1|COMPLETED|Overall Study||6
8184464|NCT02333487|20181506|P3|STARTED|Overall Study||8
8184465|NCT02333487|20181507|P2|STARTED|Overall Study||8
8184466|NCT02333487|20181508|P1|STARTED|Overall Study||6
8184467|NCT02333383|20181519|P1|NOT COMPLETED|Overall Study||41
8184468|NCT02333383|20181519|P1|COMPLETED|Overall Study||160
8184469|NCT02333383|20181519|P1|STARTED|Overall Study||201
8184470|NCT02333331|20181533|P4|NOT COMPLETED|Overall Study||3
8184471|NCT02333331|20181534|P3|NOT COMPLETED|Overall Study||18
8184472|NCT02333331|20181535|P2|NOT COMPLETED|Overall Study||6
8184473|NCT02333331|20181536|P1|NOT COMPLETED|Overall Study||2
8184474|NCT02333331|20181533|P4|COMPLETED|Overall Study||64
8184475|NCT02333331|20181534|P3|COMPLETED|Overall Study||95
8184476|NCT02333331|20181535|P2|COMPLETED|Overall Study||12
8184477|NCT02333331|20181536|P1|COMPLETED|Overall Study||17
8184478|NCT02333331|20181533|P4|STARTED|Overall Study||67
8184479|NCT02333331|20181534|P3|STARTED|Overall Study||113
8184480|NCT02333331|20181535|P2|STARTED|Overall Study||18
8184481|NCT02333331|20181536|P1|STARTED|Overall Study||19
8184482|NCT02333071|20181564|P2|NOT COMPLETED|Open Label Extension||75
8184483|NCT02333071|20181565|P1|NOT COMPLETED|Open Label Extension||144
8184484|NCT02333071|20181564|P2|COMPLETED|Open Label Extension||49
8184485|NCT02333071|20181565|P1|COMPLETED|Open Label Extension||95
8184486|NCT02333071|20181564|P2|STARTED|Open Label Extension||124
8184487|NCT02333071|20181565|P1|STARTED|Open Label Extension||239
8184488|NCT02333071|20181564|P2|NOT COMPLETED|Core Study||137
8184489|NCT02333071|20181565|P1|NOT COMPLETED|Core Study||52
8184490|NCT02333071|20181564|P2|COMPLETED|Core Study||190
8184491|NCT02333071|20181565|P1|COMPLETED|Core Study||274
8184492|NCT02333071|20181564|P2|Received Intervention|Core Study||324
8184493|NCT02333071|20181565|P1|Received Intervention|Core Study||319
8184494|NCT02333071|20181564|P2|STARTED|Core Study||327
8184495|NCT02333071|20181565|P1|STARTED|Core Study||326
8184496|NCT02333045|20181603|P2|NOT COMPLETED|Overall Study||0
8184497|NCT02333045|20181604|P1|NOT COMPLETED|Overall Study||0
8184498|NCT02333045|20181603|P2|COMPLETED|Overall Study||3
8184499|NCT02333045|20181604|P1|COMPLETED|Overall Study||1
8184500|NCT02333045|20181603|P2|STARTED|Overall Study||3
8184501|NCT02333045|20181604|P1|STARTED|Overall Study||1
8184502|NCT02332915|20181616|P2|NOT COMPLETED|Overall Study||6
8184503|NCT02332915|20181617|P1|NOT COMPLETED|Overall Study||6
8184504|NCT02332915|20181616|P2|COMPLETED|Overall Study||12
8184505|NCT02332915|20181617|P1|COMPLETED|Overall Study||12
8184506|NCT02332915|20181616|P2|STARTED|Overall Study||18
8184507|NCT02332915|20181617|P1|STARTED|Overall Study||18
8184508|NCT02332902|20181625|P1|NOT COMPLETED|Overall Study||7
8184509|NCT02332902|20181625|P1|COMPLETED|Overall Study||17
8184510|NCT02332902|20181625|P1|STARTED|Overall Study||24
8184511|NCT02332889|20181630|P1|NOT COMPLETED|Overall Study||1
8184512|NCT02332889|20181630|P1|COMPLETED|Overall Study||0
8184513|NCT02332889|20181630|P1|STARTED|Overall Study||1
8184514|NCT02332876|20181636|P2|NOT COMPLETED|Overall Study||1
8184515|NCT02332876|20181637|P1|NOT COMPLETED|Overall Study||1
8184516|NCT02332876|20181636|P2|COMPLETED|Overall Study||43
8184517|NCT02332876|20181637|P1|COMPLETED|Overall Study||42
8184518|NCT02332876|20181636|P2|STARTED|Overall Study||44
8184519|NCT02332876|20181637|P1|STARTED|Overall Study||43
8184520|NCT02332863|20181645|P2|NOT COMPLETED|Overall Study||0
8184521|NCT02332863|20181646|P1|NOT COMPLETED|Overall Study||0
8184522|NCT02332863|20181645|P2|COMPLETED|Overall Study||22
8184523|NCT02332863|20181646|P1|COMPLETED|Overall Study||22
8184524|NCT02332863|20181645|P2|STARTED|Overall Study||22
8184525|NCT02332863|20181646|P1|STARTED|Overall Study||22
8184526|NCT02332824|20181672|P6|NOT COMPLETED|Overall Study||1
8184527|NCT02332824|20181673|P5|NOT COMPLETED|Overall Study||4
8184528|NCT02332824|20181674|P4|NOT COMPLETED|Overall Study||2
8184529|NCT02332824|20181675|P3|NOT COMPLETED|Overall Study||2
8184530|NCT02332824|20181676|P2|NOT COMPLETED|Overall Study||1
8184531|NCT02332824|20181677|P1|NOT COMPLETED|Overall Study||6
8184532|NCT02332824|20181672|P6|COMPLETED|Overall Study||69
8184533|NCT02332824|20181673|P5|COMPLETED|Overall Study||65
8184534|NCT02332824|20181674|P4|COMPLETED|Overall Study||66
8184535|NCT02332824|20181675|P3|COMPLETED|Overall Study||72
8184536|NCT02332824|20181676|P2|COMPLETED|Overall Study||66
8184537|NCT02332824|20181677|P1|COMPLETED|Overall Study||61
8184538|NCT02332824|20181672|P6|STARTED|Overall Study||70
8184539|NCT02332824|20181673|P5|STARTED|Overall Study||69
8184540|NCT02332824|20181674|P4|STARTED|Overall Study||68
8184541|NCT02332824|20181675|P3|STARTED|Overall Study||74
8184542|NCT02332824|20181676|P2|STARTED|Overall Study||67
8184543|NCT02332824|20181677|P1|STARTED|Overall Study||67
8184544|NCT02332798|20181718|P3|NOT COMPLETED|Overall Study||1
8184545|NCT02332798|20181719|P2|NOT COMPLETED|Overall Study||2
8184546|NCT02332798|20181720|P1|NOT COMPLETED|Overall Study||1
8184547|NCT02332798|20181718|P3|COMPLETED|Overall Study||11
8184548|NCT02332798|20181719|P2|COMPLETED|Overall Study||12
8184549|NCT02332798|20181720|P1|COMPLETED|Overall Study||12
8184550|NCT02332798|20181718|P3|STARTED|Overall Study||12
8184551|NCT02332798|20181719|P2|STARTED|Overall Study||14
8184552|NCT02332798|20181720|P1|STARTED|Overall Study||13
8184553|NCT02332720|20181793|P23|NOT COMPLETED|Part C||0
8184554|NCT02332720|20181794|P22|NOT COMPLETED|Part C||0
8184555|NCT02332720|20181795|P21|NOT COMPLETED|Part C||0
8184556|NCT02332720|20181796|P20|NOT COMPLETED|Part C||0
8184557|NCT02332720|20181797|P19|NOT COMPLETED|Part C||0
8184558|NCT02332720|20181798|P18|NOT COMPLETED|Part C||0
8184559|NCT02332720|20181799|P17|NOT COMPLETED|Part C||0
8184560|NCT02332720|20181800|P16|NOT COMPLETED|Part C||0
8184561|NCT02332720|20181801|P15|NOT COMPLETED|Part C||0
8184562|NCT02332720|20181802|P14|NOT COMPLETED|Part C||0
8184563|NCT02332720|20181803|P13|NOT COMPLETED|Part C||0
8184564|NCT02332720|20181804|P12|NOT COMPLETED|Part C||0
8184565|NCT02332720|20181805|P11|NOT COMPLETED|Part C||0
8184566|NCT02332720|20181806|P10|NOT COMPLETED|Part C||0
8184567|NCT02332720|20181807|P9|NOT COMPLETED|Part C||0
8184568|NCT02332720|20181808|P8|NOT COMPLETED|Part C||0
8184569|NCT02332720|20181809|P7|NOT COMPLETED|Part C||0
8184570|NCT02332720|20181810|P6|NOT COMPLETED|Part C||0
8184571|NCT02332720|20181811|P5|NOT COMPLETED|Part C||0
8184572|NCT02332720|20181812|P4|NOT COMPLETED|Part C||0
8184573|NCT02332720|20181813|P3|NOT COMPLETED|Part C||0
8184574|NCT02332720|20181814|P2|NOT COMPLETED|Part C||0
8184575|NCT02332720|20181815|P1|NOT COMPLETED|Part C||0
8184576|NCT02332720|20181793|P23|COMPLETED|Part C||0
8184577|NCT02332720|20181794|P22|COMPLETED|Part C||0
8184578|NCT02332720|20181795|P21|COMPLETED|Part C||0
8184579|NCT02332720|20181796|P20|COMPLETED|Part C||0
8184580|NCT02332720|20181797|P19|COMPLETED|Part C||0
8184581|NCT02332720|20181798|P18|COMPLETED|Part C||0
8184582|NCT02332720|20181799|P17|COMPLETED|Part C||0
8184583|NCT02332720|20181800|P16|COMPLETED|Part C||0
8184584|NCT02332720|20181801|P15|COMPLETED|Part C||0
8184585|NCT02332720|20181802|P14|COMPLETED|Part C||0
8184586|NCT02332720|20181803|P13|COMPLETED|Part C||0
8184587|NCT02332720|20181804|P12|COMPLETED|Part C||0
8184588|NCT02332720|20181805|P11|COMPLETED|Part C||0
8184589|NCT02332720|20181806|P10|COMPLETED|Part C||0
8184590|NCT02332720|20181807|P9|COMPLETED|Part C||0
8184591|NCT02332720|20181808|P8|COMPLETED|Part C||0
8184592|NCT02332720|20181809|P7|COMPLETED|Part C||0
8184593|NCT02332720|20181810|P6|COMPLETED|Part C||0
8184594|NCT02332720|20181811|P5|COMPLETED|Part C||0
8184595|NCT02332720|20181812|P4|COMPLETED|Part C||2
8184596|NCT02332720|20181813|P3|COMPLETED|Part C||3
8184597|NCT02332720|20181814|P2|COMPLETED|Part C||1
8184598|NCT02332720|20181815|P1|COMPLETED|Part C||2
8184599|NCT02332720|20181793|P23|STARTED|Part C|Part B participants were not included in Part C.|0
8184600|NCT02332720|20181794|P22|STARTED|Part C||0
8184601|NCT02332720|20181795|P21|STARTED|Part C|Part B participants were not included in Part C.|0
8184602|NCT02332720|20181796|P20|STARTED|Part C|Part B participants were not included in Part C.|0
8184603|NCT02332720|20181797|P19|STARTED|Part C|Part B participants were not included in Part C.|0
8184604|NCT02332720|20181798|P18|STARTED|Part C|Part B participants were not included in Part C.|0
8184605|NCT02332720|20181799|P17|STARTED|Part C|Part B participants were not included in Part C.|0
8184606|NCT02332720|20181800|P16|STARTED|Part C|Part B participants were not included in Part C.|0
8184607|NCT02332720|20181801|P15|STARTED|Part C|Part B participants were not included in Part C.|0
8184608|NCT02332720|20181802|P14|STARTED|Part C|Part B participants were not included in Part C.|0
8184609|NCT02332720|20181803|P13|STARTED|Part C|Part B participants were not included in Part C.|0
8184610|NCT02332720|20181804|P12|STARTED|Part C|Part B participants were not included in Part C.|0
8184611|NCT02332720|20181805|P11|STARTED|Part C|Part B participants were not included in Part C.|0
8184612|NCT02332720|20181806|P10|STARTED|Part C|Part B participants were not included in Part C.|0
8184613|NCT02332720|20181807|P9|STARTED|Part C|Part B participants were not included in Part C.|0
8184614|NCT02332720|20181808|P8|STARTED|Part C|Part B participants were not included in Part C.|0
8184615|NCT02332720|20181809|P7|STARTED|Part C|Part B participants were not included in Part C.|0
8184616|NCT02332720|20181810|P6|STARTED|Part C|Part B participants were not included in Part C.|0
8184617|NCT02332720|20181811|P5|STARTED|Part C|Part B participants were not included in Part C.|0
8184618|NCT02332720|20181812|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
8184619|NCT02332720|20181813|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
8184620|NCT02332720|20181814|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
8184621|NCT02332720|20181815|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
8184622|NCT02332720|20181793|P23|NOT COMPLETED|Part A and Part B||0
8184623|NCT02332720|20181794|P22|NOT COMPLETED|Part A and Part B||0
8184624|NCT02332720|20181795|P21|NOT COMPLETED|Part A and Part B||0
8184625|NCT02332720|20181796|P20|NOT COMPLETED|Part A and Part B||1
8184626|NCT02332720|20181797|P19|NOT COMPLETED|Part A and Part B||1
8184627|NCT02332720|20181798|P18|NOT COMPLETED|Part A and Part B||1
8184628|NCT02332720|20181799|P17|NOT COMPLETED|Part A and Part B||0
8184629|NCT02332720|20181800|P16|NOT COMPLETED|Part A and Part B||1
8184630|NCT02332720|20181801|P15|NOT COMPLETED|Part A and Part B||0
8184631|NCT02332720|20181802|P14|NOT COMPLETED|Part A and Part B||0
8184632|NCT02332720|20181803|P13|NOT COMPLETED|Part A and Part B||0
8184633|NCT02332720|20181804|P12|NOT COMPLETED|Part A and Part B||0
8184634|NCT02332720|20181805|P11|NOT COMPLETED|Part A and Part B||0
8184635|NCT02332720|20181806|P10|NOT COMPLETED|Part A and Part B||0
8184636|NCT02332720|20181807|P9|NOT COMPLETED|Part A and Part B||0
8184637|NCT02332720|20181808|P8|NOT COMPLETED|Part A and Part B||1
8184638|NCT02332720|20181809|P7|NOT COMPLETED|Part A and Part B||1
8184639|NCT02332720|20181810|P6|NOT COMPLETED|Part A and Part B||3
8184640|NCT02332720|20181811|P5|NOT COMPLETED|Part A and Part B||0
8184641|NCT02332720|20181812|P4|NOT COMPLETED|Part A and Part B||0
8184642|NCT02332720|20181813|P3|NOT COMPLETED|Part A and Part B||0
8184643|NCT02332720|20181814|P2|NOT COMPLETED|Part A and Part B||0
8184644|NCT02332720|20181815|P1|NOT COMPLETED|Part A and Part B||1
8184645|NCT02332720|20181793|P23|COMPLETED|Part A and Part B||4
8184646|NCT02332720|20181794|P22|COMPLETED|Part A and Part B||0
8184647|NCT02332720|20181795|P21|COMPLETED|Part A and Part B||7
8184648|NCT02332720|20181796|P20|COMPLETED|Part A and Part B||24
8184649|NCT02332720|20181797|P19|COMPLETED|Part A and Part B||20
8184650|NCT02332720|20181798|P18|COMPLETED|Part A and Part B||13
8184651|NCT02332720|20181799|P17|COMPLETED|Part A and Part B||15
8184652|NCT02332720|20181800|P16|COMPLETED|Part A and Part B||13
8184653|NCT02332720|20181801|P15|COMPLETED|Part A and Part B||16
8184654|NCT02332720|20181802|P14|COMPLETED|Part A and Part B||13
8184655|NCT02332720|20181803|P13|COMPLETED|Part A and Part B||16
8184656|NCT02332720|20181804|P12|COMPLETED|Part A and Part B||15
8184657|NCT02332720|20181805|P11|COMPLETED|Part A and Part B||14
8184658|NCT02332720|20181806|P10|COMPLETED|Part A and Part B||14
8184659|NCT02332720|20181807|P9|COMPLETED|Part A and Part B||15
8184660|NCT02332720|20181808|P8|COMPLETED|Part A and Part B||34
8184661|NCT02332720|20181809|P7|COMPLETED|Part A and Part B||36
8184662|NCT02332720|20181810|P6|COMPLETED|Part A and Part B||33
8184663|NCT02332720|20181811|P5|COMPLETED|Part A and Part B||16
8184664|NCT02332720|20181812|P4|COMPLETED|Part A and Part B||22
8184665|NCT02332720|20181813|P3|COMPLETED|Part A and Part B||22
8184666|NCT02332720|20181814|P2|COMPLETED|Part A and Part B||21
8184667|NCT02332720|20181815|P1|COMPLETED|Part A and Part B||20
8184668|NCT02332720|20181793|P23|Treated|Part A and Part B||4
8184669|NCT02332720|20181794|P22|Treated|Part A and Part B||0
8184670|NCT02332720|20181795|P21|Treated|Part A and Part B||7
8184671|NCT02332720|20181796|P20|Treated|Part A and Part B||25
8184672|NCT02332720|20181797|P19|Treated|Part A and Part B||20
8184673|NCT02332720|20181798|P18|Treated|Part A and Part B||14
8184674|NCT02332720|20181799|P17|Treated|Part A and Part B||15
8184675|NCT02332720|20181800|P16|Treated|Part A and Part B||14
8184676|NCT02332720|20181801|P15|Treated|Part A and Part B||16
8184677|NCT02332720|20181802|P14|Treated|Part A and Part B||13
8184678|NCT02332720|20181803|P13|Treated|Part A and Part B||16
8184679|NCT02332720|20181804|P12|Treated|Part A and Part B||15
8184680|NCT02332720|20181805|P11|Treated|Part A and Part B||14
8184681|NCT02332720|20181806|P10|Treated|Part A and Part B||14
8184682|NCT02332720|20181807|P9|Treated|Part A and Part B||15
8184683|NCT02332720|20181808|P8|Treated|Part A and Part B||35
8184684|NCT02332720|20181809|P7|Treated|Part A and Part B||37
8184685|NCT02332720|20181810|P6|Treated|Part A and Part B||36
8184686|NCT02332720|20181811|P5|Treated|Part A and Part B||16
8184687|NCT02332720|20181812|P4|Treated|Part A and Part B||22
8184688|NCT02332720|20181813|P3|Treated|Part A and Part B||22
8184689|NCT02332720|20181814|P2|Treated|Part A and Part B||21
8184690|NCT02332720|20181815|P1|Treated|Part A and Part B||21
8184691|NCT02332720|20181793|P23|STARTED|Part A and Part B||4
8184692|NCT02332720|20181794|P22|STARTED|Part A and Part B||0
8184693|NCT02332720|20181795|P21|STARTED|Part A and Part B||7
8184694|NCT02332720|20181796|P20|STARTED|Part A and Part B||25
8184695|NCT02332720|20181797|P19|STARTED|Part A and Part B||21
8184696|NCT02332720|20181798|P18|STARTED|Part A and Part B||14
8184697|NCT02332720|20181799|P17|STARTED|Part A and Part B||15
8184698|NCT02332720|20181800|P16|STARTED|Part A and Part B||14
8184699|NCT02332720|20181801|P15|STARTED|Part A and Part B||16
8184700|NCT02332720|20181802|P14|STARTED|Part A and Part B||13
8184701|NCT02332720|20181803|P13|STARTED|Part A and Part B||16
8184702|NCT02332720|20181804|P12|STARTED|Part A and Part B||15
8184703|NCT02332720|20181805|P11|STARTED|Part A and Part B||14
8184704|NCT02332720|20181806|P10|STARTED|Part A and Part B||14
8184705|NCT02332720|20181807|P9|STARTED|Part A and Part B||15
8184706|NCT02332720|20181808|P8|STARTED|Part A and Part B||35
8184707|NCT02332720|20181809|P7|STARTED|Part A and Part B||37
8184708|NCT02332720|20181810|P6|STARTED|Part A and Part B||36
8184709|NCT02332720|20181811|P5|STARTED|Part A and Part B||16
8184710|NCT02332720|20181812|P4|STARTED|Part A and Part B||22
8184711|NCT02332720|20181813|P3|STARTED|Part A and Part B||22
8184712|NCT02332720|20181814|P2|STARTED|Part A and Part B||21
8184713|NCT02332720|20181815|P1|STARTED|Part A and Part B||21
8184714|NCT02332707|20181951|P18|NOT COMPLETED|Overall Study||0
8184715|NCT02332707|20181952|P17|NOT COMPLETED|Overall Study||0
8184716|NCT02332707|20181953|P16|NOT COMPLETED|Overall Study||0
8184717|NCT02332707|20181954|P15|NOT COMPLETED|Overall Study||0
8184718|NCT02332707|20181955|P14|NOT COMPLETED|Overall Study||0
8184719|NCT02332707|20181956|P13|NOT COMPLETED|Overall Study||5
8184720|NCT02332707|20181957|P12|NOT COMPLETED|Overall Study||0
8184721|NCT02332707|20181958|P11|NOT COMPLETED|Overall Study||2
8184722|NCT02332707|20181959|P10|NOT COMPLETED|Overall Study||3
8184723|NCT02332707|20181960|P9|NOT COMPLETED|Overall Study||0
8184724|NCT02332707|20181961|P8|NOT COMPLETED|Overall Study||0
8184725|NCT02332707|20181962|P7|NOT COMPLETED|Overall Study||0
8184726|NCT02332707|20181963|P6|NOT COMPLETED|Overall Study||1
8184727|NCT02332707|20181964|P5|NOT COMPLETED|Overall Study||0
8184728|NCT02332707|20181965|P4|NOT COMPLETED|Overall Study||1
8184729|NCT02332707|20181966|P3|NOT COMPLETED|Overall Study||1
8184730|NCT02332707|20181967|P2|NOT COMPLETED|Overall Study||0
8184731|NCT02332707|20181968|P1|NOT COMPLETED|Overall Study||0
8184732|NCT02332707|20181951|P18|COMPLETED|Overall Study||16
8184733|NCT02332707|20181952|P17|COMPLETED|Overall Study||30
8184734|NCT02332707|20181953|P16|COMPLETED|Overall Study||26
8184735|NCT02332707|20181954|P15|COMPLETED|Overall Study||16
8184736|NCT02332707|20181955|P14|COMPLETED|Overall Study||15
8184737|NCT02332707|20181956|P13|COMPLETED|Overall Study||35
8184738|NCT02332707|20181957|P12|COMPLETED|Overall Study||35
8184739|NCT02332707|20181958|P11|COMPLETED|Overall Study||29
8184740|NCT02332707|20181959|P10|COMPLETED|Overall Study||28
8184741|NCT02332707|20181960|P9|COMPLETED|Overall Study||48
8184742|NCT02332707|20181961|P8|COMPLETED|Overall Study||16
8184743|NCT02332707|20181962|P7|COMPLETED|Overall Study||15
8184744|NCT02332707|20181963|P6|COMPLETED|Overall Study||22
8184745|NCT02332707|20181964|P5|COMPLETED|Overall Study||23
8184746|NCT02332707|20181965|P4|COMPLETED|Overall Study||13
8184747|NCT02332707|20181966|P3|COMPLETED|Overall Study||15
8184748|NCT02332707|20181967|P2|COMPLETED|Overall Study||24
8184749|NCT02332707|20181968|P1|COMPLETED|Overall Study||23
8184750|NCT02332707|20181951|P18|STARTED|Overall Study||16
8184751|NCT02332707|20181952|P17|STARTED|Overall Study||30
8184752|NCT02332707|20181953|P16|STARTED|Overall Study||26
8184753|NCT02332707|20181954|P15|STARTED|Overall Study||16
8184754|NCT02332707|20181955|P14|STARTED|Overall Study||15
8184755|NCT02332707|20181956|P13|STARTED|Overall Study||40
8184756|NCT02332707|20181957|P12|STARTED|Overall Study||35
8184757|NCT02332707|20181958|P11|STARTED|Overall Study||31
8184758|NCT02332707|20181959|P10|STARTED|Overall Study||31
8184759|NCT02332707|20181960|P9|STARTED|Overall Study||48
8184760|NCT02332707|20181961|P8|STARTED|Overall Study||16
8184761|NCT02332707|20181962|P7|STARTED|Overall Study||15
8184762|NCT02332707|20181963|P6|STARTED|Overall Study||23
8184763|NCT02332707|20181964|P5|STARTED|Overall Study||23
8184764|NCT02332707|20181965|P4|STARTED|Overall Study||14
8184765|NCT02332707|20181966|P3|STARTED|Overall Study||16
8184766|NCT02332707|20181967|P2|STARTED|Overall Study||24
8184767|NCT02332707|20181968|P1|STARTED|Overall Study||23
8184768|NCT02332239|20182062|P2|NOT COMPLETED|Overall Study||6
8184769|NCT02332239|20182063|P1|NOT COMPLETED|Overall Study||4
8184770|NCT02332239|20182062|P2|COMPLETED|Overall Study||52
8184771|NCT02332239|20182063|P1|COMPLETED|Overall Study||54
8184772|NCT02332239|20182062|P2|STARTED|Overall Study||58
8184773|NCT02332239|20182063|P1|STARTED|Overall Study||58
8184774|NCT02331992|20182076|P1|NOT COMPLETED|Overall Study||0
8184775|NCT02331992|20182076|P1|COMPLETED|Overall Study||34
8184776|NCT02331992|20182076|P1|STARTED|Overall Study||34
8184777|NCT02331940|20182083|P2|NOT COMPLETED|Overall Study||5
8184778|NCT02331940|20182084|P1|NOT COMPLETED|Overall Study||7
8184779|NCT02331940|20182083|P2|COMPLETED|Overall Study||95
8184780|NCT02331940|20182084|P1|COMPLETED|Overall Study||93
8184781|NCT02331940|20182083|P2|STARTED|Overall Study||100
8184782|NCT02331940|20182084|P1|STARTED|Overall Study||100
8184783|NCT02331680|20182099|P3|NOT COMPLETED|Overall Study||15
8184784|NCT02331680|20182100|P2|NOT COMPLETED|Overall Study||4
8184785|NCT02331680|20182101|P1|NOT COMPLETED|Overall Study||6
8184786|NCT02331680|20182099|P3|COMPLETED|Overall Study||29
8184787|NCT02331680|20182100|P2|COMPLETED|Overall Study||36
8184788|NCT02331680|20182101|P1|COMPLETED|Overall Study||34
8184789|NCT02331680|20182099|P3|STARTED|Overall Study||44
8184790|NCT02331680|20182100|P2|STARTED|Overall Study||40
8184791|NCT02331680|20182101|P1|STARTED|Overall Study||40
8184792|NCT02331589|20182114|P2|NOT COMPLETED|Overall Study||5
8184793|NCT02331589|20182115|P1|NOT COMPLETED|Overall Study||5
8184794|NCT02331589|20182114|P2|COMPLETED|Overall Study||31
8184795|NCT02331589|20182115|P1|COMPLETED|Overall Study||34
8184796|NCT02331589|20182114|P2|STARTED|Overall Study||36
8184797|NCT02331589|20182115|P1|STARTED|Overall Study||39
8184798|NCT02331446|20182131|P4|NOT COMPLETED|Overall Study||3
8184799|NCT02331446|20182132|P3|NOT COMPLETED|Overall Study||3
8184800|NCT02331446|20182133|P2|NOT COMPLETED|Overall Study||5
8184801|NCT02331446|20182134|P1|NOT COMPLETED|Overall Study||4
8184802|NCT02331446|20182131|P4|COMPLETED|Overall Study||8
8184803|NCT02331446|20182132|P3|COMPLETED|Overall Study||8
8184804|NCT02331446|20182133|P2|COMPLETED|Overall Study||6
8184805|NCT02331446|20182134|P1|COMPLETED|Overall Study||5
8184806|NCT02331446|20182131|P4|STARTED|Overall Study||11
8184807|NCT02331446|20182132|P3|STARTED|Overall Study||11
8184808|NCT02331446|20182133|P2|STARTED|Overall Study||11
8184809|NCT02331446|20182134|P1|STARTED|Overall Study||9
8184810|NCT02331407|20182204|P1|NOT COMPLETED|Overall Study||0
8184811|NCT02331407|20182204|P1|COMPLETED|Overall Study||9
8184812|NCT02331407|20182204|P1|STARTED|Overall Study||9
8184813|NCT02331394|20182210|P1|NOT COMPLETED|Overall Study||1
8184814|NCT02331394|20182210|P1|COMPLETED|Overall Study|14 patients, 1 dropped out|14
8184815|NCT02331394|20182210|P1|STARTED|Overall Study||15
8184816|NCT02331368|20182221|P1|NOT COMPLETED|Overall Study||3
8184817|NCT02331368|20182221|P1|COMPLETED|Overall Study||29
8184818|NCT02331368|20182221|P1|STARTED|Overall Study||32
8184819|NCT02331108|20182233|P6|NOT COMPLETED|Overall Study||2
8184820|NCT02331108|20182234|P5|NOT COMPLETED|Overall Study||2
8184821|NCT02331108|20182235|P4|NOT COMPLETED|Overall Study||1
8184822|NCT02331108|20182236|P3|NOT COMPLETED|Overall Study||1
8184823|NCT02331108|20182237|P2|NOT COMPLETED|Overall Study||2
8184824|NCT02331108|20182238|P1|NOT COMPLETED|Overall Study||1
8184825|NCT02331108|20182233|P6|COMPLETED|Overall Study||50
8184826|NCT02331108|20182234|P5|COMPLETED|Overall Study||50
8184827|NCT02331108|20182235|P4|COMPLETED|Overall Study||50
8184828|NCT02331108|20182236|P3|COMPLETED|Overall Study||50
8184829|NCT02331108|20182237|P2|COMPLETED|Overall Study||50
8184830|NCT02331108|20182238|P1|COMPLETED|Overall Study||50
8184831|NCT02331108|20182233|P6|STARTED|Overall Study||52
8184832|NCT02331108|20182234|P5|STARTED|Overall Study||52
8184833|NCT02331108|20182235|P4|STARTED|Overall Study||51
8184834|NCT02331108|20182236|P3|STARTED|Overall Study||51
8184835|NCT02331108|20182237|P2|STARTED|Overall Study||52
8184836|NCT02331108|20182238|P1|STARTED|Overall Study||51
8184837|NCT02331095|20182262|P2|NOT COMPLETED|Overall Study||1
8184838|NCT02331095|20182263|P1|NOT COMPLETED|Overall Study||4
8184839|NCT02331095|20182262|P2|COMPLETED|Overall Study||9
8184840|NCT02331095|20182263|P1|COMPLETED|Overall Study||7
8184841|NCT02331095|20182262|P2|STARTED|Overall Study||10
8184842|NCT02331095|20182263|P1|STARTED|Overall Study||11
8184843|NCT02330978|20182289|P1|NOT COMPLETED|The Second Patient Included at Study||0
8184844|NCT02330978|20182289|P1|COMPLETED|The Second Patient Included at Study||1
8184845|NCT02330978|20182289|P1|STARTED|The Second Patient Included at Study||1
8184846|NCT02330978|20182289|P1|NOT COMPLETED|The First Patient Included at Study||0
8184847|NCT02330978|20182289|P1|COMPLETED|The First Patient Included at Study||1
8184848|NCT02330978|20182289|P1|STARTED|The First Patient Included at Study||1
8184849|NCT02330627|20182295|P2|NOT COMPLETED|Overall Study||1
8184850|NCT02330627|20182296|P1|NOT COMPLETED|Overall Study||1
8184851|NCT02330627|20182295|P2|COMPLETED|Overall Study||12
8184852|NCT02330627|20182296|P1|COMPLETED|Overall Study||15
8184853|NCT02330627|20182295|P2|STARTED|Overall Study||13
8184854|NCT02330627|20182296|P1|STARTED|Overall Study||16
8184855|NCT02330588|20182315|P5|NOT COMPLETED|Overall Study||19
8184856|NCT02330588|20182316|P4|NOT COMPLETED|Overall Study||22
8184857|NCT02330588|20182317|P3|NOT COMPLETED|Overall Study||15
8184858|NCT02330588|20182318|P2|NOT COMPLETED|Overall Study||18
8184859|NCT02330588|20182319|P1|NOT COMPLETED|Overall Study||16
8184860|NCT02330588|20182315|P5|COMPLETED|Overall Study||28
8184861|NCT02330588|20182316|P4|COMPLETED|Overall Study||24
8184862|NCT02330588|20182317|P3|COMPLETED|Overall Study||31
8184863|NCT02330588|20182318|P2|COMPLETED|Overall Study||25
8184864|NCT02330588|20182319|P1|COMPLETED|Overall Study||28
8184865|NCT02330588|20182315|P5|STARTED|Overall Study||47
8184866|NCT02330588|20182316|P4|STARTED|Overall Study||46
8184867|NCT02330588|20182317|P3|STARTED|Overall Study||46
8184868|NCT02330588|20182318|P2|STARTED|Overall Study||43
8184869|NCT02330588|20182319|P1|STARTED|Overall Study||44
8184870|NCT02330549|20182346|P2|NOT COMPLETED|Overall Study||1
8184871|NCT02330549|20182347|P1|NOT COMPLETED|Overall Study||4
8184872|NCT02330549|20182346|P2|COMPLETED|Overall Study||24
8184873|NCT02330549|20182347|P1|COMPLETED|Overall Study||16
8184874|NCT02330549|20182346|P2|STARTED|Overall Study||25
8184875|NCT02330549|20182347|P1|STARTED|Overall Study||20
8184876|NCT02330523|20182462|P2|NOT COMPLETED|Overall Study||0
8184877|NCT02330523|20182463|P1|NOT COMPLETED|Overall Study||0
8184878|NCT02330523|20182462|P2|COMPLETED|Overall Study||19
8184879|NCT02330523|20182463|P1|COMPLETED|Overall Study||21
8184880|NCT02330523|20182462|P2|STARTED|Overall Study||19
8184881|NCT02330523|20182463|P1|STARTED|Overall Study||21
8184882|NCT02330341|20182475|P2|NOT COMPLETED|Overall Study||1
8184883|NCT02330341|20182476|P1|NOT COMPLETED|Overall Study||0
8184884|NCT02330341|20182475|P2|COMPLETED|Overall Study||11
8184885|NCT02330341|20182476|P1|COMPLETED|Overall Study||12
8184886|NCT02330341|20182475|P2|STARTED|Overall Study||12
8184887|NCT02330341|20182476|P1|STARTED|Overall Study||12
8184888|NCT02330276|20182517|P3|NOT COMPLETED|Overall Study||0
8184889|NCT02330276|20182518|P2|NOT COMPLETED|Overall Study||0
8184890|NCT02330276|20182519|P1|NOT COMPLETED|Overall Study||0
8184891|NCT02330276|20182517|P3|COMPLETED|Overall Study||4
8184892|NCT02330276|20182518|P2|COMPLETED|Overall Study||4
8184893|NCT02330276|20182519|P1|COMPLETED|Overall Study||4
8184894|NCT02330276|20182517|P3|STARTED|Overall Study||4
8184895|NCT02330276|20182518|P2|STARTED|Overall Study||4
8184896|NCT02330276|20182519|P1|STARTED|Overall Study||4
8184897|NCT02330172|20182541|P2|NOT COMPLETED|Overall Study||1
8184898|NCT02330172|20182542|P1|NOT COMPLETED|Overall Study||3
8184899|NCT02330172|20182541|P2|COMPLETED|Overall Study||21
8184900|NCT02330172|20182542|P1|COMPLETED|Overall Study||19
8184901|NCT02330172|20182541|P2|STARTED|Overall Study||22
8184902|NCT02330172|20182542|P1|STARTED|Overall Study||22
8184903|NCT02330094|20182552|P2|NOT COMPLETED|Overall Study||0
8184904|NCT02330094|20182553|P1|NOT COMPLETED|Overall Study||0
8184905|NCT02330094|20182552|P2|COMPLETED|Overall Study||8
8184906|NCT02330094|20182553|P1|COMPLETED|Overall Study||8
8184907|NCT02330094|20182552|P2|STARTED|Overall Study||8
8184908|NCT02330094|20182553|P1|STARTED|Overall Study||8
8184909|NCT02330081|20182563|P1|NOT COMPLETED|Overall Study||8
8184910|NCT02330081|20182563|P1|COMPLETED|Overall Study||14
8184911|NCT02330081|20182563|P1|STARTED|Overall Study||22
8184912|NCT02330055|20182584|P2|NOT COMPLETED|Overall Study||9
8184913|NCT02330055|20182585|P1|NOT COMPLETED|Overall Study||10
8184914|NCT02330055|20182584|P2|COMPLETED|Overall Study||40
8184915|NCT02330055|20182585|P1|COMPLETED|Overall Study||40
8184916|NCT02330055|20182584|P2|STARTED|Overall Study||49
8184917|NCT02330055|20182585|P1|STARTED|Overall Study||50
8184918|NCT02329964|20182605|P2|NOT COMPLETED|Overall Study||0
8184919|NCT02329964|20182606|P1|NOT COMPLETED|Overall Study||0
8184920|NCT02329964|20182605|P2|COMPLETED|Overall Study||40
8184921|NCT02329964|20182606|P1|COMPLETED|Overall Study||40
8184922|NCT02329964|20182605|P2|STARTED|Overall Study||40
8184923|NCT02329964|20182606|P1|STARTED|Overall Study||40
8184924|NCT02329743|20182631|P3|NOT COMPLETED|Overall Study||8
8184925|NCT02329743|20182632|P2|NOT COMPLETED|Overall Study||7
8184926|NCT02329743|20182633|P1|NOT COMPLETED|Overall Study||6
8184927|NCT02329743|20182631|P3|COMPLETED|Overall Study||77
8184928|NCT02329743|20182632|P2|COMPLETED|Overall Study||80
8184929|NCT02329743|20182633|P1|COMPLETED|Overall Study||78
8184930|NCT02329743|20182631|P3|STARTED|Overall Study||85
8184931|NCT02329743|20182632|P2|STARTED|Overall Study||87
8184932|NCT02329743|20182633|P1|STARTED|Overall Study||84
8184933|NCT02329730|20182648|P12|NOT COMPLETED|Overall Study||0
8184934|NCT02329730|20182649|P11|NOT COMPLETED|Overall Study||0
8184935|NCT02329730|20182650|P10|NOT COMPLETED|Overall Study||1
8184936|NCT02329730|20182651|P9|NOT COMPLETED|Overall Study||1
8184937|NCT02329730|20182652|P8|NOT COMPLETED|Overall Study||1
8184938|NCT02329730|20182653|P7|NOT COMPLETED|Overall Study||1
8184939|NCT02329730|20182654|P6|NOT COMPLETED|Overall Study||2
8184940|NCT02329730|20182655|P5|NOT COMPLETED|Overall Study||3
8184941|NCT02329730|20182656|P4|NOT COMPLETED|Overall Study||0
8184942|NCT02329730|20182657|P3|NOT COMPLETED|Overall Study||0
8184943|NCT02329730|20182658|P2|NOT COMPLETED|Overall Study||0
8184944|NCT02329730|20182659|P1|NOT COMPLETED|Overall Study||0
8184945|NCT02329730|20182648|P12|COMPLETED|Overall Study||8
8184946|NCT02329730|20182649|P11|COMPLETED|Overall Study||8
8184947|NCT02329730|20182650|P10|COMPLETED|Overall Study||7
8184948|NCT02329730|20182651|P9|COMPLETED|Overall Study||7
8184949|NCT02329730|20182652|P8|COMPLETED|Overall Study||13
8184950|NCT02329730|20182653|P7|COMPLETED|Overall Study||13
8184951|NCT02329730|20182654|P6|COMPLETED|Overall Study||12
8184952|NCT02329730|20182655|P5|COMPLETED|Overall Study||11
8184953|NCT02329730|20182656|P4|COMPLETED|Overall Study||14
8184954|NCT02329730|20182657|P3|COMPLETED|Overall Study||14
8184955|NCT02329730|20182658|P2|COMPLETED|Overall Study||14
8184956|NCT02329730|20182659|P1|COMPLETED|Overall Study||14
8184957|NCT02329730|20182648|P12|STARTED|Overall Study||8
8184958|NCT02329730|20182649|P11|STARTED|Overall Study||8
8184959|NCT02329730|20182650|P10|STARTED|Overall Study||8
8184960|NCT02329730|20182651|P9|STARTED|Overall Study||8
8184961|NCT02329730|20182652|P8|STARTED|Overall Study||14
8184962|NCT02329730|20182653|P7|STARTED|Overall Study||14
8184963|NCT02329730|20182654|P6|STARTED|Overall Study||14
8184964|NCT02329730|20182655|P5|STARTED|Overall Study||14
8184965|NCT02329730|20182656|P4|STARTED|Overall Study||14
8184966|NCT02329730|20182657|P3|STARTED|Overall Study||14
8184967|NCT02329730|20182658|P2|STARTED|Overall Study||14
8184968|NCT02329730|20182659|P1|STARTED|Overall Study||14
8184969|NCT02329600|20182736|P3|NOT COMPLETED|Overall Study||0
8184970|NCT02329600|20182737|P2|NOT COMPLETED|Overall Study||0
8184971|NCT02329600|20182738|P1|NOT COMPLETED|Overall Study||0
8184972|NCT02329600|20182736|P3|COMPLETED|Overall Study||15
8184973|NCT02329600|20182737|P2|COMPLETED|Overall Study||15
8184974|NCT02329600|20182738|P1|COMPLETED|Overall Study||10
8184975|NCT02329600|20182736|P3|STARTED|Overall Study||15
8184976|NCT02329600|20182737|P2|STARTED|Overall Study||15
8184977|NCT02329600|20182738|P1|STARTED|Overall Study||10
8184978|NCT02329587|20182751|P2|NOT COMPLETED|1-month Follow-up||1
8184979|NCT02329587|20182752|P1|NOT COMPLETED|1-month Follow-up||0
8184980|NCT02329587|20182751|P2|COMPLETED|1-month Follow-up||5
8184981|NCT02329587|20182752|P1|COMPLETED|1-month Follow-up||4
8184982|NCT02329587|20182751|P2|STARTED|1-month Follow-up||6
8184983|NCT02329587|20182752|P1|STARTED|1-month Follow-up||4
8184984|NCT02329587|20182751|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
8184985|NCT02329587|20182752|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
8184986|NCT02329587|20182751|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
8184987|NCT02329587|20182752|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
8184988|NCT02329587|20182751|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
8184989|NCT02329587|20182752|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
8184990|NCT02329587|20182751|P2|STARTED|Baseline Thru Post-treatment Assessment||7
8184991|NCT02329587|20182752|P1|STARTED|Baseline Thru Post-treatment Assessment||5
8184992|NCT02329431|20182770|P2|NOT COMPLETED|Overall Study||13
8184993|NCT02329431|20182771|P1|NOT COMPLETED|Overall Study||20
8184994|NCT02329431|20182770|P2|COMPLETED|Overall Study||76
8184995|NCT02329431|20182771|P1|COMPLETED|Overall Study||72
8184996|NCT02329431|20182770|P2|Baseline Interview|Overall Study||85
8184997|NCT02329431|20182771|P1|Baseline Interview|Overall Study||87
8184998|NCT02329431|20182770|P2|STARTED|Overall Study||89
8184999|NCT02329431|20182771|P1|STARTED|Overall Study||92
8185000|NCT02329223|20182790|P3|NOT COMPLETED|Overall Study||6
8185001|NCT02329223|20182791|P2|NOT COMPLETED|Overall Study||3
8185002|NCT02329223|20182792|P1|NOT COMPLETED|Overall Study||1
8185003|NCT02329223|20182790|P3|COMPLETED|Overall Study||68
8185004|NCT02329223|20182791|P2|COMPLETED|Overall Study||68
8185005|NCT02329223|20182792|P1|COMPLETED|Overall Study||72
8185006|NCT02329223|20182790|P3|Safety Set|Overall Study||74
8185007|NCT02329223|20182791|P2|Safety Set|Overall Study||71
8185008|NCT02329223|20182792|P1|Safety Set|Overall Study||73
8185009|NCT02329223|20182790|P3|Full Analysis Set|Overall Study||74
8185010|NCT02329223|20182791|P2|Full Analysis Set|Overall Study||70
8185011|NCT02329223|20182792|P1|Full Analysis Set|Overall Study||73
8185012|NCT02329223|20182790|P3|STARTED|Overall Study||74
8185013|NCT02329223|20182791|P2|STARTED|Overall Study||71
8185014|NCT02329223|20182792|P1|STARTED|Overall Study||73
8185015|NCT02329015|20182825|P2|NOT COMPLETED|Overall Study||0
8185016|NCT02329015|20182826|P1|NOT COMPLETED|Overall Study||0
8185017|NCT02329015|20182825|P2|COMPLETED|Overall Study||64
8185018|NCT02329015|20182826|P1|COMPLETED|Overall Study||48
8185019|NCT02329015|20182825|P2|STARTED|Overall Study||64
8185020|NCT02329015|20182826|P1|STARTED|Overall Study||48
8185021|NCT02328937|20182842|P6|NOT COMPLETED|Period 3||0
8185022|NCT02328937|20182843|P5|NOT COMPLETED|Period 3||0
8185023|NCT02328937|20182844|P4|NOT COMPLETED|Period 3||0
8185024|NCT02328937|20182845|P3|NOT COMPLETED|Period 3||0
8185025|NCT02328937|20182846|P2|NOT COMPLETED|Period 3||0
8185026|NCT02328937|20182847|P1|NOT COMPLETED|Period 3||0
8185027|NCT02328937|20182842|P6|COMPLETED|Period 3||6
8185028|NCT02328937|20182843|P5|COMPLETED|Period 3||6
8185029|NCT02328937|20182844|P4|COMPLETED|Period 3||5
8185030|NCT02328937|20182845|P3|COMPLETED|Period 3||6
8185031|NCT02328937|20182846|P2|COMPLETED|Period 3||6
8185032|NCT02328937|20182847|P1|COMPLETED|Period 3||7
8185033|NCT02328937|20182842|P6|STARTED|Period 3||6
8185034|NCT02328937|20182843|P5|STARTED|Period 3||6
8185035|NCT02328937|20182844|P4|STARTED|Period 3||5
8185036|NCT02328937|20182845|P3|STARTED|Period 3||6
8185037|NCT02328937|20182846|P2|STARTED|Period 3||6
8185038|NCT02328937|20182847|P1|STARTED|Period 3||7
8185039|NCT02328937|20182842|P6|NOT COMPLETED|Period 2||0
8185040|NCT02328937|20182843|P5|NOT COMPLETED|Period 2||0
8185041|NCT02328937|20182844|P4|NOT COMPLETED|Period 2||0
8185042|NCT02328937|20182845|P3|NOT COMPLETED|Period 2||1
8185043|NCT02328937|20182846|P2|NOT COMPLETED|Period 2||0
8185044|NCT02328937|20182847|P1|NOT COMPLETED|Period 2||0
8185045|NCT02328937|20182842|P6|COMPLETED|Period 2||6
8185046|NCT02328937|20182843|P5|COMPLETED|Period 2||6
8185047|NCT02328937|20182844|P4|COMPLETED|Period 2||5
8185048|NCT02328937|20182845|P3|COMPLETED|Period 2||6
8185049|NCT02328937|20182846|P2|COMPLETED|Period 2||6
8185050|NCT02328937|20182847|P1|COMPLETED|Period 2||7
8185051|NCT02328937|20182842|P6|STARTED|Period 2||6
8185052|NCT02328937|20182843|P5|STARTED|Period 2||6
8185053|NCT02328937|20182844|P4|STARTED|Period 2||5
8185054|NCT02328937|20182845|P3|STARTED|Period 2||7
8185055|NCT02328937|20182846|P2|STARTED|Period 2||6
8185056|NCT02328937|20182847|P1|STARTED|Period 2||7
8185057|NCT02328937|20182842|P6|NOT COMPLETED|Period 1||0
8185058|NCT02328937|20182843|P5|NOT COMPLETED|Period 1||0
8185059|NCT02328937|20182844|P4|NOT COMPLETED|Period 1||1
8185060|NCT02328937|20182845|P3|NOT COMPLETED|Period 1||0
8185061|NCT02328937|20182846|P2|NOT COMPLETED|Period 1||0
8185062|NCT02328937|20182847|P1|NOT COMPLETED|Period 1||0
8185063|NCT02328937|20182842|P6|COMPLETED|Period 1||6
8185064|NCT02328937|20182843|P5|COMPLETED|Period 1||6
8185065|NCT02328937|20182844|P4|COMPLETED|Period 1||5
8185066|NCT02328937|20182845|P3|COMPLETED|Period 1||7
8185067|NCT02328937|20182846|P2|COMPLETED|Period 1||6
8185068|NCT02328937|20182847|P1|COMPLETED|Period 1||7
8185069|NCT02328937|20182842|P6|STARTED|Period 1||6
8185070|NCT02328937|20182843|P5|STARTED|Period 1||6
8185071|NCT02328937|20182844|P4|STARTED|Period 1||6
8185072|NCT02328937|20182845|P3|STARTED|Period 1||7
8185073|NCT02328937|20182846|P2|STARTED|Period 1||6
8185074|NCT02328937|20182847|P1|STARTED|Period 1||7
8185075|NCT02328807|20182858|P1|NOT COMPLETED|Overall Study||0
8185076|NCT02328807|20182858|P1|COMPLETED|Overall Study||6
8185077|NCT02328807|20182858|P1|STARTED|Overall Study||6
8185078|NCT02328547|20182867|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8185079|NCT02328547|20182868|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8185080|NCT02328547|20182867|P2|COMPLETED|Second Intervention (12 Weeks)||23
8185081|NCT02328547|20182868|P1|COMPLETED|Second Intervention (12 Weeks)||22
8185082|NCT02328547|20182867|P2|STARTED|Second Intervention (12 Weeks)||23
8185083|NCT02328547|20182868|P1|STARTED|Second Intervention (12 Weeks)||22
8185084|NCT02328547|20182867|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
8185085|NCT02328547|20182868|P1|NOT COMPLETED|First Intervention (12 Weeks)||3
8185086|NCT02328547|20182867|P2|COMPLETED|First Intervention (12 Weeks)||23
8185087|NCT02328547|20182868|P1|COMPLETED|First Intervention (12 Weeks)||22
8185088|NCT02328547|20182867|P2|STARTED|First Intervention (12 Weeks)||23
8185089|NCT02328547|20182868|P1|STARTED|First Intervention (12 Weeks)||25
8185090|NCT02328404|20182908|P2|NOT COMPLETED|Overall Study||1
8185091|NCT02328404|20182909|P1|NOT COMPLETED|Overall Study||1
8185092|NCT02328404|20182908|P2|COMPLETED|Overall Study||29
8185093|NCT02328404|20182909|P1|COMPLETED|Overall Study||29
8185094|NCT02328404|20182908|P2|STARTED|Overall Study||30
8185095|NCT02328404|20182909|P1|STARTED|Overall Study||30
8185096|NCT02328326|20182945|P2|NOT COMPLETED|Overall Study||8
8185097|NCT02328326|20182946|P1|NOT COMPLETED|Overall Study||22
8185098|NCT02328326|20182945|P2|COMPLETED|Overall Study||224
8185099|NCT02328326|20182946|P1|COMPLETED|Overall Study||224
8185100|NCT02328326|20182945|P2|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
8185101|NCT02328326|20182946|P1|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
8185102|NCT02328326|20182945|P2|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
8185103|NCT02328326|20182946|P1|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
8185104|NCT02328105|20182954|P1|NOT COMPLETED|Overall Study||11
8185105|NCT02328105|20182954|P1|COMPLETED|Overall Study||0
8185106|NCT02328105|20182954|P1|STARTED|Overall Study||11
8185107|NCT02328040|20182963|P2|NOT COMPLETED|Second Intervention (2 Days)||0
8185108|NCT02328040|20182964|P1|NOT COMPLETED|Second Intervention (2 Days)||0
8185109|NCT02328040|20182963|P2|COMPLETED|Second Intervention (2 Days)||8
8185110|NCT02328040|20182964|P1|COMPLETED|Second Intervention (2 Days)||7
8185111|NCT02328040|20182963|P2|STARTED|Second Intervention (2 Days)||8
8185112|NCT02328040|20182964|P1|STARTED|Second Intervention (2 Days)||7
8185113|NCT02328040|20182963|P2|NOT COMPLETED|First Intervention (2 Days)||1
8185114|NCT02328040|20182964|P1|NOT COMPLETED|First Intervention (2 Days)||1
8185115|NCT02328040|20182963|P2|COMPLETED|First Intervention (2 Days)||8
8185116|NCT02328040|20182964|P1|COMPLETED|First Intervention (2 Days)||7
8185117|NCT02328040|20182963|P2|STARTED|First Intervention (2 Days)||9
8185118|NCT02328040|20182964|P1|STARTED|First Intervention (2 Days)||8
8185119|NCT02328027|20182974|P2|NOT COMPLETED|Overall Study||1
8185120|NCT02328027|20182975|P1|NOT COMPLETED|Overall Study||0
8185121|NCT02328027|20182974|P2|COMPLETED|Overall Study||10
8185122|NCT02328027|20182975|P1|COMPLETED|Overall Study||5
8185123|NCT02328027|20182974|P2|STARTED|Overall Study||11
8185124|NCT02328027|20182975|P1|STARTED|Overall Study||5
8185125|NCT02327741|20182992|P2|NOT COMPLETED|Overall Study||0
8185126|NCT02327741|20182993|P1|NOT COMPLETED|Overall Study||0
8185127|NCT02327741|20182992|P2|COMPLETED|Overall Study||508
8185128|NCT02327741|20182993|P1|COMPLETED|Overall Study||502
8185129|NCT02327741|20182992|P2|STARTED|Overall Study||508
8185130|NCT02327741|20182993|P1|STARTED|Overall Study||502
8185131|NCT02327429|20183011|P1|NOT COMPLETED|Overall Study||2
8185132|NCT02327429|20183011|P1|COMPLETED|Overall Study||17
8185133|NCT02327429|20183011|P1|STARTED|Overall Study||19
8185134|NCT02327325|20183034|P3|NOT COMPLETED|Overall Study||5
8185135|NCT02327325|20183035|P2|NOT COMPLETED|Overall Study||4
8185136|NCT02327325|20183036|P1|NOT COMPLETED|Overall Study||1
8185137|NCT02327325|20183034|P3|COMPLETED|Overall Study||15
8185138|NCT02327325|20183035|P2|COMPLETED|Overall Study||16
8185139|NCT02327325|20183036|P1|COMPLETED|Overall Study||19
8185140|NCT02327325|20183034|P3|STARTED|Overall Study||20
8185141|NCT02327325|20183035|P2|STARTED|Overall Study||20
8185142|NCT02327325|20183036|P1|STARTED|Overall Study||20
8185143|NCT02327260|20183059|P3|NOT COMPLETED|Overall Study||2
8185144|NCT02327260|20183060|P2|NOT COMPLETED|Overall Study||4
8185145|NCT02327260|20183061|P1|NOT COMPLETED|Overall Study||6
8185146|NCT02327260|20183059|P3|COMPLETED|Overall Study||15
8185147|NCT02327260|20183060|P2|COMPLETED|Overall Study||20
8185148|NCT02327260|20183061|P1|COMPLETED|Overall Study||14
8185149|NCT02327260|20183059|P3|STARTED|Overall Study||17
8185150|NCT02327260|20183060|P2|STARTED|Overall Study||24
8185151|NCT02327260|20183061|P1|STARTED|Overall Study||20
8185152|NCT02327169|20183108|P15|NOT COMPLETED|Overall Study||10
8185153|NCT02327169|20183109|P14|NOT COMPLETED|Overall Study||7
8185154|NCT02327169|20183110|P13|NOT COMPLETED|Overall Study||1
8185155|NCT02327169|20183111|P12|NOT COMPLETED|Overall Study||7
8185156|NCT02327169|20183112|P11|NOT COMPLETED|Overall Study||6
8185157|NCT02327169|20183113|P10|NOT COMPLETED|Overall Study||8
8185158|NCT02327169|20183114|P9|NOT COMPLETED|Overall Study||6
8185159|NCT02327169|20183115|P8|NOT COMPLETED|Overall Study||4
8185160|NCT02327169|20183116|P7|NOT COMPLETED|Overall Study||3
8185161|NCT02327169|20183117|P6|NOT COMPLETED|Overall Study||4
8185162|NCT02327169|20183118|P5|NOT COMPLETED|Overall Study||8
8185163|NCT02327169|20183119|P4|NOT COMPLETED|Overall Study||3
8185164|NCT02327169|20183120|P3|NOT COMPLETED|Overall Study||7
8185165|NCT02327169|20183121|P2|NOT COMPLETED|Overall Study||3
8185166|NCT02327169|20183122|P1|NOT COMPLETED|Overall Study||4
8185167|NCT02327169|20183108|P15|COMPLETED|Overall Study||0
8185168|NCT02327169|20183109|P14|COMPLETED|Overall Study||0
8185169|NCT02327169|20183110|P13|COMPLETED|Overall Study||0
8185170|NCT02327169|20183111|P12|COMPLETED|Overall Study||0
8185171|NCT02327169|20183112|P11|COMPLETED|Overall Study||0
8185172|NCT02327169|20183113|P10|COMPLETED|Overall Study||0
8185173|NCT02327169|20183114|P9|COMPLETED|Overall Study||0
8185174|NCT02327169|20183115|P8|COMPLETED|Overall Study||0
8185175|NCT02327169|20183116|P7|COMPLETED|Overall Study||0
8185176|NCT02327169|20183117|P6|COMPLETED|Overall Study||0
8185177|NCT02327169|20183118|P5|COMPLETED|Overall Study||0
8185178|NCT02327169|20183119|P4|COMPLETED|Overall Study||0
8185179|NCT02327169|20183120|P3|COMPLETED|Overall Study||0
8185180|NCT02327169|20183121|P2|COMPLETED|Overall Study||0
8185181|NCT02327169|20183122|P1|COMPLETED|Overall Study||0
8185182|NCT02327169|20183108|P15|STARTED|Overall Study||10
8185183|NCT02327169|20183109|P14|STARTED|Overall Study||7
8185184|NCT02327169|20183110|P13|STARTED|Overall Study||1
8185185|NCT02327169|20183111|P12|STARTED|Overall Study||7
8185186|NCT02327169|20183112|P11|STARTED|Overall Study||6
8185187|NCT02327169|20183113|P10|STARTED|Overall Study||8
8185188|NCT02327169|20183114|P9|STARTED|Overall Study||6
8185189|NCT02327169|20183115|P8|STARTED|Overall Study||4
8185190|NCT02327169|20183116|P7|STARTED|Overall Study||3
8185191|NCT02327169|20183117|P6|STARTED|Overall Study||4
8185192|NCT02327169|20183118|P5|STARTED|Overall Study||8
8185193|NCT02327169|20183119|P4|STARTED|Overall Study||3
8185194|NCT02327169|20183120|P3|STARTED|Overall Study||7
8185195|NCT02327169|20183121|P2|STARTED|Overall Study||3
8185196|NCT02327169|20183122|P1|STARTED|Overall Study||4
8185197|NCT02327143|20183343|P2|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8185198|NCT02327143|20183344|P1|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8185199|NCT02327143|20183343|P2|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
8185200|NCT02327143|20183344|P1|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8185201|NCT02327143|20183343|P2|STARTED|Day 1: Time 6 Hrs - to Day 9||11
8185202|NCT02327143|20183344|P1|STARTED|Day 1: Time 6 Hrs - to Day 9||0
8185203|NCT02327143|20183343|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8185204|NCT02327143|20183344|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8185205|NCT02327143|20183343|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8185206|NCT02327143|20183344|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
8185207|NCT02327143|20183343|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
8185208|NCT02327143|20183344|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
8185209|NCT02327130|20183352|P1|NOT COMPLETED|Overall Study||12
8185210|NCT02327130|20183352|P1|COMPLETED|Overall Study||20
8185211|NCT02327130|20183352|P1|STARTED|Overall Study||32
8185212|NCT02327117|20183361|P2|NOT COMPLETED|Overall Study||0
8185213|NCT02327117|20183362|P1|NOT COMPLETED|Overall Study||0
8185214|NCT02327117|20183361|P2|COMPLETED|Overall Study||45
8185215|NCT02327117|20183362|P1|COMPLETED|Overall Study||45
8185216|NCT02327117|20183361|P2|STARTED|Overall Study||45
8185217|NCT02327117|20183362|P1|STARTED|Overall Study||45
8185218|NCT02327013|20183371|P5|NOT COMPLETED|Overall Study||4
8185219|NCT02327013|20183372|P4|NOT COMPLETED|Overall Study||1
8185220|NCT02327013|20183373|P3|NOT COMPLETED|Overall Study||42
8185221|NCT02327013|20183374|P2|NOT COMPLETED|Overall Study||16
8185222|NCT02327013|20183375|P1|NOT COMPLETED|Overall Study||13
8185223|NCT02327013|20183371|P5|COMPLETED|Overall Study||12
8185224|NCT02327013|20183372|P4|COMPLETED|Overall Study||20
8185225|NCT02327013|20183373|P3|COMPLETED|Overall Study||54
8185226|NCT02327013|20183374|P2|COMPLETED|Overall Study||29
8185227|NCT02327013|20183375|P1|COMPLETED|Overall Study||36
8185228|NCT02327013|20183371|P5|STARTED|Overall Study||16
8185229|NCT02327013|20183372|P4|STARTED|Overall Study||21
8185230|NCT02327013|20183373|P3|STARTED|Overall Study||96
8185231|NCT02327013|20183374|P2|STARTED|Overall Study||45
8185232|NCT02327013|20183375|P1|STARTED|Overall Study||49
8185233|NCT02326844|20183548|P1|NOT COMPLETED|Overall Study||0
8185234|NCT02326844|20183548|P1|COMPLETED|Overall Study||3
8185235|NCT02326844|20183548|P1|STARTED|Overall Study||3
8185236|NCT02326649|20183557|P1|NOT COMPLETED|Overall Study||12
8185237|NCT02326649|20183557|P1|COMPLETED|Overall Study||21
8185238|NCT02326649|20183557|P1|STARTED|Overall Study||33
8185239|NCT02326597|20183563|P2|NOT COMPLETED|Overall Study||32
8185240|NCT02326597|20183564|P1|NOT COMPLETED|Overall Study||42
8185241|NCT02326597|20183563|P2|COMPLETED|Overall Study||28
8185242|NCT02326597|20183564|P1|COMPLETED|Overall Study||18
8185243|NCT02326597|20183563|P2|STARTED|Overall Study||60
8185244|NCT02326597|20183564|P1|STARTED|Overall Study||60
8185251|NCT02326298|20183610|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
8185252|NCT02326298|20183611|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
8185253|NCT02326298|20183612|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
8185254|NCT02326298|20183613|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185255|NCT02326298|20183614|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185256|NCT02326298|20183615|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185257|NCT02326298|20183616|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185258|NCT02326298|20183617|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185259|NCT02326298|20183618|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185260|NCT02326298|20183619|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185261|NCT02326298|20183620|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185262|NCT02326298|20183621|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185263|NCT02326298|20183622|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185264|NCT02326298|20183623|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185265|NCT02326298|20183610|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||44
8185266|NCT02326298|20183611|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||51
8185267|NCT02326298|20183612|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||54
8185268|NCT02326298|20183613|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||3
8185269|NCT02326298|20183614|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185270|NCT02326298|20183615|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185271|NCT02326298|20183616|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185272|NCT02326298|20183617|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185273|NCT02326298|20183618|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185274|NCT02326298|20183619|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185275|NCT02326298|20183620|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185276|NCT02326298|20183621|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185277|NCT02326298|20183622|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185278|NCT02326298|20183623|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185279|NCT02326298|20183610|P14|STARTED|Open-label Period (Week 48 to Week 144)||53
8185280|NCT02326298|20183611|P13|STARTED|Open-label Period (Week 48 to Week 144)||70
8185281|NCT02326298|20183612|P12|STARTED|Open-label Period (Week 48 to Week 144)||74
8185282|NCT02326298|20183613|P11|STARTED|Open-label Period (Week 48 to Week 144)||3
8185283|NCT02326298|20183614|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
8185284|NCT02326298|20183615|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
8185285|NCT02326298|20183616|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
8185286|NCT02326298|20183617|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
8185287|NCT02326298|20183618|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
8185288|NCT02326298|20183619|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
8185289|NCT02326298|20183620|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
8185290|NCT02326298|20183621|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
8185291|NCT02326298|20183622|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
8185292|NCT02326298|20183623|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
8185293|NCT02326298|20183610|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185294|NCT02326298|20183611|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185295|NCT02326298|20183612|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185296|NCT02326298|20183613|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185297|NCT02326298|20183614|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8185298|NCT02326298|20183615|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185299|NCT02326298|20183616|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185300|NCT02326298|20183617|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8185301|NCT02326298|20183618|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185302|NCT02326298|20183619|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185303|NCT02326298|20183620|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185304|NCT02326298|20183621|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185305|NCT02326298|20183622|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185306|NCT02326298|20183623|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185307|NCT02326298|20183610|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185308|NCT02326298|20183611|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185309|NCT02326298|20183612|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185310|NCT02326298|20183613|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185311|NCT02326298|20183614|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8185312|NCT02326298|20183615|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
8185313|NCT02326298|20183616|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
8185314|NCT02326298|20183617|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
8185315|NCT02326298|20183618|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
8185316|NCT02326298|20183619|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185317|NCT02326298|20183620|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8185318|NCT02326298|20183621|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185319|NCT02326298|20183622|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185320|NCT02326298|20183623|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185321|NCT02326298|20183610|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185322|NCT02326298|20183611|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185323|NCT02326298|20183612|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185324|NCT02326298|20183613|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185325|NCT02326298|20183614|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
8185326|NCT02326298|20183615|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
8185327|NCT02326298|20183616|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
8185328|NCT02326298|20183617|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
8185329|NCT02326298|20183618|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
8185330|NCT02326298|20183619|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
8185331|NCT02326298|20183620|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8185332|NCT02326298|20183621|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185333|NCT02326298|20183622|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185334|NCT02326298|20183623|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185335|NCT02326298|20183610|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185336|NCT02326298|20183611|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185337|NCT02326298|20183612|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185338|NCT02326298|20183613|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185339|NCT02326298|20183614|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
8185340|NCT02326298|20183615|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
8185341|NCT02326298|20183616|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
8185342|NCT02326298|20183617|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
8185343|NCT02326298|20183618|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
8185344|NCT02326298|20183619|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
8185345|NCT02326298|20183620|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8185346|NCT02326298|20183621|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185347|NCT02326298|20183622|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185348|NCT02326298|20183623|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185349|NCT02326298|20183610|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185350|NCT02326298|20183611|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185351|NCT02326298|20183612|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185352|NCT02326298|20183613|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185353|NCT02326298|20183614|P10|STARTED|Maintenance Period (Week 16 to Week 48)||8
8185354|NCT02326298|20183615|P9|STARTED|Maintenance Period (Week 16 to Week 48)||18
8185355|NCT02326298|20183616|P8|STARTED|Maintenance Period (Week 16 to Week 48)||38
8185356|NCT02326298|20183617|P7|STARTED|Maintenance Period (Week 16 to Week 48)||77
8185357|NCT02326298|20183618|P6|STARTED|Maintenance Period (Week 16 to Week 48)||74
8185358|NCT02326298|20183619|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
8185359|NCT02326298|20183620|P4|STARTED|Maintenance Period (Week 16 to Week 48)||3
8185360|NCT02326298|20183621|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185361|NCT02326298|20183622|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185362|NCT02326298|20183623|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185363|NCT02326298|20183610|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185364|NCT02326298|20183611|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185365|NCT02326298|20183612|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185366|NCT02326298|20183613|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185367|NCT02326298|20183614|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185368|NCT02326298|20183615|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185369|NCT02326298|20183616|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185370|NCT02326298|20183617|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185371|NCT02326298|20183618|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185372|NCT02326298|20183619|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185373|NCT02326298|20183620|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185374|NCT02326298|20183621|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8185375|NCT02326298|20183622|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8185376|NCT02326298|20183623|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
8185377|NCT02326298|20183610|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185378|NCT02326298|20183611|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185379|NCT02326298|20183612|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185380|NCT02326298|20183613|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185381|NCT02326298|20183614|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185382|NCT02326298|20183615|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185383|NCT02326298|20183616|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185384|NCT02326298|20183617|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185385|NCT02326298|20183618|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185386|NCT02326298|20183619|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185387|NCT02326298|20183620|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185388|NCT02326298|20183621|P3|COMPLETED|Initial Period (Week 0 to Week 16)||85
8185389|NCT02326298|20183622|P2|COMPLETED|Initial Period (Week 0 to Week 16)||92
8185390|NCT02326298|20183623|P1|COMPLETED|Initial Period (Week 0 to Week 16)||46
8185391|NCT02326298|20183610|P14|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185392|NCT02326298|20183611|P13|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185393|NCT02326298|20183612|P12|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185394|NCT02326298|20183613|P11|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185395|NCT02326298|20183614|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185396|NCT02326298|20183615|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185397|NCT02326298|20183616|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185398|NCT02326298|20183617|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185399|NCT02326298|20183618|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185400|NCT02326298|20183619|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185401|NCT02326298|20183620|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185402|NCT02326298|20183621|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
8185403|NCT02326298|20183622|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
8185404|NCT02326298|20183623|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
8185405|NCT02326298|20183610|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185406|NCT02326298|20183611|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185407|NCT02326298|20183612|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185408|NCT02326298|20183613|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185409|NCT02326298|20183614|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185410|NCT02326298|20183615|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185411|NCT02326298|20183616|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185412|NCT02326298|20183617|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185413|NCT02326298|20183618|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185414|NCT02326298|20183619|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185415|NCT02326298|20183620|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185416|NCT02326298|20183621|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||87
8185417|NCT02326298|20183622|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||92
8185418|NCT02326298|20183623|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||46
8185419|NCT02326298|20183610|P14|STARTED|Initial Period (Week 0 to Week 16)||0
8185420|NCT02326298|20183611|P13|STARTED|Initial Period (Week 0 to Week 16)||0
8185421|NCT02326298|20183612|P12|STARTED|Initial Period (Week 0 to Week 16)||0
8185422|NCT02326298|20183613|P11|STARTED|Initial Period (Week 0 to Week 16)||0
8185423|NCT02326298|20183614|P10|STARTED|Initial Period (Week 0 to Week 16)||0
8185424|NCT02326298|20183615|P9|STARTED|Initial Period (Week 0 to Week 16)||0
8185425|NCT02326298|20183616|P8|STARTED|Initial Period (Week 0 to Week 16)||0
8185426|NCT02326298|20183617|P7|STARTED|Initial Period (Week 0 to Week 16)||0
8185427|NCT02326298|20183618|P6|STARTED|Initial Period (Week 0 to Week 16)||0
8185428|NCT02326298|20183619|P5|STARTED|Initial Period (Week 0 to Week 16)||0
8185429|NCT02326298|20183620|P4|STARTED|Initial Period (Week 0 to Week 16)||0
8185430|NCT02326298|20183621|P3|STARTED|Initial Period (Week 0 to Week 16)||88
8185431|NCT02326298|20183622|P2|STARTED|Initial Period (Week 0 to Week 16)||95
8185432|NCT02326298|20183623|P1|STARTED|Initial Period (Week 0 to Week 16)||51
8185433|NCT02326272|20183646|P15|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
8185434|NCT02326272|20183647|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185435|NCT02326272|20183648|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
8185436|NCT02326272|20183649|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
8185437|NCT02326272|20183650|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
8185438|NCT02326272|20183651|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185439|NCT02326272|20183652|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185440|NCT02326272|20183653|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185441|NCT02326272|20183654|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185442|NCT02326272|20183655|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185443|NCT02326272|20183656|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185444|NCT02326272|20183657|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185445|NCT02326272|20183658|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185446|NCT02326272|20183659|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185447|NCT02326272|20183660|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185448|NCT02326272|20183646|P15|COMPLETED|Open-label Period (Week 48 to Week 144)||31
8185449|NCT02326272|20183647|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||1
8185450|NCT02326272|20183648|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||48
8185451|NCT02326272|20183649|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||51
8185452|NCT02326272|20183650|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||2
8185453|NCT02326272|20183651|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185454|NCT02326272|20183652|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185455|NCT02326272|20183653|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185456|NCT02326272|20183654|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185457|NCT02326272|20183655|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185458|NCT02326272|20183656|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185459|NCT02326272|20183657|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185460|NCT02326272|20183658|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185461|NCT02326272|20183659|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185462|NCT02326272|20183660|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185463|NCT02326272|20183646|P15|STARTED|Open-label Period (Week 48 to Week 144)||40
8185464|NCT02326272|20183647|P14|STARTED|Open-label Period (Week 48 to Week 144)||1
8185465|NCT02326272|20183648|P13|STARTED|Open-label Period (Week 48 to Week 144)||59
8185466|NCT02326272|20183649|P12|STARTED|Open-label Period (Week 48 to Week 144)||66
8185467|NCT02326272|20183650|P11|STARTED|Open-label Period (Week 48 to Week 144)||5
8185468|NCT02326272|20183651|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
8185469|NCT02326272|20183652|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
8185470|NCT02326272|20183653|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
8185471|NCT02326272|20183654|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
8185472|NCT02326272|20183655|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
8185473|NCT02326272|20183656|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
8185474|NCT02326272|20183657|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
8185475|NCT02326272|20183658|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
8185476|NCT02326272|20183659|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
8185477|NCT02326272|20183660|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
8185478|NCT02326272|20183646|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185479|NCT02326272|20183647|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185480|NCT02326272|20183648|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185481|NCT02326272|20183649|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185482|NCT02326272|20183650|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185483|NCT02326272|20183651|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8185484|NCT02326272|20183652|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185485|NCT02326272|20183653|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8185486|NCT02326272|20183654|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
8185487|NCT02326272|20183655|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
8185488|NCT02326272|20183656|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8185489|NCT02326272|20183657|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8185490|NCT02326272|20183658|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185491|NCT02326272|20183659|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185492|NCT02326272|20183660|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185493|NCT02326272|20183646|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185494|NCT02326272|20183647|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185495|NCT02326272|20183648|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185496|NCT02326272|20183649|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185497|NCT02326272|20183650|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185498|NCT02326272|20183651|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
8185499|NCT02326272|20183652|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8185500|NCT02326272|20183653|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
8185501|NCT02326272|20183654|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
8185502|NCT02326272|20183655|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
8185503|NCT02326272|20183656|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8185504|NCT02326272|20183657|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185505|NCT02326272|20183658|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185506|NCT02326272|20183659|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185507|NCT02326272|20183660|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185508|NCT02326272|20183646|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185509|NCT02326272|20183647|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185510|NCT02326272|20183648|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185511|NCT02326272|20183649|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185512|NCT02326272|20183650|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185513|NCT02326272|20183651|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
8185514|NCT02326272|20183652|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8185515|NCT02326272|20183653|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
8185516|NCT02326272|20183654|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
8185517|NCT02326272|20183655|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
8185518|NCT02326272|20183656|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8185519|NCT02326272|20183657|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
8185520|NCT02326272|20183658|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185521|NCT02326272|20183659|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185522|NCT02326272|20183660|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185523|NCT02326272|20183646|P15|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185524|NCT02326272|20183647|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185525|NCT02326272|20183648|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185526|NCT02326272|20183649|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185527|NCT02326272|20183650|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185528|NCT02326272|20183651|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
8185529|NCT02326272|20183652|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8185530|NCT02326272|20183653|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
8185531|NCT02326272|20183654|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
8185532|NCT02326272|20183655|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
8185533|NCT02326272|20183656|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8185534|NCT02326272|20183657|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
8185535|NCT02326272|20183658|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185536|NCT02326272|20183659|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185537|NCT02326272|20183660|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185538|NCT02326272|20183646|P15|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185539|NCT02326272|20183647|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185540|NCT02326272|20183648|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185541|NCT02326272|20183649|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185542|NCT02326272|20183650|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185543|NCT02326272|20183651|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
8185544|NCT02326272|20183652|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
8185545|NCT02326272|20183653|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
8185546|NCT02326272|20183654|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
8185547|NCT02326272|20183655|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
8185548|NCT02326272|20183656|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
8185549|NCT02326272|20183657|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
8185550|NCT02326272|20183658|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185551|NCT02326272|20183659|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185552|NCT02326272|20183660|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185553|NCT02326272|20183646|P15|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185554|NCT02326272|20183647|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185555|NCT02326272|20183648|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185556|NCT02326272|20183649|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185557|NCT02326272|20183650|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185558|NCT02326272|20183651|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185559|NCT02326272|20183652|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185560|NCT02326272|20183653|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185561|NCT02326272|20183654|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185562|NCT02326272|20183655|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185563|NCT02326272|20183656|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185564|NCT02326272|20183657|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185565|NCT02326272|20183658|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
8185566|NCT02326272|20183659|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
8185567|NCT02326272|20183660|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
8185568|NCT02326272|20183646|P15|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185569|NCT02326272|20183647|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185570|NCT02326272|20183648|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185571|NCT02326272|20183649|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185572|NCT02326272|20183650|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185573|NCT02326272|20183651|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185574|NCT02326272|20183652|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185575|NCT02326272|20183653|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185576|NCT02326272|20183654|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185577|NCT02326272|20183655|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185578|NCT02326272|20183656|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185579|NCT02326272|20183657|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185580|NCT02326272|20183658|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
8185581|NCT02326272|20183659|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
8185582|NCT02326272|20183660|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
8185583|NCT02326272|20183646|P15|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185584|NCT02326272|20183647|P14|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185585|NCT02326272|20183648|P13|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185586|NCT02326272|20183649|P12|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185587|NCT02326272|20183650|P11|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185588|NCT02326272|20183651|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185589|NCT02326272|20183652|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185590|NCT02326272|20183653|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185591|NCT02326272|20183654|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185592|NCT02326272|20183655|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185593|NCT02326272|20183656|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185594|NCT02326272|20183657|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185595|NCT02326272|20183658|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
8185596|NCT02326272|20183659|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
8185597|NCT02326272|20183660|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
8185598|NCT02326272|20183646|P15|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185599|NCT02326272|20183647|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185600|NCT02326272|20183648|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185601|NCT02326272|20183649|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185602|NCT02326272|20183650|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185603|NCT02326272|20183651|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185604|NCT02326272|20183652|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185605|NCT02326272|20183653|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185606|NCT02326272|20183654|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185607|NCT02326272|20183655|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185608|NCT02326272|20183656|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185609|NCT02326272|20183657|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185610|NCT02326272|20183658|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
8185611|NCT02326272|20183659|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
8185612|NCT02326272|20183660|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
8185613|NCT02326272|20183646|P15|STARTED|Initial Period (Week 0 to Week 16)||0
8185614|NCT02326272|20183647|P14|STARTED|Initial Period (Week 0 to Week 16)||0
8185615|NCT02326272|20183648|P13|STARTED|Initial Period (Week 0 to Week 16)||0
8185616|NCT02326272|20183649|P12|STARTED|Initial Period (Week 0 to Week 16)||0
8185617|NCT02326272|20183650|P11|STARTED|Initial Period (Week 0 to Week 16)||0
8185618|NCT02326272|20183651|P10|STARTED|Initial Period (Week 0 to Week 16)||0
8185619|NCT02326272|20183652|P9|STARTED|Initial Period (Week 0 to Week 16)||0
8185620|NCT02326272|20183653|P8|STARTED|Initial Period (Week 0 to Week 16)||0
8185621|NCT02326272|20183654|P7|STARTED|Initial Period (Week 0 to Week 16)||0
8185622|NCT02326272|20183655|P6|STARTED|Initial Period (Week 0 to Week 16)||0
8185623|NCT02326272|20183656|P5|STARTED|Initial Period (Week 0 to Week 16)||0
8185624|NCT02326272|20183657|P4|STARTED|Initial Period (Week 0 to Week 16)||0
8185625|NCT02326272|20183658|P3|STARTED|Initial Period (Week 0 to Week 16)||87
8185626|NCT02326272|20183659|P2|STARTED|Initial Period (Week 0 to Week 16)||91
8185627|NCT02326272|20183660|P1|STARTED|Initial Period (Week 0 to Week 16)||49
8185628|NCT02326233|20183682|P2|NOT COMPLETED|Overall Study||1
8185629|NCT02326233|20183683|P1|NOT COMPLETED|Overall Study||0
8185630|NCT02326233|20183682|P2|COMPLETED|Overall Study||94
8185631|NCT02326233|20183683|P1|COMPLETED|Overall Study||95
8185632|NCT02326233|20183682|P2|STARTED|Overall Study||95
8185633|NCT02326233|20183683|P1|STARTED|Overall Study||95
8185634|NCT02326220|20183697|P3|NOT COMPLETED|Open-label Treatment Period||2
8185635|NCT02326220|20183698|P2|NOT COMPLETED|Open-label Treatment Period||0
8185636|NCT02326220|20183699|P1|NOT COMPLETED|Open-label Treatment Period||0
8185637|NCT02326220|20183697|P3|COMPLETED|Open-label Treatment Period||27
8185638|NCT02326220|20183698|P2|COMPLETED|Open-label Treatment Period||0
8185639|NCT02326220|20183699|P1|COMPLETED|Open-label Treatment Period||0
8185640|NCT02326220|20183697|P3|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
8185641|NCT02326220|20183698|P2|STARTED|Open-label Treatment Period||0
8185642|NCT02326220|20183699|P1|STARTED|Open-label Treatment Period||0
8185643|NCT02326220|20183697|P3|NOT COMPLETED|Double-blind Treatment Period||0
8185644|NCT02326220|20183698|P2|NOT COMPLETED|Double-blind Treatment Period||4
8185645|NCT02326220|20183699|P1|NOT COMPLETED|Double-blind Treatment Period||1
8185646|NCT02326220|20183697|P3|COMPLETED|Double-blind Treatment Period||0
8185647|NCT02326220|20183698|P2|COMPLETED|Double-blind Treatment Period||37
8185648|NCT02326220|20183699|P1|COMPLETED|Double-blind Treatment Period||20
8185649|NCT02326220|20183697|P3|STARTED|Double-blind Treatment Period||0
8185650|NCT02326220|20183698|P2|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
8185651|NCT02326220|20183699|P1|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
8185652|NCT02326025|20183752|P2|NOT COMPLETED|Overall Study||5
8185653|NCT02326025|20183753|P1|NOT COMPLETED|Overall Study||5
8185654|NCT02326025|20183752|P2|COMPLETED|Overall Study||19
8185655|NCT02326025|20183753|P1|COMPLETED|Overall Study||20
8185656|NCT02326025|20183752|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
8185657|NCT02326025|20183753|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
8185658|NCT02326025|20183752|P2|STARTED|Overall Study||24
8185659|NCT02326025|20183753|P1|STARTED|Overall Study||25
8185660|NCT02325856|20183787|P2|NOT COMPLETED|Overall Study||27
8185661|NCT02325856|20183788|P1|NOT COMPLETED|Overall Study||20
8185662|NCT02325856|20183787|P2|COMPLETED|Overall Study||123
8185663|NCT02325856|20183788|P1|COMPLETED|Overall Study||128
8185664|NCT02325856|20183787|P2|STARTED|Overall Study||150
8185665|NCT02325856|20183788|P1|STARTED|Overall Study||148
8185666|NCT02325791|20183800|P4|NOT COMPLETED|Overall Study||26
8185667|NCT02325791|20183801|P3|NOT COMPLETED|Overall Study||25
8185668|NCT02325791|20183802|P2|NOT COMPLETED|Overall Study||25
8185669|NCT02325791|20183803|P1|NOT COMPLETED|Overall Study||0
8185670|NCT02325791|20183800|P4|COMPLETED|Overall Study||355
8185671|NCT02325791|20183801|P3|COMPLETED|Overall Study||360
8185672|NCT02325791|20183802|P2|COMPLETED|Overall Study||358
8185673|NCT02325791|20183803|P1|COMPLETED|Overall Study||23
8185674|NCT02325791|20183800|P4|STARTED|Overall Study||381
8185675|NCT02325791|20183801|P3|STARTED|Overall Study||385
8185676|NCT02325791|20183802|P2|STARTED|Overall Study||383
8185677|NCT02325791|20183803|P1|STARTED|Overall Study||23
8185678|NCT02325739|20183833|P11|NOT COMPLETED|Phase II Part||20
8185679|NCT02325739|20183834|P10|NOT COMPLETED|Phase II Part||36
8185680|NCT02325739|20183835|P9|NOT COMPLETED|Phase II Part||30
8185681|NCT02325739|20183836|P8|NOT COMPLETED|Phase II Part||0
8185682|NCT02325739|20183837|P7|NOT COMPLETED|Phase II Part||0
8185683|NCT02325739|20183838|P6|NOT COMPLETED|Phase II Part||0
8185684|NCT02325739|20183839|P5|NOT COMPLETED|Phase II Part||0
8185685|NCT02325739|20183840|P4|NOT COMPLETED|Phase II Part||0
8185686|NCT02325739|20183841|P3|NOT COMPLETED|Phase II Part||0
8185687|NCT02325739|20183842|P2|NOT COMPLETED|Phase II Part||0
8185688|NCT02325739|20183843|P1|NOT COMPLETED|Phase II Part||0
8185689|NCT02325739|20183833|P11|COMPLETED|Phase II Part||0
8185690|NCT02325739|20183834|P10|COMPLETED|Phase II Part||0
8185691|NCT02325739|20183835|P9|COMPLETED|Phase II Part||0
8185692|NCT02325739|20183836|P8|COMPLETED|Phase II Part||0
8185693|NCT02325739|20183837|P7|COMPLETED|Phase II Part||0
8185694|NCT02325739|20183838|P6|COMPLETED|Phase II Part||0
8185695|NCT02325739|20183839|P5|COMPLETED|Phase II Part||0
8185696|NCT02325739|20183840|P4|COMPLETED|Phase II Part||0
8185697|NCT02325739|20183841|P3|COMPLETED|Phase II Part||0
8185698|NCT02325739|20183842|P2|COMPLETED|Phase II Part||0
8185699|NCT02325739|20183843|P1|COMPLETED|Phase II Part||0
8185700|NCT02325739|20183833|P11|STARTED|Phase II Part||20
8185701|NCT02325739|20183834|P10|STARTED|Phase II Part||36
8185702|NCT02325739|20183835|P9|STARTED|Phase II Part||30
8185703|NCT02325739|20183836|P8|STARTED|Phase II Part||0
8185704|NCT02325739|20183837|P7|STARTED|Phase II Part||0
8185705|NCT02325739|20183838|P6|STARTED|Phase II Part||0
8185706|NCT02325739|20183839|P5|STARTED|Phase II Part||0
8185707|NCT02325739|20183840|P4|STARTED|Phase II Part||0
8185708|NCT02325739|20183841|P3|STARTED|Phase II Part||0
8185709|NCT02325739|20183842|P2|STARTED|Phase II Part||0
8185710|NCT02325739|20183843|P1|STARTED|Phase II Part||0
8185711|NCT02325739|20183833|P11|NOT COMPLETED|Phase I Part||0
8185712|NCT02325739|20183834|P10|NOT COMPLETED|Phase I Part||0
8185713|NCT02325739|20183835|P9|NOT COMPLETED|Phase I Part||0
8185714|NCT02325739|20183836|P8|NOT COMPLETED|Phase I Part||6
8185715|NCT02325739|20183837|P7|NOT COMPLETED|Phase I Part||6
8185716|NCT02325739|20183838|P6|NOT COMPLETED|Phase I Part||7
8185717|NCT02325739|20183839|P5|NOT COMPLETED|Phase I Part||19
8185718|NCT02325739|20183840|P4|NOT COMPLETED|Phase I Part||26
8185719|NCT02325739|20183841|P3|NOT COMPLETED|Phase I Part||5
8185720|NCT02325739|20183842|P2|NOT COMPLETED|Phase I Part||6
8185721|NCT02325739|20183843|P1|NOT COMPLETED|Phase I Part||11
8185722|NCT02325739|20183833|P11|COMPLETED|Phase I Part||0
8185723|NCT02325739|20183834|P10|COMPLETED|Phase I Part||0
8185724|NCT02325739|20183835|P9|COMPLETED|Phase I Part||0
8185725|NCT02325739|20183836|P8|COMPLETED|Phase I Part||0
8185726|NCT02325739|20183837|P7|COMPLETED|Phase I Part||0
8185727|NCT02325739|20183838|P6|COMPLETED|Phase I Part||0
8185728|NCT02325739|20183839|P5|COMPLETED|Phase I Part||0
8185729|NCT02325739|20183840|P4|COMPLETED|Phase I Part||0
8185730|NCT02325739|20183841|P3|COMPLETED|Phase I Part||0
8185731|NCT02325739|20183842|P2|COMPLETED|Phase I Part||0
8185732|NCT02325739|20183843|P1|COMPLETED|Phase I Part||0
8185733|NCT02325739|20183833|P11|STARTED|Phase I Part||0
8185734|NCT02325739|20183834|P10|STARTED|Phase I Part||0
8185735|NCT02325739|20183835|P9|STARTED|Phase I Part||0
8185736|NCT02325739|20183836|P8|STARTED|Phase I Part||6
8185737|NCT02325739|20183837|P7|STARTED|Phase I Part||6
8185738|NCT02325739|20183838|P6|STARTED|Phase I Part||7
8185739|NCT02325739|20183839|P5|STARTED|Phase I Part||19
8185740|NCT02325739|20183840|P4|STARTED|Phase I Part||26
8185741|NCT02325739|20183841|P3|STARTED|Phase I Part||5
8185742|NCT02325739|20183842|P2|STARTED|Phase I Part||6
8185743|NCT02325739|20183843|P1|STARTED|Phase I Part||11
8185744|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185745|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185746|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185747|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185748|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185749|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185750|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185751|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185752|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185753|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185754|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185755|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185756|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185757|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185758|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185759|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185760|NCT02325713|20183973|P16|COMPLETED|Intervention Period 4 (2 Days)||2
8185761|NCT02325713|20183974|P15|COMPLETED|Intervention Period 4 (2 Days)||2
8185762|NCT02325713|20183975|P14|COMPLETED|Intervention Period 4 (2 Days)||2
8185763|NCT02325713|20183976|P13|COMPLETED|Intervention Period 4 (2 Days)||2
8185764|NCT02325713|20183977|P12|COMPLETED|Intervention Period 4 (2 Days)||2
8185765|NCT02325713|20183978|P11|COMPLETED|Intervention Period 4 (2 Days)||1
8185766|NCT02325713|20183979|P10|COMPLETED|Intervention Period 4 (2 Days)||1
8185767|NCT02325713|20183980|P9|COMPLETED|Intervention Period 4 (2 Days)||2
8185768|NCT02325713|20183981|P8|COMPLETED|Intervention Period 4 (2 Days)||2
8185769|NCT02325713|20183982|P7|COMPLETED|Intervention Period 4 (2 Days)||2
8185770|NCT02325713|20183983|P6|COMPLETED|Intervention Period 4 (2 Days)||2
8185771|NCT02325713|20183984|P5|COMPLETED|Intervention Period 4 (2 Days)||2
8185772|NCT02325713|20183985|P4|COMPLETED|Intervention Period 4 (2 Days)||2
8185773|NCT02325713|20183986|P3|COMPLETED|Intervention Period 4 (2 Days)||2
8185774|NCT02325713|20183987|P2|COMPLETED|Intervention Period 4 (2 Days)||2
8185775|NCT02325713|20183988|P1|COMPLETED|Intervention Period 4 (2 Days)||1
8185776|NCT02325713|20183973|P16|STARTED|Intervention Period 4 (2 Days)||2
8185777|NCT02325713|20183974|P15|STARTED|Intervention Period 4 (2 Days)||2
8185778|NCT02325713|20183975|P14|STARTED|Intervention Period 4 (2 Days)||2
8185779|NCT02325713|20183976|P13|STARTED|Intervention Period 4 (2 Days)||2
8185780|NCT02325713|20183977|P12|STARTED|Intervention Period 4 (2 Days)||2
8185781|NCT02325713|20183978|P11|STARTED|Intervention Period 4 (2 Days)||1
8185782|NCT02325713|20183979|P10|STARTED|Intervention Period 4 (2 Days)||1
8185783|NCT02325713|20183980|P9|STARTED|Intervention Period 4 (2 Days)||2
8185784|NCT02325713|20183981|P8|STARTED|Intervention Period 4 (2 Days)||2
8185785|NCT02325713|20183982|P7|STARTED|Intervention Period 4 (2 Days)||2
8185786|NCT02325713|20183983|P6|STARTED|Intervention Period 4 (2 Days)||2
8185787|NCT02325713|20183984|P5|STARTED|Intervention Period 4 (2 Days)||2
8185788|NCT02325713|20183985|P4|STARTED|Intervention Period 4 (2 Days)||2
8185789|NCT02325713|20183986|P3|STARTED|Intervention Period 4 (2 Days)||2
8185790|NCT02325713|20183987|P2|STARTED|Intervention Period 4 (2 Days)||2
8185791|NCT02325713|20183988|P1|STARTED|Intervention Period 4 (2 Days)||1
8185792|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185793|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185794|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185795|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185796|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185797|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185798|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
8185799|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185800|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185801|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185802|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185803|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185804|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185805|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185806|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185807|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185808|NCT02325713|20183973|P16|COMPLETED|Intervention Period 3 (2 Days)||2
8185809|NCT02325713|20183974|P15|COMPLETED|Intervention Period 3 (2 Days)||2
8185810|NCT02325713|20183975|P14|COMPLETED|Intervention Period 3 (2 Days)||2
8185811|NCT02325713|20183976|P13|COMPLETED|Intervention Period 3 (2 Days)||2
8185812|NCT02325713|20183977|P12|COMPLETED|Intervention Period 3 (2 Days)||2
8185813|NCT02325713|20183978|P11|COMPLETED|Intervention Period 3 (2 Days)||1
8185814|NCT02325713|20183979|P10|COMPLETED|Intervention Period 3 (2 Days)||1
8185815|NCT02325713|20183980|P9|COMPLETED|Intervention Period 3 (2 Days)||2
8185816|NCT02325713|20183981|P8|COMPLETED|Intervention Period 3 (2 Days)||2
8185817|NCT02325713|20183982|P7|COMPLETED|Intervention Period 3 (2 Days)||2
8185818|NCT02325713|20183983|P6|COMPLETED|Intervention Period 3 (2 Days)||2
8185819|NCT02325713|20183984|P5|COMPLETED|Intervention Period 3 (2 Days)||2
8185820|NCT02325713|20183985|P4|COMPLETED|Intervention Period 3 (2 Days)||2
8185821|NCT02325713|20183986|P3|COMPLETED|Intervention Period 3 (2 Days)||2
8185822|NCT02325713|20183987|P2|COMPLETED|Intervention Period 3 (2 Days)||2
8185823|NCT02325713|20183988|P1|COMPLETED|Intervention Period 3 (2 Days)||1
8185824|NCT02325713|20183973|P16|STARTED|Intervention Period 3 (2 Days)||2
8185825|NCT02325713|20183974|P15|STARTED|Intervention Period 3 (2 Days)||2
8185826|NCT02325713|20183975|P14|STARTED|Intervention Period 3 (2 Days)||2
8185827|NCT02325713|20183976|P13|STARTED|Intervention Period 3 (2 Days)||2
8185828|NCT02325713|20183977|P12|STARTED|Intervention Period 3 (2 Days)||2
8185829|NCT02325713|20183978|P11|STARTED|Intervention Period 3 (2 Days)||1
8185830|NCT02325713|20183979|P10|STARTED|Intervention Period 3 (2 Days)||2
8185831|NCT02325713|20183980|P9|STARTED|Intervention Period 3 (2 Days)||2
8185832|NCT02325713|20183981|P8|STARTED|Intervention Period 3 (2 Days)||2
8185833|NCT02325713|20183982|P7|STARTED|Intervention Period 3 (2 Days)||2
8185834|NCT02325713|20183983|P6|STARTED|Intervention Period 3 (2 Days)||2
8185835|NCT02325713|20183984|P5|STARTED|Intervention Period 3 (2 Days)||2
8185836|NCT02325713|20183985|P4|STARTED|Intervention Period 3 (2 Days)||2
8185837|NCT02325713|20183986|P3|STARTED|Intervention Period 3 (2 Days)||2
8185838|NCT02325713|20183987|P2|STARTED|Intervention Period 3 (2 Days)||2
8185839|NCT02325713|20183988|P1|STARTED|Intervention Period 3 (2 Days)||1
8185840|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185841|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185842|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185843|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185844|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185845|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185846|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185847|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185848|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185849|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185850|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185851|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185852|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185853|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185854|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185855|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
8185856|NCT02325713|20183973|P16|COMPLETED|Intervention Period 2 (2 Days)||2
8185857|NCT02325713|20183974|P15|COMPLETED|Intervention Period 2 (2 Days)||2
8185858|NCT02325713|20183975|P14|COMPLETED|Intervention Period 2 (2 Days)||2
8185859|NCT02325713|20183976|P13|COMPLETED|Intervention Period 2 (2 Days)||2
8185860|NCT02325713|20183977|P12|COMPLETED|Intervention Period 2 (2 Days)||2
8185861|NCT02325713|20183978|P11|COMPLETED|Intervention Period 2 (2 Days)||1
8185862|NCT02325713|20183979|P10|COMPLETED|Intervention Period 2 (2 Days)||2
8185863|NCT02325713|20183980|P9|COMPLETED|Intervention Period 2 (2 Days)||2
8185864|NCT02325713|20183981|P8|COMPLETED|Intervention Period 2 (2 Days)||2
8185865|NCT02325713|20183982|P7|COMPLETED|Intervention Period 2 (2 Days)||2
8185866|NCT02325713|20183983|P6|COMPLETED|Intervention Period 2 (2 Days)||2
8185867|NCT02325713|20183984|P5|COMPLETED|Intervention Period 2 (2 Days)||2
8185868|NCT02325713|20183985|P4|COMPLETED|Intervention Period 2 (2 Days)||2
8185869|NCT02325713|20183986|P3|COMPLETED|Intervention Period 2 (2 Days)||2
8185870|NCT02325713|20183987|P2|COMPLETED|Intervention Period 2 (2 Days)||2
8185871|NCT02325713|20183988|P1|COMPLETED|Intervention Period 2 (2 Days)||1
8185872|NCT02325713|20183973|P16|STARTED|Intervention Period 2 (2 Days)||2
8185873|NCT02325713|20183974|P15|STARTED|Intervention Period 2 (2 Days)||2
8185874|NCT02325713|20183975|P14|STARTED|Intervention Period 2 (2 Days)||2
8185875|NCT02325713|20183976|P13|STARTED|Intervention Period 2 (2 Days)||2
8185876|NCT02325713|20183977|P12|STARTED|Intervention Period 2 (2 Days)||2
8185877|NCT02325713|20183978|P11|STARTED|Intervention Period 2 (2 Days)||1
8185878|NCT02325713|20183979|P10|STARTED|Intervention Period 2 (2 Days)||2
8185879|NCT02325713|20183980|P9|STARTED|Intervention Period 2 (2 Days)||2
8185880|NCT02325713|20183981|P8|STARTED|Intervention Period 2 (2 Days)||2
8185881|NCT02325713|20183982|P7|STARTED|Intervention Period 2 (2 Days)||2
8185882|NCT02325713|20183983|P6|STARTED|Intervention Period 2 (2 Days)||2
8185883|NCT02325713|20183984|P5|STARTED|Intervention Period 2 (2 Days)||2
8185884|NCT02325713|20183985|P4|STARTED|Intervention Period 2 (2 Days)||2
8185885|NCT02325713|20183986|P3|STARTED|Intervention Period 2 (2 Days)||2
8185886|NCT02325713|20183987|P2|STARTED|Intervention Period 2 (2 Days)||2
8185887|NCT02325713|20183988|P1|STARTED|Intervention Period 2 (2 Days)||2
8185888|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185889|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185890|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185891|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185892|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185893|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
8185894|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185895|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185896|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185897|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185898|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185899|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185900|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185901|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185902|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185903|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185904|NCT02325713|20183973|P16|COMPLETED|Intervention Period 1 (2 Days)||2
8185905|NCT02325713|20183974|P15|COMPLETED|Intervention Period 1 (2 Days)||2
8185906|NCT02325713|20183975|P14|COMPLETED|Intervention Period 1 (2 Days)||2
8185907|NCT02325713|20183976|P13|COMPLETED|Intervention Period 1 (2 Days)||2
8185908|NCT02325713|20183977|P12|COMPLETED|Intervention Period 1 (2 Days)||2
8185909|NCT02325713|20183978|P11|COMPLETED|Intervention Period 1 (2 Days)||1
8185910|NCT02325713|20183979|P10|COMPLETED|Intervention Period 1 (2 Days)||2
8185911|NCT02325713|20183980|P9|COMPLETED|Intervention Period 1 (2 Days)||2
8185912|NCT02325713|20183981|P8|COMPLETED|Intervention Period 1 (2 Days)||2
8185913|NCT02325713|20183982|P7|COMPLETED|Intervention Period 1 (2 Days)||2
8185914|NCT02325713|20183983|P6|COMPLETED|Intervention Period 1 (2 Days)||2
8185915|NCT02325713|20183984|P5|COMPLETED|Intervention Period 1 (2 Days)||2
8185916|NCT02325713|20183985|P4|COMPLETED|Intervention Period 1 (2 Days)||2
8185917|NCT02325713|20183986|P3|COMPLETED|Intervention Period 1 (2 Days)||2
8185918|NCT02325713|20183987|P2|COMPLETED|Intervention Period 1 (2 Days)||2
8185919|NCT02325713|20183988|P1|COMPLETED|Intervention Period 1 (2 Days)||2
8185920|NCT02325713|20183973|P16|STARTED|Intervention Period 1 (2 Days)||2
8185921|NCT02325713|20183974|P15|STARTED|Intervention Period 1 (2 Days)||2
8185922|NCT02325713|20183975|P14|STARTED|Intervention Period 1 (2 Days)||2
8185923|NCT02325713|20183976|P13|STARTED|Intervention Period 1 (2 Days)||2
8185924|NCT02325713|20183977|P12|STARTED|Intervention Period 1 (2 Days)||2
8185925|NCT02325713|20183978|P11|STARTED|Intervention Period 1 (2 Days)||2
8185926|NCT02325713|20183979|P10|STARTED|Intervention Period 1 (2 Days)||2
8185927|NCT02325713|20183980|P9|STARTED|Intervention Period 1 (2 Days)||2
8185928|NCT02325713|20183981|P8|STARTED|Intervention Period 1 (2 Days)||2
8185929|NCT02325713|20183982|P7|STARTED|Intervention Period 1 (2 Days)||2
8185930|NCT02325713|20183983|P6|STARTED|Intervention Period 1 (2 Days)||2
8185931|NCT02325713|20183984|P5|STARTED|Intervention Period 1 (2 Days)||2
8185932|NCT02325713|20183985|P4|STARTED|Intervention Period 1 (2 Days)||2
8185933|NCT02325713|20183986|P3|STARTED|Intervention Period 1 (2 Days)||2
8185934|NCT02325713|20183987|P2|STARTED|Intervention Period 1 (2 Days)||2
8185935|NCT02325713|20183988|P1|STARTED|Intervention Period 1 (2 Days)||2
8185936|NCT02325687|20184084|P3|NOT COMPLETED|Overall Study||6
8185937|NCT02325687|20184085|P2|NOT COMPLETED|Overall Study||3
8185938|NCT02325687|20184086|P1|NOT COMPLETED|Overall Study||4
8185939|NCT02325687|20184084|P3|COMPLETED|Overall Study||13
8185940|NCT02325687|20184085|P2|COMPLETED|Overall Study||12
8185941|NCT02325687|20184086|P1|COMPLETED|Overall Study||12
8185942|NCT02325687|20184084|P3|STARTED|Overall Study||19
8185943|NCT02325687|20184085|P2|STARTED|Overall Study||15
8185944|NCT02325687|20184086|P1|STARTED|Overall Study||16
8185945|NCT02325518|20184102|P2|NOT COMPLETED|Overall Study||3
8185946|NCT02325518|20184103|P1|NOT COMPLETED|Overall Study||4
8185947|NCT02325518|20184102|P2|COMPLETED|Overall Study||100
8185948|NCT02325518|20184103|P1|COMPLETED|Overall Study||94
8185949|NCT02325518|20184102|P2|Per Protocol Set (PPS)|Overall Study||97
8185950|NCT02325518|20184103|P1|Per Protocol Set (PPS)|Overall Study||92
8185951|NCT02325518|20184102|P2|Full Analysis Set (FAS)|Overall Study||101
8185952|NCT02325518|20184103|P1|Full Analysis Set (FAS)|Overall Study||98
8185953|NCT02325518|20184102|P2|Safety Set|Overall Study||103
8185954|NCT02325518|20184103|P1|Safety Set|Overall Study||98
8185955|NCT02325518|20184102|P2|STARTED|Overall Study||103
8185956|NCT02325518|20184103|P1|STARTED|Overall Study||98
8185957|NCT02325401|20184112|P3|NOT COMPLETED|Overall Study||1
8185958|NCT02325401|20184113|P2|NOT COMPLETED|Overall Study||1
8185959|NCT02325401|20184114|P1|NOT COMPLETED|Overall Study||0
8185960|NCT02325401|20184112|P3|COMPLETED|Overall Study||4
8185961|NCT02325401|20184113|P2|COMPLETED|Overall Study||8
8185962|NCT02325401|20184114|P1|COMPLETED|Overall Study||6
8185963|NCT02325401|20184112|P3|STARTED|Overall Study||5
8185964|NCT02325401|20184113|P2|STARTED|Overall Study||9
8185965|NCT02325401|20184114|P1|STARTED|Overall Study||6
8185966|NCT02325219|20184137|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
8185967|NCT02325219|20184138|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8185968|NCT02325219|20184139|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8185969|NCT02325219|20184140|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
8185970|NCT02325219|20184141|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8185971|NCT02325219|20184137|P5|COMPLETED|After Controlled Period (Week 16 - 52)||25
8185972|NCT02325219|20184138|P4|COMPLETED|After Controlled Period (Week 16 - 52)||26
8185973|NCT02325219|20184139|P3|COMPLETED|After Controlled Period (Week 16 - 52)||62
8185974|NCT02325219|20184140|P2|COMPLETED|After Controlled Period (Week 16 - 52)||60
8185975|NCT02325219|20184141|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
8185976|NCT02325219|20184137|P5|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
8185977|NCT02325219|20184138|P4|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
8185978|NCT02325219|20184139|P3|STARTED|After Controlled Period (Week 16 - 52)||62
8185979|NCT02325219|20184140|P2|STARTED|After Controlled Period (Week 16 - 52)||63
8185980|NCT02325219|20184141|P1|STARTED|After Controlled Period (Week 16 - 52)||0
8185981|NCT02325219|20184137|P5|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
8185982|NCT02325219|20184138|P4|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
8185983|NCT02325219|20184139|P3|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
8185984|NCT02325219|20184140|P2|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
8185985|NCT02325219|20184141|P1|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
8185986|NCT02325219|20184137|P5|COMPLETED|Controlled Period (Week 0 - 16)||0
8185987|NCT02325219|20184138|P4|COMPLETED|Controlled Period (Week 0 - 16)||0
8185988|NCT02325219|20184139|P3|COMPLETED|Controlled Period (Week 0 - 16)||62
8185989|NCT02325219|20184140|P2|COMPLETED|Controlled Period (Week 0 - 16)||63
8185990|NCT02325219|20184141|P1|COMPLETED|Controlled Period (Week 0 - 16)||52
8185991|NCT02325219|20184137|P5|STARTED|Controlled Period (Week 0 - 16)||0
8185992|NCT02325219|20184138|P4|STARTED|Controlled Period (Week 0 - 16)||0
8185993|NCT02325219|20184139|P3|STARTED|Controlled Period (Week 0 - 16)||63
8185994|NCT02325219|20184140|P2|STARTED|Controlled Period (Week 0 - 16)||65
8185995|NCT02325219|20184141|P1|STARTED|Controlled Period (Week 0 - 16)||64
8185996|NCT02324972|20184315|P2|NOT COMPLETED|Overall Study||5
8185997|NCT02324972|20184316|P1|NOT COMPLETED|Overall Study||7
8185998|NCT02324972|20184315|P2|COMPLETED|Overall Study||23
8185999|NCT02324972|20184316|P1|COMPLETED|Overall Study||19
8186000|NCT02324972|20184315|P2|STARTED|Overall Study||28
8186001|NCT02324972|20184316|P1|STARTED|Overall Study||26
8186002|NCT02324842|20184333|P3|NOT COMPLETED|Overall Study||2
8186003|NCT02324842|20184334|P2|NOT COMPLETED|Overall Study||1
8186004|NCT02324842|20184335|P1|NOT COMPLETED|Overall Study||1
8186005|NCT02324842|20184333|P3|COMPLETED|Overall Study||13
8186006|NCT02324842|20184334|P2|COMPLETED|Overall Study||14
8186007|NCT02324842|20184335|P1|COMPLETED|Overall Study||14
8186008|NCT02324842|20184333|P3|STARTED|Overall Study||15
8186009|NCT02324842|20184334|P2|STARTED|Overall Study||15
8186010|NCT02324842|20184335|P1|STARTED|Overall Study||15
8186011|NCT02324816|20184364|P1|NOT COMPLETED|Overall Study||0
8186012|NCT02324816|20184364|P1|COMPLETED|Overall Study||19
8186013|NCT02324816|20184364|P1|STARTED|Overall Study||19
8186014|NCT02324699|20184369|P1|NOT COMPLETED|Overall Study||1
8186015|NCT02324699|20184369|P1|COMPLETED|Overall Study||0
8186016|NCT02324699|20184369|P1|STARTED|Overall Study||1
8186017|NCT02324673|20184379|P3|NOT COMPLETED|Overall Study||0
8186018|NCT02324673|20184380|P2|NOT COMPLETED|Overall Study||0
8186019|NCT02324673|20184381|P1|NOT COMPLETED|Overall Study||0
8186020|NCT02324673|20184379|P3|COMPLETED|Overall Study||21
8186021|NCT02324673|20184380|P2|COMPLETED|Overall Study||20
8186022|NCT02324673|20184381|P1|COMPLETED|Overall Study||20
8186023|NCT02324673|20184379|P3|STARTED|Overall Study||21
8186024|NCT02324673|20184380|P2|STARTED|Overall Study||20
8186025|NCT02324673|20184381|P1|STARTED|Overall Study||20
8186026|NCT02324660|20184482|P1|NOT COMPLETED|Overall Study||32
8186027|NCT02324660|20184482|P1|COMPLETED|Overall Study||137
8186028|NCT02324660|20184482|P1|STARTED|Overall Study||169
8186029|NCT02324569|20184489|P2|NOT COMPLETED|Overall Study||21
8186030|NCT02324569|20184490|P1|NOT COMPLETED|Overall Study||16
8186031|NCT02324569|20184489|P2|COMPLETED|Overall Study||103
8186032|NCT02324569|20184490|P1|COMPLETED|Overall Study||100
8186033|NCT02324569|20184489|P2|STARTED|Overall Study||124
8186034|NCT02324569|20184490|P1|STARTED|Overall Study||116
8186035|NCT02324543|20184520|P6|NOT COMPLETED|Overall Study||0
8186036|NCT02324543|20184521|P5|NOT COMPLETED|Overall Study||0
8186037|NCT02324543|20184522|P4|NOT COMPLETED|Overall Study||0
8186038|NCT02324543|20184523|P3|NOT COMPLETED|Overall Study||0
8186039|NCT02324543|20184524|P2|NOT COMPLETED|Overall Study||0
8186040|NCT02324543|20184525|P1|NOT COMPLETED|Overall Study||0
8186041|NCT02324543|20184520|P6|COMPLETED|Overall Study||24
8186042|NCT02324543|20184521|P5|COMPLETED|Overall Study||4
8186043|NCT02324543|20184522|P4|COMPLETED|Overall Study||4
8186044|NCT02324543|20184523|P3|COMPLETED|Overall Study||3
8186045|NCT02324543|20184524|P2|COMPLETED|Overall Study||6
8186046|NCT02324543|20184525|P1|COMPLETED|Overall Study||6
8186047|NCT02324543|20184520|P6|STARTED|Overall Study||24
8186048|NCT02324543|20184521|P5|STARTED|Overall Study||4
8186049|NCT02324543|20184522|P4|STARTED|Overall Study||4
8186050|NCT02324543|20184523|P3|STARTED|Overall Study||3
8186051|NCT02324543|20184524|P2|STARTED|Overall Study||6
8186052|NCT02324543|20184525|P1|STARTED|Overall Study||6
8186056|NCT02324465|20184552|P2|NOT COMPLETED|Overall Study||1
8186057|NCT02324465|20184553|P1|NOT COMPLETED|Overall Study||0
8186058|NCT02324465|20184552|P2|COMPLETED|Overall Study||21
8186059|NCT02324465|20184553|P1|COMPLETED|Overall Study||18
8186060|NCT02324465|20184552|P2|STARTED|Overall Study||22
8186061|NCT02324465|20184553|P1|STARTED|Overall Study||18
8186062|NCT02324361|20184567|P2|NOT COMPLETED|Overall Study||2
8186063|NCT02324361|20184568|P1|NOT COMPLETED|Overall Study||5
8186064|NCT02324361|20184567|P2|COMPLETED|Overall Study||22
8186065|NCT02324361|20184568|P1|COMPLETED|Overall Study||19
8186066|NCT02324361|20184567|P2|STARTED|Overall Study||24
8186067|NCT02324361|20184568|P1|STARTED|Overall Study||24
8186068|NCT02324335|20184582|P2|NOT COMPLETED|Overall Study||9
8186069|NCT02324335|20184583|P1|NOT COMPLETED|Overall Study||9
8186070|NCT02324335|20184582|P2|COMPLETED|Overall Study||20
8186071|NCT02324335|20184583|P1|COMPLETED|Overall Study||21
8186072|NCT02324335|20184582|P2|STARTED|Overall Study||29
8186073|NCT02324335|20184583|P1|STARTED|Overall Study||30
8186074|NCT02324270|20184598|P3|NOT COMPLETED|Overall Study||5
8186075|NCT02324270|20184599|P2|NOT COMPLETED|Overall Study||7
8186076|NCT02324270|20184600|P1|NOT COMPLETED|Overall Study||5
8186077|NCT02324270|20184598|P3|COMPLETED|Overall Study||216
8186078|NCT02324270|20184599|P2|COMPLETED|Overall Study||212
8186079|NCT02324270|20184600|P1|COMPLETED|Overall Study||213
8186080|NCT02324270|20184598|P3|PP Population|Overall Study||171
8186081|NCT02324270|20184599|P2|PP Population|Overall Study||177
8186082|NCT02324270|20184600|P1|PP Population|Overall Study||180
8186083|NCT02324270|20184598|P3|mITT Population|Overall Study||217
8186084|NCT02324270|20184599|P2|mITT Population|Overall Study||216
8186085|NCT02324270|20184600|P1|mITT Population|Overall Study||214
8186086|NCT02324270|20184598|P3|Safety Population|Overall Study||217
8186087|NCT02324270|20184599|P2|Safety Population|Overall Study||216
8186088|NCT02324270|20184600|P1|Safety Population|Overall Study||214
8186089|NCT02324270|20184598|P3|STARTED|Overall Study||221
8186090|NCT02324270|20184599|P2|STARTED|Overall Study||219
8186091|NCT02324270|20184600|P1|STARTED|Overall Study||218
8186092|NCT02324205|20184610|P1|NOT COMPLETED|Overall Study||37
8186093|NCT02324205|20184610|P1|COMPLETED|Overall Study||159
8186094|NCT02324205|20184610|P1|STARTED|Overall Study||196
8186095|NCT02324153|20184622|P2|NOT COMPLETED|Overall Study||1
8186096|NCT02324153|20184623|P1|NOT COMPLETED|Overall Study||8
8186097|NCT02324153|20184622|P2|COMPLETED|Overall Study||38
8186098|NCT02324153|20184623|P1|COMPLETED|Overall Study||33
8186099|NCT02324153|20184622|P2|STARTED|Overall Study||39
8186100|NCT02324153|20184623|P1|STARTED|Overall Study||41
8186101|NCT02324075|20184635|P2|NOT COMPLETED|Overall Study||9
8186102|NCT02324075|20184636|P1|NOT COMPLETED|Overall Study||3
8186103|NCT02324075|20184635|P2|COMPLETED|Overall Study||605
8186104|NCT02324075|20184636|P1|COMPLETED|Overall Study||609
8186105|NCT02324075|20184635|P2|STARTED|Overall Study||614
8186106|NCT02324075|20184636|P1|STARTED|Overall Study||612
8186107|NCT02324049|20184668|P1|NOT COMPLETED|Part C||11
8186108|NCT02324049|20184668|P1|COMPLETED|Part C||0
8186109|NCT02324049|20184668|P1|Safety Analysis Set|Part C||11
8186110|NCT02324049|20184668|P1|STARTED|Part C||11
8186111|NCT02324049|20184668|P1|NOT COMPLETED|Part B||0
8186112|NCT02324049|20184668|P1|COMPLETED|Part B||11
8186113|NCT02324049|20184668|P1|Safety Analysis Set|Part B||11
8186114|NCT02324049|20184668|P1|STARTED|Part B||11
8186115|NCT02324049|20184668|P1|NOT COMPLETED|Part A||0
8186116|NCT02324049|20184668|P1|COMPLETED|Part A||11
8186117|NCT02324049|20184668|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
8186118|NCT02324049|20184668|P1|STARTED|Part A||11
8186119|NCT02323854|20184672|P1|NOT COMPLETED|Overall Study||0
8186120|NCT02323854|20184672|P1|COMPLETED|Overall Study||15
8186121|NCT02323854|20184672|P1|STARTED|Overall Study||15
8186122|NCT02323646|20184681|P3|NOT COMPLETED|Treatment Course 2||3
8186123|NCT02323646|20184682|P2|NOT COMPLETED|Treatment Course 2||1
8186124|NCT02323646|20184683|P1|NOT COMPLETED|Treatment Course 2||1
8186125|NCT02323646|20184681|P3|COMPLETED|Treatment Course 2||9
8186126|NCT02323646|20184682|P2|COMPLETED|Treatment Course 2||9
8186127|NCT02323646|20184683|P1|COMPLETED|Treatment Course 2||10
8186128|NCT02323646|20184681|P3|STARTED|Treatment Course 2||12
8186129|NCT02323646|20184682|P2|STARTED|Treatment Course 2||10
8186130|NCT02323646|20184683|P1|STARTED|Treatment Course 2||11
8186131|NCT02323646|20184681|P3|NOT COMPLETED|Treatment Course 1||3
8186132|NCT02323646|20184682|P2|NOT COMPLETED|Treatment Course 1||3
8186133|NCT02323646|20184683|P1|NOT COMPLETED|Treatment Course 1||3
8186134|NCT02323646|20184681|P3|COMPLETED|Treatment Course 1||12
8186135|NCT02323646|20184682|P2|COMPLETED|Treatment Course 1||10
8186136|NCT02323646|20184683|P1|COMPLETED|Treatment Course 1||11
8186137|NCT02323646|20184681|P3|STARTED|Treatment Course 1||15
8186138|NCT02323646|20184682|P2|STARTED|Treatment Course 1||13
8186139|NCT02323646|20184683|P1|STARTED|Treatment Course 1||14
8186140|NCT02323204|20184731|P4|NOT COMPLETED|6-month Follow-up Survey Completion||44
8186141|NCT02323204|20184732|P3|NOT COMPLETED|6-month Follow-up Survey Completion||41
8186142|NCT02323204|20184733|P2|NOT COMPLETED|6-month Follow-up Survey Completion||50
8186143|NCT02323204|20184734|P1|NOT COMPLETED|6-month Follow-up Survey Completion||49
8186144|NCT02323204|20184731|P4|COMPLETED|6-month Follow-up Survey Completion||112
8186145|NCT02323204|20184732|P3|COMPLETED|6-month Follow-up Survey Completion||113
8186146|NCT02323204|20184733|P2|COMPLETED|6-month Follow-up Survey Completion||96
8186147|NCT02323204|20184734|P1|COMPLETED|6-month Follow-up Survey Completion||96
8186148|NCT02323204|20184731|P4|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
8186149|NCT02323204|20184732|P3|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
8186150|NCT02323204|20184733|P2|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
8186151|NCT02323204|20184734|P1|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
8186152|NCT02323204|20184731|P4|NOT COMPLETED|3-month Follow-up Survey Completion||44
8186153|NCT02323204|20184732|P3|NOT COMPLETED|3-month Follow-up Survey Completion||41
8186154|NCT02323204|20184733|P2|NOT COMPLETED|3-month Follow-up Survey Completion||47
8186155|NCT02323204|20184734|P1|NOT COMPLETED|3-month Follow-up Survey Completion||54
8186156|NCT02323204|20184731|P4|COMPLETED|3-month Follow-up Survey Completion||112
8186157|NCT02323204|20184732|P3|COMPLETED|3-month Follow-up Survey Completion||113
8186158|NCT02323204|20184733|P2|COMPLETED|3-month Follow-up Survey Completion||99
8186159|NCT02323204|20184734|P1|COMPLETED|3-month Follow-up Survey Completion||91
8186160|NCT02323204|20184731|P4|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
8186161|NCT02323204|20184732|P3|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
8186162|NCT02323204|20184733|P2|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
8186163|NCT02323204|20184734|P1|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
8186164|NCT02323204|20184731|P4|NOT COMPLETED|6-week Follow-up Intervention Booster||36
8186165|NCT02323204|20184732|P3|NOT COMPLETED|6-week Follow-up Intervention Booster||0
8186166|NCT02323204|20184733|P2|NOT COMPLETED|6-week Follow-up Intervention Booster||43
8186167|NCT02323204|20184734|P1|NOT COMPLETED|6-week Follow-up Intervention Booster||0
8186168|NCT02323204|20184731|P4|COMPLETED|6-week Follow-up Intervention Booster||120
8186169|NCT02323204|20184732|P3|COMPLETED|6-week Follow-up Intervention Booster||0
8186170|NCT02323204|20184733|P2|COMPLETED|6-week Follow-up Intervention Booster||103
8186171|NCT02323204|20184734|P1|COMPLETED|6-week Follow-up Intervention Booster||0
8186172|NCT02323204|20184731|P4|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
8186173|NCT02323204|20184732|P3|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
8186174|NCT02323204|20184733|P2|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
8186265|NCT02322788|20184877|P3|COMPLETED|Visit 6||15
8186175|NCT02323204|20184734|P1|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
8186176|NCT02323204|20184731|P4|NOT COMPLETED|6-week Follow-up Survey Completion||37
8186177|NCT02323204|20184732|P3|NOT COMPLETED|6-week Follow-up Survey Completion||42
8186178|NCT02323204|20184733|P2|NOT COMPLETED|6-week Follow-up Survey Completion||36
8186179|NCT02323204|20184734|P1|NOT COMPLETED|6-week Follow-up Survey Completion||41
8186180|NCT02323204|20184731|P4|COMPLETED|6-week Follow-up Survey Completion||119
8186181|NCT02323204|20184732|P3|COMPLETED|6-week Follow-up Survey Completion||112
8186182|NCT02323204|20184733|P2|COMPLETED|6-week Follow-up Survey Completion||110
8186183|NCT02323204|20184734|P1|COMPLETED|6-week Follow-up Survey Completion||104
8186184|NCT02323204|20184731|P4|STARTED|6-week Follow-up Survey Completion||156
8186185|NCT02323204|20184732|P3|STARTED|6-week Follow-up Survey Completion||154
8186186|NCT02323204|20184733|P2|STARTED|6-week Follow-up Survey Completion||146
8186187|NCT02323204|20184734|P1|STARTED|6-week Follow-up Survey Completion||145
8186188|NCT02323204|20184731|P4|NOT COMPLETED|Baseline Survey Completion||3
8186189|NCT02323204|20184732|P3|NOT COMPLETED|Baseline Survey Completion||5
8186190|NCT02323204|20184733|P2|NOT COMPLETED|Baseline Survey Completion||9
8186191|NCT02323204|20184734|P1|NOT COMPLETED|Baseline Survey Completion||10
8186192|NCT02323204|20184731|P4|COMPLETED|Baseline Survey Completion||156
8186193|NCT02323204|20184732|P3|COMPLETED|Baseline Survey Completion||154
8186194|NCT02323204|20184733|P2|COMPLETED|Baseline Survey Completion||146
8186195|NCT02323204|20184734|P1|COMPLETED|Baseline Survey Completion||145
8186196|NCT02323204|20184731|P4|STARTED|Baseline Survey Completion||159
8186197|NCT02323204|20184732|P3|STARTED|Baseline Survey Completion||159
8186198|NCT02323204|20184733|P2|STARTED|Baseline Survey Completion||155
8186199|NCT02323204|20184734|P1|STARTED|Baseline Survey Completion||155
8186200|NCT02323048|20184789|P5|NOT COMPLETED|Overall Study||0
8186201|NCT02323048|20184790|P4|NOT COMPLETED|Overall Study||0
8186202|NCT02323048|20184791|P3|NOT COMPLETED|Overall Study||0
8186203|NCT02323048|20184792|P2|NOT COMPLETED|Overall Study||2
8186204|NCT02323048|20184793|P1|NOT COMPLETED|Overall Study||1
8186205|NCT02323048|20184789|P5|COMPLETED|Overall Study||9
8186206|NCT02323048|20184790|P4|COMPLETED|Overall Study||7
8186207|NCT02323048|20184791|P3|COMPLETED|Overall Study||23
8186208|NCT02323048|20184792|P2|COMPLETED|Overall Study||24
8186209|NCT02323048|20184793|P1|COMPLETED|Overall Study||24
8186210|NCT02323048|20184789|P5|STARTED|Overall Study||9
8186211|NCT02323048|20184790|P4|STARTED|Overall Study||7
8186212|NCT02323048|20184791|P3|STARTED|Overall Study||23
8186213|NCT02323048|20184792|P2|STARTED|Overall Study||26
8186214|NCT02323048|20184793|P1|STARTED|Overall Study||25
8186215|NCT02322892|20184807|P2|NOT COMPLETED|Overall Study||3
8186216|NCT02322892|20184808|P1|NOT COMPLETED|Overall Study||2
8186217|NCT02322892|20184807|P2|COMPLETED|Overall Study|Received thiamine|31
8186218|NCT02322892|20184808|P1|COMPLETED|Overall Study|Received placebo|33
8186219|NCT02322892|20184807|P2|STARTED|Overall Study|Number randomized|34
8186220|NCT02322892|20184808|P1|STARTED|Overall Study|Number randomized|35
8186221|NCT02322879|20184824|P2|NOT COMPLETED|Second Intervention||0
8186222|NCT02322879|20184825|P1|NOT COMPLETED|Second Intervention||0
8186223|NCT02322879|20184824|P2|COMPLETED|Second Intervention||10
8186224|NCT02322879|20184825|P1|COMPLETED|Second Intervention||10
8186225|NCT02322879|20184824|P2|STARTED|Second Intervention||10
8186226|NCT02322879|20184825|P1|STARTED|Second Intervention||10
8186227|NCT02322879|20184824|P2|NOT COMPLETED|Washout||0
8186228|NCT02322879|20184825|P1|NOT COMPLETED|Washout||0
8186229|NCT02322879|20184824|P2|COMPLETED|Washout||10
8186230|NCT02322879|20184825|P1|COMPLETED|Washout||10
8186231|NCT02322879|20184824|P2|STARTED|Washout||10
8186232|NCT02322879|20184825|P1|STARTED|Washout||10
8186233|NCT02322879|20184824|P2|NOT COMPLETED|First Intervention||0
8186234|NCT02322879|20184825|P1|NOT COMPLETED|First Intervention||1
8186235|NCT02322879|20184824|P2|COMPLETED|First Intervention||10
8186236|NCT02322879|20184825|P1|COMPLETED|First Intervention||10
8186237|NCT02322879|20184824|P2|STARTED|First Intervention||10
8186238|NCT02322879|20184825|P1|STARTED|First Intervention||11
8186239|NCT02322866|20184833|P2|NOT COMPLETED|Overall Study||86
8186240|NCT02322866|20184834|P1|NOT COMPLETED|Overall Study||71
8186241|NCT02322866|20184833|P2|COMPLETED|Overall Study||433
8186242|NCT02322866|20184834|P1|COMPLETED|Overall Study||444
8186243|NCT02322866|20184833|P2|STARTED|Overall Study||519
8186244|NCT02322866|20184834|P1|STARTED|Overall Study||515
8186260|NCT02322788|20184876|P4|NOT COMPLETED|Visit 6||0
8186261|NCT02322788|20184877|P3|NOT COMPLETED|Visit 6||0
8186262|NCT02322788|20184878|P2|NOT COMPLETED|Visit 6||0
8186263|NCT02322788|20184879|P1|NOT COMPLETED|Visit 6||0
8186264|NCT02322788|20184876|P4|COMPLETED|Visit 6||15
8186266|NCT02322788|20184878|P2|COMPLETED|Visit 6||16
8186267|NCT02322788|20184879|P1|COMPLETED|Visit 6||14
8186268|NCT02322788|20184876|P4|STARTED|Visit 6||15
8186269|NCT02322788|20184877|P3|STARTED|Visit 6||15
8186270|NCT02322788|20184878|P2|STARTED|Visit 6||16
8186271|NCT02322788|20184879|P1|STARTED|Visit 6||14
8186272|NCT02322788|20184876|P4|NOT COMPLETED|Visit 5||0
8186273|NCT02322788|20184877|P3|NOT COMPLETED|Visit 5||0
8186274|NCT02322788|20184878|P2|NOT COMPLETED|Visit 5||0
8186275|NCT02322788|20184879|P1|NOT COMPLETED|Visit 5||0
8186276|NCT02322788|20184876|P4|COMPLETED|Visit 5||14
8186277|NCT02322788|20184877|P3|COMPLETED|Visit 5||15
8186278|NCT02322788|20184878|P2|COMPLETED|Visit 5||15
8186279|NCT02322788|20184879|P1|COMPLETED|Visit 5||16
8186280|NCT02322788|20184876|P4|STARTED|Visit 5||14
8186281|NCT02322788|20184877|P3|STARTED|Visit 5||15
8186282|NCT02322788|20184878|P2|STARTED|Visit 5||15
8186283|NCT02322788|20184879|P1|STARTED|Visit 5||16
8186284|NCT02322788|20184876|P4|NOT COMPLETED|Visit 4||0
8186285|NCT02322788|20184877|P3|NOT COMPLETED|Visit 4||0
8186286|NCT02322788|20184878|P2|NOT COMPLETED|Visit 4||0
8186287|NCT02322788|20184879|P1|NOT COMPLETED|Visit 4||0
8186288|NCT02322788|20184876|P4|COMPLETED|Visit 4||15
8186289|NCT02322788|20184877|P3|COMPLETED|Visit 4||16
8186290|NCT02322788|20184878|P2|COMPLETED|Visit 4||14
8186291|NCT02322788|20184879|P1|COMPLETED|Visit 4||15
8186292|NCT02322788|20184876|P4|STARTED|Visit 4||15
8186293|NCT02322788|20184877|P3|STARTED|Visit 4||16
8186294|NCT02322788|20184878|P2|STARTED|Visit 4||14
8186295|NCT02322788|20184879|P1|STARTED|Visit 4||15
8186296|NCT02322788|20184876|P4|NOT COMPLETED|Visit 3||0
8186297|NCT02322788|20184877|P3|NOT COMPLETED|Visit 3||0
8186298|NCT02322788|20184878|P2|NOT COMPLETED|Visit 3||0
8186299|NCT02322788|20184879|P1|NOT COMPLETED|Visit 3||0
8186300|NCT02322788|20184876|P4|COMPLETED|Visit 3||16
8186301|NCT02322788|20184877|P3|COMPLETED|Visit 3||14
8186302|NCT02322788|20184878|P2|COMPLETED|Visit 3||15
8186303|NCT02322788|20184879|P1|COMPLETED|Visit 3||15
8186304|NCT02322788|20184876|P4|STARTED|Visit 3||16
8186305|NCT02322788|20184877|P3|STARTED|Visit 3||14
8186306|NCT02322788|20184878|P2|STARTED|Visit 3||15
8186307|NCT02322788|20184879|P1|STARTED|Visit 3||15
8186308|NCT02322775|20184891|P2|NOT COMPLETED|Overall Study||6
8186309|NCT02322775|20184892|P1|NOT COMPLETED|Overall Study||5
8186310|NCT02322775|20184891|P2|COMPLETED|Overall Study||99
8186311|NCT02322775|20184892|P1|COMPLETED|Overall Study||101
8186312|NCT02322775|20184891|P2|STARTED|Overall Study||105
8186313|NCT02322775|20184892|P1|STARTED|Overall Study||106
8186314|NCT02322749|20184918|P6|NOT COMPLETED|Period 3||0
8186315|NCT02322749|20184919|P5|NOT COMPLETED|Period 3||0
8186316|NCT02322749|20184920|P4|NOT COMPLETED|Period 3||0
8186317|NCT02322749|20184921|P3|NOT COMPLETED|Period 3||1
8186318|NCT02322749|20184922|P2|NOT COMPLETED|Period 3||0
8186319|NCT02322749|20184923|P1|NOT COMPLETED|Period 3||0
8186320|NCT02322749|20184918|P6|COMPLETED|Period 3||8
8186321|NCT02322749|20184919|P5|COMPLETED|Period 3||8
8186322|NCT02322749|20184920|P4|COMPLETED|Period 3||6
8186323|NCT02322749|20184921|P3|COMPLETED|Period 3||7
8186324|NCT02322749|20184922|P2|COMPLETED|Period 3||8
8186325|NCT02322749|20184923|P1|COMPLETED|Period 3||8
8186326|NCT02322749|20184918|P6|STARTED|Period 3||8
8186327|NCT02322749|20184919|P5|STARTED|Period 3||8
8186328|NCT02322749|20184920|P4|STARTED|Period 3||6
8186329|NCT02322749|20184921|P3|STARTED|Period 3||8
8186330|NCT02322749|20184922|P2|STARTED|Period 3||8
8186331|NCT02322749|20184923|P1|STARTED|Period 3||8
8186332|NCT02322749|20184918|P6|NOT COMPLETED|Period 2||0
8186333|NCT02322749|20184919|P5|NOT COMPLETED|Period 2||0
8186334|NCT02322749|20184920|P4|NOT COMPLETED|Period 2||2
8186335|NCT02322749|20184921|P3|NOT COMPLETED|Period 2||0
8186336|NCT02322749|20184922|P2|NOT COMPLETED|Period 2||0
8186337|NCT02322749|20184923|P1|NOT COMPLETED|Period 2||0
8186338|NCT02322749|20184918|P6|COMPLETED|Period 2||8
8186339|NCT02322749|20184919|P5|COMPLETED|Period 2||8
8186340|NCT02322749|20184920|P4|COMPLETED|Period 2||6
8186341|NCT02322749|20184921|P3|COMPLETED|Period 2||8
8186342|NCT02322749|20184922|P2|COMPLETED|Period 2||8
8186343|NCT02322749|20184923|P1|COMPLETED|Period 2||8
8186344|NCT02322749|20184918|P6|STARTED|Period 2||8
8186345|NCT02322749|20184919|P5|STARTED|Period 2||8
8186346|NCT02322749|20184920|P4|STARTED|Period 2||8
8186347|NCT02322749|20184921|P3|STARTED|Period 2||8
8186348|NCT02322749|20184922|P2|STARTED|Period 2||8
8186349|NCT02322749|20184923|P1|STARTED|Period 2||8
8186350|NCT02322749|20184918|P6|NOT COMPLETED|Period 1||0
8186351|NCT02322749|20184919|P5|NOT COMPLETED|Period 1||0
8186352|NCT02322749|20184920|P4|NOT COMPLETED|Period 1||0
8186353|NCT02322749|20184921|P3|NOT COMPLETED|Period 1||0
8186354|NCT02322749|20184922|P2|NOT COMPLETED|Period 1||0
8186355|NCT02322749|20184923|P1|NOT COMPLETED|Period 1||0
8186356|NCT02322749|20184918|P6|COMPLETED|Period 1||8
8186357|NCT02322749|20184919|P5|COMPLETED|Period 1||8
8186358|NCT02322749|20184920|P4|COMPLETED|Period 1||8
8186359|NCT02322749|20184921|P3|COMPLETED|Period 1||8
8186360|NCT02322749|20184922|P2|COMPLETED|Period 1||8
8186361|NCT02322749|20184923|P1|COMPLETED|Period 1||8
8186362|NCT02322749|20184918|P6|STARTED|Period 1||8
8186363|NCT02322749|20184919|P5|STARTED|Period 1||8
8186364|NCT02322749|20184920|P4|STARTED|Period 1||8
8186365|NCT02322749|20184921|P3|STARTED|Period 1||8
8186366|NCT02322749|20184922|P2|STARTED|Period 1||8
8186367|NCT02322749|20184923|P1|STARTED|Period 1||8
8186368|NCT02322710|20184948|P2|NOT COMPLETED|Overall Study||26
8186369|NCT02322710|20184949|P1|NOT COMPLETED|Overall Study||20
8186370|NCT02322710|20184948|P2|COMPLETED|Overall Study||73
8186371|NCT02322710|20184949|P1|COMPLETED|Overall Study||85
8186372|NCT02322710|20184948|P2|Full Analysis Population|Overall Study||98
8186373|NCT02322710|20184949|P1|Full Analysis Population|Overall Study||105
8186374|NCT02322710|20184948|P2|Safety Population|Overall Study||99
8186375|NCT02322710|20184949|P1|Safety Population|Overall Study||105
8186376|NCT02322710|20184948|P2|STARTED|Overall Study||99
8186377|NCT02322710|20184949|P1|STARTED|Overall Study||105
8186378|NCT02322528|20184955|P1|NOT COMPLETED|Overall Study||0
8186379|NCT02322528|20184955|P1|COMPLETED|Overall Study||10
8186380|NCT02322528|20184955|P1|STARTED|Overall Study||10
8186381|NCT02322411|20184962|P2|NOT COMPLETED|Overall Study||7
8186382|NCT02322411|20184963|P1|NOT COMPLETED|Overall Study||5
8186383|NCT02322411|20184962|P2|COMPLETED|Overall Study||9
8186384|NCT02322411|20184963|P1|COMPLETED|Overall Study||9
8186385|NCT02322411|20184962|P2|All Baseline Measures Analyzed|Overall Study||16
8186386|NCT02322411|20184963|P1|All Baseline Measures Analyzed|Overall Study||13
8186387|NCT02322411|20184962|P2|Randomized|Overall Study||16
8186388|NCT02322411|20184963|P1|Randomized|Overall Study||14
8186389|NCT02322411|20184962|P2|STARTED|Overall Study||16
8186390|NCT02322411|20184963|P1|STARTED|Overall Study||14
8186391|NCT02322333|20184983|P2|NOT COMPLETED|Overall Study||16
8186392|NCT02322333|20184984|P1|NOT COMPLETED|Overall Study||17
8186393|NCT02322333|20184983|P2|COMPLETED|Overall Study||61
8186394|NCT02322333|20184984|P1|COMPLETED|Overall Study||63
8186395|NCT02322333|20184983|P2|STARTED|Overall Study||77
8186396|NCT02322333|20184984|P1|STARTED|Overall Study||80
8186397|NCT02322320|20185007|P3|NOT COMPLETED|Overall Study||0
8186398|NCT02322320|20185008|P2|NOT COMPLETED|Overall Study||0
8186399|NCT02322320|20185009|P1|NOT COMPLETED|Overall Study||0
8186400|NCT02322320|20185007|P3|COMPLETED|Overall Study||89
8186401|NCT02322320|20185008|P2|COMPLETED|Overall Study||86
8186402|NCT02322320|20185009|P1|COMPLETED|Overall Study||98
8186403|NCT02322320|20185007|P3|STARTED|Overall Study||89
8186404|NCT02322320|20185008|P2|STARTED|Overall Study||86
8186405|NCT02322320|20185009|P1|STARTED|Overall Study||98
8186406|NCT02322281|20185032|P3|NOT COMPLETED|Overall Study||74
8186407|NCT02322281|20185033|P2|NOT COMPLETED|Overall Study||22
8186408|NCT02322281|20185034|P1|NOT COMPLETED|Overall Study||53
8186409|NCT02322281|20185032|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8186410|NCT02322281|20185033|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8186411|NCT02322281|20185034|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8186412|NCT02322281|20185032|P3|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
8186413|NCT02322281|20185033|P2|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
8186414|NCT02322281|20185034|P1|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
8186415|NCT02322281|20185032|P3|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
8186416|NCT02322281|20185033|P2|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
8186417|NCT02322281|20185034|P1|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
8186418|NCT02322281|20185032|P3|STARTED|Overall Study||74
8186419|NCT02322281|20185033|P2|STARTED|Overall Study||22
8186420|NCT02322281|20185034|P1|STARTED|Overall Study||53
8186421|NCT02322242|20185057|P2|NOT COMPLETED|Overall Study||0
8186422|NCT02322242|20185058|P1|NOT COMPLETED|Overall Study||0
8186423|NCT02322242|20185057|P2|COMPLETED|Overall Study||90
8186424|NCT02322242|20185058|P1|COMPLETED|Overall Study||92
8186425|NCT02322242|20185057|P2|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
8186426|NCT02322242|20185058|P1|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
8186427|NCT02322242|20185057|P2|Primary Outcome|Overall Study||90
8186428|NCT02322242|20185058|P1|Primary Outcome|Overall Study||92
8186429|NCT02322242|20185057|P2|STARTED|Overall Study||90
8186430|NCT02322242|20185058|P1|STARTED|Overall Study||92
8186431|NCT02322229|20185082|P1|NOT COMPLETED|Overall Study||2
8186432|NCT02322229|20185082|P1|COMPLETED|Overall Study||50
8186433|NCT02322229|20185082|P1|STARTED|Overall Study||52
8186434|NCT02322216|20185094|P2|NOT COMPLETED|Overall Study||4
8186435|NCT02322216|20185095|P1|NOT COMPLETED|Overall Study||2
8186436|NCT02322216|20185094|P2|COMPLETED|Overall Study||123
8186437|NCT02322216|20185095|P1|COMPLETED|Overall Study||124
8186438|NCT02322216|20185094|P2|Per Protocol Set (PPS)|Overall Study||122
8186439|NCT02322216|20185095|P1|Per Protocol Set (PPS)|Overall Study||123
8186440|NCT02322216|20185094|P2|Treated (Safety Set)|Overall Study||126
8186441|NCT02322216|20185095|P1|Treated (Safety Set)|Overall Study||126
8186442|NCT02322216|20185094|P2|STARTED|Overall Study||127
8186443|NCT02322216|20185095|P1|STARTED|Overall Study||126
8186444|NCT02322190|20185102|P2|NOT COMPLETED|Overall Study||0
8186445|NCT02322190|20185103|P1|NOT COMPLETED|Overall Study||1
8186446|NCT02322190|20185102|P2|COMPLETED|Overall Study||0
8186447|NCT02322190|20185103|P1|COMPLETED|Overall Study||4
8186448|NCT02322190|20185102|P2|STARTED|Overall Study||0
8186449|NCT02322190|20185103|P1|STARTED|Overall Study||5
8186450|NCT02322047|20185115|P4|NOT COMPLETED|Overall Study||2
8186451|NCT02322047|20185116|P3|NOT COMPLETED|Overall Study||1
8186452|NCT02322047|20185117|P2|NOT COMPLETED|Overall Study||1
8186453|NCT02322047|20185118|P1|NOT COMPLETED|Overall Study||2
8186454|NCT02322047|20185115|P4|COMPLETED|Overall Study||7
8186455|NCT02322047|20185116|P3|COMPLETED|Overall Study||6
8186456|NCT02322047|20185117|P2|COMPLETED|Overall Study||6
8186457|NCT02322047|20185118|P1|COMPLETED|Overall Study||6
8186458|NCT02322047|20185115|P4|STARTED|Overall Study||9
8186459|NCT02322047|20185116|P3|STARTED|Overall Study||7
8186460|NCT02322047|20185117|P2|STARTED|Overall Study||7
8186461|NCT02322047|20185118|P1|STARTED|Overall Study||8
8186462|NCT02321930|20185140|P1|NOT COMPLETED|Overall Study||1
8186463|NCT02321930|20185140|P1|COMPLETED|Overall Study||24
8186464|NCT02321930|20185140|P1|STARTED|Overall Study||25
8186465|NCT02321800|20185150|P2|NOT COMPLETED|Overall Study||11
8186466|NCT02321800|20185151|P1|NOT COMPLETED|Overall Study||20
8186467|NCT02321800|20185150|P2|COMPLETED|Overall Study||138
8186468|NCT02321800|20185151|P1|COMPLETED|Overall Study||283
8186469|NCT02321800|20185150|P2|Received Study Drug|Overall Study||148
8186470|NCT02321800|20185151|P1|Received Study Drug|Overall Study||300
8186471|NCT02321800|20185150|P2|STARTED|Overall Study||149
8186472|NCT02321800|20185151|P1|STARTED|Overall Study||303
8186473|NCT02321748|20185201|P2|NOT COMPLETED|Overall Study||0
8186474|NCT02321748|20185202|P1|NOT COMPLETED|Overall Study||0
8186475|NCT02321748|20185201|P2|COMPLETED|Overall Study||12
8186476|NCT02321748|20185202|P1|COMPLETED|Overall Study||12
8186477|NCT02321748|20185201|P2|Second Intervention (4 Days)|Overall Study||12
8186478|NCT02321748|20185202|P1|Second Intervention (4 Days)|Overall Study||12
8186479|NCT02321748|20185201|P2|Wasout (2weeks)|Overall Study||12
8186480|NCT02321748|20185202|P1|Wasout (2weeks)|Overall Study||12
8186481|NCT02321748|20185201|P2|First Intervention (4 Days)|Overall Study||12
8186482|NCT02321748|20185202|P1|First Intervention (4 Days)|Overall Study||12
8186483|NCT02321748|20185201|P2|STARTED|Overall Study||12
8186484|NCT02321748|20185202|P1|STARTED|Overall Study||12
8186485|NCT02321527|20185234|P1|NOT COMPLETED|Overall Study||1
8186486|NCT02321527|20185234|P1|COMPLETED|Overall Study||20
8186487|NCT02321527|20185234|P1|STARTED|Overall Study||21
8186488|NCT02321462|20185240|P2|NOT COMPLETED|Overall Study||3
8186489|NCT02321462|20185241|P1|NOT COMPLETED|Overall Study||6
8186490|NCT02321462|20185240|P2|COMPLETED|Overall Study||146
8186491|NCT02321462|20185241|P1|COMPLETED|Overall Study||141
8186492|NCT02321462|20185240|P2|Safety Population|Overall Study||147
8186493|NCT02321462|20185241|P1|Safety Population|Overall Study||147
8186494|NCT02321462|20185240|P2|Treated Patients|Overall Study||147
8186495|NCT02321462|20185241|P1|Treated Patients|Overall Study||147
8186496|NCT02321462|20185240|P2|ITT Population|Overall Study||148
8186497|NCT02321462|20185241|P1|ITT Population|Overall Study||146
8186498|NCT02321462|20185240|P2|STARTED|Overall Study||149
8186499|NCT02321462|20185241|P1|STARTED|Overall Study||147
8186500|NCT02321436|20185263|P2|NOT COMPLETED|Overall Study||1
8186501|NCT02321436|20185264|P1|NOT COMPLETED|Overall Study||1
8186502|NCT02321436|20185263|P2|COMPLETED|Overall Study||13
8186503|NCT02321436|20185264|P1|COMPLETED|Overall Study||27
8186504|NCT02321436|20185263|P2|STARTED|Overall Study||14
8186505|NCT02321436|20185264|P1|STARTED|Overall Study||28
8186506|NCT02321319|20185280|P1|NOT COMPLETED|Overall Study||5
8186507|NCT02321319|20185280|P1|COMPLETED|Overall Study||0
8186508|NCT02321319|20185280|P1|STARTED|Overall Study||5
8186509|NCT02321111|20185284|P6|NOT COMPLETED|Infusion3||0
8186510|NCT02321111|20185285|P5|NOT COMPLETED|Infusion3||0
8186511|NCT02321111|20185286|P4|NOT COMPLETED|Infusion3||0
8186512|NCT02321111|20185287|P3|NOT COMPLETED|Infusion3||0
8186513|NCT02321111|20185288|P2|NOT COMPLETED|Infusion3||0
8186514|NCT02321111|20185289|P1|NOT COMPLETED|Infusion3||0
8186515|NCT02321111|20185284|P6|COMPLETED|Infusion3||0
8186516|NCT02321111|20185285|P5|COMPLETED|Infusion3||0
8186517|NCT02321111|20185286|P4|COMPLETED|Infusion3||1
8186518|NCT02321111|20185287|P3|COMPLETED|Infusion3||4
8186519|NCT02321111|20185288|P2|COMPLETED|Infusion3||4
8186520|NCT02321111|20185289|P1|COMPLETED|Infusion3||1
8186521|NCT02321111|20185284|P6|STARTED|Infusion3||0
8186522|NCT02321111|20185285|P5|STARTED|Infusion3||0
8186523|NCT02321111|20185286|P4|STARTED|Infusion3||1
8186524|NCT02321111|20185287|P3|STARTED|Infusion3||4
8186525|NCT02321111|20185288|P2|STARTED|Infusion3||4
8186526|NCT02321111|20185289|P1|STARTED|Infusion3||1
8186527|NCT02321111|20185284|P6|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186528|NCT02321111|20185285|P5|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186529|NCT02321111|20185286|P4|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186530|NCT02321111|20185287|P3|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186531|NCT02321111|20185288|P2|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186532|NCT02321111|20185289|P1|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186533|NCT02321111|20185284|P6|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186534|NCT02321111|20185285|P5|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186535|NCT02321111|20185286|P4|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
8186536|NCT02321111|20185287|P3|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
8186537|NCT02321111|20185288|P2|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
8186538|NCT02321111|20185289|P1|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
8186539|NCT02321111|20185284|P6|STARTED|Washout2 (3-4weeks Between Infusions)||0
8186540|NCT02321111|20185285|P5|STARTED|Washout2 (3-4weeks Between Infusions)||0
8186541|NCT02321111|20185286|P4|STARTED|Washout2 (3-4weeks Between Infusions)||1
8186542|NCT02321111|20185287|P3|STARTED|Washout2 (3-4weeks Between Infusions)||4
8186543|NCT02321111|20185288|P2|STARTED|Washout2 (3-4weeks Between Infusions)||4
8186544|NCT02321111|20185289|P1|STARTED|Washout2 (3-4weeks Between Infusions)||1
8186545|NCT02321111|20185284|P6|NOT COMPLETED|Infusion2||0
8186546|NCT02321111|20185285|P5|NOT COMPLETED|Infusion2||0
8186547|NCT02321111|20185286|P4|NOT COMPLETED|Infusion2||0
8186548|NCT02321111|20185287|P3|NOT COMPLETED|Infusion2||0
8186549|NCT02321111|20185288|P2|NOT COMPLETED|Infusion2||0
8186550|NCT02321111|20185289|P1|NOT COMPLETED|Infusion2||0
8186551|NCT02321111|20185284|P6|COMPLETED|Infusion2||0
8186552|NCT02321111|20185285|P5|COMPLETED|Infusion2||0
8186553|NCT02321111|20185286|P4|COMPLETED|Infusion2||1
8186554|NCT02321111|20185287|P3|COMPLETED|Infusion2||4
8186555|NCT02321111|20185288|P2|COMPLETED|Infusion2||4
8186556|NCT02321111|20185289|P1|COMPLETED|Infusion2||1
8186557|NCT02321111|20185284|P6|STARTED|Infusion2||0
8186558|NCT02321111|20185285|P5|STARTED|Infusion2||0
8186559|NCT02321111|20185286|P4|STARTED|Infusion2||1
8186560|NCT02321111|20185287|P3|STARTED|Infusion2||4
8186561|NCT02321111|20185288|P2|STARTED|Infusion2||4
8186562|NCT02321111|20185289|P1|STARTED|Infusion2||1
8186563|NCT02321111|20185284|P6|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186564|NCT02321111|20185285|P5|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186565|NCT02321111|20185286|P4|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186566|NCT02321111|20185287|P3|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186567|NCT02321111|20185288|P2|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186568|NCT02321111|20185289|P1|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186569|NCT02321111|20185284|P6|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186570|NCT02321111|20185285|P5|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186571|NCT02321111|20185286|P4|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
8186572|NCT02321111|20185287|P3|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
8186573|NCT02321111|20185288|P2|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
8186574|NCT02321111|20185289|P1|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
8186575|NCT02321111|20185284|P6|STARTED|Washout1 (3-4weeks Between Infusions)||0
8186576|NCT02321111|20185285|P5|STARTED|Washout1 (3-4weeks Between Infusions)||0
8186577|NCT02321111|20185286|P4|STARTED|Washout1 (3-4weeks Between Infusions)||1
8186578|NCT02321111|20185287|P3|STARTED|Washout1 (3-4weeks Between Infusions)||4
8186579|NCT02321111|20185288|P2|STARTED|Washout1 (3-4weeks Between Infusions)||4
8186580|NCT02321111|20185289|P1|STARTED|Washout1 (3-4weeks Between Infusions)||1
8186581|NCT02321111|20185284|P6|NOT COMPLETED|Infusion1||0
8186582|NCT02321111|20185285|P5|NOT COMPLETED|Infusion1||0
8186583|NCT02321111|20185286|P4|NOT COMPLETED|Infusion1||0
8186584|NCT02321111|20185287|P3|NOT COMPLETED|Infusion1||0
8186585|NCT02321111|20185288|P2|NOT COMPLETED|Infusion1||0
8186586|NCT02321111|20185289|P1|NOT COMPLETED|Infusion1||0
8186587|NCT02321111|20185284|P6|COMPLETED|Infusion1||0
8186588|NCT02321111|20185285|P5|COMPLETED|Infusion1||0
8186589|NCT02321111|20185286|P4|COMPLETED|Infusion1||1
8186590|NCT02321111|20185287|P3|COMPLETED|Infusion1||4
8186591|NCT02321111|20185288|P2|COMPLETED|Infusion1||4
8186592|NCT02321111|20185289|P1|COMPLETED|Infusion1||1
8186593|NCT02321111|20185284|P6|STARTED|Infusion1||0
8186594|NCT02321111|20185285|P5|STARTED|Infusion1||0
8186595|NCT02321111|20185286|P4|STARTED|Infusion1||1
8186596|NCT02321111|20185287|P3|STARTED|Infusion1||4
8186597|NCT02321111|20185288|P2|STARTED|Infusion1||4
8186598|NCT02321111|20185289|P1|STARTED|Infusion1||1
8186599|NCT02321098|20185312|P3|NOT COMPLETED|Additional 15 Months Treatment||8
8186600|NCT02321098|20185313|P2|NOT COMPLETED|Additional 15 Months Treatment||0
8186601|NCT02321098|20185314|P1|NOT COMPLETED|Additional 15 Months Treatment||0
8186602|NCT02321098|20185312|P3|COMPLETED|Additional 15 Months Treatment||21
8186603|NCT02321098|20185313|P2|COMPLETED|Additional 15 Months Treatment||0
8186604|NCT02321098|20185314|P1|COMPLETED|Additional 15 Months Treatment||0
8186605|NCT02321098|20185312|P3|STARTED|Additional 15 Months Treatment||29
8186606|NCT02321098|20185313|P2|STARTED|Additional 15 Months Treatment||0
8186607|NCT02321098|20185314|P1|STARTED|Additional 15 Months Treatment||0
8186608|NCT02321098|20185312|P3|NOT COMPLETED|12 Weeks Treament||0
8186609|NCT02321098|20185313|P2|NOT COMPLETED|12 Weeks Treament||1
8186610|NCT02321098|20185314|P1|NOT COMPLETED|12 Weeks Treament||1
8186611|NCT02321098|20185312|P3|COMPLETED|12 Weeks Treament||0
8186612|NCT02321098|20185313|P2|COMPLETED|12 Weeks Treament||23
8186613|NCT02321098|20185314|P1|COMPLETED|12 Weeks Treament||25
8186614|NCT02321098|20185312|P3|STARTED|12 Weeks Treament||0
8186615|NCT02321098|20185313|P2|STARTED|12 Weeks Treament||24
8186616|NCT02321098|20185314|P1|STARTED|12 Weeks Treament||26
8186617|NCT02320903|20185326|P3|NOT COMPLETED|Overall Study||16
8186618|NCT02320903|20185327|P2|NOT COMPLETED|Overall Study||16
8186619|NCT02320903|20185328|P1|NOT COMPLETED|Overall Study||8
8186620|NCT02320903|20185326|P3|COMPLETED|Overall Study||16
8186621|NCT02320903|20185327|P2|COMPLETED|Overall Study||16
8186622|NCT02320903|20185328|P1|COMPLETED|Overall Study||16
8186623|NCT02320903|20185326|P3|STARTED|Overall Study||32
8186624|NCT02320903|20185327|P2|STARTED|Overall Study||32
8186625|NCT02320903|20185328|P1|STARTED|Overall Study||24
8186626|NCT02320838|20185361|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8186627|NCT02320838|20185362|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8186628|NCT02320838|20185363|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8186629|NCT02320838|20185364|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8186630|NCT02320838|20185365|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8186631|NCT02320838|20185361|P5|COMPLETED|Third Intervention (1 Day)||7
8186632|NCT02320838|20185362|P4|COMPLETED|Third Intervention (1 Day)||7
8186633|NCT02320838|20185363|P3|COMPLETED|Third Intervention (1 Day)||8
8186634|NCT02320838|20185364|P2|COMPLETED|Third Intervention (1 Day)||8
8186635|NCT02320838|20185365|P1|COMPLETED|Third Intervention (1 Day)||8
8186636|NCT02320838|20185361|P5|STARTED|Third Intervention (1 Day)||7
8186637|NCT02320838|20185362|P4|STARTED|Third Intervention (1 Day)||7
8186638|NCT02320838|20185363|P3|STARTED|Third Intervention (1 Day)||8
8186639|NCT02320838|20185364|P2|STARTED|Third Intervention (1 Day)||8
8186640|NCT02320838|20185365|P1|STARTED|Third Intervention (1 Day)||8
8186641|NCT02320838|20185361|P5|NOT COMPLETED|Washout (1 Day)||0
8186642|NCT02320838|20185362|P4|NOT COMPLETED|Washout (1 Day)||0
8186643|NCT02320838|20185363|P3|NOT COMPLETED|Washout (1 Day)||0
8186644|NCT02320838|20185364|P2|NOT COMPLETED|Washout (1 Day)||0
8186645|NCT02320838|20185365|P1|NOT COMPLETED|Washout (1 Day)||0
8186646|NCT02320838|20185361|P5|COMPLETED|Washout (1 Day)||7
8186647|NCT02320838|20185362|P4|COMPLETED|Washout (1 Day)||7
8186648|NCT02320838|20185363|P3|COMPLETED|Washout (1 Day)||8
8186649|NCT02320838|20185364|P2|COMPLETED|Washout (1 Day)||8
8186650|NCT02320838|20185365|P1|COMPLETED|Washout (1 Day)||8
8186651|NCT02320838|20185361|P5|STARTED|Washout (1 Day)||7
8186652|NCT02320838|20185362|P4|STARTED|Washout (1 Day)||7
8186653|NCT02320838|20185363|P3|STARTED|Washout (1 Day)||8
8186654|NCT02320838|20185364|P2|STARTED|Washout (1 Day)||8
8186655|NCT02320838|20185365|P1|STARTED|Washout (1 Day)||8
8186656|NCT02320838|20185361|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8186657|NCT02320838|20185362|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8186658|NCT02320838|20185363|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8186659|NCT02320838|20185364|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8186660|NCT02320838|20185365|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8186661|NCT02320838|20185361|P5|COMPLETED|Second Intervention (1 Day)||7
8186662|NCT02320838|20185362|P4|COMPLETED|Second Intervention (1 Day)||7
8186663|NCT02320838|20185363|P3|COMPLETED|Second Intervention (1 Day)||8
8186664|NCT02320838|20185364|P2|COMPLETED|Second Intervention (1 Day)||8
8186665|NCT02320838|20185365|P1|COMPLETED|Second Intervention (1 Day)||8
8186666|NCT02320838|20185361|P5|STARTED|Second Intervention (1 Day)||7
8186667|NCT02320838|20185362|P4|STARTED|Second Intervention (1 Day)||7
8186668|NCT02320838|20185363|P3|STARTED|Second Intervention (1 Day)||8
8186669|NCT02320838|20185364|P2|STARTED|Second Intervention (1 Day)||8
8186670|NCT02320838|20185365|P1|STARTED|Second Intervention (1 Day)||8
8186671|NCT02320838|20185361|P5|NOT COMPLETED|Washout (1 Day)||0
8186672|NCT02320838|20185362|P4|NOT COMPLETED|Washout (1 Day)||0
8186673|NCT02320838|20185363|P3|NOT COMPLETED|Washout (1 Day)||0
8186674|NCT02320838|20185364|P2|NOT COMPLETED|Washout (1 Day)||0
8186675|NCT02320838|20185365|P1|NOT COMPLETED|Washout (1 Day)||0
8186676|NCT02320838|20185361|P5|COMPLETED|Washout (1 Day)||7
8186677|NCT02320838|20185362|P4|COMPLETED|Washout (1 Day)||7
8186678|NCT02320838|20185363|P3|COMPLETED|Washout (1 Day)||8
8186679|NCT02320838|20185364|P2|COMPLETED|Washout (1 Day)||8
8186680|NCT02320838|20185365|P1|COMPLETED|Washout (1 Day)||8
8186681|NCT02320838|20185361|P5|STARTED|Washout (1 Day)||7
8186682|NCT02320838|20185362|P4|STARTED|Washout (1 Day)||7
8186683|NCT02320838|20185363|P3|STARTED|Washout (1 Day)||8
8186684|NCT02320838|20185364|P2|STARTED|Washout (1 Day)||8
8186685|NCT02320838|20185365|P1|STARTED|Washout (1 Day)||8
8186686|NCT02320838|20185361|P5|NOT COMPLETED|First Intervention (1 Day)||0
8186687|NCT02320838|20185362|P4|NOT COMPLETED|First Intervention (1 Day)||0
8186688|NCT02320838|20185363|P3|NOT COMPLETED|First Intervention (1 Day)||0
8186689|NCT02320838|20185364|P2|NOT COMPLETED|First Intervention (1 Day)||0
8186690|NCT02320838|20185365|P1|NOT COMPLETED|First Intervention (1 Day)||0
8186691|NCT02320838|20185361|P5|COMPLETED|First Intervention (1 Day)||7
8186692|NCT02320838|20185362|P4|COMPLETED|First Intervention (1 Day)||7
8186693|NCT02320838|20185363|P3|COMPLETED|First Intervention (1 Day)||8
8186694|NCT02320838|20185364|P2|COMPLETED|First Intervention (1 Day)||8
8186695|NCT02320838|20185365|P1|COMPLETED|First Intervention (1 Day)||8
8186696|NCT02320838|20185361|P5|STARTED|First Intervention (1 Day)||7
8186697|NCT02320838|20185362|P4|STARTED|First Intervention (1 Day)||7
8186698|NCT02320838|20185363|P3|STARTED|First Intervention (1 Day)||8
8186699|NCT02320838|20185364|P2|STARTED|First Intervention (1 Day)||8
8186700|NCT02320838|20185365|P1|STARTED|First Intervention (1 Day)||8
8186701|NCT02320825|20185432|P2|NOT COMPLETED|Overall Study||0
8186702|NCT02320825|20185433|P1|NOT COMPLETED|Overall Study||0
8186703|NCT02320825|20185432|P2|COMPLETED|Overall Study||8
8186704|NCT02320825|20185433|P1|COMPLETED|Overall Study||8
8186705|NCT02320825|20185432|P2|STARTED|Overall Study||8
8186706|NCT02320825|20185433|P1|STARTED|Overall Study||8
8186707|NCT02320812|20185443|P1|NOT COMPLETED|Overall Study||0
8186708|NCT02320812|20185443|P1|COMPLETED|Overall Study||28
8186709|NCT02320812|20185443|P1|STARTED|Overall Study||28
8186710|NCT02320721|20185453|P2|NOT COMPLETED|Overall Study||34
8186711|NCT02320721|20185454|P1|NOT COMPLETED|Overall Study||27
8186712|NCT02320721|20185453|P2|COMPLETED|Overall Study||472
8186713|NCT02320721|20185454|P1|COMPLETED|Overall Study||481
8186714|NCT02320721|20185453|P2|Treated (Safety Population)|Overall Study||505
8186715|NCT02320721|20185454|P1|Treated (Safety Population)|Overall Study||508
8186716|NCT02320721|20185453|P2|STARTED|Overall Study||506
8186717|NCT02320721|20185454|P1|STARTED|Overall Study||508
8186718|NCT02320695|20185482|P1|NOT COMPLETED|Overall Study||0
8186719|NCT02320695|20185482|P1|COMPLETED|Overall Study||60
8186720|NCT02320695|20185482|P1|Pain Relief Ointment|Overall Study||60
8186721|NCT02320695|20185482|P1|Original Ointment|Overall Study||60
8186722|NCT02320695|20185482|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
8186723|NCT02320695|20185482|P1|Pain Relieving Cream|Overall Study||59
8186724|NCT02320695|20185482|P1|Alcohol|Overall Study||60
8186725|NCT02320695|20185482|P1|Saline|Overall Study||60
8186726|NCT02320695|20185482|P1|STARTED|Overall Study||60
8186727|NCT02320487|20185509|P1|NOT COMPLETED|Overall Study||21
8186821|NCT02319668|20185823|P2|COMPLETED|Overall Study||17
8186728|NCT02320487|20185509|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
8186729|NCT02320487|20185509|P1|STARTED|Overall Study||102
8186730|NCT02320396|20185529|P2|NOT COMPLETED|Overall Study||4
8186731|NCT02320396|20185530|P1|NOT COMPLETED|Overall Study||4
8186732|NCT02320396|20185529|P2|COMPLETED|Overall Study||221
8186733|NCT02320396|20185530|P1|COMPLETED|Overall Study||220
8186734|NCT02320396|20185529|P2|Treated (Full Analysis Set)|Overall Study||225
8186735|NCT02320396|20185530|P1|Treated (Full Analysis Set)|Overall Study||223
8186736|NCT02320396|20185529|P2|STARTED|Overall Study||225
8186737|NCT02320396|20185530|P1|STARTED|Overall Study||224
8186738|NCT02320227|20185560|P1|NOT COMPLETED|Overall Study||0
8186739|NCT02320227|20185560|P1|COMPLETED|Overall Study||30
8186740|NCT02320227|20185560|P1|STARTED|Overall Study||30
8186741|NCT02320214|20185565|P1|NOT COMPLETED|Overall Study||0
8186742|NCT02320214|20185565|P1|COMPLETED|Overall Study||30
8186743|NCT02320214|20185565|P1|STARTED|Overall Study||30
8186744|NCT02320175|20185572|P2|NOT COMPLETED|Overall Study||0
8186745|NCT02320175|20185573|P1|NOT COMPLETED|Overall Study||0
8186746|NCT02320175|20185572|P2|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
8186747|NCT02320175|20185573|P1|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
8186748|NCT02320175|20185572|P2|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
8186749|NCT02320175|20185573|P1|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
8186750|NCT02320149|20185589|P2|NOT COMPLETED|Overall Study||80
8186751|NCT02320149|20185590|P1|NOT COMPLETED|Overall Study||63
8186752|NCT02320149|20185589|P2|COMPLETED|Overall Study||405
8186753|NCT02320149|20185590|P1|COMPLETED|Overall Study||420
8186754|NCT02320149|20185589|P2|STARTED|Overall Study||485
8186755|NCT02320149|20185590|P1|STARTED|Overall Study||483
8186756|NCT02320123|20185630|P2|NOT COMPLETED|Overall Study||11
8186757|NCT02320123|20185631|P1|NOT COMPLETED|Overall Study||10
8186758|NCT02320123|20185630|P2|COMPLETED|Overall Study||1
8186759|NCT02320123|20185631|P1|COMPLETED|Overall Study||0
8186760|NCT02320123|20185630|P2|STARTED|Overall Study||12
8186761|NCT02320123|20185631|P1|STARTED|Overall Study||10
8186762|NCT02319967|20185656|P3|NOT COMPLETED|Overall Study||45
8186763|NCT02319967|20185657|P2|NOT COMPLETED|Overall Study||44
8186764|NCT02319967|20185658|P1|NOT COMPLETED|Overall Study||48
8186765|NCT02319967|20185656|P3|COMPLETED|Overall Study||76
8186766|NCT02319967|20185657|P2|COMPLETED|Overall Study||82
8186767|NCT02319967|20185658|P1|COMPLETED|Overall Study||78
8186768|NCT02319967|20185656|P3|STARTED|Overall Study||121
8186769|NCT02319967|20185657|P2|STARTED|Overall Study||126
8186770|NCT02319967|20185658|P1|STARTED|Overall Study||126
8186771|NCT02319824|20185714|P1|NOT COMPLETED|Overall Study||0
8186772|NCT02319824|20185714|P1|COMPLETED|Overall Study||2
8186773|NCT02319824|20185714|P1|STARTED|Overall Study||2
8186774|NCT02319759|20185722|P5|NOT COMPLETED|Week 24 - 56||2
8186775|NCT02319759|20185723|P4|NOT COMPLETED|Week 24 - 56||2
8186776|NCT02319759|20185724|P3|NOT COMPLETED|Week 24 - 56||2
8186777|NCT02319759|20185725|P2|NOT COMPLETED|Week 24 - 56||1
8186778|NCT02319759|20185726|P1|NOT COMPLETED|Week 24 - 56||0
8186779|NCT02319759|20185722|P5|COMPLETED|Week 24 - 56||8
8186780|NCT02319759|20185723|P4|COMPLETED|Week 24 - 56||15
8186781|NCT02319759|20185724|P3|COMPLETED|Week 24 - 56||84
8186782|NCT02319759|20185725|P2|COMPLETED|Week 24 - 56||28
8186783|NCT02319759|20185726|P1|COMPLETED|Week 24 - 56||0
8186784|NCT02319759|20185722|P5|STARTED|Week 24 - 56||10
8186785|NCT02319759|20185723|P4|STARTED|Week 24 - 56||17
8186786|NCT02319759|20185724|P3|STARTED|Week 24 - 56||86
8186787|NCT02319759|20185725|P2|STARTED|Week 24 - 56||29
8186788|NCT02319759|20185726|P1|STARTED|Week 24 - 56||0
8186789|NCT02319759|20185722|P5|NOT COMPLETED|Week 16 - 24||0
8186790|NCT02319759|20185723|P4|NOT COMPLETED|Week 16 - 24||0
8186791|NCT02319759|20185724|P3|NOT COMPLETED|Week 16 - 24||3
8186792|NCT02319759|20185725|P2|NOT COMPLETED|Week 16 - 24||0
8186793|NCT02319759|20185726|P1|NOT COMPLETED|Week 16 - 24||2
8186794|NCT02319759|20185722|P5|COMPLETED|Week 16 - 24||10
8186795|NCT02319759|20185723|P4|COMPLETED|Week 16 - 24||17
8186796|NCT02319759|20185724|P3|COMPLETED|Week 16 - 24||86
8186797|NCT02319759|20185725|P2|COMPLETED|Week 16 - 24||0
8186798|NCT02319759|20185726|P1|COMPLETED|Week 16 - 24||29
8186799|NCT02319759|20185722|P5|STARTED|Week 16 - 24||10
8186800|NCT02319759|20185723|P4|STARTED|Week 16 - 24||17
8186801|NCT02319759|20185724|P3|STARTED|Week 16 - 24||89
8186802|NCT02319759|20185725|P2|STARTED|Week 16 - 24||0
8186803|NCT02319759|20185726|P1|STARTED|Week 16 - 24||31
8186804|NCT02319759|20185722|P5|NOT COMPLETED|Week 0 - 16||0
8186805|NCT02319759|20185723|P4|NOT COMPLETED|Week 0 - 16||0
8186806|NCT02319759|20185724|P3|NOT COMPLETED|Week 0 - 16||1
8186807|NCT02319759|20185725|P2|NOT COMPLETED|Week 0 - 16||0
8186808|NCT02319759|20185726|P1|NOT COMPLETED|Week 0 - 16||1
8186809|NCT02319759|20185722|P5|COMPLETED|Week 0 - 16||0
8186810|NCT02319759|20185723|P4|COMPLETED|Week 0 - 16||0
8186811|NCT02319759|20185724|P3|COMPLETED|Week 0 - 16||99
8186812|NCT02319759|20185725|P2|COMPLETED|Week 0 - 16||0
8186813|NCT02319759|20185726|P1|COMPLETED|Week 0 - 16||48
8186814|NCT02319759|20185722|P5|STARTED|Week 0 - 16||0
8186815|NCT02319759|20185723|P4|STARTED|Week 0 - 16||0
8186816|NCT02319759|20185724|P3|STARTED|Week 0 - 16||100
8186817|NCT02319759|20185725|P2|STARTED|Week 0 - 16||0
8186818|NCT02319759|20185726|P1|STARTED|Week 0 - 16||49
8186819|NCT02319668|20185823|P2|NOT COMPLETED|Overall Study||2
8186820|NCT02319668|20185824|P1|NOT COMPLETED|Overall Study||0
8186822|NCT02319668|20185824|P1|COMPLETED|Overall Study||19
8186823|NCT02319668|20185823|P2|STARTED|Overall Study||19
8186824|NCT02319668|20185824|P1|STARTED|Overall Study||19
8186825|NCT02319642|20185838|P2|NOT COMPLETED|Overall Study||6
8186826|NCT02319642|20185839|P1|NOT COMPLETED|Overall Study||4
8186827|NCT02319642|20185838|P2|COMPLETED|Overall Study||245
8186828|NCT02319642|20185839|P1|COMPLETED|Overall Study||91
8186829|NCT02319642|20185838|P2|STARTED|Overall Study||251
8186830|NCT02319642|20185839|P1|STARTED|Overall Study||95
8186831|NCT02319525|20185859|P2|NOT COMPLETED|Overall Study||1
8186832|NCT02319525|20185860|P1|NOT COMPLETED|Overall Study||2
8186833|NCT02319525|20185859|P2|COMPLETED|Overall Study||147
8186834|NCT02319525|20185860|P1|COMPLETED|Overall Study||151
8186835|NCT02319525|20185859|P2|Primary Research Completion|Overall Study||147
8186836|NCT02319525|20185860|P1|Primary Research Completion|Overall Study||151
8186837|NCT02319525|20185859|P2|STARTED|Overall Study||148
8186838|NCT02319525|20185860|P1|STARTED|Overall Study||153
8186839|NCT02319486|20185878|P1|NOT COMPLETED|Overall Study||0
8186840|NCT02319486|20185878|P1|COMPLETED|Overall Study||26
8186841|NCT02319486|20185878|P1|STARTED|Overall Study||26
8186842|NCT02319317|20185886|P2|NOT COMPLETED|Overall Study||0
8186843|NCT02319317|20185887|P1|NOT COMPLETED|Overall Study||0
8186844|NCT02319317|20185886|P2|COMPLETED|Overall Study||29
8186845|NCT02319317|20185887|P1|COMPLETED|Overall Study||31
8186846|NCT02319317|20185886|P2|STARTED|Overall Study||29
8186847|NCT02319317|20185887|P1|STARTED|Overall Study||31
8186848|NCT02319174|20185893|P1|NOT COMPLETED|Overall Study||1
8186849|NCT02319174|20185893|P1|COMPLETED|Overall Study||42
8186850|NCT02319174|20185893|P1|STARTED|Overall Study||43
8186851|NCT02319148|20185902|P4|NOT COMPLETED|Second Intervention Period||2
8186852|NCT02319148|20185903|P3|NOT COMPLETED|Second Intervention Period||1
8186853|NCT02319148|20185904|P2|NOT COMPLETED|Second Intervention Period||1
8186854|NCT02319148|20185905|P1|NOT COMPLETED|Second Intervention Period||0
8186855|NCT02319148|20185902|P4|COMPLETED|Second Intervention Period||6
8186856|NCT02319148|20185903|P3|COMPLETED|Second Intervention Period||6
8186857|NCT02319148|20185904|P2|COMPLETED|Second Intervention Period||6
8186858|NCT02319148|20185905|P1|COMPLETED|Second Intervention Period||0
8186859|NCT02319148|20185902|P4|STARTED|Second Intervention Period||8
8186860|NCT02319148|20185903|P3|STARTED|Second Intervention Period||7
8186861|NCT02319148|20185904|P2|STARTED|Second Intervention Period||7
8186862|NCT02319148|20185905|P1|STARTED|Second Intervention Period||0
8186863|NCT02319148|20185902|P4|NOT COMPLETED|Washout Period 4 Days||0
8186864|NCT02319148|20185903|P3|NOT COMPLETED|Washout Period 4 Days||0
8186865|NCT02319148|20185904|P2|NOT COMPLETED|Washout Period 4 Days||0
8186866|NCT02319148|20185905|P1|NOT COMPLETED|Washout Period 4 Days||0
8186867|NCT02319148|20185902|P4|COMPLETED|Washout Period 4 Days||0
8186868|NCT02319148|20185903|P3|COMPLETED|Washout Period 4 Days||0
8186869|NCT02319148|20185904|P2|COMPLETED|Washout Period 4 Days||0
8186870|NCT02319148|20185905|P1|COMPLETED|Washout Period 4 Days||22
8186871|NCT02319148|20185902|P4|STARTED|Washout Period 4 Days||0
8186872|NCT02319148|20185903|P3|STARTED|Washout Period 4 Days||0
8186873|NCT02319148|20185904|P2|STARTED|Washout Period 4 Days||0
8186874|NCT02319148|20185905|P1|STARTED|Washout Period 4 Days||22
8186875|NCT02319148|20185902|P4|NOT COMPLETED|First Intervention Period||0
8186876|NCT02319148|20185903|P3|NOT COMPLETED|First Intervention Period||0
8186877|NCT02319148|20185904|P2|NOT COMPLETED|First Intervention Period||0
8186878|NCT02319148|20185905|P1|NOT COMPLETED|First Intervention Period||0
8186879|NCT02319148|20185902|P4|COMPLETED|First Intervention Period||0
8186880|NCT02319148|20185903|P3|COMPLETED|First Intervention Period||0
8186881|NCT02319148|20185904|P2|COMPLETED|First Intervention Period||0
8186882|NCT02319148|20185905|P1|COMPLETED|First Intervention Period||22
8186883|NCT02319148|20185902|P4|STARTED|First Intervention Period||0
8186884|NCT02319148|20185903|P3|STARTED|First Intervention Period||0
8186885|NCT02319148|20185904|P2|STARTED|First Intervention Period||0
8186886|NCT02319148|20185905|P1|STARTED|First Intervention Period||22
8186887|NCT02319044|20185968|P3|NOT COMPLETED|Overall Study||67
8186888|NCT02319044|20185969|P2|NOT COMPLETED|Overall Study||60
8186889|NCT02319044|20185970|P1|NOT COMPLETED|Overall Study||122
8186890|NCT02319044|20185968|P3|COMPLETED|Overall Study||0
8186891|NCT02319044|20185969|P2|COMPLETED|Overall Study||7
8186892|NCT02319044|20185970|P1|COMPLETED|Overall Study||11
8186893|NCT02319044|20185968|P3|STARTED|Overall Study||67
8186894|NCT02319044|20185969|P2|STARTED|Overall Study||67
8186895|NCT02319044|20185970|P1|STARTED|Overall Study||133
8186896|NCT02319031|20186026|P2|NOT COMPLETED|Follow-Up Period||0
8186897|NCT02319031|20186027|P1|NOT COMPLETED|Follow-Up Period||0
8186898|NCT02319031|20186026|P2|COMPLETED|Follow-Up Period||26
8186899|NCT02319031|20186027|P1|COMPLETED|Follow-Up Period||23
8186900|NCT02319031|20186026|P2|STARTED|Follow-Up Period||26
8186901|NCT02319031|20186027|P1|STARTED|Follow-Up Period||23
8186902|NCT02319031|20186026|P2|NOT COMPLETED|Treatment Period||0
8186903|NCT02319031|20186027|P1|NOT COMPLETED|Treatment Period||1
8186904|NCT02319031|20186026|P2|COMPLETED|Treatment Period||26
8186905|NCT02319031|20186027|P1|COMPLETED|Treatment Period||23
8186906|NCT02319031|20186026|P2|STARTED|Treatment Period||26
8186907|NCT02319031|20186027|P1|STARTED|Treatment Period||24
8186908|NCT02319005|20186039|P2|NOT COMPLETED|Overall Study||15
8186909|NCT02319005|20186040|P1|NOT COMPLETED|Overall Study||48
8186910|NCT02319005|20186039|P2|COMPLETED|Overall Study||51
8186911|NCT02319005|20186040|P1|COMPLETED|Overall Study||92
8186912|NCT02319005|20186039|P2|STARTED|Overall Study||66
8186913|NCT02319005|20186040|P1|STARTED|Overall Study||140
8186914|NCT02318992|20186063|P3|NOT COMPLETED|Overall Study||4
8186915|NCT02318992|20186064|P2|NOT COMPLETED|Overall Study||2
8186916|NCT02318992|20186065|P1|NOT COMPLETED|Overall Study||2
8186917|NCT02318992|20186063|P3|COMPLETED|Overall Study||20
8186918|NCT02318992|20186064|P2|COMPLETED|Overall Study||25
8186919|NCT02318992|20186065|P1|COMPLETED|Overall Study||25
8186920|NCT02318992|20186063|P3|STARTED|Overall Study||24
8186921|NCT02318992|20186064|P2|STARTED|Overall Study||27
8186922|NCT02318992|20186065|P1|STARTED|Overall Study||27
8186923|NCT02318979|20186078|P2|NOT COMPLETED|Overall Study||0
8186924|NCT02318979|20186079|P1|NOT COMPLETED|Overall Study||0
8186925|NCT02318979|20186078|P2|COMPLETED|Overall Study||15
8186926|NCT02318979|20186079|P1|COMPLETED|Overall Study||15
8186927|NCT02318979|20186078|P2|STARTED|Overall Study||15
8186928|NCT02318979|20186079|P1|STARTED|Overall Study||15
8186929|NCT02318940|20186091|P2|NOT COMPLETED|Overall Study||0
8186930|NCT02318940|20186092|P1|NOT COMPLETED|Overall Study||1
8186931|NCT02318940|20186091|P2|COMPLETED|Overall Study||50
8186932|NCT02318940|20186092|P1|COMPLETED|Overall Study||49
8186933|NCT02318940|20186091|P2|STARTED|Overall Study||50
8186934|NCT02318940|20186092|P1|STARTED|Overall Study|in the last patient we lost the record.|50
8186935|NCT02318901|20186107|P3|NOT COMPLETED|Overall Study||10
8186936|NCT02318901|20186108|P2|NOT COMPLETED|Overall Study||1
8186937|NCT02318901|20186109|P1|NOT COMPLETED|Overall Study||5
8186938|NCT02318901|20186107|P3|COMPLETED|Overall Study||0
8186939|NCT02318901|20186108|P2|COMPLETED|Overall Study||0
8186940|NCT02318901|20186109|P1|COMPLETED|Overall Study||0
8186941|NCT02318901|20186107|P3|STARTED|Overall Study||10
8186942|NCT02318901|20186108|P2|STARTED|Overall Study||1
8186943|NCT02318901|20186109|P1|STARTED|Overall Study||5
8186944|NCT02318797|20186134|P2|NOT COMPLETED|Overall Study||102
8186945|NCT02318797|20186135|P1|NOT COMPLETED|Overall Study||88
8186946|NCT02318797|20186134|P2|COMPLETED|Overall Study||611
8186947|NCT02318797|20186135|P1|COMPLETED|Overall Study||428
8186948|NCT02318797|20186134|P2|STARTED|Overall Study||713
8186949|NCT02318797|20186135|P1|STARTED|Overall Study||516
8186950|NCT02318719|20186177|P5|NOT COMPLETED|Open-label Extension Phase||55
8186951|NCT02318719|20186178|P4|NOT COMPLETED|Open-label Extension Phase||0
8186952|NCT02318719|20186179|P3|NOT COMPLETED|Open-label Extension Phase||0
8186953|NCT02318719|20186180|P2|NOT COMPLETED|Open-label Extension Phase||0
8186954|NCT02318719|20186181|P1|NOT COMPLETED|Open-label Extension Phase||0
8186955|NCT02318719|20186177|P5|COMPLETED|Open-label Extension Phase||184
8186956|NCT02318719|20186178|P4|COMPLETED|Open-label Extension Phase||0
8186957|NCT02318719|20186179|P3|COMPLETED|Open-label Extension Phase||0
8186958|NCT02318719|20186180|P2|COMPLETED|Open-label Extension Phase||0
8186959|NCT02318719|20186181|P1|COMPLETED|Open-label Extension Phase||0
8186960|NCT02318719|20186177|P5|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
8186961|NCT02318719|20186178|P4|STARTED|Open-label Extension Phase||0
8186962|NCT02318719|20186179|P3|STARTED|Open-label Extension Phase||0
8186963|NCT02318719|20186180|P2|STARTED|Open-label Extension Phase||0
8186964|NCT02318719|20186181|P1|STARTED|Open-label Extension Phase||0
8186965|NCT02318719|20186177|P5|NOT COMPLETED|Double-blind Phase||0
8186966|NCT02318719|20186178|P4|NOT COMPLETED|Double-blind Phase||15
8186967|NCT02318719|20186179|P3|NOT COMPLETED|Double-blind Phase||25
8186968|NCT02318719|20186180|P2|NOT COMPLETED|Double-blind Phase||16
8186969|NCT02318719|20186181|P1|NOT COMPLETED|Double-blind Phase||38
8186970|NCT02318719|20186177|P5|COMPLETED|Double-blind Phase||0
8186971|NCT02318719|20186178|P4|COMPLETED|Double-blind Phase||140
8186972|NCT02318719|20186179|P3|COMPLETED|Double-blind Phase||128
8186973|NCT02318719|20186180|P2|COMPLETED|Double-blind Phase||137
8186974|NCT02318719|20186181|P1|COMPLETED|Double-blind Phase||266
8186975|NCT02318719|20186177|P5|Did Not Receive Treatment|Double-blind Phase||0
8186976|NCT02318719|20186178|P4|Did Not Receive Treatment|Double-blind Phase||0
8186977|NCT02318719|20186179|P3|Did Not Receive Treatment|Double-blind Phase||0
8186978|NCT02318719|20186180|P2|Did Not Receive Treatment|Double-blind Phase||1
8186979|NCT02318719|20186181|P1|Did Not Receive Treatment|Double-blind Phase||1
8186980|NCT02318719|20186177|P5|STARTED|Double-blind Phase||0
8186981|NCT02318719|20186178|P4|STARTED|Double-blind Phase||155
8186982|NCT02318719|20186179|P3|STARTED|Double-blind Phase||153
8186983|NCT02318719|20186180|P2|STARTED|Double-blind Phase||153
8186984|NCT02318719|20186181|P1|STARTED|Double-blind Phase||304
8186985|NCT02318706|20186197|P5|NOT COMPLETED|Open-label Extension Phase||42
8186986|NCT02318706|20186198|P4|NOT COMPLETED|Open-label Extension Phase||0
8186987|NCT02318706|20186199|P3|NOT COMPLETED|Open-label Extension Phase||0
8186988|NCT02318706|20186200|P2|NOT COMPLETED|Open-label Extension Phase||0
8186989|NCT02318706|20186201|P1|NOT COMPLETED|Open-label Extension Phase||0
8186990|NCT02318706|20186197|P5|COMPLETED|Open-label Extension Phase||172
8186991|NCT02318706|20186198|P4|COMPLETED|Open-label Extension Phase||0
8186992|NCT02318706|20186199|P3|COMPLETED|Open-label Extension Phase||0
8186993|NCT02318706|20186200|P2|COMPLETED|Open-label Extension Phase||0
8186994|NCT02318706|20186201|P1|COMPLETED|Open-label Extension Phase||0
8186995|NCT02318706|20186197|P5|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
8186996|NCT02318706|20186198|P4|STARTED|Open-label Extension Phase||0
8186997|NCT02318706|20186199|P3|STARTED|Open-label Extension Phase||0
8186998|NCT02318706|20186200|P2|STARTED|Open-label Extension Phase||0
8186999|NCT02318706|20186201|P1|STARTED|Open-label Extension Phase||0
8187000|NCT02318706|20186197|P5|NOT COMPLETED|Double-blind Phase||0
8187001|NCT02318706|20186198|P4|NOT COMPLETED|Double-blind Phase||24
8187002|NCT02318706|20186199|P3|NOT COMPLETED|Double-blind Phase||18
8187003|NCT02318706|20186200|P2|NOT COMPLETED|Double-blind Phase||12
8187004|NCT02318706|20186201|P1|NOT COMPLETED|Double-blind Phase||25
8187005|NCT02318706|20186197|P5|COMPLETED|Double-blind Phase||0
8187006|NCT02318706|20186198|P4|COMPLETED|Double-blind Phase||142
8187007|NCT02318706|20186199|P3|COMPLETED|Double-blind Phase||150
8187008|NCT02318706|20186200|P2|COMPLETED|Double-blind Phase||154
8187009|NCT02318706|20186201|P1|COMPLETED|Double-blind Phase||309
8187010|NCT02318706|20186197|P5|STARTED|Double-blind Phase||0
8187011|NCT02318706|20186198|P4|STARTED|Double-blind Phase||166
8187012|NCT02318706|20186199|P3|STARTED|Double-blind Phase||168
8187013|NCT02318706|20186200|P2|STARTED|Double-blind Phase||166
8187014|NCT02318706|20186201|P1|STARTED|Double-blind Phase||334
8187015|NCT02318693|20186215|P2|NOT COMPLETED|Overall Study||1
8187016|NCT02318693|20186216|P1|NOT COMPLETED|Overall Study||0
8187017|NCT02318693|20186215|P2|COMPLETED|Overall Study||26
8187018|NCT02318693|20186216|P1|COMPLETED|Overall Study||26
8187019|NCT02318693|20186215|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
8187020|NCT02318693|20186216|P1|Treated|Overall Study||26
8187021|NCT02318693|20186215|P2|STARTED|Overall Study||27
8187022|NCT02318693|20186216|P1|STARTED|Overall Study||26
8187023|NCT02318667|20186230|P1|NOT COMPLETED|Overall Study||9
8187024|NCT02318667|20186230|P1|COMPLETED|Overall Study||29
8187025|NCT02318667|20186230|P1|STARTED|Overall Study||38
8187026|NCT02318602|20186249|P3|NOT COMPLETED|Overall Study||2
8187027|NCT02318602|20186250|P2|NOT COMPLETED|Overall Study||4
8187028|NCT02318602|20186251|P1|NOT COMPLETED|Overall Study||1
8187029|NCT02318602|20186249|P3|COMPLETED|Overall Study||15
8187030|NCT02318602|20186250|P2|COMPLETED|Overall Study||22
8187031|NCT02318602|20186251|P1|COMPLETED|Overall Study||8
8187032|NCT02318602|20186249|P3|STARTED|Overall Study||17
8187033|NCT02318602|20186250|P2|STARTED|Overall Study||26
8187034|NCT02318602|20186251|P1|STARTED|Overall Study||9
8187035|NCT02318368|20186284|P2|NOT COMPLETED|Overall Study||3
8187036|NCT02318368|20186285|P1|NOT COMPLETED|Overall Study||7
8187037|NCT02318368|20186284|P2|COMPLETED|Overall Study||0
8187038|NCT02318368|20186285|P1|COMPLETED|Overall Study||0
8187039|NCT02318368|20186284|P2|STARTED|Overall Study||3
8187040|NCT02318368|20186285|P1|STARTED|Overall Study||7
8187041|NCT02318329|20186303|P10|NOT COMPLETED|Overall Study||52
8187042|NCT02318329|20186304|P9|NOT COMPLETED|Overall Study||6
8187043|NCT02318329|20186305|P8|NOT COMPLETED|Overall Study||1
8187044|NCT02318329|20186306|P7|NOT COMPLETED|Overall Study||1
8187045|NCT02318329|20186307|P6|NOT COMPLETED|Overall Study||3
8187046|NCT02318329|20186308|P5|NOT COMPLETED|Overall Study||3
8187047|NCT02318329|20186309|P4|NOT COMPLETED|Overall Study||3
8187048|NCT02318329|20186310|P3|NOT COMPLETED|Overall Study||3
8187049|NCT02318329|20186311|P2|NOT COMPLETED|Overall Study||4
8187050|NCT02318329|20186312|P1|NOT COMPLETED|Overall Study||3
8187051|NCT02318329|20186303|P10|COMPLETED|Overall Study||0
8187052|NCT02318329|20186304|P9|COMPLETED|Overall Study||0
8187053|NCT02318329|20186305|P8|COMPLETED|Overall Study||0
8187054|NCT02318329|20186306|P7|COMPLETED|Overall Study||0
8187055|NCT02318329|20186307|P6|COMPLETED|Overall Study||0
8187056|NCT02318329|20186308|P5|COMPLETED|Overall Study||0
8187057|NCT02318329|20186309|P4|COMPLETED|Overall Study||0
8187058|NCT02318329|20186310|P3|COMPLETED|Overall Study||0
8187059|NCT02318329|20186311|P2|COMPLETED|Overall Study||0
8187060|NCT02318329|20186312|P1|COMPLETED|Overall Study||0
8187061|NCT02318329|20186303|P10|STARTED|Overall Study||52
8187062|NCT02318329|20186304|P9|STARTED|Overall Study||6
8187063|NCT02318329|20186305|P8|STARTED|Overall Study||1
8187064|NCT02318329|20186306|P7|STARTED|Overall Study||1
8187065|NCT02318329|20186307|P6|STARTED|Overall Study||3
8187066|NCT02318329|20186308|P5|STARTED|Overall Study||3
8187067|NCT02318329|20186309|P4|STARTED|Overall Study||3
8187068|NCT02318329|20186310|P3|STARTED|Overall Study||3
8187069|NCT02318329|20186311|P2|STARTED|Overall Study||4
8187070|NCT02318329|20186312|P1|STARTED|Overall Study||3
8187071|NCT02318303|20186375|P7|NOT COMPLETED|Overall Study||2
8187072|NCT02318303|20186376|P6|NOT COMPLETED|Overall Study||6
8187073|NCT02318303|20186377|P5|NOT COMPLETED|Overall Study||5
8187074|NCT02318303|20186378|P4|NOT COMPLETED|Overall Study||3
8187075|NCT02318303|20186379|P3|NOT COMPLETED|Overall Study||3
8187076|NCT02318303|20186380|P2|NOT COMPLETED|Overall Study||3
8187077|NCT02318303|20186381|P1|NOT COMPLETED|Overall Study||4
8187078|NCT02318303|20186375|P7|COMPLETED|Overall Study||158
8187079|NCT02318303|20186376|P6|COMPLETED|Overall Study||153
8187080|NCT02318303|20186377|P5|COMPLETED|Overall Study||152
8187081|NCT02318303|20186378|P4|COMPLETED|Overall Study||155
8187082|NCT02318303|20186379|P3|COMPLETED|Overall Study||157
8187083|NCT02318303|20186380|P2|COMPLETED|Overall Study||155
8187084|NCT02318303|20186381|P1|COMPLETED|Overall Study||155
8187085|NCT02318303|20186375|P7|STARTED|Overall Study||160
8187086|NCT02318303|20186376|P6|STARTED|Overall Study||159
8187087|NCT02318303|20186377|P5|STARTED|Overall Study||157
8187088|NCT02318303|20186378|P4|STARTED|Overall Study||158
8187089|NCT02318303|20186379|P3|STARTED|Overall Study||160
8187090|NCT02318303|20186380|P2|STARTED|Overall Study||158
8187091|NCT02318303|20186381|P1|STARTED|Overall Study||159
8187092|NCT02318277|20186405|P8|NOT COMPLETED|Overall Study||93
8187093|NCT02318277|20186406|P7|NOT COMPLETED|Overall Study||49
8187094|NCT02318277|20186407|P6|NOT COMPLETED|Overall Study||9
8187095|NCT02318277|20186408|P5|NOT COMPLETED|Overall Study||8
8187096|NCT02318277|20186409|P4|NOT COMPLETED|Overall Study||4
8187097|NCT02318277|20186410|P3|NOT COMPLETED|Overall Study||4
8187098|NCT02318277|20186411|P2|NOT COMPLETED|Overall Study||3
8187099|NCT02318277|20186412|P1|NOT COMPLETED|Overall Study||6
8187100|NCT02318277|20186405|P8|COMPLETED|Overall Study||0
8187101|NCT02318277|20186406|P7|COMPLETED|Overall Study||0
8187102|NCT02318277|20186407|P6|COMPLETED|Overall Study||0
8187103|NCT02318277|20186408|P5|COMPLETED|Overall Study||0
8187104|NCT02318277|20186409|P4|COMPLETED|Overall Study||0
8187105|NCT02318277|20186410|P3|COMPLETED|Overall Study||0
8187106|NCT02318277|20186411|P2|COMPLETED|Overall Study||0
8187107|NCT02318277|20186412|P1|COMPLETED|Overall Study||0
8187108|NCT02318277|20186405|P8|STARTED|Overall Study||93
8187109|NCT02318277|20186406|P7|STARTED|Overall Study||49
8187110|NCT02318277|20186407|P6|STARTED|Overall Study||9
8187111|NCT02318277|20186408|P5|STARTED|Overall Study||8
8187112|NCT02318277|20186409|P4|STARTED|Overall Study||4
8187113|NCT02318277|20186410|P3|STARTED|Overall Study||4
8187114|NCT02318277|20186411|P2|STARTED|Overall Study||3
8187115|NCT02318277|20186412|P1|STARTED|Overall Study||6
8187116|NCT02317809|20186475|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
8187117|NCT02317809|20186476|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
8187118|NCT02317809|20186475|P2|COMPLETED|Second Intervention Period (8 Days)||17
8187119|NCT02317809|20186476|P1|COMPLETED|Second Intervention Period (8 Days)||14
8187120|NCT02317809|20186475|P2|STARTED|Second Intervention Period (8 Days)||17
8187121|NCT02317809|20186476|P1|STARTED|Second Intervention Period (8 Days)||14
8187122|NCT02317809|20186475|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
8187123|NCT02317809|20186476|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
8187124|NCT02317809|20186475|P2|COMPLETED|First Intervention Period (8 Days)||17
8187125|NCT02317809|20186476|P1|COMPLETED|First Intervention Period (8 Days)||14
8187126|NCT02317809|20186475|P2|STARTED|First Intervention Period (8 Days)||17
8187127|NCT02317809|20186476|P1|STARTED|First Intervention Period (8 Days)||17
8187128|NCT02317744|20186528|P2|NOT COMPLETED|Overall Study||2
8187129|NCT02317744|20186529|P1|NOT COMPLETED|Overall Study||1
8187130|NCT02317744|20186528|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
8187131|NCT02317744|20186529|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
8187132|NCT02317744|20186528|P2|Completed Treatment|Overall Study||7
8187133|NCT02317744|20186529|P1|Completed Treatment|Overall Study||10
8187134|NCT02317744|20186528|P2|STARTED|Overall Study||10
8187135|NCT02317744|20186529|P1|STARTED|Overall Study||12
8187136|NCT02317692|20186543|P2|NOT COMPLETED|Overall Study||0
8187137|NCT02317692|20186544|P1|NOT COMPLETED|Overall Study||6
8187138|NCT02317692|20186543|P2|COMPLETED|Overall Study||77
8187139|NCT02317692|20186544|P1|COMPLETED|Overall Study||63
8187140|NCT02317692|20186543|P2|STARTED|Overall Study||77
8187141|NCT02317692|20186544|P1|STARTED|Overall Study||69
8187142|NCT02317614|20186564|P2|NOT COMPLETED|Overall Study||2
8187143|NCT02317614|20186565|P1|NOT COMPLETED|Overall Study||3
8187144|NCT02317614|20186564|P2|COMPLETED|Overall Study||23
8187145|NCT02317614|20186565|P1|COMPLETED|Overall Study||23
8187146|NCT02317614|20186564|P2|STARTED|Overall Study||25
8187147|NCT02317614|20186565|P1|STARTED|Overall Study||26
8187148|NCT02317575|20186581|P5|NOT COMPLETED|Period 5||0
8187149|NCT02317575|20186582|P4|NOT COMPLETED|Period 5||0
8187150|NCT02317575|20186583|P3|NOT COMPLETED|Period 5||0
8187151|NCT02317575|20186584|P2|NOT COMPLETED|Period 5||0
8187152|NCT02317575|20186585|P1|NOT COMPLETED|Period 5||0
8187153|NCT02317575|20186581|P5|COMPLETED|Period 5||6
8187154|NCT02317575|20186582|P4|COMPLETED|Period 5||6
8187155|NCT02317575|20186583|P3|COMPLETED|Period 5||6
8187156|NCT02317575|20186584|P2|COMPLETED|Period 5||5
8187157|NCT02317575|20186585|P1|COMPLETED|Period 5||4
8187158|NCT02317575|20186581|P5|STARTED|Period 5||6
8187159|NCT02317575|20186582|P4|STARTED|Period 5||6
8187160|NCT02317575|20186583|P3|STARTED|Period 5||6
8187161|NCT02317575|20186584|P2|STARTED|Period 5||5
8187162|NCT02317575|20186585|P1|STARTED|Period 5||4
8187163|NCT02317575|20186581|P5|NOT COMPLETED|Period 4||0
8187164|NCT02317575|20186582|P4|NOT COMPLETED|Period 4||0
8187165|NCT02317575|20186583|P3|NOT COMPLETED|Period 4||0
8187166|NCT02317575|20186584|P2|NOT COMPLETED|Period 4||0
8187167|NCT02317575|20186585|P1|NOT COMPLETED|Period 4||0
8187168|NCT02317575|20186581|P5|COMPLETED|Period 4||6
8187169|NCT02317575|20186582|P4|COMPLETED|Period 4||6
8187170|NCT02317575|20186583|P3|COMPLETED|Period 4||6
8187171|NCT02317575|20186584|P2|COMPLETED|Period 4||5
8187172|NCT02317575|20186585|P1|COMPLETED|Period 4||4
8187173|NCT02317575|20186581|P5|STARTED|Period 4||6
8187174|NCT02317575|20186582|P4|STARTED|Period 4||6
8187175|NCT02317575|20186583|P3|STARTED|Period 4||6
8187176|NCT02317575|20186584|P2|STARTED|Period 4||5
8187177|NCT02317575|20186585|P1|STARTED|Period 4||4
8187178|NCT02317575|20186581|P5|NOT COMPLETED|Period 3||0
8187179|NCT02317575|20186582|P4|NOT COMPLETED|Period 3||0
8187180|NCT02317575|20186583|P3|NOT COMPLETED|Period 3||0
8187181|NCT02317575|20186584|P2|NOT COMPLETED|Period 3||0
8187182|NCT02317575|20186585|P1|NOT COMPLETED|Period 3||0
8187183|NCT02317575|20186581|P5|COMPLETED|Period 3||6
8187184|NCT02317575|20186582|P4|COMPLETED|Period 3||6
8187185|NCT02317575|20186583|P3|COMPLETED|Period 3||6
8187186|NCT02317575|20186584|P2|COMPLETED|Period 3||5
8187187|NCT02317575|20186585|P1|COMPLETED|Period 3||4
8187188|NCT02317575|20186581|P5|STARTED|Period 3||6
8187189|NCT02317575|20186582|P4|STARTED|Period 3||6
8187190|NCT02317575|20186583|P3|STARTED|Period 3||6
8187191|NCT02317575|20186584|P2|STARTED|Period 3||5
8187192|NCT02317575|20186585|P1|STARTED|Period 3||4
8187193|NCT02317575|20186581|P5|NOT COMPLETED|Period 2||0
8187194|NCT02317575|20186582|P4|NOT COMPLETED|Period 2||0
8187195|NCT02317575|20186583|P3|NOT COMPLETED|Period 2||0
8187196|NCT02317575|20186584|P2|NOT COMPLETED|Period 2||0
8187197|NCT02317575|20186585|P1|NOT COMPLETED|Period 2||0
8187198|NCT02317575|20186581|P5|COMPLETED|Period 2||6
8187199|NCT02317575|20186582|P4|COMPLETED|Period 2||6
8187200|NCT02317575|20186583|P3|COMPLETED|Period 2||6
8187201|NCT02317575|20186584|P2|COMPLETED|Period 2||5
8187202|NCT02317575|20186585|P1|COMPLETED|Period 2||4
8187203|NCT02317575|20186581|P5|STARTED|Period 2||6
8187204|NCT02317575|20186582|P4|STARTED|Period 2||6
8187205|NCT02317575|20186583|P3|STARTED|Period 2||6
8187206|NCT02317575|20186584|P2|STARTED|Period 2||5
8187207|NCT02317575|20186585|P1|STARTED|Period 2||4
8187208|NCT02317575|20186581|P5|NOT COMPLETED|Period 1||0
8187209|NCT02317575|20186582|P4|NOT COMPLETED|Period 1||0
8187210|NCT02317575|20186583|P3|NOT COMPLETED|Period 1||0
8187211|NCT02317575|20186584|P2|NOT COMPLETED|Period 1||1
8187212|NCT02317575|20186585|P1|NOT COMPLETED|Period 1||1
8187213|NCT02317575|20186581|P5|COMPLETED|Period 1||6
8187214|NCT02317575|20186582|P4|COMPLETED|Period 1||6
8187215|NCT02317575|20186583|P3|COMPLETED|Period 1||6
8187216|NCT02317575|20186584|P2|COMPLETED|Period 1||5
8187217|NCT02317575|20186585|P1|COMPLETED|Period 1||4
8187218|NCT02317575|20186581|P5|Received at Least 1 Dose of Study Drug|Period 1||6
8187219|NCT02317575|20186582|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8187220|NCT02317575|20186583|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8187221|NCT02317575|20186584|P2|Received at Least 1 Dose of Study Drug|Period 1||5
8187222|NCT02317575|20186585|P1|Received at Least 1 Dose of Study Drug|Period 1||5
8187223|NCT02317575|20186581|P5|STARTED|Period 1||6
8187224|NCT02317575|20186582|P4|STARTED|Period 1||6
8187225|NCT02317575|20186583|P3|STARTED|Period 1||6
8187226|NCT02317575|20186584|P2|STARTED|Period 1||6
8187227|NCT02317575|20186585|P1|STARTED|Period 1||5
8187228|NCT02317549|20186611|P2|NOT COMPLETED|Overall Study||0
8187229|NCT02317549|20186612|P1|NOT COMPLETED|Overall Study||0
8187230|NCT02317549|20186611|P2|COMPLETED|Overall Study||3
8187231|NCT02317549|20186612|P1|COMPLETED|Overall Study||5
8187232|NCT02317549|20186611|P2|STARTED|Overall Study||3
8187233|NCT02317549|20186612|P1|STARTED|Overall Study||5
8187234|NCT02317510|20186620|P2|NOT COMPLETED|Overall Study||1
8187235|NCT02317510|20186621|P1|NOT COMPLETED|Overall Study||0
8187236|NCT02317510|20186620|P2|COMPLETED|Overall Study||24
8187237|NCT02317510|20186621|P1|COMPLETED|Overall Study||25
8187238|NCT02317510|20186620|P2|STARTED|Overall Study||25
8187239|NCT02317510|20186621|P1|STARTED|Overall Study||25
8187240|NCT02317276|20186649|P1|NOT COMPLETED|Overall Study||6
8187241|NCT02317276|20186649|P1|COMPLETED|Overall Study||5
8187242|NCT02317276|20186649|P1|STARTED|Overall Study||11
8187243|NCT02317016|20186653|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
8187244|NCT02317016|20186653|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
8187245|NCT02317016|20186653|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
8187246|NCT02317016|20186653|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
8187247|NCT02317016|20186653|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
8187248|NCT02317016|20186653|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
8187249|NCT02317016|20186653|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
8187250|NCT02317016|20186653|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
8187251|NCT02317016|20186653|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
8187252|NCT02317016|20186653|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
8187253|NCT02317016|20186653|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
8187254|NCT02317016|20186653|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
8187255|NCT02316847|20186681|P2|NOT COMPLETED|Overall Study||86
8187256|NCT02316847|20186682|P1|NOT COMPLETED|Overall Study||9
8187257|NCT02316847|20186681|P2|COMPLETED|Overall Study||13
8187258|NCT02316847|20186682|P1|COMPLETED|Overall Study||0
8187259|NCT02316847|20186681|P2|STARTED|Overall Study||99
8187260|NCT02316847|20186682|P1|STARTED|Overall Study||9
8187261|NCT02316769|20186693|P2|NOT COMPLETED|Overall Study||0
8187262|NCT02316769|20186694|P1|NOT COMPLETED|Overall Study||2
8187263|NCT02316769|20186693|P2|COMPLETED|Overall Study||33
8187264|NCT02316769|20186694|P1|COMPLETED|Overall Study||31
8187265|NCT02316769|20186693|P2|STARTED|Overall Study||33
8187266|NCT02316769|20186694|P1|STARTED|Overall Study||33
8187267|NCT02316717|20186705|P3|NOT COMPLETED|Overall Study||3
8187268|NCT02316717|20186706|P2|NOT COMPLETED|Overall Study||7
8187269|NCT02316717|20186707|P1|NOT COMPLETED|Overall Study||11
8187270|NCT02316717|20186705|P3|COMPLETED|Overall Study||41
8187271|NCT02316717|20186706|P2|COMPLETED|Overall Study||39
8187272|NCT02316717|20186707|P1|COMPLETED|Overall Study||32
8187273|NCT02316717|20186705|P3|STARTED|Overall Study||44
8187274|NCT02316717|20186706|P2|STARTED|Overall Study||46
8187275|NCT02316717|20186707|P1|STARTED|Overall Study||43
8187276|NCT02316678|20186837|P2|NOT COMPLETED|Overall Study||0
8187277|NCT02316678|20186838|P1|NOT COMPLETED|Overall Study||0
8187278|NCT02316678|20186837|P2|COMPLETED|Overall Study||7694
8187279|NCT02316678|20186838|P1|COMPLETED|Overall Study||1879
8187280|NCT02316678|20186837|P2|STARTED|Overall Study||7694
8187281|NCT02316678|20186838|P1|STARTED|Overall Study||1879
8187282|NCT02316613|20186844|P1|NOT COMPLETED|Overall Study||104
8187283|NCT02316613|20186844|P1|COMPLETED|Overall Study||156
8187284|NCT02316613|20186844|P1|Overall Population|Overall Study||241
8187285|NCT02316613|20186844|P1|Safety Population|Overall Study||255
8187286|NCT02316613|20186844|P1|STARTED|Overall Study||260
8187287|NCT02316548|20186883|P2|NOT COMPLETED|Overall Study||1
8187288|NCT02316548|20186884|P1|NOT COMPLETED|Overall Study||0
8187289|NCT02316548|20186883|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
8187290|NCT02316548|20186884|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
8187291|NCT02316548|20186883|P2|Eligible With Adverse Event Data|Overall Study||2
8187292|NCT02316548|20186884|P1|Eligible With Adverse Event Data|Overall Study||4
8187293|NCT02316548|20186883|P2|Eligible With Disease Assessment|Overall Study||1
8187294|NCT02316548|20186884|P1|Eligible With Disease Assessment|Overall Study||4
8187295|NCT02316548|20186883|P2|Eligible Population|Overall Study||6
8187296|NCT02316548|20186884|P1|Eligible Population|Overall Study||6
8187297|NCT02316548|20186883|P2|STARTED|Overall Study|Randomized|7
8187298|NCT02316548|20186884|P1|STARTED|Overall Study|Randomized|6
8187299|NCT02316470|20186898|P4|NOT COMPLETED|Overall Study||2
8187300|NCT02316470|20186899|P3|NOT COMPLETED|Overall Study||5
8187301|NCT02316470|20186900|P2|NOT COMPLETED|Overall Study||6
8187302|NCT02316470|20186901|P1|NOT COMPLETED|Overall Study||5
8187303|NCT02316470|20186898|P4|COMPLETED|Overall Study||46
8187304|NCT02316470|20186899|P3|COMPLETED|Overall Study||147
8187305|NCT02316470|20186900|P2|COMPLETED|Overall Study||146
8187306|NCT02316470|20186901|P1|COMPLETED|Overall Study||143
8187307|NCT02316470|20186898|P4|STARTED|Overall Study||48
8187308|NCT02316470|20186899|P3|STARTED|Overall Study||152
8187309|NCT02316470|20186900|P2|STARTED|Overall Study||152
8187310|NCT02316470|20186901|P1|STARTED|Overall Study||148
8187311|NCT02316366|20186997|P2|NOT COMPLETED|Overall Study||0
8187312|NCT02316366|20186998|P1|NOT COMPLETED|Overall Study||0
8187313|NCT02316366|20186997|P2|COMPLETED|Overall Study||40
8187314|NCT02316366|20186998|P1|COMPLETED|Overall Study||40
8187315|NCT02316366|20186997|P2|STARTED|Overall Study||40
8187316|NCT02316366|20186998|P1|STARTED|Overall Study||40
8187317|NCT02316353|20187014|P2|NOT COMPLETED|Overall Study||8
8187318|NCT02316353|20187015|P1|NOT COMPLETED|Overall Study||8
8187319|NCT02316353|20187014|P2|COMPLETED|Overall Study||55
8187320|NCT02316353|20187015|P1|COMPLETED|Overall Study||55
8187321|NCT02316353|20187014|P2|STARTED|Overall Study||63
8187322|NCT02316353|20187015|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
8187323|NCT02316171|20187035|P4|NOT COMPLETED|Overall Study||0
8187324|NCT02316171|20187036|P3|NOT COMPLETED|Overall Study||0
8187325|NCT02316171|20187037|P2|NOT COMPLETED|Overall Study||0
8187326|NCT02316171|20187038|P1|NOT COMPLETED|Overall Study||1
8187327|NCT02316171|20187035|P4|COMPLETED|Overall Study||3
8187328|NCT02316171|20187036|P3|COMPLETED|Overall Study||3
8187329|NCT02316171|20187037|P2|COMPLETED|Overall Study||6
8187330|NCT02316171|20187038|P1|COMPLETED|Overall Study||3
8187331|NCT02316171|20187035|P4|STARTED|Overall Study||3
8187332|NCT02316171|20187036|P3|STARTED|Overall Study||3
8187333|NCT02316171|20187037|P2|STARTED|Overall Study||6
8187334|NCT02316171|20187038|P1|STARTED|Overall Study||4
8187335|NCT02316002|20187044|P1|NOT COMPLETED|Overall Study||6
8187336|NCT02316002|20187044|P1|COMPLETED|Overall Study||45
8187337|NCT02316002|20187044|P1|STARTED|Overall Study||51
8187338|NCT02315989|20187048|P1|NOT COMPLETED|Overall Study||0
8187339|NCT02315989|20187048|P1|COMPLETED|Overall Study||6
8187340|NCT02315989|20187048|P1|STARTED|Overall Study||6
8187341|NCT02315872|20187058|P2|NOT COMPLETED|Overall Study||1
8187342|NCT02315872|20187059|P1|NOT COMPLETED|Overall Study||3
8187343|NCT02315872|20187058|P2|COMPLETED|Overall Study||3
8187344|NCT02315872|20187059|P1|COMPLETED|Overall Study||1
8187345|NCT02315872|20187058|P2|STARTED|Overall Study||4
8187346|NCT02315872|20187059|P1|STARTED|Overall Study||4
8187347|NCT02315755|20187071|P1|NOT COMPLETED|Overall Study||0
8187348|NCT02315755|20187071|P1|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
8187349|NCT02315755|20187071|P1|STARTED|Overall Study||102
8187350|NCT02315703|20187108|P8|NOT COMPLETED|Overall Study||7
8187351|NCT02315703|20187109|P7|NOT COMPLETED|Overall Study||13
8187352|NCT02315703|20187110|P6|NOT COMPLETED|Overall Study||6
8187353|NCT02315703|20187111|P5|NOT COMPLETED|Overall Study||8
8187354|NCT02315703|20187112|P4|NOT COMPLETED|Overall Study||9
8187355|NCT02315703|20187113|P3|NOT COMPLETED|Overall Study||5
8187356|NCT02315703|20187114|P2|NOT COMPLETED|Overall Study||10
8187357|NCT02315703|20187115|P1|NOT COMPLETED|Overall Study||6
8187358|NCT02315703|20187108|P8|COMPLETED|Overall Study||42
8187359|NCT02315703|20187109|P7|COMPLETED|Overall Study||37
8187360|NCT02315703|20187110|P6|COMPLETED|Overall Study||43
8187361|NCT02315703|20187111|P5|COMPLETED|Overall Study||41
8187362|NCT02315703|20187112|P4|COMPLETED|Overall Study||39
8187363|NCT02315703|20187113|P3|COMPLETED|Overall Study||44
8187364|NCT02315703|20187114|P2|COMPLETED|Overall Study||39
8187365|NCT02315703|20187115|P1|COMPLETED|Overall Study||44
8187366|NCT02315703|20187108|P8|STARTED|Overall Study||49
8187367|NCT02315703|20187109|P7|STARTED|Overall Study||50
8187368|NCT02315703|20187110|P6|STARTED|Overall Study||49
8187369|NCT02315703|20187111|P5|STARTED|Overall Study||49
8187370|NCT02315703|20187112|P4|STARTED|Overall Study||48
8187371|NCT02315703|20187113|P3|STARTED|Overall Study||49
8187372|NCT02315703|20187114|P2|STARTED|Overall Study||49
8187373|NCT02315703|20187115|P1|STARTED|Overall Study||50
8187374|NCT02315664|20187215|P2|NOT COMPLETED|Overall Study||4
8187375|NCT02315664|20187216|P1|NOT COMPLETED|Overall Study||1
8187376|NCT02315664|20187215|P2|COMPLETED|Overall Study||27
8187377|NCT02315664|20187216|P1|COMPLETED|Overall Study||29
8187378|NCT02315664|20187215|P2|STARTED|Overall Study||31
8187379|NCT02315664|20187216|P1|STARTED|Overall Study||30
8187380|NCT02315625|20187238|P2|NOT COMPLETED|Second Intervention||1
8187381|NCT02315625|20187239|P1|NOT COMPLETED|Second Intervention||4
8187382|NCT02315625|20187238|P2|COMPLETED|Second Intervention||1
8187383|NCT02315625|20187239|P1|COMPLETED|Second Intervention||9
8187384|NCT02315625|20187238|P2|STARTED|Second Intervention||2
8187385|NCT02315625|20187239|P1|STARTED|Second Intervention||13
8187386|NCT02315625|20187238|P2|NOT COMPLETED|First Intervention||0
8187387|NCT02315625|20187239|P1|NOT COMPLETED|First Intervention||1
8187388|NCT02315625|20187238|P2|COMPLETED|First Intervention||2
8187389|NCT02315625|20187239|P1|COMPLETED|First Intervention||13
8187390|NCT02315625|20187238|P2|STARTED|First Intervention||2
8187391|NCT02315625|20187239|P1|STARTED|First Intervention||14
8187392|NCT02315560|20187253|P1|NOT COMPLETED|Overall Study||3
8187393|NCT02315560|20187253|P1|COMPLETED|Overall Study||22
8187394|NCT02315560|20187253|P1|STARTED|Overall Study||25
8187395|NCT02315430|20187258|P1|NOT COMPLETED|Overall Study||0
8187396|NCT02315430|20187258|P1|COMPLETED|Overall Study||13
8187397|NCT02315430|20187258|P1|STARTED|Overall Study||13
8187398|NCT02315352|20187268|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187399|NCT02315352|20187269|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187400|NCT02315352|20187270|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187401|NCT02315352|20187271|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187402|NCT02315352|20187272|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187403|NCT02315352|20187273|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187404|NCT02315352|20187274|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187405|NCT02315352|20187275|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187406|NCT02315352|20187268|P8|COMPLETED|Fifth Intervention (Day 2)||8
8187407|NCT02315352|20187269|P7|COMPLETED|Fifth Intervention (Day 2)||9
8187408|NCT02315352|20187270|P6|COMPLETED|Fifth Intervention (Day 2)||7
8187409|NCT02315352|20187271|P5|COMPLETED|Fifth Intervention (Day 2)||8
8187410|NCT02315352|20187272|P4|COMPLETED|Fifth Intervention (Day 2)||8
8187411|NCT02315352|20187273|P3|COMPLETED|Fifth Intervention (Day 2)||7
8187412|NCT02315352|20187274|P2|COMPLETED|Fifth Intervention (Day 2)||0
8187413|NCT02315352|20187275|P1|COMPLETED|Fifth Intervention (Day 2)||0
8187414|NCT02315352|20187268|P8|STARTED|Fifth Intervention (Day 2)||8
8187415|NCT02315352|20187269|P7|STARTED|Fifth Intervention (Day 2)||9
8187416|NCT02315352|20187270|P6|STARTED|Fifth Intervention (Day 2)||7
8187417|NCT02315352|20187271|P5|STARTED|Fifth Intervention (Day 2)||8
8187418|NCT02315352|20187272|P4|STARTED|Fifth Intervention (Day 2)||8
8187419|NCT02315352|20187273|P3|STARTED|Fifth Intervention (Day 2)||7
8187420|NCT02315352|20187274|P2|STARTED|Fifth Intervention (Day 2)||0
8187421|NCT02315352|20187275|P1|STARTED|Fifth Intervention (Day 2)||0
8187422|NCT02315352|20187268|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187423|NCT02315352|20187269|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187424|NCT02315352|20187270|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187425|NCT02315352|20187271|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187426|NCT02315352|20187272|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187427|NCT02315352|20187273|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187428|NCT02315352|20187274|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187429|NCT02315352|20187275|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187430|NCT02315352|20187268|P8|COMPLETED|Fourth Intervention (Day 2)||8
8187431|NCT02315352|20187269|P7|COMPLETED|Fourth Intervention (Day 2)||9
8187432|NCT02315352|20187270|P6|COMPLETED|Fourth Intervention (Day 2)||7
8187433|NCT02315352|20187271|P5|COMPLETED|Fourth Intervention (Day 2)||8
8187434|NCT02315352|20187272|P4|COMPLETED|Fourth Intervention (Day 2)||8
8187435|NCT02315352|20187273|P3|COMPLETED|Fourth Intervention (Day 2)||7
8187436|NCT02315352|20187274|P2|COMPLETED|Fourth Intervention (Day 2)||0
8187437|NCT02315352|20187275|P1|COMPLETED|Fourth Intervention (Day 2)||0
8187438|NCT02315352|20187268|P8|STARTED|Fourth Intervention (Day 2)||8
8187439|NCT02315352|20187269|P7|STARTED|Fourth Intervention (Day 2)||9
8187440|NCT02315352|20187270|P6|STARTED|Fourth Intervention (Day 2)||7
8187441|NCT02315352|20187271|P5|STARTED|Fourth Intervention (Day 2)||8
8187442|NCT02315352|20187272|P4|STARTED|Fourth Intervention (Day 2)||8
8187443|NCT02315352|20187273|P3|STARTED|Fourth Intervention (Day 2)||7
8187444|NCT02315352|20187274|P2|STARTED|Fourth Intervention (Day 2)||0
8187445|NCT02315352|20187275|P1|STARTED|Fourth Intervention (Day 2)||0
8187446|NCT02315352|20187268|P8|NOT COMPLETED|Third Intervention (Day 2)||0
8187447|NCT02315352|20187269|P7|NOT COMPLETED|Third Intervention (Day 2)||0
8187448|NCT02315352|20187270|P6|NOT COMPLETED|Third Intervention (Day 2)||0
8187449|NCT02315352|20187271|P5|NOT COMPLETED|Third Intervention (Day 2)||0
8187450|NCT02315352|20187272|P4|NOT COMPLETED|Third Intervention (Day 2)||0
8187451|NCT02315352|20187273|P3|NOT COMPLETED|Third Intervention (Day 2)||0
8187452|NCT02315352|20187274|P2|NOT COMPLETED|Third Intervention (Day 2)||0
8187453|NCT02315352|20187275|P1|NOT COMPLETED|Third Intervention (Day 2)||0
8187454|NCT02315352|20187268|P8|COMPLETED|Third Intervention (Day 2)||8
8187455|NCT02315352|20187269|P7|COMPLETED|Third Intervention (Day 2)||9
8187456|NCT02315352|20187270|P6|COMPLETED|Third Intervention (Day 2)||7
8187457|NCT02315352|20187271|P5|COMPLETED|Third Intervention (Day 2)||8
8187458|NCT02315352|20187272|P4|COMPLETED|Third Intervention (Day 2)||8
8187459|NCT02315352|20187273|P3|COMPLETED|Third Intervention (Day 2)||7
8187460|NCT02315352|20187274|P2|COMPLETED|Third Intervention (Day 2)||0
8187461|NCT02315352|20187275|P1|COMPLETED|Third Intervention (Day 2)||0
8187462|NCT02315352|20187268|P8|STARTED|Third Intervention (Day 2)||8
8187463|NCT02315352|20187269|P7|STARTED|Third Intervention (Day 2)||9
8187464|NCT02315352|20187270|P6|STARTED|Third Intervention (Day 2)||7
8187465|NCT02315352|20187271|P5|STARTED|Third Intervention (Day 2)||8
8187466|NCT02315352|20187272|P4|STARTED|Third Intervention (Day 2)||8
8187467|NCT02315352|20187273|P3|STARTED|Third Intervention (Day 2)||7
8187468|NCT02315352|20187274|P2|STARTED|Third Intervention (Day 2)||0
8187469|NCT02315352|20187275|P1|STARTED|Third Intervention (Day 2)||0
8187470|NCT02315352|20187268|P8|NOT COMPLETED|Second Intervention (Day 1)||0
8187471|NCT02315352|20187269|P7|NOT COMPLETED|Second Intervention (Day 1)||0
8187472|NCT02315352|20187270|P6|NOT COMPLETED|Second Intervention (Day 1)||0
8187473|NCT02315352|20187271|P5|NOT COMPLETED|Second Intervention (Day 1)||0
8187474|NCT02315352|20187272|P4|NOT COMPLETED|Second Intervention (Day 1)||0
8187475|NCT02315352|20187273|P3|NOT COMPLETED|Second Intervention (Day 1)||0
8187476|NCT02315352|20187274|P2|NOT COMPLETED|Second Intervention (Day 1)||0
8187477|NCT02315352|20187275|P1|NOT COMPLETED|Second Intervention (Day 1)||0
8187478|NCT02315352|20187268|P8|COMPLETED|Second Intervention (Day 1)||0
8187479|NCT02315352|20187269|P7|COMPLETED|Second Intervention (Day 1)||0
8187480|NCT02315352|20187270|P6|COMPLETED|Second Intervention (Day 1)||0
8187481|NCT02315352|20187271|P5|COMPLETED|Second Intervention (Day 1)||0
8187482|NCT02315352|20187272|P4|COMPLETED|Second Intervention (Day 1)||0
8187483|NCT02315352|20187273|P3|COMPLETED|Second Intervention (Day 1)||0
8187484|NCT02315352|20187274|P2|COMPLETED|Second Intervention (Day 1)||24
8187485|NCT02315352|20187275|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
8187486|NCT02315352|20187268|P8|STARTED|Second Intervention (Day 1)||0
8187487|NCT02315352|20187269|P7|STARTED|Second Intervention (Day 1)||0
8187488|NCT02315352|20187270|P6|STARTED|Second Intervention (Day 1)||0
8187489|NCT02315352|20187271|P5|STARTED|Second Intervention (Day 1)||0
8187490|NCT02315352|20187272|P4|STARTED|Second Intervention (Day 1)||0
8187491|NCT02315352|20187273|P3|STARTED|Second Intervention (Day 1)||0
8187492|NCT02315352|20187274|P2|STARTED|Second Intervention (Day 1)||24
8187493|NCT02315352|20187275|P1|STARTED|Second Intervention (Day 1)||24
8187494|NCT02315352|20187268|P8|NOT COMPLETED|First Intervention (Day 1)||0
8187495|NCT02315352|20187269|P7|NOT COMPLETED|First Intervention (Day 1)||0
8187496|NCT02315352|20187270|P6|NOT COMPLETED|First Intervention (Day 1)||0
8187497|NCT02315352|20187271|P5|NOT COMPLETED|First Intervention (Day 1)||0
8187498|NCT02315352|20187272|P4|NOT COMPLETED|First Intervention (Day 1)||0
8187499|NCT02315352|20187273|P3|NOT COMPLETED|First Intervention (Day 1)||0
8187500|NCT02315352|20187274|P2|NOT COMPLETED|First Intervention (Day 1)||0
8187501|NCT02315352|20187275|P1|NOT COMPLETED|First Intervention (Day 1)||0
8187502|NCT02315352|20187268|P8|COMPLETED|First Intervention (Day 1)||0
8187503|NCT02315352|20187269|P7|COMPLETED|First Intervention (Day 1)||0
8187504|NCT02315352|20187270|P6|COMPLETED|First Intervention (Day 1)||0
8187505|NCT02315352|20187271|P5|COMPLETED|First Intervention (Day 1)||0
8187506|NCT02315352|20187272|P4|COMPLETED|First Intervention (Day 1)||0
8187507|NCT02315352|20187273|P3|COMPLETED|First Intervention (Day 1)||0
8187508|NCT02315352|20187274|P2|COMPLETED|First Intervention (Day 1)||24
8187509|NCT02315352|20187275|P1|COMPLETED|First Intervention (Day 1)||24
8187510|NCT02315352|20187268|P8|STARTED|First Intervention (Day 1)||0
8187511|NCT02315352|20187269|P7|STARTED|First Intervention (Day 1)||0
8187512|NCT02315352|20187270|P6|STARTED|First Intervention (Day 1)||0
8187513|NCT02315352|20187271|P5|STARTED|First Intervention (Day 1)||0
8187514|NCT02315352|20187272|P4|STARTED|First Intervention (Day 1)||0
8187515|NCT02315352|20187273|P3|STARTED|First Intervention (Day 1)||0
8187516|NCT02315352|20187274|P2|STARTED|First Intervention (Day 1)||24
8187517|NCT02315352|20187275|P1|STARTED|First Intervention (Day 1)||24
8187518|NCT02315261|20187302|P1|NOT COMPLETED|Overall Study||0
8187519|NCT02315261|20187302|P1|COMPLETED|Overall Study||364
8187520|NCT02315261|20187302|P1|STARTED|Overall Study||364
8187521|NCT02314936|20187313|P4|NOT COMPLETED|Overall Study||0
8187522|NCT02314936|20187314|P3|NOT COMPLETED|Overall Study||2
8187523|NCT02314936|20187315|P2|NOT COMPLETED|Overall Study||0
8187524|NCT02314936|20187316|P1|NOT COMPLETED|Overall Study||0
8187525|NCT02314936|20187313|P4|COMPLETED|Overall Study||48
8187526|NCT02314936|20187314|P3|COMPLETED|Overall Study||46
8187527|NCT02314936|20187315|P2|COMPLETED|Overall Study||48
8187528|NCT02314936|20187316|P1|COMPLETED|Overall Study||48
8187529|NCT02314936|20187313|P4|STARTED|Overall Study||48
8187530|NCT02314936|20187314|P3|STARTED|Overall Study||48
8187531|NCT02314936|20187315|P2|STARTED|Overall Study||48
8187532|NCT02314936|20187316|P1|STARTED|Overall Study||48
8187533|NCT02314923|20187512|P10|NOT COMPLETED|Overall Study||0
8187534|NCT02314923|20187513|P9|NOT COMPLETED|Overall Study||2
8187535|NCT02314923|20187514|P8|NOT COMPLETED|Overall Study||5
8187536|NCT02314923|20187515|P7|NOT COMPLETED|Overall Study||5
8187537|NCT02314923|20187516|P6|NOT COMPLETED|Overall Study||1
8187538|NCT02314923|20187517|P5|NOT COMPLETED|Overall Study||1
8187539|NCT02314923|20187518|P4|NOT COMPLETED|Overall Study||1
8187540|NCT02314923|20187519|P3|NOT COMPLETED|Overall Study||2
8187541|NCT02314923|20187520|P2|NOT COMPLETED|Overall Study||4
8187542|NCT02314923|20187521|P1|NOT COMPLETED|Overall Study||3
8187543|NCT02314923|20187512|P10|COMPLETED|Overall Study||20
8187544|NCT02314923|20187513|P9|COMPLETED|Overall Study||46
8187545|NCT02314923|20187514|P8|COMPLETED|Overall Study||42
8187546|NCT02314923|20187515|P7|COMPLETED|Overall Study||43
8187547|NCT02314923|20187516|P6|COMPLETED|Overall Study||19
8187548|NCT02314923|20187517|P5|COMPLETED|Overall Study||73
8187549|NCT02314923|20187518|P4|COMPLETED|Overall Study||63
8187550|NCT02314923|20187519|P3|COMPLETED|Overall Study||62
8187551|NCT02314923|20187520|P2|COMPLETED|Overall Study||60
8187552|NCT02314923|20187521|P1|COMPLETED|Overall Study||61
8187553|NCT02314923|20187512|P10|Treated|Overall Study||20
8187554|NCT02314923|20187513|P9|Treated|Overall Study||48
8187555|NCT02314923|20187514|P8|Treated|Overall Study||47
8187556|NCT02314923|20187515|P7|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
8187557|NCT02314923|20187516|P6|Treated|Overall Study||20
8187558|NCT02314923|20187517|P5|Treated|Overall Study||74
8187559|NCT02314923|20187518|P4|Treated|Overall Study||64
8187560|NCT02314923|20187519|P3|Treated|Overall Study||64
8187561|NCT02314923|20187520|P2|Treated|Overall Study||64
8187562|NCT02314923|20187521|P1|Treated|Overall Study||64
8187563|NCT02314923|20187512|P10|STARTED|Overall Study||20
8187564|NCT02314923|20187513|P9|STARTED|Overall Study||48
8187565|NCT02314923|20187514|P8|STARTED|Overall Study||47
8187566|NCT02314923|20187515|P7|STARTED|Overall Study||48
8187567|NCT02314923|20187516|P6|STARTED|Overall Study||20
8187568|NCT02314923|20187517|P5|STARTED|Overall Study||74
8187569|NCT02314923|20187518|P4|STARTED|Overall Study||64
8187570|NCT02314923|20187519|P3|STARTED|Overall Study||64
8187571|NCT02314923|20187520|P2|STARTED|Overall Study||64
8187572|NCT02314923|20187521|P1|STARTED|Overall Study||64
8187573|NCT02314689|20187614|P1|NOT COMPLETED|Overall Study||0
8187574|NCT02314689|20187614|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
8187575|NCT02314689|20187614|P1|STARTED|Overall Study||4
8187576|NCT02314637|20187620|P2|NOT COMPLETED|Overall Study||14
8187577|NCT02314637|20187621|P1|NOT COMPLETED|Overall Study||16
8187578|NCT02314637|20187620|P2|COMPLETED|Overall Study||75
8187579|NCT02314637|20187621|P1|COMPLETED|Overall Study||135
8187580|NCT02314637|20187620|P2|STARTED|Overall Study||89
8187581|NCT02314637|20187621|P1|STARTED|Overall Study||151
8187582|NCT02314598|20187631|P1|NOT COMPLETED|Overall Study||0
8187583|NCT02314598|20187631|P1|COMPLETED|Overall Study||46
8187584|NCT02314598|20187631|P1|STARTED|Overall Study||46
8187585|NCT02314546|20187640|P3|NOT COMPLETED|Overall Study||0
8187586|NCT02314546|20187641|P2|NOT COMPLETED|Overall Study||0
8187587|NCT02314546|20187642|P1|NOT COMPLETED|Overall Study||0
8187588|NCT02314546|20187640|P3|COMPLETED|Overall Study||5
8187589|NCT02314546|20187641|P2|COMPLETED|Overall Study||5
8187590|NCT02314546|20187642|P1|COMPLETED|Overall Study||5
8187591|NCT02314546|20187640|P3|STARTED|Overall Study||5
8187592|NCT02314546|20187641|P2|STARTED|Overall Study||5
8187593|NCT02314546|20187642|P1|STARTED|Overall Study||5
8187594|NCT02314520|20187670|P2|NOT COMPLETED|Overall Study||0
8187595|NCT02314520|20187671|P1|NOT COMPLETED|Overall Study||0
8187596|NCT02314520|20187670|P2|COMPLETED|Overall Study||80
8187597|NCT02314520|20187671|P1|COMPLETED|Overall Study||72
8187598|NCT02314520|20187670|P2|STARTED|Overall Study||80
8187599|NCT02314520|20187671|P1|STARTED|Overall Study||72
8187600|NCT02314260|20187683|P1|NOT COMPLETED|Overall Study||0
8187601|NCT02314260|20187683|P1|COMPLETED|Overall Study||80
8187602|NCT02314260|20187683|P1|STARTED|Overall Study||80
8187603|NCT02314247|20187692|P3|NOT COMPLETED|Overall Study||1
8187604|NCT02314247|20187693|P2|NOT COMPLETED|Overall Study||6
8187605|NCT02314247|20187694|P1|NOT COMPLETED|Overall Study||9
8187606|NCT02314247|20187692|P3|COMPLETED|Overall Study||0
8187607|NCT02314247|20187693|P2|COMPLETED|Overall Study||0
8187608|NCT02314247|20187694|P1|COMPLETED|Overall Study||0
8187609|NCT02314247|20187692|P3|STARTED|Overall Study||1
8187610|NCT02314247|20187693|P2|STARTED|Overall Study||6
8187611|NCT02314247|20187694|P1|STARTED|Overall Study||9
8187612|NCT02314143|20187719|P3|NOT COMPLETED|Overall Study||9
8187613|NCT02314143|20187720|P2|NOT COMPLETED|Overall Study||10
8187614|NCT02314143|20187721|P1|NOT COMPLETED|Overall Study||8
8187615|NCT02314143|20187719|P3|COMPLETED|Overall Study||7
8187616|NCT02314143|20187720|P2|COMPLETED|Overall Study||6
8187617|NCT02314143|20187721|P1|COMPLETED|Overall Study||8
8187618|NCT02314143|20187719|P3|STARTED|Overall Study||16
8187619|NCT02314143|20187720|P2|STARTED|Overall Study||16
8187620|NCT02314143|20187721|P1|STARTED|Overall Study||16
8187621|NCT02314117|20187767|P2|NOT COMPLETED|Overall Study||38
8187622|NCT02314117|20187768|P1|NOT COMPLETED|Overall Study||41
8187623|NCT02314117|20187767|P2|COMPLETED|Overall Study||281
8187624|NCT02314117|20187768|P1|COMPLETED|Overall Study||285
8187625|NCT02314117|20187767|P2|Alive But Off Treatment|Overall Study||50
8187626|NCT02314117|20187768|P1|Alive But Off Treatment|Overall Study||46
8187627|NCT02314117|20187767|P2|Death|Overall Study||231
8187628|NCT02314117|20187768|P1|Death|Overall Study||239
8187629|NCT02314117|20187767|P2|Received at Least One Dose of Study Drug|Overall Study||315
8187630|NCT02314117|20187768|P1|Received at Least One Dose of Study Drug|Overall Study||323
8187631|NCT02314117|20187767|P2|STARTED|Overall Study||319
8187632|NCT02314117|20187768|P1|STARTED|Overall Study||326
8187633|NCT02314104|20187799|P3|NOT COMPLETED|Overall Study||18
8187634|NCT02314104|20187800|P2|NOT COMPLETED|Overall Study||20
8187635|NCT02314104|20187801|P1|NOT COMPLETED|Overall Study||14
8187636|NCT02314104|20187799|P3|COMPLETED|Overall Study||53
8187637|NCT02314104|20187800|P2|COMPLETED|Overall Study||58
8187638|NCT02314104|20187801|P1|COMPLETED|Overall Study||57
8187639|NCT02314104|20187799|P3|STARTED|Overall Study||71
8187640|NCT02314104|20187800|P2|STARTED|Overall Study||78
8187641|NCT02314104|20187801|P1|STARTED|Overall Study||71
8187642|NCT02314052|20187821|P6|NOT COMPLETED|Cycles 6 -10.5||0
8187643|NCT02314052|20187822|P5|NOT COMPLETED|Cycles 6 -10.5||0
8187644|NCT02314052|20187823|P4|NOT COMPLETED|Cycles 6 -10.5||0
8187645|NCT02314052|20187824|P3|NOT COMPLETED|Cycles 6 -10.5||0
8187646|NCT02314052|20187825|P2|NOT COMPLETED|Cycles 6 -10.5||0
8187647|NCT02314052|20187826|P1|NOT COMPLETED|Cycles 6 -10.5||0
8187648|NCT02314052|20187821|P6|COMPLETED|Cycles 6 -10.5||0
8187649|NCT02314052|20187822|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
8187650|NCT02314052|20187823|P4|COMPLETED|Cycles 6 -10.5||1
8187651|NCT02314052|20187824|P3|COMPLETED|Cycles 6 -10.5||0
8187652|NCT02314052|20187825|P2|COMPLETED|Cycles 6 -10.5||0
8187653|NCT02314052|20187826|P1|COMPLETED|Cycles 6 -10.5||0
8187654|NCT02314052|20187821|P6|STARTED|Cycles 6 -10.5||0
8187655|NCT02314052|20187822|P5|STARTED|Cycles 6 -10.5||2
8187656|NCT02314052|20187823|P4|STARTED|Cycles 6 -10.5||1
8187657|NCT02314052|20187824|P3|STARTED|Cycles 6 -10.5||0
8187658|NCT02314052|20187825|P2|STARTED|Cycles 6 -10.5||0
8187659|NCT02314052|20187826|P1|STARTED|Cycles 6 -10.5||0
8187660|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Five||0
8187661|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Five||0
8187662|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Five||0
8187663|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Five||1
8187664|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Five||2
8187665|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Five||0
8187666|NCT02314052|20187821|P6|COMPLETED|Cycle Five||0
8187667|NCT02314052|20187822|P5|COMPLETED|Cycle Five||2
8187668|NCT02314052|20187823|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
8187669|NCT02314052|20187824|P3|COMPLETED|Cycle Five||0
8187670|NCT02314052|20187825|P2|COMPLETED|Cycle Five||0
8187671|NCT02314052|20187826|P1|COMPLETED|Cycle Five||0
8187672|NCT02314052|20187821|P6|STARTED|Cycle Five||0
8187673|NCT02314052|20187822|P5|STARTED|Cycle Five||2
8187674|NCT02314052|20187823|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
8187675|NCT02314052|20187824|P3|STARTED|Cycle Five||1
8187676|NCT02314052|20187825|P2|STARTED|Cycle Five||2
8187677|NCT02314052|20187826|P1|STARTED|Cycle Five||0
8187678|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Four||3
8187679|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Four||0
8187680|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Four||1
8187681|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Four||1
8187682|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Four||0
8187683|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Four||3
8187684|NCT02314052|20187821|P6|COMPLETED|Cycle Four||0
8187685|NCT02314052|20187822|P5|COMPLETED|Cycle Four||2
8187686|NCT02314052|20187823|P4|COMPLETED|Cycle Four||0
8187687|NCT02314052|20187824|P3|COMPLETED|Cycle Four||1
8187688|NCT02314052|20187825|P2|COMPLETED|Cycle Four||2
8187689|NCT02314052|20187826|P1|COMPLETED|Cycle Four||0
8187690|NCT02314052|20187821|P6|STARTED|Cycle Four||3
8187691|NCT02314052|20187822|P5|STARTED|Cycle Four||2
8187692|NCT02314052|20187823|P4|STARTED|Cycle Four||1
8187693|NCT02314052|20187824|P3|STARTED|Cycle Four||2
8187694|NCT02314052|20187825|P2|STARTED|Cycle Four||2
8187695|NCT02314052|20187826|P1|STARTED|Cycle Four||3
8187696|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Three||0
8187697|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Three||0
8187698|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Three||0
8187699|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Three||0
8187700|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Three||0
8187701|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Three||0
8187702|NCT02314052|20187821|P6|COMPLETED|Cycle Three||3
8187703|NCT02314052|20187822|P5|COMPLETED|Cycle Three||2
8187704|NCT02314052|20187823|P4|COMPLETED|Cycle Three||1
8187705|NCT02314052|20187824|P3|COMPLETED|Cycle Three||2
8187706|NCT02314052|20187825|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
8187707|NCT02314052|20187826|P1|COMPLETED|Cycle Three||3
8187708|NCT02314052|20187821|P6|STARTED|Cycle Three||3
8187709|NCT02314052|20187822|P5|STARTED|Cycle Three||2
8187710|NCT02314052|20187823|P4|STARTED|Cycle Three||1
8187711|NCT02314052|20187824|P3|STARTED|Cycle Three||2
8187712|NCT02314052|20187825|P2|STARTED|Cycle Three||2
8187713|NCT02314052|20187826|P1|STARTED|Cycle Three||3
8187714|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Two||0
8187715|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Two||4
8187716|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Two||1
8187717|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Two||1
8187718|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Two||1
8187719|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Two||0
8187720|NCT02314052|20187821|P6|COMPLETED|Cycle Two||3
8187721|NCT02314052|20187822|P5|COMPLETED|Cycle Two||2
8187722|NCT02314052|20187823|P4|COMPLETED|Cycle Two||1
8187723|NCT02314052|20187824|P3|COMPLETED|Cycle Two||2
8187724|NCT02314052|20187825|P2|COMPLETED|Cycle Two||2
8187725|NCT02314052|20187826|P1|COMPLETED|Cycle Two||3
8187726|NCT02314052|20187821|P6|STARTED|Cycle Two||3
8187727|NCT02314052|20187822|P5|STARTED|Cycle Two||6
8187728|NCT02314052|20187823|P4|STARTED|Cycle Two||2
8187729|NCT02314052|20187824|P3|STARTED|Cycle Two||3
8187730|NCT02314052|20187825|P2|STARTED|Cycle Two||3
8187731|NCT02314052|20187826|P1|STARTED|Cycle Two||3
8187732|NCT02314052|20187821|P6|NOT COMPLETED|Cycle One||0
8187733|NCT02314052|20187822|P5|NOT COMPLETED|Cycle One||0
8187734|NCT02314052|20187823|P4|NOT COMPLETED|Cycle One||1
8187735|NCT02314052|20187824|P3|NOT COMPLETED|Cycle One||0
8187736|NCT02314052|20187825|P2|NOT COMPLETED|Cycle One||0
8187737|NCT02314052|20187826|P1|NOT COMPLETED|Cycle One||0
8187738|NCT02314052|20187821|P6|COMPLETED|Cycle One||3
8187739|NCT02314052|20187822|P5|COMPLETED|Cycle One||6
8187740|NCT02314052|20187823|P4|COMPLETED|Cycle One||2
8187741|NCT02314052|20187824|P3|COMPLETED|Cycle One||3
8187742|NCT02314052|20187825|P2|COMPLETED|Cycle One||3
8187743|NCT02314052|20187826|P1|COMPLETED|Cycle One||3
8187744|NCT02314052|20187821|P6|STARTED|Cycle One||3
8187745|NCT02314052|20187822|P5|STARTED|Cycle One||6
8187746|NCT02314052|20187823|P4|STARTED|Cycle One||3
8187747|NCT02314052|20187824|P3|STARTED|Cycle One||3
8187748|NCT02314052|20187825|P2|STARTED|Cycle One||3
8187749|NCT02314052|20187826|P1|STARTED|Cycle One||3
8187750|NCT02314026|20187894|P1|NOT COMPLETED|Overall Study||28
8187751|NCT02314026|20187894|P1|COMPLETED|Overall Study||107
8187752|NCT02314026|20187894|P1|STARTED|Overall Study||135
8187759|NCT02313909|20187912|P2|NOT COMPLETED|Overall Study||50
8187760|NCT02313909|20187913|P1|NOT COMPLETED|Overall Study||57
8187761|NCT02313909|20187912|P2|COMPLETED|Overall Study||3554
8187762|NCT02313909|20187913|P1|COMPLETED|Overall Study||3552
8187763|NCT02313909|20187912|P2|Treated|Overall Study||3559
8187764|NCT02313909|20187913|P1|Treated|Overall Study||3562
8187765|NCT02313909|20187912|P2|STARTED|Overall Study||3604
8187766|NCT02313909|20187913|P1|STARTED|Overall Study||3609
8187767|NCT02313766|20187936|P3|NOT COMPLETED|Overall Study||0
8187768|NCT02313766|20187937|P2|NOT COMPLETED|Overall Study||3
8187769|NCT02313766|20187938|P1|NOT COMPLETED|Overall Study||1
8187770|NCT02313766|20187936|P3|COMPLETED|Overall Study||50
8187771|NCT02313766|20187937|P2|COMPLETED|Overall Study||47
8187772|NCT02313766|20187938|P1|COMPLETED|Overall Study||49
8187773|NCT02313766|20187936|P3|STARTED|Overall Study||50
8187774|NCT02313766|20187937|P2|STARTED|Overall Study||50
8187775|NCT02313766|20187938|P1|STARTED|Overall Study||50
8187776|NCT02313675|20187956|P4|NOT COMPLETED|Overall Study||0
8187777|NCT02313675|20187957|P3|NOT COMPLETED|Overall Study||0
8187778|NCT02313675|20187958|P2|NOT COMPLETED|Overall Study||0
8187779|NCT02313675|20187959|P1|NOT COMPLETED|Overall Study||0
8187780|NCT02313675|20187956|P4|COMPLETED|Overall Study||11
8187781|NCT02313675|20187957|P3|COMPLETED|Overall Study||11
8187782|NCT02313675|20187958|P2|COMPLETED|Overall Study||11
8187783|NCT02313675|20187959|P1|COMPLETED|Overall Study||11
8187784|NCT02313675|20187956|P4|STARTED|Overall Study||11
8187785|NCT02313675|20187957|P3|STARTED|Overall Study||11
8187786|NCT02313675|20187958|P2|STARTED|Overall Study||11
8187787|NCT02313675|20187959|P1|STARTED|Overall Study||11
8187788|NCT02313597|20187975|P2|NOT COMPLETED|Overall Study||0
8187789|NCT02313597|20187976|P1|NOT COMPLETED|Overall Study||0
8187790|NCT02313597|20187975|P2|COMPLETED|Overall Study||40
8187791|NCT02313597|20187976|P1|COMPLETED|Overall Study||40
8187792|NCT02313597|20187975|P2|STARTED|Overall Study||40
8187793|NCT02313597|20187976|P1|STARTED|Overall Study||40
8187794|NCT02313558|20187992|P2|NOT COMPLETED|Overall Study||4
8187795|NCT02313558|20187993|P1|NOT COMPLETED|Overall Study||6
8187796|NCT02313558|20187992|P2|COMPLETED|Overall Study||46
8187797|NCT02313558|20187993|P1|COMPLETED|Overall Study||44
8187798|NCT02313558|20187992|P2|STARTED|Overall Study||50
8187799|NCT02313558|20187993|P1|STARTED|Overall Study||50
8187800|NCT02313506|20188007|P2|NOT COMPLETED|Overall Study||0
8187801|NCT02313506|20188008|P1|NOT COMPLETED|Overall Study||0
8187802|NCT02313506|20188007|P2|COMPLETED|Overall Study||17
8187803|NCT02313506|20188008|P1|COMPLETED|Overall Study||17
8187804|NCT02313506|20188007|P2|STARTED|Overall Study||17
8187805|NCT02313506|20188008|P1|STARTED|Overall Study||17
8187806|NCT02313454|20188028|P2|NOT COMPLETED|Treatment 2||0
8187807|NCT02313454|20188029|P1|NOT COMPLETED|Treatment 2||0
8187808|NCT02313454|20188028|P2|COMPLETED|Treatment 2||10
8187809|NCT02313454|20188029|P1|COMPLETED|Treatment 2||8
8187810|NCT02313454|20188028|P2|STARTED|Treatment 2|1 participant did not receive the second application.|10
8187811|NCT02313454|20188029|P1|STARTED|Treatment 2|1 participant did not receive the second application.|8
8187812|NCT02313454|20188028|P2|NOT COMPLETED|Treatment 1||0
8187813|NCT02313454|20188029|P1|NOT COMPLETED|Treatment 1||0
8187814|NCT02313454|20188028|P2|COMPLETED|Treatment 1||11
8187815|NCT02313454|20188029|P1|COMPLETED|Treatment 1||9
8187816|NCT02313454|20188028|P2|STARTED|Treatment 1||11
8187817|NCT02313454|20188029|P1|STARTED|Treatment 1||9
8187818|NCT02313233|20188039|P2|NOT COMPLETED|Overall Study||3
8187819|NCT02313233|20188040|P1|NOT COMPLETED|Overall Study||2
8187820|NCT02313233|20188039|P2|COMPLETED|Overall Study||18
8187821|NCT02313233|20188040|P1|COMPLETED|Overall Study||18
8187822|NCT02313233|20188039|P2|STARTED|Overall Study||21
8187823|NCT02313233|20188040|P1|STARTED|Overall Study||20
8187824|NCT02313155|20188062|P2|NOT COMPLETED|Overall Study||1
8187825|NCT02313155|20188063|P1|NOT COMPLETED|Overall Study||0
8187826|NCT02313155|20188062|P2|COMPLETED|Overall Study||54
8187827|NCT02313155|20188063|P1|COMPLETED|Overall Study||55
8187828|NCT02313155|20188062|P2|STARTED|Overall Study||55
8187829|NCT02313155|20188063|P1|STARTED|Overall Study||55
8187830|NCT02312934|20188113|P2|NOT COMPLETED|Overall Study||0
8187831|NCT02312934|20188114|P1|NOT COMPLETED|Overall Study||2
8187832|NCT02312934|20188113|P2|COMPLETED|Overall Study||11
8187833|NCT02312934|20188114|P1|COMPLETED|Overall Study||9
8187834|NCT02312934|20188113|P2|STARTED|Overall Study||11
8187835|NCT02312934|20188114|P1|STARTED|Overall Study||11
8187836|NCT02312882|20188122|P1|NOT COMPLETED|Overall Study||4
8187837|NCT02312882|20188122|P1|COMPLETED|Overall Study||36
8187838|NCT02312882|20188122|P1|STARTED|Overall Study||40
8187839|NCT02312856|20188126|P1|NOT COMPLETED|Overall Study||4
8187840|NCT02312856|20188126|P1|COMPLETED|Overall Study||30
8187841|NCT02312856|20188126|P1|STARTED|Overall Study||34
8187842|NCT02312765|20188132|P2|NOT COMPLETED|Overall Study||36
8187843|NCT02312765|20188133|P1|NOT COMPLETED|Overall Study||55
8187844|NCT02312765|20188132|P2|COMPLETED|Overall Study||36
8187845|NCT02312765|20188133|P1|COMPLETED|Overall Study||19
8187846|NCT02312765|20188132|P2|STARTED|Overall Study||72
8187847|NCT02312765|20188133|P1|STARTED|Overall Study||74
8187848|NCT02312739|20188141|P2|NOT COMPLETED|Overall Study||2
8187849|NCT02312739|20188142|P1|NOT COMPLETED|Overall Study||6
8187850|NCT02312739|20188141|P2|COMPLETED|Overall Study||34
8187851|NCT02312739|20188142|P1|COMPLETED|Overall Study||30
8187852|NCT02312739|20188141|P2|Withdrawn Prior to Procedure|Overall Study||2
8187853|NCT02312739|20188142|P1|Withdrawn Prior to Procedure|Overall Study||6
8187854|NCT02312739|20188141|P2|STARTED|Overall Study||36
8187855|NCT02312739|20188142|P1|STARTED|Overall Study||36
8187856|NCT02312726|20188156|P3|NOT COMPLETED|Overall Study||67
8187857|NCT02312726|20188157|P2|NOT COMPLETED|Overall Study||0
8187858|NCT02312726|20188158|P1|NOT COMPLETED|Overall Study||0
8187859|NCT02312726|20188156|P3|COMPLETED|Overall Study||0
8187860|NCT02312726|20188157|P2|COMPLETED|Overall Study||30
8187861|NCT02312726|20188158|P1|COMPLETED|Overall Study||38
8187862|NCT02312726|20188156|P3|STARTED|Overall Study||67
8187863|NCT02312726|20188157|P2|STARTED|Overall Study||30
8187864|NCT02312726|20188158|P1|STARTED|Overall Study||38
8187865|NCT02312713|20188173|P3|NOT COMPLETED|Overall Study||5
8187866|NCT02312713|20188174|P2|NOT COMPLETED|Overall Study||30
8187867|NCT02312713|20188175|P1|NOT COMPLETED|Overall Study||11
8187868|NCT02312713|20188173|P3|COMPLETED|Overall Study||63
8187869|NCT02312713|20188174|P2|COMPLETED|Overall Study||112
8187870|NCT02312713|20188175|P1|COMPLETED|Overall Study||129
8187871|NCT02312713|20188173|P3|STARTED|Overall Study||68
8187872|NCT02312713|20188174|P2|STARTED|Overall Study||142
8187873|NCT02312713|20188175|P1|STARTED|Overall Study||140
8187874|NCT02312687|20188219|P1|NOT COMPLETED|Overall Study||1
8187875|NCT02312687|20188219|P1|COMPLETED|Overall Study||19
8187876|NCT02312687|20188219|P1|STARTED|Overall Study||20
8187877|NCT02312622|20188250|P3|NOT COMPLETED|Overall Study||0
8187878|NCT02312622|20188251|P2|NOT COMPLETED|Overall Study||0
8187879|NCT02312622|20188252|P1|NOT COMPLETED|Overall Study||0
8187880|NCT02312622|20188250|P3|COMPLETED|Overall Study||12
8187881|NCT02312622|20188251|P2|COMPLETED|Overall Study||3
8187882|NCT02312622|20188252|P1|COMPLETED|Overall Study||12
8187883|NCT02312622|20188250|P3|STARTED|Overall Study||12
8187884|NCT02312622|20188251|P2|STARTED|Overall Study||3
8187885|NCT02312622|20188252|P1|STARTED|Overall Study||12
8187886|NCT02312310|20188280|P4|NOT COMPLETED|Overall Study||0
8187887|NCT02312310|20188281|P3|NOT COMPLETED|Overall Study||3
8187888|NCT02312310|20188282|P2|NOT COMPLETED|Overall Study||2
8187889|NCT02312310|20188283|P1|NOT COMPLETED|Overall Study||2
8187890|NCT02312310|20188280|P4|COMPLETED|Overall Study||52
8187891|NCT02312310|20188281|P3|COMPLETED|Overall Study||50
8187892|NCT02312310|20188282|P2|COMPLETED|Overall Study||51
8187893|NCT02312310|20188283|P1|COMPLETED|Overall Study||51
8187894|NCT02312310|20188280|P4|STARTED|Overall Study||52
8187895|NCT02312310|20188281|P3|STARTED|Overall Study||53
8187896|NCT02312310|20188282|P2|STARTED|Overall Study||53
8187897|NCT02312310|20188283|P1|STARTED|Overall Study||53
8187898|NCT02312258|20188311|P2|NOT COMPLETED|Overall Study||359
8187899|NCT02312258|20188312|P1|NOT COMPLETED|Overall Study||251
8187900|NCT02312258|20188311|P2|COMPLETED|Overall Study||66
8187901|NCT02312258|20188312|P1|COMPLETED|Overall Study||30
8187902|NCT02312258|20188311|P2|STARTED|Overall Study||425
8187903|NCT02312258|20188312|P1|STARTED|Overall Study||281
8187904|NCT02312219|20188320|P2|NOT COMPLETED|Overall Study||6
8187905|NCT02312219|20188321|P1|NOT COMPLETED|Overall Study||1
8187906|NCT02312219|20188320|P2|COMPLETED|Overall Study||16
8187907|NCT02312219|20188321|P1|COMPLETED|Overall Study||12
8187908|NCT02312219|20188320|P2|STARTED|Overall Study||22
8187909|NCT02312219|20188321|P1|STARTED|Overall Study||13
8187910|NCT02312206|20188331|P2|NOT COMPLETED|Overall Study||130
8187911|NCT02312206|20188332|P1|NOT COMPLETED|Overall Study||130
8187912|NCT02312206|20188331|P2|COMPLETED|Overall Study||0
8187913|NCT02312206|20188332|P1|COMPLETED|Overall Study||0
8187914|NCT02312206|20188331|P2|Informed Consent Obtained|Overall Study||130
8187915|NCT02312206|20188332|P1|Informed Consent Obtained|Overall Study||130
8187916|NCT02312206|20188331|P2|STARTED|Overall Study||130
8187917|NCT02312206|20188332|P1|STARTED|Overall Study||130
8187918|NCT02312154|20188338|P1|NOT COMPLETED|Overall Study||1
8187919|NCT02312154|20188338|P1|COMPLETED|Overall Study||24
8187920|NCT02312154|20188338|P1|STARTED|Overall Study||25
8187921|NCT02312063|20188355|P2|NOT COMPLETED|Overall Study||1
8187922|NCT02312063|20188356|P1|NOT COMPLETED|Overall Study||0
8187923|NCT02312063|20188355|P2|COMPLETED|Overall Study||24
8187924|NCT02312063|20188356|P1|COMPLETED|Overall Study||23
8187925|NCT02312063|20188355|P2|STARTED|Overall Study||25
8187926|NCT02312063|20188356|P1|STARTED|Overall Study||23
8187927|NCT02311972|20188366|P2|NOT COMPLETED|Overall Study||0
8187928|NCT02311972|20188367|P1|NOT COMPLETED|Overall Study||0
8187929|NCT02311972|20188366|P2|COMPLETED|Overall Study||8
8187930|NCT02311972|20188367|P1|COMPLETED|Overall Study||12
8187931|NCT02311972|20188366|P2|STARTED|Overall Study||8
8187932|NCT02311972|20188367|P1|STARTED|Overall Study||12
8187933|NCT02311907|20188386|P2|NOT COMPLETED|Overall Study||0
8187934|NCT02311907|20188387|P1|NOT COMPLETED|Overall Study||0
8187935|NCT02311907|20188386|P2|COMPLETED|Overall Study||91
8187936|NCT02311907|20188387|P1|COMPLETED|Overall Study||94
8187937|NCT02311907|20188386|P2|STARTED|Overall Study||91
8187938|NCT02311907|20188387|P1|STARTED|Overall Study||94
8187939|NCT02311894|20188409|P1|NOT COMPLETED|Overall Study||4
8187940|NCT02311894|20188409|P1|COMPLETED|Overall Study||78
8187941|NCT02311894|20188409|P1|Modified ITT Population|Overall Study||81
8187942|NCT02311894|20188409|P1|STARTED|Overall Study||82
8187943|NCT02311881|20188421|P3|NOT COMPLETED|Overall Study||41
8187944|NCT02311881|20188422|P2|NOT COMPLETED|Overall Study||43
8187945|NCT02311881|20188423|P1|NOT COMPLETED|Overall Study||35
8187946|NCT02311881|20188421|P3|COMPLETED|Overall Study||196
8187947|NCT02311881|20188422|P2|COMPLETED|Overall Study||193
8187948|NCT02311881|20188423|P1|COMPLETED|Overall Study||200
8187949|NCT02311881|20188421|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
8187950|NCT02311881|20188422|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
8187951|NCT02311881|20188423|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
8187952|NCT02311881|20188421|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
8187953|NCT02311881|20188422|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
8187954|NCT02311881|20188423|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
8187955|NCT02311478|20188458|P1|NOT COMPLETED|Overall Study||7
8187956|NCT02311478|20188458|P1|COMPLETED|Overall Study||72
8187957|NCT02311478|20188458|P1|IUD Insertion|Overall Study||78
8187958|NCT02311478|20188458|P1|STARTED|Overall Study||79
8187959|NCT02311361|20188467|P4|NOT COMPLETED|Overall Study||1
8187960|NCT02311361|20188468|P3|NOT COMPLETED|Overall Study||0
8187961|NCT02311361|20188469|P2|NOT COMPLETED|Overall Study||1
8187962|NCT02311361|20188470|P1|NOT COMPLETED|Overall Study||0
8187963|NCT02311361|20188467|P4|COMPLETED|Overall Study||20
8187964|NCT02311361|20188468|P3|COMPLETED|Overall Study||19
8187965|NCT02311361|20188469|P2|COMPLETED|Overall Study||10
8187966|NCT02311361|20188470|P1|COMPLETED|Overall Study||14
8187967|NCT02311361|20188467|P4|Received Radiation Therapy Only|Overall Study||1
8187968|NCT02311361|20188468|P3|Received Radiation Therapy Only|Overall Study||1
8187969|NCT02311361|20188469|P2|Received Radiation Therapy Only|Overall Study||1
8187970|NCT02311361|20188470|P1|Received Radiation Therapy Only|Overall Study||0
8187971|NCT02311361|20188467|P4|STARTED|Overall Study||21
8187972|NCT02311361|20188468|P3|STARTED|Overall Study||19
8187973|NCT02311361|20188469|P2|STARTED|Overall Study||11
8187974|NCT02311361|20188470|P1|STARTED|Overall Study||14
8187975|NCT02311309|20188507|P3|NOT COMPLETED|Overall Study||0
8187976|NCT02311309|20188508|P2|NOT COMPLETED|Overall Study||0
8187977|NCT02311309|20188509|P1|NOT COMPLETED|Overall Study||0
8187978|NCT02311309|20188507|P3|COMPLETED|Overall Study||863
8187979|NCT02311309|20188508|P2|COMPLETED|Overall Study||35
8187980|NCT02311309|20188509|P1|COMPLETED|Overall Study||541
8187981|NCT02311309|20188507|P3|STARTED|Overall Study||863
8187982|NCT02311309|20188508|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
8187983|NCT02311309|20188509|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
8187984|NCT02311153|20188522|P2|NOT COMPLETED|Overall Study||7
8187985|NCT02311153|20188523|P1|NOT COMPLETED|Overall Study||5
8187986|NCT02311153|20188522|P2|COMPLETED|Overall Study||42
8187987|NCT02311153|20188523|P1|COMPLETED|Overall Study||48
8187988|NCT02311153|20188522|P2|STARTED|Overall Study||49
8187989|NCT02311153|20188523|P1|STARTED|Overall Study||53
8187990|NCT02310906|20188543|P4|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
8187991|NCT02310906|20188544|P3|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
8187992|NCT02310906|20188545|P2|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187993|NCT02310906|20188546|P1|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187994|NCT02310906|20188543|P4|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
8187995|NCT02310906|20188544|P3|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
8187996|NCT02310906|20188545|P2|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187997|NCT02310906|20188546|P1|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187998|NCT02310906|20188543|P4|STARTED|Part 2: Open Label Phase (168 Weeks)||14
8187999|NCT02310906|20188544|P3|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
8188000|NCT02310906|20188545|P2|STARTED|Part 2: Open Label Phase (168 Weeks)||0
8188001|NCT02310906|20188546|P1|STARTED|Part 2: Open Label Phase (168 Weeks)||0
8188002|NCT02310906|20188543|P4|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188003|NCT02310906|20188544|P3|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188004|NCT02310906|20188545|P2|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188005|NCT02310906|20188546|P1|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188006|NCT02310906|20188543|P4|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188007|NCT02310906|20188544|P3|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188008|NCT02310906|20188545|P2|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
8188009|NCT02310906|20188546|P1|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
8188010|NCT02310906|20188543|P4|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188011|NCT02310906|20188544|P3|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188012|NCT02310906|20188545|P2|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188013|NCT02310906|20188546|P1|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188014|NCT02310906|20188543|P4|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188015|NCT02310906|20188544|P3|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188016|NCT02310906|20188545|P2|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188017|NCT02310906|20188546|P1|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188018|NCT02310906|20188543|P4|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188019|NCT02310906|20188544|P3|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188020|NCT02310906|20188545|P2|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188021|NCT02310906|20188546|P1|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188022|NCT02310906|20188543|P4|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188023|NCT02310906|20188544|P3|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188024|NCT02310906|20188545|P2|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188025|NCT02310906|20188546|P1|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188026|NCT02310906|20188543|P4|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
8188027|NCT02310906|20188544|P3|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
8188028|NCT02310906|20188545|P2|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
8188029|NCT02310906|20188546|P1|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
8188030|NCT02310789|20188625|P1|NOT COMPLETED|Overall Study||1
8188031|NCT02310789|20188625|P1|COMPLETED|Overall Study||7
8188032|NCT02310789|20188625|P1|STARTED|Overall Study||8
8188033|NCT02310776|20188630|P1|NOT COMPLETED|Overall Study||0
8188034|NCT02310776|20188630|P1|COMPLETED|Overall Study||501
8188035|NCT02310776|20188630|P1|STARTED|Overall Study||501
8188036|NCT02310763|20188637|P3|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8188037|NCT02310763|20188638|P2|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8188038|NCT02310763|20188639|P1|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8188039|NCT02310763|20188637|P3|COMPLETED|Period 2 (Weeks 49 to 96)||22
8188040|NCT02310763|20188638|P2|COMPLETED|Period 2 (Weeks 49 to 96)||21
8188041|NCT02310763|20188639|P1|COMPLETED|Period 2 (Weeks 49 to 96)||22
8188042|NCT02310763|20188637|P3|STARTED|Period 2 (Weeks 49 to 96)||38
8188043|NCT02310763|20188638|P2|STARTED|Period 2 (Weeks 49 to 96)||37
8188044|NCT02310763|20188639|P1|STARTED|Period 2 (Weeks 49 to 96)||38
8188045|NCT02310763|20188637|P3|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
8188046|NCT02310763|20188638|P2|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
8188047|NCT02310763|20188639|P1|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
8188048|NCT02310763|20188637|P3|COMPLETED|Period 1 (Weeks 1 to 48)||38
8188049|NCT02310763|20188638|P2|COMPLETED|Period 1 (Weeks 1 to 48)||37
8188050|NCT02310763|20188639|P1|COMPLETED|Period 1 (Weeks 1 to 48)||38
8188051|NCT02310763|20188637|P3|STARTED|Period 1 (Weeks 1 to 48)||40
8188052|NCT02310763|20188638|P2|STARTED|Period 1 (Weeks 1 to 48)||39
8188053|NCT02310763|20188639|P1|STARTED|Period 1 (Weeks 1 to 48)||41
8188054|NCT02310750|20188842|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188055|NCT02310750|20188843|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188056|NCT02310750|20188844|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188057|NCT02310750|20188845|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188058|NCT02310750|20188846|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188059|NCT02310750|20188847|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188060|NCT02310750|20188848|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188061|NCT02310750|20188849|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188062|NCT02310750|20188850|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188063|NCT02310750|20188851|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188064|NCT02310750|20188852|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188065|NCT02310750|20188853|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
8188066|NCT02310750|20188854|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188067|NCT02310750|20188855|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188068|NCT02310750|20188856|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188069|NCT02310750|20188857|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188070|NCT02310750|20188842|P16|COMPLETED|HP MAD and Fasted/Fed||2
8188071|NCT02310750|20188843|P15|COMPLETED|HP MAD and Fasted/Fed||2
8188072|NCT02310750|20188844|P14|COMPLETED|HP MAD and Fasted/Fed||2
8188073|NCT02310750|20188845|P13|COMPLETED|HP MAD and Fasted/Fed||2
8188074|NCT02310750|20188846|P12|COMPLETED|HP MAD and Fasted/Fed||2
8188075|NCT02310750|20188847|P11|COMPLETED|HP MAD and Fasted/Fed||2
8188076|NCT02310750|20188848|P10|COMPLETED|HP MAD and Fasted/Fed||0
8188077|NCT02310750|20188849|P9|COMPLETED|HP MAD and Fasted/Fed||0
8188078|NCT02310750|20188850|P8|COMPLETED|HP MAD and Fasted/Fed||0
8188079|NCT02310750|20188851|P7|COMPLETED|HP MAD and Fasted/Fed||2
8188080|NCT02310750|20188852|P6|COMPLETED|HP MAD and Fasted/Fed||0
8188081|NCT02310750|20188853|P5|COMPLETED|HP MAD and Fasted/Fed||4
8188082|NCT02310750|20188854|P4|COMPLETED|HP MAD and Fasted/Fed||0
8188083|NCT02310750|20188855|P3|COMPLETED|HP MAD and Fasted/Fed||0
8188084|NCT02310750|20188856|P2|COMPLETED|HP MAD and Fasted/Fed||0
8188085|NCT02310750|20188857|P1|COMPLETED|HP MAD and Fasted/Fed||0
8188086|NCT02310750|20188842|P16|STARTED|HP MAD and Fasted/Fed||2
8188087|NCT02310750|20188843|P15|STARTED|HP MAD and Fasted/Fed||2
8188088|NCT02310750|20188844|P14|STARTED|HP MAD and Fasted/Fed||2
8188089|NCT02310750|20188845|P13|STARTED|HP MAD and Fasted/Fed||2
8188090|NCT02310750|20188846|P12|STARTED|HP MAD and Fasted/Fed||2
8188091|NCT02310750|20188847|P11|STARTED|HP MAD and Fasted/Fed||2
8188092|NCT02310750|20188848|P10|STARTED|HP MAD and Fasted/Fed||0
8188093|NCT02310750|20188849|P9|STARTED|HP MAD and Fasted/Fed||0
8188094|NCT02310750|20188850|P8|STARTED|HP MAD and Fasted/Fed||0
8188095|NCT02310750|20188851|P7|STARTED|HP MAD and Fasted/Fed||2
8188096|NCT02310750|20188852|P6|STARTED|HP MAD and Fasted/Fed||0
8188097|NCT02310750|20188853|P5|STARTED|HP MAD and Fasted/Fed||5
8188098|NCT02310750|20188854|P4|STARTED|HP MAD and Fasted/Fed||0
8188099|NCT02310750|20188855|P3|STARTED|HP MAD and Fasted/Fed||0
8188100|NCT02310750|20188856|P2|STARTED|HP MAD and Fasted/Fed||0
8188101|NCT02310750|20188857|P1|STARTED|HP MAD and Fasted/Fed||0
8188102|NCT02310750|20188842|P16|NOT COMPLETED|HP Washout 2||0
8188103|NCT02310750|20188843|P15|NOT COMPLETED|HP Washout 2||0
8188104|NCT02310750|20188844|P14|NOT COMPLETED|HP Washout 2||0
8188105|NCT02310750|20188845|P13|NOT COMPLETED|HP Washout 2||0
8188106|NCT02310750|20188846|P12|NOT COMPLETED|HP Washout 2||0
8188107|NCT02310750|20188847|P11|NOT COMPLETED|HP Washout 2||0
8188108|NCT02310750|20188848|P10|NOT COMPLETED|HP Washout 2||0
8188109|NCT02310750|20188849|P9|NOT COMPLETED|HP Washout 2||0
8188110|NCT02310750|20188850|P8|NOT COMPLETED|HP Washout 2||0
8188111|NCT02310750|20188851|P7|NOT COMPLETED|HP Washout 2||7
8188112|NCT02310750|20188852|P6|NOT COMPLETED|HP Washout 2||0
8188113|NCT02310750|20188853|P5|NOT COMPLETED|HP Washout 2||1
8188114|NCT02310750|20188854|P4|NOT COMPLETED|HP Washout 2||0
8188115|NCT02310750|20188855|P3|NOT COMPLETED|HP Washout 2||0
8188116|NCT02310750|20188856|P2|NOT COMPLETED|HP Washout 2||0
8188117|NCT02310750|20188857|P1|NOT COMPLETED|HP Washout 2||0
8188118|NCT02310750|20188842|P16|COMPLETED|HP Washout 2||2
8188119|NCT02310750|20188843|P15|COMPLETED|HP Washout 2||2
8188120|NCT02310750|20188844|P14|COMPLETED|HP Washout 2||2
8188121|NCT02310750|20188845|P13|COMPLETED|HP Washout 2||2
8188122|NCT02310750|20188846|P12|COMPLETED|HP Washout 2||2
8188123|NCT02310750|20188847|P11|COMPLETED|HP Washout 2||2
8188124|NCT02310750|20188848|P10|COMPLETED|HP Washout 2||0
8188125|NCT02310750|20188849|P9|COMPLETED|HP Washout 2||0
8188126|NCT02310750|20188850|P8|COMPLETED|HP Washout 2||0
8188127|NCT02310750|20188851|P7|COMPLETED|HP Washout 2||2
8188128|NCT02310750|20188852|P6|COMPLETED|HP Washout 2||0
8188129|NCT02310750|20188853|P5|COMPLETED|HP Washout 2||5
8188130|NCT02310750|20188854|P4|COMPLETED|HP Washout 2||0
8188131|NCT02310750|20188855|P3|COMPLETED|HP Washout 2||0
8188132|NCT02310750|20188856|P2|COMPLETED|HP Washout 2||0
8188133|NCT02310750|20188857|P1|COMPLETED|HP Washout 2||0
8188134|NCT02310750|20188842|P16|STARTED|HP Washout 2||2
8188135|NCT02310750|20188843|P15|STARTED|HP Washout 2||2
8188136|NCT02310750|20188844|P14|STARTED|HP Washout 2||2
8188137|NCT02310750|20188845|P13|STARTED|HP Washout 2||2
8188138|NCT02310750|20188846|P12|STARTED|HP Washout 2||2
8188139|NCT02310750|20188847|P11|STARTED|HP Washout 2||2
8188140|NCT02310750|20188848|P10|STARTED|HP Washout 2||0
8188141|NCT02310750|20188849|P9|STARTED|HP Washout 2||0
8188142|NCT02310750|20188850|P8|STARTED|HP Washout 2||0
8188143|NCT02310750|20188851|P7|STARTED|HP Washout 2||9
8188144|NCT02310750|20188852|P6|STARTED|HP Washout 2||0
8188145|NCT02310750|20188853|P5|STARTED|HP Washout 2||6
8188146|NCT02310750|20188854|P4|STARTED|HP Washout 2||0
8188147|NCT02310750|20188855|P3|STARTED|HP Washout 2||0
8188148|NCT02310750|20188856|P2|STARTED|HP Washout 2||0
8188149|NCT02310750|20188857|P1|STARTED|HP Washout 2||0
8188150|NCT02310750|20188842|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188151|NCT02310750|20188843|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188152|NCT02310750|20188844|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188153|NCT02310750|20188845|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188154|NCT02310750|20188846|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188155|NCT02310750|20188847|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188156|NCT02310750|20188848|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
8188157|NCT02310750|20188849|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
8188158|NCT02310750|20188850|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188159|NCT02310750|20188851|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188160|NCT02310750|20188852|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188161|NCT02310750|20188853|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188162|NCT02310750|20188854|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
8188163|NCT02310750|20188855|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188164|NCT02310750|20188856|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188165|NCT02310750|20188857|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188166|NCT02310750|20188842|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188167|NCT02310750|20188843|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188168|NCT02310750|20188844|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188169|NCT02310750|20188845|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188170|NCT02310750|20188846|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188171|NCT02310750|20188847|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188172|NCT02310750|20188848|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8188173|NCT02310750|20188849|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188174|NCT02310750|20188850|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
8188175|NCT02310750|20188851|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8188176|NCT02310750|20188852|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8188177|NCT02310750|20188853|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188178|NCT02310750|20188854|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
8188179|NCT02310750|20188855|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
8188180|NCT02310750|20188856|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188181|NCT02310750|20188857|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188182|NCT02310750|20188842|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188183|NCT02310750|20188843|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188184|NCT02310750|20188844|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188185|NCT02310750|20188845|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188186|NCT02310750|20188846|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188187|NCT02310750|20188847|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188188|NCT02310750|20188848|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
8188189|NCT02310750|20188849|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
8188190|NCT02310750|20188850|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8188191|NCT02310750|20188851|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8188192|NCT02310750|20188852|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188193|NCT02310750|20188853|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188194|NCT02310750|20188854|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8188195|NCT02310750|20188855|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
8188196|NCT02310750|20188856|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188197|NCT02310750|20188857|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188198|NCT02310750|20188842|P16|NOT COMPLETED|HP Washout 1||0
8188199|NCT02310750|20188843|P15|NOT COMPLETED|HP Washout 1||0
8188200|NCT02310750|20188844|P14|NOT COMPLETED|HP Washout 1||0
8188201|NCT02310750|20188845|P13|NOT COMPLETED|HP Washout 1||0
8188202|NCT02310750|20188846|P12|NOT COMPLETED|HP Washout 1||0
8188203|NCT02310750|20188847|P11|NOT COMPLETED|HP Washout 1||0
8188204|NCT02310750|20188848|P10|NOT COMPLETED|HP Washout 1||0
8188205|NCT02310750|20188849|P9|NOT COMPLETED|HP Washout 1||0
8188206|NCT02310750|20188850|P8|NOT COMPLETED|HP Washout 1||0
8188207|NCT02310750|20188851|P7|NOT COMPLETED|HP Washout 1||3
8188208|NCT02310750|20188852|P6|NOT COMPLETED|HP Washout 1||2
8188209|NCT02310750|20188853|P5|NOT COMPLETED|HP Washout 1||2
8188210|NCT02310750|20188854|P4|NOT COMPLETED|HP Washout 1||1
8188211|NCT02310750|20188855|P3|NOT COMPLETED|HP Washout 1||1
8188212|NCT02310750|20188856|P2|NOT COMPLETED|HP Washout 1||0
8188213|NCT02310750|20188857|P1|NOT COMPLETED|HP Washout 1||0
8188214|NCT02310750|20188842|P16|COMPLETED|HP Washout 1||2
8188215|NCT02310750|20188843|P15|COMPLETED|HP Washout 1||2
8188216|NCT02310750|20188844|P14|COMPLETED|HP Washout 1||2
8188217|NCT02310750|20188845|P13|COMPLETED|HP Washout 1||2
8188218|NCT02310750|20188846|P12|COMPLETED|HP Washout 1||2
8188219|NCT02310750|20188847|P11|COMPLETED|HP Washout 1||2
8188220|NCT02310750|20188848|P10|COMPLETED|HP Washout 1||0
8188221|NCT02310750|20188849|P9|COMPLETED|HP Washout 1||0
8188222|NCT02310750|20188850|P8|COMPLETED|HP Washout 1||0
8188223|NCT02310750|20188851|P7|COMPLETED|HP Washout 1||9
8188224|NCT02310750|20188852|P6|COMPLETED|HP Washout 1||6
8188225|NCT02310750|20188853|P5|COMPLETED|HP Washout 1||6
8188226|NCT02310750|20188854|P4|COMPLETED|HP Washout 1||4
8188227|NCT02310750|20188855|P3|COMPLETED|HP Washout 1||5
8188228|NCT02310750|20188856|P2|COMPLETED|HP Washout 1||0
8188229|NCT02310750|20188857|P1|COMPLETED|HP Washout 1||0
8188230|NCT02310750|20188842|P16|STARTED|HP Washout 1||2
8188231|NCT02310750|20188843|P15|STARTED|HP Washout 1||2
8188232|NCT02310750|20188844|P14|STARTED|HP Washout 1||2
8188233|NCT02310750|20188845|P13|STARTED|HP Washout 1||2
8188234|NCT02310750|20188846|P12|STARTED|HP Washout 1||2
8188235|NCT02310750|20188847|P11|STARTED|HP Washout 1||2
8188236|NCT02310750|20188848|P10|STARTED|HP Washout 1||0
8188237|NCT02310750|20188849|P9|STARTED|HP Washout 1||0
8188238|NCT02310750|20188850|P8|STARTED|HP Washout 1||0
8188239|NCT02310750|20188851|P7|STARTED|HP Washout 1||12
8188240|NCT02310750|20188852|P6|STARTED|HP Washout 1||8
8188241|NCT02310750|20188853|P5|STARTED|HP Washout 1||8
8188242|NCT02310750|20188854|P4|STARTED|HP Washout 1||5
8188243|NCT02310750|20188855|P3|STARTED|HP Washout 1||6
8188244|NCT02310750|20188856|P2|STARTED|HP Washout 1||0
8188245|NCT02310750|20188857|P1|STARTED|HP Washout 1||0
8188246|NCT02310750|20188842|P16|NOT COMPLETED|HP Period 1||0
8188247|NCT02310750|20188843|P15|NOT COMPLETED|HP Period 1||0
8188248|NCT02310750|20188844|P14|NOT COMPLETED|HP Period 1||0
8188249|NCT02310750|20188845|P13|NOT COMPLETED|HP Period 1||0
8188250|NCT02310750|20188846|P12|NOT COMPLETED|HP Period 1||0
8188251|NCT02310750|20188847|P11|NOT COMPLETED|HP Period 1||0
8188252|NCT02310750|20188848|P10|NOT COMPLETED|HP Period 1||0
8188253|NCT02310750|20188849|P9|NOT COMPLETED|HP Period 1||0
8188254|NCT02310750|20188850|P8|NOT COMPLETED|HP Period 1||0
8188255|NCT02310750|20188851|P7|NOT COMPLETED|HP Period 1||1
8188256|NCT02310750|20188852|P6|NOT COMPLETED|HP Period 1||0
8188257|NCT02310750|20188853|P5|NOT COMPLETED|HP Period 1||0
8188258|NCT02310750|20188854|P4|NOT COMPLETED|HP Period 1||1
8188259|NCT02310750|20188855|P3|NOT COMPLETED|HP Period 1||0
8188260|NCT02310750|20188856|P2|NOT COMPLETED|HP Period 1||0
8188261|NCT02310750|20188857|P1|NOT COMPLETED|HP Period 1||1
8188262|NCT02310750|20188842|P16|COMPLETED|HP Period 1||2
8188263|NCT02310750|20188843|P15|COMPLETED|HP Period 1||2
8188264|NCT02310750|20188844|P14|COMPLETED|HP Period 1||2
8188265|NCT02310750|20188845|P13|COMPLETED|HP Period 1||2
8188266|NCT02310750|20188846|P12|COMPLETED|HP Period 1||2
8188267|NCT02310750|20188847|P11|COMPLETED|HP Period 1||2
8188268|NCT02310750|20188848|P10|COMPLETED|HP Period 1||0
8188269|NCT02310750|20188849|P9|COMPLETED|HP Period 1||0
8188270|NCT02310750|20188850|P8|COMPLETED|HP Period 1||0
8188271|NCT02310750|20188851|P7|COMPLETED|HP Period 1||12
8188272|NCT02310750|20188852|P6|COMPLETED|HP Period 1||8
8188273|NCT02310750|20188853|P5|COMPLETED|HP Period 1||8
8188274|NCT02310750|20188854|P4|COMPLETED|HP Period 1||5
8188275|NCT02310750|20188855|P3|COMPLETED|HP Period 1||6
8188276|NCT02310750|20188856|P2|COMPLETED|HP Period 1||6
8188277|NCT02310750|20188857|P1|COMPLETED|HP Period 1||6
8188278|NCT02310750|20188842|P16|STARTED|HP Period 1||2
8188279|NCT02310750|20188843|P15|STARTED|HP Period 1||2
8188280|NCT02310750|20188844|P14|STARTED|HP Period 1||2
8188281|NCT02310750|20188845|P13|STARTED|HP Period 1||2
8188282|NCT02310750|20188846|P12|STARTED|HP Period 1||2
8188283|NCT02310750|20188847|P11|STARTED|HP Period 1||2
8188284|NCT02310750|20188848|P10|STARTED|HP Period 1||0
8188285|NCT02310750|20188849|P9|STARTED|HP Period 1||0
8188286|NCT02310750|20188850|P8|STARTED|HP Period 1||0
8188287|NCT02310750|20188851|P7|STARTED|HP Period 1||13
8188288|NCT02310750|20188852|P6|STARTED|HP Period 1||8
8188289|NCT02310750|20188853|P5|STARTED|HP Period 1||8
8188290|NCT02310750|20188854|P4|STARTED|HP Period 1||6
8188291|NCT02310750|20188855|P3|STARTED|HP Period 1||6
8188292|NCT02310750|20188856|P2|STARTED|HP Period 1||6
8188293|NCT02310750|20188857|P1|STARTED|HP Period 1||7
8188294|NCT02310672|20189296|P1|NOT COMPLETED|Overall Study||15
8188295|NCT02310672|20189296|P1|COMPLETED|Overall Study||72
8188296|NCT02310672|20189296|P1|STARTED|Overall Study||87
8188297|NCT02310646|20189309|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
8188298|NCT02310646|20189310|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
8188299|NCT02310646|20189309|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
8188300|NCT02310646|20189310|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
8188301|NCT02310646|20189309|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
8188302|NCT02310646|20189310|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
8188303|NCT02310646|20189309|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
8188304|NCT02310646|20189310|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
8188305|NCT02310646|20189309|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
8188306|NCT02310646|20189310|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
8188307|NCT02310646|20189309|P2|STARTED|First Intervention (Day 1 - Day 7)||104
8188308|NCT02310646|20189310|P1|STARTED|First Intervention (Day 1 - Day 7)||109
8188309|NCT02310581|20189338|P4|NOT COMPLETED|Overall Study||1
8188310|NCT02310581|20189339|P3|NOT COMPLETED|Overall Study||1
8188311|NCT02310581|20189340|P2|NOT COMPLETED|Overall Study||2
8188312|NCT02310581|20189341|P1|NOT COMPLETED|Overall Study||3
8188313|NCT02310581|20189338|P4|COMPLETED|Overall Study||9
8188314|NCT02310581|20189339|P3|COMPLETED|Overall Study||9
8188315|NCT02310581|20189340|P2|COMPLETED|Overall Study||9
8188316|NCT02310581|20189341|P1|COMPLETED|Overall Study||6
8188317|NCT02310581|20189338|P4|STARTED|Overall Study||10
8188318|NCT02310581|20189339|P3|STARTED|Overall Study||10
8188319|NCT02310581|20189340|P2|STARTED|Overall Study||11
8188320|NCT02310581|20189341|P1|STARTED|Overall Study||9
8188321|NCT02310568|20189380|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188322|NCT02310568|20189381|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
8188323|NCT02310568|20189382|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188324|NCT02310568|20189383|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188325|NCT02310568|20189384|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188326|NCT02310568|20189380|P5|COMPLETED|Stage 2 (4 Weeks)||19
8188327|NCT02310568|20189381|P4|COMPLETED|Stage 2 (4 Weeks)||17
8188328|NCT02310568|20189382|P3|COMPLETED|Stage 2 (4 Weeks)||13
8188329|NCT02310568|20189383|P2|COMPLETED|Stage 2 (4 Weeks)||12
8188330|NCT02310568|20189384|P1|COMPLETED|Stage 2 (4 Weeks)||11
8188331|NCT02310568|20189380|P5|STARTED|Stage 2 (4 Weeks)||20
8188332|NCT02310568|20189381|P4|STARTED|Stage 2 (4 Weeks)||22
8188333|NCT02310568|20189382|P3|STARTED|Stage 2 (4 Weeks)||14
8188334|NCT02310568|20189383|P2|STARTED|Stage 2 (4 Weeks)||13
8188335|NCT02310568|20189384|P1|STARTED|Stage 2 (4 Weeks)||12
8188336|NCT02310568|20189380|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
8188337|NCT02310568|20189381|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
8188338|NCT02310568|20189382|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
8188339|NCT02310568|20189383|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
8188340|NCT02310568|20189384|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
8188341|NCT02310568|20189380|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
8188342|NCT02310568|20189381|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
8188343|NCT02310568|20189382|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
8188344|NCT02310568|20189383|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
8188345|NCT02310568|20189384|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
8188346|NCT02310568|20189380|P5|STARTED|Stage 1 ( 4 Weeks)||21
8188347|NCT02310568|20189381|P4|STARTED|Stage 1 ( 4 Weeks)||24
8188348|NCT02310568|20189382|P3|STARTED|Stage 1 ( 4 Weeks)||15
8188349|NCT02310568|20189383|P2|STARTED|Stage 1 ( 4 Weeks)||15
8188350|NCT02310568|20189384|P1|STARTED|Stage 1 ( 4 Weeks)||15
8188351|NCT02310126|20189464|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
8188352|NCT02310126|20189465|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
8188353|NCT02310126|20189464|P2|COMPLETED|Period 2 (15 Minutes)||95
8188354|NCT02310126|20189465|P1|COMPLETED|Period 2 (15 Minutes)||94
8188355|NCT02310126|20189464|P2|Myopes|Period 2 (15 Minutes)||63
8188356|NCT02310126|20189465|P1|Myopes|Period 2 (15 Minutes)||56
8188357|NCT02310126|20189464|P2|Hyperopes|Period 2 (15 Minutes)||32
8188358|NCT02310126|20189465|P1|Hyperopes|Period 2 (15 Minutes)||38
8188359|NCT02310126|20189464|P2|STARTED|Period 2 (15 Minutes)||95
8188360|NCT02310126|20189465|P1|STARTED|Period 2 (15 Minutes)||94
8188361|NCT02310126|20189464|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
8188362|NCT02310126|20189465|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
8188363|NCT02310126|20189464|P2|COMPLETED|Period 1 (15 Minutes)||95
8188364|NCT02310126|20189465|P1|COMPLETED|Period 1 (15 Minutes)||94
8188365|NCT02310126|20189464|P2|Myopes|Period 1 (15 Minutes)||64
8188366|NCT02310126|20189465|P1|Myopes|Period 1 (15 Minutes)||56
8188367|NCT02310126|20189464|P2|Hyperopes|Period 1 (15 Minutes)||33
8188368|NCT02310126|20189465|P1|Hyperopes|Period 1 (15 Minutes)||38
8188369|NCT02310126|20189464|P2|STARTED|Period 1 (15 Minutes)||97
8188370|NCT02310126|20189465|P1|STARTED|Period 1 (15 Minutes)||94
8188371|NCT02310100|20189471|P1|NOT COMPLETED|Overall Study||18
8188372|NCT02310100|20189471|P1|COMPLETED|Overall Study||160
8188373|NCT02310100|20189471|P1|STARTED|Overall Study|First enrollment|178
8188374|NCT02309944|20189478|P2|NOT COMPLETED|Overall Study||0
8188375|NCT02309944|20189479|P1|NOT COMPLETED|Overall Study||0
8188376|NCT02309944|20189478|P2|COMPLETED|Overall Study||43
8188377|NCT02309944|20189479|P1|COMPLETED|Overall Study||38
8188378|NCT02309944|20189478|P2|STARTED|Overall Study||43
8188379|NCT02309944|20189479|P1|STARTED|Overall Study||38
8188380|NCT02309723|20189490|P3|NOT COMPLETED|Overall Study||24
8188381|NCT02309723|20189491|P2|NOT COMPLETED|Overall Study||23
8188382|NCT02309723|20189492|P1|NOT COMPLETED|Overall Study||24
8188383|NCT02309723|20189490|P3|COMPLETED|Overall Study||105
8188384|NCT02309723|20189491|P2|COMPLETED|Overall Study||105
8188385|NCT02309723|20189492|P1|COMPLETED|Overall Study||105
8188386|NCT02309723|20189490|P3|STARTED|Overall Study||129
8188387|NCT02309723|20189491|P2|STARTED|Overall Study||128
8188388|NCT02309723|20189492|P1|STARTED|Overall Study||129
8188389|NCT02309515|20189508|P2|NOT COMPLETED|Overall Study||1
8188390|NCT02309515|20189509|P1|NOT COMPLETED|Overall Study||0
8188391|NCT02309515|20189508|P2|COMPLETED|Overall Study||6
8188392|NCT02309515|20189509|P1|COMPLETED|Overall Study||5
8188393|NCT02309515|20189508|P2|STARTED|Overall Study||7
8188394|NCT02309515|20189509|P1|STARTED|Overall Study||5
8188395|NCT02309489|20189523|P2|NOT COMPLETED|Overall Study||14
8188396|NCT02309489|20189524|P1|NOT COMPLETED|Overall Study||15
8188397|NCT02309489|20189523|P2|COMPLETED|Overall Study||547
8188398|NCT02309489|20189524|P1|COMPLETED|Overall Study||568
8188399|NCT02309489|20189523|P2|Follow-up at 3 Months Postpartum|Overall Study||541
8188400|NCT02309489|20189524|P1|Follow-up at 3 Months Postpartum|Overall Study||560
8188401|NCT02309489|20189523|P2|STARTED|Overall Study||561
8188402|NCT02309489|20189524|P1|STARTED|Overall Study||583
8188403|NCT02309411|20189550|P3|NOT COMPLETED|Overall Study||0
8188404|NCT02309411|20189551|P2|NOT COMPLETED|Overall Study||1
8188405|NCT02309411|20189552|P1|NOT COMPLETED|Overall Study||2
8188406|NCT02309411|20189550|P3|COMPLETED|Overall Study||6
8188407|NCT02309411|20189551|P2|COMPLETED|Overall Study||14
8188408|NCT02309411|20189552|P1|COMPLETED|Overall Study||23
8188409|NCT02309411|20189550|P3|STARTED|Overall Study||6
8188410|NCT02309411|20189551|P2|STARTED|Overall Study||15
8188411|NCT02309411|20189552|P1|STARTED|Overall Study||25
8188412|NCT02309372|20189573|P2|NOT COMPLETED|Overall Study||2
8188413|NCT02309372|20189574|P1|NOT COMPLETED|Overall Study||3
8188414|NCT02309372|20189573|P2|COMPLETED|Overall Study||25
8188415|NCT02309372|20189574|P1|COMPLETED|Overall Study||24
8188416|NCT02309372|20189573|P2|STARTED|Overall Study||27
8188417|NCT02309372|20189574|P1|STARTED|Overall Study||27
8188418|NCT02309359|20189591|P5|NOT COMPLETED|Overall Study||9
8188419|NCT02309359|20189592|P4|NOT COMPLETED|Overall Study||12
8188420|NCT02309359|20189593|P3|NOT COMPLETED|Overall Study||11
8188421|NCT02309359|20189594|P2|NOT COMPLETED|Overall Study||8
8188422|NCT02309359|20189595|P1|NOT COMPLETED|Overall Study||12
8188423|NCT02309359|20189591|P5|COMPLETED|Overall Study||60
8188424|NCT02309359|20189592|P4|COMPLETED|Overall Study||57
8188425|NCT02309359|20189593|P3|COMPLETED|Overall Study||57
8188426|NCT02309359|20189594|P2|COMPLETED|Overall Study||62
8188427|NCT02309359|20189595|P1|COMPLETED|Overall Study||57
8188428|NCT02309359|20189591|P5|STARTED|Overall Study||69
8188429|NCT02309359|20189592|P4|STARTED|Overall Study||69
8188430|NCT02309359|20189593|P3|STARTED|Overall Study||68
8188431|NCT02309359|20189594|P2|STARTED|Overall Study||70
8188432|NCT02309359|20189595|P1|STARTED|Overall Study||69
8188433|NCT02309294|20189722|P1|NOT COMPLETED|Overall Study||2
8188434|NCT02309294|20189722|P1|COMPLETED|Overall Study||41
8188435|NCT02309294|20189722|P1|STARTED|Overall Study||43
8188436|NCT02309138|20189728|P2|NOT COMPLETED|Overall Study||18
8188437|NCT02309138|20189729|P1|NOT COMPLETED|Overall Study||48
8188438|NCT02309138|20189728|P2|COMPLETED|Overall Study||443
8188439|NCT02309138|20189729|P1|COMPLETED|Overall Study||412
8188440|NCT02309138|20189728|P2|STARTED|Overall Study||461
8188441|NCT02309138|20189729|P1|STARTED|Overall Study||460
8188442|NCT02309112|20189752|P3|NOT COMPLETED|Overall Study||1
8188443|NCT02309112|20189753|P2|NOT COMPLETED|Overall Study||1
8188444|NCT02309112|20189754|P1|NOT COMPLETED|Overall Study||1
8188445|NCT02309112|20189752|P3|COMPLETED|Overall Study||4
8188446|NCT02309112|20189753|P2|COMPLETED|Overall Study||4
8188447|NCT02309112|20189754|P1|COMPLETED|Overall Study||4
8188448|NCT02309112|20189752|P3|Completed Yoga Intervention|Overall Study||4
8188449|NCT02309112|20189753|P2|Completed Yoga Intervention|Overall Study||5
8188450|NCT02309112|20189754|P1|Completed Yoga Intervention|Overall Study||4
8188451|NCT02309112|20189752|P3|STARTED|Overall Study||5
8188452|NCT02309112|20189753|P2|STARTED|Overall Study||5
8188453|NCT02309112|20189754|P1|STARTED|Overall Study||5
8188454|NCT02309099|20189777|P2|NOT COMPLETED|Overall Study||0
8188455|NCT02309099|20189778|P1|NOT COMPLETED|Overall Study||2
8188456|NCT02309099|20189777|P2|COMPLETED|Overall Study||3
8188457|NCT02309099|20189778|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
8188458|NCT02309099|20189777|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
8188558|NCT02308748|20189855|P4|STARTED|Period 3||2
8188459|NCT02309099|20189778|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
8188460|NCT02309099|20189777|P2|Initial Activation|Overall Study||3
8188461|NCT02309099|20189778|P1|Initial Activation|Overall Study||7
8188462|NCT02309099|20189777|P2|Cochlear Implantation|Overall Study||3
8188463|NCT02309099|20189778|P1|Cochlear Implantation|Overall Study||7
8188464|NCT02309099|20189777|P2|STARTED|Overall Study||3
8188465|NCT02309099|20189778|P1|STARTED|Overall Study||7
8188466|NCT02308839|20189824|P1|NOT COMPLETED|Overall Study||109
8188467|NCT02308839|20189824|P1|COMPLETED|Overall Study||72
8188468|NCT02308839|20189824|P1|STARTED|Overall Study||181
8188469|NCT02308787|20189834|P1|NOT COMPLETED|Overall Study||0
8188470|NCT02308787|20189834|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
8188471|NCT02308787|20189834|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
8188472|NCT02308748|20189849|P10|NOT COMPLETED|Period 5||0
8188473|NCT02308748|20189850|P9|NOT COMPLETED|Period 5||1
8188474|NCT02308748|20189851|P8|NOT COMPLETED|Period 5||0
8188475|NCT02308748|20189852|P7|NOT COMPLETED|Period 5||0
8188476|NCT02308748|20189853|P6|NOT COMPLETED|Period 5||0
8188477|NCT02308748|20189854|P5|NOT COMPLETED|Period 5||0
8188478|NCT02308748|20189855|P4|NOT COMPLETED|Period 5||0
8188479|NCT02308748|20189856|P3|NOT COMPLETED|Period 5||0
8188480|NCT02308748|20189857|P2|NOT COMPLETED|Period 5||0
8188481|NCT02308748|20189858|P1|NOT COMPLETED|Period 5||1
8188482|NCT02308748|20189849|P10|COMPLETED|Period 5||2
8188483|NCT02308748|20189850|P9|COMPLETED|Period 5||1
8188484|NCT02308748|20189851|P8|COMPLETED|Period 5||1
8188485|NCT02308748|20189852|P7|COMPLETED|Period 5||2
8188486|NCT02308748|20189853|P6|COMPLETED|Period 5||3
8188487|NCT02308748|20189854|P5|COMPLETED|Period 5||2
8188488|NCT02308748|20189855|P4|COMPLETED|Period 5||2
8188489|NCT02308748|20189856|P3|COMPLETED|Period 5||1
8188490|NCT02308748|20189857|P2|COMPLETED|Period 5||2
8188491|NCT02308748|20189858|P1|COMPLETED|Period 5||1
8188492|NCT02308748|20189849|P10|STARTED|Period 5||2
8188493|NCT02308748|20189850|P9|STARTED|Period 5||2
8188494|NCT02308748|20189851|P8|STARTED|Period 5||1
8188495|NCT02308748|20189852|P7|STARTED|Period 5||2
8188496|NCT02308748|20189853|P6|STARTED|Period 5||3
8188497|NCT02308748|20189854|P5|STARTED|Period 5||2
8188498|NCT02308748|20189855|P4|STARTED|Period 5||2
8188499|NCT02308748|20189856|P3|STARTED|Period 5||1
8188500|NCT02308748|20189857|P2|STARTED|Period 5||2
8188501|NCT02308748|20189858|P1|STARTED|Period 5||2
8188502|NCT02308748|20189849|P10|NOT COMPLETED|Period 4||0
8188503|NCT02308748|20189850|P9|NOT COMPLETED|Period 4||0
8188504|NCT02308748|20189851|P8|NOT COMPLETED|Period 4||0
8188505|NCT02308748|20189852|P7|NOT COMPLETED|Period 4||0
8188506|NCT02308748|20189853|P6|NOT COMPLETED|Period 4||0
8188507|NCT02308748|20189854|P5|NOT COMPLETED|Period 4||0
8188508|NCT02308748|20189855|P4|NOT COMPLETED|Period 4||0
8188509|NCT02308748|20189856|P3|NOT COMPLETED|Period 4||0
8188510|NCT02308748|20189857|P2|NOT COMPLETED|Period 4||0
8188511|NCT02308748|20189858|P1|NOT COMPLETED|Period 4||0
8188512|NCT02308748|20189849|P10|COMPLETED|Period 4||2
8188513|NCT02308748|20189850|P9|COMPLETED|Period 4||2
8188514|NCT02308748|20189851|P8|COMPLETED|Period 4||1
8188515|NCT02308748|20189852|P7|COMPLETED|Period 4||2
8188516|NCT02308748|20189853|P6|COMPLETED|Period 4||3
8188517|NCT02308748|20189854|P5|COMPLETED|Period 4||2
8188518|NCT02308748|20189855|P4|COMPLETED|Period 4||2
8188519|NCT02308748|20189856|P3|COMPLETED|Period 4||1
8188520|NCT02308748|20189857|P2|COMPLETED|Period 4||2
8188521|NCT02308748|20189858|P1|COMPLETED|Period 4||2
8188522|NCT02308748|20189849|P10|STARTED|Period 4||2
8188523|NCT02308748|20189850|P9|STARTED|Period 4||2
8188524|NCT02308748|20189851|P8|STARTED|Period 4||1
8188525|NCT02308748|20189852|P7|STARTED|Period 4||2
8188526|NCT02308748|20189853|P6|STARTED|Period 4||3
8188527|NCT02308748|20189854|P5|STARTED|Period 4||2
8188528|NCT02308748|20189855|P4|STARTED|Period 4||2
8188529|NCT02308748|20189856|P3|STARTED|Period 4||1
8188530|NCT02308748|20189857|P2|STARTED|Period 4||2
8188531|NCT02308748|20189858|P1|STARTED|Period 4||2
8188532|NCT02308748|20189849|P10|NOT COMPLETED|Period 3||1
8188533|NCT02308748|20189850|P9|NOT COMPLETED|Period 3||0
8188534|NCT02308748|20189851|P8|NOT COMPLETED|Period 3||0
8188535|NCT02308748|20189852|P7|NOT COMPLETED|Period 3||0
8188536|NCT02308748|20189853|P6|NOT COMPLETED|Period 3||0
8188537|NCT02308748|20189854|P5|NOT COMPLETED|Period 3||0
8188538|NCT02308748|20189855|P4|NOT COMPLETED|Period 3||0
8188539|NCT02308748|20189856|P3|NOT COMPLETED|Period 3||0
8188540|NCT02308748|20189857|P2|NOT COMPLETED|Period 3||0
8188541|NCT02308748|20189858|P1|NOT COMPLETED|Period 3||0
8188542|NCT02308748|20189849|P10|COMPLETED|Period 3||2
8188543|NCT02308748|20189850|P9|COMPLETED|Period 3||2
8188544|NCT02308748|20189851|P8|COMPLETED|Period 3||1
8188545|NCT02308748|20189852|P7|COMPLETED|Period 3||2
8188546|NCT02308748|20189853|P6|COMPLETED|Period 3||3
8188547|NCT02308748|20189854|P5|COMPLETED|Period 3||2
8188548|NCT02308748|20189855|P4|COMPLETED|Period 3||2
8188549|NCT02308748|20189856|P3|COMPLETED|Period 3||1
8188550|NCT02308748|20189857|P2|COMPLETED|Period 3||2
8188551|NCT02308748|20189858|P1|COMPLETED|Period 3||2
8188552|NCT02308748|20189849|P10|STARTED|Period 3||3
8188553|NCT02308748|20189850|P9|STARTED|Period 3||2
8188554|NCT02308748|20189851|P8|STARTED|Period 3||1
8188555|NCT02308748|20189852|P7|STARTED|Period 3||2
8188556|NCT02308748|20189853|P6|STARTED|Period 3||3
8188557|NCT02308748|20189854|P5|STARTED|Period 3||2
8188559|NCT02308748|20189856|P3|STARTED|Period 3||1
8188560|NCT02308748|20189857|P2|STARTED|Period 3||2
8188561|NCT02308748|20189858|P1|STARTED|Period 3||2
8188562|NCT02308748|20189849|P10|NOT COMPLETED|Period 2||0
8188563|NCT02308748|20189850|P9|NOT COMPLETED|Period 2||0
8188564|NCT02308748|20189851|P8|NOT COMPLETED|Period 2||1
8188565|NCT02308748|20189852|P7|NOT COMPLETED|Period 2||0
8188566|NCT02308748|20189853|P6|NOT COMPLETED|Period 2||0
8188567|NCT02308748|20189854|P5|NOT COMPLETED|Period 2||0
8188568|NCT02308748|20189855|P4|NOT COMPLETED|Period 2||0
8188569|NCT02308748|20189856|P3|NOT COMPLETED|Period 2||0
8188570|NCT02308748|20189857|P2|NOT COMPLETED|Period 2||0
8188571|NCT02308748|20189858|P1|NOT COMPLETED|Period 2||0
8188572|NCT02308748|20189849|P10|COMPLETED|Period 2||3
8188573|NCT02308748|20189850|P9|COMPLETED|Period 2||2
8188574|NCT02308748|20189851|P8|COMPLETED|Period 2||1
8188575|NCT02308748|20189852|P7|COMPLETED|Period 2||2
8188576|NCT02308748|20189853|P6|COMPLETED|Period 2||3
8188577|NCT02308748|20189854|P5|COMPLETED|Period 2||2
8188578|NCT02308748|20189855|P4|COMPLETED|Period 2||2
8188579|NCT02308748|20189856|P3|COMPLETED|Period 2||1
8188580|NCT02308748|20189857|P2|COMPLETED|Period 2||2
8188581|NCT02308748|20189858|P1|COMPLETED|Period 2||2
8188582|NCT02308748|20189849|P10|STARTED|Period 2||3
8188583|NCT02308748|20189850|P9|STARTED|Period 2||2
8188584|NCT02308748|20189851|P8|STARTED|Period 2||2
8188585|NCT02308748|20189852|P7|STARTED|Period 2||2
8188586|NCT02308748|20189853|P6|STARTED|Period 2||3
8188587|NCT02308748|20189854|P5|STARTED|Period 2||2
8188588|NCT02308748|20189855|P4|STARTED|Period 2||2
8188589|NCT02308748|20189856|P3|STARTED|Period 2||1
8188590|NCT02308748|20189857|P2|STARTED|Period 2||2
8188591|NCT02308748|20189858|P1|STARTED|Period 2||2
8188592|NCT02308748|20189849|P10|NOT COMPLETED|Period 1||0
8188593|NCT02308748|20189850|P9|NOT COMPLETED|Period 1||0
8188594|NCT02308748|20189851|P8|NOT COMPLETED|Period 1||0
8188595|NCT02308748|20189852|P7|NOT COMPLETED|Period 1||0
8188596|NCT02308748|20189853|P6|NOT COMPLETED|Period 1||0
8188597|NCT02308748|20189854|P5|NOT COMPLETED|Period 1||0
8188598|NCT02308748|20189855|P4|NOT COMPLETED|Period 1||0
8188599|NCT02308748|20189856|P3|NOT COMPLETED|Period 1||1
8188600|NCT02308748|20189857|P2|NOT COMPLETED|Period 1||0
8188601|NCT02308748|20189858|P1|NOT COMPLETED|Period 1||0
8188602|NCT02308748|20189849|P10|COMPLETED|Period 1||3
8188603|NCT02308748|20189850|P9|COMPLETED|Period 1||2
8188604|NCT02308748|20189851|P8|COMPLETED|Period 1||2
8188605|NCT02308748|20189852|P7|COMPLETED|Period 1||2
8188606|NCT02308748|20189853|P6|COMPLETED|Period 1||3
8188607|NCT02308748|20189854|P5|COMPLETED|Period 1||2
8188608|NCT02308748|20189855|P4|COMPLETED|Period 1||2
8188609|NCT02308748|20189856|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
8188610|NCT02308748|20189857|P2|COMPLETED|Period 1||2
8188611|NCT02308748|20189858|P1|COMPLETED|Period 1||2
8188612|NCT02308748|20189849|P10|STARTED|Period 1||3
8188613|NCT02308748|20189850|P9|STARTED|Period 1||2
8188614|NCT02308748|20189851|P8|STARTED|Period 1||2
8188615|NCT02308748|20189852|P7|STARTED|Period 1||2
8188616|NCT02308748|20189853|P6|STARTED|Period 1||3
8188617|NCT02308748|20189854|P5|STARTED|Period 1||2
8188618|NCT02308748|20189855|P4|STARTED|Period 1||2
8188619|NCT02308748|20189856|P3|STARTED|Period 1||2
8188620|NCT02308748|20189857|P2|STARTED|Period 1||2
8188621|NCT02308748|20189858|P1|STARTED|Period 1||2
8188622|NCT02308696|20189872|P2|NOT COMPLETED|Overall Study||31
8188623|NCT02308696|20189873|P1|NOT COMPLETED|Overall Study||53
8188624|NCT02308696|20189872|P2|COMPLETED|Overall Study||203
8188625|NCT02308696|20189873|P1|COMPLETED|Overall Study||169
8188626|NCT02308696|20189872|P2|STARTED|Overall Study||234
8188627|NCT02308696|20189873|P1|STARTED|Overall Study||222
8188628|NCT02308540|20189907|P6|NOT COMPLETED|Overall Study||1
8188629|NCT02308540|20189908|P5|NOT COMPLETED|Overall Study||0
8188630|NCT02308540|20189909|P4|NOT COMPLETED|Overall Study||0
8188631|NCT02308540|20189910|P3|NOT COMPLETED|Overall Study||0
8188632|NCT02308540|20189911|P2|NOT COMPLETED|Overall Study||0
8188633|NCT02308540|20189912|P1|NOT COMPLETED|Overall Study||0
8188634|NCT02308540|20189907|P6|COMPLETED|Overall Study||99
8188635|NCT02308540|20189908|P5|COMPLETED|Overall Study||100
8188636|NCT02308540|20189909|P4|COMPLETED|Overall Study||56
8188637|NCT02308540|20189910|P3|COMPLETED|Overall Study||56
8188638|NCT02308540|20189911|P2|COMPLETED|Overall Study||17
8188639|NCT02308540|20189912|P1|COMPLETED|Overall Study||17
8188640|NCT02308540|20189907|P6|Vaccinated|Overall Study||100
8188641|NCT02308540|20189908|P5|Vaccinated|Overall Study||100
8188642|NCT02308540|20189909|P4|Vaccinated|Overall Study||56
8188643|NCT02308540|20189910|P3|Vaccinated|Overall Study||56
8188644|NCT02308540|20189911|P2|Vaccinated|Overall Study||17
8188645|NCT02308540|20189912|P1|Vaccinated|Overall Study||17
8188646|NCT02308540|20189907|P6|Randomized|Overall Study||100
8188647|NCT02308540|20189908|P5|Randomized|Overall Study||100
8188648|NCT02308540|20189909|P4|Randomized|Overall Study||56
8188649|NCT02308540|20189910|P3|Randomized|Overall Study||56
8188650|NCT02308540|20189911|P2|Randomized|Overall Study||17
8188651|NCT02308540|20189912|P1|Randomized|Overall Study||17
8188652|NCT02308540|20189907|P6|STARTED|Overall Study||100
8188653|NCT02308540|20189908|P5|STARTED|Overall Study||100
8188654|NCT02308540|20189909|P4|STARTED|Overall Study||56
8188655|NCT02308540|20189910|P3|STARTED|Overall Study||56
8188656|NCT02308540|20189911|P2|STARTED|Overall Study||17
8188657|NCT02308540|20189912|P1|STARTED|Overall Study||17
8188658|NCT02308475|20189976|P1|NOT COMPLETED|Overall Study||0
8188659|NCT02308475|20189976|P1|COMPLETED|Overall Study||2
8188660|NCT02308475|20189976|P1|STARTED|Overall Study||2
8188661|NCT02308371|20189984|P2|NOT COMPLETED|Overall Study||0
8188662|NCT02308371|20189985|P1|NOT COMPLETED|Overall Study||0
8188663|NCT02308371|20189984|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
8188664|NCT02308371|20189985|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
8188665|NCT02308371|20189984|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
8188666|NCT02308371|20189985|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
8188667|NCT02308228|20190001|P2|NOT COMPLETED|Overall Study||7
8188668|NCT02308228|20190002|P1|NOT COMPLETED|Overall Study||8
8188669|NCT02308228|20190001|P2|COMPLETED|Overall Study||48
8188670|NCT02308228|20190002|P1|COMPLETED|Overall Study||46
8188671|NCT02308228|20190001|P2|STARTED|Overall Study||55
8188672|NCT02308228|20190002|P1|STARTED|Overall Study||54
8188673|NCT02308189|20190016|P2|NOT COMPLETED|Overall Study||1
8188674|NCT02308189|20190017|P1|NOT COMPLETED|Overall Study||1
8188675|NCT02308189|20190016|P2|COMPLETED|Overall Study||14
8188676|NCT02308189|20190017|P1|COMPLETED|Overall Study||16
8188677|NCT02308189|20190016|P2|STARTED|Overall Study||15
8188678|NCT02308189|20190017|P1|STARTED|Overall Study||17
8188679|NCT02308163|20190031|P5|NOT COMPLETED|Overall Study||34
8188680|NCT02308163|20190032|P4|NOT COMPLETED|Overall Study||13
8188681|NCT02308163|20190033|P3|NOT COMPLETED|Overall Study||14
8188682|NCT02308163|20190034|P2|NOT COMPLETED|Overall Study||18
8188683|NCT02308163|20190035|P1|NOT COMPLETED|Overall Study||31
8188684|NCT02308163|20190031|P5|COMPLETED|Overall Study||167
8188685|NCT02308163|20190032|P4|COMPLETED|Overall Study||39
8188686|NCT02308163|20190033|P3|COMPLETED|Overall Study||36
8188687|NCT02308163|20190034|P2|COMPLETED|Overall Study||84
8188688|NCT02308163|20190035|P1|COMPLETED|Overall Study||73
8188689|NCT02308163|20190031|P5|STARTED|Overall Study||201
8188690|NCT02308163|20190032|P4|STARTED|Overall Study||52
8188691|NCT02308163|20190033|P3|STARTED|Overall Study||50
8188692|NCT02308163|20190034|P2|STARTED|Overall Study||102
8188693|NCT02308163|20190035|P1|STARTED|Overall Study||104
8188694|NCT02308124|20190345|P3|NOT COMPLETED|Overall Study||8
8188695|NCT02308124|20190346|P2|NOT COMPLETED|Overall Study||8
8188696|NCT02308124|20190347|P1|NOT COMPLETED|Overall Study||6
8188697|NCT02308124|20190345|P3|COMPLETED|Overall Study||21
8188698|NCT02308124|20190346|P2|COMPLETED|Overall Study||21
8188699|NCT02308124|20190347|P1|COMPLETED|Overall Study||23
8188700|NCT02308124|20190345|P3|STARTED|Overall Study||29
8188701|NCT02308124|20190346|P2|STARTED|Overall Study||29
8188702|NCT02308124|20190347|P1|STARTED|Overall Study||29
8188703|NCT02308046|20190369|P2|NOT COMPLETED|Overall Study||38
8188704|NCT02308046|20190370|P1|NOT COMPLETED|Overall Study||34
8188705|NCT02308046|20190369|P2|COMPLETED|Overall Study||67
8188706|NCT02308046|20190370|P1|COMPLETED|Overall Study||73
8188707|NCT02308046|20190369|P2|STARTED|Overall Study||105
8188708|NCT02308046|20190370|P1|STARTED|Overall Study||107
8188709|NCT02308033|20190386|P2|NOT COMPLETED|Overall Study||19
8188710|NCT02308033|20190387|P1|NOT COMPLETED|Overall Study||26
8188711|NCT02308033|20190386|P2|COMPLETED|Overall Study||83
8188712|NCT02308033|20190387|P1|COMPLETED|Overall Study||76
8188713|NCT02308033|20190386|P2|STARTED|Overall Study||102
8188714|NCT02308033|20190387|P1|STARTED|Overall Study||102
8188715|NCT02308020|20190407|P6|NOT COMPLETED|Overall Study||5
8188716|NCT02308020|20190408|P5|NOT COMPLETED|Overall Study||4
8188717|NCT02308020|20190409|P4|NOT COMPLETED|Overall Study||4
8188718|NCT02308020|20190410|P3|NOT COMPLETED|Overall Study||3
8188719|NCT02308020|20190411|P2|NOT COMPLETED|Overall Study||20
8188720|NCT02308020|20190412|P1|NOT COMPLETED|Overall Study||4
8188721|NCT02308020|20190407|P6|COMPLETED|Overall Study||12
8188722|NCT02308020|20190408|P5|COMPLETED|Overall Study||19
8188723|NCT02308020|20190409|P4|COMPLETED|Overall Study||24
8188724|NCT02308020|20190410|P3|COMPLETED|Overall Study||6
8188725|NCT02308020|20190411|P2|COMPLETED|Overall Study||38
8188726|NCT02308020|20190412|P1|COMPLETED|Overall Study||23
8188727|NCT02308020|20190407|P6|Received at Least One Dose of Study Drug|Overall Study||17
8188728|NCT02308020|20190408|P5|Received at Least One Dose of Study Drug|Overall Study||23
8188729|NCT02308020|20190409|P4|Received at Least One Dose of Study Drug|Overall Study||28
8188730|NCT02308020|20190410|P3|Received at Least One Dose of Study Drug|Overall Study||9
8188731|NCT02308020|20190411|P2|Received at Least One Dose of Study Drug|Overall Study||58
8188732|NCT02308020|20190412|P1|Received at Least One Dose of Study Drug|Overall Study||27
8188733|NCT02308020|20190407|P6|STARTED|Overall Study||17
8188734|NCT02308020|20190408|P5|STARTED|Overall Study||23
8188735|NCT02308020|20190409|P4|STARTED|Overall Study||28
8188736|NCT02308020|20190410|P3|STARTED|Overall Study||9
8188737|NCT02308020|20190411|P2|STARTED|Overall Study||58
8188738|NCT02308020|20190412|P1|STARTED|Overall Study||27
8188739|NCT02308007|20190469|P3|NOT COMPLETED|Overall Study||75
8188740|NCT02308007|20190470|P2|NOT COMPLETED|Overall Study||75
8188741|NCT02308007|20190471|P1|NOT COMPLETED|Overall Study||76
8188742|NCT02308007|20190469|P3|COMPLETED|Overall Study||82
8188743|NCT02308007|20190470|P2|COMPLETED|Overall Study||84
8188744|NCT02308007|20190471|P1|COMPLETED|Overall Study||83
8188745|NCT02308007|20190469|P3|STARTED|Overall Study||157
8188746|NCT02308007|20190470|P2|STARTED|Overall Study||159
8188747|NCT02308007|20190471|P1|STARTED|Overall Study||159
8188748|NCT02307916|20190496|P2|NOT COMPLETED|Overall Study||1
8188749|NCT02307916|20190497|P1|NOT COMPLETED|Overall Study||2
8188750|NCT02307916|20190496|P2|COMPLETED|Overall Study||14
8188751|NCT02307916|20190497|P1|COMPLETED|Overall Study||40
8188752|NCT02307916|20190496|P2|STARTED|Overall Study||15
8188753|NCT02307916|20190497|P1|STARTED|Overall Study||42
8188754|NCT02307838|20190514|P3|NOT COMPLETED|Overall Study||0
8188755|NCT02307838|20190515|P2|NOT COMPLETED|Overall Study||0
8188756|NCT02307838|20190516|P1|NOT COMPLETED|Overall Study||0
8188757|NCT02307838|20190514|P3|COMPLETED|Overall Study||55
8188758|NCT02307838|20190515|P2|COMPLETED|Overall Study||64
8188759|NCT02307838|20190516|P1|COMPLETED|Overall Study||56
8188760|NCT02307838|20190514|P3|STARTED|Overall Study||55
8188761|NCT02307838|20190515|P2|STARTED|Overall Study||64
8188762|NCT02307838|20190516|P1|STARTED|Overall Study||56
8188763|NCT02307682|20190562|P3|NOT COMPLETED|Overall Study||64
8188764|NCT02307682|20190563|P2|NOT COMPLETED|Overall Study||57
8188765|NCT02307682|20190564|P1|NOT COMPLETED|Overall Study||50
8188766|NCT02307682|20190562|P3|COMPLETED|Overall Study||297
8188767|NCT02307682|20190563|P2|COMPLETED|Overall Study||304
8188768|NCT02307682|20190564|P1|COMPLETED|Overall Study||310
8188769|NCT02307682|20190562|P3|Randomized and Treated|Overall Study||360
8188770|NCT02307682|20190563|P2|Randomized and Treated|Overall Study||360
8188771|NCT02307682|20190564|P1|Randomized and Treated|Overall Study||358
8188772|NCT02307682|20190562|P3|STARTED|Overall Study||361
8188773|NCT02307682|20190563|P2|STARTED|Overall Study||361
8188774|NCT02307682|20190564|P1|STARTED|Overall Study||360
8188775|NCT02307552|20190664|P1|NOT COMPLETED|Overall Study||0
8188776|NCT02307552|20190664|P1|COMPLETED|Overall Study||1
8188777|NCT02307552|20190664|P1|STARTED|Overall Study||1
8188778|NCT02307526|20190668|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
8188779|NCT02307526|20190668|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
8188780|NCT02307526|20190668|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
8188781|NCT02307526|20190668|P1|NOT COMPLETED|Day 1 - No Drug||0
8188782|NCT02307526|20190668|P1|COMPLETED|Day 1 - No Drug||10
8188783|NCT02307526|20190668|P1|STARTED|Day 1 - No Drug||10
8188784|NCT02307513|20190680|P2|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
8188785|NCT02307513|20190681|P1|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
8188786|NCT02307513|20190680|P2|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
8188787|NCT02307513|20190681|P1|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
8188788|NCT02307513|20190680|P2|STARTED|Active Treatment Phase (Weeks 13-64)||83
8188789|NCT02307513|20190681|P1|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
8188790|NCT02307513|20190680|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
8188791|NCT02307513|20190681|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
8188792|NCT02307513|20190680|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
8188793|NCT02307513|20190681|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
8188794|NCT02307513|20190680|P2|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
8188795|NCT02307513|20190681|P1|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
8188796|NCT02307318|20190722|P1|NOT COMPLETED|Overall Study||0
8188797|NCT02307318|20190722|P1|COMPLETED|Overall Study||51
8188798|NCT02307318|20190722|P1|STARTED|Overall Study||51
8188808|NCT02307188|20190742|P1|NOT COMPLETED|Overall Study||4
8188809|NCT02307188|20190742|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
8188810|NCT02307188|20190742|P1|STARTED|Overall Study||5
8188811|NCT02307123|20190746|P1|NOT COMPLETED|Overall Study||0
8188812|NCT02307123|20190746|P1|COMPLETED|Overall Study||483
8188813|NCT02307123|20190746|P1|STARTED|Overall Study||483
8188814|NCT02306928|20190751|P1|NOT COMPLETED|Overall Study||0
8188815|NCT02306928|20190751|P1|COMPLETED|Overall Study||15
8188816|NCT02306928|20190751|P1|STARTED|Overall Study||15
8188817|NCT02306850|20190759|P1|NOT COMPLETED|Overall Study||2
8188818|NCT02306850|20190759|P1|COMPLETED|Overall Study||8
8188819|NCT02306850|20190759|P1|STARTED|Overall Study||10
8188820|NCT02306759|20190766|P2|NOT COMPLETED|Overall Study||0
8188821|NCT02306759|20190767|P1|NOT COMPLETED|Overall Study||0
8188822|NCT02306759|20190766|P2|COMPLETED|Overall Study||30
8188823|NCT02306759|20190767|P1|COMPLETED|Overall Study||30
8188824|NCT02306759|20190766|P2|STARTED|Overall Study||30
8188825|NCT02306759|20190767|P1|STARTED|Overall Study||30
8188826|NCT02306694|20190781|P1|NOT COMPLETED|Overall Study||4
8188827|NCT02306694|20190781|P1|COMPLETED|Overall Study||12
8188828|NCT02306694|20190781|P1|STARTED|Overall Study||16
8188829|NCT02306265|20190791|P1|NOT COMPLETED|Overall Study||1
8188830|NCT02306265|20190791|P1|COMPLETED|Overall Study||249
8188831|NCT02306265|20190791|P1|STARTED|Overall Study||250
8188832|NCT02305888|20190800|P3|NOT COMPLETED|Overall Study||1
8188833|NCT02305888|20190801|P2|NOT COMPLETED|Overall Study||1
8188834|NCT02305888|20190802|P1|NOT COMPLETED|Overall Study||0
8188835|NCT02305888|20190800|P3|COMPLETED|Overall Study||62
8188836|NCT02305888|20190801|P2|COMPLETED|Overall Study||62
8188837|NCT02305888|20190802|P1|COMPLETED|Overall Study||63
8188838|NCT02305888|20190800|P3|STARTED|Overall Study||63
8188839|NCT02305888|20190801|P2|STARTED|Overall Study||63
8188840|NCT02305888|20190802|P1|STARTED|Overall Study||63
8188841|NCT02305849|20190822|P4|NOT COMPLETED|Overall Study||19
8188842|NCT02305849|20190823|P3|NOT COMPLETED|Overall Study||18
8188843|NCT02305849|20190824|P2|NOT COMPLETED|Overall Study||28
8188844|NCT02305849|20190825|P1|NOT COMPLETED|Overall Study||27
8188845|NCT02305849|20190822|P4|COMPLETED|Overall Study||66
8188846|NCT02305849|20190823|P3|COMPLETED|Overall Study||67
8188847|NCT02305849|20190824|P2|COMPLETED|Overall Study||146
8188848|NCT02305849|20190825|P1|COMPLETED|Overall Study||148
8188849|NCT02305849|20190822|P4|STARTED|Overall Study||85
8188850|NCT02305849|20190823|P3|STARTED|Overall Study||85
8188851|NCT02305849|20190824|P2|STARTED|Overall Study||174
8188852|NCT02305849|20190825|P1|STARTED|Overall Study||175
8188853|NCT02305797|20191059|P2|NOT COMPLETED|Overall Study||38
8188854|NCT02305797|20191060|P1|NOT COMPLETED|Overall Study||45
8188855|NCT02305797|20191059|P2|COMPLETED|Overall Study||210
8188856|NCT02305797|20191060|P1|COMPLETED|Overall Study||202
8188857|NCT02305797|20191059|P2|STARTED|Overall Study||248
8188858|NCT02305797|20191060|P1|STARTED|Overall Study||247
8188859|NCT02305758|20191070|P2|NOT COMPLETED|Overall Study||65
8188860|NCT02305758|20191071|P1|NOT COMPLETED|Overall Study||65
8188861|NCT02305758|20191070|P2|COMPLETED|Overall Study||0
8188862|NCT02305758|20191071|P1|COMPLETED|Overall Study||0
8188863|NCT02305758|20191070|P2|STARTED|Overall Study||65
8188864|NCT02305758|20191071|P1|STARTED|Overall Study||65
8188865|NCT02305732|20191081|P1|NOT COMPLETED|Overall Study||18
8188866|NCT02305732|20191081|P1|COMPLETED|Overall Study||72
8188867|NCT02305732|20191081|P1|STARTED|Overall Study||90
8188868|NCT02305446|20191089|P1|NOT COMPLETED|Overall Study||1
8188869|NCT02305446|20191089|P1|COMPLETED|Overall Study||54
8188870|NCT02305446|20191089|P1|STARTED|Overall Study||55
8188871|NCT02305381|20191097|P3|NOT COMPLETED|Overall Study||7
8188872|NCT02305381|20191098|P2|NOT COMPLETED|Overall Study||5
8188873|NCT02305381|20191099|P1|NOT COMPLETED|Overall Study||5
8188874|NCT02305381|20191097|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
8188875|NCT02305381|20191098|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
8188876|NCT02305381|20191099|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
8188877|NCT02305381|20191097|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
8188878|NCT02305381|20191098|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
8188879|NCT02305381|20191099|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
8188880|NCT02305381|20191097|P3|Exposed|Overall Study||133
8188881|NCT02305381|20191098|P2|Exposed|Overall Study||131
8188882|NCT02305381|20191099|P1|Exposed|Overall Study||132
8188883|NCT02305381|20191097|P3|STARTED|Overall Study||133
8188884|NCT02305381|20191098|P2|STARTED|Overall Study||132
8188885|NCT02305381|20191099|P1|STARTED|Overall Study||132
8188886|NCT02305329|20191132|P4|NOT COMPLETED|Overall Study||0
8188887|NCT02305329|20191133|P3|NOT COMPLETED|Overall Study||0
8188888|NCT02305329|20191134|P2|NOT COMPLETED|Overall Study||1
8188889|NCT02305329|20191135|P1|NOT COMPLETED|Overall Study||0
8188890|NCT02305329|20191132|P4|COMPLETED|Overall Study||14
8188891|NCT02305329|20191133|P3|COMPLETED|Overall Study||14
8188892|NCT02305329|20191134|P2|COMPLETED|Overall Study||13
8188893|NCT02305329|20191135|P1|COMPLETED|Overall Study||14
8188894|NCT02305329|20191132|P4|Period 2|Overall Study||14
8188895|NCT02305329|20191133|P3|Period 2|Overall Study||14
8188896|NCT02305329|20191134|P2|Period 2|Overall Study||13
8188897|NCT02305329|20191135|P1|Period 2|Overall Study||14
8188898|NCT02305329|20191132|P4|Period 1|Overall Study||14
8188899|NCT02305329|20191133|P3|Period 1|Overall Study||14
8188900|NCT02305329|20191134|P2|Period 1|Overall Study||14
8188901|NCT02305329|20191135|P1|Period 1|Overall Study||14
8188902|NCT02305329|20191132|P4|STARTED|Overall Study||14
8188903|NCT02305329|20191133|P3|STARTED|Overall Study||14
8188904|NCT02305329|20191134|P2|STARTED|Overall Study||14
8188905|NCT02305329|20191135|P1|STARTED|Overall Study||14
8188906|NCT02305316|20191159|P2|NOT COMPLETED|Overall Study||0
8188907|NCT02305316|20191160|P1|NOT COMPLETED|Overall Study||0
8188908|NCT02305316|20191159|P2|COMPLETED|Overall Study||14
8188909|NCT02305316|20191160|P1|COMPLETED|Overall Study||14
8188910|NCT02305316|20191159|P2|STARTED|Overall Study||14
8188911|NCT02305316|20191160|P1|STARTED|Overall Study||14
8188912|NCT02305277|20191178|P6|NOT COMPLETED|Overall Study||0
8188913|NCT02305277|20191179|P5|NOT COMPLETED|Overall Study||1
8188914|NCT02305277|20191180|P4|NOT COMPLETED|Overall Study||0
8188915|NCT02305277|20191181|P3|NOT COMPLETED|Overall Study||0
8188916|NCT02305277|20191182|P2|NOT COMPLETED|Overall Study||0
8188917|NCT02305277|20191183|P1|NOT COMPLETED|Overall Study||1
8188918|NCT02305277|20191178|P6|COMPLETED|Overall Study||14
8188919|NCT02305277|20191179|P5|COMPLETED|Overall Study||13
8188920|NCT02305277|20191180|P4|COMPLETED|Overall Study||14
8188921|NCT02305277|20191181|P3|COMPLETED|Overall Study||14
8188922|NCT02305277|20191182|P2|COMPLETED|Overall Study||14
8188923|NCT02305277|20191183|P1|COMPLETED|Overall Study||14
8188924|NCT02305277|20191178|P6|Received TBM|Overall Study||14
8188925|NCT02305277|20191179|P5|Received TBM|Overall Study||14
8188926|NCT02305277|20191180|P4|Received TBM|Overall Study||14
8188927|NCT02305277|20191181|P3|Received TBM|Overall Study||14
8188928|NCT02305277|20191182|P2|Received TBM|Overall Study||14
8188929|NCT02305277|20191183|P1|Received TBM|Overall Study||15
8188930|NCT02305277|20191178|P6|Received CM|Overall Study||14
8188931|NCT02305277|20191179|P5|Received CM|Overall Study||14
8188932|NCT02305277|20191180|P4|Received CM|Overall Study||14
8188933|NCT02305277|20191181|P3|Received CM|Overall Study||14
8188934|NCT02305277|20191182|P2|Received CM|Overall Study||14
8188935|NCT02305277|20191183|P1|Received CM|Overall Study||15
8188936|NCT02305277|20191178|P6|STARTED|Overall Study||14
8188937|NCT02305277|20191179|P5|STARTED|Overall Study||14
8188938|NCT02305277|20191180|P4|STARTED|Overall Study||14
8188939|NCT02305277|20191181|P3|STARTED|Overall Study||14
8188940|NCT02305277|20191182|P2|STARTED|Overall Study||14
8188941|NCT02305277|20191183|P1|STARTED|Overall Study||15
8188942|NCT02305238|20191212|P3|NOT COMPLETED|Overall Study||8
8188943|NCT02305238|20191213|P2|NOT COMPLETED|Overall Study||19
8188944|NCT02305238|20191214|P1|NOT COMPLETED|Overall Study||16
8188945|NCT02305238|20191212|P3|COMPLETED|Overall Study||0
8188946|NCT02305238|20191213|P2|COMPLETED|Overall Study||104
8188947|NCT02305238|20191214|P1|COMPLETED|Overall Study||108
8188948|NCT02305238|20191212|P3|BCVA Post-randomization Assessment|Overall Study||0
8188949|NCT02305238|20191213|P2|BCVA Post-randomization Assessment|Overall Study||123
8188950|NCT02305238|20191214|P1|BCVA Post-randomization Assessment|Overall Study||123
8188951|NCT02305238|20191212|P3|Randomized|Overall Study||0
8188952|NCT02305238|20191213|P2|Randomized|Overall Study||123
8188953|NCT02305238|20191214|P1|Randomized|Overall Study||124
8188954|NCT02305238|20191212|P3|Treated|Overall Study||7
8188955|NCT02305238|20191213|P2|Treated|Overall Study||123
8188956|NCT02305238|20191214|P1|Treated|Overall Study||124
8188957|NCT02305238|20191212|P3|STARTED|Overall Study||8
8188958|NCT02305238|20191213|P2|STARTED|Overall Study||123
8188959|NCT02305238|20191214|P1|STARTED|Overall Study||124
8188960|NCT02305017|20191231|P2|NOT COMPLETED|Overall Study||0
8188961|NCT02305017|20191232|P1|NOT COMPLETED|Overall Study||0
8188962|NCT02305017|20191231|P2|COMPLETED|Overall Study||14
8188963|NCT02305017|20191232|P1|COMPLETED|Overall Study||14
8188964|NCT02305017|20191231|P2|STARTED|Overall Study||14
8188965|NCT02305017|20191232|P1|STARTED|Overall Study||14
8188966|NCT02304926|20191246|P2|NOT COMPLETED|Overall Study||1
8188967|NCT02304926|20191247|P1|NOT COMPLETED|Overall Study||2
8188968|NCT02304926|20191246|P2|COMPLETED|Overall Study||19
8188969|NCT02304926|20191247|P1|COMPLETED|Overall Study||20
8188970|NCT02304926|20191246|P2|STARTED|Overall Study||20
8188971|NCT02304926|20191247|P1|STARTED|Overall Study||22
8188972|NCT02304705|20191293|P2|NOT COMPLETED|Overall Study||7
8188973|NCT02304705|20191294|P1|NOT COMPLETED|Overall Study||4
8188974|NCT02304705|20191293|P2|COMPLETED|Overall Study||10
8188975|NCT02304705|20191294|P1|COMPLETED|Overall Study||12
8188976|NCT02304705|20191293|P2|STARTED|Overall Study||17
8188977|NCT02304705|20191294|P1|STARTED|Overall Study||16
8188978|NCT02304484|20191300|P1|NOT COMPLETED|Overall Study||25
8188979|NCT02304484|20191300|P1|COMPLETED|Overall Study||745
8188980|NCT02304484|20191300|P1|STARTED|Overall Study||770
8188981|NCT02304432|20191305|P4|NOT COMPLETED|Second Open Label DCS||0
8188982|NCT02304432|20191306|P3|NOT COMPLETED|Second Open Label DCS||0
8188983|NCT02304432|20191307|P2|NOT COMPLETED|Second Open Label DCS||0
8188984|NCT02304432|20191308|P1|NOT COMPLETED|Second Open Label DCS||0
8188985|NCT02304432|20191305|P4|COMPLETED|Second Open Label DCS||2
8188986|NCT02304432|20191306|P3|COMPLETED|Second Open Label DCS||0
8188987|NCT02304432|20191307|P2|COMPLETED|Second Open Label DCS||0
8188988|NCT02304432|20191308|P1|COMPLETED|Second Open Label DCS||0
8188989|NCT02304432|20191305|P4|STARTED|Second Open Label DCS||2
8188990|NCT02304432|20191306|P3|STARTED|Second Open Label DCS||0
8188991|NCT02304432|20191307|P2|STARTED|Second Open Label DCS||0
8188992|NCT02304432|20191308|P1|STARTED|Second Open Label DCS||0
8188993|NCT02304432|20191305|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188994|NCT02304432|20191306|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188995|NCT02304432|20191307|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188996|NCT02304432|20191308|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188997|NCT02304432|20191305|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
8188998|NCT02304432|20191306|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
8188999|NCT02304432|20191307|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
8189000|NCT02304432|20191308|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
8189001|NCT02304432|20191305|P4|STARTED|Double-Blind DCS Placebo Crossover||0
8189002|NCT02304432|20191306|P3|STARTED|Double-Blind DCS Placebo Crossover||1
8189003|NCT02304432|20191307|P2|STARTED|Double-Blind DCS Placebo Crossover||1
8189004|NCT02304432|20191308|P1|STARTED|Double-Blind DCS Placebo Crossover||0
8189005|NCT02304432|20191305|P4|NOT COMPLETED|Open Label DCS||0
8189006|NCT02304432|20191306|P3|NOT COMPLETED|Open Label DCS||0
8189007|NCT02304432|20191307|P2|NOT COMPLETED|Open Label DCS||0
8189008|NCT02304432|20191308|P1|NOT COMPLETED|Open Label DCS||0
8189009|NCT02304432|20191305|P4|COMPLETED|Open Label DCS||0
8189010|NCT02304432|20191306|P3|COMPLETED|Open Label DCS||0
8189011|NCT02304432|20191307|P2|COMPLETED|Open Label DCS||0
8189012|NCT02304432|20191308|P1|COMPLETED|Open Label DCS||2
8189013|NCT02304432|20191305|P4|STARTED|Open Label DCS||0
8189014|NCT02304432|20191306|P3|STARTED|Open Label DCS||0
8189015|NCT02304432|20191307|P2|STARTED|Open Label DCS||0
8189016|NCT02304432|20191308|P1|STARTED|Open Label DCS||2
8189017|NCT02304406|20191340|P1|NOT COMPLETED|Overall Study||0
8189018|NCT02304406|20191340|P1|COMPLETED|Overall Study||449
8189019|NCT02304406|20191340|P1|STARTED|Overall Study||449
8189020|NCT02304380|20191363|P6|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189021|NCT02304380|20191364|P5|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189022|NCT02304380|20191365|P4|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189023|NCT02304380|20191366|P3|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189024|NCT02304380|20191367|P2|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189025|NCT02304380|20191368|P1|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189026|NCT02304380|20191363|P6|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189027|NCT02304380|20191364|P5|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189028|NCT02304380|20191365|P4|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189029|NCT02304380|20191366|P3|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189030|NCT02304380|20191367|P2|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189031|NCT02304380|20191368|P1|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
8189032|NCT02304380|20191363|P6|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189033|NCT02304380|20191364|P5|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189034|NCT02304380|20191365|P4|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189035|NCT02304380|20191366|P3|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189036|NCT02304380|20191367|P2|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189037|NCT02304380|20191368|P1|STARTED|ACO Stakeholder Interviews (Aim 1)||24
8189038|NCT02304380|20191363|P6|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189039|NCT02304380|20191364|P5|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189040|NCT02304380|20191365|P4|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189041|NCT02304380|20191366|P3|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189042|NCT02304380|20191367|P2|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189043|NCT02304380|20191368|P1|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189044|NCT02304380|20191363|P6|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189045|NCT02304380|20191364|P5|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189046|NCT02304380|20191365|P4|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189047|NCT02304380|20191366|P3|COMPLETED|Interviews & Focus Groups (Aim 1)||33
8189048|NCT02304380|20191367|P2|COMPLETED|Interviews & Focus Groups (Aim 1)||35
8189049|NCT02304380|20191368|P1|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189050|NCT02304380|20191363|P6|STARTED|Interviews & Focus Groups (Aim 1)||0
8189051|NCT02304380|20191364|P5|STARTED|Interviews & Focus Groups (Aim 1)||0
8189052|NCT02304380|20191365|P4|STARTED|Interviews & Focus Groups (Aim 1)||0
8189053|NCT02304380|20191366|P3|STARTED|Interviews & Focus Groups (Aim 1)||33
8189054|NCT02304380|20191367|P2|STARTED|Interviews & Focus Groups (Aim 1)||35
8189055|NCT02304380|20191368|P1|STARTED|Interviews & Focus Groups (Aim 1)||0
8189056|NCT02304380|20191363|P6|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189057|NCT02304380|20191364|P5|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189058|NCT02304380|20191365|P4|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
8189059|NCT02304380|20191366|P3|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189060|NCT02304380|20191367|P2|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189061|NCT02304380|20191368|P1|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189062|NCT02304380|20191363|P6|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189063|NCT02304380|20191364|P5|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189064|NCT02304380|20191365|P4|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
8189065|NCT02304380|20191366|P3|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189066|NCT02304380|20191367|P2|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189067|NCT02304380|20191368|P1|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189068|NCT02304380|20191363|P6|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189069|NCT02304380|20191364|P5|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189070|NCT02304380|20191365|P4|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
8189071|NCT02304380|20191366|P3|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189072|NCT02304380|20191367|P2|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189073|NCT02304380|20191368|P1|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189074|NCT02304380|20191363|P6|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189075|NCT02304380|20191364|P5|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189076|NCT02304380|20191365|P4|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189077|NCT02304380|20191366|P3|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189078|NCT02304380|20191367|P2|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189079|NCT02304380|20191368|P1|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189080|NCT02304380|20191363|P6|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
8189081|NCT02304380|20191364|P5|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
8189082|NCT02304380|20191365|P4|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189083|NCT02304380|20191366|P3|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189084|NCT02304380|20191367|P2|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189085|NCT02304380|20191368|P1|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189086|NCT02304380|20191363|P6|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
8189087|NCT02304380|20191364|P5|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
8189088|NCT02304380|20191365|P4|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189089|NCT02304380|20191366|P3|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189090|NCT02304380|20191367|P2|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189091|NCT02304380|20191368|P1|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189097|NCT02304159|20191478|P2|NOT COMPLETED|Overall Study||2
8189098|NCT02304159|20191479|P1|NOT COMPLETED|Overall Study||2
8189099|NCT02304159|20191478|P2|COMPLETED|Overall Study||16
8189100|NCT02304159|20191479|P1|COMPLETED|Overall Study||19
8189101|NCT02304159|20191478|P2|STARTED|Overall Study||18
8189102|NCT02304159|20191479|P1|STARTED|Overall Study||21
8189103|NCT02303743|20191491|P2|NOT COMPLETED|Overall Study||0
8189104|NCT02303743|20191492|P1|NOT COMPLETED|Overall Study||0
8189105|NCT02303743|20191491|P2|COMPLETED|Overall Study||152
8189106|NCT02303743|20191492|P1|COMPLETED|Overall Study||108
8189107|NCT02303743|20191491|P2|STARTED|Overall Study||152
8189108|NCT02303743|20191492|P1|STARTED|Overall Study||108
8189115|NCT02303574|20191531|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189116|NCT02303574|20191532|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189117|NCT02303574|20191533|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
8189118|NCT02303574|20191534|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189119|NCT02303574|20191535|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189120|NCT02303574|20191536|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189121|NCT02303574|20191537|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189122|NCT02303574|20191538|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189123|NCT02303574|20191539|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189124|NCT02303574|20191540|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189125|NCT02303574|20191531|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
8189126|NCT02303574|20191532|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
8189127|NCT02303574|20191533|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
8189128|NCT02303574|20191534|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
8189129|NCT02303574|20191535|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189130|NCT02303574|20191536|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189131|NCT02303574|20191537|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189132|NCT02303574|20191538|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189133|NCT02303574|20191539|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189134|NCT02303574|20191540|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189135|NCT02303574|20191531|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
8189136|NCT02303574|20191532|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
8189137|NCT02303574|20191533|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
8189138|NCT02303574|20191534|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
8189139|NCT02303574|20191535|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189140|NCT02303574|20191536|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189141|NCT02303574|20191537|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189142|NCT02303574|20191538|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189143|NCT02303574|20191539|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189144|NCT02303574|20191540|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189145|NCT02303574|20191531|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189146|NCT02303574|20191532|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189147|NCT02303574|20191533|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189148|NCT02303574|20191534|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189149|NCT02303574|20191535|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189150|NCT02303574|20191536|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189151|NCT02303574|20191537|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189152|NCT02303574|20191538|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189153|NCT02303574|20191539|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189154|NCT02303574|20191540|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189155|NCT02303574|20191531|P10|COMPLETED|Part 1b (Fed State) - SAD||3
8189156|NCT02303574|20191532|P9|COMPLETED|Part 1b (Fed State) - SAD||0
8189157|NCT02303574|20191533|P8|COMPLETED|Part 1b (Fed State) - SAD||0
8189158|NCT02303574|20191534|P7|COMPLETED|Part 1b (Fed State) - SAD||0
8189159|NCT02303574|20191535|P6|COMPLETED|Part 1b (Fed State) - SAD||5
8189160|NCT02303574|20191536|P5|COMPLETED|Part 1b (Fed State) - SAD||0
8189161|NCT02303574|20191537|P4|COMPLETED|Part 1b (Fed State) - SAD||0
8189162|NCT02303574|20191538|P3|COMPLETED|Part 1b (Fed State) - SAD||0
8189163|NCT02303574|20191539|P2|COMPLETED|Part 1b (Fed State) - SAD||0
8189164|NCT02303574|20191540|P1|COMPLETED|Part 1b (Fed State) - SAD||0
8189165|NCT02303574|20191531|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
8189166|NCT02303574|20191532|P9|STARTED|Part 1b (Fed State) - SAD||0
8189167|NCT02303574|20191533|P8|STARTED|Part 1b (Fed State) - SAD||0
8189168|NCT02303574|20191534|P7|STARTED|Part 1b (Fed State) - SAD||0
8189169|NCT02303574|20191535|P6|STARTED|Part 1b (Fed State) - SAD||5
8189170|NCT02303574|20191536|P5|STARTED|Part 1b (Fed State) - SAD||0
8189171|NCT02303574|20191537|P4|STARTED|Part 1b (Fed State) - SAD||0
8189172|NCT02303574|20191538|P3|STARTED|Part 1b (Fed State) - SAD||0
8189173|NCT02303574|20191539|P2|STARTED|Part 1b (Fed State) - SAD||0
8189174|NCT02303574|20191540|P1|STARTED|Part 1b (Fed State) - SAD||0
8189175|NCT02303574|20191531|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189176|NCT02303574|20191532|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189177|NCT02303574|20191533|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189178|NCT02303574|20191534|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189179|NCT02303574|20191535|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189180|NCT02303574|20191536|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189181|NCT02303574|20191537|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189182|NCT02303574|20191538|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
8189183|NCT02303574|20191539|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189184|NCT02303574|20191540|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189185|NCT02303574|20191531|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
8189186|NCT02303574|20191532|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
8189187|NCT02303574|20191533|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
8189188|NCT02303574|20191534|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
8189189|NCT02303574|20191535|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
8189190|NCT02303574|20191536|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
8189191|NCT02303574|20191537|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
8189192|NCT02303574|20191538|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
8189193|NCT02303574|20191539|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
8189194|NCT02303574|20191540|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
8189195|NCT02303574|20191531|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
8189196|NCT02303574|20191532|P9|STARTED|Part 1a (Fasted State)- SAD||0
8189197|NCT02303574|20191533|P8|STARTED|Part 1a (Fasted State)- SAD||0
8189198|NCT02303574|20191534|P7|STARTED|Part 1a (Fasted State)- SAD||0
8189199|NCT02303574|20191535|P6|STARTED|Part 1a (Fasted State)- SAD||0
8189200|NCT02303574|20191536|P5|STARTED|Part 1a (Fasted State)- SAD||6
8189201|NCT02303574|20191537|P4|STARTED|Part 1a (Fasted State)- SAD||6
8189202|NCT02303574|20191538|P3|STARTED|Part 1a (Fasted State)- SAD||6
8189203|NCT02303574|20191539|P2|STARTED|Part 1a (Fasted State)- SAD||6
8189204|NCT02303574|20191540|P1|STARTED|Part 1a (Fasted State)- SAD||6
8189205|NCT02303548|20191754|P2|NOT COMPLETED|Overall Study||0
8189206|NCT02303548|20191755|P1|NOT COMPLETED|Overall Study||0
8189207|NCT02303548|20191754|P2|COMPLETED|Overall Study||25
8189208|NCT02303548|20191755|P1|COMPLETED|Overall Study||25
8189209|NCT02303548|20191754|P2|STARTED|Overall Study||25
8189210|NCT02303548|20191755|P1|STARTED|Overall Study||25
8189211|NCT02303262|20191761|P1|NOT COMPLETED|Overall Study||2
8189212|NCT02303262|20191761|P1|COMPLETED|Overall Study||18
8189213|NCT02303262|20191761|P1|STARTED|Overall Study||20
8189214|NCT02303041|20191769|P2|NOT COMPLETED|Overall Study||2
8189215|NCT02303041|20191770|P1|NOT COMPLETED|Overall Study||1
8189216|NCT02303041|20191769|P2|COMPLETED|Overall Study||4
8189217|NCT02303041|20191770|P1|COMPLETED|Overall Study||3
8189218|NCT02303041|20191769|P2|STARTED|Overall Study||6
8189219|NCT02303041|20191770|P1|STARTED|Overall Study||4
8189220|NCT02302859|20191786|P2|NOT COMPLETED|Overall Study||2
8189221|NCT02302859|20191787|P1|NOT COMPLETED|Overall Study||1
8189222|NCT02302859|20191786|P2|COMPLETED|Overall Study||4
8189223|NCT02302859|20191787|P1|COMPLETED|Overall Study||1
8189224|NCT02302859|20191786|P2|STARTED|Overall Study||6
8189225|NCT02302859|20191787|P1|STARTED|Overall Study||2
8189226|NCT02302846|20191793|P1|NOT COMPLETED|Overall Study||1
8189227|NCT02302846|20191793|P1|COMPLETED|Overall Study||4
8189228|NCT02302846|20191793|P1|STARTED|Overall Study||5
8189229|NCT02302807|20191799|P2|NOT COMPLETED|Overall Study||467
8189230|NCT02302807|20191800|P1|NOT COMPLETED|Overall Study||464
8189231|NCT02302807|20191799|P2|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
8189232|NCT02302807|20191800|P1|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
8189233|NCT02302807|20191799|P2|Received Treatment|Overall Study||459
8189234|NCT02302807|20191800|P1|Received Treatment|Overall Study||443
8189235|NCT02302807|20191799|P2|STARTED|Overall Study||467
8189236|NCT02302807|20191800|P1|STARTED|Overall Study||464
8189237|NCT02302716|20191847|P2|NOT COMPLETED|Overall Study||19
8189238|NCT02302716|20191848|P1|NOT COMPLETED|Overall Study||19
8189239|NCT02302716|20191847|P2|COMPLETED|Overall Study||225
8189240|NCT02302716|20191848|P1|COMPLETED|Overall Study||230
8189241|NCT02302716|20191847|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
8189242|NCT02302716|20191848|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
8189243|NCT02302716|20191847|P2|STARTED|Overall Study||244
8189244|NCT02302716|20191848|P1|STARTED|Overall Study||249
8189245|NCT02302365|20191874|P1|NOT COMPLETED|0-24 Hour Period||0
8189246|NCT02302365|20191874|P1|COMPLETED|0-24 Hour Period||32
8189247|NCT02302365|20191874|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
8189248|NCT02302365|20191874|P1|NOT COMPLETED|0-2 Hour Period||2
8189249|NCT02302365|20191874|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
8189250|NCT02302365|20191874|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
8189251|NCT02302339|20191896|P4|NOT COMPLETED|Overall Study||0
8189252|NCT02302339|20191897|P3|NOT COMPLETED|Overall Study||1
8189253|NCT02302339|20191898|P2|NOT COMPLETED|Overall Study||2
8189254|NCT02302339|20191899|P1|NOT COMPLETED|Overall Study||1
8189255|NCT02302339|20191896|P4|COMPLETED|Overall Study||7
8189256|NCT02302339|20191897|P3|COMPLETED|Overall Study||28
8189257|NCT02302339|20191898|P2|COMPLETED|Overall Study||32
8189258|NCT02302339|20191899|P1|COMPLETED|Overall Study||61
8189259|NCT02302339|20191896|P4|STARTED|Overall Study||7
8189260|NCT02302339|20191897|P3|STARTED|Overall Study||29
8189261|NCT02302339|20191898|P2|STARTED|Overall Study||34
8189262|NCT02302339|20191899|P1|STARTED|Overall Study||62
8189263|NCT02302222|20191932|P2|NOT COMPLETED|Overall Study||6
8189264|NCT02302222|20191933|P1|NOT COMPLETED|Overall Study||1
8189265|NCT02302222|20191932|P2|COMPLETED|Overall Study||31
8189266|NCT02302222|20191933|P1|COMPLETED|Overall Study||33
8189267|NCT02302222|20191932|P2|STARTED|Overall Study||37
8189268|NCT02302222|20191933|P1|STARTED|Overall Study||34
8189269|NCT02302092|20191941|P2|NOT COMPLETED|Overall Study||0
8189270|NCT02302092|20191942|P1|NOT COMPLETED|Overall Study||0
8189271|NCT02302092|20191941|P2|COMPLETED|Overall Study||7
8189272|NCT02302092|20191942|P1|COMPLETED|Overall Study||6
8189273|NCT02302092|20191941|P2|STARTED|Overall Study||7
8189274|NCT02302092|20191942|P1|STARTED|Overall Study||6
8189275|NCT02302066|20191972|P4|NOT COMPLETED|Overall Study||41
8189276|NCT02302066|20191973|P3|NOT COMPLETED|Overall Study||172
8189277|NCT02302066|20191974|P2|NOT COMPLETED|Overall Study||75
8189278|NCT02302066|20191975|P1|NOT COMPLETED|Overall Study||33
8189279|NCT02302066|20191972|P4|COMPLETED|Overall Study||158
8189280|NCT02302066|20191973|P3|COMPLETED|Overall Study||830
8189281|NCT02302066|20191974|P2|COMPLETED|Overall Study||323
8189282|NCT02302066|20191975|P1|COMPLETED|Overall Study||168
8189283|NCT02302066|20191972|P4|Per-Protocol Set (PPS)|Overall Study||81
8189284|NCT02302066|20191973|P3|Per-Protocol Set (PPS)|Overall Study||174
8189285|NCT02302066|20191974|P2|Per-Protocol Set (PPS)|Overall Study||171
8189286|NCT02302066|20191975|P1|Per-Protocol Set (PPS)|Overall Study||83
8189287|NCT02302066|20191972|P4|Immunogenicity Subset|Overall Study||94
8189288|NCT02302066|20191973|P3|Immunogenicity Subset|Overall Study||192
8189289|NCT02302066|20191974|P2|Immunogenicity Subset|Overall Study||187
8189290|NCT02302066|20191975|P1|Immunogenicity Subset|Overall Study||92
8189291|NCT02302066|20191972|P4|Safety Analysis Set|Overall Study||198
8189292|NCT02302066|20191973|P3|Safety Analysis Set|Overall Study||998
8189293|NCT02302066|20191974|P2|Safety Analysis Set|Overall Study||398
8189294|NCT02302066|20191975|P1|Safety Analysis Set|Overall Study||200
8189295|NCT02302066|20191972|P4|STARTED|Overall Study||199
8189296|NCT02302066|20191973|P3|STARTED|Overall Study||1002
8189297|NCT02302066|20191974|P2|STARTED|Overall Study||398
8189298|NCT02302066|20191975|P1|STARTED|Overall Study||201
8189299|NCT02301988|20192019|P2|NOT COMPLETED|Overall Study||9
8189300|NCT02301988|20192020|P1|NOT COMPLETED|Overall Study||10
8189301|NCT02301988|20192019|P2|COMPLETED|Overall Study||66
8189302|NCT02301988|20192020|P1|COMPLETED|Overall Study||66
8189303|NCT02301988|20192019|P2|STARTED|Overall Study||75
8189304|NCT02301988|20192020|P1|STARTED|Overall Study||76
8189305|NCT02301975|20192053|P3|NOT COMPLETED|Overall Study||22
8189306|NCT02301975|20192054|P2|NOT COMPLETED|Overall Study||25
8189307|NCT02301975|20192055|P1|NOT COMPLETED|Overall Study||31
8189308|NCT02301975|20192053|P3|COMPLETED|Overall Study||477
8189309|NCT02301975|20192054|P2|COMPLETED|Overall Study||476
8189310|NCT02301975|20192055|P1|COMPLETED|Overall Study||473
8189311|NCT02301975|20192053|P3|STARTED|Overall Study||499
8189312|NCT02301975|20192054|P2|STARTED|Overall Study||501
8189313|NCT02301975|20192055|P1|STARTED|Overall Study||504
8189314|NCT02301936|20192083|P2|NOT COMPLETED|Overall Study||0
8189315|NCT02301936|20192084|P1|NOT COMPLETED|Overall Study||1
8189316|NCT02301936|20192083|P2|COMPLETED|Overall Study||1
8189317|NCT02301936|20192084|P1|COMPLETED|Overall Study||8
8189318|NCT02301936|20192083|P2|STARTED|Overall Study||1
8189319|NCT02301936|20192084|P1|STARTED|Overall Study||9
8189320|NCT02301897|20192109|P3|NOT COMPLETED|Treatment Course 2||1
8189321|NCT02301897|20192110|P2|NOT COMPLETED|Treatment Course 2||5
8189322|NCT02301897|20192111|P1|NOT COMPLETED|Treatment Course 2||1
8189323|NCT02301897|20192109|P3|COMPLETED|Treatment Course 2||7
8189324|NCT02301897|20192110|P2|COMPLETED|Treatment Course 2||9
8189325|NCT02301897|20192111|P1|COMPLETED|Treatment Course 2||8
8189326|NCT02301897|20192109|P3|STARTED|Treatment Course 2||8
8189327|NCT02301897|20192110|P2|STARTED|Treatment Course 2||14
8189328|NCT02301897|20192111|P1|STARTED|Treatment Course 2||9
8189329|NCT02301897|20192109|P3|NOT COMPLETED|Treatment Course 1||6
8189330|NCT02301897|20192110|P2|NOT COMPLETED|Treatment Course 1||3
8189331|NCT02301897|20192111|P1|NOT COMPLETED|Treatment Course 1||3
8189332|NCT02301897|20192109|P3|COMPLETED|Treatment Course 1||8
8189333|NCT02301897|20192110|P2|COMPLETED|Treatment Course 1||14
8189334|NCT02301897|20192111|P1|COMPLETED|Treatment Course 1||9
8189335|NCT02301897|20192109|P3|STARTED|Treatment Course 1||14
8189336|NCT02301897|20192110|P2|STARTED|Treatment Course 1||17
8189337|NCT02301897|20192111|P1|STARTED|Treatment Course 1||12
8189338|NCT02301793|20192160|P2|NOT COMPLETED|During and Post Education Study Period||49
8189339|NCT02301793|20192161|P1|NOT COMPLETED|During and Post Education Study Period||83
8189340|NCT02301793|20192160|P2|COMPLETED|During and Post Education Study Period||396
8189341|NCT02301793|20192161|P1|COMPLETED|During and Post Education Study Period||405
8189342|NCT02301793|20192160|P2|STARTED|During and Post Education Study Period||445
8189343|NCT02301793|20192161|P1|STARTED|During and Post Education Study Period||488
8189344|NCT02301793|20192160|P2|NOT COMPLETED|Pre Education Study Period||0
8189345|NCT02301793|20192161|P1|NOT COMPLETED|Pre Education Study Period||0
8189346|NCT02301793|20192160|P2|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
8189347|NCT02301793|20192161|P1|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
8189348|NCT02301793|20192160|P2|STARTED|Pre Education Study Period|Nurses had not been randomized|0
8189349|NCT02301793|20192161|P1|STARTED|Pre Education Study Period|Nurses had not been randomized|0
8189350|NCT02301624|20192177|P2|NOT COMPLETED|Open-label Maintenance Phase||17
8189351|NCT02301624|20192178|P1|NOT COMPLETED|Open-label Maintenance Phase||12
8189352|NCT02301624|20192177|P2|COMPLETED|Open-label Maintenance Phase||44
8189353|NCT02301624|20192178|P1|COMPLETED|Open-label Maintenance Phase||43
8189354|NCT02301624|20192177|P2|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
8189355|NCT02301624|20192178|P1|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
8189356|NCT02301624|20192177|P2|STARTED|Open-label Maintenance Phase||61
8189357|NCT02301624|20192178|P1|STARTED|Open-label Maintenance Phase||55
8189358|NCT02301624|20192177|P2|NOT COMPLETED|Blind Induction Phase||0
8189359|NCT02301624|20192178|P1|NOT COMPLETED|Blind Induction Phase||1
8189360|NCT02301624|20192177|P2|COMPLETED|Blind Induction Phase||61
8189361|NCT02301624|20192178|P1|COMPLETED|Blind Induction Phase||55
8189362|NCT02301624|20192177|P2|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
8189363|NCT02301624|20192178|P1|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
8189364|NCT02301624|20192177|P2|STARTED|Blind Induction Phase||61
8189365|NCT02301624|20192178|P1|STARTED|Blind Induction Phase||56
8189366|NCT02301546|20192189|P2|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
8189367|NCT02301546|20192190|P1|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
8189368|NCT02301546|20192189|P2|COMPLETED|Long Term Effectiveness (~1 Year)||51
8189369|NCT02301546|20192190|P1|COMPLETED|Long Term Effectiveness (~1 Year)||43
8189370|NCT02301546|20192189|P2|STARTED|Long Term Effectiveness (~1 Year)||58
8189371|NCT02301546|20192190|P1|STARTED|Long Term Effectiveness (~1 Year)||55
8189372|NCT02301546|20192189|P2|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
8189373|NCT02301546|20192190|P1|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
8189374|NCT02301546|20192189|P2|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
8189375|NCT02301546|20192190|P1|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
8189376|NCT02301546|20192189|P2|STARTED|Short-term Effectiveness (~13 Weeks)||73
8189377|NCT02301546|20192190|P1|STARTED|Short-term Effectiveness (~13 Weeks)||73
8189378|NCT02301429|20192196|P1|NOT COMPLETED|Overall Study||3
8189379|NCT02301429|20192196|P1|COMPLETED|Overall Study||13
8189380|NCT02301429|20192196|P1|STARTED|Overall Study||16
8189381|NCT02301416|20192202|P2|NOT COMPLETED|Overall Study||0
8189382|NCT02301416|20192203|P1|NOT COMPLETED|Overall Study||10
8189383|NCT02301416|20192202|P2|COMPLETED|Overall Study||40
8189384|NCT02301416|20192203|P1|COMPLETED|Overall Study||15
8189385|NCT02301416|20192202|P2|STARTED|Overall Study||40
8189386|NCT02301416|20192203|P1|STARTED|Overall Study||25
8189387|NCT02301403|20192242|P2|NOT COMPLETED|Overall Study||41
8189388|NCT02301403|20192243|P1|NOT COMPLETED|Overall Study||28
8189389|NCT02301403|20192242|P2|COMPLETED|Overall Study||267
8189390|NCT02301403|20192243|P1|COMPLETED|Overall Study||287
8189391|NCT02301403|20192242|P2|STARTED|Overall Study||308
8189392|NCT02301403|20192243|P1|STARTED|Overall Study||315
8189393|NCT02301390|20192251|P2|NOT COMPLETED|Overall Study||13
8189394|NCT02301390|20192252|P1|NOT COMPLETED|Overall Study||10
8189395|NCT02301390|20192251|P2|COMPLETED|Overall Study||13
8189396|NCT02301390|20192252|P1|COMPLETED|Overall Study||17
8189397|NCT02301390|20192251|P2|STARTED|Overall Study||26
8189398|NCT02301390|20192252|P1|STARTED|Overall Study||27
8189399|NCT02301377|20192266|P2|NOT COMPLETED|Overall Study||0
8189400|NCT02301377|20192267|P1|NOT COMPLETED|Overall Study||0
8189401|NCT02301377|20192266|P2|COMPLETED|Overall Study||2
8189402|NCT02301377|20192267|P1|COMPLETED|Overall Study||3
8189403|NCT02301377|20192266|P2|STARTED|Overall Study||2
8189404|NCT02301377|20192267|P1|STARTED|Overall Study||3
8189405|NCT02301364|20192277|P1|NOT COMPLETED|Overall Study||0
8189406|NCT02301364|20192277|P1|COMPLETED|Overall Study||4
8189407|NCT02301364|20192277|P1|STARTED|Overall Study||4
8189408|NCT02301299|20192284|P1|NOT COMPLETED|Overall Study||0
8189409|NCT02301299|20192284|P1|COMPLETED|Overall Study||1322
8189410|NCT02301299|20192284|P1|STARTED|Overall Study||1322
8189411|NCT02301169|20192293|P2|NOT COMPLETED|Overall Study||0
8189412|NCT02301169|20192294|P1|NOT COMPLETED|Overall Study||1
8189413|NCT02301169|20192293|P2|COMPLETED|Overall Study||21
8189414|NCT02301169|20192294|P1|COMPLETED|Overall Study||20
8189415|NCT02301169|20192293|P2|STARTED|Overall Study||21
8189416|NCT02301169|20192294|P1|STARTED|Overall Study||21
8189417|NCT02301143|20192308|P2|NOT COMPLETED|Investigator's Choice||10
8189418|NCT02301143|20192309|P1|NOT COMPLETED|Investigator's Choice||0
8189419|NCT02301143|20192308|P2|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
8189420|NCT02301143|20192309|P1|COMPLETED|Investigator's Choice||0
8189421|NCT02301143|20192308|P2|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
8189422|NCT02301143|20192309|P1|STARTED|Investigator's Choice||0
8189423|NCT02301143|20192308|P2|NOT COMPLETED|Induction Period||0
8189424|NCT02301143|20192309|P1|NOT COMPLETED|Induction Period||45
8189425|NCT02301143|20192308|P2|COMPLETED|Induction Period||0
8189426|NCT02301143|20192309|P1|COMPLETED|Induction Period||62
8189427|NCT02301143|20192308|P2|STARTED|Induction Period||0
8189428|NCT02301143|20192309|P1|STARTED|Induction Period||107
8189429|NCT02301039|20192328|P3|NOT COMPLETED|Overall Study||0
8189430|NCT02301039|20192329|P2|NOT COMPLETED|Overall Study||0
8189431|NCT02301039|20192330|P1|NOT COMPLETED|Overall Study||0
8189432|NCT02301039|20192328|P3|COMPLETED|Overall Study||60
8189433|NCT02301039|20192329|P2|COMPLETED|Overall Study||42
8189434|NCT02301039|20192330|P1|COMPLETED|Overall Study||42
8189435|NCT02301039|20192328|P3|STARTED|Overall Study||60
8189436|NCT02301039|20192329|P2|STARTED|Overall Study||42
8189437|NCT02301039|20192330|P1|STARTED|Overall Study||42
8189438|NCT02300987|20192352|P2|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
8189439|NCT02300987|20192353|P1|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
8189440|NCT02300987|20192352|P2|COMPLETED|Secondary Phase : Cross-over to LEE011||1
8189441|NCT02300987|20192353|P1|COMPLETED|Secondary Phase : Cross-over to LEE011||0
8189442|NCT02300987|20192352|P2|STARTED|Secondary Phase : Cross-over to LEE011||2
8189443|NCT02300987|20192353|P1|STARTED|Secondary Phase : Cross-over to LEE011||1
8189444|NCT02300987|20192352|P2|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
8189445|NCT02300987|20192353|P1|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
8189446|NCT02300987|20192352|P2|COMPLETED|Primary Phase : Prior to Cross-over||0
8189447|NCT02300987|20192353|P1|COMPLETED|Primary Phase : Prior to Cross-over||2
8189448|NCT02300987|20192352|P2|STARTED|Primary Phase : Prior to Cross-over||2
8189449|NCT02300987|20192353|P1|STARTED|Primary Phase : Prior to Cross-over||8
8189450|NCT02300727|20192378|P6|NOT COMPLETED|Overall Study||0
8189451|NCT02300727|20192379|P5|NOT COMPLETED|Overall Study||0
8189452|NCT02300727|20192380|P4|NOT COMPLETED|Overall Study||1
8189453|NCT02300727|20192381|P3|NOT COMPLETED|Overall Study||0
8189454|NCT02300727|20192382|P2|NOT COMPLETED|Overall Study||0
8189455|NCT02300727|20192383|P1|NOT COMPLETED|Overall Study||0
8189456|NCT02300727|20192378|P6|COMPLETED|Overall Study||0
8189457|NCT02300727|20192379|P5|COMPLETED|Overall Study||0
8189458|NCT02300727|20192380|P4|COMPLETED|Overall Study||2
8189459|NCT02300727|20192381|P3|COMPLETED|Overall Study||3
8189460|NCT02300727|20192382|P2|COMPLETED|Overall Study||0
8189461|NCT02300727|20192383|P1|COMPLETED|Overall Study||0
8189462|NCT02300727|20192378|P6|STARTED|Overall Study||0
8189463|NCT02300727|20192379|P5|STARTED|Overall Study||0
8189464|NCT02300727|20192380|P4|STARTED|Overall Study||3
8189465|NCT02300727|20192381|P3|STARTED|Overall Study||3
8189466|NCT02300727|20192382|P2|STARTED|Overall Study||0
8189467|NCT02300727|20192383|P1|STARTED|Overall Study||0
8189468|NCT02300610|20192400|P3|NOT COMPLETED|Overall Study||1
8189469|NCT02300610|20192401|P2|NOT COMPLETED|Overall Study||0
8189470|NCT02300610|20192402|P1|NOT COMPLETED|Overall Study||1
8189471|NCT02300610|20192400|P3|COMPLETED|Overall Study||3
8189472|NCT02300610|20192401|P2|COMPLETED|Overall Study||3
8189473|NCT02300610|20192402|P1|COMPLETED|Overall Study||2
8189474|NCT02300610|20192400|P3|STARTED|Overall Study||4
8189475|NCT02300610|20192401|P2|STARTED|Overall Study||3
8189476|NCT02300610|20192402|P1|STARTED|Overall Study||3
8189477|NCT02300558|20192417|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
8189478|NCT02300558|20192417|P1|COMPLETED|Open-Label (OL) Extension Phase||0
8189479|NCT02300558|20192417|P1|STARTED|Open-Label (OL) Extension Phase||32
8189480|NCT02300558|20192417|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
8189481|NCT02300558|20192417|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
8189482|NCT02300558|20192417|P1|STARTED|Single Blind Phase (24 Weeks)||41
8189483|NCT02300545|20192428|P1|NOT COMPLETED|Overall Study||0
8189484|NCT02300545|20192428|P1|COMPLETED|Overall Study||56
8189485|NCT02300545|20192428|P1|STARTED|Overall Study||56
8189486|NCT02300311|20192439|P2|NOT COMPLETED|Overall Study||0
8189487|NCT02300311|20192440|P1|NOT COMPLETED|Overall Study||19
8189488|NCT02300311|20192439|P2|COMPLETED|Overall Study||69
8189489|NCT02300311|20192440|P1|COMPLETED|Overall Study||50
8189490|NCT02300311|20192439|P2|STARTED|Overall Study||69
8189491|NCT02300311|20192440|P1|STARTED|Overall Study||69
8189492|NCT02300298|20192452|P2|NOT COMPLETED|Disposition for Docetaxel||10
8189493|NCT02300298|20192453|P1|NOT COMPLETED|Disposition for Docetaxel||0
8189494|NCT02300298|20192452|P2|COMPLETED|Disposition for Docetaxel||0
8189495|NCT02300298|20192453|P1|COMPLETED|Disposition for Docetaxel||0
8189496|NCT02300298|20192452|P2|STARTED|Disposition for Docetaxel||10
8189497|NCT02300298|20192453|P1|STARTED|Disposition for Docetaxel||0
8189498|NCT02300298|20192452|P2|NOT COMPLETED|Disposition for Nintedanib||0
8189499|NCT02300298|20192453|P1|NOT COMPLETED|Disposition for Nintedanib||10
8189500|NCT02300298|20192452|P2|COMPLETED|Disposition for Nintedanib||0
8189501|NCT02300298|20192453|P1|COMPLETED|Disposition for Nintedanib||0
8189502|NCT02300298|20192452|P2|STARTED|Disposition for Nintedanib||0
8189503|NCT02300298|20192453|P1|STARTED|Disposition for Nintedanib||10
8189504|NCT02300259|20192466|P3|NOT COMPLETED|Period 2||1
8189505|NCT02300259|20192467|P2|NOT COMPLETED|Period 2||0
8189506|NCT02300259|20192468|P1|NOT COMPLETED|Period 2||1
8189507|NCT02300259|20192466|P3|COMPLETED|Period 2||13
8189508|NCT02300259|20192467|P2|COMPLETED|Period 2||0
8189509|NCT02300259|20192468|P1|COMPLETED|Period 2||15
8189510|NCT02300259|20192466|P3|STARTED|Period 2||14
8189511|NCT02300259|20192467|P2|STARTED|Period 2|There was no period 2 for Group 2.|0
8189512|NCT02300259|20192468|P1|STARTED|Period 2||16
8189513|NCT02300259|20192466|P3|NOT COMPLETED|Period 1||2
8189514|NCT02300259|20192467|P2|NOT COMPLETED|Period 1||0
8189515|NCT02300259|20192468|P1|NOT COMPLETED|Period 1||0
8189516|NCT02300259|20192466|P3|COMPLETED|Period 1||14
8189517|NCT02300259|20192467|P2|COMPLETED|Period 1||16
8189518|NCT02300259|20192468|P1|COMPLETED|Period 1||16
8189519|NCT02300259|20192466|P3|Received at Least One Dose of Study Drug|Period 1||16
8189520|NCT02300259|20192467|P2|Received at Least One Dose of Study Drug|Period 1||16
8189521|NCT02300259|20192468|P1|Received at Least One Dose of Study Drug|Period 1||16
8189522|NCT02300259|20192466|P3|STARTED|Period 1||16
8189523|NCT02300259|20192467|P2|STARTED|Period 1||16
8189524|NCT02300259|20192468|P1|STARTED|Period 1||16
8189525|NCT02300129|20192497|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189526|NCT02300129|20192498|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189527|NCT02300129|20192499|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189528|NCT02300129|20192500|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189529|NCT02300129|20192497|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
8189530|NCT02300129|20192498|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
8189531|NCT02300129|20192499|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
8189532|NCT02300129|20192500|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
8189533|NCT02300129|20192497|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
8189534|NCT02300129|20192498|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
8189535|NCT02300129|20192499|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
8189536|NCT02300129|20192500|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
8189537|NCT02300129|20192497|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
8189538|NCT02300129|20192498|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
8189539|NCT02300129|20192499|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
8189540|NCT02300129|20192500|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
8189541|NCT02300129|20192497|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
8189542|NCT02300129|20192498|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
8189543|NCT02300129|20192499|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
8189544|NCT02300129|20192500|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
8189545|NCT02300129|20192497|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
8189546|NCT02300129|20192498|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
8189547|NCT02300129|20192499|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
8189548|NCT02300129|20192500|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
8189549|NCT02300129|20192497|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189550|NCT02300129|20192498|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189551|NCT02300129|20192499|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189552|NCT02300129|20192500|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189553|NCT02300129|20192497|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
8189554|NCT02300129|20192498|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
8189555|NCT02300129|20192499|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
8189556|NCT02300129|20192500|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
8189557|NCT02300129|20192497|P4|STARTED|Period 1 Session 3 (Day 5)||11
8189558|NCT02300129|20192498|P3|STARTED|Period 1 Session 3 (Day 5)||7
8189559|NCT02300129|20192499|P2|STARTED|Period 1 Session 3 (Day 5)||4
8189560|NCT02300129|20192500|P1|STARTED|Period 1 Session 3 (Day 5)||11
8189561|NCT02300129|20192497|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8189562|NCT02300129|20192498|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8189563|NCT02300129|20192499|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
8189564|NCT02300129|20192500|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8189565|NCT02300129|20192497|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
8189566|NCT02300129|20192498|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
8189567|NCT02300129|20192499|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
8189568|NCT02300129|20192500|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
8189569|NCT02300129|20192497|P4|STARTED|Period 1 Session 2 (Day 3)||11
8189570|NCT02300129|20192498|P3|STARTED|Period 1 Session 2 (Day 3)||7
8189571|NCT02300129|20192499|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
8189572|NCT02300129|20192500|P1|STARTED|Period 1 Session 2 (Day 3)||11
8189573|NCT02300129|20192497|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189574|NCT02300129|20192498|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189575|NCT02300129|20192499|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189576|NCT02300129|20192500|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189577|NCT02300129|20192497|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
8189578|NCT02300129|20192498|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
8189579|NCT02300129|20192499|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
8189580|NCT02300129|20192500|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
8189581|NCT02300129|20192497|P4|STARTED|Period 1 Session 1 (Day 1)||11
8189582|NCT02300129|20192498|P3|STARTED|Period 1 Session 1 (Day 1)||7
8189583|NCT02300129|20192499|P2|STARTED|Period 1 Session 1 (Day 1)||5
8189584|NCT02300129|20192500|P1|STARTED|Period 1 Session 1 (Day 1)||11
8189585|NCT02300103|20192510|P1|NOT COMPLETED|Overall Study||6
8189586|NCT02300103|20192510|P1|COMPLETED|Overall Study||63
8189587|NCT02300103|20192510|P1|STARTED|Overall Study||69
8189588|NCT02300077|20192522|P3|NOT COMPLETED|Overall Study||0
8189589|NCT02300077|20192523|P2|NOT COMPLETED|Overall Study||0
8189590|NCT02300077|20192524|P1|NOT COMPLETED|Overall Study||0
8189591|NCT02300077|20192522|P3|COMPLETED|Overall Study||21
8189592|NCT02300077|20192523|P2|COMPLETED|Overall Study||18
8189593|NCT02300077|20192524|P1|COMPLETED|Overall Study||21
8189594|NCT02300077|20192522|P3|STARTED|Overall Study||21
8189595|NCT02300077|20192523|P2|STARTED|Overall Study||18
8189596|NCT02300077|20192524|P1|STARTED|Overall Study||21
8189597|NCT02300025|20192545|P4|NOT COMPLETED|Overall Study||0
8189598|NCT02300025|20192546|P3|NOT COMPLETED|Overall Study||0
8189599|NCT02300025|20192547|P2|NOT COMPLETED|Overall Study||0
8189600|NCT02300025|20192548|P1|NOT COMPLETED|Overall Study||0
8189601|NCT02300025|20192545|P4|COMPLETED|Overall Study||6
8189602|NCT02300025|20192546|P3|COMPLETED|Overall Study||6
8189603|NCT02300025|20192547|P2|COMPLETED|Overall Study||6
8189604|NCT02300025|20192548|P1|COMPLETED|Overall Study||10
8189605|NCT02300025|20192545|P4|STARTED|Overall Study||6
8189606|NCT02300025|20192546|P3|STARTED|Overall Study||6
8189607|NCT02300025|20192547|P2|STARTED|Overall Study||6
8189608|NCT02300025|20192548|P1|STARTED|Overall Study||10
8189609|NCT02299934|20192590|P1|NOT COMPLETED|Overall Study||13
8189610|NCT02299934|20192590|P1|COMPLETED|Overall Study||0
8189611|NCT02299934|20192590|P1|STARTED|Overall Study||13
8189612|NCT02299869|20192605|P4|NOT COMPLETED|Overall Study||0
8189613|NCT02299869|20192606|P3|NOT COMPLETED|Overall Study||0
8189614|NCT02299869|20192607|P2|NOT COMPLETED|Overall Study||0
8189615|NCT02299869|20192608|P1|NOT COMPLETED|Overall Study||0
8189616|NCT02299869|20192605|P4|COMPLETED|Overall Study||10
8189617|NCT02299869|20192606|P3|COMPLETED|Overall Study||10
8189618|NCT02299869|20192607|P2|COMPLETED|Overall Study||10
8189619|NCT02299869|20192608|P1|COMPLETED|Overall Study||10
8189620|NCT02299869|20192605|P4|STARTED|Overall Study||10
8189621|NCT02299869|20192606|P3|STARTED|Overall Study||10
8189622|NCT02299869|20192607|P2|STARTED|Overall Study||10
8189623|NCT02299869|20192608|P1|STARTED|Overall Study||10
8189624|NCT02299791|20192633|P2|NOT COMPLETED|Overall Study||0
8189625|NCT02299791|20192634|P1|NOT COMPLETED|Overall Study||0
8189626|NCT02299791|20192633|P2|COMPLETED|Overall Study||2803
8189627|NCT02299791|20192634|P1|COMPLETED|Overall Study||2053
8189628|NCT02299791|20192633|P2|STARTED|Overall Study||2803
8189629|NCT02299791|20192634|P1|STARTED|Overall Study||2053
8189630|NCT02299635|20192640|P1|NOT COMPLETED|Overall Study||19
8189631|NCT02299635|20192640|P1|COMPLETED|Overall Study||0
8189632|NCT02299635|20192640|P1|STARTED|Overall Study||19
8189633|NCT02299570|20192662|P3|NOT COMPLETED|Overall Study||19
8189634|NCT02299570|20192663|P2|NOT COMPLETED|Overall Study||9
8189635|NCT02299570|20192664|P1|NOT COMPLETED|Overall Study||14
8189636|NCT02299570|20192662|P3|COMPLETED|Overall Study||25
8189637|NCT02299570|20192663|P2|COMPLETED|Overall Study||35
8189638|NCT02299570|20192664|P1|COMPLETED|Overall Study||31
8189639|NCT02299570|20192662|P3|STARTED|Overall Study||44
8189640|NCT02299570|20192663|P2|STARTED|Overall Study||44
8189641|NCT02299570|20192664|P1|STARTED|Overall Study||45
8189642|NCT02299479|20192684|P1|NOT COMPLETED|Overall Study||2
8189643|NCT02299479|20192684|P1|COMPLETED|Overall Study||18
8189644|NCT02299479|20192684|P1|STARTED|Overall Study||20
8189645|NCT02299427|20192692|P2|NOT COMPLETED|Overall Study||3
8189646|NCT02299427|20192693|P1|NOT COMPLETED|Overall Study||23
8189647|NCT02299427|20192692|P2|COMPLETED|Overall Study||31
8189648|NCT02299427|20192693|P1|COMPLETED|Overall Study||12
8189649|NCT02299427|20192692|P2|STARTED|Overall Study||34
8189650|NCT02299427|20192693|P1|STARTED|Overall Study||35
8189651|NCT02299388|20192703|P2|NOT COMPLETED|Overall Study||1
8189652|NCT02299388|20192704|P1|NOT COMPLETED|Overall Study||0
8189653|NCT02299388|20192703|P2|COMPLETED|Overall Study||4
8189654|NCT02299388|20192704|P1|COMPLETED|Overall Study||6
8189655|NCT02299388|20192703|P2|STARTED|Overall Study||5
8189656|NCT02299388|20192704|P1|STARTED|Overall Study||6
8189657|NCT02299375|20192714|P2|NOT COMPLETED|Overall Study||80
8189658|NCT02299375|20192715|P1|NOT COMPLETED|Overall Study||80
8189659|NCT02299375|20192714|P2|COMPLETED|Overall Study||10
8189660|NCT02299375|20192715|P1|COMPLETED|Overall Study||14
8189661|NCT02299375|20192714|P2|STARTED|Overall Study||90
8189662|NCT02299375|20192715|P1|STARTED|Overall Study||94
8189663|NCT02299349|20192765|P2|NOT COMPLETED|Overall Study||0
8189664|NCT02299349|20192766|P1|NOT COMPLETED|Overall Study||0
8189665|NCT02299349|20192765|P2|COMPLETED|Overall Study||35
8189666|NCT02299349|20192766|P1|COMPLETED|Overall Study||35
8189667|NCT02299349|20192765|P2|STARTED|Overall Study||35
8189668|NCT02299349|20192766|P1|STARTED|Overall Study||35
8189669|NCT02299336|20192774|P1|NOT COMPLETED|Overall Study||14
8189670|NCT02299336|20192774|P1|COMPLETED|Overall Study||46
8189671|NCT02299336|20192774|P1|STARTED|Overall Study||60
8189672|NCT02299297|20192790|P1|NOT COMPLETED|Overall Study||1
8189673|NCT02299297|20192790|P1|COMPLETED|Overall Study||11
8189674|NCT02299297|20192790|P1|STARTED|Overall Study||12
8189675|NCT02299258|20192800|P2|NOT COMPLETED|Overall Study||1
8189676|NCT02299258|20192801|P1|NOT COMPLETED|Overall Study||1
8189677|NCT02299258|20192800|P2|COMPLETED|Overall Study||30
8189678|NCT02299258|20192801|P1|COMPLETED|Overall Study||31
8189679|NCT02299258|20192800|P2|STARTED|Overall Study||31
8189680|NCT02299258|20192801|P1|STARTED|Overall Study||32
8189681|NCT02299206|20192809|P1|NOT COMPLETED|Overall Study||2
8189682|NCT02299206|20192809|P1|COMPLETED|Overall Study||2
8189683|NCT02299206|20192809|P1|STARTED|Overall Study||4
8189684|NCT02299167|20192817|P1|NOT COMPLETED|Overall Study||11
8189685|NCT02299167|20192817|P1|COMPLETED|Overall Study||24
8189686|NCT02299167|20192817|P1|Adverse Effects|Overall Study||24
8189687|NCT02299167|20192817|P1|Success Rate|Overall Study||24
8189688|NCT02299167|20192817|P1|Dural Puncture|Overall Study||24
8189689|NCT02299167|20192817|P1|STARTED|Overall Study||35
8189690|NCT02299089|20192829|P4|NOT COMPLETED|Overall Study||0
8189691|NCT02299089|20192830|P3|NOT COMPLETED|Overall Study||0
8189692|NCT02299089|20192831|P2|NOT COMPLETED|Overall Study||0
8189693|NCT02299089|20192832|P1|NOT COMPLETED|Overall Study||0
8189694|NCT02299089|20192829|P4|COMPLETED|Overall Study||4
8189695|NCT02299089|20192830|P3|COMPLETED|Overall Study||1
8189696|NCT02299089|20192831|P2|COMPLETED|Overall Study||4
8189697|NCT02299089|20192832|P1|COMPLETED|Overall Study||3
8189698|NCT02299089|20192829|P4|STARTED|Overall Study||4
8189699|NCT02299089|20192830|P3|STARTED|Overall Study||1
8189700|NCT02299089|20192831|P2|STARTED|Overall Study||4
8189701|NCT02299089|20192832|P1|STARTED|Overall Study||3
8189702|NCT02299076|20192878|P2|NOT COMPLETED|Overall Study||14
8189703|NCT02299076|20192879|P1|NOT COMPLETED|Overall Study||20
8189704|NCT02299076|20192878|P2|COMPLETED|Overall Study||212
8189705|NCT02299076|20192879|P1|COMPLETED|Overall Study||210
8189706|NCT02299076|20192878|P2|STARTED|Overall Study||226
8189707|NCT02299076|20192879|P1|STARTED|Overall Study||230
8189708|NCT02299050|20192887|P1|NOT COMPLETED|Overall Study||8
8189709|NCT02299050|20192887|P1|COMPLETED|Overall Study||15
8189710|NCT02299050|20192887|P1|STARTED|Overall Study||23
8189711|NCT02298946|20192900|P2|NOT COMPLETED|Overall Study||1
8189712|NCT02298946|20192901|P1|NOT COMPLETED|Overall Study||4
8189713|NCT02298946|20192900|P2|COMPLETED|Overall Study||8
8189714|NCT02298946|20192901|P1|COMPLETED|Overall Study||4
8189715|NCT02298946|20192900|P2|STARTED|Overall Study||9
8189716|NCT02298946|20192901|P1|STARTED|Overall Study||8
8189717|NCT02298933|20192925|P1|NOT COMPLETED|Overall Study||0
8189718|NCT02298933|20192925|P1|COMPLETED|Overall Study||10
8189719|NCT02298933|20192925|P1|STARTED|Overall Study||10
8189720|NCT02298868|20192929|P1|NOT COMPLETED|Overall Study||3
8189721|NCT02298868|20192929|P1|COMPLETED|Overall Study||7
8189722|NCT02298868|20192929|P1|STARTED|Overall Study||10
8189723|NCT02298842|20192943|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
8189724|NCT02298842|20192944|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
8189725|NCT02298842|20192943|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
8189726|NCT02298842|20192944|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
8189727|NCT02298842|20192943|P2|STARTED|Second Platelet Donation (Day 6-8)||36
8189728|NCT02298842|20192944|P1|STARTED|Second Platelet Donation (Day 6-8)||38
8189729|NCT02298842|20192943|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
8189730|NCT02298842|20192944|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
8189731|NCT02298842|20192943|P2|COMPLETED|First Platelet Donation (Day 0)||36
8189732|NCT02298842|20192944|P1|COMPLETED|First Platelet Donation (Day 0)||38
8189733|NCT02298842|20192943|P2|STARTED|First Platelet Donation (Day 0)||41
8189734|NCT02298842|20192944|P1|STARTED|First Platelet Donation (Day 0)||44
8189735|NCT02298803|20192970|P1|NOT COMPLETED|Overall Study||0
8189736|NCT02298803|20192970|P1|COMPLETED|Overall Study||30
8189737|NCT02298803|20192970|P1|STARTED|Overall Study||30
8189738|NCT02298361|20192982|P3|NOT COMPLETED|Overall Study||0
8189739|NCT02298361|20192983|P2|NOT COMPLETED|Overall Study||0
8189740|NCT02298361|20192984|P1|NOT COMPLETED|Overall Study||0
8189741|NCT02298361|20192982|P3|COMPLETED|Overall Study||12227
8189742|NCT02298361|20192983|P2|COMPLETED|Overall Study||12784
8189743|NCT02298361|20192984|P1|COMPLETED|Overall Study||2240
8189744|NCT02298361|20192982|P3|STARTED|Overall Study||12227
8189745|NCT02298361|20192983|P2|STARTED|Overall Study||12784
8189746|NCT02298361|20192984|P1|STARTED|Overall Study||2240
8189747|NCT02298322|20192998|P1|NOT COMPLETED|Overall Study||0
8189748|NCT02298322|20192998|P1|COMPLETED|Overall Study||60
8189749|NCT02298322|20192998|P1|STARTED|Overall Study||60
8189750|NCT02298192|20193007|P2|NOT COMPLETED|Overall Study||6
8189751|NCT02298192|20193008|P1|NOT COMPLETED|Overall Study||19
8189752|NCT02298192|20193007|P2|COMPLETED|Overall Study||204
8189753|NCT02298192|20193008|P1|COMPLETED|Overall Study||191
8189754|NCT02298192|20193007|P2|STARTED|Overall Study||210
8189755|NCT02298192|20193008|P1|STARTED|Overall Study||210
8189756|NCT02298179|20193032|P12|NOT COMPLETED|Overall Study||0
8189757|NCT02298179|20193033|P11|NOT COMPLETED|Overall Study||0
8189758|NCT02298179|20193034|P10|NOT COMPLETED|Overall Study||0
8189759|NCT02298179|20193035|P9|NOT COMPLETED|Overall Study||0
8189760|NCT02298179|20193036|P8|NOT COMPLETED|Overall Study||1
8189761|NCT02298179|20193037|P7|NOT COMPLETED|Overall Study||0
8189762|NCT02298179|20193038|P6|NOT COMPLETED|Overall Study||0
8189763|NCT02298179|20193039|P5|NOT COMPLETED|Overall Study||0
8189764|NCT02298179|20193040|P4|NOT COMPLETED|Overall Study||0
8189765|NCT02298179|20193041|P3|NOT COMPLETED|Overall Study||1
8189766|NCT02298179|20193042|P2|NOT COMPLETED|Overall Study||0
8189767|NCT02298179|20193043|P1|NOT COMPLETED|Overall Study||0
8189768|NCT02298179|20193032|P12|COMPLETED|Overall Study||24
8189769|NCT02298179|20193033|P11|COMPLETED|Overall Study||24
8189770|NCT02298179|20193034|P10|COMPLETED|Overall Study||24
8189771|NCT02298179|20193035|P9|COMPLETED|Overall Study||24
8189772|NCT02298179|20193036|P8|COMPLETED|Overall Study||23
8189773|NCT02298179|20193037|P7|COMPLETED|Overall Study||24
8189774|NCT02298179|20193038|P6|COMPLETED|Overall Study||24
8189775|NCT02298179|20193039|P5|COMPLETED|Overall Study||24
8189776|NCT02298179|20193040|P4|COMPLETED|Overall Study||24
8189777|NCT02298179|20193041|P3|COMPLETED|Overall Study||23
8189778|NCT02298179|20193042|P2|COMPLETED|Overall Study||24
8189779|NCT02298179|20193043|P1|COMPLETED|Overall Study||24
8189780|NCT02298179|20193032|P12|STARTED|Overall Study||24
8189781|NCT02298179|20193033|P11|STARTED|Overall Study||24
8189782|NCT02298179|20193034|P10|STARTED|Overall Study||24
8189783|NCT02298179|20193035|P9|STARTED|Overall Study||24
8189784|NCT02298179|20193036|P8|STARTED|Overall Study||24
8189785|NCT02298179|20193037|P7|STARTED|Overall Study||24
8189786|NCT02298179|20193038|P6|STARTED|Overall Study||24
8189787|NCT02298179|20193039|P5|STARTED|Overall Study||24
8189788|NCT02298179|20193040|P4|STARTED|Overall Study||24
8189789|NCT02298179|20193041|P3|STARTED|Overall Study||24
8189790|NCT02298179|20193042|P2|STARTED|Overall Study||24
8189791|NCT02298179|20193043|P1|STARTED|Overall Study||24
8189792|NCT02297841|20193285|P1|NOT COMPLETED|Overall Study||8
8189793|NCT02297841|20193285|P1|COMPLETED|Overall Study||201
8189794|NCT02297841|20193285|P1|Challenge Phase|Overall Study||201
8189795|NCT02297841|20193285|P1|Induction Phase|Overall Study||209
8189796|NCT02297841|20193285|P1|STARTED|Overall Study||209
8189797|NCT02297815|20193291|P2|NOT COMPLETED|Overall Study||140
8189798|NCT02297815|20193292|P1|NOT COMPLETED|Overall Study||236
8189799|NCT02297815|20193291|P2|COMPLETED|Overall Study||728
8189800|NCT02297815|20193292|P1|COMPLETED|Overall Study||1368
8189801|NCT02297815|20193291|P2|14-20 Day Interview|Overall Study||728
8189802|NCT02297815|20193292|P1|14-20 Day Interview|Overall Study||1368
8189803|NCT02297815|20193291|P2|5-10 Day Interview|Overall Study||868
8189804|NCT02297815|20193292|P1|5-10 Day Interview|Overall Study||1604
8189805|NCT02297815|20193291|P2|STARTED|Overall Study||868
8189806|NCT02297815|20193292|P1|STARTED|Overall Study||1604
8189807|NCT02297516|20193310|P2|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
8189808|NCT02297516|20193311|P1|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
8189809|NCT02297516|20193310|P2|COMPLETED|Combination Treatment Phase (up to 18 m)||30
8189810|NCT02297516|20193311|P1|COMPLETED|Combination Treatment Phase (up to 18 m)||31
8189811|NCT02297516|20193310|P2|STARTED|Combination Treatment Phase (up to 18 m)||31
8189812|NCT02297516|20193311|P1|STARTED|Combination Treatment Phase (up to 18 m)||31
8189813|NCT02297516|20193310|P2|NOT COMPLETED|Single Treatment Phase (6 Months)||2
8189814|NCT02297516|20193311|P1|NOT COMPLETED|Single Treatment Phase (6 Months)||1
8189815|NCT02297516|20193310|P2|COMPLETED|Single Treatment Phase (6 Months)||31
8189816|NCT02297516|20193311|P1|COMPLETED|Single Treatment Phase (6 Months)||31
8189817|NCT02297516|20193310|P2|STARTED|Single Treatment Phase (6 Months)||33
8189818|NCT02297516|20193311|P1|STARTED|Single Treatment Phase (6 Months)||32
8189819|NCT02297503|20193332|P2|NOT COMPLETED|Overall Study||4
8189820|NCT02297503|20193333|P1|NOT COMPLETED|Overall Study||2
8189821|NCT02297503|20193332|P2|COMPLETED|Overall Study||27
8189822|NCT02297503|20193333|P1|COMPLETED|Overall Study||28
8189823|NCT02297503|20193332|P2|Second Combined Treatment|Overall Study||28
8189824|NCT02297503|20193333|P1|Second Combined Treatment|Overall Study||28
8189825|NCT02297503|20193332|P2|First Combined Treatment|Overall Study||28
8189826|NCT02297503|20193333|P1|First Combined Treatment|Overall Study||28
8189827|NCT02297503|20193332|P2|Initial Single Treatment|Overall Study||31
8189828|NCT02297503|20193333|P1|Initial Single Treatment|Overall Study||29
8189829|NCT02297503|20193332|P2|STARTED|Overall Study||31
8189830|NCT02297503|20193333|P1|STARTED|Overall Study||30
8189831|NCT02297412|20193360|P2|NOT COMPLETED|Overall Study||1
8189832|NCT02297412|20193361|P1|NOT COMPLETED|Overall Study||1
8189833|NCT02297412|20193360|P2|COMPLETED|Overall Study||23
8189834|NCT02297412|20193361|P1|COMPLETED|Overall Study||22
8189835|NCT02297412|20193360|P2|STARTED|Overall Study||24
8189836|NCT02297412|20193361|P1|STARTED|Overall Study||23
8189837|NCT02297308|20193371|P1|NOT COMPLETED|Overall Study||0
8189838|NCT02297308|20193371|P1|COMPLETED|Overall Study||90
8189839|NCT02297308|20193371|P1|STARTED|Overall Study||90
8189840|NCT02297230|20193380|P4|NOT COMPLETED|Overall Study||0
8189841|NCT02297230|20193381|P3|NOT COMPLETED|Overall Study||0
8189842|NCT02297230|20193382|P2|NOT COMPLETED|Overall Study||0
8189843|NCT02297230|20193383|P1|NOT COMPLETED|Overall Study||0
8189844|NCT02297230|20193380|P4|COMPLETED|Overall Study||11
8189845|NCT02297230|20193381|P3|COMPLETED|Overall Study||11
8189846|NCT02297230|20193382|P2|COMPLETED|Overall Study||11
8189847|NCT02297230|20193383|P1|COMPLETED|Overall Study||11
8189848|NCT02297230|20193380|P4|STARTED|Overall Study||11
8189849|NCT02297230|20193381|P3|STARTED|Overall Study||11
8189850|NCT02297230|20193382|P2|STARTED|Overall Study||11
8189851|NCT02297230|20193383|P1|STARTED|Overall Study||11
8189852|NCT02297100|20193407|P2|NOT COMPLETED|Overall Study||0
8189853|NCT02297100|20193408|P1|NOT COMPLETED|Overall Study||0
8189854|NCT02297100|20193407|P2|COMPLETED|Overall Study||14
8189855|NCT02297100|20193408|P1|COMPLETED|Overall Study||13
8189856|NCT02297100|20193407|P2|STARTED|Overall Study||14
8189857|NCT02297100|20193408|P1|STARTED|Overall Study||13
8189858|NCT02296931|20193422|P2|NOT COMPLETED|Overall Study||2
8189859|NCT02296931|20193423|P1|NOT COMPLETED|Overall Study||0
8189860|NCT02296931|20193422|P2|COMPLETED|Overall Study||22
8189861|NCT02296931|20193423|P1|COMPLETED|Overall Study||10
8189862|NCT02296931|20193422|P2|STARTED|Overall Study||24
8189863|NCT02296931|20193423|P1|STARTED|Overall Study||10
8189864|NCT02296892|20193432|P3|NOT COMPLETED|Overall Study||5
8189865|NCT02296892|20193433|P2|NOT COMPLETED|Overall Study||4
8189866|NCT02296892|20193434|P1|NOT COMPLETED|Overall Study||12
8189867|NCT02296892|20193432|P3|COMPLETED|Overall Study||68
8189868|NCT02296892|20193433|P2|COMPLETED|Overall Study||59
8189869|NCT02296892|20193434|P1|COMPLETED|Overall Study||298
8189870|NCT02296892|20193432|P3|Complete Trial Treatment Period|Overall Study||69
8189871|NCT02296892|20193433|P2|Complete Trial Treatment Period|Overall Study||59
8189872|NCT02296892|20193434|P1|Complete Trial Treatment Period|Overall Study||303
8189873|NCT02296892|20193432|P3|Safety Population|Overall Study||69
8189874|NCT02296892|20193433|P2|Safety Population|Overall Study||59
8189875|NCT02296892|20193434|P1|Safety Population|Overall Study||303
8189876|NCT02296892|20193432|P3|STARTED|Overall Study||73
8189877|NCT02296892|20193433|P2|STARTED|Overall Study||63
8189878|NCT02296892|20193434|P1|STARTED|Overall Study||310
8189879|NCT02296853|20193453|P2|NOT COMPLETED|Overall Study||0
8189880|NCT02296853|20193454|P1|NOT COMPLETED|Overall Study||0
8189881|NCT02296853|20193453|P2|COMPLETED|Overall Study||10
8189882|NCT02296853|20193454|P1|COMPLETED|Overall Study||10
8189883|NCT02296853|20193453|P2|STARTED|Overall Study||10
8189884|NCT02296853|20193454|P1|STARTED|Overall Study||10
8189885|NCT02296840|20193470|P2|NOT COMPLETED|Overall Study||19
8189886|NCT02296840|20193471|P1|NOT COMPLETED|Overall Study||9
8189887|NCT02296840|20193470|P2|COMPLETED|Overall Study||8
8189888|NCT02296840|20193471|P1|COMPLETED|Overall Study||9
8189889|NCT02296840|20193470|P2|STARTED|Overall Study||27
8189890|NCT02296840|20193471|P1|STARTED|Overall Study||18
8189891|NCT02296775|20193482|P3|NOT COMPLETED|Recovery and Follow-up||4
8189892|NCT02296775|20193483|P2|NOT COMPLETED|Recovery and Follow-up||5
8189893|NCT02296775|20193484|P1|NOT COMPLETED|Recovery and Follow-up||5
8189894|NCT02296775|20193482|P3|COMPLETED|Recovery and Follow-up||79
8189895|NCT02296775|20193483|P2|COMPLETED|Recovery and Follow-up||79
8189896|NCT02296775|20193484|P1|COMPLETED|Recovery and Follow-up||82
8189897|NCT02296775|20193482|P3|STARTED|Recovery and Follow-up||83
8189898|NCT02296775|20193483|P2|STARTED|Recovery and Follow-up||84
8189899|NCT02296775|20193484|P1|STARTED|Recovery and Follow-up||87
8189900|NCT02296775|20193482|P3|NOT COMPLETED|Treatment and Evaluation||10
8189901|NCT02296775|20193483|P2|NOT COMPLETED|Treatment and Evaluation||8
8189902|NCT02296775|20193484|P1|NOT COMPLETED|Treatment and Evaluation||4
8189903|NCT02296775|20193482|P3|COMPLETED|Treatment and Evaluation||83
8189904|NCT02296775|20193483|P2|COMPLETED|Treatment and Evaluation||84
8189905|NCT02296775|20193484|P1|COMPLETED|Treatment and Evaluation||87
8189906|NCT02296775|20193482|P3|STARTED|Treatment and Evaluation||93
8189907|NCT02296775|20193483|P2|STARTED|Treatment and Evaluation||92
8189908|NCT02296775|20193484|P1|STARTED|Treatment and Evaluation||91
8189909|NCT02296606|20193552|P1|NOT COMPLETED|Overall Study||0
8189910|NCT02296606|20193552|P1|COMPLETED|Overall Study||127
8189911|NCT02296606|20193552|P1|STARTED|Overall Study||127
8189912|NCT02296502|20193560|P4|NOT COMPLETED|Overall Study||0
8189913|NCT02296502|20193561|P3|NOT COMPLETED|Overall Study||0
8189914|NCT02296502|20193562|P2|NOT COMPLETED|Overall Study||0
8189915|NCT02296502|20193563|P1|NOT COMPLETED|Overall Study||0
8189916|NCT02296502|20193560|P4|COMPLETED|Overall Study||160
8189917|NCT02296502|20193561|P3|COMPLETED|Overall Study||30
8189918|NCT02296502|20193562|P2|COMPLETED|Overall Study||1
8189919|NCT02296502|20193563|P1|COMPLETED|Overall Study||248
8189920|NCT02296502|20193560|P4|STARTED|Overall Study||160
8189921|NCT02296502|20193561|P3|STARTED|Overall Study||30
8189922|NCT02296502|20193562|P2|STARTED|Overall Study||1
8189923|NCT02296502|20193563|P1|STARTED|Overall Study||248
8189924|NCT02296476|20193579|P3|NOT COMPLETED|Overall Study||2
8189925|NCT02296476|20193580|P2|NOT COMPLETED|Overall Study||4
8189926|NCT02296476|20193581|P1|NOT COMPLETED|Overall Study||6
8189927|NCT02296476|20193579|P3|COMPLETED|Overall Study||0
8189928|NCT02296476|20193580|P2|COMPLETED|Overall Study||0
8189929|NCT02296476|20193581|P1|COMPLETED|Overall Study||0
8189930|NCT02296476|20193579|P3|STARTED|Overall Study||2
8189931|NCT02296476|20193580|P2|STARTED|Overall Study||4
8189932|NCT02296476|20193581|P1|STARTED|Overall Study||6
8189933|NCT02296424|20193636|P4|NOT COMPLETED|Part 2||0
8189934|NCT02296424|20193637|P3|NOT COMPLETED|Part 2||3
8189935|NCT02296424|20193638|P2|NOT COMPLETED|Part 2||0
8189936|NCT02296424|20193639|P1|NOT COMPLETED|Part 2||0
8189937|NCT02296424|20193636|P4|COMPLETED|Part 2||37
8189938|NCT02296424|20193637|P3|COMPLETED|Part 2||35
8189939|NCT02296424|20193638|P2|COMPLETED|Part 2||0
8189940|NCT02296424|20193639|P1|COMPLETED|Part 2||0
8189941|NCT02296424|20193636|P4|STARTED|Part 2||37
8189942|NCT02296424|20193637|P3|STARTED|Part 2||38
8189943|NCT02296424|20193638|P2|STARTED|Part 2||0
8189944|NCT02296424|20193639|P1|STARTED|Part 2||0
8189945|NCT02296424|20193636|P4|NOT COMPLETED|Part 1||0
8189946|NCT02296424|20193637|P3|NOT COMPLETED|Part 1||0
8189947|NCT02296424|20193638|P2|NOT COMPLETED|Part 1||33
8189948|NCT02296424|20193639|P1|NOT COMPLETED|Part 1||23
8189949|NCT02296424|20193636|P4|COMPLETED|Part 1||0
8189950|NCT02296424|20193637|P3|COMPLETED|Part 1||0
8189951|NCT02296424|20193638|P2|COMPLETED|Part 1||65
8189952|NCT02296424|20193639|P1|COMPLETED|Part 1||61
8189953|NCT02296424|20193636|P4|STARTED|Part 1||0
8189954|NCT02296424|20193637|P3|STARTED|Part 1||0
8189955|NCT02296424|20193638|P2|STARTED|Part 1||98
8189956|NCT02296424|20193639|P1|STARTED|Part 1|16 patients immediately went into Part II|84
8189957|NCT02296346|20193652|P2|NOT COMPLETED|Overall Study||6
8189958|NCT02296346|20193653|P1|NOT COMPLETED|Overall Study||5
8189959|NCT02296346|20193652|P2|COMPLETED|Overall Study||0
8189960|NCT02296346|20193653|P1|COMPLETED|Overall Study||2
8189961|NCT02296346|20193652|P2|STARTED|Overall Study||6
8189962|NCT02296346|20193653|P1|STARTED|Overall Study||7
8189963|NCT02296320|20193664|P3|NOT COMPLETED|Overall Study||37
8189964|NCT02296320|20193665|P2|NOT COMPLETED|Overall Study||5
8189965|NCT02296320|20193666|P1|NOT COMPLETED|Overall Study||35
8189966|NCT02296320|20193664|P3|COMPLETED|Overall Study||59
8189967|NCT02296320|20193665|P2|COMPLETED|Overall Study||10
8189968|NCT02296320|20193666|P1|COMPLETED|Overall Study||67
8189969|NCT02296320|20193664|P3|Treated|Overall Study||96
8189970|NCT02296320|20193665|P2|Treated|Overall Study||15
8189971|NCT02296320|20193666|P1|Treated|Overall Study||100
8189972|NCT02296320|20193664|P3|STARTED|Overall Study||96
8189973|NCT02296320|20193665|P2|STARTED|Overall Study||15
8189974|NCT02296320|20193666|P1|STARTED|Overall Study||102
8189975|NCT02296242|20193705|P5|NOT COMPLETED|Overall Study||21
8189976|NCT02296242|20193706|P4|NOT COMPLETED|Overall Study||14
8189977|NCT02296242|20193707|P3|NOT COMPLETED|Overall Study||7
8189978|NCT02296242|20193708|P2|NOT COMPLETED|Overall Study||6
8189979|NCT02296242|20193709|P1|NOT COMPLETED|Overall Study||5
8189980|NCT02296242|20193705|P5|COMPLETED|Overall Study||0
8189981|NCT02296242|20193706|P4|COMPLETED|Overall Study||0
8189982|NCT02296242|20193707|P3|COMPLETED|Overall Study||0
8189983|NCT02296242|20193708|P2|COMPLETED|Overall Study||0
8189984|NCT02296242|20193709|P1|COMPLETED|Overall Study||0
8189985|NCT02296242|20193705|P5|STARTED|Overall Study||21
8189986|NCT02296242|20193706|P4|STARTED|Overall Study||14
8189987|NCT02296242|20193707|P3|STARTED|Overall Study||7
8189988|NCT02296242|20193708|P2|STARTED|Overall Study||6
8189989|NCT02296242|20193709|P1|STARTED|Overall Study||5
8189990|NCT02296190|20193737|P6|NOT COMPLETED|Overall Study||0
8189991|NCT02296190|20193738|P5|NOT COMPLETED|Overall Study||16
8189992|NCT02296190|20193739|P4|NOT COMPLETED|Overall Study||23
8189993|NCT02296190|20193740|P3|NOT COMPLETED|Overall Study||12
8189994|NCT02296190|20193741|P2|NOT COMPLETED|Overall Study||21
8189995|NCT02296190|20193742|P1|NOT COMPLETED|Overall Study||14
8189996|NCT02296190|20193737|P6|COMPLETED|Overall Study||9
8189997|NCT02296190|20193738|P5|COMPLETED|Overall Study||20
8189998|NCT02296190|20193739|P4|COMPLETED|Overall Study||20
8189999|NCT02296190|20193740|P3|COMPLETED|Overall Study||23
8190000|NCT02296190|20193741|P2|COMPLETED|Overall Study||20
8190001|NCT02296190|20193742|P1|COMPLETED|Overall Study||21
8190002|NCT02296190|20193737|P6|STARTED|Overall Study||9
8190003|NCT02296190|20193738|P5|STARTED|Overall Study||36
8190004|NCT02296190|20193739|P4|STARTED|Overall Study||43
8190005|NCT02296190|20193740|P3|STARTED|Overall Study||35
8190006|NCT02296190|20193741|P2|STARTED|Overall Study||41
8190007|NCT02296190|20193742|P1|STARTED|Overall Study||35
8190008|NCT02296164|20193755|P1|NOT COMPLETED|Overall Study||110
8190009|NCT02296164|20193755|P1|COMPLETED|Overall Study||188
8190010|NCT02296164|20193755|P1|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
8190011|NCT02296138|20193761|P2|NOT COMPLETED|Overall Study||500
8190012|NCT02296138|20193762|P1|NOT COMPLETED|Overall Study||661
8190013|NCT02296138|20193761|P2|COMPLETED|Overall Study||3451
8190014|NCT02296138|20193762|P1|COMPLETED|Overall Study||3291
8190015|NCT02296138|20193761|P2|Treated|Overall Study||3939
8190016|NCT02296138|20193762|P1|Treated|Overall Study||3941
8190017|NCT02296138|20193761|P2|STARTED|Overall Study||3951
8190018|NCT02296138|20193762|P1|STARTED|Overall Study||3952
8190019|NCT02296125|20193778|P4|NOT COMPLETED|Overall Study||62
8190020|NCT02296125|20193779|P3|NOT COMPLETED|Overall Study||56
8190021|NCT02296125|20193780|P2|NOT COMPLETED|Overall Study||264
8190022|NCT02296125|20193781|P1|NOT COMPLETED|Overall Study||218
8190023|NCT02296125|20193778|P4|COMPLETED|Overall Study||3
8190024|NCT02296125|20193779|P3|COMPLETED|Overall Study||15
8190025|NCT02296125|20193780|P2|COMPLETED|Overall Study||13
8190026|NCT02296125|20193781|P1|COMPLETED|Overall Study||61
8190027|NCT02296125|20193778|P4|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
8190028|NCT02296125|20193779|P3|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
8190029|NCT02296125|20193780|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
8190030|NCT02296125|20193781|P1|STARTED|Overall Study||279
8190031|NCT02296112|20193833|P1|NOT COMPLETED|Overall Study||9
8190032|NCT02296112|20193833|P1|COMPLETED|Overall Study||0
8190033|NCT02296112|20193833|P1|STARTED|Overall Study||9
8190034|NCT02296099|20193848|P2|NOT COMPLETED|Overall Study||2
8190035|NCT02296099|20193849|P1|NOT COMPLETED|Overall Study||3
8190036|NCT02296099|20193848|P2|COMPLETED|Overall Study||55
8190037|NCT02296099|20193849|P1|COMPLETED|Overall Study||54
8190038|NCT02296099|20193848|P2|STARTED|Overall Study||57
8190039|NCT02296099|20193849|P1|STARTED|Overall Study||57
8190040|NCT02295995|20193875|P2|NOT COMPLETED|Overall Study||1
8190041|NCT02295995|20193876|P1|NOT COMPLETED|Overall Study||5
8190042|NCT02295995|20193875|P2|COMPLETED|Overall Study||17
8190043|NCT02295995|20193876|P1|COMPLETED|Overall Study||31
8190044|NCT02295995|20193875|P2|STARTED|Overall Study||18
8190045|NCT02295995|20193876|P1|STARTED|Overall Study||36
8190046|NCT02295774|20193887|P1|NOT COMPLETED|Overall Study||3
8190047|NCT02295774|20193887|P1|COMPLETED|Overall Study||10
8190048|NCT02295774|20193887|P1|STARTED|Overall Study||13
8190049|NCT02295735|20193894|P2|NOT COMPLETED|Overall Study||27
8190050|NCT02295735|20193895|P1|NOT COMPLETED|Overall Study||26
8190051|NCT02295735|20193894|P2|COMPLETED|Overall Study||210
8190052|NCT02295735|20193895|P1|COMPLETED|Overall Study||212
8190053|NCT02295735|20193894|P2|STARTED|Overall Study||237
8190054|NCT02295735|20193895|P1|STARTED|Overall Study||238
8190055|NCT02295644|20193927|P4|NOT COMPLETED|Overall Study||2
8190056|NCT02295644|20193928|P3|NOT COMPLETED|Overall Study||1
8190057|NCT02295644|20193929|P2|NOT COMPLETED|Overall Study||0
8190058|NCT02295644|20193930|P1|NOT COMPLETED|Overall Study||0
8190059|NCT02295644|20193927|P4|COMPLETED|Overall Study||5
8190060|NCT02295644|20193928|P3|COMPLETED|Overall Study||6
8190061|NCT02295644|20193929|P2|COMPLETED|Overall Study||7
8190062|NCT02295644|20193930|P1|COMPLETED|Overall Study||7
8190063|NCT02295644|20193927|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190064|NCT02295644|20193928|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190065|NCT02295644|20193929|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190066|NCT02295644|20193930|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190067|NCT02295553|20193952|P4|NOT COMPLETED|Overall Study||1
8190068|NCT02295553|20193953|P3|NOT COMPLETED|Overall Study||1
8190069|NCT02295553|20193954|P2|NOT COMPLETED|Overall Study||0
8190070|NCT02295553|20193955|P1|NOT COMPLETED|Overall Study||0
8190071|NCT02295553|20193952|P4|COMPLETED|Overall Study||13
8190072|NCT02295553|20193953|P3|COMPLETED|Overall Study||13
8190073|NCT02295553|20193954|P2|COMPLETED|Overall Study||14
8190074|NCT02295553|20193955|P1|COMPLETED|Overall Study||14
8190075|NCT02295553|20193952|P4|STARTED|Overall Study||14
8190076|NCT02295553|20193953|P3|STARTED|Overall Study||14
8190077|NCT02295553|20193954|P2|STARTED|Overall Study||14
8190078|NCT02295553|20193955|P1|STARTED|Overall Study||14
8190079|NCT02295280|20193979|P2|NOT COMPLETED|Overall Study||1
8190080|NCT02295280|20193980|P1|NOT COMPLETED|Overall Study||0
8190081|NCT02295280|20193979|P2|COMPLETED|Overall Study||34
8190082|NCT02295280|20193980|P1|COMPLETED|Overall Study||35
8190083|NCT02295280|20193979|P2|STARTED|Overall Study||35
8190084|NCT02295280|20193980|P1|STARTED|Overall Study||35
8190085|NCT02295020|20193988|P2|NOT COMPLETED|Overall Study||3
8190086|NCT02295020|20193989|P1|NOT COMPLETED|Overall Study||3
8190087|NCT02295020|20193988|P2|COMPLETED|Overall Study||17
8190088|NCT02295020|20193989|P1|COMPLETED|Overall Study||17
8190089|NCT02295020|20193988|P2|STARTED|Overall Study||20
8190090|NCT02295020|20193989|P1|STARTED|Overall Study||20
8190091|NCT02294981|20194019|P1|NOT COMPLETED|Overall Study||1
8190092|NCT02294981|20194019|P1|COMPLETED|Overall Study||3
8190093|NCT02294981|20194019|P1|STARTED|Overall Study||4
8190094|NCT02294786|20194025|P2|NOT COMPLETED|Overall Study||14
8190095|NCT02294786|20194026|P1|NOT COMPLETED|Overall Study||11
8190096|NCT02294786|20194025|P2|COMPLETED|Overall Study||18
8190097|NCT02294786|20194026|P1|COMPLETED|Overall Study||19
8190098|NCT02294786|20194025|P2|ITT Population|Overall Study||32
8190099|NCT02294786|20194026|P1|ITT Population|Overall Study||30
8190100|NCT02294786|20194025|P2|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
8190101|NCT02294786|20194026|P1|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
8190102|NCT02294786|20194025|P2|STARTED|Overall Study||32
8190103|NCT02294786|20194026|P1|STARTED|Overall Study||30
8190104|NCT02294773|20194073|P2|NOT COMPLETED|Overall Study||2
8190105|NCT02294773|20194074|P1|NOT COMPLETED|Overall Study||0
8190106|NCT02294773|20194073|P2|COMPLETED|Overall Study||4
8190107|NCT02294773|20194074|P1|COMPLETED|Overall Study||7
8190108|NCT02294773|20194073|P2|STARTED|Overall Study||6
8190109|NCT02294773|20194074|P1|STARTED|Overall Study||7
8190110|NCT02294734|20194090|P2|NOT COMPLETED|Overall Study||8
8190111|NCT02294734|20194091|P1|NOT COMPLETED|Overall Study||14
8190112|NCT02294734|20194090|P2|COMPLETED|Overall Study||55
8190113|NCT02294734|20194091|P1|COMPLETED|Overall Study||49
8190114|NCT02294734|20194090|P2|STARTED|Overall Study||63
8190115|NCT02294734|20194091|P1|STARTED|Overall Study||63
8190116|NCT02294682|20194143|P2|NOT COMPLETED|Overall Study||0
8190117|NCT02294682|20194144|P1|NOT COMPLETED|Overall Study||1
8190118|NCT02294682|20194143|P2|COMPLETED|Overall Study||53
8190119|NCT02294682|20194144|P1|COMPLETED|Overall Study||52
8190120|NCT02294682|20194143|P2|STARTED|Overall Study||53
8190121|NCT02294682|20194144|P1|STARTED|Overall Study||53
8190122|NCT02294604|20194187|P3|NOT COMPLETED|Overall Study||0
8190123|NCT02294604|20194188|P2|NOT COMPLETED|Overall Study||3
8190124|NCT02294604|20194189|P1|NOT COMPLETED|Overall Study||1
8190125|NCT02294604|20194187|P3|COMPLETED|Overall Study||80
8190126|NCT02294604|20194188|P2|COMPLETED|Overall Study||77
8190127|NCT02294604|20194189|P1|COMPLETED|Overall Study||79
8190128|NCT02294604|20194187|P3|STARTED|Overall Study||80
8190129|NCT02294604|20194188|P2|STARTED|Overall Study||80
8190130|NCT02294604|20194189|P1|STARTED|Overall Study||80
8190131|NCT02294474|20194208|P2|NOT COMPLETED|Overall Study||22
8190132|NCT02294474|20194209|P1|NOT COMPLETED|Overall Study||25
8190133|NCT02294474|20194208|P2|COMPLETED|Overall Study||230
8190134|NCT02294474|20194209|P1|COMPLETED|Overall Study||228
8190135|NCT02294474|20194208|P2|STARTED|Overall Study||252
8190136|NCT02294474|20194209|P1|STARTED|Overall Study||253
8190137|NCT02294461|20194233|P2|NOT COMPLETED|Overall Study||131
8190138|NCT02294461|20194234|P1|NOT COMPLETED|Overall Study||62
8190139|NCT02294461|20194233|P2|COMPLETED|Overall Study||59
8190140|NCT02294461|20194234|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
8190141|NCT02294461|20194233|P2|Treated/Received Study Drug|Overall Study||190
8190142|NCT02294461|20194234|P1|Treated/Received Study Drug|Overall Study||198
8190143|NCT02294461|20194233|P2|STARTED|Overall Study||190
8190144|NCT02294461|20194234|P1|STARTED|Overall Study||198
8190145|NCT02294396|20194290|P4|NOT COMPLETED|Overall Study||37
8190146|NCT02294396|20194291|P3|NOT COMPLETED|Overall Study||35
8190147|NCT02294396|20194292|P2|NOT COMPLETED|Overall Study||33
8190148|NCT02294396|20194293|P1|NOT COMPLETED|Overall Study||40
8190149|NCT02294396|20194290|P4|COMPLETED|Overall Study||123
8190150|NCT02294396|20194291|P3|COMPLETED|Overall Study||126
8190151|NCT02294396|20194292|P2|COMPLETED|Overall Study||128
8190152|NCT02294396|20194293|P1|COMPLETED|Overall Study||127
8190153|NCT02294396|20194290|P4|STARTED|Overall Study||160
8190154|NCT02294396|20194291|P3|STARTED|Overall Study||161
8190155|NCT02294396|20194292|P2|STARTED|Overall Study||161
8190156|NCT02294396|20194293|P1|STARTED|Overall Study||167
8190157|NCT02294318|20194365|P2|NOT COMPLETED|Overall Study||2
8190158|NCT02294318|20194366|P1|NOT COMPLETED|Overall Study||3
8190159|NCT02294318|20194365|P2|COMPLETED|Overall Study||21
8190160|NCT02294318|20194366|P1|COMPLETED|Overall Study||21
8190161|NCT02294318|20194365|P2|STARTED|Overall Study||23
8190162|NCT02294318|20194366|P1|STARTED|Overall Study||24
8190163|NCT02294253|20194378|P1|NOT COMPLETED|Overall Study||15
8190164|NCT02294253|20194378|P1|COMPLETED|Overall Study||15
8190165|NCT02294253|20194378|P1|STARTED|Overall Study||30
8190166|NCT02294227|20194385|P3|NOT COMPLETED|Overall Study||19
8190167|NCT02294227|20194386|P2|NOT COMPLETED|Overall Study||25
8190168|NCT02294227|20194387|P1|NOT COMPLETED|Overall Study||25
8190169|NCT02294227|20194385|P3|COMPLETED|Overall Study||95
8190170|NCT02294227|20194386|P2|COMPLETED|Overall Study||88
8190171|NCT02294227|20194387|P1|COMPLETED|Overall Study||89
8190172|NCT02294227|20194385|P3|STARTED|Overall Study||114
8190173|NCT02294227|20194386|P2|STARTED|Overall Study||113
8190174|NCT02294227|20194387|P1|STARTED|Overall Study||114
8190175|NCT02294175|20194413|P2|NOT COMPLETED|Overall Study||6
8190176|NCT02294175|20194414|P1|NOT COMPLETED|Overall Study||5
8190177|NCT02294175|20194413|P2|COMPLETED|Overall Study||16
8190178|NCT02294175|20194414|P1|COMPLETED|Overall Study||18
8190179|NCT02294175|20194413|P2|STARTED|Overall Study||22
8190180|NCT02294175|20194414|P1|STARTED|Overall Study||23
8190181|NCT02294058|20194441|P3|NOT COMPLETED|Overall Study||29
8190182|NCT02294058|20194442|P2|NOT COMPLETED|Overall Study||26
8190183|NCT02294058|20194443|P1|NOT COMPLETED|Overall Study||36
8190184|NCT02294058|20194441|P3|COMPLETED|Overall Study||418
8190185|NCT02294058|20194442|P2|COMPLETED|Overall Study||425
8190186|NCT02294058|20194443|P1|COMPLETED|Overall Study||412
8190187|NCT02294058|20194441|P3|Safety Population|Overall Study||448
8190188|NCT02294058|20194442|P2|Safety Population|Overall Study||453
8190189|NCT02294058|20194443|P1|Safety Population|Overall Study||445
8190190|NCT02294058|20194441|P3|STARTED|Overall Study||447
8190191|NCT02294058|20194442|P2|STARTED|Overall Study||451
8190192|NCT02294058|20194443|P1|STARTED|Overall Study||448
8190193|NCT02294019|20194481|P1|NOT COMPLETED|Overall Study||103
8190194|NCT02294019|20194481|P1|COMPLETED|Overall Study||635
8190195|NCT02294019|20194481|P1|STARTED|Overall Study||738
8190196|NCT02293902|20194489|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
8190197|NCT02293902|20194490|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
8190198|NCT02293902|20194491|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
8190199|NCT02293902|20194492|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
8190200|NCT02293902|20194493|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
8190201|NCT02293902|20194489|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
8190202|NCT02293902|20194490|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
8190203|NCT02293902|20194491|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
8190204|NCT02293902|20194492|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
8190205|NCT02293902|20194493|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
8190206|NCT02293902|20194489|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
8190207|NCT02293902|20194490|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
8190208|NCT02293902|20194491|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
8190209|NCT02293902|20194492|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
8190210|NCT02293902|20194493|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
8190211|NCT02293902|20194489|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
8190212|NCT02293902|20194490|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
8190213|NCT02293902|20194491|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
8190214|NCT02293902|20194492|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
8190215|NCT02293902|20194493|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
8190216|NCT02293902|20194489|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
8190217|NCT02293902|20194490|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
8190218|NCT02293902|20194491|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
8190219|NCT02293902|20194492|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
8190220|NCT02293902|20194493|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
8190221|NCT02293902|20194489|P5|Rescued|Double-Blind Period (Up to Week 24)||0
8190222|NCT02293902|20194490|P4|Rescued|Double-Blind Period (Up to Week 24)||0
8190223|NCT02293902|20194491|P3|Rescued|Double-Blind Period (Up to Week 24)||8
8190224|NCT02293902|20194492|P2|Rescued|Double-Blind Period (Up to Week 24)||6
8190225|NCT02293902|20194493|P1|Rescued|Double-Blind Period (Up to Week 24)||44
8190226|NCT02293902|20194489|P5|Treated|Double-Blind Period (Up to Week 24)||0
8190227|NCT02293902|20194490|P4|Treated|Double-Blind Period (Up to Week 24)||0
8190228|NCT02293902|20194491|P3|Treated|Double-Blind Period (Up to Week 24)||80
8190229|NCT02293902|20194492|P2|Treated|Double-Blind Period (Up to Week 24)||81
8190230|NCT02293902|20194493|P1|Treated|Double-Blind Period (Up to Week 24)||81
8190231|NCT02293902|20194489|P5|STARTED|Double-Blind Period (Up to Week 24)||0
8190232|NCT02293902|20194490|P4|STARTED|Double-Blind Period (Up to Week 24)||0
8190233|NCT02293902|20194491|P3|STARTED|Double-Blind Period (Up to Week 24)||80
8190234|NCT02293902|20194492|P2|STARTED|Double-Blind Period (Up to Week 24)||81
8190235|NCT02293902|20194493|P1|STARTED|Double-Blind Period (Up to Week 24)||82
8190236|NCT02293863|20194555|P3|NOT COMPLETED|Overall Study||9
8190237|NCT02293863|20194556|P2|NOT COMPLETED|Overall Study||13
8190238|NCT02293863|20194557|P1|NOT COMPLETED|Overall Study||9
8190239|NCT02293863|20194555|P3|COMPLETED|Overall Study||38
8190240|NCT02293863|20194556|P2|COMPLETED|Overall Study||42
8190241|NCT02293863|20194557|P1|COMPLETED|Overall Study||47
8190242|NCT02293863|20194555|P3|STARTED|Overall Study||47
8190243|NCT02293863|20194556|P2|STARTED|Overall Study||55
8190244|NCT02293863|20194557|P1|STARTED|Overall Study||56
8190245|NCT02293798|20194620|P1|NOT COMPLETED|Overall Study||0
8190246|NCT02293798|20194620|P1|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
8190247|NCT02293798|20194620|P1|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
8190248|NCT02293538|20194626|P2|NOT COMPLETED|Overall Study||2
8190249|NCT02293538|20194627|P1|NOT COMPLETED|Overall Study||1
8190250|NCT02293538|20194626|P2|COMPLETED|Overall Study||69
8190251|NCT02293538|20194627|P1|COMPLETED|Overall Study||72
8190252|NCT02293538|20194626|P2|STARTED|Overall Study||71
8190253|NCT02293538|20194627|P1|STARTED|Overall Study||73
8190254|NCT02293512|20194644|P4|NOT COMPLETED|Overall Study||2
8190255|NCT02293512|20194645|P3|NOT COMPLETED|Overall Study||3
8190256|NCT02293512|20194646|P2|NOT COMPLETED|Overall Study||6
8190257|NCT02293512|20194647|P1|NOT COMPLETED|Overall Study||4
8190258|NCT02293512|20194644|P4|COMPLETED|Overall Study||8
8190259|NCT02293512|20194645|P3|COMPLETED|Overall Study||7
8190260|NCT02293512|20194646|P2|COMPLETED|Overall Study||4
8190261|NCT02293512|20194647|P1|COMPLETED|Overall Study||6
8190262|NCT02293512|20194644|P4|STARTED|Overall Study||10
8190263|NCT02293512|20194645|P3|STARTED|Overall Study||10
8190264|NCT02293512|20194646|P2|STARTED|Overall Study||10
8190265|NCT02293512|20194647|P1|STARTED|Overall Study||10
8190266|NCT02293460|20194657|P1|NOT COMPLETED|Overall Study||6
8190267|NCT02293460|20194657|P1|COMPLETED|Overall Study||37
8190268|NCT02293460|20194657|P1|STARTED|Overall Study||43
8190269|NCT02293395|20194663|P2|NOT COMPLETED|Overall Study||7
8190270|NCT02293395|20194664|P1|NOT COMPLETED|Overall Study||9
8190271|NCT02293395|20194663|P2|COMPLETED|Overall Study||1511
8190272|NCT02293395|20194664|P1|COMPLETED|Overall Study||1510
8190273|NCT02293395|20194663|P2|Treated|Overall Study||1506
8190274|NCT02293395|20194664|P1|Treated|Overall Study||1510
8190275|NCT02293395|20194663|P2|STARTED|Overall Study||1518
8190276|NCT02293395|20194664|P1|STARTED|Overall Study||1519
8190277|NCT02293044|20194670|P1|NOT COMPLETED|Overall Study||0
8190278|NCT02293044|20194670|P1|COMPLETED|Overall Study||15
8190279|NCT02293044|20194670|P1|STARTED|Overall Study||15
8190280|NCT02292927|20194677|P2|NOT COMPLETED|Overall Study||7
8190281|NCT02292927|20194678|P1|NOT COMPLETED|Overall Study||13
8190282|NCT02292927|20194677|P2|COMPLETED|Overall Study||5
8190283|NCT02292927|20194678|P1|COMPLETED|Overall Study||0
8190284|NCT02292927|20194677|P2|STARTED|Overall Study||12
8190285|NCT02292927|20194678|P1|STARTED|Overall Study||13
8190286|NCT02292849|20194695|P3|NOT COMPLETED|Overall Study||2
8190287|NCT02292849|20194696|P2|NOT COMPLETED|Overall Study||2
8190288|NCT02292849|20194697|P1|NOT COMPLETED|Overall Study||4
8190289|NCT02292849|20194695|P3|COMPLETED|Overall Study||8
8190290|NCT02292849|20194696|P2|COMPLETED|Overall Study||6
8190291|NCT02292849|20194697|P1|COMPLETED|Overall Study||7
8190292|NCT02292849|20194695|P3|STARTED|Overall Study||10
8190293|NCT02292849|20194696|P2|STARTED|Overall Study||8
8190294|NCT02292849|20194697|P1|STARTED|Overall Study||11
8190295|NCT02292784|20194708|P3|NOT COMPLETED|Overall Study||21
8190296|NCT02292784|20194709|P2|NOT COMPLETED|Overall Study||20
8190297|NCT02292784|20194710|P1|NOT COMPLETED|Overall Study||1
8190298|NCT02292784|20194708|P3|COMPLETED|Overall Study||28
8190299|NCT02292784|20194709|P2|COMPLETED|Overall Study||24
8190300|NCT02292784|20194710|P1|COMPLETED|Overall Study||4
8190301|NCT02292784|20194708|P3|STARTED|Overall Study||49
8190302|NCT02292784|20194709|P2|STARTED|Overall Study||44
8190303|NCT02292784|20194710|P1|STARTED|Overall Study||5
8190304|NCT02292771|20194777|P2|NOT COMPLETED|Overall Study||2
8190305|NCT02292771|20194778|P1|NOT COMPLETED|Overall Study||4
8190306|NCT02292771|20194777|P2|COMPLETED|Overall Study||48
8190307|NCT02292771|20194778|P1|COMPLETED|Overall Study||43
8190308|NCT02292771|20194777|P2|STARTED|Overall Study||50
8190309|NCT02292771|20194778|P1|STARTED|Overall Study||47
8190310|NCT02292758|20194870|P2|NOT COMPLETED|Overall Study||0
8190311|NCT02292758|20194871|P1|NOT COMPLETED|Overall Study||0
8190312|NCT02292758|20194870|P2|COMPLETED|Overall Study||17
8190313|NCT02292758|20194871|P1|COMPLETED|Overall Study||19
8190314|NCT02292758|20194870|P2|STARTED|Overall Study||17
8190315|NCT02292758|20194871|P1|STARTED|Overall Study||19
8190316|NCT02292719|20194901|P6|NOT COMPLETED|Overall Study||0
8190317|NCT02292719|20194902|P5|NOT COMPLETED|Overall Study||1
8190318|NCT02292719|20194903|P4|NOT COMPLETED|Overall Study||1
8190319|NCT02292719|20194904|P3|NOT COMPLETED|Overall Study||1
8190320|NCT02292719|20194905|P2|NOT COMPLETED|Overall Study||0
8190321|NCT02292719|20194906|P1|NOT COMPLETED|Overall Study||0
8190322|NCT02292719|20194901|P6|COMPLETED|Overall Study||10
8190323|NCT02292719|20194902|P5|COMPLETED|Overall Study||20
8190324|NCT02292719|20194903|P4|COMPLETED|Overall Study||8
8190325|NCT02292719|20194904|P3|COMPLETED|Overall Study||9
8190326|NCT02292719|20194905|P2|COMPLETED|Overall Study||11
8190327|NCT02292719|20194906|P1|COMPLETED|Overall Study||9
8190328|NCT02292719|20194901|P6|STARTED|Overall Study||10
8190329|NCT02292719|20194902|P5|STARTED|Overall Study||21
8190330|NCT02292719|20194903|P4|STARTED|Overall Study||9
8190331|NCT02292719|20194904|P3|STARTED|Overall Study||10
8190332|NCT02292719|20194905|P2|STARTED|Overall Study||11
8190333|NCT02292719|20194906|P1|STARTED|Overall Study||9
8190342|NCT02292446|20194969|P1|NOT COMPLETED|Overall Study||20
8190343|NCT02292446|20194969|P1|COMPLETED|Overall Study||141
8190344|NCT02292446|20194969|P1|STARTED|Overall Study||161
8190345|NCT02292433|20194985|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
8190346|NCT02292433|20194986|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
8190347|NCT02292433|20194987|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
8190348|NCT02292433|20194985|P3|COMPLETED|Third Intervention Period (7 Days)||4
8190349|NCT02292433|20194986|P2|COMPLETED|Third Intervention Period (7 Days)||4
8190350|NCT02292433|20194987|P1|COMPLETED|Third Intervention Period (7 Days)||4
8190351|NCT02292433|20194985|P3|STARTED|Third Intervention Period (7 Days)||4
8190352|NCT02292433|20194986|P2|STARTED|Third Intervention Period (7 Days)||4
8190353|NCT02292433|20194987|P1|STARTED|Third Intervention Period (7 Days)||4
8190354|NCT02292433|20194985|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8190355|NCT02292433|20194986|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8190356|NCT02292433|20194987|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8190357|NCT02292433|20194985|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
8190358|NCT02292433|20194986|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
8190359|NCT02292433|20194987|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
8190360|NCT02292433|20194985|P3|STARTED|Second Washout Period (7 to 14 Days)||4
8190361|NCT02292433|20194986|P2|STARTED|Second Washout Period (7 to 14 Days)||4
8190362|NCT02292433|20194987|P1|STARTED|Second Washout Period (7 to 14 Days)||4
8190363|NCT02292433|20194985|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
8190364|NCT02292433|20194986|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
8190365|NCT02292433|20194987|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
8190366|NCT02292433|20194985|P3|COMPLETED|Second Intervention Period (7 Days)||4
8190367|NCT02292433|20194986|P2|COMPLETED|Second Intervention Period (7 Days)||4
8190368|NCT02292433|20194987|P1|COMPLETED|Second Intervention Period (7 Days)||4
8190369|NCT02292433|20194985|P3|STARTED|Second Intervention Period (7 Days)||4
8190370|NCT02292433|20194986|P2|STARTED|Second Intervention Period (7 Days)||4
8190371|NCT02292433|20194987|P1|STARTED|Second Intervention Period (7 Days)||4
8190372|NCT02292433|20194985|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8190373|NCT02292433|20194986|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8190374|NCT02292433|20194987|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8190375|NCT02292433|20194985|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
8190376|NCT02292433|20194986|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
8190377|NCT02292433|20194987|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
8190378|NCT02292433|20194985|P3|STARTED|First Washout Period (7 to 14 Days)||4
8190379|NCT02292433|20194986|P2|STARTED|First Washout Period (7 to 14 Days)||4
8190380|NCT02292433|20194987|P1|STARTED|First Washout Period (7 to 14 Days)||4
8190381|NCT02292433|20194985|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
8190382|NCT02292433|20194986|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
8190383|NCT02292433|20194987|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
8190384|NCT02292433|20194985|P3|COMPLETED|First Intervention Period (7 Days)||4
8190385|NCT02292433|20194986|P2|COMPLETED|First Intervention Period (7 Days)||4
8190386|NCT02292433|20194987|P1|COMPLETED|First Intervention Period (7 Days)||4
8190387|NCT02292433|20194985|P3|STARTED|First Intervention Period (7 Days)||4
8190388|NCT02292433|20194986|P2|STARTED|First Intervention Period (7 Days)||4
8190389|NCT02292433|20194987|P1|STARTED|First Intervention Period (7 Days)||4
8190390|NCT02292212|20195058|P1|NOT COMPLETED|Post-ViE Phase||0
8190391|NCT02292212|20195058|P1|COMPLETED|Post-ViE Phase||14
8190392|NCT02292212|20195058|P1|STARTED|Post-ViE Phase||14
8190393|NCT02292212|20195058|P1|NOT COMPLETED|ViE Phase||3
8190394|NCT02292212|20195058|P1|COMPLETED|ViE Phase||14
8190395|NCT02292212|20195058|P1|STARTED|ViE Phase||17
8190396|NCT02292212|20195058|P1|NOT COMPLETED|Pre-ViE Phase||0
8190397|NCT02292212|20195058|P1|COMPLETED|Pre-ViE Phase||17
8190398|NCT02292212|20195058|P1|STARTED|Pre-ViE Phase||17
8190399|NCT02292186|20195090|P1|NOT COMPLETED|Overall Study||18
8190400|NCT02292186|20195090|P1|COMPLETED|Overall Study||7
8190401|NCT02292186|20195090|P1|STARTED|Overall Study||25
8190402|NCT02292082|20195100|P2|NOT COMPLETED|Overall Study||0
8190403|NCT02292082|20195101|P1|NOT COMPLETED|Overall Study||0
8190404|NCT02292082|20195100|P2|COMPLETED|Overall Study||55
8190405|NCT02292082|20195101|P1|COMPLETED|Overall Study||56
8190406|NCT02292082|20195100|P2|STARTED|Overall Study||55
8190407|NCT02292082|20195101|P1|STARTED|Overall Study||56
8190408|NCT02291913|20195127|P1|NOT COMPLETED|Overall Study||48
8190409|NCT02291913|20195127|P1|COMPLETED|Overall Study||0
8190410|NCT02291913|20195127|P1|STARTED|Overall Study||48
8190411|NCT02291861|20195140|P4|NOT COMPLETED|Overall Study||10
8190412|NCT02291861|20195141|P3|NOT COMPLETED|Overall Study||9
8190413|NCT02291861|20195142|P2|NOT COMPLETED|Overall Study||8
8190414|NCT02291861|20195143|P1|NOT COMPLETED|Overall Study||7
8190415|NCT02291861|20195140|P4|COMPLETED|Overall Study||65
8190416|NCT02291861|20195141|P3|COMPLETED|Overall Study||65
8190417|NCT02291861|20195142|P2|COMPLETED|Overall Study||67
8190418|NCT02291861|20195143|P1|COMPLETED|Overall Study||67
8190419|NCT02291861|20195140|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
8190420|NCT02291861|20195141|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
8190421|NCT02291861|20195142|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
8190422|NCT02291861|20195143|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
8190423|NCT02291861|20195140|P4|Safety Population|Overall Study||74
8190424|NCT02291861|20195141|P3|Safety Population|Overall Study||73
8190425|NCT02291861|20195142|P2|Safety Population|Overall Study||74
8190426|NCT02291861|20195143|P1|Safety Population|Overall Study||72
8190427|NCT02291861|20195140|P4|STARTED|Overall Study||75
8190428|NCT02291861|20195141|P3|STARTED|Overall Study||74
8190429|NCT02291861|20195142|P2|STARTED|Overall Study||75
8190430|NCT02291861|20195143|P1|STARTED|Overall Study||74
8190431|NCT02291718|20195184|P3|NOT COMPLETED|Overall Study||0
8190432|NCT02291718|20195185|P2|NOT COMPLETED|Overall Study||0
8190433|NCT02291718|20195186|P1|NOT COMPLETED|Overall Study||0
8190434|NCT02291718|20195184|P3|COMPLETED|Overall Study||50
8190435|NCT02291718|20195185|P2|COMPLETED|Overall Study||50
8190436|NCT02291718|20195186|P1|COMPLETED|Overall Study||50
8190437|NCT02291718|20195184|P3|STARTED|Overall Study||50
8190438|NCT02291718|20195185|P2|STARTED|Overall Study||50
8190439|NCT02291718|20195186|P1|STARTED|Overall Study||50
8190440|NCT02291679|20195206|P3|NOT COMPLETED|Overall Study||59
8190441|NCT02291679|20195207|P2|NOT COMPLETED|Overall Study||42
8190442|NCT02291679|20195208|P1|NOT COMPLETED|Overall Study||44
8190443|NCT02291679|20195206|P3|COMPLETED|Overall Study||352
8190444|NCT02291679|20195207|P2|COMPLETED|Overall Study||369
8190445|NCT02291679|20195208|P1|COMPLETED|Overall Study||357
8190446|NCT02291679|20195206|P3|STARTED|Overall Study||411
8190447|NCT02291679|20195207|P2|STARTED|Overall Study||411
8190448|NCT02291679|20195208|P1|STARTED|Overall Study||401
8190449|NCT02291549|20195239|P2|NOT COMPLETED|Overall Study||1
8190450|NCT02291549|20195240|P1|NOT COMPLETED|Overall Study||1
8190451|NCT02291549|20195239|P2|COMPLETED|Overall Study||98
8190452|NCT02291549|20195240|P1|COMPLETED|Overall Study||200
8190453|NCT02291549|20195239|P2|STARTED|Overall Study||99
8190454|NCT02291549|20195240|P1|STARTED|Overall Study||201
8190455|NCT02291510|20195262|P4|NOT COMPLETED|Overall Study||1
8190456|NCT02291510|20195263|P3|NOT COMPLETED|Overall Study||0
8190457|NCT02291510|20195264|P2|NOT COMPLETED|Overall Study||0
8190458|NCT02291510|20195265|P1|NOT COMPLETED|Overall Study||0
8190459|NCT02291510|20195262|P4|COMPLETED|Overall Study||4
8190460|NCT02291510|20195263|P3|COMPLETED|Overall Study||5
8190461|NCT02291510|20195264|P2|COMPLETED|Overall Study||5
8190462|NCT02291510|20195265|P1|COMPLETED|Overall Study||5
8190463|NCT02291510|20195262|P4|Completed Treatment D|Overall Study||5
8190464|NCT02291510|20195263|P3|Completed Treatment D|Overall Study||5
8190465|NCT02291510|20195264|P2|Completed Treatment D|Overall Study||5
8190466|NCT02291510|20195265|P1|Completed Treatment D|Overall Study||5
8190467|NCT02291510|20195262|P4|Completed Treatment C|Overall Study||4
8190468|NCT02291510|20195263|P3|Completed Treatment C|Overall Study||5
8190469|NCT02291510|20195264|P2|Completed Treatment C|Overall Study||5
8190470|NCT02291510|20195265|P1|Completed Treatment C|Overall Study||5
8190471|NCT02291510|20195262|P4|Completed Treatment B|Overall Study||4
8190472|NCT02291510|20195263|P3|Completed Treatment B|Overall Study||5
8190473|NCT02291510|20195264|P2|Completed Treatment B|Overall Study||5
8190474|NCT02291510|20195265|P1|Completed Treatment B|Overall Study||5
8190475|NCT02291510|20195262|P4|Completed Treatment A|Overall Study||5
8190476|NCT02291510|20195263|P3|Completed Treatment A|Overall Study||5
8190477|NCT02291510|20195264|P2|Completed Treatment A|Overall Study||5
8190478|NCT02291510|20195265|P1|Completed Treatment A|Overall Study||5
8190479|NCT02291510|20195262|P4|STARTED|Overall Study||5
8190480|NCT02291510|20195263|P3|STARTED|Overall Study||5
8190481|NCT02291510|20195264|P2|STARTED|Overall Study||5
8190482|NCT02291510|20195265|P1|STARTED|Overall Study||5
8190483|NCT02291419|20195281|P2|NOT COMPLETED|Overall Study||5
8190484|NCT02291419|20195282|P1|NOT COMPLETED|Overall Study||1
8190485|NCT02291419|20195281|P2|COMPLETED|Overall Study||0
8190486|NCT02291419|20195282|P1|COMPLETED|Overall Study||0
8190487|NCT02291419|20195281|P2|STARTED|Overall Study||5
8190488|NCT02291419|20195282|P1|STARTED|Overall Study||1
8190489|NCT02291302|20195302|P4|NOT COMPLETED|Overall Study||0
8190490|NCT02291302|20195303|P3|NOT COMPLETED|Overall Study||0
8190491|NCT02291302|20195304|P2|NOT COMPLETED|Overall Study||0
8190492|NCT02291302|20195305|P1|NOT COMPLETED|Overall Study||0
8190493|NCT02291302|20195302|P4|COMPLETED|Overall Study||59
8190494|NCT02291302|20195303|P3|COMPLETED|Overall Study||59
8190495|NCT02291302|20195304|P2|COMPLETED|Overall Study||59
8190496|NCT02291302|20195305|P1|COMPLETED|Overall Study||59
8190497|NCT02291302|20195302|P4|STARTED|Overall Study||59
8190498|NCT02291302|20195303|P3|STARTED|Overall Study||59
8190499|NCT02291302|20195304|P2|STARTED|Overall Study||59
8190500|NCT02291302|20195305|P1|STARTED|Overall Study||59
8190585|NCT02291237|20195394|P2|NOT COMPLETED|Overall Study||86
8190586|NCT02291237|20195395|P1|NOT COMPLETED|Overall Study||86
8190587|NCT02291237|20195394|P2|COMPLETED|Overall Study||0
8190588|NCT02291237|20195395|P1|COMPLETED|Overall Study||0
8190589|NCT02291237|20195394|P2|STARTED|Overall Study||86
8190590|NCT02291237|20195395|P1|STARTED|Overall Study||86
8190591|NCT02291029|20195417|P6|NOT COMPLETED|Overall Study||0
8190592|NCT02291029|20195418|P5|NOT COMPLETED|Overall Study||0
8190593|NCT02291029|20195419|P4|NOT COMPLETED|Overall Study||0
8190594|NCT02291029|20195420|P3|NOT COMPLETED|Overall Study||1
8190595|NCT02291029|20195421|P2|NOT COMPLETED|Overall Study||1
8190596|NCT02291029|20195422|P1|NOT COMPLETED|Overall Study||0
8190597|NCT02291029|20195417|P6|COMPLETED|Overall Study||12
8190598|NCT02291029|20195418|P5|COMPLETED|Overall Study||13
8190599|NCT02291029|20195419|P4|COMPLETED|Overall Study||11
8190600|NCT02291029|20195420|P3|COMPLETED|Overall Study||20
8190601|NCT02291029|20195421|P2|COMPLETED|Overall Study||3
8190602|NCT02291029|20195422|P1|COMPLETED|Overall Study||8
8190603|NCT02291029|20195417|P6|STARTED|Overall Study||12
8190604|NCT02291029|20195418|P5|STARTED|Overall Study||13
8190605|NCT02291029|20195419|P4|STARTED|Overall Study||11
8190606|NCT02291029|20195420|P3|STARTED|Overall Study||21
8190607|NCT02291029|20195421|P2|STARTED|Overall Study||4
8190608|NCT02291029|20195422|P1|STARTED|Overall Study||8
8190609|NCT02291016|20195468|P2|NOT COMPLETED|Visit 2||0
8190610|NCT02291016|20195469|P1|NOT COMPLETED|Visit 2||1
8190611|NCT02291016|20195468|P2|COMPLETED|Visit 2||5
8190612|NCT02291016|20195469|P1|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
8190613|NCT02291016|20195468|P2|STARTED|Visit 2||5
8190614|NCT02291016|20195469|P1|STARTED|Visit 2||2
8190615|NCT02291016|20195468|P2|NOT COMPLETED|Visit 1||0
8190616|NCT02291016|20195469|P1|NOT COMPLETED|Visit 1||0
8190617|NCT02291016|20195468|P2|COMPLETED|Visit 1||5
8190618|NCT02291016|20195469|P1|COMPLETED|Visit 1||2
8190619|NCT02291016|20195468|P2|STARTED|Visit 1||5
8190620|NCT02291016|20195469|P1|STARTED|Visit 1||2
8190621|NCT02290925|20195493|P2|NOT COMPLETED|Second Period of 3 Months||4
8190622|NCT02290925|20195494|P1|NOT COMPLETED|Second Period of 3 Months||1
8190623|NCT02290925|20195493|P2|COMPLETED|Second Period of 3 Months||65
8190624|NCT02290925|20195494|P1|COMPLETED|Second Period of 3 Months||57
8190625|NCT02290925|20195493|P2|STARTED|Second Period of 3 Months||69
8190626|NCT02290925|20195494|P1|STARTED|Second Period of 3 Months||58
8190627|NCT02290925|20195493|P2|NOT COMPLETED|First Period of Three Months||2
8190628|NCT02290925|20195494|P1|NOT COMPLETED|First Period of Three Months||4
8190629|NCT02290925|20195493|P2|COMPLETED|First Period of Three Months||69
8190630|NCT02290925|20195494|P1|COMPLETED|First Period of Three Months||58
8190631|NCT02290925|20195493|P2|STARTED|First Period of Three Months||71
8190632|NCT02290925|20195494|P1|STARTED|First Period of Three Months||62
8190633|NCT02290873|20195509|P3|NOT COMPLETED|Overall Study||2
8190634|NCT02290873|20195510|P2|NOT COMPLETED|Overall Study||1
8190635|NCT02290873|20195511|P1|NOT COMPLETED|Overall Study||2
8190636|NCT02290873|20195509|P3|COMPLETED|Overall Study||101
8190637|NCT02290873|20195510|P2|COMPLETED|Overall Study||59
8190638|NCT02290873|20195511|P1|COMPLETED|Overall Study||296
8190639|NCT02290873|20195509|P3|Safety Population|Overall Study||102
8190640|NCT02290873|20195510|P2|Safety Population|Overall Study||60
8190641|NCT02290873|20195511|P1|Safety Population|Overall Study||296
8190642|NCT02290873|20195509|P3|Modified Intention to Treat (mITT)|Overall Study||102
8190643|NCT02290873|20195510|P2|Modified Intention to Treat (mITT)|Overall Study||60
8190644|NCT02290873|20195511|P1|Modified Intention to Treat (mITT)|Overall Study||296
8190645|NCT02290873|20195509|P3|STARTED|Overall Study||103
8190646|NCT02290873|20195510|P2|STARTED|Overall Study||60
8190647|NCT02290873|20195511|P1|STARTED|Overall Study||298
8190648|NCT02290821|20195530|P2|NOT COMPLETED|Overall Study||3
8190649|NCT02290821|20195531|P1|NOT COMPLETED|Overall Study||6
8190650|NCT02290821|20195530|P2|COMPLETED|Overall Study||103
8190651|NCT02290821|20195531|P1|COMPLETED|Overall Study||103
8190652|NCT02290821|20195530|P2|STARTED|Overall Study||106
8190653|NCT02290821|20195531|P1|STARTED|Overall Study||109
8190654|NCT02290691|20195539|P2|NOT COMPLETED|Overall Study||9
8190655|NCT02290691|20195540|P1|NOT COMPLETED|Overall Study||8
8190656|NCT02290691|20195539|P2|COMPLETED|Overall Study||479
8190657|NCT02290691|20195540|P1|COMPLETED|Overall Study||488
8190658|NCT02290691|20195539|P2|STARTED|Overall Study||488
8190659|NCT02290691|20195540|P1|STARTED|Overall Study||496
8190660|NCT02290613|20195556|P2|NOT COMPLETED|Overall Study||4
8190661|NCT02290613|20195557|P1|NOT COMPLETED|Overall Study||2
8190662|NCT02290613|20195556|P2|COMPLETED|Overall Study||15
8190663|NCT02290613|20195557|P1|COMPLETED|Overall Study||17
8190664|NCT02290613|20195556|P2|STARTED|Overall Study||19
8190665|NCT02290613|20195557|P1|STARTED|Overall Study||19
8190666|NCT02290574|20195605|P1|NOT COMPLETED|Overall Study||1
8190667|NCT02290574|20195605|P1|COMPLETED|Overall Study||13
8190668|NCT02290574|20195605|P1|STARTED|Overall Study||14
8190669|NCT02290509|20195615|P2|NOT COMPLETED|Overall Study||14
8190670|NCT02290509|20195616|P1|NOT COMPLETED|Overall Study||49
8190671|NCT02290509|20195615|P2|COMPLETED|Overall Study||325
8190672|NCT02290509|20195616|P1|COMPLETED|Overall Study||962
8190673|NCT02290509|20195615|P2|STARTED|Overall Study||339
8190674|NCT02290509|20195616|P1|STARTED|Overall Study||1011
8190675|NCT02290444|20195630|P2|NOT COMPLETED|Overall Study||2
8190676|NCT02290444|20195631|P1|NOT COMPLETED|Overall Study||1
8190677|NCT02290444|20195630|P2|COMPLETED|Overall Study||32
8190678|NCT02290444|20195631|P1|COMPLETED|Overall Study||29
8190679|NCT02290444|20195630|P2|STARTED|Overall Study||34
8190680|NCT02290444|20195631|P1|STARTED|Overall Study||30
8190681|NCT02290431|20195653|P1|NOT COMPLETED|Overall Study||27
8190682|NCT02290431|20195653|P1|COMPLETED|Overall Study||4
8190683|NCT02290431|20195653|P1|Entered Treatment Phase 2|Overall Study||17
8190684|NCT02290431|20195653|P1|Subjects Entered Survival f/u Phase|Overall Study||24
8190685|NCT02290431|20195653|P1|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
8190686|NCT02290431|20195653|P1|Subjects Completed Study Per Protocol|Overall Study||8
8190687|NCT02290431|20195653|P1|Subjects. Discont. Prematurely|Overall Study||27
8190688|NCT02290431|20195653|P1|STARTED|Overall Study||31
8190689|NCT02290340|20195676|P4|NOT COMPLETED|Overall Study||2
8190690|NCT02290340|20195677|P3|NOT COMPLETED|Overall Study||0
8190691|NCT02290340|20195678|P2|NOT COMPLETED|Overall Study||0
8190692|NCT02290340|20195679|P1|NOT COMPLETED|Overall Study||2
8190693|NCT02290340|20195676|P4|COMPLETED|Overall Study||30
8190694|NCT02290340|20195677|P3|COMPLETED|Overall Study||31
8190695|NCT02290340|20195678|P2|COMPLETED|Overall Study||8
8190696|NCT02290340|20195679|P1|COMPLETED|Overall Study||16
8190697|NCT02290340|20195676|P4|STARTED|Overall Study||32
8190698|NCT02290340|20195677|P3|STARTED|Overall Study||31
8190699|NCT02290340|20195678|P2|STARTED|Overall Study||8
8190700|NCT02290340|20195679|P1|STARTED|Overall Study||18
8190701|NCT02290223|20195724|P2|NOT COMPLETED|12 Months||11
8190702|NCT02290223|20195725|P1|NOT COMPLETED|12 Months||16
8190703|NCT02290223|20195724|P2|COMPLETED|12 Months||176
8190704|NCT02290223|20195725|P1|COMPLETED|12 Months||166
8190705|NCT02290223|20195724|P2|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
8190706|NCT02290223|20195725|P1|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
8190707|NCT02290223|20195724|P2|NOT COMPLETED|6 Months||6
8190708|NCT02290223|20195725|P1|NOT COMPLETED|6 Months||16
8190709|NCT02290223|20195724|P2|COMPLETED|6 Months||181
8190710|NCT02290223|20195725|P1|COMPLETED|6 Months||173
8190711|NCT02290223|20195724|P2|STARTED|6 Months||187
8190712|NCT02290223|20195725|P1|STARTED|6 Months||189
8190713|NCT02290223|20195724|P2|NOT COMPLETED|Baseline||0
8190714|NCT02290223|20195725|P1|NOT COMPLETED|Baseline||0
8190715|NCT02290223|20195724|P2|COMPLETED|Baseline||187
8190716|NCT02290223|20195725|P1|COMPLETED|Baseline||189
8190717|NCT02290223|20195724|P2|STARTED|Baseline||187
8190718|NCT02290223|20195725|P1|STARTED|Baseline||189
8190719|NCT02290184|20195785|P2|NOT COMPLETED|Overall Study||0
8190720|NCT02290184|20195786|P1|NOT COMPLETED|Overall Study||0
8190721|NCT02290184|20195785|P2|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
8190722|NCT02290184|20195786|P1|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
8190723|NCT02290184|20195785|P2|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
8190724|NCT02290184|20195786|P1|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
8190725|NCT02290184|20195785|P2|STARTED|Overall Study||23
8190726|NCT02290184|20195786|P1|STARTED|Overall Study||22
8190727|NCT02290106|20195800|P2|NOT COMPLETED|Overall Study||2
8190728|NCT02290106|20195801|P1|NOT COMPLETED|Overall Study||1
8190729|NCT02290106|20195800|P2|COMPLETED|Overall Study||23
8190730|NCT02290106|20195801|P1|COMPLETED|Overall Study||24
8190731|NCT02290106|20195800|P2|STARTED|Overall Study||25
8190732|NCT02290106|20195801|P1|STARTED|Overall Study||25
8190733|NCT02289989|20195821|P2|NOT COMPLETED|Overall Study||0
8190734|NCT02289989|20195822|P1|NOT COMPLETED|Overall Study||0
8190735|NCT02289989|20195821|P2|COMPLETED|Overall Study||1
8190736|NCT02289989|20195822|P1|COMPLETED|Overall Study||0
8190737|NCT02289989|20195821|P2|STARTED|Overall Study||1
8190738|NCT02289989|20195822|P1|STARTED|Overall Study||0
8190739|NCT02289963|20195840|P2|NOT COMPLETED|Overall Study||10
8190740|NCT02289963|20195841|P1|NOT COMPLETED|Overall Study||5
8190741|NCT02289963|20195840|P2|COMPLETED|Overall Study||87
8190742|NCT02289963|20195841|P1|COMPLETED|Overall Study||97
8190743|NCT02289963|20195840|P2|Treated|Overall Study||97
8190744|NCT02289963|20195841|P1|Treated|Overall Study||102
8190745|NCT02289963|20195840|P2|STARTED|Overall Study|Randomized|97
8190746|NCT02289963|20195841|P1|STARTED|Overall Study|Randomized|102
8190747|NCT02289898|20195892|P3|NOT COMPLETED|Overall Study||56
8190748|NCT02289898|20195893|P2|NOT COMPLETED|Overall Study||53
8190749|NCT02289898|20195894|P1|NOT COMPLETED|Overall Study||52
8190750|NCT02289898|20195892|P3|COMPLETED|Overall Study||9
8190751|NCT02289898|20195893|P2|COMPLETED|Overall Study||18
8190752|NCT02289898|20195894|P1|COMPLETED|Overall Study||16
8190753|NCT02289898|20195892|P3|STARTED|Overall Study||65
8190754|NCT02289898|20195893|P2|STARTED|Overall Study||71
8190755|NCT02289898|20195894|P1|STARTED|Overall Study||68
8190756|NCT02289833|20195903|P2|NOT COMPLETED|Overall Study||17
8190757|NCT02289833|20195904|P1|NOT COMPLETED|Overall Study||27
8190758|NCT02289833|20195903|P2|COMPLETED|Overall Study||3
8190759|NCT02289833|20195904|P1|COMPLETED|Overall Study||2
8190760|NCT02289833|20195903|P2|STARTED|Overall Study||20
8190761|NCT02289833|20195904|P1|STARTED|Overall Study||29
8190762|NCT02289820|20195940|P7|NOT COMPLETED|Overall Study||2
8190763|NCT02289820|20195941|P6|NOT COMPLETED|Overall Study||1
8190764|NCT02289820|20195942|P5|NOT COMPLETED|Overall Study||0
8190765|NCT02289820|20195943|P4|NOT COMPLETED|Overall Study||2
8190766|NCT02289820|20195944|P3|NOT COMPLETED|Overall Study||6
8190767|NCT02289820|20195945|P2|NOT COMPLETED|Overall Study||2
8190768|NCT02289820|20195946|P1|NOT COMPLETED|Overall Study||2
8190769|NCT02289820|20195940|P7|COMPLETED|Overall Study||37
8190770|NCT02289820|20195941|P6|COMPLETED|Overall Study||39
8190771|NCT02289820|20195942|P5|COMPLETED|Overall Study||40
8190772|NCT02289820|20195943|P4|COMPLETED|Overall Study||37
8190773|NCT02289820|20195944|P3|COMPLETED|Overall Study||38
8190774|NCT02289820|20195945|P2|COMPLETED|Overall Study||18
8190775|NCT02289820|20195946|P1|COMPLETED|Overall Study||37
8190776|NCT02289820|20195940|P7|STARTED|Overall Study||39
8190777|NCT02289820|20195941|P6|STARTED|Overall Study||40
8190778|NCT02289820|20195942|P5|STARTED|Overall Study||40
8190779|NCT02289820|20195943|P4|STARTED|Overall Study||39
8190780|NCT02289820|20195944|P3|STARTED|Overall Study||44
8190781|NCT02289820|20195945|P2|STARTED|Overall Study||20
8190782|NCT02289820|20195946|P1|STARTED|Overall Study||39
8190783|NCT02289755|20196057|P1|NOT COMPLETED|Follow up Period [4 Days]||0
8190784|NCT02289755|20196057|P1|COMPLETED|Follow up Period [4 Days]||16
8190785|NCT02289755|20196057|P1|STARTED|Follow up Period [4 Days]||16
8190786|NCT02289755|20196057|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
8190787|NCT02289755|20196057|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
8190788|NCT02289755|20196057|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
8190789|NCT02289755|20196057|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
8190790|NCT02289755|20196057|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
8190791|NCT02289755|20196057|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
8190792|NCT02289742|20196064|P4|NOT COMPLETED|Third Wear Period||1
8190793|NCT02289742|20196065|P3|NOT COMPLETED|Third Wear Period||0
8190794|NCT02289742|20196066|P2|NOT COMPLETED|Third Wear Period||1
8190795|NCT02289742|20196067|P1|NOT COMPLETED|Third Wear Period||0
8190796|NCT02289742|20196064|P4|COMPLETED|Third Wear Period||8
8190797|NCT02289742|20196065|P3|COMPLETED|Third Wear Period||11
8190798|NCT02289742|20196066|P2|COMPLETED|Third Wear Period||10
8190799|NCT02289742|20196067|P1|COMPLETED|Third Wear Period||11
8190800|NCT02289742|20196064|P4|STARTED|Third Wear Period||9
8190801|NCT02289742|20196065|P3|STARTED|Third Wear Period||11
8190802|NCT02289742|20196066|P2|STARTED|Third Wear Period||11
8190803|NCT02289742|20196067|P1|STARTED|Third Wear Period||11
8190804|NCT02289742|20196064|P4|NOT COMPLETED|Second Wear Period||0
8190805|NCT02289742|20196065|P3|NOT COMPLETED|Second Wear Period||0
8190806|NCT02289742|20196066|P2|NOT COMPLETED|Second Wear Period||0
8190807|NCT02289742|20196067|P1|NOT COMPLETED|Second Wear Period||0
8190808|NCT02289742|20196064|P4|COMPLETED|Second Wear Period||9
8190809|NCT02289742|20196065|P3|COMPLETED|Second Wear Period||11
8190810|NCT02289742|20196066|P2|COMPLETED|Second Wear Period||11
8190811|NCT02289742|20196067|P1|COMPLETED|Second Wear Period||11
8190812|NCT02289742|20196064|P4|STARTED|Second Wear Period||9
8190813|NCT02289742|20196065|P3|STARTED|Second Wear Period||11
8190814|NCT02289742|20196066|P2|STARTED|Second Wear Period||11
8190815|NCT02289742|20196067|P1|STARTED|Second Wear Period||11
8190816|NCT02289742|20196064|P4|NOT COMPLETED|First Wear Period||1
8190817|NCT02289742|20196065|P3|NOT COMPLETED|First Wear Period||1
8190818|NCT02289742|20196066|P2|NOT COMPLETED|First Wear Period||1
8190819|NCT02289742|20196067|P1|NOT COMPLETED|First Wear Period||0
8190820|NCT02289742|20196064|P4|COMPLETED|First Wear Period||9
8190821|NCT02289742|20196065|P3|COMPLETED|First Wear Period||11
8190822|NCT02289742|20196066|P2|COMPLETED|First Wear Period||11
8190823|NCT02289742|20196067|P1|COMPLETED|First Wear Period||11
8190824|NCT02289742|20196064|P4|Treated|First Wear Period||9
8190825|NCT02289742|20196065|P3|Treated|First Wear Period||12
8190826|NCT02289742|20196066|P2|Treated|First Wear Period||11
8190827|NCT02289742|20196067|P1|Treated|First Wear Period||11
8190828|NCT02289742|20196064|P4|STARTED|First Wear Period||10
8190829|NCT02289742|20196065|P3|STARTED|First Wear Period||12
8190830|NCT02289742|20196066|P2|STARTED|First Wear Period||12
8190831|NCT02289742|20196067|P1|STARTED|First Wear Period||11
8190832|NCT02289729|20196084|P1|NOT COMPLETED|Overall Study||6
8190833|NCT02289729|20196084|P1|COMPLETED|Overall Study||53
8190834|NCT02289729|20196084|P1|STARTED|Overall Study||59
8190835|NCT02289690|20196148|P10|NOT COMPLETED|Overall Study||61
8190836|NCT02289690|20196149|P9|NOT COMPLETED|Overall Study||59
8190837|NCT02289690|20196150|P8|NOT COMPLETED|Overall Study||61
8190838|NCT02289690|20196151|P7|NOT COMPLETED|Overall Study||4
8190839|NCT02289690|20196152|P6|NOT COMPLETED|Overall Study||14
8190840|NCT02289690|20196153|P5|NOT COMPLETED|Overall Study||8
8190841|NCT02289690|20196154|P4|NOT COMPLETED|Overall Study||3
8190842|NCT02289690|20196155|P3|NOT COMPLETED|Overall Study||4
8190843|NCT02289690|20196156|P2|NOT COMPLETED|Overall Study||3
8190844|NCT02289690|20196157|P1|NOT COMPLETED|Overall Study||4
8190845|NCT02289690|20196148|P10|COMPLETED|Overall Study||0
8190846|NCT02289690|20196149|P9|COMPLETED|Overall Study||0
8190847|NCT02289690|20196150|P8|COMPLETED|Overall Study||0
8190848|NCT02289690|20196151|P7|COMPLETED|Overall Study||0
8190849|NCT02289690|20196152|P6|COMPLETED|Overall Study||0
8190850|NCT02289690|20196153|P5|COMPLETED|Overall Study||0
8190851|NCT02289690|20196154|P4|COMPLETED|Overall Study||0
8190852|NCT02289690|20196155|P3|COMPLETED|Overall Study||0
8190853|NCT02289690|20196156|P2|COMPLETED|Overall Study||0
8190854|NCT02289690|20196157|P1|COMPLETED|Overall Study||0
8190855|NCT02289690|20196148|P10|Received Study Drug|Overall Study||60
8190856|NCT02289690|20196149|P9|Received Study Drug|Overall Study||58
8190857|NCT02289690|20196150|P8|Received Study Drug|Overall Study||60
8190858|NCT02289690|20196151|P7|Received Study Drug|Overall Study||4
8190859|NCT02289690|20196152|P6|Received Study Drug|Overall Study||14
8190860|NCT02289690|20196153|P5|Received Study Drug|Overall Study||8
8190861|NCT02289690|20196154|P4|Received Study Drug|Overall Study||3
8190862|NCT02289690|20196155|P3|Received Study Drug|Overall Study||4
8190863|NCT02289690|20196156|P2|Received Study Drug|Overall Study||3
8190864|NCT02289690|20196157|P1|Received Study Drug|Overall Study||4
8190865|NCT02289690|20196148|P10|STARTED|Overall Study||61
8190866|NCT02289690|20196149|P9|STARTED|Overall Study||59
8190867|NCT02289690|20196150|P8|STARTED|Overall Study||61
8190868|NCT02289690|20196151|P7|STARTED|Overall Study||4
8190869|NCT02289690|20196152|P6|STARTED|Overall Study||14
8190870|NCT02289690|20196153|P5|STARTED|Overall Study||8
8190871|NCT02289690|20196154|P4|STARTED|Overall Study||3
8190872|NCT02289690|20196155|P3|STARTED|Overall Study||4
8190873|NCT02289690|20196156|P2|STARTED|Overall Study||3
8190874|NCT02289690|20196157|P1|STARTED|Overall Study||4
8190875|NCT02289469|20196245|P2|NOT COMPLETED|Overall Study||0
8190876|NCT02289469|20196246|P1|NOT COMPLETED|Overall Study||6
8190877|NCT02289469|20196245|P2|COMPLETED|Overall Study||244
8190878|NCT02289469|20196246|P1|COMPLETED|Overall Study||244
8190879|NCT02289469|20196245|P2|STARTED|Overall Study||244
8190880|NCT02289469|20196246|P1|STARTED|Overall Study||250
8190881|NCT02289456|20196254|P1|NOT COMPLETED|Monotherapy Period||16
8190882|NCT02289456|20196254|P1|COMPLETED|Monotherapy Period||0
8190883|NCT02289456|20196254|P1|STARTED|Monotherapy Period||16
8190884|NCT02289456|20196254|P1|NOT COMPLETED|Induction Period||24
8190885|NCT02289456|20196254|P1|COMPLETED|Induction Period||16
8190886|NCT02289456|20196254|P1|Treated Population|Induction Period||40
8190887|NCT02289456|20196254|P1|STARTED|Induction Period||40
8190888|NCT02289417|20196277|P9|NOT COMPLETED|Extension Phase Weeks 52-104||6
8190889|NCT02289417|20196278|P8|NOT COMPLETED|Extension Phase Weeks 52-104||7
8190890|NCT02289417|20196279|P7|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190891|NCT02289417|20196280|P6|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190892|NCT02289417|20196281|P5|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190893|NCT02289417|20196282|P4|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190894|NCT02289417|20196283|P3|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190895|NCT02289417|20196284|P2|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190896|NCT02289417|20196285|P1|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190897|NCT02289417|20196277|P9|COMPLETED|Extension Phase Weeks 52-104||48
8190898|NCT02289417|20196278|P8|COMPLETED|Extension Phase Weeks 52-104||38
8190899|NCT02289417|20196279|P7|COMPLETED|Extension Phase Weeks 52-104||0
8190900|NCT02289417|20196280|P6|COMPLETED|Extension Phase Weeks 52-104||0
8190901|NCT02289417|20196281|P5|COMPLETED|Extension Phase Weeks 52-104||0
8190902|NCT02289417|20196282|P4|COMPLETED|Extension Phase Weeks 52-104||0
8190903|NCT02289417|20196283|P3|COMPLETED|Extension Phase Weeks 52-104||0
8190904|NCT02289417|20196284|P2|COMPLETED|Extension Phase Weeks 52-104||0
8190905|NCT02289417|20196285|P1|COMPLETED|Extension Phase Weeks 52-104||0
8190906|NCT02289417|20196277|P9|STARTED|Extension Phase Weeks 52-104||54
8190907|NCT02289417|20196278|P8|STARTED|Extension Phase Weeks 52-104||45
8190908|NCT02289417|20196279|P7|STARTED|Extension Phase Weeks 52-104||0
8190909|NCT02289417|20196280|P6|STARTED|Extension Phase Weeks 52-104||0
8190910|NCT02289417|20196281|P5|STARTED|Extension Phase Weeks 52-104||0
8190911|NCT02289417|20196282|P4|STARTED|Extension Phase Weeks 52-104||0
8190912|NCT02289417|20196283|P3|STARTED|Extension Phase Weeks 52-104||0
8190913|NCT02289417|20196284|P2|STARTED|Extension Phase Weeks 52-104||0
8190914|NCT02289417|20196285|P1|STARTED|Extension Phase Weeks 52-104||0
8190915|NCT02289417|20196277|P9|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8190916|NCT02289417|20196278|P8|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8190917|NCT02289417|20196279|P7|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
8190918|NCT02289417|20196280|P6|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
8190919|NCT02289417|20196281|P5|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
8190920|NCT02289417|20196282|P4|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
8190921|NCT02289417|20196283|P3|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
8190922|NCT02289417|20196284|P2|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
8190923|NCT02289417|20196285|P1|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8190924|NCT02289417|20196277|P9|COMPLETED|Active Treatment Phase Weeks 12-52||0
8190925|NCT02289417|20196278|P8|COMPLETED|Active Treatment Phase Weeks 12-52||0
8190926|NCT02289417|20196279|P7|COMPLETED|Active Treatment Phase Weeks 12-52||5
8190927|NCT02289417|20196280|P6|COMPLETED|Active Treatment Phase Weeks 12-52||7
8190928|NCT02289417|20196281|P5|COMPLETED|Active Treatment Phase Weeks 12-52||20
8190929|NCT02289417|20196282|P4|COMPLETED|Active Treatment Phase Weeks 12-52||17
8190930|NCT02289417|20196283|P3|COMPLETED|Active Treatment Phase Weeks 12-52||32
8190931|NCT02289417|20196284|P2|COMPLETED|Active Treatment Phase Weeks 12-52||39
8190932|NCT02289417|20196285|P1|COMPLETED|Active Treatment Phase Weeks 12-52||0
8190933|NCT02289417|20196277|P9|STARTED|Active Treatment Phase Weeks 12-52||0
8190934|NCT02289417|20196278|P8|STARTED|Active Treatment Phase Weeks 12-52||0
8190935|NCT02289417|20196279|P7|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
8190936|NCT02289417|20196280|P6|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
8190937|NCT02289417|20196281|P5|STARTED|Active Treatment Phase Weeks 12-52||25
8190938|NCT02289417|20196282|P4|STARTED|Active Treatment Phase Weeks 12-52||26
8190939|NCT02289417|20196283|P3|STARTED|Active Treatment Phase Weeks 12-52||42
8190940|NCT02289417|20196284|P2|STARTED|Active Treatment Phase Weeks 12-52||41
8190941|NCT02289417|20196285|P1|STARTED|Active Treatment Phase Weeks 12-52||0
8190942|NCT02289417|20196277|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190943|NCT02289417|20196278|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190944|NCT02289417|20196279|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190945|NCT02289417|20196280|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190946|NCT02289417|20196281|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190947|NCT02289417|20196282|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190948|NCT02289417|20196283|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
8190949|NCT02289417|20196284|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
8190950|NCT02289417|20196285|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
8190951|NCT02289417|20196277|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190952|NCT02289417|20196278|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190953|NCT02289417|20196279|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190954|NCT02289417|20196280|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190955|NCT02289417|20196281|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190956|NCT02289417|20196282|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190957|NCT02289417|20196283|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
8190958|NCT02289417|20196284|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
8190959|NCT02289417|20196285|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
8190960|NCT02289417|20196277|P9|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190961|NCT02289417|20196278|P8|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190962|NCT02289417|20196279|P7|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190963|NCT02289417|20196280|P6|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190964|NCT02289417|20196281|P5|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190965|NCT02289417|20196282|P4|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190966|NCT02289417|20196283|P3|STARTED|Placebo-Controlled Phase Weeks 0-12||55
8190967|NCT02289417|20196284|P2|STARTED|Placebo-Controlled Phase Weeks 0-12||57
8190968|NCT02289417|20196285|P1|STARTED|Placebo-Controlled Phase Weeks 0-12||58
8190969|NCT02289352|20196334|P3|NOT COMPLETED|Overall Study||0
8190970|NCT02289352|20196335|P2|NOT COMPLETED|Overall Study||1
8190971|NCT02289352|20196336|P1|NOT COMPLETED|Overall Study||1
8190972|NCT02289352|20196334|P3|COMPLETED|Overall Study||64
8190973|NCT02289352|20196335|P2|COMPLETED|Overall Study||198
8190974|NCT02289352|20196336|P1|COMPLETED|Overall Study||198
8190975|NCT02289352|20196334|P3|PP Population|Overall Study||54
8190976|NCT02289352|20196335|P2|PP Population|Overall Study||173
8190977|NCT02289352|20196336|P1|PP Population|Overall Study||173
8190978|NCT02289352|20196334|P3|mITT Population|Overall Study||58
8190979|NCT02289352|20196335|P2|mITT Population|Overall Study||193
8190980|NCT02289352|20196336|P1|mITT Population|Overall Study||191
8190981|NCT02289352|20196334|P3|Safety Population|Overall Study||64
8190982|NCT02289352|20196335|P2|Safety Population|Overall Study||199
8190983|NCT02289352|20196336|P1|Safety Population|Overall Study||199
8190984|NCT02289352|20196334|P3|STARTED|Overall Study||64
8190985|NCT02289352|20196335|P2|STARTED|Overall Study||199
8190986|NCT02289352|20196336|P1|STARTED|Overall Study||199
8190987|NCT02289222|20196347|P1|NOT COMPLETED|Overall Study||0
8190988|NCT02289222|20196347|P1|COMPLETED|Overall Study||48
8190989|NCT02289222|20196347|P1|STARTED|Overall Study||48
8190990|NCT02289157|20196355|P2|NOT COMPLETED|Overall Study||0
8190991|NCT02289157|20196356|P1|NOT COMPLETED|Overall Study||0
8190992|NCT02289157|20196355|P2|COMPLETED|Overall Study||219
8190993|NCT02289157|20196356|P1|COMPLETED|Overall Study||222
8190994|NCT02289157|20196355|P2|No Post op Check or Follow up Phone Call|Overall Study||4
8190995|NCT02289157|20196356|P1|No Post op Check or Follow up Phone Call|Overall Study||2
8190996|NCT02289157|20196355|P2|STARTED|Overall Study||219
8190997|NCT02289157|20196356|P1|STARTED|Overall Study||222
8190998|NCT02289105|20196390|P2|NOT COMPLETED|Overall Study||0
8190999|NCT02289105|20196391|P1|NOT COMPLETED|Overall Study||0
8191000|NCT02289105|20196390|P2|COMPLETED|Overall Study||637
8191001|NCT02289105|20196391|P1|COMPLETED|Overall Study||642
8191002|NCT02289105|20196390|P2|STARTED|Overall Study||637
8191003|NCT02289105|20196391|P1|STARTED|Overall Study||642
8191004|NCT02289079|20196403|P2|NOT COMPLETED|Overall Study||1
8191005|NCT02289079|20196404|P1|NOT COMPLETED|Overall Study||2
8191006|NCT02289079|20196403|P2|COMPLETED|Overall Study||29
8191007|NCT02289079|20196404|P1|COMPLETED|Overall Study||28
8191008|NCT02289079|20196403|P2|STARTED|Overall Study||30
8191009|NCT02289079|20196404|P1|STARTED|Overall Study||30
8191010|NCT02288819|20196416|P1|NOT COMPLETED|Overall Study||0
8191011|NCT02288819|20196416|P1|COMPLETED|Overall Study||50
8191012|NCT02288819|20196416|P1|STARTED|Overall Study||50
8191013|NCT02288559|20196433|P4|NOT COMPLETED|Overall Study||2
8191014|NCT02288559|20196434|P3|NOT COMPLETED|Overall Study||11
8191015|NCT02288559|20196435|P2|NOT COMPLETED|Overall Study||1
8191016|NCT02288559|20196436|P1|NOT COMPLETED|Overall Study||1
8191017|NCT02288559|20196433|P4|COMPLETED|Overall Study||20
8191018|NCT02288559|20196434|P3|COMPLETED|Overall Study||35
8191019|NCT02288559|20196435|P2|COMPLETED|Overall Study||10
8191020|NCT02288559|20196436|P1|COMPLETED|Overall Study||9
8191021|NCT02288559|20196433|P4|STARTED|Overall Study||22
8191022|NCT02288559|20196434|P3|STARTED|Overall Study||46
8191023|NCT02288559|20196435|P2|STARTED|Overall Study||11
8191024|NCT02288559|20196436|P1|STARTED|Overall Study||10
8191025|NCT02288364|20196462|P2|NOT COMPLETED|Overall Study||0
8191026|NCT02288364|20196463|P1|NOT COMPLETED|Overall Study||0
8191027|NCT02288364|20196462|P2|COMPLETED|Overall Study||44
8191028|NCT02288364|20196463|P1|COMPLETED|Overall Study||42
8191029|NCT02288364|20196462|P2|STARTED|Overall Study||44
8191030|NCT02288364|20196463|P1|STARTED|Overall Study||42
8191031|NCT02288325|20196487|P3|NOT COMPLETED|Double-blind Treatment Period||26
8191032|NCT02288325|20196488|P2|NOT COMPLETED|Double-blind Treatment Period||24
8191033|NCT02288325|20196489|P1|NOT COMPLETED|Double-blind Treatment Period||0
8191034|NCT02288325|20196487|P3|COMPLETED|Double-blind Treatment Period||139
8191035|NCT02288325|20196488|P2|COMPLETED|Double-blind Treatment Period||135
8191036|NCT02288325|20196489|P1|COMPLETED|Double-blind Treatment Period||0
8191037|NCT02288325|20196487|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
8191038|NCT02288325|20196488|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
8191039|NCT02288325|20196489|P1|STARTED|Double-blind Treatment Period||0
8191040|NCT02288325|20196487|P3|NOT COMPLETED|Stabilization Period||0
8191041|NCT02288325|20196488|P2|NOT COMPLETED|Stabilization Period||0
8191042|NCT02288325|20196489|P1|NOT COMPLETED|Stabilization Period||98
8191043|NCT02288325|20196487|P3|COMPLETED|Stabilization Period||0
8191044|NCT02288325|20196488|P2|COMPLETED|Stabilization Period||0
8191045|NCT02288325|20196489|P1|COMPLETED|Stabilization Period||331
8191046|NCT02288325|20196487|P3|STARTED|Stabilization Period||0
8191047|NCT02288325|20196488|P2|STARTED|Stabilization Period||0
8191048|NCT02288325|20196489|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
8191049|NCT02288325|20196487|P3|NOT COMPLETED|Run-in Period||0
8191050|NCT02288325|20196488|P2|NOT COMPLETED|Run-in Period||0
8191051|NCT02288325|20196489|P1|NOT COMPLETED|Run-in Period||145
8191052|NCT02288325|20196487|P3|COMPLETED|Run-in Period||0
8191053|NCT02288325|20196488|P2|COMPLETED|Run-in Period||0
8191054|NCT02288325|20196489|P1|COMPLETED|Run-in Period||499
8191055|NCT02288325|20196487|P3|STARTED|Run-in Period||0
8191056|NCT02288325|20196488|P2|STARTED|Run-in Period||0
8191057|NCT02288325|20196489|P1|STARTED|Run-in Period||644
8191058|NCT02288312|20196499|P3|NOT COMPLETED|Overall Study||0
8191059|NCT02288312|20196500|P2|NOT COMPLETED|Overall Study||0
8191060|NCT02288312|20196501|P1|NOT COMPLETED|Overall Study||1
8191061|NCT02288312|20196499|P3|COMPLETED|Overall Study||6
8191062|NCT02288312|20196500|P2|COMPLETED|Overall Study||6
8191063|NCT02288312|20196501|P1|COMPLETED|Overall Study||5
8191064|NCT02288312|20196499|P3|STARTED|Overall Study||6
8191065|NCT02288312|20196500|P2|STARTED|Overall Study||6
8191066|NCT02288312|20196501|P1|STARTED|Overall Study||6
8191067|NCT02288273|20196520|P2|NOT COMPLETED|Overall Study||8
8191068|NCT02288273|20196521|P1|NOT COMPLETED|Overall Study||8
8191069|NCT02288273|20196520|P2|COMPLETED|Overall Study||48
8191070|NCT02288273|20196521|P1|COMPLETED|Overall Study||53
8191071|NCT02288273|20196520|P2|STARTED|Overall Study||56
8191072|NCT02288273|20196521|P1|STARTED|Overall Study||61
8191073|NCT02288182|20196541|P2|NOT COMPLETED|Overall Study||2
8191074|NCT02288182|20196542|P1|NOT COMPLETED|Overall Study||0
8191075|NCT02288182|20196541|P2|COMPLETED|Overall Study||25
8191076|NCT02288182|20196542|P1|COMPLETED|Overall Study||25
8191077|NCT02288182|20196541|P2|STARTED|Overall Study||27
8191078|NCT02288182|20196542|P1|STARTED|Overall Study||25
8191079|NCT02288156|20196558|P4|NOT COMPLETED|Overall Study||2
8191080|NCT02288156|20196559|P3|NOT COMPLETED|Overall Study||2
8191081|NCT02288156|20196560|P2|NOT COMPLETED|Overall Study||4
8191082|NCT02288156|20196561|P1|NOT COMPLETED|Overall Study||4
8191083|NCT02288156|20196558|P4|COMPLETED|Overall Study||18
8191084|NCT02288156|20196559|P3|COMPLETED|Overall Study||18
8191085|NCT02288156|20196560|P2|COMPLETED|Overall Study||16
8191086|NCT02288156|20196561|P1|COMPLETED|Overall Study||16
8191087|NCT02288156|20196558|P4|STARTED|Overall Study||20
8191088|NCT02288156|20196559|P3|STARTED|Overall Study||20
8191089|NCT02288156|20196560|P2|STARTED|Overall Study||20
8191090|NCT02288156|20196561|P1|STARTED|Overall Study||20
8191091|NCT02288091|20196571|P1|NOT COMPLETED|Overall Study||8
8191092|NCT02288091|20196571|P1|COMPLETED|Overall Study||24
8191093|NCT02288091|20196571|P1|Randomized/Treated|Overall Study||25
8191094|NCT02288091|20196571|P1|STARTED|Overall Study||32
8191095|NCT02287922|20196583|P4|NOT COMPLETED|Overall Study||7
8191096|NCT02287922|20196584|P3|NOT COMPLETED|Overall Study||7
8191097|NCT02287922|20196585|P2|NOT COMPLETED|Overall Study||2
8191098|NCT02287922|20196586|P1|NOT COMPLETED|Overall Study||3
8191099|NCT02287922|20196583|P4|COMPLETED|Overall Study||57
8191100|NCT02287922|20196584|P3|COMPLETED|Overall Study||56
8191101|NCT02287922|20196585|P2|COMPLETED|Overall Study||60
8191102|NCT02287922|20196586|P1|COMPLETED|Overall Study||59
8191103|NCT02287922|20196583|P4|STARTED|Overall Study||64
8191104|NCT02287922|20196584|P3|STARTED|Overall Study||63
8191105|NCT02287922|20196585|P2|STARTED|Overall Study||62
8191106|NCT02287922|20196586|P1|STARTED|Overall Study||62
8191107|NCT02287909|20196679|P4|NOT COMPLETED|Overall Study||1
8191108|NCT02287909|20196680|P3|NOT COMPLETED|Overall Study||0
8191109|NCT02287909|20196681|P2|NOT COMPLETED|Overall Study||1
8191110|NCT02287909|20196682|P1|NOT COMPLETED|Overall Study||2
8191111|NCT02287909|20196679|P4|COMPLETED|Overall Study||19
8191112|NCT02287909|20196680|P3|COMPLETED|Overall Study||20
8191113|NCT02287909|20196681|P2|COMPLETED|Overall Study||19
8191114|NCT02287909|20196682|P1|COMPLETED|Overall Study||18
8191115|NCT02287909|20196679|P4|STARTED|Overall Study||20
8191116|NCT02287909|20196680|P3|STARTED|Overall Study||20
8191117|NCT02287909|20196681|P2|STARTED|Overall Study||20
8191118|NCT02287909|20196682|P1|STARTED|Overall Study||20
8191119|NCT02287896|20196694|P2|NOT COMPLETED|Second Injection Visit||1
8191120|NCT02287896|20196695|P1|NOT COMPLETED|Second Injection Visit||0
8191121|NCT02287896|20196694|P2|COMPLETED|Second Injection Visit||25
8191122|NCT02287896|20196695|P1|COMPLETED|Second Injection Visit||36
8191123|NCT02287896|20196694|P2|STARTED|Second Injection Visit||26
8191124|NCT02287896|20196695|P1|STARTED|Second Injection Visit||36
8191125|NCT02287896|20196694|P2|NOT COMPLETED|First Injection Visit||0
8191126|NCT02287896|20196695|P1|NOT COMPLETED|First Injection Visit||0
8191127|NCT02287896|20196694|P2|COMPLETED|First Injection Visit||26
8191128|NCT02287896|20196695|P1|COMPLETED|First Injection Visit||36
8191129|NCT02287896|20196694|P2|STARTED|First Injection Visit||26
8191130|NCT02287896|20196695|P1|STARTED|First Injection Visit||36
8191131|NCT02287896|20196694|P2|NOT COMPLETED|Screening Visit V1||0
8191132|NCT02287896|20196695|P1|NOT COMPLETED|Screening Visit V1||0
8191133|NCT02287896|20196694|P2|COMPLETED|Screening Visit V1||26
8191134|NCT02287896|20196695|P1|COMPLETED|Screening Visit V1||36
8191135|NCT02287896|20196694|P2|STARTED|Screening Visit V1||26
8191136|NCT02287896|20196695|P1|STARTED|Screening Visit V1||36
8191137|NCT02287883|20196713|P2|NOT COMPLETED|Overall Study||426
8191138|NCT02287883|20196714|P1|NOT COMPLETED|Overall Study||459
8191139|NCT02287883|20196713|P2|COMPLETED|Overall Study||669
8191140|NCT02287883|20196714|P1|COMPLETED|Overall Study||622
8191141|NCT02287883|20196713|P2|One-year Follow-up Survey|Overall Study||669
8191142|NCT02287883|20196714|P1|One-year Follow-up Survey|Overall Study||622
8191143|NCT02287883|20196713|P2|STARTED|Overall Study||1095
8191144|NCT02287883|20196714|P1|STARTED|Overall Study||1081
8191145|NCT02287818|20196726|P2|NOT COMPLETED|Overall Study||13
8191146|NCT02287818|20196727|P1|NOT COMPLETED|Overall Study||7
8191147|NCT02287818|20196726|P2|COMPLETED|Overall Study||54
8191148|NCT02287818|20196727|P1|COMPLETED|Overall Study||53
8191149|NCT02287818|20196726|P2|STARTED|Overall Study||67
8191150|NCT02287818|20196727|P1|STARTED|Overall Study||60
8191151|NCT02287779|20196741|P8|NOT COMPLETED|Overall Study||0
8191152|NCT02287779|20196742|P7|NOT COMPLETED|Overall Study||0
8191153|NCT02287779|20196743|P6|NOT COMPLETED|Overall Study||0
8191154|NCT02287779|20196744|P5|NOT COMPLETED|Overall Study||0
8191155|NCT02287779|20196745|P4|NOT COMPLETED|Overall Study||0
8191156|NCT02287779|20196746|P3|NOT COMPLETED|Overall Study||0
8191157|NCT02287779|20196747|P2|NOT COMPLETED|Overall Study||0
8191158|NCT02287779|20196748|P1|NOT COMPLETED|Overall Study||0
8191159|NCT02287779|20196741|P8|COMPLETED|Overall Study||9
8191160|NCT02287779|20196742|P7|COMPLETED|Overall Study||9
8191161|NCT02287779|20196743|P6|COMPLETED|Overall Study||9
8191162|NCT02287779|20196744|P5|COMPLETED|Overall Study||9
8191163|NCT02287779|20196745|P4|COMPLETED|Overall Study||9
8191164|NCT02287779|20196746|P3|COMPLETED|Overall Study||9
8191165|NCT02287779|20196747|P2|COMPLETED|Overall Study||9
8191166|NCT02287779|20196748|P1|COMPLETED|Overall Study||21
8191167|NCT02287779|20196741|P8|STARTED|Overall Study||9
8191168|NCT02287779|20196742|P7|STARTED|Overall Study||9
8191169|NCT02287779|20196743|P6|STARTED|Overall Study||9
8191170|NCT02287779|20196744|P5|STARTED|Overall Study||9
8191171|NCT02287779|20196745|P4|STARTED|Overall Study||9
8191172|NCT02287779|20196746|P3|STARTED|Overall Study||9
8191173|NCT02287779|20196747|P2|STARTED|Overall Study||9
8191174|NCT02287779|20196748|P1|STARTED|Overall Study||21
8191175|NCT02287688|20196886|P1|NOT COMPLETED|Overall Study||0
8191176|NCT02287688|20196886|P1|COMPLETED|Overall Study||138
8191177|NCT02287688|20196886|P1|STARTED|Overall Study||138
8191178|NCT02287675|20196897|P2|NOT COMPLETED|Overall Study||0
8191179|NCT02287675|20196898|P1|NOT COMPLETED|Overall Study||0
8191180|NCT02287675|20196897|P2|COMPLETED|Overall Study||18
8191181|NCT02287675|20196898|P1|COMPLETED|Overall Study||22
8191182|NCT02287675|20196897|P2|STARTED|Overall Study||18
8191183|NCT02287675|20196898|P1|STARTED|Overall Study||22
8191184|NCT02287636|20196914|P1|NOT COMPLETED|Overall Study||0
8191185|NCT02287636|20196914|P1|COMPLETED|Overall Study||13
8191186|NCT02287636|20196914|P1|STARTED|Overall Study||13
8191187|NCT02287623|20196925|P2|NOT COMPLETED|Overall Study||1
8191188|NCT02287623|20196926|P1|NOT COMPLETED|Overall Study||0
8191189|NCT02287623|20196925|P2|COMPLETED|Overall Study||29
8191190|NCT02287623|20196926|P1|COMPLETED|Overall Study||30
8191191|NCT02287623|20196925|P2|STARTED|Overall Study||30
8191192|NCT02287623|20196926|P1|STARTED|Overall Study||30
8191193|NCT02287610|20196942|P1|NOT COMPLETED|Overall Study||16
8191194|NCT02287610|20196942|P1|COMPLETED|Overall Study||48
8191195|NCT02287610|20196942|P1|Per Protocol Follow-Up|Overall Study||56
8191196|NCT02287610|20196942|P1|STARTED|Overall Study||64
8191197|NCT02287584|20196978|P6|NOT COMPLETED|the Open-label Phase||57
8191198|NCT02287584|20196979|P5|NOT COMPLETED|the Open-label Phase||62
8191199|NCT02287584|20196980|P4|NOT COMPLETED|the Open-label Phase||57
8191200|NCT02287584|20196981|P3|NOT COMPLETED|the Open-label Phase||0
8191201|NCT02287584|20196982|P2|NOT COMPLETED|the Open-label Phase||0
8191202|NCT02287584|20196983|P1|NOT COMPLETED|the Open-label Phase||0
8191203|NCT02287584|20196978|P6|COMPLETED|the Open-label Phase||104
8191204|NCT02287584|20196979|P5|COMPLETED|the Open-label Phase||87
8191205|NCT02287584|20196980|P4|COMPLETED|the Open-label Phase||81
8191206|NCT02287584|20196981|P3|COMPLETED|the Open-label Phase||0
8191207|NCT02287584|20196982|P2|COMPLETED|the Open-label Phase||0
8191208|NCT02287584|20196983|P1|COMPLETED|the Open-label Phase||0
8191209|NCT02287584|20196978|P6|Treated|the Open-label Phase||157
8191210|NCT02287584|20196979|P5|Treated|the Open-label Phase||143
8191211|NCT02287584|20196980|P4|Treated|the Open-label Phase||131
8191212|NCT02287584|20196981|P3|Treated|the Open-label Phase||0
8191213|NCT02287584|20196982|P2|Treated|the Open-label Phase||0
8191214|NCT02287584|20196983|P1|Treated|the Open-label Phase||0
8191215|NCT02287584|20196978|P6|STARTED|the Open-label Phase||161
8191216|NCT02287584|20196979|P5|STARTED|the Open-label Phase||149
8191217|NCT02287584|20196980|P4|STARTED|the Open-label Phase||138
8191218|NCT02287584|20196981|P3|STARTED|the Open-label Phase||0
8191219|NCT02287584|20196982|P2|STARTED|the Open-label Phase||0
8191220|NCT02287584|20196983|P1|STARTED|the Open-label Phase||0
8191221|NCT02287584|20196978|P6|NOT COMPLETED|the Double-blind Phase||0
8191222|NCT02287584|20196979|P5|NOT COMPLETED|the Double-blind Phase||0
8191223|NCT02287584|20196980|P4|NOT COMPLETED|the Double-blind Phase||0
8191224|NCT02287584|20196981|P3|NOT COMPLETED|the Double-blind Phase||33
8191225|NCT02287584|20196982|P2|NOT COMPLETED|the Double-blind Phase||47
8191226|NCT02287584|20196983|P1|NOT COMPLETED|the Double-blind Phase||52
8191227|NCT02287584|20196978|P6|COMPLETED|the Double-blind Phase||0
8191228|NCT02287584|20196979|P5|COMPLETED|the Double-blind Phase||0
8191229|NCT02287584|20196980|P4|COMPLETED|the Double-blind Phase||0
8191230|NCT02287584|20196981|P3|COMPLETED|the Double-blind Phase||161
8191231|NCT02287584|20196982|P2|COMPLETED|the Double-blind Phase||149
8191232|NCT02287584|20196983|P1|COMPLETED|the Double-blind Phase||138
8191233|NCT02287584|20196978|P6|STARTED|the Double-blind Phase||0
8191234|NCT02287584|20196979|P5|STARTED|the Double-blind Phase||0
8191235|NCT02287584|20196980|P4|STARTED|the Double-blind Phase||0
8191236|NCT02287584|20196981|P3|STARTED|the Double-blind Phase||194
8191237|NCT02287584|20196982|P2|STARTED|the Double-blind Phase||196
8191238|NCT02287584|20196983|P1|STARTED|the Double-blind Phase||190
8191239|NCT02287467|20197002|P2|NOT COMPLETED|Overall Study||9
8191240|NCT02287467|20197003|P1|NOT COMPLETED|Overall Study||12
8191241|NCT02287467|20197002|P2|COMPLETED|Overall Study||152
8191242|NCT02287467|20197003|P1|COMPLETED|Overall Study||156
8191243|NCT02287467|20197002|P2|STARTED|Overall Study||161
8191244|NCT02287467|20197003|P1|STARTED|Overall Study||168
8191245|NCT02287415|20197045|P1|NOT COMPLETED|Overall Study||0
8191246|NCT02287415|20197045|P1|COMPLETED|Overall Study||13
8191247|NCT02287415|20197045|P1|STARTED|Overall Study||13
8191248|NCT02287402|20197051|P1|NOT COMPLETED|Follow-up||3
8191249|NCT02287402|20197051|P1|COMPLETED|Follow-up||103
8191250|NCT02287402|20197051|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
8191251|NCT02287402|20197051|P1|NOT COMPLETED|Treatment Period||27
8191252|NCT02287402|20197051|P1|COMPLETED|Treatment Period||170
8191253|NCT02287402|20197051|P1|STARTED|Treatment Period||197
8191254|NCT02287376|20197066|P1|NOT COMPLETED|Overall Study||0
8191255|NCT02287376|20197066|P1|COMPLETED|Overall Study||25
8191256|NCT02287376|20197066|P1|STARTED|Overall Study||25
8191257|NCT02287350|20197109|P1|NOT COMPLETED|Overall Study||3
8191258|NCT02287350|20197109|P1|COMPLETED|Overall Study||48
8191259|NCT02287350|20197109|P1|STARTED|Overall Study||51
8191260|NCT02287038|20197156|P2|NOT COMPLETED|Overall Study||3
8191261|NCT02287038|20197157|P1|NOT COMPLETED|Overall Study||5
8191262|NCT02287038|20197156|P2|COMPLETED|Overall Study||18
8191263|NCT02287038|20197157|P1|COMPLETED|Overall Study||18
8191264|NCT02287038|20197156|P2|STARTED|Overall Study||21
8191265|NCT02287038|20197157|P1|STARTED|Overall Study||23
8191266|NCT02287025|20197167|P2|NOT COMPLETED|Overall Study||9
8191267|NCT02287025|20197168|P1|NOT COMPLETED|Overall Study||10
8191268|NCT02287025|20197167|P2|COMPLETED|Overall Study||2
8191269|NCT02287025|20197168|P1|COMPLETED|Overall Study||2
8191270|NCT02287025|20197167|P2|STARTED|Overall Study||11
8191271|NCT02287025|20197168|P1|STARTED|Overall Study||12
8191272|NCT02286960|20197179|P2|NOT COMPLETED|Overall Study||3
8191273|NCT02286960|20197180|P1|NOT COMPLETED|Overall Study||3
8191274|NCT02286960|20197179|P2|COMPLETED|Overall Study||14
8191275|NCT02286960|20197180|P1|COMPLETED|Overall Study||16
8191276|NCT02286960|20197179|P2|STARTED|Overall Study||17
8191277|NCT02286960|20197180|P1|STARTED|Overall Study||19
8191278|NCT02286947|20197192|P1|NOT COMPLETED|Overall Study||2
8191279|NCT02286947|20197192|P1|COMPLETED|Overall Study||22
8191280|NCT02286947|20197192|P1|STARTED|Overall Study||24
8191281|NCT02286921|20197203|P2|NOT COMPLETED|Overall Study||0
8191282|NCT02286921|20197204|P1|NOT COMPLETED|Overall Study||0
8191283|NCT02286921|20197203|P2|COMPLETED|Overall Study||101
8191284|NCT02286921|20197204|P1|COMPLETED|Overall Study||94
8191285|NCT02286921|20197203|P2|STARTED|Overall Study||101
8191286|NCT02286921|20197204|P1|STARTED|Overall Study||94
8191287|NCT02286895|20197238|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
8191288|NCT02286895|20197239|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
8191289|NCT02286895|20197238|P2|COMPLETED|Assessed for Measles Seroconversion||261
8191290|NCT02286895|20197239|P1|COMPLETED|Assessed for Measles Seroconversion||252
8191291|NCT02286895|20197238|P2|STARTED|Assessed for Measles Seroconversion||300
8191292|NCT02286895|20197239|P1|STARTED|Assessed for Measles Seroconversion||300
8191293|NCT02286895|20197238|P2|NOT COMPLETED|Randomized and Vaccinated||0
8191294|NCT02286895|20197239|P1|NOT COMPLETED|Randomized and Vaccinated||0
8191295|NCT02286895|20197238|P2|COMPLETED|Randomized and Vaccinated||300
8191296|NCT02286895|20197239|P1|COMPLETED|Randomized and Vaccinated||300
8191297|NCT02286895|20197238|P2|STARTED|Randomized and Vaccinated||300
8191298|NCT02286895|20197239|P1|STARTED|Randomized and Vaccinated||300
8191299|NCT02286726|20197284|P3|NOT COMPLETED|Overall Study||0
8191300|NCT02286726|20197285|P2|NOT COMPLETED|Overall Study||0
8191301|NCT02286726|20197286|P1|NOT COMPLETED|Overall Study||0
8191302|NCT02286726|20197284|P3|COMPLETED|Overall Study||16
8191303|NCT02286726|20197285|P2|COMPLETED|Overall Study||24
8191304|NCT02286726|20197286|P1|COMPLETED|Overall Study||16
8191305|NCT02286726|20197284|P3|STARTED|Overall Study||16
8191306|NCT02286726|20197285|P2|STARTED|Overall Study||24
8191307|NCT02286726|20197286|P1|STARTED|Overall Study||16
8191326|NCT02286518|20197326|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191327|NCT02286518|20197327|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191328|NCT02286518|20197328|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191329|NCT02286518|20197329|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191330|NCT02286518|20197330|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191331|NCT02286518|20197331|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191332|NCT02286518|20197332|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191333|NCT02286518|20197333|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191334|NCT02286518|20197334|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191335|NCT02286518|20197335|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191336|NCT02286518|20197336|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191337|NCT02286518|20197337|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191338|NCT02286518|20197338|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191339|NCT02286518|20197339|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191340|NCT02286518|20197326|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191341|NCT02286518|20197327|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191342|NCT02286518|20197328|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191343|NCT02286518|20197329|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191344|NCT02286518|20197330|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191345|NCT02286518|20197331|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
8191346|NCT02286518|20197332|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
8191347|NCT02286518|20197333|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191348|NCT02286518|20197334|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191349|NCT02286518|20197335|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191350|NCT02286518|20197336|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191351|NCT02286518|20197337|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191352|NCT02286518|20197338|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191353|NCT02286518|20197339|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191354|NCT02286518|20197326|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191355|NCT02286518|20197327|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191356|NCT02286518|20197328|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191357|NCT02286518|20197329|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191358|NCT02286518|20197330|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191359|NCT02286518|20197331|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
8191360|NCT02286518|20197332|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
8191361|NCT02286518|20197333|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191362|NCT02286518|20197334|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191363|NCT02286518|20197335|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191364|NCT02286518|20197336|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191365|NCT02286518|20197337|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191366|NCT02286518|20197338|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191367|NCT02286518|20197339|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191368|NCT02286518|20197326|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191369|NCT02286518|20197327|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191370|NCT02286518|20197328|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191371|NCT02286518|20197329|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191372|NCT02286518|20197330|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191373|NCT02286518|20197331|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191374|NCT02286518|20197332|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191375|NCT02286518|20197333|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191376|NCT02286518|20197334|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191377|NCT02286518|20197335|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191378|NCT02286518|20197336|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191379|NCT02286518|20197337|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191380|NCT02286518|20197338|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191381|NCT02286518|20197339|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191382|NCT02286518|20197326|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191383|NCT02286518|20197327|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191384|NCT02286518|20197328|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191385|NCT02286518|20197329|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191386|NCT02286518|20197330|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191387|NCT02286518|20197331|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
8191388|NCT02286518|20197332|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
8191389|NCT02286518|20197333|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191390|NCT02286518|20197334|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191391|NCT02286518|20197335|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191392|NCT02286518|20197336|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191393|NCT02286518|20197337|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191394|NCT02286518|20197338|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191395|NCT02286518|20197339|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191396|NCT02286518|20197326|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191397|NCT02286518|20197327|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191398|NCT02286518|20197328|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191399|NCT02286518|20197329|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191400|NCT02286518|20197330|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191401|NCT02286518|20197331|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
8191402|NCT02286518|20197332|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
8191403|NCT02286518|20197333|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191404|NCT02286518|20197334|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191405|NCT02286518|20197335|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191406|NCT02286518|20197336|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191407|NCT02286518|20197337|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191408|NCT02286518|20197338|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191409|NCT02286518|20197339|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191410|NCT02286518|20197326|P14|NOT COMPLETED|All Parts (16 Days)||0
8191411|NCT02286518|20197327|P13|NOT COMPLETED|All Parts (16 Days)||0
8191412|NCT02286518|20197328|P12|NOT COMPLETED|All Parts (16 Days)||0
8191413|NCT02286518|20197329|P11|NOT COMPLETED|All Parts (16 Days)||0
8191414|NCT02286518|20197330|P10|NOT COMPLETED|All Parts (16 Days)||0
8191415|NCT02286518|20197331|P9|NOT COMPLETED|All Parts (16 Days)||0
8191416|NCT02286518|20197332|P8|NOT COMPLETED|All Parts (16 Days)||0
8191417|NCT02286518|20197333|P7|NOT COMPLETED|All Parts (16 Days)||0
8191418|NCT02286518|20197334|P6|NOT COMPLETED|All Parts (16 Days)||0
8191419|NCT02286518|20197335|P5|NOT COMPLETED|All Parts (16 Days)||0
8191420|NCT02286518|20197336|P4|NOT COMPLETED|All Parts (16 Days)||0
8191421|NCT02286518|20197337|P3|NOT COMPLETED|All Parts (16 Days)||0
8191422|NCT02286518|20197338|P2|NOT COMPLETED|All Parts (16 Days)||0
8191423|NCT02286518|20197339|P1|NOT COMPLETED|All Parts (16 Days)||0
8191424|NCT02286518|20197326|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191425|NCT02286518|20197327|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191426|NCT02286518|20197328|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191427|NCT02286518|20197329|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191428|NCT02286518|20197330|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
8191429|NCT02286518|20197331|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
8191430|NCT02286518|20197332|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
8191431|NCT02286518|20197333|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191432|NCT02286518|20197334|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191433|NCT02286518|20197335|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191434|NCT02286518|20197336|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191435|NCT02286518|20197337|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191436|NCT02286518|20197338|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191437|NCT02286518|20197339|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191438|NCT02286518|20197326|P14|STARTED|All Parts (16 Days)||6
8191439|NCT02286518|20197327|P13|STARTED|All Parts (16 Days)||6
8191440|NCT02286518|20197328|P12|STARTED|All Parts (16 Days)||6
8191441|NCT02286518|20197329|P11|STARTED|All Parts (16 Days)||6
8191442|NCT02286518|20197330|P10|STARTED|All Parts (16 Days)||4
8191443|NCT02286518|20197331|P9|STARTED|All Parts (16 Days)||6
8191444|NCT02286518|20197332|P8|STARTED|All Parts (16 Days)||6
8191445|NCT02286518|20197333|P7|STARTED|All Parts (16 Days)||6
8191446|NCT02286518|20197334|P6|STARTED|All Parts (16 Days)||6
8191447|NCT02286518|20197335|P5|STARTED|All Parts (16 Days)||6
8191448|NCT02286518|20197336|P4|STARTED|All Parts (16 Days)||6
8191449|NCT02286518|20197337|P3|STARTED|All Parts (16 Days)||6
8191450|NCT02286518|20197338|P2|STARTED|All Parts (16 Days)||6
8191451|NCT02286518|20197339|P1|STARTED|All Parts (16 Days)||6
8191452|NCT02286466|20197481|P2|NOT COMPLETED|Overall Study||10
8191453|NCT02286466|20197482|P1|NOT COMPLETED|Overall Study||7
8191454|NCT02286466|20197481|P2|COMPLETED|Overall Study||63
8191455|NCT02286466|20197482|P1|COMPLETED|Overall Study||65
8191456|NCT02286466|20197481|P2|Post Self-report|Overall Study||68
8191457|NCT02286466|20197482|P1|Post Self-report|Overall Study||67
8191458|NCT02286466|20197481|P2|Baseline Clinician Assessment|Overall Study||72
8191459|NCT02286466|20197482|P1|Baseline Clinician Assessment|Overall Study||72
8191460|NCT02286466|20197481|P2|STARTED|Overall Study||73
8191461|NCT02286466|20197482|P1|STARTED|Overall Study||72
8191462|NCT02286193|20197494|P1|NOT COMPLETED|Overall Study||204
8191463|NCT02286193|20197494|P1|COMPLETED|Overall Study||418
8191464|NCT02286193|20197494|P1|STARTED|Overall Study||622
8191465|NCT02286102|20197501|P2|NOT COMPLETED|Overall Study||1
8191466|NCT02286102|20197502|P1|NOT COMPLETED|Overall Study||1
8191467|NCT02286102|20197501|P2|COMPLETED|Overall Study||33
8191468|NCT02286102|20197502|P1|COMPLETED|Overall Study||35
8191469|NCT02286102|20197501|P2|STARTED|Overall Study||34
8191470|NCT02286102|20197502|P1|STARTED|Overall Study||36
8191471|NCT02285998|20197514|P2|NOT COMPLETED|Overall Study||253
8191472|NCT02285998|20197515|P1|NOT COMPLETED|Overall Study||246
8191473|NCT02285998|20197514|P2|COMPLETED|Overall Study||4236
8191474|NCT02285998|20197515|P1|COMPLETED|Overall Study||4228
8191475|NCT02285998|20197514|P2|STARTED|Overall Study||4489
8191476|NCT02285998|20197515|P1|STARTED|Overall Study||4474
8191477|NCT02285920|20197543|P4|NOT COMPLETED|Overall Study||1
8191478|NCT02285920|20197544|P3|NOT COMPLETED|Overall Study||5
8191479|NCT02285920|20197545|P2|NOT COMPLETED|Overall Study||4
8191480|NCT02285920|20197546|P1|NOT COMPLETED|Overall Study||4
8191481|NCT02285920|20197543|P4|COMPLETED|Overall Study||24
8191482|NCT02285920|20197544|P3|COMPLETED|Overall Study||21
8191483|NCT02285920|20197545|P2|COMPLETED|Overall Study||23
8191484|NCT02285920|20197546|P1|COMPLETED|Overall Study||47
8191485|NCT02285920|20197543|P4|STARTED|Overall Study||25
8191486|NCT02285920|20197544|P3|STARTED|Overall Study||26
8191487|NCT02285920|20197545|P2|STARTED|Overall Study||27
8191488|NCT02285920|20197546|P1|STARTED|Overall Study||51
8191489|NCT02285907|20197608|P1|NOT COMPLETED|Overall Study||0
8191490|NCT02285907|20197608|P1|COMPLETED|Overall Study||21
8191491|NCT02285907|20197608|P1|Began 4th Intervention|Overall Study||21
8191492|NCT02285907|20197608|P1|Began 3rd Intervention|Overall Study||21
8191493|NCT02285907|20197608|P1|Began 2nd Intervention|Overall Study||21
8191494|NCT02285907|20197608|P1|Began 1st Intervention|Overall Study||21
8191495|NCT02285907|20197608|P1|STARTED|Overall Study||21
8191496|NCT02285855|20197636|P2|NOT COMPLETED|Overall Study||1
8191497|NCT02285855|20197637|P1|NOT COMPLETED|Overall Study||2
8191498|NCT02285855|20197636|P2|COMPLETED|Overall Study||1
8191499|NCT02285855|20197637|P1|COMPLETED|Overall Study||14
8191500|NCT02285855|20197636|P2|Randomized|Overall Study||2
8191501|NCT02285855|20197637|P1|Randomized|Overall Study||16
8191502|NCT02285855|20197636|P2|STARTED|Overall Study||2
8191503|NCT02285855|20197637|P1|STARTED|Overall Study||16
8191504|NCT02285777|20197645|P2|NOT COMPLETED|Overall Study||3
8191505|NCT02285777|20197646|P1|NOT COMPLETED|Overall Study||5
8191506|NCT02285777|20197645|P2|COMPLETED|Overall Study||91
8191507|NCT02285777|20197646|P1|COMPLETED|Overall Study||90
8191508|NCT02285777|20197645|P2|STARTED|Overall Study||94
8191509|NCT02285777|20197646|P1|STARTED|Overall Study||95
8191510|NCT02285634|20197702|P4|NOT COMPLETED|Overall Study||1
8191511|NCT02285634|20197703|P3|NOT COMPLETED|Overall Study||4
8191512|NCT02285634|20197704|P2|NOT COMPLETED|Overall Study||0
8191513|NCT02285634|20197705|P1|NOT COMPLETED|Overall Study||0
8191514|NCT02285634|20197702|P4|COMPLETED|Overall Study||17
8191515|NCT02285634|20197703|P3|COMPLETED|Overall Study||11
8191516|NCT02285634|20197704|P2|COMPLETED|Overall Study||20
8191517|NCT02285634|20197705|P1|COMPLETED|Overall Study||15
8191518|NCT02285634|20197702|P4|STARTED|Overall Study||18
8191519|NCT02285634|20197703|P3|STARTED|Overall Study||15
8191520|NCT02285634|20197704|P2|STARTED|Overall Study||20
8191521|NCT02285634|20197705|P1|STARTED|Overall Study||15
8191522|NCT02285283|20197729|P2|NOT COMPLETED|Overall Study||9
8191523|NCT02285283|20197730|P1|NOT COMPLETED|Overall Study||4
8191524|NCT02285283|20197729|P2|COMPLETED|Overall Study||20
8191525|NCT02285283|20197730|P1|COMPLETED|Overall Study||25
8191526|NCT02285283|20197729|P2|STARTED|Overall Study||29
8191527|NCT02285283|20197730|P1|STARTED|Overall Study||29
8191528|NCT02285270|20197738|P1|NOT COMPLETED|Overall Study||5
8191529|NCT02285270|20197738|P1|COMPLETED|Overall Study||5
8191530|NCT02285270|20197738|P1|STARTED|Overall Study||10
8191531|NCT02285153|20197746|P2|NOT COMPLETED|Overall Study||0
8191532|NCT02285153|20197747|P1|NOT COMPLETED|Overall Study||1
8191533|NCT02285153|20197746|P2|COMPLETED|Overall Study||8
8191534|NCT02285153|20197747|P1|COMPLETED|Overall Study||6
8191535|NCT02285153|20197746|P2|STARTED|Overall Study||8
8191536|NCT02285153|20197747|P1|STARTED|Overall Study||7
8191537|NCT02285114|20197762|P3|NOT COMPLETED|Overall Study||3
8191538|NCT02285114|20197763|P2|NOT COMPLETED|Overall Study||7
8191539|NCT02285114|20197764|P1|NOT COMPLETED|Overall Study||22
8191540|NCT02285114|20197762|P3|COMPLETED|Overall Study||0
8191541|NCT02285114|20197763|P2|COMPLETED|Overall Study||2
8191542|NCT02285114|20197764|P1|COMPLETED|Overall Study||7
8191543|NCT02285114|20197762|P3|STARTED|Overall Study||3
8191544|NCT02285114|20197763|P2|STARTED|Overall Study||9
8191545|NCT02285114|20197764|P1|STARTED|Overall Study||29
8191546|NCT02285062|20197829|P2|NOT COMPLETED|Overall Study||84
8191547|NCT02285062|20197830|P1|NOT COMPLETED|Overall Study||78
8191548|NCT02285062|20197829|P2|COMPLETED|Overall Study||201
8191549|NCT02285062|20197830|P1|COMPLETED|Overall Study||207
8191550|NCT02285062|20197829|P2|Ongoing Study Treatment|Overall Study||0
8191551|NCT02285062|20197830|P1|Ongoing Study Treatment|Overall Study||0
8191552|NCT02285062|20197829|P2|Received Study Treatment|Overall Study||284
8191553|NCT02285062|20197830|P1|Received Study Treatment|Overall Study||283
8191554|NCT02285062|20197829|P2|STARTED|Overall Study||285
8191555|NCT02285062|20197830|P1|STARTED|Overall Study||285
8191556|NCT02285023|20197866|P1|NOT COMPLETED|Overall Study||0
8191557|NCT02285023|20197866|P1|COMPLETED|Overall Study||166
8191558|NCT02285023|20197866|P1|STARTED|Overall Study||166
8191559|NCT02285010|20197878|P2|NOT COMPLETED|Overall Study||1
8191560|NCT02285010|20197879|P1|NOT COMPLETED|Overall Study||5
8191561|NCT02285010|20197878|P2|COMPLETED|Overall Study||61
8191562|NCT02285010|20197879|P1|COMPLETED|Overall Study||58
8191563|NCT02285010|20197878|P2|STARTED|Overall Study||62
8191564|NCT02285010|20197879|P1|STARTED|Overall Study||63
8191565|NCT02284906|20197896|P3|NOT COMPLETED|Overall Study||19
8191566|NCT02284906|20197897|P2|NOT COMPLETED|Overall Study||18
8191567|NCT02284906|20197898|P1|NOT COMPLETED|Overall Study||3
8191568|NCT02284906|20197896|P3|COMPLETED|Overall Study||0
8191569|NCT02284906|20197897|P2|COMPLETED|Overall Study||0
8191570|NCT02284906|20197898|P1|COMPLETED|Overall Study||0
8191571|NCT02284906|20197896|P3|STARTED|Overall Study||19
8191572|NCT02284906|20197897|P2|STARTED|Overall Study||18
8191573|NCT02284906|20197898|P1|STARTED|Overall Study||3
8191574|NCT02284893|20197911|P2|NOT COMPLETED|52 Week (Long Term)||13
8191575|NCT02284893|20197912|P1|NOT COMPLETED|52 Week (Long Term)||11
8191576|NCT02284893|20197911|P2|COMPLETED|52 Week (Long Term)||180
8191577|NCT02284893|20197912|P1|COMPLETED|52 Week (Long Term)||198
8191578|NCT02284893|20197911|P2|STARTED|52 Week (Long Term)||193
8191579|NCT02284893|20197912|P1|STARTED|52 Week (Long Term)||209
8191580|NCT02284893|20197911|P2|NOT COMPLETED|26 Week (Short Term)||31
8191581|NCT02284893|20197912|P1|NOT COMPLETED|26 Week (Short Term)||19
8191582|NCT02284893|20197911|P2|COMPLETED|26 Week (Short Term)||198
8191583|NCT02284893|20197912|P1|COMPLETED|26 Week (Short Term)||213
8191584|NCT02284893|20197911|P2|STARTED|26 Week (Short Term)||229
8191585|NCT02284893|20197912|P1|STARTED|26 Week (Short Term)||232
8191586|NCT02284880|20197926|P4|NOT COMPLETED|Overall Study||0
8191587|NCT02284880|20197927|P3|NOT COMPLETED|Overall Study||2
8191588|NCT02284880|20197928|P2|NOT COMPLETED|Overall Study||0
8191589|NCT02284880|20197929|P1|NOT COMPLETED|Overall Study||0
8191590|NCT02284880|20197926|P4|COMPLETED|Overall Study||10
8191591|NCT02284880|20197927|P3|COMPLETED|Overall Study||8
8191592|NCT02284880|20197928|P2|COMPLETED|Overall Study||9
8191593|NCT02284880|20197929|P1|COMPLETED|Overall Study||11
8191594|NCT02284880|20197926|P4|Second Period (4 Days)|Overall Study||10
8191595|NCT02284880|20197927|P3|Second Period (4 Days)|Overall Study||8
8191596|NCT02284880|20197928|P2|Second Period (4 Days)|Overall Study||9
8191597|NCT02284880|20197929|P1|Second Period (4 Days)|Overall Study||11
8191598|NCT02284880|20197926|P4|Wash-out Period (7 Days)|Overall Study||10
8191599|NCT02284880|20197927|P3|Wash-out Period (7 Days)|Overall Study||10
8191600|NCT02284880|20197928|P2|Wash-out Period (7 Days)|Overall Study||9
8191601|NCT02284880|20197929|P1|Wash-out Period (7 Days)|Overall Study||11
8191602|NCT02284880|20197926|P4|First Period (4 Days)|Overall Study||10
8191603|NCT02284880|20197927|P3|First Period (4 Days)|Overall Study||10
8191604|NCT02284880|20197928|P2|First Period (4 Days)|Overall Study||9
8191605|NCT02284880|20197929|P1|First Period (4 Days)|Overall Study||11
8191606|NCT02284880|20197926|P4|STARTED|Overall Study||10
8191607|NCT02284880|20197927|P3|STARTED|Overall Study||10
8191608|NCT02284880|20197928|P2|STARTED|Overall Study||9
8191609|NCT02284880|20197929|P1|STARTED|Overall Study||11
8191610|NCT02284867|20197945|P2|NOT COMPLETED|Overall Study||0
8191611|NCT02284867|20197946|P1|NOT COMPLETED|Overall Study||0
8191612|NCT02284867|20197945|P2|COMPLETED|Overall Study||30
8191613|NCT02284867|20197946|P1|COMPLETED|Overall Study||30
8191614|NCT02284867|20197945|P2|STARTED|Overall Study||30
8191615|NCT02284867|20197946|P1|STARTED|Overall Study||30
8191616|NCT02284854|20197956|P2|NOT COMPLETED|Overall Study||0
8191617|NCT02284854|20197957|P1|NOT COMPLETED|Overall Study||5
8191618|NCT02284854|20197956|P2|COMPLETED|Overall Study||20
8191619|NCT02284854|20197957|P1|COMPLETED|Overall Study||18
8191620|NCT02284854|20197956|P2|STARTED|Overall Study||20
8191621|NCT02284854|20197957|P1|STARTED|Overall Study||23
8191622|NCT02284828|20197974|P1|NOT COMPLETED|Overall Study||4
8191623|NCT02284828|20197974|P1|COMPLETED|Overall Study||22
8191624|NCT02284828|20197974|P1|STARTED|Overall Study||26
8191625|NCT02284568|20197989|P3|NOT COMPLETED|Overall Study||95
8191626|NCT02284568|20197990|P2|NOT COMPLETED|Overall Study||46
8191627|NCT02284568|20197991|P1|NOT COMPLETED|Overall Study||31
8191628|NCT02284568|20197989|P3|COMPLETED|Overall Study||0
8191629|NCT02284568|20197990|P2|COMPLETED|Overall Study||93
8191630|NCT02284568|20197991|P1|COMPLETED|Overall Study||109
8191631|NCT02284568|20197989|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
8191632|NCT02284568|20197990|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
8191633|NCT02284568|20197991|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
8191634|NCT02284568|20197989|P3|Safety Population|Overall Study||95
8191635|NCT02284568|20197990|P2|Safety Population|Overall Study||138
8191636|NCT02284568|20197991|P1|Safety Population|Overall Study||140
8191637|NCT02284568|20197989|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
8191638|NCT02284568|20197990|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
8191639|NCT02284568|20197991|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
8191640|NCT02284555|20198017|P1|NOT COMPLETED|Overall Study||0
8191641|NCT02284555|20198017|P1|COMPLETED|Overall Study||12
8191642|NCT02284555|20198017|P1|STARTED|Overall Study||12
8191643|NCT02284516|20198024|P2|NOT COMPLETED|Overall Study||36
8191644|NCT02284516|20198025|P1|NOT COMPLETED|Overall Study||38
8191645|NCT02284516|20198024|P2|COMPLETED|Overall Study||319
8191646|NCT02284516|20198025|P1|COMPLETED|Overall Study||318
8191647|NCT02284516|20198024|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
8191648|NCT02284516|20198025|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
8191649|NCT02284516|20198024|P2|STARTED|Overall Study||355
8191650|NCT02284516|20198025|P1|STARTED|Overall Study||356
8191651|NCT02284464|20198035|P2|NOT COMPLETED|Overall Study||17
8191652|NCT02284464|20198036|P1|NOT COMPLETED|Overall Study||13
8191653|NCT02284464|20198035|P2|COMPLETED|Overall Study||36
8191654|NCT02284464|20198036|P1|COMPLETED|Overall Study||39
8191655|NCT02284464|20198035|P2|STARTED|Overall Study||53
8191656|NCT02284464|20198036|P1|STARTED|Overall Study||52
8191657|NCT02284399|20198064|P2|NOT COMPLETED|Overall Study||0
8191658|NCT02284399|20198065|P1|NOT COMPLETED|Overall Study||0
8191659|NCT02284399|20198064|P2|COMPLETED|Overall Study||3074
8191660|NCT02284399|20198065|P1|COMPLETED|Overall Study||1414
8191661|NCT02284399|20198064|P2|STARTED|Overall Study||3074
8191662|NCT02284399|20198065|P1|STARTED|Overall Study||1414
8191663|NCT02284386|20198073|P1|NOT COMPLETED|Overall Study||0
8191664|NCT02284386|20198073|P1|COMPLETED|Overall Study||15
8191665|NCT02284386|20198073|P1|STARTED|Overall Study||15
8191666|NCT02284373|20198085|P3|NOT COMPLETED|Overall Study||0
8191667|NCT02284373|20198086|P2|NOT COMPLETED|Overall Study||3
8191668|NCT02284373|20198087|P1|NOT COMPLETED|Overall Study||0
8191669|NCT02284373|20198085|P3|COMPLETED|Overall Study||29
8191670|NCT02284373|20198086|P2|COMPLETED|Overall Study||2
8191671|NCT02284373|20198087|P1|COMPLETED|Overall Study||5
8191672|NCT02284373|20198085|P3|STARTED|Overall Study||29
8191673|NCT02284373|20198086|P2|STARTED|Overall Study||5
8191674|NCT02284373|20198087|P1|STARTED|Overall Study||5
8191675|NCT02284347|20198095|P1|NOT COMPLETED|Overall Study||3
8191676|NCT02284347|20198095|P1|COMPLETED|Overall Study||48
8191677|NCT02284347|20198095|P1|STARTED|Overall Study||51
8191678|NCT02284243|20198103|P2|NOT COMPLETED|Overall Study||3
8191679|NCT02284243|20198104|P1|NOT COMPLETED|Overall Study||4
8191680|NCT02284243|20198103|P2|COMPLETED|Overall Study||81
8191681|NCT02284243|20198104|P1|COMPLETED|Overall Study||80
8191682|NCT02284243|20198103|P2|STARTED|Overall Study||84
8191683|NCT02284243|20198104|P1|STARTED|Overall Study||84
8191684|NCT02284178|20198124|P2|NOT COMPLETED|Overall Study||54
8191685|NCT02284178|20198125|P1|NOT COMPLETED|Overall Study||49
8191686|NCT02284178|20198124|P2|COMPLETED|Overall Study||204
8191687|NCT02284178|20198125|P1|COMPLETED|Overall Study||206
8191688|NCT02284178|20198124|P2|STARTED|Overall Study||258
8191689|NCT02284178|20198125|P1|STARTED|Overall Study||255
8191690|NCT02284165|20198148|P3|NOT COMPLETED|Overall Study||0
8191691|NCT02284165|20198149|P2|NOT COMPLETED|Overall Study||0
8191692|NCT02284165|20198150|P1|NOT COMPLETED|Overall Study||0
8191693|NCT02284165|20198148|P3|COMPLETED|Overall Study||70996
8191694|NCT02284165|20198149|P2|COMPLETED|Overall Study||40272
8191695|NCT02284165|20198150|P1|COMPLETED|Overall Study||36448
8191696|NCT02284165|20198148|P3|STARTED|Overall Study||70996
8191697|NCT02284165|20198149|P2|STARTED|Overall Study||40272
8191698|NCT02284165|20198150|P1|STARTED|Overall Study||36448
8191699|NCT02284126|20198168|P2|NOT COMPLETED|Overall Study||62
8191700|NCT02284126|20198169|P1|NOT COMPLETED|Overall Study||68
8191701|NCT02284126|20198168|P2|COMPLETED|Overall Study||489
8191702|NCT02284126|20198169|P1|COMPLETED|Overall Study||484
8191703|NCT02284126|20198168|P2|STARTED|Overall Study||551
8191704|NCT02284126|20198169|P1|STARTED|Overall Study||552
8191705|NCT02284009|20198179|P2|NOT COMPLETED|Overall Study||10
8191706|NCT02284009|20198180|P1|NOT COMPLETED|Overall Study||6
8191707|NCT02284009|20198179|P2|COMPLETED|Overall Study||40
8191708|NCT02284009|20198180|P1|COMPLETED|Overall Study||11
8191709|NCT02284009|20198179|P2|STARTED|Overall Study||50
8191710|NCT02284009|20198180|P1|STARTED|Overall Study||17
8191711|NCT02283840|20198225|P3|NOT COMPLETED|Overall Study||0
8191712|NCT02283840|20198226|P2|NOT COMPLETED|Overall Study||1
8191713|NCT02283840|20198227|P1|NOT COMPLETED|Overall Study||0
8191714|NCT02283840|20198225|P3|COMPLETED|Overall Study||20
8191715|NCT02283840|20198226|P2|COMPLETED|Overall Study||19
8191716|NCT02283840|20198227|P1|COMPLETED|Overall Study||20
8191717|NCT02283840|20198225|P3|STARTED|Overall Study||20
8191718|NCT02283840|20198226|P2|STARTED|Overall Study||20
8191719|NCT02283840|20198227|P1|STARTED|Overall Study||20
8191720|NCT02283827|20198246|P2|NOT COMPLETED|Overall Study||3
8191721|NCT02283827|20198247|P1|NOT COMPLETED|Overall Study||1
8191722|NCT02283827|20198246|P2|COMPLETED|Overall Study||13
8191723|NCT02283827|20198247|P1|COMPLETED|Overall Study||15
8191724|NCT02283827|20198246|P2|STARTED|Overall Study||16
8191725|NCT02283827|20198247|P1|STARTED|Overall Study||16
8191726|NCT02283814|20198264|P2|NOT COMPLETED|Overall Study||2
8191727|NCT02283814|20198265|P1|NOT COMPLETED|Overall Study||3
8191728|NCT02283814|20198264|P2|COMPLETED|Overall Study||14
8191729|NCT02283814|20198265|P1|COMPLETED|Overall Study||13
8191730|NCT02283814|20198264|P2|STARTED|Overall Study||16
8191731|NCT02283814|20198265|P1|STARTED|Overall Study||16
8191732|NCT02283788|20198279|P4|NOT COMPLETED|Overall Study||2
8191733|NCT02283788|20198280|P3|NOT COMPLETED|Overall Study||5
8191734|NCT02283788|20198281|P2|NOT COMPLETED|Overall Study||4
8191735|NCT02283788|20198282|P1|NOT COMPLETED|Overall Study||1
8191736|NCT02283788|20198279|P4|COMPLETED|Overall Study||14
8191737|NCT02283788|20198280|P3|COMPLETED|Overall Study||12
8191738|NCT02283788|20198281|P2|COMPLETED|Overall Study||13
8191739|NCT02283788|20198282|P1|COMPLETED|Overall Study||16
8191740|NCT02283788|20198279|P4|STARTED|Overall Study||16
8191741|NCT02283788|20198280|P3|STARTED|Overall Study||17
8191742|NCT02283788|20198281|P2|STARTED|Overall Study||17
8191743|NCT02283788|20198282|P1|STARTED|Overall Study||17
8191744|NCT02283762|20198294|P2|NOT COMPLETED|Long-term Extension Phase (LTE)||14
8191745|NCT02283762|20198295|P1|NOT COMPLETED|Long-term Extension Phase (LTE)||10
8191746|NCT02283762|20198294|P2|COMPLETED|Long-term Extension Phase (LTE)||31
8191747|NCT02283762|20198295|P1|COMPLETED|Long-term Extension Phase (LTE)||32
8191748|NCT02283762|20198294|P2|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
8191749|NCT02283762|20198295|P1|STARTED|Long-term Extension Phase (LTE)||42
8191750|NCT02283762|20198294|P2|NOT COMPLETED|Main Treatment Phase (MT)||15
8191751|NCT02283762|20198295|P1|NOT COMPLETED|Main Treatment Phase (MT)||18
8191752|NCT02283762|20198294|P2|COMPLETED|Main Treatment Phase (MT)||46
8191753|NCT02283762|20198295|P1|COMPLETED|Main Treatment Phase (MT)||42
8191754|NCT02283762|20198294|P2|STARTED|Main Treatment Phase (MT)||61
8191755|NCT02283762|20198295|P1|STARTED|Main Treatment Phase (MT)||60
8191759|NCT02283658|20198319|P1|NOT COMPLETED|Overall Study||1
8191760|NCT02283658|20198319|P1|COMPLETED|Overall Study||19
8191761|NCT02283658|20198319|P1|STARTED|Overall Study||20
8191762|NCT02283528|20198330|P2|NOT COMPLETED|Overall Study||0
8191763|NCT02283528|20198331|P1|NOT COMPLETED|Overall Study||0
8191764|NCT02283528|20198330|P2|COMPLETED|Overall Study||24
8191765|NCT02283528|20198331|P1|COMPLETED|Overall Study||26
8191766|NCT02283528|20198330|P2|STARTED|Overall Study||24
8191767|NCT02283528|20198331|P1|STARTED|Overall Study||26
8191768|NCT02283411|20198341|P1|NOT COMPLETED|Overall Study||31
8191769|NCT02283411|20198341|P1|COMPLETED|Overall Study||125
8191770|NCT02283411|20198341|P1|STARTED|Overall Study||156
8191771|NCT02283268|20198349|P1|NOT COMPLETED|Overall Study||1
8191772|NCT02283268|20198349|P1|COMPLETED|Overall Study||14
8191773|NCT02283268|20198349|P1|STARTED|Overall Study||15
8191774|NCT02282982|20198410|P1|NOT COMPLETED|Overall Study||206
8191775|NCT02282982|20198410|P1|COMPLETED|Overall Study||153
8191776|NCT02282982|20198410|P1|Attended Follow-up Visit|Overall Study||349
8191777|NCT02282982|20198410|P1|Attended Visit 5|Overall Study||83
8191778|NCT02282982|20198410|P1|Attended Visit 4|Overall Study||194
8191779|NCT02282982|20198410|P1|Attended Visit 3|Overall Study||298
8191780|NCT02282982|20198410|P1|Attended Visit 2|Overall Study||341
8191781|NCT02282982|20198410|P1|Attended Visit 1|Overall Study||359
8191782|NCT02282982|20198410|P1|STARTED|Overall Study||359
8191783|NCT02282930|20198425|P1|NOT COMPLETED|Overall Study||1
8191784|NCT02282930|20198425|P1|COMPLETED|Overall Study||19
8191785|NCT02282930|20198425|P1|STARTED|Overall Study||20
8191786|NCT02282904|20198430|P1|NOT COMPLETED|Overall Study||0
8191787|NCT02282904|20198430|P1|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
8191788|NCT02282904|20198430|P1|STARTED|Overall Study||7
8191789|NCT02282813|20198438|P3|NOT COMPLETED|Overall Study||3
8191790|NCT02282813|20198439|P2|NOT COMPLETED|Overall Study||23
8191791|NCT02282813|20198440|P1|NOT COMPLETED|Overall Study||12
8191792|NCT02282813|20198438|P3|COMPLETED|Overall Study||39
8191793|NCT02282813|20198439|P2|COMPLETED|Overall Study||130
8191794|NCT02282813|20198440|P1|COMPLETED|Overall Study||91
8191795|NCT02282813|20198438|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
8191796|NCT02282813|20198439|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
8191797|NCT02282813|20198440|P1|STARTED|Overall Study|ITT Population|103
8191798|NCT02282722|20198459|P2|NOT COMPLETED|Overall Study||19
8191799|NCT02282722|20198460|P1|NOT COMPLETED|Overall Study||23
8191800|NCT02282722|20198459|P2|COMPLETED|Overall Study||73
8191801|NCT02282722|20198460|P1|COMPLETED|Overall Study||71
8191802|NCT02282722|20198459|P2|3-month Assessment|Overall Study||73
8191803|NCT02282722|20198460|P1|3-month Assessment|Overall Study||71
8191804|NCT02282722|20198459|P2|2-week Assessment|Overall Study||75
8191805|NCT02282722|20198460|P1|2-week Assessment|Overall Study||79
8191806|NCT02282722|20198459|P2|STARTED|Overall Study||92
8191807|NCT02282722|20198460|P1|STARTED|Overall Study||94
8191808|NCT02282631|20198486|P2|NOT COMPLETED|Overall Study||0
8191809|NCT02282631|20198487|P1|NOT COMPLETED|Overall Study||2
8191810|NCT02282631|20198486|P2|COMPLETED|Overall Study||15
8191811|NCT02282631|20198487|P1|COMPLETED|Overall Study||12
8191812|NCT02282631|20198486|P2|STARTED|Overall Study||15
8191813|NCT02282631|20198487|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
8191814|NCT02282605|20198528|P3|NOT COMPLETED|Overall Study||0
8191815|NCT02282605|20198529|P2|NOT COMPLETED|Overall Study||0
8191816|NCT02282605|20198530|P1|NOT COMPLETED|Overall Study||3
8191817|NCT02282605|20198528|P3|COMPLETED|Overall Study||24
8191818|NCT02282605|20198529|P2|COMPLETED|Overall Study||12
8191819|NCT02282605|20198530|P1|COMPLETED|Overall Study||24
8191820|NCT02282605|20198528|P3|STARTED|Overall Study||24
8191821|NCT02282605|20198529|P2|STARTED|Overall Study||12
8191822|NCT02282605|20198530|P1|STARTED|Overall Study||27
8191823|NCT02282527|20198552|P2|NOT COMPLETED|Overall Study||1
8191824|NCT02282527|20198553|P1|NOT COMPLETED|Overall Study||1
8191825|NCT02282527|20198552|P2|COMPLETED|Overall Study||15
8191826|NCT02282527|20198553|P1|COMPLETED|Overall Study||15
8191827|NCT02282527|20198552|P2|STARTED|Overall Study||16
8191828|NCT02282527|20198553|P1|STARTED|Overall Study||16
8191829|NCT02282514|20198563|P1|NOT COMPLETED|Overall Study||0
8191830|NCT02282514|20198563|P1|COMPLETED|Overall Study||23
8191831|NCT02282514|20198563|P1|STARTED|Overall Study||23
8191832|NCT02282293|20198571|P2|NOT COMPLETED|Overall Study||3
8191833|NCT02282293|20198572|P1|NOT COMPLETED|Overall Study||3
8191834|NCT02282293|20198571|P2|COMPLETED|Overall Study||97
8191835|NCT02282293|20198572|P1|COMPLETED|Overall Study||97
8191836|NCT02282293|20198571|P2|STARTED|Overall Study||100
8191837|NCT02282293|20198572|P1|STARTED|Overall Study||100
8191838|NCT02282163|20198590|P1|NOT COMPLETED|Overall Study||1
8191839|NCT02282163|20198590|P1|COMPLETED|Overall Study||12
8191840|NCT02282163|20198590|P1|STARTED|Overall Study||13
8191841|NCT02282111|20198605|P2|NOT COMPLETED|Overall Study||8
8191842|NCT02282111|20198606|P1|NOT COMPLETED|Overall Study||7
8191843|NCT02282111|20198605|P2|COMPLETED|Overall Study||22
8191844|NCT02282111|20198606|P1|COMPLETED|Overall Study||19
8191845|NCT02282111|20198605|P2|STARTED|Overall Study||30
8191846|NCT02282111|20198606|P1|STARTED|Overall Study||26
8191847|NCT02282020|20198622|P2|NOT COMPLETED|Overall Study||87
8191848|NCT02282020|20198623|P1|NOT COMPLETED|Overall Study||135
8191849|NCT02282020|20198622|P2|COMPLETED|Overall Study||1
8191850|NCT02282020|20198623|P1|COMPLETED|Overall Study||43
8191851|NCT02282020|20198622|P2|Received Treatment|Overall Study||76
8191852|NCT02282020|20198623|P1|Received Treatment|Overall Study||178
8191853|NCT02282020|20198622|P2|STARTED|Overall Study||88
8191854|NCT02282020|20198623|P1|STARTED|Overall Study||178
8191855|NCT02281955|20198668|P1|NOT COMPLETED|Overall Study||1
8191856|NCT02281955|20198668|P1|COMPLETED|Overall Study||113
8191857|NCT02281955|20198668|P1|STARTED|Overall Study||114
8191858|NCT02281851|20198679|P2|NOT COMPLETED|Overall Study||0
8191859|NCT02281851|20198680|P1|NOT COMPLETED|Overall Study||0
8191860|NCT02281851|20198679|P2|COMPLETED|Overall Study||10
8191861|NCT02281851|20198680|P1|COMPLETED|Overall Study||4
8191862|NCT02281851|20198679|P2|STARTED|Overall Study||10
8191863|NCT02281851|20198680|P1|STARTED|Overall Study||4
8191864|NCT02281773|20198691|P5|NOT COMPLETED|Overall Study||30
8191865|NCT02281773|20198692|P4|NOT COMPLETED|Overall Study||21
8191866|NCT02281773|20198693|P3|NOT COMPLETED|Overall Study||18
8191867|NCT02281773|20198694|P2|NOT COMPLETED|Overall Study||15
8191868|NCT02281773|20198695|P1|NOT COMPLETED|Overall Study||11
8191869|NCT02281773|20198691|P5|COMPLETED|Overall Study||143
8191870|NCT02281773|20198692|P4|COMPLETED|Overall Study||65
8191871|NCT02281773|20198693|P3|COMPLETED|Overall Study||67
8191872|NCT02281773|20198694|P2|COMPLETED|Overall Study||70
8191873|NCT02281773|20198695|P1|COMPLETED|Overall Study||76
8191874|NCT02281773|20198691|P5|STARTED|Overall Study|Started are the treated patients|173
8191875|NCT02281773|20198692|P4|STARTED|Overall Study||86
8191876|NCT02281773|20198693|P3|STARTED|Overall Study||85
8191877|NCT02281773|20198694|P2|STARTED|Overall Study|Started are the treated patients|85
8191878|NCT02281773|20198695|P1|STARTED|Overall Study||87
8191879|NCT02281591|20198756|P4|NOT COMPLETED|Overall Study||0
8191880|NCT02281591|20198757|P3|NOT COMPLETED|Overall Study||0
8191881|NCT02281591|20198758|P2|NOT COMPLETED|Overall Study||0
8191882|NCT02281591|20198759|P1|NOT COMPLETED|Overall Study||0
8191883|NCT02281591|20198756|P4|COMPLETED|Overall Study||8
8191884|NCT02281591|20198757|P3|COMPLETED|Overall Study||8
8191885|NCT02281591|20198758|P2|COMPLETED|Overall Study||8
8191886|NCT02281591|20198759|P1|COMPLETED|Overall Study||8
8191887|NCT02281591|20198756|P4|STARTED|Overall Study||8
8191888|NCT02281591|20198757|P3|STARTED|Overall Study||8
8191889|NCT02281591|20198758|P2|STARTED|Overall Study||8
8191890|NCT02281591|20198759|P1|STARTED|Overall Study||8
8191891|NCT02281552|20198783|P2|NOT COMPLETED|Overall Study||10
8191892|NCT02281552|20198784|P1|NOT COMPLETED|Overall Study||4
8191893|NCT02281552|20198783|P2|COMPLETED|Overall Study||95
8191894|NCT02281552|20198784|P1|COMPLETED|Overall Study||100
8191895|NCT02281552|20198783|P2|STARTED|Overall Study||105
8191896|NCT02281552|20198784|P1|STARTED|Overall Study||104
8191897|NCT02281526|20198824|P2|NOT COMPLETED|Overall Study||0
8191898|NCT02281526|20198825|P1|NOT COMPLETED|Overall Study||1
8191899|NCT02281526|20198824|P2|COMPLETED|Overall Study||8
8191900|NCT02281526|20198825|P1|COMPLETED|Overall Study||8
8191901|NCT02281526|20198824|P2|STARTED|Overall Study||8
8191902|NCT02281526|20198825|P1|STARTED|Overall Study||9
8191903|NCT02281500|20198833|P1|NOT COMPLETED|Overall Study||0
8191904|NCT02281500|20198833|P1|COMPLETED|Overall Study||22
8191905|NCT02281500|20198833|P1|STARTED|Overall Study||22
8191906|NCT02281448|20198864|P2|NOT COMPLETED|Overall Study||1
8191907|NCT02281448|20198865|P1|NOT COMPLETED|Overall Study||2
8191908|NCT02281448|20198864|P2|COMPLETED|Overall Study||9
8191909|NCT02281448|20198865|P1|COMPLETED|Overall Study||8
8191910|NCT02281448|20198864|P2|STARTED|Overall Study||10
8191911|NCT02281448|20198865|P1|STARTED|Overall Study||10
8191912|NCT02281422|20198878|P5|NOT COMPLETED|Overall Study||0
8191913|NCT02281422|20198879|P4|NOT COMPLETED|Overall Study||0
8191914|NCT02281422|20198880|P3|NOT COMPLETED|Overall Study||0
8191915|NCT02281422|20198881|P2|NOT COMPLETED|Overall Study||0
8191916|NCT02281422|20198882|P1|NOT COMPLETED|Overall Study||0
8191917|NCT02281422|20198878|P5|COMPLETED|Overall Study||8
8191918|NCT02281422|20198879|P4|COMPLETED|Overall Study||8
8191919|NCT02281422|20198880|P3|COMPLETED|Overall Study||8
8191920|NCT02281422|20198881|P2|COMPLETED|Overall Study||8
8191921|NCT02281422|20198882|P1|COMPLETED|Overall Study||8
8191922|NCT02281422|20198878|P5|STARTED|Overall Study||8
8191923|NCT02281422|20198879|P4|STARTED|Overall Study||8
8191924|NCT02281422|20198880|P3|STARTED|Overall Study||8
8191925|NCT02281422|20198881|P2|STARTED|Overall Study||8
8191926|NCT02281422|20198882|P1|STARTED|Overall Study||8
8191927|NCT02281357|20198906|P2|NOT COMPLETED|Overall Study||4
8191928|NCT02281357|20198907|P1|NOT COMPLETED|Overall Study||7
8191929|NCT02281357|20198906|P2|COMPLETED|Overall Study||66
8191930|NCT02281357|20198907|P1|COMPLETED|Overall Study||63
8191931|NCT02281357|20198906|P2|STARTED|Overall Study||70
8191932|NCT02281357|20198907|P1|STARTED|Overall Study||70
8191933|NCT02281344|20198919|P1|NOT COMPLETED|Overall Study||0
8191934|NCT02281344|20198919|P1|COMPLETED|Overall Study||6
8191935|NCT02281344|20198919|P1|STARTED|Overall Study||6
8191936|NCT02281318|20198926|P2|NOT COMPLETED|Overall Study||5
8191937|NCT02281318|20198927|P1|NOT COMPLETED|Overall Study||14
8191938|NCT02281318|20198926|P2|COMPLETED|Overall Study||269
8191939|NCT02281318|20198927|P1|COMPLETED|Overall Study||263
8191940|NCT02281318|20198926|P2|STARTED|Overall Study||274
8191941|NCT02281318|20198927|P1|STARTED|Overall Study||277
8191942|NCT02281136|20198939|P1|NOT COMPLETED|Overall Study||0
8191943|NCT02281136|20198939|P1|COMPLETED|Overall Study||29
8191944|NCT02281136|20198939|P1|STARTED|Overall Study||29
8191945|NCT02281084|20198975|P4|NOT COMPLETED|Overall Study||5
8191946|NCT02281084|20198976|P3|NOT COMPLETED|Overall Study||4
8191947|NCT02281084|20198977|P2|NOT COMPLETED|Overall Study||18
8191948|NCT02281084|20198978|P1|NOT COMPLETED|Overall Study||22
8191949|NCT02281084|20198975|P4|COMPLETED|Overall Study||0
8191950|NCT02281084|20198976|P3|COMPLETED|Overall Study||2
8191951|NCT02281084|20198977|P2|COMPLETED|Overall Study||4
8191952|NCT02281084|20198978|P1|COMPLETED|Overall Study||10
8191953|NCT02281084|20198975|P4|STARTED|Overall Study||5
8191954|NCT02281084|20198976|P3|STARTED|Overall Study||6
8191955|NCT02281084|20198977|P2|STARTED|Overall Study||22
8191956|NCT02281084|20198978|P1|STARTED|Overall Study||32
8191957|NCT02280863|20199034|P2|NOT COMPLETED|Integrated Platform||1
8191958|NCT02280863|20199035|P1|NOT COMPLETED|Integrated Platform||0
8191959|NCT02280863|20199034|P2|COMPLETED|Integrated Platform||14
8191960|NCT02280863|20199035|P1|COMPLETED|Integrated Platform||9
8191961|NCT02280863|20199034|P2|STARTED|Integrated Platform||15
8191962|NCT02280863|20199035|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
8191963|NCT02280863|20199034|P2|NOT COMPLETED|Android Platform||0
8191964|NCT02280863|20199035|P1|NOT COMPLETED|Android Platform||0
8191965|NCT02280863|20199034|P2|COMPLETED|Android Platform||0
8191966|NCT02280863|20199035|P1|COMPLETED|Android Platform||8
8191967|NCT02280863|20199034|P2|STARTED|Android Platform||0
8191968|NCT02280863|20199035|P1|STARTED|Android Platform||8
8191969|NCT02280811|20199065|P5|NOT COMPLETED|Retreated at the MTD||0
8191970|NCT02280811|20199066|P4|NOT COMPLETED|Retreated at the MTD||0
8191971|NCT02280811|20199067|P3|NOT COMPLETED|Retreated at the MTD||0
8191972|NCT02280811|20199068|P2|NOT COMPLETED|Retreated at the MTD||0
8191973|NCT02280811|20199069|P1|NOT COMPLETED|Retreated at the MTD||0
8191974|NCT02280811|20199065|P5|COMPLETED|Retreated at the MTD||1
8191975|NCT02280811|20199066|P4|COMPLETED|Retreated at the MTD||0
8191976|NCT02280811|20199067|P3|COMPLETED|Retreated at the MTD||0
8191977|NCT02280811|20199068|P2|COMPLETED|Retreated at the MTD||0
8191978|NCT02280811|20199069|P1|COMPLETED|Retreated at the MTD||0
8191979|NCT02280811|20199065|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
8191980|NCT02280811|20199066|P4|STARTED|Retreated at the MTD||0
8191981|NCT02280811|20199067|P3|STARTED|Retreated at the MTD||0
8191982|NCT02280811|20199068|P2|STARTED|Retreated at the MTD||0
8191983|NCT02280811|20199069|P1|STARTED|Retreated at the MTD||0
8191984|NCT02280811|20199065|P5|NOT COMPLETED|Drug Administration||0
8191985|NCT02280811|20199066|P4|NOT COMPLETED|Drug Administration||0
8191986|NCT02280811|20199067|P3|NOT COMPLETED|Drug Administration||0
8191987|NCT02280811|20199068|P2|NOT COMPLETED|Drug Administration||0
8191988|NCT02280811|20199069|P1|NOT COMPLETED|Drug Administration||0
8191989|NCT02280811|20199065|P5|COMPLETED|Drug Administration||2
8191990|NCT02280811|20199066|P4|COMPLETED|Drug Administration||6
8191991|NCT02280811|20199067|P3|COMPLETED|Drug Administration||1
8191992|NCT02280811|20199068|P2|COMPLETED|Drug Administration||2
8191993|NCT02280811|20199069|P1|COMPLETED|Drug Administration||1
8191994|NCT02280811|20199065|P5|STARTED|Drug Administration||2
8191995|NCT02280811|20199066|P4|STARTED|Drug Administration||6
8191996|NCT02280811|20199067|P3|STARTED|Drug Administration||1
8191997|NCT02280811|20199068|P2|STARTED|Drug Administration||2
8191998|NCT02280811|20199069|P1|STARTED|Drug Administration||1
8191999|NCT02280655|20199110|P2|NOT COMPLETED|Overall Study||0
8192000|NCT02280655|20199111|P1|NOT COMPLETED|Overall Study||0
8192001|NCT02280655|20199110|P2|COMPLETED|Overall Study||18
8192002|NCT02280655|20199111|P1|COMPLETED|Overall Study||25
8192003|NCT02280655|20199110|P2|STARTED|Overall Study||18
8192004|NCT02280655|20199111|P1|STARTED|Overall Study||25
8192005|NCT02280499|20199119|P1|NOT COMPLETED|Overall Study||61
8192006|NCT02280499|20199119|P1|COMPLETED|Overall Study||26
8192007|NCT02280499|20199119|P1|STARTED|Overall Study||87
8192008|NCT02280473|20199127|P2|NOT COMPLETED|Overall Study||3
8192009|NCT02280473|20199128|P1|NOT COMPLETED|Overall Study||1
8192010|NCT02280473|20199127|P2|COMPLETED|Overall Study||91
8192011|NCT02280473|20199128|P1|COMPLETED|Overall Study||93
8192012|NCT02280473|20199127|P2|STARTED|Overall Study||94
8192013|NCT02280473|20199128|P1|STARTED|Overall Study||94
8192014|NCT02280421|20199144|P2|NOT COMPLETED|Second Intervention(2 Weeks)||0
8192015|NCT02280421|20199145|P1|NOT COMPLETED|Second Intervention(2 Weeks)||0
8192016|NCT02280421|20199144|P2|COMPLETED|Second Intervention(2 Weeks)||12
8192017|NCT02280421|20199145|P1|COMPLETED|Second Intervention(2 Weeks)||12
8192018|NCT02280421|20199144|P2|Received Intervention|Second Intervention(2 Weeks)||12
8192019|NCT02280421|20199145|P1|Received Intervention|Second Intervention(2 Weeks)||12
8192020|NCT02280421|20199144|P2|STARTED|Second Intervention(2 Weeks)||12
8192021|NCT02280421|20199145|P1|STARTED|Second Intervention(2 Weeks)||12
8192022|NCT02280421|20199144|P2|NOT COMPLETED|Washout (2 Weeks)||1
8192023|NCT02280421|20199145|P1|NOT COMPLETED|Washout (2 Weeks)||1
8192024|NCT02280421|20199144|P2|COMPLETED|Washout (2 Weeks)||11
8192025|NCT02280421|20199145|P1|COMPLETED|Washout (2 Weeks)||11
8192026|NCT02280421|20199144|P2|STARTED|Washout (2 Weeks)||12
8192027|NCT02280421|20199145|P1|STARTED|Washout (2 Weeks)||12
8192028|NCT02280421|20199144|P2|NOT COMPLETED|First Intervention(2 Weeks)||0
8192029|NCT02280421|20199145|P1|NOT COMPLETED|First Intervention(2 Weeks)||0
8192030|NCT02280421|20199144|P2|COMPLETED|First Intervention(2 Weeks)||12
8192031|NCT02280421|20199145|P1|COMPLETED|First Intervention(2 Weeks)||12
8192032|NCT02280421|20199144|P2|Received Intervention|First Intervention(2 Weeks)||12
8192033|NCT02280421|20199145|P1|Received Intervention|First Intervention(2 Weeks)||12
8192034|NCT02280421|20199144|P2|STARTED|First Intervention(2 Weeks)||12
8192035|NCT02280421|20199145|P1|STARTED|First Intervention(2 Weeks)||12
8192036|NCT02280408|20199211|P4|NOT COMPLETED|Overall Study||0
8192037|NCT02280408|20199212|P3|NOT COMPLETED|Overall Study||0
8192038|NCT02280408|20199213|P2|NOT COMPLETED|Overall Study||2
8192039|NCT02280408|20199214|P1|NOT COMPLETED|Overall Study||0
8192040|NCT02280408|20199211|P4|COMPLETED|Overall Study||9
8192041|NCT02280408|20199212|P3|COMPLETED|Overall Study||10
8192042|NCT02280408|20199213|P2|COMPLETED|Overall Study||8
8192043|NCT02280408|20199214|P1|COMPLETED|Overall Study||10
8192044|NCT02280408|20199211|P4|Vaccination 2|Overall Study||9
8192045|NCT02280408|20199212|P3|Vaccination 2|Overall Study||10
8192046|NCT02280408|20199213|P2|Vaccination 2|Overall Study||10
8192047|NCT02280408|20199214|P1|Vaccination 2|Overall Study||10
8192048|NCT02280408|20199211|P4|Vaccination 1|Overall Study||9
8192049|NCT02280408|20199212|P3|Vaccination 1|Overall Study||10
8192050|NCT02280408|20199213|P2|Vaccination 1|Overall Study||10
8192051|NCT02280408|20199214|P1|Vaccination 1|Overall Study||10
8192052|NCT02280408|20199211|P4|STARTED|Overall Study||9
8192053|NCT02280408|20199212|P3|STARTED|Overall Study||10
8192054|NCT02280408|20199213|P2|STARTED|Overall Study||10
8192055|NCT02280408|20199214|P1|STARTED|Overall Study||10
8192056|NCT02280304|20199286|P2|NOT COMPLETED|Overall Study||8
8192057|NCT02280304|20199287|P1|NOT COMPLETED|Overall Study||7
8192058|NCT02280304|20199286|P2|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
8192059|NCT02280304|20199287|P1|COMPLETED|Overall Study||12
8192060|NCT02280304|20199286|P2|STARTED|Overall Study||18
8192061|NCT02280304|20199287|P1|STARTED|Overall Study||19
8192062|NCT02280291|20199308|P4|NOT COMPLETED|Overall Study||8
8192063|NCT02280291|20199309|P3|NOT COMPLETED|Overall Study||3
8192064|NCT02280291|20199310|P2|NOT COMPLETED|Overall Study||2
8192065|NCT02280291|20199311|P1|NOT COMPLETED|Overall Study||4
8192066|NCT02280291|20199308|P4|COMPLETED|Overall Study||18
8192067|NCT02280291|20199309|P3|COMPLETED|Overall Study||21
8192068|NCT02280291|20199310|P2|COMPLETED|Overall Study||23
8192069|NCT02280291|20199311|P1|COMPLETED|Overall Study||21
8192070|NCT02280291|20199308|P4|STARTED|Overall Study||26
8192071|NCT02280291|20199309|P3|STARTED|Overall Study||24
8192072|NCT02280291|20199310|P2|STARTED|Overall Study||25
8192073|NCT02280291|20199311|P1|STARTED|Overall Study||25
8192074|NCT02280252|20199323|P1|NOT COMPLETED|Overall Study||0
8192075|NCT02280252|20199323|P1|COMPLETED|Overall Study||0
8192076|NCT02280252|20199323|P1|STARTED|Overall Study||0
8192077|NCT02280226|20199330|P1|NOT COMPLETED|Overall Study||0
8192078|NCT02280226|20199330|P1|COMPLETED|Overall Study||17
8192079|NCT02280226|20199330|P1|STARTED|Overall Study||17
8192080|NCT02280200|20199337|P2|NOT COMPLETED|Overall Study||3
8192081|NCT02280200|20199338|P1|NOT COMPLETED|Overall Study||3
8192082|NCT02280200|20199337|P2|COMPLETED|Overall Study||10
8192083|NCT02280200|20199338|P1|COMPLETED|Overall Study||12
8192084|NCT02280200|20199337|P2|STARTED|Overall Study||13
8192085|NCT02280200|20199338|P1|STARTED|Overall Study||15
8192086|NCT02280187|20199352|P1|NOT COMPLETED|Overall Study||218
8192087|NCT02280187|20199352|P1|COMPLETED|Overall Study||182
8192088|NCT02280187|20199352|P1|STARTED|Overall Study||400
8192089|NCT02280122|20199370|P3|NOT COMPLETED|Overall Study||0
8192090|NCT02280122|20199371|P2|NOT COMPLETED|Overall Study||0
8192091|NCT02280122|20199372|P1|NOT COMPLETED|Overall Study||0
8192092|NCT02280122|20199370|P3|COMPLETED|Overall Study||30
8192093|NCT02280122|20199371|P2|COMPLETED|Overall Study||15
8192094|NCT02280122|20199372|P1|COMPLETED|Overall Study||15
8192095|NCT02280122|20199370|P3|STARTED|Overall Study||30
8192096|NCT02280122|20199371|P2|STARTED|Overall Study||15
8192097|NCT02280122|20199372|P1|STARTED|Overall Study||15
8192098|NCT02280096|20199380|P2|NOT COMPLETED|Overall Study||1
8192099|NCT02280096|20199381|P1|NOT COMPLETED|Overall Study||2
8192100|NCT02280096|20199380|P2|COMPLETED|Overall Study||10
8192101|NCT02280096|20199381|P1|COMPLETED|Overall Study||11
8192102|NCT02280096|20199380|P2|STARTED|Overall Study||11
8192103|NCT02280096|20199381|P1|STARTED|Overall Study||13
8192104|NCT02280044|20199411|P2|NOT COMPLETED|Overall Study||2
8192105|NCT02280044|20199412|P1|NOT COMPLETED|Overall Study||0
8192106|NCT02280044|20199411|P2|COMPLETED|Overall Study||13
8192107|NCT02280044|20199412|P1|COMPLETED|Overall Study||15
8192108|NCT02280044|20199411|P2|STARTED|Overall Study||15
8192109|NCT02280044|20199412|P1|STARTED|Overall Study||15
8192110|NCT02279862|20199422|P2|NOT COMPLETED|Overall Study||25
8192111|NCT02279862|20199423|P1|NOT COMPLETED|Overall Study||26
8192112|NCT02279862|20199422|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
8192113|NCT02279862|20199423|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
8192114|NCT02279862|20199422|P2|Treated|Overall Study||26
8192115|NCT02279862|20199423|P1|Treated|Overall Study||25
8192116|NCT02279862|20199422|P2|STARTED|Overall Study||27
8192117|NCT02279862|20199423|P1|STARTED|Overall Study||26
8192118|NCT02279732|20199441|P2|NOT COMPLETED|Overall Study||106
8192119|NCT02279732|20199442|P1|NOT COMPLETED|Overall Study||98
8192120|NCT02279732|20199441|P2|COMPLETED|Overall Study||0
8192121|NCT02279732|20199442|P1|COMPLETED|Overall Study||0
8192122|NCT02279732|20199441|P2|STARTED|Overall Study||106
8192123|NCT02279732|20199442|P1|STARTED|Overall Study||98
8192124|NCT02279667|20199455|P3|NOT COMPLETED|Overall Study||0
8192125|NCT02279667|20199456|P2|NOT COMPLETED|Overall Study||0
8192126|NCT02279667|20199457|P1|NOT COMPLETED|Overall Study||0
8192127|NCT02279667|20199455|P3|COMPLETED|Overall Study||6
8192128|NCT02279667|20199456|P2|COMPLETED|Overall Study||6
8192129|NCT02279667|20199457|P1|COMPLETED|Overall Study||6
8192130|NCT02279667|20199455|P3|STARTED|Overall Study||6
8192131|NCT02279667|20199456|P2|STARTED|Overall Study||6
8192132|NCT02279667|20199457|P1|STARTED|Overall Study||6
8192133|NCT02279641|20199477|P2|NOT COMPLETED|Overall Study||0
8192134|NCT02279641|20199478|P1|NOT COMPLETED|Overall Study||0
8192135|NCT02279641|20199477|P2|COMPLETED|Overall Study||6
8192136|NCT02279641|20199478|P1|COMPLETED|Overall Study||6
8192137|NCT02279641|20199477|P2|STARTED|Overall Study||6
8192138|NCT02279641|20199478|P1|STARTED|Overall Study||6
8192139|NCT02279498|20199534|P2|NOT COMPLETED|Overall Study||4
8192140|NCT02279498|20199535|P1|NOT COMPLETED|Overall Study||18
8192141|NCT02279498|20199534|P2|COMPLETED|Overall Study||59
8192142|NCT02279498|20199535|P1|COMPLETED|Overall Study||47
8192143|NCT02279498|20199534|P2|STARTED|Overall Study||63
8192144|NCT02279498|20199535|P1|STARTED|Overall Study||65
8192145|NCT02279420|20199544|P1|NOT COMPLETED|Overall Study||23
8192146|NCT02279420|20199544|P1|COMPLETED|Overall Study||50
8192147|NCT02279420|20199544|P1|STARTED|Overall Study||73
8192148|NCT02279407|20199552|P4|NOT COMPLETED|Overall Study||1
8192149|NCT02279407|20199553|P3|NOT COMPLETED|Overall Study||5
8192150|NCT02279407|20199554|P2|NOT COMPLETED|Overall Study||1
8192151|NCT02279407|20199555|P1|NOT COMPLETED|Overall Study||2
8192152|NCT02279407|20199552|P4|COMPLETED|Overall Study||20
8192153|NCT02279407|20199553|P3|COMPLETED|Overall Study||15
8192154|NCT02279407|20199554|P2|COMPLETED|Overall Study||20
8192155|NCT02279407|20199555|P1|COMPLETED|Overall Study||20
8192156|NCT02279407|20199552|P4|STARTED|Overall Study||21
8192157|NCT02279407|20199553|P3|STARTED|Overall Study||20
8192158|NCT02279407|20199554|P2|STARTED|Overall Study||21
8192159|NCT02279407|20199555|P1|STARTED|Overall Study||22
8192160|NCT02279173|20199566|P1|NOT COMPLETED|Overall Study||94
8192161|NCT02279173|20199566|P1|COMPLETED|Overall Study||109
8192162|NCT02279173|20199566|P1|Enrolled Under Protocol Supplement|Overall Study||79
8192163|NCT02279173|20199566|P1|Received Treatment|Overall Study||203
8192164|NCT02279173|20199566|P1|STARTED|Overall Study||203
8192165|NCT02279160|20199585|P2|NOT COMPLETED|Overall Study||2
8192166|NCT02279160|20199586|P1|NOT COMPLETED|Overall Study||6
8192167|NCT02279160|20199585|P2|COMPLETED|Overall Study||19
8192168|NCT02279160|20199586|P1|COMPLETED|Overall Study||34
8192169|NCT02279160|20199585|P2|STARTED|Overall Study||21
8192170|NCT02279160|20199586|P1|STARTED|Overall Study||40
8192171|NCT02279108|20199596|P2|NOT COMPLETED|Overall Study||1
8192172|NCT02279108|20199597|P1|NOT COMPLETED|Overall Study||0
8192173|NCT02279108|20199596|P2|COMPLETED|Overall Study||49
8192174|NCT02279108|20199597|P1|COMPLETED|Overall Study||50
8192175|NCT02279108|20199596|P2|STARTED|Overall Study||50
8192176|NCT02279108|20199597|P1|STARTED|Overall Study||50
8192177|NCT02279082|20199619|P1|NOT COMPLETED|Overall Study||33
8192178|NCT02279082|20199619|P1|COMPLETED|Overall Study||134
8192179|NCT02279082|20199619|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
8192180|NCT02279043|20199626|P3|NOT COMPLETED|Overall Study||0
8192181|NCT02279043|20199627|P2|NOT COMPLETED|Overall Study||89
8192182|NCT02279043|20199628|P1|NOT COMPLETED|Overall Study||47
8192183|NCT02279043|20199626|P3|COMPLETED|Overall Study||140
8192184|NCT02279043|20199627|P2|COMPLETED|Overall Study||226
8192185|NCT02279043|20199628|P1|COMPLETED|Overall Study||128
8192186|NCT02279043|20199626|P3|STARTED|Overall Study||140
8192187|NCT02279043|20199627|P2|STARTED|Overall Study||315
8192188|NCT02279043|20199628|P1|STARTED|Overall Study||175
8192189|NCT02278952|20199658|P1|NOT COMPLETED|Overall Study||6
8192190|NCT02278952|20199658|P1|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
8192191|NCT02278952|20199658|P1|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
8192192|NCT02278939|20199670|P2|NOT COMPLETED|Overall Study||1
8192193|NCT02278939|20199671|P1|NOT COMPLETED|Overall Study||5
8192194|NCT02278939|20199670|P2|COMPLETED|Overall Study||33
8192195|NCT02278939|20199671|P1|COMPLETED|Overall Study||28
8192196|NCT02278939|20199670|P2|STARTED|Overall Study||34
8192197|NCT02278939|20199671|P1|STARTED|Overall Study||33
8192198|NCT02278783|20199683|P1|NOT COMPLETED|Overall Study||0
8192199|NCT02278783|20199683|P1|COMPLETED|Overall Study||1
8192200|NCT02278783|20199683|P1|STARTED|Overall Study||1
8192201|NCT02278640|20199690|P1|NOT COMPLETED|Overall Study||0
8192202|NCT02278640|20199690|P1|COMPLETED|Overall Study||40
8192203|NCT02278640|20199690|P1|STARTED|Overall Study||40
8192204|NCT02278614|20199699|P2|NOT COMPLETED|Overall Study||5
8192205|NCT02278614|20199700|P1|NOT COMPLETED|Overall Study||5
8192206|NCT02278614|20199699|P2|COMPLETED|Overall Study||110
8192207|NCT02278614|20199700|P1|COMPLETED|Overall Study||122
8192208|NCT02278614|20199699|P2|STARTED|Overall Study||115
8192209|NCT02278614|20199700|P1|STARTED|Overall Study||127
8192210|NCT02278562|20199709|P3|NOT COMPLETED|Overall Study||0
8192211|NCT02278562|20199710|P2|NOT COMPLETED|Overall Study||0
8192212|NCT02278562|20199711|P1|NOT COMPLETED|Overall Study||0
8192213|NCT02278562|20199709|P3|COMPLETED|Overall Study||8
8192214|NCT02278562|20199710|P2|COMPLETED|Overall Study||7
8192215|NCT02278562|20199711|P1|COMPLETED|Overall Study||9
8192216|NCT02278562|20199709|P3|STARTED|Overall Study||8
8192217|NCT02278562|20199710|P2|STARTED|Overall Study||7
8192218|NCT02278562|20199711|P1|STARTED|Overall Study||9
8192219|NCT02278484|20199725|P1|NOT COMPLETED|Overall Study||0
8192220|NCT02278484|20199725|P1|COMPLETED|Overall Study||50
8192221|NCT02278484|20199725|P1|STARTED|Overall Study||50
8192222|NCT02278471|20199734|P2|NOT COMPLETED|Overall Study||20
8192223|NCT02278471|20199735|P1|NOT COMPLETED|Overall Study||8
8192224|NCT02278471|20199734|P2|COMPLETED|Overall Study||128
8192225|NCT02278471|20199735|P1|COMPLETED|Overall Study||147
8192226|NCT02278471|20199734|P2|STARTED|Overall Study||148
8192227|NCT02278471|20199735|P1|STARTED|Overall Study||155
8192228|NCT02278367|20199753|P2|NOT COMPLETED|Overall Study||0
8192229|NCT02278367|20199754|P1|NOT COMPLETED|Overall Study||10
8192230|NCT02278367|20199753|P2|COMPLETED|Overall Study||110
8192231|NCT02278367|20199754|P1|COMPLETED|Overall Study||59
8192232|NCT02278367|20199753|P2|STARTED|Overall Study||110
8192233|NCT02278367|20199754|P1|STARTED|Overall Study||69
8192234|NCT02278354|20199764|P2|NOT COMPLETED|Overall Study||3
8192235|NCT02278354|20199765|P1|NOT COMPLETED|Overall Study||4
8192236|NCT02278354|20199764|P2|COMPLETED|Overall Study||20
8192237|NCT02278354|20199765|P1|COMPLETED|Overall Study||8
8192238|NCT02278354|20199764|P2|Flortaucipir PET Scan|Overall Study||20
8192239|NCT02278354|20199765|P1|Flortaucipir PET Scan|Overall Study||10
8192240|NCT02278354|20199764|P2|STARTED|Overall Study||23
8192241|NCT02278354|20199765|P1|STARTED|Overall Study||12
8192250|NCT02278328|20199874|P3|NOT COMPLETED|Third Washout (1 Week)||0
8192251|NCT02278328|20199875|P2|NOT COMPLETED|Third Washout (1 Week)||0
8192252|NCT02278328|20199876|P1|NOT COMPLETED|Third Washout (1 Week)||0
8192253|NCT02278328|20199874|P3|COMPLETED|Third Washout (1 Week)||6
8192254|NCT02278328|20199875|P2|COMPLETED|Third Washout (1 Week)||6
8192255|NCT02278328|20199876|P1|COMPLETED|Third Washout (1 Week)||9
8192256|NCT02278328|20199874|P3|STARTED|Third Washout (1 Week)||6
8192257|NCT02278328|20199875|P2|STARTED|Third Washout (1 Week)||6
8192258|NCT02278328|20199876|P1|STARTED|Third Washout (1 Week)||9
8192259|NCT02278328|20199874|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8192260|NCT02278328|20199875|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8192261|NCT02278328|20199876|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8192262|NCT02278328|20199874|P3|COMPLETED|Third Intervention (1 Day)||6
8192263|NCT02278328|20199875|P2|COMPLETED|Third Intervention (1 Day)||6
8192264|NCT02278328|20199876|P1|COMPLETED|Third Intervention (1 Day)||9
8192265|NCT02278328|20199874|P3|STARTED|Third Intervention (1 Day)||6
8192266|NCT02278328|20199875|P2|STARTED|Third Intervention (1 Day)||6
8192267|NCT02278328|20199876|P1|STARTED|Third Intervention (1 Day)||9
8192268|NCT02278328|20199874|P3|NOT COMPLETED|Second Washout (1 Week)||0
8192269|NCT02278328|20199875|P2|NOT COMPLETED|Second Washout (1 Week)||0
8192270|NCT02278328|20199876|P1|NOT COMPLETED|Second Washout (1 Week)||0
8192271|NCT02278328|20199874|P3|COMPLETED|Second Washout (1 Week)||6
8192272|NCT02278328|20199875|P2|COMPLETED|Second Washout (1 Week)||6
8192273|NCT02278328|20199876|P1|COMPLETED|Second Washout (1 Week)||9
8192274|NCT02278328|20199874|P3|STARTED|Second Washout (1 Week)||6
8192275|NCT02278328|20199875|P2|STARTED|Second Washout (1 Week)||6
8192276|NCT02278328|20199876|P1|STARTED|Second Washout (1 Week)||9
8192277|NCT02278328|20199874|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8192278|NCT02278328|20199875|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8192279|NCT02278328|20199876|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8192280|NCT02278328|20199874|P3|COMPLETED|Second Intervention (1 Day)||6
8192281|NCT02278328|20199875|P2|COMPLETED|Second Intervention (1 Day)||6
8192282|NCT02278328|20199876|P1|COMPLETED|Second Intervention (1 Day)||9
8192283|NCT02278328|20199874|P3|STARTED|Second Intervention (1 Day)||6
8192284|NCT02278328|20199875|P2|STARTED|Second Intervention (1 Day)||6
8192285|NCT02278328|20199876|P1|STARTED|Second Intervention (1 Day)||9
8192286|NCT02278328|20199874|P3|NOT COMPLETED|Washout (1 Week)||0
8192287|NCT02278328|20199875|P2|NOT COMPLETED|Washout (1 Week)||0
8192288|NCT02278328|20199876|P1|NOT COMPLETED|Washout (1 Week)||0
8192289|NCT02278328|20199874|P3|COMPLETED|Washout (1 Week)||6
8192290|NCT02278328|20199875|P2|COMPLETED|Washout (1 Week)||6
8192291|NCT02278328|20199876|P1|COMPLETED|Washout (1 Week)||9
8192292|NCT02278328|20199874|P3|STARTED|Washout (1 Week)||6
8192293|NCT02278328|20199875|P2|STARTED|Washout (1 Week)||6
8192294|NCT02278328|20199876|P1|STARTED|Washout (1 Week)||9
8192295|NCT02278328|20199874|P3|NOT COMPLETED|First Intervention (1 Day)||0
8192296|NCT02278328|20199875|P2|NOT COMPLETED|First Intervention (1 Day)||0
8192297|NCT02278328|20199876|P1|NOT COMPLETED|First Intervention (1 Day)||0
8192298|NCT02278328|20199874|P3|COMPLETED|First Intervention (1 Day)||6
8192299|NCT02278328|20199875|P2|COMPLETED|First Intervention (1 Day)||6
8192300|NCT02278328|20199876|P1|COMPLETED|First Intervention (1 Day)||9
8192301|NCT02278328|20199874|P3|STARTED|First Intervention (1 Day)||6
8192302|NCT02278328|20199875|P2|STARTED|First Intervention (1 Day)||6
8192303|NCT02278328|20199876|P1|STARTED|First Intervention (1 Day)||9
8192304|NCT02278328|20199874|P3|NOT COMPLETED|Neuropsych Screening||2
8192305|NCT02278328|20199875|P2|NOT COMPLETED|Neuropsych Screening||1
8192306|NCT02278328|20199876|P1|NOT COMPLETED|Neuropsych Screening||1
8192307|NCT02278328|20199874|P3|COMPLETED|Neuropsych Screening||6
8192308|NCT02278328|20199875|P2|COMPLETED|Neuropsych Screening||6
8192309|NCT02278328|20199876|P1|COMPLETED|Neuropsych Screening||9
8192310|NCT02278328|20199874|P3|STARTED|Neuropsych Screening||8
8192311|NCT02278328|20199875|P2|STARTED|Neuropsych Screening||7
8192312|NCT02278328|20199876|P1|STARTED|Neuropsych Screening||10
8192313|NCT02278263|20199889|P3|NOT COMPLETED|Overall Study||9
8192314|NCT02278263|20199890|P2|NOT COMPLETED|Overall Study||0
8192315|NCT02278263|20199891|P1|NOT COMPLETED|Overall Study||7
8192316|NCT02278263|20199889|P3|COMPLETED|Overall Study||51
8192317|NCT02278263|20199890|P2|COMPLETED|Overall Study|Correction|60
8192318|NCT02278263|20199891|P1|COMPLETED|Overall Study||23
8192319|NCT02278263|20199889|P3|STARTED|Overall Study||60
8192320|NCT02278263|20199890|P2|STARTED|Overall Study||60
8192321|NCT02278263|20199891|P1|STARTED|Overall Study||30
8192322|NCT02278237|20199917|P1|NOT COMPLETED|Overall Study||7
8192323|NCT02278237|20199917|P1|COMPLETED|Overall Study||83
8192324|NCT02278237|20199917|P1|STARTED|Overall Study||90
8192325|NCT02278146|20199923|P2|NOT COMPLETED|Overall Study||2
8192326|NCT02278146|20199924|P1|NOT COMPLETED|Overall Study||0
8192327|NCT02278146|20199923|P2|COMPLETED|Overall Study||8
8192328|NCT02278146|20199924|P1|COMPLETED|Overall Study||6
8192329|NCT02278146|20199923|P2|STARTED|Overall Study||10
8192330|NCT02278146|20199924|P1|STARTED|Overall Study||6
8192331|NCT02278120|20199936|P2|NOT COMPLETED|Overall Study||216
8192332|NCT02278120|20199937|P1|NOT COMPLETED|Overall Study||161
8192333|NCT02278120|20199936|P2|COMPLETED|Overall Study||121
8192334|NCT02278120|20199937|P1|COMPLETED|Overall Study||174
8192335|NCT02278120|20199936|P2|STARTED|Overall Study||337
8192336|NCT02278120|20199937|P1|STARTED|Overall Study||335
8192337|NCT02278003|20199953|P2|NOT COMPLETED|Overall Study||0
8192338|NCT02278003|20199954|P1|NOT COMPLETED|Overall Study||19
8192339|NCT02278003|20199953|P2|COMPLETED|Overall Study||20
8192340|NCT02278003|20199954|P1|COMPLETED|Overall Study||30
8192341|NCT02278003|20199953|P2|STARTED|Overall Study||20
8192342|NCT02278003|20199954|P1|STARTED|Overall Study||49
8192343|NCT02277990|20199964|P2|NOT COMPLETED|Overall Study||376
8192344|NCT02277990|20199965|P1|NOT COMPLETED|Overall Study||366
8192345|NCT02277990|20199964|P2|COMPLETED|Overall Study||3112
8192346|NCT02277990|20199965|P1|COMPLETED|Overall Study||3129
8192347|NCT02277990|20199964|P2|STARTED|Overall Study||3488
8192348|NCT02277990|20199965|P1|STARTED|Overall Study||3495
8192349|NCT02277925|20199979|P2|NOT COMPLETED|Overall Study||15
8192350|NCT02277925|20199980|P1|NOT COMPLETED|Overall Study||7
8192351|NCT02277925|20199979|P2|COMPLETED|Overall Study||87
8192352|NCT02277925|20199980|P1|COMPLETED|Overall Study||95
8192353|NCT02277925|20199979|P2|Surgery|Overall Study||101
8192354|NCT02277925|20199980|P1|Surgery|Overall Study||99
8192355|NCT02277925|20199979|P2|STARTED|Overall Study||102
8192356|NCT02277925|20199980|P1|STARTED|Overall Study||102
8192357|NCT02277769|20199993|P3|NOT COMPLETED|Overall Study||18
8192358|NCT02277769|20199994|P2|NOT COMPLETED|Overall Study||13
8192359|NCT02277769|20199995|P1|NOT COMPLETED|Overall Study||46
8192360|NCT02277769|20199993|P3|COMPLETED|Overall Study||221
8192361|NCT02277769|20199994|P2|COMPLETED|Overall Study||220
8192362|NCT02277769|20199995|P1|COMPLETED|Overall Study||190
8192363|NCT02277769|20199993|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
8192364|NCT02277769|20199994|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
8192365|NCT02277769|20199995|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
8192366|NCT02277769|20199993|P3|Treated|Overall Study||239
8192367|NCT02277769|20199994|P2|Treated|Overall Study||233
8192368|NCT02277769|20199995|P1|Treated|Overall Study||235
8192369|NCT02277769|20199993|P3|STARTED|Overall Study||239
8192370|NCT02277769|20199994|P2|STARTED|Overall Study||233
8192371|NCT02277769|20199995|P1|STARTED|Overall Study||236
8192372|NCT02277743|20200066|P3|NOT COMPLETED|Overall Study||26
8192373|NCT02277743|20200067|P2|NOT COMPLETED|Overall Study||16
8192374|NCT02277743|20200068|P1|NOT COMPLETED|Overall Study||40
8192375|NCT02277743|20200066|P3|COMPLETED|Overall Study||197
8192376|NCT02277743|20200067|P2|COMPLETED|Overall Study||208
8192377|NCT02277743|20200068|P1|COMPLETED|Overall Study||184
8192378|NCT02277743|20200066|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
8192379|NCT02277743|20200067|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
8192380|NCT02277743|20200068|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
8192381|NCT02277743|20200066|P3|Treated|Overall Study||223
8192382|NCT02277743|20200067|P2|Treated|Overall Study||223
8192383|NCT02277743|20200068|P1|Treated|Overall Study||223
8192384|NCT02277743|20200066|P3|STARTED|Overall Study||223
8192385|NCT02277743|20200067|P2|STARTED|Overall Study||224
8192386|NCT02277743|20200068|P1|STARTED|Overall Study||224
8192387|NCT02277691|20200136|P1|NOT COMPLETED|Overall Study||46
8192388|NCT02277691|20200136|P1|COMPLETED|Overall Study||295
8192389|NCT02277691|20200136|P1|STARTED|Overall Study||341
8192390|NCT02277665|20200148|P2|NOT COMPLETED|Overall Study||0
8192391|NCT02277665|20200149|P1|NOT COMPLETED|Overall Study||0
8192392|NCT02277665|20200148|P2|COMPLETED|Overall Study||34
8192393|NCT02277665|20200149|P1|COMPLETED|Overall Study||33
8192394|NCT02277665|20200148|P2|STARTED|Overall Study||34
8192395|NCT02277665|20200149|P1|STARTED|Overall Study||33
8192396|NCT02277639|20200167|P2|NOT COMPLETED|Overall Study||0
8192397|NCT02277639|20200168|P1|NOT COMPLETED|Overall Study||0
8192398|NCT02277639|20200167|P2|COMPLETED|Overall Study||2
8192399|NCT02277639|20200168|P1|COMPLETED|Overall Study||0
8192400|NCT02277639|20200167|P2|STARTED|Overall Study||2
8192401|NCT02277639|20200168|P1|STARTED|Overall Study||0
8192402|NCT02277626|20200174|P2|NOT COMPLETED|Overall Study||0
8192403|NCT02277626|20200175|P1|NOT COMPLETED|Overall Study||0
8192404|NCT02277626|20200174|P2|COMPLETED|Overall Study||9
8192405|NCT02277626|20200175|P1|COMPLETED|Overall Study||6
8192406|NCT02277626|20200174|P2|STARTED|Overall Study||9
8192407|NCT02277626|20200175|P1|STARTED|Overall Study||6
8192408|NCT02277548|20200191|P2|NOT COMPLETED|Overall Study||2
8192409|NCT02277548|20200192|P1|NOT COMPLETED|Overall Study||0
8192410|NCT02277548|20200191|P2|COMPLETED|Overall Study||9
8192411|NCT02277548|20200192|P1|COMPLETED|Overall Study||9
8192412|NCT02277548|20200191|P2|STARTED|Overall Study||11
8192413|NCT02277548|20200192|P1|STARTED|Overall Study||9
8192414|NCT02277444|20200198|P1|NOT COMPLETED|Overall Study||130
8192415|NCT02277444|20200198|P1|COMPLETED|Overall Study||0
8192416|NCT02277444|20200198|P1|Treated|Overall Study||127
8192417|NCT02277444|20200198|P1|STARTED|Overall Study||130
8192418|NCT02277249|20200207|P2|NOT COMPLETED|Overall Study||0
8192419|NCT02277249|20200208|P1|NOT COMPLETED|Overall Study||0
8192420|NCT02277249|20200207|P2|COMPLETED|Overall Study||30
8192421|NCT02277249|20200208|P1|COMPLETED|Overall Study||30
8192422|NCT02277249|20200207|P2|STARTED|Overall Study||30
8192423|NCT02277249|20200208|P1|STARTED|Overall Study||30
8192424|NCT02277119|20200217|P3|NOT COMPLETED|Overall Study||8
8192425|NCT02277119|20200218|P2|NOT COMPLETED|Overall Study||4
8192426|NCT02277119|20200219|P1|NOT COMPLETED|Overall Study||3
8192427|NCT02277119|20200217|P3|COMPLETED|Overall Study||19
8192428|NCT02277119|20200218|P2|COMPLETED|Overall Study||20
8192429|NCT02277119|20200219|P1|COMPLETED|Overall Study||55
8192430|NCT02277119|20200217|P3|STARTED|Overall Study||27
8192431|NCT02277119|20200218|P2|STARTED|Overall Study||24
8192432|NCT02277119|20200219|P1|STARTED|Overall Study||58
8192433|NCT02277093|20200236|P1|NOT COMPLETED|Overall Study||0
8192434|NCT02277093|20200236|P1|COMPLETED|Overall Study||11
8192435|NCT02277093|20200236|P1|STARTED|Overall Study||11
8192436|NCT02277054|20200244|P1|NOT COMPLETED|Overall Study||0
8192437|NCT02277054|20200244|P1|COMPLETED|Overall Study||5
8192438|NCT02277054|20200244|P1|STARTED|Overall Study||5
8192439|NCT02276963|20200250|P1|NOT COMPLETED|Overall Study||3
8192440|NCT02276963|20200250|P1|COMPLETED|Overall Study||3
8192441|NCT02276963|20200250|P1|STARTED|Overall Study||6
8192442|NCT02276872|20200257|P3|NOT COMPLETED|Overall Study||0
8192443|NCT02276872|20200258|P2|NOT COMPLETED|Overall Study||0
8192444|NCT02276872|20200259|P1|NOT COMPLETED|Overall Study||1
8192445|NCT02276872|20200257|P3|COMPLETED|Overall Study||12
8192446|NCT02276872|20200258|P2|COMPLETED|Overall Study||10
8192447|NCT02276872|20200259|P1|COMPLETED|Overall Study||9
8192448|NCT02276872|20200257|P3|STARTED|Overall Study||12
8192449|NCT02276872|20200258|P2|STARTED|Overall Study||10
8192450|NCT02276872|20200259|P1|STARTED|Overall Study||10
8192451|NCT02276807|20200335|P2|NOT COMPLETED|Overall Study||17
8192452|NCT02276807|20200336|P1|NOT COMPLETED|Overall Study||18
8192453|NCT02276807|20200335|P2|COMPLETED|Overall Study||55
8192454|NCT02276807|20200336|P1|COMPLETED|Overall Study||50
8192455|NCT02276807|20200335|P2|12-week Assessment|Overall Study||63
8192456|NCT02276807|20200336|P1|12-week Assessment|Overall Study||57
8192457|NCT02276807|20200335|P2|STARTED|Overall Study||72
8192458|NCT02276807|20200336|P1|STARTED|Overall Study||68
8192459|NCT02276638|20200353|P3|NOT COMPLETED|Overall Study||0
8192460|NCT02276638|20200354|P2|NOT COMPLETED|Overall Study||0
8192461|NCT02276638|20200355|P1|NOT COMPLETED|Overall Study||0
8192462|NCT02276638|20200353|P3|COMPLETED|Overall Study||23
8192463|NCT02276638|20200354|P2|COMPLETED|Overall Study||28
8192464|NCT02276638|20200355|P1|COMPLETED|Overall Study||28
8192465|NCT02276638|20200353|P3|STARTED|Overall Study||23
8192466|NCT02276638|20200354|P2|STARTED|Overall Study||28
8192467|NCT02276638|20200355|P1|STARTED|Overall Study||28
8192468|NCT02276612|20200371|P2|NOT COMPLETED|Overall Study||0
8192469|NCT02276612|20200372|P1|NOT COMPLETED|Overall Study||4
8192470|NCT02276612|20200371|P2|COMPLETED|Overall Study||10
8192471|NCT02276612|20200372|P1|COMPLETED|Overall Study||46
8192472|NCT02276612|20200371|P2|STARTED|Overall Study||10
8192473|NCT02276612|20200372|P1|STARTED|Overall Study||50
8192474|NCT02276560|20200395|P3|NOT COMPLETED|Overall Study||0
8192475|NCT02276560|20200396|P2|NOT COMPLETED|Overall Study||0
8192476|NCT02276560|20200397|P1|NOT COMPLETED|Overall Study||1
8192477|NCT02276560|20200395|P3|COMPLETED|Overall Study||0
8192478|NCT02276560|20200396|P2|COMPLETED|Overall Study||0
8192479|NCT02276560|20200397|P1|COMPLETED|Overall Study||0
8192480|NCT02276560|20200395|P3|STARTED|Overall Study||0
8192481|NCT02276560|20200396|P2|STARTED|Overall Study||0
8192482|NCT02276560|20200397|P1|STARTED|Overall Study||1
8192483|NCT02276482|20200407|P2|NOT COMPLETED|Overall Study||1
8192484|NCT02276482|20200408|P1|NOT COMPLETED|Overall Study||3
8192485|NCT02276482|20200407|P2|COMPLETED|Overall Study||28
8192486|NCT02276482|20200408|P1|COMPLETED|Overall Study||88
8192487|NCT02276482|20200407|P2|STARTED|Overall Study||29
8192488|NCT02276482|20200408|P1|STARTED|Overall Study||91
8192489|NCT02276274|20200432|P2|NOT COMPLETED|Second Intervention Period||0
8192490|NCT02276274|20200433|P1|NOT COMPLETED|Second Intervention Period||0
8192491|NCT02276274|20200432|P2|COMPLETED|Second Intervention Period||6
8192492|NCT02276274|20200433|P1|COMPLETED|Second Intervention Period||6
8192493|NCT02276274|20200432|P2|STARTED|Second Intervention Period||6
8192494|NCT02276274|20200433|P1|STARTED|Second Intervention Period||6
8192495|NCT02276274|20200432|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
8192496|NCT02276274|20200433|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
8192497|NCT02276274|20200432|P2|COMPLETED|Washout Period (at Least 15 Days)||6
8192498|NCT02276274|20200433|P1|COMPLETED|Washout Period (at Least 15 Days)||6
8192499|NCT02276274|20200432|P2|STARTED|Washout Period (at Least 15 Days)||6
8192500|NCT02276274|20200433|P1|STARTED|Washout Period (at Least 15 Days)||6
8192501|NCT02276274|20200432|P2|NOT COMPLETED|First Intervention Period||0
8192502|NCT02276274|20200433|P1|NOT COMPLETED|First Intervention Period||0
8192503|NCT02276274|20200432|P2|COMPLETED|First Intervention Period||6
8192504|NCT02276274|20200433|P1|COMPLETED|First Intervention Period||6
8192505|NCT02276274|20200432|P2|STARTED|First Intervention Period||6
8192506|NCT02276274|20200433|P1|STARTED|First Intervention Period||6
8192507|NCT02276222|20200543|P2|NOT COMPLETED|Overall Study||64
8192508|NCT02276222|20200544|P1|NOT COMPLETED|Overall Study||185
8192509|NCT02276222|20200543|P2|COMPLETED|Overall Study||402
8192510|NCT02276222|20200544|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
8192511|NCT02276222|20200543|P2|STARTED|Overall Study||466
8192512|NCT02276222|20200544|P1|STARTED|Overall Study||621
8192513|NCT02276053|20200568|P1|NOT COMPLETED|Overall Study||14
8192514|NCT02276053|20200568|P1|COMPLETED|Overall Study||79
8192515|NCT02276053|20200568|P1|STARTED|Overall Study||93
8192516|NCT02276040|20200584|P1|NOT COMPLETED|Overall Study||15
8192517|NCT02276040|20200584|P1|COMPLETED|Overall Study||11
8192518|NCT02276040|20200584|P1|STARTED|Overall Study||26
8192519|NCT02276027|20200592|P4|NOT COMPLETED|Overall Study||22
8192520|NCT02276027|20200593|P3|NOT COMPLETED|Overall Study||20
8192521|NCT02276027|20200594|P2|NOT COMPLETED|Overall Study||16
8192522|NCT02276027|20200595|P1|NOT COMPLETED|Overall Study||2
8192523|NCT02276027|20200592|P4|COMPLETED|Overall Study||0
8192524|NCT02276027|20200593|P3|COMPLETED|Overall Study||6
8192525|NCT02276027|20200594|P2|COMPLETED|Overall Study||0
8192526|NCT02276027|20200595|P1|COMPLETED|Overall Study||0
8192527|NCT02276027|20200592|P4|STARTED|Overall Study||22
8192528|NCT02276027|20200593|P3|STARTED|Overall Study||26
8192529|NCT02276027|20200594|P2|STARTED|Overall Study||16
8192530|NCT02276027|20200595|P1|STARTED|Overall Study||2
8192531|NCT02275923|20200637|P1|NOT COMPLETED|Overall Study||2
8192532|NCT02275923|20200637|P1|COMPLETED|Overall Study||7
8192533|NCT02275923|20200637|P1|STARTED|Overall Study||9
8192548|NCT02275767|20200684|P3|NOT COMPLETED|Overall Study||3
8192549|NCT02275767|20200685|P2|NOT COMPLETED|Overall Study||4
8192550|NCT02275767|20200686|P1|NOT COMPLETED|Overall Study||2
8192551|NCT02275767|20200684|P3|COMPLETED|Overall Study||19
8192552|NCT02275767|20200685|P2|COMPLETED|Overall Study||18
8192553|NCT02275767|20200686|P1|COMPLETED|Overall Study||20
8192554|NCT02275767|20200684|P3|STARTED|Overall Study||22
8192555|NCT02275767|20200685|P2|STARTED|Overall Study||22
8192556|NCT02275767|20200686|P1|STARTED|Overall Study||22
8192557|NCT02275611|20200701|P4|NOT COMPLETED|Outpatient Drinking||0
8192558|NCT02275611|20200702|P3|NOT COMPLETED|Outpatient Drinking||0
8192559|NCT02275611|20200703|P2|NOT COMPLETED|Outpatient Drinking||0
8192560|NCT02275611|20200704|P1|NOT COMPLETED|Outpatient Drinking||0
8192561|NCT02275611|20200701|P4|COMPLETED|Outpatient Drinking||3
8192562|NCT02275611|20200702|P3|COMPLETED|Outpatient Drinking||6
8192563|NCT02275611|20200703|P2|COMPLETED|Outpatient Drinking||0
8192564|NCT02275611|20200704|P1|COMPLETED|Outpatient Drinking||0
8192565|NCT02275611|20200701|P4|STARTED|Outpatient Drinking||3
8192566|NCT02275611|20200702|P3|STARTED|Outpatient Drinking||6
8192567|NCT02275611|20200703|P2|STARTED|Outpatient Drinking||0
8192568|NCT02275611|20200704|P1|STARTED|Outpatient Drinking||0
8192569|NCT02275611|20200701|P4|NOT COMPLETED|Inpatient Withdrawal||0
8192570|NCT02275611|20200702|P3|NOT COMPLETED|Inpatient Withdrawal||0
8192571|NCT02275611|20200703|P2|NOT COMPLETED|Inpatient Withdrawal||0
8192572|NCT02275611|20200704|P1|NOT COMPLETED|Inpatient Withdrawal||1
8192573|NCT02275611|20200701|P4|COMPLETED|Inpatient Withdrawal||0
8192574|NCT02275611|20200702|P3|COMPLETED|Inpatient Withdrawal||0
8192575|NCT02275611|20200703|P2|COMPLETED|Inpatient Withdrawal||4
8192576|NCT02275611|20200704|P1|COMPLETED|Inpatient Withdrawal||4
8192577|NCT02275611|20200701|P4|STARTED|Inpatient Withdrawal||0
8192578|NCT02275611|20200702|P3|STARTED|Inpatient Withdrawal||0
8192579|NCT02275611|20200703|P2|STARTED|Inpatient Withdrawal||4
8192580|NCT02275611|20200704|P1|STARTED|Inpatient Withdrawal||5
8192581|NCT02275546|20200716|P2|NOT COMPLETED|Treatment Period 2||2
8192582|NCT02275546|20200717|P1|NOT COMPLETED|Treatment Period 2||2
8192583|NCT02275546|20200716|P2|COMPLETED|Treatment Period 2||81
8192584|NCT02275546|20200717|P1|COMPLETED|Treatment Period 2||79
8192585|NCT02275546|20200716|P2|STARTED|Treatment Period 2||83
8192586|NCT02275546|20200717|P1|STARTED|Treatment Period 2||81
8192587|NCT02275546|20200716|P2|NOT COMPLETED|Treatment Period 1||0
8192588|NCT02275546|20200717|P1|NOT COMPLETED|Treatment Period 1||0
8192589|NCT02275546|20200716|P2|COMPLETED|Treatment Period 1||83
8192590|NCT02275546|20200717|P1|COMPLETED|Treatment Period 1||81
8192591|NCT02275546|20200716|P2|STARTED|Treatment Period 1||83
8192592|NCT02275546|20200717|P1|STARTED|Treatment Period 1||81
8192593|NCT02275481|20200727|P2|NOT COMPLETED|Overall Study||3
8192594|NCT02275481|20200728|P1|NOT COMPLETED|Overall Study||9
8192595|NCT02275481|20200727|P2|COMPLETED|Overall Study||31
8192596|NCT02275481|20200728|P1|COMPLETED|Overall Study||23
8192597|NCT02275481|20200727|P2|STARTED|Overall Study||34
8192598|NCT02275481|20200728|P1|STARTED|Overall Study||32
8192599|NCT02275364|20200734|P2|NOT COMPLETED|Period 4||0
8192600|NCT02275364|20200735|P1|NOT COMPLETED|Period 4||0
8192601|NCT02275364|20200734|P2|COMPLETED|Period 4||14
8192602|NCT02275364|20200735|P1|COMPLETED|Period 4||12
8192603|NCT02275364|20200734|P2|STARTED|Period 4||14
8192604|NCT02275364|20200735|P1|STARTED|Period 4||12
8192605|NCT02275364|20200734|P2|NOT COMPLETED|Period 3||0
8192606|NCT02275364|20200735|P1|NOT COMPLETED|Period 3||0
8192607|NCT02275364|20200734|P2|COMPLETED|Period 3||14
8192608|NCT02275364|20200735|P1|COMPLETED|Period 3||12
8192609|NCT02275364|20200734|P2|STARTED|Period 3||14
8192610|NCT02275364|20200735|P1|STARTED|Period 3||12
8192611|NCT02275364|20200734|P2|NOT COMPLETED|Washout Period 2||0
8192612|NCT02275364|20200735|P1|NOT COMPLETED|Washout Period 2||0
8192613|NCT02275364|20200734|P2|COMPLETED|Washout Period 2||14
8192614|NCT02275364|20200735|P1|COMPLETED|Washout Period 2||12
8192615|NCT02275364|20200734|P2|STARTED|Washout Period 2||14
8192616|NCT02275364|20200735|P1|STARTED|Washout Period 2||12
8192617|NCT02275364|20200734|P2|NOT COMPLETED|Period 2||0
8192618|NCT02275364|20200735|P1|NOT COMPLETED|Period 2||0
8192619|NCT02275364|20200734|P2|COMPLETED|Period 2||14
8192620|NCT02275364|20200735|P1|COMPLETED|Period 2||12
8192621|NCT02275364|20200734|P2|STARTED|Period 2||14
8192622|NCT02275364|20200735|P1|STARTED|Period 2||12
8192623|NCT02275364|20200734|P2|NOT COMPLETED|Washout Period 1||0
8192624|NCT02275364|20200735|P1|NOT COMPLETED|Washout Period 1||0
8192625|NCT02275364|20200734|P2|COMPLETED|Washout Period 1||14
8192626|NCT02275364|20200735|P1|COMPLETED|Washout Period 1||12
8192627|NCT02275364|20200734|P2|STARTED|Washout Period 1||14
8192628|NCT02275364|20200735|P1|STARTED|Washout Period 1||12
8192629|NCT02275364|20200734|P2|NOT COMPLETED|Period 1||0
8192630|NCT02275364|20200735|P1|NOT COMPLETED|Period 1||2
8192631|NCT02275364|20200734|P2|COMPLETED|Period 1||14
8192632|NCT02275364|20200735|P1|COMPLETED|Period 1||12
8192633|NCT02275364|20200734|P2|STARTED|Period 1||14
8192634|NCT02275364|20200735|P1|STARTED|Period 1||14
8192635|NCT02275338|20200764|P1|NOT COMPLETED|Overall Study||33
8192636|NCT02275338|20200764|P1|COMPLETED|Overall Study||19
8192637|NCT02275338|20200764|P1|Started Phase 2|Overall Study||21
8192638|NCT02275338|20200764|P1|Completed Phase 1|Overall Study||25
8192639|NCT02275338|20200764|P1|STARTED|Overall Study||52
8192640|NCT02275156|20200779|P3|NOT COMPLETED|Overall Study||0
8192641|NCT02275156|20200780|P2|NOT COMPLETED|Overall Study||0
8192642|NCT02275156|20200781|P1|NOT COMPLETED|Overall Study||0
8192643|NCT02275156|20200779|P3|COMPLETED|Overall Study||6
8192644|NCT02275156|20200780|P2|COMPLETED|Overall Study||6
8192645|NCT02275156|20200781|P1|COMPLETED|Overall Study||6
8192646|NCT02275156|20200779|P3|STARTED|Overall Study||6
8192647|NCT02275156|20200780|P2|STARTED|Overall Study||6
8192648|NCT02275156|20200781|P1|STARTED|Overall Study||6
8192649|NCT02275117|20200813|P5|NOT COMPLETED|Overall Study||36
8192650|NCT02275117|20200814|P4|NOT COMPLETED|Overall Study||33
8192651|NCT02275117|20200815|P3|NOT COMPLETED|Overall Study||42
8192652|NCT02275117|20200816|P2|NOT COMPLETED|Overall Study||37
8192653|NCT02275117|20200817|P1|NOT COMPLETED|Overall Study||34
8192654|NCT02275117|20200813|P5|COMPLETED|Overall Study||98
8192655|NCT02275117|20200814|P4|COMPLETED|Overall Study||100
8192656|NCT02275117|20200815|P3|COMPLETED|Overall Study||92
8192657|NCT02275117|20200816|P2|COMPLETED|Overall Study||96
8192658|NCT02275117|20200817|P1|COMPLETED|Overall Study||97
8192659|NCT02275117|20200813|P5|Randomized and Treated|Overall Study||121
8192660|NCT02275117|20200814|P4|Randomized and Treated|Overall Study||130
8192661|NCT02275117|20200815|P3|Randomized and Treated|Overall Study||122
8192662|NCT02275117|20200816|P2|Randomized and Treated|Overall Study||123
8192663|NCT02275117|20200817|P1|Randomized and Treated|Overall Study||120
8192664|NCT02275117|20200813|P5|STARTED|Overall Study||134
8192665|NCT02275117|20200814|P4|STARTED|Overall Study||133
8192666|NCT02275117|20200815|P3|STARTED|Overall Study||134
8192667|NCT02275117|20200816|P2|STARTED|Overall Study||133
8192668|NCT02275117|20200817|P1|STARTED|Overall Study||131
8192669|NCT02275065|20200929|P5|NOT COMPLETED|Overall Study||0
8192670|NCT02275065|20200930|P4|NOT COMPLETED|Overall Study||1
8192671|NCT02275065|20200931|P3|NOT COMPLETED|Overall Study||1
8192672|NCT02275065|20200932|P2|NOT COMPLETED|Overall Study||0
8192673|NCT02275065|20200933|P1|NOT COMPLETED|Overall Study||1
8192674|NCT02275065|20200929|P5|COMPLETED|Overall Study||4
8192675|NCT02275065|20200930|P4|COMPLETED|Overall Study||4
8192676|NCT02275065|20200931|P3|COMPLETED|Overall Study||4
8192677|NCT02275065|20200932|P2|COMPLETED|Overall Study||4
8192678|NCT02275065|20200933|P1|COMPLETED|Overall Study||4
8192679|NCT02275065|20200929|P5|STARTED|Overall Study||4
8192680|NCT02275065|20200930|P4|STARTED|Overall Study||5
8192681|NCT02275065|20200931|P3|STARTED|Overall Study||5
8192682|NCT02275065|20200932|P2|STARTED|Overall Study||4
8192683|NCT02275065|20200933|P1|STARTED|Overall Study||5
8192684|NCT02275052|20201014|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
8192685|NCT02275052|20201015|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
8192686|NCT02275052|20201016|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192687|NCT02275052|20201017|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192688|NCT02275052|20201014|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
8192689|NCT02275052|20201015|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
8192690|NCT02275052|20201016|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192691|NCT02275052|20201017|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192692|NCT02275052|20201014|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
8192693|NCT02275052|20201015|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
8192694|NCT02275052|20201016|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
8192695|NCT02275052|20201017|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
8192696|NCT02275052|20201014|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
8192697|NCT02275052|20201015|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
8192698|NCT02275052|20201016|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
8192699|NCT02275052|20201017|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
8192700|NCT02275052|20201014|P4|COMPLETED|Washout Period (12-17 Days)||0
8192701|NCT02275052|20201015|P3|COMPLETED|Washout Period (12-17 Days)||0
8192702|NCT02275052|20201016|P2|COMPLETED|Washout Period (12-17 Days)||93
8192703|NCT02275052|20201017|P1|COMPLETED|Washout Period (12-17 Days)||86
8192704|NCT02275052|20201014|P4|STARTED|Washout Period (12-17 Days)||0
8192705|NCT02275052|20201015|P3|STARTED|Washout Period (12-17 Days)||0
8192706|NCT02275052|20201016|P2|STARTED|Washout Period (12-17 Days)||93
8192707|NCT02275052|20201017|P1|STARTED|Washout Period (12-17 Days)||90
8192708|NCT02275052|20201014|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192709|NCT02275052|20201015|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192710|NCT02275052|20201016|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
8192711|NCT02275052|20201017|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
8192712|NCT02275052|20201014|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192713|NCT02275052|20201015|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192714|NCT02275052|20201016|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
8192715|NCT02275052|20201017|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
8192716|NCT02275052|20201014|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
8192717|NCT02275052|20201015|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
8192718|NCT02275052|20201016|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
8192719|NCT02275052|20201017|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
8192720|NCT02274948|20201031|P2|NOT COMPLETED|Overall Study||91
8192721|NCT02274948|20201032|P1|NOT COMPLETED|Overall Study||98
8192722|NCT02274948|20201031|P2|COMPLETED|Overall Study||82
8192723|NCT02274948|20201032|P1|COMPLETED|Overall Study||68
8192724|NCT02274948|20201031|P2|STARTED|Overall Study||173
8192725|NCT02274948|20201032|P1|STARTED|Overall Study||166
8192726|NCT02274870|20201048|P2|NOT COMPLETED|Overall Study||0
8192727|NCT02274870|20201049|P1|NOT COMPLETED|Overall Study||0
8192728|NCT02274870|20201048|P2|COMPLETED|Overall Study||33
8192729|NCT02274870|20201049|P1|COMPLETED|Overall Study||32
8192730|NCT02274870|20201048|P2|STARTED|Overall Study||33
8192731|NCT02274870|20201049|P1|STARTED|Overall Study||32
8192732|NCT02274857|20201075|P2|NOT COMPLETED|Overall Study||6
8192733|NCT02274857|20201076|P1|NOT COMPLETED|Overall Study||20
8192734|NCT02274857|20201075|P2|COMPLETED|Overall Study||165
8192735|NCT02274857|20201076|P1|COMPLETED|Overall Study||159
8192736|NCT02274857|20201075|P2|Completed Per Protocol|Overall Study||114
8192737|NCT02274857|20201076|P1|Completed Per Protocol|Overall Study||102
8192738|NCT02274857|20201075|P2|STARTED|Overall Study||171
8192739|NCT02274857|20201076|P1|STARTED|Overall Study||179
8192740|NCT02274844|20201091|P2|NOT COMPLETED|Overall Study||32
8192741|NCT02274844|20201092|P1|NOT COMPLETED|Overall Study||38
8192742|NCT02274844|20201091|P2|COMPLETED|Overall Study||238
8192743|NCT02274844|20201092|P1|COMPLETED|Overall Study||165
8192744|NCT02274844|20201091|P2|STARTED|Overall Study||270
8192745|NCT02274844|20201092|P1|STARTED|Overall Study||203
8192746|NCT02274792|20201128|P1|NOT COMPLETED|Overall Study||25
8192747|NCT02274792|20201128|P1|COMPLETED|Overall Study||107
8192748|NCT02274792|20201128|P1|Received Treatment|Overall Study||131
8192749|NCT02274792|20201128|P1|STARTED|Overall Study||132
8192750|NCT02274766|20201138|P2|NOT COMPLETED|Overall Study||9
8192751|NCT02274766|20201139|P1|NOT COMPLETED|Overall Study||4
8192752|NCT02274766|20201138|P2|COMPLETED|Overall Study||29
8192753|NCT02274766|20201139|P1|COMPLETED|Overall Study||35
8192754|NCT02274766|20201138|P2|Received Study Drug|Overall Study||37
8192755|NCT02274766|20201139|P1|Received Study Drug|Overall Study||38
8192756|NCT02274766|20201138|P2|STARTED|Overall Study||38
8192757|NCT02274766|20201139|P1|STARTED|Overall Study||39
8192758|NCT02274688|20201149|P2|NOT COMPLETED|Overall Study||13
8192759|NCT02274688|20201150|P1|NOT COMPLETED|Overall Study||14
8192760|NCT02274688|20201149|P2|COMPLETED|Overall Study||72
8192761|NCT02274688|20201150|P1|COMPLETED|Overall Study||72
8192762|NCT02274688|20201149|P2|STARTED|Overall Study||85
8192763|NCT02274688|20201150|P1|STARTED|Overall Study||86
8192764|NCT02274675|20201172|P1|NOT COMPLETED|Overall Study||0
8192765|NCT02274675|20201172|P1|COMPLETED|Overall Study||7
8192766|NCT02274675|20201172|P1|STARTED|Overall Study||7
8192767|NCT02274649|20201184|P2|NOT COMPLETED|Overall Study||12
8192768|NCT02274649|20201185|P1|NOT COMPLETED|Overall Study||24
8192769|NCT02274649|20201184|P2|COMPLETED|Overall Study||81
8192770|NCT02274649|20201185|P1|COMPLETED|Overall Study||77
8192771|NCT02274649|20201184|P2|STARTED|Overall Study||93
8192772|NCT02274649|20201185|P1|STARTED|Overall Study||101
8192773|NCT02274558|20201206|P3|NOT COMPLETED|Overall Study||9
8192774|NCT02274558|20201207|P2|NOT COMPLETED|Overall Study||13
8192775|NCT02274558|20201208|P1|NOT COMPLETED|Overall Study||7
8192776|NCT02274558|20201206|P3|COMPLETED|Overall Study||71
8192777|NCT02274558|20201207|P2|COMPLETED|Overall Study||63
8192778|NCT02274558|20201208|P1|COMPLETED|Overall Study||71
8192779|NCT02274558|20201206|P3|Included in the Safety Analysis Set|Overall Study||79
8192780|NCT02274558|20201207|P2|Included in the Safety Analysis Set|Overall Study||72
8192781|NCT02274558|20201208|P1|Included in the Safety Analysis Set|Overall Study||76
8192782|NCT02274558|20201206|P3|STARTED|Overall Study||80
8192783|NCT02274558|20201207|P2|STARTED|Overall Study||76
8192784|NCT02274558|20201208|P1|STARTED|Overall Study||78
8192785|NCT02274493|20201222|P1|NOT COMPLETED|Overall Study||1
8192786|NCT02274493|20201222|P1|COMPLETED|Overall Study||14
8192787|NCT02274493|20201222|P1|STARTED|Overall Study||15
8192788|NCT02274311|20201229|P1|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
8192789|NCT02274311|20201229|P1|COMPLETED|Three Months of Clomiphene Wash-out||15
8192790|NCT02274311|20201229|P1|STARTED|Three Months of Clomiphene Wash-out||16
8192791|NCT02274311|20201229|P1|NOT COMPLETED|Three Months of Clomiphene Treatment||0
8192792|NCT02274311|20201229|P1|COMPLETED|Three Months of Clomiphene Treatment||16
8192793|NCT02274311|20201229|P1|STARTED|Three Months of Clomiphene Treatment||16
8192794|NCT02273973|20201237|P2|NOT COMPLETED|Overall Study||8
8192795|NCT02273973|20201238|P1|NOT COMPLETED|Overall Study||9
8192796|NCT02273973|20201237|P2|COMPLETED|Overall Study||160
8192797|NCT02273973|20201238|P1|COMPLETED|Overall Study||157
8192798|NCT02273973|20201237|P2|STARTED|Overall Study||168
8192799|NCT02273973|20201238|P1|STARTED|Overall Study||166
8192800|NCT02273960|20201282|P4|NOT COMPLETED|Long Term Extension||1
8192801|NCT02273960|20201283|P3|NOT COMPLETED|Long Term Extension||0
8192802|NCT02273960|20201284|P2|NOT COMPLETED|Long Term Extension||0
8192803|NCT02273960|20201285|P1|NOT COMPLETED|Long Term Extension||0
8192804|NCT02273960|20201282|P4|COMPLETED|Long Term Extension||3
8192805|NCT02273960|20201283|P3|COMPLETED|Long Term Extension||1
8192806|NCT02273960|20201284|P2|COMPLETED|Long Term Extension||0
8192807|NCT02273960|20201285|P1|COMPLETED|Long Term Extension||0
8192808|NCT02273960|20201282|P4|STARTED|Long Term Extension||4
8192809|NCT02273960|20201283|P3|STARTED|Long Term Extension||1
8192810|NCT02273960|20201284|P2|STARTED|Long Term Extension||0
8192811|NCT02273960|20201285|P1|STARTED|Long Term Extension||0
8192812|NCT02273960|20201282|P4|NOT COMPLETED|Short Term Period||6
8192813|NCT02273960|20201283|P3|NOT COMPLETED|Short Term Period||4
8192814|NCT02273960|20201284|P2|NOT COMPLETED|Short Term Period||6
8192815|NCT02273960|20201285|P1|NOT COMPLETED|Short Term Period||5
8192816|NCT02273960|20201282|P4|COMPLETED|Short Term Period||4
8192817|NCT02273960|20201283|P3|COMPLETED|Short Term Period||1
8192818|NCT02273960|20201284|P2|COMPLETED|Short Term Period||0
8192819|NCT02273960|20201285|P1|COMPLETED|Short Term Period||0
8192820|NCT02273960|20201282|P4|STARTED|Short Term Period||10
8192821|NCT02273960|20201283|P3|STARTED|Short Term Period||5
8192822|NCT02273960|20201284|P2|STARTED|Short Term Period||6
8192823|NCT02273960|20201285|P1|STARTED|Short Term Period||5
8192830|NCT02273752|20201352|P1|NOT COMPLETED|Overall Study||2
8192831|NCT02273752|20201352|P1|COMPLETED|Overall Study||0
8192832|NCT02273752|20201352|P1|STARTED|Overall Study||2
8192833|NCT02273323|20201363|P2|NOT COMPLETED|Overall Study||0
8192834|NCT02273323|20201364|P1|NOT COMPLETED|Overall Study||0
8192835|NCT02273323|20201363|P2|COMPLETED|Overall Study||15
8192836|NCT02273323|20201364|P1|COMPLETED|Overall Study||15
8192837|NCT02273323|20201363|P2|STARTED|Overall Study||15
8192838|NCT02273323|20201364|P1|STARTED|Overall Study||15
8192839|NCT02273310|20201382|P2|NOT COMPLETED|Overall Study||3
8192840|NCT02273310|20201383|P1|NOT COMPLETED|Overall Study||18
8192841|NCT02273310|20201382|P2|COMPLETED|Overall Study||38
8192842|NCT02273310|20201383|P1|COMPLETED|Overall Study||24
8192843|NCT02273310|20201382|P2|STARTED|Overall Study||41
8192844|NCT02273310|20201383|P1|STARTED|Overall Study||42
8192845|NCT02273206|20201396|P2|NOT COMPLETED|Overall Study||42
8192846|NCT02273206|20201397|P1|NOT COMPLETED|Overall Study||25
8192847|NCT02273206|20201396|P2|COMPLETED|Overall Study||337
8192848|NCT02273206|20201397|P1|COMPLETED|Overall Study||353
8192849|NCT02273206|20201396|P2|STARTED|Overall Study||379
8192850|NCT02273206|20201397|P1|STARTED|Overall Study||378
8192851|NCT02273180|20201443|P2|NOT COMPLETED|Overall Study||19
8192852|NCT02273180|20201444|P1|NOT COMPLETED|Overall Study||27
8192853|NCT02273180|20201443|P2|COMPLETED|Overall Study||235
8192854|NCT02273180|20201444|P1|COMPLETED|Overall Study||226
8192855|NCT02273180|20201443|P2|Treated|Overall Study||254
8192856|NCT02273180|20201444|P1|Treated|Overall Study||252
8192857|NCT02273180|20201443|P2|STARTED|Overall Study||254
8192858|NCT02273180|20201444|P1|STARTED|Overall Study||253
8192859|NCT02273167|20201469|P3|NOT COMPLETED|Overall Study||21
8192860|NCT02273167|20201470|P2|NOT COMPLETED|Overall Study||23
8192861|NCT02273167|20201471|P1|NOT COMPLETED|Overall Study||24
8192862|NCT02273167|20201469|P3|COMPLETED|Overall Study||262
8192863|NCT02273167|20201470|P2|COMPLETED|Overall Study||260
8192864|NCT02273167|20201471|P1|COMPLETED|Overall Study||259
8192865|NCT02273167|20201469|P3|STARTED|Overall Study||283
8192866|NCT02273167|20201470|P2|STARTED|Overall Study||283
8192867|NCT02273167|20201471|P1|STARTED|Overall Study||283
8192868|NCT02273141|20201496|P2|NOT COMPLETED|Overall Study||25
8192869|NCT02273141|20201497|P1|NOT COMPLETED|Overall Study||17
8192870|NCT02273141|20201496|P2|COMPLETED|Overall Study||233
8192871|NCT02273141|20201497|P1|COMPLETED|Overall Study||240
8192872|NCT02273141|20201496|P2|STARTED|Overall Study||258
8192873|NCT02273141|20201497|P1|STARTED|Overall Study||257
8192874|NCT02273115|20201517|P4|NOT COMPLETED|Overall Study||1
8192875|NCT02273115|20201518|P3|NOT COMPLETED|Overall Study||0
8192876|NCT02273115|20201519|P2|NOT COMPLETED|Overall Study||0
8192877|NCT02273115|20201520|P1|NOT COMPLETED|Overall Study||0
8192878|NCT02273115|20201517|P4|COMPLETED|Overall Study||71
8192879|NCT02273115|20201518|P3|COMPLETED|Overall Study||67
8192880|NCT02273115|20201519|P2|COMPLETED|Overall Study||90
8192881|NCT02273115|20201520|P1|COMPLETED|Overall Study||94
8192882|NCT02273115|20201517|P4|STARTED|Overall Study||72
8192883|NCT02273115|20201518|P3|STARTED|Overall Study||67
8192884|NCT02273115|20201519|P2|STARTED|Overall Study||90
8192885|NCT02273115|20201520|P1|STARTED|Overall Study||94
8192886|NCT02273063|20201562|P1|NOT COMPLETED|Overall Study||5
8192887|NCT02273063|20201562|P1|COMPLETED|Overall Study||35
8192888|NCT02273063|20201562|P1|STARTED|Overall Study||40
8192889|NCT02273050|20201570|P3|NOT COMPLETED|Overall Study||29
8192890|NCT02273050|20201571|P2|NOT COMPLETED|Overall Study||22
8192891|NCT02273050|20201572|P1|NOT COMPLETED|Overall Study||24
8192892|NCT02273050|20201570|P3|COMPLETED|Overall Study||185
8192893|NCT02273050|20201571|P2|COMPLETED|Overall Study||194
8192894|NCT02273050|20201572|P1|COMPLETED|Overall Study||186
8192895|NCT02273050|20201570|P3|STARTED|Overall Study||214
8192896|NCT02273050|20201571|P2|STARTED|Overall Study||216
8192897|NCT02273050|20201572|P1|STARTED|Overall Study||210
8192898|NCT02273037|20201600|P2|NOT COMPLETED|Overall Study||8
8192899|NCT02273037|20201601|P1|NOT COMPLETED|Overall Study||8
8192900|NCT02273037|20201600|P2|COMPLETED|Overall Study||992
8192901|NCT02273037|20201601|P1|COMPLETED|Overall Study||979
8192902|NCT02273037|20201600|P2|STARTED|Overall Study||1000
8192903|NCT02273037|20201601|P1|STARTED|Overall Study||987
8192904|NCT02272985|20201611|P1|NOT COMPLETED|Overall Study||3
8192905|NCT02272985|20201611|P1|COMPLETED|Overall Study||12
8192906|NCT02272985|20201611|P1|STARTED|Overall Study||15
8192907|NCT02272816|20201616|P1|NOT COMPLETED|Overall Study||1
8192908|NCT02272816|20201616|P1|COMPLETED|Overall Study||47
8192909|NCT02272816|20201616|P1|STARTED|Overall Study||48
8192910|NCT02272803|20201624|P2|NOT COMPLETED|Overall Study||17
8192911|NCT02272803|20201625|P1|NOT COMPLETED|Overall Study||9
8192912|NCT02272803|20201624|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
8192913|NCT02272803|20201625|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
8192914|NCT02272803|20201624|P2|STARTED|Overall Study||42
8192915|NCT02272803|20201625|P1|STARTED|Overall Study||40
8192934|NCT02272777|20201783|P2|NOT COMPLETED|Overall Study||4
8192935|NCT02272777|20201784|P1|NOT COMPLETED|Overall Study||4
8192936|NCT02272777|20201783|P2|COMPLETED|Overall Study||109
8192937|NCT02272777|20201784|P1|COMPLETED|Overall Study||108
8192938|NCT02272777|20201783|P2|STARTED|Overall Study||113
8192939|NCT02272777|20201784|P1|STARTED|Overall Study||112
8192940|NCT02272725|20201792|P2|NOT COMPLETED|Overall Study||0
8192941|NCT02272725|20201793|P1|NOT COMPLETED|Overall Study||2
8192942|NCT02272725|20201792|P2|COMPLETED|Overall Study||42
8192943|NCT02272725|20201793|P1|COMPLETED|Overall Study||47
8192944|NCT02272725|20201792|P2|STARTED|Overall Study||42
8192945|NCT02272725|20201793|P1|STARTED|Overall Study||49
8192946|NCT02272686|20201803|P1|NOT COMPLETED|Overall Study||0
8192947|NCT02272686|20201803|P1|COMPLETED|Overall Study||1
8192948|NCT02272686|20201803|P1|STARTED|Overall Study||1
8192949|NCT02272413|20201810|P2|NOT COMPLETED|Post-switch Period||46
8192950|NCT02272413|20201811|P1|NOT COMPLETED|Post-switch Period||42
8192951|NCT02272413|20201810|P2|COMPLETED|Post-switch Period||0
8192952|NCT02272413|20201811|P1|COMPLETED|Post-switch Period||0
8192953|NCT02272413|20201810|P2|STARTED|Post-switch Period|Started for this period|46
8192954|NCT02272413|20201811|P1|STARTED|Post-switch Period|Started for this period|42
8192955|NCT02272413|20201810|P2|NOT COMPLETED|Pre-switch Period||282
8192956|NCT02272413|20201811|P1|NOT COMPLETED|Pre-switch Period||293
8192957|NCT02272413|20201810|P2|COMPLETED|Pre-switch Period||46
8192958|NCT02272413|20201811|P1|COMPLETED|Pre-switch Period||42
8192959|NCT02272413|20201810|P2|STARTED|Pre-switch Period|Started for this period|328
8192960|NCT02272413|20201811|P1|STARTED|Pre-switch Period|Started for this period|335
8192961|NCT02272413|20201810|P2|NOT COMPLETED|Randomized Through Treatment Start||5
8192962|NCT02272413|20201811|P1|NOT COMPLETED|Randomized Through Treatment Start||3
8192963|NCT02272413|20201810|P2|COMPLETED|Randomized Through Treatment Start||328
8192964|NCT02272413|20201811|P1|COMPLETED|Randomized Through Treatment Start||335
8192965|NCT02272413|20201810|P2|Treated|Randomized Through Treatment Start||328
8192966|NCT02272413|20201811|P1|Treated|Randomized Through Treatment Start||335
8192967|NCT02272413|20201810|P2|STARTED|Randomized Through Treatment Start|Started for this period|333
8192968|NCT02272413|20201811|P1|STARTED|Randomized Through Treatment Start|Started for this period|338
8192969|NCT02272244|20201829|P2|NOT COMPLETED|Overall Study||0
8192970|NCT02272244|20201830|P1|NOT COMPLETED|Overall Study||0
8192971|NCT02272244|20201829|P2|COMPLETED|Overall Study||197
8192972|NCT02272244|20201830|P1|COMPLETED|Overall Study||203
8192973|NCT02272244|20201829|P2|STARTED|Overall Study||197
8192974|NCT02272244|20201830|P1|STARTED|Overall Study||203
8192975|NCT02271984|20201842|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192976|NCT02271984|20201843|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192977|NCT02271984|20201844|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192978|NCT02271984|20201845|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192979|NCT02271984|20201846|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192980|NCT02271984|20201847|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192981|NCT02271984|20201848|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192982|NCT02271984|20201849|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192983|NCT02271984|20201850|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192984|NCT02271984|20201851|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192985|NCT02271984|20201852|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192986|NCT02271984|20201853|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192987|NCT02271984|20201842|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
8192988|NCT02271984|20201843|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
8192989|NCT02271984|20201844|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
8192990|NCT02271984|20201845|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
8192991|NCT02271984|20201846|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
8192992|NCT02271984|20201847|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
8192993|NCT02271984|20201848|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
8192994|NCT02271984|20201849|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
8192995|NCT02271984|20201850|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
8192996|NCT02271984|20201851|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
8192997|NCT02271984|20201852|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
8192998|NCT02271984|20201853|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
8192999|NCT02271984|20201842|P12|STARTED|Fifth Intervention Period (1 Day)||3
8193000|NCT02271984|20201843|P11|STARTED|Fifth Intervention Period (1 Day)||3
8193001|NCT02271984|20201844|P10|STARTED|Fifth Intervention Period (1 Day)||3
8193002|NCT02271984|20201845|P9|STARTED|Fifth Intervention Period (1 Day)||3
8193003|NCT02271984|20201846|P8|STARTED|Fifth Intervention Period (1 Day)||2
8193004|NCT02271984|20201847|P7|STARTED|Fifth Intervention Period (1 Day)||3
8193005|NCT02271984|20201848|P6|STARTED|Fifth Intervention Period (1 Day)||2
8193006|NCT02271984|20201849|P5|STARTED|Fifth Intervention Period (1 Day)||3
8193007|NCT02271984|20201850|P4|STARTED|Fifth Intervention Period (1 Day)||3
8193008|NCT02271984|20201851|P3|STARTED|Fifth Intervention Period (1 Day)||3
8193009|NCT02271984|20201852|P2|STARTED|Fifth Intervention Period (1 Day)||3
8193010|NCT02271984|20201853|P1|STARTED|Fifth Intervention Period (1 Day)||3
8193011|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193012|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193013|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193014|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193015|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
8193016|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193017|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
8193018|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193019|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193020|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193021|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193022|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193023|NCT02271984|20201842|P12|COMPLETED|Washout Period 4 (7 Days)||3
8193024|NCT02271984|20201843|P11|COMPLETED|Washout Period 4 (7 Days)||3
8193025|NCT02271984|20201844|P10|COMPLETED|Washout Period 4 (7 Days)||3
8193026|NCT02271984|20201845|P9|COMPLETED|Washout Period 4 (7 Days)||3
8193027|NCT02271984|20201846|P8|COMPLETED|Washout Period 4 (7 Days)||2
8193028|NCT02271984|20201847|P7|COMPLETED|Washout Period 4 (7 Days)||3
8193029|NCT02271984|20201848|P6|COMPLETED|Washout Period 4 (7 Days)||2
8193030|NCT02271984|20201849|P5|COMPLETED|Washout Period 4 (7 Days)||3
8193031|NCT02271984|20201850|P4|COMPLETED|Washout Period 4 (7 Days)||3
8193032|NCT02271984|20201851|P3|COMPLETED|Washout Period 4 (7 Days)||3
8193033|NCT02271984|20201852|P2|COMPLETED|Washout Period 4 (7 Days)||3
8193034|NCT02271984|20201853|P1|COMPLETED|Washout Period 4 (7 Days)||3
8193035|NCT02271984|20201842|P12|STARTED|Washout Period 4 (7 Days)||3
8193036|NCT02271984|20201843|P11|STARTED|Washout Period 4 (7 Days)||3
8193037|NCT02271984|20201844|P10|STARTED|Washout Period 4 (7 Days)||3
8193038|NCT02271984|20201845|P9|STARTED|Washout Period 4 (7 Days)||3
8193039|NCT02271984|20201846|P8|STARTED|Washout Period 4 (7 Days)||3
8193040|NCT02271984|20201847|P7|STARTED|Washout Period 4 (7 Days)||3
8193041|NCT02271984|20201848|P6|STARTED|Washout Period 4 (7 Days)||3
8193042|NCT02271984|20201849|P5|STARTED|Washout Period 4 (7 Days)||3
8193043|NCT02271984|20201850|P4|STARTED|Washout Period 4 (7 Days)||3
8193044|NCT02271984|20201851|P3|STARTED|Washout Period 4 (7 Days)||3
8193045|NCT02271984|20201852|P2|STARTED|Washout Period 4 (7 Days)||3
8193046|NCT02271984|20201853|P1|STARTED|Washout Period 4 (7 Days)||3
8193047|NCT02271984|20201842|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193048|NCT02271984|20201843|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193049|NCT02271984|20201844|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193050|NCT02271984|20201845|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193051|NCT02271984|20201846|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193052|NCT02271984|20201847|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193053|NCT02271984|20201848|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193054|NCT02271984|20201849|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193055|NCT02271984|20201850|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193056|NCT02271984|20201851|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193057|NCT02271984|20201852|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193058|NCT02271984|20201853|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193059|NCT02271984|20201842|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
8193060|NCT02271984|20201843|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
8193061|NCT02271984|20201844|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
8193062|NCT02271984|20201845|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
8193063|NCT02271984|20201846|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
8193064|NCT02271984|20201847|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
8193065|NCT02271984|20201848|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
8193066|NCT02271984|20201849|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
8193067|NCT02271984|20201850|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
8193068|NCT02271984|20201851|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
8193069|NCT02271984|20201852|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
8193070|NCT02271984|20201853|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
8193071|NCT02271984|20201842|P12|STARTED|Fourth Intervention Period (Day 1)||3
8193072|NCT02271984|20201843|P11|STARTED|Fourth Intervention Period (Day 1)||3
8193073|NCT02271984|20201844|P10|STARTED|Fourth Intervention Period (Day 1)||3
8193074|NCT02271984|20201845|P9|STARTED|Fourth Intervention Period (Day 1)||3
8193075|NCT02271984|20201846|P8|STARTED|Fourth Intervention Period (Day 1)||3
8193076|NCT02271984|20201847|P7|STARTED|Fourth Intervention Period (Day 1)||3
8193077|NCT02271984|20201848|P6|STARTED|Fourth Intervention Period (Day 1)||3
8193078|NCT02271984|20201849|P5|STARTED|Fourth Intervention Period (Day 1)||3
8193079|NCT02271984|20201850|P4|STARTED|Fourth Intervention Period (Day 1)||3
8193080|NCT02271984|20201851|P3|STARTED|Fourth Intervention Period (Day 1)||3
8193081|NCT02271984|20201852|P2|STARTED|Fourth Intervention Period (Day 1)||3
8193082|NCT02271984|20201853|P1|STARTED|Fourth Intervention Period (Day 1)||3
8193083|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193084|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193085|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193086|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193087|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193088|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193089|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193090|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193091|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193092|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193093|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193094|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193095|NCT02271984|20201842|P12|COMPLETED|Washout Period 3 (7 Days)||3
8193096|NCT02271984|20201843|P11|COMPLETED|Washout Period 3 (7 Days)||3
8193097|NCT02271984|20201844|P10|COMPLETED|Washout Period 3 (7 Days)||3
8193098|NCT02271984|20201845|P9|COMPLETED|Washout Period 3 (7 Days)||3
8193099|NCT02271984|20201846|P8|COMPLETED|Washout Period 3 (7 Days)||3
8193100|NCT02271984|20201847|P7|COMPLETED|Washout Period 3 (7 Days)||3
8193101|NCT02271984|20201848|P6|COMPLETED|Washout Period 3 (7 Days)||3
8193102|NCT02271984|20201849|P5|COMPLETED|Washout Period 3 (7 Days)||3
8193103|NCT02271984|20201850|P4|COMPLETED|Washout Period 3 (7 Days)||3
8193104|NCT02271984|20201851|P3|COMPLETED|Washout Period 3 (7 Days)||3
8193105|NCT02271984|20201852|P2|COMPLETED|Washout Period 3 (7 Days)||3
8193106|NCT02271984|20201853|P1|COMPLETED|Washout Period 3 (7 Days)||3
8193107|NCT02271984|20201842|P12|STARTED|Washout Period 3 (7 Days)||3
8193108|NCT02271984|20201843|P11|STARTED|Washout Period 3 (7 Days)||3
8193109|NCT02271984|20201844|P10|STARTED|Washout Period 3 (7 Days)||3
8193110|NCT02271984|20201845|P9|STARTED|Washout Period 3 (7 Days)||3
8193111|NCT02271984|20201846|P8|STARTED|Washout Period 3 (7 Days)||3
8193112|NCT02271984|20201847|P7|STARTED|Washout Period 3 (7 Days)||3
8193113|NCT02271984|20201848|P6|STARTED|Washout Period 3 (7 Days)||3
8193114|NCT02271984|20201849|P5|STARTED|Washout Period 3 (7 Days)||3
8193115|NCT02271984|20201850|P4|STARTED|Washout Period 3 (7 Days)||3
8193116|NCT02271984|20201851|P3|STARTED|Washout Period 3 (7 Days)||3
8193117|NCT02271984|20201852|P2|STARTED|Washout Period 3 (7 Days)||3
8193118|NCT02271984|20201853|P1|STARTED|Washout Period 3 (7 Days)||3
8193119|NCT02271984|20201842|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193120|NCT02271984|20201843|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193121|NCT02271984|20201844|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193122|NCT02271984|20201845|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193123|NCT02271984|20201846|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193124|NCT02271984|20201847|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193125|NCT02271984|20201848|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193126|NCT02271984|20201849|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193127|NCT02271984|20201850|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193128|NCT02271984|20201851|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193129|NCT02271984|20201852|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193130|NCT02271984|20201853|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193131|NCT02271984|20201842|P12|COMPLETED|Third Intervention Period (1 Day)||3
8193132|NCT02271984|20201843|P11|COMPLETED|Third Intervention Period (1 Day)||3
8193133|NCT02271984|20201844|P10|COMPLETED|Third Intervention Period (1 Day)||3
8193134|NCT02271984|20201845|P9|COMPLETED|Third Intervention Period (1 Day)||3
8193135|NCT02271984|20201846|P8|COMPLETED|Third Intervention Period (1 Day)||3
8193136|NCT02271984|20201847|P7|COMPLETED|Third Intervention Period (1 Day)||3
8193137|NCT02271984|20201848|P6|COMPLETED|Third Intervention Period (1 Day)||3
8193138|NCT02271984|20201849|P5|COMPLETED|Third Intervention Period (1 Day)||3
8193139|NCT02271984|20201850|P4|COMPLETED|Third Intervention Period (1 Day)||3
8193140|NCT02271984|20201851|P3|COMPLETED|Third Intervention Period (1 Day)||3
8193141|NCT02271984|20201852|P2|COMPLETED|Third Intervention Period (1 Day)||3
8193142|NCT02271984|20201853|P1|COMPLETED|Third Intervention Period (1 Day)||3
8193143|NCT02271984|20201842|P12|STARTED|Third Intervention Period (1 Day)||3
8193144|NCT02271984|20201843|P11|STARTED|Third Intervention Period (1 Day)||3
8193145|NCT02271984|20201844|P10|STARTED|Third Intervention Period (1 Day)||3
8193146|NCT02271984|20201845|P9|STARTED|Third Intervention Period (1 Day)||3
8193147|NCT02271984|20201846|P8|STARTED|Third Intervention Period (1 Day)||3
8193148|NCT02271984|20201847|P7|STARTED|Third Intervention Period (1 Day)||3
8193149|NCT02271984|20201848|P6|STARTED|Third Intervention Period (1 Day)||3
8193150|NCT02271984|20201849|P5|STARTED|Third Intervention Period (1 Day)||3
8193151|NCT02271984|20201850|P4|STARTED|Third Intervention Period (1 Day)||3
8193152|NCT02271984|20201851|P3|STARTED|Third Intervention Period (1 Day)||3
8193153|NCT02271984|20201852|P2|STARTED|Third Intervention Period (1 Day)||3
8193154|NCT02271984|20201853|P1|STARTED|Third Intervention Period (1 Day)||3
8193155|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193156|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193157|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193158|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193159|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193160|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193161|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193162|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193163|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193164|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193165|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193166|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193167|NCT02271984|20201842|P12|COMPLETED|Washout Period 2 (7 Days)||3
8193168|NCT02271984|20201843|P11|COMPLETED|Washout Period 2 (7 Days)||3
8193169|NCT02271984|20201844|P10|COMPLETED|Washout Period 2 (7 Days)||3
8193170|NCT02271984|20201845|P9|COMPLETED|Washout Period 2 (7 Days)||3
8193171|NCT02271984|20201846|P8|COMPLETED|Washout Period 2 (7 Days)||3
8193172|NCT02271984|20201847|P7|COMPLETED|Washout Period 2 (7 Days)||3
8193173|NCT02271984|20201848|P6|COMPLETED|Washout Period 2 (7 Days)||3
8193174|NCT02271984|20201849|P5|COMPLETED|Washout Period 2 (7 Days)||3
8193175|NCT02271984|20201850|P4|COMPLETED|Washout Period 2 (7 Days)||3
8193176|NCT02271984|20201851|P3|COMPLETED|Washout Period 2 (7 Days)||3
8193177|NCT02271984|20201852|P2|COMPLETED|Washout Period 2 (7 Days)||3
8193178|NCT02271984|20201853|P1|COMPLETED|Washout Period 2 (7 Days)||3
8193179|NCT02271984|20201842|P12|STARTED|Washout Period 2 (7 Days)||3
8193180|NCT02271984|20201843|P11|STARTED|Washout Period 2 (7 Days)||3
8193181|NCT02271984|20201844|P10|STARTED|Washout Period 2 (7 Days)||3
8193182|NCT02271984|20201845|P9|STARTED|Washout Period 2 (7 Days)||3
8193183|NCT02271984|20201846|P8|STARTED|Washout Period 2 (7 Days)||3
8193184|NCT02271984|20201847|P7|STARTED|Washout Period 2 (7 Days)||3
8193185|NCT02271984|20201848|P6|STARTED|Washout Period 2 (7 Days)||3
8193186|NCT02271984|20201849|P5|STARTED|Washout Period 2 (7 Days)||3
8193187|NCT02271984|20201850|P4|STARTED|Washout Period 2 (7 Days)||3
8193188|NCT02271984|20201851|P3|STARTED|Washout Period 2 (7 Days)||3
8193189|NCT02271984|20201852|P2|STARTED|Washout Period 2 (7 Days)||3
8193190|NCT02271984|20201853|P1|STARTED|Washout Period 2 (7 Days)||3
8193191|NCT02271984|20201842|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193192|NCT02271984|20201843|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193193|NCT02271984|20201844|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193194|NCT02271984|20201845|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193195|NCT02271984|20201846|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193196|NCT02271984|20201847|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193197|NCT02271984|20201848|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193198|NCT02271984|20201849|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193199|NCT02271984|20201850|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193200|NCT02271984|20201851|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193201|NCT02271984|20201852|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193202|NCT02271984|20201853|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193203|NCT02271984|20201842|P12|COMPLETED|Second Intervention Period (1 Day)||3
8193204|NCT02271984|20201843|P11|COMPLETED|Second Intervention Period (1 Day)||3
8193205|NCT02271984|20201844|P10|COMPLETED|Second Intervention Period (1 Day)||3
8193206|NCT02271984|20201845|P9|COMPLETED|Second Intervention Period (1 Day)||3
8193207|NCT02271984|20201846|P8|COMPLETED|Second Intervention Period (1 Day)||3
8193208|NCT02271984|20201847|P7|COMPLETED|Second Intervention Period (1 Day)||3
8193209|NCT02271984|20201848|P6|COMPLETED|Second Intervention Period (1 Day)||3
8193210|NCT02271984|20201849|P5|COMPLETED|Second Intervention Period (1 Day)||3
8193211|NCT02271984|20201850|P4|COMPLETED|Second Intervention Period (1 Day)||3
8193212|NCT02271984|20201851|P3|COMPLETED|Second Intervention Period (1 Day)||3
8193213|NCT02271984|20201852|P2|COMPLETED|Second Intervention Period (1 Day)||3
8193214|NCT02271984|20201853|P1|COMPLETED|Second Intervention Period (1 Day)||3
8193215|NCT02271984|20201842|P12|STARTED|Second Intervention Period (1 Day)||3
8193216|NCT02271984|20201843|P11|STARTED|Second Intervention Period (1 Day)||3
8193217|NCT02271984|20201844|P10|STARTED|Second Intervention Period (1 Day)||3
8193218|NCT02271984|20201845|P9|STARTED|Second Intervention Period (1 Day)||3
8193219|NCT02271984|20201846|P8|STARTED|Second Intervention Period (1 Day)||3
8193220|NCT02271984|20201847|P7|STARTED|Second Intervention Period (1 Day)||3
8193221|NCT02271984|20201848|P6|STARTED|Second Intervention Period (1 Day)||3
8193222|NCT02271984|20201849|P5|STARTED|Second Intervention Period (1 Day)||3
8193223|NCT02271984|20201850|P4|STARTED|Second Intervention Period (1 Day)||3
8193224|NCT02271984|20201851|P3|STARTED|Second Intervention Period (1 Day)||3
8193225|NCT02271984|20201852|P2|STARTED|Second Intervention Period (1 Day)||3
8193226|NCT02271984|20201853|P1|STARTED|Second Intervention Period (1 Day)||3
8193227|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193228|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193229|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193230|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193231|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193232|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193233|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193234|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193235|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193236|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193237|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193238|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193239|NCT02271984|20201842|P12|COMPLETED|Washout Period 1 (7 Days)||3
8193240|NCT02271984|20201843|P11|COMPLETED|Washout Period 1 (7 Days)||3
8193241|NCT02271984|20201844|P10|COMPLETED|Washout Period 1 (7 Days)||3
8193242|NCT02271984|20201845|P9|COMPLETED|Washout Period 1 (7 Days)||3
8193243|NCT02271984|20201846|P8|COMPLETED|Washout Period 1 (7 Days)||3
8193244|NCT02271984|20201847|P7|COMPLETED|Washout Period 1 (7 Days)||3
8193245|NCT02271984|20201848|P6|COMPLETED|Washout Period 1 (7 Days)||3
8193246|NCT02271984|20201849|P5|COMPLETED|Washout Period 1 (7 Days)||3
8193247|NCT02271984|20201850|P4|COMPLETED|Washout Period 1 (7 Days)||3
8193248|NCT02271984|20201851|P3|COMPLETED|Washout Period 1 (7 Days)||3
8193249|NCT02271984|20201852|P2|COMPLETED|Washout Period 1 (7 Days)||3
8193250|NCT02271984|20201853|P1|COMPLETED|Washout Period 1 (7 Days)||3
8193251|NCT02271984|20201842|P12|STARTED|Washout Period 1 (7 Days)||3
8193252|NCT02271984|20201843|P11|STARTED|Washout Period 1 (7 Days)||3
8193253|NCT02271984|20201844|P10|STARTED|Washout Period 1 (7 Days)||3
8193254|NCT02271984|20201845|P9|STARTED|Washout Period 1 (7 Days)||3
8193255|NCT02271984|20201846|P8|STARTED|Washout Period 1 (7 Days)||3
8193256|NCT02271984|20201847|P7|STARTED|Washout Period 1 (7 Days)||3
8193257|NCT02271984|20201848|P6|STARTED|Washout Period 1 (7 Days)||3
8193258|NCT02271984|20201849|P5|STARTED|Washout Period 1 (7 Days)||3
8193259|NCT02271984|20201850|P4|STARTED|Washout Period 1 (7 Days)||3
8193260|NCT02271984|20201851|P3|STARTED|Washout Period 1 (7 Days)||3
8193261|NCT02271984|20201852|P2|STARTED|Washout Period 1 (7 Days)||3
8193262|NCT02271984|20201853|P1|STARTED|Washout Period 1 (7 Days)||3
8193263|NCT02271984|20201842|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
8193264|NCT02271984|20201843|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
8193265|NCT02271984|20201844|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
8193266|NCT02271984|20201845|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
8193267|NCT02271984|20201846|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
8193268|NCT02271984|20201847|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
8193269|NCT02271984|20201848|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
8193270|NCT02271984|20201849|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
8193271|NCT02271984|20201850|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
8193272|NCT02271984|20201851|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
8193273|NCT02271984|20201852|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
8193274|NCT02271984|20201853|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
8193275|NCT02271984|20201842|P12|COMPLETED|First Intervention Period (1 Day)||3
8193276|NCT02271984|20201843|P11|COMPLETED|First Intervention Period (1 Day)||3
8193277|NCT02271984|20201844|P10|COMPLETED|First Intervention Period (1 Day)||3
8193278|NCT02271984|20201845|P9|COMPLETED|First Intervention Period (1 Day)||3
8193279|NCT02271984|20201846|P8|COMPLETED|First Intervention Period (1 Day)||3
8193280|NCT02271984|20201847|P7|COMPLETED|First Intervention Period (1 Day)||3
8193281|NCT02271984|20201848|P6|COMPLETED|First Intervention Period (1 Day)||3
8193282|NCT02271984|20201849|P5|COMPLETED|First Intervention Period (1 Day)||3
8193283|NCT02271984|20201850|P4|COMPLETED|First Intervention Period (1 Day)||3
8193284|NCT02271984|20201851|P3|COMPLETED|First Intervention Period (1 Day)||3
8193285|NCT02271984|20201852|P2|COMPLETED|First Intervention Period (1 Day)||3
8193286|NCT02271984|20201853|P1|COMPLETED|First Intervention Period (1 Day)||3
8193287|NCT02271984|20201842|P12|STARTED|First Intervention Period (1 Day)||3
8193288|NCT02271984|20201843|P11|STARTED|First Intervention Period (1 Day)||3
8193289|NCT02271984|20201844|P10|STARTED|First Intervention Period (1 Day)||3
8193290|NCT02271984|20201845|P9|STARTED|First Intervention Period (1 Day)||3
8193291|NCT02271984|20201846|P8|STARTED|First Intervention Period (1 Day)||3
8193292|NCT02271984|20201847|P7|STARTED|First Intervention Period (1 Day)||3
8193293|NCT02271984|20201848|P6|STARTED|First Intervention Period (1 Day)||3
8193294|NCT02271984|20201849|P5|STARTED|First Intervention Period (1 Day)||3
8193295|NCT02271984|20201850|P4|STARTED|First Intervention Period (1 Day)||3
8193296|NCT02271984|20201851|P3|STARTED|First Intervention Period (1 Day)||3
8193297|NCT02271984|20201852|P2|STARTED|First Intervention Period (1 Day)||3
8193298|NCT02271984|20201853|P1|STARTED|First Intervention Period (1 Day)||3
8193299|NCT02271945|20201942|P2|NOT COMPLETED|Overall Study||5
8193300|NCT02271945|20201943|P1|NOT COMPLETED|Overall Study||5
8193301|NCT02271945|20201942|P2|COMPLETED|Overall Study||0
8193302|NCT02271945|20201943|P1|COMPLETED|Overall Study||0
8193303|NCT02271945|20201942|P2|STARTED|Overall Study||5
8193304|NCT02271945|20201943|P1|STARTED|Overall Study||5
8193305|NCT02271906|20201979|P1|NOT COMPLETED|Overall Study||0
8193306|NCT02271906|20201979|P1|COMPLETED|Overall Study||2
8193307|NCT02271906|20201979|P1|STARTED|Overall Study||2
8193308|NCT02271880|20201986|P2|NOT COMPLETED|Overall Study||4
8193309|NCT02271880|20201987|P1|NOT COMPLETED|Overall Study||3
8193310|NCT02271880|20201986|P2|COMPLETED|Overall Study||0
8193311|NCT02271880|20201987|P1|COMPLETED|Overall Study||0
8193312|NCT02271880|20201986|P2|STARTED|Overall Study||4
8193313|NCT02271880|20201987|P1|STARTED|Overall Study||3
8193314|NCT02271854|20202017|P1|NOT COMPLETED|Overall Study||4
8193315|NCT02271854|20202017|P1|COMPLETED|Overall Study||98
8193316|NCT02271854|20202017|P1|STARTED|Overall Study||102
8193317|NCT02271698|20202028|P4|NOT COMPLETED|Overall Study||0
8193318|NCT02271698|20202029|P3|NOT COMPLETED|Overall Study||0
8193319|NCT02271698|20202030|P2|NOT COMPLETED|Overall Study||0
8193320|NCT02271698|20202031|P1|NOT COMPLETED|Overall Study||0
8193321|NCT02271698|20202028|P4|COMPLETED|Overall Study||11
8193322|NCT02271698|20202029|P3|COMPLETED|Overall Study||10
8193323|NCT02271698|20202030|P2|COMPLETED|Overall Study||10
8193324|NCT02271698|20202031|P1|COMPLETED|Overall Study||11
8193325|NCT02271698|20202028|P4|STARTED|Overall Study||11
8193326|NCT02271698|20202029|P3|STARTED|Overall Study||10
8193327|NCT02271698|20202030|P2|STARTED|Overall Study||10
8193328|NCT02271698|20202031|P1|STARTED|Overall Study||11
8193329|NCT02271529|20202057|P1|NOT COMPLETED|Overall Study||1
8193330|NCT02271529|20202057|P1|COMPLETED|Overall Study||39
8193331|NCT02271529|20202057|P1|STARTED|Overall Study||40
8193332|NCT02271477|20202063|P2|NOT COMPLETED|Overall Study||0
8193333|NCT02271477|20202064|P1|NOT COMPLETED|Overall Study||0
8193334|NCT02271477|20202063|P2|COMPLETED|Overall Study||80
8193335|NCT02271477|20202064|P1|COMPLETED|Overall Study||80
8193336|NCT02271477|20202063|P2|STARTED|Overall Study||80
8193337|NCT02271477|20202064|P1|STARTED|Overall Study||80
8193338|NCT02271451|20202078|P2|NOT COMPLETED|Overall Study||1
8193339|NCT02271451|20202079|P1|NOT COMPLETED|Overall Study||0
8193340|NCT02271451|20202078|P2|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
8193341|NCT02271451|20202079|P1|COMPLETED|Overall Study||7
8193342|NCT02271451|20202078|P2|STARTED|Overall Study||8
8193343|NCT02271451|20202079|P1|STARTED|Overall Study||7
8193344|NCT02271425|20202085|P1|NOT COMPLETED|Overall Study||0
8193345|NCT02271425|20202085|P1|COMPLETED|Overall Study||8
8193346|NCT02271425|20202085|P1|STARTED|Overall Study||8
8193347|NCT02271386|20202094|P4|NOT COMPLETED|Intervention Period- 8 Months||0
8193348|NCT02271386|20202095|P3|NOT COMPLETED|Intervention Period- 8 Months||0
8193349|NCT02271386|20202096|P2|NOT COMPLETED|Intervention Period- 8 Months||0
8193350|NCT02271386|20202097|P1|NOT COMPLETED|Intervention Period- 8 Months||0
8193351|NCT02271386|20202094|P4|COMPLETED|Intervention Period- 8 Months||197
8193352|NCT02271386|20202095|P3|COMPLETED|Intervention Period- 8 Months||202
8193353|NCT02271386|20202096|P2|COMPLETED|Intervention Period- 8 Months||52
8193354|NCT02271386|20202097|P1|COMPLETED|Intervention Period- 8 Months||53
8193355|NCT02271386|20202094|P4|STARTED|Intervention Period- 8 Months||197
8193356|NCT02271386|20202095|P3|STARTED|Intervention Period- 8 Months||202
8193357|NCT02271386|20202096|P2|STARTED|Intervention Period- 8 Months||52
8193358|NCT02271386|20202097|P1|STARTED|Intervention Period- 8 Months||53
8193359|NCT02271386|20202094|P4|NOT COMPLETED|Baseline Period- 8 Months||0
8193360|NCT02271386|20202095|P3|NOT COMPLETED|Baseline Period- 8 Months||0
8193361|NCT02271386|20202096|P2|NOT COMPLETED|Baseline Period- 8 Months||0
8193362|NCT02271386|20202097|P1|NOT COMPLETED|Baseline Period- 8 Months||0
8193363|NCT02271386|20202094|P4|COMPLETED|Baseline Period- 8 Months||191
8193364|NCT02271386|20202095|P3|COMPLETED|Baseline Period- 8 Months||200
8193365|NCT02271386|20202096|P2|COMPLETED|Baseline Period- 8 Months||52
8193366|NCT02271386|20202097|P1|COMPLETED|Baseline Period- 8 Months||53
8193367|NCT02271386|20202094|P4|STARTED|Baseline Period- 8 Months||191
8193368|NCT02271386|20202095|P3|STARTED|Baseline Period- 8 Months||200
8193369|NCT02271386|20202096|P2|STARTED|Baseline Period- 8 Months||52
8193370|NCT02271386|20202097|P1|STARTED|Baseline Period- 8 Months||53
8193371|NCT02271217|20202162|P3|NOT COMPLETED|Overall Study||12
8193372|NCT02271217|20202163|P2|NOT COMPLETED|Overall Study||13
8193373|NCT02271217|20202164|P1|NOT COMPLETED|Overall Study||11
8193374|NCT02271217|20202162|P3|COMPLETED|Overall Study||113
8193375|NCT02271217|20202163|P2|COMPLETED|Overall Study||113
8193376|NCT02271217|20202164|P1|COMPLETED|Overall Study||115
8193377|NCT02271217|20202162|P3|STARTED|Overall Study||125
8193378|NCT02271217|20202163|P2|STARTED|Overall Study||126
8193379|NCT02271217|20202164|P1|STARTED|Overall Study||126
8193380|NCT02270983|20202178|P3|NOT COMPLETED|Overall Study||12
8193381|NCT02270983|20202179|P2|NOT COMPLETED|Overall Study||7
8193382|NCT02270983|20202180|P1|NOT COMPLETED|Overall Study||9
8193383|NCT02270983|20202178|P3|COMPLETED|Overall Study||76
8193384|NCT02270983|20202179|P2|COMPLETED|Overall Study||80
8193385|NCT02270983|20202180|P1|COMPLETED|Overall Study||70
8193386|NCT02270983|20202178|P3|STARTED|Overall Study||88
8193387|NCT02270983|20202179|P2|STARTED|Overall Study||87
8193388|NCT02270983|20202180|P1|STARTED|Overall Study||79
8193389|NCT02270957|20202205|P2|NOT COMPLETED|Overall Study||4
8193390|NCT02270957|20202206|P1|NOT COMPLETED|Overall Study||4
8193391|NCT02270957|20202205|P2|COMPLETED|Overall Study||31
8193392|NCT02270957|20202206|P1|COMPLETED|Overall Study||27
8193393|NCT02270957|20202205|P2|STARTED|Overall Study||35
8193394|NCT02270957|20202206|P1|STARTED|Overall Study||31
8193395|NCT02270944|20202218|P2|NOT COMPLETED|Overall Study||5
8193396|NCT02270944|20202219|P1|NOT COMPLETED|Overall Study||11
8193397|NCT02270944|20202218|P2|COMPLETED|Overall Study||516
8193398|NCT02270944|20202219|P1|COMPLETED|Overall Study||518
8193399|NCT02270944|20202218|P2|STARTED|Overall Study||521
8193400|NCT02270944|20202219|P1|STARTED|Overall Study||529
8193401|NCT02270736|20202238|P5|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8193402|NCT02270736|20202239|P4|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
8193403|NCT02270736|20202240|P3|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8193404|NCT02270736|20202241|P2|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8193405|NCT02270736|20202242|P1|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8193406|NCT02270736|20202238|P5|COMPLETED|OLEX Period (up to 48 Weeks)||33
8193407|NCT02270736|20202239|P4|COMPLETED|OLEX Period (up to 48 Weeks)||189
8193408|NCT02270736|20202240|P3|COMPLETED|OLEX Period (up to 48 Weeks)||0
8193409|NCT02270736|20202241|P2|COMPLETED|OLEX Period (up to 48 Weeks)||0
8193410|NCT02270736|20202242|P1|COMPLETED|OLEX Period (up to 48 Weeks)||0
8193411|NCT02270736|20202238|P5|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
8193412|NCT02270736|20202239|P4|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
8193413|NCT02270736|20202240|P3|STARTED|OLEX Period (up to 48 Weeks)||0
8193414|NCT02270736|20202241|P2|STARTED|OLEX Period (up to 48 Weeks)||0
8193415|NCT02270736|20202242|P1|STARTED|OLEX Period (up to 48 Weeks)||0
8193416|NCT02270736|20202238|P5|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8193417|NCT02270736|20202239|P4|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8193418|NCT02270736|20202240|P3|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8193419|NCT02270736|20202241|P2|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8193420|NCT02270736|20202242|P1|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8193421|NCT02270736|20202238|P5|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8193422|NCT02270736|20202239|P4|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8193423|NCT02270736|20202240|P3|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
8193424|NCT02270736|20202241|P2|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
8193425|NCT02270736|20202242|P1|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
8193426|NCT02270736|20202238|P5|Treated|Main Period (MP) (up to 16 Weeks)||0
8193427|NCT02270736|20202239|P4|Treated|Main Period (MP) (up to 16 Weeks)||0
8193428|NCT02270736|20202240|P3|Treated|Main Period (MP) (up to 16 Weeks)||35
8193429|NCT02270736|20202241|P2|Treated|Main Period (MP) (up to 16 Weeks)||148
8193430|NCT02270736|20202242|P1|Treated|Main Period (MP) (up to 16 Weeks)||72
8193431|NCT02270736|20202238|P5|STARTED|Main Period (MP) (up to 16 Weeks)||0
8193432|NCT02270736|20202239|P4|STARTED|Main Period (MP) (up to 16 Weeks)||0
8193433|NCT02270736|20202240|P3|STARTED|Main Period (MP) (up to 16 Weeks)||36
8193434|NCT02270736|20202241|P2|STARTED|Main Period (MP) (up to 16 Weeks)||148
8193435|NCT02270736|20202242|P1|STARTED|Main Period (MP) (up to 16 Weeks)||72
8193436|NCT02270684|20202284|P2|NOT COMPLETED|Overall Study||3
8193437|NCT02270684|20202285|P1|NOT COMPLETED|Overall Study||1
8193438|NCT02270684|20202284|P2|COMPLETED|Overall Study||0
8193439|NCT02270684|20202285|P1|COMPLETED|Overall Study||0
8193440|NCT02270684|20202284|P2|STARTED|Overall Study||3
8193441|NCT02270684|20202285|P1|STARTED|Overall Study||1
8193442|NCT02270671|20202293|P2|NOT COMPLETED|Overall Study||5
8193443|NCT02270671|20202294|P1|NOT COMPLETED|Overall Study||5
8193444|NCT02270671|20202293|P2|COMPLETED|Overall Study||61
8193445|NCT02270671|20202294|P1|COMPLETED|Overall Study||59
8193446|NCT02270671|20202293|P2|STARTED|Overall Study||66
8193447|NCT02270671|20202294|P1|STARTED|Overall Study||64
8193448|NCT02270645|20202310|P2|NOT COMPLETED|Overall Study||0
8193449|NCT02270645|20202311|P1|NOT COMPLETED|Overall Study||2
8193450|NCT02270645|20202310|P2|COMPLETED|Overall Study||4
8193451|NCT02270645|20202311|P1|COMPLETED|Overall Study||6
8193452|NCT02270645|20202310|P2|STARTED|Overall Study||4
8193453|NCT02270645|20202311|P1|STARTED|Overall Study||8
8193454|NCT02270515|20202319|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
8193455|NCT02270515|20202319|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
8193456|NCT02270515|20202319|P1|STARTED|Intervention Period 3: 12-18 Months||127
8193457|NCT02270515|20202319|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
8193458|NCT02270515|20202319|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
8193459|NCT02270515|20202319|P1|STARTED|Intervention Period 2: 6-12 Months||159
8193460|NCT02270515|20202319|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
8193461|NCT02270515|20202319|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
8193462|NCT02270515|20202319|P1|STARTED|Intervention Period 1: 0-6 Months||175
8193463|NCT02270255|20202336|P2|NOT COMPLETED|Overall Study||0
8193464|NCT02270255|20202337|P1|NOT COMPLETED|Overall Study||1
8193465|NCT02270255|20202336|P2|COMPLETED|Overall Study||22
8193466|NCT02270255|20202337|P1|COMPLETED|Overall Study||21
8193467|NCT02270255|20202336|P2|Complete Data From Home Survey|Overall Study||22
8193468|NCT02270255|20202337|P1|Complete Data From Home Survey|Overall Study||21
8193469|NCT02270255|20202336|P2|Complete Data at Discharge PACU|Overall Study||22
8193470|NCT02270255|20202337|P1|Complete Data at Discharge PACU|Overall Study||22
8193471|NCT02270255|20202336|P2|STARTED|Overall Study||22
8193472|NCT02270255|20202337|P1|STARTED|Overall Study||22
8193473|NCT02270242|20202347|P2|NOT COMPLETED|Overall Study||53
8193474|NCT02270242|20202348|P1|NOT COMPLETED|Overall Study||59
8193475|NCT02270242|20202347|P2|COMPLETED|Overall Study||3511
8193476|NCT02270242|20202348|P1|COMPLETED|Overall Study||3496
8193477|NCT02270242|20202347|P2|STARTED|Overall Study||3564
8193478|NCT02270242|20202348|P1|STARTED|Overall Study||3555
8193479|NCT02270060|20202359|P3|NOT COMPLETED|Overall Study||0
8193480|NCT02270060|20202360|P2|NOT COMPLETED|Overall Study||0
8193481|NCT02270060|20202361|P1|NOT COMPLETED|Overall Study||0
8193482|NCT02270060|20202359|P3|COMPLETED|Overall Study||20
8193483|NCT02270060|20202360|P2|COMPLETED|Overall Study||20
8193484|NCT02270060|20202361|P1|COMPLETED|Overall Study||20
8193485|NCT02270060|20202359|P3|STARTED|Overall Study||20
8193486|NCT02270060|20202360|P2|STARTED|Overall Study||20
8193487|NCT02270060|20202361|P1|STARTED|Overall Study||20
8193488|NCT02269943|20202389|P2|NOT COMPLETED|Follow-Up Survival Period||26
8193489|NCT02269943|20202390|P1|NOT COMPLETED|Follow-Up Survival Period||5
8193490|NCT02269943|20202389|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
8193491|NCT02269943|20202390|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
8193492|NCT02269943|20202389|P2|STARTED|Follow-Up Survival Period||26
8193493|NCT02269943|20202390|P1|STARTED|Follow-Up Survival Period||5
8193494|NCT02269943|20202389|P2|NOT COMPLETED|Treatment Period||30
8193495|NCT02269943|20202390|P1|NOT COMPLETED|Treatment Period||6
8193496|NCT02269943|20202389|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
8193497|NCT02269943|20202390|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
8193498|NCT02269943|20202389|P2|Investigational Product (IP) Stopped|Treatment Period||30
8193499|NCT02269943|20202390|P1|Investigational Product (IP) Stopped|Treatment Period||6
8193500|NCT02269943|20202389|P2|STARTED|Treatment Period||30
8193501|NCT02269943|20202390|P1|STARTED|Treatment Period||6
8193502|NCT02269917|20202420|P2|NOT COMPLETED|Overall Study||383
8193503|NCT02269917|20202421|P1|NOT COMPLETED|Overall Study||766
8193504|NCT02269917|20202420|P2|COMPLETED|Overall Study||0
8193505|NCT02269917|20202421|P1|COMPLETED|Overall Study||0
8193506|NCT02269917|20202420|P2|Treated|Overall Study||378
8193507|NCT02269917|20202421|P1|Treated|Overall Study||763
8193508|NCT02269917|20202420|P2|STARTED|Overall Study||383
8193509|NCT02269917|20202421|P1|STARTED|Overall Study||766
8193510|NCT02269787|20202474|P2|NOT COMPLETED|Overall Study||10
8193511|NCT02269787|20202475|P1|NOT COMPLETED|Overall Study||22
8193512|NCT02269787|20202474|P2|COMPLETED|Overall Study||140
8193513|NCT02269787|20202475|P1|COMPLETED|Overall Study||126
8193514|NCT02269787|20202474|P2|STARTED|Overall Study||150
8193515|NCT02269787|20202475|P1|STARTED|Overall Study||148
8193516|NCT02269709|20202481|P1|NOT COMPLETED|Six Month Follow-up||12
8193517|NCT02269709|20202481|P1|COMPLETED|Six Month Follow-up||5
8193518|NCT02269709|20202481|P1|STARTED|Six Month Follow-up||17
8193519|NCT02269709|20202481|P1|NOT COMPLETED|Prior to Hospital Discharge||0
8193520|NCT02269709|20202481|P1|COMPLETED|Prior to Hospital Discharge||17
8193521|NCT02269709|20202481|P1|STARTED|Prior to Hospital Discharge||17
8193522|NCT02269709|20202481|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
8193523|NCT02269709|20202481|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
8193524|NCT02269709|20202481|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
8193525|NCT02269709|20202481|P1|NOT COMPLETED|Time of Enrollment||3
8193526|NCT02269709|20202481|P1|COMPLETED|Time of Enrollment||18
8193527|NCT02269709|20202481|P1|STARTED|Time of Enrollment||21
8193528|NCT02269657|20202486|P1|NOT COMPLETED|Overall Study||3
8193529|NCT02269657|20202486|P1|COMPLETED|Overall Study||37
8193530|NCT02269657|20202486|P1|STARTED|Overall Study||40
8193531|NCT02269631|20202502|P2|NOT COMPLETED|Overall Study||0
8193532|NCT02269631|20202503|P1|NOT COMPLETED|Overall Study||0
8193533|NCT02269631|20202502|P2|COMPLETED|Overall Study||5
8193534|NCT02269631|20202503|P1|COMPLETED|Overall Study||7
8193535|NCT02269631|20202502|P2|STARTED|Overall Study||5
8193536|NCT02269631|20202503|P1|STARTED|Overall Study||7
8193537|NCT02269488|20202517|P1|NOT COMPLETED|Overall Study||0
8193538|NCT02269488|20202517|P1|COMPLETED|Overall Study||100
8193539|NCT02269488|20202517|P1|STARTED|Overall Study||100
8193540|NCT02269475|20202523|P2|NOT COMPLETED|Overall Study||1
8193541|NCT02269475|20202524|P1|NOT COMPLETED|Overall Study||3
8193542|NCT02269475|20202523|P2|COMPLETED|Overall Study||432
8193543|NCT02269475|20202524|P1|COMPLETED|Overall Study||865
8193544|NCT02269475|20202523|P2|Per Protocol Population|Overall Study||430
8193545|NCT02269475|20202524|P1|Per Protocol Population|Overall Study||849
8193546|NCT02269475|20202523|P2|Received IP (Safety Population)|Overall Study||433
8193547|NCT02269475|20202524|P1|Received IP (Safety Population)|Overall Study||868
8193548|NCT02269475|20202523|P2|STARTED|Overall Study||433
8193549|NCT02269475|20202524|P1|STARTED|Overall Study||868
8193550|NCT02269423|20202539|P4|NOT COMPLETED|Overall Study||1
8193551|NCT02269423|20202540|P3|NOT COMPLETED|Overall Study||0
8193552|NCT02269423|20202541|P2|NOT COMPLETED|Overall Study||1
8193553|NCT02269423|20202542|P1|NOT COMPLETED|Overall Study||0
8193554|NCT02269423|20202539|P4|COMPLETED|Overall Study||8
8193555|NCT02269423|20202540|P3|COMPLETED|Overall Study||10
8193556|NCT02269423|20202541|P2|COMPLETED|Overall Study||9
8193557|NCT02269423|20202542|P1|COMPLETED|Overall Study||10
8193558|NCT02269423|20202539|P4|STARTED|Overall Study||9
8193559|NCT02269423|20202540|P3|STARTED|Overall Study||10
8193560|NCT02269423|20202541|P2|STARTED|Overall Study||10
8193561|NCT02269423|20202542|P1|STARTED|Overall Study||10
8193562|NCT02269241|20202604|P1|NOT COMPLETED|Overall Study||1200
8193563|NCT02269241|20202604|P1|COMPLETED|Overall Study||352
8193564|NCT02269241|20202604|P1|STARTED|Overall Study||1552
8193565|NCT02269098|20202618|P2|NOT COMPLETED|Overall Study||9
8193566|NCT02269098|20202619|P1|NOT COMPLETED|Overall Study||14
8193567|NCT02269098|20202618|P2|COMPLETED|Overall Study||41
8193568|NCT02269098|20202619|P1|COMPLETED|Overall Study||37
8193569|NCT02269098|20202618|P2|STARTED|Overall Study||50
8193570|NCT02269098|20202619|P1|STARTED|Overall Study||51
8193571|NCT02268994|20202635|P2|NOT COMPLETED|Overall Study||35
8193572|NCT02268994|20202636|P1|NOT COMPLETED|Overall Study||31
8193573|NCT02268994|20202635|P2|COMPLETED|Overall Study||81
8193574|NCT02268994|20202636|P1|COMPLETED|Overall Study||86
8193575|NCT02268994|20202635|P2|STARTED|Overall Study||116
8193576|NCT02268994|20202636|P1|STARTED|Overall Study||117
8193577|NCT02268955|20202654|P2|NOT COMPLETED|Overall Study||2
8193578|NCT02268955|20202655|P1|NOT COMPLETED|Overall Study||2
8193579|NCT02268955|20202654|P2|COMPLETED|Overall Study||9
8193580|NCT02268955|20202655|P1|COMPLETED|Overall Study||9
8193581|NCT02268955|20202654|P2|STARTED|Overall Study||11
8193582|NCT02268955|20202655|P1|STARTED|Overall Study||11
8193583|NCT02268942|20202661|P1|NOT COMPLETED|Overall Study||0
8193584|NCT02268942|20202661|P1|COMPLETED|Overall Study||144
8193585|NCT02268942|20202661|P1|STARTED|Overall Study||144
8193586|NCT02268877|20202668|P2|NOT COMPLETED|Overall Study||5
8193587|NCT02268877|20202669|P1|NOT COMPLETED|Overall Study||4
8193588|NCT02268877|20202668|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
8193589|NCT02268877|20202669|P1|COMPLETED|Overall Study||118
8193590|NCT02268877|20202668|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
8193591|NCT02268877|20202669|P1|STARTED|Overall Study||122
8193592|NCT02268864|20202680|P3|NOT COMPLETED|Overall Study||0
8193593|NCT02268864|20202681|P2|NOT COMPLETED|Overall Study||1
8193594|NCT02268864|20202682|P1|NOT COMPLETED|Overall Study||2
8193595|NCT02268864|20202680|P3|COMPLETED|Overall Study||64
8193596|NCT02268864|20202681|P2|COMPLETED|Overall Study||24
8193597|NCT02268864|20202682|P1|COMPLETED|Overall Study||15
8193598|NCT02268864|20202680|P3|STARTED|Overall Study||64
8193599|NCT02268864|20202681|P2|STARTED|Overall Study||25
8193600|NCT02268864|20202682|P1|STARTED|Overall Study||17
8193601|NCT02268851|20202710|P6|NOT COMPLETED|Overall Study||11
8193602|NCT02268851|20202711|P5|NOT COMPLETED|Overall Study||7
8193603|NCT02268851|20202712|P4|NOT COMPLETED|Overall Study||3
8193604|NCT02268851|20202713|P3|NOT COMPLETED|Overall Study||1
8193605|NCT02268851|20202714|P2|NOT COMPLETED|Overall Study||3
8193606|NCT02268851|20202715|P1|NOT COMPLETED|Overall Study||1
8193607|NCT02268851|20202710|P6|COMPLETED|Overall Study||4
8193608|NCT02268851|20202711|P5|COMPLETED|Overall Study||8
8193609|NCT02268851|20202712|P4|COMPLETED|Overall Study||0
8193610|NCT02268851|20202713|P3|COMPLETED|Overall Study||3
8193611|NCT02268851|20202714|P2|COMPLETED|Overall Study||0
8193612|NCT02268851|20202715|P1|COMPLETED|Overall Study||2
8193613|NCT02268851|20202710|P6|STARTED|Overall Study||15
8193614|NCT02268851|20202711|P5|STARTED|Overall Study||15
8193615|NCT02268851|20202712|P4|STARTED|Overall Study||3
8193616|NCT02268851|20202713|P3|STARTED|Overall Study||4
8193617|NCT02268851|20202714|P2|STARTED|Overall Study||3
8193618|NCT02268851|20202715|P1|STARTED|Overall Study||3
8193619|NCT02268812|20202733|P4|NOT COMPLETED|Overall Study||14
8193620|NCT02268812|20202734|P3|NOT COMPLETED|Overall Study||9
8193621|NCT02268812|20202735|P2|NOT COMPLETED|Overall Study||32
8193622|NCT02268812|20202736|P1|NOT COMPLETED|Overall Study||16
8193623|NCT02268812|20202733|P4|COMPLETED|Overall Study||26
8193624|NCT02268812|20202734|P3|COMPLETED|Overall Study||21
8193625|NCT02268812|20202735|P2|COMPLETED|Overall Study||40
8193626|NCT02268812|20202736|P1|COMPLETED|Overall Study||61
8193627|NCT02268812|20202733|P4|STARTED|Overall Study||40
8193628|NCT02268812|20202734|P3|STARTED|Overall Study||30
8193629|NCT02268812|20202735|P2|STARTED|Overall Study||72
8193630|NCT02268812|20202736|P1|STARTED|Overall Study||77
8193631|NCT02268786|20202768|P2|NOT COMPLETED|Overall Study||18
8193632|NCT02268786|20202769|P1|NOT COMPLETED|Overall Study||56
8193633|NCT02268786|20202768|P2|COMPLETED|Overall Study||313
8193634|NCT02268786|20202769|P1|COMPLETED|Overall Study||274
8193635|NCT02268786|20202768|P2|STARTED|Overall Study||331
8193636|NCT02268786|20202769|P1|STARTED|Overall Study||330
8193637|NCT02268526|20202778|P3|NOT COMPLETED|Overall Study||5
8193638|NCT02268526|20202779|P2|NOT COMPLETED|Overall Study||21
8193639|NCT02268526|20202780|P1|NOT COMPLETED|Overall Study||1
8193640|NCT02268526|20202778|P3|COMPLETED|Overall Study||16
8193641|NCT02268526|20202779|P2|COMPLETED|Overall Study||38
8193642|NCT02268526|20202780|P1|COMPLETED|Overall Study||5
8193643|NCT02268526|20202778|P3|PD Analysis Set (Cohort 2)|Overall Study||17
8193644|NCT02268526|20202779|P2|PD Analysis Set (Cohort 2)|Overall Study||42
8193645|NCT02268526|20202780|P1|PD Analysis Set (Cohort 2)|Overall Study||0
8193646|NCT02268526|20202778|P3|STARTED|Overall Study||21
8193647|NCT02268526|20202779|P2|STARTED|Overall Study||59
8193648|NCT02268526|20202780|P1|STARTED|Overall Study||6
8193649|NCT02268396|20202801|P1|NOT COMPLETED|Overall Study||12
8193650|NCT02268396|20202801|P1|COMPLETED|Overall Study||126
8193651|NCT02268396|20202801|P1|STARTED|Overall Study||138
8193652|NCT02268214|20202813|P3|NOT COMPLETED|Overall Study||42
8193653|NCT02268214|20202814|P2|NOT COMPLETED|Overall Study||41
8193654|NCT02268214|20202815|P1|NOT COMPLETED|Overall Study||42
8193655|NCT02268214|20202813|P3|COMPLETED|Overall Study||218
8193656|NCT02268214|20202814|P2|COMPLETED|Overall Study||255
8193657|NCT02268214|20202815|P1|COMPLETED|Overall Study||235
8193658|NCT02268214|20202813|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
8193659|NCT02268214|20202814|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
8193660|NCT02268214|20202815|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
8193661|NCT02268214|20202813|P3|STARTED|Overall Study||260
8193662|NCT02268214|20202814|P2|STARTED|Overall Study||296
8193663|NCT02268214|20202815|P1|STARTED|Overall Study||277
8193664|NCT02268175|20202843|P2|NOT COMPLETED|Overall Study||0
8193665|NCT02268175|20202844|P1|NOT COMPLETED|Overall Study||0
8193666|NCT02268175|20202843|P2|COMPLETED|Overall Study||25
8193667|NCT02268175|20202844|P1|COMPLETED|Overall Study||50
8193668|NCT02268175|20202843|P2|STARTED|Overall Study||25
8193669|NCT02268175|20202844|P1|STARTED|Overall Study||50
8193670|NCT02268058|20202862|P4|NOT COMPLETED|Overall Study||0
8193671|NCT02268058|20202863|P3|NOT COMPLETED|Overall Study||0
8193672|NCT02268058|20202864|P2|NOT COMPLETED|Overall Study||0
8193673|NCT02268058|20202865|P1|NOT COMPLETED|Overall Study||1
8193674|NCT02268058|20202862|P4|COMPLETED|Overall Study||20
8193675|NCT02268058|20202863|P3|COMPLETED|Overall Study||20
8193676|NCT02268058|20202864|P2|COMPLETED|Overall Study||20
8193677|NCT02268058|20202865|P1|COMPLETED|Overall Study||19
8193678|NCT02268058|20202862|P4|STARTED|Overall Study||20
8193679|NCT02268058|20202863|P3|STARTED|Overall Study||20
8193680|NCT02268058|20202864|P2|STARTED|Overall Study||20
8193681|NCT02268058|20202865|P1|STARTED|Overall Study||20
8193682|NCT02268045|20202889|P2|NOT COMPLETED|Overall Study||20
8193683|NCT02268045|20202890|P1|NOT COMPLETED|Overall Study||16
8193684|NCT02268045|20202889|P2|COMPLETED|Overall Study||116
8193685|NCT02268045|20202890|P1|COMPLETED|Overall Study||120
8193686|NCT02268045|20202889|P2|STARTED|Overall Study||136
8193687|NCT02268045|20202890|P1|STARTED|Overall Study||136
8193688|NCT02267850|20202914|P2|NOT COMPLETED|Overall Study||2
8193689|NCT02267850|20202915|P1|NOT COMPLETED|Overall Study||1
8193690|NCT02267850|20202914|P2|COMPLETED|Overall Study||12
8193691|NCT02267850|20202915|P1|COMPLETED|Overall Study||14
8193692|NCT02267850|20202914|P2|STARTED|Overall Study||14
8193693|NCT02267850|20202915|P1|STARTED|Overall Study||15
8193694|NCT02267837|20202923|P2|NOT COMPLETED|Overall Study||0
8193695|NCT02267837|20202924|P1|NOT COMPLETED|Overall Study||0
8193696|NCT02267837|20202923|P2|COMPLETED|Overall Study||9
8193697|NCT02267837|20202924|P1|COMPLETED|Overall Study||11
8193698|NCT02267837|20202923|P2|STARTED|Overall Study||9
8193699|NCT02267837|20202924|P1|STARTED|Overall Study||11
8193700|NCT02267824|20202932|P2|NOT COMPLETED|Overall Study||1
8193701|NCT02267824|20202933|P1|NOT COMPLETED|Overall Study||10
8193702|NCT02267824|20202932|P2|COMPLETED|Overall Study||17
8193703|NCT02267824|20202933|P1|COMPLETED|Overall Study||73
8193704|NCT02267824|20202932|P2|STARTED|Overall Study||18
8193705|NCT02267824|20202933|P1|STARTED|Overall Study||83
8193706|NCT02267811|20202941|P2|NOT COMPLETED|Overall Study||2
8193707|NCT02267811|20202942|P1|NOT COMPLETED|Overall Study||1
8193708|NCT02267811|20202941|P2|COMPLETED|Overall Study||15
8193709|NCT02267811|20202942|P1|COMPLETED|Overall Study||15
8193710|NCT02267811|20202941|P2|STARTED|Overall Study||17
8193711|NCT02267811|20202942|P1|STARTED|Overall Study||16
8193712|NCT02267772|20202954|P2|NOT COMPLETED|Overall Study||0
8193713|NCT02267772|20202955|P1|NOT COMPLETED|Overall Study||2
8193714|NCT02267772|20202954|P2|COMPLETED|Overall Study||52
8193715|NCT02267772|20202955|P1|COMPLETED|Overall Study||48
8193716|NCT02267772|20202954|P2|Received Study Drug|Overall Study||52
8193717|NCT02267772|20202955|P1|Received Study Drug|Overall Study||48
8193718|NCT02267772|20202954|P2|Randomized|Overall Study||52
8193719|NCT02267772|20202955|P1|Randomized|Overall Study||50
8193720|NCT02267772|20202954|P2|STARTED|Overall Study||52
8193721|NCT02267772|20202955|P1|STARTED|Overall Study||50
8193722|NCT02267746|20202978|P3|NOT COMPLETED|Overall Study||21
8193723|NCT02267746|20202979|P2|NOT COMPLETED|Overall Study||22
8193724|NCT02267746|20202980|P1|NOT COMPLETED|Overall Study||21
8193725|NCT02267746|20202978|P3|COMPLETED|Overall Study||278
8193726|NCT02267746|20202979|P2|COMPLETED|Overall Study||274
8193727|NCT02267746|20202980|P1|COMPLETED|Overall Study||277
8193728|NCT02267746|20202978|P3|STARTED|Overall Study||299
8193729|NCT02267746|20202979|P2|STARTED|Overall Study||296
8193730|NCT02267746|20202980|P1|STARTED|Overall Study||298
8193731|NCT02267629|20202994|P1|NOT COMPLETED|Overall Study||0
8193732|NCT02267629|20202994|P1|COMPLETED|Overall Study||7
8193733|NCT02267629|20202994|P1|STARTED|Overall Study||7
8193734|NCT02267603|20202999|P1|NOT COMPLETED|Overall Study||44
8193735|NCT02267603|20202999|P1|COMPLETED|Overall Study||6
8193736|NCT02267603|20202999|P1|STARTED|Overall Study||50
8193737|NCT02267577|20203003|P1|NOT COMPLETED|Overall Study||4
8193738|NCT02267577|20203003|P1|COMPLETED|Overall Study||81
8193739|NCT02267577|20203003|P1|STARTED|Overall Study||85
8193740|NCT02267538|20203010|P2|NOT COMPLETED|Overall Study||0
8193741|NCT02267538|20203011|P1|NOT COMPLETED|Overall Study||0
8193742|NCT02267538|20203010|P2|COMPLETED|Overall Study||143
8193743|NCT02267538|20203011|P1|COMPLETED|Overall Study||142
8193744|NCT02267538|20203010|P2|STARTED|Overall Study||143
8193745|NCT02267538|20203011|P1|STARTED|Overall Study||142
8193746|NCT02267447|20203031|P2|NOT COMPLETED|Overall Study||0
8193747|NCT02267447|20203032|P1|NOT COMPLETED|Overall Study||0
8193748|NCT02267447|20203031|P2|COMPLETED|Overall Study||26968
8193749|NCT02267447|20203032|P1|COMPLETED|Overall Study||77251
8193750|NCT02267447|20203031|P2|STARTED|Overall Study||26968
8193751|NCT02267447|20203032|P1|STARTED|Overall Study||77251
8193752|NCT02267382|20203045|P5|NOT COMPLETED|Overall Study||7
8193753|NCT02267382|20203046|P4|NOT COMPLETED|Overall Study||6
8193754|NCT02267382|20203047|P3|NOT COMPLETED|Overall Study||9
8193755|NCT02267382|20203048|P2|NOT COMPLETED|Overall Study||10
8193756|NCT02267382|20203049|P1|NOT COMPLETED|Overall Study||7
8193757|NCT02267382|20203045|P5|COMPLETED|Overall Study||39
8193758|NCT02267382|20203046|P4|COMPLETED|Overall Study||35
8193759|NCT02267382|20203047|P3|COMPLETED|Overall Study||34
8193760|NCT02267382|20203048|P2|COMPLETED|Overall Study||33
8193761|NCT02267382|20203049|P1|COMPLETED|Overall Study||35
8193762|NCT02267382|20203045|P5|STARTED|Overall Study||46
8193763|NCT02267382|20203046|P4|STARTED|Overall Study||41
8193764|NCT02267382|20203047|P3|STARTED|Overall Study||43
8193765|NCT02267382|20203048|P2|STARTED|Overall Study||43
8193766|NCT02267382|20203049|P1|STARTED|Overall Study||42
8193767|NCT02267356|20203066|P5|NOT COMPLETED|Study Extension||0
8193768|NCT02267356|20203067|P4|NOT COMPLETED|Study Extension||2
8193769|NCT02267356|20203068|P3|NOT COMPLETED|Study Extension||1
8193770|NCT02267356|20203069|P2|NOT COMPLETED|Study Extension||0
8193771|NCT02267356|20203070|P1|NOT COMPLETED|Study Extension||1
8193772|NCT02267356|20203066|P5|COMPLETED|Study Extension||26
8193773|NCT02267356|20203067|P4|COMPLETED|Study Extension||30
8193774|NCT02267356|20203068|P3|COMPLETED|Study Extension||29
8193775|NCT02267356|20203069|P2|COMPLETED|Study Extension||37
8193776|NCT02267356|20203070|P1|COMPLETED|Study Extension||32
8193777|NCT02267356|20203066|P5|STARTED|Study Extension||26
8193778|NCT02267356|20203067|P4|STARTED|Study Extension||32
8193779|NCT02267356|20203068|P3|STARTED|Study Extension||30
8193780|NCT02267356|20203069|P2|STARTED|Study Extension||37
8193781|NCT02267356|20203070|P1|STARTED|Study Extension||33
8193782|NCT02267356|20203066|P5|NOT COMPLETED|Initial Study||5
8193783|NCT02267356|20203067|P4|NOT COMPLETED|Initial Study||11
8193784|NCT02267356|20203068|P3|NOT COMPLETED|Initial Study||10
8193785|NCT02267356|20203069|P2|NOT COMPLETED|Initial Study||5
8193786|NCT02267356|20203070|P1|NOT COMPLETED|Initial Study||6
8193787|NCT02267356|20203066|P5|COMPLETED|Initial Study||42
8193788|NCT02267356|20203067|P4|COMPLETED|Initial Study||43
8193789|NCT02267356|20203068|P3|COMPLETED|Initial Study||42
8193790|NCT02267356|20203069|P2|COMPLETED|Initial Study||48
8193791|NCT02267356|20203070|P1|COMPLETED|Initial Study||47
8193792|NCT02267356|20203066|P5|STARTED|Initial Study||47
8193793|NCT02267356|20203067|P4|STARTED|Initial Study||54
8193794|NCT02267356|20203068|P3|STARTED|Initial Study||52
8193795|NCT02267356|20203069|P2|STARTED|Initial Study||53
8193796|NCT02267356|20203070|P1|STARTED|Initial Study||53
8193797|NCT02267317|20203090|P6|NOT COMPLETED|Infusion2||0
8193798|NCT02267317|20203091|P5|NOT COMPLETED|Infusion2||0
8193799|NCT02267317|20203092|P4|NOT COMPLETED|Infusion2||0
8193800|NCT02267317|20203093|P3|NOT COMPLETED|Infusion2||0
8193801|NCT02267317|20203094|P2|NOT COMPLETED|Infusion2||0
8193802|NCT02267317|20203095|P1|NOT COMPLETED|Infusion2||0
8193803|NCT02267317|20203090|P6|COMPLETED|Infusion2||1
8193804|NCT02267317|20203091|P5|COMPLETED|Infusion2||0
8193805|NCT02267317|20203092|P4|COMPLETED|Infusion2||2
8193806|NCT02267317|20203093|P3|COMPLETED|Infusion2||1
8193807|NCT02267317|20203094|P2|COMPLETED|Infusion2||3
8193808|NCT02267317|20203095|P1|COMPLETED|Infusion2||6
8193809|NCT02267317|20203090|P6|STARTED|Infusion2||1
8193810|NCT02267317|20203091|P5|STARTED|Infusion2||0
8193811|NCT02267317|20203092|P4|STARTED|Infusion2||2
8193812|NCT02267317|20203093|P3|STARTED|Infusion2||1
8193813|NCT02267317|20203094|P2|STARTED|Infusion2||3
8193814|NCT02267317|20203095|P1|STARTED|Infusion2||6
8193815|NCT02267317|20203090|P6|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193816|NCT02267317|20203091|P5|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193817|NCT02267317|20203092|P4|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193818|NCT02267317|20203093|P3|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193819|NCT02267317|20203094|P2|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193820|NCT02267317|20203095|P1|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
8193821|NCT02267317|20203090|P6|COMPLETED|Washout (3-4weeks Between Infusions)||1
8193822|NCT02267317|20203091|P5|COMPLETED|Washout (3-4weeks Between Infusions)||0
8193823|NCT02267317|20203092|P4|COMPLETED|Washout (3-4weeks Between Infusions)||2
8193824|NCT02267317|20203093|P3|COMPLETED|Washout (3-4weeks Between Infusions)||1
8193825|NCT02267317|20203094|P2|COMPLETED|Washout (3-4weeks Between Infusions)||3
8193826|NCT02267317|20203095|P1|COMPLETED|Washout (3-4weeks Between Infusions)||6
8193827|NCT02267317|20203090|P6|STARTED|Washout (3-4weeks Between Infusions)||1
8193828|NCT02267317|20203091|P5|STARTED|Washout (3-4weeks Between Infusions)||0
8193829|NCT02267317|20203092|P4|STARTED|Washout (3-4weeks Between Infusions)||2
8193830|NCT02267317|20203093|P3|STARTED|Washout (3-4weeks Between Infusions)||1
8193831|NCT02267317|20203094|P2|STARTED|Washout (3-4weeks Between Infusions)||3
8193832|NCT02267317|20203095|P1|STARTED|Washout (3-4weeks Between Infusions)||8
8193833|NCT02267317|20203090|P6|NOT COMPLETED|Infusion1||0
8193834|NCT02267317|20203091|P5|NOT COMPLETED|Infusion1||0
8193835|NCT02267317|20203092|P4|NOT COMPLETED|Infusion1||0
8193836|NCT02267317|20203093|P3|NOT COMPLETED|Infusion1||0
8193837|NCT02267317|20203094|P2|NOT COMPLETED|Infusion1||0
8193838|NCT02267317|20203095|P1|NOT COMPLETED|Infusion1||0
8193839|NCT02267317|20203090|P6|COMPLETED|Infusion1||1
8193840|NCT02267317|20203091|P5|COMPLETED|Infusion1||0
8193841|NCT02267317|20203092|P4|COMPLETED|Infusion1||2
8193842|NCT02267317|20203093|P3|COMPLETED|Infusion1||1
8193843|NCT02267317|20203094|P2|COMPLETED|Infusion1||3
8193844|NCT02267317|20203095|P1|COMPLETED|Infusion1||8
8193845|NCT02267317|20203090|P6|STARTED|Infusion1||1
8193846|NCT02267317|20203091|P5|STARTED|Infusion1||0
8193847|NCT02267317|20203092|P4|STARTED|Infusion1||2
8193848|NCT02267317|20203093|P3|STARTED|Infusion1||1
8193849|NCT02267317|20203094|P2|STARTED|Infusion1||3
8193850|NCT02267317|20203095|P1|STARTED|Infusion1||8
8193851|NCT02267278|20203145|P1|NOT COMPLETED|Overall Study||5
8193852|NCT02267278|20203145|P1|COMPLETED|Overall Study||20
8193853|NCT02267278|20203145|P1|STARTED|Overall Study||25
8193854|NCT02267226|20203150|P1|NOT COMPLETED|Overall Study||7
8193855|NCT02267226|20203150|P1|COMPLETED|Overall Study||18
8193856|NCT02267226|20203150|P1|Surgical Prophylaxis Population|Overall Study||9
8193857|NCT02267226|20203150|P1|FAS-Bleeding Population|Overall Study||24
8193858|NCT02267226|20203150|P1|SAFETY Population|Overall Study||25
8193859|NCT02267226|20203150|P1|STARTED|Overall Study||25
8193860|NCT02267187|20203169|P1|NOT COMPLETED|Overall Study||5
8193861|NCT02267187|20203169|P1|COMPLETED|Overall Study||10
8193862|NCT02267187|20203169|P1|STARTED|Overall Study||15
8193863|NCT02267135|20203177|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
8193864|NCT02267135|20203178|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
8193865|NCT02267135|20203177|P2|COMPLETED|Period 2 (Randomized Set)||46
8193866|NCT02267135|20203178|P1|COMPLETED|Period 2 (Randomized Set)||46
8193867|NCT02267135|20203177|P2|STARTED|Period 2 (Randomized Set)||47
8193868|NCT02267135|20203178|P1|STARTED|Period 2 (Randomized Set)||50
8193869|NCT02267135|20203177|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
8193870|NCT02267135|20203178|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
8193871|NCT02267135|20203177|P2|COMPLETED|Period 1 (Randomized Set)||47
8193872|NCT02267135|20203178|P1|COMPLETED|Period 1 (Randomized Set)||50
8193873|NCT02267135|20203177|P2|STARTED|Period 1 (Randomized Set)||51
8193874|NCT02267135|20203178|P1|STARTED|Period 1 (Randomized Set)||51
8193875|NCT02267083|20203209|P1|NOT COMPLETED|Overall Study||19
8193876|NCT02267083|20203209|P1|COMPLETED|Overall Study||3
8193877|NCT02267083|20203209|P1|STARTED|Overall Study||22
8193878|NCT02266914|20203216|P1|NOT COMPLETED|Overall Study||9
8193879|NCT02266914|20203216|P1|COMPLETED|Overall Study||0
8193880|NCT02266914|20203216|P1|STARTED|Overall Study||9
8193881|NCT02266888|20203222|P4|NOT COMPLETED|Overall Study||7
8193882|NCT02266888|20203223|P3|NOT COMPLETED|Overall Study||11
8193883|NCT02266888|20203224|P2|NOT COMPLETED|Overall Study||4
8193884|NCT02266888|20203225|P1|NOT COMPLETED|Overall Study||7
8193885|NCT02266888|20203222|P4|COMPLETED|Overall Study||0
8193886|NCT02266888|20203223|P3|COMPLETED|Overall Study||0
8193887|NCT02266888|20203224|P2|COMPLETED|Overall Study||8
8193888|NCT02266888|20203225|P1|COMPLETED|Overall Study||8
8193889|NCT02266888|20203222|P4|STARTED|Overall Study||7
8193890|NCT02266888|20203223|P3|STARTED|Overall Study||11
8193891|NCT02266888|20203224|P2|STARTED|Overall Study||12
8193892|NCT02266888|20203225|P1|STARTED|Overall Study||15
8193893|NCT02266875|20203259|P2|NOT COMPLETED|Overall Study||0
8193894|NCT02266875|20203260|P1|NOT COMPLETED|Overall Study||11
8193895|NCT02266875|20203259|P2|COMPLETED|Overall Study||30
8193896|NCT02266875|20203260|P1|COMPLETED|Overall Study||29
8193897|NCT02266875|20203259|P2|STARTED|Overall Study||30
8193898|NCT02266875|20203260|P1|STARTED|Overall Study||40
8193899|NCT02266810|20203272|P2|NOT COMPLETED|Overall Study||1
8193900|NCT02266810|20203273|P1|NOT COMPLETED|Overall Study||1
8193901|NCT02266810|20203272|P2|COMPLETED|Overall Study|sinus sides|79
8193902|NCT02266810|20203273|P1|COMPLETED|Overall Study|sinus sides|79
8193903|NCT02266810|20203272|P2|STARTED|Overall Study|sinus sides|80
8193904|NCT02266810|20203273|P1|STARTED|Overall Study|sinus sides|80
8193905|NCT02266797|20203299|P2|NOT COMPLETED|Overall Study||1
8193906|NCT02266797|20203300|P1|NOT COMPLETED|Overall Study||0
8193907|NCT02266797|20203299|P2|COMPLETED|Overall Study||2
8193908|NCT02266797|20203300|P1|COMPLETED|Overall Study||1
8193909|NCT02266797|20203299|P2|STARTED|Overall Study||3
8193910|NCT02266797|20203300|P1|STARTED|Overall Study||1
8193911|NCT02266706|20203325|P9|NOT COMPLETED|Overall Study||0
8193912|NCT02266706|20203326|P8|NOT COMPLETED|Overall Study||0
8193913|NCT02266706|20203327|P7|NOT COMPLETED|Overall Study||1
8193914|NCT02266706|20203328|P6|NOT COMPLETED|Overall Study||2
8193915|NCT02266706|20203329|P5|NOT COMPLETED|Overall Study||0
8193916|NCT02266706|20203330|P4|NOT COMPLETED|Overall Study||1
8193917|NCT02266706|20203331|P3|NOT COMPLETED|Overall Study||1
8193918|NCT02266706|20203332|P2|NOT COMPLETED|Overall Study||1
8193919|NCT02266706|20203333|P1|NOT COMPLETED|Overall Study||0
8193920|NCT02266706|20203325|P9|COMPLETED|Overall Study||4
8193921|NCT02266706|20203326|P8|COMPLETED|Overall Study||2
8193922|NCT02266706|20203327|P7|COMPLETED|Overall Study||7
8193923|NCT02266706|20203328|P6|COMPLETED|Overall Study||5
8193924|NCT02266706|20203329|P5|COMPLETED|Overall Study||1
8193925|NCT02266706|20203330|P4|COMPLETED|Overall Study||3
8193926|NCT02266706|20203331|P3|COMPLETED|Overall Study||3
8193927|NCT02266706|20203332|P2|COMPLETED|Overall Study||6
8193928|NCT02266706|20203333|P1|COMPLETED|Overall Study||6
8193929|NCT02266706|20203325|P9|Treated|Overall Study||4
8193930|NCT02266706|20203326|P8|Treated|Overall Study||2
8193931|NCT02266706|20203327|P7|Treated|Overall Study||7
8193932|NCT02266706|20203328|P6|Treated|Overall Study||5
8193933|NCT02266706|20203329|P5|Treated|Overall Study||1
8193934|NCT02266706|20203330|P4|Treated|Overall Study||3
8193935|NCT02266706|20203331|P3|Treated|Overall Study||3
8193936|NCT02266706|20203332|P2|Treated|Overall Study||6
8193937|NCT02266706|20203333|P1|Treated|Overall Study||6
8193938|NCT02266706|20203325|P9|STARTED|Overall Study||4
8193939|NCT02266706|20203326|P8|STARTED|Overall Study||2
8193940|NCT02266706|20203327|P7|STARTED|Overall Study||8
8193941|NCT02266706|20203328|P6|STARTED|Overall Study||7
8193942|NCT02266706|20203329|P5|STARTED|Overall Study||1
8193943|NCT02266706|20203330|P4|STARTED|Overall Study||4
8193944|NCT02266706|20203331|P3|STARTED|Overall Study||4
8193945|NCT02266706|20203332|P2|STARTED|Overall Study||7
8193946|NCT02266706|20203333|P1|STARTED|Overall Study||6
8193947|NCT02266576|20203526|P2|NOT COMPLETED|Overall Study||15
8193948|NCT02266576|20203527|P1|NOT COMPLETED|Overall Study||17
8193949|NCT02266576|20203526|P2|COMPLETED|Overall Study||90
8193950|NCT02266576|20203527|P1|COMPLETED|Overall Study||85
8193951|NCT02266576|20203526|P2|STARTED|Overall Study||105
8193952|NCT02266576|20203527|P1|STARTED|Overall Study||102
8193953|NCT02266472|20203545|P2|NOT COMPLETED|Period 2+ Washout||0
8193954|NCT02266472|20203546|P1|NOT COMPLETED|Period 2+ Washout||0
8193955|NCT02266472|20203545|P2|COMPLETED|Period 2+ Washout||15
8193956|NCT02266472|20203546|P1|COMPLETED|Period 2+ Washout||15
8193957|NCT02266472|20203545|P2|STARTED|Period 2+ Washout||15
8193958|NCT02266472|20203546|P1|STARTED|Period 2+ Washout||15
8193959|NCT02266472|20203545|P2|NOT COMPLETED|Period 1+ Washout||0
8193960|NCT02266472|20203546|P1|NOT COMPLETED|Period 1+ Washout||0
8193961|NCT02266472|20203545|P2|COMPLETED|Period 1+ Washout||15
8193962|NCT02266472|20203546|P1|COMPLETED|Period 1+ Washout||15
8193963|NCT02266472|20203545|P2|STARTED|Period 1+ Washout||15
8193964|NCT02266472|20203546|P1|STARTED|Period 1+ Washout||15
8193965|NCT02266433|20203564|P2|NOT COMPLETED|Overall Study||53
8193966|NCT02266433|20203565|P1|NOT COMPLETED|Overall Study||59
8193967|NCT02266433|20203564|P2|COMPLETED|Overall Study||65
8193968|NCT02266433|20203565|P1|COMPLETED|Overall Study||68
8193969|NCT02266433|20203564|P2|STARTED|Overall Study||118
8193970|NCT02266433|20203565|P1|STARTED|Overall Study||127
8193971|NCT02266381|20203682|P3|NOT COMPLETED|Overall Study||4
8193972|NCT02266381|20203683|P2|NOT COMPLETED|Overall Study||5
8193973|NCT02266381|20203684|P1|NOT COMPLETED|Overall Study||3
8193974|NCT02266381|20203682|P3|COMPLETED|Overall Study||146
8193975|NCT02266381|20203683|P2|COMPLETED|Overall Study||145
8193976|NCT02266381|20203684|P1|COMPLETED|Overall Study||147
8193977|NCT02266381|20203682|P3|STARTED|Overall Study||150
8193978|NCT02266381|20203683|P2|STARTED|Overall Study||150
8193979|NCT02266381|20203684|P1|STARTED|Overall Study||150
8193980|NCT02266277|20203707|P6|NOT COMPLETED|Overall Study||0
8193981|NCT02266277|20203708|P5|NOT COMPLETED|Overall Study||0
8193982|NCT02266277|20203709|P4|NOT COMPLETED|Overall Study||0
8193983|NCT02266277|20203710|P3|NOT COMPLETED|Overall Study||0
8193984|NCT02266277|20203711|P2|NOT COMPLETED|Overall Study||0
8193985|NCT02266277|20203712|P1|NOT COMPLETED|Overall Study||0
8193986|NCT02266277|20203707|P6|COMPLETED|Overall Study||5000
8193987|NCT02266277|20203708|P5|COMPLETED|Overall Study||5000
8193988|NCT02266277|20203709|P4|COMPLETED|Overall Study||5000
8193989|NCT02266277|20203710|P3|COMPLETED|Overall Study||5000
8193990|NCT02266277|20203711|P2|COMPLETED|Overall Study||5000
8193991|NCT02266277|20203712|P1|COMPLETED|Overall Study||5000
8193992|NCT02266277|20203707|P6|STARTED|Overall Study||5000
8193993|NCT02266277|20203708|P5|STARTED|Overall Study||5000
8193994|NCT02266277|20203709|P4|STARTED|Overall Study||5000
8193995|NCT02266277|20203710|P3|STARTED|Overall Study||5000
8193996|NCT02266277|20203711|P2|STARTED|Overall Study||5000
8193997|NCT02266277|20203712|P1|STARTED|Overall Study||5000
8193998|NCT02266225|20203734|P1|NOT COMPLETED|Overall Study||16
8193999|NCT02266225|20203734|P1|COMPLETED|Overall Study||32
8194000|NCT02266225|20203734|P1|Enrolled in Intervention|Overall Study||44
8194001|NCT02266225|20203734|P1|STARTED|Overall Study||48
8194002|NCT02266147|20203759|P4|NOT COMPLETED|PART 2: Dose Expansion||9
8194003|NCT02266147|20203760|P3|NOT COMPLETED|PART 2: Dose Expansion||0
8194004|NCT02266147|20203761|P2|NOT COMPLETED|PART 2: Dose Expansion||0
8194005|NCT02266147|20203762|P1|NOT COMPLETED|PART 2: Dose Expansion||7
8194006|NCT02266147|20203759|P4|COMPLETED|PART 2: Dose Expansion||0
8194007|NCT02266147|20203760|P3|COMPLETED|PART 2: Dose Expansion||0
8194008|NCT02266147|20203761|P2|COMPLETED|PART 2: Dose Expansion||0
8194009|NCT02266147|20203762|P1|COMPLETED|PART 2: Dose Expansion||0
8194010|NCT02266147|20203759|P4|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
8194011|NCT02266147|20203760|P3|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
8194012|NCT02266147|20203761|P2|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
8194013|NCT02266147|20203762|P1|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
8194014|NCT02266147|20203759|P4|NOT COMPLETED|PART 1: Dose Escalation||4
8194015|NCT02266147|20203760|P3|NOT COMPLETED|PART 1: Dose Escalation||3
8194016|NCT02266147|20203761|P2|NOT COMPLETED|PART 1: Dose Escalation||3
8194017|NCT02266147|20203762|P1|NOT COMPLETED|PART 1: Dose Escalation||1
8194018|NCT02266147|20203759|P4|COMPLETED|PART 1: Dose Escalation||0
8194019|NCT02266147|20203760|P3|COMPLETED|PART 1: Dose Escalation||0
8194020|NCT02266147|20203761|P2|COMPLETED|PART 1: Dose Escalation||0
8194021|NCT02266147|20203762|P1|COMPLETED|PART 1: Dose Escalation||2
8194022|NCT02266147|20203759|P4|STARTED|PART 1: Dose Escalation||4
8194023|NCT02266147|20203760|P3|STARTED|PART 1: Dose Escalation||3
8194024|NCT02266147|20203761|P2|STARTED|PART 1: Dose Escalation||3
8194025|NCT02266147|20203762|P1|STARTED|PART 1: Dose Escalation||3
8194026|NCT02266108|20203794|P2|NOT COMPLETED|Overall Study||0
8194027|NCT02266108|20203795|P1|NOT COMPLETED|Overall Study||0
8194028|NCT02266108|20203794|P2|COMPLETED|Overall Study||71
8194029|NCT02266108|20203795|P1|COMPLETED|Overall Study||80
8194030|NCT02266108|20203794|P2|STARTED|Overall Study||71
8194031|NCT02266108|20203795|P1|STARTED|Overall Study||80
8194032|NCT02266004|20203805|P1|NOT COMPLETED|Overall Study||2
8194033|NCT02266004|20203805|P1|COMPLETED|Overall Study||7
8194034|NCT02266004|20203805|P1|STARTED|Overall Study||9
8194035|NCT02265965|20203822|P2|NOT COMPLETED|Overall Study||0
8194036|NCT02265965|20203823|P1|NOT COMPLETED|Overall Study||0
8194037|NCT02265965|20203822|P2|COMPLETED|Overall Study||11
8194038|NCT02265965|20203823|P1|COMPLETED|Overall Study||7
8194039|NCT02265965|20203822|P2|STARTED|Overall Study||11
8194040|NCT02265965|20203823|P1|STARTED|Overall Study||7
8194041|NCT02265952|20203843|P2|NOT COMPLETED|Open Label Extension (OLE) Period||8
8194042|NCT02265952|20203844|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
8194043|NCT02265952|20203843|P2|COMPLETED|Open Label Extension (OLE) Period||0
8194044|NCT02265952|20203844|P1|COMPLETED|Open Label Extension (OLE) Period||0
8194045|NCT02265952|20203843|P2|STARTED|Open Label Extension (OLE) Period||8
8194046|NCT02265952|20203844|P1|STARTED|Open Label Extension (OLE) Period||0
8194047|NCT02265952|20203843|P2|NOT COMPLETED|Main Study Period||0
8194048|NCT02265952|20203844|P1|NOT COMPLETED|Main Study Period||0
8194049|NCT02265952|20203843|P2|COMPLETED|Main Study Period||0
8194050|NCT02265952|20203844|P1|COMPLETED|Main Study Period||9
8194051|NCT02265952|20203843|P2|STARTED|Main Study Period||0
8194052|NCT02265952|20203844|P1|STARTED|Main Study Period||9
8194053|NCT02265913|20203873|P3|NOT COMPLETED|Overall Study||545
8194054|NCT02265913|20203874|P2|NOT COMPLETED|Overall Study||551
8194055|NCT02265913|20203875|P1|NOT COMPLETED|Overall Study||564
8194056|NCT02265913|20203873|P3|COMPLETED|Overall Study||813
8194057|NCT02265913|20203874|P2|COMPLETED|Overall Study||810
8194058|NCT02265913|20203875|P1|COMPLETED|Overall Study||793
8194059|NCT02265913|20203873|P3|STARTED|Overall Study||1358
8194060|NCT02265913|20203874|P2|STARTED|Overall Study||1361
8194061|NCT02265913|20203875|P1|STARTED|Overall Study||1357
8194062|NCT02265848|20203885|P2|NOT COMPLETED|Overall Study||0
8194063|NCT02265848|20203886|P1|NOT COMPLETED|Overall Study||0
8194064|NCT02265848|20203885|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
8194065|NCT02265848|20203886|P1|COMPLETED|Overall Study||11
8194066|NCT02265848|20203885|P2|STARTED|Overall Study||11
8194067|NCT02265848|20203886|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
8194068|NCT02265796|20203900|P2|NOT COMPLETED|Overall Study||1
8194069|NCT02265796|20203901|P1|NOT COMPLETED|Overall Study||3
8194070|NCT02265796|20203900|P2|COMPLETED|Overall Study||24
8194071|NCT02265796|20203901|P1|COMPLETED|Overall Study||22
8194072|NCT02265796|20203900|P2|STARTED|Overall Study||25
8194073|NCT02265796|20203901|P1|STARTED|Overall Study||25
8194074|NCT02265783|20203911|P1|NOT COMPLETED|Overall Study||0
8194075|NCT02265783|20203911|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
8194076|NCT02265783|20203911|P1|STARTED|Overall Study||20
8194077|NCT02265744|20203920|P5|NOT COMPLETED|Overall Study||13
8194078|NCT02265744|20203921|P4|NOT COMPLETED|Overall Study||23
8194079|NCT02265744|20203922|P3|NOT COMPLETED|Overall Study||17
8194080|NCT02265744|20203923|P2|NOT COMPLETED|Overall Study||15
8194081|NCT02265744|20203924|P1|NOT COMPLETED|Overall Study||20
8194082|NCT02265744|20203920|P5|COMPLETED|Overall Study||58
8194083|NCT02265744|20203921|P4|COMPLETED|Overall Study||47
8194084|NCT02265744|20203922|P3|COMPLETED|Overall Study||51
8194085|NCT02265744|20203923|P2|COMPLETED|Overall Study||53
8194086|NCT02265744|20203924|P1|COMPLETED|Overall Study||49
8194087|NCT02265744|20203920|P5|STARTED|Overall Study||71
8194088|NCT02265744|20203921|P4|STARTED|Overall Study||70
8194089|NCT02265744|20203922|P3|STARTED|Overall Study||68
8194090|NCT02265744|20203923|P2|STARTED|Overall Study||68
8194091|NCT02265744|20203924|P1|STARTED|Overall Study||69
8194092|NCT02265705|20204103|P7|NOT COMPLETED|Follow-up Period||11
8194093|NCT02265705|20204104|P6|NOT COMPLETED|Follow-up Period||1
8194094|NCT02265705|20204105|P5|NOT COMPLETED|Follow-up Period||0
8194095|NCT02265705|20204106|P4|NOT COMPLETED|Follow-up Period||0
8194096|NCT02265705|20204107|P3|NOT COMPLETED|Follow-up Period||0
8194097|NCT02265705|20204108|P2|NOT COMPLETED|Follow-up Period||0
8194098|NCT02265705|20204109|P1|NOT COMPLETED|Follow-up Period||0
8194099|NCT02265705|20204103|P7|COMPLETED|Follow-up Period||47
8194100|NCT02265705|20204104|P6|COMPLETED|Follow-up Period||1
8194101|NCT02265705|20204105|P5|COMPLETED|Follow-up Period||0
8194102|NCT02265705|20204106|P4|COMPLETED|Follow-up Period||0
8194103|NCT02265705|20204107|P3|COMPLETED|Follow-up Period||0
8194104|NCT02265705|20204108|P2|COMPLETED|Follow-up Period||0
8194105|NCT02265705|20204109|P1|COMPLETED|Follow-up Period||0
8194106|NCT02265705|20204103|P7|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
8194107|NCT02265705|20204104|P6|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
8194108|NCT02265705|20204105|P5|STARTED|Follow-up Period||0
8194109|NCT02265705|20204106|P4|STARTED|Follow-up Period||0
8194110|NCT02265705|20204107|P3|STARTED|Follow-up Period||0
8194111|NCT02265705|20204108|P2|STARTED|Follow-up Period||0
8194112|NCT02265705|20204109|P1|STARTED|Follow-up Period||0
8194113|NCT02265705|20204103|P7|NOT COMPLETED|Open Label Period||0
8194114|NCT02265705|20204104|P6|NOT COMPLETED|Open Label Period||0
8194115|NCT02265705|20204105|P5|NOT COMPLETED|Open Label Period||5
8194116|NCT02265705|20204106|P4|NOT COMPLETED|Open Label Period||2
8194117|NCT02265705|20204107|P3|NOT COMPLETED|Open Label Period||0
8194118|NCT02265705|20204108|P2|NOT COMPLETED|Open Label Period||0
8194119|NCT02265705|20204109|P1|NOT COMPLETED|Open Label Period||0
8194120|NCT02265705|20204103|P7|COMPLETED|Open Label Period||0
8194121|NCT02265705|20204104|P6|COMPLETED|Open Label Period||0
8194122|NCT02265705|20204105|P5|COMPLETED|Open Label Period||115
8194123|NCT02265705|20204106|P4|COMPLETED|Open Label Period||72
8194124|NCT02265705|20204107|P3|COMPLETED|Open Label Period||0
8194125|NCT02265705|20204108|P2|COMPLETED|Open Label Period||0
8194126|NCT02265705|20204109|P1|COMPLETED|Open Label Period||0
8194127|NCT02265705|20204103|P7|STARTED|Open Label Period||0
8194128|NCT02265705|20204104|P6|STARTED|Open Label Period||0
8194129|NCT02265705|20204105|P5|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
8194130|NCT02265705|20204106|P4|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
8194131|NCT02265705|20204107|P3|STARTED|Open Label Period||0
8194132|NCT02265705|20204108|P2|STARTED|Open Label Period||0
8194133|NCT02265705|20204109|P1|STARTED|Open Label Period||0
8194134|NCT02265705|20204103|P7|NOT COMPLETED|Rescue Period||0
8194135|NCT02265705|20204104|P6|NOT COMPLETED|Rescue Period||0
8194136|NCT02265705|20204105|P5|NOT COMPLETED|Rescue Period||0
8194137|NCT02265705|20204106|P4|NOT COMPLETED|Rescue Period||0
8194138|NCT02265705|20204107|P3|NOT COMPLETED|Rescue Period||3
8194139|NCT02265705|20204108|P2|NOT COMPLETED|Rescue Period||0
8194140|NCT02265705|20204109|P1|NOT COMPLETED|Rescue Period||0
8194141|NCT02265705|20204103|P7|COMPLETED|Rescue Period||0
8194142|NCT02265705|20204104|P6|COMPLETED|Rescue Period||0
8194143|NCT02265705|20204105|P5|COMPLETED|Rescue Period||0
8194144|NCT02265705|20204106|P4|COMPLETED|Rescue Period||0
8194145|NCT02265705|20204107|P3|COMPLETED|Rescue Period||74
8194146|NCT02265705|20204108|P2|COMPLETED|Rescue Period||0
8194147|NCT02265705|20204109|P1|COMPLETED|Rescue Period||0
8194148|NCT02265705|20204103|P7|STARTED|Rescue Period||0
8194149|NCT02265705|20204104|P6|STARTED|Rescue Period||0
8194150|NCT02265705|20204105|P5|STARTED|Rescue Period||0
8194151|NCT02265705|20204106|P4|STARTED|Rescue Period||0
8194152|NCT02265705|20204107|P3|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
8194153|NCT02265705|20204108|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8194154|NCT02265705|20204109|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8194155|NCT02265705|20204103|P7|NOT COMPLETED|Treatment Period Week 0-24||0
8194156|NCT02265705|20204104|P6|NOT COMPLETED|Treatment Period Week 0-24||0
8194157|NCT02265705|20204105|P5|NOT COMPLETED|Treatment Period Week 0-24||0
8194158|NCT02265705|20204106|P4|NOT COMPLETED|Treatment Period Week 0-24||0
8194159|NCT02265705|20204107|P3|NOT COMPLETED|Treatment Period Week 0-24||0
8194160|NCT02265705|20204108|P2|NOT COMPLETED|Treatment Period Week 0-24||9
8194161|NCT02265705|20204109|P1|NOT COMPLETED|Treatment Period Week 0-24||12
8194162|NCT02265705|20204103|P7|COMPLETED|Treatment Period Week 0-24||0
8194163|NCT02265705|20204104|P6|COMPLETED|Treatment Period Week 0-24||0
8194164|NCT02265705|20204105|P5|COMPLETED|Treatment Period Week 0-24||0
8194165|NCT02265705|20204106|P4|COMPLETED|Treatment Period Week 0-24||0
8194166|NCT02265705|20204107|P3|COMPLETED|Treatment Period Week 0-24||0
8194167|NCT02265705|20204108|P2|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
8194168|NCT02265705|20204109|P1|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
8194169|NCT02265705|20204103|P7|Rescued|Treatment Period Week 0-24||0
8194170|NCT02265705|20204104|P6|Rescued|Treatment Period Week 0-24||0
8194171|NCT02265705|20204105|P5|Rescued|Treatment Period Week 0-24||0
8194172|NCT02265705|20204106|P4|Rescued|Treatment Period Week 0-24||0
8194173|NCT02265705|20204107|P3|Rescued|Treatment Period Week 0-24||0
8194174|NCT02265705|20204108|P2|Rescued|Treatment Period Week 0-24||17
8194175|NCT02265705|20204109|P1|Rescued|Treatment Period Week 0-24||59
8194176|NCT02265705|20204103|P7|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194177|NCT02265705|20204104|P6|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194178|NCT02265705|20204105|P5|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194179|NCT02265705|20204106|P4|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194180|NCT02265705|20204107|P3|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194181|NCT02265705|20204108|P2|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
8194182|NCT02265705|20204109|P1|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
8194183|NCT02265705|20204103|P7|STARTED|Treatment Period Week 0-24||0
8194184|NCT02265705|20204104|P6|STARTED|Treatment Period Week 0-24||0
8194185|NCT02265705|20204105|P5|STARTED|Treatment Period Week 0-24||0
8194186|NCT02265705|20204106|P4|STARTED|Treatment Period Week 0-24||0
8194187|NCT02265705|20204107|P3|STARTED|Treatment Period Week 0-24||0
8194188|NCT02265705|20204108|P2|STARTED|Treatment Period Week 0-24||145
8194189|NCT02265705|20204109|P1|STARTED|Treatment Period Week 0-24||145
8194190|NCT02265510|20204148|P14|NOT COMPLETED|Overall Study||10
8194191|NCT02265510|20204149|P13|NOT COMPLETED|Overall Study||9
8194192|NCT02265510|20204150|P12|NOT COMPLETED|Overall Study||16
8194193|NCT02265510|20204151|P11|NOT COMPLETED|Overall Study||5
8194194|NCT02265510|20204152|P10|NOT COMPLETED|Overall Study||7
8194195|NCT02265510|20204153|P9|NOT COMPLETED|Overall Study||4
8194196|NCT02265510|20204154|P8|NOT COMPLETED|Overall Study||4
8194197|NCT02265510|20204155|P7|NOT COMPLETED|Overall Study||3
8194198|NCT02265510|20204156|P6|NOT COMPLETED|Overall Study||6
8194199|NCT02265510|20204157|P5|NOT COMPLETED|Overall Study||3
8194200|NCT02265510|20204158|P4|NOT COMPLETED|Overall Study||4
8194201|NCT02265510|20204159|P3|NOT COMPLETED|Overall Study||6
8194202|NCT02265510|20204160|P2|NOT COMPLETED|Overall Study||3
8194203|NCT02265510|20204161|P1|NOT COMPLETED|Overall Study||3
8194204|NCT02265510|20204148|P14|COMPLETED|Overall Study||0
8194205|NCT02265510|20204149|P13|COMPLETED|Overall Study||0
8194206|NCT02265510|20204150|P12|COMPLETED|Overall Study||0
8194207|NCT02265510|20204151|P11|COMPLETED|Overall Study||0
8194208|NCT02265510|20204152|P10|COMPLETED|Overall Study||0
8194209|NCT02265510|20204153|P9|COMPLETED|Overall Study||0
8194210|NCT02265510|20204154|P8|COMPLETED|Overall Study||0
8194211|NCT02265510|20204155|P7|COMPLETED|Overall Study||0
8194212|NCT02265510|20204156|P6|COMPLETED|Overall Study||0
8194213|NCT02265510|20204157|P5|COMPLETED|Overall Study||0
8194214|NCT02265510|20204158|P4|COMPLETED|Overall Study||0
8194215|NCT02265510|20204159|P3|COMPLETED|Overall Study||0
8194216|NCT02265510|20204160|P2|COMPLETED|Overall Study||0
8194217|NCT02265510|20204161|P1|COMPLETED|Overall Study||0
8194218|NCT02265510|20204148|P14|STARTED|Overall Study||10
8194219|NCT02265510|20204149|P13|STARTED|Overall Study||9
8194220|NCT02265510|20204150|P12|STARTED|Overall Study||16
8194221|NCT02265510|20204151|P11|STARTED|Overall Study||5
8194222|NCT02265510|20204152|P10|STARTED|Overall Study||7
8194223|NCT02265510|20204153|P9|STARTED|Overall Study||4
8194224|NCT02265510|20204154|P8|STARTED|Overall Study||4
8194225|NCT02265510|20204155|P7|STARTED|Overall Study||3
8194226|NCT02265510|20204156|P6|STARTED|Overall Study||6
8194227|NCT02265510|20204157|P5|STARTED|Overall Study||3
8194228|NCT02265510|20204158|P4|STARTED|Overall Study||4
8194229|NCT02265510|20204159|P3|STARTED|Overall Study||6
8194230|NCT02265510|20204160|P2|STARTED|Overall Study||3
8194231|NCT02265510|20204161|P1|STARTED|Overall Study||3
8194232|NCT02265341|20204249|P1|NOT COMPLETED|Overall Study||0
8194233|NCT02265341|20204249|P1|COMPLETED|Overall Study||12
8194234|NCT02265341|20204249|P1|STARTED|Overall Study||12
8194235|NCT02265237|20204261|P4|NOT COMPLETED|As Treated (Overall Study)||1
8194236|NCT02265237|20204262|P3|NOT COMPLETED|As Treated (Overall Study)||10
8194237|NCT02265237|20204263|P2|NOT COMPLETED|As Treated (Overall Study)||3
8194238|NCT02265237|20204264|P1|NOT COMPLETED|As Treated (Overall Study)||5
8194239|NCT02265237|20204261|P4|COMPLETED|As Treated (Overall Study)||2
8194240|NCT02265237|20204262|P3|COMPLETED|As Treated (Overall Study)||51
8194241|NCT02265237|20204263|P2|COMPLETED|As Treated (Overall Study)||57
8194242|NCT02265237|20204264|P1|COMPLETED|As Treated (Overall Study)||55
8194243|NCT02265237|20204261|P4|STARTED|As Treated (Overall Study)||3
8194244|NCT02265237|20204262|P3|STARTED|As Treated (Overall Study)||61
8194245|NCT02265237|20204263|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
8194246|NCT02265237|20204264|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
8194247|NCT02265237|20204261|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
8194248|NCT02265237|20204262|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
8194249|NCT02265237|20204263|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
8194250|NCT02265237|20204264|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
8194251|NCT02265237|20204261|P4|COMPLETED|As Enrolled (Overall Study)||2
8194252|NCT02265237|20204262|P3|COMPLETED|As Enrolled (Overall Study)||51
8194253|NCT02265237|20204263|P2|COMPLETED|As Enrolled (Overall Study)||58
8194254|NCT02265237|20204264|P1|COMPLETED|As Enrolled (Overall Study)||54
8194255|NCT02265237|20204261|P4|STARTED|As Enrolled (Overall Study)||3
8194256|NCT02265237|20204262|P3|STARTED|As Enrolled (Overall Study)||61
8194257|NCT02265237|20204263|P2|STARTED|As Enrolled (Overall Study)||61
8194258|NCT02265237|20204264|P1|STARTED|As Enrolled (Overall Study)||59
8194259|NCT02264977|20204283|P1|NOT COMPLETED|Overall Study||5
8194260|NCT02264977|20204283|P1|COMPLETED|Overall Study||4
8194261|NCT02264977|20204283|P1|STARTED|Overall Study||9
8194262|NCT02264821|20204294|P3|NOT COMPLETED|Overall Study||6
8194263|NCT02264821|20204295|P2|NOT COMPLETED|Overall Study||3
8194264|NCT02264821|20204296|P1|NOT COMPLETED|Overall Study||1
8194265|NCT02264821|20204294|P3|COMPLETED|Overall Study||58
8194266|NCT02264821|20204295|P2|COMPLETED|Overall Study||61
8194267|NCT02264821|20204296|P1|COMPLETED|Overall Study||63
8194268|NCT02264821|20204294|P3|STARTED|Overall Study|Double Blind|64
8194269|NCT02264821|20204295|P2|STARTED|Overall Study|Double Blind|64
8194270|NCT02264821|20204296|P1|STARTED|Overall Study|Double Blind|64
8194271|NCT02264639|20204312|P5|NOT COMPLETED|Overall Study||1
8194272|NCT02264639|20204313|P4|NOT COMPLETED|Overall Study||0
8194273|NCT02264639|20204314|P3|NOT COMPLETED|Overall Study||1
8194274|NCT02264639|20204315|P2|NOT COMPLETED|Overall Study||0
8194275|NCT02264639|20204316|P1|NOT COMPLETED|Overall Study||2
8194276|NCT02264639|20204312|P5|COMPLETED|Overall Study||3
8194277|NCT02264639|20204313|P4|COMPLETED|Overall Study||1
8194278|NCT02264639|20204314|P3|COMPLETED|Overall Study||0
8194279|NCT02264639|20204315|P2|COMPLETED|Overall Study||1
8194280|NCT02264639|20204316|P1|COMPLETED|Overall Study||0
8194281|NCT02264639|20204312|P5|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
8194282|NCT02264639|20204313|P4|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
8194283|NCT02264639|20204314|P3|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
8194284|NCT02264639|20204315|P2|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
8194285|NCT02264639|20204316|P1|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
8194286|NCT02264574|20204334|P2|NOT COMPLETED|Overall Study||30
8194287|NCT02264574|20204335|P1|NOT COMPLETED|Overall Study||29
8194288|NCT02264574|20204334|P2|COMPLETED|Overall Study||86
8194289|NCT02264574|20204335|P1|COMPLETED|Overall Study||84
8194290|NCT02264574|20204334|P2|STARTED|Overall Study||116
8194291|NCT02264574|20204335|P1|STARTED|Overall Study||113
8194292|NCT02264353|20204371|P2|NOT COMPLETED|Overall Study||0
8194293|NCT02264353|20204372|P1|NOT COMPLETED|Overall Study||3
8194294|NCT02264353|20204371|P2|COMPLETED|Overall Study||24
8194295|NCT02264353|20204372|P1|COMPLETED|Overall Study||17
8194296|NCT02264353|20204371|P2|STARTED|Overall Study||24
8194297|NCT02264353|20204372|P1|STARTED|Overall Study||20
8194298|NCT02264249|20204385|P3|NOT COMPLETED|Overall Study||0
8194299|NCT02264249|20204386|P2|NOT COMPLETED|Overall Study||0
8194300|NCT02264249|20204387|P1|NOT COMPLETED|Overall Study||0
8194301|NCT02264249|20204385|P3|COMPLETED|Overall Study||241
8194302|NCT02264249|20204386|P2|COMPLETED|Overall Study||187
8194303|NCT02264249|20204387|P1|COMPLETED|Overall Study||21
8194304|NCT02264249|20204385|P3|STARTED|Overall Study||241
8194305|NCT02264249|20204386|P2|STARTED|Overall Study||187
8194306|NCT02264249|20204387|P1|STARTED|Overall Study||21
8194307|NCT02263911|20204401|P4|NOT COMPLETED|Period 5||0
8194308|NCT02263911|20204402|P3|NOT COMPLETED|Period 5||0
8194309|NCT02263911|20204403|P2|NOT COMPLETED|Period 5||0
8194310|NCT02263911|20204404|P1|NOT COMPLETED|Period 5||0
8194311|NCT02263911|20204401|P4|COMPLETED|Period 5||4
8194312|NCT02263911|20204402|P3|COMPLETED|Period 5||4
8194313|NCT02263911|20204403|P2|COMPLETED|Period 5||4
8194314|NCT02263911|20204404|P1|COMPLETED|Period 5||4
8194315|NCT02263911|20204401|P4|STARTED|Period 5||4
8194316|NCT02263911|20204402|P3|STARTED|Period 5||4
8194317|NCT02263911|20204403|P2|STARTED|Period 5||4
8194318|NCT02263911|20204404|P1|STARTED|Period 5||4
8194319|NCT02263911|20204401|P4|NOT COMPLETED|Period 4 Washout||0
8194320|NCT02263911|20204402|P3|NOT COMPLETED|Period 4 Washout||0
8194321|NCT02263911|20204403|P2|NOT COMPLETED|Period 4 Washout||0
8194322|NCT02263911|20204404|P1|NOT COMPLETED|Period 4 Washout||0
8194323|NCT02263911|20204401|P4|COMPLETED|Period 4 Washout||4
8194324|NCT02263911|20204402|P3|COMPLETED|Period 4 Washout||4
8194325|NCT02263911|20204403|P2|COMPLETED|Period 4 Washout||4
8194326|NCT02263911|20204404|P1|COMPLETED|Period 4 Washout||4
8194327|NCT02263911|20204401|P4|STARTED|Period 4 Washout||4
8194328|NCT02263911|20204402|P3|STARTED|Period 4 Washout||4
8194329|NCT02263911|20204403|P2|STARTED|Period 4 Washout||4
8194330|NCT02263911|20204404|P1|STARTED|Period 4 Washout||4
8194331|NCT02263911|20204401|P4|NOT COMPLETED|Period 4||0
8194332|NCT02263911|20204402|P3|NOT COMPLETED|Period 4||0
8194333|NCT02263911|20204403|P2|NOT COMPLETED|Period 4||0
8194334|NCT02263911|20204404|P1|NOT COMPLETED|Period 4||0
8194335|NCT02263911|20204401|P4|COMPLETED|Period 4||4
8194336|NCT02263911|20204402|P3|COMPLETED|Period 4||4
8194337|NCT02263911|20204403|P2|COMPLETED|Period 4||4
8194338|NCT02263911|20204404|P1|COMPLETED|Period 4||4
8194339|NCT02263911|20204401|P4|STARTED|Period 4||4
8194340|NCT02263911|20204402|P3|STARTED|Period 4||4
8194341|NCT02263911|20204403|P2|STARTED|Period 4||4
8194342|NCT02263911|20204404|P1|STARTED|Period 4||4
8194343|NCT02263911|20204401|P4|NOT COMPLETED|Period 3 Washout||0
8194344|NCT02263911|20204402|P3|NOT COMPLETED|Period 3 Washout||0
8194345|NCT02263911|20204403|P2|NOT COMPLETED|Period 3 Washout||0
8194346|NCT02263911|20204404|P1|NOT COMPLETED|Period 3 Washout||0
8194347|NCT02263911|20204401|P4|COMPLETED|Period 3 Washout||4
8194348|NCT02263911|20204402|P3|COMPLETED|Period 3 Washout||4
8194349|NCT02263911|20204403|P2|COMPLETED|Period 3 Washout||4
8194350|NCT02263911|20204404|P1|COMPLETED|Period 3 Washout||4
8194351|NCT02263911|20204401|P4|STARTED|Period 3 Washout||4
8194352|NCT02263911|20204402|P3|STARTED|Period 3 Washout||4
8194353|NCT02263911|20204403|P2|STARTED|Period 3 Washout||4
8194354|NCT02263911|20204404|P1|STARTED|Period 3 Washout||4
8194355|NCT02263911|20204401|P4|NOT COMPLETED|Period 3||0
8194356|NCT02263911|20204402|P3|NOT COMPLETED|Period 3||0
8194357|NCT02263911|20204403|P2|NOT COMPLETED|Period 3||0
8194358|NCT02263911|20204404|P1|NOT COMPLETED|Period 3||0
8194359|NCT02263911|20204401|P4|COMPLETED|Period 3||4
8194360|NCT02263911|20204402|P3|COMPLETED|Period 3||4
8194361|NCT02263911|20204403|P2|COMPLETED|Period 3||4
8194362|NCT02263911|20204404|P1|COMPLETED|Period 3||4
8194363|NCT02263911|20204401|P4|STARTED|Period 3||4
8194364|NCT02263911|20204402|P3|STARTED|Period 3||4
8194365|NCT02263911|20204403|P2|STARTED|Period 3||4
8194366|NCT02263911|20204404|P1|STARTED|Period 3||4
8194367|NCT02263911|20204401|P4|NOT COMPLETED|Period 2 Washout||0
8194368|NCT02263911|20204402|P3|NOT COMPLETED|Period 2 Washout||0
8194369|NCT02263911|20204403|P2|NOT COMPLETED|Period 2 Washout||0
8194370|NCT02263911|20204404|P1|NOT COMPLETED|Period 2 Washout||0
8194371|NCT02263911|20204401|P4|COMPLETED|Period 2 Washout||4
8194372|NCT02263911|20204402|P3|COMPLETED|Period 2 Washout||4
8194373|NCT02263911|20204403|P2|COMPLETED|Period 2 Washout||4
8194374|NCT02263911|20204404|P1|COMPLETED|Period 2 Washout||4
8194375|NCT02263911|20204401|P4|STARTED|Period 2 Washout||4
8194376|NCT02263911|20204402|P3|STARTED|Period 2 Washout||4
8194377|NCT02263911|20204403|P2|STARTED|Period 2 Washout||4
8194378|NCT02263911|20204404|P1|STARTED|Period 2 Washout||4
8194379|NCT02263911|20204401|P4|NOT COMPLETED|Period 2||0
8194380|NCT02263911|20204402|P3|NOT COMPLETED|Period 2||0
8194381|NCT02263911|20204403|P2|NOT COMPLETED|Period 2||0
8194382|NCT02263911|20204404|P1|NOT COMPLETED|Period 2||0
8194383|NCT02263911|20204401|P4|COMPLETED|Period 2||4
8194384|NCT02263911|20204402|P3|COMPLETED|Period 2||4
8194385|NCT02263911|20204403|P2|COMPLETED|Period 2||4
8194386|NCT02263911|20204404|P1|COMPLETED|Period 2||4
8194387|NCT02263911|20204401|P4|STARTED|Period 2||4
8194388|NCT02263911|20204402|P3|STARTED|Period 2||4
8194389|NCT02263911|20204403|P2|STARTED|Period 2||4
8194390|NCT02263911|20204404|P1|STARTED|Period 2||4
8194391|NCT02263911|20204401|P4|NOT COMPLETED|Period 1 Washout||0
8194392|NCT02263911|20204402|P3|NOT COMPLETED|Period 1 Washout||0
8194393|NCT02263911|20204403|P2|NOT COMPLETED|Period 1 Washout||0
8194394|NCT02263911|20204404|P1|NOT COMPLETED|Period 1 Washout||0
8194395|NCT02263911|20204401|P4|COMPLETED|Period 1 Washout||4
8194396|NCT02263911|20204402|P3|COMPLETED|Period 1 Washout||4
8194397|NCT02263911|20204403|P2|COMPLETED|Period 1 Washout||4
8194398|NCT02263911|20204404|P1|COMPLETED|Period 1 Washout||4
8194399|NCT02263911|20204401|P4|STARTED|Period 1 Washout||4
8194400|NCT02263911|20204402|P3|STARTED|Period 1 Washout||4
8194401|NCT02263911|20204403|P2|STARTED|Period 1 Washout||4
8194402|NCT02263911|20204404|P1|STARTED|Period 1 Washout||4
8194403|NCT02263911|20204401|P4|NOT COMPLETED|Period 1||0
8194404|NCT02263911|20204402|P3|NOT COMPLETED|Period 1||0
8194405|NCT02263911|20204403|P2|NOT COMPLETED|Period 1||0
8194406|NCT02263911|20204404|P1|NOT COMPLETED|Period 1||0
8194407|NCT02263911|20204401|P4|COMPLETED|Period 1||4
8194408|NCT02263911|20204402|P3|COMPLETED|Period 1||4
8194409|NCT02263911|20204403|P2|COMPLETED|Period 1||4
8194410|NCT02263911|20204404|P1|COMPLETED|Period 1||4
8194411|NCT02263911|20204401|P4|STARTED|Period 1||4
8194412|NCT02263911|20204402|P3|STARTED|Period 1||4
8194413|NCT02263911|20204403|P2|STARTED|Period 1||4
8194414|NCT02263911|20204404|P1|STARTED|Period 1||4
8194415|NCT02263833|20204426|P1|NOT COMPLETED|Overall Study||0
8194416|NCT02263833|20204426|P1|COMPLETED|Overall Study||742
8194417|NCT02263833|20204426|P1|STARTED|Overall Study||742
8194418|NCT02263547|20204431|P1|NOT COMPLETED|Overall Study||3
8194419|NCT02263547|20204431|P1|COMPLETED|Overall Study||11
8194420|NCT02263547|20204431|P1|STARTED|Overall Study||14
8194421|NCT02263365|20204438|P2|NOT COMPLETED|Overall Study||18
8194422|NCT02263365|20204439|P1|NOT COMPLETED|Overall Study||22
8194423|NCT02263365|20204438|P2|COMPLETED|Overall Study||0
8194424|NCT02263365|20204439|P1|COMPLETED|Overall Study||0
8194425|NCT02263365|20204438|P2|STARTED|Overall Study||18
8194426|NCT02263365|20204439|P1|STARTED|Overall Study||22
8194427|NCT02263326|20204453|P2|NOT COMPLETED|Overall Study||1
8194428|NCT02263326|20204454|P1|NOT COMPLETED|Overall Study||1
8194429|NCT02263326|20204453|P2|COMPLETED|Overall Study||44
8194430|NCT02263326|20204454|P1|COMPLETED|Overall Study||43
8194431|NCT02263326|20204453|P2|STARTED|Overall Study||45
8194432|NCT02263326|20204454|P1|STARTED|Overall Study||44
8194433|NCT02263131|20204476|P2|NOT COMPLETED|Overall Study||1
8194434|NCT02263131|20204477|P1|NOT COMPLETED|Overall Study||10
8194435|NCT02263131|20204476|P2|COMPLETED|Overall Study||68
8194436|NCT02263131|20204477|P1|COMPLETED|Overall Study||337
8194437|NCT02263131|20204476|P2|STARTED|Overall Study||69
8194438|NCT02263131|20204477|P1|STARTED|Overall Study||347
8194439|NCT02263118|20204499|P4|NOT COMPLETED|Overall Study||2
8194440|NCT02263118|20204500|P3|NOT COMPLETED|Overall Study||8
8194441|NCT02263118|20204501|P2|NOT COMPLETED|Overall Study||8
8194442|NCT02263118|20204502|P1|NOT COMPLETED|Overall Study||4
8194443|NCT02263118|20204499|P4|COMPLETED|Overall Study||12
8194444|NCT02263118|20204500|P3|COMPLETED|Overall Study||22
8194445|NCT02263118|20204501|P2|COMPLETED|Overall Study||24
8194446|NCT02263118|20204502|P1|COMPLETED|Overall Study||20
8194447|NCT02263118|20204499|P4|STARTED|Overall Study||14
8194448|NCT02263118|20204500|P3|STARTED|Overall Study||30
8194449|NCT02263118|20204501|P2|STARTED|Overall Study||32
8194450|NCT02263118|20204502|P1|STARTED|Overall Study||24
8194451|NCT02263079|20204527|P3|NOT COMPLETED|Overall Study||0
8194452|NCT02263079|20204528|P2|NOT COMPLETED|Overall Study||8
8194453|NCT02263079|20204529|P1|NOT COMPLETED|Overall Study||3
8194454|NCT02263079|20204527|P3|COMPLETED|Overall Study|Completed study but not included in the analysis|3
8194455|NCT02263079|20204528|P2|COMPLETED|Overall Study||25
8194456|NCT02263079|20204529|P1|COMPLETED|Overall Study||23
8194457|NCT02263079|20204527|P3|STARTED|Overall Study||3
8194458|NCT02263079|20204528|P2|STARTED|Overall Study||33
8194459|NCT02263079|20204529|P1|STARTED|Overall Study||26
8194460|NCT02263040|20204557|P2|NOT COMPLETED|Overall Study||0
8194461|NCT02263040|20204558|P1|NOT COMPLETED|Overall Study||0
8194462|NCT02263040|20204557|P2|COMPLETED|Overall Study||83
8194463|NCT02263040|20204558|P1|COMPLETED|Overall Study||87
8194464|NCT02263040|20204557|P2|STARTED|Overall Study||83
8194465|NCT02263040|20204558|P1|STARTED|Overall Study||87
8194466|NCT02263014|20204588|P2|NOT COMPLETED|Overall Study||0
8194467|NCT02263014|20204589|P1|NOT COMPLETED|Overall Study||0
8194468|NCT02263014|20204588|P2|COMPLETED|Overall Study||208
8194469|NCT02263014|20204589|P1|COMPLETED|Overall Study||44
8194470|NCT02263014|20204588|P2|STARTED|Overall Study||208
8194471|NCT02263014|20204589|P1|STARTED|Overall Study||44
8194472|NCT02262754|20204600|P3|NOT COMPLETED|Overall Study||9
8194473|NCT02262754|20204601|P2|NOT COMPLETED|Overall Study||9
8194474|NCT02262754|20204602|P1|NOT COMPLETED|Overall Study||16
8194475|NCT02262754|20204600|P3|COMPLETED|Overall Study||65
8194476|NCT02262754|20204601|P2|COMPLETED|Overall Study||65
8194477|NCT02262754|20204602|P1|COMPLETED|Overall Study||58
8194478|NCT02262754|20204600|P3|STARTED|Overall Study||74
8194479|NCT02262754|20204601|P2|STARTED|Overall Study||74
8194480|NCT02262754|20204602|P1|STARTED|Overall Study||74
8194481|NCT02262728|20204677|P2|NOT COMPLETED|Follow-up Phase (3 Years)||3
8194482|NCT02262728|20204678|P1|NOT COMPLETED|Follow-up Phase (3 Years)||4
8194483|NCT02262728|20204677|P2|COMPLETED|Follow-up Phase (3 Years)||18
8194484|NCT02262728|20204678|P1|COMPLETED|Follow-up Phase (3 Years)||15
8194485|NCT02262728|20204677|P2|STARTED|Follow-up Phase (3 Years)||21
8194486|NCT02262728|20204678|P1|STARTED|Follow-up Phase (3 Years)||19
8194487|NCT02262728|20204677|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
8194488|NCT02262728|20204678|P1|NOT COMPLETED|Treatment Period (12 Weeks)||0
8194489|NCT02262728|20204677|P2|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
8194490|NCT02262728|20204678|P1|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
8194491|NCT02262728|20204677|P2|STARTED|Treatment Period (12 Weeks)||21
8194492|NCT02262728|20204678|P1|STARTED|Treatment Period (12 Weeks)||19
8194493|NCT02262507|20204708|P1|NOT COMPLETED|Overall Study||0
8194494|NCT02262507|20204708|P1|COMPLETED|Overall Study||410
8194495|NCT02262507|20204708|P1|STARTED|Overall Study||410
8194496|NCT02262377|20204715|P2|NOT COMPLETED|Overall Study||6
8194497|NCT02262377|20204716|P1|NOT COMPLETED|Overall Study||12
8194498|NCT02262377|20204715|P2|COMPLETED|Overall Study||73
8194499|NCT02262377|20204716|P1|COMPLETED|Overall Study||68
8194500|NCT02262377|20204715|P2|STARTED|Overall Study||79
8194501|NCT02262377|20204716|P1|STARTED|Overall Study||80
8194502|NCT02262364|20204731|P1|NOT COMPLETED|Follow-Up Through 12 Months||0
8194503|NCT02262364|20204731|P1|COMPLETED|Follow-Up Through 12 Months||10
8194504|NCT02262364|20204731|P1|STARTED|Follow-Up Through 12 Months||10
8194505|NCT02262364|20204731|P1|NOT COMPLETED|Injection With APS||0
8194506|NCT02262364|20204731|P1|COMPLETED|Injection With APS||10
8194507|NCT02262364|20204731|P1|STARTED|Injection With APS||10
8194508|NCT02262364|20204731|P1|NOT COMPLETED|Blood Draw for Device Processing||1
8194509|NCT02262364|20204731|P1|COMPLETED|Blood Draw for Device Processing||10
8194510|NCT02262364|20204731|P1|STARTED|Blood Draw for Device Processing||11
8194511|NCT02262364|20204731|P1|NOT COMPLETED|Study Enrollment||0
8194512|NCT02262364|20204731|P1|COMPLETED|Study Enrollment||11
8194513|NCT02262364|20204731|P1|STARTED|Study Enrollment||11
8194514|NCT02262260|20204740|P2|NOT COMPLETED|Overall Study||10
8194515|NCT02262260|20204741|P1|NOT COMPLETED|Overall Study||11
8194516|NCT02262260|20204740|P2|COMPLETED|Overall Study||32
8194517|NCT02262260|20204741|P1|COMPLETED|Overall Study||34
8194518|NCT02262260|20204740|P2|STARTED|Overall Study||42
8194519|NCT02262260|20204741|P1|STARTED|Overall Study||45
8194520|NCT02262130|20204759|P1|NOT COMPLETED|Overall Study||0
8194521|NCT02262130|20204759|P1|COMPLETED|Overall Study||10
8194522|NCT02262130|20204759|P1|STARTED|Overall Study||10
8194523|NCT02262078|20204769|P2|NOT COMPLETED|Overall Study||0
8194524|NCT02262078|20204770|P1|NOT COMPLETED|Overall Study||0
8194525|NCT02262078|20204769|P2|COMPLETED|Overall Study||13
8194526|NCT02262078|20204770|P1|COMPLETED|Overall Study||13
8194527|NCT02262078|20204769|P2|STARTED|Overall Study||13
8194528|NCT02262078|20204770|P1|STARTED|Overall Study||13
8194529|NCT02262039|20204778|P2|NOT COMPLETED|Overall Study||0
8194530|NCT02262039|20204779|P1|NOT COMPLETED|Overall Study||0
8194531|NCT02262039|20204778|P2|COMPLETED|Overall Study||27
8194532|NCT02262039|20204779|P1|COMPLETED|Overall Study||14
8194533|NCT02262039|20204778|P2|STARTED|Overall Study||27
8194534|NCT02262039|20204779|P1|STARTED|Overall Study||14
8194535|NCT02262000|20204799|P2|NOT COMPLETED|Overall Study||0
8194536|NCT02262000|20204800|P1|NOT COMPLETED|Overall Study||0
8194537|NCT02262000|20204799|P2|COMPLETED|Overall Study||0
8194538|NCT02262000|20204800|P1|COMPLETED|Overall Study||3
8194539|NCT02262000|20204799|P2|STARTED|Overall Study||0
8194540|NCT02262000|20204800|P1|STARTED|Overall Study||3
8194541|NCT02261974|20204810|P2|NOT COMPLETED|Overall Study||7
8194542|NCT02261974|20204811|P1|NOT COMPLETED|Overall Study||15
8194543|NCT02261974|20204810|P2|COMPLETED|Overall Study||56
8194544|NCT02261974|20204811|P1|COMPLETED|Overall Study||108
8194545|NCT02261974|20204810|P2|Treated|Overall Study||57
8194546|NCT02261974|20204811|P1|Treated|Overall Study||117
8194547|NCT02261974|20204810|P2|STARTED|Overall Study||63
8194548|NCT02261974|20204811|P1|STARTED|Overall Study||123
8194549|NCT02261948|20204827|P2|NOT COMPLETED|Overall Study||0
8194550|NCT02261948|20204828|P1|NOT COMPLETED|Overall Study||0
8194551|NCT02261948|20204827|P2|COMPLETED|Overall Study||19
8194552|NCT02261948|20204828|P1|COMPLETED|Overall Study||23
8194553|NCT02261948|20204827|P2|STARTED|Overall Study||19
8194554|NCT02261948|20204828|P1|STARTED|Overall Study||23
8194555|NCT02261818|20204838|P1|NOT COMPLETED|Overall Study||3
8194556|NCT02261818|20204838|P1|COMPLETED|Overall Study||27
8194557|NCT02261818|20204838|P1|STARTED|Overall Study||30
8194558|NCT02261805|20204842|P3|NOT COMPLETED|Overall Study||0
8194559|NCT02261805|20204843|P2|NOT COMPLETED|Overall Study||0
8194560|NCT02261805|20204844|P1|NOT COMPLETED|Overall Study||0
8194561|NCT02261805|20204842|P3|COMPLETED|Overall Study||2
8194562|NCT02261805|20204843|P2|COMPLETED|Overall Study||6
8194563|NCT02261805|20204844|P1|COMPLETED|Overall Study||3
8194564|NCT02261805|20204842|P3|STARTED|Overall Study||2
8194565|NCT02261805|20204843|P2|STARTED|Overall Study||6
8194566|NCT02261805|20204844|P1|STARTED|Overall Study||3
8194567|NCT02261714|20204852|P1|NOT COMPLETED|Overall Study||28
8194568|NCT02261714|20204852|P1|COMPLETED|Overall Study||4
8194569|NCT02261714|20204852|P1|STARTED|Overall Study||32
8194570|NCT02261597|20204861|P2|NOT COMPLETED|Overall Study||0
8194571|NCT02261597|20204862|P1|NOT COMPLETED|Overall Study||0
8194572|NCT02261597|20204861|P2|COMPLETED|Overall Study||22
8194573|NCT02261597|20204862|P1|COMPLETED|Overall Study||22
8194574|NCT02261597|20204861|P2|STARTED|Overall Study||22
8194575|NCT02261597|20204862|P1|STARTED|Overall Study||22
8194576|NCT02261493|20204875|P3|NOT COMPLETED|Overall Study||26
8194577|NCT02261493|20204876|P2|NOT COMPLETED|Overall Study||47
8194578|NCT02261493|20204877|P1|NOT COMPLETED|Overall Study||30
8194579|NCT02261493|20204875|P3|COMPLETED|Overall Study||287
8194580|NCT02261493|20204876|P2|COMPLETED|Overall Study||271
8194581|NCT02261493|20204877|P1|COMPLETED|Overall Study||126
8194582|NCT02261493|20204875|P3|STARTED|Overall Study||313
8194583|NCT02261493|20204876|P2|STARTED|Overall Study||318
8194584|NCT02261493|20204877|P1|STARTED|Overall Study||156
8194585|NCT02261467|20204905|P2|NOT COMPLETED|Overall Study||37
8194586|NCT02261467|20204906|P1|NOT COMPLETED|Overall Study||21
8194587|NCT02261467|20204905|P2|COMPLETED|Overall Study||253
8194588|NCT02261467|20204906|P1|COMPLETED|Overall Study||80
8194589|NCT02261467|20204905|P2|STARTED|Overall Study||290
8194590|NCT02261467|20204906|P1|STARTED|Overall Study||101
8194591|NCT02261428|20204926|P2|NOT COMPLETED|Overall Study||0
8194592|NCT02261428|20204927|P1|NOT COMPLETED|Overall Study||0
8194593|NCT02261428|20204926|P2|COMPLETED|Overall Study||10
8194594|NCT02261428|20204927|P1|COMPLETED|Overall Study||10
8194595|NCT02261428|20204926|P2|STARTED|Overall Study|Washout (30 minutes)|10
8194596|NCT02261428|20204927|P1|STARTED|Overall Study|Washout (30 minutes)|10
8194597|NCT02260986|20204948|P3|NOT COMPLETED|Overall Study||41
8194598|NCT02260986|20204949|P2|NOT COMPLETED|Overall Study||13
8194599|NCT02260986|20204950|P1|NOT COMPLETED|Overall Study||90
8194600|NCT02260986|20204948|P3|COMPLETED|Overall Study||278
8194601|NCT02260986|20204949|P2|COMPLETED|Overall Study||93
8194602|NCT02260986|20204950|P1|COMPLETED|Overall Study||225
8194603|NCT02260986|20204948|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
8194604|NCT02260986|20204949|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
8194605|NCT02260986|20204950|P1|Safety Population|Overall Study||315
8194606|NCT02260986|20204948|P3|STARTED|Overall Study||319
8194607|NCT02260986|20204949|P2|STARTED|Overall Study||106
8194608|NCT02260986|20204950|P1|STARTED|Overall Study||315
8194609|NCT02260934|20205068|P2|NOT COMPLETED|Overall Study||4
8194610|NCT02260934|20205069|P1|NOT COMPLETED|Overall Study||3
8194611|NCT02260934|20205068|P2|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
8194612|NCT02260934|20205069|P1|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
8194613|NCT02260934|20205068|P2|STARTED|Overall Study||21
8194614|NCT02260934|20205069|P1|STARTED|Overall Study||22
8194623|NCT02260882|20205132|P2|NOT COMPLETED|Overall Study||1
8194624|NCT02260882|20205133|P1|NOT COMPLETED|Overall Study||0
8194625|NCT02260882|20205132|P2|COMPLETED|Overall Study||81
8194626|NCT02260882|20205133|P1|COMPLETED|Overall Study||161
8194627|NCT02260882|20205132|P2|STARTED|Overall Study||82
8194628|NCT02260882|20205133|P1|STARTED|Overall Study||161
8194629|NCT02260817|20205157|P2|NOT COMPLETED|Overall Study||37
8194630|NCT02260817|20205158|P1|NOT COMPLETED|Overall Study||0
8194631|NCT02260817|20205157|P2|COMPLETED|Overall Study||58
8194632|NCT02260817|20205158|P1|COMPLETED|Overall Study||14
8194633|NCT02260817|20205157|P2|STARTED|Overall Study||95
8194634|NCT02260817|20205158|P1|STARTED|Overall Study||14
8194635|NCT02260791|20205206|P2|NOT COMPLETED|Overall Study||34
8194636|NCT02260791|20205207|P1|NOT COMPLETED|Overall Study||33
8194637|NCT02260791|20205206|P2|COMPLETED|Overall Study||328
8194638|NCT02260791|20205207|P1|COMPLETED|Overall Study||333
8194639|NCT02260791|20205206|P2|STARTED|Overall Study||362
8194640|NCT02260791|20205207|P1|STARTED|Overall Study||366
8194641|NCT02260648|20205246|P3|NOT COMPLETED|Overall Study||8
8194642|NCT02260648|20205247|P2|NOT COMPLETED|Overall Study||13
8194643|NCT02260648|20205248|P1|NOT COMPLETED|Overall Study||18
8194644|NCT02260648|20205246|P3|COMPLETED|Overall Study||42
8194645|NCT02260648|20205247|P2|COMPLETED|Overall Study||33
8194646|NCT02260648|20205248|P1|COMPLETED|Overall Study||35
8194647|NCT02260648|20205246|P3|Received at Least One Dose of Study Drug|Overall Study||50
8194648|NCT02260648|20205247|P2|Received at Least One Dose of Study Drug|Overall Study||46
8194649|NCT02260648|20205248|P1|Received at Least One Dose of Study Drug|Overall Study||53
8194650|NCT02260648|20205246|P3|STARTED|Overall Study||50
8194651|NCT02260648|20205247|P2|STARTED|Overall Study||46
8194652|NCT02260648|20205248|P1|STARTED|Overall Study||53
8194653|NCT02260635|20205276|P2|NOT COMPLETED|Open-Label Extension||25
8194654|NCT02260635|20205277|P1|NOT COMPLETED|Open-Label Extension||26
8194655|NCT02260635|20205276|P2|COMPLETED|Open-Label Extension||0
8194656|NCT02260635|20205277|P1|COMPLETED|Open-Label Extension||0
8194657|NCT02260635|20205276|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
8194658|NCT02260635|20205277|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
8194659|NCT02260635|20205276|P2|STARTED|Open-Label Extension||25
8194660|NCT02260635|20205277|P1|STARTED|Open-Label Extension||26
8194661|NCT02260635|20205276|P2|NOT COMPLETED|Double-Blind Treatment Period||2
8194662|NCT02260635|20205277|P1|NOT COMPLETED|Double-Blind Treatment Period||1
8194663|NCT02260635|20205276|P2|COMPLETED|Double-Blind Treatment Period||25
8194664|NCT02260635|20205277|P1|COMPLETED|Double-Blind Treatment Period||26
8194665|NCT02260635|20205276|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
8194666|NCT02260635|20205277|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
8194667|NCT02260635|20205276|P2|STARTED|Double-Blind Treatment Period||27
8194668|NCT02260635|20205277|P1|STARTED|Double-Blind Treatment Period||27
8194669|NCT02260622|20205299|P2|NOT COMPLETED|Overall Study||0
8194670|NCT02260622|20205300|P1|NOT COMPLETED|Overall Study||0
8194671|NCT02260622|20205299|P2|COMPLETED|Overall Study||9
8194672|NCT02260622|20205300|P1|COMPLETED|Overall Study||11
8194673|NCT02260622|20205299|P2|STARTED|Overall Study||9
8194674|NCT02260622|20205300|P1|STARTED|Overall Study||11
8194675|NCT02260492|20205329|P3|NOT COMPLETED|Overall Study||5
8194676|NCT02260492|20205330|P2|NOT COMPLETED|Overall Study||13
8194677|NCT02260492|20205331|P1|NOT COMPLETED|Overall Study||23
8194678|NCT02260492|20205329|P3|COMPLETED|Overall Study||37
8194679|NCT02260492|20205330|P2|COMPLETED|Overall Study||406
8194680|NCT02260492|20205331|P1|COMPLETED|Overall Study||395
8194681|NCT02260492|20205329|P3|Completed Day 1|Overall Study||42
8194682|NCT02260492|20205330|P2|Completed Day 1|Overall Study||419
8194683|NCT02260492|20205331|P1|Completed Day 1|Overall Study||418
8194684|NCT02260492|20205329|P3|STARTED|Overall Study||42
8194685|NCT02260492|20205330|P2|STARTED|Overall Study||419
8194686|NCT02260492|20205331|P1|STARTED|Overall Study||418
8194687|NCT02260440|20205345|P1|NOT COMPLETED|Overall Study||0
8194688|NCT02260440|20205345|P1|COMPLETED|Overall Study||31
8194689|NCT02260440|20205345|P1|STARTED|Overall Study||31
8194690|NCT02260401|20205353|P2|NOT COMPLETED|Overall Study||12
8194691|NCT02260401|20205354|P1|NOT COMPLETED|Overall Study||5
8194692|NCT02260401|20205353|P2|COMPLETED|Overall Study||73
8194693|NCT02260401|20205354|P1|COMPLETED|Overall Study||75
8194694|NCT02260401|20205353|P2|STARTED|Overall Study||85
8194695|NCT02260401|20205354|P1|STARTED|Overall Study||80
8194696|NCT02260388|20205364|P4|NOT COMPLETED|Overall Study||4
8194697|NCT02260388|20205365|P3|NOT COMPLETED|Overall Study||3
8194698|NCT02260388|20205366|P2|NOT COMPLETED|Overall Study||8
8194699|NCT02260388|20205367|P1|NOT COMPLETED|Overall Study||2
8194700|NCT02260388|20205364|P4|COMPLETED|Overall Study||65
8194701|NCT02260388|20205365|P3|COMPLETED|Overall Study||70
8194702|NCT02260388|20205366|P2|COMPLETED|Overall Study||118
8194703|NCT02260388|20205367|P1|COMPLETED|Overall Study||132
8194704|NCT02260388|20205364|P4|STARTED|Overall Study||69
8194705|NCT02260388|20205365|P3|STARTED|Overall Study||73
8194706|NCT02260388|20205366|P2|STARTED|Overall Study||126
8194707|NCT02260388|20205367|P1|STARTED|Overall Study||134
8194708|NCT02260180|20205396|P3|NOT COMPLETED|Overall Study||1
8194709|NCT02260180|20205397|P2|NOT COMPLETED|Overall Study||0
8194710|NCT02260180|20205398|P1|NOT COMPLETED|Overall Study||2
8194711|NCT02260180|20205396|P3|COMPLETED|Overall Study||40
8194712|NCT02260180|20205397|P2|COMPLETED|Overall Study||39
8194713|NCT02260180|20205398|P1|COMPLETED|Overall Study||37
8194714|NCT02260180|20205396|P3|STARTED|Overall Study||41
8194715|NCT02260180|20205397|P2|STARTED|Overall Study||39
8194716|NCT02260180|20205398|P1|STARTED|Overall Study||39
8194717|NCT02260154|20205409|P1|NOT COMPLETED|Overall Study||2
8194718|NCT02260154|20205409|P1|COMPLETED|Overall Study||218
8194719|NCT02260154|20205409|P1|STARTED|Overall Study||220
8194720|NCT02259699|20205425|P2|NOT COMPLETED|Overall Study||20
8194721|NCT02259699|20205426|P1|NOT COMPLETED|Overall Study||27
8194722|NCT02259699|20205425|P2|COMPLETED|Overall Study||40
8194723|NCT02259699|20205426|P1|COMPLETED|Overall Study||37
8194724|NCT02259699|20205425|P2|STARTED|Overall Study||60
8194725|NCT02259699|20205426|P1|STARTED|Overall Study||64
8194726|NCT02259608|20205441|P1|NOT COMPLETED|Overall Study||0
8194727|NCT02259608|20205441|P1|COMPLETED|Overall Study||15
8194728|NCT02259608|20205441|P1|STARTED|Overall Study||15
8194729|NCT02259582|20205449|P3|NOT COMPLETED|Overall Study||21
8194730|NCT02259582|20205450|P2|NOT COMPLETED|Overall Study||17
8194731|NCT02259582|20205451|P1|NOT COMPLETED|Overall Study||16
8194732|NCT02259582|20205449|P3|COMPLETED|Overall Study||8
8194733|NCT02259582|20205450|P2|COMPLETED|Overall Study||11
8194734|NCT02259582|20205451|P1|COMPLETED|Overall Study||9
8194735|NCT02259582|20205449|P3|STARTED|Overall Study||29
8194736|NCT02259582|20205450|P2|STARTED|Overall Study||28
8194737|NCT02259582|20205451|P1|STARTED|Overall Study||25
8194738|NCT02259400|20205461|P2|NOT COMPLETED|Overall Study||2
8194739|NCT02259400|20205462|P1|NOT COMPLETED|Overall Study||0
8194740|NCT02259400|20205461|P2|COMPLETED|Overall Study||60
8194741|NCT02259400|20205462|P1|COMPLETED|Overall Study||62
8194742|NCT02259400|20205461|P2|STARTED|Overall Study||62
8194743|NCT02259400|20205462|P1|STARTED|Overall Study||62
8194744|NCT02259348|20205494|P1|NOT COMPLETED|Overall Study||10
8194745|NCT02259348|20205494|P1|COMPLETED|Overall Study||2
8194746|NCT02259348|20205494|P1|One Year Post-transplant|Overall Study||2
8194747|NCT02259348|20205494|P1|STARTED|Overall Study||12
8194748|NCT02259114|20205511|P5|NOT COMPLETED|Overall Study||6
8194749|NCT02259114|20205512|P4|NOT COMPLETED|Overall Study||3
8194750|NCT02259114|20205513|P3|NOT COMPLETED|Overall Study||13
8194751|NCT02259114|20205514|P2|NOT COMPLETED|Overall Study||4
8194752|NCT02259114|20205515|P1|NOT COMPLETED|Overall Study||21
8194753|NCT02259114|20205511|P5|COMPLETED|Overall Study||0
8194754|NCT02259114|20205512|P4|COMPLETED|Overall Study||0
8194755|NCT02259114|20205513|P3|COMPLETED|Overall Study||0
8194756|NCT02259114|20205514|P2|COMPLETED|Overall Study||0
8194757|NCT02259114|20205515|P1|COMPLETED|Overall Study||0
8194758|NCT02259114|20205511|P5|Treated|Overall Study||6
8194759|NCT02259114|20205512|P4|Treated|Overall Study||3
8194760|NCT02259114|20205513|P3|Treated|Overall Study||13
8194761|NCT02259114|20205514|P2|Treated|Overall Study||4
8194762|NCT02259114|20205515|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
8194763|NCT02259114|20205511|P5|STARTED|Overall Study||6
8194764|NCT02259114|20205512|P4|STARTED|Overall Study||3
8194765|NCT02259114|20205513|P3|STARTED|Overall Study||13
8194766|NCT02259114|20205514|P2|STARTED|Overall Study||4
8194767|NCT02259114|20205515|P1|STARTED|Overall Study||21
8194768|NCT02259088|20205574|P2|NOT COMPLETED|Overall Study||14
8194769|NCT02259088|20205575|P1|NOT COMPLETED|Overall Study||28
8194770|NCT02259088|20205574|P2|COMPLETED|Overall Study||63
8194771|NCT02259088|20205575|P1|COMPLETED|Overall Study||279
8194772|NCT02259088|20205574|P2|Treated (Safety Analysis Set)|Overall Study||75
8194773|NCT02259088|20205575|P1|Treated (Safety Analysis Set)|Overall Study||307
8194774|NCT02259088|20205574|P2|Full Analysis Set|Overall Study||77
8194775|NCT02259088|20205575|P1|Full Analysis Set|Overall Study||307
8194776|NCT02259088|20205574|P2|STARTED|Overall Study||77
8194777|NCT02259088|20205575|P1|STARTED|Overall Study||307
8194778|NCT02259010|20205620|P1|NOT COMPLETED|Overall Study||5
8194779|NCT02259010|20205620|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
8194780|NCT02259010|20205620|P1|STARTED|Overall Study||24
8194781|NCT02258659|20205645|P1|NOT COMPLETED|Overall Study||1
8194782|NCT02258659|20205645|P1|COMPLETED|Overall Study||61
8194783|NCT02258659|20205645|P1|STARTED|Overall Study||62
8194784|NCT02258542|20205662|P4|NOT COMPLETED|Overall Study||5
8194785|NCT02258542|20205663|P3|NOT COMPLETED|Overall Study||8
8194786|NCT02258542|20205664|P2|NOT COMPLETED|Overall Study||49
8194787|NCT02258542|20205665|P1|NOT COMPLETED|Overall Study||42
8194788|NCT02258542|20205662|P4|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
8194789|NCT02258542|20205663|P3|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
8194790|NCT02258542|20205664|P2|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
8194791|NCT02258542|20205665|P1|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
8194792|NCT02258542|20205662|P4|Adolescents Only|Overall Study||0
8194793|NCT02258542|20205663|P3|Adolescents Only|Overall Study||0
8194794|NCT02258542|20205664|P2|Adolescents Only|Overall Study||61
8194795|NCT02258542|20205665|P1|Adolescents Only|Overall Study||25
8194796|NCT02258542|20205662|P4|Treated|Overall Study||97
8194797|NCT02258542|20205663|P3|Treated|Overall Study||100
8194798|NCT02258542|20205664|P2|Treated|Overall Study||971
8194799|NCT02258542|20205665|P1|Treated|Overall Study||953
8194800|NCT02258542|20205662|P4|STARTED|Overall Study||97
8194801|NCT02258542|20205663|P3|STARTED|Overall Study||100
8194802|NCT02258542|20205664|P2|STARTED|Overall Study||973
8194803|NCT02258542|20205665|P1|STARTED|Overall Study||953
8194804|NCT02258529|20205889|P1|NOT COMPLETED|Overall Study||10
8194805|NCT02258529|20205889|P1|COMPLETED|Overall Study||0
8194806|NCT02258529|20205889|P1|STARTED|Overall Study||10
8194807|NCT02258477|20205901|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194808|NCT02258477|20205902|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194809|NCT02258477|20205903|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194810|NCT02258477|20205904|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194811|NCT02258477|20205901|P4|COMPLETED|Fourth Intervention (1 Week)||8
8194812|NCT02258477|20205902|P3|COMPLETED|Fourth Intervention (1 Week)||8
8194813|NCT02258477|20205903|P2|COMPLETED|Fourth Intervention (1 Week)||8
8194814|NCT02258477|20205904|P1|COMPLETED|Fourth Intervention (1 Week)||9
8194815|NCT02258477|20205901|P4|STARTED|Fourth Intervention (1 Week)||8
8194816|NCT02258477|20205902|P3|STARTED|Fourth Intervention (1 Week)||8
8194817|NCT02258477|20205903|P2|STARTED|Fourth Intervention (1 Week)||8
8194818|NCT02258477|20205904|P1|STARTED|Fourth Intervention (1 Week)||9
8194819|NCT02258477|20205901|P4|NOT COMPLETED|Third Intervention (1 Week)||0
8194820|NCT02258477|20205902|P3|NOT COMPLETED|Third Intervention (1 Week)||0
8194821|NCT02258477|20205903|P2|NOT COMPLETED|Third Intervention (1 Week)||0
8194822|NCT02258477|20205904|P1|NOT COMPLETED|Third Intervention (1 Week)||0
8194823|NCT02258477|20205901|P4|COMPLETED|Third Intervention (1 Week)||8
8194824|NCT02258477|20205902|P3|COMPLETED|Third Intervention (1 Week)||8
8194825|NCT02258477|20205903|P2|COMPLETED|Third Intervention (1 Week)||8
8194826|NCT02258477|20205904|P1|COMPLETED|Third Intervention (1 Week)||9
8194827|NCT02258477|20205901|P4|STARTED|Third Intervention (1 Week)||8
8194828|NCT02258477|20205902|P3|STARTED|Third Intervention (1 Week)||8
8194829|NCT02258477|20205903|P2|STARTED|Third Intervention (1 Week)||8
8194830|NCT02258477|20205904|P1|STARTED|Third Intervention (1 Week)||9
8194831|NCT02258477|20205901|P4|NOT COMPLETED|Second Intervention (1 Week)||1
8194832|NCT02258477|20205902|P3|NOT COMPLETED|Second Intervention (1 Week)||1
8194833|NCT02258477|20205903|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8194834|NCT02258477|20205904|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8194835|NCT02258477|20205901|P4|COMPLETED|Second Intervention (1 Week)||8
8194836|NCT02258477|20205902|P3|COMPLETED|Second Intervention (1 Week)||8
8194837|NCT02258477|20205903|P2|COMPLETED|Second Intervention (1 Week)||8
8194838|NCT02258477|20205904|P1|COMPLETED|Second Intervention (1 Week)||9
8194839|NCT02258477|20205901|P4|STARTED|Second Intervention (1 Week)||9
8194840|NCT02258477|20205902|P3|STARTED|Second Intervention (1 Week)||9
8194841|NCT02258477|20205903|P2|STARTED|Second Intervention (1 Week)||8
8194842|NCT02258477|20205904|P1|STARTED|Second Intervention (1 Week)||9
8194843|NCT02258477|20205901|P4|NOT COMPLETED|First Intervention (1 Week)||0
8194844|NCT02258477|20205902|P3|NOT COMPLETED|First Intervention (1 Week)||0
8194845|NCT02258477|20205903|P2|NOT COMPLETED|First Intervention (1 Week)||1
8194846|NCT02258477|20205904|P1|NOT COMPLETED|First Intervention (1 Week)||1
8194847|NCT02258477|20205901|P4|COMPLETED|First Intervention (1 Week)||9
8194848|NCT02258477|20205902|P3|COMPLETED|First Intervention (1 Week)||9
8194849|NCT02258477|20205903|P2|COMPLETED|First Intervention (1 Week)||8
8194850|NCT02258477|20205904|P1|COMPLETED|First Intervention (1 Week)||9
8194851|NCT02258477|20205901|P4|STARTED|First Intervention (1 Week)||9
8194852|NCT02258477|20205902|P3|STARTED|First Intervention (1 Week)||9
8194853|NCT02258477|20205903|P2|STARTED|First Intervention (1 Week)||9
8194854|NCT02258477|20205904|P1|STARTED|First Intervention (1 Week)||10
8194855|NCT02258464|20205921|P2|NOT COMPLETED|Overall Study||25
8194856|NCT02258464|20205922|P1|NOT COMPLETED|Overall Study||17
8194857|NCT02258464|20205921|P2|COMPLETED|Overall Study||25
8194858|NCT02258464|20205922|P1|COMPLETED|Overall Study||32
8194859|NCT02258464|20205921|P2|STARTED|Overall Study||50
8194860|NCT02258464|20205922|P1|STARTED|Overall Study||49
8194861|NCT02258412|20205947|P3|NOT COMPLETED|Overall Study||0
8194862|NCT02258412|20205948|P2|NOT COMPLETED|Overall Study||0
8194863|NCT02258412|20205949|P1|NOT COMPLETED|Overall Study||0
8194864|NCT02258412|20205947|P3|COMPLETED|Overall Study||61
8194865|NCT02258412|20205948|P2|COMPLETED|Overall Study||25
8194866|NCT02258412|20205949|P1|COMPLETED|Overall Study||26
8194867|NCT02258412|20205947|P3|STARTED|Overall Study||61
8194868|NCT02258412|20205948|P2|STARTED|Overall Study||25
8194869|NCT02258412|20205949|P1|STARTED|Overall Study||26
8194870|NCT02258373|20205958|P2|NOT COMPLETED|Overall Study||2
8194871|NCT02258373|20205959|P1|NOT COMPLETED|Overall Study||7
8194872|NCT02258373|20205958|P2|COMPLETED|Overall Study||75
8194873|NCT02258373|20205959|P1|COMPLETED|Overall Study||142
8194874|NCT02258373|20205958|P2|STARTED|Overall Study||77
8194875|NCT02258373|20205959|P1|STARTED|Overall Study||149
8194876|NCT02258334|20206003|P4|NOT COMPLETED|Overall Study||0
8194877|NCT02258334|20206004|P3|NOT COMPLETED|Overall Study||0
8194878|NCT02258334|20206005|P2|NOT COMPLETED|Overall Study||0
8194879|NCT02258334|20206006|P1|NOT COMPLETED|Overall Study||1
8194880|NCT02258334|20206003|P4|COMPLETED|Overall Study||52
8194881|NCT02258334|20206004|P3|COMPLETED|Overall Study||52
8194882|NCT02258334|20206005|P2|COMPLETED|Overall Study||54
8194883|NCT02258334|20206006|P1|COMPLETED|Overall Study||49
8194884|NCT02258334|20206003|P4|STARTED|Overall Study||52
8194885|NCT02258334|20206004|P3|STARTED|Overall Study||52
8194886|NCT02258334|20206005|P2|STARTED|Overall Study||54
8194887|NCT02258334|20206006|P1|STARTED|Overall Study||50
8194888|NCT02258256|20206032|P1|NOT COMPLETED|Overall Study||0
8194889|NCT02258256|20206032|P1|COMPLETED|Overall Study||11
8194890|NCT02258256|20206032|P1|STARTED|Overall Study||11
8194891|NCT02258217|20206036|P1|NOT COMPLETED|Overall Study||0
8194892|NCT02258217|20206036|P1|COMPLETED|Overall Study||30
8194893|NCT02258217|20206036|P1|STARTED|Overall Study||30
8194894|NCT02258152|20206050|P2|NOT COMPLETED|Overall Study||4
8194895|NCT02258152|20206051|P1|NOT COMPLETED|Overall Study||6
8194896|NCT02258152|20206050|P2|COMPLETED|Overall Study||34
8194897|NCT02258152|20206051|P1|COMPLETED|Overall Study||38
8194898|NCT02258152|20206050|P2|STARTED|Overall Study||38
8194899|NCT02258152|20206051|P1|STARTED|Overall Study||44
8194900|NCT02258139|20206059|P1|NOT COMPLETED|Overall Study||8
8194901|NCT02258139|20206059|P1|COMPLETED|Overall Study||30
8194902|NCT02258139|20206059|P1|STARTED|Overall Study||38
8194903|NCT02257970|20206069|P4|NOT COMPLETED|Part 3||7
8194904|NCT02257970|20206070|P3|NOT COMPLETED|Part 3||7
8194905|NCT02257970|20206071|P2|NOT COMPLETED|Part 3||0
8194906|NCT02257970|20206072|P1|NOT COMPLETED|Part 3||0
8194907|NCT02257970|20206069|P4|COMPLETED|Part 3||14
8194908|NCT02257970|20206070|P3|COMPLETED|Part 3||16
8194909|NCT02257970|20206071|P2|COMPLETED|Part 3||0
8194910|NCT02257970|20206072|P1|COMPLETED|Part 3||0
8194911|NCT02257970|20206069|P4|STARTED|Part 3||21
8194912|NCT02257970|20206070|P3|STARTED|Part 3||23
8194913|NCT02257970|20206071|P2|STARTED|Part 3||0
8194914|NCT02257970|20206072|P1|STARTED|Part 3||0
8194915|NCT02257970|20206069|P4|NOT COMPLETED|Part 2||0
8194916|NCT02257970|20206070|P3|NOT COMPLETED|Part 2||0
8194917|NCT02257970|20206071|P2|NOT COMPLETED|Part 2||7
8194918|NCT02257970|20206072|P1|NOT COMPLETED|Part 2||0
8194919|NCT02257970|20206069|P4|COMPLETED|Part 2||0
8194920|NCT02257970|20206070|P3|COMPLETED|Part 2||0
8194921|NCT02257970|20206071|P2|COMPLETED|Part 2||16
8194922|NCT02257970|20206072|P1|COMPLETED|Part 2||0
8194923|NCT02257970|20206069|P4|STARTED|Part 2||0
8194924|NCT02257970|20206070|P3|STARTED|Part 2||0
8194925|NCT02257970|20206071|P2|STARTED|Part 2||23
8194926|NCT02257970|20206072|P1|STARTED|Part 2||0
8194927|NCT02257970|20206069|P4|NOT COMPLETED|Part 1||0
8194928|NCT02257970|20206070|P3|NOT COMPLETED|Part 1||0
8194929|NCT02257970|20206071|P2|NOT COMPLETED|Part 1||0
8194930|NCT02257970|20206072|P1|NOT COMPLETED|Part 1||0
8194931|NCT02257970|20206069|P4|COMPLETED|Part 1||0
8194932|NCT02257970|20206070|P3|COMPLETED|Part 1||0
8194933|NCT02257970|20206071|P2|COMPLETED|Part 1||0
8194934|NCT02257970|20206072|P1|COMPLETED|Part 1||50
8194935|NCT02257970|20206069|P4|STARTED|Part 1||0
8194936|NCT02257970|20206070|P3|STARTED|Part 1||0
8194937|NCT02257970|20206071|P2|STARTED|Part 1||0
8194938|NCT02257970|20206072|P1|STARTED|Part 1||50
8194939|NCT02257918|20206098|P3|NOT COMPLETED|Overall Study||2
8194940|NCT02257918|20206099|P2|NOT COMPLETED|Overall Study||1
8194941|NCT02257918|20206100|P1|NOT COMPLETED|Overall Study||4
8194942|NCT02257918|20206098|P3|COMPLETED|Overall Study||39
8194943|NCT02257918|20206099|P2|COMPLETED|Overall Study||66
8194944|NCT02257918|20206100|P1|COMPLETED|Overall Study||68
8194945|NCT02257918|20206098|P3|Test of Cure Visit|Overall Study||40
8194946|NCT02257918|20206099|P2|Test of Cure Visit|Overall Study||67
8194947|NCT02257918|20206100|P1|Test of Cure Visit|Overall Study||72
8194948|NCT02257918|20206098|P3|STARTED|Overall Study||41
8194949|NCT02257918|20206099|P2|STARTED|Overall Study||67
8194950|NCT02257918|20206100|P1|STARTED|Overall Study||72
8194951|NCT02257684|20206150|P1|NOT COMPLETED|Overall Study||4
8194952|NCT02257684|20206150|P1|COMPLETED|Overall Study||0
8194953|NCT02257684|20206150|P1|STARTED|Overall Study||4
8194954|NCT02257632|20206160|P2|NOT COMPLETED|Overall Study||3
8194955|NCT02257632|20206161|P1|NOT COMPLETED|Overall Study||1
8194956|NCT02257632|20206160|P2|COMPLETED|Overall Study||19
8194957|NCT02257632|20206161|P1|COMPLETED|Overall Study||18
8194958|NCT02257632|20206160|P2|Per-Protocol Set (PPS)|Overall Study||20
8194959|NCT02257632|20206161|P1|Per-Protocol Set (PPS)|Overall Study||17
8194960|NCT02257632|20206160|P2|Safety Set (SAF)|Overall Study||21
8194961|NCT02257632|20206161|P1|Safety Set (SAF)|Overall Study||19
8194962|NCT02257632|20206160|P2|Full Analysis Set (FAS)|Overall Study||21
8194963|NCT02257632|20206161|P1|Full Analysis Set (FAS)|Overall Study||19
8194964|NCT02257632|20206160|P2|STARTED|Overall Study||22
8194965|NCT02257632|20206161|P1|STARTED|Overall Study||19
8194966|NCT02257541|20206178|P5|NOT COMPLETED|Overall Study||0
8194967|NCT02257541|20206179|P4|NOT COMPLETED|Overall Study||0
8194968|NCT02257541|20206180|P3|NOT COMPLETED|Overall Study||0
8194969|NCT02257541|20206181|P2|NOT COMPLETED|Overall Study||0
8194970|NCT02257541|20206182|P1|NOT COMPLETED|Overall Study||0
8194971|NCT02257541|20206178|P5|COMPLETED|Overall Study||1
8194972|NCT02257541|20206179|P4|COMPLETED|Overall Study||3
8194973|NCT02257541|20206180|P3|COMPLETED|Overall Study||1
8194974|NCT02257541|20206181|P2|COMPLETED|Overall Study||8
8194975|NCT02257541|20206182|P1|COMPLETED|Overall Study||3
8194976|NCT02257541|20206178|P5|STARTED|Overall Study||1
8194977|NCT02257541|20206179|P4|STARTED|Overall Study||3
8194978|NCT02257541|20206180|P3|STARTED|Overall Study||1
8194979|NCT02257541|20206181|P2|STARTED|Overall Study||8
8194980|NCT02257541|20206182|P1|STARTED|Overall Study||3
8194981|NCT02257528|20206201|P1|NOT COMPLETED|Overall Study||1
8194982|NCT02257528|20206201|P1|COMPLETED|Overall Study||25
8194983|NCT02257528|20206201|P1|STARTED|Overall Study||26
8194984|NCT02257489|20206217|P9|NOT COMPLETED|Overall Study||0
8194985|NCT02257489|20206218|P8|NOT COMPLETED|Overall Study||0
8194986|NCT02257489|20206219|P7|NOT COMPLETED|Overall Study||0
8194987|NCT02257489|20206220|P6|NOT COMPLETED|Overall Study||0
8194988|NCT02257489|20206221|P5|NOT COMPLETED|Overall Study||0
8194989|NCT02257489|20206222|P4|NOT COMPLETED|Overall Study||1
8194990|NCT02257489|20206223|P3|NOT COMPLETED|Overall Study||0
8194991|NCT02257489|20206224|P2|NOT COMPLETED|Overall Study||0
8194992|NCT02257489|20206225|P1|NOT COMPLETED|Overall Study||0
8194993|NCT02257489|20206217|P9|COMPLETED|Overall Study||6
8194994|NCT02257489|20206218|P8|COMPLETED|Overall Study||10
8194995|NCT02257489|20206219|P7|COMPLETED|Overall Study||6
8194996|NCT02257489|20206220|P6|COMPLETED|Overall Study||6
8194997|NCT02257489|20206221|P5|COMPLETED|Overall Study||6
8194998|NCT02257489|20206222|P4|COMPLETED|Overall Study||5
8194999|NCT02257489|20206223|P3|COMPLETED|Overall Study||6
8195000|NCT02257489|20206224|P2|COMPLETED|Overall Study||6
8195001|NCT02257489|20206225|P1|COMPLETED|Overall Study||6
8195002|NCT02257489|20206217|P9|STARTED|Overall Study||6
8195003|NCT02257489|20206218|P8|STARTED|Overall Study||10
8195004|NCT02257489|20206219|P7|STARTED|Overall Study||6
8195005|NCT02257489|20206220|P6|STARTED|Overall Study||6
8195006|NCT02257489|20206221|P5|STARTED|Overall Study||6
8195007|NCT02257489|20206222|P4|STARTED|Overall Study||6
8195008|NCT02257489|20206223|P3|STARTED|Overall Study||6
8195009|NCT02257489|20206224|P2|STARTED|Overall Study||6
8195010|NCT02257489|20206225|P1|STARTED|Overall Study||6
8195011|NCT02257385|20206261|P2|NOT COMPLETED|Overall Study||22
8195012|NCT02257385|20206262|P1|NOT COMPLETED|Overall Study||22
8195013|NCT02257385|20206261|P2|COMPLETED|Overall Study||457
8195014|NCT02257385|20206262|P1|COMPLETED|Overall Study||460
8195015|NCT02257385|20206261|P2|STARTED|Overall Study||479
8195016|NCT02257385|20206262|P1|STARTED|Overall Study||482
8195017|NCT02257372|20206272|P2|NOT COMPLETED|Overall Study||10
8195018|NCT02257372|20206273|P1|NOT COMPLETED|Overall Study||7
8195019|NCT02257372|20206272|P2|COMPLETED|Overall Study||109
8195020|NCT02257372|20206273|P1|COMPLETED|Overall Study||110
8195021|NCT02257372|20206272|P2|STARTED|Overall Study||119
8195022|NCT02257372|20206273|P1|STARTED|Overall Study||117
8195023|NCT02257099|20206281|P1|NOT COMPLETED|Overall Study||0
8195024|NCT02257099|20206281|P1|COMPLETED|Overall Study||20
8195025|NCT02257099|20206281|P1|STARTED|Overall Study||20
8195026|NCT02256982|20206290|P2|NOT COMPLETED|Overall Study||1
8195027|NCT02256982|20206291|P1|NOT COMPLETED|Overall Study||0
8195028|NCT02256982|20206290|P2|COMPLETED|Overall Study||1
8195029|NCT02256982|20206291|P1|COMPLETED|Overall Study||1
8195030|NCT02256982|20206290|P2|STARTED|Overall Study||2
8195031|NCT02256982|20206291|P1|STARTED|Overall Study||1
8195032|NCT02256969|20206300|P3|NOT COMPLETED|Overall Study||1
8195033|NCT02256969|20206301|P2|NOT COMPLETED|Overall Study||1
8195034|NCT02256969|20206302|P1|NOT COMPLETED|Overall Study||2
8195035|NCT02256969|20206300|P3|COMPLETED|Overall Study||14
8195036|NCT02256969|20206301|P2|COMPLETED|Overall Study||14
8195037|NCT02256969|20206302|P1|COMPLETED|Overall Study||13
8195038|NCT02256969|20206300|P3|STARTED|Overall Study||15
8195039|NCT02256969|20206301|P2|STARTED|Overall Study||15
8195040|NCT02256969|20206302|P1|STARTED|Overall Study||15
8195041|NCT02256917|20206319|P1|NOT COMPLETED|Prophylactic Treatment Phase II||4
8195042|NCT02256917|20206319|P1|COMPLETED|Prophylactic Treatment Phase II||52
8195043|NCT02256917|20206319|P1|STARTED|Prophylactic Treatment Phase II||56
8195044|NCT02256917|20206319|P1|NOT COMPLETED|Prophylactic Treatment Phase I||1
8195045|NCT02256917|20206319|P1|COMPLETED|Prophylactic Treatment Phase I||56
8195046|NCT02256917|20206319|P1|STARTED|Prophylactic Treatment Phase I||57
8195047|NCT02256917|20206319|P1|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
8195048|NCT02256917|20206319|P1|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
8195049|NCT02256917|20206319|P1|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
8195050|NCT02256891|20206340|P2|NOT COMPLETED|Overall Study||13
8195051|NCT02256891|20206341|P1|NOT COMPLETED|Overall Study||12
8195052|NCT02256891|20206340|P2|COMPLETED|Overall Study||29
8195053|NCT02256891|20206341|P1|COMPLETED|Overall Study||43
8195054|NCT02256891|20206340|P2|STARTED|Overall Study||42
8195055|NCT02256891|20206341|P1|STARTED|Overall Study||55
8195056|NCT02256839|20206367|P2|NOT COMPLETED|Overall Study||3
8195057|NCT02256839|20206368|P1|NOT COMPLETED|Overall Study||2
8195058|NCT02256839|20206367|P2|COMPLETED|Overall Study||212
8195059|NCT02256839|20206368|P1|COMPLETED|Overall Study||51
8195060|NCT02256839|20206367|P2|STARTED|Overall Study||215
8195061|NCT02256839|20206368|P1|STARTED|Overall Study||53
8195062|NCT02256553|20206374|P1|NOT COMPLETED|Period III||3
8195063|NCT02256553|20206374|P1|COMPLETED|Period III||91
8195064|NCT02256553|20206374|P1|STARTED|Period III||94
8195065|NCT02256553|20206374|P1|NOT COMPLETED|Period II||2
8195066|NCT02256553|20206374|P1|COMPLETED|Period II||94
8195067|NCT02256553|20206374|P1|STARTED|Period II||96
8195068|NCT02256553|20206374|P1|NOT COMPLETED|Period I||6
8195069|NCT02256553|20206374|P1|COMPLETED|Period I||96
8195070|NCT02256553|20206374|P1|STARTED|Period I||102
8195071|NCT02256540|20206383|P3|NOT COMPLETED|Overall Study||2
8195072|NCT02256540|20206384|P2|NOT COMPLETED|Overall Study||1
8195073|NCT02256540|20206385|P1|NOT COMPLETED|Overall Study||0
8195074|NCT02256540|20206383|P3|COMPLETED|Overall Study||4
8195075|NCT02256540|20206384|P2|COMPLETED|Overall Study||5
8195076|NCT02256540|20206385|P1|COMPLETED|Overall Study||6
8195077|NCT02256540|20206383|P3|STARTED|Overall Study||6
8195078|NCT02256540|20206384|P2|STARTED|Overall Study||6
8195079|NCT02256540|20206385|P1|STARTED|Overall Study||6
8195080|NCT02256488|20206403|P4|NOT COMPLETED|Overall Study||6
8195081|NCT02256488|20206404|P3|NOT COMPLETED|Overall Study||10
8195082|NCT02256488|20206405|P2|NOT COMPLETED|Overall Study||6
8195083|NCT02256488|20206406|P1|NOT COMPLETED|Overall Study||8
8195084|NCT02256488|20206403|P4|COMPLETED|Overall Study||384
8195085|NCT02256488|20206404|P3|COMPLETED|Overall Study||382
8195086|NCT02256488|20206405|P2|COMPLETED|Overall Study||386
8195087|NCT02256488|20206406|P1|COMPLETED|Overall Study||379
8195088|NCT02256488|20206403|P4|STARTED|Overall Study||390
8195089|NCT02256488|20206404|P3|STARTED|Overall Study||392
8195090|NCT02256488|20206405|P2|STARTED|Overall Study||392
8195091|NCT02256488|20206406|P1|STARTED|Overall Study||387
8195092|NCT02256436|20206422|P2|NOT COMPLETED|Overall Study||272
8195093|NCT02256436|20206423|P1|NOT COMPLETED|Overall Study||270
8195094|NCT02256436|20206422|P2|COMPLETED|Overall Study||0
8195095|NCT02256436|20206423|P1|COMPLETED|Overall Study||0
8195096|NCT02256436|20206422|P2|Treated|Overall Study||255
8195097|NCT02256436|20206423|P1|Treated|Overall Study||266
8195098|NCT02256436|20206422|P2|STARTED|Overall Study||272
8195099|NCT02256436|20206423|P1|STARTED|Overall Study||270
8195100|NCT02256384|20206459|P1|NOT COMPLETED|Overall Study||14
8195101|NCT02256384|20206459|P1|COMPLETED|Overall Study||62
8195102|NCT02256384|20206459|P1|STARTED|Overall Study||76
8195103|NCT02256358|20206470|P2|NOT COMPLETED|Overall Study||1
8195104|NCT02256358|20206471|P1|NOT COMPLETED|Overall Study||0
8195105|NCT02256358|20206470|P2|COMPLETED|Overall Study||33
8195106|NCT02256358|20206471|P1|COMPLETED|Overall Study||34
8195107|NCT02256358|20206470|P2|STARTED|Overall Study||34
8195108|NCT02256358|20206471|P1|STARTED|Overall Study||34
8195109|NCT02256345|20206479|P2|NOT COMPLETED|Overall Study||0
8195110|NCT02256345|20206480|P1|NOT COMPLETED|Overall Study||0
8195111|NCT02256345|20206479|P2|COMPLETED|Overall Study||3
8195112|NCT02256345|20206480|P1|COMPLETED|Overall Study||9
8195113|NCT02256345|20206479|P2|STARTED|Overall Study||3
8195114|NCT02256345|20206480|P1|STARTED|Overall Study||9
8195115|NCT02256267|20206492|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
8195116|NCT02256267|20206492|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
8195117|NCT02256267|20206492|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
8195118|NCT02256267|20206492|P1|STARTED|Period 2 (Day 7 to Day 14)||23
8195119|NCT02256267|20206492|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
8195120|NCT02256267|20206492|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
8195121|NCT02256267|20206492|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
8195122|NCT02256267|20206492|P1|STARTED|Period 2 (Day 1 to Day 6)||23
8195123|NCT02256267|20206492|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
8195124|NCT02256267|20206492|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
8195125|NCT02256267|20206492|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
8195126|NCT02256267|20206492|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
8195127|NCT02256189|20206503|P2|NOT COMPLETED|Overall Study||0
8195128|NCT02256189|20206504|P1|NOT COMPLETED|Overall Study||0
8195129|NCT02256189|20206503|P2|COMPLETED|Overall Study||13
8195130|NCT02256189|20206504|P1|COMPLETED|Overall Study||15
8195131|NCT02256189|20206503|P2|STARTED|Overall Study||13
8195132|NCT02256189|20206504|P1|STARTED|Overall Study||15
8195133|NCT02256111|20206514|P2|NOT COMPLETED|Overall Study||0
8195134|NCT02256111|20206515|P1|NOT COMPLETED|Overall Study||0
8195135|NCT02256111|20206514|P2|COMPLETED|Overall Study||13
8195136|NCT02256111|20206515|P1|COMPLETED|Overall Study||13
8195137|NCT02256111|20206514|P2|STARTED|Overall Study||13
8195138|NCT02256111|20206515|P1|STARTED|Overall Study||13
8195139|NCT02256072|20206550|P2|NOT COMPLETED|Overall Study||29
8195140|NCT02256072|20206551|P1|NOT COMPLETED|Overall Study||42
8195141|NCT02256072|20206550|P2|COMPLETED|Overall Study||162
8195142|NCT02256072|20206551|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
8195143|NCT02256072|20206550|P2|Completed 1 Month Follow-Up|Overall Study||179
8195144|NCT02256072|20206551|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
8195145|NCT02256072|20206550|P2|STARTED|Overall Study||191
8195146|NCT02256072|20206551|P1|STARTED|Overall Study||194
8195147|NCT02255981|20206565|P1|NOT COMPLETED|Overall Study||4
8195148|NCT02255981|20206565|P1|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
8195149|NCT02255981|20206565|P1|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
8195150|NCT02255760|20206580|P5|NOT COMPLETED|Overall Study||0
8195151|NCT02255760|20206581|P4|NOT COMPLETED|Overall Study||0
8195152|NCT02255760|20206582|P3|NOT COMPLETED|Overall Study||0
8195153|NCT02255760|20206583|P2|NOT COMPLETED|Overall Study||1
8195154|NCT02255760|20206584|P1|NOT COMPLETED|Overall Study||0
8195155|NCT02255760|20206580|P5|COMPLETED|Overall Study||9
8195156|NCT02255760|20206581|P4|COMPLETED|Overall Study||15
8195157|NCT02255760|20206582|P3|COMPLETED|Overall Study||15
8195158|NCT02255760|20206583|P2|COMPLETED|Overall Study||2
8195159|NCT02255760|20206584|P1|COMPLETED|Overall Study||14
8195160|NCT02255760|20206580|P5|STARTED|Overall Study||9
8195161|NCT02255760|20206581|P4|STARTED|Overall Study||15
8195162|NCT02255760|20206582|P3|STARTED|Overall Study||15
8195163|NCT02255760|20206583|P2|STARTED|Overall Study||3
8195164|NCT02255760|20206584|P1|STARTED|Overall Study||14
8195165|NCT02255565|20206639|P3|NOT COMPLETED|Overall Study||0
8195166|NCT02255565|20206640|P2|NOT COMPLETED|Overall Study||1
8195167|NCT02255565|20206641|P1|NOT COMPLETED|Overall Study||0
8195168|NCT02255565|20206639|P3|COMPLETED|Overall Study||9
8195169|NCT02255565|20206640|P2|COMPLETED|Overall Study||8
8195170|NCT02255565|20206641|P1|COMPLETED|Overall Study||9
8195171|NCT02255565|20206639|P3|STARTED|Overall Study||9
8195172|NCT02255565|20206640|P2|STARTED|Overall Study||9
8195173|NCT02255565|20206641|P1|STARTED|Overall Study||9
8195174|NCT02255552|20206702|P2|NOT COMPLETED|Overall Study||15
8195175|NCT02255552|20206703|P1|NOT COMPLETED|Overall Study||1
8195176|NCT02255552|20206702|P2|COMPLETED|Overall Study||15
8195177|NCT02255552|20206703|P1|COMPLETED|Overall Study||78
8195178|NCT02255552|20206702|P2|STARTED|Overall Study||30
8195179|NCT02255552|20206703|P1|STARTED|Overall Study||79
8195180|NCT02255500|20206721|P2|NOT COMPLETED|Overall Study||0
8195181|NCT02255500|20206722|P1|NOT COMPLETED|Overall Study||1
8195182|NCT02255500|20206721|P2|COMPLETED|Overall Study||7
8195183|NCT02255500|20206722|P1|COMPLETED|Overall Study||15
8195184|NCT02255500|20206721|P2|STARTED|Overall Study||7
8195185|NCT02255500|20206722|P1|STARTED|Overall Study||16
8195186|NCT02255461|20206743|P5|NOT COMPLETED|Overall Study||2
8195187|NCT02255461|20206744|P4|NOT COMPLETED|Overall Study||0
8195188|NCT02255461|20206745|P3|NOT COMPLETED|Overall Study||1
8195189|NCT02255461|20206746|P2|NOT COMPLETED|Overall Study||2
8195190|NCT02255461|20206747|P1|NOT COMPLETED|Overall Study||0
8195191|NCT02255461|20206743|P5|COMPLETED|Overall Study||8
8195192|NCT02255461|20206744|P4|COMPLETED|Overall Study||4
8195193|NCT02255461|20206745|P3|COMPLETED|Overall Study||5
8195194|NCT02255461|20206746|P2|COMPLETED|Overall Study||10
8195195|NCT02255461|20206747|P1|COMPLETED|Overall Study||3
8195196|NCT02255461|20206743|P5|STARTED|Overall Study||10
8195197|NCT02255461|20206744|P4|STARTED|Overall Study||4
8195198|NCT02255461|20206745|P3|STARTED|Overall Study||6
8195199|NCT02255461|20206746|P2|STARTED|Overall Study||12
8195200|NCT02255461|20206747|P1|STARTED|Overall Study||3
8195201|NCT02255422|20206826|P7|NOT COMPLETED|Overall Study||2
8195202|NCT02255422|20206827|P6|NOT COMPLETED|Overall Study||0
8195203|NCT02255422|20206828|P5|NOT COMPLETED|Overall Study||0
8195204|NCT02255422|20206829|P4|NOT COMPLETED|Overall Study||0
8195205|NCT02255422|20206830|P3|NOT COMPLETED|Overall Study||1
8195206|NCT02255422|20206831|P2|NOT COMPLETED|Overall Study||0
8195207|NCT02255422|20206832|P1|NOT COMPLETED|Overall Study||0
8195208|NCT02255422|20206826|P7|COMPLETED|Overall Study||8
8195209|NCT02255422|20206827|P6|COMPLETED|Overall Study||6
8195210|NCT02255422|20206828|P5|COMPLETED|Overall Study||6
8195211|NCT02255422|20206829|P4|COMPLETED|Overall Study||6
8195212|NCT02255422|20206830|P3|COMPLETED|Overall Study||5
8195213|NCT02255422|20206831|P2|COMPLETED|Overall Study||6
8195214|NCT02255422|20206832|P1|COMPLETED|Overall Study||13
8195215|NCT02255422|20206826|P7|STARTED|Overall Study||10
8195216|NCT02255422|20206827|P6|STARTED|Overall Study||6
8195217|NCT02255422|20206828|P5|STARTED|Overall Study||6
8195218|NCT02255422|20206829|P4|STARTED|Overall Study||6
8195219|NCT02255422|20206830|P3|STARTED|Overall Study||6
8195220|NCT02255422|20206831|P2|STARTED|Overall Study||6
8195221|NCT02255422|20206832|P1|STARTED|Overall Study||13
8195222|NCT02255357|20206857|P2|NOT COMPLETED|Overall Study||10
8195223|NCT02255357|20206858|P1|NOT COMPLETED|Overall Study||7
8195224|NCT02255357|20206857|P2|COMPLETED|Overall Study||5
8195225|NCT02255357|20206858|P1|COMPLETED|Overall Study||4
8195226|NCT02255357|20206857|P2|STARTED|Overall Study||15
8195227|NCT02255357|20206858|P1|STARTED|Overall Study||11
8195228|NCT02255279|20206866|P2|NOT COMPLETED|Overall Study||9
8195229|NCT02255279|20206867|P1|NOT COMPLETED|Overall Study||5
8195230|NCT02255279|20206866|P2|COMPLETED|Overall Study||134
8195231|NCT02255279|20206867|P1|COMPLETED|Overall Study||139
8195232|NCT02255279|20206866|P2|STARTED|Overall Study||143
8195233|NCT02255279|20206867|P1|STARTED|Overall Study||144
8195234|NCT02255175|20206895|P2|NOT COMPLETED|Overall Study||12
8195235|NCT02255175|20206896|P1|NOT COMPLETED|Overall Study||17
8195236|NCT02255175|20206895|P2|COMPLETED|Overall Study||19
8195237|NCT02255175|20206896|P1|COMPLETED|Overall Study||16
8195238|NCT02255175|20206895|P2|STARTED|Overall Study||31
8195239|NCT02255175|20206896|P1|STARTED|Overall Study||33
8195240|NCT02255149|20206920|P1|NOT COMPLETED|Overall Study||5
8195241|NCT02255149|20206920|P1|COMPLETED|Overall Study||5
8195242|NCT02255149|20206920|P1|STARTED|Overall Study||10
8195243|NCT02255110|20206924|P1|NOT COMPLETED|Overall Study||0
8195244|NCT02255110|20206924|P1|COMPLETED|Overall Study||6
8195245|NCT02255110|20206924|P1|STARTED|Overall Study||6
8195250|NCT02254772|20206957|P1|NOT COMPLETED|Overall Study||2
8195251|NCT02254772|20206957|P1|COMPLETED|Overall Study||7
8195252|NCT02254772|20206957|P1|STARTED|Overall Study||9
8195253|NCT02254681|20206963|P1|NOT COMPLETED|Overall Study||6
8195254|NCT02254681|20206963|P1|COMPLETED|Overall Study||0
8195255|NCT02254681|20206963|P1|STARTED|Overall Study||6
8195256|NCT02254551|20206973|P1|NOT COMPLETED|Maintenance||0
8195257|NCT02254551|20206973|P1|COMPLETED|Maintenance||0
8195258|NCT02254551|20206973|P1|STARTED|Maintenance||0
8195259|NCT02254551|20206973|P1|NOT COMPLETED|Expansion||0
8195260|NCT02254551|20206973|P1|COMPLETED|Expansion||0
8195261|NCT02254551|20206973|P1|STARTED|Expansion||0
8195262|NCT02254551|20206973|P1|NOT COMPLETED|Dose Escalation||3
8195263|NCT02254551|20206973|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
8195264|NCT02254551|20206973|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
8195265|NCT02254551|20206973|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
8195266|NCT02254551|20206973|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
8195267|NCT02254551|20206973|P1|STARTED|Dose Escalation||7
8195268|NCT02254486|20206983|P2|NOT COMPLETED|Overall Study||55
8195269|NCT02254486|20206984|P1|NOT COMPLETED|Overall Study||50
8195270|NCT02254486|20206983|P2|COMPLETED|Overall Study||255
8195271|NCT02254486|20206984|P1|COMPLETED|Overall Study||261
8195272|NCT02254486|20206983|P2|STARTED|Overall Study||310
8195273|NCT02254486|20206984|P1|STARTED|Overall Study||311
8195274|NCT02254473|20207002|P2|NOT COMPLETED|Overall Study||1
8195275|NCT02254473|20207003|P1|NOT COMPLETED|Overall Study||2
8195276|NCT02254473|20207002|P2|COMPLETED|Overall Study||2
8195277|NCT02254473|20207003|P1|COMPLETED|Overall Study||7
8195278|NCT02254473|20207002|P2|STARTED|Overall Study||3
8195279|NCT02254473|20207003|P1|STARTED|Overall Study||9
8195280|NCT02254460|20207023|P2|NOT COMPLETED|Overall Study||0
8195281|NCT02254460|20207024|P1|NOT COMPLETED|Overall Study||1
8195282|NCT02254460|20207023|P2|COMPLETED|Overall Study||12
8195283|NCT02254460|20207024|P1|COMPLETED|Overall Study||12
8195284|NCT02254460|20207023|P2|STARTED|Overall Study||12
8195285|NCT02254460|20207024|P1|STARTED|Overall Study||13
8195286|NCT02254421|20207032|P2|NOT COMPLETED|Overall Study||3
8195287|NCT02254421|20207033|P1|NOT COMPLETED|Overall Study||2
8195288|NCT02254421|20207032|P2|COMPLETED|Overall Study||26
8195289|NCT02254421|20207033|P1|COMPLETED|Overall Study||29
8195290|NCT02254421|20207032|P2|STARTED|Overall Study||29
8195291|NCT02254421|20207033|P1|STARTED|Overall Study||31
8195292|NCT02254408|20207047|P2|NOT COMPLETED|Overall Study||10
8195293|NCT02254408|20207048|P1|NOT COMPLETED|Overall Study||8
8195294|NCT02254408|20207047|P2|COMPLETED|Overall Study||83
8195295|NCT02254408|20207048|P1|COMPLETED|Overall Study||88
8195296|NCT02254408|20207047|P2|STARTED|Overall Study||93
8195297|NCT02254408|20207048|P1|STARTED|Overall Study||96
8195298|NCT02254304|20207060|P2|NOT COMPLETED|Overall Study||4
8195299|NCT02254304|20207061|P1|NOT COMPLETED|Overall Study||14
8195300|NCT02254304|20207060|P2|COMPLETED|Overall Study||13
8195301|NCT02254304|20207061|P1|COMPLETED|Overall Study||75
8195302|NCT02254304|20207060|P2|STARTED|Overall Study||17
8195303|NCT02254304|20207061|P1|STARTED|Overall Study||89
8195304|NCT02254291|20207121|P3|NOT COMPLETED|Overall Study||2
8195305|NCT02254291|20207122|P2|NOT COMPLETED|Overall Study||3
8195306|NCT02254291|20207123|P1|NOT COMPLETED|Overall Study||0
8195307|NCT02254291|20207121|P3|COMPLETED|Overall Study||101
8195308|NCT02254291|20207122|P2|COMPLETED|Overall Study||99
8195309|NCT02254291|20207123|P1|COMPLETED|Overall Study||103
8195310|NCT02254291|20207121|P3|Exposed|Overall Study||103
8195311|NCT02254291|20207122|P2|Exposed|Overall Study||102
8195312|NCT02254291|20207123|P1|Exposed|Overall Study||103
8195313|NCT02254291|20207121|P3|STARTED|Overall Study||103
8195314|NCT02254291|20207122|P2|STARTED|Overall Study||102
8195315|NCT02254291|20207123|P1|STARTED|Overall Study||103
8195316|NCT02254278|20207139|P2|NOT COMPLETED|Overall Study||1
8195317|NCT02254278|20207140|P1|NOT COMPLETED|Overall Study||1
8195318|NCT02254278|20207139|P2|COMPLETED|Overall Study||149
8195319|NCT02254278|20207140|P1|COMPLETED|Overall Study||157
8195320|NCT02254278|20207139|P2|Negative Post-treatment PET|Overall Study||57
8195321|NCT02254278|20207140|P1|Negative Post-treatment PET|Overall Study||58
8195322|NCT02254278|20207139|P2|Started Study Treatment|Overall Study||147
8195323|NCT02254278|20207140|P1|Started Study Treatment|Overall Study||152
8195324|NCT02254278|20207139|P2|Eligible|Overall Study||149
8195325|NCT02254278|20207140|P1|Eligible|Overall Study||157
8195326|NCT02254278|20207139|P2|STARTED|Overall Study||150
8195327|NCT02254278|20207140|P1|STARTED|Overall Study||158
8195328|NCT02254265|20207160|P3|NOT COMPLETED|Overall Study||8
8195329|NCT02254265|20207161|P2|NOT COMPLETED|Overall Study||12
8195330|NCT02254265|20207162|P1|NOT COMPLETED|Overall Study||9
8195331|NCT02254265|20207160|P3|COMPLETED|Overall Study||144
8195332|NCT02254265|20207161|P2|COMPLETED|Overall Study||140
8195333|NCT02254265|20207162|P1|COMPLETED|Overall Study||142
8195334|NCT02254265|20207160|P3|STARTED|Overall Study||152
8195335|NCT02254265|20207161|P2|STARTED|Overall Study||152
8195336|NCT02254265|20207162|P1|STARTED|Overall Study||151
8195337|NCT02254252|20207187|P2|NOT COMPLETED|Overall Study||2
8195338|NCT02254252|20207188|P1|NOT COMPLETED|Overall Study||3
8195339|NCT02254252|20207187|P2|COMPLETED|Overall Study||25
8195340|NCT02254252|20207188|P1|COMPLETED|Overall Study||24
8195341|NCT02254252|20207187|P2|STARTED|Overall Study||27
8195342|NCT02254252|20207188|P1|STARTED|Overall Study||27
8195343|NCT02253992|20207201|P3|NOT COMPLETED|Overall Study||144
8195344|NCT02253992|20207202|P2|NOT COMPLETED|Overall Study||4
8195345|NCT02253992|20207203|P1|NOT COMPLETED|Overall Study||6
8195346|NCT02253992|20207201|P3|COMPLETED|Overall Study||6
8195347|NCT02253992|20207202|P2|COMPLETED|Overall Study||0
8195348|NCT02253992|20207203|P1|COMPLETED|Overall Study||0
8195349|NCT02253992|20207201|P3|STARTED|Overall Study||150
8195350|NCT02253992|20207202|P2|STARTED|Overall Study||4
8195351|NCT02253992|20207203|P1|STARTED|Overall Study||6
8195352|NCT02253654|20207269|P2|NOT COMPLETED|Overall Study||18
8195353|NCT02253654|20207270|P1|NOT COMPLETED|Overall Study||23
8195354|NCT02253654|20207269|P2|COMPLETED|Overall Study||90
8195355|NCT02253654|20207270|P1|COMPLETED|Overall Study||85
8195356|NCT02253654|20207269|P2|Received Treatment|Overall Study||107
8195357|NCT02253654|20207270|P1|Received Treatment|Overall Study||104
8195358|NCT02253654|20207269|P2|STARTED|Overall Study||108
8195359|NCT02253654|20207270|P1|STARTED|Overall Study||108
8195360|NCT02253537|20207290|P1|NOT COMPLETED|Overall Study||0
8195361|NCT02253537|20207290|P1|COMPLETED|Overall Study||15
8195362|NCT02253537|20207290|P1|STARTED|Overall Study||15
8195363|NCT02253433|20207296|P2|NOT COMPLETED|Overall Study||55
8195364|NCT02253433|20207297|P1|NOT COMPLETED|Overall Study||16
8195365|NCT02253433|20207296|P2|COMPLETED|Overall Study||79
8195366|NCT02253433|20207297|P1|COMPLETED|Overall Study||114
8195367|NCT02253433|20207296|P2|STARTED|Overall Study||134
8195368|NCT02253433|20207297|P1|STARTED|Overall Study||130
8195369|NCT02253394|20207307|P2|NOT COMPLETED|Overall Study||0
8195370|NCT02253394|20207308|P1|NOT COMPLETED|Overall Study||0
8195371|NCT02253394|20207307|P2|COMPLETED|Overall Study||2
8195372|NCT02253394|20207308|P1|COMPLETED|Overall Study||0
8195373|NCT02253394|20207307|P2|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
8195374|NCT02253394|20207308|P1|STARTED|Overall Study||0
8195375|NCT02253173|20207318|P4|NOT COMPLETED|Overall Study||14
8195376|NCT02253173|20207319|P3|NOT COMPLETED|Overall Study||13
8195377|NCT02253173|20207320|P2|NOT COMPLETED|Overall Study||17
8195378|NCT02253173|20207321|P1|NOT COMPLETED|Overall Study||16
8195379|NCT02253173|20207318|P4|COMPLETED|Overall Study||178
8195380|NCT02253173|20207319|P3|COMPLETED|Overall Study||177
8195381|NCT02253173|20207320|P2|COMPLETED|Overall Study||174
8195382|NCT02253173|20207321|P1|COMPLETED|Overall Study||175
8195383|NCT02253173|20207318|P4|STARTED|Overall Study||192
8195384|NCT02253173|20207319|P3|STARTED|Overall Study||190
8195385|NCT02253173|20207320|P2|STARTED|Overall Study||191
8195386|NCT02253173|20207321|P1|STARTED|Overall Study||191
8195387|NCT02253160|20207518|P3|NOT COMPLETED|Overall Study||0
8195388|NCT02253160|20207519|P2|NOT COMPLETED|Overall Study||0
8195389|NCT02253160|20207520|P1|NOT COMPLETED|Overall Study||0
8195390|NCT02253160|20207518|P3|COMPLETED|Overall Study||10
8195391|NCT02253160|20207519|P2|COMPLETED|Overall Study||12
8195392|NCT02253160|20207520|P1|COMPLETED|Overall Study||1
8195393|NCT02253160|20207518|P3|STARTED|Overall Study||10
8195394|NCT02253160|20207519|P2|STARTED|Overall Study||12
8195395|NCT02253160|20207520|P1|STARTED|Overall Study||1
8195396|NCT02253147|20207556|P1|NOT COMPLETED|Overall Study||47
8195397|NCT02253147|20207556|P1|COMPLETED|Overall Study||71
8195398|NCT02253147|20207556|P1|N Patients at W52|Overall Study||84
8195399|NCT02253147|20207556|P1|N Patients at W36|Overall Study||86
8195400|NCT02253147|20207556|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
8195401|NCT02253147|20207556|P1|STARTED|Overall Study||118
8195402|NCT02252965|20207590|P2|NOT COMPLETED|Overall Study||43
8195403|NCT02252965|20207591|P1|NOT COMPLETED|Overall Study||40
8195404|NCT02252965|20207590|P2|COMPLETED|Overall Study||222
8195405|NCT02252965|20207591|P1|COMPLETED|Overall Study||227
8195406|NCT02252965|20207590|P2|Safety Population|Overall Study||264
8195407|NCT02252965|20207591|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
8195408|NCT02252965|20207590|P2|STARTED|Overall Study||265
8195409|NCT02252965|20207591|P1|STARTED|Overall Study||267
8195410|NCT02252939|20207618|P1|NOT COMPLETED|Overall Study||3
8195411|NCT02252939|20207618|P1|COMPLETED|Overall Study||59
8195412|NCT02252939|20207618|P1|STARTED|Overall Study||62
8195413|NCT02252744|20207627|P1|NOT COMPLETED|Overall Study||0
8195414|NCT02252744|20207627|P1|COMPLETED|Overall Study||286
8195415|NCT02252744|20207627|P1|STARTED|Overall Study||286
8195416|NCT02252718|20207631|P1|NOT COMPLETED|Overall Study||0
8195417|NCT02252718|20207631|P1|COMPLETED|Overall Study||100
8195418|NCT02252718|20207631|P1|STARTED|Overall Study||100
8195419|NCT02252666|20207635|P1|NOT COMPLETED|Overall Study||0
8195420|NCT02252666|20207635|P1|COMPLETED|Overall Study||6
8195421|NCT02252666|20207635|P1|STARTED|Overall Study||6
8195422|NCT02252588|20207659|P2|NOT COMPLETED|Overall Study||0
8195423|NCT02252588|20207660|P1|NOT COMPLETED|Overall Study||4
8195424|NCT02252588|20207659|P2|COMPLETED|Overall Study||20
8195425|NCT02252588|20207660|P1|COMPLETED|Overall Study||20
8195426|NCT02252588|20207659|P2|STARTED|Overall Study||20
8195427|NCT02252588|20207660|P1|STARTED|Overall Study||24
8195428|NCT02252562|20207672|P2|NOT COMPLETED|Overall Study||0
8195429|NCT02252562|20207673|P1|NOT COMPLETED|Overall Study||0
8195430|NCT02252562|20207672|P2|COMPLETED|Overall Study||1636
8195431|NCT02252562|20207673|P1|COMPLETED|Overall Study||1620
8195432|NCT02252562|20207672|P2|STARTED|Overall Study||1636
8195433|NCT02252562|20207673|P1|STARTED|Overall Study||1620
8195434|NCT02252536|20207688|P2|NOT COMPLETED|Overall Study||3
8195435|NCT02252536|20207689|P1|NOT COMPLETED|Overall Study||5
8195436|NCT02252536|20207688|P2|COMPLETED|Overall Study||170
8195437|NCT02252536|20207689|P1|COMPLETED|Overall Study||168
8195438|NCT02252536|20207688|P2|STARTED|Overall Study||173
8195439|NCT02252536|20207689|P1|STARTED|Overall Study||173
8195440|NCT02252445|20207723|P2|NOT COMPLETED|Overall Study||0
8195441|NCT02252445|20207724|P1|NOT COMPLETED|Overall Study||0
8195442|NCT02252445|20207723|P2|COMPLETED|Overall Study||41
8195443|NCT02252445|20207724|P1|COMPLETED|Overall Study||41
8195444|NCT02252445|20207723|P2|STARTED|Overall Study||41
8195445|NCT02252445|20207724|P1|STARTED|Overall Study||41
8195446|NCT02252406|20207750|P2|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
8195447|NCT02252406|20207751|P1|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
8195448|NCT02252406|20207750|P2|COMPLETED|Titrated to Ranolazine 1000mg BID||13
8195449|NCT02252406|20207751|P1|COMPLETED|Titrated to Ranolazine 1000mg BID||9
8195450|NCT02252406|20207750|P2|STARTED|Titrated to Ranolazine 1000mg BID||14
8195451|NCT02252406|20207751|P1|STARTED|Titrated to Ranolazine 1000mg BID||12
8195452|NCT02252406|20207750|P2|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
8195453|NCT02252406|20207751|P1|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
8195454|NCT02252406|20207750|P2|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
8195455|NCT02252406|20207751|P1|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
8195456|NCT02252406|20207750|P2|STARTED|Starting Dose Ranolazine 500 mg BID||17
8195457|NCT02252406|20207751|P1|STARTED|Starting Dose Ranolazine 500 mg BID||16
8195458|NCT02252354|20207761|P2|NOT COMPLETED|Overall Study||0
8195459|NCT02252354|20207762|P1|NOT COMPLETED|Overall Study||0
8195460|NCT02252354|20207761|P2|COMPLETED|Overall Study||6
8195461|NCT02252354|20207762|P1|COMPLETED|Overall Study||6
8195462|NCT02252354|20207761|P2|STARTED|Overall Study||6
8195463|NCT02252354|20207762|P1|STARTED|Overall Study||6
8195464|NCT02252211|20207809|P3|NOT COMPLETED|Overall Study||1
8195465|NCT02252211|20207810|P2|NOT COMPLETED|Overall Study||3
8195466|NCT02252211|20207811|P1|NOT COMPLETED|Overall Study||5
8195467|NCT02252211|20207809|P3|COMPLETED|Overall Study||0
8195468|NCT02252211|20207810|P2|COMPLETED|Overall Study||0
8195469|NCT02252211|20207811|P1|COMPLETED|Overall Study||0
8195470|NCT02252211|20207809|P3|Received Further Doses (Through Dose 24)|Overall Study||0
8195471|NCT02252211|20207810|P2|Received Further Doses (Through Dose 24)|Overall Study||0
8195472|NCT02252211|20207811|P1|Received Further Doses (Through Dose 24)|Overall Study||1
8195473|NCT02252211|20207809|P3|Received Dose 4 (Day 36)|Overall Study||0
8195474|NCT02252211|20207810|P2|Received Dose 4 (Day 36)|Overall Study||1
8195475|NCT02252211|20207811|P1|Received Dose 4 (Day 36)|Overall Study||1
8195476|NCT02252211|20207809|P3|Received Dose 3 (Day 22)|Overall Study||0
8195477|NCT02252211|20207810|P2|Received Dose 3 (Day 22)|Overall Study||3
8195478|NCT02252211|20207811|P1|Received Dose 3 (Day 22)|Overall Study||3
8195479|NCT02252211|20207809|P3|Received Dose 2 (Day 8)|Overall Study||0
8195480|NCT02252211|20207810|P2|Received Dose 2 (Day 8)|Overall Study||3
8195481|NCT02252211|20207811|P1|Received Dose 2 (Day 8)|Overall Study||4
8195482|NCT02252211|20207809|P3|Received Dose 1 (Day 1)|Overall Study||0
8195483|NCT02252211|20207810|P2|Received Dose 1 (Day 1)|Overall Study||3
8195484|NCT02252211|20207811|P1|Received Dose 1 (Day 1)|Overall Study||4
8195485|NCT02252211|20207809|P3|STARTED|Overall Study||1
8195486|NCT02252211|20207810|P2|STARTED|Overall Study||3
8195487|NCT02252211|20207811|P1|STARTED|Overall Study||5
8195488|NCT02252172|20207848|P2|NOT COMPLETED|Overall Study||299
8195489|NCT02252172|20207849|P1|NOT COMPLETED|Overall Study||279
8195490|NCT02252172|20207848|P2|COMPLETED|Overall Study||69
8195491|NCT02252172|20207849|P1|COMPLETED|Overall Study||90
8195492|NCT02252172|20207848|P2|Treated|Overall Study||364
8195493|NCT02252172|20207849|P1|Treated|Overall Study||365
8195494|NCT02252172|20207848|P2|STARTED|Overall Study||368
8195495|NCT02252172|20207849|P1|STARTED|Overall Study||369
8195496|NCT02252146|20207861|P1|NOT COMPLETED|Overall Study||6
8195497|NCT02252146|20207861|P1|COMPLETED|Overall Study||0
8195498|NCT02252146|20207861|P1|STARTED|Overall Study||6
8195499|NCT02252133|20207865|P2|NOT COMPLETED|Period 2||0
8195500|NCT02252133|20207866|P1|NOT COMPLETED|Period 2||0
8195501|NCT02252133|20207865|P2|COMPLETED|Period 2||24
8195502|NCT02252133|20207866|P1|COMPLETED|Period 2||23
8195503|NCT02252133|20207865|P2|STARTED|Period 2||24
8195504|NCT02252133|20207866|P1|STARTED|Period 2||23
8195505|NCT02252133|20207865|P2|NOT COMPLETED|Period 1||0
8195506|NCT02252133|20207866|P1|NOT COMPLETED|Period 1||0
8195507|NCT02252133|20207865|P2|COMPLETED|Period 1||24
8195508|NCT02252133|20207866|P1|COMPLETED|Period 1||23
8195509|NCT02252133|20207865|P2|STARTED|Period 1||24
8195510|NCT02252133|20207866|P1|STARTED|Period 1||23
8195511|NCT02252068|20207875|P3|NOT COMPLETED|Overall Study||0
8195512|NCT02252068|20207876|P2|NOT COMPLETED|Overall Study||0
8195513|NCT02252068|20207877|P1|NOT COMPLETED|Overall Study||2
8195514|NCT02252068|20207875|P3|COMPLETED|Overall Study||13
8195515|NCT02252068|20207876|P2|COMPLETED|Overall Study||13
8195516|NCT02252068|20207877|P1|COMPLETED|Overall Study||3
8195517|NCT02252068|20207875|P3|STARTED|Overall Study||13
8195518|NCT02252068|20207876|P2|STARTED|Overall Study||13
8195519|NCT02252068|20207877|P1|STARTED|Overall Study||5
8195520|NCT02252042|20207902|P2|NOT COMPLETED|Overall Study||248
8195521|NCT02252042|20207903|P1|NOT COMPLETED|Overall Study||247
8195522|NCT02252042|20207902|P2|COMPLETED|Overall Study||0
8195523|NCT02252042|20207903|P1|COMPLETED|Overall Study||0
8195524|NCT02252042|20207902|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
8195525|NCT02252042|20207903|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
8195526|NCT02252042|20207902|P2|STARTED|Overall Study||248
8195527|NCT02252042|20207903|P1|STARTED|Overall Study||247
8195528|NCT02252016|20207943|P2|NOT COMPLETED|Overall Study||3
8195529|NCT02252016|20207944|P1|NOT COMPLETED|Overall Study||3
8195530|NCT02252016|20207943|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
8195531|NCT02252016|20207944|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
8195532|NCT02252016|20207943|P2|STARTED|Overall Study||52
8195533|NCT02252016|20207944|P1|STARTED|Overall Study||107
8195534|NCT02251990|20207958|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
8195535|NCT02251990|20207959|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
8195536|NCT02251990|20207958|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
8195537|NCT02251990|20207959|P1|COMPLETED|Period 3 (DTG Follow-up)||0
8195538|NCT02251990|20207958|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
8195539|NCT02251990|20207959|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
8195540|NCT02251990|20207958|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
8195541|NCT02251990|20207959|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
8195542|NCT02251990|20207958|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
8195543|NCT02251990|20207959|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
8195544|NCT02251990|20207958|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
8195545|NCT02251990|20207959|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
8195546|NCT02251990|20207958|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
8195547|NCT02251990|20207959|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
8195548|NCT02251990|20207958|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
8195549|NCT02251990|20207959|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
8195550|NCT02251990|20207958|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
8195551|NCT02251990|20207959|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
8195552|NCT02251990|20207958|P2|STARTED|Period 1 (Double-blind [DB])||123
8195553|NCT02251990|20207959|P1|STARTED|Period 1 (Double-blind [DB])||366
8195554|NCT02251938|20207974|P1|NOT COMPLETED|Overall Study||17
8195555|NCT02251938|20207974|P1|COMPLETED|Overall Study||43
8195556|NCT02251938|20207974|P1|STARTED|Overall Study||60
8195557|NCT02251912|20207987|P2|NOT COMPLETED|Overall Study||5
8195558|NCT02251912|20207988|P1|NOT COMPLETED|Overall Study||2
8195559|NCT02251912|20207987|P2|COMPLETED|Overall Study||5
8195560|NCT02251912|20207988|P1|COMPLETED|Overall Study||10
8195561|NCT02251912|20207987|P2|STARTED|Overall Study||10
8195562|NCT02251912|20207988|P1|STARTED|Overall Study||12
8195563|NCT02251886|20208002|P4|NOT COMPLETED|Overall Study||0
8195564|NCT02251886|20208003|P3|NOT COMPLETED|Overall Study||0
8195565|NCT02251886|20208004|P2|NOT COMPLETED|Overall Study||0
8195566|NCT02251886|20208005|P1|NOT COMPLETED|Overall Study||0
8195567|NCT02251886|20208002|P4|COMPLETED|Overall Study||54
8195568|NCT02251886|20208003|P3|COMPLETED|Overall Study||44
8195569|NCT02251886|20208004|P2|COMPLETED|Overall Study||54
8195570|NCT02251886|20208005|P1|COMPLETED|Overall Study||48
8195571|NCT02251886|20208002|P4|STARTED|Overall Study||54
8195572|NCT02251886|20208003|P3|STARTED|Overall Study||44
8195573|NCT02251886|20208004|P2|STARTED|Overall Study||54
8195574|NCT02251886|20208005|P1|STARTED|Overall Study||48
8195575|NCT02251743|20208017|P2|NOT COMPLETED|Overall Study||1
8195576|NCT02251743|20208018|P1|NOT COMPLETED|Overall Study||1
8195577|NCT02251743|20208017|P2|COMPLETED|Overall Study||58
8195578|NCT02251743|20208018|P1|COMPLETED|Overall Study||84
8195579|NCT02251743|20208017|P2|STARTED|Overall Study||59
8195580|NCT02251743|20208018|P1|STARTED|Overall Study||85
8195581|NCT02251717|20208026|P2|NOT COMPLETED|Overall Study||1
8195582|NCT02251717|20208027|P1|NOT COMPLETED|Overall Study||1
8195583|NCT02251717|20208026|P2|COMPLETED|Overall Study||56
8195584|NCT02251717|20208027|P1|COMPLETED|Overall Study||56
8195585|NCT02251717|20208026|P2|STARTED|Overall Study||57
8195586|NCT02251717|20208027|P1|STARTED|Overall Study||57
8195587|NCT02251652|20208039|P1|NOT COMPLETED|Overall Study||1
8195588|NCT02251652|20208039|P1|COMPLETED|Overall Study||16
8195589|NCT02251652|20208039|P1|STARTED|Overall Study||17
8195590|NCT02251613|20208049|P1|NOT COMPLETED|Overall Study||0
8195591|NCT02251613|20208049|P1|COMPLETED|Overall Study||50
8195592|NCT02251613|20208049|P1|STARTED|Overall Study||50
8195593|NCT02251561|20208057|P1|NOT COMPLETED|Overall Study||0
8195594|NCT02251561|20208057|P1|COMPLETED|Overall Study||28
8195595|NCT02251561|20208057|P1|STARTED|Overall Study||28
8195596|NCT02251548|20208065|P1|NOT COMPLETED|Overall Study||85
8195597|NCT02251548|20208065|P1|COMPLETED|Overall Study||0
8195598|NCT02251548|20208065|P1|STARTED|Overall Study||85
8195599|NCT02251496|20208073|P2|NOT COMPLETED|Overall Study||4
8195600|NCT02251496|20208074|P1|NOT COMPLETED|Overall Study||5
8195601|NCT02251496|20208073|P2|COMPLETED|Overall Study||11
8195602|NCT02251496|20208074|P1|COMPLETED|Overall Study||14
8195603|NCT02251496|20208073|P2|STARTED|Overall Study||15
8195604|NCT02251496|20208074|P1|STARTED|Overall Study||19
8195605|NCT02251379|20208084|P2|NOT COMPLETED|Overall Study||20
8195606|NCT02251379|20208085|P1|NOT COMPLETED|Overall Study||20
8195607|NCT02251379|20208084|P2|COMPLETED|Overall Study||58
8195608|NCT02251379|20208085|P1|COMPLETED|Overall Study||57
8195609|NCT02251379|20208084|P2|STARTED|Overall Study||78
8195610|NCT02251379|20208085|P1|STARTED|Overall Study||77
8195611|NCT02251275|20208106|P5|NOT COMPLETED|Overall Study||1
8195612|NCT02251275|20208107|P4|NOT COMPLETED|Overall Study||1
8195613|NCT02251275|20208108|P3|NOT COMPLETED|Overall Study||94
8195614|NCT02251275|20208109|P2|NOT COMPLETED|Overall Study||147
8195615|NCT02251275|20208110|P1|NOT COMPLETED|Overall Study||72
8195616|NCT02251275|20208106|P5|COMPLETED|Overall Study||2
8195617|NCT02251275|20208107|P4|COMPLETED|Overall Study||5
8195618|NCT02251275|20208108|P3|COMPLETED|Overall Study||624
8195619|NCT02251275|20208109|P2|COMPLETED|Overall Study||423
8195620|NCT02251275|20208110|P1|COMPLETED|Overall Study||434
8195621|NCT02251275|20208106|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8195622|NCT02251275|20208107|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8195623|NCT02251275|20208108|P3|Received at Least 1 Dose of Study Drug|Overall Study||717
8195624|NCT02251275|20208109|P2|Received at Least 1 Dose of Study Drug|Overall Study||569
8195625|NCT02251275|20208110|P1|Received at Least 1 Dose of Study Drug|Overall Study||505
8195626|NCT02251275|20208106|P5|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
8195627|NCT02251275|20208107|P4|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
8195628|NCT02251275|20208108|P3|STARTED|Overall Study||718
8195629|NCT02251275|20208109|P2|STARTED|Overall Study||570
8195630|NCT02251275|20208110|P1|STARTED|Overall Study||506
8195631|NCT02251236|20208125|P3|NOT COMPLETED|Overall Study||0
8195632|NCT02251236|20208126|P2|NOT COMPLETED|Overall Study||0
8195633|NCT02251236|20208127|P1|NOT COMPLETED|Overall Study||0
8195634|NCT02251236|20208125|P3|COMPLETED|Overall Study||0
8195635|NCT02251236|20208126|P2|COMPLETED|Overall Study||5
8195636|NCT02251236|20208127|P1|COMPLETED|Overall Study||9
8195637|NCT02251236|20208125|P3|STARTED|Overall Study||0
8195638|NCT02251236|20208126|P2|STARTED|Overall Study||5
8195639|NCT02251236|20208127|P1|STARTED|Overall Study||9
8195640|NCT02250807|20208144|P1|NOT COMPLETED|Overall Study||0
8195641|NCT02250807|20208144|P1|COMPLETED|Overall Study||40
8195642|NCT02250807|20208144|P1|STARTED|Overall Study||40
8195643|NCT02250703|20208156|P2|NOT COMPLETED|Overall Study||1
8195644|NCT02250703|20208157|P1|NOT COMPLETED|Overall Study||1
8195645|NCT02250703|20208156|P2|COMPLETED|Overall Study||36
8195646|NCT02250703|20208157|P1|COMPLETED|Overall Study||37
8195647|NCT02250703|20208156|P2|STARTED|Overall Study||37
8195648|NCT02250703|20208157|P1|STARTED|Overall Study||38
8195649|NCT02250612|20208174|P5|NOT COMPLETED|Overall Study||1
8195650|NCT02250612|20208175|P4|NOT COMPLETED|Overall Study||0
8195651|NCT02250612|20208176|P3|NOT COMPLETED|Overall Study||2
8195652|NCT02250612|20208177|P2|NOT COMPLETED|Overall Study||2
8195653|NCT02250612|20208178|P1|NOT COMPLETED|Overall Study||1
8195654|NCT02250612|20208174|P5|COMPLETED|Overall Study||36
8195655|NCT02250612|20208175|P4|COMPLETED|Overall Study||33
8195656|NCT02250612|20208176|P3|COMPLETED|Overall Study||35
8195657|NCT02250612|20208177|P2|COMPLETED|Overall Study||38
8195658|NCT02250612|20208178|P1|COMPLETED|Overall Study||36
8195659|NCT02250612|20208174|P5|STARTED|Overall Study||37
8195660|NCT02250612|20208175|P4|STARTED|Overall Study||33
8195661|NCT02250612|20208176|P3|STARTED|Overall Study||37
8195662|NCT02250612|20208177|P2|STARTED|Overall Study||40
8195663|NCT02250612|20208178|P1|STARTED|Overall Study||37
8195664|NCT02250521|20208200|P1|NOT COMPLETED|Overall Study||1
8195665|NCT02250521|20208200|P1|COMPLETED|Overall Study||99
8195666|NCT02250521|20208200|P1|STARTED|Overall Study||100
8195667|NCT02250443|20208214|P1|NOT COMPLETED|Overall Study||10
8195668|NCT02250443|20208214|P1|COMPLETED|Overall Study||0
8195669|NCT02250443|20208214|P1|STARTED|Overall Study||10
8195670|NCT02250417|20208227|P2|NOT COMPLETED|Second Intervention (1 Night)||0
8195671|NCT02250417|20208228|P1|NOT COMPLETED|Second Intervention (1 Night)||0
8195672|NCT02250417|20208227|P2|COMPLETED|Second Intervention (1 Night)||6
8195673|NCT02250417|20208228|P1|COMPLETED|Second Intervention (1 Night)||6
8195674|NCT02250417|20208227|P2|STARTED|Second Intervention (1 Night)||6
8195675|NCT02250417|20208228|P1|STARTED|Second Intervention (1 Night)||6
8195676|NCT02250417|20208227|P2|NOT COMPLETED|First Intervention (1 Night)||0
8195677|NCT02250417|20208228|P1|NOT COMPLETED|First Intervention (1 Night)||0
8195678|NCT02250417|20208227|P2|COMPLETED|First Intervention (1 Night)||6
8195679|NCT02250417|20208228|P1|COMPLETED|First Intervention (1 Night)||6
8195680|NCT02250417|20208227|P2|STARTED|First Intervention (1 Night)||6
8195681|NCT02250417|20208228|P1|STARTED|First Intervention (1 Night)||6
8195682|NCT02250326|20208243|P3|NOT COMPLETED|Follow-Up Period||38
8195683|NCT02250326|20208244|P2|NOT COMPLETED|Follow-Up Period||30
8195684|NCT02250326|20208245|P1|NOT COMPLETED|Follow-Up Period||49
8195685|NCT02250326|20208243|P3|COMPLETED|Follow-Up Period||26
8195686|NCT02250326|20208244|P2|COMPLETED|Follow-Up Period||13
8195687|NCT02250326|20208245|P1|COMPLETED|Follow-Up Period||18
8195688|NCT02250326|20208243|P3|STARTED|Follow-Up Period||64
8195689|NCT02250326|20208244|P2|STARTED|Follow-Up Period||43
8195690|NCT02250326|20208245|P1|STARTED|Follow-Up Period||67
8195691|NCT02250326|20208243|P3|NOT COMPLETED|Treatment Period||77
8195692|NCT02250326|20208244|P2|NOT COMPLETED|Treatment Period||64
8195693|NCT02250326|20208245|P1|NOT COMPLETED|Treatment Period||81
8195694|NCT02250326|20208243|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
8195695|NCT02250326|20208244|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
8195696|NCT02250326|20208245|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
8195697|NCT02250326|20208243|P3|Treated Population|Treatment Period||79
8195698|NCT02250326|20208244|P2|Treated Population|Treatment Period||78
8195699|NCT02250326|20208245|P1|Treated Population|Treatment Period||79
8195700|NCT02250326|20208243|P3|STARTED|Treatment Period||80
8195701|NCT02250326|20208244|P2|STARTED|Treatment Period||79
8195702|NCT02250326|20208245|P1|STARTED|Treatment Period||81
8195703|NCT02250274|20208278|P2|NOT COMPLETED|Overall Study||6
8195704|NCT02250274|20208279|P1|NOT COMPLETED|Overall Study||7
8195705|NCT02250274|20208278|P2|COMPLETED|Overall Study||40
8195706|NCT02250274|20208279|P1|COMPLETED|Overall Study||78
8195707|NCT02250274|20208278|P2|STARTED|Overall Study||46
8195708|NCT02250274|20208279|P1|STARTED|Overall Study||85
8195709|NCT02250183|20208295|P1|NOT COMPLETED|Overall Study||8
8195710|NCT02250183|20208295|P1|COMPLETED|Overall Study||13
8195711|NCT02250183|20208295|P1|STARTED|Overall Study||21
8195712|NCT02250092|20208306|P2|NOT COMPLETED|Overall Study||0
8195713|NCT02250092|20208307|P1|NOT COMPLETED|Overall Study||0
8195714|NCT02250092|20208306|P2|COMPLETED|Overall Study||10
8195715|NCT02250092|20208307|P1|COMPLETED|Overall Study||10
8195716|NCT02250092|20208306|P2|STARTED|Overall Study||10
8195717|NCT02250092|20208307|P1|STARTED|Overall Study||10
8195718|NCT02249949|20208317|P1|NOT COMPLETED|Overall Study||2
8195719|NCT02249949|20208317|P1|COMPLETED|Overall Study||11
8195720|NCT02249949|20208317|P1|STARTED|Overall Study||13
8195721|NCT02249832|20208324|P1|NOT COMPLETED|Overall Study||13
8195722|NCT02249832|20208324|P1|COMPLETED|Overall Study||42
8195723|NCT02249832|20208324|P1|STARTED|Overall Study||55
8195724|NCT02249819|20208336|P2|NOT COMPLETED|Overall Study||0
8195725|NCT02249819|20208337|P1|NOT COMPLETED|Overall Study||0
8195726|NCT02249819|20208336|P2|COMPLETED|Overall Study||7
8195727|NCT02249819|20208337|P1|COMPLETED|Overall Study||8
8195728|NCT02249819|20208336|P2|STARTED|Overall Study||7
8195729|NCT02249819|20208337|P1|STARTED|Overall Study||8
8195730|NCT02249793|20208343|P1|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
8195731|NCT02249793|20208343|P1|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
8195732|NCT02249793|20208343|P1|STARTED|Session 2, 48-Hours Healthy Volunteers||6
8195733|NCT02249793|20208343|P1|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
8195734|NCT02249793|20208343|P1|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
8195735|NCT02249793|20208343|P1|STARTED|Session 1, 48-hours Healthy Volunteers||6
8195736|NCT02249767|20208368|P3|NOT COMPLETED|Overall Study||8
8195737|NCT02249767|20208369|P2|NOT COMPLETED|Overall Study||9
8195738|NCT02249767|20208370|P1|NOT COMPLETED|Overall Study||8
8195739|NCT02249767|20208368|P3|COMPLETED|Overall Study||107
8195740|NCT02249767|20208369|P2|COMPLETED|Overall Study||220
8195741|NCT02249767|20208370|P1|COMPLETED|Overall Study||222
8195742|NCT02249767|20208368|P3|STARTED|Overall Study||115
8195743|NCT02249767|20208369|P2|STARTED|Overall Study||229
8195744|NCT02249767|20208370|P1|STARTED|Overall Study||230
8195745|NCT02249728|20208378|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
8195746|NCT02249728|20208378|P1|COMPLETED|Part Two (up to 6 Days)||6
8195747|NCT02249728|20208378|P1|STARTED|Part Two (up to 6 Days)||6
8195748|NCT02249728|20208378|P1|NOT COMPLETED|Part One (4 Days)||0
8195749|NCT02249728|20208378|P1|COMPLETED|Part One (4 Days)||6
8195750|NCT02249728|20208378|P1|STARTED|Part One (4 Days)||6
8195751|NCT02249585|20208391|P3|NOT COMPLETED|Overall Study||0
8195752|NCT02249585|20208392|P2|NOT COMPLETED|Overall Study||0
8195753|NCT02249585|20208393|P1|NOT COMPLETED|Overall Study||0
8195754|NCT02249585|20208391|P3|COMPLETED|Overall Study||44
8195755|NCT02249585|20208392|P2|COMPLETED|Overall Study||44
8195756|NCT02249585|20208393|P1|COMPLETED|Overall Study||43
8195757|NCT02249585|20208391|P3|STARTED|Overall Study||44
8195758|NCT02249585|20208392|P2|STARTED|Overall Study||44
8195759|NCT02249585|20208393|P1|STARTED|Overall Study||43
8195760|NCT02249377|20208418|P2|NOT COMPLETED|Overall Study||24
8195761|NCT02249377|20208419|P1|NOT COMPLETED|Overall Study||25
8195762|NCT02249377|20208418|P2|COMPLETED|Overall Study||1
8195763|NCT02249377|20208419|P1|COMPLETED|Overall Study||0
8195764|NCT02249377|20208418|P2|STARTED|Overall Study||25
8195765|NCT02249377|20208419|P1|STARTED|Overall Study||25
8195766|NCT02249182|20208436|P5|NOT COMPLETED|Treatment Phase||0
8195767|NCT02249182|20208437|P4|NOT COMPLETED|Treatment Phase||0
8195768|NCT02249182|20208438|P3|NOT COMPLETED|Treatment Phase||0
8195769|NCT02249182|20208439|P2|NOT COMPLETED|Treatment Phase||0
8195770|NCT02249182|20208440|P1|NOT COMPLETED|Treatment Phase||4
8195771|NCT02249182|20208436|P5|COMPLETED|Treatment Phase||34
8195772|NCT02249182|20208437|P4|COMPLETED|Treatment Phase||2
8195773|NCT02249182|20208438|P3|COMPLETED|Treatment Phase||1
8195774|NCT02249182|20208439|P2|COMPLETED|Treatment Phase||89
8195775|NCT02249182|20208440|P1|COMPLETED|Treatment Phase||96
8195776|NCT02249182|20208436|P5|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
8195777|NCT02249182|20208437|P4|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
8195778|NCT02249182|20208438|P3|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
8195779|NCT02249182|20208439|P2|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
8195780|NCT02249182|20208440|P1|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
8195781|NCT02249182|20208436|P5|NOT COMPLETED|PK Lead-In Phase||0
8195782|NCT02249182|20208437|P4|NOT COMPLETED|PK Lead-In Phase||0
8195783|NCT02249182|20208438|P3|NOT COMPLETED|PK Lead-In Phase||0
8195784|NCT02249182|20208439|P2|NOT COMPLETED|PK Lead-In Phase||0
8195785|NCT02249182|20208440|P1|NOT COMPLETED|PK Lead-In Phase||0
8195786|NCT02249182|20208436|P5|COMPLETED|PK Lead-In Phase||17
8195787|NCT02249182|20208437|P4|COMPLETED|PK Lead-In Phase||0
8195788|NCT02249182|20208438|P3|COMPLETED|PK Lead-In Phase||0
8195789|NCT02249182|20208439|P2|COMPLETED|PK Lead-In Phase||12
8195790|NCT02249182|20208440|P1|COMPLETED|PK Lead-In Phase||10
8195791|NCT02249182|20208436|P5|STARTED|PK Lead-In Phase||17
8195792|NCT02249182|20208437|P4|STARTED|PK Lead-In Phase||0
8195793|NCT02249182|20208438|P3|STARTED|PK Lead-In Phase||0
8195794|NCT02249182|20208439|P2|STARTED|PK Lead-In Phase||12
8195795|NCT02249182|20208440|P1|STARTED|PK Lead-In Phase||10
8195796|NCT02249143|20208528|P2|NOT COMPLETED|Overall Study||4
8195797|NCT02249143|20208529|P1|NOT COMPLETED|Overall Study||2
8195798|NCT02249143|20208528|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
8195799|NCT02249143|20208529|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
8195800|NCT02249143|20208528|P2|STARTED|Overall Study|randomized|26
8195801|NCT02249143|20208529|P1|STARTED|Overall Study||24
8195802|NCT02249104|20208555|P1|NOT COMPLETED|Overall Study||3
8195803|NCT02249104|20208555|P1|COMPLETED|Overall Study||25
8195804|NCT02249104|20208555|P1|STARTED|Overall Study||28
8195805|NCT02249065|20208564|P1|NOT COMPLETED|Overall Study||29
8195806|NCT02249065|20208564|P1|COMPLETED|Overall Study||176
8195807|NCT02249065|20208564|P1|Treated|Overall Study||181
8195808|NCT02249065|20208564|P1|STARTED|Overall Study||205
8195809|NCT02249052|20208572|P1|NOT COMPLETED|Overall Study||0
8195810|NCT02249052|20208572|P1|COMPLETED|Overall Study||19
8195811|NCT02249052|20208572|P1|STARTED|Overall Study||19
8195812|NCT02248974|20208590|P2|NOT COMPLETED|1-Month Follow-Up||3
8195813|NCT02248974|20208591|P1|NOT COMPLETED|1-Month Follow-Up||2
8195814|NCT02248974|20208590|P2|COMPLETED|1-Month Follow-Up||31
8195815|NCT02248974|20208591|P1|COMPLETED|1-Month Follow-Up||27
8195816|NCT02248974|20208590|P2|STARTED|1-Month Follow-Up||34
8195817|NCT02248974|20208591|P1|STARTED|1-Month Follow-Up||29
8195818|NCT02248974|20208590|P2|NOT COMPLETED|1-Week Follow-Up||17
8195819|NCT02248974|20208591|P1|NOT COMPLETED|1-Week Follow-Up||8
8195820|NCT02248974|20208590|P2|COMPLETED|1-Week Follow-Up||34
8195821|NCT02248974|20208591|P1|COMPLETED|1-Week Follow-Up||29
8195822|NCT02248974|20208590|P2|STARTED|1-Week Follow-Up||51
8195823|NCT02248974|20208591|P1|STARTED|1-Week Follow-Up||37
8195824|NCT02248974|20208590|P2|NOT COMPLETED|1-Day Follow-Up||0
8195825|NCT02248974|20208591|P1|NOT COMPLETED|1-Day Follow-Up||10
8195826|NCT02248974|20208590|P2|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
8195827|NCT02248974|20208591|P1|COMPLETED|1-Day Follow-Up||37
8195828|NCT02248974|20208590|P2|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
8195829|NCT02248974|20208591|P1|STARTED|1-Day Follow-Up||47
8195830|NCT02248974|20208590|P2|NOT COMPLETED|Baseline||0
8195831|NCT02248974|20208591|P1|NOT COMPLETED|Baseline||0
8195832|NCT02248974|20208590|P2|COMPLETED|Baseline||51
8195833|NCT02248974|20208591|P1|COMPLETED|Baseline||47
8195834|NCT02248974|20208590|P2|STARTED|Baseline||51
8195835|NCT02248974|20208591|P1|STARTED|Baseline||47
8195836|NCT02248961|20208669|P2|NOT COMPLETED|Overall Study||2
8195837|NCT02248961|20208670|P1|NOT COMPLETED|Overall Study||3
8195838|NCT02248961|20208669|P2|COMPLETED|Overall Study||88
8195839|NCT02248961|20208670|P1|COMPLETED|Overall Study||86
8195840|NCT02248961|20208669|P2|STARTED|Overall Study||90
8195841|NCT02248961|20208670|P1|STARTED|Overall Study||89
8195842|NCT02248922|20208690|P2|NOT COMPLETED|Overall Study||0
8195843|NCT02248922|20208691|P1|NOT COMPLETED|Overall Study||0
8195844|NCT02248922|20208690|P2|COMPLETED|Overall Study||12
8195845|NCT02248922|20208691|P1|COMPLETED|Overall Study||5
8195846|NCT02248922|20208690|P2|STARTED|Overall Study||12
8195847|NCT02248922|20208691|P1|STARTED|Overall Study||5
8195848|NCT02248857|20208705|P3|NOT COMPLETED|6 Month||17
8195849|NCT02248857|20208706|P2|NOT COMPLETED|6 Month||29
8195850|NCT02248857|20208707|P1|NOT COMPLETED|6 Month||28
8195851|NCT02248857|20208705|P3|COMPLETED|6 Month||106
8195852|NCT02248857|20208706|P2|COMPLETED|6 Month||136
8195853|NCT02248857|20208707|P1|COMPLETED|6 Month||120
8195854|NCT02248857|20208705|P3|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
8195855|NCT02248857|20208706|P2|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
8195856|NCT02248857|20208707|P1|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
8195857|NCT02248857|20208705|P3|NOT COMPLETED|3 Month||31
8195858|NCT02248857|20208706|P2|NOT COMPLETED|3 Month||34
8195859|NCT02248857|20208707|P1|NOT COMPLETED|3 Month||46
8195860|NCT02248857|20208705|P3|COMPLETED|3 Month||96
8195861|NCT02248857|20208706|P2|COMPLETED|3 Month||134
8195862|NCT02248857|20208707|P1|COMPLETED|3 Month||111
8195863|NCT02248857|20208705|P3|STARTED|3 Month||127
8195864|NCT02248857|20208706|P2|STARTED|3 Month||168
8195865|NCT02248857|20208707|P1|STARTED|3 Month||157
8195866|NCT02248857|20208705|P3|NOT COMPLETED|Baseline||0
8195867|NCT02248857|20208706|P2|NOT COMPLETED|Baseline||0
8195868|NCT02248857|20208707|P1|NOT COMPLETED|Baseline||0
8195869|NCT02248857|20208705|P3|COMPLETED|Baseline||127
8195870|NCT02248857|20208706|P2|COMPLETED|Baseline||168
8195871|NCT02248857|20208707|P1|COMPLETED|Baseline||157
8195872|NCT02248857|20208705|P3|STARTED|Baseline||127
8195873|NCT02248857|20208706|P2|STARTED|Baseline||168
8195874|NCT02248857|20208707|P1|STARTED|Baseline||157
8195875|NCT02248818|20208744|P9|NOT COMPLETED|Randomised Study||0
8195876|NCT02248818|20208745|P8|NOT COMPLETED|Randomised Study||0
8195877|NCT02248818|20208746|P7|NOT COMPLETED|Randomised Study||0
8195878|NCT02248818|20208747|P6|NOT COMPLETED|Randomised Study||8
8195879|NCT02248818|20208748|P5|NOT COMPLETED|Randomised Study||0
8195880|NCT02248818|20208749|P4|NOT COMPLETED|Randomised Study||0
8195881|NCT02248818|20208750|P3|NOT COMPLETED|Randomised Study||0
8195882|NCT02248818|20208751|P2|NOT COMPLETED|Randomised Study||0
8195883|NCT02248818|20208752|P1|NOT COMPLETED|Randomised Study||0
8195884|NCT02248818|20208744|P9|COMPLETED|Randomised Study||0
8195885|NCT02248818|20208745|P8|COMPLETED|Randomised Study||4
8195886|NCT02248818|20208746|P7|COMPLETED|Randomised Study||6
8195887|NCT02248818|20208747|P6|COMPLETED|Randomised Study||0
8195888|NCT02248818|20208748|P5|COMPLETED|Randomised Study||6
8195889|NCT02248818|20208749|P4|COMPLETED|Randomised Study||6
8195890|NCT02248818|20208750|P3|COMPLETED|Randomised Study||6
8195891|NCT02248818|20208751|P2|COMPLETED|Randomised Study||6
8195892|NCT02248818|20208752|P1|COMPLETED|Randomised Study||6
8195893|NCT02248818|20208744|P9|STARTED|Randomised Study||0
8195894|NCT02248818|20208745|P8|STARTED|Randomised Study||4
8195895|NCT02248818|20208746|P7|STARTED|Randomised Study||6
8195896|NCT02248818|20208747|P6|STARTED|Randomised Study||8
8195897|NCT02248818|20208748|P5|STARTED|Randomised Study||6
8195898|NCT02248818|20208749|P4|STARTED|Randomised Study||6
8195899|NCT02248818|20208750|P3|STARTED|Randomised Study||6
8195900|NCT02248818|20208751|P2|STARTED|Randomised Study||6
8195901|NCT02248818|20208752|P1|STARTED|Randomised Study||6
8195902|NCT02248818|20208744|P9|NOT COMPLETED|Screening||107
8195903|NCT02248818|20208745|P8|NOT COMPLETED|Screening||0
8195904|NCT02248818|20208746|P7|NOT COMPLETED|Screening||0
8195905|NCT02248818|20208747|P6|NOT COMPLETED|Screening||0
8195906|NCT02248818|20208748|P5|NOT COMPLETED|Screening||0
8195907|NCT02248818|20208749|P4|NOT COMPLETED|Screening||0
8195908|NCT02248818|20208750|P3|NOT COMPLETED|Screening||0
8195909|NCT02248818|20208751|P2|NOT COMPLETED|Screening||0
8195910|NCT02248818|20208752|P1|NOT COMPLETED|Screening||0
8195911|NCT02248818|20208744|P9|COMPLETED|Screening||48
8195912|NCT02248818|20208745|P8|COMPLETED|Screening||0
8195913|NCT02248818|20208746|P7|COMPLETED|Screening||0
8195914|NCT02248818|20208747|P6|COMPLETED|Screening||0
8195915|NCT02248818|20208748|P5|COMPLETED|Screening||0
8195916|NCT02248818|20208749|P4|COMPLETED|Screening||0
8195917|NCT02248818|20208750|P3|COMPLETED|Screening||0
8195918|NCT02248818|20208751|P2|COMPLETED|Screening||0
8195919|NCT02248818|20208752|P1|COMPLETED|Screening||0
8195920|NCT02248818|20208744|P9|STARTED|Screening||155
8195921|NCT02248818|20208745|P8|STARTED|Screening||0
8195922|NCT02248818|20208746|P7|STARTED|Screening||0
8195923|NCT02248818|20208747|P6|STARTED|Screening||0
8195924|NCT02248818|20208748|P5|STARTED|Screening||0
8195925|NCT02248818|20208749|P4|STARTED|Screening||0
8195926|NCT02248818|20208750|P3|STARTED|Screening||0
8195927|NCT02248818|20208751|P2|STARTED|Screening||0
8195928|NCT02248818|20208752|P1|STARTED|Screening||0
8195929|NCT02248766|20208890|P1|NOT COMPLETED|Overall Study||0
8195930|NCT02248766|20208890|P1|COMPLETED|Overall Study||30
8195931|NCT02248766|20208890|P1|STARTED|Overall Study||30
8195932|NCT02248740|20208904|P2|NOT COMPLETED|Overall Study||18
8195933|NCT02248740|20208905|P1|NOT COMPLETED|Overall Study||18
8195934|NCT02248740|20208904|P2|COMPLETED|Overall Study||0
8195935|NCT02248740|20208905|P1|COMPLETED|Overall Study||0
8195936|NCT02248740|20208904|P2|STARTED|Overall Study||18
8195937|NCT02248740|20208905|P1|STARTED|Overall Study||18
8195938|NCT02248727|20208915|P1|NOT COMPLETED|Overall Study||0
8195939|NCT02248727|20208915|P1|COMPLETED|Overall Study||30
8195940|NCT02248727|20208915|P1|STARTED|Overall Study||30
8195941|NCT02248714|20208928|P2|NOT COMPLETED|Overall Study||4
8195942|NCT02248714|20208929|P1|NOT COMPLETED|Overall Study||4
8195943|NCT02248714|20208928|P2|COMPLETED|Overall Study||61
8195944|NCT02248714|20208929|P1|COMPLETED|Overall Study||62
8195945|NCT02248714|20208928|P2|STARTED|Overall Study||65
8195946|NCT02248714|20208929|P1|STARTED|Overall Study||66
8195947|NCT02248675|20208967|P2|NOT COMPLETED|Overall Study||1
8195948|NCT02248675|20208968|P1|NOT COMPLETED|Overall Study||3
8195949|NCT02248675|20208967|P2|COMPLETED|Overall Study||27
8195950|NCT02248675|20208968|P1|COMPLETED|Overall Study||23
8195951|NCT02248675|20208967|P2|STARTED|Overall Study||28
8195952|NCT02248675|20208968|P1|STARTED|Overall Study||26
8195953|NCT02248662|20208982|P2|NOT COMPLETED|Overall Study||30515
8195954|NCT02248662|20208983|P1|NOT COMPLETED|Overall Study||4563
8195955|NCT02248662|20208982|P2|COMPLETED|Overall Study||2679
8195956|NCT02248662|20208983|P1|COMPLETED|Overall Study||757
8195957|NCT02248662|20208982|P2|STARTED|Overall Study||33194
8195958|NCT02248662|20208983|P1|STARTED|Overall Study||5320
8195959|NCT02248649|20208995|P2|NOT COMPLETED|Overall Study||21
8195960|NCT02248649|20208996|P1|NOT COMPLETED|Overall Study||21
8195961|NCT02248649|20208995|P2|COMPLETED|Overall Study||59
8195962|NCT02248649|20208996|P1|COMPLETED|Overall Study||59
8195963|NCT02248649|20208995|P2|STARTED|Overall Study||80
8195964|NCT02248649|20208996|P1|STARTED|Overall Study||80
8195965|NCT02248636|20209008|P2|NOT COMPLETED|Overall Study||3
8195966|NCT02248636|20209009|P1|NOT COMPLETED|Overall Study||6
8195967|NCT02248636|20209008|P2|COMPLETED|Overall Study||32
8195968|NCT02248636|20209009|P1|COMPLETED|Overall Study||20
8195969|NCT02248636|20209008|P2|STARTED|Overall Study||35
8195970|NCT02248636|20209009|P1|STARTED|Overall Study||26
8195971|NCT02248558|20209027|P2|NOT COMPLETED|Overall Study||45
8195972|NCT02248558|20209028|P1|NOT COMPLETED|Overall Study||52
8195973|NCT02248558|20209027|P2|COMPLETED|Overall Study||307
8195974|NCT02248558|20209028|P1|COMPLETED|Overall Study||317
8195975|NCT02248558|20209027|P2|STARTED|Overall Study||352
8195976|NCT02248558|20209028|P1|STARTED|Overall Study||369
8195977|NCT02248480|20209040|P2|NOT COMPLETED|Overall Study||14
8195978|NCT02248480|20209041|P1|NOT COMPLETED|Overall Study||17
8195979|NCT02248480|20209040|P2|COMPLETED|Overall Study||162
8195980|NCT02248480|20209041|P1|COMPLETED|Overall Study||161
8195981|NCT02248480|20209040|P2|Efficacy Population|Overall Study||176
8195982|NCT02248480|20209041|P1|Efficacy Population|Overall Study||177
8195983|NCT02248480|20209040|P2|STARTED|Overall Study||176
8195984|NCT02248480|20209041|P1|STARTED|Overall Study||178
8195985|NCT02248285|20209081|P2|NOT COMPLETED|Overall Study||287
8195986|NCT02248285|20209082|P1|NOT COMPLETED|Overall Study||101
8195987|NCT02248285|20209081|P2|COMPLETED|Overall Study||571
8195988|NCT02248285|20209082|P1|COMPLETED|Overall Study||586
8195989|NCT02248285|20209081|P2|STARTED|Overall Study||858
8195990|NCT02248285|20209082|P1|STARTED|Overall Study||687
8195991|NCT02248246|20209088|P1|NOT COMPLETED|Overall Study||0
8195992|NCT02248246|20209088|P1|COMPLETED|Overall Study||40
8195993|NCT02248246|20209088|P1|STARTED|Overall Study||40
8195994|NCT02248103|20209095|P2|NOT COMPLETED|Overall Study||0
8195995|NCT02248103|20209096|P1|NOT COMPLETED|Overall Study||0
8195996|NCT02248103|20209095|P2|COMPLETED|Overall Study||10
8195997|NCT02248103|20209096|P1|COMPLETED|Overall Study||10
8195998|NCT02248103|20209095|P2|STARTED|Overall Study||10
8195999|NCT02248103|20209096|P1|STARTED|Overall Study||10
8196000|NCT02247960|20209108|P2|NOT COMPLETED|Catheter Removed||10
8196001|NCT02247960|20209109|P1|NOT COMPLETED|Catheter Removed||7
8196002|NCT02247960|20209108|P2|COMPLETED|Catheter Removed||74
8196003|NCT02247960|20209109|P1|COMPLETED|Catheter Removed||76
8196004|NCT02247960|20209108|P2|STARTED|Catheter Removed||84
8196005|NCT02247960|20209109|P1|STARTED|Catheter Removed||83
8196006|NCT02247960|20209108|P2|NOT COMPLETED|Patient Consent and Randomization||6
8196007|NCT02247960|20209109|P1|NOT COMPLETED|Patient Consent and Randomization||2
8196008|NCT02247960|20209108|P2|COMPLETED|Patient Consent and Randomization||84
8196009|NCT02247960|20209109|P1|COMPLETED|Patient Consent and Randomization||83
8196010|NCT02247960|20209108|P2|STARTED|Patient Consent and Randomization||90
8196011|NCT02247960|20209109|P1|STARTED|Patient Consent and Randomization||85
8196012|NCT02247804|20209122|P3|NOT COMPLETED|Treatment Period 3||10
8196013|NCT02247804|20209123|P2|NOT COMPLETED|Treatment Period 3||10
8196014|NCT02247804|20209124|P1|NOT COMPLETED|Treatment Period 3||11
8196015|NCT02247804|20209122|P3|COMPLETED|Treatment Period 3||167
8196016|NCT02247804|20209123|P2|COMPLETED|Treatment Period 3||173
8196017|NCT02247804|20209124|P1|COMPLETED|Treatment Period 3||147
8196018|NCT02247804|20209122|P3|STARTED|Treatment Period 3||177
8196019|NCT02247804|20209123|P2|STARTED|Treatment Period 3||183
8196020|NCT02247804|20209124|P1|STARTED|Treatment Period 3||158
8196021|NCT02247804|20209122|P3|NOT COMPLETED|Treatment Period 2||8
8196022|NCT02247804|20209123|P2|NOT COMPLETED|Treatment Period 2||5
8196023|NCT02247804|20209124|P1|NOT COMPLETED|Treatment Period 2||8
8196024|NCT02247804|20209122|P3|COMPLETED|Treatment Period 2||179
8196025|NCT02247804|20209123|P2|COMPLETED|Treatment Period 2||186
8196026|NCT02247804|20209124|P1|COMPLETED|Treatment Period 2||164
8196027|NCT02247804|20209122|P3|STARTED|Treatment Period 2||187
8196028|NCT02247804|20209123|P2|STARTED|Treatment Period 2||191
8196029|NCT02247804|20209124|P1|STARTED|Treatment Period 2||172
8196030|NCT02247804|20209122|P3|NOT COMPLETED|Treatment Period 1||8
8196031|NCT02247804|20209123|P2|NOT COMPLETED|Treatment Period 1||4
8196032|NCT02247804|20209124|P1|NOT COMPLETED|Treatment Period 1||22
8196033|NCT02247804|20209122|P3|COMPLETED|Treatment Period 1||190
8196034|NCT02247804|20209123|P2|COMPLETED|Treatment Period 1||194
8196035|NCT02247804|20209124|P1|COMPLETED|Treatment Period 1||176
8196036|NCT02247804|20209122|P3|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
8196037|NCT02247804|20209123|P2|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
8196038|NCT02247804|20209124|P1|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
8196039|NCT02247804|20209122|P3|STARTED|Treatment Period 1||198
8196040|NCT02247804|20209123|P2|STARTED|Treatment Period 1||198
8196041|NCT02247804|20209124|P1|STARTED|Treatment Period 1||198
8196042|NCT02247765|20209153|P1|NOT COMPLETED|Overall Study||0
8196043|NCT02247765|20209153|P1|COMPLETED|Overall Study||18
8196044|NCT02247765|20209153|P1|STARTED|Overall Study||18
8196045|NCT02247739|20209158|P6|NOT COMPLETED|Overall Study||1
8196046|NCT02247739|20209159|P5|NOT COMPLETED|Overall Study||1
8196047|NCT02247739|20209160|P4|NOT COMPLETED|Overall Study||0
8196048|NCT02247739|20209161|P3|NOT COMPLETED|Overall Study||1
8196049|NCT02247739|20209162|P2|NOT COMPLETED|Overall Study||3
8196050|NCT02247739|20209163|P1|NOT COMPLETED|Overall Study||0
8196051|NCT02247739|20209158|P6|COMPLETED|Overall Study||4
8196052|NCT02247739|20209159|P5|COMPLETED|Overall Study||5
8196053|NCT02247739|20209160|P4|COMPLETED|Overall Study||5
8196054|NCT02247739|20209161|P3|COMPLETED|Overall Study||4
8196055|NCT02247739|20209162|P2|COMPLETED|Overall Study||3
8196056|NCT02247739|20209163|P1|COMPLETED|Overall Study||5
8196057|NCT02247739|20209158|P6|STARTED|Overall Study||5
8196058|NCT02247739|20209159|P5|STARTED|Overall Study||6
8196059|NCT02247739|20209160|P4|STARTED|Overall Study||5
8196060|NCT02247739|20209161|P3|STARTED|Overall Study||5
8196061|NCT02247739|20209162|P2|STARTED|Overall Study||6
8196062|NCT02247739|20209163|P1|STARTED|Overall Study||5
8196063|NCT02247531|20209182|P3|NOT COMPLETED|Overall Study||110
8196064|NCT02247531|20209183|P2|NOT COMPLETED|Overall Study||125
8196065|NCT02247531|20209184|P1|NOT COMPLETED|Overall Study||106
8196066|NCT02247531|20209182|P3|COMPLETED|Overall Study||214
8196067|NCT02247531|20209183|P2|COMPLETED|Overall Study||205
8196068|NCT02247531|20209184|P1|COMPLETED|Overall Study||215
8196069|NCT02247531|20209182|P3|STARTED|Overall Study||324
8196070|NCT02247531|20209183|P2|STARTED|Overall Study||330
8196071|NCT02247531|20209184|P1|STARTED|Overall Study||321
8196072|NCT02247479|20209234|P3|NOT COMPLETED|Overall Study||138
8196073|NCT02247479|20209235|P2|NOT COMPLETED|Overall Study||138
8196074|NCT02247479|20209236|P1|NOT COMPLETED|Overall Study||142
8196075|NCT02247479|20209234|P3|COMPLETED|Overall Study||165
8196076|NCT02247479|20209235|P2|COMPLETED|Overall Study||160
8196077|NCT02247479|20209236|P1|COMPLETED|Overall Study||163
8196078|NCT02247479|20209234|P3|STARTED|Overall Study||303
8196079|NCT02247479|20209235|P2|STARTED|Overall Study||298
8196080|NCT02247479|20209236|P1|STARTED|Overall Study||305
8196081|NCT02247466|20209285|P2|NOT COMPLETED|Overall Study||3
8196082|NCT02247466|20209286|P1|NOT COMPLETED|Overall Study||0
8196083|NCT02247466|20209285|P2|COMPLETED|Overall Study||15
8196084|NCT02247466|20209286|P1|COMPLETED|Overall Study||19
8196085|NCT02247466|20209285|P2|STARTED|Overall Study||18
8196086|NCT02247466|20209286|P1|STARTED|Overall Study||19
8196087|NCT02247440|20209304|P1|NOT COMPLETED|Overall Study||4
8196088|NCT02247440|20209304|P1|COMPLETED|Overall Study||14
8196089|NCT02247440|20209304|P1|STARTED|Overall Study||18
8196090|NCT02247401|20209317|P3|NOT COMPLETED|Overall Study||2
8196091|NCT02247401|20209318|P2|NOT COMPLETED|Overall Study||2
8196092|NCT02247401|20209319|P1|NOT COMPLETED|Overall Study||6
8196093|NCT02247401|20209317|P3|COMPLETED|Overall Study||27
8196094|NCT02247401|20209318|P2|COMPLETED|Overall Study||29
8196095|NCT02247401|20209319|P1|COMPLETED|Overall Study||94
8196096|NCT02247401|20209317|P3|STARTED|Overall Study||29
8196097|NCT02247401|20209318|P2|STARTED|Overall Study||31
8196098|NCT02247401|20209319|P1|STARTED|Overall Study||100
8196099|NCT02247245|20209340|P4|NOT COMPLETED|Overall Study||0
8196100|NCT02247245|20209341|P3|NOT COMPLETED|Overall Study||0
8196101|NCT02247245|20209342|P2|NOT COMPLETED|Overall Study||0
8196102|NCT02247245|20209343|P1|NOT COMPLETED|Overall Study||0
8196103|NCT02247245|20209340|P4|COMPLETED|Overall Study||7
8196104|NCT02247245|20209341|P3|COMPLETED|Overall Study||7
8196105|NCT02247245|20209342|P2|COMPLETED|Overall Study||13
8196106|NCT02247245|20209343|P1|COMPLETED|Overall Study||13
8196107|NCT02247245|20209340|P4|STARTED|Overall Study||7
8196108|NCT02247245|20209341|P3|STARTED|Overall Study||7
8196109|NCT02247245|20209342|P2|STARTED|Overall Study||13
8196110|NCT02247245|20209343|P1|STARTED|Overall Study||13
8196111|NCT02247063|20209355|P2|NOT COMPLETED|Overall Study||0
8196112|NCT02247063|20209356|P1|NOT COMPLETED|Overall Study||0
8196113|NCT02247063|20209355|P2|COMPLETED|Overall Study||12
8196114|NCT02247063|20209356|P1|COMPLETED|Overall Study||12
8196115|NCT02247063|20209355|P2|STARTED|Overall Study||12
8196116|NCT02247063|20209356|P1|STARTED|Overall Study||12
8196117|NCT02247011|20209366|P1|NOT COMPLETED|Overall Study||125
8196118|NCT02247011|20209366|P1|COMPLETED|Overall Study||975
8196119|NCT02247011|20209366|P1|STARTED|Overall Study||1100
8196120|NCT02246998|20209387|P4|NOT COMPLETED|Overall Study||2
8196121|NCT02246998|20209388|P3|NOT COMPLETED|Overall Study||3
8196122|NCT02246998|20209389|P2|NOT COMPLETED|Overall Study||3
8196123|NCT02246998|20209390|P1|NOT COMPLETED|Overall Study||2
8196124|NCT02246998|20209387|P4|COMPLETED|Overall Study||16
8196125|NCT02246998|20209388|P3|COMPLETED|Overall Study||15
8196126|NCT02246998|20209389|P2|COMPLETED|Overall Study||15
8196127|NCT02246998|20209390|P1|COMPLETED|Overall Study||16
8196128|NCT02246998|20209387|P4|STARTED|Overall Study||18
8196129|NCT02246998|20209388|P3|STARTED|Overall Study||18
8196130|NCT02246998|20209389|P2|STARTED|Overall Study||18
8196131|NCT02246998|20209390|P1|STARTED|Overall Study||18
8196132|NCT02246777|20209500|P1|NOT COMPLETED|Overall Study||3
8196133|NCT02246777|20209500|P1|COMPLETED|Overall Study||29
8196134|NCT02246777|20209500|P1|STARTED|Overall Study||32
8196135|NCT02246764|20209516|P3|NOT COMPLETED|Overall Study||4
8196136|NCT02246764|20209517|P2|NOT COMPLETED|Overall Study||32
8196137|NCT02246764|20209518|P1|NOT COMPLETED|Overall Study||18
8196138|NCT02246764|20209516|P3|COMPLETED|Overall Study||19
8196139|NCT02246764|20209517|P2|COMPLETED|Overall Study||4
8196140|NCT02246764|20209518|P1|COMPLETED|Overall Study||16
8196141|NCT02246764|20209516|P3|STARTED|Overall Study||23
8196142|NCT02246764|20209517|P2|STARTED|Overall Study||36
8196143|NCT02246764|20209518|P1|STARTED|Overall Study||34
8196144|NCT02246673|20209531|P5|NOT COMPLETED|Overall Study||1
8196145|NCT02246673|20209532|P4|NOT COMPLETED|Overall Study||2
8196146|NCT02246673|20209533|P3|NOT COMPLETED|Overall Study||0
8196147|NCT02246673|20209534|P2|NOT COMPLETED|Overall Study||0
8196148|NCT02246673|20209535|P1|NOT COMPLETED|Overall Study||1
8196149|NCT02246673|20209531|P5|COMPLETED|Overall Study||11
8196150|NCT02246673|20209532|P4|COMPLETED|Overall Study||12
8196151|NCT02246673|20209533|P3|COMPLETED|Overall Study||12
8196152|NCT02246673|20209534|P2|COMPLETED|Overall Study||12
8196153|NCT02246673|20209535|P1|COMPLETED|Overall Study||13
8196154|NCT02246673|20209531|P5|STARTED|Overall Study||12
8196155|NCT02246673|20209532|P4|STARTED|Overall Study||14
8196156|NCT02246673|20209533|P3|STARTED|Overall Study||12
8196157|NCT02246673|20209534|P2|STARTED|Overall Study||12
8196158|NCT02246673|20209535|P1|STARTED|Overall Study||14
8196159|NCT02246660|20209643|P3|NOT COMPLETED|Overall Study||1
8196160|NCT02246660|20209644|P2|NOT COMPLETED|Overall Study||1
8196161|NCT02246660|20209645|P1|NOT COMPLETED|Overall Study||0
8196162|NCT02246660|20209643|P3|COMPLETED|Overall Study||21
8196163|NCT02246660|20209644|P2|COMPLETED|Overall Study||20
8196164|NCT02246660|20209645|P1|COMPLETED|Overall Study||23
8196165|NCT02246660|20209643|P3|STARTED|Overall Study||22
8196166|NCT02246660|20209644|P2|STARTED|Overall Study||21
8196167|NCT02246660|20209645|P1|STARTED|Overall Study||23
8196168|NCT02246647|20209655|P2|NOT COMPLETED|Overall Study||1
8196169|NCT02246647|20209656|P1|NOT COMPLETED|Overall Study||1
8196170|NCT02246647|20209655|P2|COMPLETED|Overall Study||19
8196171|NCT02246647|20209656|P1|COMPLETED|Overall Study||18
8196172|NCT02246647|20209655|P2|STARTED|Overall Study||20
8196173|NCT02246647|20209656|P1|STARTED|Overall Study||19
8196174|NCT02246621|20209690|P2|NOT COMPLETED|Overall Study||135
8196175|NCT02246621|20209691|P1|NOT COMPLETED|Overall Study||265
8196176|NCT02246621|20209690|P2|COMPLETED|Overall Study||30
8196177|NCT02246621|20209691|P1|COMPLETED|Overall Study||63
8196178|NCT02246621|20209690|P2|Received At Least One Dose of Study Drug|Overall Study||161
8196179|NCT02246621|20209691|P1|Received At Least One Dose of Study Drug|Overall Study||327
8196180|NCT02246621|20209690|P2|STARTED|Overall Study||165
8196181|NCT02246621|20209691|P1|STARTED|Overall Study||328
8196182|NCT02246608|20209719|P2|NOT COMPLETED|Overall Study||10
8196183|NCT02246608|20209720|P1|NOT COMPLETED|Overall Study||12
8196184|NCT02246608|20209719|P2|COMPLETED|Overall Study||11
8196185|NCT02246608|20209720|P1|COMPLETED|Overall Study||10
8196186|NCT02246608|20209719|P2|STARTED|Overall Study||21
8196187|NCT02246608|20209720|P1|STARTED|Overall Study||22
8196188|NCT02246582|20209728|P2|NOT COMPLETED|Overall Study||4
8196189|NCT02246582|20209729|P1|NOT COMPLETED|Overall Study||3
8196190|NCT02246582|20209728|P2|COMPLETED|Overall Study||41
8196191|NCT02246582|20209729|P1|COMPLETED|Overall Study||41
8196192|NCT02246582|20209728|P2|STARTED|Overall Study||45
8196193|NCT02246582|20209729|P1|STARTED|Overall Study||44
8196194|NCT02246439|20209737|P2|NOT COMPLETED|Overall Study||11
8196195|NCT02246439|20209738|P1|NOT COMPLETED|Overall Study||12
8196196|NCT02246439|20209737|P2|COMPLETED|Overall Study||118
8196197|NCT02246439|20209738|P1|COMPLETED|Overall Study||180
8196198|NCT02246439|20209737|P2|Randomized|Overall Study||132
8196199|NCT02246439|20209738|P1|Randomized|Overall Study||198
8196200|NCT02246439|20209737|P2|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
8196201|NCT02246439|20209738|P1|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
8196202|NCT02246413|20209776|P2|NOT COMPLETED|24-months (Secondary Outcome)||32
8196203|NCT02246413|20209777|P1|NOT COMPLETED|24-months (Secondary Outcome)||51
8196204|NCT02246413|20209776|P2|COMPLETED|24-months (Secondary Outcome)||173
8196205|NCT02246413|20209777|P1|COMPLETED|24-months (Secondary Outcome)||153
8196206|NCT02246413|20209776|P2|STARTED|24-months (Secondary Outcome)||205
8196207|NCT02246413|20209777|P1|STARTED|24-months (Secondary Outcome)||204
8196208|NCT02246413|20209776|P2|NOT COMPLETED|12-months (Primary Outcome)||30
8196209|NCT02246413|20209777|P1|NOT COMPLETED|12-months (Primary Outcome)||35
8196210|NCT02246413|20209776|P2|COMPLETED|12-months (Primary Outcome)||175
8196211|NCT02246413|20209777|P1|COMPLETED|12-months (Primary Outcome)||169
8196212|NCT02246413|20209776|P2|STARTED|12-months (Primary Outcome)||205
8196213|NCT02246413|20209777|P1|STARTED|12-months (Primary Outcome)||204
8196214|NCT02246309|20209857|P2|NOT COMPLETED|Overall Study||0
8196215|NCT02246309|20209858|P1|NOT COMPLETED|Overall Study||0
8196216|NCT02246309|20209857|P2|COMPLETED|Overall Study||15
8196217|NCT02246309|20209858|P1|COMPLETED|Overall Study||16
8196218|NCT02246309|20209857|P2|STARTED|Overall Study||15
8196219|NCT02246309|20209858|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
8196220|NCT02246218|20209870|P2|NOT COMPLETED|Overall Study||6
8196221|NCT02246218|20209871|P1|NOT COMPLETED|Overall Study||4
8196222|NCT02246218|20209870|P2|COMPLETED|Overall Study||10
8196223|NCT02246218|20209871|P1|COMPLETED|Overall Study||6
8196224|NCT02246218|20209870|P2|STARTED|Overall Study||16
8196225|NCT02246218|20209871|P1|STARTED|Overall Study||10
8196226|NCT02246166|20209931|P2|NOT COMPLETED|Overall Study||0
8196227|NCT02246166|20209932|P1|NOT COMPLETED|Overall Study||1
8196228|NCT02246166|20209931|P2|COMPLETED|Overall Study||27
8196229|NCT02246166|20209932|P1|COMPLETED|Overall Study||25
8196230|NCT02246166|20209931|P2|STARTED|Overall Study||27
8196231|NCT02246166|20209932|P1|STARTED|Overall Study||26
8196232|NCT02246114|20209968|P2|NOT COMPLETED|Overall Study||0
8196233|NCT02246114|20209969|P1|NOT COMPLETED|Overall Study||1
8196234|NCT02246114|20209968|P2|COMPLETED|Overall Study||0
8196235|NCT02246114|20209969|P1|COMPLETED|Overall Study||0
8196236|NCT02246114|20209968|P2|STARTED|Overall Study||0
8196237|NCT02246114|20209969|P1|STARTED|Overall Study||1
8196238|NCT02246062|20209979|P4|NOT COMPLETED|Overall Study||0
8196239|NCT02246062|20209980|P3|NOT COMPLETED|Overall Study||0
8196240|NCT02246062|20209981|P2|NOT COMPLETED|Overall Study||0
8196241|NCT02246062|20209982|P1|NOT COMPLETED|Overall Study||0
8196242|NCT02246062|20209979|P4|COMPLETED|Overall Study||21
8196243|NCT02246062|20209980|P3|COMPLETED|Overall Study||21
8196244|NCT02246062|20209981|P2|COMPLETED|Overall Study||21
8196245|NCT02246062|20209982|P1|COMPLETED|Overall Study||21
8196246|NCT02246062|20209979|P4|STARTED|Overall Study||21
8196247|NCT02246062|20209980|P3|STARTED|Overall Study||21
8196248|NCT02246062|20209981|P2|STARTED|Overall Study||21
8196249|NCT02246062|20209982|P1|STARTED|Overall Study||21
8196250|NCT02246010|20210002|P2|NOT COMPLETED|Overall Study||0
8196251|NCT02246010|20210003|P1|NOT COMPLETED|Overall Study||0
8196252|NCT02246010|20210002|P2|COMPLETED|Overall Study||2
8196253|NCT02246010|20210003|P1|COMPLETED|Overall Study||4
8196254|NCT02246010|20210002|P2|STARTED|Overall Study||2
8196255|NCT02246010|20210003|P1|STARTED|Overall Study||4
8196256|NCT02245737|20210020|P3|NOT COMPLETED|Overall Study||571
8196257|NCT02245737|20210021|P2|NOT COMPLETED|Overall Study||555
8196258|NCT02245737|20210022|P1|NOT COMPLETED|Overall Study||553
8196259|NCT02245737|20210020|P3|COMPLETED|Overall Study||168
8196260|NCT02245737|20210021|P2|COMPLETED|Overall Study||184
8196261|NCT02245737|20210022|P1|COMPLETED|Overall Study||187
8196262|NCT02245737|20210020|P3|Received at Least 1 Dose of Study Drug|Overall Study||735
8196263|NCT02245737|20210021|P2|Received at Least 1 Dose of Study Drug|Overall Study||736
8196264|NCT02245737|20210022|P1|Received at Least 1 Dose of Study Drug|Overall Study||738
8196265|NCT02245737|20210020|P3|STARTED|Overall Study||739
8196266|NCT02245737|20210021|P2|STARTED|Overall Study||739
8196267|NCT02245737|20210022|P1|STARTED|Overall Study||740
8196268|NCT02245672|20210080|P3|NOT COMPLETED|Overall Study||5
8196269|NCT02245672|20210081|P2|NOT COMPLETED|Overall Study||13
8196270|NCT02245672|20210082|P1|NOT COMPLETED|Overall Study||13
8196271|NCT02245672|20210080|P3|COMPLETED|Overall Study||98
8196272|NCT02245672|20210081|P2|COMPLETED|Overall Study||500
8196273|NCT02245672|20210082|P1|COMPLETED|Overall Study||499
8196274|NCT02245672|20210080|P3|STARTED|Overall Study||103
8196275|NCT02245672|20210081|P2|STARTED|Overall Study||513
8196276|NCT02245672|20210082|P1|STARTED|Overall Study||512
8196277|NCT02245620|20210101|P2|NOT COMPLETED|Overall Study||1
8196278|NCT02245620|20210102|P1|NOT COMPLETED|Overall Study||1
8196279|NCT02245620|20210101|P2|COMPLETED|Overall Study||20
8196280|NCT02245620|20210102|P1|COMPLETED|Overall Study||19
8196281|NCT02245620|20210101|P2|STARTED|Overall Study||21
8196282|NCT02245620|20210102|P1|STARTED|Overall Study||20
8196283|NCT02245568|20210114|P1|NOT COMPLETED|Overall Study||853
8196284|NCT02245568|20210114|P1|COMPLETED|Overall Study||60
8196285|NCT02245568|20210114|P1|STARTED|Overall Study||913
8196286|NCT02245516|20210120|P2|NOT COMPLETED|Overall Study||3
8196287|NCT02245516|20210121|P1|NOT COMPLETED|Overall Study||0
8196288|NCT02245516|20210120|P2|COMPLETED|Overall Study||4
8196289|NCT02245516|20210121|P1|COMPLETED|Overall Study||9
8196290|NCT02245516|20210120|P2|STARTED|Overall Study||7
8196291|NCT02245516|20210121|P1|STARTED|Overall Study||9
8196292|NCT02245412|20210136|P3|NOT COMPLETED|Follow-Up Period||2
8196293|NCT02245412|20210137|P2|NOT COMPLETED|Follow-Up Period||2
8196294|NCT02245412|20210138|P1|NOT COMPLETED|Follow-Up Period||5
8196295|NCT02245412|20210136|P3|COMPLETED|Follow-Up Period||0
8196296|NCT02245412|20210137|P2|COMPLETED|Follow-Up Period||2
8196297|NCT02245412|20210138|P1|COMPLETED|Follow-Up Period||8
8196298|NCT02245412|20210136|P3|STARTED|Follow-Up Period||2
8196299|NCT02245412|20210137|P2|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
8196300|NCT02245412|20210138|P1|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
8196301|NCT02245412|20210136|P3|NOT COMPLETED|Treatment Period||0
8196302|NCT02245412|20210137|P2|NOT COMPLETED|Treatment Period||3
8196303|NCT02245412|20210138|P1|NOT COMPLETED|Treatment Period||5
8196304|NCT02245412|20210136|P3|COMPLETED|Treatment Period||2
8196305|NCT02245412|20210137|P2|COMPLETED|Treatment Period||3
8196306|NCT02245412|20210138|P1|COMPLETED|Treatment Period||12
8196307|NCT02245412|20210136|P3|Modified Full Analysis Set (mFAS)|Treatment Period||2
8196308|NCT02245412|20210137|P2|Modified Full Analysis Set (mFAS)|Treatment Period||6
8196309|NCT02245412|20210138|P1|Modified Full Analysis Set (mFAS)|Treatment Period||16
8196310|NCT02245412|20210136|P3|Received at Least 1 Dose of Study Drug|Treatment Period||2
8196311|NCT02245412|20210137|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
8196312|NCT02245412|20210138|P1|Received at Least 1 Dose of Study Drug|Treatment Period||17
8196313|NCT02245412|20210136|P3|STARTED|Treatment Period||2
8196314|NCT02245412|20210137|P2|STARTED|Treatment Period||6
8196315|NCT02245412|20210138|P1|STARTED|Treatment Period||17
8196316|NCT02245360|20210157|P2|NOT COMPLETED|Overall Study||2
8196317|NCT02245360|20210158|P1|NOT COMPLETED|Overall Study||5
8196318|NCT02245360|20210157|P2|COMPLETED|Overall Study||52
8196319|NCT02245360|20210158|P1|COMPLETED|Overall Study||48
8196320|NCT02245360|20210157|P2|STARTED|Overall Study||54
8196321|NCT02245360|20210158|P1|STARTED|Overall Study||53
8196322|NCT02245308|20210168|P2|NOT COMPLETED|Overall Study||0
8196323|NCT02245308|20210169|P1|NOT COMPLETED|Overall Study||0
8196324|NCT02245308|20210168|P2|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
8196325|NCT02245308|20210169|P1|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
8196326|NCT02245308|20210168|P2|STARTED|Overall Study||64
8196327|NCT02245308|20210169|P1|STARTED|Overall Study||63
8196328|NCT02245217|20210177|P1|NOT COMPLETED|Overall Study||2
8196329|NCT02245217|20210177|P1|COMPLETED|Overall Study||7
8196330|NCT02245217|20210177|P1|STARTED|Overall Study||9
8196331|NCT02244996|20210185|P2|NOT COMPLETED|Overall Study||6
8196332|NCT02244996|20210186|P1|NOT COMPLETED|Overall Study||2
8196333|NCT02244996|20210185|P2|COMPLETED|Overall Study||19
8196334|NCT02244996|20210186|P1|COMPLETED|Overall Study||23
8196335|NCT02244996|20210185|P2|STARTED|Overall Study||25
8196336|NCT02244996|20210186|P1|STARTED|Overall Study||25
8196337|NCT02244957|20210200|P2|NOT COMPLETED|Overall Study||0
8196338|NCT02244957|20210201|P1|NOT COMPLETED|Overall Study||1
8196339|NCT02244957|20210200|P2|COMPLETED|Overall Study||16
8196340|NCT02244957|20210201|P1|COMPLETED|Overall Study||6
8196341|NCT02244957|20210200|P2|STARTED|Overall Study||16
8196342|NCT02244957|20210201|P1|STARTED|Overall Study||7
8196343|NCT02244944|20210245|P1|NOT COMPLETED|Overall Study||2
8196344|NCT02244944|20210245|P1|COMPLETED|Overall Study||0
8196345|NCT02244944|20210245|P1|STARTED|Overall Study||2
8196346|NCT02244918|20210253|P2|NOT COMPLETED|Overall Study||0
8196347|NCT02244918|20210254|P1|NOT COMPLETED|Overall Study||0
8196348|NCT02244918|20210253|P2|COMPLETED|Overall Study||93
8196349|NCT02244918|20210254|P1|COMPLETED|Overall Study||185
8196350|NCT02244918|20210253|P2|Week 12|Overall Study||83
8196351|NCT02244918|20210254|P1|Week 12|Overall Study||160
8196352|NCT02244918|20210253|P2|STARTED|Overall Study||93
8196353|NCT02244918|20210254|P1|STARTED|Overall Study||185
8196354|NCT02244840|20210270|P1|NOT COMPLETED|Overall Study||0
8196355|NCT02244840|20210270|P1|COMPLETED|Overall Study||40
8196356|NCT02244840|20210270|P1|STARTED|Overall Study||40
8196357|NCT02244619|20210276|P2|NOT COMPLETED|Overall Study||21
8196358|NCT02244619|20210277|P1|NOT COMPLETED|Overall Study||8
8196359|NCT02244619|20210276|P2|COMPLETED|Overall Study||245
8196360|NCT02244619|20210277|P1|COMPLETED|Overall Study||241
8196361|NCT02244619|20210276|P2|STARTED|Overall Study||266
8196362|NCT02244619|20210277|P1|STARTED|Overall Study||249
8196363|NCT02244580|20210295|P1|NOT COMPLETED|Overall Study||241
8196364|NCT02244580|20210295|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
8196365|NCT02244580|20210295|P1|STARTED|Overall Study||1010
8196366|NCT02244424|20210305|P2|NOT COMPLETED|Overall Study||10
8196367|NCT02244424|20210306|P1|NOT COMPLETED|Overall Study||20
8196368|NCT02244424|20210305|P2|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
8196369|NCT02244424|20210306|P1|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
8196370|NCT02244424|20210305|P2|Mothers|Overall Study||31
8196371|NCT02244424|20210306|P1|Mothers|Overall Study||51
8196372|NCT02244424|20210305|P2|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
8196373|NCT02244424|20210306|P1|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
8196374|NCT02244424|20210305|P2|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
8196375|NCT02244424|20210306|P1|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
8196376|NCT02243943|20210314|P2|NOT COMPLETED|Overall Study||0
8196377|NCT02243943|20210315|P1|NOT COMPLETED|Overall Study||0
8196378|NCT02243943|20210314|P2|COMPLETED|Overall Study||50
8196379|NCT02243943|20210315|P1|COMPLETED|Overall Study||50
8196380|NCT02243943|20210314|P2|STARTED|Overall Study||50
8196381|NCT02243943|20210315|P1|STARTED|Overall Study||50
8196382|NCT02243696|20210325|P1|NOT COMPLETED|Overall Study||1694
8196383|NCT02243696|20210325|P1|COMPLETED|Overall Study||0
8196384|NCT02243696|20210325|P1|STARTED|Overall Study||1694
8196385|NCT02243605|20210337|P2|NOT COMPLETED|Stage 2 - Final Analysis Population||3
8196386|NCT02243605|20210338|P1|NOT COMPLETED|Stage 2 - Final Analysis Population||6
8196387|NCT02243605|20210337|P2|COMPLETED|Stage 2 - Final Analysis Population||42
8196388|NCT02243605|20210338|P1|COMPLETED|Stage 2 - Final Analysis Population||39
8196389|NCT02243605|20210337|P2|STARTED|Stage 2 - Final Analysis Population||45
8196390|NCT02243605|20210338|P1|STARTED|Stage 2 - Final Analysis Population||45
8196391|NCT02243605|20210337|P2|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
8196392|NCT02243605|20210338|P1|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
8196393|NCT02243605|20210337|P2|COMPLETED|Stage 1 - Interim Analysis Population||21
8196394|NCT02243605|20210338|P1|COMPLETED|Stage 1 - Interim Analysis Population||21
8196395|NCT02243605|20210337|P2|STARTED|Stage 1 - Interim Analysis Population||22
8196396|NCT02243605|20210338|P1|STARTED|Stage 1 - Interim Analysis Population||23
8196397|NCT02243579|20210346|P1|NOT COMPLETED|Overall Study||20
8196398|NCT02243579|20210346|P1|COMPLETED|Overall Study||4
8196399|NCT02243579|20210346|P1|STARTED|Overall Study||24
8196400|NCT02243527|20210357|P2|NOT COMPLETED|Overall Study||0
8196401|NCT02243527|20210358|P1|NOT COMPLETED|Overall Study||0
8196402|NCT02243527|20210357|P2|COMPLETED|Overall Study||13
8196403|NCT02243527|20210358|P1|COMPLETED|Overall Study||12
8196404|NCT02243527|20210357|P2|STARTED|Overall Study||13
8196405|NCT02243527|20210358|P1|STARTED|Overall Study||12
8196406|NCT02243371|20210372|P2|NOT COMPLETED|Overall Study||32
8196407|NCT02243371|20210373|P1|NOT COMPLETED|Overall Study||37
8196408|NCT02243371|20210372|P2|COMPLETED|Overall Study||10
8196409|NCT02243371|20210373|P1|COMPLETED|Overall Study||14
8196410|NCT02243371|20210372|P2|STARTED|Overall Study||42
8196411|NCT02243371|20210373|P1|STARTED|Overall Study||51
8196412|NCT02243306|20210393|P2|NOT COMPLETED|Overall Study||3
8196413|NCT02243306|20210394|P1|NOT COMPLETED|Overall Study||0
8196414|NCT02243306|20210393|P2|COMPLETED|Overall Study||4
8196415|NCT02243306|20210394|P1|COMPLETED|Overall Study||1
8196416|NCT02243306|20210393|P2|STARTED|Overall Study||7
8196417|NCT02243306|20210394|P1|STARTED|Overall Study||1
8196418|NCT02243293|20210469|P22|NOT COMPLETED|Overall Study||3
8196419|NCT02243293|20210470|P21|NOT COMPLETED|Overall Study||2
8196420|NCT02243293|20210471|P20|NOT COMPLETED|Overall Study||1
8196421|NCT02243293|20210472|P19|NOT COMPLETED|Overall Study||0
8196422|NCT02243293|20210473|P18|NOT COMPLETED|Overall Study||1
8196423|NCT02243293|20210474|P17|NOT COMPLETED|Overall Study||3
8196424|NCT02243293|20210475|P16|NOT COMPLETED|Overall Study||1
8196425|NCT02243293|20210476|P15|NOT COMPLETED|Overall Study||1
8196426|NCT02243293|20210477|P14|NOT COMPLETED|Overall Study||0
8196427|NCT02243293|20210478|P13|NOT COMPLETED|Overall Study||0
8196428|NCT02243293|20210479|P12|NOT COMPLETED|Overall Study||3
8196429|NCT02243293|20210480|P11|NOT COMPLETED|Overall Study||0
8196430|NCT02243293|20210481|P10|NOT COMPLETED|Overall Study||2
8196431|NCT02243293|20210482|P9|NOT COMPLETED|Overall Study||0
8196432|NCT02243293|20210483|P8|NOT COMPLETED|Overall Study||0
8196433|NCT02243293|20210484|P7|NOT COMPLETED|Overall Study||3
8196434|NCT02243293|20210485|P6|NOT COMPLETED|Overall Study||0
8196435|NCT02243293|20210486|P5|NOT COMPLETED|Overall Study||1
8196436|NCT02243293|20210487|P4|NOT COMPLETED|Overall Study||1
8196437|NCT02243293|20210488|P3|NOT COMPLETED|Overall Study||1
8196438|NCT02243293|20210489|P2|NOT COMPLETED|Overall Study||1
8196439|NCT02243293|20210490|P1|NOT COMPLETED|Overall Study||2
8196440|NCT02243293|20210469|P22|COMPLETED|Overall Study||55
8196441|NCT02243293|20210470|P21|COMPLETED|Overall Study||143
8196442|NCT02243293|20210471|P20|COMPLETED|Overall Study||47
8196443|NCT02243293|20210472|P19|COMPLETED|Overall Study||22
8196444|NCT02243293|20210473|P18|COMPLETED|Overall Study||21
8196445|NCT02243293|20210474|P17|COMPLETED|Overall Study||37
8196446|NCT02243293|20210475|P16|COMPLETED|Overall Study||26
8196447|NCT02243293|20210476|P15|COMPLETED|Overall Study||27
8196448|NCT02243293|20210477|P14|COMPLETED|Overall Study||0
8196449|NCT02243293|20210478|P13|COMPLETED|Overall Study||0
8196450|NCT02243293|20210479|P12|COMPLETED|Overall Study||50
8196451|NCT02243293|20210480|P11|COMPLETED|Overall Study||0
8196452|NCT02243293|20210481|P10|COMPLETED|Overall Study||53
8196453|NCT02243293|20210482|P9|COMPLETED|Overall Study||0
8196454|NCT02243293|20210483|P8|COMPLETED|Overall Study||0
8196455|NCT02243293|20210484|P7|COMPLETED|Overall Study||27
8196456|NCT02243293|20210485|P6|COMPLETED|Overall Study||31
8196457|NCT02243293|20210486|P5|COMPLETED|Overall Study||30
8196458|NCT02243293|20210487|P4|COMPLETED|Overall Study||29
8196459|NCT02243293|20210488|P3|COMPLETED|Overall Study||24
8196460|NCT02243293|20210489|P2|COMPLETED|Overall Study||23
8196461|NCT02243293|20210490|P1|COMPLETED|Overall Study||23
8196462|NCT02243293|20210469|P22|STARTED|Overall Study||58
8196463|NCT02243293|20210470|P21|STARTED|Overall Study||145
8196464|NCT02243293|20210471|P20|STARTED|Overall Study||48
8196465|NCT02243293|20210472|P19|STARTED|Overall Study||22
8196466|NCT02243293|20210473|P18|STARTED|Overall Study||22
8196467|NCT02243293|20210474|P17|STARTED|Overall Study||40
8196468|NCT02243293|20210475|P16|STARTED|Overall Study||27
8196469|NCT02243293|20210476|P15|STARTED|Overall Study||28
8196470|NCT02243293|20210477|P14|STARTED|Overall Study||0
8196471|NCT02243293|20210478|P13|STARTED|Overall Study||0
8196472|NCT02243293|20210479|P12|STARTED|Overall Study||53
8196473|NCT02243293|20210480|P11|STARTED|Overall Study||0
8196474|NCT02243293|20210481|P10|STARTED|Overall Study||55
8196475|NCT02243293|20210482|P9|STARTED|Overall Study||0
8196476|NCT02243293|20210483|P8|STARTED|Overall Study||0
8196477|NCT02243293|20210484|P7|STARTED|Overall Study||30
8196478|NCT02243293|20210485|P6|STARTED|Overall Study||31
8196479|NCT02243293|20210486|P5|STARTED|Overall Study||31
8196480|NCT02243293|20210487|P4|STARTED|Overall Study||30
8196481|NCT02243293|20210488|P3|STARTED|Overall Study||25
8196482|NCT02243293|20210489|P2|STARTED|Overall Study||24
8196483|NCT02243293|20210490|P1|STARTED|Overall Study||25
8196484|NCT02243280|20210589|P11|NOT COMPLETED|Treated||3
8196485|NCT02243280|20210590|P10|NOT COMPLETED|Treated||0
8196486|NCT02243280|20210591|P9|NOT COMPLETED|Treated||1
8196487|NCT02243280|20210592|P8|NOT COMPLETED|Treated||0
8196488|NCT02243280|20210593|P7|NOT COMPLETED|Treated||0
8196489|NCT02243280|20210594|P6|NOT COMPLETED|Treated||0
8196490|NCT02243280|20210595|P5|NOT COMPLETED|Treated||0
8196491|NCT02243280|20210596|P4|NOT COMPLETED|Treated||0
8196492|NCT02243280|20210597|P3|NOT COMPLETED|Treated||0
8196493|NCT02243280|20210598|P2|NOT COMPLETED|Treated||0
8196494|NCT02243280|20210599|P1|NOT COMPLETED|Treated||1
8196495|NCT02243280|20210589|P11|COMPLETED|Treated||31
8196496|NCT02243280|20210590|P10|COMPLETED|Treated||0
8196497|NCT02243280|20210591|P9|COMPLETED|Treated||31
8196498|NCT02243280|20210592|P8|COMPLETED|Treated||0
8196499|NCT02243280|20210593|P7|COMPLETED|Treated||0
8196500|NCT02243280|20210594|P6|COMPLETED|Treated||27
8196501|NCT02243280|20210595|P5|COMPLETED|Treated||0
8196502|NCT02243280|20210596|P4|COMPLETED|Treated||0
8196503|NCT02243280|20210597|P3|COMPLETED|Treated||0
8196504|NCT02243280|20210598|P2|COMPLETED|Treated||39
8196505|NCT02243280|20210599|P1|COMPLETED|Treated||41
8196506|NCT02243280|20210589|P11|Completed Treatment|Treated||33
8196507|NCT02243280|20210590|P10|Completed Treatment|Treated||0
8196508|NCT02243280|20210591|P9|Completed Treatment|Treated||32
8196509|NCT02243280|20210592|P8|Completed Treatment|Treated||0
8196510|NCT02243280|20210593|P7|Completed Treatment|Treated||0
8196511|NCT02243280|20210594|P6|Completed Treatment|Treated||27
8196512|NCT02243280|20210595|P5|Completed Treatment|Treated||0
8196513|NCT02243280|20210596|P4|Completed Treatment|Treated||0
8196514|NCT02243280|20210597|P3|Completed Treatment|Treated||0
8196515|NCT02243280|20210598|P2|Completed Treatment|Treated||38
8196516|NCT02243280|20210599|P1|Completed Treatment|Treated||42
8196517|NCT02243280|20210589|P11|STARTED|Treated||34
8196518|NCT02243280|20210590|P10|STARTED|Treated||0
8196519|NCT02243280|20210591|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
8196520|NCT02243280|20210592|P8|STARTED|Treated||0
8196521|NCT02243280|20210593|P7|STARTED|Treated||0
8196522|NCT02243280|20210594|P6|STARTED|Treated||27
8196523|NCT02243280|20210595|P5|STARTED|Treated||0
8196524|NCT02243280|20210596|P4|STARTED|Treated||0
8196525|NCT02243280|20210597|P3|STARTED|Treated||0
8196526|NCT02243280|20210598|P2|STARTED|Treated||39
8196527|NCT02243280|20210599|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
8196528|NCT02243280|20210589|P11|NOT COMPLETED|Enrolled||0
8196529|NCT02243280|20210590|P10|NOT COMPLETED|Enrolled||0
8196530|NCT02243280|20210591|P9|NOT COMPLETED|Enrolled||0
8196531|NCT02243280|20210592|P8|NOT COMPLETED|Enrolled||0
8196532|NCT02243280|20210593|P7|NOT COMPLETED|Enrolled||0
8196533|NCT02243280|20210594|P6|NOT COMPLETED|Enrolled||0
8196534|NCT02243280|20210595|P5|NOT COMPLETED|Enrolled||0
8196535|NCT02243280|20210596|P4|NOT COMPLETED|Enrolled||0
8196536|NCT02243280|20210597|P3|NOT COMPLETED|Enrolled||0
8196537|NCT02243280|20210598|P2|NOT COMPLETED|Enrolled||0
8196538|NCT02243280|20210599|P1|NOT COMPLETED|Enrolled||0
8196539|NCT02243280|20210589|P11|COMPLETED|Enrolled||34
8196540|NCT02243280|20210590|P10|COMPLETED|Enrolled||0
8196541|NCT02243280|20210591|P9|COMPLETED|Enrolled||34
8196542|NCT02243280|20210592|P8|COMPLETED|Enrolled||0
8196543|NCT02243280|20210593|P7|COMPLETED|Enrolled||0
8196544|NCT02243280|20210594|P6|COMPLETED|Enrolled||27
8196545|NCT02243280|20210595|P5|COMPLETED|Enrolled||0
8196546|NCT02243280|20210596|P4|COMPLETED|Enrolled||0
8196547|NCT02243280|20210597|P3|COMPLETED|Enrolled||0
8196548|NCT02243280|20210598|P2|COMPLETED|Enrolled||39
8196549|NCT02243280|20210599|P1|COMPLETED|Enrolled||40
8196550|NCT02243280|20210589|P11|STARTED|Enrolled||34
8196551|NCT02243280|20210590|P10|STARTED|Enrolled||0
8196552|NCT02243280|20210591|P9|STARTED|Enrolled||34
8196553|NCT02243280|20210592|P8|STARTED|Enrolled||0
8196554|NCT02243280|20210593|P7|STARTED|Enrolled||0
8196555|NCT02243280|20210594|P6|STARTED|Enrolled||27
8196556|NCT02243280|20210595|P5|STARTED|Enrolled||0
8196557|NCT02243280|20210596|P4|STARTED|Enrolled||0
8196558|NCT02243280|20210597|P3|STARTED|Enrolled||0
8196559|NCT02243280|20210598|P2|STARTED|Enrolled||39
8196560|NCT02243280|20210599|P1|STARTED|Enrolled||40
8196561|NCT02243202|20210654|P4|NOT COMPLETED|Overall Study||23
8196562|NCT02243202|20210655|P3|NOT COMPLETED|Overall Study||31
8196563|NCT02243202|20210656|P2|NOT COMPLETED|Overall Study||25
8196564|NCT02243202|20210657|P1|NOT COMPLETED|Overall Study||25
8196565|NCT02243202|20210654|P4|COMPLETED|Overall Study||61
8196566|NCT02243202|20210655|P3|COMPLETED|Overall Study||53
8196567|NCT02243202|20210656|P2|COMPLETED|Overall Study||60
8196568|NCT02243202|20210657|P1|COMPLETED|Overall Study||57
8196569|NCT02243202|20210654|P4|Treated|Overall Study||83
8196570|NCT02243202|20210655|P3|Treated|Overall Study||84
8196571|NCT02243202|20210656|P2|Treated|Overall Study||85
8196572|NCT02243202|20210657|P1|Treated|Overall Study||82
8196573|NCT02243202|20210654|P4|STARTED|Overall Study||84
8196574|NCT02243202|20210655|P3|STARTED|Overall Study||84
8196575|NCT02243202|20210656|P2|STARTED|Overall Study||85
8196576|NCT02243202|20210657|P1|STARTED|Overall Study||82
8196577|NCT02243176|20210693|P2|NOT COMPLETED|Overall Study||15
8196578|NCT02243176|20210694|P1|NOT COMPLETED|Overall Study||14
8196579|NCT02243176|20210693|P2|COMPLETED|Overall Study||229
8196580|NCT02243176|20210694|P1|COMPLETED|Overall Study||230
8196581|NCT02243176|20210693|P2|STARTED|Overall Study||244
8196582|NCT02243176|20210694|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
8196583|NCT02243046|20210719|P3|NOT COMPLETED|Overall Study||4
8196584|NCT02243046|20210720|P2|NOT COMPLETED|Overall Study||1
8196585|NCT02243046|20210721|P1|NOT COMPLETED|Overall Study||1
8196586|NCT02243046|20210719|P3|COMPLETED|Overall Study||49
8196587|NCT02243046|20210720|P2|COMPLETED|Overall Study||53
8196588|NCT02243046|20210721|P1|COMPLETED|Overall Study||54
8196589|NCT02243046|20210719|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
8196590|NCT02243046|20210720|P2|6 Month|Overall Study||53
8196591|NCT02243046|20210721|P1|6 Month|Overall Study||54
8196592|NCT02243046|20210719|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
8196593|NCT02243046|20210720|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
8196594|NCT02243046|20210721|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
8196595|NCT02243046|20210719|P3|STARTED|Overall Study||53
8196596|NCT02243046|20210720|P2|STARTED|Overall Study||54
8196597|NCT02243046|20210721|P1|STARTED|Overall Study||55
8196598|NCT02243020|20210746|P2|NOT COMPLETED|Overall Study||0
8196599|NCT02243020|20210747|P1|NOT COMPLETED|Overall Study||0
8196600|NCT02243020|20210746|P2|COMPLETED|Overall Study||9
8196601|NCT02243020|20210747|P1|COMPLETED|Overall Study||8
8196602|NCT02243020|20210746|P2|STARTED|Overall Study||9
8196603|NCT02243020|20210747|P1|STARTED|Overall Study||8
8196604|NCT02243007|20210757|P2|NOT COMPLETED|Overall Study||0
8196605|NCT02243007|20210758|P1|NOT COMPLETED|Overall Study||0
8196606|NCT02243007|20210757|P2|COMPLETED|Overall Study||3
8196607|NCT02243007|20210758|P1|COMPLETED|Overall Study||4
8196608|NCT02243007|20210757|P2|STARTED|Overall Study||3
8196609|NCT02243007|20210758|P1|STARTED|Overall Study||4
8196610|NCT02242994|20210780|P1|NOT COMPLETED|Overall Study||0
8196611|NCT02242994|20210780|P1|COMPLETED|Overall Study||5
8196612|NCT02242994|20210780|P1|STARTED|Overall Study||5
8196613|NCT02242981|20210785|P1|NOT COMPLETED|Overall Study||1
8196614|NCT02242981|20210785|P1|COMPLETED|Overall Study||5
8196615|NCT02242981|20210785|P1|Received Study Drug|Overall Study||6
8196616|NCT02242981|20210785|P1|STARTED|Overall Study||6
8196629|NCT02242903|20210832|P7|NOT COMPLETED|Overall Study||0
8196630|NCT02242903|20210833|P6|NOT COMPLETED|Overall Study||0
8196631|NCT02242903|20210834|P5|NOT COMPLETED|Overall Study||0
8196632|NCT02242903|20210835|P4|NOT COMPLETED|Overall Study||0
8196633|NCT02242903|20210836|P3|NOT COMPLETED|Overall Study||0
8196634|NCT02242903|20210837|P2|NOT COMPLETED|Overall Study||0
8196635|NCT02242903|20210838|P1|NOT COMPLETED|Overall Study||1
8196636|NCT02242903|20210832|P7|COMPLETED|Overall Study||6
8196637|NCT02242903|20210833|P6|COMPLETED|Overall Study||6
8196638|NCT02242903|20210834|P5|COMPLETED|Overall Study||6
8196639|NCT02242903|20210835|P4|COMPLETED|Overall Study||6
8196640|NCT02242903|20210836|P3|COMPLETED|Overall Study||6
8196641|NCT02242903|20210837|P2|COMPLETED|Overall Study||6
8196642|NCT02242903|20210838|P1|COMPLETED|Overall Study||11
8196643|NCT02242903|20210832|P7|Received at Least One Dose of Study Drug|Overall Study||6
8196644|NCT02242903|20210833|P6|Received at Least One Dose of Study Drug|Overall Study||6
8196645|NCT02242903|20210834|P5|Received at Least One Dose of Study Drug|Overall Study||6
8196646|NCT02242903|20210835|P4|Received at Least One Dose of Study Drug|Overall Study||6
8196647|NCT02242903|20210836|P3|Received at Least One Dose of Study Drug|Overall Study||6
8196648|NCT02242903|20210837|P2|Received at Least One Dose of Study Drug|Overall Study||6
8196649|NCT02242903|20210838|P1|Received at Least One Dose of Study Drug|Overall Study||12
8196650|NCT02242903|20210832|P7|STARTED|Overall Study||6
8196651|NCT02242903|20210833|P6|STARTED|Overall Study||6
8196652|NCT02242903|20210834|P5|STARTED|Overall Study||6
8196653|NCT02242903|20210835|P4|STARTED|Overall Study||6
8196654|NCT02242903|20210836|P3|STARTED|Overall Study||6
8196655|NCT02242903|20210837|P2|STARTED|Overall Study||6
8196656|NCT02242903|20210838|P1|STARTED|Overall Study||12
8196657|NCT02242643|20210868|P2|NOT COMPLETED|Overall Study||78
8196658|NCT02242643|20210869|P1|NOT COMPLETED|Overall Study||75
8196659|NCT02242643|20210868|P2|COMPLETED|Overall Study||1139
8196660|NCT02242643|20210869|P1|COMPLETED|Overall Study||1132
8196661|NCT02242643|20210868|P2|STARTED|Overall Study||1217
8196662|NCT02242643|20210869|P1|STARTED|Overall Study||1207
8196663|NCT02242630|20210905|P4|NOT COMPLETED|Overall Study||0
8196664|NCT02242630|20210906|P3|NOT COMPLETED|Overall Study||0
8196665|NCT02242630|20210907|P2|NOT COMPLETED|Overall Study||0
8196666|NCT02242630|20210908|P1|NOT COMPLETED|Overall Study||0
8196667|NCT02242630|20210905|P4|COMPLETED|Overall Study||16
8196668|NCT02242630|20210906|P3|COMPLETED|Overall Study||15
8196669|NCT02242630|20210907|P2|COMPLETED|Overall Study||15
8196670|NCT02242630|20210908|P1|COMPLETED|Overall Study||15
8196671|NCT02242630|20210905|P4|STARTED|Overall Study||16
8196672|NCT02242630|20210906|P3|STARTED|Overall Study||15
8196673|NCT02242630|20210907|P2|STARTED|Overall Study||15
8196674|NCT02242630|20210908|P1|STARTED|Overall Study||15
8196675|NCT02242487|20210924|P2|NOT COMPLETED|Overall Study||47
8196676|NCT02242487|20210925|P1|NOT COMPLETED|Overall Study||62
8196677|NCT02242487|20210924|P2|COMPLETED|Overall Study||117
8196678|NCT02242487|20210925|P1|COMPLETED|Overall Study||99
8196679|NCT02242487|20210924|P2|STARTED|Overall Study||164
8196680|NCT02242487|20210925|P1|STARTED|Overall Study||161
8196681|NCT02242305|20210941|P2|NOT COMPLETED|Overall Study||10
8196682|NCT02242305|20210942|P1|NOT COMPLETED|Overall Study||6
8196683|NCT02242305|20210941|P2|COMPLETED|Overall Study||141
8196684|NCT02242305|20210942|P1|COMPLETED|Overall Study||145
8196685|NCT02242305|20210941|P2|STARTED|Overall Study||151
8196686|NCT02242305|20210942|P1|STARTED|Overall Study||151
8196687|NCT02242201|20210963|P3|NOT COMPLETED|Overall Study||1
8196688|NCT02242201|20210964|P2|NOT COMPLETED|Overall Study||1
8196689|NCT02242201|20210965|P1|NOT COMPLETED|Overall Study||4
8196690|NCT02242201|20210963|P3|COMPLETED|Overall Study||54
8196691|NCT02242201|20210964|P2|COMPLETED|Overall Study||54
8196692|NCT02242201|20210965|P1|COMPLETED|Overall Study||51
8196693|NCT02242201|20210963|P3|STARTED|Overall Study||55
8196694|NCT02242201|20210964|P2|STARTED|Overall Study||55
8196695|NCT02242201|20210965|P1|STARTED|Overall Study||55
8196696|NCT02242019|20210997|P1|NOT COMPLETED|Overall Study||0
8196697|NCT02242019|20210997|P1|COMPLETED|Overall Study||109
8196698|NCT02242019|20210997|P1|STARTED|Overall Study||109
8196699|NCT02241889|20211003|P6|NOT COMPLETED|Overall Study||1
8196700|NCT02241889|20211004|P5|NOT COMPLETED|Overall Study||0
8196701|NCT02241889|20211005|P4|NOT COMPLETED|Overall Study||0
8196702|NCT02241889|20211006|P3|NOT COMPLETED|Overall Study||1
8196703|NCT02241889|20211007|P2|NOT COMPLETED|Overall Study||0
8196704|NCT02241889|20211008|P1|NOT COMPLETED|Overall Study||0
8196705|NCT02241889|20211003|P6|COMPLETED|Overall Study||3
8196706|NCT02241889|20211004|P5|COMPLETED|Overall Study||5
8196707|NCT02241889|20211005|P4|COMPLETED|Overall Study||3
8196708|NCT02241889|20211006|P3|COMPLETED|Overall Study||2
8196709|NCT02241889|20211007|P2|COMPLETED|Overall Study||4
8196710|NCT02241889|20211008|P1|COMPLETED|Overall Study||4
8196711|NCT02241889|20211003|P6|STARTED|Overall Study||4
8196712|NCT02241889|20211004|P5|STARTED|Overall Study||5
8196713|NCT02241889|20211005|P4|STARTED|Overall Study||3
8196714|NCT02241889|20211006|P3|STARTED|Overall Study||3
8196715|NCT02241889|20211007|P2|STARTED|Overall Study||4
8196716|NCT02241889|20211008|P1|STARTED|Overall Study||4
8196717|NCT02241785|20211043|P1|NOT COMPLETED|Overall Study||47
8196718|NCT02241785|20211043|P1|COMPLETED|Overall Study||0
8196719|NCT02241785|20211043|P1|STARTED|Overall Study||47
8196720|NCT02241733|20211053|P2|NOT COMPLETED|Overall Study||10
8196721|NCT02241733|20211054|P1|NOT COMPLETED|Overall Study||15
8196722|NCT02241733|20211053|P2|COMPLETED|Overall Study||30
8196723|NCT02241733|20211054|P1|COMPLETED|Overall Study||25
8196724|NCT02241733|20211053|P2|STARTED|Overall Study||40
8196725|NCT02241733|20211054|P1|STARTED|Overall Study||40
8196726|NCT02241720|20211066|P1|NOT COMPLETED|Overall Study||4
8196727|NCT02241720|20211066|P1|COMPLETED|Overall Study||1
8196728|NCT02241720|20211066|P1|STARTED|Overall Study||5
8196729|NCT02241655|20211072|P2|NOT COMPLETED|Overall Study||0
8196730|NCT02241655|20211073|P1|NOT COMPLETED|Overall Study||0
8196731|NCT02241655|20211072|P2|COMPLETED|Overall Study||618
8196732|NCT02241655|20211073|P1|COMPLETED|Overall Study||614
8196733|NCT02241655|20211072|P2|STARTED|Overall Study||618
8196734|NCT02241655|20211073|P1|STARTED|Overall Study||614
8196735|NCT02241551|20211093|P2|NOT COMPLETED|Overall Study||0
8196736|NCT02241551|20211094|P1|NOT COMPLETED|Overall Study||1
8196737|NCT02241551|20211093|P2|COMPLETED|Overall Study||0
8196738|NCT02241551|20211094|P1|COMPLETED|Overall Study||0
8196739|NCT02241551|20211093|P2|STARTED|Overall Study||0
8196740|NCT02241551|20211094|P1|STARTED|Overall Study||1
8196741|NCT02241512|20211116|P2|NOT COMPLETED|Overall Study||0
8196742|NCT02241512|20211117|P1|NOT COMPLETED|Overall Study||1
8196743|NCT02241512|20211116|P2|COMPLETED|Overall Study||29
8196744|NCT02241512|20211117|P1|COMPLETED|Overall Study||29
8196745|NCT02241512|20211116|P2|STARTED|Overall Study||29
8196746|NCT02241512|20211117|P1|STARTED|Overall Study||30
8196747|NCT02241486|20211129|P1|NOT COMPLETED|Overall Study||0
8196748|NCT02241486|20211129|P1|COMPLETED|Overall Study||2
8196749|NCT02241486|20211129|P1|STARTED|Overall Study||2
8196750|NCT02241343|20211133|P1|NOT COMPLETED|Overall Study||1
8196751|NCT02241343|20211133|P1|COMPLETED|Overall Study||0
8196752|NCT02241343|20211133|P1|STARTED|Overall Study||1
8196753|NCT02241187|20211138|P1|NOT COMPLETED|Overall Study||2
8196754|NCT02241187|20211138|P1|COMPLETED|Overall Study||0
8196755|NCT02241187|20211138|P1|STARTED|Overall Study||2
8196756|NCT02240810|20211145|P2|NOT COMPLETED|Overall Study||60
8196757|NCT02240810|20211146|P1|NOT COMPLETED|Overall Study||60
8196758|NCT02240810|20211145|P2|COMPLETED|Overall Study||2621
8196759|NCT02240810|20211146|P1|COMPLETED|Overall Study||1441
8196760|NCT02240810|20211145|P2|STARTED|Overall Study|correct typo|2681
8196761|NCT02240810|20211146|P1|STARTED|Overall Study||1501
8196762|NCT02240706|20211170|P7|NOT COMPLETED|Overall Study||0
8196763|NCT02240706|20211171|P6|NOT COMPLETED|Overall Study||0
8196764|NCT02240706|20211172|P5|NOT COMPLETED|Overall Study||11
8196765|NCT02240706|20211173|P4|NOT COMPLETED|Overall Study||4
8196766|NCT02240706|20211174|P3|NOT COMPLETED|Overall Study||6
8196767|NCT02240706|20211175|P2|NOT COMPLETED|Overall Study||3
8196768|NCT02240706|20211176|P1|NOT COMPLETED|Overall Study||3
8196769|NCT02240706|20211170|P7|COMPLETED|Overall Study||0
8196770|NCT02240706|20211171|P6|COMPLETED|Overall Study||0
8196771|NCT02240706|20211172|P5|COMPLETED|Overall Study||0
8196772|NCT02240706|20211173|P4|COMPLETED|Overall Study||0
8196773|NCT02240706|20211174|P3|COMPLETED|Overall Study||0
8196774|NCT02240706|20211175|P2|COMPLETED|Overall Study||0
8196775|NCT02240706|20211176|P1|COMPLETED|Overall Study||0
8196776|NCT02240706|20211170|P7|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
8196777|NCT02240706|20211171|P6|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
8196778|NCT02240706|20211172|P5|STARTED|Overall Study||11
8196779|NCT02240706|20211173|P4|STARTED|Overall Study||4
8196780|NCT02240706|20211174|P3|STARTED|Overall Study||6
8196781|NCT02240706|20211175|P2|STARTED|Overall Study||3
8196782|NCT02240706|20211176|P1|STARTED|Overall Study||3
8196783|NCT02240693|20211236|P5|NOT COMPLETED|Overall Study||1
8196784|NCT02240693|20211237|P4|NOT COMPLETED|Overall Study||1
8196785|NCT02240693|20211238|P3|NOT COMPLETED|Overall Study||4
8196786|NCT02240693|20211239|P2|NOT COMPLETED|Overall Study||0
8196787|NCT02240693|20211240|P1|NOT COMPLETED|Overall Study||0
8196788|NCT02240693|20211236|P5|COMPLETED|Overall Study||42
8196789|NCT02240693|20211237|P4|COMPLETED|Overall Study||20
8196790|NCT02240693|20211238|P3|COMPLETED|Overall Study||17
8196791|NCT02240693|20211239|P2|COMPLETED|Overall Study||21
8196792|NCT02240693|20211240|P1|COMPLETED|Overall Study||22
8196793|NCT02240693|20211236|P5|STARTED|Overall Study||43
8196794|NCT02240693|20211237|P4|STARTED|Overall Study||21
8196795|NCT02240693|20211238|P3|STARTED|Overall Study||21
8196796|NCT02240693|20211239|P2|STARTED|Overall Study||21
8196797|NCT02240693|20211240|P1|STARTED|Overall Study||22
8196798|NCT02240680|20211276|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
8196799|NCT02240680|20211277|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
8196800|NCT02240680|20211278|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196801|NCT02240680|20211279|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196802|NCT02240680|20211276|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
8196803|NCT02240680|20211277|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
8196804|NCT02240680|20211278|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196805|NCT02240680|20211279|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196806|NCT02240680|20211276|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
8196807|NCT02240680|20211277|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
8196808|NCT02240680|20211278|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
8196809|NCT02240680|20211279|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
8196810|NCT02240680|20211276|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
8196811|NCT02240680|20211277|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
8196812|NCT02240680|20211278|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
8196813|NCT02240680|20211279|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
8196814|NCT02240680|20211276|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
8196815|NCT02240680|20211277|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
8196816|NCT02240680|20211278|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
8196817|NCT02240680|20211279|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
8196818|NCT02240680|20211276|P4|STARTED|Overall Study (Up to 24 Weeks)||0
8196819|NCT02240680|20211277|P3|STARTED|Overall Study (Up to 24 Weeks)||0
8196820|NCT02240680|20211278|P2|STARTED|Overall Study (Up to 24 Weeks)||151
8196821|NCT02240680|20211279|P1|STARTED|Overall Study (Up to 24 Weeks)||151
8196822|NCT02240667|20211299|P2|NOT COMPLETED|Overall Study||0
8196823|NCT02240667|20211300|P1|NOT COMPLETED|Overall Study||0
8196824|NCT02240667|20211299|P2|COMPLETED|Overall Study||650
8196825|NCT02240667|20211300|P1|COMPLETED|Overall Study||771
8196826|NCT02240667|20211299|P2|STARTED|Overall Study||650
8196827|NCT02240667|20211300|P1|STARTED|Overall Study||771
8196828|NCT02240654|20211315|P5|NOT COMPLETED|Overall Study||0
8196829|NCT02240654|20211316|P4|NOT COMPLETED|Overall Study||0
8196830|NCT02240654|20211317|P3|NOT COMPLETED|Overall Study||0
8196831|NCT02240654|20211318|P2|NOT COMPLETED|Overall Study||0
8196832|NCT02240654|20211319|P1|NOT COMPLETED|Overall Study||0
8196833|NCT02240654|20211315|P5|COMPLETED|Overall Study||1285
8196834|NCT02240654|20211316|P4|COMPLETED|Overall Study||2150
8196835|NCT02240654|20211317|P3|COMPLETED|Overall Study||28619
8196836|NCT02240654|20211318|P2|COMPLETED|Overall Study||2813
8196837|NCT02240654|20211319|P1|COMPLETED|Overall Study||1706
8196838|NCT02240654|20211315|P5|STARTED|Overall Study||1285
8196839|NCT02240654|20211316|P4|STARTED|Overall Study||2150
8196840|NCT02240654|20211317|P3|STARTED|Overall Study||28619
8196841|NCT02240654|20211318|P2|STARTED|Overall Study||2813
8196842|NCT02240654|20211319|P1|STARTED|Overall Study||1706
8196843|NCT02240628|20211333|P2|NOT COMPLETED|Overall Study||5
8196844|NCT02240628|20211334|P1|NOT COMPLETED|Overall Study||6
8196845|NCT02240628|20211333|P2|COMPLETED|Overall Study||33
8196846|NCT02240628|20211334|P1|COMPLETED|Overall Study||32
8196847|NCT02240628|20211333|P2|STARTED|Overall Study||38
8196848|NCT02240628|20211334|P1|STARTED|Overall Study||38
8196849|NCT02240589|20211344|P2|NOT COMPLETED|Overall Study||2
8196850|NCT02240589|20211345|P1|NOT COMPLETED|Overall Study||2
8196851|NCT02240589|20211344|P2|COMPLETED|Overall Study||4
8196852|NCT02240589|20211345|P1|COMPLETED|Overall Study||3
8196853|NCT02240589|20211344|P2|STARTED|Overall Study||6
8196854|NCT02240589|20211345|P1|STARTED|Overall Study||5
8196855|NCT02240368|20211368|P3|NOT COMPLETED|Overall Study||1
8196856|NCT02240368|20211369|P2|NOT COMPLETED|Overall Study||0
8196857|NCT02240368|20211370|P1|NOT COMPLETED|Overall Study||1
8196858|NCT02240368|20211368|P3|COMPLETED|Overall Study||18
8196859|NCT02240368|20211369|P2|COMPLETED|Overall Study||22
8196860|NCT02240368|20211370|P1|COMPLETED|Overall Study||8
8196861|NCT02240368|20211368|P3|STARTED|Overall Study||19
8196862|NCT02240368|20211369|P2|STARTED|Overall Study||22
8196863|NCT02240368|20211370|P1|STARTED|Overall Study||9
8196864|NCT02240329|20211387|P1|NOT COMPLETED|Overall Study||0
8196865|NCT02240329|20211387|P1|COMPLETED|Overall Study||4
8196866|NCT02240329|20211387|P1|Determination of Urge to Cough|Overall Study||4
8196867|NCT02240329|20211387|P1|STARTED|Overall Study||4
8196868|NCT02240186|20211392|P1|NOT COMPLETED|Overall Study||27
8196869|NCT02240186|20211392|P1|COMPLETED|Overall Study||23
8196870|NCT02240186|20211392|P1|STARTED|Overall Study||50
8196871|NCT02240121|20211402|P2|NOT COMPLETED|Overall Study||20
8196872|NCT02240121|20211403|P1|NOT COMPLETED|Overall Study||18
8196873|NCT02240121|20211402|P2|COMPLETED|Overall Study||20
8196874|NCT02240121|20211403|P1|COMPLETED|Overall Study||22
8196875|NCT02240121|20211402|P2|STARTED|Overall Study||40
8196876|NCT02240121|20211403|P1|STARTED|Overall Study||40
8196877|NCT02240108|20211431|P2|NOT COMPLETED|Overall Study||25
8196878|NCT02240108|20211432|P1|NOT COMPLETED|Overall Study||14
8196879|NCT02240108|20211431|P2|COMPLETED|Overall Study||21
8196880|NCT02240108|20211432|P1|COMPLETED|Overall Study||21
8196881|NCT02240108|20211431|P2|Intent-to-treat (ITT) Population|Overall Study||45
8196882|NCT02240108|20211432|P1|Intent-to-treat (ITT) Population|Overall Study||35
8196883|NCT02240108|20211431|P2|STARTED|Overall Study||46
8196884|NCT02240108|20211432|P1|STARTED|Overall Study||35
8196885|NCT02240030|20211461|P3|NOT COMPLETED|Overall Study||15
8196886|NCT02240030|20211462|P2|NOT COMPLETED|Overall Study||17
8196887|NCT02240030|20211463|P1|NOT COMPLETED|Overall Study||17
8196888|NCT02240030|20211461|P3|COMPLETED|Overall Study||97
8196889|NCT02240030|20211462|P2|COMPLETED|Overall Study||97
8196890|NCT02240030|20211463|P1|COMPLETED|Overall Study||96
8196891|NCT02240030|20211461|P3|STARTED|Overall Study||112
8196892|NCT02240030|20211462|P2|STARTED|Overall Study||114
8196893|NCT02240030|20211463|P1|STARTED|Overall Study||113
8196894|NCT02239978|20211487|P2|NOT COMPLETED|Overall Study||0
8196895|NCT02239978|20211488|P1|NOT COMPLETED|Overall Study||2
8196896|NCT02239978|20211487|P2|COMPLETED|Overall Study||12
8196897|NCT02239978|20211488|P1|COMPLETED|Overall Study||28
8196898|NCT02239978|20211487|P2|STARTED|Overall Study||12
8196899|NCT02239978|20211488|P1|STARTED|Overall Study||30
8196900|NCT02239939|20211505|P2|NOT COMPLETED|Overall Study||2
8196901|NCT02239939|20211506|P1|NOT COMPLETED|Overall Study||2
8196902|NCT02239939|20211505|P2|COMPLETED|Overall Study||15
8196903|NCT02239939|20211506|P1|COMPLETED|Overall Study||18
8196904|NCT02239939|20211505|P2|STARTED|Overall Study||17
8196905|NCT02239939|20211506|P1|STARTED|Overall Study||20
8196906|NCT02239926|20211522|P2|NOT COMPLETED|Overall Study||1
8196907|NCT02239926|20211523|P1|NOT COMPLETED|Overall Study||0
8196908|NCT02239926|20211522|P2|COMPLETED|Overall Study||1
8196909|NCT02239926|20211523|P1|COMPLETED|Overall Study||0
8196910|NCT02239926|20211522|P2|STARTED|Overall Study||2
8196911|NCT02239926|20211523|P1|STARTED|Overall Study||0
8196912|NCT02239770|20211537|P6|NOT COMPLETED|Part 2||0
8196913|NCT02239770|20211538|P5|NOT COMPLETED|Part 2||0
8196914|NCT02239770|20211539|P4|NOT COMPLETED|Part 2||0
8196915|NCT02239770|20211540|P3|NOT COMPLETED|Part 2||0
8196916|NCT02239770|20211541|P2|NOT COMPLETED|Part 2||0
8196917|NCT02239770|20211542|P1|NOT COMPLETED|Part 2||0
8196918|NCT02239770|20211537|P6|COMPLETED|Part 2||4
8196919|NCT02239770|20211538|P5|COMPLETED|Part 2||4
8196920|NCT02239770|20211539|P4|COMPLETED|Part 2||4
8196921|NCT02239770|20211540|P3|COMPLETED|Part 2||0
8196922|NCT02239770|20211541|P2|COMPLETED|Part 2||0
8196923|NCT02239770|20211542|P1|COMPLETED|Part 2||0
8196924|NCT02239770|20211537|P6|STARTED|Part 2||4
8196925|NCT02239770|20211538|P5|STARTED|Part 2||4
8196926|NCT02239770|20211539|P4|STARTED|Part 2||4
8196927|NCT02239770|20211540|P3|STARTED|Part 2||0
8196928|NCT02239770|20211541|P2|STARTED|Part 2||0
8196929|NCT02239770|20211542|P1|STARTED|Part 2||0
8196930|NCT02239770|20211537|P6|NOT COMPLETED|Part 1||0
8196931|NCT02239770|20211538|P5|NOT COMPLETED|Part 1||0
8196932|NCT02239770|20211539|P4|NOT COMPLETED|Part 1||0
8196933|NCT02239770|20211540|P3|NOT COMPLETED|Part 1||0
8196934|NCT02239770|20211541|P2|NOT COMPLETED|Part 1||0
8196935|NCT02239770|20211542|P1|NOT COMPLETED|Part 1||0
8196936|NCT02239770|20211537|P6|COMPLETED|Part 1||0
8196937|NCT02239770|20211538|P5|COMPLETED|Part 1||0
8196938|NCT02239770|20211539|P4|COMPLETED|Part 1||0
8196939|NCT02239770|20211540|P3|COMPLETED|Part 1||4
8196940|NCT02239770|20211541|P2|COMPLETED|Part 1||4
8196941|NCT02239770|20211542|P1|COMPLETED|Part 1||4
8196942|NCT02239770|20211537|P6|STARTED|Part 1||0
8196943|NCT02239770|20211538|P5|STARTED|Part 1||0
8196944|NCT02239770|20211539|P4|STARTED|Part 1||0
8196945|NCT02239770|20211540|P3|STARTED|Part 1||4
8196946|NCT02239770|20211541|P2|STARTED|Part 1||4
8196947|NCT02239770|20211542|P1|STARTED|Part 1||4
8196948|NCT02239744|20211570|P2|NOT COMPLETED|Period 2||0
8196949|NCT02239744|20211571|P1|NOT COMPLETED|Period 2||0
8196950|NCT02239744|20211570|P2|COMPLETED|Period 2||18
8196951|NCT02239744|20211571|P1|COMPLETED|Period 2||17
8196952|NCT02239744|20211570|P2|STARTED|Period 2||18
8196953|NCT02239744|20211571|P1|STARTED|Period 2||17
8196954|NCT02239744|20211570|P2|NOT COMPLETED|Period 1||0
8196955|NCT02239744|20211571|P1|NOT COMPLETED|Period 1||0
8196956|NCT02239744|20211570|P2|COMPLETED|Period 1||18
8196957|NCT02239744|20211571|P1|COMPLETED|Period 1||17
8196958|NCT02239744|20211570|P2|STARTED|Period 1||18
8196959|NCT02239744|20211571|P1|STARTED|Period 1||17
8196960|NCT02239692|20211585|P2|NOT COMPLETED|Overall Study||13
8196961|NCT02239692|20211586|P1|NOT COMPLETED|Overall Study||6
8196962|NCT02239692|20211585|P2|COMPLETED|Overall Study||118
8196963|NCT02239692|20211586|P1|COMPLETED|Overall Study||67
8196964|NCT02239692|20211585|P2|Safety Analysis Set|Overall Study||125
8196965|NCT02239692|20211586|P1|Safety Analysis Set|Overall Study||70
8196966|NCT02239692|20211585|P2|Per-protocol Analysis Set|Overall Study||120
8196967|NCT02239692|20211586|P1|Per-protocol Analysis Set|Overall Study||66
8196968|NCT02239692|20211585|P2|Intention-to-treat Analysis Set|Overall Study||131
8196969|NCT02239692|20211586|P1|Intention-to-treat Analysis Set|Overall Study||73
8196970|NCT02239692|20211585|P2|STARTED|Overall Study||131
8196971|NCT02239692|20211586|P1|STARTED|Overall Study||73
8196972|NCT02239679|20211605|P3|NOT COMPLETED|Overall Study||1
8196973|NCT02239679|20211606|P2|NOT COMPLETED|Overall Study||3
8196974|NCT02239679|20211607|P1|NOT COMPLETED|Overall Study||3
8196975|NCT02239679|20211605|P3|COMPLETED|Overall Study||53
8196976|NCT02239679|20211606|P2|COMPLETED|Overall Study||56
8196977|NCT02239679|20211607|P1|COMPLETED|Overall Study||50
8196978|NCT02239679|20211605|P3|STARTED|Overall Study||54
8196979|NCT02239679|20211606|P2|STARTED|Overall Study||59
8196980|NCT02239679|20211607|P1|STARTED|Overall Study||53
8196981|NCT02239640|20211819|P1|NOT COMPLETED|Overall Study||217
8196982|NCT02239640|20211819|P1|COMPLETED|Overall Study||767
8196983|NCT02239640|20211819|P1|STARTED|Overall Study||984
8196984|NCT02239627|20211831|P2|NOT COMPLETED|Overall Study||0
8196985|NCT02239627|20211832|P1|NOT COMPLETED|Overall Study||0
8196986|NCT02239627|20211831|P2|COMPLETED|Overall Study||0
8196987|NCT02239627|20211832|P1|COMPLETED|Overall Study||0
8196988|NCT02239627|20211831|P2|STARTED|Overall Study||0
8196989|NCT02239627|20211832|P1|STARTED|Overall Study||0
8196990|NCT02239601|20211846|P2|NOT COMPLETED|Overall Study||6
8196991|NCT02239601|20211847|P1|NOT COMPLETED|Overall Study||7
8196992|NCT02239601|20211846|P2|COMPLETED|Overall Study||26
8196993|NCT02239601|20211847|P1|COMPLETED|Overall Study||22
8196994|NCT02239601|20211846|P2|STARTED|Overall Study||32
8196995|NCT02239601|20211847|P1|STARTED|Overall Study||29
8196996|NCT02239562|20211871|P6|NOT COMPLETED|Overall Study||0
8196997|NCT02239562|20211872|P5|NOT COMPLETED|Overall Study||0
8196998|NCT02239562|20211873|P4|NOT COMPLETED|Overall Study||0
8196999|NCT02239562|20211874|P3|NOT COMPLETED|Overall Study||0
8197000|NCT02239562|20211875|P2|NOT COMPLETED|Overall Study||0
8197001|NCT02239562|20211876|P1|NOT COMPLETED|Overall Study||0
8197002|NCT02239562|20211871|P6|COMPLETED|Overall Study||6
8197003|NCT02239562|20211872|P5|COMPLETED|Overall Study||6
8197004|NCT02239562|20211873|P4|COMPLETED|Overall Study||6
8197005|NCT02239562|20211874|P3|COMPLETED|Overall Study||6
8197006|NCT02239562|20211875|P2|COMPLETED|Overall Study||6
8197007|NCT02239562|20211876|P1|COMPLETED|Overall Study||6
8197008|NCT02239562|20211871|P6|STARTED|Overall Study||6
8197009|NCT02239562|20211872|P5|STARTED|Overall Study||6
8197010|NCT02239562|20211873|P4|STARTED|Overall Study||6
8197011|NCT02239562|20211874|P3|STARTED|Overall Study||6
8197012|NCT02239562|20211875|P2|STARTED|Overall Study||6
8197013|NCT02239562|20211876|P1|STARTED|Overall Study||6
8197014|NCT02239536|20211900|P2|NOT COMPLETED|Overall Study||17
8197015|NCT02239536|20211901|P1|NOT COMPLETED|Overall Study||23
8197016|NCT02239536|20211900|P2|COMPLETED|Overall Study||155
8197017|NCT02239536|20211901|P1|COMPLETED|Overall Study||167
8197018|NCT02239536|20211900|P2|STARTED|Overall Study||172
8197019|NCT02239536|20211901|P1|STARTED|Overall Study||190
8197020|NCT02239510|20211911|P2|NOT COMPLETED|Overall Study||1
8197021|NCT02239510|20211912|P1|NOT COMPLETED|Overall Study||2
8197022|NCT02239510|20211911|P2|COMPLETED|Overall Study||3
8197023|NCT02239510|20211912|P1|COMPLETED|Overall Study||3
8197024|NCT02239510|20211911|P2|STARTED|Overall Study||4
8197025|NCT02239510|20211912|P1|STARTED|Overall Study||5
8197026|NCT02239380|20211924|P1|NOT COMPLETED|Overall Study||0
8197027|NCT02239380|20211924|P1|COMPLETED|Overall Study||26
8197028|NCT02239380|20211924|P1|STARTED|Overall Study||26
8197029|NCT02239328|20211934|P1|NOT COMPLETED|Overall Study||8
8197030|NCT02239328|20211934|P1|COMPLETED|Overall Study||174
8197031|NCT02239328|20211934|P1|STARTED|Overall Study||182
8197032|NCT02239289|20211938|P1|NOT COMPLETED|Overall Study||0
8197033|NCT02239289|20211938|P1|COMPLETED|Overall Study||21
8197034|NCT02239289|20211938|P1|STARTED|Overall Study||21
8197035|NCT02239120|20211959|P2|NOT COMPLETED|Overall Study||72
8197036|NCT02239120|20211960|P1|NOT COMPLETED|Overall Study||75
8197037|NCT02239120|20211959|P2|COMPLETED|Overall Study||2623
8197038|NCT02239120|20211960|P1|COMPLETED|Overall Study||2620
8197039|NCT02239120|20211959|P2|STARTED|Overall Study||2695
8197040|NCT02239120|20211960|P1|STARTED|Overall Study||2695
8197041|NCT02239094|20211984|P1|NOT COMPLETED|Overall Study||2
8197042|NCT02239094|20211984|P1|COMPLETED|Overall Study||18
8197043|NCT02239094|20211984|P1|STARTED|Overall Study||20
8197044|NCT02238977|20211991|P2|NOT COMPLETED|Overall Study||0
8197045|NCT02238977|20211992|P1|NOT COMPLETED|Overall Study||0
8197046|NCT02238977|20211991|P2|COMPLETED|Overall Study||1
8197047|NCT02238977|20211992|P1|COMPLETED|Overall Study||0
8197048|NCT02238977|20211991|P2|STARTED|Overall Study||1
8197049|NCT02238977|20211992|P1|STARTED|Overall Study||0
8197050|NCT02238925|20211998|P1|NOT COMPLETED|Overall Study||25
8197051|NCT02238925|20211998|P1|COMPLETED|Overall Study||1
8197052|NCT02238925|20211998|P1|STARTED|Overall Study||26
8197053|NCT02238847|20212008|P2|NOT COMPLETED|Overall Study||24
8197054|NCT02238847|20212009|P1|NOT COMPLETED|Overall Study||22
8197055|NCT02238847|20212008|P2|COMPLETED|Overall Study||36
8197056|NCT02238847|20212009|P1|COMPLETED|Overall Study||37
8197057|NCT02238847|20212008|P2|STARTED|Overall Study||60
8197058|NCT02238847|20212009|P1|STARTED|Overall Study||59
8197059|NCT02238782|20212033|P1|NOT COMPLETED|Overall Study||0
8197060|NCT02238782|20212033|P1|COMPLETED|Overall Study||12
8197061|NCT02238782|20212033|P1|Subjects Treated|Overall Study||12
8197062|NCT02238782|20212033|P1|STARTED|Overall Study||12
8197063|NCT02238483|20212039|P2|NOT COMPLETED|Overall Study||14
8197064|NCT02238483|20212040|P1|NOT COMPLETED|Overall Study||15
8197065|NCT02238483|20212039|P2|COMPLETED|Overall Study||91
8197066|NCT02238483|20212040|P1|COMPLETED|Overall Study||93
8197067|NCT02238483|20212039|P2|STARTED|Overall Study||105
8197068|NCT02238483|20212040|P1|STARTED|Overall Study||108
8197069|NCT02238379|20212078|P2|NOT COMPLETED|Overall Study||0
8197070|NCT02238379|20212079|P1|NOT COMPLETED|Overall Study||1
8197071|NCT02238379|20212078|P2|COMPLETED|Overall Study||14
8197072|NCT02238379|20212079|P1|COMPLETED|Overall Study||11
8197073|NCT02238379|20212078|P2|STARTED|Overall Study||14
8197074|NCT02238379|20212079|P1|STARTED|Overall Study||12
8197075|NCT02238080|20212105|P1|NOT COMPLETED|Overall Study||25
8197076|NCT02238080|20212105|P1|COMPLETED|Overall Study||172
8197077|NCT02238080|20212105|P1|STARTED|Overall Study||197
8197078|NCT02238067|20212119|P1|NOT COMPLETED|Overall Study||45
8197079|NCT02238067|20212119|P1|COMPLETED|Overall Study||151
8197080|NCT02238067|20212119|P1|STARTED|Overall Study||196
8197081|NCT02238028|20212142|P2|NOT COMPLETED|Overall Study||2
8197082|NCT02238028|20212143|P1|NOT COMPLETED|Overall Study||2
8197083|NCT02238028|20212142|P2|COMPLETED|Overall Study||12
8197084|NCT02238028|20212143|P1|COMPLETED|Overall Study||12
8197085|NCT02238028|20212142|P2|STARTED|Overall Study||14
8197086|NCT02238028|20212143|P1|STARTED|Overall Study||14
8197087|NCT02237989|20212164|P2|NOT COMPLETED|Overall Study||0
8197088|NCT02237989|20212165|P1|NOT COMPLETED|Overall Study||0
8197089|NCT02237989|20212164|P2|COMPLETED|Overall Study||20
8197090|NCT02237989|20212165|P1|COMPLETED|Overall Study||19
8197091|NCT02237989|20212164|P2|STARTED|Overall Study||20
8197092|NCT02237989|20212165|P1|STARTED|Overall Study||19
8197093|NCT02237950|20212181|P2|NOT COMPLETED|Overall Study||48
8197094|NCT02237950|20212182|P1|NOT COMPLETED|Overall Study||48
8197095|NCT02237950|20212181|P2|COMPLETED|Overall Study||243
8197096|NCT02237950|20212182|P1|COMPLETED|Overall Study||247
8197097|NCT02237950|20212181|P2|STARTED|Overall Study||291
8197098|NCT02237950|20212182|P1|STARTED|Overall Study||295
8197099|NCT02237911|20212207|P3|NOT COMPLETED|Overall Study||3
8197100|NCT02237911|20212208|P2|NOT COMPLETED|Overall Study||8
8197101|NCT02237911|20212209|P1|NOT COMPLETED|Overall Study||7
8197102|NCT02237911|20212207|P3|COMPLETED|Overall Study||45
8197103|NCT02237911|20212208|P2|COMPLETED|Overall Study||88
8197104|NCT02237911|20212209|P1|COMPLETED|Overall Study||89
8197105|NCT02237911|20212207|P3|6 Months|Overall Study||45
8197106|NCT02237911|20212208|P2|6 Months|Overall Study||88
8197107|NCT02237911|20212209|P1|6 Months|Overall Study||89
8197108|NCT02237911|20212207|P3|3 Months|Overall Study||44
8197109|NCT02237911|20212208|P2|3 Months|Overall Study||87
8197110|NCT02237911|20212209|P1|3 Months|Overall Study||90
8197111|NCT02237911|20212207|P3|STARTED|Overall Study||48
8197112|NCT02237911|20212208|P2|STARTED|Overall Study||96
8197113|NCT02237911|20212209|P1|STARTED|Overall Study||96
8197114|NCT02237898|20212225|P2|NOT COMPLETED|Overall Study||12
8197115|NCT02237898|20212226|P1|NOT COMPLETED|Overall Study||7
8197116|NCT02237898|20212225|P2|COMPLETED|Overall Study||2
8197117|NCT02237898|20212226|P1|COMPLETED|Overall Study||5
8197118|NCT02237898|20212225|P2|Completed 15 Month Follow-up|Overall Study||8
8197119|NCT02237898|20212226|P1|Completed 15 Month Follow-up|Overall Study||8
8197120|NCT02237898|20212225|P2|Completed 9 Month Follow-up|Overall Study||7
8197121|NCT02237898|20212226|P1|Completed 9 Month Follow-up|Overall Study||6
8197122|NCT02237898|20212225|P2|Completed 3 Month Follow-up|Overall Study||6
8197123|NCT02237898|20212226|P1|Completed 3 Month Follow-up|Overall Study||6
8197124|NCT02237898|20212225|P2|Completed 12 Weeks of CM|Overall Study||2
8197125|NCT02237898|20212226|P1|Completed 12 Weeks of CM|Overall Study||7
8197126|NCT02237898|20212225|P2|STARTED|Overall Study||14
8197127|NCT02237898|20212226|P1|STARTED|Overall Study||12
8197128|NCT02237196|20212249|P4|NOT COMPLETED|Overall Study||11
8197129|NCT02237196|20212250|P3|NOT COMPLETED|Overall Study||10
8197130|NCT02237196|20212251|P2|NOT COMPLETED|Overall Study||6
8197131|NCT02237196|20212252|P1|NOT COMPLETED|Overall Study||8
8197132|NCT02237196|20212249|P4|COMPLETED|Overall Study||17
8197133|NCT02237196|20212250|P3|COMPLETED|Overall Study||20
8197134|NCT02237196|20212251|P2|COMPLETED|Overall Study||25
8197135|NCT02237196|20212252|P1|COMPLETED|Overall Study||24
8197136|NCT02237196|20212249|P4|STARTED|Overall Study||28
8197137|NCT02237196|20212250|P3|STARTED|Overall Study||30
8197138|NCT02237196|20212251|P2|STARTED|Overall Study||31
8197139|NCT02237196|20212252|P1|STARTED|Overall Study||32
8197140|NCT02237118|20212296|P2|NOT COMPLETED|Overall Study||1
8197141|NCT02237118|20212297|P1|NOT COMPLETED|Overall Study||1
8197142|NCT02237118|20212296|P2|COMPLETED|Overall Study||62
8197143|NCT02237118|20212297|P1|COMPLETED|Overall Study||59
8197144|NCT02237118|20212296|P2|STARTED|Overall Study||63
8197145|NCT02237118|20212297|P1|STARTED|Overall Study||60
8197146|NCT02237092|20212311|P1|NOT COMPLETED|Overall Study||0
8197147|NCT02237092|20212311|P1|COMPLETED|Overall Study||196
8197148|NCT02237092|20212311|P1|STARTED|Overall Study||196
8197149|NCT02237001|20212328|P1|NOT COMPLETED|Overall Study||11
8197150|NCT02237001|20212328|P1|COMPLETED|Overall Study||19
8197151|NCT02237001|20212328|P1|24 Month Follow-up|Overall Study||19
8197152|NCT02237001|20212328|P1|12 Month Follow-up|Overall Study||21
8197153|NCT02237001|20212328|P1|6 Month Follow-up|Overall Study||27
8197154|NCT02237001|20212328|P1|STARTED|Overall Study||30
8197155|NCT02236767|20212340|P1|NOT COMPLETED|Overall Study||0
8197156|NCT02236767|20212340|P1|COMPLETED|Overall Study||1
8197157|NCT02236767|20212340|P1|STARTED|Overall Study||1
8197158|NCT02236611|20212346|P2|NOT COMPLETED|Overall Study||34
8197159|NCT02236611|20212347|P1|NOT COMPLETED|Overall Study||26
8197160|NCT02236611|20212346|P2|COMPLETED|Overall Study||484
8197161|NCT02236611|20212347|P1|COMPLETED|Overall Study||490
8197162|NCT02236611|20212346|P2|STARTED|Overall Study||518
8197163|NCT02236611|20212347|P1|STARTED|Overall Study||516
8197164|NCT02236598|20212355|P2|NOT COMPLETED|Overall Study||2
8197165|NCT02236598|20212356|P1|NOT COMPLETED|Overall Study||0
8197166|NCT02236598|20212355|P2|COMPLETED|Overall Study||12
8197167|NCT02236598|20212356|P1|COMPLETED|Overall Study||15
8197168|NCT02236598|20212355|P2|STARTED|Overall Study||14
8197169|NCT02236598|20212356|P1|STARTED|Overall Study||15
8197170|NCT02236559|20212370|P2|NOT COMPLETED|Overall Study||12
8197171|NCT02236559|20212371|P1|NOT COMPLETED|Overall Study||12
8197172|NCT02236559|20212370|P2|COMPLETED|Overall Study||104
8197173|NCT02236559|20212371|P1|COMPLETED|Overall Study||100
8197174|NCT02236559|20212370|P2|STARTED|Overall Study||116
8197175|NCT02236559|20212371|P1|STARTED|Overall Study||112
8197176|NCT02236546|20212397|P1|NOT COMPLETED|Overall Study||0
8197177|NCT02236546|20212397|P1|COMPLETED|Overall Study||3
8197178|NCT02236546|20212397|P1|STARTED|Overall Study||3
8197179|NCT02236520|20212408|P4|NOT COMPLETED|Overall Study||1
8197180|NCT02236520|20212409|P3|NOT COMPLETED|Overall Study||0
8197181|NCT02236520|20212410|P2|NOT COMPLETED|Overall Study||5
8197182|NCT02236520|20212411|P1|NOT COMPLETED|Overall Study||2
8197183|NCT02236520|20212408|P4|COMPLETED|Overall Study||14
8197184|NCT02236520|20212409|P3|COMPLETED|Overall Study||15
8197185|NCT02236520|20212410|P2|COMPLETED|Overall Study||8
8197186|NCT02236520|20212411|P1|COMPLETED|Overall Study||14
8197187|NCT02236520|20212408|P4|STARTED|Overall Study||15
8197188|NCT02236520|20212409|P3|STARTED|Overall Study||15
8197189|NCT02236520|20212410|P2|STARTED|Overall Study||13
8197190|NCT02236520|20212411|P1|STARTED|Overall Study||16
8197191|NCT02236338|20212423|P2|NOT COMPLETED|Overall Study||0
8197192|NCT02236338|20212424|P1|NOT COMPLETED|Overall Study||0
8197193|NCT02236338|20212423|P2|COMPLETED|Overall Study||100
8197194|NCT02236338|20212424|P1|COMPLETED|Overall Study||100
8197195|NCT02236338|20212423|P2|STARTED|Overall Study||100
8197196|NCT02236338|20212424|P1|STARTED|Overall Study||100
8197197|NCT02236130|20212438|P2|NOT COMPLETED|Overall Study||12
8197198|NCT02236130|20212439|P1|NOT COMPLETED|Overall Study||7
8197199|NCT02236130|20212438|P2|COMPLETED|Overall Study||15
8197200|NCT02236130|20212439|P1|COMPLETED|Overall Study||15
8197201|NCT02236130|20212438|P2|STARTED|Overall Study||27
8197202|NCT02236130|20212439|P1|STARTED|Overall Study||22
8197203|NCT02235987|20212447|P1|NOT COMPLETED|Overall Study||1
8197204|NCT02235987|20212447|P1|COMPLETED|Overall Study||19
8197205|NCT02235987|20212447|P1|Received 1800 µg DG3173|Overall Study||19
8197206|NCT02235987|20212447|P1|Received 900 µg DG3173|Overall Study||19
8197207|NCT02235987|20212447|P1|Received 300 µg DG3173|Overall Study||20
8197208|NCT02235987|20212447|P1|Received 100 µg DG3173|Overall Study||20
8197209|NCT02235987|20212447|P1|Received Octreotide|Overall Study||20
8197210|NCT02235987|20212447|P1|STARTED|Overall Study||20
8197211|NCT02235870|20212462|P2|NOT COMPLETED|Overall Study||61
8197212|NCT02235870|20212463|P1|NOT COMPLETED|Overall Study||38
8197213|NCT02235870|20212462|P2|COMPLETED|Overall Study||128
8197214|NCT02235870|20212463|P1|COMPLETED|Overall Study||160
8197215|NCT02235870|20212462|P2|Crossover (Week 24)|Overall Study||138
8197216|NCT02235870|20212463|P1|Crossover (Week 24)|Overall Study||170
8197217|NCT02235870|20212462|P2|Completed Phase I (Week 24)|Overall Study||179
8197218|NCT02235870|20212463|P1|Completed Phase I (Week 24)|Overall Study||182
8197219|NCT02235870|20212462|P2|STARTED|Overall Study||189
8197220|NCT02235870|20212463|P1|STARTED|Overall Study||198
8197221|NCT02235831|20212472|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197222|NCT02235831|20212473|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197223|NCT02235831|20212474|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197224|NCT02235831|20212475|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197225|NCT02235831|20212476|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197226|NCT02235831|20212477|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197227|NCT02235831|20212472|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
8197228|NCT02235831|20212473|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
8197229|NCT02235831|20212474|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
8197230|NCT02235831|20212475|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
8197231|NCT02235831|20212476|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
8197232|NCT02235831|20212477|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
8197233|NCT02235831|20212472|P6|STARTED|Period 3, Third 5 Days of Wear||4
8197234|NCT02235831|20212473|P5|STARTED|Period 3, Third 5 Days of Wear||4
8197235|NCT02235831|20212474|P4|STARTED|Period 3, Third 5 Days of Wear||4
8197236|NCT02235831|20212475|P3|STARTED|Period 3, Third 5 Days of Wear||4
8197237|NCT02235831|20212476|P2|STARTED|Period 3, Third 5 Days of Wear||4
8197238|NCT02235831|20212477|P1|STARTED|Period 3, Third 5 Days of Wear||4
8197239|NCT02235831|20212472|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197240|NCT02235831|20212473|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197241|NCT02235831|20212474|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197242|NCT02235831|20212475|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197243|NCT02235831|20212476|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197244|NCT02235831|20212477|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197245|NCT02235831|20212472|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
8197246|NCT02235831|20212473|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
8197247|NCT02235831|20212474|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
8197248|NCT02235831|20212475|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
8197249|NCT02235831|20212476|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
8197250|NCT02235831|20212477|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
8197251|NCT02235831|20212472|P6|STARTED|Period 2, Second 5 Days of Wear||4
8197252|NCT02235831|20212473|P5|STARTED|Period 2, Second 5 Days of Wear||4
8197253|NCT02235831|20212474|P4|STARTED|Period 2, Second 5 Days of Wear||4
8197254|NCT02235831|20212475|P3|STARTED|Period 2, Second 5 Days of Wear||4
8197255|NCT02235831|20212476|P2|STARTED|Period 2, Second 5 Days of Wear||4
8197256|NCT02235831|20212477|P1|STARTED|Period 2, Second 5 Days of Wear||4
8197257|NCT02235831|20212472|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197258|NCT02235831|20212473|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197259|NCT02235831|20212474|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197260|NCT02235831|20212475|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197261|NCT02235831|20212476|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197262|NCT02235831|20212477|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197263|NCT02235831|20212472|P6|COMPLETED|Period 1, First 5 Days of Wear||4
8197264|NCT02235831|20212473|P5|COMPLETED|Period 1, First 5 Days of Wear||4
8197265|NCT02235831|20212474|P4|COMPLETED|Period 1, First 5 Days of Wear||4
8197266|NCT02235831|20212475|P3|COMPLETED|Period 1, First 5 Days of Wear||4
8197267|NCT02235831|20212476|P2|COMPLETED|Period 1, First 5 Days of Wear||4
8197268|NCT02235831|20212477|P1|COMPLETED|Period 1, First 5 Days of Wear||4
8197269|NCT02235831|20212472|P6|STARTED|Period 1, First 5 Days of Wear||4
8197270|NCT02235831|20212473|P5|STARTED|Period 1, First 5 Days of Wear||4
8197271|NCT02235831|20212474|P4|STARTED|Period 1, First 5 Days of Wear||4
8197272|NCT02235831|20212475|P3|STARTED|Period 1, First 5 Days of Wear||4
8197273|NCT02235831|20212476|P2|STARTED|Period 1, First 5 Days of Wear||4
8197274|NCT02235831|20212477|P1|STARTED|Period 1, First 5 Days of Wear||4
8197275|NCT02235493|20212484|P1|NOT COMPLETED|Overall Study||0
8197276|NCT02235493|20212484|P1|COMPLETED|Overall Study||6
8197277|NCT02235493|20212484|P1|STARTED|Overall Study||6
8197278|NCT02235454|20212489|P1|NOT COMPLETED|Overall Study||2
8197279|NCT02235454|20212489|P1|COMPLETED|Overall Study||55
8197280|NCT02235454|20212489|P1|STARTED|Overall Study||57
8197281|NCT02235311|20212495|P2|NOT COMPLETED|Overall Study||2
8197282|NCT02235311|20212496|P1|NOT COMPLETED|Overall Study||0
8197283|NCT02235311|20212495|P2|COMPLETED|Overall Study||0
8197284|NCT02235311|20212496|P1|COMPLETED|Overall Study||1
8197285|NCT02235311|20212495|P2|STARTED|Overall Study||2
8197286|NCT02235311|20212496|P1|STARTED|Overall Study||1
8197287|NCT02235285|20212508|P1|NOT COMPLETED|Overall Study||13
8197288|NCT02235285|20212508|P1|COMPLETED|Overall Study||149
8197289|NCT02235285|20212508|P1|STARTED|Overall Study||162
8197290|NCT02235077|20212514|P2|NOT COMPLETED|Overall Study||19
8197291|NCT02235077|20212515|P1|NOT COMPLETED|Overall Study||18
8197292|NCT02235077|20212514|P2|COMPLETED|Overall Study||159
8197293|NCT02235077|20212515|P1|COMPLETED|Overall Study||164
8197294|NCT02235077|20212514|P2|STARTED|Overall Study||178
8197295|NCT02235077|20212515|P1|STARTED|Overall Study||182
8197296|NCT02235064|20212543|P2|NOT COMPLETED|Overall Study||0
8197297|NCT02235064|20212544|P1|NOT COMPLETED|Overall Study||0
8197298|NCT02235064|20212543|P2|COMPLETED|Overall Study||1
8197299|NCT02235064|20212544|P1|COMPLETED|Overall Study||1
8197300|NCT02235064|20212543|P2|STARTED|Overall Study||1
8197301|NCT02235064|20212544|P1|STARTED|Overall Study||1
8197302|NCT02234843|20212580|P10|NOT COMPLETED|Overall Study||0
8197303|NCT02234843|20212581|P9|NOT COMPLETED|Overall Study||1
8197304|NCT02234843|20212582|P8|NOT COMPLETED|Overall Study||2
8197305|NCT02234843|20212583|P7|NOT COMPLETED|Overall Study||2
8197306|NCT02234843|20212584|P6|NOT COMPLETED|Overall Study||13
8197307|NCT02234843|20212585|P5|NOT COMPLETED|Overall Study||2
8197308|NCT02234843|20212586|P4|NOT COMPLETED|Overall Study||5
8197309|NCT02234843|20212587|P3|NOT COMPLETED|Overall Study||3
8197310|NCT02234843|20212588|P2|NOT COMPLETED|Overall Study||6
8197311|NCT02234843|20212589|P1|NOT COMPLETED|Overall Study||22
8197312|NCT02234843|20212580|P10|COMPLETED|Overall Study||8
8197313|NCT02234843|20212581|P9|COMPLETED|Overall Study||8
8197314|NCT02234843|20212582|P8|COMPLETED|Overall Study||20
8197315|NCT02234843|20212583|P7|COMPLETED|Overall Study||32
8197316|NCT02234843|20212584|P6|COMPLETED|Overall Study||79
8197317|NCT02234843|20212585|P5|COMPLETED|Overall Study||14
8197318|NCT02234843|20212586|P4|COMPLETED|Overall Study||16
8197319|NCT02234843|20212587|P3|COMPLETED|Overall Study||44
8197320|NCT02234843|20212588|P2|COMPLETED|Overall Study||61
8197321|NCT02234843|20212589|P1|COMPLETED|Overall Study||162
8197322|NCT02234843|20212580|P10|STARTED|Overall Study||8
8197323|NCT02234843|20212581|P9|STARTED|Overall Study||9
8197324|NCT02234843|20212582|P8|STARTED|Overall Study||22
8197325|NCT02234843|20212583|P7|STARTED|Overall Study||34
8197326|NCT02234843|20212584|P6|STARTED|Overall Study||92
8197327|NCT02234843|20212585|P5|STARTED|Overall Study||16
8197328|NCT02234843|20212586|P4|STARTED|Overall Study||21
8197329|NCT02234843|20212587|P3|STARTED|Overall Study||47
8197330|NCT02234843|20212588|P2|STARTED|Overall Study||67
8197331|NCT02234843|20212589|P1|STARTED|Overall Study||184
8197332|NCT02234752|20212696|P1|NOT COMPLETED|Overall Study||1
8197333|NCT02234752|20212696|P1|COMPLETED|Overall Study||2
8197334|NCT02234752|20212696|P1|STARTED|Overall Study||3
8197335|NCT02234713|20212709|P2|NOT COMPLETED|Overall Study||5
8197336|NCT02234713|20212710|P1|NOT COMPLETED|Overall Study||6
8197337|NCT02234713|20212709|P2|COMPLETED|Overall Study||27
8197338|NCT02234713|20212710|P1|COMPLETED|Overall Study||25
8197339|NCT02234713|20212709|P2|STARTED|Overall Study||32
8197340|NCT02234713|20212710|P1|STARTED|Overall Study||31
8197341|NCT02234687|20212735|P3|NOT COMPLETED|Overall Study||4
8197342|NCT02234687|20212736|P2|NOT COMPLETED|Overall Study||4
8197343|NCT02234687|20212737|P1|NOT COMPLETED|Overall Study||6
8197344|NCT02234687|20212735|P3|COMPLETED|Overall Study||0
8197345|NCT02234687|20212736|P2|COMPLETED|Overall Study||0
8197346|NCT02234687|20212737|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
8197347|NCT02234687|20212735|P3|STARTED|Overall Study||4
8197348|NCT02234687|20212736|P2|STARTED|Overall Study||4
8197349|NCT02234687|20212737|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
8197350|NCT02234622|20212747|P2|NOT COMPLETED|Overall Study||36
8197351|NCT02234622|20212748|P1|NOT COMPLETED|Overall Study||43
8197352|NCT02234622|20212747|P2|COMPLETED|Overall Study||68
8197353|NCT02234622|20212748|P1|COMPLETED|Overall Study||65
8197354|NCT02234622|20212747|P2|STARTED|Overall Study||104
8197355|NCT02234622|20212748|P1|STARTED|Overall Study||108
8197356|NCT02234596|20212766|P1|NOT COMPLETED|Overall Study||2
8197357|NCT02234596|20212766|P1|COMPLETED|Overall Study||32
8197358|NCT02234596|20212766|P1|STARTED|Overall Study||34
8197359|NCT02234583|20212774|P2|NOT COMPLETED|Overall Study||556
8197360|NCT02234583|20212775|P1|NOT COMPLETED|Overall Study||413
8197361|NCT02234583|20212774|P2|COMPLETED|Overall Study||685
8197362|NCT02234583|20212775|P1|COMPLETED|Overall Study||434
8197363|NCT02234583|20212774|P2|STARTED|Overall Study||1241
8197364|NCT02234583|20212775|P1|STARTED|Overall Study||847
8197365|NCT02234570|20212811|P8|NOT COMPLETED|Overall Study||0
8197366|NCT02234570|20212812|P7|NOT COMPLETED|Overall Study||0
8197367|NCT02234570|20212813|P6|NOT COMPLETED|Overall Study||0
8197368|NCT02234570|20212814|P5|NOT COMPLETED|Overall Study||0
8197369|NCT02234570|20212815|P4|NOT COMPLETED|Overall Study||0
8197370|NCT02234570|20212816|P3|NOT COMPLETED|Overall Study||0
8197371|NCT02234570|20212817|P2|NOT COMPLETED|Overall Study||0
8197372|NCT02234570|20212818|P1|NOT COMPLETED|Overall Study||0
8197373|NCT02234570|20212811|P8|COMPLETED|Overall Study||14
8197374|NCT02234570|20212812|P7|COMPLETED|Overall Study||8
8197375|NCT02234570|20212813|P6|COMPLETED|Overall Study||8
8197376|NCT02234570|20212814|P5|COMPLETED|Overall Study||8
8197377|NCT02234570|20212815|P4|COMPLETED|Overall Study||8
8197378|NCT02234570|20212816|P3|COMPLETED|Overall Study||8
8197379|NCT02234570|20212817|P2|COMPLETED|Overall Study||8
8197380|NCT02234570|20212818|P1|COMPLETED|Overall Study||8
8197381|NCT02234570|20212811|P8|STARTED|Overall Study||14
8197382|NCT02234570|20212812|P7|STARTED|Overall Study||8
8197383|NCT02234570|20212813|P6|STARTED|Overall Study||8
8197384|NCT02234570|20212814|P5|STARTED|Overall Study||8
8197385|NCT02234570|20212815|P4|STARTED|Overall Study||8
8197386|NCT02234570|20212816|P3|STARTED|Overall Study||8
8197387|NCT02234570|20212817|P2|STARTED|Overall Study||8
8197388|NCT02234570|20212818|P1|STARTED|Overall Study||8
8197389|NCT02234479|20212894|P2|NOT COMPLETED|Overall Study||3
8197390|NCT02234479|20212895|P1|NOT COMPLETED|Overall Study||1
8197391|NCT02234479|20212894|P2|COMPLETED|Overall Study||15
8197392|NCT02234479|20212895|P1|COMPLETED|Overall Study||15
8197393|NCT02234479|20212894|P2|STARTED|Overall Study||18
8197394|NCT02234479|20212895|P1|STARTED|Overall Study||16
8197395|NCT02234427|20212901|P1|NOT COMPLETED|Overall Study||1
8197396|NCT02234427|20212901|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
8197397|NCT02234427|20212901|P1|STARTED|Overall Study||34
8197398|NCT02234362|20212905|P1|NOT COMPLETED|Overall Study||26
8197399|NCT02234362|20212905|P1|COMPLETED|Overall Study||21
8197400|NCT02234362|20212905|P1|Received at Least One Dose of Medication|Overall Study||27
8197401|NCT02234362|20212905|P1|STARTED|Overall Study||47
8197402|NCT02234323|20212922|P1|NOT COMPLETED|All Treated||18
8197403|NCT02234323|20212922|P1|COMPLETED|All Treated||85
8197404|NCT02234323|20212922|P1|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
8197405|NCT02234323|20212922|P1|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
8197406|NCT02234323|20212922|P1|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
8197407|NCT02234323|20212922|P1|STARTED|All Treated||103
8197408|NCT02234323|20212922|P1|NOT COMPLETED|All Enrolled||5
8197409|NCT02234323|20212922|P1|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
8197410|NCT02234323|20212922|P1|STARTED|All Enrolled||108
8197411|NCT02234310|20212935|P1|NOT COMPLETED|Overall Study||6
8197412|NCT02234310|20212935|P1|COMPLETED|Overall Study||27
8197413|NCT02234310|20212935|P1|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
8197414|NCT02234310|20212935|P1|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
8197415|NCT02234310|20212935|P1|STARTED|Overall Study||33
8197416|NCT02234284|20212949|P2|NOT COMPLETED|Overall Study||9
8197417|NCT02234284|20212950|P1|NOT COMPLETED|Overall Study||25
8197418|NCT02234284|20212949|P2|COMPLETED|Overall Study||83
8197419|NCT02234284|20212950|P1|COMPLETED|Overall Study||75
8197420|NCT02234284|20212949|P2|STARTED|Overall Study||92
8197421|NCT02234284|20212950|P1|STARTED|Overall Study||100
8197422|NCT02234180|20212998|P2|NOT COMPLETED|Overall Study||0
8197423|NCT02234180|20212999|P1|NOT COMPLETED|Overall Study||0
8197424|NCT02234180|20212998|P2|COMPLETED|Overall Study||1
8197425|NCT02234180|20212999|P1|COMPLETED|Overall Study||2
8197426|NCT02234180|20212998|P2|STARTED|Overall Study||1
8197427|NCT02234180|20212999|P1|STARTED|Overall Study||2
8197428|NCT02234141|20213009|P7|NOT COMPLETED|Long-Term Treatment Period||10
8197429|NCT02234141|20213010|P6|NOT COMPLETED|Long-Term Treatment Period||12
8197430|NCT02234141|20213011|P5|NOT COMPLETED|Long-Term Treatment Period||10
8197431|NCT02234141|20213012|P4|NOT COMPLETED|Long-Term Treatment Period||0
8197432|NCT02234141|20213013|P3|NOT COMPLETED|Long-Term Treatment Period||33
8197433|NCT02234141|20213014|P2|NOT COMPLETED|Long-Term Treatment Period||31
8197434|NCT02234141|20213015|P1|NOT COMPLETED|Long-Term Treatment Period||33
8197435|NCT02234141|20213009|P7|COMPLETED|Long-Term Treatment Period||0
8197436|NCT02234141|20213010|P6|COMPLETED|Long-Term Treatment Period||0
8197437|NCT02234141|20213011|P5|COMPLETED|Long-Term Treatment Period||0
8197438|NCT02234141|20213012|P4|COMPLETED|Long-Term Treatment Period||0
8197439|NCT02234141|20213013|P3|COMPLETED|Long-Term Treatment Period||0
8197440|NCT02234141|20213014|P2|COMPLETED|Long-Term Treatment Period||0
8197441|NCT02234141|20213015|P1|COMPLETED|Long-Term Treatment Period||0
8197442|NCT02234141|20213009|P7|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
8197443|NCT02234141|20213010|P6|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
8197444|NCT02234141|20213011|P5|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
8197445|NCT02234141|20213012|P4|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
8197446|NCT02234141|20213013|P3|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
8197447|NCT02234141|20213014|P2|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
8197448|NCT02234141|20213015|P1|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
8197449|NCT02234141|20213009|P7|NOT COMPLETED|Treatment Period (24 Weeks)||0
8197450|NCT02234141|20213010|P6|NOT COMPLETED|Treatment Period (24 Weeks)||0
8197451|NCT02234141|20213011|P5|NOT COMPLETED|Treatment Period (24 Weeks)||0
8197452|NCT02234141|20213012|P4|NOT COMPLETED|Treatment Period (24 Weeks)||5
8197453|NCT02234141|20213013|P3|NOT COMPLETED|Treatment Period (24 Weeks)||2
8197454|NCT02234141|20213014|P2|NOT COMPLETED|Treatment Period (24 Weeks)||6
8197455|NCT02234141|20213015|P1|NOT COMPLETED|Treatment Period (24 Weeks)||4
8197456|NCT02234141|20213009|P7|COMPLETED|Treatment Period (24 Weeks)||0
8197457|NCT02234141|20213010|P6|COMPLETED|Treatment Period (24 Weeks)||0
8197458|NCT02234141|20213011|P5|COMPLETED|Treatment Period (24 Weeks)||0
8197459|NCT02234141|20213012|P4|COMPLETED|Treatment Period (24 Weeks)||32
8197460|NCT02234141|20213013|P3|COMPLETED|Treatment Period (24 Weeks)||35
8197461|NCT02234141|20213014|P2|COMPLETED|Treatment Period (24 Weeks)||32
8197462|NCT02234141|20213015|P1|COMPLETED|Treatment Period (24 Weeks)||35
8197463|NCT02234141|20213009|P7|STARTED|Treatment Period (24 Weeks)||0
8197464|NCT02234141|20213010|P6|STARTED|Treatment Period (24 Weeks)||0
8197465|NCT02234141|20213011|P5|STARTED|Treatment Period (24 Weeks)||0
8197466|NCT02234141|20213012|P4|STARTED|Treatment Period (24 Weeks)||37
8197467|NCT02234141|20213013|P3|STARTED|Treatment Period (24 Weeks)||37
8197468|NCT02234141|20213014|P2|STARTED|Treatment Period (24 Weeks)||38
8197469|NCT02234141|20213015|P1|STARTED|Treatment Period (24 Weeks)||39
8197470|NCT02234128|20213100|P3|NOT COMPLETED|Overall Study||4
8197471|NCT02234128|20213101|P2|NOT COMPLETED|Overall Study||2
8197472|NCT02234128|20213102|P1|NOT COMPLETED|Overall Study||5
8197473|NCT02234128|20213100|P3|COMPLETED|Overall Study||48
8197474|NCT02234128|20213101|P2|COMPLETED|Overall Study||29
8197475|NCT02234128|20213102|P1|COMPLETED|Overall Study||30
8197476|NCT02234128|20213100|P3|STARTED|Overall Study||52
8197477|NCT02234128|20213101|P2|STARTED|Overall Study||31
8197478|NCT02234128|20213102|P1|STARTED|Overall Study||35
8197479|NCT02234115|20213113|P1|NOT COMPLETED|Overall Study||15
8197480|NCT02234115|20213113|P1|COMPLETED|Overall Study||122
8197481|NCT02234115|20213113|P1|PK Subgroup|Overall Study||31
8197482|NCT02234115|20213113|P1|PP|Overall Study||124
8197483|NCT02234115|20213113|P1|ITT|Overall Study||137
8197484|NCT02234115|20213113|P1|STARTED|Overall Study||137
8197485|NCT02234063|20213120|P2|NOT COMPLETED|Overall Study||43
8197486|NCT02234063|20213121|P1|NOT COMPLETED|Overall Study||255
8197487|NCT02234063|20213120|P2|COMPLETED|Overall Study||212
8197488|NCT02234063|20213121|P1|COMPLETED|Overall Study||1540
8197489|NCT02234063|20213120|P2|STARTED|Overall Study||255
8197490|NCT02234063|20213121|P1|STARTED|Overall Study||1795
8197491|NCT02234011|20213141|P1|NOT COMPLETED|Overall Study||0
8197492|NCT02234011|20213141|P1|COMPLETED|Overall Study||0
8197493|NCT02234011|20213141|P1|STARTED|Overall Study||0
8197494|NCT02233998|20213148|P3|NOT COMPLETED|Overall Study||0
8197495|NCT02233998|20213149|P2|NOT COMPLETED|Overall Study||0
8197496|NCT02233998|20213150|P1|NOT COMPLETED|Overall Study||0
8197497|NCT02233998|20213148|P3|COMPLETED|Overall Study||53
8197498|NCT02233998|20213149|P2|COMPLETED|Overall Study||52
8197499|NCT02233998|20213150|P1|COMPLETED|Overall Study||53
8197500|NCT02233998|20213148|P3|STARTED|Overall Study||53
8197501|NCT02233998|20213149|P2|STARTED|Overall Study||52
8197502|NCT02233998|20213150|P1|STARTED|Overall Study||53
8197503|NCT02233985|20213184|P2|NOT COMPLETED|Overall Study||0
8197504|NCT02233985|20213185|P1|NOT COMPLETED|Overall Study||0
8197505|NCT02233985|20213184|P2|COMPLETED|Overall Study||31
8197506|NCT02233985|20213185|P1|COMPLETED|Overall Study||33
8197507|NCT02233985|20213184|P2|STARTED|Overall Study||31
8197508|NCT02233985|20213185|P1|STARTED|Overall Study||33
8197509|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
8197510|NCT02233842|20213193|P1|COMPLETED|Questionnaire 3 Version 2||5
8197511|NCT02233842|20213193|P1|STARTED|Questionnaire 3 Version 2||5
8197512|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
8197513|NCT02233842|20213193|P1|COMPLETED|Questionnaire 3 Version 1||5
8197514|NCT02233842|20213193|P1|STARTED|Questionnaire 3 Version 1||5
8197515|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
8197516|NCT02233842|20213193|P1|COMPLETED|Questionnaire 2 Version 2||5
8197517|NCT02233842|20213193|P1|STARTED|Questionnaire 2 Version 2||5
8197518|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
8197519|NCT02233842|20213193|P1|COMPLETED|Questionnaire 2 Version 1||5
8197520|NCT02233842|20213193|P1|STARTED|Questionnaire 2 Version 1||5
8197521|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
8197522|NCT02233842|20213193|P1|COMPLETED|Questionnaire 1 Version 2||5
8197523|NCT02233842|20213193|P1|STARTED|Questionnaire 1 Version 2||5
8197524|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
8197525|NCT02233842|20213193|P1|COMPLETED|Questionnaire 1 Version 1||5
8197526|NCT02233842|20213193|P1|STARTED|Questionnaire 1 Version 1||5
8197527|NCT02233803|20213200|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
8197528|NCT02233803|20213201|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
8197529|NCT02233803|20213200|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
8197530|NCT02233803|20213201|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
8197531|NCT02233803|20213200|P2|STARTED|Treatment Period 2 (4-Wks)||93
8197532|NCT02233803|20213201|P1|STARTED|Treatment Period 2 (4-Wks)||95
8197533|NCT02233803|20213200|P2|NOT COMPLETED|Washout Period (4-Wks)||2
8197534|NCT02233803|20213201|P1|NOT COMPLETED|Washout Period (4-Wks)||2
8197535|NCT02233803|20213200|P2|COMPLETED|Washout Period (4-Wks)||93
8197536|NCT02233803|20213201|P1|COMPLETED|Washout Period (4-Wks)||95
8197537|NCT02233803|20213200|P2|STARTED|Washout Period (4-Wks)||95
8197538|NCT02233803|20213201|P1|STARTED|Washout Period (4-Wks)||97
8197539|NCT02233803|20213200|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
8197540|NCT02233803|20213201|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
8197541|NCT02233803|20213200|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
8197542|NCT02233803|20213201|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
8197543|NCT02233803|20213200|P2|STARTED|Treatment Period 1 (4-Wks)||99
8197544|NCT02233803|20213201|P1|STARTED|Treatment Period 1 (4-Wks)||100
8197545|NCT02233751|20213213|P2|NOT COMPLETED|Overall Study||0
8197546|NCT02233751|20213214|P1|NOT COMPLETED|Overall Study||0
8197547|NCT02233751|20213213|P2|COMPLETED|Overall Study||6
8197548|NCT02233751|20213214|P1|COMPLETED|Overall Study||6
8197549|NCT02233751|20213213|P2|STARTED|Overall Study||6
8197550|NCT02233751|20213214|P1|STARTED|Overall Study||6
8197551|NCT02233738|20213234|P2|NOT COMPLETED|Overall Study||16
8197552|NCT02233738|20213235|P1|NOT COMPLETED|Overall Study||8
8197553|NCT02233738|20213234|P2|COMPLETED|Overall Study||75
8197554|NCT02233738|20213235|P1|COMPLETED|Overall Study||85
8197555|NCT02233738|20213234|P2|6 Month Follow-Up|Overall Study||75
8197556|NCT02233738|20213235|P1|6 Month Follow-Up|Overall Study||85
8197557|NCT02233738|20213234|P2|3 Month Follow-Up|Overall Study||77
8197558|NCT02233738|20213235|P1|3 Month Follow-Up|Overall Study||87
8197559|NCT02233738|20213234|P2|1 Month Follow-Up|Overall Study||82
8197560|NCT02233738|20213235|P1|1 Month Follow-Up|Overall Study||89
8197561|NCT02233738|20213234|P2|STARTED|Overall Study||91
8197562|NCT02233738|20213235|P1|STARTED|Overall Study||93
8197563|NCT02233647|20213405|P1|NOT COMPLETED|Overall Study||1
8197564|NCT02233647|20213405|P1|COMPLETED|Overall Study||10
8197565|NCT02233647|20213405|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197566|NCT02233647|20213405|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197567|NCT02233647|20213405|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197568|NCT02233647|20213405|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197569|NCT02233647|20213405|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
8197570|NCT02233647|20213405|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197571|NCT02233647|20213405|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197572|NCT02233647|20213405|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197573|NCT02233647|20213405|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197574|NCT02233647|20213405|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
8197575|NCT02233647|20213405|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197576|NCT02233647|20213405|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197577|NCT02233647|20213405|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197578|NCT02233647|20213405|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197579|NCT02233647|20213405|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197580|NCT02233647|20213405|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8197581|NCT02233647|20213405|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8197582|NCT02233647|20213405|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8197583|NCT02233647|20213405|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
8197584|NCT02233647|20213405|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
8197585|NCT02233647|20213405|P1|STARTED|Overall Study||11
8197586|NCT02233543|20213434|P2|NOT COMPLETED|Period 2||1
8197587|NCT02233543|20213435|P1|NOT COMPLETED|Period 2||2
8197588|NCT02233543|20213434|P2|COMPLETED|Period 2||12
8197589|NCT02233543|20213435|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
8197590|NCT02233543|20213434|P2|STARTED|Period 2||13
8197591|NCT02233543|20213435|P1|STARTED|Period 2||19
8197592|NCT02233543|20213434|P2|NOT COMPLETED|Period 1||3
8197593|NCT02233543|20213435|P1|NOT COMPLETED|Period 1||3
8197594|NCT02233543|20213434|P2|COMPLETED|Period 1||13
8197595|NCT02233543|20213435|P1|COMPLETED|Period 1||19
8197596|NCT02233543|20213434|P2|STARTED|Period 1||16
8197597|NCT02233543|20213435|P1|STARTED|Period 1||22
8197598|NCT02233517|20213445|P2|NOT COMPLETED|Overall Study||4
8197599|NCT02233517|20213446|P1|NOT COMPLETED|Overall Study||7
8197600|NCT02233517|20213445|P2|COMPLETED|Overall Study||13
8197601|NCT02233517|20213446|P1|COMPLETED|Overall Study||12
8197602|NCT02233517|20213445|P2|STARTED|Overall Study||17
8197603|NCT02233517|20213446|P1|STARTED|Overall Study||19
8197604|NCT02233478|20213472|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8197605|NCT02233478|20213473|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8197606|NCT02233478|20213474|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8197607|NCT02233478|20213475|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8197608|NCT02233478|20213476|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8197609|NCT02233478|20213477|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8197610|NCT02233478|20213472|P6|COMPLETED|Third Intervention (1 Day)||3
8197611|NCT02233478|20213473|P5|COMPLETED|Third Intervention (1 Day)||3
8197612|NCT02233478|20213474|P4|COMPLETED|Third Intervention (1 Day)||3
8197613|NCT02233478|20213475|P3|COMPLETED|Third Intervention (1 Day)||3
8197614|NCT02233478|20213476|P2|COMPLETED|Third Intervention (1 Day)||3
8197615|NCT02233478|20213477|P1|COMPLETED|Third Intervention (1 Day)||3
8197616|NCT02233478|20213472|P6|STARTED|Third Intervention (1 Day)||3
8197617|NCT02233478|20213473|P5|STARTED|Third Intervention (1 Day)||3
8197618|NCT02233478|20213474|P4|STARTED|Third Intervention (1 Day)||3
8197619|NCT02233478|20213475|P3|STARTED|Third Intervention (1 Day)||3
8197620|NCT02233478|20213476|P2|STARTED|Third Intervention (1 Day)||3
8197621|NCT02233478|20213477|P1|STARTED|Third Intervention (1 Day)||3
8197622|NCT02233478|20213472|P6|NOT COMPLETED|Washout (7 Days)||0
8197623|NCT02233478|20213473|P5|NOT COMPLETED|Washout (7 Days)||0
8197624|NCT02233478|20213474|P4|NOT COMPLETED|Washout (7 Days)||0
8197625|NCT02233478|20213475|P3|NOT COMPLETED|Washout (7 Days)||0
8197626|NCT02233478|20213476|P2|NOT COMPLETED|Washout (7 Days)||0
8197627|NCT02233478|20213477|P1|NOT COMPLETED|Washout (7 Days)||0
8197628|NCT02233478|20213472|P6|COMPLETED|Washout (7 Days)||3
8197629|NCT02233478|20213473|P5|COMPLETED|Washout (7 Days)||3
8197630|NCT02233478|20213474|P4|COMPLETED|Washout (7 Days)||3
8197631|NCT02233478|20213475|P3|COMPLETED|Washout (7 Days)||3
8197632|NCT02233478|20213476|P2|COMPLETED|Washout (7 Days)||3
8197633|NCT02233478|20213477|P1|COMPLETED|Washout (7 Days)||3
8197634|NCT02233478|20213472|P6|STARTED|Washout (7 Days)||3
8197635|NCT02233478|20213473|P5|STARTED|Washout (7 Days)||3
8197636|NCT02233478|20213474|P4|STARTED|Washout (7 Days)||3
8197637|NCT02233478|20213475|P3|STARTED|Washout (7 Days)||3
8197638|NCT02233478|20213476|P2|STARTED|Washout (7 Days)||3
8197639|NCT02233478|20213477|P1|STARTED|Washout (7 Days)||3
8197640|NCT02233478|20213472|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8197641|NCT02233478|20213473|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8197642|NCT02233478|20213474|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8197643|NCT02233478|20213475|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8197644|NCT02233478|20213476|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8197645|NCT02233478|20213477|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8197646|NCT02233478|20213472|P6|COMPLETED|Second Intervention (1 Day)||3
8197647|NCT02233478|20213473|P5|COMPLETED|Second Intervention (1 Day)||3
8197648|NCT02233478|20213474|P4|COMPLETED|Second Intervention (1 Day)||3
8197649|NCT02233478|20213475|P3|COMPLETED|Second Intervention (1 Day)||3
8197650|NCT02233478|20213476|P2|COMPLETED|Second Intervention (1 Day)||3
8197651|NCT02233478|20213477|P1|COMPLETED|Second Intervention (1 Day)||3
8197652|NCT02233478|20213472|P6|STARTED|Second Intervention (1 Day)||3
8197653|NCT02233478|20213473|P5|STARTED|Second Intervention (1 Day)||3
8197654|NCT02233478|20213474|P4|STARTED|Second Intervention (1 Day)||3
8197655|NCT02233478|20213475|P3|STARTED|Second Intervention (1 Day)||3
8197656|NCT02233478|20213476|P2|STARTED|Second Intervention (1 Day)||3
8197657|NCT02233478|20213477|P1|STARTED|Second Intervention (1 Day)||3
8197658|NCT02233478|20213472|P6|NOT COMPLETED|Washout (7 Days)||0
8197659|NCT02233478|20213473|P5|NOT COMPLETED|Washout (7 Days)||0
8197660|NCT02233478|20213474|P4|NOT COMPLETED|Washout (7 Days)||0
8197661|NCT02233478|20213475|P3|NOT COMPLETED|Washout (7 Days)||0
8197662|NCT02233478|20213476|P2|NOT COMPLETED|Washout (7 Days)||0
8197663|NCT02233478|20213477|P1|NOT COMPLETED|Washout (7 Days)||0
8197664|NCT02233478|20213472|P6|COMPLETED|Washout (7 Days)||3
8197665|NCT02233478|20213473|P5|COMPLETED|Washout (7 Days)||3
8197666|NCT02233478|20213474|P4|COMPLETED|Washout (7 Days)||3
8197667|NCT02233478|20213475|P3|COMPLETED|Washout (7 Days)||3
8197668|NCT02233478|20213476|P2|COMPLETED|Washout (7 Days)||3
8197669|NCT02233478|20213477|P1|COMPLETED|Washout (7 Days)||3
8197670|NCT02233478|20213472|P6|STARTED|Washout (7 Days)||3
8197671|NCT02233478|20213473|P5|STARTED|Washout (7 Days)||3
8197672|NCT02233478|20213474|P4|STARTED|Washout (7 Days)||3
8197673|NCT02233478|20213475|P3|STARTED|Washout (7 Days)||3
8197674|NCT02233478|20213476|P2|STARTED|Washout (7 Days)||3
8197675|NCT02233478|20213477|P1|STARTED|Washout (7 Days)||3
8197676|NCT02233478|20213472|P6|NOT COMPLETED|First Intervention (1 Day)||0
8197677|NCT02233478|20213473|P5|NOT COMPLETED|First Intervention (1 Day)||0
8197678|NCT02233478|20213474|P4|NOT COMPLETED|First Intervention (1 Day)||0
8197679|NCT02233478|20213475|P3|NOT COMPLETED|First Intervention (1 Day)||0
8197680|NCT02233478|20213476|P2|NOT COMPLETED|First Intervention (1 Day)||0
8197681|NCT02233478|20213477|P1|NOT COMPLETED|First Intervention (1 Day)||0
8197682|NCT02233478|20213472|P6|COMPLETED|First Intervention (1 Day)||3
8197683|NCT02233478|20213473|P5|COMPLETED|First Intervention (1 Day)||3
8197684|NCT02233478|20213474|P4|COMPLETED|First Intervention (1 Day)||3
8197685|NCT02233478|20213475|P3|COMPLETED|First Intervention (1 Day)||3
8197686|NCT02233478|20213476|P2|COMPLETED|First Intervention (1 Day)||3
8197687|NCT02233478|20213477|P1|COMPLETED|First Intervention (1 Day)||3
8197688|NCT02233478|20213472|P6|STARTED|First Intervention (1 Day)||3
8197689|NCT02233478|20213473|P5|STARTED|First Intervention (1 Day)||3
8197690|NCT02233478|20213474|P4|STARTED|First Intervention (1 Day)||3
8197691|NCT02233478|20213475|P3|STARTED|First Intervention (1 Day)||3
8197692|NCT02233478|20213476|P2|STARTED|First Intervention (1 Day)||3
8197693|NCT02233478|20213477|P1|STARTED|First Intervention (1 Day)||3
8197694|NCT02233413|20213487|P2|NOT COMPLETED|Overall Study||14
8197695|NCT02233413|20213488|P1|NOT COMPLETED|Overall Study||11
8197696|NCT02233413|20213487|P2|COMPLETED|Overall Study||19
8197697|NCT02233413|20213488|P1|COMPLETED|Overall Study||24
8197698|NCT02233413|20213487|P2|STARTED|Overall Study||33
8197699|NCT02233413|20213488|P1|STARTED|Overall Study||35
8197700|NCT02233309|20213500|P1|NOT COMPLETED|Overall Study||5
8197701|NCT02233309|20213500|P1|COMPLETED|Overall Study||31
8197702|NCT02233309|20213500|P1|STARTED|Overall Study||36
8197703|NCT02233296|20213506|P2|NOT COMPLETED|Overall Study||0
8197704|NCT02233296|20213507|P1|NOT COMPLETED|Overall Study||0
8197705|NCT02233296|20213506|P2|COMPLETED|Overall Study||14
8197706|NCT02233296|20213507|P1|COMPLETED|Overall Study||16
8197707|NCT02233296|20213506|P2|STARTED|Overall Study||14
8197708|NCT02233296|20213507|P1|STARTED|Overall Study||16
8197709|NCT02233101|20213525|P2|NOT COMPLETED|Overall Study||1
8197710|NCT02233101|20213526|P1|NOT COMPLETED|Overall Study||12
8197711|NCT02233101|20213525|P2|COMPLETED|Overall Study||80
8197712|NCT02233101|20213526|P1|COMPLETED|Overall Study||74
8197713|NCT02233101|20213525|P2|STARTED|Overall Study||81
8197714|NCT02233101|20213526|P1|STARTED|Overall Study||86
8197715|NCT02232984|20213534|P1|NOT COMPLETED|Overall Study||77
8197716|NCT02232984|20213534|P1|COMPLETED|Overall Study|Total number of subjects who completed study|672
8197717|NCT02232984|20213534|P1|Successfully Implanted|Overall Study|Successfully implanted subjects|675
8197718|NCT02232984|20213534|P1|STARTED|Overall Study|Enrolled subjects|749
8197719|NCT02232893|20213545|P2|NOT COMPLETED|Overall Study||7
8197720|NCT02232893|20213546|P1|NOT COMPLETED|Overall Study||4
8197721|NCT02232893|20213545|P2|COMPLETED|Overall Study||27
8197722|NCT02232893|20213546|P1|COMPLETED|Overall Study||31
8197723|NCT02232893|20213545|P2|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
8197724|NCT02232893|20213546|P1|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
8197725|NCT02232893|20213545|P2|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
8197726|NCT02232893|20213546|P1|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
8197727|NCT02232893|20213545|P2|STARTED|Overall Study||34
8197728|NCT02232893|20213546|P1|STARTED|Overall Study||35
8197729|NCT02232880|20213552|P1|NOT COMPLETED|Overall Study||1
8197730|NCT02232880|20213552|P1|COMPLETED|Overall Study||0
8197731|NCT02232880|20213552|P1|STARTED|Overall Study||1
8197732|NCT02232802|20213561|P2|NOT COMPLETED|Washout||0
8197733|NCT02232802|20213562|P1|NOT COMPLETED|Washout||0
8197734|NCT02232802|20213561|P2|COMPLETED|Washout||22
8197735|NCT02232802|20213562|P1|COMPLETED|Washout||22
8197736|NCT02232802|20213561|P2|STARTED|Washout||22
8197737|NCT02232802|20213562|P1|STARTED|Washout||22
8197738|NCT02232802|20213561|P2|NOT COMPLETED|Period 2||0
8197739|NCT02232802|20213562|P1|NOT COMPLETED|Period 2||0
8197740|NCT02232802|20213561|P2|COMPLETED|Period 2||22
8197741|NCT02232802|20213562|P1|COMPLETED|Period 2||22
8197742|NCT02232802|20213561|P2|STARTED|Period 2||22
8197743|NCT02232802|20213562|P1|STARTED|Period 2||22
8197744|NCT02232802|20213561|P2|NOT COMPLETED|Washout||0
8197745|NCT02232802|20213562|P1|NOT COMPLETED|Washout||0
8197746|NCT02232802|20213561|P2|COMPLETED|Washout||22
8197747|NCT02232802|20213562|P1|COMPLETED|Washout||22
8197748|NCT02232802|20213561|P2|STARTED|Washout||22
8197749|NCT02232802|20213562|P1|STARTED|Washout||22
8197750|NCT02232802|20213561|P2|NOT COMPLETED|Period 1||1
8197751|NCT02232802|20213562|P1|NOT COMPLETED|Period 1||2
8197752|NCT02232802|20213561|P2|COMPLETED|Period 1||22
8197753|NCT02232802|20213562|P1|COMPLETED|Period 1||22
8197754|NCT02232802|20213561|P2|STARTED|Period 1||23
8197755|NCT02232802|20213562|P1|STARTED|Period 1||24
8197756|NCT02232698|20213628|P2|NOT COMPLETED|Overall Study||20
8197757|NCT02232698|20213629|P1|NOT COMPLETED|Overall Study||10
8197758|NCT02232698|20213628|P2|COMPLETED|Overall Study||101
8197759|NCT02232698|20213629|P1|COMPLETED|Overall Study||110
8197760|NCT02232698|20213628|P2|STARTED|Overall Study||121
8197761|NCT02232698|20213629|P1|STARTED|Overall Study||120
8197762|NCT02232425|20213652|P2|NOT COMPLETED|Overall Study||8
8197763|NCT02232425|20213653|P1|NOT COMPLETED|Overall Study||14
8197764|NCT02232425|20213652|P2|COMPLETED|Overall Study||22
8197765|NCT02232425|20213653|P1|COMPLETED|Overall Study||44
8197766|NCT02232425|20213652|P2|STARTED|Overall Study||30
8197767|NCT02232425|20213653|P1|STARTED|Overall Study||58
8197768|NCT02232243|20213686|P3|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8197769|NCT02232243|20213687|P2|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8197770|NCT02232243|20213688|P1|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8197771|NCT02232243|20213686|P3|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
8197772|NCT02232243|20213687|P2|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8197773|NCT02232243|20213688|P1|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8197774|NCT02232243|20213686|P3|STARTED|Third Dose(200mg HCQ Twice Daily)||3
8197775|NCT02232243|20213687|P2|STARTED|Third Dose(200mg HCQ Twice Daily)||0
8197776|NCT02232243|20213688|P1|STARTED|Third Dose(200mg HCQ Twice Daily)||0
8197777|NCT02232243|20213686|P3|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8197778|NCT02232243|20213687|P2|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
8197779|NCT02232243|20213688|P1|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8197780|NCT02232243|20213686|P3|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8197781|NCT02232243|20213687|P2|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
8197782|NCT02232243|20213688|P1|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8197783|NCT02232243|20213686|P3|STARTED|Second Dose (400mg HCQ Twice Daily)||0
8197784|NCT02232243|20213687|P2|STARTED|Second Dose (400mg HCQ Twice Daily)||4
8197785|NCT02232243|20213688|P1|STARTED|Second Dose (400mg HCQ Twice Daily)||0
8197786|NCT02232243|20213686|P3|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8197787|NCT02232243|20213687|P2|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8197788|NCT02232243|20213688|P1|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8197789|NCT02232243|20213686|P3|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8197790|NCT02232243|20213687|P2|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8197791|NCT02232243|20213688|P1|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
8197792|NCT02232243|20213686|P3|STARTED|First Dose (200mg HCQ Twice Daily)||0
8197793|NCT02232243|20213687|P2|STARTED|First Dose (200mg HCQ Twice Daily)||0
8197794|NCT02232243|20213688|P1|STARTED|First Dose (200mg HCQ Twice Daily)||3
8197795|NCT02232178|20213700|P3|NOT COMPLETED|Overall Study||1
8197796|NCT02232178|20213701|P2|NOT COMPLETED|Overall Study||1
8197797|NCT02232178|20213702|P1|NOT COMPLETED|Overall Study||1
8197798|NCT02232178|20213700|P3|COMPLETED|Overall Study||12
8197799|NCT02232178|20213701|P2|COMPLETED|Overall Study||24
8197800|NCT02232178|20213702|P1|COMPLETED|Overall Study||25
8197801|NCT02232178|20213700|P3|Safety Population|Overall Study||12
8197802|NCT02232178|20213701|P2|Safety Population|Overall Study||24
8197803|NCT02232178|20213702|P1|Safety Population|Overall Study||26
8197804|NCT02232178|20213700|P3|Per Protocol PK Population|Overall Study||11
8197805|NCT02232178|20213701|P2|Per Protocol PK Population|Overall Study||24
8197806|NCT02232178|20213702|P1|Per Protocol PK Population|Overall Study||26
8197807|NCT02232178|20213700|P3|STARTED|Overall Study||13
8197808|NCT02232178|20213701|P2|STARTED|Overall Study||25
8197809|NCT02232178|20213702|P1|STARTED|Overall Study||26
8197810|NCT02232126|20213721|P2|NOT COMPLETED|Overall Study||0
8197811|NCT02232126|20213722|P1|NOT COMPLETED|Overall Study||0
8197812|NCT02232126|20213721|P2|COMPLETED|Overall Study||90
8197813|NCT02232126|20213722|P1|COMPLETED|Overall Study||91
8197814|NCT02232126|20213721|P2|STARTED|Overall Study||90
8197815|NCT02232126|20213722|P1|STARTED|Overall Study||91
8197816|NCT02232087|20213730|P6|NOT COMPLETED|Overall Study||3
8197817|NCT02232087|20213731|P5|NOT COMPLETED|Overall Study||1
8197818|NCT02232087|20213732|P4|NOT COMPLETED|Overall Study||1
8197819|NCT02232087|20213733|P3|NOT COMPLETED|Overall Study||0
8197820|NCT02232087|20213734|P2|NOT COMPLETED|Overall Study||2
8197821|NCT02232087|20213735|P1|NOT COMPLETED|Overall Study||2
8197822|NCT02232087|20213730|P6|COMPLETED|Overall Study||6
8197823|NCT02232087|20213731|P5|COMPLETED|Overall Study||7
8197824|NCT02232087|20213732|P4|COMPLETED|Overall Study||7
8197825|NCT02232087|20213733|P3|COMPLETED|Overall Study||8
8197826|NCT02232087|20213734|P2|COMPLETED|Overall Study||8
8197827|NCT02232087|20213735|P1|COMPLETED|Overall Study||7
8197828|NCT02232087|20213730|P6|STARTED|Overall Study||9
8197829|NCT02232087|20213731|P5|STARTED|Overall Study||8
8197830|NCT02232087|20213732|P4|STARTED|Overall Study||8
8197831|NCT02232087|20213733|P3|STARTED|Overall Study||8
8197832|NCT02232087|20213734|P2|STARTED|Overall Study||10
8197833|NCT02232087|20213735|P1|STARTED|Overall Study||9
8197834|NCT02232074|20213771|P2|NOT COMPLETED|Overall Study||45
8197835|NCT02232074|20213772|P1|NOT COMPLETED|Overall Study||41
8197836|NCT02232074|20213771|P2|COMPLETED|Overall Study||107
8197837|NCT02232074|20213772|P1|COMPLETED|Overall Study||113
8197838|NCT02232074|20213771|P2|STARTED|Overall Study||152
8197839|NCT02232074|20213772|P1|STARTED|Overall Study||154
8197840|NCT02232022|20213818|P1|NOT COMPLETED|Overall Study||2
8197841|NCT02232022|20213818|P1|COMPLETED|Overall Study||51
8197842|NCT02232022|20213818|P1|STARTED|Overall Study||53
8197843|NCT02232009|20213827|P1|NOT COMPLETED|Overall Study||0
8197844|NCT02232009|20213827|P1|COMPLETED|Overall Study||9
8197845|NCT02232009|20213827|P1|STARTED|Overall Study||9
8197846|NCT02231918|20213839|P3|NOT COMPLETED|Overall Study||1
8197847|NCT02231918|20213840|P2|NOT COMPLETED|Overall Study||1
8197848|NCT02231918|20213841|P1|NOT COMPLETED|Overall Study||0
8197849|NCT02231918|20213839|P3|COMPLETED|Overall Study||1
8197850|NCT02231918|20213840|P2|COMPLETED|Overall Study||14
8197851|NCT02231918|20213841|P1|COMPLETED|Overall Study||9
8197852|NCT02231918|20213839|P3|STARTED|Overall Study||2
8197853|NCT02231918|20213840|P2|STARTED|Overall Study||15
8197854|NCT02231918|20213841|P1|STARTED|Overall Study||9
8197855|NCT02231892|20213906|P3|NOT COMPLETED|Overall Study||45
8197856|NCT02231892|20213907|P2|NOT COMPLETED|Overall Study||12
8197857|NCT02231892|20213908|P1|NOT COMPLETED|Overall Study||11
8197858|NCT02231892|20213906|P3|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
8197859|NCT02231892|20213907|P2|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
8197860|NCT02231892|20213908|P1|COMPLETED|Overall Study||6
8197861|NCT02231892|20213906|P3|110% MT|Overall Study||27
8197862|NCT02231892|20213907|P2|110% MT|Overall Study||5
8197863|NCT02231892|20213908|P1|110% MT|Overall Study||7
8197864|NCT02231892|20213906|P3|100% MT|Overall Study||25
8197865|NCT02231892|20213907|P2|100% MT|Overall Study||6
8197866|NCT02231892|20213908|P1|100% MT|Overall Study||7
8197867|NCT02231892|20213906|P3|Sham|Overall Study||26
8197868|NCT02231892|20213907|P2|Sham|Overall Study||5
8197869|NCT02231892|20213908|P1|Sham|Overall Study||8
8197870|NCT02231892|20213906|P3|STARTED|Overall Study||70
8197871|NCT02231892|20213907|P2|STARTED|Overall Study||17
8197872|NCT02231892|20213908|P1|STARTED|Overall Study||17
8197873|NCT02231762|20213925|P4|NOT COMPLETED|Maintenance Phase||5
8197874|NCT02231762|20213926|P3|NOT COMPLETED|Maintenance Phase||5
8197875|NCT02231762|20213927|P2|NOT COMPLETED|Maintenance Phase||3
8197876|NCT02231762|20213928|P1|NOT COMPLETED|Maintenance Phase||0
8197877|NCT02231762|20213925|P4|COMPLETED|Maintenance Phase||7
8197878|NCT02231762|20213926|P3|COMPLETED|Maintenance Phase||9
8197879|NCT02231762|20213927|P2|COMPLETED|Maintenance Phase||8
8197880|NCT02231762|20213928|P1|COMPLETED|Maintenance Phase||0
8197881|NCT02231762|20213925|P4|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
8197882|NCT02231762|20213926|P3|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
8197883|NCT02231762|20213927|P2|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
8197884|NCT02231762|20213928|P1|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
8197885|NCT02231762|20213925|P4|NOT COMPLETED|Combination Phase||0
8197886|NCT02231762|20213926|P3|NOT COMPLETED|Combination Phase||0
8197887|NCT02231762|20213927|P2|NOT COMPLETED|Combination Phase||0
8197888|NCT02231762|20213928|P1|NOT COMPLETED|Combination Phase||20
8197889|NCT02231762|20213925|P4|COMPLETED|Combination Phase||0
8197890|NCT02231762|20213926|P3|COMPLETED|Combination Phase||0
8197891|NCT02231762|20213927|P2|COMPLETED|Combination Phase||0
8197892|NCT02231762|20213928|P1|COMPLETED|Combination Phase||37
8197893|NCT02231762|20213925|P4|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
8197894|NCT02231762|20213926|P3|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
8197895|NCT02231762|20213927|P2|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
8197896|NCT02231762|20213928|P1|STARTED|Combination Phase||57
8197897|NCT02231749|20213961|P2|NOT COMPLETED|Overall Study||449
8197898|NCT02231749|20213962|P1|NOT COMPLETED|Overall Study||422
8197899|NCT02231749|20213961|P2|COMPLETED|Overall Study||97
8197900|NCT02231749|20213962|P1|COMPLETED|Overall Study||128
8197901|NCT02231749|20213961|P2|Received Treatment|Overall Study||535
8197902|NCT02231749|20213962|P1|Received Treatment|Overall Study||547
8197903|NCT02231749|20213961|P2|STARTED|Overall Study||546
8197904|NCT02231749|20213962|P1|STARTED|Overall Study||550
8197905|NCT02231580|20213980|P2|NOT COMPLETED|Overall Study||0
8197906|NCT02231580|20213981|P1|NOT COMPLETED|Overall Study||5
8197907|NCT02231580|20213980|P2|COMPLETED|Overall Study||3
8197908|NCT02231580|20213981|P1|COMPLETED|Overall Study||9
8197909|NCT02231580|20213980|P2|Cohort 2|Overall Study||1
8197910|NCT02231580|20213981|P1|Cohort 2|Overall Study||6
8197911|NCT02231580|20213980|P2|Cohort 1|Overall Study||2
8197912|NCT02231580|20213981|P1|Cohort 1|Overall Study||8
8197913|NCT02231580|20213980|P2|STARTED|Overall Study||3
8197914|NCT02231580|20213981|P1|STARTED|Overall Study||14
8197915|NCT02231177|20214037|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197916|NCT02231177|20214038|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197917|NCT02231177|20214039|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197918|NCT02231177|20214040|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197919|NCT02231177|20214041|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197920|NCT02231177|20214042|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197921|NCT02231177|20214037|P6|COMPLETED|Treatment Period 3 (21 Days)||9
8197922|NCT02231177|20214038|P5|COMPLETED|Treatment Period 3 (21 Days)||8
8197923|NCT02231177|20214039|P4|COMPLETED|Treatment Period 3 (21 Days)||7
8197924|NCT02231177|20214040|P3|COMPLETED|Treatment Period 3 (21 Days)||8
8197925|NCT02231177|20214041|P2|COMPLETED|Treatment Period 3 (21 Days)||7
8197926|NCT02231177|20214042|P1|COMPLETED|Treatment Period 3 (21 Days)||8
8197927|NCT02231177|20214037|P6|STARTED|Treatment Period 3 (21 Days)||9
8197928|NCT02231177|20214038|P5|STARTED|Treatment Period 3 (21 Days)||8
8197929|NCT02231177|20214039|P4|STARTED|Treatment Period 3 (21 Days)||7
8197930|NCT02231177|20214040|P3|STARTED|Treatment Period 3 (21 Days)||8
8197931|NCT02231177|20214041|P2|STARTED|Treatment Period 3 (21 Days)||7
8197932|NCT02231177|20214042|P1|STARTED|Treatment Period 3 (21 Days)||8
8197933|NCT02231177|20214037|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197934|NCT02231177|20214038|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197935|NCT02231177|20214039|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197936|NCT02231177|20214040|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197937|NCT02231177|20214041|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197938|NCT02231177|20214042|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197939|NCT02231177|20214037|P6|COMPLETED|Treatment Period 2 (21 Days)||9
8197940|NCT02231177|20214038|P5|COMPLETED|Treatment Period 2 (21 Days)||8
8197941|NCT02231177|20214039|P4|COMPLETED|Treatment Period 2 (21 Days)||7
8197942|NCT02231177|20214040|P3|COMPLETED|Treatment Period 2 (21 Days)||8
8197943|NCT02231177|20214041|P2|COMPLETED|Treatment Period 2 (21 Days)||7
8197944|NCT02231177|20214042|P1|COMPLETED|Treatment Period 2 (21 Days)||8
8197945|NCT02231177|20214037|P6|STARTED|Treatment Period 2 (21 Days)||9
8197946|NCT02231177|20214038|P5|STARTED|Treatment Period 2 (21 Days)||8
8197947|NCT02231177|20214039|P4|STARTED|Treatment Period 2 (21 Days)||7
8197948|NCT02231177|20214040|P3|STARTED|Treatment Period 2 (21 Days)||8
8197949|NCT02231177|20214041|P2|STARTED|Treatment Period 2 (21 Days)||7
8197950|NCT02231177|20214042|P1|STARTED|Treatment Period 2 (21 Days)||8
8197951|NCT02231177|20214037|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197952|NCT02231177|20214038|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197953|NCT02231177|20214039|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197954|NCT02231177|20214040|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197955|NCT02231177|20214041|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197956|NCT02231177|20214042|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197957|NCT02231177|20214037|P6|COMPLETED|Treatment Period 1 (21 Days)||9
8197958|NCT02231177|20214038|P5|COMPLETED|Treatment Period 1 (21 Days)||8
8197959|NCT02231177|20214039|P4|COMPLETED|Treatment Period 1 (21 Days)||7
8197960|NCT02231177|20214040|P3|COMPLETED|Treatment Period 1 (21 Days)||8
8197961|NCT02231177|20214041|P2|COMPLETED|Treatment Period 1 (21 Days)||7
8197962|NCT02231177|20214042|P1|COMPLETED|Treatment Period 1 (21 Days)||8
8197963|NCT02231177|20214037|P6|STARTED|Treatment Period 1 (21 Days)||9
8197964|NCT02231177|20214038|P5|STARTED|Treatment Period 1 (21 Days)||8
8197965|NCT02231177|20214039|P4|STARTED|Treatment Period 1 (21 Days)||7
8197966|NCT02231177|20214040|P3|STARTED|Treatment Period 1 (21 Days)||8
8197967|NCT02231177|20214041|P2|STARTED|Treatment Period 1 (21 Days)||7
8197968|NCT02231177|20214042|P1|STARTED|Treatment Period 1 (21 Days)||8
8197969|NCT02231164|20214098|P2|NOT COMPLETED|Overall Study||6
8197970|NCT02231164|20214099|P1|NOT COMPLETED|Overall Study||6
8197971|NCT02231164|20214098|P2|COMPLETED|Overall Study||0
8197972|NCT02231164|20214099|P1|COMPLETED|Overall Study||0
8197973|NCT02231164|20214098|P2|STARTED|Overall Study||6
8197974|NCT02231164|20214099|P1|STARTED|Overall Study||6
8197975|NCT02230995|20214107|P2|NOT COMPLETED|Period 2 + Washout||0
8197976|NCT02230995|20214108|P1|NOT COMPLETED|Period 2 + Washout||0
8197977|NCT02230995|20214107|P2|COMPLETED|Period 2 + Washout||15
8197978|NCT02230995|20214108|P1|COMPLETED|Period 2 + Washout||15
8197979|NCT02230995|20214107|P2|STARTED|Period 2 + Washout||15
8197980|NCT02230995|20214108|P1|STARTED|Period 2 + Washout||15
8197981|NCT02230995|20214107|P2|NOT COMPLETED|Period 1 + Washout||0
8197982|NCT02230995|20214108|P1|NOT COMPLETED|Period 1 + Washout||0
8197983|NCT02230995|20214107|P2|COMPLETED|Period 1 + Washout||15
8197984|NCT02230995|20214108|P1|COMPLETED|Period 1 + Washout||15
8197985|NCT02230995|20214107|P2|STARTED|Period 1 + Washout||15
8197986|NCT02230995|20214108|P1|STARTED|Period 1 + Washout||15
8197987|NCT02230956|20214127|P3|NOT COMPLETED|Overall Study||7
8197988|NCT02230956|20214128|P2|NOT COMPLETED|Overall Study||6
8197989|NCT02230956|20214129|P1|NOT COMPLETED|Overall Study||5
8197990|NCT02230956|20214127|P3|COMPLETED|Overall Study||82
8197991|NCT02230956|20214128|P2|COMPLETED|Overall Study||37
8197992|NCT02230956|20214129|P1|COMPLETED|Overall Study||39
8197993|NCT02230956|20214127|P3|STARTED|Overall Study||89
8197994|NCT02230956|20214128|P2|STARTED|Overall Study||43
8197995|NCT02230956|20214129|P1|STARTED|Overall Study||44
8197996|NCT02230904|20214151|P2|NOT COMPLETED|Overall Study||1
8197997|NCT02230904|20214152|P1|NOT COMPLETED|Overall Study||0
8197998|NCT02230904|20214151|P2|COMPLETED|Overall Study||27
8197999|NCT02230904|20214152|P1|COMPLETED|Overall Study||29
8198000|NCT02230904|20214151|P2|STARTED|Overall Study||28
8198001|NCT02230904|20214152|P1|STARTED|Overall Study||29
8198002|NCT02230761|20214174|P2|NOT COMPLETED|Overall Study||1
8198003|NCT02230761|20214175|P1|NOT COMPLETED|Overall Study||0
8198004|NCT02230761|20214174|P2|COMPLETED|Overall Study||29
8198005|NCT02230761|20214175|P1|COMPLETED|Overall Study||60
8198006|NCT02230761|20214174|P2|STARTED|Overall Study||30
8198007|NCT02230761|20214175|P1|STARTED|Overall Study||60
8198008|NCT02230683|20214185|P1|NOT COMPLETED|Overall Study||1
8198009|NCT02230683|20214185|P1|COMPLETED|Overall Study||22
8198010|NCT02230683|20214185|P1|STARTED|Overall Study||23
8198011|NCT02230670|20214202|P2|NOT COMPLETED|Overall Study||8
8198012|NCT02230670|20214203|P1|NOT COMPLETED|Overall Study||4
8198013|NCT02230670|20214202|P2|COMPLETED|Overall Study||34
8198014|NCT02230670|20214203|P1|COMPLETED|Overall Study||40
8198015|NCT02230670|20214202|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
8198016|NCT02230670|20214203|P1|STARTED|Overall Study||44
8198017|NCT02230579|20214220|P7|NOT COMPLETED|Overall Study||0
8198018|NCT02230579|20214221|P6|NOT COMPLETED|Overall Study||0
8198019|NCT02230579|20214222|P5|NOT COMPLETED|Overall Study||0
8198020|NCT02230579|20214223|P4|NOT COMPLETED|Overall Study||0
8198021|NCT02230579|20214224|P3|NOT COMPLETED|Overall Study||0
8198022|NCT02230579|20214225|P2|NOT COMPLETED|Overall Study||0
8198023|NCT02230579|20214226|P1|NOT COMPLETED|Overall Study||0
8198024|NCT02230579|20214220|P7|COMPLETED|Overall Study||12
8198025|NCT02230579|20214221|P6|COMPLETED|Overall Study||6
8198026|NCT02230579|20214222|P5|COMPLETED|Overall Study||6
8198027|NCT02230579|20214223|P4|COMPLETED|Overall Study||6
8198028|NCT02230579|20214224|P3|COMPLETED|Overall Study||6
8198029|NCT02230579|20214225|P2|COMPLETED|Overall Study||6
8198030|NCT02230579|20214226|P1|COMPLETED|Overall Study||6
8198031|NCT02230579|20214220|P7|STARTED|Overall Study||12
8198032|NCT02230579|20214221|P6|STARTED|Overall Study||6
8198033|NCT02230579|20214222|P5|STARTED|Overall Study||6
8198034|NCT02230579|20214223|P4|STARTED|Overall Study||6
8198035|NCT02230579|20214224|P3|STARTED|Overall Study||6
8198036|NCT02230579|20214225|P2|STARTED|Overall Study||6
8198037|NCT02230579|20214226|P1|STARTED|Overall Study||6
8198038|NCT02230566|20214264|P4|NOT COMPLETED|Overall Study||0
8198039|NCT02230566|20214265|P3|NOT COMPLETED|Overall Study||0
8198040|NCT02230566|20214266|P2|NOT COMPLETED|Overall Study||0
8198041|NCT02230566|20214267|P1|NOT COMPLETED|Overall Study||0
8198042|NCT02230566|20214264|P4|COMPLETED|Overall Study||3
8198043|NCT02230566|20214265|P3|COMPLETED|Overall Study||3
8198044|NCT02230566|20214266|P2|COMPLETED|Overall Study||3
8198045|NCT02230566|20214267|P1|COMPLETED|Overall Study||3
8198046|NCT02230566|20214264|P4|STARTED|Overall Study||3
8198047|NCT02230566|20214265|P3|STARTED|Overall Study||3
8198048|NCT02230566|20214266|P2|STARTED|Overall Study||3
8198049|NCT02230566|20214267|P1|STARTED|Overall Study||3
8198050|NCT02230540|20214282|P2|NOT COMPLETED|Overall Study||0
8198051|NCT02230540|20214283|P1|NOT COMPLETED|Overall Study||0
8198052|NCT02230540|20214282|P2|COMPLETED|Overall Study||0
8198053|NCT02230540|20214283|P1|COMPLETED|Overall Study||8
8198054|NCT02230540|20214282|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
8198055|NCT02230540|20214283|P1|STARTED|Overall Study||8
8198056|NCT02230384|20214289|P2|NOT COMPLETED|Phase 2 Wash Out||0
8198057|NCT02230384|20214290|P1|NOT COMPLETED|Phase 2 Wash Out||0
8198058|NCT02230384|20214289|P2|COMPLETED|Phase 2 Wash Out||30
8198059|NCT02230384|20214290|P1|COMPLETED|Phase 2 Wash Out||26
8198060|NCT02230384|20214289|P2|STARTED|Phase 2 Wash Out||30
8198061|NCT02230384|20214290|P1|STARTED|Phase 2 Wash Out||26
8198062|NCT02230384|20214289|P2|NOT COMPLETED|Phase 2 - Switch||1
8198063|NCT02230384|20214290|P1|NOT COMPLETED|Phase 2 - Switch||3
8198064|NCT02230384|20214289|P2|COMPLETED|Phase 2 - Switch||30
8198065|NCT02230384|20214290|P1|COMPLETED|Phase 2 - Switch||26
8198066|NCT02230384|20214289|P2|STARTED|Phase 2 - Switch||31
8198067|NCT02230384|20214290|P1|STARTED|Phase 2 - Switch||29
8198068|NCT02230384|20214289|P2|NOT COMPLETED|Phase 1 Wash Out||0
8198069|NCT02230384|20214290|P1|NOT COMPLETED|Phase 1 Wash Out||0
8198070|NCT02230384|20214289|P2|COMPLETED|Phase 1 Wash Out||31
8198071|NCT02230384|20214290|P1|COMPLETED|Phase 1 Wash Out||29
8198072|NCT02230384|20214289|P2|STARTED|Phase 1 Wash Out||31
8198073|NCT02230384|20214290|P1|STARTED|Phase 1 Wash Out||29
8198074|NCT02230384|20214289|P2|NOT COMPLETED|Phase 1||1
8198075|NCT02230384|20214290|P1|NOT COMPLETED|Phase 1||1
8198076|NCT02230384|20214289|P2|COMPLETED|Phase 1||31
8198077|NCT02230384|20214290|P1|COMPLETED|Phase 1||29
8198078|NCT02230384|20214289|P2|STARTED|Phase 1||32
8198079|NCT02230384|20214290|P1|STARTED|Phase 1||30
8198080|NCT02230332|20214310|P2|NOT COMPLETED|Overall Study||1
8198081|NCT02230332|20214311|P1|NOT COMPLETED|Overall Study||4
8198082|NCT02230332|20214310|P2|COMPLETED|Overall Study||39
8198083|NCT02230332|20214311|P1|COMPLETED|Overall Study||34
8198084|NCT02230332|20214310|P2|STARTED|Overall Study||40
8198085|NCT02230332|20214311|P1|STARTED|Overall Study||38
8198086|NCT02230306|20214327|P1|NOT COMPLETED|Overall Study||1
8198087|NCT02230306|20214327|P1|COMPLETED|Overall Study||4
8198088|NCT02230306|20214327|P1|STARTED|Overall Study||5
8198089|NCT02230085|20214338|P1|NOT COMPLETED|Overall Study||4
8198090|NCT02230085|20214338|P1|COMPLETED|Overall Study||106
8198091|NCT02230085|20214338|P1|STARTED|Overall Study||110
8198092|NCT02229864|20214342|P1|NOT COMPLETED|Overall Study||3
8198093|NCT02229864|20214342|P1|COMPLETED|Overall Study||9
8198094|NCT02229864|20214342|P1|STARTED|Overall Study||12
8198095|NCT02229851|20214366|P7|NOT COMPLETED|Extension Phase (Open-label Phase)||3
8198096|NCT02229851|20214367|P6|NOT COMPLETED|Extension Phase (Open-label Phase)||5
8198097|NCT02229851|20214368|P5|NOT COMPLETED|Extension Phase (Open-label Phase)||5
8198098|NCT02229851|20214369|P4|NOT COMPLETED|Extension Phase (Open-label Phase)||2
8198099|NCT02229851|20214370|P3|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8198100|NCT02229851|20214371|P2|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8198101|NCT02229851|20214372|P1|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8198102|NCT02229851|20214366|P7|COMPLETED|Extension Phase (Open-label Phase)||48
8198103|NCT02229851|20214367|P6|COMPLETED|Extension Phase (Open-label Phase)||47
8198179|NCT02229513|20214824|P1|NOT COMPLETED|Overall Study||0
8198104|NCT02229851|20214368|P5|COMPLETED|Extension Phase (Open-label Phase)||109
8198105|NCT02229851|20214369|P4|COMPLETED|Extension Phase (Open-label Phase)||53
8198106|NCT02229851|20214370|P3|COMPLETED|Extension Phase (Open-label Phase)||0
8198107|NCT02229851|20214371|P2|COMPLETED|Extension Phase (Open-label Phase)||0
8198108|NCT02229851|20214372|P1|COMPLETED|Extension Phase (Open-label Phase)||0
8198109|NCT02229851|20214366|P7|STARTED|Extension Phase (Open-label Phase)||51
8198110|NCT02229851|20214367|P6|STARTED|Extension Phase (Open-label Phase)||52
8198111|NCT02229851|20214368|P5|STARTED|Extension Phase (Open-label Phase)||114
8198112|NCT02229851|20214369|P4|STARTED|Extension Phase (Open-label Phase)||55
8198113|NCT02229851|20214370|P3|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8198114|NCT02229851|20214371|P2|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8198115|NCT02229851|20214372|P1|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8198116|NCT02229851|20214366|P7|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198117|NCT02229851|20214367|P6|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198118|NCT02229851|20214368|P5|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198119|NCT02229851|20214369|P4|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198120|NCT02229851|20214370|P3|NOT COMPLETED|Main Phase (Double-blind Phase)||6
8198121|NCT02229851|20214371|P2|NOT COMPLETED|Main Phase (Double-blind Phase)||16
8198122|NCT02229851|20214372|P1|NOT COMPLETED|Main Phase (Double-blind Phase)||6
8198123|NCT02229851|20214366|P7|COMPLETED|Main Phase (Double-blind Phase)||0
8198124|NCT02229851|20214367|P6|COMPLETED|Main Phase (Double-blind Phase)||0
8198125|NCT02229851|20214368|P5|COMPLETED|Main Phase (Double-blind Phase)||0
8198126|NCT02229851|20214369|P4|COMPLETED|Main Phase (Double-blind Phase)||0
8198127|NCT02229851|20214370|P3|COMPLETED|Main Phase (Double-blind Phase)||114
8198128|NCT02229851|20214371|P2|COMPLETED|Main Phase (Double-blind Phase)||103
8198129|NCT02229851|20214372|P1|COMPLETED|Main Phase (Double-blind Phase)||55
8198130|NCT02229851|20214366|P7|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198131|NCT02229851|20214367|P6|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198132|NCT02229851|20214368|P5|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198133|NCT02229851|20214369|P4|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198134|NCT02229851|20214370|P3|Safety Analysis Set|Main Phase (Double-blind Phase)||120
8198135|NCT02229851|20214371|P2|Safety Analysis Set|Main Phase (Double-blind Phase)||119
8198136|NCT02229851|20214372|P1|Safety Analysis Set|Main Phase (Double-blind Phase)||61
8198137|NCT02229851|20214366|P7|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198138|NCT02229851|20214367|P6|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198139|NCT02229851|20214368|P5|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198140|NCT02229851|20214369|P4|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198141|NCT02229851|20214370|P3|Full Analysis Set|Main Phase (Double-blind Phase)||120
8198142|NCT02229851|20214371|P2|Full Analysis Set|Main Phase (Double-blind Phase)||119
8198143|NCT02229851|20214372|P1|Full Analysis Set|Main Phase (Double-blind Phase)||61
8198144|NCT02229851|20214366|P7|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198145|NCT02229851|20214367|P6|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198146|NCT02229851|20214368|P5|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198147|NCT02229851|20214369|P4|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198148|NCT02229851|20214370|P3|STARTED|Main Phase (Double-blind Phase)||120
8198149|NCT02229851|20214371|P2|STARTED|Main Phase (Double-blind Phase)||119
8198150|NCT02229851|20214372|P1|STARTED|Main Phase (Double-blind Phase)||61
8198151|NCT02229552|20214804|P1|NOT COMPLETED|2-Year Follow up||26
8198152|NCT02229552|20214804|P1|COMPLETED|2-Year Follow up||205
8198153|NCT02229552|20214804|P1|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
8198154|NCT02229552|20214804|P1|NOT COMPLETED|1-year Follow up||25
8198155|NCT02229552|20214804|P1|COMPLETED|1-year Follow up||206
8198156|NCT02229552|20214804|P1|STARTED|1-year Follow up||231
8198157|NCT02229552|20214804|P1|NOT COMPLETED|Baseline||6
8198158|NCT02229552|20214804|P1|COMPLETED|Baseline||231
8198159|NCT02229552|20214804|P1|STARTED|Baseline||237
8198160|NCT02229539|20214811|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
8198161|NCT02229539|20214812|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
8198162|NCT02229539|20214813|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
8198163|NCT02229539|20214811|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
8198164|NCT02229539|20214812|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
8198165|NCT02229539|20214813|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
8198166|NCT02229539|20214811|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
8198167|NCT02229539|20214812|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
8198168|NCT02229539|20214813|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
8198169|NCT02229539|20214811|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
8198170|NCT02229539|20214812|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
8198171|NCT02229539|20214813|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
8198172|NCT02229539|20214811|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
8198173|NCT02229539|20214812|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
8198174|NCT02229539|20214813|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
8198175|NCT02229539|20214811|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
8198176|NCT02229539|20214812|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
8198177|NCT02229539|20214813|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
8198178|NCT02229513|20214823|P2|NOT COMPLETED|Overall Study||0
8198180|NCT02229513|20214823|P2|COMPLETED|Overall Study||100
8198181|NCT02229513|20214824|P1|COMPLETED|Overall Study||100
8198182|NCT02229513|20214823|P2|STARTED|Overall Study||100
8198183|NCT02229513|20214824|P1|STARTED|Overall Study||100
8198184|NCT02229487|20214860|P2|NOT COMPLETED|Overall Study||0
8198185|NCT02229487|20214861|P1|NOT COMPLETED|Overall Study||0
8198186|NCT02229487|20214860|P2|COMPLETED|Overall Study||27
8198187|NCT02229487|20214861|P1|COMPLETED|Overall Study||24
8198188|NCT02229487|20214860|P2|STARTED|Overall Study||27
8198189|NCT02229487|20214861|P1|STARTED|Overall Study||24
8198190|NCT02229474|20214869|P2|NOT COMPLETED|Overall Study||3
8198191|NCT02229474|20214870|P1|NOT COMPLETED|Overall Study||0
8198192|NCT02229474|20214869|P2|COMPLETED|Overall Study||15
8198193|NCT02229474|20214870|P1|COMPLETED|Overall Study||16
8198194|NCT02229474|20214869|P2|STARTED|Overall Study||18
8198195|NCT02229474|20214870|P1|STARTED|Overall Study||16
8198196|NCT02229461|20214903|P6|NOT COMPLETED|Overall Study||0
8198197|NCT02229461|20214904|P5|NOT COMPLETED|Overall Study||0
8198198|NCT02229461|20214905|P4|NOT COMPLETED|Overall Study||0
8198199|NCT02229461|20214906|P3|NOT COMPLETED|Overall Study||0
8198200|NCT02229461|20214907|P2|NOT COMPLETED|Overall Study||0
8198201|NCT02229461|20214908|P1|NOT COMPLETED|Overall Study||0
8198202|NCT02229461|20214903|P6|COMPLETED|Overall Study||17
8198203|NCT02229461|20214904|P5|COMPLETED|Overall Study||17
8198204|NCT02229461|20214905|P4|COMPLETED|Overall Study||17
8198205|NCT02229461|20214906|P3|COMPLETED|Overall Study||17
8198206|NCT02229461|20214907|P2|COMPLETED|Overall Study||17
8198207|NCT02229461|20214908|P1|COMPLETED|Overall Study||17
8198208|NCT02229461|20214903|P6|STARTED|Overall Study|Randomized and received treatment|17
8198209|NCT02229461|20214904|P5|STARTED|Overall Study|Randomized and received treatment|17
8198210|NCT02229461|20214905|P4|STARTED|Overall Study|Randomized and received treatment|17
8198211|NCT02229461|20214906|P3|STARTED|Overall Study|Randomized and received treatment|17
8198212|NCT02229461|20214907|P2|STARTED|Overall Study|Randomized and received treatment|17
8198213|NCT02229461|20214908|P1|STARTED|Overall Study|Randomized and received treatment|17
8198214|NCT02229396|20214944|P3|NOT COMPLETED|Overall Study||95
8198215|NCT02229396|20214945|P2|NOT COMPLETED|Overall Study||77
8198216|NCT02229396|20214946|P1|NOT COMPLETED|Overall Study||78
8198217|NCT02229396|20214944|P3|COMPLETED|Overall Study||136
8198218|NCT02229396|20214945|P2|COMPLETED|Overall Study||154
8198219|NCT02229396|20214946|P1|COMPLETED|Overall Study||155
8198220|NCT02229396|20214944|P3|Completed 52-Week Study Period|Overall Study||177
8198221|NCT02229396|20214945|P2|Completed 52-Week Study Period|Overall Study||193
8198222|NCT02229396|20214946|P1|Completed 52-Week Study Period|Overall Study||194
8198223|NCT02229396|20214944|P3|Completed 28-Week Study Period|Overall Study||193
8198224|NCT02229396|20214945|P2|Completed 28-Week Study Period|Overall Study||202
8198225|NCT02229396|20214946|P1|Completed 28-Week Study Period|Overall Study||208
8198226|NCT02229396|20214944|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
8198227|NCT02229396|20214945|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
8198228|NCT02229396|20214946|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
8198229|NCT02229396|20214944|P3|Safety Analysis Set|Overall Study||230
8198230|NCT02229396|20214945|P2|Safety Analysis Set|Overall Study||231
8198231|NCT02229396|20214946|P1|Safety Analysis Set|Overall Study||233
8198232|NCT02229396|20214944|P3|Randomization Code Allocated|Overall Study||231
8198233|NCT02229396|20214945|P2|Randomization Code Allocated|Overall Study||231
8198234|NCT02229396|20214946|P1|Randomization Code Allocated|Overall Study||233
8198235|NCT02229396|20214944|P3|STARTED|Overall Study||231
8198236|NCT02229396|20214945|P2|STARTED|Overall Study||231
8198237|NCT02229396|20214946|P1|STARTED|Overall Study||233
8198238|NCT02229383|20214977|P2|NOT COMPLETED|Overall Study||22
8198239|NCT02229383|20214978|P1|NOT COMPLETED|Overall Study||20
8198240|NCT02229383|20214977|P2|COMPLETED|Overall Study||207
8198241|NCT02229383|20214978|P1|COMPLETED|Overall Study||212
8198242|NCT02229383|20214977|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||228
8198243|NCT02229383|20214978|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||230
8198244|NCT02229383|20214977|P2|Safety Analysis Set|Overall Study||229
8198245|NCT02229383|20214978|P1|Safety Analysis Set|Overall Study||231
8198246|NCT02229383|20214977|P2|Received Treatment|Overall Study||229
8198247|NCT02229383|20214978|P1|Received Treatment|Overall Study||231
8198248|NCT02229383|20214977|P2|STARTED|Overall Study||229
8198249|NCT02229383|20214978|P1|STARTED|Overall Study||232
8198250|NCT02229318|20214996|P1|NOT COMPLETED|Overall Study||0
8198251|NCT02229318|20214996|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
8198252|NCT02229318|20214996|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
8198253|NCT02229227|20215003|P2|NOT COMPLETED|Overall Study||62
8198254|NCT02229227|20215004|P1|NOT COMPLETED|Overall Study||51
8198255|NCT02229227|20215003|P2|COMPLETED|Overall Study||350
8198256|NCT02229227|20215004|P1|COMPLETED|Overall Study||351
8198257|NCT02229227|20215003|P2|STARTED|Overall Study||412
8198258|NCT02229227|20215004|P1|STARTED|Overall Study||402
8198259|NCT02229214|20215089|P2|NOT COMPLETED|Overall Study||0
8198260|NCT02229214|20215090|P1|NOT COMPLETED|Overall Study||6
8198261|NCT02229214|20215089|P2|COMPLETED|Overall Study||10
8198262|NCT02229214|20215090|P1|COMPLETED|Overall Study||35
8198263|NCT02229214|20215089|P2|STARTED|Overall Study||10
8198264|NCT02229214|20215090|P1|STARTED|Overall Study||41
8198265|NCT02228980|20215114|P4|NOT COMPLETED|Overall Study||3
8198266|NCT02228980|20215115|P3|NOT COMPLETED|Overall Study||2
8198267|NCT02228980|20215116|P2|NOT COMPLETED|Overall Study||3
8198268|NCT02228980|20215117|P1|NOT COMPLETED|Overall Study||24
8198269|NCT02228980|20215114|P4|COMPLETED|Overall Study||148
8198270|NCT02228980|20215115|P3|COMPLETED|Overall Study||149
8198271|NCT02228980|20215116|P2|COMPLETED|Overall Study||147
8198272|NCT02228980|20215117|P1|COMPLETED|Overall Study||126
8198273|NCT02228980|20215114|P4|STARTED|Overall Study||151
8198274|NCT02228980|20215115|P3|STARTED|Overall Study||151
8198275|NCT02228980|20215116|P2|STARTED|Overall Study||150
8198276|NCT02228980|20215117|P1|STARTED|Overall Study||150
8198277|NCT02228967|20215141|P2|NOT COMPLETED|Overall Study||160
8198278|NCT02228967|20215142|P1|NOT COMPLETED|Overall Study||159
8198279|NCT02228967|20215141|P2|COMPLETED|Overall Study||228
8198280|NCT02228967|20215142|P1|COMPLETED|Overall Study||244
8198281|NCT02228967|20215141|P2|STARTED|Overall Study||388
8198282|NCT02228967|20215142|P1|STARTED|Overall Study||403
8198283|NCT02228824|20215188|P2|NOT COMPLETED|Overall Study||22
8198284|NCT02228824|20215189|P1|NOT COMPLETED|Overall Study||29
8198285|NCT02228824|20215188|P2|COMPLETED|Overall Study||98
8198286|NCT02228824|20215189|P1|COMPLETED|Overall Study||89
8198287|NCT02228824|20215188|P2|STARTED|Overall Study||120
8198288|NCT02228824|20215189|P1|STARTED|Overall Study||118
8198289|NCT02228720|20215203|P1|NOT COMPLETED|Open Label - Day 90||0
8198290|NCT02228720|20215203|P1|COMPLETED|Open Label - Day 90||14
8198291|NCT02228720|20215203|P1|STARTED|Open Label - Day 90||14
8198292|NCT02228720|20215203|P1|NOT COMPLETED|Open Label - Day 30||1
8198293|NCT02228720|20215203|P1|COMPLETED|Open Label - Day 30||14
8198294|NCT02228720|20215203|P1|STARTED|Open Label - Day 30||15
8198295|NCT02228720|20215203|P1|NOT COMPLETED|Open Label - Baseline||0
8198296|NCT02228720|20215203|P1|COMPLETED|Open Label - Baseline||15
8198297|NCT02228720|20215203|P1|STARTED|Open Label - Baseline||15
8198298|NCT02228681|20215213|P2|NOT COMPLETED|Overall Study||0
8198299|NCT02228681|20215214|P1|NOT COMPLETED|Overall Study||0
8198300|NCT02228681|20215213|P2|COMPLETED|Overall Study||37
8198301|NCT02228681|20215214|P1|COMPLETED|Overall Study||37
8198302|NCT02228681|20215213|P2|STARTED|Overall Study||37
8198303|NCT02228681|20215214|P1|STARTED|Overall Study||37
8198304|NCT02228590|20215226|P1|NOT COMPLETED|Overall Study||1
8198305|NCT02228590|20215226|P1|COMPLETED|Overall Study||19
8198306|NCT02228590|20215226|P1|STARTED|Overall Study||20
8198307|NCT02228564|20215239|P1|NOT COMPLETED|Overall Study||49
8198308|NCT02228564|20215239|P1|COMPLETED|Overall Study||106
8198309|NCT02228564|20215239|P1|STARTED|Overall Study||155
8198310|NCT02228499|20215256|P2|NOT COMPLETED|Overall Study||26
8198311|NCT02228499|20215257|P1|NOT COMPLETED|Overall Study||23
8198312|NCT02228499|20215256|P2|COMPLETED|Overall Study||10
8198313|NCT02228499|20215257|P1|COMPLETED|Overall Study||7
8198314|NCT02228499|20215256|P2|STARTED|Overall Study||36
8198315|NCT02228499|20215257|P1|STARTED|Overall Study||30
8198316|NCT02228460|20215263|P1|NOT COMPLETED|Overall Study||2
8198317|NCT02228460|20215263|P1|COMPLETED|Overall Study||9
8198318|NCT02228460|20215263|P1|STARTED|Overall Study||11
8198319|NCT02228395|20215286|P3|NOT COMPLETED|Third Intervention Period||0
8198320|NCT02228395|20215287|P2|NOT COMPLETED|Third Intervention Period||0
8198321|NCT02228395|20215288|P1|NOT COMPLETED|Third Intervention Period||0
8198322|NCT02228395|20215286|P3|COMPLETED|Third Intervention Period||3
8198323|NCT02228395|20215287|P2|COMPLETED|Third Intervention Period||3
8198324|NCT02228395|20215288|P1|COMPLETED|Third Intervention Period||3
8198325|NCT02228395|20215286|P3|STARTED|Third Intervention Period||3
8198326|NCT02228395|20215287|P2|STARTED|Third Intervention Period||3
8198327|NCT02228395|20215288|P1|STARTED|Third Intervention Period||3
8198328|NCT02228395|20215286|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198329|NCT02228395|20215287|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198330|NCT02228395|20215288|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198331|NCT02228395|20215286|P3|COMPLETED|Washout Period (at Least 10 Days)||3
8198332|NCT02228395|20215287|P2|COMPLETED|Washout Period (at Least 10 Days)||3
8198333|NCT02228395|20215288|P1|COMPLETED|Washout Period (at Least 10 Days)||3
8198334|NCT02228395|20215286|P3|STARTED|Washout Period (at Least 10 Days)||3
8198335|NCT02228395|20215287|P2|STARTED|Washout Period (at Least 10 Days)||3
8198336|NCT02228395|20215288|P1|STARTED|Washout Period (at Least 10 Days)||3
8198337|NCT02228395|20215286|P3|NOT COMPLETED|Second Intervention Period||0
8198338|NCT02228395|20215287|P2|NOT COMPLETED|Second Intervention Period||0
8198339|NCT02228395|20215288|P1|NOT COMPLETED|Second Intervention Period||0
8198340|NCT02228395|20215286|P3|COMPLETED|Second Intervention Period||3
8198341|NCT02228395|20215287|P2|COMPLETED|Second Intervention Period||3
8198342|NCT02228395|20215288|P1|COMPLETED|Second Intervention Period||3
8198343|NCT02228395|20215286|P3|STARTED|Second Intervention Period||3
8198344|NCT02228395|20215287|P2|STARTED|Second Intervention Period||3
8198345|NCT02228395|20215288|P1|STARTED|Second Intervention Period||3
8198346|NCT02228395|20215286|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198347|NCT02228395|20215287|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198348|NCT02228395|20215288|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198349|NCT02228395|20215286|P3|COMPLETED|Washout Period (at Least 10 Days)||3
8198350|NCT02228395|20215287|P2|COMPLETED|Washout Period (at Least 10 Days)||3
8198351|NCT02228395|20215288|P1|COMPLETED|Washout Period (at Least 10 Days)||3
8198352|NCT02228395|20215286|P3|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8198353|NCT02228395|20215287|P2|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8198354|NCT02228395|20215288|P1|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8198355|NCT02228395|20215286|P3|NOT COMPLETED|First Intervention Period||1
8198356|NCT02228395|20215287|P2|NOT COMPLETED|First Intervention Period||1
8198357|NCT02228395|20215288|P1|NOT COMPLETED|First Intervention Period||1
8198358|NCT02228395|20215286|P3|COMPLETED|First Intervention Period||2
8198359|NCT02228395|20215287|P2|COMPLETED|First Intervention Period||2
8198360|NCT02228395|20215288|P1|COMPLETED|First Intervention Period||2
8198361|NCT02228395|20215286|P3|STARTED|First Intervention Period||3
8198362|NCT02228395|20215287|P2|STARTED|First Intervention Period||3
8198363|NCT02228395|20215288|P1|STARTED|First Intervention Period||3
8198364|NCT02228174|20215352|P1|NOT COMPLETED|Overall Study||5
8198365|NCT02228174|20215352|P1|COMPLETED|Overall Study||142
8198366|NCT02228174|20215352|P1|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
8198367|NCT02228174|20215352|P1|STARTED|Overall Study||147
8198368|NCT02228096|20215374|P1|NOT COMPLETED|Overall Study||71
8198369|NCT02228096|20215374|P1|COMPLETED|Overall Study|Completed = study follow-up completed|4
8198370|NCT02228096|20215374|P1|Enrolled and Infused|Overall Study||64
8198371|NCT02228096|20215374|P1|Enrolled But Not Infused|Overall Study||11
8198372|NCT02228096|20215374|P1|Enrolled Into Long-term f/u Protocol|Overall Study||31
8198373|NCT02228096|20215374|P1|STARTED|Overall Study||75
8198374|NCT02227875|20215476|P2|NOT COMPLETED|Overall Study||33
8198375|NCT02227875|20215477|P1|NOT COMPLETED|Overall Study||37
8198376|NCT02227875|20215476|P2|COMPLETED|Overall Study||250
8198377|NCT02227875|20215477|P1|COMPLETED|Overall Study||240
8198378|NCT02227875|20215476|P2|STARTED|Overall Study||283
8198379|NCT02227875|20215477|P1|STARTED|Overall Study||277
8198380|NCT02227862|20215497|P2|NOT COMPLETED|Overall Study||22
8198381|NCT02227862|20215498|P1|NOT COMPLETED|Overall Study||19
8198382|NCT02227862|20215497|P2|COMPLETED|Overall Study||256
8198383|NCT02227862|20215498|P1|COMPLETED|Overall Study||261
8198384|NCT02227862|20215497|P2|Week 24|Overall Study||263
8198385|NCT02227862|20215498|P1|Week 24|Overall Study||269
8198386|NCT02227862|20215497|P2|STARTED|Overall Study||278
8198387|NCT02227862|20215498|P1|STARTED|Overall Study||280
8198388|NCT02227849|20215528|P1|NOT COMPLETED|Overall Study||8
8198389|NCT02227849|20215528|P1|COMPLETED|Overall Study||63
8198390|NCT02227849|20215528|P1|STARTED|Overall Study||71
8198391|NCT02227836|20215536|P1|NOT COMPLETED|Overall Study||0
8198392|NCT02227836|20215536|P1|COMPLETED|Overall Study||8
8198393|NCT02227836|20215536|P1|STARTED|Overall Study||8
8198394|NCT02227810|20215542|P2|NOT COMPLETED|Overall Study||5
8198395|NCT02227810|20215543|P1|NOT COMPLETED|Overall Study||2
8198396|NCT02227810|20215542|P2|COMPLETED|Overall Study||29
8198397|NCT02227810|20215543|P1|COMPLETED|Overall Study||17
8198398|NCT02227810|20215542|P2|STARTED|Overall Study||34
8198399|NCT02227810|20215543|P1|STARTED|Overall Study||19
8198400|NCT02227784|20215559|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
8198401|NCT02227784|20215560|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198402|NCT02227784|20215561|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198403|NCT02227784|20215562|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198404|NCT02227784|20215563|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198405|NCT02227784|20215559|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
8198406|NCT02227784|20215560|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
8198407|NCT02227784|20215561|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
8198408|NCT02227784|20215562|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
8198409|NCT02227784|20215563|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
8198410|NCT02227784|20215559|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
8198411|NCT02227784|20215560|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198412|NCT02227784|20215561|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198413|NCT02227784|20215562|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198414|NCT02227784|20215563|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198415|NCT02227784|20215559|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
8198416|NCT02227784|20215560|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198417|NCT02227784|20215561|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198418|NCT02227784|20215562|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198419|NCT02227784|20215563|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198420|NCT02227784|20215559|P5|NOT COMPLETED|Double-Blind Phase||0
8198421|NCT02227784|20215560|P4|NOT COMPLETED|Double-Blind Phase||39
8198422|NCT02227784|20215561|P3|NOT COMPLETED|Double-Blind Phase||21
8198423|NCT02227784|20215562|P2|NOT COMPLETED|Double-Blind Phase||18
8198424|NCT02227784|20215563|P1|NOT COMPLETED|Double-Blind Phase||40
8198425|NCT02227784|20215559|P5|COMPLETED|Double-Blind Phase||0
8198426|NCT02227784|20215560|P4|COMPLETED|Double-Blind Phase||88
8198427|NCT02227784|20215561|P3|COMPLETED|Double-Blind Phase||41
8198428|NCT02227784|20215562|P2|COMPLETED|Double-Blind Phase||36
8198429|NCT02227784|20215563|P1|COMPLETED|Double-Blind Phase||83
8198430|NCT02227784|20215559|P5|STARTED|Double-Blind Phase||0
8198431|NCT02227784|20215560|P4|STARTED|Double-Blind Phase||127
8198432|NCT02227784|20215561|P3|STARTED|Double-Blind Phase||62
8198433|NCT02227784|20215562|P2|STARTED|Double-Blind Phase||54
8198434|NCT02227784|20215563|P1|STARTED|Double-Blind Phase||123
8198435|NCT02227758|20215598|P1|NOT COMPLETED|Overall Study||67
8198436|NCT02227758|20215598|P1|COMPLETED|Overall Study||45
8198437|NCT02227758|20215598|P1|STARTED|Overall Study||112
8198438|NCT02227706|20215612|P2|NOT COMPLETED|Overall Study||0
8198439|NCT02227706|20215613|P1|NOT COMPLETED|Overall Study||0
8198440|NCT02227706|20215612|P2|COMPLETED|Overall Study||20
8198441|NCT02227706|20215613|P1|COMPLETED|Overall Study||20
8198442|NCT02227706|20215612|P2|STARTED|Overall Study||20
8198443|NCT02227706|20215613|P1|STARTED|Overall Study||20
8198444|NCT02227693|20215659|P4|NOT COMPLETED|Overall Study||0
8198445|NCT02227693|20215660|P3|NOT COMPLETED|Overall Study||0
8198446|NCT02227693|20215661|P2|NOT COMPLETED|Overall Study||0
8198447|NCT02227693|20215662|P1|NOT COMPLETED|Overall Study||0
8198448|NCT02227693|20215659|P4|COMPLETED|Overall Study||10
8198449|NCT02227693|20215660|P3|COMPLETED|Overall Study||11
8198450|NCT02227693|20215661|P2|COMPLETED|Overall Study||7
8198451|NCT02227693|20215662|P1|COMPLETED|Overall Study||11
8198452|NCT02227693|20215659|P4|STARTED|Overall Study||10
8198453|NCT02227693|20215660|P3|STARTED|Overall Study||11
8198454|NCT02227693|20215661|P2|STARTED|Overall Study||7
8198455|NCT02227693|20215662|P1|STARTED|Overall Study||11
8198456|NCT02227485|20215718|P2|NOT COMPLETED|Second Follow-up||2
8198457|NCT02227485|20215719|P1|NOT COMPLETED|Second Follow-up||2
8198458|NCT02227485|20215718|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
8198459|NCT02227485|20215719|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
8198460|NCT02227485|20215718|P2|STARTED|Second Follow-up||38
8198461|NCT02227485|20215719|P1|STARTED|Second Follow-up||36
8198462|NCT02227485|20215718|P2|NOT COMPLETED|First Follow-up||2
8198463|NCT02227485|20215719|P1|NOT COMPLETED|First Follow-up||4
8198464|NCT02227485|20215718|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
8198465|NCT02227485|20215719|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
8198466|NCT02227485|20215718|P2|STARTED|First Follow-up||40
8198467|NCT02227485|20215719|P1|STARTED|First Follow-up||40
8198468|NCT02227368|20215737|P2|NOT COMPLETED|Overall Study||4
8198469|NCT02227368|20215738|P1|NOT COMPLETED|Overall Study||2
8198470|NCT02227368|20215737|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
8198471|NCT02227368|20215738|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
8198472|NCT02227368|20215737|P2|Sujects Who Completed Treatment|Overall Study||17
8198473|NCT02227368|20215738|P1|Sujects Who Completed Treatment|Overall Study||10
8198474|NCT02227368|20215737|P2|Sujects Who Received Treatment|Overall Study||24
8198475|NCT02227368|20215738|P1|Sujects Who Received Treatment|Overall Study||16
8198476|NCT02227368|20215737|P2|STARTED|Overall Study||24
8198477|NCT02227368|20215738|P1|STARTED|Overall Study||16
8198478|NCT02227329|20215748|P2|NOT COMPLETED|Overall Study||0
8198479|NCT02227329|20215749|P1|NOT COMPLETED|Overall Study||0
8198480|NCT02227329|20215748|P2|COMPLETED|Overall Study||20
8198481|NCT02227329|20215749|P1|COMPLETED|Overall Study||18
8198482|NCT02227329|20215748|P2|STARTED|Overall Study||20
8198483|NCT02227329|20215749|P1|STARTED|Overall Study||18
8198484|NCT02227316|20215759|P4|NOT COMPLETED|Overall Study||0
8198485|NCT02227316|20215760|P3|NOT COMPLETED|Overall Study||0
8198486|NCT02227316|20215761|P2|NOT COMPLETED|Overall Study||0
8198487|NCT02227316|20215762|P1|NOT COMPLETED|Overall Study||0
8198488|NCT02227316|20215759|P4|COMPLETED|Overall Study||16
8198489|NCT02227316|20215760|P3|COMPLETED|Overall Study||16
8198490|NCT02227316|20215761|P2|COMPLETED|Overall Study||4
8198491|NCT02227316|20215762|P1|COMPLETED|Overall Study||4
8198492|NCT02227316|20215759|P4|STARTED|Overall Study||16
8198493|NCT02227316|20215760|P3|STARTED|Overall Study||16
8198494|NCT02227316|20215761|P2|STARTED|Overall Study||4
8198495|NCT02227316|20215762|P1|STARTED|Overall Study||4
8198502|NCT02227147|20215861|P2|NOT COMPLETED|Follow-up Period||5
8198503|NCT02227147|20215862|P1|NOT COMPLETED|Follow-up Period||3
8198504|NCT02227147|20215861|P2|COMPLETED|Follow-up Period||16
8198505|NCT02227147|20215862|P1|COMPLETED|Follow-up Period||15
8198506|NCT02227147|20215861|P2|STARTED|Follow-up Period||21
8198507|NCT02227147|20215862|P1|STARTED|Follow-up Period||18
8198508|NCT02227147|20215861|P2|NOT COMPLETED|Controlled Treatment Period||3
8198509|NCT02227147|20215862|P1|NOT COMPLETED|Controlled Treatment Period||6
8198510|NCT02227147|20215861|P2|COMPLETED|Controlled Treatment Period||21
8198511|NCT02227147|20215862|P1|COMPLETED|Controlled Treatment Period||18
8198512|NCT02227147|20215861|P2|STARTED|Controlled Treatment Period||24
8198513|NCT02227147|20215862|P1|STARTED|Controlled Treatment Period||24
8198514|NCT02227121|20215885|P1|NOT COMPLETED|Overall Study||0
8198515|NCT02227121|20215885|P1|COMPLETED|Overall Study||16
8198516|NCT02227121|20215885|P1|STARTED|Overall Study||16
8198517|NCT02227108|20215889|P1|NOT COMPLETED|Overall Study||31
8198518|NCT02227108|20215889|P1|COMPLETED|Overall Study||1
8198519|NCT02227108|20215889|P1|Treated|Overall Study||30
8198520|NCT02227108|20215889|P1|STARTED|Overall Study||32
8198521|NCT02226965|20215916|P1|NOT COMPLETED|Overall Study||41
8198522|NCT02226965|20215916|P1|COMPLETED|Overall Study||4
8198523|NCT02226965|20215916|P1|STARTED|Overall Study||45
8198524|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
8198525|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
8198526|NCT02226653|20215928|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
8198527|NCT02226653|20215929|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
8198528|NCT02226653|20215928|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
8198529|NCT02226653|20215929|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
8198530|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
8198531|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
8198532|NCT02226653|20215928|P2|COMPLETED|Treatment Period 5 Fed State||23
8198533|NCT02226653|20215929|P1|COMPLETED|Treatment Period 5 Fed State||23
8198534|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
8198535|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
8198536|NCT02226653|20215928|P2|STARTED|Treatment Period 5 Fed State||24
8198537|NCT02226653|20215929|P1|STARTED|Treatment Period 5 Fed State||23
8198538|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
8198539|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
8198540|NCT02226653|20215928|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
8198541|NCT02226653|20215929|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
8198542|NCT02226653|20215928|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
8198543|NCT02226653|20215929|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
8198544|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
8198545|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
8198546|NCT02226653|20215928|P2|COMPLETED|Treatment Period 4 Fasted State||24
8198547|NCT02226653|20215929|P1|COMPLETED|Treatment Period 4 Fasted State||23
8198548|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
8198549|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
8198550|NCT02226653|20215928|P2|STARTED|Treatment Period 4 Fasted State||24
8198551|NCT02226653|20215929|P1|STARTED|Treatment Period 4 Fasted State||23
8198552|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
8198553|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
8198554|NCT02226653|20215928|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
8198555|NCT02226653|20215929|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
8198556|NCT02226653|20215928|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
8198557|NCT02226653|20215929|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
8198558|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
8198559|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
8198560|NCT02226653|20215928|P2|COMPLETED|Treatment Period 3 Fasted State||24
8198561|NCT02226653|20215929|P1|COMPLETED|Treatment Period 3 Fasted State||23
8198562|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
8198563|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
8198564|NCT02226653|20215928|P2|STARTED|Treatment Period 3 Fasted State||24
8198565|NCT02226653|20215929|P1|STARTED|Treatment Period 3 Fasted State||23
8198566|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
8198567|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
8198568|NCT02226653|20215928|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
8198569|NCT02226653|20215929|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
8198570|NCT02226653|20215928|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
8198571|NCT02226653|20215929|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
8198572|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
8198573|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
8198574|NCT02226653|20215928|P2|COMPLETED|Treatment Period 2 Fasted State||24
8198575|NCT02226653|20215929|P1|COMPLETED|Treatment Period 2 Fasted State||23
8198576|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
8198577|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
8198578|NCT02226653|20215928|P2|STARTED|Treatment Period 2 Fasted State||24
8198579|NCT02226653|20215929|P1|STARTED|Treatment Period 2 Fasted State||24
8198580|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
8198581|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
8198582|NCT02226653|20215928|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
8198583|NCT02226653|20215929|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
8198584|NCT02226653|20215928|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
8198585|NCT02226653|20215929|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
8198586|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
8198587|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
8198588|NCT02226653|20215928|P2|COMPLETED|Treatment Period 1 Fasted State||24
8198589|NCT02226653|20215929|P1|COMPLETED|Treatment Period 1 Fasted State||24
8198590|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
8198591|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
8198592|NCT02226653|20215928|P2|STARTED|Treatment Period 1 Fasted State||24
8198593|NCT02226653|20215929|P1|STARTED|Treatment Period 1 Fasted State||24
8198594|NCT02226562|20215953|P2|NOT COMPLETED|Overall Study||1
8198595|NCT02226562|20215954|P1|NOT COMPLETED|Overall Study||0
8198596|NCT02226562|20215953|P2|COMPLETED|Overall Study|Lost to follow up|95
8198597|NCT02226562|20215954|P1|COMPLETED|Overall Study||95
8198598|NCT02226562|20215953|P2|STARTED|Overall Study||96
8198599|NCT02226562|20215954|P1|STARTED|Overall Study||95
8198600|NCT02226549|20215972|P2|NOT COMPLETED|Overall Study||1
8198601|NCT02226549|20215973|P1|NOT COMPLETED|Overall Study||1
8198602|NCT02226549|20215972|P2|COMPLETED|Overall Study||23
8198603|NCT02226549|20215973|P1|COMPLETED|Overall Study||22
8198604|NCT02226549|20215972|P2|STARTED|Overall Study||24
8198605|NCT02226549|20215973|P1|STARTED|Overall Study||23
8198606|NCT02226198|20215983|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8198607|NCT02226198|20215984|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8198608|NCT02226198|20215985|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8198609|NCT02226198|20215983|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
8198610|NCT02226198|20215984|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
8198611|NCT02226198|20215985|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
8198612|NCT02226198|20215983|P3|STARTED|Maintenance Phase (12 Weeks)||0
8198613|NCT02226198|20215984|P2|STARTED|Maintenance Phase (12 Weeks)||0
8198614|NCT02226198|20215985|P1|STARTED|Maintenance Phase (12 Weeks)||13
8198615|NCT02226198|20215983|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198616|NCT02226198|20215984|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198617|NCT02226198|20215985|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198618|NCT02226198|20215983|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
8198619|NCT02226198|20215984|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
8198620|NCT02226198|20215985|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198621|NCT02226198|20215983|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
8198622|NCT02226198|20215984|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
8198623|NCT02226198|20215985|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
8198624|NCT02226198|20215983|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8198625|NCT02226198|20215984|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
8198626|NCT02226198|20215985|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8198627|NCT02226198|20215983|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
8198628|NCT02226198|20215984|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
8198629|NCT02226198|20215985|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8198630|NCT02226198|20215983|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
8198631|NCT02226198|20215984|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
8198632|NCT02226198|20215985|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
8198633|NCT02226198|20215983|P3|NOT COMPLETED|Lead-in Phase||0
8198634|NCT02226198|20215984|P2|NOT COMPLETED|Lead-in Phase||0
8198635|NCT02226198|20215985|P1|NOT COMPLETED|Lead-in Phase||1
8198636|NCT02226198|20215983|P3|COMPLETED|Lead-in Phase||0
8198637|NCT02226198|20215984|P2|COMPLETED|Lead-in Phase||0
8198638|NCT02226198|20215985|P1|COMPLETED|Lead-in Phase||10
8198639|NCT02226198|20215983|P3|STARTED|Lead-in Phase||0
8198640|NCT02226198|20215984|P2|STARTED|Lead-in Phase||0
8198641|NCT02226198|20215985|P1|STARTED|Lead-in Phase||11
8198642|NCT02226172|20216058|P1|NOT COMPLETED|Overall Study||17
8198643|NCT02226172|20216058|P1|COMPLETED|Overall Study||4
8198644|NCT02226172|20216058|P1|STARTED|Overall Study||21
8198651|NCT02226120|20216122|P1|NOT COMPLETED|Overall Study||320
8198652|NCT02226120|20216122|P1|COMPLETED|Overall Study||1660
8198653|NCT02226120|20216122|P1|STARTED|Overall Study||1980
8198654|NCT02226003|20216129|P3|NOT COMPLETED|Overall Study||6
8198655|NCT02226003|20216130|P2|NOT COMPLETED|Overall Study||1
8198656|NCT02226003|20216131|P1|NOT COMPLETED|Overall Study||2
8198657|NCT02226003|20216129|P3|COMPLETED|Overall Study||91
8198658|NCT02226003|20216130|P2|COMPLETED|Overall Study||95
8198659|NCT02226003|20216131|P1|COMPLETED|Overall Study||96
8198660|NCT02226003|20216129|P3|STARTED|Overall Study||97
8198661|NCT02226003|20216130|P2|STARTED|Overall Study||96
8198662|NCT02226003|20216131|P1|STARTED|Overall Study||98
8198666|NCT02225860|20216176|P2|NOT COMPLETED|Overall Study||0
8198667|NCT02225860|20216177|P1|NOT COMPLETED|Overall Study||1
8198668|NCT02225860|20216176|P2|COMPLETED|Overall Study||17
8198669|NCT02225860|20216177|P1|COMPLETED|Overall Study||16
8198670|NCT02225860|20216176|P2|STARTED|Overall Study||17
8198671|NCT02225860|20216177|P1|STARTED|Overall Study||17
8198672|NCT02225743|20216187|P1|NOT COMPLETED|Overall Study||18
8198673|NCT02225743|20216187|P1|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
8198674|NCT02225743|20216187|P1|STARTED|Overall Study||120
8198675|NCT02225587|20216193|P2|NOT COMPLETED|Overall Study||38
8198676|NCT02225587|20216194|P1|NOT COMPLETED|Overall Study||28
8198677|NCT02225587|20216193|P2|COMPLETED|Overall Study||162
8198678|NCT02225587|20216194|P1|COMPLETED|Overall Study||172
8198679|NCT02225587|20216193|P2|Vaccination 3|Overall Study||164
8198680|NCT02225587|20216194|P1|Vaccination 3|Overall Study||172
8198681|NCT02225587|20216193|P2|Vaccination 2|Overall Study||185
8198682|NCT02225587|20216194|P1|Vaccination 2|Overall Study||188
8198683|NCT02225587|20216193|P2|STARTED|Overall Study||200
8198684|NCT02225587|20216194|P1|STARTED|Overall Study||200
8198685|NCT02225353|20216223|P3|NOT COMPLETED|Overall Study||15
8198686|NCT02225353|20216224|P2|NOT COMPLETED|Overall Study||6
8198687|NCT02225353|20216225|P1|NOT COMPLETED|Overall Study||4
8198688|NCT02225353|20216223|P3|COMPLETED|Overall Study||75
8198689|NCT02225353|20216224|P2|COMPLETED|Overall Study||84
8198690|NCT02225353|20216225|P1|COMPLETED|Overall Study||87
8198691|NCT02225353|20216223|P3|STARTED|Overall Study||90
8198692|NCT02225353|20216224|P2|STARTED|Overall Study||90
8198693|NCT02225353|20216225|P1|STARTED|Overall Study||91
8198694|NCT02225132|20216248|P1|NOT COMPLETED|Overall Study||0
8198695|NCT02225132|20216248|P1|COMPLETED|Overall Study||10
8198696|NCT02225132|20216248|P1|STARTED|Overall Study||10
8198697|NCT02225106|20216253|P1|NOT COMPLETED|Overall Study||0
8198698|NCT02225106|20216253|P1|COMPLETED|Overall Study||11
8198699|NCT02225106|20216253|P1|STARTED|Overall Study||11
8198700|NCT02225080|20216257|P1|NOT COMPLETED|Overall Study||0
8198701|NCT02225080|20216257|P1|COMPLETED|Overall Study||100
8198702|NCT02225080|20216257|P1|STARTED|Overall Study||100
8198703|NCT02224846|20216266|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
8198704|NCT02224846|20216267|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
8198705|NCT02224846|20216266|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
8198706|NCT02224846|20216267|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
8198707|NCT02224846|20216266|P2|STARTED|Period 2 (Month 12 to Month 24)||357
8198708|NCT02224846|20216267|P1|STARTED|Period 2 (Month 12 to Month 24)||173
8198709|NCT02224846|20216266|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
8198710|NCT02224846|20216267|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
8198711|NCT02224846|20216266|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
8198712|NCT02224846|20216267|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
8198713|NCT02224846|20216266|P2|STARTED|Period 2 (Month 3 to Month 12)||388
8198714|NCT02224846|20216267|P1|STARTED|Period 2 (Month 3 to Month 12)||192
8198715|NCT02224846|20216266|P2|NOT COMPLETED|Period 1 (Month 3)||36
8198716|NCT02224846|20216267|P1|NOT COMPLETED|Period 1 (Month 3)||19
8198717|NCT02224846|20216266|P2|COMPLETED|Period 1 (Month 3)||388
8198718|NCT02224846|20216267|P1|COMPLETED|Period 1 (Month 3)||192
8198719|NCT02224846|20216266|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
8198720|NCT02224846|20216267|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
8198721|NCT02224846|20216266|P2|STARTED|Period 1 (Month 3)||424
8198722|NCT02224846|20216267|P1|STARTED|Period 1 (Month 3)||211
8198723|NCT02224820|20216287|P1|NOT COMPLETED|Overall Study||0
8198724|NCT02224820|20216287|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
8198725|NCT02224820|20216287|P1|STARTED|Overall Study||8
8198726|NCT02224755|20216297|P2|NOT COMPLETED|Two Year Follow up Post-implant||226
8198727|NCT02224755|20216298|P1|NOT COMPLETED|Two Year Follow up Post-implant||258
8198728|NCT02224755|20216297|P2|COMPLETED|Two Year Follow up Post-implant||289
8198729|NCT02224755|20216298|P1|COMPLETED|Two Year Follow up Post-implant||247
8198730|NCT02224755|20216297|P2|STARTED|Two Year Follow up Post-implant||515
8198731|NCT02224755|20216298|P1|STARTED|Two Year Follow up Post-implant||505
8198732|NCT02224755|20216297|P2|NOT COMPLETED|Randomization to Device Implant||1
8198733|NCT02224755|20216298|P1|NOT COMPLETED|Randomization to Device Implant||7
8198734|NCT02224755|20216297|P2|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
8198735|NCT02224755|20216298|P1|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
8198736|NCT02224755|20216297|P2|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
8198737|NCT02224755|20216298|P1|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
8198738|NCT02224729|20216322|P1|NOT COMPLETED|Overall Study||0
8198739|NCT02224729|20216322|P1|COMPLETED|Overall Study||24
8198740|NCT02224729|20216322|P1|STARTED|Overall Study||24
8198741|NCT02224703|20216333|P3|NOT COMPLETED|Overall Study||0
8198742|NCT02224703|20216334|P2|NOT COMPLETED|Overall Study||6
8198743|NCT02224703|20216335|P1|NOT COMPLETED|Overall Study||3
8198744|NCT02224703|20216333|P3|COMPLETED|Overall Study||65
8198745|NCT02224703|20216334|P2|COMPLETED|Overall Study||61
8198746|NCT02224703|20216335|P1|COMPLETED|Overall Study||64
8198747|NCT02224703|20216333|P3|Intent to Treat (ITT) Analysis Set|Overall Study||65
8198748|NCT02224703|20216334|P2|Intent to Treat (ITT) Analysis Set|Overall Study||67
8198749|NCT02224703|20216335|P1|Intent to Treat (ITT) Analysis Set|Overall Study||66
8198750|NCT02224703|20216333|P3|Safety Analysis Set|Overall Study||65
8198751|NCT02224703|20216334|P2|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
8198752|NCT02224703|20216335|P1|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
8198753|NCT02224703|20216333|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
8198754|NCT02224703|20216334|P2|Received at Least 1 Dose of Study Drug|Overall Study||67
8198755|NCT02224703|20216335|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
8198756|NCT02224703|20216333|P3|STARTED|Overall Study||65
8198757|NCT02224703|20216334|P2|STARTED|Overall Study||67
8198758|NCT02224703|20216335|P1|STARTED|Overall Study||67
8198759|NCT02224690|20216354|P2|NOT COMPLETED|Overall Study||1
8198760|NCT02224690|20216355|P1|NOT COMPLETED|Overall Study||14
8198761|NCT02224690|20216354|P2|COMPLETED|Overall Study||84
8198762|NCT02224690|20216355|P1|COMPLETED|Overall Study||72
8198763|NCT02224690|20216354|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
8198764|NCT02224690|20216355|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
8198765|NCT02224690|20216354|P2|Safety Analysis Set|Overall Study||85
8198766|NCT02224690|20216355|P1|Safety Analysis Set|Overall Study||86
8198767|NCT02224690|20216354|P2|STARTED|Overall Study||85
8198768|NCT02224690|20216355|P1|STARTED|Overall Study||86
8198769|NCT02224664|20216367|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
8198770|NCT02224664|20216368|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
8198771|NCT02224664|20216369|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
8198772|NCT02224664|20216370|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
8198773|NCT02224664|20216371|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
8198774|NCT02224664|20216367|P5|COMPLETED|Dose Escalation Period (21 Days)||8
8198775|NCT02224664|20216368|P4|COMPLETED|Dose Escalation Period (21 Days)||3
8198776|NCT02224664|20216369|P3|COMPLETED|Dose Escalation Period (21 Days)||9
8198777|NCT02224664|20216370|P2|COMPLETED|Dose Escalation Period (21 Days)||9
8198778|NCT02224664|20216371|P1|COMPLETED|Dose Escalation Period (21 Days)||0
8198779|NCT02224664|20216367|P5|STARTED|Dose Escalation Period (21 Days)||19
8198780|NCT02224664|20216368|P4|STARTED|Dose Escalation Period (21 Days)||6
8198781|NCT02224664|20216369|P3|STARTED|Dose Escalation Period (21 Days)||11
8198782|NCT02224664|20216370|P2|STARTED|Dose Escalation Period (21 Days)||9
8198783|NCT02224664|20216371|P1|STARTED|Dose Escalation Period (21 Days)||0
8198784|NCT02224664|20216367|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
8198785|NCT02224664|20216368|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
8198786|NCT02224664|20216369|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
8198787|NCT02224664|20216370|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
8198788|NCT02224664|20216371|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
8198789|NCT02224664|20216367|P5|COMPLETED|Lead-in Period (3 Days)||0
8198790|NCT02224664|20216368|P4|COMPLETED|Lead-in Period (3 Days)||0
8198791|NCT02224664|20216369|P3|COMPLETED|Lead-in Period (3 Days)||0
8198792|NCT02224664|20216370|P2|COMPLETED|Lead-in Period (3 Days)||0
8198793|NCT02224664|20216371|P1|COMPLETED|Lead-in Period (3 Days)||45
8198794|NCT02224664|20216367|P5|STARTED|Lead-in Period (3 Days)||0
8198795|NCT02224664|20216368|P4|STARTED|Lead-in Period (3 Days)||0
8198796|NCT02224664|20216369|P3|STARTED|Lead-in Period (3 Days)||0
8198797|NCT02224664|20216370|P2|STARTED|Lead-in Period (3 Days)||0
8198798|NCT02224664|20216371|P1|STARTED|Lead-in Period (3 Days)||50
8198799|NCT02224638|20216453|P2|NOT COMPLETED|Overall Study||1
8198800|NCT02224638|20216454|P1|NOT COMPLETED|Overall Study||1
8198801|NCT02224638|20216453|P2|COMPLETED|Overall Study||9
8198802|NCT02224638|20216454|P1|COMPLETED|Overall Study||10
8198803|NCT02224638|20216453|P2|STARTED|Overall Study||10
8198804|NCT02224638|20216454|P1|STARTED|Overall Study||11
8198805|NCT02224625|20216462|P1|NOT COMPLETED|Sensitization||55
8198806|NCT02224625|20216462|P1|COMPLETED|Sensitization||194
8198807|NCT02224625|20216462|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
8198808|NCT02224625|20216462|P1|NOT COMPLETED|Irritation||6
8198809|NCT02224625|20216462|P1|COMPLETED|Irritation||33
8198810|NCT02224625|20216462|P1|STARTED|Irritation||39
8198811|NCT02224612|20216474|P2|NOT COMPLETED|Overall Study||0
8198812|NCT02224612|20216475|P1|NOT COMPLETED|Overall Study||0
8198813|NCT02224612|20216474|P2|COMPLETED|Overall Study||48
8198814|NCT02224612|20216475|P1|COMPLETED|Overall Study||48
8198815|NCT02224612|20216474|P2|STARTED|Overall Study||48
8198816|NCT02224612|20216475|P1|STARTED|Overall Study||48
8198817|NCT02224599|20216483|P1|NOT COMPLETED|Overall Study||2
8198818|NCT02224599|20216483|P1|COMPLETED|Overall Study||1
8198819|NCT02224599|20216483|P1|STARTED|Overall Study||3
8198820|NCT02224560|20216492|P3|NOT COMPLETED|Overall Study||2
8198821|NCT02224560|20216493|P2|NOT COMPLETED|Overall Study||2
8198822|NCT02224560|20216494|P1|NOT COMPLETED|Overall Study||9
8198823|NCT02224560|20216492|P3|COMPLETED|Overall Study||74
8198824|NCT02224560|20216493|P2|COMPLETED|Overall Study||71
8198825|NCT02224560|20216494|P1|COMPLETED|Overall Study||67
8198826|NCT02224560|20216492|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
8198827|NCT02224560|20216493|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
8198828|NCT02224560|20216494|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
8198829|NCT02224560|20216492|P3|Safety Analysis Set|Overall Study||76
8198830|NCT02224560|20216493|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
8198831|NCT02224560|20216494|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
8198832|NCT02224560|20216492|P3|STARTED|Overall Study||76
8198833|NCT02224560|20216493|P2|STARTED|Overall Study||73
8198834|NCT02224560|20216494|P1|STARTED|Overall Study||76
8198835|NCT02224508|20216513|P2|NOT COMPLETED|Overall Study||0
8198836|NCT02224508|20216514|P1|NOT COMPLETED|Overall Study||0
8198837|NCT02224508|20216513|P2|COMPLETED|Overall Study||653
8198838|NCT02224508|20216514|P1|COMPLETED|Overall Study||935
8198839|NCT02224508|20216513|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
8198840|NCT02224508|20216514|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
8198841|NCT02224404|20216524|P1|NOT COMPLETED|Overall Study||0
8198842|NCT02224404|20216524|P1|COMPLETED|Overall Study||21
8198843|NCT02224404|20216524|P1|STARTED|Overall Study||21
8198844|NCT02224313|20216531|P2|NOT COMPLETED|Overall Study||1
8198845|NCT02224313|20216532|P1|NOT COMPLETED|Overall Study||3
8198846|NCT02224313|20216531|P2|COMPLETED|Overall Study||9
8198847|NCT02224313|20216532|P1|COMPLETED|Overall Study||7
8198848|NCT02224313|20216531|P2|STARTED|Overall Study||10
8198849|NCT02224313|20216532|P1|STARTED|Overall Study||10
8198850|NCT02224274|20216542|P2|NOT COMPLETED|Overall Study||0
8198851|NCT02224274|20216543|P1|NOT COMPLETED|Overall Study||1
8198852|NCT02224274|20216542|P2|COMPLETED|Overall Study||20
8198853|NCT02224274|20216543|P1|COMPLETED|Overall Study||16
8198854|NCT02224274|20216542|P2|STARTED|Overall Study||20
8198855|NCT02224274|20216543|P1|STARTED|Overall Study||17
8198856|NCT02224157|20216555|P2|NOT COMPLETED|Overall Study||111
8198857|NCT02224157|20216556|P1|NOT COMPLETED|Overall Study||110
8198858|NCT02224157|20216555|P2|COMPLETED|Overall Study||1983
8198859|NCT02224157|20216556|P1|COMPLETED|Overall Study||1985
8198860|NCT02224157|20216555|P2|Patients Who Completed Treatment|Overall Study||1903
8198861|NCT02224157|20216556|P1|Patients Who Completed Treatment|Overall Study||1924
8198862|NCT02224157|20216555|P2|STARTED|Overall Study||2094
8198863|NCT02224157|20216556|P1|STARTED|Overall Study||2095
8198864|NCT02224053|20216580|P1|NOT COMPLETED|AZD9291 Alone||0
8198865|NCT02224053|20216580|P1|COMPLETED|AZD9291 Alone||47
8198866|NCT02224053|20216580|P1|STARTED|AZD9291 Alone||47
8198867|NCT02224053|20216580|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
8198868|NCT02224053|20216580|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
8198869|NCT02224053|20216580|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
8198870|NCT02223871|20216612|P1|NOT COMPLETED|Overall Study||0
8198871|NCT02223871|20216612|P1|COMPLETED|Overall Study||8
8198872|NCT02223871|20216612|P1|STARTED|Overall Study||8
8198873|NCT02223858|20216626|P2|NOT COMPLETED|Overall Study||26
8198874|NCT02223858|20216627|P1|NOT COMPLETED|Overall Study||24
8198875|NCT02223858|20216626|P2|COMPLETED|Overall Study||154
8198876|NCT02223858|20216627|P1|COMPLETED|Overall Study||156
8198877|NCT02223858|20216626|P2|6-month Follow-up|Overall Study||154
8198878|NCT02223858|20216627|P1|6-month Follow-up|Overall Study||156
8198879|NCT02223858|20216626|P2|3-month Follow-up|Overall Study||154
8198880|NCT02223858|20216627|P1|3-month Follow-up|Overall Study||155
8198881|NCT02223858|20216626|P2|1-month Follow-up|Overall Study||150
8198882|NCT02223858|20216627|P1|1-month Follow-up|Overall Study||156
8198883|NCT02223858|20216626|P2|STARTED|Overall Study||180
8198884|NCT02223858|20216627|P1|STARTED|Overall Study||180
8198885|NCT02223793|20216640|P3|NOT COMPLETED|Overall Study||13
8198886|NCT02223793|20216641|P2|NOT COMPLETED|Overall Study||9
8198887|NCT02223793|20216642|P1|NOT COMPLETED|Overall Study||17
8198888|NCT02223793|20216640|P3|COMPLETED|Overall Study||185
8198889|NCT02223793|20216641|P2|COMPLETED|Overall Study||190
8198890|NCT02223793|20216642|P1|COMPLETED|Overall Study||168
8198891|NCT02223793|20216640|P3|STARTED|Overall Study||198
8198892|NCT02223793|20216641|P2|STARTED|Overall Study||199
8198893|NCT02223793|20216642|P1|STARTED|Overall Study||185
8198894|NCT02223754|20216655|P2|NOT COMPLETED|Period 2||3
8198895|NCT02223754|20216656|P1|NOT COMPLETED|Period 2||3
8198896|NCT02223754|20216655|P2|COMPLETED|Period 2||141
8198897|NCT02223754|20216656|P1|COMPLETED|Period 2||156
8198898|NCT02223754|20216655|P2|STARTED|Period 2||144
8198899|NCT02223754|20216656|P1|STARTED|Period 2||159
8198900|NCT02223754|20216655|P2|NOT COMPLETED|Period 1||15
8198901|NCT02223754|20216656|P1|NOT COMPLETED|Period 1||4
8198902|NCT02223754|20216655|P2|COMPLETED|Period 1||144
8198903|NCT02223754|20216656|P1|COMPLETED|Period 1||159
8198904|NCT02223754|20216655|P2|STARTED|Period 1||159
8198905|NCT02223754|20216656|P1|STARTED|Period 1||163
8198906|NCT02223715|20216676|P1|NOT COMPLETED|Overall Study||104
8198907|NCT02223715|20216676|P1|COMPLETED|Overall Study||496
8198908|NCT02223715|20216676|P1|STARTED|Overall Study||600
8198909|NCT02223702|20216685|P2|NOT COMPLETED|Overall Study||4
8198910|NCT02223702|20216686|P1|NOT COMPLETED|Overall Study||1
8198911|NCT02223702|20216685|P2|COMPLETED|Overall Study||15
8198912|NCT02223702|20216686|P1|COMPLETED|Overall Study||19
8198913|NCT02223702|20216685|P2|STARTED|Overall Study||19
8198914|NCT02223702|20216686|P1|STARTED|Overall Study||20
8198915|NCT02223689|20216694|P1|NOT COMPLETED|Overall Study||0
8198916|NCT02223689|20216694|P1|COMPLETED|Overall Study||35
8198917|NCT02223689|20216694|P1|STARTED|Overall Study||35
8198918|NCT02223650|20216701|P2|NOT COMPLETED|Overall Study||0
8198919|NCT02223650|20216702|P1|NOT COMPLETED|Overall Study||0
8198920|NCT02223650|20216701|P2|COMPLETED|Overall Study||31
8198921|NCT02223650|20216702|P1|COMPLETED|Overall Study||27
8198922|NCT02223650|20216701|P2|STARTED|Overall Study||31
8198923|NCT02223650|20216702|P1|STARTED|Overall Study||27
8198924|NCT02223637|20216732|P1|NOT COMPLETED|Overall Study||0
8198925|NCT02223637|20216732|P1|COMPLETED|Overall Study||82
8198926|NCT02223637|20216732|P1|STARTED|Overall Study||82
8198927|NCT02223546|20216755|P1|NOT COMPLETED|Overall Study||0
8198928|NCT02223546|20216755|P1|COMPLETED|Overall Study||15
8198929|NCT02223546|20216755|P1|STARTED|Overall Study||15
8198930|NCT02223520|20216762|P2|NOT COMPLETED|Overall Study||0
8198931|NCT02223520|20216763|P1|NOT COMPLETED|Overall Study||0
8198932|NCT02223520|20216762|P2|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
8198933|NCT02223520|20216763|P1|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
8198934|NCT02223520|20216762|P2|STARTED|Overall Study||160
8198935|NCT02223520|20216763|P1|STARTED|Overall Study||147
8198936|NCT02223455|20216772|P3|NOT COMPLETED|Overall Study||0
8198937|NCT02223455|20216773|P2|NOT COMPLETED|Overall Study||0
8198938|NCT02223455|20216774|P1|NOT COMPLETED|Overall Study||0
8198939|NCT02223455|20216772|P3|COMPLETED|Overall Study|Participant level data not collected.|0
8198940|NCT02223455|20216773|P2|COMPLETED|Overall Study|Participant level data not collected.|0
8198941|NCT02223455|20216774|P1|COMPLETED|Overall Study|Participant level data not collected.|0
8198942|NCT02223455|20216772|P3|STARTED|Overall Study|Participant level data not collected.|0
8198943|NCT02223455|20216773|P2|STARTED|Overall Study|Participant level data not collected.|0
8198944|NCT02223455|20216774|P1|STARTED|Overall Study|Participant level data not collected.|0
8198945|NCT02223429|20216786|P4|NOT COMPLETED|Overall Study||0
8198946|NCT02223429|20216787|P3|NOT COMPLETED|Overall Study||0
8198947|NCT02223429|20216788|P2|NOT COMPLETED|Overall Study||0
8198948|NCT02223429|20216789|P1|NOT COMPLETED|Overall Study||1
8198949|NCT02223429|20216786|P4|COMPLETED|Overall Study||8
8198950|NCT02223429|20216787|P3|COMPLETED|Overall Study||8
8198951|NCT02223429|20216788|P2|COMPLETED|Overall Study||8
8198952|NCT02223429|20216789|P1|COMPLETED|Overall Study||7
8198953|NCT02223429|20216786|P4|STARTED|Overall Study||8
8198954|NCT02223429|20216787|P3|STARTED|Overall Study||8
8198955|NCT02223429|20216788|P2|STARTED|Overall Study||8
8198956|NCT02223429|20216789|P1|STARTED|Overall Study||8
8198957|NCT02223390|20216819|P2|NOT COMPLETED|Overall Study||4
8198958|NCT02223390|20216820|P1|NOT COMPLETED|Overall Study||9
8198959|NCT02223390|20216819|P2|COMPLETED|Overall Study||28
8198960|NCT02223390|20216820|P1|COMPLETED|Overall Study||23
8198961|NCT02223390|20216819|P2|STARTED|Overall Study||32
8198962|NCT02223390|20216820|P1|STARTED|Overall Study||32
8198963|NCT02223364|20216831|P3|NOT COMPLETED|Overall Study||3
8198964|NCT02223364|20216832|P2|NOT COMPLETED|Overall Study||0
8198965|NCT02223364|20216833|P1|NOT COMPLETED|Overall Study||5
8198966|NCT02223364|20216831|P3|COMPLETED|Overall Study||52
8198967|NCT02223364|20216832|P2|COMPLETED|Overall Study||55
8198968|NCT02223364|20216833|P1|COMPLETED|Overall Study||50
8198969|NCT02223364|20216831|P3|STARTED|Overall Study||55
8198970|NCT02223364|20216832|P2|STARTED|Overall Study||55
8198971|NCT02223364|20216833|P1|STARTED|Overall Study||55
8198972|NCT02223351|20216885|P2|NOT COMPLETED|Overall Study||0
8198973|NCT02223351|20216886|P1|NOT COMPLETED|Overall Study||0
8198974|NCT02223351|20216885|P2|COMPLETED|Overall Study||24
8198975|NCT02223351|20216886|P1|COMPLETED|Overall Study||24
8198976|NCT02223351|20216885|P2|Second Intervention (8 Days)|Overall Study||24
8198977|NCT02223351|20216886|P1|Second Intervention (8 Days)|Overall Study||24
8198978|NCT02223351|20216885|P2|Wasout (2weeks)|Overall Study||24
8198979|NCT02223351|20216886|P1|Wasout (2weeks)|Overall Study||24
8198980|NCT02223351|20216885|P2|First Intervention (8 Days)|Overall Study||24
8198981|NCT02223351|20216886|P1|First Intervention (8 Days)|Overall Study||24
8198982|NCT02223351|20216885|P2|STARTED|Overall Study||24
8198983|NCT02223351|20216886|P1|STARTED|Overall Study||24
8198984|NCT02223338|20216946|P2|NOT COMPLETED|Overall Study||0
8198985|NCT02223338|20216947|P1|NOT COMPLETED|Overall Study||0
8198986|NCT02223338|20216946|P2|COMPLETED|Overall Study||60
8198987|NCT02223338|20216947|P1|COMPLETED|Overall Study||60
8198988|NCT02223338|20216946|P2|STARTED|Overall Study||60
8198989|NCT02223338|20216947|P1|STARTED|Overall Study||60
8198990|NCT02223260|20216955|P1|NOT COMPLETED|Overall Study||0
8198991|NCT02223260|20216955|P1|COMPLETED|Overall Study||8
8198992|NCT02223260|20216955|P1|STARTED|Overall Study||8
8198993|NCT02223065|20216973|P2|NOT COMPLETED|Overall Study||0
8198994|NCT02223065|20216974|P1|NOT COMPLETED|Overall Study||0
8198995|NCT02223065|20216973|P2|COMPLETED|Overall Study||18
8198996|NCT02223065|20216974|P1|COMPLETED|Overall Study||18
8198997|NCT02223065|20216973|P2|STARTED|Overall Study||18
8198998|NCT02223065|20216974|P1|STARTED|Overall Study||18
8198999|NCT02222922|20216999|P9|NOT COMPLETED|Overall Study||6
8199000|NCT02222922|20217000|P8|NOT COMPLETED|Overall Study||4
8199001|NCT02222922|20217001|P7|NOT COMPLETED|Overall Study||2
8199002|NCT02222922|20217002|P6|NOT COMPLETED|Overall Study||3
8199003|NCT02222922|20217003|P5|NOT COMPLETED|Overall Study||38
8199004|NCT02222922|20217004|P4|NOT COMPLETED|Overall Study||3
8199005|NCT02222922|20217005|P3|NOT COMPLETED|Overall Study||1
8199006|NCT02222922|20217006|P2|NOT COMPLETED|Overall Study||0
8199007|NCT02222922|20217007|P1|NOT COMPLETED|Overall Study||1
8199008|NCT02222922|20216999|P9|COMPLETED|Overall Study||6
8199009|NCT02222922|20217000|P8|COMPLETED|Overall Study||6
8199010|NCT02222922|20217001|P7|COMPLETED|Overall Study||1
8199011|NCT02222922|20217002|P6|COMPLETED|Overall Study||3
8199012|NCT02222922|20217003|P5|COMPLETED|Overall Study||58
8199013|NCT02222922|20217004|P4|COMPLETED|Overall Study||2
8199014|NCT02222922|20217005|P3|COMPLETED|Overall Study||1
8199015|NCT02222922|20217006|P2|COMPLETED|Overall Study||2
8199016|NCT02222922|20217007|P1|COMPLETED|Overall Study||1
8199017|NCT02222922|20216999|P9|Received Treatment|Overall Study||12
8199018|NCT02222922|20217000|P8|Received Treatment|Overall Study||10
8199019|NCT02222922|20217001|P7|Received Treatment|Overall Study||3
8199020|NCT02222922|20217002|P6|Received Treatment|Overall Study||6
8199021|NCT02222922|20217003|P5|Received Treatment|Overall Study||96
8199022|NCT02222922|20217004|P4|Received Treatment|Overall Study||4
8199023|NCT02222922|20217005|P3|Received Treatment|Overall Study||2
8199024|NCT02222922|20217006|P2|Received Treatment|Overall Study||2
8199025|NCT02222922|20217007|P1|Received Treatment|Overall Study||2
8199026|NCT02222922|20216999|P9|STARTED|Overall Study||12
8199027|NCT02222922|20217000|P8|STARTED|Overall Study||10
8199028|NCT02222922|20217001|P7|STARTED|Overall Study||3
8199029|NCT02222922|20217002|P6|STARTED|Overall Study||6
8199030|NCT02222922|20217003|P5|STARTED|Overall Study||96
8199031|NCT02222922|20217004|P4|STARTED|Overall Study||5
8199032|NCT02222922|20217005|P3|STARTED|Overall Study||2
8199033|NCT02222922|20217006|P2|STARTED|Overall Study||2
8199034|NCT02222922|20217007|P1|STARTED|Overall Study||2
8199035|NCT02222870|20217357|P2|NOT COMPLETED|Overall Study||0
8199036|NCT02222870|20217358|P1|NOT COMPLETED|Overall Study||0
8199037|NCT02222870|20217357|P2|COMPLETED|Overall Study||30
8199038|NCT02222870|20217358|P1|COMPLETED|Overall Study||30
8199039|NCT02222870|20217357|P2|STARTED|Overall Study||30
8199040|NCT02222870|20217358|P1|STARTED|Overall Study||30
8199041|NCT02222818|20217374|P2|NOT COMPLETED|Period 2||0
8199042|NCT02222818|20217375|P1|NOT COMPLETED|Period 2||0
8199043|NCT02222818|20217374|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
8199044|NCT02222818|20217375|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
8199045|NCT02222818|20217374|P2|STARTED|Period 2|Start of CAFR evaluation period|30
8199046|NCT02222818|20217375|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
8199047|NCT02222818|20217374|P2|NOT COMPLETED|Period 1||3
8199048|NCT02222818|20217375|P1|NOT COMPLETED|Period 1||0
8199049|NCT02222818|20217374|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
8199050|NCT02222818|20217375|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
8199051|NCT02222818|20217374|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
8199052|NCT02222818|20217375|P1|STARTED|Period 1|Start of CAFR evaluation period|33
8199053|NCT02222714|20217387|P5|NOT COMPLETED|Overall Study||7
8199054|NCT02222714|20217388|P4|NOT COMPLETED|Overall Study||4
8199055|NCT02222714|20217389|P3|NOT COMPLETED|Overall Study||4
8199056|NCT02222714|20217390|P2|NOT COMPLETED|Overall Study||2
8199057|NCT02222714|20217391|P1|NOT COMPLETED|Overall Study||0
8199058|NCT02222714|20217387|P5|COMPLETED|Overall Study||37
8199059|NCT02222714|20217388|P4|COMPLETED|Overall Study||11
8199060|NCT02222714|20217389|P3|COMPLETED|Overall Study||8
8199061|NCT02222714|20217390|P2|COMPLETED|Overall Study||22
8199062|NCT02222714|20217391|P1|COMPLETED|Overall Study||15
8199063|NCT02222714|20217387|P5|STARTED|Overall Study||44
8199064|NCT02222714|20217388|P4|STARTED|Overall Study||15
8199065|NCT02222714|20217389|P3|STARTED|Overall Study||12
8199066|NCT02222714|20217390|P2|STARTED|Overall Study||24
8199067|NCT02222714|20217391|P1|STARTED|Overall Study||15
8199068|NCT02222688|20217437|P7|NOT COMPLETED|Overall Study||1
8199069|NCT02222688|20217438|P6|NOT COMPLETED|Overall Study||0
8199070|NCT02222688|20217439|P5|NOT COMPLETED|Overall Study||1
8199071|NCT02222688|20217440|P4|NOT COMPLETED|Overall Study||2
8199072|NCT02222688|20217441|P3|NOT COMPLETED|Overall Study||0
8199073|NCT02222688|20217442|P2|NOT COMPLETED|Overall Study||0
8199074|NCT02222688|20217443|P1|NOT COMPLETED|Overall Study||1
8199075|NCT02222688|20217437|P7|COMPLETED|Overall Study||5
8199076|NCT02222688|20217438|P6|COMPLETED|Overall Study||3
8199077|NCT02222688|20217439|P5|COMPLETED|Overall Study||2
8199078|NCT02222688|20217440|P4|COMPLETED|Overall Study||3
8199079|NCT02222688|20217441|P3|COMPLETED|Overall Study||3
8199080|NCT02222688|20217442|P2|COMPLETED|Overall Study||3
8199081|NCT02222688|20217443|P1|COMPLETED|Overall Study||3
8199082|NCT02222688|20217437|P7|STARTED|Overall Study||6
8199083|NCT02222688|20217438|P6|STARTED|Overall Study||3
8199084|NCT02222688|20217439|P5|STARTED|Overall Study||3
8199085|NCT02222688|20217440|P4|STARTED|Overall Study||5
8199086|NCT02222688|20217441|P3|STARTED|Overall Study||3
8199087|NCT02222688|20217442|P2|STARTED|Overall Study||3
8199088|NCT02222688|20217443|P1|STARTED|Overall Study||4
8199089|NCT02222558|20217481|P6|NOT COMPLETED|Period 3||1
8199090|NCT02222558|20217482|P5|NOT COMPLETED|Period 3||0
8199091|NCT02222558|20217483|P4|NOT COMPLETED|Period 3||0
8199092|NCT02222558|20217484|P3|NOT COMPLETED|Period 3||0
8199093|NCT02222558|20217485|P2|NOT COMPLETED|Period 3||0
8199094|NCT02222558|20217486|P1|NOT COMPLETED|Period 3||0
8199095|NCT02222558|20217481|P6|COMPLETED|Period 3||7
8199096|NCT02222558|20217482|P5|COMPLETED|Period 3||8
8199097|NCT02222558|20217483|P4|COMPLETED|Period 3||1
8199098|NCT02222558|20217484|P3|COMPLETED|Period 3||4
8199099|NCT02222558|20217485|P2|COMPLETED|Period 3||0
8199100|NCT02222558|20217486|P1|COMPLETED|Period 3||0
8199101|NCT02222558|20217481|P6|STARTED|Period 3||8
8199102|NCT02222558|20217482|P5|STARTED|Period 3||8
8199103|NCT02222558|20217483|P4|STARTED|Period 3||1
8199104|NCT02222558|20217484|P3|STARTED|Period 3||4
8199105|NCT02222558|20217485|P2|STARTED|Period 3||0
8199106|NCT02222558|20217486|P1|STARTED|Period 3||0
8199107|NCT02222558|20217481|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199108|NCT02222558|20217482|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199109|NCT02222558|20217483|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199110|NCT02222558|20217484|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199111|NCT02222558|20217485|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199112|NCT02222558|20217486|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199113|NCT02222558|20217481|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199114|NCT02222558|20217482|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199115|NCT02222558|20217483|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199116|NCT02222558|20217484|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199117|NCT02222558|20217485|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
8199118|NCT02222558|20217486|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199119|NCT02222558|20217481|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199120|NCT02222558|20217482|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199121|NCT02222558|20217483|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199122|NCT02222558|20217484|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199123|NCT02222558|20217485|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
8199124|NCT02222558|20217486|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199125|NCT02222558|20217481|P6|NOT COMPLETED|Period 1: Single Dose||0
8199126|NCT02222558|20217482|P5|NOT COMPLETED|Period 1: Single Dose||0
8199127|NCT02222558|20217483|P4|NOT COMPLETED|Period 1: Single Dose||0
8199128|NCT02222558|20217484|P3|NOT COMPLETED|Period 1: Single Dose||0
8199129|NCT02222558|20217485|P2|NOT COMPLETED|Period 1: Single Dose||0
8199130|NCT02222558|20217486|P1|NOT COMPLETED|Period 1: Single Dose||4
8199131|NCT02222558|20217481|P6|COMPLETED|Period 1: Single Dose||0
8199132|NCT02222558|20217482|P5|COMPLETED|Period 1: Single Dose||0
8199133|NCT02222558|20217483|P4|COMPLETED|Period 1: Single Dose||0
8199134|NCT02222558|20217484|P3|COMPLETED|Period 1: Single Dose||0
8199135|NCT02222558|20217485|P2|COMPLETED|Period 1: Single Dose||0
8199136|NCT02222558|20217486|P1|COMPLETED|Period 1: Single Dose||21
8199137|NCT02222558|20217481|P6|STARTED|Period 1: Single Dose||0
8199138|NCT02222558|20217482|P5|STARTED|Period 1: Single Dose||0
8199139|NCT02222558|20217483|P4|STARTED|Period 1: Single Dose||0
8199140|NCT02222558|20217484|P3|STARTED|Period 1: Single Dose||0
8199141|NCT02222558|20217485|P2|STARTED|Period 1: Single Dose||0
8199142|NCT02222558|20217486|P1|STARTED|Period 1: Single Dose||25
8199143|NCT02222493|20217502|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
8199144|NCT02222493|20217503|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
8199145|NCT02222493|20217502|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
8199146|NCT02222493|20217503|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
8199147|NCT02222493|20217502|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
8199148|NCT02222493|20217503|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
8199149|NCT02222493|20217502|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
8199150|NCT02222493|20217503|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
8199151|NCT02222493|20217502|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
8199152|NCT02222493|20217503|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
8199153|NCT02222493|20217502|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
8199154|NCT02222493|20217503|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
8199155|NCT02222493|20217502|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
8199156|NCT02222493|20217503|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
8199157|NCT02222493|20217502|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
8199158|NCT02222493|20217503|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
8199159|NCT02222493|20217502|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
8199160|NCT02222493|20217503|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
8199161|NCT02222493|20217502|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
8199162|NCT02222493|20217503|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
8199163|NCT02222337|20217621|P2|NOT COMPLETED|Overall Study||24
8199164|NCT02222337|20217622|P1|NOT COMPLETED|Overall Study||26
8199165|NCT02222337|20217621|P2|COMPLETED|Overall Study||108
8199166|NCT02222337|20217622|P1|COMPLETED|Overall Study||114
8199167|NCT02222337|20217621|P2|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
8199168|NCT02222337|20217622|P1|STARTED|Overall Study||140
8199169|NCT02222246|20217654|P2|NOT COMPLETED|Overall Study||27
8199170|NCT02222246|20217655|P1|NOT COMPLETED|Overall Study||27
8199171|NCT02222246|20217654|P2|COMPLETED|Overall Study||26
8199172|NCT02222246|20217655|P1|COMPLETED|Overall Study||26
8199173|NCT02222246|20217654|P2|STARTED|Overall Study||53
8199174|NCT02222246|20217655|P1|STARTED|Overall Study||53
8199175|NCT02222207|20217683|P1|NOT COMPLETED|Overall Study||4
8199176|NCT02222207|20217683|P1|COMPLETED|Overall Study||48
8199177|NCT02222207|20217683|P1|Treated and Valid for Full Analysis Set|Overall Study||51
8199178|NCT02222207|20217683|P1|STARTED|Overall Study||52
8199179|NCT02222181|20217690|P1|NOT COMPLETED|Overall Study||108
8199180|NCT02222181|20217690|P1|COMPLETED|Overall Study||55
8199181|NCT02222181|20217690|P1|STARTED|Overall Study||163
8199182|NCT02222129|20217702|P2|NOT COMPLETED|Overall Study||0
8199183|NCT02222129|20217703|P1|NOT COMPLETED|Overall Study||0
8199184|NCT02222129|20217702|P2|COMPLETED|Overall Study||106
8199185|NCT02222129|20217703|P1|COMPLETED|Overall Study||100
8199186|NCT02222129|20217702|P2|STARTED|Overall Study||106
8199187|NCT02222129|20217703|P1|STARTED|Overall Study||100
8199188|NCT02221947|20217711|P2|NOT COMPLETED|Overall Study||0
8199189|NCT02221947|20217712|P1|NOT COMPLETED|Overall Study||0
8199190|NCT02221947|20217711|P2|COMPLETED|Overall Study||3
8199191|NCT02221947|20217712|P1|COMPLETED|Overall Study||6
8199192|NCT02221947|20217711|P2|STARTED|Overall Study||3
8199193|NCT02221947|20217712|P1|STARTED|Overall Study||6
8199194|NCT02221882|20217730|P6|NOT COMPLETED|Overall Study||2
8199195|NCT02221882|20217731|P5|NOT COMPLETED|Overall Study||2
8199196|NCT02221882|20217732|P4|NOT COMPLETED|Overall Study||2
8199197|NCT02221882|20217733|P3|NOT COMPLETED|Overall Study||4
8199198|NCT02221882|20217734|P2|NOT COMPLETED|Overall Study||1
8199199|NCT02221882|20217735|P1|NOT COMPLETED|Overall Study||0
8199200|NCT02221882|20217730|P6|COMPLETED|Overall Study||2
8199201|NCT02221882|20217731|P5|COMPLETED|Overall Study||3
8199202|NCT02221882|20217732|P4|COMPLETED|Overall Study||1
8199203|NCT02221882|20217733|P3|COMPLETED|Overall Study||7
8199204|NCT02221882|20217734|P2|COMPLETED|Overall Study||2
8199205|NCT02221882|20217735|P1|COMPLETED|Overall Study||3
8199206|NCT02221882|20217730|P6|Received at Least One Dose of Study Drug|Overall Study||4
8199207|NCT02221882|20217731|P5|Received at Least One Dose of Study Drug|Overall Study||5
8199208|NCT02221882|20217732|P4|Received at Least One Dose of Study Drug|Overall Study||3
8199209|NCT02221882|20217733|P3|Received at Least One Dose of Study Drug|Overall Study||11
8199210|NCT02221882|20217734|P2|Received at Least One Dose of Study Drug|Overall Study||3
8199211|NCT02221882|20217735|P1|Received at Least One Dose of Study Drug|Overall Study||3
8199212|NCT02221882|20217730|P6|STARTED|Overall Study||4
8199213|NCT02221882|20217731|P5|STARTED|Overall Study||5
8199214|NCT02221882|20217732|P4|STARTED|Overall Study||3
8199215|NCT02221882|20217733|P3|STARTED|Overall Study||11
8199216|NCT02221882|20217734|P2|STARTED|Overall Study||3
8199217|NCT02221882|20217735|P1|STARTED|Overall Study||3
8199218|NCT02221869|20217778|P3|NOT COMPLETED|Overall Study||10
8199219|NCT02221869|20217779|P2|NOT COMPLETED|Overall Study||0
8199220|NCT02221869|20217780|P1|NOT COMPLETED|Overall Study||1
8199221|NCT02221869|20217778|P3|COMPLETED|Overall Study||33
8199222|NCT02221869|20217779|P2|COMPLETED|Overall Study||32
8199223|NCT02221869|20217780|P1|COMPLETED|Overall Study||30
8199224|NCT02221869|20217778|P3|STARTED|Overall Study||43
8199225|NCT02221869|20217779|P2|STARTED|Overall Study||32
8199226|NCT02221869|20217780|P1|STARTED|Overall Study||31
8199227|NCT02221817|20217796|P2|NOT COMPLETED|Overall Study||0
8199228|NCT02221817|20217797|P1|NOT COMPLETED|Overall Study||0
8199229|NCT02221817|20217796|P2|COMPLETED|Overall Study||0
8199230|NCT02221817|20217797|P1|COMPLETED|Overall Study||0
8199231|NCT02221817|20217796|P2|STARTED|Overall Study||0
8199232|NCT02221817|20217797|P1|STARTED|Overall Study||0
8199233|NCT02221739|20217809|P1|NOT COMPLETED|Overall Study||18
8199234|NCT02221739|20217809|P1|COMPLETED|Overall Study||21
8199235|NCT02221739|20217809|P1|STARTED|Overall Study||39
8199236|NCT02221674|20217817|P3|NOT COMPLETED|Overall Study||0
8199237|NCT02221674|20217818|P2|NOT COMPLETED|Overall Study||0
8199238|NCT02221674|20217819|P1|NOT COMPLETED|Overall Study||1
8199239|NCT02221674|20217817|P3|COMPLETED|Overall Study||5
8199240|NCT02221674|20217818|P2|COMPLETED|Overall Study||6
8199241|NCT02221674|20217819|P1|COMPLETED|Overall Study||7
8199242|NCT02221674|20217817|P3|STARTED|Overall Study||5
8199243|NCT02221674|20217818|P2|STARTED|Overall Study||6
8199244|NCT02221674|20217819|P1|STARTED|Overall Study||8
8199245|NCT02221648|20217835|P2|NOT COMPLETED|Overall Study||3
8199246|NCT02221648|20217836|P1|NOT COMPLETED|Overall Study||3
8199247|NCT02221648|20217835|P2|COMPLETED|Overall Study||18
8199248|NCT02221648|20217836|P1|COMPLETED|Overall Study||19
8199249|NCT02221648|20217835|P2|STARTED|Overall Study||21
8199250|NCT02221648|20217836|P1|STARTED|Overall Study||22
8199251|NCT02221557|20217846|P1|NOT COMPLETED|Overall Study||3
8199252|NCT02221557|20217846|P1|COMPLETED|Overall Study||5
8199253|NCT02221557|20217846|P1|STARTED|Overall Study||8
8199254|NCT02221349|20217852|P2|NOT COMPLETED|Overall Study||0
8199255|NCT02221349|20217853|P1|NOT COMPLETED|Overall Study||1
8199256|NCT02221349|20217852|P2|COMPLETED|Overall Study||15
8199257|NCT02221349|20217853|P1|COMPLETED|Overall Study||14
8199258|NCT02221349|20217852|P2|STARTED|Overall Study||15
8199259|NCT02221349|20217853|P1|STARTED|Overall Study||15
8199260|NCT02221284|20217865|P1|NOT COMPLETED|Overall Study||61
8199261|NCT02221284|20217865|P1|COMPLETED|Overall Study||903
8199262|NCT02221284|20217865|P1|STARTED|Overall Study||964
8199263|NCT02221219|20217897|P4|NOT COMPLETED|Overall Study||0
8199264|NCT02221219|20217898|P3|NOT COMPLETED|Overall Study||0
8199265|NCT02221219|20217899|P2|NOT COMPLETED|Overall Study||0
8199266|NCT02221219|20217900|P1|NOT COMPLETED|Overall Study||0
8199267|NCT02221219|20217897|P4|COMPLETED|Overall Study||92
8199268|NCT02221219|20217898|P3|COMPLETED|Overall Study||41
8199269|NCT02221219|20217899|P2|COMPLETED|Overall Study||87
8199270|NCT02221219|20217900|P1|COMPLETED|Overall Study||36
8199271|NCT02221219|20217897|P4|STARTED|Overall Study||92
8199272|NCT02221219|20217898|P3|STARTED|Overall Study||41
8199273|NCT02221219|20217899|P2|STARTED|Overall Study||87
8199274|NCT02221219|20217900|P1|STARTED|Overall Study||36
8199275|NCT02221037|20217914|P4|NOT COMPLETED|Overall Study||0
8199276|NCT02221037|20217915|P3|NOT COMPLETED|Overall Study||1
8199277|NCT02221037|20217916|P2|NOT COMPLETED|Overall Study||0
8199278|NCT02221037|20217917|P1|NOT COMPLETED|Overall Study||0
8199279|NCT02221037|20217914|P4|COMPLETED|Overall Study||9
8199280|NCT02221037|20217915|P3|COMPLETED|Overall Study||7
8199281|NCT02221037|20217916|P2|COMPLETED|Overall Study||11
8199282|NCT02221037|20217917|P1|COMPLETED|Overall Study||5
8199283|NCT02221037|20217914|P4|STARTED|Overall Study||9
8199284|NCT02221037|20217915|P3|STARTED|Overall Study||8
8199285|NCT02221037|20217916|P2|STARTED|Overall Study||11
8199286|NCT02221037|20217917|P1|STARTED|Overall Study||5
8199287|NCT02220998|20218003|P2|NOT COMPLETED|Overall Study||11
8199288|NCT02220998|20218004|P1|NOT COMPLETED|Overall Study||7
8199289|NCT02220998|20218003|P2|COMPLETED|Overall Study||123
8199290|NCT02220998|20218004|P1|COMPLETED|Overall Study||128
8199291|NCT02220998|20218003|P2|STARTED|Overall Study||134
8199292|NCT02220998|20218004|P1|STARTED|Overall Study||135
8199293|NCT02220920|20218022|P2|NOT COMPLETED|Overall Study||3
8199294|NCT02220920|20218023|P1|NOT COMPLETED|Overall Study||3
8199295|NCT02220920|20218022|P2|COMPLETED|Overall Study||67
8199296|NCT02220920|20218023|P1|COMPLETED|Overall Study||73
8199297|NCT02220920|20218022|P2|STARTED|Overall Study||70
8199298|NCT02220920|20218023|P1|STARTED|Overall Study||76
8199299|NCT02220907|20218037|P1|NOT COMPLETED|Overall Study||11
8199300|NCT02220907|20218037|P1|COMPLETED|Overall Study||142
8199301|NCT02220907|20218037|P1|STARTED|Overall Study||153
8199302|NCT02220894|20218046|P2|NOT COMPLETED|Overall Study||637
8199303|NCT02220894|20218047|P1|NOT COMPLETED|Overall Study||637
8199304|NCT02220894|20218046|P2|COMPLETED|Overall Study||0
8199305|NCT02220894|20218047|P1|COMPLETED|Overall Study||0
8199306|NCT02220894|20218046|P2|Treated|Overall Study||615
8199307|NCT02220894|20218047|P1|Treated|Overall Study||636
8199308|NCT02220894|20218046|P2|STARTED|Overall Study||637
8199309|NCT02220894|20218047|P1|STARTED|Overall Study|1 additional participant was randomized in error|637
8199310|NCT02220855|20218073|P1|NOT COMPLETED|Overall Study||14
8199311|NCT02220855|20218073|P1|COMPLETED|Overall Study||0
8199312|NCT02220855|20218073|P1|STARTED|Overall Study||14
8199313|NCT02220764|20218083|P2|NOT COMPLETED|Overall Study||1
8199314|NCT02220764|20218084|P1|NOT COMPLETED|Overall Study||4
8199315|NCT02220764|20218083|P2|COMPLETED|Overall Study||7
8199316|NCT02220764|20218084|P1|COMPLETED|Overall Study||20
8199317|NCT02220764|20218083|P2|STARTED|Overall Study||8
8199318|NCT02220764|20218084|P1|STARTED|Overall Study||24
8199319|NCT02220725|20218098|P4|NOT COMPLETED|Overall Study||2
8199320|NCT02220725|20218099|P3|NOT COMPLETED|Overall Study||0
8199321|NCT02220725|20218100|P2|NOT COMPLETED|Overall Study||0
8199322|NCT02220725|20218101|P1|NOT COMPLETED|Overall Study||0
8199323|NCT02220725|20218098|P4|COMPLETED|Overall Study||24
8199324|NCT02220725|20218099|P3|COMPLETED|Overall Study||13
8199325|NCT02220725|20218100|P2|COMPLETED|Overall Study||27
8199326|NCT02220725|20218101|P1|COMPLETED|Overall Study||14
8199327|NCT02220725|20218098|P4|STARTED|Overall Study||26
8199328|NCT02220725|20218099|P3|STARTED|Overall Study||13
8199329|NCT02220725|20218100|P2|STARTED|Overall Study||27
8199330|NCT02220725|20218101|P1|STARTED|Overall Study||14
8199331|NCT02220712|20218129|P1|NOT COMPLETED|Overall Study||4
8199332|NCT02220712|20218129|P1|COMPLETED|Overall Study||13
8199333|NCT02220712|20218129|P1|STARTED|Overall Study||17
8199334|NCT02220205|20218139|P2|NOT COMPLETED|Overall Study||0
8199335|NCT02220205|20218140|P1|NOT COMPLETED|Overall Study||1
8199336|NCT02220205|20218139|P2|COMPLETED|Overall Study||30
8199337|NCT02220205|20218140|P1|COMPLETED|Overall Study||29
8199338|NCT02220205|20218139|P2|STARTED|Overall Study||30
8199339|NCT02220205|20218140|P1|STARTED|Overall Study||30
8199340|NCT02219997|20218150|P3|NOT COMPLETED|Second Filter||0
8199341|NCT02219997|20218151|P2|NOT COMPLETED|Second Filter||0
8199342|NCT02219997|20218152|P1|NOT COMPLETED|Second Filter||0
8199343|NCT02219997|20218150|P3|COMPLETED|Second Filter||18
8199344|NCT02219997|20218151|P2|COMPLETED|Second Filter||17
8199345|NCT02219997|20218152|P1|COMPLETED|Second Filter||0
8199346|NCT02219997|20218150|P3|STARTED|Second Filter||18
8199347|NCT02219997|20218151|P2|STARTED|Second Filter||17
8199348|NCT02219997|20218152|P1|STARTED|Second Filter||0
8199349|NCT02219997|20218150|P3|NOT COMPLETED|First Filter||0
8199350|NCT02219997|20218151|P2|NOT COMPLETED|First Filter||0
8199351|NCT02219997|20218152|P1|NOT COMPLETED|First Filter||0
8199352|NCT02219997|20218150|P3|COMPLETED|First Filter||18
8199353|NCT02219997|20218151|P2|COMPLETED|First Filter||17
8199354|NCT02219997|20218152|P1|COMPLETED|First Filter||33
8199355|NCT02219997|20218150|P3|STARTED|First Filter||18
8199356|NCT02219997|20218151|P2|STARTED|First Filter||17
8199357|NCT02219997|20218152|P1|STARTED|First Filter||33
8199358|NCT02219932|20218165|P2|NOT COMPLETED|Overall Study||51
8199359|NCT02219932|20218166|P1|NOT COMPLETED|Overall Study||65
8199360|NCT02219932|20218165|P2|COMPLETED|Overall Study||266
8199361|NCT02219932|20218166|P1|COMPLETED|Overall Study||254
8199362|NCT02219932|20218165|P2|Randomized, Not Treated|Overall Study||1
8199363|NCT02219932|20218166|P1|Randomized, Not Treated|Overall Study||0
8199364|NCT02219932|20218165|P2|STARTED|Overall Study||317
8199365|NCT02219932|20218166|P1|STARTED|Overall Study||319
8199366|NCT02219685|20218182|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
8199367|NCT02219685|20218183|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
8199368|NCT02219685|20218182|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
8199369|NCT02219685|20218183|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
8199370|NCT02219685|20218182|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
8199371|NCT02219685|20218183|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
8199372|NCT02219685|20218182|P2|NOT COMPLETED|Blinded Treatment Phase||0
8199373|NCT02219685|20218183|P1|NOT COMPLETED|Blinded Treatment Phase||2
8199374|NCT02219685|20218182|P2|COMPLETED|Blinded Treatment Phase||14
8199375|NCT02219685|20218183|P1|COMPLETED|Blinded Treatment Phase||24
8199376|NCT02219685|20218182|P2|STARTED|Blinded Treatment Phase||14
8199377|NCT02219685|20218183|P1|STARTED|Blinded Treatment Phase||26
8199378|NCT02219516|20218231|P4|NOT COMPLETED|Overall Study||0
8199379|NCT02219516|20218232|P3|NOT COMPLETED|Overall Study||0
8199380|NCT02219516|20218233|P2|NOT COMPLETED|Overall Study||0
8199381|NCT02219516|20218234|P1|NOT COMPLETED|Overall Study||0
8199382|NCT02219516|20218231|P4|COMPLETED|Overall Study||8
8199383|NCT02219516|20218232|P3|COMPLETED|Overall Study||7
8199384|NCT02219516|20218233|P2|COMPLETED|Overall Study||8
8199385|NCT02219516|20218234|P1|COMPLETED|Overall Study||8
8199386|NCT02219516|20218231|P4|STARTED|Overall Study||8
8199387|NCT02219516|20218232|P3|STARTED|Overall Study||7
8199388|NCT02219516|20218233|P2|STARTED|Overall Study||8
8199389|NCT02219516|20218234|P1|STARTED|Overall Study||8
8199390|NCT02219503|20218280|P1|NOT COMPLETED|Overall Study||0
8199391|NCT02219503|20218280|P1|COMPLETED|Overall Study||60
8199392|NCT02219503|20218280|P1|STARTED|Overall Study||60
8199393|NCT02219477|20218289|P3|NOT COMPLETED|Overall Study||1
8199394|NCT02219477|20218290|P2|NOT COMPLETED|Overall Study||2
8199395|NCT02219477|20218291|P1|NOT COMPLETED|Overall Study||0
8199396|NCT02219477|20218289|P3|COMPLETED|Overall Study||2
8199397|NCT02219477|20218290|P2|COMPLETED|Overall Study||22
8199398|NCT02219477|20218291|P1|COMPLETED|Overall Study||9
8199399|NCT02219477|20218289|P3|STARTED|Overall Study||3
8199400|NCT02219477|20218290|P2|STARTED|Overall Study||24
8199401|NCT02219477|20218291|P1|STARTED|Overall Study||9
8199402|NCT02219464|20218319|P2|NOT COMPLETED|Overall Study||0
8199403|NCT02219464|20218320|P1|NOT COMPLETED|Overall Study||3
8199404|NCT02219464|20218319|P2|COMPLETED|Overall Study||30
8199405|NCT02219464|20218320|P1|COMPLETED|Overall Study||27
8199406|NCT02219464|20218319|P2|STARTED|Overall Study||30
8199407|NCT02219464|20218320|P1|STARTED|Overall Study||30
8199408|NCT02219334|20218330|P2|NOT COMPLETED|Overall Study||3
8199409|NCT02219334|20218331|P1|NOT COMPLETED|Overall Study||8
8199410|NCT02219334|20218330|P2|COMPLETED|Overall Study||20
8199411|NCT02219334|20218331|P1|COMPLETED|Overall Study||24
8199412|NCT02219334|20218330|P2|STARTED|Overall Study||23
8199413|NCT02219334|20218331|P1|STARTED|Overall Study||32
8199414|NCT02219321|20218343|P2|NOT COMPLETED|Overall Study||0
8199415|NCT02219321|20218344|P1|NOT COMPLETED|Overall Study||0
8199416|NCT02219321|20218343|P2|COMPLETED|Overall Study||2
8199417|NCT02219321|20218344|P1|COMPLETED|Overall Study||1
8199418|NCT02219321|20218343|P2|STARTED|Overall Study||2
8199419|NCT02219321|20218344|P1|STARTED|Overall Study||1
8199420|NCT02219308|20218354|P2|NOT COMPLETED|Overall Study||2
8199421|NCT02219308|20218355|P1|NOT COMPLETED|Overall Study||1
8199422|NCT02219308|20218354|P2|COMPLETED|Overall Study||33
8199423|NCT02219308|20218355|P1|COMPLETED|Overall Study||31
8199424|NCT02219308|20218354|P2|STARTED|Overall Study||35
8199425|NCT02219308|20218355|P1|STARTED|Overall Study||32
8199426|NCT02219282|20218365|P2|NOT COMPLETED|Overall Study||1
8199427|NCT02219282|20218366|P1|NOT COMPLETED|Overall Study||1
8199428|NCT02219282|20218365|P2|COMPLETED|Overall Study||32
8199429|NCT02219282|20218366|P1|COMPLETED|Overall Study||32
8199430|NCT02219282|20218365|P2|STARTED|Overall Study||33
8199431|NCT02219282|20218366|P1|STARTED|Overall Study||33
8199432|NCT02219256|20218392|P12|NOT COMPLETED|Overall Study||0
8199433|NCT02219256|20218393|P11|NOT COMPLETED|Overall Study||0
8199434|NCT02219256|20218394|P10|NOT COMPLETED|Overall Study||0
8199435|NCT02219256|20218395|P9|NOT COMPLETED|Overall Study||0
8199436|NCT02219256|20218396|P8|NOT COMPLETED|Overall Study||0
8199437|NCT02219256|20218397|P7|NOT COMPLETED|Overall Study||0
8199438|NCT02219256|20218398|P6|NOT COMPLETED|Overall Study||0
8199439|NCT02219256|20218399|P5|NOT COMPLETED|Overall Study||0
8199440|NCT02219256|20218400|P4|NOT COMPLETED|Overall Study||0
8199441|NCT02219256|20218401|P3|NOT COMPLETED|Overall Study||0
8199442|NCT02219256|20218402|P2|NOT COMPLETED|Overall Study||0
8199443|NCT02219256|20218403|P1|NOT COMPLETED|Overall Study||0
8199444|NCT02219256|20218392|P12|COMPLETED|Overall Study||6
8199445|NCT02219256|20218393|P11|COMPLETED|Overall Study||6
8199446|NCT02219256|20218394|P10|COMPLETED|Overall Study||6
8199447|NCT02219256|20218395|P9|COMPLETED|Overall Study||6
8199448|NCT02219256|20218396|P8|COMPLETED|Overall Study||8
8199449|NCT02219256|20218397|P7|COMPLETED|Overall Study||6
8199450|NCT02219256|20218398|P6|COMPLETED|Overall Study||6
8199451|NCT02219256|20218399|P5|COMPLETED|Overall Study||6
8199452|NCT02219256|20218400|P4|COMPLETED|Overall Study||4
8199453|NCT02219256|20218401|P3|COMPLETED|Overall Study||4
8199454|NCT02219256|20218402|P2|COMPLETED|Overall Study||4
8199455|NCT02219256|20218403|P1|COMPLETED|Overall Study||12
8199456|NCT02219256|20218392|P12|STARTED|Overall Study||6
8199457|NCT02219256|20218393|P11|STARTED|Overall Study||6
8199458|NCT02219256|20218394|P10|STARTED|Overall Study||6
8199459|NCT02219256|20218395|P9|STARTED|Overall Study||6
8199460|NCT02219256|20218396|P8|STARTED|Overall Study||8
8199461|NCT02219256|20218397|P7|STARTED|Overall Study||6
8199462|NCT02219256|20218398|P6|STARTED|Overall Study||6
8199463|NCT02219256|20218399|P5|STARTED|Overall Study||6
8199464|NCT02219256|20218400|P4|STARTED|Overall Study||4
8199465|NCT02219256|20218401|P3|STARTED|Overall Study||4
8199466|NCT02219256|20218402|P2|STARTED|Overall Study||4
8199467|NCT02219256|20218403|P1|STARTED|Overall Study||12
8199468|NCT02219087|20218515|P2|NOT COMPLETED|Overall Study||1
8199469|NCT02219087|20218516|P1|NOT COMPLETED|Overall Study||0
8199470|NCT02219087|20218515|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
8199471|NCT02219087|20218516|P1|COMPLETED|Overall Study||30
8199472|NCT02219087|20218515|P2|STARTED|Overall Study||30
8199473|NCT02219087|20218516|P1|STARTED|Overall Study||30
8199474|NCT02219048|20218536|P2|NOT COMPLETED|Overall Study||21
8199475|NCT02219048|20218537|P1|NOT COMPLETED|Overall Study||21
8199476|NCT02219048|20218536|P2|COMPLETED|Overall Study||4
8199477|NCT02219048|20218537|P1|COMPLETED|Overall Study||5
8199478|NCT02219048|20218536|P2|STARTED|Overall Study||25
8199479|NCT02219048|20218537|P1|STARTED|Overall Study||26
8199480|NCT02219009|20218563|P2|NOT COMPLETED|Overall Study||8
8199481|NCT02219009|20218564|P1|NOT COMPLETED|Overall Study||10
8199482|NCT02219009|20218563|P2|COMPLETED|Overall Study||22
8199483|NCT02219009|20218564|P1|COMPLETED|Overall Study||27
8199484|NCT02219009|20218563|P2|STARTED|Overall Study||30
8199485|NCT02219009|20218564|P1|STARTED|Overall Study||37
8199486|NCT02218736|20218576|P2|NOT COMPLETED|Overall Study||9
8199487|NCT02218736|20218577|P1|NOT COMPLETED|Overall Study||12
8199488|NCT02218736|20218576|P2|COMPLETED|Overall Study||35
8199489|NCT02218736|20218577|P1|COMPLETED|Overall Study||33
8199490|NCT02218736|20218576|P2|STARTED|Overall Study||44
8199491|NCT02218736|20218577|P1|STARTED|Overall Study||45
8199492|NCT02218697|20218589|P2|NOT COMPLETED|Overall Study||6
8199493|NCT02218697|20218590|P1|NOT COMPLETED|Overall Study||2
8199494|NCT02218697|20218589|P2|COMPLETED|Overall Study||171
8199495|NCT02218697|20218590|P1|COMPLETED|Overall Study||177
8199496|NCT02218697|20218589|P2|STARTED|Overall Study||177
8199497|NCT02218697|20218590|P1|STARTED|Overall Study||179
8199498|NCT02218541|20218630|P2|NOT COMPLETED|Overall Study||2
8199499|NCT02218541|20218631|P1|NOT COMPLETED|Overall Study||6
8199500|NCT02218541|20218630|P2|COMPLETED|Overall Study||9
8199501|NCT02218541|20218631|P1|COMPLETED|Overall Study||5
8199502|NCT02218541|20218630|P2|STARTED|Overall Study||11
8199503|NCT02218541|20218631|P1|STARTED|Overall Study||11
8199504|NCT02218489|20218643|P2|NOT COMPLETED|Overall Study||3
8199505|NCT02218489|20218644|P1|NOT COMPLETED|Overall Study||5
8199506|NCT02218489|20218643|P2|COMPLETED|Overall Study||101
8199507|NCT02218489|20218644|P1|COMPLETED|Overall Study||96
8199508|NCT02218489|20218643|P2|STARTED|Overall Study||104
8199509|NCT02218489|20218644|P1|STARTED|Overall Study||101
8199510|NCT02218463|20218662|P2|NOT COMPLETED|Overall Study||3
8199511|NCT02218463|20218663|P1|NOT COMPLETED|Overall Study||3
8199512|NCT02218463|20218662|P2|COMPLETED|Overall Study||19
8199513|NCT02218463|20218663|P1|COMPLETED|Overall Study||18
8199514|NCT02218463|20218662|P2|STARTED|Overall Study||22
8199515|NCT02218463|20218663|P1|STARTED|Overall Study||21
8199516|NCT02218424|20218673|P2|NOT COMPLETED|Overall Study||0
8199517|NCT02218424|20218674|P1|NOT COMPLETED|Overall Study||0
8199518|NCT02218424|20218673|P2|COMPLETED|Overall Study||30
8199519|NCT02218424|20218674|P1|COMPLETED|Overall Study||30
8199520|NCT02218424|20218673|P2|STARTED|Overall Study||30
8199521|NCT02218424|20218674|P1|STARTED|Overall Study||30
8199522|NCT02218372|20218696|P2|NOT COMPLETED|Overall Study||6
8199523|NCT02218372|20218697|P1|NOT COMPLETED|Overall Study||5
8199524|NCT02218372|20218696|P2|COMPLETED|Overall Study||42
8199525|NCT02218372|20218697|P1|COMPLETED|Overall Study||95
8199526|NCT02218372|20218696|P2|Treated|Overall Study||44
8199527|NCT02218372|20218697|P1|Treated|Overall Study||98
8199528|NCT02218372|20218696|P2|STARTED|Overall Study||48
8199529|NCT02218372|20218697|P1|STARTED|Overall Study||100
8199530|NCT02218320|20218755|P2|NOT COMPLETED|Overall Study||0
8199531|NCT02218320|20218756|P1|NOT COMPLETED|Overall Study||0
8199532|NCT02218320|20218755|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
8199533|NCT02218320|20218756|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
8199534|NCT02218320|20218755|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
8199535|NCT02218320|20218756|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
8199536|NCT02218307|20218768|P2|NOT COMPLETED|Overall Study||1
8199537|NCT02218307|20218769|P1|NOT COMPLETED|Overall Study||9
8199538|NCT02218307|20218768|P2|COMPLETED|Overall Study||33
8199539|NCT02218307|20218769|P1|COMPLETED|Overall Study||25
8199540|NCT02218307|20218768|P2|STARTED|Overall Study||34
8199541|NCT02218307|20218769|P1|STARTED|Overall Study||34
8199542|NCT02218268|20218777|P2|NOT COMPLETED|Final Phase (2 Hours)||0
8199543|NCT02218268|20218778|P1|NOT COMPLETED|Final Phase (2 Hours)||0
8199544|NCT02218268|20218777|P2|COMPLETED|Final Phase (2 Hours)||21
8199545|NCT02218268|20218778|P1|COMPLETED|Final Phase (2 Hours)||19
8199546|NCT02218268|20218777|P2|STARTED|Final Phase (2 Hours)||21
8199547|NCT02218268|20218778|P1|STARTED|Final Phase (2 Hours)||19
8199548|NCT02218268|20218777|P2|NOT COMPLETED|24 Hour Washout||9
8199549|NCT02218268|20218778|P1|NOT COMPLETED|24 Hour Washout||11
8199550|NCT02218268|20218777|P2|COMPLETED|24 Hour Washout||21
8199551|NCT02218268|20218778|P1|COMPLETED|24 Hour Washout||19
8199552|NCT02218268|20218777|P2|STARTED|24 Hour Washout||30
8199553|NCT02218268|20218778|P1|STARTED|24 Hour Washout||30
8199554|NCT02218268|20218777|P2|NOT COMPLETED|First Phase (2 Hours)||0
8199555|NCT02218268|20218778|P1|NOT COMPLETED|First Phase (2 Hours)||0
8199556|NCT02218268|20218777|P2|COMPLETED|First Phase (2 Hours)||30
8199557|NCT02218268|20218778|P1|COMPLETED|First Phase (2 Hours)||30
8199558|NCT02218268|20218777|P2|STARTED|First Phase (2 Hours)||30
8199559|NCT02218268|20218778|P1|STARTED|First Phase (2 Hours)||30
8199560|NCT02218242|20218784|P1|NOT COMPLETED|Overall Study||0
8199561|NCT02218242|20218784|P1|COMPLETED|Overall Study||9
8199562|NCT02218242|20218784|P1|STARTED|Overall Study||9
8199563|NCT02218216|20218790|P3|NOT COMPLETED|Overall Study||0
8199564|NCT02218216|20218791|P2|NOT COMPLETED|Overall Study||0
8199565|NCT02218216|20218792|P1|NOT COMPLETED|Overall Study||6
8199566|NCT02218216|20218790|P3|COMPLETED|Overall Study||3
8199567|NCT02218216|20218791|P2|COMPLETED|Overall Study||2
8199568|NCT02218216|20218792|P1|COMPLETED|Overall Study||8
8199569|NCT02218216|20218790|P3|STARTED|Overall Study||3
8199570|NCT02218216|20218791|P2|STARTED|Overall Study||2
8199571|NCT02218216|20218792|P1|STARTED|Overall Study||14
8199572|NCT02218203|20218800|P1|NOT COMPLETED|Overall Study||0
8199573|NCT02218203|20218800|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
8199574|NCT02218203|20218800|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8199575|NCT02218203|20218800|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8199576|NCT02218203|20218800|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8199577|NCT02218203|20218800|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8199578|NCT02218203|20218800|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8199579|NCT02218203|20218800|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8199580|NCT02218203|20218800|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8199581|NCT02218203|20218800|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8199582|NCT02218203|20218800|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
8199583|NCT02218203|20218800|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
8199584|NCT02218203|20218800|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
8199585|NCT02218203|20218800|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
8199586|NCT02218203|20218800|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8199587|NCT02218203|20218800|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8199588|NCT02218203|20218800|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8199589|NCT02218203|20218800|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8199590|NCT02218203|20218800|P1|STARTED|Overall Study||26
8199591|NCT02218190|20218824|P2|NOT COMPLETED|Overall Study||0
8199592|NCT02218190|20218825|P1|NOT COMPLETED|Overall Study||0
8199593|NCT02218190|20218824|P2|COMPLETED|Overall Study||13
8199594|NCT02218190|20218825|P1|COMPLETED|Overall Study||13
8199595|NCT02218190|20218824|P2|STARTED|Overall Study||13
8199596|NCT02218190|20218825|P1|STARTED|Overall Study||13
8199597|NCT02218164|20218835|P1|NOT COMPLETED|Overall Study||0
8199598|NCT02218164|20218835|P1|COMPLETED|Overall Study||8
8199599|NCT02218164|20218835|P1|STARTED|Overall Study||8
8199600|NCT02218008|20218845|P6|NOT COMPLETED|Stage 2 (S2)||6
8199601|NCT02218008|20218846|P5|NOT COMPLETED|Stage 2 (S2)||4
8199602|NCT02218008|20218847|P4|NOT COMPLETED|Stage 2 (S2)||4
8199603|NCT02218008|20218848|P3|NOT COMPLETED|Stage 2 (S2)||0
8199604|NCT02218008|20218849|P2|NOT COMPLETED|Stage 2 (S2)||0
8199605|NCT02218008|20218850|P1|NOT COMPLETED|Stage 2 (S2)||0
8199606|NCT02218008|20218845|P6|COMPLETED|Stage 2 (S2)||57
8199607|NCT02218008|20218846|P5|COMPLETED|Stage 2 (S2)||58
8199608|NCT02218008|20218847|P4|COMPLETED|Stage 2 (S2)||58
8199609|NCT02218008|20218848|P3|COMPLETED|Stage 2 (S2)||0
8199610|NCT02218008|20218849|P2|COMPLETED|Stage 2 (S2)||0
8199611|NCT02218008|20218850|P1|COMPLETED|Stage 2 (S2)||0
8199612|NCT02218008|20218845|P6|STARTED|Stage 2 (S2)||63
8199613|NCT02218008|20218846|P5|STARTED|Stage 2 (S2)||62
8199614|NCT02218008|20218847|P4|STARTED|Stage 2 (S2)||62
8199615|NCT02218008|20218848|P3|STARTED|Stage 2 (S2)||0
8199616|NCT02218008|20218849|P2|STARTED|Stage 2 (S2)||0
8199617|NCT02218008|20218850|P1|STARTED|Stage 2 (S2)||0
8199618|NCT02218008|20218845|P6|NOT COMPLETED|Stage 1 (S1)||0
8199619|NCT02218008|20218846|P5|NOT COMPLETED|Stage 1 (S1)||0
8199620|NCT02218008|20218847|P4|NOT COMPLETED|Stage 1 (S1)||0
8199621|NCT02218008|20218848|P3|NOT COMPLETED|Stage 1 (S1)||15
8199622|NCT02218008|20218849|P2|NOT COMPLETED|Stage 1 (S1)||7
8199623|NCT02218008|20218850|P1|NOT COMPLETED|Stage 1 (S1)||22
8199624|NCT02218008|20218845|P6|COMPLETED|Stage 1 (S1)||0
8199625|NCT02218008|20218846|P5|COMPLETED|Stage 1 (S1)||0
8199626|NCT02218008|20218847|P4|COMPLETED|Stage 1 (S1)||0
8199627|NCT02218008|20218848|P3|COMPLETED|Stage 1 (S1)||48
8199628|NCT02218008|20218849|P2|COMPLETED|Stage 1 (S1)||56
8199629|NCT02218008|20218850|P1|COMPLETED|Stage 1 (S1)||258
8199630|NCT02218008|20218845|P6|STARTED|Stage 1 (S1)||0
8199631|NCT02218008|20218846|P5|STARTED|Stage 1 (S1)||0
8199632|NCT02218008|20218847|P4|STARTED|Stage 1 (S1)||0
8199633|NCT02218008|20218848|P3|STARTED|Stage 1 (S1)||63
8199634|NCT02218008|20218849|P2|STARTED|Stage 1 (S1)||63
8199635|NCT02218008|20218850|P1|STARTED|Stage 1 (S1)||280
8199636|NCT02217982|20218896|P2|NOT COMPLETED|Overall Study||1
8199637|NCT02217982|20218897|P1|NOT COMPLETED|Overall Study||1
8199638|NCT02217982|20218896|P2|COMPLETED|Overall Study||3
8199639|NCT02217982|20218897|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
8199640|NCT02217982|20218896|P2|STARTED|Overall Study||4
8199641|NCT02217982|20218897|P1|STARTED|Overall Study||1
8199642|NCT02217904|20218910|P7|NOT COMPLETED|Overall Study||0
8199643|NCT02217904|20218911|P6|NOT COMPLETED|Overall Study||0
8199644|NCT02217904|20218912|P5|NOT COMPLETED|Overall Study||0
8199645|NCT02217904|20218913|P4|NOT COMPLETED|Overall Study||0
8199646|NCT02217904|20218914|P3|NOT COMPLETED|Overall Study||0
8199647|NCT02217904|20218915|P2|NOT COMPLETED|Overall Study||0
8199648|NCT02217904|20218916|P1|NOT COMPLETED|Overall Study||0
8199649|NCT02217904|20218910|P7|COMPLETED|Overall Study||0
8199650|NCT02217904|20218911|P6|COMPLETED|Overall Study||0
8199651|NCT02217904|20218912|P5|COMPLETED|Overall Study||6
8199652|NCT02217904|20218913|P4|COMPLETED|Overall Study||6
8199653|NCT02217904|20218914|P3|COMPLETED|Overall Study||6
8199654|NCT02217904|20218915|P2|COMPLETED|Overall Study||6
8199655|NCT02217904|20218916|P1|COMPLETED|Overall Study||6
8199656|NCT02217904|20218910|P7|STARTED|Overall Study||0
8199657|NCT02217904|20218911|P6|STARTED|Overall Study||0
8199658|NCT02217904|20218912|P5|STARTED|Overall Study||6
8199659|NCT02217904|20218913|P4|STARTED|Overall Study||6
8199660|NCT02217904|20218914|P3|STARTED|Overall Study||6
8199661|NCT02217904|20218915|P2|STARTED|Overall Study||6
8199662|NCT02217904|20218916|P1|STARTED|Overall Study||6
8199663|NCT02217878|20218980|P2|NOT COMPLETED|Overall Study||2
8199664|NCT02217878|20218981|P1|NOT COMPLETED|Overall Study||2
8199665|NCT02217878|20218980|P2|COMPLETED|Overall Study||35
8199666|NCT02217878|20218981|P1|COMPLETED|Overall Study||35
8199667|NCT02217878|20218980|P2|STARTED|Overall Study||37
8199668|NCT02217878|20218981|P1|STARTED|Overall Study||37
8199669|NCT02217800|20219061|P1|NOT COMPLETED|Overall Study||0
8199670|NCT02217800|20219061|P1|COMPLETED|Overall Study||8
8199671|NCT02217800|20219061|P1|STARTED|Overall Study||8
8199672|NCT02217618|20219073|P1|NOT COMPLETED|Overall Study||0
8199673|NCT02217618|20219073|P1|COMPLETED|Overall Study||16
8199674|NCT02217618|20219073|P1|Received Study Drug|Overall Study||16
8199675|NCT02217618|20219073|P1|STARTED|Overall Study||16
8199676|NCT02217566|20219079|P1|NOT COMPLETED|Overall Study||11
8199677|NCT02217566|20219079|P1|COMPLETED|Overall Study||35
8199678|NCT02217566|20219079|P1|STARTED|Overall Study||46
8199679|NCT02217527|20219090|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
8199680|NCT02217527|20219091|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
8199681|NCT02217527|20219090|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
8199682|NCT02217527|20219091|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
8199683|NCT02217527|20219090|P2|STARTED|Drug Condition 2: Second Study Phase||15
8199684|NCT02217527|20219091|P1|STARTED|Drug Condition 2: Second Study Phase||17
8199685|NCT02217527|20219090|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
8199686|NCT02217527|20219091|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
8199687|NCT02217527|20219090|P2|COMPLETED|Drug Condition 1: First Study Phase||15
8199688|NCT02217527|20219091|P1|COMPLETED|Drug Condition 1: First Study Phase||17
8199689|NCT02217527|20219090|P2|STARTED|Drug Condition 1: First Study Phase||18
8199690|NCT02217527|20219091|P1|STARTED|Drug Condition 1: First Study Phase||18
8199691|NCT02217475|20219104|P3|NOT COMPLETED|Treatment Period 2 (Year 2)||12
8199692|NCT02217475|20219105|P2|NOT COMPLETED|Treatment Period 2 (Year 2)||2
8199693|NCT02217475|20219106|P1|NOT COMPLETED|Treatment Period 2 (Year 2)||2
8199694|NCT02217475|20219104|P3|COMPLETED|Treatment Period 2 (Year 2)||109
8199695|NCT02217475|20219105|P2|COMPLETED|Treatment Period 2 (Year 2)||59
8199696|NCT02217475|20219106|P1|COMPLETED|Treatment Period 2 (Year 2)||58
8199697|NCT02217475|20219104|P3|STARTED|Treatment Period 2 (Year 2)||121
8199698|NCT02217475|20219105|P2|STARTED|Treatment Period 2 (Year 2)||61
8199699|NCT02217475|20219106|P1|STARTED|Treatment Period 2 (Year 2)||60
8199700|NCT02217475|20219104|P3|NOT COMPLETED|Discontinued After Period 1||3
8199701|NCT02217475|20219105|P2|NOT COMPLETED|Discontinued After Period 1||3
8199702|NCT02217475|20219106|P1|NOT COMPLETED|Discontinued After Period 1||2
8199703|NCT02217475|20219104|P3|COMPLETED|Discontinued After Period 1||121
8199704|NCT02217475|20219105|P2|COMPLETED|Discontinued After Period 1||61
8199705|NCT02217475|20219106|P1|COMPLETED|Discontinued After Period 1||60
8199706|NCT02217475|20219104|P3|STARTED|Discontinued After Period 1||124
8199707|NCT02217475|20219105|P2|STARTED|Discontinued After Period 1||64
8199708|NCT02217475|20219106|P1|STARTED|Discontinued After Period 1||62
8199709|NCT02217475|20219104|P3|NOT COMPLETED|Treatment Period 1 (Year 1)||21
8199710|NCT02217475|20219105|P2|NOT COMPLETED|Treatment Period 1 (Year 1)||8
8199711|NCT02217475|20219106|P1|NOT COMPLETED|Treatment Period 1 (Year 1)||10
8199712|NCT02217475|20219104|P3|COMPLETED|Treatment Period 1 (Year 1)||124
8199713|NCT02217475|20219105|P2|COMPLETED|Treatment Period 1 (Year 1)||64
8199714|NCT02217475|20219106|P1|COMPLETED|Treatment Period 1 (Year 1)||62
8199715|NCT02217475|20219104|P3|Safety Analysis Set|Treatment Period 1 (Year 1)||144
8199716|NCT02217475|20219105|P2|Safety Analysis Set|Treatment Period 1 (Year 1)||72
8199717|NCT02217475|20219106|P1|Safety Analysis Set|Treatment Period 1 (Year 1)||72
8199718|NCT02217475|20219104|P3|STARTED|Treatment Period 1 (Year 1)||145
8199719|NCT02217475|20219105|P2|STARTED|Treatment Period 1 (Year 1)||72
8199720|NCT02217475|20219106|P1|STARTED|Treatment Period 1 (Year 1)||72
8199721|NCT02217436|20219223|P2|NOT COMPLETED|Overall Study||2
8199722|NCT02217436|20219224|P1|NOT COMPLETED|Overall Study||1
8199723|NCT02217436|20219223|P2|COMPLETED|Overall Study||38
8199724|NCT02217436|20219224|P1|COMPLETED|Overall Study||39
8199725|NCT02217436|20219223|P2|STARTED|Overall Study||40
8199726|NCT02217436|20219224|P1|STARTED|Overall Study||40
8199727|NCT02217410|20219235|P3|NOT COMPLETED|Overall Study||5
8199728|NCT02217410|20219236|P2|NOT COMPLETED|Overall Study||4
8199729|NCT02217410|20219237|P1|NOT COMPLETED|Overall Study||1
8199730|NCT02217410|20219235|P3|COMPLETED|Overall Study||13
8199731|NCT02217410|20219236|P2|COMPLETED|Overall Study||30
8199732|NCT02217410|20219237|P1|COMPLETED|Overall Study||6
8199733|NCT02217410|20219235|P3|STARTED|Overall Study||18
8199734|NCT02217410|20219236|P2|STARTED|Overall Study||34
8199735|NCT02217410|20219237|P1|STARTED|Overall Study||7
8199736|NCT02217280|20219260|P1|NOT COMPLETED|Overall Study||4
8199737|NCT02217280|20219260|P1|COMPLETED|Overall Study||16
8199738|NCT02217280|20219260|P1|STARTED|Overall Study||20
8199739|NCT02216812|20219267|P2|NOT COMPLETED|Overall Study||5
8199740|NCT02216812|20219268|P1|NOT COMPLETED|Overall Study||10
8199741|NCT02216812|20219267|P2|COMPLETED|Overall Study||62
8199742|NCT02216812|20219268|P1|COMPLETED|Overall Study||57
8199743|NCT02216812|20219267|P2|STARTED|Overall Study||67
8199744|NCT02216812|20219268|P1|STARTED|Overall Study||67
8199745|NCT02216773|20219284|P2|NOT COMPLETED|Overall Study||5
8199746|NCT02216773|20219285|P1|NOT COMPLETED|Overall Study||12
8199747|NCT02216773|20219284|P2|COMPLETED|Overall Study||24
8199748|NCT02216773|20219285|P1|COMPLETED|Overall Study||16
8199749|NCT02216773|20219284|P2|Underwent Procedure (PVE/RALPPS)|Overall Study||26
8199750|NCT02216773|20219285|P1|Underwent Procedure (PVE/RALPPS)|Overall Study||24
8199751|NCT02216773|20219284|P2|STARTED|Overall Study||29
8199752|NCT02216773|20219285|P1|STARTED|Overall Study||28
8199753|NCT02216695|20219295|P1|NOT COMPLETED|Overall Study||0
8199754|NCT02216695|20219295|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
8199755|NCT02216695|20219295|P1|STARTED|Overall Study||64882
8199756|NCT02216591|20219306|P2|NOT COMPLETED|Overall Study||1
8199757|NCT02216591|20219307|P1|NOT COMPLETED|Overall Study||0
8199758|NCT02216591|20219306|P2|COMPLETED|Overall Study||9
8199759|NCT02216591|20219307|P1|COMPLETED|Overall Study||11
8199760|NCT02216591|20219306|P2|STARTED|Overall Study||10
8199761|NCT02216591|20219307|P1|STARTED|Overall Study||11
8199762|NCT02216526|20219320|P3|NOT COMPLETED|Overall Study||8
8199763|NCT02216526|20219321|P2|NOT COMPLETED|Overall Study||3
8199764|NCT02216526|20219322|P1|NOT COMPLETED|Overall Study||5
8199765|NCT02216526|20219320|P3|COMPLETED|Overall Study||36
8199766|NCT02216526|20219321|P2|COMPLETED|Overall Study||41
8199767|NCT02216526|20219322|P1|COMPLETED|Overall Study||40
8199768|NCT02216526|20219320|P3|STARTED|Overall Study||44
8199769|NCT02216526|20219321|P2|STARTED|Overall Study||44
8199770|NCT02216526|20219322|P1|STARTED|Overall Study||45
8199771|NCT02216422|20219432|P1|NOT COMPLETED|Overall Study||0
8199772|NCT02216422|20219432|P1|COMPLETED|Overall Study||36
8199773|NCT02216422|20219432|P1|STARTED|Overall Study||36
8199774|NCT02216357|20219440|P2|NOT COMPLETED|Overall Study||1
8199775|NCT02216357|20219441|P1|NOT COMPLETED|Overall Study||2
8199776|NCT02216357|20219440|P2|COMPLETED|Overall Study||4
8199777|NCT02216357|20219441|P1|COMPLETED|Overall Study||12
8199778|NCT02216357|20219440|P2|STARTED|Overall Study||5
8199779|NCT02216357|20219441|P1|STARTED|Overall Study||14
8199780|NCT02216214|20219467|P2|NOT COMPLETED|Overall Study||36
8199781|NCT02216214|20219468|P1|NOT COMPLETED|Overall Study||43
8199782|NCT02216214|20219467|P2|COMPLETED|Overall Study||409
8199783|NCT02216214|20219468|P1|COMPLETED|Overall Study||400
8199784|NCT02216214|20219467|P2|Treated|Overall Study||445
8199785|NCT02216214|20219468|P1|Treated|Overall Study||442
8199786|NCT02216214|20219467|P2|STARTED|Overall Study||445
8199787|NCT02216214|20219468|P1|STARTED|Overall Study||443
8199788|NCT02216136|20219527|P3|NOT COMPLETED|Overall Study||0
8199789|NCT02216136|20219528|P2|NOT COMPLETED|Overall Study||0
8199790|NCT02216136|20219529|P1|NOT COMPLETED|Overall Study||0
8199791|NCT02216136|20219527|P3|COMPLETED|Overall Study||0
8199792|NCT02216136|20219528|P2|COMPLETED|Overall Study||90
8199793|NCT02216136|20219529|P1|COMPLETED|Overall Study||72
8199794|NCT02216136|20219527|P3|STARTED|Overall Study||0
8199795|NCT02216136|20219528|P2|STARTED|Overall Study||90
8199796|NCT02216136|20219529|P1|STARTED|Overall Study||72
8199797|NCT02216123|20219539|P2|NOT COMPLETED|Overall Study||2
8199798|NCT02216123|20219540|P1|NOT COMPLETED|Overall Study||6
8199799|NCT02216123|20219539|P2|COMPLETED|Overall Study||83
8199800|NCT02216123|20219540|P1|COMPLETED|Overall Study||160
8199801|NCT02216123|20219539|P2|STARTED|Overall Study||85
8199802|NCT02216123|20219540|P1|STARTED|Overall Study||166
8199803|NCT02216097|20219606|P2|NOT COMPLETED|Overall Study||0
8199804|NCT02216097|20219607|P1|NOT COMPLETED|Overall Study||0
8199805|NCT02216097|20219606|P2|COMPLETED|Overall Study||6
8199806|NCT02216097|20219607|P1|COMPLETED|Overall Study||8
8199807|NCT02216097|20219606|P2|STARTED|Overall Study||6
8199808|NCT02216097|20219607|P1|STARTED|Overall Study||8
8199809|NCT02215967|20219633|P4|NOT COMPLETED|Overall Study||3
8199810|NCT02215967|20219634|P3|NOT COMPLETED|Overall Study||1
8199811|NCT02215967|20219635|P2|NOT COMPLETED|Overall Study||0
8199812|NCT02215967|20219636|P1|NOT COMPLETED|Overall Study||0
8199813|NCT02215967|20219633|P4|COMPLETED|Overall Study||16
8199814|NCT02215967|20219634|P3|COMPLETED|Overall Study||4
8199815|NCT02215967|20219635|P2|COMPLETED|Overall Study||3
8199816|NCT02215967|20219636|P1|COMPLETED|Overall Study||3
8199817|NCT02215967|20219633|P4|STARTED|Overall Study||19
8199818|NCT02215967|20219634|P3|STARTED|Overall Study||5
8199819|NCT02215967|20219635|P2|STARTED|Overall Study||3
8199820|NCT02215967|20219636|P1|STARTED|Overall Study||3
8199821|NCT02215954|20219657|P3|NOT COMPLETED|Overall Study||6
8199822|NCT02215954|20219658|P2|NOT COMPLETED|Overall Study||1
8199823|NCT02215954|20219659|P1|NOT COMPLETED|Overall Study||1
8199824|NCT02215954|20219657|P3|COMPLETED|Overall Study||205
8199825|NCT02215954|20219658|P2|COMPLETED|Overall Study||211
8199826|NCT02215954|20219659|P1|COMPLETED|Overall Study||213
8199827|NCT02215954|20219657|P3|Safety Analysis Set|Overall Study||208
8199828|NCT02215954|20219658|P2|Safety Analysis Set|Overall Study||211
8199829|NCT02215954|20219659|P1|Safety Analysis Set|Overall Study||213
8199830|NCT02215954|20219657|P3|Per Protocol (PP) Analysis Set|Overall Study||205
8199831|NCT02215954|20219658|P2|Per Protocol (PP) Analysis Set|Overall Study||208
8199832|NCT02215954|20219659|P1|Per Protocol (PP) Analysis Set|Overall Study||212
8199833|NCT02215954|20219657|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
8199834|NCT02215954|20219658|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
8199835|NCT02215954|20219659|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
8199836|NCT02215954|20219657|P3|STARTED|Overall Study||211
8199837|NCT02215954|20219658|P2|STARTED|Overall Study||212
8199838|NCT02215954|20219659|P1|STARTED|Overall Study||214
8199839|NCT02215616|20219683|P4|NOT COMPLETED|Overall Study||13
8199840|NCT02215616|20219684|P3|NOT COMPLETED|Overall Study||14
8199841|NCT02215616|20219685|P2|NOT COMPLETED|Overall Study||17
8199842|NCT02215616|20219686|P1|NOT COMPLETED|Overall Study||11
8199843|NCT02215616|20219683|P4|COMPLETED|Overall Study||17
8199844|NCT02215616|20219684|P3|COMPLETED|Overall Study||93
8199845|NCT02215616|20219685|P2|COMPLETED|Overall Study||90
8199846|NCT02215616|20219686|P1|COMPLETED|Overall Study||97
8199847|NCT02215616|20219683|P4|Received at Least 1 Dose of Study Drug|Overall Study||29
8199848|NCT02215616|20219684|P3|Received at Least 1 Dose of Study Drug|Overall Study||106
8199849|NCT02215616|20219685|P2|Received at Least 1 Dose of Study Drug|Overall Study||107
8199850|NCT02215616|20219686|P1|Received at Least 1 Dose of Study Drug|Overall Study||108
8199851|NCT02215616|20219683|P4|STARTED|Overall Study||30
8199852|NCT02215616|20219684|P3|STARTED|Overall Study||107
8199853|NCT02215616|20219685|P2|STARTED|Overall Study||107
8199854|NCT02215616|20219686|P1|STARTED|Overall Study||108
8199855|NCT02215369|20219700|P1|NOT COMPLETED|Overall Study||42
8199856|NCT02215369|20219700|P1|COMPLETED|Overall Study||70
8199857|NCT02215369|20219700|P1|STARTED|Overall Study||112
8199858|NCT02215252|20219708|P3|NOT COMPLETED|Overall Study||4
8199859|NCT02215252|20219709|P2|NOT COMPLETED|Overall Study||8
8199860|NCT02215252|20219710|P1|NOT COMPLETED|Overall Study||2
8199861|NCT02215252|20219708|P3|COMPLETED|Overall Study||41
8199862|NCT02215252|20219709|P2|COMPLETED|Overall Study||38
8199863|NCT02215252|20219710|P1|COMPLETED|Overall Study||42
8199864|NCT02215252|20219708|P3|STARTED|Overall Study||45
8199865|NCT02215252|20219709|P2|STARTED|Overall Study||46
8199866|NCT02215252|20219710|P1|STARTED|Overall Study||44
8199867|NCT02215200|20219770|P3|NOT COMPLETED|Overall Study||1
8199868|NCT02215200|20219771|P2|NOT COMPLETED|Overall Study||1
8199869|NCT02215200|20219772|P1|NOT COMPLETED|Overall Study||0
8199870|NCT02215200|20219770|P3|COMPLETED|Overall Study||30
8199871|NCT02215200|20219771|P2|COMPLETED|Overall Study||28
8199872|NCT02215200|20219772|P1|COMPLETED|Overall Study||29
8199873|NCT02215200|20219770|P3|STARTED|Overall Study||31
8199874|NCT02215200|20219771|P2|STARTED|Overall Study||29
8199875|NCT02215200|20219772|P1|STARTED|Overall Study||29
8199876|NCT02215161|20219780|P1|NOT COMPLETED|Overall Study||0
8199877|NCT02215161|20219780|P1|COMPLETED|Overall Study||14
8199878|NCT02215161|20219780|P1|STARTED|Overall Study||14
8199879|NCT02215096|20219798|P5|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
8199880|NCT02215096|20219799|P4|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
8199881|NCT02215096|20219800|P3|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
8199882|NCT02215096|20219801|P2|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
8199883|NCT02215096|20219802|P1|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
8199884|NCT02215096|20219798|P5|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
8199885|NCT02215096|20219799|P4|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
8199886|NCT02215096|20219800|P3|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
8199887|NCT02215096|20219801|P2|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
8199888|NCT02215096|20219802|P1|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
8199889|NCT02215096|20219798|P5|STARTED|Combination TP (Up to Maximum 654 Days)||2
8199890|NCT02215096|20219799|P4|STARTED|Combination TP (Up to Maximum 654 Days)||12
8199891|NCT02215096|20219800|P3|STARTED|Combination TP (Up to Maximum 654 Days)||11
8199892|NCT02215096|20219801|P2|STARTED|Combination TP (Up to Maximum 654 Days)||11
8199893|NCT02215096|20219802|P1|STARTED|Combination TP (Up to Maximum 654 Days)||0
8199894|NCT02215096|20219798|P5|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199895|NCT02215096|20219799|P4|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199896|NCT02215096|20219800|P3|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199897|NCT02215096|20219801|P2|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199898|NCT02215096|20219802|P1|NOT COMPLETED|Run-In Period (Up to Week 2)||1
8199899|NCT02215096|20219798|P5|COMPLETED|Run-In Period (Up to Week 2)||0
8199900|NCT02215096|20219799|P4|COMPLETED|Run-In Period (Up to Week 2)||0
8199901|NCT02215096|20219800|P3|COMPLETED|Run-In Period (Up to Week 2)||0
8199902|NCT02215096|20219801|P2|COMPLETED|Run-In Period (Up to Week 2)||0
8199903|NCT02215096|20219802|P1|COMPLETED|Run-In Period (Up to Week 2)||36
8199904|NCT02215096|20219798|P5|STARTED|Run-In Period (Up to Week 2)||0
8199905|NCT02215096|20219799|P4|STARTED|Run-In Period (Up to Week 2)||0
8199906|NCT02215096|20219800|P3|STARTED|Run-In Period (Up to Week 2)||0
8199907|NCT02215096|20219801|P2|STARTED|Run-In Period (Up to Week 2)||0
8199908|NCT02215096|20219802|P1|STARTED|Run-In Period (Up to Week 2)||37
8199909|NCT02215070|20219887|P1|NOT COMPLETED|Overall Study||6
8199910|NCT02215070|20219887|P1|COMPLETED|Overall Study||20
8199911|NCT02215070|20219887|P1|STARTED|Overall Study||26
8199912|NCT02214628|20219895|P2|NOT COMPLETED|Overall Study||29
8199913|NCT02214628|20219896|P1|NOT COMPLETED|Overall Study||27
8199914|NCT02214628|20219895|P2|COMPLETED|Overall Study||9
8199915|NCT02214628|20219896|P1|COMPLETED|Overall Study||36
8199916|NCT02214628|20219895|P2|STARTED|Overall Study||38
8199917|NCT02214628|20219896|P1|STARTED|Overall Study||63
8199918|NCT02214615|20219906|P2|NOT COMPLETED|Second Intervention||0
8199919|NCT02214615|20219907|P1|NOT COMPLETED|Second Intervention||0
8199920|NCT02214615|20219906|P2|COMPLETED|Second Intervention||1
8199921|NCT02214615|20219907|P1|COMPLETED|Second Intervention||1
8199922|NCT02214615|20219906|P2|STARTED|Second Intervention||1
8199923|NCT02214615|20219907|P1|STARTED|Second Intervention||1
8199924|NCT02214615|20219906|P2|NOT COMPLETED|Washout||0
8199925|NCT02214615|20219907|P1|NOT COMPLETED|Washout||0
8199926|NCT02214615|20219906|P2|COMPLETED|Washout||1
8199927|NCT02214615|20219907|P1|COMPLETED|Washout||1
8199928|NCT02214615|20219906|P2|STARTED|Washout||1
8199929|NCT02214615|20219907|P1|STARTED|Washout||1
8199930|NCT02214615|20219906|P2|NOT COMPLETED|First Intervention||0
8199931|NCT02214615|20219907|P1|NOT COMPLETED|First Intervention||0
8199932|NCT02214615|20219906|P2|COMPLETED|First Intervention||1
8199933|NCT02214615|20219907|P1|COMPLETED|First Intervention||1
8199934|NCT02214615|20219906|P2|STARTED|First Intervention||1
8199935|NCT02214615|20219907|P1|STARTED|First Intervention||1
8199936|NCT02214420|20219917|P2|NOT COMPLETED|Overall Study||0
8199937|NCT02214420|20219918|P1|NOT COMPLETED|Overall Study||1
8199938|NCT02214420|20219917|P2|COMPLETED|Overall Study||10
8199939|NCT02214420|20219918|P1|COMPLETED|Overall Study||13
8199940|NCT02214420|20219917|P2|STARTED|Overall Study||10
8199941|NCT02214420|20219918|P1|STARTED|Overall Study||14
8199942|NCT02214290|20219924|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8199943|NCT02214290|20219925|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8199944|NCT02214290|20219924|P2|COMPLETED|Second Intervention (7 Days)||8
8199945|NCT02214290|20219925|P1|COMPLETED|Second Intervention (7 Days)||8
8199946|NCT02214290|20219924|P2|STARTED|Second Intervention (7 Days)||8
8199947|NCT02214290|20219925|P1|STARTED|Second Intervention (7 Days)||8
8199948|NCT02214290|20219924|P2|NOT COMPLETED|Washout (14 Days)||0
8199949|NCT02214290|20219925|P1|NOT COMPLETED|Washout (14 Days)||0
8199950|NCT02214290|20219924|P2|COMPLETED|Washout (14 Days)||8
8199951|NCT02214290|20219925|P1|COMPLETED|Washout (14 Days)||8
8199952|NCT02214290|20219924|P2|STARTED|Washout (14 Days)||8
8199953|NCT02214290|20219925|P1|STARTED|Washout (14 Days)||8
8199954|NCT02214290|20219924|P2|NOT COMPLETED|First Intervention (7 Days)||0
8199955|NCT02214290|20219925|P1|NOT COMPLETED|First Intervention (7 Days)||0
8199956|NCT02214290|20219924|P2|COMPLETED|First Intervention (7 Days)||8
8199957|NCT02214290|20219925|P1|COMPLETED|First Intervention (7 Days)||8
8199958|NCT02214290|20219924|P2|STARTED|First Intervention (7 Days)||8
8199959|NCT02214290|20219925|P1|STARTED|First Intervention (7 Days)||8
8199960|NCT02214277|20219938|P3|NOT COMPLETED|Overall Study||34
8199961|NCT02214277|20219939|P2|NOT COMPLETED|Overall Study||25
8199962|NCT02214277|20219940|P1|NOT COMPLETED|Overall Study||19
8199963|NCT02214277|20219938|P3|COMPLETED|Overall Study||85
8199964|NCT02214277|20219939|P2|COMPLETED|Overall Study||96
8199965|NCT02214277|20219940|P1|COMPLETED|Overall Study||104
8199966|NCT02214277|20219938|P3|STARTED|Overall Study||119
8199967|NCT02214277|20219939|P2|STARTED|Overall Study||121
8199968|NCT02214277|20219940|P1|STARTED|Overall Study||123
8199969|NCT02214238|20219950|P2|NOT COMPLETED|Overall Study||6
8199970|NCT02214238|20219951|P1|NOT COMPLETED|Overall Study||6
8199971|NCT02214238|20219950|P2|COMPLETED|Overall Study||17
8199972|NCT02214238|20219951|P1|COMPLETED|Overall Study||20
8199973|NCT02214238|20219950|P2|STARTED|Overall Study||23
8199974|NCT02214238|20219951|P1|STARTED|Overall Study||26
8199975|NCT02214225|20219964|P3|NOT COMPLETED|Overall Study||22
8199976|NCT02214225|20219965|P2|NOT COMPLETED|Overall Study||19
8199977|NCT02214225|20219966|P1|NOT COMPLETED|Overall Study||55
8199978|NCT02214225|20219964|P3|COMPLETED|Overall Study||850
8199979|NCT02214225|20219965|P2|COMPLETED|Overall Study||852
8199980|NCT02214225|20219966|P1|COMPLETED|Overall Study||1686
8199981|NCT02214225|20219964|P3|STARTED|Overall Study||872
8199982|NCT02214225|20219965|P2|STARTED|Overall Study||871
8199983|NCT02214225|20219966|P1|STARTED|Overall Study||1741
8199984|NCT02214186|20220025|P2|NOT COMPLETED|Overall Study||2
8199985|NCT02214186|20220026|P1|NOT COMPLETED|Overall Study||2
8199986|NCT02214186|20220025|P2|COMPLETED|Overall Study||21
8199987|NCT02214186|20220026|P1|COMPLETED|Overall Study||21
8199988|NCT02214186|20220025|P2|STARTED|Overall Study||23
8199989|NCT02214186|20220026|P1|STARTED|Overall Study||23
8199990|NCT02214147|20220051|P3|NOT COMPLETED|Overall Study||0
8199991|NCT02214147|20220052|P2|NOT COMPLETED|Overall Study||0
8199992|NCT02214147|20220053|P1|NOT COMPLETED|Overall Study||0
8199993|NCT02214147|20220051|P3|COMPLETED|Overall Study||8
8199994|NCT02214147|20220052|P2|COMPLETED|Overall Study||12
8199995|NCT02214147|20220053|P1|COMPLETED|Overall Study||16
8199996|NCT02214147|20220051|P3|STARTED|Overall Study||8
8199997|NCT02214147|20220052|P2|STARTED|Overall Study||12
8199998|NCT02214147|20220053|P1|STARTED|Overall Study||16
8199999|NCT02214121|20220094|P3|NOT COMPLETED|Part B||1
8200000|NCT02214121|20220095|P2|NOT COMPLETED|Part B||3
8200001|NCT02214121|20220096|P1|NOT COMPLETED|Part B||0
8200002|NCT02214121|20220094|P3|COMPLETED|Part B||7
8200003|NCT02214121|20220095|P2|COMPLETED|Part B||14
8200004|NCT02214121|20220096|P1|COMPLETED|Part B||0
8200005|NCT02214121|20220094|P3|STARTED|Part B||8
8200006|NCT02214121|20220095|P2|STARTED|Part B||17
8200007|NCT02214121|20220096|P1|STARTED|Part B||0
8200008|NCT02214121|20220094|P3|NOT COMPLETED|Part A||0
8200009|NCT02214121|20220095|P2|NOT COMPLETED|Part A||0
8200010|NCT02214121|20220096|P1|NOT COMPLETED|Part A||7
8200011|NCT02214121|20220094|P3|COMPLETED|Part A||0
8200012|NCT02214121|20220095|P2|COMPLETED|Part A||0
8200013|NCT02214121|20220096|P1|COMPLETED|Part A||39
8200014|NCT02214121|20220094|P3|STARTED|Part A||0
8200015|NCT02214121|20220095|P2|STARTED|Part A||0
8200016|NCT02214121|20220096|P1|STARTED|Part A||46
8200017|NCT02214017|20220175|P2|NOT COMPLETED|Overall Study||0
8200018|NCT02214017|20220176|P1|NOT COMPLETED|Overall Study||0
8200019|NCT02214017|20220175|P2|COMPLETED|Overall Study||18
8200020|NCT02214017|20220176|P1|COMPLETED|Overall Study||22
8200021|NCT02214017|20220175|P2|STARTED|Overall Study||18
8200022|NCT02214017|20220176|P1|STARTED|Overall Study||22
8200023|NCT02213926|20220186|P1|NOT COMPLETED|Overall Study||70
8200024|NCT02213926|20220186|P1|COMPLETED|Overall Study||54
8200025|NCT02213926|20220186|P1|STARTED|Overall Study||124
8200026|NCT02213900|20220192|P2|NOT COMPLETED|Overall Study||0
8200027|NCT02213900|20220193|P1|NOT COMPLETED|Overall Study||0
8200028|NCT02213900|20220192|P2|COMPLETED|Overall Study||67
8200029|NCT02213900|20220193|P1|COMPLETED|Overall Study||68
8200030|NCT02213900|20220192|P2|STARTED|Overall Study||67
8200031|NCT02213900|20220193|P1|STARTED|Overall Study||68
8200032|NCT02213666|20220205|P1|NOT COMPLETED|Overall Study||1
8200033|NCT02213666|20220205|P1|COMPLETED|Overall Study||71
8200034|NCT02213666|20220205|P1|STARTED|Overall Study||72
8200035|NCT02213510|20220211|P2|NOT COMPLETED|Overall Study||1
8200036|NCT02213510|20220212|P1|NOT COMPLETED|Overall Study||1
8200037|NCT02213510|20220211|P2|COMPLETED|Overall Study||18
8200038|NCT02213510|20220212|P1|COMPLETED|Overall Study||20
8200039|NCT02213510|20220211|P2|STARTED|Overall Study||19
8200040|NCT02213510|20220212|P1|STARTED|Overall Study||21
8200041|NCT02213263|20220240|P2|NOT COMPLETED|Overall Study||26
8200042|NCT02213263|20220241|P1|NOT COMPLETED|Overall Study||28
8200043|NCT02213263|20220240|P2|COMPLETED|Overall Study||170
8200044|NCT02213263|20220241|P1|COMPLETED|Overall Study||170
8200045|NCT02213263|20220240|P2|Treated|Overall Study||196
8200046|NCT02213263|20220241|P1|Treated|Overall Study||197
8200047|NCT02213263|20220240|P2|STARTED|Overall Study||196
8200048|NCT02213263|20220241|P1|STARTED|Overall Study||198
8200049|NCT02213250|20220277|P2|NOT COMPLETED|Overall Study||0
8200050|NCT02213250|20220278|P1|NOT COMPLETED|Overall Study||0
8200051|NCT02213250|20220277|P2|COMPLETED|Overall Study||8
8200052|NCT02213250|20220278|P1|COMPLETED|Overall Study||4
8200053|NCT02213250|20220277|P2|STARTED|Overall Study||8
8200054|NCT02213250|20220278|P1|STARTED|Overall Study||4
8200055|NCT02213198|20220309|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
8200056|NCT02213198|20220310|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
8200057|NCT02213198|20220309|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
8200058|NCT02213198|20220310|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
8200059|NCT02213198|20220309|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
8200060|NCT02213198|20220310|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
8200061|NCT02213198|20220309|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
8200062|NCT02213198|20220310|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
8200063|NCT02213198|20220309|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
8200064|NCT02213198|20220310|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
8200065|NCT02213198|20220309|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
8200066|NCT02213198|20220310|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
8200067|NCT02213198|20220309|P2|NOT COMPLETED|Baseline||51
8200068|NCT02213198|20220310|P1|NOT COMPLETED|Baseline||88
8200069|NCT02213198|20220309|P2|COMPLETED|Baseline||108
8200070|NCT02213198|20220310|P1|COMPLETED|Baseline||218
8200071|NCT02213198|20220309|P2|STARTED|Baseline||159
8200072|NCT02213198|20220310|P1|STARTED|Baseline||306
8200073|NCT02213133|20220321|P3|NOT COMPLETED|Overall Study||3
8200074|NCT02213133|20220322|P2|NOT COMPLETED|Overall Study||5
8200075|NCT02213133|20220323|P1|NOT COMPLETED|Overall Study||37
8200076|NCT02213133|20220321|P3|COMPLETED|Overall Study||0
8200077|NCT02213133|20220322|P2|COMPLETED|Overall Study||0
8200078|NCT02213133|20220323|P1|COMPLETED|Overall Study||0
8200079|NCT02213133|20220321|P3|Treated|Overall Study||1
8200080|NCT02213133|20220322|P2|Treated|Overall Study||4
8200081|NCT02213133|20220323|P1|Treated|Overall Study||33
8200082|NCT02213133|20220321|P3|STARTED|Overall Study||3
8200083|NCT02213133|20220322|P2|STARTED|Overall Study||5
8200084|NCT02213133|20220323|P1|STARTED|Overall Study||37
8200085|NCT02213094|20220339|P2|NOT COMPLETED|Overall Study||0
8200086|NCT02213094|20220340|P1|NOT COMPLETED|Overall Study||1
8200087|NCT02213094|20220339|P2|COMPLETED|Overall Study||5
8200088|NCT02213094|20220340|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
8200089|NCT02213094|20220339|P2|STARTED|Overall Study||5
8200090|NCT02213094|20220340|P1|STARTED|Overall Study||5
8200091|NCT02213055|20220348|P2|NOT COMPLETED|Overall Study||0
8200092|NCT02213055|20220349|P1|NOT COMPLETED|Overall Study||39
8200093|NCT02213055|20220348|P2|COMPLETED|Overall Study||0
8200094|NCT02213055|20220349|P1|COMPLETED|Overall Study||58
8200095|NCT02213055|20220348|P2|STARTED|Overall Study||0
8200096|NCT02213055|20220349|P1|STARTED|Overall Study||97
8200097|NCT02212977|20220357|P2|NOT COMPLETED|Overall Study||6
8200098|NCT02212977|20220358|P1|NOT COMPLETED|Overall Study||5
8200099|NCT02212977|20220357|P2|COMPLETED|Overall Study||48
8200100|NCT02212977|20220358|P1|COMPLETED|Overall Study||50
8200101|NCT02212977|20220357|P2|STARTED|Overall Study||54
8200102|NCT02212977|20220358|P1|STARTED|Overall Study||55
8200103|NCT02212834|20220374|P2|NOT COMPLETED|Overall Study||0
8200104|NCT02212834|20220375|P1|NOT COMPLETED|Overall Study||0
8200105|NCT02212834|20220374|P2|COMPLETED|Overall Study||2506
8200106|NCT02212834|20220375|P1|COMPLETED|Overall Study||33938
8200107|NCT02212834|20220374|P2|STARTED|Overall Study||2506
8200108|NCT02212834|20220375|P1|STARTED|Overall Study||33938
8200109|NCT02212730|20220383|P2|NOT COMPLETED|Overall Study||1
8200110|NCT02212730|20220384|P1|NOT COMPLETED|Overall Study||2
8200111|NCT02212730|20220383|P2|COMPLETED|Overall Study||3
8200112|NCT02212730|20220384|P1|COMPLETED|Overall Study||4
8200113|NCT02212730|20220383|P2|Received Post-RCC Pembrolizumab|Overall Study||1
8200114|NCT02212730|20220384|P1|Received Post-RCC Pembrolizumab|Overall Study||1
8200115|NCT02212730|20220383|P2|Underwent RCC|Overall Study||3
8200116|NCT02212730|20220384|P1|Underwent RCC|Overall Study||4
8200117|NCT02212730|20220383|P2|Received Neoadjuvant Pembrolizumab|Overall Study||0
8200118|NCT02212730|20220384|P1|Received Neoadjuvant Pembrolizumab|Overall Study||4
8200119|NCT02212730|20220383|P2|STARTED|Overall Study||4
8200120|NCT02212730|20220384|P1|STARTED|Overall Study||6
8200121|NCT02212678|20220406|P1|NOT COMPLETED|Overall Study||1
8200122|NCT02212678|20220406|P1|COMPLETED|Overall Study||7
8200123|NCT02212678|20220406|P1|STARTED|Overall Study||8
8200124|NCT02212587|20220410|P1|NOT COMPLETED|Overall Study||1
8200125|NCT02212587|20220410|P1|COMPLETED|Overall Study||9
8200126|NCT02212587|20220410|P1|STARTED|Overall Study||10
8200127|NCT02212457|20220426|P6|NOT COMPLETED|Overall Study||13
8200128|NCT02212457|20220427|P5|NOT COMPLETED|Overall Study||15
8200129|NCT02212457|20220428|P4|NOT COMPLETED|Overall Study||11
8200130|NCT02212457|20220429|P3|NOT COMPLETED|Overall Study||16
8200131|NCT02212457|20220430|P2|NOT COMPLETED|Overall Study||21
8200132|NCT02212457|20220431|P1|NOT COMPLETED|Overall Study||19
8200133|NCT02212457|20220426|P6|COMPLETED|Overall Study||147
8200134|NCT02212457|20220427|P5|COMPLETED|Overall Study||137
8200135|NCT02212457|20220428|P4|COMPLETED|Overall Study||123
8200136|NCT02212457|20220429|P3|COMPLETED|Overall Study||141
8200137|NCT02212457|20220430|P2|COMPLETED|Overall Study||211
8200138|NCT02212457|20220431|P1|COMPLETED|Overall Study||209
8200139|NCT02212457|20220426|P6|STARTED|Overall Study||160
8200140|NCT02212457|20220427|P5|STARTED|Overall Study||152
8200141|NCT02212457|20220428|P4|STARTED|Overall Study||134
8200142|NCT02212457|20220429|P3|STARTED|Overall Study||157
8200143|NCT02212457|20220430|P2|STARTED|Overall Study||232
8200144|NCT02212457|20220431|P1|STARTED|Overall Study||228
8200145|NCT02212301|20220555|P2|NOT COMPLETED|Period 2||0
8200146|NCT02212301|20220556|P1|NOT COMPLETED|Period 2||0
8200147|NCT02212301|20220555|P2|COMPLETED|Period 2||21
8200148|NCT02212301|20220556|P1|COMPLETED|Period 2||21
8200149|NCT02212301|20220555|P2|STARTED|Period 2||21
8200150|NCT02212301|20220556|P1|STARTED|Period 2||21
8200151|NCT02212301|20220555|P2|NOT COMPLETED|Period 1||1
8200152|NCT02212301|20220556|P1|NOT COMPLETED|Period 1||0
8200153|NCT02212301|20220555|P2|COMPLETED|Period 1||21
8200154|NCT02212301|20220556|P1|COMPLETED|Period 1||21
8200155|NCT02212301|20220555|P2|STARTED|Period 1||22
8200156|NCT02212301|20220556|P1|STARTED|Period 1||21
8200157|NCT02212197|20220567|P3|NOT COMPLETED|Overall Study||0
8200158|NCT02212197|20220568|P2|NOT COMPLETED|Overall Study||0
8200159|NCT02212197|20220569|P1|NOT COMPLETED|Overall Study||1
8200160|NCT02212197|20220567|P3|COMPLETED|Overall Study||17
8200161|NCT02212197|20220568|P2|COMPLETED|Overall Study||15
8200162|NCT02212197|20220569|P1|COMPLETED|Overall Study||18
8200163|NCT02212197|20220567|P3|STARTED|Overall Study||17
8200164|NCT02212197|20220568|P2|STARTED|Overall Study||15
8200165|NCT02212197|20220569|P1|STARTED|Overall Study||19
8200166|NCT02212106|20220594|P2|NOT COMPLETED|Overall Study||4
8200167|NCT02212106|20220595|P1|NOT COMPLETED|Overall Study||10
8200168|NCT02212106|20220594|P2|COMPLETED|Overall Study||96
8200169|NCT02212106|20220595|P1|COMPLETED|Overall Study||292
8200170|NCT02212106|20220594|P2|STARTED|Overall Study||100
8200171|NCT02212106|20220595|P1|STARTED|Overall Study||302
8200172|NCT02212028|20220613|P2|NOT COMPLETED|Overall Study||0
8200173|NCT02212028|20220614|P1|NOT COMPLETED|Overall Study||0
8200174|NCT02212028|20220613|P2|COMPLETED|Overall Study||26
8200175|NCT02212028|20220614|P1|COMPLETED|Overall Study||26
8200176|NCT02212028|20220613|P2|STARTED|Overall Study||26
8200177|NCT02212028|20220614|P1|STARTED|Overall Study||26
8200178|NCT02211638|20220622|P1|NOT COMPLETED|Overall Study||983
8200179|NCT02211638|20220622|P1|COMPLETED|Overall Study||17130
8200180|NCT02211638|20220622|P1|STARTED|Overall Study||18113
8200181|NCT02211534|20220633|P2|NOT COMPLETED|Overall Study||5
8200182|NCT02211534|20220634|P1|NOT COMPLETED|Overall Study||13
8200183|NCT02211534|20220633|P2|COMPLETED|Overall Study||6
8200184|NCT02211534|20220634|P1|COMPLETED|Overall Study||11
8200185|NCT02211534|20220633|P2|STARTED|Overall Study||11
8200186|NCT02211534|20220634|P1|STARTED|Overall Study||24
8200187|NCT02211495|20220656|P2|NOT COMPLETED|Overall Study||0
8200188|NCT02211495|20220657|P1|NOT COMPLETED|Overall Study||0
8200189|NCT02211495|20220656|P2|COMPLETED|Overall Study||4
8200190|NCT02211495|20220657|P1|COMPLETED|Overall Study||4
8200191|NCT02211495|20220656|P2|STARTED|Overall Study||4
8200192|NCT02211495|20220657|P1|STARTED|Overall Study||4
8200193|NCT02211313|20220669|P2|NOT COMPLETED|Overall Study||3
8200194|NCT02211313|20220670|P1|NOT COMPLETED|Overall Study||6
8200195|NCT02211313|20220669|P2|COMPLETED|Overall Study||20
8200196|NCT02211313|20220670|P1|COMPLETED|Overall Study||12
8200197|NCT02211313|20220669|P2|STARTED|Overall Study||23
8200198|NCT02211313|20220670|P1|STARTED|Overall Study||18
8200199|NCT02211261|20220687|P11|NOT COMPLETED|Overall Study||0
8200200|NCT02211261|20220688|P10|NOT COMPLETED|Overall Study||2
8200201|NCT02211261|20220689|P9|NOT COMPLETED|Overall Study||0
8200202|NCT02211261|20220690|P8|NOT COMPLETED|Overall Study||1
8200203|NCT02211261|20220691|P7|NOT COMPLETED|Overall Study||0
8200204|NCT02211261|20220692|P6|NOT COMPLETED|Overall Study||1
8200205|NCT02211261|20220693|P5|NOT COMPLETED|Overall Study||2
8200206|NCT02211261|20220694|P4|NOT COMPLETED|Overall Study||0
8200207|NCT02211261|20220695|P3|NOT COMPLETED|Overall Study||1
8200208|NCT02211261|20220696|P2|NOT COMPLETED|Overall Study||0
8200209|NCT02211261|20220697|P1|NOT COMPLETED|Overall Study||0
8200210|NCT02211261|20220687|P11|COMPLETED|Overall Study||8
8200211|NCT02211261|20220688|P10|COMPLETED|Overall Study||14
8200212|NCT02211261|20220689|P9|COMPLETED|Overall Study||8
8200213|NCT02211261|20220690|P8|COMPLETED|Overall Study||7
8200214|NCT02211261|20220691|P7|COMPLETED|Overall Study||6
8200215|NCT02211261|20220692|P6|COMPLETED|Overall Study||1
8200216|NCT02211261|20220693|P5|COMPLETED|Overall Study||7
8200217|NCT02211261|20220694|P4|COMPLETED|Overall Study||6
8200218|NCT02211261|20220695|P3|COMPLETED|Overall Study||5
8200219|NCT02211261|20220696|P2|COMPLETED|Overall Study||6
8200220|NCT02211261|20220697|P1|COMPLETED|Overall Study||9
8200221|NCT02211261|20220687|P11|STARTED|Overall Study||8
8200222|NCT02211261|20220688|P10|STARTED|Overall Study||16
8200223|NCT02211261|20220689|P9|STARTED|Overall Study||8
8200224|NCT02211261|20220690|P8|STARTED|Overall Study||8
8200225|NCT02211261|20220691|P7|STARTED|Overall Study||6
8200226|NCT02211261|20220692|P6|STARTED|Overall Study||2
8200227|NCT02211261|20220693|P5|STARTED|Overall Study||9
8200228|NCT02211261|20220694|P4|STARTED|Overall Study||6
8200229|NCT02211261|20220695|P3|STARTED|Overall Study||6
8200230|NCT02211261|20220696|P2|STARTED|Overall Study||6
8200231|NCT02211261|20220697|P1|STARTED|Overall Study||9
8200232|NCT02211131|20220820|P2|NOT COMPLETED|Overall Study||76
8200233|NCT02211131|20220821|P1|NOT COMPLETED|Overall Study||74
8200234|NCT02211131|20220820|P2|COMPLETED|Overall Study||0
8200235|NCT02211131|20220821|P1|COMPLETED|Overall Study||0
8200236|NCT02211131|20220820|P2|STARTED|Overall Study||76
8200237|NCT02211131|20220821|P1|STARTED|Overall Study||74
8200238|NCT02211014|20220855|P2|NOT COMPLETED|Overall Study||6
8200239|NCT02211014|20220856|P1|NOT COMPLETED|Overall Study||2
8200240|NCT02211014|20220855|P2|COMPLETED|Overall Study||8
8200241|NCT02211014|20220856|P1|COMPLETED|Overall Study||11
8200242|NCT02211014|20220855|P2|STARTED|Overall Study||14
8200243|NCT02211014|20220856|P1|STARTED|Overall Study||13
8200244|NCT02210780|20220882|P2|NOT COMPLETED|Overall Study||8
8200245|NCT02210780|20220883|P1|NOT COMPLETED|Overall Study||5
8200246|NCT02210780|20220882|P2|COMPLETED|Overall Study||89
8200247|NCT02210780|20220883|P1|COMPLETED|Overall Study||92
8200248|NCT02210780|20220882|P2|STARTED|Overall Study||97
8200249|NCT02210780|20220883|P1|STARTED|Overall Study||97
8200250|NCT02210689|20220912|P3|NOT COMPLETED|Overall Study||23
8200251|NCT02210689|20220913|P2|NOT COMPLETED|Overall Study||47
8200252|NCT02210689|20220914|P1|NOT COMPLETED|Overall Study||52
8200253|NCT02210689|20220912|P3|COMPLETED|Overall Study||99
8200254|NCT02210689|20220913|P2|COMPLETED|Overall Study||193
8200255|NCT02210689|20220914|P1|COMPLETED|Overall Study||190
8200256|NCT02210689|20220912|P3|PP Population|Overall Study||84
8200257|NCT02210689|20220913|P2|PP Population|Overall Study||169
8200258|NCT02210689|20220914|P1|PP Population|Overall Study||164
8200259|NCT02210689|20220912|P3|mITT Population|Overall Study||107
8200260|NCT02210689|20220913|P2|mITT Population|Overall Study||207
8200261|NCT02210689|20220914|P1|mITT Population|Overall Study||199
8200262|NCT02210689|20220912|P3|Safety Population|Overall Study||122
8200263|NCT02210689|20220913|P2|Safety Population|Overall Study||236
8200264|NCT02210689|20220914|P1|Safety Population|Overall Study||233
8200265|NCT02210689|20220912|P3|STARTED|Overall Study||122
8200266|NCT02210689|20220913|P2|STARTED|Overall Study||240
8200267|NCT02210689|20220914|P1|STARTED|Overall Study||242
8200268|NCT02210221|20220922|P1|NOT COMPLETED|Overall Study||50
8200269|NCT02210221|20220922|P1|COMPLETED|Overall Study||4509
8200270|NCT02210221|20220922|P1|STARTED|Overall Study||4559
8200271|NCT02210208|20220937|P1|NOT COMPLETED|Period B (Donor Site)||7
8200272|NCT02210208|20220937|P1|COMPLETED|Period B (Donor Site)||12
8200273|NCT02210208|20220937|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
8200274|NCT02210208|20220937|P1|NOT COMPLETED|Period A (Graft Site)||2
8200275|NCT02210208|20220937|P1|COMPLETED|Period A (Graft Site)||23
8200276|NCT02210208|20220937|P1|STARTED|Period A (Graft Site)||25
8200277|NCT02210195|20220946|P2|NOT COMPLETED|Overall Study||0
8200278|NCT02210195|20220947|P1|NOT COMPLETED|Overall Study||4
8200279|NCT02210195|20220946|P2|COMPLETED|Overall Study||10
8200280|NCT02210195|20220947|P1|COMPLETED|Overall Study||6
8200281|NCT02210195|20220946|P2|STARTED|Overall Study||10
8200282|NCT02210195|20220947|P1|STARTED|Overall Study||10
8200283|NCT02210091|20220957|P2|NOT COMPLETED|Overall Study||2
8200284|NCT02210091|20220958|P1|NOT COMPLETED|Overall Study||0
8200285|NCT02210091|20220957|P2|COMPLETED|Overall Study||32
8200286|NCT02210091|20220958|P1|COMPLETED|Overall Study||32
8200287|NCT02210091|20220957|P2|STARTED|Overall Study||34
8200288|NCT02210091|20220958|P1|STARTED|Overall Study||32
8200289|NCT02210065|20221030|P1|NOT COMPLETED|Overall Study||0
8200290|NCT02210065|20221030|P1|COMPLETED|Overall Study||1
8200291|NCT02210065|20221030|P1|STARTED|Overall Study||1
8200292|NCT02210052|20221035|P1|NOT COMPLETED|Overall Study||0
8200293|NCT02210052|20221035|P1|COMPLETED|Overall Study||6
8200294|NCT02210052|20221035|P1|STARTED|Overall Study||6
8200295|NCT02210039|20221039|P1|NOT COMPLETED|Overall Study||0
8200296|NCT02210039|20221039|P1|COMPLETED|Overall Study||6
8200297|NCT02210039|20221039|P1|STARTED|Overall Study||6
8200298|NCT02210000|20221045|P2|NOT COMPLETED|Overall Study||21
8200299|NCT02210000|20221046|P1|NOT COMPLETED|Overall Study||19
8200300|NCT02210000|20221045|P2|COMPLETED|Overall Study||36
8200301|NCT02210000|20221046|P1|COMPLETED|Overall Study||38
8200302|NCT02210000|20221045|P2|STARTED|Overall Study||57
8200303|NCT02210000|20221046|P1|STARTED|Overall Study||57
8200304|NCT02209948|20221070|P2|NOT COMPLETED|Overall Study||0
8200305|NCT02209948|20221071|P1|NOT COMPLETED|Overall Study||0
8200306|NCT02209948|20221070|P2|COMPLETED|Overall Study||79
8200307|NCT02209948|20221071|P1|COMPLETED|Overall Study||80
8200308|NCT02209948|20221070|P2|Discontinued Due to Progression|Overall Study||39
8200309|NCT02209948|20221071|P1|Discontinued Due to Progression|Overall Study||31
8200310|NCT02209948|20221070|P2|Lost to Follow up|Overall Study||1
8200311|NCT02209948|20221071|P1|Lost to Follow up|Overall Study||0
8200312|NCT02209948|20221070|P2|Recieved Alocated Intervention|Overall Study||79
8200313|NCT02209948|20221071|P1|Recieved Alocated Intervention|Overall Study||80
8200314|NCT02209948|20221070|P2|STARTED|Overall Study||79
8200315|NCT02209948|20221071|P1|STARTED|Overall Study||80
8200316|NCT02209766|20221093|P5|NOT COMPLETED|Overall Study||0
8200317|NCT02209766|20221094|P4|NOT COMPLETED|Overall Study||1
8200318|NCT02209766|20221095|P3|NOT COMPLETED|Overall Study||0
8200319|NCT02209766|20221096|P2|NOT COMPLETED|Overall Study||0
8200320|NCT02209766|20221097|P1|NOT COMPLETED|Overall Study||0
8200321|NCT02209766|20221093|P5|COMPLETED|Overall Study||6
8200322|NCT02209766|20221094|P4|COMPLETED|Overall Study||2
8200323|NCT02209766|20221095|P3|COMPLETED|Overall Study||6
8200324|NCT02209766|20221096|P2|COMPLETED|Overall Study||3
8200325|NCT02209766|20221097|P1|COMPLETED|Overall Study||6
8200326|NCT02209766|20221093|P5|STARTED|Overall Study||6
8200327|NCT02209766|20221094|P4|STARTED|Overall Study||3
8200328|NCT02209766|20221095|P3|STARTED|Overall Study||6
8200329|NCT02209766|20221096|P2|STARTED|Overall Study||3
8200330|NCT02209766|20221097|P1|STARTED|Overall Study||6
8200331|NCT02209610|20221145|P2|NOT COMPLETED|Overall Study||0
8200332|NCT02209610|20221146|P1|NOT COMPLETED|Overall Study||0
8200333|NCT02209610|20221145|P2|COMPLETED|Overall Study||16
8200334|NCT02209610|20221146|P1|COMPLETED|Overall Study||16
8200335|NCT02209610|20221145|P2|STARTED|Overall Study||16
8200336|NCT02209610|20221146|P1|STARTED|Overall Study||16
8200337|NCT02209597|20221156|P1|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
8200338|NCT02209597|20221156|P1|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
8200339|NCT02209597|20221156|P1|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
8200340|NCT02209597|20221156|P1|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
8200341|NCT02209597|20221156|P1|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
8200342|NCT02209597|20221156|P1|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
8200343|NCT02209597|20221156|P1|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
8200344|NCT02209597|20221156|P1|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
8200345|NCT02209597|20221156|P1|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
8200346|NCT02209597|20221156|P1|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
8200347|NCT02209597|20221156|P1|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
8200348|NCT02209597|20221156|P1|STARTED|Phase 1 Current Tx (Non-randomized)||74
8200349|NCT02209532|20221168|P2|NOT COMPLETED|Overall Study||1
8200350|NCT02209532|20221169|P1|NOT COMPLETED|Overall Study||3
8200351|NCT02209532|20221168|P2|COMPLETED|Overall Study||89
8200352|NCT02209532|20221169|P1|COMPLETED|Overall Study||87
8200353|NCT02209532|20221168|P2|STARTED|Overall Study||90
8200354|NCT02209532|20221169|P1|STARTED|Overall Study||90
8200355|NCT02209519|20221187|P2|NOT COMPLETED|Overall Study||0
8200356|NCT02209519|20221188|P1|NOT COMPLETED|Overall Study||0
8200357|NCT02209519|20221187|P2|COMPLETED|Overall Study||107
8200358|NCT02209519|20221188|P1|COMPLETED|Overall Study||107
8200359|NCT02209519|20221187|P2|STARTED|Overall Study||107
8200360|NCT02209519|20221188|P1|STARTED|Overall Study||107
8200361|NCT02209506|20221201|P5|NOT COMPLETED|Overall Study||1
8200362|NCT02209506|20221202|P4|NOT COMPLETED|Overall Study||0
8200363|NCT02209506|20221203|P3|NOT COMPLETED|Overall Study||0
8200364|NCT02209506|20221204|P2|NOT COMPLETED|Overall Study||0
8200365|NCT02209506|20221205|P1|NOT COMPLETED|Overall Study||0
8200366|NCT02209506|20221201|P5|COMPLETED|Overall Study||5
8200367|NCT02209506|20221202|P4|COMPLETED|Overall Study||2
8200368|NCT02209506|20221203|P3|COMPLETED|Overall Study||6
8200369|NCT02209506|20221204|P2|COMPLETED|Overall Study||6
8200370|NCT02209506|20221205|P1|COMPLETED|Overall Study||3
8200371|NCT02209506|20221201|P5|STARTED|Overall Study||6
8200372|NCT02209506|20221202|P4|STARTED|Overall Study||2
8200373|NCT02209506|20221203|P3|STARTED|Overall Study||6
8200374|NCT02209506|20221204|P2|STARTED|Overall Study||6
8200375|NCT02209506|20221205|P1|STARTED|Overall Study||3
8200376|NCT02209454|20221280|P2|NOT COMPLETED|Second Period||0
8200377|NCT02209454|20221281|P1|NOT COMPLETED|Second Period||1
8200378|NCT02209454|20221280|P2|COMPLETED|Second Period||13
8200379|NCT02209454|20221281|P1|COMPLETED|Second Period||12
8200380|NCT02209454|20221280|P2|STARTED|Second Period||13
8200381|NCT02209454|20221281|P1|STARTED|Second Period||13
8200382|NCT02209454|20221280|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8200383|NCT02209454|20221281|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8200384|NCT02209454|20221280|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
8200385|NCT02209454|20221281|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
8200386|NCT02209454|20221280|P2|STARTED|Washout Period a Minimum of a 7 Day||13
8200387|NCT02209454|20221281|P1|STARTED|Washout Period a Minimum of a 7 Day||13
8200388|NCT02209454|20221280|P2|NOT COMPLETED|First Period||0
8200389|NCT02209454|20221281|P1|NOT COMPLETED|First Period||0
8200390|NCT02209454|20221280|P2|COMPLETED|First Period||13
8200391|NCT02209454|20221281|P1|COMPLETED|First Period||13
8200392|NCT02209454|20221280|P2|STARTED|First Period||13
8200393|NCT02209454|20221281|P1|STARTED|First Period||13
8200394|NCT02209272|20221297|P2|NOT COMPLETED|Overall Study||0
8200395|NCT02209272|20221298|P1|NOT COMPLETED|Overall Study||0
8200396|NCT02209272|20221297|P2|COMPLETED|Overall Study||36
8200397|NCT02209272|20221298|P1|COMPLETED|Overall Study||32
8200398|NCT02209272|20221297|P2|STARTED|Overall Study||36
8200399|NCT02209272|20221298|P1|STARTED|Overall Study||32
8200400|NCT02209259|20221311|P3|NOT COMPLETED|Overall Study||0
8200401|NCT02209259|20221312|P2|NOT COMPLETED|Overall Study||0
8200402|NCT02209259|20221313|P1|NOT COMPLETED|Overall Study||0
8200403|NCT02209259|20221311|P3|COMPLETED|Overall Study||56
8200404|NCT02209259|20221312|P2|COMPLETED|Overall Study||56
8200405|NCT02209259|20221313|P1|COMPLETED|Overall Study||56
8200406|NCT02209259|20221311|P3|STARTED|Overall Study||56
8200407|NCT02209259|20221312|P2|STARTED|Overall Study||56
8200408|NCT02209259|20221313|P1|STARTED|Overall Study||56
8200409|NCT02209181|20221331|P4|NOT COMPLETED|Overall Study||0
8200410|NCT02209181|20221332|P3|NOT COMPLETED|Overall Study||1
8200411|NCT02209181|20221333|P2|NOT COMPLETED|Overall Study||1
8200412|NCT02209181|20221334|P1|NOT COMPLETED|Overall Study||1
8200413|NCT02209181|20221331|P4|COMPLETED|Overall Study||66
8200414|NCT02209181|20221332|P3|COMPLETED|Overall Study||68
8200415|NCT02209181|20221333|P2|COMPLETED|Overall Study||66
8200416|NCT02209181|20221334|P1|COMPLETED|Overall Study||66
8200417|NCT02209181|20221331|P4|STARTED|Overall Study||66
8200418|NCT02209181|20221332|P3|STARTED|Overall Study||69
8200419|NCT02209181|20221333|P2|STARTED|Overall Study||67
8200420|NCT02209181|20221334|P1|STARTED|Overall Study||67
8200421|NCT02209064|20221496|P1|NOT COMPLETED|Overall Study||0
8200422|NCT02209064|20221496|P1|COMPLETED|Overall Study||25
8200423|NCT02209064|20221496|P1|STARTED|Overall Study||25
8200424|NCT02208999|20221505|P1|NOT COMPLETED|Overall Study||1
8200425|NCT02208999|20221505|P1|COMPLETED|Overall Study||105
8200426|NCT02208999|20221505|P1|STARTED|Overall Study||106
8200427|NCT02208843|20221527|P1|NOT COMPLETED|Overall Study||60
8200428|NCT02208843|20221527|P1|COMPLETED|Overall Study||0
8200429|NCT02208843|20221527|P1|STARTED|Overall Study||60
8200430|NCT02208349|20221535|P2|NOT COMPLETED|Sixth 6 Month||0
8200431|NCT02208349|20221536|P1|NOT COMPLETED|Sixth 6 Month||0
8200432|NCT02208349|20221535|P2|COMPLETED|Sixth 6 Month||2
8200433|NCT02208349|20221536|P1|COMPLETED|Sixth 6 Month||3
8200434|NCT02208349|20221535|P2|STARTED|Sixth 6 Month||2
8200435|NCT02208349|20221536|P1|STARTED|Sixth 6 Month||3
8200436|NCT02208349|20221535|P2|NOT COMPLETED|Fifth 6 Month||0
8200437|NCT02208349|20221536|P1|NOT COMPLETED|Fifth 6 Month||0
8200438|NCT02208349|20221535|P2|COMPLETED|Fifth 6 Month||2
8200439|NCT02208349|20221536|P1|COMPLETED|Fifth 6 Month||7
8200440|NCT02208349|20221535|P2|STARTED|Fifth 6 Month||2
8200441|NCT02208349|20221536|P1|STARTED|Fifth 6 Month||7
8200442|NCT02208349|20221535|P2|NOT COMPLETED|Fourth 6 Month||0
8200443|NCT02208349|20221536|P1|NOT COMPLETED|Fourth 6 Month||0
8200444|NCT02208349|20221535|P2|COMPLETED|Fourth 6 Month||2
8200445|NCT02208349|20221536|P1|COMPLETED|Fourth 6 Month||14
8200446|NCT02208349|20221535|P2|STARTED|Fourth 6 Month||2
8200447|NCT02208349|20221536|P1|STARTED|Fourth 6 Month||14
8200448|NCT02208349|20221535|P2|NOT COMPLETED|Third 6 Month||0
8200449|NCT02208349|20221536|P1|NOT COMPLETED|Third 6 Month||0
8200450|NCT02208349|20221535|P2|COMPLETED|Third 6 Month||3
8200451|NCT02208349|20221536|P1|COMPLETED|Third 6 Month||6
8200452|NCT02208349|20221535|P2|STARTED|Third 6 Month||3
8200453|NCT02208349|20221536|P1|STARTED|Third 6 Month||6
8200454|NCT02208349|20221535|P2|NOT COMPLETED|Second 6 Months||0
8200455|NCT02208349|20221536|P1|NOT COMPLETED|Second 6 Months||0
8200456|NCT02208349|20221535|P2|COMPLETED|Second 6 Months||7
8200457|NCT02208349|20221536|P1|COMPLETED|Second 6 Months||11
8200458|NCT02208349|20221535|P2|STARTED|Second 6 Months||7
8200459|NCT02208349|20221536|P1|STARTED|Second 6 Months||11
8200460|NCT02208349|20221535|P2|NOT COMPLETED|Initial 6 Months||0
8200461|NCT02208349|20221536|P1|NOT COMPLETED|Initial 6 Months||0
8200462|NCT02208349|20221535|P2|COMPLETED|Initial 6 Months||9
8200463|NCT02208349|20221536|P1|COMPLETED|Initial 6 Months||16
8200464|NCT02208349|20221535|P2|STARTED|Initial 6 Months||9
8200465|NCT02208349|20221536|P1|STARTED|Initial 6 Months||16
8200466|NCT02208310|20221546|P2|NOT COMPLETED|Overall Study||5
8200467|NCT02208310|20221547|P1|NOT COMPLETED|Overall Study||6
8200468|NCT02208310|20221546|P2|COMPLETED|Overall Study||0
8200469|NCT02208310|20221547|P1|COMPLETED|Overall Study||0
8200470|NCT02208310|20221546|P2|Day 180|Overall Study||1
8200471|NCT02208310|20221547|P1|Day 180|Overall Study||0
8200472|NCT02208310|20221546|P2|STARTED|Overall Study||5
8200473|NCT02208310|20221547|P1|STARTED|Overall Study||6
8200474|NCT02208297|20221579|P2|NOT COMPLETED|Overall Study||56
8200475|NCT02208297|20221580|P1|NOT COMPLETED|Overall Study||22
8200476|NCT02208297|20221579|P2|COMPLETED|Overall Study||107
8200477|NCT02208297|20221580|P1|COMPLETED|Overall Study||141
8200478|NCT02208297|20221579|P2|STARTED|Overall Study||163
8200479|NCT02208297|20221580|P1|STARTED|Overall Study||163
8200480|NCT02208089|20221598|P2|NOT COMPLETED|Overall Study||0
8200481|NCT02208089|20221599|P1|NOT COMPLETED|Overall Study||7
8200482|NCT02208089|20221598|P2|COMPLETED|Overall Study||47
8200483|NCT02208089|20221599|P1|COMPLETED|Overall Study||40
8200484|NCT02208089|20221598|P2|STARTED|Overall Study||47
8200485|NCT02208089|20221599|P1|STARTED|Overall Study||47
8200486|NCT02208063|20221615|P2|NOT COMPLETED|Overall Study||11
8200487|NCT02208063|20221616|P1|NOT COMPLETED|Overall Study||12
8200488|NCT02208063|20221615|P2|COMPLETED|Overall Study||50
8200489|NCT02208063|20221616|P1|COMPLETED|Overall Study||48
8200490|NCT02208063|20221615|P2|Microbiological All Treated|Overall Study||52
8200491|NCT02208063|20221616|P1|Microbiological All Treated|Overall Study||47
8200492|NCT02208063|20221615|P2|Randomized and Treated|Overall Study||60
8200493|NCT02208063|20221616|P1|Randomized and Treated|Overall Study||58
8200494|NCT02208063|20221615|P2|STARTED|Overall Study||61
8200495|NCT02208063|20221616|P1|STARTED|Overall Study||60
8200496|NCT02208037|20221631|P3|NOT COMPLETED|Overall Study||1
8200497|NCT02208037|20221632|P2|NOT COMPLETED|Overall Study||1
8200498|NCT02208037|20221633|P1|NOT COMPLETED|Overall Study||4
8200499|NCT02208037|20221631|P3|COMPLETED|Overall Study||92
8200500|NCT02208037|20221632|P2|COMPLETED|Overall Study||92
8200501|NCT02208037|20221633|P1|COMPLETED|Overall Study||89
8200502|NCT02208037|20221631|P3|STARTED|Overall Study||93
8200503|NCT02208037|20221632|P2|STARTED|Overall Study||93
8200504|NCT02208037|20221633|P1|STARTED|Overall Study||93
8200505|NCT02207972|20221682|P2|NOT COMPLETED|Overall Study||0
8200506|NCT02207972|20221683|P1|NOT COMPLETED|Overall Study||0
8200507|NCT02207972|20221682|P2|COMPLETED|Overall Study||24
8200508|NCT02207972|20221683|P1|COMPLETED|Overall Study||22
8200509|NCT02207972|20221682|P2|STARTED|Overall Study||24
8200510|NCT02207972|20221683|P1|STARTED|Overall Study||22
8200511|NCT02207907|20221695|P2|NOT COMPLETED|Overall Study||8
8200512|NCT02207907|20221696|P1|NOT COMPLETED|Overall Study||11
8200513|NCT02207907|20221695|P2|COMPLETED|Overall Study||115
8200514|NCT02207907|20221696|P1|COMPLETED|Overall Study||113
8200515|NCT02207907|20221695|P2|STARTED|Overall Study||123
8200516|NCT02207907|20221696|P1|STARTED|Overall Study||124
8200517|NCT02207829|20221714|P2|NOT COMPLETED|Overall Study||34
8200518|NCT02207829|20221715|P1|NOT COMPLETED|Overall Study||42
8200519|NCT02207829|20221714|P2|COMPLETED|Overall Study||474
8200520|NCT02207829|20221715|P1|COMPLETED|Overall Study||467
8200521|NCT02207829|20221714|P2|STARTED|Overall Study||508
8200522|NCT02207829|20221715|P1|STARTED|Overall Study||509
8200523|NCT02207816|20221724|P3|NOT COMPLETED|Overall Study||67
8200524|NCT02207816|20221725|P2|NOT COMPLETED|Overall Study||86
8200525|NCT02207816|20221726|P1|NOT COMPLETED|Overall Study||51
8200526|NCT02207816|20221724|P3|COMPLETED|Overall Study||961
8200527|NCT02207816|20221725|P2|COMPLETED|Overall Study||924
8200528|NCT02207816|20221726|P1|COMPLETED|Overall Study||995
8200529|NCT02207816|20221724|P3|STARTED|Overall Study||1028
8200530|NCT02207816|20221725|P2|STARTED|Overall Study||1010
8200531|NCT02207816|20221726|P1|STARTED|Overall Study||1046
8200532|NCT02207803|20221871|P2|NOT COMPLETED|Overall Study||17
8200533|NCT02207803|20221872|P1|NOT COMPLETED|Overall Study||15
8200534|NCT02207803|20221871|P2|COMPLETED|Overall Study||108
8200535|NCT02207803|20221872|P1|COMPLETED|Overall Study||110
8200536|NCT02207803|20221871|P2|STARTED|Overall Study||125
8200537|NCT02207803|20221872|P1|STARTED|Overall Study||125
8200538|NCT02207725|20221884|P4|NOT COMPLETED|Overall Study||1
8200539|NCT02207725|20221885|P3|NOT COMPLETED|Overall Study||1
8200540|NCT02207725|20221886|P2|NOT COMPLETED|Overall Study||1
8200541|NCT02207725|20221887|P1|NOT COMPLETED|Overall Study||0
8200542|NCT02207725|20221884|P4|COMPLETED|Overall Study||24
8200543|NCT02207725|20221885|P3|COMPLETED|Overall Study||8
8200544|NCT02207725|20221886|P2|COMPLETED|Overall Study||24
8200545|NCT02207725|20221887|P1|COMPLETED|Overall Study||9
8200546|NCT02207725|20221884|P4|STARTED|Overall Study||25
8200547|NCT02207725|20221885|P3|STARTED|Overall Study||9
8200548|NCT02207725|20221886|P2|STARTED|Overall Study||25
8200549|NCT02207725|20221887|P1|STARTED|Overall Study||9
8200550|NCT02207634|20221917|P2|NOT COMPLETED|Overall Study||31
8200551|NCT02207634|20221918|P1|NOT COMPLETED|Overall Study||22
8200552|NCT02207634|20221917|P2|COMPLETED|Overall Study||953
8200553|NCT02207634|20221918|P1|COMPLETED|Overall Study||968
8200554|NCT02207634|20221917|P2|Received Treatment|Overall Study||983
8200555|NCT02207634|20221918|P1|Received Treatment|Overall Study||990
8200556|NCT02207634|20221917|P2|STARTED|Overall Study||984
8200557|NCT02207634|20221918|P1|STARTED|Overall Study||990
8200558|NCT02207621|20221933|P3|NOT COMPLETED|Overall Study||168
8200559|NCT02207621|20221934|P2|NOT COMPLETED|Overall Study||47
8200560|NCT02207621|20221935|P1|NOT COMPLETED|Overall Study||105
8200561|NCT02207621|20221933|P3|COMPLETED|Overall Study||86
8200562|NCT02207621|20221934|P2|COMPLETED|Overall Study||204
8200563|NCT02207621|20221935|P1|COMPLETED|Overall Study||146
8200564|NCT02207621|20221933|P3|STARTED|Overall Study||254
8200565|NCT02207621|20221934|P2|STARTED|Overall Study||251
8200566|NCT02207621|20221935|P1|STARTED|Overall Study||251
8200567|NCT02207608|20221948|P2|NOT COMPLETED|Overall Study||0
8200568|NCT02207608|20221949|P1|NOT COMPLETED|Overall Study||1
8200569|NCT02207608|20221948|P2|COMPLETED|Overall Study||15
8200570|NCT02207608|20221949|P1|COMPLETED|Overall Study||14
8200571|NCT02207608|20221948|P2|STARTED|Overall Study||15
8200572|NCT02207608|20221949|P1|STARTED|Overall Study||15
8200573|NCT02207569|20221955|P1|NOT COMPLETED|6 Months - 1 Year||9
8200574|NCT02207569|20221955|P1|COMPLETED|6 Months - 1 Year||213
8200575|NCT02207569|20221955|P1|STARTED|6 Months - 1 Year||222
8200576|NCT02207569|20221955|P1|NOT COMPLETED|30 Days to 6 Months||11
8200577|NCT02207569|20221955|P1|COMPLETED|30 Days to 6 Months||222
8200578|NCT02207569|20221955|P1|STARTED|30 Days to 6 Months||233
8200579|NCT02207569|20221955|P1|NOT COMPLETED|Implant to 30 Days||4
8200580|NCT02207569|20221955|P1|COMPLETED|Implant to 30 Days||233
8200581|NCT02207569|20221955|P1|STARTED|Implant to 30 Days||237
8200582|NCT02207569|20221955|P1|NOT COMPLETED|Enrolled to Implant||4
8200583|NCT02207569|20221955|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
8200584|NCT02207569|20221955|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
8200585|NCT02207556|20221975|P2|NOT COMPLETED|Overall Study||5
8200586|NCT02207556|20221976|P1|NOT COMPLETED|Overall Study||2
8200587|NCT02207556|20221975|P2|COMPLETED|Overall Study||20
8200588|NCT02207556|20221976|P1|COMPLETED|Overall Study||5
8200589|NCT02207556|20221975|P2|STARTED|Overall Study||25
8200590|NCT02207556|20221976|P1|STARTED|Overall Study||7
8200591|NCT02207530|20221981|P1|NOT COMPLETED|Overall Study||91
8200592|NCT02207530|20221981|P1|COMPLETED|Overall Study||21
8200593|NCT02207530|20221981|P1|STARTED|Overall Study||112
8200594|NCT02207491|20221995|P2|NOT COMPLETED|Overall Study||13
8200595|NCT02207491|20221996|P1|NOT COMPLETED|Overall Study||31
8200596|NCT02207491|20221995|P2|COMPLETED|Overall Study||196
8200597|NCT02207491|20221996|P1|COMPLETED|Overall Study||171
8200598|NCT02207491|20221995|P2|STARTED|Overall Study||209
8200599|NCT02207491|20221996|P1|STARTED|Overall Study||202
8200600|NCT02207478|20222006|P2|NOT COMPLETED|Overall Study||0
8200601|NCT02207478|20222007|P1|NOT COMPLETED|Overall Study||0
8200602|NCT02207478|20222006|P2|COMPLETED|Overall Study||46
8200603|NCT02207478|20222007|P1|COMPLETED|Overall Study||40
8200604|NCT02207478|20222006|P2|STARTED|Overall Study||46
8200605|NCT02207478|20222007|P1|STARTED|Overall Study||40
8200606|NCT02207413|20222021|P6|NOT COMPLETED|Overall Study||13
8200607|NCT02207413|20222022|P5|NOT COMPLETED|Overall Study||7
8200608|NCT02207413|20222023|P4|NOT COMPLETED|Overall Study||1
8200609|NCT02207413|20222024|P3|NOT COMPLETED|Overall Study||0
8200610|NCT02207413|20222025|P2|NOT COMPLETED|Overall Study||0
8200611|NCT02207413|20222026|P1|NOT COMPLETED|Overall Study||1
8200612|NCT02207413|20222021|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
8200839|NCT02206607|20222352|P5|STARTED|Fourth Intervention Period||10
8200613|NCT02207413|20222022|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
8200614|NCT02207413|20222023|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
8200615|NCT02207413|20222024|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
8200616|NCT02207413|20222025|P2|COMPLETED|Overall Study||60
8200617|NCT02207413|20222026|P1|COMPLETED|Overall Study||59
8200618|NCT02207413|20222021|P6|STARTED|Overall Study||474
8200619|NCT02207413|20222022|P5|STARTED|Overall Study||466
8200620|NCT02207413|20222023|P4|STARTED|Overall Study||411
8200621|NCT02207413|20222024|P3|STARTED|Overall Study||410
8200622|NCT02207413|20222025|P2|STARTED|Overall Study||60
8200623|NCT02207413|20222026|P1|STARTED|Overall Study||60
8200624|NCT02207400|20222122|P2|NOT COMPLETED|Overall Study||14
8200625|NCT02207400|20222123|P1|NOT COMPLETED|Overall Study||16
8200626|NCT02207400|20222122|P2|COMPLETED|Overall Study||109
8200627|NCT02207400|20222123|P1|COMPLETED|Overall Study||107
8200628|NCT02207400|20222122|P2|STARTED|Overall Study||123
8200629|NCT02207400|20222123|P1|STARTED|Overall Study||123
8200630|NCT02207374|20222144|P3|NOT COMPLETED|Overall Study||6
8200631|NCT02207374|20222145|P2|NOT COMPLETED|Overall Study||10
8200632|NCT02207374|20222146|P1|NOT COMPLETED|Overall Study||6
8200633|NCT02207374|20222144|P3|COMPLETED|Overall Study||115
8200634|NCT02207374|20222145|P2|COMPLETED|Overall Study||231
8200635|NCT02207374|20222146|P1|COMPLETED|Overall Study||233
8200636|NCT02207374|20222144|P3|Exposed|Overall Study||120
8200637|NCT02207374|20222145|P2|Exposed|Overall Study||241
8200638|NCT02207374|20222146|P1|Exposed|Overall Study||239
8200639|NCT02207374|20222144|P3|STARTED|Overall Study||121
8200640|NCT02207374|20222145|P2|STARTED|Overall Study||241
8200641|NCT02207374|20222146|P1|STARTED|Overall Study||239
8200642|NCT02207322|20222162|P2|NOT COMPLETED|Overall Study||10
8200643|NCT02207322|20222163|P1|NOT COMPLETED|Overall Study||9
8200644|NCT02207322|20222162|P2|COMPLETED|Overall Study|6-month|71
8200645|NCT02207322|20222163|P1|COMPLETED|Overall Study|6-month|70
8200646|NCT02207322|20222162|P2|3-month|Overall Study||75
8200647|NCT02207322|20222163|P1|3-month|Overall Study||74
8200648|NCT02207322|20222162|P2|Week-2|Overall Study||80
8200649|NCT02207322|20222163|P1|Week-2|Overall Study||77
8200650|NCT02207322|20222162|P2|STARTED|Overall Study||81
8200651|NCT02207322|20222163|P1|STARTED|Overall Study||79
8200652|NCT02207244|20222210|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
8200653|NCT02207244|20222211|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
8200654|NCT02207244|20222212|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
8200655|NCT02207244|20222213|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200656|NCT02207244|20222214|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200657|NCT02207244|20222215|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200658|NCT02207244|20222216|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200659|NCT02207244|20222217|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200660|NCT02207244|20222218|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200661|NCT02207244|20222210|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
8200662|NCT02207244|20222211|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
8200663|NCT02207244|20222212|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
8200664|NCT02207244|20222213|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200665|NCT02207244|20222214|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200666|NCT02207244|20222215|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200667|NCT02207244|20222216|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200668|NCT02207244|20222217|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200669|NCT02207244|20222218|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
8200670|NCT02207244|20222210|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
8200671|NCT02207244|20222211|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
8200672|NCT02207244|20222212|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
8200673|NCT02207244|20222213|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
8200674|NCT02207244|20222214|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
8200675|NCT02207244|20222215|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
8200676|NCT02207244|20222216|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
8200677|NCT02207244|20222217|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
8200678|NCT02207244|20222218|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
8200679|NCT02207244|20222210|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200680|NCT02207244|20222211|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
8200681|NCT02207244|20222212|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200682|NCT02207244|20222213|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200683|NCT02207244|20222214|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200684|NCT02207244|20222215|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200685|NCT02207244|20222216|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200686|NCT02207244|20222217|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200687|NCT02207244|20222218|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200688|NCT02207244|20222210|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
8200689|NCT02207244|20222211|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
8200690|NCT02207244|20222212|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
8200691|NCT02207244|20222213|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200692|NCT02207244|20222214|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200693|NCT02207244|20222215|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200694|NCT02207244|20222216|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200695|NCT02207244|20222217|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200696|NCT02207244|20222218|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
8200697|NCT02207244|20222210|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
8200698|NCT02207244|20222211|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
8200699|NCT02207244|20222212|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
8200700|NCT02207244|20222213|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
8200701|NCT02207244|20222214|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
8200702|NCT02207244|20222215|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
8200703|NCT02207244|20222216|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
8200704|NCT02207244|20222217|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
8200705|NCT02207244|20222218|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
8200706|NCT02207244|20222210|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
8200707|NCT02207244|20222211|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
8200708|NCT02207244|20222212|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
8200709|NCT02207244|20222213|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
8200710|NCT02207244|20222214|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
8200711|NCT02207244|20222215|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
8200712|NCT02207244|20222216|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
8200713|NCT02207244|20222217|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
8200714|NCT02207244|20222218|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
8200715|NCT02207244|20222210|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200716|NCT02207244|20222211|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200717|NCT02207244|20222212|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200718|NCT02207244|20222213|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
8200719|NCT02207244|20222214|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
8200720|NCT02207244|20222215|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
8200721|NCT02207244|20222216|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200722|NCT02207244|20222217|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200723|NCT02207244|20222218|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200724|NCT02207244|20222210|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200725|NCT02207244|20222211|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200726|NCT02207244|20222212|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200727|NCT02207244|20222213|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
8200728|NCT02207244|20222214|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
8200729|NCT02207244|20222215|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
8200730|NCT02207244|20222216|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200731|NCT02207244|20222217|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200732|NCT02207244|20222218|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
8200733|NCT02207244|20222210|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
8200734|NCT02207244|20222211|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
8200735|NCT02207244|20222212|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
8200736|NCT02207244|20222213|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
8200737|NCT02207244|20222214|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
8200738|NCT02207244|20222215|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
8200739|NCT02207244|20222216|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
8200740|NCT02207244|20222217|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
8200741|NCT02207244|20222218|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
8200742|NCT02207244|20222210|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200743|NCT02207244|20222211|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200744|NCT02207244|20222212|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200745|NCT02207244|20222213|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200746|NCT02207244|20222214|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200747|NCT02207244|20222215|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200748|NCT02207244|20222216|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
8200749|NCT02207244|20222217|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
8200750|NCT02207244|20222218|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
8200751|NCT02207244|20222210|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200752|NCT02207244|20222211|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200753|NCT02207244|20222212|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200754|NCT02207244|20222213|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200755|NCT02207244|20222214|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200756|NCT02207244|20222215|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8200757|NCT02207244|20222216|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
8200758|NCT02207244|20222217|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
8200759|NCT02207244|20222218|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
8200760|NCT02207244|20222210|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
8200761|NCT02207244|20222211|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
8200762|NCT02207244|20222212|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
8200763|NCT02207244|20222213|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
8200764|NCT02207244|20222214|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
8200765|NCT02207244|20222215|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
8200766|NCT02207244|20222216|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
8200767|NCT02207244|20222217|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
8200768|NCT02207244|20222218|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
8200769|NCT02207244|20222210|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
8200770|NCT02207244|20222211|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
8200771|NCT02207244|20222212|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
8200772|NCT02207244|20222213|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
8200773|NCT02207244|20222214|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
8200774|NCT02207244|20222215|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
8200775|NCT02207244|20222216|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
8200776|NCT02207244|20222217|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
8200777|NCT02207244|20222218|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
8200778|NCT02207231|20222259|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
8200779|NCT02207231|20222260|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
8200780|NCT02207231|20222261|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
8200781|NCT02207231|20222259|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
8200782|NCT02207231|20222260|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
8200783|NCT02207231|20222261|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
8200784|NCT02207231|20222259|P3|STARTED|Active Controlled Period: Week 16 - 48||324
8200785|NCT02207231|20222260|P2|STARTED|Active Controlled Period: Week 16 - 48||322
8200786|NCT02207231|20222261|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
8200787|NCT02207231|20222259|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
8200788|NCT02207231|20222260|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
8200789|NCT02207231|20222261|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
8200790|NCT02207231|20222259|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
8200791|NCT02207231|20222260|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
8200792|NCT02207231|20222261|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
8200793|NCT02207231|20222259|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
8200794|NCT02207231|20222260|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
8200795|NCT02207231|20222261|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
8200796|NCT02207231|20222259|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
8200797|NCT02207231|20222260|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
8200798|NCT02207231|20222261|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
8200799|NCT02207088|20222293|P1|NOT COMPLETED|Overall Study||2
8200800|NCT02207088|20222293|P1|COMPLETED|Overall Study||66
8200801|NCT02207088|20222293|P1|STARTED|Overall Study||68
8200802|NCT02206828|20222299|P1|NOT COMPLETED|Overall Study||7
8200803|NCT02206828|20222299|P1|COMPLETED|Overall Study||93
8200804|NCT02206828|20222299|P1|STARTED|Overall Study||100
8200805|NCT02206776|20222328|P2|NOT COMPLETED|Overall Study||0
8200806|NCT02206776|20222329|P1|NOT COMPLETED|Overall Study||0
8200807|NCT02206776|20222328|P2|COMPLETED|Overall Study||1
8200808|NCT02206776|20222329|P1|COMPLETED|Overall Study||1
8200809|NCT02206776|20222328|P2|STARTED|Overall Study||1
8200810|NCT02206776|20222329|P1|STARTED|Overall Study||1
8200811|NCT02206620|20222335|P2|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
8200812|NCT02206620|20222336|P1|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
8200813|NCT02206620|20222335|P2|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
8200814|NCT02206620|20222336|P1|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
8200815|NCT02206620|20222335|P2|STARTED|Phase II - Second Intervention (6 Weeks)||26
8200816|NCT02206620|20222336|P1|STARTED|Phase II - Second Intervention (6 Weeks)||21
8200817|NCT02206620|20222335|P2|NOT COMPLETED|Washout (6 Weeks)||0
8200818|NCT02206620|20222336|P1|NOT COMPLETED|Washout (6 Weeks)||0
8200819|NCT02206620|20222335|P2|COMPLETED|Washout (6 Weeks)||26
8200820|NCT02206620|20222336|P1|COMPLETED|Washout (6 Weeks)||21
8200821|NCT02206620|20222335|P2|STARTED|Washout (6 Weeks)||26
8200822|NCT02206620|20222336|P1|STARTED|Washout (6 Weeks)||21
8200823|NCT02206620|20222335|P2|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
8200824|NCT02206620|20222336|P1|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
8200825|NCT02206620|20222335|P2|COMPLETED|Phase I - First Intervention (6 Weeks)||26
8200826|NCT02206620|20222336|P1|COMPLETED|Phase I - First Intervention (6 Weeks)||21
8200827|NCT02206620|20222335|P2|STARTED|Phase I - First Intervention (6 Weeks)||27
8200828|NCT02206620|20222336|P1|STARTED|Phase I - First Intervention (6 Weeks)||22
8200829|NCT02206607|20222352|P5|NOT COMPLETED|Fourth Intervention Period||0
8200830|NCT02206607|20222353|P4|NOT COMPLETED|Fourth Intervention Period||0
8200831|NCT02206607|20222354|P3|NOT COMPLETED|Fourth Intervention Period||0
8200832|NCT02206607|20222355|P2|NOT COMPLETED|Fourth Intervention Period||0
8200833|NCT02206607|20222356|P1|NOT COMPLETED|Fourth Intervention Period||0
8200834|NCT02206607|20222352|P5|COMPLETED|Fourth Intervention Period||10
8200835|NCT02206607|20222353|P4|COMPLETED|Fourth Intervention Period||10
8200836|NCT02206607|20222354|P3|COMPLETED|Fourth Intervention Period||9
8200837|NCT02206607|20222355|P2|COMPLETED|Fourth Intervention Period||9
8200838|NCT02206607|20222356|P1|COMPLETED|Fourth Intervention Period||0
8200840|NCT02206607|20222353|P4|STARTED|Fourth Intervention Period||10
8200841|NCT02206607|20222354|P3|STARTED|Fourth Intervention Period||9
8200842|NCT02206607|20222355|P2|STARTED|Fourth Intervention Period||9
8200843|NCT02206607|20222356|P1|STARTED|Fourth Intervention Period||0
8200844|NCT02206607|20222352|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200845|NCT02206607|20222353|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200846|NCT02206607|20222354|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200847|NCT02206607|20222355|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200848|NCT02206607|20222356|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200849|NCT02206607|20222352|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
8200850|NCT02206607|20222353|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
8200851|NCT02206607|20222354|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
8200852|NCT02206607|20222355|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
8200853|NCT02206607|20222356|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
8200854|NCT02206607|20222352|P5|STARTED|Third Washout Period 5 to 10 Days||10
8200855|NCT02206607|20222353|P4|STARTED|Third Washout Period 5 to 10 Days||10
8200856|NCT02206607|20222354|P3|STARTED|Third Washout Period 5 to 10 Days||9
8200857|NCT02206607|20222355|P2|STARTED|Third Washout Period 5 to 10 Days||9
8200858|NCT02206607|20222356|P1|STARTED|Third Washout Period 5 to 10 Days||0
8200859|NCT02206607|20222352|P5|NOT COMPLETED|Third Intervention Period||0
8200860|NCT02206607|20222353|P4|NOT COMPLETED|Third Intervention Period||0
8200861|NCT02206607|20222354|P3|NOT COMPLETED|Third Intervention Period||0
8200862|NCT02206607|20222355|P2|NOT COMPLETED|Third Intervention Period||0
8200863|NCT02206607|20222356|P1|NOT COMPLETED|Third Intervention Period||0
8200864|NCT02206607|20222352|P5|COMPLETED|Third Intervention Period||10
8200865|NCT02206607|20222353|P4|COMPLETED|Third Intervention Period||10
8200866|NCT02206607|20222354|P3|COMPLETED|Third Intervention Period||9
8200867|NCT02206607|20222355|P2|COMPLETED|Third Intervention Period||9
8200868|NCT02206607|20222356|P1|COMPLETED|Third Intervention Period||0
8200869|NCT02206607|20222352|P5|STARTED|Third Intervention Period||10
8200870|NCT02206607|20222353|P4|STARTED|Third Intervention Period||10
8200871|NCT02206607|20222354|P3|STARTED|Third Intervention Period||9
8200872|NCT02206607|20222355|P2|STARTED|Third Intervention Period||9
8200873|NCT02206607|20222356|P1|STARTED|Third Intervention Period||0
8200874|NCT02206607|20222352|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200875|NCT02206607|20222353|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200876|NCT02206607|20222354|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200877|NCT02206607|20222355|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200878|NCT02206607|20222356|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200879|NCT02206607|20222352|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
8200880|NCT02206607|20222353|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
8200881|NCT02206607|20222354|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
8200882|NCT02206607|20222355|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
8200883|NCT02206607|20222356|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
8200884|NCT02206607|20222352|P5|STARTED|Second Washout Period 5 to 10 Days||10
8200885|NCT02206607|20222353|P4|STARTED|Second Washout Period 5 to 10 Days||10
8200886|NCT02206607|20222354|P3|STARTED|Second Washout Period 5 to 10 Days||9
8200887|NCT02206607|20222355|P2|STARTED|Second Washout Period 5 to 10 Days||9
8200888|NCT02206607|20222356|P1|STARTED|Second Washout Period 5 to 10 Days||0
8200889|NCT02206607|20222352|P5|NOT COMPLETED|Second Intervention Period||0
8200890|NCT02206607|20222353|P4|NOT COMPLETED|Second Intervention Period||1
8200891|NCT02206607|20222354|P3|NOT COMPLETED|Second Intervention Period||0
8200892|NCT02206607|20222355|P2|NOT COMPLETED|Second Intervention Period||0
8200893|NCT02206607|20222356|P1|NOT COMPLETED|Second Intervention Period||0
8200894|NCT02206607|20222352|P5|COMPLETED|Second Intervention Period||10
8200895|NCT02206607|20222353|P4|COMPLETED|Second Intervention Period||10
8200896|NCT02206607|20222354|P3|COMPLETED|Second Intervention Period||9
8200897|NCT02206607|20222355|P2|COMPLETED|Second Intervention Period||9
8200898|NCT02206607|20222356|P1|COMPLETED|Second Intervention Period||0
8200899|NCT02206607|20222352|P5|STARTED|Second Intervention Period||10
8200900|NCT02206607|20222353|P4|STARTED|Second Intervention Period||11
8200901|NCT02206607|20222354|P3|STARTED|Second Intervention Period||9
8200902|NCT02206607|20222355|P2|STARTED|Second Intervention Period||9
8200903|NCT02206607|20222356|P1|STARTED|Second Intervention Period||0
8200904|NCT02206607|20222352|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200905|NCT02206607|20222353|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200906|NCT02206607|20222354|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200907|NCT02206607|20222355|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200908|NCT02206607|20222356|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200909|NCT02206607|20222352|P5|COMPLETED|First Washout Period 5 to 10 Days||10
8200910|NCT02206607|20222353|P4|COMPLETED|First Washout Period 5 to 10 Days||11
8200911|NCT02206607|20222354|P3|COMPLETED|First Washout Period 5 to 10 Days||9
8200912|NCT02206607|20222355|P2|COMPLETED|First Washout Period 5 to 10 Days||9
8200913|NCT02206607|20222356|P1|COMPLETED|First Washout Period 5 to 10 Days||0
8200914|NCT02206607|20222352|P5|STARTED|First Washout Period 5 to 10 Days||10
8200915|NCT02206607|20222353|P4|STARTED|First Washout Period 5 to 10 Days||11
8200916|NCT02206607|20222354|P3|STARTED|First Washout Period 5 to 10 Days||9
8200917|NCT02206607|20222355|P2|STARTED|First Washout Period 5 to 10 Days||9
8200918|NCT02206607|20222356|P1|STARTED|First Washout Period 5 to 10 Days||0
8200919|NCT02206607|20222352|P5|NOT COMPLETED|First Intervention Period||0
8200920|NCT02206607|20222353|P4|NOT COMPLETED|First Intervention Period||0
8200921|NCT02206607|20222354|P3|NOT COMPLETED|First Intervention Period||0
8200922|NCT02206607|20222355|P2|NOT COMPLETED|First Intervention Period||0
8200923|NCT02206607|20222356|P1|NOT COMPLETED|First Intervention Period||0
8200924|NCT02206607|20222352|P5|COMPLETED|First Intervention Period||10
8200925|NCT02206607|20222353|P4|COMPLETED|First Intervention Period||11
8200926|NCT02206607|20222354|P3|COMPLETED|First Intervention Period||9
8200927|NCT02206607|20222355|P2|COMPLETED|First Intervention Period||9
8200928|NCT02206607|20222356|P1|COMPLETED|First Intervention Period||0
8200929|NCT02206607|20222352|P5|STARTED|First Intervention Period||10
8200930|NCT02206607|20222353|P4|STARTED|First Intervention Period||11
8200931|NCT02206607|20222354|P3|STARTED|First Intervention Period||9
8200932|NCT02206607|20222355|P2|STARTED|First Intervention Period||9
8200933|NCT02206607|20222356|P1|STARTED|First Intervention Period||0
8200934|NCT02206607|20222352|P5|NOT COMPLETED|Open-Label Run-In||0
8200935|NCT02206607|20222353|P4|NOT COMPLETED|Open-Label Run-In||0
8200936|NCT02206607|20222354|P3|NOT COMPLETED|Open-Label Run-In||0
8200937|NCT02206607|20222355|P2|NOT COMPLETED|Open-Label Run-In||0
8200938|NCT02206607|20222356|P1|NOT COMPLETED|Open-Label Run-In||3
8200939|NCT02206607|20222352|P5|COMPLETED|Open-Label Run-In||0
8200940|NCT02206607|20222353|P4|COMPLETED|Open-Label Run-In||0
8200941|NCT02206607|20222354|P3|COMPLETED|Open-Label Run-In||0
8200942|NCT02206607|20222355|P2|COMPLETED|Open-Label Run-In||0
8200943|NCT02206607|20222356|P1|COMPLETED|Open-Label Run-In||39
8200944|NCT02206607|20222352|P5|STARTED|Open-Label Run-In||0
8200945|NCT02206607|20222353|P4|STARTED|Open-Label Run-In||0
8200946|NCT02206607|20222354|P3|STARTED|Open-Label Run-In||0
8200947|NCT02206607|20222355|P2|STARTED|Open-Label Run-In||0
8200948|NCT02206607|20222356|P1|STARTED|Open-Label Run-In||42
8200949|NCT02206217|20222410|P2|NOT COMPLETED|Overall Study||14
8200950|NCT02206217|20222411|P1|NOT COMPLETED|Overall Study||9
8200951|NCT02206217|20222410|P2|COMPLETED|Overall Study||79
8200952|NCT02206217|20222411|P1|COMPLETED|Overall Study||81
8200953|NCT02206217|20222410|P2|STARTED|Overall Study||93
8200954|NCT02206217|20222411|P1|STARTED|Overall Study||90
8200955|NCT02206152|20222419|P1|NOT COMPLETED|NAC, Then Placebo||0
8200956|NCT02206152|20222419|P1|COMPLETED|NAC, Then Placebo||10
8200957|NCT02206152|20222419|P1|STARTED|NAC, Then Placebo||10
8200958|NCT02206152|20222419|P1|NOT COMPLETED|Placebo, Then NAC||0
8200959|NCT02206152|20222419|P1|COMPLETED|Placebo, Then NAC||10
8200960|NCT02206152|20222419|P1|STARTED|Placebo, Then NAC||10
8200961|NCT02206152|20222419|P1|NOT COMPLETED|Pre-Randomization||2
8200962|NCT02206152|20222419|P1|COMPLETED|Pre-Randomization||20
8200963|NCT02206152|20222419|P1|STARTED|Pre-Randomization||22
8200964|NCT02205983|20222429|P4|NOT COMPLETED|Overall Study||0
8200965|NCT02205983|20222430|P3|NOT COMPLETED|Overall Study||0
8200966|NCT02205983|20222431|P2|NOT COMPLETED|Overall Study||0
8200967|NCT02205983|20222432|P1|NOT COMPLETED|Overall Study||0
8200968|NCT02205983|20222429|P4|COMPLETED|Overall Study||13
8200969|NCT02205983|20222430|P3|COMPLETED|Overall Study||13
8200970|NCT02205983|20222431|P2|COMPLETED|Overall Study||12
8200971|NCT02205983|20222432|P1|COMPLETED|Overall Study||12
8200972|NCT02205983|20222429|P4|STARTED|Overall Study||13
8200973|NCT02205983|20222430|P3|STARTED|Overall Study||13
8200974|NCT02205983|20222431|P2|STARTED|Overall Study||12
8200975|NCT02205983|20222432|P1|STARTED|Overall Study||12
8200976|NCT02205814|20222446|P4|NOT COMPLETED|Overall Study||4
8200977|NCT02205814|20222447|P3|NOT COMPLETED|Overall Study||5
8200978|NCT02205814|20222448|P2|NOT COMPLETED|Overall Study||1
8200979|NCT02205814|20222449|P1|NOT COMPLETED|Overall Study||2
8200980|NCT02205814|20222446|P4|COMPLETED|Overall Study||104
8200981|NCT02205814|20222447|P3|COMPLETED|Overall Study||103
8200982|NCT02205814|20222448|P2|COMPLETED|Overall Study||109
8200983|NCT02205814|20222449|P1|COMPLETED|Overall Study||108
8200984|NCT02205814|20222446|P4|STARTED|Overall Study||108
8200985|NCT02205814|20222447|P3|STARTED|Overall Study||108
8200986|NCT02205814|20222448|P2|STARTED|Overall Study||110
8200987|NCT02205814|20222449|P1|STARTED|Overall Study||110
8200988|NCT02205801|20222475|P4|NOT COMPLETED|Overall Study||0
8200989|NCT02205801|20222476|P3|NOT COMPLETED|Overall Study||0
8200990|NCT02205801|20222477|P2|NOT COMPLETED|Overall Study||0
8200991|NCT02205801|20222478|P1|NOT COMPLETED|Overall Study||0
8200992|NCT02205801|20222475|P4|COMPLETED|Overall Study||8
8200993|NCT02205801|20222476|P3|COMPLETED|Overall Study||9
8200994|NCT02205801|20222477|P2|COMPLETED|Overall Study||8
8200995|NCT02205801|20222478|P1|COMPLETED|Overall Study||11
8200996|NCT02205801|20222475|P4|STARTED|Overall Study||8
8200997|NCT02205801|20222476|P3|STARTED|Overall Study||9
8200998|NCT02205801|20222477|P2|STARTED|Overall Study||8
8200999|NCT02205801|20222478|P1|STARTED|Overall Study||11
8201000|NCT02205476|20222502|P2|NOT COMPLETED|Overall Study||3
8201001|NCT02205476|20222503|P1|NOT COMPLETED|Overall Study||7
8201002|NCT02205476|20222502|P2|COMPLETED|Overall Study||0
8201003|NCT02205476|20222503|P1|COMPLETED|Overall Study||0
8201004|NCT02205476|20222502|P2|STARTED|Overall Study||3
8201005|NCT02205476|20222503|P1|STARTED|Overall Study||7
8201006|NCT02205333|20222542|P9|NOT COMPLETED|Overall Study||0
8201007|NCT02205333|20222543|P8|NOT COMPLETED|Overall Study||2
8201008|NCT02205333|20222544|P7|NOT COMPLETED|Overall Study||5
8201009|NCT02205333|20222545|P6|NOT COMPLETED|Overall Study||3
8201010|NCT02205333|20222546|P5|NOT COMPLETED|Overall Study||5
8201011|NCT02205333|20222547|P4|NOT COMPLETED|Overall Study||7
8201012|NCT02205333|20222548|P3|NOT COMPLETED|Overall Study||2
8201013|NCT02205333|20222549|P2|NOT COMPLETED|Overall Study||6
8201014|NCT02205333|20222550|P1|NOT COMPLETED|Overall Study||6
8201015|NCT02205333|20222542|P9|COMPLETED|Overall Study||1
8201016|NCT02205333|20222543|P8|COMPLETED|Overall Study||1
8201017|NCT02205333|20222544|P7|COMPLETED|Overall Study||2
8201018|NCT02205333|20222545|P6|COMPLETED|Overall Study||4
8201019|NCT02205333|20222546|P5|COMPLETED|Overall Study||1
8201020|NCT02205333|20222547|P4|COMPLETED|Overall Study||0
8201021|NCT02205333|20222548|P3|COMPLETED|Overall Study||1
8201022|NCT02205333|20222549|P2|COMPLETED|Overall Study||0
8201023|NCT02205333|20222550|P1|COMPLETED|Overall Study||2
8201024|NCT02205333|20222542|P9|STARTED|Overall Study||1
8201025|NCT02205333|20222543|P8|STARTED|Overall Study||3
8201026|NCT02205333|20222544|P7|STARTED|Overall Study||7
8201027|NCT02205333|20222545|P6|STARTED|Overall Study||7
8201028|NCT02205333|20222546|P5|STARTED|Overall Study||6
8201029|NCT02205333|20222547|P4|STARTED|Overall Study||7
8201030|NCT02205333|20222548|P3|STARTED|Overall Study||3
8201031|NCT02205333|20222549|P2|STARTED|Overall Study||6
8201032|NCT02205333|20222550|P1|STARTED|Overall Study||8
8201033|NCT02205307|20222725|P2|NOT COMPLETED|Overall Study||6
8201034|NCT02205307|20222726|P1|NOT COMPLETED|Overall Study||17
8201035|NCT02205307|20222725|P2|COMPLETED|Overall Study||163
8201036|NCT02205307|20222726|P1|COMPLETED|Overall Study||161
8201037|NCT02205307|20222725|P2|STARTED|Overall Study||169
8201038|NCT02205307|20222726|P1|STARTED|Overall Study||178
8201039|NCT02205177|20222738|P2|NOT COMPLETED|Overall Study||0
8201040|NCT02205177|20222739|P1|NOT COMPLETED|Overall Study||2
8201041|NCT02205177|20222738|P2|COMPLETED|Overall Study||2
8201042|NCT02205177|20222739|P1|COMPLETED|Overall Study||6
8201043|NCT02205177|20222738|P2|STARTED|Overall Study||2
8201044|NCT02205177|20222739|P1|STARTED|Overall Study||8
8201045|NCT02204982|20222749|P2|NOT COMPLETED|Overall Study||7
8201046|NCT02204982|20222750|P1|NOT COMPLETED|Overall Study||4
8201047|NCT02204982|20222749|P2|COMPLETED|Overall Study||0
8201048|NCT02204982|20222750|P1|COMPLETED|Overall Study||2
8201049|NCT02204982|20222749|P2|STARTED|Overall Study||7
8201050|NCT02204982|20222750|P1|STARTED|Overall Study||6
8201051|NCT02204917|20222758|P1|NOT COMPLETED|Overall Study||1
8201052|NCT02204917|20222758|P1|COMPLETED|Overall Study||30
8201053|NCT02204917|20222758|P1|STARTED|Overall Study||31
8201054|NCT02204761|20222765|P1|NOT COMPLETED|Overall Study||0
8201055|NCT02204761|20222765|P1|COMPLETED|Overall Study||6
8201056|NCT02204761|20222765|P1|STARTED|Overall Study||6
8201057|NCT02204748|20222772|P1|NOT COMPLETED|Overall Study||0
8201058|NCT02204748|20222772|P1|COMPLETED|Overall Study||5
8201059|NCT02204748|20222772|P1|STARTED|Overall Study||5
8201060|NCT02204657|20222786|P2|NOT COMPLETED|Overall Study||0
8201061|NCT02204657|20222787|P1|NOT COMPLETED|Overall Study||7
8201062|NCT02204657|20222786|P2|COMPLETED|Overall Study||25
8201063|NCT02204657|20222787|P1|COMPLETED|Overall Study||25
8201064|NCT02204657|20222786|P2|STARTED|Overall Study||25
8201065|NCT02204657|20222787|P1|STARTED|Overall Study||32
8201066|NCT02204579|20222795|P1|NOT COMPLETED|Overall Study||2
8201067|NCT02204579|20222795|P1|COMPLETED|Overall Study||5
8201068|NCT02204579|20222795|P1|Treated|Overall Study||5
8201069|NCT02204579|20222795|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
8201070|NCT02204579|20222795|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
8201071|NCT02204579|20222795|P1|STARTED|Overall Study||7
8201072|NCT02204566|20222847|P1|NOT COMPLETED|Overall Study||4
8201073|NCT02204566|20222847|P1|COMPLETED|Overall Study||1
8201074|NCT02204566|20222847|P1|STARTED|Overall Study||5
8201075|NCT02204449|20222853|P2|NOT COMPLETED|Overall Study||11
8201076|NCT02204449|20222854|P1|NOT COMPLETED|Overall Study||7
8201077|NCT02204449|20222853|P2|COMPLETED|Overall Study||37
8201078|NCT02204449|20222854|P1|COMPLETED|Overall Study||39
8201079|NCT02204449|20222853|P2|STARTED|Overall Study||48
8201080|NCT02204449|20222854|P1|STARTED|Overall Study||46
8201081|NCT02204410|20222864|P1|NOT COMPLETED|Overall Study||11
8201082|NCT02204410|20222864|P1|COMPLETED|Overall Study||10
8201083|NCT02204410|20222864|P1|STARTED|Overall Study||21
8201084|NCT02204371|20222869|P1|NOT COMPLETED|Overall Study||1
8201085|NCT02204371|20222869|P1|COMPLETED|Overall Study||6
8201086|NCT02204371|20222869|P1|STARTED|Overall Study||7
8201087|NCT02204319|20222892|P1|NOT COMPLETED|Overall Study||3
8201088|NCT02204319|20222892|P1|COMPLETED|Overall Study|3 did not complete study.|7
8201089|NCT02204319|20222892|P1|STARTED|Overall Study||10
8201090|NCT02204293|20222900|P6|NOT COMPLETED|LTE Phase||7
8201091|NCT02204293|20222901|P5|NOT COMPLETED|LTE Phase||0
8201092|NCT02204293|20222902|P4|NOT COMPLETED|LTE Phase||0
8201093|NCT02204293|20222903|P3|NOT COMPLETED|LTE Phase||0
8201094|NCT02204293|20222904|P2|NOT COMPLETED|LTE Phase||0
8201095|NCT02204293|20222905|P1|NOT COMPLETED|LTE Phase||0
8201096|NCT02204293|20222900|P6|COMPLETED|LTE Phase||0
8201097|NCT02204293|20222901|P5|COMPLETED|LTE Phase||0
8201098|NCT02204293|20222902|P4|COMPLETED|LTE Phase||0
8201099|NCT02204293|20222903|P3|COMPLETED|LTE Phase||0
8201100|NCT02204293|20222904|P2|COMPLETED|LTE Phase||0
8201101|NCT02204293|20222905|P1|COMPLETED|LTE Phase||0
8201102|NCT02204293|20222900|P6|STARTED|LTE Phase||7
8201103|NCT02204293|20222901|P5|STARTED|LTE Phase||0
8201104|NCT02204293|20222902|P4|STARTED|LTE Phase||0
8201105|NCT02204293|20222903|P3|STARTED|LTE Phase||0
8201106|NCT02204293|20222904|P2|STARTED|LTE Phase||0
8201107|NCT02204293|20222905|P1|STARTED|LTE Phase||0
8201108|NCT02204293|20222900|P6|NOT COMPLETED|Core Study Part 2||0
8201109|NCT02204293|20222901|P5|NOT COMPLETED|Core Study Part 2||0
8201110|NCT02204293|20222902|P4|NOT COMPLETED|Core Study Part 2||0
8201111|NCT02204293|20222903|P3|NOT COMPLETED|Core Study Part 2||0
8201112|NCT02204293|20222904|P2|NOT COMPLETED|Core Study Part 2||0
8201113|NCT02204293|20222905|P1|NOT COMPLETED|Core Study Part 2||0
8201114|NCT02204293|20222900|P6|COMPLETED|Core Study Part 2||0
8201115|NCT02204293|20222901|P5|COMPLETED|Core Study Part 2||7
8201116|NCT02204293|20222902|P4|COMPLETED|Core Study Part 2||4
8201117|NCT02204293|20222903|P3|COMPLETED|Core Study Part 2||12
8201118|NCT02204293|20222904|P2|COMPLETED|Core Study Part 2||0
8201119|NCT02204293|20222905|P1|COMPLETED|Core Study Part 2||0
8201120|NCT02204293|20222900|P6|Safety Population|Core Study Part 2||0
8201121|NCT02204293|20222901|P5|Safety Population|Core Study Part 2||7
8201122|NCT02204293|20222902|P4|Safety Population|Core Study Part 2||2
8201123|NCT02204293|20222903|P3|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
8201124|NCT02204293|20222904|P2|Safety Population|Core Study Part 2||0
8201125|NCT02204293|20222905|P1|Safety Population|Core Study Part 2||0
8201126|NCT02204293|20222900|P6|STARTED|Core Study Part 2||0
8201127|NCT02204293|20222901|P5|STARTED|Core Study Part 2||7
8201128|NCT02204293|20222902|P4|STARTED|Core Study Part 2||4
8201129|NCT02204293|20222903|P3|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
8201130|NCT02204293|20222904|P2|STARTED|Core Study Part 2||0
8201131|NCT02204293|20222905|P1|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
8201132|NCT02204293|20222900|P6|NOT COMPLETED|Core Study Part I||0
8201133|NCT02204293|20222901|P5|NOT COMPLETED|Core Study Part I||0
8201134|NCT02204293|20222902|P4|NOT COMPLETED|Core Study Part I||0
8201135|NCT02204293|20222903|P3|NOT COMPLETED|Core Study Part I||0
8201136|NCT02204293|20222904|P2|NOT COMPLETED|Core Study Part I||3
8201137|NCT02204293|20222905|P1|NOT COMPLETED|Core Study Part I||2
8201138|NCT02204293|20222900|P6|COMPLETED|Core Study Part I||0
8201139|NCT02204293|20222901|P5|COMPLETED|Core Study Part I||0
8201140|NCT02204293|20222902|P4|COMPLETED|Core Study Part I||0
8201141|NCT02204293|20222903|P3|COMPLETED|Core Study Part I||0
8201142|NCT02204293|20222904|P2|COMPLETED|Core Study Part I||14
8201143|NCT02204293|20222905|P1|COMPLETED|Core Study Part I||17
8201144|NCT02204293|20222900|P6|Safety Population|Core Study Part I||0
8201145|NCT02204293|20222901|P5|Safety Population|Core Study Part I||0
8201146|NCT02204293|20222902|P4|Safety Population|Core Study Part I||0
8201147|NCT02204293|20222903|P3|Safety Population|Core Study Part I||0
8201148|NCT02204293|20222904|P2|Safety Population|Core Study Part I||15
8201149|NCT02204293|20222905|P1|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
8201150|NCT02204293|20222900|P6|Intention-to-treat Population|Core Study Part I||0
8201151|NCT02204293|20222901|P5|Intention-to-treat Population|Core Study Part I||0
8201152|NCT02204293|20222902|P4|Intention-to-treat Population|Core Study Part I||0
8201153|NCT02204293|20222903|P3|Intention-to-treat Population|Core Study Part I||0
8201154|NCT02204293|20222904|P2|Intention-to-treat Population|Core Study Part I||17
8201155|NCT02204293|20222905|P1|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
8201156|NCT02204293|20222900|P6|STARTED|Core Study Part I||0
8201157|NCT02204293|20222901|P5|STARTED|Core Study Part I||0
8201158|NCT02204293|20222902|P4|STARTED|Core Study Part I||0
8201159|NCT02204293|20222903|P3|STARTED|Core Study Part I||0
8201160|NCT02204293|20222904|P2|STARTED|Core Study Part I||17
8201161|NCT02204293|20222905|P1|STARTED|Core Study Part I||19
8201162|NCT02204176|20222974|P3|NOT COMPLETED|Overall Study||16
8201163|NCT02204176|20222975|P2|NOT COMPLETED|Overall Study||12
8201164|NCT02204176|20222976|P1|NOT COMPLETED|Overall Study||10
8201165|NCT02204176|20222974|P3|COMPLETED|Overall Study||58
8201166|NCT02204176|20222975|P2|COMPLETED|Overall Study||61
8201167|NCT02204176|20222976|P1|COMPLETED|Overall Study||64
8201168|NCT02204176|20222974|P3|STARTED|Overall Study||74
8201169|NCT02204176|20222975|P2|STARTED|Overall Study||73
8201170|NCT02204176|20222976|P1|STARTED|Overall Study||74
8201171|NCT02204150|20222999|P1|NOT COMPLETED|Overall Study||0
8201172|NCT02204150|20222999|P1|COMPLETED|Overall Study||56
8201173|NCT02204150|20222999|P1|STARTED|Overall Study||56
8201174|NCT02204124|20223005|P2|NOT COMPLETED|Overall Study||0
8201175|NCT02204124|20223006|P1|NOT COMPLETED|Overall Study||0
8201176|NCT02204124|20223005|P2|COMPLETED|Overall Study||19
8201177|NCT02204124|20223006|P1|COMPLETED|Overall Study||13
8201178|NCT02204124|20223005|P2|STARTED|Overall Study||19
8201179|NCT02204124|20223006|P1|STARTED|Overall Study||13
8201180|NCT02204007|20223026|P2|NOT COMPLETED|Overall Study||1
8201181|NCT02204007|20223027|P1|NOT COMPLETED|Overall Study||1
8201182|NCT02204007|20223026|P2|COMPLETED|Overall Study||17
8201183|NCT02204007|20223027|P1|COMPLETED|Overall Study||17
8201184|NCT02204007|20223026|P2|STARTED|Overall Study||18
8201185|NCT02204007|20223027|P1|STARTED|Overall Study||18
8201186|NCT02203916|20223038|P3|NOT COMPLETED|Overall Study||11
8201187|NCT02203916|20223039|P2|NOT COMPLETED|Overall Study||10
8201188|NCT02203916|20223040|P1|NOT COMPLETED|Overall Study||8
8201189|NCT02203916|20223038|P3|COMPLETED|Overall Study||120
8201190|NCT02203916|20223039|P2|COMPLETED|Overall Study||122
8201191|NCT02203916|20223040|P1|COMPLETED|Overall Study||57
8201192|NCT02203916|20223038|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
8201193|NCT02203916|20223039|P2|Safety Analysis Set (SAS)|Overall Study||132
8201194|NCT02203916|20223040|P1|Safety Analysis Set (SAS)|Overall Study||65
8201195|NCT02203916|20223038|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
8201196|NCT02203916|20223039|P2|Full Analysis Set (FAS)|Overall Study||132
8201197|NCT02203916|20223040|P1|Full Analysis Set (FAS)|Overall Study||65
8201198|NCT02203916|20223038|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
8201199|NCT02203916|20223039|P2|STARTED|Overall Study||132
8201200|NCT02203916|20223040|P1|STARTED|Overall Study||65
8201201|NCT02203851|20223060|P1|NOT COMPLETED|Overall Study||11
8201202|NCT02203851|20223060|P1|COMPLETED|Overall Study||99
8201203|NCT02203851|20223060|P1|STARTED|Overall Study||110
8201204|NCT02203838|20223098|P4|NOT COMPLETED|Overall Study||18
8201205|NCT02203838|20223099|P3|NOT COMPLETED|Overall Study||16
8201206|NCT02203838|20223100|P2|NOT COMPLETED|Overall Study||22
8201207|NCT02203838|20223101|P1|NOT COMPLETED|Overall Study||210
8201208|NCT02203838|20223098|P4|COMPLETED|Overall Study||15
8201209|NCT02203838|20223099|P3|COMPLETED|Overall Study||15
8201210|NCT02203838|20223100|P2|COMPLETED|Overall Study||6
8201211|NCT02203838|20223101|P1|COMPLETED|Overall Study||198
8201212|NCT02203838|20223098|P4|STARTED|Overall Study||33
8201213|NCT02203838|20223099|P3|STARTED|Overall Study||31
8201214|NCT02203838|20223100|P2|STARTED|Overall Study||28
8201215|NCT02203838|20223101|P1|STARTED|Overall Study||408
8201216|NCT02203786|20223135|P4|NOT COMPLETED|Overall Study||0
8201217|NCT02203786|20223136|P3|NOT COMPLETED|Overall Study||2
8201218|NCT02203786|20223137|P2|NOT COMPLETED|Overall Study||0
8201219|NCT02203786|20223138|P1|NOT COMPLETED|Overall Study||0
8201220|NCT02203786|20223135|P4|COMPLETED|Overall Study||15
8201221|NCT02203786|20223136|P3|COMPLETED|Overall Study||15
8201222|NCT02203786|20223137|P2|COMPLETED|Overall Study||15
8201223|NCT02203786|20223138|P1|COMPLETED|Overall Study||15
8201224|NCT02203786|20223135|P4|STARTED|Overall Study||15
8201225|NCT02203786|20223136|P3|STARTED|Overall Study||17
8201226|NCT02203786|20223137|P2|STARTED|Overall Study||15
8201227|NCT02203786|20223138|P1|STARTED|Overall Study||15
8201228|NCT02203747|20223170|P2|NOT COMPLETED|Overall Study||0
8201229|NCT02203747|20223171|P1|NOT COMPLETED|Overall Study||0
8201230|NCT02203747|20223170|P2|COMPLETED|Overall Study||34
8201231|NCT02203747|20223171|P1|COMPLETED|Overall Study||45
8201232|NCT02203747|20223170|P2|STARTED|Overall Study||34
8201233|NCT02203747|20223171|P1|STARTED|Overall Study||45
8201234|NCT02203721|20223181|P2|NOT COMPLETED|Overall Study||3
8201235|NCT02203721|20223182|P1|NOT COMPLETED|Overall Study||1
8201236|NCT02203721|20223181|P2|COMPLETED|Overall Study||148
8201237|NCT02203721|20223182|P1|COMPLETED|Overall Study||147
8201238|NCT02203721|20223181|P2|STARTED|Overall Study||151
8201239|NCT02203721|20223182|P1|STARTED|Overall Study||148
8201240|NCT02203630|20223192|P2|NOT COMPLETED|Overall Study||0
8201241|NCT02203630|20223193|P1|NOT COMPLETED|Overall Study||0
8201242|NCT02203630|20223192|P2|COMPLETED|Overall Study||9
8201243|NCT02203630|20223193|P1|COMPLETED|Overall Study||8
8201244|NCT02203630|20223192|P2|STARTED|Overall Study||9
8201245|NCT02203630|20223193|P1|STARTED|Overall Study||8
8201246|NCT02203591|20223271|P8|NOT COMPLETED|Overall Study||13
8201247|NCT02203591|20223272|P7|NOT COMPLETED|Overall Study||29
8201248|NCT02203591|20223273|P6|NOT COMPLETED|Overall Study||35
8201249|NCT02203591|20223274|P5|NOT COMPLETED|Overall Study||34
8201250|NCT02203591|20223275|P4|NOT COMPLETED|Overall Study||45
8201251|NCT02203591|20223276|P3|NOT COMPLETED|Overall Study||151
8201252|NCT02203591|20223277|P2|NOT COMPLETED|Overall Study||142
8201253|NCT02203591|20223278|P1|NOT COMPLETED|Overall Study||147
8201254|NCT02203591|20223271|P8|COMPLETED|Overall Study||61
8201255|NCT02203591|20223272|P7|COMPLETED|Overall Study||219
8201256|NCT02203591|20223273|P6|COMPLETED|Overall Study||209
8201257|NCT02203591|20223274|P5|COMPLETED|Overall Study||208
8201258|NCT02203591|20223275|P4|COMPLETED|Overall Study||59
8201259|NCT02203591|20223276|P3|COMPLETED|Overall Study||196
8201260|NCT02203591|20223277|P2|COMPLETED|Overall Study||202
8201261|NCT02203591|20223278|P1|COMPLETED|Overall Study||196
8201262|NCT02203591|20223271|P8|STARTED|Overall Study||74
8201263|NCT02203591|20223272|P7|STARTED|Overall Study||248
8201264|NCT02203591|20223273|P6|STARTED|Overall Study||244
8201265|NCT02203591|20223274|P5|STARTED|Overall Study||242
8201266|NCT02203591|20223275|P4|STARTED|Overall Study||104
8201267|NCT02203591|20223276|P3|STARTED|Overall Study||347
8201268|NCT02203591|20223277|P2|STARTED|Overall Study||344
8201269|NCT02203591|20223278|P1|STARTED|Overall Study||343
8201270|NCT02203578|20223363|P1|NOT COMPLETED|Overall Study||0
8201271|NCT02203578|20223363|P1|COMPLETED|Overall Study||1
8201272|NCT02203578|20223363|P1|STARTED|Overall Study||1
8201273|NCT02203565|20223375|P1|NOT COMPLETED|Overall Study||1
8201274|NCT02203565|20223375|P1|COMPLETED|Overall Study||19
8201275|NCT02203565|20223375|P1|STARTED|Overall Study||20
8201276|NCT02203357|20223382|P3|NOT COMPLETED|Overall Study||70
8201277|NCT02203357|20223383|P2|NOT COMPLETED|Overall Study||66
8201278|NCT02203357|20223384|P1|NOT COMPLETED|Overall Study||58
8201279|NCT02203357|20223382|P3|COMPLETED|Overall Study||55
8201280|NCT02203357|20223383|P2|COMPLETED|Overall Study||45
8201281|NCT02203357|20223384|P1|COMPLETED|Overall Study||59
8201282|NCT02203357|20223382|P3|mon24|Overall Study||55
8201283|NCT02203357|20223383|P2|mon24|Overall Study||45
8201284|NCT02203357|20223384|P1|mon24|Overall Study||59
8201285|NCT02203357|20223382|P3|mon12|Overall Study||122
8201286|NCT02203357|20223383|P2|mon12|Overall Study||101
8201287|NCT02203357|20223384|P1|mon12|Overall Study||113
8201288|NCT02203357|20223382|P3|mon7/2/3|Overall Study||124
8201289|NCT02203357|20223383|P2|mon7/2/3|Overall Study||110
8201290|NCT02203357|20223384|P1|mon7/2/3|Overall Study||114
8201291|NCT02203357|20223382|P3|STARTED|Overall Study||125
8201292|NCT02203357|20223383|P2|STARTED|Overall Study||111
8201293|NCT02203357|20223384|P1|STARTED|Overall Study||117
8201294|NCT02203331|20223407|P6|NOT COMPLETED|Overall Study||7
8201295|NCT02203331|20223408|P5|NOT COMPLETED|Overall Study||7
8201296|NCT02203331|20223409|P4|NOT COMPLETED|Overall Study||7
8201297|NCT02203331|20223410|P3|NOT COMPLETED|Overall Study||5
8201298|NCT02203331|20223411|P2|NOT COMPLETED|Overall Study||14
8201299|NCT02203331|20223412|P1|NOT COMPLETED|Overall Study||7
8201300|NCT02203331|20223407|P6|COMPLETED|Overall Study||46
8201301|NCT02203331|20223408|P5|COMPLETED|Overall Study||46
8201302|NCT02203331|20223409|P4|COMPLETED|Overall Study||46
8201303|NCT02203331|20223410|P3|COMPLETED|Overall Study||50
8201304|NCT02203331|20223411|P2|COMPLETED|Overall Study||39
8201305|NCT02203331|20223412|P1|COMPLETED|Overall Study||45
8201306|NCT02203331|20223407|P6|Treated|Overall Study||53
8201307|NCT02203331|20223408|P5|Treated|Overall Study||50
8201308|NCT02203331|20223409|P4|Treated|Overall Study||49
8201309|NCT02203331|20223410|P3|Treated|Overall Study||54
8201310|NCT02203331|20223411|P2|Treated|Overall Study||50
8201311|NCT02203331|20223412|P1|Treated|Overall Study||49
8201312|NCT02203331|20223407|P6|STARTED|Overall Study||53
8201313|NCT02203331|20223408|P5|STARTED|Overall Study||53
8201314|NCT02203331|20223409|P4|STARTED|Overall Study||53
8201315|NCT02203331|20223410|P3|STARTED|Overall Study||55
8201316|NCT02203331|20223411|P2|STARTED|Overall Study||53
8201317|NCT02203331|20223412|P1|STARTED|Overall Study||52
8201318|NCT02203162|20223462|P1|NOT COMPLETED|Overall Study||0
8201319|NCT02203162|20223462|P1|COMPLETED|Overall Study||30
8201320|NCT02203162|20223462|P1|STARTED|Overall Study||30
8201321|NCT02203149|20223471|P5|NOT COMPLETED|Part 2||1
8201322|NCT02203149|20223472|P4|NOT COMPLETED|Part 2||3
8201323|NCT02203149|20223473|P3|NOT COMPLETED|Part 2||1
8201324|NCT02203149|20223474|P2|NOT COMPLETED|Part 2||0
8201325|NCT02203149|20223475|P1|NOT COMPLETED|Part 2||0
8201326|NCT02203149|20223471|P5|COMPLETED|Part 2||34
8201327|NCT02203149|20223472|P4|COMPLETED|Part 2||71
8201328|NCT02203149|20223473|P3|COMPLETED|Part 2||226
8201329|NCT02203149|20223474|P2|COMPLETED|Part 2||0
8201330|NCT02203149|20223475|P1|COMPLETED|Part 2||0
8201331|NCT02203149|20223471|P5|Started Deferred Active Treatment|Part 2||0
8201332|NCT02203149|20223472|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
8201333|NCT02203149|20223473|P3|Started Deferred Active Treatment|Part 2||0
8201334|NCT02203149|20223474|P2|Started Deferred Active Treatment|Part 2||0
8201335|NCT02203149|20223475|P1|Started Deferred Active Treatment|Part 2||0
8201336|NCT02203149|20223471|P5|STARTED|Part 2||35
8201337|NCT02203149|20223472|P4|STARTED|Part 2||74
8201338|NCT02203149|20223473|P3|STARTED|Part 2||227
8201339|NCT02203149|20223474|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8201340|NCT02203149|20223475|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8201341|NCT02203149|20223471|P5|NOT COMPLETED|Part 1||0
8201342|NCT02203149|20223472|P4|NOT COMPLETED|Part 1||0
8201343|NCT02203149|20223473|P3|NOT COMPLETED|Part 1||0
8201344|NCT02203149|20223474|P2|NOT COMPLETED|Part 1||1
8201345|NCT02203149|20223475|P1|NOT COMPLETED|Part 1||0
8201346|NCT02203149|20223471|P5|COMPLETED|Part 1||0
8201347|NCT02203149|20223472|P4|COMPLETED|Part 1||0
8201348|NCT02203149|20223473|P3|COMPLETED|Part 1||0
8201349|NCT02203149|20223474|P2|COMPLETED|Part 1||31
8201350|NCT02203149|20223475|P1|COMPLETED|Part 1||31
8201351|NCT02203149|20223471|P5|STARTED|Part 1||0
8201352|NCT02203149|20223472|P4|STARTED|Part 1||0
8201353|NCT02203149|20223473|P3|STARTED|Part 1||0
8201354|NCT02203149|20223474|P2|STARTED|Part 1||32
8201355|NCT02203149|20223475|P1|STARTED|Part 1||31
8201356|NCT02203071|20223510|P2|NOT COMPLETED|Overall Study||1
8201357|NCT02203071|20223511|P1|NOT COMPLETED|Overall Study||3
8201358|NCT02203071|20223510|P2|COMPLETED|Overall Study||5
8201359|NCT02203071|20223511|P1|COMPLETED|Overall Study||10
8201360|NCT02203071|20223510|P2|STARTED|Overall Study||6
8201361|NCT02203071|20223511|P1|STARTED|Overall Study||13
8201362|NCT02203032|20223527|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
8201363|NCT02203032|20223528|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
8201364|NCT02203032|20223529|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
8201365|NCT02203032|20223530|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
8201366|NCT02203032|20223527|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
8201367|NCT02203032|20223528|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
8201368|NCT02203032|20223529|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
8201369|NCT02203032|20223530|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
8201370|NCT02203032|20223527|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
8201371|NCT02203032|20223528|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
8201372|NCT02203032|20223529|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
8201373|NCT02203032|20223530|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
8201374|NCT02203032|20223527|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201375|NCT02203032|20223528|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201376|NCT02203032|20223529|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201377|NCT02203032|20223530|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
8201378|NCT02203032|20223527|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201379|NCT02203032|20223528|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201380|NCT02203032|20223529|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201381|NCT02203032|20223530|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
8201382|NCT02203032|20223527|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
8201383|NCT02203032|20223528|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
8201384|NCT02203032|20223529|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
8201385|NCT02203032|20223530|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
8201386|NCT02203032|20223527|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8201387|NCT02203032|20223528|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8201388|NCT02203032|20223529|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8201389|NCT02203032|20223530|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
8201390|NCT02203019|20223546|P2|NOT COMPLETED|Overall Study||0
8201391|NCT02203019|20223547|P1|NOT COMPLETED|Overall Study||0
8201392|NCT02203019|20223546|P2|COMPLETED|Overall Study||17
8201393|NCT02203019|20223547|P1|COMPLETED|Overall Study||19
8201394|NCT02203019|20223546|P2|STARTED|Overall Study||17
8201395|NCT02203019|20223547|P1|STARTED|Overall Study||19
8201396|NCT02202980|20223573|P14|NOT COMPLETED|Overall Study||0
8201397|NCT02202980|20223574|P13|NOT COMPLETED|Overall Study||11
8201398|NCT02202980|20223575|P12|NOT COMPLETED|Overall Study||3
8201399|NCT02202980|20223576|P11|NOT COMPLETED|Overall Study||0
8201400|NCT02202980|20223577|P10|NOT COMPLETED|Overall Study||0
8201401|NCT02202980|20223578|P9|NOT COMPLETED|Overall Study||4
8201402|NCT02202980|20223579|P8|NOT COMPLETED|Overall Study||3
8201403|NCT02202980|20223580|P7|NOT COMPLETED|Overall Study||11
8201404|NCT02202980|20223581|P6|NOT COMPLETED|Overall Study||1
8201405|NCT02202980|20223582|P5|NOT COMPLETED|Overall Study||6
8201406|NCT02202980|20223583|P4|NOT COMPLETED|Overall Study||4
8201407|NCT02202980|20223584|P3|NOT COMPLETED|Overall Study||10
8201408|NCT02202980|20223585|P2|NOT COMPLETED|Overall Study||2
8201409|NCT02202980|20223586|P1|NOT COMPLETED|Overall Study||1
8201410|NCT02202980|20223573|P14|COMPLETED|Overall Study||4
8201411|NCT02202980|20223574|P13|COMPLETED|Overall Study||19
8201412|NCT02202980|20223575|P12|COMPLETED|Overall Study||25
8201413|NCT02202980|20223576|P11|COMPLETED|Overall Study||19
8201414|NCT02202980|20223577|P10|COMPLETED|Overall Study||17
8201415|NCT02202980|20223578|P9|COMPLETED|Overall Study||14
8201416|NCT02202980|20223579|P8|COMPLETED|Overall Study||12
8201417|NCT02202980|20223580|P7|COMPLETED|Overall Study||4
8201418|NCT02202980|20223581|P6|COMPLETED|Overall Study||14
8201419|NCT02202980|20223582|P5|COMPLETED|Overall Study||7
8201420|NCT02202980|20223583|P4|COMPLETED|Overall Study||28
8201421|NCT02202980|20223584|P3|COMPLETED|Overall Study||17
8201422|NCT02202980|20223585|P2|COMPLETED|Overall Study||24
8201423|NCT02202980|20223586|P1|COMPLETED|Overall Study||13
8201424|NCT02202980|20223573|P14|STARTED|Overall Study||4
8201425|NCT02202980|20223574|P13|STARTED|Overall Study||30
8201426|NCT02202980|20223575|P12|STARTED|Overall Study||28
8201427|NCT02202980|20223576|P11|STARTED|Overall Study||19
8201428|NCT02202980|20223577|P10|STARTED|Overall Study||17
8201429|NCT02202980|20223578|P9|STARTED|Overall Study||18
8201430|NCT02202980|20223579|P8|STARTED|Overall Study||15
8201431|NCT02202980|20223580|P7|STARTED|Overall Study||15
8201432|NCT02202980|20223581|P6|STARTED|Overall Study||15
8201433|NCT02202980|20223582|P5|STARTED|Overall Study||13
8201434|NCT02202980|20223583|P4|STARTED|Overall Study||32
8201435|NCT02202980|20223584|P3|STARTED|Overall Study||27
8201436|NCT02202980|20223585|P2|STARTED|Overall Study||26
8201437|NCT02202980|20223586|P1|STARTED|Overall Study||14
8201438|NCT02202850|20223674|P2|NOT COMPLETED|Overall Study||6
8201439|NCT02202850|20223675|P1|NOT COMPLETED|Overall Study||24
8201440|NCT02202850|20223674|P2|COMPLETED|Overall Study||8
8201441|NCT02202850|20223675|P1|COMPLETED|Overall Study||46
8201442|NCT02202850|20223674|P2|STARTED|Overall Study||14
8201443|NCT02202850|20223675|P1|STARTED|Overall Study||70
8201444|NCT02202837|20223727|P2|NOT COMPLETED|Overall Study||5
8201445|NCT02202837|20223728|P1|NOT COMPLETED|Overall Study||53
8201446|NCT02202837|20223727|P2|COMPLETED|Overall Study||12
8201447|NCT02202837|20223728|P1|COMPLETED|Overall Study||87
8201448|NCT02202837|20223727|P2|STARTED|Overall Study||17
8201449|NCT02202837|20223728|P1|STARTED|Overall Study||140
8201450|NCT02202785|20223779|P3|NOT COMPLETED|Overall Study||17
8201451|NCT02202785|20223780|P2|NOT COMPLETED|Overall Study||15
8201452|NCT02202785|20223781|P1|NOT COMPLETED|Overall Study||11
8201453|NCT02202785|20223779|P3|COMPLETED|Overall Study||0
8201454|NCT02202785|20223780|P2|COMPLETED|Overall Study||0
8201455|NCT02202785|20223781|P1|COMPLETED|Overall Study||0
8201456|NCT02202785|20223779|P3|STARTED|Overall Study||17
8201457|NCT02202785|20223780|P2|STARTED|Overall Study||15
8201458|NCT02202785|20223781|P1|STARTED|Overall Study||11
8201459|NCT02202759|20223818|P3|NOT COMPLETED|Overall Study||14
8201460|NCT02202759|20223819|P2|NOT COMPLETED|Overall Study||15
8201461|NCT02202759|20223820|P1|NOT COMPLETED|Overall Study||9
8201462|NCT02202759|20223818|P3|COMPLETED|Overall Study||0
8201463|NCT02202759|20223819|P2|COMPLETED|Overall Study||0
8201464|NCT02202759|20223820|P1|COMPLETED|Overall Study||0
8201465|NCT02202759|20223818|P3|STARTED|Overall Study||14
8201466|NCT02202759|20223819|P2|STARTED|Overall Study||15
8201467|NCT02202759|20223820|P1|STARTED|Overall Study||9
8201468|NCT02202746|20223856|P2|NOT COMPLETED|Overall Study||0
8201469|NCT02202746|20223857|P1|NOT COMPLETED|Overall Study||0
8201470|NCT02202746|20223856|P2|COMPLETED|Overall Study||69
8201471|NCT02202746|20223857|P1|COMPLETED|Overall Study||109
8201472|NCT02202746|20223856|P2|STARTED|Overall Study||69
8201473|NCT02202746|20223857|P1|STARTED|Overall Study||109
8201474|NCT02202616|20223887|P1|NOT COMPLETED|Overall Study||100
8201475|NCT02202616|20223887|P1|COMPLETED|Overall Study||301
8201476|NCT02202616|20223887|P1|Intent to Treat Set (ITT)|Overall Study||338
8201477|NCT02202616|20223887|P1|STARTED|Overall Study||401
8201478|NCT02202551|20223902|P4|NOT COMPLETED|Overall Study||22
8201479|NCT02202551|20223903|P3|NOT COMPLETED|Overall Study||10
8201480|NCT02202551|20223904|P2|NOT COMPLETED|Overall Study||37
8201481|NCT02202551|20223905|P1|NOT COMPLETED|Overall Study||25
8201482|NCT02202551|20223902|P4|COMPLETED|Overall Study||39
8201483|NCT02202551|20223903|P3|COMPLETED|Overall Study||14
8201484|NCT02202551|20223904|P2|COMPLETED|Overall Study||41
8201485|NCT02202551|20223905|P1|COMPLETED|Overall Study||35
8201486|NCT02202551|20223902|P4|STARTED|Overall Study||61
8201487|NCT02202551|20223903|P3|STARTED|Overall Study||24
8201488|NCT02202551|20223904|P2|STARTED|Overall Study||78
8201489|NCT02202551|20223905|P1|STARTED|Overall Study||60
8201490|NCT02202538|20223923|P1|NOT COMPLETED|Overall Study||8
8201491|NCT02202538|20223923|P1|COMPLETED|Overall Study||45
8201492|NCT02202538|20223923|P1|Screen Failure|Overall Study||2
8201493|NCT02202538|20223923|P1|STARTED|Overall Study||53
8201494|NCT02202499|20223937|P3|NOT COMPLETED|Overall Study||2
8201495|NCT02202499|20223938|P2|NOT COMPLETED|Overall Study||0
8201496|NCT02202499|20223939|P1|NOT COMPLETED|Overall Study||2
8201497|NCT02202499|20223937|P3|COMPLETED|Overall Study||19
8201498|NCT02202499|20223938|P2|COMPLETED|Overall Study||20
8201499|NCT02202499|20223939|P1|COMPLETED|Overall Study||19
8201500|NCT02202499|20223937|P3|STARTED|Overall Study||21
8201501|NCT02202499|20223938|P2|STARTED|Overall Study||20
8201502|NCT02202499|20223939|P1|STARTED|Overall Study||21
8201515|NCT02202317|20224093|P1|NOT COMPLETED|Overall Study||1
8201516|NCT02202317|20224093|P1|COMPLETED|Overall Study||8
8201517|NCT02202317|20224093|P1|STARTED|Overall Study||9
8201518|NCT02202252|20224101|P2|NOT COMPLETED|Overall Study||0
8201519|NCT02202252|20224102|P1|NOT COMPLETED|Overall Study||0
8201520|NCT02202252|20224101|P2|COMPLETED|Overall Study||30
8201521|NCT02202252|20224102|P1|COMPLETED|Overall Study||30
8201522|NCT02202252|20224101|P2|STARTED|Overall Study||30
8201523|NCT02202252|20224102|P1|STARTED|Overall Study||30
8201524|NCT02202161|20224120|P8|NOT COMPLETED|Overall Study||6
8201525|NCT02202161|20224121|P7|NOT COMPLETED|Overall Study||0
8201526|NCT02202161|20224122|P6|NOT COMPLETED|Overall Study||1
8201527|NCT02202161|20224123|P5|NOT COMPLETED|Overall Study||1
8201528|NCT02202161|20224124|P4|NOT COMPLETED|Overall Study||0
8201529|NCT02202161|20224125|P3|NOT COMPLETED|Overall Study||0
8201530|NCT02202161|20224126|P2|NOT COMPLETED|Overall Study||1
8201531|NCT02202161|20224127|P1|NOT COMPLETED|Overall Study||1
8201532|NCT02202161|20224120|P8|COMPLETED|Overall Study||0
8201533|NCT02202161|20224121|P7|COMPLETED|Overall Study||13
8201534|NCT02202161|20224122|P6|COMPLETED|Overall Study||9
8201535|NCT02202161|20224123|P5|COMPLETED|Overall Study||8
8201536|NCT02202161|20224124|P4|COMPLETED|Overall Study||9
8201537|NCT02202161|20224125|P3|COMPLETED|Overall Study||5
8201538|NCT02202161|20224126|P2|COMPLETED|Overall Study||4
8201539|NCT02202161|20224127|P1|COMPLETED|Overall Study||12
8201540|NCT02202161|20224120|P8|STARTED|Overall Study||6
8201541|NCT02202161|20224121|P7|STARTED|Overall Study||13
8201542|NCT02202161|20224122|P6|STARTED|Overall Study||10
8201543|NCT02202161|20224123|P5|STARTED|Overall Study||9
8201544|NCT02202161|20224124|P4|STARTED|Overall Study||9
8201545|NCT02202161|20224125|P3|STARTED|Overall Study||5
8201546|NCT02202161|20224126|P2|STARTED|Overall Study||5
8201547|NCT02202161|20224127|P1|STARTED|Overall Study||13
8201548|NCT02202135|20224281|P1|NOT COMPLETED|Overall Study||0
8201549|NCT02202135|20224281|P1|COMPLETED|Overall Study||4
8201550|NCT02202135|20224281|P1|STARTED|Overall Study||4
8201551|NCT02202109|20224287|P2|NOT COMPLETED|Overall Study||87
8201552|NCT02202109|20224288|P1|NOT COMPLETED|Overall Study||90
8201553|NCT02202109|20224287|P2|COMPLETED|Overall Study||213
8201554|NCT02202109|20224288|P1|COMPLETED|Overall Study||212
8201555|NCT02202109|20224287|P2|STARTED|Overall Study||300
8201556|NCT02202109|20224288|P1|STARTED|Overall Study||302
8201557|NCT02202044|20224298|P1|NOT COMPLETED|Overall Study||0
8201558|NCT02202044|20224298|P1|COMPLETED|Overall Study||0
8201559|NCT02202044|20224298|P1|STARTED|Overall Study||0
8201560|NCT02202031|20224305|P2|NOT COMPLETED|Overall Study||5
8201561|NCT02202031|20224306|P1|NOT COMPLETED|Overall Study||5
8201562|NCT02202031|20224305|P2|COMPLETED|Overall Study||74
8201563|NCT02202031|20224306|P1|COMPLETED|Overall Study||77
8201564|NCT02202031|20224305|P2|STARTED|Overall Study||79
8201565|NCT02202031|20224306|P1|STARTED|Overall Study||82
8201566|NCT02201953|20224354|P2|NOT COMPLETED|Overall Study||56
8201567|NCT02201953|20224355|P1|NOT COMPLETED|Overall Study||20
8201568|NCT02201953|20224354|P2|COMPLETED|Overall Study||224
8201569|NCT02201953|20224355|P1|COMPLETED|Overall Study||258
8201570|NCT02201953|20224354|P2|STARTED|Overall Study||280
8201571|NCT02201953|20224355|P1|STARTED|Overall Study||278
8201572|NCT02201940|20224373|P2|NOT COMPLETED|Overall Study||116
8201573|NCT02201940|20224374|P1|NOT COMPLETED|Overall Study||12
8201574|NCT02201940|20224373|P2|COMPLETED|Overall Study||0
8201575|NCT02201940|20224374|P1|COMPLETED|Overall Study||613
8201576|NCT02201940|20224373|P2|STARTED|Overall Study||116
8201577|NCT02201940|20224374|P1|STARTED|Overall Study||625
8201578|NCT02201901|20224393|P3|NOT COMPLETED|Overall Study||13
8201579|NCT02201901|20224394|P2|NOT COMPLETED|Overall Study||9
8201580|NCT02201901|20224395|P1|NOT COMPLETED|Overall Study||15
8201581|NCT02201901|20224393|P3|COMPLETED|Overall Study||77
8201582|NCT02201901|20224394|P2|COMPLETED|Overall Study||79
8201583|NCT02201901|20224395|P1|COMPLETED|Overall Study||75
8201584|NCT02201901|20224393|P3|STARTED|Overall Study||90
8201585|NCT02201901|20224394|P2|STARTED|Overall Study||88
8201586|NCT02201901|20224395|P1|STARTED|Overall Study||90
8201587|NCT02201784|20224426|P2|NOT COMPLETED|Overall Study||0
8201588|NCT02201784|20224427|P1|NOT COMPLETED|Overall Study||2
8201589|NCT02201784|20224426|P2|COMPLETED|Overall Study||30
8201590|NCT02201784|20224427|P1|COMPLETED|Overall Study||28
8201591|NCT02201784|20224426|P2|STARTED|Overall Study||30
8201592|NCT02201784|20224427|P1|STARTED|Overall Study||30
8201593|NCT02201771|20224444|P3|NOT COMPLETED|Overall Study||10
8201594|NCT02201771|20224445|P2|NOT COMPLETED|Overall Study||10
8201595|NCT02201771|20224446|P1|NOT COMPLETED|Overall Study||13
8201596|NCT02201771|20224444|P3|COMPLETED|Overall Study||156
8201597|NCT02201771|20224445|P2|COMPLETED|Overall Study||158
8201598|NCT02201771|20224446|P1|COMPLETED|Overall Study||153
8201599|NCT02201771|20224444|P3|STARTED|Overall Study||166
8201600|NCT02201771|20224445|P2|STARTED|Overall Study||168
8201601|NCT02201771|20224446|P1|STARTED|Overall Study||166
8201602|NCT02201524|20224473|P4|NOT COMPLETED|Overall Study||4
8201603|NCT02201524|20224474|P3|NOT COMPLETED|Overall Study||4
8201604|NCT02201524|20224475|P2|NOT COMPLETED|Overall Study||3
8201605|NCT02201524|20224476|P1|NOT COMPLETED|Overall Study||2
8201606|NCT02201524|20224473|P4|COMPLETED|Overall Study||10
8201607|NCT02201524|20224474|P3|COMPLETED|Overall Study||12
8201608|NCT02201524|20224475|P2|COMPLETED|Overall Study||12
8201609|NCT02201524|20224476|P1|COMPLETED|Overall Study||12
8201610|NCT02201524|20224473|P4|STARTED|Overall Study||14
8201611|NCT02201524|20224474|P3|STARTED|Overall Study||16
8201612|NCT02201524|20224475|P2|STARTED|Overall Study||15
8201613|NCT02201524|20224476|P1|STARTED|Overall Study||14
8201614|NCT02201472|20224558|P1|NOT COMPLETED|Overall Study||2
8201615|NCT02201472|20224558|P1|COMPLETED|Overall Study||0
8201616|NCT02201472|20224558|P1|STARTED|Overall Study||2
8201617|NCT02201446|20224564|P2|NOT COMPLETED|Overall Study||0
8201618|NCT02201446|20224565|P1|NOT COMPLETED|Overall Study||0
8201619|NCT02201446|20224564|P2|COMPLETED|Overall Study||58
8201620|NCT02201446|20224565|P1|COMPLETED|Overall Study||81
8201621|NCT02201446|20224564|P2|STARTED|Overall Study||58
8201622|NCT02201446|20224565|P1|STARTED|Overall Study||81
8201623|NCT02201420|20224593|P1|NOT COMPLETED|Overall Study||0
8201624|NCT02201420|20224593|P1|COMPLETED|Overall Study||5
8201625|NCT02201420|20224593|P1|STARTED|Overall Study||5
8201626|NCT02201394|20224598|P1|NOT COMPLETED|Maintenance Dose||0
8201627|NCT02201394|20224598|P1|COMPLETED|Maintenance Dose||20
8201628|NCT02201394|20224598|P1|STARTED|Maintenance Dose||20
8201629|NCT02201394|20224598|P1|NOT COMPLETED|Loading Dose||0
8201630|NCT02201394|20224598|P1|COMPLETED|Loading Dose||20
8201631|NCT02201394|20224598|P1|STARTED|Loading Dose||20
8201632|NCT02201329|20224605|P1|NOT COMPLETED|Overall Study||5
8201633|NCT02201329|20224605|P1|COMPLETED|Overall Study||0
8201634|NCT02201329|20224605|P1|STARTED|Overall Study||5
8201635|NCT02201290|20224613|P1|NOT COMPLETED|Overall Study||5
8201636|NCT02201290|20224613|P1|COMPLETED|Overall Study||4
8201637|NCT02201290|20224613|P1|STARTED|Overall Study||9
8201638|NCT02201277|20224619|P2|NOT COMPLETED|Overall Study||5
8201639|NCT02201277|20224620|P1|NOT COMPLETED|Overall Study||7
8201640|NCT02201277|20224619|P2|COMPLETED|Overall Study||16
8201641|NCT02201277|20224620|P1|COMPLETED|Overall Study||17
8201642|NCT02201277|20224619|P2|Failed Retrieval (Referred Elsewhere)|Overall Study||0
8201643|NCT02201277|20224620|P1|Failed Retrieval (Referred Elsewhere)|Overall Study||1
8201644|NCT02201277|20224619|P2|Complicated Retrieval|Overall Study||0
8201645|NCT02201277|20224620|P1|Complicated Retrieval|Overall Study||2
8201646|NCT02201277|20224619|P2|Death (Before Removal)|Overall Study||4
8201647|NCT02201277|20224620|P1|Death (Before Removal)|Overall Study||3
8201648|NCT02201277|20224619|P2|Lost to Follow up|Overall Study||1
8201649|NCT02201277|20224620|P1|Lost to Follow up|Overall Study||2
8201650|NCT02201277|20224619|P2|Filter Ruled to be Permanent|Overall Study||2
8201651|NCT02201277|20224620|P1|Filter Ruled to be Permanent|Overall Study||2
8201652|NCT02201277|20224619|P2|Signed ICF But Did Not Enroll|Overall Study||1
8201653|NCT02201277|20224620|P1|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
8201654|NCT02201277|20224619|P2|Filter Retrieval|Overall Study||16
8201655|NCT02201277|20224620|P1|Filter Retrieval|Overall Study||17
8201656|NCT02201277|20224619|P2|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
8201657|NCT02201277|20224620|P1|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
8201658|NCT02201212|20224640|P1|NOT COMPLETED|Overall Study||0
8201659|NCT02201212|20224640|P1|COMPLETED|Overall Study||30
8201660|NCT02201212|20224640|P1|STARTED|Overall Study||30
8201661|NCT02201108|20224650|P2|NOT COMPLETED|Overall Study||7
8201662|NCT02201108|20224651|P1|NOT COMPLETED|Overall Study||4
8201663|NCT02201108|20224650|P2|COMPLETED|Overall Study||102
8201664|NCT02201108|20224651|P1|COMPLETED|Overall Study||53
8201665|NCT02201108|20224650|P2|On-going Participants|Overall Study||58
8201666|NCT02201108|20224651|P1|On-going Participants|Overall Study||0
8201667|NCT02201108|20224650|P2|STARTED|Overall Study||109
8201668|NCT02201108|20224651|P1|STARTED|Overall Study||57
8201669|NCT02201056|20224703|P7|NOT COMPLETED|Overall Study||0
8201670|NCT02201056|20224704|P6|NOT COMPLETED|Overall Study||0
8201671|NCT02201056|20224705|P5|NOT COMPLETED|Overall Study||0
8201672|NCT02201056|20224706|P4|NOT COMPLETED|Overall Study||0
8201673|NCT02201056|20224707|P3|NOT COMPLETED|Overall Study||0
8201674|NCT02201056|20224708|P2|NOT COMPLETED|Overall Study||0
8201675|NCT02201056|20224709|P1|NOT COMPLETED|Overall Study||0
8201676|NCT02201056|20224703|P7|COMPLETED|Overall Study||6
8201677|NCT02201056|20224704|P6|COMPLETED|Overall Study||6
8201678|NCT02201056|20224705|P5|COMPLETED|Overall Study||6
8201679|NCT02201056|20224706|P4|COMPLETED|Overall Study||6
8201680|NCT02201056|20224707|P3|COMPLETED|Overall Study||6
8201681|NCT02201056|20224708|P2|COMPLETED|Overall Study||6
8201682|NCT02201056|20224709|P1|COMPLETED|Overall Study||12
8201683|NCT02201056|20224703|P7|STARTED|Overall Study||6
8201684|NCT02201056|20224704|P6|STARTED|Overall Study||6
8201685|NCT02201056|20224705|P5|STARTED|Overall Study||6
8201686|NCT02201056|20224706|P4|STARTED|Overall Study||6
8201687|NCT02201056|20224707|P3|STARTED|Overall Study||6
8201688|NCT02201056|20224708|P2|STARTED|Overall Study||6
8201689|NCT02201056|20224709|P1|STARTED|Overall Study||12
8201690|NCT02200770|20224766|P2|NOT COMPLETED|Open-label Period (OLP)||162
8201691|NCT02200770|20224767|P1|NOT COMPLETED|Open-label Period (OLP)||51
8201692|NCT02200770|20224766|P2|COMPLETED|Open-label Period (OLP)||0
8201693|NCT02200770|20224767|P1|COMPLETED|Open-label Period (OLP)||0
8201694|NCT02200770|20224766|P2|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 169 participants who completed RCP, only 162 entered in OLP.|162
8201695|NCT02200770|20224767|P1|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 54 participants who completed RCP, only 51 entered in OLP.|51
8201696|NCT02200770|20224766|P2|NOT COMPLETED|Randomized-controlled Period (RCP)||6
8201697|NCT02200770|20224767|P1|NOT COMPLETED|Randomized-controlled Period (RCP)||2
8201698|NCT02200770|20224766|P2|COMPLETED|Randomized-controlled Period (RCP)||169
8201699|NCT02200770|20224767|P1|COMPLETED|Randomized-controlled Period (RCP)||54
8201700|NCT02200770|20224766|P2|Treated|Randomized-controlled Period (RCP)||174
8201701|NCT02200770|20224767|P1|Treated|Randomized-controlled Period (RCP)||56
8201702|NCT02200770|20224766|P2|STARTED|Randomized-controlled Period (RCP)||175
8201703|NCT02200770|20224767|P1|STARTED|Randomized-controlled Period (RCP)||56
8201716|NCT02200536|20224824|P3|NOT COMPLETED|Overall Study||0
8201717|NCT02200536|20224825|P2|NOT COMPLETED|Overall Study||0
8201718|NCT02200536|20224826|P1|NOT COMPLETED|Overall Study||0
8201719|NCT02200536|20224824|P3|COMPLETED|Overall Study||30
8201720|NCT02200536|20224825|P2|COMPLETED|Overall Study||30
8201721|NCT02200536|20224826|P1|COMPLETED|Overall Study||32
8201722|NCT02200536|20224824|P3|STARTED|Overall Study||30
8201723|NCT02200536|20224825|P2|STARTED|Overall Study||30
8201724|NCT02200536|20224826|P1|STARTED|Overall Study||32
8201725|NCT02200523|20224839|P2|NOT COMPLETED|Overall Study||0
8201726|NCT02200523|20224840|P1|NOT COMPLETED|Overall Study||0
8201727|NCT02200523|20224839|P2|COMPLETED|Overall Study||20
8201728|NCT02200523|20224840|P1|COMPLETED|Overall Study||20
8201729|NCT02200523|20224839|P2|STARTED|Overall Study||20
8201730|NCT02200523|20224840|P1|STARTED|Overall Study||20
8201731|NCT02200510|20224848|P2|NOT COMPLETED|Overall Study||3
8201732|NCT02200510|20224849|P1|NOT COMPLETED|Overall Study||9
8201733|NCT02200510|20224848|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
8201734|NCT02200510|20224849|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
8201735|NCT02200510|20224848|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
8201736|NCT02200510|20224849|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
8201737|NCT02200458|20224855|P1|NOT COMPLETED|Overall Study||0
8201738|NCT02200458|20224855|P1|COMPLETED|Overall Study||62
8201739|NCT02200458|20224855|P1|STARTED|Overall Study||62
8201740|NCT02200445|20224862|P3|NOT COMPLETED|Overall Study||2
8201741|NCT02200445|20224863|P2|NOT COMPLETED|Overall Study||4
8201742|NCT02200445|20224864|P1|NOT COMPLETED|Overall Study||1
8201743|NCT02200445|20224862|P3|COMPLETED|Overall Study||3
8201744|NCT02200445|20224863|P2|COMPLETED|Overall Study||13
8201745|NCT02200445|20224864|P1|COMPLETED|Overall Study||3
8201746|NCT02200445|20224862|P3|STARTED|Overall Study||5
8201747|NCT02200445|20224863|P2|STARTED|Overall Study||17
8201748|NCT02200445|20224864|P1|STARTED|Overall Study||4
8201749|NCT02200328|20224880|P2|NOT COMPLETED|Overall Study||33
8201750|NCT02200328|20224881|P1|NOT COMPLETED|Overall Study||43
8201751|NCT02200328|20224880|P2|COMPLETED|Overall Study||0
8201752|NCT02200328|20224881|P1|COMPLETED|Overall Study||0
8201753|NCT02200328|20224880|P2|STARTED|Overall Study||33
8201754|NCT02200328|20224881|P1|STARTED|Overall Study||43
8201755|NCT02200211|20224893|P4|NOT COMPLETED|Overall Study||2
8201756|NCT02200211|20224894|P3|NOT COMPLETED|Overall Study||1
8201757|NCT02200211|20224895|P2|NOT COMPLETED|Overall Study||7
8201758|NCT02200211|20224896|P1|NOT COMPLETED|Overall Study||8
8201759|NCT02200211|20224893|P4|COMPLETED|Overall Study||58
8201760|NCT02200211|20224894|P3|COMPLETED|Overall Study||39
8201761|NCT02200211|20224895|P2|COMPLETED|Overall Study||188
8201762|NCT02200211|20224896|P1|COMPLETED|Overall Study||182
8201763|NCT02200211|20224893|P4|Included in 16-week Primary Analysis|Overall Study||56
8201764|NCT02200211|20224894|P3|Included in 16-week Primary Analysis|Overall Study||39
8201765|NCT02200211|20224895|P2|Included in 16-week Primary Analysis|Overall Study||186
8201766|NCT02200211|20224896|P1|Included in 16-week Primary Analysis|Overall Study||177
8201767|NCT02200211|20224893|P4|STARTED|Overall Study||60
8201768|NCT02200211|20224894|P3|STARTED|Overall Study||40
8201769|NCT02200211|20224895|P2|STARTED|Overall Study||195
8201770|NCT02200211|20224896|P1|STARTED|Overall Study||190
8201771|NCT02200055|20224992|P1|NOT COMPLETED|Overall Study||0
8201772|NCT02200055|20224992|P1|COMPLETED|Overall Study||86
8201773|NCT02200055|20224992|P1|STARTED|Overall Study||86
8201774|NCT02200042|20225009|P2|NOT COMPLETED|Overall Study||1
8201775|NCT02200042|20225010|P1|NOT COMPLETED|Overall Study||0
8201776|NCT02200042|20225009|P2|COMPLETED|Overall Study||0
8201777|NCT02200042|20225010|P1|COMPLETED|Overall Study||0
8201778|NCT02200042|20225009|P2|STARTED|Overall Study||1
8201779|NCT02200042|20225010|P1|STARTED|Overall Study||0
8201780|NCT02199964|20225028|P2|NOT COMPLETED|Overall Study||0
8201781|NCT02199964|20225029|P1|NOT COMPLETED|Overall Study||0
8201782|NCT02199964|20225028|P2|COMPLETED|Overall Study||2
8201783|NCT02199964|20225029|P1|COMPLETED|Overall Study||2
8201784|NCT02199964|20225028|P2|STARTED|Overall Study||2
8201785|NCT02199964|20225029|P1|STARTED|Overall Study||2
8201786|NCT02199795|20225039|P2|NOT COMPLETED|Overall Study||0
8201787|NCT02199795|20225040|P1|NOT COMPLETED|Overall Study||2
8201788|NCT02199795|20225039|P2|COMPLETED|Overall Study||3
8201789|NCT02199795|20225040|P1|COMPLETED|Overall Study||2
8201790|NCT02199795|20225039|P2|STARTED|Overall Study||3
8201791|NCT02199795|20225040|P1|STARTED|Overall Study||4
8201792|NCT02199717|20225052|P1|NOT COMPLETED|Overall Study||0
8201793|NCT02199717|20225052|P1|COMPLETED|Overall Study||66
8201794|NCT02199717|20225052|P1|STARTED|Overall Study||66
8201795|NCT02199691|20225063|P4|NOT COMPLETED|Overall Study||30
8201796|NCT02199691|20225064|P3|NOT COMPLETED|Overall Study||27
8201797|NCT02199691|20225065|P2|NOT COMPLETED|Overall Study||7
8201798|NCT02199691|20225066|P1|NOT COMPLETED|Overall Study||10
8201799|NCT02199691|20225063|P4|COMPLETED|Overall Study||270
8201800|NCT02199691|20225064|P3|COMPLETED|Overall Study||376
8201801|NCT02199691|20225065|P2|COMPLETED|Overall Study||500
8201802|NCT02199691|20225066|P1|COMPLETED|Overall Study||495
8201803|NCT02199691|20225063|P4|Safety Analysis Set (SafAS)|Overall Study||296
8201804|NCT02199691|20225064|P3|Safety Analysis Set (SafAS)|Overall Study||392
8201805|NCT02199691|20225065|P2|Safety Analysis Set (SafAS)|Overall Study||501
8201806|NCT02199691|20225066|P1|Safety Analysis Set (SafAS)|Overall Study||503
8201807|NCT02199691|20225063|P4|STARTED|Overall Study||300
8201808|NCT02199691|20225064|P3|STARTED|Overall Study||403
8201809|NCT02199691|20225065|P2|STARTED|Overall Study||507
8201810|NCT02199691|20225066|P1|STARTED|Overall Study||505
8201811|NCT02199652|20225088|P2|NOT COMPLETED|Overall Study||7
8201812|NCT02199652|20225089|P1|NOT COMPLETED|Overall Study||7
8201813|NCT02199652|20225088|P2|COMPLETED|Overall Study||3
8201814|NCT02199652|20225089|P1|COMPLETED|Overall Study||3
8201815|NCT02199652|20225088|P2|STARTED|Overall Study||10
8201816|NCT02199652|20225089|P1|STARTED|Overall Study||10
8201817|NCT02199574|20225099|P1|NOT COMPLETED|Overall Study||0
8201818|NCT02199574|20225099|P1|COMPLETED|Overall Study||12
8201819|NCT02199574|20225099|P1|STARTED|Overall Study||12
8201820|NCT02199509|20225108|P2|NOT COMPLETED|Overall Study||1
8201821|NCT02199509|20225109|P1|NOT COMPLETED|Overall Study||1
8201822|NCT02199509|20225108|P2|COMPLETED|Overall Study||3
8201823|NCT02199509|20225109|P1|COMPLETED|Overall Study||2
8201824|NCT02199509|20225108|P2|STARTED|Overall Study||4
8201825|NCT02199509|20225109|P1|STARTED|Overall Study||3
8201826|NCT02199496|20225123|P2|NOT COMPLETED|Ustekinumab-Multi-dose||0
8201827|NCT02199496|20225124|P1|NOT COMPLETED|Ustekinumab-Multi-dose||0
8201828|NCT02199496|20225123|P2|COMPLETED|Ustekinumab-Multi-dose||2
8201829|NCT02199496|20225124|P1|COMPLETED|Ustekinumab-Multi-dose||3
8201830|NCT02199496|20225123|P2|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
8201831|NCT02199496|20225124|P1|STARTED|Ustekinumab-Multi-dose||3
8201832|NCT02199496|20225123|P2|NOT COMPLETED|Ustekinumab-Single Dose||0
8201833|NCT02199496|20225124|P1|NOT COMPLETED|Ustekinumab-Single Dose||0
8201834|NCT02199496|20225123|P2|COMPLETED|Ustekinumab-Single Dose||0
8201835|NCT02199496|20225124|P1|COMPLETED|Ustekinumab-Single Dose||3
8201836|NCT02199496|20225123|P2|STARTED|Ustekinumab-Single Dose||0
8201837|NCT02199496|20225124|P1|STARTED|Ustekinumab-Single Dose||3
8201838|NCT02199314|20225132|P1|NOT COMPLETED|Overall Study||16
8201839|NCT02199314|20225132|P1|COMPLETED|Overall Study||14
8201840|NCT02199314|20225132|P1|STARTED|Overall Study||30
8201841|NCT02199197|20225138|P2|NOT COMPLETED|Overall Study||2
8201842|NCT02199197|20225139|P1|NOT COMPLETED|Overall Study||0
8201843|NCT02199197|20225138|P2|COMPLETED|Overall Study||12
8201844|NCT02199197|20225139|P1|COMPLETED|Overall Study||35
8201845|NCT02199197|20225138|P2|STARTED|Overall Study||14
8201846|NCT02199197|20225139|P1|STARTED|Overall Study||35
8201847|NCT02199080|20225159|P1|NOT COMPLETED|Overall Study||12
8201848|NCT02199080|20225159|P1|COMPLETED|Overall Study||2494
8201849|NCT02199080|20225159|P1|STARTED|Overall Study||2506
8201850|NCT02199041|20225169|P1|NOT COMPLETED|Overall Study||0
8201851|NCT02199041|20225169|P1|COMPLETED|Overall Study||12
8201852|NCT02199041|20225169|P1|STARTED|Overall Study||12
8201853|NCT02199028|20225184|P2|NOT COMPLETED|Week 4||0
8201854|NCT02199028|20225185|P1|NOT COMPLETED|Week 4||0
8201855|NCT02199028|20225184|P2|COMPLETED|Week 4||15
8201856|NCT02199028|20225185|P1|COMPLETED|Week 4||13
8201857|NCT02199028|20225184|P2|STARTED|Week 4||15
8201858|NCT02199028|20225185|P1|STARTED|Week 4||13
8201859|NCT02199028|20225184|P2|NOT COMPLETED|Week 3||0
8201860|NCT02199028|20225185|P1|NOT COMPLETED|Week 3||1
8201861|NCT02199028|20225184|P2|COMPLETED|Week 3||15
8201862|NCT02199028|20225185|P1|COMPLETED|Week 3||13
8201863|NCT02199028|20225184|P2|STARTED|Week 3||15
8201864|NCT02199028|20225185|P1|STARTED|Week 3||14
8201865|NCT02199028|20225184|P2|NOT COMPLETED|Week 2||0
8201866|NCT02199028|20225185|P1|NOT COMPLETED|Week 2||0
8201867|NCT02199028|20225184|P2|COMPLETED|Week 2||15
8201868|NCT02199028|20225185|P1|COMPLETED|Week 2||14
8201869|NCT02199028|20225184|P2|STARTED|Week 2||15
8201870|NCT02199028|20225185|P1|STARTED|Week 2||14
8201871|NCT02199028|20225184|P2|NOT COMPLETED|Week 1||0
8201872|NCT02199028|20225185|P1|NOT COMPLETED|Week 1||1
8201873|NCT02199028|20225184|P2|COMPLETED|Week 1||15
8201874|NCT02199028|20225185|P1|COMPLETED|Week 1||14
8201875|NCT02199028|20225184|P2|STARTED|Week 1||15
8201876|NCT02199028|20225185|P1|STARTED|Week 1||15
8201877|NCT02198963|20225194|P1|NOT COMPLETED|Overall Study||7
8201878|NCT02198963|20225194|P1|COMPLETED|Overall Study||36
8201879|NCT02198963|20225194|P1|STARTED|Overall Study||43
8201880|NCT02198833|20225205|P2|NOT COMPLETED|Overall Study||0
8201881|NCT02198833|20225206|P1|NOT COMPLETED|Overall Study||0
8201882|NCT02198833|20225205|P2|COMPLETED|Overall Study||1
8201883|NCT02198833|20225206|P1|COMPLETED|Overall Study||1
8201884|NCT02198833|20225205|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
8201885|NCT02198833|20225206|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
8201886|NCT02198651|20225218|P5|NOT COMPLETED|Open-label Rescue Period||0
8201887|NCT02198651|20225219|P4|NOT COMPLETED|Open-label Rescue Period||3
8201888|NCT02198651|20225220|P3|NOT COMPLETED|Open-label Rescue Period||0
8201889|NCT02198651|20225221|P2|NOT COMPLETED|Open-label Rescue Period||0
8201890|NCT02198651|20225222|P1|NOT COMPLETED|Open-label Rescue Period||0
8201891|NCT02198651|20225218|P5|COMPLETED|Open-label Rescue Period||8
8201892|NCT02198651|20225219|P4|COMPLETED|Open-label Rescue Period||28
8201893|NCT02198651|20225220|P3|COMPLETED|Open-label Rescue Period||0
8201894|NCT02198651|20225221|P2|COMPLETED|Open-label Rescue Period||0
8201895|NCT02198651|20225222|P1|COMPLETED|Open-label Rescue Period||0
8201896|NCT02198651|20225218|P5|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
8201897|NCT02198651|20225219|P4|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
8201898|NCT02198651|20225220|P3|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8201899|NCT02198651|20225221|P2|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8201900|NCT02198651|20225222|P1|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8201901|NCT02198651|20225218|P5|STARTED|Open-label Rescue Period||8
8201902|NCT02198651|20225219|P4|STARTED|Open-label Rescue Period||31
8201903|NCT02198651|20225220|P3|STARTED|Open-label Rescue Period||0
8201904|NCT02198651|20225221|P2|STARTED|Open-label Rescue Period||0
8201905|NCT02198651|20225222|P1|STARTED|Open-label Rescue Period||0
8201906|NCT02198651|20225218|P5|NOT COMPLETED|Double-blind Period||0
8201907|NCT02198651|20225219|P4|NOT COMPLETED|Double-blind Period||0
8201908|NCT02198651|20225220|P3|NOT COMPLETED|Double-blind Period||1
8201909|NCT02198651|20225221|P2|NOT COMPLETED|Double-blind Period||9
8201910|NCT02198651|20225222|P1|NOT COMPLETED|Double-blind Period||0
8201911|NCT02198651|20225218|P5|COMPLETED|Double-blind Period||0
8201912|NCT02198651|20225219|P4|COMPLETED|Double-blind Period||0
8201913|NCT02198651|20225220|P3|COMPLETED|Double-blind Period||19
8201914|NCT02198651|20225221|P2|COMPLETED|Double-blind Period||93
8201915|NCT02198651|20225222|P1|COMPLETED|Double-blind Period||0
8201916|NCT02198651|20225218|P5|STARTED|Double-blind Period||0
8201917|NCT02198651|20225219|P4|STARTED|Double-blind Period||0
8201918|NCT02198651|20225220|P3|STARTED|Double-blind Period||20
8201919|NCT02198651|20225221|P2|STARTED|Double-blind Period||102
8201920|NCT02198651|20225222|P1|STARTED|Double-blind Period||0
8201921|NCT02198651|20225218|P5|NOT COMPLETED|Lead-in Period||0
8201922|NCT02198651|20225219|P4|NOT COMPLETED|Lead-in Period||0
8201923|NCT02198651|20225220|P3|NOT COMPLETED|Lead-in Period||0
8201924|NCT02198651|20225221|P2|NOT COMPLETED|Lead-in Period||0
8201925|NCT02198651|20225222|P1|NOT COMPLETED|Lead-in Period||37
8201926|NCT02198651|20225218|P5|COMPLETED|Lead-in Period||0
8201927|NCT02198651|20225219|P4|COMPLETED|Lead-in Period||0
8201928|NCT02198651|20225220|P3|COMPLETED|Lead-in Period||0
8201929|NCT02198651|20225221|P2|COMPLETED|Lead-in Period||0
8201930|NCT02198651|20225222|P1|COMPLETED|Lead-in Period||112
8201931|NCT02198651|20225218|P5|Participants Treated in Lead-In Period|Lead-in Period||0
8201932|NCT02198651|20225219|P4|Participants Treated in Lead-In Period|Lead-in Period||0
8201933|NCT02198651|20225220|P3|Participants Treated in Lead-In Period|Lead-in Period||0
8201934|NCT02198651|20225221|P2|Participants Treated in Lead-In Period|Lead-in Period||0
8201935|NCT02198651|20225222|P1|Participants Treated in Lead-In Period|Lead-in Period||146
8201936|NCT02198651|20225218|P5|STARTED|Lead-in Period||0
8201937|NCT02198651|20225219|P4|STARTED|Lead-in Period||0
8201938|NCT02198651|20225220|P3|STARTED|Lead-in Period||0
8201939|NCT02198651|20225221|P2|STARTED|Lead-in Period||0
8201940|NCT02198651|20225222|P1|STARTED|Lead-in Period||149
8201941|NCT02198430|20225307|P2|NOT COMPLETED|Overall Study||0
8201942|NCT02198430|20225308|P1|NOT COMPLETED|Overall Study||0
8201943|NCT02198430|20225307|P2|COMPLETED|Overall Study||51
8201944|NCT02198430|20225308|P1|COMPLETED|Overall Study||53
8201945|NCT02198430|20225307|P2|STARTED|Overall Study||51
8201946|NCT02198430|20225308|P1|STARTED|Overall Study||53
8201947|NCT02198235|20225323|P3|NOT COMPLETED|Overall Study||2
8201948|NCT02198235|20225324|P2|NOT COMPLETED|Overall Study||2
8201949|NCT02198235|20225325|P1|NOT COMPLETED|Overall Study||3
8201950|NCT02198235|20225323|P3|COMPLETED|Overall Study||28
8201951|NCT02198235|20225324|P2|COMPLETED|Overall Study||28
8201952|NCT02198235|20225325|P1|COMPLETED|Overall Study||27
8201953|NCT02198235|20225323|P3|STARTED|Overall Study||30
8201954|NCT02198235|20225324|P2|STARTED|Overall Study||30
8201955|NCT02198235|20225325|P1|STARTED|Overall Study||30
8201956|NCT02198040|20225345|P3|NOT COMPLETED|Overall Study||1
8201957|NCT02198040|20225346|P2|NOT COMPLETED|Overall Study||1
8201958|NCT02198040|20225347|P1|NOT COMPLETED|Overall Study||0
8201959|NCT02198040|20225345|P3|COMPLETED|Overall Study||8
8201960|NCT02198040|20225346|P2|COMPLETED|Overall Study||8
8201961|NCT02198040|20225347|P1|COMPLETED|Overall Study||9
8201962|NCT02198040|20225345|P3|STARTED|Overall Study||9
8201963|NCT02198040|20225346|P2|STARTED|Overall Study||9
8201964|NCT02198040|20225347|P1|STARTED|Overall Study||9
8201965|NCT02197897|20225373|P1|NOT COMPLETED|Overall Study||1
8201966|NCT02197897|20225373|P1|COMPLETED|Overall Study||14
8201967|NCT02197897|20225373|P1|STARTED|Overall Study||15
8201968|NCT02197806|20225381|P4|NOT COMPLETED|Overall Study||1
8201969|NCT02197806|20225382|P3|NOT COMPLETED|Overall Study||0
8201970|NCT02197806|20225383|P2|NOT COMPLETED|Overall Study||1
8201971|NCT02197806|20225384|P1|NOT COMPLETED|Overall Study||0
8201972|NCT02197806|20225381|P4|COMPLETED|Overall Study||16
8201973|NCT02197806|20225382|P3|COMPLETED|Overall Study||16
8201974|NCT02197806|20225383|P2|COMPLETED|Overall Study||16
8201975|NCT02197806|20225384|P1|COMPLETED|Overall Study||15
8201976|NCT02197806|20225381|P4|STARTED|Overall Study||17
8201977|NCT02197806|20225382|P3|STARTED|Overall Study||16
8201978|NCT02197806|20225383|P2|STARTED|Overall Study||17
8201979|NCT02197806|20225384|P1|STARTED|Overall Study||15
8201980|NCT02197767|20225394|P1|NOT COMPLETED|Overall Study||0
8201981|NCT02197767|20225394|P1|COMPLETED|Overall Study||11
8201982|NCT02197767|20225394|P1|STARTED|Overall Study||11
8201983|NCT02197572|20225399|P1|NOT COMPLETED|Overall Study||44
8201984|NCT02197572|20225399|P1|COMPLETED|Overall Study||0
8201985|NCT02197572|20225399|P1|STARTED|Overall Study||44
8201986|NCT02197520|20225416|P2|NOT COMPLETED|Period 2||2
8201987|NCT02197520|20225417|P1|NOT COMPLETED|Period 2||1
8201988|NCT02197520|20225416|P2|COMPLETED|Period 2||10
8201989|NCT02197520|20225417|P1|COMPLETED|Period 2||10
8201990|NCT02197520|20225416|P2|STARTED|Period 2||12
8201991|NCT02197520|20225417|P1|STARTED|Period 2||11
8201992|NCT02197520|20225416|P2|NOT COMPLETED|Period 1||0
8201993|NCT02197520|20225417|P1|NOT COMPLETED|Period 1||1
8201994|NCT02197520|20225416|P2|COMPLETED|Period 1||12
8201995|NCT02197520|20225417|P1|COMPLETED|Period 1||11
8201996|NCT02197520|20225416|P2|STARTED|Period 1||12
8201997|NCT02197520|20225417|P1|STARTED|Period 1||12
8201998|NCT02197481|20225435|P2|NOT COMPLETED|Overall Study||0
8201999|NCT02197481|20225436|P1|NOT COMPLETED|Overall Study||0
8202000|NCT02197481|20225435|P2|COMPLETED|Overall Study||43
8202001|NCT02197481|20225436|P1|COMPLETED|Overall Study|February 2016|43
8202002|NCT02197481|20225435|P2|STARTED|Overall Study||43
8202003|NCT02197481|20225436|P1|STARTED|Overall Study|October 2014|43
8202004|NCT02197455|20225456|P1|NOT COMPLETED|Overall Study||0
8202005|NCT02197455|20225456|P1|COMPLETED|Overall Study||30
8202006|NCT02197455|20225456|P1|STARTED|Overall Study||30
8202007|NCT02197416|20225464|P3|NOT COMPLETED|Overall Study||8
8202008|NCT02197416|20225465|P2|NOT COMPLETED|Overall Study||4
8202009|NCT02197416|20225466|P1|NOT COMPLETED|Overall Study||1
8202010|NCT02197416|20225464|P3|COMPLETED|Overall Study||153
8202011|NCT02197416|20225465|P2|COMPLETED|Overall Study||39
8202012|NCT02197416|20225466|P1|COMPLETED|Overall Study||8
8202013|NCT02197416|20225464|P3|STARTED|Overall Study||161
8202014|NCT02197416|20225465|P2|STARTED|Overall Study||43
8202015|NCT02197416|20225466|P1|STARTED|Overall Study||9
8202016|NCT02197377|20225504|P2|NOT COMPLETED|Overall Study||3
8202017|NCT02197377|20225505|P1|NOT COMPLETED|Overall Study||0
8202018|NCT02197377|20225504|P2|COMPLETED|Overall Study||27
8202019|NCT02197377|20225505|P1|COMPLETED|Overall Study||30
8202020|NCT02197377|20225504|P2|STARTED|Overall Study||30
8202021|NCT02197377|20225505|P1|STARTED|Overall Study||30
8202022|NCT02197273|20225515|P2|NOT COMPLETED|Overall Study||0
8202023|NCT02197273|20225516|P1|NOT COMPLETED|Overall Study||0
8202024|NCT02197273|20225515|P2|COMPLETED|Overall Study||104
8202025|NCT02197273|20225516|P1|COMPLETED|Overall Study||107
8202026|NCT02197273|20225515|P2|STARTED|Overall Study||104
8202027|NCT02197273|20225516|P1|STARTED|Overall Study||107
8202028|NCT02197247|20225526|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
8202029|NCT02197247|20225526|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
8202030|NCT02197247|20225526|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
8202031|NCT02197247|20225526|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
8202032|NCT02197247|20225526|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
8202033|NCT02197247|20225526|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
8202034|NCT02197247|20225526|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
8202035|NCT02197247|20225526|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
8202036|NCT02197247|20225526|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
8202037|NCT02197247|20225526|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
8202038|NCT02197247|20225526|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
8202039|NCT02197247|20225526|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
8202040|NCT02197234|20225571|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
8202041|NCT02197234|20225571|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
8202042|NCT02197234|20225571|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
8202043|NCT02197234|20225571|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
8202044|NCT02197234|20225571|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
8202045|NCT02197234|20225571|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
8202046|NCT02197234|20225571|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
8202047|NCT02197234|20225571|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
8202048|NCT02197234|20225571|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
8202049|NCT02197234|20225571|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
8202050|NCT02197234|20225571|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
8202051|NCT02197234|20225571|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
8202052|NCT02197130|20225593|P3|NOT COMPLETED|Overall Study||32
8202053|NCT02197130|20225594|P2|NOT COMPLETED|Overall Study||8
8202054|NCT02197130|20225595|P1|NOT COMPLETED|Overall Study||16
8202055|NCT02197130|20225593|P3|COMPLETED|Overall Study||56
8202056|NCT02197130|20225594|P2|COMPLETED|Overall Study||81
8202057|NCT02197130|20225595|P1|COMPLETED|Overall Study||79
8202058|NCT02197130|20225593|P3|Received Treatment|Overall Study||87
8202059|NCT02197130|20225594|P2|Received Treatment|Overall Study||88
8202060|NCT02197130|20225595|P1|Received Treatment|Overall Study||95
8202061|NCT02197130|20225593|P3|STARTED|Overall Study||88
8202062|NCT02197130|20225594|P2|STARTED|Overall Study||89
8202063|NCT02197130|20225595|P1|STARTED|Overall Study||95
8202064|NCT02197078|20225657|P12|NOT COMPLETED|Overall Study||0
8202065|NCT02197078|20225658|P11|NOT COMPLETED|Overall Study||0
8202066|NCT02197078|20225659|P10|NOT COMPLETED|Overall Study||0
8202067|NCT02197078|20225660|P9|NOT COMPLETED|Overall Study||0
8202068|NCT02197078|20225661|P8|NOT COMPLETED|Overall Study||0
8202069|NCT02197078|20225662|P7|NOT COMPLETED|Overall Study||0
8202070|NCT02197078|20225663|P6|NOT COMPLETED|Overall Study||0
8202071|NCT02197078|20225664|P5|NOT COMPLETED|Overall Study||0
8202072|NCT02197078|20225665|P4|NOT COMPLETED|Overall Study||0
8202073|NCT02197078|20225666|P3|NOT COMPLETED|Overall Study||0
8202074|NCT02197078|20225667|P2|NOT COMPLETED|Overall Study||0
8202075|NCT02197078|20225668|P1|NOT COMPLETED|Overall Study||0
8202076|NCT02197078|20225657|P12|COMPLETED|Overall Study||15742
8202077|NCT02197078|20225658|P11|COMPLETED|Overall Study||15742
8202078|NCT02197078|20225659|P10|COMPLETED|Overall Study||18996
8202079|NCT02197078|20225660|P9|COMPLETED|Overall Study||18996
8202080|NCT02197078|20225661|P8|COMPLETED|Overall Study||25135
8202081|NCT02197078|20225662|P7|COMPLETED|Overall Study||25135
8202082|NCT02197078|20225663|P6|COMPLETED|Overall Study||9538
8202083|NCT02197078|20225664|P5|COMPLETED|Overall Study||9538
8202084|NCT02197078|20225665|P4|COMPLETED|Overall Study||10614
8202085|NCT02197078|20225666|P3|COMPLETED|Overall Study||10614
8202086|NCT02197078|20225667|P2|COMPLETED|Overall Study||14688
8202087|NCT02197078|20225668|P1|COMPLETED|Overall Study||14688
8202088|NCT02197078|20225657|P12|STARTED|Overall Study||15742
8202089|NCT02197078|20225658|P11|STARTED|Overall Study||15742
8202090|NCT02197078|20225659|P10|STARTED|Overall Study||18996
8202091|NCT02197078|20225660|P9|STARTED|Overall Study||18996
8202092|NCT02197078|20225661|P8|STARTED|Overall Study||25135
8202093|NCT02197078|20225662|P7|STARTED|Overall Study||25135
8202094|NCT02197078|20225663|P6|STARTED|Overall Study||9538
8202095|NCT02197078|20225664|P5|STARTED|Overall Study||9538
8202096|NCT02197078|20225665|P4|STARTED|Overall Study||10614
8202097|NCT02197078|20225666|P3|STARTED|Overall Study||10614
8202098|NCT02197078|20225667|P2|STARTED|Overall Study||14688
8202099|NCT02197078|20225668|P1|STARTED|Overall Study||14688
8202100|NCT02197065|20225780|P2|NOT COMPLETED|Overall Study||0
8202101|NCT02197065|20225781|P1|NOT COMPLETED|Overall Study||0
8202102|NCT02197065|20225780|P2|COMPLETED|Overall Study||10
8202103|NCT02197065|20225781|P1|COMPLETED|Overall Study||10
8202104|NCT02197065|20225780|P2|STARTED|Overall Study||10
8202105|NCT02197065|20225781|P1|STARTED|Overall Study||10
8202106|NCT02196922|20225792|P2|NOT COMPLETED|Overall Study||0
8202107|NCT02196922|20225793|P1|NOT COMPLETED|Overall Study||0
8202108|NCT02196922|20225792|P2|COMPLETED|Overall Study||46
8202109|NCT02196922|20225793|P1|COMPLETED|Overall Study||58
8202110|NCT02196922|20225792|P2|STARTED|Overall Study||46
8202111|NCT02196922|20225793|P1|STARTED|Overall Study||58
8202112|NCT02196857|20225803|P1|NOT COMPLETED|Overall Study||0
8202113|NCT02196857|20225803|P1|COMPLETED|Overall Study||16
8202114|NCT02196857|20225803|P1|STARTED|Overall Study||16
8202115|NCT02196831|20225810|P2|NOT COMPLETED|Overall Study||4
8202116|NCT02196831|20225811|P1|NOT COMPLETED|Overall Study||9
8202117|NCT02196831|20225810|P2|COMPLETED|Overall Study||26
8202118|NCT02196831|20225811|P1|COMPLETED|Overall Study||21
8202119|NCT02196831|20225810|P2|Received Follow-up Imaging|Overall Study||28
8202120|NCT02196831|20225811|P1|Received Follow-up Imaging|Overall Study||26
8202121|NCT02196831|20225810|P2|STARTED|Overall Study||30
8202122|NCT02196831|20225811|P1|STARTED|Overall Study||30
8202123|NCT02196766|20225824|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8202124|NCT02196766|20225825|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8202125|NCT02196766|20225824|P2|COMPLETED|Second Intervention (7 Days)||15
8202126|NCT02196766|20225825|P1|COMPLETED|Second Intervention (7 Days)||15
8202127|NCT02196766|20225824|P2|STARTED|Second Intervention (7 Days)||15
8202128|NCT02196766|20225825|P1|STARTED|Second Intervention (7 Days)||15
8202129|NCT02196766|20225824|P2|NOT COMPLETED|First Intervention (7 Days)||0
8202130|NCT02196766|20225825|P1|NOT COMPLETED|First Intervention (7 Days)||0
8202131|NCT02196766|20225824|P2|COMPLETED|First Intervention (7 Days)||15
8202132|NCT02196766|20225825|P1|COMPLETED|First Intervention (7 Days)||15
8202133|NCT02196766|20225824|P2|STARTED|First Intervention (7 Days)||15
8202134|NCT02196766|20225825|P1|STARTED|First Intervention (7 Days)||15
8202135|NCT02196714|20225841|P4|NOT COMPLETED|Overall Study||0
8202136|NCT02196714|20225842|P3|NOT COMPLETED|Overall Study||1
8202137|NCT02196714|20225843|P2|NOT COMPLETED|Overall Study||0
8202138|NCT02196714|20225844|P1|NOT COMPLETED|Overall Study||0
8202139|NCT02196714|20225841|P4|COMPLETED|Overall Study||24
8202140|NCT02196714|20225842|P3|COMPLETED|Overall Study||23
8202141|NCT02196714|20225843|P2|COMPLETED|Overall Study||23
8202142|NCT02196714|20225844|P1|COMPLETED|Overall Study||24
8202143|NCT02196714|20225841|P4|STARTED|Overall Study||24
8202144|NCT02196714|20225842|P3|STARTED|Overall Study||24
8202145|NCT02196714|20225843|P2|STARTED|Overall Study||23
8202146|NCT02196714|20225844|P1|STARTED|Overall Study||24
8202147|NCT02196701|20225966|P1|NOT COMPLETED|Overall Study||3
8202148|NCT02196701|20225966|P1|COMPLETED|Overall Study||43
8202149|NCT02196701|20225966|P1|STARTED|Overall Study||46
8202150|NCT02196688|20226024|P2|NOT COMPLETED|Overall Study||1
8202151|NCT02196688|20226025|P1|NOT COMPLETED|Overall Study||7
8202152|NCT02196688|20226024|P2|COMPLETED|Overall Study||23
8202153|NCT02196688|20226025|P1|COMPLETED|Overall Study||40
8202154|NCT02196688|20226024|P2|STARTED|Overall Study||24
8202155|NCT02196688|20226025|P1|STARTED|Overall Study||47
8202156|NCT02196675|20226040|P3|NOT COMPLETED|Overall Study||1
8202157|NCT02196675|20226041|P2|NOT COMPLETED|Overall Study||2
8202158|NCT02196675|20226042|P1|NOT COMPLETED|Overall Study||2
8202159|NCT02196675|20226040|P3|COMPLETED|Overall Study||7
8202160|NCT02196675|20226041|P2|COMPLETED|Overall Study||68
8202161|NCT02196675|20226042|P1|COMPLETED|Overall Study||25
8202162|NCT02196675|20226040|P3|STARTED|Overall Study||8
8202163|NCT02196675|20226041|P2|STARTED|Overall Study||70
8202164|NCT02196675|20226042|P1|STARTED|Overall Study||27
8202165|NCT02196558|20226065|P3|NOT COMPLETED|Extension Phase (40 Weeks)||1
8202166|NCT02196558|20226066|P2|NOT COMPLETED|Extension Phase (40 Weeks)||3
8202167|NCT02196558|20226067|P1|NOT COMPLETED|Extension Phase (40 Weeks)||2
8202168|NCT02196558|20226065|P3|COMPLETED|Extension Phase (40 Weeks)||5
8202169|NCT02196558|20226066|P2|COMPLETED|Extension Phase (40 Weeks)||8
8202170|NCT02196558|20226067|P1|COMPLETED|Extension Phase (40 Weeks)||9
8202171|NCT02196558|20226065|P3|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
8202172|NCT02196558|20226066|P2|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
8202173|NCT02196558|20226067|P1|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
8202174|NCT02196558|20226065|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||2
8202175|NCT02196558|20226066|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||3
8202176|NCT02196558|20226067|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8202177|NCT02196558|20226065|P3|COMPLETED|Treatment Phase (12 Weeks)||8
8202178|NCT02196558|20226066|P2|COMPLETED|Treatment Phase (12 Weeks)||12
8202179|NCT02196558|20226067|P1|COMPLETED|Treatment Phase (12 Weeks)||12
8202180|NCT02196558|20226065|P3|STARTED|Treatment Phase (12 Weeks)||10
8202181|NCT02196558|20226066|P2|STARTED|Treatment Phase (12 Weeks)||15
8202182|NCT02196558|20226067|P1|STARTED|Treatment Phase (12 Weeks)||12
8202183|NCT02196506|20226083|P4|NOT COMPLETED|Phase A+||14
8202184|NCT02196506|20226084|P3|NOT COMPLETED|Phase A+||0
8202185|NCT02196506|20226085|P2|NOT COMPLETED|Phase A+||0
8202186|NCT02196506|20226086|P1|NOT COMPLETED|Phase A+||0
8202187|NCT02196506|20226083|P4|COMPLETED|Phase A+||308
8202188|NCT02196506|20226084|P3|COMPLETED|Phase A+||0
8202189|NCT02196506|20226085|P2|COMPLETED|Phase A+||0
8202190|NCT02196506|20226086|P1|COMPLETED|Phase A+||0
8202191|NCT02196506|20226083|P4|STARTED|Phase A+||322
8202192|NCT02196506|20226084|P3|STARTED|Phase A+||0
8202193|NCT02196506|20226085|P2|STARTED|Phase A+||0
8202194|NCT02196506|20226086|P1|STARTED|Phase A+||0
8202195|NCT02196506|20226083|P4|NOT COMPLETED|Phase B||0
8202196|NCT02196506|20226084|P3|NOT COMPLETED|Phase B||6
8202197|NCT02196506|20226085|P2|NOT COMPLETED|Phase B||15
8202198|NCT02196506|20226086|P1|NOT COMPLETED|Phase B||0
8202199|NCT02196506|20226083|P4|COMPLETED|Phase B||0
8202200|NCT02196506|20226084|P3|COMPLETED|Phase B||196
8202201|NCT02196506|20226085|P2|COMPLETED|Phase B||177
8202202|NCT02196506|20226086|P1|COMPLETED|Phase B||0
8202203|NCT02196506|20226083|P4|STARTED|Phase B||0
8202204|NCT02196506|20226084|P3|STARTED|Phase B||202
8202205|NCT02196506|20226085|P2|STARTED|Phase B||192
8202206|NCT02196506|20226086|P1|STARTED|Phase B||0
8202207|NCT02196506|20226083|P4|NOT COMPLETED|Phase A||0
8202208|NCT02196506|20226084|P3|NOT COMPLETED|Phase A||0
8202209|NCT02196506|20226085|P2|NOT COMPLETED|Phase A||0
8202210|NCT02196506|20226086|P1|NOT COMPLETED|Phase A||121
8202211|NCT02196506|20226083|P4|COMPLETED|Phase A||0
8202212|NCT02196506|20226084|P3|COMPLETED|Phase A||0
8202213|NCT02196506|20226085|P2|COMPLETED|Phase A||0
8202214|NCT02196506|20226086|P1|COMPLETED|Phase A||716
8202215|NCT02196506|20226083|P4|STARTED|Phase A||0
8202216|NCT02196506|20226084|P3|STARTED|Phase A||0
8202217|NCT02196506|20226085|P2|STARTED|Phase A||0
8202218|NCT02196506|20226086|P1|STARTED|Phase A||837
8202219|NCT02196259|20226101|P3|NOT COMPLETED|Overall Study||1
8202220|NCT02196259|20226102|P2|NOT COMPLETED|Overall Study||3
8202221|NCT02196259|20226103|P1|NOT COMPLETED|Overall Study||0
8202222|NCT02196259|20226101|P3|COMPLETED|Overall Study||2
8202223|NCT02196259|20226102|P2|COMPLETED|Overall Study||4
8202224|NCT02196259|20226103|P1|COMPLETED|Overall Study||3
8202225|NCT02196259|20226101|P3|STARTED|Overall Study||3
8202226|NCT02196259|20226102|P2|STARTED|Overall Study||7
8202227|NCT02196259|20226103|P1|STARTED|Overall Study||3
8202228|NCT02196168|20226112|P2|NOT COMPLETED|Overall Study||0
8202229|NCT02196168|20226113|P1|NOT COMPLETED|Overall Study||0
8202230|NCT02196168|20226112|P2|COMPLETED|Overall Study||0
8202231|NCT02196168|20226113|P1|COMPLETED|Overall Study||6
8202232|NCT02196168|20226112|P2|STARTED|Overall Study||0
8202233|NCT02196168|20226113|P1|STARTED|Overall Study||6
8202234|NCT02196077|20226131|P1|NOT COMPLETED|Overall Study||47
8202235|NCT02196077|20226131|P1|COMPLETED|Overall Study||133
8202236|NCT02196077|20226131|P1|FF MDI 9.6 μg|Overall Study||157
8202237|NCT02196077|20226131|P1|BD MDI 320 μg|Overall Study||108
8202238|NCT02196077|20226131|P1|BFF MDI 80/9.6 μg|Overall Study||103
8202239|NCT02196077|20226131|P1|BFF MDI 160/9.6 μg|Overall Study||106
8202240|NCT02196077|20226131|P1|BFF MDI 320/9.6 μg|Overall Study||155
8202241|NCT02196077|20226131|P1|STARTED|Overall Study||180
8202242|NCT02195986|20226181|P3|NOT COMPLETED|Overall Study||2
8202243|NCT02195986|20226182|P2|NOT COMPLETED|Overall Study||5
8202244|NCT02195986|20226183|P1|NOT COMPLETED|Overall Study||3
8202245|NCT02195986|20226181|P3|COMPLETED|Overall Study||71
8202246|NCT02195986|20226182|P2|COMPLETED|Overall Study||142
8202247|NCT02195986|20226183|P1|COMPLETED|Overall Study||143
8202248|NCT02195986|20226181|P3|STARTED|Overall Study||73
8202249|NCT02195986|20226182|P2|STARTED|Overall Study||147
8202250|NCT02195986|20226183|P1|STARTED|Overall Study||146
8202251|NCT02195895|20226198|P1|NOT COMPLETED|Overall Study||0
8202252|NCT02195895|20226198|P1|COMPLETED|Overall Study||17
8202253|NCT02195895|20226198|P1|STARTED|Overall Study||17
8202254|NCT02195869|20226206|P1|NOT COMPLETED|Overall Study||42
8202255|NCT02195869|20226206|P1|COMPLETED|Overall Study||0
8202256|NCT02195869|20226206|P1|All-Treated Population|Overall Study||42
8202257|NCT02195869|20226206|P1|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
8202258|NCT02195713|20226219|P2|NOT COMPLETED|Overall Study||0
8202259|NCT02195713|20226220|P1|NOT COMPLETED|Overall Study||0
8202260|NCT02195713|20226219|P2|COMPLETED|Overall Study||10
8202261|NCT02195713|20226220|P1|COMPLETED|Overall Study||10
8202262|NCT02195713|20226219|P2|STARTED|Overall Study||10
8202263|NCT02195713|20226220|P1|STARTED|Overall Study||10
8202264|NCT02195700|20226228|P2|NOT COMPLETED|Overall Study||7
8202265|NCT02195700|20226229|P1|NOT COMPLETED|Overall Study||6
8202266|NCT02195700|20226228|P2|COMPLETED|Overall Study||52
8202267|NCT02195700|20226229|P1|COMPLETED|Overall Study||52
8202268|NCT02195700|20226228|P2|Maintenance Period|Overall Study||54
8202269|NCT02195700|20226229|P1|Maintenance Period|Overall Study||53
8202270|NCT02195700|20226228|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
8202271|NCT02195700|20226229|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
8202272|NCT02195700|20226228|P2|Safety and ITT Populations|Overall Study||59
8202273|NCT02195700|20226229|P1|Safety and ITT Populations|Overall Study||58
8202274|NCT02195700|20226228|P2|STARTED|Overall Study||59
8202275|NCT02195700|20226229|P1|STARTED|Overall Study||58
8202276|NCT02195687|20226251|P2|NOT COMPLETED|Overall Study||2
8202277|NCT02195687|20226252|P1|NOT COMPLETED|Overall Study||5
8202278|NCT02195687|20226251|P2|COMPLETED|Overall Study||99
8202279|NCT02195687|20226252|P1|COMPLETED|Overall Study||311
8202280|NCT02195687|20226251|P2|STARTED|Overall Study||101
8202281|NCT02195687|20226252|P1|STARTED|Overall Study||316
8202282|NCT02195622|20226270|P2|NOT COMPLETED|Overall Study||0
8202283|NCT02195622|20226271|P1|NOT COMPLETED|Overall Study||0
8202284|NCT02195622|20226270|P2|COMPLETED|Overall Study||37
8202285|NCT02195622|20226271|P1|COMPLETED|Overall Study||37
8202286|NCT02195622|20226270|P2|STARTED|Overall Study||37
8202287|NCT02195622|20226271|P1|STARTED|Overall Study||37
8202288|NCT02195583|20226277|P1|NOT COMPLETED|Overall Study||9
8202289|NCT02195583|20226277|P1|COMPLETED|Overall Study||53
8202290|NCT02195583|20226277|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
8202291|NCT02195583|20226277|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
8202292|NCT02195583|20226277|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
8202383|NCT02195011|20226768|P1|STARTED|Overall Study||25
8202293|NCT02195583|20226277|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
8202294|NCT02195583|20226277|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
8202295|NCT02195583|20226277|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
8202296|NCT02195583|20226277|P1|STARTED|Overall Study||62
8202297|NCT02195531|20226312|P3|NOT COMPLETED|Overall Study||1
8202298|NCT02195531|20226313|P2|NOT COMPLETED|Overall Study||1
8202299|NCT02195531|20226314|P1|NOT COMPLETED|Overall Study||1
8202300|NCT02195531|20226312|P3|COMPLETED|Overall Study||55
8202301|NCT02195531|20226313|P2|COMPLETED|Overall Study||48
8202302|NCT02195531|20226314|P1|COMPLETED|Overall Study||63
8202303|NCT02195531|20226312|P3|STARTED|Overall Study||56
8202304|NCT02195531|20226313|P2|STARTED|Overall Study||49
8202305|NCT02195531|20226314|P1|STARTED|Overall Study||64
8202306|NCT02195518|20226339|P1|NOT COMPLETED|Overall Study||9
8202307|NCT02195518|20226339|P1|COMPLETED|Overall Study||204
8202308|NCT02195518|20226339|P1|STARTED|Overall Study||213
8202309|NCT02195479|20226362|P2|NOT COMPLETED|Overall Study||350
8202310|NCT02195479|20226363|P1|NOT COMPLETED|Overall Study||356
8202311|NCT02195479|20226362|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
8202312|NCT02195479|20226363|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
8202313|NCT02195479|20226362|P2|Treated|Overall Study||346
8202314|NCT02195479|20226363|P1|Treated|Overall Study||354
8202315|NCT02195479|20226362|P2|STARTED|Overall Study||350
8202316|NCT02195479|20226363|P1|STARTED|Overall Study||356
8202317|NCT02195427|20226401|P2|NOT COMPLETED|Overall Study||27
8202318|NCT02195427|20226402|P1|NOT COMPLETED|Overall Study||26
8202319|NCT02195427|20226401|P2|COMPLETED|Overall Study||47
8202320|NCT02195427|20226402|P1|COMPLETED|Overall Study||47
8202321|NCT02195427|20226401|P2|N Patients at W52|Overall Study||56
8202322|NCT02195427|20226402|P1|N Patients at W52|Overall Study||63
8202323|NCT02195427|20226401|P2|N Patients at W36|Overall Study||59
8202324|NCT02195427|20226402|P1|N Patients at W36|Overall Study||65
8202325|NCT02195427|20226401|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
8202326|NCT02195427|20226402|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
8202327|NCT02195427|20226401|P2|STARTED|Overall Study||74
8202328|NCT02195427|20226402|P1|STARTED|Overall Study||73
8202329|NCT02195414|20226464|P1|NOT COMPLETED|Overall Study||0
8202330|NCT02195414|20226464|P1|COMPLETED|Overall Study||31
8202331|NCT02195414|20226464|P1|Primary Endpoint|Overall Study||31
8202332|NCT02195414|20226464|P1|STARTED|Overall Study||31
8202333|NCT02195349|20226482|P11|NOT COMPLETED|Overall Study||0
8202334|NCT02195349|20226483|P10|NOT COMPLETED|Overall Study||0
8202335|NCT02195349|20226484|P9|NOT COMPLETED|Overall Study||0
8202336|NCT02195349|20226485|P8|NOT COMPLETED|Overall Study||0
8202337|NCT02195349|20226486|P7|NOT COMPLETED|Overall Study||0
8202338|NCT02195349|20226487|P6|NOT COMPLETED|Overall Study||0
8202339|NCT02195349|20226488|P5|NOT COMPLETED|Overall Study||0
8202340|NCT02195349|20226489|P4|NOT COMPLETED|Overall Study||0
8202341|NCT02195349|20226490|P3|NOT COMPLETED|Overall Study||0
8202342|NCT02195349|20226491|P2|NOT COMPLETED|Overall Study||0
8202343|NCT02195349|20226492|P1|NOT COMPLETED|Overall Study||0
8202344|NCT02195349|20226482|P11|COMPLETED|Overall Study||6
8202345|NCT02195349|20226483|P10|COMPLETED|Overall Study||6
8202346|NCT02195349|20226484|P9|COMPLETED|Overall Study||6
8202347|NCT02195349|20226485|P8|COMPLETED|Overall Study||9
8202348|NCT02195349|20226486|P7|COMPLETED|Overall Study||6
8202349|NCT02195349|20226487|P6|COMPLETED|Overall Study||6
8202350|NCT02195349|20226488|P5|COMPLETED|Overall Study||6
8202351|NCT02195349|20226489|P4|COMPLETED|Overall Study||6
8202352|NCT02195349|20226490|P3|COMPLETED|Overall Study||1
8202353|NCT02195349|20226491|P2|COMPLETED|Overall Study||1
8202354|NCT02195349|20226492|P1|COMPLETED|Overall Study||14
8202355|NCT02195349|20226482|P11|STARTED|Overall Study||6
8202356|NCT02195349|20226483|P10|STARTED|Overall Study||6
8202357|NCT02195349|20226484|P9|STARTED|Overall Study||6
8202358|NCT02195349|20226485|P8|STARTED|Overall Study||9
8202359|NCT02195349|20226486|P7|STARTED|Overall Study||6
8202360|NCT02195349|20226487|P6|STARTED|Overall Study||6
8202361|NCT02195349|20226488|P5|STARTED|Overall Study||6
8202362|NCT02195349|20226489|P4|STARTED|Overall Study||6
8202363|NCT02195349|20226490|P3|STARTED|Overall Study||1
8202364|NCT02195349|20226491|P2|STARTED|Overall Study||1
8202365|NCT02195349|20226492|P1|STARTED|Overall Study||14
8202366|NCT02195310|20226745|P2|NOT COMPLETED|Overall Study||16
8202367|NCT02195310|20226746|P1|NOT COMPLETED|Overall Study||20
8202368|NCT02195310|20226745|P2|COMPLETED|Overall Study||153
8202369|NCT02195310|20226746|P1|COMPLETED|Overall Study||153
8202370|NCT02195310|20226745|P2|STARTED|Overall Study||169
8202371|NCT02195310|20226746|P1|STARTED|Overall Study||173
8202372|NCT02195232|20226754|P2|NOT COMPLETED|Overall Study||3
8202373|NCT02195232|20226755|P1|NOT COMPLETED|Overall Study||4
8202374|NCT02195232|20226754|P2|COMPLETED|Overall Study|Evaluated for VTE and safety|29
8202375|NCT02195232|20226755|P1|COMPLETED|Overall Study|Evaluated for VTE and safety|28
8202376|NCT02195232|20226754|P2|STARTED|Overall Study|patients consented|32
8202377|NCT02195232|20226755|P1|STARTED|Overall Study|patients consented|32
8202378|NCT02195011|20226767|P2|NOT COMPLETED|Overall Study||1
8202379|NCT02195011|20226768|P1|NOT COMPLETED|Overall Study||25
8202380|NCT02195011|20226767|P2|COMPLETED|Overall Study||0
8202381|NCT02195011|20226768|P1|COMPLETED|Overall Study||0
8202382|NCT02195011|20226767|P2|STARTED|Overall Study||1
8202384|NCT02194998|20226784|P4|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
8202385|NCT02194998|20226785|P3|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
8202386|NCT02194998|20226786|P2|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
8202387|NCT02194998|20226787|P1|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
8202388|NCT02194998|20226784|P4|COMPLETED|Post-HCV Treatment Follow-Up||4
8202389|NCT02194998|20226785|P3|COMPLETED|Post-HCV Treatment Follow-Up||14
8202390|NCT02194998|20226786|P2|COMPLETED|Post-HCV Treatment Follow-Up||5
8202391|NCT02194998|20226787|P1|COMPLETED|Post-HCV Treatment Follow-Up||20
8202392|NCT02194998|20226784|P4|STARTED|Post-HCV Treatment Follow-Up||4
8202393|NCT02194998|20226785|P3|STARTED|Post-HCV Treatment Follow-Up||15
8202394|NCT02194998|20226786|P2|STARTED|Post-HCV Treatment Follow-Up||5
8202395|NCT02194998|20226787|P1|STARTED|Post-HCV Treatment Follow-Up||21
8202396|NCT02194998|20226784|P4|NOT COMPLETED|On-HCV Treatment||0
8202397|NCT02194998|20226785|P3|NOT COMPLETED|On-HCV Treatment||0
8202398|NCT02194998|20226786|P2|NOT COMPLETED|On-HCV Treatment||1
8202399|NCT02194998|20226787|P1|NOT COMPLETED|On-HCV Treatment||0
8202400|NCT02194998|20226784|P4|COMPLETED|On-HCV Treatment||4
8202401|NCT02194998|20226785|P3|COMPLETED|On-HCV Treatment||15
8202402|NCT02194998|20226786|P2|COMPLETED|On-HCV Treatment||5
8202403|NCT02194998|20226787|P1|COMPLETED|On-HCV Treatment||21
8202404|NCT02194998|20226784|P4|STARTED|On-HCV Treatment||4
8202405|NCT02194998|20226785|P3|STARTED|On-HCV Treatment||15
8202406|NCT02194998|20226786|P2|STARTED|On-HCV Treatment||6
8202407|NCT02194998|20226787|P1|STARTED|On-HCV Treatment||21
8202408|NCT02194985|20226849|P1|NOT COMPLETED|Overall Study||11
8202409|NCT02194985|20226849|P1|COMPLETED|Overall Study||73
8202410|NCT02194985|20226849|P1|Received at Least 1 Dose of Study Drug|Overall Study||84
8202411|NCT02194985|20226849|P1|STARTED|Overall Study||84
8202412|NCT02194933|20226863|P2|NOT COMPLETED|Overall Study||9
8202413|NCT02194933|20226864|P1|NOT COMPLETED|Overall Study||3
8202414|NCT02194933|20226863|P2|COMPLETED|Overall Study||10
8202415|NCT02194933|20226864|P1|COMPLETED|Overall Study||16
8202416|NCT02194933|20226863|P2|STARTED|Overall Study||19
8202417|NCT02194933|20226864|P1|STARTED|Overall Study||19
8202418|NCT02194699|20226918|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
8202419|NCT02194699|20226919|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
8202420|NCT02194699|20226918|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
8202421|NCT02194699|20226919|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
8202422|NCT02194699|20226918|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
8202423|NCT02194699|20226919|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
8202424|NCT02194699|20226918|P2|NOT COMPLETED|Randomised||11
8202425|NCT02194699|20226919|P1|NOT COMPLETED|Randomised||8
8202426|NCT02194699|20226918|P2|COMPLETED|Randomised||417
8202427|NCT02194699|20226919|P1|COMPLETED|Randomised||420
8202428|NCT02194699|20226918|P2|STARTED|Randomised||428
8202429|NCT02194699|20226919|P1|STARTED|Randomised||428
8202430|NCT02194621|20227027|P3|NOT COMPLETED|Overall Study||9
8202431|NCT02194621|20227028|P2|NOT COMPLETED|Overall Study||6
8202432|NCT02194621|20227029|P1|NOT COMPLETED|Overall Study||6
8202433|NCT02194621|20227027|P3|COMPLETED|Overall Study||34
8202434|NCT02194621|20227028|P2|COMPLETED|Overall Study||36
8202435|NCT02194621|20227029|P1|COMPLETED|Overall Study||37
8202436|NCT02194621|20227027|P3|STARTED|Overall Study||43
8202437|NCT02194621|20227028|P2|STARTED|Overall Study||42
8202438|NCT02194621|20227029|P1|STARTED|Overall Study||43
8202439|NCT02194465|20227053|P7|NOT COMPLETED|Overall Study||2
8202440|NCT02194465|20227054|P6|NOT COMPLETED|Overall Study||4
8202441|NCT02194465|20227055|P5|NOT COMPLETED|Overall Study||9
8202442|NCT02194465|20227056|P4|NOT COMPLETED|Overall Study||8
8202443|NCT02194465|20227057|P3|NOT COMPLETED|Overall Study||8
8202444|NCT02194465|20227058|P2|NOT COMPLETED|Overall Study||7
8202445|NCT02194465|20227059|P1|NOT COMPLETED|Overall Study||9
8202446|NCT02194465|20227053|P7|COMPLETED|Overall Study||24
8202447|NCT02194465|20227054|P6|COMPLETED|Overall Study||21
8202448|NCT02194465|20227055|P5|COMPLETED|Overall Study||42
8202449|NCT02194465|20227056|P4|COMPLETED|Overall Study||41
8202450|NCT02194465|20227057|P3|COMPLETED|Overall Study||44
8202451|NCT02194465|20227058|P2|COMPLETED|Overall Study||43
8202452|NCT02194465|20227059|P1|COMPLETED|Overall Study||42
8202453|NCT02194465|20227053|P7|Received at Least 1 Dose of Study Drug|Overall Study||26
8202454|NCT02194465|20227054|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
8202455|NCT02194465|20227055|P5|Received at Least 1 Dose of Study Drug|Overall Study||51
8202456|NCT02194465|20227056|P4|Received at Least 1 Dose of Study Drug|Overall Study||49
8202457|NCT02194465|20227057|P3|Received at Least 1 Dose of Study Drug|Overall Study||51
8202458|NCT02194465|20227058|P2|Received at Least 1 Dose of Study Drug|Overall Study||50
8202459|NCT02194465|20227059|P1|Received at Least 1 Dose of Study Drug|Overall Study||51
8202460|NCT02194465|20227053|P7|STARTED|Overall Study||26
8202461|NCT02194465|20227054|P6|STARTED|Overall Study||25
8202462|NCT02194465|20227055|P5|STARTED|Overall Study||51
8202463|NCT02194465|20227056|P4|STARTED|Overall Study||49
8202464|NCT02194465|20227057|P3|STARTED|Overall Study||52
8202465|NCT02194465|20227058|P2|STARTED|Overall Study||50
8202466|NCT02194465|20227059|P1|STARTED|Overall Study||51
8202467|NCT02194088|20227102|P2|NOT COMPLETED|Overall Study||0
8202468|NCT02194088|20227103|P1|NOT COMPLETED|Overall Study||0
8202469|NCT02194088|20227102|P2|COMPLETED|Overall Study||25
8202470|NCT02194088|20227103|P1|COMPLETED|Overall Study||75
8202471|NCT02194088|20227102|P2|STARTED|Overall Study||25
8202472|NCT02194088|20227103|P1|STARTED|Overall Study||75
8202473|NCT02194062|20227116|P3|NOT COMPLETED|Overall Study||5
8202474|NCT02194062|20227117|P2|NOT COMPLETED|Overall Study||2
8202475|NCT02194062|20227118|P1|NOT COMPLETED|Overall Study||2
8202476|NCT02194062|20227116|P3|COMPLETED|Overall Study||7
8202477|NCT02194062|20227117|P2|COMPLETED|Overall Study||8
8202478|NCT02194062|20227118|P1|COMPLETED|Overall Study||8
8202479|NCT02194062|20227116|P3|STARTED|Overall Study||12
8202480|NCT02194062|20227117|P2|STARTED|Overall Study||10
8202481|NCT02194062|20227118|P1|STARTED|Overall Study||10
8202482|NCT02193880|20227129|P1|NOT COMPLETED|Overall Study||3
8202483|NCT02193880|20227129|P1|COMPLETED|Overall Study||4
8202484|NCT02193880|20227129|P1|STARTED|Overall Study||7
8202485|NCT02193867|20227134|P1|NOT COMPLETED|Overall Study||4
8202486|NCT02193867|20227134|P1|COMPLETED|Overall Study||6
8202487|NCT02193867|20227134|P1|Completed 18 Months Of Treatment|Overall Study||8
8202488|NCT02193867|20227134|P1|Received At Least 1 Dose Of Study Drug|Overall Study||10
8202489|NCT02193867|20227134|P1|STARTED|Overall Study||10
8202490|NCT02193828|20227152|P4|NOT COMPLETED|Overall Study||1
8202491|NCT02193828|20227153|P3|NOT COMPLETED|Overall Study||1
8202492|NCT02193828|20227154|P2|NOT COMPLETED|Overall Study||0
8202493|NCT02193828|20227155|P1|NOT COMPLETED|Overall Study||0
8202494|NCT02193828|20227152|P4|COMPLETED|Overall Study||16
8202495|NCT02193828|20227153|P3|COMPLETED|Overall Study||22
8202496|NCT02193828|20227154|P2|COMPLETED|Overall Study||18
8202497|NCT02193828|20227155|P1|COMPLETED|Overall Study||18
8202498|NCT02193828|20227152|P4|STARTED|Overall Study||17
8202499|NCT02193828|20227153|P3|STARTED|Overall Study||23
8202500|NCT02193828|20227154|P2|STARTED|Overall Study||18
8202501|NCT02193828|20227155|P1|STARTED|Overall Study||18
8202502|NCT02193815|20227193|P1|NOT COMPLETED|Overall Study||0
8202503|NCT02193815|20227193|P1|COMPLETED|Overall Study||15
8202504|NCT02193815|20227193|P1|STARTED|Overall Study||15
8202505|NCT02193776|20227232|P4|NOT COMPLETED|Overall Study||2
8202506|NCT02193776|20227233|P3|NOT COMPLETED|Overall Study||2
8202507|NCT02193776|20227234|P2|NOT COMPLETED|Overall Study||7
8202508|NCT02193776|20227235|P1|NOT COMPLETED|Overall Study||8
8202509|NCT02193776|20227232|P4|COMPLETED|Overall Study||58
8202510|NCT02193776|20227233|P3|COMPLETED|Overall Study||59
8202511|NCT02193776|20227234|P2|COMPLETED|Overall Study||53
8202512|NCT02193776|20227235|P1|COMPLETED|Overall Study||51
8202513|NCT02193776|20227232|P4|Completed Day 140 Follow-up|Overall Study||58
8202514|NCT02193776|20227233|P3|Completed Day 140 Follow-up|Overall Study||58
8202515|NCT02193776|20227234|P2|Completed Day 140 Follow-up|Overall Study||52
8202516|NCT02193776|20227235|P1|Completed Day 140 Follow-up|Overall Study||52
8202517|NCT02193776|20227232|P4|Completed Day 70 Follow-up|Overall Study||60
8202518|NCT02193776|20227233|P3|Completed Day 70 Follow-up|Overall Study||60
8202519|NCT02193776|20227234|P2|Completed Day 70 Follow-up|Overall Study||56
8202520|NCT02193776|20227235|P1|Completed Day 70 Follow-up|Overall Study||54
8202521|NCT02193776|20227232|P4|STARTED|Overall Study||60
8202522|NCT02193776|20227233|P3|STARTED|Overall Study||61
8202523|NCT02193776|20227234|P2|STARTED|Overall Study||60
8202524|NCT02193776|20227235|P1|STARTED|Overall Study||59
8202525|NCT02193490|20227251|P2|NOT COMPLETED|Overall Study||2
8202526|NCT02193490|20227252|P1|NOT COMPLETED|Overall Study||4
8202527|NCT02193490|20227251|P2|COMPLETED|Overall Study||20
8202528|NCT02193490|20227252|P1|COMPLETED|Overall Study||21
8202529|NCT02193490|20227251|P2|STARTED|Overall Study||22
8202530|NCT02193490|20227252|P1|STARTED|Overall Study||25
8202531|NCT02193178|20227262|P1|NOT COMPLETED|Overall Study||2
8202532|NCT02193178|20227262|P1|COMPLETED|Overall Study||13
8202533|NCT02193178|20227262|P1|STARTED|Overall Study||15
8202534|NCT02193165|20227312|P3|NOT COMPLETED|6 Week Product Use||0
8202535|NCT02193165|20227313|P2|NOT COMPLETED|6 Week Product Use||1
8202536|NCT02193165|20227314|P1|NOT COMPLETED|6 Week Product Use||0
8202537|NCT02193165|20227312|P3|COMPLETED|6 Week Product Use||39
8202538|NCT02193165|20227313|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
8202539|NCT02193165|20227314|P1|COMPLETED|6 Week Product Use||39
8202540|NCT02193165|20227312|P3|STARTED|6 Week Product Use||39
8202541|NCT02193165|20227313|P2|STARTED|6 Week Product Use||39
8202542|NCT02193165|20227314|P1|STARTED|6 Week Product Use||39
8202543|NCT02193165|20227312|P3|NOT COMPLETED|4 Week Product Use||1
8202544|NCT02193165|20227313|P2|NOT COMPLETED|4 Week Product Use||1
8202545|NCT02193165|20227314|P1|NOT COMPLETED|4 Week Product Use||1
8202546|NCT02193165|20227312|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8202547|NCT02193165|20227313|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8202548|NCT02193165|20227314|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8202549|NCT02193165|20227312|P3|STARTED|4 Week Product Use||40
8202550|NCT02193165|20227313|P2|STARTED|4 Week Product Use||40
8202551|NCT02193165|20227314|P1|STARTED|4 Week Product Use||40
8202552|NCT02193152|20227337|P1|NOT COMPLETED|Overall Study||0
8202553|NCT02193152|20227337|P1|COMPLETED|Overall Study||16
8202554|NCT02193152|20227337|P1|STARTED|Overall Study||16
8202555|NCT02193087|20227349|P4|NOT COMPLETED|Overall Study||79
8202556|NCT02193087|20227350|P3|NOT COMPLETED|Overall Study||7
8202557|NCT02193087|20227351|P2|NOT COMPLETED|Overall Study||14
8202558|NCT02193087|20227352|P1|NOT COMPLETED|Overall Study||37
8202559|NCT02193087|20227349|P4|COMPLETED|Overall Study||524
8202560|NCT02193087|20227350|P3|COMPLETED|Overall Study||93
8202561|NCT02193087|20227351|P2|COMPLETED|Overall Study||86
8202562|NCT02193087|20227352|P1|COMPLETED|Overall Study||162
8202563|NCT02193087|20227349|P4|Received Vaccination|Overall Study||602
8202564|NCT02193087|20227350|P3|Received Vaccination|Overall Study||100
8202565|NCT02193087|20227351|P2|Received Vaccination|Overall Study||97
8202566|NCT02193087|20227352|P1|Received Vaccination|Overall Study||197
8202567|NCT02193087|20227349|P4|STARTED|Overall Study||603
8202568|NCT02193087|20227350|P3|STARTED|Overall Study||100
8202569|NCT02193087|20227351|P2|STARTED|Overall Study||100
8202570|NCT02193087|20227352|P1|STARTED|Overall Study||199
8202581|NCT02192905|20227430|P1|NOT COMPLETED|Overall Study||1
8202582|NCT02192905|20227430|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
8202583|NCT02192905|20227430|P1|STARTED|Overall Study||43
8202584|NCT02192879|20227444|P3|NOT COMPLETED|Overall Study||0
8202585|NCT02192879|20227445|P2|NOT COMPLETED|Overall Study||0
8202586|NCT02192879|20227446|P1|NOT COMPLETED|Overall Study||0
8202587|NCT02192879|20227444|P3|COMPLETED|Overall Study||3
8202588|NCT02192879|20227445|P2|COMPLETED|Overall Study||4
8202589|NCT02192879|20227446|P1|COMPLETED|Overall Study||3
8202590|NCT02192879|20227444|P3|STARTED|Overall Study||3
8202591|NCT02192879|20227445|P2|STARTED|Overall Study||4
8202592|NCT02192879|20227446|P1|STARTED|Overall Study||3
8202593|NCT02192814|20227472|P1|NOT COMPLETED|Overall Study||0
8202594|NCT02192814|20227472|P1|COMPLETED|Overall Study||9
8202595|NCT02192814|20227472|P1|STARTED|Overall Study||9
8202596|NCT02192775|20227483|P1|NOT COMPLETED|Overall Study||2
8202597|NCT02192775|20227483|P1|COMPLETED|Overall Study||0
8202598|NCT02192775|20227483|P1|STARTED|Overall Study||2
8202599|NCT02192684|20227489|P2|NOT COMPLETED|Overall Study||0
8202600|NCT02192684|20227490|P1|NOT COMPLETED|Overall Study||0
8202601|NCT02192684|20227489|P2|COMPLETED|Overall Study||15
8202602|NCT02192684|20227490|P1|COMPLETED|Overall Study||30
8202603|NCT02192684|20227489|P2|STARTED|Overall Study||15
8202604|NCT02192684|20227490|P1|STARTED|Overall Study||30
8202605|NCT02192606|20227498|P2|NOT COMPLETED|Overall Study||4
8202606|NCT02192606|20227499|P1|NOT COMPLETED|Overall Study||2
8202607|NCT02192606|20227498|P2|COMPLETED|Overall Study||24
8202608|NCT02192606|20227499|P1|COMPLETED|Overall Study||27
8202609|NCT02192606|20227498|P2|STARTED|Overall Study||28
8202610|NCT02192606|20227499|P1|STARTED|Overall Study||29
8202611|NCT02192541|20227509|P2|NOT COMPLETED|Overall Study||0
8202612|NCT02192541|20227510|P1|NOT COMPLETED|Overall Study||0
8202613|NCT02192541|20227509|P2|COMPLETED|Overall Study||3
8202614|NCT02192541|20227510|P1|COMPLETED|Overall Study||2
8202615|NCT02192541|20227509|P2|Evaluable for Response|Overall Study||3
8202616|NCT02192541|20227510|P1|Evaluable for Response|Overall Study||1
8202617|NCT02192541|20227509|P2|Treated|Overall Study||3
8202618|NCT02192541|20227510|P1|Treated|Overall Study||2
8202619|NCT02192541|20227509|P2|STARTED|Overall Study||3
8202620|NCT02192541|20227510|P1|STARTED|Overall Study||2
8202621|NCT02192307|20227532|P2|NOT COMPLETED|Overall Study||0
8202622|NCT02192307|20227533|P1|NOT COMPLETED|Overall Study||0
8202623|NCT02192307|20227532|P2|COMPLETED|Overall Study||30
8202624|NCT02192307|20227533|P1|COMPLETED|Overall Study||30
8202625|NCT02192307|20227532|P2|STARTED|Overall Study||30
8202626|NCT02192307|20227533|P1|STARTED|Overall Study||30
8202627|NCT02192190|20227547|P6|NOT COMPLETED|Overall Study||29
8202628|NCT02192190|20227548|P5|NOT COMPLETED|Overall Study||30
8202629|NCT02192190|20227549|P4|NOT COMPLETED|Overall Study||26
8202630|NCT02192190|20227550|P3|NOT COMPLETED|Overall Study||25
8202631|NCT02192190|20227551|P2|NOT COMPLETED|Overall Study||29
8202632|NCT02192190|20227552|P1|NOT COMPLETED|Overall Study||54
8202633|NCT02192190|20227547|P6|COMPLETED|Overall Study||9
8202634|NCT02192190|20227548|P5|COMPLETED|Overall Study||9
8202635|NCT02192190|20227549|P4|COMPLETED|Overall Study||12
8202636|NCT02192190|20227550|P3|COMPLETED|Overall Study||13
8202637|NCT02192190|20227551|P2|COMPLETED|Overall Study||10
8202638|NCT02192190|20227552|P1|COMPLETED|Overall Study||22
8202639|NCT02192190|20227547|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
8202640|NCT02192190|20227548|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
8202641|NCT02192190|20227549|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
8202642|NCT02192190|20227550|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
8202643|NCT02192190|20227551|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
8202644|NCT02192190|20227552|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
8202645|NCT02192190|20227547|P6|STARTED|Overall Study||38
8202646|NCT02192190|20227548|P5|STARTED|Overall Study||39
8202647|NCT02192190|20227549|P4|STARTED|Overall Study||38
8202648|NCT02192190|20227550|P3|STARTED|Overall Study||38
8202649|NCT02192190|20227551|P2|STARTED|Overall Study||39
8202650|NCT02192190|20227552|P1|STARTED|Overall Study||76
8202651|NCT02192164|20227596|P1|NOT COMPLETED|Overall Study||14
8202652|NCT02192164|20227596|P1|COMPLETED|Overall Study||112
8202653|NCT02192164|20227596|P1|Etanercept Treated Population|Overall Study||112
8202654|NCT02192164|20227596|P1|STARTED|Overall Study||126
8202655|NCT02192099|20227612|P1|NOT COMPLETED|Overall Study||61
8202656|NCT02192099|20227612|P1|COMPLETED|Overall Study||0
8202657|NCT02192099|20227612|P1|STARTED|Overall Study||61
8202658|NCT02191865|20227619|P3|NOT COMPLETED|Overall Study||0
8202659|NCT02191865|20227620|P2|NOT COMPLETED|Overall Study||0
8202660|NCT02191865|20227621|P1|NOT COMPLETED|Overall Study||0
8202661|NCT02191865|20227619|P3|COMPLETED|Overall Study||17
8202662|NCT02191865|20227620|P2|COMPLETED|Overall Study||8
8202663|NCT02191865|20227621|P1|COMPLETED|Overall Study||8
8202664|NCT02191865|20227619|P3|STARTED|Overall Study||17
8202665|NCT02191865|20227620|P2|STARTED|Overall Study||8
8202666|NCT02191865|20227621|P1|STARTED|Overall Study||8
8202667|NCT02191618|20227641|P1|NOT COMPLETED|Overall Study||7
8202668|NCT02191618|20227641|P1|COMPLETED|Overall Study||143
8202669|NCT02191618|20227641|P1|STARTED|Overall Study||150
8202670|NCT02191605|20227651|P5|NOT COMPLETED|Overall Study||4
8202671|NCT02191605|20227652|P4|NOT COMPLETED|Overall Study||3
8202672|NCT02191605|20227653|P3|NOT COMPLETED|Overall Study||7
8202673|NCT02191605|20227654|P2|NOT COMPLETED|Overall Study||4
8202674|NCT02191605|20227655|P1|NOT COMPLETED|Overall Study||9
8202675|NCT02191605|20227651|P5|COMPLETED|Overall Study||3
8202676|NCT02191605|20227652|P4|COMPLETED|Overall Study||5
8202677|NCT02191605|20227653|P3|COMPLETED|Overall Study||8
8202678|NCT02191605|20227654|P2|COMPLETED|Overall Study||11
8202679|NCT02191605|20227655|P1|COMPLETED|Overall Study||6
8202680|NCT02191605|20227651|P5|Completed Intervention Portion|Overall Study||7
8202681|NCT02191605|20227652|P4|Completed Intervention Portion|Overall Study||8
8202682|NCT02191605|20227653|P3|Completed Intervention Portion|Overall Study||15
8202683|NCT02191605|20227654|P2|Completed Intervention Portion|Overall Study||15
8202684|NCT02191605|20227655|P1|Completed Intervention Portion|Overall Study||15
8202685|NCT02191605|20227651|P5|STARTED|Overall Study||7
8202686|NCT02191605|20227652|P4|STARTED|Overall Study||8
8202687|NCT02191605|20227653|P3|STARTED|Overall Study||15
8202688|NCT02191605|20227654|P2|STARTED|Overall Study||15
8202689|NCT02191605|20227655|P1|STARTED|Overall Study||15
8202690|NCT02191579|20227674|P2|NOT COMPLETED|Treatment 2||25
8202691|NCT02191579|20227675|P1|NOT COMPLETED|Treatment 2||0
8202692|NCT02191579|20227674|P2|COMPLETED|Treatment 2||55
8202693|NCT02191579|20227675|P1|COMPLETED|Treatment 2||0
8202694|NCT02191579|20227674|P2|STARTED|Treatment 2||80
8202695|NCT02191579|20227675|P1|STARTED|Treatment 2||0
8202696|NCT02191579|20227674|P2|NOT COMPLETED|Treatment 1||58
8202697|NCT02191579|20227675|P1|NOT COMPLETED|Treatment 1||27
8202698|NCT02191579|20227674|P2|COMPLETED|Treatment 1||84
8202699|NCT02191579|20227675|P1|COMPLETED|Treatment 1||113
8202700|NCT02191579|20227674|P2|STARTED|Treatment 1||142
8202701|NCT02191579|20227675|P1|STARTED|Treatment 1||140
8202702|NCT02191397|20227689|P2|NOT COMPLETED|Overall Study||70
8202703|NCT02191397|20227690|P1|NOT COMPLETED|Overall Study||83
8202704|NCT02191397|20227689|P2|COMPLETED|Overall Study||198
8202705|NCT02191397|20227690|P1|COMPLETED|Overall Study||183
8202706|NCT02191397|20227689|P2|STARTED|Overall Study||268
8202707|NCT02191397|20227690|P1|STARTED|Overall Study||266
8202708|NCT02191267|20227751|P3|NOT COMPLETED|Overall Study||0
8202709|NCT02191267|20227752|P2|NOT COMPLETED|Overall Study||0
8202710|NCT02191267|20227753|P1|NOT COMPLETED|Overall Study||1
8202711|NCT02191267|20227751|P3|COMPLETED|Overall Study||4
8202712|NCT02191267|20227752|P2|COMPLETED|Overall Study||6
8202713|NCT02191267|20227753|P1|COMPLETED|Overall Study||19
8202714|NCT02191267|20227751|P3|STARTED|Overall Study||4
8202715|NCT02191267|20227752|P2|STARTED|Overall Study||6
8202716|NCT02191267|20227753|P1|STARTED|Overall Study||20
8202717|NCT02191137|20227764|P1|NOT COMPLETED|Follow-up||5
8202718|NCT02191137|20227764|P1|COMPLETED|Follow-up||60
8202719|NCT02191137|20227764|P1|STARTED|Follow-up||65
8202720|NCT02191137|20227764|P1|NOT COMPLETED|Treatment||10
8202721|NCT02191137|20227764|P1|COMPLETED|Treatment||65
8202722|NCT02191137|20227764|P1|STARTED|Treatment||75
8202723|NCT02191046|20227794|P2|NOT COMPLETED|Overall Study||1
8202724|NCT02191046|20227795|P1|NOT COMPLETED|Overall Study||5
8202725|NCT02191046|20227794|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
8202726|NCT02191046|20227795|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
8202727|NCT02191046|20227794|P2|STARTED|Overall Study||39
8202728|NCT02191046|20227795|P1|STARTED|Overall Study||41
8202729|NCT02191033|20227803|P2|NOT COMPLETED|Overall Study||1
8202730|NCT02191033|20227804|P1|NOT COMPLETED|Overall Study||2
8202731|NCT02191033|20227803|P2|COMPLETED|Overall Study||19
8202732|NCT02191033|20227804|P1|COMPLETED|Overall Study||18
8202733|NCT02191033|20227803|P2|STARTED|Overall Study||20
8202734|NCT02191033|20227804|P1|STARTED|Overall Study||20
8202735|NCT02190903|20227816|P2|NOT COMPLETED|Overall Study||0
8202736|NCT02190903|20227817|P1|NOT COMPLETED|Overall Study||0
8202737|NCT02190903|20227816|P2|COMPLETED|Overall Study||6
8202738|NCT02190903|20227817|P1|COMPLETED|Overall Study||6
8202739|NCT02190903|20227816|P2|STARTED|Overall Study||6
8202740|NCT02190903|20227817|P1|STARTED|Overall Study||6
8202750|NCT02190721|20227902|P3|NOT COMPLETED|Overall Study||0
8202751|NCT02190721|20227903|P2|NOT COMPLETED|Overall Study||1
8202752|NCT02190721|20227904|P1|NOT COMPLETED|Overall Study||0
8202753|NCT02190721|20227902|P3|COMPLETED|Overall Study||18
8202754|NCT02190721|20227903|P2|COMPLETED|Overall Study||29
8202755|NCT02190721|20227904|P1|COMPLETED|Overall Study||2
8202756|NCT02190721|20227902|P3|Completed 90 Day Follow-up|Overall Study||18
8202757|NCT02190721|20227903|P2|Completed 90 Day Follow-up|Overall Study||29
8202758|NCT02190721|20227904|P1|Completed 90 Day Follow-up|Overall Study||2
8202759|NCT02190721|20227902|P3|Completed 30 Day Follow-up|Overall Study||18
8202760|NCT02190721|20227903|P2|Completed 30 Day Follow-up|Overall Study||29
8202761|NCT02190721|20227904|P1|Completed 30 Day Follow-up|Overall Study||2
8202762|NCT02190721|20227902|P3|Completed Treatment|Overall Study||18
8202763|NCT02190721|20227903|P2|Completed Treatment|Overall Study||30
8202764|NCT02190721|20227904|P1|Completed Treatment|Overall Study||2
8202765|NCT02190721|20227902|P3|STARTED|Overall Study||18
8202766|NCT02190721|20227903|P2|STARTED|Overall Study||30
8202767|NCT02190721|20227904|P1|STARTED|Overall Study||2
8202768|NCT02190604|20228027|P19|NOT COMPLETED|Part 3 (Patients)||0
8202769|NCT02190604|20228028|P18|NOT COMPLETED|Part 3 (Patients)||0
8202770|NCT02190604|20228029|P17|NOT COMPLETED|Part 3 (Patients)||0
8202771|NCT02190604|20228030|P16|NOT COMPLETED|Part 3 (Patients)||0
8202772|NCT02190604|20228031|P15|NOT COMPLETED|Part 3 (Patients)||0
8202773|NCT02190604|20228032|P14|NOT COMPLETED|Part 3 (Patients)||0
8202774|NCT02190604|20228033|P13|NOT COMPLETED|Part 3 (Patients)||0
8202775|NCT02190604|20228034|P12|NOT COMPLETED|Part 3 (Patients)||0
8202776|NCT02190604|20228035|P11|NOT COMPLETED|Part 3 (Patients)||0
8202777|NCT02190604|20228036|P10|NOT COMPLETED|Part 3 (Patients)||0
8202778|NCT02190604|20228037|P9|NOT COMPLETED|Part 3 (Patients)||0
8202779|NCT02190604|20228038|P8|NOT COMPLETED|Part 3 (Patients)||0
8202780|NCT02190604|20228039|P7|NOT COMPLETED|Part 3 (Patients)||0
8202781|NCT02190604|20228040|P6|NOT COMPLETED|Part 3 (Patients)||0
8202782|NCT02190604|20228041|P5|NOT COMPLETED|Part 3 (Patients)||0
8202783|NCT02190604|20228042|P4|NOT COMPLETED|Part 3 (Patients)||0
8202784|NCT02190604|20228043|P3|NOT COMPLETED|Part 3 (Patients)||0
8202785|NCT02190604|20228044|P2|NOT COMPLETED|Part 3 (Patients)||0
8202786|NCT02190604|20228045|P1|NOT COMPLETED|Part 3 (Patients)||0
8202787|NCT02190604|20228027|P19|COMPLETED|Part 3 (Patients)||12
8202788|NCT02190604|20228028|P18|COMPLETED|Part 3 (Patients)||19
8202789|NCT02190604|20228029|P17|COMPLETED|Part 3 (Patients)||12
8202790|NCT02190604|20228030|P16|COMPLETED|Part 3 (Patients)||6
8202791|NCT02190604|20228031|P15|COMPLETED|Part 3 (Patients)||0
8202792|NCT02190604|20228032|P14|COMPLETED|Part 3 (Patients)||0
8202793|NCT02190604|20228033|P13|COMPLETED|Part 3 (Patients)||0
8202794|NCT02190604|20228034|P12|COMPLETED|Part 3 (Patients)||0
8202795|NCT02190604|20228035|P11|COMPLETED|Part 3 (Patients)||0
8202796|NCT02190604|20228036|P10|COMPLETED|Part 3 (Patients)||0
8202797|NCT02190604|20228037|P9|COMPLETED|Part 3 (Patients)||0
8202798|NCT02190604|20228038|P8|COMPLETED|Part 3 (Patients)||0
8202799|NCT02190604|20228039|P7|COMPLETED|Part 3 (Patients)||0
8202800|NCT02190604|20228040|P6|COMPLETED|Part 3 (Patients)||0
8202801|NCT02190604|20228041|P5|COMPLETED|Part 3 (Patients)||0
8202802|NCT02190604|20228042|P4|COMPLETED|Part 3 (Patients)||0
8202803|NCT02190604|20228043|P3|COMPLETED|Part 3 (Patients)||0
8202804|NCT02190604|20228044|P2|COMPLETED|Part 3 (Patients)||0
8202805|NCT02190604|20228045|P1|COMPLETED|Part 3 (Patients)||0
8202806|NCT02190604|20228027|P19|STARTED|Part 3 (Patients)||12
8202807|NCT02190604|20228028|P18|STARTED|Part 3 (Patients)||19
8202808|NCT02190604|20228029|P17|STARTED|Part 3 (Patients)||12
8202809|NCT02190604|20228030|P16|STARTED|Part 3 (Patients)||6
8202810|NCT02190604|20228031|P15|STARTED|Part 3 (Patients)||0
8202811|NCT02190604|20228032|P14|STARTED|Part 3 (Patients)||0
8202812|NCT02190604|20228033|P13|STARTED|Part 3 (Patients)||0
8202813|NCT02190604|20228034|P12|STARTED|Part 3 (Patients)||0
8202814|NCT02190604|20228035|P11|STARTED|Part 3 (Patients)||0
8202815|NCT02190604|20228036|P10|STARTED|Part 3 (Patients)||0
8202816|NCT02190604|20228037|P9|STARTED|Part 3 (Patients)||0
8202817|NCT02190604|20228038|P8|STARTED|Part 3 (Patients)||0
8202818|NCT02190604|20228039|P7|STARTED|Part 3 (Patients)||0
8202819|NCT02190604|20228040|P6|STARTED|Part 3 (Patients)||0
8202820|NCT02190604|20228041|P5|STARTED|Part 3 (Patients)||0
8202821|NCT02190604|20228042|P4|STARTED|Part 3 (Patients)||0
8202822|NCT02190604|20228043|P3|STARTED|Part 3 (Patients)||0
8202823|NCT02190604|20228044|P2|STARTED|Part 3 (Patients)||0
8202824|NCT02190604|20228045|P1|STARTED|Part 3 (Patients)||0
8202825|NCT02190604|20228027|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202826|NCT02190604|20228028|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202827|NCT02190604|20228029|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202828|NCT02190604|20228030|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202829|NCT02190604|20228031|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
8202830|NCT02190604|20228032|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
8202831|NCT02190604|20228033|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202832|NCT02190604|20228034|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202833|NCT02190604|20228035|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202834|NCT02190604|20228036|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202835|NCT02190604|20228037|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202836|NCT02190604|20228038|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202837|NCT02190604|20228039|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202838|NCT02190604|20228040|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202839|NCT02190604|20228041|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202840|NCT02190604|20228042|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202841|NCT02190604|20228043|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202842|NCT02190604|20228044|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202843|NCT02190604|20228045|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202844|NCT02190604|20228027|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202845|NCT02190604|20228028|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202846|NCT02190604|20228029|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202847|NCT02190604|20228030|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202848|NCT02190604|20228031|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
8202849|NCT02190604|20228032|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
8202850|NCT02190604|20228033|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202851|NCT02190604|20228034|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202852|NCT02190604|20228035|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202853|NCT02190604|20228036|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202854|NCT02190604|20228037|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
8202855|NCT02190604|20228038|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202856|NCT02190604|20228039|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202857|NCT02190604|20228040|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202858|NCT02190604|20228041|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202859|NCT02190604|20228042|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202860|NCT02190604|20228043|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202861|NCT02190604|20228044|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202862|NCT02190604|20228045|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202863|NCT02190604|20228027|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202864|NCT02190604|20228028|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202865|NCT02190604|20228029|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202866|NCT02190604|20228030|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202867|NCT02190604|20228031|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
8202868|NCT02190604|20228032|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202869|NCT02190604|20228033|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202870|NCT02190604|20228034|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202871|NCT02190604|20228035|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202872|NCT02190604|20228036|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202873|NCT02190604|20228037|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
8202874|NCT02190604|20228038|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202875|NCT02190604|20228039|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202876|NCT02190604|20228040|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202877|NCT02190604|20228041|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202878|NCT02190604|20228042|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202879|NCT02190604|20228043|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202880|NCT02190604|20228044|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202881|NCT02190604|20228045|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202882|NCT02190591|20228236|P2|NOT COMPLETED|Overall Study||11
8202883|NCT02190591|20228237|P1|NOT COMPLETED|Overall Study||2
8202884|NCT02190591|20228236|P2|COMPLETED|Overall Study||91
8202885|NCT02190591|20228237|P1|COMPLETED|Overall Study||100
8202886|NCT02190591|20228236|P2|STARTED|Overall Study||102
8202887|NCT02190591|20228237|P1|STARTED|Overall Study||102
8202888|NCT02190552|20228247|P1|NOT COMPLETED|Overall Study||4
8202889|NCT02190552|20228247|P1|COMPLETED|Overall Study||36
8202890|NCT02190552|20228247|P1|STARTED|Overall Study||40
8202891|NCT02190435|20228260|P2|NOT COMPLETED|Overall Study||0
8202892|NCT02190435|20228261|P1|NOT COMPLETED|Overall Study||15
8202893|NCT02190435|20228260|P2|COMPLETED|Overall Study||24
8202894|NCT02190435|20228261|P1|COMPLETED|Overall Study||26
8202895|NCT02190435|20228260|P2|STARTED|Overall Study||24
8202896|NCT02190435|20228261|P1|STARTED|Overall Study||41
8202897|NCT02190279|20228272|P3|NOT COMPLETED|Overall Study||3
8202898|NCT02190279|20228273|P2|NOT COMPLETED|Overall Study||0
8202899|NCT02190279|20228274|P1|NOT COMPLETED|Overall Study||3
8202900|NCT02190279|20228272|P3|COMPLETED|Overall Study||28
8202901|NCT02190279|20228273|P2|COMPLETED|Overall Study||69
8202902|NCT02190279|20228274|P1|COMPLETED|Overall Study||13
8202903|NCT02190279|20228272|P3|STARTED|Overall Study||31
8202904|NCT02190279|20228273|P2|STARTED|Overall Study||69
8202905|NCT02190279|20228274|P1|STARTED|Overall Study||16
8202906|NCT02190045|20228295|P2|NOT COMPLETED|Overall Study||0
8202907|NCT02190045|20228296|P1|NOT COMPLETED|Overall Study||3
8202908|NCT02190045|20228295|P2|COMPLETED|Overall Study||15
8202909|NCT02190045|20228296|P1|COMPLETED|Overall Study||12
8202910|NCT02190045|20228295|P2|STARTED|Overall Study||15
8202911|NCT02190045|20228296|P1|STARTED|Overall Study||15
8202912|NCT02189954|20228304|P2|NOT COMPLETED|Overall Study||0
8202913|NCT02189954|20228305|P1|NOT COMPLETED|Overall Study||0
8202914|NCT02189954|20228304|P2|COMPLETED|Overall Study||45
8202915|NCT02189954|20228305|P1|COMPLETED|Overall Study||45
8202916|NCT02189954|20228304|P2|STARTED|Overall Study||45
8202917|NCT02189954|20228305|P1|STARTED|Overall Study||45
8202918|NCT02189941|20228313|P3|NOT COMPLETED|Overall Study||1
8202919|NCT02189941|20228314|P2|NOT COMPLETED|Overall Study||0
8202920|NCT02189941|20228315|P1|NOT COMPLETED|Overall Study||0
8202921|NCT02189941|20228313|P3|COMPLETED|Overall Study||2
8202922|NCT02189941|20228314|P2|COMPLETED|Overall Study||4
8202923|NCT02189941|20228315|P1|COMPLETED|Overall Study||4
8202924|NCT02189941|20228313|P3|STARTED|Overall Study||3
8202925|NCT02189941|20228314|P2|STARTED|Overall Study||4
8202926|NCT02189941|20228315|P1|STARTED|Overall Study||4
8202927|NCT02189915|20228338|P1|NOT COMPLETED|Overall Study||3
8202928|NCT02189915|20228338|P1|COMPLETED|Overall Study||11
8202929|NCT02189915|20228338|P1|STARTED|Overall Study||14
8202930|NCT02189889|20228345|P2|NOT COMPLETED|Overall Study||0
8202931|NCT02189889|20228346|P1|NOT COMPLETED|Overall Study||0
8202932|NCT02189889|20228345|P2|COMPLETED|Overall Study||3
8202933|NCT02189889|20228346|P1|COMPLETED|Overall Study||2
8202934|NCT02189889|20228345|P2|STARTED|Overall Study||3
8202935|NCT02189889|20228346|P1|STARTED|Overall Study||2
8202936|NCT02189863|20228360|P2|NOT COMPLETED|Second 2 Weeks||0
8202937|NCT02189863|20228361|P1|NOT COMPLETED|Second 2 Weeks||0
8202938|NCT02189863|20228360|P2|COMPLETED|Second 2 Weeks||13
8202939|NCT02189863|20228361|P1|COMPLETED|Second 2 Weeks||8
8202940|NCT02189863|20228360|P2|STARTED|Second 2 Weeks||13
8202941|NCT02189863|20228361|P1|STARTED|Second 2 Weeks||8
8202942|NCT02189863|20228360|P2|NOT COMPLETED|First 2 Weeks||2
8202943|NCT02189863|20228361|P1|NOT COMPLETED|First 2 Weeks||4
8202944|NCT02189863|20228360|P2|COMPLETED|First 2 Weeks||13
8202945|NCT02189863|20228361|P1|COMPLETED|First 2 Weeks||8
8202946|NCT02189863|20228360|P2|STARTED|First 2 Weeks||15
8202947|NCT02189863|20228361|P1|STARTED|First 2 Weeks||12
8202948|NCT02189837|20228376|P4|NOT COMPLETED|Overall Study||2
8202949|NCT02189837|20228377|P3|NOT COMPLETED|Overall Study||3
8202950|NCT02189837|20228378|P2|NOT COMPLETED|Overall Study||1
8202951|NCT02189837|20228379|P1|NOT COMPLETED|Overall Study||2
8202952|NCT02189837|20228376|P4|COMPLETED|Overall Study||19
8202953|NCT02189837|20228377|P3|COMPLETED|Overall Study||20
8202954|NCT02189837|20228378|P2|COMPLETED|Overall Study||22
8202955|NCT02189837|20228379|P1|COMPLETED|Overall Study||20
8202956|NCT02189837|20228376|P4|Received Treatment|Overall Study||20
8202957|NCT02189837|20228377|P3|Received Treatment|Overall Study||22
8202958|NCT02189837|20228378|P2|Received Treatment|Overall Study||22
8202959|NCT02189837|20228379|P1|Received Treatment|Overall Study||21
8202960|NCT02189837|20228376|P4|STARTED|Overall Study||21
8202961|NCT02189837|20228377|P3|STARTED|Overall Study||23
8202962|NCT02189837|20228378|P2|STARTED|Overall Study||23
8202963|NCT02189837|20228379|P1|STARTED|Overall Study||22
8202964|NCT02189759|20228409|P4|NOT COMPLETED|Overall Study||5
8202965|NCT02189759|20228410|P3|NOT COMPLETED|Overall Study||2
8202966|NCT02189759|20228411|P2|NOT COMPLETED|Overall Study||0
8202967|NCT02189759|20228412|P1|NOT COMPLETED|Overall Study||0
8202968|NCT02189759|20228409|P4|COMPLETED|Overall Study||84
8202969|NCT02189759|20228410|P3|COMPLETED|Overall Study||81
8202970|NCT02189759|20228411|P2|COMPLETED|Overall Study||101
8202971|NCT02189759|20228412|P1|COMPLETED|Overall Study||102
8202972|NCT02189759|20228409|P4|STARTED|Overall Study||89
8202973|NCT02189759|20228410|P3|STARTED|Overall Study||83
8202974|NCT02189759|20228411|P2|STARTED|Overall Study||101
8202975|NCT02189759|20228412|P1|STARTED|Overall Study||102
8202976|NCT02189668|20228432|P2|NOT COMPLETED|Overall Study||0
8202977|NCT02189668|20228433|P1|NOT COMPLETED|Overall Study||0
8202978|NCT02189668|20228432|P2|COMPLETED|Overall Study||9
8202979|NCT02189668|20228433|P1|COMPLETED|Overall Study||5
8202980|NCT02189668|20228432|P2|STARTED|Overall Study||9
8202981|NCT02189668|20228433|P1|STARTED|Overall Study||5
8202982|NCT02189629|20228441|P1|NOT COMPLETED|Overall Study||105
8202983|NCT02189629|20228441|P1|COMPLETED|Overall Study||348
8202984|NCT02189629|20228441|P1|STARTED|Overall Study||453
8202985|NCT02189473|20228448|P2|NOT COMPLETED|Overall Study||25
8202986|NCT02189473|20228449|P1|NOT COMPLETED|Overall Study||23
8202987|NCT02189473|20228448|P2|COMPLETED|Overall Study||77
8202988|NCT02189473|20228449|P1|COMPLETED|Overall Study||78
8202989|NCT02189473|20228448|P2|STARTED|Overall Study||102
8202990|NCT02189473|20228449|P1|STARTED|Overall Study||101
8202991|NCT02189382|20228471|P2|NOT COMPLETED|Overall Study||0
8202992|NCT02189382|20228472|P1|NOT COMPLETED|Overall Study||0
8202993|NCT02189382|20228471|P2|COMPLETED|Overall Study||35
8202994|NCT02189382|20228472|P1|COMPLETED|Overall Study||35
8202995|NCT02189382|20228471|P2|STARTED|Overall Study||35
8202996|NCT02189382|20228472|P1|STARTED|Overall Study||35
8202997|NCT02189317|20228482|P2|NOT COMPLETED|Overall Study||0
8202998|NCT02189317|20228483|P1|NOT COMPLETED|Overall Study||0
8202999|NCT02189317|20228482|P2|COMPLETED|Overall Study||16
8203000|NCT02189317|20228483|P1|COMPLETED|Overall Study||16
8203001|NCT02189317|20228482|P2|STARTED|Overall Study||16
8203002|NCT02189317|20228483|P1|STARTED|Overall Study||16
8203003|NCT02189252|20228497|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203004|NCT02189252|20228498|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203005|NCT02189252|20228499|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203006|NCT02189252|20228500|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203007|NCT02189252|20228497|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
8203008|NCT02189252|20228498|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
8203009|NCT02189252|20228499|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
8203010|NCT02189252|20228500|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
8203011|NCT02189252|20228497|P4|STARTED|Period 2 (Visit6b, Week 12)||4
8203012|NCT02189252|20228498|P3|STARTED|Period 2 (Visit6b, Week 12)||3
8203013|NCT02189252|20228499|P2|STARTED|Period 2 (Visit6b, Week 12)||2
8203014|NCT02189252|20228500|P1|STARTED|Period 2 (Visit6b, Week 12)||4
8203015|NCT02189252|20228497|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8203016|NCT02189252|20228498|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8203017|NCT02189252|20228499|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
8203018|NCT02189252|20228500|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8203019|NCT02189252|20228497|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8203020|NCT02189252|20228498|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
8203021|NCT02189252|20228499|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
8203022|NCT02189252|20228500|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8203023|NCT02189252|20228497|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
8203024|NCT02189252|20228498|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
8203025|NCT02189252|20228499|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
8203026|NCT02189252|20228500|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
8203027|NCT02189161|20228532|P1|NOT COMPLETED|Overall Study||0
8203028|NCT02189161|20228532|P1|COMPLETED|Overall Study||10
8203029|NCT02189161|20228532|P1|STARTED|Overall Study||10
8203030|NCT02189122|20228540|P2|NOT COMPLETED|Overall Study||0
8203031|NCT02189122|20228541|P1|NOT COMPLETED|Overall Study||0
8203032|NCT02189122|20228540|P2|COMPLETED|Overall Study||18
8203033|NCT02189122|20228541|P1|COMPLETED|Overall Study||18
8203034|NCT02189122|20228540|P2|STARTED|Overall Study||18
8203035|NCT02189122|20228541|P1|STARTED|Overall Study||18
8203036|NCT02188849|20228559|P2|NOT COMPLETED|Overall Study||8
8203037|NCT02188849|20228560|P1|NOT COMPLETED|Overall Study||3
8203038|NCT02188849|20228559|P2|COMPLETED|Overall Study||17
8203039|NCT02188849|20228560|P1|COMPLETED|Overall Study||22
8203040|NCT02188849|20228559|P2|STARTED|Overall Study||25
8203041|NCT02188849|20228560|P1|STARTED|Overall Study||25
8203042|NCT02188784|20228574|P2|NOT COMPLETED|Overall Study||13
8203043|NCT02188784|20228575|P1|NOT COMPLETED|Overall Study||9
8203044|NCT02188784|20228574|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
8203045|NCT02188784|20228575|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
8203046|NCT02188784|20228574|P2|STARTED|Overall Study||114
8203047|NCT02188784|20228575|P1|STARTED|Overall Study||111
8203048|NCT02188719|20228595|P4|NOT COMPLETED|Overall Study||0
8203049|NCT02188719|20228596|P3|NOT COMPLETED|Overall Study||0
8203050|NCT02188719|20228597|P2|NOT COMPLETED|Overall Study||1
8203051|NCT02188719|20228598|P1|NOT COMPLETED|Overall Study||0
8203052|NCT02188719|20228595|P4|COMPLETED|Overall Study||0
8203053|NCT02188719|20228596|P3|COMPLETED|Overall Study||0
8203054|NCT02188719|20228597|P2|COMPLETED|Overall Study||8
8203055|NCT02188719|20228598|P1|COMPLETED|Overall Study||6
8203056|NCT02188719|20228595|P4|STARTED|Overall Study||0
8203057|NCT02188719|20228596|P3|STARTED|Overall Study||0
8203058|NCT02188719|20228597|P2|STARTED|Overall Study||9
8203059|NCT02188719|20228598|P1|STARTED|Overall Study||6
8203060|NCT02188589|20228622|P1|NOT COMPLETED|Overall Study||5
8203061|NCT02188589|20228622|P1|COMPLETED|Overall Study||25
8203062|NCT02188589|20228622|P1|24 Months|Overall Study||25
8203063|NCT02188589|20228622|P1|12 Months|Overall Study||30
8203064|NCT02188589|20228622|P1|6 Months|Overall Study||30
8203065|NCT02188589|20228622|P1|STARTED|Overall Study||30
8203066|NCT02188576|20228630|P2|NOT COMPLETED|Overall Study||0
8203067|NCT02188576|20228631|P1|NOT COMPLETED|Overall Study||0
8203068|NCT02188576|20228630|P2|COMPLETED|Overall Study||34
8203069|NCT02188576|20228631|P1|COMPLETED|Overall Study||32
8203070|NCT02188576|20228630|P2|STARTED|Overall Study||34
8203071|NCT02188576|20228631|P1|STARTED|Overall Study||32
8203072|NCT02188160|20228641|P2|NOT COMPLETED|Overall Study||1
8203073|NCT02188160|20228642|P1|NOT COMPLETED|Overall Study||1
8203074|NCT02188160|20228641|P2|COMPLETED|Overall Study||76
8203075|NCT02188160|20228642|P1|COMPLETED|Overall Study||72
8203076|NCT02188160|20228641|P2|STARTED|Overall Study||77
8203077|NCT02188160|20228642|P1|STARTED|Overall Study||73
8203078|NCT02187887|20228658|P2|NOT COMPLETED|Overall Study||4
8203079|NCT02187887|20228659|P1|NOT COMPLETED|Overall Study||5
8203080|NCT02187887|20228658|P2|COMPLETED|Overall Study||396
8203081|NCT02187887|20228659|P1|COMPLETED|Overall Study||388
8203082|NCT02187887|20228658|P2|STARTED|Overall Study||400
8203083|NCT02187887|20228659|P1|STARTED|Overall Study||393
8203084|NCT02187861|20228671|P4|NOT COMPLETED|Overall Study||32
8203085|NCT02187861|20228672|P3|NOT COMPLETED|Overall Study||32
8203086|NCT02187861|20228673|P2|NOT COMPLETED|Overall Study||48
8203087|NCT02187861|20228674|P1|NOT COMPLETED|Overall Study||6
8203088|NCT02187861|20228671|P4|COMPLETED|Overall Study||19
8203089|NCT02187861|20228672|P3|COMPLETED|Overall Study||19
8203090|NCT02187861|20228673|P2|COMPLETED|Overall Study||4
8203091|NCT02187861|20228674|P1|COMPLETED|Overall Study||3
8203092|NCT02187861|20228671|P4|Treated|Overall Study||50
8203093|NCT02187861|20228672|P3|Treated|Overall Study||49
8203094|NCT02187861|20228673|P2|Treated|Overall Study||52
8203095|NCT02187861|20228674|P1|Treated|Overall Study||9
8203096|NCT02187861|20228671|P4|STARTED|Overall Study||51
8203097|NCT02187861|20228672|P3|STARTED|Overall Study||51
8203098|NCT02187861|20228673|P2|STARTED|Overall Study||52
8203099|NCT02187861|20228674|P1|STARTED|Overall Study||9
8203100|NCT02187809|20228770|P1|NOT COMPLETED|Overall Study||3
8203101|NCT02187809|20228770|P1|COMPLETED|Overall Study||0
8203102|NCT02187809|20228770|P1|Treated|Overall Study||1
8203103|NCT02187809|20228770|P1|STARTED|Overall Study||3
8203104|NCT02187783|20228780|P1|NOT COMPLETED|Overall Study||106
8203105|NCT02187783|20228780|P1|COMPLETED|Overall Study||0
8203106|NCT02187783|20228780|P1|Patients With Solid Tumors|Overall Study||105
8203107|NCT02187783|20228780|P1|STARTED|Overall Study||106
8203108|NCT02187744|20228791|P2|NOT COMPLETED|Treatment||5
8203109|NCT02187744|20228792|P1|NOT COMPLETED|Treatment||4
8203110|NCT02187744|20228791|P2|COMPLETED|Treatment||107
8203111|NCT02187744|20228792|P1|COMPLETED|Treatment||109
8203112|NCT02187744|20228791|P2|STARTED|Treatment||112
8203113|NCT02187744|20228792|P1|STARTED|Treatment||113
8203114|NCT02187744|20228791|P2|NOT COMPLETED|Study||6
8203115|NCT02187744|20228792|P1|NOT COMPLETED|Study||4
8203116|NCT02187744|20228791|P2|COMPLETED|Study||106
8203117|NCT02187744|20228792|P1|COMPLETED|Study||109
8203118|NCT02187744|20228791|P2|STARTED|Study|Received treatment|112
8203119|NCT02187744|20228792|P1|STARTED|Study|Received treatment|113
8203120|NCT02187471|20228812|P4|NOT COMPLETED|Overall Study||80
8203121|NCT02187471|20228813|P3|NOT COMPLETED|Overall Study||86
8203122|NCT02187471|20228814|P2|NOT COMPLETED|Overall Study||82
8203123|NCT02187471|20228815|P1|NOT COMPLETED|Overall Study||76
8203124|NCT02187471|20228812|P4|COMPLETED|Overall Study||246
8203125|NCT02187471|20228813|P3|COMPLETED|Overall Study||240
8203126|NCT02187471|20228814|P2|COMPLETED|Overall Study||242
8203127|NCT02187471|20228815|P1|COMPLETED|Overall Study||249
8203128|NCT02187471|20228812|P4|STARTED|Overall Study||326
8203129|NCT02187471|20228813|P3|STARTED|Overall Study||326
8203130|NCT02187471|20228814|P2|STARTED|Overall Study||324
8203131|NCT02187471|20228815|P1|STARTED|Overall Study||325
8203132|NCT02187172|20228871|P2|NOT COMPLETED|Overall Study||6
8203133|NCT02187172|20228872|P1|NOT COMPLETED|Overall Study||3
8203134|NCT02187172|20228871|P2|COMPLETED|Overall Study||15
8203135|NCT02187172|20228872|P1|COMPLETED|Overall Study||19
8203136|NCT02187172|20228871|P2|RCT Phase Completed|Overall Study||19
8203137|NCT02187172|20228872|P1|RCT Phase Completed|Overall Study||22
8203138|NCT02187172|20228871|P2|STARTED|Overall Study||21
8203139|NCT02187172|20228872|P1|STARTED|Overall Study||22
8203140|NCT02187159|20229040|P4|NOT COMPLETED|Overall Study||96
8203141|NCT02187159|20229041|P3|NOT COMPLETED|Overall Study||77
8203142|NCT02187159|20229042|P2|NOT COMPLETED|Overall Study||79
8203143|NCT02187159|20229043|P1|NOT COMPLETED|Overall Study||69
8203144|NCT02187159|20229040|P4|COMPLETED|Overall Study||221
8203145|NCT02187159|20229041|P3|COMPLETED|Overall Study||241
8203146|NCT02187159|20229042|P2|COMPLETED|Overall Study||238
8203147|NCT02187159|20229043|P1|COMPLETED|Overall Study||249
8203148|NCT02187159|20229040|P4|STARTED|Overall Study||317
8203149|NCT02187159|20229041|P3|STARTED|Overall Study||318
8203150|NCT02187159|20229042|P2|STARTED|Overall Study||317
8203151|NCT02187159|20229043|P1|STARTED|Overall Study||318
8203152|NCT02187055|20229100|P3|NOT COMPLETED|Overall Study||74
8203153|NCT02187055|20229101|P2|NOT COMPLETED|Overall Study||73
8203154|NCT02187055|20229102|P1|NOT COMPLETED|Overall Study||69
8203155|NCT02187055|20229100|P3|COMPLETED|Overall Study||312
8203156|NCT02187055|20229101|P2|COMPLETED|Overall Study||303
8203157|NCT02187055|20229102|P1|COMPLETED|Overall Study||315
8203158|NCT02187055|20229100|P3|STARTED|Overall Study|Treated|386
8203159|NCT02187055|20229101|P2|STARTED|Overall Study|Treated|376
8203160|NCT02187055|20229102|P1|STARTED|Overall Study|Treated|384
8203161|NCT02187042|20229202|P2|NOT COMPLETED|Overall Study||14
8203162|NCT02187042|20229203|P1|NOT COMPLETED|Overall Study||13
8203163|NCT02187042|20229202|P2|COMPLETED|Overall Study||13
8203164|NCT02187042|20229203|P1|COMPLETED|Overall Study||29
8203165|NCT02187042|20229202|P2|STARTED|Overall Study||27
8203166|NCT02187042|20229203|P1|STARTED|Overall Study||42
8203167|NCT02187029|20229249|P4|NOT COMPLETED|Overall Study||3
8203168|NCT02187029|20229250|P3|NOT COMPLETED|Overall Study||11
8203169|NCT02187029|20229251|P2|NOT COMPLETED|Overall Study||1
8203170|NCT02187029|20229252|P1|NOT COMPLETED|Overall Study||1
8203171|NCT02187029|20229249|P4|COMPLETED|Overall Study||6
8203172|NCT02187029|20229250|P3|COMPLETED|Overall Study||0
8203173|NCT02187029|20229251|P2|COMPLETED|Overall Study||2
8203174|NCT02187029|20229252|P1|COMPLETED|Overall Study||6
8203175|NCT02187029|20229249|P4|STARTED|Overall Study||9
8203176|NCT02187029|20229250|P3|STARTED|Overall Study||11
8203177|NCT02187029|20229251|P2|STARTED|Overall Study||3
8203178|NCT02187029|20229252|P1|STARTED|Overall Study||7
8203179|NCT02187016|20229328|P4|NOT COMPLETED|Overall Study||0
8203180|NCT02187016|20229329|P3|NOT COMPLETED|Overall Study||1
8203181|NCT02187016|20229330|P2|NOT COMPLETED|Overall Study||2
8203182|NCT02187016|20229331|P1|NOT COMPLETED|Overall Study||1
8203183|NCT02187016|20229328|P4|COMPLETED|Overall Study||51
8203184|NCT02187016|20229329|P3|COMPLETED|Overall Study||78
8203185|NCT02187016|20229330|P2|COMPLETED|Overall Study||78
8203186|NCT02187016|20229331|P1|COMPLETED|Overall Study||79
8203187|NCT02187016|20229328|P4|STARTED|Overall Study||51
8203188|NCT02187016|20229329|P3|STARTED|Overall Study||79
8203189|NCT02187016|20229330|P2|STARTED|Overall Study||80
8203190|NCT02187016|20229331|P1|STARTED|Overall Study||80
8203191|NCT02186938|20229363|P2|NOT COMPLETED|Overall Study||3
8203192|NCT02186938|20229364|P1|NOT COMPLETED|Overall Study||9
8203193|NCT02186938|20229363|P2|COMPLETED|Overall Study||44
8203194|NCT02186938|20229364|P1|COMPLETED|Overall Study||38
8203195|NCT02186938|20229363|P2|STARTED|Overall Study||47
8203196|NCT02186938|20229364|P1|STARTED|Overall Study|2012|47
8203197|NCT02186873|20229374|P2|NOT COMPLETED|Overall Study||8
8203198|NCT02186873|20229375|P1|NOT COMPLETED|Overall Study||9
8203199|NCT02186873|20229374|P2|COMPLETED|Overall Study||97
8203200|NCT02186873|20229375|P1|COMPLETED|Overall Study||94
8203201|NCT02186873|20229374|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
8203202|NCT02186873|20229375|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
8203203|NCT02186873|20229374|P2|STARTED|Overall Study||105
8203204|NCT02186873|20229375|P1|STARTED|Overall Study||103
8203205|NCT02186847|20229400|P2|NOT COMPLETED|Overall Study||0
8203206|NCT02186847|20229401|P1|NOT COMPLETED|Overall Study||3
8203207|NCT02186847|20229400|P2|COMPLETED|Overall Study||86
8203208|NCT02186847|20229401|P1|COMPLETED|Overall Study||81
8203209|NCT02186847|20229400|P2|Eligible and Started Protocol Treatment|Overall Study||82
8203210|NCT02186847|20229401|P1|Eligible and Started Protocol Treatment|Overall Study||76
8203211|NCT02186847|20229400|P2|Eligible Population|Overall Study||86
8203212|NCT02186847|20229401|P1|Eligible Population|Overall Study||81
8203213|NCT02186847|20229400|P2|STARTED|Overall Study||86
8203214|NCT02186847|20229401|P1|STARTED|Overall Study||84
8203251|NCT02186808|20229431|P1|NOT COMPLETED|Overall Study||13
8203252|NCT02186808|20229431|P1|COMPLETED|Overall Study||67
8203253|NCT02186808|20229431|P1|STARTED|Overall Study||80
8203254|NCT02186795|20229438|P2|NOT COMPLETED|Overall Study||0
8203255|NCT02186795|20229439|P1|NOT COMPLETED|Overall Study||0
8203256|NCT02186795|20229438|P2|COMPLETED|Overall Study||24
8203257|NCT02186795|20229439|P1|COMPLETED|Overall Study||24
8203258|NCT02186795|20229438|P2|STARTED|Overall Study||24
8203259|NCT02186795|20229439|P1|STARTED|Overall Study||24
8203266|NCT02186652|20229456|P2|NOT COMPLETED|Overall Study||0
8203267|NCT02186652|20229457|P1|NOT COMPLETED|Overall Study||2
8203268|NCT02186652|20229456|P2|COMPLETED|Overall Study||22
8203269|NCT02186652|20229457|P1|COMPLETED|Overall Study||17
8203270|NCT02186652|20229456|P2|STARTED|Overall Study||22
8203271|NCT02186652|20229457|P1|STARTED|Overall Study||19
8203272|NCT02186587|20229484|P2|NOT COMPLETED|Overall Study||0
8203273|NCT02186587|20229485|P1|NOT COMPLETED|Overall Study||5
8203274|NCT02186587|20229484|P2|COMPLETED|Overall Study||0
8203275|NCT02186587|20229485|P1|COMPLETED|Overall Study||23
8203276|NCT02186587|20229484|P2|STARTED|Overall Study||0
8203277|NCT02186587|20229485|P1|STARTED|Overall Study||28
8203278|NCT02186561|20229490|P1|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
8203279|NCT02186561|20229490|P1|COMPLETED|3 - Year Post Index Procedure Visit||128
8203280|NCT02186561|20229490|P1|STARTED|3 - Year Post Index Procedure Visit||141
8203281|NCT02186561|20229490|P1|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
8203282|NCT02186561|20229490|P1|COMPLETED|2 - Year Post Index Procedure Visit||134
8203283|NCT02186561|20229490|P1|STARTED|2 - Year Post Index Procedure Visit||141
8203284|NCT02186561|20229490|P1|NOT COMPLETED|1- Year Post Index Procedure Visit||2
8203285|NCT02186561|20229490|P1|COMPLETED|1- Year Post Index Procedure Visit||139
8203286|NCT02186561|20229490|P1|STARTED|1- Year Post Index Procedure Visit||141
8203287|NCT02186561|20229490|P1|NOT COMPLETED|180- Day Post Index Procedure Visit||7
8203288|NCT02186561|20229490|P1|COMPLETED|180- Day Post Index Procedure Visit||134
8203289|NCT02186561|20229490|P1|STARTED|180- Day Post Index Procedure Visit||141
8203290|NCT02186561|20229490|P1|NOT COMPLETED|30-Day Post Index Procedure Visit||1
8203291|NCT02186561|20229490|P1|COMPLETED|30-Day Post Index Procedure Visit||140
8203292|NCT02186561|20229490|P1|STARTED|30-Day Post Index Procedure Visit||141
8203293|NCT02186561|20229490|P1|NOT COMPLETED|Subjects Implanted With Device||0
8203294|NCT02186561|20229490|P1|COMPLETED|Subjects Implanted With Device||141
8203295|NCT02186561|20229490|P1|STARTED|Subjects Implanted With Device||141
8203296|NCT02186561|20229490|P1|NOT COMPLETED|Enrollment||56
8203297|NCT02186561|20229490|P1|COMPLETED|Enrollment||141
8203298|NCT02186561|20229490|P1|STARTED|Enrollment||197
8203299|NCT02186509|20229500|P1|NOT COMPLETED|Overall Study||0
8203300|NCT02186509|20229500|P1|COMPLETED|Overall Study||17
8203301|NCT02186509|20229500|P1|STARTED|Overall Study||17
8203302|NCT02186301|20229510|P3|NOT COMPLETED|Overall Study||50
8203303|NCT02186301|20229511|P2|NOT COMPLETED|Overall Study||30
8203304|NCT02186301|20229512|P1|NOT COMPLETED|Overall Study||20
8203305|NCT02186301|20229510|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8203306|NCT02186301|20229511|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8203307|NCT02186301|20229512|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8203308|NCT02186301|20229510|P3|STARTED|Overall Study||50
8203309|NCT02186301|20229511|P2|STARTED|Overall Study||30
8203310|NCT02186301|20229512|P1|STARTED|Overall Study||20
8203311|NCT02186223|20229528|P1|NOT COMPLETED|Overall Study||21
8203312|NCT02186223|20229528|P1|COMPLETED|Overall Study||151
8203313|NCT02186223|20229528|P1|Device Placed|Overall Study||163
8203314|NCT02186223|20229528|P1|STARTED|Overall Study||172
8203315|NCT02186210|20229539|P2|NOT COMPLETED|Overall Study||0
8203316|NCT02186210|20229540|P1|NOT COMPLETED|Overall Study||0
8203317|NCT02186210|20229539|P2|COMPLETED|Overall Study||20
8203318|NCT02186210|20229540|P1|COMPLETED|Overall Study||20
8203319|NCT02186210|20229539|P2|STARTED|Overall Study||20
8203320|NCT02186210|20229540|P1|STARTED|Overall Study||20
8203321|NCT02186171|20229550|P2|NOT COMPLETED|Overall Study||15
8203322|NCT02186171|20229551|P1|NOT COMPLETED|Overall Study||4
8203323|NCT02186171|20229550|P2|COMPLETED|Overall Study||148
8203324|NCT02186171|20229551|P1|COMPLETED|Overall Study||78
8203325|NCT02186171|20229550|P2|Received Treatment|Overall Study||163
8203326|NCT02186171|20229551|P1|Received Treatment|Overall Study||81
8203327|NCT02186171|20229550|P2|STARTED|Overall Study||163
8203328|NCT02186171|20229551|P1|STARTED|Overall Study||82
8203329|NCT02185794|20229573|P6|NOT COMPLETED|Overall Study||16
8203330|NCT02185794|20229574|P5|NOT COMPLETED|Overall Study||3
8203331|NCT02185794|20229575|P4|NOT COMPLETED|Overall Study||8
8203332|NCT02185794|20229576|P3|NOT COMPLETED|Overall Study||16
8203333|NCT02185794|20229577|P2|NOT COMPLETED|Overall Study||13
8203334|NCT02185794|20229578|P1|NOT COMPLETED|Overall Study||5
8203335|NCT02185794|20229573|P6|COMPLETED|Overall Study||0
8203336|NCT02185794|20229574|P5|COMPLETED|Overall Study||4
8203337|NCT02185794|20229575|P4|COMPLETED|Overall Study||8
8203338|NCT02185794|20229576|P3|COMPLETED|Overall Study||17
8203339|NCT02185794|20229577|P2|COMPLETED|Overall Study||7
8203340|NCT02185794|20229578|P1|COMPLETED|Overall Study||4
8203341|NCT02185794|20229573|P6|STARTED|Overall Study||16
8203342|NCT02185794|20229574|P5|STARTED|Overall Study||7
8203343|NCT02185794|20229575|P4|STARTED|Overall Study||16
8203344|NCT02185794|20229576|P3|STARTED|Overall Study||33
8203345|NCT02185794|20229577|P2|STARTED|Overall Study||20
8203346|NCT02185794|20229578|P1|STARTED|Overall Study||9
8203347|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
8203348|NCT02185729|20229650|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
8203349|NCT02185729|20229650|P1|STARTED|24 Hours Into Dextrose Infusion||12
8203350|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
8203351|NCT02185729|20229650|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
8203352|NCT02185729|20229650|P1|STARTED|4 Hours Into Dextrose Infusion||12
8203353|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
8203354|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
8203355|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
8203356|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
8203357|NCT02185729|20229650|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
8203358|NCT02185729|20229650|P1|STARTED|24 Hours Into ClinOleic Infusion||12
8203359|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
8203360|NCT02185729|20229650|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
8203361|NCT02185729|20229650|P1|STARTED|4 Hours Into ClinOleic Infusion||12
8203362|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
8203363|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
8203364|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
8203365|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
8203366|NCT02185729|20229650|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
8203367|NCT02185729|20229650|P1|STARTED|24 Hours Into Intralipid Infusion||12
8203368|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
8203369|NCT02185729|20229650|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
8203370|NCT02185729|20229650|P1|STARTED|4 Hours Into Intralipid Infusion||12
8203371|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
8203372|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
8203373|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
8203374|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
8203375|NCT02185729|20229650|P1|COMPLETED|24 Hours Into Saline Infusion||12
8203376|NCT02185729|20229650|P1|STARTED|24 Hours Into Saline Infusion||12
8203377|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
8203378|NCT02185729|20229650|P1|COMPLETED|4 Hours Into Saline Infusion||12
8203379|NCT02185729|20229650|P1|STARTED|4 Hours Into Saline Infusion||12
8203380|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
8203381|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
8203382|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
8203383|NCT02185534|20229671|P6|NOT COMPLETED|Third Period||0
8203384|NCT02185534|20229672|P5|NOT COMPLETED|Third Period||0
8203385|NCT02185534|20229673|P4|NOT COMPLETED|Third Period||0
8203386|NCT02185534|20229674|P3|NOT COMPLETED|Third Period||0
8203387|NCT02185534|20229675|P2|NOT COMPLETED|Third Period||0
8203388|NCT02185534|20229676|P1|NOT COMPLETED|Third Period||0
8203389|NCT02185534|20229671|P6|COMPLETED|Third Period||13
8203390|NCT02185534|20229672|P5|COMPLETED|Third Period||13
8203391|NCT02185534|20229673|P4|COMPLETED|Third Period||13
8203392|NCT02185534|20229674|P3|COMPLETED|Third Period||14
8203393|NCT02185534|20229675|P2|COMPLETED|Third Period||14
8203394|NCT02185534|20229676|P1|COMPLETED|Third Period||13
8203395|NCT02185534|20229671|P6|STARTED|Third Period||13
8203396|NCT02185534|20229672|P5|STARTED|Third Period||13
8203397|NCT02185534|20229673|P4|STARTED|Third Period||13
8203398|NCT02185534|20229674|P3|STARTED|Third Period||14
8203399|NCT02185534|20229675|P2|STARTED|Third Period||14
8203400|NCT02185534|20229676|P1|STARTED|Third Period||13
8203401|NCT02185534|20229671|P6|NOT COMPLETED|Second Washout Period||0
8203402|NCT02185534|20229672|P5|NOT COMPLETED|Second Washout Period||0
8203403|NCT02185534|20229673|P4|NOT COMPLETED|Second Washout Period||0
8203404|NCT02185534|20229674|P3|NOT COMPLETED|Second Washout Period||0
8203405|NCT02185534|20229675|P2|NOT COMPLETED|Second Washout Period||0
8203406|NCT02185534|20229676|P1|NOT COMPLETED|Second Washout Period||0
8203407|NCT02185534|20229671|P6|COMPLETED|Second Washout Period||13
8203408|NCT02185534|20229672|P5|COMPLETED|Second Washout Period||13
8203409|NCT02185534|20229673|P4|COMPLETED|Second Washout Period||13
8203410|NCT02185534|20229674|P3|COMPLETED|Second Washout Period||14
8203411|NCT02185534|20229675|P2|COMPLETED|Second Washout Period||14
8203412|NCT02185534|20229676|P1|COMPLETED|Second Washout Period||13
8203413|NCT02185534|20229671|P6|STARTED|Second Washout Period||13
8203414|NCT02185534|20229672|P5|STARTED|Second Washout Period||13
8203415|NCT02185534|20229673|P4|STARTED|Second Washout Period||13
8203416|NCT02185534|20229674|P3|STARTED|Second Washout Period||14
8203417|NCT02185534|20229675|P2|STARTED|Second Washout Period||14
8203418|NCT02185534|20229676|P1|STARTED|Second Washout Period||13
8203419|NCT02185534|20229671|P6|NOT COMPLETED|Second Period||0
8203420|NCT02185534|20229672|P5|NOT COMPLETED|Second Period||0
8203421|NCT02185534|20229673|P4|NOT COMPLETED|Second Period||0
8203422|NCT02185534|20229674|P3|NOT COMPLETED|Second Period||0
8203423|NCT02185534|20229675|P2|NOT COMPLETED|Second Period||0
8203424|NCT02185534|20229676|P1|NOT COMPLETED|Second Period||0
8203425|NCT02185534|20229671|P6|COMPLETED|Second Period||13
8203426|NCT02185534|20229672|P5|COMPLETED|Second Period||13
8203427|NCT02185534|20229673|P4|COMPLETED|Second Period||13
8203428|NCT02185534|20229674|P3|COMPLETED|Second Period||14
8203429|NCT02185534|20229675|P2|COMPLETED|Second Period||14
8203430|NCT02185534|20229676|P1|COMPLETED|Second Period||13
8203431|NCT02185534|20229671|P6|STARTED|Second Period||13
8203432|NCT02185534|20229672|P5|STARTED|Second Period||13
8203433|NCT02185534|20229673|P4|STARTED|Second Period||13
8203434|NCT02185534|20229674|P3|STARTED|Second Period||14
8203435|NCT02185534|20229675|P2|STARTED|Second Period||14
8203436|NCT02185534|20229676|P1|STARTED|Second Period||13
8203437|NCT02185534|20229671|P6|NOT COMPLETED|First Washout Period||1
8203438|NCT02185534|20229672|P5|NOT COMPLETED|First Washout Period||1
8203439|NCT02185534|20229673|P4|NOT COMPLETED|First Washout Period||0
8203440|NCT02185534|20229674|P3|NOT COMPLETED|First Washout Period||0
8203441|NCT02185534|20229675|P2|NOT COMPLETED|First Washout Period||0
8203442|NCT02185534|20229676|P1|NOT COMPLETED|First Washout Period||1
8203443|NCT02185534|20229671|P6|COMPLETED|First Washout Period||13
8203444|NCT02185534|20229672|P5|COMPLETED|First Washout Period||13
8203445|NCT02185534|20229673|P4|COMPLETED|First Washout Period||13
8203446|NCT02185534|20229674|P3|COMPLETED|First Washout Period||14
8203447|NCT02185534|20229675|P2|COMPLETED|First Washout Period||14
8203448|NCT02185534|20229676|P1|COMPLETED|First Washout Period||13
8203449|NCT02185534|20229671|P6|STARTED|First Washout Period||14
8203450|NCT02185534|20229672|P5|STARTED|First Washout Period||14
8203451|NCT02185534|20229673|P4|STARTED|First Washout Period||13
8203452|NCT02185534|20229674|P3|STARTED|First Washout Period||14
8203453|NCT02185534|20229675|P2|STARTED|First Washout Period||14
8203454|NCT02185534|20229676|P1|STARTED|First Washout Period||14
8203455|NCT02185534|20229671|P6|NOT COMPLETED|First Period||0
8203456|NCT02185534|20229672|P5|NOT COMPLETED|First Period||0
8203457|NCT02185534|20229673|P4|NOT COMPLETED|First Period||1
8203458|NCT02185534|20229674|P3|NOT COMPLETED|First Period||0
8203459|NCT02185534|20229675|P2|NOT COMPLETED|First Period||0
8203460|NCT02185534|20229676|P1|NOT COMPLETED|First Period||0
8203461|NCT02185534|20229671|P6|COMPLETED|First Period||14
8203462|NCT02185534|20229672|P5|COMPLETED|First Period||14
8203463|NCT02185534|20229673|P4|COMPLETED|First Period||13
8203464|NCT02185534|20229674|P3|COMPLETED|First Period||14
8203465|NCT02185534|20229675|P2|COMPLETED|First Period||14
8203466|NCT02185534|20229676|P1|COMPLETED|First Period||14
8203467|NCT02185534|20229671|P6|STARTED|First Period||14
8203468|NCT02185534|20229672|P5|STARTED|First Period||14
8203469|NCT02185534|20229673|P4|STARTED|First Period||14
8203470|NCT02185534|20229674|P3|STARTED|First Period||14
8203471|NCT02185534|20229675|P2|STARTED|First Period||14
8203472|NCT02185534|20229676|P1|STARTED|First Period||14
8203473|NCT02185521|20229691|P1|NOT COMPLETED|Overall Study||2
8203474|NCT02185521|20229691|P1|COMPLETED|Overall Study||125
8203475|NCT02185521|20229691|P1|STARTED|Overall Study||127
8203476|NCT02185339|20229698|P2|NOT COMPLETED|Overall Study||1
8203477|NCT02185339|20229699|P1|NOT COMPLETED|Overall Study||0
8203478|NCT02185339|20229698|P2|COMPLETED|Overall Study||30
8203479|NCT02185339|20229699|P1|COMPLETED|Overall Study||30
8203480|NCT02185339|20229698|P2|STARTED|Overall Study||31
8203481|NCT02185339|20229699|P1|STARTED|Overall Study||30
8203482|NCT02185183|20229721|P1|NOT COMPLETED|Overall Study||0
8203483|NCT02185183|20229721|P1|COMPLETED|Overall Study||14
8203484|NCT02185183|20229721|P1|STARTED|Overall Study||14
8203485|NCT02185131|20229727|P2|NOT COMPLETED|Overall Study||1
8203486|NCT02185131|20229728|P1|NOT COMPLETED|Overall Study||1
8203487|NCT02185131|20229727|P2|COMPLETED|Overall Study||8
8203488|NCT02185131|20229728|P1|COMPLETED|Overall Study||6
8203489|NCT02185131|20229727|P2|STARTED|Overall Study||9
8203490|NCT02185131|20229728|P1|STARTED|Overall Study||7
8203491|NCT02185105|20229736|P1|NOT COMPLETED|Overall Study||0
8203492|NCT02185105|20229736|P1|COMPLETED|Overall Study||30
8203493|NCT02185105|20229736|P1|STARTED|Overall Study||30
8203494|NCT02185053|20229779|P3|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
8203495|NCT02185053|20229780|P2|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
8203496|NCT02185053|20229781|P1|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
8203497|NCT02185053|20229779|P3|COMPLETED|Donepezil Dose Maintenance Phase||30
8203498|NCT02185053|20229780|P2|COMPLETED|Donepezil Dose Maintenance Phase||0
8203499|NCT02185053|20229781|P1|COMPLETED|Donepezil Dose Maintenance Phase||0
8203500|NCT02185053|20229779|P3|STARTED|Donepezil Dose Maintenance Phase||33
8203501|NCT02185053|20229780|P2|STARTED|Donepezil Dose Maintenance Phase||0
8203502|NCT02185053|20229781|P1|STARTED|Donepezil Dose Maintenance Phase||0
8203503|NCT02185053|20229779|P3|NOT COMPLETED|Donepezil Dose Escalation Phase||0
8203504|NCT02185053|20229780|P2|NOT COMPLETED|Donepezil Dose Escalation Phase||5
8203505|NCT02185053|20229781|P1|NOT COMPLETED|Donepezil Dose Escalation Phase||0
8203506|NCT02185053|20229779|P3|COMPLETED|Donepezil Dose Escalation Phase||0
8203507|NCT02185053|20229780|P2|COMPLETED|Donepezil Dose Escalation Phase||33
8203508|NCT02185053|20229781|P1|COMPLETED|Donepezil Dose Escalation Phase||0
8203509|NCT02185053|20229779|P3|STARTED|Donepezil Dose Escalation Phase||0
8203510|NCT02185053|20229780|P2|STARTED|Donepezil Dose Escalation Phase||38
8203511|NCT02185053|20229781|P1|STARTED|Donepezil Dose Escalation Phase||0
8203512|NCT02185053|20229779|P3|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
8203513|NCT02185053|20229780|P2|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
8203514|NCT02185053|20229781|P1|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
8203515|NCT02185053|20229779|P3|COMPLETED|Solifenacin Dose Escalation Phase||0
8203516|NCT02185053|20229780|P2|COMPLETED|Solifenacin Dose Escalation Phase||0
8203517|NCT02185053|20229781|P1|COMPLETED|Solifenacin Dose Escalation Phase||38
8203518|NCT02185053|20229779|P3|STARTED|Solifenacin Dose Escalation Phase||0
8203519|NCT02185053|20229780|P2|STARTED|Solifenacin Dose Escalation Phase||0
8203520|NCT02185053|20229781|P1|STARTED|Solifenacin Dose Escalation Phase||41
8203521|NCT02185040|20229795|P7|NOT COMPLETED|Active Treatment Extension Phase||7
8203522|NCT02185040|20229796|P6|NOT COMPLETED|Active Treatment Extension Phase||3
8203523|NCT02185040|20229797|P5|NOT COMPLETED|Active Treatment Extension Phase||0
8203524|NCT02185040|20229798|P4|NOT COMPLETED|Active Treatment Extension Phase||0
8203525|NCT02185040|20229799|P3|NOT COMPLETED|Active Treatment Extension Phase||0
8203526|NCT02185040|20229800|P2|NOT COMPLETED|Active Treatment Extension Phase||0
8203527|NCT02185040|20229801|P1|NOT COMPLETED|Active Treatment Extension Phase||0
8203528|NCT02185040|20229795|P7|COMPLETED|Active Treatment Extension Phase||1
8203529|NCT02185040|20229796|P6|COMPLETED|Active Treatment Extension Phase||6
8203530|NCT02185040|20229797|P5|COMPLETED|Active Treatment Extension Phase||0
8203531|NCT02185040|20229798|P4|COMPLETED|Active Treatment Extension Phase||0
8203532|NCT02185040|20229799|P3|COMPLETED|Active Treatment Extension Phase||0
8203533|NCT02185040|20229800|P2|COMPLETED|Active Treatment Extension Phase||0
8203534|NCT02185040|20229801|P1|COMPLETED|Active Treatment Extension Phase||0
8203535|NCT02185040|20229795|P7|STARTED|Active Treatment Extension Phase||8
8203536|NCT02185040|20229796|P6|STARTED|Active Treatment Extension Phase||9
8203537|NCT02185040|20229797|P5|STARTED|Active Treatment Extension Phase||0
8203538|NCT02185040|20229798|P4|STARTED|Active Treatment Extension Phase||0
8203539|NCT02185040|20229799|P3|STARTED|Active Treatment Extension Phase||0
8203540|NCT02185040|20229800|P2|STARTED|Active Treatment Extension Phase||0
8203541|NCT02185040|20229801|P1|STARTED|Active Treatment Extension Phase||0
8203542|NCT02185040|20229795|P7|NOT COMPLETED|Part 1 Treatment Phase||0
8203543|NCT02185040|20229796|P6|NOT COMPLETED|Part 1 Treatment Phase||0
8203544|NCT02185040|20229797|P5|NOT COMPLETED|Part 1 Treatment Phase||3
8203545|NCT02185040|20229798|P4|NOT COMPLETED|Part 1 Treatment Phase||2
8203546|NCT02185040|20229799|P3|NOT COMPLETED|Part 1 Treatment Phase||1
8203547|NCT02185040|20229800|P2|NOT COMPLETED|Part 1 Treatment Phase||2
8203548|NCT02185040|20229801|P1|NOT COMPLETED|Part 1 Treatment Phase||1
8203549|NCT02185040|20229795|P7|COMPLETED|Part 1 Treatment Phase||0
8203550|NCT02185040|20229796|P6|COMPLETED|Part 1 Treatment Phase||0
8203551|NCT02185040|20229797|P5|COMPLETED|Part 1 Treatment Phase||6
8203552|NCT02185040|20229798|P4|COMPLETED|Part 1 Treatment Phase||7
8203553|NCT02185040|20229799|P3|COMPLETED|Part 1 Treatment Phase||7
8203554|NCT02185040|20229800|P2|COMPLETED|Part 1 Treatment Phase||6
8203555|NCT02185040|20229801|P1|COMPLETED|Part 1 Treatment Phase||7
8203556|NCT02185040|20229795|P7|STARTED|Part 1 Treatment Phase||0
8203557|NCT02185040|20229796|P6|STARTED|Part 1 Treatment Phase||0
8203558|NCT02185040|20229797|P5|STARTED|Part 1 Treatment Phase||9
8203559|NCT02185040|20229798|P4|STARTED|Part 1 Treatment Phase||9
8203560|NCT02185040|20229799|P3|STARTED|Part 1 Treatment Phase||8
8203561|NCT02185040|20229800|P2|STARTED|Part 1 Treatment Phase||8
8203562|NCT02185040|20229801|P1|STARTED|Part 1 Treatment Phase||8
8203563|NCT02185014|20229855|P1|NOT COMPLETED|Overall Study||54
8203564|NCT02185014|20229855|P1|COMPLETED|Overall Study||198
8203565|NCT02185014|20229855|P1|STARTED|Overall Study||252
8203566|NCT02184988|20229859|P1|NOT COMPLETED|Overall Study||55
8203567|NCT02184988|20229859|P1|COMPLETED|Overall Study||297
8203568|NCT02184988|20229859|P1|STARTED|Overall Study||352
8203569|NCT02184624|20229869|P5|NOT COMPLETED|Overall Study||0
8203570|NCT02184624|20229870|P4|NOT COMPLETED|Overall Study||0
8203571|NCT02184624|20229871|P3|NOT COMPLETED|Overall Study||0
8203572|NCT02184624|20229872|P2|NOT COMPLETED|Overall Study||0
8203573|NCT02184624|20229873|P1|NOT COMPLETED|Overall Study||0
8203574|NCT02184624|20229869|P5|COMPLETED|Overall Study||98
8203575|NCT02184624|20229870|P4|COMPLETED|Overall Study||118
8203576|NCT02184624|20229871|P3|COMPLETED|Overall Study||100
8203577|NCT02184624|20229872|P2|COMPLETED|Overall Study||80
8203578|NCT02184624|20229873|P1|COMPLETED|Overall Study||171
8203579|NCT02184624|20229869|P5|STARTED|Overall Study||98
8203580|NCT02184624|20229870|P4|STARTED|Overall Study||118
8203581|NCT02184624|20229871|P3|STARTED|Overall Study||100
8203582|NCT02184624|20229872|P2|STARTED|Overall Study||80
8203583|NCT02184624|20229873|P1|STARTED|Overall Study||171
8203584|NCT02184611|20229917|P2|NOT COMPLETED|Overall Study||28
8203585|NCT02184611|20229918|P1|NOT COMPLETED|Overall Study||21
8203586|NCT02184611|20229917|P2|COMPLETED|Overall Study||177
8203587|NCT02184611|20229918|P1|COMPLETED|Overall Study||80
8203588|NCT02184611|20229917|P2|STARTED|Overall Study||205
8203589|NCT02184611|20229918|P1|STARTED|Overall Study||101
8203590|NCT02184572|20229954|P2|NOT COMPLETED|Overall Study||30
8203591|NCT02184572|20229955|P1|NOT COMPLETED|Overall Study||47
8203592|NCT02184572|20229954|P2|COMPLETED|Overall Study||542
8203593|NCT02184572|20229955|P1|COMPLETED|Overall Study||1117
8203594|NCT02184572|20229954|P2|STARTED|Overall Study||572
8203595|NCT02184572|20229955|P1|STARTED|Overall Study||1164
8203596|NCT02184494|20229994|P3|NOT COMPLETED|Overall Study||0
8203597|NCT02184494|20229995|P2|NOT COMPLETED|Overall Study||2
8203598|NCT02184494|20229996|P1|NOT COMPLETED|Overall Study||1
8203599|NCT02184494|20229994|P3|COMPLETED|Overall Study||8
8203600|NCT02184494|20229995|P2|COMPLETED|Overall Study||11
8203601|NCT02184494|20229996|P1|COMPLETED|Overall Study||12
8203602|NCT02184494|20229994|P3|STARTED|Overall Study||8
8203603|NCT02184494|20229995|P2|STARTED|Overall Study||13
8203604|NCT02184494|20229996|P1|STARTED|Overall Study||13
8203605|NCT02184455|20230016|P1|NOT COMPLETED|Overall Study||1
8203606|NCT02184455|20230016|P1|COMPLETED|Overall Study||10
8203607|NCT02184455|20230016|P1|STARTED|Overall Study||11
8203608|NCT02184442|20230027|P2|NOT COMPLETED|Overall Study||76
8203609|NCT02184442|20230028|P1|NOT COMPLETED|Overall Study||64
8203610|NCT02184442|20230027|P2|COMPLETED|Overall Study||200
8203611|NCT02184442|20230028|P1|COMPLETED|Overall Study||220
8203612|NCT02184442|20230027|P2|Valve-Implant|Overall Study||263
8203613|NCT02184442|20230028|P1|Valve-Implant|Overall Study||280
8203614|NCT02184442|20230027|P2|As-Treated|Overall Study||271
8203615|NCT02184442|20230028|P1|As-Treated|Overall Study||282
8203616|NCT02184442|20230027|P2|STARTED|Overall Study||276
8203617|NCT02184442|20230028|P1|STARTED|Overall Study||284
8203618|NCT02184208|20230040|P1|NOT COMPLETED|Overall Study||56
8203619|NCT02184208|20230040|P1|COMPLETED|Overall Study||222
8203620|NCT02184208|20230040|P1|STARTED|Overall Study||278
8203621|NCT02184195|20230048|P2|NOT COMPLETED|Overall Study||35
8203622|NCT02184195|20230049|P1|NOT COMPLETED|Overall Study||43
8203623|NCT02184195|20230048|P2|COMPLETED|Overall Study||27
8203624|NCT02184195|20230049|P1|COMPLETED|Overall Study||49
8203625|NCT02184195|20230048|P2|STARTED|Overall Study||62
8203626|NCT02184195|20230049|P1|STARTED|Overall Study||92
8203627|NCT02184169|20230075|P2|NOT COMPLETED|Overall Study||0
8203628|NCT02184169|20230076|P1|NOT COMPLETED|Overall Study||0
8203629|NCT02184169|20230075|P2|COMPLETED|Overall Study||6
8203630|NCT02184169|20230076|P1|COMPLETED|Overall Study||21
8203631|NCT02184169|20230075|P2|STARTED|Overall Study||6
8203632|NCT02184169|20230076|P1|STARTED|Overall Study||21
8203633|NCT02184143|20230086|P2|NOT COMPLETED|Overall Study||7
8203634|NCT02184143|20230087|P1|NOT COMPLETED|Overall Study||10
8203635|NCT02184143|20230086|P2|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
8203636|NCT02184143|20230087|P1|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
8203637|NCT02184143|20230086|P2|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
8203638|NCT02184143|20230087|P1|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
8203639|NCT02183792|20230101|P2|NOT COMPLETED|Overall Study||0
8203640|NCT02183792|20230102|P1|NOT COMPLETED|Overall Study||0
8203641|NCT02183792|20230101|P2|COMPLETED|Overall Study||15
8203642|NCT02183792|20230102|P1|COMPLETED|Overall Study||18
8203643|NCT02183792|20230101|P2|STARTED|Overall Study||15
8203644|NCT02183792|20230102|P1|STARTED|Overall Study||18
8203645|NCT02183675|20230116|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203646|NCT02183675|20230117|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203647|NCT02183675|20230118|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203648|NCT02183675|20230119|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203649|NCT02183675|20230120|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203650|NCT02183675|20230121|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203651|NCT02183675|20230116|P6|COMPLETED|Treatment Period 3 (10 Days)||4
8203652|NCT02183675|20230117|P5|COMPLETED|Treatment Period 3 (10 Days)||6
8203653|NCT02183675|20230118|P4|COMPLETED|Treatment Period 3 (10 Days)||6
8203654|NCT02183675|20230119|P3|COMPLETED|Treatment Period 3 (10 Days)||6
8203655|NCT02183675|20230120|P2|COMPLETED|Treatment Period 3 (10 Days)||6
8203656|NCT02183675|20230121|P1|COMPLETED|Treatment Period 3 (10 Days)||6
8203657|NCT02183675|20230116|P6|STARTED|Treatment Period 3 (10 Days)||4
8203658|NCT02183675|20230117|P5|STARTED|Treatment Period 3 (10 Days)||6
8203659|NCT02183675|20230118|P4|STARTED|Treatment Period 3 (10 Days)||6
8203660|NCT02183675|20230119|P3|STARTED|Treatment Period 3 (10 Days)||6
8203661|NCT02183675|20230120|P2|STARTED|Treatment Period 3 (10 Days)||6
8203662|NCT02183675|20230121|P1|STARTED|Treatment Period 3 (10 Days)||6
8203663|NCT02183675|20230116|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
8203664|NCT02183675|20230117|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203665|NCT02183675|20230118|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203666|NCT02183675|20230119|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203667|NCT02183675|20230120|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203668|NCT02183675|20230121|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203669|NCT02183675|20230116|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
8203670|NCT02183675|20230117|P5|COMPLETED|Treatment Period 2 (10 Days)||6
8203671|NCT02183675|20230118|P4|COMPLETED|Treatment Period 2 (10 Days)||6
8203672|NCT02183675|20230119|P3|COMPLETED|Treatment Period 2 (10 Days)||6
8203673|NCT02183675|20230120|P2|COMPLETED|Treatment Period 2 (10 Days)||6
8203674|NCT02183675|20230121|P1|COMPLETED|Treatment Period 2 (10 Days)||6
8203675|NCT02183675|20230116|P6|STARTED|Treatment Period 2 (10 Days)||6
8203676|NCT02183675|20230117|P5|STARTED|Treatment Period 2 (10 Days)||6
8203677|NCT02183675|20230118|P4|STARTED|Treatment Period 2 (10 Days)||6
8203678|NCT02183675|20230119|P3|STARTED|Treatment Period 2 (10 Days)||6
8203679|NCT02183675|20230120|P2|STARTED|Treatment Period 2 (10 Days)||6
8203680|NCT02183675|20230121|P1|STARTED|Treatment Period 2 (10 Days)||6
8203681|NCT02183675|20230116|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203682|NCT02183675|20230117|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203683|NCT02183675|20230118|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203684|NCT02183675|20230119|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203685|NCT02183675|20230120|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203686|NCT02183675|20230121|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203687|NCT02183675|20230116|P6|COMPLETED|Treatment Period 1 (10 Days)||6
8203688|NCT02183675|20230117|P5|COMPLETED|Treatment Period 1 (10 Days)||6
8203689|NCT02183675|20230118|P4|COMPLETED|Treatment Period 1 (10 Days)||6
8203690|NCT02183675|20230119|P3|COMPLETED|Treatment Period 1 (10 Days)||6
8203691|NCT02183675|20230120|P2|COMPLETED|Treatment Period 1 (10 Days)||6
8203692|NCT02183675|20230121|P1|COMPLETED|Treatment Period 1 (10 Days)||6
8203693|NCT02183675|20230116|P6|STARTED|Treatment Period 1 (10 Days)||6
8203694|NCT02183675|20230117|P5|STARTED|Treatment Period 1 (10 Days)||6
8203695|NCT02183675|20230118|P4|STARTED|Treatment Period 1 (10 Days)||6
8203696|NCT02183675|20230119|P3|STARTED|Treatment Period 1 (10 Days)||6
8203697|NCT02183675|20230120|P2|STARTED|Treatment Period 1 (10 Days)||6
8203698|NCT02183675|20230121|P1|STARTED|Treatment Period 1 (10 Days)||6
8203699|NCT02183519|20230145|P2|NOT COMPLETED|Overall Study||3
8203700|NCT02183519|20230146|P1|NOT COMPLETED|Overall Study||3
8203701|NCT02183519|20230145|P2|COMPLETED|Overall Study||13
8203702|NCT02183519|20230146|P1|COMPLETED|Overall Study||25
8203703|NCT02183519|20230145|P2|STARTED|Overall Study||16
8203704|NCT02183519|20230146|P1|STARTED|Overall Study||28
8203705|NCT02182999|20230154|P2|NOT COMPLETED|Overall Study||3
8203706|NCT02182999|20230155|P1|NOT COMPLETED|Overall Study||5
8203707|NCT02182999|20230154|P2|COMPLETED|Overall Study||22
8203708|NCT02182999|20230155|P1|COMPLETED|Overall Study||20
8203709|NCT02182999|20230154|P2|STARTED|Overall Study||25
8203710|NCT02182999|20230155|P1|STARTED|Overall Study||25
8203711|NCT02182973|20230171|P2|NOT COMPLETED|Overall Study||0
8203712|NCT02182973|20230172|P1|NOT COMPLETED|Overall Study||3
8203713|NCT02182973|20230171|P2|COMPLETED|Overall Study||9
8203714|NCT02182973|20230172|P1|COMPLETED|Overall Study||9
8203715|NCT02182973|20230171|P2|STARTED|Overall Study||9
8203716|NCT02182973|20230172|P1|STARTED|Overall Study||12
8203717|NCT02182895|20230184|P2|NOT COMPLETED|Overall Study||4
8203718|NCT02182895|20230185|P1|NOT COMPLETED|Overall Study||2
8203719|NCT02182895|20230184|P2|COMPLETED|Overall Study||33
8203720|NCT02182895|20230185|P1|COMPLETED|Overall Study||33
8203721|NCT02182895|20230184|P2|STARTED|Overall Study||37
8203722|NCT02182895|20230185|P1|STARTED|Overall Study||35
8203723|NCT02182843|20230205|P1|NOT COMPLETED|Overall Study||10
8203724|NCT02182843|20230205|P1|COMPLETED|Overall Study||71
8203725|NCT02182843|20230205|P1|STARTED|Overall Study||81
8203726|NCT02182830|20230212|P2|NOT COMPLETED|Overall Study||15
8203727|NCT02182830|20230213|P1|NOT COMPLETED|Overall Study||15
8203728|NCT02182830|20230212|P2|COMPLETED|Overall Study||68
8203729|NCT02182830|20230213|P1|COMPLETED|Overall Study||68
8203730|NCT02182830|20230212|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
8203731|NCT02182830|20230213|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
8203732|NCT02182830|20230212|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
8203826|NCT02181673|20230548|P3|NOT COMPLETED|Week 24-Week 60||17
8203733|NCT02182830|20230213|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
8203734|NCT02182830|20230212|P2|STARTED|Overall Study||83
8203735|NCT02182830|20230213|P1|STARTED|Overall Study||83
8203736|NCT02182804|20230239|P1|NOT COMPLETED|Overall Study||0
8203737|NCT02182804|20230239|P1|COMPLETED|Overall Study||44
8203738|NCT02182804|20230239|P1|STARTED|Overall Study||44
8203739|NCT02182492|20230245|P2|NOT COMPLETED|Overall Study||8
8203740|NCT02182492|20230246|P1|NOT COMPLETED|Overall Study||7
8203741|NCT02182492|20230245|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
8203742|NCT02182492|20230246|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
8203743|NCT02182492|20230245|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
8203744|NCT02182492|20230246|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
8203745|NCT02182440|20230258|P4|NOT COMPLETED|Overall Study||30
8203746|NCT02182440|20230259|P3|NOT COMPLETED|Overall Study||11
8203747|NCT02182440|20230260|P2|NOT COMPLETED|Overall Study||14
8203748|NCT02182440|20230261|P1|NOT COMPLETED|Overall Study||45
8203749|NCT02182440|20230258|P4|COMPLETED|Overall Study||81
8203750|NCT02182440|20230259|P3|COMPLETED|Overall Study||24
8203751|NCT02182440|20230260|P2|COMPLETED|Overall Study||25
8203752|NCT02182440|20230261|P1|COMPLETED|Overall Study||71
8203753|NCT02182440|20230258|P4|Safety Population|Overall Study||109
8203754|NCT02182440|20230259|P3|Safety Population|Overall Study||35
8203755|NCT02182440|20230260|P2|Safety Population|Overall Study||38
8203756|NCT02182440|20230261|P1|Safety Population|Overall Study||112
8203757|NCT02182440|20230258|P4|ITTinterim|Overall Study||29
8203758|NCT02182440|20230259|P3|ITTinterim|Overall Study||32
8203759|NCT02182440|20230260|P2|ITTinterim|Overall Study||31
8203760|NCT02182440|20230261|P1|ITTinterim|Overall Study||30
8203761|NCT02182440|20230258|P4|ITTcombined|Overall Study||111
8203762|NCT02182440|20230259|P3|ITTcombined|Overall Study||32
8203763|NCT02182440|20230260|P2|ITTcombined|Overall Study||31
8203764|NCT02182440|20230261|P1|ITTcombined|Overall Study||116
8203765|NCT02182440|20230258|P4|STARTED|Overall Study||111
8203766|NCT02182440|20230259|P3|STARTED|Overall Study||35
8203767|NCT02182440|20230260|P2|STARTED|Overall Study||39
8203768|NCT02182440|20230261|P1|STARTED|Overall Study||116
8203769|NCT02182115|20230293|P2|NOT COMPLETED|Overall Study||0
8203770|NCT02182115|20230294|P1|NOT COMPLETED|Overall Study||0
8203771|NCT02182115|20230293|P2|COMPLETED|Overall Study||57
8203772|NCT02182115|20230294|P1|COMPLETED|Overall Study||53
8203773|NCT02182115|20230293|P2|STARTED|Overall Study||57
8203774|NCT02182115|20230294|P1|STARTED|Overall Study||53
8203775|NCT02181842|20230300|P1|NOT COMPLETED|Overall Study||2
8203776|NCT02181842|20230300|P1|COMPLETED|Overall Study||244
8203777|NCT02181842|20230300|P1|STARTED|Overall Study||246
8203778|NCT02181816|20230317|P1|NOT COMPLETED|Overall Study||59
8203779|NCT02181816|20230317|P1|COMPLETED|Overall Study||1031
8203780|NCT02181816|20230317|P1|STARTED|Overall Study||1090
8203781|NCT02181803|20230332|P9|NOT COMPLETED|Overall Study||0
8203782|NCT02181803|20230333|P8|NOT COMPLETED|Overall Study||1
8203783|NCT02181803|20230334|P7|NOT COMPLETED|Overall Study||1
8203784|NCT02181803|20230335|P6|NOT COMPLETED|Overall Study||0
8203785|NCT02181803|20230336|P5|NOT COMPLETED|Overall Study||0
8203786|NCT02181803|20230337|P4|NOT COMPLETED|Overall Study||2
8203787|NCT02181803|20230338|P3|NOT COMPLETED|Overall Study||0
8203788|NCT02181803|20230339|P2|NOT COMPLETED|Overall Study||4
8203789|NCT02181803|20230340|P1|NOT COMPLETED|Overall Study||0
8203790|NCT02181803|20230332|P9|COMPLETED|Overall Study||2
8203791|NCT02181803|20230333|P8|COMPLETED|Overall Study||0
8203792|NCT02181803|20230334|P7|COMPLETED|Overall Study||8
8203793|NCT02181803|20230335|P6|COMPLETED|Overall Study||6
8203794|NCT02181803|20230336|P5|COMPLETED|Overall Study||6
8203795|NCT02181803|20230337|P4|COMPLETED|Overall Study||11
8203796|NCT02181803|20230338|P3|COMPLETED|Overall Study||4
8203797|NCT02181803|20230339|P2|COMPLETED|Overall Study||9
8203798|NCT02181803|20230340|P1|COMPLETED|Overall Study||1
8203799|NCT02181803|20230332|P9|STARTED|Overall Study||2
8203800|NCT02181803|20230333|P8|STARTED|Overall Study||1
8203801|NCT02181803|20230334|P7|STARTED|Overall Study||9
8203802|NCT02181803|20230335|P6|STARTED|Overall Study||6
8203803|NCT02181803|20230336|P5|STARTED|Overall Study||6
8203804|NCT02181803|20230337|P4|STARTED|Overall Study||13
8203805|NCT02181803|20230338|P3|STARTED|Overall Study||4
8203806|NCT02181803|20230339|P2|STARTED|Overall Study||13
8203807|NCT02181803|20230340|P1|STARTED|Overall Study||1
8203808|NCT02181790|20230491|P2|NOT COMPLETED|Overall Study||0
8203809|NCT02181790|20230492|P1|NOT COMPLETED|Overall Study||2
8203810|NCT02181790|20230491|P2|COMPLETED|Overall Study||0
8203811|NCT02181790|20230492|P1|COMPLETED|Overall Study||0
8203812|NCT02181790|20230491|P2|STARTED|Overall Study||0
8203813|NCT02181790|20230492|P1|STARTED|Overall Study||2
8203814|NCT02181738|20230504|P4|NOT COMPLETED|Overall Study||2
8203815|NCT02181738|20230505|P3|NOT COMPLETED|Overall Study||10
8203816|NCT02181738|20230506|P2|NOT COMPLETED|Overall Study||9
8203817|NCT02181738|20230507|P1|NOT COMPLETED|Overall Study||2
8203818|NCT02181738|20230504|P4|COMPLETED|Overall Study||49
8203819|NCT02181738|20230505|P3|COMPLETED|Overall Study||90
8203820|NCT02181738|20230506|P2|COMPLETED|Overall Study||71
8203821|NCT02181738|20230507|P1|COMPLETED|Overall Study||61
8203822|NCT02181738|20230504|P4|STARTED|Overall Study||51
8203823|NCT02181738|20230505|P3|STARTED|Overall Study||100
8203824|NCT02181738|20230506|P2|STARTED|Overall Study||80
8203825|NCT02181738|20230507|P1|STARTED|Overall Study||63
8203827|NCT02181673|20230549|P2|NOT COMPLETED|Week 24-Week 60||8
8203828|NCT02181673|20230550|P1|NOT COMPLETED|Week 24-Week 60||0
8203829|NCT02181673|20230548|P3|COMPLETED|Week 24-Week 60||213
8203830|NCT02181673|20230549|P2|COMPLETED|Week 24-Week 60||214
8203831|NCT02181673|20230550|P1|COMPLETED|Week 24-Week 60||0
8203832|NCT02181673|20230548|P3|Treated|Week 24-Week 60||230
8203833|NCT02181673|20230549|P2|Treated|Week 24-Week 60||220
8203834|NCT02181673|20230550|P1|Treated|Week 24-Week 60||0
8203835|NCT02181673|20230548|P3|STARTED|Week 24-Week 60||230
8203836|NCT02181673|20230549|P2|STARTED|Week 24-Week 60||222
8203837|NCT02181673|20230550|P1|STARTED|Week 24-Week 60||0
8203838|NCT02181673|20230548|P3|NOT COMPLETED|Up to Week 24||11
8203839|NCT02181673|20230549|P2|NOT COMPLETED|Up to Week 24||0
8203840|NCT02181673|20230550|P1|NOT COMPLETED|Up to Week 24||17
8203841|NCT02181673|20230548|P3|COMPLETED|Up to Week 24||230
8203842|NCT02181673|20230549|P2|COMPLETED|Up to Week 24||0
8203843|NCT02181673|20230550|P1|COMPLETED|Up to Week 24||222
8203844|NCT02181673|20230548|P3|Treated|Up to Week 24||240
8203845|NCT02181673|20230549|P2|Treated|Up to Week 24||0
8203846|NCT02181673|20230550|P1|Treated|Up to Week 24||239
8203847|NCT02181673|20230548|P3|STARTED|Up to Week 24||241
8203848|NCT02181673|20230549|P2|STARTED|Up to Week 24||0
8203849|NCT02181673|20230550|P1|STARTED|Up to Week 24||239
8203850|NCT02181634|20230577|P1|NOT COMPLETED|Overall Study||72
8203851|NCT02181634|20230577|P1|COMPLETED|Overall Study||2
8203852|NCT02181634|20230577|P1|Eligible and Treated|Overall Study||73
8203853|NCT02181634|20230577|P1|STARTED|Overall Study||74
8203854|NCT02181530|20230588|P1|NOT COMPLETED|Overall Study||0
8203855|NCT02181530|20230588|P1|COMPLETED|Overall Study||43
8203856|NCT02181530|20230588|P1|STARTED|Overall Study||43
8203857|NCT02181517|20230601|P3|NOT COMPLETED|Overall Study||0
8203858|NCT02181517|20230602|P2|NOT COMPLETED|Overall Study||0
8203859|NCT02181517|20230603|P1|NOT COMPLETED|Overall Study||0
8203860|NCT02181517|20230601|P3|COMPLETED|Overall Study||5
8203861|NCT02181517|20230602|P2|COMPLETED|Overall Study||10
8203862|NCT02181517|20230603|P1|COMPLETED|Overall Study||10
8203863|NCT02181517|20230601|P3|STARTED|Overall Study||5
8203864|NCT02181517|20230602|P2|STARTED|Overall Study||10
8203865|NCT02181517|20230603|P1|STARTED|Overall Study||10
8203866|NCT02181504|20230626|P3|NOT COMPLETED|Overall Study||1
8203867|NCT02181504|20230627|P2|NOT COMPLETED|Overall Study||1
8203868|NCT02181504|20230628|P1|NOT COMPLETED|Overall Study||1
8203869|NCT02181504|20230626|P3|COMPLETED|Overall Study||4
8203870|NCT02181504|20230627|P2|COMPLETED|Overall Study||9
8203871|NCT02181504|20230628|P1|COMPLETED|Overall Study||9
8203872|NCT02181504|20230626|P3|STARTED|Overall Study||5
8203873|NCT02181504|20230627|P2|STARTED|Overall Study||10
8203874|NCT02181504|20230628|P1|STARTED|Overall Study||10
8203875|NCT02181426|20230652|P4|NOT COMPLETED|Overall Study||0
8203876|NCT02181426|20230653|P3|NOT COMPLETED|Overall Study||0
8203877|NCT02181426|20230654|P2|NOT COMPLETED|Overall Study||0
8203878|NCT02181426|20230655|P1|NOT COMPLETED|Overall Study||0
8203879|NCT02181426|20230652|P4|COMPLETED|Overall Study||28
8203880|NCT02181426|20230653|P3|COMPLETED|Overall Study||28
8203881|NCT02181426|20230654|P2|COMPLETED|Overall Study||28
8203882|NCT02181426|20230655|P1|COMPLETED|Overall Study||28
8203883|NCT02181426|20230652|P4|STARTED|Overall Study||28
8203884|NCT02181426|20230653|P3|STARTED|Overall Study||28
8203885|NCT02181426|20230654|P2|STARTED|Overall Study||28
8203886|NCT02181426|20230655|P1|STARTED|Overall Study||28
8203887|NCT02181413|20230667|P2|NOT COMPLETED|Overall Study||197
8203888|NCT02181413|20230668|P1|NOT COMPLETED|Overall Study||152
8203889|NCT02181413|20230667|P2|COMPLETED|Overall Study||198
8203890|NCT02181413|20230668|P1|COMPLETED|Overall Study||109
8203891|NCT02181413|20230667|P2|Per Protocol (PP) Population|Overall Study||387
8203892|NCT02181413|20230668|P1|Per Protocol (PP) Population|Overall Study||256
8203893|NCT02181413|20230667|P2|Safety Population|Overall Study||394
8203894|NCT02181413|20230668|P1|Safety Population|Overall Study||259
8203895|NCT02181413|20230667|P2|Intent-to-Treat (ITT) Population|Overall Study||395
8203896|NCT02181413|20230668|P1|Intent-to-Treat (ITT) Population|Overall Study||261
8203897|NCT02181413|20230667|P2|STARTED|Overall Study||395
8203898|NCT02181413|20230668|P1|STARTED|Overall Study||261
8203899|NCT02181400|20230677|P3|NOT COMPLETED|Overall Study||0
8203900|NCT02181400|20230678|P2|NOT COMPLETED|Overall Study||0
8203901|NCT02181400|20230679|P1|NOT COMPLETED|Overall Study||0
8203902|NCT02181400|20230677|P3|COMPLETED|Overall Study||7
8203903|NCT02181400|20230678|P2|COMPLETED|Overall Study||7
8203904|NCT02181400|20230679|P1|COMPLETED|Overall Study||7
8203905|NCT02181400|20230677|P3|STARTED|Overall Study||7
8203906|NCT02181400|20230678|P2|STARTED|Overall Study||7
8203907|NCT02181400|20230679|P1|STARTED|Overall Study||7
8203908|NCT02181387|20230704|P2|NOT COMPLETED|Overall Study||4
8203909|NCT02181387|20230705|P1|NOT COMPLETED|Overall Study||2
8203910|NCT02181387|20230704|P2|COMPLETED|Overall Study||15
8203911|NCT02181387|20230705|P1|COMPLETED|Overall Study||12
8203912|NCT02181387|20230704|P2|STARTED|Overall Study||19
8203913|NCT02181387|20230705|P1|STARTED|Overall Study||14
8203914|NCT02181296|20230713|P2|NOT COMPLETED|Overall Study||6
8203915|NCT02181296|20230714|P1|NOT COMPLETED|Overall Study||7
8203916|NCT02181296|20230713|P2|COMPLETED|Overall Study||19
8203917|NCT02181296|20230714|P1|COMPLETED|Overall Study||18
8203918|NCT02181296|20230713|P2|STARTED|Overall Study||25
8203919|NCT02181296|20230714|P1|STARTED|Overall Study||25
8203920|NCT02181231|20230728|P2|NOT COMPLETED|Overall Study||0
8203921|NCT02181231|20230729|P1|NOT COMPLETED|Overall Study||2
8203922|NCT02181231|20230728|P2|COMPLETED|Overall Study||6
8203923|NCT02181231|20230729|P1|COMPLETED|Overall Study||10
8203924|NCT02181231|20230728|P2|STARTED|Overall Study||6
8203925|NCT02181231|20230729|P1|STARTED|Overall Study||12
8203926|NCT02181140|20230745|P1|NOT COMPLETED|Overall Study||0
8203927|NCT02181140|20230745|P1|COMPLETED|Overall Study||56
8203928|NCT02181140|20230745|P1|STARTED|Overall Study||56
8203929|NCT02181127|20230751|P1|NOT COMPLETED|Overall Study||0
8203930|NCT02181127|20230751|P1|COMPLETED|Overall Study||22
8203931|NCT02181127|20230751|P1|STARTED|Overall Study||22
8203932|NCT02181075|20230797|P2|NOT COMPLETED|Overall Study||0
8203933|NCT02181075|20230798|P1|NOT COMPLETED|Overall Study||0
8203934|NCT02181075|20230797|P2|COMPLETED|Overall Study||4
8203935|NCT02181075|20230798|P1|COMPLETED|Overall Study||6
8203936|NCT02181075|20230797|P2|STARTED|Overall Study||4
8203937|NCT02181075|20230798|P1|STARTED|Overall Study||6
8203938|NCT02180893|20230816|P2|NOT COMPLETED|Overall Study||7
8203939|NCT02180893|20230817|P1|NOT COMPLETED|Overall Study||3
8203940|NCT02180893|20230816|P2|COMPLETED|Overall Study||23
8203941|NCT02180893|20230817|P1|COMPLETED|Overall Study||27
8203942|NCT02180893|20230816|P2|STARTED|Overall Study||30
8203943|NCT02180893|20230817|P1|STARTED|Overall Study||30
8203944|NCT02180828|20230831|P2|NOT COMPLETED|Overall Study||7
8203945|NCT02180828|20230832|P1|NOT COMPLETED|Overall Study||5
8203946|NCT02180828|20230831|P2|COMPLETED|Overall Study||113
8203947|NCT02180828|20230832|P1|COMPLETED|Overall Study||115
8203948|NCT02180828|20230831|P2|STARTED|Overall Study||120
8203949|NCT02180828|20230832|P1|STARTED|Overall Study||120
8203950|NCT02180724|20230856|P2|NOT COMPLETED|Overall Study||14
8203951|NCT02180724|20230857|P1|NOT COMPLETED|Overall Study||92
8203952|NCT02180724|20230856|P2|COMPLETED|Overall Study||0
8203953|NCT02180724|20230857|P1|COMPLETED|Overall Study||0
8203954|NCT02180724|20230856|P2|Discontinued Treatment|Overall Study||7
8203955|NCT02180724|20230857|P1|Discontinued Treatment|Overall Study||23
8203956|NCT02180724|20230856|P2|Discontinued Study|Overall Study||3
8203957|NCT02180724|20230857|P1|Discontinued Study|Overall Study||14
8203958|NCT02180724|20230856|P2|Received Study Medication|Overall Study||14
8203959|NCT02180724|20230857|P1|Received Study Medication|Overall Study||92
8203960|NCT02180724|20230856|P2|Enrolled|Overall Study||14
8203961|NCT02180724|20230857|P1|Enrolled|Overall Study||92
8203962|NCT02180724|20230856|P2|STARTED|Overall Study||14
8203963|NCT02180724|20230857|P1|STARTED|Overall Study||92
8203964|NCT02180659|20230871|P2|NOT COMPLETED|Overall Study||5
8203965|NCT02180659|20230872|P1|NOT COMPLETED|Overall Study||6
8203966|NCT02180659|20230871|P2|COMPLETED|Overall Study||84
8203967|NCT02180659|20230872|P1|COMPLETED|Overall Study||81
8203968|NCT02180659|20230871|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
8203969|NCT02180659|20230872|P1|STARTED|Overall Study||87
8203970|NCT02180646|20230894|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8203971|NCT02180646|20230895|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8203972|NCT02180646|20230894|P2|COMPLETED|Second Intervention (7 Days)||6
8203973|NCT02180646|20230895|P1|COMPLETED|Second Intervention (7 Days)||6
8203974|NCT02180646|20230894|P2|STARTED|Second Intervention (7 Days)||6
8203975|NCT02180646|20230895|P1|STARTED|Second Intervention (7 Days)||6
8203976|NCT02180646|20230894|P2|NOT COMPLETED|Washout (7 Days)||0
8203977|NCT02180646|20230895|P1|NOT COMPLETED|Washout (7 Days)||0
8203978|NCT02180646|20230894|P2|COMPLETED|Washout (7 Days)||6
8203979|NCT02180646|20230895|P1|COMPLETED|Washout (7 Days)||6
8203980|NCT02180646|20230894|P2|STARTED|Washout (7 Days)||6
8203981|NCT02180646|20230895|P1|STARTED|Washout (7 Days)||6
8203982|NCT02180646|20230894|P2|NOT COMPLETED|First Intervention (7 Days)||0
8203983|NCT02180646|20230895|P1|NOT COMPLETED|First Intervention (7 Days)||0
8203984|NCT02180646|20230894|P2|COMPLETED|First Intervention (7 Days)||6
8203985|NCT02180646|20230895|P1|COMPLETED|First Intervention (7 Days)||6
8203986|NCT02180646|20230894|P2|STARTED|First Intervention (7 Days)||6
8203987|NCT02180646|20230895|P1|STARTED|First Intervention (7 Days)||6
8203988|NCT02180438|20230907|P1|NOT COMPLETED|Overall Study||1
8203989|NCT02180438|20230907|P1|COMPLETED|Overall Study||29
8203990|NCT02180438|20230907|P1|STARTED|Overall Study||30
8203991|NCT02180230|20230922|P1|NOT COMPLETED|Overall Study||7
8203992|NCT02180230|20230922|P1|COMPLETED|Overall Study||31
8203993|NCT02180230|20230922|P1|STARTED|Overall Study||38
8203994|NCT02180217|20230930|P3|NOT COMPLETED|Overall Study||38
8203995|NCT02180217|20230931|P2|NOT COMPLETED|Overall Study||8
8203996|NCT02180217|20230932|P1|NOT COMPLETED|Overall Study||12
8203997|NCT02180217|20230930|P3|COMPLETED|Overall Study||28
8203998|NCT02180217|20230931|P2|COMPLETED|Overall Study||27
8203999|NCT02180217|20230932|P1|COMPLETED|Overall Study||24
8204000|NCT02180217|20230930|P3|Completed Ext. Phase|Overall Study||25
8204001|NCT02180217|20230931|P2|Completed Ext. Phase|Overall Study||24
8204002|NCT02180217|20230932|P1|Completed Ext. Phase|Overall Study||23
8204003|NCT02180217|20230930|P3|Discontinued Extension Phase|Overall Study||16
8204004|NCT02180217|20230931|P2|Discontinued Extension Phase|Overall Study||6
8204005|NCT02180217|20230932|P1|Discontinued Extension Phase|Overall Study||12
8204006|NCT02180217|20230930|P3|Completed W48, Entered Ext. Phase|Overall Study||41
8204007|NCT02180217|20230931|P2|Completed W48, Entered Ext. Phase|Overall Study||30
8204008|NCT02180217|20230932|P1|Completed W48, Entered Ext. Phase|Overall Study||35
8204009|NCT02180217|20230930|P3|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
8204010|NCT02180217|20230931|P2|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
8204011|NCT02180217|20230932|P1|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
8204012|NCT02180217|20230930|P3|Completed Week 48 (Core Phase)|Overall Study||44
8204013|NCT02180217|20230931|P2|Completed Week 48 (Core Phase)|Overall Study||33
8204014|NCT02180217|20230932|P1|Completed Week 48 (Core Phase)|Overall Study||36
8204015|NCT02180217|20230930|P3|Discontinued Prior to W48 But After W26|Overall Study||3
8204016|NCT02180217|20230931|P2|Discontinued Prior to W48 But After W26|Overall Study||2
8204017|NCT02180217|20230932|P1|Discontinued Prior to W48 But After W26|Overall Study||0
8204018|NCT02180217|20230930|P3|Discont. at/Prior to W26 But After W12|Overall Study||12
8204019|NCT02180217|20230931|P2|Discont. at/Prior to W26 But After W12|Overall Study||0
8204020|NCT02180217|20230932|P1|Discont. at/Prior to W26 But After W12|Overall Study||0
8204021|NCT02180217|20230930|P3|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
8204022|NCT02180217|20230931|P2|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
8204023|NCT02180217|20230932|P1|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
8204024|NCT02180217|20230930|P3|STARTED|Overall Study||66
8204025|NCT02180217|20230931|P2|STARTED|Overall Study||35
8204026|NCT02180217|20230932|P1|STARTED|Overall Study||36
8204027|NCT02180100|20231004|P2|NOT COMPLETED|Overall Study||4
8204028|NCT02180100|20231005|P1|NOT COMPLETED|Overall Study||12
8204029|NCT02180100|20231004|P2|COMPLETED|Overall Study||66
8204030|NCT02180100|20231005|P1|COMPLETED|Overall Study||58
8204031|NCT02180100|20231004|P2|STARTED|Overall Study||70
8204032|NCT02180100|20231005|P1|STARTED|Overall Study||70
8204033|NCT02180061|20231015|P2|NOT COMPLETED|Overall Study||8
8204034|NCT02180061|20231016|P1|NOT COMPLETED|Overall Study||25
8204035|NCT02180061|20231015|P2|COMPLETED|Overall Study||0
8204036|NCT02180061|20231016|P1|COMPLETED|Overall Study||9
8204037|NCT02180061|20231015|P2|STARTED|Overall Study||8
8204038|NCT02180061|20231016|P1|STARTED|Overall Study||34
8204039|NCT02179918|20231035|P5|NOT COMPLETED|Overall Study||8
8204040|NCT02179918|20231036|P4|NOT COMPLETED|Overall Study||3
8204041|NCT02179918|20231037|P3|NOT COMPLETED|Overall Study||2
8204042|NCT02179918|20231038|P2|NOT COMPLETED|Overall Study||3
8204043|NCT02179918|20231039|P1|NOT COMPLETED|Overall Study||4
8204044|NCT02179918|20231035|P5|COMPLETED|Overall Study||1
8204045|NCT02179918|20231036|P4|COMPLETED|Overall Study||0
8204046|NCT02179918|20231037|P3|COMPLETED|Overall Study||1
8204047|NCT02179918|20231038|P2|COMPLETED|Overall Study||0
8204048|NCT02179918|20231039|P1|COMPLETED|Overall Study||1
8204049|NCT02179918|20231035|P5|STARTED|Overall Study||9
8204050|NCT02179918|20231036|P4|STARTED|Overall Study||3
8204051|NCT02179918|20231037|P3|STARTED|Overall Study||3
8204052|NCT02179918|20231038|P2|STARTED|Overall Study||3
8204053|NCT02179918|20231039|P1|STARTED|Overall Study||5
8204054|NCT02179892|20231165|P2|NOT COMPLETED|Overall Study||0
8204055|NCT02179892|20231166|P1|NOT COMPLETED|Overall Study||0
8204056|NCT02179892|20231165|P2|COMPLETED|Overall Study||4
8204057|NCT02179892|20231166|P1|COMPLETED|Overall Study||5
8204058|NCT02179892|20231165|P2|STARTED|Overall Study||4
8204059|NCT02179892|20231166|P1|STARTED|Overall Study||5
8204060|NCT02179788|20231180|P2|NOT COMPLETED|Overall Study||0
8204061|NCT02179788|20231181|P1|NOT COMPLETED|Overall Study||0
8204062|NCT02179788|20231180|P2|COMPLETED|Overall Study||5
8204063|NCT02179788|20231181|P1|COMPLETED|Overall Study||10
8204064|NCT02179788|20231180|P2|STARTED|Overall Study||5
8204065|NCT02179788|20231181|P1|STARTED|Overall Study||10
8204066|NCT02179671|20231192|P5|NOT COMPLETED|Overall Study||13
8204067|NCT02179671|20231193|P4|NOT COMPLETED|Overall Study||13
8204068|NCT02179671|20231194|P3|NOT COMPLETED|Overall Study||1
8204069|NCT02179671|20231195|P2|NOT COMPLETED|Overall Study||1
8204070|NCT02179671|20231196|P1|NOT COMPLETED|Overall Study||1
8204071|NCT02179671|20231192|P5|COMPLETED|Overall Study||1
8204072|NCT02179671|20231193|P4|COMPLETED|Overall Study||1
8204073|NCT02179671|20231194|P3|COMPLETED|Overall Study||1
8204074|NCT02179671|20231195|P2|COMPLETED|Overall Study||0
8204075|NCT02179671|20231196|P1|COMPLETED|Overall Study||0
8204076|NCT02179671|20231192|P5|STARTED|Overall Study||14
8204077|NCT02179671|20231193|P4|STARTED|Overall Study||14
8204078|NCT02179671|20231194|P3|STARTED|Overall Study||2
8204079|NCT02179671|20231195|P2|STARTED|Overall Study||1
8204080|NCT02179671|20231196|P1|STARTED|Overall Study||1
8204081|NCT02179515|20231231|P3|NOT COMPLETED|Overall Study||14
8204082|NCT02179515|20231232|P2|NOT COMPLETED|Overall Study||16
8204083|NCT02179515|20231233|P1|NOT COMPLETED|Overall Study||2
8204084|NCT02179515|20231231|P3|COMPLETED|Overall Study||4
8204085|NCT02179515|20231232|P2|COMPLETED|Overall Study||1
8204086|NCT02179515|20231233|P1|COMPLETED|Overall Study||1
8204087|NCT02179515|20231231|P3|STARTED|Overall Study||18
8204088|NCT02179515|20231232|P2|STARTED|Overall Study||17
8204089|NCT02179515|20231233|P1|STARTED|Overall Study||3
8204090|NCT02179424|20231276|P4|NOT COMPLETED|Overall Study||0
8204091|NCT02179424|20231277|P3|NOT COMPLETED|Overall Study||0
8204092|NCT02179424|20231278|P2|NOT COMPLETED|Overall Study||0
8204093|NCT02179424|20231279|P1|NOT COMPLETED|Overall Study||0
8204094|NCT02179424|20231276|P4|COMPLETED|Overall Study||39
8204095|NCT02179424|20231277|P3|COMPLETED|Overall Study||516
8204096|NCT02179424|20231278|P2|COMPLETED|Overall Study||11
8204097|NCT02179424|20231279|P1|COMPLETED|Overall Study||76
8204098|NCT02179424|20231276|P4|STARTED|Overall Study||39
8204099|NCT02179424|20231277|P3|STARTED|Overall Study||516
8204100|NCT02179424|20231278|P2|STARTED|Overall Study||11
8204101|NCT02179424|20231279|P1|STARTED|Overall Study||76
8204102|NCT02179398|20231296|P2|NOT COMPLETED|Overall Study||4
8204103|NCT02179398|20231297|P1|NOT COMPLETED|Overall Study||3
8204104|NCT02179398|20231296|P2|COMPLETED|Overall Study||140
8204105|NCT02179398|20231297|P1|COMPLETED|Overall Study||131
8204106|NCT02179398|20231296|P2|STARTED|Overall Study||144
8204107|NCT02179398|20231297|P1|STARTED|Overall Study||134
8204108|NCT02179190|20231315|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
8204109|NCT02179190|20231315|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
8204110|NCT02179190|20231315|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
8204111|NCT02179190|20231315|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
8204112|NCT02179190|20231315|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
8204113|NCT02179190|20231315|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
8204114|NCT02179190|20231315|P1|NOT COMPLETED|Enrollment||11
8204115|NCT02179190|20231315|P1|COMPLETED|Enrollment||127
8204116|NCT02179190|20231315|P1|STARTED|Enrollment||138
8204117|NCT02179177|20231328|P2|NOT COMPLETED|Overall Study||2
8204118|NCT02179177|20231329|P1|NOT COMPLETED|Overall Study||2
8204119|NCT02179177|20231328|P2|COMPLETED|Overall Study||6
8204120|NCT02179177|20231329|P1|COMPLETED|Overall Study||6
8204121|NCT02179177|20231328|P2|STARTED|Overall Study||8
8204122|NCT02179177|20231329|P1|STARTED|Overall Study||8
8204123|NCT02179047|20231343|P2|NOT COMPLETED|Overall Study||0
8204124|NCT02179047|20231344|P1|NOT COMPLETED|Overall Study||7
8204125|NCT02179047|20231343|P2|COMPLETED|Overall Study||20
8204126|NCT02179047|20231344|P1|COMPLETED|Overall Study||187
8204127|NCT02179047|20231343|P2|STARTED|Overall Study||20
8204128|NCT02179047|20231344|P1|STARTED|Overall Study||194
8204129|NCT02178995|20231369|P9|NOT COMPLETED|Open Label||0
8204130|NCT02178995|20231370|P8|NOT COMPLETED|Open Label||0
8204131|NCT02178995|20231371|P7|NOT COMPLETED|Open Label||0
8204132|NCT02178995|20231372|P6|NOT COMPLETED|Open Label||0
8204133|NCT02178995|20231373|P5|NOT COMPLETED|Open Label||0
8204134|NCT02178995|20231374|P4|NOT COMPLETED|Open Label||0
8204135|NCT02178995|20231375|P3|NOT COMPLETED|Open Label||0
8204136|NCT02178995|20231376|P2|NOT COMPLETED|Open Label||0
8204137|NCT02178995|20231377|P1|NOT COMPLETED|Open Label||2
8204138|NCT02178995|20231369|P9|COMPLETED|Open Label||0
8204139|NCT02178995|20231370|P8|COMPLETED|Open Label||0
8204140|NCT02178995|20231371|P7|COMPLETED|Open Label||0
8204141|NCT02178995|20231372|P6|COMPLETED|Open Label||0
8204142|NCT02178995|20231373|P5|COMPLETED|Open Label||0
8204143|NCT02178995|20231374|P4|COMPLETED|Open Label||0
8204144|NCT02178995|20231375|P3|COMPLETED|Open Label||0
8204145|NCT02178995|20231376|P2|COMPLETED|Open Label||14
8204146|NCT02178995|20231377|P1|COMPLETED|Open Label||28
8204147|NCT02178995|20231369|P9|STARTED|Open Label||0
8204148|NCT02178995|20231370|P8|STARTED|Open Label||0
8204149|NCT02178995|20231371|P7|STARTED|Open Label||0
8204150|NCT02178995|20231372|P6|STARTED|Open Label||0
8204151|NCT02178995|20231373|P5|STARTED|Open Label||0
8204152|NCT02178995|20231374|P4|STARTED|Open Label||0
8204153|NCT02178995|20231375|P3|STARTED|Open Label||0
8204154|NCT02178995|20231376|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
8204155|NCT02178995|20231377|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
8204156|NCT02178995|20231369|P9|NOT COMPLETED|Double Blind||1
8204157|NCT02178995|20231370|P8|NOT COMPLETED|Double Blind||2
8204158|NCT02178995|20231371|P7|NOT COMPLETED|Double Blind||0
8204159|NCT02178995|20231372|P6|NOT COMPLETED|Double Blind||1
8204160|NCT02178995|20231373|P5|NOT COMPLETED|Double Blind||0
8204161|NCT02178995|20231374|P4|NOT COMPLETED|Double Blind||0
8204162|NCT02178995|20231375|P3|NOT COMPLETED|Double Blind||0
8204163|NCT02178995|20231376|P2|NOT COMPLETED|Double Blind||1
8204164|NCT02178995|20231377|P1|NOT COMPLETED|Double Blind||0
8204165|NCT02178995|20231369|P9|COMPLETED|Double Blind||0
8204166|NCT02178995|20231370|P8|COMPLETED|Double Blind||4
8204167|NCT02178995|20231371|P7|COMPLETED|Double Blind||5
8204168|NCT02178995|20231372|P6|COMPLETED|Double Blind||5
8204169|NCT02178995|20231373|P5|COMPLETED|Double Blind||6
8204170|NCT02178995|20231374|P4|COMPLETED|Double Blind||6
8204171|NCT02178995|20231375|P3|COMPLETED|Double Blind||5
8204172|NCT02178995|20231376|P2|COMPLETED|Double Blind||15
8204173|NCT02178995|20231377|P1|COMPLETED|Double Blind||0
8204174|NCT02178995|20231369|P9|STARTED|Double Blind||1
8204175|NCT02178995|20231370|P8|STARTED|Double Blind||6
8204176|NCT02178995|20231371|P7|STARTED|Double Blind||5
8204177|NCT02178995|20231372|P6|STARTED|Double Blind||6
8204178|NCT02178995|20231373|P5|STARTED|Double Blind||6
8204179|NCT02178995|20231374|P4|STARTED|Double Blind||6
8204180|NCT02178995|20231375|P3|STARTED|Double Blind||5
8204181|NCT02178995|20231376|P2|STARTED|Double Blind||16
8204182|NCT02178995|20231377|P1|STARTED|Double Blind||0
8204183|NCT02178800|20231450|P2|NOT COMPLETED|Overall Study||6
8204184|NCT02178800|20231451|P1|NOT COMPLETED|Overall Study||20
8204185|NCT02178800|20231450|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
8204186|NCT02178800|20231451|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
8204187|NCT02178800|20231450|P2|STARTED|Overall Study||48
8204188|NCT02178800|20231451|P1|STARTED|Overall Study||151
8204189|NCT02178787|20231485|P2|NOT COMPLETED|Overall Study||9
8204190|NCT02178787|20231486|P1|NOT COMPLETED|Overall Study||5
8204191|NCT02178787|20231485|P2|COMPLETED|Overall Study||30
8204192|NCT02178787|20231486|P1|COMPLETED|Overall Study||30
8204193|NCT02178787|20231485|P2|STARTED|Overall Study||39
8204194|NCT02178787|20231486|P1|STARTED|Overall Study||35
8204210|NCT02178709|20231515|P1|NOT COMPLETED|Overall Study||16
8204211|NCT02178709|20231515|P1|COMPLETED|Overall Study||32
8204212|NCT02178709|20231515|P1|STARTED|Overall Study||48
8204213|NCT02178696|20231526|P2|NOT COMPLETED|Open-label Antidepressant||7
8204214|NCT02178696|20231527|P1|NOT COMPLETED|Open-label Antidepressant||6
8204215|NCT02178696|20231526|P2|COMPLETED|Open-label Antidepressant||13
8204216|NCT02178696|20231527|P1|COMPLETED|Open-label Antidepressant||14
8204217|NCT02178696|20231526|P2|STARTED|Open-label Antidepressant||20
8204218|NCT02178696|20231527|P1|STARTED|Open-label Antidepressant||20
8204219|NCT02178696|20231526|P2|NOT COMPLETED|Second Assignment After Crossover||0
8204220|NCT02178696|20231527|P1|NOT COMPLETED|Second Assignment After Crossover||0
8204221|NCT02178696|20231526|P2|COMPLETED|Second Assignment After Crossover||20
8204222|NCT02178696|20231527|P1|COMPLETED|Second Assignment After Crossover||20
8204223|NCT02178696|20231526|P2|STARTED|Second Assignment After Crossover||20
8204224|NCT02178696|20231527|P1|STARTED|Second Assignment After Crossover||20
8204225|NCT02178696|20231526|P2|NOT COMPLETED|First Assignment and Washout||0
8204226|NCT02178696|20231527|P1|NOT COMPLETED|First Assignment and Washout||0
8204227|NCT02178696|20231526|P2|COMPLETED|First Assignment and Washout||20
8204228|NCT02178696|20231527|P1|COMPLETED|First Assignment and Washout||20
8204229|NCT02178696|20231526|P2|STARTED|First Assignment and Washout||20
8204230|NCT02178696|20231527|P1|STARTED|First Assignment and Washout||20
8204231|NCT02178592|20231542|P2|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
8204232|NCT02178592|20231543|P1|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
8204233|NCT02178592|20231542|P2|COMPLETED|OLE Phase (Week 52 to Week 252)||16
8204234|NCT02178592|20231543|P1|COMPLETED|OLE Phase (Week 52 to Week 252)||35
8204235|NCT02178592|20231542|P2|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
8204236|NCT02178592|20231543|P1|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
8204237|NCT02178592|20231542|P2|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
8204238|NCT02178592|20231543|P1|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
8204239|NCT02178592|20231542|P2|COMPLETED|Randomized Phase (Up to Week 52)||35
8204240|NCT02178592|20231543|P1|COMPLETED|Randomized Phase (Up to Week 52)||50
8204241|NCT02178592|20231542|P2|STARTED|Randomized Phase (Up to Week 52)||44
8204242|NCT02178592|20231543|P1|STARTED|Randomized Phase (Up to Week 52)||69
8204243|NCT02178553|20231585|P2|NOT COMPLETED|Overall Study||10
8204244|NCT02178553|20231586|P1|NOT COMPLETED|Overall Study||8
8204245|NCT02178553|20231585|P2|COMPLETED|Overall Study||39
8204246|NCT02178553|20231586|P1|COMPLETED|Overall Study||45
8204247|NCT02178553|20231585|P2|STARTED|Overall Study||49
8204248|NCT02178553|20231586|P1|STARTED|Overall Study||53
8204249|NCT02178540|20231598|P1|NOT COMPLETED|Overall Study||0
8204250|NCT02178540|20231598|P1|COMPLETED|Overall Study||45
8204251|NCT02178540|20231598|P1|STARTED|Overall Study||45
8204252|NCT02178475|20231605|P1|NOT COMPLETED|Overall Study||129
8204253|NCT02178475|20231605|P1|COMPLETED|Overall Study||814
8204254|NCT02178475|20231605|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
8204255|NCT02178475|20231605|P1|STARTED|Overall Study||943
8204256|NCT02178241|20231625|P1|NOT COMPLETED|Overall Study||0
8204257|NCT02178241|20231625|P1|COMPLETED|Overall Study||24
8204258|NCT02178241|20231625|P1|STARTED|Overall Study||24
8204259|NCT02178059|20231632|P2|NOT COMPLETED|Second Intervention||0
8204260|NCT02178059|20231633|P1|NOT COMPLETED|Second Intervention||0
8204261|NCT02178059|20231632|P2|COMPLETED|Second Intervention||17
8204262|NCT02178059|20231633|P1|COMPLETED|Second Intervention||16
8204263|NCT02178059|20231632|P2|STARTED|Second Intervention||17
8204264|NCT02178059|20231633|P1|STARTED|Second Intervention||16
8204265|NCT02178059|20231632|P2|NOT COMPLETED|Washout||0
8204266|NCT02178059|20231633|P1|NOT COMPLETED|Washout||1
8204267|NCT02178059|20231632|P2|COMPLETED|Washout||17
8204268|NCT02178059|20231633|P1|COMPLETED|Washout||16
8204269|NCT02178059|20231632|P2|STARTED|Washout||17
8204270|NCT02178059|20231633|P1|STARTED|Washout||17
8204271|NCT02178059|20231632|P2|NOT COMPLETED|First Intervention||0
8204272|NCT02178059|20231633|P1|NOT COMPLETED|First Intervention||0
8204273|NCT02178059|20231632|P2|COMPLETED|First Intervention||17
8204274|NCT02178059|20231633|P1|COMPLETED|First Intervention||17
8204275|NCT02178059|20231632|P2|STARTED|First Intervention||17
8204276|NCT02178059|20231633|P1|STARTED|First Intervention||17
8204277|NCT02177942|20231651|P2|NOT COMPLETED|Overall Study||88
8204278|NCT02177942|20231652|P1|NOT COMPLETED|Overall Study||77
8204279|NCT02177942|20231651|P2|COMPLETED|Overall Study||178
8204280|NCT02177942|20231652|P1|COMPLETED|Overall Study||185
8204281|NCT02177942|20231651|P2|STARTED|Overall Study||266
8204282|NCT02177942|20231652|P1|STARTED|Overall Study||262
8204283|NCT02177838|20231674|P1|NOT COMPLETED|Overall Study||3
8204284|NCT02177838|20231674|P1|COMPLETED|Overall Study||5
8204285|NCT02177838|20231674|P1|STARTED|Overall Study||8
8204286|NCT02177812|20231689|P9|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204287|NCT02177812|20231690|P8|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204288|NCT02177812|20231691|P7|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204289|NCT02177812|20231692|P6|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204290|NCT02177812|20231693|P5|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204291|NCT02177812|20231694|P4|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204292|NCT02177812|20231695|P3|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204293|NCT02177812|20231696|P2|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204294|NCT02177812|20231697|P1|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204295|NCT02177812|20231689|P9|COMPLETED|Part 2 (Up to 14 Months)||0
8204296|NCT02177812|20231690|P8|COMPLETED|Part 2 (Up to 14 Months)||0
8204297|NCT02177812|20231691|P7|COMPLETED|Part 2 (Up to 14 Months)||0
8204298|NCT02177812|20231692|P6|COMPLETED|Part 2 (Up to 14 Months)||0
8204299|NCT02177812|20231693|P5|COMPLETED|Part 2 (Up to 14 Months)||0
8204300|NCT02177812|20231694|P4|COMPLETED|Part 2 (Up to 14 Months)||0
8204301|NCT02177812|20231695|P3|COMPLETED|Part 2 (Up to 14 Months)||0
8204302|NCT02177812|20231696|P2|COMPLETED|Part 2 (Up to 14 Months)||0
8204303|NCT02177812|20231697|P1|COMPLETED|Part 2 (Up to 14 Months)||0
8204304|NCT02177812|20231689|P9|STARTED|Part 2 (Up to 14 Months)||0
8204305|NCT02177812|20231690|P8|STARTED|Part 2 (Up to 14 Months)||0
8204306|NCT02177812|20231691|P7|STARTED|Part 2 (Up to 14 Months)||0
8204307|NCT02177812|20231692|P6|STARTED|Part 2 (Up to 14 Months)||0
8204308|NCT02177812|20231693|P5|STARTED|Part 2 (Up to 14 Months)||0
8204309|NCT02177812|20231694|P4|STARTED|Part 2 (Up to 14 Months)||0
8204310|NCT02177812|20231695|P3|STARTED|Part 2 (Up to 14 Months)||0
8204311|NCT02177812|20231696|P2|STARTED|Part 2 (Up to 14 Months)||0
8204312|NCT02177812|20231697|P1|STARTED|Part 2 (Up to 14 Months)||0
8204313|NCT02177812|20231689|P9|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204314|NCT02177812|20231690|P8|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
8204315|NCT02177812|20231691|P7|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
8204316|NCT02177812|20231692|P6|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
8204317|NCT02177812|20231693|P5|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
8204318|NCT02177812|20231694|P4|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
8204319|NCT02177812|20231695|P3|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204320|NCT02177812|20231696|P2|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204321|NCT02177812|20231697|P1|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204322|NCT02177812|20231689|P9|COMPLETED|Part 1 (Median of 4 Weeks)||0
8204323|NCT02177812|20231690|P8|COMPLETED|Part 1 (Median of 4 Weeks)||4
8204324|NCT02177812|20231691|P7|COMPLETED|Part 1 (Median of 4 Weeks)||1
8204325|NCT02177812|20231692|P6|COMPLETED|Part 1 (Median of 4 Weeks)||1
8204326|NCT02177812|20231693|P5|COMPLETED|Part 1 (Median of 4 Weeks)||5
8204327|NCT02177812|20231694|P4|COMPLETED|Part 1 (Median of 4 Weeks)||4
8204328|NCT02177812|20231695|P3|COMPLETED|Part 1 (Median of 4 Weeks)||7
8204329|NCT02177812|20231696|P2|COMPLETED|Part 1 (Median of 4 Weeks)||2
8204330|NCT02177812|20231697|P1|COMPLETED|Part 1 (Median of 4 Weeks)||1
8204331|NCT02177812|20231689|P9|STARTED|Part 1 (Median of 4 Weeks)||0
8204332|NCT02177812|20231690|P8|STARTED|Part 1 (Median of 4 Weeks)||6
8204333|NCT02177812|20231691|P7|STARTED|Part 1 (Median of 4 Weeks)||10
8204334|NCT02177812|20231692|P6|STARTED|Part 1 (Median of 4 Weeks)||4
8204335|NCT02177812|20231693|P5|STARTED|Part 1 (Median of 4 Weeks)||6
8204336|NCT02177812|20231694|P4|STARTED|Part 1 (Median of 4 Weeks)||5
8204337|NCT02177812|20231695|P3|STARTED|Part 1 (Median of 4 Weeks)||7
8204338|NCT02177812|20231696|P2|STARTED|Part 1 (Median of 4 Weeks)||2
8204339|NCT02177812|20231697|P1|STARTED|Part 1 (Median of 4 Weeks)||1
8204340|NCT02177786|20231914|P4|NOT COMPLETED|Overall Study||13
8204341|NCT02177786|20231915|P3|NOT COMPLETED|Overall Study||18
8204342|NCT02177786|20231916|P2|NOT COMPLETED|Overall Study||14
8204343|NCT02177786|20231917|P1|NOT COMPLETED|Overall Study||6
8204344|NCT02177786|20231914|P4|COMPLETED|Overall Study||72
8204345|NCT02177786|20231915|P3|COMPLETED|Overall Study||66
8204346|NCT02177786|20231916|P2|COMPLETED|Overall Study||70
8204347|NCT02177786|20231917|P1|COMPLETED|Overall Study||75
8204348|NCT02177786|20231914|P4|Randomized and Treated|Overall Study||85
8204349|NCT02177786|20231915|P3|Randomized and Treated|Overall Study||83
8204350|NCT02177786|20231916|P2|Randomized and Treated|Overall Study||84
8204351|NCT02177786|20231917|P1|Randomized and Treated|Overall Study||81
8204352|NCT02177786|20231914|P4|STARTED|Overall Study||85
8204353|NCT02177786|20231915|P3|STARTED|Overall Study||84
8204354|NCT02177786|20231916|P2|STARTED|Overall Study||84
8204355|NCT02177786|20231917|P1|STARTED|Overall Study||81
8204356|NCT02177773|20231931|P1|NOT COMPLETED|Overall Study||0
8204357|NCT02177773|20231931|P1|COMPLETED|Overall Study||300
8204358|NCT02177773|20231931|P1|STARTED|Overall Study||300
8204359|NCT02177266|20231940|P2|NOT COMPLETED|Overall Study||1
8204360|NCT02177266|20231941|P1|NOT COMPLETED|Overall Study||1
8204361|NCT02177266|20231940|P2|COMPLETED|Overall Study||0
8204362|NCT02177266|20231941|P1|COMPLETED|Overall Study||0
8204363|NCT02177266|20231940|P2|STARTED|Overall Study||1
8204364|NCT02177266|20231941|P1|STARTED|Overall Study||1
8204365|NCT02177201|20231953|P2|NOT COMPLETED|Overall Study||3
8204366|NCT02177201|20231954|P1|NOT COMPLETED|Overall Study||3
8204367|NCT02177201|20231953|P2|COMPLETED|Overall Study||77
8204368|NCT02177201|20231954|P1|COMPLETED|Overall Study||77
8204369|NCT02177201|20231953|P2|STARTED|Overall Study||80
8204370|NCT02177201|20231954|P1|STARTED|Overall Study||80
8204371|NCT02177136|20231963|P3|NOT COMPLETED|Overall Study||4
8204372|NCT02177136|20231964|P2|NOT COMPLETED|Overall Study||5
8204373|NCT02177136|20231965|P1|NOT COMPLETED|Overall Study||6
8204374|NCT02177136|20231963|P3|COMPLETED|Overall Study||21
8204375|NCT02177136|20231964|P2|COMPLETED|Overall Study||21
8204376|NCT02177136|20231965|P1|COMPLETED|Overall Study||19
8204377|NCT02177136|20231963|P3|STARTED|Overall Study||25
8204378|NCT02177136|20231964|P2|STARTED|Overall Study||26
8204379|NCT02177136|20231965|P1|STARTED|Overall Study||25
8204380|NCT02177032|20231998|P4|NOT COMPLETED|Overall Study||0
8204381|NCT02177032|20231999|P3|NOT COMPLETED|Overall Study||3
8204382|NCT02177032|20232000|P2|NOT COMPLETED|Overall Study||2
8204383|NCT02177032|20232001|P1|NOT COMPLETED|Overall Study||5
8204384|NCT02177032|20231998|P4|COMPLETED|Overall Study||88
8204385|NCT02177032|20231999|P3|COMPLETED|Overall Study||351
8204386|NCT02177032|20232000|P2|COMPLETED|Overall Study||86
8204387|NCT02177032|20232001|P1|COMPLETED|Overall Study||350
8204388|NCT02177032|20231998|P4|STARTED|Overall Study||88
8204389|NCT02177032|20231999|P3|STARTED|Overall Study||354
8204390|NCT02177032|20232000|P2|STARTED|Overall Study||88
8204391|NCT02177032|20232001|P1|STARTED|Overall Study||355
8204392|NCT02176928|20232037|P2|NOT COMPLETED|Overall Study||4
8204393|NCT02176928|20232038|P1|NOT COMPLETED|Overall Study||2
8204394|NCT02176928|20232037|P2|COMPLETED|Overall Study||17
8204395|NCT02176928|20232038|P1|COMPLETED|Overall Study||19
8204396|NCT02176928|20232037|P2|STARTED|Overall Study||21
8204397|NCT02176928|20232038|P1|STARTED|Overall Study||21
8204398|NCT02176837|20232044|P1|NOT COMPLETED|Overall Study||6
8204399|NCT02176837|20232044|P1|COMPLETED|Overall Study||0
8204400|NCT02176837|20232044|P1|STARTED|Overall Study||6
8204401|NCT02176655|20232048|P1|NOT COMPLETED|Overall Study||6
8204402|NCT02176655|20232048|P1|COMPLETED|Overall Study||25
8204403|NCT02176655|20232048|P1|STARTED|Overall Study||31
8204404|NCT02176642|20232071|P2|NOT COMPLETED|Overall Study||1
8204405|NCT02176642|20232072|P1|NOT COMPLETED|Overall Study||0
8204406|NCT02176642|20232071|P2|COMPLETED|Overall Study||16
8204407|NCT02176642|20232072|P1|COMPLETED|Overall Study||18
8204408|NCT02176642|20232071|P2|STARTED|Overall Study||17
8204409|NCT02176642|20232072|P1|STARTED|Overall Study||18
8204410|NCT02176525|20232102|P8|NOT COMPLETED|Overall Study||0
8204411|NCT02176525|20232103|P7|NOT COMPLETED|Overall Study||1
8204412|NCT02176525|20232104|P6|NOT COMPLETED|Overall Study||1
8204413|NCT02176525|20232105|P5|NOT COMPLETED|Overall Study||1
8204414|NCT02176525|20232106|P4|NOT COMPLETED|Overall Study||1
8204415|NCT02176525|20232107|P3|NOT COMPLETED|Overall Study||0
8204416|NCT02176525|20232108|P2|NOT COMPLETED|Overall Study||0
8204417|NCT02176525|20232109|P1|NOT COMPLETED|Overall Study||1
8204418|NCT02176525|20232102|P8|COMPLETED|Overall Study||10
8204419|NCT02176525|20232103|P7|COMPLETED|Overall Study||8
8204420|NCT02176525|20232104|P6|COMPLETED|Overall Study||5
8204421|NCT02176525|20232105|P5|COMPLETED|Overall Study||7
8204422|NCT02176525|20232106|P4|COMPLETED|Overall Study||8
8204423|NCT02176525|20232107|P3|COMPLETED|Overall Study||9
8204424|NCT02176525|20232108|P2|COMPLETED|Overall Study||9
8204425|NCT02176525|20232109|P1|COMPLETED|Overall Study||14
8204426|NCT02176525|20232102|P8|STARTED|Overall Study||10
8204427|NCT02176525|20232103|P7|STARTED|Overall Study||9
8204428|NCT02176525|20232104|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
8204429|NCT02176525|20232105|P5|STARTED|Overall Study||8
8204430|NCT02176525|20232106|P4|STARTED|Overall Study||9
8204431|NCT02176525|20232107|P3|STARTED|Overall Study||9
8204432|NCT02176525|20232108|P2|STARTED|Overall Study||9
8204433|NCT02176525|20232109|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
8204434|NCT02176486|20232289|P3|NOT COMPLETED|Overall Study||0
8204435|NCT02176486|20232290|P2|NOT COMPLETED|Overall Study||0
8204436|NCT02176486|20232291|P1|NOT COMPLETED|Overall Study||0
8204437|NCT02176486|20232289|P3|COMPLETED|Overall Study||4
8204438|NCT02176486|20232290|P2|COMPLETED|Overall Study||5
8204439|NCT02176486|20232291|P1|COMPLETED|Overall Study||3
8204440|NCT02176486|20232289|P3|STARTED|Overall Study||4
8204441|NCT02176486|20232290|P2|STARTED|Overall Study||5
8204442|NCT02176486|20232291|P1|STARTED|Overall Study||3
8204443|NCT02176421|20232325|P1|NOT COMPLETED|Overall Study||5
8204444|NCT02176421|20232325|P1|COMPLETED|Overall Study||75
8204445|NCT02176421|20232325|P1|STARTED|Overall Study||80
8204446|NCT02176408|20232336|P2|NOT COMPLETED|Overall Study||4
8204447|NCT02176408|20232337|P1|NOT COMPLETED|Overall Study||6
8204448|NCT02176408|20232336|P2|COMPLETED|Overall Study||12
8204449|NCT02176408|20232337|P1|COMPLETED|Overall Study||9
8204450|NCT02176408|20232336|P2|STARTED|Overall Study||16
8204451|NCT02176408|20232337|P1|STARTED|Overall Study||15
8204464|NCT02176356|20232366|P1|NOT COMPLETED|Overall Study||23
8204465|NCT02176356|20232366|P1|COMPLETED|Overall Study||93
8204466|NCT02176356|20232366|P1|Eligible and Received Treatment|Overall Study||100
8204467|NCT02176356|20232366|P1|STARTED|Overall Study||116
8204468|NCT02176343|20232383|P1|NOT COMPLETED|Overall Study||0
8204469|NCT02176343|20232383|P1|COMPLETED|Overall Study||31
8204470|NCT02176343|20232383|P1|STARTED|Overall Study||31
8204471|NCT02176291|20232396|P2|NOT COMPLETED|Overall Study||0
8204472|NCT02176291|20232397|P1|NOT COMPLETED|Overall Study||5
8204473|NCT02176291|20232396|P2|COMPLETED|Overall Study||11
8204474|NCT02176291|20232397|P1|COMPLETED|Overall Study||15
8204475|NCT02176291|20232396|P2|STARTED|Overall Study||11
8204476|NCT02176291|20232397|P1|STARTED|Overall Study||20
8204477|NCT02176226|20232405|P1|NOT COMPLETED|Overall Study||9
8204478|NCT02176226|20232405|P1|COMPLETED|Overall Study||96
8204479|NCT02176226|20232405|P1|STARTED|Overall Study||105
8204480|NCT02176083|20232413|P2|NOT COMPLETED|Overall Study||0
8204481|NCT02176083|20232414|P1|NOT COMPLETED|Overall Study||0
8204482|NCT02176083|20232413|P2|COMPLETED|Overall Study||27
8204483|NCT02176083|20232414|P1|COMPLETED|Overall Study||11
8204484|NCT02176083|20232413|P2|STARTED|Overall Study||27
8204485|NCT02176083|20232414|P1|STARTED|Overall Study||11
8204486|NCT02176031|20232420|P1|NOT COMPLETED|Overall Study||12
8204487|NCT02176031|20232420|P1|COMPLETED|Overall Study||9
8204488|NCT02176031|20232420|P1|STARTED|Overall Study||21
8204489|NCT02176018|20232431|P2|NOT COMPLETED|Overall Study||6
8204490|NCT02176018|20232432|P1|NOT COMPLETED|Overall Study||5
8204491|NCT02176018|20232431|P2|COMPLETED|Overall Study||17
8204492|NCT02176018|20232432|P1|COMPLETED|Overall Study||17
8204493|NCT02176018|20232431|P2|STARTED|Overall Study||23
8204494|NCT02176018|20232432|P1|STARTED|Overall Study||22
8204495|NCT02176005|20232460|P4|NOT COMPLETED|Overall Study||0
8204496|NCT02176005|20232461|P3|NOT COMPLETED|Overall Study||0
8204497|NCT02176005|20232462|P2|NOT COMPLETED|Overall Study||0
8204498|NCT02176005|20232463|P1|NOT COMPLETED|Overall Study||0
8204499|NCT02176005|20232460|P4|COMPLETED|Overall Study||8
8204500|NCT02176005|20232461|P3|COMPLETED|Overall Study||8
8204501|NCT02176005|20232462|P2|COMPLETED|Overall Study||14
8204502|NCT02176005|20232463|P1|COMPLETED|Overall Study||14
8204503|NCT02176005|20232460|P4|STARTED|Overall Study||8
8204504|NCT02176005|20232461|P3|STARTED|Overall Study||8
8204505|NCT02176005|20232462|P2|STARTED|Overall Study||14
8204506|NCT02176005|20232463|P1|STARTED|Overall Study||14
8204507|NCT02175979|20232491|P2|NOT COMPLETED|Overall Study||8
8204508|NCT02175979|20232492|P1|NOT COMPLETED|Overall Study||7
8204509|NCT02175979|20232491|P2|COMPLETED|Overall Study||132
8204510|NCT02175979|20232492|P1|COMPLETED|Overall Study||133
8204511|NCT02175979|20232491|P2|STARTED|Overall Study||140
8204512|NCT02175979|20232492|P1|STARTED|Overall Study||140
8204513|NCT02175966|20232516|P2|NOT COMPLETED|Follow-up Period||6
8204514|NCT02175966|20232517|P1|NOT COMPLETED|Follow-up Period||10
8204515|NCT02175966|20232516|P2|COMPLETED|Follow-up Period||8
8204516|NCT02175966|20232517|P1|COMPLETED|Follow-up Period||4
8204517|NCT02175966|20232516|P2|STARTED|Follow-up Period||14
8204518|NCT02175966|20232517|P1|STARTED|Follow-up Period||14
8204519|NCT02175966|20232516|P2|NOT COMPLETED|Treatment Period||0
8204520|NCT02175966|20232517|P1|NOT COMPLETED|Treatment Period||0
8204521|NCT02175966|20232516|P2|COMPLETED|Treatment Period||14
8204522|NCT02175966|20232517|P1|COMPLETED|Treatment Period||14
8204523|NCT02175966|20232516|P2|STARTED|Treatment Period||14
8204524|NCT02175966|20232517|P1|STARTED|Treatment Period||14
8204525|NCT02175771|20232545|P9|NOT COMPLETED|Treatment Period||6
8204526|NCT02175771|20232546|P8|NOT COMPLETED|Treatment Period||17
8204527|NCT02175771|20232547|P7|NOT COMPLETED|Treatment Period||5
8204528|NCT02175771|20232548|P6|NOT COMPLETED|Treatment Period||10
8204529|NCT02175771|20232549|P5|NOT COMPLETED|Treatment Period||5
8204530|NCT02175771|20232550|P4|NOT COMPLETED|Treatment Period||13
8204531|NCT02175771|20232551|P3|NOT COMPLETED|Treatment Period||7
8204532|NCT02175771|20232552|P2|NOT COMPLETED|Treatment Period||16
8204533|NCT02175771|20232553|P1|NOT COMPLETED|Treatment Period||0
8204534|NCT02175771|20232545|P9|COMPLETED|Treatment Period||38
8204535|NCT02175771|20232546|P8|COMPLETED|Treatment Period||116
8204536|NCT02175771|20232547|P7|COMPLETED|Treatment Period||36
8204537|NCT02175771|20232548|P6|COMPLETED|Treatment Period||110
8204538|NCT02175771|20232549|P5|COMPLETED|Treatment Period||36
8204539|NCT02175771|20232550|P4|COMPLETED|Treatment Period||113
8204540|NCT02175771|20232551|P3|COMPLETED|Treatment Period||35
8204541|NCT02175771|20232552|P2|COMPLETED|Treatment Period||111
8204542|NCT02175771|20232553|P1|COMPLETED|Treatment Period||0
8204543|NCT02175771|20232545|P9|STARTED|Treatment Period||44
8204544|NCT02175771|20232546|P8|STARTED|Treatment Period||133
8204545|NCT02175771|20232547|P7|STARTED|Treatment Period||41
8204546|NCT02175771|20232548|P6|STARTED|Treatment Period||120
8204547|NCT02175771|20232549|P5|STARTED|Treatment Period||41
8204548|NCT02175771|20232550|P4|STARTED|Treatment Period||126
8204549|NCT02175771|20232551|P3|STARTED|Treatment Period||42
8204550|NCT02175771|20232552|P2|STARTED|Treatment Period||127
8204551|NCT02175771|20232553|P1|STARTED|Treatment Period||0
8204552|NCT02175771|20232545|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204553|NCT02175771|20232546|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204554|NCT02175771|20232547|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204555|NCT02175771|20232548|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204556|NCT02175771|20232549|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204557|NCT02175771|20232550|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204558|NCT02175771|20232551|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204559|NCT02175771|20232552|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204560|NCT02175771|20232553|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
8204561|NCT02175771|20232545|P9|COMPLETED|Run-In Period (Pre-assignment)||0
8204562|NCT02175771|20232546|P8|COMPLETED|Run-In Period (Pre-assignment)||0
8204563|NCT02175771|20232547|P7|COMPLETED|Run-In Period (Pre-assignment)||0
8204564|NCT02175771|20232548|P6|COMPLETED|Run-In Period (Pre-assignment)||0
8204565|NCT02175771|20232549|P5|COMPLETED|Run-In Period (Pre-assignment)||0
8204566|NCT02175771|20232550|P4|COMPLETED|Run-In Period (Pre-assignment)||0
8204567|NCT02175771|20232551|P3|COMPLETED|Run-In Period (Pre-assignment)||0
8204568|NCT02175771|20232552|P2|COMPLETED|Run-In Period (Pre-assignment)||0
8204569|NCT02175771|20232553|P1|COMPLETED|Run-In Period (Pre-assignment)||674
8204570|NCT02175771|20232545|P9|STARTED|Run-In Period (Pre-assignment)||0
8204571|NCT02175771|20232546|P8|STARTED|Run-In Period (Pre-assignment)||0
8204572|NCT02175771|20232547|P7|STARTED|Run-In Period (Pre-assignment)||0
8204573|NCT02175771|20232548|P6|STARTED|Run-In Period (Pre-assignment)||0
8204574|NCT02175771|20232549|P5|STARTED|Run-In Period (Pre-assignment)||0
8204575|NCT02175771|20232550|P4|STARTED|Run-In Period (Pre-assignment)||0
8204576|NCT02175771|20232551|P3|STARTED|Run-In Period (Pre-assignment)||0
8204577|NCT02175771|20232552|P2|STARTED|Run-In Period (Pre-assignment)||0
8204578|NCT02175771|20232553|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
8204579|NCT02175758|20232617|P6|NOT COMPLETED|Treatment Phase||0
8204580|NCT02175758|20232618|P5|NOT COMPLETED|Treatment Phase||1
8204581|NCT02175758|20232619|P4|NOT COMPLETED|Treatment Phase||0
8204582|NCT02175758|20232620|P3|NOT COMPLETED|Treatment Phase||0
8204583|NCT02175758|20232621|P2|NOT COMPLETED|Treatment Phase||1
8204584|NCT02175758|20232622|P1|NOT COMPLETED|Treatment Phase||0
8204585|NCT02175758|20232617|P6|COMPLETED|Treatment Phase||8
8204586|NCT02175758|20232618|P5|COMPLETED|Treatment Phase||4
8204587|NCT02175758|20232619|P4|COMPLETED|Treatment Phase||28
8204588|NCT02175758|20232620|P3|COMPLETED|Treatment Phase||13
8204589|NCT02175758|20232621|P2|COMPLETED|Treatment Phase||38
8204590|NCT02175758|20232622|P1|COMPLETED|Treatment Phase||13
8204591|NCT02175758|20232617|P6|STARTED|Treatment Phase||8
8204592|NCT02175758|20232618|P5|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
8204593|NCT02175758|20232619|P4|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
8204594|NCT02175758|20232620|P3|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
8204595|NCT02175758|20232621|P2|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
8204596|NCT02175758|20232622|P1|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
8204597|NCT02175758|20232617|P6|NOT COMPLETED|PK Lead-in Phase||0
8204598|NCT02175758|20232618|P5|NOT COMPLETED|PK Lead-in Phase||0
8204599|NCT02175758|20232619|P4|NOT COMPLETED|PK Lead-in Phase||0
8204600|NCT02175758|20232620|P3|NOT COMPLETED|PK Lead-in Phase||0
8204601|NCT02175758|20232621|P2|NOT COMPLETED|PK Lead-in Phase||0
8204602|NCT02175758|20232622|P1|NOT COMPLETED|PK Lead-in Phase||0
8204603|NCT02175758|20232617|P6|COMPLETED|PK Lead-in Phase||8
8204604|NCT02175758|20232618|P5|COMPLETED|PK Lead-in Phase||4
8204605|NCT02175758|20232619|P4|COMPLETED|PK Lead-in Phase||10
8204606|NCT02175758|20232620|P3|COMPLETED|PK Lead-in Phase||2
8204607|NCT02175758|20232621|P2|COMPLETED|PK Lead-in Phase||6
8204608|NCT02175758|20232622|P1|COMPLETED|PK Lead-in Phase||4
8204609|NCT02175758|20232617|P6|STARTED|PK Lead-in Phase||8
8204610|NCT02175758|20232618|P5|STARTED|PK Lead-in Phase||4
8204611|NCT02175758|20232619|P4|STARTED|PK Lead-in Phase||10
8204612|NCT02175758|20232620|P3|STARTED|PK Lead-in Phase||2
8204613|NCT02175758|20232621|P2|STARTED|PK Lead-in Phase||6
8204614|NCT02175758|20232622|P1|STARTED|PK Lead-in Phase||4
8204615|NCT02175745|20232725|P1|NOT COMPLETED|Overall Study||1
8204616|NCT02175745|20232725|P1|COMPLETED|Overall Study||1
8204617|NCT02175745|20232725|P1|STARTED|Overall Study||2
8204618|NCT02175628|20232732|P2|NOT COMPLETED|Overall Study||0
8204619|NCT02175628|20232733|P1|NOT COMPLETED|Overall Study||0
8204620|NCT02175628|20232732|P2|COMPLETED|Overall Study||17
8204621|NCT02175628|20232733|P1|COMPLETED|Overall Study||6
8204622|NCT02175628|20232732|P2|STARTED|Overall Study||17
8204623|NCT02175628|20232733|P1|STARTED|Overall Study||6
8204624|NCT02175472|20232749|P2|NOT COMPLETED|Overall Study||2
8204625|NCT02175472|20232750|P1|NOT COMPLETED|Overall Study||7
8204626|NCT02175472|20232749|P2|COMPLETED|Overall Study||45
8204627|NCT02175472|20232750|P1|COMPLETED|Overall Study||38
8204628|NCT02175472|20232749|P2|STARTED|Overall Study||47
8204629|NCT02175472|20232750|P1|STARTED|Overall Study||45
8204630|NCT02175368|20232764|P1|NOT COMPLETED|Overall Study||1
8204631|NCT02175368|20232764|P1|COMPLETED|Overall Study||27
8204632|NCT02175368|20232764|P1|STARTED|Overall Study||28
8204633|NCT02175277|20232769|P1|NOT COMPLETED|Overall Study||1
8204634|NCT02175277|20232769|P1|COMPLETED|Overall Study||8
8204635|NCT02175277|20232769|P1|STARTED|Overall Study||9
8204636|NCT02175225|20232775|P2|NOT COMPLETED|Overall Study||11
8204637|NCT02175225|20232776|P1|NOT COMPLETED|Overall Study||8
8204638|NCT02175225|20232775|P2|COMPLETED|Overall Study||138
8204639|NCT02175225|20232776|P1|COMPLETED|Overall Study||137
8204640|NCT02175225|20232775|P2|180 Day Outcome Obtained|Overall Study||135
8204641|NCT02175225|20232776|P1|180 Day Outcome Obtained|Overall Study||135
8204642|NCT02175225|20232775|P2|90 Day Outcome Obtained|Overall Study||143
8204643|NCT02175225|20232776|P1|90 Day Outcome Obtained|Overall Study||140
8204644|NCT02175225|20232775|P2|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
8204645|NCT02175225|20232776|P1|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
8204646|NCT02175225|20232775|P2|STARTED|Overall Study||149
8204647|NCT02175225|20232776|P1|STARTED|Overall Study||145
8204648|NCT02175212|20232810|P2|NOT COMPLETED|Overall Study||147
8204649|NCT02175212|20232811|P1|NOT COMPLETED|Overall Study||163
8204650|NCT02175212|20232810|P2|COMPLETED|Overall Study||31
8204651|NCT02175212|20232811|P1|COMPLETED|Overall Study||14
8204652|NCT02175212|20232810|P2|STARTED|Overall Study||178
8204653|NCT02175212|20232811|P1|STARTED|Overall Study||177
8204654|NCT02175199|20232827|P2|NOT COMPLETED|Overall Study||5
8204655|NCT02175199|20232828|P1|NOT COMPLETED|Overall Study||3
8204656|NCT02175199|20232827|P2|COMPLETED|Overall Study||71
8204657|NCT02175199|20232828|P1|COMPLETED|Overall Study||71
8204658|NCT02175199|20232827|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
8204659|NCT02175199|20232828|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
8204660|NCT02175199|20232827|P2|STARTED|Overall Study||76
8204661|NCT02175199|20232828|P1|STARTED|Overall Study||74
8204662|NCT02175121|20232842|P5|NOT COMPLETED|Overall Study||1
8204663|NCT02175121|20232843|P4|NOT COMPLETED|Overall Study||1
8204664|NCT02175121|20232844|P3|NOT COMPLETED|Overall Study||2
8204665|NCT02175121|20232845|P2|NOT COMPLETED|Overall Study||1
8204666|NCT02175121|20232846|P1|NOT COMPLETED|Overall Study||1
8204667|NCT02175121|20232842|P5|COMPLETED|Overall Study||33
8204668|NCT02175121|20232843|P4|COMPLETED|Overall Study||34
8204669|NCT02175121|20232844|P3|COMPLETED|Overall Study||32
8204670|NCT02175121|20232845|P2|COMPLETED|Overall Study||34
8204671|NCT02175121|20232846|P1|COMPLETED|Overall Study||33
8204672|NCT02175121|20232842|P5|STARTED|Overall Study||34
8204673|NCT02175121|20232843|P4|STARTED|Overall Study||35
8204674|NCT02175121|20232844|P3|STARTED|Overall Study||34
8204675|NCT02175121|20232845|P2|STARTED|Overall Study||35
8204676|NCT02175121|20232846|P1|STARTED|Overall Study||34
8204677|NCT02174913|20232975|P2|NOT COMPLETED|Overall Study||0
8204678|NCT02174913|20232976|P1|NOT COMPLETED|Overall Study||0
8204679|NCT02174913|20232975|P2|COMPLETED|Overall Study||17
8204680|NCT02174913|20232976|P1|COMPLETED|Overall Study||17
8204681|NCT02174913|20232975|P2|STARTED|Overall Study||17
8204682|NCT02174913|20232976|P1|STARTED|Overall Study||17
8204683|NCT02174861|20232984|P1|NOT COMPLETED|Overall Study||158
8204684|NCT02174861|20232984|P1|COMPLETED|Overall Study||451
8204685|NCT02174861|20232984|P1|Enrolled in CHU Substudy|Overall Study||53
8204686|NCT02174861|20232984|P1|STARTED|Overall Study||609
8204687|NCT02174848|20232998|P2|NOT COMPLETED|Overall Study||6
8204688|NCT02174848|20232999|P1|NOT COMPLETED|Overall Study||7
8204689|NCT02174848|20232998|P2|COMPLETED|Overall Study||38
8204690|NCT02174848|20232999|P1|COMPLETED|Overall Study||17
8204691|NCT02174848|20232998|P2|Provided Post-baseline Efficacy Data|Overall Study||43
8204692|NCT02174848|20232999|P1|Provided Post-baseline Efficacy Data|Overall Study||19
8204693|NCT02174848|20232998|P2|STARTED|Overall Study||44
8204694|NCT02174848|20232999|P1|STARTED|Overall Study||24
8204695|NCT02174731|20233016|P2|NOT COMPLETED|Overall Study||65
8204696|NCT02174731|20233017|P1|NOT COMPLETED|Overall Study||69
8204697|NCT02174731|20233016|P2|COMPLETED|Overall Study||990
8204698|NCT02174731|20233017|P1|COMPLETED|Overall Study||982
8204699|NCT02174731|20233016|P2|Received Treatment|Overall Study||1053
8204700|NCT02174731|20233017|P1|Received Treatment|Overall Study||1048
8204701|NCT02174731|20233016|P2|STARTED|Overall Study||1055
8204702|NCT02174731|20233017|P1|STARTED|Overall Study||1051
8204703|NCT02174627|20233039|P2|NOT COMPLETED|Overall Study||130
8204704|NCT02174627|20233040|P1|NOT COMPLETED|Overall Study||84
8204705|NCT02174627|20233039|P2|COMPLETED|Overall Study||1247
8204706|NCT02174627|20233040|P1|COMPLETED|Overall Study||1300
8204707|NCT02174627|20233039|P2|Discontinued Treatment|Overall Study||801
8204708|NCT02174627|20233040|P1|Discontinued Treatment|Overall Study||499
8204709|NCT02174627|20233039|P2|Received Treatment|Overall Study||1376
8204710|NCT02174627|20233040|P1|Received Treatment|Overall Study||1384
8204711|NCT02174627|20233039|P2|STARTED|Overall Study||1377
8204712|NCT02174627|20233040|P1|STARTED|Overall Study||1384
8204713|NCT02174562|20233068|P2|NOT COMPLETED|Overall Study||5
8204714|NCT02174562|20233069|P1|NOT COMPLETED|Overall Study||9
8204715|NCT02174562|20233068|P2|COMPLETED|Overall Study||46
8204716|NCT02174562|20233069|P1|COMPLETED|Overall Study||41
8204717|NCT02174562|20233068|P2|STARTED|Overall Study||51
8204718|NCT02174562|20233069|P1|STARTED|Overall Study||50
8204719|NCT02174523|20233079|P2|NOT COMPLETED|Overall Study||0
8204720|NCT02174523|20233080|P1|NOT COMPLETED|Overall Study||1
8204721|NCT02174523|20233079|P2|COMPLETED|Overall Study||4
8204722|NCT02174523|20233080|P1|COMPLETED|Overall Study||9
8204723|NCT02174523|20233079|P2|STARTED|Overall Study||4
8204724|NCT02174523|20233080|P1|STARTED|Overall Study||10
8204725|NCT02174510|20233111|P4|NOT COMPLETED|Overall Study||0
8204726|NCT02174510|20233112|P3|NOT COMPLETED|Overall Study||0
8204727|NCT02174510|20233113|P2|NOT COMPLETED|Overall Study||0
8204728|NCT02174510|20233114|P1|NOT COMPLETED|Overall Study||0
8204729|NCT02174510|20233111|P4|COMPLETED|Overall Study||9
8204730|NCT02174510|20233112|P3|COMPLETED|Overall Study||12
8204731|NCT02174510|20233113|P2|COMPLETED|Overall Study||8
8204732|NCT02174510|20233114|P1|COMPLETED|Overall Study||8
8204733|NCT02174510|20233111|P4|STARTED|Overall Study||9
8204734|NCT02174510|20233112|P3|STARTED|Overall Study||12
8204735|NCT02174510|20233113|P2|STARTED|Overall Study||8
8204736|NCT02174510|20233114|P1|STARTED|Overall Study||8
8204737|NCT02174432|20233144|P1|NOT COMPLETED|Overall Study||20
8204738|NCT02174432|20233144|P1|COMPLETED|Overall Study||16
8204739|NCT02174432|20233144|P1|STARTED|Overall Study||36
8204740|NCT02174419|20233151|P3|NOT COMPLETED|Overall Study||2
8204741|NCT02174419|20233152|P2|NOT COMPLETED|Overall Study||6
8204742|NCT02174419|20233153|P1|NOT COMPLETED|Overall Study||4
8204743|NCT02174419|20233151|P3|COMPLETED|Overall Study||20
8204744|NCT02174419|20233152|P2|COMPLETED|Overall Study||12
8204745|NCT02174419|20233153|P1|COMPLETED|Overall Study||18
8204746|NCT02174419|20233151|P3|STARTED|Overall Study||22
8204747|NCT02174419|20233152|P2|STARTED|Overall Study||18
8204748|NCT02174419|20233153|P1|STARTED|Overall Study||22
8204749|NCT02174276|20233165|P4|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
8204750|NCT02174276|20233166|P3|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
8204751|NCT02174276|20233167|P2|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
8204752|NCT02174276|20233168|P1|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
8204753|NCT02174276|20233165|P4|COMPLETED|OTEP (Weeks 48 to 144)||50
8204754|NCT02174276|20233166|P3|COMPLETED|OTEP (Weeks 48 to 144)||48
8204755|NCT02174276|20233167|P2|COMPLETED|OTEP (Weeks 48 to 144)||54
8204756|NCT02174276|20233168|P1|COMPLETED|OTEP (Weeks 48 to 144)||25
8204757|NCT02174276|20233165|P4|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
8204758|NCT02174276|20233166|P3|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
8204759|NCT02174276|20233167|P2|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
8204760|NCT02174276|20233168|P1|STARTED|OTEP (Weeks 48 to 144)||26
8204761|NCT02174276|20233165|P4|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
8204762|NCT02174276|20233166|P3|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
8204763|NCT02174276|20233167|P2|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
8204764|NCT02174276|20233168|P1|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
8204765|NCT02174276|20233165|P4|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
8204766|NCT02174276|20233166|P3|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
8204767|NCT02174276|20233167|P2|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
8204768|NCT02174276|20233168|P1|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
8204769|NCT02174276|20233165|P4|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
8204770|NCT02174276|20233166|P3|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
8204771|NCT02174276|20233167|P2|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
8204772|NCT02174276|20233168|P1|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
8204773|NCT02174198|20233252|P2|NOT COMPLETED|Overall Study||0
8204774|NCT02174198|20233253|P1|NOT COMPLETED|Overall Study||0
8204775|NCT02174198|20233252|P2|COMPLETED|Overall Study||16
8204776|NCT02174198|20233253|P1|COMPLETED|Overall Study||16
8204777|NCT02174198|20233252|P2|STARTED|Overall Study||16
8204778|NCT02174198|20233253|P1|STARTED|Overall Study||16
8204779|NCT02173769|20233275|P1|NOT COMPLETED|Overall Study||4
8204780|NCT02173769|20233275|P1|COMPLETED|Overall Study||1854
8204781|NCT02173769|20233275|P1|STARTED|Overall Study||1858
8204782|NCT02173704|20233288|P2|NOT COMPLETED|Overall Study||4
8204783|NCT02173704|20233289|P1|NOT COMPLETED|Overall Study||13
8204784|NCT02173704|20233288|P2|COMPLETED|Overall Study||71
8204785|NCT02173704|20233289|P1|COMPLETED|Overall Study||137
8204786|NCT02173704|20233288|P2|STARTED|Overall Study||75
8204787|NCT02173704|20233289|P1|STARTED|Overall Study||150
8204788|NCT02173548|20233317|P2|NOT COMPLETED|Overall Study||2
8204789|NCT02173548|20233318|P1|NOT COMPLETED|Overall Study||1
8204790|NCT02173548|20233317|P2|COMPLETED|Overall Study||8
8204791|NCT02173548|20233318|P1|COMPLETED|Overall Study||20
8204792|NCT02173548|20233317|P2|STARTED|Overall Study||10
8204793|NCT02173548|20233318|P1|STARTED|Overall Study||21
8204794|NCT02173535|20233358|P20|NOT COMPLETED|Period 5||0
8204795|NCT02173535|20233359|P19|NOT COMPLETED|Period 5||0
8204796|NCT02173535|20233360|P18|NOT COMPLETED|Period 5||0
8204797|NCT02173535|20233361|P17|NOT COMPLETED|Period 5||0
8204798|NCT02173535|20233362|P16|NOT COMPLETED|Period 5||0
8204799|NCT02173535|20233363|P15|NOT COMPLETED|Period 5||0
8204800|NCT02173535|20233364|P14|NOT COMPLETED|Period 5||0
8204801|NCT02173535|20233365|P13|NOT COMPLETED|Period 5||0
8204802|NCT02173535|20233366|P12|NOT COMPLETED|Period 5||0
8204803|NCT02173535|20233367|P11|NOT COMPLETED|Period 5||0
8204804|NCT02173535|20233368|P10|NOT COMPLETED|Period 5||0
8204805|NCT02173535|20233369|P9|NOT COMPLETED|Period 5||0
8204806|NCT02173535|20233370|P8|NOT COMPLETED|Period 5||0
8204807|NCT02173535|20233371|P7|NOT COMPLETED|Period 5||0
8204808|NCT02173535|20233372|P6|NOT COMPLETED|Period 5||0
8204809|NCT02173535|20233373|P5|NOT COMPLETED|Period 5||0
8204810|NCT02173535|20233374|P4|NOT COMPLETED|Period 5||0
8204811|NCT02173535|20233375|P3|NOT COMPLETED|Period 5||0
8204812|NCT02173535|20233376|P2|NOT COMPLETED|Period 5||0
8204813|NCT02173535|20233377|P1|NOT COMPLETED|Period 5||0
8204814|NCT02173535|20233358|P20|COMPLETED|Period 5||12
8204815|NCT02173535|20233359|P19|COMPLETED|Period 5||12
8204816|NCT02173535|20233360|P18|COMPLETED|Period 5||12
8204817|NCT02173535|20233361|P17|COMPLETED|Period 5||12
8204818|NCT02173535|20233362|P16|COMPLETED|Period 5||12
8204819|NCT02173535|20233363|P15|COMPLETED|Period 5||12
8204820|NCT02173535|20233364|P14|COMPLETED|Period 5||12
8204821|NCT02173535|20233365|P13|COMPLETED|Period 5||12
8204822|NCT02173535|20233366|P12|COMPLETED|Period 5||12
8204823|NCT02173535|20233367|P11|COMPLETED|Period 5||12
8204824|NCT02173535|20233368|P10|COMPLETED|Period 5||12
8204825|NCT02173535|20233369|P9|COMPLETED|Period 5||12
8204826|NCT02173535|20233370|P8|COMPLETED|Period 5||12
8204827|NCT02173535|20233371|P7|COMPLETED|Period 5||12
8204828|NCT02173535|20233372|P6|COMPLETED|Period 5||12
8204829|NCT02173535|20233373|P5|COMPLETED|Period 5||12
8204830|NCT02173535|20233374|P4|COMPLETED|Period 5||12
8204831|NCT02173535|20233375|P3|COMPLETED|Period 5||12
8204832|NCT02173535|20233376|P2|COMPLETED|Period 5||12
8204833|NCT02173535|20233377|P1|COMPLETED|Period 5||12
8204834|NCT02173535|20233358|P20|STARTED|Period 5||12
8204835|NCT02173535|20233359|P19|STARTED|Period 5||12
8204836|NCT02173535|20233360|P18|STARTED|Period 5||12
8204837|NCT02173535|20233361|P17|STARTED|Period 5||12
8204838|NCT02173535|20233362|P16|STARTED|Period 5||12
8204839|NCT02173535|20233363|P15|STARTED|Period 5||12
8204840|NCT02173535|20233364|P14|STARTED|Period 5||12
8204841|NCT02173535|20233365|P13|STARTED|Period 5||12
8204842|NCT02173535|20233366|P12|STARTED|Period 5||12
8204843|NCT02173535|20233367|P11|STARTED|Period 5||12
8204844|NCT02173535|20233368|P10|STARTED|Period 5||12
8204845|NCT02173535|20233369|P9|STARTED|Period 5||12
8204846|NCT02173535|20233370|P8|STARTED|Period 5||12
8204847|NCT02173535|20233371|P7|STARTED|Period 5||12
8204848|NCT02173535|20233372|P6|STARTED|Period 5||12
8204849|NCT02173535|20233373|P5|STARTED|Period 5||12
8204850|NCT02173535|20233374|P4|STARTED|Period 5||12
8204851|NCT02173535|20233375|P3|STARTED|Period 5||12
8204852|NCT02173535|20233376|P2|STARTED|Period 5||12
8204853|NCT02173535|20233377|P1|STARTED|Period 5||12
8204854|NCT02173535|20233358|P20|NOT COMPLETED|Period 4||0
8204855|NCT02173535|20233359|P19|NOT COMPLETED|Period 4||0
8204856|NCT02173535|20233360|P18|NOT COMPLETED|Period 4||0
8204857|NCT02173535|20233361|P17|NOT COMPLETED|Period 4||0
8204858|NCT02173535|20233362|P16|NOT COMPLETED|Period 4||0
8204859|NCT02173535|20233363|P15|NOT COMPLETED|Period 4||0
8204860|NCT02173535|20233364|P14|NOT COMPLETED|Period 4||0
8204861|NCT02173535|20233365|P13|NOT COMPLETED|Period 4||0
8204862|NCT02173535|20233366|P12|NOT COMPLETED|Period 4||0
8204863|NCT02173535|20233367|P11|NOT COMPLETED|Period 4||0
8204864|NCT02173535|20233368|P10|NOT COMPLETED|Period 4||0
8204865|NCT02173535|20233369|P9|NOT COMPLETED|Period 4||0
8204866|NCT02173535|20233370|P8|NOT COMPLETED|Period 4||0
8204867|NCT02173535|20233371|P7|NOT COMPLETED|Period 4||0
8204868|NCT02173535|20233372|P6|NOT COMPLETED|Period 4||0
8204869|NCT02173535|20233373|P5|NOT COMPLETED|Period 4||0
8204870|NCT02173535|20233374|P4|NOT COMPLETED|Period 4||0
8204871|NCT02173535|20233375|P3|NOT COMPLETED|Period 4||0
8204872|NCT02173535|20233376|P2|NOT COMPLETED|Period 4||0
8204873|NCT02173535|20233377|P1|NOT COMPLETED|Period 4||0
8204874|NCT02173535|20233358|P20|COMPLETED|Period 4||12
8204875|NCT02173535|20233359|P19|COMPLETED|Period 4||12
8204876|NCT02173535|20233360|P18|COMPLETED|Period 4||12
8204877|NCT02173535|20233361|P17|COMPLETED|Period 4||12
8204878|NCT02173535|20233362|P16|COMPLETED|Period 4||12
8204879|NCT02173535|20233363|P15|COMPLETED|Period 4||12
8204880|NCT02173535|20233364|P14|COMPLETED|Period 4||12
8204881|NCT02173535|20233365|P13|COMPLETED|Period 4||12
8204882|NCT02173535|20233366|P12|COMPLETED|Period 4||12
8204883|NCT02173535|20233367|P11|COMPLETED|Period 4||12
8204884|NCT02173535|20233368|P10|COMPLETED|Period 4||12
8204885|NCT02173535|20233369|P9|COMPLETED|Period 4||12
8204886|NCT02173535|20233370|P8|COMPLETED|Period 4||12
8204887|NCT02173535|20233371|P7|COMPLETED|Period 4||12
8204888|NCT02173535|20233372|P6|COMPLETED|Period 4||12
8204889|NCT02173535|20233373|P5|COMPLETED|Period 4||12
8204890|NCT02173535|20233374|P4|COMPLETED|Period 4||12
8204891|NCT02173535|20233375|P3|COMPLETED|Period 4||12
8204892|NCT02173535|20233376|P2|COMPLETED|Period 4||12
8204893|NCT02173535|20233377|P1|COMPLETED|Period 4||12
8204894|NCT02173535|20233358|P20|STARTED|Period 4||12
8204895|NCT02173535|20233359|P19|STARTED|Period 4||12
8204896|NCT02173535|20233360|P18|STARTED|Period 4||12
8204897|NCT02173535|20233361|P17|STARTED|Period 4||12
8204898|NCT02173535|20233362|P16|STARTED|Period 4||12
8204899|NCT02173535|20233363|P15|STARTED|Period 4||12
8204900|NCT02173535|20233364|P14|STARTED|Period 4||12
8204901|NCT02173535|20233365|P13|STARTED|Period 4||12
8204902|NCT02173535|20233366|P12|STARTED|Period 4||12
8204903|NCT02173535|20233367|P11|STARTED|Period 4||12
8204904|NCT02173535|20233368|P10|STARTED|Period 4||12
8204905|NCT02173535|20233369|P9|STARTED|Period 4||12
8204906|NCT02173535|20233370|P8|STARTED|Period 4||12
8204907|NCT02173535|20233371|P7|STARTED|Period 4||12
8204908|NCT02173535|20233372|P6|STARTED|Period 4||12
8204909|NCT02173535|20233373|P5|STARTED|Period 4||12
8204910|NCT02173535|20233374|P4|STARTED|Period 4||12
8204911|NCT02173535|20233375|P3|STARTED|Period 4||12
8204912|NCT02173535|20233376|P2|STARTED|Period 4||12
8204913|NCT02173535|20233377|P1|STARTED|Period 4||12
8204914|NCT02173535|20233358|P20|NOT COMPLETED|Period 3||0
8204915|NCT02173535|20233359|P19|NOT COMPLETED|Period 3||0
8204916|NCT02173535|20233360|P18|NOT COMPLETED|Period 3||0
8204917|NCT02173535|20233361|P17|NOT COMPLETED|Period 3||0
8204918|NCT02173535|20233362|P16|NOT COMPLETED|Period 3||0
8204919|NCT02173535|20233363|P15|NOT COMPLETED|Period 3||0
8204920|NCT02173535|20233364|P14|NOT COMPLETED|Period 3||0
8204921|NCT02173535|20233365|P13|NOT COMPLETED|Period 3||0
8204922|NCT02173535|20233366|P12|NOT COMPLETED|Period 3||0
8204923|NCT02173535|20233367|P11|NOT COMPLETED|Period 3||0
8204924|NCT02173535|20233368|P10|NOT COMPLETED|Period 3||0
8204925|NCT02173535|20233369|P9|NOT COMPLETED|Period 3||0
8204926|NCT02173535|20233370|P8|NOT COMPLETED|Period 3||0
8204927|NCT02173535|20233371|P7|NOT COMPLETED|Period 3||0
8204928|NCT02173535|20233372|P6|NOT COMPLETED|Period 3||0
8204929|NCT02173535|20233373|P5|NOT COMPLETED|Period 3||0
8204930|NCT02173535|20233374|P4|NOT COMPLETED|Period 3||0
8204931|NCT02173535|20233375|P3|NOT COMPLETED|Period 3||0
8204932|NCT02173535|20233376|P2|NOT COMPLETED|Period 3||0
8204933|NCT02173535|20233377|P1|NOT COMPLETED|Period 3||0
8204934|NCT02173535|20233358|P20|COMPLETED|Period 3||12
8204935|NCT02173535|20233359|P19|COMPLETED|Period 3||12
8204936|NCT02173535|20233360|P18|COMPLETED|Period 3||12
8204937|NCT02173535|20233361|P17|COMPLETED|Period 3||12
8204938|NCT02173535|20233362|P16|COMPLETED|Period 3||12
8204939|NCT02173535|20233363|P15|COMPLETED|Period 3||12
8204940|NCT02173535|20233364|P14|COMPLETED|Period 3||12
8204941|NCT02173535|20233365|P13|COMPLETED|Period 3||12
8204942|NCT02173535|20233366|P12|COMPLETED|Period 3||12
8204943|NCT02173535|20233367|P11|COMPLETED|Period 3||12
8204944|NCT02173535|20233368|P10|COMPLETED|Period 3||12
8204945|NCT02173535|20233369|P9|COMPLETED|Period 3||12
8204946|NCT02173535|20233370|P8|COMPLETED|Period 3||12
8204947|NCT02173535|20233371|P7|COMPLETED|Period 3||12
8204948|NCT02173535|20233372|P6|COMPLETED|Period 3||12
8204949|NCT02173535|20233373|P5|COMPLETED|Period 3||12
8204950|NCT02173535|20233374|P4|COMPLETED|Period 3||12
8204951|NCT02173535|20233375|P3|COMPLETED|Period 3||12
8204952|NCT02173535|20233376|P2|COMPLETED|Period 3||12
8204953|NCT02173535|20233377|P1|COMPLETED|Period 3||12
8204954|NCT02173535|20233358|P20|STARTED|Period 3||12
8204955|NCT02173535|20233359|P19|STARTED|Period 3||12
8204956|NCT02173535|20233360|P18|STARTED|Period 3||12
8204957|NCT02173535|20233361|P17|STARTED|Period 3||12
8204958|NCT02173535|20233362|P16|STARTED|Period 3||12
8204959|NCT02173535|20233363|P15|STARTED|Period 3||12
8204960|NCT02173535|20233364|P14|STARTED|Period 3||12
8204961|NCT02173535|20233365|P13|STARTED|Period 3||12
8204962|NCT02173535|20233366|P12|STARTED|Period 3||12
8204963|NCT02173535|20233367|P11|STARTED|Period 3||12
8204964|NCT02173535|20233368|P10|STARTED|Period 3||12
8204965|NCT02173535|20233369|P9|STARTED|Period 3||12
8204966|NCT02173535|20233370|P8|STARTED|Period 3||12
8204967|NCT02173535|20233371|P7|STARTED|Period 3||12
8204968|NCT02173535|20233372|P6|STARTED|Period 3||12
8204969|NCT02173535|20233373|P5|STARTED|Period 3||12
8204970|NCT02173535|20233374|P4|STARTED|Period 3||12
8204971|NCT02173535|20233375|P3|STARTED|Period 3||12
8204972|NCT02173535|20233376|P2|STARTED|Period 3||12
8204973|NCT02173535|20233377|P1|STARTED|Period 3||12
8204974|NCT02173535|20233358|P20|NOT COMPLETED|Period 2||0
8204975|NCT02173535|20233359|P19|NOT COMPLETED|Period 2||0
8204976|NCT02173535|20233360|P18|NOT COMPLETED|Period 2||0
8204977|NCT02173535|20233361|P17|NOT COMPLETED|Period 2||0
8204978|NCT02173535|20233362|P16|NOT COMPLETED|Period 2||0
8204979|NCT02173535|20233363|P15|NOT COMPLETED|Period 2||0
8204980|NCT02173535|20233364|P14|NOT COMPLETED|Period 2||0
8204981|NCT02173535|20233365|P13|NOT COMPLETED|Period 2||0
8204982|NCT02173535|20233366|P12|NOT COMPLETED|Period 2||0
8204983|NCT02173535|20233367|P11|NOT COMPLETED|Period 2||0
8204984|NCT02173535|20233368|P10|NOT COMPLETED|Period 2||0
8204985|NCT02173535|20233369|P9|NOT COMPLETED|Period 2||0
8204986|NCT02173535|20233370|P8|NOT COMPLETED|Period 2||0
8204987|NCT02173535|20233371|P7|NOT COMPLETED|Period 2||0
8204988|NCT02173535|20233372|P6|NOT COMPLETED|Period 2||0
8204989|NCT02173535|20233373|P5|NOT COMPLETED|Period 2||0
8204990|NCT02173535|20233374|P4|NOT COMPLETED|Period 2||0
8204991|NCT02173535|20233375|P3|NOT COMPLETED|Period 2||0
8204992|NCT02173535|20233376|P2|NOT COMPLETED|Period 2||0
8204993|NCT02173535|20233377|P1|NOT COMPLETED|Period 2||0
8204994|NCT02173535|20233358|P20|COMPLETED|Period 2||12
8204995|NCT02173535|20233359|P19|COMPLETED|Period 2||12
8204996|NCT02173535|20233360|P18|COMPLETED|Period 2||12
8204997|NCT02173535|20233361|P17|COMPLETED|Period 2||12
8204998|NCT02173535|20233362|P16|COMPLETED|Period 2||12
8204999|NCT02173535|20233363|P15|COMPLETED|Period 2||12
8205000|NCT02173535|20233364|P14|COMPLETED|Period 2||12
8205001|NCT02173535|20233365|P13|COMPLETED|Period 2||12
8205002|NCT02173535|20233366|P12|COMPLETED|Period 2||12
8205003|NCT02173535|20233367|P11|COMPLETED|Period 2||12
8205004|NCT02173535|20233368|P10|COMPLETED|Period 2||12
8205005|NCT02173535|20233369|P9|COMPLETED|Period 2||12
8205006|NCT02173535|20233370|P8|COMPLETED|Period 2||12
8205007|NCT02173535|20233371|P7|COMPLETED|Period 2||12
8205008|NCT02173535|20233372|P6|COMPLETED|Period 2||12
8205009|NCT02173535|20233373|P5|COMPLETED|Period 2||12
8205010|NCT02173535|20233374|P4|COMPLETED|Period 2||12
8205011|NCT02173535|20233375|P3|COMPLETED|Period 2||12
8205012|NCT02173535|20233376|P2|COMPLETED|Period 2||12
8205013|NCT02173535|20233377|P1|COMPLETED|Period 2||12
8205014|NCT02173535|20233358|P20|STARTED|Period 2||12
8205015|NCT02173535|20233359|P19|STARTED|Period 2||12
8205016|NCT02173535|20233360|P18|STARTED|Period 2||12
8205017|NCT02173535|20233361|P17|STARTED|Period 2||12
8205018|NCT02173535|20233362|P16|STARTED|Period 2||12
8205019|NCT02173535|20233363|P15|STARTED|Period 2||12
8205020|NCT02173535|20233364|P14|STARTED|Period 2||12
8205021|NCT02173535|20233365|P13|STARTED|Period 2||12
8205022|NCT02173535|20233366|P12|STARTED|Period 2||12
8205023|NCT02173535|20233367|P11|STARTED|Period 2||12
8205024|NCT02173535|20233368|P10|STARTED|Period 2||12
8205025|NCT02173535|20233369|P9|STARTED|Period 2||12
8205026|NCT02173535|20233370|P8|STARTED|Period 2||12
8205027|NCT02173535|20233371|P7|STARTED|Period 2||12
8205028|NCT02173535|20233372|P6|STARTED|Period 2||12
8205029|NCT02173535|20233373|P5|STARTED|Period 2||12
8205030|NCT02173535|20233374|P4|STARTED|Period 2||12
8205031|NCT02173535|20233375|P3|STARTED|Period 2||12
8205032|NCT02173535|20233376|P2|STARTED|Period 2||12
8205033|NCT02173535|20233377|P1|STARTED|Period 2||12
8205034|NCT02173535|20233358|P20|NOT COMPLETED|Period 1||0
8205035|NCT02173535|20233359|P19|NOT COMPLETED|Period 1||0
8205036|NCT02173535|20233360|P18|NOT COMPLETED|Period 1||0
8205037|NCT02173535|20233361|P17|NOT COMPLETED|Period 1||0
8205038|NCT02173535|20233362|P16|NOT COMPLETED|Period 1||0
8205039|NCT02173535|20233363|P15|NOT COMPLETED|Period 1||0
8205040|NCT02173535|20233364|P14|NOT COMPLETED|Period 1||0
8205041|NCT02173535|20233365|P13|NOT COMPLETED|Period 1||0
8205042|NCT02173535|20233366|P12|NOT COMPLETED|Period 1||0
8205043|NCT02173535|20233367|P11|NOT COMPLETED|Period 1||0
8205044|NCT02173535|20233368|P10|NOT COMPLETED|Period 1||0
8205045|NCT02173535|20233369|P9|NOT COMPLETED|Period 1||0
8205046|NCT02173535|20233370|P8|NOT COMPLETED|Period 1||0
8205047|NCT02173535|20233371|P7|NOT COMPLETED|Period 1||0
8205048|NCT02173535|20233372|P6|NOT COMPLETED|Period 1||0
8205049|NCT02173535|20233373|P5|NOT COMPLETED|Period 1||0
8205050|NCT02173535|20233374|P4|NOT COMPLETED|Period 1||0
8205051|NCT02173535|20233375|P3|NOT COMPLETED|Period 1||0
8205052|NCT02173535|20233376|P2|NOT COMPLETED|Period 1||0
8205053|NCT02173535|20233377|P1|NOT COMPLETED|Period 1||0
8205054|NCT02173535|20233358|P20|COMPLETED|Period 1||12
8205055|NCT02173535|20233359|P19|COMPLETED|Period 1||12
8205056|NCT02173535|20233360|P18|COMPLETED|Period 1||12
8205057|NCT02173535|20233361|P17|COMPLETED|Period 1||12
8205058|NCT02173535|20233362|P16|COMPLETED|Period 1||12
8205059|NCT02173535|20233363|P15|COMPLETED|Period 1||12
8205060|NCT02173535|20233364|P14|COMPLETED|Period 1||12
8205061|NCT02173535|20233365|P13|COMPLETED|Period 1||12
8205062|NCT02173535|20233366|P12|COMPLETED|Period 1||12
8205063|NCT02173535|20233367|P11|COMPLETED|Period 1||12
8205064|NCT02173535|20233368|P10|COMPLETED|Period 1||12
8205065|NCT02173535|20233369|P9|COMPLETED|Period 1||12
8205066|NCT02173535|20233370|P8|COMPLETED|Period 1||12
8205067|NCT02173535|20233371|P7|COMPLETED|Period 1||12
8205068|NCT02173535|20233372|P6|COMPLETED|Period 1||12
8205069|NCT02173535|20233373|P5|COMPLETED|Period 1||12
8205070|NCT02173535|20233374|P4|COMPLETED|Period 1||12
8205071|NCT02173535|20233375|P3|COMPLETED|Period 1||12
8205072|NCT02173535|20233376|P2|COMPLETED|Period 1||12
8205073|NCT02173535|20233377|P1|COMPLETED|Period 1||12
8205074|NCT02173535|20233358|P20|STARTED|Period 1||12
8205075|NCT02173535|20233359|P19|STARTED|Period 1||12
8205076|NCT02173535|20233360|P18|STARTED|Period 1||12
8205077|NCT02173535|20233361|P17|STARTED|Period 1||12
8205078|NCT02173535|20233362|P16|STARTED|Period 1||12
8205079|NCT02173535|20233363|P15|STARTED|Period 1||12
8205080|NCT02173535|20233364|P14|STARTED|Period 1||12
8205081|NCT02173535|20233365|P13|STARTED|Period 1||12
8205082|NCT02173535|20233366|P12|STARTED|Period 1||12
8205083|NCT02173535|20233367|P11|STARTED|Period 1||12
8205084|NCT02173535|20233368|P10|STARTED|Period 1||12
8205085|NCT02173535|20233369|P9|STARTED|Period 1||12
8205086|NCT02173535|20233370|P8|STARTED|Period 1||12
8205087|NCT02173535|20233371|P7|STARTED|Period 1||12
8205088|NCT02173535|20233372|P6|STARTED|Period 1||12
8205089|NCT02173535|20233373|P5|STARTED|Period 1||12
8205090|NCT02173535|20233374|P4|STARTED|Period 1||12
8205091|NCT02173535|20233375|P3|STARTED|Period 1||12
8205092|NCT02173535|20233376|P2|STARTED|Period 1||12
8205093|NCT02173535|20233377|P1|STARTED|Period 1||12
8205094|NCT02173522|20233416|P2|NOT COMPLETED|Overall Study||0
8205095|NCT02173522|20233417|P1|NOT COMPLETED|Overall Study||0
8205096|NCT02173522|20233416|P2|COMPLETED|Overall Study||0
8205097|NCT02173522|20233417|P1|COMPLETED|Overall Study||4
8205098|NCT02173522|20233416|P2|STARTED|Overall Study||0
8205099|NCT02173522|20233417|P1|STARTED|Overall Study||4
8205100|NCT02173392|20233437|P2|NOT COMPLETED|Overall Study||4
8205101|NCT02173392|20233438|P1|NOT COMPLETED|Overall Study||14
8205102|NCT02173392|20233437|P2|COMPLETED|Overall Study||68
8205103|NCT02173392|20233438|P1|COMPLETED|Overall Study||59
8205104|NCT02173392|20233437|P2|STARTED|Overall Study||72
8205105|NCT02173392|20233438|P1|STARTED|Overall Study||73
8205106|NCT02173379|20233450|P2|NOT COMPLETED|Overall Study||77
8205107|NCT02173379|20233451|P1|NOT COMPLETED|Overall Study||91
8205108|NCT02173379|20233450|P2|COMPLETED|Overall Study||1231
8205109|NCT02173379|20233451|P1|COMPLETED|Overall Study||1205
8205110|NCT02173379|20233450|P2|STARTED|Overall Study||1308
8205111|NCT02173379|20233451|P1|STARTED|Overall Study||1296
8205112|NCT02173158|20233695|P1|NOT COMPLETED|Safety Phase||0
8205113|NCT02173158|20233695|P1|COMPLETED|Safety Phase||8
8205114|NCT02173158|20233695|P1|STARTED|Safety Phase||8
8205115|NCT02173158|20233695|P1|NOT COMPLETED|Efficacy Phase||1
8205116|NCT02173158|20233695|P1|COMPLETED|Efficacy Phase||8
8205117|NCT02173158|20233695|P1|STARTED|Efficacy Phase||9
8205118|NCT02173054|20233712|P3|NOT COMPLETED|Overall Study||1
8205119|NCT02173054|20233713|P2|NOT COMPLETED|Overall Study||0
8205120|NCT02173054|20233714|P1|NOT COMPLETED|Overall Study||1
8205121|NCT02173054|20233712|P3|COMPLETED|Overall Study||39
8205122|NCT02173054|20233713|P2|COMPLETED|Overall Study||40
8205123|NCT02173054|20233714|P1|COMPLETED|Overall Study||39
8205124|NCT02173054|20233712|P3|STARTED|Overall Study||40
8205125|NCT02173054|20233713|P2|STARTED|Overall Study||40
8205126|NCT02173054|20233714|P1|STARTED|Overall Study||40
8205127|NCT02172820|20233736|P2|NOT COMPLETED|Overall Study||0
8205128|NCT02172820|20233737|P1|NOT COMPLETED|Overall Study||0
8205129|NCT02172820|20233736|P2|COMPLETED|Overall Study||65
8205130|NCT02172820|20233737|P1|COMPLETED|Overall Study||65
8205131|NCT02172820|20233736|P2|STARTED|Overall Study||65
8205132|NCT02172820|20233737|P1|STARTED|Overall Study||65
8205133|NCT02172755|20233749|P2|NOT COMPLETED|Overall Study||4
8205134|NCT02172755|20233750|P1|NOT COMPLETED|Overall Study||2
8205135|NCT02172755|20233749|P2|COMPLETED|Overall Study||12
8205136|NCT02172755|20233750|P1|COMPLETED|Overall Study||12
8205137|NCT02172755|20233749|P2|STARTED|Overall Study||16
8205138|NCT02172755|20233750|P1|STARTED|Overall Study||14
8205139|NCT02172742|20233762|P2|NOT COMPLETED|Overall Study||0
8205140|NCT02172742|20233763|P1|NOT COMPLETED|Overall Study||1
8205141|NCT02172742|20233762|P2|COMPLETED|Overall Study||6
8205142|NCT02172742|20233763|P1|COMPLETED|Overall Study||6
8205143|NCT02172742|20233762|P2|STARTED|Overall Study||6
8205144|NCT02172742|20233763|P1|STARTED|Overall Study||7
8205145|NCT02172664|20233770|P2|NOT COMPLETED|Overall Study||6
8205146|NCT02172664|20233771|P1|NOT COMPLETED|Overall Study||6
8205147|NCT02172664|20233770|P2|COMPLETED|Overall Study||27
8205148|NCT02172664|20233771|P1|COMPLETED|Overall Study||27
8205149|NCT02172664|20233770|P2|STARTED|Overall Study||33
8205150|NCT02172664|20233771|P1|STARTED|Overall Study||33
8205151|NCT02172625|20233780|P2|NOT COMPLETED|Overall Study||3
8205152|NCT02172625|20233781|P1|NOT COMPLETED|Overall Study||0
8205153|NCT02172625|20233780|P2|COMPLETED|Overall Study||16
8205154|NCT02172625|20233781|P1|COMPLETED|Overall Study||19
8205155|NCT02172625|20233780|P2|STARTED|Overall Study||19
8205156|NCT02172625|20233781|P1|STARTED|Overall Study||19
8205157|NCT02172040|20233803|P4|NOT COMPLETED|Overall Study||1
8205158|NCT02172040|20233804|P3|NOT COMPLETED|Overall Study||2
8205159|NCT02172040|20233805|P2|NOT COMPLETED|Overall Study||3
8205160|NCT02172040|20233806|P1|NOT COMPLETED|Overall Study||0
8205161|NCT02172040|20233803|P4|COMPLETED|Overall Study||26
8205162|NCT02172040|20233804|P3|COMPLETED|Overall Study||29
8205163|NCT02172040|20233805|P2|COMPLETED|Overall Study||42
8205164|NCT02172040|20233806|P1|COMPLETED|Overall Study||49
8205165|NCT02172040|20233803|P4|STARTED|Overall Study||27
8205166|NCT02172040|20233804|P3|STARTED|Overall Study||31
8205167|NCT02172040|20233805|P2|STARTED|Overall Study||45
8205168|NCT02172040|20233806|P1|STARTED|Overall Study||49
8205169|NCT02171819|20233855|P3|NOT COMPLETED|Overall Study||0
8205170|NCT02171819|20233856|P2|NOT COMPLETED|Overall Study||0
8205171|NCT02171819|20233857|P1|NOT COMPLETED|Overall Study||0
8205172|NCT02171819|20233855|P3|COMPLETED|Overall Study||12
8205173|NCT02171819|20233856|P2|COMPLETED|Overall Study||32
8205174|NCT02171819|20233857|P1|COMPLETED|Overall Study||31
8205175|NCT02171819|20233855|P3|STARTED|Overall Study||12
8205176|NCT02171819|20233856|P2|STARTED|Overall Study||32
8205177|NCT02171819|20233857|P1|STARTED|Overall Study||31
8205178|NCT02171611|20233892|P6|NOT COMPLETED|Overall Study||0
8205179|NCT02171611|20233893|P5|NOT COMPLETED|Overall Study||0
8205180|NCT02171611|20233894|P4|NOT COMPLETED|Overall Study||0
8205181|NCT02171611|20233895|P3|NOT COMPLETED|Overall Study||0
8205182|NCT02171611|20233896|P2|NOT COMPLETED|Overall Study||0
8205183|NCT02171611|20233897|P1|NOT COMPLETED|Overall Study||0
8205184|NCT02171611|20233892|P6|COMPLETED|Overall Study||5
8205185|NCT02171611|20233893|P5|COMPLETED|Overall Study||5
8205186|NCT02171611|20233894|P4|COMPLETED|Overall Study||5
8205187|NCT02171611|20233895|P3|COMPLETED|Overall Study||5
8205188|NCT02171611|20233896|P2|COMPLETED|Overall Study||5
8205189|NCT02171611|20233897|P1|COMPLETED|Overall Study||5
8205190|NCT02171611|20233892|P6|STARTED|Overall Study||5
8205191|NCT02171611|20233893|P5|STARTED|Overall Study||5
8205192|NCT02171611|20233894|P4|STARTED|Overall Study||5
8205193|NCT02171611|20233895|P3|STARTED|Overall Study||5
8205194|NCT02171611|20233896|P2|STARTED|Overall Study||5
8205195|NCT02171611|20233897|P1|STARTED|Overall Study||5
8205196|NCT02171260|20233969|P4|NOT COMPLETED|Overall Study||5
8205197|NCT02171260|20233970|P3|NOT COMPLETED|Overall Study||5
8205198|NCT02171260|20233971|P2|NOT COMPLETED|Overall Study||6
8205199|NCT02171260|20233972|P1|NOT COMPLETED|Overall Study||6
8205200|NCT02171260|20233969|P4|COMPLETED|Overall Study||0
8205201|NCT02171260|20233970|P3|COMPLETED|Overall Study||0
8205202|NCT02171260|20233971|P2|COMPLETED|Overall Study||0
8205203|NCT02171260|20233972|P1|COMPLETED|Overall Study||0
8205204|NCT02171260|20233969|P4|STARTED|Overall Study||5
8205205|NCT02171260|20233970|P3|STARTED|Overall Study||5
8205206|NCT02171260|20233971|P2|STARTED|Overall Study||6
8205207|NCT02171260|20233972|P1|STARTED|Overall Study||6
8205208|NCT02171247|20234029|P2|NOT COMPLETED|Overall Study||0
8205209|NCT02171247|20234030|P1|NOT COMPLETED|Overall Study||0
8205210|NCT02171247|20234029|P2|COMPLETED|Overall Study||17
8205211|NCT02171247|20234030|P1|COMPLETED|Overall Study||16
8205212|NCT02171247|20234029|P2|STARTED|Overall Study||17
8205213|NCT02171247|20234030|P1|STARTED|Overall Study||16
8205214|NCT02171234|20234047|P5|NOT COMPLETED|Overall Study||0
8205215|NCT02171234|20234048|P4|NOT COMPLETED|Overall Study||0
8205216|NCT02171234|20234049|P3|NOT COMPLETED|Overall Study||0
8205217|NCT02171234|20234050|P2|NOT COMPLETED|Overall Study||0
8205218|NCT02171234|20234051|P1|NOT COMPLETED|Overall Study||0
8205219|NCT02171234|20234047|P5|COMPLETED|Overall Study||6
8205220|NCT02171234|20234048|P4|COMPLETED|Overall Study||6
8205221|NCT02171234|20234049|P3|COMPLETED|Overall Study||6
8205222|NCT02171234|20234050|P2|COMPLETED|Overall Study||6
8205223|NCT02171234|20234051|P1|COMPLETED|Overall Study||8
8205224|NCT02171234|20234047|P5|STARTED|Overall Study||6
8205225|NCT02171234|20234048|P4|STARTED|Overall Study||6
8205226|NCT02171234|20234049|P3|STARTED|Overall Study||6
8205227|NCT02171234|20234050|P2|STARTED|Overall Study||6
8205228|NCT02171234|20234051|P1|STARTED|Overall Study||8
8205229|NCT02171195|20234080|P9|NOT COMPLETED|Overall Study||0
8205230|NCT02171195|20234081|P8|NOT COMPLETED|Overall Study||0
8205231|NCT02171195|20234082|P7|NOT COMPLETED|Overall Study||0
8205232|NCT02171195|20234083|P6|NOT COMPLETED|Overall Study||0
8205233|NCT02171195|20234084|P5|NOT COMPLETED|Overall Study||0
8205234|NCT02171195|20234085|P4|NOT COMPLETED|Overall Study||0
8205235|NCT02171195|20234086|P3|NOT COMPLETED|Overall Study||0
8205236|NCT02171195|20234087|P2|NOT COMPLETED|Overall Study||0
8205237|NCT02171195|20234088|P1|NOT COMPLETED|Overall Study||0
8205238|NCT02171195|20234080|P9|COMPLETED|Overall Study||6
8205239|NCT02171195|20234081|P8|COMPLETED|Overall Study||6
8205240|NCT02171195|20234082|P7|COMPLETED|Overall Study||6
8205241|NCT02171195|20234083|P6|COMPLETED|Overall Study||6
8205242|NCT02171195|20234084|P5|COMPLETED|Overall Study||6
8205243|NCT02171195|20234085|P4|COMPLETED|Overall Study||6
8205244|NCT02171195|20234086|P3|COMPLETED|Overall Study||6
8205245|NCT02171195|20234087|P2|COMPLETED|Overall Study||6
8205246|NCT02171195|20234088|P1|COMPLETED|Overall Study||16
8205247|NCT02171195|20234080|P9|STARTED|Overall Study||6
8205248|NCT02171195|20234081|P8|STARTED|Overall Study||6
8205249|NCT02171195|20234082|P7|STARTED|Overall Study||6
8205250|NCT02171195|20234083|P6|STARTED|Overall Study||6
8205251|NCT02171195|20234084|P5|STARTED|Overall Study||6
8205252|NCT02171195|20234085|P4|STARTED|Overall Study||6
8205253|NCT02171195|20234086|P3|STARTED|Overall Study||6
8205254|NCT02171195|20234087|P2|STARTED|Overall Study||6
8205255|NCT02171195|20234088|P1|STARTED|Overall Study||16
8205256|NCT02171130|20234108|P1|NOT COMPLETED|Overall Study||28
8205257|NCT02171130|20234108|P1|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
8205258|NCT02171130|20234108|P1|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
8205259|NCT02171130|20234108|P1|Received at Least One Dose of Study Drug|Overall Study||87
8205260|NCT02171130|20234108|P1|STARTED|Overall Study||129
8205261|NCT02170870|20234122|P6|NOT COMPLETED|Overall Study||0
8205262|NCT02170870|20234123|P5|NOT COMPLETED|Overall Study||0
8205263|NCT02170870|20234124|P4|NOT COMPLETED|Overall Study||0
8205264|NCT02170870|20234125|P3|NOT COMPLETED|Overall Study||0
8205265|NCT02170870|20234126|P2|NOT COMPLETED|Overall Study||0
8205266|NCT02170870|20234127|P1|NOT COMPLETED|Overall Study||0
8205267|NCT02170870|20234122|P6|COMPLETED|Overall Study||20
8205268|NCT02170870|20234123|P5|COMPLETED|Overall Study||20
8205269|NCT02170870|20234124|P4|COMPLETED|Overall Study||20
8205270|NCT02170870|20234125|P3|COMPLETED|Overall Study||20
8205271|NCT02170870|20234126|P2|COMPLETED|Overall Study||11
8205272|NCT02170870|20234127|P1|COMPLETED|Overall Study||13
8205273|NCT02170870|20234122|P6|STARTED|Overall Study||20
8205274|NCT02170870|20234123|P5|STARTED|Overall Study||20
8205275|NCT02170870|20234124|P4|STARTED|Overall Study||20
8205276|NCT02170870|20234125|P3|STARTED|Overall Study||20
8205277|NCT02170870|20234126|P2|STARTED|Overall Study||11
8205278|NCT02170870|20234127|P1|STARTED|Overall Study||13
8205279|NCT02170779|20234149|P2|NOT COMPLETED|Overall Study||1
8205280|NCT02170779|20234150|P1|NOT COMPLETED|Overall Study||1
8205281|NCT02170779|20234149|P2|COMPLETED|Overall Study||19
8205282|NCT02170779|20234150|P1|COMPLETED|Overall Study||19
8205283|NCT02170779|20234149|P2|STARTED|Overall Study||20
8205284|NCT02170779|20234150|P1|STARTED|Overall Study||20
8205285|NCT02170727|20234174|P2|NOT COMPLETED|Overall Study||0
8205286|NCT02170727|20234175|P1|NOT COMPLETED|Overall Study||3
8205287|NCT02170727|20234174|P2|COMPLETED|Overall Study||31
8205288|NCT02170727|20234175|P1|COMPLETED|Overall Study||135
8205289|NCT02170727|20234174|P2|STARTED|Overall Study||31
8205290|NCT02170727|20234175|P1|STARTED|Overall Study||138
8205291|NCT02170688|20234206|P5|NOT COMPLETED|Overall Study||0
8205292|NCT02170688|20234207|P4|NOT COMPLETED|Overall Study||2
8205293|NCT02170688|20234208|P3|NOT COMPLETED|Overall Study||4
8205294|NCT02170688|20234209|P2|NOT COMPLETED|Overall Study||3
8205295|NCT02170688|20234210|P1|NOT COMPLETED|Overall Study||4
8205296|NCT02170688|20234206|P5|COMPLETED|Overall Study||25
8205297|NCT02170688|20234207|P4|COMPLETED|Overall Study||25
8205298|NCT02170688|20234208|P3|COMPLETED|Overall Study||25
8205299|NCT02170688|20234209|P2|COMPLETED|Overall Study||26
8205300|NCT02170688|20234210|P1|COMPLETED|Overall Study||25
8205301|NCT02170688|20234206|P5|STARTED|Overall Study||25
8205302|NCT02170688|20234207|P4|STARTED|Overall Study||27
8205303|NCT02170688|20234208|P3|STARTED|Overall Study||29
8205304|NCT02170688|20234209|P2|STARTED|Overall Study||29
8205305|NCT02170688|20234210|P1|STARTED|Overall Study||29
8205306|NCT02170662|20234229|P2|NOT COMPLETED|Overall Study||0
8205307|NCT02170662|20234230|P1|NOT COMPLETED|Overall Study||0
8205308|NCT02170662|20234229|P2|COMPLETED|Overall Study||6
8205309|NCT02170662|20234230|P1|COMPLETED|Overall Study||3
8205310|NCT02170662|20234229|P2|STARTED|Overall Study||6
8205311|NCT02170662|20234230|P1|STARTED|Overall Study||3
8205312|NCT02170649|20234242|P1|NOT COMPLETED|Fed Period||0
8205313|NCT02170649|20234242|P1|COMPLETED|Fed Period||12
8205314|NCT02170649|20234242|P1|STARTED|Fed Period||12
8205315|NCT02170649|20234242|P1|NOT COMPLETED|Fasting Period||0
8205316|NCT02170649|20234242|P1|COMPLETED|Fasting Period||12
8205317|NCT02170649|20234242|P1|STARTED|Fasting Period||12
8205318|NCT02170532|20234249|P1|NOT COMPLETED|Overall Study||0
8205319|NCT02170532|20234249|P1|COMPLETED|Overall Study||10
8205320|NCT02170532|20234249|P1|STARTED|Overall Study||10
8205321|NCT02170519|20234279|P2|NOT COMPLETED|Overall Study||0
8205322|NCT02170519|20234280|P1|NOT COMPLETED|Overall Study||0
8205323|NCT02170519|20234279|P2|COMPLETED|Overall Study||5
8205324|NCT02170519|20234280|P1|COMPLETED|Overall Study||22
8205325|NCT02170519|20234279|P2|STARTED|Overall Study||5
8205326|NCT02170519|20234280|P1|STARTED|Overall Study||22
8205327|NCT02170389|20234296|P1|NOT COMPLETED|Overall Study||1
8205328|NCT02170389|20234296|P1|COMPLETED|Overall Study||4
8205329|NCT02170389|20234296|P1|STARTED|Overall Study||5
8205330|NCT02170376|20234306|P5|NOT COMPLETED|Overall Study||0
8205331|NCT02170376|20234307|P4|NOT COMPLETED|Overall Study||0
8205332|NCT02170376|20234308|P3|NOT COMPLETED|Overall Study||0
8205333|NCT02170376|20234309|P2|NOT COMPLETED|Overall Study||1
8205334|NCT02170376|20234310|P1|NOT COMPLETED|Overall Study||0
8205335|NCT02170376|20234306|P5|COMPLETED|Overall Study||16
8205336|NCT02170376|20234307|P4|COMPLETED|Overall Study||16
8205337|NCT02170376|20234308|P3|COMPLETED|Overall Study||16
8205338|NCT02170376|20234309|P2|COMPLETED|Overall Study||15
8205339|NCT02170376|20234310|P1|COMPLETED|Overall Study||16
8205340|NCT02170376|20234306|P5|Pharmacokinetic Population|Overall Study||16
8205341|NCT02170376|20234307|P4|Pharmacokinetic Population|Overall Study||16
8205342|NCT02170376|20234308|P3|Pharmacokinetic Population|Overall Study||16
8205343|NCT02170376|20234309|P2|Pharmacokinetic Population|Overall Study||15
8205344|NCT02170376|20234310|P1|Pharmacokinetic Population|Overall Study||16
8205345|NCT02170376|20234306|P5|STARTED|Overall Study||16
8205346|NCT02170376|20234307|P4|STARTED|Overall Study||16
8205347|NCT02170376|20234308|P3|STARTED|Overall Study||16
8205348|NCT02170376|20234309|P2|STARTED|Overall Study||16
8205349|NCT02170376|20234310|P1|STARTED|Overall Study||16
8205350|NCT02170363|20234347|P1|NOT COMPLETED|Overall Study||0
8205351|NCT02170363|20234347|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
8205352|NCT02170363|20234347|P1|STARTED|Overall Study||50
8205353|NCT02170298|20234361|P2|NOT COMPLETED|Overall Study||1
8205354|NCT02170298|20234362|P1|NOT COMPLETED|Overall Study||1
8205355|NCT02170298|20234361|P2|COMPLETED|Overall Study||4
8205356|NCT02170298|20234362|P1|COMPLETED|Overall Study||0
8205357|NCT02170298|20234361|P2|STARTED|Overall Study||5
8205358|NCT02170298|20234362|P1|STARTED|Overall Study||1
8205359|NCT02170220|20234372|P2|NOT COMPLETED|Overall Study||0
8205360|NCT02170220|20234373|P1|NOT COMPLETED|Overall Study||0
8205361|NCT02170220|20234372|P2|COMPLETED|Overall Study||6
8205362|NCT02170220|20234373|P1|COMPLETED|Overall Study||6
8205363|NCT02170220|20234372|P2|STARTED|Overall Study||6
8205364|NCT02170220|20234373|P1|STARTED|Overall Study||6
8205365|NCT02170207|20234399|P1|NOT COMPLETED|Overall Study||5
8205366|NCT02170207|20234399|P1|COMPLETED|Overall Study||58
8205367|NCT02170207|20234399|P1|STARTED|Overall Study||63
8205368|NCT02170077|20234410|P3|NOT COMPLETED|Overall Study||12
8205369|NCT02170077|20234411|P2|NOT COMPLETED|Overall Study||13
8205370|NCT02170077|20234412|P1|NOT COMPLETED|Overall Study||9
8205371|NCT02170077|20234410|P3|COMPLETED|Overall Study||35
8205372|NCT02170077|20234411|P2|COMPLETED|Overall Study||34
8205373|NCT02170077|20234412|P1|COMPLETED|Overall Study||41
8205374|NCT02170077|20234410|P3|Intent to Treat (ITT) Population|Overall Study||47
8205375|NCT02170077|20234411|P2|Intent to Treat (ITT) Population|Overall Study||46
8205376|NCT02170077|20234412|P1|Intent to Treat (ITT) Population|Overall Study||50
8205377|NCT02170077|20234410|P3|STARTED|Overall Study||47
8205378|NCT02170077|20234411|P2|STARTED|Overall Study||47
8205379|NCT02170077|20234412|P1|STARTED|Overall Study||50
8205380|NCT02170064|20234423|P3|NOT COMPLETED|Overall Study||1
8205381|NCT02170064|20234424|P2|NOT COMPLETED|Overall Study||2
8205382|NCT02170064|20234425|P1|NOT COMPLETED|Overall Study||6
8205383|NCT02170064|20234423|P3|COMPLETED|Overall Study||10
8205384|NCT02170064|20234424|P2|COMPLETED|Overall Study||7
8205385|NCT02170064|20234425|P1|COMPLETED|Overall Study||9
8205386|NCT02170064|20234423|P3|Efficacy Population (EP)|Overall Study||10
8205387|NCT02170064|20234424|P2|Efficacy Population (EP)|Overall Study||8
8205388|NCT02170064|20234425|P1|Efficacy Population (EP)|Overall Study||11
8205389|NCT02170064|20234423|P3|Pharmacokinetic Population (PKP)|Overall Study||10
8205390|NCT02170064|20234424|P2|Pharmacokinetic Population (PKP)|Overall Study||8
8205391|NCT02170064|20234425|P1|Pharmacokinetic Population (PKP)|Overall Study||11
8205392|NCT02170064|20234423|P3|Safety Population (SP)|Overall Study||11
8205393|NCT02170064|20234424|P2|Safety Population (SP)|Overall Study||8
8205394|NCT02170064|20234425|P1|Safety Population (SP)|Overall Study||12
8205395|NCT02170064|20234423|P3|STARTED|Overall Study||11
8205396|NCT02170064|20234424|P2|STARTED|Overall Study||9
8205397|NCT02170064|20234425|P1|STARTED|Overall Study||15
8205398|NCT02170051|20234441|P2|NOT COMPLETED|Overall Study||13
8205399|NCT02170051|20234442|P1|NOT COMPLETED|Overall Study||11
8205400|NCT02170051|20234441|P2|COMPLETED|Overall Study||16
8205401|NCT02170051|20234442|P1|COMPLETED|Overall Study||15
8205402|NCT02170051|20234441|P2|Tested at Post-treatment|Overall Study||16
8205403|NCT02170051|20234442|P1|Tested at Post-treatment|Overall Study||15
8205404|NCT02170051|20234441|P2|Tested at Mid-point|Overall Study||18
8205405|NCT02170051|20234442|P1|Tested at Mid-point|Overall Study||13
8205406|NCT02170051|20234441|P2|STARTED|Overall Study||29
8205407|NCT02170051|20234442|P1|STARTED|Overall Study||26
8205408|NCT02170025|20234462|P2|NOT COMPLETED|Overall Study||0
8205409|NCT02170025|20234463|P1|NOT COMPLETED|Overall Study||2
8205410|NCT02170025|20234462|P2|COMPLETED|Overall Study||7
8205411|NCT02170025|20234463|P1|COMPLETED|Overall Study||12
8205412|NCT02170025|20234462|P2|STARTED|Overall Study||7
8205413|NCT02170025|20234463|P1|STARTED|Overall Study||14
8205414|NCT02169895|20234475|P4|NOT COMPLETED|Overall Study||2
8205415|NCT02169895|20234476|P3|NOT COMPLETED|Overall Study||0
8205416|NCT02169895|20234477|P2|NOT COMPLETED|Overall Study||0
8205417|NCT02169895|20234478|P1|NOT COMPLETED|Overall Study||0
8205418|NCT02169895|20234475|P4|COMPLETED|Overall Study||2
8205419|NCT02169895|20234476|P3|COMPLETED|Overall Study||4
8205420|NCT02169895|20234477|P2|COMPLETED|Overall Study||4
8205421|NCT02169895|20234478|P1|COMPLETED|Overall Study||4
8205422|NCT02169895|20234475|P4|Placebo|Overall Study||4
8205423|NCT02169895|20234476|P3|Placebo|Overall Study||4
8205424|NCT02169895|20234477|P2|Placebo|Overall Study||4
8205425|NCT02169895|20234478|P1|Placebo|Overall Study||4
8205426|NCT02169895|20234475|P4|100 mg BIA 9-1067|Overall Study||2
8205427|NCT02169895|20234476|P3|100 mg BIA 9-1067|Overall Study||4
8205428|NCT02169895|20234477|P2|100 mg BIA 9-1067|Overall Study||4
8205429|NCT02169895|20234478|P1|100 mg BIA 9-1067|Overall Study||4
8205430|NCT02169895|20234475|P4|50 mg BIA 9-1067|Overall Study||4
8205431|NCT02169895|20234476|P3|50 mg BIA 9-1067|Overall Study||4
8205432|NCT02169895|20234477|P2|50 mg BIA 9-1067|Overall Study||4
8205433|NCT02169895|20234478|P1|50 mg BIA 9-1067|Overall Study||4
8205434|NCT02169895|20234475|P4|25 mg BIA 9-1067|Overall Study||4
8205435|NCT02169895|20234476|P3|25 mg BIA 9-1067|Overall Study||4
8205436|NCT02169895|20234477|P2|25 mg BIA 9-1067|Overall Study||4
8205437|NCT02169895|20234478|P1|25 mg BIA 9-1067|Overall Study||4
8205438|NCT02169895|20234475|P4|STARTED|Overall Study||4
8205439|NCT02169895|20234476|P3|STARTED|Overall Study||4
8205440|NCT02169895|20234477|P2|STARTED|Overall Study||4
8205441|NCT02169895|20234478|P1|STARTED|Overall Study||4
8205442|NCT02169869|20234498|P2|NOT COMPLETED|Overall Study||0
8205443|NCT02169869|20234499|P1|NOT COMPLETED|Overall Study||0
8205444|NCT02169869|20234498|P2|COMPLETED|Overall Study||16
8205445|NCT02169869|20234499|P1|COMPLETED|Overall Study||17
8205446|NCT02169869|20234498|P2|STARTED|Overall Study||16
8205447|NCT02169869|20234499|P1|STARTED|Overall Study||17
8205448|NCT02169674|20234507|P2|NOT COMPLETED|Overall Study||78
8205449|NCT02169674|20234508|P1|NOT COMPLETED|Overall Study||32
8205450|NCT02169674|20234507|P2|COMPLETED|Overall Study||135
8205451|NCT02169674|20234508|P1|COMPLETED|Overall Study||105
8205452|NCT02169674|20234507|P2|STARTED|Overall Study||213
8205453|NCT02169674|20234508|P1|STARTED|Overall Study||137
8205454|NCT02169505|20234522|P1|NOT COMPLETED|Overall Study||1
8205455|NCT02169505|20234522|P1|COMPLETED|Overall Study||1
8205456|NCT02169505|20234522|P1|STARTED|Overall Study||2
8205457|NCT02169479|20234537|P4|NOT COMPLETED|Overall Study||0
8205458|NCT02169479|20234538|P3|NOT COMPLETED|Overall Study||0
8205459|NCT02169479|20234539|P2|NOT COMPLETED|Overall Study||1
8205460|NCT02169479|20234540|P1|NOT COMPLETED|Overall Study||1
8205461|NCT02169479|20234537|P4|COMPLETED|Overall Study||4
8205462|NCT02169479|20234538|P3|COMPLETED|Overall Study||4
8205463|NCT02169479|20234539|P2|COMPLETED|Overall Study||3
8205464|NCT02169479|20234540|P1|COMPLETED|Overall Study||3
8205465|NCT02169479|20234537|P4|Placebo|Overall Study||4
8205466|NCT02169479|20234538|P3|Placebo|Overall Study||4
8205467|NCT02169479|20234539|P2|Placebo|Overall Study||3
8205468|NCT02169479|20234540|P1|Placebo|Overall Study||3
8205469|NCT02169479|20234537|P4|100 mg BIA 9-1067|Overall Study||4
8205470|NCT02169479|20234538|P3|100 mg BIA 9-1067|Overall Study||4
8205471|NCT02169479|20234539|P2|100 mg BIA 9-1067|Overall Study||4
8205472|NCT02169479|20234540|P1|100 mg BIA 9-1067|Overall Study||3
8205473|NCT02169479|20234537|P4|50 mg BIA 9-1067|Overall Study||4
8205474|NCT02169479|20234538|P3|50 mg BIA 9-1067|Overall Study||4
8205475|NCT02169479|20234539|P2|50 mg BIA 9-1067|Overall Study||4
8205476|NCT02169479|20234540|P1|50 mg BIA 9-1067|Overall Study||4
8205477|NCT02169479|20234537|P4|25 mg BIA 9-1067|Overall Study||4
8205478|NCT02169479|20234538|P3|25 mg BIA 9-1067|Overall Study||4
8205479|NCT02169479|20234539|P2|25 mg BIA 9-1067|Overall Study||3
8205480|NCT02169479|20234540|P1|25 mg BIA 9-1067|Overall Study||4
8205481|NCT02169479|20234537|P4|STARTED|Overall Study||4
8205482|NCT02169479|20234538|P3|STARTED|Overall Study||4
8205483|NCT02169479|20234539|P2|STARTED|Overall Study||4
8205484|NCT02169479|20234540|P1|STARTED|Overall Study||4
8205485|NCT02169466|20234562|P4|NOT COMPLETED|Overall Study||0
8205486|NCT02169466|20234563|P3|NOT COMPLETED|Overall Study||0
8205487|NCT02169466|20234564|P2|NOT COMPLETED|Overall Study||1
8205488|NCT02169466|20234565|P1|NOT COMPLETED|Overall Study||1
8205489|NCT02169466|20234562|P4|COMPLETED|Overall Study||5
8205490|NCT02169466|20234563|P3|COMPLETED|Overall Study||5
8205491|NCT02169466|20234564|P2|COMPLETED|Overall Study||5
8205492|NCT02169466|20234565|P1|COMPLETED|Overall Study||5
8205493|NCT02169466|20234562|P4|Placebo|Overall Study||5
8205494|NCT02169466|20234563|P3|Placebo|Overall Study||5
8205495|NCT02169466|20234564|P2|Placebo|Overall Study||6
8205496|NCT02169466|20234565|P1|Placebo|Overall Study||5
8205497|NCT02169466|20234562|P4|100 mg BIA 9-1067|Overall Study||5
8205498|NCT02169466|20234563|P3|100 mg BIA 9-1067|Overall Study||5
8205499|NCT02169466|20234564|P2|100 mg BIA 9-1067|Overall Study||6
8205500|NCT02169466|20234565|P1|100 mg BIA 9-1067|Overall Study||6
8205501|NCT02169466|20234562|P4|50 mg BIA 9-1067|Overall Study||5
8205502|NCT02169466|20234563|P3|50 mg BIA 9-1067|Overall Study||5
8205503|NCT02169466|20234564|P2|50 mg BIA 9-1067|Overall Study||6
8205504|NCT02169466|20234565|P1|50 mg BIA 9-1067|Overall Study||6
8205505|NCT02169466|20234562|P4|25 mg BIA 9-1067|Overall Study||5
8205506|NCT02169466|20234563|P3|25 mg BIA 9-1067|Overall Study||5
8205507|NCT02169466|20234564|P2|25 mg BIA 9-1067|Overall Study||5
8205508|NCT02169466|20234565|P1|25 mg BIA 9-1067|Overall Study||6
8205509|NCT02169466|20234562|P4|STARTED|Overall Study||5
8205510|NCT02169466|20234563|P3|STARTED|Overall Study||5
8205511|NCT02169466|20234564|P2|STARTED|Overall Study||6
8205512|NCT02169466|20234565|P1|STARTED|Overall Study||6
8205513|NCT02169453|20234591|P4|NOT COMPLETED|Overall Study||0
8205514|NCT02169453|20234592|P3|NOT COMPLETED|Overall Study||1
8205515|NCT02169453|20234593|P2|NOT COMPLETED|Overall Study||0
8205516|NCT02169453|20234594|P1|NOT COMPLETED|Overall Study||0
8205517|NCT02169453|20234591|P4|COMPLETED|Overall Study||3
8205518|NCT02169453|20234592|P3|COMPLETED|Overall Study||2
8205519|NCT02169453|20234593|P2|COMPLETED|Overall Study||3
8205520|NCT02169453|20234594|P1|COMPLETED|Overall Study||3
8205521|NCT02169453|20234591|P4|Placebo|Overall Study||3
8205522|NCT02169453|20234592|P3|Placebo|Overall Study||3
8205523|NCT02169453|20234593|P2|Placebo|Overall Study||3
8205524|NCT02169453|20234594|P1|Placebo|Overall Study||3
8205525|NCT02169453|20234591|P4|100 mg BIA 9-1067|Overall Study||3
8205526|NCT02169453|20234592|P3|100 mg BIA 9-1067|Overall Study||3
8205527|NCT02169453|20234593|P2|100 mg BIA 9-1067|Overall Study||3
8205528|NCT02169453|20234594|P1|100 mg BIA 9-1067|Overall Study||3
8205529|NCT02169453|20234591|P4|50 mg BIA 9-1067|Overall Study||3
8205530|NCT02169453|20234592|P3|50 mg BIA 9-1067|Overall Study||2
8205531|NCT02169453|20234593|P2|50 mg BIA 9-1067|Overall Study||3
8205532|NCT02169453|20234594|P1|50 mg BIA 9-1067|Overall Study||3
8205533|NCT02169453|20234591|P4|25 mg BIA 9-1067|Overall Study||3
8205534|NCT02169453|20234592|P3|25 mg BIA 9-1067|Overall Study||3
8205535|NCT02169453|20234593|P2|25 mg BIA 9-1067|Overall Study||3
8205536|NCT02169453|20234594|P1|25 mg BIA 9-1067|Overall Study||3
8205537|NCT02169453|20234591|P4|STARTED|Overall Study||3
8205538|NCT02169453|20234592|P3|STARTED|Overall Study||3
8205539|NCT02169453|20234593|P2|STARTED|Overall Study||3
8205540|NCT02169453|20234594|P1|STARTED|Overall Study||3
8205541|NCT02169440|20234626|P2|NOT COMPLETED|Overall Study||0
8205542|NCT02169440|20234627|P1|NOT COMPLETED|Overall Study||0
8205543|NCT02169440|20234626|P2|COMPLETED|Overall Study||10
8205544|NCT02169440|20234627|P1|COMPLETED|Overall Study||10
8205545|NCT02169440|20234626|P2|STARTED|Overall Study||10
8205546|NCT02169440|20234627|P1|STARTED|Overall Study||10
8205547|NCT02169427|20234640|P1|NOT COMPLETED|Overall Study||0
8205548|NCT02169427|20234640|P1|COMPLETED|Overall Study||6
8205549|NCT02169427|20234640|P1|STARTED|Overall Study||6
8205550|NCT02169414|20234650|P4|NOT COMPLETED|Overall Study||0
8205551|NCT02169414|20234651|P3|NOT COMPLETED|Overall Study||0
8205552|NCT02169414|20234652|P2|NOT COMPLETED|Overall Study||1
8205553|NCT02169414|20234653|P1|NOT COMPLETED|Overall Study||1
8205554|NCT02169414|20234650|P4|COMPLETED|Overall Study||18
8205555|NCT02169414|20234651|P3|COMPLETED|Overall Study||18
8205556|NCT02169414|20234652|P2|COMPLETED|Overall Study||18
8205557|NCT02169414|20234653|P1|COMPLETED|Overall Study||18
8205558|NCT02169414|20234650|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205559|NCT02169414|20234651|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205560|NCT02169414|20234652|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205561|NCT02169414|20234653|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205562|NCT02169414|20234650|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8205563|NCT02169414|20234651|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8205564|NCT02169414|20234652|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
8205565|NCT02169414|20234653|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8205566|NCT02169414|20234650|P4|STARTED|Overall Study||18
8205567|NCT02169414|20234651|P3|STARTED|Overall Study||18
8205568|NCT02169414|20234652|P2|STARTED|Overall Study||19
8205569|NCT02169414|20234653|P1|STARTED|Overall Study||19
8205570|NCT02169336|20234694|P3|NOT COMPLETED|Overall Study||3
8205571|NCT02169336|20234695|P2|NOT COMPLETED|Overall Study||4
8205572|NCT02169336|20234696|P1|NOT COMPLETED|Overall Study||4
8205573|NCT02169336|20234694|P3|COMPLETED|Overall Study||29
8205574|NCT02169336|20234695|P2|COMPLETED|Overall Study||28
8205575|NCT02169336|20234696|P1|COMPLETED|Overall Study||27
8205576|NCT02169336|20234694|P3|STARTED|Overall Study||32
8205577|NCT02169336|20234695|P2|STARTED|Overall Study||32
8205578|NCT02169336|20234696|P1|STARTED|Overall Study||31
8205579|NCT02169284|20234706|P2|NOT COMPLETED|Overall Study||1
8205580|NCT02169284|20234707|P1|NOT COMPLETED|Overall Study||0
8205581|NCT02169284|20234706|P2|COMPLETED|Overall Study||12
8205582|NCT02169284|20234707|P1|COMPLETED|Overall Study||24
8205583|NCT02169284|20234706|P2|STARTED|Overall Study||13
8205584|NCT02169284|20234707|P1|STARTED|Overall Study||24
8205585|NCT02169271|20234733|P2|NOT COMPLETED|Overall Study||2
8205586|NCT02169271|20234734|P1|NOT COMPLETED|Overall Study||1
8205587|NCT02169271|20234733|P2|COMPLETED|Overall Study||47
8205588|NCT02169271|20234734|P1|COMPLETED|Overall Study||48
8205589|NCT02169271|20234733|P2|STARTED|Overall Study||49
8205590|NCT02169271|20234734|P1|STARTED|Overall Study||49
8205591|NCT02169219|20234756|P1|NOT COMPLETED|Overall Study||6
8205592|NCT02169219|20234756|P1|COMPLETED|Overall Study||14
8205593|NCT02169219|20234756|P1|STARTED|Overall Study||20
8205594|NCT02169115|20234770|P3|NOT COMPLETED|Overall Study||0
8205595|NCT02169115|20234771|P2|NOT COMPLETED|Overall Study||0
8205596|NCT02169115|20234772|P1|NOT COMPLETED|Overall Study||0
8205597|NCT02169115|20234770|P3|COMPLETED|Overall Study||21
8205598|NCT02169115|20234771|P2|COMPLETED|Overall Study||21
8205599|NCT02169115|20234772|P1|COMPLETED|Overall Study||19
8205600|NCT02169115|20234770|P3|STARTED|Overall Study||21
8205601|NCT02169115|20234771|P2|STARTED|Overall Study||21
8205602|NCT02169115|20234772|P1|STARTED|Overall Study||19
8205603|NCT02168946|20234800|P2|NOT COMPLETED|Overall Study||5
8205604|NCT02168946|20234801|P1|NOT COMPLETED|Overall Study||12
8205605|NCT02168946|20234800|P2|COMPLETED|Overall Study||20
8205606|NCT02168946|20234801|P1|COMPLETED|Overall Study||38
8205607|NCT02168946|20234800|P2|STARTED|Overall Study||25
8205608|NCT02168946|20234801|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
8205609|NCT02168933|20234837|P1|NOT COMPLETED|Overall Study||1
8205610|NCT02168933|20234837|P1|COMPLETED|Overall Study||7
8205611|NCT02168933|20234837|P1|STARTED|Overall Study||8
8205612|NCT02168855|20234847|P2|NOT COMPLETED|Overall Study||11
8205613|NCT02168855|20234848|P1|NOT COMPLETED|Overall Study||12
8205614|NCT02168855|20234847|P2|COMPLETED|Overall Study||177
8205615|NCT02168855|20234848|P1|COMPLETED|Overall Study||169
8205616|NCT02168855|20234847|P2|STARTED|Overall Study||188
8205617|NCT02168855|20234848|P1|STARTED|Overall Study||181
8205618|NCT02168842|20234860|P2|NOT COMPLETED|Overall Study||8
8205619|NCT02168842|20234861|P1|NOT COMPLETED|Overall Study||8
8205620|NCT02168842|20234860|P2|COMPLETED|Overall Study||158
8205621|NCT02168842|20234861|P1|COMPLETED|Overall Study||162
8205622|NCT02168842|20234860|P2|STARTED|Overall Study||166
8205623|NCT02168842|20234861|P1|STARTED|Overall Study||170
8205624|NCT02168816|20234919|P2|NOT COMPLETED|Overall Study||2
8205625|NCT02168816|20234920|P1|NOT COMPLETED|Overall Study||2
8205626|NCT02168816|20234919|P2|COMPLETED|Overall Study||5
8205627|NCT02168816|20234920|P1|COMPLETED|Overall Study||3
8205628|NCT02168816|20234919|P2|STARTED|Overall Study||7
8205629|NCT02168816|20234920|P1|STARTED|Overall Study||5
8205630|NCT02168803|20234931|P3|NOT COMPLETED|Overall Study||6
8205631|NCT02168803|20234932|P2|NOT COMPLETED|Overall Study||3
8205632|NCT02168803|20234933|P1|NOT COMPLETED|Overall Study||2
8205633|NCT02168803|20234931|P3|COMPLETED|Overall Study||33
8205634|NCT02168803|20234932|P2|COMPLETED|Overall Study||29
8205635|NCT02168803|20234933|P1|COMPLETED|Overall Study||28
8205636|NCT02168803|20234931|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
8205637|NCT02168803|20234932|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
8205638|NCT02168803|20234933|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
8205639|NCT02168803|20234931|P3|STARTED|Overall Study||39
8205640|NCT02168803|20234932|P2|STARTED|Overall Study||32
8205641|NCT02168803|20234933|P1|STARTED|Overall Study||30
8205642|NCT02168777|20234963|P3|NOT COMPLETED|Overall Study||11
8205643|NCT02168777|20234964|P2|NOT COMPLETED|Overall Study||7
8205644|NCT02168777|20234965|P1|NOT COMPLETED|Overall Study||2
8205645|NCT02168777|20234963|P3|COMPLETED|Overall Study||0
8205646|NCT02168777|20234964|P2|COMPLETED|Overall Study||0
8205647|NCT02168777|20234965|P1|COMPLETED|Overall Study||0
8205648|NCT02168777|20234963|P3|STARTED|Overall Study||11
8205649|NCT02168777|20234964|P2|STARTED|Overall Study||7
8205650|NCT02168777|20234965|P1|STARTED|Overall Study||2
8205651|NCT02168660|20235045|P3|NOT COMPLETED|Overall Study||15
8205652|NCT02168660|20235046|P2|NOT COMPLETED|Overall Study||17
8205653|NCT02168660|20235047|P1|NOT COMPLETED|Overall Study||16
8205654|NCT02168660|20235045|P3|COMPLETED|Overall Study||21
8205655|NCT02168660|20235046|P2|COMPLETED|Overall Study||18
8205656|NCT02168660|20235047|P1|COMPLETED|Overall Study||22
8205657|NCT02168660|20235045|P3|STARTED|Overall Study||36
8205658|NCT02168660|20235046|P2|STARTED|Overall Study||35
8205659|NCT02168660|20235047|P1|STARTED|Overall Study||38
8205660|NCT02168491|20235061|P1|NOT COMPLETED|Overall Study||1
8205661|NCT02168491|20235061|P1|COMPLETED|Overall Study||8
8205662|NCT02168491|20235061|P1|STARTED|Overall Study||9
8205663|NCT02168478|20235067|P1|NOT COMPLETED|Overall Study||4
8205664|NCT02168478|20235067|P1|COMPLETED|Overall Study||202
8205665|NCT02168478|20235067|P1|STARTED|Overall Study||206
8205666|NCT02168439|20235073|P2|NOT COMPLETED|Overall Study||2
8205667|NCT02168439|20235074|P1|NOT COMPLETED|Overall Study||0
8205668|NCT02168439|20235073|P2|COMPLETED|Overall Study||18
8205669|NCT02168439|20235074|P1|COMPLETED|Overall Study||20
8205670|NCT02168439|20235073|P2|STARTED|Overall Study||20
8205671|NCT02168439|20235074|P1|STARTED|Overall Study||20
8205672|NCT02168387|20235092|P2|NOT COMPLETED|Overall Study||3
8205673|NCT02168387|20235093|P1|NOT COMPLETED|Overall Study||7
8205674|NCT02168387|20235092|P2|COMPLETED|Overall Study||16
8205675|NCT02168387|20235093|P1|COMPLETED|Overall Study||13
8205676|NCT02168387|20235092|P2|STARTED|Overall Study||19
8205677|NCT02168387|20235093|P1|STARTED|Overall Study||20
8205678|NCT02168361|20235105|P2|NOT COMPLETED|Overall Study||10
8205679|NCT02168361|20235106|P1|NOT COMPLETED|Overall Study||5
8205680|NCT02168361|20235105|P2|COMPLETED|Overall Study||21
8205681|NCT02168361|20235106|P1|COMPLETED|Overall Study||57
8205682|NCT02168361|20235105|P2|STARTED|Overall Study||31
8205683|NCT02168361|20235106|P1|STARTED|Overall Study||62
8205684|NCT02168309|20235116|P2|NOT COMPLETED|Overall Study||0
8205685|NCT02168309|20235117|P1|NOT COMPLETED|Overall Study||0
8205686|NCT02168309|20235116|P2|COMPLETED|Overall Study||25
8205687|NCT02168309|20235117|P1|COMPLETED|Overall Study||25
8205688|NCT02168309|20235116|P2|STARTED|Overall Study||25
8205689|NCT02168309|20235117|P1|STARTED|Overall Study||25
8205690|NCT02168270|20235125|P1|NOT COMPLETED|Overall Study||4
8205691|NCT02168270|20235125|P1|COMPLETED|Overall Study||0
8205692|NCT02168270|20235125|P1|STARTED|Overall Study||4
8205693|NCT02168153|20235134|P2|NOT COMPLETED|Overall Study||0
8205694|NCT02168153|20235135|P1|NOT COMPLETED|Overall Study||3
8205695|NCT02168153|20235134|P2|COMPLETED|Overall Study||60
8205696|NCT02168153|20235135|P1|COMPLETED|Overall Study||57
8205697|NCT02168153|20235134|P2|STARTED|Overall Study||60
8205698|NCT02168153|20235135|P1|STARTED|Overall Study||60
8205699|NCT02168101|20235152|P3|NOT COMPLETED|Overall Study||1
8205700|NCT02168101|20235153|P2|NOT COMPLETED|Overall Study||2
8205701|NCT02168101|20235154|P1|NOT COMPLETED|Overall Study||2
8205702|NCT02168101|20235152|P3|COMPLETED|Overall Study||2
8205703|NCT02168101|20235153|P2|COMPLETED|Overall Study||1
8205704|NCT02168101|20235154|P1|COMPLETED|Overall Study||1
8205705|NCT02168101|20235152|P3|STARTED|Overall Study||3
8205706|NCT02168101|20235153|P2|STARTED|Overall Study||3
8205707|NCT02168101|20235154|P1|STARTED|Overall Study||3
8205708|NCT02168062|20235176|P3|NOT COMPLETED|Overall Study||0
8205709|NCT02168062|20235177|P2|NOT COMPLETED|Overall Study||0
8205710|NCT02168062|20235178|P1|NOT COMPLETED|Overall Study||0
8205711|NCT02168062|20235176|P3|COMPLETED|Overall Study||8
8205712|NCT02168062|20235177|P2|COMPLETED|Overall Study||26
8205713|NCT02168062|20235178|P1|COMPLETED|Overall Study||23
8205714|NCT02168062|20235176|P3|STARTED|Overall Study||8
8205715|NCT02168062|20235177|P2|STARTED|Overall Study||26
8205716|NCT02168062|20235178|P1|STARTED|Overall Study||23
8205717|NCT02167893|20235224|P1|NOT COMPLETED|Overall Study||163
8205718|NCT02167893|20235224|P1|COMPLETED|Overall Study||11125
8205719|NCT02167893|20235224|P1|STARTED|Overall Study||11288
8205720|NCT02167867|20235235|P2|NOT COMPLETED|Overall Study||0
8205721|NCT02167867|20235236|P1|NOT COMPLETED|Overall Study||0
8205722|NCT02167867|20235235|P2|COMPLETED|Overall Study||22
8205723|NCT02167867|20235236|P1|COMPLETED|Overall Study||22
8205724|NCT02167867|20235235|P2|STARTED|Overall Study||22
8205725|NCT02167867|20235236|P1|STARTED|Overall Study||22
8205726|NCT02167815|20235244|P2|NOT COMPLETED|Overall Study||0
8205727|NCT02167815|20235245|P1|NOT COMPLETED|Overall Study||0
8205728|NCT02167815|20235244|P2|COMPLETED|Overall Study||21
8205729|NCT02167815|20235245|P1|COMPLETED|Overall Study||9
8205730|NCT02167815|20235244|P2|STARTED|Overall Study||21
8205731|NCT02167815|20235245|P1|STARTED|Overall Study||9
8205732|NCT02167594|20235259|P3|NOT COMPLETED|Overall Study||0
8205733|NCT02167594|20235260|P2|NOT COMPLETED|Overall Study||1
8205734|NCT02167594|20235261|P1|NOT COMPLETED|Overall Study||2
8205735|NCT02167594|20235259|P3|COMPLETED|Overall Study||3
8205736|NCT02167594|20235260|P2|COMPLETED|Overall Study||5
8205737|NCT02167594|20235261|P1|COMPLETED|Overall Study||18
8205738|NCT02167594|20235259|P3|STARTED|Overall Study||3
8205739|NCT02167594|20235260|P2|STARTED|Overall Study||6
8205740|NCT02167594|20235261|P1|STARTED|Overall Study||20
8205741|NCT02167451|20235270|P1|NOT COMPLETED|Overall Study||1
8205742|NCT02167451|20235270|P1|COMPLETED|Overall Study||30
8205743|NCT02167451|20235270|P1|STARTED|Overall Study||31
8205744|NCT02167256|20235287|P2|NOT COMPLETED|Overall Study||10
8205745|NCT02167256|20235288|P1|NOT COMPLETED|Overall Study||21
8205746|NCT02167256|20235287|P2|COMPLETED|Overall Study||70
8205747|NCT02167256|20235288|P1|COMPLETED|Overall Study||58
8205748|NCT02167256|20235287|P2|STARTED|Overall Study||80
8205749|NCT02167256|20235288|P1|STARTED|Overall Study||79
8205750|NCT02167217|20235304|P1|NOT COMPLETED|Overall Study||2
8205751|NCT02167217|20235304|P1|COMPLETED|Overall Study||23
8205752|NCT02167217|20235304|P1|STARTED|Overall Study||25
8205753|NCT02167204|20235308|P1|NOT COMPLETED|Overall Study||0
8205754|NCT02167204|20235308|P1|COMPLETED|Overall Study||9
8205755|NCT02167204|20235308|P1|STARTED|Overall Study||9
8205756|NCT02167139|20235321|P4|NOT COMPLETED|Transition-extension||5
8205757|NCT02167139|20235322|P3|NOT COMPLETED|Transition-extension||8
8205758|NCT02167139|20235323|P2|NOT COMPLETED|Transition-extension||0
8205759|NCT02167139|20235324|P1|NOT COMPLETED|Transition-extension||6
8205760|NCT02167139|20235321|P4|COMPLETED|Transition-extension||124
8205761|NCT02167139|20235322|P3|COMPLETED|Transition-extension||117
8205762|NCT02167139|20235323|P2|COMPLETED|Transition-extension||0
8205763|NCT02167139|20235324|P1|COMPLETED|Transition-extension||248
8205764|NCT02167139|20235321|P4|STARTED|Transition-extension||129
8205765|NCT02167139|20235322|P3|STARTED|Transition-extension||125
8205766|NCT02167139|20235323|P2|STARTED|Transition-extension||0
8205767|NCT02167139|20235324|P1|STARTED|Transition-extension||254
8205768|NCT02167139|20235321|P4|NOT COMPLETED|Randomised, Double-blind||0
8205769|NCT02167139|20235322|P3|NOT COMPLETED|Randomised, Double-blind||0
8205770|NCT02167139|20235323|P2|NOT COMPLETED|Randomised, Double-blind||19
8205771|NCT02167139|20235324|P1|NOT COMPLETED|Randomised, Double-blind||17
8205772|NCT02167139|20235321|P4|COMPLETED|Randomised, Double-blind||0
8205773|NCT02167139|20235322|P3|COMPLETED|Randomised, Double-blind||0
8205774|NCT02167139|20235323|P2|COMPLETED|Randomised, Double-blind||254
8205775|NCT02167139|20235324|P1|COMPLETED|Randomised, Double-blind||254
8205776|NCT02167139|20235321|P4|STARTED|Randomised, Double-blind||0
8205777|NCT02167139|20235322|P3|STARTED|Randomised, Double-blind||0
8205778|NCT02167139|20235323|P2|STARTED|Randomised, Double-blind||273
8205779|NCT02167139|20235324|P1|STARTED|Randomised, Double-blind||271
8205780|NCT02167074|20235340|P2|NOT COMPLETED|Overall Study||0
8205781|NCT02167074|20235341|P1|NOT COMPLETED|Overall Study||0
8205782|NCT02167074|20235340|P2|COMPLETED|Overall Study||302
8205783|NCT02167074|20235341|P1|COMPLETED|Overall Study||306
8205784|NCT02167074|20235340|P2|STARTED|Overall Study||302
8205785|NCT02167074|20235341|P1|STARTED|Overall Study||306
8205786|NCT02167035|20235359|P2|NOT COMPLETED|Overall Study||6
8205787|NCT02167035|20235360|P1|NOT COMPLETED|Overall Study||5
8205788|NCT02167035|20235359|P2|COMPLETED|Overall Study||16
8205789|NCT02167035|20235360|P1|COMPLETED|Overall Study||16
8205790|NCT02167035|20235359|P2|STARTED|Overall Study||22
8205791|NCT02167035|20235360|P1|STARTED|Overall Study||21
8205792|NCT02166697|20235368|P1|NOT COMPLETED|Overall Study||347
8205793|NCT02166697|20235368|P1|COMPLETED|Overall Study||13804
8205794|NCT02166697|20235368|P1|STARTED|Overall Study||14151
8205795|NCT02166606|20235377|P1|NOT COMPLETED|Overall Study||78
8205796|NCT02166606|20235377|P1|COMPLETED|Overall Study||1106
8205797|NCT02166606|20235377|P1|Consent Eligible|Overall Study||1174
8205798|NCT02166606|20235377|P1|Actively Enrolled|Overall Study||1180
8205799|NCT02166606|20235377|P1|STARTED|Overall Study||1184
8205800|NCT02166476|20235384|P2|NOT COMPLETED|Overall Study||23
8205801|NCT02166476|20235385|P1|NOT COMPLETED|Overall Study||14
8205802|NCT02166476|20235384|P2|COMPLETED|Overall Study||250
8205803|NCT02166476|20235385|P1|COMPLETED|Overall Study||258
8205804|NCT02166476|20235384|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
8205805|NCT02166476|20235385|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
8205806|NCT02166476|20235384|P2|STARTED|Overall Study||273
8205807|NCT02166476|20235385|P1|STARTED|Overall Study||272
8205808|NCT02166346|20235418|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
8205809|NCT02166346|20235419|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
8205810|NCT02166346|20235418|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
8205811|NCT02166346|20235419|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
8205812|NCT02166346|20235418|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
8205813|NCT02166346|20235419|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
8205814|NCT02166346|20235418|P2|NOT COMPLETED|Intervention - Phase 1||2
8205815|NCT02166346|20235419|P1|NOT COMPLETED|Intervention - Phase 1||0
8205816|NCT02166346|20235418|P2|COMPLETED|Intervention - Phase 1||6
8205817|NCT02166346|20235419|P1|COMPLETED|Intervention - Phase 1||8
8205818|NCT02166346|20235418|P2|STARTED|Intervention - Phase 1||8
8205819|NCT02166346|20235419|P1|STARTED|Intervention - Phase 1||8
8205820|NCT02166346|20235418|P2|NOT COMPLETED|Screening and Randomization||4
8205821|NCT02166346|20235419|P1|NOT COMPLETED|Screening and Randomization||4
8205822|NCT02166346|20235418|P2|COMPLETED|Screening and Randomization||8
8205823|NCT02166346|20235419|P1|COMPLETED|Screening and Randomization||8
8205824|NCT02166346|20235418|P2|STARTED|Screening and Randomization||12
8205825|NCT02166346|20235419|P1|STARTED|Screening and Randomization||12
8205826|NCT02166047|20235439|P12|NOT COMPLETED|Overall Study||0
8205827|NCT02166047|20235440|P11|NOT COMPLETED|Overall Study||2
8205828|NCT02166047|20235441|P10|NOT COMPLETED|Overall Study||0
8205829|NCT02166047|20235442|P9|NOT COMPLETED|Overall Study||0
8205830|NCT02166047|20235443|P8|NOT COMPLETED|Overall Study||0
8205831|NCT02166047|20235444|P7|NOT COMPLETED|Overall Study||2
8205832|NCT02166047|20235445|P6|NOT COMPLETED|Overall Study||0
8205833|NCT02166047|20235446|P5|NOT COMPLETED|Overall Study||1
8205834|NCT02166047|20235447|P4|NOT COMPLETED|Overall Study||0
8205835|NCT02166047|20235448|P3|NOT COMPLETED|Overall Study||2
8205836|NCT02166047|20235449|P2|NOT COMPLETED|Overall Study||1
8205837|NCT02166047|20235450|P1|NOT COMPLETED|Overall Study||0
8205838|NCT02166047|20235439|P12|COMPLETED|Overall Study||6
8205839|NCT02166047|20235440|P11|COMPLETED|Overall Study||12
8205840|NCT02166047|20235441|P10|COMPLETED|Overall Study||17
8205841|NCT02166047|20235442|P9|COMPLETED|Overall Study||16
8205842|NCT02166047|20235443|P8|COMPLETED|Overall Study||5
8205843|NCT02166047|20235444|P7|COMPLETED|Overall Study||15
8205844|NCT02166047|20235445|P6|COMPLETED|Overall Study||17
8205845|NCT02166047|20235446|P5|COMPLETED|Overall Study||17
8205846|NCT02166047|20235447|P4|COMPLETED|Overall Study||5
8205847|NCT02166047|20235448|P3|COMPLETED|Overall Study||14
8205848|NCT02166047|20235449|P2|COMPLETED|Overall Study||14
8205849|NCT02166047|20235450|P1|COMPLETED|Overall Study||16
8205850|NCT02166047|20235439|P12|STARTED|Overall Study||6
8205851|NCT02166047|20235440|P11|STARTED|Overall Study||14
8205852|NCT02166047|20235441|P10|STARTED|Overall Study||17
8205853|NCT02166047|20235442|P9|STARTED|Overall Study||16
8205854|NCT02166047|20235443|P8|STARTED|Overall Study||5
8205855|NCT02166047|20235444|P7|STARTED|Overall Study||17
8205856|NCT02166047|20235445|P6|STARTED|Overall Study||17
8205857|NCT02166047|20235446|P5|STARTED|Overall Study||18
8205858|NCT02166047|20235447|P4|STARTED|Overall Study||5
8205859|NCT02166047|20235448|P3|STARTED|Overall Study||16
8205860|NCT02166047|20235449|P2|STARTED|Overall Study||15
8205861|NCT02166047|20235450|P1|STARTED|Overall Study||16
8205862|NCT02165904|20235572|P1|NOT COMPLETED|Overall Study||0
8205863|NCT02165904|20235572|P1|COMPLETED|Overall Study||10
8205864|NCT02165904|20235572|P1|STARTED|Overall Study||10
8205865|NCT02165839|20235593|P2|NOT COMPLETED|Overall Study||0
8205866|NCT02165839|20235594|P1|NOT COMPLETED|Overall Study||0
8205867|NCT02165839|20235593|P2|COMPLETED|Overall Study||73
8205868|NCT02165839|20235594|P1|COMPLETED|Overall Study||66
8205869|NCT02165839|20235593|P2|STARTED|Overall Study||73
8205870|NCT02165839|20235594|P1|STARTED|Overall Study||66
8205871|NCT02165826|20235617|P3|NOT COMPLETED|Down-Titration Period||7
8205872|NCT02165826|20235618|P2|NOT COMPLETED|Down-Titration Period||11
8205873|NCT02165826|20235619|P1|NOT COMPLETED|Down-Titration Period||7
8205874|NCT02165826|20235617|P3|COMPLETED|Down-Titration Period||31
8205875|NCT02165826|20235618|P2|COMPLETED|Down-Titration Period||28
8205876|NCT02165826|20235619|P1|COMPLETED|Down-Titration Period||20
8205877|NCT02165826|20235617|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
8205878|NCT02165826|20235618|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
8205879|NCT02165826|20235619|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
8205880|NCT02165826|20235617|P3|STARTED|Down-Titration Period||38
8205881|NCT02165826|20235618|P2|STARTED|Down-Titration Period||39
8205882|NCT02165826|20235619|P1|STARTED|Down-Titration Period||27
8205883|NCT02165826|20235617|P3|NOT COMPLETED|Main Treatment Period||109
8205884|NCT02165826|20235618|P2|NOT COMPLETED|Main Treatment Period||90
8205885|NCT02165826|20235619|P1|NOT COMPLETED|Main Treatment Period||81
8205886|NCT02165826|20235617|P3|COMPLETED|Main Treatment Period||334
8205887|NCT02165826|20235618|P2|COMPLETED|Main Treatment Period||349
8205888|NCT02165826|20235619|P1|COMPLETED|Main Treatment Period||360
8205889|NCT02165826|20235617|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
8205890|NCT02165826|20235618|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
8205891|NCT02165826|20235619|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
8205892|NCT02165826|20235617|P3|STARTED|Main Treatment Period||443
8205893|NCT02165826|20235618|P2|STARTED|Main Treatment Period||439
8205894|NCT02165826|20235619|P1|STARTED|Main Treatment Period||441
8205895|NCT02165761|20235678|P2|NOT COMPLETED|Overall Study||14
8205896|NCT02165761|20235679|P1|NOT COMPLETED|Overall Study||19
8205897|NCT02165761|20235678|P2|COMPLETED|Overall Study||5
8205898|NCT02165761|20235679|P1|COMPLETED|Overall Study||4
8205899|NCT02165761|20235678|P2|STARTED|Overall Study||19
8205900|NCT02165761|20235679|P1|STARTED|Overall Study||23
8205901|NCT02165735|20235687|P2|NOT COMPLETED|Overall Study||14
8205902|NCT02165735|20235688|P1|NOT COMPLETED|Overall Study||16
8205903|NCT02165735|20235687|P2|COMPLETED|Overall Study||166
8205904|NCT02165735|20235688|P1|COMPLETED|Overall Study||164
8205905|NCT02165735|20235687|P2|STARTED|Overall Study||180
8205906|NCT02165735|20235688|P1|STARTED|Overall Study||180
8205907|NCT02165722|20235716|P2|NOT COMPLETED|Overall Study||0
8205908|NCT02165722|20235717|P1|NOT COMPLETED|Overall Study||0
8205909|NCT02165722|20235716|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
8205910|NCT02165722|20235717|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
8205911|NCT02165722|20235716|P2|STARTED|Overall Study||2202
8205912|NCT02165722|20235717|P1|STARTED|Overall Study||1971
8205913|NCT02165605|20235729|P1|NOT COMPLETED|Overall Study||0
8205914|NCT02165605|20235729|P1|COMPLETED|Overall Study||28
8205915|NCT02165605|20235729|P1|STARTED|Overall Study||28
8205916|NCT02165462|20235742|P1|NOT COMPLETED|Overall Study||0
8205917|NCT02165462|20235742|P1|COMPLETED|Overall Study||17
8205918|NCT02165462|20235742|P1|STARTED|Overall Study||17
8205919|NCT02165397|20235762|P3|NOT COMPLETED|Overall Study||10
8205920|NCT02165397|20235763|P2|NOT COMPLETED|Overall Study||19
8205921|NCT02165397|20235764|P1|NOT COMPLETED|Overall Study||14
8205922|NCT02165397|20235762|P3|COMPLETED|Overall Study||21
8205923|NCT02165397|20235763|P2|COMPLETED|Overall Study||56
8205924|NCT02165397|20235764|P1|COMPLETED|Overall Study||61
8205925|NCT02165397|20235762|P3|STARTED|Overall Study||31
8205926|NCT02165397|20235763|P2|STARTED|Overall Study||75
8205927|NCT02165397|20235764|P1|STARTED|Overall Study||75
8205928|NCT02165384|20235787|P1|NOT COMPLETED|Overall Study||0
8205929|NCT02165384|20235787|P1|COMPLETED|Overall Study||199
8205930|NCT02165384|20235787|P1|STARTED|Overall Study||199
8205931|NCT02165202|20235794|P2|NOT COMPLETED|Injection Phase||6
8205932|NCT02165202|20235795|P1|NOT COMPLETED|Injection Phase||10
8205933|NCT02165202|20235794|P2|COMPLETED|Injection Phase||36
8205934|NCT02165202|20235795|P1|COMPLETED|Injection Phase||70
8205935|NCT02165202|20235794|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
8205936|NCT02165202|20235795|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
8205937|NCT02165202|20235794|P2|NOT COMPLETED|Oral Phase||3
8205938|NCT02165202|20235795|P1|NOT COMPLETED|Oral Phase||11
8205939|NCT02165202|20235794|P2|COMPLETED|Oral Phase||42
8205940|NCT02165202|20235795|P1|COMPLETED|Oral Phase||80
8205941|NCT02165202|20235794|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
8205942|NCT02165202|20235795|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
8205943|NCT02165124|20235801|P1|NOT COMPLETED|Overall Study||5
8205944|NCT02165124|20235801|P1|COMPLETED|Overall Study||15
8205945|NCT02165124|20235801|P1|STARTED|Overall Study||20
8205946|NCT02165111|20235807|P2|NOT COMPLETED|Overall Study||0
8205947|NCT02165111|20235808|P1|NOT COMPLETED|Overall Study||0
8205948|NCT02165111|20235807|P2|COMPLETED|Overall Study||40
8205949|NCT02165111|20235808|P1|COMPLETED|Overall Study||40
8205950|NCT02165111|20235807|P2|STARTED|Overall Study||40
8205951|NCT02165111|20235808|P1|STARTED|Overall Study||40
8205952|NCT02165072|20235824|P1|NOT COMPLETED|Overall Study||0
8205953|NCT02165072|20235824|P1|COMPLETED|Overall Study||30
8205954|NCT02165072|20235824|P1|STARTED|Overall Study||30
8205955|NCT02164981|20235832|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
8205956|NCT02164981|20235833|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
8205957|NCT02164981|20235834|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
8205958|NCT02164981|20235832|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
8205959|NCT02164981|20235833|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
8205960|NCT02164981|20235834|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
8205961|NCT02164981|20235832|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
8205962|NCT02164981|20235833|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
8205963|NCT02164981|20235834|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
8205964|NCT02164981|20235832|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
8205965|NCT02164981|20235833|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
8205966|NCT02164981|20235834|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
8205967|NCT02164981|20235832|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
8205968|NCT02164981|20235833|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
8205969|NCT02164981|20235834|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
8205970|NCT02164981|20235832|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
8205971|NCT02164981|20235833|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
8205972|NCT02164981|20235834|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
8205973|NCT02164981|20235832|P3|NOT COMPLETED|Started||0
8205974|NCT02164981|20235833|P2|NOT COMPLETED|Started||3
8205975|NCT02164981|20235834|P1|NOT COMPLETED|Started||5
8205976|NCT02164981|20235832|P3|COMPLETED|Started||18
8205977|NCT02164981|20235833|P2|COMPLETED|Started||16
8205978|NCT02164981|20235834|P1|COMPLETED|Started||18
8205979|NCT02164981|20235832|P3|STARTED|Started||18
8205980|NCT02164981|20235833|P2|STARTED|Started||19
8205981|NCT02164981|20235834|P1|STARTED|Started||23
8205982|NCT02164929|20235907|P4|NOT COMPLETED|Overall Study||2
8205983|NCT02164929|20235908|P3|NOT COMPLETED|Overall Study||1
8205984|NCT02164929|20235909|P2|NOT COMPLETED|Overall Study||0
8205985|NCT02164929|20235910|P1|NOT COMPLETED|Overall Study||1
8205986|NCT02164929|20235907|P4|COMPLETED|Overall Study||2
8205987|NCT02164929|20235908|P3|COMPLETED|Overall Study||4
8205988|NCT02164929|20235909|P2|COMPLETED|Overall Study||3
8205989|NCT02164929|20235910|P1|COMPLETED|Overall Study||3
8205990|NCT02164929|20235907|P4|STARTED|Overall Study||4
8205991|NCT02164929|20235908|P3|STARTED|Overall Study||5
8205992|NCT02164929|20235909|P2|STARTED|Overall Study||3
8205993|NCT02164929|20235910|P1|STARTED|Overall Study||4
8205994|NCT02164916|20235954|P2|NOT COMPLETED|Overall Study||54
8205995|NCT02164916|20235955|P1|NOT COMPLETED|Overall Study||52
8205996|NCT02164916|20235954|P2|COMPLETED|Overall Study||0
8205997|NCT02164916|20235955|P1|COMPLETED|Overall Study||0
8205998|NCT02164916|20235954|P2|Cross-over to Arm II|Overall Study||0
8205999|NCT02164916|20235955|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
8206000|NCT02164916|20235954|P2|Eligible|Overall Study||49
8206001|NCT02164916|20235955|P1|Eligible|Overall Study||50
8206002|NCT02164916|20235954|P2|STARTED|Overall Study||54
8206003|NCT02164916|20235955|P1|STARTED|Overall Study||52
8206004|NCT02164864|20235975|P3|NOT COMPLETED|Overall Study||132
8206005|NCT02164864|20235976|P2|NOT COMPLETED|Overall Study||60
8206006|NCT02164864|20235977|P1|NOT COMPLETED|Overall Study||95
8206007|NCT02164864|20235975|P3|COMPLETED|Overall Study||849
8206008|NCT02164864|20235976|P2|COMPLETED|Overall Study||703
8206009|NCT02164864|20235977|P1|COMPLETED|Overall Study||886
8206010|NCT02164864|20235975|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
8206011|NCT02164864|20235976|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
8206012|NCT02164864|20235977|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
8206013|NCT02164721|20236036|P1|NOT COMPLETED|Overall Study||0
8206014|NCT02164721|20236036|P1|COMPLETED|Overall Study||30
8206015|NCT02164721|20236036|P1|STARTED|Overall Study||30
8206016|NCT02164539|20236052|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
8206017|NCT02164539|20236053|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206018|NCT02164539|20236054|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206019|NCT02164539|20236055|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206020|NCT02164539|20236056|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206021|NCT02164539|20236057|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206022|NCT02164539|20236058|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
8206023|NCT02164539|20236052|P7|COMPLETED|Treatment Phase C (1 Week)||78
8206024|NCT02164539|20236053|P6|COMPLETED|Treatment Phase C (1 Week)||82
8206025|NCT02164539|20236054|P5|COMPLETED|Treatment Phase C (1 Week)||84
8206026|NCT02164539|20236055|P4|COMPLETED|Treatment Phase C (1 Week)||0
8206027|NCT02164539|20236056|P3|COMPLETED|Treatment Phase C (1 Week)||0
8206028|NCT02164539|20236057|P2|COMPLETED|Treatment Phase C (1 Week)||0
8206029|NCT02164539|20236058|P1|COMPLETED|Treatment Phase C (1 Week)||78
8206030|NCT02164539|20236052|P7|STARTED|Treatment Phase C (1 Week)||80
8206031|NCT02164539|20236053|P6|STARTED|Treatment Phase C (1 Week)||82
8206032|NCT02164539|20236054|P5|STARTED|Treatment Phase C (1 Week)||84
8206033|NCT02164539|20236055|P4|STARTED|Treatment Phase C (1 Week)||0
8206034|NCT02164539|20236056|P3|STARTED|Treatment Phase C (1 Week)||0
8206035|NCT02164539|20236057|P2|STARTED|Treatment Phase C (1 Week)||0
8206036|NCT02164539|20236058|P1|STARTED|Treatment Phase C (1 Week)||79
8206037|NCT02164539|20236052|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
8206038|NCT02164539|20236053|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206039|NCT02164539|20236054|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
8206040|NCT02164539|20236055|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206041|NCT02164539|20236056|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206042|NCT02164539|20236057|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206043|NCT02164539|20236058|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206044|NCT02164539|20236052|P7|COMPLETED|Treatment Phase B (1 Week)||162
8206045|NCT02164539|20236053|P6|COMPLETED|Treatment Phase B (1 Week)||0
8206046|NCT02164539|20236054|P5|COMPLETED|Treatment Phase B (1 Week)||163
8206047|NCT02164539|20236055|P4|COMPLETED|Treatment Phase B (1 Week)||0
8206048|NCT02164539|20236056|P3|COMPLETED|Treatment Phase B (1 Week)||0
8206049|NCT02164539|20236057|P2|COMPLETED|Treatment Phase B (1 Week)||0
8206050|NCT02164539|20236058|P1|COMPLETED|Treatment Phase B (1 Week)||0
8206051|NCT02164539|20236052|P7|STARTED|Treatment Phase B (1 Week)||163
8206052|NCT02164539|20236053|P6|STARTED|Treatment Phase B (1 Week)||0
8206053|NCT02164539|20236054|P5|STARTED|Treatment Phase B (1 Week)||166
8206054|NCT02164539|20236055|P4|STARTED|Treatment Phase B (1 Week)||0
8206055|NCT02164539|20236056|P3|STARTED|Treatment Phase B (1 Week)||0
8206056|NCT02164539|20236057|P2|STARTED|Treatment Phase B (1 Week)||0
8206057|NCT02164539|20236058|P1|STARTED|Treatment Phase B (1 Week)||0
8206058|NCT02164539|20236052|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
8206059|NCT02164539|20236053|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
8206060|NCT02164539|20236054|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
8206061|NCT02164539|20236055|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
8206062|NCT02164539|20236056|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
8206063|NCT02164539|20236057|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
8206064|NCT02164539|20236058|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
8206065|NCT02164539|20236052|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
8206066|NCT02164539|20236053|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
8206067|NCT02164539|20236054|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
8206068|NCT02164539|20236055|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
8206069|NCT02164539|20236056|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
8206070|NCT02164539|20236057|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
8206071|NCT02164539|20236058|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
8206072|NCT02164539|20236052|P7|STARTED|Treatment Phase A (4 Weeks)||0
8206073|NCT02164539|20236053|P6|STARTED|Treatment Phase A (4 Weeks)||84
8206074|NCT02164539|20236054|P5|STARTED|Treatment Phase A (4 Weeks)||85
8206075|NCT02164539|20236055|P4|STARTED|Treatment Phase A (4 Weeks)||46
8206076|NCT02164539|20236056|P3|STARTED|Treatment Phase A (4 Weeks)||40
8206077|NCT02164539|20236057|P2|STARTED|Treatment Phase A (4 Weeks)||42
8206078|NCT02164539|20236058|P1|STARTED|Treatment Phase A (4 Weeks)||41
8206079|NCT02164513|20236106|P3|NOT COMPLETED|Overall Study||295
8206080|NCT02164513|20236107|P2|NOT COMPLETED|Overall Study||536
8206081|NCT02164513|20236108|P1|NOT COMPLETED|Overall Study||437
8206082|NCT02164513|20236106|P3|COMPLETED|Overall Study||1775
8206083|NCT02164513|20236107|P2|COMPLETED|Overall Study||3598
8206084|NCT02164513|20236108|P1|COMPLETED|Overall Study||3714
8206085|NCT02164513|20236106|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
8206086|NCT02164513|20236107|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
8206087|NCT02164513|20236108|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
8206088|NCT02164513|20236106|P3|WIP: Withdrawal by Participant|Overall Study||153
8206089|NCT02164513|20236107|P2|WIP: Withdrawal by Participant|Overall Study||296
8206090|NCT02164513|20236108|P1|WIP: Withdrawal by Participant|Overall Study||250
8206091|NCT02164513|20236106|P3|WIP: Investigator Discretion|Overall Study||15
8206092|NCT02164513|20236107|P2|WIP: Investigator Discretion|Overall Study||36
8206093|NCT02164513|20236108|P1|WIP: Investigator Discretion|Overall Study||33
8206094|NCT02164513|20236106|P3|WIP: Lost to Follow-up|Overall Study||14
8206095|NCT02164513|20236107|P2|WIP: Lost to Follow-up|Overall Study||25
8206096|NCT02164513|20236108|P1|WIP: Lost to Follow-up|Overall Study||21
8206097|NCT02164513|20236106|P3|WIP: Study Closed/Terminated|Overall Study||5
8206098|NCT02164513|20236107|P2|WIP: Study Closed/Terminated|Overall Study||2
8206099|NCT02164513|20236108|P1|WIP: Study Closed/Terminated|Overall Study||5
8206100|NCT02164513|20236106|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
8206101|NCT02164513|20236107|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
8206102|NCT02164513|20236108|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
8206103|NCT02164513|20236106|P3|Withdrew IP: Protocol Deviation|Overall Study||19
8206104|NCT02164513|20236107|P2|Withdrew IP: Protocol Deviation|Overall Study||41
8206105|NCT02164513|20236108|P1|Withdrew IP: Protocol Deviation|Overall Study||32
8206106|NCT02164513|20236106|P3|WIP: Lack of Efficacy|Overall Study||172
8206107|NCT02164513|20236107|P2|WIP: Lack of Efficacy|Overall Study||313
8206108|NCT02164513|20236108|P1|WIP: Lack of Efficacy|Overall Study||163
8206109|NCT02164513|20236106|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
8206110|NCT02164513|20236107|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
8206111|NCT02164513|20236108|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
8206112|NCT02164513|20236106|P3|Not Completed IP|Overall Study||566
8206113|NCT02164513|20236107|P2|Not Completed IP|Overall Study||1040
8206114|NCT02164513|20236108|P1|Not Completed IP|Overall Study||758
8206115|NCT02164513|20236106|P3|Completed Investigational Product (IP)|Overall Study||1504
8206116|NCT02164513|20236107|P2|Completed Investigational Product (IP)|Overall Study||3094
8206117|NCT02164513|20236108|P1|Completed Investigational Product (IP)|Overall Study||3393
8206118|NCT02164513|20236106|P3|STARTED|Overall Study||2070
8206119|NCT02164513|20236107|P2|STARTED|Overall Study||4134
8206120|NCT02164513|20236108|P1|STARTED|Overall Study||4151
8206121|NCT02164396|20236133|P3|NOT COMPLETED|Overall Study||0
8206122|NCT02164396|20236134|P2|NOT COMPLETED|Overall Study||0
8206123|NCT02164396|20236135|P1|NOT COMPLETED|Overall Study||0
8206124|NCT02164396|20236133|P3|COMPLETED|Overall Study||10
8206125|NCT02164396|20236134|P2|COMPLETED|Overall Study||10
8206126|NCT02164396|20236135|P1|COMPLETED|Overall Study||10
8206127|NCT02164396|20236133|P3|STARTED|Overall Study||10
8206128|NCT02164396|20236134|P2|STARTED|Overall Study||10
8206129|NCT02164396|20236135|P1|STARTED|Overall Study||10
8206130|NCT02164383|20236145|P2|NOT COMPLETED|Overall Study||0
8206131|NCT02164383|20236146|P1|NOT COMPLETED|Overall Study||1
8206132|NCT02164383|20236145|P2|COMPLETED|Overall Study||14
8206133|NCT02164383|20236146|P1|COMPLETED|Overall Study||15
8206134|NCT02164383|20236145|P2|STARTED|Overall Study||14
8206135|NCT02164383|20236146|P1|STARTED|Overall Study||16
8206136|NCT02164318|20236156|P4|NOT COMPLETED|Overall Study||1
8206137|NCT02164318|20236157|P3|NOT COMPLETED|Overall Study||0
8206138|NCT02164318|20236158|P2|NOT COMPLETED|Overall Study||1
8206139|NCT02164318|20236159|P1|NOT COMPLETED|Overall Study||0
8206140|NCT02164318|20236156|P4|COMPLETED|Overall Study||2
8206141|NCT02164318|20236157|P3|COMPLETED|Overall Study||1
8206142|NCT02164318|20236158|P2|COMPLETED|Overall Study||2
8206143|NCT02164318|20236159|P1|COMPLETED|Overall Study||4
8206144|NCT02164318|20236156|P4|STARTED|Overall Study||3
8206145|NCT02164318|20236157|P3|STARTED|Overall Study||1
8206146|NCT02164318|20236158|P2|STARTED|Overall Study||3
8206147|NCT02164318|20236159|P1|STARTED|Overall Study||4
8206148|NCT02164240|20236177|P3|NOT COMPLETED|Overall Study||0
8206149|NCT02164240|20236178|P2|NOT COMPLETED|Overall Study||0
8206150|NCT02164240|20236179|P1|NOT COMPLETED|Overall Study||0
8206151|NCT02164240|20236177|P3|COMPLETED|Overall Study||4
8206152|NCT02164240|20236178|P2|COMPLETED|Overall Study||5
8206153|NCT02164240|20236179|P1|COMPLETED|Overall Study||4
8206154|NCT02164240|20236177|P3|STARTED|Overall Study||4
8206155|NCT02164240|20236178|P2|STARTED|Overall Study||5
8206156|NCT02164240|20236179|P1|STARTED|Overall Study||4
8206157|NCT02163993|20236194|P5|NOT COMPLETED|Post-treatment Period||3
8206158|NCT02163993|20236195|P4|NOT COMPLETED|Post-treatment Period||2
8206159|NCT02163993|20236196|P3|NOT COMPLETED|Post-treatment Period||4
8206160|NCT02163993|20236197|P2|NOT COMPLETED|Post-treatment Period||6
8206161|NCT02163993|20236198|P1|NOT COMPLETED|Post-treatment Period||4
8206162|NCT02163993|20236194|P5|COMPLETED|Post-treatment Period||62
8206163|NCT02163993|20236195|P4|COMPLETED|Post-treatment Period||61
8206164|NCT02163993|20236196|P3|COMPLETED|Post-treatment Period||62
8206165|NCT02163993|20236197|P2|COMPLETED|Post-treatment Period||55
8206166|NCT02163993|20236198|P1|COMPLETED|Post-treatment Period||121
8206167|NCT02163993|20236194|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
8206168|NCT02163993|20236195|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
8206169|NCT02163993|20236196|P3|STARTED|Post-treatment Period||66
8206170|NCT02163993|20236197|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
8206171|NCT02163993|20236198|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
8206172|NCT02163993|20236194|P5|NOT COMPLETED|Treatment Period||7
8206173|NCT02163993|20236195|P4|NOT COMPLETED|Treatment Period||9
8206174|NCT02163993|20236196|P3|NOT COMPLETED|Treatment Period||2
8206175|NCT02163993|20236197|P2|NOT COMPLETED|Treatment Period||9
8206176|NCT02163993|20236198|P1|NOT COMPLETED|Treatment Period||12
8206177|NCT02163993|20236194|P5|COMPLETED|Treatment Period||62
8206178|NCT02163993|20236195|P4|COMPLETED|Treatment Period||62
8206179|NCT02163993|20236196|P3|COMPLETED|Treatment Period||66
8206180|NCT02163993|20236197|P2|COMPLETED|Treatment Period||59
8206181|NCT02163993|20236198|P1|COMPLETED|Treatment Period||126
8206182|NCT02163993|20236194|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
8206183|NCT02163993|20236195|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
8206184|NCT02163993|20236196|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
8206185|NCT02163993|20236197|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
8206186|NCT02163993|20236198|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
8206187|NCT02163993|20236194|P5|STARTED|Treatment Period||69
8206188|NCT02163993|20236195|P4|STARTED|Treatment Period||71
8206189|NCT02163993|20236196|P3|STARTED|Treatment Period||68
8206190|NCT02163993|20236197|P2|STARTED|Treatment Period||68
8206191|NCT02163993|20236198|P1|STARTED|Treatment Period||138
8206192|NCT02163967|20236274|P6|NOT COMPLETED|Third Intervention/Day 3||0
8206193|NCT02163967|20236275|P5|NOT COMPLETED|Third Intervention/Day 3||0
8206194|NCT02163967|20236276|P4|NOT COMPLETED|Third Intervention/Day 3||0
8206195|NCT02163967|20236277|P3|NOT COMPLETED|Third Intervention/Day 3||0
8206196|NCT02163967|20236278|P2|NOT COMPLETED|Third Intervention/Day 3||0
8206197|NCT02163967|20236279|P1|NOT COMPLETED|Third Intervention/Day 3||0
8206198|NCT02163967|20236274|P6|COMPLETED|Third Intervention/Day 3||3
8206199|NCT02163967|20236275|P5|COMPLETED|Third Intervention/Day 3||3
8206200|NCT02163967|20236276|P4|COMPLETED|Third Intervention/Day 3||4
8206201|NCT02163967|20236277|P3|COMPLETED|Third Intervention/Day 3||2
8206202|NCT02163967|20236278|P2|COMPLETED|Third Intervention/Day 3||3
8206203|NCT02163967|20236279|P1|COMPLETED|Third Intervention/Day 3||3
8206204|NCT02163967|20236274|P6|STARTED|Third Intervention/Day 3||3
8206205|NCT02163967|20236275|P5|STARTED|Third Intervention/Day 3||3
8206206|NCT02163967|20236276|P4|STARTED|Third Intervention/Day 3||4
8206207|NCT02163967|20236277|P3|STARTED|Third Intervention/Day 3||2
8206208|NCT02163967|20236278|P2|STARTED|Third Intervention/Day 3||3
8206209|NCT02163967|20236279|P1|STARTED|Third Intervention/Day 3||3
8206210|NCT02163967|20236274|P6|NOT COMPLETED|Second Intevention/Day 2||0
8206211|NCT02163967|20236275|P5|NOT COMPLETED|Second Intevention/Day 2||0
8206212|NCT02163967|20236276|P4|NOT COMPLETED|Second Intevention/Day 2||0
8206213|NCT02163967|20236277|P3|NOT COMPLETED|Second Intevention/Day 2||0
8206214|NCT02163967|20236278|P2|NOT COMPLETED|Second Intevention/Day 2||0
8206215|NCT02163967|20236279|P1|NOT COMPLETED|Second Intevention/Day 2||0
8206216|NCT02163967|20236274|P6|COMPLETED|Second Intevention/Day 2||3
8206217|NCT02163967|20236275|P5|COMPLETED|Second Intevention/Day 2||3
8206218|NCT02163967|20236276|P4|COMPLETED|Second Intevention/Day 2||4
8206219|NCT02163967|20236277|P3|COMPLETED|Second Intevention/Day 2||2
8206220|NCT02163967|20236278|P2|COMPLETED|Second Intevention/Day 2||4
8206221|NCT02163967|20236279|P1|COMPLETED|Second Intevention/Day 2||3
8206222|NCT02163967|20236274|P6|STARTED|Second Intevention/Day 2||3
8206223|NCT02163967|20236275|P5|STARTED|Second Intevention/Day 2||3
8206224|NCT02163967|20236276|P4|STARTED|Second Intevention/Day 2||4
8206225|NCT02163967|20236277|P3|STARTED|Second Intevention/Day 2||2
8206226|NCT02163967|20236278|P2|STARTED|Second Intevention/Day 2||4
8206227|NCT02163967|20236279|P1|STARTED|Second Intevention/Day 2||3
8206228|NCT02163967|20236274|P6|NOT COMPLETED|First Intervention/ Day 1||0
8206229|NCT02163967|20236275|P5|NOT COMPLETED|First Intervention/ Day 1||0
8206230|NCT02163967|20236276|P4|NOT COMPLETED|First Intervention/ Day 1||0
8206231|NCT02163967|20236277|P3|NOT COMPLETED|First Intervention/ Day 1||0
8206232|NCT02163967|20236278|P2|NOT COMPLETED|First Intervention/ Day 1||0
8206233|NCT02163967|20236279|P1|NOT COMPLETED|First Intervention/ Day 1||0
8206234|NCT02163967|20236274|P6|COMPLETED|First Intervention/ Day 1||3
8206235|NCT02163967|20236275|P5|COMPLETED|First Intervention/ Day 1||3
8206236|NCT02163967|20236276|P4|COMPLETED|First Intervention/ Day 1||4
8206237|NCT02163967|20236277|P3|COMPLETED|First Intervention/ Day 1||3
8206238|NCT02163967|20236278|P2|COMPLETED|First Intervention/ Day 1||4
8206239|NCT02163967|20236279|P1|COMPLETED|First Intervention/ Day 1||4
8206240|NCT02163967|20236274|P6|STARTED|First Intervention/ Day 1||3
8206241|NCT02163967|20236275|P5|STARTED|First Intervention/ Day 1||3
8206242|NCT02163967|20236276|P4|STARTED|First Intervention/ Day 1||4
8206243|NCT02163967|20236277|P3|STARTED|First Intervention/ Day 1||3
8206244|NCT02163967|20236278|P2|STARTED|First Intervention/ Day 1||4
8206245|NCT02163967|20236279|P1|STARTED|First Intervention/ Day 1||4
8206246|NCT02163915|20236301|P5|NOT COMPLETED|Overall Study||4
8206247|NCT02163915|20236302|P4|NOT COMPLETED|Overall Study||3
8206248|NCT02163915|20236303|P3|NOT COMPLETED|Overall Study||2
8206249|NCT02163915|20236304|P2|NOT COMPLETED|Overall Study||0
8206250|NCT02163915|20236305|P1|NOT COMPLETED|Overall Study||3
8206251|NCT02163915|20236301|P5|COMPLETED|Overall Study||6
8206252|NCT02163915|20236302|P4|COMPLETED|Overall Study||6
8206253|NCT02163915|20236303|P3|COMPLETED|Overall Study||8
8206254|NCT02163915|20236304|P2|COMPLETED|Overall Study||8
8206255|NCT02163915|20236305|P1|COMPLETED|Overall Study||7
8206256|NCT02163915|20236301|P5|STARTED|Overall Study||10
8206257|NCT02163915|20236302|P4|STARTED|Overall Study||9
8206258|NCT02163915|20236303|P3|STARTED|Overall Study||10
8206259|NCT02163915|20236304|P2|STARTED|Overall Study||8
8206260|NCT02163915|20236305|P1|STARTED|Overall Study||10
8206261|NCT02163902|20236360|P2|NOT COMPLETED|Overall Study||13
8206262|NCT02163902|20236361|P1|NOT COMPLETED|Overall Study||11
8206263|NCT02163902|20236360|P2|COMPLETED|Overall Study||98
8206264|NCT02163902|20236361|P1|COMPLETED|Overall Study||102
8206265|NCT02163902|20236360|P2|STARTED|Overall Study||111
8206266|NCT02163902|20236361|P1|STARTED|Overall Study||113
8206267|NCT02163837|20236377|P1|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
8206268|NCT02163837|20236377|P1|COMPLETED|Day 28 of Rifaximin Treatment||15
8206269|NCT02163837|20236377|P1|STARTED|Day 28 of Rifaximin Treatment||15
8206270|NCT02163837|20236377|P1|NOT COMPLETED|Before Rifaximin||0
8206271|NCT02163837|20236377|P1|COMPLETED|Before Rifaximin||15
8206272|NCT02163837|20236377|P1|STARTED|Before Rifaximin||15
8206273|NCT02163811|20236387|P2|NOT COMPLETED|Overall Study||16
8206274|NCT02163811|20236388|P1|NOT COMPLETED|Overall Study||36
8206275|NCT02163811|20236387|P2|COMPLETED|Overall Study||60
8206276|NCT02163811|20236388|P1|COMPLETED|Overall Study||35
8206277|NCT02163811|20236387|P2|STARTED|Overall Study||76
8206278|NCT02163811|20236388|P1|STARTED|Overall Study||71
8206279|NCT02163733|20236410|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
8206280|NCT02163733|20236411|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8206281|NCT02163733|20236412|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8206282|NCT02163733|20236410|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
8206283|NCT02163733|20236411|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8206284|NCT02163733|20236412|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8206285|NCT02163733|20236410|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
8206286|NCT02163733|20236411|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
8206287|NCT02163733|20236412|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
8206288|NCT02163733|20236410|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8206289|NCT02163733|20236411|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8206290|NCT02163733|20236412|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8206291|NCT02163733|20236410|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8206292|NCT02163733|20236411|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
8206293|NCT02163733|20236412|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
8206294|NCT02163733|20236410|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
8206295|NCT02163733|20236411|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
8206296|NCT02163733|20236412|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
8206297|NCT02163733|20236410|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8206298|NCT02163733|20236411|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8206299|NCT02163733|20236412|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8206300|NCT02163733|20236410|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8206301|NCT02163733|20236411|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
8206302|NCT02163733|20236412|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
8206303|NCT02163733|20236410|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
8206304|NCT02163733|20236411|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
8206305|NCT02163733|20236412|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
8206306|NCT02163577|20236449|P2|NOT COMPLETED|Overall Study||0
8206307|NCT02163577|20236450|P1|NOT COMPLETED|Overall Study||0
8206308|NCT02163577|20236449|P2|COMPLETED|Overall Study||26
8206309|NCT02163577|20236450|P1|COMPLETED|Overall Study||26
8206310|NCT02163577|20236449|P2|STARTED|Overall Study||26
8206311|NCT02163577|20236450|P1|STARTED|Overall Study||26
8206312|NCT02163538|20236514|P2|NOT COMPLETED|Overall Study||1
8206313|NCT02163538|20236515|P1|NOT COMPLETED|Overall Study||1
8206314|NCT02163538|20236514|P2|COMPLETED|Overall Study||70
8206315|NCT02163538|20236515|P1|COMPLETED|Overall Study||70
8206316|NCT02163538|20236514|P2|STARTED|Overall Study||71
8206317|NCT02163538|20236515|P1|STARTED|Overall Study||71
8206318|NCT02163499|20236531|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
8206319|NCT02163499|20236531|P1|COMPLETED|Extended Dosing Phase: ZS||466
8206320|NCT02163499|20236531|P1|STARTED|Extended Dosing Phase: ZS||746
8206321|NCT02163499|20236531|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
8206322|NCT02163499|20236531|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
8206323|NCT02163499|20236531|P1|STARTED|Acute Phase: ZS 10 g TID||751
8206324|NCT02163486|20236541|P2|NOT COMPLETED|Overall Study||2
8206325|NCT02163486|20236542|P1|NOT COMPLETED|Overall Study||1
8206326|NCT02163486|20236541|P2|COMPLETED|Overall Study||50
8206327|NCT02163486|20236542|P1|COMPLETED|Overall Study||50
8206328|NCT02163486|20236541|P2|STARTED|Overall Study||52
8206329|NCT02163486|20236542|P1|STARTED|Overall Study||51
8206330|NCT02163447|20236559|P3|NOT COMPLETED|Overall Study||3
8206331|NCT02163447|20236560|P2|NOT COMPLETED|Overall Study||6
8206332|NCT02163447|20236561|P1|NOT COMPLETED|Overall Study||6
8206333|NCT02163447|20236559|P3|COMPLETED|Overall Study||97
8206334|NCT02163447|20236560|P2|COMPLETED|Overall Study||88
8206335|NCT02163447|20236561|P1|COMPLETED|Overall Study||100
8206336|NCT02163447|20236559|P3|Infants Born|Overall Study||100
8206337|NCT02163447|20236560|P2|Infants Born|Overall Study||93
8206338|NCT02163447|20236561|P1|Infants Born|Overall Study||101
8206339|NCT02163447|20236559|P3|STARTED|Overall Study||100
8206340|NCT02163447|20236560|P2|STARTED|Overall Study||94
8206341|NCT02163447|20236561|P1|STARTED|Overall Study||106
8206342|NCT02163421|20236626|P4|NOT COMPLETED|Overall Study||0
8206343|NCT02163421|20236627|P3|NOT COMPLETED|Overall Study||0
8206344|NCT02163421|20236628|P2|NOT COMPLETED|Overall Study||0
8206345|NCT02163421|20236629|P1|NOT COMPLETED|Overall Study||0
8206346|NCT02163421|20236626|P4|COMPLETED|Overall Study||12
8206347|NCT02163421|20236627|P3|COMPLETED|Overall Study||12
8206348|NCT02163421|20236628|P2|COMPLETED|Overall Study||12
8206349|NCT02163421|20236629|P1|COMPLETED|Overall Study||12
8206350|NCT02163421|20236626|P4|STARTED|Overall Study||12
8206351|NCT02163421|20236627|P3|STARTED|Overall Study||12
8206352|NCT02163421|20236628|P2|STARTED|Overall Study||12
8206353|NCT02163421|20236629|P1|STARTED|Overall Study||12
8206354|NCT02163395|20236636|P1|NOT COMPLETED|Overall Study||5
8206355|NCT02163395|20236636|P1|COMPLETED|Overall Study||39
8206356|NCT02163395|20236636|P1|STARTED|Overall Study||44
8206357|NCT02163187|20236645|P2|NOT COMPLETED|Overall Study||0
8206358|NCT02163187|20236646|P1|NOT COMPLETED|Overall Study||2
8206359|NCT02163187|20236645|P2|COMPLETED|Overall Study||0
8206360|NCT02163187|20236646|P1|COMPLETED|Overall Study||2
8206361|NCT02163187|20236645|P2|Treatment|Overall Study||0
8206362|NCT02163187|20236646|P1|Treatment|Overall Study||2
8206363|NCT02163187|20236645|P2|STARTED|Overall Study||0
8206364|NCT02163187|20236646|P1|STARTED|Overall Study||4
8206365|NCT02163057|20236656|P2|NOT COMPLETED|Overall Study||5
8206366|NCT02163057|20236657|P1|NOT COMPLETED|Overall Study||3
8206367|NCT02163057|20236656|P2|COMPLETED|Overall Study||11
8206368|NCT02163057|20236657|P1|COMPLETED|Overall Study||3
8206369|NCT02163057|20236656|P2|STARTED|Overall Study||16
8206370|NCT02163057|20236657|P1|STARTED|Overall Study||6
8206371|NCT02162992|20236679|P2|NOT COMPLETED|Overall Study||1
8206372|NCT02162992|20236680|P1|NOT COMPLETED|Overall Study||5
8206373|NCT02162992|20236679|P2|COMPLETED|Overall Study||99
8206374|NCT02162992|20236680|P1|COMPLETED|Overall Study||46
8206375|NCT02162992|20236679|P2|STARTED|Overall Study||100
8206376|NCT02162992|20236680|P1|STARTED|Overall Study||51
8206377|NCT02162979|20236690|P2|NOT COMPLETED|Overall Study||0
8206378|NCT02162979|20236691|P1|NOT COMPLETED|Overall Study||0
8206379|NCT02162979|20236690|P2|COMPLETED|Overall Study||0
8206380|NCT02162979|20236691|P1|COMPLETED|Overall Study||0
8206381|NCT02162979|20236690|P2|STARTED|Overall Study||0
8206382|NCT02162979|20236691|P1|STARTED|Overall Study||0
8206383|NCT02162862|20236704|P3|NOT COMPLETED|Overall Study||4
8206384|NCT02162862|20236705|P2|NOT COMPLETED|Overall Study||11
8206385|NCT02162862|20236706|P1|NOT COMPLETED|Overall Study||0
8206386|NCT02162862|20236704|P3|COMPLETED|Overall Study||29
8206387|NCT02162862|20236705|P2|COMPLETED|Overall Study||24
8206388|NCT02162862|20236706|P1|COMPLETED|Overall Study||31
8206389|NCT02162862|20236704|P3|STARTED|Overall Study||33
8206390|NCT02162862|20236705|P2|STARTED|Overall Study||35
8206391|NCT02162862|20236706|P1|STARTED|Overall Study||31
8206392|NCT02162771|20236719|P2|NOT COMPLETED|Maintenance Study Period (Part 2)||22
8206393|NCT02162771|20236720|P1|NOT COMPLETED|Maintenance Study Period (Part 2)||16
8206394|NCT02162771|20236719|P2|COMPLETED|Maintenance Study Period (Part 2)||38
8206395|NCT02162771|20236720|P1|COMPLETED|Maintenance Study Period (Part 2)||46
8206396|NCT02162771|20236719|P2|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
8206397|NCT02162771|20236720|P1|STARTED|Maintenance Study Period (Part 2)||62
8206398|NCT02162771|20236719|P2|NOT COMPLETED|Core Study Period (Part 2)||8
8206399|NCT02162771|20236720|P1|NOT COMPLETED|Core Study Period (Part 2)||8
8206400|NCT02162771|20236719|P2|COMPLETED|Core Study Period (Part 2)||62
8206401|NCT02162771|20236720|P1|COMPLETED|Core Study Period (Part 2)||62
8206402|NCT02162771|20236719|P2|STARTED|Core Study Period (Part 2)||70
8206403|NCT02162771|20236720|P1|STARTED|Core Study Period (Part 2)||70
8206404|NCT02162758|20236734|P2|NOT COMPLETED|Overall Study||1
8206405|NCT02162758|20236735|P1|NOT COMPLETED|Overall Study||0
8206406|NCT02162758|20236734|P2|COMPLETED|Overall Study||2
8206407|NCT02162758|20236735|P1|COMPLETED|Overall Study||3
8206408|NCT02162758|20236734|P2|STARTED|Overall Study||3
8206409|NCT02162758|20236735|P1|STARTED|Overall Study||3
8206416|NCT02162680|20236795|P3|NOT COMPLETED|Overall Study||0
8206417|NCT02162680|20236796|P2|NOT COMPLETED|Overall Study||0
8206418|NCT02162680|20236797|P1|NOT COMPLETED|Overall Study||0
8206419|NCT02162680|20236795|P3|COMPLETED|Overall Study||32
8206420|NCT02162680|20236796|P2|COMPLETED|Overall Study||33
8206421|NCT02162680|20236797|P1|COMPLETED|Overall Study||33
8206422|NCT02162680|20236795|P3|STARTED|Overall Study||32
8206423|NCT02162680|20236796|P2|STARTED|Overall Study||33
8206424|NCT02162680|20236797|P1|STARTED|Overall Study||33
8206425|NCT02162667|20236807|P2|NOT COMPLETED|Adjuvant Period||13
8206426|NCT02162667|20236808|P1|NOT COMPLETED|Adjuvant Period||12
8206427|NCT02162667|20236807|P2|COMPLETED|Adjuvant Period||255
8206428|NCT02162667|20236808|P1|COMPLETED|Adjuvant Period||248
8206429|NCT02162667|20236807|P2|STARTED|Adjuvant Period||268
8206430|NCT02162667|20236808|P1|STARTED|Adjuvant Period||260
8206431|NCT02162667|20236807|P2|NOT COMPLETED|Neoadjuvant Period||17
8206432|NCT02162667|20236808|P1|NOT COMPLETED|Neoadjuvant Period||14
8206433|NCT02162667|20236807|P2|COMPLETED|Neoadjuvant Period||267
8206434|NCT02162667|20236808|P1|COMPLETED|Neoadjuvant Period||264
8206435|NCT02162667|20236807|P2|STARTED|Neoadjuvant Period||284
8206436|NCT02162667|20236808|P1|STARTED|Neoadjuvant Period||278
8206437|NCT02162576|20236834|P1|NOT COMPLETED|Overall Study||0
8206438|NCT02162576|20236834|P1|COMPLETED|Overall Study||95
8206439|NCT02162576|20236834|P1|STARTED|Overall Study||95
8206440|NCT02162446|20236840|P1|NOT COMPLETED|Overall Study||0
8206441|NCT02162446|20236840|P1|COMPLETED|Overall Study||12
8206442|NCT02162446|20236840|P1|STARTED|Overall Study||12
8206443|NCT02162433|20236875|P4|NOT COMPLETED|Overall Study||1
8206444|NCT02162433|20236876|P3|NOT COMPLETED|Overall Study||2
8206445|NCT02162433|20236877|P2|NOT COMPLETED|Overall Study||2
8206446|NCT02162433|20236878|P1|NOT COMPLETED|Overall Study||1
8206447|NCT02162433|20236875|P4|COMPLETED|Overall Study||22
8206448|NCT02162433|20236876|P3|COMPLETED|Overall Study||21
8206449|NCT02162433|20236877|P2|COMPLETED|Overall Study||21
8206450|NCT02162433|20236878|P1|COMPLETED|Overall Study||22
8206451|NCT02162433|20236875|P4|STARTED|Overall Study||23
8206452|NCT02162433|20236876|P3|STARTED|Overall Study||23
8206453|NCT02162433|20236877|P2|STARTED|Overall Study||23
8206454|NCT02162433|20236878|P1|STARTED|Overall Study||23
8206455|NCT02161757|20236915|P3|NOT COMPLETED|Treatment Through Study Completion||39
8206456|NCT02161757|20236916|P2|NOT COMPLETED|Treatment Through Study Completion||43
8206457|NCT02161757|20236917|P1|NOT COMPLETED|Treatment Through Study Completion||57
8206458|NCT02161757|20236915|P3|COMPLETED|Treatment Through Study Completion||361
8206459|NCT02161757|20236916|P2|COMPLETED|Treatment Through Study Completion||361
8206460|NCT02161757|20236917|P1|COMPLETED|Treatment Through Study Completion||341
8206461|NCT02161757|20236915|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
8206462|NCT02161757|20236916|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
8206463|NCT02161757|20236917|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
8206464|NCT02161757|20236915|P3|STARTED|Treatment Through Study Completion||400
8206465|NCT02161757|20236916|P2|STARTED|Treatment Through Study Completion||404
8206466|NCT02161757|20236917|P1|STARTED|Treatment Through Study Completion||398
8206467|NCT02161757|20236915|P3|NOT COMPLETED|Randomised Through Start Treatment||0
8206468|NCT02161757|20236916|P2|NOT COMPLETED|Randomised Through Start Treatment||2
8206469|NCT02161757|20236917|P1|NOT COMPLETED|Randomised Through Start Treatment||3
8206470|NCT02161757|20236915|P3|COMPLETED|Randomised Through Start Treatment||400
8206471|NCT02161757|20236916|P2|COMPLETED|Randomised Through Start Treatment||404
8206472|NCT02161757|20236917|P1|COMPLETED|Randomised Through Start Treatment||398
8206473|NCT02161757|20236915|P3|STARTED|Randomised Through Start Treatment||400
8206474|NCT02161757|20236916|P2|STARTED|Randomised Through Start Treatment||406
8206475|NCT02161757|20236917|P1|STARTED|Randomised Through Start Treatment||401
8206476|NCT02161731|20236975|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
8206477|NCT02161731|20236976|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
8206478|NCT02161731|20236975|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
8206479|NCT02161731|20236976|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
8206480|NCT02161731|20236975|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
8206481|NCT02161731|20236976|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
8206482|NCT02161731|20236975|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
8206483|NCT02161731|20236976|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
8206484|NCT02161731|20236975|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8206485|NCT02161731|20236976|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8206486|NCT02161731|20236975|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8206487|NCT02161731|20236976|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
8206488|NCT02161731|20236975|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
8206489|NCT02161731|20236976|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
8206490|NCT02161731|20236975|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
8206491|NCT02161731|20236976|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
8206492|NCT02161705|20236995|P2|NOT COMPLETED|Overall Study||0
8206493|NCT02161705|20236996|P1|NOT COMPLETED|Overall Study||0
8206494|NCT02161705|20236995|P2|COMPLETED|Overall Study||9
8206495|NCT02161705|20236996|P1|COMPLETED|Overall Study||9
8206496|NCT02161705|20236995|P2|STARTED|Overall Study||9
8206497|NCT02161705|20236996|P1|STARTED|Overall Study||9
8206498|NCT02161575|20237004|P1|NOT COMPLETED|Overall Study||11
8206499|NCT02161575|20237004|P1|COMPLETED|Overall Study||92
8206500|NCT02161575|20237004|P1|Safety (SAF) Population|Overall Study||100
8206501|NCT02161575|20237004|P1|Full Analysis Set (FAS) Population|Overall Study||100
8206502|NCT02161575|20237004|P1|STARTED|Overall Study||103
8206503|NCT02161562|20237024|P2|NOT COMPLETED|Overall Study||17
8206504|NCT02161562|20237025|P1|NOT COMPLETED|Overall Study||26
8206505|NCT02161562|20237024|P2|COMPLETED|Overall Study||119
8206506|NCT02161562|20237025|P1|COMPLETED|Overall Study||152
8206507|NCT02161562|20237024|P2|STARTED|Overall Study||136
8206508|NCT02161562|20237025|P1|STARTED|Overall Study||178
8206509|NCT02161549|20237053|P2|NOT COMPLETED|Overall Study||2
8206510|NCT02161549|20237054|P1|NOT COMPLETED|Overall Study||6
8206511|NCT02161549|20237053|P2|COMPLETED|Overall Study||29
8206512|NCT02161549|20237054|P1|COMPLETED|Overall Study||34
8206513|NCT02161549|20237053|P2|STARTED|Overall Study||31
8206514|NCT02161549|20237054|P1|STARTED|Overall Study||40
8206515|NCT02161536|20237063|P3|NOT COMPLETED|Overall Study||0
8206516|NCT02161536|20237064|P2|NOT COMPLETED|Overall Study||0
8206517|NCT02161536|20237065|P1|NOT COMPLETED|Overall Study||0
8206518|NCT02161536|20237063|P3|COMPLETED|Overall Study||20
8206519|NCT02161536|20237064|P2|COMPLETED|Overall Study||21
8206520|NCT02161536|20237065|P1|COMPLETED|Overall Study||6
8206521|NCT02161536|20237063|P3|STARTED|Overall Study||20
8206522|NCT02161536|20237064|P2|STARTED|Overall Study||21
8206523|NCT02161536|20237065|P1|STARTED|Overall Study||6
8206524|NCT02161484|20237075|P2|NOT COMPLETED|Overall Study||3
8206525|NCT02161484|20237076|P1|NOT COMPLETED|Overall Study||4
8206526|NCT02161484|20237075|P2|COMPLETED|Overall Study||2
8206527|NCT02161484|20237076|P1|COMPLETED|Overall Study||1
8206528|NCT02161484|20237075|P2|STARTED|Overall Study||5
8206529|NCT02161484|20237076|P1|STARTED|Overall Study||5
8206530|NCT02161458|20237102|P4|NOT COMPLETED|Overall Study||0
8206531|NCT02161458|20237103|P3|NOT COMPLETED|Overall Study||5
8206532|NCT02161458|20237104|P2|NOT COMPLETED|Overall Study||6
8206533|NCT02161458|20237105|P1|NOT COMPLETED|Overall Study||0
8206534|NCT02161458|20237102|P4|COMPLETED|Overall Study||8
8206535|NCT02161458|20237103|P3|COMPLETED|Overall Study||28
8206536|NCT02161458|20237104|P2|COMPLETED|Overall Study||29
8206537|NCT02161458|20237105|P1|COMPLETED|Overall Study||22
8206538|NCT02161458|20237102|P4|STARTED|Overall Study||8
8206539|NCT02161458|20237103|P3|STARTED|Overall Study||33
8206540|NCT02161458|20237104|P2|STARTED|Overall Study||35
8206541|NCT02161458|20237105|P1|STARTED|Overall Study||22
8206542|NCT02161406|20237117|P2|NOT COMPLETED|Overall Study||9
8206543|NCT02161406|20237118|P1|NOT COMPLETED|Overall Study||10
8206544|NCT02161406|20237117|P2|COMPLETED|Overall Study||35
8206545|NCT02161406|20237118|P1|COMPLETED|Overall Study||34
8206546|NCT02161406|20237117|P2|STARTED|Overall Study||44
8206547|NCT02161406|20237118|P1|STARTED|Overall Study||44
8206548|NCT02161185|20237192|P1|NOT COMPLETED|Treatment Phase||7
8206549|NCT02161185|20237192|P1|COMPLETED|Treatment Phase||0
8206550|NCT02161185|20237192|P1|STARTED|Treatment Phase||7
8206551|NCT02161185|20237192|P1|NOT COMPLETED|Test Dose Phase||0
8206552|NCT02161185|20237192|P1|COMPLETED|Test Dose Phase||7
8206553|NCT02161185|20237192|P1|STARTED|Test Dose Phase||7
8206554|NCT02161146|20237202|P5|NOT COMPLETED|Overall Study||1
8206555|NCT02161146|20237203|P4|NOT COMPLETED|Overall Study||3
8206556|NCT02161146|20237204|P3|NOT COMPLETED|Overall Study||0
8206557|NCT02161146|20237205|P2|NOT COMPLETED|Overall Study||4
8206558|NCT02161146|20237206|P1|NOT COMPLETED|Overall Study||1
8206559|NCT02161146|20237202|P5|COMPLETED|Overall Study||48
8206560|NCT02161146|20237203|P4|COMPLETED|Overall Study||45
8206561|NCT02161146|20237204|P3|COMPLETED|Overall Study||49
8206562|NCT02161146|20237205|P2|COMPLETED|Overall Study||43
8206563|NCT02161146|20237206|P1|COMPLETED|Overall Study||46
8206564|NCT02161146|20237202|P5|STARTED|Overall Study||49
8206565|NCT02161146|20237203|P4|STARTED|Overall Study||48
8206566|NCT02161146|20237204|P3|STARTED|Overall Study||49
8206567|NCT02161146|20237205|P2|STARTED|Overall Study||47
8206568|NCT02161146|20237206|P1|STARTED|Overall Study||47
8206569|NCT02161133|20237221|P2|NOT COMPLETED|Overall Study||11
8206570|NCT02161133|20237222|P1|NOT COMPLETED|Overall Study||19
8206571|NCT02161133|20237221|P2|COMPLETED|Overall Study||122
8206572|NCT02161133|20237222|P1|COMPLETED|Overall Study||116
8206573|NCT02161133|20237221|P2|STARTED|Overall Study||133
8206574|NCT02161133|20237222|P1|STARTED|Overall Study||135
8206575|NCT02161016|20237242|P1|NOT COMPLETED|Overall Study||1
8206576|NCT02161016|20237242|P1|COMPLETED|Overall Study||0
8206577|NCT02161016|20237242|P1|STARTED|Overall Study||1
8206578|NCT02160990|20237252|P2|NOT COMPLETED|Overall Study||0
8206579|NCT02160990|20237253|P1|NOT COMPLETED|Overall Study||0
8206580|NCT02160990|20237252|P2|COMPLETED|Overall Study||10
8206581|NCT02160990|20237253|P1|COMPLETED|Overall Study||10
8206582|NCT02160990|20237252|P2|STARTED|Overall Study||10
8206583|NCT02160990|20237253|P1|STARTED|Overall Study||10
8206584|NCT02160977|20237273|P2|NOT COMPLETED|Six Months After Surgery||1
8206585|NCT02160977|20237274|P1|NOT COMPLETED|Six Months After Surgery||2
8206586|NCT02160977|20237273|P2|COMPLETED|Six Months After Surgery||42
8206587|NCT02160977|20237274|P1|COMPLETED|Six Months After Surgery||42
8206588|NCT02160977|20237273|P2|STARTED|Six Months After Surgery||43
8206589|NCT02160977|20237274|P1|STARTED|Six Months After Surgery||44
8206590|NCT02160977|20237273|P2|NOT COMPLETED|Three Months After Surgery||2
8206591|NCT02160977|20237274|P1|NOT COMPLETED|Three Months After Surgery||0
8206592|NCT02160977|20237273|P2|COMPLETED|Three Months After Surgery||43
8206593|NCT02160977|20237274|P1|COMPLETED|Three Months After Surgery||44
8206594|NCT02160977|20237273|P2|STARTED|Three Months After Surgery||45
8206595|NCT02160977|20237274|P1|STARTED|Three Months After Surgery||44
8206596|NCT02160977|20237273|P2|NOT COMPLETED|Six Weeks After Surgery||0
8206597|NCT02160977|20237274|P1|NOT COMPLETED|Six Weeks After Surgery||1
8206598|NCT02160977|20237273|P2|COMPLETED|Six Weeks After Surgery||45
8206599|NCT02160977|20237274|P1|COMPLETED|Six Weeks After Surgery||44
8206600|NCT02160977|20237273|P2|STARTED|Six Weeks After Surgery||45
8206601|NCT02160977|20237274|P1|STARTED|Six Weeks After Surgery||45
8206602|NCT02160977|20237273|P2|NOT COMPLETED|One Week After Surgery||0
8206603|NCT02160977|20237274|P1|NOT COMPLETED|One Week After Surgery||0
8206604|NCT02160977|20237273|P2|COMPLETED|One Week After Surgery||45
8206605|NCT02160977|20237274|P1|COMPLETED|One Week After Surgery||45
8206606|NCT02160977|20237273|P2|STARTED|One Week After Surgery||45
8206607|NCT02160977|20237274|P1|STARTED|One Week After Surgery||45
8206608|NCT02160899|20237290|P6|NOT COMPLETED|Overall Study||0
8206609|NCT02160899|20237291|P5|NOT COMPLETED|Overall Study||2
8206610|NCT02160899|20237292|P4|NOT COMPLETED|Overall Study||1
8206611|NCT02160899|20237293|P3|NOT COMPLETED|Overall Study||0
8206612|NCT02160899|20237294|P2|NOT COMPLETED|Overall Study||1
8206613|NCT02160899|20237295|P1|NOT COMPLETED|Overall Study||0
8206614|NCT02160899|20237290|P6|COMPLETED|Overall Study||8
8206615|NCT02160899|20237291|P5|COMPLETED|Overall Study||0
8206616|NCT02160899|20237292|P4|COMPLETED|Overall Study||2
8206617|NCT02160899|20237293|P3|COMPLETED|Overall Study||21
8206618|NCT02160899|20237294|P2|COMPLETED|Overall Study||3
8206619|NCT02160899|20237295|P1|COMPLETED|Overall Study||26
8206620|NCT02160899|20237290|P6|STARTED|Overall Study||8
8206621|NCT02160899|20237291|P5|STARTED|Overall Study||2
8206622|NCT02160899|20237292|P4|STARTED|Overall Study||3
8206623|NCT02160899|20237293|P3|STARTED|Overall Study||21
8206624|NCT02160899|20237294|P2|STARTED|Overall Study||4
8206625|NCT02160899|20237295|P1|STARTED|Overall Study||26
8206626|NCT02160873|20237317|P2|NOT COMPLETED|Overall Study||0
8206627|NCT02160873|20237318|P1|NOT COMPLETED|Overall Study||0
8206628|NCT02160873|20237317|P2|COMPLETED|Overall Study||6
8206629|NCT02160873|20237318|P1|COMPLETED|Overall Study||6
8206630|NCT02160873|20237317|P2|STARTED|Overall Study||6
8206631|NCT02160873|20237318|P1|STARTED|Overall Study||6
8206632|NCT02160847|20237332|P2|NOT COMPLETED|Overall Study||0
8206633|NCT02160847|20237333|P1|NOT COMPLETED|Overall Study||0
8206634|NCT02160847|20237332|P2|COMPLETED|Overall Study||16
8206635|NCT02160847|20237333|P1|COMPLETED|Overall Study||16
8206636|NCT02160847|20237332|P2|STARTED|Overall Study||16
8206637|NCT02160847|20237333|P1|STARTED|Overall Study||16
8206638|NCT02160808|20237343|P2|NOT COMPLETED|Overall Study||0
8206639|NCT02160808|20237344|P1|NOT COMPLETED|Overall Study||0
8206640|NCT02160808|20237343|P2|COMPLETED|Overall Study||83
8206641|NCT02160808|20237344|P1|COMPLETED|Overall Study||87
8206642|NCT02160808|20237343|P2|STARTED|Overall Study||83
8206643|NCT02160808|20237344|P1|STARTED|Overall Study||87
8206644|NCT02160626|20237357|P3|NOT COMPLETED|Overall Study||1
8206645|NCT02160626|20237358|P2|NOT COMPLETED|Overall Study||1
8206646|NCT02160626|20237359|P1|NOT COMPLETED|Overall Study||1
8206647|NCT02160626|20237357|P3|COMPLETED|Overall Study||56
8206648|NCT02160626|20237358|P2|COMPLETED|Overall Study||56
8206649|NCT02160626|20237359|P1|COMPLETED|Overall Study||57
8206650|NCT02160626|20237357|P3|STARTED|Overall Study||57
8206651|NCT02160626|20237358|P2|STARTED|Overall Study||57
8206652|NCT02160626|20237359|P1|STARTED|Overall Study||58
8206653|NCT02160535|20237373|P1|NOT COMPLETED|Overall Study||3
8206654|NCT02160535|20237373|P1|COMPLETED|Overall Study||10
8206655|NCT02160535|20237373|P1|STARTED|Overall Study||13
8206656|NCT02160314|20237382|P2|NOT COMPLETED|Overall Study||13
8206657|NCT02160314|20237383|P1|NOT COMPLETED|Overall Study||1
8206658|NCT02160314|20237382|P2|COMPLETED|Overall Study||59
8206659|NCT02160314|20237383|P1|COMPLETED|Overall Study||72
8206660|NCT02160314|20237382|P2|STARTED|Overall Study||72
8206661|NCT02160314|20237383|P1|STARTED|Overall Study||73
8206662|NCT02160288|20237391|P2|NOT COMPLETED|Overall Study||0
8206663|NCT02160288|20237392|P1|NOT COMPLETED|Overall Study||0
8206664|NCT02160288|20237391|P2|COMPLETED|Overall Study||0
8206665|NCT02160288|20237392|P1|COMPLETED|Overall Study||1
8206666|NCT02160288|20237391|P2|STARTED|Overall Study||0
8206667|NCT02160288|20237392|P1|STARTED|Overall Study||1
8206668|NCT02160145|20237418|P3|NOT COMPLETED|Randomized Double-blind Period||28
8206669|NCT02160145|20237419|P2|NOT COMPLETED|Randomized Double-blind Period||29
8206670|NCT02160145|20237420|P1|NOT COMPLETED|Randomized Double-blind Period||0
8206671|NCT02160145|20237418|P3|COMPLETED|Randomized Double-blind Period||659
8206672|NCT02160145|20237419|P2|COMPLETED|Randomized Double-blind Period||654
8206673|NCT02160145|20237420|P1|COMPLETED|Randomized Double-blind Period||0
8206674|NCT02160145|20237418|P3|Off-treatment Completers|Randomized Double-blind Period||22
8206675|NCT02160145|20237419|P2|Off-treatment Completers|Randomized Double-blind Period||76
8206676|NCT02160145|20237420|P1|Off-treatment Completers|Randomized Double-blind Period||0
8206677|NCT02160145|20237418|P3|On-treatment Completers|Randomized Double-blind Period||637
8206678|NCT02160145|20237419|P2|On-treatment Completers|Randomized Double-blind Period||578
8206679|NCT02160145|20237420|P1|On-treatment Completers|Randomized Double-blind Period||0
8206680|NCT02160145|20237418|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
8206681|NCT02160145|20237419|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
8206682|NCT02160145|20237420|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
8206683|NCT02160145|20237418|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
8206684|NCT02160145|20237419|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
8206685|NCT02160145|20237420|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
8206686|NCT02160145|20237418|P3|COMPLETED|Prerandomization Single-blind Period||0
8206687|NCT02160145|20237419|P2|COMPLETED|Prerandomization Single-blind Period||0
8206688|NCT02160145|20237420|P1|COMPLETED|Prerandomization Single-blind Period||1370
8206689|NCT02160145|20237418|P3|Randomized|Prerandomization Single-blind Period||0
8206690|NCT02160145|20237419|P2|Randomized|Prerandomization Single-blind Period||0
8206691|NCT02160145|20237420|P1|Randomized|Prerandomization Single-blind Period||1370
8206692|NCT02160145|20237418|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
8206693|NCT02160145|20237419|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
8206694|NCT02160145|20237420|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
8206695|NCT02160145|20237418|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
8206696|NCT02160145|20237419|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
8206697|NCT02160145|20237420|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
8206698|NCT02160145|20237418|P3|STARTED|Prerandomization Single-blind Period||0
8206699|NCT02160145|20237419|P2|STARTED|Prerandomization Single-blind Period||0
8206700|NCT02160145|20237420|P1|STARTED|Prerandomization Single-blind Period||1519
8206701|NCT02160041|20237433|P1|NOT COMPLETED|Overall Study||84
8206702|NCT02160041|20237433|P1|COMPLETED|Overall Study||0
8206703|NCT02160041|20237433|P1|STARTED|Overall Study||84
8206704|NCT02160002|20237445|P2|NOT COMPLETED|Overall Study||1
8206705|NCT02160002|20237446|P1|NOT COMPLETED|Overall Study||2
8206706|NCT02160002|20237445|P2|COMPLETED|Overall Study||178
8206707|NCT02160002|20237446|P1|COMPLETED|Overall Study||185
8206708|NCT02160002|20237445|P2|Primary Outcome|Overall Study||178
8206709|NCT02160002|20237446|P1|Primary Outcome|Overall Study||185
8206710|NCT02160002|20237445|P2|STARTED|Overall Study||179
8206711|NCT02160002|20237446|P1|STARTED|Overall Study||187
8206712|NCT02159976|20237478|P2|NOT COMPLETED|Overall Study||25
8206713|NCT02159976|20237479|P1|NOT COMPLETED|Overall Study||30
8206714|NCT02159976|20237478|P2|COMPLETED|Overall Study||170
8206715|NCT02159976|20237479|P1|COMPLETED|Overall Study||165
8206716|NCT02159976|20237478|P2|STARTED|Overall Study||195
8206717|NCT02159976|20237479|P1|STARTED|Overall Study||195
8206718|NCT02159950|20237493|P2|NOT COMPLETED|Overall Study||2
8206719|NCT02159950|20237494|P1|NOT COMPLETED|Overall Study||0
8206720|NCT02159950|20237493|P2|COMPLETED|Overall Study||0
8206721|NCT02159950|20237494|P1|COMPLETED|Overall Study||0
8206722|NCT02159950|20237493|P2|STARTED|Overall Study||2
8206723|NCT02159950|20237494|P1|STARTED|Overall Study||0
8206724|NCT02159898|20237528|P2|NOT COMPLETED|Overall Study||0
8206725|NCT02159898|20237529|P1|NOT COMPLETED|Overall Study||1
8206726|NCT02159898|20237528|P2|COMPLETED|Overall Study||30
8206727|NCT02159898|20237529|P1|COMPLETED|Overall Study||29
8206728|NCT02159898|20237528|P2|STARTED|Overall Study||30
8206729|NCT02159898|20237529|P1|STARTED|Overall Study||30
8206730|NCT02159859|20237537|P1|NOT COMPLETED|Overall Study||0
8206731|NCT02159859|20237537|P1|COMPLETED|Overall Study||7
8206732|NCT02159859|20237537|P1|STARTED|Overall Study||7
8206733|NCT02159807|20237553|P3|NOT COMPLETED|Overall Study||3
8206734|NCT02159807|20237554|P2|NOT COMPLETED|Overall Study||1
8206735|NCT02159807|20237555|P1|NOT COMPLETED|Overall Study||1
8206736|NCT02159807|20237553|P3|COMPLETED|Overall Study||48
8206737|NCT02159807|20237554|P2|COMPLETED|Overall Study||51
8206738|NCT02159807|20237555|P1|COMPLETED|Overall Study||66
8206739|NCT02159807|20237553|P3|STARTED|Overall Study||51
8206740|NCT02159807|20237554|P2|STARTED|Overall Study||52
8206741|NCT02159807|20237555|P1|STARTED|Overall Study||67
8206742|NCT02159768|20237569|P1|NOT COMPLETED|Overall Study||0
8206743|NCT02159768|20237569|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
8206744|NCT02159768|20237569|P1|STARTED|Overall Study|Started 16 July 2014|30
8206745|NCT02159729|20237576|P2|NOT COMPLETED|Overall Study||21
8206746|NCT02159729|20237577|P1|NOT COMPLETED|Overall Study||42
8206747|NCT02159729|20237576|P2|COMPLETED|Overall Study||44
8206748|NCT02159729|20237577|P1|COMPLETED|Overall Study||98
8206749|NCT02159729|20237576|P2|STARTED|Overall Study||65
8206750|NCT02159729|20237577|P1|STARTED|Overall Study||140
8206751|NCT02159703|20237589|P1|NOT COMPLETED|Overall Study||0
8206752|NCT02159703|20237589|P1|COMPLETED|Overall Study||60
8206753|NCT02159703|20237589|P1|STARTED|Overall Study||60
8206754|NCT02159547|20237595|P2|NOT COMPLETED|Overall Study||0
8206755|NCT02159547|20237596|P1|NOT COMPLETED|Overall Study||0
8206756|NCT02159547|20237595|P2|COMPLETED|Overall Study||112
8206757|NCT02159547|20237596|P1|COMPLETED|Overall Study||112
8206758|NCT02159547|20237595|P2|STARTED|Overall Study||112
8206759|NCT02159547|20237596|P1|STARTED|Overall Study||112
8206760|NCT02159521|20237604|P1|NOT COMPLETED|Overall Study||18
8206761|NCT02159521|20237604|P1|COMPLETED|Overall Study||63
8206762|NCT02159521|20237604|P1|Received EkoSonic® Treatment|Overall Study||78
8206763|NCT02159521|20237604|P1|STARTED|Overall Study|4 participants had both limbs treated.|81
8206764|NCT02159482|20237625|P1|NOT COMPLETED|Overall Study||5
8206765|NCT02159482|20237625|P1|COMPLETED|Overall Study||6
8206766|NCT02159482|20237625|P1|STARTED|Overall Study||11
8206767|NCT02159469|20237630|P1|NOT COMPLETED|Overall Study||53
8206768|NCT02159469|20237630|P1|COMPLETED|Overall Study||97
8206769|NCT02159469|20237630|P1|Completed 12 Week|Overall Study||137
8206770|NCT02159469|20237630|P1|STARTED|Overall Study||150
8206771|NCT02159365|20237635|P1|NOT COMPLETED|Overall Study||70
8206772|NCT02159365|20237635|P1|COMPLETED|Overall Study|Completed = Still on treatment|0
8206773|NCT02159365|20237635|P1|STARTED|Overall Study||70
8206774|NCT02159352|20237642|P2|NOT COMPLETED|Overall Study||2
8206775|NCT02159352|20237643|P1|NOT COMPLETED|Overall Study||3
8206776|NCT02159352|20237642|P2|COMPLETED|Overall Study||12
8206777|NCT02159352|20237643|P1|COMPLETED|Overall Study||11
8206778|NCT02159352|20237642|P2|Phase 2 (Day 5-14)|Overall Study||12
8206779|NCT02159352|20237643|P1|Phase 2 (Day 5-14)|Overall Study||11
8206780|NCT02159352|20237642|P2|Phase 1 (Day 1- 4)|Overall Study||14
8206781|NCT02159352|20237643|P1|Phase 1 (Day 1- 4)|Overall Study||14
8206782|NCT02159352|20237642|P2|STARTED|Overall Study||14
8206783|NCT02159352|20237643|P1|STARTED|Overall Study||14
8206784|NCT02159183|20237695|P2|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
8206785|NCT02159183|20237696|P1|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
8206786|NCT02159183|20237695|P2|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
8206787|NCT02159183|20237696|P1|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
8206788|NCT02159183|20237695|P2|STARTED|Analysis of Primary Endpoint (12 Mts)||21
8206789|NCT02159183|20237696|P1|STARTED|Analysis of Primary Endpoint (12 Mts)||22
8206790|NCT02159183|20237695|P2|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
8206791|NCT02159183|20237696|P1|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
8206792|NCT02159183|20237695|P2|COMPLETED|Analysis After the 36 Months Follow-up||19
8206793|NCT02159183|20237696|P1|COMPLETED|Analysis After the 36 Months Follow-up||19
8206794|NCT02159183|20237695|P2|STARTED|Analysis After the 36 Months Follow-up||21
8206795|NCT02159183|20237696|P1|STARTED|Analysis After the 36 Months Follow-up||22
8206796|NCT02159118|20237722|P2|NOT COMPLETED|Overall Study||0
8206797|NCT02159118|20237723|P1|NOT COMPLETED|Overall Study||0
8206798|NCT02159118|20237722|P2|COMPLETED|Overall Study||22
8206799|NCT02159118|20237723|P1|COMPLETED|Overall Study||22
8206800|NCT02159118|20237722|P2|STARTED|Overall Study||22
8206801|NCT02159118|20237723|P1|STARTED|Overall Study||22
8206802|NCT02159079|20237747|P2|NOT COMPLETED|Overall Study||0
8206803|NCT02159079|20237748|P1|NOT COMPLETED|Overall Study||0
8206804|NCT02159079|20237747|P2|COMPLETED|Overall Study||15
8206805|NCT02159079|20237748|P1|COMPLETED|Overall Study||15
8206806|NCT02159079|20237747|P2|STARTED|Overall Study||15
8206807|NCT02159079|20237748|P1|STARTED|Overall Study||15
8206808|NCT02159053|20237769|P3|NOT COMPLETED|Overall Study||20
8206809|NCT02159053|20237770|P2|NOT COMPLETED|Overall Study||21
8206810|NCT02159053|20237771|P1|NOT COMPLETED|Overall Study||20
8206811|NCT02159053|20237769|P3|COMPLETED|Overall Study||97
8206812|NCT02159053|20237770|P2|COMPLETED|Overall Study||96
8206813|NCT02159053|20237771|P1|COMPLETED|Overall Study||96
8206814|NCT02159053|20237769|P3|Paticipants Week 16 Onwards|Overall Study||113
8206815|NCT02159053|20237770|P2|Paticipants Week 16 Onwards|Overall Study||117
8206816|NCT02159053|20237771|P1|Paticipants Week 16 Onwards|Overall Study||116
8206817|NCT02159053|20237769|P3|STARTED|Overall Study||117
8206818|NCT02159053|20237770|P2|STARTED|Overall Study||117
8206819|NCT02159053|20237771|P1|STARTED|Overall Study||116
8206820|NCT02159040|20237808|P1|NOT COMPLETED|Overall Study||1
8206821|NCT02159040|20237808|P1|COMPLETED|Overall Study||0
8206822|NCT02159040|20237808|P1|STARTED|Overall Study||1
8206823|NCT02158975|20237821|P1|NOT COMPLETED|Overall Study||1
8206824|NCT02158975|20237821|P1|COMPLETED|Overall Study||12
8206825|NCT02158975|20237821|P1|STARTED|Overall Study||13
8206826|NCT02158949|20237831|P2|NOT COMPLETED|Overall Study||11
8206827|NCT02158949|20237832|P1|NOT COMPLETED|Overall Study||6
8206828|NCT02158949|20237831|P2|COMPLETED|Overall Study||13
8206829|NCT02158949|20237832|P1|COMPLETED|Overall Study||18
8206830|NCT02158949|20237831|P2|STARTED|Overall Study||24
8206831|NCT02158949|20237832|P1|STARTED|Overall Study||24
8206832|NCT02158936|20237848|P2|NOT COMPLETED|Overall Study||177
8206833|NCT02158936|20237849|P1|NOT COMPLETED|Overall Study||179
8206834|NCT02158936|20237848|P2|COMPLETED|Overall Study||0
8206835|NCT02158936|20237849|P1|COMPLETED|Overall Study||0
8206836|NCT02158936|20237848|P2|Untreated|Overall Study||0
8206837|NCT02158936|20237849|P1|Untreated|Overall Study||2
8206838|NCT02158936|20237848|P2|Treated|Overall Study||177
8206839|NCT02158936|20237849|P1|Treated|Overall Study||177
8206840|NCT02158936|20237848|P2|STARTED|Overall Study||177
8206841|NCT02158936|20237849|P1|STARTED|Overall Study||179
8206842|NCT02158884|20237891|P1|NOT COMPLETED|12 Month Assessment||17
8206843|NCT02158884|20237891|P1|COMPLETED|12 Month Assessment||64
8206844|NCT02158884|20237891|P1|STARTED|12 Month Assessment||81
8206845|NCT02158884|20237891|P1|NOT COMPLETED|6 Month Assessment||20
8206846|NCT02158884|20237891|P1|COMPLETED|6 Month Assessment||61
8206847|NCT02158884|20237891|P1|STARTED|6 Month Assessment||81
8206848|NCT02158884|20237891|P1|NOT COMPLETED|Post Intervention (~4 Weeks)||10
8206849|NCT02158884|20237891|P1|COMPLETED|Post Intervention (~4 Weeks)||71
8206850|NCT02158884|20237891|P1|STARTED|Post Intervention (~4 Weeks)||81
8206851|NCT02158884|20237891|P1|NOT COMPLETED|Intervention: IDEO and PT Program||6
8206852|NCT02158884|20237891|P1|COMPLETED|Intervention: IDEO and PT Program||81
8206853|NCT02158884|20237891|P1|STARTED|Intervention: IDEO and PT Program||87
8206854|NCT02158884|20237891|P1|NOT COMPLETED|Baseline Assessment||4
8206855|NCT02158884|20237891|P1|COMPLETED|Baseline Assessment||87
8206856|NCT02158884|20237891|P1|STARTED|Baseline Assessment||91
8206857|NCT02158806|20237926|P2|NOT COMPLETED|Overall Study||5
8206858|NCT02158806|20237927|P1|NOT COMPLETED|Overall Study||4
8206859|NCT02158806|20237926|P2|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
8206860|NCT02158806|20237927|P1|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
8206861|NCT02158806|20237926|P2|STARTED|Overall Study||126
8206862|NCT02158806|20237927|P1|STARTED|Overall Study||125
8206863|NCT02158728|20237947|P1|NOT COMPLETED|Overall Study||27
8206864|NCT02158728|20237947|P1|COMPLETED|Overall Study||53
8206865|NCT02158728|20237947|P1|STARTED|Overall Study||80
8206866|NCT02158663|20237953|P2|NOT COMPLETED|Overall Study||4
8206867|NCT02158663|20237954|P1|NOT COMPLETED|Overall Study||5
8206868|NCT02158663|20237953|P2|COMPLETED|Overall Study||18
8206869|NCT02158663|20237954|P1|COMPLETED|Overall Study||17
8206870|NCT02158663|20237953|P2|STARTED|Overall Study||22
8206871|NCT02158663|20237954|P1|STARTED|Overall Study||22
8206872|NCT02158572|20237962|P1|NOT COMPLETED|Overall Study||1043
8206873|NCT02158572|20237962|P1|COMPLETED|Overall Study||989
8206874|NCT02158572|20237962|P1|STARTED|Overall Study||2032
8206875|NCT02158546|20237977|P4|NOT COMPLETED|Overall Study||6
8206876|NCT02158546|20237978|P3|NOT COMPLETED|Overall Study||4
8206877|NCT02158546|20237979|P2|NOT COMPLETED|Overall Study||17
8206878|NCT02158546|20237980|P1|NOT COMPLETED|Overall Study||19
8206879|NCT02158546|20237977|P4|COMPLETED|Overall Study||13
8206880|NCT02158546|20237978|P3|COMPLETED|Overall Study||14
8206881|NCT02158546|20237979|P2|COMPLETED|Overall Study||136
8206882|NCT02158546|20237980|P1|COMPLETED|Overall Study||133
8206883|NCT02158546|20237977|P4|STARTED|Overall Study||19
8206884|NCT02158546|20237978|P3|STARTED|Overall Study||18
8206885|NCT02158546|20237979|P2|STARTED|Overall Study||153
8206886|NCT02158546|20237980|P1|STARTED|Overall Study||152
8206887|NCT02158533|20237999|P6|NOT COMPLETED|Stage 2||6
8206888|NCT02158533|20238000|P5|NOT COMPLETED|Stage 2||4
8206889|NCT02158533|20238001|P4|NOT COMPLETED|Stage 2||3
8206890|NCT02158533|20238002|P3|NOT COMPLETED|Stage 2||0
8206891|NCT02158533|20238003|P2|NOT COMPLETED|Stage 2||0
8206892|NCT02158533|20238004|P1|NOT COMPLETED|Stage 2||0
8206893|NCT02158533|20237999|P6|COMPLETED|Stage 2||50
8206894|NCT02158533|20238000|P5|COMPLETED|Stage 2||52
8206895|NCT02158533|20238001|P4|COMPLETED|Stage 2||53
8206896|NCT02158533|20238002|P3|COMPLETED|Stage 2||0
8206897|NCT02158533|20238003|P2|COMPLETED|Stage 2||0
8206898|NCT02158533|20238004|P1|COMPLETED|Stage 2||0
8206899|NCT02158533|20237999|P6|STARTED|Stage 2||56
8206900|NCT02158533|20238000|P5|STARTED|Stage 2||56
8206901|NCT02158533|20238001|P4|STARTED|Stage 2||56
8206902|NCT02158533|20238002|P3|STARTED|Stage 2||0
8206903|NCT02158533|20238003|P2|STARTED|Stage 2||0
8206904|NCT02158533|20238004|P1|STARTED|Stage 2||0
8206905|NCT02158533|20237999|P6|NOT COMPLETED|Stage 1||0
8206906|NCT02158533|20238000|P5|NOT COMPLETED|Stage 1||0
8206907|NCT02158533|20238001|P4|NOT COMPLETED|Stage 1||0
8206908|NCT02158533|20238002|P3|NOT COMPLETED|Stage 1||8
8206909|NCT02158533|20238003|P2|NOT COMPLETED|Stage 1||8
8206910|NCT02158533|20238004|P1|NOT COMPLETED|Stage 1||14
8206911|NCT02158533|20237999|P6|COMPLETED|Stage 1||0
8206912|NCT02158533|20238000|P5|COMPLETED|Stage 1||0
8206913|NCT02158533|20238001|P4|COMPLETED|Stage 1||0
8206914|NCT02158533|20238002|P3|COMPLETED|Stage 1||52
8206915|NCT02158533|20238003|P2|COMPLETED|Stage 1||51
8206916|NCT02158533|20238004|P1|COMPLETED|Stage 1||251
8206917|NCT02158533|20237999|P6|STARTED|Stage 1||0
8206918|NCT02158533|20238000|P5|STARTED|Stage 1||0
8206919|NCT02158533|20238001|P4|STARTED|Stage 1||0
8206920|NCT02158533|20238002|P3|STARTED|Stage 1||60
8206921|NCT02158533|20238003|P2|STARTED|Stage 1||59
8206922|NCT02158533|20238004|P1|STARTED|Stage 1||265
8206923|NCT02158520|20238038|P2|NOT COMPLETED|Overall Study||0
8206924|NCT02158520|20238039|P1|NOT COMPLETED|Overall Study||0
8206925|NCT02158520|20238038|P2|COMPLETED|Overall Study||12
8206926|NCT02158520|20238039|P1|COMPLETED|Overall Study||12
8206927|NCT02158520|20238038|P2|Crossover Cohort|Overall Study||6
8206928|NCT02158520|20238039|P1|Crossover Cohort|Overall Study||4
8206929|NCT02158520|20238038|P2|Eligible for Crossover With AE Evaluated|Overall Study||7
8206930|NCT02158520|20238039|P1|Eligible for Crossover With AE Evaluated|Overall Study||7
8206931|NCT02158520|20238038|P2|Eligible for Crossover|Overall Study||8
8206932|NCT02158520|20238039|P1|Eligible for Crossover|Overall Study||8
8206933|NCT02158520|20238038|P2|AE Evaluated Prior to Crossover|Overall Study||12
8206934|NCT02158520|20238039|P1|AE Evaluated Prior to Crossover|Overall Study||12
8206935|NCT02158520|20238038|P2|STARTED|Overall Study||12
8206936|NCT02158520|20238039|P1|STARTED|Overall Study||12
8206937|NCT02158494|20238055|P2|NOT COMPLETED|Overall Study||1
8206938|NCT02158494|20238056|P1|NOT COMPLETED|Overall Study||0
8206939|NCT02158494|20238055|P2|COMPLETED|Overall Study||21
8206940|NCT02158494|20238056|P1|COMPLETED|Overall Study||22
8206941|NCT02158494|20238055|P2|STARTED|Overall Study||22
8206942|NCT02158494|20238056|P1|STARTED|Overall Study||22
8206943|NCT02158442|20238080|P2|NOT COMPLETED|Overall Study||0
8206944|NCT02158442|20238081|P1|NOT COMPLETED|Overall Study||2
8206945|NCT02158442|20238080|P2|COMPLETED|Overall Study||7
8206946|NCT02158442|20238081|P1|COMPLETED|Overall Study||6
8206947|NCT02158442|20238080|P2|STARTED|Overall Study||7
8206948|NCT02158442|20238081|P1|STARTED|Overall Study||8
8206949|NCT02158364|20238087|P1|NOT COMPLETED|Overall Study||60
8206950|NCT02158364|20238087|P1|COMPLETED|Overall Study||3271
8206951|NCT02158364|20238087|P1|STARTED|Overall Study||3331
8206952|NCT02158273|20238094|P2|NOT COMPLETED|Overall Study||3
8206953|NCT02158273|20238095|P1|NOT COMPLETED|Overall Study||3
8206954|NCT02158273|20238094|P2|COMPLETED|Overall Study||22
8206955|NCT02158273|20238095|P1|COMPLETED|Overall Study||22
8206956|NCT02158273|20238094|P2|STARTED|Overall Study||25
8206957|NCT02158273|20238095|P1|STARTED|Overall Study||25
8206958|NCT02158247|20238105|P1|NOT COMPLETED|Overall Study||5
8206959|NCT02158247|20238105|P1|COMPLETED|Overall Study||176
8206960|NCT02158247|20238105|P1|STARTED|Overall Study||181
8206961|NCT02158091|20238124|P3|NOT COMPLETED|Overall Study||0
8206962|NCT02158091|20238125|P2|NOT COMPLETED|Overall Study||1
8206963|NCT02158091|20238126|P1|NOT COMPLETED|Overall Study||2
8206964|NCT02158091|20238124|P3|COMPLETED|Overall Study||20
8206965|NCT02158091|20238125|P2|COMPLETED|Overall Study||5
8206966|NCT02158091|20238126|P1|COMPLETED|Overall Study||4
8206967|NCT02158091|20238124|P3|STARTED|Overall Study||20
8206968|NCT02158091|20238125|P2|STARTED|Overall Study||6
8206969|NCT02158091|20238126|P1|STARTED|Overall Study||6
8206970|NCT02158039|20238134|P1|NOT COMPLETED|Overall Study||10
8206971|NCT02158039|20238134|P1|COMPLETED|Overall Study||23
8206972|NCT02158039|20238134|P1|STARTED|Overall Study||33
8206973|NCT02157948|20238141|P2|NOT COMPLETED|Overall Study||9
8206974|NCT02157948|20238142|P1|NOT COMPLETED|Overall Study||9
8206975|NCT02157948|20238141|P2|COMPLETED|Overall Study||188
8206976|NCT02157948|20238142|P1|COMPLETED|Overall Study||188
8206977|NCT02157948|20238141|P2|Received Treatment|Overall Study||196
8206978|NCT02157948|20238142|P1|Received Treatment|Overall Study||196
8206979|NCT02157948|20238141|P2|STARTED|Overall Study||197
8206980|NCT02157948|20238142|P1|STARTED|Overall Study||197
8206981|NCT02157935|20238154|P2|NOT COMPLETED|Overall Study||65
8206982|NCT02157935|20238155|P1|NOT COMPLETED|Overall Study||39
8206983|NCT02157935|20238154|P2|COMPLETED|Overall Study||548
8206984|NCT02157935|20238155|P1|COMPLETED|Overall Study||567
8206985|NCT02157935|20238154|P2|STARTED|Overall Study||613
8206986|NCT02157935|20238155|P1|STARTED|Overall Study||606
8206987|NCT02157909|20238173|P2|NOT COMPLETED|Overall Study||0
8206988|NCT02157909|20238174|P1|NOT COMPLETED|Overall Study||0
8206989|NCT02157909|20238173|P2|COMPLETED|Overall Study||66
8206990|NCT02157909|20238174|P1|COMPLETED|Overall Study||66
8206991|NCT02157909|20238173|P2|STARTED|Overall Study||66
8206992|NCT02157909|20238174|P1|STARTED|Overall Study||66
8206993|NCT02157883|20238181|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
8206994|NCT02157883|20238181|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
8206995|NCT02157883|20238181|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
8206996|NCT02157883|20238181|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
8206997|NCT02157883|20238181|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
8206998|NCT02157883|20238181|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
8206999|NCT02157883|20238181|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
8207000|NCT02157883|20238181|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
8207001|NCT02157883|20238181|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
8207002|NCT02157779|20238212|P2|NOT COMPLETED|Overall Study||11
8207003|NCT02157779|20238213|P1|NOT COMPLETED|Overall Study||24
8207004|NCT02157779|20238212|P2|COMPLETED|Overall Study||34
8207005|NCT02157779|20238213|P1|COMPLETED|Overall Study||23
8207006|NCT02157779|20238212|P2|STARTED|Overall Study||45
8207007|NCT02157779|20238213|P1|STARTED|Overall Study||47
8207008|NCT02157623|20238235|P1|NOT COMPLETED|Overall Study||0
8207009|NCT02157623|20238235|P1|COMPLETED|Overall Study||3
8207010|NCT02157623|20238235|P1|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
8207011|NCT02157519|20238247|P2|NOT COMPLETED|Overall Study||1
8207012|NCT02157519|20238248|P1|NOT COMPLETED|Overall Study||11
8207013|NCT02157519|20238247|P2|COMPLETED|Overall Study||89
8207014|NCT02157519|20238248|P1|COMPLETED|Overall Study||80
8207015|NCT02157519|20238247|P2|MEMScap Collected|Overall Study||86
8207016|NCT02157519|20238248|P1|MEMScap Collected|Overall Study||84
8207017|NCT02157519|20238247|P2|STARTED|Overall Study||90
8207018|NCT02157519|20238248|P1|STARTED|Overall Study||91
8207019|NCT02157506|20238271|P5|NOT COMPLETED|Overall Study||0
8207020|NCT02157506|20238272|P4|NOT COMPLETED|Overall Study||0
8207021|NCT02157506|20238273|P3|NOT COMPLETED|Overall Study||1
8207022|NCT02157506|20238274|P2|NOT COMPLETED|Overall Study||1
8207023|NCT02157506|20238275|P1|NOT COMPLETED|Overall Study||0
8207024|NCT02157506|20238271|P5|COMPLETED|Overall Study||7
8207025|NCT02157506|20238272|P4|COMPLETED|Overall Study||12
8207026|NCT02157506|20238273|P3|COMPLETED|Overall Study||8
8207027|NCT02157506|20238274|P2|COMPLETED|Overall Study||5
8207028|NCT02157506|20238275|P1|COMPLETED|Overall Study||12
8207029|NCT02157506|20238271|P5|STARTED|Overall Study||7
8207030|NCT02157506|20238272|P4|STARTED|Overall Study||12
8207031|NCT02157506|20238273|P3|STARTED|Overall Study||9
8207032|NCT02157506|20238274|P2|STARTED|Overall Study||6
8207033|NCT02157506|20238275|P1|STARTED|Overall Study||12
8207034|NCT02157376|20238334|P2|NOT COMPLETED|Overall Study||18
8207035|NCT02157376|20238335|P1|NOT COMPLETED|Overall Study||22
8207036|NCT02157376|20238334|P2|COMPLETED|Overall Study||138
8207037|NCT02157376|20238335|P1|COMPLETED|Overall Study||133
8207038|NCT02157376|20238334|P2|STARTED|Overall Study||156
8207039|NCT02157376|20238335|P1|STARTED|Overall Study||155
8207040|NCT02157298|20238345|P2|NOT COMPLETED|Overall Study||2
8207041|NCT02157298|20238346|P1|NOT COMPLETED|Overall Study||4
8207042|NCT02157298|20238345|P2|COMPLETED|Overall Study||58
8207043|NCT02157298|20238346|P1|COMPLETED|Overall Study||119
8207044|NCT02157298|20238345|P2|STARTED|Overall Study||60
8207045|NCT02157298|20238346|P1|STARTED|Overall Study||123
8207046|NCT02157168|20238363|P3|NOT COMPLETED|Overall Study||0
8207047|NCT02157168|20238364|P2|NOT COMPLETED|Overall Study||0
8207048|NCT02157168|20238365|P1|NOT COMPLETED|Overall Study||0
8207049|NCT02157168|20238363|P3|COMPLETED|Overall Study||1362
8207050|NCT02157168|20238364|P2|COMPLETED|Overall Study||159
8207051|NCT02157168|20238365|P1|COMPLETED|Overall Study||746
8207052|NCT02157168|20238363|P3|STARTED|Overall Study||1362
8207053|NCT02157168|20238364|P2|STARTED|Overall Study||159
8207054|NCT02157168|20238365|P1|STARTED|Overall Study||746
8207055|NCT02157116|20238385|P1|NOT COMPLETED|Overall Study||9
8207056|NCT02157116|20238385|P1|COMPLETED|Overall Study||4
8207057|NCT02157116|20238385|P1|STARTED|Overall Study|signed consent form|13
8207058|NCT02157103|20238394|P1|NOT COMPLETED|Overall Study||0
8207059|NCT02157103|20238394|P1|COMPLETED|Overall Study||3
8207060|NCT02157103|20238394|P1|STARTED|Overall Study||3
8207061|NCT02156908|20238402|P2|NOT COMPLETED|Overall Study||0
8207062|NCT02156908|20238403|P1|NOT COMPLETED|Overall Study||0
8207063|NCT02156908|20238402|P2|COMPLETED|Overall Study||3
8207064|NCT02156908|20238403|P1|COMPLETED|Overall Study||5
8207065|NCT02156908|20238402|P2|STARTED|Overall Study||3
8207066|NCT02156908|20238403|P1|STARTED|Overall Study||5
8207067|NCT02156804|20238411|P1|NOT COMPLETED|Overall Study||1
8207068|NCT02156804|20238411|P1|COMPLETED|Overall Study||1008
8207069|NCT02156804|20238411|P1|STARTED|Overall Study||1009
8207070|NCT02156687|20238421|P2|NOT COMPLETED|Overall Study||5
8207071|NCT02156687|20238422|P1|NOT COMPLETED|Overall Study||10
8207072|NCT02156687|20238421|P2|COMPLETED|Overall Study||24
8207073|NCT02156687|20238422|P1|COMPLETED|Overall Study||20
8207074|NCT02156687|20238421|P2|STARTED|Overall Study||29
8207075|NCT02156687|20238422|P1|STARTED|Overall Study||30
8207076|NCT02156674|20238442|P1|NOT COMPLETED|Overall Study||0
8207077|NCT02156674|20238442|P1|COMPLETED|Overall Study||1
8207078|NCT02156674|20238442|P1|STARTED|Overall Study||1
8207079|NCT02156492|20238453|P3|NOT COMPLETED|Period 3||0
8207080|NCT02156492|20238454|P2|NOT COMPLETED|Period 3||1
8207081|NCT02156492|20238455|P1|NOT COMPLETED|Period 3||0
8207082|NCT02156492|20238453|P3|COMPLETED|Period 3||22
8207083|NCT02156492|20238454|P2|COMPLETED|Period 3||22
8207084|NCT02156492|20238455|P1|COMPLETED|Period 3||0
8207085|NCT02156492|20238453|P3|STARTED|Period 3||22
8207086|NCT02156492|20238454|P2|STARTED|Period 3||23
8207087|NCT02156492|20238455|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
8207088|NCT02156492|20238453|P3|NOT COMPLETED|Period 2||0
8207089|NCT02156492|20238454|P2|NOT COMPLETED|Period 2||0
8207090|NCT02156492|20238455|P1|NOT COMPLETED|Period 2||0
8207091|NCT02156492|20238453|P3|COMPLETED|Period 2||22
8207092|NCT02156492|20238454|P2|COMPLETED|Period 2||23
8207093|NCT02156492|20238455|P1|COMPLETED|Period 2||16
8207094|NCT02156492|20238453|P3|STARTED|Period 2||22
8207095|NCT02156492|20238454|P2|STARTED|Period 2||23
8207096|NCT02156492|20238455|P1|STARTED|Period 2||16
8207097|NCT02156492|20238453|P3|NOT COMPLETED|Period 1||0
8207098|NCT02156492|20238454|P2|NOT COMPLETED|Period 1||1
8207099|NCT02156492|20238455|P1|NOT COMPLETED|Period 1||0
8207100|NCT02156492|20238453|P3|COMPLETED|Period 1||22
8207101|NCT02156492|20238454|P2|COMPLETED|Period 1||23
8207102|NCT02156492|20238455|P1|COMPLETED|Period 1||16
8207103|NCT02156492|20238453|P3|Received at Least One Dose of Study Drug|Period 1||22
8207104|NCT02156492|20238454|P2|Received at Least One Dose of Study Drug|Period 1||24
8207105|NCT02156492|20238455|P1|Received at Least One Dose of Study Drug|Period 1||16
8207106|NCT02156492|20238453|P3|STARTED|Period 1||22
8207107|NCT02156492|20238454|P2|STARTED|Period 1||24
8207108|NCT02156492|20238455|P1|STARTED|Period 1||16
8207109|NCT02156466|20238481|P5|NOT COMPLETED|Overall Study||0
8207110|NCT02156466|20238482|P4|NOT COMPLETED|Overall Study||2
8207111|NCT02156466|20238483|P3|NOT COMPLETED|Overall Study||1
8207112|NCT02156466|20238484|P2|NOT COMPLETED|Overall Study||0
8207113|NCT02156466|20238485|P1|NOT COMPLETED|Overall Study||0
8207114|NCT02156466|20238481|P5|COMPLETED|Overall Study||8
8207115|NCT02156466|20238482|P4|COMPLETED|Overall Study||7
8207116|NCT02156466|20238483|P3|COMPLETED|Overall Study||7
8207117|NCT02156466|20238484|P2|COMPLETED|Overall Study||8
8207118|NCT02156466|20238485|P1|COMPLETED|Overall Study||8
8207119|NCT02156466|20238481|P5|STARTED|Overall Study||8
8207120|NCT02156466|20238482|P4|STARTED|Overall Study||9
8207121|NCT02156466|20238483|P3|STARTED|Overall Study||8
8207122|NCT02156466|20238484|P2|STARTED|Overall Study||8
8207123|NCT02156466|20238485|P1|STARTED|Overall Study||8
8207124|NCT02156271|20238666|P2|NOT COMPLETED|Overall Study||3
8207125|NCT02156271|20238667|P1|NOT COMPLETED|Overall Study||4
8207126|NCT02156271|20238666|P2|COMPLETED|Overall Study||10
8207127|NCT02156271|20238667|P1|COMPLETED|Overall Study||22
8207128|NCT02156271|20238666|P2|STARTED|Overall Study||13
8207129|NCT02156271|20238667|P1|STARTED|Overall Study||26
8207130|NCT02156258|20238702|P3|NOT COMPLETED|Overall Study||111
8207131|NCT02156258|20238703|P2|NOT COMPLETED|Overall Study||79
8207132|NCT02156258|20238704|P1|NOT COMPLETED|Overall Study||32
8207133|NCT02156258|20238702|P3|COMPLETED|Overall Study||244
8207134|NCT02156258|20238703|P2|COMPLETED|Overall Study||124
8207135|NCT02156258|20238704|P1|COMPLETED|Overall Study||642
8207136|NCT02156258|20238702|P3|STARTED|Overall Study||355
8207137|NCT02156258|20238703|P2|STARTED|Overall Study||203
8207138|NCT02156258|20238704|P1|STARTED|Overall Study||674
8207139|NCT02156167|20238712|P1|NOT COMPLETED|Overall Study||0
8207140|NCT02156167|20238712|P1|COMPLETED|Overall Study||15
8207141|NCT02156167|20238712|P1|STARTED|Overall Study||15
8207142|NCT02156076|20238720|P4|NOT COMPLETED|Follow-up Period||0
8207143|NCT02156076|20238721|P3|NOT COMPLETED|Follow-up Period||0
8207144|NCT02156076|20238722|P2|NOT COMPLETED|Follow-up Period||0
8207145|NCT02156076|20238723|P1|NOT COMPLETED|Follow-up Period||1
8207146|NCT02156076|20238720|P4|COMPLETED|Follow-up Period||4
8207147|NCT02156076|20238721|P3|COMPLETED|Follow-up Period||4
8207148|NCT02156076|20238722|P2|COMPLETED|Follow-up Period||5
8207149|NCT02156076|20238723|P1|COMPLETED|Follow-up Period||6
8207150|NCT02156076|20238720|P4|STARTED|Follow-up Period||4
8207151|NCT02156076|20238721|P3|STARTED|Follow-up Period||4
8207152|NCT02156076|20238722|P2|STARTED|Follow-up Period||5
8207153|NCT02156076|20238723|P1|STARTED|Follow-up Period||7
8207154|NCT02156076|20238720|P4|NOT COMPLETED|Treatment Period||2
8207155|NCT02156076|20238721|P3|NOT COMPLETED|Treatment Period||2
8207156|NCT02156076|20238722|P2|NOT COMPLETED|Treatment Period||2
8207157|NCT02156076|20238723|P1|NOT COMPLETED|Treatment Period||0
8207158|NCT02156076|20238720|P4|COMPLETED|Treatment Period||4
8207159|NCT02156076|20238721|P3|COMPLETED|Treatment Period||4
8207160|NCT02156076|20238722|P2|COMPLETED|Treatment Period||5
8207161|NCT02156076|20238723|P1|COMPLETED|Treatment Period||7
8207162|NCT02156076|20238720|P4|STARTED|Treatment Period||6
8207163|NCT02156076|20238721|P3|STARTED|Treatment Period||6
8207164|NCT02156076|20238722|P2|STARTED|Treatment Period||7
8207165|NCT02156076|20238723|P1|STARTED|Treatment Period||7
8207166|NCT02155985|20238780|P3|NOT COMPLETED|Overall Study||1
8207167|NCT02155985|20238781|P2|NOT COMPLETED|Overall Study||0
8207168|NCT02155985|20238782|P1|NOT COMPLETED|Overall Study||1
8207169|NCT02155985|20238780|P3|COMPLETED|Overall Study||39
8207170|NCT02155985|20238781|P2|COMPLETED|Overall Study||41
8207171|NCT02155985|20238782|P1|COMPLETED|Overall Study||39
8207172|NCT02155985|20238780|P3|STARTED|Overall Study||40
8207173|NCT02155985|20238781|P2|STARTED|Overall Study||41
8207174|NCT02155985|20238782|P1|STARTED|Overall Study||40
8207175|NCT02155881|20238849|P2|NOT COMPLETED|Overall Study||4
8207176|NCT02155881|20238850|P1|NOT COMPLETED|Overall Study||2
8207177|NCT02155881|20238849|P2|COMPLETED|Overall Study||36
8207178|NCT02155881|20238850|P1|COMPLETED|Overall Study||38
8207179|NCT02155881|20238849|P2|STARTED|Overall Study||40
8207180|NCT02155881|20238850|P1|STARTED|Overall Study||40
8207181|NCT02155829|20238872|P2|NOT COMPLETED|Overall Study||3
8207182|NCT02155829|20238873|P1|NOT COMPLETED|Overall Study||6
8207183|NCT02155829|20238872|P2|COMPLETED|Overall Study||35
8207184|NCT02155829|20238873|P1|COMPLETED|Overall Study||31
8207185|NCT02155829|20238872|P2|STARTED|Overall Study||38
8207186|NCT02155829|20238873|P1|STARTED|Overall Study||37
8207187|NCT02155738|20238895|P4|NOT COMPLETED|Overall Study||1
8207188|NCT02155738|20238896|P3|NOT COMPLETED|Overall Study||0
8207189|NCT02155738|20238897|P2|NOT COMPLETED|Overall Study||0
8207190|NCT02155738|20238898|P1|NOT COMPLETED|Overall Study||1
8207191|NCT02155738|20238895|P4|COMPLETED|Overall Study||50
8207192|NCT02155738|20238896|P3|COMPLETED|Overall Study||51
8207193|NCT02155738|20238897|P2|COMPLETED|Overall Study||52
8207194|NCT02155738|20238898|P1|COMPLETED|Overall Study||49
8207195|NCT02155738|20238895|P4|STARTED|Overall Study||51
8207196|NCT02155738|20238896|P3|STARTED|Overall Study||51
8207197|NCT02155738|20238897|P2|STARTED|Overall Study||52
8207198|NCT02155738|20238898|P1|STARTED|Overall Study||50
8207199|NCT02155725|20238918|P2|NOT COMPLETED|Follow-up Period||11
8207200|NCT02155725|20238919|P1|NOT COMPLETED|Follow-up Period||17
8207201|NCT02155725|20238918|P2|COMPLETED|Follow-up Period||202
8207202|NCT02155725|20238919|P1|COMPLETED|Follow-up Period||207
8207203|NCT02155725|20238918|P2|STARTED|Follow-up Period||213
8207204|NCT02155725|20238919|P1|STARTED|Follow-up Period||224
8207205|NCT02155725|20238918|P2|NOT COMPLETED|Treatment Period||0
8207206|NCT02155725|20238919|P1|NOT COMPLETED|Treatment Period||0
8207207|NCT02155725|20238918|P2|COMPLETED|Treatment Period||213
8207208|NCT02155725|20238919|P1|COMPLETED|Treatment Period||224
8207209|NCT02155725|20238918|P2|STARTED|Treatment Period||213
8207210|NCT02155725|20238919|P1|STARTED|Treatment Period||224
8207211|NCT02155712|20238935|P2|NOT COMPLETED|Secondary Objectives||134
8207212|NCT02155712|20238936|P1|NOT COMPLETED|Secondary Objectives||319
8207213|NCT02155712|20238935|P2|COMPLETED|Secondary Objectives||0
8207214|NCT02155712|20238936|P1|COMPLETED|Secondary Objectives||0
8207215|NCT02155712|20238935|P2|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
8207216|NCT02155712|20238936|P1|STARTED|Secondary Objectives||319
8207217|NCT02155712|20238935|P2|NOT COMPLETED|Primary Objective||0
8207218|NCT02155712|20238936|P1|NOT COMPLETED|Primary Objective||60
8207219|NCT02155712|20238935|P2|COMPLETED|Primary Objective||0
8207220|NCT02155712|20238936|P1|COMPLETED|Primary Objective||259
8207221|NCT02155712|20238935|P2|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
8207222|NCT02155712|20238936|P1|STARTED|Primary Objective||319
8207223|NCT02155660|20238946|P4|NOT COMPLETED|Overall Study||61
8207224|NCT02155660|20238947|P3|NOT COMPLETED|Overall Study||60
8207225|NCT02155660|20238948|P2|NOT COMPLETED|Overall Study||73
8207226|NCT02155660|20238949|P1|NOT COMPLETED|Overall Study||58
8207227|NCT02155660|20238946|P4|COMPLETED|Overall Study||507
8207228|NCT02155660|20238947|P3|COMPLETED|Overall Study||502
8207229|NCT02155660|20238948|P2|COMPLETED|Overall Study||489
8207230|NCT02155660|20238949|P1|COMPLETED|Overall Study||504
8207231|NCT02155660|20238946|P4|STARTED|Overall Study||568
8207232|NCT02155660|20238947|P3|STARTED|Overall Study||562
8207233|NCT02155660|20238948|P2|STARTED|Overall Study||562
8207234|NCT02155660|20238949|P1|STARTED|Overall Study||562
8207235|NCT02155647|20239032|P2|NOT COMPLETED|Overall Study||52
8207236|NCT02155647|20239033|P1|NOT COMPLETED|Overall Study||41
8207237|NCT02155647|20239032|P2|COMPLETED|Overall Study||64
8207238|NCT02155647|20239033|P1|COMPLETED|Overall Study||47
8207239|NCT02155647|20239032|P2|STARTED|Overall Study||116
8207240|NCT02155647|20239033|P1|STARTED|Overall Study||88
8207241|NCT02155608|20239061|P2|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
8207242|NCT02155608|20239062|P1|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
8207243|NCT02155608|20239061|P2|COMPLETED|1b: 1 Week Blinded Post Treatment||28
8207244|NCT02155608|20239062|P1|COMPLETED|1b: 1 Week Blinded Post Treatment||31
8207245|NCT02155608|20239061|P2|STARTED|1b: 1 Week Blinded Post Treatment||29
8207246|NCT02155608|20239062|P1|STARTED|1b: 1 Week Blinded Post Treatment||32
8207247|NCT02155608|20239061|P2|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
8207248|NCT02155608|20239062|P1|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
8207249|NCT02155608|20239061|P2|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
8207250|NCT02155608|20239062|P1|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
8207251|NCT02155608|20239061|P2|STARTED|1a: 4 Week Double Blind Sham Controlled||30
8207252|NCT02155608|20239062|P1|STARTED|1a: 4 Week Double Blind Sham Controlled||32
8207253|NCT02155543|20239101|P7|NOT COMPLETED|Overall Study||0
8207254|NCT02155543|20239102|P6|NOT COMPLETED|Overall Study||0
8207255|NCT02155543|20239103|P5|NOT COMPLETED|Overall Study||0
8207256|NCT02155543|20239104|P4|NOT COMPLETED|Overall Study||0
8207257|NCT02155543|20239105|P3|NOT COMPLETED|Overall Study||0
8207258|NCT02155543|20239106|P2|NOT COMPLETED|Overall Study||0
8207259|NCT02155543|20239107|P1|NOT COMPLETED|Overall Study||0
8207260|NCT02155543|20239101|P7|COMPLETED|Overall Study||9
8207261|NCT02155543|20239102|P6|COMPLETED|Overall Study||3
8207262|NCT02155543|20239103|P5|COMPLETED|Overall Study||3
8207263|NCT02155543|20239104|P4|COMPLETED|Overall Study||9
8207264|NCT02155543|20239105|P3|COMPLETED|Overall Study||9
8207265|NCT02155543|20239106|P2|COMPLETED|Overall Study||9
8207266|NCT02155543|20239107|P1|COMPLETED|Overall Study||9
8207267|NCT02155543|20239101|P7|STARTED|Overall Study||9
8207268|NCT02155543|20239102|P6|STARTED|Overall Study||3
8207269|NCT02155543|20239103|P5|STARTED|Overall Study||3
8207270|NCT02155543|20239104|P4|STARTED|Overall Study||9
8207271|NCT02155543|20239105|P3|STARTED|Overall Study||9
8207272|NCT02155543|20239106|P2|STARTED|Overall Study||9
8207273|NCT02155543|20239107|P1|STARTED|Overall Study||9
8207274|NCT02155465|20239127|P7|NOT COMPLETED|Overall Study||0
8207275|NCT02155465|20239128|P6|NOT COMPLETED|Overall Study||0
8207276|NCT02155465|20239129|P5|NOT COMPLETED|Overall Study||0
8207277|NCT02155465|20239130|P4|NOT COMPLETED|Overall Study||0
8207278|NCT02155465|20239131|P3|NOT COMPLETED|Overall Study||0
8207279|NCT02155465|20239132|P2|NOT COMPLETED|Overall Study||0
8207280|NCT02155465|20239133|P1|NOT COMPLETED|Overall Study||0
8207281|NCT02155465|20239127|P7|COMPLETED|Overall Study||5
8207282|NCT02155465|20239128|P6|COMPLETED|Overall Study||2
8207283|NCT02155465|20239129|P5|COMPLETED|Overall Study||1
8207284|NCT02155465|20239130|P4|COMPLETED|Overall Study||2
8207285|NCT02155465|20239131|P3|COMPLETED|Overall Study||6
8207286|NCT02155465|20239132|P2|COMPLETED|Overall Study||3
8207287|NCT02155465|20239133|P1|COMPLETED|Overall Study||3
8207288|NCT02155465|20239127|P7|STARTED|Overall Study||5
8207289|NCT02155465|20239128|P6|STARTED|Overall Study||2
8207290|NCT02155465|20239129|P5|STARTED|Overall Study||1
8207291|NCT02155465|20239130|P4|STARTED|Overall Study||2
8207292|NCT02155465|20239131|P3|STARTED|Overall Study||6
8207293|NCT02155465|20239132|P2|STARTED|Overall Study||3
8207294|NCT02155465|20239133|P1|STARTED|Overall Study||3
8207295|NCT02155335|20239153|P2|NOT COMPLETED|Period 2||0
8207296|NCT02155335|20239154|P1|NOT COMPLETED|Period 2||0
8207297|NCT02155335|20239153|P2|COMPLETED|Period 2||49
8207298|NCT02155335|20239154|P1|COMPLETED|Period 2||50
8207299|NCT02155335|20239153|P2|STARTED|Period 2||49
8207300|NCT02155335|20239154|P1|STARTED|Period 2||50
8207301|NCT02155335|20239153|P2|NOT COMPLETED|Period 1||1
8207302|NCT02155335|20239154|P1|NOT COMPLETED|Period 1||0
8207303|NCT02155335|20239153|P2|COMPLETED|Period 1||49
8207304|NCT02155335|20239154|P1|COMPLETED|Period 1||50
8207305|NCT02155335|20239153|P2|Treated|Period 1||49
8207306|NCT02155335|20239154|P1|Treated|Period 1||50
8207307|NCT02155335|20239153|P2|STARTED|Period 1||50
8207308|NCT02155335|20239154|P1|STARTED|Period 1||50
8207309|NCT02155322|20239159|P1|NOT COMPLETED|Overall Study||14
8207310|NCT02155322|20239159|P1|COMPLETED|Overall Study||19
8207311|NCT02155322|20239159|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
8207312|NCT02155322|20239159|P1|STARTED|Overall Study||33
8207313|NCT02155309|20239166|P3|NOT COMPLETED|Overall Study||1
8207314|NCT02155309|20239167|P2|NOT COMPLETED|Overall Study||0
8207315|NCT02155309|20239168|P1|NOT COMPLETED|Overall Study||0
8207316|NCT02155309|20239166|P3|COMPLETED|Overall Study||12
8207317|NCT02155309|20239167|P2|COMPLETED|Overall Study||10
8207318|NCT02155309|20239168|P1|COMPLETED|Overall Study||13
8207319|NCT02155309|20239166|P3|STARTED|Overall Study||13
8207320|NCT02155309|20239167|P2|STARTED|Overall Study||10
8207321|NCT02155309|20239168|P1|STARTED|Overall Study||13
8207322|NCT02155283|20239175|P1|NOT COMPLETED|Overall Study||7
8207323|NCT02155283|20239175|P1|COMPLETED|Overall Study||9
8207324|NCT02155283|20239175|P1|STARTED|Overall Study||16
8207325|NCT02155257|20239183|P3|NOT COMPLETED|Overall Study||0
8207326|NCT02155257|20239184|P2|NOT COMPLETED|Overall Study||0
8207327|NCT02155257|20239185|P1|NOT COMPLETED|Overall Study||0
8207328|NCT02155257|20239183|P3|COMPLETED|Overall Study||10
8207329|NCT02155257|20239184|P2|COMPLETED|Overall Study||10
8207330|NCT02155257|20239185|P1|COMPLETED|Overall Study||10
8207331|NCT02155257|20239183|P3|STARTED|Overall Study||10
8207332|NCT02155257|20239184|P2|STARTED|Overall Study||10
8207333|NCT02155257|20239185|P1|STARTED|Overall Study||10
8207334|NCT02155101|20239201|P2|NOT COMPLETED|Overall Study||1
8207335|NCT02155101|20239202|P1|NOT COMPLETED|Overall Study||0
8207336|NCT02155101|20239201|P2|COMPLETED|Overall Study||80
8207337|NCT02155101|20239202|P1|COMPLETED|Overall Study||39
8207338|NCT02155101|20239201|P2|STARTED|Overall Study||81
8207339|NCT02155101|20239202|P1|STARTED|Overall Study||39
8207340|NCT02155010|20239214|P2|NOT COMPLETED|Overall Study||6
8207341|NCT02155010|20239215|P1|NOT COMPLETED|Overall Study||6
8207342|NCT02155010|20239214|P2|COMPLETED|Overall Study||31
8207343|NCT02155010|20239215|P1|COMPLETED|Overall Study||31
8207344|NCT02155010|20239214|P2|STARTED|Overall Study||37
8207345|NCT02155010|20239215|P1|STARTED|Overall Study||37
8207346|NCT02154906|20239225|P2|NOT COMPLETED|Overall Study||3
8207347|NCT02154906|20239226|P1|NOT COMPLETED|Overall Study||2
8207348|NCT02154906|20239225|P2|COMPLETED|Overall Study||17
8207349|NCT02154906|20239226|P1|COMPLETED|Overall Study||19
8207350|NCT02154906|20239225|P2|STARTED|Overall Study||20
8207351|NCT02154906|20239226|P1|STARTED|Overall Study||21
8207352|NCT02154763|20239236|P2|NOT COMPLETED|Overall Study||14
8207353|NCT02154763|20239237|P1|NOT COMPLETED|Overall Study||14
8207354|NCT02154763|20239236|P2|COMPLETED|Overall Study||46
8207355|NCT02154763|20239237|P1|COMPLETED|Overall Study||46
8207356|NCT02154763|20239236|P2|STARTED|Overall Study||60
8207357|NCT02154763|20239237|P1|STARTED|Overall Study||60
8207358|NCT02154581|20239351|P2|NOT COMPLETED|Overall Study||8
8207359|NCT02154581|20239352|P1|NOT COMPLETED|Overall Study||7
8207360|NCT02154581|20239351|P2|COMPLETED|Overall Study||12
8207361|NCT02154581|20239352|P1|COMPLETED|Overall Study||14
8207362|NCT02154581|20239351|P2|STARTED|Overall Study||20
8207363|NCT02154581|20239352|P1|STARTED|Overall Study||21
8207364|NCT02154477|20239370|P2|NOT COMPLETED|Overall Study||0
8207365|NCT02154477|20239371|P1|NOT COMPLETED|Overall Study||0
8207366|NCT02154477|20239370|P2|COMPLETED|Overall Study||8
8207367|NCT02154477|20239371|P1|COMPLETED|Overall Study||6
8207368|NCT02154477|20239370|P2|STARTED|Overall Study||8
8207369|NCT02154477|20239371|P1|STARTED|Overall Study||6
8207370|NCT02154425|20239377|P1|NOT COMPLETED|Sampling Period||0
8207371|NCT02154425|20239377|P1|COMPLETED|Sampling Period||17
8207372|NCT02154425|20239377|P1|STARTED|Sampling Period||17
8207373|NCT02154425|20239377|P1|NOT COMPLETED|Screening Period||1
8207374|NCT02154425|20239377|P1|COMPLETED|Screening Period||17
8207375|NCT02154425|20239377|P1|STARTED|Screening Period||18
8207376|NCT02154386|20239409|P2|NOT COMPLETED|Overall Study||2
8207377|NCT02154386|20239410|P1|NOT COMPLETED|Overall Study||1
8207378|NCT02154386|20239409|P2|COMPLETED|Overall Study||21
8207379|NCT02154386|20239410|P1|COMPLETED|Overall Study||22
8207380|NCT02154386|20239409|P2|STARTED|Overall Study||23
8207381|NCT02154386|20239410|P1|STARTED|Overall Study||23
8207382|NCT02154347|20239422|P2|NOT COMPLETED|Open-label Period||25
8207383|NCT02154347|20239423|P1|NOT COMPLETED|Open-label Period||7
8207384|NCT02154347|20239422|P2|COMPLETED|Open-label Period||88
8207385|NCT02154347|20239423|P1|COMPLETED|Open-label Period||50
8207386|NCT02154347|20239422|P2|STARTED|Open-label Period||113
8207387|NCT02154347|20239423|P1|STARTED|Open-label Period||57
8207388|NCT02154347|20239422|P2|NOT COMPLETED|Double-blind Period||4
8207389|NCT02154347|20239423|P1|NOT COMPLETED|Double-blind Period||3
8207390|NCT02154347|20239422|P2|COMPLETED|Double-blind Period||114
8207391|NCT02154347|20239423|P1|COMPLETED|Double-blind Period||57
8207392|NCT02154347|20239422|P2|STARTED|Double-blind Period||118
8207393|NCT02154347|20239423|P1|STARTED|Double-blind Period||60
8207394|NCT02154243|20239433|P3|NOT COMPLETED|Overall Study||0
8207395|NCT02154243|20239434|P2|NOT COMPLETED|Overall Study||0
8207396|NCT02154243|20239435|P1|NOT COMPLETED|Overall Study||0
8207397|NCT02154243|20239433|P3|COMPLETED|Overall Study||4
8207398|NCT02154243|20239434|P2|COMPLETED|Overall Study||4
8207399|NCT02154243|20239435|P1|COMPLETED|Overall Study||5
8207400|NCT02154243|20239433|P3|STARTED|Overall Study||4
8207401|NCT02154243|20239434|P2|STARTED|Overall Study||4
8207402|NCT02154243|20239435|P1|STARTED|Overall Study||5
8207403|NCT02154139|20239446|P1|NOT COMPLETED|Overall Study||7
8207404|NCT02154139|20239446|P1|COMPLETED|Overall Study||644
8207405|NCT02154139|20239446|P1|STARTED|Overall Study||651
8207406|NCT02154087|20239454|P1|NOT COMPLETED|Overall Study||1
8207407|NCT02154087|20239454|P1|COMPLETED|Overall Study||0
8207408|NCT02154087|20239454|P1|STARTED|Overall Study||1
8207409|NCT02154061|20239460|P2|NOT COMPLETED|Overall Study||0
8207410|NCT02154061|20239461|P1|NOT COMPLETED|Overall Study||2
8207411|NCT02154061|20239460|P2|COMPLETED|Overall Study||17
8207412|NCT02154061|20239461|P1|COMPLETED|Overall Study||14
8207413|NCT02154061|20239460|P2|STARTED|Overall Study||17
8207414|NCT02154061|20239461|P1|STARTED|Overall Study||16
8207415|NCT02154048|20239470|P3|NOT COMPLETED|Overall Study||0
8207416|NCT02154048|20239471|P2|NOT COMPLETED|Overall Study||0
8207417|NCT02154048|20239472|P1|NOT COMPLETED|Overall Study||0
8207418|NCT02154048|20239470|P3|COMPLETED|Overall Study||1
8207419|NCT02154048|20239471|P2|COMPLETED|Overall Study||2
8207420|NCT02154048|20239472|P1|COMPLETED|Overall Study||2
8207421|NCT02154048|20239470|P3|STARTED|Overall Study||1
8207422|NCT02154048|20239471|P2|STARTED|Overall Study||2
8207423|NCT02154048|20239472|P1|STARTED|Overall Study||2
8207424|NCT02153983|20239486|P6|NOT COMPLETED|Overall Study||0
8207425|NCT02153983|20239487|P5|NOT COMPLETED|Overall Study||0
8207426|NCT02153983|20239488|P4|NOT COMPLETED|Overall Study||0
8207427|NCT02153983|20239489|P3|NOT COMPLETED|Overall Study||2
8207428|NCT02153983|20239490|P2|NOT COMPLETED|Overall Study||3
8207429|NCT02153983|20239491|P1|NOT COMPLETED|Overall Study||0
8207430|NCT02153983|20239486|P6|COMPLETED|Overall Study||1
8207431|NCT02153983|20239487|P5|COMPLETED|Overall Study||19
8207432|NCT02153983|20239488|P4|COMPLETED|Overall Study||13
8207433|NCT02153983|20239489|P3|COMPLETED|Overall Study||2
8207434|NCT02153983|20239490|P2|COMPLETED|Overall Study||18
8207435|NCT02153983|20239491|P1|COMPLETED|Overall Study||19
8207436|NCT02153983|20239486|P6|STARTED|Overall Study||1
8207437|NCT02153983|20239487|P5|STARTED|Overall Study||19
8207438|NCT02153983|20239488|P4|STARTED|Overall Study||13
8207439|NCT02153983|20239489|P3|STARTED|Overall Study||4
8207440|NCT02153983|20239490|P2|STARTED|Overall Study||21
8207441|NCT02153983|20239491|P1|STARTED|Overall Study||19
8207442|NCT02153918|20239508|P1|NOT COMPLETED|Overall Study||1
8207443|NCT02153918|20239508|P1|COMPLETED|Overall Study||26
8207444|NCT02153918|20239508|P1|STARTED|Overall Study||27
8207445|NCT02153905|20239519|P2|NOT COMPLETED|Overall Study||0
8207446|NCT02153905|20239520|P1|NOT COMPLETED|Overall Study||1
8207447|NCT02153905|20239519|P2|COMPLETED|Overall Study||2
8207448|NCT02153905|20239520|P1|COMPLETED|Overall Study||0
8207449|NCT02153905|20239519|P2|STARTED|Overall Study||2
8207450|NCT02153905|20239520|P1|STARTED|Overall Study||1
8207451|NCT02153827|20239538|P2|NOT COMPLETED|Overall Study||9
8207452|NCT02153827|20239539|P1|NOT COMPLETED|Overall Study||3
8207453|NCT02153827|20239538|P2|COMPLETED|Overall Study||14
8207454|NCT02153827|20239539|P1|COMPLETED|Overall Study||22
8207455|NCT02153827|20239538|P2|STARTED|Overall Study||23
8207456|NCT02153827|20239539|P1|STARTED|Overall Study||25
8207457|NCT02153788|20239555|P2|NOT COMPLETED|Overall Study||1
8207458|NCT02153788|20239556|P1|NOT COMPLETED|Overall Study||2
8207459|NCT02153788|20239555|P2|COMPLETED|Overall Study||18
8207460|NCT02153788|20239556|P1|COMPLETED|Overall Study||23
8207461|NCT02153788|20239555|P2|STARTED|Overall Study||19
8207462|NCT02153788|20239556|P1|STARTED|Overall Study||25
8207463|NCT02153736|20239576|P2|NOT COMPLETED|Overall Study||2
8207464|NCT02153736|20239577|P1|NOT COMPLETED|Overall Study||2
8207465|NCT02153736|20239576|P2|COMPLETED|Overall Study||5
8207466|NCT02153736|20239577|P1|COMPLETED|Overall Study||5
8207467|NCT02153736|20239576|P2|STARTED|Overall Study||7
8207468|NCT02153736|20239577|P1|STARTED|Overall Study||7
8207469|NCT02153723|20239593|P1|NOT COMPLETED|Overall Study||0
8207470|NCT02153723|20239593|P1|COMPLETED|Overall Study||10
8207471|NCT02153723|20239593|P1|STARTED|Overall Study||10
8207472|NCT02153710|20239604|P2|NOT COMPLETED|Overall Study||0
8207473|NCT02153710|20239605|P1|NOT COMPLETED|Overall Study||0
8207474|NCT02153710|20239604|P2|COMPLETED|Overall Study||30
8207475|NCT02153710|20239605|P1|COMPLETED|Overall Study||28
8207476|NCT02153710|20239604|P2|STARTED|Overall Study||30
8207477|NCT02153710|20239605|P1|STARTED|Overall Study||28
8207478|NCT02153671|20239617|P2|NOT COMPLETED|Overall Study||0
8207479|NCT02153671|20239618|P1|NOT COMPLETED|Overall Study||0
8207480|NCT02153671|20239617|P2|COMPLETED|Overall Study||24
8207481|NCT02153671|20239618|P1|COMPLETED|Overall Study||19
8207482|NCT02153671|20239617|P2|STARTED|Overall Study||24
8207483|NCT02153671|20239618|P1|STARTED|Overall Study||19
8207484|NCT02153645|20239697|P3|NOT COMPLETED|Overall Study||10
8207485|NCT02153645|20239698|P2|NOT COMPLETED|Overall Study||10
8207486|NCT02153645|20239699|P1|NOT COMPLETED|Overall Study||13
8207487|NCT02153645|20239697|P3|COMPLETED|Overall Study||18
8207488|NCT02153645|20239698|P2|COMPLETED|Overall Study||19
8207489|NCT02153645|20239699|P1|COMPLETED|Overall Study||17
8207490|NCT02153645|20239697|P3|STARTED|Overall Study||28
8207491|NCT02153645|20239698|P2|STARTED|Overall Study||29
8207492|NCT02153645|20239699|P1|STARTED|Overall Study||30
8207493|NCT02153632|20239713|P3|NOT COMPLETED|Overall Study||19
8207494|NCT02153632|20239714|P2|NOT COMPLETED|Overall Study||19
8207495|NCT02153632|20239715|P1|NOT COMPLETED|Overall Study||18
8207496|NCT02153632|20239713|P3|COMPLETED|Overall Study||25
8207497|NCT02153632|20239714|P2|COMPLETED|Overall Study||27
8207498|NCT02153632|20239715|P1|COMPLETED|Overall Study||27
8207499|NCT02153632|20239713|P3|STARTED|Overall Study||44
8207500|NCT02153632|20239714|P2|STARTED|Overall Study||46
8207501|NCT02153632|20239715|P1|STARTED|Overall Study||45
8207502|NCT02153528|20239728|P2|NOT COMPLETED|Overall Study||0
8207503|NCT02153528|20239729|P1|NOT COMPLETED|Overall Study||0
8207504|NCT02153528|20239728|P2|COMPLETED|Overall Study||353
8207505|NCT02153528|20239729|P1|COMPLETED|Overall Study||348
8207506|NCT02153528|20239728|P2|STARTED|Overall Study||353
8207507|NCT02153528|20239729|P1|STARTED|Overall Study||348
8207508|NCT02153489|20239751|P2|NOT COMPLETED|Period 2||0
8207509|NCT02153489|20239752|P1|NOT COMPLETED|Period 2||0
8207510|NCT02153489|20239751|P2|COMPLETED|Period 2||15
8207511|NCT02153489|20239752|P1|COMPLETED|Period 2||15
8207512|NCT02153489|20239751|P2|STARTED|Period 2||15
8207513|NCT02153489|20239752|P1|STARTED|Period 2||15
8207514|NCT02153489|20239751|P2|NOT COMPLETED|Period 1||0
8207515|NCT02153489|20239752|P1|NOT COMPLETED|Period 1||0
8207516|NCT02153489|20239751|P2|COMPLETED|Period 1||15
8207517|NCT02153489|20239752|P1|COMPLETED|Period 1||15
8207518|NCT02153489|20239751|P2|STARTED|Period 1||15
8207519|NCT02153489|20239752|P1|STARTED|Period 1||15
8207520|NCT02153476|20239792|P2|NOT COMPLETED|Overall Study||0
8207521|NCT02153476|20239793|P1|NOT COMPLETED|Overall Study||1
8207522|NCT02153476|20239792|P2|COMPLETED|Overall Study||22
8207523|NCT02153476|20239793|P1|COMPLETED|Overall Study||22
8207524|NCT02153476|20239792|P2|STARTED|Overall Study||22
8207525|NCT02153476|20239793|P1|STARTED|Overall Study||23
8207526|NCT02153398|20239804|P5|NOT COMPLETED|Overall Study||0
8207527|NCT02153398|20239805|P4|NOT COMPLETED|Overall Study||1
8207528|NCT02153398|20239806|P3|NOT COMPLETED|Overall Study||1
8207529|NCT02153398|20239807|P2|NOT COMPLETED|Overall Study||0
8207530|NCT02153398|20239808|P1|NOT COMPLETED|Overall Study||1
8207531|NCT02153398|20239804|P5|COMPLETED|Overall Study||10
8207532|NCT02153398|20239805|P4|COMPLETED|Overall Study||9
8207533|NCT02153398|20239806|P3|COMPLETED|Overall Study||9
8207534|NCT02153398|20239807|P2|COMPLETED|Overall Study||10
8207535|NCT02153398|20239808|P1|COMPLETED|Overall Study||9
8207536|NCT02153398|20239804|P5|STARTED|Overall Study||10
8207537|NCT02153398|20239805|P4|STARTED|Overall Study||10
8207538|NCT02153398|20239806|P3|STARTED|Overall Study||10
8207539|NCT02153398|20239807|P2|STARTED|Overall Study||10
8207540|NCT02153398|20239808|P1|STARTED|Overall Study||10
8207541|NCT02153359|20239930|P2|NOT COMPLETED|Intervention 2 (1 Month)||2
8207542|NCT02153359|20239931|P1|NOT COMPLETED|Intervention 2 (1 Month)||0
8207543|NCT02153359|20239930|P2|COMPLETED|Intervention 2 (1 Month)||10
8207544|NCT02153359|20239931|P1|COMPLETED|Intervention 2 (1 Month)||11
8207545|NCT02153359|20239930|P2|STARTED|Intervention 2 (1 Month)||12
8207546|NCT02153359|20239931|P1|STARTED|Intervention 2 (1 Month)||11
8207547|NCT02153359|20239930|P2|NOT COMPLETED|Washout (at Least 1 Month)||0
8207548|NCT02153359|20239931|P1|NOT COMPLETED|Washout (at Least 1 Month)||0
8207549|NCT02153359|20239930|P2|COMPLETED|Washout (at Least 1 Month)||12
8207550|NCT02153359|20239931|P1|COMPLETED|Washout (at Least 1 Month)||11
8207551|NCT02153359|20239930|P2|STARTED|Washout (at Least 1 Month)||12
8207552|NCT02153359|20239931|P1|STARTED|Washout (at Least 1 Month)||11
8207553|NCT02153359|20239930|P2|NOT COMPLETED|Intervention 1 (1 Month)||0
8207554|NCT02153359|20239931|P1|NOT COMPLETED|Intervention 1 (1 Month)||0
8207555|NCT02153359|20239930|P2|COMPLETED|Intervention 1 (1 Month)||12
8207556|NCT02153359|20239931|P1|COMPLETED|Intervention 1 (1 Month)||11
8207557|NCT02153359|20239930|P2|STARTED|Intervention 1 (1 Month)||12
8207558|NCT02153359|20239931|P1|STARTED|Intervention 1 (1 Month)||11
8207559|NCT02153346|20239965|P1|NOT COMPLETED|Overall Study||11
8207560|NCT02153346|20239965|P1|COMPLETED|Overall Study||90
8207561|NCT02153346|20239965|P1|STARTED|Overall Study||101
8207562|NCT02153112|20239982|P10|NOT COMPLETED|Overall Study||14
8207563|NCT02153112|20239983|P9|NOT COMPLETED|Overall Study||15
8207564|NCT02153112|20239984|P8|NOT COMPLETED|Overall Study||2
8207565|NCT02153112|20239985|P7|NOT COMPLETED|Overall Study||8
8207566|NCT02153112|20239986|P6|NOT COMPLETED|Overall Study||2
8207567|NCT02153112|20239987|P5|NOT COMPLETED|Overall Study||3
8207568|NCT02153112|20239988|P4|NOT COMPLETED|Overall Study||2
8207569|NCT02153112|20239989|P3|NOT COMPLETED|Overall Study||3
8207570|NCT02153112|20239990|P2|NOT COMPLETED|Overall Study||2
8207571|NCT02153112|20239991|P1|NOT COMPLETED|Overall Study||4
8207572|NCT02153112|20239982|P10|COMPLETED|Overall Study||166
8207573|NCT02153112|20239983|P9|COMPLETED|Overall Study||165
8207574|NCT02153112|20239984|P8|COMPLETED|Overall Study||58
8207575|NCT02153112|20239985|P7|COMPLETED|Overall Study||52
8207576|NCT02153112|20239986|P6|COMPLETED|Overall Study||58
8207577|NCT02153112|20239987|P5|COMPLETED|Overall Study||57
8207578|NCT02153112|20239988|P4|COMPLETED|Overall Study||57
8207579|NCT02153112|20239989|P3|COMPLETED|Overall Study||58
8207580|NCT02153112|20239990|P2|COMPLETED|Overall Study||57
8207581|NCT02153112|20239991|P1|COMPLETED|Overall Study||57
8207582|NCT02153112|20239982|P10|STARTED|Overall Study||180
8207583|NCT02153112|20239983|P9|STARTED|Overall Study||180
8207584|NCT02153112|20239984|P8|STARTED|Overall Study||60
8207585|NCT02153112|20239985|P7|STARTED|Overall Study||60
8207586|NCT02153112|20239986|P6|STARTED|Overall Study||60
8207587|NCT02153112|20239987|P5|STARTED|Overall Study||60
8207588|NCT02153112|20239988|P4|STARTED|Overall Study||59
8207589|NCT02153112|20239989|P3|STARTED|Overall Study||61
8207590|NCT02153112|20239990|P2|STARTED|Overall Study||59
8207591|NCT02153112|20239991|P1|STARTED|Overall Study||61
8207592|NCT02153099|20240270|P7|NOT COMPLETED|Overall Study||0
8207593|NCT02153099|20240271|P6|NOT COMPLETED|Overall Study||0
8207594|NCT02153099|20240272|P5|NOT COMPLETED|Overall Study||0
8207595|NCT02153099|20240273|P4|NOT COMPLETED|Overall Study||0
8207596|NCT02153099|20240274|P3|NOT COMPLETED|Overall Study||0
8207597|NCT02153099|20240275|P2|NOT COMPLETED|Overall Study||0
8207598|NCT02153099|20240276|P1|NOT COMPLETED|Overall Study||0
8207599|NCT02153099|20240270|P7|COMPLETED|Overall Study||12
8207600|NCT02153099|20240271|P6|COMPLETED|Overall Study||6
8207601|NCT02153099|20240272|P5|COMPLETED|Overall Study||6
8207602|NCT02153099|20240273|P4|COMPLETED|Overall Study||6
8207603|NCT02153099|20240274|P3|COMPLETED|Overall Study||6
8207604|NCT02153099|20240275|P2|COMPLETED|Overall Study||6
8207605|NCT02153099|20240276|P1|COMPLETED|Overall Study||6
8207606|NCT02153099|20240270|P7|STARTED|Overall Study||12
8207607|NCT02153099|20240271|P6|STARTED|Overall Study||6
8207608|NCT02153099|20240272|P5|STARTED|Overall Study||6
8207609|NCT02153099|20240273|P4|STARTED|Overall Study||6
8207610|NCT02153099|20240274|P3|STARTED|Overall Study||6
8207611|NCT02153099|20240275|P2|STARTED|Overall Study||6
8207612|NCT02153099|20240276|P1|STARTED|Overall Study||6
8207613|NCT02153086|20240330|P1|NOT COMPLETED|Overall Study||4
8207614|NCT02153086|20240330|P1|COMPLETED|Overall Study||232
8207615|NCT02153086|20240330|P1|STARTED|Overall Study||236
8207616|NCT02153073|20240344|P1|NOT COMPLETED|Overall Study||298
8207617|NCT02153073|20240344|P1|COMPLETED|Overall Study||2786
8207618|NCT02153073|20240344|P1|STARTED|Overall Study||3084
8207619|NCT02152826|20240359|P2|NOT COMPLETED|Overall Study||1
8207620|NCT02152826|20240360|P1|NOT COMPLETED|Overall Study||1
8207621|NCT02152826|20240359|P2|COMPLETED|Overall Study||34
8207622|NCT02152826|20240360|P1|COMPLETED|Overall Study||44
8207623|NCT02152826|20240359|P2|STARTED|Overall Study||35
8207624|NCT02152826|20240360|P1|STARTED|Overall Study||45
8207625|NCT02152761|20240372|P4|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
8207626|NCT02152761|20240373|P3|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
8207627|NCT02152761|20240374|P2|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
8207628|NCT02152761|20240375|P1|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
8207629|NCT02152761|20240372|P4|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
8207630|NCT02152761|20240373|P3|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
8207631|NCT02152761|20240374|P2|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
8207632|NCT02152761|20240375|P1|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
8207633|NCT02152761|20240372|P4|STARTED|Epoch: Post-treatment Follow-up Epoch||68
8207634|NCT02152761|20240373|P3|STARTED|Epoch: Post-treatment Follow-up Epoch||30
8207635|NCT02152761|20240374|P2|STARTED|Epoch: Post-treatment Follow-up Epoch||54
8207636|NCT02152761|20240375|P1|STARTED|Epoch: Post-treatment Follow-up Epoch||67
8207637|NCT02152761|20240372|P4|NOT COMPLETED|Epoch: Treatment Epoch||8
8207638|NCT02152761|20240373|P3|NOT COMPLETED|Epoch: Treatment Epoch||5
8207639|NCT02152761|20240374|P2|NOT COMPLETED|Epoch: Treatment Epoch||20
8207640|NCT02152761|20240375|P1|NOT COMPLETED|Epoch: Treatment Epoch||11
8207641|NCT02152761|20240372|P4|COMPLETED|Epoch: Treatment Epoch||64
8207642|NCT02152761|20240373|P3|COMPLETED|Epoch: Treatment Epoch||29
8207643|NCT02152761|20240374|P2|COMPLETED|Epoch: Treatment Epoch||50
8207644|NCT02152761|20240375|P1|COMPLETED|Epoch: Treatment Epoch||64
8207645|NCT02152761|20240372|P4|STARTED|Epoch: Treatment Epoch||72
8207646|NCT02152761|20240373|P3|STARTED|Epoch: Treatment Epoch||34
8207647|NCT02152761|20240374|P2|STARTED|Epoch: Treatment Epoch||70
8207648|NCT02152761|20240375|P1|STARTED|Epoch: Treatment Epoch||75
8207649|NCT02152696|20240399|P3|NOT COMPLETED|Overall Study||1
8207650|NCT02152696|20240400|P2|NOT COMPLETED|Overall Study||1
8207651|NCT02152696|20240401|P1|NOT COMPLETED|Overall Study||0
8207652|NCT02152696|20240399|P3|COMPLETED|Overall Study||81
8207653|NCT02152696|20240400|P2|COMPLETED|Overall Study||86
8207654|NCT02152696|20240401|P1|COMPLETED|Overall Study||86
8207655|NCT02152696|20240399|P3|STARTED|Overall Study||82
8207656|NCT02152696|20240400|P2|STARTED|Overall Study||87
8207657|NCT02152696|20240401|P1|STARTED|Overall Study||86
8207661|NCT02152631|20240415|P2|NOT COMPLETED|Overall Study||26
8207662|NCT02152631|20240416|P1|NOT COMPLETED|Overall Study||66
8207663|NCT02152631|20240415|P2|COMPLETED|Overall Study||157
8207664|NCT02152631|20240416|P1|COMPLETED|Overall Study||204
8207665|NCT02152631|20240415|P2|Progressive Disease|Overall Study||137
8207666|NCT02152631|20240416|P1|Progressive Disease|Overall Study||174
8207667|NCT02152631|20240415|P2|Death Due to Any Cause|Overall Study||20
8207668|NCT02152631|20240416|P1|Death Due to Any Cause|Overall Study||30
8207669|NCT02152631|20240415|P2|Off Treatment|Overall Study||172
8207670|NCT02152631|20240416|P1|Off Treatment|Overall Study||246
8207671|NCT02152631|20240415|P2|Received at Least One Dose of Study Drug|Overall Study||175
8207672|NCT02152631|20240416|P1|Received at Least One Dose of Study Drug|Overall Study||265
8207673|NCT02152631|20240415|P2|STARTED|Overall Study||183
8207674|NCT02152631|20240416|P1|STARTED|Overall Study||270
8207675|NCT02152605|20240435|P2|NOT COMPLETED|Overall Study||18
8207676|NCT02152605|20240436|P1|NOT COMPLETED|Overall Study||19
8207677|NCT02152605|20240435|P2|COMPLETED|Overall Study||230
8207678|NCT02152605|20240436|P1|COMPLETED|Overall Study||229
8207679|NCT02152605|20240435|P2|STARTED|Overall Study||248
8207680|NCT02152605|20240436|P1|STARTED|Overall Study||248
8207681|NCT02152566|20240446|P1|NOT COMPLETED|Overall Study||3
8207682|NCT02152566|20240446|P1|COMPLETED|Overall Study||3
8207683|NCT02152566|20240446|P1|STARTED|Overall Study||6
8207684|NCT02152540|20240452|P2|NOT COMPLETED|Overall Study||0
8207685|NCT02152540|20240453|P1|NOT COMPLETED|Overall Study||0
8207686|NCT02152540|20240452|P2|COMPLETED|Overall Study||16
8207687|NCT02152540|20240453|P1|COMPLETED|Overall Study||17
8207688|NCT02152540|20240452|P2|STARTED|Overall Study||16
8207689|NCT02152540|20240453|P1|STARTED|Overall Study||17
8207690|NCT02152384|20240469|P2|NOT COMPLETED|Period 2||0
8207691|NCT02152384|20240470|P1|NOT COMPLETED|Period 2||0
8207692|NCT02152384|20240469|P2|COMPLETED|Period 2||12
8207693|NCT02152384|20240470|P1|COMPLETED|Period 2||13
8207694|NCT02152384|20240469|P2|STARTED|Period 2||12
8207695|NCT02152384|20240470|P1|STARTED|Period 2||13
8207696|NCT02152384|20240469|P2|NOT COMPLETED|Period 1||2
8207697|NCT02152384|20240470|P1|NOT COMPLETED|Period 1||1
8207698|NCT02152384|20240469|P2|COMPLETED|Period 1||12
8207699|NCT02152384|20240470|P1|COMPLETED|Period 1||13
8207700|NCT02152384|20240469|P2|Received at Least 1 Dose of Study Drug|Period 1||14
8207701|NCT02152384|20240470|P1|Received at Least 1 Dose of Study Drug|Period 1||14
8207702|NCT02152384|20240469|P2|STARTED|Period 1||14
8207703|NCT02152384|20240470|P1|STARTED|Period 1||14
8207704|NCT02152384|20240469|P2|NOT COMPLETED|Run In (1-5 Week Transition)||0
8207705|NCT02152384|20240470|P1|NOT COMPLETED|Run In (1-5 Week Transition)||0
8207706|NCT02152384|20240469|P2|COMPLETED|Run In (1-5 Week Transition)||14
8207707|NCT02152384|20240470|P1|COMPLETED|Run In (1-5 Week Transition)||14
8207708|NCT02152384|20240469|P2|STARTED|Run In (1-5 Week Transition)||14
8207709|NCT02152384|20240470|P1|STARTED|Run In (1-5 Week Transition)||14
8207710|NCT02152371|20240490|P2|NOT COMPLETED|Overall Study||16
8207711|NCT02152371|20240491|P1|NOT COMPLETED|Overall Study||12
8207712|NCT02152371|20240490|P2|COMPLETED|Overall Study||134
8207713|NCT02152371|20240491|P1|COMPLETED|Overall Study||138
8207714|NCT02152371|20240490|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
8207715|NCT02152371|20240491|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
8207716|NCT02152371|20240490|P2|STARTED|Overall Study||150
8207717|NCT02152371|20240491|P1|STARTED|Overall Study||150
8207724|NCT02152137|20240542|P1|NOT COMPLETED|Overall Study||4
8207725|NCT02152137|20240542|P1|COMPLETED|Overall Study||15
8207726|NCT02152137|20240542|P1|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
8207727|NCT02152137|20240542|P1|Originally Assigned to Arm A|Overall Study||16
8207728|NCT02152137|20240542|P1|STARTED|Overall Study||19
8207729|NCT02152007|20240550|P1|NOT COMPLETED|Overall Study||1
8207730|NCT02152007|20240550|P1|COMPLETED|Overall Study||14
8207731|NCT02152007|20240550|P1|STARTED|Overall Study||15
8207732|NCT02151994|20240559|P13|NOT COMPLETED|Food Effect (FE): Fed||0
8207733|NCT02151994|20240560|P12|NOT COMPLETED|Food Effect (FE): Fed||0
8207734|NCT02151994|20240561|P11|NOT COMPLETED|Food Effect (FE): Fed||0
8207735|NCT02151994|20240562|P10|NOT COMPLETED|Food Effect (FE): Fed||0
8207736|NCT02151994|20240563|P9|NOT COMPLETED|Food Effect (FE): Fed||0
8207737|NCT02151994|20240564|P8|NOT COMPLETED|Food Effect (FE): Fed||0
8207738|NCT02151994|20240565|P7|NOT COMPLETED|Food Effect (FE): Fed||0
8207739|NCT02151994|20240566|P6|NOT COMPLETED|Food Effect (FE): Fed||0
8207740|NCT02151994|20240567|P5|NOT COMPLETED|Food Effect (FE): Fed||0
8207741|NCT02151994|20240568|P4|NOT COMPLETED|Food Effect (FE): Fed||0
8207742|NCT02151994|20240569|P3|NOT COMPLETED|Food Effect (FE): Fed||0
8207743|NCT02151994|20240570|P2|NOT COMPLETED|Food Effect (FE): Fed||0
8207744|NCT02151994|20240571|P1|NOT COMPLETED|Food Effect (FE): Fed||0
8207745|NCT02151994|20240559|P13|COMPLETED|Food Effect (FE): Fed||12
8207746|NCT02151994|20240560|P12|COMPLETED|Food Effect (FE): Fed||0
8207747|NCT02151994|20240561|P11|COMPLETED|Food Effect (FE): Fed||0
8207748|NCT02151994|20240562|P10|COMPLETED|Food Effect (FE): Fed||0
8207749|NCT02151994|20240563|P9|COMPLETED|Food Effect (FE): Fed||0
8207750|NCT02151994|20240564|P8|COMPLETED|Food Effect (FE): Fed||0
8207751|NCT02151994|20240565|P7|COMPLETED|Food Effect (FE): Fed||0
8207752|NCT02151994|20240566|P6|COMPLETED|Food Effect (FE): Fed||0
8207753|NCT02151994|20240567|P5|COMPLETED|Food Effect (FE): Fed||0
8207754|NCT02151994|20240568|P4|COMPLETED|Food Effect (FE): Fed||0
8207755|NCT02151994|20240569|P3|COMPLETED|Food Effect (FE): Fed||0
8207756|NCT02151994|20240570|P2|COMPLETED|Food Effect (FE): Fed||0
8207757|NCT02151994|20240571|P1|COMPLETED|Food Effect (FE): Fed||0
8207758|NCT02151994|20240559|P13|STARTED|Food Effect (FE): Fed||12
8207759|NCT02151994|20240560|P12|STARTED|Food Effect (FE): Fed||0
8207760|NCT02151994|20240561|P11|STARTED|Food Effect (FE): Fed||0
8207761|NCT02151994|20240562|P10|STARTED|Food Effect (FE): Fed||0
8207762|NCT02151994|20240563|P9|STARTED|Food Effect (FE): Fed||0
8207763|NCT02151994|20240564|P8|STARTED|Food Effect (FE): Fed||0
8207764|NCT02151994|20240565|P7|STARTED|Food Effect (FE): Fed||0
8207765|NCT02151994|20240566|P6|STARTED|Food Effect (FE): Fed||0
8207766|NCT02151994|20240567|P5|STARTED|Food Effect (FE): Fed||0
8207767|NCT02151994|20240568|P4|STARTED|Food Effect (FE): Fed||0
8207768|NCT02151994|20240569|P3|STARTED|Food Effect (FE): Fed||0
8207769|NCT02151994|20240570|P2|STARTED|Food Effect (FE): Fed||0
8207770|NCT02151994|20240571|P1|STARTED|Food Effect (FE): Fed||0
8207771|NCT02151994|20240559|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
8207772|NCT02151994|20240560|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
8207773|NCT02151994|20240561|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
8207774|NCT02151994|20240562|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
8207775|NCT02151994|20240563|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
8207776|NCT02151994|20240564|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
8207777|NCT02151994|20240565|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
8207778|NCT02151994|20240566|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
8207779|NCT02151994|20240567|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
8207780|NCT02151994|20240568|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
8207781|NCT02151994|20240569|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
8207782|NCT02151994|20240570|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
8207783|NCT02151994|20240571|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
8207784|NCT02151994|20240559|P13|COMPLETED|Food Effect (FE): Fasted||0
8207785|NCT02151994|20240560|P12|COMPLETED|Food Effect (FE): Fasted||12
8207786|NCT02151994|20240561|P11|COMPLETED|Food Effect (FE): Fasted||0
8207787|NCT02151994|20240562|P10|COMPLETED|Food Effect (FE): Fasted||0
8207788|NCT02151994|20240563|P9|COMPLETED|Food Effect (FE): Fasted||0
8207789|NCT02151994|20240564|P8|COMPLETED|Food Effect (FE): Fasted||0
8207790|NCT02151994|20240565|P7|COMPLETED|Food Effect (FE): Fasted||0
8207791|NCT02151994|20240566|P6|COMPLETED|Food Effect (FE): Fasted||0
8207792|NCT02151994|20240567|P5|COMPLETED|Food Effect (FE): Fasted||0
8207793|NCT02151994|20240568|P4|COMPLETED|Food Effect (FE): Fasted||0
8207794|NCT02151994|20240569|P3|COMPLETED|Food Effect (FE): Fasted||0
8207795|NCT02151994|20240570|P2|COMPLETED|Food Effect (FE): Fasted||0
8207796|NCT02151994|20240571|P1|COMPLETED|Food Effect (FE): Fasted||0
8207797|NCT02151994|20240559|P13|STARTED|Food Effect (FE): Fasted||0
8207798|NCT02151994|20240560|P12|STARTED|Food Effect (FE): Fasted||12
8207799|NCT02151994|20240561|P11|STARTED|Food Effect (FE): Fasted||0
8207800|NCT02151994|20240562|P10|STARTED|Food Effect (FE): Fasted||0
8207801|NCT02151994|20240563|P9|STARTED|Food Effect (FE): Fasted||0
8207802|NCT02151994|20240564|P8|STARTED|Food Effect (FE): Fasted||0
8207803|NCT02151994|20240565|P7|STARTED|Food Effect (FE): Fasted||0
8207804|NCT02151994|20240566|P6|STARTED|Food Effect (FE): Fasted||0
8207805|NCT02151994|20240567|P5|STARTED|Food Effect (FE): Fasted||0
8207806|NCT02151994|20240568|P4|STARTED|Food Effect (FE): Fasted||0
8207807|NCT02151994|20240569|P3|STARTED|Food Effect (FE): Fasted||0
8207808|NCT02151994|20240570|P2|STARTED|Food Effect (FE): Fasted||0
8207809|NCT02151994|20240571|P1|STARTED|Food Effect (FE): Fasted||0
8207810|NCT02151994|20240559|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207811|NCT02151994|20240560|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207812|NCT02151994|20240561|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207813|NCT02151994|20240562|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207814|NCT02151994|20240563|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207815|NCT02151994|20240564|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207816|NCT02151994|20240565|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207817|NCT02151994|20240566|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207818|NCT02151994|20240567|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207819|NCT02151994|20240568|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207820|NCT02151994|20240569|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207821|NCT02151994|20240570|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207822|NCT02151994|20240571|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207823|NCT02151994|20240559|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
8207824|NCT02151994|20240560|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
8207825|NCT02151994|20240561|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
8207826|NCT02151994|20240562|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
8207827|NCT02151994|20240563|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
8207828|NCT02151994|20240564|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
8207829|NCT02151994|20240565|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
8207830|NCT02151994|20240566|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
8207831|NCT02151994|20240567|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
8207832|NCT02151994|20240568|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
8207833|NCT02151994|20240569|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
8207834|NCT02151994|20240570|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
8207835|NCT02151994|20240571|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
8207836|NCT02151994|20240559|P13|STARTED|Multiple Ascending Dose (MAD)||0
8207837|NCT02151994|20240560|P12|STARTED|Multiple Ascending Dose (MAD)||0
8207838|NCT02151994|20240561|P11|STARTED|Multiple Ascending Dose (MAD)||0
8207839|NCT02151994|20240562|P10|STARTED|Multiple Ascending Dose (MAD)||0
8207840|NCT02151994|20240563|P9|STARTED|Multiple Ascending Dose (MAD)||6
8207841|NCT02151994|20240564|P8|STARTED|Multiple Ascending Dose (MAD)||0
8207842|NCT02151994|20240565|P7|STARTED|Multiple Ascending Dose (MAD)||6
8207843|NCT02151994|20240566|P6|STARTED|Multiple Ascending Dose (MAD)||6
8207844|NCT02151994|20240567|P5|STARTED|Multiple Ascending Dose (MAD)||6
8207845|NCT02151994|20240568|P4|STARTED|Multiple Ascending Dose (MAD)||6
8207846|NCT02151994|20240569|P3|STARTED|Multiple Ascending Dose (MAD)||0
8207847|NCT02151994|20240570|P2|STARTED|Multiple Ascending Dose (MAD)||0
8207848|NCT02151994|20240571|P1|STARTED|Multiple Ascending Dose (MAD)||10
8207849|NCT02151994|20240559|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207850|NCT02151994|20240560|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207851|NCT02151994|20240561|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207852|NCT02151994|20240562|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207853|NCT02151994|20240563|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207854|NCT02151994|20240564|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207855|NCT02151994|20240565|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207856|NCT02151994|20240566|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207857|NCT02151994|20240567|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207858|NCT02151994|20240568|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207859|NCT02151994|20240569|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207860|NCT02151994|20240570|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207861|NCT02151994|20240571|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207862|NCT02151994|20240559|P13|COMPLETED|Single Ascending Dose (SAD)||0
8207863|NCT02151994|20240560|P12|COMPLETED|Single Ascending Dose (SAD)||0
8207864|NCT02151994|20240561|P11|COMPLETED|Single Ascending Dose (SAD)||6
8207865|NCT02151994|20240562|P10|COMPLETED|Single Ascending Dose (SAD)||6
8207866|NCT02151994|20240563|P9|COMPLETED|Single Ascending Dose (SAD)||0
8207867|NCT02151994|20240564|P8|COMPLETED|Single Ascending Dose (SAD)||6
8207868|NCT02151994|20240565|P7|COMPLETED|Single Ascending Dose (SAD)||6
8207869|NCT02151994|20240566|P6|COMPLETED|Single Ascending Dose (SAD)||6
8207870|NCT02151994|20240567|P5|COMPLETED|Single Ascending Dose (SAD)||6
8207871|NCT02151994|20240568|P4|COMPLETED|Single Ascending Dose (SAD)||6
8207872|NCT02151994|20240569|P3|COMPLETED|Single Ascending Dose (SAD)||6
8207873|NCT02151994|20240570|P2|COMPLETED|Single Ascending Dose (SAD)||6
8207874|NCT02151994|20240571|P1|COMPLETED|Single Ascending Dose (SAD)||18
8207875|NCT02151994|20240559|P13|STARTED|Single Ascending Dose (SAD)||0
8207876|NCT02151994|20240560|P12|STARTED|Single Ascending Dose (SAD)||0
8207877|NCT02151994|20240561|P11|STARTED|Single Ascending Dose (SAD)||6
8207878|NCT02151994|20240562|P10|STARTED|Single Ascending Dose (SAD)||6
8207879|NCT02151994|20240563|P9|STARTED|Single Ascending Dose (SAD)||0
8207880|NCT02151994|20240564|P8|STARTED|Single Ascending Dose (SAD)||6
8207881|NCT02151994|20240565|P7|STARTED|Single Ascending Dose (SAD)||6
8207882|NCT02151994|20240566|P6|STARTED|Single Ascending Dose (SAD)||6
8207883|NCT02151994|20240567|P5|STARTED|Single Ascending Dose (SAD)||6
8207884|NCT02151994|20240568|P4|STARTED|Single Ascending Dose (SAD)||6
8207885|NCT02151994|20240569|P3|STARTED|Single Ascending Dose (SAD)||6
8207886|NCT02151994|20240570|P2|STARTED|Single Ascending Dose (SAD)||6
8207887|NCT02151994|20240571|P1|STARTED|Single Ascending Dose (SAD)||18
8207900|NCT02151903|20240630|P2|NOT COMPLETED|Overall Study||1
8207901|NCT02151903|20240631|P1|NOT COMPLETED|Overall Study||3
8207902|NCT02151903|20240630|P2|COMPLETED|Overall Study||1
8207903|NCT02151903|20240631|P1|COMPLETED|Overall Study||0
8207904|NCT02151903|20240630|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8207905|NCT02151903|20240631|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8207906|NCT02151903|20240630|P2|STARTED|Overall Study||2
8207907|NCT02151903|20240631|P1|STARTED|Overall Study||3
8207908|NCT02151877|20240649|P2|NOT COMPLETED|Overall Study||0
8207909|NCT02151877|20240650|P1|NOT COMPLETED|Overall Study||0
8207910|NCT02151877|20240649|P2|COMPLETED|Overall Study||12
8207911|NCT02151877|20240650|P1|COMPLETED|Overall Study||12
8207912|NCT02151877|20240649|P2|STARTED|Overall Study||12
8207913|NCT02151877|20240650|P1|STARTED|Overall Study||12
8207914|NCT02151851|20240668|P2|NOT COMPLETED|Overall Study||130
8207915|NCT02151851|20240669|P1|NOT COMPLETED|Overall Study||76
8207916|NCT02151851|20240668|P2|COMPLETED|Overall Study||186
8207917|NCT02151851|20240669|P1|COMPLETED|Overall Study||38
8207918|NCT02151851|20240668|P2|Included in the Safety Set|Overall Study||316
8207919|NCT02151851|20240669|P1|Included in the Safety Set|Overall Study||113
8207920|NCT02151851|20240668|P2|STARTED|Overall Study||316
8207921|NCT02151851|20240669|P1|STARTED|Overall Study||114
8207922|NCT02151786|20240681|P1|NOT COMPLETED|Overall Study||36
8207923|NCT02151786|20240681|P1|COMPLETED|Overall Study||1084
8207924|NCT02151786|20240681|P1|STARTED|Overall Study||1120
8207925|NCT02151773|20240692|P1|NOT COMPLETED|Overall Study||64
8207926|NCT02151773|20240692|P1|COMPLETED|Overall Study||3429
8207927|NCT02151773|20240692|P1|STARTED|Overall Study||3493
8207928|NCT02151682|20240699|P6|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
8207929|NCT02151682|20240700|P5|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207930|NCT02151682|20240701|P4|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207931|NCT02151682|20240702|P3|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207932|NCT02151682|20240703|P2|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207933|NCT02151682|20240704|P1|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207934|NCT02151682|20240699|P6|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
8207935|NCT02151682|20240700|P5|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207936|NCT02151682|20240701|P4|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207937|NCT02151682|20240702|P3|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207938|NCT02151682|20240703|P2|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207939|NCT02151682|20240704|P1|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207940|NCT02151682|20240699|P6|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
8207941|NCT02151682|20240700|P5|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8207942|NCT02151682|20240701|P4|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8207943|NCT02151682|20240702|P3|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8207944|NCT02151682|20240703|P2|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
8207945|NCT02151682|20240704|P1|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
8207946|NCT02151682|20240699|P6|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207947|NCT02151682|20240700|P5|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207948|NCT02151682|20240701|P4|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
8207949|NCT02151682|20240702|P3|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
8207950|NCT02151682|20240703|P2|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207951|NCT02151682|20240704|P1|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207952|NCT02151682|20240699|P6|COMPLETED|Part 2: Tapent. Extension or Observation||0
8207953|NCT02151682|20240700|P5|COMPLETED|Part 2: Tapent. Extension or Observation||14
8207954|NCT02151682|20240701|P4|COMPLETED|Part 2: Tapent. Extension or Observation||14
8207955|NCT02151682|20240702|P3|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
8207956|NCT02151682|20240703|P2|COMPLETED|Part 2: Tapent. Extension or Observation||0
8207957|NCT02151682|20240704|P1|COMPLETED|Part 2: Tapent. Extension or Observation||0
8207958|NCT02151682|20240699|P6|STARTED|Part 2: Tapent. Extension or Observation||0
8207959|NCT02151682|20240700|P5|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
8207960|NCT02151682|20240701|P4|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
8207961|NCT02151682|20240702|P3|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
8207962|NCT02151682|20240703|P2|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
8207963|NCT02151682|20240704|P1|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
8207964|NCT02151682|20240699|P6|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207965|NCT02151682|20240700|P5|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207966|NCT02151682|20240701|P4|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207967|NCT02151682|20240702|P3|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207968|NCT02151682|20240703|P2|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
8207969|NCT02151682|20240704|P1|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
8207970|NCT02151682|20240699|P6|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207971|NCT02151682|20240700|P5|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207972|NCT02151682|20240701|P4|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207973|NCT02151682|20240702|P3|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207974|NCT02151682|20240703|P2|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
8207975|NCT02151682|20240704|P1|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
8207976|NCT02151682|20240699|P6|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207977|NCT02151682|20240700|P5|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207978|NCT02151682|20240701|P4|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207979|NCT02151682|20240702|P3|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207980|NCT02151682|20240703|P2|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
8207981|NCT02151682|20240704|P1|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
8207982|NCT02151643|20240754|P5|NOT COMPLETED|Overall Study||3
8207983|NCT02151643|20240755|P4|NOT COMPLETED|Overall Study||7
8207984|NCT02151643|20240756|P3|NOT COMPLETED|Overall Study||4
8207985|NCT02151643|20240757|P2|NOT COMPLETED|Overall Study||4
8207986|NCT02151643|20240758|P1|NOT COMPLETED|Overall Study||6
8207987|NCT02151643|20240754|P5|COMPLETED|Overall Study||35
8207988|NCT02151643|20240755|P4|COMPLETED|Overall Study||32
8207989|NCT02151643|20240756|P3|COMPLETED|Overall Study||21
8207990|NCT02151643|20240757|P2|COMPLETED|Overall Study||21
8207991|NCT02151643|20240758|P1|COMPLETED|Overall Study||20
8207992|NCT02151643|20240754|P5|STARTED|Overall Study||38
8207993|NCT02151643|20240755|P4|STARTED|Overall Study||39
8207994|NCT02151643|20240756|P3|STARTED|Overall Study||25
8207995|NCT02151643|20240757|P2|STARTED|Overall Study||25
8207996|NCT02151643|20240758|P1|STARTED|Overall Study||26
8207997|NCT02151591|20240797|P2|NOT COMPLETED|Overall Study||3
8207998|NCT02151591|20240798|P1|NOT COMPLETED|Overall Study||6
8207999|NCT02151591|20240797|P2|COMPLETED|Overall Study||10
8208000|NCT02151591|20240798|P1|COMPLETED|Overall Study||7
8208001|NCT02151591|20240797|P2|STARTED|Overall Study||13
8208002|NCT02151591|20240798|P1|STARTED|Overall Study||13
8208003|NCT02151526|20240810|P2|NOT COMPLETED|Overall Study||0
8208004|NCT02151526|20240811|P1|NOT COMPLETED|Overall Study||0
8208005|NCT02151526|20240810|P2|COMPLETED|Overall Study||4
8208006|NCT02151526|20240811|P1|COMPLETED|Overall Study||3
8208007|NCT02151526|20240810|P2|STARTED|Overall Study||4
8208008|NCT02151526|20240811|P1|STARTED|Overall Study||3
8208009|NCT02151487|20240848|P4|NOT COMPLETED|Overall Study||3
8208010|NCT02151487|20240849|P3|NOT COMPLETED|Overall Study||4
8208011|NCT02151487|20240850|P2|NOT COMPLETED|Overall Study||5
8208012|NCT02151487|20240851|P1|NOT COMPLETED|Overall Study||2
8208013|NCT02151487|20240848|P4|COMPLETED|Overall Study||20
8208014|NCT02151487|20240849|P3|COMPLETED|Overall Study||16
8208015|NCT02151487|20240850|P2|COMPLETED|Overall Study||22
8208016|NCT02151487|20240851|P1|COMPLETED|Overall Study||25
8208017|NCT02151487|20240848|P4|STARTED|Overall Study||23
8208018|NCT02151487|20240849|P3|STARTED|Overall Study||20
8208019|NCT02151487|20240850|P2|STARTED|Overall Study||27
8208020|NCT02151487|20240851|P1|STARTED|Overall Study||27
8208021|NCT02151461|20240869|P4|NOT COMPLETED|Overall Study||4
8208022|NCT02151461|20240870|P3|NOT COMPLETED|Overall Study||3
8208023|NCT02151461|20240871|P2|NOT COMPLETED|Overall Study||1
8208024|NCT02151461|20240872|P1|NOT COMPLETED|Overall Study||6
8208025|NCT02151461|20240869|P4|COMPLETED|Overall Study||19
8208026|NCT02151461|20240870|P3|COMPLETED|Overall Study||21
8208027|NCT02151461|20240871|P2|COMPLETED|Overall Study||24
8208028|NCT02151461|20240872|P1|COMPLETED|Overall Study||18
8208029|NCT02151461|20240869|P4|STARTED|Overall Study||23
8208030|NCT02151461|20240870|P3|STARTED|Overall Study||24
8208031|NCT02151461|20240871|P2|STARTED|Overall Study||25
8208032|NCT02151461|20240872|P1|STARTED|Overall Study||24
8208033|NCT02151448|20240910|P1|NOT COMPLETED|Phase 2||0
8208034|NCT02151448|20240910|P1|COMPLETED|Phase 2||55
8208035|NCT02151448|20240910|P1|STARTED|Phase 2||55
8208036|NCT02151448|20240910|P1|NOT COMPLETED|Phase 1||0
8208037|NCT02151448|20240910|P1|COMPLETED|Phase 1||9
8208038|NCT02151448|20240910|P1|STARTED|Phase 1||9
8208039|NCT02151383|20240928|P3|NOT COMPLETED|Overall Study||0
8208040|NCT02151383|20240929|P2|NOT COMPLETED|Overall Study||0
8208041|NCT02151383|20240930|P1|NOT COMPLETED|Overall Study||0
8208042|NCT02151383|20240928|P3|COMPLETED|Overall Study||1
8208043|NCT02151383|20240929|P2|COMPLETED|Overall Study||3
8208044|NCT02151383|20240930|P1|COMPLETED|Overall Study||8
8208045|NCT02151383|20240928|P3|High-dose|Overall Study||0
8208046|NCT02151383|20240929|P2|High-dose|Overall Study||0
8208047|NCT02151383|20240930|P1|High-dose|Overall Study||6
8208048|NCT02151383|20240928|P3|Low-dose|Overall Study||1
8208049|NCT02151383|20240929|P2|Low-dose|Overall Study||3
8208050|NCT02151383|20240930|P1|Low-dose|Overall Study||2
8208051|NCT02151383|20240928|P3|STARTED|Overall Study||1
8208052|NCT02151383|20240929|P2|STARTED|Overall Study||3
8208053|NCT02151383|20240930|P1|STARTED|Overall Study||8
8208054|NCT02151331|20240988|P2|NOT COMPLETED|Overall Study||40
8208055|NCT02151331|20240989|P1|NOT COMPLETED|Overall Study||32
8208056|NCT02151331|20240988|P2|COMPLETED|Overall Study||52
8208057|NCT02151331|20240989|P1|COMPLETED|Overall Study||45
8208058|NCT02151331|20240988|P2|STARTED|Overall Study||92
8208059|NCT02151331|20240989|P1|STARTED|Overall Study||77
8208060|NCT02151266|20241004|P3|NOT COMPLETED|Overall Study||7
8208061|NCT02151266|20241005|P2|NOT COMPLETED|Overall Study||15
8208062|NCT02151266|20241006|P1|NOT COMPLETED|Overall Study||8
8208063|NCT02151266|20241004|P3|COMPLETED|Overall Study||14
8208064|NCT02151266|20241005|P2|COMPLETED|Overall Study||14
8208065|NCT02151266|20241006|P1|COMPLETED|Overall Study||11
8208066|NCT02151266|20241004|P3|STARTED|Overall Study||21
8208067|NCT02151266|20241005|P2|STARTED|Overall Study||29
8208068|NCT02151266|20241006|P1|STARTED|Overall Study||19
8208069|NCT02151253|20241032|P2|NOT COMPLETED|Overall Study||0
8208070|NCT02151253|20241033|P1|NOT COMPLETED|Overall Study||0
8208071|NCT02151253|20241032|P2|COMPLETED|Overall Study||15
8208072|NCT02151253|20241033|P1|COMPLETED|Overall Study||13
8208073|NCT02151253|20241032|P2|STARTED|Overall Study||15
8208074|NCT02151253|20241033|P1|STARTED|Overall Study||13
8208075|NCT02151149|20241049|P2|NOT COMPLETED|Follow-Up Period||37
8208076|NCT02151149|20241050|P1|NOT COMPLETED|Follow-Up Period||39
8208077|NCT02151149|20241049|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
8208078|NCT02151149|20241050|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
8208079|NCT02151149|20241049|P2|STARTED|Follow-Up Period||55
8208080|NCT02151149|20241050|P1|STARTED|Follow-Up Period||58
8208081|NCT02151149|20241049|P2|NOT COMPLETED|Treatment Period||71
8208082|NCT02151149|20241050|P1|NOT COMPLETED|Treatment Period||70
8208083|NCT02151149|20241049|P2|COMPLETED|Treatment Period||1
8208084|NCT02151149|20241050|P1|COMPLETED|Treatment Period||1
8208085|NCT02151149|20241049|P2|Treated Population|Treatment Period||70
8208086|NCT02151149|20241050|P1|Treated Population|Treatment Period||68
8208087|NCT02151149|20241049|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
8208088|NCT02151149|20241050|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
8208089|NCT02151110|20241082|P8|NOT COMPLETED|Overall Study||3
8208090|NCT02151110|20241083|P7|NOT COMPLETED|Overall Study||0
8208091|NCT02151110|20241084|P6|NOT COMPLETED|Overall Study||0
8208092|NCT02151110|20241085|P5|NOT COMPLETED|Overall Study||0
8208093|NCT02151110|20241086|P4|NOT COMPLETED|Overall Study||0
8208094|NCT02151110|20241087|P3|NOT COMPLETED|Overall Study||0
8208095|NCT02151110|20241088|P2|NOT COMPLETED|Overall Study||0
8208096|NCT02151110|20241089|P1|NOT COMPLETED|Overall Study||0
8208097|NCT02151110|20241082|P8|COMPLETED|Overall Study||5
8208098|NCT02151110|20241083|P7|COMPLETED|Overall Study||8
8208099|NCT02151110|20241084|P6|COMPLETED|Overall Study||8
8208100|NCT02151110|20241085|P5|COMPLETED|Overall Study||8
8208101|NCT02151110|20241086|P4|COMPLETED|Overall Study||8
8208102|NCT02151110|20241087|P3|COMPLETED|Overall Study||2
8208103|NCT02151110|20241088|P2|COMPLETED|Overall Study||2
8208104|NCT02151110|20241089|P1|COMPLETED|Overall Study||12
8208105|NCT02151110|20241082|P8|STARTED|Overall Study||8
8208106|NCT02151110|20241083|P7|STARTED|Overall Study||8
8208107|NCT02151110|20241084|P6|STARTED|Overall Study||8
8208108|NCT02151110|20241085|P5|STARTED|Overall Study||8
8208109|NCT02151110|20241086|P4|STARTED|Overall Study||8
8208110|NCT02151110|20241087|P3|STARTED|Overall Study||2
8208111|NCT02151110|20241088|P2|STARTED|Overall Study||2
8208112|NCT02151110|20241089|P1|STARTED|Overall Study||12
8208113|NCT02151058|20241182|P3|NOT COMPLETED|Overall Study||5
8208114|NCT02151058|20241183|P2|NOT COMPLETED|Overall Study||1
8208115|NCT02151058|20241184|P1|NOT COMPLETED|Overall Study||2
8208116|NCT02151058|20241182|P3|COMPLETED|Overall Study||86
8208117|NCT02151058|20241183|P2|COMPLETED|Overall Study||90
8208118|NCT02151058|20241184|P1|COMPLETED|Overall Study||43
8208119|NCT02151058|20241182|P3|STARTED|Overall Study||91
8208120|NCT02151058|20241183|P2|STARTED|Overall Study||91
8208121|NCT02151058|20241184|P1|STARTED|Overall Study||45
8208122|NCT02150954|20241218|P2|NOT COMPLETED|Overall Study||0
8208123|NCT02150954|20241219|P1|NOT COMPLETED|Overall Study||1
8208124|NCT02150954|20241218|P2|COMPLETED|Overall Study||59
8208125|NCT02150954|20241219|P1|COMPLETED|Overall Study||57
8208126|NCT02150954|20241218|P2|STARTED|Overall Study||59
8208127|NCT02150954|20241219|P1|STARTED|Overall Study||58
8208128|NCT02150863|20241244|P3|NOT COMPLETED|Overall Study||0
8208129|NCT02150863|20241245|P2|NOT COMPLETED|Overall Study||1
8208130|NCT02150863|20241246|P1|NOT COMPLETED|Overall Study||0
8208131|NCT02150863|20241244|P3|COMPLETED|Overall Study||0
8208132|NCT02150863|20241245|P2|COMPLETED|Overall Study||0
8208133|NCT02150863|20241246|P1|COMPLETED|Overall Study||0
8208134|NCT02150863|20241244|P3|STARTED|Overall Study||0
8208135|NCT02150863|20241245|P2|STARTED|Overall Study||1
8208136|NCT02150863|20241246|P1|STARTED|Overall Study||0
8208137|NCT02150837|20241256|P2|NOT COMPLETED|Overall Study||125
8208138|NCT02150837|20241257|P1|NOT COMPLETED|Overall Study||25
8208139|NCT02150837|20241256|P2|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
8208140|NCT02150837|20241257|P1|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
8208141|NCT02150837|20241256|P2|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
8208142|NCT02150837|20241257|P1|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
8208143|NCT02150759|20241429|P2|NOT COMPLETED|Overall Study||2
8208144|NCT02150759|20241430|P1|NOT COMPLETED|Overall Study||1
8208145|NCT02150759|20241429|P2|COMPLETED|Overall Study||21
8208146|NCT02150759|20241430|P1|COMPLETED|Overall Study||22
8208147|NCT02150759|20241429|P2|STARTED|Overall Study||23
8208148|NCT02150759|20241430|P1|STARTED|Overall Study||23
8208149|NCT02150499|20241440|P2|NOT COMPLETED|Overall Study||0
8208150|NCT02150499|20241441|P1|NOT COMPLETED|Overall Study||0
8208151|NCT02150499|20241440|P2|COMPLETED|Overall Study||9
8208152|NCT02150499|20241441|P1|COMPLETED|Overall Study||9
8208153|NCT02150499|20241440|P2|STARTED|Overall Study||9
8208154|NCT02150499|20241441|P1|STARTED|Overall Study||9
8208155|NCT02150460|20241463|P2|NOT COMPLETED|Overall Study||0
8208156|NCT02150460|20241464|P1|NOT COMPLETED|Overall Study||0
8208157|NCT02150460|20241463|P2|COMPLETED|Overall Study||50
8208158|NCT02150460|20241464|P1|COMPLETED|Overall Study||50
8208159|NCT02150460|20241463|P2|STARTED|Overall Study||50
8208160|NCT02150460|20241464|P1|STARTED|Overall Study||50
8208161|NCT02150343|20241492|P4|NOT COMPLETED|Overall Study||10
8208162|NCT02150343|20241493|P3|NOT COMPLETED|Overall Study||12
8208163|NCT02150343|20241494|P2|NOT COMPLETED|Overall Study||20
8208164|NCT02150343|20241495|P1|NOT COMPLETED|Overall Study||21
8208165|NCT02150343|20241492|P4|COMPLETED|Overall Study||168
8208166|NCT02150343|20241493|P3|COMPLETED|Overall Study||166
8208167|NCT02150343|20241494|P2|COMPLETED|Overall Study||158
8208168|NCT02150343|20241495|P1|COMPLETED|Overall Study||159
8208169|NCT02150343|20241492|P4|STARTED|Overall Study||178
8208170|NCT02150343|20241493|P3|STARTED|Overall Study||178
8208171|NCT02150343|20241494|P2|STARTED|Overall Study||178
8208172|NCT02150343|20241495|P1|STARTED|Overall Study||180
8208173|NCT02150213|20241533|P1|NOT COMPLETED|Overall Study||2
8208174|NCT02150213|20241533|P1|COMPLETED|Overall Study||57
8208175|NCT02150213|20241533|P1|STARTED|Overall Study||59
8208176|NCT02150109|20241538|P1|NOT COMPLETED|Overall Study||0
8208177|NCT02150109|20241538|P1|COMPLETED|Overall Study||372
8208178|NCT02150109|20241538|P1|STARTED|Overall Study||372
8208179|NCT02150057|20241552|P2|NOT COMPLETED|Overall Study||4
8208180|NCT02150057|20241553|P1|NOT COMPLETED|Overall Study||6
8208181|NCT02150057|20241552|P2|COMPLETED|Overall Study||22
8208182|NCT02150057|20241553|P1|COMPLETED|Overall Study||19
8208183|NCT02150057|20241552|P2|STARTED|Overall Study||26
8208184|NCT02150057|20241553|P1|STARTED|Overall Study||25
8208185|NCT02150044|20241559|P1|NOT COMPLETED|Overall Study||0
8208186|NCT02150044|20241559|P1|COMPLETED|Overall Study||29
8208187|NCT02150044|20241559|P1|Study Cohort|Overall Study||13
8208188|NCT02150044|20241559|P1|Lead-In Subjects|Overall Study||16
8208189|NCT02150044|20241559|P1|STARTED|Overall Study||29
8208190|NCT02149875|20241568|P3|NOT COMPLETED|Overall Study||9
8208191|NCT02149875|20241569|P2|NOT COMPLETED|Overall Study||8
8208192|NCT02149875|20241570|P1|NOT COMPLETED|Overall Study||7
8208193|NCT02149875|20241568|P3|COMPLETED|Overall Study||20
8208194|NCT02149875|20241569|P2|COMPLETED|Overall Study||20
8208195|NCT02149875|20241570|P1|COMPLETED|Overall Study||20
8208196|NCT02149875|20241568|P3|STARTED|Overall Study||29
8208197|NCT02149875|20241569|P2|STARTED|Overall Study||28
8208198|NCT02149875|20241570|P1|STARTED|Overall Study||27
8208199|NCT02149836|20241581|P1|NOT COMPLETED|Overall Study||1
8208200|NCT02149836|20241581|P1|COMPLETED|Overall Study||17
8208201|NCT02149836|20241581|P1|STARTED|Overall Study||18
8208202|NCT02149524|20241590|P2|NOT COMPLETED|Overall Study||57
8208203|NCT02149524|20241591|P1|NOT COMPLETED|Overall Study||54
8208204|NCT02149524|20241590|P2|COMPLETED|Overall Study||380
8208205|NCT02149524|20241591|P1|COMPLETED|Overall Study||384
8208206|NCT02149524|20241590|P2|STARTED|Overall Study||437
8208207|NCT02149524|20241591|P1|STARTED|Overall Study||438
8208208|NCT02149420|20241608|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208209|NCT02149420|20241609|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208210|NCT02149420|20241610|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
8208211|NCT02149420|20241608|P3|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208212|NCT02149420|20241609|P2|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208213|NCT02149420|20241610|P1|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
8208214|NCT02149420|20241608|P3|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
8208215|NCT02149420|20241609|P2|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
8208216|NCT02149420|20241610|P1|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
8208217|NCT02149420|20241608|P3|NOT COMPLETED|Core Study||2
8208218|NCT02149420|20241609|P2|NOT COMPLETED|Core Study||1
8208219|NCT02149420|20241610|P1|NOT COMPLETED|Core Study||0
8208220|NCT02149420|20241608|P3|COMPLETED|Core Study||10
8208221|NCT02149420|20241609|P2|COMPLETED|Core Study||5
8208222|NCT02149420|20241610|P1|COMPLETED|Core Study||9
8208223|NCT02149420|20241608|P3|PD (Pharmacodynamics) Analysis Set|Core Study||12
8208224|NCT02149420|20241609|P2|PD (Pharmacodynamics) Analysis Set|Core Study||6
8208225|NCT02149420|20241610|P1|PD (Pharmacodynamics) Analysis Set|Core Study||9
8208226|NCT02149420|20241608|P3|PK Analysis Set|Core Study||12
8208227|NCT02149420|20241609|P2|PK Analysis Set|Core Study||6
8208228|NCT02149420|20241610|P1|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
8208229|NCT02149420|20241608|P3|Safety Analysis Set|Core Study||12
8208230|NCT02149420|20241609|P2|Safety Analysis Set|Core Study||6
8208231|NCT02149420|20241610|P1|Safety Analysis Set|Core Study||9
8208232|NCT02149420|20241608|P3|STARTED|Core Study||12
8208233|NCT02149420|20241609|P2|STARTED|Core Study||6
8208234|NCT02149420|20241610|P1|STARTED|Core Study||9
8208235|NCT02149342|20241660|P1|NOT COMPLETED|Overall Study||0
8208236|NCT02149342|20241660|P1|COMPLETED|Overall Study|14 patients|14
8208237|NCT02149342|20241660|P1|STARTED|Overall Study|14 patients|14
8208238|NCT02149303|20241672|P1|NOT COMPLETED|Overall Study||0
8208239|NCT02149303|20241672|P1|COMPLETED|Overall Study||191
8208240|NCT02149303|20241672|P1|STARTED|Overall Study||191
8208241|NCT02149290|20241678|P1|NOT COMPLETED|Overall Study||0
8208242|NCT02149290|20241678|P1|COMPLETED|Overall Study||198
8208243|NCT02149290|20241678|P1|STARTED|Overall Study||198
8208244|NCT02149264|20241686|P1|NOT COMPLETED|Overall Study||20
8208245|NCT02149264|20241686|P1|COMPLETED|Overall Study||139
8208246|NCT02149264|20241686|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
8208247|NCT02149199|20241702|P3|NOT COMPLETED|Overall Study||147
8208248|NCT02149199|20241703|P2|NOT COMPLETED|Overall Study||193
8208249|NCT02149199|20241704|P1|NOT COMPLETED|Overall Study||133
8208250|NCT02149199|20241702|P3|COMPLETED|Overall Study||1135
8208251|NCT02149199|20241703|P2|COMPLETED|Overall Study||1084
8208252|NCT02149199|20241704|P1|COMPLETED|Overall Study||1144
8208253|NCT02149199|20241702|P3|STARTED|Overall Study||1282
8208254|NCT02149199|20241703|P2|STARTED|Overall Study||1277
8208255|NCT02149199|20241704|P1|STARTED|Overall Study||1277
8208256|NCT02149173|20241769|P1|NOT COMPLETED|Overall Study||0
8208257|NCT02149173|20241769|P1|COMPLETED|Overall Study||29
8208258|NCT02149173|20241769|P1|STARTED|Overall Study||29
8208259|NCT02149108|20241783|P2|NOT COMPLETED|Overall Study||383
8208260|NCT02149108|20241784|P1|NOT COMPLETED|Overall Study||380
8208261|NCT02149108|20241783|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
8208262|NCT02149108|20241784|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
8208263|NCT02149108|20241783|P2|STARTED|Overall Study|Randomised patients.|386
8208264|NCT02149108|20241784|P1|STARTED|Overall Study|Randomised patients.|382
8208265|NCT02148952|20241798|P2|NOT COMPLETED|Follow-Up||279
8208266|NCT02148952|20241799|P1|NOT COMPLETED|Follow-Up||265
8208267|NCT02148952|20241798|P2|COMPLETED|Follow-Up||77347
8208268|NCT02148952|20241799|P1|COMPLETED|Follow-Up||79798
8208269|NCT02148952|20241798|P2|STARTED|Follow-Up||77626
8208270|NCT02148952|20241799|P1|STARTED|Follow-Up||80063
8208271|NCT02148952|20241798|P2|NOT COMPLETED|Assessing Eligibility and Consent||3147
8208272|NCT02148952|20241799|P1|NOT COMPLETED|Assessing Eligibility and Consent||3103
8208273|NCT02148952|20241798|P2|COMPLETED|Assessing Eligibility and Consent||77626
8208274|NCT02148952|20241799|P1|COMPLETED|Assessing Eligibility and Consent||80063
8208275|NCT02148952|20241798|P2|STARTED|Assessing Eligibility and Consent||80773
8208276|NCT02148952|20241799|P1|STARTED|Assessing Eligibility and Consent||83166
8208277|NCT02148874|20241857|P2|NOT COMPLETED|Overall Study||2
8208278|NCT02148874|20241858|P1|NOT COMPLETED|Overall Study||7
8208279|NCT02148874|20241857|P2|COMPLETED|Overall Study||84
8208280|NCT02148874|20241858|P1|COMPLETED|Overall Study||194
8208281|NCT02148874|20241857|P2|STARTED|Overall Study||86
8208282|NCT02148874|20241858|P1|STARTED|Overall Study||201
8208283|NCT02148835|20241870|P2|NOT COMPLETED|Overall Study||0
8208284|NCT02148835|20241871|P1|NOT COMPLETED|Overall Study||0
8208285|NCT02148835|20241870|P2|COMPLETED|Overall Study||22
8208286|NCT02148835|20241871|P1|COMPLETED|Overall Study||22
8208287|NCT02148835|20241870|P2|STARTED|Overall Study||22
8208288|NCT02148835|20241871|P1|STARTED|Overall Study||22
8208289|NCT02148809|20241877|P1|NOT COMPLETED|Overall Study||0
8208290|NCT02148809|20241877|P1|COMPLETED|Overall Study||14
8208291|NCT02148809|20241877|P1|STARTED|Overall Study||14
8208292|NCT02148718|20241882|P1|NOT COMPLETED|Overall Study||31
8208293|NCT02148718|20241882|P1|COMPLETED|Overall Study||55
8208294|NCT02148718|20241882|P1|STARTED|Overall Study||86
8208295|NCT02148588|20241903|P1|NOT COMPLETED|Overall Study||0
8208296|NCT02148588|20241903|P1|COMPLETED|Overall Study||8
8208297|NCT02148588|20241903|P1|STARTED|Overall Study||8
8208298|NCT02148523|20241915|P3|NOT COMPLETED|Overall Study||0
8208299|NCT02148523|20241916|P2|NOT COMPLETED|Overall Study||0
8208300|NCT02148523|20241917|P1|NOT COMPLETED|Overall Study||0
8208301|NCT02148523|20241915|P3|COMPLETED|Overall Study||67
8208302|NCT02148523|20241916|P2|COMPLETED|Overall Study||67
8208303|NCT02148523|20241917|P1|COMPLETED|Overall Study||67
8208304|NCT02148523|20241915|P3|STARTED|Overall Study||67
8208305|NCT02148523|20241916|P2|STARTED|Overall Study||67
8208306|NCT02148523|20241917|P1|STARTED|Overall Study||67
8208307|NCT02148445|20241930|P2|NOT COMPLETED|Overall Study||3
8208308|NCT02148445|20241931|P1|NOT COMPLETED|Overall Study||1
8208309|NCT02148445|20241930|P2|COMPLETED|Overall Study||197
8208310|NCT02148445|20241931|P1|COMPLETED|Overall Study||197
8208311|NCT02148445|20241930|P2|STARTED|Overall Study||200
8208312|NCT02148445|20241931|P1|STARTED|Overall Study||198
8208313|NCT02148302|20241969|P2|NOT COMPLETED|Overall Study||0
8208314|NCT02148302|20241970|P1|NOT COMPLETED|Overall Study||0
8208315|NCT02148302|20241969|P2|COMPLETED|Overall Study||66
8208316|NCT02148302|20241970|P1|COMPLETED|Overall Study||57
8208317|NCT02148302|20241969|P2|STARTED|Overall Study||66
8208318|NCT02148302|20241970|P1|STARTED|Overall Study||57
8208319|NCT02148250|20241982|P2|NOT COMPLETED|Period 2||0
8208320|NCT02148250|20241983|P1|NOT COMPLETED|Period 2||0
8208321|NCT02148250|20241982|P2|COMPLETED|Period 2||6
8208322|NCT02148250|20241983|P1|COMPLETED|Period 2||6
8208323|NCT02148250|20241982|P2|STARTED|Period 2||6
8208324|NCT02148250|20241983|P1|STARTED|Period 2||6
8208325|NCT02148250|20241982|P2|NOT COMPLETED|Period 1||0
8208326|NCT02148250|20241983|P1|NOT COMPLETED|Period 1||0
8208327|NCT02148250|20241982|P2|COMPLETED|Period 1||6
8208328|NCT02148250|20241983|P1|COMPLETED|Period 1||6
8208329|NCT02148250|20241982|P2|STARTED|Period 1||6
8208330|NCT02148250|20241983|P1|STARTED|Period 1||6
8208331|NCT02148250|20241982|P2|NOT COMPLETED|Screening||0
8208332|NCT02148250|20241983|P1|NOT COMPLETED|Screening||5
8208333|NCT02148250|20241982|P2|COMPLETED|Screening||0
8208334|NCT02148250|20241983|P1|COMPLETED|Screening||12
8208335|NCT02148250|20241982|P2|STARTED|Screening||0
8208336|NCT02148250|20241983|P1|STARTED|Screening||17
8208337|NCT02148211|20241997|P1|NOT COMPLETED|Overall Study||352
8208338|NCT02148211|20241997|P1|COMPLETED|Overall Study||155
8208339|NCT02148211|20241997|P1|STARTED|Overall Study||507
8208340|NCT02148133|20242006|P1|NOT COMPLETED|Overall Study||5
8208341|NCT02148133|20242006|P1|COMPLETED|Overall Study||16
8208342|NCT02148133|20242006|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
8208343|NCT02148133|20242006|P1|Safety Set (SS)|Overall Study||21
8208344|NCT02148133|20242006|P1|STARTED|Overall Study||21
8208345|NCT02148107|20242028|P3|NOT COMPLETED|Overall Study||0
8208346|NCT02148107|20242029|P2|NOT COMPLETED|Overall Study||0
8208347|NCT02148107|20242030|P1|NOT COMPLETED|Overall Study||0
8208348|NCT02148107|20242028|P3|COMPLETED|Overall Study||3
8208349|NCT02148107|20242029|P2|COMPLETED|Overall Study||7
8208350|NCT02148107|20242030|P1|COMPLETED|Overall Study||8
8208351|NCT02148107|20242028|P3|STARTED|Overall Study||3
8208352|NCT02148107|20242029|P2|STARTED|Overall Study||7
8208353|NCT02148107|20242030|P1|STARTED|Overall Study||8
8208354|NCT02147990|20242049|P3|NOT COMPLETED|Overall Study||0
8208355|NCT02147990|20242050|P2|NOT COMPLETED|Overall Study||0
8208356|NCT02147990|20242051|P1|NOT COMPLETED|Overall Study||0
8208357|NCT02147990|20242049|P3|COMPLETED|Overall Study||63
8208358|NCT02147990|20242050|P2|COMPLETED|Overall Study||100
8208359|NCT02147990|20242051|P1|COMPLETED|Overall Study||154
8208360|NCT02147990|20242049|P3|STARTED|Overall Study||63
8208361|NCT02147990|20242050|P2|STARTED|Overall Study||100
8208362|NCT02147990|20242051|P1|STARTED|Overall Study||154
8208363|NCT02147899|20242116|P3|NOT COMPLETED|Overall Study||0
8208364|NCT02147899|20242117|P2|NOT COMPLETED|Overall Study||0
8208365|NCT02147899|20242118|P1|NOT COMPLETED|Overall Study||0
8208366|NCT02147899|20242116|P3|COMPLETED|Overall Study||72
8208367|NCT02147899|20242117|P2|COMPLETED|Overall Study||72
8208368|NCT02147899|20242118|P1|COMPLETED|Overall Study||71
8208369|NCT02147899|20242116|P3|STARTED|Overall Study||72
8208370|NCT02147899|20242117|P2|STARTED|Overall Study||72
8208371|NCT02147899|20242118|P1|STARTED|Overall Study||71
8208372|NCT02147834|20242137|P2|NOT COMPLETED|Overall Study||0
8208373|NCT02147834|20242138|P1|NOT COMPLETED|Overall Study||0
8208374|NCT02147834|20242137|P2|COMPLETED|Overall Study||2
8208375|NCT02147834|20242138|P1|COMPLETED|Overall Study||3
8208376|NCT02147834|20242137|P2|STARTED|Overall Study||2
8208377|NCT02147834|20242138|P1|STARTED|Overall Study||3
8208378|NCT02147769|20242148|P1|NOT COMPLETED|Overall Study||0
8208379|NCT02147769|20242148|P1|COMPLETED|Overall Study||111
8208380|NCT02147769|20242148|P1|STARTED|Overall Study||111
8208381|NCT02147691|20242155|P2|NOT COMPLETED|Overall Study||1
8208382|NCT02147691|20242156|P1|NOT COMPLETED|Overall Study||4
8208383|NCT02147691|20242155|P2|COMPLETED|Overall Study||11
8208384|NCT02147691|20242156|P1|COMPLETED|Overall Study||6
8208385|NCT02147691|20242155|P2|STARTED|Overall Study||12
8208386|NCT02147691|20242156|P1|STARTED|Overall Study||10
8208387|NCT02147613|20242202|P2|NOT COMPLETED|Overall Study||3
8208388|NCT02147613|20242203|P1|NOT COMPLETED|Overall Study||1
8208389|NCT02147613|20242202|P2|COMPLETED|Overall Study||6
8208390|NCT02147613|20242203|P1|COMPLETED|Overall Study||9
8208391|NCT02147613|20242202|P2|STARTED|Overall Study||9
8208392|NCT02147613|20242203|P1|STARTED|Overall Study||10
8208393|NCT02147587|20242215|P2|NOT COMPLETED|Overall Study||5
8208394|NCT02147587|20242216|P1|NOT COMPLETED|Overall Study||11
8208395|NCT02147587|20242215|P2|COMPLETED|Overall Study||50
8208396|NCT02147587|20242216|P1|COMPLETED|Overall Study||46
8208397|NCT02147587|20242215|P2|STARTED|Overall Study||55
8208398|NCT02147587|20242216|P1|STARTED|Overall Study||57
8208399|NCT02147561|20242236|P1|NOT COMPLETED|Overall Study||4
8208400|NCT02147561|20242236|P1|COMPLETED|Overall Study||276
8208401|NCT02147561|20242236|P1|STARTED|Overall Study||280
8208402|NCT02147522|20242244|P2|NOT COMPLETED|Overall Study||48
8208403|NCT02147522|20242245|P1|NOT COMPLETED|Overall Study||56
8208404|NCT02147522|20242244|P2|COMPLETED|Overall Study||122
8208405|NCT02147522|20242245|P1|COMPLETED|Overall Study||122
8208406|NCT02147522|20242244|P2|STARTED|Overall Study||170
8208407|NCT02147522|20242245|P1|STARTED|Overall Study||178
8208408|NCT02147353|20242257|P2|NOT COMPLETED|Overall Study||0
8208409|NCT02147353|20242258|P1|NOT COMPLETED|Overall Study||9
8208410|NCT02147353|20242257|P2|COMPLETED|Overall Study||21
8208411|NCT02147353|20242258|P1|COMPLETED|Overall Study||12
8208412|NCT02147353|20242257|P2|STARTED|Overall Study||21
8208413|NCT02147353|20242258|P1|STARTED|Overall Study||21
8208414|NCT02147301|20242276|P1|NOT COMPLETED|Overall Study||0
8208415|NCT02147301|20242276|P1|COMPLETED|Overall Study||17
8208416|NCT02147301|20242276|P1|STARTED|Overall Study||17
8208417|NCT02147288|20242291|P10|NOT COMPLETED|Overall Study||0
8208418|NCT02147288|20242292|P9|NOT COMPLETED|Overall Study||0
8208419|NCT02147288|20242293|P8|NOT COMPLETED|Overall Study||0
8208420|NCT02147288|20242294|P7|NOT COMPLETED|Overall Study||0
8208421|NCT02147288|20242295|P6|NOT COMPLETED|Overall Study||0
8208422|NCT02147288|20242296|P5|NOT COMPLETED|Overall Study||0
8208423|NCT02147288|20242297|P4|NOT COMPLETED|Overall Study||0
8208424|NCT02147288|20242298|P3|NOT COMPLETED|Overall Study||0
8208425|NCT02147288|20242299|P2|NOT COMPLETED|Overall Study||2
8208426|NCT02147288|20242300|P1|NOT COMPLETED|Overall Study||1
8208427|NCT02147288|20242291|P10|COMPLETED|Overall Study||0
8208428|NCT02147288|20242292|P9|COMPLETED|Overall Study||0
8208429|NCT02147288|20242293|P8|COMPLETED|Overall Study||0
8208430|NCT02147288|20242294|P7|COMPLETED|Overall Study||0
8208431|NCT02147288|20242295|P6|COMPLETED|Overall Study||0
8208432|NCT02147288|20242296|P5|COMPLETED|Overall Study||0
8208433|NCT02147288|20242297|P4|COMPLETED|Overall Study||0
8208434|NCT02147288|20242298|P3|COMPLETED|Overall Study||0
8208435|NCT02147288|20242299|P2|COMPLETED|Overall Study||22
8208436|NCT02147288|20242300|P1|COMPLETED|Overall Study||21
8208437|NCT02147288|20242291|P10|STARTED|Overall Study||0
8208438|NCT02147288|20242292|P9|STARTED|Overall Study||0
8208439|NCT02147288|20242293|P8|STARTED|Overall Study||0
8208440|NCT02147288|20242294|P7|STARTED|Overall Study||0
8208441|NCT02147288|20242295|P6|STARTED|Overall Study||0
8208442|NCT02147288|20242296|P5|STARTED|Overall Study||0
8208443|NCT02147288|20242297|P4|STARTED|Overall Study||0
8208444|NCT02147288|20242298|P3|STARTED|Overall Study||0
8208445|NCT02147288|20242299|P2|STARTED|Overall Study||24
8208446|NCT02147288|20242300|P1|STARTED|Overall Study||22
8208447|NCT02147197|20242309|P3|NOT COMPLETED|Overall Study||9
8208448|NCT02147197|20242310|P2|NOT COMPLETED|Overall Study||6
8208449|NCT02147197|20242311|P1|NOT COMPLETED|Overall Study||9
8208450|NCT02147197|20242309|P3|COMPLETED|Overall Study||39
8208451|NCT02147197|20242310|P2|COMPLETED|Overall Study||47
8208452|NCT02147197|20242311|P1|COMPLETED|Overall Study||47
8208453|NCT02147197|20242309|P3|STARTED|Overall Study||48
8208454|NCT02147197|20242310|P2|STARTED|Overall Study||53
8208455|NCT02147197|20242311|P1|STARTED|Overall Study||56
8208456|NCT02147184|20242330|P2|NOT COMPLETED|Overall Study||27
8208457|NCT02147184|20242331|P1|NOT COMPLETED|Overall Study||49
8208458|NCT02147184|20242330|P2|COMPLETED|Overall Study||110
8208459|NCT02147184|20242331|P1|COMPLETED|Overall Study||78
8208460|NCT02147184|20242330|P2|STARTED|Overall Study||137
8208461|NCT02147184|20242331|P1|STARTED|Overall Study||127
8208462|NCT02147158|20242355|P6|NOT COMPLETED|Off-Treatment Interval 2||4
8208463|NCT02147158|20242356|P5|NOT COMPLETED|Off-Treatment Interval 2||2
8208464|NCT02147158|20242357|P4|NOT COMPLETED|Off-Treatment Interval 2||11
8208465|NCT02147158|20242358|P3|NOT COMPLETED|Off-Treatment Interval 2||10
8208466|NCT02147158|20242359|P2|NOT COMPLETED|Off-Treatment Interval 2||4
8208467|NCT02147158|20242360|P1|NOT COMPLETED|Off-Treatment Interval 2||4
8208468|NCT02147158|20242355|P6|COMPLETED|Off-Treatment Interval 2||39
8208469|NCT02147158|20242356|P5|COMPLETED|Off-Treatment Interval 2||39
8208470|NCT02147158|20242357|P4|COMPLETED|Off-Treatment Interval 2||66
8208471|NCT02147158|20242358|P3|COMPLETED|Off-Treatment Interval 2||69
8208472|NCT02147158|20242359|P2|COMPLETED|Off-Treatment Interval 2||25
8208473|NCT02147158|20242360|P1|COMPLETED|Off-Treatment Interval 2||36
8208474|NCT02147158|20242355|P6|STARTED|Off-Treatment Interval 2||43
8208475|NCT02147158|20242356|P5|STARTED|Off-Treatment Interval 2||41
8208476|NCT02147158|20242357|P4|STARTED|Off-Treatment Interval 2||77
8208477|NCT02147158|20242358|P3|STARTED|Off-Treatment Interval 2||79
8208478|NCT02147158|20242359|P2|STARTED|Off-Treatment Interval 2||29
8208479|NCT02147158|20242360|P1|STARTED|Off-Treatment Interval 2||40
8208480|NCT02147158|20242355|P6|NOT COMPLETED|Treatment Course 2||2
8208481|NCT02147158|20242356|P5|NOT COMPLETED|Treatment Course 2||0
8208482|NCT02147158|20242357|P4|NOT COMPLETED|Treatment Course 2||5
8208483|NCT02147158|20242358|P3|NOT COMPLETED|Treatment Course 2||5
8208484|NCT02147158|20242359|P2|NOT COMPLETED|Treatment Course 2||5
8208485|NCT02147158|20242360|P1|NOT COMPLETED|Treatment Course 2||1
8208486|NCT02147158|20242355|P6|COMPLETED|Treatment Course 2||43
8208487|NCT02147158|20242356|P5|COMPLETED|Treatment Course 2||41
8208488|NCT02147158|20242357|P4|COMPLETED|Treatment Course 2||77
8208489|NCT02147158|20242358|P3|COMPLETED|Treatment Course 2||79
8208490|NCT02147158|20242359|P2|COMPLETED|Treatment Course 2||29
8208491|NCT02147158|20242360|P1|COMPLETED|Treatment Course 2||40
8208492|NCT02147158|20242355|P6|STARTED|Treatment Course 2||45
8208493|NCT02147158|20242356|P5|STARTED|Treatment Course 2||41
8208494|NCT02147158|20242357|P4|STARTED|Treatment Course 2||82
8208495|NCT02147158|20242358|P3|STARTED|Treatment Course 2||84
8208496|NCT02147158|20242359|P2|STARTED|Treatment Course 2||34
8208497|NCT02147158|20242360|P1|STARTED|Treatment Course 2||41
8208498|NCT02147158|20242355|P6|NOT COMPLETED|Off-Treatment Interval 1||5
8208499|NCT02147158|20242356|P5|NOT COMPLETED|Off-Treatment Interval 1||8
8208500|NCT02147158|20242357|P4|NOT COMPLETED|Off-Treatment Interval 1||15
8208501|NCT02147158|20242358|P3|NOT COMPLETED|Off-Treatment Interval 1||15
8208502|NCT02147158|20242359|P2|NOT COMPLETED|Off-Treatment Interval 1||4
8208503|NCT02147158|20242360|P1|NOT COMPLETED|Off-Treatment Interval 1||10
8208504|NCT02147158|20242355|P6|COMPLETED|Off-Treatment Interval 1||45
8208505|NCT02147158|20242356|P5|COMPLETED|Off-Treatment Interval 1||41
8208506|NCT02147158|20242357|P4|COMPLETED|Off-Treatment Interval 1||82
8208507|NCT02147158|20242358|P3|COMPLETED|Off-Treatment Interval 1||84
8208508|NCT02147158|20242359|P2|COMPLETED|Off-Treatment Interval 1||34
8208509|NCT02147158|20242360|P1|COMPLETED|Off-Treatment Interval 1||41
8208510|NCT02147158|20242355|P6|STARTED|Off-Treatment Interval 1||50
8208511|NCT02147158|20242356|P5|STARTED|Off-Treatment Interval 1||49
8208512|NCT02147158|20242357|P4|STARTED|Off-Treatment Interval 1||97
8208513|NCT02147158|20242358|P3|STARTED|Off-Treatment Interval 1||99
8208514|NCT02147158|20242359|P2|STARTED|Off-Treatment Interval 1||38
8208515|NCT02147158|20242360|P1|STARTED|Off-Treatment Interval 1||51
8208516|NCT02147158|20242355|P6|NOT COMPLETED|Treatment Course 1||8
8208517|NCT02147158|20242356|P5|NOT COMPLETED|Treatment Course 1||6
8208518|NCT02147158|20242357|P4|NOT COMPLETED|Treatment Course 1||13
8208519|NCT02147158|20242358|P3|NOT COMPLETED|Treatment Course 1||8
8208520|NCT02147158|20242359|P2|NOT COMPLETED|Treatment Course 1||9
8208521|NCT02147158|20242360|P1|NOT COMPLETED|Treatment Course 1||4
8208522|NCT02147158|20242355|P6|COMPLETED|Treatment Course 1||50
8208523|NCT02147158|20242356|P5|COMPLETED|Treatment Course 1||49
8208524|NCT02147158|20242357|P4|COMPLETED|Treatment Course 1||97
8208525|NCT02147158|20242358|P3|COMPLETED|Treatment Course 1||99
8208526|NCT02147158|20242359|P2|COMPLETED|Treatment Course 1||38
8208527|NCT02147158|20242360|P1|COMPLETED|Treatment Course 1||51
8208528|NCT02147158|20242355|P6|STARTED|Treatment Course 1||58
8208529|NCT02147158|20242356|P5|STARTED|Treatment Course 1||55
8208530|NCT02147158|20242357|P4|STARTED|Treatment Course 1||110
8208531|NCT02147158|20242358|P3|STARTED|Treatment Course 1||107
8208532|NCT02147158|20242359|P2|STARTED|Treatment Course 1||47
8208533|NCT02147158|20242360|P1|STARTED|Treatment Course 1||55
8208534|NCT02147132|20242389|P4|NOT COMPLETED|Overall Study||0
8208535|NCT02147132|20242390|P3|NOT COMPLETED|Overall Study||0
8208536|NCT02147132|20242391|P2|NOT COMPLETED|Overall Study||0
8208537|NCT02147132|20242392|P1|NOT COMPLETED|Overall Study||1
8208538|NCT02147132|20242389|P4|COMPLETED|Overall Study||2
8208539|NCT02147132|20242390|P3|COMPLETED|Overall Study||1
8208540|NCT02147132|20242391|P2|COMPLETED|Overall Study||2
8208541|NCT02147132|20242392|P1|COMPLETED|Overall Study||1
8208542|NCT02147132|20242389|P4|STARTED|Overall Study||2
8208543|NCT02147132|20242390|P3|STARTED|Overall Study||1
8208544|NCT02147132|20242391|P2|STARTED|Overall Study||2
8208545|NCT02147132|20242392|P1|STARTED|Overall Study||2
8208546|NCT02147093|20242412|P2|NOT COMPLETED|Period 2||0
8208547|NCT02147093|20242413|P1|NOT COMPLETED|Period 2||2
8208548|NCT02147093|20242412|P2|COMPLETED|Period 2||19
8208549|NCT02147093|20242413|P1|COMPLETED|Period 2||18
8208550|NCT02147093|20242412|P2|STARTED|Period 2||19
8208551|NCT02147093|20242413|P1|STARTED|Period 2||20
8208552|NCT02147093|20242412|P2|NOT COMPLETED|Period 1||1
8208553|NCT02147093|20242413|P1|NOT COMPLETED|Period 1||0
8208554|NCT02147093|20242412|P2|COMPLETED|Period 1||19
8208555|NCT02147093|20242413|P1|COMPLETED|Period 1||20
8208556|NCT02147093|20242412|P2|STARTED|Period 1||20
8208557|NCT02147093|20242413|P1|STARTED|Period 1||20
8208558|NCT02147067|20242423|P2|NOT COMPLETED|Overall Study||2
8208559|NCT02147067|20242424|P1|NOT COMPLETED|Overall Study||2
8208560|NCT02147067|20242423|P2|COMPLETED|Overall Study||11
8208561|NCT02147067|20242424|P1|COMPLETED|Overall Study||11
8208562|NCT02147067|20242423|P2|STARTED|Overall Study||13
8208563|NCT02147067|20242424|P1|STARTED|Overall Study||13
8208564|NCT02146833|20242450|P1|NOT COMPLETED|Overall Study||11
8208565|NCT02146833|20242450|P1|COMPLETED|Overall Study||9
8208566|NCT02146833|20242450|P1|STARTED|Overall Study||20
8208567|NCT02146599|20242462|P1|NOT COMPLETED|Overall Study||5
8208568|NCT02146599|20242462|P1|COMPLETED|Overall Study||296
8208569|NCT02146599|20242462|P1|STARTED|Overall Study||301
8208570|NCT02146482|20242468|P2|NOT COMPLETED|Overall Study||0
8208571|NCT02146482|20242469|P1|NOT COMPLETED|Overall Study||0
8208572|NCT02146482|20242468|P2|COMPLETED|Overall Study||25
8208573|NCT02146482|20242469|P1|COMPLETED|Overall Study||21
8208574|NCT02146482|20242468|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
8208575|NCT02146482|20242469|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
8208576|NCT02146430|20242479|P4|NOT COMPLETED|Overall Study||99
8208577|NCT02146430|20242480|P3|NOT COMPLETED|Overall Study||82
8208578|NCT02146430|20242481|P2|NOT COMPLETED|Overall Study||87
8208579|NCT02146430|20242482|P1|NOT COMPLETED|Overall Study||67
8208580|NCT02146430|20242479|P4|COMPLETED|Overall Study||224
8208581|NCT02146430|20242480|P3|COMPLETED|Overall Study||242
8208582|NCT02146430|20242481|P2|COMPLETED|Overall Study||236
8208583|NCT02146430|20242482|P1|COMPLETED|Overall Study||256
8208584|NCT02146430|20242479|P4|Modified Intent to Treat Set (mITT)|Overall Study||319
8208585|NCT02146430|20242480|P3|Modified Intent to Treat Set (mITT)|Overall Study||319
8208586|NCT02146430|20242481|P2|Modified Intent to Treat Set (mITT)|Overall Study||317
8208587|NCT02146430|20242482|P1|Modified Intent to Treat Set (mITT)|Overall Study||318
8208588|NCT02146430|20242479|P4|Safety Analysis Set|Overall Study||320
8208589|NCT02146430|20242480|P3|Safety Analysis Set|Overall Study||320
8208590|NCT02146430|20242481|P2|Safety Analysis Set|Overall Study||318
8208591|NCT02146430|20242482|P1|Safety Analysis Set|Overall Study||318
8208592|NCT02146430|20242479|P4|STARTED|Overall Study||323
8208593|NCT02146430|20242480|P3|STARTED|Overall Study||324
8208594|NCT02146430|20242481|P2|STARTED|Overall Study||323
8208595|NCT02146430|20242482|P1|STARTED|Overall Study||323
8208596|NCT02146365|20242542|P8|NOT COMPLETED|Overall Study||1
8208597|NCT02146365|20242543|P7|NOT COMPLETED|Overall Study||0
8208598|NCT02146365|20242544|P6|NOT COMPLETED|Overall Study||1
8208599|NCT02146365|20242545|P5|NOT COMPLETED|Overall Study||2
8208600|NCT02146365|20242546|P4|NOT COMPLETED|Overall Study||9
8208601|NCT02146365|20242547|P3|NOT COMPLETED|Overall Study||7
8208602|NCT02146365|20242548|P2|NOT COMPLETED|Overall Study||4
8208603|NCT02146365|20242549|P1|NOT COMPLETED|Overall Study||4
8208604|NCT02146365|20242542|P8|COMPLETED|Overall Study||24
8208605|NCT02146365|20242543|P7|COMPLETED|Overall Study||25
8208606|NCT02146365|20242544|P6|COMPLETED|Overall Study||24
8208607|NCT02146365|20242545|P5|COMPLETED|Overall Study||22
8208608|NCT02146365|20242546|P4|COMPLETED|Overall Study||41
8208609|NCT02146365|20242547|P3|COMPLETED|Overall Study||43
8208610|NCT02146365|20242548|P2|COMPLETED|Overall Study||45
8208611|NCT02146365|20242549|P1|COMPLETED|Overall Study||45
8208612|NCT02146365|20242542|P8|STARTED|Overall Study||25
8208613|NCT02146365|20242543|P7|STARTED|Overall Study||25
8208614|NCT02146365|20242544|P6|STARTED|Overall Study||25
8208615|NCT02146365|20242545|P5|STARTED|Overall Study||24
8208616|NCT02146365|20242546|P4|STARTED|Overall Study||50
8208617|NCT02146365|20242547|P3|STARTED|Overall Study||50
8208618|NCT02146365|20242548|P2|STARTED|Overall Study||49
8208619|NCT02146365|20242549|P1|STARTED|Overall Study||49
8208620|NCT02146352|20242675|P1|NOT COMPLETED|Overall Study||2
8208621|NCT02146352|20242675|P1|COMPLETED|Overall Study||28
8208622|NCT02146352|20242675|P1|7 Days Post-stent Removal|Overall Study||28
8208623|NCT02146352|20242675|P1|30 or 60 Days Post-procedure|Overall Study||30
8208624|NCT02146352|20242675|P1|STARTED|Overall Study||30
8208625|NCT02146326|20242693|P4|NOT COMPLETED|Overall Study||48
8208626|NCT02146326|20242694|P3|NOT COMPLETED|Overall Study||43
8208627|NCT02146326|20242695|P2|NOT COMPLETED|Overall Study||37
8208628|NCT02146326|20242696|P1|NOT COMPLETED|Overall Study||28
8208629|NCT02146326|20242693|P4|COMPLETED|Overall Study||210
8208630|NCT02146326|20242694|P3|COMPLETED|Overall Study||168
8208631|NCT02146326|20242695|P2|COMPLETED|Overall Study||66
8208632|NCT02146326|20242696|P1|COMPLETED|Overall Study||61
8208633|NCT02146326|20242693|P4|12 Months|Overall Study||210
8208634|NCT02146326|20242694|P3|12 Months|Overall Study||168
8208635|NCT02146326|20242695|P2|12 Months|Overall Study||66
8208636|NCT02146326|20242696|P1|12 Months|Overall Study||61
8208637|NCT02146326|20242693|P4|6 Months|Overall Study||235
8208638|NCT02146326|20242694|P3|6 Months|Overall Study||186
8208639|NCT02146326|20242695|P2|6 Months|Overall Study||71
8208640|NCT02146326|20242696|P1|6 Months|Overall Study||71
8208641|NCT02146326|20242693|P4|3 Months|Overall Study||0
8208642|NCT02146326|20242694|P3|3 Months|Overall Study||0
8208643|NCT02146326|20242695|P2|3 Months|Overall Study||83
8208644|NCT02146326|20242696|P1|3 Months|Overall Study||71
8208645|NCT02146326|20242693|P4|Baseline|Overall Study||258
8208646|NCT02146326|20242694|P3|Baseline|Overall Study||211
8208647|NCT02146326|20242695|P2|Baseline|Overall Study||103
8208648|NCT02146326|20242696|P1|Baseline|Overall Study||89
8208649|NCT02146326|20242693|P4|STARTED|Overall Study||258
8208650|NCT02146326|20242694|P3|STARTED|Overall Study||211
8208651|NCT02146326|20242695|P2|STARTED|Overall Study||103
8208652|NCT02146326|20242696|P1|STARTED|Overall Study||89
8208653|NCT02146274|20242858|P1|NOT COMPLETED|Overall Study||73
8208654|NCT02146274|20242858|P1|COMPLETED|Overall Study||1804
8208655|NCT02146274|20242858|P1|STARTED|Overall Study||1877
8208656|NCT02146248|20242865|P1|NOT COMPLETED|Overall Study||2
8208657|NCT02146248|20242865|P1|COMPLETED|Overall Study||9
8208658|NCT02146248|20242865|P1|HSG 5|Overall Study||1
8208659|NCT02146248|20242865|P1|HSG 4|Overall Study||7
8208660|NCT02146248|20242865|P1|HSG 3|Overall Study||9
8208661|NCT02146248|20242865|P1|HSG 2|Overall Study||10
8208662|NCT02146248|20242865|P1|HSG 1|Overall Study||10
8208663|NCT02146248|20242865|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
8208664|NCT02146248|20242865|P1|Enrolled|Overall Study||11
8208665|NCT02146248|20242865|P1|STARTED|Overall Study||11
8208666|NCT02146131|20242875|P2|NOT COMPLETED|Overall Study||56
8208667|NCT02146131|20242876|P1|NOT COMPLETED|Overall Study||61
8208668|NCT02146131|20242875|P2|COMPLETED|Overall Study||113
8208669|NCT02146131|20242876|P1|COMPLETED|Overall Study||109
8208670|NCT02146131|20242875|P2|STARTED|Overall Study||169
8208671|NCT02146131|20242876|P1|STARTED|Overall Study||170
8208672|NCT02146105|20242882|P1|NOT COMPLETED|Overall Study||6
8208673|NCT02146105|20242882|P1|COMPLETED|Overall Study||39
8208674|NCT02146105|20242882|P1|STARTED|Overall Study||45
8208675|NCT02146001|20242888|P2|NOT COMPLETED|Overall Study||0
8208676|NCT02146001|20242889|P1|NOT COMPLETED|Overall Study||0
8208677|NCT02146001|20242888|P2|COMPLETED|Overall Study||19
8208678|NCT02146001|20242889|P1|COMPLETED|Overall Study||19
8208679|NCT02146001|20242888|P2|STARTED|Overall Study||19
8208680|NCT02146001|20242889|P1|STARTED|Overall Study||19
8208681|NCT02145754|20242899|P1|NOT COMPLETED|Overall Study||0
8208682|NCT02145754|20242899|P1|COMPLETED|Overall Study||235
8208683|NCT02145754|20242899|P1|STARTED|Overall Study||235
8208684|NCT02145676|20242906|P3|NOT COMPLETED|Overall Study||0
8208685|NCT02145676|20242907|P2|NOT COMPLETED|Overall Study||0
8208686|NCT02145676|20242908|P1|NOT COMPLETED|Overall Study||0
8208687|NCT02145676|20242906|P3|COMPLETED|Overall Study||18
8208688|NCT02145676|20242907|P2|COMPLETED|Overall Study||18
8208689|NCT02145676|20242908|P1|COMPLETED|Overall Study||17
8208690|NCT02145676|20242906|P3|STARTED|Overall Study||18
8208691|NCT02145676|20242907|P2|STARTED|Overall Study||18
8208692|NCT02145676|20242908|P1|STARTED|Overall Study||17
8208693|NCT02145468|20242933|P2|NOT COMPLETED|Overall Study||8
8208694|NCT02145468|20242934|P1|NOT COMPLETED|Overall Study||5
8208695|NCT02145468|20242933|P2|COMPLETED|Overall Study||1723
8208696|NCT02145468|20242934|P1|COMPLETED|Overall Study||1753
8208697|NCT02145468|20242933|P2|STARTED|Overall Study||1731
8208698|NCT02145468|20242934|P1|STARTED|Overall Study||1758
8208699|NCT02145429|20242992|P2|NOT COMPLETED|Overall Study||11
8208700|NCT02145429|20242993|P1|NOT COMPLETED|Overall Study||16
8208701|NCT02145429|20242992|P2|COMPLETED|Overall Study||79
8208702|NCT02145429|20242993|P1|COMPLETED|Overall Study||75
8208703|NCT02145429|20242992|P2|STARTED|Overall Study||90
8208704|NCT02145429|20242993|P1|STARTED|Overall Study||91
8208765|NCT02145390|20243024|P1|NOT COMPLETED|Overall Study||1
8208766|NCT02145390|20243024|P1|COMPLETED|Overall Study||0
8208767|NCT02145390|20243024|P1|STARTED|Overall Study||1
8208768|NCT02145299|20243035|P2|NOT COMPLETED|Overall Study||0
8208769|NCT02145299|20243036|P1|NOT COMPLETED|Overall Study||0
8208770|NCT02145299|20243035|P2|COMPLETED|Overall Study||2
8208771|NCT02145299|20243036|P1|COMPLETED|Overall Study||6
8208772|NCT02145299|20243035|P2|STARTED|Overall Study||2
8208773|NCT02145299|20243036|P1|STARTED|Overall Study||6
8208774|NCT02145247|20243064|P2|NOT COMPLETED|Overall Study||0
8208775|NCT02145247|20243065|P1|NOT COMPLETED|Overall Study||0
8208776|NCT02145247|20243064|P2|COMPLETED|Overall Study||19
8208777|NCT02145247|20243065|P1|COMPLETED|Overall Study||20
8208778|NCT02145247|20243064|P2|STARTED|Overall Study||19
8208779|NCT02145247|20243065|P1|STARTED|Overall Study||20
8208780|NCT02145182|20243073|P2|NOT COMPLETED|Overall Study||16
8208781|NCT02145182|20243074|P1|NOT COMPLETED|Overall Study||18
8208782|NCT02145182|20243073|P2|COMPLETED|Overall Study||130
8208783|NCT02145182|20243074|P1|COMPLETED|Overall Study||124
8208784|NCT02145182|20243073|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
8208785|NCT02145182|20243074|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
8208786|NCT02145182|20243073|P2|STARTED|Overall Study||146
8208787|NCT02145182|20243074|P1|STARTED|Overall Study||142
8208788|NCT02145169|20243088|P1|NOT COMPLETED|Overall Study||0
8208789|NCT02145169|20243088|P1|COMPLETED|Overall Study||0
8208790|NCT02145169|20243088|P1|STARTED|Overall Study||0
8208791|NCT02145156|20243107|P3|NOT COMPLETED|Overall Study||41
8208792|NCT02145156|20243108|P2|NOT COMPLETED|Overall Study||52
8208793|NCT02145156|20243109|P1|NOT COMPLETED|Overall Study||60
8208794|NCT02145156|20243107|P3|COMPLETED|Overall Study||398
8208795|NCT02145156|20243108|P2|COMPLETED|Overall Study||373
8208796|NCT02145156|20243109|P1|COMPLETED|Overall Study||370
8208797|NCT02145156|20243107|P3|STARTED|Overall Study||439
8208798|NCT02145156|20243108|P2|STARTED|Overall Study||425
8208799|NCT02145156|20243109|P1|STARTED|Overall Study||430
8208800|NCT02145078|20243150|P1|NOT COMPLETED|Overall Study||4
8208801|NCT02145078|20243150|P1|COMPLETED|Overall Study||0
8208802|NCT02145078|20243150|P1|STARTED|Overall Study||4
8208803|NCT02145039|20243158|P1|NOT COMPLETED|Overall Study||0
8208804|NCT02145039|20243158|P1|COMPLETED|Overall Study||2
8208805|NCT02145039|20243158|P1|STARTED|Overall Study||2
8208806|NCT02145026|20243167|P1|NOT COMPLETED|Overall Study||12
8208807|NCT02145026|20243167|P1|COMPLETED|Overall Study||88
8208808|NCT02145026|20243167|P1|STARTED|Overall Study||100
8208809|NCT02144714|20243177|P3|NOT COMPLETED|Overall Study||0
8208810|NCT02144714|20243178|P2|NOT COMPLETED|Overall Study||0
8208811|NCT02144714|20243179|P1|NOT COMPLETED|Overall Study||0
8208812|NCT02144714|20243177|P3|COMPLETED|Overall Study||63
8208813|NCT02144714|20243178|P2|COMPLETED|Overall Study||63
8208814|NCT02144714|20243179|P1|COMPLETED|Overall Study||63
8208815|NCT02144714|20243177|P3|STARTED|Overall Study||63
8208816|NCT02144714|20243178|P2|STARTED|Overall Study||63
8208817|NCT02144714|20243179|P1|STARTED|Overall Study||63
8208818|NCT02144701|20243198|P2|NOT COMPLETED|Overall Study||3
8208819|NCT02144701|20243199|P1|NOT COMPLETED|Overall Study||9
8208820|NCT02144701|20243198|P2|COMPLETED|Overall Study||8
8208821|NCT02144701|20243199|P1|COMPLETED|Overall Study||13
8208822|NCT02144701|20243198|P2|STARTED|Overall Study||11
8208823|NCT02144701|20243199|P1|STARTED|Overall Study||22
8208824|NCT02144675|20243217|P2|NOT COMPLETED|Overall Study||0
8208825|NCT02144675|20243218|P1|NOT COMPLETED|Overall Study||0
8208826|NCT02144675|20243217|P2|COMPLETED|Overall Study||14
8208827|NCT02144675|20243218|P1|COMPLETED|Overall Study||13
8208828|NCT02144675|20243217|P2|STARTED|Overall Study||14
8208829|NCT02144675|20243218|P1|STARTED|Overall Study||13
8208830|NCT02144610|20243226|P2|NOT COMPLETED|Overall Study||22
8208831|NCT02144610|20243227|P1|NOT COMPLETED|Overall Study||23
8208832|NCT02144610|20243226|P2|COMPLETED|Overall Study||1
8208833|NCT02144610|20243227|P1|COMPLETED|Overall Study||0
8208834|NCT02144610|20243226|P2|STARTED|Overall Study||23
8208835|NCT02144610|20243227|P1|STARTED|Overall Study||23
8208836|NCT02144519|20243257|P2|NOT COMPLETED|Year 3||0
8208837|NCT02144519|20243258|P1|NOT COMPLETED|Year 3||0
8208838|NCT02144519|20243257|P2|COMPLETED|Year 3||760
8208839|NCT02144519|20243258|P1|COMPLETED|Year 3||894
8208840|NCT02144519|20243257|P2|STARTED|Year 3||760
8208841|NCT02144519|20243258|P1|STARTED|Year 3||894
8208842|NCT02144519|20243257|P2|NOT COMPLETED|Year 2||0
8208843|NCT02144519|20243258|P1|NOT COMPLETED|Year 2||0
8208844|NCT02144519|20243257|P2|COMPLETED|Year 2||864
8208845|NCT02144519|20243258|P1|COMPLETED|Year 2||763
8208846|NCT02144519|20243257|P2|STARTED|Year 2||864
8208847|NCT02144519|20243258|P1|STARTED|Year 2||763
8208848|NCT02144519|20243257|P2|NOT COMPLETED|Year 1||0
8208849|NCT02144519|20243258|P1|NOT COMPLETED|Year 1||0
8208850|NCT02144519|20243257|P2|COMPLETED|Year 1||870
8208851|NCT02144519|20243258|P1|COMPLETED|Year 1||895
8208852|NCT02144519|20243257|P2|STARTED|Year 1||870
8208853|NCT02144519|20243258|P1|STARTED|Year 1||895
8208854|NCT02144337|20243268|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
8208855|NCT02144337|20243269|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
8208856|NCT02144337|20243268|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
8208857|NCT02144337|20243269|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
8208858|NCT02144337|20243268|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
8208859|NCT02144337|20243269|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
8208860|NCT02144337|20243268|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
8208861|NCT02144337|20243269|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
8208862|NCT02144337|20243268|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
8208863|NCT02144337|20243269|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
8208864|NCT02144337|20243268|P2|STARTED|T2 Follow-up (Post-intervention)||5
8208865|NCT02144337|20243269|P1|STARTED|T2 Follow-up (Post-intervention)||8
8208866|NCT02144337|20243268|P2|NOT COMPLETED|Baseline 0 Months||0
8208867|NCT02144337|20243269|P1|NOT COMPLETED|Baseline 0 Months||0
8208868|NCT02144337|20243268|P2|COMPLETED|Baseline 0 Months||5
8208869|NCT02144337|20243269|P1|COMPLETED|Baseline 0 Months||8
8208870|NCT02144337|20243268|P2|STARTED|Baseline 0 Months||5
8208871|NCT02144337|20243269|P1|STARTED|Baseline 0 Months||8
8208872|NCT02144285|20243289|P10|NOT COMPLETED|Overall Study||0
8208873|NCT02144285|20243290|P9|NOT COMPLETED|Overall Study||0
8208874|NCT02144285|20243291|P8|NOT COMPLETED|Overall Study||0
8208875|NCT02144285|20243292|P7|NOT COMPLETED|Overall Study||0
8208876|NCT02144285|20243293|P6|NOT COMPLETED|Overall Study||0
8208877|NCT02144285|20243294|P5|NOT COMPLETED|Overall Study||1
8208878|NCT02144285|20243295|P4|NOT COMPLETED|Overall Study||0
8208879|NCT02144285|20243296|P3|NOT COMPLETED|Overall Study||0
8208880|NCT02144285|20243297|P2|NOT COMPLETED|Overall Study||0
8208881|NCT02144285|20243298|P1|NOT COMPLETED|Overall Study||0
8208882|NCT02144285|20243289|P10|COMPLETED|Overall Study||6
8208883|NCT02144285|20243290|P9|COMPLETED|Overall Study||2
8208884|NCT02144285|20243291|P8|COMPLETED|Overall Study||6
8208885|NCT02144285|20243292|P7|COMPLETED|Overall Study||6
8208886|NCT02144285|20243293|P6|COMPLETED|Overall Study||6
8208887|NCT02144285|20243294|P5|COMPLETED|Overall Study||5
8208888|NCT02144285|20243295|P4|COMPLETED|Overall Study||6
8208889|NCT02144285|20243296|P3|COMPLETED|Overall Study||6
8208890|NCT02144285|20243297|P2|COMPLETED|Overall Study||6
8208891|NCT02144285|20243298|P1|COMPLETED|Overall Study||14
8208892|NCT02144285|20243289|P10|Received At Least One Dose of Study Drug|Overall Study||6
8208893|NCT02144285|20243290|P9|Received At Least One Dose of Study Drug|Overall Study||2
8208894|NCT02144285|20243291|P8|Received At Least One Dose of Study Drug|Overall Study||6
8208895|NCT02144285|20243292|P7|Received At Least One Dose of Study Drug|Overall Study||6
8208896|NCT02144285|20243293|P6|Received At Least One Dose of Study Drug|Overall Study||6
8208897|NCT02144285|20243294|P5|Received At Least One Dose of Study Drug|Overall Study||6
8208898|NCT02144285|20243295|P4|Received At Least One Dose of Study Drug|Overall Study||6
8208899|NCT02144285|20243296|P3|Received At Least One Dose of Study Drug|Overall Study||6
8208900|NCT02144285|20243297|P2|Received At Least One Dose of Study Drug|Overall Study||6
8208901|NCT02144285|20243298|P1|Received At Least One Dose of Study Drug|Overall Study||14
8208902|NCT02144285|20243289|P10|STARTED|Overall Study||6
8208903|NCT02144285|20243290|P9|STARTED|Overall Study||2
8208904|NCT02144285|20243291|P8|STARTED|Overall Study||6
8208905|NCT02144285|20243292|P7|STARTED|Overall Study||6
8208906|NCT02144285|20243293|P6|STARTED|Overall Study||6
8208907|NCT02144285|20243294|P5|STARTED|Overall Study||6
8208908|NCT02144285|20243295|P4|STARTED|Overall Study||6
8208909|NCT02144285|20243296|P3|STARTED|Overall Study||6
8208910|NCT02144285|20243297|P2|STARTED|Overall Study||6
8208911|NCT02144285|20243298|P1|STARTED|Overall Study||14
8208912|NCT02144259|20243371|P3|NOT COMPLETED|Overall Study||18
8208913|NCT02144259|20243372|P2|NOT COMPLETED|Overall Study||5
8208914|NCT02144259|20243373|P1|NOT COMPLETED|Overall Study||10
8208915|NCT02144259|20243371|P3|COMPLETED|Overall Study||16
8208916|NCT02144259|20243372|P2|COMPLETED|Overall Study||28
8208917|NCT02144259|20243373|P1|COMPLETED|Overall Study||23
8208918|NCT02144259|20243371|P3|STARTED|Overall Study||34
8208919|NCT02144259|20243372|P2|STARTED|Overall Study||33
8208920|NCT02144259|20243373|P1|STARTED|Overall Study||33
8208921|NCT02144233|20243389|P2|NOT COMPLETED|Overall Study||0
8208922|NCT02144233|20243390|P1|NOT COMPLETED|Overall Study||0
8208923|NCT02144233|20243389|P2|COMPLETED|Overall Study||38
8208924|NCT02144233|20243390|P1|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
8208925|NCT02144233|20243389|P2|STARTED|Overall Study||38
8208926|NCT02144233|20243390|P1|STARTED|Overall Study||39
8208927|NCT02144220|20243424|P1|NOT COMPLETED|Overall Study||19
8208928|NCT02144220|20243424|P1|COMPLETED|Overall Study||258
8208929|NCT02144220|20243424|P1|STARTED|Overall Study||277
8208930|NCT02144155|20243432|P1|NOT COMPLETED|Overall Study||0
8208931|NCT02144155|20243432|P1|COMPLETED|Overall Study||14
8208932|NCT02144155|20243432|P1|STARTED|Overall Study||14
8208933|NCT02144077|20243443|P2|NOT COMPLETED|Overall Study||11
8208934|NCT02144077|20243444|P1|NOT COMPLETED|Overall Study||10
8208935|NCT02144077|20243443|P2|COMPLETED|Overall Study||132
8208936|NCT02144077|20243444|P1|COMPLETED|Overall Study||128
8208937|NCT02144077|20243443|P2|STARTED|Overall Study||143
8208938|NCT02144077|20243444|P1|STARTED|Overall Study||138
8208939|NCT02144012|20243462|P2|NOT COMPLETED|Overall Study||15
8208940|NCT02144012|20243463|P1|NOT COMPLETED|Overall Study||34
8208941|NCT02144012|20243462|P2|COMPLETED|Overall Study||0
8208942|NCT02144012|20243463|P1|COMPLETED|Overall Study||0
8208943|NCT02144012|20243462|P2|STARTED|Overall Study||15
8208944|NCT02144012|20243463|P1|STARTED|Overall Study||34
8208945|NCT02143973|20243498|P1|NOT COMPLETED|Overall Study||66
8208946|NCT02143973|20243498|P1|COMPLETED|Overall Study||101
8208947|NCT02143973|20243498|P1|STARTED|Overall Study||167
8208948|NCT02143947|20243504|P2|NOT COMPLETED|Overall Study||2
8208949|NCT02143947|20243505|P1|NOT COMPLETED|Overall Study||4
8208950|NCT02143947|20243504|P2|COMPLETED|Overall Study||42
8208951|NCT02143947|20243505|P1|COMPLETED|Overall Study||32
8208952|NCT02143947|20243504|P2|STARTED|Overall Study||44
8208953|NCT02143947|20243505|P1|STARTED|Overall Study||36
8208954|NCT02143843|20243517|P1|NOT COMPLETED|Overall Study||12
8208955|NCT02143843|20243517|P1|COMPLETED|Overall Study||63
8208956|NCT02143843|20243517|P1|STARTED|Overall Study||75
8208957|NCT02143778|20243522|P1|NOT COMPLETED|Overall Study||3
8208958|NCT02143778|20243522|P1|COMPLETED|Overall Study||243
8208959|NCT02143778|20243522|P1|STARTED|Overall Study||246
8208960|NCT02143713|20243531|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
8208961|NCT02143713|20243532|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
8208962|NCT02143713|20243533|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
8208963|NCT02143713|20243534|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
8208964|NCT02143713|20243531|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
8208965|NCT02143713|20243532|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
8208966|NCT02143713|20243533|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
8208967|NCT02143713|20243534|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
8208968|NCT02143713|20243531|P4|STARTED|Post-treatment Follow-up (12 Months)||122
8208969|NCT02143713|20243532|P3|STARTED|Post-treatment Follow-up (12 Months)||125
8208970|NCT02143713|20243533|P2|STARTED|Post-treatment Follow-up (12 Months)||105
8208971|NCT02143713|20243534|P1|STARTED|Post-treatment Follow-up (12 Months)||85
8208972|NCT02143713|20243531|P4|NOT COMPLETED|Treatment Period (6 Months)||28
8208973|NCT02143713|20243532|P3|NOT COMPLETED|Treatment Period (6 Months)||22
8208974|NCT02143713|20243533|P2|NOT COMPLETED|Treatment Period (6 Months)||12
8208975|NCT02143713|20243534|P1|NOT COMPLETED|Treatment Period (6 Months)||20
8208976|NCT02143713|20243531|P4|COMPLETED|Treatment Period (6 Months)||112
8208977|NCT02143713|20243532|P3|COMPLETED|Treatment Period (6 Months)||120
8208978|NCT02143713|20243533|P2|COMPLETED|Treatment Period (6 Months)||99
8208979|NCT02143713|20243534|P1|COMPLETED|Treatment Period (6 Months)||82
8208980|NCT02143713|20243531|P4|Received Elagolix|Treatment Period (6 Months)||140
8208981|NCT02143713|20243532|P3|Received Elagolix|Treatment Period (6 Months)||142
8208982|NCT02143713|20243533|P2|Received Elagolix|Treatment Period (6 Months)||111
8208983|NCT02143713|20243534|P1|Received Elagolix|Treatment Period (6 Months)||102
8208984|NCT02143713|20243531|P4|STARTED|Treatment Period (6 Months)||140
8208985|NCT02143713|20243532|P3|STARTED|Treatment Period (6 Months)||142
8208986|NCT02143713|20243533|P2|STARTED|Treatment Period (6 Months)||111
8208987|NCT02143713|20243534|P1|STARTED|Treatment Period (6 Months)||102
8208988|NCT02143648|20243615|P3|NOT COMPLETED|Overall Study||24
8208989|NCT02143648|20243616|P2|NOT COMPLETED|Overall Study||42
8208990|NCT02143648|20243617|P1|NOT COMPLETED|Overall Study||54
8208991|NCT02143648|20243615|P3|COMPLETED|Overall Study||101
8208992|NCT02143648|20243616|P2|COMPLETED|Overall Study||78
8208993|NCT02143648|20243617|P1|COMPLETED|Overall Study||74
8208994|NCT02143648|20243615|P3|STARTED|Overall Study||125
8208995|NCT02143648|20243616|P2|STARTED|Overall Study||120
8208996|NCT02143648|20243617|P1|STARTED|Overall Study||128
8208997|NCT02143583|20243628|P3|NOT COMPLETED|Overall Study||2
8208998|NCT02143583|20243629|P2|NOT COMPLETED|Overall Study||0
8208999|NCT02143583|20243630|P1|NOT COMPLETED|Overall Study||1
8209000|NCT02143583|20243628|P3|COMPLETED|Overall Study||66
8209001|NCT02143583|20243629|P2|COMPLETED|Overall Study||66
8209002|NCT02143583|20243630|P1|COMPLETED|Overall Study||61
8209003|NCT02143583|20243628|P3|STARTED|Overall Study||68
8209004|NCT02143583|20243629|P2|STARTED|Overall Study||66
8209005|NCT02143583|20243630|P1|STARTED|Overall Study||62
8209006|NCT02143310|20243641|P1|NOT COMPLETED|Overall Study||107
8209007|NCT02143310|20243641|P1|COMPLETED|Overall Study||102
8209008|NCT02143310|20243641|P1|STARTED|Overall Study||209
8209009|NCT02143141|20243653|P2|NOT COMPLETED|Overall Study||0
8209010|NCT02143141|20243654|P1|NOT COMPLETED|Overall Study||1
8209011|NCT02143141|20243653|P2|COMPLETED|Overall Study||6
8209012|NCT02143141|20243654|P1|COMPLETED|Overall Study||6
8209013|NCT02143141|20243653|P2|STARTED|Overall Study||6
8209014|NCT02143141|20243654|P1|STARTED|Overall Study||7
8209015|NCT02143102|20243666|P2|NOT COMPLETED|Overall Study||0
8209016|NCT02143102|20243667|P1|NOT COMPLETED|Overall Study||11
8209017|NCT02143102|20243666|P2|COMPLETED|Overall Study||28
8209018|NCT02143102|20243667|P1|COMPLETED|Overall Study||86
8209019|NCT02143102|20243666|P2|STARTED|Overall Study||28
8209020|NCT02143102|20243667|P1|STARTED|Overall Study||97
8209021|NCT02143024|20243677|P2|NOT COMPLETED|Overall Study||1
8209022|NCT02143024|20243678|P1|NOT COMPLETED|Overall Study||2
8209023|NCT02143024|20243677|P2|COMPLETED|Overall Study||7
8209024|NCT02143024|20243678|P1|COMPLETED|Overall Study||13
8209025|NCT02143024|20243677|P2|Received Treatment|Overall Study||7
8209026|NCT02143024|20243678|P1|Received Treatment|Overall Study||13
8209027|NCT02143024|20243677|P2|STARTED|Overall Study||8
8209028|NCT02143024|20243678|P1|STARTED|Overall Study||15
8209029|NCT02142894|20243684|P1|NOT COMPLETED|Overall Study||8
8209030|NCT02142894|20243684|P1|COMPLETED|Overall Study||25
8209031|NCT02142894|20243684|P1|STARTED|Overall Study||33
8209032|NCT02142738|20243690|P2|NOT COMPLETED|Overall Study||151
8209033|NCT02142738|20243691|P1|NOT COMPLETED|Overall Study||154
8209034|NCT02142738|20243690|P2|COMPLETED|Overall Study||0
8209035|NCT02142738|20243691|P1|COMPLETED|Overall Study||0
8209036|NCT02142738|20243690|P2|Treated|Overall Study||150
8209037|NCT02142738|20243691|P1|Treated|Overall Study||154
8209038|NCT02142738|20243690|P2|STARTED|Overall Study||151
8209039|NCT02142738|20243691|P1|STARTED|Overall Study||154
8209040|NCT02142712|20243704|P4|NOT COMPLETED|Overall Study||0
8209041|NCT02142712|20243705|P3|NOT COMPLETED|Overall Study||1
8209042|NCT02142712|20243706|P2|NOT COMPLETED|Overall Study||1
8209043|NCT02142712|20243707|P1|NOT COMPLETED|Overall Study||1
8209044|NCT02142712|20243704|P4|COMPLETED|Overall Study||0
8209045|NCT02142712|20243705|P3|COMPLETED|Overall Study||0
8209046|NCT02142712|20243706|P2|COMPLETED|Overall Study||0
8209047|NCT02142712|20243707|P1|COMPLETED|Overall Study||0
8209048|NCT02142712|20243704|P4|STARTED|Overall Study||0
8209049|NCT02142712|20243705|P3|STARTED|Overall Study||1
8209050|NCT02142712|20243706|P2|STARTED|Overall Study||1
8209051|NCT02142712|20243707|P1|STARTED|Overall Study||1
8209052|NCT02142608|20243727|P1|NOT COMPLETED|Overall Study||5
8209053|NCT02142608|20243727|P1|COMPLETED|Overall Study||13
8209054|NCT02142608|20243727|P1|STARTED|Overall Study||18
8209055|NCT02142504|20243735|P3|NOT COMPLETED|Overall Study||43
8209056|NCT02142504|20243736|P2|NOT COMPLETED|Overall Study||42
8209057|NCT02142504|20243737|P1|NOT COMPLETED|Overall Study||31
8209058|NCT02142504|20243735|P3|COMPLETED|Overall Study||111
8209059|NCT02142504|20243736|P2|COMPLETED|Overall Study||105
8209060|NCT02142504|20243737|P1|COMPLETED|Overall Study||122
8209061|NCT02142504|20243735|P3|Received Booster (Second Vaccination)|Overall Study||116
8209062|NCT02142504|20243736|P2|Received Booster (Second Vaccination)|Overall Study||109
8209063|NCT02142504|20243737|P1|Received Booster (Second Vaccination)|Overall Study||126
8209064|NCT02142504|20243735|P3|Randomized and Received Treatment|Overall Study||154
8209065|NCT02142504|20243736|P2|Randomized and Received Treatment|Overall Study||145
8209066|NCT02142504|20243737|P1|Randomized and Received Treatment|Overall Study||153
8209067|NCT02142504|20243735|P3|STARTED|Overall Study||154
8209068|NCT02142504|20243736|P2|STARTED|Overall Study||147
8209069|NCT02142504|20243737|P1|STARTED|Overall Study||153
8209070|NCT02142387|20243825|P2|NOT COMPLETED|Overall Study||7630
8209071|NCT02142387|20243826|P1|NOT COMPLETED|Overall Study||1065
8209072|NCT02142387|20243825|P2|COMPLETED|Overall Study||8641
8209073|NCT02142387|20243826|P1|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
8209074|NCT02142387|20243825|P2|STARTED|Overall Study||16271
8209075|NCT02142387|20243826|P1|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
8209076|NCT02142361|20243836|P3|NOT COMPLETED|Overall Study||0
8209077|NCT02142361|20243837|P2|NOT COMPLETED|Overall Study||0
8209078|NCT02142361|20243838|P1|NOT COMPLETED|Overall Study||0
8209079|NCT02142361|20243836|P3|COMPLETED|Overall Study||20
8209080|NCT02142361|20243837|P2|COMPLETED|Overall Study||20
8209081|NCT02142361|20243838|P1|COMPLETED|Overall Study||20
8209082|NCT02142361|20243836|P3|STARTED|Overall Study||20
8209083|NCT02142361|20243837|P2|STARTED|Overall Study||20
8209084|NCT02142361|20243838|P1|STARTED|Overall Study||20
8209085|NCT02142283|20243939|P2|NOT COMPLETED|Overall Study||21
8209086|NCT02142283|20243940|P1|NOT COMPLETED|Overall Study||21
8209087|NCT02142283|20243939|P2|COMPLETED|Overall Study||78
8209088|NCT02142283|20243940|P1|COMPLETED|Overall Study||86
8209089|NCT02142283|20243939|P2|STARTED|Overall Study||99
8209090|NCT02142283|20243940|P1|STARTED|Overall Study||107
8209091|NCT02142153|20243970|P10|NOT COMPLETED|Overall Study||0
8209092|NCT02142153|20243971|P9|NOT COMPLETED|Overall Study||0
8209093|NCT02142153|20243972|P8|NOT COMPLETED|Overall Study||0
8209094|NCT02142153|20243973|P7|NOT COMPLETED|Overall Study||0
8209095|NCT02142153|20243974|P6|NOT COMPLETED|Overall Study||0
8209096|NCT02142153|20243975|P5|NOT COMPLETED|Overall Study||0
8209097|NCT02142153|20243976|P4|NOT COMPLETED|Overall Study||0
8209098|NCT02142153|20243977|P3|NOT COMPLETED|Overall Study||0
8209099|NCT02142153|20243978|P2|NOT COMPLETED|Overall Study||0
8209100|NCT02142153|20243979|P1|NOT COMPLETED|Overall Study||0
8209101|NCT02142153|20243970|P10|COMPLETED|Overall Study||2
8209102|NCT02142153|20243971|P9|COMPLETED|Overall Study||6
8209103|NCT02142153|20243972|P8|COMPLETED|Overall Study||2
8209104|NCT02142153|20243973|P7|COMPLETED|Overall Study||6
8209105|NCT02142153|20243974|P6|COMPLETED|Overall Study||2
8209106|NCT02142153|20243975|P5|COMPLETED|Overall Study||6
8209107|NCT02142153|20243976|P4|COMPLETED|Overall Study||2
8209108|NCT02142153|20243977|P3|COMPLETED|Overall Study||6
8209109|NCT02142153|20243978|P2|COMPLETED|Overall Study||2
8209110|NCT02142153|20243979|P1|COMPLETED|Overall Study||6
8209111|NCT02142153|20243970|P10|STARTED|Overall Study||2
8209112|NCT02142153|20243971|P9|STARTED|Overall Study||6
8209113|NCT02142153|20243972|P8|STARTED|Overall Study||2
8209114|NCT02142153|20243973|P7|STARTED|Overall Study||6
8209115|NCT02142153|20243974|P6|STARTED|Overall Study||2
8209116|NCT02142153|20243975|P5|STARTED|Overall Study||6
8209117|NCT02142153|20243976|P4|STARTED|Overall Study||2
8209118|NCT02142153|20243977|P3|STARTED|Overall Study||6
8209119|NCT02142153|20243978|P2|STARTED|Overall Study||2
8209120|NCT02142153|20243979|P1|STARTED|Overall Study||6
8209121|NCT02142049|20244016|P5|NOT COMPLETED|Overall Study||0
8209122|NCT02142049|20244017|P4|NOT COMPLETED|Overall Study||0
8209123|NCT02142049|20244018|P3|NOT COMPLETED|Overall Study||0
8209124|NCT02142049|20244019|P2|NOT COMPLETED|Overall Study||0
8209125|NCT02142049|20244020|P1|NOT COMPLETED|Overall Study||0
8209126|NCT02142049|20244016|P5|COMPLETED|Overall Study||20
8209127|NCT02142049|20244017|P4|COMPLETED|Overall Study||6
8209128|NCT02142049|20244018|P3|COMPLETED|Overall Study||3
8209129|NCT02142049|20244019|P2|COMPLETED|Overall Study||3
8209130|NCT02142049|20244020|P1|COMPLETED|Overall Study||3
8209131|NCT02142049|20244016|P5|STARTED|Overall Study||20
8209132|NCT02142049|20244017|P4|STARTED|Overall Study||6
8209133|NCT02142049|20244018|P3|STARTED|Overall Study||3
8209134|NCT02142049|20244019|P2|STARTED|Overall Study||3
8209135|NCT02142049|20244020|P1|STARTED|Overall Study||3
8209136|NCT02141997|20244049|P4|NOT COMPLETED|Overall Study||1
8209137|NCT02141997|20244050|P3|NOT COMPLETED|Overall Study||3
8209138|NCT02141997|20244051|P2|NOT COMPLETED|Overall Study||6
8209139|NCT02141997|20244052|P1|NOT COMPLETED|Overall Study||3
8209140|NCT02141997|20244049|P4|COMPLETED|Overall Study||54
8209141|NCT02141997|20244050|P3|COMPLETED|Overall Study||53
8209142|NCT02141997|20244051|P2|COMPLETED|Overall Study||49
8209143|NCT02141997|20244052|P1|COMPLETED|Overall Study||53
8209144|NCT02141997|20244049|P4|STARTED|Overall Study||55
8209145|NCT02141997|20244050|P3|STARTED|Overall Study||56
8209146|NCT02141997|20244051|P2|STARTED|Overall Study||55
8209147|NCT02141997|20244052|P1|STARTED|Overall Study||56
8209148|NCT02141984|20244090|P1|NOT COMPLETED|Overall Study||2
8209149|NCT02141984|20244090|P1|COMPLETED|Overall Study||26
8209150|NCT02141984|20244090|P1|STARTED|Overall Study||28
8209151|NCT02141867|20244097|P1|NOT COMPLETED|Overall Study||94
8209152|NCT02141867|20244097|P1|COMPLETED|Overall Study||3927
8209153|NCT02141867|20244097|P1|STARTED|Overall Study||4021
8209154|NCT02141854|20244109|P6|NOT COMPLETED|Treatment Period||38
8209155|NCT02141854|20244110|P5|NOT COMPLETED|Treatment Period||10
8209156|NCT02141854|20244111|P4|NOT COMPLETED|Treatment Period||11
8209157|NCT02141854|20244112|P3|NOT COMPLETED|Treatment Period||9
8209158|NCT02141854|20244113|P2|NOT COMPLETED|Treatment Period||10
8209159|NCT02141854|20244114|P1|NOT COMPLETED|Treatment Period||0
8209160|NCT02141854|20244109|P6|COMPLETED|Treatment Period||107
8209161|NCT02141854|20244110|P5|COMPLETED|Treatment Period||136
8209162|NCT02141854|20244111|P4|COMPLETED|Treatment Period||135
8209163|NCT02141854|20244112|P3|COMPLETED|Treatment Period||136
8209164|NCT02141854|20244113|P2|COMPLETED|Treatment Period||136
8209165|NCT02141854|20244114|P1|COMPLETED|Treatment Period||0
8209166|NCT02141854|20244109|P6|Full Analysis Set|Treatment Period||143
8209167|NCT02141854|20244110|P5|Full Analysis Set|Treatment Period||145
8209168|NCT02141854|20244111|P4|Full Analysis Set|Treatment Period||146
8209169|NCT02141854|20244112|P3|Full Analysis Set|Treatment Period||141
8209170|NCT02141854|20244113|P2|Full Analysis Set|Treatment Period||145
8209171|NCT02141854|20244114|P1|Full Analysis Set|Treatment Period||0
8209172|NCT02141854|20244109|P6|Safety Population|Treatment Period||144
8209173|NCT02141854|20244110|P5|Safety Population|Treatment Period||145
8209174|NCT02141854|20244111|P4|Safety Population|Treatment Period||146
8209175|NCT02141854|20244112|P3|Safety Population|Treatment Period||143
8209176|NCT02141854|20244113|P2|Safety Population|Treatment Period||145
8209177|NCT02141854|20244114|P1|Safety Population|Treatment Period||0
8209178|NCT02141854|20244109|P6|Intent to Treat Population|Treatment Period||145
8209179|NCT02141854|20244110|P5|Intent to Treat Population|Treatment Period||146
8209180|NCT02141854|20244111|P4|Intent to Treat Population|Treatment Period||146
8209181|NCT02141854|20244112|P3|Intent to Treat Population|Treatment Period||145
8209182|NCT02141854|20244113|P2|Intent to Treat Population|Treatment Period||146
8209183|NCT02141854|20244114|P1|Intent to Treat Population|Treatment Period||0
8209184|NCT02141854|20244109|P6|STARTED|Treatment Period||145
8209185|NCT02141854|20244110|P5|STARTED|Treatment Period||146
8209186|NCT02141854|20244111|P4|STARTED|Treatment Period||146
8209187|NCT02141854|20244112|P3|STARTED|Treatment Period||145
8209188|NCT02141854|20244113|P2|STARTED|Treatment Period||146
8209189|NCT02141854|20244114|P1|STARTED|Treatment Period||0
8209190|NCT02141854|20244109|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209191|NCT02141854|20244110|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209192|NCT02141854|20244111|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209193|NCT02141854|20244112|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209194|NCT02141854|20244113|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209195|NCT02141854|20244114|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
8209196|NCT02141854|20244109|P6|COMPLETED|Run-In Period (Pre-assignment)||0
8209197|NCT02141854|20244110|P5|COMPLETED|Run-In Period (Pre-assignment)||0
8209198|NCT02141854|20244111|P4|COMPLETED|Run-In Period (Pre-assignment)||0
8209199|NCT02141854|20244112|P3|COMPLETED|Run-In Period (Pre-assignment)||0
8209200|NCT02141854|20244113|P2|COMPLETED|Run-In Period (Pre-assignment)||0
8209201|NCT02141854|20244114|P1|COMPLETED|Run-In Period (Pre-assignment)||728
8209202|NCT02141854|20244109|P6|STARTED|Run-In Period (Pre-assignment)||0
8209203|NCT02141854|20244110|P5|STARTED|Run-In Period (Pre-assignment)||0
8209204|NCT02141854|20244111|P4|STARTED|Run-In Period (Pre-assignment)||0
8209205|NCT02141854|20244112|P3|STARTED|Run-In Period (Pre-assignment)||0
8209206|NCT02141854|20244113|P2|STARTED|Run-In Period (Pre-assignment)||0
8209207|NCT02141854|20244114|P1|STARTED|Run-In Period (Pre-assignment)||882
8209208|NCT02141659|20244172|P6|NOT COMPLETED|Overall Study||2
8209209|NCT02141659|20244173|P5|NOT COMPLETED|Overall Study||2
8209210|NCT02141659|20244174|P4|NOT COMPLETED|Overall Study||0
8209211|NCT02141659|20244175|P3|NOT COMPLETED|Overall Study||0
8209212|NCT02141659|20244176|P2|NOT COMPLETED|Overall Study||1
8209213|NCT02141659|20244177|P1|NOT COMPLETED|Overall Study||0
8209214|NCT02141659|20244172|P6|COMPLETED|Overall Study||13
8209215|NCT02141659|20244173|P5|COMPLETED|Overall Study||13
8209216|NCT02141659|20244174|P4|COMPLETED|Overall Study||3
8209217|NCT02141659|20244175|P3|COMPLETED|Overall Study||3
8209218|NCT02141659|20244176|P2|COMPLETED|Overall Study||3
8209219|NCT02141659|20244177|P1|COMPLETED|Overall Study||3
8209220|NCT02141659|20244172|P6|STARTED|Overall Study||15
8209221|NCT02141659|20244173|P5|STARTED|Overall Study||15
8209222|NCT02141659|20244174|P4|STARTED|Overall Study||3
8209223|NCT02141659|20244175|P3|STARTED|Overall Study||3
8209224|NCT02141659|20244176|P2|STARTED|Overall Study||4
8209225|NCT02141659|20244177|P1|STARTED|Overall Study||3
8209226|NCT02141633|20244233|P2|NOT COMPLETED|Overall Study||0
8209227|NCT02141633|20244234|P1|NOT COMPLETED|Overall Study||1
8209228|NCT02141633|20244233|P2|COMPLETED|Overall Study||15
8209229|NCT02141633|20244234|P1|COMPLETED|Overall Study||15
8209230|NCT02141633|20244233|P2|STARTED|Overall Study||15
8209231|NCT02141633|20244234|P1|STARTED|Overall Study||16
8209232|NCT02141620|20244242|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
8209233|NCT02141620|20244243|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
8209234|NCT02141620|20244242|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
8209235|NCT02141620|20244243|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
8209236|NCT02141620|20244242|P2|STARTED|Treatment Condition 2 (7 Days)||7
8209237|NCT02141620|20244243|P1|STARTED|Treatment Condition 2 (7 Days)||7
8209238|NCT02141620|20244242|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
8209239|NCT02141620|20244243|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
8209240|NCT02141620|20244242|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
8209241|NCT02141620|20244243|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
8209242|NCT02141620|20244242|P2|STARTED|Treatment Condition 1 (7 Days)||7
8209243|NCT02141620|20244243|P1|STARTED|Treatment Condition 1 (7 Days)||8
8209244|NCT02141581|20244304|P3|NOT COMPLETED|Overall Study||0
8209245|NCT02141581|20244305|P2|NOT COMPLETED|Overall Study||0
8209246|NCT02141581|20244306|P1|NOT COMPLETED|Overall Study||0
8209247|NCT02141581|20244304|P3|COMPLETED|Overall Study||25
8209248|NCT02141581|20244305|P2|COMPLETED|Overall Study||19
8209249|NCT02141581|20244306|P1|COMPLETED|Overall Study||42
8209250|NCT02141581|20244304|P3|STARTED|Overall Study||25
8209251|NCT02141581|20244305|P2|STARTED|Overall Study||19
8209252|NCT02141581|20244306|P1|STARTED|Overall Study||42
8209253|NCT02141555|20244319|P2|NOT COMPLETED|Overall Study||0
8209254|NCT02141555|20244320|P1|NOT COMPLETED|Overall Study||0
8209255|NCT02141555|20244319|P2|COMPLETED|Overall Study||2
8209256|NCT02141555|20244320|P1|COMPLETED|Overall Study||2
8209257|NCT02141555|20244319|P2|STARTED|Overall Study||2
8209258|NCT02141555|20244320|P1|STARTED|Overall Study||2
8209259|NCT02141516|20244335|P3|NOT COMPLETED|Overall Study||0
8209260|NCT02141516|20244336|P2|NOT COMPLETED|Overall Study||5
8209261|NCT02141516|20244337|P1|NOT COMPLETED|Overall Study||0
8209262|NCT02141516|20244335|P3|COMPLETED|Overall Study||87
8209263|NCT02141516|20244336|P2|COMPLETED|Overall Study||107
8209264|NCT02141516|20244337|P1|COMPLETED|Overall Study||40
8209265|NCT02141516|20244335|P3|STARTED|Overall Study||87
8209266|NCT02141516|20244336|P2|STARTED|Overall Study||112
8209267|NCT02141516|20244337|P1|STARTED|Overall Study||40
8209268|NCT02141490|20244388|P3|NOT COMPLETED|Overall Study||0
8209269|NCT02141490|20244389|P2|NOT COMPLETED|Overall Study||0
8209270|NCT02141490|20244390|P1|NOT COMPLETED|Overall Study||4
8209271|NCT02141490|20244388|P3|COMPLETED|Overall Study||3
8209272|NCT02141490|20244389|P2|COMPLETED|Overall Study||6
8209273|NCT02141490|20244390|P1|COMPLETED|Overall Study||30
8209274|NCT02141490|20244388|P3|STARTED|Overall Study||3
8209275|NCT02141490|20244389|P2|STARTED|Overall Study||6
8209276|NCT02141490|20244390|P1|STARTED|Overall Study||34
8209277|NCT02141451|20244407|P4|NOT COMPLETED|Overall Study||9
8209278|NCT02141451|20244408|P3|NOT COMPLETED|Overall Study||5
8209279|NCT02141451|20244409|P2|NOT COMPLETED|Overall Study||2
8209280|NCT02141451|20244410|P1|NOT COMPLETED|Overall Study||0
8209281|NCT02141451|20244407|P4|COMPLETED|Overall Study||7
8209282|NCT02141451|20244408|P3|COMPLETED|Overall Study||2
8209283|NCT02141451|20244409|P2|COMPLETED|Overall Study||2
8209284|NCT02141451|20244410|P1|COMPLETED|Overall Study||3
8209285|NCT02141451|20244407|P4|STARTED|Overall Study||16
8209286|NCT02141451|20244408|P3|STARTED|Overall Study||7
8209287|NCT02141451|20244409|P2|STARTED|Overall Study||4
8209288|NCT02141451|20244410|P1|STARTED|Overall Study||3
8209289|NCT02141399|20244435|P1|NOT COMPLETED|Overall Study||744
8209290|NCT02141399|20244435|P1|COMPLETED|Overall Study||741
8209291|NCT02141399|20244435|P1|STARTED|Overall Study||1485
8209292|NCT02141360|20244441|P3|NOT COMPLETED|Overall Study||0
8209293|NCT02141360|20244442|P2|NOT COMPLETED|Overall Study||0
8209294|NCT02141360|20244443|P1|NOT COMPLETED|Overall Study||7
8209295|NCT02141360|20244441|P3|COMPLETED|Overall Study||6
8209296|NCT02141360|20244442|P2|COMPLETED|Overall Study||6
8209297|NCT02141360|20244443|P1|COMPLETED|Overall Study||4
8209298|NCT02141360|20244441|P3|STARTED|Overall Study||6
8209299|NCT02141360|20244442|P2|STARTED|Overall Study||6
8209300|NCT02141360|20244443|P1|STARTED|Overall Study||11
8209301|NCT02141295|20244454|P3|NOT COMPLETED|Overall Study||95
8209302|NCT02141295|20244455|P2|NOT COMPLETED|Overall Study||94
8209303|NCT02141295|20244456|P1|NOT COMPLETED|Overall Study||6
8209304|NCT02141295|20244454|P3|COMPLETED|Overall Study||0
8209305|NCT02141295|20244455|P2|COMPLETED|Overall Study||0
8209306|NCT02141295|20244456|P1|COMPLETED|Overall Study||2
8209307|NCT02141295|20244454|P3|STARTED|Overall Study||95
8209308|NCT02141295|20244455|P2|STARTED|Overall Study||94
8209309|NCT02141295|20244456|P1|STARTED|Overall Study||8
8209310|NCT02141217|20244492|P2|NOT COMPLETED|Overall Study||8
8209311|NCT02141217|20244493|P1|NOT COMPLETED|Overall Study||11
8209312|NCT02141217|20244492|P2|COMPLETED|Overall Study||229
8209313|NCT02141217|20244493|P1|COMPLETED|Overall Study||223
8209314|NCT02141217|20244492|P2|ITT Population-Actual Treatment Received|Overall Study||235
8209315|NCT02141217|20244493|P1|ITT Population-Actual Treatment Received|Overall Study||236
8209316|NCT02141217|20244492|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
8209317|NCT02141217|20244493|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
8209318|NCT02141217|20244492|P2|STARTED|Overall Study||237
8209319|NCT02141217|20244493|P1|STARTED|Overall Study||234
8209320|NCT02141204|20244513|P2|NOT COMPLETED|Overall Study||15
8209321|NCT02141204|20244514|P1|NOT COMPLETED|Overall Study||15
8209322|NCT02141204|20244513|P2|COMPLETED|Overall Study||210
8209323|NCT02141204|20244514|P1|COMPLETED|Overall Study||209
8209324|NCT02141204|20244513|P2|STARTED|Overall Study||225
8209325|NCT02141204|20244514|P1|STARTED|Overall Study||224
8209326|NCT02140957|20244530|P2|NOT COMPLETED|Overall Study||23
8209327|NCT02140957|20244531|P1|NOT COMPLETED|Overall Study||27
8209328|NCT02140957|20244530|P2|COMPLETED|Overall Study||99
8209329|NCT02140957|20244531|P1|COMPLETED|Overall Study||102
8209330|NCT02140957|20244530|P2|STARTED|Overall Study||122
8209331|NCT02140957|20244531|P1|STARTED|Overall Study||129
8209332|NCT02140788|20244541|P4|NOT COMPLETED|Overall Study||0
8209333|NCT02140788|20244542|P3|NOT COMPLETED|Overall Study||0
8209334|NCT02140788|20244543|P2|NOT COMPLETED|Overall Study||0
8209335|NCT02140788|20244544|P1|NOT COMPLETED|Overall Study||0
8209336|NCT02140788|20244541|P4|COMPLETED|Overall Study||0
8209337|NCT02140788|20244542|P3|COMPLETED|Overall Study||0
8209338|NCT02140788|20244543|P2|COMPLETED|Overall Study||0
8209339|NCT02140788|20244544|P1|COMPLETED|Overall Study||0
8209340|NCT02140788|20244541|P4|STARTED|Overall Study||0
8209341|NCT02140788|20244542|P3|STARTED|Overall Study||0
8209342|NCT02140788|20244543|P2|STARTED|Overall Study||0
8209343|NCT02140788|20244544|P1|STARTED|Overall Study||0
8209344|NCT02140775|20244572|P2|NOT COMPLETED|Overall Study||7
8209345|NCT02140775|20244573|P1|NOT COMPLETED|Overall Study||30
8209346|NCT02140775|20244572|P2|COMPLETED|Overall Study||22
8209347|NCT02140775|20244573|P1|COMPLETED|Overall Study||57
8209348|NCT02140775|20244572|P2|STARTED|Overall Study||29
8209349|NCT02140775|20244573|P1|STARTED|Overall Study||87
8209350|NCT02140762|20244585|P2|NOT COMPLETED|Overall Study||12
8209351|NCT02140762|20244586|P1|NOT COMPLETED|Overall Study||17
8209352|NCT02140762|20244585|P2|COMPLETED|Overall Study||139
8209353|NCT02140762|20244586|P1|COMPLETED|Overall Study||137
8209354|NCT02140762|20244585|P2|STARTED|Overall Study||151
8209355|NCT02140762|20244586|P1|STARTED|Overall Study||154
8209356|NCT02140645|20244652|P6|NOT COMPLETED|Overall Study||70896
8209357|NCT02140645|20244653|P5|NOT COMPLETED|Overall Study||3286
8209358|NCT02140645|20244654|P4|NOT COMPLETED|Overall Study||13833
8209359|NCT02140645|20244655|P3|NOT COMPLETED|Overall Study||4236
8209360|NCT02140645|20244656|P2|NOT COMPLETED|Overall Study||61654
8209361|NCT02140645|20244657|P1|NOT COMPLETED|Overall Study||5489
8209362|NCT02140645|20244652|P6|COMPLETED|Overall Study||3050
8209363|NCT02140645|20244653|P5|COMPLETED|Overall Study||150
8209364|NCT02140645|20244654|P4|COMPLETED|Overall Study||530
8209365|NCT02140645|20244655|P3|COMPLETED|Overall Study||205
8209366|NCT02140645|20244656|P2|COMPLETED|Overall Study||3041
8209367|NCT02140645|20244657|P1|COMPLETED|Overall Study||243
8209368|NCT02140645|20244652|P6|STARTED|Overall Study||73946
8209369|NCT02140645|20244653|P5|STARTED|Overall Study||3436
8209370|NCT02140645|20244654|P4|STARTED|Overall Study||14363
8209371|NCT02140645|20244655|P3|STARTED|Overall Study||4441
8209372|NCT02140645|20244656|P2|STARTED|Overall Study||64695
8209373|NCT02140645|20244657|P1|STARTED|Overall Study||5732
8209374|NCT02140593|20244746|P2|NOT COMPLETED|Overall Study||0
8209375|NCT02140593|20244747|P1|NOT COMPLETED|Overall Study||0
8209376|NCT02140593|20244746|P2|COMPLETED|Overall Study||65
8209377|NCT02140593|20244747|P1|COMPLETED|Overall Study||63
8209378|NCT02140593|20244746|P2|STARTED|Overall Study||65
8209379|NCT02140593|20244747|P1|STARTED|Overall Study||63
8209380|NCT02140567|20244755|P1|NOT COMPLETED|Overall Study||6
8209381|NCT02140567|20244755|P1|COMPLETED|Overall Study||134
8209382|NCT02140567|20244755|P1|STARTED|Overall Study||140
8209383|NCT02140411|20244760|P1|NOT COMPLETED|Overall Study||1
8209384|NCT02140411|20244760|P1|COMPLETED|Overall Study||20
8209385|NCT02140411|20244760|P1|STARTED|Overall Study||21
8209386|NCT02140372|20244769|P1|NOT COMPLETED|Overall Study||0
8209387|NCT02140372|20244769|P1|COMPLETED|Overall Study||10
8209388|NCT02140372|20244769|P1|STARTED|Overall Study||10
8209389|NCT02140164|20244780|P1|NOT COMPLETED|Overall Study||2
8209390|NCT02140164|20244780|P1|COMPLETED|Overall Study||5
8209391|NCT02140164|20244780|P1|STARTED|Overall Study||7
8209392|NCT02140060|20244801|P6|NOT COMPLETED|Overall Study||1
8209393|NCT02140060|20244802|P5|NOT COMPLETED|Overall Study||1
8209394|NCT02140060|20244803|P4|NOT COMPLETED|Overall Study||2
8209395|NCT02140060|20244804|P3|NOT COMPLETED|Overall Study||0
8209396|NCT02140060|20244805|P2|NOT COMPLETED|Overall Study||0
8209397|NCT02140060|20244806|P1|NOT COMPLETED|Overall Study||0
8209398|NCT02140060|20244801|P6|COMPLETED|Overall Study||43
8209399|NCT02140060|20244802|P5|COMPLETED|Overall Study||44
8209400|NCT02140060|20244803|P4|COMPLETED|Overall Study||43
8209401|NCT02140060|20244804|P3|COMPLETED|Overall Study||44
8209402|NCT02140060|20244805|P2|COMPLETED|Overall Study||44
8209403|NCT02140060|20244806|P1|COMPLETED|Overall Study||44
8209404|NCT02140060|20244801|P6|STARTED|Overall Study||44
8209405|NCT02140060|20244802|P5|STARTED|Overall Study||45
8209406|NCT02140060|20244803|P4|STARTED|Overall Study||45
8209407|NCT02140060|20244804|P3|STARTED|Overall Study||44
8209408|NCT02140060|20244805|P2|STARTED|Overall Study||44
8209409|NCT02140060|20244806|P1|STARTED|Overall Study||44
8209410|NCT02139982|20244831|P10|NOT COMPLETED|Overall Study||0
8209411|NCT02139982|20244832|P9|NOT COMPLETED|Overall Study||0
8209412|NCT02139982|20244833|P8|NOT COMPLETED|Overall Study||0
8209413|NCT02139982|20244834|P7|NOT COMPLETED|Overall Study||0
8209414|NCT02139982|20244835|P6|NOT COMPLETED|Overall Study||0
8209415|NCT02139982|20244836|P5|NOT COMPLETED|Overall Study||0
8209416|NCT02139982|20244837|P4|NOT COMPLETED|Overall Study||1
8209417|NCT02139982|20244838|P3|NOT COMPLETED|Overall Study||0
8209418|NCT02139982|20244839|P2|NOT COMPLETED|Overall Study||1
8209419|NCT02139982|20244840|P1|NOT COMPLETED|Overall Study||0
8209420|NCT02139982|20244831|P10|COMPLETED|Overall Study||13
8209421|NCT02139982|20244832|P9|COMPLETED|Overall Study||13
8209422|NCT02139982|20244833|P8|COMPLETED|Overall Study||13
8209423|NCT02139982|20244834|P7|COMPLETED|Overall Study||13
8209424|NCT02139982|20244835|P6|COMPLETED|Overall Study||13
8209425|NCT02139982|20244836|P5|COMPLETED|Overall Study||13
8209426|NCT02139982|20244837|P4|COMPLETED|Overall Study||7
8209427|NCT02139982|20244838|P3|COMPLETED|Overall Study||8
8209428|NCT02139982|20244839|P2|COMPLETED|Overall Study||7
8209429|NCT02139982|20244840|P1|COMPLETED|Overall Study||8
8209430|NCT02139982|20244831|P10|STARTED|Overall Study||13
8209431|NCT02139982|20244832|P9|STARTED|Overall Study||13
8209432|NCT02139982|20244833|P8|STARTED|Overall Study||13
8209433|NCT02139982|20244834|P7|STARTED|Overall Study||13
8209434|NCT02139982|20244835|P6|STARTED|Overall Study||13
8209435|NCT02139982|20244836|P5|STARTED|Overall Study||13
8209436|NCT02139982|20244837|P4|STARTED|Overall Study||8
8209437|NCT02139982|20244838|P3|STARTED|Overall Study||8
8209438|NCT02139982|20244839|P2|STARTED|Overall Study||8
8209439|NCT02139982|20244840|P1|STARTED|Overall Study||8
8209440|NCT02139969|20244882|P1|NOT COMPLETED|Overall Study||0
8209441|NCT02139969|20244882|P1|COMPLETED|Overall Study||956
8209442|NCT02139969|20244882|P1|STARTED|Overall Study||956
8209443|NCT02139943|20244904|P3|NOT COMPLETED|Overall Study||7
8209444|NCT02139943|20244905|P2|NOT COMPLETED|Overall Study||6
8209445|NCT02139943|20244906|P1|NOT COMPLETED|Overall Study||10
8209446|NCT02139943|20244904|P3|COMPLETED|Overall Study||110
8209447|NCT02139943|20244905|P2|COMPLETED|Overall Study||111
8209448|NCT02139943|20244906|P1|COMPLETED|Overall Study||107
8209449|NCT02139943|20244904|P3|STARTED|Overall Study||117
8209450|NCT02139943|20244905|P2|STARTED|Overall Study||117
8209451|NCT02139943|20244906|P1|STARTED|Overall Study||117
8209452|NCT02139878|20244917|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8209453|NCT02139878|20244918|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8209454|NCT02139878|20244917|P2|COMPLETED|Second Intervention (7 Days)||10
8209455|NCT02139878|20244918|P1|COMPLETED|Second Intervention (7 Days)||9
8209456|NCT02139878|20244917|P2|STARTED|Second Intervention (7 Days)||10
8209457|NCT02139878|20244918|P1|STARTED|Second Intervention (7 Days)||9
8209458|NCT02139878|20244917|P2|NOT COMPLETED|Washout Period (8 Days)||0
8209459|NCT02139878|20244918|P1|NOT COMPLETED|Washout Period (8 Days)||0
8209460|NCT02139878|20244917|P2|COMPLETED|Washout Period (8 Days)||10
8209461|NCT02139878|20244918|P1|COMPLETED|Washout Period (8 Days)||9
8209462|NCT02139878|20244917|P2|STARTED|Washout Period (8 Days)||10
8209463|NCT02139878|20244918|P1|STARTED|Washout Period (8 Days)||9
8209464|NCT02139878|20244917|P2|NOT COMPLETED|First Intervention (7 Days)||0
8209465|NCT02139878|20244918|P1|NOT COMPLETED|First Intervention (7 Days)||1
8209466|NCT02139878|20244917|P2|COMPLETED|First Intervention (7 Days)||10
8209467|NCT02139878|20244918|P1|COMPLETED|First Intervention (7 Days)||9
8209468|NCT02139878|20244917|P2|STARTED|First Intervention (7 Days)||10
8209469|NCT02139878|20244918|P1|STARTED|First Intervention (7 Days)||10
8209470|NCT02139826|20244926|P1|NOT COMPLETED|Overall Study||1
8209471|NCT02139826|20244926|P1|COMPLETED|Overall Study||11
8209472|NCT02139826|20244926|P1|STARTED|Overall Study||12
8209473|NCT02139800|20244959|P2|NOT COMPLETED|Overall Study||21
8209474|NCT02139800|20244960|P1|NOT COMPLETED|Overall Study||13
8209475|NCT02139800|20244959|P2|COMPLETED|Overall Study||215
8209476|NCT02139800|20244960|P1|COMPLETED|Overall Study||211
8209477|NCT02139800|20244959|P2|STARTED|Overall Study||236
8209478|NCT02139800|20244960|P1|STARTED|Overall Study||224
8209479|NCT02139644|20244971|P6|NOT COMPLETED|Treatment Period||17
8209480|NCT02139644|20244972|P5|NOT COMPLETED|Treatment Period||8
8209481|NCT02139644|20244973|P4|NOT COMPLETED|Treatment Period||9
8209482|NCT02139644|20244974|P3|NOT COMPLETED|Treatment Period||8
8209483|NCT02139644|20244975|P2|NOT COMPLETED|Treatment Period||3
8209484|NCT02139644|20244976|P1|NOT COMPLETED|Treatment Period||0
8209485|NCT02139644|20244971|P6|COMPLETED|Treatment Period||113
8209486|NCT02139644|20244972|P5|COMPLETED|Treatment Period||121
8209487|NCT02139644|20244973|P4|COMPLETED|Treatment Period||121
8209488|NCT02139644|20244974|P3|COMPLETED|Treatment Period||121
8209489|NCT02139644|20244975|P2|COMPLETED|Treatment Period||126
8209490|NCT02139644|20244976|P1|COMPLETED|Treatment Period||0
8209491|NCT02139644|20244971|P6|STARTED|Treatment Period|Randomized|130
8209492|NCT02139644|20244972|P5|STARTED|Treatment Period|Randomized|129
8209493|NCT02139644|20244973|P4|STARTED|Treatment Period|Randomized|130
8209494|NCT02139644|20244974|P3|STARTED|Treatment Period|Randomized|129
8209495|NCT02139644|20244975|P2|STARTED|Treatment Period|Randomized|129
8209496|NCT02139644|20244976|P1|STARTED|Treatment Period||0
8209497|NCT02139644|20244971|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209498|NCT02139644|20244972|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209499|NCT02139644|20244973|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209500|NCT02139644|20244974|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209501|NCT02139644|20244975|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209502|NCT02139644|20244976|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
8209503|NCT02139644|20244971|P6|COMPLETED|Run-In Period (Pre-assignment)||0
8209504|NCT02139644|20244972|P5|COMPLETED|Run-In Period (Pre-assignment)||0
8209505|NCT02139644|20244973|P4|COMPLETED|Run-In Period (Pre-assignment)||0
8209506|NCT02139644|20244974|P3|COMPLETED|Run-In Period (Pre-assignment)||0
8209507|NCT02139644|20244975|P2|COMPLETED|Run-In Period (Pre-assignment)||0
8209508|NCT02139644|20244976|P1|COMPLETED|Run-In Period (Pre-assignment)||647
8209509|NCT02139644|20244971|P6|STARTED|Run-In Period (Pre-assignment)||0
8209510|NCT02139644|20244972|P5|STARTED|Run-In Period (Pre-assignment)||0
8209511|NCT02139644|20244973|P4|STARTED|Run-In Period (Pre-assignment)||0
8209512|NCT02139644|20244974|P3|STARTED|Run-In Period (Pre-assignment)||0
8209513|NCT02139644|20244975|P2|STARTED|Run-In Period (Pre-assignment)||0
8209514|NCT02139644|20244976|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
8209515|NCT02139592|20245028|P1|NOT COMPLETED|Overall Study||8
8209516|NCT02139592|20245028|P1|COMPLETED|Overall Study||284
8209517|NCT02139592|20245028|P1|STARTED|Overall Study||292
8209518|NCT02139540|20245036|P2|NOT COMPLETED|Overall Study||0
8209519|NCT02139540|20245037|P1|NOT COMPLETED|Overall Study||1
8209520|NCT02139540|20245036|P2|COMPLETED|Overall Study||10
8209521|NCT02139540|20245037|P1|COMPLETED|Overall Study||10
8209522|NCT02139540|20245036|P2|STARTED|Overall Study||10
8209523|NCT02139540|20245037|P1|STARTED|Overall Study||11
8209527|NCT02139306|20245054|P2|NOT COMPLETED|Overall Study||14
8209528|NCT02139306|20245055|P1|NOT COMPLETED|Overall Study||13
8209529|NCT02139306|20245054|P2|COMPLETED|Overall Study||125
8209530|NCT02139306|20245055|P1|COMPLETED|Overall Study||127
8209531|NCT02139306|20245054|P2|STARTED|Overall Study||139
8209532|NCT02139306|20245055|P1|STARTED|Overall Study||140
8209533|NCT02139228|20245081|P2|NOT COMPLETED|Overall Study||0
8209534|NCT02139228|20245082|P1|NOT COMPLETED|Overall Study||0
8209535|NCT02139228|20245081|P2|COMPLETED|Overall Study||211
8209536|NCT02139228|20245082|P1|COMPLETED|Overall Study||215
8209537|NCT02139228|20245081|P2|STARTED|Overall Study||211
8209538|NCT02139228|20245082|P1|STARTED|Overall Study||215
8209539|NCT02139176|20245092|P2|NOT COMPLETED|Overall Study||0
8209540|NCT02139176|20245093|P1|NOT COMPLETED|Overall Study||0
8209541|NCT02139176|20245092|P2|COMPLETED|Overall Study||100
8209542|NCT02139176|20245093|P1|COMPLETED|Overall Study||100
8209543|NCT02139176|20245092|P2|STARTED|Overall Study||100
8209544|NCT02139176|20245093|P1|STARTED|Overall Study||100
8209545|NCT02139137|20245105|P2|NOT COMPLETED|Overall Study||10
8209546|NCT02139137|20245106|P1|NOT COMPLETED|Overall Study||7
8209547|NCT02139137|20245105|P2|COMPLETED|Overall Study||10
8209548|NCT02139137|20245106|P1|COMPLETED|Overall Study||15
8209549|NCT02139137|20245105|P2|STARTED|Overall Study||20
8209550|NCT02139137|20245106|P1|STARTED|Overall Study||22
8209551|NCT02139124|20245125|P5|NOT COMPLETED|Overall Study||13
8209552|NCT02139124|20245126|P4|NOT COMPLETED|Overall Study||12
8209553|NCT02139124|20245127|P3|NOT COMPLETED|Overall Study||4
8209554|NCT02139124|20245128|P2|NOT COMPLETED|Overall Study||4
8209555|NCT02139124|20245129|P1|NOT COMPLETED|Overall Study||9
8209556|NCT02139124|20245125|P5|COMPLETED|Overall Study||61
8209557|NCT02139124|20245126|P4|COMPLETED|Overall Study||61
8209558|NCT02139124|20245127|P3|COMPLETED|Overall Study||69
8209559|NCT02139124|20245128|P2|COMPLETED|Overall Study||73
8209560|NCT02139124|20245129|P1|COMPLETED|Overall Study||69
8209561|NCT02139124|20245125|P5|STARTED|Overall Study||74
8209562|NCT02139124|20245126|P4|STARTED|Overall Study||73
8209563|NCT02139124|20245127|P3|STARTED|Overall Study||73
8209564|NCT02139124|20245128|P2|STARTED|Overall Study||77
8209565|NCT02139124|20245129|P1|STARTED|Overall Study||78
8209566|NCT02139046|20245146|P5|NOT COMPLETED|Overall Study||57
8209567|NCT02139046|20245147|P4|NOT COMPLETED|Overall Study||68
8209568|NCT02139046|20245148|P3|NOT COMPLETED|Overall Study||59
8209569|NCT02139046|20245149|P2|NOT COMPLETED|Overall Study||54
8209570|NCT02139046|20245150|P1|NOT COMPLETED|Overall Study||62
8209571|NCT02139046|20245146|P5|COMPLETED|Overall Study||301
8209572|NCT02139046|20245147|P4|COMPLETED|Overall Study||290
8209573|NCT02139046|20245148|P3|COMPLETED|Overall Study||298
8209574|NCT02139046|20245149|P2|COMPLETED|Overall Study||305
8209575|NCT02139046|20245150|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
8209576|NCT02139046|20245146|P5|Full Analysis Set|Overall Study||357
8209577|NCT02139046|20245147|P4|Full Analysis Set|Overall Study||357
8209578|NCT02139046|20245148|P3|Full Analysis Set|Overall Study||355
8209579|NCT02139046|20245149|P2|Full Analysis Set|Overall Study||357
8209580|NCT02139046|20245150|P1|Full Analysis Set|Overall Study||357
8209581|NCT02139046|20245146|P5|Safety Analysis Set|Overall Study||357
8209582|NCT02139046|20245147|P4|Safety Analysis Set|Overall Study||357
8209583|NCT02139046|20245148|P3|Safety Analysis Set|Overall Study||355
8209584|NCT02139046|20245149|P2|Safety Analysis Set|Overall Study||358
8209585|NCT02139046|20245150|P1|Safety Analysis Set|Overall Study||356
8209586|NCT02139046|20245146|P5|STARTED|Overall Study||358
8209587|NCT02139046|20245147|P4|STARTED|Overall Study||358
8209588|NCT02139046|20245148|P3|STARTED|Overall Study||357
8209589|NCT02139046|20245149|P2|STARTED|Overall Study||359
8209590|NCT02139046|20245150|P1|STARTED|Overall Study||358
8209591|NCT02139007|20245174|P2|NOT COMPLETED|Patient Participant Recruitment||1
8209592|NCT02139007|20245175|P1|NOT COMPLETED|Patient Participant Recruitment||2
8209593|NCT02139007|20245174|P2|COMPLETED|Patient Participant Recruitment||13
8209594|NCT02139007|20245175|P1|COMPLETED|Patient Participant Recruitment||11
8209595|NCT02139007|20245174|P2|STARTED|Patient Participant Recruitment||14
8209596|NCT02139007|20245175|P1|STARTED|Patient Participant Recruitment||13
8209597|NCT02139007|20245174|P2|NOT COMPLETED|Study Site Recruitment||4
8209598|NCT02139007|20245175|P1|NOT COMPLETED|Study Site Recruitment||3
8209599|NCT02139007|20245174|P2|COMPLETED|Study Site Recruitment||1
8209600|NCT02139007|20245175|P1|COMPLETED|Study Site Recruitment||1
8209601|NCT02139007|20245174|P2|STARTED|Study Site Recruitment||5
8209602|NCT02139007|20245175|P1|STARTED|Study Site Recruitment||4
8209603|NCT02138916|20245191|P3|NOT COMPLETED|Overall Study||59
8209604|NCT02138916|20245192|P2|NOT COMPLETED|Overall Study||60
8209605|NCT02138916|20245193|P1|NOT COMPLETED|Overall Study||57
8209606|NCT02138916|20245191|P3|COMPLETED|Overall Study||491
8209607|NCT02138916|20245192|P2|COMPLETED|Overall Study||492
8209608|NCT02138916|20245193|P1|COMPLETED|Overall Study||497
8209609|NCT02138916|20245191|P3|STARTED|Overall Study||550
8209610|NCT02138916|20245192|P2|STARTED|Overall Study||552
8209611|NCT02138916|20245193|P1|STARTED|Overall Study||554
8209618|NCT02138838|20245299|P2|NOT COMPLETED|Overall Study||11
8209619|NCT02138838|20245300|P1|NOT COMPLETED|Overall Study||8
8209620|NCT02138838|20245299|P2|COMPLETED|Overall Study||16
8209621|NCT02138838|20245300|P1|COMPLETED|Overall Study||20
8209622|NCT02138838|20245299|P2|Received Study Drug|Overall Study||25
8209623|NCT02138838|20245300|P1|Received Study Drug|Overall Study||28
8209624|NCT02138838|20245299|P2|STARTED|Overall Study||27
8209625|NCT02138838|20245300|P1|STARTED|Overall Study||28
8209626|NCT02138825|20245318|P2|NOT COMPLETED|Safety Follow-up||17
8209627|NCT02138825|20245319|P1|NOT COMPLETED|Safety Follow-up||22
8209628|NCT02138825|20245318|P2|COMPLETED|Safety Follow-up||47
8209629|NCT02138825|20245319|P1|COMPLETED|Safety Follow-up||50
8209630|NCT02138825|20245318|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
8209631|NCT02138825|20245319|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
8209632|NCT02138825|20245318|P2|NOT COMPLETED|Long-term Extension||38
8209633|NCT02138825|20245319|P1|NOT COMPLETED|Long-term Extension||32
8209634|NCT02138825|20245318|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
8209635|NCT02138825|20245319|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
8209636|NCT02138825|20245318|P2|STARTED|Long-term Extension||38
8209637|NCT02138825|20245319|P1|STARTED|Long-term Extension||32
8209638|NCT02138825|20245318|P2|NOT COMPLETED|Main Study Treatment||35
8209639|NCT02138825|20245319|P1|NOT COMPLETED|Main Study Treatment||40
8209640|NCT02138825|20245318|P2|COMPLETED|Main Study Treatment||39
8209641|NCT02138825|20245319|P1|COMPLETED|Main Study Treatment||33
8209642|NCT02138825|20245318|P2|STARTED|Main Study Treatment|safety population|74
8209643|NCT02138825|20245319|P1|STARTED|Main Study Treatment|safety population|73
8209644|NCT02138786|20245336|P3|NOT COMPLETED|Overall Study||8
8209645|NCT02138786|20245337|P2|NOT COMPLETED|Overall Study||15
8209646|NCT02138786|20245338|P1|NOT COMPLETED|Overall Study||3
8209647|NCT02138786|20245336|P3|COMPLETED|Overall Study||0
8209648|NCT02138786|20245337|P2|COMPLETED|Overall Study||0
8209649|NCT02138786|20245338|P1|COMPLETED|Overall Study||0
8209650|NCT02138786|20245336|P3|STARTED|Overall Study||8
8209651|NCT02138786|20245337|P2|STARTED|Overall Study||15
8209652|NCT02138786|20245338|P1|STARTED|Overall Study||3
8209653|NCT02138747|20245355|P4|NOT COMPLETED|Treatment Period 2||3
8209654|NCT02138747|20245356|P3|NOT COMPLETED|Treatment Period 2||2
8209655|NCT02138747|20245357|P2|NOT COMPLETED|Treatment Period 2||7
8209656|NCT02138747|20245358|P1|NOT COMPLETED|Treatment Period 2||17
8209657|NCT02138747|20245355|P4|COMPLETED|Treatment Period 2||24
8209658|NCT02138747|20245356|P3|COMPLETED|Treatment Period 2||24
8209659|NCT02138747|20245357|P2|COMPLETED|Treatment Period 2||125
8209660|NCT02138747|20245358|P1|COMPLETED|Treatment Period 2||121
8209661|NCT02138747|20245355|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
8209662|NCT02138747|20245356|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
8209663|NCT02138747|20245357|P2|STARTED|Treatment Period 2||132
8209664|NCT02138747|20245358|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
8209665|NCT02138747|20245355|P4|NOT COMPLETED|Treatment Period 1||4
8209666|NCT02138747|20245356|P3|NOT COMPLETED|Treatment Period 1||4
8209667|NCT02138747|20245357|P2|NOT COMPLETED|Treatment Period 1||25
8209668|NCT02138747|20245358|P1|NOT COMPLETED|Treatment Period 1||20
8209669|NCT02138747|20245355|P4|COMPLETED|Treatment Period 1||28
8209670|NCT02138747|20245356|P3|COMPLETED|Treatment Period 1||27
8209671|NCT02138747|20245357|P2|COMPLETED|Treatment Period 1||132
8209672|NCT02138747|20245358|P1|COMPLETED|Treatment Period 1||136
8209673|NCT02138747|20245355|P4|STARTED|Treatment Period 1||32
8209674|NCT02138747|20245356|P3|STARTED|Treatment Period 1||31
8209675|NCT02138747|20245357|P2|STARTED|Treatment Period 1||157
8209676|NCT02138747|20245358|P1|STARTED|Treatment Period 1||156
8209677|NCT02138578|20245393|P3|NOT COMPLETED|Overall Study||0
8209678|NCT02138578|20245394|P2|NOT COMPLETED|Overall Study||0
8209679|NCT02138578|20245395|P1|NOT COMPLETED|Overall Study||0
8209680|NCT02138578|20245393|P3|COMPLETED|Overall Study||3
8209681|NCT02138578|20245394|P2|COMPLETED|Overall Study||0
8209682|NCT02138578|20245395|P1|COMPLETED|Overall Study||1
8209683|NCT02138578|20245393|P3|STARTED|Overall Study||3
8209684|NCT02138578|20245394|P2|STARTED|Overall Study||0
8209685|NCT02138578|20245395|P1|STARTED|Overall Study||1
8209686|NCT02138461|20245423|P2|NOT COMPLETED|Overall Study||0
8209687|NCT02138461|20245424|P1|NOT COMPLETED|Overall Study||0
8209688|NCT02138461|20245423|P2|COMPLETED|Overall Study||110
8209689|NCT02138461|20245424|P1|COMPLETED|Overall Study||101
8209690|NCT02138461|20245423|P2|STARTED|Overall Study||110
8209691|NCT02138461|20245424|P1|STARTED|Overall Study||101
8209692|NCT02138253|20245432|P2|NOT COMPLETED|Overall Study||4
8209693|NCT02138253|20245433|P1|NOT COMPLETED|Overall Study||9
8209694|NCT02138253|20245432|P2|COMPLETED|Overall Study||19
8209695|NCT02138253|20245433|P1|COMPLETED|Overall Study||32
8209696|NCT02138253|20245432|P2|STARTED|Overall Study||23
8209697|NCT02138253|20245433|P1|STARTED|Overall Study||41
8209698|NCT02138240|20245461|P1|NOT COMPLETED|Overall Study||0
8209699|NCT02138240|20245461|P1|COMPLETED|Overall Study||34
8209700|NCT02138240|20245461|P1|STARTED|Overall Study||34
8209701|NCT02138227|20245473|P2|NOT COMPLETED|Overall Study||0
8209702|NCT02138227|20245474|P1|NOT COMPLETED|Overall Study||0
8209703|NCT02138227|20245473|P2|COMPLETED|Overall Study||218
8209704|NCT02138227|20245474|P1|COMPLETED|Overall Study||55
8209705|NCT02138227|20245473|P2|STARTED|Overall Study||218
8209706|NCT02138227|20245474|P1|STARTED|Overall Study||55
8209707|NCT02138214|20245508|P3|NOT COMPLETED|Overall Study||4
8209708|NCT02138214|20245509|P2|NOT COMPLETED|Overall Study||4
8209709|NCT02138214|20245510|P1|NOT COMPLETED|Overall Study||0
8209710|NCT02138214|20245508|P3|COMPLETED|Overall Study||26
8209711|NCT02138214|20245509|P2|COMPLETED|Overall Study||26
8209712|NCT02138214|20245510|P1|COMPLETED|Overall Study||30
8209713|NCT02138214|20245508|P3|Analyzed for Baseline Measures|Overall Study||30
8209714|NCT02138214|20245509|P2|Analyzed for Baseline Measures|Overall Study||29
8209715|NCT02138214|20245510|P1|Analyzed for Baseline Measures|Overall Study||30
8209716|NCT02138214|20245508|P3|STARTED|Overall Study||30
8209717|NCT02138214|20245509|P2|STARTED|Overall Study||30
8209718|NCT02138214|20245510|P1|STARTED|Overall Study||30
8209719|NCT02138136|20245531|P1|NOT COMPLETED|Overall Study||139
8209720|NCT02138136|20245531|P1|COMPLETED|Overall Study||280
8209721|NCT02138136|20245531|P1|Modified Intent to Treat (mITT)|Overall Study||418
8209722|NCT02138136|20245531|P1|Safety Analysis Set|Overall Study||419
8209723|NCT02138136|20245531|P1|STARTED|Overall Study||419
8209724|NCT02138110|20245538|P1|NOT COMPLETED|Overall Scaffold Implantation||3
8209725|NCT02138110|20245538|P1|COMPLETED|Overall Scaffold Implantation||16
8209726|NCT02138110|20245538|P1|6-month Follow-Up|Overall Scaffold Implantation||16
8209727|NCT02138110|20245538|P1|STARTED|Overall Scaffold Implantation||19
8209728|NCT02138110|20245538|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
8209729|NCT02138110|20245538|P1|COMPLETED|Enrolled for Scaffold Implantation||19
8209730|NCT02138110|20245538|P1|STARTED|Enrolled for Scaffold Implantation||20
8209731|NCT02138110|20245538|P1|NOT COMPLETED|Enrolled in Study||0
8209732|NCT02138110|20245538|P1|COMPLETED|Enrolled in Study||20
8209733|NCT02138110|20245538|P1|STARTED|Enrolled in Study||20
8209734|NCT02138097|20245566|P2|NOT COMPLETED|Overall Study||0
8209735|NCT02138097|20245567|P1|NOT COMPLETED|Overall Study||0
8209736|NCT02138097|20245566|P2|COMPLETED|Overall Study||459722
8209737|NCT02138097|20245567|P1|COMPLETED|Overall Study||155345
8209738|NCT02138097|20245566|P2|STARTED|Overall Study||459722
8209739|NCT02138097|20245567|P1|STARTED|Overall Study||155345
8209740|NCT02138006|20245759|P2|NOT COMPLETED|Overall Study||0
8209741|NCT02138006|20245760|P1|NOT COMPLETED|Overall Study||0
8209742|NCT02138006|20245759|P2|COMPLETED|Overall Study||54
8209743|NCT02138006|20245760|P1|COMPLETED|Overall Study||48
8209744|NCT02138006|20245759|P2|STARTED|Overall Study||54
8209745|NCT02138006|20245760|P1|STARTED|Overall Study||48
8209746|NCT02137785|20245770|P2|NOT COMPLETED|Overall Study||4
8209747|NCT02137785|20245771|P1|NOT COMPLETED|Overall Study||3
8209748|NCT02137785|20245770|P2|COMPLETED|Overall Study||130
8209749|NCT02137785|20245771|P1|COMPLETED|Overall Study||132
8209750|NCT02137785|20245770|P2|STARTED|Overall Study||134
8209751|NCT02137785|20245771|P1|STARTED|Overall Study||135
8209752|NCT02137772|20245879|P2|NOT COMPLETED|Overall Study||75
8209753|NCT02137772|20245880|P1|NOT COMPLETED|Overall Study||132
8209754|NCT02137772|20245879|P2|COMPLETED|Overall Study||119
8209755|NCT02137772|20245880|P1|COMPLETED|Overall Study||244
8209756|NCT02137772|20245879|P2|Treated Participants|Overall Study||192
8209757|NCT02137772|20245880|P1|Treated Participants|Overall Study||373
8209758|NCT02137772|20245879|P2|STARTED|Overall Study|Randomized participants|194
8209759|NCT02137772|20245880|P1|STARTED|Overall Study|Randomized participants|376
8209760|NCT02137603|20245906|P2|NOT COMPLETED|Overall Study||0
8209761|NCT02137603|20245907|P1|NOT COMPLETED|Overall Study||2
8209762|NCT02137603|20245906|P2|COMPLETED|Overall Study||18
8209763|NCT02137603|20245907|P1|COMPLETED|Overall Study||16
8209764|NCT02137603|20245906|P2|STARTED|Overall Study||18
8209765|NCT02137603|20245907|P1|STARTED|Overall Study||18
8209766|NCT02137512|20245915|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
8209767|NCT02137512|20245915|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
8209768|NCT02137512|20245915|P1|STARTED|5-Month 24/7 Closed-Loop||14
8209769|NCT02137512|20245915|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
8209770|NCT02137512|20245915|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
8209771|NCT02137512|20245915|P1|STARTED|2-Week 24/7 Closed-Loop||30
8209772|NCT02137512|20245915|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
8209773|NCT02137512|20245915|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
8209774|NCT02137512|20245915|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
8209775|NCT02137512|20245915|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
8209776|NCT02137512|20245915|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
8209777|NCT02137512|20245915|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
8209778|NCT02137499|20246072|P4|NOT COMPLETED|Overall Study||0
8209779|NCT02137499|20246073|P3|NOT COMPLETED|Overall Study||0
8209780|NCT02137499|20246074|P2|NOT COMPLETED|Overall Study||0
8209781|NCT02137499|20246075|P1|NOT COMPLETED|Overall Study||0
8209782|NCT02137499|20246072|P4|COMPLETED|Overall Study||10
8209783|NCT02137499|20246073|P3|COMPLETED|Overall Study||10
8209784|NCT02137499|20246074|P2|COMPLETED|Overall Study||10
8209785|NCT02137499|20246075|P1|COMPLETED|Overall Study||10
8209786|NCT02137499|20246072|P4|STARTED|Overall Study||10
8209787|NCT02137499|20246073|P3|STARTED|Overall Study||10
8209788|NCT02137499|20246074|P2|STARTED|Overall Study||10
8209789|NCT02137499|20246075|P1|STARTED|Overall Study||10
8209790|NCT02137486|20246095|P2|NOT COMPLETED|Overall Study||0
8209791|NCT02137486|20246096|P1|NOT COMPLETED|Overall Study||0
8209792|NCT02137486|20246095|P2|COMPLETED|Overall Study||102
8209793|NCT02137486|20246096|P1|COMPLETED|Overall Study||112
8209794|NCT02137486|20246095|P2|STARTED|Overall Study||102
8209795|NCT02137486|20246096|P1|STARTED|Overall Study||112
8209796|NCT02137447|20246112|P1|NOT COMPLETED|Overall Study||0
8209797|NCT02137447|20246112|P1|COMPLETED|Overall Study||10
8209798|NCT02137447|20246112|P1|STARTED|Overall Study||10
8209799|NCT02137382|20246117|P2|NOT COMPLETED|Cross-over Period 2||0
8209800|NCT02137382|20246118|P1|NOT COMPLETED|Cross-over Period 2||0
8209801|NCT02137382|20246117|P2|COMPLETED|Cross-over Period 2||21
8209802|NCT02137382|20246118|P1|COMPLETED|Cross-over Period 2||18
8209803|NCT02137382|20246117|P2|STARTED|Cross-over Period 2||21
8209804|NCT02137382|20246118|P1|STARTED|Cross-over Period 2||18
8209805|NCT02137382|20246117|P2|NOT COMPLETED|Wash Out||0
8209806|NCT02137382|20246118|P1|NOT COMPLETED|Wash Out||0
8209807|NCT02137382|20246117|P2|COMPLETED|Wash Out||21
8209808|NCT02137382|20246118|P1|COMPLETED|Wash Out||18
8209809|NCT02137382|20246117|P2|STARTED|Wash Out||21
8209810|NCT02137382|20246118|P1|STARTED|Wash Out||18
8209811|NCT02137382|20246117|P2|NOT COMPLETED|Cross-over Period 1||0
8209812|NCT02137382|20246118|P1|NOT COMPLETED|Cross-over Period 1||2
8209813|NCT02137382|20246117|P2|COMPLETED|Cross-over Period 1||21
8209814|NCT02137382|20246118|P1|COMPLETED|Cross-over Period 1||18
8209815|NCT02137382|20246117|P2|STARTED|Cross-over Period 1||21
8209816|NCT02137382|20246118|P1|STARTED|Cross-over Period 1||20
8209817|NCT02137369|20246138|P2|NOT COMPLETED|Overall Study||2
8209818|NCT02137369|20246139|P1|NOT COMPLETED|Overall Study||8
8209819|NCT02137369|20246138|P2|COMPLETED|Overall Study||9
8209820|NCT02137369|20246139|P1|COMPLETED|Overall Study||41
8209821|NCT02137369|20246138|P2|STARTED|Overall Study||11
8209822|NCT02137369|20246139|P1|STARTED|Overall Study||49
8209823|NCT02137226|20246149|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
8209824|NCT02137226|20246150|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
8209825|NCT02137226|20246151|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
8209826|NCT02137226|20246152|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
8209827|NCT02137226|20246153|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
8209828|NCT02137226|20246149|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
8209829|NCT02137226|20246150|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
8209830|NCT02137226|20246151|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
8209831|NCT02137226|20246152|P2|COMPLETED|Period 2 (Re - Randomization)||0
8209832|NCT02137226|20246153|P1|COMPLETED|Period 2 (Re - Randomization)||0
8209833|NCT02137226|20246149|P5|STARTED|Period 2 (Re - Randomization)||147
8209834|NCT02137226|20246150|P4|STARTED|Period 2 (Re - Randomization)||148
8209835|NCT02137226|20246151|P3|STARTED|Period 2 (Re - Randomization)||298
8209836|NCT02137226|20246152|P2|STARTED|Period 2 (Re - Randomization)||0
8209837|NCT02137226|20246153|P1|STARTED|Period 2 (Re - Randomization)||0
8209838|NCT02137226|20246149|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
8209839|NCT02137226|20246150|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
8209840|NCT02137226|20246151|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
8209841|NCT02137226|20246152|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
8209842|NCT02137226|20246153|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
8209843|NCT02137226|20246149|P5|COMPLETED|Period 1 (Initial Randomization)||0
8209844|NCT02137226|20246150|P4|COMPLETED|Period 1 (Initial Randomization)||0
8209845|NCT02137226|20246151|P3|COMPLETED|Period 1 (Initial Randomization)||0
8209846|NCT02137226|20246152|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
8209847|NCT02137226|20246153|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
8209848|NCT02137226|20246149|P5|STARTED|Period 1 (Initial Randomization)||0
8209849|NCT02137226|20246150|P4|STARTED|Period 1 (Initial Randomization)||0
8209850|NCT02137226|20246151|P3|STARTED|Period 1 (Initial Randomization)||0
8209851|NCT02137226|20246152|P2|STARTED|Period 1 (Initial Randomization)||321
8209852|NCT02137226|20246153|P1|STARTED|Period 1 (Initial Randomization)||324
8209853|NCT02137096|20246165|P1|NOT COMPLETED|Overall Study||0
8209854|NCT02137096|20246165|P1|COMPLETED|Overall Study||1
8209855|NCT02137096|20246165|P1|STARTED|Overall Study||1
8209856|NCT02136914|20246171|P2|NOT COMPLETED|Overall Study||21
8209857|NCT02136914|20246172|P1|NOT COMPLETED|Overall Study||21
8209858|NCT02136914|20246171|P2|COMPLETED|Overall Study||42
8209859|NCT02136914|20246172|P1|COMPLETED|Overall Study||42
8209860|NCT02136914|20246171|P2|Received Study Drug|Overall Study||63
8209861|NCT02136914|20246172|P1|Received Study Drug|Overall Study||60
8209862|NCT02136914|20246171|P2|STARTED|Overall Study||63
8209863|NCT02136914|20246172|P1|STARTED|Overall Study||63
8209864|NCT02136810|20246186|P1|NOT COMPLETED|Overall Study||0
8209865|NCT02136810|20246186|P1|COMPLETED|Overall Study||200
8209866|NCT02136810|20246186|P1|STARTED|Overall Study||200
8209867|NCT02136680|20246192|P2|NOT COMPLETED|Overall Study||29
8209868|NCT02136680|20246193|P1|NOT COMPLETED|Overall Study||32
8209869|NCT02136680|20246192|P2|COMPLETED|Overall Study||56
8209870|NCT02136680|20246193|P1|COMPLETED|Overall Study||80
8209871|NCT02136680|20246192|P2|Interview 3|Overall Study||56
8209872|NCT02136680|20246193|P1|Interview 3|Overall Study||80
8209873|NCT02136680|20246192|P2|Interview 2|Overall Study||70
8209874|NCT02136680|20246193|P1|Interview 2|Overall Study||97
8209875|NCT02136680|20246192|P2|Interview 1|Overall Study||85
8209876|NCT02136680|20246193|P1|Interview 1|Overall Study||112
8209877|NCT02136680|20246192|P2|STARTED|Overall Study||85
8209878|NCT02136680|20246193|P1|STARTED|Overall Study||112
8209879|NCT02136576|20246210|P3|NOT COMPLETED|Overall Study||0
8209880|NCT02136576|20246211|P2|NOT COMPLETED|Overall Study||0
8209881|NCT02136576|20246212|P1|NOT COMPLETED|Overall Study||2
8209882|NCT02136576|20246210|P3|COMPLETED|Overall Study||13
8209883|NCT02136576|20246211|P2|COMPLETED|Overall Study||13
8209884|NCT02136576|20246212|P1|COMPLETED|Overall Study||11
8209885|NCT02136576|20246210|P3|STARTED|Overall Study||13
8209886|NCT02136576|20246211|P2|STARTED|Overall Study||13
8209887|NCT02136576|20246212|P1|STARTED|Overall Study||13
8209888|NCT02136498|20246222|P2|NOT COMPLETED|Overall Study||0
8209889|NCT02136498|20246223|P1|NOT COMPLETED|Overall Study||0
8209890|NCT02136498|20246222|P2|COMPLETED|Overall Study||33
8209891|NCT02136498|20246223|P1|COMPLETED|Overall Study||33
8209892|NCT02136498|20246222|P2|STARTED|Overall Study||33
8209893|NCT02136498|20246223|P1|STARTED|Overall Study||33
8209894|NCT02136420|20246235|P10|NOT COMPLETED|Overall Study||0
8209895|NCT02136420|20246236|P9|NOT COMPLETED|Overall Study||0
8209896|NCT02136420|20246237|P8|NOT COMPLETED|Overall Study||0
8209897|NCT02136420|20246238|P7|NOT COMPLETED|Overall Study||0
8209898|NCT02136420|20246239|P6|NOT COMPLETED|Overall Study||0
8209899|NCT02136420|20246240|P5|NOT COMPLETED|Overall Study||0
8209900|NCT02136420|20246241|P4|NOT COMPLETED|Overall Study||0
8209901|NCT02136420|20246242|P3|NOT COMPLETED|Overall Study||0
8209902|NCT02136420|20246243|P2|NOT COMPLETED|Overall Study||0
8209903|NCT02136420|20246244|P1|NOT COMPLETED|Overall Study||1
8209904|NCT02136420|20246235|P10|COMPLETED|Overall Study||5
8209905|NCT02136420|20246236|P9|COMPLETED|Overall Study||5
8209906|NCT02136420|20246237|P8|COMPLETED|Overall Study||0
8209907|NCT02136420|20246238|P7|COMPLETED|Overall Study||0
8209908|NCT02136420|20246239|P6|COMPLETED|Overall Study||0
8209909|NCT02136420|20246240|P5|COMPLETED|Overall Study||10
8209910|NCT02136420|20246241|P4|COMPLETED|Overall Study||0
8209911|NCT02136420|20246242|P3|COMPLETED|Overall Study||0
8209912|NCT02136420|20246243|P2|COMPLETED|Overall Study||0
8209913|NCT02136420|20246244|P1|COMPLETED|Overall Study||9
8209914|NCT02136420|20246235|P10|STARTED|Overall Study||5
8209915|NCT02136420|20246236|P9|STARTED|Overall Study||5
8209916|NCT02136420|20246237|P8|STARTED|Overall Study||0
8209917|NCT02136420|20246238|P7|STARTED|Overall Study||0
8209918|NCT02136420|20246239|P6|STARTED|Overall Study||0
8209919|NCT02136420|20246240|P5|STARTED|Overall Study||10
8209920|NCT02136420|20246241|P4|STARTED|Overall Study||0
8209921|NCT02136420|20246242|P3|STARTED|Overall Study||0
8209922|NCT02136420|20246243|P2|STARTED|Overall Study||0
8209923|NCT02136420|20246244|P1|STARTED|Overall Study||10
8209924|NCT02136238|20246266|P3|NOT COMPLETED|Overall Study||0
8209925|NCT02136238|20246267|P2|NOT COMPLETED|Overall Study||0
8209926|NCT02136238|20246268|P1|NOT COMPLETED|Overall Study||0
8209927|NCT02136238|20246266|P3|COMPLETED|Overall Study||10
8209928|NCT02136238|20246267|P2|COMPLETED|Overall Study||4
8209929|NCT02136238|20246268|P1|COMPLETED|Overall Study||4
8209930|NCT02136238|20246266|P3|STARTED|Overall Study||10
8209931|NCT02136238|20246267|P2|STARTED|Overall Study||4
8209932|NCT02136238|20246268|P1|STARTED|Overall Study||4
8209933|NCT02136134|20246281|P2|NOT COMPLETED|Overall Study||251
8209934|NCT02136134|20246282|P1|NOT COMPLETED|Overall Study||247
8209935|NCT02136134|20246281|P2|COMPLETED|Overall Study||0
8209936|NCT02136134|20246282|P1|COMPLETED|Overall Study||0
8209937|NCT02136134|20246281|P2|Treated|Overall Study||243
8209938|NCT02136134|20246282|P1|Treated|Overall Study||237
8209939|NCT02136134|20246281|P2|STARTED|Overall Study||251
8209940|NCT02136134|20246282|P1|STARTED|Overall Study||247
8209941|NCT02136004|20246300|P1|NOT COMPLETED|Overall Study||1
8209942|NCT02136004|20246300|P1|COMPLETED|Overall Study||219
8209943|NCT02136004|20246300|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
8209944|NCT02135900|20246311|P1|NOT COMPLETED|Overall Study||0
8209945|NCT02135900|20246311|P1|COMPLETED|Overall Study||32
8209946|NCT02135900|20246311|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
8209947|NCT02135861|20246321|P3|NOT COMPLETED|Overall Study||0
8209948|NCT02135861|20246322|P2|NOT COMPLETED|Overall Study||0
8209949|NCT02135861|20246323|P1|NOT COMPLETED|Overall Study||0
8209950|NCT02135861|20246321|P3|COMPLETED|Overall Study||3
8209951|NCT02135861|20246322|P2|COMPLETED|Overall Study||12
8209952|NCT02135861|20246323|P1|COMPLETED|Overall Study||21
8209953|NCT02135861|20246321|P3|STARTED|Overall Study||3
8209954|NCT02135861|20246322|P2|STARTED|Overall Study||12
8209955|NCT02135861|20246323|P1|STARTED|Overall Study||21
8209956|NCT02135848|20246344|P2|NOT COMPLETED|Overall Study||1
8209957|NCT02135848|20246345|P1|NOT COMPLETED|Overall Study||3
8209958|NCT02135848|20246344|P2|COMPLETED|Overall Study||19
8209959|NCT02135848|20246345|P1|COMPLETED|Overall Study||23
8209960|NCT02135848|20246344|P2|STARTED|Overall Study||20
8209961|NCT02135848|20246345|P1|STARTED|Overall Study||26
8209962|NCT02135692|20246403|P1|NOT COMPLETED|Overall Study||339
8209963|NCT02135692|20246403|P1|COMPLETED|Overall Study||0
8209964|NCT02135692|20246403|P1|STARTED|Overall Study||339
8209965|NCT02135614|20246422|P2|NOT COMPLETED|Overall Study||5
8209966|NCT02135614|20246423|P1|NOT COMPLETED|Overall Study||8
8209967|NCT02135614|20246422|P2|COMPLETED|Overall Study||90
8209968|NCT02135614|20246423|P1|COMPLETED|Overall Study||86
8209969|NCT02135614|20246422|P2|STARTED|Overall Study||95
8209970|NCT02135614|20246423|P1|STARTED|Overall Study||94
8209971|NCT02135445|20246437|P2|NOT COMPLETED|Overall Study||0
8209972|NCT02135445|20246438|P1|NOT COMPLETED|Overall Study||2
8209973|NCT02135445|20246437|P2|COMPLETED|Overall Study||38
8209974|NCT02135445|20246438|P1|COMPLETED|Overall Study||63
8209975|NCT02135445|20246437|P2|STARTED|Overall Study||38
8209976|NCT02135445|20246438|P1|STARTED|Overall Study||65
8209977|NCT02135432|20246489|P2|NOT COMPLETED|Overall Study||0
8209978|NCT02135432|20246490|P1|NOT COMPLETED|Overall Study||0
8209979|NCT02135432|20246489|P2|COMPLETED|Overall Study||4
8209980|NCT02135432|20246490|P1|COMPLETED|Overall Study||8
8209981|NCT02135432|20246489|P2|STARTED|Overall Study||4
8209982|NCT02135432|20246490|P1|STARTED|Overall Study||8
8209983|NCT02135146|20246504|P2|NOT COMPLETED|Overall Study||0
8209984|NCT02135146|20246505|P1|NOT COMPLETED|Overall Study||0
8209985|NCT02135146|20246504|P2|COMPLETED|Overall Study||20
8209986|NCT02135146|20246505|P1|COMPLETED|Overall Study||20
8209987|NCT02135146|20246504|P2|STARTED|Overall Study||20
8209988|NCT02135146|20246505|P1|STARTED|Overall Study||20
8209989|NCT02135107|20246523|P4|NOT COMPLETED|Maintenance Therapy Period||20
8209990|NCT02135107|20246524|P3|NOT COMPLETED|Maintenance Therapy Period||15
8209991|NCT02135107|20246525|P2|NOT COMPLETED|Maintenance Therapy Period||0
8209992|NCT02135107|20246526|P1|NOT COMPLETED|Maintenance Therapy Period||0
8209993|NCT02135107|20246523|P4|COMPLETED|Maintenance Therapy Period||161
8209994|NCT02135107|20246524|P3|COMPLETED|Maintenance Therapy Period||163
8209995|NCT02135107|20246525|P2|COMPLETED|Maintenance Therapy Period||0
8209996|NCT02135107|20246526|P1|COMPLETED|Maintenance Therapy Period||0
8209997|NCT02135107|20246523|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
8209998|NCT02135107|20246524|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
8209999|NCT02135107|20246525|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
8210000|NCT02135107|20246526|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
8210001|NCT02135107|20246523|P4|NOT COMPLETED|Treatment Period||0
8210002|NCT02135107|20246524|P3|NOT COMPLETED|Treatment Period||0
8210003|NCT02135107|20246525|P2|NOT COMPLETED|Treatment Period||26
8210004|NCT02135107|20246526|P1|NOT COMPLETED|Treatment Period||132
8210005|NCT02135107|20246523|P4|COMPLETED|Treatment Period||0
8210006|NCT02135107|20246524|P3|COMPLETED|Treatment Period||0
8210007|NCT02135107|20246525|P2|COMPLETED|Treatment Period||54
8210008|NCT02135107|20246526|P1|COMPLETED|Treatment Period||305
8210009|NCT02135107|20246523|P4|STARTED|Treatment Period||0
8210010|NCT02135107|20246524|P3|STARTED|Treatment Period||0
8210011|NCT02135107|20246525|P2|STARTED|Treatment Period||80
8210012|NCT02135107|20246526|P1|STARTED|Treatment Period||437
8210013|NCT02135094|20246554|P2|NOT COMPLETED|Overall Study||0
8210014|NCT02135094|20246555|P1|NOT COMPLETED|Overall Study||0
8210015|NCT02135094|20246554|P2|COMPLETED|Overall Study||8
8210016|NCT02135094|20246555|P1|COMPLETED|Overall Study||25
8210017|NCT02135094|20246554|P2|Week 4|Overall Study||8
8210018|NCT02135094|20246555|P1|Week 4|Overall Study||25
8210019|NCT02135094|20246554|P2|Week 3|Overall Study||8
8210020|NCT02135094|20246555|P1|Week 3|Overall Study||25
8210021|NCT02135094|20246554|P2|Week 2|Overall Study||8
8210022|NCT02135094|20246555|P1|Week 2|Overall Study||25
8210023|NCT02135094|20246554|P2|STARTED|Overall Study||8
8210024|NCT02135094|20246555|P1|STARTED|Overall Study||25
8210025|NCT02135029|20246572|P3|NOT COMPLETED|Overall Study||3
8210026|NCT02135029|20246573|P2|NOT COMPLETED|Overall Study||5
8210027|NCT02135029|20246574|P1|NOT COMPLETED|Overall Study||4
8210028|NCT02135029|20246572|P3|COMPLETED|Overall Study||34
8210029|NCT02135029|20246573|P2|COMPLETED|Overall Study||69
8210030|NCT02135029|20246574|P1|COMPLETED|Overall Study||69
8210031|NCT02135029|20246572|P3|Treated|Overall Study||36
8210032|NCT02135029|20246573|P2|Treated|Overall Study||74
8210033|NCT02135029|20246574|P1|Treated|Overall Study||73
8210034|NCT02135029|20246572|P3|STARTED|Overall Study||37
8210035|NCT02135029|20246573|P2|STARTED|Overall Study||74
8210036|NCT02135029|20246574|P1|STARTED|Overall Study||73
8210037|NCT02135016|20246657|P3|NOT COMPLETED|Overall Study||0
8210038|NCT02135016|20246658|P2|NOT COMPLETED|Overall Study||0
8210039|NCT02135016|20246659|P1|NOT COMPLETED|Overall Study||0
8210040|NCT02135016|20246657|P3|COMPLETED|Overall Study||15
8210041|NCT02135016|20246658|P2|COMPLETED|Overall Study||15
8210042|NCT02135016|20246659|P1|COMPLETED|Overall Study||15
8210043|NCT02135016|20246657|P3|STARTED|Overall Study||15
8210044|NCT02135016|20246658|P2|STARTED|Overall Study||15
8210045|NCT02135016|20246659|P1|STARTED|Overall Study||15
8210046|NCT02134977|20246679|P1|NOT COMPLETED|Overall Study||102
8210047|NCT02134977|20246679|P1|COMPLETED|Overall Study||2714
8210048|NCT02134977|20246679|P1|STARTED|Overall Study||2816
8210049|NCT02134951|20246702|P2|NOT COMPLETED|Overall Study||0
8210050|NCT02134951|20246703|P1|NOT COMPLETED|Overall Study||0
8210051|NCT02134951|20246702|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
8210052|NCT02134951|20246703|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
8210053|NCT02134951|20246702|P2|STARTED|Overall Study||20
8210054|NCT02134951|20246703|P1|STARTED|Overall Study||39
8210055|NCT02134925|20246713|P2|NOT COMPLETED|Overall Study||6
8210056|NCT02134925|20246714|P1|NOT COMPLETED|Overall Study||2
8210057|NCT02134925|20246713|P2|COMPLETED|Overall Study||50
8210058|NCT02134925|20246714|P1|COMPLETED|Overall Study||52
8210059|NCT02134925|20246713|P2|Received at Least One Dose of Treatment|Overall Study||50
8210060|NCT02134925|20246714|P1|Received at Least One Dose of Treatment|Overall Study||53
8210061|NCT02134925|20246713|P2|STARTED|Overall Study||56
8210062|NCT02134925|20246714|P1|STARTED|Overall Study||54
8210063|NCT02134912|20246732|P2|NOT COMPLETED|Overall Study||0
8210064|NCT02134912|20246733|P1|NOT COMPLETED|Overall Study||0
8210065|NCT02134912|20246732|P2|COMPLETED|Overall Study||0
8210066|NCT02134912|20246733|P1|COMPLETED|Overall Study||0
8210067|NCT02134912|20246732|P2|STARTED|Overall Study||0
8210068|NCT02134912|20246733|P1|STARTED|Overall Study||0
8210069|NCT02134756|20246751|P2|NOT COMPLETED|Overall Study||2
8210070|NCT02134756|20246752|P1|NOT COMPLETED|Overall Study||1
8210071|NCT02134756|20246751|P2|COMPLETED|Overall Study||13
8210072|NCT02134756|20246752|P1|COMPLETED|Overall Study||14
8210073|NCT02134756|20246751|P2|STARTED|Overall Study||15
8210074|NCT02134756|20246752|P1|STARTED|Overall Study||15
8210075|NCT02134717|20246762|P1|NOT COMPLETED|Overall Study||0
8210076|NCT02134717|20246762|P1|COMPLETED|Overall Study||3
8210077|NCT02134717|20246762|P1|STARTED|Overall Study||3
8210078|NCT02134587|20246768|P1|NOT COMPLETED|Overall Study||30
8210079|NCT02134587|20246768|P1|COMPLETED|Overall Study||173
8210080|NCT02134587|20246768|P1|STARTED|Overall Study||203
8210081|NCT02134522|20246777|P1|NOT COMPLETED|Overall Study||0
8210082|NCT02134522|20246777|P1|COMPLETED|Overall Study||1
8210083|NCT02134522|20246777|P1|STARTED|Overall Study||1
8210084|NCT02134353|20246784|P2|NOT COMPLETED|Overall Study||24
8210085|NCT02134353|20246785|P1|NOT COMPLETED|Overall Study||26
8210086|NCT02134353|20246784|P2|COMPLETED|Overall Study||190
8210087|NCT02134353|20246785|P1|COMPLETED|Overall Study||183
8210088|NCT02134353|20246784|P2|STARTED|Overall Study||214
8210089|NCT02134353|20246785|P1|STARTED|Overall Study||209
8210090|NCT02134314|20246811|P2|NOT COMPLETED|Overall Study||1
8210091|NCT02134314|20246812|P1|NOT COMPLETED|Overall Study||1
8210092|NCT02134314|20246811|P2|COMPLETED|Overall Study||34
8210093|NCT02134314|20246812|P1|COMPLETED|Overall Study||34
8210094|NCT02134314|20246811|P2|STARTED|Overall Study||35
8210095|NCT02134314|20246812|P1|STARTED|Overall Study||35
8210096|NCT02134210|20246844|P2|NOT COMPLETED|Part Two: Weeks 13-48||28
8210097|NCT02134210|20246845|P1|NOT COMPLETED|Part Two: Weeks 13-48||30
8210098|NCT02134210|20246844|P2|COMPLETED|Part Two: Weeks 13-48||227
8210099|NCT02134210|20246845|P1|COMPLETED|Part Two: Weeks 13-48||211
8210100|NCT02134210|20246844|P2|STARTED|Part Two: Weeks 13-48||255
8210101|NCT02134210|20246845|P1|STARTED|Part Two: Weeks 13-48||241
8210102|NCT02134210|20246844|P2|NOT COMPLETED|Part One: Weeks 0-12||6
8210103|NCT02134210|20246845|P1|NOT COMPLETED|Part One: Weeks 0-12||19
8210104|NCT02134210|20246844|P2|COMPLETED|Part One: Weeks 0-12||255
8210105|NCT02134210|20246845|P1|COMPLETED|Part One: Weeks 0-12||241
8210106|NCT02134210|20246844|P2|STARTED|Part One: Weeks 0-12||261
8210107|NCT02134210|20246845|P1|STARTED|Part One: Weeks 0-12||260
8210108|NCT02134184|20246878|P3|NOT COMPLETED|Overall Study||0
8210109|NCT02134184|20246879|P2|NOT COMPLETED|Overall Study||0
8210110|NCT02134184|20246880|P1|NOT COMPLETED|Overall Study||0
8210111|NCT02134184|20246878|P3|COMPLETED|Overall Study||8
8210112|NCT02134184|20246879|P2|COMPLETED|Overall Study||37
8210113|NCT02134184|20246880|P1|COMPLETED|Overall Study||33
8210114|NCT02134184|20246878|P3|STARTED|Overall Study||8
8210115|NCT02134184|20246879|P2|STARTED|Overall Study||37
8210116|NCT02134184|20246880|P1|STARTED|Overall Study||33
8210117|NCT02134119|20246893|P2|NOT COMPLETED|Overall Study||0
8210118|NCT02134119|20246894|P1|NOT COMPLETED|Overall Study||0
8210119|NCT02134119|20246893|P2|COMPLETED|Overall Study||15
8210120|NCT02134119|20246894|P1|COMPLETED|Overall Study||30
8210121|NCT02134119|20246893|P2|STARTED|Overall Study||15
8210122|NCT02134119|20246894|P1|STARTED|Overall Study||30
8210123|NCT02134028|20246940|P8|NOT COMPLETED|Overall Study||3
8210124|NCT02134028|20246941|P7|NOT COMPLETED|Overall Study||4
8210125|NCT02134028|20246942|P6|NOT COMPLETED|Overall Study||14
8210126|NCT02134028|20246943|P5|NOT COMPLETED|Overall Study||14
8210127|NCT02134028|20246944|P4|NOT COMPLETED|Overall Study||105
8210128|NCT02134028|20246945|P3|NOT COMPLETED|Overall Study||52
8210129|NCT02134028|20246946|P2|NOT COMPLETED|Overall Study||42
8210130|NCT02134028|20246947|P1|NOT COMPLETED|Overall Study||9
8210131|NCT02134028|20246940|P8|COMPLETED|Overall Study||11
8210132|NCT02134028|20246941|P7|COMPLETED|Overall Study||15
8210133|NCT02134028|20246942|P6|COMPLETED|Overall Study||76
8210134|NCT02134028|20246943|P5|COMPLETED|Overall Study||83
8210135|NCT02134028|20246944|P4|COMPLETED|Overall Study||908
8210136|NCT02134028|20246945|P3|COMPLETED|Overall Study||465
8210137|NCT02134028|20246946|P2|COMPLETED|Overall Study||379
8210138|NCT02134028|20246947|P1|COMPLETED|Overall Study||102
8210139|NCT02134028|20246940|P8|STARTED|Overall Study||14
8210140|NCT02134028|20246941|P7|STARTED|Overall Study||19
8210141|NCT02134028|20246942|P6|STARTED|Overall Study||90
8210142|NCT02134028|20246943|P5|STARTED|Overall Study||97
8210143|NCT02134028|20246944|P4|STARTED|Overall Study||1013
8210144|NCT02134028|20246945|P3|STARTED|Overall Study||517
8210145|NCT02134028|20246946|P2|STARTED|Overall Study||421
8210146|NCT02134028|20246947|P1|STARTED|Overall Study||111
8210147|NCT02134015|20247105|P2|NOT COMPLETED|Overall Study||74
8210148|NCT02134015|20247106|P1|NOT COMPLETED|Overall Study||71
8210149|NCT02134015|20247105|P2|COMPLETED|Overall Study||0
8210150|NCT02134015|20247106|P1|COMPLETED|Overall Study||0
8210151|NCT02134015|20247105|P2|STARTED|Overall Study||74
8210152|NCT02134015|20247106|P1|STARTED|Overall Study||71
8210153|NCT02133781|20247129|P3|NOT COMPLETED|Overall Study||0
8210154|NCT02133781|20247130|P2|NOT COMPLETED|Overall Study||0
8210155|NCT02133781|20247131|P1|NOT COMPLETED|Overall Study||0
8210156|NCT02133781|20247129|P3|COMPLETED|Overall Study||21
8210157|NCT02133781|20247130|P2|COMPLETED|Overall Study||24
8210158|NCT02133781|20247131|P1|COMPLETED|Overall Study||6
8210159|NCT02133781|20247129|P3|STARTED|Overall Study||21
8210160|NCT02133781|20247130|P2|STARTED|Overall Study||24
8210161|NCT02133781|20247131|P1|STARTED|Overall Study||6
8210162|NCT02133742|20247142|P1|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
8210163|NCT02133742|20247142|P1|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
8210164|NCT02133742|20247142|P1|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
8210165|NCT02133742|20247142|P1|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
8210166|NCT02133742|20247142|P1|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
8210167|NCT02133742|20247142|P1|STARTED|Period 1: Dose Finding Phase (6 Months)||11
8210168|NCT02133664|20247171|P2|NOT COMPLETED|Overall Study||7
8210169|NCT02133664|20247172|P1|NOT COMPLETED|Overall Study||5
8210170|NCT02133664|20247171|P2|COMPLETED|Overall Study||21
8210171|NCT02133664|20247172|P1|COMPLETED|Overall Study||21
8210172|NCT02133664|20247171|P2|STARTED|Overall Study||28
8210173|NCT02133664|20247172|P1|STARTED|Overall Study||26
8210174|NCT02133534|20247184|P1|NOT COMPLETED|Overall Study||0
8210175|NCT02133534|20247184|P1|COMPLETED|Overall Study||1
8210176|NCT02133534|20247184|P1|STARTED|Overall Study||1
8210177|NCT02133508|20247188|P1|NOT COMPLETED|Overall Study||15
8210178|NCT02133508|20247188|P1|COMPLETED|Overall Study||141
8210179|NCT02133508|20247188|P1|STARTED|Overall Study||156
8210180|NCT02133352|20247196|P1|NOT COMPLETED|Longer Term Extension||6
8210181|NCT02133352|20247196|P1|COMPLETED|Longer Term Extension||4
8210182|NCT02133352|20247196|P1|STARTED|Longer Term Extension||10
8210183|NCT02133352|20247196|P1|NOT COMPLETED|Main Study (180 Day)||0
8210184|NCT02133352|20247196|P1|COMPLETED|Main Study (180 Day)||10
8210185|NCT02133352|20247196|P1|STARTED|Main Study (180 Day)||10
8210186|NCT02133235|20247207|P2|NOT COMPLETED|Overall Study||0
8210187|NCT02133235|20247208|P1|NOT COMPLETED|Overall Study||0
8210188|NCT02133235|20247207|P2|COMPLETED|Overall Study||57
8210189|NCT02133235|20247208|P1|COMPLETED|Overall Study||55
8210190|NCT02133235|20247207|P2|STARTED|Overall Study||57
8210191|NCT02133235|20247208|P1|STARTED|Overall Study||55
8210213|NCT02133066|20247272|P2|NOT COMPLETED|Overall Study||0
8210214|NCT02133066|20247273|P1|NOT COMPLETED|Overall Study||0
8210215|NCT02133066|20247272|P2|COMPLETED|Overall Study||64
8210216|NCT02133066|20247273|P1|COMPLETED|Overall Study||64
8210217|NCT02133066|20247272|P2|STARTED|Overall Study||64
8210218|NCT02133066|20247273|P1|STARTED|Overall Study||64
8210219|NCT02133001|20247287|P2|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
8210220|NCT02133001|20247288|P1|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
8210221|NCT02133001|20247287|P2|COMPLETED|Follow-Up Phase (Day 26-81)||24
8210222|NCT02133001|20247288|P1|COMPLETED|Follow-Up Phase (Day 26-81)||20
8210223|NCT02133001|20247287|P2|STARTED|Follow-Up Phase (Day 26-81)||27
8210224|NCT02133001|20247288|P1|STARTED|Follow-Up Phase (Day 26-81)||22
8210225|NCT02133001|20247287|P2|NOT COMPLETED|Double Blind (Day 1-25)||9
8210226|NCT02133001|20247288|P1|NOT COMPLETED|Double Blind (Day 1-25)||10
8210227|NCT02133001|20247287|P2|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
8210228|NCT02133001|20247288|P1|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
8210229|NCT02133001|20247287|P2|Safety|Double Blind (Day 1-25)||35
8210230|NCT02133001|20247288|P1|Safety|Double Blind (Day 1-25)||31
8210231|NCT02133001|20247287|P2|STARTED|Double Blind (Day 1-25)||36
8210232|NCT02133001|20247288|P1|STARTED|Double Blind (Day 1-25)||32
8210233|NCT02132949|20247336|P2|NOT COMPLETED|Adjuvant Treatment Period||167
8210234|NCT02132949|20247337|P1|NOT COMPLETED|Adjuvant Treatment Period||149
8210235|NCT02132949|20247336|P2|COMPLETED|Adjuvant Treatment Period||23
8210236|NCT02132949|20247337|P1|COMPLETED|Adjuvant Treatment Period||29
8210237|NCT02132949|20247336|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
8210238|NCT02132949|20247337|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
8210239|NCT02132949|20247336|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
8210240|NCT02132949|20247337|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
8210241|NCT02132949|20247336|P2|COMPLETED|Neoadjuvant Treatment Period||189
8210242|NCT02132949|20247337|P1|COMPLETED|Neoadjuvant Treatment Period||182
8210243|NCT02132949|20247336|P2|No Treatment|Neoadjuvant Treatment Period||3
8210244|NCT02132949|20247337|P1|No Treatment|Neoadjuvant Treatment Period||1
8210245|NCT02132949|20247336|P2|STARTED|Neoadjuvant Treatment Period||201
8210246|NCT02132949|20247337|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
8210247|NCT02132936|20247369|P4|NOT COMPLETED|Overall Study||14
8210248|NCT02132936|20247370|P3|NOT COMPLETED|Overall Study||14
8210249|NCT02132936|20247371|P2|NOT COMPLETED|Overall Study||9
8210250|NCT02132936|20247372|P1|NOT COMPLETED|Overall Study||10
8210251|NCT02132936|20247369|P4|COMPLETED|Overall Study||29
8210252|NCT02132936|20247370|P3|COMPLETED|Overall Study||174
8210253|NCT02132936|20247371|P2|COMPLETED|Overall Study||38
8210254|NCT02132936|20247372|P1|COMPLETED|Overall Study||175
8210255|NCT02132936|20247369|P4|STARTED|Overall Study||43
8210256|NCT02132936|20247370|P3|STARTED|Overall Study||188
8210257|NCT02132936|20247371|P2|STARTED|Overall Study||47
8210258|NCT02132936|20247372|P1|STARTED|Overall Study||185
8210259|NCT02132910|20247390|P2|NOT COMPLETED|Overall Study||0
8210260|NCT02132910|20247391|P1|NOT COMPLETED|Overall Study||0
8210261|NCT02132910|20247390|P2|COMPLETED|Overall Study||34
8210262|NCT02132910|20247391|P1|COMPLETED|Overall Study||34
8210263|NCT02132910|20247390|P2|STARTED|Overall Study||34
8210264|NCT02132910|20247391|P1|STARTED|Overall Study||34
8210265|NCT02132884|20247405|P2|NOT COMPLETED|Overall Study||0
8210266|NCT02132884|20247406|P1|NOT COMPLETED|Overall Study||0
8210267|NCT02132884|20247405|P2|COMPLETED|Overall Study||0
8210268|NCT02132884|20247406|P1|COMPLETED|Overall Study||0
8210269|NCT02132884|20247405|P2|STARTED|Overall Study||0
8210270|NCT02132884|20247406|P1|STARTED|Overall Study||0
8210271|NCT02132832|20247418|P2|NOT COMPLETED|Overall Study||7
8210272|NCT02132832|20247419|P1|NOT COMPLETED|Overall Study||3
8210273|NCT02132832|20247418|P2|COMPLETED|Overall Study||16
8210274|NCT02132832|20247419|P1|COMPLETED|Overall Study||16
8210275|NCT02132832|20247418|P2|STARTED|Overall Study||23
8210276|NCT02132832|20247419|P1|STARTED|Overall Study||19
8210277|NCT02132767|20247449|P2|NOT COMPLETED|Overall Study||15
8210278|NCT02132767|20247450|P1|NOT COMPLETED|Overall Study||17
8210279|NCT02132767|20247449|P2|COMPLETED|Overall Study||246
8210280|NCT02132767|20247450|P1|COMPLETED|Overall Study||245
8210281|NCT02132767|20247449|P2|STARTED|Overall Study||261
8210282|NCT02132767|20247450|P1|STARTED|Overall Study||262
8210283|NCT02132676|20247472|P2|NOT COMPLETED|Overall Study||0
8210284|NCT02132676|20247473|P1|NOT COMPLETED|Overall Study||0
8210285|NCT02132676|20247472|P2|COMPLETED|Overall Study||809
8210286|NCT02132676|20247473|P1|COMPLETED|Overall Study||727
8210287|NCT02132676|20247472|P2|STARTED|Overall Study||809
8210288|NCT02132676|20247473|P1|STARTED|Overall Study||727
8210289|NCT02132650|20247505|P2|NOT COMPLETED|Overall Study||4
8210290|NCT02132650|20247506|P1|NOT COMPLETED|Overall Study||3
8210291|NCT02132650|20247505|P2|COMPLETED|Overall Study||14
8210292|NCT02132650|20247506|P1|COMPLETED|Overall Study||17
8210293|NCT02132650|20247505|P2|Post-Intervention Assessment|Overall Study||17
8210294|NCT02132650|20247506|P1|Post-Intervention Assessment|Overall Study||19
8210295|NCT02132650|20247505|P2|STARTED|Overall Study||18
8210296|NCT02132650|20247506|P1|STARTED|Overall Study||20
8210297|NCT02132637|20247516|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
8210298|NCT02132637|20247517|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
8210299|NCT02132637|20247516|P2|COMPLETED|Study Period 2 (Crossover)||29
8210300|NCT02132637|20247517|P1|COMPLETED|Study Period 2 (Crossover)||31
8210301|NCT02132637|20247516|P2|STARTED|Study Period 2 (Crossover)||30
8210302|NCT02132637|20247517|P1|STARTED|Study Period 2 (Crossover)||33
8210303|NCT02132637|20247516|P2|NOT COMPLETED|Study Period 1||4
8210304|NCT02132637|20247517|P1|NOT COMPLETED|Study Period 1||1
8210305|NCT02132637|20247516|P2|COMPLETED|Study Period 1||30
8210306|NCT02132637|20247517|P1|COMPLETED|Study Period 1||33
8210307|NCT02132637|20247516|P2|Received at Least One Dose of Study Drug|Study Period 1||34
8210308|NCT02132637|20247517|P1|Received at Least One Dose of Study Drug|Study Period 1||34
8210309|NCT02132637|20247516|P2|STARTED|Study Period 1||34
8210310|NCT02132637|20247517|P1|STARTED|Study Period 1||34
8210311|NCT02132611|20247541|P1|NOT COMPLETED|Overall Study||2
8210312|NCT02132611|20247541|P1|COMPLETED|Overall Study||98
8210313|NCT02132611|20247541|P1|STARTED|Overall Study||100
8210314|NCT02132598|20247546|P1|NOT COMPLETED|Overall Study||0
8210315|NCT02132598|20247546|P1|COMPLETED|Overall Study||5
8210316|NCT02132598|20247546|P1|STARTED|Overall Study||5
8210317|NCT02132572|20247558|P1|NOT COMPLETED|Overall Study||0
8210318|NCT02132572|20247558|P1|COMPLETED|Overall Study||201
8210319|NCT02132572|20247558|P1|STARTED|Overall Study||201
8210320|NCT02132533|20247564|P2|NOT COMPLETED|Overall Study||0
8210321|NCT02132533|20247565|P1|NOT COMPLETED|Overall Study||0
8210322|NCT02132533|20247564|P2|COMPLETED|Overall Study||42
8210323|NCT02132533|20247565|P1|COMPLETED|Overall Study||46
8210324|NCT02132533|20247564|P2|STARTED|Overall Study||42
8210325|NCT02132533|20247565|P1|STARTED|Overall Study||46
8210326|NCT02132520|20247580|P3|NOT COMPLETED|Overall Study||0
8210327|NCT02132520|20247581|P2|NOT COMPLETED|Overall Study||0
8210328|NCT02132520|20247582|P1|NOT COMPLETED|Overall Study||0
8210329|NCT02132520|20247580|P3|COMPLETED|Overall Study||2
8210330|NCT02132520|20247581|P2|COMPLETED|Overall Study||1
8210331|NCT02132520|20247582|P1|COMPLETED|Overall Study||0
8210332|NCT02132520|20247580|P3|STARTED|Overall Study||2
8210333|NCT02132520|20247581|P2|STARTED|Overall Study||1
8210334|NCT02132520|20247582|P1|STARTED|Overall Study||0
8210335|NCT02132468|20247595|P1|NOT COMPLETED|Overall Study||7
8210336|NCT02132468|20247595|P1|COMPLETED|Overall Study||11
8210337|NCT02132468|20247595|P1|STARTED|Overall Study||18
8210338|NCT02132247|20247604|P2|NOT COMPLETED|Overall Study||0
8210339|NCT02132247|20247605|P1|NOT COMPLETED|Overall Study||1
8210340|NCT02132247|20247604|P2|COMPLETED|Overall Study||52
8210341|NCT02132247|20247605|P1|COMPLETED|Overall Study||51
8210342|NCT02132247|20247604|P2|STARTED|Overall Study||52
8210343|NCT02132247|20247605|P1|STARTED|Overall Study||52
8210344|NCT02132195|20247620|P3|NOT COMPLETED|Rescue Therapy||11
8210345|NCT02132195|20247621|P2|NOT COMPLETED|Rescue Therapy||0
8210346|NCT02132195|20247622|P1|NOT COMPLETED|Rescue Therapy||0
8210347|NCT02132195|20247620|P3|COMPLETED|Rescue Therapy||2
8210348|NCT02132195|20247621|P2|COMPLETED|Rescue Therapy||0
8210349|NCT02132195|20247622|P1|COMPLETED|Rescue Therapy||0
8210350|NCT02132195|20247620|P3|STARTED|Rescue Therapy||13
8210351|NCT02132195|20247621|P2|STARTED|Rescue Therapy||0
8210352|NCT02132195|20247622|P1|STARTED|Rescue Therapy||0
8210353|NCT02132195|20247620|P3|NOT COMPLETED|Initial Assignment||0
8210354|NCT02132195|20247621|P2|NOT COMPLETED|Initial Assignment||0
8210355|NCT02132195|20247622|P1|NOT COMPLETED|Initial Assignment||14
8210356|NCT02132195|20247620|P3|COMPLETED|Initial Assignment||0
8210357|NCT02132195|20247621|P2|COMPLETED|Initial Assignment||16
8210358|NCT02132195|20247622|P1|COMPLETED|Initial Assignment||1
8210359|NCT02132195|20247620|P3|STARTED|Initial Assignment||0
8210360|NCT02132195|20247621|P2|STARTED|Initial Assignment||16
8210361|NCT02132195|20247622|P1|STARTED|Initial Assignment||15
8210362|NCT02132169|20247638|P2|NOT COMPLETED|Overall Study||9
8210363|NCT02132169|20247639|P1|NOT COMPLETED|Overall Study||15
8210364|NCT02132169|20247638|P2|COMPLETED|Overall Study||162
8210365|NCT02132169|20247639|P1|COMPLETED|Overall Study||326
8210366|NCT02132169|20247638|P2|STARTED|Overall Study||171
8210367|NCT02132169|20247639|P1|STARTED|Overall Study||341
8210368|NCT02132117|20247653|P2|NOT COMPLETED|Overall Study||5
8210369|NCT02132117|20247654|P1|NOT COMPLETED|Overall Study||11
8210370|NCT02132117|20247653|P2|COMPLETED|Overall Study||216
8210371|NCT02132117|20247654|P1|COMPLETED|Overall Study||213
8210372|NCT02132117|20247653|P2|STARTED|Overall Study||221
8210373|NCT02132117|20247654|P1|STARTED|Overall Study||224
8210374|NCT02131766|20247670|P1|NOT COMPLETED|Overall Study||4
8210375|NCT02131766|20247670|P1|COMPLETED|Overall Study||40
8210376|NCT02131766|20247670|P1|STARTED|Overall Study||44
8210377|NCT02131662|20247686|P5|NOT COMPLETED|Overall Study||18
8210378|NCT02131662|20247687|P4|NOT COMPLETED|Overall Study||21
8210379|NCT02131662|20247688|P3|NOT COMPLETED|Overall Study||7
8210380|NCT02131662|20247689|P2|NOT COMPLETED|Overall Study||14
8210381|NCT02131662|20247690|P1|NOT COMPLETED|Overall Study||8
8210382|NCT02131662|20247686|P5|COMPLETED|Overall Study||43
8210383|NCT02131662|20247687|P4|COMPLETED|Overall Study||41
8210384|NCT02131662|20247688|P3|COMPLETED|Overall Study||56
8210385|NCT02131662|20247689|P2|COMPLETED|Overall Study||47
8210386|NCT02131662|20247690|P1|COMPLETED|Overall Study||54
8210387|NCT02131662|20247686|P5|Completed Follow-up|Overall Study||44
8210388|NCT02131662|20247687|P4|Completed Follow-up|Overall Study||42
8210389|NCT02131662|20247688|P3|Completed Follow-up|Overall Study||56
8210390|NCT02131662|20247689|P2|Completed Follow-up|Overall Study||47
8210391|NCT02131662|20247690|P1|Completed Follow-up|Overall Study||54
8210392|NCT02131662|20247686|P5|Completed Treatment|Overall Study||52
8210393|NCT02131662|20247687|P4|Completed Treatment|Overall Study||56
8210394|NCT02131662|20247688|P3|Completed Treatment|Overall Study||61
8210395|NCT02131662|20247689|P2|Completed Treatment|Overall Study||60
8210396|NCT02131662|20247690|P1|Completed Treatment|Overall Study||57
8210397|NCT02131662|20247686|P5|Treated|Overall Study||58
8210398|NCT02131662|20247687|P4|Treated|Overall Study||60
8210399|NCT02131662|20247688|P3|Treated|Overall Study||61
8210400|NCT02131662|20247689|P2|Treated|Overall Study||61
8210401|NCT02131662|20247690|P1|Treated|Overall Study||60
8210402|NCT02131662|20247686|P5|STARTED|Overall Study||61
8210403|NCT02131662|20247687|P4|STARTED|Overall Study||62
8210404|NCT02131662|20247688|P3|STARTED|Overall Study||63
8210405|NCT02131662|20247689|P2|STARTED|Overall Study||61
8210406|NCT02131662|20247690|P1|STARTED|Overall Study||62
8210407|NCT02131636|20247736|P2|NOT COMPLETED|Overall Study||5
8210408|NCT02131636|20247737|P1|NOT COMPLETED|Overall Study||12
8210409|NCT02131636|20247736|P2|COMPLETED|Overall Study||213
8210410|NCT02131636|20247737|P1|COMPLETED|Overall Study||210
8210411|NCT02131636|20247736|P2|STARTED|Overall Study||218
8210412|NCT02131636|20247737|P1|STARTED|Overall Study||222
8210413|NCT02131532|20247753|P1|NOT COMPLETED|Overall Study||4
8210414|NCT02131532|20247753|P1|COMPLETED|Overall Study||8
8210415|NCT02131532|20247753|P1|STARTED|Overall Study||12
8210416|NCT02131402|20247772|P1|NOT COMPLETED|Overall Study||0
8210417|NCT02131402|20247772|P1|COMPLETED|Overall Study||60
8210418|NCT02131402|20247772|P1|STARTED|Overall Study||60
8210419|NCT02131324|20247845|P2|NOT COMPLETED|Overall Study||3
8210420|NCT02131324|20247846|P1|NOT COMPLETED|Overall Study||2
8210421|NCT02131324|20247845|P2|COMPLETED|Overall Study||23
8210422|NCT02131324|20247846|P1|COMPLETED|Overall Study||22
8210423|NCT02131324|20247845|P2|Analyzed|Overall Study||24
8210424|NCT02131324|20247846|P1|Analyzed|Overall Study||22
8210425|NCT02131324|20247845|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
8210426|NCT02131324|20247846|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
8210427|NCT02131311|20247852|P1|NOT COMPLETED|Overall Study||4
8210428|NCT02131311|20247852|P1|COMPLETED|Overall Study||86
8210429|NCT02131311|20247852|P1|STARTED|Overall Study||90
8210430|NCT02131272|20247864|P2|NOT COMPLETED|Overall Study||2
8210431|NCT02131272|20247865|P1|NOT COMPLETED|Overall Study||1
8210432|NCT02131272|20247864|P2|COMPLETED|Overall Study||20
8210433|NCT02131272|20247865|P1|COMPLETED|Overall Study||19
8210434|NCT02131272|20247864|P2|STARTED|Overall Study||22
8210435|NCT02131272|20247865|P1|STARTED|Overall Study||20
8210436|NCT02131259|20247883|P1|NOT COMPLETED|Overall Study||1225
8210437|NCT02131259|20247883|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
8210438|NCT02131259|20247883|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
8210439|NCT02131233|20247890|P2|NOT COMPLETED|Overall Study||42
8210440|NCT02131233|20247891|P1|NOT COMPLETED|Overall Study||66
8210441|NCT02131233|20247890|P2|COMPLETED|Overall Study|Completed to Week 96|227
8210442|NCT02131233|20247891|P1|COMPLETED|Overall Study|Completed to Week 96|467
8210443|NCT02131233|20247890|P2|Treated|Overall Study||266
8210444|NCT02131233|20247891|P1|Treated|Overall Study||531
8210445|NCT02131233|20247890|P2|STARTED|Overall Study|Enrolled participants|269
8210446|NCT02131233|20247891|P1|STARTED|Overall Study|Enrolled participants|533
8210447|NCT02131155|20247925|P2|NOT COMPLETED|Overall Study||11
8210448|NCT02131155|20247926|P1|NOT COMPLETED|Overall Study||25
8210449|NCT02131155|20247925|P2|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
8210450|NCT02131155|20247926|P1|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
8210451|NCT02131155|20247925|P2|STARTED|Overall Study|Started are treated patients.|11
8210452|NCT02131155|20247926|P1|STARTED|Overall Study|Started are treated patients.|25
8210453|NCT02131129|20247940|P2|NOT COMPLETED|Overall Study||0
8210454|NCT02131129|20247941|P1|NOT COMPLETED|Overall Study||1
8210455|NCT02131129|20247940|P2|COMPLETED|Overall Study||10
8210456|NCT02131129|20247941|P1|COMPLETED|Overall Study||9
8210457|NCT02131129|20247940|P2|STARTED|Overall Study||10
8210458|NCT02131129|20247941|P1|STARTED|Overall Study||10
8210459|NCT02131064|20247959|P2|NOT COMPLETED|Overall Study||34
8210460|NCT02131064|20247960|P1|NOT COMPLETED|Overall Study||25
8210461|NCT02131064|20247959|P2|COMPLETED|Overall Study||189
8210462|NCT02131064|20247960|P1|COMPLETED|Overall Study||196
8210463|NCT02131064|20247959|P2|STARTED|Overall Study||223
8210464|NCT02131064|20247960|P1|STARTED|Overall Study||221
8210465|NCT02130999|20248000|P2|NOT COMPLETED|Overall Study||0
8210466|NCT02130999|20248001|P1|NOT COMPLETED|Overall Study||0
8210467|NCT02130999|20248000|P2|COMPLETED|Overall Study||8
8210468|NCT02130999|20248001|P1|COMPLETED|Overall Study||6
8210469|NCT02130999|20248000|P2|STARTED|Overall Study||8
8210470|NCT02130999|20248001|P1|STARTED|Overall Study||6
8210471|NCT02130986|20248029|P2|NOT COMPLETED|Overall Study||164
8210472|NCT02130986|20248030|P1|NOT COMPLETED|Overall Study||155
8210473|NCT02130986|20248029|P2|COMPLETED|Overall Study||670
8210474|NCT02130986|20248030|P1|COMPLETED|Overall Study||675
8210475|NCT02130986|20248029|P2|STARTED|Overall Study||834
8210476|NCT02130986|20248030|P1|STARTED|Overall Study||830
8210477|NCT02130765|20248044|P4|NOT COMPLETED|Overall Study||0
8210478|NCT02130765|20248045|P3|NOT COMPLETED|Overall Study||0
8210479|NCT02130765|20248046|P2|NOT COMPLETED|Overall Study||0
8210480|NCT02130765|20248047|P1|NOT COMPLETED|Overall Study||4
8210481|NCT02130765|20248044|P4|COMPLETED|Overall Study||19
8210482|NCT02130765|20248045|P3|COMPLETED|Overall Study||26
8210483|NCT02130765|20248046|P2|COMPLETED|Overall Study||8
8210484|NCT02130765|20248047|P1|COMPLETED|Overall Study||7
8210485|NCT02130765|20248044|P4|STARTED|Overall Study||19
8210486|NCT02130765|20248045|P3|STARTED|Overall Study||26
8210487|NCT02130765|20248046|P2|STARTED|Overall Study||8
8210488|NCT02130765|20248047|P1|STARTED|Overall Study||11
8210489|NCT02130635|20248075|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210490|NCT02130635|20248076|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210491|NCT02130635|20248077|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210492|NCT02130635|20248078|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210493|NCT02130635|20248079|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210494|NCT02130635|20248080|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210495|NCT02130635|20248081|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210496|NCT02130635|20248082|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210497|NCT02130635|20248083|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210498|NCT02130635|20248075|P9|COMPLETED|Part B-Dose-Response Relationship||5
8210499|NCT02130635|20248076|P8|COMPLETED|Part B-Dose-Response Relationship||5
8210500|NCT02130635|20248077|P7|COMPLETED|Part B-Dose-Response Relationship||6
8210501|NCT02130635|20248078|P6|COMPLETED|Part B-Dose-Response Relationship||5
8210502|NCT02130635|20248079|P5|COMPLETED|Part B-Dose-Response Relationship||5
8210503|NCT02130635|20248080|P4|COMPLETED|Part B-Dose-Response Relationship||5
8210504|NCT02130635|20248081|P3|COMPLETED|Part B-Dose-Response Relationship||5
8210505|NCT02130635|20248082|P2|COMPLETED|Part B-Dose-Response Relationship||0
8210506|NCT02130635|20248083|P1|COMPLETED|Part B-Dose-Response Relationship||0
8210507|NCT02130635|20248075|P9|STARTED|Part B-Dose-Response Relationship||5
8210508|NCT02130635|20248076|P8|STARTED|Part B-Dose-Response Relationship||5
8210509|NCT02130635|20248077|P7|STARTED|Part B-Dose-Response Relationship||6
8210510|NCT02130635|20248078|P6|STARTED|Part B-Dose-Response Relationship||5
8210511|NCT02130635|20248079|P5|STARTED|Part B-Dose-Response Relationship||5
8210512|NCT02130635|20248080|P4|STARTED|Part B-Dose-Response Relationship||5
8210513|NCT02130635|20248081|P3|STARTED|Part B-Dose-Response Relationship||5
8210514|NCT02130635|20248082|P2|STARTED|Part B-Dose-Response Relationship||0
8210515|NCT02130635|20248083|P1|STARTED|Part B-Dose-Response Relationship||0
8210516|NCT02130635|20248075|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
8210517|NCT02130635|20248076|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
8210518|NCT02130635|20248077|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
8210519|NCT02130635|20248078|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
8210520|NCT02130635|20248079|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
8210521|NCT02130635|20248080|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
8210522|NCT02130635|20248081|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
8210523|NCT02130635|20248082|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
8210524|NCT02130635|20248083|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
8210525|NCT02130635|20248075|P9|COMPLETED|Part A-Safety and Tolerability||0
8210526|NCT02130635|20248076|P8|COMPLETED|Part A-Safety and Tolerability||0
8210527|NCT02130635|20248077|P7|COMPLETED|Part A-Safety and Tolerability||0
8210528|NCT02130635|20248078|P6|COMPLETED|Part A-Safety and Tolerability||0
8210529|NCT02130635|20248079|P5|COMPLETED|Part A-Safety and Tolerability||0
8210530|NCT02130635|20248080|P4|COMPLETED|Part A-Safety and Tolerability||0
8210531|NCT02130635|20248081|P3|COMPLETED|Part A-Safety and Tolerability||0
8210532|NCT02130635|20248082|P2|COMPLETED|Part A-Safety and Tolerability||21
8210533|NCT02130635|20248083|P1|COMPLETED|Part A-Safety and Tolerability||7
8210534|NCT02130635|20248075|P9|STARTED|Part A-Safety and Tolerability||0
8210535|NCT02130635|20248076|P8|STARTED|Part A-Safety and Tolerability||0
8210536|NCT02130635|20248077|P7|STARTED|Part A-Safety and Tolerability||0
8210537|NCT02130635|20248078|P6|STARTED|Part A-Safety and Tolerability||0
8210538|NCT02130635|20248079|P5|STARTED|Part A-Safety and Tolerability||0
8210539|NCT02130635|20248080|P4|STARTED|Part A-Safety and Tolerability||0
8210540|NCT02130635|20248081|P3|STARTED|Part A-Safety and Tolerability||0
8210541|NCT02130635|20248082|P2|STARTED|Part A-Safety and Tolerability||21
8210542|NCT02130635|20248083|P1|STARTED|Part A-Safety and Tolerability||7
8210543|NCT02130622|20248257|P2|NOT COMPLETED|Overall Study||0
8210544|NCT02130622|20248258|P1|NOT COMPLETED|Overall Study||0
8210545|NCT02130622|20248257|P2|COMPLETED|Overall Study||1
8210546|NCT02130622|20248258|P1|COMPLETED|Overall Study||2
8210547|NCT02130622|20248257|P2|STARTED|Overall Study||1
8210548|NCT02130622|20248258|P1|STARTED|Overall Study||2
8210549|NCT02130583|20248272|P2|NOT COMPLETED|Overall Study||7
8210550|NCT02130583|20248273|P1|NOT COMPLETED|Overall Study||9
8210551|NCT02130583|20248272|P2|COMPLETED|Overall Study||19
8210552|NCT02130583|20248273|P1|COMPLETED|Overall Study||17
8210553|NCT02130583|20248272|P2|STARTED|Overall Study||26
8210554|NCT02130583|20248273|P1|STARTED|Overall Study||26
8210555|NCT02130570|20248293|P2|NOT COMPLETED|Overall Study||13
8210556|NCT02130570|20248294|P1|NOT COMPLETED|Overall Study||9
8210557|NCT02130570|20248293|P2|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
8210558|NCT02130570|20248294|P1|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
8210559|NCT02130570|20248293|P2|STARTED|Overall Study||692
8210560|NCT02130570|20248294|P1|STARTED|Overall Study||987
8210561|NCT02130557|20248312|P2|NOT COMPLETED|Overall Study||268
8210562|NCT02130557|20248313|P1|NOT COMPLETED|Overall Study||268
8210563|NCT02130557|20248312|P2|COMPLETED|Overall Study||0
8210564|NCT02130557|20248313|P1|COMPLETED|Overall Study||0
8210565|NCT02130557|20248312|P2|mITT Population|Overall Study||241
8210566|NCT02130557|20248313|P1|mITT Population|Overall Study||246
8210567|NCT02130557|20248312|P2|Treated|Overall Study||265
8210568|NCT02130557|20248313|P1|Treated|Overall Study||268
8210569|NCT02130557|20248312|P2|STARTED|Overall Study||268
8210570|NCT02130557|20248313|P1|STARTED|Overall Study||268
8210571|NCT02130284|20248345|P1|NOT COMPLETED|Overall Study||9
8210572|NCT02130284|20248345|P1|COMPLETED|Overall Study||71
8210573|NCT02130284|20248345|P1|STARTED|Overall Study||80
8210574|NCT02130258|20248358|P2|NOT COMPLETED|Overall Study||0
8210575|NCT02130258|20248359|P1|NOT COMPLETED|Overall Study||0
8210576|NCT02130258|20248358|P2|COMPLETED|Overall Study||11
8210577|NCT02130258|20248359|P1|COMPLETED|Overall Study||9
8210578|NCT02130258|20248358|P2|STARTED|Overall Study||11
8210579|NCT02130258|20248359|P1|STARTED|Overall Study||9
8210580|NCT02130193|20248371|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
8210581|NCT02130193|20248372|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
8210582|NCT02130193|20248373|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
8210583|NCT02130193|20248371|P3|COMPLETED|Part B: 52-week Double-blind Period||37
8210584|NCT02130193|20248372|P2|COMPLETED|Part B: 52-week Double-blind Period||38
8210585|NCT02130193|20248373|P1|COMPLETED|Part B: 52-week Double-blind Period||0
8210586|NCT02130193|20248371|P3|STARTED|Part B: 52-week Double-blind Period||45
8210587|NCT02130193|20248372|P2|STARTED|Part B: 52-week Double-blind Period||48
8210588|NCT02130193|20248373|P1|STARTED|Part B: 52-week Double-blind Period||0
8210589|NCT02130193|20248371|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
8210590|NCT02130193|20248372|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
8210591|NCT02130193|20248373|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
8210592|NCT02130193|20248371|P3|COMPLETED|Part A: 4-week Open-label Period||0
8210593|NCT02130193|20248372|P2|COMPLETED|Part A: 4-week Open-label Period||0
8210594|NCT02130193|20248373|P1|COMPLETED|Part A: 4-week Open-label Period||9
8210595|NCT02130193|20248371|P3|STARTED|Part A: 4-week Open-label Period||0
8210596|NCT02130193|20248372|P2|STARTED|Part A: 4-week Open-label Period||0
8210597|NCT02130193|20248373|P1|STARTED|Part A: 4-week Open-label Period||9
8210598|NCT02130063|20248439|P2|NOT COMPLETED|Overall Study||17
8210599|NCT02130063|20248440|P1|NOT COMPLETED|Overall Study||25
8210600|NCT02130063|20248439|P2|COMPLETED|Overall Study||152
8210601|NCT02130063|20248440|P1|COMPLETED|Overall Study||317
8210602|NCT02130063|20248439|P2|STARTED|Overall Study||169
8210603|NCT02130063|20248440|P1|STARTED|Overall Study||342
8210604|NCT02130024|20248454|P2|NOT COMPLETED|Overall Study||31
8210605|NCT02130024|20248455|P1|NOT COMPLETED|Overall Study||25
8210606|NCT02130024|20248454|P2|COMPLETED|Overall Study||108
8210607|NCT02130024|20248455|P1|COMPLETED|Overall Study||117
8210608|NCT02130024|20248454|P2|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
8210609|NCT02130024|20248455|P1|Full Analysis Set (FAS)|Overall Study||141
8210610|NCT02130024|20248454|P2|Safety Set|Overall Study||139
8210611|NCT02130024|20248455|P1|Safety Set|Overall Study|One randomized patient did not receive treatment|141
8210612|NCT02130024|20248454|P2|STARTED|Overall Study||139
8210613|NCT02130024|20248455|P1|STARTED|Overall Study||142
8210614|NCT02129803|20248489|P2|NOT COMPLETED|Overall Study||3
8210615|NCT02129803|20248490|P1|NOT COMPLETED|Overall Study||6
8210616|NCT02129803|20248489|P2|COMPLETED|Overall Study||9
8210617|NCT02129803|20248490|P1|COMPLETED|Overall Study||6
8210618|NCT02129803|20248489|P2|STARTED|Overall Study||12
8210619|NCT02129803|20248490|P1|STARTED|Overall Study||12
8210620|NCT02129777|20248503|P7|NOT COMPLETED|Open-Label Period||48
8210621|NCT02129777|20248504|P6|NOT COMPLETED|Open-Label Period||12
8210622|NCT02129777|20248505|P5|NOT COMPLETED|Open-Label Period||0
8210623|NCT02129777|20248506|P4|NOT COMPLETED|Open-Label Period||0
8210624|NCT02129777|20248507|P3|NOT COMPLETED|Open-Label Period||0
8210625|NCT02129777|20248508|P2|NOT COMPLETED|Open-Label Period||0
8210626|NCT02129777|20248509|P1|NOT COMPLETED|Open-Label Period||0
8210627|NCT02129777|20248503|P7|COMPLETED|Open-Label Period||0
8210628|NCT02129777|20248504|P6|COMPLETED|Open-Label Period||0
8210629|NCT02129777|20248505|P5|COMPLETED|Open-Label Period||0
8210630|NCT02129777|20248506|P4|COMPLETED|Open-Label Period||0
8210631|NCT02129777|20248507|P3|COMPLETED|Open-Label Period||0
8210632|NCT02129777|20248508|P2|COMPLETED|Open-Label Period||0
8210633|NCT02129777|20248509|P1|COMPLETED|Open-Label Period||0
8210634|NCT02129777|20248503|P7|STARTED|Open-Label Period||48
8210635|NCT02129777|20248504|P6|STARTED|Open-Label Period||12
8210636|NCT02129777|20248505|P5|STARTED|Open-Label Period||0
8210637|NCT02129777|20248506|P4|STARTED|Open-Label Period||0
8210638|NCT02129777|20248507|P3|STARTED|Open-Label Period||0
8210639|NCT02129777|20248508|P2|STARTED|Open-Label Period||0
8210640|NCT02129777|20248509|P1|STARTED|Open-Label Period||0
8210641|NCT02129777|20248503|P7|NOT COMPLETED|Double-Blind Period||0
8210642|NCT02129777|20248504|P6|NOT COMPLETED|Double-Blind Period||0
8210643|NCT02129777|20248505|P5|NOT COMPLETED|Double-Blind Period||7
8210644|NCT02129777|20248506|P4|NOT COMPLETED|Double-Blind Period||7
8210645|NCT02129777|20248507|P3|NOT COMPLETED|Double-Blind Period||4
8210646|NCT02129777|20248508|P2|NOT COMPLETED|Double-Blind Period||8
8210647|NCT02129777|20248509|P1|NOT COMPLETED|Double-Blind Period||7
8210648|NCT02129777|20248503|P7|COMPLETED|Double-Blind Period||0
8210649|NCT02129777|20248504|P6|COMPLETED|Double-Blind Period||0
8210650|NCT02129777|20248505|P5|COMPLETED|Double-Blind Period||18
8210651|NCT02129777|20248506|P4|COMPLETED|Double-Blind Period||18
8210652|NCT02129777|20248507|P3|COMPLETED|Double-Blind Period||20
8210653|NCT02129777|20248508|P2|COMPLETED|Double-Blind Period||16
8210654|NCT02129777|20248509|P1|COMPLETED|Double-Blind Period||17
8210655|NCT02129777|20248503|P7|STARTED|Double-Blind Period||0
8210656|NCT02129777|20248504|P6|STARTED|Double-Blind Period||0
8210657|NCT02129777|20248505|P5|STARTED|Double-Blind Period||25
8210658|NCT02129777|20248506|P4|STARTED|Double-Blind Period||25
8210659|NCT02129777|20248507|P3|STARTED|Double-Blind Period||24
8210660|NCT02129777|20248508|P2|STARTED|Double-Blind Period||24
8210661|NCT02129777|20248509|P1|STARTED|Double-Blind Period||24
8210662|NCT02129725|20248615|P2|NOT COMPLETED|Overall Study||3
8210663|NCT02129725|20248616|P1|NOT COMPLETED|Overall Study||2
8210664|NCT02129725|20248615|P2|COMPLETED|Overall Study||4
8210665|NCT02129725|20248616|P1|COMPLETED|Overall Study||6
8210666|NCT02129725|20248615|P2|STARTED|Overall Study||7
8210667|NCT02129725|20248616|P1|STARTED|Overall Study||8
8210668|NCT02129660|20248627|P5|NOT COMPLETED|Overall Study||2
8210669|NCT02129660|20248628|P4|NOT COMPLETED|Overall Study||0
8210670|NCT02129660|20248629|P3|NOT COMPLETED|Overall Study||1
8210671|NCT02129660|20248630|P2|NOT COMPLETED|Overall Study||0
8210672|NCT02129660|20248631|P1|NOT COMPLETED|Overall Study||2
8210673|NCT02129660|20248627|P5|COMPLETED|Overall Study||20
8210674|NCT02129660|20248628|P4|COMPLETED|Overall Study||20
8210675|NCT02129660|20248629|P3|COMPLETED|Overall Study||21
8210676|NCT02129660|20248630|P2|COMPLETED|Overall Study||20
8210677|NCT02129660|20248631|P1|COMPLETED|Overall Study||19
8210678|NCT02129660|20248627|P5|STARTED|Overall Study||22
8210679|NCT02129660|20248628|P4|STARTED|Overall Study||20
8210680|NCT02129660|20248629|P3|STARTED|Overall Study||22
8210681|NCT02129660|20248630|P2|STARTED|Overall Study||20
8210682|NCT02129660|20248631|P1|STARTED|Overall Study||21
8210683|NCT02129608|20248676|P3|NOT COMPLETED|Overall Study||3
8210684|NCT02129608|20248677|P2|NOT COMPLETED|Overall Study||1
8210685|NCT02129608|20248678|P1|NOT COMPLETED|Overall Study||0
8210686|NCT02129608|20248676|P3|COMPLETED|Overall Study||12
8210687|NCT02129608|20248677|P2|COMPLETED|Overall Study||13
8210688|NCT02129608|20248678|P1|COMPLETED|Overall Study||15
8210689|NCT02129608|20248676|P3|End of Treatment|Overall Study||12
8210690|NCT02129608|20248677|P2|End of Treatment|Overall Study||13
8210691|NCT02129608|20248678|P1|End of Treatment|Overall Study||15
8210692|NCT02129608|20248676|P3|STARTED|Overall Study||15
8210693|NCT02129608|20248677|P2|STARTED|Overall Study||14
8210694|NCT02129608|20248678|P1|STARTED|Overall Study||15
8210695|NCT02129556|20248692|P4|NOT COMPLETED|Overall Study||0
8210696|NCT02129556|20248693|P3|NOT COMPLETED|Overall Study||3
8210697|NCT02129556|20248694|P2|NOT COMPLETED|Overall Study||0
8210698|NCT02129556|20248695|P1|NOT COMPLETED|Overall Study||0
8210699|NCT02129556|20248692|P4|COMPLETED|Overall Study||12
8210700|NCT02129556|20248693|P3|COMPLETED|Overall Study||37
8210701|NCT02129556|20248694|P2|COMPLETED|Overall Study||3
8210702|NCT02129556|20248695|P1|COMPLETED|Overall Study||3
8210703|NCT02129556|20248692|P4|STARTED|Overall Study||12
8210704|NCT02129556|20248693|P3|STARTED|Overall Study||40
8210705|NCT02129556|20248694|P2|STARTED|Overall Study||3
8210706|NCT02129556|20248695|P1|STARTED|Overall Study||3
8210707|NCT02129478|20248719|P1|NOT COMPLETED|Overall Study||0
8210708|NCT02129478|20248719|P1|COMPLETED|Overall Study||15
8210709|NCT02129478|20248719|P1|STARTED|Overall Study||15
8210710|NCT02129205|20248735|P10|NOT COMPLETED|Overall Study||0
8210711|NCT02129205|20248736|P9|NOT COMPLETED|Overall Study||2
8210712|NCT02129205|20248737|P8|NOT COMPLETED|Overall Study||2
8210713|NCT02129205|20248738|P7|NOT COMPLETED|Overall Study||4
8210714|NCT02129205|20248739|P6|NOT COMPLETED|Overall Study||4
8210715|NCT02129205|20248740|P5|NOT COMPLETED|Overall Study||3
8210716|NCT02129205|20248741|P4|NOT COMPLETED|Overall Study||0
8210717|NCT02129205|20248742|P3|NOT COMPLETED|Overall Study||0
8210718|NCT02129205|20248743|P2|NOT COMPLETED|Overall Study||0
8210719|NCT02129205|20248744|P1|NOT COMPLETED|Overall Study||1
8210720|NCT02129205|20248735|P10|COMPLETED|Overall Study||0
8210721|NCT02129205|20248736|P9|COMPLETED|Overall Study||0
8210722|NCT02129205|20248737|P8|COMPLETED|Overall Study||4
8210723|NCT02129205|20248738|P7|COMPLETED|Overall Study||2
8210724|NCT02129205|20248739|P6|COMPLETED|Overall Study||7
8210725|NCT02129205|20248740|P5|COMPLETED|Overall Study||4
8210726|NCT02129205|20248741|P4|COMPLETED|Overall Study||2
8210727|NCT02129205|20248742|P3|COMPLETED|Overall Study||2
8210728|NCT02129205|20248743|P2|COMPLETED|Overall Study||2
8210729|NCT02129205|20248744|P1|COMPLETED|Overall Study||1
8210730|NCT02129205|20248735|P10|STARTED|Overall Study||0
8210731|NCT02129205|20248736|P9|STARTED|Overall Study||2
8210732|NCT02129205|20248737|P8|STARTED|Overall Study||6
8210733|NCT02129205|20248738|P7|STARTED|Overall Study||6
8210734|NCT02129205|20248739|P6|STARTED|Overall Study||11
8210735|NCT02129205|20248740|P5|STARTED|Overall Study||7
8210736|NCT02129205|20248741|P4|STARTED|Overall Study||2
8210737|NCT02129205|20248742|P3|STARTED|Overall Study||2
8210738|NCT02129205|20248743|P2|STARTED|Overall Study||2
8210739|NCT02129205|20248744|P1|STARTED|Overall Study||2
8210740|NCT02129192|20248897|P2|NOT COMPLETED|Period 5||0
8210741|NCT02129192|20248898|P1|NOT COMPLETED|Period 5||0
8210742|NCT02129192|20248897|P2|COMPLETED|Period 5||0
8210743|NCT02129192|20248898|P1|COMPLETED|Period 5||36
8210744|NCT02129192|20248897|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
8210745|NCT02129192|20248898|P1|STARTED|Period 5||36
8210746|NCT02129192|20248897|P2|NOT COMPLETED|Period 4 Including Washout Period||0
8210747|NCT02129192|20248898|P1|NOT COMPLETED|Period 4 Including Washout Period||0
8210748|NCT02129192|20248897|P2|COMPLETED|Period 4 Including Washout Period||35
8210749|NCT02129192|20248898|P1|COMPLETED|Period 4 Including Washout Period||36
8210750|NCT02129192|20248897|P2|STARTED|Period 4 Including Washout Period||35
8210751|NCT02129192|20248898|P1|STARTED|Period 4 Including Washout Period||36
8210752|NCT02129192|20248897|P2|NOT COMPLETED|Period 3 Including Washout Period||0
8210753|NCT02129192|20248898|P1|NOT COMPLETED|Period 3 Including Washout Period||0
8210754|NCT02129192|20248897|P2|COMPLETED|Period 3 Including Washout Period||35
8210755|NCT02129192|20248898|P1|COMPLETED|Period 3 Including Washout Period||36
8210756|NCT02129192|20248897|P2|STARTED|Period 3 Including Washout Period||35
8210757|NCT02129192|20248898|P1|STARTED|Period 3 Including Washout Period||36
8210758|NCT02129192|20248897|P2|NOT COMPLETED|Period 2 Including Washout Period||0
8210759|NCT02129192|20248898|P1|NOT COMPLETED|Period 2 Including Washout Period||0
8210760|NCT02129192|20248897|P2|COMPLETED|Period 2 Including Washout Period||35
8210761|NCT02129192|20248898|P1|COMPLETED|Period 2 Including Washout Period||36
8210762|NCT02129192|20248897|P2|STARTED|Period 2 Including Washout Period||35
8210763|NCT02129192|20248898|P1|STARTED|Period 2 Including Washout Period||36
8210764|NCT02129192|20248897|P2|NOT COMPLETED|Period 1 Including Washout Period||1
8210765|NCT02129192|20248898|P1|NOT COMPLETED|Period 1 Including Washout Period||0
8210766|NCT02129192|20248897|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
8210767|NCT02129192|20248898|P1|COMPLETED|Period 1 Including Washout Period||36
8210768|NCT02129192|20248897|P2|STARTED|Period 1 Including Washout Period||36
8210769|NCT02129192|20248898|P1|STARTED|Period 1 Including Washout Period||36
8210770|NCT02129062|20248915|P1|NOT COMPLETED|Overall Study||3
8210771|NCT02129062|20248915|P1|COMPLETED|Overall Study||0
8210772|NCT02129062|20248915|P1|STARTED|Overall Study||3
8210773|NCT02128997|20248922|P2|NOT COMPLETED|Overall Study||11
8210774|NCT02128997|20248923|P1|NOT COMPLETED|Overall Study||6
8210775|NCT02128997|20248922|P2|COMPLETED|Overall Study||58
8210776|NCT02128997|20248923|P1|COMPLETED|Overall Study||61
8210777|NCT02128997|20248922|P2|STARTED|Overall Study||69
8210778|NCT02128997|20248923|P1|STARTED|Overall Study||67
8210779|NCT02128932|20248938|P3|NOT COMPLETED|Overall Study||18
8210780|NCT02128932|20248939|P2|NOT COMPLETED|Overall Study||19
8210781|NCT02128932|20248940|P1|NOT COMPLETED|Overall Study||27
8210782|NCT02128932|20248938|P3|COMPLETED|Overall Study||342
8210783|NCT02128932|20248939|P2|COMPLETED|Overall Study||341
8210784|NCT02128932|20248940|P1|COMPLETED|Overall Study||335
8210785|NCT02128932|20248938|P3|STARTED|Overall Study||360
8210786|NCT02128932|20248939|P2|STARTED|Overall Study||360
8210787|NCT02128932|20248940|P1|STARTED|Overall Study||362
8210788|NCT02128919|20248971|P2|NOT COMPLETED|Overall Study||1
8210789|NCT02128919|20248972|P1|NOT COMPLETED|Overall Study||3
8210790|NCT02128919|20248971|P2|COMPLETED|Overall Study||15
8210791|NCT02128919|20248972|P1|COMPLETED|Overall Study||14
8210792|NCT02128919|20248971|P2|STARTED|Overall Study||16
8210793|NCT02128919|20248972|P1|STARTED|Overall Study||17
8210794|NCT02128867|20248985|P3|NOT COMPLETED|Overall Study||4
8210795|NCT02128867|20248986|P2|NOT COMPLETED|Overall Study||2
8210796|NCT02128867|20248987|P1|NOT COMPLETED|Overall Study||3
8210797|NCT02128867|20248985|P3|COMPLETED|Overall Study||50
8210798|NCT02128867|20248986|P2|COMPLETED|Overall Study||50
8210799|NCT02128867|20248987|P1|COMPLETED|Overall Study||50
8210800|NCT02128867|20248985|P3|STARTED|Overall Study||54
8210801|NCT02128867|20248986|P2|STARTED|Overall Study||52
8210802|NCT02128867|20248987|P1|STARTED|Overall Study||53
8210803|NCT02128828|20248995|P1|NOT COMPLETED|Overall Study||3
8210804|NCT02128828|20248995|P1|COMPLETED|Overall Study||17
8210805|NCT02128828|20248995|P1|STARTED|Overall Study||20
8210806|NCT02128763|20249001|P2|NOT COMPLETED|Overall Study||16
8210807|NCT02128763|20249002|P1|NOT COMPLETED|Overall Study||20
8210808|NCT02128763|20249001|P2|COMPLETED|Overall Study||170
8210809|NCT02128763|20249002|P1|COMPLETED|Overall Study||329
8210810|NCT02128763|20249001|P2|STARTED|Overall Study||186
8210811|NCT02128763|20249002|P1|STARTED|Overall Study||349
8210812|NCT02128724|20249048|P4|NOT COMPLETED|Overall Study||3
8210813|NCT02128724|20249049|P3|NOT COMPLETED|Overall Study||0
8210814|NCT02128724|20249050|P2|NOT COMPLETED|Overall Study||1
8210815|NCT02128724|20249051|P1|NOT COMPLETED|Overall Study||1
8210816|NCT02128724|20249048|P4|COMPLETED|Overall Study||7
8210817|NCT02128724|20249049|P3|COMPLETED|Overall Study||3
8210818|NCT02128724|20249050|P2|COMPLETED|Overall Study||3
8210819|NCT02128724|20249051|P1|COMPLETED|Overall Study||3
8210820|NCT02128724|20249048|P4|STARTED|Overall Study||10
8210821|NCT02128724|20249049|P3|STARTED|Overall Study||3
8210822|NCT02128724|20249050|P2|STARTED|Overall Study||4
8210823|NCT02128724|20249051|P1|STARTED|Overall Study||4
8210824|NCT02128542|20249106|P2|NOT COMPLETED|Overall Study||0
8210825|NCT02128542|20249107|P1|NOT COMPLETED|Overall Study||4
8210826|NCT02128542|20249106|P2|COMPLETED|Overall Study||19
8210827|NCT02128542|20249107|P1|COMPLETED|Overall Study||43
8210828|NCT02128542|20249106|P2|STARTED|Overall Study||19
8210829|NCT02128542|20249107|P1|STARTED|Overall Study||47
8210830|NCT02128490|20249125|P5|NOT COMPLETED|Overall Study||7
8210831|NCT02128490|20249126|P4|NOT COMPLETED|Overall Study||6
8210832|NCT02128490|20249127|P3|NOT COMPLETED|Overall Study||5
8210833|NCT02128490|20249128|P2|NOT COMPLETED|Overall Study||6
8210834|NCT02128490|20249129|P1|NOT COMPLETED|Overall Study||5
8210835|NCT02128490|20249125|P5|COMPLETED|Overall Study||31
8210836|NCT02128490|20249126|P4|COMPLETED|Overall Study||31
8210837|NCT02128490|20249127|P3|COMPLETED|Overall Study||34
8210838|NCT02128490|20249128|P2|COMPLETED|Overall Study||31
8210839|NCT02128490|20249129|P1|COMPLETED|Overall Study||33
8210840|NCT02128490|20249125|P5|STARTED|Overall Study||38
8210841|NCT02128490|20249126|P4|STARTED|Overall Study||37
8210842|NCT02128490|20249127|P3|STARTED|Overall Study||39
8210843|NCT02128490|20249128|P2|STARTED|Overall Study||37
8210844|NCT02128490|20249129|P1|STARTED|Overall Study||38
8210845|NCT02128269|20249151|P1|NOT COMPLETED|Follow-up||0
8210846|NCT02128269|20249151|P1|COMPLETED|Follow-up||9
8210847|NCT02128269|20249151|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
8210848|NCT02128269|20249151|P1|NOT COMPLETED|Treatment Period||2
8210849|NCT02128269|20249151|P1|COMPLETED|Treatment Period||7
8210850|NCT02128269|20249151|P1|STARTED|Treatment Period||9
8210851|NCT02128217|20249157|P2|NOT COMPLETED|Overall Study||1
8210852|NCT02128217|20249158|P1|NOT COMPLETED|Overall Study||0
8210853|NCT02128217|20249157|P2|COMPLETED|Overall Study||26
8210854|NCT02128217|20249158|P1|COMPLETED|Overall Study||17
8210855|NCT02128217|20249157|P2|STARTED|Overall Study||27
8210856|NCT02128217|20249158|P1|STARTED|Overall Study||17
8210857|NCT02128074|20249200|P1|NOT COMPLETED|Overall Study||6
8210858|NCT02128074|20249200|P1|COMPLETED|Overall Study||26
8210859|NCT02128074|20249200|P1|STARTED|Overall Study||32
8210860|NCT02127970|20249206|P2|NOT COMPLETED|Overall Study||27
8210861|NCT02127970|20249207|P1|NOT COMPLETED|Overall Study||26
8210862|NCT02127970|20249206|P2|COMPLETED|Overall Study||322
8210863|NCT02127970|20249207|P1|COMPLETED|Overall Study||323
8210864|NCT02127970|20249206|P2|STARTED|Overall Study||349
8210865|NCT02127970|20249207|P1|STARTED|Overall Study||349
8210866|NCT02127931|20249229|P1|NOT COMPLETED|Overall Study||1
8210867|NCT02127931|20249229|P1|COMPLETED|Overall Study||17
8210868|NCT02127931|20249229|P1|STARTED|Overall Study||18
8210869|NCT02127892|20249239|P4|NOT COMPLETED|Overall Study||0
8210870|NCT02127892|20249240|P3|NOT COMPLETED|Overall Study||0
8210871|NCT02127892|20249241|P2|NOT COMPLETED|Overall Study||1
8210872|NCT02127892|20249242|P1|NOT COMPLETED|Overall Study||1
8210873|NCT02127892|20249239|P4|COMPLETED|Overall Study||0
8210874|NCT02127892|20249240|P3|COMPLETED|Overall Study||0
8210875|NCT02127892|20249241|P2|COMPLETED|Overall Study||1
8210876|NCT02127892|20249242|P1|COMPLETED|Overall Study||6
8210877|NCT02127892|20249239|P4|STARTED|Overall Study||0
8210878|NCT02127892|20249240|P3|STARTED|Overall Study||0
8210879|NCT02127892|20249241|P2|STARTED|Overall Study||2
8210880|NCT02127892|20249242|P1|STARTED|Overall Study||7
8210881|NCT02127723|20249268|P1|NOT COMPLETED|Overall Study||1
8210882|NCT02127723|20249268|P1|COMPLETED|Overall Study||19
8210883|NCT02127723|20249268|P1|STARTED|Overall Study||20
8210884|NCT02127710|20249278|P3|NOT COMPLETED|Overall Study||0
8210885|NCT02127710|20249279|P2|NOT COMPLETED|Overall Study||0
8210886|NCT02127710|20249280|P1|NOT COMPLETED|Overall Study||0
8210887|NCT02127710|20249278|P3|COMPLETED|Overall Study||19
8210888|NCT02127710|20249279|P2|COMPLETED|Overall Study||46
8210889|NCT02127710|20249280|P1|COMPLETED|Overall Study||44
8210890|NCT02127710|20249278|P3|STARTED|Overall Study||19
8210891|NCT02127710|20249279|P2|STARTED|Overall Study||46
8210892|NCT02127710|20249280|P1|STARTED|Overall Study||44
8210893|NCT02127632|20249322|P2|NOT COMPLETED|Overall Study||0
8210894|NCT02127632|20249323|P1|NOT COMPLETED|Overall Study||0
8210895|NCT02127632|20249322|P2|COMPLETED|Overall Study||50
8210896|NCT02127632|20249323|P1|COMPLETED|Overall Study||50
8210897|NCT02127632|20249322|P2|STARTED|Overall Study||50
8210898|NCT02127632|20249323|P1|STARTED|Overall Study||50
8210899|NCT02127567|20249333|P1|NOT COMPLETED|Overall Study||0
8210900|NCT02127567|20249333|P1|COMPLETED|Overall Study||41
8210901|NCT02127567|20249333|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
8210902|NCT02127372|20249355|P2|NOT COMPLETED|Overall Study||0
8210903|NCT02127372|20249356|P1|NOT COMPLETED|Overall Study||1
8210904|NCT02127372|20249355|P2|COMPLETED|Overall Study||28
8210905|NCT02127372|20249356|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
8210906|NCT02127372|20249355|P2|Started Study Treatment|Overall Study||28
8210907|NCT02127372|20249356|P1|Started Study Treatment|Overall Study||15
8210908|NCT02127372|20249355|P2|STARTED|Overall Study|Signed Consent|28
8210909|NCT02127372|20249356|P1|STARTED|Overall Study|Signed Consent|15
8210910|NCT02127307|20249366|P1|NOT COMPLETED|Overall Study||308
8210911|NCT02127307|20249366|P1|COMPLETED|Overall Study||656
8210912|NCT02127307|20249366|P1|STARTED|Overall Study||964
8210913|NCT02127281|20249372|P2|NOT COMPLETED|Overall Study||0
8210914|NCT02127281|20249373|P1|NOT COMPLETED|Overall Study||1
8210915|NCT02127281|20249372|P2|COMPLETED|Overall Study||80
8210916|NCT02127281|20249373|P1|COMPLETED|Overall Study||79
8210917|NCT02127281|20249372|P2|STARTED|Overall Study||80
8210918|NCT02127281|20249373|P1|STARTED|Overall Study||80
8210919|NCT02127125|20249408|P9|NOT COMPLETED|Overall Study||0
8210920|NCT02127125|20249409|P8|NOT COMPLETED|Overall Study||0
8210921|NCT02127125|20249410|P7|NOT COMPLETED|Overall Study||0
8210922|NCT02127125|20249411|P6|NOT COMPLETED|Overall Study||3
8210923|NCT02127125|20249412|P5|NOT COMPLETED|Overall Study||3
8210924|NCT02127125|20249413|P4|NOT COMPLETED|Overall Study||1
8210925|NCT02127125|20249414|P3|NOT COMPLETED|Overall Study||1
8210926|NCT02127125|20249415|P2|NOT COMPLETED|Overall Study||0
8210927|NCT02127125|20249416|P1|NOT COMPLETED|Overall Study||0
8210928|NCT02127125|20249408|P9|COMPLETED|Overall Study||1
8210929|NCT02127125|20249409|P8|COMPLETED|Overall Study||0
8210930|NCT02127125|20249410|P7|COMPLETED|Overall Study||2
8210931|NCT02127125|20249411|P6|COMPLETED|Overall Study||9
8210932|NCT02127125|20249412|P5|COMPLETED|Overall Study||9
8210933|NCT02127125|20249413|P4|COMPLETED|Overall Study||10
8210934|NCT02127125|20249414|P3|COMPLETED|Overall Study||8
8210935|NCT02127125|20249415|P2|COMPLETED|Overall Study||8
8210936|NCT02127125|20249416|P1|COMPLETED|Overall Study||6
8210937|NCT02127125|20249408|P9|STARTED|Overall Study||1
8210938|NCT02127125|20249409|P8|STARTED|Overall Study||0
8210939|NCT02127125|20249410|P7|STARTED|Overall Study||2
8210940|NCT02127125|20249411|P6|STARTED|Overall Study||12
8210941|NCT02127125|20249412|P5|STARTED|Overall Study||12
8210942|NCT02127125|20249413|P4|STARTED|Overall Study||11
8210943|NCT02127125|20249414|P3|STARTED|Overall Study||9
8210944|NCT02127125|20249415|P2|STARTED|Overall Study||8
8210945|NCT02127125|20249416|P1|STARTED|Overall Study||6
8210946|NCT02126969|20249456|P2|NOT COMPLETED|Overall Study||2
8210947|NCT02126969|20249457|P1|NOT COMPLETED|Overall Study||1
8210948|NCT02126969|20249456|P2|COMPLETED|Overall Study||20
8210949|NCT02126969|20249457|P1|COMPLETED|Overall Study||22
8210950|NCT02126969|20249456|P2|STARTED|Overall Study||22
8210951|NCT02126969|20249457|P1|STARTED|Overall Study||23
8210952|NCT02126878|20249470|P3|NOT COMPLETED|Overall Study||0
8210953|NCT02126878|20249471|P2|NOT COMPLETED|Overall Study||0
8210954|NCT02126878|20249472|P1|NOT COMPLETED|Overall Study||0
8210955|NCT02126878|20249470|P3|COMPLETED|Overall Study||0
8210956|NCT02126878|20249471|P2|COMPLETED|Overall Study||0
8210957|NCT02126878|20249472|P1|COMPLETED|Overall Study||0
8210958|NCT02126878|20249470|P3|STARTED|Overall Study||0
8210959|NCT02126878|20249471|P2|STARTED|Overall Study||0
8210960|NCT02126878|20249472|P1|STARTED|Overall Study||0
8210961|NCT02126839|20249488|P2|NOT COMPLETED|Overall Study||14
8210962|NCT02126839|20249489|P1|NOT COMPLETED|Overall Study||10
8210963|NCT02126839|20249488|P2|COMPLETED|Overall Study||80
8210964|NCT02126839|20249489|P1|COMPLETED|Overall Study||82
8210965|NCT02126839|20249488|P2|Full Analysis Set|Overall Study||92
8210966|NCT02126839|20249489|P1|Full Analysis Set|Overall Study||92
8210967|NCT02126839|20249488|P2|Safety Population|Overall Study||93
8210968|NCT02126839|20249489|P1|Safety Population|Overall Study||92
8210969|NCT02126839|20249488|P2|STARTED|Overall Study||94
8210970|NCT02126839|20249489|P1|STARTED|Overall Study||92
8210971|NCT02126826|20249506|P7|NOT COMPLETED|Overall Study||0
8210972|NCT02126826|20249507|P6|NOT COMPLETED|Overall Study||0
8210973|NCT02126826|20249508|P5|NOT COMPLETED|Overall Study||0
8210974|NCT02126826|20249509|P4|NOT COMPLETED|Overall Study||1
8210975|NCT02126826|20249510|P3|NOT COMPLETED|Overall Study||0
8210976|NCT02126826|20249511|P2|NOT COMPLETED|Overall Study||0
8210977|NCT02126826|20249512|P1|NOT COMPLETED|Overall Study||0
8210978|NCT02126826|20249506|P7|COMPLETED|Overall Study||8
8210979|NCT02126826|20249507|P6|COMPLETED|Overall Study||9
8210980|NCT02126826|20249508|P5|COMPLETED|Overall Study||5
8210981|NCT02126826|20249509|P4|COMPLETED|Overall Study||8
8210982|NCT02126826|20249510|P3|COMPLETED|Overall Study||9
8210983|NCT02126826|20249511|P2|COMPLETED|Overall Study||9
8210984|NCT02126826|20249512|P1|COMPLETED|Overall Study||9
8210985|NCT02126826|20249506|P7|STARTED|Overall Study||8
8210986|NCT02126826|20249507|P6|STARTED|Overall Study||9
8210987|NCT02126826|20249508|P5|STARTED|Overall Study||5
8210988|NCT02126826|20249509|P4|STARTED|Overall Study||9
8210989|NCT02126826|20249510|P3|STARTED|Overall Study||9
8210990|NCT02126826|20249511|P2|STARTED|Overall Study||9
8210991|NCT02126826|20249512|P1|STARTED|Overall Study||9
8210992|NCT02126748|20249566|P3|NOT COMPLETED|Overall Study||5
8210993|NCT02126748|20249567|P2|NOT COMPLETED|Overall Study||3
8210994|NCT02126748|20249568|P1|NOT COMPLETED|Overall Study||2
8210995|NCT02126748|20249566|P3|COMPLETED|Overall Study||31
8210996|NCT02126748|20249567|P2|COMPLETED|Overall Study||31
8210997|NCT02126748|20249568|P1|COMPLETED|Overall Study||31
8210998|NCT02126748|20249566|P3|STARTED|Overall Study||36
8210999|NCT02126748|20249567|P2|STARTED|Overall Study||34
8211000|NCT02126748|20249568|P1|STARTED|Overall Study||33
8211001|NCT02126670|20249580|P4|NOT COMPLETED|Overall Study||1
8211002|NCT02126670|20249581|P3|NOT COMPLETED|Overall Study||0
8211003|NCT02126670|20249582|P2|NOT COMPLETED|Overall Study||0
8211004|NCT02126670|20249583|P1|NOT COMPLETED|Overall Study||1
8211005|NCT02126670|20249580|P4|COMPLETED|Overall Study||24
8211006|NCT02126670|20249581|P3|COMPLETED|Overall Study||25
8211007|NCT02126670|20249582|P2|COMPLETED|Overall Study||24
8211008|NCT02126670|20249583|P1|COMPLETED|Overall Study||25
8211009|NCT02126670|20249580|P4|STARTED|Overall Study||25
8211010|NCT02126670|20249581|P3|STARTED|Overall Study||25
8211011|NCT02126670|20249582|P2|STARTED|Overall Study||24
8211012|NCT02126670|20249583|P1|STARTED|Overall Study||26
8211013|NCT02126319|20249599|P2|NOT COMPLETED|Overall Study||24
8211014|NCT02126319|20249600|P1|NOT COMPLETED|Overall Study||21
8211015|NCT02126319|20249599|P2|COMPLETED|Overall Study||43
8211016|NCT02126319|20249600|P1|COMPLETED|Overall Study||40
8211017|NCT02126319|20249599|P2|STARTED|Overall Study||67
8211018|NCT02126319|20249600|P1|STARTED|Overall Study||61
8211019|NCT02126306|20249626|P2|NOT COMPLETED|Overall Study||0
8211020|NCT02126306|20249627|P1|NOT COMPLETED|Overall Study||0
8211021|NCT02126306|20249626|P2|COMPLETED|Overall Study||13
8211022|NCT02126306|20249627|P1|COMPLETED|Overall Study||10
8211023|NCT02126306|20249626|P2|STARTED|Overall Study||13
8211024|NCT02126306|20249627|P1|STARTED|Overall Study||10
8211025|NCT02125877|20249635|P2|NOT COMPLETED|Overall Study||10
8211026|NCT02125877|20249636|P1|NOT COMPLETED|Overall Study||13
8211027|NCT02125877|20249635|P2|COMPLETED|Overall Study||77
8211028|NCT02125877|20249636|P1|COMPLETED|Overall Study||73
8211029|NCT02125877|20249635|P2|Safety Set|Overall Study||87
8211030|NCT02125877|20249636|P1|Safety Set|Overall Study||86
8211031|NCT02125877|20249635|P2|Pharmacokinetic Subset A|Overall Study||15
8211032|NCT02125877|20249636|P1|Pharmacokinetic Subset A|Overall Study||16
8211033|NCT02125877|20249635|P2|Pharmacokinetic Analysis Set|Overall Study||83
8211034|NCT02125877|20249636|P1|Pharmacokinetic Analysis Set|Overall Study||83
8211035|NCT02125877|20249635|P2|STARTED|Overall Study||87
8211036|NCT02125877|20249636|P1|STARTED|Overall Study||86
8211037|NCT02125838|20249666|P2|NOT COMPLETED|Overall Study||4
8211038|NCT02125838|20249667|P1|NOT COMPLETED|Overall Study||4
8211039|NCT02125838|20249666|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
8211040|NCT02125838|20249667|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
8211041|NCT02125838|20249666|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
8211042|NCT02125838|20249667|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
8211043|NCT02125734|20249685|P2|NOT COMPLETED|Period 2||1
8211044|NCT02125734|20249686|P1|NOT COMPLETED|Period 2||0
8211045|NCT02125734|20249685|P2|COMPLETED|Period 2||47
8211046|NCT02125734|20249686|P1|COMPLETED|Period 2||40
8211047|NCT02125734|20249685|P2|STARTED|Period 2||48
8211048|NCT02125734|20249686|P1|STARTED|Period 2||40
8211049|NCT02125734|20249685|P2|NOT COMPLETED|Period 1||0
8211050|NCT02125734|20249686|P1|NOT COMPLETED|Period 1||0
8211051|NCT02125734|20249685|P2|COMPLETED|Period 1||48
8211052|NCT02125734|20249686|P1|COMPLETED|Period 1||40
8211053|NCT02125734|20249685|P2|STARTED|Period 1||48
8211054|NCT02125734|20249686|P1|STARTED|Period 1||40
8211055|NCT02125604|20249696|P1|NOT COMPLETED|Overall Study||31
8211056|NCT02125604|20249696|P1|COMPLETED|Overall Study||180
8211057|NCT02125604|20249696|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
8211058|NCT02125461|20249712|P2|NOT COMPLETED|Overall Study||129
8211059|NCT02125461|20249713|P1|NOT COMPLETED|Overall Study||203
8211060|NCT02125461|20249712|P2|COMPLETED|Overall Study||108
8211061|NCT02125461|20249713|P1|COMPLETED|Overall Study||273
8211062|NCT02125461|20249712|P2|Completed 12 Months of Treatment|Overall Study||82
8211063|NCT02125461|20249713|P1|Completed 12 Months of Treatment|Overall Study||232
8211064|NCT02125461|20249712|P2|Safety Analysis Set|Overall Study||234
8211065|NCT02125461|20249713|P1|Safety Analysis Set|Overall Study||475
8211066|NCT02125461|20249712|P2|Receieved Treatment|Overall Study||236
8211067|NCT02125461|20249713|P1|Receieved Treatment|Overall Study||473
8211068|NCT02125461|20249712|P2|Full Analysis Set (FAS)|Overall Study||237
8211069|NCT02125461|20249713|P1|Full Analysis Set (FAS)|Overall Study||476
8211070|NCT02125461|20249712|P2|STARTED|Overall Study||237
8211071|NCT02125461|20249713|P1|STARTED|Overall Study||476
8211072|NCT02125331|20249744|P2|NOT COMPLETED|Overall Study||0
8211073|NCT02125331|20249745|P1|NOT COMPLETED|Overall Study||5
8211074|NCT02125331|20249744|P2|COMPLETED|Overall Study||25
8211075|NCT02125331|20249745|P1|COMPLETED|Overall Study||53
8211076|NCT02125331|20249744|P2|STARTED|Overall Study||25
8211077|NCT02125331|20249745|P1|STARTED|Overall Study||58
8211078|NCT02125292|20249751|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
8211079|NCT02125292|20249752|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
8211080|NCT02125292|20249753|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
8211081|NCT02125292|20249754|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
8211082|NCT02125292|20249755|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
8211083|NCT02125292|20249756|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
8211084|NCT02125292|20249751|P6|COMPLETED|Third Intervention (1 Hour)||3
8211085|NCT02125292|20249752|P5|COMPLETED|Third Intervention (1 Hour)||3
8211086|NCT02125292|20249753|P4|COMPLETED|Third Intervention (1 Hour)||3
8211087|NCT02125292|20249754|P3|COMPLETED|Third Intervention (1 Hour)||3
8211088|NCT02125292|20249755|P2|COMPLETED|Third Intervention (1 Hour)||3
8211089|NCT02125292|20249756|P1|COMPLETED|Third Intervention (1 Hour)||3
8211090|NCT02125292|20249751|P6|STARTED|Third Intervention (1 Hour)||3
8211091|NCT02125292|20249752|P5|STARTED|Third Intervention (1 Hour)||3
8211092|NCT02125292|20249753|P4|STARTED|Third Intervention (1 Hour)||3
8211093|NCT02125292|20249754|P3|STARTED|Third Intervention (1 Hour)||3
8211094|NCT02125292|20249755|P2|STARTED|Third Intervention (1 Hour)||3
8211095|NCT02125292|20249756|P1|STARTED|Third Intervention (1 Hour)||3
8211096|NCT02125292|20249751|P6|NOT COMPLETED|Washout (2 Hours)||0
8211097|NCT02125292|20249752|P5|NOT COMPLETED|Washout (2 Hours)||0
8211098|NCT02125292|20249753|P4|NOT COMPLETED|Washout (2 Hours)||0
8211099|NCT02125292|20249754|P3|NOT COMPLETED|Washout (2 Hours)||0
8211100|NCT02125292|20249755|P2|NOT COMPLETED|Washout (2 Hours)||0
8211101|NCT02125292|20249756|P1|NOT COMPLETED|Washout (2 Hours)||0
8211102|NCT02125292|20249751|P6|COMPLETED|Washout (2 Hours)||3
8211103|NCT02125292|20249752|P5|COMPLETED|Washout (2 Hours)||3
8211104|NCT02125292|20249753|P4|COMPLETED|Washout (2 Hours)||3
8211105|NCT02125292|20249754|P3|COMPLETED|Washout (2 Hours)||3
8211106|NCT02125292|20249755|P2|COMPLETED|Washout (2 Hours)||3
8211107|NCT02125292|20249756|P1|COMPLETED|Washout (2 Hours)||3
8211108|NCT02125292|20249751|P6|STARTED|Washout (2 Hours)||3
8211109|NCT02125292|20249752|P5|STARTED|Washout (2 Hours)||3
8211110|NCT02125292|20249753|P4|STARTED|Washout (2 Hours)||3
8211111|NCT02125292|20249754|P3|STARTED|Washout (2 Hours)||3
8211112|NCT02125292|20249755|P2|STARTED|Washout (2 Hours)||3
8211113|NCT02125292|20249756|P1|STARTED|Washout (2 Hours)||3
8211114|NCT02125292|20249751|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
8211115|NCT02125292|20249752|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
8211116|NCT02125292|20249753|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
8211117|NCT02125292|20249754|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
8211118|NCT02125292|20249755|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
8211119|NCT02125292|20249756|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
8211120|NCT02125292|20249751|P6|COMPLETED|Second Intervention (1 Hour)||3
8211121|NCT02125292|20249752|P5|COMPLETED|Second Intervention (1 Hour)||3
8211122|NCT02125292|20249753|P4|COMPLETED|Second Intervention (1 Hour)||3
8211123|NCT02125292|20249754|P3|COMPLETED|Second Intervention (1 Hour)||3
8211124|NCT02125292|20249755|P2|COMPLETED|Second Intervention (1 Hour)||3
8211125|NCT02125292|20249756|P1|COMPLETED|Second Intervention (1 Hour)||3
8211126|NCT02125292|20249751|P6|STARTED|Second Intervention (1 Hour)||3
8211127|NCT02125292|20249752|P5|STARTED|Second Intervention (1 Hour)||3
8211128|NCT02125292|20249753|P4|STARTED|Second Intervention (1 Hour)||3
8211129|NCT02125292|20249754|P3|STARTED|Second Intervention (1 Hour)||3
8211130|NCT02125292|20249755|P2|STARTED|Second Intervention (1 Hour)||3
8211131|NCT02125292|20249756|P1|STARTED|Second Intervention (1 Hour)||3
8211132|NCT02125292|20249751|P6|NOT COMPLETED|Washout (2 Hours)||0
8211133|NCT02125292|20249752|P5|NOT COMPLETED|Washout (2 Hours)||0
8211134|NCT02125292|20249753|P4|NOT COMPLETED|Washout (2 Hours)||0
8211135|NCT02125292|20249754|P3|NOT COMPLETED|Washout (2 Hours)||0
8211136|NCT02125292|20249755|P2|NOT COMPLETED|Washout (2 Hours)||0
8211137|NCT02125292|20249756|P1|NOT COMPLETED|Washout (2 Hours)||0
8211138|NCT02125292|20249751|P6|COMPLETED|Washout (2 Hours)||3
8211139|NCT02125292|20249752|P5|COMPLETED|Washout (2 Hours)||3
8211140|NCT02125292|20249753|P4|COMPLETED|Washout (2 Hours)||3
8211141|NCT02125292|20249754|P3|COMPLETED|Washout (2 Hours)||3
8211142|NCT02125292|20249755|P2|COMPLETED|Washout (2 Hours)||3
8211143|NCT02125292|20249756|P1|COMPLETED|Washout (2 Hours)||3
8211144|NCT02125292|20249751|P6|STARTED|Washout (2 Hours)||3
8211145|NCT02125292|20249752|P5|STARTED|Washout (2 Hours)||3
8211146|NCT02125292|20249753|P4|STARTED|Washout (2 Hours)||3
8211147|NCT02125292|20249754|P3|STARTED|Washout (2 Hours)||3
8211148|NCT02125292|20249755|P2|STARTED|Washout (2 Hours)||3
8211149|NCT02125292|20249756|P1|STARTED|Washout (2 Hours)||3
8211150|NCT02125292|20249751|P6|NOT COMPLETED|First Intervention (1 Hour)||0
8211151|NCT02125292|20249752|P5|NOT COMPLETED|First Intervention (1 Hour)||0
8211152|NCT02125292|20249753|P4|NOT COMPLETED|First Intervention (1 Hour)||0
8211153|NCT02125292|20249754|P3|NOT COMPLETED|First Intervention (1 Hour)||0
8211154|NCT02125292|20249755|P2|NOT COMPLETED|First Intervention (1 Hour)||0
8211155|NCT02125292|20249756|P1|NOT COMPLETED|First Intervention (1 Hour)||0
8211156|NCT02125292|20249751|P6|COMPLETED|First Intervention (1 Hour)||3
8211157|NCT02125292|20249752|P5|COMPLETED|First Intervention (1 Hour)||3
8211158|NCT02125292|20249753|P4|COMPLETED|First Intervention (1 Hour)||3
8211159|NCT02125292|20249754|P3|COMPLETED|First Intervention (1 Hour)||3
8211160|NCT02125292|20249755|P2|COMPLETED|First Intervention (1 Hour)||3
8211161|NCT02125292|20249756|P1|COMPLETED|First Intervention (1 Hour)||3
8211162|NCT02125292|20249751|P6|STARTED|First Intervention (1 Hour)||3
8211163|NCT02125292|20249752|P5|STARTED|First Intervention (1 Hour)||3
8211164|NCT02125292|20249753|P4|STARTED|First Intervention (1 Hour)||3
8211165|NCT02125292|20249754|P3|STARTED|First Intervention (1 Hour)||3
8211166|NCT02125292|20249755|P2|STARTED|First Intervention (1 Hour)||3
8211167|NCT02125292|20249756|P1|STARTED|First Intervention (1 Hour)||3
8211171|NCT02124889|20249806|P2|NOT COMPLETED|Overall Study||0
8211172|NCT02124889|20249807|P1|NOT COMPLETED|Overall Study||0
8211173|NCT02124889|20249806|P2|COMPLETED|Overall Study||12
8211174|NCT02124889|20249807|P1|COMPLETED|Overall Study||12
8211175|NCT02124889|20249806|P2|STARTED|Overall Study||12
8211176|NCT02124889|20249807|P1|STARTED|Overall Study||12
8211177|NCT02124863|20249813|P1|NOT COMPLETED|Overall Study||17
8211178|NCT02124863|20249813|P1|COMPLETED|Overall Study||50
8211179|NCT02124863|20249813|P1|STARTED|Overall Study||67
8211180|NCT02124811|20249821|P2|NOT COMPLETED|Overall Study||2
8211181|NCT02124811|20249822|P1|NOT COMPLETED|Overall Study||3
8211182|NCT02124811|20249821|P2|COMPLETED|Overall Study||3
8211183|NCT02124811|20249822|P1|COMPLETED|Overall Study||2
8211184|NCT02124811|20249821|P2|STARTED|Overall Study||5
8211185|NCT02124811|20249822|P1|STARTED|Overall Study||5
8211186|NCT02124798|20249838|P1|NOT COMPLETED|Overall Study||4
8211187|NCT02124798|20249838|P1|COMPLETED|Overall Study||91
8211188|NCT02124798|20249838|P1|STARTED|Overall Study||95
8211189|NCT02124707|20249844|P1|NOT COMPLETED|Overall Study||7
8211190|NCT02124707|20249844|P1|COMPLETED|Overall Study||7
8211191|NCT02124707|20249844|P1|STARTED|Overall Study||14
8211192|NCT02124603|20249852|P1|NOT COMPLETED|Overall Study||0
8211193|NCT02124603|20249852|P1|COMPLETED|Overall Study||120
8211194|NCT02124603|20249852|P1|STARTED|Overall Study||120
8211195|NCT02124564|20249858|P1|NOT COMPLETED|Taper Period||0
8211196|NCT02124564|20249858|P1|COMPLETED|Taper Period||2
8211197|NCT02124564|20249858|P1|STARTED|Taper Period||2
8211198|NCT02124564|20249858|P1|NOT COMPLETED|Treatment Period||7
8211199|NCT02124564|20249858|P1|COMPLETED|Treatment Period||12
8211200|NCT02124564|20249858|P1|Started Follow-Up Period|Treatment Period||13
8211201|NCT02124564|20249858|P1|Started Evaluation Period|Treatment Period||17
8211202|NCT02124564|20249858|P1|Started Monotherapy Period|Treatment Period||17
8211203|NCT02124564|20249858|P1|Started AED Withdrawal Period|Treatment Period||19
8211204|NCT02124564|20249858|P1|Started Titration Period|Treatment Period||19
8211205|NCT02124564|20249858|P1|Started Treatment Period|Treatment Period||19
8211206|NCT02124564|20249858|P1|STARTED|Treatment Period||19
8211207|NCT02124512|20249870|P2|NOT COMPLETED|Overall Study||0
8211208|NCT02124512|20249871|P1|NOT COMPLETED|Overall Study||0
8211209|NCT02124512|20249870|P2|COMPLETED|Overall Study||6
8211210|NCT02124512|20249871|P1|COMPLETED|Overall Study||6
8211211|NCT02124512|20249870|P2|STARTED|Overall Study||6
8211212|NCT02124512|20249871|P1|STARTED|Overall Study||6
8211213|NCT02124460|20249881|P2|NOT COMPLETED|Overall Study||24
8211214|NCT02124460|20249882|P1|NOT COMPLETED|Overall Study||33
8211215|NCT02124460|20249881|P2|COMPLETED|Overall Study||336
8211216|NCT02124460|20249882|P1|COMPLETED|Overall Study||328
8211217|NCT02124460|20249881|P2|STARTED|Overall Study||360
8211218|NCT02124460|20249882|P1|STARTED|Overall Study||361
8211219|NCT02124304|20249914|P2|NOT COMPLETED|Overall Study||0
8211220|NCT02124304|20249915|P1|NOT COMPLETED|Overall Study||0
8211221|NCT02124304|20249914|P2|COMPLETED|Overall Study||15
8211222|NCT02124304|20249915|P1|COMPLETED|Overall Study||15
8211223|NCT02124304|20249914|P2|STARTED|Overall Study||15
8211224|NCT02124304|20249915|P1|STARTED|Overall Study||15
8211225|NCT02124265|20249923|P1|NOT COMPLETED|Overall Study||1
8211226|NCT02124265|20249923|P1|COMPLETED|Overall Study||2
8211227|NCT02124265|20249923|P1|STARTED|Overall Study||3
8211228|NCT02124161|20249929|P2|NOT COMPLETED|Overall Study||15
8211229|NCT02124161|20249930|P1|NOT COMPLETED|Overall Study||16
8211230|NCT02124161|20249929|P2|COMPLETED|Overall Study||426
8211231|NCT02124161|20249930|P1|COMPLETED|Overall Study||425
8211232|NCT02124161|20249929|P2|Vaccination 2|Overall Study||432
8211233|NCT02124161|20249930|P1|Vaccination 2|Overall Study||431
8211234|NCT02124161|20249929|P2|Vaccination 1|Overall Study||437
8211235|NCT02124161|20249930|P1|Vaccination 1|Overall Study||439
8211236|NCT02124161|20249929|P2|STARTED|Overall Study||441
8211237|NCT02124161|20249930|P1|STARTED|Overall Study||441
8211238|NCT02124122|20249962|P2|NOT COMPLETED|Overall Study||0
8211239|NCT02124122|20249963|P1|NOT COMPLETED|Overall Study||0
8211240|NCT02124122|20249962|P2|COMPLETED|Overall Study||19
8211241|NCT02124122|20249963|P1|COMPLETED|Overall Study||41
8211242|NCT02124122|20249962|P2|STARTED|Overall Study||19
8211243|NCT02124122|20249963|P1|STARTED|Overall Study||41
8211244|NCT02124083|20249971|P1|NOT COMPLETED|Overall Study||1
8211245|NCT02124083|20249971|P1|COMPLETED|Overall Study||11
8211246|NCT02124083|20249971|P1|STARTED|Overall Study||12
8211247|NCT02124044|20249982|P2|NOT COMPLETED|Overall Study||1
8211248|NCT02124044|20249983|P1|NOT COMPLETED|Overall Study||0
8211249|NCT02124044|20249982|P2|COMPLETED|Overall Study||9
8211250|NCT02124044|20249983|P1|COMPLETED|Overall Study||20
8211251|NCT02124044|20249982|P2|STARTED|Overall Study||10
8211252|NCT02124044|20249983|P1|STARTED|Overall Study||20
8211253|NCT02124018|20249992|P3|NOT COMPLETED|Overall Study||0
8211254|NCT02124018|20249993|P2|NOT COMPLETED|Overall Study||0
8211255|NCT02124018|20249994|P1|NOT COMPLETED|Overall Study||0
8211256|NCT02124018|20249992|P3|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
8211257|NCT02124018|20249993|P2|COMPLETED|Overall Study||111
8211258|NCT02124018|20249994|P1|COMPLETED|Overall Study||371
8211259|NCT02124018|20249992|P3|STARTED|Overall Study||41
8211260|NCT02124018|20249993|P2|STARTED|Overall Study||111
8211261|NCT02124018|20249994|P1|STARTED|Overall Study||371
8211262|NCT02123966|20250005|P1|NOT COMPLETED|Overall Study||1
8211263|NCT02123966|20250005|P1|COMPLETED|Overall Study||9
8211264|NCT02123966|20250005|P1|STARTED|Overall Study||10
8211265|NCT02123849|20250012|P2|NOT COMPLETED|Overall Study||9
8211266|NCT02123849|20250013|P1|NOT COMPLETED|Overall Study||4
8211267|NCT02123849|20250012|P2|COMPLETED|Overall Study||18
8211268|NCT02123849|20250013|P1|COMPLETED|Overall Study||23
8211269|NCT02123849|20250012|P2|STARTED|Overall Study||27
8211270|NCT02123849|20250013|P1|STARTED|Overall Study||27
8211271|NCT02123797|20250039|P5|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
8211272|NCT02123797|20250040|P4|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
8211273|NCT02123797|20250041|P3|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
8211274|NCT02123797|20250042|P2|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
8211275|NCT02123797|20250043|P1|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
8211276|NCT02123797|20250039|P5|COMPLETED|6-month Follow up (Cumulative Counts)||5
8211277|NCT02123797|20250040|P4|COMPLETED|6-month Follow up (Cumulative Counts)||31
8211278|NCT02123797|20250041|P3|COMPLETED|6-month Follow up (Cumulative Counts)||34
8211279|NCT02123797|20250042|P2|COMPLETED|6-month Follow up (Cumulative Counts)||178
8211280|NCT02123797|20250043|P1|COMPLETED|6-month Follow up (Cumulative Counts)||101
8211281|NCT02123797|20250039|P5|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
8211282|NCT02123797|20250040|P4|STARTED|6-month Follow up (Cumulative Counts)||144
8211283|NCT02123797|20250041|P3|STARTED|6-month Follow up (Cumulative Counts)||100
8211284|NCT02123797|20250042|P2|STARTED|6-month Follow up (Cumulative Counts)||306
8211285|NCT02123797|20250043|P1|STARTED|6-month Follow up (Cumulative Counts)||156
8211286|NCT02123797|20250039|P5|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
8211287|NCT02123797|20250040|P4|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
8211288|NCT02123797|20250041|P3|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
8211289|NCT02123797|20250042|P2|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
8211290|NCT02123797|20250043|P1|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
8211291|NCT02123797|20250039|P5|COMPLETED|3-month Follow up (Cumulative Counts)||8
8211292|NCT02123797|20250040|P4|COMPLETED|3-month Follow up (Cumulative Counts)||62
8211293|NCT02123797|20250041|P3|COMPLETED|3-month Follow up (Cumulative Counts)||50
8211294|NCT02123797|20250042|P2|COMPLETED|3-month Follow up (Cumulative Counts)||189
8211295|NCT02123797|20250043|P1|COMPLETED|3-month Follow up (Cumulative Counts)||99
8211296|NCT02123797|20250039|P5|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
8211297|NCT02123797|20250040|P4|STARTED|3-month Follow up (Cumulative Counts)||144
8211298|NCT02123797|20250041|P3|STARTED|3-month Follow up (Cumulative Counts)||100
8211299|NCT02123797|20250042|P2|STARTED|3-month Follow up (Cumulative Counts)||306
8211300|NCT02123797|20250043|P1|STARTED|3-month Follow up (Cumulative Counts)||156
8211301|NCT02123797|20250039|P5|NOT COMPLETED|Baseline Intervention||0
8211302|NCT02123797|20250040|P4|NOT COMPLETED|Baseline Intervention||0
8211303|NCT02123797|20250041|P3|NOT COMPLETED|Baseline Intervention||0
8211304|NCT02123797|20250042|P2|NOT COMPLETED|Baseline Intervention||42
8211305|NCT02123797|20250043|P1|NOT COMPLETED|Baseline Intervention||22
8211306|NCT02123797|20250039|P5|COMPLETED|Baseline Intervention||11
8211307|NCT02123797|20250040|P4|COMPLETED|Baseline Intervention||144
8211308|NCT02123797|20250041|P3|COMPLETED|Baseline Intervention||100
8211309|NCT02123797|20250042|P2|COMPLETED|Baseline Intervention||306
8211310|NCT02123797|20250043|P1|COMPLETED|Baseline Intervention||156
8211311|NCT02123797|20250039|P5|STARTED|Baseline Intervention||11
8211312|NCT02123797|20250040|P4|STARTED|Baseline Intervention||144
8211313|NCT02123797|20250041|P3|STARTED|Baseline Intervention||100
8211314|NCT02123797|20250042|P2|STARTED|Baseline Intervention||348
8211315|NCT02123797|20250043|P1|STARTED|Baseline Intervention||178
8211316|NCT02123745|20250142|P1|NOT COMPLETED|Overall Study||0
8211317|NCT02123745|20250142|P1|COMPLETED|Overall Study||71
8211318|NCT02123745|20250142|P1|STARTED|Overall Study||71
8211319|NCT02123576|20250152|P2|NOT COMPLETED|Overall Study||0
8211320|NCT02123576|20250153|P1|NOT COMPLETED|Overall Study||1
8211321|NCT02123576|20250152|P2|COMPLETED|Overall Study||6
8211322|NCT02123576|20250153|P1|COMPLETED|Overall Study||5
8211323|NCT02123576|20250152|P2|STARTED|Overall Study||6
8211324|NCT02123576|20250153|P1|STARTED|Overall Study||6
8211325|NCT02123511|20250171|P2|NOT COMPLETED|Overall Study||4
8211326|NCT02123511|20250172|P1|NOT COMPLETED|Overall Study||2
8211327|NCT02123511|20250171|P2|COMPLETED|Overall Study||12
8211328|NCT02123511|20250172|P1|COMPLETED|Overall Study||16
8211329|NCT02123511|20250171|P2|Eligible Patients|Overall Study||15
8211330|NCT02123511|20250172|P1|Eligible Patients|Overall Study||17
8211331|NCT02123511|20250171|P2|STARTED|Overall Study||16
8211332|NCT02123511|20250172|P1|STARTED|Overall Study||18
8211333|NCT02123472|20250196|P2|NOT COMPLETED|Period 2 (7 Days)||1
8211334|NCT02123472|20250197|P1|NOT COMPLETED|Period 2 (7 Days)||0
8211335|NCT02123472|20250196|P2|COMPLETED|Period 2 (7 Days)||13
8211336|NCT02123472|20250197|P1|COMPLETED|Period 2 (7 Days)||14
8211337|NCT02123472|20250196|P2|STARTED|Period 2 (7 Days)||14
8211338|NCT02123472|20250197|P1|STARTED|Period 2 (7 Days)||14
8211339|NCT02123472|20250196|P2|NOT COMPLETED|Washout Period (1 Day)||0
8211340|NCT02123472|20250197|P1|NOT COMPLETED|Washout Period (1 Day)||0
8211341|NCT02123472|20250196|P2|COMPLETED|Washout Period (1 Day)||14
8211342|NCT02123472|20250197|P1|COMPLETED|Washout Period (1 Day)||14
8211343|NCT02123472|20250196|P2|STARTED|Washout Period (1 Day)||14
8211344|NCT02123472|20250197|P1|STARTED|Washout Period (1 Day)||14
8211345|NCT02123472|20250196|P2|NOT COMPLETED|Period 1 (7 Days)||0
8211346|NCT02123472|20250197|P1|NOT COMPLETED|Period 1 (7 Days)||0
8211347|NCT02123472|20250196|P2|COMPLETED|Period 1 (7 Days)||14
8211348|NCT02123472|20250197|P1|COMPLETED|Period 1 (7 Days)||14
8211349|NCT02123472|20250196|P2|STARTED|Period 1 (7 Days)||14
8211350|NCT02123472|20250197|P1|STARTED|Period 1 (7 Days)||14
8211351|NCT02123459|20250207|P2|NOT COMPLETED|Period 2 (7 Days)||0
8211352|NCT02123459|20250208|P1|NOT COMPLETED|Period 2 (7 Days)||0
8211353|NCT02123459|20250207|P2|COMPLETED|Period 2 (7 Days)||14
8211354|NCT02123459|20250208|P1|COMPLETED|Period 2 (7 Days)||13
8211355|NCT02123459|20250207|P2|STARTED|Period 2 (7 Days)||14
8211356|NCT02123459|20250208|P1|STARTED|Period 2 (7 Days)||13
8211357|NCT02123459|20250207|P2|NOT COMPLETED|Washout Period (1 Day)||0
8211358|NCT02123459|20250208|P1|NOT COMPLETED|Washout Period (1 Day)||1
8211359|NCT02123459|20250207|P2|COMPLETED|Washout Period (1 Day)||14
8211360|NCT02123459|20250208|P1|COMPLETED|Washout Period (1 Day)||13
8211361|NCT02123459|20250207|P2|STARTED|Washout Period (1 Day)||14
8211362|NCT02123459|20250208|P1|STARTED|Washout Period (1 Day)||14
8211363|NCT02123459|20250207|P2|NOT COMPLETED|Period 1 (7 Days)||0
8211364|NCT02123459|20250208|P1|NOT COMPLETED|Period 1 (7 Days)||0
8211365|NCT02123459|20250207|P2|COMPLETED|Period 1 (7 Days)||14
8211366|NCT02123459|20250208|P1|COMPLETED|Period 1 (7 Days)||14
8211367|NCT02123459|20250207|P2|STARTED|Period 1 (7 Days)||14
8211368|NCT02123459|20250208|P1|STARTED|Period 1 (7 Days)||14
8211369|NCT02123446|20250218|P2|NOT COMPLETED|Period 2 (7 Days)||0
8211370|NCT02123446|20250219|P1|NOT COMPLETED|Period 2 (7 Days)||0
8211371|NCT02123446|20250218|P2|COMPLETED|Period 2 (7 Days)||14
8211372|NCT02123446|20250219|P1|COMPLETED|Period 2 (7 Days)||13
8211373|NCT02123446|20250218|P2|STARTED|Period 2 (7 Days)||14
8211374|NCT02123446|20250219|P1|STARTED|Period 2 (7 Days)||13
8211375|NCT02123446|20250218|P2|NOT COMPLETED|Washout Period (1 Day)||0
8211376|NCT02123446|20250219|P1|NOT COMPLETED|Washout Period (1 Day)||1
8211377|NCT02123446|20250218|P2|COMPLETED|Washout Period (1 Day)||14
8211378|NCT02123446|20250219|P1|COMPLETED|Washout Period (1 Day)||13
8211379|NCT02123446|20250218|P2|STARTED|Washout Period (1 Day)||14
8211380|NCT02123446|20250219|P1|STARTED|Washout Period (1 Day)||14
8211381|NCT02123446|20250218|P2|NOT COMPLETED|Period 1 (7 Days)||0
8211382|NCT02123446|20250219|P1|NOT COMPLETED|Period 1 (7 Days)||0
8211383|NCT02123446|20250218|P2|COMPLETED|Period 1 (7 Days)||14
8211384|NCT02123446|20250219|P1|COMPLETED|Period 1 (7 Days)||14
8211385|NCT02123446|20250218|P2|STARTED|Period 1 (7 Days)||14
8211386|NCT02123446|20250219|P1|STARTED|Period 1 (7 Days)||14
8211387|NCT02123329|20250231|P2|NOT COMPLETED|12 Month Outcome Measure||79
8211388|NCT02123329|20250232|P1|NOT COMPLETED|12 Month Outcome Measure||64
8211389|NCT02123329|20250231|P2|COMPLETED|12 Month Outcome Measure||88
8211390|NCT02123329|20250232|P1|COMPLETED|12 Month Outcome Measure||83
8211391|NCT02123329|20250231|P2|STARTED|12 Month Outcome Measure||167
8211392|NCT02123329|20250232|P1|STARTED|12 Month Outcome Measure||147
8211393|NCT02123329|20250231|P2|NOT COMPLETED|6 Month Outcome Measure||67
8211394|NCT02123329|20250232|P1|NOT COMPLETED|6 Month Outcome Measure||48
8211395|NCT02123329|20250231|P2|COMPLETED|6 Month Outcome Measure||100
8211396|NCT02123329|20250232|P1|COMPLETED|6 Month Outcome Measure||99
8211397|NCT02123329|20250231|P2|STARTED|6 Month Outcome Measure||167
8211398|NCT02123329|20250232|P1|STARTED|6 Month Outcome Measure||147
8211399|NCT02123329|20250231|P2|NOT COMPLETED|3 Month Outcome Measure||66
8211400|NCT02123329|20250232|P1|NOT COMPLETED|3 Month Outcome Measure||49
8211401|NCT02123329|20250231|P2|COMPLETED|3 Month Outcome Measure||101
8211402|NCT02123329|20250232|P1|COMPLETED|3 Month Outcome Measure||98
8211403|NCT02123329|20250231|P2|STARTED|3 Month Outcome Measure||167
8211404|NCT02123329|20250232|P1|STARTED|3 Month Outcome Measure||147
8211405|NCT02123251|20250260|P2|NOT COMPLETED|Overall Study||30
8211406|NCT02123251|20250261|P1|NOT COMPLETED|Overall Study||34
8211407|NCT02123251|20250260|P2|COMPLETED|Overall Study||131
8211408|NCT02123251|20250261|P1|COMPLETED|Overall Study||125
8211409|NCT02123251|20250260|P2|STARTED|Overall Study||161
8211410|NCT02123251|20250261|P1|STARTED|Overall Study||159
8211411|NCT02123134|20250287|P2|NOT COMPLETED|Overall Study||3
8211412|NCT02123134|20250288|P1|NOT COMPLETED|Overall Study||3
8211413|NCT02123134|20250287|P2|COMPLETED|Overall Study||24
8211414|NCT02123134|20250288|P1|COMPLETED|Overall Study||25
8211415|NCT02123134|20250287|P2|STARTED|Overall Study||27
8211416|NCT02123134|20250288|P1|STARTED|Overall Study||28
8211417|NCT02123017|20250309|P3|NOT COMPLETED|Overall Study||0
8211418|NCT02123017|20250310|P2|NOT COMPLETED|Overall Study||0
8211419|NCT02123017|20250311|P1|NOT COMPLETED|Overall Study||0
8211420|NCT02123017|20250309|P3|COMPLETED|Overall Study||12
8211421|NCT02123017|20250310|P2|COMPLETED|Overall Study||12
8211422|NCT02123017|20250311|P1|COMPLETED|Overall Study||8
8211423|NCT02123017|20250309|P3|STARTED|Overall Study||12
8211424|NCT02123017|20250310|P2|STARTED|Overall Study||12
8211425|NCT02123017|20250311|P1|STARTED|Overall Study||8
8211426|NCT02122952|20250330|P2|NOT COMPLETED|Overall Study||0
8211427|NCT02122952|20250331|P1|NOT COMPLETED|Overall Study||0
8211428|NCT02122952|20250330|P2|COMPLETED|Overall Study||12
8211429|NCT02122952|20250331|P1|COMPLETED|Overall Study||3
8211430|NCT02122952|20250330|P2|STARTED|Overall Study||12
8211431|NCT02122952|20250331|P1|STARTED|Overall Study||3
8211432|NCT02122887|20250345|P2|NOT COMPLETED|Overall Study||2
8211433|NCT02122887|20250346|P1|NOT COMPLETED|Overall Study||20
8211434|NCT02122887|20250345|P2|COMPLETED|Overall Study||39
8211435|NCT02122887|20250346|P1|COMPLETED|Overall Study||40
8211436|NCT02122887|20250345|P2|STARTED|Overall Study||41
8211437|NCT02122887|20250346|P1|STARTED|Overall Study||60
8211438|NCT02122796|20250368|P2|NOT COMPLETED|Visit 2||1
8211439|NCT02122796|20250369|P1|NOT COMPLETED|Visit 2||3
8211440|NCT02122796|20250368|P2|COMPLETED|Visit 2||14
8211441|NCT02122796|20250369|P1|COMPLETED|Visit 2||12
8211442|NCT02122796|20250368|P2|STARTED|Visit 2||15
8211443|NCT02122796|20250369|P1|STARTED|Visit 2||15
8211444|NCT02122796|20250368|P2|NOT COMPLETED|Visit 1||0
8211445|NCT02122796|20250369|P1|NOT COMPLETED|Visit 1||0
8211446|NCT02122796|20250368|P2|COMPLETED|Visit 1||15
8211447|NCT02122796|20250369|P1|COMPLETED|Visit 1||15
8211448|NCT02122796|20250368|P2|STARTED|Visit 1||15
8211449|NCT02122796|20250369|P1|STARTED|Visit 1||15
8211450|NCT02122783|20250384|P2|NOT COMPLETED|Overall Study||1
8211451|NCT02122783|20250385|P1|NOT COMPLETED|Overall Study||0
8211452|NCT02122783|20250384|P2|COMPLETED|Overall Study||2
8211453|NCT02122783|20250385|P1|COMPLETED|Overall Study||2
8211454|NCT02122783|20250384|P2|STARTED|Overall Study||3
8211455|NCT02122783|20250385|P1|STARTED|Overall Study||2
8211456|NCT02122770|20250399|P6|NOT COMPLETED|Part B: Standard of Care||13
8211457|NCT02122770|20250400|P5|NOT COMPLETED|Part B: Standard of Care||23
8211458|NCT02122770|20250401|P4|NOT COMPLETED|Part B: Standard of Care||0
8211459|NCT02122770|20250402|P3|NOT COMPLETED|Part B: Standard of Care||0
8211460|NCT02122770|20250403|P2|NOT COMPLETED|Part B: Standard of Care||0
8211461|NCT02122770|20250404|P1|NOT COMPLETED|Part B: Standard of Care||0
8211462|NCT02122770|20250399|P6|COMPLETED|Part B: Standard of Care||0
8211463|NCT02122770|20250400|P5|COMPLETED|Part B: Standard of Care||0
8211464|NCT02122770|20250401|P4|COMPLETED|Part B: Standard of Care||0
8211465|NCT02122770|20250402|P3|COMPLETED|Part B: Standard of Care||0
8211466|NCT02122770|20250403|P2|COMPLETED|Part B: Standard of Care||0
8211467|NCT02122770|20250404|P1|COMPLETED|Part B: Standard of Care||0
8211468|NCT02122770|20250399|P6|STARTED|Part B: Standard of Care||13
8211469|NCT02122770|20250400|P5|STARTED|Part B: Standard of Care||23
8211470|NCT02122770|20250401|P4|STARTED|Part B: Standard of Care||0
8211471|NCT02122770|20250402|P3|STARTED|Part B: Standard of Care||0
8211472|NCT02122770|20250403|P2|STARTED|Part B: Standard of Care||0
8211473|NCT02122770|20250404|P1|STARTED|Part B: Standard of Care||0
8211474|NCT02122770|20250399|P6|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
8211475|NCT02122770|20250400|P5|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
8211476|NCT02122770|20250401|P4|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
8211477|NCT02122770|20250402|P3|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
8211478|NCT02122770|20250403|P2|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
8211479|NCT02122770|20250404|P1|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
8211480|NCT02122770|20250399|P6|COMPLETED|Part A: Drug-drug Interaction 2||0
8211481|NCT02122770|20250400|P5|COMPLETED|Part A: Drug-drug Interaction 2||0
8211482|NCT02122770|20250401|P4|COMPLETED|Part A: Drug-drug Interaction 2||16
8211483|NCT02122770|20250402|P3|COMPLETED|Part A: Drug-drug Interaction 2||4
8211484|NCT02122770|20250403|P2|COMPLETED|Part A: Drug-drug Interaction 2||7
8211485|NCT02122770|20250404|P1|COMPLETED|Part A: Drug-drug Interaction 2||9
8211486|NCT02122770|20250399|P6|STARTED|Part A: Drug-drug Interaction 2||0
8211487|NCT02122770|20250400|P5|STARTED|Part A: Drug-drug Interaction 2||0
8211488|NCT02122770|20250401|P4|STARTED|Part A: Drug-drug Interaction 2||19
8211489|NCT02122770|20250402|P3|STARTED|Part A: Drug-drug Interaction 2||6
8211490|NCT02122770|20250403|P2|STARTED|Part A: Drug-drug Interaction 2||13
8211491|NCT02122770|20250404|P1|STARTED|Part A: Drug-drug Interaction 2||13
8211492|NCT02122549|20250484|P1|NOT COMPLETED|Overall Study||0
8211493|NCT02122549|20250484|P1|COMPLETED|Overall Study||59
8211494|NCT02122549|20250484|P1|STARTED|Overall Study||59
8211495|NCT02122471|20250491|P3|NOT COMPLETED|Overall Study||44
8211496|NCT02122471|20250492|P2|NOT COMPLETED|Overall Study||51
8211497|NCT02122471|20250493|P1|NOT COMPLETED|Overall Study||39
8211498|NCT02122471|20250491|P3|COMPLETED|Overall Study||405
8211499|NCT02122471|20250492|P2|COMPLETED|Overall Study||392
8211500|NCT02122471|20250493|P1|COMPLETED|Overall Study||406
8211501|NCT02122471|20250491|P3|STARTED|Overall Study||449
8211502|NCT02122471|20250492|P2|STARTED|Overall Study||443
8211503|NCT02122471|20250493|P1|STARTED|Overall Study||445
8211504|NCT02122445|20250513|P1|NOT COMPLETED|Overall Study||0
8211505|NCT02122445|20250513|P1|COMPLETED|Overall Study||20
8211506|NCT02122445|20250513|P1|STARTED|Overall Study||20
8211507|NCT02122406|20250518|P1|NOT COMPLETED|Overall Study||0
8211508|NCT02122406|20250518|P1|COMPLETED|Overall Study||200
8211509|NCT02122406|20250518|P1|STARTED|Overall Study||200
8211510|NCT02122380|20250524|P2|NOT COMPLETED|Second Intervention (30 Days)||2
8211511|NCT02122380|20250525|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8211512|NCT02122380|20250524|P2|COMPLETED|Second Intervention (30 Days)||7
8211513|NCT02122380|20250525|P1|COMPLETED|Second Intervention (30 Days)||9
8211514|NCT02122380|20250524|P2|STARTED|Second Intervention (30 Days)||9
8211515|NCT02122380|20250525|P1|STARTED|Second Intervention (30 Days)||9
8211516|NCT02122380|20250524|P2|NOT COMPLETED|Washout (8 Weeks)||2
8211517|NCT02122380|20250525|P1|NOT COMPLETED|Washout (8 Weeks)||1
8211518|NCT02122380|20250524|P2|COMPLETED|Washout (8 Weeks)||9
8211519|NCT02122380|20250525|P1|COMPLETED|Washout (8 Weeks)||9
8211520|NCT02122380|20250524|P2|STARTED|Washout (8 Weeks)||11
8211521|NCT02122380|20250525|P1|STARTED|Washout (8 Weeks)||10
8211522|NCT02122380|20250524|P2|NOT COMPLETED|First Intervention (30 Days)||1
8211523|NCT02122380|20250525|P1|NOT COMPLETED|First Intervention (30 Days)||1
8211524|NCT02122380|20250524|P2|COMPLETED|First Intervention (30 Days)||11
8211525|NCT02122380|20250525|P1|COMPLETED|First Intervention (30 Days)||10
8211526|NCT02122380|20250524|P2|STARTED|First Intervention (30 Days)||12
8211527|NCT02122380|20250525|P1|STARTED|First Intervention (30 Days)||11
8211528|NCT02122341|20250541|P2|NOT COMPLETED|Overall Study||0
8211529|NCT02122341|20250542|P1|NOT COMPLETED|Overall Study||0
8211530|NCT02122341|20250541|P2|COMPLETED|Overall Study||18
8211531|NCT02122341|20250542|P1|COMPLETED|Overall Study||17
8211532|NCT02122341|20250541|P2|STARTED|Overall Study||18
8211533|NCT02122341|20250542|P1|STARTED|Overall Study||17
8211534|NCT02122146|20250564|P8|NOT COMPLETED|Part 3: Expansion||0
8211535|NCT02122146|20250565|P7|NOT COMPLETED|Part 3: Expansion||0
8211536|NCT02122146|20250566|P6|NOT COMPLETED|Part 3: Expansion||0
8211537|NCT02122146|20250567|P5|NOT COMPLETED|Part 3: Expansion||0
8211538|NCT02122146|20250568|P4|NOT COMPLETED|Part 3: Expansion||0
8211539|NCT02122146|20250569|P3|NOT COMPLETED|Part 3: Expansion||0
8211540|NCT02122146|20250570|P2|NOT COMPLETED|Part 3: Expansion||0
8211541|NCT02122146|20250571|P1|NOT COMPLETED|Part 3: Expansion||0
8211542|NCT02122146|20250564|P8|COMPLETED|Part 3: Expansion||0
8211543|NCT02122146|20250565|P7|COMPLETED|Part 3: Expansion||0
8211544|NCT02122146|20250566|P6|COMPLETED|Part 3: Expansion||0
8211545|NCT02122146|20250567|P5|COMPLETED|Part 3: Expansion||0
8211546|NCT02122146|20250568|P4|COMPLETED|Part 3: Expansion||0
8211547|NCT02122146|20250569|P3|COMPLETED|Part 3: Expansion||0
8211548|NCT02122146|20250570|P2|COMPLETED|Part 3: Expansion||0
8211549|NCT02122146|20250571|P1|COMPLETED|Part 3: Expansion||0
8211550|NCT02122146|20250564|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211551|NCT02122146|20250565|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211552|NCT02122146|20250566|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211553|NCT02122146|20250567|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211554|NCT02122146|20250568|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211555|NCT02122146|20250569|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211556|NCT02122146|20250570|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211557|NCT02122146|20250571|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211558|NCT02122146|20250564|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211559|NCT02122146|20250565|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211560|NCT02122146|20250566|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211561|NCT02122146|20250567|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211562|NCT02122146|20250568|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211563|NCT02122146|20250569|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211564|NCT02122146|20250570|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211565|NCT02122146|20250571|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211566|NCT02122146|20250564|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211567|NCT02122146|20250565|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211568|NCT02122146|20250566|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211569|NCT02122146|20250567|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211570|NCT02122146|20250568|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211571|NCT02122146|20250569|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211572|NCT02122146|20250570|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211573|NCT02122146|20250571|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211574|NCT02122146|20250564|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211575|NCT02122146|20250565|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211576|NCT02122146|20250566|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211577|NCT02122146|20250567|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211578|NCT02122146|20250568|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211579|NCT02122146|20250569|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211580|NCT02122146|20250570|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211581|NCT02122146|20250571|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211582|NCT02122146|20250564|P8|NOT COMPLETED|Part 1: Dose Escalation||2
8211583|NCT02122146|20250565|P7|NOT COMPLETED|Part 1: Dose Escalation||1
8211584|NCT02122146|20250566|P6|NOT COMPLETED|Part 1: Dose Escalation||1
8211585|NCT02122146|20250567|P5|NOT COMPLETED|Part 1: Dose Escalation||1
8211586|NCT02122146|20250568|P4|NOT COMPLETED|Part 1: Dose Escalation||1
8211587|NCT02122146|20250569|P3|NOT COMPLETED|Part 1: Dose Escalation||2
8211588|NCT02122146|20250570|P2|NOT COMPLETED|Part 1: Dose Escalation||1
8211589|NCT02122146|20250571|P1|NOT COMPLETED|Part 1: Dose Escalation||1
8211590|NCT02122146|20250564|P8|COMPLETED|Part 1: Dose Escalation||6
8211591|NCT02122146|20250565|P7|COMPLETED|Part 1: Dose Escalation||0
8211592|NCT02122146|20250566|P6|COMPLETED|Part 1: Dose Escalation||5
8211593|NCT02122146|20250567|P5|COMPLETED|Part 1: Dose Escalation||3
8211594|NCT02122146|20250568|P4|COMPLETED|Part 1: Dose Escalation||3
8211595|NCT02122146|20250569|P3|COMPLETED|Part 1: Dose Escalation||2
8211596|NCT02122146|20250570|P2|COMPLETED|Part 1: Dose Escalation||1
8211597|NCT02122146|20250571|P1|COMPLETED|Part 1: Dose Escalation||1
8211598|NCT02122146|20250564|P8|STARTED|Part 1: Dose Escalation||8
8211599|NCT02122146|20250565|P7|STARTED|Part 1: Dose Escalation||1
8211600|NCT02122146|20250566|P6|STARTED|Part 1: Dose Escalation||6
8211601|NCT02122146|20250567|P5|STARTED|Part 1: Dose Escalation||4
8211602|NCT02122146|20250568|P4|STARTED|Part 1: Dose Escalation||4
8211603|NCT02122146|20250569|P3|STARTED|Part 1: Dose Escalation||4
8211604|NCT02122146|20250570|P2|STARTED|Part 1: Dose Escalation||2
8211605|NCT02122146|20250571|P1|STARTED|Part 1: Dose Escalation||2
8211606|NCT02121912|20250808|P2|NOT COMPLETED|Overall Study||0
8211607|NCT02121912|20250809|P1|NOT COMPLETED|Overall Study||4
8211608|NCT02121912|20250808|P2|COMPLETED|Overall Study||25
8211609|NCT02121912|20250809|P1|COMPLETED|Overall Study||21
8211610|NCT02121912|20250808|P2|STARTED|Overall Study||25
8211611|NCT02121912|20250809|P1|STARTED|Overall Study||25
8211612|NCT02121860|20250823|P4|NOT COMPLETED|Overall Study||0
8211613|NCT02121860|20250824|P3|NOT COMPLETED|Overall Study||0
8211614|NCT02121860|20250825|P2|NOT COMPLETED|Overall Study||0
8211615|NCT02121860|20250826|P1|NOT COMPLETED|Overall Study||0
8211616|NCT02121860|20250823|P4|COMPLETED|Overall Study||8
8211617|NCT02121860|20250824|P3|COMPLETED|Overall Study||8
8211618|NCT02121860|20250825|P2|COMPLETED|Overall Study||12
8211619|NCT02121860|20250826|P1|COMPLETED|Overall Study||8
8211620|NCT02121860|20250823|P4|STARTED|Overall Study||8
8211621|NCT02121860|20250824|P3|STARTED|Overall Study||8
8211622|NCT02121860|20250825|P2|STARTED|Overall Study||12
8211623|NCT02121860|20250826|P1|STARTED|Overall Study||8
8211624|NCT02121847|20250845|P1|NOT COMPLETED|Overall Study||3
8211625|NCT02121847|20250845|P1|COMPLETED|Overall Study||37
8211626|NCT02121847|20250845|P1|STARTED|Overall Study||40
8211627|NCT02121834|20250871|P7|NOT COMPLETED|Overall Study||0
8211628|NCT02121834|20250872|P6|NOT COMPLETED|Overall Study||0
8211629|NCT02121834|20250873|P5|NOT COMPLETED|Overall Study||0
8211630|NCT02121834|20250874|P4|NOT COMPLETED|Overall Study||0
8211631|NCT02121834|20250875|P3|NOT COMPLETED|Overall Study||2
8211632|NCT02121834|20250876|P2|NOT COMPLETED|Overall Study||2
8211633|NCT02121834|20250877|P1|NOT COMPLETED|Overall Study||0
8211634|NCT02121834|20250871|P7|COMPLETED|Overall Study||3
8211635|NCT02121834|20250872|P6|COMPLETED|Overall Study||9
8211636|NCT02121834|20250873|P5|COMPLETED|Overall Study||9
8211637|NCT02121834|20250874|P4|COMPLETED|Overall Study||10
8211638|NCT02121834|20250875|P3|COMPLETED|Overall Study||7
8211639|NCT02121834|20250876|P2|COMPLETED|Overall Study||9
8211640|NCT02121834|20250877|P1|COMPLETED|Overall Study||12
8211641|NCT02121834|20250871|P7|Received at Least One Dose of Study Drug|Overall Study||3
8211642|NCT02121834|20250872|P6|Received at Least One Dose of Study Drug|Overall Study||9
8211643|NCT02121834|20250873|P5|Received at Least One Dose of Study Drug|Overall Study||9
8211644|NCT02121834|20250874|P4|Received at Least One Dose of Study Drug|Overall Study||10
8211645|NCT02121834|20250875|P3|Received at Least One Dose of Study Drug|Overall Study||9
8211646|NCT02121834|20250876|P2|Received at Least One Dose of Study Drug|Overall Study||11
8211647|NCT02121834|20250877|P1|Received at Least One Dose of Study Drug|Overall Study||12
8211648|NCT02121834|20250871|P7|STARTED|Overall Study||3
8211649|NCT02121834|20250872|P6|STARTED|Overall Study||9
8211650|NCT02121834|20250873|P5|STARTED|Overall Study||9
8211651|NCT02121834|20250874|P4|STARTED|Overall Study||10
8211652|NCT02121834|20250875|P3|STARTED|Overall Study||9
8211653|NCT02121834|20250876|P2|STARTED|Overall Study||11
8211654|NCT02121834|20250877|P1|STARTED|Overall Study||12
8211655|NCT02121808|20250903|P1|NOT COMPLETED|Overall Study||3
8211656|NCT02121808|20250903|P1|COMPLETED|Overall Study||17
8211657|NCT02121808|20250903|P1|STARTED|Overall Study||20
8211658|NCT02121795|20250914|P2|NOT COMPLETED|Open-Label Phase||10
8211659|NCT02121795|20250915|P1|NOT COMPLETED|Open-Label Phase||12
8211660|NCT02121795|20250914|P2|COMPLETED|Open-Label Phase||21
8211661|NCT02121795|20250915|P1|COMPLETED|Open-Label Phase||21
8211662|NCT02121795|20250914|P2|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
8211663|NCT02121795|20250915|P1|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
8211664|NCT02121795|20250914|P2|NOT COMPLETED|Double-Blind Phase||34
8211665|NCT02121795|20250915|P1|NOT COMPLETED|Double-Blind Phase||38
8211666|NCT02121795|20250914|P2|COMPLETED|Double-Blind Phase||300
8211667|NCT02121795|20250915|P1|COMPLETED|Double-Blind Phase||296
8211668|NCT02121795|20250914|P2|Safety Analysis Set|Double-Blind Phase||330
8211669|NCT02121795|20250915|P1|Safety Analysis Set|Double-Blind Phase||333
8211670|NCT02121795|20250914|P2|STARTED|Double-Blind Phase||334
8211671|NCT02121795|20250915|P1|STARTED|Double-Blind Phase||334
8211672|NCT02121756|20250943|P2|NOT COMPLETED|Overall Study||2
8211673|NCT02121756|20250944|P1|NOT COMPLETED|Overall Study||6
8211674|NCT02121756|20250943|P2|COMPLETED|Overall Study||17
8211675|NCT02121756|20250944|P1|COMPLETED|Overall Study||15
8211676|NCT02121756|20250943|P2|STARTED|Overall Study||19
8211677|NCT02121756|20250944|P1|STARTED|Overall Study||21
8211678|NCT02121535|20250981|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
8211679|NCT02121535|20250982|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
8211680|NCT02121535|20250981|P2|COMPLETED|Period 4 (8 Trial Days)||35
8211681|NCT02121535|20250982|P1|COMPLETED|Period 4 (8 Trial Days)||35
8211682|NCT02121535|20250981|P2|STARTED|Period 4 (8 Trial Days)||35
8211683|NCT02121535|20250982|P1|STARTED|Period 4 (8 Trial Days)||35
8211684|NCT02121535|20250981|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
8211685|NCT02121535|20250982|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
8211686|NCT02121535|20250981|P2|COMPLETED|Period 3 (8 Trial Days)||35
8211687|NCT02121535|20250982|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
8211688|NCT02121535|20250981|P2|STARTED|Period 3 (8 Trial Days)||35
8211689|NCT02121535|20250982|P1|STARTED|Period 3 (8 Trial Days)||36
8211690|NCT02121535|20250981|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
8211691|NCT02121535|20250982|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
8211692|NCT02121535|20250981|P2|COMPLETED|Period 2 (8 Trial Days)||35
8211693|NCT02121535|20250982|P1|COMPLETED|Period 2 (8 Trial Days)||36
8211694|NCT02121535|20250981|P2|STARTED|Period 2 (8 Trial Days)||35
8211695|NCT02121535|20250982|P1|STARTED|Period 2 (8 Trial Days)||36
8211696|NCT02121535|20250981|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
8211697|NCT02121535|20250982|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
8211698|NCT02121535|20250981|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
8211699|NCT02121535|20250982|P1|COMPLETED|Period 1 (8 Trial Days)||36
8211700|NCT02121535|20250981|P2|STARTED|Period 1 (8 Trial Days)||36
8211701|NCT02121535|20250982|P1|STARTED|Period 1 (8 Trial Days)||36
8211702|NCT02121522|20251005|P1|NOT COMPLETED|Overall Study||1
8211703|NCT02121522|20251005|P1|COMPLETED|Overall Study||13
8211704|NCT02121522|20251005|P1|STARTED|Overall Study||14
8211705|NCT02121509|20251012|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211706|NCT02121509|20251013|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211707|NCT02121509|20251014|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211708|NCT02121509|20251015|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211709|NCT02121509|20251012|P4|COMPLETED|Treatment Period-2 (4 Days)||8
8211710|NCT02121509|20251013|P3|COMPLETED|Treatment Period-2 (4 Days)||8
8211711|NCT02121509|20251014|P2|COMPLETED|Treatment Period-2 (4 Days)||24
8211712|NCT02121509|20251015|P1|COMPLETED|Treatment Period-2 (4 Days)||28
8211713|NCT02121509|20251012|P4|STARTED|Treatment Period-2 (4 Days)||8
8211714|NCT02121509|20251013|P3|STARTED|Treatment Period-2 (4 Days)||8
8211715|NCT02121509|20251014|P2|STARTED|Treatment Period-2 (4 Days)||24
8211716|NCT02121509|20251015|P1|STARTED|Treatment Period-2 (4 Days)||28
8211717|NCT02121509|20251012|P4|NOT COMPLETED|Washout Period (35 Days)||0
8211718|NCT02121509|20251013|P3|NOT COMPLETED|Washout Period (35 Days)||0
8211719|NCT02121509|20251014|P2|NOT COMPLETED|Washout Period (35 Days)||4
8211720|NCT02121509|20251015|P1|NOT COMPLETED|Washout Period (35 Days)||2
8211721|NCT02121509|20251012|P4|COMPLETED|Washout Period (35 Days)||8
8211722|NCT02121509|20251013|P3|COMPLETED|Washout Period (35 Days)||8
8211723|NCT02121509|20251014|P2|COMPLETED|Washout Period (35 Days)||24
8211724|NCT02121509|20251015|P1|COMPLETED|Washout Period (35 Days)||28
8211725|NCT02121509|20251012|P4|STARTED|Washout Period (35 Days)||8
8211726|NCT02121509|20251013|P3|STARTED|Washout Period (35 Days)||8
8211727|NCT02121509|20251014|P2|STARTED|Washout Period (35 Days)||28
8211728|NCT02121509|20251015|P1|STARTED|Washout Period (35 Days)||30
8211729|NCT02121509|20251012|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211730|NCT02121509|20251013|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211731|NCT02121509|20251014|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211732|NCT02121509|20251015|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211733|NCT02121509|20251012|P4|COMPLETED|Treatment Period-1 (4 Days)||8
8211734|NCT02121509|20251013|P3|COMPLETED|Treatment Period-1 (4 Days)||8
8211735|NCT02121509|20251014|P2|COMPLETED|Treatment Period-1 (4 Days)||28
8211736|NCT02121509|20251015|P1|COMPLETED|Treatment Period-1 (4 Days)||30
8211737|NCT02121509|20251012|P4|STARTED|Treatment Period-1 (4 Days)||8
8211738|NCT02121509|20251013|P3|STARTED|Treatment Period-1 (4 Days)||8
8211739|NCT02121509|20251014|P2|STARTED|Treatment Period-1 (4 Days)||28
8211740|NCT02121509|20251015|P1|STARTED|Treatment Period-1 (4 Days)||30
8211741|NCT02121483|20251048|P3|NOT COMPLETED|Overall Study||0
8211742|NCT02121483|20251049|P2|NOT COMPLETED|Overall Study||0
8211743|NCT02121483|20251050|P1|NOT COMPLETED|Overall Study||0
8211744|NCT02121483|20251048|P3|COMPLETED|Overall Study||10
8211745|NCT02121483|20251049|P2|COMPLETED|Overall Study||8
8211746|NCT02121483|20251050|P1|COMPLETED|Overall Study||9
8211747|NCT02121483|20251048|P3|STARTED|Overall Study||10
8211748|NCT02121483|20251049|P2|STARTED|Overall Study||8
8211749|NCT02121483|20251050|P1|STARTED|Overall Study||9
8211750|NCT02121418|20251079|P1|NOT COMPLETED|Overall Study||0
8211751|NCT02121418|20251079|P1|COMPLETED|Overall Study||12
8211752|NCT02121418|20251079|P1|STARTED|Overall Study||12
8211753|NCT02121392|20251086|P2|NOT COMPLETED|After Placement of AC Block vs Sham||3
8211754|NCT02121392|20251087|P1|NOT COMPLETED|After Placement of AC Block vs Sham||3
8211755|NCT02121392|20251086|P2|COMPLETED|After Placement of AC Block vs Sham||38
8211756|NCT02121392|20251087|P1|COMPLETED|After Placement of AC Block vs Sham||32
8211757|NCT02121392|20251086|P2|STARTED|After Placement of AC Block vs Sham||41
8211758|NCT02121392|20251087|P1|STARTED|After Placement of AC Block vs Sham||35
8211759|NCT02121392|20251086|P2|NOT COMPLETED|Prior to Intervention||41
8211760|NCT02121392|20251087|P1|NOT COMPLETED|Prior to Intervention||48
8211761|NCT02121392|20251086|P2|COMPLETED|Prior to Intervention||41
8211762|NCT02121392|20251087|P1|COMPLETED|Prior to Intervention||35
8211763|NCT02121392|20251086|P2|STARTED|Prior to Intervention||82
8211764|NCT02121392|20251087|P1|STARTED|Prior to Intervention||83
8211765|NCT02121301|20251112|P3|NOT COMPLETED|Overall Study||1
8211766|NCT02121301|20251113|P2|NOT COMPLETED|Overall Study||4
8211767|NCT02121301|20251114|P1|NOT COMPLETED|Overall Study||1
8211768|NCT02121301|20251112|P3|COMPLETED|Overall Study||30
8211769|NCT02121301|20251113|P2|COMPLETED|Overall Study||26
8211770|NCT02121301|20251114|P1|COMPLETED|Overall Study||29
8211771|NCT02121301|20251112|P3|STARTED|Overall Study||31
8211772|NCT02121301|20251113|P2|STARTED|Overall Study||30
8211773|NCT02121301|20251114|P1|STARTED|Overall Study||30
8211774|NCT02121262|20251127|P2|NOT COMPLETED|Overall Study||10
8211775|NCT02121262|20251128|P1|NOT COMPLETED|Overall Study||31
8211776|NCT02121262|20251127|P2|COMPLETED|Overall Study||135
8211777|NCT02121262|20251128|P1|COMPLETED|Overall Study||108
8211778|NCT02121262|20251127|P2|Modified Intent-to-treat Population|Overall Study||145
8211779|NCT02121262|20251128|P1|Modified Intent-to-treat Population|Overall Study||127
8211780|NCT02121262|20251127|P2|Treated|Overall Study||145
8211781|NCT02121262|20251128|P1|Treated|Overall Study||129
8211782|NCT02121262|20251127|P2|STARTED|Overall Study||145
8211783|NCT02121262|20251128|P1|STARTED|Overall Study||139
8211784|NCT02121210|20251142|P2|NOT COMPLETED|Overall Study||9
8211785|NCT02121210|20251143|P1|NOT COMPLETED|Overall Study||7
8211786|NCT02121210|20251142|P2|COMPLETED|Overall Study||58
8211787|NCT02121210|20251143|P1|COMPLETED|Overall Study||58
8211788|NCT02121210|20251142|P2|STARTED|Overall Study||67
8211789|NCT02121210|20251143|P1|STARTED|Overall Study||65
8211790|NCT02121067|20251151|P1|NOT COMPLETED|Overall Study||0
8211791|NCT02121067|20251151|P1|COMPLETED|Overall Study||50
8211792|NCT02121067|20251151|P1|STARTED|Overall Study||50
8211793|NCT02121041|20251159|P2|NOT COMPLETED|Overall Study||6
8211794|NCT02121041|20251160|P1|NOT COMPLETED|Overall Study||1
8211795|NCT02121041|20251159|P2|COMPLETED|Overall Study||8
8211796|NCT02121041|20251160|P1|COMPLETED|Overall Study||13
8211797|NCT02121041|20251159|P2|STARTED|Overall Study||14
8211798|NCT02121041|20251160|P1|STARTED|Overall Study||14
8211799|NCT02120950|20251168|P3|NOT COMPLETED|Overall Study||15
8211800|NCT02120950|20251169|P2|NOT COMPLETED|Overall Study||14
8211801|NCT02120950|20251170|P1|NOT COMPLETED|Overall Study||20
8211802|NCT02120950|20251168|P3|COMPLETED|Overall Study||0
8211803|NCT02120950|20251169|P2|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
8211804|NCT02120950|20251170|P1|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
8211805|NCT02120950|20251168|P3|STARTED|Overall Study||15
8211806|NCT02120950|20251169|P2|STARTED|Overall Study||161
8211807|NCT02120950|20251170|P1|STARTED|Overall Study||157
8211808|NCT02120924|20251206|P3|NOT COMPLETED|Overall Study||29
8211809|NCT02120924|20251207|P2|NOT COMPLETED|Overall Study||46
8211810|NCT02120924|20251208|P1|NOT COMPLETED|Overall Study||42
8211811|NCT02120924|20251206|P3|COMPLETED|Overall Study||173
8211812|NCT02120924|20251207|P2|COMPLETED|Overall Study||357
8211813|NCT02120924|20251208|P1|COMPLETED|Overall Study||362
8211814|NCT02120924|20251206|P3|STARTED|Overall Study||202
8211815|NCT02120924|20251207|P2|STARTED|Overall Study||403
8211816|NCT02120924|20251208|P1|STARTED|Overall Study||404
8211817|NCT02120898|20251222|P3|NOT COMPLETED|Overall Study||4
8211818|NCT02120898|20251223|P2|NOT COMPLETED|Overall Study||6
8211819|NCT02120898|20251224|P1|NOT COMPLETED|Overall Study||9
8211820|NCT02120898|20251222|P3|COMPLETED|Overall Study||89
8211821|NCT02120898|20251223|P2|COMPLETED|Overall Study||181
8211822|NCT02120898|20251224|P1|COMPLETED|Overall Study||178
8211823|NCT02120898|20251222|P3|Intent-to-Treat (ITT) Population|Overall Study||93
8211824|NCT02120898|20251223|P2|Intent-to-Treat (ITT) Population|Overall Study||185
8211825|NCT02120898|20251224|P1|Intent-to-Treat (ITT) Population|Overall Study||183
8211826|NCT02120898|20251222|P3|Safety Population|Overall Study||93
8211827|NCT02120898|20251223|P2|Safety Population|Overall Study||187
8211828|NCT02120898|20251224|P1|Safety Population|Overall Study||187
8211829|NCT02120898|20251222|P3|STARTED|Overall Study||93
8211830|NCT02120898|20251223|P2|STARTED|Overall Study||187
8211831|NCT02120898|20251224|P1|STARTED|Overall Study||187
8211832|NCT02120833|20251246|P2|NOT COMPLETED|Overall Study||1
8211833|NCT02120833|20251247|P1|NOT COMPLETED|Overall Study||4
8211834|NCT02120833|20251246|P2|COMPLETED|Overall Study||11
8211835|NCT02120833|20251247|P1|COMPLETED|Overall Study||35
8211836|NCT02120833|20251246|P2|STARTED|Overall Study||12
8211837|NCT02120833|20251247|P1|STARTED|Overall Study||39
8211838|NCT02120794|20251401|P1|NOT COMPLETED|Overall Study||58
8211839|NCT02120794|20251401|P1|COMPLETED|Overall Study||136
8211840|NCT02120794|20251401|P1|STARTED|Overall Study||194
8211841|NCT02120716|20251410|P2|NOT COMPLETED|Overall Study||0
8211842|NCT02120716|20251411|P1|NOT COMPLETED|Overall Study||1
8211843|NCT02120716|20251410|P2|COMPLETED|Overall Study||19
8211844|NCT02120716|20251411|P1|COMPLETED|Overall Study||30
8211845|NCT02120716|20251410|P2|STARTED|Overall Study||19
8211846|NCT02120716|20251411|P1|STARTED|Overall Study||31
8211847|NCT02120664|20251425|P5|NOT COMPLETED|Overall Study||0
8211848|NCT02120664|20251426|P4|NOT COMPLETED|Overall Study||1
8211849|NCT02120664|20251427|P3|NOT COMPLETED|Overall Study||0
8211850|NCT02120664|20251428|P2|NOT COMPLETED|Overall Study||0
8211851|NCT02120664|20251429|P1|NOT COMPLETED|Overall Study||0
8211852|NCT02120664|20251425|P5|COMPLETED|Overall Study||10
8211853|NCT02120664|20251426|P4|COMPLETED|Overall Study||3
8211854|NCT02120664|20251427|P3|COMPLETED|Overall Study||7
8211855|NCT02120664|20251428|P2|COMPLETED|Overall Study||4
8211856|NCT02120664|20251429|P1|COMPLETED|Overall Study||10
8211857|NCT02120664|20251425|P5|STARTED|Overall Study||10
8211858|NCT02120664|20251426|P4|STARTED|Overall Study||4
8211859|NCT02120664|20251427|P3|STARTED|Overall Study||7
8211860|NCT02120664|20251428|P2|STARTED|Overall Study||4
8211861|NCT02120664|20251429|P1|STARTED|Overall Study||10
8211862|NCT02120625|20251447|P1|NOT COMPLETED|Overall Study||2
8211863|NCT02120625|20251447|P1|COMPLETED|Overall Study||6
8211864|NCT02120625|20251447|P1|STARTED|Overall Study||8
8211865|NCT02120456|20251463|P9|NOT COMPLETED|Part 2 Double-blind Phase||1
8211866|NCT02120456|20251464|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
8211867|NCT02120456|20251465|P7|NOT COMPLETED|Part 2 Double-blind Phase||2
8211868|NCT02120456|20251466|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
8211869|NCT02120456|20251467|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
8211870|NCT02120456|20251468|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
8211871|NCT02120456|20251469|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
8211872|NCT02120456|20251470|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
8211873|NCT02120456|20251471|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
8211874|NCT02120456|20251463|P9|COMPLETED|Part 2 Double-blind Phase||62
8211875|NCT02120456|20251464|P8|COMPLETED|Part 2 Double-blind Phase||60
8211876|NCT02120456|20251465|P7|COMPLETED|Part 2 Double-blind Phase||30
8211877|NCT02120456|20251466|P6|COMPLETED|Part 2 Double-blind Phase||0
8211878|NCT02120456|20251467|P5|COMPLETED|Part 2 Double-blind Phase||0
8211879|NCT02120456|20251468|P4|COMPLETED|Part 2 Double-blind Phase||0
8211880|NCT02120456|20251469|P3|COMPLETED|Part 2 Double-blind Phase||0
8211881|NCT02120456|20251470|P2|COMPLETED|Part 2 Double-blind Phase||0
8211882|NCT02120456|20251471|P1|COMPLETED|Part 2 Double-blind Phase||0
8211883|NCT02120456|20251463|P9|STARTED|Part 2 Double-blind Phase||63
8211884|NCT02120456|20251464|P8|STARTED|Part 2 Double-blind Phase||60
8211885|NCT02120456|20251465|P7|STARTED|Part 2 Double-blind Phase||32
8211886|NCT02120456|20251466|P6|STARTED|Part 2 Double-blind Phase||0
8211887|NCT02120456|20251467|P5|STARTED|Part 2 Double-blind Phase||0
8211888|NCT02120456|20251468|P4|STARTED|Part 2 Double-blind Phase||0
8211889|NCT02120456|20251469|P3|STARTED|Part 2 Double-blind Phase||0
8211890|NCT02120456|20251470|P2|STARTED|Part 2 Double-blind Phase||0
8211891|NCT02120456|20251471|P1|STARTED|Part 2 Double-blind Phase||0
8211892|NCT02120456|20251463|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211893|NCT02120456|20251464|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211894|NCT02120456|20251465|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211895|NCT02120456|20251466|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211896|NCT02120456|20251467|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211897|NCT02120456|20251468|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211898|NCT02120456|20251469|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211899|NCT02120456|20251470|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211900|NCT02120456|20251471|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211901|NCT02120456|20251463|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211902|NCT02120456|20251464|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211903|NCT02120456|20251465|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211904|NCT02120456|20251466|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
8211905|NCT02120456|20251467|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211906|NCT02120456|20251468|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211907|NCT02120456|20251469|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211908|NCT02120456|20251470|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211909|NCT02120456|20251471|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211910|NCT02120456|20251463|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8211911|NCT02120456|20251464|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8211912|NCT02120456|20251465|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8211913|NCT02120456|20251466|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||9
8211914|NCT02120456|20251467|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211915|NCT02120456|20251468|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211916|NCT02120456|20251469|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211917|NCT02120456|20251470|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211918|NCT02120456|20251471|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211919|NCT02120443|20251497|P1|NOT COMPLETED|Overall Study||0
8211920|NCT02120443|20251497|P1|COMPLETED|Overall Study||43
8211921|NCT02120443|20251497|P1|STARTED|Overall Study||43
8211922|NCT02120417|20251505|P2|NOT COMPLETED|Overall Study||68
8211923|NCT02120417|20251506|P1|NOT COMPLETED|Overall Study||60
8211924|NCT02120417|20251505|P2|COMPLETED|Overall Study||5
8211925|NCT02120417|20251506|P1|COMPLETED|Overall Study||16
8211926|NCT02120417|20251505|P2|STARTED|Overall Study||73
8211927|NCT02120417|20251506|P1|STARTED|Overall Study||76
8211928|NCT02120352|20251524|P4|NOT COMPLETED|Maintenance Period (32 Weeks)||56
8211929|NCT02120352|20251525|P3|NOT COMPLETED|Maintenance Period (32 Weeks)||115
8211930|NCT02120352|20251526|P2|NOT COMPLETED|Maintenance Period (32 Weeks)||115
8211931|NCT02120352|20251527|P1|NOT COMPLETED|Maintenance Period (32 Weeks)||0
8211932|NCT02120352|20251524|P4|COMPLETED|Maintenance Period (32 Weeks)||0
8211933|NCT02120352|20251525|P3|COMPLETED|Maintenance Period (32 Weeks)||0
8211934|NCT02120352|20251526|P2|COMPLETED|Maintenance Period (32 Weeks)||0
8211935|NCT02120352|20251527|P1|COMPLETED|Maintenance Period (32 Weeks)||0
8211936|NCT02120352|20251524|P4|STARTED|Maintenance Period (32 Weeks)||56
8211937|NCT02120352|20251525|P3|STARTED|Maintenance Period (32 Weeks)||115
8211938|NCT02120352|20251526|P2|STARTED|Maintenance Period (32 Weeks)||115
8211939|NCT02120352|20251527|P1|STARTED|Maintenance Period (32 Weeks)||0
8211940|NCT02120352|20251524|P4|NOT COMPLETED|Induction Period (20 Weeks)||0
8211941|NCT02120352|20251525|P3|NOT COMPLETED|Induction Period (20 Weeks)||0
8211942|NCT02120352|20251526|P2|NOT COMPLETED|Induction Period (20 Weeks)||0
8211943|NCT02120352|20251527|P1|NOT COMPLETED|Induction Period (20 Weeks)||21
8211944|NCT02120352|20251524|P4|COMPLETED|Induction Period (20 Weeks)||0
8211945|NCT02120352|20251525|P3|COMPLETED|Induction Period (20 Weeks)||0
8211946|NCT02120352|20251526|P2|COMPLETED|Induction Period (20 Weeks)||0
8211947|NCT02120352|20251527|P1|COMPLETED|Induction Period (20 Weeks)||288
8211948|NCT02120352|20251524|P4|STARTED|Induction Period (20 Weeks)||0
8211949|NCT02120352|20251525|P3|STARTED|Induction Period (20 Weeks)||0
8211950|NCT02120352|20251526|P2|STARTED|Induction Period (20 Weeks)||0
8211951|NCT02120352|20251527|P1|STARTED|Induction Period (20 Weeks)||309
8211952|NCT02120300|20251678|P4|NOT COMPLETED|Overall Study||1
8211953|NCT02120300|20251679|P3|NOT COMPLETED|Overall Study||0
8211954|NCT02120300|20251680|P2|NOT COMPLETED|Overall Study||0
8211955|NCT02120300|20251681|P1|NOT COMPLETED|Overall Study||3
8211956|NCT02120300|20251678|P4|COMPLETED|Overall Study||5
8211957|NCT02120300|20251679|P3|COMPLETED|Overall Study||10
8211958|NCT02120300|20251680|P2|COMPLETED|Overall Study||5
8211959|NCT02120300|20251681|P1|COMPLETED|Overall Study||98
8211960|NCT02120300|20251678|P4|STARTED|Overall Study||6
8211961|NCT02120300|20251679|P3|STARTED|Overall Study||10
8211962|NCT02120300|20251680|P2|STARTED|Overall Study||5
8211963|NCT02120300|20251681|P1|STARTED|Overall Study||101
8211964|NCT02120287|20251717|P1|NOT COMPLETED|Overall Study||0
8211965|NCT02120287|20251717|P1|COMPLETED|Overall Study||16
8211966|NCT02120287|20251717|P1|STARTED|Overall Study||16
8211967|NCT02120261|20251737|P2|NOT COMPLETED|Overall Study||0
8211968|NCT02120261|20251738|P1|NOT COMPLETED|Overall Study||0
8211969|NCT02120261|20251737|P2|COMPLETED|Overall Study||25
8211970|NCT02120261|20251738|P1|COMPLETED|Overall Study||23
8211971|NCT02120261|20251737|P2|STARTED|Overall Study||25
8211972|NCT02120261|20251738|P1|STARTED|Overall Study||23
8211973|NCT02120157|20251752|P2|NOT COMPLETED|Overall Study||2
8211974|NCT02120157|20251753|P1|NOT COMPLETED|Overall Study||6
8211975|NCT02120157|20251752|P2|COMPLETED|Overall Study||11
8211976|NCT02120157|20251753|P1|COMPLETED|Overall Study||13
8211977|NCT02120157|20251752|P2|Undergoing Follow-up|Overall Study||8
8211978|NCT02120157|20251753|P1|Undergoing Follow-up|Overall Study||7
8211979|NCT02120157|20251752|P2|Completed 180 Days|Overall Study||3
8211980|NCT02120157|20251753|P1|Completed 180 Days|Overall Study||5
8211981|NCT02120157|20251752|P2|STARTED|Overall Study||13
8211982|NCT02120157|20251753|P1|STARTED|Overall Study||19
8211983|NCT02120027|20251763|P2|NOT COMPLETED|Overall Study||119
8211984|NCT02120027|20251764|P1|NOT COMPLETED|Overall Study||116
8211985|NCT02120027|20251763|P2|COMPLETED|Overall Study||160
8211986|NCT02120027|20251764|P1|COMPLETED|Overall Study||161
8211987|NCT02120027|20251763|P2|STARTED|Overall Study||279
8211988|NCT02120027|20251764|P1|STARTED|Overall Study||277
8211989|NCT02120001|20251780|P2|NOT COMPLETED|Overall Study||0
8211990|NCT02120001|20251781|P1|NOT COMPLETED|Overall Study||0
8211991|NCT02120001|20251780|P2|COMPLETED|Overall Study||19
8211992|NCT02120001|20251781|P1|COMPLETED|Overall Study||17
8211993|NCT02120001|20251780|P2|STARTED|Overall Study||19
8211994|NCT02120001|20251781|P1|STARTED|Overall Study||17
8211995|NCT02119936|20251789|P1|NOT COMPLETED|Overall Study||10
8211996|NCT02119936|20251789|P1|COMPLETED|Overall Study||0
8211997|NCT02119936|20251789|P1|STARTED|Overall Study||10
8211998|NCT02119871|20251800|P2|NOT COMPLETED|Overall Study||0
8211999|NCT02119871|20251801|P1|NOT COMPLETED|Overall Study||0
8212000|NCT02119871|20251800|P2|COMPLETED|Overall Study||10
8212001|NCT02119871|20251801|P1|COMPLETED|Overall Study||10
8212002|NCT02119871|20251800|P2|STARTED|Overall Study||10
8212003|NCT02119871|20251801|P1|STARTED|Overall Study||10
8212004|NCT02119676|20251823|P4|NOT COMPLETED|Overall Study||101
8212005|NCT02119676|20251824|P3|NOT COMPLETED|Overall Study||97
8212006|NCT02119676|20251825|P2|NOT COMPLETED|Overall Study||86
8212007|NCT02119676|20251826|P1|NOT COMPLETED|Overall Study||83
8212008|NCT02119676|20251823|P4|COMPLETED|Overall Study||10
8212009|NCT02119676|20251824|P3|COMPLETED|Overall Study||13
8212010|NCT02119676|20251825|P2|COMPLETED|Overall Study||2
8212011|NCT02119676|20251826|P1|COMPLETED|Overall Study||4
8212012|NCT02119676|20251823|P4|Treated Patients|Overall Study||106
8212013|NCT02119676|20251824|P3|Treated Patients|Overall Study||106
8212014|NCT02119676|20251825|P2|Treated Patients|Overall Study||86
8212015|NCT02119676|20251826|P1|Treated Patients|Overall Study||85
8212016|NCT02119676|20251823|P4|STARTED|Overall Study||111
8212017|NCT02119676|20251824|P3|STARTED|Overall Study||110
8212018|NCT02119676|20251825|P2|STARTED|Overall Study||88
8212019|NCT02119676|20251826|P1|STARTED|Overall Study||87
8212020|NCT02119663|20251858|P2|NOT COMPLETED|Overall Study||41
8212021|NCT02119663|20251859|P1|NOT COMPLETED|Overall Study||40
8212022|NCT02119663|20251858|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
8212023|NCT02119663|20251859|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
8212024|NCT02119663|20251858|P2|STARTED|Overall Study||43
8212025|NCT02119663|20251859|P1|STARTED|Overall Study||43
8212026|NCT02119650|20251877|P2|NOT COMPLETED|Overall Study||26
8212027|NCT02119650|20251878|P1|NOT COMPLETED|Overall Study||25
8212028|NCT02119650|20251877|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
8212029|NCT02119650|20251878|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
8212030|NCT02119650|20251877|P2|STARTED|Overall Study||37
8212031|NCT02119650|20251878|P1|STARTED|Overall Study||39
8212032|NCT02119455|20251894|P2|NOT COMPLETED|Overall Study||3
8212033|NCT02119455|20251895|P1|NOT COMPLETED|Overall Study||0
8212034|NCT02119455|20251894|P2|COMPLETED|Overall Study||17
8212035|NCT02119455|20251895|P1|COMPLETED|Overall Study||20
8212036|NCT02119455|20251894|P2|STARTED|Overall Study||20
8212037|NCT02119455|20251895|P1|STARTED|Overall Study||20
8212038|NCT02119442|20251909|P1|NOT COMPLETED|Overall Study||0
8212039|NCT02119442|20251909|P1|COMPLETED|Overall Study||90
8212040|NCT02119442|20251909|P1|STARTED|Overall Study||90
8212041|NCT02119325|20251913|P2|NOT COMPLETED|Period 2||0
8212042|NCT02119325|20251914|P1|NOT COMPLETED|Period 2||0
8212043|NCT02119325|20251913|P2|COMPLETED|Period 2||47
8212044|NCT02119325|20251914|P1|COMPLETED|Period 2||48
8212045|NCT02119325|20251913|P2|STARTED|Period 2||47
8212046|NCT02119325|20251914|P1|STARTED|Period 2||48
8212047|NCT02119325|20251913|P2|NOT COMPLETED|Washout Period 1||1
8212048|NCT02119325|20251914|P1|NOT COMPLETED|Washout Period 1||0
8212049|NCT02119325|20251913|P2|COMPLETED|Washout Period 1||47
8212050|NCT02119325|20251914|P1|COMPLETED|Washout Period 1||48
8212051|NCT02119325|20251913|P2|STARTED|Washout Period 1||48
8212052|NCT02119325|20251914|P1|STARTED|Washout Period 1||48
8212053|NCT02119325|20251913|P2|NOT COMPLETED|Period 1||0
8212054|NCT02119325|20251914|P1|NOT COMPLETED|Period 1||0
8212055|NCT02119325|20251913|P2|COMPLETED|Period 1||48
8212056|NCT02119325|20251914|P1|COMPLETED|Period 1||48
8212057|NCT02119325|20251913|P2|STARTED|Period 1||48
8212058|NCT02119325|20251914|P1|STARTED|Period 1||48
8212059|NCT02119299|20251958|P1|NOT COMPLETED|Overall Study||9
8212060|NCT02119299|20251958|P1|COMPLETED|Overall Study||67
8212061|NCT02119299|20251958|P1|STARTED|Overall Study||76
8212062|NCT02119286|20251972|P3|NOT COMPLETED|Overall Study||7
8212063|NCT02119286|20251973|P2|NOT COMPLETED|Overall Study||11
8212064|NCT02119286|20251974|P1|NOT COMPLETED|Overall Study||26
8212065|NCT02119286|20251972|P3|COMPLETED|Overall Study||200
8212066|NCT02119286|20251973|P2|COMPLETED|Overall Study||195
8212067|NCT02119286|20251974|P1|COMPLETED|Overall Study||180
8212068|NCT02119286|20251972|P3|STARTED|Overall Study||207
8212069|NCT02119286|20251973|P2|STARTED|Overall Study||206
8212070|NCT02119286|20251974|P1|STARTED|Overall Study||206
8212071|NCT02119260|20251992|P7|NOT COMPLETED|Overall Study||0
8212072|NCT02119260|20251993|P6|NOT COMPLETED|Overall Study||0
8212073|NCT02119260|20251994|P5|NOT COMPLETED|Overall Study||0
8212074|NCT02119260|20251995|P4|NOT COMPLETED|Overall Study||0
8212075|NCT02119260|20251996|P3|NOT COMPLETED|Overall Study||1
8212076|NCT02119260|20251997|P2|NOT COMPLETED|Overall Study||1
8212077|NCT02119260|20251998|P1|NOT COMPLETED|Overall Study||1
8212078|NCT02119260|20251992|P7|COMPLETED|Overall Study||2
8212079|NCT02119260|20251993|P6|COMPLETED|Overall Study||6
8212080|NCT02119260|20251994|P5|COMPLETED|Overall Study||13
8212081|NCT02119260|20251995|P4|COMPLETED|Overall Study||10
8212082|NCT02119260|20251996|P3|COMPLETED|Overall Study||7
8212083|NCT02119260|20251997|P2|COMPLETED|Overall Study||11
8212084|NCT02119260|20251998|P1|COMPLETED|Overall Study||8
8212085|NCT02119260|20251992|P7|STARTED|Overall Study||2
8212086|NCT02119260|20251993|P6|STARTED|Overall Study||6
8212087|NCT02119260|20251994|P5|STARTED|Overall Study||13
8212088|NCT02119260|20251995|P4|STARTED|Overall Study||10
8212089|NCT02119260|20251996|P3|STARTED|Overall Study||8
8212090|NCT02119260|20251997|P2|STARTED|Overall Study||12
8212091|NCT02119260|20251998|P1|STARTED|Overall Study||9
8212092|NCT02119156|20252071|P3|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
8212093|NCT02119156|20252072|P2|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
8212094|NCT02119156|20252073|P1|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
8212095|NCT02119156|20252071|P3|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
8212096|NCT02119156|20252072|P2|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
8212097|NCT02119156|20252073|P1|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
8212188|NCT02118714|20252356|P1|STARTED|Overall Study||20
8212098|NCT02119156|20252071|P3|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
8212099|NCT02119156|20252072|P2|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
8212100|NCT02119156|20252073|P1|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
8212101|NCT02119156|20252071|P3|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
8212102|NCT02119156|20252072|P2|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
8212103|NCT02119156|20252073|P1|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
8212104|NCT02119156|20252071|P3|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
8212105|NCT02119156|20252072|P2|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
8212106|NCT02119156|20252073|P1|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
8212107|NCT02119156|20252071|P3|STARTED|Treatment Phase (Up to 52 Weeks)||12
8212108|NCT02119156|20252072|P2|STARTED|Treatment Phase (Up to 52 Weeks)||29
8212109|NCT02119156|20252073|P1|STARTED|Treatment Phase (Up to 52 Weeks)||39
8212110|NCT02119104|20252131|P1|NOT COMPLETED|Overall Study||16
8212111|NCT02119104|20252131|P1|COMPLETED|Overall Study||1071
8212112|NCT02119104|20252131|P1|STARTED|Overall Study||1087
8212113|NCT02119026|20252137|P2|NOT COMPLETED|2nd-line Treatment||2
8212114|NCT02119026|20252138|P1|NOT COMPLETED|2nd-line Treatment||9
8212115|NCT02119026|20252137|P2|COMPLETED|2nd-line Treatment||22
8212116|NCT02119026|20252138|P1|COMPLETED|2nd-line Treatment||23
8212117|NCT02119026|20252137|P2|STARTED|2nd-line Treatment||24
8212118|NCT02119026|20252138|P1|STARTED|2nd-line Treatment||32
8212119|NCT02119026|20252137|P2|NOT COMPLETED|1st-line Treatment||38
8212120|NCT02119026|20252138|P1|NOT COMPLETED|1st-line Treatment||26
8212121|NCT02119026|20252137|P2|COMPLETED|1st-line Treatment||24
8212122|NCT02119026|20252138|P1|COMPLETED|1st-line Treatment||32
8212123|NCT02119026|20252137|P2|STARTED|1st-line Treatment||62
8212124|NCT02119026|20252138|P1|STARTED|1st-line Treatment||58
8212125|NCT02118961|20252162|P2|NOT COMPLETED|Overall Study||0
8212126|NCT02118961|20252163|P1|NOT COMPLETED|Overall Study||1
8212127|NCT02118961|20252162|P2|COMPLETED|Overall Study||222
8212128|NCT02118961|20252163|P1|COMPLETED|Overall Study||223
8212129|NCT02118961|20252162|P2|STARTED|Overall Study||222
8212130|NCT02118961|20252163|P1|STARTED|Overall Study||224
8212131|NCT02118896|20252191|P10|NOT COMPLETED|Overall Study||2
8212132|NCT02118896|20252192|P9|NOT COMPLETED|Overall Study||4
8212133|NCT02118896|20252193|P8|NOT COMPLETED|Overall Study||2
8212134|NCT02118896|20252194|P7|NOT COMPLETED|Overall Study||2
8212135|NCT02118896|20252195|P6|NOT COMPLETED|Overall Study||28
8212136|NCT02118896|20252196|P5|NOT COMPLETED|Overall Study||17
8212137|NCT02118896|20252197|P4|NOT COMPLETED|Overall Study||24
8212138|NCT02118896|20252198|P3|NOT COMPLETED|Overall Study||14
8212139|NCT02118896|20252199|P2|NOT COMPLETED|Overall Study||15
8212140|NCT02118896|20252200|P1|NOT COMPLETED|Overall Study||17
8212141|NCT02118896|20252191|P10|COMPLETED|Overall Study||7
8212142|NCT02118896|20252192|P9|COMPLETED|Overall Study||84
8212143|NCT02118896|20252193|P8|COMPLETED|Overall Study||105
8212144|NCT02118896|20252194|P7|COMPLETED|Overall Study||83
8212145|NCT02118896|20252195|P6|COMPLETED|Overall Study||163
8212146|NCT02118896|20252196|P5|COMPLETED|Overall Study||113
8212147|NCT02118896|20252197|P4|COMPLETED|Overall Study||55
8212148|NCT02118896|20252198|P3|COMPLETED|Overall Study||53
8212149|NCT02118896|20252199|P2|COMPLETED|Overall Study||32
8212150|NCT02118896|20252200|P1|COMPLETED|Overall Study||30
8212151|NCT02118896|20252191|P10|STARTED|Overall Study||9
8212152|NCT02118896|20252192|P9|STARTED|Overall Study||88
8212153|NCT02118896|20252193|P8|STARTED|Overall Study||107
8212154|NCT02118896|20252194|P7|STARTED|Overall Study||85
8212155|NCT02118896|20252195|P6|STARTED|Overall Study||191
8212156|NCT02118896|20252196|P5|STARTED|Overall Study||130
8212157|NCT02118896|20252197|P4|STARTED|Overall Study||79
8212158|NCT02118896|20252198|P3|STARTED|Overall Study||67
8212159|NCT02118896|20252199|P2|STARTED|Overall Study||47
8212160|NCT02118896|20252200|P1|STARTED|Overall Study||47
8212161|NCT02118831|20252275|P3|NOT COMPLETED|Overall Study||0
8212162|NCT02118831|20252276|P2|NOT COMPLETED|Overall Study||0
8212163|NCT02118831|20252277|P1|NOT COMPLETED|Overall Study||0
8212164|NCT02118831|20252275|P3|COMPLETED|Overall Study||20
8212165|NCT02118831|20252276|P2|COMPLETED|Overall Study||15
8212166|NCT02118831|20252277|P1|COMPLETED|Overall Study||21
8212167|NCT02118831|20252275|P3|STARTED|Overall Study||20
8212168|NCT02118831|20252276|P2|STARTED|Overall Study||15
8212169|NCT02118831|20252277|P1|STARTED|Overall Study||21
8212170|NCT02118792|20252290|P2|NOT COMPLETED|Overall Study||37
8212171|NCT02118792|20252291|P1|NOT COMPLETED|Overall Study||31
8212172|NCT02118792|20252290|P2|COMPLETED|Overall Study||213
8212173|NCT02118792|20252291|P1|COMPLETED|Overall Study||483
8212174|NCT02118792|20252290|P2|Treated|Overall Study||250
8212175|NCT02118792|20252291|P1|Treated|Overall Study||513
8212176|NCT02118792|20252290|P2|STARTED|Overall Study||250
8212177|NCT02118792|20252291|P1|STARTED|Overall Study||514
8212178|NCT02118766|20252333|P2|NOT COMPLETED|Overall Study||31
8212179|NCT02118766|20252334|P1|NOT COMPLETED|Overall Study||30
8212180|NCT02118766|20252333|P2|COMPLETED|Overall Study||225
8212181|NCT02118766|20252334|P1|COMPLETED|Overall Study||477
8212182|NCT02118766|20252333|P2|Treated|Overall Study||256
8212183|NCT02118766|20252334|P1|Treated|Overall Study||503
8212184|NCT02118766|20252333|P2|STARTED|Overall Study||256
8212185|NCT02118766|20252334|P1|STARTED|Overall Study||507
8212186|NCT02118714|20252356|P1|NOT COMPLETED|Overall Study||3
8212187|NCT02118714|20252356|P1|COMPLETED|Overall Study||17
8212189|NCT02118610|20252372|P2|NOT COMPLETED|Overall Study||1
8212190|NCT02118610|20252373|P1|NOT COMPLETED|Overall Study||1
8212191|NCT02118610|20252372|P2|COMPLETED|Overall Study||32
8212192|NCT02118610|20252373|P1|COMPLETED|Overall Study||29
8212193|NCT02118610|20252372|P2|STARTED|Overall Study||33
8212194|NCT02118610|20252373|P1|STARTED|Overall Study||30
8212195|NCT02118597|20252381|P1|NOT COMPLETED|Overall Study||16
8212196|NCT02118597|20252381|P1|COMPLETED|Overall Study||3
8212197|NCT02118597|20252381|P1|STARTED|Overall Study||19
8212198|NCT02118441|20252397|P2|NOT COMPLETED|Overall Study||1
8212199|NCT02118441|20252398|P1|NOT COMPLETED|Overall Study||3
8212200|NCT02118441|20252397|P2|COMPLETED|Overall Study||63
8212201|NCT02118441|20252398|P1|COMPLETED|Overall Study||62
8212202|NCT02118441|20252397|P2|STARTED|Overall Study||64
8212203|NCT02118441|20252398|P1|STARTED|Overall Study||65
8212204|NCT02118428|20252412|P3|NOT COMPLETED|Overall Study||1
8212205|NCT02118428|20252413|P2|NOT COMPLETED|Overall Study||9
8212206|NCT02118428|20252414|P1|NOT COMPLETED|Overall Study||13
8212207|NCT02118428|20252412|P3|COMPLETED|Overall Study||0
8212208|NCT02118428|20252413|P2|COMPLETED|Overall Study||104
8212209|NCT02118428|20252414|P1|COMPLETED|Overall Study||100
8212210|NCT02118428|20252412|P3|Received Study Transfusion|Overall Study||0
8212211|NCT02118428|20252413|P2|Received Study Transfusion|Overall Study||112
8212212|NCT02118428|20252414|P1|Received Study Transfusion|Overall Study||111
8212213|NCT02118428|20252412|P3|STARTED|Overall Study||1
8212214|NCT02118428|20252413|P2|STARTED|Overall Study||113
8212215|NCT02118428|20252414|P1|STARTED|Overall Study||113
8212216|NCT02118012|20252454|P2|NOT COMPLETED|Overall Study||2
8212217|NCT02118012|20252455|P1|NOT COMPLETED|Overall Study||0
8212218|NCT02118012|20252454|P2|COMPLETED|Overall Study||10
8212219|NCT02118012|20252455|P1|COMPLETED|Overall Study||12
8212220|NCT02118012|20252454|P2|Day 14|Overall Study||10
8212221|NCT02118012|20252455|P1|Day 14|Overall Study||12
8212222|NCT02118012|20252454|P2|Day 5|Overall Study||11
8212223|NCT02118012|20252455|P1|Day 5|Overall Study||12
8212224|NCT02118012|20252454|P2|STARTED|Overall Study||12
8212225|NCT02118012|20252455|P1|STARTED|Overall Study||12
8212226|NCT02117999|20252469|P2|NOT COMPLETED|Overall Study||0
8212227|NCT02117999|20252470|P1|NOT COMPLETED|Overall Study||0
8212228|NCT02117999|20252469|P2|COMPLETED|Overall Study||10
8212229|NCT02117999|20252470|P1|COMPLETED|Overall Study||20
8212230|NCT02117999|20252469|P2|Mean Kmax Change in Corneal Topography|Overall Study||10
8212231|NCT02117999|20252470|P1|Mean Kmax Change in Corneal Topography|Overall Study||20
8212232|NCT02117999|20252469|P2|STARTED|Overall Study||10
8212233|NCT02117999|20252470|P1|STARTED|Overall Study||20
8212234|NCT02117934|20252488|P2|NOT COMPLETED|Overall Study||215
8212235|NCT02117934|20252489|P1|NOT COMPLETED|Overall Study||500
8212236|NCT02117934|20252488|P2|COMPLETED|Overall Study||2567
8212237|NCT02117934|20252489|P1|COMPLETED|Overall Study||5092
8212238|NCT02117934|20252488|P2|STARTED|Overall Study||2782
8212239|NCT02117934|20252489|P1|STARTED|Overall Study||5592
8212240|NCT02117687|20252499|P2|NOT COMPLETED|Overall Study||4
8212241|NCT02117687|20252500|P1|NOT COMPLETED|Overall Study||1
8212242|NCT02117687|20252499|P2|COMPLETED|Overall Study||36
8212243|NCT02117687|20252500|P1|COMPLETED|Overall Study||39
8212244|NCT02117687|20252499|P2|STARTED|Overall Study||40
8212245|NCT02117687|20252500|P1|STARTED|Overall Study||40
8212246|NCT02117648|20252532|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
8212247|NCT02117648|20252532|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
8212248|NCT02117648|20252532|P1|STARTED|Abemaciclib Safety-Extension Phase||20
8212249|NCT02117648|20252532|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
8212250|NCT02117648|20252532|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
8212251|NCT02117648|20252532|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
8212252|NCT02117648|20252532|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
8212253|NCT02117648|20252532|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
8212254|NCT02117648|20252532|P1|COMPLETED|Abemaciclib Alone Period 1||24
8212255|NCT02117648|20252532|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
8212256|NCT02117648|20252532|P1|STARTED|Abemaciclib Alone Period 1||26
8212257|NCT02117570|20252545|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
8212258|NCT02117570|20252546|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
8212259|NCT02117570|20252547|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
8212260|NCT02117570|20252545|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
8212261|NCT02117570|20252546|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
8212262|NCT02117570|20252547|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
8212263|NCT02117570|20252545|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
8212264|NCT02117570|20252546|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
8212265|NCT02117570|20252547|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
8212266|NCT02117570|20252545|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
8212267|NCT02117570|20252546|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
8212268|NCT02117570|20252547|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
8212269|NCT02117570|20252545|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
8212270|NCT02117570|20252546|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
8212271|NCT02117570|20252547|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
8212272|NCT02117570|20252545|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
8212273|NCT02117570|20252546|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
8212274|NCT02117570|20252547|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
8212275|NCT02117570|20252545|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
8212276|NCT02117570|20252546|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
8212277|NCT02117570|20252547|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
8212278|NCT02117570|20252545|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
8212279|NCT02117570|20252546|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
8212280|NCT02117570|20252547|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
8212281|NCT02117570|20252545|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
8212282|NCT02117570|20252546|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
8212283|NCT02117570|20252547|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
8212284|NCT02117570|20252545|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
8212285|NCT02117570|20252546|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
8212286|NCT02117570|20252547|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
8212287|NCT02117570|20252545|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
8212288|NCT02117570|20252546|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
8212289|NCT02117570|20252547|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
8212290|NCT02117570|20252545|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
8212291|NCT02117570|20252546|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
8212292|NCT02117570|20252547|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
8212293|NCT02117544|20252597|P2|NOT COMPLETED|Period 2||0
8212294|NCT02117544|20252598|P1|NOT COMPLETED|Period 2||0
8212295|NCT02117544|20252597|P2|COMPLETED|Period 2||55
8212296|NCT02117544|20252598|P1|COMPLETED|Period 2||52
8212297|NCT02117544|20252597|P2|STARTED|Period 2||55
8212298|NCT02117544|20252598|P1|STARTED|Period 2||52
8212299|NCT02117544|20252597|P2|NOT COMPLETED|Period 1||0
8212300|NCT02117544|20252598|P1|NOT COMPLETED|Period 1||2
8212301|NCT02117544|20252597|P2|COMPLETED|Period 1||55
8212302|NCT02117544|20252598|P1|COMPLETED|Period 1||52
8212303|NCT02117544|20252597|P2|Treated|Period 1||55
8212304|NCT02117544|20252598|P1|Treated|Period 1||52
8212305|NCT02117544|20252597|P2|STARTED|Period 1||55
8212306|NCT02117544|20252598|P1|STARTED|Period 1||54
8212307|NCT02117479|20252613|P2|NOT COMPLETED|Overall Study||156
8212308|NCT02117479|20252614|P1|NOT COMPLETED|Overall Study||156
8212309|NCT02117479|20252613|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
8212310|NCT02117479|20252614|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
8212311|NCT02117479|20252613|P2|STARTED|Overall Study||160
8212312|NCT02117479|20252614|P1|STARTED|Overall Study||161
8212313|NCT02117427|20252633|P3|NOT COMPLETED|Overall Study||0
8212314|NCT02117427|20252634|P2|NOT COMPLETED|Overall Study||5
8212315|NCT02117427|20252635|P1|NOT COMPLETED|Overall Study||5
8212316|NCT02117427|20252633|P3|COMPLETED|Overall Study||0
8212317|NCT02117427|20252634|P2|COMPLETED|Overall Study||0
8212318|NCT02117427|20252635|P1|COMPLETED|Overall Study||1
8212319|NCT02117427|20252633|P3|Long Term Safety Follow-up|Overall Study||0
8212320|NCT02117427|20252634|P2|Long Term Safety Follow-up|Overall Study||0
8212321|NCT02117427|20252635|P1|Long Term Safety Follow-up|Overall Study||1
8212322|NCT02117427|20252633|P3|Safety Follow-up|Overall Study||0
8212323|NCT02117427|20252634|P2|Safety Follow-up|Overall Study||0
8212324|NCT02117427|20252635|P1|Safety Follow-up|Overall Study||1
8212325|NCT02117427|20252633|P3|Implantation & Efficacy|Overall Study||0
8212326|NCT02117427|20252634|P2|Implantation & Efficacy|Overall Study||4
8212327|NCT02117427|20252635|P1|Implantation & Efficacy|Overall Study||6
8212328|NCT02117427|20252633|P3|Run in Phase & Harvest|Overall Study||0
8212329|NCT02117427|20252634|P2|Run in Phase & Harvest|Overall Study||4
8212330|NCT02117427|20252635|P1|Run in Phase & Harvest|Overall Study||6
8212331|NCT02117427|20252633|P3|STARTED|Overall Study||0
8212332|NCT02117427|20252634|P2|STARTED|Overall Study||5
8212333|NCT02117427|20252635|P1|STARTED|Overall Study||6
8212334|NCT02117414|20252645|P2|NOT COMPLETED|Overall Study||6
8212335|NCT02117414|20252646|P1|NOT COMPLETED|Overall Study||15
8212336|NCT02117414|20252645|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
8212337|NCT02117414|20252646|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
8212338|NCT02117414|20252645|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
8212339|NCT02117414|20252646|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
8212340|NCT02117349|20252666|P2|NOT COMPLETED|Overall Study||1
8212341|NCT02117349|20252667|P1|NOT COMPLETED|Overall Study||3
8212342|NCT02117349|20252666|P2|COMPLETED|Overall Study||17
8212343|NCT02117349|20252667|P1|COMPLETED|Overall Study||34
8212344|NCT02117349|20252666|P2|Modified Intent-to-treat (mITT)|Overall Study||18
8212345|NCT02117349|20252667|P1|Modified Intent-to-treat (mITT)|Overall Study||36
8212346|NCT02117349|20252666|P2|Safety Population|Overall Study||18
8212347|NCT02117349|20252667|P1|Safety Population|Overall Study||36
8212348|NCT02117349|20252666|P2|Intent-to-treat Population|Overall Study||18
8212349|NCT02117349|20252667|P1|Intent-to-treat Population|Overall Study||37
8212350|NCT02117349|20252666|P2|STARTED|Overall Study||18
8212351|NCT02117349|20252667|P1|STARTED|Overall Study||37
8212352|NCT02117310|20252677|P1|NOT COMPLETED|Overall Study||0
8212353|NCT02117310|20252677|P1|COMPLETED|Overall Study||5
8212354|NCT02117310|20252677|P1|STARTED|Overall Study||5
8212355|NCT02117193|20252681|P1|NOT COMPLETED|Overall Study||0
8212356|NCT02117193|20252681|P1|COMPLETED|Overall Study||10
8212357|NCT02117193|20252681|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
8212358|NCT02117193|20252681|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
8212359|NCT02117193|20252681|P1|Placebo Intake + Normal Sleep|Overall Study||10
8212360|NCT02117193|20252681|P1|Alcohol Intake + Normal Sleep|Overall Study||10
8212361|NCT02117193|20252681|P1|STARTED|Overall Study||10
8212362|NCT02117050|20252703|P1|NOT COMPLETED|Overall Study||1
8212363|NCT02117050|20252703|P1|COMPLETED|Overall Study||0
8212364|NCT02117050|20252703|P1|STARTED|Overall Study||1
8212365|NCT02117024|20252717|P2|NOT COMPLETED|Overall Study||20
8212366|NCT02117024|20252718|P1|NOT COMPLETED|Overall Study||44
8212367|NCT02117024|20252717|P2|COMPLETED|Overall Study||1
8212368|NCT02117024|20252718|P1|COMPLETED|Overall Study||1
8212369|NCT02117024|20252717|P2|STARTED|Overall Study||21
8212370|NCT02117024|20252718|P1|STARTED|Overall Study||45
8212371|NCT02116972|20252745|P3|NOT COMPLETED|Overall Study||19
8212372|NCT02116972|20252746|P2|NOT COMPLETED|Overall Study||17
8212373|NCT02116972|20252747|P1|NOT COMPLETED|Overall Study||19
8212374|NCT02116972|20252745|P3|COMPLETED|Overall Study||85
8212375|NCT02116972|20252746|P2|COMPLETED|Overall Study||87
8212376|NCT02116972|20252747|P1|COMPLETED|Overall Study||83
8212377|NCT02116972|20252745|P3|STARTED|Overall Study||104
8212378|NCT02116972|20252746|P2|STARTED|Overall Study||104
8212379|NCT02116972|20252747|P1|STARTED|Overall Study||102
8212380|NCT02116803|20252779|P2|NOT COMPLETED|Overall Study||2
8212381|NCT02116803|20252780|P1|NOT COMPLETED|Overall Study||10
8212382|NCT02116803|20252779|P2|COMPLETED|Overall Study||0
8212383|NCT02116803|20252780|P1|COMPLETED|Overall Study||0
8212384|NCT02116803|20252779|P2|STARTED|Overall Study||2
8212385|NCT02116803|20252780|P1|STARTED|Overall Study||10
8212386|NCT02116660|20252788|P2|NOT COMPLETED|Overall Study||4
8212387|NCT02116660|20252789|P1|NOT COMPLETED|Overall Study||2
8212388|NCT02116660|20252788|P2|COMPLETED|Overall Study||1
8212389|NCT02116660|20252789|P1|COMPLETED|Overall Study||4
8212390|NCT02116660|20252788|P2|STARTED|Overall Study||5
8212391|NCT02116660|20252789|P1|STARTED|Overall Study||6
8212392|NCT02116621|20252833|P2|NOT COMPLETED|Twelve Month Follow-up||12
8212393|NCT02116621|20252834|P1|NOT COMPLETED|Twelve Month Follow-up||16
8212394|NCT02116621|20252833|P2|COMPLETED|Twelve Month Follow-up||86
8212395|NCT02116621|20252834|P1|COMPLETED|Twelve Month Follow-up||84
8212396|NCT02116621|20252833|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
8212397|NCT02116621|20252834|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
8212398|NCT02116621|20252833|P2|NOT COMPLETED|Six Month Follow-up||3
8212399|NCT02116621|20252834|P1|NOT COMPLETED|Six Month Follow-up||4
8212400|NCT02116621|20252833|P2|COMPLETED|Six Month Follow-up||97
8212401|NCT02116621|20252834|P1|COMPLETED|Six Month Follow-up||99
8212402|NCT02116621|20252833|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
8212403|NCT02116621|20252834|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
8212404|NCT02116621|20252833|P2|NOT COMPLETED|Three Month Follow-up||7
8212405|NCT02116621|20252834|P1|NOT COMPLETED|Three Month Follow-up||19
8212406|NCT02116621|20252833|P2|COMPLETED|Three Month Follow-up||96
8212407|NCT02116621|20252834|P1|COMPLETED|Three Month Follow-up||89
8212408|NCT02116621|20252833|P2|STARTED|Three Month Follow-up||103
8212409|NCT02116621|20252834|P1|STARTED|Three Month Follow-up||108
8212410|NCT02116621|20252833|P2|NOT COMPLETED|Baseline||4
8212411|NCT02116621|20252834|P1|NOT COMPLETED|Baseline||0
8212412|NCT02116621|20252833|P2|COMPLETED|Baseline||103
8212413|NCT02116621|20252834|P1|COMPLETED|Baseline||108
8212414|NCT02116621|20252833|P2|Completed Intervention Period|Baseline||103
8212415|NCT02116621|20252834|P1|Completed Intervention Period|Baseline||95
8212416|NCT02116621|20252833|P2|Completed Baseline Visit|Baseline||103
8212417|NCT02116621|20252834|P1|Completed Baseline Visit|Baseline||108
8212418|NCT02116621|20252833|P2|STARTED|Baseline||107
8212419|NCT02116621|20252834|P1|STARTED|Baseline||108
8212420|NCT02116582|20252922|P1|NOT COMPLETED|Overall Study||215
8212421|NCT02116582|20252922|P1|COMPLETED|Overall Study||0
8212422|NCT02116582|20252922|P1|Treated|Overall Study||214
8212423|NCT02116582|20252922|P1|STARTED|Overall Study||215
8212424|NCT02116530|20252932|P2|NOT COMPLETED|Overall Study||4
8212425|NCT02116530|20252933|P1|NOT COMPLETED|Overall Study||9
8212426|NCT02116530|20252932|P2|COMPLETED|Overall Study||184
8212427|NCT02116530|20252933|P1|COMPLETED|Overall Study||183
8212428|NCT02116530|20252932|P2|STARTED|Overall Study||188
8212429|NCT02116530|20252933|P1|STARTED|Overall Study||192
8212430|NCT02116361|20252951|P4|NOT COMPLETED|Overall Study||31
8212431|NCT02116361|20252952|P3|NOT COMPLETED|Overall Study||26
8212432|NCT02116361|20252953|P2|NOT COMPLETED|Overall Study||31
8212433|NCT02116361|20252954|P1|NOT COMPLETED|Overall Study||31
8212434|NCT02116361|20252951|P4|COMPLETED|Overall Study||34
8212435|NCT02116361|20252952|P3|COMPLETED|Overall Study||33
8212436|NCT02116361|20252953|P2|COMPLETED|Overall Study||34
8212437|NCT02116361|20252954|P1|COMPLETED|Overall Study||38
8212438|NCT02116361|20252951|P4|STARTED|Overall Study||65
8212439|NCT02116361|20252952|P3|STARTED|Overall Study||59
8212440|NCT02116361|20252953|P2|STARTED|Overall Study||65
8212441|NCT02116361|20252954|P1|STARTED|Overall Study||69
8212442|NCT02116322|20252984|P1|NOT COMPLETED|Overall Study||0
8212443|NCT02116322|20252984|P1|COMPLETED|Overall Study||1
8212444|NCT02116322|20252984|P1|STARTED|Overall Study||1
8212445|NCT02116309|20252991|P2|NOT COMPLETED|Overall Study||1
8212446|NCT02116309|20252992|P1|NOT COMPLETED|Overall Study||0
8212447|NCT02116309|20252991|P2|COMPLETED|Overall Study||477
8212448|NCT02116309|20252992|P1|COMPLETED|Overall Study||482
8212449|NCT02116309|20252991|P2|STARTED|Overall Study||478
8212450|NCT02116309|20252992|P1|STARTED|Overall Study||482
8212463|NCT02115984|20253027|P2|NOT COMPLETED|Overall Study||7
8212464|NCT02115984|20253028|P1|NOT COMPLETED|Overall Study||6
8212465|NCT02115984|20253027|P2|COMPLETED|Overall Study||16
8212466|NCT02115984|20253028|P1|COMPLETED|Overall Study||51
8212467|NCT02115984|20253027|P2|STARTED|Overall Study||23
8212468|NCT02115984|20253028|P1|STARTED|Overall Study||57
8212469|NCT02115828|20253034|P1|NOT COMPLETED|Overall Study||0
8212470|NCT02115828|20253034|P1|COMPLETED|Overall Study||9
8212471|NCT02115828|20253034|P1|STARTED|Overall Study||9
8212472|NCT02115815|20253049|P7|NOT COMPLETED|Overall Study||0
8212473|NCT02115815|20253050|P6|NOT COMPLETED|Overall Study||2
8212474|NCT02115815|20253051|P5|NOT COMPLETED|Overall Study||0
8212475|NCT02115815|20253052|P4|NOT COMPLETED|Overall Study||0
8212476|NCT02115815|20253053|P3|NOT COMPLETED|Overall Study||0
8212477|NCT02115815|20253054|P2|NOT COMPLETED|Overall Study||0
8212478|NCT02115815|20253055|P1|NOT COMPLETED|Overall Study||2
8212479|NCT02115815|20253049|P7|COMPLETED|Overall Study||20
8212480|NCT02115815|20253050|P6|COMPLETED|Overall Study||20
8212481|NCT02115815|20253051|P5|COMPLETED|Overall Study||20
8212482|NCT02115815|20253052|P4|COMPLETED|Overall Study||20
8212483|NCT02115815|20253053|P3|COMPLETED|Overall Study||20
8212484|NCT02115815|20253054|P2|COMPLETED|Overall Study||20
8212485|NCT02115815|20253055|P1|COMPLETED|Overall Study||22
8212486|NCT02115815|20253049|P7|STARTED|Overall Study||20
8212487|NCT02115815|20253050|P6|STARTED|Overall Study||22
8212488|NCT02115815|20253051|P5|STARTED|Overall Study||20
8212489|NCT02115815|20253052|P4|STARTED|Overall Study||20
8212490|NCT02115815|20253053|P3|STARTED|Overall Study||20
8212491|NCT02115815|20253054|P2|STARTED|Overall Study||20
8212492|NCT02115815|20253055|P1|STARTED|Overall Study||24
8212493|NCT02115750|20253150|P2|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
8212494|NCT02115750|20253151|P1|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
8212495|NCT02115750|20253150|P2|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
8212496|NCT02115750|20253151|P1|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
8212497|NCT02115750|20253150|P2|STARTED|Part 2: All Subjects Receive CHS-0214||284
8212498|NCT02115750|20253151|P1|STARTED|Part 2: All Subjects Receive CHS-0214||280
8212499|NCT02115750|20253150|P2|NOT COMPLETED|Part 1||12
8212500|NCT02115750|20253151|P1|NOT COMPLETED|Part 1||22
8212501|NCT02115750|20253150|P2|COMPLETED|Part 1||312
8212502|NCT02115750|20253151|P1|COMPLETED|Part 1||301
8212503|NCT02115750|20253150|P2|STARTED|Part 1||324
8212504|NCT02115750|20253151|P1|STARTED|Part 1||323
8212505|NCT02115646|20253169|P1|NOT COMPLETED|Overall Study||7
8212506|NCT02115646|20253169|P1|COMPLETED|Overall Study||22
8212507|NCT02115646|20253169|P1|STARTED|Overall Study||29
8212508|NCT02115633|20253184|P2|NOT COMPLETED|Overall Study||0
8212509|NCT02115633|20253185|P1|NOT COMPLETED|Overall Study||0
8212510|NCT02115633|20253184|P2|COMPLETED|Overall Study||16
8212511|NCT02115633|20253185|P1|COMPLETED|Overall Study||15
8212512|NCT02115633|20253184|P2|STARTED|Overall Study||16
8212513|NCT02115633|20253185|P1|STARTED|Overall Study||15
8212514|NCT02115607|20253197|P1|NOT COMPLETED|Overall Study||1
8212515|NCT02115607|20253197|P1|COMPLETED|Overall Study||16
8212516|NCT02115607|20253197|P1|STARTED|Overall Study||17
8212517|NCT02115581|20253206|P2|NOT COMPLETED|Overall Study||0
8212518|NCT02115581|20253207|P1|NOT COMPLETED|Overall Study||0
8212519|NCT02115581|20253206|P2|COMPLETED|Overall Study||21
8212520|NCT02115581|20253207|P1|COMPLETED|Overall Study||17
8212521|NCT02115581|20253206|P2|STARTED|Overall Study||21
8212522|NCT02115581|20253207|P1|STARTED|Overall Study||17
8212523|NCT02115542|20253217|P1|NOT COMPLETED|Overall Study||0
8212524|NCT02115542|20253217|P1|COMPLETED|Overall Study||39
8212525|NCT02115542|20253217|P1|STARTED|Overall Study||39
8212526|NCT02115386|20253223|P1|NOT COMPLETED|Overall Study||7
8212527|NCT02115386|20253223|P1|COMPLETED|Overall Study||0
8212528|NCT02115386|20253223|P1|STARTED|Overall Study||7
8212529|NCT02115373|20253236|P3|NOT COMPLETED|Overall Study||0
8212530|NCT02115373|20253237|P2|NOT COMPLETED|Overall Study||0
8212531|NCT02115373|20253238|P1|NOT COMPLETED|Overall Study||0
8212532|NCT02115373|20253236|P3|COMPLETED|Overall Study||49
8212533|NCT02115373|20253237|P2|COMPLETED|Overall Study||13
8212534|NCT02115373|20253238|P1|COMPLETED|Overall Study||4
8212535|NCT02115373|20253236|P3|STARTED|Overall Study||49
8212536|NCT02115373|20253237|P2|STARTED|Overall Study||13
8212537|NCT02115373|20253238|P1|STARTED|Overall Study||4
8212538|NCT02115347|20253304|P3|NOT COMPLETED|Overall Study||0
8212539|NCT02115347|20253305|P2|NOT COMPLETED|Overall Study||0
8212540|NCT02115347|20253306|P1|NOT COMPLETED|Overall Study||0
8212541|NCT02115347|20253304|P3|COMPLETED|Overall Study||0
8212542|NCT02115347|20253305|P2|COMPLETED|Overall Study||8
8212543|NCT02115347|20253306|P1|COMPLETED|Overall Study||8
8212544|NCT02115347|20253304|P3|STARTED|Overall Study||0
8212545|NCT02115347|20253305|P2|STARTED|Overall Study||8
8212546|NCT02115347|20253306|P1|STARTED|Overall Study||8
8212547|NCT02115321|20253326|P2|NOT COMPLETED|Overall Study||0
8212548|NCT02115321|20253327|P1|NOT COMPLETED|Overall Study||1
8212549|NCT02115321|20253326|P2|COMPLETED|Overall Study||10
8212550|NCT02115321|20253327|P1|COMPLETED|Overall Study||29
8212551|NCT02115321|20253326|P2|STARTED|Overall Study||10
8212552|NCT02115321|20253327|P1|STARTED|Overall Study||30
8212553|NCT02115308|20253349|P2|NOT COMPLETED|Overall Study||2
8212554|NCT02115308|20253350|P1|NOT COMPLETED|Overall Study||2
8212555|NCT02115308|20253349|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
8212556|NCT02115308|20253350|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
8212557|NCT02115308|20253349|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
8212558|NCT02115308|20253350|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
8212559|NCT02115269|20253366|P1|NOT COMPLETED|Overall Study||57
8212560|NCT02115269|20253366|P1|COMPLETED|Overall Study||702
8212561|NCT02115269|20253366|P1|STARTED|Overall Study||759
8212562|NCT02115256|20253386|P2|NOT COMPLETED|Overall Study||1
8212563|NCT02115256|20253387|P1|NOT COMPLETED|Overall Study||0
8212564|NCT02115256|20253386|P2|COMPLETED|Overall Study||2
8212565|NCT02115256|20253387|P1|COMPLETED|Overall Study||3
8212566|NCT02115256|20253386|P2|STARTED|Overall Study||3
8212567|NCT02115256|20253387|P1|STARTED|Overall Study||3
8212568|NCT02115113|20253399|P3|NOT COMPLETED|Participants Randomized||0
8212569|NCT02115113|20253400|P2|NOT COMPLETED|Participants Randomized||0
8212570|NCT02115113|20253401|P1|NOT COMPLETED|Participants Randomized||2
8212571|NCT02115113|20253399|P3|COMPLETED|Participants Randomized||0
8212572|NCT02115113|20253400|P2|COMPLETED|Participants Randomized||26
8212573|NCT02115113|20253401|P1|COMPLETED|Participants Randomized||22
8212574|NCT02115113|20253399|P3|STARTED|Participants Randomized||0
8212575|NCT02115113|20253400|P2|STARTED|Participants Randomized||26
8212576|NCT02115113|20253401|P1|STARTED|Participants Randomized||24
8212577|NCT02115113|20253399|P3|NOT COMPLETED|Participants in Run-in Period||10
8212578|NCT02115113|20253400|P2|NOT COMPLETED|Participants in Run-in Period||0
8212579|NCT02115113|20253401|P1|NOT COMPLETED|Participants in Run-in Period||0
8212580|NCT02115113|20253399|P3|COMPLETED|Participants in Run-in Period||68
8212581|NCT02115113|20253400|P2|COMPLETED|Participants in Run-in Period||0
8212582|NCT02115113|20253401|P1|COMPLETED|Participants in Run-in Period||0
8212583|NCT02115113|20253399|P3|STARTED|Participants in Run-in Period||78
8212584|NCT02115113|20253400|P2|STARTED|Participants in Run-in Period||0
8212585|NCT02115113|20253401|P1|STARTED|Participants in Run-in Period||0
8212586|NCT02115048|20253416|P2|NOT COMPLETED|Overall Study||0
8212587|NCT02115048|20253417|P1|NOT COMPLETED|Overall Study||0
8212588|NCT02115048|20253416|P2|COMPLETED|Overall Study||21
8212589|NCT02115048|20253417|P1|COMPLETED|Overall Study||23
8212590|NCT02115048|20253416|P2|STARTED|Overall Study||21
8212591|NCT02115048|20253417|P1|STARTED|Overall Study||23
8212592|NCT02114931|20253433|P2|NOT COMPLETED|Overall Study||30
8212593|NCT02114931|20253434|P1|NOT COMPLETED|Overall Study||25
8212594|NCT02114931|20253433|P2|COMPLETED|Overall Study||207
8212595|NCT02114931|20253434|P1|COMPLETED|Overall Study||205
8212596|NCT02114931|20253433|P2|Received Treatment|Overall Study||237
8212597|NCT02114931|20253434|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
8212598|NCT02114931|20253433|P2|STARTED|Overall Study||237
8212599|NCT02114931|20253434|P1|STARTED|Overall Study||230
8212600|NCT02114892|20253450|P2|NOT COMPLETED|Overall Study||2
8212601|NCT02114892|20253451|P1|NOT COMPLETED|Overall Study||1
8212602|NCT02114892|20253450|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
8212603|NCT02114892|20253451|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8212604|NCT02114892|20253450|P2|STARTED|Overall Study||12
8212605|NCT02114892|20253451|P1|STARTED|Overall Study||12
8212606|NCT02114879|20253487|P2|NOT COMPLETED|Overall Study||24
8212607|NCT02114879|20253488|P1|NOT COMPLETED|Overall Study||19
8212608|NCT02114879|20253487|P2|COMPLETED|Overall Study||90
8212609|NCT02114879|20253488|P1|COMPLETED|Overall Study||96
8212610|NCT02114879|20253487|P2|STARTED|Overall Study||114
8212611|NCT02114879|20253488|P1|STARTED|Overall Study||115
8212612|NCT02114697|20253506|P2|NOT COMPLETED|Overall Study||4
8212613|NCT02114697|20253507|P1|NOT COMPLETED|Overall Study||5
8212614|NCT02114697|20253506|P2|COMPLETED|Overall Study||0
8212615|NCT02114697|20253507|P1|COMPLETED|Overall Study||0
8212616|NCT02114697|20253506|P2|Completed Month 18 Visit|Overall Study||1
8212617|NCT02114697|20253507|P1|Completed Month 18 Visit|Overall Study||0
8212618|NCT02114697|20253506|P2|STARTED|Overall Study||4
8212619|NCT02114697|20253507|P1|STARTED|Overall Study||5
8212620|NCT02114684|20253515|P2|NOT COMPLETED|Overall Study||10
8212621|NCT02114684|20253516|P1|NOT COMPLETED|Overall Study||12
8212622|NCT02114684|20253515|P2|COMPLETED|Overall Study||88
8212623|NCT02114684|20253516|P1|COMPLETED|Overall Study||86
8212624|NCT02114684|20253515|P2|STARTED|Overall Study||98
8212625|NCT02114684|20253516|P1|STARTED|Overall Study||98
8212626|NCT02114515|20253534|P2|NOT COMPLETED|Overall Study||150
8212627|NCT02114515|20253535|P1|NOT COMPLETED|Overall Study||133
8212628|NCT02114515|20253534|P2|COMPLETED|Overall Study||368
8212629|NCT02114515|20253535|P1|COMPLETED|Overall Study||378
8212630|NCT02114515|20253534|P2|STARTED|Overall Study||518
8212631|NCT02114515|20253535|P1|STARTED|Overall Study||511
8212632|NCT02114385|20253581|P2|NOT COMPLETED|Overall Study||8
8212633|NCT02114385|20253582|P1|NOT COMPLETED|Overall Study||3
8212634|NCT02114385|20253581|P2|COMPLETED|Overall Study||243
8212635|NCT02114385|20253582|P1|COMPLETED|Overall Study||246
8212636|NCT02114385|20253581|P2|Vaccinated|Overall Study||251
8212637|NCT02114385|20253582|P1|Vaccinated|Overall Study||249
8212638|NCT02114385|20253581|P2|STARTED|Overall Study||251
8212639|NCT02114385|20253582|P1|STARTED|Overall Study||249
8212640|NCT02114307|20253606|P2|NOT COMPLETED|Overall Study||0
8212641|NCT02114307|20253607|P1|NOT COMPLETED|Overall Study||1
8212642|NCT02114307|20253606|P2|COMPLETED|Overall Study||11
8212643|NCT02114307|20253607|P1|COMPLETED|Overall Study||10
8212644|NCT02114307|20253606|P2|STARTED|Overall Study||11
8212645|NCT02114307|20253607|P1|STARTED|Overall Study||11
8212646|NCT02114268|20253623|P6|NOT COMPLETED|Overall Study||3
8212647|NCT02114268|20253624|P5|NOT COMPLETED|Overall Study||0
8212648|NCT02114268|20253625|P4|NOT COMPLETED|Overall Study||0
8212649|NCT02114268|20253626|P3|NOT COMPLETED|Overall Study||1
8212650|NCT02114268|20253627|P2|NOT COMPLETED|Overall Study||1
8212651|NCT02114268|20253628|P1|NOT COMPLETED|Overall Study||6
8212652|NCT02114268|20253623|P6|COMPLETED|Overall Study||75
8212653|NCT02114268|20253624|P5|COMPLETED|Overall Study||6
8212654|NCT02114268|20253625|P4|COMPLETED|Overall Study||6
8212655|NCT02114268|20253626|P3|COMPLETED|Overall Study||5
8212656|NCT02114268|20253627|P2|COMPLETED|Overall Study||5
8212657|NCT02114268|20253628|P1|COMPLETED|Overall Study||28
8212658|NCT02114268|20253623|P6|STARTED|Overall Study||78
8212659|NCT02114268|20253624|P5|STARTED|Overall Study||6
8212660|NCT02114268|20253625|P4|STARTED|Overall Study||6
8212661|NCT02114268|20253626|P3|STARTED|Overall Study||6
8212662|NCT02114268|20253627|P2|STARTED|Overall Study||6
8212663|NCT02114268|20253628|P1|STARTED|Overall Study||34
8212664|NCT02114216|20253681|P3|NOT COMPLETED|Overall Study||0
8212665|NCT02114216|20253682|P2|NOT COMPLETED|Overall Study||0
8212666|NCT02114216|20253683|P1|NOT COMPLETED|Overall Study||0
8212667|NCT02114216|20253681|P3|COMPLETED|Overall Study||14
8212668|NCT02114216|20253682|P2|COMPLETED|Overall Study||45
8212669|NCT02114216|20253683|P1|COMPLETED|Overall Study||16
8212670|NCT02114216|20253681|P3|STARTED|Overall Study||14
8212671|NCT02114216|20253682|P2|STARTED|Overall Study||45
8212672|NCT02114216|20253683|P1|STARTED|Overall Study||16
8212673|NCT02114203|20253697|P3|NOT COMPLETED|Overall Study||0
8212674|NCT02114203|20253698|P2|NOT COMPLETED|Overall Study||2
8212675|NCT02114203|20253699|P1|NOT COMPLETED|Overall Study||0
8212676|NCT02114203|20253697|P3|COMPLETED|Overall Study||7
8212677|NCT02114203|20253698|P2|COMPLETED|Overall Study||14
8212678|NCT02114203|20253699|P1|COMPLETED|Overall Study||7
8212679|NCT02114203|20253697|P3|STARTED|Overall Study||7
8212680|NCT02114203|20253698|P2|STARTED|Overall Study||16
8212681|NCT02114203|20253699|P1|STARTED|Overall Study||7
8212682|NCT02114177|20253733|P2|NOT COMPLETED|Overall Study||4
8212683|NCT02114177|20253734|P1|NOT COMPLETED|Overall Study||9
8212684|NCT02114177|20253733|P2|COMPLETED|Overall Study||151
8212685|NCT02114177|20253734|P1|COMPLETED|Overall Study||146
8212686|NCT02114177|20253733|P2|STARTED|Overall Study||155
8212687|NCT02114177|20253734|P1|STARTED|Overall Study||155
8212688|NCT02114151|20253758|P1|NOT COMPLETED|Overall Study||7
8212689|NCT02114151|20253758|P1|COMPLETED|Overall Study||96
8212690|NCT02114151|20253758|P1|STARTED|Overall Study||103
8212691|NCT02113956|20253775|P2|NOT COMPLETED|3 Month Post-intervention||2
8212692|NCT02113956|20253776|P1|NOT COMPLETED|3 Month Post-intervention||4
8212693|NCT02113956|20253775|P2|COMPLETED|3 Month Post-intervention||146
8212694|NCT02113956|20253776|P1|COMPLETED|3 Month Post-intervention||137
8212695|NCT02113956|20253775|P2|STARTED|3 Month Post-intervention||148
8212696|NCT02113956|20253776|P1|STARTED|3 Month Post-intervention||141
8212697|NCT02113956|20253775|P2|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
8212698|NCT02113956|20253776|P1|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
8212699|NCT02113956|20253775|P2|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
8212700|NCT02113956|20253776|P1|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
8212701|NCT02113956|20253775|P2|STARTED|Intervention End (5 Weeks Post Baseline)||152
8212702|NCT02113956|20253776|P1|STARTED|Intervention End (5 Weeks Post Baseline)||150
8212703|NCT02113579|20253810|P2|NOT COMPLETED|Overall Study||4
8212704|NCT02113579|20253811|P1|NOT COMPLETED|Overall Study||10
8212705|NCT02113579|20253810|P2|COMPLETED|Overall Study||185
8212706|NCT02113579|20253811|P1|COMPLETED|Overall Study||176
8212707|NCT02113579|20253810|P2|STARTED|Overall Study||189
8212708|NCT02113579|20253811|P1|STARTED|Overall Study||186
8212709|NCT02113449|20253835|P1|NOT COMPLETED|Overall Study||4
8212710|NCT02113449|20253835|P1|COMPLETED|Overall Study||143
8212711|NCT02113449|20253835|P1|STARTED|Overall Study||147
8212712|NCT02113436|20253851|P4|NOT COMPLETED|Period 2: 16 Weeks||11
8212713|NCT02113436|20253852|P3|NOT COMPLETED|Period 2: 16 Weeks||9
8212714|NCT02113436|20253853|P2|NOT COMPLETED|Period 2: 16 Weeks||0
8212715|NCT02113436|20253854|P1|NOT COMPLETED|Period 2: 16 Weeks||0
8212716|NCT02113436|20253851|P4|COMPLETED|Period 2: 16 Weeks||136
8212717|NCT02113436|20253852|P3|COMPLETED|Period 2: 16 Weeks||132
8212718|NCT02113436|20253853|P2|COMPLETED|Period 2: 16 Weeks||0
8212719|NCT02113436|20253854|P1|COMPLETED|Period 2: 16 Weeks||0
8212720|NCT02113436|20253851|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
8212812|NCT02112526|20254092|P1|NOT COMPLETED|Overall Study||11
8212721|NCT02113436|20253852|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
8212722|NCT02113436|20253853|P2|STARTED|Period 2: 16 Weeks||0
8212723|NCT02113436|20253854|P1|STARTED|Period 2: 16 Weeks||0
8212724|NCT02113436|20253851|P4|NOT COMPLETED|Period 1: 8 Weeks||0
8212725|NCT02113436|20253852|P3|NOT COMPLETED|Period 1: 8 Weeks||0
8212726|NCT02113436|20253853|P2|NOT COMPLETED|Period 1: 8 Weeks||2
8212727|NCT02113436|20253854|P1|NOT COMPLETED|Period 1: 8 Weeks||8
8212728|NCT02113436|20253851|P4|COMPLETED|Period 1: 8 Weeks||0
8212729|NCT02113436|20253852|P3|COMPLETED|Period 1: 8 Weeks||0
8212730|NCT02113436|20253853|P2|COMPLETED|Period 1: 8 Weeks||148
8212731|NCT02113436|20253854|P1|COMPLETED|Period 1: 8 Weeks||142
8212732|NCT02113436|20253851|P4|STARTED|Period 1: 8 Weeks||0
8212733|NCT02113436|20253852|P3|STARTED|Period 1: 8 Weeks||0
8212734|NCT02113436|20253853|P2|STARTED|Period 1: 8 Weeks||150
8212735|NCT02113436|20253854|P1|STARTED|Period 1: 8 Weeks||150
8212736|NCT02113410|20253877|P2|NOT COMPLETED|Overall Study||3
8212737|NCT02113410|20253878|P1|NOT COMPLETED|Overall Study||16
8212738|NCT02113410|20253877|P2|COMPLETED|Overall Study||63
8212739|NCT02113410|20253878|P1|COMPLETED|Overall Study||49
8212740|NCT02113410|20253877|P2|STARTED|Overall Study||66
8212741|NCT02113410|20253878|P1|STARTED|Overall Study||65
8212742|NCT02113241|20253904|P2|NOT COMPLETED|Overall Study||1
8212743|NCT02113241|20253905|P1|NOT COMPLETED|Overall Study||0
8212744|NCT02113241|20253904|P2|COMPLETED|Overall Study||11
8212745|NCT02113241|20253905|P1|COMPLETED|Overall Study||12
8212746|NCT02113241|20253904|P2|STARTED|Overall Study||12
8212747|NCT02113241|20253905|P1|STARTED|Overall Study||12
8212748|NCT02113189|20253960|P3|NOT COMPLETED|Overall Study||3
8212749|NCT02113189|20253961|P2|NOT COMPLETED|Overall Study||1
8212750|NCT02113189|20253962|P1|NOT COMPLETED|Overall Study||2
8212751|NCT02113189|20253960|P3|COMPLETED|Overall Study||2
8212752|NCT02113189|20253961|P2|COMPLETED|Overall Study||3
8212753|NCT02113189|20253962|P1|COMPLETED|Overall Study||2
8212754|NCT02113189|20253960|P3|STARTED|Overall Study||5
8212755|NCT02113189|20253961|P2|STARTED|Overall Study||4
8212756|NCT02113189|20253962|P1|STARTED|Overall Study||4
8212757|NCT02113124|20253978|P2|NOT COMPLETED|Overall Study||1
8212758|NCT02113124|20253979|P1|NOT COMPLETED|Overall Study||1
8212759|NCT02113124|20253978|P2|COMPLETED|Overall Study||24
8212760|NCT02113124|20253979|P1|COMPLETED|Overall Study||17
8212761|NCT02113124|20253978|P2|STARTED|Overall Study||25
8212762|NCT02113124|20253979|P1|STARTED|Overall Study||18
8212763|NCT02113007|20253985|P1|NOT COMPLETED|Overall Study||2
8212764|NCT02113007|20253985|P1|COMPLETED|Overall Study||0
8212765|NCT02113007|20253985|P1|STARTED|Overall Study||2
8212766|NCT02112994|20253991|P3|NOT COMPLETED|Overall Study||3
8212767|NCT02112994|20253992|P2|NOT COMPLETED|Overall Study||2
8212768|NCT02112994|20253993|P1|NOT COMPLETED|Overall Study||0
8212769|NCT02112994|20253991|P3|COMPLETED|Overall Study||6
8212770|NCT02112994|20253992|P2|COMPLETED|Overall Study||14
8212771|NCT02112994|20253993|P1|COMPLETED|Overall Study||6
8212772|NCT02112994|20253991|P3|Completed 96-week Treatment Period|Overall Study||8
8212773|NCT02112994|20253992|P2|Completed 96-week Treatment Period|Overall Study||14
8212774|NCT02112994|20253993|P1|Completed 96-week Treatment Period|Overall Study||6
8212775|NCT02112994|20253991|P3|Received 3 mg/kg QW|Overall Study||1
8212776|NCT02112994|20253992|P2|Received 3 mg/kg QW|Overall Study||1
8212777|NCT02112994|20253993|P1|Received 3 mg/kg QW|Overall Study||2
8212778|NCT02112994|20253991|P3|Received 3 mg/kg QOW|Overall Study||3
8212779|NCT02112994|20253992|P2|Received 3 mg/kg QOW|Overall Study||5
8212780|NCT02112994|20253993|P1|Received 3 mg/kg QOW|Overall Study||3
8212781|NCT02112994|20253991|P3|Received 1 mg/kg QW|Overall Study||0
8212782|NCT02112994|20253992|P2|Received 1 mg/kg QW|Overall Study||1
8212783|NCT02112994|20253993|P1|Received 1 mg/kg QW|Overall Study||1
8212784|NCT02112994|20253991|P3|Received 1 mg/kg QOW|Overall Study||9
8212785|NCT02112994|20253992|P2|Received 1 mg/kg QOW|Overall Study||16
8212786|NCT02112994|20253993|P1|Received 1 mg/kg QOW|Overall Study||6
8212787|NCT02112994|20253991|P3|Received 0.35 mg/kg QOW|Overall Study||1
8212788|NCT02112994|20253992|P2|Received 0.35 mg/kg QOW|Overall Study||0
8212789|NCT02112994|20253993|P1|Received 0.35 mg/kg QOW|Overall Study||0
8212790|NCT02112994|20253991|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8212791|NCT02112994|20253992|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8212792|NCT02112994|20253993|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8212793|NCT02112994|20253991|P3|STARTED|Overall Study||9
8212794|NCT02112994|20253992|P2|STARTED|Overall Study||16
8212795|NCT02112994|20253993|P1|STARTED|Overall Study||6
8212802|NCT02112838|20254037|P3|NOT COMPLETED|Overall Study||1
8212803|NCT02112838|20254038|P2|NOT COMPLETED|Overall Study||2
8212804|NCT02112838|20254039|P1|NOT COMPLETED|Overall Study||5
8212805|NCT02112838|20254037|P3|COMPLETED|Overall Study||24
8212806|NCT02112838|20254038|P2|COMPLETED|Overall Study||24
8212807|NCT02112838|20254039|P1|COMPLETED|Overall Study||20
8212808|NCT02112838|20254037|P3|STARTED|Overall Study||25
8212809|NCT02112838|20254038|P2|STARTED|Overall Study||26
8212810|NCT02112838|20254039|P1|STARTED|Overall Study||25
8212811|NCT02112526|20254091|P2|NOT COMPLETED|Overall Study||9
8212813|NCT02112526|20254091|P2|COMPLETED|Overall Study||1
8212814|NCT02112526|20254092|P1|COMPLETED|Overall Study||0
8212815|NCT02112526|20254091|P2|Subjects Continuing Study Medication|Overall Study||1
8212816|NCT02112526|20254092|P1|Subjects Continuing Study Medication|Overall Study||0
8212817|NCT02112526|20254091|P2|Discontinued Study|Overall Study||9
8212818|NCT02112526|20254092|P1|Discontinued Study|Overall Study||11
8212819|NCT02112526|20254091|P2|Received Study Medication|Overall Study||10
8212820|NCT02112526|20254092|P1|Received Study Medication|Overall Study||11
8212821|NCT02112526|20254091|P2|Enrolled|Overall Study||10
8212822|NCT02112526|20254092|P1|Enrolled|Overall Study||11
8212823|NCT02112526|20254091|P2|STARTED|Overall Study||10
8212824|NCT02112526|20254092|P1|STARTED|Overall Study||11
8212825|NCT02112448|20254100|P2|NOT COMPLETED|Overall Study||10
8212826|NCT02112448|20254101|P1|NOT COMPLETED|Overall Study||8
8212827|NCT02112448|20254100|P2|COMPLETED|Overall Study||30
8212828|NCT02112448|20254101|P1|COMPLETED|Overall Study||30
8212829|NCT02112448|20254100|P2|STARTED|Overall Study||40
8212830|NCT02112448|20254101|P1|STARTED|Overall Study||38
8212831|NCT02112370|20254111|P2|NOT COMPLETED|Overall Study||0
8212832|NCT02112370|20254112|P1|NOT COMPLETED|Overall Study||0
8212833|NCT02112370|20254111|P2|COMPLETED|Overall Study||74
8212834|NCT02112370|20254112|P1|COMPLETED|Overall Study||74
8212835|NCT02112370|20254111|P2|STARTED|Overall Study||74
8212836|NCT02112370|20254112|P1|STARTED|Overall Study||74
8212837|NCT02112045|20254134|P2|NOT COMPLETED|Overall Study||0
8212838|NCT02112045|20254135|P1|NOT COMPLETED|Overall Study||1
8212839|NCT02112045|20254134|P2|COMPLETED|Overall Study||45
8212840|NCT02112045|20254135|P1|COMPLETED|Overall Study||44
8212841|NCT02112045|20254134|P2|STARTED|Overall Study||45
8212842|NCT02112045|20254135|P1|STARTED|Overall Study||45
8212843|NCT02111993|20254155|P2|NOT COMPLETED|Overall Study||4
8212844|NCT02111993|20254156|P1|NOT COMPLETED|Overall Study||5
8212845|NCT02111993|20254155|P2|COMPLETED|Overall Study||26
8212846|NCT02111993|20254156|P1|COMPLETED|Overall Study||25
8212847|NCT02111993|20254155|P2|STARTED|Overall Study||30
8212848|NCT02111993|20254156|P1|STARTED|Overall Study||30
8212849|NCT02111980|20254166|P1|NOT COMPLETED|Overall Study||0
8212850|NCT02111980|20254166|P1|COMPLETED|Overall Study||50
8212851|NCT02111980|20254166|P1|STARTED|Overall Study||50
8212852|NCT02111863|20254189|P1|NOT COMPLETED|Overall Study||0
8212853|NCT02111863|20254189|P1|COMPLETED|Overall Study||6
8212854|NCT02111863|20254189|P1|STARTED|Overall Study||6
8212855|NCT02111811|20254197|P2|NOT COMPLETED|Follow up Period (Aim 2)||17
8212856|NCT02111811|20254198|P1|NOT COMPLETED|Follow up Period (Aim 2)||28
8212857|NCT02111811|20254197|P2|COMPLETED|Follow up Period (Aim 2)||97
8212858|NCT02111811|20254198|P1|COMPLETED|Follow up Period (Aim 2)||111
8212859|NCT02111811|20254197|P2|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
8212860|NCT02111811|20254198|P1|STARTED|Follow up Period (Aim 2)||139
8212861|NCT02111811|20254197|P2|NOT COMPLETED|Treatment Phase||18
8212862|NCT02111811|20254198|P1|NOT COMPLETED|Treatment Phase||24
8212863|NCT02111811|20254197|P2|COMPLETED|Treatment Phase||96
8212864|NCT02111811|20254198|P1|COMPLETED|Treatment Phase||115
8212865|NCT02111811|20254197|P2|STARTED|Treatment Phase||114
8212866|NCT02111811|20254198|P1|STARTED|Treatment Phase||139
8212867|NCT02111785|20254211|P4|NOT COMPLETED|Overall Study||0
8212868|NCT02111785|20254212|P3|NOT COMPLETED|Overall Study||0
8212869|NCT02111785|20254213|P2|NOT COMPLETED|Overall Study||1
8212870|NCT02111785|20254214|P1|NOT COMPLETED|Overall Study||0
8212871|NCT02111785|20254211|P4|COMPLETED|Overall Study||1
8212872|NCT02111785|20254212|P3|COMPLETED|Overall Study||1
8212873|NCT02111785|20254213|P2|COMPLETED|Overall Study||4
8212874|NCT02111785|20254214|P1|COMPLETED|Overall Study||3
8212875|NCT02111785|20254211|P4|STARTED|Overall Study||1
8212876|NCT02111785|20254212|P3|STARTED|Overall Study||1
8212877|NCT02111785|20254213|P2|STARTED|Overall Study||5
8212878|NCT02111785|20254214|P1|STARTED|Overall Study||3
8212879|NCT02111772|20254242|P2|NOT COMPLETED|Overall Study||0
8212880|NCT02111772|20254243|P1|NOT COMPLETED|Overall Study||0
8212881|NCT02111772|20254242|P2|COMPLETED|Overall Study||14
8212882|NCT02111772|20254243|P1|COMPLETED|Overall Study||12
8212883|NCT02111772|20254242|P2|STARTED|Overall Study||14
8212884|NCT02111772|20254243|P1|STARTED|Overall Study||12
8212885|NCT02111746|20254253|P2|NOT COMPLETED|Overall Study||2
8212886|NCT02111746|20254254|P1|NOT COMPLETED|Overall Study||3
8212887|NCT02111746|20254253|P2|COMPLETED|Overall Study||169
8212888|NCT02111746|20254254|P1|COMPLETED|Overall Study||169
8212889|NCT02111746|20254253|P2|STARTED|Overall Study||171
8212890|NCT02111746|20254254|P1|STARTED|Overall Study||172
8212891|NCT02111603|20254276|P1|NOT COMPLETED|Overall Study||1
8212892|NCT02111603|20254276|P1|COMPLETED|Overall Study||12
8212893|NCT02111603|20254276|P1|STARTED|Overall Study||13
8212894|NCT02111564|20254287|P2|NOT COMPLETED|Overall Study||143
8212895|NCT02111564|20254288|P1|NOT COMPLETED|Overall Study||131
8212896|NCT02111564|20254287|P2|COMPLETED|Overall Study||5869
8212897|NCT02111564|20254288|P1|COMPLETED|Overall Study||5876
8212898|NCT02111564|20254287|P2|Treated|Overall Study||5980
8212899|NCT02111564|20254288|P1|Treated|Overall Study||5982
8212900|NCT02111564|20254287|P2|STARTED|Overall Study||6012
8212901|NCT02111564|20254288|P1|STARTED|Overall Study||6007
8212902|NCT02111447|20254310|P4|NOT COMPLETED|Overall Study||0
8212903|NCT02111447|20254311|P3|NOT COMPLETED|Overall Study||0
8212904|NCT02111447|20254312|P2|NOT COMPLETED|Overall Study||0
8212905|NCT02111447|20254313|P1|NOT COMPLETED|Overall Study||0
8212906|NCT02111447|20254310|P4|COMPLETED|Overall Study||0
8212907|NCT02111447|20254311|P3|COMPLETED|Overall Study||1
8212908|NCT02111447|20254312|P2|COMPLETED|Overall Study||5
8212909|NCT02111447|20254313|P1|COMPLETED|Overall Study||0
8212910|NCT02111447|20254310|P4|STARTED|Overall Study||0
8212911|NCT02111447|20254311|P3|STARTED|Overall Study||1
8212912|NCT02111447|20254312|P2|STARTED|Overall Study||5
8212913|NCT02111447|20254313|P1|STARTED|Overall Study||0
8212914|NCT02111369|20254327|P1|NOT COMPLETED|Overall Study||3
8212915|NCT02111369|20254327|P1|COMPLETED|Overall Study||15
8212916|NCT02111369|20254327|P1|STARTED|Overall Study||18
8212917|NCT02111252|20254335|P1|NOT COMPLETED|Overall Study||0
8212918|NCT02111252|20254335|P1|COMPLETED|Overall Study||55
8212919|NCT02111252|20254335|P1|STARTED|Overall Study||55
8212920|NCT02111213|20254351|P2|NOT COMPLETED|Overall Study||6
8212921|NCT02111213|20254352|P1|NOT COMPLETED|Overall Study||6
8212922|NCT02111213|20254351|P2|COMPLETED|Overall Study||117
8212923|NCT02111213|20254352|P1|COMPLETED|Overall Study||116
8212924|NCT02111213|20254351|P2|STARTED|Overall Study||123
8212925|NCT02111213|20254352|P1|STARTED|Overall Study||122
8212926|NCT02111200|20254366|P4|NOT COMPLETED|Overall Study||0
8212927|NCT02111200|20254367|P3|NOT COMPLETED|Overall Study||0
8212928|NCT02111200|20254368|P2|NOT COMPLETED|Overall Study||0
8212929|NCT02111200|20254369|P1|NOT COMPLETED|Overall Study||0
8212930|NCT02111200|20254366|P4|COMPLETED|Overall Study||1
8212931|NCT02111200|20254367|P3|COMPLETED|Overall Study||1
8212932|NCT02111200|20254368|P2|COMPLETED|Overall Study||2
8212933|NCT02111200|20254369|P1|COMPLETED|Overall Study||3
8212934|NCT02111200|20254366|P4|STARTED|Overall Study||1
8212935|NCT02111200|20254367|P3|STARTED|Overall Study||1
8212936|NCT02111200|20254368|P2|STARTED|Overall Study||2
8212937|NCT02111200|20254369|P1|STARTED|Overall Study||3
8212938|NCT02111187|20254385|P2|NOT COMPLETED|Overall Study||0
8212939|NCT02111187|20254386|P1|NOT COMPLETED|Overall Study||0
8212940|NCT02111187|20254385|P2|COMPLETED|Overall Study||7
8212941|NCT02111187|20254386|P1|COMPLETED|Overall Study||7
8212942|NCT02111187|20254385|P2|STARTED|Overall Study||7
8212943|NCT02111187|20254386|P1|STARTED|Overall Study||7
8212944|NCT02111174|20254400|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
8212945|NCT02111174|20254401|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
8212946|NCT02111174|20254400|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
8212947|NCT02111174|20254401|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
8212948|NCT02111174|20254400|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
8212949|NCT02111174|20254401|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
8212950|NCT02111174|20254400|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
8212951|NCT02111174|20254401|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
8212952|NCT02111174|20254400|P2|NOT COMPLETED|Treatment and Primary Outcome||2
8212953|NCT02111174|20254401|P1|NOT COMPLETED|Treatment and Primary Outcome||3
8212954|NCT02111174|20254400|P2|COMPLETED|Treatment and Primary Outcome||16
8212955|NCT02111174|20254401|P1|COMPLETED|Treatment and Primary Outcome||15
8212956|NCT02111174|20254400|P2|STARTED|Treatment and Primary Outcome||18
8212957|NCT02111174|20254401|P1|STARTED|Treatment and Primary Outcome||18
8212958|NCT02111096|20254430|P3|NOT COMPLETED|Overall Study||66
8212959|NCT02111096|20254431|P2|NOT COMPLETED|Overall Study||41
8212960|NCT02111096|20254432|P1|NOT COMPLETED|Overall Study||64
8212961|NCT02111096|20254430|P3|COMPLETED|Overall Study||2
8212962|NCT02111096|20254431|P2|COMPLETED|Overall Study||0
8212963|NCT02111096|20254432|P1|COMPLETED|Overall Study||1
8212964|NCT02111096|20254430|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
8212965|NCT02111096|20254431|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
8212966|NCT02111096|20254432|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
8212967|NCT02111096|20254430|P3|STARTED|Overall Study||68
8212968|NCT02111096|20254431|P2|STARTED|Overall Study||41
8212969|NCT02111096|20254432|P1|STARTED|Overall Study||65
8212970|NCT02111083|20254480|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8212971|NCT02111083|20254481|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8212972|NCT02111083|20254480|P2|COMPLETED|Fourth Intervention (1 Day)||18
8212973|NCT02111083|20254481|P1|COMPLETED|Fourth Intervention (1 Day)||18
8212974|NCT02111083|20254480|P2|STARTED|Fourth Intervention (1 Day)||18
8212975|NCT02111083|20254481|P1|STARTED|Fourth Intervention (1 Day)||18
8212976|NCT02111083|20254480|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
8212977|NCT02111083|20254481|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
8212978|NCT02111083|20254480|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
8212979|NCT02111083|20254481|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
8212980|NCT02111083|20254480|P2|STARTED|Interval Between Dosing (7-8 Days)||19
8212981|NCT02111083|20254481|P1|STARTED|Interval Between Dosing (7-8 Days)||19
8212982|NCT02111083|20254480|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8212983|NCT02111083|20254481|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8212984|NCT02111083|20254480|P2|COMPLETED|Third Intervention (1 Day)||19
8212985|NCT02111083|20254481|P1|COMPLETED|Third Intervention (1 Day)||19
8212986|NCT02111083|20254480|P2|STARTED|Third Intervention (1 Day)||19
8212987|NCT02111083|20254481|P1|STARTED|Third Intervention (1 Day)||19
8212988|NCT02111083|20254480|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8212989|NCT02111083|20254481|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8212990|NCT02111083|20254480|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
8212991|NCT02111083|20254481|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
8212992|NCT02111083|20254480|P2|STARTED|Interval Between Dosing (7-8 Days)||19
8212993|NCT02111083|20254481|P1|STARTED|Interval Between Dosing (7-8 Days)||19
8212994|NCT02111083|20254480|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8212995|NCT02111083|20254481|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8212996|NCT02111083|20254480|P2|COMPLETED|Second Intervention (1 Day)||19
8212997|NCT02111083|20254481|P1|COMPLETED|Second Intervention (1 Day)||19
8212998|NCT02111083|20254480|P2|STARTED|Second Intervention (1 Day)||19
8212999|NCT02111083|20254481|P1|STARTED|Second Intervention (1 Day)||19
8213000|NCT02111083|20254480|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8213001|NCT02111083|20254481|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8213002|NCT02111083|20254480|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
8213003|NCT02111083|20254481|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
8213004|NCT02111083|20254480|P2|STARTED|Interval Between Dosing (7-8 Days)||19
8213005|NCT02111083|20254481|P1|STARTED|Interval Between Dosing (7-8 Days)||19
8213006|NCT02111083|20254480|P2|NOT COMPLETED|First Intervention (1 Day)||0
8213007|NCT02111083|20254481|P1|NOT COMPLETED|First Intervention (1 Day)||0
8213008|NCT02111083|20254480|P2|COMPLETED|First Intervention (1 Day)||19
8213009|NCT02111083|20254481|P1|COMPLETED|First Intervention (1 Day)||19
8213010|NCT02111083|20254480|P2|STARTED|First Intervention (1 Day)||19
8213011|NCT02111083|20254481|P1|STARTED|First Intervention (1 Day)||19
8213012|NCT02110901|20254501|P2|NOT COMPLETED|Overall Study||14
8213013|NCT02110901|20254502|P1|NOT COMPLETED|Overall Study||30
8213014|NCT02110901|20254501|P2|COMPLETED|Overall Study||88
8213015|NCT02110901|20254502|P1|COMPLETED|Overall Study||179
8213016|NCT02110901|20254501|P2|STARTED|Overall Study||102
8213017|NCT02110901|20254502|P1|STARTED|Overall Study||209
8213018|NCT02110706|20254516|P2|NOT COMPLETED|Overall Study||4
8213019|NCT02110706|20254517|P1|NOT COMPLETED|Overall Study||5
8213020|NCT02110706|20254516|P2|COMPLETED|Overall Study||23
8213021|NCT02110706|20254517|P1|COMPLETED|Overall Study||20
8213022|NCT02110706|20254516|P2|No. Completing Study Through Week 52|Overall Study||24
8213023|NCT02110706|20254517|P1|No. Completing Study Through Week 52|Overall Study||23
8213024|NCT02110706|20254516|P2|STARTED|Overall Study||27
8213025|NCT02110706|20254517|P1|STARTED|Overall Study||25
8213026|NCT02110693|20254529|P2|NOT COMPLETED|Overall Study||29
8213027|NCT02110693|20254530|P1|NOT COMPLETED|Overall Study||28
8213028|NCT02110693|20254529|P2|COMPLETED|Overall Study||1002
8213029|NCT02110693|20254530|P1|COMPLETED|Overall Study||998
8213030|NCT02110693|20254529|P2|STARTED|Overall Study||1031
8213031|NCT02110693|20254530|P1|STARTED|Overall Study||1026
8213032|NCT02110485|20254557|P2|NOT COMPLETED|Overall Study||19
8213033|NCT02110485|20254558|P1|NOT COMPLETED|Overall Study||7
8213034|NCT02110485|20254557|P2|COMPLETED|Overall Study||83
8213035|NCT02110485|20254558|P1|COMPLETED|Overall Study||91
8213036|NCT02110485|20254557|P2|STARTED|Overall Study||102
8213037|NCT02110485|20254558|P1|STARTED|Overall Study||98
8213038|NCT02110381|20254576|P2|NOT COMPLETED|Dual Modality||1
8213039|NCT02110381|20254577|P1|NOT COMPLETED|Dual Modality||2
8213040|NCT02110381|20254576|P2|COMPLETED|Dual Modality||7
8213041|NCT02110381|20254577|P1|COMPLETED|Dual Modality||5
8213042|NCT02110381|20254576|P2|Began Active Treatment|Dual Modality||7
8213043|NCT02110381|20254577|P1|Began Active Treatment|Dual Modality||7
8213044|NCT02110381|20254576|P2|STARTED|Dual Modality||8
8213045|NCT02110381|20254577|P1|STARTED|Dual Modality||7
8213046|NCT02110381|20254576|P2|NOT COMPLETED|Single Modality||1
8213047|NCT02110381|20254577|P1|NOT COMPLETED|Single Modality||2
8213048|NCT02110381|20254576|P2|COMPLETED|Single Modality||8
8213049|NCT02110381|20254577|P1|COMPLETED|Single Modality||7
8213050|NCT02110381|20254576|P2|STARTED|Single Modality||9
8213051|NCT02110381|20254577|P1|STARTED|Single Modality||9
8213052|NCT02110277|20254588|P1|NOT COMPLETED|Overall Study||2
8213053|NCT02110277|20254588|P1|COMPLETED|Overall Study||0
8213054|NCT02110277|20254588|P1|STARTED|Overall Study||2
8213055|NCT02110264|20254596|P3|NOT COMPLETED|Overall Study||9
8213056|NCT02110264|20254597|P2|NOT COMPLETED|Overall Study||12
8213057|NCT02110264|20254598|P1|NOT COMPLETED|Overall Study||18
8213058|NCT02110264|20254596|P3|COMPLETED|Overall Study||39
8213059|NCT02110264|20254597|P2|COMPLETED|Overall Study||38
8213060|NCT02110264|20254598|P1|COMPLETED|Overall Study||35
8213061|NCT02110264|20254596|P3|STARTED|Overall Study||48
8213062|NCT02110264|20254597|P2|STARTED|Overall Study||50
8213063|NCT02110264|20254598|P1|STARTED|Overall Study||53
8213064|NCT02110238|20254611|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
8213065|NCT02110238|20254612|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
8213066|NCT02110238|20254611|P2|COMPLETED|14 Week Blinded Extension Phase||188
8213067|NCT02110238|20254612|P1|COMPLETED|14 Week Blinded Extension Phase||190
8213068|NCT02110238|20254611|P2|STARTED|14 Week Blinded Extension Phase||200
8213069|NCT02110238|20254612|P1|STARTED|14 Week Blinded Extension Phase||202
8213070|NCT02110238|20254611|P2|NOT COMPLETED|12 Week Pivotal Phase||9
8213071|NCT02110238|20254612|P1|NOT COMPLETED|12 Week Pivotal Phase||10
8213072|NCT02110238|20254611|P2|COMPLETED|12 Week Pivotal Phase||200
8213073|NCT02110238|20254612|P1|COMPLETED|12 Week Pivotal Phase||202
8213074|NCT02110238|20254611|P2|STARTED|12 Week Pivotal Phase||209
8213075|NCT02110238|20254612|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
8213076|NCT02110225|20254621|P3|NOT COMPLETED|Overall Study||0
8213077|NCT02110225|20254622|P2|NOT COMPLETED|Overall Study||1
8213078|NCT02110225|20254623|P1|NOT COMPLETED|Overall Study||0
8213079|NCT02110225|20254621|P3|COMPLETED|Overall Study||10
8213080|NCT02110225|20254622|P2|COMPLETED|Overall Study||19
8213081|NCT02110225|20254623|P1|COMPLETED|Overall Study||20
8213082|NCT02110225|20254621|P3|STARTED|Overall Study||10
8213083|NCT02110225|20254622|P2|STARTED|Overall Study||20
8213084|NCT02110225|20254623|P1|STARTED|Overall Study||20
8213085|NCT02110147|20254675|P1|NOT COMPLETED|Overall Study||0
8213086|NCT02110147|20254675|P1|COMPLETED|Overall Study||4
8213087|NCT02110147|20254675|P1|STARTED|Overall Study||4
8213088|NCT02110095|20254681|P1|NOT COMPLETED|Overall Study||7
8213089|NCT02110095|20254681|P1|COMPLETED|Overall Study||8
8213090|NCT02110095|20254681|P1|STARTED|Overall Study||15
8213091|NCT02109939|20254688|P2|NOT COMPLETED|Overall Study||110
8213092|NCT02109939|20254689|P1|NOT COMPLETED|Overall Study||121
8213093|NCT02109939|20254688|P2|COMPLETED|Overall Study||607
8213094|NCT02109939|20254689|P1|COMPLETED|Overall Study||560
8213095|NCT02109939|20254688|P2|STARTED|Overall Study||717
8213096|NCT02109939|20254689|P1|STARTED|Overall Study||681
8213097|NCT02109809|20254712|P1|NOT COMPLETED|Overall Study||3
8213098|NCT02109809|20254712|P1|COMPLETED|Overall Study||1
8213099|NCT02109809|20254712|P1|STARTED|Overall Study||4
8213100|NCT02109731|20254718|P1|NOT COMPLETED|Overall Study||0
8213101|NCT02109731|20254718|P1|COMPLETED|Overall Study||15
8213102|NCT02109731|20254718|P1|STARTED|Overall Study||15
8213103|NCT02109640|20254724|P2|NOT COMPLETED|Overall Study||0
8213104|NCT02109640|20254725|P1|NOT COMPLETED|Overall Study||0
8213105|NCT02109640|20254724|P2|COMPLETED|Overall Study||23
8213106|NCT02109640|20254725|P1|COMPLETED|Overall Study||27
8213107|NCT02109640|20254724|P2|STARTED|Overall Study||23
8213108|NCT02109640|20254725|P1|STARTED|Overall Study||27
8213109|NCT02109562|20254738|P3|NOT COMPLETED|Overall Study||35
8213110|NCT02109562|20254739|P2|NOT COMPLETED|Overall Study||34
8213111|NCT02109562|20254740|P1|NOT COMPLETED|Overall Study||26
8213112|NCT02109562|20254738|P3|COMPLETED|Overall Study||84
8213113|NCT02109562|20254739|P2|COMPLETED|Overall Study||85
8213114|NCT02109562|20254740|P1|COMPLETED|Overall Study||90
8213115|NCT02109562|20254738|P3|Intent to Treat (ITT)|Overall Study||112
8213116|NCT02109562|20254739|P2|Intent to Treat (ITT)|Overall Study||114
8213117|NCT02109562|20254740|P1|Intent to Treat (ITT)|Overall Study||111
8213118|NCT02109562|20254738|P3|Safety|Overall Study||118
8213119|NCT02109562|20254739|P2|Safety|Overall Study||117
8213120|NCT02109562|20254740|P1|Safety|Overall Study||115
8213121|NCT02109562|20254738|P3|STARTED|Overall Study||119
8213122|NCT02109562|20254739|P2|STARTED|Overall Study||119
8213123|NCT02109562|20254740|P1|STARTED|Overall Study||116
8213124|NCT02109497|20254754|P1|NOT COMPLETED|Overall Study||1
8213125|NCT02109497|20254754|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
8213126|NCT02109497|20254754|P1|STARTED|Overall Study||18
8213127|NCT02109484|20254767|P8|NOT COMPLETED|Overall Study||3
8213128|NCT02109484|20254768|P7|NOT COMPLETED|Overall Study||3
8213129|NCT02109484|20254769|P6|NOT COMPLETED|Overall Study||1
8213130|NCT02109484|20254770|P5|NOT COMPLETED|Overall Study||4
8213131|NCT02109484|20254771|P4|NOT COMPLETED|Overall Study||1
8213132|NCT02109484|20254772|P3|NOT COMPLETED|Overall Study||0
8213133|NCT02109484|20254773|P2|NOT COMPLETED|Overall Study||0
8213134|NCT02109484|20254774|P1|NOT COMPLETED|Overall Study||0
8213135|NCT02109484|20254767|P8|COMPLETED|Overall Study||47
8213136|NCT02109484|20254768|P7|COMPLETED|Overall Study||47
8213137|NCT02109484|20254769|P6|COMPLETED|Overall Study||11
8213138|NCT02109484|20254770|P5|COMPLETED|Overall Study||46
8213139|NCT02109484|20254771|P4|COMPLETED|Overall Study||11
8213140|NCT02109484|20254772|P3|COMPLETED|Overall Study||12
8213141|NCT02109484|20254773|P2|COMPLETED|Overall Study||13
8213142|NCT02109484|20254774|P1|COMPLETED|Overall Study||5
8213143|NCT02109484|20254767|P8|STARTED|Overall Study||50
8213144|NCT02109484|20254768|P7|STARTED|Overall Study||50
8213145|NCT02109484|20254769|P6|STARTED|Overall Study||12
8213146|NCT02109484|20254770|P5|STARTED|Overall Study||50
8213147|NCT02109484|20254771|P4|STARTED|Overall Study||12
8213148|NCT02109484|20254772|P3|STARTED|Overall Study||12
8213149|NCT02109484|20254773|P2|STARTED|Overall Study||13
8213150|NCT02109484|20254774|P1|STARTED|Overall Study||5
8213151|NCT02109458|20254823|P1|NOT COMPLETED|Overall Study||0
8213152|NCT02109458|20254823|P1|COMPLETED|Overall Study||24
8213153|NCT02109458|20254823|P1|STARTED|Overall Study||24
8213154|NCT02109445|20254830|P1|NOT COMPLETED|Overall Study||3
8213155|NCT02109445|20254830|P1|COMPLETED|Overall Study||0
8213156|NCT02109445|20254830|P1|STARTED|Overall Study||3
8213157|NCT02109432|20254863|P1|NOT COMPLETED|Overall Study||1
8213158|NCT02109432|20254863|P1|COMPLETED|Overall Study||6
8213159|NCT02109432|20254863|P1|STARTED|Overall Study||7
8213160|NCT02109419|20254867|P1|NOT COMPLETED|Overall Study||0
8213161|NCT02109419|20254867|P1|COMPLETED|Overall Study||57
8213162|NCT02109419|20254867|P1|STARTED|Overall Study||57
8213163|NCT02109172|20254873|P6|NOT COMPLETED|Overall Study||1
8213164|NCT02109172|20254874|P5|NOT COMPLETED|Overall Study||1
8213165|NCT02109172|20254875|P4|NOT COMPLETED|Overall Study||1
8213166|NCT02109172|20254876|P3|NOT COMPLETED|Overall Study||1
8213167|NCT02109172|20254877|P2|NOT COMPLETED|Overall Study||0
8213168|NCT02109172|20254878|P1|NOT COMPLETED|Overall Study||1
8213169|NCT02109172|20254873|P6|COMPLETED|Overall Study||10
8213170|NCT02109172|20254874|P5|COMPLETED|Overall Study||9
8213171|NCT02109172|20254875|P4|COMPLETED|Overall Study||10
8213172|NCT02109172|20254876|P3|COMPLETED|Overall Study||9
8213173|NCT02109172|20254877|P2|COMPLETED|Overall Study||11
8213174|NCT02109172|20254878|P1|COMPLETED|Overall Study||10
8213175|NCT02109172|20254873|P6|STARTED|Overall Study||11
8213176|NCT02109172|20254874|P5|STARTED|Overall Study||10
8213177|NCT02109172|20254875|P4|STARTED|Overall Study||11
8213178|NCT02109172|20254876|P3|STARTED|Overall Study||10
8213179|NCT02109172|20254877|P2|STARTED|Overall Study||11
8213180|NCT02109172|20254878|P1|STARTED|Overall Study||11
8213181|NCT02109159|20254888|P2|NOT COMPLETED|Overall Study||0
8213182|NCT02109159|20254889|P1|NOT COMPLETED|Overall Study||0
8213183|NCT02109159|20254888|P2|COMPLETED|Overall Study||4175
8213184|NCT02109159|20254889|P1|COMPLETED|Overall Study||4178
8213185|NCT02109159|20254888|P2|STARTED|Overall Study||4175
8213186|NCT02109159|20254889|P1|STARTED|Overall Study||4178
8213187|NCT02109133|20254899|P2|NOT COMPLETED|Overall Study||0
8213188|NCT02109133|20254900|P1|NOT COMPLETED|Overall Study||1
8213189|NCT02109133|20254899|P2|COMPLETED|Overall Study||34
8213190|NCT02109133|20254900|P1|COMPLETED|Overall Study||32
8213191|NCT02109133|20254899|P2|STARTED|Overall Study||34
8213192|NCT02109133|20254900|P1|STARTED|Overall Study||33
8213193|NCT02109107|20254912|P1|NOT COMPLETED|Overall Study||2
8213194|NCT02109107|20254912|P1|COMPLETED|Overall Study||52
8213195|NCT02109107|20254912|P1|STARTED|Overall Study||54
8213196|NCT02109042|20254919|P1|NOT COMPLETED|Overall Study||15
8213197|NCT02109042|20254919|P1|COMPLETED|Overall Study||0
8213198|NCT02109042|20254919|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
8213199|NCT02109042|20254919|P1|Received 180 mg Loading Dose|Overall Study||15
8213200|NCT02109042|20254919|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8213201|NCT02109042|20254919|P1|STARTED|Overall Study||15
8213202|NCT02109029|20254928|P6|NOT COMPLETED|Part B||1
8213203|NCT02109029|20254929|P5|NOT COMPLETED|Part B||1
8213204|NCT02109029|20254930|P4|NOT COMPLETED|Part B||0
8213205|NCT02109029|20254931|P3|NOT COMPLETED|Part B||0
8213206|NCT02109029|20254932|P2|NOT COMPLETED|Part B||0
8213207|NCT02109029|20254933|P1|NOT COMPLETED|Part B||0
8213208|NCT02109029|20254928|P6|COMPLETED|Part B||5
8213209|NCT02109029|20254929|P5|COMPLETED|Part B||5
8213210|NCT02109029|20254930|P4|COMPLETED|Part B||0
8213211|NCT02109029|20254931|P3|COMPLETED|Part B||0
8213212|NCT02109029|20254932|P2|COMPLETED|Part B||0
8213213|NCT02109029|20254933|P1|COMPLETED|Part B||0
8213214|NCT02109029|20254928|P6|Received at Least One Dose of Study Drug|Part B||6
8213215|NCT02109029|20254929|P5|Received at Least One Dose of Study Drug|Part B||6
8213216|NCT02109029|20254930|P4|Received at Least One Dose of Study Drug|Part B||0
8213217|NCT02109029|20254931|P3|Received at Least One Dose of Study Drug|Part B||0
8213218|NCT02109029|20254932|P2|Received at Least One Dose of Study Drug|Part B||0
8213219|NCT02109029|20254933|P1|Received at Least One Dose of Study Drug|Part B||0
8213220|NCT02109029|20254928|P6|STARTED|Part B|New participants entered Part B.|6
8213221|NCT02109029|20254929|P5|STARTED|Part B|New participants entered Part B.|6
8213222|NCT02109029|20254930|P4|STARTED|Part B||0
8213223|NCT02109029|20254931|P3|STARTED|Part B||0
8213224|NCT02109029|20254932|P2|STARTED|Part B||0
8213225|NCT02109029|20254933|P1|STARTED|Part B||0
8213226|NCT02109029|20254928|P6|NOT COMPLETED|Part A||0
8213227|NCT02109029|20254929|P5|NOT COMPLETED|Part A||0
8213228|NCT02109029|20254930|P4|NOT COMPLETED|Part A||0
8213229|NCT02109029|20254931|P3|NOT COMPLETED|Part A||0
8213230|NCT02109029|20254932|P2|NOT COMPLETED|Part A||0
8213231|NCT02109029|20254933|P1|NOT COMPLETED|Part A||0
8213232|NCT02109029|20254928|P6|COMPLETED|Part A||0
8213233|NCT02109029|20254929|P5|COMPLETED|Part A||0
8213234|NCT02109029|20254930|P4|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
8213235|NCT02109029|20254931|P3|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
8213236|NCT02109029|20254932|P2|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
8213237|NCT02109029|20254933|P1|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
8213238|NCT02109029|20254928|P6|Received One Dose of Study Drug|Part A||0
8213239|NCT02109029|20254929|P5|Received One Dose of Study Drug|Part A||0
8213240|NCT02109029|20254930|P4|Received One Dose of Study Drug|Part A||4
8213241|NCT02109029|20254931|P3|Received One Dose of Study Drug|Part A||4
8213242|NCT02109029|20254932|P2|Received One Dose of Study Drug|Part A||2
8213243|NCT02109029|20254933|P1|Received One Dose of Study Drug|Part A||2
8213244|NCT02109029|20254928|P6|STARTED|Part A||0
8213245|NCT02109029|20254929|P5|STARTED|Part A||0
8213246|NCT02109029|20254930|P4|STARTED|Part A||4
8213247|NCT02109029|20254931|P3|STARTED|Part A||4
8213248|NCT02109029|20254932|P2|STARTED|Part A||2
8213249|NCT02109029|20254933|P1|STARTED|Part A||2
8213250|NCT02108977|20254947|P2|NOT COMPLETED|Overall Study||1
8213251|NCT02108977|20254948|P1|NOT COMPLETED|Overall Study||10
8213252|NCT02108977|20254947|P2|COMPLETED|Overall Study||19
8213253|NCT02108977|20254948|P1|COMPLETED|Overall Study||8
8213254|NCT02108977|20254947|P2|STARTED|Overall Study||20
8213255|NCT02108977|20254948|P1|STARTED|Overall Study||18
8213256|NCT02108964|20254970|P8|NOT COMPLETED|Overall Study||12
8213257|NCT02108964|20254971|P7|NOT COMPLETED|Overall Study||11
8213258|NCT02108964|20254972|P6|NOT COMPLETED|Overall Study||5
8213259|NCT02108964|20254973|P5|NOT COMPLETED|Overall Study||25
8213260|NCT02108964|20254974|P4|NOT COMPLETED|Overall Study||6
8213261|NCT02108964|20254975|P3|NOT COMPLETED|Overall Study||65
8213262|NCT02108964|20254976|P2|NOT COMPLETED|Overall Study||32
8213263|NCT02108964|20254977|P1|NOT COMPLETED|Overall Study||14
8213264|NCT02108964|20254970|P8|COMPLETED|Overall Study||33
8213265|NCT02108964|20254971|P7|COMPLETED|Overall Study||0
8213266|NCT02108964|20254972|P6|COMPLETED|Overall Study||0
8213267|NCT02108964|20254973|P5|COMPLETED|Overall Study||3
8213268|NCT02108964|20254974|P4|COMPLETED|Overall Study||2
8213269|NCT02108964|20254975|P3|COMPLETED|Overall Study||8
8213270|NCT02108964|20254976|P2|COMPLETED|Overall Study||6
8213271|NCT02108964|20254977|P1|COMPLETED|Overall Study||3
8213272|NCT02108964|20254970|P8|STARTED|Overall Study||45
8213273|NCT02108964|20254971|P7|STARTED|Overall Study||11
8213274|NCT02108964|20254972|P6|STARTED|Overall Study||5
8213275|NCT02108964|20254973|P5|STARTED|Overall Study||28
8213276|NCT02108964|20254974|P4|STARTED|Overall Study||8
8213277|NCT02108964|20254975|P3|STARTED|Overall Study||73
8213278|NCT02108964|20254976|P2|STARTED|Overall Study||38
8213279|NCT02108964|20254977|P1|STARTED|Overall Study||17
8213280|NCT02108951|20254996|P1|NOT COMPLETED|Overall Study||16
8213281|NCT02108951|20254996|P1|COMPLETED|Overall Study||4
8213282|NCT02108951|20254996|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
8213283|NCT02108912|20255015|P2|NOT COMPLETED|Overall Study||1
8213284|NCT02108912|20255016|P1|NOT COMPLETED|Overall Study||3
8213285|NCT02108912|20255015|P2|COMPLETED|Overall Study||6
8213286|NCT02108912|20255016|P1|COMPLETED|Overall Study||6
8213287|NCT02108912|20255015|P2|STARTED|Overall Study||7
8213288|NCT02108912|20255016|P1|STARTED|Overall Study||9
8213289|NCT02108691|20255026|P2|NOT COMPLETED|Overall Study||9
8213290|NCT02108691|20255027|P1|NOT COMPLETED|Overall Study||8
8213291|NCT02108691|20255026|P2|COMPLETED|Overall Study||31
8213292|NCT02108691|20255027|P1|COMPLETED|Overall Study||32
8213293|NCT02108691|20255026|P2|STARTED|Overall Study||40
8213294|NCT02108691|20255027|P1|STARTED|Overall Study||40
8213295|NCT02108652|20255045|P1|NOT COMPLETED|Overall Study||310
8213296|NCT02108652|20255045|P1|COMPLETED|Overall Study||0
8213297|NCT02108652|20255045|P1|STARTED|Overall Study||310
8213298|NCT02108600|20255068|P2|NOT COMPLETED|Overall Study||1
8213299|NCT02108600|20255069|P1|NOT COMPLETED|Overall Study||3
8213300|NCT02108600|20255068|P2|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
8213301|NCT02108600|20255069|P1|COMPLETED|Overall Study||14
8213302|NCT02108600|20255068|P2|STARTED|Overall Study||16
8213303|NCT02108600|20255069|P1|STARTED|Overall Study||17
8213304|NCT02108457|20255083|P2|NOT COMPLETED|Overall Study||2
8213305|NCT02108457|20255084|P1|NOT COMPLETED|Overall Study||0
8213306|NCT02108457|20255083|P2|COMPLETED|Overall Study||10
8213307|NCT02108457|20255084|P1|COMPLETED|Overall Study||3
8213308|NCT02108457|20255083|P2|STARTED|Overall Study||12
8213309|NCT02108457|20255084|P1|STARTED|Overall Study||3
8213310|NCT02108288|20255093|P3|NOT COMPLETED|Overall Study||0
8213311|NCT02108288|20255094|P2|NOT COMPLETED|Overall Study||0
8213312|NCT02108288|20255095|P1|NOT COMPLETED|Overall Study||0
8213313|NCT02108288|20255093|P3|COMPLETED|Overall Study||10
8213314|NCT02108288|20255094|P2|COMPLETED|Overall Study||10
8213315|NCT02108288|20255095|P1|COMPLETED|Overall Study||10
8213316|NCT02108288|20255093|P3|STARTED|Overall Study||10
8213317|NCT02108288|20255094|P2|STARTED|Overall Study||10
8213318|NCT02108288|20255095|P1|STARTED|Overall Study||10
8213319|NCT02108223|20255111|P3|NOT COMPLETED|Overall Study||0
8213320|NCT02108223|20255112|P2|NOT COMPLETED|Overall Study||0
8213321|NCT02108223|20255113|P1|NOT COMPLETED|Overall Study||0
8213322|NCT02108223|20255111|P3|COMPLETED|Overall Study||35
8213323|NCT02108223|20255112|P2|COMPLETED|Overall Study||50
8213324|NCT02108223|20255113|P1|COMPLETED|Overall Study||52
8213325|NCT02108223|20255111|P3|STARTED|Overall Study||35
8213326|NCT02108223|20255112|P2|STARTED|Overall Study||50
8213327|NCT02108223|20255113|P1|STARTED|Overall Study||52
8213328|NCT02108171|20255135|P2|NOT COMPLETED|Overall Study||0
8213329|NCT02108171|20255136|P1|NOT COMPLETED|Overall Study||0
8213330|NCT02108171|20255135|P2|COMPLETED|Overall Study||41
8213331|NCT02108171|20255136|P1|COMPLETED|Overall Study||40
8213332|NCT02108171|20255135|P2|STARTED|Overall Study||41
8213333|NCT02108171|20255136|P1|STARTED|Overall Study||40
8213334|NCT02107898|20255238|P2|NOT COMPLETED|Overall Study||12
8213335|NCT02107898|20255239|P1|NOT COMPLETED|Overall Study||6
8213336|NCT02107898|20255238|P2|COMPLETED|Overall Study||132
8213337|NCT02107898|20255239|P1|COMPLETED|Overall Study||66
8213338|NCT02107898|20255238|P2|Treated|Overall Study||143
8213339|NCT02107898|20255239|P1|Treated|Overall Study||72
8213340|NCT02107898|20255238|P2|STARTED|Overall Study|Randomized|144
8213341|NCT02107898|20255239|P1|STARTED|Overall Study|Randomized|72
8213342|NCT02107859|20255291|P1|NOT COMPLETED|Overall Study||61
8213343|NCT02107859|20255291|P1|COMPLETED|Overall Study||0
8213344|NCT02107859|20255291|P1|Intent-to-treat (ITT) Population|Overall Study||60
8213345|NCT02107859|20255291|P1|As-treated Population|Overall Study||61
8213346|NCT02107859|20255291|P1|STARTED|Overall Study||61
8213347|NCT02107703|20255307|P2|NOT COMPLETED|Overall Study||175
8213348|NCT02107703|20255308|P1|NOT COMPLETED|Overall Study||361
8213349|NCT02107703|20255307|P2|COMPLETED|Overall Study||48
8213350|NCT02107703|20255308|P1|COMPLETED|Overall Study||85
8213351|NCT02107703|20255307|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
8213352|NCT02107703|20255308|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
8213353|NCT02107703|20255307|P2|STARTED|Overall Study||223
8213354|NCT02107703|20255308|P1|STARTED|Overall Study||446
8213355|NCT02107599|20255333|P1|NOT COMPLETED|Overall Study||0
8213356|NCT02107599|20255333|P1|COMPLETED|Overall Study||96
8213357|NCT02107599|20255333|P1|STARTED|Overall Study||96
8213358|NCT02107482|20255340|P1|NOT COMPLETED|Overall Study||4
8213359|NCT02107482|20255340|P1|COMPLETED|Overall Study||17
8213360|NCT02107482|20255340|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
8213361|NCT02107443|20255348|P2|NOT COMPLETED|Overall Study||83
8213362|NCT02107443|20255349|P1|NOT COMPLETED|Overall Study||98
8213363|NCT02107443|20255348|P2|COMPLETED|Overall Study||167
8213364|NCT02107443|20255349|P1|COMPLETED|Overall Study||198
8213365|NCT02107443|20255348|P2|STARTED|Overall Study||250
8213366|NCT02107443|20255349|P1|STARTED|Overall Study||296
8213367|NCT02107339|20255365|P2|NOT COMPLETED|Overall Study||4
8213368|NCT02107339|20255366|P1|NOT COMPLETED|Overall Study||1
8213369|NCT02107339|20255365|P2|COMPLETED|Overall Study||53
8213370|NCT02107339|20255366|P1|COMPLETED|Overall Study||62
8213371|NCT02107339|20255365|P2|STARTED|Overall Study||57
8213372|NCT02107339|20255366|P1|STARTED|Overall Study||63
8213373|NCT02107313|20255402|P2|NOT COMPLETED|Overall Study||1
8213374|NCT02107313|20255403|P1|NOT COMPLETED|Overall Study||0
8213375|NCT02107313|20255402|P2|COMPLETED|Overall Study||8
8213376|NCT02107313|20255403|P1|COMPLETED|Overall Study||9
8213377|NCT02107313|20255402|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
8213378|NCT02107313|20255403|P1|STARTED|Overall Study||9
8213379|NCT02107300|20255413|P2|NOT COMPLETED|Overall Study||0
8213380|NCT02107300|20255414|P1|NOT COMPLETED|Overall Study||0
8213381|NCT02107300|20255413|P2|COMPLETED|Overall Study||15
8213382|NCT02107300|20255414|P1|COMPLETED|Overall Study||16
8213383|NCT02107300|20255413|P2|STARTED|Overall Study||15
8213384|NCT02107300|20255414|P1|STARTED|Overall Study||16
8213385|NCT02107274|20255424|P2|NOT COMPLETED|Control Phase||2
8213386|NCT02107274|20255425|P1|NOT COMPLETED|Control Phase||3
8213387|NCT02107274|20255424|P2|COMPLETED|Control Phase||35
8213388|NCT02107274|20255425|P1|COMPLETED|Control Phase||33
8213389|NCT02107274|20255424|P2|STARTED|Control Phase||37
8213390|NCT02107274|20255425|P1|STARTED|Control Phase||36
8213391|NCT02107274|20255424|P2|NOT COMPLETED|Treatment vs. Placebo||2
8213392|NCT02107274|20255425|P1|NOT COMPLETED|Treatment vs. Placebo||3
8213393|NCT02107274|20255424|P2|COMPLETED|Treatment vs. Placebo||37
8213394|NCT02107274|20255425|P1|COMPLETED|Treatment vs. Placebo||36
8213395|NCT02107274|20255424|P2|STARTED|Treatment vs. Placebo||39
8213396|NCT02107274|20255425|P1|STARTED|Treatment vs. Placebo||39
8213397|NCT02107196|20255439|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
8213398|NCT02107196|20255440|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
8213399|NCT02107196|20255439|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
8213400|NCT02107196|20255440|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
8213401|NCT02107196|20255439|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
8213402|NCT02107196|20255440|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
8213403|NCT02107196|20255439|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
8213404|NCT02107196|20255440|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
8213405|NCT02107196|20255439|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
8213406|NCT02107196|20255440|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
8213407|NCT02107196|20255439|P2|NOT COMPLETED|12-week Treatment Period||39
8213408|NCT02107196|20255440|P1|NOT COMPLETED|12-week Treatment Period||44
8213409|NCT02107196|20255439|P2|COMPLETED|12-week Treatment Period||225
8213410|NCT02107196|20255440|P1|COMPLETED|12-week Treatment Period||227
8213411|NCT02107196|20255439|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
8213412|NCT02107196|20255440|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
8213413|NCT02107196|20255439|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
8213414|NCT02107196|20255440|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
8213415|NCT02107196|20255439|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
8213416|NCT02107196|20255440|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
8213417|NCT02107157|20255456|P3|NOT COMPLETED|Overall Study||0
8213418|NCT02107157|20255457|P2|NOT COMPLETED|Overall Study||1
8213419|NCT02107157|20255458|P1|NOT COMPLETED|Overall Study||5
8213420|NCT02107157|20255456|P3|COMPLETED|Overall Study||4
8213421|NCT02107157|20255457|P2|COMPLETED|Overall Study||11
8213422|NCT02107157|20255458|P1|COMPLETED|Overall Study||6
8213423|NCT02107157|20255456|P3|STARTED|Overall Study||4
8213424|NCT02107157|20255457|P2|STARTED|Overall Study||12
8213425|NCT02107157|20255458|P1|STARTED|Overall Study||11
8213426|NCT02107131|20255468|P2|NOT COMPLETED|Overall Study||9
8213427|NCT02107131|20255469|P1|NOT COMPLETED|Overall Study||8
8213428|NCT02107131|20255468|P2|COMPLETED|Overall Study||11
8213429|NCT02107131|20255469|P1|COMPLETED|Overall Study||12
8213430|NCT02107131|20255468|P2|STARTED|Overall Study||20
8213431|NCT02107131|20255469|P1|STARTED|Overall Study||20
8213432|NCT02107092|20255481|P1|NOT COMPLETED|Overall Study||44
8213433|NCT02107092|20255481|P1|COMPLETED|Overall Study||79
8213434|NCT02107092|20255481|P1|STARTED|Overall Study||123
8213435|NCT02107014|20255486|P1|NOT COMPLETED|Overall Study||1
8213436|NCT02107014|20255486|P1|COMPLETED|Overall Study||8
8213437|NCT02107014|20255486|P1|STARTED|Overall Study||9
8213438|NCT02106975|20255556|P2|NOT COMPLETED|Overall Study||39
8213439|NCT02106975|20255557|P1|NOT COMPLETED|Overall Study||25
8213440|NCT02106975|20255556|P2|COMPLETED|Overall Study||44
8213441|NCT02106975|20255557|P1|COMPLETED|Overall Study||59
8213442|NCT02106975|20255556|P2|STARTED|Overall Study||83
8213443|NCT02106975|20255557|P1|STARTED|Overall Study||84
8213444|NCT02106962|20255605|P2|NOT COMPLETED|Overall Study||0
8213445|NCT02106962|20255606|P1|NOT COMPLETED|Overall Study||0
8213446|NCT02106962|20255605|P2|COMPLETED|Overall Study||9
8213447|NCT02106962|20255606|P1|COMPLETED|Overall Study||8
8213448|NCT02106962|20255605|P2|STARTED|Overall Study||9
8213449|NCT02106962|20255606|P1|STARTED|Overall Study||8
8213450|NCT02106923|20255617|P6|NOT COMPLETED|Overall Study||1
8213451|NCT02106923|20255618|P5|NOT COMPLETED|Overall Study||0
8213452|NCT02106923|20255619|P4|NOT COMPLETED|Overall Study||0
8213453|NCT02106923|20255620|P3|NOT COMPLETED|Overall Study||0
8213454|NCT02106923|20255621|P2|NOT COMPLETED|Overall Study||0
8213455|NCT02106923|20255622|P1|NOT COMPLETED|Overall Study||0
8213456|NCT02106923|20255617|P6|COMPLETED|Overall Study||11
8213457|NCT02106923|20255618|P5|COMPLETED|Overall Study||12
8213458|NCT02106923|20255619|P4|COMPLETED|Overall Study||12
8213459|NCT02106923|20255620|P3|COMPLETED|Overall Study||12
8213460|NCT02106923|20255621|P2|COMPLETED|Overall Study||12
8213461|NCT02106923|20255622|P1|COMPLETED|Overall Study||12
8213462|NCT02106923|20255617|P6|STARTED|Overall Study||12
8213463|NCT02106923|20255618|P5|STARTED|Overall Study||12
8213464|NCT02106923|20255619|P4|STARTED|Overall Study||12
8213465|NCT02106923|20255620|P3|STARTED|Overall Study||12
8213466|NCT02106923|20255621|P2|STARTED|Overall Study||12
8213467|NCT02106923|20255622|P1|STARTED|Overall Study||12
8213468|NCT02106910|20255668|P2|NOT COMPLETED|Overall Study||1
8213469|NCT02106910|20255669|P1|NOT COMPLETED|Overall Study||1
8213470|NCT02106910|20255668|P2|COMPLETED|Overall Study||88
8213471|NCT02106910|20255669|P1|COMPLETED|Overall Study||48
8213472|NCT02106910|20255668|P2|STARTED|Overall Study||89
8213473|NCT02106910|20255669|P1|STARTED|Overall Study||49
8213474|NCT02106884|20255685|P2|NOT COMPLETED|Overall Study||1
8213475|NCT02106884|20255686|P1|NOT COMPLETED|Overall Study||0
8213476|NCT02106884|20255685|P2|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
8213477|NCT02106884|20255686|P1|COMPLETED|Overall Study||72
8213478|NCT02106884|20255685|P2|STARTED|Overall Study||74
8213479|NCT02106884|20255686|P1|STARTED|Overall Study||72
8213480|NCT02106832|20255710|P4|NOT COMPLETED|Overall Study||15
8213481|NCT02106832|20255711|P3|NOT COMPLETED|Overall Study||16
8213482|NCT02106832|20255712|P2|NOT COMPLETED|Overall Study||25
8213483|NCT02106832|20255713|P1|NOT COMPLETED|Overall Study||23
8213484|NCT02106832|20255710|P4|COMPLETED|Overall Study||73
8213485|NCT02106832|20255711|P3|COMPLETED|Overall Study||70
8213486|NCT02106832|20255712|P2|COMPLETED|Overall Study||151
8213487|NCT02106832|20255713|P1|COMPLETED|Overall Study||148
8213488|NCT02106832|20255710|P4|Participants Received Treatment|Overall Study||88
8213489|NCT02106832|20255711|P3|Participants Received Treatment|Overall Study||86
8213490|NCT02106832|20255712|P2|Participants Received Treatment|Overall Study||174
8213491|NCT02106832|20255713|P1|Participants Received Treatment|Overall Study||171
8213492|NCT02106832|20255710|P4|STARTED|Overall Study||88
8213493|NCT02106832|20255711|P3|STARTED|Overall Study||86
8213494|NCT02106832|20255712|P2|STARTED|Overall Study||176
8213495|NCT02106832|20255713|P1|STARTED|Overall Study||171
8213496|NCT02106728|20255748|P2|NOT COMPLETED|Overall Study||0
8213497|NCT02106728|20255749|P1|NOT COMPLETED|Overall Study||0
8213498|NCT02106728|20255748|P2|COMPLETED|Overall Study||47
8213499|NCT02106728|20255749|P1|COMPLETED|Overall Study||70
8213500|NCT02106728|20255748|P2|STARTED|Overall Study||47
8213501|NCT02106728|20255749|P1|STARTED|Overall Study||70
8213502|NCT02106494|20255765|P2|NOT COMPLETED|Overall Study||25
8213503|NCT02106494|20255766|P1|NOT COMPLETED|Overall Study||26
8213504|NCT02106494|20255765|P2|COMPLETED|Overall Study||446
8213505|NCT02106494|20255766|P1|COMPLETED|Overall Study||445
8213506|NCT02106494|20255765|P2|Efficacy Population|Overall Study||452
8213507|NCT02106494|20255766|P1|Efficacy Population|Overall Study||450
8213508|NCT02106494|20255765|P2|Safety Population|Overall Study||459
8213509|NCT02106494|20255766|P1|Safety Population|Overall Study||456
8213510|NCT02106494|20255765|P2|STARTED|Overall Study||471
8213511|NCT02106494|20255766|P1|STARTED|Overall Study||471
8213512|NCT02106455|20255780|P1|NOT COMPLETED|Overall Study||8
8213513|NCT02106455|20255780|P1|COMPLETED|Overall Study||307
8213514|NCT02106455|20255780|P1|STARTED|Overall Study||315
8213515|NCT02106442|20255794|P1|NOT COMPLETED|Overall Study||37
8213516|NCT02106442|20255794|P1|COMPLETED|Overall Study||542
8213517|NCT02106442|20255794|P1|STARTED|Overall Study||579
8213518|NCT02106403|20255812|P6|NOT COMPLETED|Follow-Up Visit 3||1
8213519|NCT02106403|20255813|P5|NOT COMPLETED|Follow-Up Visit 3||0
8213520|NCT02106403|20255814|P4|NOT COMPLETED|Follow-Up Visit 3||0
8213521|NCT02106403|20255815|P3|NOT COMPLETED|Follow-Up Visit 3||0
8213522|NCT02106403|20255816|P2|NOT COMPLETED|Follow-Up Visit 3||0
8213523|NCT02106403|20255817|P1|NOT COMPLETED|Follow-Up Visit 3||0
8213524|NCT02106403|20255812|P6|COMPLETED|Follow-Up Visit 3||8
8213525|NCT02106403|20255813|P5|COMPLETED|Follow-Up Visit 3||8
8213526|NCT02106403|20255814|P4|COMPLETED|Follow-Up Visit 3||8
8213527|NCT02106403|20255815|P3|COMPLETED|Follow-Up Visit 3||9
8213528|NCT02106403|20255816|P2|COMPLETED|Follow-Up Visit 3||8
8213529|NCT02106403|20255817|P1|COMPLETED|Follow-Up Visit 3||8
8213530|NCT02106403|20255812|P6|STARTED|Follow-Up Visit 3||9
8213531|NCT02106403|20255813|P5|STARTED|Follow-Up Visit 3||8
8213532|NCT02106403|20255814|P4|STARTED|Follow-Up Visit 3||8
8213533|NCT02106403|20255815|P3|STARTED|Follow-Up Visit 3||9
8213534|NCT02106403|20255816|P2|STARTED|Follow-Up Visit 3||8
8213535|NCT02106403|20255817|P1|STARTED|Follow-Up Visit 3||8
8213536|NCT02106403|20255812|P6|NOT COMPLETED|Follow-Up Visit 2||0
8213537|NCT02106403|20255813|P5|NOT COMPLETED|Follow-Up Visit 2||0
8213538|NCT02106403|20255814|P4|NOT COMPLETED|Follow-Up Visit 2||0
8213539|NCT02106403|20255815|P3|NOT COMPLETED|Follow-Up Visit 2||0
8213540|NCT02106403|20255816|P2|NOT COMPLETED|Follow-Up Visit 2||0
8213541|NCT02106403|20255817|P1|NOT COMPLETED|Follow-Up Visit 2||0
8213542|NCT02106403|20255812|P6|COMPLETED|Follow-Up Visit 2||9
8213543|NCT02106403|20255813|P5|COMPLETED|Follow-Up Visit 2||8
8213544|NCT02106403|20255814|P4|COMPLETED|Follow-Up Visit 2||8
8213545|NCT02106403|20255815|P3|COMPLETED|Follow-Up Visit 2||9
8213546|NCT02106403|20255816|P2|COMPLETED|Follow-Up Visit 2||8
8213547|NCT02106403|20255817|P1|COMPLETED|Follow-Up Visit 2||8
8213548|NCT02106403|20255812|P6|STARTED|Follow-Up Visit 2||9
8213549|NCT02106403|20255813|P5|STARTED|Follow-Up Visit 2||8
8213550|NCT02106403|20255814|P4|STARTED|Follow-Up Visit 2||8
8213551|NCT02106403|20255815|P3|STARTED|Follow-Up Visit 2||9
8213552|NCT02106403|20255816|P2|STARTED|Follow-Up Visit 2||8
8213553|NCT02106403|20255817|P1|STARTED|Follow-Up Visit 2||8
8213554|NCT02106403|20255812|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213555|NCT02106403|20255813|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213556|NCT02106403|20255814|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213557|NCT02106403|20255815|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213558|NCT02106403|20255816|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213559|NCT02106403|20255817|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213560|NCT02106403|20255812|P6|COMPLETED|Visit 1, Treatment Period 3||9
8213561|NCT02106403|20255813|P5|COMPLETED|Visit 1, Treatment Period 3||8
8213562|NCT02106403|20255814|P4|COMPLETED|Visit 1, Treatment Period 3||8
8213563|NCT02106403|20255815|P3|COMPLETED|Visit 1, Treatment Period 3||9
8213564|NCT02106403|20255816|P2|COMPLETED|Visit 1, Treatment Period 3||8
8213565|NCT02106403|20255817|P1|COMPLETED|Visit 1, Treatment Period 3||8
8213566|NCT02106403|20255812|P6|STARTED|Visit 1, Treatment Period 3||9
8213567|NCT02106403|20255813|P5|STARTED|Visit 1, Treatment Period 3||8
8213568|NCT02106403|20255814|P4|STARTED|Visit 1, Treatment Period 3||8
8213569|NCT02106403|20255815|P3|STARTED|Visit 1, Treatment Period 3||9
8213570|NCT02106403|20255816|P2|STARTED|Visit 1, Treatment Period 3||8
8213571|NCT02106403|20255817|P1|STARTED|Visit 1, Treatment Period 3||8
8213572|NCT02106403|20255812|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213573|NCT02106403|20255813|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213574|NCT02106403|20255814|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213575|NCT02106403|20255815|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213576|NCT02106403|20255816|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213577|NCT02106403|20255817|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213578|NCT02106403|20255812|P6|COMPLETED|Visit 1, Treatment Period 2||9
8213579|NCT02106403|20255813|P5|COMPLETED|Visit 1, Treatment Period 2||8
8213580|NCT02106403|20255814|P4|COMPLETED|Visit 1, Treatment Period 2||8
8213581|NCT02106403|20255815|P3|COMPLETED|Visit 1, Treatment Period 2||9
8213582|NCT02106403|20255816|P2|COMPLETED|Visit 1, Treatment Period 2||8
8213583|NCT02106403|20255817|P1|COMPLETED|Visit 1, Treatment Period 2||8
8213584|NCT02106403|20255812|P6|STARTED|Visit 1, Treatment Period 2||9
8213585|NCT02106403|20255813|P5|STARTED|Visit 1, Treatment Period 2||8
8213586|NCT02106403|20255814|P4|STARTED|Visit 1, Treatment Period 2||8
8213587|NCT02106403|20255815|P3|STARTED|Visit 1, Treatment Period 2||9
8213588|NCT02106403|20255816|P2|STARTED|Visit 1, Treatment Period 2||8
8213589|NCT02106403|20255817|P1|STARTED|Visit 1, Treatment Period 2||8
8213590|NCT02106403|20255812|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213591|NCT02106403|20255813|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213592|NCT02106403|20255814|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213593|NCT02106403|20255815|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213594|NCT02106403|20255816|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213595|NCT02106403|20255817|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213596|NCT02106403|20255812|P6|COMPLETED|Visit 1, Treatment Period 1||9
8213597|NCT02106403|20255813|P5|COMPLETED|Visit 1, Treatment Period 1||8
8213598|NCT02106403|20255814|P4|COMPLETED|Visit 1, Treatment Period 1||8
8213599|NCT02106403|20255815|P3|COMPLETED|Visit 1, Treatment Period 1||9
8213600|NCT02106403|20255816|P2|COMPLETED|Visit 1, Treatment Period 1||8
8213601|NCT02106403|20255817|P1|COMPLETED|Visit 1, Treatment Period 1||8
8213602|NCT02106403|20255812|P6|STARTED|Visit 1, Treatment Period 1||9
8213603|NCT02106403|20255813|P5|STARTED|Visit 1, Treatment Period 1||8
8213604|NCT02106403|20255814|P4|STARTED|Visit 1, Treatment Period 1||8
8213605|NCT02106403|20255815|P3|STARTED|Visit 1, Treatment Period 1||9
8213606|NCT02106403|20255816|P2|STARTED|Visit 1, Treatment Period 1||8
8213607|NCT02106403|20255817|P1|STARTED|Visit 1, Treatment Period 1||8
8213608|NCT02106390|20255840|P3|NOT COMPLETED|Overall Study||43
8213609|NCT02106390|20255841|P2|NOT COMPLETED|Overall Study||48
8213610|NCT02106390|20255842|P1|NOT COMPLETED|Overall Study||49
8213611|NCT02106390|20255840|P3|COMPLETED|Overall Study||205
8213612|NCT02106390|20255841|P2|COMPLETED|Overall Study||202
8213613|NCT02106390|20255842|P1|COMPLETED|Overall Study||203
8213614|NCT02106390|20255840|P3|STARTED|Overall Study||248
8213615|NCT02106390|20255841|P2|STARTED|Overall Study||250
8213616|NCT02106390|20255842|P1|STARTED|Overall Study||252
8213617|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 4||2
8213618|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 4||1
8213619|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 4||0
8213620|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 4||31
8213621|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 4||21
8213622|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 4||0
8213623|NCT02106351|20255919|P3|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
8213624|NCT02106351|20255920|P2|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
8213625|NCT02106351|20255921|P1|STARTED|Treatment Cycle 4||0
8213626|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 3||5
8213627|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 3||4
8213628|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 3||0
8213629|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 3||53
8213630|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 3||45
8213631|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 3||0
8213632|NCT02106351|20255919|P3|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
8213633|NCT02106351|20255920|P2|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
8213634|NCT02106351|20255921|P1|STARTED|Treatment Cycle 3||0
8213635|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 2||3
8213636|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 2||5
8213637|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 2||0
8213638|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 2||87
8213639|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 2||83
8213640|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 2||0
8213641|NCT02106351|20255919|P3|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
8213642|NCT02106351|20255920|P2|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
8213643|NCT02106351|20255921|P1|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
8213644|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 1||4
8213645|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 1||3
8213646|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 1||5
8213647|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 1||67
8213648|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 1||67
8213649|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 1||66
8213650|NCT02106351|20255919|P3|Received Treatment in TC 1|Treatment Cycle 1||70
8213651|NCT02106351|20255920|P2|Received Treatment in TC 1|Treatment Cycle 1||70
8213652|NCT02106351|20255921|P1|Received Treatment in TC 1|Treatment Cycle 1||70
8213653|NCT02106351|20255919|P3|STARTED|Treatment Cycle 1||71
8213654|NCT02106351|20255920|P2|STARTED|Treatment Cycle 1||70
8213655|NCT02106351|20255921|P1|STARTED|Treatment Cycle 1||71
8213656|NCT02106325|20255964|P2|NOT COMPLETED|Phase 3||1
8213657|NCT02106325|20255965|P1|NOT COMPLETED|Phase 3||2
8213658|NCT02106325|20255964|P2|COMPLETED|Phase 3||2
8213659|NCT02106325|20255965|P1|COMPLETED|Phase 3||0
8213660|NCT02106325|20255964|P2|STARTED|Phase 3||3
8213661|NCT02106325|20255965|P1|STARTED|Phase 3||2
8213662|NCT02106325|20255964|P2|NOT COMPLETED|Phase 2||3
8213663|NCT02106325|20255965|P1|NOT COMPLETED|Phase 2||2
8213664|NCT02106325|20255964|P2|COMPLETED|Phase 2||1
8213665|NCT02106325|20255965|P1|COMPLETED|Phase 2||2
8213666|NCT02106325|20255964|P2|STARTED|Phase 2||4
8213667|NCT02106325|20255965|P1|STARTED|Phase 2||4
8213668|NCT02106325|20255964|P2|NOT COMPLETED|Phase 1||2
8213669|NCT02106325|20255965|P1|NOT COMPLETED|Phase 1||2
8213670|NCT02106325|20255964|P2|COMPLETED|Phase 1||1
8213671|NCT02106325|20255965|P1|COMPLETED|Phase 1||3
8213672|NCT02106325|20255964|P2|STARTED|Phase 1||3
8213673|NCT02106325|20255965|P1|STARTED|Phase 1||5
8213674|NCT02106156|20255990|P3|NOT COMPLETED|Overall Study||0
8213675|NCT02106156|20255991|P2|NOT COMPLETED|Overall Study||40
8213676|NCT02106156|20255992|P1|NOT COMPLETED|Overall Study||2549
8213677|NCT02106156|20255990|P3|COMPLETED|Overall Study||518
8213678|NCT02106156|20255991|P2|COMPLETED|Overall Study||50
8213679|NCT02106156|20255992|P1|COMPLETED|Overall Study||7071
8213680|NCT02106156|20255990|P3|STARTED|Overall Study||518
8213681|NCT02106156|20255991|P2|STARTED|Overall Study||90
8213682|NCT02106156|20255992|P1|STARTED|Overall Study||9620
8213683|NCT02105987|20256016|P6|NOT COMPLETED|Continuation Phase||0
8213684|NCT02105987|20256017|P5|NOT COMPLETED|Continuation Phase||1
8213685|NCT02105987|20256018|P4|NOT COMPLETED|Continuation Phase||0
8213686|NCT02105987|20256019|P3|NOT COMPLETED|Continuation Phase||0
8213687|NCT02105987|20256020|P2|NOT COMPLETED|Continuation Phase||0
8213688|NCT02105987|20256021|P1|NOT COMPLETED|Continuation Phase||0
8213689|NCT02105987|20256016|P6|COMPLETED|Continuation Phase||23
8213690|NCT02105987|20256017|P5|COMPLETED|Continuation Phase||13
8213691|NCT02105987|20256018|P4|COMPLETED|Continuation Phase||0
8213692|NCT02105987|20256019|P3|COMPLETED|Continuation Phase||0
8213693|NCT02105987|20256020|P2|COMPLETED|Continuation Phase||0
8213694|NCT02105987|20256021|P1|COMPLETED|Continuation Phase||0
8213695|NCT02105987|20256016|P6|STARTED|Continuation Phase||23
8213696|NCT02105987|20256017|P5|STARTED|Continuation Phase||14
8213697|NCT02105987|20256018|P4|STARTED|Continuation Phase||0
8213698|NCT02105987|20256019|P3|STARTED|Continuation Phase||0
8213699|NCT02105987|20256020|P2|STARTED|Continuation Phase||0
8213700|NCT02105987|20256021|P1|STARTED|Continuation Phase||0
8213701|NCT02105987|20256016|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213702|NCT02105987|20256017|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213703|NCT02105987|20256018|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
8213704|NCT02105987|20256019|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
8213705|NCT02105987|20256020|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213706|NCT02105987|20256021|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213707|NCT02105987|20256016|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
8213708|NCT02105987|20256017|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
8213709|NCT02105987|20256018|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
8213710|NCT02105987|20256019|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
8213711|NCT02105987|20256020|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
8213712|NCT02105987|20256021|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
8213713|NCT02105987|20256016|P6|STARTED|Late Switch Phase (24 Weeks)||0
8213714|NCT02105987|20256017|P5|STARTED|Late Switch Phase (24 Weeks)||0
8213715|NCT02105987|20256018|P4|STARTED|Late Switch Phase (24 Weeks)||244
8213716|NCT02105987|20256019|P3|STARTED|Late Switch Phase (24 Weeks)||275
8213717|NCT02105987|20256020|P2|STARTED|Late Switch Phase (24 Weeks)||0
8213718|NCT02105987|20256021|P1|STARTED|Late Switch Phase (24 Weeks)||0
8213719|NCT02105987|20256016|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213720|NCT02105987|20256017|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213721|NCT02105987|20256018|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213722|NCT02105987|20256019|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213723|NCT02105987|20256020|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
8213724|NCT02105987|20256021|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
8213725|NCT02105987|20256016|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
8213726|NCT02105987|20256017|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
8213727|NCT02105987|20256018|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
8213728|NCT02105987|20256019|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
8213729|NCT02105987|20256020|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
8213730|NCT02105987|20256021|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
8213731|NCT02105987|20256016|P6|STARTED|Early Switch Phase (24 Weeks)||0
8213732|NCT02105987|20256017|P5|STARTED|Early Switch Phase (24 Weeks)||0
8213733|NCT02105987|20256018|P4|STARTED|Early Switch Phase (24 Weeks)||0
8213734|NCT02105987|20256019|P3|STARTED|Early Switch Phase (24 Weeks)||0
8213735|NCT02105987|20256020|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
8213736|NCT02105987|20256021|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
8213737|NCT02105974|20256075|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
8213738|NCT02105974|20256076|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
8213739|NCT02105974|20256077|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
8213740|NCT02105974|20256075|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
8213741|NCT02105974|20256076|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
8213742|NCT02105974|20256077|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
8213743|NCT02105974|20256075|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
8213744|NCT02105974|20256076|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
8213745|NCT02105974|20256077|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
8213746|NCT02105974|20256075|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
8213747|NCT02105974|20256076|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
8213748|NCT02105974|20256077|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
8213749|NCT02105974|20256075|P3|NOT COMPLETED|2 Week Run-in Period||0
8213750|NCT02105974|20256076|P2|NOT COMPLETED|2 Week Run-in Period||0
8213751|NCT02105974|20256077|P1|NOT COMPLETED|2 Week Run-in Period||801
8213752|NCT02105974|20256075|P3|COMPLETED|2 Week Run-in Period||0
8213753|NCT02105974|20256076|P2|COMPLETED|2 Week Run-in Period||0
8213754|NCT02105974|20256077|P1|COMPLETED|2 Week Run-in Period||1622
8213755|NCT02105974|20256075|P3|STARTED|2 Week Run-in Period||0
8213756|NCT02105974|20256076|P2|STARTED|2 Week Run-in Period||0
8213757|NCT02105974|20256077|P1|STARTED|2 Week Run-in Period||2423
8213758|NCT02105961|20256090|P3|NOT COMPLETED|Overall Study||30
8213759|NCT02105961|20256091|P2|NOT COMPLETED|Overall Study||17
8213760|NCT02105961|20256092|P1|NOT COMPLETED|Overall Study||41
8213761|NCT02105961|20256090|P3|COMPLETED|Overall Study||195
8213762|NCT02105961|20256091|P2|COMPLETED|Overall Study||206
8213763|NCT02105961|20256092|P1|COMPLETED|Overall Study||185
8213764|NCT02105961|20256090|P3|Withdrew IP Due to: Site Closed|Overall Study||1
8213765|NCT02105961|20256091|P2|Withdrew IP Due to: Site Closed|Overall Study||0
8213766|NCT02105961|20256092|P1|Withdrew IP Due to: Site Closed|Overall Study||1
8213767|NCT02105961|20256090|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8213768|NCT02105961|20256091|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8213769|NCT02105961|20256092|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
8213770|NCT02105961|20256090|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
8213771|NCT02105961|20256091|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
8213772|NCT02105961|20256092|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
8213773|NCT02105961|20256090|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213774|NCT02105961|20256091|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213775|NCT02105961|20256092|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213776|NCT02105961|20256090|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
8213777|NCT02105961|20256091|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
8213778|NCT02105961|20256092|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
8213779|NCT02105961|20256090|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213780|NCT02105961|20256091|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213781|NCT02105961|20256092|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
8213782|NCT02105961|20256090|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213783|NCT02105961|20256091|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8213784|NCT02105961|20256092|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8213785|NCT02105961|20256090|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
8213786|NCT02105961|20256091|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
8213787|NCT02105961|20256092|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
8213788|NCT02105961|20256090|P3|Not Completed IP|Overall Study||42
8213789|NCT02105961|20256091|P2|Not Completed IP|Overall Study||27
8213790|NCT02105961|20256092|P1|Not Completed IP|Overall Study||56
8213791|NCT02105961|20256090|P3|Completed Investigational Product (IP)|Overall Study||183
8213792|NCT02105961|20256091|P2|Completed Investigational Product (IP)|Overall Study||196
8213793|NCT02105961|20256092|P1|Completed Investigational Product (IP)|Overall Study||170
8213794|NCT02105961|20256090|P3|STARTED|Overall Study||225
8213795|NCT02105961|20256091|P2|STARTED|Overall Study||223
8213796|NCT02105961|20256092|P1|STARTED|Overall Study||226
8213797|NCT02105948|20256116|P4|NOT COMPLETED|Overall Study||27
8213798|NCT02105948|20256117|P3|NOT COMPLETED|Overall Study||28
8213799|NCT02105948|20256118|P2|NOT COMPLETED|Overall Study||20
8213800|NCT02105948|20256119|P1|NOT COMPLETED|Overall Study||27
8213801|NCT02105948|20256116|P4|COMPLETED|Overall Study||157
8213802|NCT02105948|20256117|P3|COMPLETED|Overall Study||162
8213803|NCT02105948|20256118|P2|COMPLETED|Overall Study||213
8213804|NCT02105948|20256119|P1|COMPLETED|Overall Study||202
8213805|NCT02105948|20256116|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8213806|NCT02105948|20256117|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213807|NCT02105948|20256118|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213808|NCT02105948|20256119|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213809|NCT02105948|20256116|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
8213810|NCT02105948|20256117|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
8213811|NCT02105948|20256118|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
8213812|NCT02105948|20256119|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
8213813|NCT02105948|20256116|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
8213814|NCT02105948|20256117|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8213815|NCT02105948|20256118|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
8213816|NCT02105948|20256119|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
8213817|NCT02105948|20256116|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
8213818|NCT02105948|20256117|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213819|NCT02105948|20256118|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
8213820|NCT02105948|20256119|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
8213821|NCT02105948|20256116|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
8213822|NCT02105948|20256117|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
8213823|NCT02105948|20256118|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
8213824|NCT02105948|20256119|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
8213825|NCT02105948|20256116|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213826|NCT02105948|20256117|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
8213827|NCT02105948|20256118|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213828|NCT02105948|20256119|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
8213829|NCT02105948|20256116|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
8213830|NCT02105948|20256117|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
8213831|NCT02105948|20256118|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
8213832|NCT02105948|20256119|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
8213833|NCT02105948|20256116|P4|Not Completed IP|Overall Study||35
8213834|NCT02105948|20256117|P3|Not Completed IP|Overall Study||42
8213835|NCT02105948|20256118|P2|Not Completed IP|Overall Study||30
8213836|NCT02105948|20256119|P1|Not Completed IP|Overall Study||44
8213837|NCT02105948|20256116|P4|Completed Investigational Product (IP)|Overall Study||149
8213838|NCT02105948|20256117|P3|Completed Investigational Product (IP)|Overall Study||148
8213839|NCT02105948|20256118|P2|Completed Investigational Product (IP)|Overall Study||203
8213840|NCT02105948|20256119|P1|Completed Investigational Product (IP)|Overall Study||185
8213841|NCT02105948|20256116|P4|STARTED|Overall Study||184
8213842|NCT02105948|20256117|P3|STARTED|Overall Study||190
8213843|NCT02105948|20256118|P2|STARTED|Overall Study||233
8213844|NCT02105948|20256119|P1|STARTED|Overall Study||229
8213845|NCT02105740|20256147|P2|NOT COMPLETED|Overall Study||1
8213846|NCT02105740|20256148|P1|NOT COMPLETED|Overall Study||0
8213847|NCT02105740|20256147|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
8213848|NCT02105740|20256148|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
8213849|NCT02105740|20256147|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
8213850|NCT02105740|20256148|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
8213851|NCT02105740|20256147|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
8213852|NCT02105740|20256148|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
8213865|NCT02105688|20256187|P2|NOT COMPLETED|Part B: Observational Follow-up||20
8213866|NCT02105688|20256188|P1|NOT COMPLETED|Part B: Observational Follow-up||37
8213867|NCT02105688|20256187|P2|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
8213868|NCT02105688|20256188|P1|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
8213869|NCT02105688|20256187|P2|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
8213870|NCT02105688|20256188|P1|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
8213871|NCT02105688|20256187|P2|NOT COMPLETED|Part A: Double-Blind||17
8213872|NCT02105688|20256188|P1|NOT COMPLETED|Part A: Double-Blind||20
8213873|NCT02105688|20256187|P2|COMPLETED|Part A: Double-Blind|Completed Part A|83
8213874|NCT02105688|20256188|P1|COMPLETED|Part A: Double-Blind|Completed Part A|181
8213875|NCT02105688|20256187|P2|STARTED|Part A: Double-Blind||100
8213876|NCT02105688|20256188|P1|STARTED|Part A: Double-Blind||201
8213880|NCT02105636|20256210|P2|NOT COMPLETED|Overall Study||108
8213881|NCT02105636|20256211|P1|NOT COMPLETED|Overall Study||195
8213882|NCT02105636|20256210|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
8213883|NCT02105636|20256211|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
8213884|NCT02105636|20256210|P2|STARTED|Overall Study||111
8213885|NCT02105636|20256211|P1|STARTED|Overall Study||236
8213886|NCT02105558|20256223|P2|NOT COMPLETED|Overall Study||0
8213887|NCT02105558|20256224|P1|NOT COMPLETED|Overall Study||0
8213888|NCT02105558|20256223|P2|COMPLETED|Overall Study||28
8213889|NCT02105558|20256224|P1|COMPLETED|Overall Study||15
8213890|NCT02105558|20256223|P2|STARTED|Overall Study||28
8213891|NCT02105558|20256224|P1|STARTED|Overall Study||15
8213892|NCT02105467|20256254|P2|NOT COMPLETED|Period 3||1
8213893|NCT02105467|20256255|P1|NOT COMPLETED|Period 3||0
8213894|NCT02105467|20256254|P2|COMPLETED|Period 3||102
8213895|NCT02105467|20256255|P1|COMPLETED|Period 3||0
8213896|NCT02105467|20256254|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
8213897|NCT02105467|20256255|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
8213898|NCT02105467|20256254|P2|NOT COMPLETED|Period 2||2
8213899|NCT02105467|20256255|P1|NOT COMPLETED|Period 2||2
8213900|NCT02105467|20256254|P2|COMPLETED|Period 2||102
8213901|NCT02105467|20256255|P1|COMPLETED|Period 2||312
8213902|NCT02105467|20256254|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
8213903|NCT02105467|20256255|P1|STARTED|Period 2||314
8213904|NCT02105467|20256254|P2|NOT COMPLETED|Period 1||0
8213905|NCT02105467|20256255|P1|NOT COMPLETED|Period 1||2
8213906|NCT02105467|20256254|P2|COMPLETED|Period 1||105
8213907|NCT02105467|20256255|P1|COMPLETED|Period 1||314
8213908|NCT02105467|20256254|P2|STARTED|Period 1||105
8213909|NCT02105467|20256255|P1|STARTED|Period 1||316
8213910|NCT02105454|20256267|P1|NOT COMPLETED|Overall Study||1
8213911|NCT02105454|20256267|P1|COMPLETED|Overall Study||78
8213912|NCT02105454|20256267|P1|STARTED|Overall Study||79
8213913|NCT02105415|20256276|P2|NOT COMPLETED|Overall Study||5
8213914|NCT02105415|20256277|P1|NOT COMPLETED|Overall Study||3
8213915|NCT02105415|20256276|P2|COMPLETED|Overall Study||79
8213916|NCT02105415|20256277|P1|COMPLETED|Overall Study||73
8213917|NCT02105415|20256276|P2|STARTED|Overall Study||84
8213918|NCT02105415|20256277|P1|STARTED|Overall Study||76
8213919|NCT02105324|20256299|P2|NOT COMPLETED|Period 2||0
8213920|NCT02105324|20256300|P1|NOT COMPLETED|Period 2||0
8213921|NCT02105324|20256299|P2|COMPLETED|Period 2||10
8213922|NCT02105324|20256300|P1|COMPLETED|Period 2||9
8213923|NCT02105324|20256299|P2|STARTED|Period 2||10
8213924|NCT02105324|20256300|P1|STARTED|Period 2||9
8213925|NCT02105324|20256299|P2|NOT COMPLETED|Period 1||0
8213926|NCT02105324|20256300|P1|NOT COMPLETED|Period 1||0
8213927|NCT02105324|20256299|P2|COMPLETED|Period 1||10
8213928|NCT02105324|20256300|P1|COMPLETED|Period 1||9
8213929|NCT02105324|20256299|P2|STARTED|Period 1||10
8213930|NCT02105324|20256300|P1|STARTED|Period 1||9
8213931|NCT02105285|20256379|P3|NOT COMPLETED|Overall Study||0
8213932|NCT02105285|20256380|P2|NOT COMPLETED|Overall Study||2
8213933|NCT02105285|20256381|P1|NOT COMPLETED|Overall Study||2
8213934|NCT02105285|20256379|P3|COMPLETED|Overall Study||37
8213935|NCT02105285|20256380|P2|COMPLETED|Overall Study||76
8213936|NCT02105285|20256381|P1|COMPLETED|Overall Study||76
8213937|NCT02105285|20256379|P3|STARTED|Overall Study||37
8213938|NCT02105285|20256380|P2|STARTED|Overall Study||78
8213939|NCT02105285|20256381|P1|STARTED|Overall Study||78
8213940|NCT02105272|20256400|P2|NOT COMPLETED|Overall Study||3
8213941|NCT02105272|20256401|P1|NOT COMPLETED|Overall Study||5
8213942|NCT02105272|20256400|P2|COMPLETED|Overall Study||116
8213943|NCT02105272|20256401|P1|COMPLETED|Overall Study||113
8213944|NCT02105272|20256400|P2|STARTED|Overall Study||119
8213945|NCT02105272|20256401|P1|STARTED|Overall Study||118
8213946|NCT02105246|20256419|P2|NOT COMPLETED|Overall Study||0
8213947|NCT02105246|20256420|P1|NOT COMPLETED|Overall Study||0
8213948|NCT02105246|20256419|P2|COMPLETED|Overall Study||597
8213949|NCT02105246|20256420|P1|COMPLETED|Overall Study||557
8213950|NCT02105246|20256419|P2|STARTED|Overall Study||597
8213951|NCT02105246|20256420|P1|STARTED|Overall Study||557
8213952|NCT02105116|20256430|P1|NOT COMPLETED|Overall Study||6
8213953|NCT02105116|20256430|P1|COMPLETED|Overall Study||0
8213954|NCT02105116|20256430|P1|STARTED|Overall Study||6
8213955|NCT02105012|20256437|P1|NOT COMPLETED|Overall Study||33
8213956|NCT02105012|20256437|P1|COMPLETED|Overall Study||114
8213957|NCT02105012|20256437|P1|Placebo MDI|Overall Study||127
8213958|NCT02105012|20256437|P1|BD MDI 40 µg|Overall Study||63
8213959|NCT02105012|20256437|P1|BD MDI 80 µg|Overall Study||64
8213960|NCT02105012|20256437|P1|BD MDI 160 µg|Overall Study||132
8213961|NCT02105012|20256437|P1|BD MDI 320 µg|Overall Study||124
8213962|NCT02105012|20256437|P1|STARTED|Overall Study||147
8213963|NCT02104947|20256471|P2|NOT COMPLETED|Overall Study||56
8213964|NCT02104947|20256472|P1|NOT COMPLETED|Overall Study||79
8213965|NCT02104947|20256471|P2|COMPLETED|Overall Study||146
8213966|NCT02104947|20256472|P1|COMPLETED|Overall Study||222
8213967|NCT02104947|20256471|P2|STARTED|Overall Study||202
8213968|NCT02104947|20256472|P1|STARTED|Overall Study||301
8213969|NCT02104895|20256490|P2|NOT COMPLETED|Overall Study||14
8213970|NCT02104895|20256491|P1|NOT COMPLETED|Overall Study||0
8213971|NCT02104895|20256490|P2|COMPLETED|Overall Study||246
8213972|NCT02104895|20256491|P1|COMPLETED|Overall Study||260
8213973|NCT02104895|20256490|P2|STARTED|Overall Study||260
8213974|NCT02104895|20256491|P1|STARTED|Overall Study||260
8213975|NCT02104830|20256504|P3|NOT COMPLETED|Overall Study||7
8213976|NCT02104830|20256505|P2|NOT COMPLETED|Overall Study||7
8213977|NCT02104830|20256506|P1|NOT COMPLETED|Overall Study||4
8213978|NCT02104830|20256504|P3|COMPLETED|Overall Study||36
8213979|NCT02104830|20256505|P2|COMPLETED|Overall Study||36
8213980|NCT02104830|20256506|P1|COMPLETED|Overall Study||38
8213981|NCT02104830|20256504|P3|STARTED|Overall Study||43
8213982|NCT02104830|20256505|P2|STARTED|Overall Study||43
8213983|NCT02104830|20256506|P1|STARTED|Overall Study||42
8213984|NCT02104804|20256531|P2|NOT COMPLETED|Overall Study||19
8213985|NCT02104804|20256532|P1|NOT COMPLETED|Overall Study||16
8213986|NCT02104804|20256531|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
8213987|NCT02104804|20256532|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
8213988|NCT02104804|20256531|P2|STARTED|Overall Study|Number of patients who were randomized|232
8213989|NCT02104804|20256532|P1|STARTED|Overall Study|Number of patients who were randomized|234
8213990|NCT02104765|20256555|P7|NOT COMPLETED|Overall Study||1
8213991|NCT02104765|20256556|P6|NOT COMPLETED|Overall Study||0
8213992|NCT02104765|20256557|P5|NOT COMPLETED|Overall Study||1
8213993|NCT02104765|20256558|P4|NOT COMPLETED|Overall Study||1
8213994|NCT02104765|20256559|P3|NOT COMPLETED|Overall Study||1
8213995|NCT02104765|20256560|P2|NOT COMPLETED|Overall Study||0
8213996|NCT02104765|20256561|P1|NOT COMPLETED|Overall Study||0
8213997|NCT02104765|20256555|P7|COMPLETED|Overall Study||7
8213998|NCT02104765|20256556|P6|COMPLETED|Overall Study||2
8213999|NCT02104765|20256557|P5|COMPLETED|Overall Study||7
8214000|NCT02104765|20256558|P4|COMPLETED|Overall Study||6
8214001|NCT02104765|20256559|P3|COMPLETED|Overall Study||5
8214002|NCT02104765|20256560|P2|COMPLETED|Overall Study||6
8214003|NCT02104765|20256561|P1|COMPLETED|Overall Study||8
8214004|NCT02104765|20256555|P7|Received at Least 1 Dose of Study Drug|Overall Study||8
8214005|NCT02104765|20256556|P6|Received at Least 1 Dose of Study Drug|Overall Study||2
8214006|NCT02104765|20256557|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
8214007|NCT02104765|20256558|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8214008|NCT02104765|20256559|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8214009|NCT02104765|20256560|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8214010|NCT02104765|20256561|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8214011|NCT02104765|20256555|P7|STARTED|Overall Study||8
8214012|NCT02104765|20256556|P6|STARTED|Overall Study||2
8214013|NCT02104765|20256557|P5|STARTED|Overall Study||8
8214014|NCT02104765|20256558|P4|STARTED|Overall Study||7
8214015|NCT02104765|20256559|P3|STARTED|Overall Study||6
8214016|NCT02104765|20256560|P2|STARTED|Overall Study||6
8214017|NCT02104765|20256561|P1|STARTED|Overall Study||8
8214018|NCT02104752|20256589|P2|NOT COMPLETED|Overall Study||2
8214019|NCT02104752|20256590|P1|NOT COMPLETED|Overall Study||1
8214020|NCT02104752|20256589|P2|COMPLETED|Overall Study||19
8214021|NCT02104752|20256590|P1|COMPLETED|Overall Study||17
8214022|NCT02104752|20256589|P2|STARTED|Overall Study||21
8214023|NCT02104752|20256590|P1|STARTED|Overall Study||18
8214024|NCT02104739|20256604|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
8214025|NCT02104739|20256605|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214026|NCT02104739|20256606|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214027|NCT02104739|20256607|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214028|NCT02104739|20256608|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214029|NCT02104739|20256609|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214030|NCT02104739|20256610|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214031|NCT02104739|20256604|P7|COMPLETED|Extension Phase (6 Weeks)||7
8214032|NCT02104739|20256605|P6|COMPLETED|Extension Phase (6 Weeks)||0
8214033|NCT02104739|20256606|P5|COMPLETED|Extension Phase (6 Weeks)||0
8214034|NCT02104739|20256607|P4|COMPLETED|Extension Phase (6 Weeks)||0
8214035|NCT02104739|20256608|P3|COMPLETED|Extension Phase (6 Weeks)||0
8214036|NCT02104739|20256609|P2|COMPLETED|Extension Phase (6 Weeks)||0
8214037|NCT02104739|20256610|P1|COMPLETED|Extension Phase (6 Weeks)||0
8214038|NCT02104739|20256604|P7|STARTED|Extension Phase (6 Weeks)||8
8214039|NCT02104739|20256605|P6|STARTED|Extension Phase (6 Weeks)||0
8214040|NCT02104739|20256606|P5|STARTED|Extension Phase (6 Weeks)||0
8214041|NCT02104739|20256607|P4|STARTED|Extension Phase (6 Weeks)||0
8214042|NCT02104739|20256608|P3|STARTED|Extension Phase (6 Weeks)||0
8214043|NCT02104739|20256609|P2|STARTED|Extension Phase (6 Weeks)||0
8214044|NCT02104739|20256610|P1|STARTED|Extension Phase (6 Weeks)||0
8214045|NCT02104739|20256604|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
8214046|NCT02104739|20256605|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214047|NCT02104739|20256606|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214048|NCT02104739|20256607|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214049|NCT02104739|20256608|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214050|NCT02104739|20256609|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214051|NCT02104739|20256610|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214052|NCT02104739|20256604|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
8214053|NCT02104739|20256605|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214054|NCT02104739|20256606|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214055|NCT02104739|20256607|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214056|NCT02104739|20256608|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214057|NCT02104739|20256609|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214058|NCT02104739|20256610|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214059|NCT02104739|20256604|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
8214060|NCT02104739|20256605|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214061|NCT02104739|20256606|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214062|NCT02104739|20256607|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214063|NCT02104739|20256608|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214064|NCT02104739|20256609|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214065|NCT02104739|20256610|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214066|NCT02104739|20256604|P7|NOT COMPLETED|Third Intervention (1 Day)||0
8214067|NCT02104739|20256605|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8214068|NCT02104739|20256606|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8214069|NCT02104739|20256607|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8214070|NCT02104739|20256608|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8214071|NCT02104739|20256609|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8214072|NCT02104739|20256610|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8214073|NCT02104739|20256604|P7|COMPLETED|Third Intervention (1 Day)||0
8214074|NCT02104739|20256605|P6|COMPLETED|Third Intervention (1 Day)||2
8214075|NCT02104739|20256606|P5|COMPLETED|Third Intervention (1 Day)||0
8214076|NCT02104739|20256607|P4|COMPLETED|Third Intervention (1 Day)||7
8214077|NCT02104739|20256608|P3|COMPLETED|Third Intervention (1 Day)||2
8214078|NCT02104739|20256609|P2|COMPLETED|Third Intervention (1 Day)||4
8214079|NCT02104739|20256610|P1|COMPLETED|Third Intervention (1 Day)||1
8214080|NCT02104739|20256604|P7|STARTED|Third Intervention (1 Day)||0
8214081|NCT02104739|20256605|P6|STARTED|Third Intervention (1 Day)||2
8214082|NCT02104739|20256606|P5|STARTED|Third Intervention (1 Day)||0
8214083|NCT02104739|20256607|P4|STARTED|Third Intervention (1 Day)||7
8214084|NCT02104739|20256608|P3|STARTED|Third Intervention (1 Day)||2
8214085|NCT02104739|20256609|P2|STARTED|Third Intervention (1 Day)||4
8214086|NCT02104739|20256610|P1|STARTED|Third Intervention (1 Day)||1
8214087|NCT02104739|20256604|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214088|NCT02104739|20256605|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214089|NCT02104739|20256606|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214090|NCT02104739|20256607|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214091|NCT02104739|20256608|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214092|NCT02104739|20256609|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214093|NCT02104739|20256610|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214094|NCT02104739|20256604|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214095|NCT02104739|20256605|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214096|NCT02104739|20256606|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214097|NCT02104739|20256607|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
8214098|NCT02104739|20256608|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214099|NCT02104739|20256609|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
8214100|NCT02104739|20256610|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
8214101|NCT02104739|20256604|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214102|NCT02104739|20256605|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214103|NCT02104739|20256606|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214104|NCT02104739|20256607|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
8214105|NCT02104739|20256608|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214106|NCT02104739|20256609|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
8214107|NCT02104739|20256610|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
8214108|NCT02104739|20256604|P7|NOT COMPLETED|Second Intervention (1 Day)||0
8214109|NCT02104739|20256605|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8214110|NCT02104739|20256606|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8214111|NCT02104739|20256607|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8214112|NCT02104739|20256608|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8214113|NCT02104739|20256609|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8214114|NCT02104739|20256610|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8214115|NCT02104739|20256604|P7|COMPLETED|Second Intervention (1 Day)||0
8214116|NCT02104739|20256605|P6|COMPLETED|Second Intervention (1 Day)||2
8214117|NCT02104739|20256606|P5|COMPLETED|Second Intervention (1 Day)||0
8214118|NCT02104739|20256607|P4|COMPLETED|Second Intervention (1 Day)||7
8214119|NCT02104739|20256608|P3|COMPLETED|Second Intervention (1 Day)||2
8214120|NCT02104739|20256609|P2|COMPLETED|Second Intervention (1 Day)||4
8214121|NCT02104739|20256610|P1|COMPLETED|Second Intervention (1 Day)||1
8214122|NCT02104739|20256604|P7|STARTED|Second Intervention (1 Day)||0
8214123|NCT02104739|20256605|P6|STARTED|Second Intervention (1 Day)||2
8214124|NCT02104739|20256606|P5|STARTED|Second Intervention (1 Day)||0
8214125|NCT02104739|20256607|P4|STARTED|Second Intervention (1 Day)||7
8214126|NCT02104739|20256608|P3|STARTED|Second Intervention (1 Day)||2
8214127|NCT02104739|20256609|P2|STARTED|Second Intervention (1 Day)||4
8214128|NCT02104739|20256610|P1|STARTED|Second Intervention (1 Day)||1
8214129|NCT02104739|20256604|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214130|NCT02104739|20256605|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214131|NCT02104739|20256606|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214132|NCT02104739|20256607|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214133|NCT02104739|20256608|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214134|NCT02104739|20256609|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214135|NCT02104739|20256610|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214136|NCT02104739|20256604|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214137|NCT02104739|20256605|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214138|NCT02104739|20256606|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214139|NCT02104739|20256607|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
8214140|NCT02104739|20256608|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214141|NCT02104739|20256609|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
8214142|NCT02104739|20256610|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
8214143|NCT02104739|20256604|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214144|NCT02104739|20256605|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214145|NCT02104739|20256606|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214146|NCT02104739|20256607|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
8214147|NCT02104739|20256608|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214148|NCT02104739|20256609|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
8214149|NCT02104739|20256610|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
8214150|NCT02104739|20256604|P7|NOT COMPLETED|First Intervention (1 Day)||0
8214151|NCT02104739|20256605|P6|NOT COMPLETED|First Intervention (1 Day)||0
8214152|NCT02104739|20256606|P5|NOT COMPLETED|First Intervention (1 Day)||0
8214153|NCT02104739|20256607|P4|NOT COMPLETED|First Intervention (1 Day)||1
8214154|NCT02104739|20256608|P3|NOT COMPLETED|First Intervention (1 Day)||0
8214155|NCT02104739|20256609|P2|NOT COMPLETED|First Intervention (1 Day)||1
8214156|NCT02104739|20256610|P1|NOT COMPLETED|First Intervention (1 Day)||0
8214157|NCT02104739|20256604|P7|COMPLETED|First Intervention (1 Day)||0
8214158|NCT02104739|20256605|P6|COMPLETED|First Intervention (1 Day)||3
8214159|NCT02104739|20256606|P5|COMPLETED|First Intervention (1 Day)||0
8214160|NCT02104739|20256607|P4|COMPLETED|First Intervention (1 Day)||7
8214161|NCT02104739|20256608|P3|COMPLETED|First Intervention (1 Day)||2
8214162|NCT02104739|20256609|P2|COMPLETED|First Intervention (1 Day)||4
8214163|NCT02104739|20256610|P1|COMPLETED|First Intervention (1 Day)||2
8214164|NCT02104739|20256604|P7|STARTED|First Intervention (1 Day)||0
8214165|NCT02104739|20256605|P6|STARTED|First Intervention (1 Day)||3
8214166|NCT02104739|20256606|P5|STARTED|First Intervention (1 Day)||0
8214167|NCT02104739|20256607|P4|STARTED|First Intervention (1 Day)||8
8214168|NCT02104739|20256608|P3|STARTED|First Intervention (1 Day)||2
8214169|NCT02104739|20256609|P2|STARTED|First Intervention (1 Day)||5
8214170|NCT02104739|20256610|P1|STARTED|First Intervention (1 Day)||2
8214171|NCT02104583|20256673|P5|NOT COMPLETED|Overall Study||12
8214172|NCT02104583|20256674|P4|NOT COMPLETED|Overall Study||17
8214173|NCT02104583|20256675|P3|NOT COMPLETED|Overall Study||16
8214174|NCT02104583|20256676|P2|NOT COMPLETED|Overall Study||11
8214175|NCT02104583|20256677|P1|NOT COMPLETED|Overall Study||18
8214176|NCT02104583|20256673|P5|COMPLETED|Overall Study||63
8214177|NCT02104583|20256674|P4|COMPLETED|Overall Study||57
8214178|NCT02104583|20256675|P3|COMPLETED|Overall Study||54
8214179|NCT02104583|20256676|P2|COMPLETED|Overall Study||35
8214180|NCT02104583|20256677|P1|COMPLETED|Overall Study||30
8214181|NCT02104583|20256673|P5|STARTED|Overall Study||75
8214182|NCT02104583|20256674|P4|STARTED|Overall Study||74
8214183|NCT02104583|20256675|P3|STARTED|Overall Study||70
8214184|NCT02104583|20256676|P2|STARTED|Overall Study||46
8214185|NCT02104583|20256677|P1|STARTED|Overall Study||48
8214186|NCT02104505|20256740|P2|NOT COMPLETED|Second Intervention (14 Days)||1
8214187|NCT02104505|20256741|P1|NOT COMPLETED|Second Intervention (14 Days)||2
8214188|NCT02104505|20256740|P2|COMPLETED|Second Intervention (14 Days)||7
8214189|NCT02104505|20256741|P1|COMPLETED|Second Intervention (14 Days)||8
8214190|NCT02104505|20256740|P2|STARTED|Second Intervention (14 Days)||8
8214191|NCT02104505|20256741|P1|STARTED|Second Intervention (14 Days)||10
8214192|NCT02104505|20256740|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
8214193|NCT02104505|20256741|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
8214194|NCT02104505|20256740|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
8214195|NCT02104505|20256741|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
8214196|NCT02104505|20256740|P2|STARTED|Washout (Minimum 3 Weeks)||8
8214197|NCT02104505|20256741|P1|STARTED|Washout (Minimum 3 Weeks)||10
8214198|NCT02104505|20256740|P2|NOT COMPLETED|First Intervention (14 Days)||3
8214199|NCT02104505|20256741|P1|NOT COMPLETED|First Intervention (14 Days)||2
8214200|NCT02104505|20256740|P2|COMPLETED|First Intervention (14 Days)||8
8214201|NCT02104505|20256741|P1|COMPLETED|First Intervention (14 Days)||10
8214298|NCT02103218|20257028|P2|STARTED|Overall Study||59
8214202|NCT02104505|20256740|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
8214203|NCT02104505|20256741|P1|STARTED|First Intervention (14 Days)||12
8214204|NCT02104427|20256753|P1|NOT COMPLETED|Overall Study||0
8214205|NCT02104427|20256753|P1|COMPLETED|Overall Study||12
8214206|NCT02104427|20256753|P1|STARTED|Overall Study||12
8214207|NCT02104414|20256779|P3|NOT COMPLETED|Overall Study||0
8214208|NCT02104414|20256780|P2|NOT COMPLETED|Overall Study||0
8214209|NCT02104414|20256781|P1|NOT COMPLETED|Overall Study||0
8214210|NCT02104414|20256779|P3|COMPLETED|Overall Study||2
8214211|NCT02104414|20256780|P2|COMPLETED|Overall Study||4
8214212|NCT02104414|20256781|P1|COMPLETED|Overall Study||5
8214213|NCT02104414|20256779|P3|STARTED|Overall Study||2
8214214|NCT02104414|20256780|P2|STARTED|Overall Study||4
8214215|NCT02104414|20256781|P1|STARTED|Overall Study||5
8214216|NCT02104219|20256804|P1|NOT COMPLETED|Overall Study||0
8214217|NCT02104219|20256804|P1|COMPLETED|Overall Study||32
8214218|NCT02104219|20256804|P1|STARTED|Overall Study||32
8214219|NCT02104180|20256813|P2|NOT COMPLETED|Overall Study||0
8214220|NCT02104180|20256814|P1|NOT COMPLETED|Overall Study||1
8214221|NCT02104180|20256813|P2|COMPLETED|Overall Study||31
8214222|NCT02104180|20256814|P1|COMPLETED|Overall Study||30
8214223|NCT02104180|20256813|P2|STARTED|Overall Study||31
8214224|NCT02104180|20256814|P1|STARTED|Overall Study||31
8214225|NCT02104167|20256820|P1|NOT COMPLETED|Overall Study||0
8214226|NCT02104167|20256820|P1|COMPLETED|Overall Study||110
8214227|NCT02104167|20256820|P1|STARTED|Overall Study||110
8214228|NCT02104141|20256825|P1|NOT COMPLETED|Overall Study||0
8214229|NCT02104141|20256825|P1|COMPLETED|Overall Study||51
8214230|NCT02104141|20256825|P1|STARTED|Overall Study||51
8214231|NCT02103855|20256830|P1|NOT COMPLETED|Overall Study||2
8214232|NCT02103855|20256830|P1|COMPLETED|Overall Study||4
8214233|NCT02103855|20256830|P1|STARTED|Overall Study||6
8214234|NCT02103816|20256838|P1|NOT COMPLETED|Overall Study||8
8214235|NCT02103816|20256838|P1|COMPLETED|Overall Study||13
8214236|NCT02103816|20256838|P1|STARTED|Overall Study||21
8214237|NCT02103608|20256844|P1|NOT COMPLETED|Overall Study||2
8214238|NCT02103608|20256844|P1|COMPLETED|Overall Study||15
8214239|NCT02103608|20256844|P1|STARTED|Overall Study||17
8214240|NCT02103478|20256855|P9|NOT COMPLETED|Overall Study||14
8214241|NCT02103478|20256856|P8|NOT COMPLETED|Overall Study||16
8214242|NCT02103478|20256857|P7|NOT COMPLETED|Overall Study||25
8214243|NCT02103478|20256858|P6|NOT COMPLETED|Overall Study||25
8214244|NCT02103478|20256859|P5|NOT COMPLETED|Overall Study||19
8214245|NCT02103478|20256860|P4|NOT COMPLETED|Overall Study||6
8214246|NCT02103478|20256861|P3|NOT COMPLETED|Overall Study||6
8214247|NCT02103478|20256862|P2|NOT COMPLETED|Overall Study||6
8214248|NCT02103478|20256863|P1|NOT COMPLETED|Overall Study||7
8214249|NCT02103478|20256855|P9|COMPLETED|Overall Study||0
8214250|NCT02103478|20256856|P8|COMPLETED|Overall Study||0
8214251|NCT02103478|20256857|P7|COMPLETED|Overall Study||0
8214252|NCT02103478|20256858|P6|COMPLETED|Overall Study||0
8214253|NCT02103478|20256859|P5|COMPLETED|Overall Study||0
8214254|NCT02103478|20256860|P4|COMPLETED|Overall Study||0
8214255|NCT02103478|20256861|P3|COMPLETED|Overall Study||0
8214256|NCT02103478|20256862|P2|COMPLETED|Overall Study||0
8214257|NCT02103478|20256863|P1|COMPLETED|Overall Study||0
8214258|NCT02103478|20256855|P9|STARTED|Overall Study||14
8214259|NCT02103478|20256856|P8|STARTED|Overall Study||16
8214260|NCT02103478|20256857|P7|STARTED|Overall Study||25
8214261|NCT02103478|20256858|P6|STARTED|Overall Study||25
8214262|NCT02103478|20256859|P5|STARTED|Overall Study||19
8214263|NCT02103478|20256860|P4|STARTED|Overall Study||6
8214264|NCT02103478|20256861|P3|STARTED|Overall Study||6
8214265|NCT02103478|20256862|P2|STARTED|Overall Study||6
8214266|NCT02103478|20256863|P1|STARTED|Overall Study||7
8214267|NCT02103439|20256972|P2|NOT COMPLETED|Overall Study||3
8214268|NCT02103439|20256973|P1|NOT COMPLETED|Overall Study||3
8214269|NCT02103439|20256972|P2|COMPLETED|Overall Study||67
8214270|NCT02103439|20256973|P1|COMPLETED|Overall Study||67
8214271|NCT02103439|20256972|P2|STARTED|Overall Study||70
8214272|NCT02103439|20256973|P1|STARTED|Overall Study||70
8214273|NCT02103309|20256993|P2|NOT COMPLETED|Overall Study||0
8214274|NCT02103309|20256994|P1|NOT COMPLETED|Overall Study||0
8214275|NCT02103309|20256993|P2|COMPLETED|Overall Study||22
8214276|NCT02103309|20256994|P1|COMPLETED|Overall Study||20
8214277|NCT02103309|20256993|P2|STARTED|Overall Study||22
8214278|NCT02103309|20256994|P1|STARTED|Overall Study||20
8214279|NCT02103270|20257009|P3|NOT COMPLETED|Overall Study||24
8214280|NCT02103270|20257010|P2|NOT COMPLETED|Overall Study||6
8214281|NCT02103270|20257011|P1|NOT COMPLETED|Overall Study||9
8214282|NCT02103270|20257009|P3|COMPLETED|Overall Study||1
8214283|NCT02103270|20257010|P2|COMPLETED|Overall Study||29
8214284|NCT02103270|20257011|P1|COMPLETED|Overall Study||51
8214285|NCT02103270|20257009|P3|STARTED|Overall Study||25
8214286|NCT02103270|20257010|P2|STARTED|Overall Study||35
8214287|NCT02103270|20257011|P1|STARTED|Overall Study||60
8214288|NCT02103218|20257026|P4|NOT COMPLETED|Overall Study||7
8214289|NCT02103218|20257027|P3|NOT COMPLETED|Overall Study||4
8214290|NCT02103218|20257028|P2|NOT COMPLETED|Overall Study||8
8214291|NCT02103218|20257029|P1|NOT COMPLETED|Overall Study||5
8214292|NCT02103218|20257026|P4|COMPLETED|Overall Study||47
8214293|NCT02103218|20257027|P3|COMPLETED|Overall Study||44
8214294|NCT02103218|20257028|P2|COMPLETED|Overall Study||51
8214295|NCT02103218|20257029|P1|COMPLETED|Overall Study||46
8214296|NCT02103218|20257026|P4|STARTED|Overall Study||54
8214297|NCT02103218|20257027|P3|STARTED|Overall Study||48
8214299|NCT02103218|20257029|P1|STARTED|Overall Study||51
8214300|NCT02103127|20257073|P1|NOT COMPLETED|Overall Study||3
8214301|NCT02103127|20257073|P1|COMPLETED|Overall Study||17
8214302|NCT02103127|20257073|P1|STARTED|Overall Study||20
8214303|NCT02103114|20257082|P2|NOT COMPLETED|Overall Study||1
8214304|NCT02103114|20257083|P1|NOT COMPLETED|Overall Study||0
8214305|NCT02103114|20257082|P2|COMPLETED|Overall Study||19
8214306|NCT02103114|20257083|P1|COMPLETED|Overall Study||20
8214307|NCT02103114|20257082|P2|STARTED|Overall Study||20
8214308|NCT02103114|20257083|P1|STARTED|Overall Study||20
8214309|NCT02103062|20257139|P2|NOT COMPLETED|Overall Study||23
8214310|NCT02103062|20257140|P1|NOT COMPLETED|Overall Study||18
8214311|NCT02103062|20257139|P2|COMPLETED|Overall Study||0
8214312|NCT02103062|20257140|P1|COMPLETED|Overall Study||0
8214313|NCT02103062|20257139|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
8214314|NCT02103062|20257140|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
8214315|NCT02103062|20257139|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
8214316|NCT02103062|20257140|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
8214317|NCT02103062|20257139|P2|STARTED|Overall Study||23
8214318|NCT02103062|20257140|P1|STARTED|Overall Study||18
8214319|NCT02102932|20257166|P8|NOT COMPLETED|Overall Study||0
8214320|NCT02102932|20257167|P7|NOT COMPLETED|Overall Study||0
8214321|NCT02102932|20257168|P6|NOT COMPLETED|Overall Study||0
8214322|NCT02102932|20257169|P5|NOT COMPLETED|Overall Study||0
8214323|NCT02102932|20257170|P4|NOT COMPLETED|Overall Study||0
8214324|NCT02102932|20257171|P3|NOT COMPLETED|Overall Study||0
8214325|NCT02102932|20257172|P2|NOT COMPLETED|Overall Study||0
8214326|NCT02102932|20257173|P1|NOT COMPLETED|Overall Study||0
8214327|NCT02102932|20257166|P8|COMPLETED|Overall Study||12
8214328|NCT02102932|20257167|P7|COMPLETED|Overall Study||12
8214329|NCT02102932|20257168|P6|COMPLETED|Overall Study||12
8214330|NCT02102932|20257169|P5|COMPLETED|Overall Study||12
8214331|NCT02102932|20257170|P4|COMPLETED|Overall Study||12
8214332|NCT02102932|20257171|P3|COMPLETED|Overall Study||12
8214333|NCT02102932|20257172|P2|COMPLETED|Overall Study||12
8214334|NCT02102932|20257173|P1|COMPLETED|Overall Study||12
8214335|NCT02102932|20257166|P8|STARTED|Overall Study||12
8214336|NCT02102932|20257167|P7|STARTED|Overall Study||12
8214337|NCT02102932|20257168|P6|STARTED|Overall Study||12
8214338|NCT02102932|20257169|P5|STARTED|Overall Study||12
8214339|NCT02102932|20257170|P4|STARTED|Overall Study||12
8214340|NCT02102932|20257171|P3|STARTED|Overall Study||12
8214341|NCT02102932|20257172|P2|STARTED|Overall Study||12
8214342|NCT02102932|20257173|P1|STARTED|Overall Study||12
8214343|NCT02102724|20257233|P2|NOT COMPLETED|Overall Study||1
8214344|NCT02102724|20257234|P1|NOT COMPLETED|Overall Study||2
8214345|NCT02102724|20257233|P2|COMPLETED|Overall Study||18
8214346|NCT02102724|20257234|P1|COMPLETED|Overall Study||16
8214347|NCT02102724|20257233|P2|STARTED|Overall Study||19
8214348|NCT02102724|20257234|P1|STARTED|Overall Study||18
8214349|NCT02102490|20257240|P1|NOT COMPLETED|Overall Study||7
8214350|NCT02102490|20257240|P1|COMPLETED|Overall Study||125
8214351|NCT02102490|20257240|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
8214352|NCT02102490|20257240|P1|STARTED|Overall Study||132
8214353|NCT02102464|20257254|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8214354|NCT02102464|20257255|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8214355|NCT02102464|20257256|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8214356|NCT02102464|20257254|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
8214357|NCT02102464|20257255|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
8214358|NCT02102464|20257256|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
8214359|NCT02102464|20257254|P3|STARTED|Crossover LipiFlow Treatment of Control||25
8214360|NCT02102464|20257255|P2|STARTED|Crossover LipiFlow Treatment of Control||0
8214361|NCT02102464|20257256|P1|STARTED|Crossover LipiFlow Treatment of Control||0
8214362|NCT02102464|20257254|P3|NOT COMPLETED|Randomized Study||0
8214363|NCT02102464|20257255|P2|NOT COMPLETED|Randomized Study||1
8214364|NCT02102464|20257256|P1|NOT COMPLETED|Randomized Study||0
8214365|NCT02102464|20257254|P3|COMPLETED|Randomized Study||0
8214366|NCT02102464|20257255|P2|COMPLETED|Randomized Study||25
8214367|NCT02102464|20257256|P1|COMPLETED|Randomized Study||29
8214368|NCT02102464|20257254|P3|STARTED|Randomized Study||0
8214369|NCT02102464|20257255|P2|STARTED|Randomized Study||26
8214370|NCT02102464|20257256|P1|STARTED|Randomized Study||29
8214371|NCT02102399|20257275|P2|NOT COMPLETED|Overall Study||4
8214372|NCT02102399|20257276|P1|NOT COMPLETED|Overall Study||6
8214373|NCT02102399|20257275|P2|COMPLETED|Overall Study||17
8214374|NCT02102399|20257276|P1|COMPLETED|Overall Study||14
8214375|NCT02102399|20257275|P2|STARTED|Overall Study||21
8214376|NCT02102399|20257276|P1|STARTED|Overall Study||20
8214377|NCT02102230|20257327|P3|NOT COMPLETED|Overall Study||17
8214378|NCT02102230|20257328|P2|NOT COMPLETED|Overall Study||17
8214379|NCT02102230|20257329|P1|NOT COMPLETED|Overall Study||17
8214380|NCT02102230|20257327|P3|COMPLETED|Overall Study||24
8214381|NCT02102230|20257328|P2|COMPLETED|Overall Study||11
8214382|NCT02102230|20257329|P1|COMPLETED|Overall Study||25
8214383|NCT02102230|20257327|P3|STARTED|Overall Study||41
8214384|NCT02102230|20257328|P2|STARTED|Overall Study||28
8214385|NCT02102230|20257329|P1|STARTED|Overall Study||42
8214386|NCT02102204|20257346|P1|NOT COMPLETED|Overall Study||304
8214387|NCT02102204|20257346|P1|COMPLETED|Overall Study||598
8214388|NCT02102204|20257346|P1|Received Etelcalcetide|Overall Study||884
8214389|NCT02102204|20257346|P1|STARTED|Overall Study||902
8214390|NCT02102100|20257357|P2|NOT COMPLETED|Overall Study||7
8214391|NCT02102100|20257358|P1|NOT COMPLETED|Overall Study||9
8214392|NCT02102100|20257357|P2|COMPLETED|Overall Study||18
8214393|NCT02102100|20257358|P1|COMPLETED|Overall Study||23
8214394|NCT02102100|20257357|P2|STARTED|Overall Study||25
8214395|NCT02102100|20257358|P1|STARTED|Overall Study||32
8214396|NCT02101983|20257366|P2|NOT COMPLETED|Overall Study||0
8214397|NCT02101983|20257367|P1|NOT COMPLETED|Overall Study||1
8214398|NCT02101983|20257366|P2|COMPLETED|Overall Study||6
8214399|NCT02101983|20257367|P1|COMPLETED|Overall Study||4
8214400|NCT02101983|20257366|P2|STARTED|Overall Study||6
8214401|NCT02101983|20257367|P1|STARTED|Overall Study||5
8214402|NCT02101918|20257377|P1|NOT COMPLETED|Overall Study||0
8214403|NCT02101918|20257377|P1|COMPLETED|Overall Study||22
8214404|NCT02101918|20257377|P1|STARTED|Overall Study||22
8214405|NCT02101788|20257392|P2|NOT COMPLETED|Overall Study||14
8214406|NCT02101788|20257393|P1|NOT COMPLETED|Overall Study||10
8214407|NCT02101788|20257392|P2|COMPLETED|Overall Study||116
8214408|NCT02101788|20257393|P1|COMPLETED|Overall Study||120
8214409|NCT02101788|20257392|P2|Crossover From Arm A to Arm B|Overall Study||0
8214410|NCT02101788|20257393|P1|Crossover From Arm A to Arm B|Overall Study||88
8214411|NCT02101788|20257392|P2|STARTED|Overall Study||130
8214412|NCT02101788|20257393|P1|STARTED|Overall Study||130
8214413|NCT02101554|20257413|P3|NOT COMPLETED|Overall Study||1
8214414|NCT02101554|20257414|P2|NOT COMPLETED|Overall Study||5
8214415|NCT02101554|20257415|P1|NOT COMPLETED|Overall Study||3
8214416|NCT02101554|20257413|P3|COMPLETED|Overall Study||2
8214417|NCT02101554|20257414|P2|COMPLETED|Overall Study||5
8214418|NCT02101554|20257415|P1|COMPLETED|Overall Study||3
8214419|NCT02101554|20257413|P3|STARTED|Overall Study||3
8214420|NCT02101554|20257414|P2|STARTED|Overall Study||10
8214421|NCT02101554|20257415|P1|STARTED|Overall Study||6
8214422|NCT02101515|20257497|P2|NOT COMPLETED|Overall Study||0
8214423|NCT02101515|20257498|P1|NOT COMPLETED|Overall Study||0
8214424|NCT02101515|20257497|P2|COMPLETED|Overall Study||41
8214425|NCT02101515|20257498|P1|COMPLETED|Overall Study||37
8214426|NCT02101515|20257497|P2|STARTED|Overall Study||41
8214427|NCT02101515|20257498|P1|STARTED|Overall Study||37
8214428|NCT02101437|20257540|P4|NOT COMPLETED|Overall Study||0
8214429|NCT02101437|20257541|P3|NOT COMPLETED|Overall Study||0
8214430|NCT02101437|20257542|P2|NOT COMPLETED|Overall Study||0
8214431|NCT02101437|20257543|P1|NOT COMPLETED|Overall Study||0
8214432|NCT02101437|20257540|P4|COMPLETED|Overall Study||49
8214433|NCT02101437|20257541|P3|COMPLETED|Overall Study||52
8214434|NCT02101437|20257542|P2|COMPLETED|Overall Study||54
8214435|NCT02101437|20257543|P1|COMPLETED|Overall Study||20
8214436|NCT02101437|20257540|P4|STARTED|Overall Study||49
8214437|NCT02101437|20257541|P3|STARTED|Overall Study||52
8214438|NCT02101437|20257542|P2|STARTED|Overall Study||54
8214439|NCT02101437|20257543|P1|STARTED|Overall Study||20
8214440|NCT02101411|20257556|P3|NOT COMPLETED|Overall Study||10
8214441|NCT02101411|20257557|P2|NOT COMPLETED|Overall Study||7
8214442|NCT02101411|20257558|P1|NOT COMPLETED|Overall Study||4
8214443|NCT02101411|20257556|P3|COMPLETED|Overall Study||104
8214444|NCT02101411|20257557|P2|COMPLETED|Overall Study||102
8214445|NCT02101411|20257558|P1|COMPLETED|Overall Study||107
8214446|NCT02101411|20257556|P3|STARTED|Overall Study||114
8214447|NCT02101411|20257557|P2|STARTED|Overall Study||109
8214448|NCT02101411|20257558|P1|STARTED|Overall Study||111
8214449|NCT02101359|20257568|P2|NOT COMPLETED|Overall Study||19
8214450|NCT02101359|20257569|P1|NOT COMPLETED|Overall Study||29
8214451|NCT02101359|20257568|P2|COMPLETED|Overall Study||277
8214452|NCT02101359|20257569|P1|COMPLETED|Overall Study||266
8214453|NCT02101359|20257568|P2|STARTED|Overall Study||296
8214454|NCT02101359|20257569|P1|STARTED|Overall Study||295
8214455|NCT02101294|20257575|P1|NOT COMPLETED|Overall Study||11
8214456|NCT02101294|20257575|P1|COMPLETED|Overall Study||20
8214457|NCT02101294|20257575|P1|STARTED|Overall Study||31
8214458|NCT02101281|20257584|P2|NOT COMPLETED|Overall Study||1
8214459|NCT02101281|20257585|P1|NOT COMPLETED|Overall Study||0
8214460|NCT02101281|20257584|P2|COMPLETED|Overall Study||19
8214461|NCT02101281|20257585|P1|COMPLETED|Overall Study||20
8214462|NCT02101281|20257584|P2|STARTED|Overall Study||20
8214463|NCT02101281|20257585|P1|STARTED|Overall Study||20
8214464|NCT02101190|20257627|P2|NOT COMPLETED|Overall Study||0
8214465|NCT02101190|20257628|P1|NOT COMPLETED|Overall Study||0
8214466|NCT02101190|20257627|P2|COMPLETED|Overall Study||8
8214467|NCT02101190|20257628|P1|COMPLETED|Overall Study||8
8214468|NCT02101190|20257627|P2|STARTED|Overall Study||8
8214469|NCT02101190|20257628|P1|STARTED|Overall Study||8
8214470|NCT02101112|20257638|P6|NOT COMPLETED|Overall Study||0
8214471|NCT02101112|20257639|P5|NOT COMPLETED|Overall Study||1
8214472|NCT02101112|20257640|P4|NOT COMPLETED|Overall Study||0
8214473|NCT02101112|20257641|P3|NOT COMPLETED|Overall Study||1
8214474|NCT02101112|20257642|P2|NOT COMPLETED|Overall Study||0
8214475|NCT02101112|20257643|P1|NOT COMPLETED|Overall Study||0
8214476|NCT02101112|20257638|P6|COMPLETED|Overall Study||5
8214477|NCT02101112|20257639|P5|COMPLETED|Overall Study||5
8214478|NCT02101112|20257640|P4|COMPLETED|Overall Study||5
8214479|NCT02101112|20257641|P3|COMPLETED|Overall Study||5
8214480|NCT02101112|20257642|P2|COMPLETED|Overall Study||5
8214481|NCT02101112|20257643|P1|COMPLETED|Overall Study||6
8214482|NCT02101112|20257638|P6|STARTED|Overall Study||5
8214483|NCT02101112|20257639|P5|STARTED|Overall Study||6
8214484|NCT02101112|20257640|P4|STARTED|Overall Study||5
8214485|NCT02101112|20257641|P3|STARTED|Overall Study||6
8214486|NCT02101112|20257642|P2|STARTED|Overall Study||5
8214487|NCT02101112|20257643|P1|STARTED|Overall Study||6
8214488|NCT02101021|20257673|P5|NOT COMPLETED|Overall Study||4
8214489|NCT02101021|20257674|P4|NOT COMPLETED|Overall Study||3
8214490|NCT02101021|20257675|P3|NOT COMPLETED|Overall Study||7
8214491|NCT02101021|20257676|P2|NOT COMPLETED|Overall Study||4
8214492|NCT02101021|20257677|P1|NOT COMPLETED|Overall Study||7
8214493|NCT02101021|20257673|P5|COMPLETED|Overall Study||0
8214494|NCT02101021|20257674|P4|COMPLETED|Overall Study||0
8214495|NCT02101021|20257675|P3|COMPLETED|Overall Study||0
8214496|NCT02101021|20257676|P2|COMPLETED|Overall Study||0
8214497|NCT02101021|20257677|P1|COMPLETED|Overall Study||0
8214498|NCT02101021|20257673|P5|STARTED|Overall Study||4
8214499|NCT02101021|20257674|P4|STARTED|Overall Study||3
8214500|NCT02101021|20257675|P3|STARTED|Overall Study||7
8214501|NCT02101021|20257676|P2|STARTED|Overall Study||4
8214502|NCT02101021|20257677|P1|STARTED|Overall Study||7
8214503|NCT02101008|20257719|P1|NOT COMPLETED|Overall Study||0
8214504|NCT02101008|20257719|P1|COMPLETED|Overall Study||12
8214505|NCT02101008|20257719|P1|STARTED|Overall Study||12
8214506|NCT02100969|20257724|P1|NOT COMPLETED|Overall Study||1
8214507|NCT02100969|20257724|P1|COMPLETED|Overall Study||22
8214508|NCT02100969|20257724|P1|STARTED|Overall Study||23
8214509|NCT02100930|20257736|P1|NOT COMPLETED|Overall Study||0
8214510|NCT02100930|20257736|P1|COMPLETED|Overall Study||69
8214511|NCT02100930|20257736|P1|STARTED|Overall Study||69
8214512|NCT02100839|20257743|P2|NOT COMPLETED|Multiple Ascending Dose||0
8214513|NCT02100839|20257744|P1|NOT COMPLETED|Multiple Ascending Dose||4
8214514|NCT02100839|20257743|P2|COMPLETED|Multiple Ascending Dose||3
8214515|NCT02100839|20257744|P1|COMPLETED|Multiple Ascending Dose||9
8214516|NCT02100839|20257743|P2|STARTED|Multiple Ascending Dose||3
8214517|NCT02100839|20257744|P1|STARTED|Multiple Ascending Dose||13
8214518|NCT02100839|20257743|P2|NOT COMPLETED|Single Ascending Dose||0
8214519|NCT02100839|20257744|P1|NOT COMPLETED|Single Ascending Dose||0
8214520|NCT02100839|20257743|P2|COMPLETED|Single Ascending Dose||12
8214521|NCT02100839|20257744|P1|COMPLETED|Single Ascending Dose||24
8214522|NCT02100839|20257743|P2|STARTED|Single Ascending Dose||12
8214523|NCT02100839|20257744|P1|STARTED|Single Ascending Dose||24
8214524|NCT02100826|20257756|P2|NOT COMPLETED|Period 2 (7 Days)||0
8214525|NCT02100826|20257757|P1|NOT COMPLETED|Period 2 (7 Days)||0
8214526|NCT02100826|20257756|P2|COMPLETED|Period 2 (7 Days)||14
8214527|NCT02100826|20257757|P1|COMPLETED|Period 2 (7 Days)||14
8214528|NCT02100826|20257756|P2|STARTED|Period 2 (7 Days)||14
8214529|NCT02100826|20257757|P1|STARTED|Period 2 (7 Days)||14
8214530|NCT02100826|20257756|P2|NOT COMPLETED|Washout Period (1 Day)||0
8214531|NCT02100826|20257757|P1|NOT COMPLETED|Washout Period (1 Day)||0
8214532|NCT02100826|20257756|P2|COMPLETED|Washout Period (1 Day)||14
8214533|NCT02100826|20257757|P1|COMPLETED|Washout Period (1 Day)||14
8214534|NCT02100826|20257756|P2|STARTED|Washout Period (1 Day)||14
8214535|NCT02100826|20257757|P1|STARTED|Washout Period (1 Day)||14
8214536|NCT02100826|20257756|P2|NOT COMPLETED|Period 1 (7 Days)||0
8214537|NCT02100826|20257757|P1|NOT COMPLETED|Period 1 (7 Days)||0
8214538|NCT02100826|20257756|P2|COMPLETED|Period 1 (7 Days)||14
8214539|NCT02100826|20257757|P1|COMPLETED|Period 1 (7 Days)||14
8214540|NCT02100826|20257756|P2|STARTED|Period 1 (7 Days)||14
8214541|NCT02100826|20257757|P1|STARTED|Period 1 (7 Days)||14
8214542|NCT02100813|20257775|P8|NOT COMPLETED|Overall Study||1
8214543|NCT02100813|20257776|P7|NOT COMPLETED|Overall Study||0
8214544|NCT02100813|20257777|P6|NOT COMPLETED|Overall Study||0
8214545|NCT02100813|20257778|P5|NOT COMPLETED|Overall Study||0
8214546|NCT02100813|20257779|P4|NOT COMPLETED|Overall Study||0
8214547|NCT02100813|20257780|P3|NOT COMPLETED|Overall Study||0
8214548|NCT02100813|20257781|P2|NOT COMPLETED|Overall Study||0
8214549|NCT02100813|20257782|P1|NOT COMPLETED|Overall Study||0
8214550|NCT02100813|20257775|P8|COMPLETED|Overall Study||66
8214551|NCT02100813|20257776|P7|COMPLETED|Overall Study||64
8214552|NCT02100813|20257777|P6|COMPLETED|Overall Study||32
8214553|NCT02100813|20257778|P5|COMPLETED|Overall Study||12
8214554|NCT02100813|20257779|P4|COMPLETED|Overall Study||12
8214555|NCT02100813|20257780|P3|COMPLETED|Overall Study||12
8214556|NCT02100813|20257781|P2|COMPLETED|Overall Study||11
8214557|NCT02100813|20257782|P1|COMPLETED|Overall Study||10
8214558|NCT02100813|20257775|P8|STARTED|Overall Study||67
8214559|NCT02100813|20257776|P7|STARTED|Overall Study||64
8214560|NCT02100813|20257777|P6|STARTED|Overall Study||32
8214561|NCT02100813|20257778|P5|STARTED|Overall Study||12
8214562|NCT02100813|20257779|P4|STARTED|Overall Study||12
8214563|NCT02100813|20257780|P3|STARTED|Overall Study||12
8214564|NCT02100813|20257781|P2|STARTED|Overall Study||11
8214565|NCT02100813|20257782|P1|STARTED|Overall Study||10
8214566|NCT02100748|20257818|P12|NOT COMPLETED|Overall Study||0
8214567|NCT02100748|20257819|P11|NOT COMPLETED|Overall Study||2
8214568|NCT02100748|20257820|P10|NOT COMPLETED|Overall Study||2
8214569|NCT02100748|20257821|P9|NOT COMPLETED|Overall Study||3
8214570|NCT02100748|20257822|P8|NOT COMPLETED|Overall Study||4
8214571|NCT02100748|20257823|P7|NOT COMPLETED|Overall Study||2
8214572|NCT02100748|20257824|P6|NOT COMPLETED|Overall Study||0
8214573|NCT02100748|20257825|P5|NOT COMPLETED|Overall Study||2
8214574|NCT02100748|20257826|P4|NOT COMPLETED|Overall Study||1
8214575|NCT02100748|20257827|P3|NOT COMPLETED|Overall Study||1
8214576|NCT02100748|20257828|P2|NOT COMPLETED|Overall Study||1
8214577|NCT02100748|20257829|P1|NOT COMPLETED|Overall Study||2
8214578|NCT02100748|20257818|P12|COMPLETED|Overall Study||39
8214579|NCT02100748|20257819|P11|COMPLETED|Overall Study||26
8214580|NCT02100748|20257820|P10|COMPLETED|Overall Study||29
8214581|NCT02100748|20257821|P9|COMPLETED|Overall Study||33
8214582|NCT02100748|20257822|P8|COMPLETED|Overall Study||34
8214583|NCT02100748|20257823|P7|COMPLETED|Overall Study||18
8214584|NCT02100748|20257824|P6|COMPLETED|Overall Study||23
8214585|NCT02100748|20257825|P5|COMPLETED|Overall Study||23
8214586|NCT02100748|20257826|P4|COMPLETED|Overall Study||21
8214587|NCT02100748|20257827|P3|COMPLETED|Overall Study||21
8214588|NCT02100748|20257828|P2|COMPLETED|Overall Study||23
8214589|NCT02100748|20257829|P1|COMPLETED|Overall Study||23
8214590|NCT02100748|20257818|P12|STARTED|Overall Study||39
8214591|NCT02100748|20257819|P11|STARTED|Overall Study||28
8214592|NCT02100748|20257820|P10|STARTED|Overall Study||31
8214593|NCT02100748|20257821|P9|STARTED|Overall Study||36
8214594|NCT02100748|20257822|P8|STARTED|Overall Study||38
8214595|NCT02100748|20257823|P7|STARTED|Overall Study||20
8214596|NCT02100748|20257824|P6|STARTED|Overall Study||23
8214597|NCT02100748|20257825|P5|STARTED|Overall Study||25
8214598|NCT02100748|20257826|P4|STARTED|Overall Study||22
8214599|NCT02100748|20257827|P3|STARTED|Overall Study||22
8214600|NCT02100748|20257828|P2|STARTED|Overall Study||24
8214601|NCT02100748|20257829|P1|STARTED|Overall Study||25
8214602|NCT02100670|20257859|P4|NOT COMPLETED|Overall Study||1
8214603|NCT02100670|20257860|P3|NOT COMPLETED|Overall Study||4
8214604|NCT02100670|20257861|P2|NOT COMPLETED|Overall Study||7
8214605|NCT02100670|20257862|P1|NOT COMPLETED|Overall Study||13
8214606|NCT02100670|20257859|P4|COMPLETED|Overall Study||75
8214607|NCT02100670|20257860|P3|COMPLETED|Overall Study||74
8214608|NCT02100670|20257861|P2|COMPLETED|Overall Study||106
8214609|NCT02100670|20257862|P1|COMPLETED|Overall Study||105
8214610|NCT02100670|20257859|P4|STARTED|Overall Study||76
8214611|NCT02100670|20257860|P3|STARTED|Overall Study||78
8214612|NCT02100670|20257861|P2|STARTED|Overall Study||113
8214613|NCT02100670|20257862|P1|STARTED|Overall Study||118
8214614|NCT02100657|20257925|P3|NOT COMPLETED|Cohort 3: Dose Level 3||27
8214615|NCT02100657|20257926|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
8214616|NCT02100657|20257927|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
8214617|NCT02100657|20257925|P3|COMPLETED|Cohort 3: Dose Level 3||0
8214618|NCT02100657|20257926|P2|COMPLETED|Cohort 3: Dose Level 3||0
8214619|NCT02100657|20257927|P1|COMPLETED|Cohort 3: Dose Level 3||0
8214620|NCT02100657|20257925|P3|STARTED|Cohort 3: Dose Level 3||27
8214621|NCT02100657|20257926|P2|STARTED|Cohort 3: Dose Level 3||0
8214622|NCT02100657|20257927|P1|STARTED|Cohort 3: Dose Level 3||0
8214623|NCT02100657|20257925|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
8214624|NCT02100657|20257926|P2|NOT COMPLETED|Cohort 2: Dose Level 2||4
8214625|NCT02100657|20257927|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
8214626|NCT02100657|20257925|P3|COMPLETED|Cohort 2: Dose Level 2||0
8214627|NCT02100657|20257926|P2|COMPLETED|Cohort 2: Dose Level 2||0
8214628|NCT02100657|20257927|P1|COMPLETED|Cohort 2: Dose Level 2||0
8214629|NCT02100657|20257925|P3|STARTED|Cohort 2: Dose Level 2||0
8214630|NCT02100657|20257926|P2|STARTED|Cohort 2: Dose Level 2||4
8214631|NCT02100657|20257927|P1|STARTED|Cohort 2: Dose Level 2||0
8214632|NCT02100657|20257925|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
8214633|NCT02100657|20257926|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
8214634|NCT02100657|20257927|P1|NOT COMPLETED|Cohort 1: Dose Level 1||8
8214635|NCT02100657|20257925|P3|COMPLETED|Cohort 1: Dose Level 1||0
8214636|NCT02100657|20257926|P2|COMPLETED|Cohort 1: Dose Level 1||0
8214637|NCT02100657|20257927|P1|COMPLETED|Cohort 1: Dose Level 1||0
8214638|NCT02100657|20257925|P3|STARTED|Cohort 1: Dose Level 1||0
8214639|NCT02100657|20257926|P2|STARTED|Cohort 1: Dose Level 1||0
8214640|NCT02100657|20257927|P1|STARTED|Cohort 1: Dose Level 1||8
8214641|NCT02100644|20257965|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8214642|NCT02100644|20257966|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8214643|NCT02100644|20257967|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8214644|NCT02100644|20257965|P3|COMPLETED|LTG and VPA Maintenance Phase||20
8214645|NCT02100644|20257966|P2|COMPLETED|LTG and VPA Maintenance Phase||0
8214646|NCT02100644|20257967|P1|COMPLETED|LTG and VPA Maintenance Phase||0
8214647|NCT02100644|20257965|P3|STARTED|LTG and VPA Maintenance Phase||20
8214648|NCT02100644|20257966|P2|STARTED|LTG and VPA Maintenance Phase||0
8214649|NCT02100644|20257967|P1|STARTED|LTG and VPA Maintenance Phase||0
8214650|NCT02100644|20257965|P3|NOT COMPLETED|VPA Reduction Phase||0
8214651|NCT02100644|20257966|P2|NOT COMPLETED|VPA Reduction Phase||0
8214652|NCT02100644|20257967|P1|NOT COMPLETED|VPA Reduction Phase||0
8214653|NCT02100644|20257965|P3|COMPLETED|VPA Reduction Phase||0
8214654|NCT02100644|20257966|P2|COMPLETED|VPA Reduction Phase||20
8214655|NCT02100644|20257967|P1|COMPLETED|VPA Reduction Phase||0
8214656|NCT02100644|20257965|P3|STARTED|VPA Reduction Phase||0
8214657|NCT02100644|20257966|P2|STARTED|VPA Reduction Phase||20
8214658|NCT02100644|20257967|P1|STARTED|VPA Reduction Phase||0
8214659|NCT02100644|20257965|P3|NOT COMPLETED|LTG Escalation Phase||0
8214660|NCT02100644|20257966|P2|NOT COMPLETED|LTG Escalation Phase||0
8214661|NCT02100644|20257967|P1|NOT COMPLETED|LTG Escalation Phase||13
8214662|NCT02100644|20257965|P3|COMPLETED|LTG Escalation Phase||0
8214663|NCT02100644|20257966|P2|COMPLETED|LTG Escalation Phase||0
8214664|NCT02100644|20257967|P1|COMPLETED|LTG Escalation Phase||20
8214665|NCT02100644|20257965|P3|STARTED|LTG Escalation Phase||0
8214666|NCT02100644|20257966|P2|STARTED|LTG Escalation Phase||0
8214667|NCT02100644|20257967|P1|STARTED|LTG Escalation Phase||33
8214668|NCT02100579|20257979|P2|NOT COMPLETED|Overall Study||0
8214669|NCT02100579|20257980|P1|NOT COMPLETED|Overall Study||0
8214670|NCT02100579|20257979|P2|COMPLETED|Overall Study||20
8214671|NCT02100579|20257980|P1|COMPLETED|Overall Study||20
8214672|NCT02100579|20257979|P2|STARTED|Overall Study||20
8214673|NCT02100579|20257980|P1|STARTED|Overall Study||20
8214674|NCT02100514|20257992|P5|NOT COMPLETED|Extension Period||0
8214675|NCT02100514|20257993|P4|NOT COMPLETED|Extension Period||0
8214676|NCT02100514|20257994|P3|NOT COMPLETED|Extension Period||2
8214677|NCT02100514|20257995|P2|NOT COMPLETED|Extension Period||0
8214678|NCT02100514|20257996|P1|NOT COMPLETED|Extension Period||0
8214679|NCT02100514|20257992|P5|COMPLETED|Extension Period||56
8214680|NCT02100514|20257993|P4|COMPLETED|Extension Period||33
8214681|NCT02100514|20257994|P3|COMPLETED|Extension Period||42
8214682|NCT02100514|20257995|P2|COMPLETED|Extension Period||0
8214683|NCT02100514|20257996|P1|COMPLETED|Extension Period||0
8214684|NCT02100514|20257992|P5|STARTED|Extension Period||56
8214685|NCT02100514|20257993|P4|STARTED|Extension Period||33
8214686|NCT02100514|20257994|P3|STARTED|Extension Period||44
8214687|NCT02100514|20257995|P2|STARTED|Extension Period||0
8214688|NCT02100514|20257996|P1|STARTED|Extension Period||0
8214689|NCT02100514|20257992|P5|NOT COMPLETED|Treatment Period||0
8214690|NCT02100514|20257993|P4|NOT COMPLETED|Treatment Period||0
8214691|NCT02100514|20257994|P3|NOT COMPLETED|Treatment Period||0
8214692|NCT02100514|20257995|P2|NOT COMPLETED|Treatment Period||74
8214693|NCT02100514|20257996|P1|NOT COMPLETED|Treatment Period||29
8214694|NCT02100514|20257992|P5|COMPLETED|Treatment Period||0
8214695|NCT02100514|20257993|P4|COMPLETED|Treatment Period||0
8214696|NCT02100514|20257994|P3|COMPLETED|Treatment Period||0
8214697|NCT02100514|20257995|P2|COMPLETED|Treatment Period||425
8214698|NCT02100514|20257996|P1|COMPLETED|Treatment Period||218
8214699|NCT02100514|20257992|P5|STARTED|Treatment Period||0
8214700|NCT02100514|20257993|P4|STARTED|Treatment Period||0
8214701|NCT02100514|20257994|P3|STARTED|Treatment Period||0
8214702|NCT02100514|20257995|P2|STARTED|Treatment Period||499
8214703|NCT02100514|20257996|P1|STARTED|Treatment Period||247
8214704|NCT02100475|20258064|P2|NOT COMPLETED|Overall Study||2
8214705|NCT02100475|20258065|P1|NOT COMPLETED|Overall Study||2
8214706|NCT02100475|20258064|P2|COMPLETED|Overall Study||13
8214707|NCT02100475|20258065|P1|COMPLETED|Overall Study||14
8214708|NCT02100475|20258064|P2|STARTED|Overall Study||15
8214709|NCT02100475|20258065|P1|STARTED|Overall Study||16
8214710|NCT02100410|20258075|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214711|NCT02100410|20258076|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214712|NCT02100410|20258077|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214713|NCT02100410|20258078|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214714|NCT02100410|20258079|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214715|NCT02100410|20258080|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214716|NCT02100410|20258075|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
8214717|NCT02100410|20258076|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214718|NCT02100410|20258077|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214719|NCT02100410|20258078|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214720|NCT02100410|20258079|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214721|NCT02100410|20258080|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214722|NCT02100410|20258075|P6|STARTED|Exposure Pair 3, 30 Minutes||9
8214723|NCT02100410|20258076|P5|STARTED|Exposure Pair 3, 30 Minutes||8
8214724|NCT02100410|20258077|P4|STARTED|Exposure Pair 3, 30 Minutes||8
8214725|NCT02100410|20258078|P3|STARTED|Exposure Pair 3, 30 Minutes||8
8214726|NCT02100410|20258079|P2|STARTED|Exposure Pair 3, 30 Minutes||8
8214727|NCT02100410|20258080|P1|STARTED|Exposure Pair 3, 30 Minutes||8
8214728|NCT02100410|20258075|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214729|NCT02100410|20258076|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214730|NCT02100410|20258077|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214731|NCT02100410|20258078|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214732|NCT02100410|20258079|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214733|NCT02100410|20258080|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214734|NCT02100410|20258075|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
8214735|NCT02100410|20258076|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214736|NCT02100410|20258077|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214737|NCT02100410|20258078|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214738|NCT02100410|20258079|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214739|NCT02100410|20258080|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214740|NCT02100410|20258075|P6|STARTED|Exposure Pair 2, 30 Minutes||9
8214741|NCT02100410|20258076|P5|STARTED|Exposure Pair 2, 30 Minutes||8
8214742|NCT02100410|20258077|P4|STARTED|Exposure Pair 2, 30 Minutes||8
8214743|NCT02100410|20258078|P3|STARTED|Exposure Pair 2, 30 Minutes||8
8214744|NCT02100410|20258079|P2|STARTED|Exposure Pair 2, 30 Minutes||8
8214745|NCT02100410|20258080|P1|STARTED|Exposure Pair 2, 30 Minutes||8
8214746|NCT02100410|20258075|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214747|NCT02100410|20258076|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214748|NCT02100410|20258077|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214749|NCT02100410|20258078|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214750|NCT02100410|20258079|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214751|NCT02100410|20258080|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214752|NCT02100410|20258075|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
8214753|NCT02100410|20258076|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214754|NCT02100410|20258077|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214755|NCT02100410|20258078|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214756|NCT02100410|20258079|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214757|NCT02100410|20258080|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214758|NCT02100410|20258075|P6|STARTED|Exposure Pair 1, 30 Minutes||9
8214759|NCT02100410|20258076|P5|STARTED|Exposure Pair 1, 30 Minutes||8
8214760|NCT02100410|20258077|P4|STARTED|Exposure Pair 1, 30 Minutes||8
8214761|NCT02100410|20258078|P3|STARTED|Exposure Pair 1, 30 Minutes||8
8214762|NCT02100410|20258079|P2|STARTED|Exposure Pair 1, 30 Minutes||8
8214763|NCT02100410|20258080|P1|STARTED|Exposure Pair 1, 30 Minutes||8
8214764|NCT02100319|20258096|P1|NOT COMPLETED|Overall Study||16
8214765|NCT02100319|20258096|P1|COMPLETED|Overall Study||371
8214766|NCT02100319|20258096|P1|STARTED|Overall Study||387
8214767|NCT02100280|20258107|P2|NOT COMPLETED|Overall Study||4
8214768|NCT02100280|20258108|P1|NOT COMPLETED|Overall Study||4
8214769|NCT02100280|20258107|P2|COMPLETED|Overall Study||44
8214770|NCT02100280|20258108|P1|COMPLETED|Overall Study||44
8214771|NCT02100280|20258107|P2|STARTED|Overall Study||48
8214772|NCT02100280|20258108|P1|STARTED|Overall Study||48
8214773|NCT02100228|20258124|P2|NOT COMPLETED|Overall Study||90
8214774|NCT02100228|20258125|P1|NOT COMPLETED|Overall Study||75
8214775|NCT02100228|20258124|P2|COMPLETED|Overall Study||657
8214776|NCT02100228|20258125|P1|COMPLETED|Overall Study||678
8214777|NCT02100228|20258124|P2|STARTED|Overall Study|721 treated with Usual Care|747
8214778|NCT02100228|20258125|P1|STARTED|Overall Study|735 treated with Apixaban|753
8214779|NCT02100189|20258151|P1|NOT COMPLETED|Overall Study||0
8214780|NCT02100189|20258151|P1|COMPLETED|Overall Study||50
8214781|NCT02100189|20258151|P1|STARTED|Overall Study||50
8214782|NCT02100124|20258161|P3|NOT COMPLETED|Overall Study||3
8214783|NCT02100124|20258162|P2|NOT COMPLETED|Overall Study||11
8214784|NCT02100124|20258163|P1|NOT COMPLETED|Overall Study||6
8214785|NCT02100124|20258161|P3|COMPLETED|Overall Study||323
8214786|NCT02100124|20258162|P2|COMPLETED|Overall Study||318
8214787|NCT02100124|20258163|P1|COMPLETED|Overall Study||323
8214788|NCT02100124|20258161|P3|STARTED|Overall Study||326
8214789|NCT02100124|20258162|P2|STARTED|Overall Study||329
8214790|NCT02100124|20258163|P1|STARTED|Overall Study||329
8214791|NCT02100072|20258180|P1|NOT COMPLETED|Overall Study||0
8214792|NCT02100072|20258180|P1|COMPLETED|Overall Study||5
8214793|NCT02100072|20258180|P1|STARTED|Overall Study||5
8214794|NCT02100007|20258184|P1|NOT COMPLETED|Overall Study||0
8214795|NCT02100007|20258184|P1|COMPLETED|Overall Study||46
8214796|NCT02100007|20258184|P1|STARTED|Overall Study||46
8214797|NCT02099864|20258195|P1|NOT COMPLETED|Overall Study||0
8214798|NCT02099864|20258195|P1|COMPLETED|Overall Study||36
8214799|NCT02099864|20258195|P1|STARTED|Overall Study||36
8214800|NCT02099838|20258220|P2|NOT COMPLETED|Overall Study||2
8214801|NCT02099838|20258221|P1|NOT COMPLETED|Overall Study||4
8214802|NCT02099838|20258220|P2|COMPLETED|Overall Study||49
8214803|NCT02099838|20258221|P1|COMPLETED|Overall Study||43
8214804|NCT02099838|20258220|P2|STARTED|Overall Study||51
8214805|NCT02099838|20258221|P1|STARTED|Overall Study||47
8214806|NCT02099799|20258253|P2|NOT COMPLETED|Overall Study||24
8214807|NCT02099799|20258254|P1|NOT COMPLETED|Overall Study||15
8214808|NCT02099799|20258253|P2|COMPLETED|Overall Study||54
8214809|NCT02099799|20258254|P1|COMPLETED|Overall Study||60
8214810|NCT02099799|20258253|P2|STARTED|Overall Study||78
8214811|NCT02099799|20258254|P1|STARTED|Overall Study||75
8214812|NCT02099786|20258268|P2|NOT COMPLETED|Overall Study||8
8214813|NCT02099786|20258269|P1|NOT COMPLETED|Overall Study||3
8214814|NCT02099786|20258268|P2|COMPLETED|Overall Study||15
8214815|NCT02099786|20258269|P1|COMPLETED|Overall Study||21
8214816|NCT02099786|20258268|P2|Program Eval 3|Overall Study|One year post randomization|15
8214817|NCT02099786|20258269|P1|Program Eval 3|Overall Study|One year post randomization|21
8214818|NCT02099786|20258268|P2|Program Eval 2|Overall Study|One month post randomization|19
8214819|NCT02099786|20258269|P1|Program Eval 2|Overall Study|One month post randomization|23
8214820|NCT02099786|20258268|P2|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
8214821|NCT02099786|20258269|P1|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
8214822|NCT02099786|20258268|P2|STARTED|Overall Study||23
8214823|NCT02099786|20258269|P1|STARTED|Overall Study||24
8214824|NCT02099721|20258287|P6|NOT COMPLETED|Overall Study||20
8214825|NCT02099721|20258288|P5|NOT COMPLETED|Overall Study||27
8214826|NCT02099721|20258289|P4|NOT COMPLETED|Overall Study||71
8214827|NCT02099721|20258290|P3|NOT COMPLETED|Overall Study||85
8214828|NCT02099721|20258291|P2|NOT COMPLETED|Overall Study||127
8214829|NCT02099721|20258292|P1|NOT COMPLETED|Overall Study||76
8214830|NCT02099721|20258287|P6|COMPLETED|Overall Study||432
8214831|NCT02099721|20258288|P5|COMPLETED|Overall Study||304
8214832|NCT02099721|20258289|P4|COMPLETED|Overall Study||774
8214833|NCT02099721|20258290|P3|COMPLETED|Overall Study||983
8214834|NCT02099721|20258291|P2|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
8214835|NCT02099721|20258292|P1|COMPLETED|Overall Study||990
8214836|NCT02099721|20258287|P6|STARTED|Overall Study||452
8214837|NCT02099721|20258288|P5|STARTED|Overall Study||331
8214838|NCT02099721|20258289|P4|STARTED|Overall Study||845
8214839|NCT02099721|20258290|P3|STARTED|Overall Study||1068
8214840|NCT02099721|20258291|P2|STARTED|Overall Study||127
8214841|NCT02099721|20258292|P1|STARTED|Overall Study||1066
8214842|NCT02099708|20258304|P1|NOT COMPLETED|Overall Study||200
8214843|NCT02099708|20258304|P1|COMPLETED|Overall Study||3302
8214844|NCT02099708|20258304|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
8214845|NCT02099708|20258304|P1|STARTED|Overall Study|Number of cases.|3502
8214846|NCT02099682|20258315|P1|NOT COMPLETED|Overall Study||111
8214847|NCT02099682|20258315|P1|COMPLETED|Overall Study||3255
8214848|NCT02099682|20258315|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
8214849|NCT02099682|20258315|P1|STARTED|Overall Study|Number of cases.|3366
8214850|NCT02099461|20258329|P3|NOT COMPLETED|Overall Study||0
8214851|NCT02099461|20258330|P2|NOT COMPLETED|Overall Study||0
8214852|NCT02099461|20258331|P1|NOT COMPLETED|Overall Study||0
8214853|NCT02099461|20258329|P3|COMPLETED|Overall Study||28
8214854|NCT02099461|20258330|P2|COMPLETED|Overall Study||27
8214855|NCT02099461|20258331|P1|COMPLETED|Overall Study||27
8214856|NCT02099461|20258329|P3|STARTED|Overall Study||28
8214857|NCT02099461|20258330|P2|STARTED|Overall Study||27
8214858|NCT02099461|20258331|P1|STARTED|Overall Study||27
8214859|NCT02099344|20258341|P2|NOT COMPLETED|Overall Study||0
8214860|NCT02099344|20258342|P1|NOT COMPLETED|Overall Study||1
8214861|NCT02099344|20258341|P2|COMPLETED|Overall Study||0
8214862|NCT02099344|20258342|P1|COMPLETED|Overall Study||0
8214863|NCT02099344|20258341|P2|STARTED|Overall Study||0
8214864|NCT02099344|20258342|P1|STARTED|Overall Study||1
8214865|NCT02099318|20258352|P2|NOT COMPLETED|Overall Study||0
8214866|NCT02099318|20258353|P1|NOT COMPLETED|Overall Study||0
8214867|NCT02099318|20258352|P2|COMPLETED|Overall Study||20
8214868|NCT02099318|20258353|P1|COMPLETED|Overall Study||20
8214869|NCT02099318|20258352|P2|STARTED|Overall Study||20
8214870|NCT02099318|20258353|P1|STARTED|Overall Study||20
8214871|NCT02099266|20258367|P1|NOT COMPLETED|Overall Study||0
8214872|NCT02099266|20258367|P1|COMPLETED|Overall Study||15
8214873|NCT02099266|20258367|P1|STARTED|Overall Study||15
8214874|NCT02099110|20258379|P5|NOT COMPLETED|Overall Study||27
8214875|NCT02099110|20258380|P4|NOT COMPLETED|Overall Study||22
8214876|NCT02099110|20258381|P3|NOT COMPLETED|Overall Study||28
8214877|NCT02099110|20258382|P2|NOT COMPLETED|Overall Study||31
8214878|NCT02099110|20258383|P1|NOT COMPLETED|Overall Study||24
8214879|NCT02099110|20258379|P5|COMPLETED|Overall Study||218
8214880|NCT02099110|20258380|P4|COMPLETED|Overall Study||221
8214881|NCT02099110|20258381|P3|COMPLETED|Overall Study||219
8214882|NCT02099110|20258382|P2|COMPLETED|Overall Study||217
8214883|NCT02099110|20258383|P1|COMPLETED|Overall Study||226
8214884|NCT02099110|20258379|P5|Treated|Overall Study||244
8214885|NCT02099110|20258380|P4|Treated|Overall Study||243
8214886|NCT02099110|20258381|P3|Treated|Overall Study||247
8214887|NCT02099110|20258382|P2|Treated|Overall Study||248
8214888|NCT02099110|20258383|P1|Treated|Overall Study||250
8214889|NCT02099110|20258379|P5|STARTED|Overall Study||245
8214890|NCT02099110|20258380|P4|STARTED|Overall Study||243
8214891|NCT02099110|20258381|P3|STARTED|Overall Study||247
8214892|NCT02099110|20258382|P2|STARTED|Overall Study||248
8214893|NCT02099110|20258383|P1|STARTED|Overall Study||250
8214894|NCT02099084|20258430|P2|NOT COMPLETED|Second Intervention||0
8214895|NCT02099084|20258431|P1|NOT COMPLETED|Second Intervention||0
8214896|NCT02099084|20258430|P2|COMPLETED|Second Intervention||4
8214897|NCT02099084|20258431|P1|COMPLETED|Second Intervention||4
8214898|NCT02099084|20258430|P2|STARTED|Second Intervention||4
8214899|NCT02099084|20258431|P1|STARTED|Second Intervention||4
8214900|NCT02099084|20258430|P2|NOT COMPLETED|Washout Period of 14 Days||0
8214901|NCT02099084|20258431|P1|NOT COMPLETED|Washout Period of 14 Days||0
8214902|NCT02099084|20258430|P2|COMPLETED|Washout Period of 14 Days||4
8214903|NCT02099084|20258431|P1|COMPLETED|Washout Period of 14 Days||4
8214904|NCT02099084|20258430|P2|STARTED|Washout Period of 14 Days||4
8214905|NCT02099084|20258431|P1|STARTED|Washout Period of 14 Days||4
8214906|NCT02099084|20258430|P2|NOT COMPLETED|First Intervention||0
8214907|NCT02099084|20258431|P1|NOT COMPLETED|First Intervention||0
8214908|NCT02099084|20258430|P2|COMPLETED|First Intervention||4
8214909|NCT02099084|20258431|P1|COMPLETED|First Intervention||4
8214910|NCT02099084|20258430|P2|STARTED|First Intervention||4
8214911|NCT02099084|20258431|P1|STARTED|First Intervention||4
8214912|NCT02099006|20258449|P1|NOT COMPLETED|Overall Study||1
8214913|NCT02099006|20258449|P1|COMPLETED|Overall Study||8
8214914|NCT02099006|20258449|P1|Received Gabapentin|Overall Study||8
8214915|NCT02099006|20258449|P1|Received Ketamine|Overall Study||6
8214916|NCT02099006|20258449|P1|Received Loperamide|Overall Study||7
8214917|NCT02099006|20258449|P1|Received Ketoprofen|Overall Study||3
8214918|NCT02099006|20258449|P1|Received Amitriptyline/ Baclofen|Overall Study||7
8214919|NCT02099006|20258449|P1|Received Placebo|Overall Study||9
8214920|NCT02099006|20258449|P1|STARTED|Overall Study||9
8214921|NCT02098993|20258459|P2|NOT COMPLETED|Overall Study||0
8214922|NCT02098993|20258460|P1|NOT COMPLETED|Overall Study||0
8214923|NCT02098993|20258459|P2|COMPLETED|Overall Study||3
8214924|NCT02098993|20258460|P1|COMPLETED|Overall Study||4
8214925|NCT02098993|20258459|P2|STARTED|Overall Study||3
8214926|NCT02098993|20258460|P1|STARTED|Overall Study||4
8214927|NCT02098746|20258484|P1|NOT COMPLETED|Overall Study||5
8214928|NCT02098746|20258484|P1|COMPLETED|Overall Study||289
8214929|NCT02098746|20258484|P1|STARTED|Overall Study||294
8214930|NCT02098733|20258492|P1|NOT COMPLETED|Overall Study||10
8214931|NCT02098733|20258492|P1|COMPLETED|Overall Study||1158
8214932|NCT02098733|20258492|P1|STARTED|Overall Study||1168
8214933|NCT02098395|20258506|P4|NOT COMPLETED|Overall Study||27
8214934|NCT02098395|20258507|P3|NOT COMPLETED|Overall Study||42
8214935|NCT02098395|20258508|P2|NOT COMPLETED|Overall Study||32
8214936|NCT02098395|20258509|P1|NOT COMPLETED|Overall Study||26
8214937|NCT02098395|20258506|P4|COMPLETED|Overall Study||180
8214938|NCT02098395|20258507|P3|COMPLETED|Overall Study||165
8214939|NCT02098395|20258508|P2|COMPLETED|Overall Study||177
8214940|NCT02098395|20258509|P1|COMPLETED|Overall Study||186
8214941|NCT02098395|20258506|P4|Exposed|Overall Study||206
8214942|NCT02098395|20258507|P3|Exposed|Overall Study||206
8214943|NCT02098395|20258508|P2|Exposed|Overall Study||209
8214944|NCT02098395|20258509|P1|Exposed|Overall Study||211
8214945|NCT02098395|20258506|P4|STARTED|Overall Study||207
8214946|NCT02098395|20258507|P3|STARTED|Overall Study||207
8214947|NCT02098395|20258508|P2|STARTED|Overall Study||209
8214948|NCT02098395|20258509|P1|STARTED|Overall Study||212
8214949|NCT02098369|20258530|P3|NOT COMPLETED|Overall Study||5
8214950|NCT02098369|20258531|P2|NOT COMPLETED|Overall Study||9
8214951|NCT02098369|20258532|P1|NOT COMPLETED|Overall Study||7
8214952|NCT02098369|20258530|P3|COMPLETED|Overall Study||143
8214953|NCT02098369|20258531|P2|COMPLETED|Overall Study||145
8214954|NCT02098369|20258532|P1|COMPLETED|Overall Study||135
8214955|NCT02098369|20258530|P3|STARTED|Overall Study||148
8214956|NCT02098369|20258531|P2|STARTED|Overall Study||154
8214957|NCT02098369|20258532|P1|STARTED|Overall Study||142
8214958|NCT02098304|20258561|P1|NOT COMPLETED|Overall Study||0
8214959|NCT02098304|20258561|P1|COMPLETED|Overall Study||42
8214960|NCT02098304|20258561|P1|STARTED|Overall Study||42
8214961|NCT02098109|20258570|P2|NOT COMPLETED|Overall Study||0
8214962|NCT02098109|20258571|P1|NOT COMPLETED|Overall Study||3
8214963|NCT02098109|20258570|P2|COMPLETED|Overall Study||51
8214964|NCT02098109|20258571|P1|COMPLETED|Overall Study||46
8214965|NCT02098109|20258570|P2|STARTED|Overall Study||51
8214966|NCT02098109|20258571|P1|STARTED|Overall Study||49
8214967|NCT02097992|20258597|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214968|NCT02097992|20258598|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214969|NCT02097992|20258599|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214970|NCT02097992|20258600|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214971|NCT02097992|20258597|P4|COMPLETED|Treatment 3 (4 Weeks)||2
8214972|NCT02097992|20258598|P3|COMPLETED|Treatment 3 (4 Weeks)||4
8214973|NCT02097992|20258599|P2|COMPLETED|Treatment 3 (4 Weeks)||3
8214974|NCT02097992|20258600|P1|COMPLETED|Treatment 3 (4 Weeks)||2
8214975|NCT02097992|20258597|P4|STARTED|Treatment 3 (4 Weeks)||2
8214976|NCT02097992|20258598|P3|STARTED|Treatment 3 (4 Weeks)||4
8214977|NCT02097992|20258599|P2|STARTED|Treatment 3 (4 Weeks)||3
8214978|NCT02097992|20258600|P1|STARTED|Treatment 3 (4 Weeks)||2
8214979|NCT02097992|20258597|P4|NOT COMPLETED|Washout (4 Weeks)||0
8214980|NCT02097992|20258598|P3|NOT COMPLETED|Washout (4 Weeks)||0
8214981|NCT02097992|20258599|P2|NOT COMPLETED|Washout (4 Weeks)||0
8214982|NCT02097992|20258600|P1|NOT COMPLETED|Washout (4 Weeks)||0
8214983|NCT02097992|20258597|P4|COMPLETED|Washout (4 Weeks)||2
8214984|NCT02097992|20258598|P3|COMPLETED|Washout (4 Weeks)||4
8214985|NCT02097992|20258599|P2|COMPLETED|Washout (4 Weeks)||3
8214986|NCT02097992|20258600|P1|COMPLETED|Washout (4 Weeks)||2
8214987|NCT02097992|20258597|P4|STARTED|Washout (4 Weeks)||2
8214988|NCT02097992|20258598|P3|STARTED|Washout (4 Weeks)||4
8214989|NCT02097992|20258599|P2|STARTED|Washout (4 Weeks)||3
8214990|NCT02097992|20258600|P1|STARTED|Washout (4 Weeks)||2
8214991|NCT02097992|20258597|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214992|NCT02097992|20258598|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214993|NCT02097992|20258599|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214994|NCT02097992|20258600|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214995|NCT02097992|20258597|P4|COMPLETED|Treatment 2 (4 Weeks)||2
8214996|NCT02097992|20258598|P3|COMPLETED|Treatment 2 (4 Weeks)||4
8214997|NCT02097992|20258599|P2|COMPLETED|Treatment 2 (4 Weeks)||3
8214998|NCT02097992|20258600|P1|COMPLETED|Treatment 2 (4 Weeks)||2
8214999|NCT02097992|20258597|P4|STARTED|Treatment 2 (4 Weeks)||2
8215000|NCT02097992|20258598|P3|STARTED|Treatment 2 (4 Weeks)||4
8215001|NCT02097992|20258599|P2|STARTED|Treatment 2 (4 Weeks)||3
8215002|NCT02097992|20258600|P1|STARTED|Treatment 2 (4 Weeks)||2
8215003|NCT02097992|20258597|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
8215004|NCT02097992|20258598|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
8215005|NCT02097992|20258599|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
8215006|NCT02097992|20258600|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
8215007|NCT02097992|20258597|P4|COMPLETED|Treatment 1 (1 Day)||2
8215008|NCT02097992|20258598|P3|COMPLETED|Treatment 1 (1 Day)||4
8215009|NCT02097992|20258599|P2|COMPLETED|Treatment 1 (1 Day)||3
8215010|NCT02097992|20258600|P1|COMPLETED|Treatment 1 (1 Day)||2
8215011|NCT02097992|20258597|P4|STARTED|Treatment 1 (1 Day)||2
8215012|NCT02097992|20258598|P3|STARTED|Treatment 1 (1 Day)||4
8215013|NCT02097992|20258599|P2|STARTED|Treatment 1 (1 Day)||3
8215014|NCT02097992|20258600|P1|STARTED|Treatment 1 (1 Day)||2
8215015|NCT02097849|20258610|P2|NOT COMPLETED|Overall Study||0
8215016|NCT02097849|20258611|P1|NOT COMPLETED|Overall Study||0
8215017|NCT02097849|20258610|P2|COMPLETED|Overall Study||38
8215018|NCT02097849|20258611|P1|COMPLETED|Overall Study||33
8215019|NCT02097849|20258610|P2|STARTED|Overall Study||38
8215020|NCT02097849|20258611|P1|STARTED|Overall Study||33
8215021|NCT02097823|20258649|P2|NOT COMPLETED|Overall Study||1
8215022|NCT02097823|20258650|P1|NOT COMPLETED|Overall Study||1
8215023|NCT02097823|20258649|P2|COMPLETED|Overall Study||3
8215024|NCT02097823|20258650|P1|COMPLETED|Overall Study||10
8215025|NCT02097823|20258649|P2|STARTED|Overall Study||4
8215026|NCT02097823|20258650|P1|STARTED|Overall Study||11
8215027|NCT02097745|20258665|P1|NOT COMPLETED|Overall Study||178
8215028|NCT02097745|20258665|P1|COMPLETED|Overall Study||157
8215029|NCT02097745|20258665|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
8215030|NCT02097732|20258689|P2|NOT COMPLETED|Overall Study||0
8215031|NCT02097732|20258690|P1|NOT COMPLETED|Overall Study||0
8215032|NCT02097732|20258689|P2|COMPLETED|Overall Study||3
8215033|NCT02097732|20258690|P1|COMPLETED|Overall Study||1
8215034|NCT02097732|20258689|P2|STARTED|Overall Study||3
8215035|NCT02097732|20258690|P1|STARTED|Overall Study||1
8215036|NCT02097719|20258703|P2|NOT COMPLETED|Overall Study||1
8215037|NCT02097719|20258704|P1|NOT COMPLETED|Overall Study||3
8215038|NCT02097719|20258703|P2|COMPLETED|Overall Study||50
8215039|NCT02097719|20258704|P1|COMPLETED|Overall Study||46
8215040|NCT02097719|20258703|P2|STARTED|Overall Study||51
8215041|NCT02097719|20258704|P1|STARTED|Overall Study||49
8215042|NCT02097641|20258712|P2|NOT COMPLETED|Overall Study||0
8215043|NCT02097641|20258713|P1|NOT COMPLETED|Overall Study||0
8215044|NCT02097641|20258712|P2|COMPLETED|Overall Study||20
8215045|NCT02097641|20258713|P1|COMPLETED|Overall Study||40
8215046|NCT02097641|20258712|P2|STARTED|Overall Study||20
8215047|NCT02097641|20258713|P1|STARTED|Overall Study||40
8215048|NCT02097537|20258755|P1|NOT COMPLETED|Overall Study||0
8215049|NCT02097537|20258755|P1|COMPLETED|Overall Study||10
8215050|NCT02097537|20258755|P1|Follow-Up|Overall Study||10
8215051|NCT02097537|20258755|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
8215052|NCT02097537|20258755|P1|STARTED|Overall Study||10
8215053|NCT02097472|20258769|P8|NOT COMPLETED|Assessed for Immunogenicity||1
8215054|NCT02097472|20258770|P7|NOT COMPLETED|Assessed for Immunogenicity||2
8215055|NCT02097472|20258771|P6|NOT COMPLETED|Assessed for Immunogenicity||2
8215056|NCT02097472|20258772|P5|NOT COMPLETED|Assessed for Immunogenicity||0
8215057|NCT02097472|20258773|P4|NOT COMPLETED|Assessed for Immunogenicity||2
8215058|NCT02097472|20258774|P3|NOT COMPLETED|Assessed for Immunogenicity||1
8215059|NCT02097472|20258775|P2|NOT COMPLETED|Assessed for Immunogenicity||0
8215060|NCT02097472|20258776|P1|NOT COMPLETED|Assessed for Immunogenicity||0
8215061|NCT02097472|20258769|P8|COMPLETED|Assessed for Immunogenicity||49
8215062|NCT02097472|20258770|P7|COMPLETED|Assessed for Immunogenicity||47
8215063|NCT02097472|20258771|P6|COMPLETED|Assessed for Immunogenicity||48
8215064|NCT02097472|20258772|P5|COMPLETED|Assessed for Immunogenicity||50
8215065|NCT02097472|20258773|P4|COMPLETED|Assessed for Immunogenicity||48
8215066|NCT02097472|20258774|P3|COMPLETED|Assessed for Immunogenicity||17
8215067|NCT02097472|20258775|P2|COMPLETED|Assessed for Immunogenicity||18
8215068|NCT02097472|20258776|P1|COMPLETED|Assessed for Immunogenicity||18
8215069|NCT02097472|20258769|P8|STARTED|Assessed for Immunogenicity||50
8215070|NCT02097472|20258770|P7|STARTED|Assessed for Immunogenicity||49
8215071|NCT02097472|20258771|P6|STARTED|Assessed for Immunogenicity||50
8215072|NCT02097472|20258772|P5|STARTED|Assessed for Immunogenicity||50
8215073|NCT02097472|20258773|P4|STARTED|Assessed for Immunogenicity||50
8215074|NCT02097472|20258774|P3|STARTED|Assessed for Immunogenicity||18
8215075|NCT02097472|20258775|P2|STARTED|Assessed for Immunogenicity||18
8215076|NCT02097472|20258776|P1|STARTED|Assessed for Immunogenicity||18
8215077|NCT02097472|20258769|P8|NOT COMPLETED|Received Vaccination 2||0
8215078|NCT02097472|20258770|P7|NOT COMPLETED|Received Vaccination 2||1
8215079|NCT02097472|20258771|P6|NOT COMPLETED|Received Vaccination 2||0
8215080|NCT02097472|20258772|P5|NOT COMPLETED|Received Vaccination 2||0
8215081|NCT02097472|20258773|P4|NOT COMPLETED|Received Vaccination 2||0
8215082|NCT02097472|20258774|P3|NOT COMPLETED|Received Vaccination 2||0
8215083|NCT02097472|20258775|P2|NOT COMPLETED|Received Vaccination 2||0
8215084|NCT02097472|20258776|P1|NOT COMPLETED|Received Vaccination 2||0
8215085|NCT02097472|20258769|P8|COMPLETED|Received Vaccination 2||50
8215086|NCT02097472|20258770|P7|COMPLETED|Received Vaccination 2||49
8215087|NCT02097472|20258771|P6|COMPLETED|Received Vaccination 2||50
8215088|NCT02097472|20258772|P5|COMPLETED|Received Vaccination 2||50
8215089|NCT02097472|20258773|P4|COMPLETED|Received Vaccination 2||50
8215090|NCT02097472|20258774|P3|COMPLETED|Received Vaccination 2||18
8215091|NCT02097472|20258775|P2|COMPLETED|Received Vaccination 2||18
8215092|NCT02097472|20258776|P1|COMPLETED|Received Vaccination 2||18
8215093|NCT02097472|20258769|P8|STARTED|Received Vaccination 2||50
8215094|NCT02097472|20258770|P7|STARTED|Received Vaccination 2||50
8215095|NCT02097472|20258771|P6|STARTED|Received Vaccination 2||50
8215096|NCT02097472|20258772|P5|STARTED|Received Vaccination 2||50
8215097|NCT02097472|20258773|P4|STARTED|Received Vaccination 2||50
8215098|NCT02097472|20258774|P3|STARTED|Received Vaccination 2||18
8215099|NCT02097472|20258775|P2|STARTED|Received Vaccination 2||18
8215100|NCT02097472|20258776|P1|STARTED|Received Vaccination 2||18
8215101|NCT02097472|20258769|P8|NOT COMPLETED|Received Vaccination 1||0
8215102|NCT02097472|20258770|P7|NOT COMPLETED|Received Vaccination 1||0
8215103|NCT02097472|20258771|P6|NOT COMPLETED|Received Vaccination 1||0
8215104|NCT02097472|20258772|P5|NOT COMPLETED|Received Vaccination 1||0
8215105|NCT02097472|20258773|P4|NOT COMPLETED|Received Vaccination 1||0
8215106|NCT02097472|20258774|P3|NOT COMPLETED|Received Vaccination 1||0
8215107|NCT02097472|20258775|P2|NOT COMPLETED|Received Vaccination 1||0
8215108|NCT02097472|20258776|P1|NOT COMPLETED|Received Vaccination 1||0
8215109|NCT02097472|20258769|P8|COMPLETED|Received Vaccination 1||50
8215110|NCT02097472|20258770|P7|COMPLETED|Received Vaccination 1||50
8215111|NCT02097472|20258771|P6|COMPLETED|Received Vaccination 1||50
8215112|NCT02097472|20258772|P5|COMPLETED|Received Vaccination 1||50
8215113|NCT02097472|20258773|P4|COMPLETED|Received Vaccination 1||50
8215114|NCT02097472|20258774|P3|COMPLETED|Received Vaccination 1||18
8215115|NCT02097472|20258775|P2|COMPLETED|Received Vaccination 1||18
8215116|NCT02097472|20258776|P1|COMPLETED|Received Vaccination 1||18
8215117|NCT02097472|20258769|P8|STARTED|Received Vaccination 1||50
8215118|NCT02097472|20258770|P7|STARTED|Received Vaccination 1||50
8215119|NCT02097472|20258771|P6|STARTED|Received Vaccination 1||50
8215120|NCT02097472|20258772|P5|STARTED|Received Vaccination 1||50
8215121|NCT02097472|20258773|P4|STARTED|Received Vaccination 1||50
8215122|NCT02097472|20258774|P3|STARTED|Received Vaccination 1||18
8215123|NCT02097472|20258775|P2|STARTED|Received Vaccination 1||18
8215124|NCT02097472|20258776|P1|STARTED|Received Vaccination 1||18
8215125|NCT02097420|20259197|P1|NOT COMPLETED|Overall Study||14
8215126|NCT02097420|20259197|P1|COMPLETED|Overall Study||6
8215127|NCT02097420|20259197|P1|STARTED|Overall Study||20
8215128|NCT02097303|20259210|P1|NOT COMPLETED|Overall Study||5
8215129|NCT02097303|20259210|P1|COMPLETED|Overall Study||31
8215130|NCT02097303|20259210|P1|STARTED|Overall Study||36
8215131|NCT02097290|20259220|P1|NOT COMPLETED|Overall Study||17
8215132|NCT02097290|20259220|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
8215133|NCT02097290|20259220|P1|STARTED|Overall Study||210
8215134|NCT02097277|20259235|P5|NOT COMPLETED|Overall Study||1
8215135|NCT02097277|20259236|P4|NOT COMPLETED|Overall Study||4
8215136|NCT02097277|20259237|P3|NOT COMPLETED|Overall Study||2
8215137|NCT02097277|20259238|P2|NOT COMPLETED|Overall Study||3
8215138|NCT02097277|20259239|P1|NOT COMPLETED|Overall Study||2
8215139|NCT02097277|20259235|P5|COMPLETED|Overall Study||23
8215140|NCT02097277|20259236|P4|COMPLETED|Overall Study||20
8215141|NCT02097277|20259237|P3|COMPLETED|Overall Study||22
8215142|NCT02097277|20259238|P2|COMPLETED|Overall Study||21
8215143|NCT02097277|20259239|P1|COMPLETED|Overall Study||22
8215144|NCT02097277|20259235|P5|STARTED|Overall Study||24
8215145|NCT02097277|20259236|P4|STARTED|Overall Study||24
8215146|NCT02097277|20259237|P3|STARTED|Overall Study||24
8215147|NCT02097277|20259238|P2|STARTED|Overall Study||24
8215148|NCT02097277|20259239|P1|STARTED|Overall Study||24
8215149|NCT02097238|20259322|P1|NOT COMPLETED|Overall Study||19
8215150|NCT02097238|20259322|P1|COMPLETED|Overall Study||0
8215151|NCT02097238|20259322|P1|STARTED|Overall Study||19
8215152|NCT02097134|20259331|P1|NOT COMPLETED|Overall Study||9
8215153|NCT02097134|20259331|P1|COMPLETED|Overall Study||5
8215154|NCT02097134|20259331|P1|STARTED|Overall Study||14
8215155|NCT02097108|20259339|P1|NOT COMPLETED|Overall Study||2
8215156|NCT02097108|20259339|P1|COMPLETED|Overall Study||9
8215157|NCT02097108|20259339|P1|STARTED|Overall Study||11
8215158|NCT02097056|20259346|P1|NOT COMPLETED|Overall Study||58
8215159|NCT02097056|20259346|P1|COMPLETED|Overall Study||113
8215160|NCT02097056|20259346|P1|ParticipantsTreated|Overall Study||170
8215161|NCT02097056|20259346|P1|STARTED|Overall Study||171
8215162|NCT02097030|20259354|P2|NOT COMPLETED|Second Intervention (3 Days)||0
8215163|NCT02097030|20259355|P1|NOT COMPLETED|Second Intervention (3 Days)||0
8215164|NCT02097030|20259354|P2|COMPLETED|Second Intervention (3 Days)||16
8215165|NCT02097030|20259355|P1|COMPLETED|Second Intervention (3 Days)||14
8215166|NCT02097030|20259354|P2|STARTED|Second Intervention (3 Days)||16
8215167|NCT02097030|20259355|P1|STARTED|Second Intervention (3 Days)||14
8215168|NCT02097030|20259354|P2|NOT COMPLETED|First Intervention (3 Days)||1
8215169|NCT02097030|20259355|P1|NOT COMPLETED|First Intervention (3 Days)||1
8215170|NCT02097030|20259354|P2|COMPLETED|First Intervention (3 Days)||16
8215171|NCT02097030|20259355|P1|COMPLETED|First Intervention (3 Days)||14
8215172|NCT02097030|20259354|P2|STARTED|First Intervention (3 Days)||17
8215173|NCT02097030|20259355|P1|STARTED|First Intervention (3 Days)||15
8215174|NCT02096952|20259416|P1|NOT COMPLETED|Overall Study||1
8215175|NCT02096952|20259416|P1|COMPLETED|Overall Study||14
8215176|NCT02096952|20259416|P1|STARTED|Overall Study||15
8215177|NCT02096900|20259422|P2|NOT COMPLETED|Overall Study||2
8215178|NCT02096900|20259423|P1|NOT COMPLETED|Overall Study||4
8215179|NCT02096900|20259422|P2|COMPLETED|Overall Study||42
8215180|NCT02096900|20259423|P1|COMPLETED|Overall Study||38
8215181|NCT02096900|20259422|P2|STARTED|Overall Study|Allocated to Zolpidem|44
8215182|NCT02096900|20259423|P1|STARTED|Overall Study|Allocated to Midazolam|42
8215183|NCT02096861|20259441|P4|NOT COMPLETED|Overall Study||10
8215184|NCT02096861|20259442|P3|NOT COMPLETED|Overall Study||17
8215185|NCT02096861|20259443|P2|NOT COMPLETED|Overall Study||15
8215186|NCT02096861|20259444|P1|NOT COMPLETED|Overall Study||12
8215187|NCT02096861|20259441|P4|COMPLETED|Overall Study||45
8215188|NCT02096861|20259442|P3|COMPLETED|Overall Study||37
8215189|NCT02096861|20259443|P2|COMPLETED|Overall Study||40
8215190|NCT02096861|20259444|P1|COMPLETED|Overall Study||44
8215191|NCT02096861|20259441|P4|Drug Switching at Week 30|Overall Study||47
8215192|NCT02096861|20259442|P3|Drug Switching at Week 30|Overall Study||41
8215193|NCT02096861|20259443|P2|Drug Switching at Week 30|Overall Study||44
8215194|NCT02096861|20259444|P1|Drug Switching at Week 30|Overall Study||48
8215195|NCT02096861|20259441|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
8215196|NCT02096861|20259442|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
8215197|NCT02096861|20259443|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
8215198|NCT02096861|20259444|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
8215199|NCT02096835|20259475|P3|NOT COMPLETED|Overall Study||1
8215200|NCT02096835|20259476|P2|NOT COMPLETED|Overall Study||0
8215201|NCT02096835|20259477|P1|NOT COMPLETED|Overall Study||3
8215202|NCT02096835|20259475|P3|COMPLETED|Overall Study||50
8215203|NCT02096835|20259476|P2|COMPLETED|Overall Study||53
8215204|NCT02096835|20259477|P1|COMPLETED|Overall Study||50
8215205|NCT02096835|20259475|P3|STARTED|Overall Study||51
8215206|NCT02096835|20259476|P2|STARTED|Overall Study||53
8215207|NCT02096835|20259477|P1|STARTED|Overall Study||53
8215208|NCT02096744|20259494|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8215209|NCT02096744|20259495|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8215210|NCT02096744|20259494|P2|COMPLETED|Treatment Period 3 (7 Days)||27
8215211|NCT02096744|20259495|P1|COMPLETED|Treatment Period 3 (7 Days)||28
8215212|NCT02096744|20259494|P2|STARTED|Treatment Period 3 (7 Days)||28
8215213|NCT02096744|20259495|P1|STARTED|Treatment Period 3 (7 Days)||28
8215214|NCT02096744|20259494|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
8215215|NCT02096744|20259495|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
8215216|NCT02096744|20259494|P2|COMPLETED|Washout Period 2 (3 Days)||28
8215217|NCT02096744|20259495|P1|COMPLETED|Washout Period 2 (3 Days)||28
8215218|NCT02096744|20259494|P2|STARTED|Washout Period 2 (3 Days)||28
8215219|NCT02096744|20259495|P1|STARTED|Washout Period 2 (3 Days)||28
8215220|NCT02096744|20259494|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8215221|NCT02096744|20259495|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8215222|NCT02096744|20259494|P2|COMPLETED|Treatment Period 2 (7 Days)||28
8215223|NCT02096744|20259495|P1|COMPLETED|Treatment Period 2 (7 Days)||28
8215224|NCT02096744|20259494|P2|STARTED|Treatment Period 2 (7 Days)||28
8215225|NCT02096744|20259495|P1|STARTED|Treatment Period 2 (7 Days)||28
8215226|NCT02096744|20259494|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
8215227|NCT02096744|20259495|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
8215228|NCT02096744|20259494|P2|COMPLETED|Washout Period 1(7 Days)||28
8215229|NCT02096744|20259495|P1|COMPLETED|Washout Period 1(7 Days)||28
8215230|NCT02096744|20259494|P2|STARTED|Washout Period 1(7 Days)||28
8215231|NCT02096744|20259495|P1|STARTED|Washout Period 1(7 Days)||28
8215232|NCT02096744|20259494|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
8215233|NCT02096744|20259495|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
8215234|NCT02096744|20259494|P2|COMPLETED|Treatment Period 1(7 Days)||28
8215235|NCT02096744|20259495|P1|COMPLETED|Treatment Period 1(7 Days)||28
8215236|NCT02096744|20259494|P2|STARTED|Treatment Period 1(7 Days)||29
8215237|NCT02096744|20259495|P1|STARTED|Treatment Period 1(7 Days)||29
8215238|NCT02096731|20259510|P2|NOT COMPLETED|Overall Study||0
8215239|NCT02096731|20259511|P1|NOT COMPLETED|Overall Study||0
8215240|NCT02096731|20259510|P2|COMPLETED|Overall Study||88955
8215241|NCT02096731|20259511|P1|COMPLETED|Overall Study||26442
8215242|NCT02096731|20259510|P2|STARTED|Overall Study||88955
8215243|NCT02096731|20259511|P1|STARTED|Overall Study||26442
8215244|NCT02096718|20259528|P3|NOT COMPLETED|Overall Study||0
8215245|NCT02096718|20259529|P2|NOT COMPLETED|Overall Study||0
8215246|NCT02096718|20259530|P1|NOT COMPLETED|Overall Study||0
8215247|NCT02096718|20259528|P3|COMPLETED|Overall Study||14
8215248|NCT02096718|20259529|P2|COMPLETED|Overall Study||8
8215249|NCT02096718|20259530|P1|COMPLETED|Overall Study||8
8215250|NCT02096718|20259528|P3|STARTED|Overall Study||14
8215251|NCT02096718|20259529|P2|STARTED|Overall Study||8
8215252|NCT02096718|20259530|P1|STARTED|Overall Study||8
8215253|NCT02096705|20259549|P2|NOT COMPLETED|Follow-up||4
8215254|NCT02096705|20259550|P1|NOT COMPLETED|Follow-up||4
8215255|NCT02096705|20259549|P2|COMPLETED|Follow-up||135
8215256|NCT02096705|20259550|P1|COMPLETED|Follow-up||125
8215257|NCT02096705|20259549|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
8215258|NCT02096705|20259550|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
8215259|NCT02096705|20259549|P2|NOT COMPLETED|Treatment||5
8215260|NCT02096705|20259550|P1|NOT COMPLETED|Treatment||9
8215261|NCT02096705|20259549|P2|COMPLETED|Treatment||134
8215262|NCT02096705|20259550|P1|COMPLETED|Treatment||124
8215263|NCT02096705|20259549|P2|STARTED|Treatment||139
8215264|NCT02096705|20259550|P1|STARTED|Treatment||133
8215265|NCT02096692|20259562|P1|NOT COMPLETED|Overall Study||4
8215266|NCT02096692|20259562|P1|COMPLETED|Overall Study||150
8215267|NCT02096692|20259562|P1|STARTED|Overall Study||154
8215268|NCT02096679|20259568|P1|NOT COMPLETED|Overall Study||0
8215269|NCT02096679|20259568|P1|COMPLETED|Overall Study||8
8215270|NCT02096679|20259568|P1|STARTED|Overall Study||8
8215271|NCT02096588|20259593|P2|NOT COMPLETED|Overall Study||1
8215272|NCT02096588|20259594|P1|NOT COMPLETED|Overall Study||2
8215273|NCT02096588|20259593|P2|COMPLETED|Overall Study||15
8215274|NCT02096588|20259594|P1|COMPLETED|Overall Study||13
8215275|NCT02096588|20259593|P2|STARTED|Overall Study||16
8215276|NCT02096588|20259594|P1|STARTED|Overall Study||15
8215277|NCT02096575|20259604|P3|NOT COMPLETED|Overall Study||5
8215278|NCT02096575|20259605|P2|NOT COMPLETED|Overall Study||0
8215279|NCT02096575|20259606|P1|NOT COMPLETED|Overall Study||0
8215280|NCT02096575|20259604|P3|COMPLETED|Overall Study||0
8215281|NCT02096575|20259605|P2|COMPLETED|Overall Study||67
8215282|NCT02096575|20259606|P1|COMPLETED|Overall Study||68
8215283|NCT02096575|20259604|P3|STARTED|Overall Study||5
8215284|NCT02096575|20259605|P2|STARTED|Overall Study||67
8215285|NCT02096575|20259606|P1|STARTED|Overall Study||68
8215286|NCT02096471|20259620|P1|NOT COMPLETED|Overall Study||13
8215287|NCT02096471|20259620|P1|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
8215288|NCT02096471|20259620|P1|STARTED|Overall Study||19
8215289|NCT02096458|20259631|P1|NOT COMPLETED|Overall Study||0
8215290|NCT02096458|20259631|P1|COMPLETED|Overall Study||8
8215291|NCT02096458|20259631|P1|STARTED|Overall Study||8
8215292|NCT02096276|20259637|P2|NOT COMPLETED|Overall Study||0
8215293|NCT02096276|20259638|P1|NOT COMPLETED|Overall Study||0
8215294|NCT02096276|20259637|P2|COMPLETED|Overall Study||55
8215295|NCT02096276|20259638|P1|COMPLETED|Overall Study||250
8215296|NCT02096276|20259637|P2|STARTED|Overall Study||55
8215297|NCT02096276|20259638|P1|STARTED|Overall Study||250
8215298|NCT02096263|20259647|P3|NOT COMPLETED|Overall Study||39
8215299|NCT02096263|20259648|P2|NOT COMPLETED|Overall Study||36
8215300|NCT02096263|20259649|P1|NOT COMPLETED|Overall Study||34
8215301|NCT02096263|20259647|P3|COMPLETED|Overall Study||157
8215302|NCT02096263|20259648|P2|COMPLETED|Overall Study||158
8215303|NCT02096263|20259649|P1|COMPLETED|Overall Study||161
8215304|NCT02096263|20259647|P3|STARTED|Overall Study||196
8215305|NCT02096263|20259648|P2|STARTED|Overall Study||194
8215306|NCT02096263|20259649|P1|STARTED|Overall Study||195
8215307|NCT02096107|20259785|P2|NOT COMPLETED|Overall Study||0
8215308|NCT02096107|20259786|P1|NOT COMPLETED|Overall Study||0
8215309|NCT02096107|20259785|P2|COMPLETED|Overall Study||30
8215310|NCT02096107|20259786|P1|COMPLETED|Overall Study||30
8215311|NCT02096107|20259785|P2|STARTED|Overall Study||30
8215312|NCT02096107|20259786|P1|STARTED|Overall Study||30
8215313|NCT02096081|20259804|P2|NOT COMPLETED|Overall Study||4
8215314|NCT02096081|20259805|P1|NOT COMPLETED|Overall Study||3
8215315|NCT02096081|20259804|P2|COMPLETED|Overall Study||124
8215316|NCT02096081|20259805|P1|COMPLETED|Overall Study||119
8215317|NCT02096081|20259804|P2|STARTED|Overall Study||128
8215318|NCT02096081|20259805|P1|STARTED|Overall Study||122
8215319|NCT02096042|20259837|P3|NOT COMPLETED|Overall Study||0
8215320|NCT02096042|20259838|P2|NOT COMPLETED|Overall Study||0
8215321|NCT02096042|20259839|P1|NOT COMPLETED|Overall Study||1
8215322|NCT02096042|20259837|P3|COMPLETED|Overall Study||0
8215323|NCT02096042|20259838|P2|COMPLETED|Overall Study||0
8215324|NCT02096042|20259839|P1|COMPLETED|Overall Study||0
8215325|NCT02096042|20259837|P3|STARTED|Overall Study||0
8215326|NCT02096042|20259838|P2|STARTED|Overall Study||0
8215327|NCT02096042|20259839|P1|STARTED|Overall Study||1
8215328|NCT02096029|20259848|P2|NOT COMPLETED|Overall Study||0
8215329|NCT02096029|20259849|P1|NOT COMPLETED|Overall Study||0
8215330|NCT02096029|20259848|P2|COMPLETED|Overall Study||593
8215331|NCT02096029|20259849|P1|COMPLETED|Overall Study||652
8215332|NCT02096029|20259848|P2|STARTED|Overall Study||593
8215333|NCT02096029|20259849|P1|STARTED|Overall Study||652
8215334|NCT02096003|20259861|P2|NOT COMPLETED|Overall Study||3
8215335|NCT02096003|20259862|P1|NOT COMPLETED|Overall Study||2
8215336|NCT02096003|20259861|P2|COMPLETED|Overall Study||37
8215337|NCT02096003|20259862|P1|COMPLETED|Overall Study||38
8215338|NCT02096003|20259861|P2|STARTED|Overall Study||40
8215339|NCT02096003|20259862|P1|STARTED|Overall Study||40
8215340|NCT02095951|20259878|P2|NOT COMPLETED|Overall Study||6
8215341|NCT02095951|20259879|P1|NOT COMPLETED|Overall Study||9
8215342|NCT02095951|20259878|P2|COMPLETED|Overall Study||8
8215343|NCT02095951|20259879|P1|COMPLETED|Overall Study||4
8215344|NCT02095951|20259878|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
8215345|NCT02095951|20259879|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
8215346|NCT02095873|20259899|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8215347|NCT02095873|20259900|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
8215348|NCT02095873|20259899|P2|COMPLETED|Second Intervention (8 Weeks)||16
8215349|NCT02095873|20259900|P1|COMPLETED|Second Intervention (8 Weeks)||13
8215350|NCT02095873|20259899|P2|STARTED|Second Intervention (8 Weeks)||16
8215351|NCT02095873|20259900|P1|STARTED|Second Intervention (8 Weeks)||15
8215352|NCT02095873|20259899|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8215353|NCT02095873|20259900|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
8215354|NCT02095873|20259899|P2|COMPLETED|First Intervention (8 Weeks)||16
8215355|NCT02095873|20259900|P1|COMPLETED|First Intervention (8 Weeks)||15
8215356|NCT02095873|20259899|P2|STARTED|First Intervention (8 Weeks)||16
8215357|NCT02095873|20259900|P1|STARTED|First Intervention (8 Weeks)||16
8215358|NCT02095691|20259912|P1|NOT COMPLETED|Overall Study||1
8215359|NCT02095691|20259912|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
8215360|NCT02095691|20259912|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
8215367|NCT02095561|20259951|P2|NOT COMPLETED|Overall Study||0
8215368|NCT02095561|20259952|P1|NOT COMPLETED|Overall Study||0
8215369|NCT02095561|20259951|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
8215370|NCT02095561|20259952|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
8215371|NCT02095561|20259951|P2|HPV Tested at Health Centers|Overall Study||599
8215372|NCT02095561|20259952|P1|HPV Tested at Health Centers|Overall Study||99
8215373|NCT02095561|20259951|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
8215374|NCT02095561|20259952|P1|HPV Self-tested Women|Overall Study||2519
8215375|NCT02095561|20259951|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
8215376|NCT02095561|20259952|P1|Self-testing Acceptability|Overall Study||2616
8215377|NCT02095561|20259951|P2|STARTED|Overall Study||2964
8215378|NCT02095561|20259952|P1|STARTED|Overall Study||3049
8215379|NCT02095535|20259964|P1|NOT COMPLETED|Analysis||0
8215380|NCT02095535|20259964|P1|COMPLETED|Analysis||18
8215381|NCT02095535|20259964|P1|STARTED|Analysis||18
8215382|NCT02095535|20259964|P1|NOT COMPLETED|Recruitment||2
8215383|NCT02095535|20259964|P1|COMPLETED|Recruitment||18
8215384|NCT02095535|20259964|P1|STARTED|Recruitment||20
8215385|NCT02095340|20259971|P3|NOT COMPLETED|Overall Study||0
8215386|NCT02095340|20259972|P2|NOT COMPLETED|Overall Study||0
8215387|NCT02095340|20259973|P1|NOT COMPLETED|Overall Study||0
8215388|NCT02095340|20259971|P3|COMPLETED|Overall Study||105
8215389|NCT02095340|20259972|P2|COMPLETED|Overall Study||54
8215390|NCT02095340|20259973|P1|COMPLETED|Overall Study||51
8215391|NCT02095340|20259971|P3|STARTED|Overall Study||105
8215392|NCT02095340|20259972|P2|STARTED|Overall Study|Mother (not the child) received the training.|54
8215393|NCT02095340|20259973|P1|STARTED|Overall Study|Mother (not the child) received the training.|51
8215394|NCT02095223|20259986|P2|NOT COMPLETED|Overall Study||0
8215395|NCT02095223|20259987|P1|NOT COMPLETED|Overall Study||1
8215396|NCT02095223|20259986|P2|COMPLETED|Overall Study||2
8215397|NCT02095223|20259987|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
8215398|NCT02095223|20259986|P2|STARTED|Overall Study||2
8215399|NCT02095223|20259987|P1|STARTED|Overall Study||2
8215400|NCT02095197|20259997|P2|NOT COMPLETED|Overall Study||3
8215401|NCT02095197|20259998|P1|NOT COMPLETED|Overall Study||0
8215402|NCT02095197|20259997|P2|COMPLETED|Overall Study||36
8215403|NCT02095197|20259998|P1|COMPLETED|Overall Study||40
8215404|NCT02095197|20259997|P2|STARTED|Overall Study||39
8215405|NCT02095197|20259998|P1|STARTED|Overall Study||40
8215406|NCT02095158|20260010|P1|NOT COMPLETED|Overall Study||75
8215407|NCT02095158|20260010|P1|COMPLETED|Overall Study||365
8215408|NCT02095158|20260010|P1|STARTED|Overall Study||440
8215409|NCT02095145|20260017|P2|NOT COMPLETED|Overall Study||0
8215410|NCT02095145|20260018|P1|NOT COMPLETED|Overall Study||1
8215411|NCT02095145|20260017|P2|COMPLETED|Overall Study||15
8215412|NCT02095145|20260018|P1|COMPLETED|Overall Study||14
8215413|NCT02095145|20260017|P2|STARTED|Overall Study||15
8215414|NCT02095145|20260018|P1|STARTED|Overall Study||15
8215415|NCT02095106|20260064|P2|NOT COMPLETED|Second Intervention (14 Days)||1
8215416|NCT02095106|20260065|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8215417|NCT02095106|20260064|P2|COMPLETED|Second Intervention (14 Days)||12
8215418|NCT02095106|20260065|P1|COMPLETED|Second Intervention (14 Days)||14
8215419|NCT02095106|20260064|P2|STARTED|Second Intervention (14 Days)||13
8215420|NCT02095106|20260065|P1|STARTED|Second Intervention (14 Days)||14
8215421|NCT02095106|20260064|P2|NOT COMPLETED|First Intervention (14 Days)||0
8215422|NCT02095106|20260065|P1|NOT COMPLETED|First Intervention (14 Days)||0
8215423|NCT02095106|20260064|P2|COMPLETED|First Intervention (14 Days)||13
8215424|NCT02095106|20260065|P1|COMPLETED|First Intervention (14 Days)||14
8215425|NCT02095106|20260064|P2|STARTED|First Intervention (14 Days)||13
8215426|NCT02095106|20260065|P1|STARTED|First Intervention (14 Days)||14
8215427|NCT02094937|20260081|P4|NOT COMPLETED|12 Weeks in Period 2||12
8215428|NCT02094937|20260082|P3|NOT COMPLETED|12 Weeks in Period 2||12
8215429|NCT02094937|20260083|P2|NOT COMPLETED|12 Weeks in Period 2||11
8215430|NCT02094937|20260084|P1|NOT COMPLETED|12 Weeks in Period 2||0
8215431|NCT02094937|20260081|P4|COMPLETED|12 Weeks in Period 2||112
8215432|NCT02094937|20260082|P3|COMPLETED|12 Weeks in Period 2||112
8215433|NCT02094937|20260083|P2|COMPLETED|12 Weeks in Period 2||112
8215434|NCT02094937|20260084|P1|COMPLETED|12 Weeks in Period 2||0
8215435|NCT02094937|20260081|P4|STARTED|12 Weeks in Period 2||124
8215436|NCT02094937|20260082|P3|STARTED|12 Weeks in Period 2||124
8215437|NCT02094937|20260083|P2|STARTED|12 Weeks in Period 2||123
8215438|NCT02094937|20260084|P1|STARTED|12 Weeks in Period 2||0
8215439|NCT02094937|20260081|P4|NOT COMPLETED|8 Weeks in Period 1||0
8215440|NCT02094937|20260082|P3|NOT COMPLETED|8 Weeks in Period 1||0
8215441|NCT02094937|20260083|P2|NOT COMPLETED|8 Weeks in Period 1||0
8215442|NCT02094937|20260084|P1|NOT COMPLETED|8 Weeks in Period 1||60
8215443|NCT02094937|20260081|P4|COMPLETED|8 Weeks in Period 1||0
8215444|NCT02094937|20260082|P3|COMPLETED|8 Weeks in Period 1||0
8215445|NCT02094937|20260083|P2|COMPLETED|8 Weeks in Period 1||0
8215446|NCT02094937|20260084|P1|COMPLETED|8 Weeks in Period 1||370
8215447|NCT02094937|20260081|P4|STARTED|8 Weeks in Period 1||0
8215448|NCT02094937|20260082|P3|STARTED|8 Weeks in Period 1||0
8215449|NCT02094937|20260083|P2|STARTED|8 Weeks in Period 1||0
8215450|NCT02094937|20260084|P1|STARTED|8 Weeks in Period 1||430
8215451|NCT02094898|20260114|P1|NOT COMPLETED|Overall Study||5
8215452|NCT02094898|20260114|P1|COMPLETED|Overall Study||7
8215453|NCT02094898|20260114|P1|STARTED|Overall Study||12
8215454|NCT02094885|20260161|P2|NOT COMPLETED|Overall Study||5
8215455|NCT02094885|20260162|P1|NOT COMPLETED|Overall Study||2
8215456|NCT02094885|20260161|P2|COMPLETED|Overall Study||122
8215457|NCT02094885|20260162|P1|COMPLETED|Overall Study||123
8215458|NCT02094885|20260161|P2|STARTED|Overall Study||127
8215459|NCT02094885|20260162|P1|STARTED|Overall Study||125
8215460|NCT02094872|20260174|P1|NOT COMPLETED|Overall Study||29
8215461|NCT02094872|20260174|P1|COMPLETED|Overall Study||20
8215462|NCT02094872|20260174|P1|Patients Treated With MEK162|Overall Study||20
8215463|NCT02094872|20260174|P1|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
8215464|NCT02094872|20260174|P1|Received Targeted Therapy|Overall Study||20
8215465|NCT02094872|20260174|P1|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
8215466|NCT02094872|20260174|P1|Received Biopsy|Overall Study||37
8215467|NCT02094872|20260174|P1|STARTED|Overall Study||49
8215468|NCT02094755|20260179|P1|NOT COMPLETED|Overall Study||0
8215469|NCT02094755|20260179|P1|COMPLETED|Overall Study||100
8215470|NCT02094755|20260179|P1|STARTED|Overall Study||100
8215471|NCT02094716|20260186|P3|NOT COMPLETED|Overall Study||4
8215472|NCT02094716|20260187|P2|NOT COMPLETED|Overall Study||7
8215473|NCT02094716|20260188|P1|NOT COMPLETED|Overall Study||2
8215474|NCT02094716|20260186|P3|COMPLETED|Overall Study||40
8215475|NCT02094716|20260187|P2|COMPLETED|Overall Study||36
8215476|NCT02094716|20260188|P1|COMPLETED|Overall Study||41
8215477|NCT02094716|20260186|P3|Received Second Dose at Day 14|Overall Study||17
8215478|NCT02094716|20260187|P2|Received Second Dose at Day 14|Overall Study||10
8215479|NCT02094716|20260188|P1|Received Second Dose at Day 14|Overall Study||15
8215480|NCT02094716|20260186|P3|STARTED|Overall Study||44
8215481|NCT02094716|20260187|P2|STARTED|Overall Study||43
8215482|NCT02094716|20260188|P1|STARTED|Overall Study||43
8215483|NCT02094677|20260210|P2|NOT COMPLETED|Overall Study||1
8215484|NCT02094677|20260211|P1|NOT COMPLETED|Overall Study||3
8215485|NCT02094677|20260210|P2|COMPLETED|Overall Study||30
8215486|NCT02094677|20260211|P1|COMPLETED|Overall Study||40
8215487|NCT02094677|20260210|P2|STARTED|Overall Study||31
8215488|NCT02094677|20260211|P1|STARTED|Overall Study||43
8215489|NCT02094664|20260275|P2|NOT COMPLETED|Overall Study||0
8215490|NCT02094664|20260276|P1|NOT COMPLETED|Overall Study||0
8215491|NCT02094664|20260275|P2|COMPLETED|Overall Study||16
8215492|NCT02094664|20260276|P1|COMPLETED|Overall Study||16
8215493|NCT02094664|20260275|P2|STARTED|Overall Study||16
8215494|NCT02094664|20260276|P1|STARTED|Overall Study||16
8215495|NCT02094612|20260290|P2|NOT COMPLETED|Overall Study||70
8215496|NCT02094612|20260291|P1|NOT COMPLETED|Overall Study||79
8215497|NCT02094612|20260290|P2|COMPLETED|Overall Study||25
8215498|NCT02094612|20260291|P1|COMPLETED|Overall Study||33
8215499|NCT02094612|20260290|P2|6 Month Follow up|Overall Study||25
8215500|NCT02094612|20260291|P1|6 Month Follow up|Overall Study||33
8215501|NCT02094612|20260290|P2|3 Month Follow up|Overall Study||43
8215502|NCT02094612|20260291|P1|3 Month Follow up|Overall Study||50
8215503|NCT02094612|20260290|P2|1 Month Follow up|Overall Study||50
8215504|NCT02094612|20260291|P1|1 Month Follow up|Overall Study||67
8215505|NCT02094612|20260290|P2|STARTED|Overall Study||95
8215506|NCT02094612|20260291|P1|STARTED|Overall Study||112
8215507|NCT02094573|20260311|P2|NOT COMPLETED|Overall Study||110
8215508|NCT02094573|20260312|P1|NOT COMPLETED|Overall Study||112
8215509|NCT02094573|20260311|P2|COMPLETED|Overall Study||0
8215510|NCT02094573|20260312|P1|COMPLETED|Overall Study||0
8215511|NCT02094573|20260311|P2|Treated|Overall Study||110
8215512|NCT02094573|20260312|P1|Treated|Overall Study||109
8215513|NCT02094573|20260311|P2|STARTED|Overall Study||110
8215514|NCT02094573|20260312|P1|STARTED|Overall Study||112
8215515|NCT02094534|20260346|P2|NOT COMPLETED|Overall Study||0
8215516|NCT02094534|20260347|P1|NOT COMPLETED|Overall Study||0
8215517|NCT02094534|20260346|P2|COMPLETED|Overall Study||10
8215518|NCT02094534|20260347|P1|COMPLETED|Overall Study||15
8215519|NCT02094534|20260346|P2|STARTED|Overall Study||10
8215520|NCT02094534|20260347|P1|STARTED|Overall Study||15
8215521|NCT02094443|20260357|P2|NOT COMPLETED|Overall Study||17
8215522|NCT02094443|20260358|P1|NOT COMPLETED|Overall Study||15
8215523|NCT02094443|20260357|P2|COMPLETED|Overall Study||9
8215524|NCT02094443|20260358|P1|COMPLETED|Overall Study||11
8215525|NCT02094443|20260357|P2|Completed at Week 24|Overall Study||8
8215526|NCT02094443|20260358|P1|Completed at Week 24|Overall Study||11
8215527|NCT02094443|20260357|P2|Completed at Week 12|Overall Study||1
8215528|NCT02094443|20260358|P1|Completed at Week 12|Overall Study||0
8215529|NCT02094443|20260357|P2|STARTED|Overall Study||26
8215530|NCT02094443|20260358|P1|STARTED|Overall Study||26
8215531|NCT02094352|20260378|P2|NOT COMPLETED|Overall Study||0
8215532|NCT02094352|20260379|P1|NOT COMPLETED|Overall Study||0
8215533|NCT02094352|20260378|P2|COMPLETED|Overall Study||1
8215534|NCT02094352|20260379|P1|COMPLETED|Overall Study||2
8215535|NCT02094352|20260378|P2|STARTED|Overall Study||1
8215536|NCT02094352|20260379|P1|STARTED|Overall Study||2
8215537|NCT02094326|20260385|P1|NOT COMPLETED|Overall Study||0
8215538|NCT02094326|20260385|P1|COMPLETED|Overall Study||301
8215539|NCT02094326|20260385|P1|STARTED|Overall Study||301
8215540|NCT02094300|20260394|P1|NOT COMPLETED|Overall Study||20
8215541|NCT02094300|20260394|P1|COMPLETED|Overall Study||6
8215542|NCT02094300|20260394|P1|30 Days|Overall Study||24
8215543|NCT02094300|20260394|P1|STARTED|Overall Study||26
8215547|NCT02093962|20260407|P2|NOT COMPLETED|Overall Study||131
8215548|NCT02093962|20260408|P1|NOT COMPLETED|Overall Study||134
8215549|NCT02093962|20260407|P2|COMPLETED|Overall Study||0
8215550|NCT02093962|20260408|P1|COMPLETED|Overall Study||0
8215551|NCT02093962|20260407|P2|Received Treatment|Overall Study||130
8215552|NCT02093962|20260408|P1|Received Treatment|Overall Study||130
8215553|NCT02093962|20260407|P2|STARTED|Overall Study||131
8215554|NCT02093962|20260408|P1|STARTED|Overall Study||134
8215555|NCT02093949|20260416|P2|NOT COMPLETED|Overall Study||0
8215556|NCT02093949|20260417|P1|NOT COMPLETED|Overall Study||0
8215557|NCT02093949|20260416|P2|COMPLETED|Overall Study||47
8215558|NCT02093949|20260417|P1|COMPLETED|Overall Study||105
8215559|NCT02093949|20260416|P2|STARTED|Overall Study||47
8215560|NCT02093949|20260417|P1|STARTED|Overall Study||105
8215561|NCT02093923|20260440|P5|NOT COMPLETED|Overall Study||0
8215562|NCT02093923|20260441|P4|NOT COMPLETED|Overall Study||2
8215563|NCT02093923|20260442|P3|NOT COMPLETED|Overall Study||0
8215564|NCT02093923|20260443|P2|NOT COMPLETED|Overall Study||0
8215565|NCT02093923|20260444|P1|NOT COMPLETED|Overall Study||0
8215566|NCT02093923|20260440|P5|COMPLETED|Overall Study||13
8215567|NCT02093923|20260441|P4|COMPLETED|Overall Study||10
8215568|NCT02093923|20260442|P3|COMPLETED|Overall Study||5
8215569|NCT02093923|20260443|P2|COMPLETED|Overall Study||4
8215570|NCT02093923|20260444|P1|COMPLETED|Overall Study||4
8215571|NCT02093923|20260440|P5|Treated - 2 Doses:|Overall Study||13
8215572|NCT02093923|20260441|P4|Treated - 2 Doses:|Overall Study||10
8215573|NCT02093923|20260442|P3|Treated - 2 Doses:|Overall Study||5
8215574|NCT02093923|20260443|P2|Treated - 2 Doses:|Overall Study||4
8215575|NCT02093923|20260444|P1|Treated - 2 Doses:|Overall Study||4
8215576|NCT02093923|20260440|P5|Treated - 1 Dose Only:|Overall Study||0
8215577|NCT02093923|20260441|P4|Treated - 1 Dose Only:|Overall Study||1
8215578|NCT02093923|20260442|P3|Treated - 1 Dose Only:|Overall Study||0
8215579|NCT02093923|20260443|P2|Treated - 1 Dose Only:|Overall Study||0
8215580|NCT02093923|20260444|P1|Treated - 1 Dose Only:|Overall Study||0
8215581|NCT02093923|20260440|P5|Total Treated|Overall Study||13
8215582|NCT02093923|20260441|P4|Total Treated|Overall Study||11
8215583|NCT02093923|20260442|P3|Total Treated|Overall Study||5
8215584|NCT02093923|20260443|P2|Total Treated|Overall Study||4
8215585|NCT02093923|20260444|P1|Total Treated|Overall Study||4
8215586|NCT02093923|20260440|P5|STARTED|Overall Study||13
8215587|NCT02093923|20260441|P4|STARTED|Overall Study||12
8215588|NCT02093923|20260442|P3|STARTED|Overall Study||5
8215589|NCT02093923|20260443|P2|STARTED|Overall Study||4
8215590|NCT02093923|20260444|P1|STARTED|Overall Study||4
8215591|NCT02093897|20260499|P1|NOT COMPLETED|Overall Study||19
8215592|NCT02093897|20260499|P1|COMPLETED|Overall Study||65
8215593|NCT02093897|20260499|P1|STARTED|Overall Study||84
8215594|NCT02093819|20260527|P8|NOT COMPLETED|Overall Study||0
8215595|NCT02093819|20260528|P7|NOT COMPLETED|Overall Study||0
8215596|NCT02093819|20260529|P6|NOT COMPLETED|Overall Study||0
8215597|NCT02093819|20260530|P5|NOT COMPLETED|Overall Study||0
8215598|NCT02093819|20260531|P4|NOT COMPLETED|Overall Study||0
8215599|NCT02093819|20260532|P3|NOT COMPLETED|Overall Study||0
8215600|NCT02093819|20260533|P2|NOT COMPLETED|Overall Study||0
8215601|NCT02093819|20260534|P1|NOT COMPLETED|Overall Study||0
8215602|NCT02093819|20260527|P8|COMPLETED|Overall Study||6
8215603|NCT02093819|20260528|P7|COMPLETED|Overall Study||5
8215604|NCT02093819|20260529|P6|COMPLETED|Overall Study||6
8215605|NCT02093819|20260530|P5|COMPLETED|Overall Study||6
8215606|NCT02093819|20260531|P4|COMPLETED|Overall Study||6
8215607|NCT02093819|20260532|P3|COMPLETED|Overall Study||10
8215608|NCT02093819|20260533|P2|COMPLETED|Overall Study||6
8215609|NCT02093819|20260534|P1|COMPLETED|Overall Study||15
8215610|NCT02093819|20260527|P8|STARTED|Overall Study||6
8215611|NCT02093819|20260528|P7|STARTED|Overall Study||5
8215612|NCT02093819|20260529|P6|STARTED|Overall Study||6
8215613|NCT02093819|20260530|P5|STARTED|Overall Study||6
8215614|NCT02093819|20260531|P4|STARTED|Overall Study||6
8215615|NCT02093819|20260532|P3|STARTED|Overall Study||10
8215616|NCT02093819|20260533|P2|STARTED|Overall Study||6
8215617|NCT02093819|20260534|P1|STARTED|Overall Study||15
8215618|NCT02093793|20260571|P3|NOT COMPLETED|Overall Study||3
8215619|NCT02093793|20260572|P2|NOT COMPLETED|Overall Study||10
8215620|NCT02093793|20260573|P1|NOT COMPLETED|Overall Study||7
8215621|NCT02093793|20260571|P3|COMPLETED|Overall Study||65
8215622|NCT02093793|20260572|P2|COMPLETED|Overall Study||80
8215623|NCT02093793|20260573|P1|COMPLETED|Overall Study||91
8215624|NCT02093793|20260571|P3|STARTED|Overall Study||68
8215625|NCT02093793|20260572|P2|STARTED|Overall Study||90
8215626|NCT02093793|20260573|P1|STARTED|Overall Study||98
8215627|NCT02093702|20260583|P2|NOT COMPLETED|Overall Study||0
8215628|NCT02093702|20260584|P1|NOT COMPLETED|Overall Study||0
8215629|NCT02093702|20260583|P2|COMPLETED|Overall Study||3
8215630|NCT02093702|20260584|P1|COMPLETED|Overall Study||2
8215631|NCT02093702|20260583|P2|STARTED|Overall Study||3
8215632|NCT02093702|20260584|P1|STARTED|Overall Study||2
8215633|NCT02093689|20260615|P3|NOT COMPLETED|Overall Study||0
8215634|NCT02093689|20260616|P2|NOT COMPLETED|Overall Study||0
8215635|NCT02093689|20260617|P1|NOT COMPLETED|Overall Study||4
8215636|NCT02093689|20260615|P3|COMPLETED|Overall Study||0
8215637|NCT02093689|20260616|P2|COMPLETED|Overall Study||0
8215638|NCT02093689|20260617|P1|COMPLETED|Overall Study||14
8215639|NCT02093689|20260615|P3|STARTED|Overall Study||0
8215640|NCT02093689|20260616|P2|STARTED|Overall Study||0
8215641|NCT02093689|20260617|P1|STARTED|Overall Study||18
8215642|NCT02093663|20260623|P5|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
8215643|NCT02093663|20260624|P4|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
8215644|NCT02093663|20260625|P3|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8215645|NCT02093663|20260626|P2|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8215646|NCT02093663|20260627|P1|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8215647|NCT02093663|20260623|P5|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
8215648|NCT02093663|20260624|P4|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
8215649|NCT02093663|20260625|P3|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8215650|NCT02093663|20260626|P2|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8215651|NCT02093663|20260627|P1|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8215652|NCT02093663|20260623|P5|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
8215653|NCT02093663|20260624|P4|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
8215654|NCT02093663|20260625|P3|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8215655|NCT02093663|20260626|P2|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8215656|NCT02093663|20260627|P1|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8215657|NCT02093663|20260623|P5|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
8215658|NCT02093663|20260624|P4|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
8215659|NCT02093663|20260625|P3|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8215660|NCT02093663|20260626|P2|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8215661|NCT02093663|20260627|P1|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8215662|NCT02093663|20260623|P5|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
8215663|NCT02093663|20260624|P4|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
8215664|NCT02093663|20260625|P3|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8215665|NCT02093663|20260626|P2|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8215666|NCT02093663|20260627|P1|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8215667|NCT02093663|20260623|P5|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
8215668|NCT02093663|20260624|P4|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
8215669|NCT02093663|20260625|P3|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8215670|NCT02093663|20260626|P2|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8215671|NCT02093663|20260627|P1|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8215672|NCT02093663|20260623|P5|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215673|NCT02093663|20260624|P4|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215674|NCT02093663|20260625|P3|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
8215675|NCT02093663|20260626|P2|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215676|NCT02093663|20260627|P1|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215677|NCT02093663|20260623|P5|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215678|NCT02093663|20260624|P4|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215679|NCT02093663|20260625|P3|COMPLETED|Open Label Acute Phase (8 Weeks)||12
8215680|NCT02093663|20260626|P2|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215681|NCT02093663|20260627|P1|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8215682|NCT02093663|20260623|P5|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8215683|NCT02093663|20260624|P4|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8215684|NCT02093663|20260625|P3|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
8215685|NCT02093663|20260626|P2|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8215686|NCT02093663|20260627|P1|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8215687|NCT02093663|20260623|P5|STARTED|Open Label Acute Phase (8 Weeks)||0
8215688|NCT02093663|20260624|P4|STARTED|Open Label Acute Phase (8 Weeks)||0
8215689|NCT02093663|20260625|P3|STARTED|Open Label Acute Phase (8 Weeks)||18
8215690|NCT02093663|20260626|P2|STARTED|Open Label Acute Phase (8 Weeks)||0
8215691|NCT02093663|20260627|P1|STARTED|Open Label Acute Phase (8 Weeks)||0
8215692|NCT02093663|20260623|P5|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8215693|NCT02093663|20260624|P4|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8215694|NCT02093663|20260625|P3|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8215695|NCT02093663|20260626|P2|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
8215696|NCT02093663|20260627|P1|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
8215697|NCT02093663|20260623|P5|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8215698|NCT02093663|20260624|P4|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8215699|NCT02093663|20260625|P3|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8215700|NCT02093663|20260626|P2|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
8215701|NCT02093663|20260627|P1|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
8215702|NCT02093663|20260623|P5|STARTED|Double Blind Acute Phase (8 Weeks)||0
8215703|NCT02093663|20260624|P4|STARTED|Double Blind Acute Phase (8 Weeks)||0
8215704|NCT02093663|20260625|P3|STARTED|Double Blind Acute Phase (8 Weeks)||0
8215705|NCT02093663|20260626|P2|STARTED|Double Blind Acute Phase (8 Weeks)||26
8215706|NCT02093663|20260627|P1|STARTED|Double Blind Acute Phase (8 Weeks)||27
8215707|NCT02093520|20260656|P2|NOT COMPLETED|Overall Study||22
8215708|NCT02093520|20260657|P1|NOT COMPLETED|Overall Study||6
8215709|NCT02093520|20260656|P2|COMPLETED|Overall Study||131
8215710|NCT02093520|20260657|P1|COMPLETED|Overall Study||143
8215711|NCT02093520|20260656|P2|STARTED|Overall Study||153
8215712|NCT02093520|20260657|P1|STARTED|Overall Study||149
8215713|NCT02093390|20260669|P2|NOT COMPLETED|Overall Study||1
8215714|NCT02093390|20260670|P1|NOT COMPLETED|Overall Study||0
8215715|NCT02093390|20260669|P2|COMPLETED|Overall Study||19
8215716|NCT02093390|20260670|P1|COMPLETED|Overall Study||20
8215717|NCT02093390|20260669|P2|STARTED|Overall Study||20
8215718|NCT02093390|20260670|P1|STARTED|Overall Study||20
8215719|NCT02093351|20260709|P4|NOT COMPLETED|Part B||63
8215720|NCT02093351|20260710|P3|NOT COMPLETED|Part B||0
8215721|NCT02093351|20260711|P2|NOT COMPLETED|Part B||0
8215722|NCT02093351|20260712|P1|NOT COMPLETED|Part B||0
8215723|NCT02093351|20260709|P4|COMPLETED|Part B||6
8215724|NCT02093351|20260710|P3|COMPLETED|Part B||0
8215725|NCT02093351|20260711|P2|COMPLETED|Part B||0
8215726|NCT02093351|20260712|P1|COMPLETED|Part B||0
8215727|NCT02093351|20260709|P4|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
8215728|NCT02093351|20260710|P3|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8215729|NCT02093351|20260711|P2|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8215730|NCT02093351|20260712|P1|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8215731|NCT02093351|20260709|P4|NOT COMPLETED|Part A||0
8215732|NCT02093351|20260710|P3|NOT COMPLETED|Part A||3
8215733|NCT02093351|20260711|P2|NOT COMPLETED|Part A||2
8215734|NCT02093351|20260712|P1|NOT COMPLETED|Part A||2
8215735|NCT02093351|20260709|P4|COMPLETED|Part A||0
8215736|NCT02093351|20260710|P3|COMPLETED|Part A||23
8215737|NCT02093351|20260711|P2|COMPLETED|Part A||21
8215738|NCT02093351|20260712|P1|COMPLETED|Part A||28
8215739|NCT02093351|20260709|P4|Completing Treatment Period 3|Part A||0
8215740|NCT02093351|20260710|P3|Completing Treatment Period 3|Part A||23
8215741|NCT02093351|20260711|P2|Completing Treatment Period 3|Part A||21
8215742|NCT02093351|20260712|P1|Completing Treatment Period 3|Part A||28
8215743|NCT02093351|20260709|P4|Completing Treatment Period 2|Part A||0
8215744|NCT02093351|20260710|P3|Completing Treatment Period 2|Part A||23
8215745|NCT02093351|20260711|P2|Completing Treatment Period 2|Part A||21
8215746|NCT02093351|20260712|P1|Completing Treatment Period 2|Part A||29
8215747|NCT02093351|20260709|P4|Completing Treatment Period 1|Part A||0
8215748|NCT02093351|20260710|P3|Completing Treatment Period 1|Part A||23
8215749|NCT02093351|20260711|P2|Completing Treatment Period 1|Part A||22
8215750|NCT02093351|20260712|P1|Completing Treatment Period 1|Part A||29
8215751|NCT02093351|20260709|P4|STARTED|Part A||0
8215752|NCT02093351|20260710|P3|STARTED|Part A||26
8215753|NCT02093351|20260711|P2|STARTED|Part A||23
8215754|NCT02093351|20260712|P1|STARTED|Part A||30
8215755|NCT02093234|20260745|P3|NOT COMPLETED|Overall Study||4
8215756|NCT02093234|20260746|P2|NOT COMPLETED|Overall Study||4
8215757|NCT02093234|20260747|P1|NOT COMPLETED|Overall Study||3
8215758|NCT02093234|20260745|P3|COMPLETED|Overall Study||50
8215759|NCT02093234|20260746|P2|COMPLETED|Overall Study||52
8215760|NCT02093234|20260747|P1|COMPLETED|Overall Study||53
8215761|NCT02093234|20260745|P3|STARTED|Overall Study||54
8215762|NCT02093234|20260746|P2|STARTED|Overall Study||56
8215763|NCT02093234|20260747|P1|STARTED|Overall Study||56
8215764|NCT02093221|20260769|P5|NOT COMPLETED|Overall Study||8
8215765|NCT02093221|20260770|P4|NOT COMPLETED|Overall Study||8
8215766|NCT02093221|20260771|P3|NOT COMPLETED|Overall Study||9
8215767|NCT02093221|20260772|P2|NOT COMPLETED|Overall Study||8
8215768|NCT02093221|20260773|P1|NOT COMPLETED|Overall Study||10
8215769|NCT02093221|20260769|P5|COMPLETED|Overall Study||7
8215770|NCT02093221|20260770|P4|COMPLETED|Overall Study||7
8215771|NCT02093221|20260771|P3|COMPLETED|Overall Study||6
8215772|NCT02093221|20260772|P2|COMPLETED|Overall Study||8
8215773|NCT02093221|20260773|P1|COMPLETED|Overall Study||5
8215774|NCT02093221|20260769|P5|STARTED|Overall Study||15
8215775|NCT02093221|20260770|P4|STARTED|Overall Study||15
8215776|NCT02093221|20260771|P3|STARTED|Overall Study||15
8215777|NCT02093221|20260772|P2|STARTED|Overall Study||16
8215778|NCT02093221|20260773|P1|STARTED|Overall Study||15
8215779|NCT02093026|20260810|P1|NOT COMPLETED|Overall Study||193
8215780|NCT02093026|20260810|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
8215781|NCT02093026|20260810|P1|STARTED|Overall Study||465
8215782|NCT02092961|20260832|P3|NOT COMPLETED|Overall Study||16
8215783|NCT02092961|20260833|P2|NOT COMPLETED|Overall Study||14
8215784|NCT02092961|20260834|P1|NOT COMPLETED|Overall Study||21
8215785|NCT02092961|20260832|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
8215786|NCT02092961|20260833|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
8215787|NCT02092961|20260834|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
8215788|NCT02092961|20260832|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
8215789|NCT02092961|20260833|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
8215790|NCT02092961|20260834|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
8215791|NCT02092961|20260832|P3|STARTED|Overall Study|Patients who received treatment|29
8215792|NCT02092961|20260833|P2|STARTED|Overall Study|Patients who received treatment|28
8215793|NCT02092961|20260834|P1|STARTED|Overall Study|Patients who received treatment|33
8215794|NCT02092909|20260859|P4|NOT COMPLETED|Overall Study||6
8215795|NCT02092909|20260860|P3|NOT COMPLETED|Overall Study||9
8215796|NCT02092909|20260861|P2|NOT COMPLETED|Overall Study||3
8215797|NCT02092909|20260862|P1|NOT COMPLETED|Overall Study||1
8215798|NCT02092909|20260859|P4|COMPLETED|Overall Study||0
8215799|NCT02092909|20260860|P3|COMPLETED|Overall Study||5
8215800|NCT02092909|20260861|P2|COMPLETED|Overall Study||2
8215801|NCT02092909|20260862|P1|COMPLETED|Overall Study||5
8215802|NCT02092909|20260859|P4|STARTED|Overall Study||6
8215803|NCT02092909|20260860|P3|STARTED|Overall Study||14
8215804|NCT02092909|20260861|P2|STARTED|Overall Study||5
8215805|NCT02092909|20260862|P1|STARTED|Overall Study||6
8215806|NCT02092857|20260891|P3|NOT COMPLETED|Overall Study||13
8215807|NCT02092857|20260892|P2|NOT COMPLETED|Overall Study||12
8215808|NCT02092857|20260893|P1|NOT COMPLETED|Overall Study||10
8215809|NCT02092857|20260891|P3|COMPLETED|Overall Study||16
8215810|NCT02092857|20260892|P2|COMPLETED|Overall Study||18
8215811|NCT02092857|20260893|P1|COMPLETED|Overall Study||20
8215812|NCT02092857|20260891|P3|STARTED|Overall Study||29
8215813|NCT02092857|20260892|P2|STARTED|Overall Study||30
8215814|NCT02092857|20260893|P1|STARTED|Overall Study||30
8215815|NCT02092662|20260903|P2|NOT COMPLETED|Overall Study||0
8215816|NCT02092662|20260904|P1|NOT COMPLETED|Overall Study||13
8215817|NCT02092662|20260903|P2|COMPLETED|Overall Study||19
8215818|NCT02092662|20260904|P1|COMPLETED|Overall Study||25
8215819|NCT02092662|20260903|P2|Recruited|Overall Study||19
8215820|NCT02092662|20260904|P1|Recruited|Overall Study||38
8215821|NCT02092662|20260903|P2|STARTED|Overall Study||19
8215822|NCT02092662|20260904|P1|STARTED|Overall Study||38
8215823|NCT02092649|20260913|P2|NOT COMPLETED|Overall Study||0
8215824|NCT02092649|20260914|P1|NOT COMPLETED|Overall Study||0
8215825|NCT02092649|20260913|P2|COMPLETED|Overall Study|13 participants finished study|13
8215826|NCT02092649|20260914|P1|COMPLETED|Overall Study|13 participants finished study|13
8215827|NCT02092649|20260913|P2|STARTED|Overall Study|13 participants recruited|13
8215828|NCT02092649|20260914|P1|STARTED|Overall Study|13 participants recruited|13
8215829|NCT02092610|20260932|P2|NOT COMPLETED|Overall Study||12
8215830|NCT02092610|20260933|P1|NOT COMPLETED|Overall Study||8
8215831|NCT02092610|20260932|P2|COMPLETED|Overall Study||40
8215832|NCT02092610|20260933|P1|COMPLETED|Overall Study||17
8215833|NCT02092610|20260932|P2|STARTED|Overall Study||52
8215834|NCT02092610|20260933|P1|STARTED|Overall Study||25
8215835|NCT02092441|20260947|P2|NOT COMPLETED|Overall Study||0
8215836|NCT02092441|20260948|P1|NOT COMPLETED|Overall Study||0
8215837|NCT02092441|20260947|P2|COMPLETED|Overall Study||43
8215838|NCT02092441|20260948|P1|COMPLETED|Overall Study||37
8215839|NCT02092441|20260947|P2|STARTED|Overall Study||43
8215840|NCT02092441|20260948|P1|STARTED|Overall Study||37
8215841|NCT02092415|20260958|P1|NOT COMPLETED|Overall Study||0
8215842|NCT02092415|20260958|P1|COMPLETED|Overall Study||10
8215843|NCT02092415|20260958|P1|STARTED|Overall Study||10
8215844|NCT02092389|20260963|P1|NOT COMPLETED|Overall Study||6
8215845|NCT02092389|20260963|P1|COMPLETED|Overall Study||4
8215846|NCT02092389|20260963|P1|STARTED|Overall Study||10
8215847|NCT02092350|20260975|P2|NOT COMPLETED|Overall Study||12
8215848|NCT02092350|20260976|P1|NOT COMPLETED|Overall Study||10
8215849|NCT02092350|20260975|P2|COMPLETED|Overall Study||102
8215850|NCT02092350|20260976|P1|COMPLETED|Overall Study||113
8215851|NCT02092350|20260975|P2|STARTED|Overall Study||114
8215852|NCT02092350|20260976|P1|STARTED|Overall Study||123
8215853|NCT02092324|20260993|P1|NOT COMPLETED|Overall Study||19
8215854|NCT02092324|20260993|P1|COMPLETED|Overall Study||32
8215855|NCT02092324|20260993|P1|Mutant CSF3R|Overall Study||26
8215856|NCT02092324|20260993|P1|Wildtype CSF3R|Overall Study||23
8215857|NCT02092324|20260993|P1|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
8215858|NCT02092324|20260993|P1|STARTED|Overall Study||51
8215859|NCT02092311|20261013|P2|NOT COMPLETED|Overall Study||0
8215860|NCT02092311|20261014|P1|NOT COMPLETED|Overall Study||0
8215861|NCT02092311|20261013|P2|COMPLETED|Overall Study||285
8215862|NCT02092311|20261014|P1|COMPLETED|Overall Study||285
8215863|NCT02092311|20261013|P2|STARTED|Overall Study||285
8215864|NCT02092311|20261014|P1|STARTED|Overall Study||285
8215865|NCT02092285|20261024|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
8215866|NCT02092285|20261024|P1|COMPLETED|Maintenance Phase & Follow-up||60
8215867|NCT02092285|20261024|P1|STARTED|Maintenance Phase & Follow-up||170
8215868|NCT02092285|20261024|P1|NOT COMPLETED|Induction Phase||35
8215869|NCT02092285|20261024|P1|COMPLETED|Induction Phase||170
8215870|NCT02092285|20261024|P1|STARTED|Induction Phase||205
8215871|NCT02092220|20261028|P2|NOT COMPLETED|Period 2||1
8215872|NCT02092220|20261029|P1|NOT COMPLETED|Period 2||1
8215873|NCT02092220|20261028|P2|COMPLETED|Period 2||19
8215874|NCT02092220|20261029|P1|COMPLETED|Period 2||20
8215875|NCT02092220|20261028|P2|STARTED|Period 2||20
8215876|NCT02092220|20261029|P1|STARTED|Period 2||21
8215877|NCT02092220|20261028|P2|NOT COMPLETED|Period 1||2
8215878|NCT02092220|20261029|P1|NOT COMPLETED|Period 1||0
8215879|NCT02092220|20261028|P2|COMPLETED|Period 1||20
8215880|NCT02092220|20261029|P1|COMPLETED|Period 1||21
8215881|NCT02092220|20261028|P2|STARTED|Period 1||22
8215882|NCT02092220|20261029|P1|STARTED|Period 1||21
8215883|NCT02092168|20261089|P2|NOT COMPLETED|Overall Study||0
8215884|NCT02092168|20261090|P1|NOT COMPLETED|Overall Study||0
8215885|NCT02092168|20261089|P2|COMPLETED|Overall Study||12
8215886|NCT02092168|20261090|P1|COMPLETED|Overall Study||12
8215887|NCT02092168|20261089|P2|STARTED|Overall Study||12
8215888|NCT02092168|20261090|P1|STARTED|Overall Study||12
8215889|NCT02092116|20261102|P2|NOT COMPLETED|Overall Study||4
8215890|NCT02092116|20261103|P1|NOT COMPLETED|Overall Study||0
8215891|NCT02092116|20261102|P2|COMPLETED|Overall Study||16
8215892|NCT02092116|20261103|P1|COMPLETED|Overall Study||6
8215893|NCT02092116|20261102|P2|STARTED|Overall Study||20
8215894|NCT02092116|20261103|P1|STARTED|Overall Study||6
8215895|NCT02092025|20261112|P1|NOT COMPLETED|Overall Study||68
8215896|NCT02092025|20261112|P1|COMPLETED|Overall Study||3369
8215897|NCT02092025|20261112|P1|STARTED|Overall Study||3437
8215898|NCT02091986|20261121|P3|NOT COMPLETED|Overall Study||8
8215899|NCT02091986|20261122|P2|NOT COMPLETED|Overall Study||11
8215900|NCT02091986|20261123|P1|NOT COMPLETED|Overall Study||7
8215901|NCT02091986|20261121|P3|COMPLETED|Overall Study||84
8215902|NCT02091986|20261122|P2|COMPLETED|Overall Study||84
8215903|NCT02091986|20261123|P1|COMPLETED|Overall Study||85
8215904|NCT02091986|20261121|P3|STARTED|Overall Study||92
8215905|NCT02091986|20261122|P2|STARTED|Overall Study||95
8215906|NCT02091986|20261123|P1|STARTED|Overall Study||92
8215907|NCT02091960|20261170|P1|NOT COMPLETED|Overall Study||51
8215908|NCT02091960|20261170|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
8215909|NCT02091960|20261170|P1|Received Treatment|Overall Study||103
8215910|NCT02091960|20261170|P1|STARTED|Overall Study||103
8215911|NCT02091921|20261181|P1|NOT COMPLETED|Overall Study||3
8215912|NCT02091921|20261181|P1|COMPLETED|Overall Study||50
8215913|NCT02091921|20261181|P1|STARTED|Overall Study||53
8215914|NCT02091869|20261190|P2|NOT COMPLETED|Overall Study||3
8215915|NCT02091869|20261191|P1|NOT COMPLETED|Overall Study||0
8215916|NCT02091869|20261190|P2|COMPLETED|Overall Study||14
8215917|NCT02091869|20261191|P1|COMPLETED|Overall Study||17
8215918|NCT02091869|20261190|P2|STARTED|Overall Study||17
8215919|NCT02091869|20261191|P1|STARTED|Overall Study||17
8215920|NCT02091856|20261206|P3|NOT COMPLETED|Follow-up Assessment||0
8215921|NCT02091856|20261207|P2|NOT COMPLETED|Follow-up Assessment||3
8215922|NCT02091856|20261208|P1|NOT COMPLETED|Follow-up Assessment||5
8215923|NCT02091856|20261206|P3|COMPLETED|Follow-up Assessment||0
8215924|NCT02091856|20261207|P2|COMPLETED|Follow-up Assessment||9
8215925|NCT02091856|20261208|P1|COMPLETED|Follow-up Assessment||10
8215926|NCT02091856|20261206|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
8215927|NCT02091856|20261207|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
8215928|NCT02091856|20261208|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
8215929|NCT02091856|20261206|P3|NOT COMPLETED|Active Intervention Interval||7
8215930|NCT02091856|20261207|P2|NOT COMPLETED|Active Intervention Interval||7
8215931|NCT02091856|20261208|P1|NOT COMPLETED|Active Intervention Interval||19
8215932|NCT02091856|20261206|P3|COMPLETED|Active Intervention Interval||19
8215933|NCT02091856|20261207|P2|COMPLETED|Active Intervention Interval||12
8215934|NCT02091856|20261208|P1|COMPLETED|Active Intervention Interval||15
8215935|NCT02091856|20261206|P3|STARTED|Active Intervention Interval||26
8215936|NCT02091856|20261207|P2|STARTED|Active Intervention Interval||19
8215937|NCT02091856|20261208|P1|STARTED|Active Intervention Interval||34
8215938|NCT02091778|20261228|P1|NOT COMPLETED|Overall Study||1
8215939|NCT02091778|20261228|P1|COMPLETED|Overall Study||20
8215940|NCT02091778|20261228|P1|STARTED|Overall Study||21
8215941|NCT02091752|20261232|P1|NOT COMPLETED|Overall Study||3
8215942|NCT02091752|20261232|P1|COMPLETED|Overall Study||0
8215943|NCT02091752|20261232|P1|STARTED|Overall Study||3
8215944|NCT02091739|20261246|P5|NOT COMPLETED|EP: 48 Weeks||14
8215945|NCT02091739|20261247|P4|NOT COMPLETED|EP: 48 Weeks||8
8215946|NCT02091739|20261248|P3|NOT COMPLETED|EP: 48 Weeks||0
8215947|NCT02091739|20261249|P2|NOT COMPLETED|EP: 48 Weeks||0
8215948|NCT02091739|20261250|P1|NOT COMPLETED|EP: 48 Weeks||0
8215949|NCT02091739|20261246|P5|COMPLETED|EP: 48 Weeks||75
8215950|NCT02091739|20261247|P4|COMPLETED|EP: 48 Weeks||76
8215951|NCT02091739|20261248|P3|COMPLETED|EP: 48 Weeks||0
8215952|NCT02091739|20261249|P2|COMPLETED|EP: 48 Weeks||0
8215953|NCT02091739|20261250|P1|COMPLETED|EP: 48 Weeks||0
8215954|NCT02091739|20261246|P5|STARTED|EP: 48 Weeks||89
8215955|NCT02091739|20261247|P4|STARTED|EP: 48 Weeks||84
8215956|NCT02091739|20261248|P3|STARTED|EP: 48 Weeks||0
8215957|NCT02091739|20261249|P2|STARTED|EP: 48 Weeks||0
8215958|NCT02091739|20261250|P1|STARTED|EP: 48 Weeks||0
8215959|NCT02091739|20261246|P5|NOT COMPLETED|MP: 16 Weeks||0
8215960|NCT02091739|20261247|P4|NOT COMPLETED|MP: 16 Weeks||0
8215961|NCT02091739|20261248|P3|NOT COMPLETED|MP: 16 Weeks||2
8215962|NCT02091739|20261249|P2|NOT COMPLETED|MP: 16 Weeks||5
8215963|NCT02091739|20261250|P1|NOT COMPLETED|MP: 16 Weeks||4
8215964|NCT02091739|20261246|P5|COMPLETED|MP: 16 Weeks||0
8215965|NCT02091739|20261247|P4|COMPLETED|MP: 16 Weeks||0
8215966|NCT02091739|20261248|P3|COMPLETED|MP: 16 Weeks||72
8215967|NCT02091739|20261249|P2|COMPLETED|MP: 16 Weeks||69
8215968|NCT02091739|20261250|P1|COMPLETED|MP: 16 Weeks||32
8215969|NCT02091739|20261246|P5|STARTED|MP: 16 Weeks||0
8215970|NCT02091739|20261247|P4|STARTED|MP: 16 Weeks||0
8215971|NCT02091739|20261248|P3|STARTED|MP: 16 Weeks||74
8215972|NCT02091739|20261249|P2|STARTED|MP: 16 Weeks||74
8215973|NCT02091739|20261250|P1|STARTED|MP: 16 Weeks||36
8215974|NCT02091726|20261269|P1|NOT COMPLETED|Overall Study||6
8215975|NCT02091726|20261269|P1|COMPLETED|Overall Study||104
8215976|NCT02091726|20261269|P1|4 Week Followup|Overall Study||104
8215977|NCT02091726|20261269|P1|1 Week Followup|Overall Study||110
8215978|NCT02091726|20261269|P1|STARTED|Overall Study||110
8215979|NCT02091531|20261277|P1|NOT COMPLETED|Overall Study||0
8215980|NCT02091531|20261277|P1|COMPLETED|Overall Study||9
8215981|NCT02091531|20261277|P1|STARTED|Overall Study||9
8215982|NCT02091466|20261285|P2|NOT COMPLETED|Overall Study||0
8215983|NCT02091466|20261286|P1|NOT COMPLETED|Overall Study||0
8215984|NCT02091466|20261285|P2|COMPLETED|Overall Study||20
8215985|NCT02091466|20261286|P1|COMPLETED|Overall Study||20
8215986|NCT02091466|20261285|P2|STARTED|Overall Study||20
8215987|NCT02091466|20261286|P1|STARTED|Overall Study||20
8215988|NCT02091440|20261292|P1|NOT COMPLETED|Overall Study||2
8215989|NCT02091440|20261292|P1|COMPLETED|Overall Study||4
8215990|NCT02091440|20261292|P1|Overall Survival at 180 Days|Overall Study||6
8215991|NCT02091440|20261292|P1|Primary Endpoint (Success at 180 Days)|Overall Study||6
8215992|NCT02091440|20261292|P1|STARTED|Overall Study||6
8215993|NCT02091414|20261302|P1|NOT COMPLETED|Overall Study||4
8215994|NCT02091414|20261302|P1|COMPLETED|Overall Study||32
8215995|NCT02091414|20261302|P1|STARTED|Overall Study||36
8215996|NCT02091375|20261316|P2|NOT COMPLETED|Overall Study||3
8215997|NCT02091375|20261317|P1|NOT COMPLETED|Overall Study||9
8215998|NCT02091375|20261316|P2|COMPLETED|Overall Study||56
8215999|NCT02091375|20261317|P1|COMPLETED|Overall Study||52
8216000|NCT02091375|20261316|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
8216001|NCT02091375|20261317|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
8216002|NCT02091375|20261316|P2|Safety Analysis Set|Overall Study||59
8216003|NCT02091375|20261317|P1|Safety Analysis Set|Overall Study||61
8216004|NCT02091375|20261316|P2|STARTED|Overall Study||59
8216005|NCT02091375|20261317|P1|STARTED|Overall Study||61
8216006|NCT02091362|20261347|P2|NOT COMPLETED|Period 2||2
8216007|NCT02091362|20261348|P1|NOT COMPLETED|Period 2||2
8216008|NCT02091362|20261347|P2|COMPLETED|Period 2||128
8216009|NCT02091362|20261348|P1|COMPLETED|Period 2||125
8216010|NCT02091362|20261347|P2|STARTED|Period 2||130
8216011|NCT02091362|20261348|P1|STARTED|Period 2||127
8216012|NCT02091362|20261347|P2|NOT COMPLETED|Wash-out||3
8216013|NCT02091362|20261348|P1|NOT COMPLETED|Wash-out||1
8216014|NCT02091362|20261347|P2|COMPLETED|Wash-out||130
8216015|NCT02091362|20261348|P1|COMPLETED|Wash-out||127
8216016|NCT02091362|20261347|P2|STARTED|Wash-out||133
8216017|NCT02091362|20261348|P1|STARTED|Wash-out||128
8216018|NCT02091362|20261347|P2|NOT COMPLETED|Period 1||4
8216019|NCT02091362|20261348|P1|NOT COMPLETED|Period 1||5
8216020|NCT02091362|20261347|P2|COMPLETED|Period 1||133
8216021|NCT02091362|20261348|P1|COMPLETED|Period 1||128
8216022|NCT02091362|20261347|P2|STARTED|Period 1||137
8216023|NCT02091362|20261348|P1|STARTED|Period 1||133
8216024|NCT02091284|20261370|P2|NOT COMPLETED|Overall Study||1
8216025|NCT02091284|20261371|P1|NOT COMPLETED|Overall Study||3
8216026|NCT02091284|20261370|P2|COMPLETED|Overall Study||22
8216027|NCT02091284|20261371|P1|COMPLETED|Overall Study||23
8216028|NCT02091284|20261370|P2|STARTED|Overall Study|One subject from this group discontinued the protocol|23
8216029|NCT02091284|20261371|P1|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
8216030|NCT02091206|20261393|P4|NOT COMPLETED|Taper Period||2
8216031|NCT02091206|20261394|P3|NOT COMPLETED|Taper Period||0
8216032|NCT02091206|20261395|P2|NOT COMPLETED|Taper Period||0
8216033|NCT02091206|20261396|P1|NOT COMPLETED|Taper Period||1
8216034|NCT02091206|20261393|P4|COMPLETED|Taper Period||5
8216035|NCT02091206|20261394|P3|COMPLETED|Taper Period||8
8216036|NCT02091206|20261395|P2|COMPLETED|Taper Period||7
8216037|NCT02091206|20261396|P1|COMPLETED|Taper Period||9
8216038|NCT02091206|20261393|P4|STARTED|Taper Period||7
8216039|NCT02091206|20261394|P3|STARTED|Taper Period||8
8216040|NCT02091206|20261395|P2|STARTED|Taper Period||7
8216041|NCT02091206|20261396|P1|STARTED|Taper Period||10
8216042|NCT02091206|20261393|P4|NOT COMPLETED|Treatment Period||0
8216043|NCT02091206|20261394|P3|NOT COMPLETED|Treatment Period||1
8216044|NCT02091206|20261395|P2|NOT COMPLETED|Treatment Period||1
8216045|NCT02091206|20261396|P1|NOT COMPLETED|Treatment Period||0
8216046|NCT02091206|20261393|P4|COMPLETED|Treatment Period||7
8216047|NCT02091206|20261394|P3|COMPLETED|Treatment Period||8
8216048|NCT02091206|20261395|P2|COMPLETED|Treatment Period||7
8216049|NCT02091206|20261396|P1|COMPLETED|Treatment Period||10
8216050|NCT02091206|20261393|P4|Safety Analysis Set|Treatment Period||7
8216051|NCT02091206|20261394|P3|Safety Analysis Set|Treatment Period||9
8216052|NCT02091206|20261395|P2|Safety Analysis Set|Treatment Period||8
8216053|NCT02091206|20261396|P1|Safety Analysis Set|Treatment Period||10
8216054|NCT02091206|20261393|P4|STARTED|Treatment Period||7
8216055|NCT02091206|20261394|P3|STARTED|Treatment Period||9
8216056|NCT02091206|20261395|P2|STARTED|Treatment Period||8
8216057|NCT02091206|20261396|P1|STARTED|Treatment Period||10
8216058|NCT02091167|20261415|P2|NOT COMPLETED|Overall Study||2
8216059|NCT02091167|20261416|P1|NOT COMPLETED|Overall Study||0
8216060|NCT02091167|20261415|P2|COMPLETED|Overall Study||14
8216061|NCT02091167|20261416|P1|COMPLETED|Overall Study||19
8216062|NCT02091167|20261415|P2|STARTED|Overall Study||16
8216063|NCT02091167|20261416|P1|STARTED|Overall Study||19
8216064|NCT02091102|20261424|P1|NOT COMPLETED|Overall Study||0
8216065|NCT02091102|20261424|P1|COMPLETED|Overall Study||20
8216066|NCT02091102|20261424|P1|STARTED|Overall Study||20
8216067|NCT02091089|20261432|P1|NOT COMPLETED|Overall Study||2
8216068|NCT02091089|20261432|P1|COMPLETED|Overall Study||18
8216069|NCT02091089|20261432|P1|STARTED|Overall Study||20
8216070|NCT02090959|20261440|P1|NOT COMPLETED|Overall Study||151
8216071|NCT02090959|20261440|P1|COMPLETED|Overall Study||68
8216072|NCT02090959|20261440|P1|As-treated Population|Overall Study||218
8216073|NCT02090959|20261440|P1|STARTED|Overall Study||219
8216074|NCT02090894|20261462|P1|NOT COMPLETED|Overall Study||0
8216075|NCT02090894|20261462|P1|COMPLETED|Overall Study||11
8216076|NCT02090894|20261462|P1|STARTED|Overall Study||11
8216077|NCT02090855|20261467|P1|NOT COMPLETED|Overall Study||2
8216078|NCT02090855|20261467|P1|COMPLETED|Overall Study||106
8216079|NCT02090855|20261467|P1|STARTED|Overall Study||108
8216080|NCT02090777|20261474|P1|NOT COMPLETED|Overall Study||0
8216081|NCT02090777|20261474|P1|COMPLETED|Overall Study||4
8216082|NCT02090777|20261474|P1|STARTED|Overall Study||4
8216083|NCT02090764|20261480|P2|NOT COMPLETED|Overall Study||20
8216084|NCT02090764|20261481|P1|NOT COMPLETED|Overall Study||6
8216085|NCT02090764|20261480|P2|COMPLETED|Overall Study||186
8216086|NCT02090764|20261481|P1|COMPLETED|Overall Study||200
8216087|NCT02090764|20261480|P2|STARTED|Overall Study||206
8216088|NCT02090764|20261481|P1|STARTED|Overall Study||206
8216089|NCT02090725|20261487|P1|NOT COMPLETED|Overall Study||4
8216090|NCT02090725|20261487|P1|COMPLETED|Overall Study||0
8216091|NCT02090725|20261487|P1|STARTED|Overall Study||4
8216092|NCT02090426|20261493|P2|NOT COMPLETED|Overall Study||6
8216093|NCT02090426|20261494|P1|NOT COMPLETED|Overall Study||12
8216094|NCT02090426|20261493|P2|COMPLETED|Overall Study||393
8216095|NCT02090426|20261494|P1|COMPLETED|Overall Study||389
8216096|NCT02090426|20261493|P2|Analysis Population|Overall Study||393
8216097|NCT02090426|20261494|P1|Analysis Population|Overall Study||389
8216098|NCT02090426|20261493|P2|STARTED|Overall Study||399
8216099|NCT02090426|20261494|P1|STARTED|Overall Study||401
8216100|NCT02090413|20261525|P3|NOT COMPLETED|Overall Study||23
8216101|NCT02090413|20261526|P2|NOT COMPLETED|Overall Study||20
8216102|NCT02090413|20261527|P1|NOT COMPLETED|Overall Study||19
8216103|NCT02090413|20261525|P3|COMPLETED|Overall Study||57
8216104|NCT02090413|20261526|P2|COMPLETED|Overall Study||60
8216105|NCT02090413|20261527|P1|COMPLETED|Overall Study||62
8216106|NCT02090413|20261525|P3|STARTED|Overall Study||80
8216107|NCT02090413|20261526|P2|STARTED|Overall Study||80
8216108|NCT02090413|20261527|P1|STARTED|Overall Study||81
8216109|NCT02090283|20261604|P3|NOT COMPLETED|Overall Study||10
8216110|NCT02090283|20261605|P2|NOT COMPLETED|Overall Study||15
8216111|NCT02090283|20261606|P1|NOT COMPLETED|Overall Study||17
8216112|NCT02090283|20261604|P3|COMPLETED|Overall Study||0
8216113|NCT02090283|20261605|P2|COMPLETED|Overall Study||0
8216114|NCT02090283|20261606|P1|COMPLETED|Overall Study||0
8216115|NCT02090283|20261604|P3|Received At Least 1 Dose Of Study Drug|Overall Study||10
8216116|NCT02090283|20261605|P2|Received At Least 1 Dose Of Study Drug|Overall Study||15
8216117|NCT02090283|20261606|P1|Received At Least 1 Dose Of Study Drug|Overall Study||17
8216118|NCT02090283|20261604|P3|STARTED|Overall Study||10
8216119|NCT02090283|20261605|P2|STARTED|Overall Study||15
8216120|NCT02090283|20261606|P1|STARTED|Overall Study||17
8216121|NCT02090088|20261617|P1|NOT COMPLETED|Overall Study||0
8216122|NCT02090088|20261617|P1|COMPLETED|Overall Study||4
8216123|NCT02090088|20261617|P1|Gave Birth|Overall Study||4
8216124|NCT02090088|20261617|P1|STARTED|Overall Study||4
8216125|NCT02090075|20261631|P2|NOT COMPLETED|Overall Study||3
8216126|NCT02090075|20261632|P1|NOT COMPLETED|Overall Study||7
8216127|NCT02090075|20261631|P2|COMPLETED|Overall Study||30
8216128|NCT02090075|20261632|P1|COMPLETED|Overall Study||26
8216129|NCT02090075|20261631|P2|STARTED|Overall Study||33
8216130|NCT02090075|20261632|P1|STARTED|Overall Study||33
8216131|NCT02089997|20261640|P1|NOT COMPLETED|Overall Study||246
8216132|NCT02089997|20261640|P1|COMPLETED|Overall Study||3058
8216133|NCT02089997|20261640|P1|STARTED|Overall Study||3304
8216134|NCT02089737|20261655|P1|NOT COMPLETED|Overall Study||6
8216135|NCT02089737|20261655|P1|COMPLETED|Overall Study||3085
8216136|NCT02089737|20261655|P1|STARTED|Overall Study||3091
8216137|NCT02089659|20261664|P3|NOT COMPLETED|Overall Study||0
8216138|NCT02089659|20261665|P2|NOT COMPLETED|Overall Study||0
8216139|NCT02089659|20261666|P1|NOT COMPLETED|Overall Study||0
8216140|NCT02089659|20261664|P3|COMPLETED|Overall Study||0
8216141|NCT02089659|20261665|P2|COMPLETED|Overall Study||8
8216142|NCT02089659|20261666|P1|COMPLETED|Overall Study||8
8216143|NCT02089659|20261664|P3|STARTED|Overall Study||0
8216144|NCT02089659|20261665|P2|STARTED|Overall Study||8
8216145|NCT02089659|20261666|P1|STARTED|Overall Study||8
8216146|NCT02089464|20261680|P2|NOT COMPLETED|Overall Study||16
8216147|NCT02089464|20261681|P1|NOT COMPLETED|Overall Study||28
8216148|NCT02089464|20261680|P2|COMPLETED|Overall Study||51
8216149|NCT02089464|20261681|P1|COMPLETED|Overall Study||104
8216150|NCT02089464|20261680|P2|STARTED|Overall Study||67
8216151|NCT02089464|20261681|P1|STARTED|Overall Study||132
8216152|NCT02089347|20261705|P2|NOT COMPLETED|Overall Study||0
8216153|NCT02089347|20261706|P1|NOT COMPLETED|Overall Study||1
8216154|NCT02089347|20261705|P2|COMPLETED|Overall Study||178
8216155|NCT02089347|20261706|P1|COMPLETED|Overall Study||355
8216156|NCT02089347|20261705|P2|STARTED|Overall Study||178
8216157|NCT02089347|20261706|P1|STARTED|Overall Study||356
8216158|NCT02089334|20261732|P4|NOT COMPLETED|Overall Study||7
8216159|NCT02089334|20261733|P3|NOT COMPLETED|Overall Study||1
8216160|NCT02089334|20261734|P2|NOT COMPLETED|Overall Study||0
8216161|NCT02089334|20261735|P1|NOT COMPLETED|Overall Study||0
8216162|NCT02089334|20261732|P4|COMPLETED|Overall Study||6
8216163|NCT02089334|20261733|P3|COMPLETED|Overall Study||3
8216164|NCT02089334|20261734|P2|COMPLETED|Overall Study||4
8216165|NCT02089334|20261735|P1|COMPLETED|Overall Study||3
8216166|NCT02089334|20261732|P4|Received Study Drug|Overall Study||11
8216167|NCT02089334|20261733|P3|Received Study Drug|Overall Study||3
8216168|NCT02089334|20261734|P2|Received Study Drug|Overall Study||4
8216169|NCT02089334|20261735|P1|Received Study Drug|Overall Study||3
8216170|NCT02089334|20261732|P4|STARTED|Overall Study||13
8216171|NCT02089334|20261733|P3|STARTED|Overall Study||4
8216172|NCT02089334|20261734|P2|STARTED|Overall Study||4
8216173|NCT02089334|20261735|P1|STARTED|Overall Study||3
8216174|NCT02089191|20261752|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
8216175|NCT02089191|20261753|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
8216176|NCT02089191|20261752|P2|COMPLETED|Period 2, Second 12 Hours||15
8216177|NCT02089191|20261753|P1|COMPLETED|Period 2, Second 12 Hours||15
8216178|NCT02089191|20261752|P2|STARTED|Period 2, Second 12 Hours||15
8216179|NCT02089191|20261753|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
8216180|NCT02089191|20261752|P2|NOT COMPLETED|Period 1, First 12 Hours||0
8216181|NCT02089191|20261753|P1|NOT COMPLETED|Period 1, First 12 Hours||0
8216182|NCT02089191|20261752|P2|COMPLETED|Period 1, First 12 Hours||15
8216183|NCT02089191|20261753|P1|COMPLETED|Period 1, First 12 Hours||16
8216184|NCT02089191|20261752|P2|STARTED|Period 1, First 12 Hours||15
8216185|NCT02089191|20261753|P1|STARTED|Period 1, First 12 Hours||16
8216186|NCT02089113|20261763|P2|NOT COMPLETED|Overall Study||0
8216187|NCT02089113|20261764|P1|NOT COMPLETED|Overall Study||1
8216188|NCT02089113|20261763|P2|COMPLETED|Overall Study||80
8216189|NCT02089113|20261764|P1|COMPLETED|Overall Study||160
8216190|NCT02089113|20261763|P2|STARTED|Overall Study||80
8216191|NCT02089113|20261764|P1|STARTED|Overall Study||161
8216192|NCT02088957|20261772|P2|NOT COMPLETED|Overall Study||0
8216193|NCT02088957|20261773|P1|NOT COMPLETED|Overall Study||1
8216194|NCT02088957|20261772|P2|COMPLETED|Overall Study||0
8216195|NCT02088957|20261773|P1|COMPLETED|Overall Study||0
8216196|NCT02088957|20261772|P2|STARTED|Overall Study||0
8216197|NCT02088957|20261773|P1|STARTED|Overall Study||1
8216198|NCT02088905|20261791|P2|NOT COMPLETED|Overall Study||1
8216199|NCT02088905|20261792|P1|NOT COMPLETED|Overall Study||5
8216200|NCT02088905|20261791|P2|COMPLETED|Overall Study||9
8216201|NCT02088905|20261792|P1|COMPLETED|Overall Study||8
8216202|NCT02088905|20261791|P2|Week 9|Overall Study||9
8216203|NCT02088905|20261792|P1|Week 9|Overall Study||10
8216204|NCT02088905|20261791|P2|STARTED|Overall Study||10
8216205|NCT02088905|20261792|P1|STARTED|Overall Study||13
8216206|NCT02088788|20261814|P2|NOT COMPLETED|Overall Study||41
8216207|NCT02088788|20261815|P1|NOT COMPLETED|Overall Study||30
8216208|NCT02088788|20261814|P2|COMPLETED|Overall Study||89
8216209|NCT02088788|20261815|P1|COMPLETED|Overall Study||105
8216210|NCT02088788|20261814|P2|STARTED|Overall Study||130
8216211|NCT02088788|20261815|P1|STARTED|Overall Study||135
8216212|NCT02088541|20261828|P5|NOT COMPLETED|Overall Study||58
8216213|NCT02088541|20261829|P4|NOT COMPLETED|Overall Study||44
8216214|NCT02088541|20261830|P3|NOT COMPLETED|Overall Study||117
8216215|NCT02088541|20261831|P2|NOT COMPLETED|Overall Study||27
8216216|NCT02088541|20261832|P1|NOT COMPLETED|Overall Study||71
8216217|NCT02088541|20261828|P5|COMPLETED|Overall Study||0
8216218|NCT02088541|20261829|P4|COMPLETED|Overall Study||0
8216219|NCT02088541|20261830|P3|COMPLETED|Overall Study||0
8216220|NCT02088541|20261831|P2|COMPLETED|Overall Study||0
8216221|NCT02088541|20261832|P1|COMPLETED|Overall Study||0
8216222|NCT02088541|20261828|P5|Intent-to-treat (ITT) Population|Overall Study||57
8216223|NCT02088541|20261829|P4|Intent-to-treat (ITT) Population|Overall Study||0
8216224|NCT02088541|20261830|P3|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
8216225|NCT02088541|20261831|P2|Intent-to-treat (ITT) Population|Overall Study||0
8216226|NCT02088541|20261832|P1|Intent-to-treat (ITT) Population|Overall Study||0
8216227|NCT02088541|20261828|P5|Safety Population|Overall Study||45
8216228|NCT02088541|20261829|P4|Safety Population|Overall Study||39
8216229|NCT02088541|20261830|P3|Safety Population|Overall Study||115
8216230|NCT02088541|20261831|P2|Safety Population|Overall Study||27
8216231|NCT02088541|20261832|P1|Safety Population|Overall Study||71
8216232|NCT02088541|20261828|P5|STARTED|Overall Study||58
8216233|NCT02088541|20261829|P4|STARTED|Overall Study||44
8216234|NCT02088541|20261830|P3|STARTED|Overall Study||117
8216235|NCT02088541|20261831|P2|STARTED|Overall Study||27
8216236|NCT02088541|20261832|P1|STARTED|Overall Study||71
8216237|NCT02088385|20261865|P2|NOT COMPLETED|Overall Study||0
8216238|NCT02088385|20261866|P1|NOT COMPLETED|Overall Study||0
8216239|NCT02088385|20261865|P2|COMPLETED|Overall Study||10
8216240|NCT02088385|20261866|P1|COMPLETED|Overall Study||10
8216241|NCT02088385|20261865|P2|STARTED|Overall Study||10
8216242|NCT02088385|20261866|P1|STARTED|Overall Study||10
8216243|NCT02088216|20261876|P2|NOT COMPLETED|Overall Study||10
8216244|NCT02088216|20261877|P1|NOT COMPLETED|Overall Study||12
8216245|NCT02088216|20261876|P2|COMPLETED|Overall Study||70
8216246|NCT02088216|20261877|P1|COMPLETED|Overall Study||69
8216247|NCT02088216|20261876|P2|STARTED|Overall Study||80
8216248|NCT02088216|20261877|P1|STARTED|Overall Study||81
8216249|NCT02088177|20261903|P1|NOT COMPLETED|Overall Study||3
8216250|NCT02088177|20261903|P1|COMPLETED|Overall Study||9
8216251|NCT02088177|20261903|P1|STARTED|Overall Study||12
8216252|NCT02088073|20261913|P5|NOT COMPLETED|Maintanance Phase||7
8216253|NCT02088073|20261914|P4|NOT COMPLETED|Maintanance Phase||7
8216254|NCT02088073|20261915|P3|NOT COMPLETED|Maintanance Phase||5
8216255|NCT02088073|20261916|P2|NOT COMPLETED|Maintanance Phase||10
8216256|NCT02088073|20261917|P1|NOT COMPLETED|Maintanance Phase||0
8216257|NCT02088073|20261913|P5|COMPLETED|Maintanance Phase||49
8216258|NCT02088073|20261914|P4|COMPLETED|Maintanance Phase||44
8216259|NCT02088073|20261915|P3|COMPLETED|Maintanance Phase||40
8216260|NCT02088073|20261916|P2|COMPLETED|Maintanance Phase||75
8216261|NCT02088073|20261917|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
8216262|NCT02088073|20261913|P5|STARTED|Maintanance Phase||56
8216263|NCT02088073|20261914|P4|STARTED|Maintanance Phase||51
8216264|NCT02088073|20261915|P3|STARTED|Maintanance Phase||45
8216265|NCT02088073|20261916|P2|STARTED|Maintanance Phase||85
8216266|NCT02088073|20261917|P1|STARTED|Maintanance Phase||0
8216267|NCT02088073|20261913|P5|NOT COMPLETED|Acute Phase||0
8216268|NCT02088073|20261914|P4|NOT COMPLETED|Acute Phase||0
8216269|NCT02088073|20261915|P3|NOT COMPLETED|Acute Phase||0
8216270|NCT02088073|20261916|P2|NOT COMPLETED|Acute Phase||0
8216271|NCT02088073|20261917|P1|NOT COMPLETED|Acute Phase||7
8216272|NCT02088073|20261913|P5|COMPLETED|Acute Phase||0
8216273|NCT02088073|20261914|P4|COMPLETED|Acute Phase||0
8216274|NCT02088073|20261915|P3|COMPLETED|Acute Phase||0
8216275|NCT02088073|20261916|P2|COMPLETED|Acute Phase||0
8216276|NCT02088073|20261917|P1|COMPLETED|Acute Phase||251
8216277|NCT02088073|20261913|P5|STARTED|Acute Phase||0
8216278|NCT02088073|20261914|P4|STARTED|Acute Phase||0
8216279|NCT02088073|20261915|P3|STARTED|Acute Phase||0
8216280|NCT02088073|20261916|P2|STARTED|Acute Phase||0
8216281|NCT02088073|20261917|P1|STARTED|Acute Phase||258
8216282|NCT02088047|20261971|P2|NOT COMPLETED|Overall Study||0
8216283|NCT02088047|20261972|P1|NOT COMPLETED|Overall Study||1
8216284|NCT02088047|20261971|P2|COMPLETED|Overall Study||1
8216285|NCT02088047|20261972|P1|COMPLETED|Overall Study||2
8216286|NCT02088047|20261971|P2|STARTED|Overall Study||1
8216287|NCT02088047|20261972|P1|STARTED|Overall Study||3
8216288|NCT02088034|20261981|P3|NOT COMPLETED|Overall Study||2
8216289|NCT02088034|20261982|P2|NOT COMPLETED|Overall Study||2
8216290|NCT02088034|20261983|P1|NOT COMPLETED|Overall Study||3
8216291|NCT02088034|20261981|P3|COMPLETED|Overall Study||27
8216292|NCT02088034|20261982|P2|COMPLETED|Overall Study||28
8216293|NCT02088034|20261983|P1|COMPLETED|Overall Study||30
8216294|NCT02088034|20261981|P3|STARTED|Overall Study||29
8216295|NCT02088034|20261982|P2|STARTED|Overall Study||30
8216296|NCT02088034|20261983|P1|STARTED|Overall Study||33
8216297|NCT02087995|20261991|P1|NOT COMPLETED|Overall Study||0
8216298|NCT02087995|20261991|P1|COMPLETED|Overall Study||51
8216299|NCT02087995|20261991|P1|STARTED|Overall Study||51
8216300|NCT02087956|20261997|P2|NOT COMPLETED|Overall Study||5
8216301|NCT02087956|20261998|P1|NOT COMPLETED|Overall Study||6
8216302|NCT02087956|20261997|P2|COMPLETED|Overall Study||107
8216303|NCT02087956|20261998|P1|COMPLETED|Overall Study||105
8216304|NCT02087956|20261997|P2|STARTED|Overall Study||112
8216305|NCT02087956|20261998|P1|STARTED|Overall Study||111
8216306|NCT02087943|20262013|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
8216307|NCT02087943|20262014|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
8216308|NCT02087943|20262015|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
8216309|NCT02087943|20262016|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
8216310|NCT02087943|20262017|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
8216311|NCT02087943|20262013|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
8216312|NCT02087943|20262014|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
8216313|NCT02087943|20262015|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
8216314|NCT02087943|20262016|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
8216315|NCT02087943|20262017|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
8216316|NCT02087943|20262013|P5|STARTED|Observational Follow-up Phase Week 24-30||23
8216317|NCT02087943|20262014|P4|STARTED|Observational Follow-up Phase Week 24-30||24
8216318|NCT02087943|20262015|P3|STARTED|Observational Follow-up Phase Week 24-30||48
8216319|NCT02087943|20262016|P2|STARTED|Observational Follow-up Phase Week 24-30||46
8216320|NCT02087943|20262017|P1|STARTED|Observational Follow-up Phase Week 24-30||0
8216321|NCT02087943|20262013|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
8216322|NCT02087943|20262014|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
8216323|NCT02087943|20262015|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
8216324|NCT02087943|20262016|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
8216325|NCT02087943|20262017|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
8216326|NCT02087943|20262013|P5|COMPLETED|Active Treatment Phase Week 12-24||21
8216327|NCT02087943|20262014|P4|COMPLETED|Active Treatment Phase Week 12-24||22
8216328|NCT02087943|20262015|P3|COMPLETED|Active Treatment Phase Week 12-24||44
8216329|NCT02087943|20262016|P2|COMPLETED|Active Treatment Phase Week 12-24||42
8216330|NCT02087943|20262017|P1|COMPLETED|Active Treatment Phase Week 12-24||0
8216331|NCT02087943|20262013|P5|STARTED|Active Treatment Phase Week 12-24||23
8216332|NCT02087943|20262014|P4|STARTED|Active Treatment Phase Week 12-24||24
8216333|NCT02087943|20262015|P3|STARTED|Active Treatment Phase Week 12-24||49
8216334|NCT02087943|20262016|P2|STARTED|Active Treatment Phase Week 12-24||46
8216335|NCT02087943|20262017|P1|STARTED|Active Treatment Phase Week 12-24||0
8216336|NCT02087943|20262013|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216337|NCT02087943|20262014|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216338|NCT02087943|20262015|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
8216339|NCT02087943|20262016|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
8216340|NCT02087943|20262017|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
8216341|NCT02087943|20262013|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216342|NCT02087943|20262014|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216343|NCT02087943|20262015|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
8216344|NCT02087943|20262016|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
8216345|NCT02087943|20262017|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
8216346|NCT02087943|20262013|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
8216347|NCT02087943|20262014|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
8216348|NCT02087943|20262015|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
8216349|NCT02087943|20262016|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
8216350|NCT02087943|20262017|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
8216351|NCT02087943|20262013|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
8216352|NCT02087943|20262014|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
8216353|NCT02087943|20262015|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
8216354|NCT02087943|20262016|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
8216355|NCT02087943|20262017|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
8216356|NCT02087904|20262045|P4|NOT COMPLETED|Overall Study||25
8216357|NCT02087904|20262046|P3|NOT COMPLETED|Overall Study||22
8216358|NCT02087904|20262047|P2|NOT COMPLETED|Overall Study||19
8216359|NCT02087904|20262048|P1|NOT COMPLETED|Overall Study||25
8216360|NCT02087904|20262045|P4|COMPLETED|Overall Study||64
8216361|NCT02087904|20262046|P3|COMPLETED|Overall Study||65
8216362|NCT02087904|20262047|P2|COMPLETED|Overall Study||70
8216363|NCT02087904|20262048|P1|COMPLETED|Overall Study||60
8216364|NCT02087904|20262045|P4|STARTED|Overall Study||89
8216365|NCT02087904|20262046|P3|STARTED|Overall Study||87
8216366|NCT02087904|20262047|P2|STARTED|Overall Study||89
8216367|NCT02087904|20262048|P1|STARTED|Overall Study||85
8216368|NCT02087774|20262164|P2|NOT COMPLETED|Overall Study||20
8216369|NCT02087774|20262165|P1|NOT COMPLETED|Overall Study||8
8216370|NCT02087774|20262164|P2|COMPLETED|Overall Study||130
8216371|NCT02087774|20262165|P1|COMPLETED|Overall Study||142
8216372|NCT02087774|20262164|P2|STARTED|Overall Study||150
8216373|NCT02087774|20262165|P1|STARTED|Overall Study||150
8216374|NCT02087748|20262173|P1|NOT COMPLETED|Overall Study||0
8216375|NCT02087748|20262173|P1|COMPLETED|Overall Study||24
8216376|NCT02087748|20262173|P1|STARTED|Overall Study||24
8216377|NCT02087670|20262185|P2|NOT COMPLETED|Overall Study||2
8216378|NCT02087670|20262186|P1|NOT COMPLETED|Overall Study||3
8216379|NCT02087670|20262185|P2|COMPLETED|Overall Study||20
8216380|NCT02087670|20262186|P1|COMPLETED|Overall Study||17
8216381|NCT02087670|20262185|P2|STARTED|Overall Study||22
8216382|NCT02087670|20262186|P1|STARTED|Overall Study||20
8216383|NCT02087514|20262200|P6|NOT COMPLETED|Overall Study||1
8216384|NCT02087514|20262201|P5|NOT COMPLETED|Overall Study||0
8216385|NCT02087514|20262202|P4|NOT COMPLETED|Overall Study||2
8216386|NCT02087514|20262203|P3|NOT COMPLETED|Overall Study||3
8216387|NCT02087514|20262204|P2|NOT COMPLETED|Overall Study||0
8216388|NCT02087514|20262205|P1|NOT COMPLETED|Overall Study||2
8216389|NCT02087514|20262200|P6|COMPLETED|Overall Study||9
8216390|NCT02087514|20262201|P5|COMPLETED|Overall Study||10
8216391|NCT02087514|20262202|P4|COMPLETED|Overall Study||8
8216392|NCT02087514|20262203|P3|COMPLETED|Overall Study||7
8216393|NCT02087514|20262204|P2|COMPLETED|Overall Study||10
8216394|NCT02087514|20262205|P1|COMPLETED|Overall Study||8
8216395|NCT02087514|20262200|P6|STARTED|Overall Study||10
8216396|NCT02087514|20262201|P5|STARTED|Overall Study||10
8216397|NCT02087514|20262202|P4|STARTED|Overall Study||10
8216398|NCT02087514|20262203|P3|STARTED|Overall Study||10
8216399|NCT02087514|20262204|P2|STARTED|Overall Study||10
8216400|NCT02087514|20262205|P1|STARTED|Overall Study||10
8216401|NCT02087423|20262222|P3|NOT COMPLETED|Overall Study||68
8216402|NCT02087423|20262223|P2|NOT COMPLETED|Overall Study||265
8216403|NCT02087423|20262224|P1|NOT COMPLETED|Overall Study||111
8216404|NCT02087423|20262222|P3|COMPLETED|Overall Study||0
8216405|NCT02087423|20262223|P2|COMPLETED|Overall Study||0
8216406|NCT02087423|20262224|P1|COMPLETED|Overall Study||0
8216407|NCT02087423|20262222|P3|Completed 12 Months of Treatment|Overall Study||26
8216408|NCT02087423|20262223|P2|Completed 12 Months of Treatment|Overall Study||60
8216409|NCT02087423|20262224|P1|Completed 12 Months of Treatment|Overall Study||18
8216410|NCT02087423|20262222|P3|STARTED|Overall Study|Treated|68
8216411|NCT02087423|20262223|P2|STARTED|Overall Study|Treated|265
8216412|NCT02087423|20262224|P1|STARTED|Overall Study|Treated|111
8216413|NCT02087241|20262253|P4|NOT COMPLETED|Overall Study||7
8216414|NCT02087241|20262254|P3|NOT COMPLETED|Overall Study||1
8216415|NCT02087241|20262255|P2|NOT COMPLETED|Overall Study||3
8216416|NCT02087241|20262256|P1|NOT COMPLETED|Overall Study||3
8216417|NCT02087241|20262253|P4|COMPLETED|Overall Study||0
8216418|NCT02087241|20262254|P3|COMPLETED|Overall Study||0
8216419|NCT02087241|20262255|P2|COMPLETED|Overall Study||0
8216420|NCT02087241|20262256|P1|COMPLETED|Overall Study||0
8216421|NCT02087241|20262253|P4|STARTED|Overall Study||7
8216422|NCT02087241|20262254|P3|STARTED|Overall Study||1
8216423|NCT02087241|20262255|P2|STARTED|Overall Study||3
8216424|NCT02087241|20262256|P1|STARTED|Overall Study||3
8216425|NCT02087176|20262282|P1|NOT COMPLETED|Overall Study||32
8216426|NCT02087176|20262282|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
8216427|NCT02087176|20262282|P1|STARTED|Overall Study||32
8216428|NCT02087163|20262287|P1|NOT COMPLETED|Overall Study||17
8216429|NCT02087163|20262287|P1|COMPLETED|Overall Study||73
8216430|NCT02087163|20262287|P1|STARTED|Overall Study||90
8216431|NCT02087150|20262295|P3|NOT COMPLETED|Overall Study||11
8216432|NCT02087150|20262296|P2|NOT COMPLETED|Overall Study||34
8216433|NCT02087150|20262297|P1|NOT COMPLETED|Overall Study||10
8216434|NCT02087150|20262295|P3|COMPLETED|Overall Study||69
8216435|NCT02087150|20262296|P2|COMPLETED|Overall Study||128
8216436|NCT02087150|20262297|P1|COMPLETED|Overall Study||71
8216437|NCT02087150|20262295|P3|Received a Crossover MM ETBC Procedure|Overall Study||70
8216438|NCT02087150|20262296|P2|Received a Crossover MM ETBC Procedure|Overall Study||0
8216439|NCT02087150|20262297|P1|Received a Crossover MM ETBC Procedure|Overall Study||0
8216440|NCT02087150|20262295|P3|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
8216441|NCT02087150|20262296|P2|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
8216442|NCT02087150|20262297|P1|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
8216443|NCT02087150|20262295|P3|STARTED|Overall Study||80
8216444|NCT02087150|20262296|P2|STARTED|Overall Study||162
8216445|NCT02087150|20262297|P1|STARTED|Overall Study||81
8216446|NCT02087085|20262316|P2|NOT COMPLETED|Overall Study||116
8216447|NCT02087085|20262317|P1|NOT COMPLETED|Overall Study||120
8216448|NCT02087085|20262316|P2|COMPLETED|Overall Study||40
8216449|NCT02087085|20262317|P1|COMPLETED|Overall Study||34
8216450|NCT02087085|20262316|P2|STARTED|Overall Study||156
8216451|NCT02087085|20262317|P1|STARTED|Overall Study||154
8216452|NCT02087059|20262327|P1|NOT COMPLETED|Overall Study||7
8216453|NCT02087059|20262327|P1|COMPLETED|Overall Study||44
8216454|NCT02087059|20262327|P1|STARTED|Overall Study||51
8216455|NCT02086968|20262337|P2|NOT COMPLETED|Overall Study||13
8216456|NCT02086968|20262338|P1|NOT COMPLETED|Overall Study||8
8216457|NCT02086968|20262337|P2|COMPLETED|Overall Study||85
8216458|NCT02086968|20262338|P1|COMPLETED|Overall Study||92
8216459|NCT02086968|20262337|P2|STARTED|Overall Study||98
8216460|NCT02086968|20262338|P1|STARTED|Overall Study||100
8216461|NCT02086786|20262346|P2|NOT COMPLETED|Overall Study||16
8216462|NCT02086786|20262347|P1|NOT COMPLETED|Overall Study||18
8216463|NCT02086786|20262346|P2|COMPLETED|Overall Study||19
8216464|NCT02086786|20262347|P1|COMPLETED|Overall Study||17
8216465|NCT02086786|20262346|P2|STARTED|Overall Study||35
8216466|NCT02086786|20262347|P1|STARTED|Overall Study||35
8216467|NCT02086708|20262371|P1|NOT COMPLETED|Overall Study||0
8216468|NCT02086708|20262371|P1|COMPLETED|Overall Study||24
8216469|NCT02086708|20262371|P1|STARTED|Overall Study||24
8216470|NCT02086682|20262385|P2|NOT COMPLETED|Overall Study||0
8216471|NCT02086682|20262386|P1|NOT COMPLETED|Overall Study||0
8216472|NCT02086682|20262385|P2|COMPLETED|Overall Study||182
8216473|NCT02086682|20262386|P1|COMPLETED|Overall Study||156
8216474|NCT02086682|20262385|P2|STARTED|Overall Study||182
8216475|NCT02086682|20262386|P1|STARTED|Overall Study||156
8216476|NCT02086591|20262392|P1|NOT COMPLETED|Overall Study||5
8216477|NCT02086591|20262392|P1|COMPLETED|Overall Study||2
8216478|NCT02086591|20262392|P1|STARTED|Overall Study||7
8216479|NCT02086565|20262400|P2|NOT COMPLETED|Overall Study||12
8216480|NCT02086565|20262401|P1|NOT COMPLETED|Overall Study||16
8216481|NCT02086565|20262400|P2|COMPLETED|Overall Study||138
8216482|NCT02086565|20262401|P1|COMPLETED|Overall Study||135
8216483|NCT02086565|20262400|P2|STARTED|Overall Study||150
8216484|NCT02086565|20262401|P1|STARTED|Overall Study||151
8216485|NCT02086552|20262415|P1|NOT COMPLETED|Overall Study||1
8216486|NCT02086552|20262415|P1|COMPLETED|Overall Study||27
8216487|NCT02086552|20262415|P1|STARTED|Overall Study||28
8216488|NCT02086500|20262424|P2|NOT COMPLETED|Overall Study||0
8216489|NCT02086500|20262425|P1|NOT COMPLETED|Overall Study||0
8216490|NCT02086500|20262424|P2|COMPLETED|Overall Study||456
8216491|NCT02086500|20262425|P1|COMPLETED|Overall Study||447
8216492|NCT02086500|20262424|P2|STARTED|Overall Study||456
8216493|NCT02086500|20262425|P1|STARTED|Overall Study||447
8216494|NCT02086331|20262443|P1|NOT COMPLETED|Overall Study||0
8216495|NCT02086331|20262443|P1|COMPLETED|Overall Study||5
8216496|NCT02086331|20262443|P1|STARTED|Overall Study||5
8216500|NCT02086162|20262464|P2|NOT COMPLETED|Overall Study||7
8216501|NCT02086162|20262465|P1|NOT COMPLETED|Overall Study||10
8216502|NCT02086162|20262464|P2|COMPLETED|Overall Study||77
8216503|NCT02086162|20262465|P1|COMPLETED|Overall Study||68
8216504|NCT02086162|20262464|P2|STARTED|Overall Study||84
8216505|NCT02086162|20262465|P1|STARTED|Overall Study||78
8216506|NCT02086110|20262477|P2|NOT COMPLETED|Overall Study||1
8216507|NCT02086110|20262478|P1|NOT COMPLETED|Overall Study||1
8216508|NCT02086110|20262477|P2|COMPLETED|Overall Study||5
8216509|NCT02086110|20262478|P1|COMPLETED|Overall Study||4
8216510|NCT02086110|20262477|P2|STARTED|Overall Study||6
8216511|NCT02086110|20262478|P1|STARTED|Overall Study||5
8216512|NCT02085785|20262489|P2|NOT COMPLETED|Overall Study||2
8216513|NCT02085785|20262490|P1|NOT COMPLETED|Overall Study||2
8216514|NCT02085785|20262489|P2|COMPLETED|Overall Study||6
8216515|NCT02085785|20262490|P1|COMPLETED|Overall Study||5
8216516|NCT02085785|20262489|P2|STARTED|Overall Study||8
8216517|NCT02085785|20262490|P1|STARTED|Overall Study||7
8216518|NCT02085720|20262502|P1|NOT COMPLETED|Overall Study||0
8216519|NCT02085720|20262502|P1|COMPLETED|Overall Study||819
8216520|NCT02085720|20262502|P1|STARTED|Overall Study||819
8216521|NCT02085551|20262510|P1|NOT COMPLETED|Overall Study||0
8216522|NCT02085551|20262510|P1|COMPLETED|Overall Study||85
8216523|NCT02085551|20262510|P1|STARTED|Overall Study||85
8216524|NCT02085473|20262519|P4|NOT COMPLETED|Overall Study||0
8216525|NCT02085473|20262520|P3|NOT COMPLETED|Overall Study||0
8216526|NCT02085473|20262521|P2|NOT COMPLETED|Overall Study||0
8216527|NCT02085473|20262522|P1|NOT COMPLETED|Overall Study||0
8216528|NCT02085473|20262519|P4|COMPLETED|Overall Study||15
8216529|NCT02085473|20262520|P3|COMPLETED|Overall Study||15
8216530|NCT02085473|20262521|P2|COMPLETED|Overall Study||15
8216531|NCT02085473|20262522|P1|COMPLETED|Overall Study||15
8216532|NCT02085473|20262519|P4|STARTED|Overall Study||15
8216533|NCT02085473|20262520|P3|STARTED|Overall Study||15
8216534|NCT02085473|20262521|P2|STARTED|Overall Study||15
8216535|NCT02085473|20262522|P1|STARTED|Overall Study||15
8216536|NCT02085447|20262584|P1|NOT COMPLETED|Overall Study||4
8216537|NCT02085447|20262584|P1|COMPLETED|Overall Study||26
8216538|NCT02085447|20262584|P1|STARTED|Overall Study||30
8216539|NCT02085356|20262613|P4|NOT COMPLETED|Overall Study||0
8216540|NCT02085356|20262614|P3|NOT COMPLETED|Overall Study||0
8216541|NCT02085356|20262615|P2|NOT COMPLETED|Overall Study||0
8216542|NCT02085356|20262616|P1|NOT COMPLETED|Overall Study||0
8216543|NCT02085356|20262613|P4|COMPLETED|Overall Study||361
8216544|NCT02085356|20262614|P3|COMPLETED|Overall Study||681
8216545|NCT02085356|20262615|P2|COMPLETED|Overall Study||348
8216546|NCT02085356|20262616|P1|COMPLETED|Overall Study||577
8216547|NCT02085356|20262613|P4|STARTED|Overall Study||361
8216548|NCT02085356|20262614|P3|STARTED|Overall Study||681
8216549|NCT02085356|20262615|P2|STARTED|Overall Study||348
8216550|NCT02085356|20262616|P1|STARTED|Overall Study||577
8216551|NCT02085252|20262644|P2|NOT COMPLETED|Overall Study||4
8216552|NCT02085252|20262645|P1|NOT COMPLETED|Overall Study||1
8216553|NCT02085252|20262644|P2|COMPLETED|Overall Study||53
8216554|NCT02085252|20262645|P1|COMPLETED|Overall Study||57
8216555|NCT02085252|20262644|P2|STARTED|Overall Study||57
8216556|NCT02085252|20262645|P1|STARTED|Overall Study||58
8216557|NCT02085161|20262669|P4|NOT COMPLETED|Overall Study||10
8216558|NCT02085161|20262670|P3|NOT COMPLETED|Overall Study||5
8216559|NCT02085161|20262671|P2|NOT COMPLETED|Overall Study||10
8216560|NCT02085161|20262672|P1|NOT COMPLETED|Overall Study||12
8216561|NCT02085161|20262669|P4|COMPLETED|Overall Study||66
8216562|NCT02085161|20262670|P3|COMPLETED|Overall Study||71
8216563|NCT02085161|20262671|P2|COMPLETED|Overall Study||66
8216564|NCT02085161|20262672|P1|COMPLETED|Overall Study||64
8216565|NCT02085161|20262669|P4|STARTED|Overall Study||76
8216566|NCT02085161|20262670|P3|STARTED|Overall Study||76
8216567|NCT02085161|20262671|P2|STARTED|Overall Study||76
8216568|NCT02085161|20262672|P1|STARTED|Overall Study||76
8216569|NCT02085135|20262713|P2|NOT COMPLETED|Overall Study||9
8216570|NCT02085135|20262714|P1|NOT COMPLETED|Overall Study||11
8216571|NCT02085135|20262713|P2|COMPLETED|Overall Study||23
8216572|NCT02085135|20262714|P1|COMPLETED|Overall Study||23
8216573|NCT02085135|20262713|P2|STARTED|Overall Study||32
8216574|NCT02085135|20262714|P1|STARTED|Overall Study||34
8216575|NCT02084797|20262720|P1|NOT COMPLETED|Overall Study||0
8216576|NCT02084797|20262720|P1|COMPLETED|Overall Study||10
8216577|NCT02084797|20262720|P1|STARTED|Overall Study||10
8216578|NCT02084706|20262729|P2|NOT COMPLETED|Overall Study||0
8216579|NCT02084706|20262730|P1|NOT COMPLETED|Overall Study||0
8216580|NCT02084706|20262729|P2|COMPLETED|Overall Study||31
8216581|NCT02084706|20262730|P1|COMPLETED|Overall Study||29
8216582|NCT02084706|20262729|P2|STARTED|Overall Study||31
8216583|NCT02084706|20262730|P1|STARTED|Overall Study||29
8216584|NCT02084628|20262736|P1|NOT COMPLETED|Overall Study||0
8216585|NCT02084628|20262736|P1|COMPLETED|Overall Study||1
8216586|NCT02084628|20262736|P1|STARTED|Overall Study||1
8216587|NCT02084511|20262753|P4|NOT COMPLETED|Overall Study||0
8216588|NCT02084511|20262754|P3|NOT COMPLETED|Overall Study||0
8216589|NCT02084511|20262755|P2|NOT COMPLETED|Overall Study||0
8216590|NCT02084511|20262756|P1|NOT COMPLETED|Overall Study||0
8216591|NCT02084511|20262753|P4|COMPLETED|Overall Study||20
8216592|NCT02084511|20262754|P3|COMPLETED|Overall Study||20
8216593|NCT02084511|20262755|P2|COMPLETED|Overall Study||20
8216594|NCT02084511|20262756|P1|COMPLETED|Overall Study||20
8216595|NCT02084511|20262753|P4|STARTED|Overall Study||20
8216596|NCT02084511|20262754|P3|STARTED|Overall Study||20
8216597|NCT02084511|20262755|P2|STARTED|Overall Study||20
8216598|NCT02084511|20262756|P1|STARTED|Overall Study||20
8216599|NCT02084238|20262786|P1|NOT COMPLETED|Overall Study||2
8216600|NCT02084238|20262786|P1|COMPLETED|Overall Study||38
8216601|NCT02084238|20262786|P1|STARTED|Overall Study||40
8216602|NCT02084160|20262797|P1|NOT COMPLETED|Overall Study||0
8216603|NCT02084160|20262797|P1|COMPLETED|Overall Study||579
8216604|NCT02084160|20262797|P1|STARTED|Overall Study||579
8216605|NCT02084147|20262801|P1|NOT COMPLETED|Overall Study||0
8216606|NCT02084147|20262801|P1|COMPLETED|Overall Study||72
8216607|NCT02084147|20262801|P1|STARTED|Overall Study||72
8216608|NCT02084134|20262811|P2|NOT COMPLETED|Overall Study||3
8216609|NCT02084134|20262812|P1|NOT COMPLETED|Overall Study||4
8216610|NCT02084134|20262811|P2|COMPLETED|Overall Study||17
8216611|NCT02084134|20262812|P1|COMPLETED|Overall Study||19
8216612|NCT02084134|20262811|P2|STARTED|Overall Study||20
8216613|NCT02084134|20262812|P1|STARTED|Overall Study||23
8216614|NCT02084082|20262822|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216615|NCT02084082|20262823|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216616|NCT02084082|20262824|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216617|NCT02084082|20262825|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216618|NCT02084082|20262822|P4|COMPLETED|Treatment Period 2 (4 Days)||6
8216619|NCT02084082|20262823|P3|COMPLETED|Treatment Period 2 (4 Days)||7
8216620|NCT02084082|20262824|P2|COMPLETED|Treatment Period 2 (4 Days)||26
8216621|NCT02084082|20262825|P1|COMPLETED|Treatment Period 2 (4 Days)||26
8216622|NCT02084082|20262822|P4|STARTED|Treatment Period 2 (4 Days)||6
8216623|NCT02084082|20262823|P3|STARTED|Treatment Period 2 (4 Days)||7
8216624|NCT02084082|20262824|P2|STARTED|Treatment Period 2 (4 Days)||26
8216625|NCT02084082|20262825|P1|STARTED|Treatment Period 2 (4 Days)||26
8216626|NCT02084082|20262822|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
8216627|NCT02084082|20262823|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
8216628|NCT02084082|20262824|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216629|NCT02084082|20262825|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216630|NCT02084082|20262822|P4|COMPLETED|Washout Period 1 (35 Days)||6
8216631|NCT02084082|20262823|P3|COMPLETED|Washout Period 1 (35 Days)||7
8216632|NCT02084082|20262824|P2|COMPLETED|Washout Period 1 (35 Days)||26
8216633|NCT02084082|20262825|P1|COMPLETED|Washout Period 1 (35 Days)||26
8216634|NCT02084082|20262822|P4|STARTED|Washout Period 1 (35 Days)||8
8216635|NCT02084082|20262823|P3|STARTED|Washout Period 1 (35 Days)||8
8216636|NCT02084082|20262824|P2|STARTED|Washout Period 1 (35 Days)||26
8216637|NCT02084082|20262825|P1|STARTED|Washout Period 1 (35 Days)||26
8216638|NCT02084082|20262822|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216639|NCT02084082|20262823|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216640|NCT02084082|20262824|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216641|NCT02084082|20262825|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216642|NCT02084082|20262822|P4|COMPLETED|Treatment Period 1 (4 Days)||8
8216643|NCT02084082|20262823|P3|COMPLETED|Treatment Period 1 (4 Days)||8
8216644|NCT02084082|20262824|P2|COMPLETED|Treatment Period 1 (4 Days)||26
8216645|NCT02084082|20262825|P1|COMPLETED|Treatment Period 1 (4 Days)||26
8216646|NCT02084082|20262822|P4|STARTED|Treatment Period 1 (4 Days)||8
8216647|NCT02084082|20262823|P3|STARTED|Treatment Period 1 (4 Days)||8
8216648|NCT02084082|20262824|P2|STARTED|Treatment Period 1 (4 Days)||26
8216649|NCT02084082|20262825|P1|STARTED|Treatment Period 1 (4 Days)||26
8216650|NCT02084069|20262857|P2|NOT COMPLETED|Overall Study||0
8216651|NCT02084069|20262858|P1|NOT COMPLETED|Overall Study||0
8216652|NCT02084069|20262857|P2|COMPLETED|Overall Study||29
8216653|NCT02084069|20262858|P1|COMPLETED|Overall Study||29
8216654|NCT02084069|20262857|P2|STARTED|Overall Study||29
8216655|NCT02084069|20262858|P1|STARTED|Overall Study||29
8216656|NCT02084056|20262866|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216657|NCT02084056|20262867|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216658|NCT02084056|20262868|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216659|NCT02084056|20262869|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216660|NCT02084056|20262866|P4|COMPLETED|Treatment Period 2 (4 Days)||8
8216661|NCT02084056|20262867|P3|COMPLETED|Treatment Period 2 (4 Days)||8
8216662|NCT02084056|20262868|P2|COMPLETED|Treatment Period 2 (4 Days)||30
8216663|NCT02084056|20262869|P1|COMPLETED|Treatment Period 2 (4 Days)||26
8216664|NCT02084056|20262866|P4|STARTED|Treatment Period 2 (4 Days)||8
8216665|NCT02084056|20262867|P3|STARTED|Treatment Period 2 (4 Days)||8
8216666|NCT02084056|20262868|P2|STARTED|Treatment Period 2 (4 Days)||30
8216667|NCT02084056|20262869|P1|STARTED|Treatment Period 2 (4 Days)||26
8216668|NCT02084056|20262866|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216669|NCT02084056|20262867|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216670|NCT02084056|20262868|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216671|NCT02084056|20262869|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
8216672|NCT02084056|20262866|P4|COMPLETED|Washout Period 1 (35 Days)||8
8216673|NCT02084056|20262867|P3|COMPLETED|Washout Period 1 (35 Days)||8
8216674|NCT02084056|20262868|P2|COMPLETED|Washout Period 1 (35 Days)||30
8216675|NCT02084056|20262869|P1|COMPLETED|Washout Period 1 (35 Days)||26
8216676|NCT02084056|20262866|P4|STARTED|Washout Period 1 (35 Days)||8
8216677|NCT02084056|20262867|P3|STARTED|Washout Period 1 (35 Days)||8
8216678|NCT02084056|20262868|P2|STARTED|Washout Period 1 (35 Days)||30
8216679|NCT02084056|20262869|P1|STARTED|Washout Period 1 (35 Days)||27
8216680|NCT02084056|20262866|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216681|NCT02084056|20262867|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216682|NCT02084056|20262868|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216683|NCT02084056|20262869|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8216684|NCT02084056|20262866|P4|COMPLETED|Treatment Period 1 (4 Days)||8
8216685|NCT02084056|20262867|P3|COMPLETED|Treatment Period 1 (4 Days)||8
8216686|NCT02084056|20262868|P2|COMPLETED|Treatment Period 1 (4 Days)||30
8216687|NCT02084056|20262869|P1|COMPLETED|Treatment Period 1 (4 Days)||27
8216688|NCT02084056|20262866|P4|STARTED|Treatment Period 1 (4 Days)||8
8216689|NCT02084056|20262867|P3|STARTED|Treatment Period 1 (4 Days)||8
8216690|NCT02084056|20262868|P2|STARTED|Treatment Period 1 (4 Days)||30
8216691|NCT02084056|20262869|P1|STARTED|Treatment Period 1 (4 Days)||28
8216692|NCT02083965|20262901|P2|NOT COMPLETED|Treatment Period||0
8216693|NCT02083965|20262902|P1|NOT COMPLETED|Treatment Period||1
8216694|NCT02083965|20262901|P2|COMPLETED|Treatment Period||8
8216695|NCT02083965|20262902|P1|COMPLETED|Treatment Period||9
8216696|NCT02083965|20262901|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
8216697|NCT02083965|20262902|P1|STARTED|Treatment Period||10
8216698|NCT02083965|20262901|P2|NOT COMPLETED|PK Period 2||0
8216699|NCT02083965|20262902|P1|NOT COMPLETED|PK Period 2||0
8216700|NCT02083965|20262901|P2|COMPLETED|PK Period 2||9
8216701|NCT02083965|20262902|P1|COMPLETED|PK Period 2||10
8216702|NCT02083965|20262901|P2|STARTED|PK Period 2||9
8216703|NCT02083965|20262902|P1|STARTED|PK Period 2||10
8216704|NCT02083965|20262901|P2|NOT COMPLETED|Washout Period||0
8216705|NCT02083965|20262902|P1|NOT COMPLETED|Washout Period||0
8216706|NCT02083965|20262901|P2|COMPLETED|Washout Period||9
8216707|NCT02083965|20262902|P1|COMPLETED|Washout Period||10
8216708|NCT02083965|20262901|P2|STARTED|Washout Period||9
8216709|NCT02083965|20262902|P1|STARTED|Washout Period||10
8216710|NCT02083965|20262901|P2|NOT COMPLETED|PK Period 1||0
8216711|NCT02083965|20262902|P1|NOT COMPLETED|PK Period 1||0
8216712|NCT02083965|20262901|P2|COMPLETED|PK Period 1||9
8216713|NCT02083965|20262902|P1|COMPLETED|PK Period 1||10
8216714|NCT02083965|20262901|P2|STARTED|PK Period 1||9
8216715|NCT02083965|20262902|P1|STARTED|PK Period 1||10
8216716|NCT02083861|20262960|P2|NOT COMPLETED|Overall Study||3
8216717|NCT02083861|20262961|P1|NOT COMPLETED|Overall Study||6
8216718|NCT02083861|20262960|P2|COMPLETED|Overall Study||33
8216719|NCT02083861|20262961|P1|COMPLETED|Overall Study||51
8216720|NCT02083861|20262960|P2|Treated|Overall Study||35
8216721|NCT02083861|20262961|P1|Treated|Overall Study||55
8216722|NCT02083861|20262960|P2|STARTED|Overall Study||36
8216723|NCT02083861|20262961|P1|STARTED|Overall Study||57
8216724|NCT02083809|20262975|P2|NOT COMPLETED|Overall Study||2
8216725|NCT02083809|20262976|P1|NOT COMPLETED|Overall Study||4
8216726|NCT02083809|20262975|P2|COMPLETED|Overall Study||82
8216727|NCT02083809|20262976|P1|COMPLETED|Overall Study||78
8216728|NCT02083809|20262975|P2|STARTED|Overall Study||84
8216729|NCT02083809|20262976|P1|STARTED|Overall Study||82
8216730|NCT02083783|20262984|P2|NOT COMPLETED|Overall Study||0
8216731|NCT02083783|20262985|P1|NOT COMPLETED|Overall Study||1
8216732|NCT02083783|20262984|P2|COMPLETED|Overall Study||48
8216733|NCT02083783|20262985|P1|COMPLETED|Overall Study||51
8216734|NCT02083783|20262984|P2|STARTED|Overall Study||48
8216735|NCT02083783|20262985|P1|STARTED|Overall Study||52
8216736|NCT02083679|20262997|P4|NOT COMPLETED|Overall Study||0
8216737|NCT02083679|20262998|P3|NOT COMPLETED|Overall Study||0
8216738|NCT02083679|20262999|P2|NOT COMPLETED|Overall Study||0
8216739|NCT02083679|20263000|P1|NOT COMPLETED|Overall Study||0
8216740|NCT02083679|20262997|P4|COMPLETED|Overall Study||3
8216741|NCT02083679|20262998|P3|COMPLETED|Overall Study||3
8216742|NCT02083679|20262999|P2|COMPLETED|Overall Study||6
8216743|NCT02083679|20263000|P1|COMPLETED|Overall Study||3
8216744|NCT02083679|20262997|P4|STARTED|Overall Study||3
8216745|NCT02083679|20262998|P3|STARTED|Overall Study||3
8216746|NCT02083679|20262999|P2|STARTED|Overall Study||6
8216747|NCT02083679|20263000|P1|STARTED|Overall Study||3
8216748|NCT02083653|20263017|P3|NOT COMPLETED|Overall Study||84
8216749|NCT02083653|20263018|P2|NOT COMPLETED|Overall Study||85
8216750|NCT02083653|20263019|P1|NOT COMPLETED|Overall Study||82
8216751|NCT02083653|20263017|P3|COMPLETED|Overall Study||1
8216752|NCT02083653|20263018|P2|COMPLETED|Overall Study||1
8216753|NCT02083653|20263019|P1|COMPLETED|Overall Study||1
8216754|NCT02083653|20263017|P3|STARTED|Overall Study||85
8216755|NCT02083653|20263018|P2|STARTED|Overall Study||86
8216756|NCT02083653|20263019|P1|STARTED|Overall Study||83
8216757|NCT02083406|20263065|P3|NOT COMPLETED|Overall Study||0
8216758|NCT02083406|20263066|P2|NOT COMPLETED|Overall Study||0
8216759|NCT02083406|20263067|P1|NOT COMPLETED|Overall Study||0
8216760|NCT02083406|20263065|P3|COMPLETED|Overall Study||7
8216761|NCT02083406|20263066|P2|COMPLETED|Overall Study||8
8216762|NCT02083406|20263067|P1|COMPLETED|Overall Study||7
8216763|NCT02083406|20263065|P3|STARTED|Overall Study||7
8216764|NCT02083406|20263066|P2|STARTED|Overall Study||8
8216765|NCT02083406|20263067|P1|STARTED|Overall Study||7
8216766|NCT02083380|20263087|P3|NOT COMPLETED|Overall Study||84
8216767|NCT02083380|20263088|P2|NOT COMPLETED|Overall Study||95
8216768|NCT02083380|20263089|P1|NOT COMPLETED|Overall Study||91
8216769|NCT02083380|20263087|P3|COMPLETED|Overall Study||65
8216770|NCT02083380|20263088|P2|COMPLETED|Overall Study||56
8216771|NCT02083380|20263089|P1|COMPLETED|Overall Study||57
8216772|NCT02083380|20263087|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
8216773|NCT02083380|20263088|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
8216774|NCT02083380|20263089|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
8216775|NCT02083263|20263184|P2|NOT COMPLETED|Overall Study||0
8216776|NCT02083263|20263185|P1|NOT COMPLETED|Overall Study||0
8216777|NCT02083263|20263184|P2|COMPLETED|Overall Study||16
8216778|NCT02083263|20263185|P1|COMPLETED|Overall Study||16
8216779|NCT02083263|20263184|P2|STARTED|Overall Study||16
8216780|NCT02083263|20263185|P1|STARTED|Overall Study||16
8216781|NCT02083185|20263194|P3|NOT COMPLETED|Overall Study||7
8216782|NCT02083185|20263195|P2|NOT COMPLETED|Overall Study||29
8216783|NCT02083185|20263196|P1|NOT COMPLETED|Overall Study||20
8216784|NCT02083185|20263194|P3|COMPLETED|Overall Study||17
8216785|NCT02083185|20263195|P2|COMPLETED|Overall Study||27
8216786|NCT02083185|20263196|P1|COMPLETED|Overall Study||36
8216787|NCT02083185|20263194|P3|Safety Population|Overall Study||24
8216788|NCT02083185|20263195|P2|Safety Population|Overall Study||54
8216789|NCT02083185|20263196|P1|Safety Population|Overall Study||56
8216790|NCT02083185|20263194|P3|STARTED|Overall Study||24
8216791|NCT02083185|20263195|P2|STARTED|Overall Study||56
8216792|NCT02083185|20263196|P1|STARTED|Overall Study||56
8216793|NCT02083107|20263254|P3|NOT COMPLETED|Overall Study||0
8216794|NCT02083107|20263255|P2|NOT COMPLETED|Overall Study||0
8216795|NCT02083107|20263256|P1|NOT COMPLETED|Overall Study||0
8216796|NCT02083107|20263254|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
8216797|NCT02083107|20263255|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
8216798|NCT02083107|20263256|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
8216799|NCT02083107|20263254|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
8216800|NCT02083107|20263255|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
8216801|NCT02083107|20263256|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
8216802|NCT02082977|20263301|P10|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216803|NCT02082977|20263302|P9|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216804|NCT02082977|20263303|P8|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216805|NCT02082977|20263304|P7|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216806|NCT02082977|20263305|P6|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216807|NCT02082977|20263306|P5|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216808|NCT02082977|20263307|P4|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216809|NCT02082977|20263308|P3|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216810|NCT02082977|20263309|P2|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216811|NCT02082977|20263310|P1|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216812|NCT02082977|20263301|P10|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216813|NCT02082977|20263302|P9|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216814|NCT02082977|20263303|P8|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216815|NCT02082977|20263304|P7|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216816|NCT02082977|20263305|P6|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216817|NCT02082977|20263306|P5|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216818|NCT02082977|20263307|P4|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216819|NCT02082977|20263308|P3|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216820|NCT02082977|20263309|P2|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216821|NCT02082977|20263310|P1|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216822|NCT02082977|20263301|P10|STARTED|Part 2 (Up to 3.2 Years)||0
8216823|NCT02082977|20263302|P9|STARTED|Part 2 (Up to 3.2 Years)||0
8216824|NCT02082977|20263303|P8|STARTED|Part 2 (Up to 3.2 Years)||0
8216825|NCT02082977|20263304|P7|STARTED|Part 2 (Up to 3.2 Years)||0
8216826|NCT02082977|20263305|P6|STARTED|Part 2 (Up to 3.2 Years)||0
8216827|NCT02082977|20263306|P5|STARTED|Part 2 (Up to 3.2 Years)||0
8216828|NCT02082977|20263307|P4|STARTED|Part 2 (Up to 3.2 Years)||0
8216829|NCT02082977|20263308|P3|STARTED|Part 2 (Up to 3.2 Years)||0
8216830|NCT02082977|20263309|P2|STARTED|Part 2 (Up to 3.2 Years)||0
8216831|NCT02082977|20263310|P1|STARTED|Part 2 (Up to 3.2 Years)||0
8216832|NCT02082977|20263301|P10|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216833|NCT02082977|20263302|P9|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
8216834|NCT02082977|20263303|P8|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
8216835|NCT02082977|20263304|P7|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
8216836|NCT02082977|20263305|P6|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
8216837|NCT02082977|20263306|P5|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
8216838|NCT02082977|20263307|P4|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216839|NCT02082977|20263308|P3|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216840|NCT02082977|20263309|P2|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216841|NCT02082977|20263310|P1|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
8216842|NCT02082977|20263301|P10|COMPLETED|Part 1 (Up to 3.2 Years)||0
8216843|NCT02082977|20263302|P9|COMPLETED|Part 1 (Up to 3.2 Years)||4
8216844|NCT02082977|20263303|P8|COMPLETED|Part 1 (Up to 3.2 Years)||7
8216845|NCT02082977|20263304|P7|COMPLETED|Part 1 (Up to 3.2 Years)||4
8216846|NCT02082977|20263305|P6|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216847|NCT02082977|20263306|P5|COMPLETED|Part 1 (Up to 3.2 Years)||2
8216848|NCT02082977|20263307|P4|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216849|NCT02082977|20263308|P3|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216850|NCT02082977|20263309|P2|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216851|NCT02082977|20263310|P1|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216852|NCT02082977|20263301|P10|STARTED|Part 1 (Up to 3.2 Years)||0
8216853|NCT02082977|20263302|P9|STARTED|Part 1 (Up to 3.2 Years)||7
8216854|NCT02082977|20263303|P8|STARTED|Part 1 (Up to 3.2 Years)||12
8216855|NCT02082977|20263304|P7|STARTED|Part 1 (Up to 3.2 Years)||10
8216856|NCT02082977|20263305|P6|STARTED|Part 1 (Up to 3.2 Years)||4
8216857|NCT02082977|20263306|P5|STARTED|Part 1 (Up to 3.2 Years)||3
8216858|NCT02082977|20263307|P4|STARTED|Part 1 (Up to 3.2 Years)||1
8216859|NCT02082977|20263308|P3|STARTED|Part 1 (Up to 3.2 Years)||1
8216860|NCT02082977|20263309|P2|STARTED|Part 1 (Up to 3.2 Years)||1
8216861|NCT02082977|20263310|P1|STARTED|Part 1 (Up to 3.2 Years)||2
8216862|NCT02082912|20263564|P2|NOT COMPLETED|Overall Study||1
8216863|NCT02082912|20263565|P1|NOT COMPLETED|Overall Study||0
8216864|NCT02082912|20263564|P2|COMPLETED|Overall Study||6
8216865|NCT02082912|20263565|P1|COMPLETED|Overall Study||7
8216866|NCT02082912|20263564|P2|STARTED|Overall Study||7
8216867|NCT02082912|20263565|P1|STARTED|Overall Study||7
8216868|NCT02082769|20263582|P3|NOT COMPLETED|Overall Study||36
8216869|NCT02082769|20263583|P2|NOT COMPLETED|Overall Study||27
8216870|NCT02082769|20263584|P1|NOT COMPLETED|Overall Study||24
8216871|NCT02082769|20263582|P3|COMPLETED|Overall Study||132
8216872|NCT02082769|20263583|P2|COMPLETED|Overall Study||141
8216873|NCT02082769|20263584|P1|COMPLETED|Overall Study||144
8216874|NCT02082769|20263582|P3|STARTED|Overall Study||168
8216875|NCT02082769|20263583|P2|STARTED|Overall Study||168
8216876|NCT02082769|20263584|P1|STARTED|Overall Study||168
8216877|NCT02082678|20263600|P2|NOT COMPLETED|Overall Study||14
8216878|NCT02082678|20263601|P1|NOT COMPLETED|Overall Study||12
8216879|NCT02082678|20263600|P2|COMPLETED|Overall Study||21
8216880|NCT02082678|20263601|P1|COMPLETED|Overall Study||23
8216881|NCT02082678|20263600|P2|STARTED|Overall Study||35
8216882|NCT02082678|20263601|P1|STARTED|Overall Study||35
8216883|NCT02082522|20263613|P2|NOT COMPLETED|Overall Study||13
8216884|NCT02082522|20263614|P1|NOT COMPLETED|Overall Study||15
8216885|NCT02082522|20263613|P2|COMPLETED|Overall Study||0
8216886|NCT02082522|20263614|P1|COMPLETED|Overall Study||0
8216887|NCT02082522|20263613|P2|STARTED|Overall Study||13
8216888|NCT02082522|20263614|P1|STARTED|Overall Study||15
8216889|NCT02082483|20263664|P2|NOT COMPLETED|Overall Study||6
8216890|NCT02082483|20263665|P1|NOT COMPLETED|Overall Study||6
8216891|NCT02082483|20263664|P2|COMPLETED|Overall Study||67
8216892|NCT02082483|20263665|P1|COMPLETED|Overall Study||65
8216893|NCT02082483|20263664|P2|STARTED|Overall Study||73
8216894|NCT02082483|20263665|P1|STARTED|Overall Study||71
8216895|NCT02082392|20263682|P2|NOT COMPLETED|Overall Study||0
8216896|NCT02082392|20263683|P1|NOT COMPLETED|Overall Study||0
8216897|NCT02082392|20263682|P2|COMPLETED|Overall Study||1
8216898|NCT02082392|20263683|P1|COMPLETED|Overall Study||2
8216899|NCT02082392|20263682|P2|STARTED|Overall Study||1
8216900|NCT02082392|20263683|P1|STARTED|Overall Study||2
8216901|NCT02082340|20263717|P2|NOT COMPLETED|Overall Study||1
8216902|NCT02082340|20263718|P1|NOT COMPLETED|Overall Study||1
8216903|NCT02082340|20263717|P2|COMPLETED|Overall Study||197
8216904|NCT02082340|20263718|P1|COMPLETED|Overall Study||193
8216905|NCT02082340|20263717|P2|STARTED|Overall Study||198
8216906|NCT02082340|20263718|P1|STARTED|Overall Study||194
8216907|NCT02082288|20263724|P1|NOT COMPLETED|Overall Study||0
8216908|NCT02082288|20263724|P1|COMPLETED|Overall Study||243
8216909|NCT02082288|20263724|P1|STARTED|Overall Study||243
8216910|NCT02082262|20263728|P1|NOT COMPLETED|Overall Study||51
8216911|NCT02082262|20263728|P1|COMPLETED|Overall Study||89
8216912|NCT02082262|20263728|P1|STARTED|Overall Study||140
8216913|NCT02082210|20263738|P6|NOT COMPLETED|Overall Study||2
8216914|NCT02082210|20263739|P5|NOT COMPLETED|Overall Study||3
8216915|NCT02082210|20263740|P4|NOT COMPLETED|Overall Study||6
8216916|NCT02082210|20263741|P3|NOT COMPLETED|Overall Study||3
8216917|NCT02082210|20263742|P2|NOT COMPLETED|Overall Study||0
8216918|NCT02082210|20263743|P1|NOT COMPLETED|Overall Study||0
8216919|NCT02082210|20263738|P6|COMPLETED|Overall Study||13
8216920|NCT02082210|20263739|P5|COMPLETED|Overall Study||12
8216921|NCT02082210|20263740|P4|COMPLETED|Overall Study||39
8216922|NCT02082210|20263741|P3|COMPLETED|Overall Study||13
8216923|NCT02082210|20263742|P2|COMPLETED|Overall Study||3
8216924|NCT02082210|20263743|P1|COMPLETED|Overall Study||3
8216925|NCT02082210|20263738|P6|Received at Least One Dose of Study Drug|Overall Study||15
8216926|NCT02082210|20263739|P5|Received at Least One Dose of Study Drug|Overall Study||15
8216927|NCT02082210|20263740|P4|Received at Least One Dose of Study Drug|Overall Study||45
8216928|NCT02082210|20263741|P3|Received at Least One Dose of Study Drug|Overall Study||16
8216929|NCT02082210|20263742|P2|Received at Least One Dose of Study Drug|Overall Study||3
8216930|NCT02082210|20263743|P1|Received at Least One Dose of Study Drug|Overall Study||3
8216931|NCT02082210|20263738|P6|STARTED|Overall Study||15
8216932|NCT02082210|20263739|P5|STARTED|Overall Study||15
8216933|NCT02082210|20263740|P4|STARTED|Overall Study||45
8216934|NCT02082210|20263741|P3|STARTED|Overall Study||16
8216935|NCT02082210|20263742|P2|STARTED|Overall Study||3
8216936|NCT02082210|20263743|P1|STARTED|Overall Study||3
8216937|NCT02082184|20263791|P2|NOT COMPLETED|Overall Study||13
8216938|NCT02082184|20263792|P1|NOT COMPLETED|Overall Study||10
8216939|NCT02082184|20263791|P2|COMPLETED|Overall Study||62
8216940|NCT02082184|20263792|P1|COMPLETED|Overall Study||139
8216941|NCT02082184|20263791|P2|STARTED|Overall Study||75
8216942|NCT02082184|20263792|P1|STARTED|Overall Study||149
8216943|NCT02082158|20263817|P6|NOT COMPLETED|Overall Study||7
8216944|NCT02082158|20263818|P5|NOT COMPLETED|Overall Study||4
8216945|NCT02082158|20263819|P4|NOT COMPLETED|Overall Study||4
8216946|NCT02082158|20263820|P3|NOT COMPLETED|Overall Study||14
8216947|NCT02082158|20263821|P2|NOT COMPLETED|Overall Study||8
8216948|NCT02082158|20263822|P1|NOT COMPLETED|Overall Study||8
8216949|NCT02082158|20263817|P6|COMPLETED|Overall Study||56
8216950|NCT02082158|20263818|P5|COMPLETED|Overall Study||64
8216951|NCT02082158|20263819|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
8216952|NCT02082158|20263820|P3|COMPLETED|Overall Study||38
8216953|NCT02082158|20263821|P2|COMPLETED|Overall Study||53
8216954|NCT02082158|20263822|P1|COMPLETED|Overall Study||58
8216955|NCT02082158|20263817|P6|STARTED|Overall Study||63
8216956|NCT02082158|20263818|P5|STARTED|Overall Study||68
8216957|NCT02082158|20263819|P4|STARTED|Overall Study||72
8216958|NCT02082158|20263820|P3|STARTED|Overall Study||52
8216959|NCT02082158|20263821|P2|STARTED|Overall Study||61
8216960|NCT02082158|20263822|P1|STARTED|Overall Study||66
8216961|NCT02082145|20263844|P2|NOT COMPLETED|Overall Study||0
8216962|NCT02082145|20263845|P1|NOT COMPLETED|Overall Study||0
8216963|NCT02082145|20263844|P2|COMPLETED|Overall Study||9
8216964|NCT02082145|20263845|P1|COMPLETED|Overall Study||5
8216965|NCT02082145|20263844|P2|STARTED|Overall Study||9
8216966|NCT02082145|20263845|P1|STARTED|Overall Study||5
8216967|NCT02082119|20263857|P1|NOT COMPLETED|Overall Study||0
8216968|NCT02082119|20263857|P1|COMPLETED|Overall Study||82
8216969|NCT02082119|20263857|P1|STARTED|Overall Study||82
8216970|NCT02081963|20263863|P2|NOT COMPLETED|Overall Study||4
8216971|NCT02081963|20263864|P1|NOT COMPLETED|Overall Study||5
8216972|NCT02081963|20263863|P2|COMPLETED|Overall Study||69
8216973|NCT02081963|20263864|P1|COMPLETED|Overall Study||74
8216974|NCT02081963|20263863|P2|STARTED|Overall Study||73
8216975|NCT02081963|20263864|P1|STARTED|Overall Study||79
8216976|NCT02081950|20263878|P1|NOT COMPLETED|Treatment Period 2||0
8216977|NCT02081950|20263878|P1|COMPLETED|Treatment Period 2||14
8216978|NCT02081950|20263878|P1|STARTED|Treatment Period 2||14
8216979|NCT02081950|20263878|P1|NOT COMPLETED|Treatment Period 1||0
8216980|NCT02081950|20263878|P1|COMPLETED|Treatment Period 1||14
8216981|NCT02081950|20263878|P1|STARTED|Treatment Period 1||14
8216982|NCT02081859|20263952|P2|NOT COMPLETED|Overall Study||31
8216983|NCT02081859|20263953|P1|NOT COMPLETED|Overall Study||34
8216984|NCT02081859|20263952|P2|COMPLETED|Overall Study||119
8216985|NCT02081859|20263953|P1|COMPLETED|Overall Study||116
8216986|NCT02081859|20263952|P2|STARTED|Overall Study||150
8216987|NCT02081859|20263953|P1|STARTED|Overall Study||150
8216988|NCT02081846|20263963|P2|NOT COMPLETED|Overall Study||0
8216989|NCT02081846|20263964|P1|NOT COMPLETED|Overall Study||2
8216990|NCT02081846|20263963|P2|COMPLETED|Overall Study||749
8216991|NCT02081846|20263964|P1|COMPLETED|Overall Study||749
8216992|NCT02081846|20263963|P2|STARTED|Overall Study||749
8216993|NCT02081846|20263964|P1|STARTED|Overall Study||751
8216994|NCT02081807|20263990|P8|NOT COMPLETED|Overall Study||0
8216995|NCT02081807|20263991|P7|NOT COMPLETED|Overall Study||0
8216996|NCT02081807|20263992|P6|NOT COMPLETED|Overall Study||0
8216997|NCT02081807|20263993|P5|NOT COMPLETED|Overall Study||0
8216998|NCT02081807|20263994|P4|NOT COMPLETED|Overall Study||0
8216999|NCT02081807|20263995|P3|NOT COMPLETED|Overall Study||0
8217000|NCT02081807|20263996|P2|NOT COMPLETED|Overall Study||0
8217001|NCT02081807|20263997|P1|NOT COMPLETED|Overall Study||0
8217002|NCT02081807|20263990|P8|COMPLETED|Overall Study||19729
8217003|NCT02081807|20263991|P7|COMPLETED|Overall Study||40207
8217004|NCT02081807|20263992|P6|COMPLETED|Overall Study||76055
8217005|NCT02081807|20263993|P5|COMPLETED|Overall Study||27456
8217006|NCT02081807|20263994|P4|COMPLETED|Overall Study||9112
8217007|NCT02081807|20263995|P3|COMPLETED|Overall Study||14852
8217008|NCT02081807|20263996|P2|COMPLETED|Overall Study||26149
8217009|NCT02081807|20263997|P1|COMPLETED|Overall Study||7668
8217010|NCT02081807|20263990|P8|STARTED|Overall Study||19729
8217011|NCT02081807|20263991|P7|STARTED|Overall Study||40207
8217012|NCT02081807|20263992|P6|STARTED|Overall Study||76055
8217013|NCT02081807|20263993|P5|STARTED|Overall Study||27456
8217014|NCT02081807|20263994|P4|STARTED|Overall Study||9112
8217015|NCT02081807|20263995|P3|STARTED|Overall Study||14852
8217016|NCT02081807|20263996|P2|STARTED|Overall Study||26149
8217017|NCT02081807|20263997|P1|STARTED|Overall Study||7668
8217018|NCT02081690|20264133|P1|NOT COMPLETED|Overall Study||7
8217019|NCT02081690|20264133|P1|COMPLETED|Overall Study||81
8217020|NCT02081690|20264133|P1|STARTED|Overall Study||88
8217021|NCT02081677|20264144|P4|NOT COMPLETED|Overall Study||0
8217022|NCT02081677|20264145|P3|NOT COMPLETED|Overall Study||2
8217023|NCT02081677|20264146|P2|NOT COMPLETED|Overall Study||1
8217024|NCT02081677|20264147|P1|NOT COMPLETED|Overall Study||1
8217025|NCT02081677|20264144|P4|COMPLETED|Overall Study||19
8217026|NCT02081677|20264145|P3|COMPLETED|Overall Study||17
8217027|NCT02081677|20264146|P2|COMPLETED|Overall Study||18
8217028|NCT02081677|20264147|P1|COMPLETED|Overall Study||18
8217029|NCT02081677|20264144|P4|STARTED|Overall Study||19
8217030|NCT02081677|20264145|P3|STARTED|Overall Study||19
8217031|NCT02081677|20264146|P2|STARTED|Overall Study||19
8217032|NCT02081677|20264147|P1|STARTED|Overall Study||19
8217033|NCT02081638|20264239|P2|NOT COMPLETED|Overall Study||7
8217034|NCT02081638|20264240|P1|NOT COMPLETED|Overall Study||2
8217035|NCT02081638|20264239|P2|COMPLETED|Overall Study||20
8217036|NCT02081638|20264240|P1|COMPLETED|Overall Study||24
8217037|NCT02081638|20264239|P2|STARTED|Overall Study||27
8217038|NCT02081638|20264240|P1|STARTED|Overall Study||26
8217039|NCT02081599|20264252|P2|NOT COMPLETED|Period 2：Open-label Period||4
8217040|NCT02081599|20264253|P1|NOT COMPLETED|Period 2：Open-label Period||6
8217041|NCT02081599|20264252|P2|COMPLETED|Period 2：Open-label Period||71
8217042|NCT02081599|20264253|P1|COMPLETED|Period 2：Open-label Period||57
8217043|NCT02081599|20264252|P2|STARTED|Period 2：Open-label Period||75
8217044|NCT02081599|20264253|P1|STARTED|Period 2：Open-label Period||63
8217045|NCT02081599|20264252|P2|NOT COMPLETED|Period 1：Double-blind Period||2
8217046|NCT02081599|20264253|P1|NOT COMPLETED|Period 1：Double-blind Period||8
8217047|NCT02081599|20264252|P2|COMPLETED|Period 1：Double-blind Period||75
8217048|NCT02081599|20264253|P1|COMPLETED|Period 1：Double-blind Period||63
8217049|NCT02081599|20264252|P2|STARTED|Period 1：Double-blind Period||77
8217050|NCT02081599|20264253|P1|STARTED|Period 1：Double-blind Period||71
8217051|NCT02081586|20264271|P4|NOT COMPLETED|Overall Study||1
8217052|NCT02081586|20264272|P3|NOT COMPLETED|Overall Study||1
8217053|NCT02081586|20264273|P2|NOT COMPLETED|Overall Study||1
8217054|NCT02081586|20264274|P1|NOT COMPLETED|Overall Study||0
8217055|NCT02081586|20264271|P4|COMPLETED|Overall Study||2
8217056|NCT02081586|20264272|P3|COMPLETED|Overall Study||3
8217057|NCT02081586|20264273|P2|COMPLETED|Overall Study||2
8217058|NCT02081586|20264274|P1|COMPLETED|Overall Study||3
8217059|NCT02081586|20264271|P4|STARTED|Overall Study||3
8217060|NCT02081586|20264272|P3|STARTED|Overall Study||4
8217061|NCT02081586|20264273|P2|STARTED|Overall Study||3
8217062|NCT02081586|20264274|P1|STARTED|Overall Study||3
8217063|NCT02081573|20264301|P1|NOT COMPLETED|Overall Study||0
8217064|NCT02081573|20264301|P1|COMPLETED|Overall Study||10
8217065|NCT02081573|20264301|P1|STARTED|Overall Study||10
8217066|NCT02081534|20264317|P7|NOT COMPLETED|Overall Study||4
8217067|NCT02081534|20264318|P6|NOT COMPLETED|Overall Study||9
8217068|NCT02081534|20264319|P5|NOT COMPLETED|Overall Study||4
8217069|NCT02081534|20264320|P4|NOT COMPLETED|Overall Study||13
8217070|NCT02081534|20264321|P3|NOT COMPLETED|Overall Study||4
8217071|NCT02081534|20264322|P2|NOT COMPLETED|Overall Study||8
8217072|NCT02081534|20264323|P1|NOT COMPLETED|Overall Study||5
8217073|NCT02081534|20264317|P7|COMPLETED|Overall Study||22
8217074|NCT02081534|20264318|P6|COMPLETED|Overall Study||12
8217075|NCT02081534|20264319|P5|COMPLETED|Overall Study||18
8217076|NCT02081534|20264320|P4|COMPLETED|Overall Study||13
8217077|NCT02081534|20264321|P3|COMPLETED|Overall Study||19
8217078|NCT02081534|20264322|P2|COMPLETED|Overall Study||13
8217079|NCT02081534|20264323|P1|COMPLETED|Overall Study||18
8217080|NCT02081534|20264317|P7|STARTED|Overall Study||26
8217081|NCT02081534|20264318|P6|STARTED|Overall Study||21
8217082|NCT02081534|20264319|P5|STARTED|Overall Study||22
8217083|NCT02081534|20264320|P4|STARTED|Overall Study||26
8217084|NCT02081534|20264321|P3|STARTED|Overall Study||23
8217085|NCT02081534|20264322|P2|STARTED|Overall Study||21
8217086|NCT02081534|20264323|P1|STARTED|Overall Study||23
8217087|NCT02081456|20264348|P2|NOT COMPLETED|Overall Study||0
8217088|NCT02081456|20264349|P1|NOT COMPLETED|Overall Study||0
8217089|NCT02081456|20264348|P2|COMPLETED|Overall Study||12
8217090|NCT02081456|20264349|P1|COMPLETED|Overall Study||11
8217091|NCT02081456|20264348|P2|STARTED|Overall Study||12
8217092|NCT02081456|20264349|P1|STARTED|Overall Study||11
8217093|NCT02081443|20264363|P2|NOT COMPLETED|Overall Study||0
8217094|NCT02081443|20264364|P1|NOT COMPLETED|Overall Study||0
8217095|NCT02081443|20264363|P2|COMPLETED|Overall Study||30
8217096|NCT02081443|20264364|P1|COMPLETED|Overall Study||30
8217097|NCT02081443|20264363|P2|STARTED|Overall Study||30
8217098|NCT02081443|20264364|P1|STARTED|Overall Study||30
8217099|NCT02081417|20264376|P2|NOT COMPLETED|Overall Study||51
8217100|NCT02081417|20264377|P1|NOT COMPLETED|Overall Study||56
8217101|NCT02081417|20264376|P2|COMPLETED|Overall Study||115
8217102|NCT02081417|20264377|P1|COMPLETED|Overall Study||107
8217103|NCT02081417|20264376|P2|6-Month Follow-Up|Overall Study||92
8217104|NCT02081417|20264377|P1|6-Month Follow-Up|Overall Study||82
8217105|NCT02081417|20264376|P2|3-Month Follow-Up|Overall Study||95
8217106|NCT02081417|20264377|P1|3-Month Follow-Up|Overall Study||94
8217107|NCT02081417|20264376|P2|1st Interview Completed|Overall Study||145
8217108|NCT02081417|20264377|P1|1st Interview Completed|Overall Study||146
8217109|NCT02081417|20264376|P2|STARTED|Overall Study||166
8217110|NCT02081417|20264377|P1|STARTED|Overall Study|Randomized to intervention|163
8217111|NCT02081391|20264397|P4|NOT COMPLETED|24-hour Treatment and Trial Completion||0
8217112|NCT02081391|20264398|P3|NOT COMPLETED|24-hour Treatment and Trial Completion||1
8217113|NCT02081391|20264399|P2|NOT COMPLETED|24-hour Treatment and Trial Completion||18
8217114|NCT02081391|20264400|P1|NOT COMPLETED|24-hour Treatment and Trial Completion||27
8217115|NCT02081391|20264397|P4|COMPLETED|24-hour Treatment and Trial Completion||4
8217116|NCT02081391|20264398|P3|COMPLETED|24-hour Treatment and Trial Completion||9
8217117|NCT02081391|20264399|P2|COMPLETED|24-hour Treatment and Trial Completion||28
8217118|NCT02081391|20264400|P1|COMPLETED|24-hour Treatment and Trial Completion||63
8217119|NCT02081391|20264397|P4|STARTED|24-hour Treatment and Trial Completion||4
8217120|NCT02081391|20264398|P3|STARTED|24-hour Treatment and Trial Completion||10
8217121|NCT02081391|20264399|P2|STARTED|24-hour Treatment and Trial Completion||46
8217122|NCT02081391|20264400|P1|STARTED|24-hour Treatment and Trial Completion||90
8217123|NCT02081391|20264397|P4|NOT COMPLETED|12-hour Treatment||0
8217124|NCT02081391|20264398|P3|NOT COMPLETED|12-hour Treatment||1
8217125|NCT02081391|20264399|P2|NOT COMPLETED|12-hour Treatment||6
8217126|NCT02081391|20264400|P1|NOT COMPLETED|12-hour Treatment||18
8217127|NCT02081391|20264397|P4|COMPLETED|12-hour Treatment||4
8217128|NCT02081391|20264398|P3|COMPLETED|12-hour Treatment||10
8217129|NCT02081391|20264399|P2|COMPLETED|12-hour Treatment||46
8217130|NCT02081391|20264400|P1|COMPLETED|12-hour Treatment||90
8217131|NCT02081391|20264397|P4|STARTED|12-hour Treatment||4
8217132|NCT02081391|20264398|P3|STARTED|12-hour Treatment||11
8217133|NCT02081391|20264399|P2|STARTED|12-hour Treatment||52
8217134|NCT02081391|20264400|P1|STARTED|12-hour Treatment||108
8217135|NCT02081365|20264454|P2|NOT COMPLETED|Overall Study||23
8217136|NCT02081365|20264455|P1|NOT COMPLETED|Overall Study||30
8217137|NCT02081365|20264454|P2|COMPLETED|Overall Study||54
8217138|NCT02081365|20264455|P1|COMPLETED|Overall Study||44
8217139|NCT02081365|20264454|P2|Received Allocated Intervention|Overall Study||59
8217140|NCT02081365|20264455|P1|Received Allocated Intervention|Overall Study||46
8217141|NCT02081365|20264454|P2|STARTED|Overall Study||77
8217142|NCT02081365|20264455|P1|STARTED|Overall Study||74
8217143|NCT02081248|20264469|P2|NOT COMPLETED|Overall Study||13
8217144|NCT02081248|20264470|P1|NOT COMPLETED|Overall Study||22
8217145|NCT02081248|20264469|P2|COMPLETED|Overall Study||87
8217146|NCT02081248|20264470|P1|COMPLETED|Overall Study||76
8217147|NCT02081248|20264469|P2|STARTED|Overall Study||100
8217148|NCT02081248|20264470|P1|STARTED|Overall Study||98
8217149|NCT02081183|20264494|P2|NOT COMPLETED|Overall Study||4
8217150|NCT02081183|20264495|P1|NOT COMPLETED|Overall Study||4
8217151|NCT02081183|20264494|P2|COMPLETED|Overall Study||2
8217152|NCT02081183|20264495|P1|COMPLETED|Overall Study||1
8217153|NCT02081183|20264494|P2|STARTED|Overall Study||6
8217154|NCT02081183|20264495|P1|STARTED|Overall Study||5
8217155|NCT02081079|20264511|P2|NOT COMPLETED|Overall Study||2
8217156|NCT02081079|20264512|P1|NOT COMPLETED|Overall Study||4
8217157|NCT02081079|20264511|P2|COMPLETED|Overall Study||39
8217158|NCT02081079|20264512|P1|COMPLETED|Overall Study||40
8217159|NCT02081079|20264511|P2|STARTED|Overall Study||41
8217160|NCT02081079|20264512|P1|STARTED|Overall Study||44
8217161|NCT02081014|20264534|P6|NOT COMPLETED|Overall Study||0
8217162|NCT02081014|20264535|P5|NOT COMPLETED|Overall Study||0
8217163|NCT02081014|20264536|P4|NOT COMPLETED|Overall Study||0
8217164|NCT02081014|20264537|P3|NOT COMPLETED|Overall Study||0
8217165|NCT02081014|20264538|P2|NOT COMPLETED|Overall Study||0
8217166|NCT02081014|20264539|P1|NOT COMPLETED|Overall Study||0
8217167|NCT02081014|20264534|P6|COMPLETED|Overall Study||2
8217168|NCT02081014|20264535|P5|COMPLETED|Overall Study||2
8217169|NCT02081014|20264536|P4|COMPLETED|Overall Study||2
8217170|NCT02081014|20264537|P3|COMPLETED|Overall Study||2
8217171|NCT02081014|20264538|P2|COMPLETED|Overall Study||2
8217172|NCT02081014|20264539|P1|COMPLETED|Overall Study||2
8217173|NCT02081014|20264534|P6|STARTED|Overall Study||2
8217174|NCT02081014|20264535|P5|STARTED|Overall Study||2
8217175|NCT02081014|20264536|P4|STARTED|Overall Study||2
8217176|NCT02081014|20264537|P3|STARTED|Overall Study||2
8217177|NCT02081014|20264538|P2|STARTED|Overall Study||2
8217178|NCT02081014|20264539|P1|STARTED|Overall Study||2
8217179|NCT02081001|20264585|P12|NOT COMPLETED|Overall Study||0
8217180|NCT02081001|20264586|P11|NOT COMPLETED|Overall Study||0
8217181|NCT02081001|20264587|P10|NOT COMPLETED|Overall Study||0
8217182|NCT02081001|20264588|P9|NOT COMPLETED|Overall Study||0
8217183|NCT02081001|20264589|P8|NOT COMPLETED|Overall Study||0
8217184|NCT02081001|20264590|P7|NOT COMPLETED|Overall Study||0
8217185|NCT02081001|20264591|P6|NOT COMPLETED|Overall Study||0
8217186|NCT02081001|20264592|P5|NOT COMPLETED|Overall Study||1
8217187|NCT02081001|20264593|P4|NOT COMPLETED|Overall Study||0
8217188|NCT02081001|20264594|P3|NOT COMPLETED|Overall Study||0
8217189|NCT02081001|20264595|P2|NOT COMPLETED|Overall Study||0
8217190|NCT02081001|20264596|P1|NOT COMPLETED|Overall Study||0
8217191|NCT02081001|20264585|P12|COMPLETED|Overall Study||1
8217192|NCT02081001|20264586|P11|COMPLETED|Overall Study||2
8217193|NCT02081001|20264587|P10|COMPLETED|Overall Study||1
8217194|NCT02081001|20264588|P9|COMPLETED|Overall Study||2
8217195|NCT02081001|20264589|P8|COMPLETED|Overall Study||1
8217196|NCT02081001|20264590|P7|COMPLETED|Overall Study||2
8217197|NCT02081001|20264591|P6|COMPLETED|Overall Study||1
8217198|NCT02081001|20264592|P5|COMPLETED|Overall Study||2
8217199|NCT02081001|20264593|P4|COMPLETED|Overall Study||1
8217200|NCT02081001|20264594|P3|COMPLETED|Overall Study||2
8217201|NCT02081001|20264595|P2|COMPLETED|Overall Study||1
8217202|NCT02081001|20264596|P1|COMPLETED|Overall Study||2
8217203|NCT02081001|20264585|P12|STARTED|Overall Study||1
8217204|NCT02081001|20264586|P11|STARTED|Overall Study||2
8217205|NCT02081001|20264587|P10|STARTED|Overall Study||1
8217206|NCT02081001|20264588|P9|STARTED|Overall Study||2
8217207|NCT02081001|20264589|P8|STARTED|Overall Study||1
8217208|NCT02081001|20264590|P7|STARTED|Overall Study||2
8217209|NCT02081001|20264591|P6|STARTED|Overall Study||1
8217210|NCT02081001|20264592|P5|STARTED|Overall Study||3
8217211|NCT02081001|20264593|P4|STARTED|Overall Study||1
8217212|NCT02081001|20264594|P3|STARTED|Overall Study||2
8217213|NCT02081001|20264595|P2|STARTED|Overall Study||1
8217214|NCT02081001|20264596|P1|STARTED|Overall Study||2
8217215|NCT02080871|20264660|P1|NOT COMPLETED|Overall Study||2
8217216|NCT02080871|20264660|P1|COMPLETED|Overall Study||132
8217217|NCT02080871|20264660|P1|STARTED|Overall Study||134
8217218|NCT02080832|20264744|P3|NOT COMPLETED|Overall Study||16
8217219|NCT02080832|20264745|P2|NOT COMPLETED|Overall Study||12
8217220|NCT02080832|20264746|P1|NOT COMPLETED|Overall Study||9
8217221|NCT02080832|20264744|P3|COMPLETED|Overall Study||6
8217222|NCT02080832|20264745|P2|COMPLETED|Overall Study||5
8217223|NCT02080832|20264746|P1|COMPLETED|Overall Study||6
8217224|NCT02080832|20264744|P3|STARTED|Overall Study||22
8217225|NCT02080832|20264745|P2|STARTED|Overall Study||17
8217226|NCT02080832|20264746|P1|STARTED|Overall Study||15
8217227|NCT02080819|20264763|P3|NOT COMPLETED|Overall Study||22
8217228|NCT02080819|20264764|P2|NOT COMPLETED|Overall Study||26
8217229|NCT02080819|20264765|P1|NOT COMPLETED|Overall Study||25
8217230|NCT02080819|20264763|P3|COMPLETED|Overall Study||11
8217231|NCT02080819|20264764|P2|COMPLETED|Overall Study||9
8217232|NCT02080819|20264765|P1|COMPLETED|Overall Study||38
8217233|NCT02080819|20264763|P3|STARTED|Overall Study||33
8217234|NCT02080819|20264764|P2|STARTED|Overall Study||35
8217235|NCT02080819|20264765|P1|STARTED|Overall Study||63
8217236|NCT02080780|20264773|P1|NOT COMPLETED|Overall Study||0
8217237|NCT02080780|20264773|P1|COMPLETED|Overall Study||24
8217238|NCT02080780|20264773|P1|STARTED|Overall Study||24
8217239|NCT02080637|20264782|P2|NOT COMPLETED|Overall Study||0
8217240|NCT02080637|20264783|P1|NOT COMPLETED|Overall Study||0
8217241|NCT02080637|20264782|P2|COMPLETED|Overall Study||3
8217242|NCT02080637|20264783|P1|COMPLETED|Overall Study||13
8217243|NCT02080637|20264782|P2|STARTED|Overall Study||3
8217244|NCT02080637|20264783|P1|STARTED|Overall Study||13
8217245|NCT02080546|20264796|P2|NOT COMPLETED|Overall Study||11
8217246|NCT02080546|20264797|P1|NOT COMPLETED|Overall Study||8
8217247|NCT02080546|20264796|P2|COMPLETED|Overall Study||52
8217248|NCT02080546|20264797|P1|COMPLETED|Overall Study||49
8217249|NCT02080546|20264796|P2|STARTED|Overall Study||63
8217250|NCT02080546|20264797|P1|STARTED|Overall Study||57
8217251|NCT02080507|20264807|P2|NOT COMPLETED|Overall Study||0
8217252|NCT02080507|20264808|P1|NOT COMPLETED|Overall Study||0
8217253|NCT02080507|20264807|P2|COMPLETED|Overall Study||7
8217254|NCT02080507|20264808|P1|COMPLETED|Overall Study||5
8217255|NCT02080507|20264807|P2|STARTED|Overall Study||7
8217256|NCT02080507|20264808|P1|STARTED|Overall Study||5
8217257|NCT02080481|20264818|P2|NOT COMPLETED|Overall Study||0
8217258|NCT02080481|20264819|P1|NOT COMPLETED|Overall Study||1
8217259|NCT02080481|20264818|P2|COMPLETED|Overall Study||67
8217260|NCT02080481|20264819|P1|COMPLETED|Overall Study||67
8217261|NCT02080481|20264818|P2|STARTED|Overall Study||67
8217262|NCT02080481|20264819|P1|STARTED|Overall Study||68
8217263|NCT02080468|20264833|P2|NOT COMPLETED|Overall Study||2
8217264|NCT02080468|20264834|P1|NOT COMPLETED|Overall Study||2
8217265|NCT02080468|20264833|P2|COMPLETED|Overall Study||14
8217266|NCT02080468|20264834|P1|COMPLETED|Overall Study||14
8217267|NCT02080468|20264833|P2|STARTED|Overall Study||16
8217268|NCT02080468|20264834|P1|STARTED|Overall Study||16
8217269|NCT02080455|20264900|P2|NOT COMPLETED|Overall Study||0
8217270|NCT02080455|20264901|P1|NOT COMPLETED|Overall Study||0
8217271|NCT02080455|20264900|P2|COMPLETED|Overall Study||16
8217272|NCT02080455|20264901|P1|COMPLETED|Overall Study||16
8217273|NCT02080455|20264900|P2|STARTED|Overall Study||16
8217274|NCT02080455|20264901|P1|STARTED|Overall Study||16
8217275|NCT02080312|20264965|P1|NOT COMPLETED|Overall Study||0
8217276|NCT02080312|20264965|P1|COMPLETED|Overall Study||6
8217277|NCT02080312|20264965|P1|STARTED|Overall Study||6
8217278|NCT02080273|20264974|P3|NOT COMPLETED|Overall Study||0
8217279|NCT02080273|20264975|P2|NOT COMPLETED|Overall Study||0
8217280|NCT02080273|20264976|P1|NOT COMPLETED|Overall Study||0
8217281|NCT02080273|20264974|P3|COMPLETED|Overall Study||45
8217282|NCT02080273|20264975|P2|COMPLETED|Overall Study||45
8217283|NCT02080273|20264976|P1|COMPLETED|Overall Study||45
8217284|NCT02080273|20264974|P3|STARTED|Overall Study||45
8217285|NCT02080273|20264975|P2|STARTED|Overall Study||45
8217286|NCT02080273|20264976|P1|STARTED|Overall Study||45
8217287|NCT02080260|20265005|P1|NOT COMPLETED|Overall Study||19
8217380|NCT02079636|20265209|P1|NOT COMPLETED|Overall Study||3
8217288|NCT02080260|20265005|P1|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
8217289|NCT02080260|20265005|P1|STARTED|Overall Study||20
8217290|NCT02080195|20265013|P1|NOT COMPLETED|Overall Study||0
8217291|NCT02080195|20265013|P1|COMPLETED|Overall Study||1
8217292|NCT02080195|20265013|P1|STARTED|Overall Study||1
8217293|NCT02080091|20265022|P1|NOT COMPLETED|Overall Study||25
8217294|NCT02080091|20265022|P1|COMPLETED|Overall Study||0
8217295|NCT02080091|20265022|P1|STARTED|Overall Study||25
8217296|NCT02079987|20265030|P2|NOT COMPLETED|Overall Study||0
8217297|NCT02079987|20265031|P1|NOT COMPLETED|Overall Study||0
8217298|NCT02079987|20265030|P2|COMPLETED|Overall Study||544
8217299|NCT02079987|20265031|P1|COMPLETED|Overall Study||557
8217300|NCT02079987|20265030|P2|STARTED|Overall Study||544
8217301|NCT02079987|20265031|P1|STARTED|Overall Study||557
8217302|NCT02079909|20265050|P3|NOT COMPLETED|Overall Study||18
8217303|NCT02079909|20265051|P2|NOT COMPLETED|Overall Study||49
8217304|NCT02079909|20265052|P1|NOT COMPLETED|Overall Study||38
8217305|NCT02079909|20265050|P3|COMPLETED|Overall Study||140
8217306|NCT02079909|20265051|P2|COMPLETED|Overall Study||117
8217307|NCT02079909|20265052|P1|COMPLETED|Overall Study||120
8217308|NCT02079909|20265050|P3|STARTED|Overall Study||158
8217309|NCT02079909|20265051|P2|STARTED|Overall Study||166
8217310|NCT02079909|20265052|P1|STARTED|Overall Study||158
8217311|NCT02079844|20265069|P3|NOT COMPLETED|Treatment Period 3||0
8217312|NCT02079844|20265070|P2|NOT COMPLETED|Treatment Period 3||0
8217313|NCT02079844|20265071|P1|NOT COMPLETED|Treatment Period 3||0
8217314|NCT02079844|20265069|P3|COMPLETED|Treatment Period 3||5
8217315|NCT02079844|20265070|P2|COMPLETED|Treatment Period 3||5
8217316|NCT02079844|20265071|P1|COMPLETED|Treatment Period 3||5
8217317|NCT02079844|20265069|P3|STARTED|Treatment Period 3||5
8217318|NCT02079844|20265070|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
8217319|NCT02079844|20265071|P1|STARTED|Treatment Period 3||5
8217320|NCT02079844|20265069|P3|NOT COMPLETED|Treatment Period 2||0
8217321|NCT02079844|20265070|P2|NOT COMPLETED|Treatment Period 2||1
8217322|NCT02079844|20265071|P1|NOT COMPLETED|Treatment Period 2||0
8217323|NCT02079844|20265069|P3|COMPLETED|Treatment Period 2||5
8217324|NCT02079844|20265070|P2|COMPLETED|Treatment Period 2||6
8217325|NCT02079844|20265071|P1|COMPLETED|Treatment Period 2||5
8217326|NCT02079844|20265069|P3|STARTED|Treatment Period 2||5
8217327|NCT02079844|20265070|P2|STARTED|Treatment Period 2||7
8217328|NCT02079844|20265071|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
8217329|NCT02079844|20265069|P3|NOT COMPLETED|Treatment Period 1||2
8217330|NCT02079844|20265070|P2|NOT COMPLETED|Treatment Period 1||0
8217331|NCT02079844|20265071|P1|NOT COMPLETED|Treatment Period 1||0
8217332|NCT02079844|20265069|P3|COMPLETED|Treatment Period 1||5
8217333|NCT02079844|20265070|P2|COMPLETED|Treatment Period 1||7
8217334|NCT02079844|20265071|P1|COMPLETED|Treatment Period 1||6
8217335|NCT02079844|20265069|P3|STARTED|Treatment Period 1||7
8217336|NCT02079844|20265070|P2|STARTED|Treatment Period 1||7
8217337|NCT02079844|20265071|P1|STARTED|Treatment Period 1||6
8217338|NCT02079805|20265129|P2|NOT COMPLETED|Overall Study||2
8217339|NCT02079805|20265130|P1|NOT COMPLETED|Overall Study||0
8217340|NCT02079805|20265129|P2|COMPLETED|Overall Study||15
8217341|NCT02079805|20265130|P1|COMPLETED|Overall Study||16
8217342|NCT02079805|20265129|P2|STARTED|Overall Study||17
8217343|NCT02079805|20265130|P1|STARTED|Overall Study||16
8217344|NCT02079766|20265150|P2|NOT COMPLETED|Overall Study||0
8217345|NCT02079766|20265151|P1|NOT COMPLETED|Overall Study||2
8217346|NCT02079766|20265150|P2|COMPLETED|Overall Study||11
8217347|NCT02079766|20265151|P1|COMPLETED|Overall Study||28
8217348|NCT02079766|20265150|P2|STARTED|Overall Study||11
8217349|NCT02079766|20265151|P1|STARTED|Overall Study||30
8217350|NCT02079649|20265162|P4|NOT COMPLETED|Overall Study||2
8217351|NCT02079649|20265163|P3|NOT COMPLETED|Overall Study||1
8217352|NCT02079649|20265164|P2|NOT COMPLETED|Overall Study||0
8217353|NCT02079649|20265165|P1|NOT COMPLETED|Overall Study||1
8217354|NCT02079649|20265162|P4|COMPLETED|Overall Study||38
8217355|NCT02079649|20265163|P3|COMPLETED|Overall Study||40
8217356|NCT02079649|20265164|P2|COMPLETED|Overall Study||41
8217357|NCT02079649|20265165|P1|COMPLETED|Overall Study||41
8217358|NCT02079649|20265162|P4|Treated|Overall Study||40
8217359|NCT02079649|20265163|P3|Treated|Overall Study||40
8217360|NCT02079649|20265164|P2|Treated|Overall Study||41
8217361|NCT02079649|20265165|P1|Treated|Overall Study||41
8217362|NCT02079649|20265162|P4|STARTED|Overall Study||40
8217363|NCT02079649|20265163|P3|STARTED|Overall Study||41
8217364|NCT02079649|20265164|P2|STARTED|Overall Study||41
8217365|NCT02079649|20265165|P1|STARTED|Overall Study||42
8217366|NCT02079636|20265195|P15|NOT COMPLETED|Overall Study||5
8217367|NCT02079636|20265196|P14|NOT COMPLETED|Overall Study||0
8217368|NCT02079636|20265197|P13|NOT COMPLETED|Overall Study||3
8217369|NCT02079636|20265198|P12|NOT COMPLETED|Overall Study||2
8217370|NCT02079636|20265199|P11|NOT COMPLETED|Overall Study||2
8217371|NCT02079636|20265200|P10|NOT COMPLETED|Overall Study||3
8217372|NCT02079636|20265201|P9|NOT COMPLETED|Overall Study||0
8217373|NCT02079636|20265202|P8|NOT COMPLETED|Overall Study||1
8217374|NCT02079636|20265203|P7|NOT COMPLETED|Overall Study||1
8217375|NCT02079636|20265204|P6|NOT COMPLETED|Overall Study||6
8217376|NCT02079636|20265205|P5|NOT COMPLETED|Overall Study||2
8217377|NCT02079636|20265206|P4|NOT COMPLETED|Overall Study||12
8217378|NCT02079636|20265207|P3|NOT COMPLETED|Overall Study||0
8217379|NCT02079636|20265208|P2|NOT COMPLETED|Overall Study||2
8217381|NCT02079636|20265195|P15|COMPLETED|Overall Study||12
8217382|NCT02079636|20265196|P14|COMPLETED|Overall Study||3
8217383|NCT02079636|20265197|P13|COMPLETED|Overall Study||5
8217384|NCT02079636|20265198|P12|COMPLETED|Overall Study||4
8217385|NCT02079636|20265199|P11|COMPLETED|Overall Study||8
8217386|NCT02079636|20265200|P10|COMPLETED|Overall Study||6
8217387|NCT02079636|20265201|P9|COMPLETED|Overall Study||3
8217388|NCT02079636|20265202|P8|COMPLETED|Overall Study||3
8217389|NCT02079636|20265203|P7|COMPLETED|Overall Study||11
8217390|NCT02079636|20265204|P6|COMPLETED|Overall Study||13
8217391|NCT02079636|20265205|P5|COMPLETED|Overall Study||2
8217392|NCT02079636|20265206|P4|COMPLETED|Overall Study||9
8217393|NCT02079636|20265207|P3|COMPLETED|Overall Study||3
8217394|NCT02079636|20265208|P2|COMPLETED|Overall Study||13
8217395|NCT02079636|20265209|P1|COMPLETED|Overall Study||5
8217396|NCT02079636|20265195|P15|Received at Least One Dose of Study Drug|Overall Study||17
8217397|NCT02079636|20265196|P14|Received at Least One Dose of Study Drug|Overall Study||3
8217398|NCT02079636|20265197|P13|Received at Least One Dose of Study Drug|Overall Study||8
8217399|NCT02079636|20265198|P12|Received at Least One Dose of Study Drug|Overall Study||6
8217400|NCT02079636|20265199|P11|Received at Least One Dose of Study Drug|Overall Study||10
8217401|NCT02079636|20265200|P10|Received at Least One Dose of Study Drug|Overall Study||9
8217402|NCT02079636|20265201|P9|Received at Least One Dose of Study Drug|Overall Study||3
8217403|NCT02079636|20265202|P8|Received at Least One Dose of Study Drug|Overall Study||4
8217404|NCT02079636|20265203|P7|Received at Least One Dose of Study Drug|Overall Study||12
8217405|NCT02079636|20265204|P6|Received at Least One Dose of Study Drug|Overall Study||19
8217406|NCT02079636|20265205|P5|Received at Least One Dose of Study Drug|Overall Study||4
8217407|NCT02079636|20265206|P4|Received at Least One Dose of Study Drug|Overall Study||21
8217408|NCT02079636|20265207|P3|Received at Least One Dose of Study Drug|Overall Study||3
8217409|NCT02079636|20265208|P2|Received at Least One Dose of Study Drug|Overall Study||15
8217410|NCT02079636|20265209|P1|Received at Least One Dose of Study Drug|Overall Study||8
8217411|NCT02079636|20265195|P15|STARTED|Overall Study||17
8217412|NCT02079636|20265196|P14|STARTED|Overall Study||3
8217413|NCT02079636|20265197|P13|STARTED|Overall Study||8
8217414|NCT02079636|20265198|P12|STARTED|Overall Study||6
8217415|NCT02079636|20265199|P11|STARTED|Overall Study||10
8217416|NCT02079636|20265200|P10|STARTED|Overall Study||9
8217417|NCT02079636|20265201|P9|STARTED|Overall Study||3
8217418|NCT02079636|20265202|P8|STARTED|Overall Study||4
8217419|NCT02079636|20265203|P7|STARTED|Overall Study||12
8217420|NCT02079636|20265204|P6|STARTED|Overall Study||19
8217421|NCT02079636|20265205|P5|STARTED|Overall Study||4
8217422|NCT02079636|20265206|P4|STARTED|Overall Study||21
8217423|NCT02079636|20265207|P3|STARTED|Overall Study||3
8217424|NCT02079636|20265208|P2|STARTED|Overall Study||15
8217425|NCT02079636|20265209|P1|STARTED|Overall Study||8
8217426|NCT02079610|20265320|P2|NOT COMPLETED|Overall Study||1
8217427|NCT02079610|20265321|P1|NOT COMPLETED|Overall Study||1
8217428|NCT02079610|20265320|P2|COMPLETED|Overall Study||16
8217429|NCT02079610|20265321|P1|COMPLETED|Overall Study||18
8217430|NCT02079610|20265320|P2|STARTED|Overall Study||17
8217431|NCT02079610|20265321|P1|STARTED|Overall Study||19
8217432|NCT02079532|20265331|P1|NOT COMPLETED|Overall Study||29
8217433|NCT02079532|20265331|P1|COMPLETED|Overall Study||273
8217434|NCT02079532|20265331|P1|STARTED|Overall Study||302
8217435|NCT02079519|20265353|P1|NOT COMPLETED|Overall Study||10
8217436|NCT02079519|20265353|P1|COMPLETED|Overall Study||0
8217437|NCT02079519|20265353|P1|STARTED|Overall Study||10
8217438|NCT02079311|20265359|P2|NOT COMPLETED|Overall Study||1
8217439|NCT02079311|20265360|P1|NOT COMPLETED|Overall Study||0
8217440|NCT02079311|20265359|P2|COMPLETED|Overall Study||26
8217441|NCT02079311|20265360|P1|COMPLETED|Overall Study||28
8217442|NCT02079311|20265359|P2|STARTED|Overall Study||27
8217443|NCT02079311|20265360|P1|STARTED|Overall Study||28
8217444|NCT02079246|20265366|P2|NOT COMPLETED|OLEX-MEM||19
8217445|NCT02079246|20265367|P1|NOT COMPLETED|OLEX-MEM||0
8217446|NCT02079246|20265366|P2|COMPLETED|OLEX-MEM||82
8217447|NCT02079246|20265367|P1|COMPLETED|OLEX-MEM||0
8217448|NCT02079246|20265366|P2|STARTED|OLEX-MEM||101
8217449|NCT02079246|20265367|P1|STARTED|OLEX-MEM||0
8217450|NCT02079246|20265366|P2|NOT COMPLETED|OLEX||0
8217451|NCT02079246|20265367|P1|NOT COMPLETED|OLEX||228
8217452|NCT02079246|20265366|P2|COMPLETED|OLEX||0
8217453|NCT02079246|20265367|P1|COMPLETED|OLEX||1235
8217454|NCT02079246|20265366|P2|STARTED|OLEX||0
8217455|NCT02079246|20265367|P1|STARTED|OLEX||1463
8217456|NCT02079077|20265386|P2|NOT COMPLETED|Overall Study||9
8217457|NCT02079077|20265387|P1|NOT COMPLETED|Overall Study||6
8217458|NCT02079077|20265386|P2|COMPLETED|Overall Study||39
8217459|NCT02079077|20265387|P1|COMPLETED|Overall Study||37
8217460|NCT02079077|20265386|P2|STARTED|Overall Study||48
8217461|NCT02079077|20265387|P1|STARTED|Overall Study||43
8217462|NCT02079038|20265397|P2|NOT COMPLETED|Completed 6 Months||1
8217463|NCT02079038|20265398|P1|NOT COMPLETED|Completed 6 Months||2
8217464|NCT02079038|20265397|P2|COMPLETED|Completed 6 Months||50
8217465|NCT02079038|20265398|P1|COMPLETED|Completed 6 Months||103
8217466|NCT02079038|20265397|P2|STARTED|Completed 6 Months||51
8217467|NCT02079038|20265398|P1|STARTED|Completed 6 Months||105
8217468|NCT02079038|20265397|P2|NOT COMPLETED|Modified Intent to Treat Population||5
8217469|NCT02079038|20265398|P1|NOT COMPLETED|Modified Intent to Treat Population||7
8217470|NCT02079038|20265397|P2|COMPLETED|Modified Intent to Treat Population||51
8217566|NCT02078219|20265853|P2|COMPLETED|Overall Study||36
8217471|NCT02079038|20265398|P1|COMPLETED|Modified Intent to Treat Population||105
8217472|NCT02079038|20265397|P2|STARTED|Modified Intent to Treat Population||56
8217473|NCT02079038|20265398|P1|STARTED|Modified Intent to Treat Population||112
8217474|NCT02079025|20265406|P2|NOT COMPLETED|Overall Study||0
8217475|NCT02079025|20265407|P1|NOT COMPLETED|Overall Study||0
8217476|NCT02079025|20265406|P2|COMPLETED|Overall Study||837
8217477|NCT02079025|20265407|P1|COMPLETED|Overall Study||839
8217478|NCT02079025|20265406|P2|STARTED|Overall Study||837
8217479|NCT02079025|20265407|P1|STARTED|Overall Study||839
8217480|NCT02078960|20265419|P3|NOT COMPLETED|Follow-up Period||0
8217481|NCT02078960|20265420|P2|NOT COMPLETED|Follow-up Period||1
8217482|NCT02078960|20265421|P1|NOT COMPLETED|Follow-up Period||2
8217483|NCT02078960|20265419|P3|COMPLETED|Follow-up Period||1
8217484|NCT02078960|20265420|P2|COMPLETED|Follow-up Period||1
8217485|NCT02078960|20265421|P1|COMPLETED|Follow-up Period||0
8217486|NCT02078960|20265419|P3|STARTED|Follow-up Period||1
8217487|NCT02078960|20265420|P2|STARTED|Follow-up Period||2
8217488|NCT02078960|20265421|P1|STARTED|Follow-up Period||2
8217489|NCT02078960|20265419|P3|NOT COMPLETED|Treatment Period||3
8217490|NCT02078960|20265420|P2|NOT COMPLETED|Treatment Period||3
8217491|NCT02078960|20265421|P1|NOT COMPLETED|Treatment Period||2
8217492|NCT02078960|20265419|P3|COMPLETED|Treatment Period||1
8217493|NCT02078960|20265420|P2|COMPLETED|Treatment Period||1
8217494|NCT02078960|20265421|P1|COMPLETED|Treatment Period||0
8217495|NCT02078960|20265419|P3|STARTED|Treatment Period||4
8217496|NCT02078960|20265420|P2|STARTED|Treatment Period||4
8217497|NCT02078960|20265421|P1|STARTED|Treatment Period||2
8217498|NCT02078882|20265443|P1|NOT COMPLETED|Overall Study||0
8217499|NCT02078882|20265443|P1|COMPLETED|Overall Study||16
8217500|NCT02078882|20265443|P1|STARTED|Overall Study||16
8217501|NCT02078817|20265455|P1|NOT COMPLETED|Overall Study||1
8217502|NCT02078817|20265455|P1|COMPLETED|Overall Study||13
8217503|NCT02078817|20265455|P1|STARTED|Overall Study||14
8217504|NCT02078752|20265477|P10|NOT COMPLETED|Overall Study||10
8217505|NCT02078752|20265478|P9|NOT COMPLETED|Overall Study||0
8217506|NCT02078752|20265479|P8|NOT COMPLETED|Overall Study||3
8217507|NCT02078752|20265480|P7|NOT COMPLETED|Overall Study||2
8217508|NCT02078752|20265481|P6|NOT COMPLETED|Overall Study||4
8217509|NCT02078752|20265482|P5|NOT COMPLETED|Overall Study||1
8217510|NCT02078752|20265483|P4|NOT COMPLETED|Overall Study||2
8217511|NCT02078752|20265484|P3|NOT COMPLETED|Overall Study||1
8217512|NCT02078752|20265485|P2|NOT COMPLETED|Overall Study||7
8217513|NCT02078752|20265486|P1|NOT COMPLETED|Overall Study||2
8217514|NCT02078752|20265477|P10|COMPLETED|Overall Study||2
8217515|NCT02078752|20265478|P9|COMPLETED|Overall Study||2
8217516|NCT02078752|20265479|P8|COMPLETED|Overall Study||3
8217517|NCT02078752|20265480|P7|COMPLETED|Overall Study||1
8217518|NCT02078752|20265481|P6|COMPLETED|Overall Study||5
8217519|NCT02078752|20265482|P5|COMPLETED|Overall Study||2
8217520|NCT02078752|20265483|P4|COMPLETED|Overall Study||5
8217521|NCT02078752|20265484|P3|COMPLETED|Overall Study||1
8217522|NCT02078752|20265485|P2|COMPLETED|Overall Study||6
8217523|NCT02078752|20265486|P1|COMPLETED|Overall Study||1
8217524|NCT02078752|20265477|P10|STARTED|Overall Study||12
8217525|NCT02078752|20265478|P9|STARTED|Overall Study||2
8217526|NCT02078752|20265479|P8|STARTED|Overall Study||6
8217527|NCT02078752|20265480|P7|STARTED|Overall Study||3
8217528|NCT02078752|20265481|P6|STARTED|Overall Study||9
8217529|NCT02078752|20265482|P5|STARTED|Overall Study||3
8217530|NCT02078752|20265483|P4|STARTED|Overall Study||7
8217531|NCT02078752|20265484|P3|STARTED|Overall Study||2
8217532|NCT02078752|20265485|P2|STARTED|Overall Study||13
8217533|NCT02078752|20265486|P1|STARTED|Overall Study||3
8217534|NCT02078713|20265762|P4|NOT COMPLETED|Overall Study||0
8217535|NCT02078713|20265763|P3|NOT COMPLETED|Overall Study||0
8217536|NCT02078713|20265764|P2|NOT COMPLETED|Overall Study||61
8217537|NCT02078713|20265765|P1|NOT COMPLETED|Overall Study||52
8217538|NCT02078713|20265762|P4|COMPLETED|Overall Study||13
8217539|NCT02078713|20265763|P3|COMPLETED|Overall Study||15
8217540|NCT02078713|20265764|P2|COMPLETED|Overall Study||290
8217541|NCT02078713|20265765|P1|COMPLETED|Overall Study||355
8217542|NCT02078713|20265762|P4|STARTED|Overall Study||13
8217543|NCT02078713|20265763|P3|STARTED|Overall Study||15
8217544|NCT02078713|20265764|P2|STARTED|Overall Study||351
8217545|NCT02078713|20265765|P1|STARTED|Overall Study||407
8217546|NCT02078557|20265817|P1|NOT COMPLETED|Overall Study||0
8217547|NCT02078557|20265817|P1|COMPLETED|Overall Study||4
8217548|NCT02078557|20265817|P1|STARTED|Overall Study||4
8217549|NCT02078492|20265826|P3|NOT COMPLETED|Overall Study||0
8217550|NCT02078492|20265827|P2|NOT COMPLETED|Overall Study||0
8217551|NCT02078492|20265828|P1|NOT COMPLETED|Overall Study||0
8217552|NCT02078492|20265826|P3|COMPLETED|Overall Study||80
8217553|NCT02078492|20265827|P2|COMPLETED|Overall Study||80
8217554|NCT02078492|20265828|P1|COMPLETED|Overall Study||80
8217555|NCT02078492|20265826|P3|STARTED|Overall Study||80
8217556|NCT02078492|20265827|P2|STARTED|Overall Study||80
8217557|NCT02078492|20265828|P1|STARTED|Overall Study||80
8217558|NCT02078219|20265850|P5|NOT COMPLETED|Overall Study||2
8217559|NCT02078219|20265851|P4|NOT COMPLETED|Overall Study||4
8217560|NCT02078219|20265852|P3|NOT COMPLETED|Overall Study||6
8217561|NCT02078219|20265853|P2|NOT COMPLETED|Overall Study||4
8217562|NCT02078219|20265854|P1|NOT COMPLETED|Overall Study||3
8217563|NCT02078219|20265850|P5|COMPLETED|Overall Study||39
8217564|NCT02078219|20265851|P4|COMPLETED|Overall Study||37
8217565|NCT02078219|20265852|P3|COMPLETED|Overall Study||35
8217567|NCT02078219|20265854|P1|COMPLETED|Overall Study||38
8217568|NCT02078219|20265850|P5|STARTED|Overall Study||41
8217569|NCT02078219|20265851|P4|STARTED|Overall Study||41
8217570|NCT02078219|20265852|P3|STARTED|Overall Study||41
8217571|NCT02078219|20265853|P2|STARTED|Overall Study||40
8217572|NCT02078219|20265854|P1|STARTED|Overall Study||41
8217573|NCT02078193|20265881|P1|NOT COMPLETED|Overall Study||0
8217574|NCT02078193|20265881|P1|COMPLETED|Overall Study||3
8217575|NCT02078193|20265881|P1|STARTED|Overall Study||3
8217576|NCT02078180|20265887|P1|NOT COMPLETED|Overall Study||5
8217577|NCT02078180|20265887|P1|COMPLETED|Overall Study||29
8217578|NCT02078180|20265887|P1|XL 300|Overall Study||32
8217579|NCT02078180|20265887|P1|XL 150|Overall Study||31
8217580|NCT02078180|20265887|P1|SR150|Overall Study||32
8217581|NCT02078180|20265887|P1|SR100|Overall Study||31
8217582|NCT02078180|20265887|P1|IR100|Overall Study||31
8217583|NCT02078180|20265887|P1|IR75|Overall Study||30
8217584|NCT02078180|20265887|P1|STARTED|Overall Study||34
8217585|NCT02077465|20265904|P2|NOT COMPLETED|Overall Study||1
8217586|NCT02077465|20265905|P1|NOT COMPLETED|Overall Study||1
8217587|NCT02077465|20265904|P2|COMPLETED|Overall Study||2
8217588|NCT02077465|20265905|P1|COMPLETED|Overall Study||7
8217589|NCT02077465|20265904|P2|STARTED|Overall Study||3
8217590|NCT02077465|20265905|P1|STARTED|Overall Study||8
8217591|NCT02077374|20265928|P2|NOT COMPLETED|Overall Study||2
8217592|NCT02077374|20265929|P1|NOT COMPLETED|Overall Study||0
8217593|NCT02077374|20265928|P2|COMPLETED|Overall Study||17
8217594|NCT02077374|20265929|P1|COMPLETED|Overall Study||19
8217595|NCT02077374|20265928|P2|STARTED|Overall Study||19
8217596|NCT02077374|20265929|P1|STARTED|Overall Study||19
8217597|NCT02077140|20265950|P5|NOT COMPLETED|Overall Study||5
8217598|NCT02077140|20265951|P4|NOT COMPLETED|Overall Study||4
8217599|NCT02077140|20265952|P3|NOT COMPLETED|Overall Study||2
8217600|NCT02077140|20265953|P2|NOT COMPLETED|Overall Study||2
8217601|NCT02077140|20265954|P1|NOT COMPLETED|Overall Study||4
8217602|NCT02077140|20265950|P5|COMPLETED|Overall Study||43
8217603|NCT02077140|20265951|P4|COMPLETED|Overall Study||32
8217604|NCT02077140|20265952|P3|COMPLETED|Overall Study||34
8217605|NCT02077140|20265953|P2|COMPLETED|Overall Study||34
8217606|NCT02077140|20265954|P1|COMPLETED|Overall Study||32
8217607|NCT02077140|20265950|P5|STARTED|Overall Study||48
8217608|NCT02077140|20265951|P4|STARTED|Overall Study||36
8217609|NCT02077140|20265952|P3|STARTED|Overall Study||36
8217610|NCT02077140|20265953|P2|STARTED|Overall Study||36
8217611|NCT02077140|20265954|P1|STARTED|Overall Study||36
8217612|NCT02076919|20266053|P4|NOT COMPLETED|Overall Study||0
8217613|NCT02076919|20266054|P3|NOT COMPLETED|Overall Study||0
8217614|NCT02076919|20266055|P2|NOT COMPLETED|Overall Study||0
8217615|NCT02076919|20266056|P1|NOT COMPLETED|Overall Study||0
8217616|NCT02076919|20266053|P4|COMPLETED|Overall Study||12
8217617|NCT02076919|20266054|P3|COMPLETED|Overall Study||36
8217618|NCT02076919|20266055|P2|COMPLETED|Overall Study||8
8217619|NCT02076919|20266056|P1|COMPLETED|Overall Study||24
8217620|NCT02076919|20266053|P4|STARTED|Overall Study||12
8217621|NCT02076919|20266054|P3|STARTED|Overall Study||36
8217622|NCT02076919|20266055|P2|STARTED|Overall Study||8
8217623|NCT02076919|20266056|P1|STARTED|Overall Study||24
8217624|NCT02076776|20266157|P3|NOT COMPLETED|Overall Study||0
8217625|NCT02076776|20266158|P2|NOT COMPLETED|Overall Study||2
8217626|NCT02076776|20266159|P1|NOT COMPLETED|Overall Study||1
8217627|NCT02076776|20266157|P3|COMPLETED|Overall Study||6
8217628|NCT02076776|20266158|P2|COMPLETED|Overall Study||6
8217629|NCT02076776|20266159|P1|COMPLETED|Overall Study||5
8217630|NCT02076776|20266157|P3|STARTED|Overall Study||6
8217631|NCT02076776|20266158|P2|STARTED|Overall Study||8
8217632|NCT02076776|20266159|P1|STARTED|Overall Study||6
8217633|NCT02076425|20266175|P2|NOT COMPLETED|Overall Study||24
8217634|NCT02076425|20266176|P1|NOT COMPLETED|Overall Study||14
8217635|NCT02076425|20266175|P2|COMPLETED|Overall Study||91
8217636|NCT02076425|20266176|P1|COMPLETED|Overall Study||100
8217637|NCT02076425|20266175|P2|STARTED|Overall Study||115
8217638|NCT02076425|20266176|P1|STARTED|Overall Study||114
8217639|NCT02076412|20266188|P2|NOT COMPLETED|Overall Study||22
8217640|NCT02076412|20266189|P1|NOT COMPLETED|Overall Study||37
8217641|NCT02076412|20266188|P2|COMPLETED|Overall Study||2
8217642|NCT02076412|20266189|P1|COMPLETED|Overall Study||13
8217643|NCT02076412|20266188|P2|STARTED|Overall Study||24
8217644|NCT02076412|20266189|P1|STARTED|Overall Study||50
8217645|NCT02076399|20266209|P2|NOT COMPLETED|Overall Study||24
8217646|NCT02076399|20266210|P1|NOT COMPLETED|Overall Study||39
8217647|NCT02076399|20266209|P2|COMPLETED|Overall Study||1
8217648|NCT02076399|20266210|P1|COMPLETED|Overall Study||12
8217649|NCT02076399|20266209|P2|STARTED|Overall Study||25
8217650|NCT02076399|20266210|P1|STARTED|Overall Study||51
8217651|NCT02076334|20266232|P4|NOT COMPLETED|Overall Study||1
8217652|NCT02076334|20266233|P3|NOT COMPLETED|Overall Study||1
8217653|NCT02076334|20266234|P2|NOT COMPLETED|Overall Study||1
8217654|NCT02076334|20266235|P1|NOT COMPLETED|Overall Study||1
8217655|NCT02076334|20266232|P4|COMPLETED|Overall Study||20
8217656|NCT02076334|20266233|P3|COMPLETED|Overall Study||20
8217657|NCT02076334|20266234|P2|COMPLETED|Overall Study||20
8217658|NCT02076334|20266235|P1|COMPLETED|Overall Study||20
8217659|NCT02076334|20266232|P4|STARTED|Overall Study||21
8217660|NCT02076334|20266233|P3|STARTED|Overall Study||21
8217661|NCT02076334|20266234|P2|STARTED|Overall Study||21
8217662|NCT02076334|20266235|P1|STARTED|Overall Study||21
8217663|NCT02076321|20266251|P2|NOT COMPLETED|Overall Study||2
8217664|NCT02076321|20266252|P1|NOT COMPLETED|Overall Study||5
8217665|NCT02076321|20266251|P2|COMPLETED|Overall Study||49
8217666|NCT02076321|20266252|P1|COMPLETED|Overall Study||46
8217667|NCT02076321|20266251|P2|STARTED|Overall Study||51
8217668|NCT02076321|20266252|P1|STARTED|Overall Study||51
8217669|NCT02076243|20266258|P1|NOT COMPLETED|Overall Study||2
8217670|NCT02076243|20266258|P1|COMPLETED|Overall Study||0
8217671|NCT02076243|20266258|P1|STARTED|Overall Study||2
8217672|NCT02076178|20266268|P2|NOT COMPLETED|Injection Phase||7
8217673|NCT02076178|20266269|P1|NOT COMPLETED|Injection Phase||1
8217674|NCT02076178|20266268|P2|COMPLETED|Injection Phase||87
8217675|NCT02076178|20266269|P1|COMPLETED|Injection Phase||20
8217676|NCT02076178|20266268|P2|STARTED|Injection Phase||94
8217677|NCT02076178|20266269|P1|STARTED|Injection Phase||21
8217678|NCT02076178|20266268|P2|NOT COMPLETED|Oral Phase||12
8217679|NCT02076178|20266269|P1|NOT COMPLETED|Oral Phase||0
8217680|NCT02076178|20266268|P2|COMPLETED|Oral Phase||94
8217681|NCT02076178|20266269|P1|COMPLETED|Oral Phase||21
8217682|NCT02076178|20266268|P2|STARTED|Oral Phase||106
8217683|NCT02076178|20266269|P1|STARTED|Oral Phase||21
8217684|NCT02076165|20266303|P2|NOT COMPLETED|Overall Study||6
8217685|NCT02076165|20266304|P1|NOT COMPLETED|Overall Study||8
8217686|NCT02076165|20266303|P2|COMPLETED|Overall Study||69
8217687|NCT02076165|20266304|P1|COMPLETED|Overall Study||66
8217688|NCT02076165|20266303|P2|STARTED|Overall Study||75
8217689|NCT02076165|20266304|P1|STARTED|Overall Study||74
8217690|NCT02076100|20266335|P7|NOT COMPLETED|Overall Study||0
8217691|NCT02076100|20266336|P6|NOT COMPLETED|Overall Study||0
8217692|NCT02076100|20266337|P5|NOT COMPLETED|Overall Study||0
8217693|NCT02076100|20266338|P4|NOT COMPLETED|Overall Study||0
8217694|NCT02076100|20266339|P3|NOT COMPLETED|Overall Study||0
8217695|NCT02076100|20266340|P2|NOT COMPLETED|Overall Study||0
8217696|NCT02076100|20266341|P1|NOT COMPLETED|Overall Study||0
8217697|NCT02076100|20266335|P7|COMPLETED|Overall Study||4
8217698|NCT02076100|20266336|P6|COMPLETED|Overall Study||3
8217699|NCT02076100|20266337|P5|COMPLETED|Overall Study||3
8217700|NCT02076100|20266338|P4|COMPLETED|Overall Study||3
8217701|NCT02076100|20266339|P3|COMPLETED|Overall Study||3
8217702|NCT02076100|20266340|P2|COMPLETED|Overall Study||3
8217703|NCT02076100|20266341|P1|COMPLETED|Overall Study||3
8217704|NCT02076100|20266335|P7|STARTED|Overall Study||4
8217705|NCT02076100|20266336|P6|STARTED|Overall Study||3
8217706|NCT02076100|20266337|P5|STARTED|Overall Study||3
8217707|NCT02076100|20266338|P4|STARTED|Overall Study||3
8217708|NCT02076100|20266339|P3|STARTED|Overall Study||3
8217709|NCT02076100|20266340|P2|STARTED|Overall Study||3
8217710|NCT02076100|20266341|P1|STARTED|Overall Study||3
8217711|NCT02076022|20266374|P2|NOT COMPLETED|Overall Study||0
8217712|NCT02076022|20266375|P1|NOT COMPLETED|Overall Study||2
8217713|NCT02076022|20266374|P2|COMPLETED|Overall Study||3
8217714|NCT02076022|20266375|P1|COMPLETED|Overall Study||5
8217715|NCT02076022|20266374|P2|STARTED|Overall Study||3
8217716|NCT02076022|20266375|P1|STARTED|Overall Study||7
8217725|NCT02075840|20266410|P2|NOT COMPLETED|Overall Study||151
8217726|NCT02075840|20266411|P1|NOT COMPLETED|Overall Study||152
8217727|NCT02075840|20266410|P2|COMPLETED|Overall Study||0
8217728|NCT02075840|20266411|P1|COMPLETED|Overall Study||0
8217729|NCT02075840|20266410|P2|STARTED|Overall Study||151
8217730|NCT02075840|20266411|P1|STARTED|Overall Study||152
8217731|NCT02075658|20266467|P2|NOT COMPLETED|Overall Study||2
8217732|NCT02075658|20266468|P1|NOT COMPLETED|Overall Study||2
8217733|NCT02075658|20266467|P2|COMPLETED|Overall Study||28
8217734|NCT02075658|20266468|P1|COMPLETED|Overall Study||28
8217735|NCT02075658|20266467|P2|STARTED|Overall Study||30
8217736|NCT02075658|20266468|P1|STARTED|Overall Study||30
8217737|NCT02075632|20266478|P2|NOT COMPLETED|Overall Study||5
8217738|NCT02075632|20266479|P1|NOT COMPLETED|Overall Study||1
8217739|NCT02075632|20266478|P2|COMPLETED|Overall Study||143
8217740|NCT02075632|20266479|P1|COMPLETED|Overall Study||161
8217741|NCT02075632|20266478|P2|STARTED|Overall Study||148
8217742|NCT02075632|20266479|P1|STARTED|Overall Study||162
8217743|NCT02075606|20266489|P1|NOT COMPLETED|Overall Study||10
8217744|NCT02075606|20266489|P1|COMPLETED|Overall Study||40
8217745|NCT02075606|20266489|P1|STARTED|Overall Study||50
8217746|NCT02075541|20266513|P2|NOT COMPLETED|Overall Study||8
8217747|NCT02075541|20266514|P1|NOT COMPLETED|Overall Study||4
8217748|NCT02075541|20266513|P2|COMPLETED|Overall Study||64
8217749|NCT02075541|20266514|P1|COMPLETED|Overall Study||69
8217750|NCT02075541|20266513|P2|STARTED|Overall Study||72
8217751|NCT02075541|20266514|P1|STARTED|Overall Study||73
8217752|NCT02075515|20266563|P3|NOT COMPLETED|Overall Study||8
8217753|NCT02075515|20266564|P2|NOT COMPLETED|Overall Study||5
8217754|NCT02075515|20266565|P1|NOT COMPLETED|Overall Study||4
8217755|NCT02075515|20266563|P3|COMPLETED|Overall Study||208
8217756|NCT02075515|20266564|P2|COMPLETED|Overall Study||212
8217757|NCT02075515|20266565|P1|COMPLETED|Overall Study||214
8217758|NCT02075515|20266563|P3|STARTED|Overall Study||216
8217759|NCT02075515|20266564|P2|STARTED|Overall Study||217
8217760|NCT02075515|20266565|P1|STARTED|Overall Study||218
8217761|NCT02075476|20266602|P2|NOT COMPLETED|Overall Study||5
8217762|NCT02075476|20266603|P1|NOT COMPLETED|Overall Study||3
8217763|NCT02075476|20266602|P2|COMPLETED|Overall Study||15
8217764|NCT02075476|20266603|P1|COMPLETED|Overall Study||17
8217765|NCT02075476|20266602|P2|STARTED|Overall Study||20
8217766|NCT02075476|20266603|P1|STARTED|Overall Study||20
8217767|NCT02075463|20266613|P1|NOT COMPLETED|Overall Study||8
8217768|NCT02075463|20266613|P1|COMPLETED|Overall Study||7
8217769|NCT02075463|20266613|P1|STARTED|Overall Study||15
8217770|NCT02075411|20266642|P4|NOT COMPLETED|Overall Study||0
8217771|NCT02075411|20266643|P3|NOT COMPLETED|Overall Study||0
8217772|NCT02075411|20266644|P2|NOT COMPLETED|Overall Study||0
8217773|NCT02075411|20266645|P1|NOT COMPLETED|Overall Study||0
8217774|NCT02075411|20266642|P4|COMPLETED|Overall Study||1
8217775|NCT02075411|20266643|P3|COMPLETED|Overall Study||0
8217776|NCT02075411|20266644|P2|COMPLETED|Overall Study||0
8217777|NCT02075411|20266645|P1|COMPLETED|Overall Study||0
8217778|NCT02075411|20266642|P4|STARTED|Overall Study||1
8217779|NCT02075411|20266643|P3|STARTED|Overall Study||0
8217780|NCT02075411|20266644|P2|STARTED|Overall Study||0
8217781|NCT02075411|20266645|P1|STARTED|Overall Study||0
8217782|NCT02075320|20266663|P1|NOT COMPLETED|Overall Study||2
8217783|NCT02075320|20266663|P1|COMPLETED|Overall Study||48
8217784|NCT02075320|20266663|P1|STARTED|Overall Study||50
8217785|NCT02075255|20266673|P3|NOT COMPLETED|Overall Study||3
8217786|NCT02075255|20266674|P2|NOT COMPLETED|Overall Study||4
8217787|NCT02075255|20266675|P1|NOT COMPLETED|Overall Study||4
8217788|NCT02075255|20266673|P3|COMPLETED|Overall Study||72
8217789|NCT02075255|20266674|P2|COMPLETED|Overall Study||69
8217790|NCT02075255|20266675|P1|COMPLETED|Overall Study||68
8217791|NCT02075255|20266673|P3|STARTED|Overall Study||75
8217792|NCT02075255|20266674|P2|STARTED|Overall Study||73
8217793|NCT02075255|20266675|P1|STARTED|Overall Study||72
8217794|NCT02075203|20266785|P3|NOT COMPLETED|Overall Study||1
8217795|NCT02075203|20266786|P2|NOT COMPLETED|Overall Study||0
8217796|NCT02075203|20266787|P1|NOT COMPLETED|Overall Study||3
8217797|NCT02075203|20266785|P3|COMPLETED|Overall Study||328
8217798|NCT02075203|20266786|P2|COMPLETED|Overall Study||330
8217799|NCT02075203|20266787|P1|COMPLETED|Overall Study||327
8217800|NCT02075203|20266785|P3|STARTED|Overall Study||329
8217801|NCT02075203|20266786|P2|STARTED|Overall Study||330
8217802|NCT02075203|20266787|P1|STARTED|Overall Study||330
8217803|NCT02075125|20266806|P2|NOT COMPLETED|Overall Study||1
8217804|NCT02075125|20266807|P1|NOT COMPLETED|Overall Study||0
8217805|NCT02075125|20266806|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
8217806|NCT02075125|20266807|P1|COMPLETED|Overall Study||19
8217807|NCT02075125|20266806|P2|STARTED|Overall Study||20
8217808|NCT02075125|20266807|P1|STARTED|Overall Study||19
8217809|NCT02075073|20266828|P3|NOT COMPLETED|Overall Study||0
8217810|NCT02075073|20266829|P2|NOT COMPLETED|Overall Study||1
8217811|NCT02075073|20266830|P1|NOT COMPLETED|Overall Study||0
8217812|NCT02075073|20266828|P3|COMPLETED|Overall Study||36
8217813|NCT02075073|20266829|P2|COMPLETED|Overall Study||36
8217814|NCT02075073|20266830|P1|COMPLETED|Overall Study||36
8217815|NCT02075073|20266828|P3|STARTED|Overall Study||36
8217816|NCT02075073|20266829|P2|STARTED|Overall Study||37
8217817|NCT02075073|20266830|P1|STARTED|Overall Study||36
8217818|NCT02075021|20266847|P1|NOT COMPLETED|Overall Study||0
8217819|NCT02075021|20266847|P1|COMPLETED|Overall Study||3
8217820|NCT02075021|20266847|P1|STARTED|Overall Study||3
8217821|NCT02075008|20266852|P1|NOT COMPLETED|Overall Study||176
8217822|NCT02075008|20266852|P1|COMPLETED|Overall Study||94
8217823|NCT02075008|20266852|P1|STARTED|Overall Study||270
8217824|NCT02074995|20266856|P3|NOT COMPLETED|Overall Study||0
8217825|NCT02074995|20266857|P2|NOT COMPLETED|Overall Study||0
8217826|NCT02074995|20266858|P1|NOT COMPLETED|Overall Study||0
8217827|NCT02074995|20266856|P3|COMPLETED|Overall Study||0
8217828|NCT02074995|20266857|P2|COMPLETED|Overall Study||0
8217829|NCT02074995|20266858|P1|COMPLETED|Overall Study||1
8217830|NCT02074995|20266856|P3|STARTED|Overall Study||0
8217831|NCT02074995|20266857|P2|STARTED|Overall Study||0
8217832|NCT02074995|20266858|P1|STARTED|Overall Study||1
8217833|NCT02074982|20266875|P2|NOT COMPLETED|Overall Study||54
8217834|NCT02074982|20266876|P1|NOT COMPLETED|Overall Study||51
8217835|NCT02074982|20266875|P2|COMPLETED|Overall Study||285
8217836|NCT02074982|20266876|P1|COMPLETED|Overall Study||286
8217837|NCT02074982|20266875|P2|Safety Set (SF)|Overall Study||336
8217838|NCT02074982|20266876|P1|Safety Set (SF)|Overall Study||335
8217839|NCT02074982|20266875|P2|Full Analysis Set (FAS)|Overall Study||339
8217840|NCT02074982|20266876|P1|Full Analysis Set (FAS)|Overall Study||336
8217841|NCT02074982|20266875|P2|STARTED|Overall Study||339
8217842|NCT02074982|20266876|P1|STARTED|Overall Study||337
8217843|NCT02074904|20266888|P2|NOT COMPLETED|Overall Study||0
8217844|NCT02074904|20266889|P1|NOT COMPLETED|Overall Study||0
8217845|NCT02074904|20266888|P2|COMPLETED|Overall Study||0
8217846|NCT02074904|20266889|P1|COMPLETED|Overall Study||1
8217847|NCT02074904|20266888|P2|STARTED|Overall Study||0
8217848|NCT02074904|20266889|P1|STARTED|Overall Study||1
8217849|NCT02074735|20266905|P2|NOT COMPLETED|Overall Study||4
8217850|NCT02074735|20266906|P1|NOT COMPLETED|Overall Study||3
8217851|NCT02074735|20266905|P2|COMPLETED|Overall Study||29
8217852|NCT02074735|20266906|P1|COMPLETED|Overall Study||26
8217853|NCT02074735|20266905|P2|STARTED|Overall Study||33
8217854|NCT02074735|20266906|P1|STARTED|Overall Study||29
8217855|NCT02074709|20266914|P2|NOT COMPLETED|Overall Study||1
8217856|NCT02074709|20266915|P1|NOT COMPLETED|Overall Study||1
8217857|NCT02074709|20266914|P2|COMPLETED|Overall Study||29
8217858|NCT02074709|20266915|P1|COMPLETED|Overall Study||29
8217859|NCT02074709|20266914|P2|STARTED|Overall Study||30
8217860|NCT02074709|20266915|P1|STARTED|Overall Study||30
8217861|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 4||0
8217862|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 4||0
8217863|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 4||0
8217864|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 4||0
8217865|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 4||0
8217866|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 4||0
8217867|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 4||0
8217868|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 4||0
8217869|NCT02074553|20266923|P8|COMPLETED|Intervention Period 4||11
8217870|NCT02074553|20266924|P7|COMPLETED|Intervention Period 4||11
8217871|NCT02074553|20266925|P6|COMPLETED|Intervention Period 4||10
8217872|NCT02074553|20266926|P5|COMPLETED|Intervention Period 4||12
8217873|NCT02074553|20266927|P4|COMPLETED|Intervention Period 4||11
8217874|NCT02074553|20266928|P3|COMPLETED|Intervention Period 4||11
8217875|NCT02074553|20266929|P2|COMPLETED|Intervention Period 4||12
8217876|NCT02074553|20266930|P1|COMPLETED|Intervention Period 4||11
8217877|NCT02074553|20266923|P8|STARTED|Intervention Period 4||11
8217878|NCT02074553|20266924|P7|STARTED|Intervention Period 4||11
8217879|NCT02074553|20266925|P6|STARTED|Intervention Period 4||10
8217880|NCT02074553|20266926|P5|STARTED|Intervention Period 4||12
8217881|NCT02074553|20266927|P4|STARTED|Intervention Period 4||11
8217882|NCT02074553|20266928|P3|STARTED|Intervention Period 4||11
8217883|NCT02074553|20266929|P2|STARTED|Intervention Period 4||12
8217884|NCT02074553|20266930|P1|STARTED|Intervention Period 4||11
8217885|NCT02074553|20266923|P8|NOT COMPLETED|Washout Period 3||1
8217886|NCT02074553|20266924|P7|NOT COMPLETED|Washout Period 3||0
8217887|NCT02074553|20266925|P6|NOT COMPLETED|Washout Period 3||0
8217888|NCT02074553|20266926|P5|NOT COMPLETED|Washout Period 3||0
8217889|NCT02074553|20266927|P4|NOT COMPLETED|Washout Period 3||0
8217890|NCT02074553|20266928|P3|NOT COMPLETED|Washout Period 3||0
8217891|NCT02074553|20266929|P2|NOT COMPLETED|Washout Period 3||0
8217892|NCT02074553|20266930|P1|NOT COMPLETED|Washout Period 3||0
8217893|NCT02074553|20266923|P8|COMPLETED|Washout Period 3||11
8217894|NCT02074553|20266924|P7|COMPLETED|Washout Period 3||11
8217895|NCT02074553|20266925|P6|COMPLETED|Washout Period 3||10
8217896|NCT02074553|20266926|P5|COMPLETED|Washout Period 3||12
8217897|NCT02074553|20266927|P4|COMPLETED|Washout Period 3||11
8217898|NCT02074553|20266928|P3|COMPLETED|Washout Period 3||11
8217899|NCT02074553|20266929|P2|COMPLETED|Washout Period 3||12
8217900|NCT02074553|20266930|P1|COMPLETED|Washout Period 3||11
8217901|NCT02074553|20266923|P8|STARTED|Washout Period 3||12
8217902|NCT02074553|20266924|P7|STARTED|Washout Period 3||11
8217903|NCT02074553|20266925|P6|STARTED|Washout Period 3||10
8217904|NCT02074553|20266926|P5|STARTED|Washout Period 3||12
8217905|NCT02074553|20266927|P4|STARTED|Washout Period 3||11
8217906|NCT02074553|20266928|P3|STARTED|Washout Period 3||11
8217907|NCT02074553|20266929|P2|STARTED|Washout Period 3||12
8217908|NCT02074553|20266930|P1|STARTED|Washout Period 3||11
8217909|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 3||0
8217910|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 3||0
8217911|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 3||0
8217912|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 3||0
8217913|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 3||0
8217914|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 3||0
8217915|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 3||0
8217916|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 3||0
8217917|NCT02074553|20266923|P8|COMPLETED|Intervention Period 3||12
8217918|NCT02074553|20266924|P7|COMPLETED|Intervention Period 3||11
8217919|NCT02074553|20266925|P6|COMPLETED|Intervention Period 3||10
8217920|NCT02074553|20266926|P5|COMPLETED|Intervention Period 3||12
8217921|NCT02074553|20266927|P4|COMPLETED|Intervention Period 3||11
8217922|NCT02074553|20266928|P3|COMPLETED|Intervention Period 3||11
8217923|NCT02074553|20266929|P2|COMPLETED|Intervention Period 3||12
8217924|NCT02074553|20266930|P1|COMPLETED|Intervention Period 3||11
8217925|NCT02074553|20266923|P8|STARTED|Intervention Period 3||12
8217926|NCT02074553|20266924|P7|STARTED|Intervention Period 3||11
8217927|NCT02074553|20266925|P6|STARTED|Intervention Period 3||10
8217928|NCT02074553|20266926|P5|STARTED|Intervention Period 3||12
8217929|NCT02074553|20266927|P4|STARTED|Intervention Period 3||11
8217930|NCT02074553|20266928|P3|STARTED|Intervention Period 3||11
8217931|NCT02074553|20266929|P2|STARTED|Intervention Period 3||12
8217932|NCT02074553|20266930|P1|STARTED|Intervention Period 3||11
8217933|NCT02074553|20266923|P8|NOT COMPLETED|Washout Period 2||0
8217934|NCT02074553|20266924|P7|NOT COMPLETED|Washout Period 2||1
8217935|NCT02074553|20266925|P6|NOT COMPLETED|Washout Period 2||1
8217936|NCT02074553|20266926|P5|NOT COMPLETED|Washout Period 2||0
8217937|NCT02074553|20266927|P4|NOT COMPLETED|Washout Period 2||0
8217938|NCT02074553|20266928|P3|NOT COMPLETED|Washout Period 2||1
8217939|NCT02074553|20266929|P2|NOT COMPLETED|Washout Period 2||0
8217940|NCT02074553|20266930|P1|NOT COMPLETED|Washout Period 2||0
8217941|NCT02074553|20266923|P8|COMPLETED|Washout Period 2||12
8217942|NCT02074553|20266924|P7|COMPLETED|Washout Period 2||11
8217943|NCT02074553|20266925|P6|COMPLETED|Washout Period 2||10
8217944|NCT02074553|20266926|P5|COMPLETED|Washout Period 2||12
8217945|NCT02074553|20266927|P4|COMPLETED|Washout Period 2||11
8217946|NCT02074553|20266928|P3|COMPLETED|Washout Period 2||11
8217947|NCT02074553|20266929|P2|COMPLETED|Washout Period 2||12
8217948|NCT02074553|20266930|P1|COMPLETED|Washout Period 2||11
8217949|NCT02074553|20266923|P8|STARTED|Washout Period 2||12
8217950|NCT02074553|20266924|P7|STARTED|Washout Period 2||12
8217951|NCT02074553|20266925|P6|STARTED|Washout Period 2||11
8217952|NCT02074553|20266926|P5|STARTED|Washout Period 2||12
8217953|NCT02074553|20266927|P4|STARTED|Washout Period 2||11
8217954|NCT02074553|20266928|P3|STARTED|Washout Period 2||12
8217955|NCT02074553|20266929|P2|STARTED|Washout Period 2||12
8217956|NCT02074553|20266930|P1|STARTED|Washout Period 2||11
8217957|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 2||0
8217958|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 2||0
8217959|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 2||0
8217960|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 2||0
8217961|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 2||0
8217962|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 2||0
8217963|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 2||0
8217964|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 2||0
8217965|NCT02074553|20266923|P8|COMPLETED|Intervention Period 2||12
8217966|NCT02074553|20266924|P7|COMPLETED|Intervention Period 2||12
8217967|NCT02074553|20266925|P6|COMPLETED|Intervention Period 2||11
8217968|NCT02074553|20266926|P5|COMPLETED|Intervention Period 2||12
8217969|NCT02074553|20266927|P4|COMPLETED|Intervention Period 2||11
8217970|NCT02074553|20266928|P3|COMPLETED|Intervention Period 2||12
8217971|NCT02074553|20266929|P2|COMPLETED|Intervention Period 2||12
8217972|NCT02074553|20266930|P1|COMPLETED|Intervention Period 2||11
8217973|NCT02074553|20266923|P8|STARTED|Intervention Period 2||12
8217974|NCT02074553|20266924|P7|STARTED|Intervention Period 2||12
8217975|NCT02074553|20266925|P6|STARTED|Intervention Period 2||11
8217976|NCT02074553|20266926|P5|STARTED|Intervention Period 2||12
8217977|NCT02074553|20266927|P4|STARTED|Intervention Period 2||11
8217978|NCT02074553|20266928|P3|STARTED|Intervention Period 2||12
8217979|NCT02074553|20266929|P2|STARTED|Intervention Period 2||12
8217980|NCT02074553|20266930|P1|STARTED|Intervention Period 2||11
8217981|NCT02074553|20266923|P8|NOT COMPLETED|Washout Period 1||0
8217982|NCT02074553|20266924|P7|NOT COMPLETED|Washout Period 1||0
8217983|NCT02074553|20266925|P6|NOT COMPLETED|Washout Period 1||1
8217984|NCT02074553|20266926|P5|NOT COMPLETED|Washout Period 1||0
8217985|NCT02074553|20266927|P4|NOT COMPLETED|Washout Period 1||1
8217986|NCT02074553|20266928|P3|NOT COMPLETED|Washout Period 1||0
8217987|NCT02074553|20266929|P2|NOT COMPLETED|Washout Period 1||0
8217988|NCT02074553|20266930|P1|NOT COMPLETED|Washout Period 1||1
8217989|NCT02074553|20266923|P8|COMPLETED|Washout Period 1||12
8217990|NCT02074553|20266924|P7|COMPLETED|Washout Period 1||12
8217991|NCT02074553|20266925|P6|COMPLETED|Washout Period 1||11
8217992|NCT02074553|20266926|P5|COMPLETED|Washout Period 1||12
8217993|NCT02074553|20266927|P4|COMPLETED|Washout Period 1||11
8217994|NCT02074553|20266928|P3|COMPLETED|Washout Period 1||12
8217995|NCT02074553|20266929|P2|COMPLETED|Washout Period 1||12
8217996|NCT02074553|20266930|P1|COMPLETED|Washout Period 1||11
8217997|NCT02074553|20266923|P8|STARTED|Washout Period 1||12
8217998|NCT02074553|20266924|P7|STARTED|Washout Period 1||12
8217999|NCT02074553|20266925|P6|STARTED|Washout Period 1||12
8218000|NCT02074553|20266926|P5|STARTED|Washout Period 1||12
8218001|NCT02074553|20266927|P4|STARTED|Washout Period 1||12
8218002|NCT02074553|20266928|P3|STARTED|Washout Period 1||12
8218003|NCT02074553|20266929|P2|STARTED|Washout Period 1||12
8218004|NCT02074553|20266930|P1|STARTED|Washout Period 1||12
8218005|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 1||0
8218006|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 1||0
8218007|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 1||0
8218008|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 1||0
8218009|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 1||1
8218010|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 1||0
8218011|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 1||0
8218012|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 1||0
8218013|NCT02074553|20266923|P8|COMPLETED|Intervention Period 1||12
8218014|NCT02074553|20266924|P7|COMPLETED|Intervention Period 1||12
8218015|NCT02074553|20266925|P6|COMPLETED|Intervention Period 1||12
8218016|NCT02074553|20266926|P5|COMPLETED|Intervention Period 1||12
8218017|NCT02074553|20266927|P4|COMPLETED|Intervention Period 1||12
8218018|NCT02074553|20266928|P3|COMPLETED|Intervention Period 1||12
8218019|NCT02074553|20266929|P2|COMPLETED|Intervention Period 1||12
8218020|NCT02074553|20266930|P1|COMPLETED|Intervention Period 1||12
8218021|NCT02074553|20266923|P8|STARTED|Intervention Period 1||12
8218022|NCT02074553|20266924|P7|STARTED|Intervention Period 1||12
8218023|NCT02074553|20266925|P6|STARTED|Intervention Period 1||12
8218024|NCT02074553|20266926|P5|STARTED|Intervention Period 1||12
8218025|NCT02074553|20266927|P4|STARTED|Intervention Period 1||13
8218026|NCT02074553|20266928|P3|STARTED|Intervention Period 1||12
8218027|NCT02074553|20266929|P2|STARTED|Intervention Period 1||12
8218028|NCT02074553|20266930|P1|STARTED|Intervention Period 1||12
8218029|NCT02074514|20267112|P2|NOT COMPLETED|Overall Study||4
8218030|NCT02074514|20267113|P1|NOT COMPLETED|Overall Study||3
8218031|NCT02074514|20267112|P2|COMPLETED|Overall Study||54
8218032|NCT02074514|20267113|P1|COMPLETED|Overall Study||56
8218033|NCT02074514|20267112|P2|STARTED|Overall Study||58
8218034|NCT02074514|20267113|P1|STARTED|Overall Study||59
8218035|NCT02074384|20267134|P3|NOT COMPLETED|Overall Study||0
8218036|NCT02074384|20267135|P2|NOT COMPLETED|Overall Study||0
8218037|NCT02074384|20267136|P1|NOT COMPLETED|Overall Study||0
8218038|NCT02074384|20267134|P3|COMPLETED|Overall Study||17
8218039|NCT02074384|20267135|P2|COMPLETED|Overall Study||70
8218040|NCT02074384|20267136|P1|COMPLETED|Overall Study||74
8218041|NCT02074384|20267134|P3|STARTED|Overall Study||17
8218042|NCT02074384|20267135|P2|STARTED|Overall Study||70
8218043|NCT02074384|20267136|P1|STARTED|Overall Study||74
8218044|NCT02074358|20267144|P6|NOT COMPLETED|Overall Study||0
8218045|NCT02074358|20267145|P5|NOT COMPLETED|Overall Study||0
8218046|NCT02074358|20267146|P4|NOT COMPLETED|Overall Study||0
8218047|NCT02074358|20267147|P3|NOT COMPLETED|Overall Study||0
8218048|NCT02074358|20267148|P2|NOT COMPLETED|Overall Study||0
8218049|NCT02074358|20267149|P1|NOT COMPLETED|Overall Study||0
8218050|NCT02074358|20267144|P6|COMPLETED|Overall Study||2
8218051|NCT02074358|20267145|P5|COMPLETED|Overall Study||3
8218052|NCT02074358|20267146|P4|COMPLETED|Overall Study||2
8218053|NCT02074358|20267147|P3|COMPLETED|Overall Study||2
8218054|NCT02074358|20267148|P2|COMPLETED|Overall Study||3
8218055|NCT02074358|20267149|P1|COMPLETED|Overall Study||3
8218056|NCT02074358|20267144|P6|STARTED|Overall Study||2
8218057|NCT02074358|20267145|P5|STARTED|Overall Study||3
8218058|NCT02074358|20267146|P4|STARTED|Overall Study||2
8218059|NCT02074358|20267147|P3|STARTED|Overall Study||2
8218060|NCT02074358|20267148|P2|STARTED|Overall Study||3
8218061|NCT02074358|20267149|P1|STARTED|Overall Study||3
8218062|NCT02074345|20267238|P1|NOT COMPLETED|Overall Study||0
8218063|NCT02074345|20267238|P1|COMPLETED|Overall Study||31
8218064|NCT02074345|20267238|P1|STARTED|Overall Study||31
8218065|NCT02074059|20267254|P6|NOT COMPLETED|Overall Study||1
8218066|NCT02074059|20267255|P5|NOT COMPLETED|Overall Study||1
8218067|NCT02074059|20267256|P4|NOT COMPLETED|Overall Study||0
8218068|NCT02074059|20267257|P3|NOT COMPLETED|Overall Study||0
8218069|NCT02074059|20267258|P2|NOT COMPLETED|Overall Study||0
8218070|NCT02074059|20267259|P1|NOT COMPLETED|Overall Study||0
8218071|NCT02074059|20267254|P6|COMPLETED|Overall Study||39
8218072|NCT02074059|20267255|P5|COMPLETED|Overall Study||7
8218073|NCT02074059|20267256|P4|COMPLETED|Overall Study||8
8218074|NCT02074059|20267257|P3|COMPLETED|Overall Study||8
8218075|NCT02074059|20267258|P2|COMPLETED|Overall Study||8
8218076|NCT02074059|20267259|P1|COMPLETED|Overall Study||8
8218077|NCT02074059|20267254|P6|STARTED|Overall Study||40
8218078|NCT02074059|20267255|P5|STARTED|Overall Study||8
8218079|NCT02074059|20267256|P4|STARTED|Overall Study||8
8218080|NCT02074059|20267257|P3|STARTED|Overall Study||8
8218081|NCT02074059|20267258|P2|STARTED|Overall Study||8
8218082|NCT02074059|20267259|P1|STARTED|Overall Study||8
8218083|NCT02073968|20267297|P1|NOT COMPLETED|Overall Study||0
8218084|NCT02073968|20267297|P1|COMPLETED|Overall Study||35
8218085|NCT02073968|20267297|P1|STARTED|Overall Study||35
8218086|NCT02073929|20267303|P2|NOT COMPLETED|Overall Study||3
8218087|NCT02073929|20267304|P1|NOT COMPLETED|Overall Study||4
8218088|NCT02073929|20267303|P2|COMPLETED|Overall Study||21
8218089|NCT02073929|20267304|P1|COMPLETED|Overall Study||44
8218090|NCT02073929|20267303|P2|STARTED|Overall Study||24
8218091|NCT02073929|20267304|P1|STARTED|Overall Study||48
8218092|NCT02073747|20267332|P2|NOT COMPLETED|Overall Study||1
8218093|NCT02073747|20267333|P1|NOT COMPLETED|Overall Study||1
8218094|NCT02073747|20267332|P2|COMPLETED|Overall Study||14
8218095|NCT02073747|20267333|P1|COMPLETED|Overall Study||14
8218096|NCT02073747|20267332|P2|STARTED|Overall Study||15
8218097|NCT02073747|20267333|P1|STARTED|Overall Study||15
8218098|NCT02073682|20267341|P2|NOT COMPLETED|Overall Study||370
8218099|NCT02073682|20267342|P1|NOT COMPLETED|Overall Study||322
8218100|NCT02073682|20267341|P2|COMPLETED|Overall Study||154
8218101|NCT02073682|20267342|P1|COMPLETED|Overall Study||200
8218102|NCT02073682|20267341|P2|STARTED|Overall Study||524
8218103|NCT02073682|20267342|P1|STARTED|Overall Study||522
8218104|NCT02073656|20267360|P1|NOT COMPLETED|Retreatment Substudy||0
8218105|NCT02073656|20267360|P1|COMPLETED|Retreatment Substudy||9
8218106|NCT02073656|20267360|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
8218107|NCT02073656|20267360|P1|NOT COMPLETED|Primary Study||8
8218108|NCT02073656|20267360|P1|COMPLETED|Primary Study||327
8218109|NCT02073656|20267360|P1|STARTED|Primary Study||335
8218110|NCT02073643|20267376|P1|NOT COMPLETED|Overall Study||24
8218111|NCT02073643|20267376|P1|COMPLETED|Overall Study||180
8218112|NCT02073643|20267376|P1|STARTED|Overall Study||204
8218113|NCT02073565|20267387|P2|NOT COMPLETED|Cohort C||4
8218114|NCT02073565|20267388|P1|NOT COMPLETED|Cohort C||0
8218115|NCT02073565|20267387|P2|COMPLETED|Cohort C||211
8218116|NCT02073565|20267388|P1|COMPLETED|Cohort C||217
8218117|NCT02073565|20267387|P2|STARTED|Cohort C||215
8218118|NCT02073565|20267388|P1|STARTED|Cohort C||217
8218119|NCT02073565|20267387|P2|NOT COMPLETED|Cohort B||2
8218120|NCT02073565|20267388|P1|NOT COMPLETED|Cohort B||1
8218121|NCT02073565|20267387|P2|COMPLETED|Cohort B||54
8218122|NCT02073565|20267388|P1|COMPLETED|Cohort B||53
8218123|NCT02073565|20267387|P2|STARTED|Cohort B||56
8218124|NCT02073565|20267388|P1|STARTED|Cohort B||54
8218125|NCT02073565|20267387|P2|NOT COMPLETED|Cohort A||0
8218126|NCT02073565|20267388|P1|NOT COMPLETED|Cohort A||1
8218127|NCT02073565|20267387|P2|COMPLETED|Cohort A||14
8218128|NCT02073565|20267388|P1|COMPLETED|Cohort A||15
8218129|NCT02073565|20267387|P2|STARTED|Cohort A||14
8218130|NCT02073565|20267388|P1|STARTED|Cohort A||16
8218131|NCT02073565|20267387|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
8218132|NCT02073565|20267388|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
8218225|NCT02072668|20267646|P1|NOT COMPLETED|First Intervention||0
8218133|NCT02073565|20267387|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
8218134|NCT02073565|20267388|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
8218135|NCT02073565|20267387|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
8218136|NCT02073565|20267388|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
8218137|NCT02073461|20267403|P3|NOT COMPLETED|Overall Study||1
8218138|NCT02073461|20267404|P2|NOT COMPLETED|Overall Study||1
8218139|NCT02073461|20267405|P1|NOT COMPLETED|Overall Study||4
8218140|NCT02073461|20267403|P3|COMPLETED|Overall Study||78
8218141|NCT02073461|20267404|P2|COMPLETED|Overall Study||77
8218142|NCT02073461|20267405|P1|COMPLETED|Overall Study||75
8218143|NCT02073461|20267403|P3|STARTED|Overall Study||79
8218144|NCT02073461|20267404|P2|STARTED|Overall Study||78
8218145|NCT02073461|20267405|P1|STARTED|Overall Study||79
8218146|NCT02073448|20267434|P3|NOT COMPLETED|Overall Study||5
8218147|NCT02073448|20267435|P2|NOT COMPLETED|Overall Study||12
8218148|NCT02073448|20267436|P1|NOT COMPLETED|Overall Study||2
8218149|NCT02073448|20267434|P3|COMPLETED|Overall Study||99
8218150|NCT02073448|20267435|P2|COMPLETED|Overall Study||200
8218151|NCT02073448|20267436|P1|COMPLETED|Overall Study||99
8218152|NCT02073448|20267434|P3|STARTED|Overall Study||104
8218153|NCT02073448|20267435|P2|STARTED|Overall Study||212
8218154|NCT02073448|20267436|P1|STARTED|Overall Study||101
8218155|NCT02073435|20267464|P2|NOT COMPLETED|Overall Study||0
8218156|NCT02073435|20267465|P1|NOT COMPLETED|Overall Study||0
8218157|NCT02073435|20267464|P2|COMPLETED|Overall Study||96
8218158|NCT02073435|20267465|P1|COMPLETED|Overall Study||81
8218159|NCT02073435|20267464|P2|STARTED|Overall Study||96
8218160|NCT02073435|20267465|P1|STARTED|Overall Study||81
8218161|NCT02073331|20267473|P1|NOT COMPLETED|Overall Study||0
8218162|NCT02073331|20267473|P1|COMPLETED|Overall Study||1420
8218163|NCT02073331|20267473|P1|STARTED|Overall Study||1420
8218164|NCT02073279|20267479|P2|NOT COMPLETED|Open-label Extension Period||16
8218165|NCT02073279|20267480|P1|NOT COMPLETED|Open-label Extension Period||17
8218166|NCT02073279|20267479|P2|COMPLETED|Open-label Extension Period||0
8218167|NCT02073279|20267480|P1|COMPLETED|Open-label Extension Period||0
8218168|NCT02073279|20267479|P2|STARTED|Open-label Extension Period||16
8218169|NCT02073279|20267480|P1|STARTED|Open-label Extension Period||17
8218170|NCT02073279|20267479|P2|NOT COMPLETED|Double-blind Period||47
8218171|NCT02073279|20267480|P1|NOT COMPLETED|Double-blind Period||15
8218172|NCT02073279|20267479|P2|COMPLETED|Double-blind Period||16
8218173|NCT02073279|20267480|P1|COMPLETED|Double-blind Period||17
8218174|NCT02073279|20267479|P2|STARTED|Double-blind Period||63
8218175|NCT02073279|20267480|P1|STARTED|Double-blind Period||32
8218176|NCT02073162|20267554|P2|NOT COMPLETED|Overall Study||11
8218177|NCT02073162|20267555|P1|NOT COMPLETED|Overall Study||6
8218178|NCT02073162|20267554|P2|COMPLETED|Overall Study||1490
8218179|NCT02073162|20267555|P1|COMPLETED|Overall Study||1493
8218180|NCT02073162|20267554|P2|STARTED|Overall Study||1501
8218181|NCT02073162|20267555|P1|STARTED|Overall Study||1499
8218182|NCT02072980|20267583|P2|NOT COMPLETED|Period 2, Second Wear||1
8218183|NCT02072980|20267584|P1|NOT COMPLETED|Period 2, Second Wear||0
8218184|NCT02072980|20267583|P2|COMPLETED|Period 2, Second Wear||7
8218185|NCT02072980|20267584|P1|COMPLETED|Period 2, Second Wear||7
8218186|NCT02072980|20267583|P2|STARTED|Period 2, Second Wear||8
8218187|NCT02072980|20267584|P1|STARTED|Period 2, Second Wear||7
8218188|NCT02072980|20267583|P2|NOT COMPLETED|Period 1, First Wear||0
8218189|NCT02072980|20267584|P1|NOT COMPLETED|Period 1, First Wear||0
8218190|NCT02072980|20267583|P2|COMPLETED|Period 1, First Wear||8
8218191|NCT02072980|20267584|P1|COMPLETED|Period 1, First Wear||7
8218192|NCT02072980|20267583|P2|STARTED|Period 1, First Wear||8
8218193|NCT02072980|20267584|P1|STARTED|Period 1, First Wear||7
8218194|NCT02072941|20267592|P2|NOT COMPLETED|Overall Study||29
8218195|NCT02072941|20267593|P1|NOT COMPLETED|Overall Study||38
8218196|NCT02072941|20267592|P2|COMPLETED|Overall Study||197
8218197|NCT02072941|20267593|P1|COMPLETED|Overall Study||181
8218198|NCT02072941|20267592|P2|STARTED|Overall Study||226
8218199|NCT02072941|20267593|P1|STARTED|Overall Study||219
8218200|NCT02072928|20267601|P1|NOT COMPLETED|Overall Study||0
8218201|NCT02072928|20267601|P1|COMPLETED|Overall Study||55
8218202|NCT02072928|20267601|P1|STARTED|Overall Study||55
8218203|NCT02072824|20267608|P3|NOT COMPLETED|Overall Study||3
8218204|NCT02072824|20267609|P2|NOT COMPLETED|Overall Study||1
8218205|NCT02072824|20267610|P1|NOT COMPLETED|Overall Study||2
8218206|NCT02072824|20267608|P3|COMPLETED|Overall Study||67
8218207|NCT02072824|20267609|P2|COMPLETED|Overall Study||33
8218208|NCT02072824|20267610|P1|COMPLETED|Overall Study||69
8218209|NCT02072824|20267608|P3|STARTED|Overall Study||70
8218210|NCT02072824|20267609|P2|STARTED|Overall Study||34
8218211|NCT02072824|20267610|P1|STARTED|Overall Study||71
8218212|NCT02072668|20267645|P2|NOT COMPLETED|Second Intervention||0
8218213|NCT02072668|20267646|P1|NOT COMPLETED|Second Intervention||1
8218214|NCT02072668|20267645|P2|COMPLETED|Second Intervention||7
8218215|NCT02072668|20267646|P1|COMPLETED|Second Intervention||6
8218216|NCT02072668|20267645|P2|STARTED|Second Intervention||7
8218217|NCT02072668|20267646|P1|STARTED|Second Intervention||7
8218218|NCT02072668|20267645|P2|NOT COMPLETED|Washout (2 Weeks)||0
8218219|NCT02072668|20267646|P1|NOT COMPLETED|Washout (2 Weeks)||0
8218220|NCT02072668|20267645|P2|COMPLETED|Washout (2 Weeks)||7
8218221|NCT02072668|20267646|P1|COMPLETED|Washout (2 Weeks)||7
8218222|NCT02072668|20267645|P2|STARTED|Washout (2 Weeks)||7
8218223|NCT02072668|20267646|P1|STARTED|Washout (2 Weeks)||7
8218224|NCT02072668|20267645|P2|NOT COMPLETED|First Intervention||0
8218226|NCT02072668|20267645|P2|COMPLETED|First Intervention||7
8218227|NCT02072668|20267646|P1|COMPLETED|First Intervention||7
8218228|NCT02072668|20267645|P2|STARTED|First Intervention||7
8218229|NCT02072668|20267646|P1|STARTED|First Intervention||7
8218230|NCT02072434|20267686|P2|NOT COMPLETED|Overall Study||90
8218231|NCT02072434|20267687|P1|NOT COMPLETED|Overall Study||54
8218232|NCT02072434|20267686|P2|COMPLETED|Overall Study||1014
8218233|NCT02072434|20267687|P1|COMPLETED|Overall Study||1041
8218234|NCT02072434|20267686|P2|Safety Analysis Set|Overall Study||1082
8218235|NCT02072434|20267687|P1|Safety Analysis Set|Overall Study||1067
8218236|NCT02072434|20267686|P2|Received Study Drug|Overall Study||1082
8218237|NCT02072434|20267687|P1|Received Study Drug|Overall Study||1067
8218238|NCT02072434|20267686|P2|Intent to Treat Analysis Set|Overall Study||1104
8218239|NCT02072434|20267687|P1|Intent to Treat Analysis Set|Overall Study||1095
8218240|NCT02072434|20267686|P2|STARTED|Overall Study||1104
8218241|NCT02072434|20267687|P1|STARTED|Overall Study||1095
8218242|NCT02072421|20267697|P1|NOT COMPLETED|Overall Study||390
8218243|NCT02072421|20267697|P1|COMPLETED|Overall Study||2489
8218244|NCT02072421|20267697|P1|STARTED|Overall Study||2879
8218245|NCT02072226|20267707|P2|NOT COMPLETED|Overall Study||10
8218246|NCT02072226|20267708|P1|NOT COMPLETED|Overall Study||15
8218247|NCT02072226|20267707|P2|COMPLETED|Overall Study||147
8218248|NCT02072226|20267708|P1|COMPLETED|Overall Study||141
8218249|NCT02072226|20267707|P2|STARTED|Overall Study||157
8218250|NCT02072226|20267708|P1|STARTED|Overall Study||156
8218251|NCT02072200|20267730|P1|NOT COMPLETED|Overall Study||2
8218252|NCT02072200|20267730|P1|COMPLETED|Overall Study||145
8218253|NCT02072200|20267730|P1|STARTED|Overall Study||147
8218254|NCT02072174|20267738|P2|NOT COMPLETED|Overall Study||39
8218255|NCT02072174|20267739|P1|NOT COMPLETED|Overall Study||32
8218256|NCT02072174|20267738|P2|COMPLETED|Overall Study||240
8218257|NCT02072174|20267739|P1|COMPLETED|Overall Study||258
8218258|NCT02072174|20267738|P2|STARTED|Overall Study||279
8218259|NCT02072174|20267739|P1|STARTED|Overall Study||290
8218260|NCT02072096|20267763|P2|NOT COMPLETED|Overall Study||78
8218261|NCT02072096|20267764|P1|NOT COMPLETED|Overall Study||85
8218262|NCT02072096|20267763|P2|COMPLETED|Overall Study||15
8218263|NCT02072096|20267764|P1|COMPLETED|Overall Study||14
8218264|NCT02072096|20267763|P2|Received at Least One Dose of Study Drug|Overall Study||93
8218265|NCT02072096|20267764|P1|Received at Least One Dose of Study Drug|Overall Study||98
8218266|NCT02072096|20267763|P2|STARTED|Overall Study||93
8218267|NCT02072096|20267764|P1|STARTED|Overall Study||99
8218268|NCT02071914|20267789|P3|NOT COMPLETED|Overall Study||0
8218269|NCT02071914|20267790|P2|NOT COMPLETED|Overall Study||0
8218270|NCT02071914|20267791|P1|NOT COMPLETED|Overall Study||0
8218271|NCT02071914|20267789|P3|COMPLETED|Overall Study||27
8218272|NCT02071914|20267790|P2|COMPLETED|Overall Study||27
8218273|NCT02071914|20267791|P1|COMPLETED|Overall Study||27
8218274|NCT02071914|20267789|P3|STARTED|Overall Study||27
8218275|NCT02071914|20267790|P2|STARTED|Overall Study||27
8218276|NCT02071914|20267791|P1|STARTED|Overall Study||27
8218277|NCT02071901|20267799|P1|NOT COMPLETED|Overall Study||0
8218278|NCT02071901|20267799|P1|COMPLETED|Overall Study||31
8218279|NCT02071901|20267799|P1|STARTED|Overall Study||31
8218280|NCT02071849|20267815|P1|NOT COMPLETED|2-year Extended Follow-up||1
8218281|NCT02071849|20267815|P1|COMPLETED|2-year Extended Follow-up||14
8218282|NCT02071849|20267815|P1|STARTED|2-year Extended Follow-up||15
8218283|NCT02071849|20267815|P1|NOT COMPLETED|6-month Primary Endpoint||5
8218284|NCT02071849|20267815|P1|COMPLETED|6-month Primary Endpoint||15
8218285|NCT02071849|20267815|P1|STARTED|6-month Primary Endpoint||20
8218286|NCT02071823|20267849|P2|NOT COMPLETED|Overall Study||0
8218287|NCT02071823|20267850|P1|NOT COMPLETED|Overall Study||1
8218288|NCT02071823|20267849|P2|COMPLETED|Overall Study||6
8218289|NCT02071823|20267850|P1|COMPLETED|Overall Study||5
8218290|NCT02071823|20267849|P2|STARTED|Overall Study||6
8218291|NCT02071823|20267850|P1|STARTED|Overall Study||6
8218292|NCT02071810|20267865|P5|NOT COMPLETED|Overall Study||1
8218293|NCT02071810|20267866|P4|NOT COMPLETED|Overall Study||1
8218294|NCT02071810|20267867|P3|NOT COMPLETED|Overall Study||0
8218295|NCT02071810|20267868|P2|NOT COMPLETED|Overall Study||0
8218296|NCT02071810|20267869|P1|NOT COMPLETED|Overall Study||0
8218297|NCT02071810|20267865|P5|COMPLETED|Overall Study||8
8218298|NCT02071810|20267866|P4|COMPLETED|Overall Study||6
8218299|NCT02071810|20267867|P3|COMPLETED|Overall Study||6
8218300|NCT02071810|20267868|P2|COMPLETED|Overall Study||6
8218301|NCT02071810|20267869|P1|COMPLETED|Overall Study||6
8218302|NCT02071810|20267865|P5|STARTED|Overall Study||9
8218303|NCT02071810|20267866|P4|STARTED|Overall Study||7
8218304|NCT02071810|20267867|P3|STARTED|Overall Study||6
8218305|NCT02071810|20267868|P2|STARTED|Overall Study||6
8218306|NCT02071810|20267869|P1|STARTED|Overall Study||6
8218307|NCT02071771|20267881|P2|NOT COMPLETED|Period 2: Second 10 Days||0
8218308|NCT02071771|20267882|P1|NOT COMPLETED|Period 2: Second 10 Days||0
8218309|NCT02071771|20267881|P2|COMPLETED|Period 2: Second 10 Days||38
8218310|NCT02071771|20267882|P1|COMPLETED|Period 2: Second 10 Days||39
8218311|NCT02071771|20267881|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
8218312|NCT02071771|20267882|P1|STARTED|Period 2: Second 10 Days||39
8218313|NCT02071771|20267881|P2|NOT COMPLETED|Period 1: First 10 Days||0
8218314|NCT02071771|20267882|P1|NOT COMPLETED|Period 1: First 10 Days||2
8218315|NCT02071771|20267881|P2|COMPLETED|Period 1: First 10 Days||39
8218316|NCT02071771|20267882|P1|COMPLETED|Period 1: First 10 Days||39
8218317|NCT02071771|20267881|P2|Dispensed|Period 1: First 10 Days||39
8218318|NCT02071771|20267882|P1|Dispensed|Period 1: First 10 Days||39
8218319|NCT02071771|20267881|P2|STARTED|Period 1: First 10 Days||39
8218320|NCT02071771|20267882|P1|STARTED|Period 1: First 10 Days||41
8218321|NCT02071706|20267890|P1|NOT COMPLETED|Overall Study||3
8218322|NCT02071706|20267890|P1|COMPLETED|Overall Study||59
8218323|NCT02071706|20267890|P1|STARTED|Overall Study||62
8218324|NCT02071420|20267897|P2|NOT COMPLETED|Overall Study||3
8218325|NCT02071420|20267898|P1|NOT COMPLETED|Overall Study||3
8218326|NCT02071420|20267897|P2|COMPLETED|Overall Study||27
8218327|NCT02071420|20267898|P1|COMPLETED|Overall Study||27
8218328|NCT02071420|20267897|P2|STARTED|Overall Study||30
8218329|NCT02071420|20267898|P1|STARTED|Overall Study||30
8218330|NCT02071290|20267906|P2|NOT COMPLETED|Overall Study||7
8218331|NCT02071290|20267907|P1|NOT COMPLETED|Overall Study||4
8218332|NCT02071290|20267906|P2|COMPLETED|Overall Study||18
8218333|NCT02071290|20267907|P1|COMPLETED|Overall Study||21
8218334|NCT02071290|20267906|P2|STARTED|Overall Study||25
8218335|NCT02071290|20267907|P1|STARTED|Overall Study||25
8218336|NCT02071225|20267961|P1|NOT COMPLETED|Overall Study||30
8218337|NCT02071225|20267961|P1|COMPLETED|Overall Study||42
8218338|NCT02071225|20267961|P1|STARTED|Overall Study||72
8218339|NCT02071173|20267979|P1|NOT COMPLETED|Overall Study||1835
8218340|NCT02071173|20267979|P1|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
8218341|NCT02071173|20267979|P1|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
8218342|NCT02071173|20267979|P1|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
8218343|NCT02071173|20267979|P1|Implanted/Attempted With a Study Device|Overall Study||2200
8218344|NCT02071173|20267979|P1|STARTED|Overall Study||2244
8218345|NCT02071108|20267998|P1|NOT COMPLETED|Overall Study||0
8218346|NCT02071108|20267998|P1|COMPLETED|Overall Study||35
8218347|NCT02071108|20267998|P1|STARTED|Overall Study||35
8218348|NCT02071095|20268019|P2|NOT COMPLETED|Overall Study||0
8218349|NCT02071095|20268020|P1|NOT COMPLETED|Overall Study||0
8218350|NCT02071095|20268019|P2|COMPLETED|Overall Study||3
8218351|NCT02071095|20268020|P1|COMPLETED|Overall Study||12
8218352|NCT02071095|20268019|P2|STARTED|Overall Study||3
8218353|NCT02071095|20268020|P1|STARTED|Overall Study||12
8218354|NCT02071082|20268036|P2|NOT COMPLETED|Overall Study||7
8218355|NCT02071082|20268037|P1|NOT COMPLETED|Overall Study||2
8218356|NCT02071082|20268036|P2|COMPLETED|Overall Study||68
8218357|NCT02071082|20268037|P1|COMPLETED|Overall Study||2
8218358|NCT02071082|20268036|P2|STARTED|Overall Study||75
8218359|NCT02071082|20268037|P1|STARTED|Overall Study||4
8218360|NCT02070991|20268067|P2|NOT COMPLETED|Overall Study||0
8218361|NCT02070991|20268068|P1|NOT COMPLETED|Overall Study||3
8218362|NCT02070991|20268067|P2|COMPLETED|Overall Study||32
8218363|NCT02070991|20268068|P1|COMPLETED|Overall Study||28
8218364|NCT02070991|20268067|P2|STARTED|Overall Study||32
8218365|NCT02070991|20268068|P1|STARTED|Overall Study||31
8218366|NCT02070978|20268091|P3|NOT COMPLETED|Overall Study||53
8218367|NCT02070978|20268092|P2|NOT COMPLETED|Overall Study||53
8218368|NCT02070978|20268093|P1|NOT COMPLETED|Overall Study||47
8218369|NCT02070978|20268091|P3|COMPLETED|Overall Study||35
8218370|NCT02070978|20268092|P2|COMPLETED|Overall Study||29
8218371|NCT02070978|20268093|P1|COMPLETED|Overall Study||36
8218372|NCT02070978|20268091|P3|STARTED|Overall Study||88
8218373|NCT02070978|20268092|P2|STARTED|Overall Study||82
8218374|NCT02070978|20268093|P1|STARTED|Overall Study||83
8218375|NCT02070965|20268155|P3|NOT COMPLETED|Overall Study||1
8218376|NCT02070965|20268156|P2|NOT COMPLETED|Overall Study||2
8218377|NCT02070965|20268157|P1|NOT COMPLETED|Overall Study||2
8218378|NCT02070965|20268155|P3|COMPLETED|Overall Study||24
8218379|NCT02070965|20268156|P2|COMPLETED|Overall Study||21
8218380|NCT02070965|20268157|P1|COMPLETED|Overall Study||25
8218381|NCT02070965|20268155|P3|STARTED|Overall Study||25
8218382|NCT02070965|20268156|P2|STARTED|Overall Study||23
8218383|NCT02070965|20268157|P1|STARTED|Overall Study||27
8218384|NCT02070757|20268167|P2|NOT COMPLETED|Overall Study||114
8218385|NCT02070757|20268168|P1|NOT COMPLETED|Overall Study||117
8218386|NCT02070757|20268167|P2|COMPLETED|Overall Study||250
8218387|NCT02070757|20268168|P1|COMPLETED|Overall Study||245
8218388|NCT02070757|20268167|P2|Treated Participants|Overall Study||359
8218389|NCT02070757|20268168|P1|Treated Participants|Overall Study||361
8218390|NCT02070757|20268167|P2|STARTED|Overall Study||364
8218391|NCT02070757|20268168|P1|STARTED|Overall Study||362
8218392|NCT02070744|20268202|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
8218393|NCT02070744|20268203|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218394|NCT02070744|20268204|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218395|NCT02070744|20268205|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218396|NCT02070744|20268206|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218397|NCT02070744|20268202|P5|COMPLETED|OLE Phase (48 Weeks)||24
8218398|NCT02070744|20268203|P4|COMPLETED|OLE Phase (48 Weeks)||0
8218399|NCT02070744|20268204|P3|COMPLETED|OLE Phase (48 Weeks)||0
8218400|NCT02070744|20268205|P2|COMPLETED|OLE Phase (48 Weeks)||0
8218401|NCT02070744|20268206|P1|COMPLETED|OLE Phase (48 Weeks)||0
8218402|NCT02070744|20268202|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
8218403|NCT02070744|20268203|P4|STARTED|OLE Phase (48 Weeks)||0
8218404|NCT02070744|20268204|P3|STARTED|OLE Phase (48 Weeks)||0
8218405|NCT02070744|20268205|P2|STARTED|OLE Phase (48 Weeks)||0
8218406|NCT02070744|20268206|P1|STARTED|OLE Phase (48 Weeks)||0
8218407|NCT02070744|20268202|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
8218408|NCT02070744|20268203|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
8218409|NCT02070744|20268204|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
8218410|NCT02070744|20268205|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
8218411|NCT02070744|20268206|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
8218412|NCT02070744|20268202|P5|COMPLETED|PC Phase (12 Weeks)||0
8218413|NCT02070744|20268203|P4|COMPLETED|PC Phase (12 Weeks)||13
8218414|NCT02070744|20268204|P3|COMPLETED|PC Phase (12 Weeks)||15
8218415|NCT02070744|20268205|P2|COMPLETED|PC Phase (12 Weeks)||5
8218416|NCT02070744|20268206|P1|COMPLETED|PC Phase (12 Weeks)||6
8218417|NCT02070744|20268202|P5|Treated|PC Phase (12 Weeks)||0
8218418|NCT02070744|20268203|P4|Treated|PC Phase (12 Weeks)||13
8218419|NCT02070744|20268204|P3|Treated|PC Phase (12 Weeks)||15
8218420|NCT02070744|20268205|P2|Treated|PC Phase (12 Weeks)||5
8218421|NCT02070744|20268206|P1|Treated|PC Phase (12 Weeks)||6
8218422|NCT02070744|20268202|P5|STARTED|PC Phase (12 Weeks)||0
8218423|NCT02070744|20268203|P4|STARTED|PC Phase (12 Weeks)||14
8218424|NCT02070744|20268204|P3|STARTED|PC Phase (12 Weeks)||15
8218425|NCT02070744|20268205|P2|STARTED|PC Phase (12 Weeks)||5
8218426|NCT02070744|20268206|P1|STARTED|PC Phase (12 Weeks)||6
8218427|NCT02070692|20268258|P2|NOT COMPLETED|Overall Study||12
8218428|NCT02070692|20268259|P1|NOT COMPLETED|Overall Study||10
8218429|NCT02070692|20268258|P2|COMPLETED|Overall Study||16
8218430|NCT02070692|20268259|P1|COMPLETED|Overall Study||18
8218431|NCT02070692|20268258|P2|STARTED|Overall Study||28
8218432|NCT02070692|20268259|P1|STARTED|Overall Study||28
8218433|NCT02070640|20268275|P2|NOT COMPLETED|Overall Study||0
8218434|NCT02070640|20268276|P1|NOT COMPLETED|Overall Study||11
8218435|NCT02070640|20268275|P2|COMPLETED|Overall Study||6
8218436|NCT02070640|20268276|P1|COMPLETED|Overall Study||82
8218437|NCT02070640|20268275|P2|STARTED|Overall Study||6
8218438|NCT02070640|20268276|P1|STARTED|Overall Study||93
8218439|NCT02070588|20268289|P3|NOT COMPLETED|Overall Study||0
8218440|NCT02070588|20268290|P2|NOT COMPLETED|Overall Study||1
8218441|NCT02070588|20268291|P1|NOT COMPLETED|Overall Study||39
8218442|NCT02070588|20268289|P3|COMPLETED|Overall Study||0
8218443|NCT02070588|20268290|P2|COMPLETED|Overall Study||25
8218444|NCT02070588|20268291|P1|COMPLETED|Overall Study||47
8218445|NCT02070588|20268289|P3|STARTED|Overall Study||0
8218446|NCT02070588|20268290|P2|STARTED|Overall Study||26
8218447|NCT02070588|20268291|P1|STARTED|Overall Study||86
8218448|NCT02070484|20268307|P2|NOT COMPLETED|Overall Study||0
8218449|NCT02070484|20268308|P1|NOT COMPLETED|Overall Study||1
8218450|NCT02070484|20268307|P2|COMPLETED|Overall Study||3
8218451|NCT02070484|20268308|P1|COMPLETED|Overall Study||2
8218452|NCT02070484|20268307|P2|STARTED|Overall Study||3
8218453|NCT02070484|20268308|P1|STARTED|Overall Study||3
8218454|NCT02070380|20268330|P4|NOT COMPLETED|Second Injection||5
8218455|NCT02070380|20268331|P3|NOT COMPLETED|Second Injection||1
8218456|NCT02070380|20268332|P2|NOT COMPLETED|Second Injection||2
8218457|NCT02070380|20268333|P1|NOT COMPLETED|Second Injection||0
8218458|NCT02070380|20268330|P4|COMPLETED|Second Injection||46
8218459|NCT02070380|20268331|P3|COMPLETED|Second Injection||50
8218460|NCT02070380|20268332|P2|COMPLETED|Second Injection||32
8218461|NCT02070380|20268333|P1|COMPLETED|Second Injection||31
8218462|NCT02070380|20268330|P4|STARTED|Second Injection||51
8218463|NCT02070380|20268331|P3|STARTED|Second Injection||51
8218464|NCT02070380|20268332|P2|STARTED|Second Injection||34
8218465|NCT02070380|20268333|P1|STARTED|Second Injection||31
8218466|NCT02070380|20268330|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
8218467|NCT02070380|20268331|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
8218468|NCT02070380|20268332|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
8218469|NCT02070380|20268333|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
8218470|NCT02070380|20268330|P4|COMPLETED|Washout (no Second Injection/MRI)||51
8218471|NCT02070380|20268331|P3|COMPLETED|Washout (no Second Injection/MRI)||51
8218472|NCT02070380|20268332|P2|COMPLETED|Washout (no Second Injection/MRI)||34
8218473|NCT02070380|20268333|P1|COMPLETED|Washout (no Second Injection/MRI)||31
8218474|NCT02070380|20268330|P4|STARTED|Washout (no Second Injection/MRI)||54
8218475|NCT02070380|20268331|P3|STARTED|Washout (no Second Injection/MRI)||53
8218476|NCT02070380|20268332|P2|STARTED|Washout (no Second Injection/MRI)||39
8218477|NCT02070380|20268333|P1|STARTED|Washout (no Second Injection/MRI)||31
8218478|NCT02070380|20268330|P4|NOT COMPLETED|First Injection||0
8218479|NCT02070380|20268331|P3|NOT COMPLETED|First Injection||0
8218480|NCT02070380|20268332|P2|NOT COMPLETED|First Injection||0
8218481|NCT02070380|20268333|P1|NOT COMPLETED|First Injection||0
8218482|NCT02070380|20268330|P4|COMPLETED|First Injection||54
8218483|NCT02070380|20268331|P3|COMPLETED|First Injection||53
8218484|NCT02070380|20268332|P2|COMPLETED|First Injection||39
8218485|NCT02070380|20268333|P1|COMPLETED|First Injection||31
8218486|NCT02070380|20268330|P4|STARTED|First Injection||54
8218487|NCT02070380|20268331|P3|STARTED|First Injection||53
8218488|NCT02070380|20268332|P2|STARTED|First Injection||39
8218489|NCT02070380|20268333|P1|STARTED|First Injection||31
8218490|NCT02070302|20268383|P2|NOT COMPLETED|Overall Study||0
8218491|NCT02070302|20268384|P1|NOT COMPLETED|Overall Study||0
8218492|NCT02070302|20268383|P2|COMPLETED|Overall Study||5
8218493|NCT02070302|20268384|P1|COMPLETED|Overall Study||5
8218494|NCT02070302|20268383|P2|STARTED|Overall Study||5
8218495|NCT02070302|20268384|P1|STARTED|Overall Study||5
8218496|NCT02070276|20268403|P3|NOT COMPLETED|Overall Study||0
8218497|NCT02070276|20268404|P2|NOT COMPLETED|Overall Study||0
8218498|NCT02070276|20268405|P1|NOT COMPLETED|Overall Study||0
8218499|NCT02070276|20268403|P3|COMPLETED|Overall Study||148
8218500|NCT02070276|20268404|P2|COMPLETED|Overall Study||132
8218501|NCT02070276|20268405|P1|COMPLETED|Overall Study||149
8218502|NCT02070276|20268403|P3|STARTED|Overall Study||148
8218503|NCT02070276|20268404|P2|STARTED|Overall Study||132
8218504|NCT02070276|20268405|P1|STARTED|Overall Study||149
8218505|NCT02070237|20268421|P2|NOT COMPLETED|Overall Study||3
8218506|NCT02070237|20268422|P1|NOT COMPLETED|Overall Study||3
8218507|NCT02070237|20268421|P2|COMPLETED|Overall Study||42
8218508|NCT02070237|20268422|P1|COMPLETED|Overall Study||42
8218509|NCT02070237|20268421|P2|STARTED|Overall Study||45
8218510|NCT02070237|20268422|P1|STARTED|Overall Study||45
8218511|NCT02069847|20268432|P2|NOT COMPLETED|Overall Study||0
8218512|NCT02069847|20268433|P1|NOT COMPLETED|Overall Study||0
8218513|NCT02069847|20268432|P2|COMPLETED|Overall Study||68
8218514|NCT02069847|20268433|P1|COMPLETED|Overall Study||22
8218515|NCT02069847|20268432|P2|STARTED|Overall Study||68
8218516|NCT02069847|20268433|P1|STARTED|Overall Study||22
8218517|NCT02069704|20268442|P2|NOT COMPLETED|Overall Study||0
8218518|NCT02069704|20268443|P1|NOT COMPLETED|Overall Study||0
8218519|NCT02069704|20268442|P2|COMPLETED|Overall Study||71
8218520|NCT02069704|20268443|P1|COMPLETED|Overall Study||69
8218521|NCT02069704|20268442|P2|STARTED|Overall Study||71
8218522|NCT02069704|20268443|P1|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
8218523|NCT02069392|20268475|P2|NOT COMPLETED|Overall Study||2
8218524|NCT02069392|20268476|P1|NOT COMPLETED|Overall Study||4
8218525|NCT02069392|20268475|P2|COMPLETED|Overall Study||15
8218526|NCT02069392|20268476|P1|COMPLETED|Overall Study||10
8218527|NCT02069392|20268475|P2|STARTED|Overall Study||17
8218528|NCT02069392|20268476|P1|STARTED|Overall Study||14
8218529|NCT02069379|20268500|P4|NOT COMPLETED|Second Treatment Arm||0
8218530|NCT02069379|20268501|P3|NOT COMPLETED|Second Treatment Arm||1
8218531|NCT02069379|20268502|P2|NOT COMPLETED|Second Treatment Arm||0
8218532|NCT02069379|20268503|P1|NOT COMPLETED|Second Treatment Arm||0
8218533|NCT02069379|20268500|P4|COMPLETED|Second Treatment Arm||0
8218534|NCT02069379|20268501|P3|COMPLETED|Second Treatment Arm||0
8218535|NCT02069379|20268502|P2|COMPLETED|Second Treatment Arm||1
8218536|NCT02069379|20268503|P1|COMPLETED|Second Treatment Arm||0
8218537|NCT02069379|20268500|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
8218538|NCT02069379|20268501|P3|STARTED|Second Treatment Arm||1
8218539|NCT02069379|20268502|P2|STARTED|Second Treatment Arm||1
8218540|NCT02069379|20268503|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
8218541|NCT02069379|20268500|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
8218542|NCT02069379|20268501|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
8218543|NCT02069379|20268502|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
8218544|NCT02069379|20268503|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
8218545|NCT02069379|20268500|P4|COMPLETED|Washout Period (4 Weeks)||0
8218546|NCT02069379|20268501|P3|COMPLETED|Washout Period (4 Weeks)||1
8218547|NCT02069379|20268502|P2|COMPLETED|Washout Period (4 Weeks)||1
8218548|NCT02069379|20268503|P1|COMPLETED|Washout Period (4 Weeks)||0
8218549|NCT02069379|20268500|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
8218550|NCT02069379|20268501|P3|STARTED|Washout Period (4 Weeks)||1
8218551|NCT02069379|20268502|P2|STARTED|Washout Period (4 Weeks)||3
8218552|NCT02069379|20268503|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
8218553|NCT02069379|20268500|P4|NOT COMPLETED|First Treatment Arm||0
8218554|NCT02069379|20268501|P3|NOT COMPLETED|First Treatment Arm||1
8218555|NCT02069379|20268502|P2|NOT COMPLETED|First Treatment Arm||1
8218556|NCT02069379|20268503|P1|NOT COMPLETED|First Treatment Arm||0
8218557|NCT02069379|20268500|P4|COMPLETED|First Treatment Arm||0
8218558|NCT02069379|20268501|P3|COMPLETED|First Treatment Arm||1
8218559|NCT02069379|20268502|P2|COMPLETED|First Treatment Arm||3
8218560|NCT02069379|20268503|P1|COMPLETED|First Treatment Arm||0
8218561|NCT02069379|20268500|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
8218562|NCT02069379|20268501|P3|STARTED|First Treatment Arm||2
8218563|NCT02069379|20268502|P2|STARTED|First Treatment Arm||4
8218564|NCT02069379|20268503|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
8218565|NCT02069379|20268500|P4|NOT COMPLETED|Baseline Measurements||2
8218566|NCT02069379|20268501|P3|NOT COMPLETED|Baseline Measurements||0
8218567|NCT02069379|20268502|P2|NOT COMPLETED|Baseline Measurements||0
8218568|NCT02069379|20268503|P1|NOT COMPLETED|Baseline Measurements||3
8218569|NCT02069379|20268500|P4|COMPLETED|Baseline Measurements||4
8218570|NCT02069379|20268501|P3|COMPLETED|Baseline Measurements||2
8218571|NCT02069379|20268502|P2|COMPLETED|Baseline Measurements||4
8218572|NCT02069379|20268503|P1|COMPLETED|Baseline Measurements||27
8218573|NCT02069379|20268500|P4|Baseline Measurements Taken|Baseline Measurements||6
8218574|NCT02069379|20268501|P3|Baseline Measurements Taken|Baseline Measurements||2
8218575|NCT02069379|20268502|P2|Baseline Measurements Taken|Baseline Measurements||4
8218576|NCT02069379|20268503|P1|Baseline Measurements Taken|Baseline Measurements||30
8218577|NCT02069379|20268500|P4|STARTED|Baseline Measurements||6
8218578|NCT02069379|20268501|P3|STARTED|Baseline Measurements||2
8218579|NCT02069379|20268502|P2|STARTED|Baseline Measurements||4
8218580|NCT02069379|20268503|P1|STARTED|Baseline Measurements||30
8218581|NCT02069353|20268529|P1|NOT COMPLETED|Overall Study||0
8218582|NCT02069353|20268529|P1|COMPLETED|Overall Study||4
8218583|NCT02069353|20268529|P1|STARTED|Overall Study||4
8218584|NCT02069184|20268540|P2|NOT COMPLETED|Overall Study||2
8218585|NCT02069184|20268541|P1|NOT COMPLETED|Overall Study||6
8218586|NCT02069184|20268540|P2|COMPLETED|Overall Study||31
8218587|NCT02069184|20268541|P1|COMPLETED|Overall Study||27
8218588|NCT02069184|20268540|P2|STARTED|Overall Study||33
8218589|NCT02069184|20268541|P1|STARTED|Overall Study||33
8218590|NCT02069119|20268563|P4|NOT COMPLETED|Overall Study||0
8218591|NCT02069119|20268564|P3|NOT COMPLETED|Overall Study||0
8218592|NCT02069119|20268565|P2|NOT COMPLETED|Overall Study||0
8218593|NCT02069119|20268566|P1|NOT COMPLETED|Overall Study||0
8218594|NCT02069119|20268563|P4|COMPLETED|Overall Study||4
8218595|NCT02069119|20268564|P3|COMPLETED|Overall Study||20
8218596|NCT02069119|20268565|P2|COMPLETED|Overall Study||4
8218597|NCT02069119|20268566|P1|COMPLETED|Overall Study||20
8218598|NCT02069119|20268563|P4|STARTED|Overall Study||4
8218599|NCT02069119|20268564|P3|STARTED|Overall Study||20
8218600|NCT02069119|20268565|P2|STARTED|Overall Study||4
8218601|NCT02069119|20268566|P1|STARTED|Overall Study||20
8218602|NCT02069093|20268590|P1|NOT COMPLETED|Overall Study||30
8218603|NCT02069093|20268590|P1|COMPLETED|Overall Study||56
8218604|NCT02069093|20268590|P1|Pharmacokinetic Analysis Set|Overall Study||50
8218605|NCT02069093|20268590|P1|STARTED|Overall Study||86
8218606|NCT02069041|20268599|P1|NOT COMPLETED|Overall Study||0
8218607|NCT02069041|20268599|P1|COMPLETED|Overall Study||8
8218608|NCT02069041|20268599|P1|Received at Least One Dose of Study Drug|Overall Study||8
8218609|NCT02069041|20268599|P1|STARTED|Overall Study||8
8218610|NCT02069015|20268609|P2|NOT COMPLETED|Overall Study||33
8218611|NCT02069015|20268610|P1|NOT COMPLETED|Overall Study||40
8218612|NCT02069015|20268609|P2|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
8218613|NCT02069015|20268610|P1|COMPLETED|Overall Study|180 post ED discharge at CRC|31
8218614|NCT02069015|20268609|P2|90 Day|Overall Study|90 day post ED discharge|35
8218615|NCT02069015|20268610|P1|90 Day|Overall Study|90 day post ED discharge at CRC|32
8218616|NCT02069015|20268609|P2|30 Day|Overall Study|30 day post-discharge at CRC|43
8218617|NCT02069015|20268610|P1|30 Day|Overall Study|30 day post-discharge at CRC|38
8218618|NCT02069015|20268609|P2|7 Day|Overall Study|7 day post ED discharge at CRC|45
8218619|NCT02069015|20268610|P1|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
8218620|NCT02069015|20268609|P2|STARTED|Overall Study||68
8218621|NCT02069015|20268610|P1|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
8218640|NCT02068846|20268669|P2|NOT COMPLETED|Overall Study||1
8218641|NCT02068846|20268670|P1|NOT COMPLETED|Overall Study||1
8218642|NCT02068846|20268669|P2|COMPLETED|Overall Study||7
8218643|NCT02068846|20268670|P1|COMPLETED|Overall Study||8
8218644|NCT02068846|20268669|P2|STARTED|Overall Study||8
8218645|NCT02068846|20268670|P1|STARTED|Overall Study||9
8218646|NCT02068820|20268688|P2|NOT COMPLETED|Overall Study||0
8218647|NCT02068820|20268689|P1|NOT COMPLETED|Overall Study||0
8218648|NCT02068820|20268688|P2|COMPLETED|Overall Study||180
8218649|NCT02068820|20268689|P1|COMPLETED|Overall Study||20
8218650|NCT02068820|20268688|P2|STARTED|Overall Study||180
8218651|NCT02068820|20268689|P1|STARTED|Overall Study||20
8218652|NCT02068768|20268700|P1|NOT COMPLETED|Overall Study||7
8218653|NCT02068768|20268700|P1|COMPLETED|Overall Study||6
8218654|NCT02068768|20268700|P1|STARTED|Overall Study||13
8218655|NCT02068599|20268709|P3|NOT COMPLETED|Overall Study||13
8218656|NCT02068599|20268710|P2|NOT COMPLETED|Overall Study||10
8218657|NCT02068599|20268711|P1|NOT COMPLETED|Overall Study||11
8218658|NCT02068599|20268709|P3|COMPLETED|Overall Study||117
8218659|NCT02068599|20268710|P2|COMPLETED|Overall Study||119
8218660|NCT02068599|20268711|P1|COMPLETED|Overall Study||119
8218661|NCT02068599|20268709|P3|Full Analysis Set|Overall Study||130
8218662|NCT02068599|20268710|P2|Full Analysis Set|Overall Study||128
8218663|NCT02068599|20268711|P1|Full Analysis Set|Overall Study||129
8218664|NCT02068599|20268709|P3|Safety Analysis Set|Overall Study||130
8218665|NCT02068599|20268710|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
8218666|NCT02068599|20268711|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
8218667|NCT02068599|20268709|P3|STARTED|Overall Study||130
8218668|NCT02068599|20268710|P2|STARTED|Overall Study||129
8218669|NCT02068599|20268711|P1|STARTED|Overall Study||130
8218670|NCT02068547|20268751|P2|NOT COMPLETED|Overall Study||3
8218671|NCT02068547|20268752|P1|NOT COMPLETED|Overall Study||4
8218672|NCT02068547|20268751|P2|COMPLETED|Overall Study||1
8218673|NCT02068547|20268752|P1|COMPLETED|Overall Study||0
8218674|NCT02068547|20268751|P2|STARTED|Overall Study||4
8218675|NCT02068547|20268752|P1|STARTED|Overall Study||4
8218676|NCT02068508|20268762|P1|NOT COMPLETED|Overall Study||32
8218677|NCT02068508|20268762|P1|COMPLETED|Overall Study||1035
8218678|NCT02068508|20268762|P1|STARTED|Overall Study||1067
8218679|NCT02068495|20268772|P1|NOT COMPLETED|Overall Study||109
8218680|NCT02068495|20268772|P1|COMPLETED|Overall Study||3300
8218681|NCT02068495|20268772|P1|STARTED|Overall Study||3409
8218682|NCT02068443|20268784|P3|NOT COMPLETED|Overall Study||3
8218683|NCT02068443|20268785|P2|NOT COMPLETED|Overall Study||6
8218684|NCT02068443|20268786|P1|NOT COMPLETED|Overall Study||7
8218685|NCT02068443|20268784|P3|COMPLETED|Overall Study||148
8218686|NCT02068443|20268785|P2|COMPLETED|Overall Study||146
8218687|NCT02068443|20268786|P1|COMPLETED|Overall Study||64
8218688|NCT02068443|20268784|P3|STARTED|Overall Study||151
8218689|NCT02068443|20268785|P2|STARTED|Overall Study||152
8218690|NCT02068443|20268786|P1|STARTED|Overall Study||71
8218691|NCT02068222|20268821|P1|NOT COMPLETED|Overall Study||1
8218692|NCT02068222|20268821|P1|COMPLETED|Overall Study||9
8218693|NCT02068222|20268821|P1|STARTED|Overall Study||10
8218694|NCT02068157|20268828|P1|NOT COMPLETED|Overall Study||0
8218695|NCT02068157|20268828|P1|COMPLETED|Overall Study||3
8218696|NCT02068157|20268828|P1|STARTED|Overall Study||3
8218697|NCT02068027|20268835|P2|NOT COMPLETED|Overall Study||16
8218698|NCT02068027|20268836|P1|NOT COMPLETED|Overall Study||13
8218699|NCT02068027|20268835|P2|COMPLETED|Overall Study||114
8218700|NCT02068027|20268836|P1|COMPLETED|Overall Study||117
8218701|NCT02068027|20268835|P2|STARTED|Overall Study||130
8218702|NCT02068027|20268836|P1|STARTED|Overall Study||130
8218703|NCT02067858|20268844|P1|NOT COMPLETED|Overall Study||0
8218704|NCT02067858|20268844|P1|COMPLETED|Overall Study||6
8218705|NCT02067858|20268844|P1|STARTED|Overall Study||6
8218706|NCT02067728|20268852|P2|NOT COMPLETED|6 Month Measurements||97
8218707|NCT02067728|20268853|P1|NOT COMPLETED|6 Month Measurements||114
8218708|NCT02067728|20268852|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
8218709|NCT02067728|20268853|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
8218710|NCT02067728|20268852|P2|STARTED|6 Month Measurements||210
8218711|NCT02067728|20268853|P1|STARTED|6 Month Measurements||220
8218712|NCT02067728|20268852|P2|NOT COMPLETED|6 Month Follow up Survey||60
8218713|NCT02067728|20268853|P1|NOT COMPLETED|6 Month Follow up Survey||48
8218714|NCT02067728|20268852|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
8218715|NCT02067728|20268853|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
8218716|NCT02067728|20268852|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
8218717|NCT02067728|20268853|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
8218718|NCT02067728|20268852|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
8218719|NCT02067728|20268853|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
8218720|NCT02067728|20268852|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
8218721|NCT02067728|20268853|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
8218722|NCT02067728|20268852|P2|STARTED|Baseline - 1 Month Follow up Survey||210
8218723|NCT02067728|20268853|P1|STARTED|Baseline - 1 Month Follow up Survey||220
8218724|NCT02067676|20268887|P6|NOT COMPLETED|Overall Study||0
8218725|NCT02067676|20268888|P5|NOT COMPLETED|Overall Study||0
8218726|NCT02067676|20268889|P4|NOT COMPLETED|Overall Study||0
8218727|NCT02067676|20268890|P3|NOT COMPLETED|Overall Study||0
8218728|NCT02067676|20268891|P2|NOT COMPLETED|Overall Study||0
8218729|NCT02067676|20268892|P1|NOT COMPLETED|Overall Study||1
8218730|NCT02067676|20268887|P6|COMPLETED|Overall Study||8
8218731|NCT02067676|20268888|P5|COMPLETED|Overall Study||8
8218732|NCT02067676|20268889|P4|COMPLETED|Overall Study||8
8218733|NCT02067676|20268890|P3|COMPLETED|Overall Study||8
8218734|NCT02067676|20268891|P2|COMPLETED|Overall Study||8
8218735|NCT02067676|20268892|P1|COMPLETED|Overall Study||7
8218736|NCT02067676|20268887|P6|STARTED|Overall Study||8
8218737|NCT02067676|20268888|P5|STARTED|Overall Study||8
8218738|NCT02067676|20268889|P4|STARTED|Overall Study||8
8218739|NCT02067676|20268890|P3|STARTED|Overall Study||8
8218740|NCT02067676|20268891|P2|STARTED|Overall Study||8
8218741|NCT02067676|20268892|P1|STARTED|Overall Study||8
8218742|NCT02067663|20268932|P2|NOT COMPLETED|Overall Study||14
8218743|NCT02067663|20268933|P1|NOT COMPLETED|Overall Study||13
8218744|NCT02067663|20268932|P2|COMPLETED|Overall Study||41
8218745|NCT02067663|20268933|P1|COMPLETED|Overall Study||55
8218746|NCT02067663|20268932|P2|STARTED|Overall Study||55
8218747|NCT02067663|20268933|P1|STARTED|Overall Study||68
8218748|NCT02067611|20268953|P3|NOT COMPLETED|Overall Study||4
8218749|NCT02067611|20268954|P2|NOT COMPLETED|Overall Study||6
8218750|NCT02067611|20268955|P1|NOT COMPLETED|Overall Study||6
8218751|NCT02067611|20268953|P3|COMPLETED|Overall Study||68
8218752|NCT02067611|20268954|P2|COMPLETED|Overall Study||66
8218753|NCT02067611|20268955|P1|COMPLETED|Overall Study||66
8218754|NCT02067611|20268953|P3|STARTED|Overall Study||72
8218755|NCT02067611|20268954|P2|STARTED|Overall Study||72
8218756|NCT02067611|20268955|P1|STARTED|Overall Study||72
8218757|NCT02067585|20268993|P3|NOT COMPLETED|Overall Study||0
8218758|NCT02067585|20268994|P2|NOT COMPLETED|Overall Study||0
8218759|NCT02067585|20268995|P1|NOT COMPLETED|Overall Study||0
8218760|NCT02067585|20268993|P3|COMPLETED|Overall Study||16
8218761|NCT02067585|20268994|P2|COMPLETED|Overall Study||16
8218762|NCT02067585|20268995|P1|COMPLETED|Overall Study||16
8218763|NCT02067585|20268993|P3|STARTED|Overall Study||16
8218764|NCT02067585|20268994|P2|STARTED|Overall Study||16
8218765|NCT02067585|20268995|P1|STARTED|Overall Study||16
8218766|NCT02067533|20269032|P2|NOT COMPLETED|Overall Study||2
8218767|NCT02067533|20269033|P1|NOT COMPLETED|Overall Study||4
8218768|NCT02067533|20269032|P2|COMPLETED|Overall Study||44
8218769|NCT02067533|20269033|P1|COMPLETED|Overall Study||41
8218770|NCT02067533|20269032|P2|STARTED|Overall Study||46
8218771|NCT02067533|20269033|P1|STARTED|Overall Study||45
8218772|NCT02067468|20269042|P3|NOT COMPLETED|Overall Study||0
8218773|NCT02067468|20269043|P2|NOT COMPLETED|Overall Study||0
8218774|NCT02067468|20269044|P1|NOT COMPLETED|Overall Study||0
8218775|NCT02067468|20269042|P3|COMPLETED|Overall Study||889
8218776|NCT02067468|20269043|P2|COMPLETED|Overall Study||890
8218777|NCT02067468|20269044|P1|COMPLETED|Overall Study||882
8218778|NCT02067468|20269042|P3|Had at Least One Routine Colposcopy|Overall Study||462
8218779|NCT02067468|20269043|P2|Had at Least One Routine Colposcopy|Overall Study||372
8218780|NCT02067468|20269044|P1|Had at Least One Routine Colposcopy|Overall Study||772
8218781|NCT02067468|20269042|P3|Followed-up Through Medical Records|Overall Study||889
8218782|NCT02067468|20269043|P2|Followed-up Through Medical Records|Overall Study||890
8218783|NCT02067468|20269044|P1|Followed-up Through Medical Records|Overall Study||882
8218784|NCT02067468|20269042|P3|STARTED|Overall Study||889
8218785|NCT02067468|20269043|P2|STARTED|Overall Study||890
8218786|NCT02067468|20269044|P1|STARTED|Overall Study||882
8218787|NCT02067273|20269075|P2|NOT COMPLETED|Overall Study||3
8218788|NCT02067273|20269076|P1|NOT COMPLETED|Overall Study||0
8218789|NCT02067273|20269075|P2|COMPLETED|Overall Study||12
8218790|NCT02067273|20269076|P1|COMPLETED|Overall Study||5
8218791|NCT02067273|20269075|P2|STARTED|Overall Study||15
8218792|NCT02067273|20269076|P1|STARTED|Overall Study||5
8218793|NCT02067104|20269084|P2|NOT COMPLETED|Overall Study||5
8218794|NCT02067104|20269085|P1|NOT COMPLETED|Overall Study||4
8218795|NCT02067104|20269084|P2|COMPLETED|Overall Study||0
8218796|NCT02067104|20269085|P1|COMPLETED|Overall Study||0
8218797|NCT02067104|20269084|P2|STARTED|Overall Study||5
8218798|NCT02067104|20269085|P1|STARTED|Overall Study||4
8218799|NCT02067039|20269095|P2|NOT COMPLETED|Overall Study||508
8218800|NCT02067039|20269096|P1|NOT COMPLETED|Overall Study||573
8218801|NCT02067039|20269095|P2|COMPLETED|Overall Study||832
8218802|NCT02067039|20269096|P1|COMPLETED|Overall Study||752
8218803|NCT02067039|20269095|P2|9 Month Survey|Overall Study||838
8218804|NCT02067039|20269096|P1|9 Month Survey|Overall Study||748
8218805|NCT02067039|20269095|P2|6 Month Survey|Overall Study||756
8218806|NCT02067039|20269096|P1|6 Month Survey|Overall Study||735
8218807|NCT02067039|20269095|P2|3 Month Survey|Overall Study||766
8218808|NCT02067039|20269096|P1|3 Month Survey|Overall Study||824
8218809|NCT02067039|20269095|P2|STARTED|Overall Study||1340
8218810|NCT02067039|20269096|P1|STARTED|Overall Study||1325
8218811|NCT02067000|20269108|P1|NOT COMPLETED|Overall Study||50
8218812|NCT02067000|20269108|P1|COMPLETED|Overall Study||167
8218813|NCT02067000|20269108|P1|STARTED|Overall Study||217
8218814|NCT02066922|20269114|P1|NOT COMPLETED|Overall Study||1
8218815|NCT02066922|20269114|P1|COMPLETED|Overall Study||14
8218816|NCT02066922|20269114|P1|STARTED|Overall Study||15
8218817|NCT02066896|20269124|P2|NOT COMPLETED|Overall Study||0
8218818|NCT02066896|20269125|P1|NOT COMPLETED|Overall Study||0
8218819|NCT02066896|20269124|P2|COMPLETED|Overall Study||33
8218820|NCT02066896|20269125|P1|COMPLETED|Overall Study||33
8218821|NCT02066896|20269124|P2|STARTED|Overall Study||33
8218822|NCT02066896|20269125|P1|STARTED|Overall Study||33
8218823|NCT02066857|20269137|P2|NOT COMPLETED|Overall Study||1
8218824|NCT02066857|20269138|P1|NOT COMPLETED|Overall Study||1
8218825|NCT02066857|20269137|P2|COMPLETED|Overall Study||3
8218826|NCT02066857|20269138|P1|COMPLETED|Overall Study||0
8218827|NCT02066857|20269137|P2|STARTED|Overall Study||4
8218828|NCT02066857|20269138|P1|STARTED|Overall Study||1
8218829|NCT02066792|20269156|P4|NOT COMPLETED|Overall Study||9
8218830|NCT02066792|20269157|P3|NOT COMPLETED|Overall Study||8
8218831|NCT02066792|20269158|P2|NOT COMPLETED|Overall Study||5
8218832|NCT02066792|20269159|P1|NOT COMPLETED|Overall Study||7
8218833|NCT02066792|20269156|P4|COMPLETED|Overall Study||27
8218834|NCT02066792|20269157|P3|COMPLETED|Overall Study||30
8218835|NCT02066792|20269158|P2|COMPLETED|Overall Study||33
8218836|NCT02066792|20269159|P1|COMPLETED|Overall Study||33
8218837|NCT02066792|20269156|P4|STARTED|Overall Study||36
8218838|NCT02066792|20269157|P3|STARTED|Overall Study||38
8218839|NCT02066792|20269158|P2|STARTED|Overall Study||38
8218840|NCT02066792|20269159|P1|STARTED|Overall Study||40
8218841|NCT02066740|20269169|P1|NOT COMPLETED|Overall Study||2
8218842|NCT02066740|20269169|P1|COMPLETED|Overall Study||32
8218843|NCT02066740|20269169|P1|STARTED|Overall Study||34
8218844|NCT02066727|20269176|P2|NOT COMPLETED|Overall Study||0
8218845|NCT02066727|20269177|P1|NOT COMPLETED|Overall Study||0
8218846|NCT02066727|20269176|P2|COMPLETED|Overall Study||30
8218847|NCT02066727|20269177|P1|COMPLETED|Overall Study||30
8218848|NCT02066727|20269176|P2|STARTED|Overall Study||30
8218849|NCT02066727|20269177|P1|STARTED|Overall Study||30
8218850|NCT02066467|20269183|P1|NOT COMPLETED|Overall Study||215
8218851|NCT02066467|20269183|P1|COMPLETED|Overall Study||648
8218852|NCT02066467|20269183|P1|STARTED|Overall Study||863
8218853|NCT02066415|20269192|P3|NOT COMPLETED|Overall Study||8
8218854|NCT02066415|20269193|P2|NOT COMPLETED|Overall Study||7
8218855|NCT02066415|20269194|P1|NOT COMPLETED|Overall Study||21
8218856|NCT02066415|20269192|P3|COMPLETED|Overall Study||182
8218857|NCT02066415|20269193|P2|COMPLETED|Overall Study||184
8218858|NCT02066415|20269194|P1|COMPLETED|Overall Study||265
8218859|NCT02066415|20269192|P3|Received Study Drug|Overall Study||188
8218860|NCT02066415|20269193|P2|Received Study Drug|Overall Study||190
8218861|NCT02066415|20269194|P1|Received Study Drug|Overall Study||282
8218862|NCT02066415|20269192|P3|STARTED|Overall Study||190
8218863|NCT02066415|20269193|P2|STARTED|Overall Study||191
8218864|NCT02066415|20269194|P1|STARTED|Overall Study||286
8218865|NCT02066402|20269219|P2|NOT COMPLETED|Overall Study||23
8218866|NCT02066402|20269220|P1|NOT COMPLETED|Overall Study||26
8218867|NCT02066402|20269219|P2|COMPLETED|Overall Study||275
8218868|NCT02066402|20269220|P1|COMPLETED|Overall Study||274
8218869|NCT02066402|20269219|P2|Completed Study Treatment Period|Overall Study||256
8218870|NCT02066402|20269220|P1|Completed Study Treatment Period|Overall Study||261
8218871|NCT02066402|20269219|P2|Participants Received Treatment|Overall Study||297
8218872|NCT02066402|20269220|P1|Participants Received Treatment|Overall Study||292
8218873|NCT02066402|20269219|P2|STARTED|Overall Study||298
8218874|NCT02066402|20269220|P1|STARTED|Overall Study||300
8218875|NCT02066389|20269252|P6|NOT COMPLETED|Overall Study||5
8218876|NCT02066389|20269253|P5|NOT COMPLETED|Overall Study||7
8218877|NCT02066389|20269254|P4|NOT COMPLETED|Overall Study||3
8218878|NCT02066389|20269255|P3|NOT COMPLETED|Overall Study||6
8218879|NCT02066389|20269256|P2|NOT COMPLETED|Overall Study||1
8218880|NCT02066389|20269257|P1|NOT COMPLETED|Overall Study||5
8218881|NCT02066389|20269252|P6|COMPLETED|Overall Study||45
8218882|NCT02066389|20269253|P5|COMPLETED|Overall Study||43
8218883|NCT02066389|20269254|P4|COMPLETED|Overall Study||47
8218884|NCT02066389|20269255|P3|COMPLETED|Overall Study||44
8218885|NCT02066389|20269256|P2|COMPLETED|Overall Study||49
8218886|NCT02066389|20269257|P1|COMPLETED|Overall Study||45
8218887|NCT02066389|20269252|P6|Received Study Drug|Overall Study||49
8218888|NCT02066389|20269253|P5|Received Study Drug|Overall Study||50
8218889|NCT02066389|20269254|P4|Received Study Drug|Overall Study||50
8218890|NCT02066389|20269255|P3|Received Study Drug|Overall Study||50
8218891|NCT02066389|20269256|P2|Received Study Drug|Overall Study||50
8218892|NCT02066389|20269257|P1|Received Study Drug|Overall Study||50
8218893|NCT02066389|20269252|P6|STARTED|Overall Study||50
8218894|NCT02066389|20269253|P5|STARTED|Overall Study||50
8218895|NCT02066389|20269254|P4|STARTED|Overall Study||50
8218896|NCT02066389|20269255|P3|STARTED|Overall Study||50
8218897|NCT02066389|20269256|P2|STARTED|Overall Study||50
8218898|NCT02066389|20269257|P1|STARTED|Overall Study||50
8218899|NCT02066311|20269307|P1|NOT COMPLETED|Overall Study||5
8218900|NCT02066311|20269307|P1|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
8218901|NCT02066311|20269307|P1|STARTED|Overall Study||15
8218902|NCT02066298|20269317|P6|NOT COMPLETED|Overall Study||12
8218903|NCT02066298|20269318|P5|NOT COMPLETED|Overall Study||9
8218904|NCT02066298|20269319|P4|NOT COMPLETED|Overall Study||6
8218905|NCT02066298|20269320|P3|NOT COMPLETED|Overall Study||10
8218906|NCT02066298|20269321|P2|NOT COMPLETED|Overall Study||8
8218907|NCT02066298|20269322|P1|NOT COMPLETED|Overall Study||9
8218908|NCT02066298|20269317|P6|COMPLETED|Overall Study||38
8218909|NCT02066298|20269318|P5|COMPLETED|Overall Study||38
8218910|NCT02066298|20269319|P4|COMPLETED|Overall Study||45
8218911|NCT02066298|20269320|P3|COMPLETED|Overall Study||40
8218912|NCT02066298|20269321|P2|COMPLETED|Overall Study||40
8218913|NCT02066298|20269322|P1|COMPLETED|Overall Study||40
8218914|NCT02066298|20269317|P6|Completed 3rd Period|Overall Study||38
8218915|NCT02066298|20269318|P5|Completed 3rd Period|Overall Study||38
8218916|NCT02066298|20269319|P4|Completed 3rd Period|Overall Study||45
8218917|NCT02066298|20269320|P3|Completed 3rd Period|Overall Study||40
8218918|NCT02066298|20269321|P2|Completed 3rd Period|Overall Study||40
8218919|NCT02066298|20269322|P1|Completed 3rd Period|Overall Study||40
8218920|NCT02066298|20269317|P6|Completed 2nd Period|Overall Study||41
8218921|NCT02066298|20269318|P5|Completed 2nd Period|Overall Study||42
8218922|NCT02066298|20269319|P4|Completed 2nd Period|Overall Study||46
8218923|NCT02066298|20269320|P3|Completed 2nd Period|Overall Study||41
8218924|NCT02066298|20269321|P2|Completed 2nd Period|Overall Study||41
8218925|NCT02066298|20269322|P1|Completed 2nd Period|Overall Study||41
8218926|NCT02066298|20269317|P6|Completed 1st Period|Overall Study||45
8218927|NCT02066298|20269318|P5|Completed 1st Period|Overall Study||46
8218928|NCT02066298|20269319|P4|Completed 1st Period|Overall Study||48
8218929|NCT02066298|20269320|P3|Completed 1st Period|Overall Study||45
8218930|NCT02066298|20269321|P2|Completed 1st Period|Overall Study||47
8218931|NCT02066298|20269322|P1|Completed 1st Period|Overall Study||44
8218932|NCT02066298|20269317|P6|STARTED|Overall Study||50
8218933|NCT02066298|20269318|P5|STARTED|Overall Study||47
8218934|NCT02066298|20269319|P4|STARTED|Overall Study||51
8218935|NCT02066298|20269320|P3|STARTED|Overall Study||50
8218936|NCT02066298|20269321|P2|STARTED|Overall Study||48
8218937|NCT02066298|20269322|P1|STARTED|Overall Study||49
8218938|NCT02066233|20269346|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
8218939|NCT02066233|20269347|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
8218940|NCT02066233|20269346|P2|COMPLETED|Standard Endoscopy (Day 2)||44
8218941|NCT02066233|20269347|P1|COMPLETED|Standard Endoscopy (Day 2)||44
8218942|NCT02066233|20269346|P2|STARTED|Standard Endoscopy (Day 2)||44
8218943|NCT02066233|20269347|P1|STARTED|Standard Endoscopy (Day 2)||44
8218944|NCT02066233|20269346|P2|NOT COMPLETED|EG Scan II (Day 1)||6
8218945|NCT02066233|20269347|P1|NOT COMPLETED|EG Scan II (Day 1)||6
8218946|NCT02066233|20269346|P2|COMPLETED|EG Scan II (Day 1)||44
8218947|NCT02066233|20269347|P1|COMPLETED|EG Scan II (Day 1)||44
8218948|NCT02066233|20269346|P2|STARTED|EG Scan II (Day 1)||50
8218949|NCT02066233|20269347|P1|STARTED|EG Scan II (Day 1)||50
8218950|NCT02066181|20269357|P2|NOT COMPLETED|Overall Study||1
8218951|NCT02066181|20269358|P1|NOT COMPLETED|Overall Study||1
8218952|NCT02066181|20269357|P2|COMPLETED|Overall Study||36
8218953|NCT02066181|20269358|P1|COMPLETED|Overall Study||49
8218954|NCT02066181|20269357|P2|Crossed Over|Overall Study||28
8218955|NCT02066181|20269358|P1|Crossed Over|Overall Study||0
8218956|NCT02066181|20269357|P2|STARTED|Overall Study||37
8218957|NCT02066181|20269358|P1|STARTED|Overall Study||50
8218958|NCT02066129|20269380|P2|NOT COMPLETED|Overall Study||33
8218959|NCT02066129|20269381|P1|NOT COMPLETED|Overall Study||29
8218960|NCT02066129|20269380|P2|COMPLETED|Overall Study||94
8218961|NCT02066129|20269381|P1|COMPLETED|Overall Study||98
8218962|NCT02066129|20269380|P2|STARTED|Overall Study||127
8218963|NCT02066129|20269381|P1|STARTED|Overall Study||127
8218964|NCT02066051|20269395|P1|NOT COMPLETED|Overall Study||1
8218965|NCT02066051|20269395|P1|COMPLETED|Overall Study||7
8218966|NCT02066051|20269395|P1|STARTED|Overall Study||8
8218967|NCT02065895|20269400|P6|NOT COMPLETED|Overall Study||0
8218968|NCT02065895|20269401|P5|NOT COMPLETED|Overall Study||0
8218969|NCT02065895|20269402|P4|NOT COMPLETED|Overall Study||1
8218970|NCT02065895|20269403|P3|NOT COMPLETED|Overall Study||0
8218971|NCT02065895|20269404|P2|NOT COMPLETED|Overall Study||1
8218972|NCT02065895|20269405|P1|NOT COMPLETED|Overall Study||1
8218973|NCT02065895|20269400|P6|COMPLETED|Overall Study||1
8218974|NCT02065895|20269401|P5|COMPLETED|Overall Study||1
8218975|NCT02065895|20269402|P4|COMPLETED|Overall Study||0
8218976|NCT02065895|20269403|P3|COMPLETED|Overall Study||1
8218977|NCT02065895|20269404|P2|COMPLETED|Overall Study||2
8218978|NCT02065895|20269405|P1|COMPLETED|Overall Study||0
8218979|NCT02065895|20269400|P6|STARTED|Overall Study||1
8218980|NCT02065895|20269401|P5|STARTED|Overall Study||1
8218981|NCT02065895|20269402|P4|STARTED|Overall Study||1
8218982|NCT02065895|20269403|P3|STARTED|Overall Study||1
8218983|NCT02065895|20269404|P2|STARTED|Overall Study||3
8218984|NCT02065895|20269405|P1|STARTED|Overall Study||1
8218985|NCT02065791|20269424|P2|NOT COMPLETED|Overall Study||15
8218986|NCT02065791|20269425|P1|NOT COMPLETED|Overall Study||25
8218987|NCT02065791|20269424|P2|COMPLETED|Overall Study||2187
8218988|NCT02065791|20269425|P1|COMPLETED|Overall Study||2174
8218989|NCT02065791|20269424|P2|Treated|Overall Study||2200
8218990|NCT02065791|20269425|P1|Treated|Overall Study||2197
8218991|NCT02065791|20269424|P2|STARTED|Overall Study||2202
8218992|NCT02065791|20269425|P1|STARTED|Overall Study||2199
8218993|NCT02065713|20269447|P2|NOT COMPLETED|Overall Study||1
8218994|NCT02065713|20269448|P1|NOT COMPLETED|Overall Study||1
8218995|NCT02065713|20269447|P2|COMPLETED|Overall Study||20
8218996|NCT02065713|20269448|P1|COMPLETED|Overall Study||22
8218997|NCT02065713|20269447|P2|STARTED|Overall Study||21
8218998|NCT02065713|20269448|P1|STARTED|Overall Study||23
8218999|NCT02065687|20269456|P2|NOT COMPLETED|Overall Study||0
8219000|NCT02065687|20269457|P1|NOT COMPLETED|Overall Study||0
8219001|NCT02065687|20269456|P2|COMPLETED|Overall Study||235
8219002|NCT02065687|20269457|P1|COMPLETED|Overall Study||234
8219003|NCT02065687|20269456|P2|STARTED|Overall Study||235
8219004|NCT02065687|20269457|P1|STARTED|Overall Study||234
8219005|NCT02065622|20269479|P5|NOT COMPLETED|Maintenance Study||46
8219006|NCT02065622|20269480|P4|NOT COMPLETED|Maintenance Study||104
8219007|NCT02065622|20269481|P3|NOT COMPLETED|Maintenance Study||124
8219008|NCT02065622|20269482|P2|NOT COMPLETED|Maintenance Study||0
8219009|NCT02065622|20269483|P1|NOT COMPLETED|Maintenance Study||0
8219010|NCT02065622|20269479|P5|COMPLETED|Maintenance Study||105
8219011|NCT02065622|20269480|P4|COMPLETED|Maintenance Study||246
8219012|NCT02065622|20269481|P3|COMPLETED|Maintenance Study||221
8219013|NCT02065622|20269482|P2|COMPLETED|Maintenance Study||0
8219014|NCT02065622|20269483|P1|COMPLETED|Maintenance Study||0
8219015|NCT02065622|20269479|P5|STARTED|Maintenance Study||151
8219016|NCT02065622|20269480|P4|STARTED|Maintenance Study||350
8219017|NCT02065622|20269481|P3|STARTED|Maintenance Study||345
8219018|NCT02065622|20269482|P2|STARTED|Maintenance Study||0
8219019|NCT02065622|20269483|P1|STARTED|Maintenance Study||0
8219020|NCT02065622|20269479|P5|NOT COMPLETED|Induction Study||0
8219021|NCT02065622|20269480|P4|NOT COMPLETED|Induction Study||0
8219022|NCT02065622|20269481|P3|NOT COMPLETED|Induction Study||0
8219023|NCT02065622|20269482|P2|NOT COMPLETED|Induction Study||59
8219024|NCT02065622|20269483|P1|NOT COMPLETED|Induction Study||47
8219025|NCT02065622|20269479|P5|COMPLETED|Induction Study||0
8219026|NCT02065622|20269480|P4|COMPLETED|Induction Study||0
8219027|NCT02065622|20269481|P3|COMPLETED|Induction Study||0
8219028|NCT02065622|20269482|P2|COMPLETED|Induction Study||514
8219029|NCT02065622|20269483|P1|COMPLETED|Induction Study||332
8219030|NCT02065622|20269479|P5|Enrolled in Japan Sub-Study|Induction Study||0
8219031|NCT02065622|20269480|P4|Enrolled in Japan Sub-Study|Induction Study||0
8219032|NCT02065622|20269481|P3|Enrolled in Japan Sub-Study|Induction Study||0
8219033|NCT02065622|20269482|P2|Enrolled in Japan Sub-Study|Induction Study||61
8219034|NCT02065622|20269483|P1|Enrolled in Japan Sub-Study|Induction Study||39
8219035|NCT02065622|20269479|P5|Enrolled in Main Study|Induction Study||0
8219036|NCT02065622|20269480|P4|Enrolled in Main Study|Induction Study||0
8219037|NCT02065622|20269481|P3|Enrolled in Main Study|Induction Study||0
8219038|NCT02065622|20269482|P2|Enrolled in Main Study|Induction Study||512
8219039|NCT02065622|20269483|P1|Enrolled in Main Study|Induction Study||340
8219040|NCT02065622|20269479|P5|STARTED|Induction Study||0
8219041|NCT02065622|20269480|P4|STARTED|Induction Study||0
8219042|NCT02065622|20269481|P3|STARTED|Induction Study||0
8219043|NCT02065622|20269482|P2|STARTED|Induction Study||573
8219044|NCT02065622|20269483|P1|STARTED|Induction Study||379
8219045|NCT02065557|20269585|P6|NOT COMPLETED|Maintenance Period||4
8219046|NCT02065557|20269586|P5|NOT COMPLETED|Maintenance Period||8
8219047|NCT02065557|20269587|P4|NOT COMPLETED|Maintenance Period||1
8219048|NCT02065557|20269588|P3|NOT COMPLETED|Maintenance Period||0
8219049|NCT02065557|20269589|P2|NOT COMPLETED|Maintenance Period||0
8219050|NCT02065557|20269590|P1|NOT COMPLETED|Maintenance Period||0
8219051|NCT02065557|20269585|P6|COMPLETED|Maintenance Period||32
8219052|NCT02065557|20269586|P5|COMPLETED|Maintenance Period||25
8219053|NCT02065557|20269587|P4|COMPLETED|Maintenance Period||11
8219054|NCT02065557|20269588|P3|COMPLETED|Maintenance Period||0
8219055|NCT02065557|20269589|P2|COMPLETED|Maintenance Period||0
8219056|NCT02065557|20269590|P1|COMPLETED|Maintenance Period||0
8219057|NCT02065557|20269585|P6|STARTED|Maintenance Period||36
8219058|NCT02065557|20269586|P5|STARTED|Maintenance Period||33
8219059|NCT02065557|20269587|P4|STARTED|Maintenance Period||12
8219060|NCT02065557|20269588|P3|STARTED|Maintenance Period||0
8219061|NCT02065557|20269589|P2|STARTED|Maintenance Period||0
8219062|NCT02065557|20269590|P1|STARTED|Maintenance Period||0
8219063|NCT02065557|20269585|P6|NOT COMPLETED|Induction Period||0
8219064|NCT02065557|20269586|P5|NOT COMPLETED|Induction Period||0
8219065|NCT02065557|20269587|P4|NOT COMPLETED|Induction Period||0
8219066|NCT02065557|20269588|P3|NOT COMPLETED|Induction Period||2
8219067|NCT02065557|20269589|P2|NOT COMPLETED|Induction Period||8
8219068|NCT02065557|20269590|P1|NOT COMPLETED|Induction Period||10
8219069|NCT02065557|20269585|P6|COMPLETED|Induction Period||0
8219070|NCT02065557|20269586|P5|COMPLETED|Induction Period||0
8219071|NCT02065557|20269587|P4|COMPLETED|Induction Period||0
8219072|NCT02065557|20269588|P3|COMPLETED|Induction Period||16
8219073|NCT02065557|20269589|P2|COMPLETED|Induction Period||43
8219074|NCT02065557|20269590|P1|COMPLETED|Induction Period||22
8219075|NCT02065557|20269585|P6|Enrolled in Japan Sub-study|Induction Period||0
8219076|NCT02065557|20269586|P5|Enrolled in Japan Sub-study|Induction Period||0
8219077|NCT02065557|20269587|P4|Enrolled in Japan Sub-study|Induction Period||0
8219078|NCT02065557|20269588|P3|Enrolled in Japan Sub-study|Induction Period||2
8219079|NCT02065557|20269589|P2|Enrolled in Japan Sub-study|Induction Period||4
8219080|NCT02065557|20269590|P1|Enrolled in Japan Sub-study|Induction Period||2
8219081|NCT02065557|20269585|P6|Enrolled in Main Study|Induction Period||0
8219082|NCT02065557|20269586|P5|Enrolled in Main Study|Induction Period||0
8219083|NCT02065557|20269587|P4|Enrolled in Main Study|Induction Period||0
8219084|NCT02065557|20269588|P3|Enrolled in Main Study|Induction Period||16
8219085|NCT02065557|20269589|P2|Enrolled in Main Study|Induction Period||47
8219086|NCT02065557|20269590|P1|Enrolled in Main Study|Induction Period||30
8219087|NCT02065557|20269585|P6|STARTED|Induction Period||0
8219088|NCT02065557|20269586|P5|STARTED|Induction Period||0
8219089|NCT02065557|20269587|P4|STARTED|Induction Period||0
8219090|NCT02065557|20269588|P3|STARTED|Induction Period||18
8219091|NCT02065557|20269589|P2|STARTED|Induction Period||51
8219092|NCT02065557|20269590|P1|STARTED|Induction Period||32
8219093|NCT02065518|20269651|P4|NOT COMPLETED|Overall Study||5
8219094|NCT02065518|20269652|P3|NOT COMPLETED|Overall Study||9
8219095|NCT02065518|20269653|P2|NOT COMPLETED|Overall Study||8
8219096|NCT02065518|20269654|P1|NOT COMPLETED|Overall Study||6
8219097|NCT02065518|20269651|P4|COMPLETED|Overall Study||15
8219098|NCT02065518|20269652|P3|COMPLETED|Overall Study||11
8219099|NCT02065518|20269653|P2|COMPLETED|Overall Study||11
8219100|NCT02065518|20269654|P1|COMPLETED|Overall Study||13
8219101|NCT02065518|20269651|P4|STARTED|Overall Study||20
8219102|NCT02065518|20269652|P3|STARTED|Overall Study||20
8219103|NCT02065518|20269653|P2|STARTED|Overall Study||19
8219104|NCT02065518|20269654|P1|STARTED|Overall Study||19
8219105|NCT02065479|20269706|P2|NOT COMPLETED|Overall Study||0
8219106|NCT02065479|20269707|P1|NOT COMPLETED|Overall Study||0
8219107|NCT02065479|20269706|P2|COMPLETED|Overall Study||32
8219108|NCT02065479|20269707|P1|COMPLETED|Overall Study||33
8219109|NCT02065479|20269706|P2|STARTED|Overall Study||32
8219110|NCT02065479|20269707|P1|STARTED|Overall Study||33
8219111|NCT02065453|20269715|P2|NOT COMPLETED|Overall Study||4
8219112|NCT02065453|20269716|P1|NOT COMPLETED|Overall Study||3
8219113|NCT02065453|20269715|P2|COMPLETED|Overall Study||21
8219114|NCT02065453|20269716|P1|COMPLETED|Overall Study||24
8219115|NCT02065453|20269715|P2|STARTED|Overall Study||25
8219116|NCT02065453|20269716|P1|STARTED|Overall Study||27
8219117|NCT02065336|20269729|P10|NOT COMPLETED|Extension Phase||8
8219118|NCT02065336|20269730|P9|NOT COMPLETED|Extension Phase||2
8219119|NCT02065336|20269731|P8|NOT COMPLETED|Extension Phase||0
8219120|NCT02065336|20269732|P7|NOT COMPLETED|Extension Phase||0
8219121|NCT02065336|20269733|P6|NOT COMPLETED|Extension Phase||0
8219122|NCT02065336|20269734|P5|NOT COMPLETED|Extension Phase||0
8219123|NCT02065336|20269735|P4|NOT COMPLETED|Extension Phase||0
8219124|NCT02065336|20269736|P3|NOT COMPLETED|Extension Phase||0
8219125|NCT02065336|20269737|P2|NOT COMPLETED|Extension Phase||0
8219126|NCT02065336|20269738|P1|NOT COMPLETED|Extension Phase||0
8219127|NCT02065336|20269729|P10|COMPLETED|Extension Phase||0
8219128|NCT02065336|20269730|P9|COMPLETED|Extension Phase||0
8219129|NCT02065336|20269731|P8|COMPLETED|Extension Phase||0
8219130|NCT02065336|20269732|P7|COMPLETED|Extension Phase||0
8219131|NCT02065336|20269733|P6|COMPLETED|Extension Phase||0
8219132|NCT02065336|20269734|P5|COMPLETED|Extension Phase||0
8219133|NCT02065336|20269735|P4|COMPLETED|Extension Phase||0
8219134|NCT02065336|20269736|P3|COMPLETED|Extension Phase||0
8219135|NCT02065336|20269737|P2|COMPLETED|Extension Phase||0
8219136|NCT02065336|20269738|P1|COMPLETED|Extension Phase||0
8219137|NCT02065336|20269729|P10|STARTED|Extension Phase||8
8219138|NCT02065336|20269730|P9|STARTED|Extension Phase||2
8219139|NCT02065336|20269731|P8|STARTED|Extension Phase||0
8219140|NCT02065336|20269732|P7|STARTED|Extension Phase||0
8219141|NCT02065336|20269733|P6|STARTED|Extension Phase||0
8219142|NCT02065336|20269734|P5|STARTED|Extension Phase||0
8219143|NCT02065336|20269735|P4|STARTED|Extension Phase||0
8219144|NCT02065336|20269736|P3|STARTED|Extension Phase||0
8219145|NCT02065336|20269737|P2|STARTED|Extension Phase||0
8219146|NCT02065336|20269738|P1|STARTED|Extension Phase||0
8219147|NCT02065336|20269729|P10|NOT COMPLETED|Main Study||0
8219148|NCT02065336|20269730|P9|NOT COMPLETED|Main Study||0
8219149|NCT02065336|20269731|P8|NOT COMPLETED|Main Study||0
8219150|NCT02065336|20269732|P7|NOT COMPLETED|Main Study||0
8219151|NCT02065336|20269733|P6|NOT COMPLETED|Main Study||0
8219152|NCT02065336|20269734|P5|NOT COMPLETED|Main Study||0
8219153|NCT02065336|20269735|P4|NOT COMPLETED|Main Study||0
8219154|NCT02065336|20269736|P3|NOT COMPLETED|Main Study||0
8219155|NCT02065336|20269737|P2|NOT COMPLETED|Main Study||0
8219156|NCT02065336|20269738|P1|NOT COMPLETED|Main Study||0
8219157|NCT02065336|20269729|P10|COMPLETED|Main Study||0
8219158|NCT02065336|20269730|P9|COMPLETED|Main Study||0
8219159|NCT02065336|20269731|P8|COMPLETED|Main Study||10
8219160|NCT02065336|20269732|P7|COMPLETED|Main Study||12
8219161|NCT02065336|20269733|P6|COMPLETED|Main Study||6
8219162|NCT02065336|20269734|P5|COMPLETED|Main Study||6
8219163|NCT02065336|20269735|P4|COMPLETED|Main Study||6
8219164|NCT02065336|20269736|P3|COMPLETED|Main Study||6
8219165|NCT02065336|20269737|P2|COMPLETED|Main Study||6
8219166|NCT02065336|20269738|P1|COMPLETED|Main Study||6
8219167|NCT02065336|20269729|P10|STARTED|Main Study||0
8219168|NCT02065336|20269730|P9|STARTED|Main Study||0
8219169|NCT02065336|20269731|P8|STARTED|Main Study||10
8219170|NCT02065336|20269732|P7|STARTED|Main Study||12
8219171|NCT02065336|20269733|P6|STARTED|Main Study||6
8219172|NCT02065336|20269734|P5|STARTED|Main Study||6
8219173|NCT02065336|20269735|P4|STARTED|Main Study||6
8219174|NCT02065336|20269736|P3|STARTED|Main Study||6
8219175|NCT02065336|20269737|P2|STARTED|Main Study||6
8219176|NCT02065336|20269738|P1|STARTED|Main Study||6
8219177|NCT02064985|20269833|P3|NOT COMPLETED|Overall Study||0
8219178|NCT02064985|20269834|P2|NOT COMPLETED|Overall Study||0
8219179|NCT02064985|20269835|P1|NOT COMPLETED|Overall Study||0
8219180|NCT02064985|20269833|P3|COMPLETED|Overall Study||12
8219181|NCT02064985|20269834|P2|COMPLETED|Overall Study||12
8219182|NCT02064985|20269835|P1|COMPLETED|Overall Study||12
8219183|NCT02064985|20269833|P3|STARTED|Overall Study||12
8219184|NCT02064985|20269834|P2|STARTED|Overall Study||12
8219185|NCT02064985|20269835|P1|STARTED|Overall Study||12
8219186|NCT02064959|20269998|P2|NOT COMPLETED|Overall Study||0
8219187|NCT02064959|20269999|P1|NOT COMPLETED|Overall Study||0
8219188|NCT02064959|20269998|P2|COMPLETED|Overall Study||16
8219189|NCT02064959|20269999|P1|COMPLETED|Overall Study||16
8219190|NCT02064959|20269998|P2|STARTED|Overall Study||16
8219191|NCT02064959|20269999|P1|STARTED|Overall Study||16
8219192|NCT02064920|20270015|P2|NOT COMPLETED|Overall Study||9
8219193|NCT02064920|20270016|P1|NOT COMPLETED|Overall Study||1
8219194|NCT02064920|20270015|P2|COMPLETED|Overall Study||21
8219195|NCT02064920|20270016|P1|COMPLETED|Overall Study||5
8219196|NCT02064920|20270015|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
8219197|NCT02064920|20270016|P1|Treated|Overall Study||6
8219198|NCT02064920|20270015|P2|STARTED|Overall Study||30
8219199|NCT02064920|20270016|P1|STARTED|Overall Study||6
8219200|NCT02064907|20270026|P2|NOT COMPLETED|Period 2||0
8219201|NCT02064907|20270027|P1|NOT COMPLETED|Period 2||0
8219202|NCT02064907|20270026|P2|COMPLETED|Period 2||26
8219203|NCT02064907|20270027|P1|COMPLETED|Period 2||26
8219204|NCT02064907|20270026|P2|STARTED|Period 2||26
8219205|NCT02064907|20270027|P1|STARTED|Period 2||26
8219206|NCT02064907|20270026|P2|NOT COMPLETED|Period 1||0
8219207|NCT02064907|20270027|P1|NOT COMPLETED|Period 1||0
8219208|NCT02064907|20270026|P2|COMPLETED|Period 1||26
8219209|NCT02064907|20270027|P1|COMPLETED|Period 1||26
8219210|NCT02064907|20270026|P2|STARTED|Period 1||26
8219211|NCT02064907|20270027|P1|STARTED|Period 1||26
8219212|NCT02064894|20270046|P3|NOT COMPLETED|Overall Study||115
8219213|NCT02064894|20270047|P2|NOT COMPLETED|Overall Study||102
8219214|NCT02064894|20270048|P1|NOT COMPLETED|Overall Study||43
8219215|NCT02064894|20270046|P3|COMPLETED|Overall Study||86
8219216|NCT02064894|20270047|P2|COMPLETED|Overall Study||99
8219217|NCT02064894|20270048|P1|COMPLETED|Overall Study||56
8219218|NCT02064894|20270046|P3|Avalaible at T-90|Overall Study||129
8219219|NCT02064894|20270047|P2|Avalaible at T-90|Overall Study||134
8219220|NCT02064894|20270048|P1|Avalaible at T-90|Overall Study||74
8219221|NCT02064894|20270046|P3|Available at T-60|Overall Study||177
8219222|NCT02064894|20270047|P2|Available at T-60|Overall Study||188
8219223|NCT02064894|20270048|P1|Available at T-60|Overall Study||91
8219224|NCT02064894|20270046|P3|STARTED|Overall Study|"Received allocated intervention (n=199)
~Did not receive allocated intervention (n=2)"|201
8219225|NCT02064894|20270047|P2|STARTED|Overall Study|"Received allocated intervention (n=198)
~Did not receive allocated intervention (n=3)"|201
8219226|NCT02064894|20270048|P1|STARTED|Overall Study|"Received allocated intervention (n=98)
~Did not receive intervention (n=1)"|99
8219227|NCT02064868|20270061|P2|NOT COMPLETED|Overall Study||13
8219228|NCT02064868|20270062|P1|NOT COMPLETED|Overall Study||34
8219229|NCT02064868|20270061|P2|COMPLETED|Overall Study||881
8219230|NCT02064868|20270062|P1|COMPLETED|Overall Study||1722
8219231|NCT02064868|20270061|P2|Per Protocol Set|Overall Study||627
8219232|NCT02064868|20270062|P1|Per Protocol Set|Overall Study||1155
8219233|NCT02064868|20270061|P2|Safety Set|Overall Study||894
8219234|NCT02064868|20270062|P1|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
8219235|NCT02064868|20270061|P2|Full Analysis Set|Overall Study||894
8219236|NCT02064868|20270062|P1|Full Analysis Set|Overall Study||1756
8219237|NCT02064868|20270061|P2|STARTED|Overall Study||894
8219238|NCT02064868|20270062|P1|STARTED|Overall Study||1756
8219239|NCT02064816|20270082|P2|NOT COMPLETED|Overall Study||8
8219240|NCT02064816|20270083|P1|NOT COMPLETED|Overall Study||8
8219241|NCT02064816|20270082|P2|COMPLETED|Overall Study||88
8219242|NCT02064816|20270083|P1|COMPLETED|Overall Study||96
8219243|NCT02064816|20270082|P2|STARTED|Overall Study||96
8219244|NCT02064816|20270083|P1|STARTED|Overall Study||104
8219245|NCT02064582|20270121|P1|NOT COMPLETED|Overall Study||0
8219246|NCT02064582|20270121|P1|COMPLETED|Overall Study||7
8219247|NCT02064582|20270121|P1|STARTED|Overall Study||7
8219248|NCT02064439|20270129|P3|NOT COMPLETED|Overall Study||182
8219249|NCT02064439|20270130|P2|NOT COMPLETED|Overall Study||138
8219250|NCT02064439|20270131|P1|NOT COMPLETED|Overall Study||143
8219251|NCT02064439|20270129|P3|COMPLETED|Overall Study||949
8219252|NCT02064439|20270130|P2|COMPLETED|Overall Study||969
8219253|NCT02064439|20270131|P1|COMPLETED|Overall Study||984
8219254|NCT02064439|20270129|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
8219255|NCT02064439|20270130|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
8219256|NCT02064439|20270131|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
8219257|NCT02064387|20270160|P12|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
8219258|NCT02064387|20270161|P11|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
8219259|NCT02064387|20270162|P10|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219260|NCT02064387|20270163|P9|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219261|NCT02064387|20270164|P8|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219262|NCT02064387|20270165|P7|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219263|NCT02064387|20270166|P6|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219264|NCT02064387|20270167|P5|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219265|NCT02064387|20270168|P4|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219266|NCT02064387|20270169|P3|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219267|NCT02064387|20270170|P2|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219268|NCT02064387|20270171|P1|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219269|NCT02064387|20270160|P12|COMPLETED|Part 2 Max 35 Months Followup Duration||3
8219270|NCT02064387|20270161|P11|COMPLETED|Part 2 Max 35 Months Followup Duration||29
8219271|NCT02064387|20270162|P10|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219272|NCT02064387|20270163|P9|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219273|NCT02064387|20270164|P8|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219274|NCT02064387|20270165|P7|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219275|NCT02064387|20270166|P6|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219276|NCT02064387|20270167|P5|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219277|NCT02064387|20270168|P4|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219278|NCT02064387|20270169|P3|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219279|NCT02064387|20270170|P2|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219280|NCT02064387|20270171|P1|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219281|NCT02064387|20270160|P12|STARTED|Part 2 Max 35 Months Followup Duration||6
8219282|NCT02064387|20270161|P11|STARTED|Part 2 Max 35 Months Followup Duration||35
8219283|NCT02064387|20270162|P10|STARTED|Part 2 Max 35 Months Followup Duration||0
8219284|NCT02064387|20270163|P9|STARTED|Part 2 Max 35 Months Followup Duration||0
8219285|NCT02064387|20270164|P8|STARTED|Part 2 Max 35 Months Followup Duration||0
8219286|NCT02064387|20270165|P7|STARTED|Part 2 Max 35 Months Followup Duration||0
8219287|NCT02064387|20270166|P6|STARTED|Part 2 Max 35 Months Followup Duration||0
8219288|NCT02064387|20270167|P5|STARTED|Part 2 Max 35 Months Followup Duration||0
8219289|NCT02064387|20270168|P4|STARTED|Part 2 Max 35 Months Followup Duration||0
8219290|NCT02064387|20270169|P3|STARTED|Part 2 Max 35 Months Followup Duration||0
8219291|NCT02064387|20270170|P2|STARTED|Part 2 Max 35 Months Followup Duration||0
8219292|NCT02064387|20270171|P1|STARTED|Part 2 Max 35 Months Followup Duration||0
8219293|NCT02064387|20270160|P12|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219294|NCT02064387|20270161|P11|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219295|NCT02064387|20270162|P10|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219296|NCT02064387|20270163|P9|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219297|NCT02064387|20270164|P8|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
8219298|NCT02064387|20270165|P7|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219299|NCT02064387|20270166|P6|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219300|NCT02064387|20270167|P5|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219301|NCT02064387|20270168|P4|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219302|NCT02064387|20270169|P3|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219303|NCT02064387|20270170|P2|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219304|NCT02064387|20270171|P1|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219305|NCT02064387|20270160|P12|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219306|NCT02064387|20270161|P11|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219307|NCT02064387|20270162|P10|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
8219308|NCT02064387|20270163|P9|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
8219309|NCT02064387|20270164|P8|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
8219310|NCT02064387|20270165|P7|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219311|NCT02064387|20270166|P6|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
8219312|NCT02064387|20270167|P5|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219313|NCT02064387|20270168|P4|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219314|NCT02064387|20270169|P3|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219315|NCT02064387|20270170|P2|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219316|NCT02064387|20270171|P1|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219317|NCT02064387|20270160|P12|STARTED|Part 1 Max 23.5 Months Followup Duration||0
8219318|NCT02064387|20270161|P11|STARTED|Part 1 Max 23.5 Months Followup Duration||0
8219319|NCT02064387|20270162|P10|STARTED|Part 1 Max 23.5 Months Followup Duration||6
8219320|NCT02064387|20270163|P9|STARTED|Part 1 Max 23.5 Months Followup Duration||3
8219321|NCT02064387|20270164|P8|STARTED|Part 1 Max 23.5 Months Followup Duration||8
8219322|NCT02064387|20270165|P7|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219323|NCT02064387|20270166|P6|STARTED|Part 1 Max 23.5 Months Followup Duration||3
8219324|NCT02064387|20270167|P5|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219325|NCT02064387|20270168|P4|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219326|NCT02064387|20270169|P3|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219327|NCT02064387|20270170|P2|STARTED|Part 1 Max 23.5 Months Followup Duration||1
8219328|NCT02064387|20270171|P1|STARTED|Part 1 Max 23.5 Months Followup Duration||1
8219329|NCT02064270|20270484|P2|NOT COMPLETED|Overall Study||32
8219330|NCT02064270|20270485|P1|NOT COMPLETED|Overall Study||62
8219331|NCT02064270|20270484|P2|COMPLETED|Overall Study||231
8219332|NCT02064270|20270485|P1|COMPLETED|Overall Study||201
8219333|NCT02064270|20270484|P2|STARTED|Overall Study||263
8219334|NCT02064270|20270485|P1|STARTED|Overall Study||263
8219335|NCT02064231|20270500|P4|NOT COMPLETED|Third Test Period (Own Product)||0
8219336|NCT02064231|20270501|P3|NOT COMPLETED|Third Test Period (Own Product)||0
8219337|NCT02064231|20270502|P2|NOT COMPLETED|Third Test Period (Own Product)||0
8219338|NCT02064231|20270503|P1|NOT COMPLETED|Third Test Period (Own Product)||0
8219339|NCT02064231|20270500|P4|COMPLETED|Third Test Period (Own Product)||1
8219340|NCT02064231|20270501|P3|COMPLETED|Third Test Period (Own Product)||0
8219341|NCT02064231|20270502|P2|COMPLETED|Third Test Period (Own Product)||8
8219342|NCT02064231|20270503|P1|COMPLETED|Third Test Period (Own Product)||8
8219343|NCT02064231|20270500|P4|STARTED|Third Test Period (Own Product)||1
8219344|NCT02064231|20270501|P3|STARTED|Third Test Period (Own Product)||0
8219345|NCT02064231|20270502|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
8219346|NCT02064231|20270503|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
8219347|NCT02064231|20270500|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
8219348|NCT02064231|20270501|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
8219349|NCT02064231|20270502|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
8219350|NCT02064231|20270503|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
8219351|NCT02064231|20270500|P4|COMPLETED|Second Test Period (Test B or Test D)||1
8219352|NCT02064231|20270501|P3|COMPLETED|Second Test Period (Test B or Test D)||0
8219353|NCT02064231|20270502|P2|COMPLETED|Second Test Period (Test B or Test D)||7
8219354|NCT02064231|20270503|P1|COMPLETED|Second Test Period (Test B or Test D)||6
8219355|NCT02064231|20270500|P4|STARTED|Second Test Period (Test B or Test D)||1
8219356|NCT02064231|20270501|P3|STARTED|Second Test Period (Test B or Test D)||0
8219357|NCT02064231|20270502|P2|STARTED|Second Test Period (Test B or Test D)||8
8219358|NCT02064231|20270503|P1|STARTED|Second Test Period (Test B or Test D)||7
8219359|NCT02064231|20270500|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
8219360|NCT02064231|20270501|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
8219361|NCT02064231|20270502|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
8219362|NCT02064231|20270503|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
8219363|NCT02064231|20270500|P4|COMPLETED|First Test Period (Test A or Test C)||1
8219364|NCT02064231|20270501|P3|COMPLETED|First Test Period (Test A or Test C)||0
8219365|NCT02064231|20270502|P2|COMPLETED|First Test Period (Test A or Test C)||8
8219366|NCT02064231|20270503|P1|COMPLETED|First Test Period (Test A or Test C)||7
8219367|NCT02064231|20270500|P4|STARTED|First Test Period (Test A or Test C)||1
8219368|NCT02064231|20270501|P3|STARTED|First Test Period (Test A or Test C)||1
8219369|NCT02064231|20270502|P2|STARTED|First Test Period (Test A or Test C)||12
8219370|NCT02064231|20270503|P1|STARTED|First Test Period (Test A or Test C)||14
8219371|NCT02064205|20270515|P1|NOT COMPLETED|Overall Study||1
8219372|NCT02064205|20270515|P1|COMPLETED|Overall Study||31
8219373|NCT02064205|20270515|P1|Condition D|Overall Study||32
8219374|NCT02064205|20270515|P1|Condition C|Overall Study||31
8219375|NCT02064205|20270515|P1|Condition B|Overall Study||32
8219376|NCT02064205|20270515|P1|Condition A|Overall Study||32
8219377|NCT02064205|20270515|P1|STARTED|Overall Study||32
8219378|NCT02064166|20270533|P2|NOT COMPLETED|Overall Study||0
8219379|NCT02064166|20270534|P1|NOT COMPLETED|Overall Study||1
8219380|NCT02064166|20270533|P2|COMPLETED|Overall Study||6
8219381|NCT02064166|20270534|P1|COMPLETED|Overall Study||8
8219382|NCT02064166|20270533|P2|STARTED|Overall Study||6
8219383|NCT02064166|20270534|P1|STARTED|Overall Study||9
8219384|NCT02063880|20270564|P2|NOT COMPLETED|Overall Study||27
8219385|NCT02063880|20270565|P1|NOT COMPLETED|Overall Study||28
8219386|NCT02063880|20270564|P2|COMPLETED|Overall Study||66
8219387|NCT02063880|20270565|P1|COMPLETED|Overall Study||62
8219388|NCT02063880|20270564|P2|STARTED|Overall Study||93
8219389|NCT02063880|20270565|P1|STARTED|Overall Study||90
8219390|NCT02063867|20270577|P2|NOT COMPLETED|Overall Study||2965
8219391|NCT02063867|20270578|P1|NOT COMPLETED|Overall Study||4291
8219392|NCT02063867|20270577|P2|COMPLETED|Overall Study||180048
8219393|NCT02063867|20270578|P1|COMPLETED|Overall Study||152598
8219394|NCT02063867|20270577|P2|STARTED|Overall Study||183013
8219395|NCT02063867|20270578|P1|STARTED|Overall Study||156889
8219396|NCT02063854|20270603|P7|NOT COMPLETED|Overall Study||6
8219397|NCT02063854|20270604|P6|NOT COMPLETED|Overall Study||31
8219398|NCT02063854|20270605|P5|NOT COMPLETED|Overall Study||11
8219399|NCT02063854|20270606|P4|NOT COMPLETED|Overall Study||10
8219400|NCT02063854|20270607|P3|NOT COMPLETED|Overall Study||30
8219401|NCT02063854|20270608|P2|NOT COMPLETED|Overall Study||12
8219402|NCT02063854|20270609|P1|NOT COMPLETED|Overall Study||21
8219403|NCT02063854|20270603|P7|COMPLETED|Overall Study||60
8219404|NCT02063854|20270604|P6|COMPLETED|Overall Study||170
8219405|NCT02063854|20270605|P5|COMPLETED|Overall Study||54
8219406|NCT02063854|20270606|P4|COMPLETED|Overall Study||58
8219407|NCT02063854|20270607|P3|COMPLETED|Overall Study||176
8219408|NCT02063854|20270608|P2|COMPLETED|Overall Study||54
8219409|NCT02063854|20270609|P1|COMPLETED|Overall Study||178
8219410|NCT02063854|20270603|P7|Full Analysis Set: Received Study Drug|Overall Study||66
8219411|NCT02063854|20270604|P6|Full Analysis Set: Received Study Drug|Overall Study||200
8219412|NCT02063854|20270605|P5|Full Analysis Set: Received Study Drug|Overall Study||65
8219413|NCT02063854|20270606|P4|Full Analysis Set: Received Study Drug|Overall Study||68
8219414|NCT02063854|20270607|P3|Full Analysis Set: Received Study Drug|Overall Study||206
8219415|NCT02063854|20270608|P2|Full Analysis Set: Received Study Drug|Overall Study||66
8219416|NCT02063854|20270609|P1|Full Analysis Set: Received Study Drug|Overall Study||199
8219417|NCT02063854|20270603|P7|STARTED|Overall Study||66
8219418|NCT02063854|20270604|P6|STARTED|Overall Study||201
8219419|NCT02063854|20270605|P5|STARTED|Overall Study||65
8219420|NCT02063854|20270606|P4|STARTED|Overall Study||68
8219421|NCT02063854|20270607|P3|STARTED|Overall Study||206
8219422|NCT02063854|20270608|P2|STARTED|Overall Study||66
8219423|NCT02063854|20270609|P1|STARTED|Overall Study||199
8219424|NCT02063737|20270693|P2|NOT COMPLETED|Overall Study||4
8219425|NCT02063737|20270694|P1|NOT COMPLETED|Overall Study||11
8219426|NCT02063737|20270693|P2|COMPLETED|Overall Study||44
8219427|NCT02063737|20270694|P1|COMPLETED|Overall Study||41
8219428|NCT02063737|20270693|P2|STARTED|Overall Study||48
8219429|NCT02063737|20270694|P1|STARTED|Overall Study||52
8219433|NCT02063698|20270734|P2|NOT COMPLETED|Overall Study||2
8219434|NCT02063698|20270735|P1|NOT COMPLETED|Overall Study||1
8219435|NCT02063698|20270734|P2|COMPLETED|Overall Study||13
8219436|NCT02063698|20270735|P1|COMPLETED|Overall Study||14
8219437|NCT02063698|20270734|P2|STARTED|Overall Study||15
8219438|NCT02063698|20270735|P1|STARTED|Overall Study||15
8219439|NCT02063672|20270759|P2|NOT COMPLETED|Overall Study||22
8219440|NCT02063672|20270760|P1|NOT COMPLETED|Overall Study||35
8219441|NCT02063672|20270759|P2|COMPLETED|Overall Study||7
8219442|NCT02063672|20270760|P1|COMPLETED|Overall Study||18
8219443|NCT02063672|20270759|P2|STARTED|Overall Study||29
8219444|NCT02063672|20270760|P1|STARTED|Overall Study||53
8219445|NCT02063659|20270807|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
8219446|NCT02063659|20270808|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8219447|NCT02063659|20270809|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8219448|NCT02063659|20270810|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8219449|NCT02063659|20270807|P4|COMPLETED|Open-Label Extension Period (OLE)||47
8219450|NCT02063659|20270808|P3|COMPLETED|Open-Label Extension Period (OLE)||0
8219451|NCT02063659|20270809|P2|COMPLETED|Open-Label Extension Period (OLE)||0
8219452|NCT02063659|20270810|P1|COMPLETED|Open-Label Extension Period (OLE)||0
8219453|NCT02063659|20270807|P4|STARTED|Open-Label Extension Period (OLE)||67
8219454|NCT02063659|20270808|P3|STARTED|Open-Label Extension Period (OLE)||0
8219455|NCT02063659|20270809|P2|STARTED|Open-Label Extension Period (OLE)||0
8219456|NCT02063659|20270810|P1|STARTED|Open-Label Extension Period (OLE)||0
8219457|NCT02063659|20270807|P4|NOT COMPLETED|Double-Blind Treatment Period||0
8219458|NCT02063659|20270808|P3|NOT COMPLETED|Double-Blind Treatment Period||3
8219459|NCT02063659|20270809|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8219460|NCT02063659|20270810|P1|NOT COMPLETED|Double-Blind Treatment Period||2
8219461|NCT02063659|20270807|P4|COMPLETED|Double-Blind Treatment Period||0
8219462|NCT02063659|20270808|P3|COMPLETED|Double-Blind Treatment Period||22
8219463|NCT02063659|20270809|P2|COMPLETED|Double-Blind Treatment Period||22
8219464|NCT02063659|20270810|P1|COMPLETED|Double-Blind Treatment Period||24
8219465|NCT02063659|20270807|P4|STARTED|Double-Blind Treatment Period||0
8219466|NCT02063659|20270808|P3|STARTED|Double-Blind Treatment Period||25
8219467|NCT02063659|20270809|P2|STARTED|Double-Blind Treatment Period||25
8219468|NCT02063659|20270810|P1|STARTED|Double-Blind Treatment Period||26
8219469|NCT02063516|20270842|P2|NOT COMPLETED|Overall Study||0
8219470|NCT02063516|20270843|P1|NOT COMPLETED|Overall Study||0
8219471|NCT02063516|20270842|P2|COMPLETED|Overall Study||40
8219472|NCT02063516|20270843|P1|COMPLETED|Overall Study||40
8219473|NCT02063516|20270842|P2|STARTED|Overall Study||40
8219474|NCT02063516|20270843|P1|STARTED|Overall Study||40
8219475|NCT02063230|20270857|P4|NOT COMPLETED|Overall Study||0
8219476|NCT02063230|20270858|P3|NOT COMPLETED|Overall Study||0
8219477|NCT02063230|20270859|P2|NOT COMPLETED|Overall Study||0
8219478|NCT02063230|20270860|P1|NOT COMPLETED|Overall Study||0
8219479|NCT02063230|20270857|P4|COMPLETED|Overall Study||8
8219480|NCT02063230|20270858|P3|COMPLETED|Overall Study||8
8219481|NCT02063230|20270859|P2|COMPLETED|Overall Study||8
8219482|NCT02063230|20270860|P1|COMPLETED|Overall Study||8
8219483|NCT02063230|20270857|P4|Received Treatment|Overall Study||8
8219484|NCT02063230|20270858|P3|Received Treatment|Overall Study||8
8219485|NCT02063230|20270859|P2|Received Treatment|Overall Study||8
8219486|NCT02063230|20270860|P1|Received Treatment|Overall Study||8
8219487|NCT02063230|20270857|P4|STARTED|Overall Study||8
8219488|NCT02063230|20270858|P3|STARTED|Overall Study||8
8219489|NCT02063230|20270859|P2|STARTED|Overall Study||8
8219490|NCT02063230|20270860|P1|STARTED|Overall Study||8
8219491|NCT02063217|20270893|P3|NOT COMPLETED|Overall Study||0
8219492|NCT02063217|20270894|P2|NOT COMPLETED|Overall Study||0
8219493|NCT02063217|20270895|P1|NOT COMPLETED|Overall Study||1
8219494|NCT02063217|20270893|P3|COMPLETED|Overall Study||12
8219495|NCT02063217|20270894|P2|COMPLETED|Overall Study||12
8219496|NCT02063217|20270895|P1|COMPLETED|Overall Study||11
8219497|NCT02063217|20270893|P3|STARTED|Overall Study||12
8219498|NCT02063217|20270894|P2|STARTED|Overall Study||12
8219499|NCT02063217|20270895|P1|STARTED|Overall Study||12
8219500|NCT02063178|20270905|P2|NOT COMPLETED|Overall Study||47
8219501|NCT02063178|20270906|P1|NOT COMPLETED|Overall Study||29
8219502|NCT02063178|20270905|P2|COMPLETED|Overall Study||77
8219503|NCT02063178|20270906|P1|COMPLETED|Overall Study||95
8219504|NCT02063178|20270905|P2|STARTED|Overall Study||124
8219505|NCT02063178|20270906|P1|STARTED|Overall Study||124
8219506|NCT02063087|20270920|P2|NOT COMPLETED|7 Day Follow-up||0
8219507|NCT02063087|20270921|P1|NOT COMPLETED|7 Day Follow-up||0
8219508|NCT02063087|20270920|P2|COMPLETED|7 Day Follow-up||478
8219509|NCT02063087|20270921|P1|COMPLETED|7 Day Follow-up||493
8219510|NCT02063087|20270920|P2|STARTED|7 Day Follow-up||478
8219511|NCT02063087|20270921|P1|STARTED|7 Day Follow-up||493
8219512|NCT02063087|20270920|P2|NOT COMPLETED|Emergency Department Intervention||0
8219513|NCT02063087|20270921|P1|NOT COMPLETED|Emergency Department Intervention||0
8219514|NCT02063087|20270920|P2|COMPLETED|Emergency Department Intervention||478
8219515|NCT02063087|20270921|P1|COMPLETED|Emergency Department Intervention||493
8219516|NCT02063087|20270920|P2|STARTED|Emergency Department Intervention||478
8219517|NCT02063087|20270921|P1|STARTED|Emergency Department Intervention||493
8219518|NCT02063035|20270945|P2|NOT COMPLETED|Overall Study||0
8219519|NCT02063035|20270946|P1|NOT COMPLETED|Overall Study||0
8219520|NCT02063035|20270945|P2|COMPLETED|Overall Study||17
8219521|NCT02063035|20270946|P1|COMPLETED|Overall Study||12
8219522|NCT02063035|20270945|P2|STARTED|Overall Study||17
8219523|NCT02063035|20270946|P1|STARTED|Overall Study||12
8219524|NCT02062905|20270960|P2|NOT COMPLETED|Overall Study||2
8219525|NCT02062905|20270961|P1|NOT COMPLETED|Overall Study||7
8219526|NCT02062905|20270960|P2|COMPLETED|Overall Study||31
8219527|NCT02062905|20270961|P1|COMPLETED|Overall Study||28
8219528|NCT02062905|20270960|P2|STARTED|Overall Study||33
8219529|NCT02062905|20270961|P1|STARTED|Overall Study||35
8219530|NCT02062879|20270971|P2|NOT COMPLETED|Overall Study||1
8219531|NCT02062879|20270972|P1|NOT COMPLETED|Overall Study||4
8219532|NCT02062879|20270971|P2|COMPLETED|Overall Study||9
8219533|NCT02062879|20270972|P1|COMPLETED|Overall Study||6
8219534|NCT02062879|20270971|P2|STARTED|Overall Study||10
8219535|NCT02062879|20270972|P1|STARTED|Overall Study||10
8219536|NCT02062801|20270984|P2|NOT COMPLETED|Overall Study||4
8219537|NCT02062801|20270985|P1|NOT COMPLETED|Overall Study||2
8219538|NCT02062801|20270984|P2|COMPLETED|Overall Study||297
8219539|NCT02062801|20270985|P1|COMPLETED|Overall Study||299
8219540|NCT02062801|20270984|P2|STARTED|Overall Study||301
8219541|NCT02062801|20270985|P1|STARTED|Overall Study||301
8219542|NCT02062710|20270995|P6|NOT COMPLETED|Overall Study||0
8219543|NCT02062710|20270996|P5|NOT COMPLETED|Overall Study||0
8219544|NCT02062710|20270997|P4|NOT COMPLETED|Overall Study||0
8219545|NCT02062710|20270998|P3|NOT COMPLETED|Overall Study||0
8219546|NCT02062710|20270999|P2|NOT COMPLETED|Overall Study||0
8219547|NCT02062710|20271000|P1|NOT COMPLETED|Overall Study||0
8219548|NCT02062710|20270995|P6|COMPLETED|Overall Study||4
8219549|NCT02062710|20270996|P5|COMPLETED|Overall Study||3
8219550|NCT02062710|20270997|P4|COMPLETED|Overall Study||3
8219551|NCT02062710|20270998|P3|COMPLETED|Overall Study||5
8219552|NCT02062710|20270999|P2|COMPLETED|Overall Study||4
8219553|NCT02062710|20271000|P1|COMPLETED|Overall Study||3
8219554|NCT02062710|20270995|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
8219555|NCT02062710|20270996|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
8219556|NCT02062710|20270997|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
8219557|NCT02062710|20270998|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
8219558|NCT02062710|20270999|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
8219648|NCT02061748|20271196|P2|STARTED|Overall Study||30853
8219559|NCT02062710|20271000|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
8219560|NCT02062658|20271008|P1|NOT COMPLETED|Overall Study||2
8219561|NCT02062658|20271008|P1|COMPLETED|Overall Study||8
8219562|NCT02062658|20271008|P1|STARTED|Overall Study||10
8219563|NCT02062645|20271012|P1|NOT COMPLETED|Overall Study||15
8219564|NCT02062645|20271012|P1|COMPLETED|Overall Study||100
8219565|NCT02062645|20271012|P1|STARTED|Overall Study||115
8219566|NCT02062632|20271020|P1|NOT COMPLETED|Overall Study||1
8219567|NCT02062632|20271020|P1|COMPLETED|Overall Study||2
8219568|NCT02062632|20271020|P1|STARTED|Overall Study||3
8219569|NCT02062580|20271029|P2|NOT COMPLETED|Overall Study||13
8219570|NCT02062580|20271030|P1|NOT COMPLETED|Overall Study||12
8219571|NCT02062580|20271029|P2|COMPLETED|Overall Study||65
8219572|NCT02062580|20271030|P1|COMPLETED|Overall Study||59
8219573|NCT02062580|20271029|P2|STARTED|Overall Study||78
8219574|NCT02062580|20271030|P1|STARTED|Overall Study||71
8219575|NCT02062502|20271040|P2|NOT COMPLETED|Overall Study||35
8219576|NCT02062502|20271041|P1|NOT COMPLETED|Overall Study||43
8219577|NCT02062502|20271040|P2|COMPLETED|Overall Study||270
8219578|NCT02062502|20271041|P1|COMPLETED|Overall Study||263
8219579|NCT02062502|20271040|P2|Vaccinated Dose 1|Overall Study||305
8219580|NCT02062502|20271041|P1|Vaccinated Dose 1|Overall Study||306
8219581|NCT02062502|20271040|P2|STARTED|Overall Study||305
8219582|NCT02062502|20271041|P1|STARTED|Overall Study||306
8219583|NCT02062450|20271061|P1|NOT COMPLETED|Overall Study||124
8219584|NCT02062450|20271061|P1|COMPLETED|Overall Study||255
8219585|NCT02062450|20271061|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
8219586|NCT02062450|20271061|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
8219587|NCT02062437|20271075|P1|NOT COMPLETED|Overall Study||52
8219588|NCT02062437|20271075|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
8219589|NCT02062437|20271075|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
8219590|NCT02062398|20271084|P1|NOT COMPLETED|Overall Study||1
8219591|NCT02062398|20271084|P1|COMPLETED|Overall Study||12
8219592|NCT02062398|20271084|P1|STARTED|Overall Study||13
8219593|NCT02062385|20271096|P4|NOT COMPLETED|Overall Study||9
8219594|NCT02062385|20271097|P3|NOT COMPLETED|Overall Study||12
8219595|NCT02062385|20271098|P2|NOT COMPLETED|Overall Study||65
8219596|NCT02062385|20271099|P1|NOT COMPLETED|Overall Study||78
8219597|NCT02062385|20271096|P4|COMPLETED|Overall Study||391
8219598|NCT02062385|20271097|P3|COMPLETED|Overall Study||388
8219599|NCT02062385|20271098|P2|COMPLETED|Overall Study||1555
8219600|NCT02062385|20271099|P1|COMPLETED|Overall Study||1542
8219601|NCT02062385|20271096|P4|Received Vaccination 3|Overall Study||392
8219602|NCT02062385|20271097|P3|Received Vaccination 3|Overall Study||389
8219603|NCT02062385|20271098|P2|Received Vaccination 3|Overall Study||1554
8219604|NCT02062385|20271099|P1|Received Vaccination 3|Overall Study||1543
8219605|NCT02062385|20271096|P4|Received Vaccination 2|Overall Study||393
8219606|NCT02062385|20271097|P3|Received Vaccination 2|Overall Study||392
8219607|NCT02062385|20271098|P2|Received Vaccination 2|Overall Study||1566
8219608|NCT02062385|20271099|P1|Received Vaccination 2|Overall Study||1554
8219609|NCT02062385|20271096|P4|Received Vaccination 1|Overall Study||400
8219610|NCT02062385|20271097|P3|Received Vaccination 1|Overall Study||400
8219611|NCT02062385|20271098|P2|Received Vaccination 1|Overall Study||1619
8219612|NCT02062385|20271099|P1|Received Vaccination 1|Overall Study||1618
8219613|NCT02062385|20271096|P4|STARTED|Overall Study||400
8219614|NCT02062385|20271097|P3|STARTED|Overall Study||400
8219615|NCT02062385|20271098|P2|STARTED|Overall Study||1620
8219616|NCT02062385|20271099|P1|STARTED|Overall Study||1620
8219617|NCT02062359|20271119|P1|NOT COMPLETED|Overall Study||0
8219618|NCT02062359|20271119|P1|COMPLETED|Overall Study||2
8219619|NCT02062359|20271119|P1|STARTED|Overall Study||2
8219620|NCT02062294|20271125|P1|NOT COMPLETED|Overall Study||0
8219621|NCT02062294|20271125|P1|COMPLETED|Overall Study||14
8219622|NCT02062294|20271125|P1|STARTED|Overall Study||14
8219623|NCT02062177|20271132|P2|NOT COMPLETED|Overall Study||0
8219624|NCT02062177|20271133|P1|NOT COMPLETED|Overall Study||0
8219625|NCT02062177|20271132|P2|COMPLETED|Overall Study||70
8219626|NCT02062177|20271133|P1|COMPLETED|Overall Study||70
8219627|NCT02062177|20271132|P2|STARTED|Overall Study||70
8219628|NCT02062177|20271133|P1|STARTED|Overall Study||70
8219629|NCT02062151|20271143|P1|NOT COMPLETED|Overall Study||1
8219630|NCT02062151|20271143|P1|COMPLETED|Overall Study||20
8219631|NCT02062151|20271143|P1|STARTED|Overall Study||21
8219632|NCT02061969|20271150|P2|NOT COMPLETED|Overall Study||0
8219633|NCT02061969|20271151|P1|NOT COMPLETED|Overall Study||0
8219634|NCT02061969|20271150|P2|COMPLETED|Overall Study||67
8219635|NCT02061969|20271151|P1|COMPLETED|Overall Study||73
8219636|NCT02061969|20271150|P2|STARTED|Overall Study||67
8219637|NCT02061969|20271151|P1|STARTED|Overall Study||73
8219638|NCT02061774|20271181|P2|NOT COMPLETED|Overall Study||0
8219639|NCT02061774|20271182|P1|NOT COMPLETED|Overall Study||0
8219640|NCT02061774|20271181|P2|COMPLETED|Overall Study||11
8219641|NCT02061774|20271182|P1|COMPLETED|Overall Study||10
8219642|NCT02061774|20271181|P2|STARTED|Overall Study||11
8219643|NCT02061774|20271182|P1|STARTED|Overall Study||10
8219644|NCT02061748|20271196|P2|NOT COMPLETED|Overall Study||0
8219645|NCT02061748|20271197|P1|NOT COMPLETED|Overall Study||0
8219646|NCT02061748|20271196|P2|COMPLETED|Overall Study||30853
8219647|NCT02061748|20271197|P1|COMPLETED|Overall Study||7646
8219649|NCT02061748|20271197|P1|STARTED|Overall Study||7646
8219650|NCT02061696|20271271|P2|NOT COMPLETED|Overall Study||0
8219651|NCT02061696|20271272|P1|NOT COMPLETED|Overall Study||0
8219652|NCT02061696|20271271|P2|COMPLETED|Overall Study||22
8219653|NCT02061696|20271272|P1|COMPLETED|Overall Study||17
8219654|NCT02061696|20271271|P2|STARTED|Overall Study||22
8219655|NCT02061696|20271272|P1|STARTED|Overall Study||17
8219656|NCT02061683|20271296|P1|NOT COMPLETED|Overall Study||60
8219657|NCT02061683|20271296|P1|COMPLETED|Overall Study||203
8219658|NCT02061683|20271296|P1|STARTED|Overall Study||263
8219659|NCT02061592|20271303|P2|NOT COMPLETED|Period 2||1
8219660|NCT02061592|20271304|P1|NOT COMPLETED|Period 2||0
8219661|NCT02061592|20271303|P2|COMPLETED|Period 2||61
8219662|NCT02061592|20271304|P1|COMPLETED|Period 2||64
8219663|NCT02061592|20271303|P2|STARTED|Period 2||62
8219664|NCT02061592|20271304|P1|STARTED|Period 2||64
8219665|NCT02061592|20271303|P2|NOT COMPLETED|Period 1||0
8219666|NCT02061592|20271304|P1|NOT COMPLETED|Period 1||2
8219667|NCT02061592|20271303|P2|COMPLETED|Period 1||62
8219668|NCT02061592|20271304|P1|COMPLETED|Period 1||64
8219669|NCT02061592|20271303|P2|STARTED|Period 1||62
8219670|NCT02061592|20271304|P1|STARTED|Period 1||66
8219671|NCT02061540|20271316|P1|NOT COMPLETED|Overall Study||4
8219672|NCT02061540|20271316|P1|COMPLETED|Overall Study||23
8219673|NCT02061540|20271316|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
8219674|NCT02061540|20271316|P1|STARTED|Overall Study||27
8219675|NCT02061397|20271329|P1|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
8219676|NCT02061397|20271329|P1|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
8219677|NCT02061397|20271329|P1|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
8219678|NCT02061397|20271329|P1|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
8219679|NCT02061397|20271329|P1|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
8219680|NCT02061397|20271329|P1|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
8219681|NCT02061358|20271343|P9|NOT COMPLETED|Overall Study||0
8219682|NCT02061358|20271344|P8|NOT COMPLETED|Overall Study||0
8219683|NCT02061358|20271345|P7|NOT COMPLETED|Overall Study||0
8219684|NCT02061358|20271346|P6|NOT COMPLETED|Overall Study||0
8219685|NCT02061358|20271347|P5|NOT COMPLETED|Overall Study||0
8219686|NCT02061358|20271348|P4|NOT COMPLETED|Overall Study||0
8219687|NCT02061358|20271349|P3|NOT COMPLETED|Overall Study||0
8219688|NCT02061358|20271350|P2|NOT COMPLETED|Overall Study||0
8219689|NCT02061358|20271351|P1|NOT COMPLETED|Overall Study||0
8219690|NCT02061358|20271343|P9|COMPLETED|Overall Study||16
8219691|NCT02061358|20271344|P8|COMPLETED|Overall Study||6
8219692|NCT02061358|20271345|P7|COMPLETED|Overall Study||6
8219693|NCT02061358|20271346|P6|COMPLETED|Overall Study||6
8219694|NCT02061358|20271347|P5|COMPLETED|Overall Study||6
8219695|NCT02061358|20271348|P4|COMPLETED|Overall Study||6
8219696|NCT02061358|20271349|P3|COMPLETED|Overall Study||6
8219697|NCT02061358|20271350|P2|COMPLETED|Overall Study||6
8219698|NCT02061358|20271351|P1|COMPLETED|Overall Study||6
8219699|NCT02061358|20271343|P9|STARTED|Overall Study||16
8219700|NCT02061358|20271344|P8|STARTED|Overall Study||6
8219701|NCT02061358|20271345|P7|STARTED|Overall Study||6
8219702|NCT02061358|20271346|P6|STARTED|Overall Study||6
8219703|NCT02061358|20271347|P5|STARTED|Overall Study||6
8219704|NCT02061358|20271348|P4|STARTED|Overall Study||6
8219705|NCT02061358|20271349|P3|STARTED|Overall Study||6
8219706|NCT02061358|20271350|P2|STARTED|Overall Study||6
8219707|NCT02061358|20271351|P1|STARTED|Overall Study||6
8219708|NCT02061280|20271489|P2|NOT COMPLETED|Overall Study||12
8219709|NCT02061280|20271490|P1|NOT COMPLETED|Overall Study||18
8219710|NCT02061280|20271489|P2|COMPLETED|Overall Study||25
8219711|NCT02061280|20271490|P1|COMPLETED|Overall Study||53
8219712|NCT02061280|20271489|P2|Randomized to Treatment|Overall Study||25
8219713|NCT02061280|20271490|P1|Randomized to Treatment|Overall Study||54
8219714|NCT02061280|20271489|P2|STARTED|Overall Study||37
8219715|NCT02061280|20271490|P1|STARTED|Overall Study||71
8219716|NCT02061202|20271522|P2|NOT COMPLETED|Overall Study||1
8219717|NCT02061202|20271523|P1|NOT COMPLETED|Overall Study||1
8219718|NCT02061202|20271522|P2|COMPLETED|Overall Study||17
8219719|NCT02061202|20271523|P1|COMPLETED|Overall Study||35
8219720|NCT02061202|20271522|P2|STARTED|Overall Study||18
8219721|NCT02061202|20271523|P1|STARTED|Overall Study||36
8219722|NCT02060903|20271549|P2|NOT COMPLETED|Overall Study||7
8219723|NCT02060903|20271550|P1|NOT COMPLETED|Overall Study||4
8219724|NCT02060903|20271549|P2|COMPLETED|Overall Study||185
8219725|NCT02060903|20271550|P1|COMPLETED|Overall Study||183
8219726|NCT02060903|20271549|P2|STARTED|Overall Study||192
8219727|NCT02060903|20271550|P1|STARTED|Overall Study||187
8219728|NCT02060890|20271556|P1|NOT COMPLETED|Overall Study||4
8219729|NCT02060890|20271556|P1|COMPLETED|Overall Study||16
8219730|NCT02060890|20271556|P1|STARTED|Overall Study||20
8219731|NCT02060838|20271565|P2|NOT COMPLETED|Overall Study||0
8219732|NCT02060838|20271566|P1|NOT COMPLETED|Overall Study||0
8219733|NCT02060838|20271565|P2|COMPLETED|Overall Study||22
8219734|NCT02060838|20271566|P1|COMPLETED|Overall Study||28
8219735|NCT02060838|20271565|P2|STARTED|Overall Study||22
8219736|NCT02060838|20271566|P1|STARTED|Overall Study||28
8219737|NCT02060539|20271574|P1|NOT COMPLETED|Overall Study||0
8219738|NCT02060539|20271574|P1|COMPLETED|Overall Study||19
8219739|NCT02060539|20271574|P1|STARTED|Overall Study||19
8219740|NCT02060526|20271622|P3|NOT COMPLETED|Overall Study||0
8219741|NCT02060526|20271623|P2|NOT COMPLETED|Overall Study||0
8219742|NCT02060526|20271624|P1|NOT COMPLETED|Overall Study||0
8219743|NCT02060526|20271622|P3|COMPLETED|Overall Study||7
8219744|NCT02060526|20271623|P2|COMPLETED|Overall Study||7
8219745|NCT02060526|20271624|P1|COMPLETED|Overall Study||7
8219746|NCT02060526|20271622|P3|STARTED|Overall Study||7
8219747|NCT02060526|20271623|P2|STARTED|Overall Study||7
8219748|NCT02060526|20271624|P1|STARTED|Overall Study||7
8219749|NCT02060461|20271660|P1|NOT COMPLETED|Overall Study||0
8219750|NCT02060461|20271660|P1|COMPLETED|Overall Study||33
8219751|NCT02060461|20271660|P1|STARTED|Overall Study||33
8219752|NCT02060383|20271671|P5|NOT COMPLETED|Extension Phase||7
8219753|NCT02060383|20271672|P4|NOT COMPLETED|Extension Phase||2
8219754|NCT02060383|20271673|P3|NOT COMPLETED|Extension Phase||3
8219755|NCT02060383|20271674|P2|NOT COMPLETED|Extension Phase||3
8219756|NCT02060383|20271675|P1|NOT COMPLETED|Extension Phase||3
8219757|NCT02060383|20271671|P5|COMPLETED|Extension Phase||46
8219758|NCT02060383|20271672|P4|COMPLETED|Extension Phase||19
8219759|NCT02060383|20271673|P3|COMPLETED|Extension Phase||7
8219760|NCT02060383|20271674|P2|COMPLETED|Extension Phase||14
8219761|NCT02060383|20271675|P1|COMPLETED|Extension Phase||14
8219762|NCT02060383|20271671|P5|STARTED|Extension Phase||53
8219763|NCT02060383|20271672|P4|STARTED|Extension Phase||21
8219764|NCT02060383|20271673|P3|STARTED|Extension Phase||10
8219765|NCT02060383|20271674|P2|STARTED|Extension Phase||17
8219766|NCT02060383|20271675|P1|STARTED|Extension Phase||17
8219767|NCT02060383|20271671|P5|NOT COMPLETED|Core Phase||8
8219768|NCT02060383|20271672|P4|NOT COMPLETED|Core Phase||7
8219769|NCT02060383|20271673|P3|NOT COMPLETED|Core Phase||0
8219770|NCT02060383|20271674|P2|NOT COMPLETED|Core Phase||6
8219771|NCT02060383|20271675|P1|NOT COMPLETED|Core Phase||3
8219772|NCT02060383|20271671|P5|COMPLETED|Core Phase||95
8219773|NCT02060383|20271672|P4|COMPLETED|Core Phase||39
8219774|NCT02060383|20271673|P3|COMPLETED|Core Phase||19
8219775|NCT02060383|20271674|P2|COMPLETED|Core Phase||37
8219776|NCT02060383|20271675|P1|COMPLETED|Core Phase||35
8219777|NCT02060383|20271671|P5|Completed Core/Did Not Enter Extension|Core Phase||42
8219778|NCT02060383|20271672|P4|Completed Core/Did Not Enter Extension|Core Phase||18
8219779|NCT02060383|20271673|P3|Completed Core/Did Not Enter Extension|Core Phase||9
8219780|NCT02060383|20271674|P2|Completed Core/Did Not Enter Extension|Core Phase||20
8219781|NCT02060383|20271675|P1|Completed Core/Did Not Enter Extension|Core Phase||18
8219782|NCT02060383|20271671|P5|Completed Core/Entered Extension|Core Phase||53
8219783|NCT02060383|20271672|P4|Completed Core/Entered Extension|Core Phase||21
8219784|NCT02060383|20271673|P3|Completed Core/Entered Extension|Core Phase||10
8219785|NCT02060383|20271674|P2|Completed Core/Entered Extension|Core Phase||17
8219786|NCT02060383|20271675|P1|Completed Core/Entered Extension|Core Phase||17
8219787|NCT02060383|20271671|P5|STARTED|Core Phase||103
8219788|NCT02060383|20271672|P4|STARTED|Core Phase||46
8219789|NCT02060383|20271673|P3|STARTED|Core Phase||19
8219790|NCT02060383|20271674|P2|STARTED|Core Phase||43
8219791|NCT02060383|20271675|P1|STARTED|Core Phase||38
8219792|NCT02060370|20271701|P1|NOT COMPLETED|Overall Study||1
8219793|NCT02060370|20271701|P1|COMPLETED|Overall Study||59
8219794|NCT02060370|20271701|P1|STARTED|Overall Study||60
8219795|NCT02060058|20271713|P3|NOT COMPLETED|Overall Study||0
8219796|NCT02060058|20271714|P2|NOT COMPLETED|Overall Study||0
8219797|NCT02060058|20271715|P1|NOT COMPLETED|Overall Study||0
8219798|NCT02060058|20271713|P3|COMPLETED|Overall Study||8
8219799|NCT02060058|20271714|P2|COMPLETED|Overall Study||0
8219800|NCT02060058|20271715|P1|COMPLETED|Overall Study||4
8219801|NCT02060058|20271713|P3|STARTED|Overall Study||8
8219802|NCT02060058|20271714|P2|STARTED|Overall Study||0
8219803|NCT02060058|20271715|P1|STARTED|Overall Study||4
8219804|NCT02059993|20271731|P2|NOT COMPLETED|Overall Study||4
8219805|NCT02059993|20271732|P1|NOT COMPLETED|Overall Study||2
8219806|NCT02059993|20271731|P2|COMPLETED|Overall Study||37
8219807|NCT02059993|20271732|P1|COMPLETED|Overall Study||40
8219808|NCT02059993|20271731|P2|STARTED|Overall Study||41
8219809|NCT02059993|20271732|P1|STARTED|Overall Study||42
8219810|NCT02059980|20271742|P2|NOT COMPLETED|Overall Study||1
8219811|NCT02059980|20271743|P1|NOT COMPLETED|Overall Study||2
8219812|NCT02059980|20271742|P2|COMPLETED|Overall Study||14
8219813|NCT02059980|20271743|P1|COMPLETED|Overall Study||16
8219814|NCT02059980|20271742|P2|STARTED|Overall Study||15
8219815|NCT02059980|20271743|P1|STARTED|Overall Study||18
8219816|NCT02059928|20271755|P1|NOT COMPLETED|Overall Study||0
8219817|NCT02059928|20271755|P1|COMPLETED|Overall Study||20
8219818|NCT02059928|20271755|P1|STARTED|Overall Study||20
8219819|NCT02059902|20271761|P2|NOT COMPLETED|Overall Study||4
8219820|NCT02059902|20271762|P1|NOT COMPLETED|Overall Study||4
8219821|NCT02059902|20271761|P2|COMPLETED|Overall Study||14
8219822|NCT02059902|20271762|P1|COMPLETED|Overall Study||14
8219823|NCT02059902|20271761|P2|STARTED|Overall Study||18
8219824|NCT02059902|20271762|P1|STARTED|Overall Study||18
8219825|NCT02059642|20271770|P2|NOT COMPLETED|Overall Study||24
8219826|NCT02059642|20271771|P1|NOT COMPLETED|Overall Study||27
8219827|NCT02059642|20271770|P2|COMPLETED|Overall Study||128
8219828|NCT02059642|20271771|P1|COMPLETED|Overall Study||121
8219829|NCT02059642|20271770|P2|STARTED|Overall Study||152
8219830|NCT02059642|20271771|P1|STARTED|Overall Study||148
8219831|NCT02059434|20271788|P9|NOT COMPLETED|Period 8||0
8219832|NCT02059434|20271789|P8|NOT COMPLETED|Period 8||0
8219833|NCT02059434|20271790|P7|NOT COMPLETED|Period 8||0
8219834|NCT02059434|20271791|P6|NOT COMPLETED|Period 8||0
8219835|NCT02059434|20271792|P5|NOT COMPLETED|Period 8||0
8219836|NCT02059434|20271793|P4|NOT COMPLETED|Period 8||0
8219837|NCT02059434|20271794|P3|NOT COMPLETED|Period 8||0
8219838|NCT02059434|20271795|P2|NOT COMPLETED|Period 8||0
8219839|NCT02059434|20271796|P1|NOT COMPLETED|Period 8||0
8219840|NCT02059434|20271788|P9|COMPLETED|Period 8||34
8219841|NCT02059434|20271789|P8|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219842|NCT02059434|20271790|P7|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219843|NCT02059434|20271791|P6|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219844|NCT02059434|20271792|P5|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219845|NCT02059434|20271793|P4|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219846|NCT02059434|20271794|P3|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219847|NCT02059434|20271795|P2|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219848|NCT02059434|20271796|P1|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219849|NCT02059434|20271788|P9|STARTED|Period 8||34
8219850|NCT02059434|20271789|P8|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219851|NCT02059434|20271790|P7|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219852|NCT02059434|20271791|P6|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219853|NCT02059434|20271792|P5|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219854|NCT02059434|20271793|P4|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219855|NCT02059434|20271794|P3|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219856|NCT02059434|20271795|P2|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219857|NCT02059434|20271796|P1|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219858|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 7 and 8||2
8219859|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219860|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219861|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219862|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219863|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219864|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219865|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219866|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219867|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 7 and 8||34
8219868|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219869|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219870|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219871|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219872|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219873|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219874|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219875|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219876|NCT02059434|20271788|P9|STARTED|Washout Between Periods 7 and 8||36
8219877|NCT02059434|20271789|P8|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219878|NCT02059434|20271790|P7|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219879|NCT02059434|20271791|P6|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219880|NCT02059434|20271792|P5|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219881|NCT02059434|20271793|P4|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219882|NCT02059434|20271794|P3|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219883|NCT02059434|20271795|P2|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219884|NCT02059434|20271796|P1|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219885|NCT02059434|20271788|P9|NOT COMPLETED|Period 7||0
8219886|NCT02059434|20271789|P8|NOT COMPLETED|Period 7||0
8219887|NCT02059434|20271790|P7|NOT COMPLETED|Period 7||0
8219888|NCT02059434|20271791|P6|NOT COMPLETED|Period 7||0
8219889|NCT02059434|20271792|P5|NOT COMPLETED|Period 7||0
8219890|NCT02059434|20271793|P4|NOT COMPLETED|Period 7||0
8219891|NCT02059434|20271794|P3|NOT COMPLETED|Period 7||0
8219892|NCT02059434|20271795|P2|NOT COMPLETED|Period 7||0
8219893|NCT02059434|20271796|P1|NOT COMPLETED|Period 7||0
8219894|NCT02059434|20271788|P9|COMPLETED|Period 7||36
8219895|NCT02059434|20271789|P8|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219896|NCT02059434|20271790|P7|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219897|NCT02059434|20271791|P6|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219898|NCT02059434|20271792|P5|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219899|NCT02059434|20271793|P4|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219900|NCT02059434|20271794|P3|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219901|NCT02059434|20271795|P2|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219902|NCT02059434|20271796|P1|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219903|NCT02059434|20271788|P9|STARTED|Period 7||36
8219904|NCT02059434|20271789|P8|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219905|NCT02059434|20271790|P7|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219906|NCT02059434|20271791|P6|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219907|NCT02059434|20271792|P5|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219908|NCT02059434|20271793|P4|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219909|NCT02059434|20271794|P3|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219910|NCT02059434|20271795|P2|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219911|NCT02059434|20271796|P1|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219912|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 6 and 7||1
8219913|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219914|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219915|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219916|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219917|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219918|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219919|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219920|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219921|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 6 and 7||36
8219922|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219923|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219924|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219925|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219926|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219927|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219928|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219929|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219930|NCT02059434|20271788|P9|STARTED|Washout Between Periods 6 and 7||37
8219931|NCT02059434|20271789|P8|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219932|NCT02059434|20271790|P7|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219933|NCT02059434|20271791|P6|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219934|NCT02059434|20271792|P5|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219935|NCT02059434|20271793|P4|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219936|NCT02059434|20271794|P3|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219937|NCT02059434|20271795|P2|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219938|NCT02059434|20271796|P1|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219939|NCT02059434|20271788|P9|NOT COMPLETED|Period 6||0
8219940|NCT02059434|20271789|P8|NOT COMPLETED|Period 6||0
8219941|NCT02059434|20271790|P7|NOT COMPLETED|Period 6||0
8219942|NCT02059434|20271791|P6|NOT COMPLETED|Period 6||0
8219943|NCT02059434|20271792|P5|NOT COMPLETED|Period 6||0
8219944|NCT02059434|20271793|P4|NOT COMPLETED|Period 6||0
8219945|NCT02059434|20271794|P3|NOT COMPLETED|Period 6||0
8219946|NCT02059434|20271795|P2|NOT COMPLETED|Period 6||0
8219947|NCT02059434|20271796|P1|NOT COMPLETED|Period 6||0
8219948|NCT02059434|20271788|P9|COMPLETED|Period 6||37
8219949|NCT02059434|20271789|P8|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219950|NCT02059434|20271790|P7|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219951|NCT02059434|20271791|P6|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219952|NCT02059434|20271792|P5|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219953|NCT02059434|20271793|P4|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219954|NCT02059434|20271794|P3|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219955|NCT02059434|20271795|P2|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219956|NCT02059434|20271796|P1|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219957|NCT02059434|20271788|P9|STARTED|Period 6||37
8219958|NCT02059434|20271789|P8|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219959|NCT02059434|20271790|P7|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219960|NCT02059434|20271791|P6|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219961|NCT02059434|20271792|P5|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219962|NCT02059434|20271793|P4|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219963|NCT02059434|20271794|P3|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219964|NCT02059434|20271795|P2|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219965|NCT02059434|20271796|P1|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219966|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219967|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219968|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219969|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219970|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219971|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219972|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219973|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219974|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219975|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 5 and 6||37
8219976|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219977|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219978|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219979|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8220123|NCT02059434|20271792|P5|STARTED|Washout Between Periods 2 and 3||2
8219980|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219981|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219982|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219983|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219984|NCT02059434|20271788|P9|STARTED|Washout Between Periods 5 and 6||37
8219985|NCT02059434|20271789|P8|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219986|NCT02059434|20271790|P7|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219987|NCT02059434|20271791|P6|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219988|NCT02059434|20271792|P5|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219989|NCT02059434|20271793|P4|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219990|NCT02059434|20271794|P3|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219991|NCT02059434|20271795|P2|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219992|NCT02059434|20271796|P1|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219993|NCT02059434|20271788|P9|NOT COMPLETED|Period 5||0
8219994|NCT02059434|20271789|P8|NOT COMPLETED|Period 5||0
8219995|NCT02059434|20271790|P7|NOT COMPLETED|Period 5||0
8219996|NCT02059434|20271791|P6|NOT COMPLETED|Period 5||0
8219997|NCT02059434|20271792|P5|NOT COMPLETED|Period 5||0
8219998|NCT02059434|20271793|P4|NOT COMPLETED|Period 5||0
8219999|NCT02059434|20271794|P3|NOT COMPLETED|Period 5||0
8220000|NCT02059434|20271795|P2|NOT COMPLETED|Period 5||0
8220001|NCT02059434|20271796|P1|NOT COMPLETED|Period 5||0
8220002|NCT02059434|20271788|P9|COMPLETED|Period 5||37
8220003|NCT02059434|20271789|P8|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220004|NCT02059434|20271790|P7|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220005|NCT02059434|20271791|P6|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220006|NCT02059434|20271792|P5|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220007|NCT02059434|20271793|P4|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220008|NCT02059434|20271794|P3|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220009|NCT02059434|20271795|P2|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220010|NCT02059434|20271796|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220011|NCT02059434|20271788|P9|STARTED|Period 5||37
8220012|NCT02059434|20271789|P8|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220013|NCT02059434|20271790|P7|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220014|NCT02059434|20271791|P6|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220015|NCT02059434|20271792|P5|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220016|NCT02059434|20271793|P4|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220017|NCT02059434|20271794|P3|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220018|NCT02059434|20271795|P2|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220019|NCT02059434|20271796|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220020|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 4 and 5||1
8220021|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220022|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220023|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220024|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220025|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220026|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220027|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220028|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220029|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 4 and 5||37
8220030|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220031|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220032|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220033|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220034|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220035|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220036|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220037|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220038|NCT02059434|20271788|P9|STARTED|Washout Between Periods 4 and 5||38
8220039|NCT02059434|20271789|P8|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220040|NCT02059434|20271790|P7|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220041|NCT02059434|20271791|P6|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220042|NCT02059434|20271792|P5|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220043|NCT02059434|20271793|P4|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220044|NCT02059434|20271794|P3|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220045|NCT02059434|20271795|P2|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220046|NCT02059434|20271796|P1|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220047|NCT02059434|20271788|P9|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220048|NCT02059434|20271789|P8|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220049|NCT02059434|20271790|P7|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220050|NCT02059434|20271791|P6|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220051|NCT02059434|20271792|P5|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220052|NCT02059434|20271793|P4|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220053|NCT02059434|20271794|P3|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220054|NCT02059434|20271795|P2|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220055|NCT02059434|20271796|P1|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220056|NCT02059434|20271788|P9|COMPLETED|Period 4 (After Screening/run-in Period)||38
8220057|NCT02059434|20271789|P8|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220058|NCT02059434|20271790|P7|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220059|NCT02059434|20271791|P6|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220060|NCT02059434|20271792|P5|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220061|NCT02059434|20271793|P4|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220062|NCT02059434|20271794|P3|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220063|NCT02059434|20271795|P2|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220064|NCT02059434|20271796|P1|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220065|NCT02059434|20271788|P9|STARTED|Period 4 (After Screening/run-in Period)||38
8220066|NCT02059434|20271789|P8|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220067|NCT02059434|20271790|P7|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220068|NCT02059434|20271791|P6|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220069|NCT02059434|20271792|P5|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220070|NCT02059434|20271793|P4|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220071|NCT02059434|20271794|P3|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220072|NCT02059434|20271795|P2|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220073|NCT02059434|20271796|P1|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220074|NCT02059434|20271788|P9|NOT COMPLETED|Period 3||0
8220075|NCT02059434|20271789|P8|NOT COMPLETED|Period 3||0
8220076|NCT02059434|20271790|P7|NOT COMPLETED|Period 3||0
8220077|NCT02059434|20271791|P6|NOT COMPLETED|Period 3||0
8220078|NCT02059434|20271792|P5|NOT COMPLETED|Period 3||0
8220079|NCT02059434|20271793|P4|NOT COMPLETED|Period 3||0
8220080|NCT02059434|20271794|P3|NOT COMPLETED|Period 3||0
8220081|NCT02059434|20271795|P2|NOT COMPLETED|Period 3||0
8220082|NCT02059434|20271796|P1|NOT COMPLETED|Period 3||0
8220083|NCT02059434|20271788|P9|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220084|NCT02059434|20271789|P8|COMPLETED|Period 3||2
8220085|NCT02059434|20271790|P7|COMPLETED|Period 3||2
8220086|NCT02059434|20271791|P6|COMPLETED|Period 3||2
8220087|NCT02059434|20271792|P5|COMPLETED|Period 3||2
8220088|NCT02059434|20271793|P4|COMPLETED|Period 3||2
8220089|NCT02059434|20271794|P3|COMPLETED|Period 3||2
8220090|NCT02059434|20271795|P2|COMPLETED|Period 3||2
8220091|NCT02059434|20271796|P1|COMPLETED|Period 3||2
8220092|NCT02059434|20271788|P9|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220093|NCT02059434|20271789|P8|STARTED|Period 3||2
8220094|NCT02059434|20271790|P7|STARTED|Period 3||2
8220095|NCT02059434|20271791|P6|STARTED|Period 3||2
8220096|NCT02059434|20271792|P5|STARTED|Period 3||2
8220097|NCT02059434|20271793|P4|STARTED|Period 3||2
8220098|NCT02059434|20271794|P3|STARTED|Period 3||2
8220099|NCT02059434|20271795|P2|STARTED|Period 3||2
8220100|NCT02059434|20271796|P1|STARTED|Period 3||2
8220101|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220102|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220103|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220104|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220105|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220106|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220107|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220108|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220109|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220110|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220111|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 2 and 3||2
8220112|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 2 and 3||2
8220113|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 2 and 3||2
8220114|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 2 and 3||2
8220115|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 2 and 3||2
8220116|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 2 and 3||2
8220117|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 2 and 3||2
8220118|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 2 and 3||2
8220119|NCT02059434|20271788|P9|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220120|NCT02059434|20271789|P8|STARTED|Washout Between Periods 2 and 3||2
8220121|NCT02059434|20271790|P7|STARTED|Washout Between Periods 2 and 3||2
8220122|NCT02059434|20271791|P6|STARTED|Washout Between Periods 2 and 3||2
8220124|NCT02059434|20271793|P4|STARTED|Washout Between Periods 2 and 3||2
8220125|NCT02059434|20271794|P3|STARTED|Washout Between Periods 2 and 3||2
8220126|NCT02059434|20271795|P2|STARTED|Washout Between Periods 2 and 3||2
8220127|NCT02059434|20271796|P1|STARTED|Washout Between Periods 2 and 3||2
8220128|NCT02059434|20271788|P9|NOT COMPLETED|Period 2||0
8220129|NCT02059434|20271789|P8|NOT COMPLETED|Period 2||0
8220130|NCT02059434|20271790|P7|NOT COMPLETED|Period 2||0
8220131|NCT02059434|20271791|P6|NOT COMPLETED|Period 2||0
8220132|NCT02059434|20271792|P5|NOT COMPLETED|Period 2||0
8220133|NCT02059434|20271793|P4|NOT COMPLETED|Period 2||0
8220134|NCT02059434|20271794|P3|NOT COMPLETED|Period 2||0
8220135|NCT02059434|20271795|P2|NOT COMPLETED|Period 2||0
8220136|NCT02059434|20271796|P1|NOT COMPLETED|Period 2||0
8220137|NCT02059434|20271788|P9|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220138|NCT02059434|20271789|P8|COMPLETED|Period 2||2
8220139|NCT02059434|20271790|P7|COMPLETED|Period 2||2
8220140|NCT02059434|20271791|P6|COMPLETED|Period 2||2
8220141|NCT02059434|20271792|P5|COMPLETED|Period 2||2
8220142|NCT02059434|20271793|P4|COMPLETED|Period 2||2
8220143|NCT02059434|20271794|P3|COMPLETED|Period 2||2
8220144|NCT02059434|20271795|P2|COMPLETED|Period 2||2
8220145|NCT02059434|20271796|P1|COMPLETED|Period 2||2
8220146|NCT02059434|20271788|P9|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220147|NCT02059434|20271789|P8|STARTED|Period 2||2
8220148|NCT02059434|20271790|P7|STARTED|Period 2||2
8220149|NCT02059434|20271791|P6|STARTED|Period 2||2
8220150|NCT02059434|20271792|P5|STARTED|Period 2||2
8220151|NCT02059434|20271793|P4|STARTED|Period 2||2
8220152|NCT02059434|20271794|P3|STARTED|Period 2||2
8220153|NCT02059434|20271795|P2|STARTED|Period 2||2
8220154|NCT02059434|20271796|P1|STARTED|Period 2||2
8220155|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220156|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 1 and 2||1
8220157|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220158|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220159|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220160|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220161|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220162|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220163|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220164|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220165|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 1 and 2||2
8220166|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 1 and 2||2
8220167|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 1 and 2||2
8220168|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 1 and 2||2
8220169|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 1 and 2||2
8220170|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 1 and 2||2
8220171|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 1 and 2||2
8220172|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 1 and 2||2
8220173|NCT02059434|20271788|P9|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220174|NCT02059434|20271789|P8|STARTED|Washout Between Periods 1 and 2||3
8220175|NCT02059434|20271790|P7|STARTED|Washout Between Periods 1 and 2||2
8220176|NCT02059434|20271791|P6|STARTED|Washout Between Periods 1 and 2||2
8220177|NCT02059434|20271792|P5|STARTED|Washout Between Periods 1 and 2||2
8220178|NCT02059434|20271793|P4|STARTED|Washout Between Periods 1 and 2||2
8220179|NCT02059434|20271794|P3|STARTED|Washout Between Periods 1 and 2||2
8220180|NCT02059434|20271795|P2|STARTED|Washout Between Periods 1 and 2||2
8220181|NCT02059434|20271796|P1|STARTED|Washout Between Periods 1 and 2||2
8220182|NCT02059434|20271788|P9|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220183|NCT02059434|20271789|P8|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220184|NCT02059434|20271790|P7|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220185|NCT02059434|20271791|P6|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220186|NCT02059434|20271792|P5|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220187|NCT02059434|20271793|P4|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220188|NCT02059434|20271794|P3|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220189|NCT02059434|20271795|P2|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220190|NCT02059434|20271796|P1|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220191|NCT02059434|20271788|P9|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220192|NCT02059434|20271789|P8|COMPLETED|Period 1 (After Screening/run-in Period)||3
8220193|NCT02059434|20271790|P7|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220194|NCT02059434|20271791|P6|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220195|NCT02059434|20271792|P5|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220196|NCT02059434|20271793|P4|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220197|NCT02059434|20271794|P3|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220198|NCT02059434|20271795|P2|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220199|NCT02059434|20271796|P1|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220200|NCT02059434|20271788|P9|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220201|NCT02059434|20271789|P8|STARTED|Period 1 (After Screening/run-in Period)||3
8220202|NCT02059434|20271790|P7|STARTED|Period 1 (After Screening/run-in Period)||2
8220203|NCT02059434|20271791|P6|STARTED|Period 1 (After Screening/run-in Period)||2
8220204|NCT02059434|20271792|P5|STARTED|Period 1 (After Screening/run-in Period)||2
8220205|NCT02059434|20271793|P4|STARTED|Period 1 (After Screening/run-in Period)||2
8220206|NCT02059434|20271794|P3|STARTED|Period 1 (After Screening/run-in Period)||2
8220207|NCT02059434|20271795|P2|STARTED|Period 1 (After Screening/run-in Period)||2
8220208|NCT02059434|20271796|P1|STARTED|Period 1 (After Screening/run-in Period)||2
8220209|NCT02059408|20271861|P3|NOT COMPLETED|Overall Study||358
8220210|NCT02059408|20271862|P2|NOT COMPLETED|Overall Study||330
8220211|NCT02059408|20271863|P1|NOT COMPLETED|Overall Study||0
8220212|NCT02059408|20271861|P3|COMPLETED|Overall Study||258
8220213|NCT02059408|20271862|P2|COMPLETED|Overall Study||269
8220214|NCT02059408|20271863|P1|COMPLETED|Overall Study||604
8220215|NCT02059408|20271861|P3|STARTED|Overall Study||616
8220216|NCT02059408|20271862|P2|STARTED|Overall Study||599
8220217|NCT02059408|20271863|P1|STARTED|Overall Study||604
8220218|NCT02059395|20271882|P2|NOT COMPLETED|Overall Study||4
8220219|NCT02059395|20271883|P1|NOT COMPLETED|Overall Study||2
8220220|NCT02059395|20271882|P2|COMPLETED|Overall Study||23
8220221|NCT02059395|20271883|P1|COMPLETED|Overall Study||20
8220222|NCT02059395|20271882|P2|STARTED|Overall Study||27
8220223|NCT02059395|20271883|P1|STARTED|Overall Study||22
8220224|NCT02059291|20271898|P25|NOT COMPLETED|Epoch 4||0
8220225|NCT02059291|20271899|P24|NOT COMPLETED|Epoch 4||1
8220226|NCT02059291|20271900|P23|NOT COMPLETED|Epoch 4||1
8220227|NCT02059291|20271901|P22|NOT COMPLETED|Epoch 4||0
8220228|NCT02059291|20271902|P21|NOT COMPLETED|Epoch 4||1
8220229|NCT02059291|20271903|P20|NOT COMPLETED|Epoch 4||0
8220230|NCT02059291|20271904|P19|NOT COMPLETED|Epoch 4||0
8220231|NCT02059291|20271905|P18|NOT COMPLETED|Epoch 4||0
8220232|NCT02059291|20271906|P17|NOT COMPLETED|Epoch 4||2
8220233|NCT02059291|20271907|P16|NOT COMPLETED|Epoch 4||0
8220234|NCT02059291|20271908|P15|NOT COMPLETED|Epoch 4||0
8220235|NCT02059291|20271909|P14|NOT COMPLETED|Epoch 4||0
8220236|NCT02059291|20271910|P13|NOT COMPLETED|Epoch 4||0
8220237|NCT02059291|20271911|P12|NOT COMPLETED|Epoch 4||0
8220238|NCT02059291|20271912|P11|NOT COMPLETED|Epoch 4||0
8220239|NCT02059291|20271913|P10|NOT COMPLETED|Epoch 4||0
8220240|NCT02059291|20271914|P9|NOT COMPLETED|Epoch 4||0
8220241|NCT02059291|20271915|P8|NOT COMPLETED|Epoch 4||0
8220242|NCT02059291|20271916|P7|NOT COMPLETED|Epoch 4||0
8220243|NCT02059291|20271917|P6|NOT COMPLETED|Epoch 4||0
8220244|NCT02059291|20271918|P5|NOT COMPLETED|Epoch 4||0
8220245|NCT02059291|20271919|P4|NOT COMPLETED|Epoch 4||0
8220246|NCT02059291|20271920|P3|NOT COMPLETED|Epoch 4||0
8220247|NCT02059291|20271921|P2|NOT COMPLETED|Epoch 4||0
8220248|NCT02059291|20271922|P1|NOT COMPLETED|Epoch 4||0
8220249|NCT02059291|20271898|P25|COMPLETED|Epoch 4||0
8220250|NCT02059291|20271899|P24|COMPLETED|Epoch 4||21
8220251|NCT02059291|20271900|P23|COMPLETED|Epoch 4||30
8220252|NCT02059291|20271901|P22|COMPLETED|Epoch 4||14
8220253|NCT02059291|20271902|P21|COMPLETED|Epoch 4||33
8220254|NCT02059291|20271903|P20|COMPLETED|Epoch 4||18
8220255|NCT02059291|20271904|P19|COMPLETED|Epoch 4||2
8220256|NCT02059291|20271905|P18|COMPLETED|Epoch 4||14
8220257|NCT02059291|20271906|P17|COMPLETED|Epoch 4||41
8220258|NCT02059291|20271907|P16|COMPLETED|Epoch 4||0
8220259|NCT02059291|20271908|P15|COMPLETED|Epoch 4||0
8220260|NCT02059291|20271909|P14|COMPLETED|Epoch 4||0
8220261|NCT02059291|20271910|P13|COMPLETED|Epoch 4||0
8220262|NCT02059291|20271911|P12|COMPLETED|Epoch 4||0
8220263|NCT02059291|20271912|P11|COMPLETED|Epoch 4||0
8220264|NCT02059291|20271913|P10|COMPLETED|Epoch 4||0
8220265|NCT02059291|20271914|P9|COMPLETED|Epoch 4||0
8220266|NCT02059291|20271915|P8|COMPLETED|Epoch 4||0
8220267|NCT02059291|20271916|P7|COMPLETED|Epoch 4||0
8220268|NCT02059291|20271917|P6|COMPLETED|Epoch 4||0
8220269|NCT02059291|20271918|P5|COMPLETED|Epoch 4||0
8220270|NCT02059291|20271919|P4|COMPLETED|Epoch 4||0
8220271|NCT02059291|20271920|P3|COMPLETED|Epoch 4||0
8220272|NCT02059291|20271921|P2|COMPLETED|Epoch 4||0
8220273|NCT02059291|20271922|P1|COMPLETED|Epoch 4||0
8220274|NCT02059291|20271898|P25|STARTED|Epoch 4||0
8220275|NCT02059291|20271899|P24|STARTED|Epoch 4||22
8220276|NCT02059291|20271900|P23|STARTED|Epoch 4||31
8220277|NCT02059291|20271901|P22|STARTED|Epoch 4||14
8220278|NCT02059291|20271902|P21|STARTED|Epoch 4||34
8220279|NCT02059291|20271903|P20|STARTED|Epoch 4||18
8220280|NCT02059291|20271904|P19|STARTED|Epoch 4||2
8220281|NCT02059291|20271905|P18|STARTED|Epoch 4||14
8220282|NCT02059291|20271906|P17|STARTED|Epoch 4||43
8220283|NCT02059291|20271907|P16|STARTED|Epoch 4||0
8220284|NCT02059291|20271908|P15|STARTED|Epoch 4||0
8220285|NCT02059291|20271909|P14|STARTED|Epoch 4||0
8220286|NCT02059291|20271910|P13|STARTED|Epoch 4||0
8220287|NCT02059291|20271911|P12|STARTED|Epoch 4||0
8220288|NCT02059291|20271912|P11|STARTED|Epoch 4||0
8220289|NCT02059291|20271913|P10|STARTED|Epoch 4||0
8220290|NCT02059291|20271914|P9|STARTED|Epoch 4||0
8220291|NCT02059291|20271915|P8|STARTED|Epoch 4||0
8220292|NCT02059291|20271916|P7|STARTED|Epoch 4||0
8220293|NCT02059291|20271917|P6|STARTED|Epoch 4||0
8220294|NCT02059291|20271918|P5|STARTED|Epoch 4||0
8220295|NCT02059291|20271919|P4|STARTED|Epoch 4||0
8220296|NCT02059291|20271920|P3|STARTED|Epoch 4||0
8220297|NCT02059291|20271921|P2|STARTED|Epoch 4||0
8220298|NCT02059291|20271922|P1|STARTED|Epoch 4||0
8220299|NCT02059291|20271898|P25|NOT COMPLETED|Epoch 3||0
8220300|NCT02059291|20271899|P24|NOT COMPLETED|Epoch 3||0
8220301|NCT02059291|20271900|P23|NOT COMPLETED|Epoch 3||0
8220302|NCT02059291|20271901|P22|NOT COMPLETED|Epoch 3||0
8220303|NCT02059291|20271902|P21|NOT COMPLETED|Epoch 3||0
8220304|NCT02059291|20271903|P20|NOT COMPLETED|Epoch 3||0
8220305|NCT02059291|20271904|P19|NOT COMPLETED|Epoch 3||0
8220306|NCT02059291|20271905|P18|NOT COMPLETED|Epoch 3||0
8220307|NCT02059291|20271906|P17|NOT COMPLETED|Epoch 3||0
8220308|NCT02059291|20271907|P16|NOT COMPLETED|Epoch 3||6
8220309|NCT02059291|20271908|P15|NOT COMPLETED|Epoch 3||0
8220310|NCT02059291|20271909|P14|NOT COMPLETED|Epoch 3||1
8220311|NCT02059291|20271910|P13|NOT COMPLETED|Epoch 3||0
8220312|NCT02059291|20271911|P12|NOT COMPLETED|Epoch 3||0
8220313|NCT02059291|20271912|P11|NOT COMPLETED|Epoch 3||0
8220314|NCT02059291|20271913|P10|NOT COMPLETED|Epoch 3||0
8220315|NCT02059291|20271914|P9|NOT COMPLETED|Epoch 3||0
8220316|NCT02059291|20271915|P8|NOT COMPLETED|Epoch 3||0
8220317|NCT02059291|20271916|P7|NOT COMPLETED|Epoch 3||0
8220318|NCT02059291|20271917|P6|NOT COMPLETED|Epoch 3||0
8220319|NCT02059291|20271918|P5|NOT COMPLETED|Epoch 3||0
8220320|NCT02059291|20271919|P4|NOT COMPLETED|Epoch 3||0
8220321|NCT02059291|20271920|P3|NOT COMPLETED|Epoch 3||0
8220322|NCT02059291|20271921|P2|NOT COMPLETED|Epoch 3||0
8220323|NCT02059291|20271922|P1|NOT COMPLETED|Epoch 3||0
8220324|NCT02059291|20271898|P25|COMPLETED|Epoch 3||0
8220325|NCT02059291|20271899|P24|COMPLETED|Epoch 3||0
8220326|NCT02059291|20271900|P23|COMPLETED|Epoch 3||0
8220327|NCT02059291|20271901|P22|COMPLETED|Epoch 3||0
8220328|NCT02059291|20271902|P21|COMPLETED|Epoch 3||0
8220329|NCT02059291|20271903|P20|COMPLETED|Epoch 3||0
8220330|NCT02059291|20271904|P19|COMPLETED|Epoch 3||0
8220331|NCT02059291|20271905|P18|COMPLETED|Epoch 3||0
8220332|NCT02059291|20271906|P17|COMPLETED|Epoch 3||0
8220333|NCT02059291|20271907|P16|COMPLETED|Epoch 3||120
8220334|NCT02059291|20271908|P15|COMPLETED|Epoch 3||5
8220335|NCT02059291|20271909|P14|COMPLETED|Epoch 3||3
8220336|NCT02059291|20271910|P13|COMPLETED|Epoch 3||7
8220337|NCT02059291|20271911|P12|COMPLETED|Epoch 3||6
8220338|NCT02059291|20271912|P11|COMPLETED|Epoch 3||10
8220339|NCT02059291|20271913|P10|COMPLETED|Epoch 3||9
8220340|NCT02059291|20271914|P9|COMPLETED|Epoch 3||0
8220341|NCT02059291|20271915|P8|COMPLETED|Epoch 3||1
8220342|NCT02059291|20271916|P7|COMPLETED|Epoch 3||2
8220343|NCT02059291|20271917|P6|COMPLETED|Epoch 3||0
8220344|NCT02059291|20271918|P5|COMPLETED|Epoch 3||0
8220345|NCT02059291|20271919|P4|COMPLETED|Epoch 3||0
8220346|NCT02059291|20271920|P3|COMPLETED|Epoch 3||0
8220347|NCT02059291|20271921|P2|COMPLETED|Epoch 3||0
8220348|NCT02059291|20271922|P1|COMPLETED|Epoch 3||0
8220349|NCT02059291|20271898|P25|STARTED|Epoch 3||0
8220350|NCT02059291|20271899|P24|STARTED|Epoch 3||0
8220351|NCT02059291|20271900|P23|STARTED|Epoch 3||0
8220352|NCT02059291|20271901|P22|STARTED|Epoch 3||0
8220353|NCT02059291|20271902|P21|STARTED|Epoch 3||0
8220354|NCT02059291|20271903|P20|STARTED|Epoch 3||0
8220355|NCT02059291|20271904|P19|STARTED|Epoch 3||0
8220356|NCT02059291|20271905|P18|STARTED|Epoch 3||0
8220357|NCT02059291|20271906|P17|STARTED|Epoch 3||0
8220358|NCT02059291|20271907|P16|STARTED|Epoch 3||126
8220359|NCT02059291|20271908|P15|STARTED|Epoch 3||5
8220360|NCT02059291|20271909|P14|STARTED|Epoch 3||4
8220361|NCT02059291|20271910|P13|STARTED|Epoch 3||7
8220362|NCT02059291|20271911|P12|STARTED|Epoch 3||6
8220363|NCT02059291|20271912|P11|STARTED|Epoch 3||10
8220364|NCT02059291|20271913|P10|STARTED|Epoch 3||9
8220365|NCT02059291|20271914|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
8220366|NCT02059291|20271915|P8|STARTED|Epoch 3||1
8220367|NCT02059291|20271916|P7|STARTED|Epoch 3||2
8220368|NCT02059291|20271917|P6|STARTED|Epoch 3||0
8220369|NCT02059291|20271918|P5|STARTED|Epoch 3||0
8220370|NCT02059291|20271919|P4|STARTED|Epoch 3||0
8220371|NCT02059291|20271920|P3|STARTED|Epoch 3||0
8220372|NCT02059291|20271921|P2|STARTED|Epoch 3||0
8220373|NCT02059291|20271922|P1|STARTED|Epoch 3||0
8220374|NCT02059291|20271898|P25|NOT COMPLETED|Epoch 2||0
8220375|NCT02059291|20271899|P24|NOT COMPLETED|Epoch 2||0
8220376|NCT02059291|20271900|P23|NOT COMPLETED|Epoch 2||0
8220377|NCT02059291|20271901|P22|NOT COMPLETED|Epoch 2||0
8220378|NCT02059291|20271902|P21|NOT COMPLETED|Epoch 2||0
8220379|NCT02059291|20271903|P20|NOT COMPLETED|Epoch 2||0
8220380|NCT02059291|20271904|P19|NOT COMPLETED|Epoch 2||0
8220381|NCT02059291|20271905|P18|NOT COMPLETED|Epoch 2||0
8220382|NCT02059291|20271906|P17|NOT COMPLETED|Epoch 2||0
8220383|NCT02059291|20271907|P16|NOT COMPLETED|Epoch 2||0
8220384|NCT02059291|20271908|P15|NOT COMPLETED|Epoch 2||0
8220385|NCT02059291|20271909|P14|NOT COMPLETED|Epoch 2||0
8220386|NCT02059291|20271910|P13|NOT COMPLETED|Epoch 2||0
8220387|NCT02059291|20271911|P12|NOT COMPLETED|Epoch 2||0
8220388|NCT02059291|20271912|P11|NOT COMPLETED|Epoch 2||0
8220389|NCT02059291|20271913|P10|NOT COMPLETED|Epoch 2||0
8220390|NCT02059291|20271914|P9|NOT COMPLETED|Epoch 2||2
8220391|NCT02059291|20271915|P8|NOT COMPLETED|Epoch 2||1
8220392|NCT02059291|20271916|P7|NOT COMPLETED|Epoch 2||0
8220393|NCT02059291|20271917|P6|NOT COMPLETED|Epoch 2||2
8220394|NCT02059291|20271918|P5|NOT COMPLETED|Epoch 2||0
8220395|NCT02059291|20271919|P4|NOT COMPLETED|Epoch 2||2
8220396|NCT02059291|20271920|P3|NOT COMPLETED|Epoch 2||1
8220397|NCT02059291|20271921|P2|NOT COMPLETED|Epoch 2||1
8220398|NCT02059291|20271922|P1|NOT COMPLETED|Epoch 2||0
8220399|NCT02059291|20271898|P25|COMPLETED|Epoch 2||0
8220400|NCT02059291|20271899|P24|COMPLETED|Epoch 2||0
8220401|NCT02059291|20271900|P23|COMPLETED|Epoch 2||0
8220402|NCT02059291|20271901|P22|COMPLETED|Epoch 2||0
8220403|NCT02059291|20271902|P21|COMPLETED|Epoch 2||0
8220404|NCT02059291|20271903|P20|COMPLETED|Epoch 2||0
8220405|NCT02059291|20271904|P19|COMPLETED|Epoch 2||0
8220406|NCT02059291|20271905|P18|COMPLETED|Epoch 2||0
8220407|NCT02059291|20271906|P17|COMPLETED|Epoch 2||0
8220408|NCT02059291|20271907|P16|COMPLETED|Epoch 2||0
8220409|NCT02059291|20271908|P15|COMPLETED|Epoch 2||0
8220410|NCT02059291|20271909|P14|COMPLETED|Epoch 2||0
8220411|NCT02059291|20271910|P13|COMPLETED|Epoch 2||0
8220412|NCT02059291|20271911|P12|COMPLETED|Epoch 2||0
8220413|NCT02059291|20271912|P11|COMPLETED|Epoch 2||0
8220414|NCT02059291|20271913|P10|COMPLETED|Epoch 2||0
8220415|NCT02059291|20271914|P9|COMPLETED|Epoch 2||16
8220416|NCT02059291|20271915|P8|COMPLETED|Epoch 2||1
8220417|NCT02059291|20271916|P7|COMPLETED|Epoch 2||2
8220418|NCT02059291|20271917|P6|COMPLETED|Epoch 2||22
8220419|NCT02059291|20271918|P5|COMPLETED|Epoch 2||22
8220420|NCT02059291|20271919|P4|COMPLETED|Epoch 2||33
8220421|NCT02059291|20271920|P3|COMPLETED|Epoch 2||36
8220422|NCT02059291|20271921|P2|COMPLETED|Epoch 2||31
8220423|NCT02059291|20271922|P1|COMPLETED|Epoch 2||31
8220424|NCT02059291|20271898|P25|STARTED|Epoch 2||0
8220425|NCT02059291|20271899|P24|STARTED|Epoch 2||0
8220426|NCT02059291|20271900|P23|STARTED|Epoch 2||0
8220427|NCT02059291|20271901|P22|STARTED|Epoch 2||0
8220428|NCT02059291|20271902|P21|STARTED|Epoch 2||0
8220429|NCT02059291|20271903|P20|STARTED|Epoch 2||0
8220430|NCT02059291|20271904|P19|STARTED|Epoch 2||0
8220431|NCT02059291|20271905|P18|STARTED|Epoch 2||0
8220432|NCT02059291|20271906|P17|STARTED|Epoch 2||0
8220433|NCT02059291|20271907|P16|STARTED|Epoch 2||0
8220434|NCT02059291|20271908|P15|STARTED|Epoch 2||0
8220435|NCT02059291|20271909|P14|STARTED|Epoch 2||0
8220436|NCT02059291|20271910|P13|STARTED|Epoch 2||0
8220437|NCT02059291|20271911|P12|STARTED|Epoch 2||0
8220438|NCT02059291|20271912|P11|STARTED|Epoch 2||0
8220439|NCT02059291|20271913|P10|STARTED|Epoch 2||0
8220440|NCT02059291|20271914|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
8220441|NCT02059291|20271915|P8|STARTED|Epoch 2||2
8220442|NCT02059291|20271916|P7|STARTED|Epoch 2||2
8220443|NCT02059291|20271917|P6|STARTED|Epoch 2||24
8220444|NCT02059291|20271918|P5|STARTED|Epoch 2||22
8220445|NCT02059291|20271919|P4|STARTED|Epoch 2||35
8220446|NCT02059291|20271920|P3|STARTED|Epoch 2||37
8220447|NCT02059291|20271921|P2|STARTED|Epoch 2||32
8220448|NCT02059291|20271922|P1|STARTED|Epoch 2||31
8220449|NCT02059278|20271976|P2|NOT COMPLETED|Overall Study||4
8220450|NCT02059278|20271977|P1|NOT COMPLETED|Overall Study||3
8220451|NCT02059278|20271976|P2|COMPLETED|Overall Study||166
8220452|NCT02059278|20271977|P1|COMPLETED|Overall Study||162
8220453|NCT02059278|20271976|P2|STARTED|Overall Study||170
8220454|NCT02059278|20271977|P1|STARTED|Overall Study||165
8220455|NCT02059265|20271991|P1|NOT COMPLETED|Overall Study||4
8220456|NCT02059265|20271991|P1|COMPLETED|Overall Study||28
8220457|NCT02059265|20271991|P1|STARTED|Overall Study||32
8220458|NCT02059213|20272001|P2|NOT COMPLETED|Overall Study||2
8220459|NCT02059213|20272002|P1|NOT COMPLETED|Overall Study||0
8220460|NCT02059213|20272001|P2|COMPLETED|Overall Study||40
8220461|NCT02059213|20272002|P1|COMPLETED|Overall Study||20
8220462|NCT02059213|20272001|P2|Initiated Treatment|Overall Study||40
8220463|NCT02059213|20272002|P1|Initiated Treatment|Overall Study||20
8220464|NCT02059213|20272001|P2|STARTED|Overall Study||42
8220465|NCT02059213|20272002|P1|STARTED|Overall Study||20
8220466|NCT02059187|20272023|P2|NOT COMPLETED|Overall Study||22
8220467|NCT02059187|20272024|P1|NOT COMPLETED|Overall Study||25
8220468|NCT02059187|20272023|P2|COMPLETED|Overall Study||244
8220469|NCT02059187|20272024|P1|COMPLETED|Overall Study||240
8220470|NCT02059187|20272023|P2|STARTED|Overall Study||266
8220471|NCT02059187|20272024|P1|STARTED|Overall Study||265
8220472|NCT02059174|20272050|P2|NOT COMPLETED|Period 4||0
8220473|NCT02059174|20272051|P1|NOT COMPLETED|Period 4||0
8220474|NCT02059174|20272050|P2|COMPLETED|Period 4||35
8220475|NCT02059174|20272051|P1|COMPLETED|Period 4||35
8220476|NCT02059174|20272050|P2|STARTED|Period 4||35
8220477|NCT02059174|20272051|P1|STARTED|Period 4||35
8220478|NCT02059174|20272050|P2|NOT COMPLETED|Period 3||0
8220479|NCT02059174|20272051|P1|NOT COMPLETED|Period 3||1
8220480|NCT02059174|20272050|P2|COMPLETED|Period 3||35
8220481|NCT02059174|20272051|P1|COMPLETED|Period 3||35
8220482|NCT02059174|20272050|P2|STARTED|Period 3||35
8220483|NCT02059174|20272051|P1|STARTED|Period 3||36
8220484|NCT02059174|20272050|P2|NOT COMPLETED|Period 2||2
8220485|NCT02059174|20272051|P1|NOT COMPLETED|Period 2||1
8220486|NCT02059174|20272050|P2|COMPLETED|Period 2||35
8220487|NCT02059174|20272051|P1|COMPLETED|Period 2||36
8220488|NCT02059174|20272050|P2|STARTED|Period 2||37
8220489|NCT02059174|20272051|P1|STARTED|Period 2||37
8220490|NCT02059174|20272050|P2|NOT COMPLETED|Period 1||2
8220491|NCT02059174|20272051|P1|NOT COMPLETED|Period 1||0
8220492|NCT02059174|20272050|P2|COMPLETED|Period 1||37
8220493|NCT02059174|20272051|P1|COMPLETED|Period 1||37
8220494|NCT02059174|20272050|P2|STARTED|Period 1||39
8220495|NCT02059174|20272051|P1|STARTED|Period 1||37
8220496|NCT02059161|20272075|P2|NOT COMPLETED|Overall Study||41
8220497|NCT02059161|20272076|P1|NOT COMPLETED|Overall Study||49
8220498|NCT02059161|20272075|P2|COMPLETED|Overall Study||222
8220499|NCT02059161|20272076|P1|COMPLETED|Overall Study||196
8220500|NCT02059161|20272075|P2|Treated|Overall Study||258
8220501|NCT02059161|20272076|P1|Treated|Overall Study||241
8220502|NCT02059161|20272075|P2|STARTED|Overall Study||263
8220503|NCT02059161|20272076|P1|STARTED|Overall Study||245
8220504|NCT02059148|20272136|P6|NOT COMPLETED|Treatment 3||0
8220505|NCT02059148|20272137|P5|NOT COMPLETED|Treatment 3||0
8220506|NCT02059148|20272138|P4|NOT COMPLETED|Treatment 3||0
8220507|NCT02059148|20272139|P3|NOT COMPLETED|Treatment 3||0
8220508|NCT02059148|20272140|P2|NOT COMPLETED|Treatment 3||0
8220509|NCT02059148|20272141|P1|NOT COMPLETED|Treatment 3||0
8220510|NCT02059148|20272136|P6|COMPLETED|Treatment 3||3
8220511|NCT02059148|20272137|P5|COMPLETED|Treatment 3||4
8220512|NCT02059148|20272138|P4|COMPLETED|Treatment 3||4
8220513|NCT02059148|20272139|P3|COMPLETED|Treatment 3||4
8220514|NCT02059148|20272140|P2|COMPLETED|Treatment 3||4
8220515|NCT02059148|20272141|P1|COMPLETED|Treatment 3||4
8220516|NCT02059148|20272136|P6|STARTED|Treatment 3||3
8220517|NCT02059148|20272137|P5|STARTED|Treatment 3||4
8220518|NCT02059148|20272138|P4|STARTED|Treatment 3||4
8220519|NCT02059148|20272139|P3|STARTED|Treatment 3||4
8220520|NCT02059148|20272140|P2|STARTED|Treatment 3||4
8220521|NCT02059148|20272141|P1|STARTED|Treatment 3||4
8220522|NCT02059148|20272136|P6|NOT COMPLETED|Treatment 2||0
8220523|NCT02059148|20272137|P5|NOT COMPLETED|Treatment 2||0
8220524|NCT02059148|20272138|P4|NOT COMPLETED|Treatment 2||0
8220525|NCT02059148|20272139|P3|NOT COMPLETED|Treatment 2||0
8220526|NCT02059148|20272140|P2|NOT COMPLETED|Treatment 2||0
8220527|NCT02059148|20272141|P1|NOT COMPLETED|Treatment 2||0
8220528|NCT02059148|20272136|P6|COMPLETED|Treatment 2||3
8220529|NCT02059148|20272137|P5|COMPLETED|Treatment 2||4
8220530|NCT02059148|20272138|P4|COMPLETED|Treatment 2||4
8220531|NCT02059148|20272139|P3|COMPLETED|Treatment 2||4
8220532|NCT02059148|20272140|P2|COMPLETED|Treatment 2||4
8220533|NCT02059148|20272141|P1|COMPLETED|Treatment 2||4
8220534|NCT02059148|20272136|P6|STARTED|Treatment 2||3
8220535|NCT02059148|20272137|P5|STARTED|Treatment 2||4
8220536|NCT02059148|20272138|P4|STARTED|Treatment 2||4
8220537|NCT02059148|20272139|P3|STARTED|Treatment 2||4
8220538|NCT02059148|20272140|P2|STARTED|Treatment 2||4
8220539|NCT02059148|20272141|P1|STARTED|Treatment 2||4
8220540|NCT02059148|20272136|P6|NOT COMPLETED|Treatment 1||1
8220541|NCT02059148|20272137|P5|NOT COMPLETED|Treatment 1||0
8220542|NCT02059148|20272138|P4|NOT COMPLETED|Treatment 1||0
8220543|NCT02059148|20272139|P3|NOT COMPLETED|Treatment 1||0
8220544|NCT02059148|20272140|P2|NOT COMPLETED|Treatment 1||0
8220545|NCT02059148|20272141|P1|NOT COMPLETED|Treatment 1||0
8220546|NCT02059148|20272136|P6|COMPLETED|Treatment 1||3
8220547|NCT02059148|20272137|P5|COMPLETED|Treatment 1||4
8220548|NCT02059148|20272138|P4|COMPLETED|Treatment 1||4
8220549|NCT02059148|20272139|P3|COMPLETED|Treatment 1||4
8220550|NCT02059148|20272140|P2|COMPLETED|Treatment 1||4
8220551|NCT02059148|20272141|P1|COMPLETED|Treatment 1||4
8220552|NCT02059148|20272136|P6|STARTED|Treatment 1||4
8220553|NCT02059148|20272137|P5|STARTED|Treatment 1||4
8220554|NCT02059148|20272138|P4|STARTED|Treatment 1||4
8220555|NCT02059148|20272139|P3|STARTED|Treatment 1||4
8220556|NCT02059148|20272140|P2|STARTED|Treatment 1||4
8220557|NCT02059148|20272141|P1|STARTED|Treatment 1||4
8220558|NCT02059135|20272160|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
8220559|NCT02059135|20272161|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
8220560|NCT02059135|20272160|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
8220561|NCT02059135|20272161|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
8220562|NCT02059135|20272160|P2|STARTED|Neonatal Follow-up (Safety Population)||54
8220563|NCT02059135|20272161|P1|STARTED|Neonatal Follow-up (Safety Population)||60
8220564|NCT02059135|20272160|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
8220565|NCT02059135|20272161|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
8220566|NCT02059135|20272160|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
8220567|NCT02059135|20272161|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
8220568|NCT02059135|20272160|P2|STARTED|Maternal Follow-up (ITT Population)||58
8220569|NCT02059135|20272161|P1|STARTED|Maternal Follow-up (ITT Population)||62
8220570|NCT02059070|20272175|P2|NOT COMPLETED|Overall Study||4
8220571|NCT02059070|20272176|P1|NOT COMPLETED|Overall Study||5
8220572|NCT02059070|20272175|P2|COMPLETED|Overall Study||16
8220573|NCT02059070|20272176|P1|COMPLETED|Overall Study||14
8220574|NCT02059070|20272175|P2|STARTED|Overall Study||20
8220575|NCT02059070|20272176|P1|STARTED|Overall Study||19
8220576|NCT02059057|20272188|P1|NOT COMPLETED|Overall Study||15
8220577|NCT02059057|20272188|P1|COMPLETED|Overall Study||87
8220578|NCT02059057|20272188|P1|STARTED|Overall Study||102
8220579|NCT02059005|20272197|P2|NOT COMPLETED|Overall Study||24
8220580|NCT02059005|20272198|P1|NOT COMPLETED|Overall Study||20
8220581|NCT02059005|20272197|P2|COMPLETED|Overall Study||24
8220582|NCT02059005|20272198|P1|COMPLETED|Overall Study||29
8220583|NCT02059005|20272197|P2|6 Month Assessment|Overall Study||24
8220584|NCT02059005|20272198|P1|6 Month Assessment|Overall Study||29
8220585|NCT02059005|20272197|P2|3 Month Assessment|Overall Study||33
8220586|NCT02059005|20272198|P1|3 Month Assessment|Overall Study||37
8220587|NCT02059005|20272197|P2|STARTED|Overall Study||48
8220588|NCT02059005|20272198|P1|STARTED|Overall Study||49
8220589|NCT02058992|20272208|P1|NOT COMPLETED|Overall Study||116
8220590|NCT02058992|20272208|P1|COMPLETED|Overall Study||3223
8220591|NCT02058992|20272208|P1|STARTED|Overall Study||3339
8220592|NCT02058966|20272217|P1|NOT COMPLETED|Fourth Intervention||0
8220593|NCT02058966|20272217|P1|COMPLETED|Fourth Intervention||12
8220594|NCT02058966|20272217|P1|Received Entacapone-Meth|Fourth Intervention||2
8220595|NCT02058966|20272217|P1|Received Entacapone-Placebo|Fourth Intervention||3
8220596|NCT02058966|20272217|P1|Received Placebo-Meth|Fourth Intervention||3
8220597|NCT02058966|20272217|P1|Received Placebo-Placebo|Fourth Intervention||4
8220598|NCT02058966|20272217|P1|STARTED|Fourth Intervention||12
8220599|NCT02058966|20272217|P1|NOT COMPLETED|Third Intervention||0
8220600|NCT02058966|20272217|P1|COMPLETED|Third Intervention||12
8220601|NCT02058966|20272217|P1|Received Entacapone-Meth|Third Intervention||3
8220602|NCT02058966|20272217|P1|Received Entacapone-Placebo|Third Intervention||1
8220603|NCT02058966|20272217|P1|Received Placebo-Meth|Third Intervention||4
8220604|NCT02058966|20272217|P1|Received Placebo-Placebo|Third Intervention||4
8220605|NCT02058966|20272217|P1|STARTED|Third Intervention||12
8220606|NCT02058966|20272217|P1|NOT COMPLETED|Second Intervention||0
8220607|NCT02058966|20272217|P1|COMPLETED|Second Intervention||13
8220608|NCT02058966|20272217|P1|Received Entacapone-Meth|Second Intervention||3
8220609|NCT02058966|20272217|P1|Received Entacapone-Placebo|Second Intervention||6
8220610|NCT02058966|20272217|P1|Received Placebo-Meth|Second Intervention||2
8220611|NCT02058966|20272217|P1|Received Placebo-Placebo|Second Intervention||2
8220612|NCT02058966|20272217|P1|STARTED|Second Intervention||13
8220613|NCT02058966|20272217|P1|NOT COMPLETED|First Intervention||1
8220614|NCT02058966|20272217|P1|COMPLETED|First Intervention||14
8220615|NCT02058966|20272217|P1|Received Entacapone-Meth|First Intervention||5
8220616|NCT02058966|20272217|P1|Received Entacapone-Placebo|First Intervention||2
8220617|NCT02058966|20272217|P1|Received Placebo-Meth|First Intervention||4
8220618|NCT02058966|20272217|P1|Received Placebo-Placebo|First Intervention||3
8220619|NCT02058966|20272217|P1|STARTED|First Intervention||15
8220620|NCT02058966|20272217|P1|NOT COMPLETED|Open-Label Methamphetamine||1
8220621|NCT02058966|20272217|P1|COMPLETED|Open-Label Methamphetamine||18
8220622|NCT02058966|20272217|P1|Received Methamphetamine|Open-Label Methamphetamine||18
8220623|NCT02058966|20272217|P1|STARTED|Open-Label Methamphetamine||19
8220624|NCT02058940|20272244|P1|NOT COMPLETED|Overall Study||1
8220625|NCT02058940|20272244|P1|COMPLETED|Overall Study||7
8220626|NCT02058940|20272244|P1|STARTED|Overall Study||8
8220627|NCT02058849|20272268|P2|NOT COMPLETED|Overall Study||1
8220628|NCT02058849|20272269|P1|NOT COMPLETED|Overall Study||7
8220629|NCT02058849|20272268|P2|COMPLETED|Overall Study||1
8220630|NCT02058849|20272269|P1|COMPLETED|Overall Study||4
8220631|NCT02058849|20272268|P2|STARTED|Overall Study||2
8220632|NCT02058849|20272269|P1|STARTED|Overall Study||11
8220633|NCT02058836|20272297|P2|NOT COMPLETED|Overall Study||1
8220634|NCT02058836|20272298|P1|NOT COMPLETED|Overall Study||1
8220635|NCT02058836|20272297|P2|COMPLETED|Overall Study||3
8220636|NCT02058836|20272298|P1|COMPLETED|Overall Study||3
8220637|NCT02058836|20272297|P2|STARTED|Overall Study||4
8220638|NCT02058836|20272298|P1|STARTED|Overall Study||4
8220639|NCT02058628|20272328|P2|NOT COMPLETED|Overall Study||8
8220640|NCT02058628|20272329|P1|NOT COMPLETED|Overall Study||7
8220641|NCT02058628|20272328|P2|COMPLETED|Overall Study||102
8220642|NCT02058628|20272329|P1|COMPLETED|Overall Study||104
8220643|NCT02058628|20272328|P2|STARTED|Overall Study||110
8220644|NCT02058628|20272329|P1|STARTED|Overall Study||111
8220645|NCT02058589|20272361|P2|NOT COMPLETED|Overall Study||2
8220646|NCT02058589|20272362|P1|NOT COMPLETED|Overall Study||2
8220647|NCT02058589|20272361|P2|COMPLETED|Overall Study||130
8220648|NCT02058589|20272362|P1|COMPLETED|Overall Study||130
8220649|NCT02058589|20272361|P2|STARTED|Overall Study||132
8220650|NCT02058589|20272362|P1|STARTED|Overall Study||132
8220651|NCT02058563|20272404|P2|NOT COMPLETED|Overall Study||24
8220652|NCT02058563|20272405|P1|NOT COMPLETED|Overall Study||28
8220653|NCT02058563|20272404|P2|COMPLETED|Overall Study||433
8220654|NCT02058563|20272405|P1|COMPLETED|Overall Study||426
8220655|NCT02058563|20272404|P2|STARTED|Overall Study||457
8220656|NCT02058563|20272405|P1|STARTED|Overall Study||454
8220657|NCT02058537|20272441|P1|NOT COMPLETED|Overall Study||1
8220658|NCT02058537|20272441|P1|COMPLETED|Overall Study||2
8220659|NCT02058537|20272441|P1|STARTED|Overall Study||3
8220660|NCT02058511|20272447|P1|NOT COMPLETED|Overall Study||0
8220661|NCT02058511|20272447|P1|COMPLETED|Overall Study||24
8220662|NCT02058511|20272447|P1|STARTED|Overall Study||24
8220663|NCT02058498|20272452|P1|NOT COMPLETED|Overall Study||4
8220664|NCT02058498|20272452|P1|COMPLETED|Overall Study||8
8220665|NCT02058498|20272452|P1|6 Weeks|Overall Study||8
8220666|NCT02058498|20272452|P1|STARTED|Overall Study||12
8220667|NCT02058368|20272460|P2|NOT COMPLETED|Overall Study||54
8220668|NCT02058368|20272461|P1|NOT COMPLETED|Overall Study||41
8220669|NCT02058368|20272460|P2|COMPLETED|Overall Study||251
8220670|NCT02058368|20272461|P1|COMPLETED|Overall Study||261
8220671|NCT02058368|20272460|P2|STARTED|Overall Study||305
8220672|NCT02058368|20272461|P1|STARTED|Overall Study||302
8220673|NCT02058290|20272513|P2|NOT COMPLETED|Overall Study||9
8220674|NCT02058290|20272514|P1|NOT COMPLETED|Overall Study||11
8220675|NCT02058290|20272513|P2|COMPLETED|Overall Study||36
8220676|NCT02058290|20272514|P1|COMPLETED|Overall Study||66
8220677|NCT02058290|20272513|P2|STARTED|Overall Study||45
8220678|NCT02058290|20272514|P1|STARTED|Overall Study||77
8220679|NCT02058251|20272530|P2|NOT COMPLETED|Overall Study||0
8220680|NCT02058251|20272531|P1|NOT COMPLETED|Overall Study||0
8220681|NCT02058251|20272530|P2|COMPLETED|Overall Study||38
8220682|NCT02058251|20272531|P1|COMPLETED|Overall Study||35
8220683|NCT02058251|20272530|P2|STARTED|Overall Study||38
8220684|NCT02058251|20272531|P1|STARTED|Overall Study||35
8220685|NCT02058160|20272541|P2|NOT COMPLETED|Overall Study||14
8220686|NCT02058160|20272542|P1|NOT COMPLETED|Overall Study||31
8220687|NCT02058160|20272541|P2|COMPLETED|Overall Study||355
8220688|NCT02058160|20272542|P1|COMPLETED|Overall Study||336
8220689|NCT02058160|20272541|P2|Treated|Overall Study||365
8220690|NCT02058160|20272542|P1|Treated|Overall Study||365
8220691|NCT02058160|20272541|P2|STARTED|Overall Study||369
8220692|NCT02058160|20272542|P1|STARTED|Overall Study||367
8220693|NCT02058147|20272579|P3|NOT COMPLETED|Overall Study||29
8220694|NCT02058147|20272580|P2|NOT COMPLETED|Overall Study||27
8220695|NCT02058147|20272581|P1|NOT COMPLETED|Overall Study||29
8220696|NCT02058147|20272579|P3|COMPLETED|Overall Study||205
8220697|NCT02058147|20272580|P2|COMPLETED|Overall Study||440
8220698|NCT02058147|20272581|P1|COMPLETED|Overall Study||440
8220699|NCT02058147|20272579|P3|Treated|Overall Study||233
8220700|NCT02058147|20272580|P2|Treated|Overall Study||467
8220701|NCT02058147|20272581|P1|Treated|Overall Study||469
8220702|NCT02058147|20272579|P3|STARTED|Overall Study||234
8220703|NCT02058147|20272580|P2|STARTED|Overall Study||467
8220704|NCT02058147|20272581|P1|STARTED|Overall Study||469
8220705|NCT02058108|20272632|P2|NOT COMPLETED|Overall Study||10
8220706|NCT02058108|20272633|P1|NOT COMPLETED|Overall Study||41
8220707|NCT02058108|20272632|P2|COMPLETED|Overall Study||0
8220708|NCT02058108|20272633|P1|COMPLETED|Overall Study||2
8220709|NCT02058108|20272632|P2|Switched to Telbivudine After Week 24|Overall Study||5
8220710|NCT02058108|20272633|P1|Switched to Telbivudine After Week 24|Overall Study||0
8220711|NCT02058108|20272632|P2|STARTED|Overall Study||10
8220712|NCT02058108|20272633|P1|STARTED|Overall Study||43
8220713|NCT02058095|20272659|P2|NOT COMPLETED|Overall Study||0
8220714|NCT02058095|20272660|P1|NOT COMPLETED|Overall Study||1
8220715|NCT02058095|20272659|P2|COMPLETED|Overall Study||7
8220716|NCT02058095|20272660|P1|COMPLETED|Overall Study||14
8220717|NCT02058095|20272659|P2|STARTED|Overall Study||7
8220718|NCT02058095|20272660|P1|STARTED|Overall Study||15
8220719|NCT02058069|20272670|P1|NOT COMPLETED|Overall Study||11
8220720|NCT02058069|20272670|P1|COMPLETED|Overall Study||89
8220721|NCT02058069|20272670|P1|STARTED|Overall Study||100
8220722|NCT02057952|20272682|P3|NOT COMPLETED|Overall Study||22
8220723|NCT02057952|20272683|P2|NOT COMPLETED|Overall Study||10
8220724|NCT02057952|20272684|P1|NOT COMPLETED|Overall Study||8
8220725|NCT02057952|20272682|P3|COMPLETED|Overall Study||28
8220726|NCT02057952|20272683|P2|COMPLETED|Overall Study||39
8220727|NCT02057952|20272684|P1|COMPLETED|Overall Study||43
8220728|NCT02057952|20272682|P3|STARTED|Overall Study||50
8220729|NCT02057952|20272683|P2|STARTED|Overall Study||49
8220730|NCT02057952|20272684|P1|STARTED|Overall Study||51
8220731|NCT02057939|20272719|P1|NOT COMPLETED|Overall Study||1
8220732|NCT02057939|20272719|P1|COMPLETED|Overall Study||37
8220733|NCT02057939|20272719|P1|STARTED|Overall Study||38
8220734|NCT02057874|20272729|P1|NOT COMPLETED|Overall Study||1
8220735|NCT02057874|20272729|P1|COMPLETED|Overall Study||1
8220736|NCT02057874|20272729|P1|STARTED|Overall Study||2
8220737|NCT02057835|20272747|P10|NOT COMPLETED|Overall Study||0
8220738|NCT02057835|20272748|P9|NOT COMPLETED|Overall Study||0
8220739|NCT02057835|20272749|P8|NOT COMPLETED|Overall Study||0
8220740|NCT02057835|20272750|P7|NOT COMPLETED|Overall Study||0
8220741|NCT02057835|20272751|P6|NOT COMPLETED|Overall Study||0
8220742|NCT02057835|20272752|P5|NOT COMPLETED|Overall Study||0
8220743|NCT02057835|20272753|P4|NOT COMPLETED|Overall Study||0
8220744|NCT02057835|20272754|P3|NOT COMPLETED|Overall Study||0
8220745|NCT02057835|20272755|P2|NOT COMPLETED|Overall Study||2
8220746|NCT02057835|20272756|P1|NOT COMPLETED|Overall Study||0
8220747|NCT02057835|20272747|P10|COMPLETED|Overall Study||6
8220748|NCT02057835|20272748|P9|COMPLETED|Overall Study||6
8220749|NCT02057835|20272749|P8|COMPLETED|Overall Study||6
8220750|NCT02057835|20272750|P7|COMPLETED|Overall Study||6
8220751|NCT02057835|20272751|P6|COMPLETED|Overall Study||8
8220752|NCT02057835|20272752|P5|COMPLETED|Overall Study||6
8220753|NCT02057835|20272753|P4|COMPLETED|Overall Study||6
8220754|NCT02057835|20272754|P3|COMPLETED|Overall Study||6
8220755|NCT02057835|20272755|P2|COMPLETED|Overall Study||4
8220756|NCT02057835|20272756|P1|COMPLETED|Overall Study||8
8220757|NCT02057835|20272747|P10|STARTED|Overall Study||6
8220758|NCT02057835|20272748|P9|STARTED|Overall Study||6
8220759|NCT02057835|20272749|P8|STARTED|Overall Study||6
8220760|NCT02057835|20272750|P7|STARTED|Overall Study||6
8220761|NCT02057835|20272751|P6|STARTED|Overall Study||8
8220762|NCT02057835|20272752|P5|STARTED|Overall Study||6
8220763|NCT02057835|20272753|P4|STARTED|Overall Study||6
8220764|NCT02057835|20272754|P3|STARTED|Overall Study||6
8220765|NCT02057835|20272755|P2|STARTED|Overall Study||6
8220766|NCT02057835|20272756|P1|STARTED|Overall Study||8
8220767|NCT02057757|20272835|P2|NOT COMPLETED|Overall Study||8
8220768|NCT02057757|20272836|P1|NOT COMPLETED|Overall Study||14
8220769|NCT02057757|20272835|P2|COMPLETED|Overall Study||121
8220770|NCT02057757|20272836|P1|COMPLETED|Overall Study||117
8220771|NCT02057757|20272835|P2|Intent to Treat|Overall Study||127
8220772|NCT02057757|20272836|P1|Intent to Treat|Overall Study||130
8220773|NCT02057757|20272835|P2|STARTED|Overall Study||129
8220774|NCT02057757|20272836|P1|STARTED|Overall Study||131
8220775|NCT02057692|20272890|P4|NOT COMPLETED|Overall Study||1
8220776|NCT02057692|20272891|P3|NOT COMPLETED|Overall Study||0
8220777|NCT02057692|20272892|P2|NOT COMPLETED|Overall Study||0
8220778|NCT02057692|20272893|P1|NOT COMPLETED|Overall Study||1
8220779|NCT02057692|20272890|P4|COMPLETED|Overall Study||11
8220780|NCT02057692|20272891|P3|COMPLETED|Overall Study||6
8220781|NCT02057692|20272892|P2|COMPLETED|Overall Study||11
8220782|NCT02057692|20272893|P1|COMPLETED|Overall Study||7
8220783|NCT02057692|20272890|P4|STARTED|Overall Study||12
8220784|NCT02057692|20272891|P3|STARTED|Overall Study||6
8220785|NCT02057692|20272892|P2|STARTED|Overall Study||11
8220786|NCT02057692|20272893|P1|STARTED|Overall Study||8
8220787|NCT02057640|20272923|P2|NOT COMPLETED|Phase II Portion of Study at DL2||0
8220788|NCT02057640|20272924|P1|NOT COMPLETED|Phase II Portion of Study at DL2||0
8220789|NCT02057640|20272923|P2|COMPLETED|Phase II Portion of Study at DL2||9
8220790|NCT02057640|20272924|P1|COMPLETED|Phase II Portion of Study at DL2||0
8220791|NCT02057640|20272923|P2|STARTED|Phase II Portion of Study at DL2||9
8220792|NCT02057640|20272924|P1|STARTED|Phase II Portion of Study at DL2||0
8220793|NCT02057640|20272923|P2|NOT COMPLETED|Weeks 1-4||0
8220794|NCT02057640|20272924|P1|NOT COMPLETED|Weeks 1-4||0
8220795|NCT02057640|20272923|P2|COMPLETED|Weeks 1-4||3
8220796|NCT02057640|20272924|P1|COMPLETED|Weeks 1-4||4
8220797|NCT02057640|20272923|P2|STARTED|Weeks 1-4||3
8220798|NCT02057640|20272924|P1|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
8220799|NCT02057575|20272939|P4|NOT COMPLETED|Overall Study||1
8220800|NCT02057575|20272940|P3|NOT COMPLETED|Overall Study||0
8220801|NCT02057575|20272941|P2|NOT COMPLETED|Overall Study||4
8220802|NCT02057575|20272942|P1|NOT COMPLETED|Overall Study||1
8220803|NCT02057575|20272939|P4|COMPLETED|Overall Study||72
8220804|NCT02057575|20272940|P3|COMPLETED|Overall Study||78
8220805|NCT02057575|20272941|P2|COMPLETED|Overall Study||69
8220806|NCT02057575|20272942|P1|COMPLETED|Overall Study||73
8220807|NCT02057575|20272939|P4|STARTED|Overall Study||73
8220808|NCT02057575|20272940|P3|STARTED|Overall Study||78
8220809|NCT02057575|20272941|P2|STARTED|Overall Study||73
8220810|NCT02057575|20272942|P1|STARTED|Overall Study||74
8220811|NCT02057549|20272954|P2|NOT COMPLETED|Overall Study||0
8220812|NCT02057549|20272955|P1|NOT COMPLETED|Overall Study||3
8220813|NCT02057549|20272954|P2|COMPLETED|Overall Study||18
8220814|NCT02057549|20272955|P1|COMPLETED|Overall Study||15
8220815|NCT02057549|20272954|P2|STARTED|Overall Study||18
8220816|NCT02057549|20272955|P1|STARTED|Overall Study||18
8220817|NCT02057523|20272975|P1|NOT COMPLETED|Overall Study||2
8220818|NCT02057523|20272975|P1|COMPLETED|Overall Study||0
8220819|NCT02057523|20272975|P1|STARTED|Overall Study||2
8220820|NCT02057458|20272980|P3|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
8220821|NCT02057458|20272981|P2|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
8220822|NCT02057458|20272982|P1|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
8220823|NCT02057458|20272980|P3|COMPLETED|Sub-Chronic Study (4 Weeks)||3
8220824|NCT02057458|20272981|P2|COMPLETED|Sub-Chronic Study (4 Weeks)||7
8220825|NCT02057458|20272982|P1|COMPLETED|Sub-Chronic Study (4 Weeks)||5
8220826|NCT02057458|20272980|P3|STARTED|Sub-Chronic Study (4 Weeks)||3
8220827|NCT02057458|20272981|P2|STARTED|Sub-Chronic Study (4 Weeks)||7
8220828|NCT02057458|20272982|P1|STARTED|Sub-Chronic Study (4 Weeks)||6
8220829|NCT02057458|20272980|P3|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8220830|NCT02057458|20272981|P2|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8220831|NCT02057458|20272982|P1|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8220832|NCT02057458|20272980|P3|COMPLETED|Acute Study (1 Hour): Second Int.||0
8220833|NCT02057458|20272981|P2|COMPLETED|Acute Study (1 Hour): Second Int.||7
8220834|NCT02057458|20272982|P1|COMPLETED|Acute Study (1 Hour): Second Int.||6
8220835|NCT02057458|20272980|P3|STARTED|Acute Study (1 Hour): Second Int.||0
8220836|NCT02057458|20272981|P2|STARTED|Acute Study (1 Hour): Second Int.||7
8220837|NCT02057458|20272982|P1|STARTED|Acute Study (1 Hour): Second Int.||6
8220838|NCT02057458|20272980|P3|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
8220839|NCT02057458|20272981|P2|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
8220840|NCT02057458|20272982|P1|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
8220841|NCT02057458|20272980|P3|COMPLETED|Acute Study (1 Hour): First Intervention||0
8220842|NCT02057458|20272981|P2|COMPLETED|Acute Study (1 Hour): First Intervention||7
8220843|NCT02057458|20272982|P1|COMPLETED|Acute Study (1 Hour): First Intervention||6
8220844|NCT02057458|20272980|P3|STARTED|Acute Study (1 Hour): First Intervention||0
8220845|NCT02057458|20272981|P2|STARTED|Acute Study (1 Hour): First Intervention||7
8220846|NCT02057458|20272982|P1|STARTED|Acute Study (1 Hour): First Intervention||8
8220847|NCT02057458|20272980|P3|NOT COMPLETED|Met Inclusion Criteria||0
8220848|NCT02057458|20272981|P2|NOT COMPLETED|Met Inclusion Criteria||1
8220849|NCT02057458|20272982|P1|NOT COMPLETED|Met Inclusion Criteria||0
8220850|NCT02057458|20272980|P3|COMPLETED|Met Inclusion Criteria||3
8220851|NCT02057458|20272981|P2|COMPLETED|Met Inclusion Criteria||7
8220852|NCT02057458|20272982|P1|COMPLETED|Met Inclusion Criteria||8
8220853|NCT02057458|20272980|P3|STARTED|Met Inclusion Criteria||3
8220854|NCT02057458|20272981|P2|STARTED|Met Inclusion Criteria||8
8220855|NCT02057458|20272982|P1|STARTED|Met Inclusion Criteria||8
8220856|NCT02057458|20272980|P3|NOT COMPLETED|Recruited for Participation||0
8220857|NCT02057458|20272981|P2|NOT COMPLETED|Recruited for Participation||0
8220858|NCT02057458|20272982|P1|NOT COMPLETED|Recruited for Participation||0
8220859|NCT02057458|20272980|P3|COMPLETED|Recruited for Participation||3
8220860|NCT02057458|20272981|P2|COMPLETED|Recruited for Participation||8
8220861|NCT02057458|20272982|P1|COMPLETED|Recruited for Participation||8
8220862|NCT02057458|20272980|P3|STARTED|Recruited for Participation||3
8220863|NCT02057458|20272981|P2|STARTED|Recruited for Participation||8
8220864|NCT02057458|20272982|P1|STARTED|Recruited for Participation||8
8220865|NCT02057406|20273020|P3|NOT COMPLETED|Overall Study||4
8220866|NCT02057406|20273021|P2|NOT COMPLETED|Overall Study||3
8220867|NCT02057406|20273022|P1|NOT COMPLETED|Overall Study||1
8220868|NCT02057406|20273020|P3|COMPLETED|Overall Study||32
8220869|NCT02057406|20273021|P2|COMPLETED|Overall Study||33
8220870|NCT02057406|20273022|P1|COMPLETED|Overall Study||35
8220871|NCT02057406|20273020|P3|STARTED|Overall Study||36
8220872|NCT02057406|20273021|P2|STARTED|Overall Study||36
8220873|NCT02057406|20273022|P1|STARTED|Overall Study||36
8220874|NCT02057393|20273033|P1|NOT COMPLETED|Overall Study||2
8220875|NCT02057393|20273033|P1|COMPLETED|Overall Study||87
8220876|NCT02057393|20273033|P1|STARTED|Overall Study||89
8220877|NCT02057276|20273039|P2|NOT COMPLETED|Overall Study||0
8220878|NCT02057276|20273040|P1|NOT COMPLETED|Overall Study||0
8220879|NCT02057276|20273039|P2|COMPLETED|Overall Study||0
8220880|NCT02057276|20273040|P1|COMPLETED|Overall Study||0
8220881|NCT02057276|20273039|P2|STARTED|Overall Study||0
8220882|NCT02057276|20273040|P1|STARTED|Overall Study||0
8220883|NCT02057250|20273054|P5|NOT COMPLETED|Extension Phase||36
8220884|NCT02057250|20273055|P4|NOT COMPLETED|Extension Phase||0
8220885|NCT02057250|20273056|P3|NOT COMPLETED|Extension Phase||0
8220886|NCT02057250|20273057|P2|NOT COMPLETED|Extension Phase||0
8220887|NCT02057250|20273058|P1|NOT COMPLETED|Extension Phase||0
8220888|NCT02057250|20273054|P5|COMPLETED|Extension Phase||156
8220889|NCT02057250|20273055|P4|COMPLETED|Extension Phase||0
8220890|NCT02057250|20273056|P3|COMPLETED|Extension Phase||0
8220891|NCT02057250|20273057|P2|COMPLETED|Extension Phase||0
8220892|NCT02057250|20273058|P1|COMPLETED|Extension Phase||0
8220893|NCT02057250|20273054|P5|Treated|Extension Phase||188
8220894|NCT02057250|20273055|P4|Treated|Extension Phase||0
8220895|NCT02057250|20273056|P3|Treated|Extension Phase||0
8220896|NCT02057250|20273057|P2|Treated|Extension Phase||0
8220897|NCT02057250|20273058|P1|Treated|Extension Phase||0
8220898|NCT02057250|20273054|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
8220899|NCT02057250|20273055|P4|STARTED|Extension Phase||0
8220900|NCT02057250|20273056|P3|STARTED|Extension Phase||0
8220901|NCT02057250|20273057|P2|STARTED|Extension Phase||0
8220902|NCT02057250|20273058|P1|STARTED|Extension Phase||0
8220903|NCT02057250|20273054|P5|NOT COMPLETED|AID Assessment Phase||0
8220904|NCT02057250|20273055|P4|NOT COMPLETED|AID Assessment Phase||2
8220905|NCT02057250|20273056|P3|NOT COMPLETED|AID Assessment Phase||7
8220906|NCT02057250|20273057|P2|NOT COMPLETED|AID Assessment Phase||3
8220907|NCT02057250|20273058|P1|NOT COMPLETED|AID Assessment Phase||4
8220908|NCT02057250|20273054|P5|COMPLETED|AID Assessment Phase||0
8220909|NCT02057250|20273055|P4|COMPLETED|AID Assessment Phase||54
8220910|NCT02057250|20273056|P3|COMPLETED|AID Assessment Phase||45
8220911|NCT02057250|20273057|P2|COMPLETED|AID Assessment Phase||50
8220912|NCT02057250|20273058|P1|COMPLETED|AID Assessment Phase||52
8220913|NCT02057250|20273054|P5|STARTED|AID Assessment Phase||0
8220914|NCT02057250|20273055|P4|STARTED|AID Assessment Phase||56
8220915|NCT02057250|20273056|P3|STARTED|AID Assessment Phase||52
8220916|NCT02057250|20273057|P2|STARTED|AID Assessment Phase||53
8220917|NCT02057250|20273058|P1|STARTED|AID Assessment Phase||56
8220918|NCT02057237|20273071|P1|NOT COMPLETED|Overall Study||0
8220919|NCT02057237|20273071|P1|COMPLETED|Overall Study||1
8220920|NCT02057237|20273071|P1|STARTED|Overall Study||1
8220921|NCT02057198|20273079|P3|NOT COMPLETED|Overall Study||1
8220922|NCT02057198|20273080|P2|NOT COMPLETED|Overall Study||1
8220923|NCT02057198|20273081|P1|NOT COMPLETED|Overall Study||0
8220924|NCT02057198|20273079|P3|COMPLETED|Overall Study||10
8220925|NCT02057198|20273080|P2|COMPLETED|Overall Study||10
8220926|NCT02057198|20273081|P1|COMPLETED|Overall Study||11
8220927|NCT02057198|20273079|P3|STARTED|Overall Study||11
8220928|NCT02057198|20273080|P2|STARTED|Overall Study||11
8220929|NCT02057198|20273081|P1|STARTED|Overall Study||11
8220930|NCT02057081|20273106|P2|NOT COMPLETED|Overall Study||68
8220931|NCT02057081|20273107|P1|NOT COMPLETED|Overall Study||90
8220932|NCT02057081|20273106|P2|COMPLETED|Overall Study||44
8220933|NCT02057081|20273107|P1|COMPLETED|Overall Study||46
8220934|NCT02057081|20273106|P2|Post-Treatment Assessment|Overall Study||52
8220935|NCT02057081|20273107|P1|Post-Treatment Assessment|Overall Study||58
8220936|NCT02057081|20273106|P2|Completed Baseline|Overall Study||80
8220937|NCT02057081|20273107|P1|Completed Baseline|Overall Study||88
8220938|NCT02057081|20273106|P2|STARTED|Overall Study||112
8220939|NCT02057081|20273107|P1|STARTED|Overall Study||136
8220940|NCT02057068|20273117|P2|NOT COMPLETED|Overall Study||8
8220941|NCT02057068|20273118|P1|NOT COMPLETED|Overall Study||8
8220942|NCT02057068|20273117|P2|COMPLETED|Overall Study||28
8220943|NCT02057068|20273118|P1|COMPLETED|Overall Study||52
8220944|NCT02057068|20273117|P2|STARTED|Overall Study||36
8220945|NCT02057068|20273118|P1|STARTED|Overall Study||60
8220946|NCT02057042|20273130|P2|NOT COMPLETED|Overall Study||66
8220947|NCT02057042|20273131|P1|NOT COMPLETED|Overall Study||45
8220948|NCT02057042|20273130|P2|COMPLETED|Overall Study||101
8220949|NCT02057042|20273131|P1|COMPLETED|Overall Study||118
8220950|NCT02057042|20273130|P2|STARTED|Overall Study||167
8220951|NCT02057042|20273131|P1|STARTED|Overall Study||163
8220952|NCT02056834|20273147|P1|NOT COMPLETED|Overall Study||7
8220953|NCT02056834|20273147|P1|COMPLETED|Overall Study||29
8220954|NCT02056834|20273147|P1|6 Months|Overall Study||31
8220955|NCT02056834|20273147|P1|6 Weeks|Overall Study||34
8220956|NCT02056834|20273147|P1|STARTED|Overall Study||36
8220957|NCT02056652|20273168|P2|NOT COMPLETED|Overall Study||3
8220958|NCT02056652|20273169|P1|NOT COMPLETED|Overall Study||1
8220959|NCT02056652|20273168|P2|COMPLETED|Overall Study||58
8220960|NCT02056652|20273169|P1|COMPLETED|Overall Study||60
8220961|NCT02056652|20273168|P2|STARTED|Overall Study||61
8220962|NCT02056652|20273169|P1|STARTED|Overall Study||61
8220963|NCT02056639|20273187|P2|NOT COMPLETED|Overall Study||0
8220964|NCT02056639|20273188|P1|NOT COMPLETED|Overall Study||0
8220965|NCT02056639|20273187|P2|COMPLETED|Overall Study||23
8220966|NCT02056639|20273188|P1|COMPLETED|Overall Study||23
8220967|NCT02056639|20273187|P2|STARTED|Overall Study||23
8220968|NCT02056639|20273188|P1|STARTED|Overall Study||23
8220969|NCT02056626|20273206|P4|NOT COMPLETED|Overall Study||0
8220970|NCT02056626|20273207|P3|NOT COMPLETED|Overall Study||0
8220971|NCT02056626|20273208|P2|NOT COMPLETED|Overall Study||1
8220972|NCT02056626|20273209|P1|NOT COMPLETED|Overall Study||3
8220973|NCT02056626|20273206|P4|COMPLETED|Overall Study||14
8220974|NCT02056626|20273207|P3|COMPLETED|Overall Study||4
8220975|NCT02056626|20273208|P2|COMPLETED|Overall Study||12
8220976|NCT02056626|20273209|P1|COMPLETED|Overall Study||10
8220977|NCT02056626|20273206|P4|STARTED|Overall Study||14
8220978|NCT02056626|20273207|P3|STARTED|Overall Study||4
8220979|NCT02056626|20273208|P2|STARTED|Overall Study||13
8220980|NCT02056626|20273209|P1|STARTED|Overall Study||13
8220981|NCT02056431|20273229|P2|NOT COMPLETED|Overall Study||47
8220982|NCT02056431|20273230|P1|NOT COMPLETED|Overall Study||44
8220983|NCT02056431|20273229|P2|COMPLETED|Overall Study||619
8220984|NCT02056431|20273230|P1|COMPLETED|Overall Study||560
8220985|NCT02056431|20273229|P2|STARTED|Overall Study||666
8220986|NCT02056431|20273230|P1|STARTED|Overall Study||604
8220987|NCT02056392|20273244|P6|NOT COMPLETED|Overall Study||0
8220988|NCT02056392|20273245|P5|NOT COMPLETED|Overall Study||1
8220989|NCT02056392|20273246|P4|NOT COMPLETED|Overall Study||0
8220990|NCT02056392|20273247|P3|NOT COMPLETED|Overall Study||3
8220991|NCT02056392|20273248|P2|NOT COMPLETED|Overall Study||1
8220992|NCT02056392|20273249|P1|NOT COMPLETED|Overall Study||2
8220993|NCT02056392|20273244|P6|COMPLETED|Overall Study||9
8220994|NCT02056392|20273245|P5|COMPLETED|Overall Study||7
8220995|NCT02056392|20273246|P4|COMPLETED|Overall Study||9
8220996|NCT02056392|20273247|P3|COMPLETED|Overall Study||6
8220997|NCT02056392|20273248|P2|COMPLETED|Overall Study||8
8220998|NCT02056392|20273249|P1|COMPLETED|Overall Study||8
8220999|NCT02056392|20273244|P6|STARTED|Overall Study||9
8221000|NCT02056392|20273245|P5|STARTED|Overall Study||8
8221001|NCT02056392|20273246|P4|STARTED|Overall Study||9
8221002|NCT02056392|20273247|P3|STARTED|Overall Study||9
8221003|NCT02056392|20273248|P2|STARTED|Overall Study||9
8221004|NCT02056392|20273249|P1|STARTED|Overall Study||10
8221005|NCT02056340|20273286|P2|NOT COMPLETED|Overall Study||11
8221006|NCT02056340|20273287|P1|NOT COMPLETED|Overall Study||7
8221007|NCT02056340|20273286|P2|COMPLETED|Overall Study||46
8221008|NCT02056340|20273287|P1|COMPLETED|Overall Study||52
8221009|NCT02056340|20273286|P2|STARTED|Overall Study||57
8221010|NCT02056340|20273287|P1|STARTED|Overall Study||59
8221011|NCT02056301|20273297|P2|NOT COMPLETED|Overall Study||6
8221012|NCT02056301|20273298|P1|NOT COMPLETED|Overall Study||2
8221013|NCT02056301|20273297|P2|COMPLETED|Overall Study||23
8221014|NCT02056301|20273298|P1|COMPLETED|Overall Study||31
8221015|NCT02056301|20273297|P2|STARTED|Overall Study||29
8221016|NCT02056301|20273298|P1|STARTED|Overall Study||33
8221017|NCT02056171|20273310|P2|NOT COMPLETED|Overall Study||0
8221018|NCT02056171|20273311|P1|NOT COMPLETED|Overall Study||0
8221019|NCT02056171|20273310|P2|COMPLETED|Overall Study||3
8221020|NCT02056171|20273311|P1|COMPLETED|Overall Study||3
8221021|NCT02056171|20273310|P2|STARTED|Overall Study||3
8221022|NCT02056171|20273311|P1|STARTED|Overall Study||3
8221023|NCT02055976|20273330|P9|NOT COMPLETED|Overall Study||0
8221024|NCT02055976|20273331|P8|NOT COMPLETED|Overall Study||0
8221025|NCT02055976|20273332|P7|NOT COMPLETED|Overall Study||2
8221026|NCT02055976|20273333|P6|NOT COMPLETED|Overall Study||1
8221027|NCT02055976|20273334|P5|NOT COMPLETED|Overall Study||0
8221028|NCT02055976|20273335|P4|NOT COMPLETED|Overall Study||1
8221029|NCT02055976|20273336|P3|NOT COMPLETED|Overall Study||1
8221030|NCT02055976|20273337|P2|NOT COMPLETED|Overall Study||0
8221031|NCT02055976|20273338|P1|NOT COMPLETED|Overall Study||0
8221032|NCT02055976|20273330|P9|COMPLETED|Overall Study||23
8221033|NCT02055976|20273331|P8|COMPLETED|Overall Study||24
8221034|NCT02055976|20273332|P7|COMPLETED|Overall Study||23
8221035|NCT02055976|20273333|P6|COMPLETED|Overall Study||24
8221036|NCT02055976|20273334|P5|COMPLETED|Overall Study||22
8221037|NCT02055976|20273335|P4|COMPLETED|Overall Study||25
8221038|NCT02055976|20273336|P3|COMPLETED|Overall Study||23
8221039|NCT02055976|20273337|P2|COMPLETED|Overall Study||24
8221040|NCT02055976|20273338|P1|COMPLETED|Overall Study||25
8221041|NCT02055976|20273330|P9|STARTED|Overall Study||23
8221042|NCT02055976|20273331|P8|STARTED|Overall Study||24
8221043|NCT02055976|20273332|P7|STARTED|Overall Study||25
8221044|NCT02055976|20273333|P6|STARTED|Overall Study||25
8221045|NCT02055976|20273334|P5|STARTED|Overall Study||22
8221046|NCT02055976|20273335|P4|STARTED|Overall Study||26
8221047|NCT02055976|20273336|P3|STARTED|Overall Study||24
8221048|NCT02055976|20273337|P2|STARTED|Overall Study||24
8221049|NCT02055976|20273338|P1|STARTED|Overall Study||25
8221050|NCT02055898|20273759|P2|NOT COMPLETED|Second Intervention (5 Days)||0
8221051|NCT02055898|20273760|P1|NOT COMPLETED|Second Intervention (5 Days)||0
8221052|NCT02055898|20273759|P2|COMPLETED|Second Intervention (5 Days)||5
8221053|NCT02055898|20273760|P1|COMPLETED|Second Intervention (5 Days)||5
8221054|NCT02055898|20273759|P2|STARTED|Second Intervention (5 Days)||5
8221055|NCT02055898|20273760|P1|STARTED|Second Intervention (5 Days)||5
8221056|NCT02055898|20273759|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8221057|NCT02055898|20273760|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8221058|NCT02055898|20273759|P2|COMPLETED|Washout (at Least 14 Days)||5
8221059|NCT02055898|20273760|P1|COMPLETED|Washout (at Least 14 Days)||5
8221060|NCT02055898|20273759|P2|STARTED|Washout (at Least 14 Days)||5
8221061|NCT02055898|20273760|P1|STARTED|Washout (at Least 14 Days)||5
8221062|NCT02055898|20273759|P2|NOT COMPLETED|First Intervention (5 Days)||1
8221063|NCT02055898|20273760|P1|NOT COMPLETED|First Intervention (5 Days)||2
8221064|NCT02055898|20273759|P2|COMPLETED|First Intervention (5 Days)||5
8221065|NCT02055898|20273760|P1|COMPLETED|First Intervention (5 Days)||5
8221066|NCT02055898|20273759|P2|STARTED|First Intervention (5 Days)||6
8221067|NCT02055898|20273760|P1|STARTED|First Intervention (5 Days)||7
8221068|NCT02055820|20273782|P10|NOT COMPLETED|Phase II: Expansion||0
8221069|NCT02055820|20273783|P9|NOT COMPLETED|Phase II: Expansion||0
8221070|NCT02055820|20273784|P8|NOT COMPLETED|Phase II: Expansion||0
8221071|NCT02055820|20273785|P7|NOT COMPLETED|Phase II: Expansion||0
8221072|NCT02055820|20273786|P6|NOT COMPLETED|Phase II: Expansion||0
8221073|NCT02055820|20273787|P5|NOT COMPLETED|Phase II: Expansion||49
8221074|NCT02055820|20273788|P4|NOT COMPLETED|Phase II: Expansion||0
8221075|NCT02055820|20273789|P3|NOT COMPLETED|Phase II: Expansion||0
8221076|NCT02055820|20273790|P2|NOT COMPLETED|Phase II: Expansion||0
8221077|NCT02055820|20273791|P1|NOT COMPLETED|Phase II: Expansion||0
8221078|NCT02055820|20273782|P10|COMPLETED|Phase II: Expansion||0
8221079|NCT02055820|20273783|P9|COMPLETED|Phase II: Expansion||0
8221080|NCT02055820|20273784|P8|COMPLETED|Phase II: Expansion||0
8221081|NCT02055820|20273785|P7|COMPLETED|Phase II: Expansion||0
8221082|NCT02055820|20273786|P6|COMPLETED|Phase II: Expansion||0
8221083|NCT02055820|20273787|P5|COMPLETED|Phase II: Expansion||159
8221084|NCT02055820|20273788|P4|COMPLETED|Phase II: Expansion||0
8221085|NCT02055820|20273789|P3|COMPLETED|Phase II: Expansion||0
8221086|NCT02055820|20273790|P2|COMPLETED|Phase II: Expansion||0
8221087|NCT02055820|20273791|P1|COMPLETED|Phase II: Expansion||0
8221088|NCT02055820|20273782|P10|STARTED|Phase II: Expansion||0
8221089|NCT02055820|20273783|P9|STARTED|Phase II: Expansion||0
8221090|NCT02055820|20273784|P8|STARTED|Phase II: Expansion||0
8221091|NCT02055820|20273785|P7|STARTED|Phase II: Expansion||0
8221092|NCT02055820|20273786|P6|STARTED|Phase II: Expansion||0
8221093|NCT02055820|20273787|P5|STARTED|Phase II: Expansion||208
8221094|NCT02055820|20273788|P4|STARTED|Phase II: Expansion||0
8221095|NCT02055820|20273789|P3|STARTED|Phase II: Expansion||0
8221096|NCT02055820|20273790|P2|STARTED|Phase II: Expansion||0
8221097|NCT02055820|20273791|P1|STARTED|Phase II: Expansion||0
8221098|NCT02055820|20273782|P10|NOT COMPLETED|Phase I: Dose-Finding||0
8221099|NCT02055820|20273783|P9|NOT COMPLETED|Phase I: Dose-Finding||0
8221100|NCT02055820|20273784|P8|NOT COMPLETED|Phase I: Dose-Finding||0
8221101|NCT02055820|20273785|P7|NOT COMPLETED|Phase I: Dose-Finding||2
8221102|NCT02055820|20273786|P6|NOT COMPLETED|Phase I: Dose-Finding||2
8221103|NCT02055820|20273787|P5|NOT COMPLETED|Phase I: Dose-Finding||0
8221104|NCT02055820|20273788|P4|NOT COMPLETED|Phase I: Dose-Finding||3
8221105|NCT02055820|20273789|P3|NOT COMPLETED|Phase I: Dose-Finding||1
8221106|NCT02055820|20273790|P2|NOT COMPLETED|Phase I: Dose-Finding||0
8221107|NCT02055820|20273791|P1|NOT COMPLETED|Phase I: Dose-Finding||1
8221108|NCT02055820|20273782|P10|COMPLETED|Phase I: Dose-Finding||6
8221109|NCT02055820|20273783|P9|COMPLETED|Phase I: Dose-Finding||6
8221110|NCT02055820|20273784|P8|COMPLETED|Phase I: Dose-Finding||6
8221111|NCT02055820|20273785|P7|COMPLETED|Phase I: Dose-Finding||5
8221112|NCT02055820|20273786|P6|COMPLETED|Phase I: Dose-Finding||5
8221113|NCT02055820|20273787|P5|COMPLETED|Phase I: Dose-Finding||0
8221114|NCT02055820|20273788|P4|COMPLETED|Phase I: Dose-Finding||3
8221115|NCT02055820|20273789|P3|COMPLETED|Phase I: Dose-Finding||7
8221116|NCT02055820|20273790|P2|COMPLETED|Phase I: Dose-Finding||3
8221117|NCT02055820|20273791|P1|COMPLETED|Phase I: Dose-Finding||6
8221118|NCT02055820|20273782|P10|STARTED|Phase I: Dose-Finding||6
8221119|NCT02055820|20273783|P9|STARTED|Phase I: Dose-Finding||6
8221120|NCT02055820|20273784|P8|STARTED|Phase I: Dose-Finding||6
8221121|NCT02055820|20273785|P7|STARTED|Phase I: Dose-Finding||7
8221122|NCT02055820|20273786|P6|STARTED|Phase I: Dose-Finding||7
8221123|NCT02055820|20273787|P5|STARTED|Phase I: Dose-Finding||0
8221124|NCT02055820|20273788|P4|STARTED|Phase I: Dose-Finding||6
8221125|NCT02055820|20273789|P3|STARTED|Phase I: Dose-Finding||8
8221126|NCT02055820|20273790|P2|STARTED|Phase I: Dose-Finding||3
8221127|NCT02055820|20273791|P1|STARTED|Phase I: Dose-Finding||7
8221128|NCT02055638|20273895|P2|NOT COMPLETED|Overall Study||8
8221129|NCT02055638|20273896|P1|NOT COMPLETED|Overall Study||10
8221130|NCT02055638|20273895|P2|COMPLETED|Overall Study||40
8221131|NCT02055638|20273896|P1|COMPLETED|Overall Study||39
8221132|NCT02055638|20273895|P2|STARTED|Overall Study||48
8221133|NCT02055638|20273896|P1|STARTED|Overall Study||49
8221134|NCT02055547|20273902|P19|NOT COMPLETED|Overall Study||0
8221135|NCT02055547|20273903|P18|NOT COMPLETED|Overall Study||0
8221136|NCT02055547|20273904|P17|NOT COMPLETED|Overall Study||0
8221137|NCT02055547|20273905|P16|NOT COMPLETED|Overall Study||1
8221138|NCT02055547|20273906|P15|NOT COMPLETED|Overall Study||0
8221139|NCT02055547|20273907|P14|NOT COMPLETED|Overall Study||1
8221140|NCT02055547|20273908|P13|NOT COMPLETED|Overall Study||0
8221141|NCT02055547|20273909|P12|NOT COMPLETED|Overall Study||0
8221142|NCT02055547|20273910|P11|NOT COMPLETED|Overall Study||1
8221143|NCT02055547|20273911|P10|NOT COMPLETED|Overall Study||1
8221144|NCT02055547|20273912|P9|NOT COMPLETED|Overall Study||2
8221145|NCT02055547|20273913|P8|NOT COMPLETED|Overall Study||0
8221146|NCT02055547|20273914|P7|NOT COMPLETED|Overall Study||2
8221147|NCT02055547|20273915|P6|NOT COMPLETED|Overall Study||1
8221148|NCT02055547|20273916|P5|NOT COMPLETED|Overall Study||1
8221149|NCT02055547|20273917|P4|NOT COMPLETED|Overall Study||0
8221150|NCT02055547|20273918|P3|NOT COMPLETED|Overall Study||3
8221151|NCT02055547|20273919|P2|NOT COMPLETED|Overall Study||1
8221152|NCT02055547|20273920|P1|NOT COMPLETED|Overall Study||0
8221153|NCT02055547|20273902|P19|COMPLETED|Overall Study||2
8221154|NCT02055547|20273903|P18|COMPLETED|Overall Study||2
8221155|NCT02055547|20273904|P17|COMPLETED|Overall Study||2
8221156|NCT02055547|20273905|P16|COMPLETED|Overall Study||1
8221157|NCT02055547|20273906|P15|COMPLETED|Overall Study||2
8221158|NCT02055547|20273907|P14|COMPLETED|Overall Study||1
8221159|NCT02055547|20273908|P13|COMPLETED|Overall Study||2
8221160|NCT02055547|20273909|P12|COMPLETED|Overall Study||6
8221161|NCT02055547|20273910|P11|COMPLETED|Overall Study||5
8221162|NCT02055547|20273911|P10|COMPLETED|Overall Study||5
8221163|NCT02055547|20273912|P9|COMPLETED|Overall Study||4
8221164|NCT02055547|20273913|P8|COMPLETED|Overall Study||6
8221165|NCT02055547|20273914|P7|COMPLETED|Overall Study||0
8221166|NCT02055547|20273915|P6|COMPLETED|Overall Study||1
8221167|NCT02055547|20273916|P5|COMPLETED|Overall Study||1
8221168|NCT02055547|20273917|P4|COMPLETED|Overall Study||2
8221169|NCT02055547|20273918|P3|COMPLETED|Overall Study||2
8221170|NCT02055547|20273919|P2|COMPLETED|Overall Study||1
8221171|NCT02055547|20273920|P1|COMPLETED|Overall Study||2
8221172|NCT02055547|20273902|P19|STARTED|Overall Study||2
8221173|NCT02055547|20273903|P18|STARTED|Overall Study||2
8221174|NCT02055547|20273904|P17|STARTED|Overall Study||2
8221175|NCT02055547|20273905|P16|STARTED|Overall Study||2
8221176|NCT02055547|20273906|P15|STARTED|Overall Study||2
8221177|NCT02055547|20273907|P14|STARTED|Overall Study||2
8221178|NCT02055547|20273908|P13|STARTED|Overall Study||2
8221179|NCT02055547|20273909|P12|STARTED|Overall Study||6
8221180|NCT02055547|20273910|P11|STARTED|Overall Study||6
8221181|NCT02055547|20273911|P10|STARTED|Overall Study||6
8221182|NCT02055547|20273912|P9|STARTED|Overall Study||6
8221183|NCT02055547|20273913|P8|STARTED|Overall Study||6
8221184|NCT02055547|20273914|P7|STARTED|Overall Study||2
8221185|NCT02055547|20273915|P6|STARTED|Overall Study||2
8221186|NCT02055547|20273916|P5|STARTED|Overall Study||2
8221187|NCT02055547|20273917|P4|STARTED|Overall Study||2
8221188|NCT02055547|20273918|P3|STARTED|Overall Study||5
8221189|NCT02055547|20273919|P2|STARTED|Overall Study||2
8221190|NCT02055547|20273920|P1|STARTED|Overall Study||2
8221191|NCT02055430|20274069|P2|NOT COMPLETED|Overall Study||0
8221192|NCT02055430|20274070|P1|NOT COMPLETED|Overall Study||0
8221193|NCT02055430|20274069|P2|COMPLETED|Overall Study||45
8221194|NCT02055430|20274070|P1|COMPLETED|Overall Study||45
8221195|NCT02055430|20274069|P2|STARTED|Overall Study||45
8221196|NCT02055430|20274070|P1|STARTED|Overall Study||45
8221197|NCT02055404|20274076|P1|NOT COMPLETED|Overall Study||0
8221198|NCT02055404|20274076|P1|COMPLETED|Overall Study||3
8221199|NCT02055404|20274076|P1|STARTED|Overall Study||3
8221200|NCT02055365|20274089|P1|NOT COMPLETED|Overall Study||1
8221201|NCT02055365|20274089|P1|COMPLETED|Overall Study||9
8221202|NCT02055365|20274089|P1|STARTED|Overall Study||10
8221203|NCT02055352|20274102|P2|NOT COMPLETED|Overall Study||17
8221204|NCT02055352|20274103|P1|NOT COMPLETED|Overall Study||6
8221205|NCT02055352|20274102|P2|COMPLETED|Overall Study||96
8221206|NCT02055352|20274103|P1|COMPLETED|Overall Study||103
8221207|NCT02055352|20274102|P2|Per-Protocol Set (PPS)|Overall Study||111
8221208|NCT02055352|20274103|P1|Per-Protocol Set (PPS)|Overall Study||108
8221209|NCT02055352|20274102|P2|STARTED|Overall Study||113
8221210|NCT02055352|20274103|P1|STARTED|Overall Study||109
8221211|NCT02055157|20274121|P4|NOT COMPLETED|18-month Extension||0
8221212|NCT02055157|20274122|P3|NOT COMPLETED|18-month Extension||0
8221213|NCT02055157|20274123|P2|NOT COMPLETED|18-month Extension||1
8221214|NCT02055157|20274124|P1|NOT COMPLETED|18-month Extension||1
8221215|NCT02055157|20274121|P4|COMPLETED|18-month Extension||8
8221216|NCT02055157|20274122|P3|COMPLETED|18-month Extension||10
8221217|NCT02055157|20274123|P2|COMPLETED|18-month Extension||6
8221218|NCT02055157|20274124|P1|COMPLETED|18-month Extension||6
8221219|NCT02055157|20274121|P4|STARTED|18-month Extension||8
8221220|NCT02055157|20274122|P3|STARTED|18-month Extension||10
8221221|NCT02055157|20274123|P2|STARTED|18-month Extension||7
8221222|NCT02055157|20274124|P1|STARTED|18-month Extension||7
8221223|NCT02055157|20274121|P4|NOT COMPLETED|Initial 6 Months||1
8221224|NCT02055157|20274122|P3|NOT COMPLETED|Initial 6 Months||0
8221225|NCT02055157|20274123|P2|NOT COMPLETED|Initial 6 Months||1
8221226|NCT02055157|20274124|P1|NOT COMPLETED|Initial 6 Months||1
8221227|NCT02055157|20274121|P4|COMPLETED|Initial 6 Months||8
8221228|NCT02055157|20274122|P3|COMPLETED|Initial 6 Months||10
8221229|NCT02055157|20274123|P2|COMPLETED|Initial 6 Months||7
8221230|NCT02055157|20274124|P1|COMPLETED|Initial 6 Months||7
8221231|NCT02055157|20274121|P4|STARTED|Initial 6 Months||9
8221232|NCT02055157|20274122|P3|STARTED|Initial 6 Months||10
8221233|NCT02055157|20274123|P2|STARTED|Initial 6 Months||8
8221234|NCT02055157|20274124|P1|STARTED|Initial 6 Months||8
8221235|NCT02055118|20274204|P3|NOT COMPLETED|Overall Study||0
8221236|NCT02055118|20274205|P2|NOT COMPLETED|Overall Study||2
8221237|NCT02055118|20274206|P1|NOT COMPLETED|Overall Study||0
8221238|NCT02055118|20274204|P3|COMPLETED|Overall Study||9
8221239|NCT02055118|20274205|P2|COMPLETED|Overall Study||32
8221240|NCT02055118|20274206|P1|COMPLETED|Overall Study||15
8221241|NCT02055118|20274204|P3|STARTED|Overall Study||9
8221242|NCT02055118|20274205|P2|STARTED|Overall Study||34
8221243|NCT02055118|20274206|P1|STARTED|Overall Study||15
8221244|NCT02055053|20274265|P2|NOT COMPLETED|Overall Study||0
8221245|NCT02055053|20274266|P1|NOT COMPLETED|Overall Study||0
8221246|NCT02055053|20274265|P2|COMPLETED|Overall Study||35
8221247|NCT02055053|20274266|P1|COMPLETED|Overall Study||35
8221248|NCT02055053|20274265|P2|STARTED|Overall Study||35
8221249|NCT02055053|20274266|P1|STARTED|Overall Study||35
8221250|NCT02054910|20274276|P2|NOT COMPLETED|Overall Study||1
8221251|NCT02054910|20274277|P1|NOT COMPLETED|Overall Study||4
8221252|NCT02054910|20274276|P2|COMPLETED|Overall Study||0
8221253|NCT02054910|20274277|P1|COMPLETED|Overall Study||0
8221254|NCT02054910|20274276|P2|STARTED|Overall Study||1
8221255|NCT02054910|20274277|P1|STARTED|Overall Study||4
8221256|NCT02054897|20274296|P3|NOT COMPLETED|Overall Study||12
8221257|NCT02054897|20274297|P2|NOT COMPLETED|Overall Study||7
8221258|NCT02054897|20274298|P1|NOT COMPLETED|Overall Study||10
8221259|NCT02054897|20274296|P3|COMPLETED|Overall Study||117
8221260|NCT02054897|20274297|P2|COMPLETED|Overall Study||123
8221261|NCT02054897|20274298|P1|COMPLETED|Overall Study||119
8221262|NCT02054897|20274296|P3|Exposed|Overall Study||129
8221263|NCT02054897|20274297|P2|Exposed|Overall Study||130
8221264|NCT02054897|20274298|P1|Exposed|Overall Study||128
8221265|NCT02054897|20274296|P3|STARTED|Overall Study||129
8221266|NCT02054897|20274297|P2|STARTED|Overall Study||130
8221267|NCT02054897|20274298|P1|STARTED|Overall Study||129
8221268|NCT02054754|20274323|P6|NOT COMPLETED|Overall Study||0
8221269|NCT02054754|20274324|P5|NOT COMPLETED|Overall Study||0
8221270|NCT02054754|20274325|P4|NOT COMPLETED|Overall Study||0
8221271|NCT02054754|20274326|P3|NOT COMPLETED|Overall Study||0
8221272|NCT02054754|20274327|P2|NOT COMPLETED|Overall Study||0
8221273|NCT02054754|20274328|P1|NOT COMPLETED|Overall Study||0
8221274|NCT02054754|20274323|P6|COMPLETED|Overall Study||10
8221275|NCT02054754|20274324|P5|COMPLETED|Overall Study||6
8221276|NCT02054754|20274325|P4|COMPLETED|Overall Study||6
8221277|NCT02054754|20274326|P3|COMPLETED|Overall Study||6
8221278|NCT02054754|20274327|P2|COMPLETED|Overall Study||6
8221279|NCT02054754|20274328|P1|COMPLETED|Overall Study||6
8221280|NCT02054754|20274323|P6|STARTED|Overall Study||10
8221281|NCT02054754|20274324|P5|STARTED|Overall Study||6
8221282|NCT02054754|20274325|P4|STARTED|Overall Study||6
8221283|NCT02054754|20274326|P3|STARTED|Overall Study||6
8221284|NCT02054754|20274327|P2|STARTED|Overall Study||6
8221285|NCT02054754|20274328|P1|STARTED|Overall Study||6
8221286|NCT02054715|20274345|P2|NOT COMPLETED|Follow-up 2||19
8221287|NCT02054715|20274346|P1|NOT COMPLETED|Follow-up 2||19
8221288|NCT02054715|20274345|P2|COMPLETED|Follow-up 2||173
8221289|NCT02054715|20274346|P1|COMPLETED|Follow-up 2||192
8221290|NCT02054715|20274345|P2|STARTED|Follow-up 2||192
8221291|NCT02054715|20274346|P1|STARTED|Follow-up 2||211
8221292|NCT02054715|20274345|P2|NOT COMPLETED|Baseline/Follow-up 1||7
8221293|NCT02054715|20274346|P1|NOT COMPLETED|Baseline/Follow-up 1||8
8221294|NCT02054715|20274345|P2|COMPLETED|Baseline/Follow-up 1||192
8221295|NCT02054715|20274346|P1|COMPLETED|Baseline/Follow-up 1||211
8221296|NCT02054715|20274345|P2|STARTED|Baseline/Follow-up 1||199
8221297|NCT02054715|20274346|P1|STARTED|Baseline/Follow-up 1||219
8221298|NCT02054702|20274360|P2|NOT COMPLETED|Overall Study||12
8221299|NCT02054702|20274361|P1|NOT COMPLETED|Overall Study||24
8221300|NCT02054702|20274360|P2|COMPLETED|Overall Study||21
8221301|NCT02054702|20274361|P1|COMPLETED|Overall Study||40
8221302|NCT02054702|20274360|P2|STARTED|Overall Study||33
8221303|NCT02054702|20274361|P1|STARTED|Overall Study||64
8221304|NCT02054572|20274389|P1|NOT COMPLETED|Overall Study||0
8221305|NCT02054572|20274389|P1|COMPLETED|Overall Study||6
8221306|NCT02054572|20274389|P1|STARTED|Overall Study||6
8221307|NCT02054520|20274418|P6|NOT COMPLETED|Overall Study||3
8221308|NCT02054520|20274419|P5|NOT COMPLETED|Overall Study||5
8221309|NCT02054520|20274420|P4|NOT COMPLETED|Overall Study||6
8221310|NCT02054520|20274421|P3|NOT COMPLETED|Overall Study||6
8221311|NCT02054520|20274422|P2|NOT COMPLETED|Overall Study||5
8221312|NCT02054520|20274423|P1|NOT COMPLETED|Overall Study||9
8221313|NCT02054520|20274418|P6|COMPLETED|Overall Study||0
8221314|NCT02054520|20274419|P5|COMPLETED|Overall Study||0
8221315|NCT02054520|20274420|P4|COMPLETED|Overall Study||0
8221316|NCT02054520|20274421|P3|COMPLETED|Overall Study||0
8221317|NCT02054520|20274422|P2|COMPLETED|Overall Study||11
8221318|NCT02054520|20274423|P1|COMPLETED|Overall Study||2
8221319|NCT02054520|20274418|P6|STARTED|Overall Study||3
8221320|NCT02054520|20274419|P5|STARTED|Overall Study||5
8221321|NCT02054520|20274420|P4|STARTED|Overall Study||6
8221322|NCT02054520|20274421|P3|STARTED|Overall Study||6
8221323|NCT02054520|20274422|P2|STARTED|Overall Study||16
8221324|NCT02054520|20274423|P1|STARTED|Overall Study||11
8221325|NCT02054481|20274447|P4|NOT COMPLETED|Overall Study||1
8221326|NCT02054481|20274448|P3|NOT COMPLETED|Overall Study||2
8221327|NCT02054481|20274449|P2|NOT COMPLETED|Overall Study||2
8221328|NCT02054481|20274450|P1|NOT COMPLETED|Overall Study||4
8221329|NCT02054481|20274447|P4|COMPLETED|Overall Study||39
8221330|NCT02054481|20274448|P3|COMPLETED|Overall Study||40
8221331|NCT02054481|20274449|P2|COMPLETED|Overall Study||39
8221332|NCT02054481|20274450|P1|COMPLETED|Overall Study||39
8221333|NCT02054481|20274447|P4|STARTED|Overall Study||40
8221334|NCT02054481|20274448|P3|STARTED|Overall Study||42
8221335|NCT02054481|20274449|P2|STARTED|Overall Study||41
8221336|NCT02054481|20274450|P1|STARTED|Overall Study||43
8221337|NCT02054338|20274498|P2|NOT COMPLETED|Overall Study||501
8221338|NCT02054338|20274499|P1|NOT COMPLETED|Overall Study||503
8221339|NCT02054338|20274498|P2|COMPLETED|Overall Study||0
8221340|NCT02054338|20274499|P1|COMPLETED|Overall Study||0
8221341|NCT02054338|20274498|P2|STARTED|Overall Study||501
8221342|NCT02054338|20274499|P1|STARTED|Overall Study||503
8221343|NCT02054325|20274511|P2|NOT COMPLETED|Overall Study||5
8221344|NCT02054325|20274512|P1|NOT COMPLETED|Overall Study||8
8221345|NCT02054325|20274511|P2|COMPLETED|Overall Study||50
8221346|NCT02054325|20274512|P1|COMPLETED|Overall Study||43
8221347|NCT02054325|20274511|P2|STARTED|Overall Study||55
8221348|NCT02054325|20274512|P1|STARTED|Overall Study||51
8221349|NCT02054156|20274522|P2|NOT COMPLETED|Overall Study||81
8221350|NCT02054156|20274523|P1|NOT COMPLETED|Overall Study||75
8221351|NCT02054156|20274522|P2|COMPLETED|Overall Study||30
8221352|NCT02054156|20274523|P1|COMPLETED|Overall Study||35
8221353|NCT02054156|20274522|P2|STARTED|Overall Study||111
8221354|NCT02054156|20274523|P1|STARTED|Overall Study||110
8221355|NCT02054130|20274539|P4|NOT COMPLETED|Overall Study||22
8221356|NCT02054130|20274540|P3|NOT COMPLETED|Overall Study||15
8221357|NCT02054130|20274541|P2|NOT COMPLETED|Overall Study||11
8221358|NCT02054130|20274542|P1|NOT COMPLETED|Overall Study||8
8221359|NCT02054130|20274539|P4|COMPLETED|Overall Study||115
8221360|NCT02054130|20274540|P3|COMPLETED|Overall Study||122
8221361|NCT02054130|20274541|P2|COMPLETED|Overall Study||127
8221362|NCT02054130|20274542|P1|COMPLETED|Overall Study||130
8221363|NCT02054130|20274539|P4|STARTED|Overall Study||137
8221364|NCT02054130|20274540|P3|STARTED|Overall Study||137
8221365|NCT02054130|20274541|P2|STARTED|Overall Study||138
8221366|NCT02054130|20274542|P1|STARTED|Overall Study||138
8221367|NCT02053753|20274636|P2|NOT COMPLETED|Overall Study||8
8221368|NCT02053753|20274637|P1|NOT COMPLETED|Overall Study||7
8221369|NCT02053753|20274636|P2|COMPLETED|Overall Study||66
8221370|NCT02053753|20274637|P1|COMPLETED|Overall Study||65
8221371|NCT02053753|20274636|P2|Received Treatment|Overall Study||71
8221372|NCT02053753|20274637|P1|Received Treatment|Overall Study||71
8221373|NCT02053753|20274636|P2|STARTED|Overall Study||74
8221374|NCT02053753|20274637|P1|STARTED|Overall Study||72
8221375|NCT02053610|20274661|P2|NOT COMPLETED|Overall Study||67
8221376|NCT02053610|20274662|P1|NOT COMPLETED|Overall Study||42
8221377|NCT02053610|20274661|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
8221378|NCT02053610|20274662|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
8221379|NCT02053610|20274661|P2|Received Study Drug|Overall Study||331
8221380|NCT02053610|20274662|P1|Received Study Drug|Overall Study||326
8221381|NCT02053610|20274661|P2|STARTED|Overall Study||333
8221382|NCT02053610|20274662|P1|STARTED|Overall Study||330
8221383|NCT02053493|20274694|P2|NOT COMPLETED|Overall Study||1
8221384|NCT02053493|20274695|P1|NOT COMPLETED|Overall Study||1
8221385|NCT02053493|20274694|P2|COMPLETED|Overall Study||58
8221386|NCT02053493|20274695|P1|COMPLETED|Overall Study||50
8221387|NCT02053493|20274694|P2|STARTED|Overall Study||59
8221388|NCT02053493|20274695|P1|STARTED|Overall Study||51
8221389|NCT02053376|20274733|P1|NOT COMPLETED|Overall Study||0
8221390|NCT02053376|20274733|P1|COMPLETED|Overall Study||43
8221391|NCT02053376|20274733|P1|STARTED|Overall Study||43
8221392|NCT02053259|20274748|P4|NOT COMPLETED|Overall Study||0
8221393|NCT02053259|20274749|P3|NOT COMPLETED|Overall Study||0
8221394|NCT02053259|20274750|P2|NOT COMPLETED|Overall Study||0
8221395|NCT02053259|20274751|P1|NOT COMPLETED|Overall Study||0
8221396|NCT02053259|20274748|P4|COMPLETED|Overall Study||23
8221397|NCT02053259|20274749|P3|COMPLETED|Overall Study||24
8221398|NCT02053259|20274750|P2|COMPLETED|Overall Study||24
8221399|NCT02053259|20274751|P1|COMPLETED|Overall Study||25
8221400|NCT02053259|20274748|P4|STARTED|Overall Study||23
8221401|NCT02053259|20274749|P3|STARTED|Overall Study||24
8221402|NCT02053259|20274750|P2|STARTED|Overall Study||24
8221403|NCT02053259|20274751|P1|STARTED|Overall Study||25
8221404|NCT02053168|20274761|P1|NOT COMPLETED|Overall Study||3
8221405|NCT02053168|20274761|P1|COMPLETED|Overall Study||22
8221406|NCT02053168|20274761|P1|STARTED|Overall Study||25
8221407|NCT02052895|20274778|P3|NOT COMPLETED|Overall Study||0
8221408|NCT02052895|20274779|P2|NOT COMPLETED|Overall Study||0
8221409|NCT02052895|20274780|P1|NOT COMPLETED|Overall Study||0
8221410|NCT02052895|20274778|P3|COMPLETED|Overall Study||15
8221411|NCT02052895|20274779|P2|COMPLETED|Overall Study||15
8221412|NCT02052895|20274780|P1|COMPLETED|Overall Study||196
8221413|NCT02052895|20274778|P3|STARTED|Overall Study||15
8221414|NCT02052895|20274779|P2|STARTED|Overall Study||15
8221415|NCT02052895|20274780|P1|STARTED|Overall Study||196
8221416|NCT02052752|20274790|P3|NOT COMPLETED|Overall Study||0
8221417|NCT02052752|20274791|P2|NOT COMPLETED|Overall Study||0
8221418|NCT02052752|20274792|P1|NOT COMPLETED|Overall Study||0
8221419|NCT02052752|20274790|P3|COMPLETED|Overall Study||30
8221420|NCT02052752|20274791|P2|COMPLETED|Overall Study||30
8221421|NCT02052752|20274792|P1|COMPLETED|Overall Study||30
8221422|NCT02052752|20274790|P3|STARTED|Overall Study||30
8221423|NCT02052752|20274791|P2|STARTED|Overall Study||30
8221424|NCT02052752|20274792|P1|STARTED|Overall Study||30
8221425|NCT02052661|20274815|P1|NOT COMPLETED|Overall Study||0
8221426|NCT02052661|20274815|P1|COMPLETED|Overall Study||300
8221427|NCT02052661|20274815|P1|STARTED|Overall Study||300
8221428|NCT02052635|20274829|P2|NOT COMPLETED|Overall Study||0
8221429|NCT02052635|20274830|P1|NOT COMPLETED|Overall Study||0
8221430|NCT02052635|20274829|P2|COMPLETED|Overall Study||6
8221431|NCT02052635|20274830|P1|COMPLETED|Overall Study||7
8221432|NCT02052635|20274829|P2|STARTED|Overall Study||6
8221433|NCT02052635|20274830|P1|STARTED|Overall Study||7
8221434|NCT02052596|20274840|P2|NOT COMPLETED|Safety Phase||35
8221435|NCT02052596|20274841|P1|NOT COMPLETED|Safety Phase||27
8221436|NCT02052596|20274840|P2|COMPLETED|Safety Phase||383
8221437|NCT02052596|20274841|P1|COMPLETED|Safety Phase||385
8221438|NCT02052596|20274840|P2|STARTED|Safety Phase||418
8221439|NCT02052596|20274841|P1|STARTED|Safety Phase||412
8221440|NCT02052596|20274840|P2|NOT COMPLETED|Active Phase||20
8221441|NCT02052596|20274841|P1|NOT COMPLETED|Active Phase||16
8221442|NCT02052596|20274840|P2|COMPLETED|Active Phase||398
8221443|NCT02052596|20274841|P1|COMPLETED|Active Phase||396
8221444|NCT02052596|20274840|P2|STARTED|Active Phase||418
8221445|NCT02052596|20274841|P1|STARTED|Active Phase||412
8221446|NCT02052557|20274868|P2|NOT COMPLETED|Overall Study||0
8221447|NCT02052557|20274869|P1|NOT COMPLETED|Overall Study||0
8221448|NCT02052557|20274868|P2|COMPLETED|Overall Study||25
8221449|NCT02052557|20274869|P1|COMPLETED|Overall Study||26
8221450|NCT02052557|20274868|P2|STARTED|Overall Study||25
8221451|NCT02052557|20274869|P1|STARTED|Overall Study||26
8221452|NCT02052544|20274901|P1|NOT COMPLETED|Overall Study||0
8221453|NCT02052544|20274901|P1|COMPLETED|Overall Study|Last Subject Out|123
8221454|NCT02052544|20274901|P1|STARTED|Overall Study|First Subject In|123
8221455|NCT02052466|20274906|P1|NOT COMPLETED|Overall Study||2
8221456|NCT02052466|20274906|P1|COMPLETED|Overall Study||30
8221457|NCT02052466|20274906|P1|STARTED|Overall Study||32
8221458|NCT02052440|20274923|P2|NOT COMPLETED|Overall Study||1
8221459|NCT02052440|20274924|P1|NOT COMPLETED|Overall Study||0
8221460|NCT02052440|20274923|P2|COMPLETED|Overall Study||51
8221461|NCT02052440|20274924|P1|COMPLETED|Overall Study||50
8221462|NCT02052440|20274923|P2|STARTED|Overall Study||52
8221463|NCT02052440|20274924|P1|STARTED|Overall Study||50
8221464|NCT02052414|20274936|P1|NOT COMPLETED|Overall Study||17
8221465|NCT02052414|20274936|P1|COMPLETED|Overall Study||17
8221466|NCT02052414|20274936|P1|STARTED|Overall Study||34
8221467|NCT02052141|20274946|P2|NOT COMPLETED|Intervention Period 2||0
8221468|NCT02052141|20274947|P1|NOT COMPLETED|Intervention Period 2||0
8221469|NCT02052141|20274946|P2|COMPLETED|Intervention Period 2||7
8221470|NCT02052141|20274947|P1|COMPLETED|Intervention Period 2||5
8221471|NCT02052141|20274946|P2|STARTED|Intervention Period 2||7
8221472|NCT02052141|20274947|P1|STARTED|Intervention Period 2||5
8221473|NCT02052141|20274946|P2|NOT COMPLETED|Intervention Period 1||0
8221474|NCT02052141|20274947|P1|NOT COMPLETED|Intervention Period 1||0
8221475|NCT02052141|20274946|P2|COMPLETED|Intervention Period 1||7
8221476|NCT02052141|20274947|P1|COMPLETED|Intervention Period 1||5
8221477|NCT02052141|20274946|P2|STARTED|Intervention Period 1||7
8221478|NCT02052141|20274947|P1|STARTED|Intervention Period 1||5
8221479|NCT02052011|20274971|P2|NOT COMPLETED|Overall Study||2
8221480|NCT02052011|20274972|P1|NOT COMPLETED|Overall Study||4
8221481|NCT02052011|20274971|P2|COMPLETED|Overall Study||8
8221482|NCT02052011|20274972|P1|COMPLETED|Overall Study||17
8221483|NCT02052011|20274971|P2|STARTED|Overall Study||10
8221484|NCT02052011|20274972|P1|STARTED|Overall Study||21
8221485|NCT02051816|20274982|P4|NOT COMPLETED|Overall Study||0
8221486|NCT02051816|20274983|P3|NOT COMPLETED|Overall Study||0
8221487|NCT02051816|20274984|P2|NOT COMPLETED|Overall Study||0
8221488|NCT02051816|20274985|P1|NOT COMPLETED|Overall Study||0
8221489|NCT02051816|20274982|P4|COMPLETED|Overall Study||36
8221490|NCT02051816|20274983|P3|COMPLETED|Overall Study||37
8221491|NCT02051816|20274984|P2|COMPLETED|Overall Study||40
8221492|NCT02051816|20274985|P1|COMPLETED|Overall Study||37
8221493|NCT02051816|20274982|P4|STARTED|Overall Study||36
8221494|NCT02051816|20274983|P3|STARTED|Overall Study||37
8221495|NCT02051816|20274984|P2|STARTED|Overall Study||40
8221496|NCT02051816|20274985|P1|STARTED|Overall Study||37
8221497|NCT02051790|20275023|P1|NOT COMPLETED|Overall Study||0
8221498|NCT02051790|20275023|P1|COMPLETED|Overall Study||241
8221499|NCT02051790|20275023|P1|STARTED|Overall Study||241
8221500|NCT02051764|20275029|P2|NOT COMPLETED|Overall Study||7
8221501|NCT02051764|20275030|P1|NOT COMPLETED|Overall Study||0
8221502|NCT02051764|20275029|P2|COMPLETED|Overall Study||21
8221503|NCT02051764|20275030|P1|COMPLETED|Overall Study||16
8221504|NCT02051764|20275029|P2|STARTED|Overall Study||28
8221505|NCT02051764|20275030|P1|STARTED|Overall Study||16
8221506|NCT02051686|20275038|P2|NOT COMPLETED|Overall Study||0
8221507|NCT02051686|20275039|P1|NOT COMPLETED|Overall Study||0
8221508|NCT02051686|20275038|P2|COMPLETED|Overall Study||46
8221509|NCT02051686|20275039|P1|COMPLETED|Overall Study||42
8221510|NCT02051686|20275038|P2|STARTED|Overall Study||46
8221511|NCT02051686|20275039|P1|STARTED|Overall Study||42
8221512|NCT02051595|20275047|P1|NOT COMPLETED|Overall Study||0
8221513|NCT02051595|20275047|P1|COMPLETED|Overall Study||25
8221514|NCT02051595|20275047|P1|STARTED|Overall Study||25
8221515|NCT02051452|20275053|P2|NOT COMPLETED|Overall Study||0
8221516|NCT02051452|20275054|P1|NOT COMPLETED|Overall Study||0
8221517|NCT02051452|20275053|P2|COMPLETED|Overall Study||16
8221518|NCT02051452|20275054|P1|COMPLETED|Overall Study||16
8221519|NCT02051452|20275053|P2|STARTED|Overall Study||16
8221520|NCT02051452|20275054|P1|STARTED|Overall Study||16
8221521|NCT02051426|20275066|P2|NOT COMPLETED|Second Intervention||0
8221522|NCT02051426|20275067|P1|NOT COMPLETED|Second Intervention||0
8221523|NCT02051426|20275066|P2|COMPLETED|Second Intervention||19
8221524|NCT02051426|20275067|P1|COMPLETED|Second Intervention||16
8221525|NCT02051426|20275066|P2|STARTED|Second Intervention||19
8221526|NCT02051426|20275067|P1|STARTED|Second Intervention||16
8221527|NCT02051426|20275066|P2|NOT COMPLETED|Washout Period of 1 Month||0
8221528|NCT02051426|20275067|P1|NOT COMPLETED|Washout Period of 1 Month||0
8221529|NCT02051426|20275066|P2|COMPLETED|Washout Period of 1 Month||19
8221530|NCT02051426|20275067|P1|COMPLETED|Washout Period of 1 Month||16
8221531|NCT02051426|20275066|P2|STARTED|Washout Period of 1 Month||19
8221532|NCT02051426|20275067|P1|STARTED|Washout Period of 1 Month||16
8221533|NCT02051426|20275066|P2|NOT COMPLETED|First Intervention||0
8221534|NCT02051426|20275067|P1|NOT COMPLETED|First Intervention||0
8221535|NCT02051426|20275066|P2|COMPLETED|First Intervention||19
8221536|NCT02051426|20275067|P1|COMPLETED|First Intervention||16
8221537|NCT02051426|20275066|P2|STARTED|First Intervention||19
8221538|NCT02051426|20275067|P1|STARTED|First Intervention||16
8221539|NCT02051335|20275081|P4|NOT COMPLETED|Period 4||0
8221540|NCT02051335|20275082|P3|NOT COMPLETED|Period 4||0
8221541|NCT02051335|20275083|P2|NOT COMPLETED|Period 4||0
8221542|NCT02051335|20275084|P1|NOT COMPLETED|Period 4||0
8221543|NCT02051335|20275081|P4|COMPLETED|Period 4||4
8221544|NCT02051335|20275082|P3|COMPLETED|Period 4||5
8221545|NCT02051335|20275083|P2|COMPLETED|Period 4||7
8221546|NCT02051335|20275084|P1|COMPLETED|Period 4||7
8221547|NCT02051335|20275081|P4|STARTED|Period 4||4
8221548|NCT02051335|20275082|P3|STARTED|Period 4||5
8221549|NCT02051335|20275083|P2|STARTED|Period 4||7
8221550|NCT02051335|20275084|P1|STARTED|Period 4||7
8221551|NCT02051335|20275081|P4|NOT COMPLETED|Period 3||0
8221552|NCT02051335|20275082|P3|NOT COMPLETED|Period 3||0
8221553|NCT02051335|20275083|P2|NOT COMPLETED|Period 3||0
8221554|NCT02051335|20275084|P1|NOT COMPLETED|Period 3||0
8221555|NCT02051335|20275081|P4|COMPLETED|Period 3||4
8221556|NCT02051335|20275082|P3|COMPLETED|Period 3||5
8221557|NCT02051335|20275083|P2|COMPLETED|Period 3||7
8221558|NCT02051335|20275084|P1|COMPLETED|Period 3||7
8221559|NCT02051335|20275081|P4|STARTED|Period 3||4
8221560|NCT02051335|20275082|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
8221561|NCT02051335|20275083|P2|STARTED|Period 3||7
8221562|NCT02051335|20275084|P1|STARTED|Period 3||7
8221563|NCT02051335|20275081|P4|NOT COMPLETED|Period 2||0
8221564|NCT02051335|20275082|P3|NOT COMPLETED|Period 2||0
8221565|NCT02051335|20275083|P2|NOT COMPLETED|Period 2||0
8221566|NCT02051335|20275084|P1|NOT COMPLETED|Period 2||0
8221567|NCT02051335|20275081|P4|COMPLETED|Period 2||4
8221568|NCT02051335|20275082|P3|COMPLETED|Period 2||7
8221569|NCT02051335|20275083|P2|COMPLETED|Period 2||7
8221570|NCT02051335|20275084|P1|COMPLETED|Period 2||7
8221571|NCT02051335|20275081|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
8221572|NCT02051335|20275082|P3|STARTED|Period 2||7
8221573|NCT02051335|20275083|P2|STARTED|Period 2||7
8221574|NCT02051335|20275084|P1|STARTED|Period 2||7
8221575|NCT02051335|20275081|P4|NOT COMPLETED|Period 1||0
8221576|NCT02051335|20275082|P3|NOT COMPLETED|Period 1||0
8221577|NCT02051335|20275083|P2|NOT COMPLETED|Period 1||0
8221578|NCT02051335|20275084|P1|NOT COMPLETED|Period 1||0
8221579|NCT02051335|20275081|P4|COMPLETED|Period 1||6
8221580|NCT02051335|20275082|P3|COMPLETED|Period 1||7
8221581|NCT02051335|20275083|P2|COMPLETED|Period 1||7
8221582|NCT02051335|20275084|P1|COMPLETED|Period 1||7
8221583|NCT02051335|20275081|P4|STARTED|Period 1||6
8221584|NCT02051335|20275082|P3|STARTED|Period 1||7
8221585|NCT02051335|20275083|P2|STARTED|Period 1||7
8221586|NCT02051335|20275084|P1|STARTED|Period 1||7
8221587|NCT02051296|20275136|P2|NOT COMPLETED|Overall Study||9
8221588|NCT02051296|20275137|P1|NOT COMPLETED|Overall Study||8
8221589|NCT02051296|20275136|P2|COMPLETED|Overall Study||56
8221590|NCT02051296|20275137|P1|COMPLETED|Overall Study||58
8221591|NCT02051296|20275136|P2|Received Allocated Intervention|Overall Study||58
8221592|NCT02051296|20275137|P1|Received Allocated Intervention|Overall Study||59
8221593|NCT02051296|20275136|P2|STARTED|Overall Study||65
8221594|NCT02051296|20275137|P1|STARTED|Overall Study||66
8221595|NCT02050919|20275143|P1|NOT COMPLETED|Overall Study||0
8221596|NCT02050919|20275143|P1|COMPLETED|Overall Study||20
8221597|NCT02050919|20275143|P1|STARTED|Overall Study||20
8221598|NCT02050841|20275147|P1|NOT COMPLETED|Overall Study||1
8221599|NCT02050841|20275147|P1|COMPLETED|Overall Study||49
8221600|NCT02050841|20275147|P1|STARTED|Overall Study||50
8221601|NCT02050373|20275188|P2|NOT COMPLETED|Overall Study||10
8221602|NCT02050373|20275189|P1|NOT COMPLETED|Overall Study||7
8221603|NCT02050373|20275188|P2|COMPLETED|Overall Study||24
8221604|NCT02050373|20275189|P1|COMPLETED|Overall Study||27
8221605|NCT02050373|20275188|P2|STARTED|Overall Study||34
8221606|NCT02050373|20275189|P1|STARTED|Overall Study||34
8221607|NCT02050334|20275199|P2|NOT COMPLETED|Overall Study||0
8221608|NCT02050334|20275200|P1|NOT COMPLETED|Overall Study||0
8221609|NCT02050334|20275199|P2|COMPLETED|Overall Study||9
8221610|NCT02050334|20275200|P1|COMPLETED|Overall Study||9
8221611|NCT02050334|20275199|P2|STARTED|Overall Study||9
8221612|NCT02050334|20275200|P1|STARTED|Overall Study||9
8221613|NCT02050321|20275208|P1|NOT COMPLETED|Overall Study||2
8221614|NCT02050321|20275208|P1|COMPLETED|Overall Study||0
8221615|NCT02050321|20275208|P1|STARTED|Overall Study||2
8221616|NCT02050308|20275215|P2|NOT COMPLETED|Overall Study||102
8221617|NCT02050308|20275216|P1|NOT COMPLETED|Overall Study||99
8221618|NCT02050308|20275215|P2|COMPLETED|Overall Study||22
8221619|NCT02050308|20275216|P1|COMPLETED|Overall Study||28
8221620|NCT02050308|20275215|P2|STARTED|Overall Study||124
8221621|NCT02050308|20275216|P1|STARTED|Overall Study||127
8221622|NCT02050048|20275224|P2|NOT COMPLETED|Overall Study||2
8221623|NCT02050048|20275225|P1|NOT COMPLETED|Overall Study||5
8221624|NCT02050048|20275224|P2|COMPLETED|Overall Study||10
8221625|NCT02050048|20275225|P1|COMPLETED|Overall Study||9
8221626|NCT02050048|20275224|P2|STARTED|Overall Study||12
8221627|NCT02050048|20275225|P1|STARTED|Overall Study||14
8221628|NCT02049957|20275240|P9|NOT COMPLETED|Overall Study||8
8221629|NCT02049957|20275241|P8|NOT COMPLETED|Overall Study||35
8221630|NCT02049957|20275242|P7|NOT COMPLETED|Overall Study||8
8221631|NCT02049957|20275243|P6|NOT COMPLETED|Overall Study||43
8221632|NCT02049957|20275244|P5|NOT COMPLETED|Overall Study||6
8221633|NCT02049957|20275245|P4|NOT COMPLETED|Overall Study||3
8221634|NCT02049957|20275246|P3|NOT COMPLETED|Overall Study||3
8221635|NCT02049957|20275247|P2|NOT COMPLETED|Overall Study||6
8221636|NCT02049957|20275248|P1|NOT COMPLETED|Overall Study||6
8221637|NCT02049957|20275240|P9|COMPLETED|Overall Study||0
8221638|NCT02049957|20275241|P8|COMPLETED|Overall Study||0
8221639|NCT02049957|20275242|P7|COMPLETED|Overall Study||0
8221640|NCT02049957|20275243|P6|COMPLETED|Overall Study||0
8221641|NCT02049957|20275244|P5|COMPLETED|Overall Study||0
8221642|NCT02049957|20275245|P4|COMPLETED|Overall Study||0
8221643|NCT02049957|20275246|P3|COMPLETED|Overall Study||0
8221644|NCT02049957|20275247|P2|COMPLETED|Overall Study||0
8221645|NCT02049957|20275248|P1|COMPLETED|Overall Study||0
8221646|NCT02049957|20275240|P9|STARTED|Overall Study||8
8221647|NCT02049957|20275241|P8|STARTED|Overall Study||35
8221648|NCT02049957|20275242|P7|STARTED|Overall Study||8
8221649|NCT02049957|20275243|P6|STARTED|Overall Study||43
8221650|NCT02049957|20275244|P5|STARTED|Overall Study||6
8221651|NCT02049957|20275245|P4|STARTED|Overall Study||3
8221652|NCT02049957|20275246|P3|STARTED|Overall Study||3
8221653|NCT02049957|20275247|P2|STARTED|Overall Study||6
8221654|NCT02049957|20275248|P1|STARTED|Overall Study||6
8221655|NCT02049931|20275316|P3|NOT COMPLETED|Overall Study||3
8221656|NCT02049931|20275317|P2|NOT COMPLETED|Overall Study||5
8221657|NCT02049931|20275318|P1|NOT COMPLETED|Overall Study||3
8221658|NCT02049931|20275316|P3|COMPLETED|Overall Study||17
8221659|NCT02049931|20275317|P2|COMPLETED|Overall Study||15
8221660|NCT02049931|20275318|P1|COMPLETED|Overall Study||17
8221661|NCT02049931|20275316|P3|STARTED|Overall Study||20
8221662|NCT02049931|20275317|P2|STARTED|Overall Study||20
8221663|NCT02049931|20275318|P1|STARTED|Overall Study||20
8221664|NCT02049814|20275340|P2|NOT COMPLETED|Overall Study||27
8221665|NCT02049814|20275341|P1|NOT COMPLETED|Overall Study||29
8221666|NCT02049814|20275340|P2|COMPLETED|Overall Study||219
8221667|NCT02049814|20275341|P1|COMPLETED|Overall Study||219
8221668|NCT02049814|20275340|P2|Safety Set|Overall Study||245
8221669|NCT02049814|20275341|P1|Safety Set|Overall Study||248
8221670|NCT02049814|20275340|P2|STARTED|Overall Study||246
8221671|NCT02049814|20275341|P1|STARTED|Overall Study||248
8221672|NCT02049749|20275369|P2|NOT COMPLETED|Overall Study||0
8221673|NCT02049749|20275370|P1|NOT COMPLETED|Overall Study||0
8221674|NCT02049749|20275369|P2|COMPLETED|Overall Study|80 children plus 80 caregivers|160
8221675|NCT02049749|20275370|P1|COMPLETED|Overall Study||80
8221676|NCT02049749|20275369|P2|STARTED|Overall Study|80 children plus 80 caregivers|160
8221677|NCT02049749|20275370|P1|STARTED|Overall Study|40 children plus 40 caregivers|80
8221678|NCT02049502|20275378|P1|NOT COMPLETED|Overall Study||0
8221679|NCT02049502|20275378|P1|COMPLETED|Overall Study||8
8221680|NCT02049502|20275378|P1|STARTED|Overall Study||8
8221681|NCT02049476|20275383|P1|NOT COMPLETED|Overall Study||0
8221682|NCT02049476|20275383|P1|COMPLETED|Overall Study|20th patient completed the study|20
8221683|NCT02049476|20275383|P1|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
8221684|NCT02049450|20275390|P1|NOT COMPLETED|Overall Study||4
8221685|NCT02049450|20275390|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
8221686|NCT02049450|20275390|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
8221687|NCT02049450|20275390|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
8221688|NCT02049450|20275390|P1|STARTED|Overall Study||30
8221689|NCT02049437|20275406|P2|NOT COMPLETED|Washout 2||0
8221690|NCT02049437|20275407|P1|NOT COMPLETED|Washout 2||0
8221691|NCT02049437|20275406|P2|COMPLETED|Washout 2||16
8221692|NCT02049437|20275407|P1|COMPLETED|Washout 2||15
8221693|NCT02049437|20275406|P2|STARTED|Washout 2||16
8221694|NCT02049437|20275407|P1|STARTED|Washout 2||15
8221695|NCT02049437|20275406|P2|NOT COMPLETED|Period 2||0
8221696|NCT02049437|20275407|P1|NOT COMPLETED|Period 2||0
8221697|NCT02049437|20275406|P2|COMPLETED|Period 2||16
8221698|NCT02049437|20275407|P1|COMPLETED|Period 2||15
8221699|NCT02049437|20275406|P2|STARTED|Period 2||16
8221700|NCT02049437|20275407|P1|STARTED|Period 2||15
8221701|NCT02049437|20275406|P2|NOT COMPLETED|Washout 1||0
8221702|NCT02049437|20275407|P1|NOT COMPLETED|Washout 1||0
8221703|NCT02049437|20275406|P2|COMPLETED|Washout 1||16
8221704|NCT02049437|20275407|P1|COMPLETED|Washout 1||15
8221705|NCT02049437|20275406|P2|STARTED|Washout 1||16
8221706|NCT02049437|20275407|P1|STARTED|Washout 1||15
8221707|NCT02049437|20275406|P2|NOT COMPLETED|Period 1||1
8221708|NCT02049437|20275407|P1|NOT COMPLETED|Period 1||2
8221709|NCT02049437|20275406|P2|COMPLETED|Period 1|Dropout due to low trough levels|16
8221710|NCT02049437|20275407|P1|COMPLETED|Period 1||15
8221711|NCT02049437|20275406|P2|STARTED|Period 1||17
8221712|NCT02049437|20275407|P1|STARTED|Period 1||17
8221713|NCT02049385|20275417|P2|NOT COMPLETED|Second Intervention||2
8221714|NCT02049385|20275418|P1|NOT COMPLETED|Second Intervention||0
8221715|NCT02049385|20275417|P2|COMPLETED|Second Intervention||0
8221716|NCT02049385|20275418|P1|COMPLETED|Second Intervention||1
8221717|NCT02049385|20275417|P2|STARTED|Second Intervention||2
8221718|NCT02049385|20275418|P1|STARTED|Second Intervention||1
8221719|NCT02049385|20275417|P2|NOT COMPLETED|First Intervention||0
8221720|NCT02049385|20275418|P1|NOT COMPLETED|First Intervention||3
8221721|NCT02049385|20275417|P2|COMPLETED|First Intervention||2
8221722|NCT02049385|20275418|P1|COMPLETED|First Intervention||1
8221723|NCT02049385|20275417|P2|STARTED|First Intervention||2
8221724|NCT02049385|20275418|P1|STARTED|First Intervention||4
8221725|NCT02049307|20275426|P2|NOT COMPLETED|Overall Study||1
8221726|NCT02049307|20275427|P1|NOT COMPLETED|Overall Study||2
8221727|NCT02049307|20275426|P2|COMPLETED|Overall Study||55
8221728|NCT02049307|20275427|P1|COMPLETED|Overall Study||50
8221729|NCT02049307|20275426|P2|STARTED|Overall Study||56
8221730|NCT02049307|20275427|P1|STARTED|Overall Study||52
8221731|NCT02049151|20275437|P2|NOT COMPLETED|Overall Study||0
8221732|NCT02049151|20275438|P1|NOT COMPLETED|Overall Study||0
8221733|NCT02049151|20275437|P2|COMPLETED|Overall Study||17
8221734|NCT02049151|20275438|P1|COMPLETED|Overall Study||15
8221735|NCT02049151|20275437|P2|STARTED|Overall Study|1 subject did not receive treatment|17
8221736|NCT02049151|20275438|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
8221737|NCT02048904|20275452|P1|NOT COMPLETED|Overall Study||77
8221738|NCT02048904|20275452|P1|COMPLETED|Overall Study||65
8221739|NCT02048904|20275452|P1|STARTED|Overall Study||142
8221740|NCT02048891|20275458|P2|NOT COMPLETED|Overall Study||0
8221741|NCT02048891|20275459|P1|NOT COMPLETED|Overall Study||0
8221742|NCT02048891|20275458|P2|COMPLETED|Overall Study||1
8221743|NCT02048891|20275459|P1|COMPLETED|Overall Study||2
8221744|NCT02048891|20275458|P2|STARTED|Overall Study||1
8221745|NCT02048891|20275459|P1|STARTED|Overall Study||2
8221746|NCT02048878|20275467|P2|NOT COMPLETED|Overall Study||3
8221747|NCT02048878|20275468|P1|NOT COMPLETED|Overall Study||1
8221748|NCT02048878|20275467|P2|COMPLETED|Overall Study||12
8221749|NCT02048878|20275468|P1|COMPLETED|Overall Study||12
8221750|NCT02048878|20275467|P2|STARTED|Overall Study||15
8221751|NCT02048878|20275468|P1|STARTED|Overall Study||13
8221752|NCT02048722|20275484|P1|NOT COMPLETED|Follow up for 5 Years||29
8221753|NCT02048722|20275484|P1|COMPLETED|Follow up for 5 Years||0
8221754|NCT02048722|20275484|P1|STARTED|Follow up for 5 Years|2 patients remain on treatment and have not gone into follow up phase yet.|29
8221755|NCT02048722|20275484|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
8221756|NCT02048722|20275484|P1|COMPLETED|Reached 1st Response/Continued Treatment||13
8221757|NCT02048722|20275484|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
8221758|NCT02048722|20275484|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||23
8221759|NCT02048722|20275484|P1|STARTED|Reached 1st Response/Continued Treatment||23
8221760|NCT02048722|20275484|P1|NOT COMPLETED|2 Cycles of Treatment||8
8221761|NCT02048722|20275484|P1|COMPLETED|2 Cycles of Treatment||23
8221762|NCT02048722|20275484|P1|Attempted 2nd Cycle|2 Cycles of Treatment||23
8221763|NCT02048722|20275484|P1|Attempted 1st Cycle|2 Cycles of Treatment||31
8221764|NCT02048722|20275484|P1|STARTED|2 Cycles of Treatment||31
8221765|NCT02048670|20275496|P2|NOT COMPLETED|Overall Study||0
8221766|NCT02048670|20275497|P1|NOT COMPLETED|Overall Study||0
8221767|NCT02048670|20275496|P2|COMPLETED|Overall Study||6
8221768|NCT02048670|20275497|P1|COMPLETED|Overall Study||6
8221769|NCT02048670|20275496|P2|STARTED|Overall Study||6
8221770|NCT02048670|20275497|P1|STARTED|Overall Study||6
8221771|NCT02048241|20275507|P2|NOT COMPLETED|Overall Study||1
8221772|NCT02048241|20275508|P1|NOT COMPLETED|Overall Study||0
8221773|NCT02048241|20275507|P2|COMPLETED|Overall Study||5
8221774|NCT02048241|20275508|P1|COMPLETED|Overall Study||5
8221775|NCT02048241|20275507|P2|STARTED|Overall Study||6
8221776|NCT02048241|20275508|P1|STARTED|Overall Study||5
8221777|NCT02048072|20275514|P1|NOT COMPLETED|Overall Study||4
8221778|NCT02048072|20275514|P1|COMPLETED|Overall Study||29
8221779|NCT02048072|20275514|P1|STARTED|Overall Study||33
8221780|NCT02047981|20275520|P2|NOT COMPLETED|MORDOR Stage II Year 3||2363
8221781|NCT02047981|20275521|P1|NOT COMPLETED|MORDOR Stage II Year 3||2886
8221782|NCT02047981|20275520|P2|COMPLETED|MORDOR Stage II Year 3||30931
8221783|NCT02047981|20275521|P1|COMPLETED|MORDOR Stage II Year 3||34611
8221784|NCT02047981|20275520|P2|STARTED|MORDOR Stage II Year 3||33294
8221785|NCT02047981|20275521|P1|STARTED|MORDOR Stage II Year 3||37497
8221786|NCT02047981|20275520|P2|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
8221787|NCT02047981|20275521|P1|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
8221788|NCT02047981|20275520|P2|COMPLETED|MORDOR Stage I Year 1-2||84474
8221789|NCT02047981|20275521|P1|COMPLETED|MORDOR Stage I Year 1-2||87650
8221790|NCT02047981|20275520|P2|STARTED|MORDOR Stage I Year 1-2||93191
8221791|NCT02047981|20275521|P1|STARTED|MORDOR Stage I Year 1-2||97047
8221792|NCT02047929|20275538|P3|NOT COMPLETED|Overall Study||0
8221793|NCT02047929|20275539|P2|NOT COMPLETED|Overall Study||0
8221794|NCT02047929|20275540|P1|NOT COMPLETED|Overall Study||0
8221795|NCT02047929|20275538|P3|COMPLETED|Overall Study||2248
8221796|NCT02047929|20275539|P2|COMPLETED|Overall Study||2523
8221797|NCT02047929|20275540|P1|COMPLETED|Overall Study||1503
8221798|NCT02047929|20275538|P3|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
8221799|NCT02047929|20275539|P2|Surveys Collected|Overall Study||2523
8221800|NCT02047929|20275540|P1|Surveys Collected|Overall Study||1503
8221801|NCT02047929|20275538|P3|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
8221802|NCT02047929|20275539|P2|Practice Refresher|Overall Study||2523
8221803|NCT02047929|20275540|P1|Practice Refresher|Overall Study||1503
8221804|NCT02047929|20275538|P3|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
8221805|NCT02047929|20275539|P2|Practice Rollout|Overall Study||2523
8221806|NCT02047929|20275540|P1|Practice Rollout|Overall Study||1503
8221807|NCT02047929|20275538|P3|STARTED|Overall Study||2248
8221808|NCT02047929|20275539|P2|STARTED|Overall Study||2523
8221809|NCT02047929|20275540|P1|STARTED|Overall Study||1503
8221810|NCT02047903|20275553|P1|NOT COMPLETED|Overall Study||59
8221811|NCT02047903|20275553|P1|COMPLETED|Overall Study||102
8221812|NCT02047903|20275553|P1|Treated|Overall Study||152
8221813|NCT02047903|20275553|P1|STARTED|Overall Study||161
8221814|NCT02047747|20275565|P1|NOT COMPLETED|Overall Study||3
8221815|NCT02047747|20275565|P1|COMPLETED|Overall Study||1
8221816|NCT02047747|20275565|P1|STARTED|Overall Study||4
8221817|NCT02047643|20275570|P2|NOT COMPLETED|Overall Study||0
8221818|NCT02047643|20275571|P1|NOT COMPLETED|Overall Study||0
8221819|NCT02047643|20275570|P2|COMPLETED|Overall Study||9
8221820|NCT02047643|20275571|P1|COMPLETED|Overall Study||9
8221821|NCT02047643|20275570|P2|STARTED|Overall Study||9
8221822|NCT02047643|20275571|P1|STARTED|Overall Study||9
8221823|NCT02047500|20275579|P1|NOT COMPLETED|Overall Study||19
8221824|NCT02047500|20275579|P1|COMPLETED|Overall Study||0
8221825|NCT02047500|20275579|P1|STARTED|Overall Study||19
8221826|NCT02047344|20275585|P2|NOT COMPLETED|Overall Study||0
8221827|NCT02047344|20275586|P1|NOT COMPLETED|Overall Study||0
8221828|NCT02047344|20275585|P2|COMPLETED|Overall Study||15
8221829|NCT02047344|20275586|P1|COMPLETED|Overall Study||16
8221830|NCT02047344|20275585|P2|STARTED|Overall Study||15
8221831|NCT02047344|20275586|P1|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
8221832|NCT02047305|20275604|P1|NOT COMPLETED|Overall Study||0
8221833|NCT02047305|20275604|P1|COMPLETED|Overall Study||96
8221834|NCT02047305|20275604|P1|STARTED|Overall Study||96
8221835|NCT02047253|20275608|P1|NOT COMPLETED|Overall Study||8
8221836|NCT02047253|20275608|P1|COMPLETED|Overall Study||20
8221837|NCT02047253|20275608|P1|STARTED|Overall Study||28
8221838|NCT02047227|20275618|P2|NOT COMPLETED|Overall Study||130
8221839|NCT02047227|20275619|P1|NOT COMPLETED|Overall Study||144
8221840|NCT02047227|20275618|P2|COMPLETED|Overall Study||347
8221841|NCT02047227|20275619|P1|COMPLETED|Overall Study||318
8221842|NCT02047227|20275618|P2|Completed Ovarian Stimulation Phase|Overall Study||440
8221843|NCT02047227|20275619|P1|Completed Ovarian Stimulation Phase|Overall Study||424
8221844|NCT02047227|20275618|P2|STARTED|Overall Study||477
8221845|NCT02047227|20275619|P1|STARTED|Overall Study||462
8221846|NCT02047110|20275639|P4|NOT COMPLETED|OLE Treatment Period||0
8221847|NCT02047110|20275640|P3|NOT COMPLETED|OLE Treatment Period||1
8221848|NCT02047110|20275641|P2|NOT COMPLETED|OLE Treatment Period||0
8221849|NCT02047110|20275642|P1|NOT COMPLETED|OLE Treatment Period||0
8221850|NCT02047110|20275639|P4|COMPLETED|OLE Treatment Period||9
8221851|NCT02047110|20275640|P3|COMPLETED|OLE Treatment Period||4
8221852|NCT02047110|20275641|P2|COMPLETED|OLE Treatment Period||8
8221853|NCT02047110|20275642|P1|COMPLETED|OLE Treatment Period||4
8221854|NCT02047110|20275639|P4|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
8221855|NCT02047110|20275640|P3|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
8221856|NCT02047110|20275641|P2|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
8221857|NCT02047110|20275642|P1|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
8221858|NCT02047110|20275639|P4|NOT COMPLETED|Escape Treatment Period||2
8221859|NCT02047110|20275640|P3|NOT COMPLETED|Escape Treatment Period||3
8221860|NCT02047110|20275641|P2|NOT COMPLETED|Escape Treatment Period||6
8221861|NCT02047110|20275642|P1|NOT COMPLETED|Escape Treatment Period||3
8221862|NCT02047110|20275639|P4|COMPLETED|Escape Treatment Period||24
8221863|NCT02047110|20275640|P3|COMPLETED|Escape Treatment Period||20
8221864|NCT02047110|20275641|P2|COMPLETED|Escape Treatment Period||15
8221865|NCT02047110|20275642|P1|COMPLETED|Escape Treatment Period||23
8221866|NCT02047110|20275639|P4|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
8221867|NCT02047110|20275640|P3|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
8221868|NCT02047110|20275641|P2|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
8221869|NCT02047110|20275642|P1|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
8221870|NCT02047110|20275639|P4|NOT COMPLETED|DB (Week 12 up to Week 24)||0
8221871|NCT02047110|20275640|P3|NOT COMPLETED|DB (Week 12 up to Week 24)||1
8221872|NCT02047110|20275641|P2|NOT COMPLETED|DB (Week 12 up to Week 24)||2
8221873|NCT02047110|20275642|P1|NOT COMPLETED|DB (Week 12 up to Week 24)||0
8221874|NCT02047110|20275639|P4|COMPLETED|DB (Week 12 up to Week 24)||12
8221875|NCT02047110|20275640|P3|COMPLETED|DB (Week 12 up to Week 24)||12
8221876|NCT02047110|20275641|P2|COMPLETED|DB (Week 12 up to Week 24)||15
8221877|NCT02047110|20275642|P1|COMPLETED|DB (Week 12 up to Week 24)||9
8221878|NCT02047110|20275639|P4|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
8221879|NCT02047110|20275640|P3|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
8221880|NCT02047110|20275641|P2|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
8221881|NCT02047110|20275642|P1|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
8221882|NCT02047110|20275639|P4|NOT COMPLETED|DB Treatment Period up to Week 24||2
8221883|NCT02047110|20275640|P3|NOT COMPLETED|DB Treatment Period up to Week 24||3
8221884|NCT02047110|20275641|P2|NOT COMPLETED|DB Treatment Period up to Week 24||2
8221885|NCT02047110|20275642|P1|NOT COMPLETED|DB Treatment Period up to Week 24||5
8221886|NCT02047110|20275639|P4|COMPLETED|DB Treatment Period up to Week 24||38
8221887|NCT02047110|20275640|P3|COMPLETED|DB Treatment Period up to Week 24||36
8221888|NCT02047110|20275641|P2|COMPLETED|DB Treatment Period up to Week 24||38
8221889|NCT02047110|20275642|P1|COMPLETED|DB Treatment Period up to Week 24||35
8221982|NCT02046525|20275950|P2|STARTED|Overall Study||5
8221890|NCT02047110|20275639|P4|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8221891|NCT02047110|20275640|P3|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
8221892|NCT02047110|20275641|P2|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8221893|NCT02047110|20275642|P1|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8221894|NCT02047045|20275685|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||0
8221895|NCT02047045|20275686|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||0
8221896|NCT02047045|20275685|P2|COMPLETED|Follow-up Period (24 Weeks)||262
8221897|NCT02047045|20275686|P1|COMPLETED|Follow-up Period (24 Weeks)||265
8221898|NCT02047045|20275685|P2|STARTED|Follow-up Period (24 Weeks)||262
8221899|NCT02047045|20275686|P1|STARTED|Follow-up Period (24 Weeks)||265
8221900|NCT02047045|20275685|P2|NOT COMPLETED|Treatment Period (8 Weeks )||3
8221901|NCT02047045|20275686|P1|NOT COMPLETED|Treatment Period (8 Weeks )||7
8221902|NCT02047045|20275685|P2|COMPLETED|Treatment Period (8 Weeks )||262
8221903|NCT02047045|20275686|P1|COMPLETED|Treatment Period (8 Weeks )||265
8221904|NCT02047045|20275685|P2|STARTED|Treatment Period (8 Weeks )||265
8221905|NCT02047045|20275686|P1|STARTED|Treatment Period (8 Weeks )||272
8221906|NCT02047045|20275685|P2|NOT COMPLETED|Baseline||15
8221907|NCT02047045|20275686|P1|NOT COMPLETED|Baseline||8
8221908|NCT02047045|20275685|P2|COMPLETED|Baseline||265
8221909|NCT02047045|20275686|P1|COMPLETED|Baseline||272
8221910|NCT02047045|20275685|P2|STARTED|Baseline||280
8221911|NCT02047045|20275686|P1|STARTED|Baseline||280
8221912|NCT02047032|20275720|P2|NOT COMPLETED|Overall Study||15
8221913|NCT02047032|20275721|P1|NOT COMPLETED|Overall Study||5
8221914|NCT02047032|20275720|P2|COMPLETED|Overall Study||235
8221915|NCT02047032|20275721|P1|COMPLETED|Overall Study||245
8221916|NCT02047032|20275720|P2|STARTED|Overall Study||250
8221917|NCT02047032|20275721|P1|STARTED|Overall Study||250
8221918|NCT02046993|20275750|P2|NOT COMPLETED|Overall Study||11
8221919|NCT02046993|20275751|P1|NOT COMPLETED|Overall Study||3
8221920|NCT02046993|20275750|P2|COMPLETED|Overall Study||94
8221921|NCT02046993|20275751|P1|COMPLETED|Overall Study||102
8221922|NCT02046993|20275750|P2|6th Month|Overall Study||94
8221923|NCT02046993|20275751|P1|6th Month|Overall Study||102
8221924|NCT02046993|20275750|P2|3rd Month|Overall Study||97
8221925|NCT02046993|20275751|P1|3rd Month|Overall Study||104
8221926|NCT02046993|20275750|P2|STARTED|Overall Study||105
8221927|NCT02046993|20275751|P1|STARTED|Overall Study||105
8221928|NCT02046980|20275770|P3|NOT COMPLETED|Overall Study||1
8221929|NCT02046980|20275771|P2|NOT COMPLETED|Overall Study||5
8221930|NCT02046980|20275772|P1|NOT COMPLETED|Overall Study||2
8221931|NCT02046980|20275770|P3|COMPLETED|Overall Study||72
8221932|NCT02046980|20275771|P2|COMPLETED|Overall Study||67
8221933|NCT02046980|20275772|P1|COMPLETED|Overall Study||70
8221934|NCT02046980|20275770|P3|STARTED|Overall Study||73
8221935|NCT02046980|20275771|P2|STARTED|Overall Study||72
8221936|NCT02046980|20275772|P1|STARTED|Overall Study||72
8221937|NCT02046941|20275780|P1|NOT COMPLETED|Overall Study||7
8221938|NCT02046941|20275780|P1|COMPLETED|Overall Study||10
8221939|NCT02046941|20275780|P1|STARTED|Overall Study||17
8221940|NCT02046902|20275789|P3|NOT COMPLETED|Overall Study||0
8221941|NCT02046902|20275790|P2|NOT COMPLETED|Overall Study||0
8221942|NCT02046902|20275791|P1|NOT COMPLETED|Overall Study||0
8221943|NCT02046902|20275789|P3|COMPLETED|Overall Study||137
8221944|NCT02046902|20275790|P2|COMPLETED|Overall Study||113
8221945|NCT02046902|20275791|P1|COMPLETED|Overall Study||336
8221946|NCT02046902|20275789|P3|STARTED|Overall Study||137
8221947|NCT02046902|20275790|P2|STARTED|Overall Study||113
8221948|NCT02046902|20275791|P1|STARTED|Overall Study||336
8221949|NCT02046863|20275802|P1|NOT COMPLETED|Overall Study||0
8221950|NCT02046863|20275802|P1|COMPLETED|Overall Study||7
8221951|NCT02046863|20275802|P1|STARTED|Overall Study||7
8221952|NCT02046772|20275808|P2|NOT COMPLETED|Overall Study||0
8221953|NCT02046772|20275809|P1|NOT COMPLETED|Overall Study||0
8221954|NCT02046772|20275808|P2|COMPLETED|Overall Study||33
8221955|NCT02046772|20275809|P1|COMPLETED|Overall Study||30
8221956|NCT02046772|20275808|P2|STARTED|Overall Study||33
8221957|NCT02046772|20275809|P1|STARTED|Overall Study||30
8221958|NCT02046616|20275823|P1|NOT COMPLETED|8-Week FU Period||1
8221959|NCT02046616|20275823|P1|COMPLETED|8-Week FU Period||113
8221960|NCT02046616|20275823|P1|STARTED|8-Week FU Period||114
8221961|NCT02046616|20275823|P1|NOT COMPLETED|24-Week Treatment Period||19
8221962|NCT02046616|20275823|P1|COMPLETED|24-Week Treatment Period||114
8221963|NCT02046616|20275823|P1|STARTED|24-Week Treatment Period||133
8221964|NCT02046603|20275845|P2|NOT COMPLETED|Overall Study||75
8221965|NCT02046603|20275846|P1|NOT COMPLETED|Overall Study||15
8221966|NCT02046603|20275845|P2|COMPLETED|Overall Study||65
8221967|NCT02046603|20275846|P1|COMPLETED|Overall Study||7
8221968|NCT02046603|20275845|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
8221969|NCT02046603|20275846|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
8221970|NCT02046603|20275845|P2|STARTED|Overall Study||140
8221971|NCT02046603|20275846|P1|STARTED|Overall Study||22
8221972|NCT02046564|20275925|P2|NOT COMPLETED|Overall Study||20
8221973|NCT02046564|20275926|P1|NOT COMPLETED|Overall Study||15
8221974|NCT02046564|20275925|P2|COMPLETED|Overall Study||183
8221975|NCT02046564|20275926|P1|COMPLETED|Overall Study||194
8221976|NCT02046564|20275925|P2|STARTED|Overall Study||203
8221977|NCT02046564|20275926|P1|STARTED|Overall Study||209
8221978|NCT02046525|20275950|P2|NOT COMPLETED|Overall Study||0
8221979|NCT02046525|20275951|P1|NOT COMPLETED|Overall Study||0
8221980|NCT02046525|20275950|P2|COMPLETED|Overall Study||5
8221981|NCT02046525|20275951|P1|COMPLETED|Overall Study||5
8221983|NCT02046525|20275951|P1|STARTED|Overall Study||5
8221984|NCT02046382|20275959|P2|NOT COMPLETED|Overall Study||20
8221985|NCT02046382|20275960|P1|NOT COMPLETED|Overall Study||8
8221986|NCT02046382|20275959|P2|COMPLETED|Overall Study||47
8221987|NCT02046382|20275960|P1|COMPLETED|Overall Study||57
8221988|NCT02046382|20275959|P2|STARTED|Overall Study||67
8221989|NCT02046382|20275960|P1|STARTED|Overall Study||65
8221990|NCT02046369|20275974|P2|NOT COMPLETED|Overall Study||18
8221991|NCT02046369|20275975|P1|NOT COMPLETED|Overall Study||14
8221992|NCT02046369|20275974|P2|COMPLETED|Overall Study||156
8221993|NCT02046369|20275975|P1|COMPLETED|Overall Study||162
8221994|NCT02046369|20275974|P2|STARTED|Overall Study||174
8221995|NCT02046369|20275975|P1|STARTED|Overall Study||176
8221996|NCT02046317|20275993|P2|NOT COMPLETED|Overall Study||0
8221997|NCT02046317|20275994|P1|NOT COMPLETED|Overall Study||0
8221998|NCT02046317|20275993|P2|COMPLETED|Overall Study||8
8221999|NCT02046317|20275994|P1|COMPLETED|Overall Study||4
8222000|NCT02046317|20275993|P2|STARTED|Overall Study||8
8222001|NCT02046317|20275994|P1|STARTED|Overall Study||4
8222002|NCT02046265|20276006|P4|NOT COMPLETED|Overall Study||2
8222003|NCT02046265|20276007|P3|NOT COMPLETED|Overall Study||2
8222004|NCT02046265|20276008|P2|NOT COMPLETED|Overall Study||2
8222005|NCT02046265|20276009|P1|NOT COMPLETED|Overall Study||1
8222006|NCT02046265|20276006|P4|COMPLETED|Overall Study||12
8222007|NCT02046265|20276007|P3|COMPLETED|Overall Study||10
8222008|NCT02046265|20276008|P2|COMPLETED|Overall Study||15
8222009|NCT02046265|20276009|P1|COMPLETED|Overall Study||16
8222010|NCT02046265|20276006|P4|STARTED|Overall Study||14
8222011|NCT02046265|20276007|P3|STARTED|Overall Study||12
8222012|NCT02046265|20276008|P2|STARTED|Overall Study||17
8222013|NCT02046265|20276009|P1|STARTED|Overall Study||17
8222014|NCT02046226|20276019|P1|NOT COMPLETED|Overall Study||7
8222015|NCT02046226|20276019|P1|COMPLETED|Overall Study||0
8222016|NCT02046226|20276019|P1|STARTED|Overall Study||7
8222017|NCT02046200|20276026|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8222018|NCT02046200|20276027|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8222019|NCT02046200|20276026|P2|COMPLETED|Second Intervention (1 Day)||6
8222020|NCT02046200|20276027|P1|COMPLETED|Second Intervention (1 Day)||5
8222021|NCT02046200|20276026|P2|STARTED|Second Intervention (1 Day)||6
8222022|NCT02046200|20276027|P1|STARTED|Second Intervention (1 Day)||5
8222023|NCT02046200|20276026|P2|NOT COMPLETED|First Intervention (1 Day)||0
8222024|NCT02046200|20276027|P1|NOT COMPLETED|First Intervention (1 Day)||0
8222025|NCT02046200|20276026|P2|COMPLETED|First Intervention (1 Day)||6
8222026|NCT02046200|20276027|P1|COMPLETED|First Intervention (1 Day)||5
8222027|NCT02046200|20276026|P2|STARTED|First Intervention (1 Day)||6
8222028|NCT02046200|20276027|P1|STARTED|First Intervention (1 Day)||5
8222029|NCT02046148|20276067|P2|NOT COMPLETED|Overall Study||3
8222030|NCT02046148|20276068|P1|NOT COMPLETED|Overall Study||1
8222031|NCT02046148|20276067|P2|COMPLETED|Overall Study||23
8222032|NCT02046148|20276068|P1|COMPLETED|Overall Study||48
8222033|NCT02046148|20276067|P2|STARTED|Overall Study||26
8222034|NCT02046148|20276068|P1|STARTED|Overall Study||49
8222035|NCT02046135|20276130|P2|NOT COMPLETED|Overall Study||0
8222036|NCT02046135|20276131|P1|NOT COMPLETED|Overall Study||0
8222037|NCT02046135|20276130|P2|COMPLETED|Overall Study||25
8222038|NCT02046135|20276131|P1|COMPLETED|Overall Study||26
8222039|NCT02046135|20276130|P2|STARTED|Overall Study||25
8222040|NCT02046135|20276131|P1|STARTED|Overall Study||26
8222041|NCT02046122|20276145|P1|NOT COMPLETED|Overall Study||9
8222042|NCT02046122|20276145|P1|COMPLETED|Overall Study||8
8222043|NCT02046122|20276145|P1|STARTED|Overall Study||17
8222044|NCT02046070|20276159|P3|NOT COMPLETED|Overall Study||70
8222045|NCT02046070|20276160|P2|NOT COMPLETED|Overall Study||28
8222046|NCT02046070|20276161|P1|NOT COMPLETED|Overall Study||32
8222047|NCT02046070|20276159|P3|COMPLETED|Overall Study||8
8222048|NCT02046070|20276160|P2|COMPLETED|Overall Study||6
8222049|NCT02046070|20276161|P1|COMPLETED|Overall Study||4
8222050|NCT02046070|20276159|P3|STARTED|Overall Study||78
8222051|NCT02046070|20276160|P2|STARTED|Overall Study||34
8222052|NCT02046070|20276161|P1|STARTED|Overall Study||36
8222053|NCT02046005|20276208|P3|NOT COMPLETED|Overall Study||10
8222054|NCT02046005|20276209|P2|NOT COMPLETED|Overall Study||7
8222055|NCT02046005|20276210|P1|NOT COMPLETED|Overall Study||8
8222056|NCT02046005|20276208|P3|COMPLETED|Overall Study||70
8222057|NCT02046005|20276209|P2|COMPLETED|Overall Study||71
8222058|NCT02046005|20276210|P1|COMPLETED|Overall Study||72
8222059|NCT02046005|20276208|P3|STARTED|Overall Study||80
8222060|NCT02046005|20276209|P2|STARTED|Overall Study||78
8222061|NCT02046005|20276210|P1|STARTED|Overall Study||80
8222062|NCT02045979|20276221|P3|NOT COMPLETED|Overall Study||1
8222063|NCT02045979|20276222|P2|NOT COMPLETED|Overall Study||1
8222064|NCT02045979|20276223|P1|NOT COMPLETED|Overall Study||2
8222065|NCT02045979|20276221|P3|COMPLETED|Overall Study||107
8222066|NCT02045979|20276222|P2|COMPLETED|Overall Study||107
8222067|NCT02045979|20276223|P1|COMPLETED|Overall Study||106
8222068|NCT02045979|20276221|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
8222069|NCT02045979|20276222|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
8222070|NCT02045979|20276223|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
8222071|NCT02045875|20276260|P2|NOT COMPLETED|Overall Study||3
8222072|NCT02045875|20276261|P1|NOT COMPLETED|Overall Study||7
8222073|NCT02045875|20276260|P2|COMPLETED|Overall Study||20
8222074|NCT02045875|20276261|P1|COMPLETED|Overall Study||20
8222075|NCT02045875|20276260|P2|STARTED|Overall Study||23
8222076|NCT02045875|20276261|P1|STARTED|Overall Study||27
8222077|NCT02045862|20276272|P3|NOT COMPLETED|Overall Study||126
8222078|NCT02045862|20276273|P2|NOT COMPLETED|Overall Study||40
8222079|NCT02045862|20276274|P1|NOT COMPLETED|Overall Study||39
8222080|NCT02045862|20276272|P3|COMPLETED|Overall Study||1092
8222081|NCT02045862|20276273|P2|COMPLETED|Overall Study||265
8222082|NCT02045862|20276274|P1|COMPLETED|Overall Study||267
8222083|NCT02045862|20276272|P3|Treated|Overall Study||1210
8222084|NCT02045862|20276273|P2|Treated|Overall Study||303
8222085|NCT02045862|20276274|P1|Treated|Overall Study||306
8222086|NCT02045862|20276272|P3|STARTED|Overall Study||1218
8222087|NCT02045862|20276273|P2|STARTED|Overall Study||305
8222088|NCT02045862|20276274|P1|STARTED|Overall Study||306
8222089|NCT02045836|20276455|P2|NOT COMPLETED|Overall Study||14
8222090|NCT02045836|20276456|P1|NOT COMPLETED|Overall Study||9
8222091|NCT02045836|20276455|P2|COMPLETED|Overall Study||419
8222092|NCT02045836|20276456|P1|COMPLETED|Overall Study||423
8222093|NCT02045836|20276455|P2|STARTED|Overall Study||433
8222094|NCT02045836|20276456|P1|STARTED|Overall Study||432
8222095|NCT02045797|20276488|P3|NOT COMPLETED|Overall Study||1
8222096|NCT02045797|20276489|P2|NOT COMPLETED|Overall Study||7
8222097|NCT02045797|20276490|P1|NOT COMPLETED|Overall Study||7
8222098|NCT02045797|20276488|P3|COMPLETED|Overall Study||24
8222099|NCT02045797|20276489|P2|COMPLETED|Overall Study||32
8222100|NCT02045797|20276490|P1|COMPLETED|Overall Study||51
8222101|NCT02045797|20276488|P3|STARTED|Overall Study||25
8222102|NCT02045797|20276489|P2|STARTED|Overall Study||39
8222103|NCT02045797|20276490|P1|STARTED|Overall Study||58
8222104|NCT02045732|20276635|P2|NOT COMPLETED|Overall Study||1
8222105|NCT02045732|20276636|P1|NOT COMPLETED|Overall Study||1
8222106|NCT02045732|20276635|P2|COMPLETED|Overall Study||2
8222107|NCT02045732|20276636|P1|COMPLETED|Overall Study||0
8222108|NCT02045732|20276635|P2|STARTED|Overall Study||3
8222109|NCT02045732|20276636|P1|STARTED|Overall Study||1
8222110|NCT02045511|20276656|P2|NOT COMPLETED|Overall Study||0
8222111|NCT02045511|20276657|P1|NOT COMPLETED|Overall Study||0
8222112|NCT02045511|20276656|P2|COMPLETED|Overall Study||7
8222113|NCT02045511|20276657|P1|COMPLETED|Overall Study||8
8222114|NCT02045511|20276656|P2|STARTED|Overall Study||7
8222115|NCT02045511|20276657|P1|STARTED|Overall Study||8
8222116|NCT02045433|20276673|P1|NOT COMPLETED|Overall Study||1
8222117|NCT02045433|20276673|P1|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
8222118|NCT02045433|20276673|P1|STARTED|Overall Study||16
8222119|NCT02045277|20276681|P4|NOT COMPLETED|Overall Study||2
8222120|NCT02045277|20276682|P3|NOT COMPLETED|Overall Study||12
8222121|NCT02045277|20276683|P2|NOT COMPLETED|Overall Study||1
8222122|NCT02045277|20276684|P1|NOT COMPLETED|Overall Study||4
8222123|NCT02045277|20276681|P4|COMPLETED|Overall Study||29
8222124|NCT02045277|20276682|P3|COMPLETED|Overall Study||47
8222125|NCT02045277|20276683|P2|COMPLETED|Overall Study||62
8222126|NCT02045277|20276684|P1|COMPLETED|Overall Study||55
8222127|NCT02045277|20276681|P4|STARTED|Overall Study||31
8222128|NCT02045277|20276682|P3|STARTED|Overall Study||59
8222129|NCT02045277|20276683|P2|STARTED|Overall Study||63
8222130|NCT02045277|20276684|P1|STARTED|Overall Study||59
8222131|NCT02045264|20276698|P1|NOT COMPLETED|Overall Study||0
8222132|NCT02045264|20276698|P1|COMPLETED|Overall Study||12
8222133|NCT02045264|20276698|P1|STARTED|Overall Study||12
8222134|NCT02045238|20276715|P2|NOT COMPLETED|Overall Study||1
8222135|NCT02045238|20276716|P1|NOT COMPLETED|Overall Study||7
8222136|NCT02045238|20276715|P2|COMPLETED|Overall Study||14
8222137|NCT02045238|20276716|P1|COMPLETED|Overall Study||9
8222138|NCT02045238|20276715|P2|STARTED|Overall Study||15
8222139|NCT02045238|20276716|P1|STARTED|Overall Study||16
8222140|NCT02045212|20276726|P2|NOT COMPLETED|Overall Study||1
8222141|NCT02045212|20276727|P1|NOT COMPLETED|Overall Study||2
8222142|NCT02045212|20276726|P2|COMPLETED|Overall Study||8
8222143|NCT02045212|20276727|P1|COMPLETED|Overall Study||11
8222144|NCT02045212|20276726|P2|STARTED|Overall Study||9
8222145|NCT02045212|20276727|P1|STARTED|Overall Study||13
8222146|NCT02045108|20276743|P4|NOT COMPLETED|Overall Study||1
8222147|NCT02045108|20276744|P3|NOT COMPLETED|Overall Study||2
8222148|NCT02045108|20276745|P2|NOT COMPLETED|Overall Study||3
8222149|NCT02045108|20276746|P1|NOT COMPLETED|Overall Study||1
8222150|NCT02045108|20276743|P4|COMPLETED|Overall Study||19
8222151|NCT02045108|20276744|P3|COMPLETED|Overall Study||18
8222152|NCT02045108|20276745|P2|COMPLETED|Overall Study||12
8222153|NCT02045108|20276746|P1|COMPLETED|Overall Study||21
8222154|NCT02045108|20276743|P4|STARTED|Overall Study||20
8222155|NCT02045108|20276744|P3|STARTED|Overall Study||20
8222156|NCT02045108|20276745|P2|STARTED|Overall Study||15
8222157|NCT02045108|20276746|P1|STARTED|Overall Study||22
8222158|NCT02045095|20276792|P7|NOT COMPLETED|Overall Study||1
8222159|NCT02045095|20276793|P6|NOT COMPLETED|Overall Study||8
8222160|NCT02045095|20276794|P5|NOT COMPLETED|Overall Study||5
8222161|NCT02045095|20276795|P4|NOT COMPLETED|Overall Study||4
8222162|NCT02045095|20276796|P3|NOT COMPLETED|Overall Study||4
8222163|NCT02045095|20276797|P2|NOT COMPLETED|Overall Study||4
8222164|NCT02045095|20276798|P1|NOT COMPLETED|Overall Study||3
8222165|NCT02045095|20276792|P7|COMPLETED|Overall Study||0
8222166|NCT02045095|20276793|P6|COMPLETED|Overall Study||0
8222167|NCT02045095|20276794|P5|COMPLETED|Overall Study||0
8222168|NCT02045095|20276795|P4|COMPLETED|Overall Study||0
8222169|NCT02045095|20276796|P3|COMPLETED|Overall Study||0
8222170|NCT02045095|20276797|P2|COMPLETED|Overall Study||0
8222171|NCT02045095|20276798|P1|COMPLETED|Overall Study||0
8222172|NCT02045095|20276792|P7|STARTED|Overall Study||1
8222173|NCT02045095|20276793|P6|STARTED|Overall Study||8
8222174|NCT02045095|20276794|P5|STARTED|Overall Study||5
8222175|NCT02045095|20276795|P4|STARTED|Overall Study||4
8222176|NCT02045095|20276796|P3|STARTED|Overall Study||4
8222177|NCT02045095|20276797|P2|STARTED|Overall Study||4
8222178|NCT02045095|20276798|P1|STARTED|Overall Study||3
8222179|NCT02044991|20276942|P2|NOT COMPLETED|Overall Study||0
8222180|NCT02044991|20276943|P1|NOT COMPLETED|Overall Study||0
8222181|NCT02044991|20276942|P2|COMPLETED|Overall Study||0
8222182|NCT02044991|20276943|P1|COMPLETED|Overall Study||2
8222183|NCT02044991|20276942|P2|STARTED|Overall Study||0
8222184|NCT02044991|20276943|P1|STARTED|Overall Study||2
8222185|NCT02044874|20276956|P3|NOT COMPLETED|Overall Study||60
8222186|NCT02044874|20276957|P2|NOT COMPLETED|Overall Study||55
8222187|NCT02044874|20276958|P1|NOT COMPLETED|Overall Study||30
8222188|NCT02044874|20276956|P3|COMPLETED|Overall Study||140
8222189|NCT02044874|20276957|P2|COMPLETED|Overall Study||147
8222190|NCT02044874|20276958|P1|COMPLETED|Overall Study||171
8222191|NCT02044874|20276956|P3|STARTED|Overall Study||200
8222192|NCT02044874|20276957|P2|STARTED|Overall Study||202
8222193|NCT02044874|20276958|P1|STARTED|Overall Study||201
8222194|NCT02044848|20276980|P2|NOT COMPLETED|Overall Study||3
8222195|NCT02044848|20276981|P1|NOT COMPLETED|Overall Study||2
8222196|NCT02044848|20276980|P2|COMPLETED|Overall Study||0
8222197|NCT02044848|20276981|P1|COMPLETED|Overall Study||0
8222198|NCT02044848|20276980|P2|STARTED|Overall Study||3
8222199|NCT02044848|20276981|P1|STARTED|Overall Study||2
8222200|NCT02044822|20276987|P1|NOT COMPLETED|Overall Study||93
8222201|NCT02044822|20276987|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
8222202|NCT02044822|20276987|P1|STARTED|Overall Study||102
8222203|NCT02044796|20276999|P10|NOT COMPLETED|Overall Study||0
8222204|NCT02044796|20277000|P9|NOT COMPLETED|Overall Study||0
8222205|NCT02044796|20277001|P8|NOT COMPLETED|Overall Study||0
8222206|NCT02044796|20277002|P7|NOT COMPLETED|Overall Study||0
8222207|NCT02044796|20277003|P6|NOT COMPLETED|Overall Study||0
8222208|NCT02044796|20277004|P5|NOT COMPLETED|Overall Study||0
8222209|NCT02044796|20277005|P4|NOT COMPLETED|Overall Study||0
8222210|NCT02044796|20277006|P3|NOT COMPLETED|Overall Study||0
8222211|NCT02044796|20277007|P2|NOT COMPLETED|Overall Study||0
8222212|NCT02044796|20277008|P1|NOT COMPLETED|Overall Study||0
8222213|NCT02044796|20276999|P10|COMPLETED|Overall Study||34
8222214|NCT02044796|20277000|P9|COMPLETED|Overall Study||106
8222215|NCT02044796|20277001|P8|COMPLETED|Overall Study||4
8222216|NCT02044796|20277002|P7|COMPLETED|Overall Study||6
8222217|NCT02044796|20277003|P6|COMPLETED|Overall Study||6
8222218|NCT02044796|20277004|P5|COMPLETED|Overall Study||10
8222219|NCT02044796|20277005|P4|COMPLETED|Overall Study||6
8222220|NCT02044796|20277006|P3|COMPLETED|Overall Study||9
8222221|NCT02044796|20277007|P2|COMPLETED|Overall Study||9
8222222|NCT02044796|20277008|P1|COMPLETED|Overall Study||9
8222223|NCT02044796|20276999|P10|STARTED|Overall Study||34
8222224|NCT02044796|20277000|P9|STARTED|Overall Study||106
8222225|NCT02044796|20277001|P8|STARTED|Overall Study||4
8222226|NCT02044796|20277002|P7|STARTED|Overall Study||6
8222227|NCT02044796|20277003|P6|STARTED|Overall Study||6
8222228|NCT02044796|20277004|P5|STARTED|Overall Study||10
8222229|NCT02044796|20277005|P4|STARTED|Overall Study||6
8222230|NCT02044796|20277006|P3|STARTED|Overall Study||9
8222231|NCT02044796|20277007|P2|STARTED|Overall Study||9
8222232|NCT02044796|20277008|P1|STARTED|Overall Study||9
8222233|NCT02044510|20277029|P2|NOT COMPLETED|Overall Study||2
8222234|NCT02044510|20277030|P1|NOT COMPLETED|Overall Study||1
8222235|NCT02044510|20277029|P2|COMPLETED|Overall Study||14
8222236|NCT02044510|20277030|P1|COMPLETED|Overall Study||15
8222237|NCT02044510|20277029|P2|STARTED|Overall Study||16
8222238|NCT02044510|20277030|P1|STARTED|Overall Study||16
8222239|NCT02044458|20277038|P2|NOT COMPLETED|Overall Study||8
8222240|NCT02044458|20277039|P1|NOT COMPLETED|Overall Study||3
8222241|NCT02044458|20277038|P2|COMPLETED|Overall Study||61
8222242|NCT02044458|20277039|P1|COMPLETED|Overall Study||62
8222243|NCT02044458|20277038|P2|STARTED|Overall Study||69
8222244|NCT02044458|20277039|P1|STARTED|Overall Study||65
8222245|NCT02044419|20277052|P3|NOT COMPLETED|Third Intervention||0
8222246|NCT02044419|20277053|P2|NOT COMPLETED|Third Intervention||0
8222247|NCT02044419|20277054|P1|NOT COMPLETED|Third Intervention||0
8222248|NCT02044419|20277052|P3|COMPLETED|Third Intervention||10
8222249|NCT02044419|20277053|P2|COMPLETED|Third Intervention||9
8222250|NCT02044419|20277054|P1|COMPLETED|Third Intervention||11
8222251|NCT02044419|20277052|P3|STARTED|Third Intervention||10
8222252|NCT02044419|20277053|P2|STARTED|Third Intervention||9
8222253|NCT02044419|20277054|P1|STARTED|Third Intervention||11
8222254|NCT02044419|20277052|P3|NOT COMPLETED|Second Intervention||0
8222255|NCT02044419|20277053|P2|NOT COMPLETED|Second Intervention||0
8222256|NCT02044419|20277054|P1|NOT COMPLETED|Second Intervention||0
8222257|NCT02044419|20277052|P3|COMPLETED|Second Intervention||10
8222258|NCT02044419|20277053|P2|COMPLETED|Second Intervention||9
8222259|NCT02044419|20277054|P1|COMPLETED|Second Intervention||11
8222260|NCT02044419|20277052|P3|STARTED|Second Intervention||10
8222261|NCT02044419|20277053|P2|STARTED|Second Intervention||9
8222262|NCT02044419|20277054|P1|STARTED|Second Intervention||11
8222263|NCT02044419|20277052|P3|NOT COMPLETED|First Intervention||1
8222264|NCT02044419|20277053|P2|NOT COMPLETED|First Intervention||1
8222265|NCT02044419|20277054|P1|NOT COMPLETED|First Intervention||0
8222266|NCT02044419|20277052|P3|COMPLETED|First Intervention||10
8222267|NCT02044419|20277053|P2|COMPLETED|First Intervention||9
8222268|NCT02044419|20277054|P1|COMPLETED|First Intervention||11
8222269|NCT02044419|20277052|P3|STARTED|First Intervention||11
8222270|NCT02044419|20277053|P2|STARTED|First Intervention||10
8222271|NCT02044419|20277054|P1|STARTED|First Intervention||11
8222272|NCT02044393|20277079|P2|NOT COMPLETED|Period 2||0
8222273|NCT02044393|20277080|P1|NOT COMPLETED|Period 2||0
8222274|NCT02044393|20277079|P2|COMPLETED|Period 2||10
8222275|NCT02044393|20277080|P1|COMPLETED|Period 2||10
8222276|NCT02044393|20277079|P2|STARTED|Period 2||10
8222277|NCT02044393|20277080|P1|STARTED|Period 2||10
8222278|NCT02044393|20277079|P2|NOT COMPLETED|Period 1||0
8222279|NCT02044393|20277080|P1|NOT COMPLETED|Period 1||0
8222280|NCT02044393|20277079|P2|COMPLETED|Period 1||10
8222281|NCT02044393|20277080|P1|COMPLETED|Period 1||10
8222282|NCT02044393|20277079|P2|STARTED|Period 1||10
8222283|NCT02044393|20277080|P1|STARTED|Period 1||10
8222284|NCT02044380|20277093|P1|NOT COMPLETED|Overall Study||0
8222285|NCT02044380|20277093|P1|COMPLETED|Overall Study||14
8222286|NCT02044380|20277093|P1|STARTED|Overall Study|Started are the treated patients|14
8222287|NCT02044367|20277097|P6|NOT COMPLETED|Overall Study||0
8222288|NCT02044367|20277098|P5|NOT COMPLETED|Overall Study||0
8222289|NCT02044367|20277099|P4|NOT COMPLETED|Overall Study||0
8222290|NCT02044367|20277100|P3|NOT COMPLETED|Overall Study||0
8222291|NCT02044367|20277101|P2|NOT COMPLETED|Overall Study||0
8222292|NCT02044367|20277102|P1|NOT COMPLETED|Overall Study||0
8222293|NCT02044367|20277097|P6|COMPLETED|Overall Study||9
8222294|NCT02044367|20277098|P5|COMPLETED|Overall Study||9
8222295|NCT02044367|20277099|P4|COMPLETED|Overall Study||9
8222296|NCT02044367|20277100|P3|COMPLETED|Overall Study||9
8222297|NCT02044367|20277101|P2|COMPLETED|Overall Study||9
8222298|NCT02044367|20277102|P1|COMPLETED|Overall Study||9
8222299|NCT02044367|20277097|P6|STARTED|Overall Study||9
8222300|NCT02044367|20277098|P5|STARTED|Overall Study||9
8222301|NCT02044367|20277099|P4|STARTED|Overall Study||9
8222302|NCT02044367|20277100|P3|STARTED|Overall Study||9
8222303|NCT02044367|20277101|P2|STARTED|Overall Study||9
8222304|NCT02044367|20277102|P1|STARTED|Overall Study||9
8222305|NCT02044302|20277125|P2|NOT COMPLETED|Overall Study||0
8222306|NCT02044302|20277126|P1|NOT COMPLETED|Overall Study||2
8222307|NCT02044302|20277125|P2|COMPLETED|Overall Study||0
8222308|NCT02044302|20277126|P1|COMPLETED|Overall Study||0
8222309|NCT02044302|20277125|P2|STARTED|Overall Study||0
8222310|NCT02044302|20277126|P1|STARTED|Overall Study||2
8222311|NCT02044159|20277134|P2|NOT COMPLETED|Overall Study||4
8222312|NCT02044159|20277135|P1|NOT COMPLETED|Overall Study||4
8222313|NCT02044159|20277134|P2|COMPLETED|Overall Study||26
8222314|NCT02044159|20277135|P1|COMPLETED|Overall Study||23
8222315|NCT02044159|20277134|P2|STARTED|Overall Study||30
8222316|NCT02044159|20277135|P1|STARTED|Overall Study||27
8222317|NCT02044094|20277148|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
8222318|NCT02044094|20277148|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
8222319|NCT02044094|20277148|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
8222320|NCT02044094|20277148|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
8222321|NCT02044094|20277148|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
8222322|NCT02044094|20277148|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
8222323|NCT02044094|20277148|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
8222324|NCT02044094|20277148|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
8222325|NCT02043938|20277205|P1|NOT COMPLETED|Overall Study||10
8222326|NCT02043938|20277205|P1|COMPLETED|Overall Study||36
8222327|NCT02043938|20277205|P1|STARTED|Overall Study||46
8222328|NCT02043860|20277215|P1|NOT COMPLETED|Overall Study||0
8222329|NCT02043860|20277215|P1|COMPLETED|Overall Study||2
8222330|NCT02043860|20277215|P1|STARTED|Overall Study||2
8222331|NCT02043808|20277221|P2|NOT COMPLETED|Overall Study||0
8222332|NCT02043808|20277222|P1|NOT COMPLETED|Overall Study||0
8222333|NCT02043808|20277221|P2|COMPLETED|Overall Study||12793
8222334|NCT02043808|20277222|P1|COMPLETED|Overall Study||12793
8222335|NCT02043808|20277221|P2|STARTED|Overall Study||12793
8222336|NCT02043808|20277222|P1|STARTED|Overall Study||12793
8222337|NCT02043782|20277260|P6|NOT COMPLETED|Period 3||0
8222338|NCT02043782|20277261|P5|NOT COMPLETED|Period 3||0
8222339|NCT02043782|20277262|P4|NOT COMPLETED|Period 3||0
8222340|NCT02043782|20277263|P3|NOT COMPLETED|Period 3||0
8222341|NCT02043782|20277264|P2|NOT COMPLETED|Period 3||0
8222342|NCT02043782|20277265|P1|NOT COMPLETED|Period 3||0
8222343|NCT02043782|20277260|P6|COMPLETED|Period 3||6
8222344|NCT02043782|20277261|P5|COMPLETED|Period 3||6
8222345|NCT02043782|20277262|P4|COMPLETED|Period 3||6
8222346|NCT02043782|20277263|P3|COMPLETED|Period 3||6
8222347|NCT02043782|20277264|P2|COMPLETED|Period 3||6
8222348|NCT02043782|20277265|P1|COMPLETED|Period 3||7
8222349|NCT02043782|20277260|P6|STARTED|Period 3||6
8222350|NCT02043782|20277261|P5|STARTED|Period 3||6
8222351|NCT02043782|20277262|P4|STARTED|Period 3||6
8222352|NCT02043782|20277263|P3|STARTED|Period 3||6
8222353|NCT02043782|20277264|P2|STARTED|Period 3||6
8222354|NCT02043782|20277265|P1|STARTED|Period 3||7
8222355|NCT02043782|20277260|P6|NOT COMPLETED|Period 2||0
8222356|NCT02043782|20277261|P5|NOT COMPLETED|Period 2||0
8222357|NCT02043782|20277262|P4|NOT COMPLETED|Period 2||0
8222358|NCT02043782|20277263|P3|NOT COMPLETED|Period 2||0
8222359|NCT02043782|20277264|P2|NOT COMPLETED|Period 2||0
8222360|NCT02043782|20277265|P1|NOT COMPLETED|Period 2||0
8222361|NCT02043782|20277260|P6|COMPLETED|Period 2||6
8222362|NCT02043782|20277261|P5|COMPLETED|Period 2||6
8222363|NCT02043782|20277262|P4|COMPLETED|Period 2||6
8222364|NCT02043782|20277263|P3|COMPLETED|Period 2||6
8222365|NCT02043782|20277264|P2|COMPLETED|Period 2||6
8222366|NCT02043782|20277265|P1|COMPLETED|Period 2||7
8222367|NCT02043782|20277260|P6|STARTED|Period 2||6
8222368|NCT02043782|20277261|P5|STARTED|Period 2||6
8222369|NCT02043782|20277262|P4|STARTED|Period 2||6
8222370|NCT02043782|20277263|P3|STARTED|Period 2||6
8222371|NCT02043782|20277264|P2|STARTED|Period 2||6
8222372|NCT02043782|20277265|P1|STARTED|Period 2||7
8222373|NCT02043782|20277260|P6|NOT COMPLETED|Period 1||0
8222374|NCT02043782|20277261|P5|NOT COMPLETED|Period 1||0
8222375|NCT02043782|20277262|P4|NOT COMPLETED|Period 1||0
8222376|NCT02043782|20277263|P3|NOT COMPLETED|Period 1||1
8222377|NCT02043782|20277264|P2|NOT COMPLETED|Period 1||0
8222378|NCT02043782|20277265|P1|NOT COMPLETED|Period 1||0
8222379|NCT02043782|20277260|P6|COMPLETED|Period 1||6
8222380|NCT02043782|20277261|P5|COMPLETED|Period 1||6
8222381|NCT02043782|20277262|P4|COMPLETED|Period 1||6
8222382|NCT02043782|20277263|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
8222383|NCT02043782|20277264|P2|COMPLETED|Period 1||6
8222384|NCT02043782|20277265|P1|COMPLETED|Period 1||7
8222385|NCT02043782|20277260|P6|STARTED|Period 1||6
8222386|NCT02043782|20277261|P5|STARTED|Period 1||6
8222387|NCT02043782|20277262|P4|STARTED|Period 1||6
8222388|NCT02043782|20277263|P3|STARTED|Period 1||7
8222389|NCT02043782|20277264|P2|STARTED|Period 1||6
8222390|NCT02043782|20277265|P1|STARTED|Period 1||7
8222391|NCT02043704|20277275|P2|NOT COMPLETED|Overall Study||7
8222392|NCT02043704|20277276|P1|NOT COMPLETED|Overall Study||3
8222393|NCT02043704|20277275|P2|COMPLETED|Overall Study||43
8222394|NCT02043704|20277276|P1|COMPLETED|Overall Study||47
8222395|NCT02043704|20277275|P2|STARTED|Overall Study||50
8222396|NCT02043704|20277276|P1|STARTED|Overall Study||50
8222405|NCT02043652|20277325|P1|NOT COMPLETED|Overall Study||26
8222406|NCT02043652|20277325|P1|COMPLETED|Overall Study||93
8222407|NCT02043652|20277325|P1|STARTED|Overall Study||119
8222408|NCT02043574|20277332|P2|NOT COMPLETED|Overall Study||6
8222409|NCT02043574|20277333|P1|NOT COMPLETED|Overall Study||6
8222410|NCT02043574|20277332|P2|COMPLETED|Overall Study||20
8222411|NCT02043574|20277333|P1|COMPLETED|Overall Study||19
8222412|NCT02043574|20277332|P2|STARTED|Overall Study||26
8222413|NCT02043574|20277333|P1|STARTED|Overall Study||25
8222414|NCT02043548|20277345|P2|NOT COMPLETED|Overall Study||1
8222415|NCT02043548|20277346|P1|NOT COMPLETED|Overall Study||1
8222416|NCT02043548|20277345|P2|COMPLETED|Overall Study||17
8222417|NCT02043548|20277346|P1|COMPLETED|Overall Study||17
8222418|NCT02043548|20277345|P2|STARTED|Overall Study||18
8222419|NCT02043548|20277346|P1|STARTED|Overall Study||18
8222420|NCT02043509|20277364|P2|NOT COMPLETED|Baseline to 2nd Follow-up||72
8222421|NCT02043509|20277365|P1|NOT COMPLETED|Baseline to 2nd Follow-up||74
8222422|NCT02043509|20277364|P2|COMPLETED|Baseline to 2nd Follow-up||132
8222423|NCT02043509|20277365|P1|COMPLETED|Baseline to 2nd Follow-up||129
8222424|NCT02043509|20277364|P2|STARTED|Baseline to 2nd Follow-up||204
8222425|NCT02043509|20277365|P1|STARTED|Baseline to 2nd Follow-up||203
8222426|NCT02043509|20277364|P2|NOT COMPLETED|Baseline to 1st Follow-up||47
8222427|NCT02043509|20277365|P1|NOT COMPLETED|Baseline to 1st Follow-up||65
8222428|NCT02043509|20277364|P2|COMPLETED|Baseline to 1st Follow-up||157
8222429|NCT02043509|20277365|P1|COMPLETED|Baseline to 1st Follow-up||138
8222430|NCT02043509|20277364|P2|STARTED|Baseline to 1st Follow-up||204
8222431|NCT02043509|20277365|P1|STARTED|Baseline to 1st Follow-up||203
8222432|NCT02043379|20277390|P2|NOT COMPLETED|Overall Study||0
8222433|NCT02043379|20277391|P1|NOT COMPLETED|Overall Study||0
8222434|NCT02043379|20277390|P2|COMPLETED|Overall Study||20
8222435|NCT02043379|20277391|P1|COMPLETED|Overall Study||30
8222436|NCT02043379|20277390|P2|STARTED|Overall Study||20
8222437|NCT02043379|20277391|P1|STARTED|Overall Study||30
8222438|NCT02043366|20277453|P6|NOT COMPLETED|Overall Study||2
8222439|NCT02043366|20277454|P5|NOT COMPLETED|Overall Study||2
8222440|NCT02043366|20277455|P4|NOT COMPLETED|Overall Study||2
8222441|NCT02043366|20277456|P3|NOT COMPLETED|Overall Study||2
8222442|NCT02043366|20277457|P2|NOT COMPLETED|Overall Study||2
8222443|NCT02043366|20277458|P1|NOT COMPLETED|Overall Study||2
8222444|NCT02043366|20277453|P6|COMPLETED|Overall Study||28
8222445|NCT02043366|20277454|P5|COMPLETED|Overall Study||28
8222446|NCT02043366|20277455|P4|COMPLETED|Overall Study||28
8222447|NCT02043366|20277456|P3|COMPLETED|Overall Study||28
8222448|NCT02043366|20277457|P2|COMPLETED|Overall Study||28
8222449|NCT02043366|20277458|P1|COMPLETED|Overall Study||28
8222450|NCT02043366|20277453|P6|STARTED|Overall Study||30
8222451|NCT02043366|20277454|P5|STARTED|Overall Study||30
8222452|NCT02043366|20277455|P4|STARTED|Overall Study||30
8222453|NCT02043366|20277456|P3|STARTED|Overall Study||30
8222454|NCT02043366|20277457|P2|STARTED|Overall Study||30
8222455|NCT02043366|20277458|P1|STARTED|Overall Study||30
8222456|NCT02043301|20277481|P3|NOT COMPLETED|Overall Study||0
8222457|NCT02043301|20277482|P2|NOT COMPLETED|Overall Study||1
8222458|NCT02043301|20277483|P1|NOT COMPLETED|Overall Study||0
8222459|NCT02043301|20277481|P3|COMPLETED|Overall Study||25
8222460|NCT02043301|20277482|P2|COMPLETED|Overall Study||24
8222461|NCT02043301|20277483|P1|COMPLETED|Overall Study||25
8222462|NCT02043301|20277481|P3|STARTED|Overall Study||25
8222463|NCT02043301|20277482|P2|STARTED|Overall Study||25
8222464|NCT02043301|20277483|P1|STARTED|Overall Study||25
8222465|NCT02043197|20277541|P1|NOT COMPLETED|Overall Study||8
8222466|NCT02043197|20277541|P1|COMPLETED|Overall Study||292
8222467|NCT02043197|20277541|P1|STARTED|Overall Study||300
8222468|NCT02043145|20277565|P3|NOT COMPLETED|Overall Study||0
8222469|NCT02043145|20277566|P2|NOT COMPLETED|Overall Study||0
8222470|NCT02043145|20277567|P1|NOT COMPLETED|Overall Study||0
8222471|NCT02043145|20277565|P3|COMPLETED|Overall Study||425
8222472|NCT02043145|20277566|P2|COMPLETED|Overall Study||247
8222473|NCT02043145|20277567|P1|COMPLETED|Overall Study||55
8222474|NCT02043145|20277565|P3|STARTED|Overall Study||425
8222475|NCT02043145|20277566|P2|STARTED|Overall Study||247
8222476|NCT02043145|20277567|P1|STARTED|Overall Study||55
8222477|NCT02043132|20277580|P2|NOT COMPLETED|Overall Study||9
8222478|NCT02043132|20277581|P1|NOT COMPLETED|Overall Study||5
8222479|NCT02043132|20277580|P2|COMPLETED|Overall Study||49
8222480|NCT02043132|20277581|P1|COMPLETED|Overall Study||53
8222481|NCT02043132|20277580|P2|STARTED|Overall Study||58
8222482|NCT02043132|20277581|P1|STARTED|Overall Study||58
8222483|NCT02043015|20277601|P1|NOT COMPLETED|Overall Study||28
8222484|NCT02043015|20277601|P1|COMPLETED|Overall Study||87
8222485|NCT02043015|20277601|P1|STARTED|Overall Study||115
8222486|NCT02042950|20277614|P1|NOT COMPLETED|Overall Study||4
8222487|NCT02042950|20277614|P1|COMPLETED|Overall Study||0
8222488|NCT02042950|20277614|P1|STARTED|Overall Study||4
8222489|NCT02042924|20277620|P1|NOT COMPLETED|Overall Study||1
8222490|NCT02042924|20277620|P1|COMPLETED|Overall Study||1
8222491|NCT02042924|20277620|P1|STARTED|Overall Study||2
8222492|NCT02042911|20277626|P1|NOT COMPLETED|Overall Study||1
8222493|NCT02042911|20277626|P1|COMPLETED|Overall Study||9
8222494|NCT02042911|20277626|P1|STARTED|Overall Study||10
8222495|NCT02042872|20277640|P2|NOT COMPLETED|Overall Study||5
8222496|NCT02042872|20277641|P1|NOT COMPLETED|Overall Study||0
8222497|NCT02042872|20277640|P2|COMPLETED|Overall Study||8
8222498|NCT02042872|20277641|P1|COMPLETED|Overall Study||8
8222499|NCT02042872|20277640|P2|STARTED|Overall Study||13
8222500|NCT02042872|20277641|P1|STARTED|Overall Study||8
8222501|NCT02042534|20277651|P2|NOT COMPLETED|Overall Study||0
8222502|NCT02042534|20277652|P1|NOT COMPLETED|Overall Study||0
8222503|NCT02042534|20277651|P2|COMPLETED|Overall Study||94
8222504|NCT02042534|20277652|P1|COMPLETED|Overall Study||101
8222505|NCT02042534|20277651|P2|STARTED|Overall Study||94
8222506|NCT02042534|20277652|P1|STARTED|Overall Study||101
8222507|NCT02042443|20277668|P2|NOT COMPLETED|Overall Study||26
8222508|NCT02042443|20277669|P1|NOT COMPLETED|Overall Study||27
8222509|NCT02042443|20277668|P2|COMPLETED|Overall Study||0
8222510|NCT02042443|20277669|P1|COMPLETED|Overall Study||0
8222511|NCT02042443|20277668|P2|Eligible and Analyzable|Overall Study||20
8222512|NCT02042443|20277669|P1|Eligible and Analyzable|Overall Study||24
8222513|NCT02042443|20277668|P2|STARTED|Overall Study||26
8222514|NCT02042443|20277669|P1|STARTED|Overall Study||27
8222515|NCT02042404|20277681|P2|NOT COMPLETED|Overall Study||0
8222516|NCT02042404|20277682|P1|NOT COMPLETED|Overall Study||5
8222517|NCT02042404|20277681|P2|COMPLETED|Overall Study||5
8222518|NCT02042404|20277682|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
8222519|NCT02042404|20277681|P2|STARTED|Overall Study||5
8222520|NCT02042404|20277682|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
8222521|NCT02042274|20277693|P1|NOT COMPLETED|Overall Study||0
8222522|NCT02042274|20277693|P1|COMPLETED|Overall Study||12
8222523|NCT02042274|20277693|P1|STARTED|Overall Study||12
8222524|NCT02042183|20277700|P2|NOT COMPLETED|Overall Study||36
8222525|NCT02042183|20277701|P1|NOT COMPLETED|Overall Study||65
8222526|NCT02042183|20277700|P2|COMPLETED|Overall Study||166
8222527|NCT02042183|20277701|P1|COMPLETED|Overall Study||339
8222528|NCT02042183|20277700|P2|Modified Intent-to-treat (mITT)|Overall Study||195
8222529|NCT02042183|20277701|P1|Modified Intent-to-treat (mITT)|Overall Study||399
8222530|NCT02042183|20277700|P2|Safety Population|Overall Study||195
8222531|NCT02042183|20277701|P1|Safety Population|Overall Study||400
8222532|NCT02042183|20277700|P2|STARTED|Overall Study||202
8222533|NCT02042183|20277701|P1|STARTED|Overall Study||404
8222534|NCT02042131|20277712|P3|NOT COMPLETED|Overall Study||0
8222535|NCT02042131|20277713|P2|NOT COMPLETED|Overall Study||0
8222536|NCT02042131|20277714|P1|NOT COMPLETED|Overall Study||0
8222537|NCT02042131|20277712|P3|COMPLETED|Overall Study||33
8222538|NCT02042131|20277713|P2|COMPLETED|Overall Study||32
8222539|NCT02042131|20277714|P1|COMPLETED|Overall Study||32
8222540|NCT02042131|20277712|P3|STARTED|Overall Study||33
8222541|NCT02042131|20277713|P2|STARTED|Overall Study||32
8222542|NCT02042131|20277714|P1|STARTED|Overall Study||32
8222543|NCT02042014|20277731|P1|NOT COMPLETED|Overall Study||8
8222544|NCT02042014|20277731|P1|COMPLETED|Overall Study||0
8222545|NCT02042014|20277731|P1|STARTED|Overall Study||8
8222546|NCT02041962|20277737|P2|NOT COMPLETED|Overall Study||84
8222547|NCT02041962|20277738|P1|NOT COMPLETED|Overall Study||81
8222548|NCT02041962|20277737|P2|COMPLETED|Overall Study||31
8222549|NCT02041962|20277738|P1|COMPLETED|Overall Study||42
8222550|NCT02041962|20277737|P2|Participants Completing 12 mo. f/up|Overall Study||31
8222551|NCT02041962|20277738|P1|Participants Completing 12 mo. f/up|Overall Study||42
8222552|NCT02041962|20277737|P2|Participants Completing 6 mo. f/up|Overall Study||44
8222553|NCT02041962|20277738|P1|Participants Completing 6 mo. f/up|Overall Study||69
8222554|NCT02041962|20277737|P2|STARTED|Overall Study||115
8222555|NCT02041962|20277738|P1|STARTED|Overall Study||123
8222556|NCT02041702|20277748|P2|NOT COMPLETED|Overall Study||9
8222557|NCT02041702|20277749|P1|NOT COMPLETED|Overall Study||11
8222558|NCT02041702|20277748|P2|COMPLETED|Overall Study||134
8222559|NCT02041702|20277749|P1|COMPLETED|Overall Study||129
8222560|NCT02041702|20277748|P2|Post MRI Scan/ Post Waiting|Overall Study||140
8222561|NCT02041702|20277749|P1|Post MRI Scan/ Post Waiting|Overall Study||129
8222562|NCT02041702|20277748|P2|Pre MRI Scan/ Pre Waitng|Overall Study||140
8222563|NCT02041702|20277749|P1|Pre MRI Scan/ Pre Waitng|Overall Study||129
8222564|NCT02041702|20277748|P2|STARTED|Overall Study||143
8222565|NCT02041702|20277749|P1|STARTED|Overall Study||140
8222566|NCT02041533|20277764|P2|NOT COMPLETED|Overall Study||258
8222567|NCT02041533|20277765|P1|NOT COMPLETED|Overall Study||228
8222568|NCT02041533|20277764|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
8222569|NCT02041533|20277765|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
8222570|NCT02041533|20277764|P2|Began Treatment|Overall Study||263
8222571|NCT02041533|20277765|P1|Began Treatment|Overall Study||267
8222572|NCT02041533|20277764|P2|STARTED|Overall Study||270
8222573|NCT02041533|20277765|P1|STARTED|Overall Study||271
8222574|NCT02041520|20277787|P2|NOT COMPLETED|Overall Study||7
8222575|NCT02041520|20277788|P1|NOT COMPLETED|Overall Study||6
8222576|NCT02041520|20277787|P2|COMPLETED|Overall Study||28
8222577|NCT02041520|20277788|P1|COMPLETED|Overall Study||29
8222578|NCT02041520|20277787|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
8222579|NCT02041520|20277788|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
8222580|NCT02041377|20277808|P1|NOT COMPLETED|Overall Study||0
8222581|NCT02041377|20277808|P1|COMPLETED|Overall Study||134
8222582|NCT02041377|20277808|P1|STARTED|Overall Study||134
8222583|NCT02041325|20277818|P2|NOT COMPLETED|Overall Study||3
8222584|NCT02041325|20277819|P1|NOT COMPLETED|Overall Study||3
8222585|NCT02041325|20277818|P2|COMPLETED|Overall Study||13
8222586|NCT02041325|20277819|P1|COMPLETED|Overall Study||19
8222587|NCT02041325|20277818|P2|STARTED|Overall Study||16
8222588|NCT02041325|20277819|P1|STARTED|Overall Study||22
8222589|NCT02041286|20277831|P1|NOT COMPLETED|Overall Study||1
8222590|NCT02041286|20277831|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
8222591|NCT02041286|20277831|P1|STARTED|Overall Study||136
8222592|NCT02041221|20277845|P6|NOT COMPLETED|Part 2||0
8222593|NCT02041221|20277846|P5|NOT COMPLETED|Part 2||0
8222594|NCT02041221|20277847|P4|NOT COMPLETED|Part 2||0
8222595|NCT02041221|20277848|P3|NOT COMPLETED|Part 2||1
8222596|NCT02041221|20277849|P2|NOT COMPLETED|Part 2||0
8222597|NCT02041221|20277850|P1|NOT COMPLETED|Part 2||0
8222598|NCT02041221|20277845|P6|COMPLETED|Part 2||6
8222599|NCT02041221|20277846|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8222600|NCT02041221|20277847|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8222601|NCT02041221|20277848|P3|COMPLETED|Part 2||5
8222602|NCT02041221|20277849|P2|COMPLETED|Part 2||6
8222603|NCT02041221|20277850|P1|COMPLETED|Part 2||6
8222604|NCT02041221|20277845|P6|STARTED|Part 2||6
8222605|NCT02041221|20277846|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8222606|NCT02041221|20277847|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
8222607|NCT02041221|20277848|P3|STARTED|Part 2||6
8222608|NCT02041221|20277849|P2|STARTED|Part 2||6
8222609|NCT02041221|20277850|P1|STARTED|Part 2||6
8222610|NCT02041221|20277845|P6|NOT COMPLETED|Part 1||0
8222611|NCT02041221|20277846|P5|NOT COMPLETED|Part 1||0
8222612|NCT02041221|20277847|P4|NOT COMPLETED|Part 1||0
8222613|NCT02041221|20277848|P3|NOT COMPLETED|Part 1||0
8222614|NCT02041221|20277849|P2|NOT COMPLETED|Part 1||0
8222615|NCT02041221|20277850|P1|NOT COMPLETED|Part 1||0
8222616|NCT02041221|20277845|P6|COMPLETED|Part 1||10
8222617|NCT02041221|20277846|P5|COMPLETED|Part 1||6
8222618|NCT02041221|20277847|P4|COMPLETED|Part 1||6
8222619|NCT02041221|20277848|P3|COMPLETED|Part 1||6
8222620|NCT02041221|20277849|P2|COMPLETED|Part 1||6
8222621|NCT02041221|20277850|P1|COMPLETED|Part 1||6
8222622|NCT02041221|20277845|P6|STARTED|Part 1||10
8222623|NCT02041221|20277846|P5|STARTED|Part 1||6
8222624|NCT02041221|20277847|P4|STARTED|Part 1||6
8222625|NCT02041221|20277848|P3|STARTED|Part 1||6
8222626|NCT02041221|20277849|P2|STARTED|Part 1||6
8222627|NCT02041221|20277850|P1|STARTED|Part 1||6
8222628|NCT02041104|20277866|P2|NOT COMPLETED|Overall Study||7
8222629|NCT02041104|20277867|P1|NOT COMPLETED|Overall Study||1
8222630|NCT02041104|20277866|P2|COMPLETED|Overall Study||16
8222631|NCT02041104|20277867|P1|COMPLETED|Overall Study||27
8222632|NCT02041104|20277866|P2|STARTED|Overall Study||23
8222633|NCT02041104|20277867|P1|STARTED|Overall Study||28
8222634|NCT02041091|20277907|P2|NOT COMPLETED|Optional Safety Extension Period||82
8222635|NCT02041091|20277908|P1|NOT COMPLETED|Optional Safety Extension Period||85
8222636|NCT02041091|20277907|P2|COMPLETED|Optional Safety Extension Period||0
8222637|NCT02041091|20277908|P1|COMPLETED|Optional Safety Extension Period||0
8222638|NCT02041091|20277907|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
8222639|NCT02041091|20277908|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
8222640|NCT02041091|20277907|P2|NOT COMPLETED|Treatment||23
8222641|NCT02041091|20277908|P1|NOT COMPLETED|Treatment||22
8222642|NCT02041091|20277907|P2|COMPLETED|Treatment||91
8222643|NCT02041091|20277908|P1|COMPLETED|Treatment||90
8222644|NCT02041091|20277907|P2|Participated in Follow Up|Treatment||96
8222645|NCT02041091|20277908|P1|Participated in Follow Up|Treatment||106
8222646|NCT02041091|20277907|P2|Received At Least One Dose of Study Drug|Treatment||114
8222647|NCT02041091|20277908|P1|Received At Least One Dose of Study Drug|Treatment||112
8222648|NCT02041091|20277907|P2|STARTED|Treatment||114
8222649|NCT02041091|20277908|P1|STARTED|Treatment||112
8222650|NCT02040870|20277930|P1|NOT COMPLETED|Overall Study||103
8222651|NCT02040870|20277930|P1|COMPLETED|Overall Study||0
8222652|NCT02040870|20277930|P1|Discontinue From Study|Overall Study||26
8222653|NCT02040870|20277930|P1|Entered Survival Follow-up|Overall Study||75
8222654|NCT02040870|20277930|P1|Entered Post-treatment Follow-up|Overall Study||2
8222655|NCT02040870|20277930|P1|STARTED|Overall Study||103
8222656|NCT02040857|20277951|P1|NOT COMPLETED|Overall Study||60
8222657|NCT02040857|20277951|P1|COMPLETED|Overall Study||102
8222658|NCT02040857|20277951|P1|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
8222659|NCT02040857|20277951|P1|STARTED|Overall Study||162
8222660|NCT02040844|20277964|P3|NOT COMPLETED|Overall Study||47
8222661|NCT02040844|20277965|P2|NOT COMPLETED|Overall Study||39
8222662|NCT02040844|20277966|P1|NOT COMPLETED|Overall Study||50
8222663|NCT02040844|20277964|P3|COMPLETED|Overall Study||97
8222664|NCT02040844|20277965|P2|COMPLETED|Overall Study||109
8222665|NCT02040844|20277966|P1|COMPLETED|Overall Study||88
8222666|NCT02040844|20277964|P3|STARTED|Overall Study||144
8222667|NCT02040844|20277965|P2|STARTED|Overall Study||148
8222668|NCT02040844|20277966|P1|STARTED|Overall Study||138
8222669|NCT02040805|20277991|P2|NOT COMPLETED|Overall Study||50
8222670|NCT02040805|20277992|P1|NOT COMPLETED|Overall Study||42
8222671|NCT02040805|20277991|P2|COMPLETED|Overall Study||113
8222672|NCT02040805|20277992|P1|COMPLETED|Overall Study||118
8222673|NCT02040805|20277991|P2|STARTED|Overall Study||163
8222674|NCT02040805|20277992|P1|STARTED|Overall Study||160
8222675|NCT02040792|20278009|P5|NOT COMPLETED|Overall Study||7
8222676|NCT02040792|20278010|P4|NOT COMPLETED|Overall Study||7
8222677|NCT02040792|20278011|P3|NOT COMPLETED|Overall Study||3
8222678|NCT02040792|20278012|P2|NOT COMPLETED|Overall Study||3
8222679|NCT02040792|20278013|P1|NOT COMPLETED|Overall Study||6
8222680|NCT02040792|20278009|P5|COMPLETED|Overall Study||67
8222681|NCT02040792|20278010|P4|COMPLETED|Overall Study||64
8222682|NCT02040792|20278011|P3|COMPLETED|Overall Study||68
8222683|NCT02040792|20278012|P2|COMPLETED|Overall Study||65
8222684|NCT02040792|20278013|P1|COMPLETED|Overall Study||64
8222685|NCT02040792|20278009|P5|STARTED|Overall Study||74
8222686|NCT02040792|20278010|P4|STARTED|Overall Study||71
8222687|NCT02040792|20278011|P3|STARTED|Overall Study||71
8222688|NCT02040792|20278012|P2|STARTED|Overall Study||68
8222689|NCT02040792|20278013|P1|STARTED|Overall Study||70
8222690|NCT02040779|20278028|P3|NOT COMPLETED|Overall Study||4
8222691|NCT02040779|20278029|P2|NOT COMPLETED|Overall Study||7
8222692|NCT02040779|20278030|P1|NOT COMPLETED|Overall Study||12
8222693|NCT02040779|20278028|P3|COMPLETED|Overall Study||88
8222694|NCT02040779|20278029|P2|COMPLETED|Overall Study||83
8222695|NCT02040779|20278030|P1|COMPLETED|Overall Study||79
8222696|NCT02040779|20278028|P3|Full Analysis Set (FAS)|Overall Study||92
8222697|NCT02040779|20278029|P2|Full Analysis Set (FAS)|Overall Study||88
8222698|NCT02040779|20278030|P1|Full Analysis Set (FAS)|Overall Study||90
8222699|NCT02040779|20278028|P3|STARTED|Overall Study||92
8222700|NCT02040779|20278029|P2|STARTED|Overall Study||90
8222701|NCT02040779|20278030|P1|STARTED|Overall Study||91
8222702|NCT02040766|20278070|P5|NOT COMPLETED|Overall Study||13
8222703|NCT02040766|20278071|P4|NOT COMPLETED|Overall Study||13
8222704|NCT02040766|20278072|P3|NOT COMPLETED|Overall Study||12
8222705|NCT02040766|20278073|P2|NOT COMPLETED|Overall Study||10
8222706|NCT02040766|20278074|P1|NOT COMPLETED|Overall Study||18
8222707|NCT02040766|20278070|P5|COMPLETED|Overall Study||112
8222708|NCT02040766|20278071|P4|COMPLETED|Overall Study||112
8222709|NCT02040766|20278072|P3|COMPLETED|Overall Study||113
8222710|NCT02040766|20278073|P2|COMPLETED|Overall Study||116
8222711|NCT02040766|20278074|P1|COMPLETED|Overall Study||109
8222712|NCT02040766|20278070|P5|STARTED|Overall Study||125
8222713|NCT02040766|20278071|P4|STARTED|Overall Study||125
8222714|NCT02040766|20278072|P3|STARTED|Overall Study||125
8222715|NCT02040766|20278073|P2|STARTED|Overall Study||126
8222716|NCT02040766|20278074|P1|STARTED|Overall Study||127
8222717|NCT02040623|20278115|P3|NOT COMPLETED|Overall Study||2
8222718|NCT02040623|20278116|P2|NOT COMPLETED|Overall Study||6
8222719|NCT02040623|20278117|P1|NOT COMPLETED|Overall Study||4
8222720|NCT02040623|20278115|P3|COMPLETED|Overall Study||10
8222721|NCT02040623|20278116|P2|COMPLETED|Overall Study||6
8222722|NCT02040623|20278117|P1|COMPLETED|Overall Study||7
8222723|NCT02040623|20278115|P3|STARTED|Overall Study||12
8222724|NCT02040623|20278116|P2|STARTED|Overall Study||12
8222725|NCT02040623|20278117|P1|STARTED|Overall Study||11
8222726|NCT02040584|20278127|P2|NOT COMPLETED|Overall Study||32
8222727|NCT02040584|20278128|P1|NOT COMPLETED|Overall Study||35
8222728|NCT02040584|20278127|P2|COMPLETED|Overall Study||74
8222729|NCT02040584|20278128|P1|COMPLETED|Overall Study||70
8222730|NCT02040584|20278127|P2|STARTED|Overall Study||106
8222731|NCT02040584|20278128|P1|STARTED|Overall Study||105
8222732|NCT02040532|20278161|P1|NOT COMPLETED|Overall Study||12
8222733|NCT02040532|20278161|P1|COMPLETED|Overall Study||20
8222734|NCT02040532|20278161|P1|Received at Least One Dose of Medication|Overall Study||26
8222735|NCT02040532|20278161|P1|STARTED|Overall Study||32
8222736|NCT02040428|20278174|P2|NOT COMPLETED|Overall Study||4
8222737|NCT02040428|20278175|P1|NOT COMPLETED|Overall Study||5
8222738|NCT02040428|20278174|P2|COMPLETED|Overall Study||77
8222739|NCT02040428|20278175|P1|COMPLETED|Overall Study||70
8222740|NCT02040428|20278174|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
8222741|NCT02040428|20278175|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
8222742|NCT02040428|20278174|P2|STARTED|Overall Study||81
8222743|NCT02040428|20278175|P1|STARTED|Overall Study||75
8222744|NCT02040259|20278187|P1|NOT COMPLETED|Overall Study||363
8222745|NCT02040259|20278187|P1|COMPLETED|Overall Study||1645
8222746|NCT02040259|20278187|P1|STARTED|Overall Study||2008
8222747|NCT02040116|20278195|P1|NOT COMPLETED|Overall Study||0
8222748|NCT02040116|20278195|P1|COMPLETED|Overall Study||19
8222749|NCT02040116|20278195|P1|STARTED|Overall Study||19
8222750|NCT02040077|20278206|P3|NOT COMPLETED|Overall Study||0
8222751|NCT02040077|20278207|P2|NOT COMPLETED|Overall Study||0
8222752|NCT02040077|20278208|P1|NOT COMPLETED|Overall Study||0
8222753|NCT02040077|20278206|P3|COMPLETED|Overall Study||25
8222754|NCT02040077|20278207|P2|COMPLETED|Overall Study||24
8222755|NCT02040077|20278208|P1|COMPLETED|Overall Study||27
8222756|NCT02040077|20278206|P3|STARTED|Overall Study||25
8222757|NCT02040077|20278207|P2|STARTED|Overall Study||24
8222758|NCT02040077|20278208|P1|STARTED|Overall Study||27
8222759|NCT02039947|20278223|P4|NOT COMPLETED|Overall Study||0
8222760|NCT02039947|20278224|P3|NOT COMPLETED|Overall Study||0
8222761|NCT02039947|20278225|P2|NOT COMPLETED|Overall Study||0
8222762|NCT02039947|20278226|P1|NOT COMPLETED|Overall Study||0
8222763|NCT02039947|20278223|P4|COMPLETED|Overall Study||17
8222764|NCT02039947|20278224|P3|COMPLETED|Overall Study||16
8222765|NCT02039947|20278225|P2|COMPLETED|Overall Study||16
8222766|NCT02039947|20278226|P1|COMPLETED|Overall Study||76
8222767|NCT02039947|20278223|P4|STARTED|Overall Study||17
8222768|NCT02039947|20278224|P3|STARTED|Overall Study||16
8222769|NCT02039947|20278225|P2|STARTED|Overall Study||16
8222770|NCT02039947|20278226|P1|STARTED|Overall Study||76
8222771|NCT02039908|20278261|P4|NOT COMPLETED|Phase 2-School Year||8
8222772|NCT02039908|20278262|P3|NOT COMPLETED|Phase 2-School Year||12
8222773|NCT02039908|20278263|P2|NOT COMPLETED|Phase 2-School Year||0
8222774|NCT02039908|20278264|P1|NOT COMPLETED|Phase 2-School Year||0
8222775|NCT02039908|20278261|P4|COMPLETED|Phase 2-School Year||116
8222776|NCT02039908|20278262|P3|COMPLETED|Phase 2-School Year||109
8222777|NCT02039908|20278263|P2|COMPLETED|Phase 2-School Year||0
8222778|NCT02039908|20278264|P1|COMPLETED|Phase 2-School Year||0
8222779|NCT02039908|20278261|P4|STARTED|Phase 2-School Year||124
8222780|NCT02039908|20278262|P3|STARTED|Phase 2-School Year||121
8222781|NCT02039908|20278263|P2|STARTED|Phase 2-School Year||0
8222782|NCT02039908|20278264|P1|STARTED|Phase 2-School Year||0
8222783|NCT02039908|20278261|P4|NOT COMPLETED|Phase 1-Summer||0
8222784|NCT02039908|20278262|P3|NOT COMPLETED|Phase 1-Summer||0
8222785|NCT02039908|20278263|P2|NOT COMPLETED|Phase 1-Summer||6
8222786|NCT02039908|20278264|P1|NOT COMPLETED|Phase 1-Summer||13
8222787|NCT02039908|20278261|P4|COMPLETED|Phase 1-Summer||0
8222788|NCT02039908|20278262|P3|COMPLETED|Phase 1-Summer||0
8222789|NCT02039908|20278263|P2|COMPLETED|Phase 1-Summer||132
8222790|NCT02039908|20278264|P1|COMPLETED|Phase 1-Summer||116
8222791|NCT02039908|20278261|P4|STARTED|Phase 1-Summer||0
8222792|NCT02039908|20278262|P3|STARTED|Phase 1-Summer||0
8222793|NCT02039908|20278263|P2|STARTED|Phase 1-Summer||138
8222794|NCT02039908|20278264|P1|STARTED|Phase 1-Summer||129
8222795|NCT02039856|20278278|P2|NOT COMPLETED|Overall Study||853
8222796|NCT02039856|20278279|P1|NOT COMPLETED|Overall Study||2027
8222797|NCT02039856|20278278|P2|COMPLETED|Overall Study||327
8222798|NCT02039856|20278279|P1|COMPLETED|Overall Study||693
8222799|NCT02039856|20278278|P2|Total 24-month Completed|Overall Study||327
8222800|NCT02039856|20278279|P1|Total 24-month Completed|Overall Study||693
8222801|NCT02039856|20278278|P2|24-month Completed Providers/Staff|Overall Study||105
8222802|NCT02039856|20278279|P1|24-month Completed Providers/Staff|Overall Study||174
8222803|NCT02039856|20278278|P2|24-month Started Providers/Staff|Overall Study||304
8222804|NCT02039856|20278279|P1|24-month Started Providers/Staff|Overall Study||565
8222805|NCT02039856|20278278|P2|24-month Completed - Patients|Overall Study||222
8222806|NCT02039856|20278279|P1|24-month Completed - Patients|Overall Study||519
8222807|NCT02039856|20278278|P2|24-month Started - Patients|Overall Study||442
8222808|NCT02039856|20278279|P1|24-month Started - Patients|Overall Study||953
8222809|NCT02039856|20278278|P2|24-month Started|Overall Study||746
8222810|NCT02039856|20278279|P1|24-month Started|Overall Study||1518
8222811|NCT02039856|20278278|P2|12-month Providers/Staff|Overall Study||0
8222812|NCT02039856|20278279|P1|12-month Providers/Staff|Overall Study||0
8222813|NCT02039856|20278278|P2|12-month Completed- Patients|Overall Study||241
8222814|NCT02039856|20278279|P1|12-month Completed- Patients|Overall Study||580
8222815|NCT02039856|20278278|P2|12-month Started-patients|Overall Study||442
8222816|NCT02039856|20278279|P1|12-month Started-patients|Overall Study||953
8222817|NCT02039856|20278278|P2|Total Baseline Completed|Overall Study||536
8222818|NCT02039856|20278279|P1|Total Baseline Completed|Overall Study||1147
8222819|NCT02039856|20278278|P2|Baseline Completed -Providers/Staff|Overall Study||94
8222820|NCT02039856|20278279|P1|Baseline Completed -Providers/Staff|Overall Study||194
8222821|NCT02039856|20278278|P2|Baseline Started - Providers/Staff|Overall Study||261
8222822|NCT02039856|20278279|P1|Baseline Started - Providers/Staff|Overall Study||537
8222823|NCT02039856|20278278|P2|Baseline Completed - Patients|Overall Study||442
8222824|NCT02039856|20278279|P1|Baseline Completed - Patients|Overall Study||953
8222825|NCT02039856|20278278|P2|Baseline Started - Patients|Overall Study||919
8222826|NCT02039856|20278279|P1|Baseline Started - Patients|Overall Study||2183
8222827|NCT02039856|20278278|P2|STARTED|Overall Study||1180
8222828|NCT02039856|20278279|P1|STARTED|Overall Study||2720
8222829|NCT02039817|20278301|P2|NOT COMPLETED|Overall Study||0
8222830|NCT02039817|20278302|P1|NOT COMPLETED|Overall Study||0
8222831|NCT02039817|20278301|P2|COMPLETED|Overall Study||8
8222832|NCT02039817|20278302|P1|COMPLETED|Overall Study||8
8222833|NCT02039817|20278301|P2|STARTED|Overall Study||8
8222834|NCT02039817|20278302|P1|STARTED|Overall Study||8
8222835|NCT02039778|20278311|P1|NOT COMPLETED|Overall Study||4
8222836|NCT02039778|20278311|P1|COMPLETED|Overall Study||0
8222837|NCT02039778|20278311|P1|STARTED|Overall Study||4
8222848|NCT02039687|20278334|P4|NOT COMPLETED|Overall Study||0
8222849|NCT02039687|20278335|P3|NOT COMPLETED|Overall Study||3
8222850|NCT02039687|20278336|P2|NOT COMPLETED|Overall Study||1
8222851|NCT02039687|20278337|P1|NOT COMPLETED|Overall Study||0
8222852|NCT02039687|20278334|P4|COMPLETED|Overall Study||16
8222853|NCT02039687|20278335|P3|COMPLETED|Overall Study||13
8222854|NCT02039687|20278336|P2|COMPLETED|Overall Study||15
8222855|NCT02039687|20278337|P1|COMPLETED|Overall Study||16
8222856|NCT02039687|20278334|P4|STARTED|Overall Study||16
8222857|NCT02039687|20278335|P3|STARTED|Overall Study||16
8222858|NCT02039687|20278336|P2|STARTED|Overall Study||16
8222859|NCT02039687|20278337|P1|STARTED|Overall Study||16
8222860|NCT02039674|20278377|P14|NOT COMPLETED|Overall Study||33
8222861|NCT02039674|20278378|P13|NOT COMPLETED|Overall Study||63
8222862|NCT02039674|20278379|P12|NOT COMPLETED|Overall Study||60
8222863|NCT02039674|20278380|P11|NOT COMPLETED|Overall Study||7
8222864|NCT02039674|20278381|P10|NOT COMPLETED|Overall Study||12
8222865|NCT02039674|20278382|P9|NOT COMPLETED|Overall Study||12
8222866|NCT02039674|20278383|P8|NOT COMPLETED|Overall Study||3
8222867|NCT02039674|20278384|P7|NOT COMPLETED|Overall Study||3
8222868|NCT02039674|20278385|P6|NOT COMPLETED|Overall Study||12
8222869|NCT02039674|20278386|P5|NOT COMPLETED|Overall Study||12
8222870|NCT02039674|20278387|P4|NOT COMPLETED|Overall Study||13
8222871|NCT02039674|20278388|P3|NOT COMPLETED|Overall Study||12
8222872|NCT02039674|20278389|P2|NOT COMPLETED|Overall Study||12
8222873|NCT02039674|20278390|P1|NOT COMPLETED|Overall Study||12
8222874|NCT02039674|20278377|P14|COMPLETED|Overall Study||0
8222875|NCT02039674|20278378|P13|COMPLETED|Overall Study||0
8222876|NCT02039674|20278379|P12|COMPLETED|Overall Study||0
8222877|NCT02039674|20278380|P11|COMPLETED|Overall Study||0
8222878|NCT02039674|20278381|P10|COMPLETED|Overall Study||0
8222879|NCT02039674|20278382|P9|COMPLETED|Overall Study||0
8222880|NCT02039674|20278383|P8|COMPLETED|Overall Study||0
8222881|NCT02039674|20278384|P7|COMPLETED|Overall Study||0
8222882|NCT02039674|20278385|P6|COMPLETED|Overall Study||0
8222883|NCT02039674|20278386|P5|COMPLETED|Overall Study||0
8222884|NCT02039674|20278387|P4|COMPLETED|Overall Study||0
8222885|NCT02039674|20278388|P3|COMPLETED|Overall Study||0
8222886|NCT02039674|20278389|P2|COMPLETED|Overall Study||0
8222887|NCT02039674|20278390|P1|COMPLETED|Overall Study||1
8222888|NCT02039674|20278377|P14|Treated|Overall Study||33
8222889|NCT02039674|20278378|P13|Treated|Overall Study||62
8222890|NCT02039674|20278379|P12|Treated|Overall Study||59
8222891|NCT02039674|20278380|P11|Treated|Overall Study||7
8222892|NCT02039674|20278381|P10|Treated|Overall Study||12
8222893|NCT02039674|20278382|P9|Treated|Overall Study||12
8222894|NCT02039674|20278383|P8|Treated|Overall Study||3
8222895|NCT02039674|20278384|P7|Treated|Overall Study||3
8222896|NCT02039674|20278385|P6|Treated|Overall Study||12
8222897|NCT02039674|20278386|P5|Treated|Overall Study||12
8222898|NCT02039674|20278387|P4|Treated|Overall Study||13
8222899|NCT02039674|20278388|P3|Treated|Overall Study||11
8222900|NCT02039674|20278389|P2|Treated|Overall Study||12
8222901|NCT02039674|20278390|P1|Treated|Overall Study||13
8222902|NCT02039674|20278377|P14|STARTED|Overall Study||33
8222903|NCT02039674|20278378|P13|STARTED|Overall Study||63
8222904|NCT02039674|20278379|P12|STARTED|Overall Study||60
8222905|NCT02039674|20278380|P11|STARTED|Overall Study||7
8222906|NCT02039674|20278381|P10|STARTED|Overall Study||12
8222907|NCT02039674|20278382|P9|STARTED|Overall Study||12
8222908|NCT02039674|20278383|P8|STARTED|Overall Study||3
8222909|NCT02039674|20278384|P7|STARTED|Overall Study||3
8222910|NCT02039674|20278385|P6|STARTED|Overall Study||12
8222911|NCT02039674|20278386|P5|STARTED|Overall Study||12
8222912|NCT02039674|20278387|P4|STARTED|Overall Study||13
8222913|NCT02039674|20278388|P3|STARTED|Overall Study||12
8222914|NCT02039674|20278389|P2|STARTED|Overall Study||12
8222915|NCT02039674|20278390|P1|STARTED|Overall Study||13
8222916|NCT02039505|20278432|P7|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
8222917|NCT02039505|20278433|P6|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222918|NCT02039505|20278434|P5|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222919|NCT02039505|20278435|P4|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222920|NCT02039505|20278436|P3|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222921|NCT02039505|20278437|P2|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222922|NCT02039505|20278438|P1|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222923|NCT02039505|20278432|P7|COMPLETED|Open-Label (Week 10 up to Week 154)||188
8222924|NCT02039505|20278433|P6|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222925|NCT02039505|20278434|P5|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222926|NCT02039505|20278435|P4|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222927|NCT02039505|20278436|P3|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222928|NCT02039505|20278437|P2|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222929|NCT02039505|20278438|P1|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222930|NCT02039505|20278432|P7|STARTED|Open-Label (Week 10 up to Week 154)||259
8222931|NCT02039505|20278433|P6|STARTED|Open-Label (Week 10 up to Week 154)||0
8222932|NCT02039505|20278434|P5|STARTED|Open-Label (Week 10 up to Week 154)||0
8222933|NCT02039505|20278435|P4|STARTED|Open-Label (Week 10 up to Week 154)||0
8222934|NCT02039505|20278436|P3|STARTED|Open-Label (Week 10 up to Week 154)||0
8222935|NCT02039505|20278437|P2|STARTED|Open-Label (Week 10 up to Week 154)||0
8222936|NCT02039505|20278438|P1|STARTED|Open-Label (Week 10 up to Week 154)||0
8222937|NCT02039505|20278432|P7|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222938|NCT02039505|20278433|P6|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
8222939|NCT02039505|20278434|P5|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
8222940|NCT02039505|20278435|P4|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
8222941|NCT02039505|20278436|P3|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222942|NCT02039505|20278437|P2|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222943|NCT02039505|20278438|P1|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222944|NCT02039505|20278432|P7|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222945|NCT02039505|20278433|P6|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
8222946|NCT02039505|20278434|P5|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
8222947|NCT02039505|20278435|P4|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
8222948|NCT02039505|20278436|P3|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222949|NCT02039505|20278437|P2|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222950|NCT02039505|20278438|P1|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222951|NCT02039505|20278432|P7|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222952|NCT02039505|20278433|P6|STARTED|Maintenance Phase (Week 14 to Week 60)||26
8222953|NCT02039505|20278434|P5|STARTED|Maintenance Phase (Week 14 to Week 60)||41
8222954|NCT02039505|20278435|P4|STARTED|Maintenance Phase (Week 14 to Week 60)||42
8222955|NCT02039505|20278436|P3|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222956|NCT02039505|20278437|P2|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222957|NCT02039505|20278438|P1|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222958|NCT02039505|20278432|P7|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222959|NCT02039505|20278433|P6|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222960|NCT02039505|20278434|P5|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222961|NCT02039505|20278435|P4|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222962|NCT02039505|20278436|P3|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
8222963|NCT02039505|20278437|P2|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
8222964|NCT02039505|20278438|P1|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
8222965|NCT02039505|20278432|P7|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222966|NCT02039505|20278433|P6|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222967|NCT02039505|20278434|P5|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222968|NCT02039505|20278435|P4|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222969|NCT02039505|20278436|P3|COMPLETED|Induction Phase (Week 0 to Week 14)||36
8222970|NCT02039505|20278437|P2|COMPLETED|Induction Phase (Week 0 to Week 14)||155
8222971|NCT02039505|20278438|P1|COMPLETED|Induction Phase (Week 0 to Week 14)||78
8222972|NCT02039505|20278432|P7|STARTED|Induction Phase (Week 0 to Week 14)||0
8222973|NCT02039505|20278433|P6|STARTED|Induction Phase (Week 0 to Week 14)||0
8222974|NCT02039505|20278434|P5|STARTED|Induction Phase (Week 0 to Week 14)||0
8222975|NCT02039505|20278435|P4|STARTED|Induction Phase (Week 0 to Week 14)||0
8222976|NCT02039505|20278436|P3|STARTED|Induction Phase (Week 0 to Week 14)||46
8222977|NCT02039505|20278437|P2|STARTED|Induction Phase (Week 0 to Week 14)||164
8222978|NCT02039505|20278438|P1|STARTED|Induction Phase (Week 0 to Week 14)||82
8222979|NCT02039427|20278514|P4|NOT COMPLETED|Overall Study||5
8222980|NCT02039427|20278515|P3|NOT COMPLETED|Overall Study||3
8222981|NCT02039427|20278516|P2|NOT COMPLETED|Overall Study||1
8222982|NCT02039427|20278517|P1|NOT COMPLETED|Overall Study||3
8222983|NCT02039427|20278514|P4|COMPLETED|Overall Study||43
8222984|NCT02039427|20278515|P3|COMPLETED|Overall Study||45
8222985|NCT02039427|20278516|P2|COMPLETED|Overall Study||47
8222986|NCT02039427|20278517|P1|COMPLETED|Overall Study||45
8222987|NCT02039427|20278514|P4|STARTED|Overall Study||48
8222988|NCT02039427|20278515|P3|STARTED|Overall Study||48
8222989|NCT02039427|20278516|P2|STARTED|Overall Study||48
8222990|NCT02039427|20278517|P1|STARTED|Overall Study||48
8222991|NCT02039414|20278537|P2|NOT COMPLETED|Overall Study||2
8222992|NCT02039414|20278538|P1|NOT COMPLETED|Overall Study||6
8222993|NCT02039414|20278537|P2|COMPLETED|Overall Study||16
8222994|NCT02039414|20278538|P1|COMPLETED|Overall Study||16
8222995|NCT02039414|20278537|P2|STARTED|Overall Study||18
8222996|NCT02039414|20278538|P1|STARTED|Overall Study||22
8222997|NCT02039375|20278550|P1|NOT COMPLETED|Overall Study||2
8222998|NCT02039375|20278550|P1|COMPLETED|Overall Study||33
8222999|NCT02039375|20278550|P1|STARTED|Overall Study||35
8223000|NCT02039219|20278561|P2|NOT COMPLETED|Follow up||1
8223001|NCT02039219|20278562|P1|NOT COMPLETED|Follow up||0
8223002|NCT02039219|20278561|P2|COMPLETED|Follow up||5
8223003|NCT02039219|20278562|P1|COMPLETED|Follow up||7
8223004|NCT02039219|20278561|P2|STARTED|Follow up||6
8223005|NCT02039219|20278562|P1|STARTED|Follow up||7
8223006|NCT02039219|20278561|P2|NOT COMPLETED|Treatment||2
8223007|NCT02039219|20278562|P1|NOT COMPLETED|Treatment||4
8223008|NCT02039219|20278561|P2|COMPLETED|Treatment||6
8223009|NCT02039219|20278562|P1|COMPLETED|Treatment||7
8223010|NCT02039219|20278561|P2|STARTED|Treatment||8
8223011|NCT02039219|20278562|P1|STARTED|Treatment||11
8223012|NCT02039115|20278602|P2|NOT COMPLETED|Overall Study||0
8223013|NCT02039115|20278603|P1|NOT COMPLETED|Overall Study||0
8223014|NCT02039115|20278602|P2|COMPLETED|Overall Study||0
8223015|NCT02039115|20278603|P1|COMPLETED|Overall Study||1
8223016|NCT02039115|20278602|P2|STARTED|Overall Study||0
8223017|NCT02039115|20278603|P1|STARTED|Overall Study||1
8223018|NCT02038959|20278611|P2|NOT COMPLETED|Overall Study||8
8223019|NCT02038959|20278612|P1|NOT COMPLETED|Overall Study||6
8223020|NCT02038959|20278611|P2|COMPLETED|Overall Study||89
8223021|NCT02038959|20278612|P1|COMPLETED|Overall Study||92
8223022|NCT02038959|20278611|P2|STARTED|Overall Study||97
8223023|NCT02038959|20278612|P1|STARTED|Overall Study||98
8223024|NCT02038946|20278638|P1|NOT COMPLETED|Overall Study||11
8223025|NCT02038946|20278638|P1|COMPLETED|Overall Study||81
8223026|NCT02038946|20278638|P1|STARTED|Overall Study||92
8223027|NCT02038933|20278649|P1|NOT COMPLETED|Follow-up||19
8223028|NCT02038933|20278649|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
8223029|NCT02038933|20278649|P1|STARTED|Follow-up||121
8223030|NCT02038933|20278649|P1|NOT COMPLETED|Treatment||114
8223031|NCT02038933|20278649|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
8223032|NCT02038933|20278649|P1|STARTED|Treatment||121
8223033|NCT02038920|20278670|P6|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
8223034|NCT02038920|20278671|P5|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223035|NCT02038920|20278672|P4|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223036|NCT02038920|20278673|P3|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223037|NCT02038920|20278674|P2|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223038|NCT02038920|20278675|P1|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223039|NCT02038920|20278670|P6|COMPLETED|Open Label Cohort (Week 10 to 154)||57
8223040|NCT02038920|20278671|P5|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223041|NCT02038920|20278672|P4|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223042|NCT02038920|20278673|P3|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223043|NCT02038920|20278674|P2|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223044|NCT02038920|20278675|P1|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223045|NCT02038920|20278670|P6|STARTED|Open Label Cohort (Week 10 to 154)||134
8223046|NCT02038920|20278671|P5|STARTED|Open Label Cohort (Week 10 to 154)||0
8223047|NCT02038920|20278672|P4|STARTED|Open Label Cohort (Week 10 to 154)||0
8223048|NCT02038920|20278673|P3|STARTED|Open Label Cohort (Week 10 to 154)||0
8223049|NCT02038920|20278674|P2|STARTED|Open Label Cohort (Week 10 to 154)||0
8223050|NCT02038920|20278675|P1|STARTED|Open Label Cohort (Week 10 to 154)||0
8223051|NCT02038920|20278670|P6|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223052|NCT02038920|20278671|P5|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
8223053|NCT02038920|20278672|P4|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
8223054|NCT02038920|20278673|P3|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
8223055|NCT02038920|20278674|P2|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223056|NCT02038920|20278675|P1|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223057|NCT02038920|20278670|P6|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223058|NCT02038920|20278671|P5|COMPLETED|Maintenance Phase (Week 14 to 60)||5
8223059|NCT02038920|20278672|P4|COMPLETED|Maintenance Phase (Week 14 to 60)||4
8223060|NCT02038920|20278673|P3|COMPLETED|Maintenance Phase (Week 14 to 60)||7
8223061|NCT02038920|20278674|P2|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223062|NCT02038920|20278675|P1|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223063|NCT02038920|20278670|P6|STARTED|Maintenance Phase (Week 14 to 60)||0
8223064|NCT02038920|20278671|P5|STARTED|Maintenance Phase (Week 14 to 60)||17
8223065|NCT02038920|20278672|P4|STARTED|Maintenance Phase (Week 14 to 60)||12
8223066|NCT02038920|20278673|P3|STARTED|Maintenance Phase (Week 14 to 60)||12
8223067|NCT02038920|20278674|P2|STARTED|Maintenance Phase (Week 14 to 60)||0
8223068|NCT02038920|20278675|P1|STARTED|Maintenance Phase (Week 14 to 60)||0
8223069|NCT02038920|20278670|P6|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223070|NCT02038920|20278671|P5|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223071|NCT02038920|20278672|P4|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223072|NCT02038920|20278673|P3|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223073|NCT02038920|20278674|P2|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
8223074|NCT02038920|20278675|P1|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
8223075|NCT02038920|20278670|P6|COMPLETED|Induction Phase (Week 0 to 14)||0
8223076|NCT02038920|20278671|P5|COMPLETED|Induction Phase (Week 0 to 14)||0
8223077|NCT02038920|20278672|P4|COMPLETED|Induction Phase (Week 0 to 14)||0
8223078|NCT02038920|20278673|P3|COMPLETED|Induction Phase (Week 0 to 14)||0
8223079|NCT02038920|20278674|P2|COMPLETED|Induction Phase (Week 0 to 14)||66
8223080|NCT02038920|20278675|P1|COMPLETED|Induction Phase (Week 0 to 14)||73
8223081|NCT02038920|20278670|P6|STARTED|Induction Phase (Week 0 to 14)||0
8223082|NCT02038920|20278671|P5|STARTED|Induction Phase (Week 0 to 14)||0
8223083|NCT02038920|20278672|P4|STARTED|Induction Phase (Week 0 to 14)||0
8223084|NCT02038920|20278673|P3|STARTED|Induction Phase (Week 0 to 14)||0
8223085|NCT02038920|20278674|P2|STARTED|Induction Phase (Week 0 to 14)||78
8223086|NCT02038920|20278675|P1|STARTED|Induction Phase (Week 0 to 14)||79
8223087|NCT02038907|20278752|P14|NOT COMPLETED|Overall Study||0
8223088|NCT02038907|20278753|P13|NOT COMPLETED|Overall Study||0
8223089|NCT02038907|20278754|P12|NOT COMPLETED|Overall Study||0
8223090|NCT02038907|20278755|P11|NOT COMPLETED|Overall Study||2
8223091|NCT02038907|20278756|P10|NOT COMPLETED|Overall Study||0
8223092|NCT02038907|20278757|P9|NOT COMPLETED|Overall Study||0
8223093|NCT02038907|20278758|P8|NOT COMPLETED|Overall Study||0
8223094|NCT02038907|20278759|P7|NOT COMPLETED|Overall Study||0
8223095|NCT02038907|20278760|P6|NOT COMPLETED|Overall Study||0
8223096|NCT02038907|20278761|P5|NOT COMPLETED|Overall Study||0
8223097|NCT02038907|20278762|P4|NOT COMPLETED|Overall Study||0
8223098|NCT02038907|20278763|P3|NOT COMPLETED|Overall Study||0
8223099|NCT02038907|20278764|P2|NOT COMPLETED|Overall Study||0
8223100|NCT02038907|20278765|P1|NOT COMPLETED|Overall Study||0
8223101|NCT02038907|20278752|P14|COMPLETED|Overall Study||31
8223102|NCT02038907|20278753|P13|COMPLETED|Overall Study||29
8223103|NCT02038907|20278754|P12|COMPLETED|Overall Study||28
8223104|NCT02038907|20278755|P11|COMPLETED|Overall Study||27
8223105|NCT02038907|20278756|P10|COMPLETED|Overall Study||30
8223106|NCT02038907|20278757|P9|COMPLETED|Overall Study||29
8223107|NCT02038907|20278758|P8|COMPLETED|Overall Study||32
8223108|NCT02038907|20278759|P7|COMPLETED|Overall Study||30
8223109|NCT02038907|20278760|P6|COMPLETED|Overall Study||31
8223110|NCT02038907|20278761|P5|COMPLETED|Overall Study||30
8223111|NCT02038907|20278762|P4|COMPLETED|Overall Study||31
8223112|NCT02038907|20278763|P3|COMPLETED|Overall Study||30
8223113|NCT02038907|20278764|P2|COMPLETED|Overall Study||30
8223114|NCT02038907|20278765|P1|COMPLETED|Overall Study||30
8223115|NCT02038907|20278752|P14|STARTED|Overall Study||31
8223116|NCT02038907|20278753|P13|STARTED|Overall Study||29
8223117|NCT02038907|20278754|P12|STARTED|Overall Study||28
8223118|NCT02038907|20278755|P11|STARTED|Overall Study||29
8223119|NCT02038907|20278756|P10|STARTED|Overall Study||30
8223120|NCT02038907|20278757|P9|STARTED|Overall Study||29
8223121|NCT02038907|20278758|P8|STARTED|Overall Study||32
8223122|NCT02038907|20278759|P7|STARTED|Overall Study||30
8223123|NCT02038907|20278760|P6|STARTED|Overall Study||31
8223124|NCT02038907|20278761|P5|STARTED|Overall Study||30
8223125|NCT02038907|20278762|P4|STARTED|Overall Study||31
8223126|NCT02038907|20278763|P3|STARTED|Overall Study||30
8223127|NCT02038907|20278764|P2|STARTED|Overall Study||30
8223128|NCT02038907|20278765|P1|STARTED|Overall Study||30
8223129|NCT02038894|20279296|P3|NOT COMPLETED|Overall Study||0
8223130|NCT02038894|20279297|P2|NOT COMPLETED|Overall Study||0
8223131|NCT02038894|20279298|P1|NOT COMPLETED|Overall Study||0
8223132|NCT02038894|20279296|P3|COMPLETED|Overall Study||61
8223133|NCT02038894|20279297|P2|COMPLETED|Overall Study||58
8223134|NCT02038894|20279298|P1|COMPLETED|Overall Study||60
8223135|NCT02038894|20279296|P3|STARTED|Overall Study||61
8223136|NCT02038894|20279297|P2|STARTED|Overall Study||58
8223137|NCT02038894|20279298|P1|STARTED|Overall Study||60
8223138|NCT02038881|20279316|P3|NOT COMPLETED|Overall Study||1
8223139|NCT02038881|20279317|P2|NOT COMPLETED|Overall Study||0
8223140|NCT02038881|20279318|P1|NOT COMPLETED|Overall Study||3
8223141|NCT02038881|20279316|P3|COMPLETED|Overall Study||30
8223142|NCT02038881|20279317|P2|COMPLETED|Overall Study||29
8223143|NCT02038881|20279318|P1|COMPLETED|Overall Study||24
8223144|NCT02038881|20279316|P3|STARTED|Overall Study||31
8223145|NCT02038881|20279317|P2|STARTED|Overall Study||29
8223146|NCT02038881|20279318|P1|STARTED|Overall Study||27
8223147|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 6||0
8223148|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 6||0
8223149|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 6||0
8223150|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 6||0
8223151|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 6||0
8223152|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 6||0
8223153|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 6||0
8223154|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 6||0
8223155|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 6||0
8223156|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 6||1
8223157|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 6||0
8223158|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 6||0
8223159|NCT02038829|20279391|P12|COMPLETED|Treatment Period 6||8
8223160|NCT02038829|20279392|P11|COMPLETED|Treatment Period 6||7
8223161|NCT02038829|20279393|P10|COMPLETED|Treatment Period 6||8
8223162|NCT02038829|20279394|P9|COMPLETED|Treatment Period 6||7
8223163|NCT02038829|20279395|P8|COMPLETED|Treatment Period 6||8
8223164|NCT02038829|20279396|P7|COMPLETED|Treatment Period 6||7
8223165|NCT02038829|20279397|P6|COMPLETED|Treatment Period 6||7
8223166|NCT02038829|20279398|P5|COMPLETED|Treatment Period 6||7
8223167|NCT02038829|20279399|P4|COMPLETED|Treatment Period 6||8
8223168|NCT02038829|20279400|P3|COMPLETED|Treatment Period 6||7
8223169|NCT02038829|20279401|P2|COMPLETED|Treatment Period 6||7
8223170|NCT02038829|20279402|P1|COMPLETED|Treatment Period 6||7
8223171|NCT02038829|20279391|P12|STARTED|Treatment Period 6||8
8223172|NCT02038829|20279392|P11|STARTED|Treatment Period 6||7
8223173|NCT02038829|20279393|P10|STARTED|Treatment Period 6||8
8223174|NCT02038829|20279394|P9|STARTED|Treatment Period 6||7
8223175|NCT02038829|20279395|P8|STARTED|Treatment Period 6||8
8223176|NCT02038829|20279396|P7|STARTED|Treatment Period 6||7
8223177|NCT02038829|20279397|P6|STARTED|Treatment Period 6||7
8223178|NCT02038829|20279398|P5|STARTED|Treatment Period 6||7
8223179|NCT02038829|20279399|P4|STARTED|Treatment Period 6||8
8223180|NCT02038829|20279400|P3|STARTED|Treatment Period 6||8
8223181|NCT02038829|20279401|P2|STARTED|Treatment Period 6||7
8223182|NCT02038829|20279402|P1|STARTED|Treatment Period 6||7
8223183|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 5||0
8223184|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 5||0
8223185|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 5||0
8223186|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 5||0
8223187|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 5||0
8223188|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 5||0
8223189|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 5||0
8223190|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 5||0
8223191|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 5||0
8223192|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 5||0
8223193|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 5||0
8223194|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 5||0
8223195|NCT02038829|20279391|P12|COMPLETED|Washout Period 5||8
8223196|NCT02038829|20279392|P11|COMPLETED|Washout Period 5||7
8223197|NCT02038829|20279393|P10|COMPLETED|Washout Period 5||8
8223198|NCT02038829|20279394|P9|COMPLETED|Washout Period 5||7
8223199|NCT02038829|20279395|P8|COMPLETED|Washout Period 5||8
8223200|NCT02038829|20279396|P7|COMPLETED|Washout Period 5||7
8223201|NCT02038829|20279397|P6|COMPLETED|Washout Period 5||7
8223202|NCT02038829|20279398|P5|COMPLETED|Washout Period 5||7
8223203|NCT02038829|20279399|P4|COMPLETED|Washout Period 5||8
8223204|NCT02038829|20279400|P3|COMPLETED|Washout Period 5||8
8223205|NCT02038829|20279401|P2|COMPLETED|Washout Period 5||7
8223206|NCT02038829|20279402|P1|COMPLETED|Washout Period 5||7
8223207|NCT02038829|20279391|P12|STARTED|Washout Period 5||8
8223208|NCT02038829|20279392|P11|STARTED|Washout Period 5||7
8223209|NCT02038829|20279393|P10|STARTED|Washout Period 5||8
8223210|NCT02038829|20279394|P9|STARTED|Washout Period 5||7
8223211|NCT02038829|20279395|P8|STARTED|Washout Period 5||8
8223212|NCT02038829|20279396|P7|STARTED|Washout Period 5||7
8223213|NCT02038829|20279397|P6|STARTED|Washout Period 5||7
8223214|NCT02038829|20279398|P5|STARTED|Washout Period 5||7
8223215|NCT02038829|20279399|P4|STARTED|Washout Period 5||8
8223216|NCT02038829|20279400|P3|STARTED|Washout Period 5||8
8223217|NCT02038829|20279401|P2|STARTED|Washout Period 5||7
8223218|NCT02038829|20279402|P1|STARTED|Washout Period 5||7
8223219|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 5||0
8223220|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 5||0
8223221|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 5||0
8223222|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 5||0
8223223|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 5||0
8223224|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 5||0
8223225|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 5||0
8223226|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 5||0
8223227|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 5||0
8223228|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 5||0
8223229|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 5||0
8223230|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 5||0
8223231|NCT02038829|20279391|P12|COMPLETED|Treatment Period 5||8
8223232|NCT02038829|20279392|P11|COMPLETED|Treatment Period 5||7
8223233|NCT02038829|20279393|P10|COMPLETED|Treatment Period 5||8
8223234|NCT02038829|20279394|P9|COMPLETED|Treatment Period 5||7
8223235|NCT02038829|20279395|P8|COMPLETED|Treatment Period 5||8
8223236|NCT02038829|20279396|P7|COMPLETED|Treatment Period 5||7
8223237|NCT02038829|20279397|P6|COMPLETED|Treatment Period 5||7
8223238|NCT02038829|20279398|P5|COMPLETED|Treatment Period 5||7
8223239|NCT02038829|20279399|P4|COMPLETED|Treatment Period 5||8
8223240|NCT02038829|20279400|P3|COMPLETED|Treatment Period 5||8
8223241|NCT02038829|20279401|P2|COMPLETED|Treatment Period 5||7
8223242|NCT02038829|20279402|P1|COMPLETED|Treatment Period 5||7
8223243|NCT02038829|20279391|P12|STARTED|Treatment Period 5||8
8223244|NCT02038829|20279392|P11|STARTED|Treatment Period 5||7
8223245|NCT02038829|20279393|P10|STARTED|Treatment Period 5||8
8223246|NCT02038829|20279394|P9|STARTED|Treatment Period 5||7
8223247|NCT02038829|20279395|P8|STARTED|Treatment Period 5||8
8223248|NCT02038829|20279396|P7|STARTED|Treatment Period 5||7
8223249|NCT02038829|20279397|P6|STARTED|Treatment Period 5||7
8223250|NCT02038829|20279398|P5|STARTED|Treatment Period 5||7
8223251|NCT02038829|20279399|P4|STARTED|Treatment Period 5||8
8223252|NCT02038829|20279400|P3|STARTED|Treatment Period 5||8
8223253|NCT02038829|20279401|P2|STARTED|Treatment Period 5||7
8223254|NCT02038829|20279402|P1|STARTED|Treatment Period 5||7
8223255|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 4||0
8223256|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 4||0
8223257|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 4||0
8223258|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 4||0
8223259|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 4||0
8223260|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 4||1
8223261|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 4||0
8223262|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 4||0
8223263|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 4||0
8223264|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 4||0
8223265|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 4||0
8223266|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 4||0
8223267|NCT02038829|20279391|P12|COMPLETED|Washout Period 4||8
8223268|NCT02038829|20279392|P11|COMPLETED|Washout Period 4||7
8223269|NCT02038829|20279393|P10|COMPLETED|Washout Period 4||8
8223270|NCT02038829|20279394|P9|COMPLETED|Washout Period 4||7
8223271|NCT02038829|20279395|P8|COMPLETED|Washout Period 4||8
8223272|NCT02038829|20279396|P7|COMPLETED|Washout Period 4||7
8223273|NCT02038829|20279397|P6|COMPLETED|Washout Period 4||7
8223274|NCT02038829|20279398|P5|COMPLETED|Washout Period 4||7
8223275|NCT02038829|20279399|P4|COMPLETED|Washout Period 4||8
8223276|NCT02038829|20279400|P3|COMPLETED|Washout Period 4||8
8223277|NCT02038829|20279401|P2|COMPLETED|Washout Period 4||7
8223278|NCT02038829|20279402|P1|COMPLETED|Washout Period 4||7
8223279|NCT02038829|20279391|P12|STARTED|Washout Period 4||8
8223280|NCT02038829|20279392|P11|STARTED|Washout Period 4||7
8223281|NCT02038829|20279393|P10|STARTED|Washout Period 4||8
8223282|NCT02038829|20279394|P9|STARTED|Washout Period 4||7
8223283|NCT02038829|20279395|P8|STARTED|Washout Period 4||8
8223284|NCT02038829|20279396|P7|STARTED|Washout Period 4||8
8223285|NCT02038829|20279397|P6|STARTED|Washout Period 4||7
8223286|NCT02038829|20279398|P5|STARTED|Washout Period 4||7
8223287|NCT02038829|20279399|P4|STARTED|Washout Period 4||8
8223288|NCT02038829|20279400|P3|STARTED|Washout Period 4||8
8223289|NCT02038829|20279401|P2|STARTED|Washout Period 4||7
8223290|NCT02038829|20279402|P1|STARTED|Washout Period 4||7
8223291|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 4||0
8223292|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 4||0
8223293|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 4||0
8223294|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 4||0
8223295|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 4||0
8223296|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 4||0
8223297|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 4||0
8223298|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 4||0
8223299|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 4||0
8223300|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 4||0
8223301|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 4||1
8223302|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 4||0
8223303|NCT02038829|20279391|P12|COMPLETED|Treatment Period 4||8
8223304|NCT02038829|20279392|P11|COMPLETED|Treatment Period 4||7
8223305|NCT02038829|20279393|P10|COMPLETED|Treatment Period 4||8
8223306|NCT02038829|20279394|P9|COMPLETED|Treatment Period 4||7
8223307|NCT02038829|20279395|P8|COMPLETED|Treatment Period 4||8
8223308|NCT02038829|20279396|P7|COMPLETED|Treatment Period 4||8
8223309|NCT02038829|20279397|P6|COMPLETED|Treatment Period 4||7
8223310|NCT02038829|20279398|P5|COMPLETED|Treatment Period 4||7
8223311|NCT02038829|20279399|P4|COMPLETED|Treatment Period 4||8
8223312|NCT02038829|20279400|P3|COMPLETED|Treatment Period 4||8
8223313|NCT02038829|20279401|P2|COMPLETED|Treatment Period 4||7
8223314|NCT02038829|20279402|P1|COMPLETED|Treatment Period 4||7
8223315|NCT02038829|20279391|P12|STARTED|Treatment Period 4||8
8223316|NCT02038829|20279392|P11|STARTED|Treatment Period 4||7
8223317|NCT02038829|20279393|P10|STARTED|Treatment Period 4||8
8223318|NCT02038829|20279394|P9|STARTED|Treatment Period 4||7
8223319|NCT02038829|20279395|P8|STARTED|Treatment Period 4||8
8223320|NCT02038829|20279396|P7|STARTED|Treatment Period 4||8
8223321|NCT02038829|20279397|P6|STARTED|Treatment Period 4||7
8223322|NCT02038829|20279398|P5|STARTED|Treatment Period 4||7
8223323|NCT02038829|20279399|P4|STARTED|Treatment Period 4||8
8223324|NCT02038829|20279400|P3|STARTED|Treatment Period 4||8
8223325|NCT02038829|20279401|P2|STARTED|Treatment Period 4||8
8223326|NCT02038829|20279402|P1|STARTED|Treatment Period 4||7
8223327|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 3||0
8223328|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 3||0
8223329|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 3||0
8223330|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 3||0
8223331|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 3||0
8223332|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 3||0
8223333|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 3||0
8223334|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 3||0
8223335|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 3||0
8223336|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 3||0
8223337|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 3||0
8223338|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 3||0
8223339|NCT02038829|20279391|P12|COMPLETED|Washout Period 3||8
8223340|NCT02038829|20279392|P11|COMPLETED|Washout Period 3||7
8223341|NCT02038829|20279393|P10|COMPLETED|Washout Period 3||8
8223342|NCT02038829|20279394|P9|COMPLETED|Washout Period 3||7
8223343|NCT02038829|20279395|P8|COMPLETED|Washout Period 3||8
8223344|NCT02038829|20279396|P7|COMPLETED|Washout Period 3||8
8223345|NCT02038829|20279397|P6|COMPLETED|Washout Period 3||7
8223346|NCT02038829|20279398|P5|COMPLETED|Washout Period 3||7
8223347|NCT02038829|20279399|P4|COMPLETED|Washout Period 3||8
8223348|NCT02038829|20279400|P3|COMPLETED|Washout Period 3||8
8223349|NCT02038829|20279401|P2|COMPLETED|Washout Period 3||8
8223350|NCT02038829|20279402|P1|COMPLETED|Washout Period 3||7
8223351|NCT02038829|20279391|P12|STARTED|Washout Period 3||8
8223352|NCT02038829|20279392|P11|STARTED|Washout Period 3||7
8223353|NCT02038829|20279393|P10|STARTED|Washout Period 3||8
8223354|NCT02038829|20279394|P9|STARTED|Washout Period 3||7
8223355|NCT02038829|20279395|P8|STARTED|Washout Period 3||8
8223356|NCT02038829|20279396|P7|STARTED|Washout Period 3||8
8223357|NCT02038829|20279397|P6|STARTED|Washout Period 3||7
8223358|NCT02038829|20279398|P5|STARTED|Washout Period 3||7
8223359|NCT02038829|20279399|P4|STARTED|Washout Period 3||8
8223360|NCT02038829|20279400|P3|STARTED|Washout Period 3||8
8223361|NCT02038829|20279401|P2|STARTED|Washout Period 3||8
8223362|NCT02038829|20279402|P1|STARTED|Washout Period 3||7
8223363|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 3||0
8223364|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 3||0
8223365|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 3||0
8223366|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 3||0
8223367|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 3||0
8223368|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 3||0
8223369|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 3||0
8223370|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 3||0
8223371|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 3||0
8223372|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 3||0
8223373|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 3||0
8223374|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 3||0
8223375|NCT02038829|20279391|P12|COMPLETED|Treatment Period 3||8
8223376|NCT02038829|20279392|P11|COMPLETED|Treatment Period 3||7
8223377|NCT02038829|20279393|P10|COMPLETED|Treatment Period 3||8
8223378|NCT02038829|20279394|P9|COMPLETED|Treatment Period 3||7
8223379|NCT02038829|20279395|P8|COMPLETED|Treatment Period 3||8
8223380|NCT02038829|20279396|P7|COMPLETED|Treatment Period 3||8
8223381|NCT02038829|20279397|P6|COMPLETED|Treatment Period 3||7
8223382|NCT02038829|20279398|P5|COMPLETED|Treatment Period 3||7
8223383|NCT02038829|20279399|P4|COMPLETED|Treatment Period 3||8
8223384|NCT02038829|20279400|P3|COMPLETED|Treatment Period 3||8
8223385|NCT02038829|20279401|P2|COMPLETED|Treatment Period 3||8
8223386|NCT02038829|20279402|P1|COMPLETED|Treatment Period 3||7
8223387|NCT02038829|20279391|P12|STARTED|Treatment Period 3||8
8223388|NCT02038829|20279392|P11|STARTED|Treatment Period 3||7
8223389|NCT02038829|20279393|P10|STARTED|Treatment Period 3||8
8223390|NCT02038829|20279394|P9|STARTED|Treatment Period 3||7
8223391|NCT02038829|20279395|P8|STARTED|Treatment Period 3||8
8223392|NCT02038829|20279396|P7|STARTED|Treatment Period 3||8
8223393|NCT02038829|20279397|P6|STARTED|Treatment Period 3||7
8223394|NCT02038829|20279398|P5|STARTED|Treatment Period 3||7
8223395|NCT02038829|20279399|P4|STARTED|Treatment Period 3||8
8223396|NCT02038829|20279400|P3|STARTED|Treatment Period 3||8
8223397|NCT02038829|20279401|P2|STARTED|Treatment Period 3||8
8223398|NCT02038829|20279402|P1|STARTED|Treatment Period 3||7
8223399|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 2||0
8223400|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 2||0
8223401|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 2||0
8223402|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 2||1
8223403|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 2||0
8223404|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 2||0
8223405|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 2||1
8223406|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 2||0
8223407|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 2||0
8223408|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 2||0
8223409|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 2||0
8223410|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 2||0
8223411|NCT02038829|20279391|P12|COMPLETED|Washout Period 2||8
8223412|NCT02038829|20279392|P11|COMPLETED|Washout Period 2||7
8223413|NCT02038829|20279393|P10|COMPLETED|Washout Period 2||8
8223414|NCT02038829|20279394|P9|COMPLETED|Washout Period 2||7
8223415|NCT02038829|20279395|P8|COMPLETED|Washout Period 2||8
8223416|NCT02038829|20279396|P7|COMPLETED|Washout Period 2||8
8223417|NCT02038829|20279397|P6|COMPLETED|Washout Period 2||7
8223418|NCT02038829|20279398|P5|COMPLETED|Washout Period 2||7
8223419|NCT02038829|20279399|P4|COMPLETED|Washout Period 2||8
8223420|NCT02038829|20279400|P3|COMPLETED|Washout Period 2||8
8223421|NCT02038829|20279401|P2|COMPLETED|Washout Period 2||8
8223422|NCT02038829|20279402|P1|COMPLETED|Washout Period 2||7
8223423|NCT02038829|20279391|P12|STARTED|Washout Period 2||8
8223424|NCT02038829|20279392|P11|STARTED|Washout Period 2||7
8223425|NCT02038829|20279393|P10|STARTED|Washout Period 2||8
8223426|NCT02038829|20279394|P9|STARTED|Washout Period 2||8
8223427|NCT02038829|20279395|P8|STARTED|Washout Period 2||8
8223428|NCT02038829|20279396|P7|STARTED|Washout Period 2||8
8223429|NCT02038829|20279397|P6|STARTED|Washout Period 2||8
8223430|NCT02038829|20279398|P5|STARTED|Washout Period 2||7
8223431|NCT02038829|20279399|P4|STARTED|Washout Period 2||8
8223432|NCT02038829|20279400|P3|STARTED|Washout Period 2||8
8223433|NCT02038829|20279401|P2|STARTED|Washout Period 2||8
8223434|NCT02038829|20279402|P1|STARTED|Washout Period 2||7
8223435|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 2||0
8223436|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 2||1
8223437|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 2||0
8223438|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 2||0
8223439|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 2||0
8223440|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 2||0
8223441|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 2||0
8223442|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 2||0
8223443|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 2||0
8223444|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 2||0
8223445|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 2||0
8223446|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 2||1
8223447|NCT02038829|20279391|P12|COMPLETED|Treatment Period 2||8
8223448|NCT02038829|20279392|P11|COMPLETED|Treatment Period 2||7
8223449|NCT02038829|20279393|P10|COMPLETED|Treatment Period 2||8
8223450|NCT02038829|20279394|P9|COMPLETED|Treatment Period 2||8
8223451|NCT02038829|20279395|P8|COMPLETED|Treatment Period 2||8
8223452|NCT02038829|20279396|P7|COMPLETED|Treatment Period 2||8
8223453|NCT02038829|20279397|P6|COMPLETED|Treatment Period 2||8
8223454|NCT02038829|20279398|P5|COMPLETED|Treatment Period 2||7
8223455|NCT02038829|20279399|P4|COMPLETED|Treatment Period 2||8
8223456|NCT02038829|20279400|P3|COMPLETED|Treatment Period 2||8
8223457|NCT02038829|20279401|P2|COMPLETED|Treatment Period 2||8
8223458|NCT02038829|20279402|P1|COMPLETED|Treatment Period 2||7
8223459|NCT02038829|20279391|P12|STARTED|Treatment Period 2||8
8223460|NCT02038829|20279392|P11|STARTED|Treatment Period 2||8
8223461|NCT02038829|20279393|P10|STARTED|Treatment Period 2||8
8223462|NCT02038829|20279394|P9|STARTED|Treatment Period 2||8
8223463|NCT02038829|20279395|P8|STARTED|Treatment Period 2||8
8223464|NCT02038829|20279396|P7|STARTED|Treatment Period 2||8
8223465|NCT02038829|20279397|P6|STARTED|Treatment Period 2||8
8223466|NCT02038829|20279398|P5|STARTED|Treatment Period 2||7
8223467|NCT02038829|20279399|P4|STARTED|Treatment Period 2||8
8223468|NCT02038829|20279400|P3|STARTED|Treatment Period 2||8
8223469|NCT02038829|20279401|P2|STARTED|Treatment Period 2||8
8223470|NCT02038829|20279402|P1|STARTED|Treatment Period 2||8
8223471|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 1||0
8223472|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 1||0
8223473|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 1||0
8223474|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 1||0
8223475|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 1||0
8223476|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 1||0
8223477|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 1||0
8223478|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 1||1
8223479|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 1||0
8223480|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 1||0
8223481|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 1||0
8223482|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 1||0
8223483|NCT02038829|20279391|P12|COMPLETED|Washout Period 1||8
8223484|NCT02038829|20279392|P11|COMPLETED|Washout Period 1||8
8223485|NCT02038829|20279393|P10|COMPLETED|Washout Period 1||8
8223486|NCT02038829|20279394|P9|COMPLETED|Washout Period 1||8
8223487|NCT02038829|20279395|P8|COMPLETED|Washout Period 1||8
8223488|NCT02038829|20279396|P7|COMPLETED|Washout Period 1||8
8223489|NCT02038829|20279397|P6|COMPLETED|Washout Period 1||8
8223490|NCT02038829|20279398|P5|COMPLETED|Washout Period 1||7
8223491|NCT02038829|20279399|P4|COMPLETED|Washout Period 1||8
8223492|NCT02038829|20279400|P3|COMPLETED|Washout Period 1||8
8223493|NCT02038829|20279401|P2|COMPLETED|Washout Period 1||8
8223494|NCT02038829|20279402|P1|COMPLETED|Washout Period 1||8
8223495|NCT02038829|20279391|P12|STARTED|Washout Period 1||8
8223496|NCT02038829|20279392|P11|STARTED|Washout Period 1||8
8223497|NCT02038829|20279393|P10|STARTED|Washout Period 1||8
8223498|NCT02038829|20279394|P9|STARTED|Washout Period 1||8
8223499|NCT02038829|20279395|P8|STARTED|Washout Period 1||8
8223500|NCT02038829|20279396|P7|STARTED|Washout Period 1||8
8223501|NCT02038829|20279397|P6|STARTED|Washout Period 1||8
8223502|NCT02038829|20279398|P5|STARTED|Washout Period 1||8
8223503|NCT02038829|20279399|P4|STARTED|Washout Period 1||8
8223504|NCT02038829|20279400|P3|STARTED|Washout Period 1||8
8223505|NCT02038829|20279401|P2|STARTED|Washout Period 1||8
8223506|NCT02038829|20279402|P1|STARTED|Washout Period 1||8
8223507|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 1||0
8223508|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 1||0
8223509|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 1||0
8223510|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 1||0
8223511|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 1||0
8223512|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 1||0
8223513|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 1||0
8223514|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 1||0
8223515|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 1||0
8223516|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 1||0
8223517|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 1||0
8223518|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 1||0
8223519|NCT02038829|20279391|P12|COMPLETED|Treatment Period 1||8
8223520|NCT02038829|20279392|P11|COMPLETED|Treatment Period 1||8
8223521|NCT02038829|20279393|P10|COMPLETED|Treatment Period 1||8
8223522|NCT02038829|20279394|P9|COMPLETED|Treatment Period 1||8
8223523|NCT02038829|20279395|P8|COMPLETED|Treatment Period 1||8
8223524|NCT02038829|20279396|P7|COMPLETED|Treatment Period 1||8
8223525|NCT02038829|20279397|P6|COMPLETED|Treatment Period 1||8
8223526|NCT02038829|20279398|P5|COMPLETED|Treatment Period 1||8
8223527|NCT02038829|20279399|P4|COMPLETED|Treatment Period 1||8
8223528|NCT02038829|20279400|P3|COMPLETED|Treatment Period 1||8
8223529|NCT02038829|20279401|P2|COMPLETED|Treatment Period 1||8
8223530|NCT02038829|20279402|P1|COMPLETED|Treatment Period 1||8
8223531|NCT02038829|20279391|P12|STARTED|Treatment Period 1||8
8223532|NCT02038829|20279392|P11|STARTED|Treatment Period 1||8
8223533|NCT02038829|20279393|P10|STARTED|Treatment Period 1||8
8223534|NCT02038829|20279394|P9|STARTED|Treatment Period 1||8
8223535|NCT02038829|20279395|P8|STARTED|Treatment Period 1||8
8223536|NCT02038829|20279396|P7|STARTED|Treatment Period 1||8
8223537|NCT02038829|20279397|P6|STARTED|Treatment Period 1||8
8223538|NCT02038829|20279398|P5|STARTED|Treatment Period 1||8
8223539|NCT02038829|20279399|P4|STARTED|Treatment Period 1||8
8223540|NCT02038829|20279400|P3|STARTED|Treatment Period 1||8
8223541|NCT02038829|20279401|P2|STARTED|Treatment Period 1||8
8223542|NCT02038829|20279402|P1|STARTED|Treatment Period 1||8
8223543|NCT02038790|20279436|P2|NOT COMPLETED|Day 1 - Second Treatment||0
8223544|NCT02038790|20279437|P1|NOT COMPLETED|Day 1 - Second Treatment||0
8223545|NCT02038790|20279436|P2|COMPLETED|Day 1 - Second Treatment||16
8223546|NCT02038790|20279437|P1|COMPLETED|Day 1 - Second Treatment||15
8223547|NCT02038790|20279436|P2|STARTED|Day 1 - Second Treatment||16
8223548|NCT02038790|20279437|P1|STARTED|Day 1 - Second Treatment||15
8223549|NCT02038790|20279436|P2|NOT COMPLETED|Day 0 - First Treatment||1
8223550|NCT02038790|20279437|P1|NOT COMPLETED|Day 0 - First Treatment||1
8223551|NCT02038790|20279436|P2|COMPLETED|Day 0 - First Treatment||16
8223552|NCT02038790|20279437|P1|COMPLETED|Day 0 - First Treatment||15
8223553|NCT02038790|20279436|P2|STARTED|Day 0 - First Treatment||17
8223554|NCT02038790|20279437|P1|STARTED|Day 0 - First Treatment||16
8223555|NCT02038764|20279473|P5|NOT COMPLETED|Overall Study||1
8223556|NCT02038764|20279474|P4|NOT COMPLETED|Overall Study||0
8223557|NCT02038764|20279475|P3|NOT COMPLETED|Overall Study||2
8223558|NCT02038764|20279476|P2|NOT COMPLETED|Overall Study||1
8223559|NCT02038764|20279477|P1|NOT COMPLETED|Overall Study||1
8223560|NCT02038764|20279473|P5|COMPLETED|Overall Study||7
8223561|NCT02038764|20279474|P4|COMPLETED|Overall Study||5
8223562|NCT02038764|20279475|P3|COMPLETED|Overall Study||7
8223563|NCT02038764|20279476|P2|COMPLETED|Overall Study||7
8223564|NCT02038764|20279477|P1|COMPLETED|Overall Study||6
8223565|NCT02038764|20279473|P5|STARTED|Overall Study||8
8223566|NCT02038764|20279474|P4|STARTED|Overall Study||5
8223567|NCT02038764|20279475|P3|STARTED|Overall Study||9
8223568|NCT02038764|20279476|P2|STARTED|Overall Study||8
8223569|NCT02038764|20279477|P1|STARTED|Overall Study||7
8223570|NCT02038647|20279579|P2|NOT COMPLETED|Overall Study||89
8223571|NCT02038647|20279580|P1|NOT COMPLETED|Overall Study||89
8223572|NCT02038647|20279579|P2|COMPLETED|Overall Study||0
8223573|NCT02038647|20279580|P1|COMPLETED|Overall Study||0
8223574|NCT02038647|20279579|P2|STARTED|Overall Study||89
8223575|NCT02038647|20279580|P1|STARTED|Overall Study||89
8223576|NCT02038569|20279612|P1|NOT COMPLETED|Overall Study||5
8223577|NCT02038569|20279612|P1|COMPLETED|Overall Study||102
8223578|NCT02038569|20279612|P1|STARTED|Overall Study||107
8223579|NCT02038543|20279643|P4|NOT COMPLETED|Overall Study||2
8223580|NCT02038543|20279644|P3|NOT COMPLETED|Overall Study||0
8223581|NCT02038543|20279645|P2|NOT COMPLETED|Overall Study||0
8223582|NCT02038543|20279646|P1|NOT COMPLETED|Overall Study||0
8223583|NCT02038543|20279643|P4|COMPLETED|Overall Study||1
8223584|NCT02038543|20279644|P3|COMPLETED|Overall Study||8
8223585|NCT02038543|20279645|P2|COMPLETED|Overall Study||4
8223586|NCT02038543|20279646|P1|COMPLETED|Overall Study||7
8223587|NCT02038543|20279643|P4|STARTED|Overall Study||3
8223588|NCT02038543|20279644|P3|STARTED|Overall Study||8
8223589|NCT02038543|20279645|P2|STARTED|Overall Study||4
8223590|NCT02038543|20279646|P1|STARTED|Overall Study||7
8223591|NCT02038218|20279662|P2|NOT COMPLETED|Overall Study||0
8223592|NCT02038218|20279663|P1|NOT COMPLETED|Overall Study||0
8223593|NCT02038218|20279662|P2|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
8223594|NCT02038218|20279663|P1|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
8223595|NCT02038218|20279662|P2|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
8223596|NCT02038218|20279663|P1|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
8223597|NCT02038179|20279671|P2|NOT COMPLETED|Phase 2 (4 Weeks)||2
8223598|NCT02038179|20279672|P1|NOT COMPLETED|Phase 2 (4 Weeks)||2
8223599|NCT02038179|20279671|P2|COMPLETED|Phase 2 (4 Weeks)||38
8223600|NCT02038179|20279672|P1|COMPLETED|Phase 2 (4 Weeks)||44
8223601|NCT02038179|20279671|P2|STARTED|Phase 2 (4 Weeks)||40
8223602|NCT02038179|20279672|P1|STARTED|Phase 2 (4 Weeks)||46
8223603|NCT02038179|20279671|P2|NOT COMPLETED|Washout (2-4 Weeks)||2
8223604|NCT02038179|20279672|P1|NOT COMPLETED|Washout (2-4 Weeks)||2
8223605|NCT02038179|20279671|P2|COMPLETED|Washout (2-4 Weeks)||40
8223606|NCT02038179|20279672|P1|COMPLETED|Washout (2-4 Weeks)||46
8223607|NCT02038179|20279671|P2|STARTED|Washout (2-4 Weeks)||42
8223608|NCT02038179|20279672|P1|STARTED|Washout (2-4 Weeks)||48
8223609|NCT02038179|20279671|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
8223610|NCT02038179|20279672|P1|NOT COMPLETED|Phase 1 (4 Weeks)||4
8223611|NCT02038179|20279671|P2|COMPLETED|Phase 1 (4 Weeks)||42
8223612|NCT02038179|20279672|P1|COMPLETED|Phase 1 (4 Weeks)||48
8223613|NCT02038179|20279671|P2|STARTED|Phase 1 (4 Weeks)||47
8223614|NCT02038179|20279672|P1|STARTED|Phase 1 (4 Weeks)||52
8223615|NCT02038153|20279682|P1|NOT COMPLETED|Overall Study||1
8223616|NCT02038153|20279682|P1|COMPLETED|Overall Study||2
8223617|NCT02038153|20279682|P1|STARTED|Overall Study||3
8223618|NCT02038075|20279689|P2|NOT COMPLETED|Overall Study||0
8223619|NCT02038075|20279690|P1|NOT COMPLETED|Overall Study||3
8223620|NCT02038075|20279689|P2|COMPLETED|Overall Study||76
8223621|NCT02038075|20279690|P1|COMPLETED|Overall Study||73
8223622|NCT02038075|20279689|P2|STARTED|Overall Study||76
8223623|NCT02038075|20279690|P1|STARTED|Overall Study||76
8223624|NCT02038049|20279698|P2|NOT COMPLETED|Overall Study||0
8223625|NCT02038049|20279699|P1|NOT COMPLETED|Overall Study||1
8223626|NCT02038049|20279698|P2|COMPLETED|Overall Study||4
8223627|NCT02038049|20279699|P1|COMPLETED|Overall Study||3
8223628|NCT02038049|20279698|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8223629|NCT02038049|20279699|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8223630|NCT02038049|20279698|P2|STARTED|Overall Study||4
8223631|NCT02038049|20279699|P1|STARTED|Overall Study||4
8223632|NCT02038023|20279721|P1|NOT COMPLETED|Overall Study||1
8223633|NCT02038023|20279721|P1|COMPLETED|Overall Study||73
8223634|NCT02038023|20279721|P1|STARTED|Overall Study||74
8223635|NCT02038010|20279728|P4|NOT COMPLETED|Follow Up||0
8223636|NCT02038010|20279729|P3|NOT COMPLETED|Follow Up||0
8223637|NCT02038010|20279730|P2|NOT COMPLETED|Follow Up||3
8223638|NCT02038010|20279731|P1|NOT COMPLETED|Follow Up||7
8223639|NCT02038010|20279728|P4|COMPLETED|Follow Up||0
8223640|NCT02038010|20279729|P3|COMPLETED|Follow Up||0
8223641|NCT02038010|20279730|P2|COMPLETED|Follow Up||3
8223642|NCT02038010|20279731|P1|COMPLETED|Follow Up||4
8223643|NCT02038010|20279728|P4|STARTED|Follow Up||0
8223644|NCT02038010|20279729|P3|STARTED|Follow Up||0
8223645|NCT02038010|20279730|P2|STARTED|Follow Up||6
8223646|NCT02038010|20279731|P1|STARTED|Follow Up||11
8223647|NCT02038010|20279728|P4|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223648|NCT02038010|20279729|P3|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223649|NCT02038010|20279730|P2|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
8223650|NCT02038010|20279731|P1|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
8223651|NCT02038010|20279728|P4|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223652|NCT02038010|20279729|P3|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223653|NCT02038010|20279730|P2|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
8223654|NCT02038010|20279731|P1|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
8223655|NCT02038010|20279728|P4|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
8223656|NCT02038010|20279729|P3|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
8223657|NCT02038010|20279730|P2|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
8223658|NCT02038010|20279731|P1|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
8223659|NCT02038010|20279728|P4|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
8223660|NCT02038010|20279729|P3|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
8223661|NCT02038010|20279730|P2|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
8223662|NCT02038010|20279731|P1|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
8223663|NCT02038010|20279728|P4|STARTED|Completed 3 Cycles/Reached 1st Response||0
8223664|NCT02038010|20279729|P3|STARTED|Completed 3 Cycles/Reached 1st Response||0
8223665|NCT02038010|20279730|P2|STARTED|Completed 3 Cycles/Reached 1st Response||4
8223666|NCT02038010|20279731|P1|STARTED|Completed 3 Cycles/Reached 1st Response||10
8223667|NCT02038010|20279728|P4|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223668|NCT02038010|20279729|P3|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223669|NCT02038010|20279730|P2|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
8223670|NCT02038010|20279731|P1|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
8223671|NCT02038010|20279728|P4|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223672|NCT02038010|20279729|P3|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223673|NCT02038010|20279730|P2|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
8223674|NCT02038010|20279731|P1|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
8223675|NCT02038010|20279728|P4|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
8223676|NCT02038010|20279729|P3|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
8223677|NCT02038010|20279730|P2|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
8223678|NCT02038010|20279731|P1|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
8223679|NCT02038010|20279728|P4|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
8223680|NCT02038010|20279729|P3|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
8223681|NCT02038010|20279730|P2|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
8223682|NCT02038010|20279731|P1|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
8223683|NCT02038010|20279728|P4|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
8223684|NCT02038010|20279729|P3|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
8223685|NCT02038010|20279730|P2|STARTED|Completed 1st Cycle and Started Cycle 2||6
8223686|NCT02038010|20279731|P1|STARTED|Completed 1st Cycle and Started Cycle 2||11
8223687|NCT02037984|20279758|P8|NOT COMPLETED|Overall Study||12
8223688|NCT02037984|20279759|P7|NOT COMPLETED|Overall Study||17
8223689|NCT02037984|20279760|P6|NOT COMPLETED|Overall Study||12
8223690|NCT02037984|20279761|P5|NOT COMPLETED|Overall Study||12
8223691|NCT02037984|20279762|P4|NOT COMPLETED|Overall Study||21
8223692|NCT02037984|20279763|P3|NOT COMPLETED|Overall Study||12
8223693|NCT02037984|20279764|P2|NOT COMPLETED|Overall Study||0
8223694|NCT02037984|20279765|P1|NOT COMPLETED|Overall Study||1
8223695|NCT02037984|20279758|P8|COMPLETED|Overall Study||39
8223696|NCT02037984|20279759|P7|COMPLETED|Overall Study||33
8223697|NCT02037984|20279760|P6|COMPLETED|Overall Study||37
8223698|NCT02037984|20279761|P5|COMPLETED|Overall Study||38
8223699|NCT02037984|20279762|P4|COMPLETED|Overall Study||30
8223700|NCT02037984|20279763|P3|COMPLETED|Overall Study||38
8223701|NCT02037984|20279764|P2|COMPLETED|Overall Study||20
8223702|NCT02037984|20279765|P1|COMPLETED|Overall Study||19
8223703|NCT02037984|20279758|P8|STARTED|Overall Study||51
8223704|NCT02037984|20279759|P7|STARTED|Overall Study||50
8223705|NCT02037984|20279760|P6|STARTED|Overall Study||49
8223706|NCT02037984|20279761|P5|STARTED|Overall Study||50
8223707|NCT02037984|20279762|P4|STARTED|Overall Study||51
8223708|NCT02037984|20279763|P3|STARTED|Overall Study||50
8223709|NCT02037984|20279764|P2|STARTED|Overall Study||20
8223710|NCT02037984|20279765|P1|STARTED|Overall Study||20
8223711|NCT02037893|20279832|P4|NOT COMPLETED|Overall Study||0
8223712|NCT02037893|20279833|P3|NOT COMPLETED|Overall Study||1
8223713|NCT02037893|20279834|P2|NOT COMPLETED|Overall Study||0
8223714|NCT02037893|20279835|P1|NOT COMPLETED|Overall Study||0
8223715|NCT02037893|20279832|P4|COMPLETED|Overall Study||28
8223716|NCT02037893|20279833|P3|COMPLETED|Overall Study||26
8223717|NCT02037893|20279834|P2|COMPLETED|Overall Study||25
8223718|NCT02037893|20279835|P1|COMPLETED|Overall Study||32
8223719|NCT02037893|20279832|P4|STARTED|Overall Study||28
8223720|NCT02037893|20279833|P3|STARTED|Overall Study||27
8223721|NCT02037893|20279834|P2|STARTED|Overall Study||25
8223722|NCT02037893|20279835|P1|STARTED|Overall Study||32
8223723|NCT02037776|20279887|P2|NOT COMPLETED|Overall Study||4
8223724|NCT02037776|20279888|P1|NOT COMPLETED|Overall Study||5
8223725|NCT02037776|20279887|P2|COMPLETED|Overall Study||60
8223726|NCT02037776|20279888|P1|COMPLETED|Overall Study||56
8223727|NCT02037776|20279887|P2|STARTED|Overall Study||64
8223728|NCT02037776|20279888|P1|STARTED|Overall Study||61
8223729|NCT02037607|20279904|P1|NOT COMPLETED|Overall Study||9
8223730|NCT02037607|20279904|P1|COMPLETED|Overall Study||91
8223731|NCT02037607|20279904|P1|STARTED|Overall Study||100
8223732|NCT02037568|20279910|P2|NOT COMPLETED|Overall Study||39
8223733|NCT02037568|20279911|P1|NOT COMPLETED|Overall Study||36
8223734|NCT02037568|20279910|P2|COMPLETED|Overall Study||37
8223735|NCT02037568|20279911|P1|COMPLETED|Overall Study||47
8223736|NCT02037568|20279910|P2|Month 6 (Post Transplantation)|Overall Study||52
8223737|NCT02037568|20279911|P1|Month 6 (Post Transplantation)|Overall Study||63
8223738|NCT02037568|20279910|P2|Month 3 (Post Transplantation)|Overall Study||62
8223739|NCT02037568|20279911|P1|Month 3 (Post Transplantation)|Overall Study||66
8223740|NCT02037568|20279910|P2|Month 1.5 (Post Transplantation)|Overall Study||76
8223741|NCT02037568|20279911|P1|Month 1.5 (Post Transplantation)|Overall Study||79
8223742|NCT02037568|20279910|P2|STARTED|Overall Study||76
8223743|NCT02037568|20279911|P1|STARTED|Overall Study||83
8223744|NCT02037555|20279935|P2|NOT COMPLETED|Overall Study||21
8223745|NCT02037555|20279936|P1|NOT COMPLETED|Overall Study||23
8223746|NCT02037555|20279935|P2|COMPLETED|Overall Study||191
8223747|NCT02037555|20279936|P1|COMPLETED|Overall Study||190
8223748|NCT02037555|20279935|P2|Dosed and Operated On|Overall Study||196
8223749|NCT02037555|20279936|P1|Dosed and Operated On|Overall Study||200
8223750|NCT02037555|20279935|P2|Dosed|Overall Study||198
8223751|NCT02037555|20279936|P1|Dosed|Overall Study||201
8223752|NCT02037555|20279935|P2|STARTED|Overall Study||212
8223753|NCT02037555|20279936|P1|STARTED|Overall Study||213
8223754|NCT02037477|20279946|P4|NOT COMPLETED|Treatment Period 2||0
8223755|NCT02037477|20279947|P3|NOT COMPLETED|Treatment Period 2||0
8223756|NCT02037477|20279948|P2|NOT COMPLETED|Treatment Period 2||0
8223757|NCT02037477|20279949|P1|NOT COMPLETED|Treatment Period 2||0
8223758|NCT02037477|20279946|P4|COMPLETED|Treatment Period 2||5
8223759|NCT02037477|20279947|P3|COMPLETED|Treatment Period 2||4
8223760|NCT02037477|20279948|P2|COMPLETED|Treatment Period 2||5
8223761|NCT02037477|20279949|P1|COMPLETED|Treatment Period 2||5
8223762|NCT02037477|20279946|P4|STARTED|Treatment Period 2||5
8223763|NCT02037477|20279947|P3|STARTED|Treatment Period 2||4
8223764|NCT02037477|20279948|P2|STARTED|Treatment Period 2||5
8223765|NCT02037477|20279949|P1|STARTED|Treatment Period 2||5
8223766|NCT02037477|20279946|P4|NOT COMPLETED|Treatment Period 1||0
8223767|NCT02037477|20279947|P3|NOT COMPLETED|Treatment Period 1||1
8223768|NCT02037477|20279948|P2|NOT COMPLETED|Treatment Period 1||0
8223769|NCT02037477|20279949|P1|NOT COMPLETED|Treatment Period 1||0
8223770|NCT02037477|20279946|P4|COMPLETED|Treatment Period 1||5
8223771|NCT02037477|20279947|P3|COMPLETED|Treatment Period 1||4
8223772|NCT02037477|20279948|P2|COMPLETED|Treatment Period 1||5
8223773|NCT02037477|20279949|P1|COMPLETED|Treatment Period 1||5
8223774|NCT02037477|20279946|P4|STARTED|Treatment Period 1||5
8223775|NCT02037477|20279947|P3|STARTED|Treatment Period 1||5
8223776|NCT02037477|20279948|P2|STARTED|Treatment Period 1||5
8223777|NCT02037477|20279949|P1|STARTED|Treatment Period 1||5
8223778|NCT02037438|20279977|P2|NOT COMPLETED|Overall Study||355
8223779|NCT02037438|20279978|P1|NOT COMPLETED|Overall Study||346
8223780|NCT02037438|20279977|P2|COMPLETED|Overall Study||561
8223781|NCT02037438|20279978|P1|COMPLETED|Overall Study||574
8223782|NCT02037438|20279977|P2|STARTED|Overall Study||916
8223783|NCT02037438|20279978|P1|STARTED|Overall Study||920
8223784|NCT02037425|20279992|P1|NOT COMPLETED|Overall Study||26
8223785|NCT02037425|20279992|P1|COMPLETED|Overall Study||18
8223786|NCT02037425|20279992|P1|Randomized to Treatment|Overall Study||32
8223787|NCT02037425|20279992|P1|STARTED|Overall Study||44
8223788|NCT02037347|20280034|P1|NOT COMPLETED|Overall Study||0
8223789|NCT02037347|20280034|P1|COMPLETED|Overall Study||1
8223790|NCT02037347|20280034|P1|STARTED|Overall Study||1
8223791|NCT02037295|20280044|P4|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
8223792|NCT02037295|20280045|P3|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
8223793|NCT02037295|20280046|P2|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
8223794|NCT02037295|20280047|P1|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
8223795|NCT02037295|20280044|P4|COMPLETED|Phase 2: Vancomycin and Placebo||6
8223796|NCT02037295|20280045|P3|COMPLETED|Phase 2: Vancomycin and Placebo||4
8223797|NCT02037295|20280046|P2|COMPLETED|Phase 2: Vancomycin and Placebo||7
8223798|NCT02037295|20280047|P1|COMPLETED|Phase 2: Vancomycin and Placebo||8
8223799|NCT02037295|20280044|P4|STARTED|Phase 2: Vancomycin and Placebo||7
8223800|NCT02037295|20280045|P3|STARTED|Phase 2: Vancomycin and Placebo||4
8223801|NCT02037295|20280046|P2|STARTED|Phase 2: Vancomycin and Placebo||7
8223802|NCT02037295|20280047|P1|STARTED|Phase 2: Vancomycin and Placebo||9
8223803|NCT02037295|20280044|P4|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223804|NCT02037295|20280045|P3|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223805|NCT02037295|20280046|P2|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223806|NCT02037295|20280047|P1|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223807|NCT02037295|20280044|P4|COMPLETED|Phase 1: Crossover UF and OF||7
8223808|NCT02037295|20280045|P3|COMPLETED|Phase 1: Crossover UF and OF||4
8223809|NCT02037295|20280046|P2|COMPLETED|Phase 1: Crossover UF and OF||7
8223810|NCT02037295|20280047|P1|COMPLETED|Phase 1: Crossover UF and OF||9
8223811|NCT02037295|20280044|P4|STARTED|Phase 1: Crossover UF and OF||7
8223812|NCT02037295|20280045|P3|STARTED|Phase 1: Crossover UF and OF||4
8223813|NCT02037295|20280046|P2|STARTED|Phase 1: Crossover UF and OF||7
8223814|NCT02037295|20280047|P1|STARTED|Phase 1: Crossover UF and OF||9
8223815|NCT02037230|20280071|P4|NOT COMPLETED|Overall Study||6
8223816|NCT02037230|20280072|P3|NOT COMPLETED|Overall Study||6
8223817|NCT02037230|20280073|P2|NOT COMPLETED|Overall Study||6
8223818|NCT02037230|20280074|P1|NOT COMPLETED|Overall Study||1
8223819|NCT02037230|20280071|P4|COMPLETED|Overall Study||5
8223820|NCT02037230|20280072|P3|COMPLETED|Overall Study||3
8223821|NCT02037230|20280073|P2|COMPLETED|Overall Study||7
8223822|NCT02037230|20280074|P1|COMPLETED|Overall Study||0
8223823|NCT02037230|20280071|P4|Completed 4 Cycles of Treatment|Overall Study||9
8223824|NCT02037230|20280072|P3|Completed 4 Cycles of Treatment|Overall Study||7
8223825|NCT02037230|20280073|P2|Completed 4 Cycles of Treatment|Overall Study||9
8223826|NCT02037230|20280074|P1|Completed 4 Cycles of Treatment|Overall Study||1
8223827|NCT02037230|20280071|P4|STARTED|Overall Study||11
8223828|NCT02037230|20280072|P3|STARTED|Overall Study||9
8223829|NCT02037230|20280073|P2|STARTED|Overall Study||13
8223830|NCT02037230|20280074|P1|STARTED|Overall Study||1
8223831|NCT02037204|20280093|P1|NOT COMPLETED|Overall Study||0
8223832|NCT02037204|20280093|P1|COMPLETED|Overall Study||35
8223833|NCT02037204|20280093|P1|STARTED|Overall Study||35
8223834|NCT02037165|20280103|P5|NOT COMPLETED|Period 5 (2 Days)||0
8223835|NCT02037165|20280104|P4|NOT COMPLETED|Period 5 (2 Days)||0
8223836|NCT02037165|20280105|P3|NOT COMPLETED|Period 5 (2 Days)||0
8223837|NCT02037165|20280106|P2|NOT COMPLETED|Period 5 (2 Days)||0
8223838|NCT02037165|20280107|P1|NOT COMPLETED|Period 5 (2 Days)||0
8223839|NCT02037165|20280103|P5|COMPLETED|Period 5 (2 Days)||4
8223840|NCT02037165|20280104|P4|COMPLETED|Period 5 (2 Days)||5
8223841|NCT02037165|20280105|P3|COMPLETED|Period 5 (2 Days)||5
8223842|NCT02037165|20280106|P2|COMPLETED|Period 5 (2 Days)||5
8223843|NCT02037165|20280107|P1|COMPLETED|Period 5 (2 Days)||5
8223844|NCT02037165|20280103|P5|STARTED|Period 5 (2 Days)||4
8223845|NCT02037165|20280104|P4|STARTED|Period 5 (2 Days)||5
8223846|NCT02037165|20280105|P3|STARTED|Period 5 (2 Days)||5
8223847|NCT02037165|20280106|P2|STARTED|Period 5 (2 Days)||5
8223848|NCT02037165|20280107|P1|STARTED|Period 5 (2 Days)||5
8223849|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 4 (6 Days)||1
8223850|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223851|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223852|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223853|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223854|NCT02037165|20280103|P5|COMPLETED|Washout Period 4 (6 Days)||4
8223855|NCT02037165|20280104|P4|COMPLETED|Washout Period 4 (6 Days)||5
8223856|NCT02037165|20280105|P3|COMPLETED|Washout Period 4 (6 Days)||5
8223857|NCT02037165|20280106|P2|COMPLETED|Washout Period 4 (6 Days)||5
8223858|NCT02037165|20280107|P1|COMPLETED|Washout Period 4 (6 Days)||5
8223859|NCT02037165|20280103|P5|STARTED|Washout Period 4 (6 Days)||5
8223860|NCT02037165|20280104|P4|STARTED|Washout Period 4 (6 Days)||5
8223861|NCT02037165|20280105|P3|STARTED|Washout Period 4 (6 Days)||5
8223862|NCT02037165|20280106|P2|STARTED|Washout Period 4 (6 Days)||5
8223863|NCT02037165|20280107|P1|STARTED|Washout Period 4 (6 Days)||5
8223864|NCT02037165|20280103|P5|NOT COMPLETED|Period 4 (2 Days)||0
8223865|NCT02037165|20280104|P4|NOT COMPLETED|Period 4 (2 Days)||0
8223866|NCT02037165|20280105|P3|NOT COMPLETED|Period 4 (2 Days)||0
8223867|NCT02037165|20280106|P2|NOT COMPLETED|Period 4 (2 Days)||0
8223868|NCT02037165|20280107|P1|NOT COMPLETED|Period 4 (2 Days)||0
8223869|NCT02037165|20280103|P5|COMPLETED|Period 4 (2 Days)||5
8223870|NCT02037165|20280104|P4|COMPLETED|Period 4 (2 Days)||5
8223871|NCT02037165|20280105|P3|COMPLETED|Period 4 (2 Days)||5
8223872|NCT02037165|20280106|P2|COMPLETED|Period 4 (2 Days)||5
8223873|NCT02037165|20280107|P1|COMPLETED|Period 4 (2 Days)||5
8223874|NCT02037165|20280103|P5|STARTED|Period 4 (2 Days)||5
8223875|NCT02037165|20280104|P4|STARTED|Period 4 (2 Days)||5
8223876|NCT02037165|20280105|P3|STARTED|Period 4 (2 Days)||5
8223877|NCT02037165|20280106|P2|STARTED|Period 4 (2 Days)||5
8223878|NCT02037165|20280107|P1|STARTED|Period 4 (2 Days)||5
8223879|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223880|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223881|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223882|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223883|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223884|NCT02037165|20280103|P5|COMPLETED|Washout Period 3 (6 Days)||5
8223885|NCT02037165|20280104|P4|COMPLETED|Washout Period 3 (6 Days)||5
8223886|NCT02037165|20280105|P3|COMPLETED|Washout Period 3 (6 Days)||5
8223887|NCT02037165|20280106|P2|COMPLETED|Washout Period 3 (6 Days)||5
8223888|NCT02037165|20280107|P1|COMPLETED|Washout Period 3 (6 Days)||5
8223889|NCT02037165|20280103|P5|STARTED|Washout Period 3 (6 Days)||5
8223890|NCT02037165|20280104|P4|STARTED|Washout Period 3 (6 Days)||5
8223891|NCT02037165|20280105|P3|STARTED|Washout Period 3 (6 Days)||5
8223892|NCT02037165|20280106|P2|STARTED|Washout Period 3 (6 Days)||5
8223893|NCT02037165|20280107|P1|STARTED|Washout Period 3 (6 Days)||5
8223894|NCT02037165|20280103|P5|NOT COMPLETED|Period 3 (2 Days)||0
8223895|NCT02037165|20280104|P4|NOT COMPLETED|Period 3 (2 Days)||0
8223896|NCT02037165|20280105|P3|NOT COMPLETED|Period 3 (2 Days)||0
8223897|NCT02037165|20280106|P2|NOT COMPLETED|Period 3 (2 Days)||0
8223898|NCT02037165|20280107|P1|NOT COMPLETED|Period 3 (2 Days)||0
8223899|NCT02037165|20280103|P5|COMPLETED|Period 3 (2 Days)||5
8223900|NCT02037165|20280104|P4|COMPLETED|Period 3 (2 Days)||5
8223901|NCT02037165|20280105|P3|COMPLETED|Period 3 (2 Days)||5
8223902|NCT02037165|20280106|P2|COMPLETED|Period 3 (2 Days)||5
8223903|NCT02037165|20280107|P1|COMPLETED|Period 3 (2 Days)||5
8223904|NCT02037165|20280103|P5|STARTED|Period 3 (2 Days)||5
8223905|NCT02037165|20280104|P4|STARTED|Period 3 (2 Days)||5
8223906|NCT02037165|20280105|P3|STARTED|Period 3 (2 Days)||5
8223907|NCT02037165|20280106|P2|STARTED|Period 3 (2 Days)||5
8223908|NCT02037165|20280107|P1|STARTED|Period 3 (2 Days)||5
8223909|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223910|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223911|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223912|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223913|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223914|NCT02037165|20280103|P5|COMPLETED|Washout Period 2 (6 Days)||5
8223915|NCT02037165|20280104|P4|COMPLETED|Washout Period 2 (6 Days)||5
8223916|NCT02037165|20280105|P3|COMPLETED|Washout Period 2 (6 Days)||5
8223917|NCT02037165|20280106|P2|COMPLETED|Washout Period 2 (6 Days)||5
8223918|NCT02037165|20280107|P1|COMPLETED|Washout Period 2 (6 Days)||5
8223919|NCT02037165|20280103|P5|STARTED|Washout Period 2 (6 Days)||5
8223920|NCT02037165|20280104|P4|STARTED|Washout Period 2 (6 Days)||5
8223921|NCT02037165|20280105|P3|STARTED|Washout Period 2 (6 Days)||5
8223922|NCT02037165|20280106|P2|STARTED|Washout Period 2 (6 Days)||5
8223923|NCT02037165|20280107|P1|STARTED|Washout Period 2 (6 Days)||5
8223924|NCT02037165|20280103|P5|NOT COMPLETED|Period 2 (2 Days)||0
8223925|NCT02037165|20280104|P4|NOT COMPLETED|Period 2 (2 Days)||0
8223926|NCT02037165|20280105|P3|NOT COMPLETED|Period 2 (2 Days)||0
8223927|NCT02037165|20280106|P2|NOT COMPLETED|Period 2 (2 Days)||0
8223928|NCT02037165|20280107|P1|NOT COMPLETED|Period 2 (2 Days)||0
8223929|NCT02037165|20280103|P5|COMPLETED|Period 2 (2 Days)||5
8223930|NCT02037165|20280104|P4|COMPLETED|Period 2 (2 Days)||5
8223931|NCT02037165|20280105|P3|COMPLETED|Period 2 (2 Days)||5
8223932|NCT02037165|20280106|P2|COMPLETED|Period 2 (2 Days)||5
8223933|NCT02037165|20280107|P1|COMPLETED|Period 2 (2 Days)||5
8223934|NCT02037165|20280103|P5|STARTED|Period 2 (2 Days)||5
8223935|NCT02037165|20280104|P4|STARTED|Period 2 (2 Days)||5
8223936|NCT02037165|20280105|P3|STARTED|Period 2 (2 Days)||5
8223937|NCT02037165|20280106|P2|STARTED|Period 2 (2 Days)||5
8223938|NCT02037165|20280107|P1|STARTED|Period 2 (2 Days)||5
8223939|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223940|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223941|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223942|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223943|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223944|NCT02037165|20280103|P5|COMPLETED|Washout Period 1 (6 Days)||5
8223945|NCT02037165|20280104|P4|COMPLETED|Washout Period 1 (6 Days)||5
8223946|NCT02037165|20280105|P3|COMPLETED|Washout Period 1 (6 Days)||5
8223947|NCT02037165|20280106|P2|COMPLETED|Washout Period 1 (6 Days)||5
8223948|NCT02037165|20280107|P1|COMPLETED|Washout Period 1 (6 Days)||5
8223949|NCT02037165|20280103|P5|STARTED|Washout Period 1 (6 Days)||5
8223950|NCT02037165|20280104|P4|STARTED|Washout Period 1 (6 Days)||5
8223951|NCT02037165|20280105|P3|STARTED|Washout Period 1 (6 Days)||5
8223952|NCT02037165|20280106|P2|STARTED|Washout Period 1 (6 Days)||5
8223953|NCT02037165|20280107|P1|STARTED|Washout Period 1 (6 Days)||5
8223954|NCT02037165|20280103|P5|NOT COMPLETED|Period 1 (2 Days)||0
8223955|NCT02037165|20280104|P4|NOT COMPLETED|Period 1 (2 Days)||0
8223956|NCT02037165|20280105|P3|NOT COMPLETED|Period 1 (2 Days)||0
8223957|NCT02037165|20280106|P2|NOT COMPLETED|Period 1 (2 Days)||0
8223958|NCT02037165|20280107|P1|NOT COMPLETED|Period 1 (2 Days)||0
8223959|NCT02037165|20280103|P5|COMPLETED|Period 1 (2 Days)||5
8223960|NCT02037165|20280104|P4|COMPLETED|Period 1 (2 Days)||5
8223961|NCT02037165|20280105|P3|COMPLETED|Period 1 (2 Days)||5
8223962|NCT02037165|20280106|P2|COMPLETED|Period 1 (2 Days)||5
8223963|NCT02037165|20280107|P1|COMPLETED|Period 1 (2 Days)||5
8223964|NCT02037165|20280103|P5|STARTED|Period 1 (2 Days)|randomized subjects|5
8223965|NCT02037165|20280104|P4|STARTED|Period 1 (2 Days)|randomized subjects|5
8223966|NCT02037165|20280105|P3|STARTED|Period 1 (2 Days)|randomized subjects|5
8223967|NCT02037165|20280106|P2|STARTED|Period 1 (2 Days)|randomized subjects|5
8223968|NCT02037165|20280107|P1|STARTED|Period 1 (2 Days)|randomized subjects|5
8223969|NCT02037061|20280152|P2|NOT COMPLETED|Overall Study||0
8223970|NCT02037061|20280153|P1|NOT COMPLETED|Overall Study||0
8223971|NCT02037061|20280152|P2|COMPLETED|Overall Study||24
8223972|NCT02037061|20280153|P1|COMPLETED|Overall Study||22
8223973|NCT02037061|20280152|P2|STARTED|Overall Study||24
8223974|NCT02037061|20280153|P1|STARTED|Overall Study||22
8223975|NCT02036840|20280163|P1|NOT COMPLETED|Overall Study||0
8223976|NCT02036840|20280163|P1|COMPLETED|Overall Study||513
8223977|NCT02036840|20280163|P1|STARTED|Overall Study||513
8223978|NCT02036775|20280167|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223979|NCT02036775|20280168|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223980|NCT02036775|20280169|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223981|NCT02036775|20280170|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223982|NCT02036775|20280171|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223983|NCT02036775|20280172|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223984|NCT02036775|20280167|P6|COMPLETED|Treatment Period 3 (6 Days)||3
8223985|NCT02036775|20280168|P5|COMPLETED|Treatment Period 3 (6 Days)||4
8223986|NCT02036775|20280169|P4|COMPLETED|Treatment Period 3 (6 Days)||4
8223987|NCT02036775|20280170|P3|COMPLETED|Treatment Period 3 (6 Days)||4
8223988|NCT02036775|20280171|P2|COMPLETED|Treatment Period 3 (6 Days)||4
8223989|NCT02036775|20280172|P1|COMPLETED|Treatment Period 3 (6 Days)||4
8223990|NCT02036775|20280167|P6|STARTED|Treatment Period 3 (6 Days)||3
8223991|NCT02036775|20280168|P5|STARTED|Treatment Period 3 (6 Days)||4
8223992|NCT02036775|20280169|P4|STARTED|Treatment Period 3 (6 Days)||4
8223993|NCT02036775|20280170|P3|STARTED|Treatment Period 3 (6 Days)||4
8223994|NCT02036775|20280171|P2|STARTED|Treatment Period 3 (6 Days)||4
8223995|NCT02036775|20280172|P1|STARTED|Treatment Period 3 (6 Days)||4
8223996|NCT02036775|20280167|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
8223997|NCT02036775|20280168|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8223998|NCT02036775|20280169|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8223999|NCT02036775|20280170|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8224000|NCT02036775|20280171|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8224001|NCT02036775|20280172|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8224002|NCT02036775|20280167|P6|COMPLETED|Treatment Period 2 (6 Days)||3
8224003|NCT02036775|20280168|P5|COMPLETED|Treatment Period 2 (6 Days)||4
8224004|NCT02036775|20280169|P4|COMPLETED|Treatment Period 2 (6 Days)||4
8224005|NCT02036775|20280170|P3|COMPLETED|Treatment Period 2 (6 Days)||4
8224006|NCT02036775|20280171|P2|COMPLETED|Treatment Period 2 (6 Days)||4
8224007|NCT02036775|20280172|P1|COMPLETED|Treatment Period 2 (6 Days)||4
8224008|NCT02036775|20280167|P6|STARTED|Treatment Period 2 (6 Days)||4
8224009|NCT02036775|20280168|P5|STARTED|Treatment Period 2 (6 Days)||4
8224010|NCT02036775|20280169|P4|STARTED|Treatment Period 2 (6 Days)||4
8224011|NCT02036775|20280170|P3|STARTED|Treatment Period 2 (6 Days)||4
8224012|NCT02036775|20280171|P2|STARTED|Treatment Period 2 (6 Days)||4
8224013|NCT02036775|20280172|P1|STARTED|Treatment Period 2 (6 Days)||4
8224014|NCT02036775|20280167|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224015|NCT02036775|20280168|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224016|NCT02036775|20280169|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224017|NCT02036775|20280170|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224018|NCT02036775|20280171|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224019|NCT02036775|20280172|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224020|NCT02036775|20280167|P6|COMPLETED|Treatment Period 1 (6 Days)||4
8224021|NCT02036775|20280168|P5|COMPLETED|Treatment Period 1 (6 Days)||4
8224022|NCT02036775|20280169|P4|COMPLETED|Treatment Period 1 (6 Days)||4
8224023|NCT02036775|20280170|P3|COMPLETED|Treatment Period 1 (6 Days)||4
8224024|NCT02036775|20280171|P2|COMPLETED|Treatment Period 1 (6 Days)||4
8224025|NCT02036775|20280172|P1|COMPLETED|Treatment Period 1 (6 Days)||4
8224026|NCT02036775|20280167|P6|STARTED|Treatment Period 1 (6 Days)||4
8224027|NCT02036775|20280168|P5|STARTED|Treatment Period 1 (6 Days)||4
8224028|NCT02036775|20280169|P4|STARTED|Treatment Period 1 (6 Days)||4
8224029|NCT02036775|20280170|P3|STARTED|Treatment Period 1 (6 Days)||4
8224030|NCT02036775|20280171|P2|STARTED|Treatment Period 1 (6 Days)||4
8224031|NCT02036775|20280172|P1|STARTED|Treatment Period 1 (6 Days)||4
8224032|NCT02036645|20280222|P12|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224033|NCT02036645|20280223|P11|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224034|NCT02036645|20280224|P10|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224035|NCT02036645|20280225|P9|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224036|NCT02036645|20280226|P8|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224037|NCT02036645|20280227|P7|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224038|NCT02036645|20280228|P6|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224039|NCT02036645|20280229|P5|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224040|NCT02036645|20280230|P4|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224041|NCT02036645|20280231|P3|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224042|NCT02036645|20280232|P2|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224043|NCT02036645|20280233|P1|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224044|NCT02036645|20280222|P12|COMPLETED|MAD Cohorts: Study Part 2||6
8224045|NCT02036645|20280223|P11|COMPLETED|MAD Cohorts: Study Part 2||6
8224046|NCT02036645|20280224|P10|COMPLETED|MAD Cohorts: Study Part 2||6
8224047|NCT02036645|20280225|P9|COMPLETED|MAD Cohorts: Study Part 2||6
8224048|NCT02036645|20280226|P8|COMPLETED|MAD Cohorts: Study Part 2||8
8224049|NCT02036645|20280227|P7|COMPLETED|MAD Cohorts: Study Part 2||0
8224050|NCT02036645|20280228|P6|COMPLETED|MAD Cohorts: Study Part 2||0
8224051|NCT02036645|20280229|P5|COMPLETED|MAD Cohorts: Study Part 2||0
8224052|NCT02036645|20280230|P4|COMPLETED|MAD Cohorts: Study Part 2||0
8224053|NCT02036645|20280231|P3|COMPLETED|MAD Cohorts: Study Part 2||0
8224054|NCT02036645|20280232|P2|COMPLETED|MAD Cohorts: Study Part 2||0
8224055|NCT02036645|20280233|P1|COMPLETED|MAD Cohorts: Study Part 2||0
8224056|NCT02036645|20280222|P12|STARTED|MAD Cohorts: Study Part 2||6
8224057|NCT02036645|20280223|P11|STARTED|MAD Cohorts: Study Part 2||6
8224058|NCT02036645|20280224|P10|STARTED|MAD Cohorts: Study Part 2||6
8224059|NCT02036645|20280225|P9|STARTED|MAD Cohorts: Study Part 2||6
8224060|NCT02036645|20280226|P8|STARTED|MAD Cohorts: Study Part 2||8
8224061|NCT02036645|20280227|P7|STARTED|MAD Cohorts: Study Part 2||0
8224062|NCT02036645|20280228|P6|STARTED|MAD Cohorts: Study Part 2||0
8224063|NCT02036645|20280229|P5|STARTED|MAD Cohorts: Study Part 2||0
8224064|NCT02036645|20280230|P4|STARTED|MAD Cohorts: Study Part 2||0
8224065|NCT02036645|20280231|P3|STARTED|MAD Cohorts: Study Part 2||0
8224066|NCT02036645|20280232|P2|STARTED|MAD Cohorts: Study Part 2||0
8224067|NCT02036645|20280233|P1|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
8224068|NCT02036645|20280222|P12|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224069|NCT02036645|20280223|P11|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224070|NCT02036645|20280224|P10|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224071|NCT02036645|20280225|P9|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224072|NCT02036645|20280226|P8|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224073|NCT02036645|20280227|P7|NOT COMPLETED|SAD Cohorts : Study Part 1||1
8224074|NCT02036645|20280228|P6|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224075|NCT02036645|20280229|P5|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224076|NCT02036645|20280230|P4|NOT COMPLETED|SAD Cohorts : Study Part 1||1
8224077|NCT02036645|20280231|P3|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224078|NCT02036645|20280232|P2|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224079|NCT02036645|20280233|P1|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224080|NCT02036645|20280222|P12|COMPLETED|SAD Cohorts : Study Part 1||0
8224081|NCT02036645|20280223|P11|COMPLETED|SAD Cohorts : Study Part 1||0
8224082|NCT02036645|20280224|P10|COMPLETED|SAD Cohorts : Study Part 1||0
8224083|NCT02036645|20280225|P9|COMPLETED|SAD Cohorts : Study Part 1||0
8224084|NCT02036645|20280226|P8|COMPLETED|SAD Cohorts : Study Part 1||0
8224085|NCT02036645|20280227|P7|COMPLETED|SAD Cohorts : Study Part 1||5
8224086|NCT02036645|20280228|P6|COMPLETED|SAD Cohorts : Study Part 1||6
8224087|NCT02036645|20280229|P5|COMPLETED|SAD Cohorts : Study Part 1||6
8224088|NCT02036645|20280230|P4|COMPLETED|SAD Cohorts : Study Part 1||5
8224089|NCT02036645|20280231|P3|COMPLETED|SAD Cohorts : Study Part 1||6
8224090|NCT02036645|20280232|P2|COMPLETED|SAD Cohorts : Study Part 1||3
8224091|NCT02036645|20280233|P1|COMPLETED|SAD Cohorts : Study Part 1||12
8224092|NCT02036645|20280222|P12|STARTED|SAD Cohorts : Study Part 1||0
8224093|NCT02036645|20280223|P11|STARTED|SAD Cohorts : Study Part 1||0
8224094|NCT02036645|20280224|P10|STARTED|SAD Cohorts : Study Part 1||0
8224095|NCT02036645|20280225|P9|STARTED|SAD Cohorts : Study Part 1||0
8224096|NCT02036645|20280226|P8|STARTED|SAD Cohorts : Study Part 1||0
8224097|NCT02036645|20280227|P7|STARTED|SAD Cohorts : Study Part 1||6
8224098|NCT02036645|20280228|P6|STARTED|SAD Cohorts : Study Part 1||6
8224099|NCT02036645|20280229|P5|STARTED|SAD Cohorts : Study Part 1||6
8224100|NCT02036645|20280230|P4|STARTED|SAD Cohorts : Study Part 1||6
8224101|NCT02036645|20280231|P3|STARTED|SAD Cohorts : Study Part 1||6
8224102|NCT02036645|20280232|P2|STARTED|SAD Cohorts : Study Part 1||3
8224103|NCT02036645|20280233|P1|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
8224104|NCT02036580|20280338|P3|NOT COMPLETED|Overall Study||0
8224105|NCT02036580|20280339|P2|NOT COMPLETED|Overall Study||1
8224106|NCT02036580|20280340|P1|NOT COMPLETED|Overall Study||1
8224107|NCT02036580|20280338|P3|COMPLETED|Overall Study||4
8224108|NCT02036580|20280339|P2|COMPLETED|Overall Study||7
8224109|NCT02036580|20280340|P1|COMPLETED|Overall Study||7
8224110|NCT02036580|20280338|P3|STARTED|Overall Study||4
8224111|NCT02036580|20280339|P2|STARTED|Overall Study||8
8224112|NCT02036580|20280340|P1|STARTED|Overall Study||8
8224113|NCT02036541|20280353|P1|NOT COMPLETED|Overall Study||16
8224114|NCT02036541|20280353|P1|COMPLETED|Overall Study||49
8224115|NCT02036541|20280353|P1|Completed Endpoint Visit|Overall Study||54
8224116|NCT02036541|20280353|P1|STARTED|Overall Study||65
8224117|NCT02036515|20280361|P3|NOT COMPLETED|Overall Study||14
8224118|NCT02036515|20280362|P2|NOT COMPLETED|Overall Study||12
8224119|NCT02036515|20280363|P1|NOT COMPLETED|Overall Study||5
8224120|NCT02036515|20280361|P3|COMPLETED|Overall Study||139
8224121|NCT02036515|20280362|P2|COMPLETED|Overall Study||143
8224122|NCT02036515|20280363|P1|COMPLETED|Overall Study||151
8224123|NCT02036515|20280361|P3|Treated|Overall Study||153
8224124|NCT02036515|20280362|P2|Treated|Overall Study||153
8224125|NCT02036515|20280363|P1|Treated|Overall Study||156
8224126|NCT02036515|20280361|P3|STARTED|Overall Study||153
8224127|NCT02036515|20280362|P2|STARTED|Overall Study||155
8224128|NCT02036515|20280363|P1|STARTED|Overall Study||156
8224129|NCT02036424|20280442|P2|NOT COMPLETED|Overall Study||0
8224130|NCT02036424|20280443|P1|NOT COMPLETED|Overall Study||0
8224131|NCT02036424|20280442|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
8224132|NCT02036424|20280443|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
8224133|NCT02036424|20280442|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
8224134|NCT02036424|20280443|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
8224135|NCT02036320|20280451|P2|NOT COMPLETED|Period 2||0
8224136|NCT02036320|20280452|P1|NOT COMPLETED|Period 2||0
8224137|NCT02036320|20280451|P2|COMPLETED|Period 2||95
8224138|NCT02036320|20280452|P1|COMPLETED|Period 2||95
8224139|NCT02036320|20280451|P2|STARTED|Period 2||95
8224140|NCT02036320|20280452|P1|STARTED|Period 2||95
8224141|NCT02036320|20280451|P2|NOT COMPLETED|Period 1||0
8224142|NCT02036320|20280452|P1|NOT COMPLETED|Period 1||0
8224143|NCT02036320|20280451|P2|COMPLETED|Period 1||95
8224144|NCT02036320|20280452|P1|COMPLETED|Period 1||95
8224145|NCT02036320|20280451|P2|STARTED|Period 1||95
8224146|NCT02036320|20280452|P1|STARTED|Period 1||95
8224147|NCT02036294|20280464|P2|NOT COMPLETED|Overall Study||11
8224148|NCT02036294|20280465|P1|NOT COMPLETED|Overall Study||9
8224149|NCT02036294|20280464|P2|COMPLETED|Overall Study||109
8224150|NCT02036294|20280465|P1|COMPLETED|Overall Study||111
8224151|NCT02036294|20280464|P2|STARTED|Overall Study||120
8224152|NCT02036294|20280465|P1|STARTED|Overall Study||120
8224153|NCT02035748|20280481|P1|NOT COMPLETED|Overall Study||20
8224154|NCT02035748|20280481|P1|COMPLETED|Overall Study||448
8224155|NCT02035748|20280481|P1|STARTED|Overall Study||468
8224156|NCT02035696|20280495|P4|NOT COMPLETED|Overall Study||3
8224157|NCT02035696|20280496|P3|NOT COMPLETED|Overall Study||3
8224158|NCT02035696|20280497|P2|NOT COMPLETED|Overall Study||3
8224159|NCT02035696|20280498|P1|NOT COMPLETED|Overall Study||3
8224160|NCT02035696|20280495|P4|COMPLETED|Overall Study||161
8224161|NCT02035696|20280496|P3|COMPLETED|Overall Study||164
8224162|NCT02035696|20280497|P2|COMPLETED|Overall Study||163
8224163|NCT02035696|20280498|P1|COMPLETED|Overall Study||171
8224164|NCT02035696|20280495|P4|STARTED|Overall Study||164
8224165|NCT02035696|20280496|P3|STARTED|Overall Study||167
8224166|NCT02035696|20280497|P2|STARTED|Overall Study||166
8224167|NCT02035696|20280498|P1|STARTED|Overall Study||174
8224168|NCT02035553|20280554|P2|NOT COMPLETED|Overall Study||23
8224169|NCT02035553|20280555|P1|NOT COMPLETED|Overall Study||18
8224170|NCT02035553|20280554|P2|COMPLETED|Overall Study||67
8224171|NCT02035553|20280555|P1|COMPLETED|Overall Study||73
8224172|NCT02035553|20280554|P2|STARTED|Overall Study||90
8224173|NCT02035553|20280555|P1|STARTED|Overall Study||91
8224174|NCT02035475|20280561|P1|NOT COMPLETED|Overall Study||6
8224175|NCT02035475|20280561|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
8224176|NCT02035475|20280561|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
8224177|NCT02035345|20280567|P1|NOT COMPLETED|Overall Study||0
8224178|NCT02035345|20280567|P1|COMPLETED|Overall Study||15
8224179|NCT02035345|20280567|P1|STARTED|Overall Study||15
8224180|NCT02035332|20280572|P1|NOT COMPLETED|Overall Study||1
8224181|NCT02035332|20280572|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
8224182|NCT02035332|20280572|P1|Treated|Overall Study|Treatment Completed|20
8224183|NCT02035332|20280572|P1|STARTED|Overall Study|Treatment Attempted|21
8224184|NCT02035267|20280582|P4|NOT COMPLETED|Overall Study||1
8224185|NCT02035267|20280583|P3|NOT COMPLETED|Overall Study||2
8224186|NCT02035267|20280584|P2|NOT COMPLETED|Overall Study||1
8224187|NCT02035267|20280585|P1|NOT COMPLETED|Overall Study||0
8224188|NCT02035267|20280582|P4|COMPLETED|Overall Study||15
8224189|NCT02035267|20280583|P3|COMPLETED|Overall Study||28
8224190|NCT02035267|20280584|P2|COMPLETED|Overall Study||15
8224191|NCT02035267|20280585|P1|COMPLETED|Overall Study||31
8224192|NCT02035267|20280582|P4|STARTED|Overall Study||16
8224193|NCT02035267|20280583|P3|STARTED|Overall Study||30
8224194|NCT02035267|20280584|P2|STARTED|Overall Study||16
8224195|NCT02035267|20280585|P1|STARTED|Overall Study||31
8224196|NCT02035202|20280616|P3|NOT COMPLETED|Overall Study||2
8224197|NCT02035202|20280617|P2|NOT COMPLETED|Overall Study||16
8224198|NCT02035202|20280618|P1|NOT COMPLETED|Overall Study||8
8224199|NCT02035202|20280616|P3|COMPLETED|Overall Study||83
8224200|NCT02035202|20280617|P2|COMPLETED|Overall Study||69
8224201|NCT02035202|20280618|P1|COMPLETED|Overall Study||77
8224202|NCT02035202|20280616|P3|STARTED|Overall Study||85
8224203|NCT02035202|20280617|P2|STARTED|Overall Study||85
8224204|NCT02035202|20280618|P1|STARTED|Overall Study||85
8224205|NCT02034916|20280634|P2|NOT COMPLETED|Overall Study||35
8224206|NCT02034916|20280635|P1|NOT COMPLETED|Overall Study||49
8224207|NCT02034916|20280634|P2|COMPLETED|Overall Study||0
8224208|NCT02034916|20280635|P1|COMPLETED|Overall Study||0
8224209|NCT02034916|20280634|P2|Treated|Overall Study||35
8224210|NCT02034916|20280635|P1|Treated|Overall Study||48
8224211|NCT02034916|20280634|P2|STARTED|Overall Study||35
8224212|NCT02034916|20280635|P1|STARTED|Overall Study||49
8224213|NCT02034877|20280672|P2|NOT COMPLETED|Overall Study||6
8224214|NCT02034877|20280673|P1|NOT COMPLETED|Overall Study||0
8224215|NCT02034877|20280672|P2|COMPLETED|Overall Study||993
8224216|NCT02034877|20280673|P1|COMPLETED|Overall Study||200
8224217|NCT02034877|20280672|P2|STARTED|Overall Study||999
8224218|NCT02034877|20280673|P1|STARTED|Overall Study||200
8224219|NCT02034799|20280691|P2|NOT COMPLETED|Overall Study||4
8224220|NCT02034799|20280692|P1|NOT COMPLETED|Overall Study||2
8224221|NCT02034799|20280691|P2|COMPLETED|Overall Study||123
8224222|NCT02034799|20280692|P1|COMPLETED|Overall Study||127
8224223|NCT02034799|20280691|P2|STARTED|Overall Study||127
8224224|NCT02034799|20280692|P1|STARTED|Overall Study||129
8224225|NCT02034708|20280706|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
8224226|NCT02034708|20280707|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
8224227|NCT02034708|20280706|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
8224228|NCT02034708|20280707|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
8224229|NCT02034708|20280706|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
8224230|NCT02034708|20280707|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
8224231|NCT02034708|20280706|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
8224232|NCT02034708|20280707|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
8224233|NCT02034708|20280706|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
8224234|NCT02034708|20280707|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
8224235|NCT02034708|20280706|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
8224236|NCT02034708|20280707|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
8224237|NCT02034708|20280706|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
8224238|NCT02034708|20280707|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
8224239|NCT02034708|20280706|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
8224240|NCT02034708|20280707|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
8224241|NCT02034708|20280706|P2|STARTED|First Contrast Agent Injection (1 Day)||130
8224242|NCT02034708|20280707|P1|STARTED|First Contrast Agent Injection (1 Day)||138
8224243|NCT02034591|20280718|P6|NOT COMPLETED|Overall Study||0
8224244|NCT02034591|20280719|P5|NOT COMPLETED|Overall Study||1
8224245|NCT02034591|20280720|P4|NOT COMPLETED|Overall Study||0
8224246|NCT02034591|20280721|P3|NOT COMPLETED|Overall Study||0
8224247|NCT02034591|20280722|P2|NOT COMPLETED|Overall Study||0
8224248|NCT02034591|20280723|P1|NOT COMPLETED|Overall Study||0
8224249|NCT02034591|20280718|P6|COMPLETED|Overall Study||3
8224250|NCT02034591|20280719|P5|COMPLETED|Overall Study||3
8224251|NCT02034591|20280720|P4|COMPLETED|Overall Study||3
8224252|NCT02034591|20280721|P3|COMPLETED|Overall Study||4
8224253|NCT02034591|20280722|P2|COMPLETED|Overall Study||3
8224254|NCT02034591|20280723|P1|COMPLETED|Overall Study||4
8224255|NCT02034591|20280718|P6|STARTED|Overall Study||3
8224256|NCT02034591|20280719|P5|STARTED|Overall Study||4
8224257|NCT02034591|20280720|P4|STARTED|Overall Study||3
8224258|NCT02034591|20280721|P3|STARTED|Overall Study||4
8224259|NCT02034591|20280722|P2|STARTED|Overall Study||3
8224260|NCT02034591|20280723|P1|STARTED|Overall Study||4
8224261|NCT02034578|20280746|P6|NOT COMPLETED|Overall Study||0
8224262|NCT02034578|20280747|P5|NOT COMPLETED|Overall Study||0
8224263|NCT02034578|20280748|P4|NOT COMPLETED|Overall Study||0
8224264|NCT02034578|20280749|P3|NOT COMPLETED|Overall Study||0
8224265|NCT02034578|20280750|P2|NOT COMPLETED|Overall Study||0
8224266|NCT02034578|20280751|P1|NOT COMPLETED|Overall Study||0
8224267|NCT02034578|20280746|P6|COMPLETED|Overall Study||3
8224268|NCT02034578|20280747|P5|COMPLETED|Overall Study||4
8224269|NCT02034578|20280748|P4|COMPLETED|Overall Study||3
8224270|NCT02034578|20280749|P3|COMPLETED|Overall Study||4
8224271|NCT02034578|20280750|P2|COMPLETED|Overall Study||3
8224272|NCT02034578|20280751|P1|COMPLETED|Overall Study||4
8224273|NCT02034578|20280746|P6|STARTED|Overall Study||3
8224274|NCT02034578|20280747|P5|STARTED|Overall Study||4
8224275|NCT02034578|20280748|P4|STARTED|Overall Study||3
8224276|NCT02034578|20280749|P3|STARTED|Overall Study||4
8224277|NCT02034578|20280750|P2|STARTED|Overall Study||3
8224278|NCT02034578|20280751|P1|STARTED|Overall Study||4
8224279|NCT02034565|20280778|P2|NOT COMPLETED|Overall Study||0
8224280|NCT02034565|20280779|P1|NOT COMPLETED|Overall Study||1
8224281|NCT02034565|20280778|P2|COMPLETED|Overall Study||7
8224282|NCT02034565|20280779|P1|COMPLETED|Overall Study||6
8224283|NCT02034565|20280778|P2|STARTED|Overall Study||7
8224284|NCT02034565|20280779|P1|STARTED|Overall Study||7
8224285|NCT02034552|20280796|P3|NOT COMPLETED|Overall Study||17
8224286|NCT02034552|20280797|P2|NOT COMPLETED|Overall Study||20
8224287|NCT02034552|20280798|P1|NOT COMPLETED|Overall Study||14
8224288|NCT02034552|20280796|P3|COMPLETED|Overall Study||5
8224289|NCT02034552|20280797|P2|COMPLETED|Overall Study||4
8224290|NCT02034552|20280798|P1|COMPLETED|Overall Study||8
8224291|NCT02034552|20280796|P3|Received Treatment|Overall Study||22
8224292|NCT02034552|20280797|P2|Received Treatment|Overall Study||22
8224293|NCT02034552|20280798|P1|Received Treatment|Overall Study||19
8224294|NCT02034552|20280796|P3|STARTED|Overall Study||22
8224295|NCT02034552|20280797|P2|STARTED|Overall Study||24
8224296|NCT02034552|20280798|P1|STARTED|Overall Study||22
8224297|NCT02034513|20280829|P2|NOT COMPLETED|Overall Study||57
8224298|NCT02034513|20280830|P1|NOT COMPLETED|Overall Study||49
8224299|NCT02034513|20280829|P2|COMPLETED|Overall Study||195
8224300|NCT02034513|20280830|P1|COMPLETED|Overall Study||200
8224301|NCT02034513|20280829|P2|Exposed|Overall Study||251
8224302|NCT02034513|20280830|P1|Exposed|Overall Study||249
8224303|NCT02034513|20280829|P2|STARTED|Overall Study||252
8224304|NCT02034513|20280830|P1|STARTED|Overall Study||249
8224305|NCT02034474|20280848|P2|NOT COMPLETED|Overall Study||4
8224306|NCT02034474|20280849|P1|NOT COMPLETED|Overall Study||4
8224307|NCT02034474|20280848|P2|COMPLETED|Overall Study||13
8224308|NCT02034474|20280849|P1|COMPLETED|Overall Study||15
8224309|NCT02034474|20280848|P2|3 Doses|Overall Study||13
8224310|NCT02034474|20280849|P1|3 Doses|Overall Study||15
8224311|NCT02034474|20280848|P2|2 Doses|Overall Study||0
8224312|NCT02034474|20280849|P1|2 Doses|Overall Study||2
8224313|NCT02034474|20280848|P2|1 Dose|Overall Study||4
8224314|NCT02034474|20280849|P1|1 Dose|Overall Study||2
8224315|NCT02034474|20280848|P2|STARTED|Overall Study||17
8224316|NCT02034474|20280849|P1|STARTED|Overall Study||19
8224317|NCT02034435|20280861|P4|NOT COMPLETED|Overall Study||1
8224318|NCT02034435|20280862|P3|NOT COMPLETED|Overall Study||0
8224319|NCT02034435|20280863|P2|NOT COMPLETED|Overall Study||2
8224320|NCT02034435|20280864|P1|NOT COMPLETED|Overall Study||2
8224321|NCT02034435|20280861|P4|COMPLETED|Overall Study||8
8224322|NCT02034435|20280862|P3|COMPLETED|Overall Study||7
8224323|NCT02034435|20280863|P2|COMPLETED|Overall Study||13
8224324|NCT02034435|20280864|P1|COMPLETED|Overall Study||11
8224325|NCT02034435|20280861|P4|Aim 2|Overall Study||9
8224326|NCT02034435|20280862|P3|Aim 2|Overall Study||7
8224327|NCT02034435|20280863|P2|Aim 2|Overall Study||0
8224328|NCT02034435|20280864|P1|Aim 2|Overall Study||0
8224329|NCT02034435|20280861|P4|Aim 1|Overall Study||0
8224330|NCT02034435|20280862|P3|Aim 1|Overall Study||0
8224331|NCT02034435|20280863|P2|Aim 1|Overall Study||15
8224332|NCT02034435|20280864|P1|Aim 1|Overall Study||13
8224333|NCT02034435|20280861|P4|STARTED|Overall Study||9
8224334|NCT02034435|20280862|P3|STARTED|Overall Study||7
8224335|NCT02034435|20280863|P2|STARTED|Overall Study||15
8224336|NCT02034435|20280864|P1|STARTED|Overall Study||13
8224337|NCT02034175|20280878|P1|NOT COMPLETED|Overall Study||0
8224338|NCT02034175|20280878|P1|COMPLETED|Overall Study||190
8224339|NCT02034175|20280878|P1|STARTED|Overall Study||190
8224340|NCT02034162|20280884|P3|NOT COMPLETED|Open-label||0
8224341|NCT02034162|20280885|P2|NOT COMPLETED|Open-label||0
8224342|NCT02034162|20280886|P1|NOT COMPLETED|Open-label||0
8224343|NCT02034162|20280884|P3|COMPLETED|Open-label||278
8224344|NCT02034162|20280885|P2|COMPLETED|Open-label||0
8224345|NCT02034162|20280886|P1|COMPLETED|Open-label||0
8224346|NCT02034162|20280884|P3|STARTED|Open-label||278
8224347|NCT02034162|20280885|P2|STARTED|Open-label||0
8224348|NCT02034162|20280886|P1|STARTED|Open-label||0
8224349|NCT02034162|20280884|P3|NOT COMPLETED|Double-blind||0
8224350|NCT02034162|20280885|P2|NOT COMPLETED|Double-blind||8
8224351|NCT02034162|20280886|P1|NOT COMPLETED|Double-blind||9
8224352|NCT02034162|20280884|P3|COMPLETED|Double-blind||0
8224353|NCT02034162|20280885|P2|COMPLETED|Double-blind||141
8224354|NCT02034162|20280886|P1|COMPLETED|Double-blind||137
8224355|NCT02034162|20280884|P3|STARTED|Double-blind||0
8224356|NCT02034162|20280885|P2|STARTED|Double-blind||149
8224357|NCT02034162|20280886|P1|STARTED|Double-blind||146
8224358|NCT02034123|20280932|P18|NOT COMPLETED|Part2(Up to 2 Years)||0
8224359|NCT02034123|20280933|P17|NOT COMPLETED|Part2(Up to 2 Years)||0
8224360|NCT02034123|20280934|P16|NOT COMPLETED|Part2(Up to 2 Years)||0
8224361|NCT02034123|20280935|P15|NOT COMPLETED|Part2(Up to 2 Years)||0
8224362|NCT02034123|20280936|P14|NOT COMPLETED|Part2(Up to 2 Years)||0
8224363|NCT02034123|20280937|P13|NOT COMPLETED|Part2(Up to 2 Years)||0
8224364|NCT02034123|20280938|P12|NOT COMPLETED|Part2(Up to 2 Years)||0
8224365|NCT02034123|20280939|P11|NOT COMPLETED|Part2(Up to 2 Years)||0
8224366|NCT02034123|20280940|P10|NOT COMPLETED|Part2(Up to 2 Years)||0
8224367|NCT02034123|20280941|P9|NOT COMPLETED|Part2(Up to 2 Years)||0
8224368|NCT02034123|20280942|P8|NOT COMPLETED|Part2(Up to 2 Years)||0
8224369|NCT02034123|20280943|P7|NOT COMPLETED|Part2(Up to 2 Years)||0
8224370|NCT02034123|20280944|P6|NOT COMPLETED|Part2(Up to 2 Years)||0
8224371|NCT02034123|20280945|P5|NOT COMPLETED|Part2(Up to 2 Years)||0
8224372|NCT02034123|20280946|P4|NOT COMPLETED|Part2(Up to 2 Years)||0
8224373|NCT02034123|20280947|P3|NOT COMPLETED|Part2(Up to 2 Years)||0
8224374|NCT02034123|20280948|P2|NOT COMPLETED|Part2(Up to 2 Years)||0
8224375|NCT02034123|20280949|P1|NOT COMPLETED|Part2(Up to 2 Years)||0
8224376|NCT02034123|20280932|P18|COMPLETED|Part2(Up to 2 Years)||0
8224377|NCT02034123|20280933|P17|COMPLETED|Part2(Up to 2 Years)||0
8224378|NCT02034123|20280934|P16|COMPLETED|Part2(Up to 2 Years)||0
8224379|NCT02034123|20280935|P15|COMPLETED|Part2(Up to 2 Years)||0
8224380|NCT02034123|20280936|P14|COMPLETED|Part2(Up to 2 Years)||0
8224381|NCT02034123|20280937|P13|COMPLETED|Part2(Up to 2 Years)||0
8224382|NCT02034123|20280938|P12|COMPLETED|Part2(Up to 2 Years)||0
8224383|NCT02034123|20280939|P11|COMPLETED|Part2(Up to 2 Years)||0
8224384|NCT02034123|20280940|P10|COMPLETED|Part2(Up to 2 Years)||0
8224385|NCT02034123|20280941|P9|COMPLETED|Part2(Up to 2 Years)||0
8224386|NCT02034123|20280942|P8|COMPLETED|Part2(Up to 2 Years)||0
8224387|NCT02034123|20280943|P7|COMPLETED|Part2(Up to 2 Years)||0
8224388|NCT02034123|20280944|P6|COMPLETED|Part2(Up to 2 Years)||0
8224389|NCT02034123|20280945|P5|COMPLETED|Part2(Up to 2 Years)||0
8224390|NCT02034123|20280946|P4|COMPLETED|Part2(Up to 2 Years)||0
8224391|NCT02034123|20280947|P3|COMPLETED|Part2(Up to 2 Years)||0
8224392|NCT02034123|20280948|P2|COMPLETED|Part2(Up to 2 Years)||0
8224393|NCT02034123|20280949|P1|COMPLETED|Part2(Up to 2 Years)||0
8224394|NCT02034123|20280932|P18|STARTED|Part2(Up to 2 Years)||0
8224395|NCT02034123|20280933|P17|STARTED|Part2(Up to 2 Years)||0
8224396|NCT02034123|20280934|P16|STARTED|Part2(Up to 2 Years)||0
8224397|NCT02034123|20280935|P15|STARTED|Part2(Up to 2 Years)||0
8224398|NCT02034123|20280936|P14|STARTED|Part2(Up to 2 Years)||0
8224399|NCT02034123|20280937|P13|STARTED|Part2(Up to 2 Years)||0
8224400|NCT02034123|20280938|P12|STARTED|Part2(Up to 2 Years)||0
8224401|NCT02034123|20280939|P11|STARTED|Part2(Up to 2 Years)||0
8224402|NCT02034123|20280940|P10|STARTED|Part2(Up to 2 Years)||0
8224403|NCT02034123|20280941|P9|STARTED|Part2(Up to 2 Years)||0
8224404|NCT02034123|20280942|P8|STARTED|Part2(Up to 2 Years)||0
8224405|NCT02034123|20280943|P7|STARTED|Part2(Up to 2 Years)||0
8224406|NCT02034123|20280944|P6|STARTED|Part2(Up to 2 Years)||0
8224407|NCT02034123|20280945|P5|STARTED|Part2(Up to 2 Years)||0
8224408|NCT02034123|20280946|P4|STARTED|Part2(Up to 2 Years)||0
8224409|NCT02034123|20280947|P3|STARTED|Part2(Up to 2 Years)||0
8224410|NCT02034123|20280948|P2|STARTED|Part2(Up to 2 Years)||0
8224411|NCT02034123|20280949|P1|STARTED|Part2(Up to 2 Years)||0
8224412|NCT02034123|20280932|P18|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224413|NCT02034123|20280933|P17|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224414|NCT02034123|20280934|P16|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224415|NCT02034123|20280935|P15|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224416|NCT02034123|20280936|P14|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224417|NCT02034123|20280937|P13|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224418|NCT02034123|20280938|P12|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224419|NCT02034123|20280939|P11|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224420|NCT02034123|20280940|P10|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224421|NCT02034123|20280941|P9|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224422|NCT02034123|20280942|P8|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224423|NCT02034123|20280943|P7|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224424|NCT02034123|20280944|P6|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224425|NCT02034123|20280945|P5|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224426|NCT02034123|20280946|P4|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224427|NCT02034123|20280947|P3|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224428|NCT02034123|20280948|P2|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224429|NCT02034123|20280949|P1|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224430|NCT02034123|20280932|P18|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224431|NCT02034123|20280933|P17|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224432|NCT02034123|20280934|P16|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224433|NCT02034123|20280935|P15|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224434|NCT02034123|20280936|P14|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224435|NCT02034123|20280937|P13|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224436|NCT02034123|20280938|P12|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224437|NCT02034123|20280939|P11|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224438|NCT02034123|20280940|P10|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224439|NCT02034123|20280941|P9|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224440|NCT02034123|20280942|P8|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
8224441|NCT02034123|20280943|P7|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224442|NCT02034123|20280944|P6|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
8224443|NCT02034123|20280945|P5|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
8224444|NCT02034123|20280946|P4|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224445|NCT02034123|20280947|P3|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
8224446|NCT02034123|20280948|P2|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224447|NCT02034123|20280949|P1|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224448|NCT02034123|20280932|P18|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224449|NCT02034123|20280933|P17|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224450|NCT02034123|20280934|P16|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224451|NCT02034123|20280935|P15|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224452|NCT02034123|20280936|P14|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224453|NCT02034123|20280937|P13|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224454|NCT02034123|20280938|P12|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224455|NCT02034123|20280939|P11|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224456|NCT02034123|20280940|P10|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224457|NCT02034123|20280941|P9|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
8224458|NCT02034123|20280942|P8|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
8224459|NCT02034123|20280943|P7|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
8224460|NCT02034123|20280944|P6|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
8224461|NCT02034123|20280945|P5|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
8224462|NCT02034123|20280946|P4|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
8224463|NCT02034123|20280947|P3|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
8224464|NCT02034123|20280948|P2|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
8224465|NCT02034123|20280949|P1|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
8224466|NCT02034058|20281268|P1|NOT COMPLETED|Overall Study||3
8224467|NCT02034058|20281268|P1|COMPLETED|Overall Study||149
8224468|NCT02034058|20281268|P1|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
8224469|NCT02034019|20281278|P2|NOT COMPLETED|Overall Study||2
8224470|NCT02034019|20281279|P1|NOT COMPLETED|Overall Study||1
8224471|NCT02034019|20281278|P2|COMPLETED|Overall Study||81
8224472|NCT02034019|20281279|P1|COMPLETED|Overall Study||163
8224473|NCT02034019|20281278|P2|STARTED|Overall Study||83
8224474|NCT02034019|20281279|P1|STARTED|Overall Study||164
8224475|NCT02034006|20281289|P1|NOT COMPLETED|Overall Study||14
8224476|NCT02034006|20281289|P1|COMPLETED|Overall Study||186
8224477|NCT02034006|20281289|P1|Re-treated Patients|Overall Study||130
8224478|NCT02034006|20281289|P1|Once Treated Patients|Overall Study||70
8224479|NCT02034006|20281289|P1|STARTED|Overall Study||200
8224480|NCT02033993|20281322|P2|NOT COMPLETED|Overall Study||9
8224481|NCT02033993|20281323|P1|NOT COMPLETED|Overall Study||3
8224482|NCT02033993|20281322|P2|COMPLETED|Overall Study||91
8224483|NCT02033993|20281323|P1|COMPLETED|Overall Study||96
8224484|NCT02033993|20281322|P2|STARTED|Overall Study||100
8224485|NCT02033993|20281323|P1|STARTED|Overall Study||99
8224486|NCT02033889|20281340|P3|NOT COMPLETED|Overall Study||25
8224487|NCT02033889|20281341|P2|NOT COMPLETED|Overall Study||20
8224488|NCT02033889|20281342|P1|NOT COMPLETED|Overall Study||34
8224489|NCT02033889|20281340|P3|COMPLETED|Overall Study||180
8224490|NCT02033889|20281341|P2|COMPLETED|Overall Study||187
8224491|NCT02033889|20281342|P1|COMPLETED|Overall Study||175
8224492|NCT02033889|20281340|P3|STARTED|Overall Study||205
8224493|NCT02033889|20281341|P2|STARTED|Overall Study||207
8224494|NCT02033889|20281342|P1|STARTED|Overall Study||209
8224495|NCT02033876|20281496|P2|NOT COMPLETED|Overall Study||0
8224496|NCT02033876|20281497|P1|NOT COMPLETED|Overall Study||0
8224497|NCT02033876|20281496|P2|COMPLETED|Overall Study||12
8224498|NCT02033876|20281497|P1|COMPLETED|Overall Study||12
8224499|NCT02033876|20281496|P2|STARTED|Overall Study||12
8224500|NCT02033876|20281497|P1|STARTED|Overall Study||12
8224501|NCT02033850|20281519|P2|NOT COMPLETED|Overall Study||1
8224502|NCT02033850|20281520|P1|NOT COMPLETED|Overall Study||2
8224503|NCT02033850|20281519|P2|COMPLETED|Overall Study||22
8224504|NCT02033850|20281520|P1|COMPLETED|Overall Study||21
8224505|NCT02033850|20281519|P2|STARTED|Overall Study||23
8224506|NCT02033850|20281520|P1|STARTED|Overall Study||23
8224507|NCT02033759|20281544|P2|NOT COMPLETED|Overall Study||2
8224508|NCT02033759|20281545|P1|NOT COMPLETED|Overall Study||3
8224509|NCT02033759|20281544|P2|COMPLETED|Overall Study||19
8224510|NCT02033759|20281545|P1|COMPLETED|Overall Study||19
8224511|NCT02033759|20281544|P2|STARTED|Overall Study||21
8224512|NCT02033759|20281545|P1|STARTED|Overall Study||22
8224513|NCT02033694|20281555|P1|NOT COMPLETED|Overall Study||0
8224514|NCT02033694|20281555|P1|COMPLETED|Overall Study||1271
8224515|NCT02033694|20281555|P1|STARTED|Overall Study||1271
8224516|NCT02033499|20281563|P3|NOT COMPLETED|Overall Study||9
8224517|NCT02033499|20281564|P2|NOT COMPLETED|Overall Study||8
8224518|NCT02033499|20281565|P1|NOT COMPLETED|Overall Study||5
8224519|NCT02033499|20281563|P3|COMPLETED|Overall Study||139
8224520|NCT02033499|20281564|P2|COMPLETED|Overall Study||142
8224521|NCT02033499|20281565|P1|COMPLETED|Overall Study||147
8224522|NCT02033499|20281563|P3|STARTED|Overall Study||148
8224523|NCT02033499|20281564|P2|STARTED|Overall Study||150
8224524|NCT02033499|20281565|P1|STARTED|Overall Study||152
8224525|NCT02033382|20281605|P2|NOT COMPLETED|Overall Study||46
8224526|NCT02033382|20281606|P1|NOT COMPLETED|Overall Study||51
8224527|NCT02033382|20281605|P2|COMPLETED|Overall Study||36
8224528|NCT02033382|20281606|P1|COMPLETED|Overall Study||32
8224529|NCT02033382|20281605|P2|STARTED|Overall Study||82
8224530|NCT02033382|20281606|P1|STARTED|Overall Study||83
8224531|NCT02033369|20281626|P2|NOT COMPLETED|Overall Study||5
8224532|NCT02033369|20281627|P1|NOT COMPLETED|Overall Study||5
8224533|NCT02033369|20281626|P2|COMPLETED|Overall Study||21
8224534|NCT02033369|20281627|P1|COMPLETED|Overall Study||21
8224535|NCT02033369|20281626|P2|STARTED|Overall Study||26
8224536|NCT02033369|20281627|P1|STARTED|Overall Study||26
8224537|NCT02033317|20281637|P1|NOT COMPLETED|Overall Study||0
8224538|NCT02033317|20281637|P1|COMPLETED|Overall Study||6
8224539|NCT02033317|20281637|P1|STARTED|Overall Study||6
8224540|NCT02033213|20281644|P2|NOT COMPLETED|Overall Study||0
8224541|NCT02033213|20281645|P1|NOT COMPLETED|Overall Study||0
8224542|NCT02033213|20281644|P2|COMPLETED|Overall Study||8
8224543|NCT02033213|20281645|P1|COMPLETED|Overall Study||8
8224544|NCT02033213|20281644|P2|STARTED|Overall Study||8
8224545|NCT02033213|20281645|P1|STARTED|Overall Study||8
8224546|NCT02033200|20281663|P2|NOT COMPLETED|Overall Study||0
8224547|NCT02033200|20281664|P1|NOT COMPLETED|Overall Study||0
8224548|NCT02033200|20281663|P2|COMPLETED|Overall Study||40
8224549|NCT02033200|20281664|P1|COMPLETED|Overall Study||40
8224550|NCT02033200|20281663|P2|STARTED|Overall Study||40
8224551|NCT02033200|20281664|P1|STARTED|Overall Study||40
8224552|NCT02033174|20281684|P2|NOT COMPLETED|Second Intervention||0
8224553|NCT02033174|20281685|P1|NOT COMPLETED|Second Intervention||0
8224554|NCT02033174|20281684|P2|COMPLETED|Second Intervention||8
8224555|NCT02033174|20281685|P1|COMPLETED|Second Intervention||8
8224556|NCT02033174|20281684|P2|STARTED|Second Intervention||8
8224557|NCT02033174|20281685|P1|STARTED|Second Intervention||8
8224558|NCT02033174|20281684|P2|NOT COMPLETED|Washout (1 Week)||0
8224559|NCT02033174|20281685|P1|NOT COMPLETED|Washout (1 Week)||0
8224560|NCT02033174|20281684|P2|COMPLETED|Washout (1 Week)||8
8224561|NCT02033174|20281685|P1|COMPLETED|Washout (1 Week)||8
8224562|NCT02033174|20281684|P2|STARTED|Washout (1 Week)||8
8224563|NCT02033174|20281685|P1|STARTED|Washout (1 Week)||8
8224564|NCT02033174|20281684|P2|NOT COMPLETED|First Intervention||0
8224565|NCT02033174|20281685|P1|NOT COMPLETED|First Intervention||0
8224566|NCT02033174|20281684|P2|COMPLETED|First Intervention||8
8224567|NCT02033174|20281685|P1|COMPLETED|First Intervention||8
8224568|NCT02033174|20281684|P2|STARTED|First Intervention||8
8224569|NCT02033174|20281685|P1|STARTED|First Intervention||8
8224570|NCT02033083|20281693|P2|NOT COMPLETED|Overall Study||1
8224571|NCT02033083|20281694|P1|NOT COMPLETED|Overall Study||1
8224572|NCT02033083|20281693|P2|COMPLETED|Overall Study||88
8224573|NCT02033083|20281694|P1|COMPLETED|Overall Study||88
8224574|NCT02033083|20281693|P2|STARTED|Overall Study||89
8224575|NCT02033083|20281694|P1|STARTED|Overall Study||89
8224576|NCT02033005|20281703|P3|NOT COMPLETED|Overall Study||10
8224577|NCT02033005|20281704|P2|NOT COMPLETED|Overall Study||0
8224578|NCT02033005|20281705|P1|NOT COMPLETED|Overall Study||44
8224579|NCT02033005|20281703|P3|COMPLETED|Overall Study||25
8224580|NCT02033005|20281704|P2|COMPLETED|Overall Study||9
8224581|NCT02033005|20281705|P1|COMPLETED|Overall Study||36
8224582|NCT02033005|20281703|P3|STARTED|Overall Study||35
8224583|NCT02033005|20281704|P2|STARTED|Overall Study||9
8224584|NCT02033005|20281705|P1|STARTED|Overall Study||80
8224585|NCT02032901|20281721|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
8224586|NCT02032901|20281722|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
8224587|NCT02032901|20281721|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
8224588|NCT02032901|20281722|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
8224589|NCT02032901|20281721|P2|STARTED|Follow-Up Period (24 Weeks)||51
8224590|NCT02032901|20281722|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
8224591|NCT02032901|20281721|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
8224592|NCT02032901|20281722|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
8224593|NCT02032901|20281721|P2|COMPLETED|Treatment Period (12 Weeks)||51
8224594|NCT02032901|20281722|P1|COMPLETED|Treatment Period (12 Weeks)||100
8224595|NCT02032901|20281721|P2|STARTED|Treatment Period (12 Weeks)||51
8224596|NCT02032901|20281722|P1|STARTED|Treatment Period (12 Weeks)||101
8224597|NCT02032888|20281746|P3|NOT COMPLETED|Follow-up Period||0
8224598|NCT02032888|20281747|P2|NOT COMPLETED|Follow-up Period||2
8224599|NCT02032888|20281748|P1|NOT COMPLETED|Follow-up Period||3
8224600|NCT02032888|20281746|P3|COMPLETED|Follow-up Period||52
8224601|NCT02032888|20281747|P2|COMPLETED|Follow-up Period||47
8224602|NCT02032888|20281748|P1|COMPLETED|Follow-up Period||97
8224603|NCT02032888|20281746|P3|STARTED|Follow-up Period||52
8224604|NCT02032888|20281747|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
8224605|NCT02032888|20281748|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
8224606|NCT02032888|20281746|P3|NOT COMPLETED|Treatment Period||0
8224607|NCT02032888|20281747|P2|NOT COMPLETED|Treatment Period||2
8224608|NCT02032888|20281748|P1|NOT COMPLETED|Treatment Period||2
8224609|NCT02032888|20281746|P3|COMPLETED|Treatment Period||52
8224610|NCT02032888|20281747|P2|COMPLETED|Treatment Period||48
8224611|NCT02032888|20281748|P1|COMPLETED|Treatment Period||99
8224612|NCT02032888|20281746|P3|STARTED|Treatment Period||52
8224613|NCT02032888|20281747|P2|STARTED|Treatment Period||50
8224614|NCT02032888|20281748|P1|STARTED|Treatment Period||101
8224615|NCT02032875|20281779|P2|NOT COMPLETED|Follow-up Period||11
8224616|NCT02032875|20281780|P1|NOT COMPLETED|Follow-up Period||3
8224617|NCT02032875|20281779|P2|COMPLETED|Follow-up Period||46
8224618|NCT02032875|20281780|P1|COMPLETED|Follow-up Period||50
8224619|NCT02032875|20281779|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
8224620|NCT02032875|20281780|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
8224621|NCT02032875|20281779|P2|NOT COMPLETED|Treatment Period||4
8224622|NCT02032875|20281780|P1|NOT COMPLETED|Treatment Period||1
8224623|NCT02032875|20281779|P2|COMPLETED|Treatment Period||56
8224624|NCT02032875|20281780|P1|COMPLETED|Treatment Period||52
8224625|NCT02032875|20281779|P2|STARTED|Treatment Period||60
8224626|NCT02032875|20281780|P1|STARTED|Treatment Period||53
8224633|NCT02032758|20281814|P2|NOT COMPLETED|Overall Study||0
8224634|NCT02032758|20281815|P1|NOT COMPLETED|Overall Study||0
8224635|NCT02032758|20281814|P2|COMPLETED|Overall Study||11
8224636|NCT02032758|20281815|P1|COMPLETED|Overall Study||27
8224637|NCT02032758|20281814|P2|STARTED|Overall Study||11
8224638|NCT02032758|20281815|P1|STARTED|Overall Study||27
8224639|NCT02032706|20281823|P1|NOT COMPLETED|Overall Study||6
8224640|NCT02032706|20281823|P1|COMPLETED|Overall Study||30
8224641|NCT02032706|20281823|P1|STARTED|Overall Study||36
8224642|NCT02032680|20281838|P2|NOT COMPLETED|Overall Study||1
8224643|NCT02032680|20281839|P1|NOT COMPLETED|Overall Study||6
8224644|NCT02032680|20281838|P2|COMPLETED|Overall Study||7
8224645|NCT02032680|20281839|P1|COMPLETED|Overall Study||16
8224646|NCT02032680|20281838|P2|STARTED|Overall Study||8
8224647|NCT02032680|20281839|P1|STARTED|Overall Study||22
8224648|NCT02032641|20281845|P1|NOT COMPLETED|Overall Study||1
8224649|NCT02032641|20281845|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
8224650|NCT02032641|20281845|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
8224651|NCT02032550|20281857|P2|NOT COMPLETED|Overall Study||22
8224652|NCT02032550|20281858|P1|NOT COMPLETED|Overall Study||28
8224653|NCT02032550|20281857|P2|COMPLETED|Overall Study||350
8224654|NCT02032550|20281858|P1|COMPLETED|Overall Study||343
8224655|NCT02032550|20281857|P2|STARTED|Overall Study||372
8224656|NCT02032550|20281858|P1|STARTED|Overall Study||371
8224657|NCT02032433|20281870|P2|NOT COMPLETED|Overall Study||62
8224658|NCT02032433|20281871|P1|NOT COMPLETED|Overall Study||78
8224659|NCT02032433|20281870|P2|COMPLETED|Overall Study||225
8224660|NCT02032433|20281871|P1|COMPLETED|Overall Study||205
8224661|NCT02032433|20281870|P2|STARTED|Overall Study||287
8224662|NCT02032433|20281871|P1|STARTED|Overall Study||283
8224663|NCT02032420|20281993|P2|NOT COMPLETED|Overall Study||0
8224664|NCT02032420|20281994|P1|NOT COMPLETED|Overall Study||0
8224665|NCT02032420|20281993|P2|COMPLETED|Overall Study||17
8224666|NCT02032420|20281994|P1|COMPLETED|Overall Study||18
8224667|NCT02032420|20281993|P2|STARTED|Overall Study||17
8224668|NCT02032420|20281994|P1|STARTED|Overall Study||18
8224669|NCT02032407|20282006|P1|NOT COMPLETED|Overall Study||5
8224670|NCT02032407|20282006|P1|COMPLETED|Overall Study||63
8224671|NCT02032407|20282006|P1|STARTED|Overall Study||68
8224672|NCT02032238|20282019|P2|NOT COMPLETED|Overall Study||0
8224673|NCT02032238|20282020|P1|NOT COMPLETED|Overall Study||2
8224674|NCT02032238|20282019|P2|COMPLETED|Overall Study||0
8224675|NCT02032238|20282020|P1|COMPLETED|Overall Study||10
8224676|NCT02032238|20282019|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
8224677|NCT02032238|20282020|P1|STARTED|Overall Study||12
8224678|NCT02032212|20282030|P4|NOT COMPLETED|Overall Study||0
8224679|NCT02032212|20282031|P3|NOT COMPLETED|Overall Study||0
8224680|NCT02032212|20282032|P2|NOT COMPLETED|Overall Study||0
8224681|NCT02032212|20282033|P1|NOT COMPLETED|Overall Study||0
8224682|NCT02032212|20282030|P4|COMPLETED|Overall Study||3
8224683|NCT02032212|20282031|P3|COMPLETED|Overall Study||3
8224684|NCT02032212|20282032|P2|COMPLETED|Overall Study||3
8224685|NCT02032212|20282033|P1|COMPLETED|Overall Study||3
8224686|NCT02032212|20282030|P4|STARTED|Overall Study||3
8224687|NCT02032212|20282031|P3|STARTED|Overall Study||3
8224688|NCT02032212|20282032|P2|STARTED|Overall Study||3
8224689|NCT02032212|20282033|P1|STARTED|Overall Study||3
8224690|NCT02032173|20282059|P1|NOT COMPLETED|Overall Study||31
8224691|NCT02032173|20282059|P1|COMPLETED|Overall Study||0
8224692|NCT02032173|20282059|P1|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
8224693|NCT02032173|20282059|P1|Included Population - Main Group|Overall Study||31
8224694|NCT02032173|20282059|P1|STARTED|Overall Study||31
8224695|NCT02031770|20282072|P2|NOT COMPLETED|Overall Study||1
8224696|NCT02031770|20282073|P1|NOT COMPLETED|Overall Study||1
8224697|NCT02031770|20282072|P2|COMPLETED|Overall Study||9
8224698|NCT02031770|20282073|P1|COMPLETED|Overall Study||9
8224699|NCT02031770|20282072|P2|STARTED|Overall Study||10
8224700|NCT02031770|20282073|P1|STARTED|Overall Study||10
8224701|NCT02031679|20282081|P2|NOT COMPLETED|Overall Study||2
8224702|NCT02031679|20282082|P1|NOT COMPLETED|Overall Study||0
8224703|NCT02031679|20282081|P2|COMPLETED|Overall Study||12
8224704|NCT02031679|20282082|P1|COMPLETED|Overall Study||14
8224705|NCT02031679|20282081|P2|STARTED|Overall Study||14
8224706|NCT02031679|20282082|P1|STARTED|Overall Study||14
8224707|NCT02031640|20282097|P6|NOT COMPLETED|Double-blind Treatment Period||3
8224708|NCT02031640|20282098|P5|NOT COMPLETED|Double-blind Treatment Period||11
8224709|NCT02031640|20282099|P4|NOT COMPLETED|Double-blind Treatment Period||7
8224710|NCT02031640|20282100|P3|NOT COMPLETED|Double-blind Treatment Period||6
8224711|NCT02031640|20282101|P2|NOT COMPLETED|Double-blind Treatment Period||22
8224712|NCT02031640|20282102|P1|NOT COMPLETED|Double-blind Treatment Period||0
8224713|NCT02031640|20282097|P6|COMPLETED|Double-blind Treatment Period||104
8224714|NCT02031640|20282098|P5|COMPLETED|Double-blind Treatment Period||96
8224715|NCT02031640|20282099|P4|COMPLETED|Double-blind Treatment Period||99
8224716|NCT02031640|20282100|P3|COMPLETED|Double-blind Treatment Period||100
8224717|NCT02031640|20282101|P2|COMPLETED|Double-blind Treatment Period||84
8224718|NCT02031640|20282102|P1|COMPLETED|Double-blind Treatment Period||0
8224719|NCT02031640|20282097|P6|Full Analysis Set|Double-blind Treatment Period||107
8224720|NCT02031640|20282098|P5|Full Analysis Set|Double-blind Treatment Period||106
8224721|NCT02031640|20282099|P4|Full Analysis Set|Double-blind Treatment Period||106
8224722|NCT02031640|20282100|P3|Full Analysis Set|Double-blind Treatment Period||104
8224723|NCT02031640|20282101|P2|Full Analysis Set|Double-blind Treatment Period||106
8224724|NCT02031640|20282102|P1|Full Analysis Set|Double-blind Treatment Period||0
8224725|NCT02031640|20282097|P6|STARTED|Double-blind Treatment Period||107
8224726|NCT02031640|20282098|P5|STARTED|Double-blind Treatment Period||107
8224727|NCT02031640|20282099|P4|STARTED|Double-blind Treatment Period||106
8224728|NCT02031640|20282100|P3|STARTED|Double-blind Treatment Period||106
8224729|NCT02031640|20282101|P2|STARTED|Double-blind Treatment Period||106
8224730|NCT02031640|20282102|P1|STARTED|Double-blind Treatment Period||0
8224731|NCT02031640|20282097|P6|NOT COMPLETED|Run-In Period||0
8224732|NCT02031640|20282098|P5|NOT COMPLETED|Run-In Period||0
8224733|NCT02031640|20282099|P4|NOT COMPLETED|Run-In Period||0
8224734|NCT02031640|20282100|P3|NOT COMPLETED|Run-In Period||0
8224735|NCT02031640|20282101|P2|NOT COMPLETED|Run-In Period||0
8224736|NCT02031640|20282102|P1|NOT COMPLETED|Run-In Period||169
8224737|NCT02031640|20282097|P6|COMPLETED|Run-In Period||0
8224738|NCT02031640|20282098|P5|COMPLETED|Run-In Period||0
8224739|NCT02031640|20282099|P4|COMPLETED|Run-In Period||0
8224740|NCT02031640|20282100|P3|COMPLETED|Run-In Period||0
8224741|NCT02031640|20282101|P2|COMPLETED|Run-In Period||0
8224742|NCT02031640|20282102|P1|COMPLETED|Run-In Period||532
8224743|NCT02031640|20282097|P6|STARTED|Run-In Period||0
8224744|NCT02031640|20282098|P5|STARTED|Run-In Period||0
8224745|NCT02031640|20282099|P4|STARTED|Run-In Period||0
8224746|NCT02031640|20282100|P3|STARTED|Run-In Period||0
8224747|NCT02031640|20282101|P2|STARTED|Run-In Period||0
8224748|NCT02031640|20282102|P1|STARTED|Run-In Period||701
8224749|NCT02031640|20282097|P6|NOT COMPLETED|Screening Period||0
8224750|NCT02031640|20282098|P5|NOT COMPLETED|Screening Period||0
8224751|NCT02031640|20282099|P4|NOT COMPLETED|Screening Period||0
8224752|NCT02031640|20282100|P3|NOT COMPLETED|Screening Period||0
8224753|NCT02031640|20282101|P2|NOT COMPLETED|Screening Period||0
8224754|NCT02031640|20282102|P1|NOT COMPLETED|Screening Period||412
8224755|NCT02031640|20282097|P6|COMPLETED|Screening Period||0
8224756|NCT02031640|20282098|P5|COMPLETED|Screening Period||0
8224757|NCT02031640|20282099|P4|COMPLETED|Screening Period||0
8224758|NCT02031640|20282100|P3|COMPLETED|Screening Period||0
8224759|NCT02031640|20282101|P2|COMPLETED|Screening Period||0
8224760|NCT02031640|20282102|P1|COMPLETED|Screening Period||701
8224761|NCT02031640|20282097|P6|STARTED|Screening Period||0
8224762|NCT02031640|20282098|P5|STARTED|Screening Period||0
8224763|NCT02031640|20282099|P4|STARTED|Screening Period||0
8224764|NCT02031640|20282100|P3|STARTED|Screening Period||0
8224765|NCT02031640|20282101|P2|STARTED|Screening Period||0
8224766|NCT02031640|20282102|P1|STARTED|Screening Period|Consented|1113
8224767|NCT02031536|20282147|P2|NOT COMPLETED|Overall Study||0
8224768|NCT02031536|20282148|P1|NOT COMPLETED|Overall Study||1
8224769|NCT02031536|20282147|P2|COMPLETED|Overall Study||0
8224770|NCT02031536|20282148|P1|COMPLETED|Overall Study||1
8224771|NCT02031536|20282147|P2|STARTED|Overall Study||0
8224772|NCT02031536|20282148|P1|STARTED|Overall Study||2
8224773|NCT02031471|20282156|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
8224774|NCT02031471|20282156|P1|COMPLETED|Long Term Extension (LTE) Period||37
8224775|NCT02031471|20282156|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
8224776|NCT02031471|20282156|P1|NOT COMPLETED|24 Week Treatment Period||11
8224777|NCT02031471|20282156|P1|COMPLETED|24 Week Treatment Period||46
8224778|NCT02031471|20282156|P1|STARTED|24 Week Treatment Period||57
8224779|NCT02031458|20282189|P3|NOT COMPLETED|Baseline to May 8, 2015||253
8224780|NCT02031458|20282190|P2|NOT COMPLETED|Baseline to May 8, 2015||267
8224781|NCT02031458|20282191|P1|NOT COMPLETED|Baseline to May 8, 2015||139
8224782|NCT02031458|20282189|P3|COMPLETED|Baseline to May 8, 2015||0
8224783|NCT02031458|20282190|P2|COMPLETED|Baseline to May 8, 2015||0
8224784|NCT02031458|20282191|P1|COMPLETED|Baseline to May 8, 2015||0
8224785|NCT02031458|20282189|P3|STARTED|Baseline to May 8, 2015||253
8224786|NCT02031458|20282190|P2|STARTED|Baseline to May 8, 2015||267
8224787|NCT02031458|20282191|P1|STARTED|Baseline to May 8, 2015||139
8224788|NCT02031458|20282189|P3|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
8224789|NCT02031458|20282190|P2|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
8224790|NCT02031458|20282191|P1|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
8224791|NCT02031458|20282189|P3|COMPLETED|May 8, 2015 to January 11, 2019||0
8224792|NCT02031458|20282190|P2|COMPLETED|May 8, 2015 to January 11, 2019||0
8224793|NCT02031458|20282191|P1|COMPLETED|May 8, 2015 to January 11, 2019||0
8224794|NCT02031458|20282189|P3|STARTED|May 8, 2015 to January 11, 2019||252
8224795|NCT02031458|20282190|P2|STARTED|May 8, 2015 to January 11, 2019||269
8224796|NCT02031458|20282191|P1|STARTED|May 8, 2015 to January 11, 2019||138
8224797|NCT02031432|20282285|P1|NOT COMPLETED|Overall Study||38
8224798|NCT02031432|20282285|P1|COMPLETED|Overall Study||38
8224799|NCT02031432|20282285|P1|Completing the Treatment|Overall Study||39
8224800|NCT02031432|20282285|P1|Completing the Titration Phase|Overall Study||67
8224801|NCT02031432|20282285|P1|STARTED|Overall Study||76
8224802|NCT02031302|20282312|P2|NOT COMPLETED|Overall Study||0
8224803|NCT02031302|20282313|P1|NOT COMPLETED|Overall Study||164
8224804|NCT02031302|20282312|P2|COMPLETED|Overall Study||50
8224805|NCT02031302|20282313|P1|COMPLETED|Overall Study||850
8224806|NCT02031302|20282312|P2|STARTED|Overall Study||50
8224807|NCT02031302|20282313|P1|STARTED|Overall Study||1014
8224808|NCT02031276|20282334|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
8224809|NCT02031276|20282335|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
8224810|NCT02031276|20282336|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
8224811|NCT02031276|20282334|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
8224812|NCT02031276|20282335|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
8224813|NCT02031276|20282336|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
8224814|NCT02031276|20282334|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
8224815|NCT02031276|20282335|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
8224816|NCT02031276|20282336|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
8224817|NCT02031276|20282334|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
8224818|NCT02031276|20282335|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
8224819|NCT02031276|20282336|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
8224820|NCT02031276|20282334|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
8224821|NCT02031276|20282335|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
8224822|NCT02031276|20282336|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
8224823|NCT02031276|20282334|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
8224824|NCT02031276|20282335|P2|STARTED|Period 2 Open-label Risankizumab IV||35
8224825|NCT02031276|20282336|P1|STARTED|Period 2 Open-label Risankizumab IV||33
8224826|NCT02031276|20282334|P3|NOT COMPLETED|Period 1 Double-blind IV||1
8224827|NCT02031276|20282335|P2|NOT COMPLETED|Period 1 Double-blind IV||6
8224828|NCT02031276|20282336|P1|NOT COMPLETED|Period 1 Double-blind IV||6
8224829|NCT02031276|20282334|P3|COMPLETED|Period 1 Double-blind IV||40
8224830|NCT02031276|20282335|P2|COMPLETED|Period 1 Double-blind IV||35
8224831|NCT02031276|20282336|P1|COMPLETED|Period 1 Double-blind IV||33
8224832|NCT02031276|20282334|P3|STARTED|Period 1 Double-blind IV||41
8224833|NCT02031276|20282335|P2|STARTED|Period 1 Double-blind IV||41
8224834|NCT02031276|20282336|P1|STARTED|Period 1 Double-blind IV||39
8224835|NCT02031237|20282370|P3|NOT COMPLETED|Overall Study||3
8224836|NCT02031237|20282371|P2|NOT COMPLETED|Overall Study||14
8224837|NCT02031237|20282372|P1|NOT COMPLETED|Overall Study||5
8224838|NCT02031237|20282370|P3|COMPLETED|Overall Study||0
8224839|NCT02031237|20282371|P2|COMPLETED|Overall Study||21
8224840|NCT02031237|20282372|P1|COMPLETED|Overall Study||9
8224841|NCT02031237|20282370|P3|STARTED|Overall Study||3
8224842|NCT02031237|20282371|P2|STARTED|Overall Study||35
8224843|NCT02031237|20282372|P1|STARTED|Overall Study||14
8224844|NCT02030886|20282381|P2|NOT COMPLETED|Overall Study||0
8224845|NCT02030886|20282382|P1|NOT COMPLETED|Overall Study||0
8224846|NCT02030886|20282381|P2|COMPLETED|Overall Study||6
8224847|NCT02030886|20282382|P1|COMPLETED|Overall Study||14
8224848|NCT02030886|20282381|P2|STARTED|Overall Study||6
8224849|NCT02030886|20282382|P1|STARTED|Overall Study||14
8224850|NCT02030847|20282392|P1|NOT COMPLETED|Overall Study||37
8224851|NCT02030847|20282392|P1|COMPLETED|Overall Study||5
8224852|NCT02030847|20282392|P1|STARTED|Overall Study||42
8224853|NCT02030834|20282400|P3|NOT COMPLETED|Overall Study||3
8224854|NCT02030834|20282401|P2|NOT COMPLETED|Overall Study||0
8224855|NCT02030834|20282402|P1|NOT COMPLETED|Overall Study||11
8224856|NCT02030834|20282400|P3|COMPLETED|Overall Study||7
8224857|NCT02030834|20282401|P2|COMPLETED|Overall Study||3
8224858|NCT02030834|20282402|P1|COMPLETED|Overall Study||39
8224859|NCT02030834|20282400|P3|STARTED|Overall Study||10
8224860|NCT02030834|20282401|P2|STARTED|Overall Study||3
8224861|NCT02030834|20282402|P1|STARTED|Overall Study||50
8224862|NCT02030821|20282414|P4|NOT COMPLETED|Overall Study||2
8224863|NCT02030821|20282415|P3|NOT COMPLETED|Overall Study||5
8224864|NCT02030821|20282416|P2|NOT COMPLETED|Overall Study||2
8224865|NCT02030821|20282417|P1|NOT COMPLETED|Overall Study||2
8224866|NCT02030821|20282414|P4|COMPLETED|Overall Study||72
8224867|NCT02030821|20282415|P3|COMPLETED|Overall Study||73
8224868|NCT02030821|20282416|P2|COMPLETED|Overall Study||44
8224869|NCT02030821|20282417|P1|COMPLETED|Overall Study||46
8224870|NCT02030821|20282414|P4|STARTED|Overall Study||74
8224871|NCT02030821|20282415|P3|STARTED|Overall Study||78
8224872|NCT02030821|20282416|P2|STARTED|Overall Study||46
8224873|NCT02030821|20282417|P1|STARTED|Overall Study||48
8224874|NCT02030600|20282445|P2|NOT COMPLETED|Treatment Period 2||18
8224875|NCT02030600|20282446|P1|NOT COMPLETED|Treatment Period 2||25
8224876|NCT02030600|20282445|P2|COMPLETED|Treatment Period 2||297
8224877|NCT02030600|20282446|P1|COMPLETED|Treatment Period 2||283
8224878|NCT02030600|20282445|P2|STARTED|Treatment Period 2||315
8224879|NCT02030600|20282446|P1|STARTED|Treatment Period 2||308
8224880|NCT02030600|20282445|P2|NOT COMPLETED|Treatment Period 1||45
8224881|NCT02030600|20282446|P1|NOT COMPLETED|Treatment Period 1||53
8224882|NCT02030600|20282445|P2|COMPLETED|Treatment Period 1||315
8224883|NCT02030600|20282446|P1|COMPLETED|Treatment Period 1||308
8224884|NCT02030600|20282445|P2|Exposed|Treatment Period 1||357
8224885|NCT02030600|20282446|P1|Exposed|Treatment Period 1||356
8224886|NCT02030600|20282445|P2|STARTED|Treatment Period 1||360
8224887|NCT02030600|20282446|P1|STARTED|Treatment Period 1||361
8224888|NCT02030574|20282462|P1|NOT COMPLETED|Overall Study||0
8224889|NCT02030574|20282462|P1|COMPLETED|Overall Study||2
8224890|NCT02030574|20282462|P1|STARTED|Overall Study||2
8224891|NCT02030535|20282467|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8224892|NCT02030535|20282467|P1|COMPLETED|Treatment Period 3 (1 Day)||52
8224893|NCT02030535|20282467|P1|STARTED|Treatment Period 3 (1 Day)||52
8224894|NCT02030535|20282467|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
8224895|NCT02030535|20282467|P1|COMPLETED|Washout Period 2 (21 Days)||52
8224896|NCT02030535|20282467|P1|STARTED|Washout Period 2 (21 Days)||52
8224897|NCT02030535|20282467|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8224898|NCT02030535|20282467|P1|COMPLETED|Treatment Period 2 (1 Day)||52
8224899|NCT02030535|20282467|P1|STARTED|Treatment Period 2 (1 Day)||52
8224900|NCT02030535|20282467|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
8224901|NCT02030535|20282467|P1|COMPLETED|Washout Period 1 (21 Days)||52
8224902|NCT02030535|20282467|P1|STARTED|Washout Period 1 (21 Days)||53
8224903|NCT02030535|20282467|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8224904|NCT02030535|20282467|P1|COMPLETED|Treatment Period 1 (1 Day)||53
8224905|NCT02030535|20282467|P1|STARTED|Treatment Period 1 (1 Day)||53
8224906|NCT02030405|20282535|P1|NOT COMPLETED|Overall Study||2
8224907|NCT02030405|20282535|P1|COMPLETED|Overall Study||2
8224908|NCT02030405|20282535|P1|STARTED|Overall Study||4
8224909|NCT02030288|20282544|P2|NOT COMPLETED|Overall Study||0
8224910|NCT02030288|20282545|P1|NOT COMPLETED|Overall Study||0
8224911|NCT02030288|20282544|P2|COMPLETED|Overall Study||89
8224912|NCT02030288|20282545|P1|COMPLETED|Overall Study||89
8224913|NCT02030288|20282544|P2|STARTED|Overall Study||89
8224914|NCT02030288|20282545|P1|STARTED|Overall Study||89
8224915|NCT02030119|20282561|P4|NOT COMPLETED|Overall Study||3
8224916|NCT02030119|20282562|P3|NOT COMPLETED|Overall Study||6
8224917|NCT02030119|20282563|P2|NOT COMPLETED|Overall Study||2
8224918|NCT02030119|20282564|P1|NOT COMPLETED|Overall Study||3
8224919|NCT02030119|20282561|P4|COMPLETED|Overall Study||67
8224920|NCT02030119|20282562|P3|COMPLETED|Overall Study||65
8224921|NCT02030119|20282563|P2|COMPLETED|Overall Study||68
8224922|NCT02030119|20282564|P1|COMPLETED|Overall Study||67
8224923|NCT02030119|20282561|P4|STARTED|Overall Study||70
8224924|NCT02030119|20282562|P3|STARTED|Overall Study||71
8224925|NCT02030119|20282563|P2|STARTED|Overall Study||70
8224926|NCT02030119|20282564|P1|STARTED|Overall Study||70
8224927|NCT02030080|20282582|P4|NOT COMPLETED|Overall Study||2
8224928|NCT02030080|20282583|P3|NOT COMPLETED|Overall Study||0
8224929|NCT02030080|20282584|P2|NOT COMPLETED|Overall Study||0
8224930|NCT02030080|20282585|P1|NOT COMPLETED|Overall Study||0
8224931|NCT02030080|20282582|P4|COMPLETED|Overall Study||42
8224932|NCT02030080|20282583|P3|COMPLETED|Overall Study||80
8224933|NCT02030080|20282584|P2|COMPLETED|Overall Study||64
8224934|NCT02030080|20282585|P1|COMPLETED|Overall Study||100
8224935|NCT02030080|20282582|P4|STARTED|Overall Study|11 teams|44
8224936|NCT02030080|20282583|P3|STARTED|Overall Study|20 teams|80
8224937|NCT02030080|20282584|P2|STARTED|Overall Study|16 teams|64
8224938|NCT02030080|20282585|P1|STARTED|Overall Study|25 teams|100
8224939|NCT02030041|20282602|P3|NOT COMPLETED|Overall Study||1
8224940|NCT02030041|20282603|P2|NOT COMPLETED|Overall Study||2
8224941|NCT02030041|20282604|P1|NOT COMPLETED|Overall Study||2
8224942|NCT02030041|20282602|P3|COMPLETED|Overall Study||10
8224943|NCT02030041|20282603|P2|COMPLETED|Overall Study||9
8224944|NCT02030041|20282604|P1|COMPLETED|Overall Study||9
8224945|NCT02030041|20282602|P3|STARTED|Overall Study||11
8224946|NCT02030041|20282603|P2|STARTED|Overall Study||11
8224947|NCT02030041|20282604|P1|STARTED|Overall Study||11
8224948|NCT02030002|20282615|P1|NOT COMPLETED|Follow-up||2
8224949|NCT02030002|20282615|P1|COMPLETED|Follow-up||42
8224950|NCT02030002|20282615|P1|STARTED|Follow-up||44
8224951|NCT02030002|20282615|P1|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
8224952|NCT02030002|20282615|P1|COMPLETED|APC II Adhesive Coated Appliance System||44
8224953|NCT02030002|20282615|P1|STARTED|APC II Adhesive Coated Appliance System||44
8224954|NCT02030002|20282615|P1|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
8224955|NCT02030002|20282615|P1|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
8224956|NCT02030002|20282615|P1|STARTED|APC Flash-Free Adhesive Coated Appliance||44
8224957|NCT02030002|20282615|P1|NOT COMPLETED|Enrollment||5
8224958|NCT02030002|20282615|P1|COMPLETED|Enrollment||44
8224959|NCT02030002|20282615|P1|STARTED|Enrollment||49
8224960|NCT02029989|20282629|P2|NOT COMPLETED|Overall Study||11
8224961|NCT02029989|20282630|P1|NOT COMPLETED|Overall Study||16
8224962|NCT02029989|20282629|P2|COMPLETED|Overall Study||49
8224963|NCT02029989|20282630|P1|COMPLETED|Overall Study||45
8224964|NCT02029989|20282629|P2|STARTED|Overall Study||60
8224965|NCT02029989|20282630|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
8224966|NCT02029976|20282638|P2|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
8224967|NCT02029976|20282639|P1|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
8224968|NCT02029976|20282638|P2|COMPLETED|YR-2 Follow Up vs Baseline||124
8224969|NCT02029976|20282639|P1|COMPLETED|YR-2 Follow Up vs Baseline||122
8224970|NCT02029976|20282638|P2|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
8224971|NCT02029976|20282639|P1|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
8224972|NCT02029976|20282638|P2|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
8224973|NCT02029976|20282639|P1|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
8224974|NCT02029976|20282638|P2|COMPLETED|YR-1 Post Intervention vs Baseline||124
8224975|NCT02029976|20282639|P1|COMPLETED|YR-1 Post Intervention vs Baseline||120
8224976|NCT02029976|20282638|P2|STARTED|YR-1 Post Intervention vs Baseline||132
8224977|NCT02029976|20282639|P1|STARTED|YR-1 Post Intervention vs Baseline||132
8224978|NCT02029911|20282651|P1|NOT COMPLETED|Overall Study||0
8224979|NCT02029911|20282651|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
8224980|NCT02029911|20282651|P1|Treated|Overall Study|Treatment Completed|60
8224981|NCT02029911|20282651|P1|STARTED|Overall Study|Treatment Attempted|60
8224982|NCT02029872|20282659|P2|NOT COMPLETED|Overall Study||3
8224983|NCT02029872|20282660|P1|NOT COMPLETED|Overall Study||2
8224984|NCT02029872|20282659|P2|COMPLETED|Overall Study||6
8224985|NCT02029872|20282660|P1|COMPLETED|Overall Study||7
8224986|NCT02029872|20282659|P2|STARTED|Overall Study||9
8224987|NCT02029872|20282660|P1|STARTED|Overall Study||9
8224988|NCT02029846|20282668|P2|NOT COMPLETED|Overall Study||1
8224989|NCT02029846|20282669|P1|NOT COMPLETED|Overall Study||1
8224990|NCT02029846|20282668|P2|COMPLETED|Overall Study||0
8224991|NCT02029846|20282669|P1|COMPLETED|Overall Study||0
8224992|NCT02029846|20282668|P2|STARTED|Overall Study||1
8224993|NCT02029846|20282669|P1|STARTED|Overall Study||1
8224994|NCT02029755|20282682|P3|NOT COMPLETED|Overall Study||0
8224995|NCT02029755|20282683|P2|NOT COMPLETED|Overall Study||0
8224996|NCT02029755|20282684|P1|NOT COMPLETED|Overall Study||0
8224997|NCT02029755|20282682|P3|COMPLETED|Overall Study||36
8224998|NCT02029755|20282683|P2|COMPLETED|Overall Study||36
8224999|NCT02029755|20282684|P1|COMPLETED|Overall Study||36
8225000|NCT02029755|20282682|P3|STARTED|Overall Study||36
8225001|NCT02029755|20282683|P2|STARTED|Overall Study||36
8225002|NCT02029755|20282684|P1|STARTED|Overall Study||36
8225003|NCT02029703|20282697|P2|NOT COMPLETED|Overall Study||0
8225004|NCT02029703|20282698|P1|NOT COMPLETED|Overall Study||0
8225005|NCT02029703|20282697|P2|COMPLETED|Overall Study||22
8225006|NCT02029703|20282698|P1|COMPLETED|Overall Study||20
8225007|NCT02029703|20282697|P2|STARTED|Overall Study||22
8225008|NCT02029703|20282698|P1|STARTED|Overall Study||20
8225009|NCT02029638|20282707|P3|NOT COMPLETED|Overall Study||1
8225010|NCT02029638|20282708|P2|NOT COMPLETED|Overall Study||0
8225011|NCT02029638|20282709|P1|NOT COMPLETED|Overall Study||2
8225012|NCT02029638|20282707|P3|COMPLETED|Overall Study||0
8225013|NCT02029638|20282708|P2|COMPLETED|Overall Study||1
8225014|NCT02029638|20282709|P1|COMPLETED|Overall Study||0
8225015|NCT02029638|20282707|P3|STARTED|Overall Study||1
8225016|NCT02029638|20282708|P2|STARTED|Overall Study||1
8225017|NCT02029638|20282709|P1|STARTED|Overall Study||2
8225018|NCT02029521|20282738|P2|NOT COMPLETED|Overall Study||1
8225019|NCT02029521|20282739|P1|NOT COMPLETED|Overall Study||2
8225020|NCT02029521|20282738|P2|COMPLETED|Overall Study||22
8225021|NCT02029521|20282739|P1|COMPLETED|Overall Study||22
8225022|NCT02029521|20282738|P2|STARTED|Overall Study||23
8225023|NCT02029521|20282739|P1|STARTED|Overall Study||24
8225024|NCT02029495|20282824|P3|NOT COMPLETED|Overall Study||2
8225025|NCT02029495|20282825|P2|NOT COMPLETED|Overall Study||0
8225026|NCT02029495|20282826|P1|NOT COMPLETED|Overall Study||1
8225027|NCT02029495|20282824|P3|COMPLETED|Overall Study||159
8225028|NCT02029495|20282825|P2|COMPLETED|Overall Study||158
8225029|NCT02029495|20282826|P1|COMPLETED|Overall Study||158
8225030|NCT02029495|20282824|P3|STARTED|Overall Study||161
8225031|NCT02029495|20282825|P2|STARTED|Overall Study||158
8225032|NCT02029495|20282826|P1|STARTED|Overall Study||159
8225033|NCT02029417|20282837|P1|NOT COMPLETED|Overall Study||2
8225034|NCT02029417|20282837|P1|COMPLETED|Overall Study||0
8225035|NCT02029417|20282837|P1|STARTED|Overall Study||2
8225036|NCT02029274|20282846|P4|NOT COMPLETED|Overall Study||2
8225037|NCT02029274|20282847|P3|NOT COMPLETED|Overall Study||2
8225038|NCT02029274|20282848|P2|NOT COMPLETED|Overall Study||0
8225039|NCT02029274|20282849|P1|NOT COMPLETED|Overall Study||1
8225040|NCT02029274|20282846|P4|COMPLETED|Overall Study||2
8225041|NCT02029274|20282847|P3|COMPLETED|Overall Study||2
8225042|NCT02029274|20282848|P2|COMPLETED|Overall Study||4
8225043|NCT02029274|20282849|P1|COMPLETED|Overall Study||4
8225044|NCT02029274|20282846|P4|Fixed Dose Period 2|Overall Study||4
8225045|NCT02029274|20282847|P3|Fixed Dose Period 2|Overall Study||4
8225046|NCT02029274|20282848|P2|Fixed Dose Period 2|Overall Study||4
8225047|NCT02029274|20282849|P1|Fixed Dose Period 2|Overall Study||5
8225048|NCT02029274|20282846|P4|STARTED|Overall Study||4
8225049|NCT02029274|20282847|P3|STARTED|Overall Study||4
8225050|NCT02029274|20282848|P2|STARTED|Overall Study||4
8225051|NCT02029274|20282849|P1|STARTED|Overall Study||5
8225052|NCT02029235|20282881|P2|NOT COMPLETED|Overall Study||1
8225053|NCT02029235|20282882|P1|NOT COMPLETED|Overall Study||4
8225054|NCT02029235|20282881|P2|COMPLETED|Overall Study||30
8225055|NCT02029235|20282882|P1|COMPLETED|Overall Study||30
8225056|NCT02029235|20282881|P2|STARTED|Overall Study||31
8225057|NCT02029235|20282882|P1|STARTED|Overall Study||34
8225058|NCT02029196|20282892|P2|NOT COMPLETED|Overall Study||1
8225059|NCT02029196|20282893|P1|NOT COMPLETED|Overall Study||20
8225060|NCT02029196|20282892|P2|COMPLETED|Overall Study||101
8225061|NCT02029196|20282893|P1|COMPLETED|Overall Study||286
8225062|NCT02029196|20282892|P2|STARTED|Overall Study||102
8225063|NCT02029196|20282893|P1|STARTED|Overall Study||306
8225064|NCT02029040|20282903|P2|NOT COMPLETED|Overall Study||0
8225065|NCT02029040|20282904|P1|NOT COMPLETED|Overall Study||0
8225066|NCT02029040|20282903|P2|COMPLETED|Overall Study||25
8225067|NCT02029040|20282904|P1|COMPLETED|Overall Study||27
8225068|NCT02029040|20282903|P2|STARTED|Overall Study||25
8225069|NCT02029040|20282904|P1|STARTED|Overall Study||27
8225070|NCT02028884|20282914|P2|NOT COMPLETED|Open-label Extension Period||18
8225071|NCT02028884|20282915|P1|NOT COMPLETED|Open-label Extension Period||24
8225072|NCT02028884|20282914|P2|COMPLETED|Open-label Extension Period||0
8225073|NCT02028884|20282915|P1|COMPLETED|Open-label Extension Period||0
8225074|NCT02028884|20282914|P2|STARTED|Open-label Extension Period||18
8225075|NCT02028884|20282915|P1|STARTED|Open-label Extension Period||24
8225076|NCT02028884|20282914|P2|NOT COMPLETED|Double-blind Period||23
8225077|NCT02028884|20282915|P1|NOT COMPLETED|Double-blind Period||18
8225078|NCT02028884|20282914|P2|COMPLETED|Double-blind Period||18
8225079|NCT02028884|20282915|P1|COMPLETED|Double-blind Period||24
8225080|NCT02028884|20282914|P2|STARTED|Double-blind Period||41
8225081|NCT02028884|20282915|P1|STARTED|Double-blind Period||42
8225082|NCT02028871|20282985|P2|NOT COMPLETED|Overall Study||3
8225083|NCT02028871|20282986|P1|NOT COMPLETED|Overall Study||4
8225084|NCT02028871|20282985|P2|COMPLETED|Overall Study||9
8225085|NCT02028871|20282986|P1|COMPLETED|Overall Study||10
8225086|NCT02028871|20282985|P2|STARTED|Overall Study||12
8225087|NCT02028871|20282986|P1|STARTED|Overall Study||14
8225088|NCT02028780|20283007|P12|NOT COMPLETED|Follow up Phase||0
8225089|NCT02028780|20283008|P11|NOT COMPLETED|Follow up Phase||0
8225090|NCT02028780|20283009|P10|NOT COMPLETED|Follow up Phase||0
8225091|NCT02028780|20283010|P9|NOT COMPLETED|Follow up Phase||0
8225092|NCT02028780|20283011|P8|NOT COMPLETED|Follow up Phase||0
8225093|NCT02028780|20283012|P7|NOT COMPLETED|Follow up Phase||0
8225094|NCT02028780|20283013|P6|NOT COMPLETED|Follow up Phase||0
8225095|NCT02028780|20283014|P5|NOT COMPLETED|Follow up Phase||0
8225096|NCT02028780|20283015|P4|NOT COMPLETED|Follow up Phase||0
8225097|NCT02028780|20283016|P3|NOT COMPLETED|Follow up Phase||0
8225098|NCT02028780|20283017|P2|NOT COMPLETED|Follow up Phase||0
8225099|NCT02028780|20283018|P1|NOT COMPLETED|Follow up Phase||0
8225100|NCT02028780|20283007|P12|COMPLETED|Follow up Phase||9
8225101|NCT02028780|20283008|P11|COMPLETED|Follow up Phase||9
8225102|NCT02028780|20283009|P10|COMPLETED|Follow up Phase||9
8225103|NCT02028780|20283010|P9|COMPLETED|Follow up Phase||9
8225104|NCT02028780|20283011|P8|COMPLETED|Follow up Phase||3
8225105|NCT02028780|20283012|P7|COMPLETED|Follow up Phase||9
8225106|NCT02028780|20283013|P6|COMPLETED|Follow up Phase||6
8225107|NCT02028780|20283014|P5|COMPLETED|Follow up Phase||6
8225108|NCT02028780|20283015|P4|COMPLETED|Follow up Phase||6
8225109|NCT02028780|20283016|P3|COMPLETED|Follow up Phase||6
8225110|NCT02028780|20283017|P2|COMPLETED|Follow up Phase||2
8225111|NCT02028780|20283018|P1|COMPLETED|Follow up Phase||6
8225112|NCT02028780|20283007|P12|STARTED|Follow up Phase||9
8225113|NCT02028780|20283008|P11|STARTED|Follow up Phase||9
8225114|NCT02028780|20283009|P10|STARTED|Follow up Phase||9
8225115|NCT02028780|20283010|P9|STARTED|Follow up Phase||9
8225116|NCT02028780|20283011|P8|STARTED|Follow up Phase||3
8225117|NCT02028780|20283012|P7|STARTED|Follow up Phase||9
8225118|NCT02028780|20283013|P6|STARTED|Follow up Phase||6
8225119|NCT02028780|20283014|P5|STARTED|Follow up Phase||6
8225120|NCT02028780|20283015|P4|STARTED|Follow up Phase||6
8225121|NCT02028780|20283016|P3|STARTED|Follow up Phase||6
8225122|NCT02028780|20283017|P2|STARTED|Follow up Phase||2
8225123|NCT02028780|20283018|P1|STARTED|Follow up Phase||6
8225124|NCT02028780|20283007|P12|NOT COMPLETED|Observation Phase||0
8225125|NCT02028780|20283008|P11|NOT COMPLETED|Observation Phase||0
8225126|NCT02028780|20283009|P10|NOT COMPLETED|Observation Phase||0
8225127|NCT02028780|20283010|P9|NOT COMPLETED|Observation Phase||0
8225128|NCT02028780|20283011|P8|NOT COMPLETED|Observation Phase||0
8225129|NCT02028780|20283012|P7|NOT COMPLETED|Observation Phase||0
8225130|NCT02028780|20283013|P6|NOT COMPLETED|Observation Phase||0
8225131|NCT02028780|20283014|P5|NOT COMPLETED|Observation Phase||0
8225132|NCT02028780|20283015|P4|NOT COMPLETED|Observation Phase||0
8225133|NCT02028780|20283016|P3|NOT COMPLETED|Observation Phase||0
8225134|NCT02028780|20283017|P2|NOT COMPLETED|Observation Phase||0
8225135|NCT02028780|20283018|P1|NOT COMPLETED|Observation Phase||0
8225136|NCT02028780|20283007|P12|COMPLETED|Observation Phase||9
8225137|NCT02028780|20283008|P11|COMPLETED|Observation Phase||9
8225138|NCT02028780|20283009|P10|COMPLETED|Observation Phase||9
8225139|NCT02028780|20283010|P9|COMPLETED|Observation Phase||9
8225140|NCT02028780|20283011|P8|COMPLETED|Observation Phase||3
8225141|NCT02028780|20283012|P7|COMPLETED|Observation Phase||9
8225142|NCT02028780|20283013|P6|COMPLETED|Observation Phase||6
8225143|NCT02028780|20283014|P5|COMPLETED|Observation Phase||6
8225144|NCT02028780|20283015|P4|COMPLETED|Observation Phase||6
8225145|NCT02028780|20283016|P3|COMPLETED|Observation Phase||6
8225146|NCT02028780|20283017|P2|COMPLETED|Observation Phase||2
8225147|NCT02028780|20283018|P1|COMPLETED|Observation Phase||6
8225148|NCT02028780|20283007|P12|STARTED|Observation Phase||9
8225149|NCT02028780|20283008|P11|STARTED|Observation Phase||9
8225150|NCT02028780|20283009|P10|STARTED|Observation Phase||9
8225151|NCT02028780|20283010|P9|STARTED|Observation Phase||9
8225152|NCT02028780|20283011|P8|STARTED|Observation Phase||3
8225153|NCT02028780|20283012|P7|STARTED|Observation Phase||9
8225154|NCT02028780|20283013|P6|STARTED|Observation Phase||6
8225155|NCT02028780|20283014|P5|STARTED|Observation Phase||6
8225156|NCT02028780|20283015|P4|STARTED|Observation Phase||6
8225157|NCT02028780|20283016|P3|STARTED|Observation Phase||6
8225158|NCT02028780|20283017|P2|STARTED|Observation Phase||2
8225159|NCT02028780|20283018|P1|STARTED|Observation Phase||6
8225160|NCT02028767|20283083|P2|NOT COMPLETED|Treatment Period 2||0
8225161|NCT02028767|20283084|P1|NOT COMPLETED|Treatment Period 2||2
8225162|NCT02028767|20283083|P2|COMPLETED|Treatment Period 2||16
8225163|NCT02028767|20283084|P1|COMPLETED|Treatment Period 2||14
8225164|NCT02028767|20283083|P2|STARTED|Treatment Period 2||16
8225165|NCT02028767|20283084|P1|STARTED|Treatment Period 2||16
8225166|NCT02028767|20283083|P2|NOT COMPLETED|Treatment Period 1||0
8225167|NCT02028767|20283084|P1|NOT COMPLETED|Treatment Period 1||0
8225168|NCT02028767|20283083|P2|COMPLETED|Treatment Period 1||16
8225169|NCT02028767|20283084|P1|COMPLETED|Treatment Period 1||16
8225170|NCT02028767|20283083|P2|STARTED|Treatment Period 1||16
8225171|NCT02028767|20283084|P1|STARTED|Treatment Period 1||16
8225172|NCT02028754|20283096|P2|NOT COMPLETED|Overall Study||8
8225173|NCT02028754|20283097|P1|NOT COMPLETED|Overall Study||7
8225174|NCT02028754|20283096|P2|COMPLETED|Overall Study||82
8225175|NCT02028754|20283097|P1|COMPLETED|Overall Study||83
8225176|NCT02028754|20283096|P2|STARTED|Overall Study||90
8225177|NCT02028754|20283097|P1|STARTED|Overall Study||90
8225178|NCT02028715|20283117|P2|NOT COMPLETED|Overall Study||4
8225179|NCT02028715|20283118|P1|NOT COMPLETED|Overall Study||5
8225180|NCT02028715|20283117|P2|COMPLETED|Overall Study||30
8225181|NCT02028715|20283118|P1|COMPLETED|Overall Study||29
8225182|NCT02028715|20283117|P2|STARTED|Overall Study||34
8225183|NCT02028715|20283118|P1|STARTED|Overall Study||34
8225184|NCT02028676|20283145|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225185|NCT02028676|20283146|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225186|NCT02028676|20283147|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225187|NCT02028676|20283148|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225188|NCT02028676|20283149|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225189|NCT02028676|20283150|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225190|NCT02028676|20283151|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225191|NCT02028676|20283152|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225192|NCT02028676|20283153|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225193|NCT02028676|20283145|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
8225194|NCT02028676|20283146|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
8225195|NCT02028676|20283147|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225196|NCT02028676|20283148|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225197|NCT02028676|20283149|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225198|NCT02028676|20283150|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225199|NCT02028676|20283151|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225200|NCT02028676|20283152|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225201|NCT02028676|20283153|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225202|NCT02028676|20283145|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
8225203|NCT02028676|20283146|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
8225204|NCT02028676|20283147|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
8225205|NCT02028676|20283148|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
8225206|NCT02028676|20283149|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
8225207|NCT02028676|20283150|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
8225208|NCT02028676|20283151|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
8225209|NCT02028676|20283152|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
8225210|NCT02028676|20283153|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
8225211|NCT02028676|20283145|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225212|NCT02028676|20283146|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225213|NCT02028676|20283147|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225214|NCT02028676|20283148|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225215|NCT02028676|20283149|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225216|NCT02028676|20283150|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225217|NCT02028676|20283151|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225218|NCT02028676|20283152|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225219|NCT02028676|20283153|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225220|NCT02028676|20283145|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225221|NCT02028676|20283146|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225222|NCT02028676|20283147|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
8225223|NCT02028676|20283148|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
8225224|NCT02028676|20283149|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225225|NCT02028676|20283150|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225226|NCT02028676|20283151|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225227|NCT02028676|20283152|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225228|NCT02028676|20283153|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225229|NCT02028676|20283145|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225230|NCT02028676|20283146|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225231|NCT02028676|20283147|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
8225232|NCT02028676|20283148|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
8225233|NCT02028676|20283149|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225234|NCT02028676|20283150|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225235|NCT02028676|20283151|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225236|NCT02028676|20283152|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225237|NCT02028676|20283153|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225238|NCT02028676|20283145|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225239|NCT02028676|20283146|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225240|NCT02028676|20283147|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225241|NCT02028676|20283148|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225242|NCT02028676|20283149|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225243|NCT02028676|20283150|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225244|NCT02028676|20283151|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225245|NCT02028676|20283152|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225246|NCT02028676|20283153|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225247|NCT02028676|20283145|P9|COMPLETED|Initial Enrolment: Induction ART||0
8225248|NCT02028676|20283146|P8|COMPLETED|Initial Enrolment: Induction ART||0
8225249|NCT02028676|20283147|P7|COMPLETED|Initial Enrolment: Induction ART||0
8225250|NCT02028676|20283148|P6|COMPLETED|Initial Enrolment: Induction ART||0
8225251|NCT02028676|20283149|P5|COMPLETED|Initial Enrolment: Induction ART||405
8225252|NCT02028676|20283150|P4|COMPLETED|Initial Enrolment: Induction ART||404
8225253|NCT02028676|20283151|P3|COMPLETED|Initial Enrolment: Induction ART||397
8225254|NCT02028676|20283152|P2|COMPLETED|Initial Enrolment: Induction ART||0
8225255|NCT02028676|20283153|P1|COMPLETED|Initial Enrolment: Induction ART||0
8225256|NCT02028676|20283145|P9|STARTED|Initial Enrolment: Induction ART||0
8225257|NCT02028676|20283146|P8|STARTED|Initial Enrolment: Induction ART||0
8225258|NCT02028676|20283147|P7|STARTED|Initial Enrolment: Induction ART||0
8225259|NCT02028676|20283148|P6|STARTED|Initial Enrolment: Induction ART||0
8225260|NCT02028676|20283149|P5|STARTED|Initial Enrolment: Induction ART||405
8225261|NCT02028676|20283150|P4|STARTED|Initial Enrolment: Induction ART||404
8225262|NCT02028676|20283151|P3|STARTED|Initial Enrolment: Induction ART||397
8225263|NCT02028676|20283152|P2|STARTED|Initial Enrolment: Induction ART||0
8225264|NCT02028676|20283153|P1|STARTED|Initial Enrolment: Induction ART||0
8225265|NCT02028676|20283145|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225266|NCT02028676|20283146|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225267|NCT02028676|20283147|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225268|NCT02028676|20283148|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225269|NCT02028676|20283149|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225270|NCT02028676|20283150|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225271|NCT02028676|20283151|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225272|NCT02028676|20283152|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225273|NCT02028676|20283153|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225274|NCT02028676|20283145|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225275|NCT02028676|20283146|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225276|NCT02028676|20283147|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225277|NCT02028676|20283148|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225278|NCT02028676|20283149|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225279|NCT02028676|20283150|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225280|NCT02028676|20283151|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225281|NCT02028676|20283152|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
8225282|NCT02028676|20283153|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
8225283|NCT02028676|20283145|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225284|NCT02028676|20283146|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225285|NCT02028676|20283147|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225286|NCT02028676|20283148|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225287|NCT02028676|20283149|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8225288|NCT02028676|20283150|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8225289|NCT02028676|20283151|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8225290|NCT02028676|20283152|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
8225291|NCT02028676|20283153|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
8225292|NCT02028325|20283326|P1|NOT COMPLETED|Overall Study||10
8225293|NCT02028325|20283326|P1|COMPLETED|Overall Study||126
8225294|NCT02028325|20283326|P1|STARTED|Overall Study||136
8225295|NCT02028208|20283333|P3|NOT COMPLETED|Overall Study||1
8225296|NCT02028208|20283334|P2|NOT COMPLETED|Overall Study||0
8225297|NCT02028208|20283335|P1|NOT COMPLETED|Overall Study||0
8225298|NCT02028208|20283333|P3|COMPLETED|Overall Study||21
8225299|NCT02028208|20283334|P2|COMPLETED|Overall Study||13
8225300|NCT02028208|20283335|P1|COMPLETED|Overall Study||21
8225301|NCT02028208|20283333|P3|STARTED|Overall Study||22
8225302|NCT02028208|20283334|P2|STARTED|Overall Study||13
8225303|NCT02028208|20283335|P1|STARTED|Overall Study||21
8225304|NCT02028182|20283346|P1|NOT COMPLETED|Overall Study||2
8225305|NCT02028182|20283346|P1|COMPLETED|Overall Study||20
8225306|NCT02028182|20283346|P1|STARTED|Overall Study||22
8225307|NCT02028169|20283352|P1|NOT COMPLETED|Overall Study||28
8225308|NCT02028169|20283352|P1|COMPLETED|Overall Study||92
8225309|NCT02028169|20283352|P1|STARTED|Overall Study||120
8225310|NCT02028065|20283378|P3|NOT COMPLETED|Treatment Through Study Completion||14
8225311|NCT02028065|20283379|P2|NOT COMPLETED|Treatment Through Study Completion||15
8225312|NCT02028065|20283380|P1|NOT COMPLETED|Treatment Through Study Completion||12
8225313|NCT02028065|20283378|P3|COMPLETED|Treatment Through Study Completion||134
8225314|NCT02028065|20283379|P2|COMPLETED|Treatment Through Study Completion||136
8225315|NCT02028065|20283380|P1|COMPLETED|Treatment Through Study Completion||64
8225316|NCT02028065|20283378|P3|Received Third Dose|Treatment Through Study Completion||134
8225317|NCT02028065|20283379|P2|Received Third Dose|Treatment Through Study Completion||136
8225318|NCT02028065|20283380|P1|Received Third Dose|Treatment Through Study Completion||64
8225319|NCT02028065|20283378|P3|Received Second Dose|Treatment Through Study Completion||138
8225320|NCT02028065|20283379|P2|Received Second Dose|Treatment Through Study Completion||140
8225321|NCT02028065|20283380|P1|Received Second Dose|Treatment Through Study Completion||69
8225322|NCT02028065|20283378|P3|Received First Dose|Treatment Through Study Completion||148
8225323|NCT02028065|20283379|P2|Received First Dose|Treatment Through Study Completion||151
8225324|NCT02028065|20283380|P1|Received First Dose|Treatment Through Study Completion||76
8225325|NCT02028065|20283378|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
8225326|NCT02028065|20283379|P2|STARTED|Treatment Through Study Completion||151
8225327|NCT02028065|20283380|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
8225328|NCT02028065|20283378|P3|NOT COMPLETED|Randomization Through Start Treatment||3
8225329|NCT02028065|20283379|P2|NOT COMPLETED|Randomization Through Start Treatment||3
8225330|NCT02028065|20283380|P1|NOT COMPLETED|Randomization Through Start Treatment||1
8225331|NCT02028065|20283378|P3|COMPLETED|Randomization Through Start Treatment||149
8225332|NCT02028065|20283379|P2|COMPLETED|Randomization Through Start Treatment||151
8225333|NCT02028065|20283380|P1|COMPLETED|Randomization Through Start Treatment||75
8225334|NCT02028065|20283378|P3|STARTED|Randomization Through Start Treatment|Randomized|152
8225335|NCT02028065|20283379|P2|STARTED|Randomization Through Start Treatment|Randomized|154
8225336|NCT02028065|20283380|P1|STARTED|Randomization Through Start Treatment|Randomized|76
8225337|NCT02027883|20283393|P2|NOT COMPLETED|Overall Study||0
8225338|NCT02027883|20283394|P1|NOT COMPLETED|Overall Study||0
8225339|NCT02027883|20283393|P2|COMPLETED|Overall Study||50
8225340|NCT02027883|20283394|P1|COMPLETED|Overall Study||50
8225341|NCT02027883|20283393|P2|STARTED|Overall Study||50
8225342|NCT02027883|20283394|P1|STARTED|Overall Study||50
8225343|NCT02027844|20283407|P3|NOT COMPLETED|Overall Study||2
8225344|NCT02027844|20283408|P2|NOT COMPLETED|Overall Study||6
8225345|NCT02027844|20283409|P1|NOT COMPLETED|Overall Study||5
8225346|NCT02027844|20283407|P3|COMPLETED|Overall Study||37
8225347|NCT02027844|20283408|P2|COMPLETED|Overall Study||33
8225348|NCT02027844|20283409|P1|COMPLETED|Overall Study||34
8225349|NCT02027844|20283407|P3|STARTED|Overall Study||39
8225350|NCT02027844|20283408|P2|STARTED|Overall Study||39
8225351|NCT02027844|20283409|P1|STARTED|Overall Study||39
8225352|NCT02027701|20283426|P1|NOT COMPLETED|Overall Study||16
8225353|NCT02027701|20283426|P1|COMPLETED|Overall Study||66
8225354|NCT02027701|20283426|P1|STARTED|Overall Study||82
8225355|NCT02027623|20283444|P2|NOT COMPLETED|Overall Study||12
8225356|NCT02027623|20283445|P1|NOT COMPLETED|Overall Study||9
8225357|NCT02027623|20283444|P2|COMPLETED|Overall Study||65
8225358|NCT02027623|20283445|P1|COMPLETED|Overall Study||68
8225359|NCT02027623|20283444|P2|STARTED|Overall Study||77
8225360|NCT02027623|20283445|P1|STARTED|Overall Study||77
8225361|NCT02027558|20283541|P2|NOT COMPLETED|Overall Study||2
8225362|NCT02027558|20283542|P1|NOT COMPLETED|Overall Study||9
8225363|NCT02027558|20283541|P2|COMPLETED|Overall Study||61
8225364|NCT02027558|20283542|P1|COMPLETED|Overall Study||53
8225365|NCT02027558|20283541|P2|6-month Follow-up|Overall Study||61
8225366|NCT02027558|20283542|P1|6-month Follow-up|Overall Study||53
8225367|NCT02027558|20283541|P2|3-month Follow-up|Overall Study||58
8225368|NCT02027558|20283542|P1|3-month Follow-up|Overall Study||53
8225369|NCT02027558|20283541|P2|Post-treatment|Overall Study||60
8225370|NCT02027558|20283542|P1|Post-treatment|Overall Study||49
8225371|NCT02027558|20283541|P2|STARTED|Overall Study||63
8225372|NCT02027558|20283542|P1|STARTED|Overall Study||62
8225373|NCT02027545|20283560|P2|NOT COMPLETED|Overall Study||2
8225374|NCT02027545|20283561|P1|NOT COMPLETED|Overall Study||2
8225375|NCT02027545|20283560|P2|COMPLETED|Overall Study||173
8225376|NCT02027545|20283561|P1|COMPLETED|Overall Study||259
8225377|NCT02027545|20283560|P2|STARTED|Overall Study||175
8225378|NCT02027545|20283561|P1|STARTED|Overall Study||261
8225379|NCT02027428|20283573|P3|NOT COMPLETED|Survival Follow-up||46
8225380|NCT02027428|20283574|P2|NOT COMPLETED|Survival Follow-up||79
8225381|NCT02027428|20283575|P1|NOT COMPLETED|Survival Follow-up||0
8225382|NCT02027428|20283573|P3|COMPLETED|Survival Follow-up||9
8225383|NCT02027428|20283574|P2|COMPLETED|Survival Follow-up||38
8225384|NCT02027428|20283575|P1|COMPLETED|Survival Follow-up||0
8225385|NCT02027428|20283573|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
8225386|NCT02027428|20283574|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
8225387|NCT02027428|20283575|P1|STARTED|Survival Follow-up||0
8225388|NCT02027428|20283573|P3|NOT COMPLETED|Maintenance||60
8225389|NCT02027428|20283574|P2|NOT COMPLETED|Maintenance||124
8225390|NCT02027428|20283575|P1|NOT COMPLETED|Maintenance||0
8225391|NCT02027428|20283573|P3|COMPLETED|Maintenance||6
8225392|NCT02027428|20283574|P2|COMPLETED|Maintenance||12
8225393|NCT02027428|20283575|P1|COMPLETED|Maintenance||0
8225394|NCT02027428|20283573|P3|STARTED|Maintenance||66
8225395|NCT02027428|20283574|P2|STARTED|Maintenance||136
8225396|NCT02027428|20283575|P1|STARTED|Maintenance||0
8225397|NCT02027428|20283573|P3|NOT COMPLETED|Induction||0
8225398|NCT02027428|20283574|P2|NOT COMPLETED|Induction||0
8225399|NCT02027428|20283575|P1|NOT COMPLETED|Induction||225
8225400|NCT02027428|20283573|P3|COMPLETED|Induction||0
8225401|NCT02027428|20283574|P2|COMPLETED|Induction||0
8225402|NCT02027428|20283575|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
8225403|NCT02027428|20283573|P3|Received Study Drug|Induction||0
8225404|NCT02027428|20283574|P2|Received Study Drug|Induction||0
8225405|NCT02027428|20283575|P1|Received Study Drug|Induction||420
8225406|NCT02027428|20283573|P3|STARTED|Induction||0
8225407|NCT02027428|20283574|P2|STARTED|Induction||0
8225408|NCT02027428|20283575|P1|STARTED|Induction||427
8225409|NCT02027402|20283613|P2|NOT COMPLETED|Overall Study||1
8225410|NCT02027402|20283614|P1|NOT COMPLETED|Overall Study||4
8225411|NCT02027402|20283613|P2|COMPLETED|Overall Study||99
8225412|NCT02027402|20283614|P1|COMPLETED|Overall Study||94
8225413|NCT02027402|20283613|P2|STARTED|Overall Study||100
8225414|NCT02027402|20283614|P1|STARTED|Overall Study||98
8225415|NCT02027376|20283626|P3|NOT COMPLETED|Overall Study||0
8225416|NCT02027376|20283627|P2|NOT COMPLETED|Overall Study||0
8225417|NCT02027376|20283628|P1|NOT COMPLETED|Overall Study||1
8225418|NCT02027376|20283626|P3|COMPLETED|Overall Study||3
8225419|NCT02027376|20283627|P2|COMPLETED|Overall Study||4
8225420|NCT02027376|20283628|P1|COMPLETED|Overall Study||4
8225421|NCT02027376|20283626|P3|STARTED|Overall Study||3
8225422|NCT02027376|20283627|P2|STARTED|Overall Study||4
8225423|NCT02027376|20283628|P1|STARTED|Overall Study||5
8225424|NCT02027311|20283654|P2|NOT COMPLETED|Overall Study||2
8225425|NCT02027311|20283655|P1|NOT COMPLETED|Overall Study||3
8225426|NCT02027311|20283654|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
8225427|NCT02027311|20283655|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
8225428|NCT02027311|20283654|P2|STARTED|Overall Study||35
8225429|NCT02027311|20283655|P1|STARTED|Overall Study||33
8225430|NCT02027272|20283665|P2|NOT COMPLETED|Overall Study||1
8225431|NCT02027272|20283666|P1|NOT COMPLETED|Overall Study||0
8225432|NCT02027272|20283665|P2|COMPLETED|Overall Study||0
8225433|NCT02027272|20283666|P1|COMPLETED|Overall Study||0
8225434|NCT02027272|20283665|P2|STARTED|Overall Study||1
8225435|NCT02027272|20283666|P1|STARTED|Overall Study||0
8225436|NCT02027025|20283675|P3|NOT COMPLETED|Overall Study||1
8225437|NCT02027025|20283676|P2|NOT COMPLETED|Overall Study||5
8225438|NCT02027025|20283677|P1|NOT COMPLETED|Overall Study||1
8225439|NCT02027025|20283675|P3|COMPLETED|Overall Study||46
8225440|NCT02027025|20283676|P2|COMPLETED|Overall Study||42
8225441|NCT02027025|20283677|P1|COMPLETED|Overall Study||47
8225442|NCT02027025|20283675|P3|STARTED|Overall Study||47
8225443|NCT02027025|20283676|P2|STARTED|Overall Study||47
8225444|NCT02027025|20283677|P1|STARTED|Overall Study||48
8225445|NCT02026687|20283698|P2|NOT COMPLETED|Overall Study||2
8225446|NCT02026687|20283699|P1|NOT COMPLETED|Overall Study||1
8225447|NCT02026687|20283698|P2|COMPLETED|Overall Study||38
8225448|NCT02026687|20283699|P1|COMPLETED|Overall Study||39
8225449|NCT02026687|20283698|P2|STARTED|Overall Study||40
8225450|NCT02026687|20283699|P1|STARTED|Overall Study||40
8225451|NCT02026453|20283712|P3|NOT COMPLETED|Overall Study||13
8225452|NCT02026453|20283713|P2|NOT COMPLETED|Overall Study||9
8225453|NCT02026453|20283714|P1|NOT COMPLETED|Overall Study||6
8225454|NCT02026453|20283712|P3|COMPLETED|Overall Study||89
8225455|NCT02026453|20283713|P2|COMPLETED|Overall Study||94
8225456|NCT02026453|20283714|P1|COMPLETED|Overall Study||95
8225457|NCT02026453|20283712|P3|STARTED|Overall Study||102
8225458|NCT02026453|20283713|P2|STARTED|Overall Study||103
8225459|NCT02026453|20283714|P1|STARTED|Overall Study||101
8225460|NCT02026297|20283727|P2|NOT COMPLETED|Overall Study||0
8225461|NCT02026297|20283728|P1|NOT COMPLETED|Overall Study||0
8225462|NCT02026297|20283727|P2|COMPLETED|Overall Study||13
8225463|NCT02026297|20283728|P1|COMPLETED|Overall Study||7
8225464|NCT02026297|20283727|P2|STARTED|Overall Study||13
8225465|NCT02026297|20283728|P1|STARTED|Overall Study||7
8225466|NCT02026258|20283740|P2|NOT COMPLETED|Recieved Allocated Intervention||2
8225467|NCT02026258|20283741|P1|NOT COMPLETED|Recieved Allocated Intervention||1
8225468|NCT02026258|20283740|P2|COMPLETED|Recieved Allocated Intervention||17
8225469|NCT02026258|20283741|P1|COMPLETED|Recieved Allocated Intervention||15
8225470|NCT02026258|20283740|P2|STARTED|Recieved Allocated Intervention||19
8225471|NCT02026258|20283741|P1|STARTED|Recieved Allocated Intervention||16
8225472|NCT02026258|20283740|P2|NOT COMPLETED|Randomized||2
8225473|NCT02026258|20283741|P1|NOT COMPLETED|Randomized||4
8225474|NCT02026258|20283740|P2|COMPLETED|Randomized||19
8225475|NCT02026258|20283741|P1|COMPLETED|Randomized||16
8225476|NCT02026258|20283740|P2|STARTED|Randomized||21
8225477|NCT02026258|20283741|P1|STARTED|Randomized||20
8225478|NCT02026206|20283755|P2|NOT COMPLETED|Overall Study||8
8225479|NCT02026206|20283756|P1|NOT COMPLETED|Overall Study||4
8225480|NCT02026206|20283755|P2|COMPLETED|Overall Study||36
8225481|NCT02026206|20283756|P1|COMPLETED|Overall Study||40
8225482|NCT02026206|20283755|P2|STARTED|Overall Study||44
8225483|NCT02026206|20283756|P1|STARTED|Overall Study||44
8225484|NCT02026193|20283766|P2|NOT COMPLETED|Overall Study||0
8225485|NCT02026193|20283767|P1|NOT COMPLETED|Overall Study||0
8225486|NCT02026193|20283766|P2|COMPLETED|Overall Study||8
8225487|NCT02026193|20283767|P1|COMPLETED|Overall Study||3
8225488|NCT02026193|20283766|P2|STARTED|Overall Study||8
8225489|NCT02026193|20283767|P1|STARTED|Overall Study||3
8225490|NCT02026141|20283775|P2|NOT COMPLETED|Overall Study||1
8225491|NCT02026141|20283776|P1|NOT COMPLETED|Overall Study||0
8225492|NCT02026141|20283775|P2|COMPLETED|Overall Study||19
8225493|NCT02026141|20283776|P1|COMPLETED|Overall Study||20
8225494|NCT02026141|20283775|P2|STARTED|Overall Study||20
8225495|NCT02026141|20283776|P1|STARTED|Overall Study||20
8225496|NCT02026063|20283784|P2|NOT COMPLETED|Overall Study||49
8225497|NCT02026063|20283785|P1|NOT COMPLETED|Overall Study||9
8225498|NCT02026063|20283784|P2|COMPLETED|Overall Study||53
8225499|NCT02026063|20283785|P1|COMPLETED|Overall Study||13
8225500|NCT02026063|20283784|P2|STARTED|Overall Study||102
8225501|NCT02026063|20283785|P1|STARTED|Overall Study||22
8225502|NCT02026011|20283797|P2|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
8225503|NCT02026011|20283798|P1|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
8225504|NCT02026011|20283797|P2|COMPLETED|Allocation 2 (Second Set of Medication)||35
8225505|NCT02026011|20283798|P1|COMPLETED|Allocation 2 (Second Set of Medication)||37
8225506|NCT02026011|20283797|P2|STARTED|Allocation 2 (Second Set of Medication)||37
8225507|NCT02026011|20283798|P1|STARTED|Allocation 2 (Second Set of Medication)||38
8225508|NCT02026011|20283797|P2|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
8225509|NCT02026011|20283798|P1|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
8225510|NCT02026011|20283797|P2|COMPLETED|Allocation 1 (First Set of Medication)||39
8225511|NCT02026011|20283798|P1|COMPLETED|Allocation 1 (First Set of Medication)||38
8225512|NCT02026011|20283797|P2|STARTED|Allocation 1 (First Set of Medication)||41
8225513|NCT02026011|20283798|P1|STARTED|Allocation 1 (First Set of Medication)||46
8225514|NCT02025907|20283824|P2|NOT COMPLETED|Overall Study||12
8225515|NCT02025907|20283825|P1|NOT COMPLETED|Overall Study||27
8225516|NCT02025907|20283824|P2|COMPLETED|Overall Study||96
8225517|NCT02025907|20283825|P1|COMPLETED|Overall Study||81
8225518|NCT02025907|20283824|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
8225519|NCT02025907|20283825|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
8225520|NCT02025829|20283841|P2|NOT COMPLETED|Overall Study||0
8225521|NCT02025829|20283842|P1|NOT COMPLETED|Overall Study||0
8225522|NCT02025829|20283841|P2|COMPLETED|Overall Study||11
8225523|NCT02025829|20283842|P1|COMPLETED|Overall Study||3
8225524|NCT02025829|20283841|P2|STARTED|Overall Study||11
8225525|NCT02025829|20283842|P1|STARTED|Overall Study||3
8225526|NCT02025751|20283853|P2|NOT COMPLETED|Overall Study||3
8225527|NCT02025751|20283854|P1|NOT COMPLETED|Overall Study||1
8225528|NCT02025751|20283853|P2|COMPLETED|Overall Study||24
8225529|NCT02025751|20283854|P1|COMPLETED|Overall Study||25
8225530|NCT02025751|20283853|P2|STARTED|Overall Study||27
8225531|NCT02025751|20283854|P1|STARTED|Overall Study||26
8225532|NCT02025725|20283862|P2|NOT COMPLETED|Overall Study||4
8225533|NCT02025725|20283863|P1|NOT COMPLETED|Overall Study||11
8225534|NCT02025725|20283862|P2|COMPLETED|Overall Study||99
8225535|NCT02025725|20283863|P1|COMPLETED|Overall Study||91
8225536|NCT02025725|20283862|P2|STARTED|Overall Study||103
8225537|NCT02025725|20283863|P1|STARTED|Overall Study||102
8225538|NCT02025647|20283871|P1|NOT COMPLETED|Overall Study||0
8225539|NCT02025647|20283871|P1|COMPLETED|Overall Study||139
8225540|NCT02025647|20283871|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS
~36 lost to follow up"|76
8225541|NCT02025647|20283871|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues
~3 administered wrong session"|117
8225542|NCT02025647|20283871|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS
~15 technology issues or administered wrong session"|97
8225543|NCT02025647|20283871|P1|Session 1 (Narrative Module)|Overall Study||139
8225544|NCT02025647|20283871|P1|STARTED|Overall Study||139
8225545|NCT02025634|20283902|P2|NOT COMPLETED|Overall Study||0
8225546|NCT02025634|20283903|P1|NOT COMPLETED|Overall Study||0
8225547|NCT02025634|20283902|P2|COMPLETED|Overall Study||54
8225548|NCT02025634|20283903|P1|COMPLETED|Overall Study||65
8225549|NCT02025634|20283902|P2|STARTED|Overall Study||54
8225550|NCT02025634|20283903|P1|STARTED|Overall Study||65
8225551|NCT02025621|20283915|P2|NOT COMPLETED|Overall Study||19
8225552|NCT02025621|20283916|P1|NOT COMPLETED|Overall Study||14
8225553|NCT02025621|20283915|P2|COMPLETED|Overall Study||421
8225554|NCT02025621|20283916|P1|COMPLETED|Overall Study||428
8225555|NCT02025621|20283915|P2|STARTED|Overall Study||440
8225556|NCT02025621|20283916|P1|STARTED|Overall Study||442
8225557|NCT02025530|20283936|P2|NOT COMPLETED|Overall Study||1
8225558|NCT02025530|20283937|P1|NOT COMPLETED|Overall Study||5
8225559|NCT02025530|20283936|P2|COMPLETED|Overall Study||733
8225560|NCT02025530|20283937|P1|COMPLETED|Overall Study||291
8225561|NCT02025530|20283936|P2|STARTED|Overall Study||734
8225562|NCT02025530|20283937|P1|STARTED|Overall Study||296
8225563|NCT02025439|20283949|P2|NOT COMPLETED|Overall Study||0
8225564|NCT02025439|20283950|P1|NOT COMPLETED|Overall Study||0
8225565|NCT02025439|20283949|P2|COMPLETED|Overall Study||2
8225566|NCT02025439|20283950|P1|COMPLETED|Overall Study||2
8225567|NCT02025439|20283949|P2|STARTED|Overall Study||2
8225568|NCT02025439|20283950|P1|STARTED|Overall Study||2
8225569|NCT02025426|20283960|P2|NOT COMPLETED|Overall Study||0
8225570|NCT02025426|20283961|P1|NOT COMPLETED|Overall Study||0
8225571|NCT02025426|20283960|P2|COMPLETED|Overall Study||4
8225572|NCT02025426|20283961|P1|COMPLETED|Overall Study||9
8225573|NCT02025426|20283960|P2|STARTED|Overall Study||4
8225574|NCT02025426|20283961|P1|STARTED|Overall Study||9
8225575|NCT02025205|20283983|P2|NOT COMPLETED|Overall Study||3
8225576|NCT02025205|20283984|P1|NOT COMPLETED|Overall Study||3
8225577|NCT02025205|20283983|P2|COMPLETED|Overall Study||47
8225578|NCT02025205|20283984|P1|COMPLETED|Overall Study||40
8225579|NCT02025205|20283983|P2|STARTED|Overall Study||50
8225580|NCT02025205|20283984|P1|STARTED|Overall Study||43
8225581|NCT02025179|20284028|P3|NOT COMPLETED|Overall Study||1
8225582|NCT02025179|20284029|P2|NOT COMPLETED|Overall Study||0
8225583|NCT02025179|20284030|P1|NOT COMPLETED|Overall Study||0
8225584|NCT02025179|20284028|P3|COMPLETED|Overall Study||7
8225585|NCT02025179|20284029|P2|COMPLETED|Overall Study||9
8225586|NCT02025179|20284030|P1|COMPLETED|Overall Study||8
8225587|NCT02025179|20284028|P3|STARTED|Overall Study||8
8225588|NCT02025179|20284029|P2|STARTED|Overall Study||9
8225589|NCT02025179|20284030|P1|STARTED|Overall Study||8
8225590|NCT02025075|20284055|P2|NOT COMPLETED|Overall Study||2
8225591|NCT02025075|20284056|P1|NOT COMPLETED|Overall Study||0
8225592|NCT02025075|20284055|P2|COMPLETED|Overall Study||19
8225593|NCT02025075|20284056|P1|COMPLETED|Overall Study||16
8225594|NCT02025075|20284055|P2|STARTED|Overall Study||21
8225595|NCT02025075|20284056|P1|STARTED|Overall Study||16
8225596|NCT02024971|20284080|P1|NOT COMPLETED|Overall Study||36
8225597|NCT02024971|20284080|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
8225598|NCT02024971|20284080|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
8225599|NCT02024971|20284080|P1|STARTED|Overall Study||1103
8225600|NCT02024932|20284093|P6|NOT COMPLETED|Overall Study||0
8225601|NCT02024932|20284094|P5|NOT COMPLETED|Overall Study||2
8225602|NCT02024932|20284095|P4|NOT COMPLETED|Overall Study||2
8225603|NCT02024932|20284096|P3|NOT COMPLETED|Overall Study||0
8225604|NCT02024932|20284097|P2|NOT COMPLETED|Overall Study||3
8225605|NCT02024932|20284098|P1|NOT COMPLETED|Overall Study||2
8225606|NCT02024932|20284093|P6|COMPLETED|Overall Study||9
8225607|NCT02024932|20284094|P5|COMPLETED|Overall Study||16
8225608|NCT02024932|20284095|P4|COMPLETED|Overall Study||0
8225609|NCT02024932|20284096|P3|COMPLETED|Overall Study||2
8225610|NCT02024932|20284097|P2|COMPLETED|Overall Study||1
8225611|NCT02024932|20284098|P1|COMPLETED|Overall Study||0
8225612|NCT02024932|20284093|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
8225613|NCT02024932|20284094|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
8225614|NCT02024932|20284095|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8225615|NCT02024932|20284096|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8225616|NCT02024932|20284097|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8225617|NCT02024932|20284098|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8225618|NCT02024932|20284093|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8225619|NCT02024932|20284094|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
8225620|NCT02024932|20284095|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
8225621|NCT02024932|20284096|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8225622|NCT02024932|20284097|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8225623|NCT02024932|20284098|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
8225624|NCT02024932|20284093|P6|Safety Analysis Set|Overall Study||9
8225625|NCT02024932|20284094|P5|Safety Analysis Set|Overall Study||18
8225626|NCT02024932|20284095|P4|Safety Analysis Set|Overall Study||2
8225627|NCT02024932|20284096|P3|Safety Analysis Set|Overall Study||2
8225628|NCT02024932|20284097|P2|Safety Analysis Set|Overall Study||4
8225629|NCT02024932|20284098|P1|Safety Analysis Set|Overall Study||2
8225630|NCT02024932|20284093|P6|STARTED|Overall Study||9
8225631|NCT02024932|20284094|P5|STARTED|Overall Study||18
8225632|NCT02024932|20284095|P4|STARTED|Overall Study||2
8225633|NCT02024932|20284096|P3|STARTED|Overall Study||2
8225634|NCT02024932|20284097|P2|STARTED|Overall Study||4
8225635|NCT02024932|20284098|P1|STARTED|Overall Study||2
8225636|NCT02024867|20284157|P2|NOT COMPLETED|Overall Study||7
8225637|NCT02024867|20284158|P1|NOT COMPLETED|Overall Study||9
8225638|NCT02024867|20284157|P2|COMPLETED|Overall Study||124
8225639|NCT02024867|20284158|P1|COMPLETED|Overall Study||125
8225640|NCT02024867|20284157|P2|STARTED|Overall Study||131
8225641|NCT02024867|20284158|P1|STARTED|Overall Study||134
8225642|NCT02024750|20284176|P2|NOT COMPLETED|Overall Study||1
8225643|NCT02024750|20284177|P1|NOT COMPLETED|Overall Study||2
8225644|NCT02024750|20284176|P2|COMPLETED|Overall Study||107
8225645|NCT02024750|20284177|P1|COMPLETED|Overall Study||104
8225646|NCT02024750|20284176|P2|STARTED|Overall Study||108
8225647|NCT02024750|20284177|P1|STARTED|Overall Study||106
8225648|NCT02024724|20284191|P2|NOT COMPLETED|Overall Study||0
8225649|NCT02024724|20284192|P1|NOT COMPLETED|Overall Study||1
8225650|NCT02024724|20284191|P2|COMPLETED|Overall Study||30
8225651|NCT02024724|20284192|P1|COMPLETED|Overall Study||29
8225652|NCT02024724|20284191|P2|STARTED|Overall Study||30
8225653|NCT02024724|20284192|P1|STARTED|Overall Study||30
8225654|NCT02024711|20284200|P2|NOT COMPLETED|Overall Study||4
8225655|NCT02024711|20284201|P1|NOT COMPLETED|Overall Study||1
8225656|NCT02024711|20284200|P2|COMPLETED|Overall Study||128
8225657|NCT02024711|20284201|P1|COMPLETED|Overall Study||129
8225658|NCT02024711|20284200|P2|STARTED|Overall Study||132
8225659|NCT02024711|20284201|P1|STARTED|Overall Study||130
8225660|NCT02024698|20284213|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8225661|NCT02024698|20284214|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8225662|NCT02024698|20284213|P2|COMPLETED|Second Intervention (7 Days)||26
8225663|NCT02024698|20284214|P1|COMPLETED|Second Intervention (7 Days)||16
8225664|NCT02024698|20284213|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
8225665|NCT02024698|20284214|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
8225666|NCT02024698|20284213|P2|STARTED|Second Intervention (7 Days)||26
8225667|NCT02024698|20284214|P1|STARTED|Second Intervention (7 Days)||16
8225668|NCT02024698|20284213|P2|NOT COMPLETED|First Intervention (7 Days)||1
8225669|NCT02024698|20284214|P1|NOT COMPLETED|First Intervention (7 Days)||0
8225670|NCT02024698|20284213|P2|COMPLETED|First Intervention (7 Days)||26
8225671|NCT02024698|20284214|P1|COMPLETED|First Intervention (7 Days)||16
8225672|NCT02024698|20284213|P2|STARTED|First Intervention (7 Days)||27
8225673|NCT02024698|20284214|P1|STARTED|First Intervention (7 Days)||16
8225674|NCT02024646|20284243|P3|NOT COMPLETED|Overall Study||28
8225675|NCT02024646|20284244|P2|NOT COMPLETED|Overall Study||25
8225676|NCT02024646|20284245|P1|NOT COMPLETED|Overall Study||32
8225677|NCT02024646|20284243|P3|COMPLETED|Overall Study||133
8225678|NCT02024646|20284244|P2|COMPLETED|Overall Study||135
8225679|NCT02024646|20284245|P1|COMPLETED|Overall Study||131
8225680|NCT02024646|20284243|P3|STARTED|Overall Study||161
8225681|NCT02024646|20284244|P2|STARTED|Overall Study||160
8225682|NCT02024646|20284245|P1|STARTED|Overall Study||163
8225683|NCT02024555|20284255|P2|NOT COMPLETED|Overall Study||2
8225684|NCT02024555|20284256|P1|NOT COMPLETED|Overall Study||6
8225685|NCT02024555|20284255|P2|COMPLETED|Overall Study||46
8225686|NCT02024555|20284256|P1|COMPLETED|Overall Study||43
8225687|NCT02024555|20284255|P2|STARTED|Overall Study||48
8225688|NCT02024555|20284256|P1|STARTED|Overall Study||49
8225689|NCT02024477|20284286|P2|NOT COMPLETED|Overall Study||0
8225690|NCT02024477|20284287|P1|NOT COMPLETED|Overall Study||0
8225691|NCT02024477|20284286|P2|COMPLETED|Overall Study||21
8225692|NCT02024477|20284287|P1|COMPLETED|Overall Study||21
8225693|NCT02024477|20284286|P2|STARTED|Overall Study||21
8225694|NCT02024477|20284287|P1|STARTED|Overall Study||21
8225695|NCT02024386|20284308|P3|NOT COMPLETED|Overall Study||0
8225696|NCT02024386|20284309|P2|NOT COMPLETED|Overall Study||0
8225697|NCT02024386|20284310|P1|NOT COMPLETED|Overall Study||0
8225698|NCT02024386|20284308|P3|COMPLETED|Overall Study||5
8225699|NCT02024386|20284309|P2|COMPLETED|Overall Study||11
8225700|NCT02024386|20284310|P1|COMPLETED|Overall Study||6
8225701|NCT02024386|20284308|P3|STARTED|Overall Study||5
8225702|NCT02024386|20284309|P2|STARTED|Overall Study||11
8225703|NCT02024386|20284310|P1|STARTED|Overall Study||6
8225704|NCT02024165|20284333|P1|NOT COMPLETED|Overall Study||0
8225705|NCT02024165|20284333|P1|COMPLETED|Overall Study||71
8225706|NCT02024165|20284333|P1|STARTED|Overall Study||71
8225707|NCT02024087|20284340|P2|NOT COMPLETED|Overall Study||0
8225708|NCT02024087|20284341|P1|NOT COMPLETED|Overall Study||0
8225709|NCT02024087|20284340|P2|COMPLETED|Overall Study||16
8225710|NCT02024087|20284341|P1|COMPLETED|Overall Study||5
8225711|NCT02024087|20284340|P2|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
8225712|NCT02024087|20284341|P1|STARTED|Overall Study||5
8225713|NCT02023983|20284355|P2|NOT COMPLETED|Overall Study||0
8225714|NCT02023983|20284356|P1|NOT COMPLETED|Overall Study||0
8225715|NCT02023983|20284355|P2|COMPLETED|Overall Study||75
8225716|NCT02023983|20284356|P1|COMPLETED|Overall Study||76
8225717|NCT02023983|20284355|P2|STARTED|Overall Study||75
8225718|NCT02023983|20284356|P1|STARTED|Overall Study||76
8225719|NCT02023944|20284366|P2|NOT COMPLETED|Overall Study||1
8225720|NCT02023944|20284367|P1|NOT COMPLETED|Overall Study||0
8225721|NCT02023944|20284366|P2|COMPLETED|Overall Study||24
8225722|NCT02023944|20284367|P1|COMPLETED|Overall Study||25
8225723|NCT02023944|20284366|P2|STARTED|Overall Study||25
8225724|NCT02023944|20284367|P1|STARTED|Overall Study||25
8225725|NCT02023918|20284375|P1|NOT COMPLETED|Overall Study||0
8225726|NCT02023918|20284375|P1|COMPLETED|Overall Study||6
8225727|NCT02023918|20284375|P1|STARTED|Overall Study||6
8225728|NCT02023879|20284383|P3|NOT COMPLETED|Extension Open Label Treatment||5
8225729|NCT02023879|20284384|P2|NOT COMPLETED|Extension Open Label Treatment||17
8225730|NCT02023879|20284385|P1|NOT COMPLETED|Extension Open Label Treatment||5
8225731|NCT02023879|20284383|P3|COMPLETED|Extension Open Label Treatment||43
8225732|NCT02023879|20284384|P2|COMPLETED|Extension Open Label Treatment||89
8225733|NCT02023879|20284385|P1|COMPLETED|Extension Open Label Treatment||46
8225734|NCT02023879|20284383|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
8225735|NCT02023879|20284384|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
8225736|NCT02023879|20284385|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
8225737|NCT02023879|20284383|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
8225738|NCT02023879|20284384|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
8225739|NCT02023879|20284385|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
8225740|NCT02023879|20284383|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
8225741|NCT02023879|20284384|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
8225742|NCT02023879|20284385|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
8225743|NCT02023879|20284383|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
8225744|NCT02023879|20284384|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
8225745|NCT02023879|20284385|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
8225746|NCT02023879|20284383|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
8225747|NCT02023879|20284384|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
8225748|NCT02023879|20284385|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
8225749|NCT02023866|20284474|P1|NOT COMPLETED|Overall Study||6
8225750|NCT02023866|20284474|P1|COMPLETED|Overall Study||30
8225751|NCT02023866|20284474|P1|STARTED|Overall Study||36
8225752|NCT02023801|20284487|P1|NOT COMPLETED|Overall Study||0
8225753|NCT02023801|20284487|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
8225754|NCT02023801|20284487|P1|Treated|Overall Study|Treatment Completed|24
8225755|NCT02023801|20284487|P1|STARTED|Overall Study|Treatment Attempted|24
8225756|NCT02023697|20284496|P3|NOT COMPLETED|Long-term Follow-up Period||17
8225757|NCT02023697|20284497|P2|NOT COMPLETED|Long-term Follow-up Period||21
8225758|NCT02023697|20284498|P1|NOT COMPLETED|Long-term Follow-up Period||28
8225759|NCT02023697|20284496|P3|COMPLETED|Long-term Follow-up Period||0
8225760|NCT02023697|20284497|P2|COMPLETED|Long-term Follow-up Period||0
8225761|NCT02023697|20284498|P1|COMPLETED|Long-term Follow-up Period||0
8225762|NCT02023697|20284496|P3|STARTED|Long-term Follow-up Period||17
8225763|NCT02023697|20284497|P2|STARTED|Long-term Follow-up Period||21
8225764|NCT02023697|20284498|P1|STARTED|Long-term Follow-up Period||28
8225765|NCT02023697|20284496|P3|NOT COMPLETED|Active Follow-up Period||99
8225766|NCT02023697|20284497|P2|NOT COMPLETED|Active Follow-up Period||99
8225767|NCT02023697|20284498|P1|NOT COMPLETED|Active Follow-up Period||92
8225768|NCT02023697|20284496|P3|COMPLETED|Active Follow-up Period||17
8225769|NCT02023697|20284497|P2|COMPLETED|Active Follow-up Period||21
8225770|NCT02023697|20284498|P1|COMPLETED|Active Follow-up Period||28
8225771|NCT02023697|20284496|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
8225772|NCT02023697|20284497|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
8225773|NCT02023697|20284498|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
8225774|NCT02023697|20284496|P3|NOT COMPLETED|Treatment Period||102
8225775|NCT02023697|20284497|P2|NOT COMPLETED|Treatment Period||63
8225776|NCT02023697|20284498|P1|NOT COMPLETED|Treatment Period||46
8225777|NCT02023697|20284496|P3|COMPLETED|Treatment Period||29
8225778|NCT02023697|20284497|P2|COMPLETED|Treatment Period||67
8225779|NCT02023697|20284498|P1|COMPLETED|Treatment Period||84
8225780|NCT02023697|20284496|P3|Received Treatment|Treatment Period||121
8225781|NCT02023697|20284497|P2|Received Treatment|Treatment Period||124
8225782|NCT02023697|20284498|P1|Received Treatment|Treatment Period||125
8225783|NCT02023697|20284496|P3|STARTED|Treatment Period||131
8225784|NCT02023697|20284497|P2|STARTED|Treatment Period||130
8225785|NCT02023697|20284498|P1|STARTED|Treatment Period||130
8225786|NCT02023515|20284600|P2|NOT COMPLETED|Overall Study||3
8225787|NCT02023515|20284601|P1|NOT COMPLETED|Overall Study||1
8225788|NCT02023515|20284600|P2|COMPLETED|Overall Study||22
8225789|NCT02023515|20284601|P1|COMPLETED|Overall Study||23
8225790|NCT02023515|20284600|P2|STARTED|Overall Study||25
8225791|NCT02023515|20284601|P1|STARTED|Overall Study||24
8225792|NCT02023411|20284611|P2|NOT COMPLETED|Overall Study||0
8225793|NCT02023411|20284612|P1|NOT COMPLETED|Overall Study||0
8225794|NCT02023411|20284611|P2|COMPLETED|Overall Study||10
8225795|NCT02023411|20284612|P1|COMPLETED|Overall Study||10
8225796|NCT02023411|20284611|P2|STARTED|Overall Study||10
8225797|NCT02023411|20284612|P1|STARTED|Overall Study||10
8225798|NCT02023268|20284622|P2|NOT COMPLETED|Overall Study||4
8225799|NCT02023268|20284623|P1|NOT COMPLETED|Overall Study||0
8225800|NCT02023268|20284622|P2|COMPLETED|Overall Study||49
8225801|NCT02023268|20284623|P1|COMPLETED|Overall Study||52
8225802|NCT02023268|20284622|P2|STARTED|Overall Study||53
8225803|NCT02023268|20284623|P1|STARTED|Overall Study||52
8225804|NCT02023242|20284631|P2|NOT COMPLETED|Overall Study||2
8225805|NCT02023242|20284632|P1|NOT COMPLETED|Overall Study||3
8225806|NCT02023242|20284631|P2|COMPLETED|Overall Study||75
8225807|NCT02023242|20284632|P1|COMPLETED|Overall Study||72
8225808|NCT02023242|20284631|P2|STARTED|Overall Study||77
8225809|NCT02023242|20284632|P1|STARTED|Overall Study||75
8225810|NCT02023151|20284646|P1|NOT COMPLETED|Overall Study||4
8225811|NCT02023151|20284646|P1|COMPLETED|Overall Study||13
8225812|NCT02023151|20284646|P1|STARTED|Overall Study||17
8225813|NCT02023125|20284653|P3|NOT COMPLETED|Period 2||0
8225814|NCT02023125|20284654|P2|NOT COMPLETED|Period 2||0
8225815|NCT02023125|20284655|P1|NOT COMPLETED|Period 2||0
8225816|NCT02023125|20284653|P3|COMPLETED|Period 2||24
8225817|NCT02023125|20284654|P2|COMPLETED|Period 2||9
8225818|NCT02023125|20284655|P1|COMPLETED|Period 2||9
8225819|NCT02023125|20284653|P3|STARTED|Period 2||24
8225820|NCT02023125|20284654|P2|STARTED|Period 2||9
8225821|NCT02023125|20284655|P1|STARTED|Period 2||9
8225822|NCT02023125|20284653|P3|NOT COMPLETED|Washout Period||0
8225823|NCT02023125|20284654|P2|NOT COMPLETED|Washout Period||0
8225824|NCT02023125|20284655|P1|NOT COMPLETED|Washout Period||0
8225825|NCT02023125|20284653|P3|COMPLETED|Washout Period||24
8225826|NCT02023125|20284654|P2|COMPLETED|Washout Period||9
8225827|NCT02023125|20284655|P1|COMPLETED|Washout Period||9
8225828|NCT02023125|20284653|P3|STARTED|Washout Period||24
8225829|NCT02023125|20284654|P2|STARTED|Washout Period||9
8225830|NCT02023125|20284655|P1|STARTED|Washout Period||9
8225831|NCT02023125|20284653|P3|NOT COMPLETED|Period 1||0
8225832|NCT02023125|20284654|P2|NOT COMPLETED|Period 1||0
8225833|NCT02023125|20284655|P1|NOT COMPLETED|Period 1||0
8225834|NCT02023125|20284653|P3|COMPLETED|Period 1||24
8225835|NCT02023125|20284654|P2|COMPLETED|Period 1||9
8225836|NCT02023125|20284655|P1|COMPLETED|Period 1||9
8225837|NCT02023125|20284653|P3|STARTED|Period 1||24
8225838|NCT02023125|20284654|P2|STARTED|Period 1||9
8225839|NCT02023125|20284655|P1|STARTED|Period 1||9
8225840|NCT02023112|20284716|P2|NOT COMPLETED|Overall Study||1
8225841|NCT02023112|20284717|P1|NOT COMPLETED|Overall Study||2
8225842|NCT02023112|20284716|P2|COMPLETED|Overall Study||85
8225843|NCT02023112|20284717|P1|COMPLETED|Overall Study||83
8225844|NCT02023112|20284716|P2|STARTED|Overall Study||86
8225845|NCT02023112|20284717|P1|STARTED|Overall Study||85
8225846|NCT02023099|20284738|P3|NOT COMPLETED|Overall Study||3
8225847|NCT02023099|20284739|P2|NOT COMPLETED|Overall Study||0
8225848|NCT02023099|20284740|P1|NOT COMPLETED|Overall Study||3
8225849|NCT02023099|20284738|P3|COMPLETED|Overall Study||39
8225850|NCT02023099|20284739|P2|COMPLETED|Overall Study||106
8225851|NCT02023099|20284740|P1|COMPLETED|Overall Study||212
8225852|NCT02023099|20284738|P3|STARTED|Overall Study||42
8225853|NCT02023099|20284739|P2|STARTED|Overall Study||106
8225854|NCT02023099|20284740|P1|STARTED|Overall Study||215
8225855|NCT02022826|20284756|P1|NOT COMPLETED|Overall Study||28
8225856|NCT02022826|20284756|P1|COMPLETED|Overall Study||139
8225857|NCT02022826|20284756|P1|STARTED|Overall Study||167
8225858|NCT02022748|20284763|P3|NOT COMPLETED|Overall Study||0
8225859|NCT02022748|20284764|P2|NOT COMPLETED|Overall Study||2
8225860|NCT02022748|20284765|P1|NOT COMPLETED|Overall Study||1
8225861|NCT02022748|20284763|P3|COMPLETED|Overall Study||13
8225862|NCT02022748|20284764|P2|COMPLETED|Overall Study||4
8225863|NCT02022748|20284765|P1|COMPLETED|Overall Study||7
8225864|NCT02022748|20284763|P3|Subjects Who Completed Treatment|Overall Study||13
8225865|NCT02022748|20284764|P2|Subjects Who Completed Treatment|Overall Study||4
8225866|NCT02022748|20284765|P1|Subjects Who Completed Treatment|Overall Study||7
8225867|NCT02022748|20284763|P3|Subject Who Started Treatment|Overall Study||13
8225868|NCT02022748|20284764|P2|Subject Who Started Treatment|Overall Study||6
8225869|NCT02022748|20284765|P1|Subject Who Started Treatment|Overall Study||8
8225870|NCT02022748|20284763|P3|STARTED|Overall Study||13
8225871|NCT02022748|20284764|P2|STARTED|Overall Study||6
8225872|NCT02022748|20284765|P1|STARTED|Overall Study||8
8225873|NCT02022670|20284791|P3|NOT COMPLETED|Overall Study||1
8225874|NCT02022670|20284792|P2|NOT COMPLETED|Overall Study||0
8225875|NCT02022670|20284793|P1|NOT COMPLETED|Overall Study||1
8225876|NCT02022670|20284791|P3|COMPLETED|Overall Study||11
8225877|NCT02022670|20284792|P2|COMPLETED|Overall Study||10
8225878|NCT02022670|20284793|P1|COMPLETED|Overall Study||10
8225879|NCT02022670|20284791|P3|STARTED|Overall Study||12
8225880|NCT02022670|20284792|P2|STARTED|Overall Study||10
8225881|NCT02022670|20284793|P1|STARTED|Overall Study||11
8225882|NCT02022657|20284807|P6|NOT COMPLETED|Overall Study||1
8225883|NCT02022657|20284808|P5|NOT COMPLETED|Overall Study||0
8225884|NCT02022657|20284809|P4|NOT COMPLETED|Overall Study||0
8225885|NCT02022657|20284810|P3|NOT COMPLETED|Overall Study||1
8225886|NCT02022657|20284811|P2|NOT COMPLETED|Overall Study||0
8225887|NCT02022657|20284812|P1|NOT COMPLETED|Overall Study||2
8225888|NCT02022657|20284807|P6|COMPLETED|Overall Study||8
8225889|NCT02022657|20284808|P5|COMPLETED|Overall Study||8
8225890|NCT02022657|20284809|P4|COMPLETED|Overall Study||8
8225891|NCT02022657|20284810|P3|COMPLETED|Overall Study||8
8225892|NCT02022657|20284811|P2|COMPLETED|Overall Study||8
8225893|NCT02022657|20284812|P1|COMPLETED|Overall Study||8
8225894|NCT02022657|20284807|P6|STARTED|Overall Study||9
8225895|NCT02022657|20284808|P5|STARTED|Overall Study||8
8225896|NCT02022657|20284809|P4|STARTED|Overall Study||8
8225897|NCT02022657|20284810|P3|STARTED|Overall Study||9
8225898|NCT02022657|20284811|P2|STARTED|Overall Study||8
8225899|NCT02022657|20284812|P1|STARTED|Overall Study||10
8225900|NCT02022111|20284820|P2|NOT COMPLETED|Overall Study||15
8225901|NCT02022111|20284821|P1|NOT COMPLETED|Overall Study||10
8225902|NCT02022111|20284820|P2|COMPLETED|Overall Study||193
8225903|NCT02022111|20284821|P1|COMPLETED|Overall Study||186
8225904|NCT02022111|20284820|P2|STARTED|Overall Study||208
8225905|NCT02022111|20284821|P1|STARTED|Overall Study||196
8225906|NCT02022085|20284827|P1|NOT COMPLETED|Overall Study||1
8225907|NCT02022085|20284827|P1|COMPLETED|Overall Study||53
8225908|NCT02022085|20284827|P1|STARTED|Overall Study||54
8225909|NCT02022020|20284853|P1|NOT COMPLETED|Overall Study||0
8225910|NCT02022020|20284853|P1|COMPLETED|Overall Study||220
8225911|NCT02022020|20284853|P1|STARTED|Overall Study||220
8225912|NCT02022007|20284862|P3|NOT COMPLETED|Overall Study||2
8225913|NCT02022007|20284863|P2|NOT COMPLETED|Overall Study||1
8225914|NCT02022007|20284864|P1|NOT COMPLETED|Overall Study||1
8225915|NCT02022007|20284862|P3|COMPLETED|Overall Study||11
8225916|NCT02022007|20284863|P2|COMPLETED|Overall Study||11
8225917|NCT02022007|20284864|P1|COMPLETED|Overall Study||12
8225918|NCT02022007|20284862|P3|STARTED|Overall Study||13
8225919|NCT02022007|20284863|P2|STARTED|Overall Study||12
8225920|NCT02022007|20284864|P1|STARTED|Overall Study||13
8225921|NCT02021942|20284905|P1|NOT COMPLETED|Overall Study||0
8225922|NCT02021942|20284905|P1|COMPLETED|Overall Study||16
8225923|NCT02021942|20284905|P1|STARTED|Overall Study||16
8225924|NCT02021929|20284917|P2|NOT COMPLETED|Overall Study||1
8225925|NCT02021929|20284918|P1|NOT COMPLETED|Overall Study||2
8225926|NCT02021929|20284917|P2|COMPLETED|Overall Study||11
8225927|NCT02021929|20284918|P1|COMPLETED|Overall Study||14
8225928|NCT02021929|20284917|P2|STARTED|Overall Study||12
8225929|NCT02021929|20284918|P1|STARTED|Overall Study||16
8225930|NCT02021812|20284928|P1|NOT COMPLETED|Overall Study||21
8225931|NCT02021812|20284928|P1|COMPLETED|Overall Study||10
8225932|NCT02021812|20284928|P1|STARTED|Overall Study||31
8225933|NCT02021669|20284938|P2|NOT COMPLETED|Overall Study||3
8225934|NCT02021669|20284939|P1|NOT COMPLETED|Overall Study||7
8225935|NCT02021669|20284938|P2|COMPLETED|Overall Study||70
8225936|NCT02021669|20284939|P1|COMPLETED|Overall Study||64
8225937|NCT02021669|20284938|P2|STARTED|Overall Study||73
8225938|NCT02021669|20284939|P1|STARTED|Overall Study||71
8225939|NCT02021656|20284947|P1|NOT COMPLETED|Overall Study||6
8225940|NCT02021656|20284947|P1|COMPLETED|Overall Study||378
8225941|NCT02021656|20284947|P1|STARTED|Overall Study||384
8225942|NCT02021643|20284967|P4|NOT COMPLETED|Overall Study||12
8225943|NCT02021643|20284968|P3|NOT COMPLETED|Overall Study||0
8225944|NCT02021643|20284969|P2|NOT COMPLETED|Overall Study||10
8225945|NCT02021643|20284970|P1|NOT COMPLETED|Overall Study||9
8225946|NCT02021643|20284967|P4|COMPLETED|Overall Study||218
8225947|NCT02021643|20284968|P3|COMPLETED|Overall Study||11
8225948|NCT02021643|20284969|P2|COMPLETED|Overall Study||280
8225949|NCT02021643|20284970|P1|COMPLETED|Overall Study||147
8225950|NCT02021643|20284967|P4|STARTED|Overall Study||230
8225951|NCT02021643|20284968|P3|STARTED|Overall Study||11
8225952|NCT02021643|20284969|P2|STARTED|Overall Study||290
8225953|NCT02021643|20284970|P1|STARTED|Overall Study||156
8225954|NCT02021565|20285012|P2|NOT COMPLETED|3-month Follow-up||2
8225955|NCT02021565|20285013|P1|NOT COMPLETED|3-month Follow-up||10
8225956|NCT02021565|20285012|P2|COMPLETED|3-month Follow-up||34
8225957|NCT02021565|20285013|P1|COMPLETED|3-month Follow-up||50
8225958|NCT02021565|20285012|P2|Care Recipients|3-month Follow-up||18
8225959|NCT02021565|20285013|P1|Care Recipients|3-month Follow-up||30
8225960|NCT02021565|20285012|P2|Caregivers|3-month Follow-up||18
8225961|NCT02021565|20285013|P1|Caregivers|3-month Follow-up||30
8225962|NCT02021565|20285012|P2|STARTED|3-month Follow-up||36
8225963|NCT02021565|20285013|P1|STARTED|3-month Follow-up||60
8225964|NCT02021565|20285012|P2|NOT COMPLETED|Baseline Through Intervention||18
8225965|NCT02021565|20285013|P1|NOT COMPLETED|Baseline Through Intervention||12
8225966|NCT02021565|20285012|P2|COMPLETED|Baseline Through Intervention||36
8225967|NCT02021565|20285013|P1|COMPLETED|Baseline Through Intervention||60
8225968|NCT02021565|20285012|P2|Care Recipients|Baseline Through Intervention||27
8225969|NCT02021565|20285013|P1|Care Recipients|Baseline Through Intervention||36
8225970|NCT02021565|20285012|P2|Caregivers|Baseline Through Intervention||27
8225971|NCT02021565|20285013|P1|Caregivers|Baseline Through Intervention||36
8225972|NCT02021565|20285012|P2|STARTED|Baseline Through Intervention||54
8225973|NCT02021565|20285013|P1|STARTED|Baseline Through Intervention||72
8225974|NCT02021461|20285025|P1|NOT COMPLETED|Overall Study||0
8225975|NCT02021461|20285025|P1|COMPLETED|Overall Study||38
8225976|NCT02021461|20285025|P1|STARTED|Overall Study||38
8225977|NCT02021331|20285033|P2|NOT COMPLETED|Overall Study||2
8225978|NCT02021331|20285034|P1|NOT COMPLETED|Overall Study||0
8225979|NCT02021331|20285033|P2|COMPLETED|Overall Study||1
8225980|NCT02021331|20285034|P1|COMPLETED|Overall Study||2
8225981|NCT02021331|20285033|P2|STARTED|Overall Study||3
8225982|NCT02021331|20285034|P1|STARTED|Overall Study||2
8225983|NCT02021292|20285046|P2|NOT COMPLETED|Overall Study||3
8225984|NCT02021292|20285047|P1|NOT COMPLETED|Overall Study||0
8225985|NCT02021292|20285046|P2|COMPLETED|Overall Study||37
8225986|NCT02021292|20285047|P1|COMPLETED|Overall Study||40
8225987|NCT02021292|20285046|P2|STARTED|Overall Study||40
8225988|NCT02021292|20285047|P1|STARTED|Overall Study||40
8225989|NCT02021071|20285069|P2|NOT COMPLETED|Overall Study||0
8225990|NCT02021071|20285070|P1|NOT COMPLETED|Overall Study||0
8225991|NCT02021071|20285069|P2|COMPLETED|Overall Study||12
8225992|NCT02021071|20285070|P1|COMPLETED|Overall Study||12
8225993|NCT02021071|20285069|P2|STARTED|Overall Study||12
8225994|NCT02021071|20285070|P1|STARTED|Overall Study||12
8225995|NCT02020941|20285077|P1|NOT COMPLETED|Overall Study||8
8225996|NCT02020941|20285077|P1|COMPLETED|Overall Study||2
8225997|NCT02020941|20285077|P1|STARTED|Overall Study||10
8225998|NCT02020889|20285088|P2|NOT COMPLETED|Overall Study||3
8225999|NCT02020889|20285089|P1|NOT COMPLETED|Overall Study||7
8226000|NCT02020889|20285088|P2|COMPLETED|Overall Study||65
8226001|NCT02020889|20285089|P1|COMPLETED|Overall Study||61
8226002|NCT02020889|20285088|P2|STARTED|Overall Study||68
8226003|NCT02020889|20285089|P1|STARTED|Overall Study||68
8226004|NCT02020863|20285143|P1|NOT COMPLETED|Overall Study||5
8226005|NCT02020863|20285143|P1|COMPLETED|Overall Study||35
8226006|NCT02020863|20285143|P1|STARTED|Overall Study||40
8226007|NCT02020837|20285147|P1|NOT COMPLETED|Overall Study||0
8226008|NCT02020837|20285147|P1|COMPLETED|Overall Study||2
8226009|NCT02020837|20285147|P1|STARTED|Overall Study||2
8226010|NCT02020785|20285153|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8226011|NCT02020785|20285154|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8226012|NCT02020785|20285153|P2|COMPLETED|Second Intervention (3 Weeks)||16
8226013|NCT02020785|20285154|P1|COMPLETED|Second Intervention (3 Weeks)||15
8226014|NCT02020785|20285153|P2|STARTED|Second Intervention (3 Weeks)||16
8226015|NCT02020785|20285154|P1|STARTED|Second Intervention (3 Weeks)||15
8226016|NCT02020785|20285153|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8226017|NCT02020785|20285154|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8226018|NCT02020785|20285153|P2|COMPLETED|First Intervention (3 Weeks)||16
8226019|NCT02020785|20285154|P1|COMPLETED|First Intervention (3 Weeks)||15
8226020|NCT02020785|20285153|P2|STARTED|First Intervention (3 Weeks)||16
8226021|NCT02020785|20285154|P1|STARTED|First Intervention (3 Weeks)||15
8226022|NCT02020616|20285173|P7|NOT COMPLETED|Overall Study||4
8226023|NCT02020616|20285174|P6|NOT COMPLETED|Overall Study||5
8226024|NCT02020616|20285175|P5|NOT COMPLETED|Overall Study||2
8226025|NCT02020616|20285176|P4|NOT COMPLETED|Overall Study||2
8226026|NCT02020616|20285177|P3|NOT COMPLETED|Overall Study||2
8226027|NCT02020616|20285178|P2|NOT COMPLETED|Overall Study||1
8226028|NCT02020616|20285179|P1|NOT COMPLETED|Overall Study||0
8226029|NCT02020616|20285173|P7|COMPLETED|Overall Study||6
8226030|NCT02020616|20285174|P6|COMPLETED|Overall Study||3
8226031|NCT02020616|20285175|P5|COMPLETED|Overall Study||6
8226032|NCT02020616|20285176|P4|COMPLETED|Overall Study||6
8226033|NCT02020616|20285177|P3|COMPLETED|Overall Study||6
8226034|NCT02020616|20285178|P2|COMPLETED|Overall Study||7
8226035|NCT02020616|20285179|P1|COMPLETED|Overall Study||10
8226036|NCT02020616|20285173|P7|Received at Least One Dose of Study Drug|Overall Study||10
8226037|NCT02020616|20285174|P6|Received at Least One Dose of Study Drug|Overall Study||8
8226038|NCT02020616|20285175|P5|Received at Least One Dose of Study Drug|Overall Study||8
8226039|NCT02020616|20285176|P4|Received at Least One Dose of Study Drug|Overall Study||7
8226040|NCT02020616|20285177|P3|Received at Least One Dose of Study Drug|Overall Study||8
8226041|NCT02020616|20285178|P2|Received at Least One Dose of Study Drug|Overall Study||8
8226042|NCT02020616|20285179|P1|Received at Least One Dose of Study Drug|Overall Study||10
8226043|NCT02020616|20285173|P7|STARTED|Overall Study||10
8226044|NCT02020616|20285174|P6|STARTED|Overall Study||8
8226045|NCT02020616|20285175|P5|STARTED|Overall Study||8
8226046|NCT02020616|20285176|P4|STARTED|Overall Study||8
8226047|NCT02020616|20285177|P3|STARTED|Overall Study||8
8226048|NCT02020616|20285178|P2|STARTED|Overall Study||8
8226049|NCT02020616|20285179|P1|STARTED|Overall Study||10
8226050|NCT02020577|20285272|P2|NOT COMPLETED|Overall Study||55
8226051|NCT02020577|20285273|P1|NOT COMPLETED|Overall Study||3
8226052|NCT02020577|20285272|P2|COMPLETED|Overall Study||0
8226053|NCT02020577|20285273|P1|COMPLETED|Overall Study||0
8226054|NCT02020577|20285272|P2|STARTED|Overall Study||55
8226055|NCT02020577|20285273|P1|STARTED|Overall Study||3
8226056|NCT02020512|20285300|P1|NOT COMPLETED|Overall Study||8
8226057|NCT02020512|20285300|P1|COMPLETED|Overall Study||79
8226058|NCT02020512|20285300|P1|STARTED|Overall Study||87
8226059|NCT02020408|20285304|P1|NOT COMPLETED|Overall Study||3
8226060|NCT02020408|20285304|P1|COMPLETED|Overall Study||85
8226061|NCT02020408|20285304|P1|STARTED|Overall Study||88
8226062|NCT02020369|20285316|P2|NOT COMPLETED|Overall Study||2
8226063|NCT02020369|20285317|P1|NOT COMPLETED|Overall Study||3
8226064|NCT02020369|20285316|P2|COMPLETED|Overall Study||11
8226065|NCT02020369|20285317|P1|COMPLETED|Overall Study||11
8226066|NCT02020369|20285316|P2|STARTED|Overall Study||13
8226067|NCT02020369|20285317|P1|STARTED|Overall Study||14
8226068|NCT02020304|20285333|P2|NOT COMPLETED|Overall Study||2
8226069|NCT02020304|20285334|P1|NOT COMPLETED|Overall Study||3
8226070|NCT02020304|20285333|P2|COMPLETED|Overall Study||26
8226071|NCT02020304|20285334|P1|COMPLETED|Overall Study||27
8226072|NCT02020304|20285333|P2|STARTED|Overall Study||28
8226073|NCT02020304|20285334|P1|STARTED|Overall Study||30
8226074|NCT02020278|20285348|P1|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
8226075|NCT02020278|20285348|P1|COMPLETED|Optional Tolvaptan Treatment Component||0
8226076|NCT02020278|20285348|P1|STARTED|Optional Tolvaptan Treatment Component||0
8226077|NCT02020278|20285348|P1|NOT COMPLETED|Core Safety Follow-up Component||0
8226078|NCT02020278|20285348|P1|COMPLETED|Core Safety Follow-up Component||3
8226079|NCT02020278|20285348|P1|STARTED|Core Safety Follow-up Component||3
8226080|NCT02020135|20285367|P1|NOT COMPLETED|Overall Study||9
8226081|NCT02020135|20285367|P1|COMPLETED|Overall Study||0
8226082|NCT02020135|20285367|P1|STARTED|Overall Study||9
8226083|NCT02020031|20285379|P2|NOT COMPLETED|Overall Study||1
8226084|NCT02020031|20285380|P1|NOT COMPLETED|Overall Study||1
8226085|NCT02020031|20285379|P2|COMPLETED|Overall Study||10
8226086|NCT02020031|20285380|P1|COMPLETED|Overall Study||10
8226087|NCT02020031|20285379|P2|STARTED|Overall Study||11
8226088|NCT02020031|20285380|P1|STARTED|Overall Study||11
8226089|NCT02020018|20285390|P2|NOT COMPLETED|Overall Study||0
8226090|NCT02020018|20285391|P1|NOT COMPLETED|Overall Study||0
8226091|NCT02020018|20285390|P2|COMPLETED|Overall Study||1597
8226092|NCT02020018|20285391|P1|COMPLETED|Overall Study||272
8226093|NCT02020018|20285390|P2|STARTED|Overall Study||1597
8226094|NCT02020018|20285391|P1|STARTED|Overall Study||272
8226095|NCT02019979|20285401|P1|NOT COMPLETED|Overall Study||14
8226096|NCT02019979|20285401|P1|COMPLETED|Overall Study||0
8226097|NCT02019979|20285401|P1|STARTED|Overall Study||14
8226098|NCT02019940|20285407|P1|NOT COMPLETED|Overall Study||10
8226099|NCT02019940|20285407|P1|COMPLETED|Overall Study||8
8226100|NCT02019940|20285407|P1|STARTED|Overall Study||18
8226101|NCT02019927|20285417|P6|NOT COMPLETED|Overall Study||1
8226102|NCT02019927|20285418|P5|NOT COMPLETED|Overall Study||3
8226103|NCT02019927|20285419|P4|NOT COMPLETED|Overall Study||2
8226104|NCT02019927|20285420|P3|NOT COMPLETED|Overall Study||1
8226105|NCT02019927|20285421|P2|NOT COMPLETED|Overall Study||4
8226106|NCT02019927|20285422|P1|NOT COMPLETED|Overall Study||2
8226107|NCT02019927|20285417|P6|COMPLETED|Overall Study||3
8226108|NCT02019927|20285418|P5|COMPLETED|Overall Study||7
8226109|NCT02019927|20285419|P4|COMPLETED|Overall Study||3
8226110|NCT02019927|20285420|P3|COMPLETED|Overall Study||8
8226111|NCT02019927|20285421|P2|COMPLETED|Overall Study||19
8226112|NCT02019927|20285422|P1|COMPLETED|Overall Study||44
8226113|NCT02019927|20285417|P6|STARTED|Overall Study||4
8226114|NCT02019927|20285418|P5|STARTED|Overall Study||10
8226115|NCT02019927|20285419|P4|STARTED|Overall Study||5
8226116|NCT02019927|20285420|P3|STARTED|Overall Study||9
8226117|NCT02019927|20285421|P2|STARTED|Overall Study||23
8226118|NCT02019927|20285422|P1|STARTED|Overall Study||46
8226119|NCT02019758|20285492|P2|NOT COMPLETED|Overall Study||9
8226120|NCT02019758|20285493|P1|NOT COMPLETED|Overall Study||9
8226121|NCT02019758|20285492|P2|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
8226122|NCT02019758|20285493|P1|COMPLETED|Overall Study||56
8226123|NCT02019758|20285492|P2|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
8226124|NCT02019758|20285493|P1|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
8226125|NCT02019758|20285492|P2|Did Not Receive Intervention|Overall Study||1
8226126|NCT02019758|20285493|P1|Did Not Receive Intervention|Overall Study||1
8226127|NCT02019758|20285492|P2|Received Intervention|Overall Study||63
8226128|NCT02019758|20285493|P1|Received Intervention|Overall Study||64
8226129|NCT02019758|20285492|P2|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
8226130|NCT02019758|20285493|P1|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
8226131|NCT02019719|20285522|P5|NOT COMPLETED|Overall Study||2
8226132|NCT02019719|20285523|P4|NOT COMPLETED|Overall Study||2
8226133|NCT02019719|20285524|P3|NOT COMPLETED|Overall Study||0
8226134|NCT02019719|20285525|P2|NOT COMPLETED|Overall Study||1
8226135|NCT02019719|20285526|P1|NOT COMPLETED|Overall Study||6
8226136|NCT02019719|20285522|P5|COMPLETED|Overall Study||18
8226137|NCT02019719|20285523|P4|COMPLETED|Overall Study||17
8226138|NCT02019719|20285524|P3|COMPLETED|Overall Study||20
8226139|NCT02019719|20285525|P2|COMPLETED|Overall Study||18
8226140|NCT02019719|20285526|P1|COMPLETED|Overall Study||13
8226141|NCT02019719|20285522|P5|STARTED|Overall Study||20
8226142|NCT02019719|20285523|P4|STARTED|Overall Study||19
8226143|NCT02019719|20285524|P3|STARTED|Overall Study||20
8226144|NCT02019719|20285525|P2|STARTED|Overall Study||19
8226145|NCT02019719|20285526|P1|STARTED|Overall Study||19
8226146|NCT02019667|20285623|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
8226147|NCT02019667|20285624|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
8226148|NCT02019667|20285623|P2|COMPLETED|Washout Period (9 Weeks)||6
8226149|NCT02019667|20285624|P1|COMPLETED|Washout Period (9 Weeks)||10
8226150|NCT02019667|20285623|P2|STARTED|Washout Period (9 Weeks)||6
8226151|NCT02019667|20285624|P1|STARTED|Washout Period (9 Weeks)||10
8226152|NCT02019667|20285623|P2|NOT COMPLETED|2nd Intervention (6 Months)||2
8226153|NCT02019667|20285624|P1|NOT COMPLETED|2nd Intervention (6 Months)||0
8226154|NCT02019667|20285623|P2|COMPLETED|2nd Intervention (6 Months)||6
8226155|NCT02019667|20285624|P1|COMPLETED|2nd Intervention (6 Months)||10
8226156|NCT02019667|20285623|P2|STARTED|2nd Intervention (6 Months)||8
8226157|NCT02019667|20285624|P1|STARTED|2nd Intervention (6 Months)||10
8226158|NCT02019667|20285623|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
8226159|NCT02019667|20285624|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
8226160|NCT02019667|20285623|P2|COMPLETED|Washout Period (9 Weeks)||8
8226161|NCT02019667|20285624|P1|COMPLETED|Washout Period (9 Weeks)||10
8226162|NCT02019667|20285623|P2|STARTED|Washout Period (9 Weeks)||8
8226163|NCT02019667|20285624|P1|STARTED|Washout Period (9 Weeks)||10
8226164|NCT02019667|20285623|P2|NOT COMPLETED|First Intervention (6 Months)||1
8226165|NCT02019667|20285624|P1|NOT COMPLETED|First Intervention (6 Months)||0
8226166|NCT02019667|20285623|P2|COMPLETED|First Intervention (6 Months)||8
8226167|NCT02019667|20285624|P1|COMPLETED|First Intervention (6 Months)||10
8226168|NCT02019667|20285623|P2|STARTED|First Intervention (6 Months)||9
8226169|NCT02019667|20285624|P1|STARTED|First Intervention (6 Months)||10
8226170|NCT02019602|20285644|P2|NOT COMPLETED|Sampling Period||0
8226171|NCT02019602|20285645|P1|NOT COMPLETED|Sampling Period||0
8226172|NCT02019602|20285644|P2|COMPLETED|Sampling Period||16
8226173|NCT02019602|20285645|P1|COMPLETED|Sampling Period||16
8226174|NCT02019602|20285644|P2|STARTED|Sampling Period||16
8226175|NCT02019602|20285645|P1|STARTED|Sampling Period||16
8226176|NCT02019602|20285644|P2|NOT COMPLETED|Screening Period||0
8226177|NCT02019602|20285645|P1|NOT COMPLETED|Screening Period||5
8226178|NCT02019602|20285644|P2|COMPLETED|Screening Period||16
8226179|NCT02019602|20285645|P1|COMPLETED|Screening Period||16
8226180|NCT02019602|20285644|P2|STARTED|Screening Period||16
8226181|NCT02019602|20285645|P1|STARTED|Screening Period||21
8226182|NCT02019563|20285657|P2|NOT COMPLETED|Overall Study||0
8226183|NCT02019563|20285658|P1|NOT COMPLETED|Overall Study||0
8226184|NCT02019563|20285657|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
8226185|NCT02019563|20285658|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
8226186|NCT02019563|20285657|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
8226187|NCT02019563|20285658|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
8226188|NCT02019550|20285674|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8226189|NCT02019550|20285675|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8226190|NCT02019550|20285674|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
8226191|NCT02019550|20285675|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
8226192|NCT02019550|20285674|P2|STARTED|Treatment Period 2 (4 Weeks)||50
8226193|NCT02019550|20285675|P1|STARTED|Treatment Period 2 (4 Weeks)||46
8226194|NCT02019550|20285674|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8226195|NCT02019550|20285675|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8226196|NCT02019550|20285674|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
8226197|NCT02019550|20285675|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
8226198|NCT02019550|20285674|P2|STARTED|Treatment Period 1 (4 Weeks)||51
8226199|NCT02019550|20285675|P1|STARTED|Treatment Period 1 (4 Weeks)||46
8226200|NCT02019472|20285716|P3|NOT COMPLETED|Overall Study||42
8226201|NCT02019472|20285717|P2|NOT COMPLETED|Overall Study||52
8226202|NCT02019472|20285718|P1|NOT COMPLETED|Overall Study||37
8226203|NCT02019472|20285716|P3|COMPLETED|Overall Study||145
8226204|NCT02019472|20285717|P2|COMPLETED|Overall Study||134
8226205|NCT02019472|20285718|P1|COMPLETED|Overall Study||149
8226206|NCT02019472|20285716|P3|STARTED|Overall Study||187
8226207|NCT02019472|20285717|P2|STARTED|Overall Study||186
8226208|NCT02019472|20285718|P1|STARTED|Overall Study||186
8226209|NCT02019420|20285741|P2|NOT COMPLETED|Overall Study||106
8226210|NCT02019420|20285742|P1|NOT COMPLETED|Overall Study||108
8226211|NCT02019420|20285741|P2|COMPLETED|Overall Study||254
8226212|NCT02019420|20285742|P1|COMPLETED|Overall Study||258
8226213|NCT02019420|20285741|P2|Treated|Overall Study||357
8226214|NCT02019420|20285742|P1|Treated|Overall Study||361
8226215|NCT02019420|20285741|P2|STARTED|Overall Study||360
8226216|NCT02019420|20285742|P1|STARTED|Overall Study||366
8226217|NCT02019277|20285770|P1|NOT COMPLETED|Overall Study||12
8226218|NCT02019277|20285770|P1|COMPLETED|Overall Study||38
8226219|NCT02019277|20285770|P1|STARTED|Overall Study||50
8226220|NCT02019264|20285789|P2|NOT COMPLETED|Overall Study||207
8226221|NCT02019264|20285790|P1|NOT COMPLETED|Overall Study||248
8226222|NCT02019264|20285789|P2|COMPLETED|Overall Study||5793
8226223|NCT02019264|20285790|P1|COMPLETED|Overall Study||5752
8226224|NCT02019264|20285789|P2|Safety Analysis Set|Overall Study||5995
8226225|NCT02019264|20285790|P1|Safety Analysis Set|Overall Study||5992
8226226|NCT02019264|20285789|P2|STARTED|Overall Study||6000
8226227|NCT02019264|20285790|P1|STARTED|Overall Study||6000
8226228|NCT02019108|20285826|P2|NOT COMPLETED|Overall Study||7
8226229|NCT02019108|20285827|P1|NOT COMPLETED|Overall Study||5
8226230|NCT02019108|20285826|P2|COMPLETED|Overall Study||32
8226231|NCT02019108|20285827|P1|COMPLETED|Overall Study||35
8226232|NCT02019108|20285826|P2|Retention (Week 21)|Overall Study||32
8226233|NCT02019108|20285827|P1|Retention (Week 21)|Overall Study||35
8226234|NCT02019108|20285826|P2|Follow-up (Week 17)|Overall Study||36
8226235|NCT02019108|20285827|P1|Follow-up (Week 17)|Overall Study||38
8226236|NCT02019108|20285826|P2|Baseline (Week 0)|Overall Study||39
8226237|NCT02019108|20285827|P1|Baseline (Week 0)|Overall Study||40
8226238|NCT02019108|20285826|P2|STARTED|Overall Study||39
8226239|NCT02019108|20285827|P1|STARTED|Overall Study||40
8226240|NCT02019069|20285849|P1|NOT COMPLETED|Overall Study||0
8226241|NCT02019069|20285849|P1|COMPLETED|Overall Study||11
8226242|NCT02019069|20285849|P1|STARTED|Overall Study||11
8226243|NCT02018887|20285869|P11|NOT COMPLETED|Part C: Cohort 8 Overall||1
8226244|NCT02018887|20285870|P10|NOT COMPLETED|Part C: Cohort 8 Overall||3
8226245|NCT02018887|20285871|P9|NOT COMPLETED|Part C: Cohort 8 Overall||3
8226246|NCT02018887|20285872|P8|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226247|NCT02018887|20285873|P7|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226248|NCT02018887|20285874|P6|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226249|NCT02018887|20285875|P5|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226250|NCT02018887|20285876|P4|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226251|NCT02018887|20285877|P3|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226252|NCT02018887|20285878|P2|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226253|NCT02018887|20285879|P1|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226254|NCT02018887|20285869|P11|COMPLETED|Part C: Cohort 8 Overall||6
8226255|NCT02018887|20285870|P10|COMPLETED|Part C: Cohort 8 Overall||1
8226256|NCT02018887|20285871|P9|COMPLETED|Part C: Cohort 8 Overall||7
8226257|NCT02018887|20285872|P8|COMPLETED|Part C: Cohort 8 Overall||0
8226258|NCT02018887|20285873|P7|COMPLETED|Part C: Cohort 8 Overall||0
8226259|NCT02018887|20285874|P6|COMPLETED|Part C: Cohort 8 Overall||0
8226260|NCT02018887|20285875|P5|COMPLETED|Part C: Cohort 8 Overall||0
8226261|NCT02018887|20285876|P4|COMPLETED|Part C: Cohort 8 Overall||0
8226262|NCT02018887|20285877|P3|COMPLETED|Part C: Cohort 8 Overall||0
8226263|NCT02018887|20285878|P2|COMPLETED|Part C: Cohort 8 Overall||0
8226264|NCT02018887|20285879|P1|COMPLETED|Part C: Cohort 8 Overall||0
8226265|NCT02018887|20285869|P11|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
8226266|NCT02018887|20285870|P10|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
8226267|NCT02018887|20285871|P9|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
8226268|NCT02018887|20285872|P8|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226269|NCT02018887|20285873|P7|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226270|NCT02018887|20285874|P6|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226271|NCT02018887|20285875|P5|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226272|NCT02018887|20285876|P4|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226273|NCT02018887|20285877|P3|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226274|NCT02018887|20285878|P2|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226275|NCT02018887|20285879|P1|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226276|NCT02018887|20285869|P11|STARTED|Part C: Cohort 8 Overall||7
8226277|NCT02018887|20285870|P10|STARTED|Part C: Cohort 8 Overall||4
8226278|NCT02018887|20285871|P9|STARTED|Part C: Cohort 8 Overall||10
8226279|NCT02018887|20285872|P8|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226280|NCT02018887|20285873|P7|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226281|NCT02018887|20285874|P6|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226282|NCT02018887|20285875|P5|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226283|NCT02018887|20285876|P4|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226284|NCT02018887|20285877|P3|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
8226285|NCT02018887|20285878|P2|STARTED|Part C: Cohort 8 Overall||0
8226286|NCT02018887|20285879|P1|STARTED|Part C: Cohort 8 Overall||0
8226287|NCT02018887|20285869|P11|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226288|NCT02018887|20285870|P10|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226289|NCT02018887|20285871|P9|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226290|NCT02018887|20285872|P8|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
8226291|NCT02018887|20285873|P7|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
8226292|NCT02018887|20285874|P6|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226293|NCT02018887|20285875|P5|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
8226294|NCT02018887|20285876|P4|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226295|NCT02018887|20285877|P3|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226296|NCT02018887|20285878|P2|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226297|NCT02018887|20285879|P1|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226298|NCT02018887|20285869|P11|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226299|NCT02018887|20285870|P10|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226300|NCT02018887|20285871|P9|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226301|NCT02018887|20285872|P8|COMPLETED|Part B: Cohorts 3-7 Overall||5
8226302|NCT02018887|20285873|P7|COMPLETED|Part B: Cohorts 3-7 Overall||8
8226303|NCT02018887|20285874|P6|COMPLETED|Part B: Cohorts 3-7 Overall||9
8226304|NCT02018887|20285875|P5|COMPLETED|Part B: Cohorts 3-7 Overall||8
8226305|NCT02018887|20285876|P4|COMPLETED|Part B: Cohorts 3-7 Overall||9
8226306|NCT02018887|20285877|P3|COMPLETED|Part B: Cohorts 3-7 Overall||15
8226307|NCT02018887|20285878|P2|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226308|NCT02018887|20285879|P1|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226309|NCT02018887|20285869|P11|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226310|NCT02018887|20285870|P10|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226311|NCT02018887|20285871|P9|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226312|NCT02018887|20285872|P8|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226313|NCT02018887|20285873|P7|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226314|NCT02018887|20285874|P6|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226315|NCT02018887|20285875|P5|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226316|NCT02018887|20285876|P4|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226317|NCT02018887|20285877|P3|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
8226318|NCT02018887|20285878|P2|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226319|NCT02018887|20285879|P1|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226320|NCT02018887|20285869|P11|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
8226321|NCT02018887|20285870|P10|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
8226322|NCT02018887|20285871|P9|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
8226323|NCT02018887|20285872|P8|STARTED|Part B: Cohorts 3-7 Overall||9
8226324|NCT02018887|20285873|P7|STARTED|Part B: Cohorts 3-7 Overall||9
8226325|NCT02018887|20285874|P6|STARTED|Part B: Cohorts 3-7 Overall||9
8226326|NCT02018887|20285875|P5|STARTED|Part B: Cohorts 3-7 Overall||9
8226327|NCT02018887|20285876|P4|STARTED|Part B: Cohorts 3-7 Overall||9
8226328|NCT02018887|20285877|P3|STARTED|Part B: Cohorts 3-7 Overall||15
8226329|NCT02018887|20285878|P2|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
8226330|NCT02018887|20285879|P1|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
8226331|NCT02018887|20285869|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226332|NCT02018887|20285870|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226333|NCT02018887|20285871|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226334|NCT02018887|20285872|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226335|NCT02018887|20285873|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226336|NCT02018887|20285874|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226337|NCT02018887|20285875|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226338|NCT02018887|20285876|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226339|NCT02018887|20285877|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226340|NCT02018887|20285878|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226341|NCT02018887|20285879|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
8226342|NCT02018887|20285869|P11|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226343|NCT02018887|20285870|P10|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226344|NCT02018887|20285871|P9|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226345|NCT02018887|20285872|P8|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226346|NCT02018887|20285873|P7|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226347|NCT02018887|20285874|P6|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226348|NCT02018887|20285875|P5|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226349|NCT02018887|20285876|P4|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226350|NCT02018887|20285877|P3|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226351|NCT02018887|20285878|P2|COMPLETED|Part A: Cohorts 1-2: Period 3||9
8226352|NCT02018887|20285879|P1|COMPLETED|Part A: Cohorts 1-2: Period 3||8
8226353|NCT02018887|20285869|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226354|NCT02018887|20285870|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226355|NCT02018887|20285871|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226356|NCT02018887|20285872|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226357|NCT02018887|20285873|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226358|NCT02018887|20285874|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226359|NCT02018887|20285875|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226360|NCT02018887|20285876|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226361|NCT02018887|20285877|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226362|NCT02018887|20285878|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
8226363|NCT02018887|20285879|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
8226364|NCT02018887|20285869|P11|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226365|NCT02018887|20285870|P10|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226366|NCT02018887|20285871|P9|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
8226367|NCT02018887|20285872|P8|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226368|NCT02018887|20285873|P7|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226369|NCT02018887|20285874|P6|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226370|NCT02018887|20285875|P5|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226371|NCT02018887|20285876|P4|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226372|NCT02018887|20285877|P3|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
8226373|NCT02018887|20285878|P2|STARTED|Part A: Cohorts 1-2: Period 3||9
8226374|NCT02018887|20285879|P1|STARTED|Part A: Cohorts 1-2: Period 3||9
8226375|NCT02018887|20285869|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226376|NCT02018887|20285870|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226377|NCT02018887|20285871|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226378|NCT02018887|20285872|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226379|NCT02018887|20285873|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226380|NCT02018887|20285874|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226381|NCT02018887|20285875|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226382|NCT02018887|20285876|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226383|NCT02018887|20285877|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226384|NCT02018887|20285878|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226385|NCT02018887|20285879|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226386|NCT02018887|20285869|P11|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226387|NCT02018887|20285870|P10|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226388|NCT02018887|20285871|P9|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226389|NCT02018887|20285872|P8|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226390|NCT02018887|20285873|P7|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226391|NCT02018887|20285874|P6|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226392|NCT02018887|20285875|P5|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226393|NCT02018887|20285876|P4|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226394|NCT02018887|20285877|P3|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226395|NCT02018887|20285878|P2|COMPLETED|Part A: Cohorts 1-2: Period 2||9
8226396|NCT02018887|20285879|P1|COMPLETED|Part A: Cohorts 1-2: Period 2||9
8226397|NCT02018887|20285869|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226398|NCT02018887|20285870|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226399|NCT02018887|20285871|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226400|NCT02018887|20285872|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226401|NCT02018887|20285873|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226402|NCT02018887|20285874|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226403|NCT02018887|20285875|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226404|NCT02018887|20285876|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226405|NCT02018887|20285877|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226406|NCT02018887|20285878|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
8226407|NCT02018887|20285879|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
8226408|NCT02018887|20285869|P11|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226409|NCT02018887|20285870|P10|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226410|NCT02018887|20285871|P9|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
8226411|NCT02018887|20285872|P8|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226412|NCT02018887|20285873|P7|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226413|NCT02018887|20285874|P6|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226414|NCT02018887|20285875|P5|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226415|NCT02018887|20285876|P4|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226496|NCT02018562|20286050|P2|NOT COMPLETED|Overall Study||0
8226416|NCT02018887|20285877|P3|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
8226417|NCT02018887|20285878|P2|STARTED|Part A: Cohorts 1-2: Period 2||9
8226418|NCT02018887|20285879|P1|STARTED|Part A: Cohorts 1-2: Period 2||9
8226419|NCT02018887|20285869|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226420|NCT02018887|20285870|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226421|NCT02018887|20285871|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226422|NCT02018887|20285872|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226423|NCT02018887|20285873|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226424|NCT02018887|20285874|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226425|NCT02018887|20285875|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226426|NCT02018887|20285876|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226427|NCT02018887|20285877|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226428|NCT02018887|20285878|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226429|NCT02018887|20285879|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226430|NCT02018887|20285869|P11|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226431|NCT02018887|20285870|P10|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226432|NCT02018887|20285871|P9|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226433|NCT02018887|20285872|P8|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226434|NCT02018887|20285873|P7|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226435|NCT02018887|20285874|P6|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226436|NCT02018887|20285875|P5|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226437|NCT02018887|20285876|P4|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226438|NCT02018887|20285877|P3|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226439|NCT02018887|20285878|P2|COMPLETED|Part A: Cohorts 1-2: Period 1||9
8226440|NCT02018887|20285879|P1|COMPLETED|Part A: Cohorts 1-2: Period 1||9
8226441|NCT02018887|20285869|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226442|NCT02018887|20285870|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226443|NCT02018887|20285871|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226444|NCT02018887|20285872|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226445|NCT02018887|20285873|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226446|NCT02018887|20285874|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226447|NCT02018887|20285875|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226448|NCT02018887|20285876|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226449|NCT02018887|20285877|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226450|NCT02018887|20285878|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
8226451|NCT02018887|20285879|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
8226452|NCT02018887|20285869|P11|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226453|NCT02018887|20285870|P10|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226454|NCT02018887|20285871|P9|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
8226455|NCT02018887|20285872|P8|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226456|NCT02018887|20285873|P7|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226457|NCT02018887|20285874|P6|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226458|NCT02018887|20285875|P5|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226459|NCT02018887|20285876|P4|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226460|NCT02018887|20285877|P3|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
8226461|NCT02018887|20285878|P2|STARTED|Part A: Cohorts 1-2: Period 1||9
8226462|NCT02018887|20285879|P1|STARTED|Part A: Cohorts 1-2: Period 1||9
8226463|NCT02018822|20285968|P3|NOT COMPLETED|Overall Study||6
8226464|NCT02018822|20285969|P2|NOT COMPLETED|Overall Study||8
8226465|NCT02018822|20285970|P1|NOT COMPLETED|Overall Study||6
8226466|NCT02018822|20285968|P3|COMPLETED|Overall Study||29
8226467|NCT02018822|20285969|P2|COMPLETED|Overall Study||42
8226468|NCT02018822|20285970|P1|COMPLETED|Overall Study||44
8226469|NCT02018822|20285968|P3|STARTED|Overall Study||35
8226470|NCT02018822|20285969|P2|STARTED|Overall Study||50
8226471|NCT02018822|20285970|P1|STARTED|Overall Study||50
8226472|NCT02018809|20285997|P4|NOT COMPLETED|Overall Study||0
8226473|NCT02018809|20285998|P3|NOT COMPLETED|Overall Study||0
8226474|NCT02018809|20285999|P2|NOT COMPLETED|Overall Study||0
8226475|NCT02018809|20286000|P1|NOT COMPLETED|Overall Study||0
8226476|NCT02018809|20285997|P4|COMPLETED|Overall Study||50
8226477|NCT02018809|20285998|P3|COMPLETED|Overall Study||50
8226478|NCT02018809|20285999|P2|COMPLETED|Overall Study||50
8226479|NCT02018809|20286000|P1|COMPLETED|Overall Study||50
8226480|NCT02018809|20285997|P4|STARTED|Overall Study||50
8226481|NCT02018809|20285998|P3|STARTED|Overall Study||50
8226482|NCT02018809|20285999|P2|STARTED|Overall Study||50
8226483|NCT02018809|20286000|P1|STARTED|Overall Study||50
8226484|NCT02018653|20286016|P2|NOT COMPLETED|Overall Study||1
8226485|NCT02018653|20286017|P1|NOT COMPLETED|Overall Study||0
8226486|NCT02018653|20286016|P2|COMPLETED|Overall Study||0
8226487|NCT02018653|20286017|P1|COMPLETED|Overall Study||1
8226488|NCT02018653|20286016|P2|STARTED|Overall Study||1
8226489|NCT02018653|20286017|P1|STARTED|Overall Study||1
8226490|NCT02018627|20286025|P2|NOT COMPLETED|Overall Study||0
8226491|NCT02018627|20286026|P1|NOT COMPLETED|Overall Study||0
8226492|NCT02018627|20286025|P2|COMPLETED|Overall Study||6
8226493|NCT02018627|20286026|P1|COMPLETED|Overall Study||7
8226494|NCT02018627|20286025|P2|STARTED|Overall Study||6
8226495|NCT02018627|20286026|P1|STARTED|Overall Study||7
8226497|NCT02018562|20286051|P1|NOT COMPLETED|Overall Study||3
8226498|NCT02018562|20286050|P2|COMPLETED|Overall Study||25
8226499|NCT02018562|20286051|P1|COMPLETED|Overall Study||22
8226500|NCT02018562|20286050|P2|STARTED|Overall Study||25
8226501|NCT02018562|20286051|P1|STARTED|Overall Study||25
8226502|NCT02018458|20286069|P1|NOT COMPLETED|Overall Study||4
8226503|NCT02018458|20286069|P1|COMPLETED|Overall Study||6
8226504|NCT02018458|20286069|P1|STARTED|Overall Study||10
8226505|NCT02018445|20286075|P1|NOT COMPLETED|Overall Study||7
8226506|NCT02018445|20286075|P1|COMPLETED|Overall Study||29
8226507|NCT02018445|20286075|P1|STARTED|Overall Study||36
8226508|NCT02018315|20286086|P1|NOT COMPLETED|Overall Study||0
8226509|NCT02018315|20286086|P1|COMPLETED|Overall Study||14
8226510|NCT02018315|20286086|P1|STARTED|Overall Study||14
8226511|NCT02018107|20286091|P1|NOT COMPLETED|Overall Study||0
8226512|NCT02018107|20286091|P1|COMPLETED|Overall Study||27
8226513|NCT02018107|20286091|P1|STARTED|Overall Study||27
8226514|NCT02018042|20286096|P1|NOT COMPLETED|Overall Study||1
8226515|NCT02018042|20286096|P1|COMPLETED|Overall Study||14
8226516|NCT02018042|20286096|P1|STARTED|Overall Study||15
8226517|NCT02017964|20286102|P1|NOT COMPLETED|Overall Study||1
8226518|NCT02017964|20286102|P1|COMPLETED|Overall Study||25
8226519|NCT02017964|20286102|P1|STARTED|Overall Study||26
8226520|NCT02017899|20286116|P6|NOT COMPLETED|Overall Study||0
8226521|NCT02017899|20286117|P5|NOT COMPLETED|Overall Study||1
8226522|NCT02017899|20286118|P4|NOT COMPLETED|Overall Study||1
8226523|NCT02017899|20286119|P3|NOT COMPLETED|Overall Study||0
8226524|NCT02017899|20286120|P2|NOT COMPLETED|Overall Study||0
8226525|NCT02017899|20286121|P1|NOT COMPLETED|Overall Study||0
8226526|NCT02017899|20286116|P6|COMPLETED|Overall Study||8
8226527|NCT02017899|20286117|P5|COMPLETED|Overall Study||8
8226528|NCT02017899|20286118|P4|COMPLETED|Overall Study||7
8226529|NCT02017899|20286119|P3|COMPLETED|Overall Study||8
8226530|NCT02017899|20286120|P2|COMPLETED|Overall Study||9
8226531|NCT02017899|20286121|P1|COMPLETED|Overall Study||8
8226532|NCT02017899|20286116|P6|STARTED|Overall Study||8
8226533|NCT02017899|20286117|P5|STARTED|Overall Study||9
8226534|NCT02017899|20286118|P4|STARTED|Overall Study||8
8226535|NCT02017899|20286119|P3|STARTED|Overall Study||8
8226536|NCT02017899|20286120|P2|STARTED|Overall Study||9
8226537|NCT02017899|20286121|P1|STARTED|Overall Study||8
8226538|NCT02017860|20286195|P1|NOT COMPLETED|Overall Study||2
8226539|NCT02017860|20286195|P1|COMPLETED|Overall Study||2
8226540|NCT02017860|20286195|P1|STARTED|Overall Study||4
8226541|NCT02017574|20286201|P2|NOT COMPLETED|Overall Study||0
8226542|NCT02017574|20286202|P1|NOT COMPLETED|Overall Study||0
8226543|NCT02017574|20286201|P2|COMPLETED|Overall Study||12
8226544|NCT02017574|20286202|P1|COMPLETED|Overall Study||12
8226545|NCT02017574|20286201|P2|STARTED|Overall Study||12
8226546|NCT02017574|20286202|P1|STARTED|Overall Study||12
8226547|NCT02017535|20286214|P4|NOT COMPLETED|Overall Study||0
8226548|NCT02017535|20286215|P3|NOT COMPLETED|Overall Study||0
8226549|NCT02017535|20286216|P2|NOT COMPLETED|Overall Study||0
8226550|NCT02017535|20286217|P1|NOT COMPLETED|Overall Study||1
8226551|NCT02017535|20286214|P4|COMPLETED|Overall Study||1
8226552|NCT02017535|20286215|P3|COMPLETED|Overall Study||2
8226553|NCT02017535|20286216|P2|COMPLETED|Overall Study||3
8226554|NCT02017535|20286217|P1|COMPLETED|Overall Study||8
8226555|NCT02017535|20286214|P4|STARTED|Overall Study||1
8226556|NCT02017535|20286215|P3|STARTED|Overall Study||2
8226557|NCT02017535|20286216|P2|STARTED|Overall Study||3
8226558|NCT02017535|20286217|P1|STARTED|Overall Study||9
8226559|NCT02017522|20286239|P1|NOT COMPLETED|Overall Study||1
8226560|NCT02017522|20286239|P1|COMPLETED|Overall Study||2
8226561|NCT02017522|20286239|P1|Scan|Overall Study||2
8226562|NCT02017522|20286239|P1|STARTED|Overall Study||3
8226563|NCT02017327|20286247|P3|NOT COMPLETED|Overall Study||15
8226564|NCT02017327|20286248|P2|NOT COMPLETED|Overall Study||12
8226565|NCT02017327|20286249|P1|NOT COMPLETED|Overall Study||16
8226566|NCT02017327|20286247|P3|COMPLETED|Overall Study||117
8226567|NCT02017327|20286248|P2|COMPLETED|Overall Study||113
8226568|NCT02017327|20286249|P1|COMPLETED|Overall Study||106
8226569|NCT02017327|20286247|P3|STARTED|Overall Study||132
8226570|NCT02017327|20286248|P2|STARTED|Overall Study||125
8226571|NCT02017327|20286249|P1|STARTED|Overall Study||122
8226572|NCT02017223|20286257|P1|NOT COMPLETED|Overall Study||2
8226573|NCT02017223|20286257|P1|COMPLETED|Overall Study||10
8226574|NCT02017223|20286257|P1|STARTED|Overall Study||12
8226575|NCT02017210|20286264|P3|NOT COMPLETED|Overall Study||0
8226576|NCT02017210|20286265|P2|NOT COMPLETED|Overall Study||0
8226577|NCT02017210|20286266|P1|NOT COMPLETED|Overall Study||0
8226578|NCT02017210|20286264|P3|COMPLETED|Overall Study||20
8226579|NCT02017210|20286265|P2|COMPLETED|Overall Study||20
8226580|NCT02017210|20286266|P1|COMPLETED|Overall Study||17
8226581|NCT02017210|20286264|P3|STARTED|Overall Study||20
8226582|NCT02017210|20286265|P2|STARTED|Overall Study||20
8226583|NCT02017210|20286266|P1|STARTED|Overall Study||17
8226584|NCT02017171|20286303|P2|NOT COMPLETED|Overall Study||46
8226585|NCT02017171|20286304|P1|NOT COMPLETED|Overall Study||62
8226586|NCT02017171|20286303|P2|COMPLETED|Overall Study||217
8226587|NCT02017171|20286304|P1|COMPLETED|Overall Study||205
8226588|NCT02017171|20286303|P2|STARTED|Overall Study||263
8226589|NCT02017171|20286304|P1|STARTED|Overall Study||267
8226590|NCT02017093|20286328|P2|NOT COMPLETED|Overall Study||0
8226591|NCT02017093|20286329|P1|NOT COMPLETED|Overall Study||0
8226592|NCT02017093|20286328|P2|COMPLETED|Overall Study||3
8226593|NCT02017093|20286329|P1|COMPLETED|Overall Study||4
8226594|NCT02017093|20286328|P2|STARTED|Overall Study||3
8226595|NCT02017093|20286329|P1|STARTED|Overall Study||4
8226596|NCT02017015|20286337|P1|NOT COMPLETED|Overall Study||69
8226597|NCT02017015|20286337|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
8226598|NCT02017015|20286337|P1|Safety Population|Overall Study||83
8226599|NCT02017015|20286337|P1|STARTED|Overall Study||83
8226600|NCT02016963|20286344|P1|NOT COMPLETED|Overall Study||0
8226601|NCT02016963|20286344|P1|COMPLETED|Overall Study||20
8226602|NCT02016963|20286344|P1|STARTED|Overall Study||20
8226603|NCT02016898|20286362|P2|NOT COMPLETED|Overall Study||5
8226604|NCT02016898|20286363|P1|NOT COMPLETED|Overall Study||5
8226605|NCT02016898|20286362|P2|COMPLETED|Overall Study||40
8226606|NCT02016898|20286363|P1|COMPLETED|Overall Study||45
8226607|NCT02016898|20286362|P2|STARTED|Overall Study||45
8226608|NCT02016898|20286363|P1|STARTED|Overall Study||50
8226609|NCT02016885|20286376|P5|NOT COMPLETED|Overall Study||1
8226610|NCT02016885|20286377|P4|NOT COMPLETED|Overall Study||10
8226611|NCT02016885|20286378|P3|NOT COMPLETED|Overall Study||1
8226612|NCT02016885|20286379|P2|NOT COMPLETED|Overall Study||4
8226613|NCT02016885|20286380|P1|NOT COMPLETED|Overall Study||4
8226614|NCT02016885|20286376|P5|COMPLETED|Overall Study||39
8226615|NCT02016885|20286377|P4|COMPLETED|Overall Study||30
8226616|NCT02016885|20286378|P3|COMPLETED|Overall Study||39
8226617|NCT02016885|20286379|P2|COMPLETED|Overall Study||36
8226618|NCT02016885|20286380|P1|COMPLETED|Overall Study||34
8226619|NCT02016885|20286376|P5|STARTED|Overall Study||40
8226620|NCT02016885|20286377|P4|STARTED|Overall Study||40
8226621|NCT02016885|20286378|P3|STARTED|Overall Study||40
8226622|NCT02016885|20286379|P2|STARTED|Overall Study||40
8226623|NCT02016885|20286380|P1|STARTED|Overall Study||38
8226624|NCT02016755|20286417|P1|NOT COMPLETED|Overall Study||7
8226625|NCT02016755|20286417|P1|COMPLETED|Overall Study||3
8226626|NCT02016755|20286417|P1|Completed Month 36 LTFU Questionnaire|Overall Study||3
8226627|NCT02016755|20286417|P1|Completed Month 18 Clinic Visit|Overall Study||5
8226628|NCT02016755|20286417|P1|STARTED|Overall Study||10
8226629|NCT02016716|20286436|P3|NOT COMPLETED|Overall Study||6
8226630|NCT02016716|20286437|P2|NOT COMPLETED|Overall Study||8
8226631|NCT02016716|20286438|P1|NOT COMPLETED|Overall Study||6
8226632|NCT02016716|20286436|P3|COMPLETED|Overall Study||117
8226633|NCT02016716|20286437|P2|COMPLETED|Overall Study||110
8226634|NCT02016716|20286438|P1|COMPLETED|Overall Study||47
8226635|NCT02016716|20286436|P3|Received Study Treatment|Overall Study||123
8226636|NCT02016716|20286437|P2|Received Study Treatment|Overall Study||118
8226637|NCT02016716|20286438|P1|Received Study Treatment|Overall Study||53
8226638|NCT02016716|20286436|P3|STARTED|Overall Study||123
8226639|NCT02016716|20286437|P2|STARTED|Overall Study||118
8226640|NCT02016716|20286438|P1|STARTED|Overall Study||53
8226641|NCT02016690|20286459|P1|NOT COMPLETED|Overall Study||24
8226642|NCT02016690|20286459|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
8226643|NCT02016690|20286459|P1|Safety Analysis Set (SAS)|Overall Study||304
8226644|NCT02016690|20286459|P1|Treated|Overall Study||312
8226645|NCT02016690|20286459|P1|STARTED|Overall Study||312
8226646|NCT02016625|20286472|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
8226647|NCT02016625|20286473|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
8226648|NCT02016625|20286472|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
8226649|NCT02016625|20286473|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
8226650|NCT02016625|20286472|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
8226651|NCT02016625|20286473|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
8226652|NCT02016625|20286472|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
8226653|NCT02016625|20286473|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
8226654|NCT02016625|20286472|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
8226655|NCT02016625|20286473|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
8226656|NCT02016625|20286472|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
8226657|NCT02016625|20286473|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
8226658|NCT02016612|20286509|P4|NOT COMPLETED|Overall Study||0
8226659|NCT02016612|20286510|P3|NOT COMPLETED|Overall Study||0
8226660|NCT02016612|20286511|P2|NOT COMPLETED|Overall Study||0
8226661|NCT02016612|20286512|P1|NOT COMPLETED|Overall Study||0
8226662|NCT02016612|20286509|P4|COMPLETED|Overall Study||61
8226663|NCT02016612|20286510|P3|COMPLETED|Overall Study||26
8226664|NCT02016612|20286511|P2|COMPLETED|Overall Study||25
8226665|NCT02016612|20286512|P1|COMPLETED|Overall Study||25
8226666|NCT02016612|20286509|P4|STARTED|Overall Study||61
8226667|NCT02016612|20286510|P3|STARTED|Overall Study||26
8226668|NCT02016612|20286511|P2|STARTED|Overall Study||25
8226669|NCT02016612|20286512|P1|STARTED|Overall Study||25
8226670|NCT02016560|20286532|P6|NOT COMPLETED|Confirmatory Phase||27
8226671|NCT02016560|20286533|P5|NOT COMPLETED|Confirmatory Phase||22
8226672|NCT02016560|20286534|P4|NOT COMPLETED|Confirmatory Phase||0
8226673|NCT02016560|20286535|P3|NOT COMPLETED|Confirmatory Phase||0
8226674|NCT02016560|20286536|P2|NOT COMPLETED|Confirmatory Phase||0
8226675|NCT02016560|20286537|P1|NOT COMPLETED|Confirmatory Phase||0
8226676|NCT02016560|20286532|P6|COMPLETED|Confirmatory Phase||35
8226677|NCT02016560|20286533|P5|COMPLETED|Confirmatory Phase||76
8226678|NCT02016560|20286534|P4|COMPLETED|Confirmatory Phase||0
8226679|NCT02016560|20286535|P3|COMPLETED|Confirmatory Phase||0
8226680|NCT02016560|20286536|P2|COMPLETED|Confirmatory Phase||0
8226681|NCT02016560|20286537|P1|COMPLETED|Confirmatory Phase||0
8226682|NCT02016560|20286532|P6|STARTED|Confirmatory Phase||62
8226683|NCT02016560|20286533|P5|STARTED|Confirmatory Phase||98
8226684|NCT02016560|20286534|P4|STARTED|Confirmatory Phase||0
8226685|NCT02016560|20286535|P3|STARTED|Confirmatory Phase||0
8226686|NCT02016560|20286536|P2|STARTED|Confirmatory Phase||0
8226687|NCT02016560|20286537|P1|STARTED|Confirmatory Phase||0
8226688|NCT02016560|20286532|P6|NOT COMPLETED|Exploratory Phase||0
8226689|NCT02016560|20286533|P5|NOT COMPLETED|Exploratory Phase||0
8226690|NCT02016560|20286534|P4|NOT COMPLETED|Exploratory Phase||16
8226691|NCT02016560|20286535|P3|NOT COMPLETED|Exploratory Phase||36
8226692|NCT02016560|20286536|P2|NOT COMPLETED|Exploratory Phase||4
8226693|NCT02016560|20286537|P1|NOT COMPLETED|Exploratory Phase||0
8226694|NCT02016560|20286532|P6|COMPLETED|Exploratory Phase||0
8226695|NCT02016560|20286533|P5|COMPLETED|Exploratory Phase||0
8226696|NCT02016560|20286534|P4|COMPLETED|Exploratory Phase||35
8226697|NCT02016560|20286535|P3|COMPLETED|Exploratory Phase||62
8226698|NCT02016560|20286536|P2|COMPLETED|Exploratory Phase||54
8226699|NCT02016560|20286537|P1|COMPLETED|Exploratory Phase||16
8226700|NCT02016560|20286532|P6|STARTED|Exploratory Phase||0
8226701|NCT02016560|20286533|P5|STARTED|Exploratory Phase||0
8226702|NCT02016560|20286534|P4|STARTED|Exploratory Phase||51
8226703|NCT02016560|20286535|P3|STARTED|Exploratory Phase||98
8226704|NCT02016560|20286536|P2|STARTED|Exploratory Phase||58
8226705|NCT02016560|20286537|P1|STARTED|Exploratory Phase||16
8226706|NCT02016482|20286561|P2|NOT COMPLETED|Period B||7
8226707|NCT02016482|20286562|P1|NOT COMPLETED|Period B||13
8226708|NCT02016482|20286561|P2|COMPLETED|Period B||87
8226709|NCT02016482|20286562|P1|COMPLETED|Period B||81
8226710|NCT02016482|20286561|P2|STARTED|Period B||94
8226711|NCT02016482|20286562|P1|STARTED|Period B||94
8226712|NCT02016482|20286561|P2|NOT COMPLETED|Period A||15
8226713|NCT02016482|20286562|P1|NOT COMPLETED|Period A||14
8226714|NCT02016482|20286561|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
8226715|NCT02016482|20286562|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
8226716|NCT02016482|20286561|P2|STARTED|Period A||109
8226717|NCT02016482|20286562|P1|STARTED|Period A||108
8226718|NCT02016300|20286652|P2|NOT COMPLETED|Overall Study||3
8226719|NCT02016300|20286653|P1|NOT COMPLETED|Overall Study||0
8226720|NCT02016300|20286652|P2|COMPLETED|Overall Study||9
8226721|NCT02016300|20286653|P1|COMPLETED|Overall Study||12
8226722|NCT02016300|20286652|P2|STARTED|Overall Study||12
8226723|NCT02016300|20286653|P1|STARTED|Overall Study||12
8226724|NCT02016235|20286674|P3|NOT COMPLETED|Overall Study||0
8226725|NCT02016235|20286675|P2|NOT COMPLETED|Overall Study||0
8226726|NCT02016235|20286676|P1|NOT COMPLETED|Overall Study||0
8226727|NCT02016235|20286674|P3|COMPLETED|Overall Study||10
8226728|NCT02016235|20286675|P2|COMPLETED|Overall Study||10
8226729|NCT02016235|20286676|P1|COMPLETED|Overall Study||10
8226730|NCT02016235|20286674|P3|STARTED|Overall Study||10
8226731|NCT02016235|20286675|P2|STARTED|Overall Study||10
8226732|NCT02016235|20286676|P1|STARTED|Overall Study||10
8226733|NCT02016183|20286684|P1|NOT COMPLETED|Overall Study||65
8226734|NCT02016183|20286684|P1|COMPLETED|Overall Study||3157
8226735|NCT02016183|20286684|P1|STARTED|Overall Study||3222
8226736|NCT02016170|20286694|P3|NOT COMPLETED|Overall Study||0
8226737|NCT02016170|20286695|P2|NOT COMPLETED|Overall Study||1
8226738|NCT02016170|20286696|P1|NOT COMPLETED|Overall Study||2
8226739|NCT02016170|20286694|P3|COMPLETED|Overall Study||27
8226740|NCT02016170|20286695|P2|COMPLETED|Overall Study||27
8226741|NCT02016170|20286696|P1|COMPLETED|Overall Study||25
8226742|NCT02016170|20286694|P3|STARTED|Overall Study||27
8226743|NCT02016170|20286695|P2|STARTED|Overall Study||28
8226744|NCT02016170|20286696|P1|STARTED|Overall Study||27
8226745|NCT02016105|20286707|P6|NOT COMPLETED|EXTENSION PERIOD||6
8226746|NCT02016105|20286708|P5|NOT COMPLETED|EXTENSION PERIOD||6
8226747|NCT02016105|20286709|P4|NOT COMPLETED|EXTENSION PERIOD||5
8226748|NCT02016105|20286710|P3|NOT COMPLETED|EXTENSION PERIOD||5
8226749|NCT02016105|20286711|P2|NOT COMPLETED|EXTENSION PERIOD||0
8226750|NCT02016105|20286712|P1|NOT COMPLETED|EXTENSION PERIOD||0
8226751|NCT02016105|20286707|P6|COMPLETED|EXTENSION PERIOD||100
8226752|NCT02016105|20286708|P5|COMPLETED|EXTENSION PERIOD||50
8226753|NCT02016105|20286709|P4|COMPLETED|EXTENSION PERIOD||104
8226754|NCT02016105|20286710|P3|COMPLETED|EXTENSION PERIOD||47
8226755|NCT02016105|20286711|P2|COMPLETED|EXTENSION PERIOD||0
8226756|NCT02016105|20286712|P1|COMPLETED|EXTENSION PERIOD||0
8226757|NCT02016105|20286707|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
8226758|NCT02016105|20286708|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
8226759|NCT02016105|20286709|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
8226760|NCT02016105|20286710|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
8226761|NCT02016105|20286711|P2|STARTED|EXTENSION PERIOD||0
8226762|NCT02016105|20286712|P1|STARTED|EXTENSION PERIOD||0
8226763|NCT02016105|20286707|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
8226764|NCT02016105|20286708|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
8226765|NCT02016105|20286709|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
8226766|NCT02016105|20286710|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
8226767|NCT02016105|20286711|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
8226768|NCT02016105|20286712|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
8226769|NCT02016105|20286707|P6|COMPLETED|TREATMENT PERIOD 2||112
8226770|NCT02016105|20286708|P5|COMPLETED|TREATMENT PERIOD 2||59
8226771|NCT02016105|20286709|P4|COMPLETED|TREATMENT PERIOD 2||116
8226772|NCT02016105|20286710|P3|COMPLETED|TREATMENT PERIOD 2||57
8226773|NCT02016105|20286711|P2|COMPLETED|TREATMENT PERIOD 2||0
8226774|NCT02016105|20286712|P1|COMPLETED|TREATMENT PERIOD 2||0
8226775|NCT02016105|20286707|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
8226776|NCT02016105|20286708|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
8226777|NCT02016105|20286709|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
8226778|NCT02016105|20286710|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
8226779|NCT02016105|20286711|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8226780|NCT02016105|20286712|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8226781|NCT02016105|20286707|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
8226782|NCT02016105|20286708|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
8226783|NCT02016105|20286709|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
8226784|NCT02016105|20286710|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
8226785|NCT02016105|20286711|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
8226786|NCT02016105|20286712|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
8226787|NCT02016105|20286707|P6|COMPLETED|TREATMENT PERIOD 1||0
8226788|NCT02016105|20286708|P5|COMPLETED|TREATMENT PERIOD 1||0
8226789|NCT02016105|20286709|P4|COMPLETED|TREATMENT PERIOD 1||0
8226790|NCT02016105|20286710|P3|COMPLETED|TREATMENT PERIOD 1||0
8226791|NCT02016105|20286711|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
8226792|NCT02016105|20286712|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
8226793|NCT02016105|20286707|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226794|NCT02016105|20286708|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226795|NCT02016105|20286709|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226796|NCT02016105|20286710|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226797|NCT02016105|20286711|P2|STARTED|TREATMENT PERIOD 1||234
8226798|NCT02016105|20286712|P1|STARTED|TREATMENT PERIOD 1||231
8226799|NCT02015910|20286762|P2|NOT COMPLETED|Overall Study||0
8226800|NCT02015910|20286763|P1|NOT COMPLETED|Overall Study||0
8226801|NCT02015910|20286762|P2|COMPLETED|Overall Study||1
8226802|NCT02015910|20286763|P1|COMPLETED|Overall Study||0
8226803|NCT02015910|20286762|P2|STARTED|Overall Study||1
8226804|NCT02015910|20286763|P1|STARTED|Overall Study||0
8226805|NCT02015793|20286771|P2|NOT COMPLETED|Overall Study||4
8226806|NCT02015793|20286772|P1|NOT COMPLETED|Overall Study||4
8226807|NCT02015793|20286771|P2|COMPLETED|Overall Study||11
8226808|NCT02015793|20286772|P1|COMPLETED|Overall Study||11
8226809|NCT02015793|20286771|P2|Entered Open-label Extension Period|Overall Study||14
8226810|NCT02015793|20286772|P1|Entered Open-label Extension Period|Overall Study||13
8226811|NCT02015793|20286771|P2|Completed Double-Blind Period|Overall Study||14
8226812|NCT02015793|20286772|P1|Completed Double-Blind Period|Overall Study||14
8226813|NCT02015793|20286771|P2|STARTED|Overall Study||15
8226814|NCT02015793|20286772|P1|STARTED|Overall Study||15
8226815|NCT02015754|20286802|P1|NOT COMPLETED|Overall Study||11
8226816|NCT02015754|20286802|P1|COMPLETED|Overall Study||3
8226817|NCT02015754|20286802|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
8226818|NCT02015754|20286802|P1|Completed First TACE|Overall Study||14
8226819|NCT02015754|20286802|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
8226820|NCT02015676|20286822|P3|NOT COMPLETED|Overall Study||3
8226821|NCT02015676|20286823|P2|NOT COMPLETED|Overall Study||34
8226822|NCT02015676|20286824|P1|NOT COMPLETED|Overall Study||9
8226823|NCT02015676|20286822|P3|COMPLETED|Overall Study||3
8226824|NCT02015676|20286823|P2|COMPLETED|Overall Study||14
8226825|NCT02015676|20286824|P1|COMPLETED|Overall Study||6
8226826|NCT02015676|20286822|P3|STARTED|Overall Study||6
8226827|NCT02015676|20286823|P2|STARTED|Overall Study||48
8226828|NCT02015676|20286824|P1|STARTED|Overall Study||15
8226829|NCT02015663|20286840|P2|NOT COMPLETED|Overall Study||12
8226830|NCT02015663|20286841|P1|NOT COMPLETED|Overall Study||15
8226831|NCT02015663|20286840|P2|COMPLETED|Overall Study||4
8226832|NCT02015663|20286841|P1|COMPLETED|Overall Study||1
8226833|NCT02015663|20286840|P2|STARTED|Overall Study||16
8226834|NCT02015663|20286841|P1|STARTED|Overall Study||16
8226835|NCT02015637|20286872|P2|NOT COMPLETED|Overall Study||5
8226836|NCT02015637|20286873|P1|NOT COMPLETED|Overall Study||8
8226837|NCT02015637|20286872|P2|COMPLETED|Overall Study||149
8226838|NCT02015637|20286873|P1|COMPLETED|Overall Study||298
8226839|NCT02015637|20286872|P2|STARTED|Overall Study||154
8226840|NCT02015637|20286873|P1|STARTED|Overall Study||306
8226841|NCT02015546|20286884|P3|NOT COMPLETED|Overall Study||4
8226842|NCT02015546|20286885|P2|NOT COMPLETED|Overall Study||2
8226843|NCT02015546|20286886|P1|NOT COMPLETED|Overall Study||3
8226844|NCT02015546|20286884|P3|COMPLETED|Overall Study||22
8226845|NCT02015546|20286885|P2|COMPLETED|Overall Study||19
8226846|NCT02015546|20286886|P1|COMPLETED|Overall Study||20
8226847|NCT02015546|20286884|P3|STARTED|Overall Study||26
8226848|NCT02015546|20286885|P2|STARTED|Overall Study||21
8226849|NCT02015546|20286886|P1|STARTED|Overall Study||23
8226850|NCT02015481|20286918|P1|NOT COMPLETED|Overall Study||1
8226851|NCT02015481|20286918|P1|COMPLETED|Overall Study||24
8226852|NCT02015481|20286918|P1|STARTED|Overall Study||25
8226853|NCT02015442|20286925|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8226854|NCT02015442|20286926|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8226855|NCT02015442|20286925|P2|COMPLETED|Second Intervention (7 Days)||4
8226856|NCT02015442|20286926|P1|COMPLETED|Second Intervention (7 Days)||5
8226857|NCT02015442|20286925|P2|STARTED|Second Intervention (7 Days)||4
8226858|NCT02015442|20286926|P1|STARTED|Second Intervention (7 Days)||5
8226859|NCT02015442|20286925|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
8226860|NCT02015442|20286926|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
8226861|NCT02015442|20286925|P2|COMPLETED|Wash-out (4 Weeks)||4
8226862|NCT02015442|20286926|P1|COMPLETED|Wash-out (4 Weeks)||5
8226863|NCT02015442|20286925|P2|STARTED|Wash-out (4 Weeks)||4
8226864|NCT02015442|20286926|P1|STARTED|Wash-out (4 Weeks)||5
8226865|NCT02015442|20286925|P2|NOT COMPLETED|First Intervention (7 Days)||0
8226866|NCT02015442|20286926|P1|NOT COMPLETED|First Intervention (7 Days)||0
8226867|NCT02015442|20286925|P2|COMPLETED|First Intervention (7 Days)||4
8226868|NCT02015442|20286926|P1|COMPLETED|First Intervention (7 Days)||5
8226869|NCT02015442|20286925|P2|STARTED|First Intervention (7 Days)||4
8226870|NCT02015442|20286926|P1|STARTED|First Intervention (7 Days)||5
8226871|NCT02015234|20286936|P2|NOT COMPLETED|Overall Study||25
8226872|NCT02015234|20286937|P1|NOT COMPLETED|Overall Study||36
8226873|NCT02015234|20286936|P2|COMPLETED|Overall Study||54
8226874|NCT02015234|20286937|P1|COMPLETED|Overall Study||43
8226875|NCT02015234|20286936|P2|STARTED|Overall Study||79
8226876|NCT02015234|20286937|P1|STARTED|Overall Study||79
8226877|NCT02015221|20286951|P2|NOT COMPLETED|Overall Study||6
8226878|NCT02015221|20286952|P1|NOT COMPLETED|Overall Study||9
8226879|NCT02015221|20286951|P2|COMPLETED|Overall Study||34
8226880|NCT02015221|20286952|P1|COMPLETED|Overall Study||32
8226881|NCT02015221|20286951|P2|STARTED|Overall Study||40
8226882|NCT02015221|20286952|P1|STARTED|Overall Study||41
8226883|NCT02015195|20286965|P7|NOT COMPLETED|Overall Study||0
8226884|NCT02015195|20286966|P6|NOT COMPLETED|Overall Study||0
8226885|NCT02015195|20286967|P5|NOT COMPLETED|Overall Study||0
8226886|NCT02015195|20286968|P4|NOT COMPLETED|Overall Study||1
8226887|NCT02015195|20286969|P3|NOT COMPLETED|Overall Study||0
8226888|NCT02015195|20286970|P2|NOT COMPLETED|Overall Study||0
8226889|NCT02015195|20286971|P1|NOT COMPLETED|Overall Study||0
8226890|NCT02015195|20286965|P7|COMPLETED|Overall Study||16
8226891|NCT02015195|20286966|P6|COMPLETED|Overall Study||16
8226892|NCT02015195|20286967|P5|COMPLETED|Overall Study||16
8226893|NCT02015195|20286968|P4|COMPLETED|Overall Study||0
8226894|NCT02015195|20286969|P3|COMPLETED|Overall Study||16
8226895|NCT02015195|20286970|P2|COMPLETED|Overall Study||16
8226896|NCT02015195|20286971|P1|COMPLETED|Overall Study||16
8226897|NCT02015195|20286965|P7|STARTED|Overall Study||16
8226898|NCT02015195|20286966|P6|STARTED|Overall Study||16
8226899|NCT02015195|20286967|P5|STARTED|Overall Study||16
8226900|NCT02015195|20286968|P4|STARTED|Overall Study||1
8226901|NCT02015195|20286969|P3|STARTED|Overall Study||16
8226902|NCT02015195|20286970|P2|STARTED|Overall Study||16
8226903|NCT02015195|20286971|P1|STARTED|Overall Study||16
8226904|NCT02015104|20286994|P2|NOT COMPLETED|Overall Study||1
8226905|NCT02015104|20286995|P1|NOT COMPLETED|Overall Study||1
8226906|NCT02015104|20286994|P2|COMPLETED|Overall Study||15
8226907|NCT02015104|20286995|P1|COMPLETED|Overall Study||15
8226908|NCT02015104|20286994|P2|STARTED|Overall Study||16
8226909|NCT02015104|20286995|P1|STARTED|Overall Study||16
8226910|NCT02015065|20287012|P3|NOT COMPLETED|Overall Study||1
8226911|NCT02015065|20287013|P2|NOT COMPLETED|Overall Study||2
8226912|NCT02015065|20287014|P1|NOT COMPLETED|Overall Study||1
8226913|NCT02015065|20287012|P3|COMPLETED|Overall Study||1
8226914|NCT02015065|20287013|P2|COMPLETED|Overall Study||3
8226915|NCT02015065|20287014|P1|COMPLETED|Overall Study||1
8226916|NCT02015065|20287012|P3|STARTED|Overall Study||2
8226917|NCT02015065|20287013|P2|STARTED|Overall Study||5
8226918|NCT02015065|20287014|P1|STARTED|Overall Study||2
8226919|NCT02015039|20287036|P2|NOT COMPLETED|Overall Study||1
8226920|NCT02015039|20287037|P1|NOT COMPLETED|Overall Study||0
8226921|NCT02015039|20287036|P2|COMPLETED|Overall Study||6
8226922|NCT02015039|20287037|P1|COMPLETED|Overall Study||6
8226923|NCT02015039|20287036|P2|STARTED|Overall Study||7
8226924|NCT02015039|20287037|P1|STARTED|Overall Study||6
8226925|NCT02014740|20287057|P2|NOT COMPLETED|Overall Study||5
8226926|NCT02014740|20287058|P1|NOT COMPLETED|Overall Study||6
8226927|NCT02014740|20287057|P2|COMPLETED|Overall Study||40
8226928|NCT02014740|20287058|P1|COMPLETED|Overall Study||49
8226929|NCT02014740|20287057|P2|STARTED|Overall Study||45
8226930|NCT02014740|20287058|P1|STARTED|Overall Study||55
8226931|NCT02014597|20287066|P2|NOT COMPLETED|Overall Study||1
8226932|NCT02014597|20287067|P1|NOT COMPLETED|Overall Study||2
8226933|NCT02014597|20287066|P2|COMPLETED|Overall Study||10
8226934|NCT02014597|20287067|P1|COMPLETED|Overall Study||10
8226935|NCT02014597|20287066|P2|STARTED|Overall Study||11
8226936|NCT02014597|20287067|P1|STARTED|Overall Study||12
8226937|NCT02014584|20287083|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226938|NCT02014584|20287084|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
8226939|NCT02014584|20287085|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226940|NCT02014584|20287086|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226941|NCT02014584|20287087|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226942|NCT02014584|20287088|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226943|NCT02014584|20287083|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
8226944|NCT02014584|20287084|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
8226945|NCT02014584|20287085|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226946|NCT02014584|20287086|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226947|NCT02014584|20287087|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226948|NCT02014584|20287088|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226949|NCT02014584|20287083|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
8226950|NCT02014584|20287084|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
8226951|NCT02014584|20287085|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226952|NCT02014584|20287086|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226953|NCT02014584|20287087|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226954|NCT02014584|20287088|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226955|NCT02014584|20287083|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226956|NCT02014584|20287084|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226957|NCT02014584|20287085|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
8226958|NCT02014584|20287086|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
8226959|NCT02014584|20287087|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226960|NCT02014584|20287088|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226961|NCT02014584|20287083|P6|COMPLETED|Open-Label Period (24 Weeks)||0
8226962|NCT02014584|20287084|P5|COMPLETED|Open-Label Period (24 Weeks)||0
8226963|NCT02014584|20287085|P4|COMPLETED|Open-Label Period (24 Weeks)||47
8226964|NCT02014584|20287086|P3|COMPLETED|Open-Label Period (24 Weeks)||44
8226965|NCT02014584|20287087|P2|COMPLETED|Open-Label Period (24 Weeks)||0
8226966|NCT02014584|20287088|P1|COMPLETED|Open-Label Period (24 Weeks)||0
8226967|NCT02014584|20287083|P6|STARTED|Open-Label Period (24 Weeks)||0
8226968|NCT02014584|20287084|P5|STARTED|Open-Label Period (24 Weeks)||0
8226969|NCT02014584|20287085|P4|STARTED|Open-Label Period (24 Weeks)||48
8226970|NCT02014584|20287086|P3|STARTED|Open-Label Period (24 Weeks)||49
8226971|NCT02014584|20287087|P2|STARTED|Open-Label Period (24 Weeks)||0
8226972|NCT02014584|20287088|P1|STARTED|Open-Label Period (24 Weeks)||0
8226973|NCT02014584|20287083|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226974|NCT02014584|20287084|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226975|NCT02014584|20287085|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226976|NCT02014584|20287086|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226977|NCT02014584|20287087|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
8226978|NCT02014584|20287088|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
8226979|NCT02014584|20287083|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
8226980|NCT02014584|20287084|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
8226981|NCT02014584|20287085|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
8226982|NCT02014584|20287086|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
8226983|NCT02014584|20287087|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
8226984|NCT02014584|20287088|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
8226985|NCT02014584|20287083|P6|STARTED|Double-Blind Period (24 Weeks)||0
8226986|NCT02014584|20287084|P5|STARTED|Double-Blind Period (24 Weeks)||0
8226987|NCT02014584|20287085|P4|STARTED|Double-Blind Period (24 Weeks)||0
8226988|NCT02014584|20287086|P3|STARTED|Double-Blind Period (24 Weeks)||0
8226989|NCT02014584|20287087|P2|STARTED|Double-Blind Period (24 Weeks)||58
8226990|NCT02014584|20287088|P1|STARTED|Double-Blind Period (24 Weeks)||59
8226991|NCT02014558|20287218|P13|NOT COMPLETED|Overall Study||17
8226992|NCT02014558|20287219|P12|NOT COMPLETED|Overall Study||102
8226993|NCT02014558|20287220|P11|NOT COMPLETED|Overall Study||69
8226994|NCT02014558|20287221|P10|NOT COMPLETED|Overall Study||21
8226995|NCT02014558|20287222|P9|NOT COMPLETED|Overall Study||15
8226996|NCT02014558|20287223|P8|NOT COMPLETED|Overall Study||11
8226997|NCT02014558|20287224|P7|NOT COMPLETED|Overall Study||4
8226998|NCT02014558|20287225|P6|NOT COMPLETED|Overall Study||3
8226999|NCT02014558|20287226|P5|NOT COMPLETED|Overall Study||4
8227000|NCT02014558|20287227|P4|NOT COMPLETED|Overall Study||3
8227001|NCT02014558|20287228|P3|NOT COMPLETED|Overall Study||3
8227002|NCT02014558|20287229|P2|NOT COMPLETED|Overall Study||3
8227003|NCT02014558|20287230|P1|NOT COMPLETED|Overall Study||5
8227004|NCT02014558|20287218|P13|COMPLETED|Overall Study||0
8227005|NCT02014558|20287219|P12|COMPLETED|Overall Study||0
8227006|NCT02014558|20287220|P11|COMPLETED|Overall Study||0
8227007|NCT02014558|20287221|P10|COMPLETED|Overall Study||0
8227008|NCT02014558|20287222|P9|COMPLETED|Overall Study||0
8227009|NCT02014558|20287223|P8|COMPLETED|Overall Study||0
8227010|NCT02014558|20287224|P7|COMPLETED|Overall Study||0
8227011|NCT02014558|20287225|P6|COMPLETED|Overall Study||0
8227012|NCT02014558|20287226|P5|COMPLETED|Overall Study||0
8227013|NCT02014558|20287227|P4|COMPLETED|Overall Study||0
8227014|NCT02014558|20287228|P3|COMPLETED|Overall Study||0
8227015|NCT02014558|20287229|P2|COMPLETED|Overall Study||0
8227016|NCT02014558|20287230|P1|COMPLETED|Overall Study||0
8227017|NCT02014558|20287218|P13|Treated|Overall Study||17
8227018|NCT02014558|20287219|P12|Treated|Overall Study||100
8227019|NCT02014558|20287220|P11|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
8227020|NCT02014558|20287221|P10|Treated|Overall Study||21
8227021|NCT02014558|20287222|P9|Treated|Overall Study||13
8227022|NCT02014558|20287223|P8|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
8227023|NCT02014558|20287224|P7|Treated|Overall Study||3
8227024|NCT02014558|20287225|P6|Treated|Overall Study||3
8227025|NCT02014558|20287226|P5|Treated|Overall Study||3
8227026|NCT02014558|20287227|P4|Treated|Overall Study||3
8227027|NCT02014558|20287228|P3|Treated|Overall Study||3
8227028|NCT02014558|20287229|P2|Treated|Overall Study||3
8227029|NCT02014558|20287230|P1|Treated|Overall Study||5
8227030|NCT02014558|20287218|P13|STARTED|Overall Study||17
8227031|NCT02014558|20287219|P12|STARTED|Overall Study||102
8227032|NCT02014558|20287220|P11|STARTED|Overall Study||69
8227033|NCT02014558|20287221|P10|STARTED|Overall Study||21
8227034|NCT02014558|20287222|P9|STARTED|Overall Study||15
8227035|NCT02014558|20287223|P8|STARTED|Overall Study||11
8227036|NCT02014558|20287224|P7|STARTED|Overall Study||4
8227037|NCT02014558|20287225|P6|STARTED|Overall Study||3
8227038|NCT02014558|20287226|P5|STARTED|Overall Study||4
8227039|NCT02014558|20287227|P4|STARTED|Overall Study||3
8227040|NCT02014558|20287228|P3|STARTED|Overall Study||3
8227041|NCT02014558|20287229|P2|STARTED|Overall Study||3
8227042|NCT02014558|20287230|P1|STARTED|Overall Study||5
8227043|NCT02014519|20287538|P1|NOT COMPLETED|Overall Study||0
8227044|NCT02014519|20287538|P1|COMPLETED|Overall Study||2000
8227045|NCT02014519|20287538|P1|STARTED|Overall Study||2000
8227046|NCT02014480|20287595|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
8227047|NCT02014480|20287596|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8227048|NCT02014480|20287597|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8227049|NCT02014480|20287598|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8227050|NCT02014480|20287599|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8227051|NCT02014480|20287600|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8227052|NCT02014480|20287595|P6|COMPLETED|Treatment Period 3 (14 Days)||32
8227053|NCT02014480|20287596|P5|COMPLETED|Treatment Period 3 (14 Days)||34
8227054|NCT02014480|20287597|P4|COMPLETED|Treatment Period 3 (14 Days)||31
8227055|NCT02014480|20287598|P3|COMPLETED|Treatment Period 3 (14 Days)||29
8227056|NCT02014480|20287599|P2|COMPLETED|Treatment Period 3 (14 Days)||32
8227057|NCT02014480|20287600|P1|COMPLETED|Treatment Period 3 (14 Days)||34
8227058|NCT02014480|20287595|P6|STARTED|Treatment Period 3 (14 Days)||34
8227059|NCT02014480|20287596|P5|STARTED|Treatment Period 3 (14 Days)||34
8227060|NCT02014480|20287597|P4|STARTED|Treatment Period 3 (14 Days)||31
8227061|NCT02014480|20287598|P3|STARTED|Treatment Period 3 (14 Days)||30
8227062|NCT02014480|20287599|P2|STARTED|Treatment Period 3 (14 Days)||33
8227063|NCT02014480|20287600|P1|STARTED|Treatment Period 3 (14 Days)||34
8227064|NCT02014480|20287595|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227065|NCT02014480|20287596|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227066|NCT02014480|20287597|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227067|NCT02014480|20287598|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227068|NCT02014480|20287599|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227069|NCT02014480|20287600|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227070|NCT02014480|20287595|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8227071|NCT02014480|20287596|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8227072|NCT02014480|20287597|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
8227073|NCT02014480|20287598|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
8227074|NCT02014480|20287599|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
8227075|NCT02014480|20287600|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8227076|NCT02014480|20287595|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
8227077|NCT02014480|20287596|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
8227078|NCT02014480|20287597|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
8227079|NCT02014480|20287598|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
8227080|NCT02014480|20287599|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
8227081|NCT02014480|20287600|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
8227082|NCT02014480|20287595|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8227083|NCT02014480|20287596|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8227084|NCT02014480|20287597|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8227085|NCT02014480|20287598|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8227086|NCT02014480|20287599|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8227087|NCT02014480|20287600|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8227088|NCT02014480|20287595|P6|COMPLETED|Treatment Period 2 (14 Days)||34
8227089|NCT02014480|20287596|P5|COMPLETED|Treatment Period 2 (14 Days)||34
8227090|NCT02014480|20287597|P4|COMPLETED|Treatment Period 2 (14 Days)||31
8227091|NCT02014480|20287598|P3|COMPLETED|Treatment Period 2 (14 Days)||30
8227092|NCT02014480|20287599|P2|COMPLETED|Treatment Period 2 (14 Days)||33
8227093|NCT02014480|20287600|P1|COMPLETED|Treatment Period 2 (14 Days)||34
8227094|NCT02014480|20287595|P6|STARTED|Treatment Period 2 (14 Days)||34
8227095|NCT02014480|20287596|P5|STARTED|Treatment Period 2 (14 Days)||34
8227096|NCT02014480|20287597|P4|STARTED|Treatment Period 2 (14 Days)||32
8227097|NCT02014480|20287598|P3|STARTED|Treatment Period 2 (14 Days)||32
8227098|NCT02014480|20287599|P2|STARTED|Treatment Period 2 (14 Days)||34
8227099|NCT02014480|20287600|P1|STARTED|Treatment Period 2 (14 Days)||35
8227100|NCT02014480|20287595|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227101|NCT02014480|20287596|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227102|NCT02014480|20287597|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227103|NCT02014480|20287598|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8227104|NCT02014480|20287599|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227105|NCT02014480|20287600|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227106|NCT02014480|20287595|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8227107|NCT02014480|20287596|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8227108|NCT02014480|20287597|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
8227109|NCT02014480|20287598|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
8227110|NCT02014480|20287599|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8227111|NCT02014480|20287600|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
8227112|NCT02014480|20287595|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
8227113|NCT02014480|20287596|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
8227114|NCT02014480|20287597|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
8227115|NCT02014480|20287598|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
8227116|NCT02014480|20287599|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
8227117|NCT02014480|20287600|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
8227118|NCT02014480|20287595|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8227119|NCT02014480|20287596|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8227120|NCT02014480|20287597|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8227121|NCT02014480|20287598|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8227122|NCT02014480|20287599|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8227123|NCT02014480|20287600|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8227124|NCT02014480|20287595|P6|COMPLETED|Treatment Period 1 (14 Days)||34
8227125|NCT02014480|20287596|P5|COMPLETED|Treatment Period 1 (14 Days)||34
8227126|NCT02014480|20287597|P4|COMPLETED|Treatment Period 1 (14 Days)||32
8227127|NCT02014480|20287598|P3|COMPLETED|Treatment Period 1 (14 Days)||33
8227128|NCT02014480|20287599|P2|COMPLETED|Treatment Period 1 (14 Days)||34
8227129|NCT02014480|20287600|P1|COMPLETED|Treatment Period 1 (14 Days)||35
8227130|NCT02014480|20287595|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
8227131|NCT02014480|20287596|P5|STARTED|Treatment Period 1 (14 Days)||35
8227132|NCT02014480|20287597|P4|STARTED|Treatment Period 1 (14 Days)||34
8227133|NCT02014480|20287598|P3|STARTED|Treatment Period 1 (14 Days)||34
8227134|NCT02014480|20287599|P2|STARTED|Treatment Period 1 (14 Days)||35
8227135|NCT02014480|20287600|P1|STARTED|Treatment Period 1 (14 Days)||35
8227136|NCT02014467|20287619|P2|NOT COMPLETED|Overall Study||7
8227137|NCT02014467|20287620|P1|NOT COMPLETED|Overall Study||25
8227138|NCT02014467|20287619|P2|COMPLETED|Overall Study||112
8227139|NCT02014467|20287620|P1|COMPLETED|Overall Study||340
8227140|NCT02014467|20287619|P2|STARTED|Overall Study||119
8227141|NCT02014467|20287620|P1|STARTED|Overall Study||365
8227142|NCT02014441|20287680|P1|NOT COMPLETED|Overall Study||12
8227143|NCT02014441|20287680|P1|COMPLETED|Overall Study||49
8227144|NCT02014441|20287680|P1|Received Treatment|Overall Study||60
8227145|NCT02014441|20287680|P1|STARTED|Overall Study||61
8227146|NCT02014402|20287776|P4|NOT COMPLETED|Overall Study||3
8227147|NCT02014402|20287777|P3|NOT COMPLETED|Overall Study||3
8227148|NCT02014402|20287778|P2|NOT COMPLETED|Overall Study||3
8227149|NCT02014402|20287779|P1|NOT COMPLETED|Overall Study||2
8227150|NCT02014402|20287776|P4|COMPLETED|Overall Study||82
8227151|NCT02014402|20287777|P3|COMPLETED|Overall Study||32
8227152|NCT02014402|20287778|P2|COMPLETED|Overall Study||27
8227153|NCT02014402|20287779|P1|COMPLETED|Overall Study||29
8227154|NCT02014402|20287776|P4|Bovine Thrombin|Overall Study||28
8227155|NCT02014402|20287777|P3|Bovine Thrombin|Overall Study||12
8227156|NCT02014402|20287778|P2|Bovine Thrombin|Overall Study||10
8227157|NCT02014402|20287779|P1|Bovine Thrombin|Overall Study||11
8227158|NCT02014402|20287776|P4|Human Thrombin|Overall Study||57
8227159|NCT02014402|20287777|P3|Human Thrombin|Overall Study||23
8227160|NCT02014402|20287778|P2|Human Thrombin|Overall Study||20
8227161|NCT02014402|20287779|P1|Human Thrombin|Overall Study||20
8227162|NCT02014402|20287776|P4|STARTED|Overall Study||85
8227163|NCT02014402|20287777|P3|STARTED|Overall Study||35
8227164|NCT02014402|20287778|P2|STARTED|Overall Study||30
8227165|NCT02014402|20287779|P1|STARTED|Overall Study||31
8227166|NCT02014376|20287809|P3|NOT COMPLETED|Overall Study||0
8227167|NCT02014376|20287810|P2|NOT COMPLETED|Overall Study||1
8227168|NCT02014376|20287811|P1|NOT COMPLETED|Overall Study||3
8227169|NCT02014376|20287809|P3|COMPLETED|Overall Study||17
8227170|NCT02014376|20287810|P2|COMPLETED|Overall Study||15
8227171|NCT02014376|20287811|P1|COMPLETED|Overall Study||12
8227172|NCT02014376|20287809|P3|Received at Least 1 Dose of Study Drug|Overall Study||17
8227173|NCT02014376|20287810|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8227174|NCT02014376|20287811|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8227175|NCT02014376|20287809|P3|STARTED|Overall Study||17
8227176|NCT02014376|20287810|P2|STARTED|Overall Study||16
8227177|NCT02014376|20287811|P1|STARTED|Overall Study||15
8227178|NCT02014363|20287837|P3|NOT COMPLETED|Overall Study||24
8227179|NCT02014363|20287838|P2|NOT COMPLETED|Overall Study||19
8227180|NCT02014363|20287839|P1|NOT COMPLETED|Overall Study||17
8227181|NCT02014363|20287837|P3|COMPLETED|Overall Study||31
8227182|NCT02014363|20287838|P2|COMPLETED|Overall Study||35
8227183|NCT02014363|20287839|P1|COMPLETED|Overall Study||38
8227184|NCT02014363|20287837|P3|STARTED|Overall Study||55
8227185|NCT02014363|20287838|P2|STARTED|Overall Study||54
8227186|NCT02014363|20287839|P1|STARTED|Overall Study||55
8227187|NCT02014272|20287847|P2|NOT COMPLETED|Intervention Period 2||0
8227188|NCT02014272|20287848|P1|NOT COMPLETED|Intervention Period 2||0
8227189|NCT02014272|20287847|P2|COMPLETED|Intervention Period 2||13
8227190|NCT02014272|20287848|P1|COMPLETED|Intervention Period 2||13
8227191|NCT02014272|20287847|P2|STARTED|Intervention Period 2||13
8227192|NCT02014272|20287848|P1|STARTED|Intervention Period 2||13
8227193|NCT02014272|20287847|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8227194|NCT02014272|20287848|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8227195|NCT02014272|20287847|P2|COMPLETED|Washout Period 1 (7 Days)||13
8227196|NCT02014272|20287848|P1|COMPLETED|Washout Period 1 (7 Days)||13
8227197|NCT02014272|20287847|P2|STARTED|Washout Period 1 (7 Days)||13
8227198|NCT02014272|20287848|P1|STARTED|Washout Period 1 (7 Days)||13
8227199|NCT02014272|20287847|P2|NOT COMPLETED|Intervention Period 1||1
8227200|NCT02014272|20287848|P1|NOT COMPLETED|Intervention Period 1||1
8227201|NCT02014272|20287847|P2|COMPLETED|Intervention Period 1||13
8227202|NCT02014272|20287848|P1|COMPLETED|Intervention Period 1||13
8227203|NCT02014272|20287847|P2|STARTED|Intervention Period 1||14
8227204|NCT02014272|20287848|P1|STARTED|Intervention Period 1||14
8227205|NCT02014129|20287869|P3|NOT COMPLETED|Overall Study||0
8227206|NCT02014129|20287870|P2|NOT COMPLETED|Overall Study||0
8227207|NCT02014129|20287871|P1|NOT COMPLETED|Overall Study||0
8227208|NCT02014129|20287869|P3|COMPLETED|Overall Study||6
8227209|NCT02014129|20287870|P2|COMPLETED|Overall Study||3
8227210|NCT02014129|20287871|P1|COMPLETED|Overall Study||3
8227211|NCT02014129|20287869|P3|Received at Least One Dose of Study Drug|Overall Study||6
8227212|NCT02014129|20287870|P2|Received at Least One Dose of Study Drug|Overall Study||3
8227213|NCT02014129|20287871|P1|Received at Least One Dose of Study Drug|Overall Study||3
8227214|NCT02014129|20287869|P3|STARTED|Overall Study||6
8227215|NCT02014129|20287870|P2|STARTED|Overall Study||3
8227216|NCT02014129|20287871|P1|STARTED|Overall Study||3
8227217|NCT02014116|20287897|P9|NOT COMPLETED|Overall Study||10
8227218|NCT02014116|20287898|P8|NOT COMPLETED|Overall Study||5
8227219|NCT02014116|20287899|P7|NOT COMPLETED|Overall Study||1
8227220|NCT02014116|20287900|P6|NOT COMPLETED|Overall Study||16
8227221|NCT02014116|20287901|P5|NOT COMPLETED|Overall Study||2
8227222|NCT02014116|20287902|P4|NOT COMPLETED|Overall Study||7
8227223|NCT02014116|20287903|P3|NOT COMPLETED|Overall Study||3
8227224|NCT02014116|20287904|P2|NOT COMPLETED|Overall Study||4
8227225|NCT02014116|20287905|P1|NOT COMPLETED|Overall Study||3
8227226|NCT02014116|20287897|P9|COMPLETED|Overall Study||0
8227227|NCT02014116|20287898|P8|COMPLETED|Overall Study||0
8227228|NCT02014116|20287899|P7|COMPLETED|Overall Study||0
8227229|NCT02014116|20287900|P6|COMPLETED|Overall Study||0
8227230|NCT02014116|20287901|P5|COMPLETED|Overall Study||0
8227231|NCT02014116|20287902|P4|COMPLETED|Overall Study||0
8227232|NCT02014116|20287903|P3|COMPLETED|Overall Study||0
8227233|NCT02014116|20287904|P2|COMPLETED|Overall Study||0
8227234|NCT02014116|20287905|P1|COMPLETED|Overall Study||0
8227235|NCT02014116|20287897|P9|Received at Least One Dose of Study Drug|Overall Study||10
8227236|NCT02014116|20287898|P8|Received at Least One Dose of Study Drug|Overall Study||5
8227237|NCT02014116|20287899|P7|Received at Least One Dose of Study Drug|Overall Study||1
8227238|NCT02014116|20287900|P6|Received at Least One Dose of Study Drug|Overall Study||16
8227239|NCT02014116|20287901|P5|Received at Least One Dose of Study Drug|Overall Study||2
8227240|NCT02014116|20287902|P4|Received at Least One Dose of Study Drug|Overall Study||7
8227241|NCT02014116|20287903|P3|Received at Least One Dose of Study Drug|Overall Study||3
8227242|NCT02014116|20287904|P2|Received at Least One Dose of Study Drug|Overall Study||4
8227243|NCT02014116|20287905|P1|Received at Least One Dose of Study Drug|Overall Study||3
8227244|NCT02014116|20287897|P9|STARTED|Overall Study||10
8227245|NCT02014116|20287898|P8|STARTED|Overall Study||5
8227246|NCT02014116|20287899|P7|STARTED|Overall Study||1
8227247|NCT02014116|20287900|P6|STARTED|Overall Study||16
8227248|NCT02014116|20287901|P5|STARTED|Overall Study||2
8227249|NCT02014116|20287902|P4|STARTED|Overall Study||7
8227250|NCT02014116|20287903|P3|STARTED|Overall Study||3
8227251|NCT02014116|20287904|P2|STARTED|Overall Study||4
8227252|NCT02014116|20287905|P1|STARTED|Overall Study||3
8227253|NCT02014051|20287956|P2|NOT COMPLETED|Overall Study||1
8227254|NCT02014051|20287957|P1|NOT COMPLETED|Overall Study||1
8227255|NCT02014051|20287956|P2|COMPLETED|Overall Study||5
8227256|NCT02014051|20287957|P1|COMPLETED|Overall Study||2
8227257|NCT02014051|20287956|P2|STARTED|Overall Study||6
8227258|NCT02014051|20287957|P1|STARTED|Overall Study||3
8227259|NCT02013830|20287970|P1|NOT COMPLETED|Overall Study||30
8227260|NCT02013830|20287970|P1|COMPLETED|Overall Study||15
8227261|NCT02013830|20287970|P1|STARTED|Overall Study||45
8227262|NCT02013817|20287981|P1|NOT COMPLETED|Overall Study||27
8227263|NCT02013817|20287981|P1|COMPLETED|Overall Study||16
8227264|NCT02013817|20287981|P1|STARTED|Overall Study||43
8227265|NCT02013791|20287999|P9|NOT COMPLETED|Period 2||0
8227266|NCT02013791|20288000|P8|NOT COMPLETED|Period 2||0
8227267|NCT02013791|20288001|P7|NOT COMPLETED|Period 2||0
8227268|NCT02013791|20288002|P6|NOT COMPLETED|Period 2||0
8227269|NCT02013791|20288003|P5|NOT COMPLETED|Period 2||0
8227270|NCT02013791|20288004|P4|NOT COMPLETED|Period 2||0
8227271|NCT02013791|20288005|P3|NOT COMPLETED|Period 2||0
8227272|NCT02013791|20288006|P2|NOT COMPLETED|Period 2||0
8227273|NCT02013791|20288007|P1|NOT COMPLETED|Period 2||0
8227274|NCT02013791|20287999|P9|COMPLETED|Period 2||0
8227275|NCT02013791|20288000|P8|COMPLETED|Period 2||0
8227276|NCT02013791|20288001|P7|COMPLETED|Period 2||3
8227277|NCT02013791|20288002|P6|COMPLETED|Period 2||0
8227278|NCT02013791|20288003|P5|COMPLETED|Period 2||0
8227279|NCT02013791|20288004|P4|COMPLETED|Period 2||0
8227280|NCT02013791|20288005|P3|COMPLETED|Period 2||2
8227281|NCT02013791|20288006|P2|COMPLETED|Period 2||0
8227282|NCT02013791|20288007|P1|COMPLETED|Period 2||0
8227283|NCT02013791|20287999|P9|STARTED|Period 2||0
8227284|NCT02013791|20288000|P8|STARTED|Period 2||0
8227285|NCT02013791|20288001|P7|STARTED|Period 2||3
8227286|NCT02013791|20288002|P6|STARTED|Period 2||0
8227287|NCT02013791|20288003|P5|STARTED|Period 2||0
8227288|NCT02013791|20288004|P4|STARTED|Period 2||0
8227289|NCT02013791|20288005|P3|STARTED|Period 2||2
8227290|NCT02013791|20288006|P2|STARTED|Period 2||0
8227291|NCT02013791|20288007|P1|STARTED|Period 2||0
8227292|NCT02013791|20287999|P9|NOT COMPLETED|Period 1||0
8227293|NCT02013791|20288000|P8|NOT COMPLETED|Period 1||1
8227294|NCT02013791|20288001|P7|NOT COMPLETED|Period 1||1
8227295|NCT02013791|20288002|P6|NOT COMPLETED|Period 1||0
8227296|NCT02013791|20288003|P5|NOT COMPLETED|Period 1||0
8227297|NCT02013791|20288004|P4|NOT COMPLETED|Period 1||1
8227298|NCT02013791|20288005|P3|NOT COMPLETED|Period 1||0
8227299|NCT02013791|20288006|P2|NOT COMPLETED|Period 1||2
8227300|NCT02013791|20288007|P1|NOT COMPLETED|Period 1||0
8227301|NCT02013791|20287999|P9|COMPLETED|Period 1||3
8227302|NCT02013791|20288000|P8|COMPLETED|Period 1||7
8227303|NCT02013791|20288001|P7|COMPLETED|Period 1||3
8227304|NCT02013791|20288002|P6|COMPLETED|Period 1||8
8227305|NCT02013791|20288003|P5|COMPLETED|Period 1||4
8227306|NCT02013791|20288004|P4|COMPLETED|Period 1||7
8227307|NCT02013791|20288005|P3|COMPLETED|Period 1||4
8227308|NCT02013791|20288006|P2|COMPLETED|Period 1||6
8227309|NCT02013791|20288007|P1|COMPLETED|Period 1||8
8227310|NCT02013791|20287999|P9|STARTED|Period 1||3
8227311|NCT02013791|20288000|P8|STARTED|Period 1||8
8227312|NCT02013791|20288001|P7|STARTED|Period 1||4
8227313|NCT02013791|20288002|P6|STARTED|Period 1||8
8227314|NCT02013791|20288003|P5|STARTED|Period 1||4
8227315|NCT02013791|20288004|P4|STARTED|Period 1||8
8227316|NCT02013791|20288005|P3|STARTED|Period 1||4
8227317|NCT02013791|20288006|P2|STARTED|Period 1||8
8227318|NCT02013791|20288007|P1|STARTED|Period 1||8
8227319|NCT02013778|20288028|P1|NOT COMPLETED|Overall Study||7
8227320|NCT02013778|20288028|P1|COMPLETED|Overall Study||1
8227321|NCT02013778|20288028|P1|STARTED|Overall Study||8
8227322|NCT02013765|20288032|P1|NOT COMPLETED|Overall Study||1
8227323|NCT02013765|20288032|P1|COMPLETED|Overall Study||4
8227324|NCT02013765|20288032|P1|STARTED|Overall Study||5
8227325|NCT02013687|20288046|P4|NOT COMPLETED|Overall Study||2
8227326|NCT02013687|20288047|P3|NOT COMPLETED|Overall Study||2
8227327|NCT02013687|20288048|P2|NOT COMPLETED|Overall Study||0
8227328|NCT02013687|20288049|P1|NOT COMPLETED|Overall Study||0
8227329|NCT02013687|20288046|P4|COMPLETED|Overall Study||14
8227330|NCT02013687|20288047|P3|COMPLETED|Overall Study||14
8227331|NCT02013687|20288048|P2|COMPLETED|Overall Study||6
8227332|NCT02013687|20288049|P1|COMPLETED|Overall Study||6
8227333|NCT02013687|20288046|P4|STARTED|Overall Study||16
8227334|NCT02013687|20288047|P3|STARTED|Overall Study||16
8227335|NCT02013687|20288048|P2|STARTED|Overall Study||6
8227336|NCT02013687|20288049|P1|STARTED|Overall Study||6
8227337|NCT02013674|20288081|P2|NOT COMPLETED|Overall Study||1
8227338|NCT02013674|20288082|P1|NOT COMPLETED|Overall Study||1
8227339|NCT02013674|20288081|P2|COMPLETED|Overall Study||14
8227340|NCT02013674|20288082|P1|COMPLETED|Overall Study||14
8227341|NCT02013674|20288081|P2|STARTED|Overall Study||15
8227342|NCT02013674|20288082|P1|STARTED|Overall Study||15
8227343|NCT02013622|20288132|P1|NOT COMPLETED|Overall Study||24
8227344|NCT02013622|20288132|P1|COMPLETED|Overall Study||25
8227345|NCT02013622|20288132|P1|STARTED|Overall Study||49
8227346|NCT02013609|20288152|P1|NOT COMPLETED|Overall Study||18
8227347|NCT02013609|20288152|P1|COMPLETED|Overall Study||29
8227348|NCT02013609|20288152|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
8227349|NCT02013544|20288177|P2|NOT COMPLETED|Overall Study||20
8227350|NCT02013544|20288178|P1|NOT COMPLETED|Overall Study||11
8227351|NCT02013544|20288177|P2|COMPLETED|Overall Study||356
8227352|NCT02013544|20288178|P1|COMPLETED|Overall Study||171
8227353|NCT02013544|20288177|P2|ITT Population|Overall Study||325
8227354|NCT02013544|20288178|P1|ITT Population|Overall Study||157
8227355|NCT02013544|20288177|P2|Safety Population|Overall Study||374
8227356|NCT02013544|20288178|P1|Safety Population|Overall Study||180
8227357|NCT02013544|20288177|P2|STARTED|Overall Study||376
8227358|NCT02013544|20288178|P1|STARTED|Overall Study||182
8227359|NCT02013531|20288200|P1|NOT COMPLETED|Overall Study||5
8227360|NCT02013531|20288200|P1|COMPLETED|Overall Study||32
8227361|NCT02013531|20288200|P1|STARTED|Overall Study||37
8227362|NCT02013414|20288222|P1|NOT COMPLETED|Overall Study||0
8227363|NCT02013414|20288222|P1|COMPLETED|Overall Study||9
8227364|NCT02013414|20288222|P1|STARTED|Overall Study||9
8227365|NCT02013388|20288236|P8|NOT COMPLETED|Overall Study||0
8227366|NCT02013388|20288237|P7|NOT COMPLETED|Overall Study||0
8227367|NCT02013388|20288238|P6|NOT COMPLETED|Overall Study||0
8227368|NCT02013388|20288239|P5|NOT COMPLETED|Overall Study||1
8227369|NCT02013388|20288240|P4|NOT COMPLETED|Overall Study||0
8227370|NCT02013388|20288241|P3|NOT COMPLETED|Overall Study||0
8227371|NCT02013388|20288242|P2|NOT COMPLETED|Overall Study||0
8227372|NCT02013388|20288243|P1|NOT COMPLETED|Overall Study||1
8227373|NCT02013388|20288236|P8|COMPLETED|Overall Study||4
8227374|NCT02013388|20288237|P7|COMPLETED|Overall Study||6
8227375|NCT02013388|20288238|P6|COMPLETED|Overall Study||6
8227376|NCT02013388|20288239|P5|COMPLETED|Overall Study||5
8227377|NCT02013388|20288240|P4|COMPLETED|Overall Study||6
8227378|NCT02013388|20288241|P3|COMPLETED|Overall Study||6
8227379|NCT02013388|20288242|P2|COMPLETED|Overall Study||6
8227380|NCT02013388|20288243|P1|COMPLETED|Overall Study||8
8227381|NCT02013388|20288236|P8|STARTED|Overall Study||4
8227382|NCT02013388|20288237|P7|STARTED|Overall Study||6
8227383|NCT02013388|20288238|P6|STARTED|Overall Study||6
8227384|NCT02013388|20288239|P5|STARTED|Overall Study||6
8227385|NCT02013388|20288240|P4|STARTED|Overall Study||6
8227386|NCT02013388|20288241|P3|STARTED|Overall Study||6
8227387|NCT02013388|20288242|P2|STARTED|Overall Study||6
8227388|NCT02013388|20288243|P1|STARTED|Overall Study||9
8227389|NCT02013375|20288277|P1|NOT COMPLETED|Overall Study||2
8227390|NCT02013375|20288277|P1|COMPLETED|Overall Study||0
8227391|NCT02013375|20288277|P1|STARTED|Overall Study||2
8227392|NCT02013245|20288288|P4|NOT COMPLETED|Overall Study||0
8227393|NCT02013245|20288289|P3|NOT COMPLETED|Overall Study||0
8227394|NCT02013245|20288290|P2|NOT COMPLETED|Overall Study||1
8227395|NCT02013245|20288291|P1|NOT COMPLETED|Overall Study||0
8227396|NCT02013245|20288288|P4|COMPLETED|Overall Study||9
8227397|NCT02013245|20288289|P3|COMPLETED|Overall Study||9
8227398|NCT02013245|20288290|P2|COMPLETED|Overall Study||8
8227399|NCT02013245|20288291|P1|COMPLETED|Overall Study||9
8227400|NCT02013245|20288288|P4|STARTED|Overall Study||9
8227401|NCT02013245|20288289|P3|STARTED|Overall Study||9
8227402|NCT02013245|20288290|P2|STARTED|Overall Study||9
8227403|NCT02013245|20288291|P1|STARTED|Overall Study||9
8227404|NCT02013206|20288307|P2|NOT COMPLETED|Overall Study||22
8227405|NCT02013206|20288308|P1|NOT COMPLETED|Overall Study||27
8227406|NCT02013206|20288307|P2|COMPLETED|Overall Study||1
8227407|NCT02013206|20288308|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
8227408|NCT02013206|20288307|P2|Received Study Drug|Overall Study||23
8227409|NCT02013206|20288308|P1|Received Study Drug|Overall Study||26
8227410|NCT02013206|20288307|P2|STARTED|Overall Study||23
8227411|NCT02013206|20288308|P1|STARTED|Overall Study||29
8227412|NCT02013180|20288330|P2|NOT COMPLETED|Overall Study||0
8227413|NCT02013180|20288331|P1|NOT COMPLETED|Overall Study||0
8227414|NCT02013180|20288330|P2|COMPLETED|Overall Study||361
8227415|NCT02013180|20288331|P1|COMPLETED|Overall Study||119
8227416|NCT02013180|20288330|P2|STARTED|Overall Study||361
8227417|NCT02013180|20288331|P1|STARTED|Overall Study||119
8227418|NCT02013167|20288339|P2|NOT COMPLETED|Overall Study||178
8227419|NCT02013167|20288340|P1|NOT COMPLETED|Overall Study||101
8227420|NCT02013167|20288339|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
8227421|NCT02013167|20288340|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
8227422|NCT02013167|20288339|P2|Received Treatment|Overall Study||267
8227423|NCT02013167|20288340|P1|Received Treatment|Overall Study||109
8227424|NCT02013167|20288339|P2|STARTED|Overall Study||271
8227425|NCT02013167|20288340|P1|STARTED|Overall Study||134
8227426|NCT02013050|20288371|P4|NOT COMPLETED|Overall Study||4
8227427|NCT02013050|20288372|P3|NOT COMPLETED|Overall Study||0
8227428|NCT02013050|20288373|P2|NOT COMPLETED|Overall Study||5
8227429|NCT02013050|20288374|P1|NOT COMPLETED|Overall Study||4
8227430|NCT02013050|20288371|P4|COMPLETED|Overall Study||19
8227431|NCT02013050|20288372|P3|COMPLETED|Overall Study||3
8227432|NCT02013050|20288373|P2|COMPLETED|Overall Study||36
8227433|NCT02013050|20288374|P1|COMPLETED|Overall Study||38
8227434|NCT02013050|20288371|P4|STARTED|Overall Study||23
8227435|NCT02013050|20288372|P3|STARTED|Overall Study||3
8227436|NCT02013050|20288373|P2|STARTED|Overall Study||41
8227437|NCT02013050|20288374|P1|STARTED|Overall Study||42
8227438|NCT02012959|20288416|P5|NOT COMPLETED|Treatment Phase B||0
8227439|NCT02012959|20288417|P4|NOT COMPLETED|Treatment Phase B||0
8227440|NCT02012959|20288418|P3|NOT COMPLETED|Treatment Phase B||0
8227441|NCT02012959|20288419|P2|NOT COMPLETED|Treatment Phase B||0
8227442|NCT02012959|20288420|P1|NOT COMPLETED|Treatment Phase B||0
8227443|NCT02012959|20288416|P5|COMPLETED|Treatment Phase B||1
8227444|NCT02012959|20288417|P4|COMPLETED|Treatment Phase B||1
8227445|NCT02012959|20288418|P3|COMPLETED|Treatment Phase B||3
8227446|NCT02012959|20288419|P2|COMPLETED|Treatment Phase B||2
8227447|NCT02012959|20288420|P1|COMPLETED|Treatment Phase B||0
8227448|NCT02012959|20288416|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
8227449|NCT02012959|20288417|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
8227450|NCT02012959|20288418|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
8227451|NCT02012959|20288419|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
8227452|NCT02012959|20288420|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
8227453|NCT02012959|20288416|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
8227454|NCT02012959|20288417|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
8227455|NCT02012959|20288418|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
8227456|NCT02012959|20288419|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
8227457|NCT02012959|20288420|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
8227458|NCT02012959|20288416|P5|NOT COMPLETED|Treatment Phase A||0
8227459|NCT02012959|20288417|P4|NOT COMPLETED|Treatment Phase A||0
8227460|NCT02012959|20288418|P3|NOT COMPLETED|Treatment Phase A||0
8227461|NCT02012959|20288419|P2|NOT COMPLETED|Treatment Phase A||0
8227462|NCT02012959|20288420|P1|NOT COMPLETED|Treatment Phase A||2
8227463|NCT02012959|20288416|P5|COMPLETED|Treatment Phase A||0
8227464|NCT02012959|20288417|P4|COMPLETED|Treatment Phase A||0
8227465|NCT02012959|20288418|P3|COMPLETED|Treatment Phase A||0
8227466|NCT02012959|20288419|P2|COMPLETED|Treatment Phase A||0
8227467|NCT02012959|20288420|P1|COMPLETED|Treatment Phase A||7
8227468|NCT02012959|20288416|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227469|NCT02012959|20288417|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227470|NCT02012959|20288418|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227471|NCT02012959|20288419|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227472|NCT02012959|20288420|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
8227473|NCT02012959|20288416|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227567|NCT02012192|20288578|P1|STARTED|Overall Study||90
8227474|NCT02012959|20288417|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227475|NCT02012959|20288418|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227476|NCT02012959|20288419|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227477|NCT02012959|20288420|P1|STARTED|Treatment Phase A||9
8227478|NCT02012686|20288433|P2|NOT COMPLETED|Overall Study||2
8227479|NCT02012686|20288434|P1|NOT COMPLETED|Overall Study||0
8227480|NCT02012686|20288433|P2|COMPLETED|Overall Study||48
8227481|NCT02012686|20288434|P1|COMPLETED|Overall Study||50
8227482|NCT02012686|20288433|P2|STARTED|Overall Study||50
8227483|NCT02012686|20288434|P1|STARTED|Overall Study||50
8227484|NCT02012621|20288446|P1|NOT COMPLETED|Overall Study||0
8227485|NCT02012621|20288446|P1|COMPLETED|Overall Study||807
8227486|NCT02012621|20288446|P1|Visit 3 Completed|Overall Study||444
8227487|NCT02012621|20288446|P1|Visit 2 Completed|Overall Study||688
8227488|NCT02012621|20288446|P1|Visit 1 Completed|Overall Study||807
8227489|NCT02012621|20288446|P1|STARTED|Overall Study||807
8227490|NCT02012608|20288454|P2|NOT COMPLETED|Overall Study||0
8227491|NCT02012608|20288455|P1|NOT COMPLETED|Overall Study||3
8227492|NCT02012608|20288454|P2|COMPLETED|Overall Study||7
8227493|NCT02012608|20288455|P1|COMPLETED|Overall Study||4
8227494|NCT02012608|20288454|P2|STARTED|Overall Study||7
8227495|NCT02012608|20288455|P1|STARTED|Overall Study||7
8227496|NCT02012582|20288465|P4|NOT COMPLETED|Overall Study||1
8227497|NCT02012582|20288466|P3|NOT COMPLETED|Overall Study||0
8227498|NCT02012582|20288467|P2|NOT COMPLETED|Overall Study||0
8227499|NCT02012582|20288468|P1|NOT COMPLETED|Overall Study||0
8227500|NCT02012582|20288465|P4|COMPLETED|Overall Study||7
8227501|NCT02012582|20288466|P3|COMPLETED|Overall Study||8
8227502|NCT02012582|20288467|P2|COMPLETED|Overall Study||8
8227503|NCT02012582|20288468|P1|COMPLETED|Overall Study||8
8227504|NCT02012582|20288465|P4|STARTED|Overall Study||8
8227505|NCT02012582|20288466|P3|STARTED|Overall Study||8
8227506|NCT02012582|20288467|P2|STARTED|Overall Study||8
8227507|NCT02012582|20288468|P1|STARTED|Overall Study||8
8227508|NCT02012491|20288496|P2|NOT COMPLETED|Overall Study||1
8227509|NCT02012491|20288497|P1|NOT COMPLETED|Overall Study||2
8227510|NCT02012491|20288496|P2|COMPLETED|Overall Study||148
8227511|NCT02012491|20288497|P1|COMPLETED|Overall Study||149
8227512|NCT02012491|20288496|P2|STARTED|Overall Study||149
8227513|NCT02012491|20288497|P1|STARTED|Overall Study||151
8227514|NCT02012452|20288515|P2|NOT COMPLETED|Overall Study||1
8227515|NCT02012452|20288516|P1|NOT COMPLETED|Overall Study||6
8227516|NCT02012452|20288515|P2|COMPLETED|Overall Study||1
8227517|NCT02012452|20288516|P1|COMPLETED|Overall Study||1
8227518|NCT02012452|20288515|P2|STARTED|Overall Study||2
8227519|NCT02012452|20288516|P1|STARTED|Overall Study||7
8227520|NCT02012348|20288527|P3|NOT COMPLETED|Overall Study||0
8227521|NCT02012348|20288528|P2|NOT COMPLETED|Overall Study||0
8227522|NCT02012348|20288529|P1|NOT COMPLETED|Overall Study||0
8227523|NCT02012348|20288527|P3|COMPLETED|Overall Study||10
8227524|NCT02012348|20288528|P2|COMPLETED|Overall Study||10
8227525|NCT02012348|20288529|P1|COMPLETED|Overall Study||10
8227526|NCT02012348|20288527|P3|STARTED|Overall Study||10
8227527|NCT02012348|20288528|P2|STARTED|Overall Study||10
8227528|NCT02012348|20288529|P1|STARTED|Overall Study||10
8227529|NCT02012283|20288542|P2|NOT COMPLETED|Third Intervention||0
8227530|NCT02012283|20288543|P1|NOT COMPLETED|Third Intervention||0
8227531|NCT02012283|20288542|P2|COMPLETED|Third Intervention||10
8227532|NCT02012283|20288543|P1|COMPLETED|Third Intervention||10
8227533|NCT02012283|20288542|P2|STARTED|Third Intervention||10
8227534|NCT02012283|20288543|P1|STARTED|Third Intervention||10
8227535|NCT02012283|20288542|P2|NOT COMPLETED|Second Intervention||0
8227536|NCT02012283|20288543|P1|NOT COMPLETED|Second Intervention||0
8227537|NCT02012283|20288542|P2|COMPLETED|Second Intervention||10
8227538|NCT02012283|20288543|P1|COMPLETED|Second Intervention||10
8227539|NCT02012283|20288542|P2|STARTED|Second Intervention||10
8227540|NCT02012283|20288543|P1|STARTED|Second Intervention||10
8227541|NCT02012283|20288542|P2|NOT COMPLETED|First Intervention||0
8227542|NCT02012283|20288543|P1|NOT COMPLETED|First Intervention||0
8227543|NCT02012283|20288542|P2|COMPLETED|First Intervention||10
8227544|NCT02012283|20288543|P1|COMPLETED|First Intervention||10
8227545|NCT02012283|20288542|P2|STARTED|First Intervention||10
8227546|NCT02012283|20288543|P1|STARTED|First Intervention||10
8227547|NCT02012218|20288559|P5|NOT COMPLETED|Overall Study||1
8227548|NCT02012218|20288560|P4|NOT COMPLETED|Overall Study||2
8227549|NCT02012218|20288561|P3|NOT COMPLETED|Overall Study||2
8227550|NCT02012218|20288562|P2|NOT COMPLETED|Overall Study||1
8227551|NCT02012218|20288563|P1|NOT COMPLETED|Overall Study||4
8227552|NCT02012218|20288559|P5|COMPLETED|Overall Study||5
8227553|NCT02012218|20288560|P4|COMPLETED|Overall Study||17
8227554|NCT02012218|20288561|P3|COMPLETED|Overall Study||11
8227555|NCT02012218|20288562|P2|COMPLETED|Overall Study||10
8227556|NCT02012218|20288563|P1|COMPLETED|Overall Study||8
8227557|NCT02012218|20288559|P5|STARTED|Overall Study||6
8227558|NCT02012218|20288560|P4|STARTED|Overall Study||19
8227559|NCT02012218|20288561|P3|STARTED|Overall Study||13
8227560|NCT02012218|20288562|P2|STARTED|Overall Study||11
8227561|NCT02012218|20288563|P1|STARTED|Overall Study||12
8227562|NCT02012192|20288577|P2|NOT COMPLETED|Overall Study||0
8227563|NCT02012192|20288578|P1|NOT COMPLETED|Overall Study||27
8227564|NCT02012192|20288577|P2|COMPLETED|Overall Study||43
8227565|NCT02012192|20288578|P1|COMPLETED|Overall Study||63
8227566|NCT02012192|20288577|P2|STARTED|Overall Study||43
8227568|NCT02011945|20288587|P3|NOT COMPLETED|Overall Study||10
8227569|NCT02011945|20288588|P2|NOT COMPLETED|Overall Study||10
8227570|NCT02011945|20288589|P1|NOT COMPLETED|Overall Study||2
8227571|NCT02011945|20288587|P3|COMPLETED|Overall Study||6
8227572|NCT02011945|20288588|P2|COMPLETED|Overall Study||3
8227573|NCT02011945|20288589|P1|COMPLETED|Overall Study||0
8227574|NCT02011945|20288587|P3|STARTED|Overall Study||16
8227575|NCT02011945|20288588|P2|STARTED|Overall Study||13
8227576|NCT02011945|20288589|P1|STARTED|Overall Study||2
8227577|NCT02011893|20288666|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
8227578|NCT02011893|20288667|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8227579|NCT02011893|20288668|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8227580|NCT02011893|20288666|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
8227581|NCT02011893|20288667|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
8227582|NCT02011893|20288668|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8227583|NCT02011893|20288666|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
8227584|NCT02011893|20288667|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
8227585|NCT02011893|20288668|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
8227586|NCT02011893|20288666|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
8227587|NCT02011893|20288667|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
8227588|NCT02011893|20288668|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
8227589|NCT02011893|20288666|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
8227590|NCT02011893|20288667|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
8227591|NCT02011893|20288668|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
8227592|NCT02011893|20288666|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
8227593|NCT02011893|20288667|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8227594|NCT02011893|20288668|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8227595|NCT02011893|20288666|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
8227596|NCT02011893|20288667|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
8227597|NCT02011893|20288668|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8227598|NCT02011893|20288666|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
8227599|NCT02011893|20288667|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
8227600|NCT02011893|20288668|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
8227601|NCT02011893|20288666|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
8227602|NCT02011893|20288667|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
8227603|NCT02011893|20288668|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
8227604|NCT02011893|20288666|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
8227605|NCT02011893|20288667|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
8227606|NCT02011893|20288668|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
8227607|NCT02011893|20288666|P3|NOT COMPLETED|Enrollment to Randomization||0
8227608|NCT02011893|20288667|P2|NOT COMPLETED|Enrollment to Randomization||0
8227609|NCT02011893|20288668|P1|NOT COMPLETED|Enrollment to Randomization||73
8227610|NCT02011893|20288666|P3|COMPLETED|Enrollment to Randomization||0
8227611|NCT02011893|20288667|P2|COMPLETED|Enrollment to Randomization||0
8227612|NCT02011893|20288668|P1|COMPLETED|Enrollment to Randomization||100
8227613|NCT02011893|20288666|P3|Randomization|Enrollment to Randomization||0
8227614|NCT02011893|20288667|P2|Randomization|Enrollment to Randomization||0
8227615|NCT02011893|20288668|P1|Randomization|Enrollment to Randomization||100
8227616|NCT02011893|20288666|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
8227617|NCT02011893|20288667|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
8227618|NCT02011893|20288668|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
8227619|NCT02011893|20288666|P3|Trial Stimulation Implant|Enrollment to Randomization||0
8227620|NCT02011893|20288667|P2|Trial Stimulation Implant|Enrollment to Randomization||0
8227621|NCT02011893|20288668|P1|Trial Stimulation Implant|Enrollment to Randomization||121
8227622|NCT02011893|20288666|P3|Baseline|Enrollment to Randomization||0
8227623|NCT02011893|20288667|P2|Baseline|Enrollment to Randomization||0
8227624|NCT02011893|20288668|P1|Baseline|Enrollment to Randomization||141
8227625|NCT02011893|20288666|P3|STARTED|Enrollment to Randomization||0
8227626|NCT02011893|20288667|P2|STARTED|Enrollment to Randomization||0
8227627|NCT02011893|20288668|P1|STARTED|Enrollment to Randomization||173
8227628|NCT02011542|20288679|P1|NOT COMPLETED|Overall Study||1
8227629|NCT02011542|20288679|P1|COMPLETED|Overall Study||29
8227630|NCT02011542|20288679|P1|STARTED|Overall Study||30
8227631|NCT02011516|20288686|P2|NOT COMPLETED|Overall Study||2
8227632|NCT02011516|20288687|P1|NOT COMPLETED|Overall Study||4
8227633|NCT02011516|20288686|P2|COMPLETED|Overall Study||6
8227634|NCT02011516|20288687|P1|COMPLETED|Overall Study||4
8227635|NCT02011516|20288686|P2|STARTED|Overall Study||8
8227636|NCT02011516|20288687|P1|STARTED|Overall Study||8
8227637|NCT02011490|20288696|P6|NOT COMPLETED|Part 2||0
8227638|NCT02011490|20288697|P5|NOT COMPLETED|Part 2||0
8227639|NCT02011490|20288698|P4|NOT COMPLETED|Part 2||0
8227640|NCT02011490|20288699|P3|NOT COMPLETED|Part 2||0
8227641|NCT02011490|20288700|P2|NOT COMPLETED|Part 2||0
8227642|NCT02011490|20288701|P1|NOT COMPLETED|Part 2||0
8227643|NCT02011490|20288696|P6|COMPLETED|Part 2||6
8227644|NCT02011490|20288697|P5|COMPLETED|Part 2||6
8227645|NCT02011490|20288698|P4|COMPLETED|Part 2||6
8227646|NCT02011490|20288699|P3|COMPLETED|Part 2||0
8227647|NCT02011490|20288700|P2|COMPLETED|Part 2||0
8227648|NCT02011490|20288701|P1|COMPLETED|Part 2||0
8227649|NCT02011490|20288696|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
8227650|NCT02011490|20288697|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
8227651|NCT02011490|20288698|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
8227652|NCT02011490|20288699|P3|STARTED|Part 2||0
8227653|NCT02011490|20288700|P2|STARTED|Part 2||0
8227654|NCT02011490|20288701|P1|STARTED|Part 2||0
8227655|NCT02011490|20288696|P6|NOT COMPLETED|Part 1||0
8227656|NCT02011490|20288697|P5|NOT COMPLETED|Part 1||0
8227657|NCT02011490|20288698|P4|NOT COMPLETED|Part 1||0
8227658|NCT02011490|20288699|P3|NOT COMPLETED|Part 1||0
8227659|NCT02011490|20288700|P2|NOT COMPLETED|Part 1||0
8227660|NCT02011490|20288701|P1|NOT COMPLETED|Part 1||0
8227661|NCT02011490|20288696|P6|COMPLETED|Part 1||0
8227662|NCT02011490|20288697|P5|COMPLETED|Part 1||0
8227663|NCT02011490|20288698|P4|COMPLETED|Part 1||0
8227664|NCT02011490|20288699|P3|COMPLETED|Part 1||8
8227665|NCT02011490|20288700|P2|COMPLETED|Part 1||8
8227666|NCT02011490|20288701|P1|COMPLETED|Part 1||8
8227667|NCT02011490|20288696|P6|STARTED|Part 1||0
8227668|NCT02011490|20288697|P5|STARTED|Part 1||0
8227669|NCT02011490|20288698|P4|STARTED|Part 1||0
8227670|NCT02011490|20288699|P3|STARTED|Part 1||8
8227671|NCT02011490|20288700|P2|STARTED|Part 1||8
8227672|NCT02011490|20288701|P1|STARTED|Part 1||8
8227673|NCT02011464|20288789|P2|NOT COMPLETED|Overall Study||0
8227674|NCT02011464|20288790|P1|NOT COMPLETED|Overall Study||0
8227675|NCT02011464|20288789|P2|COMPLETED|Overall Study||10
8227676|NCT02011464|20288790|P1|COMPLETED|Overall Study||10
8227677|NCT02011464|20288789|P2|STARTED|Overall Study||10
8227678|NCT02011464|20288790|P1|STARTED|Overall Study||10
8227679|NCT02011386|20288810|P1|NOT COMPLETED|Overall Study||5
8227680|NCT02011386|20288810|P1|COMPLETED|Overall Study||48
8227681|NCT02011386|20288810|P1|STARTED|Overall Study||53
8227682|NCT02011113|20288824|P1|NOT COMPLETED|Overall Study||36
8227683|NCT02011113|20288824|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
8227684|NCT02011113|20288824|P1|STARTED|Overall Study||36
8227685|NCT02010996|20288840|P2|NOT COMPLETED|Overall Study||0
8227686|NCT02010996|20288841|P1|NOT COMPLETED|Overall Study||0
8227687|NCT02010996|20288840|P2|COMPLETED|Overall Study||36
8227688|NCT02010996|20288841|P1|COMPLETED|Overall Study||36
8227689|NCT02010996|20288840|P2|STARTED|Overall Study||36
8227690|NCT02010996|20288841|P1|STARTED|Overall Study||36
8227691|NCT02010775|20288856|P5|NOT COMPLETED|Overall Study||6
8227692|NCT02010775|20288857|P4|NOT COMPLETED|Overall Study||3
8227693|NCT02010775|20288858|P3|NOT COMPLETED|Overall Study||3
8227694|NCT02010775|20288859|P2|NOT COMPLETED|Overall Study||3
8227695|NCT02010775|20288860|P1|NOT COMPLETED|Overall Study||5
8227696|NCT02010775|20288856|P5|COMPLETED|Overall Study||31
8227697|NCT02010775|20288857|P4|COMPLETED|Overall Study||34
8227698|NCT02010775|20288858|P3|COMPLETED|Overall Study||34
8227699|NCT02010775|20288859|P2|COMPLETED|Overall Study||35
8227700|NCT02010775|20288860|P1|COMPLETED|Overall Study||33
8227701|NCT02010775|20288856|P5|STARTED|Overall Study||37
8227702|NCT02010775|20288857|P4|STARTED|Overall Study||37
8227703|NCT02010775|20288858|P3|STARTED|Overall Study||37
8227704|NCT02010775|20288859|P2|STARTED|Overall Study||38
8227705|NCT02010775|20288860|P1|STARTED|Overall Study||38
8227706|NCT02010697|20288880|P3|NOT COMPLETED|Overall Study||0
8227707|NCT02010697|20288881|P2|NOT COMPLETED|Overall Study||0
8227708|NCT02010697|20288882|P1|NOT COMPLETED|Overall Study||0
8227709|NCT02010697|20288880|P3|COMPLETED|Overall Study||1043
8227710|NCT02010697|20288881|P2|COMPLETED|Overall Study||1038
8227711|NCT02010697|20288882|P1|COMPLETED|Overall Study||1044
8227712|NCT02010697|20288880|P3|STARTED|Overall Study||1043
8227713|NCT02010697|20288881|P2|STARTED|Overall Study||1038
8227714|NCT02010697|20288882|P1|STARTED|Overall Study||1044
8227715|NCT02010684|20288901|P2|NOT COMPLETED|Overall Study||23
8227716|NCT02010684|20288902|P1|NOT COMPLETED|Overall Study||12
8227717|NCT02010684|20288901|P2|COMPLETED|Overall Study||59
8227718|NCT02010684|20288902|P1|COMPLETED|Overall Study||27
8227719|NCT02010684|20288901|P2|STARTED|Overall Study||82
8227720|NCT02010684|20288902|P1|STARTED|Overall Study||39
8227721|NCT02010645|20288920|P1|NOT COMPLETED|Overall Study||0
8227722|NCT02010645|20288920|P1|COMPLETED|Overall Study||6
8227723|NCT02010645|20288920|P1|STARTED|Overall Study||6
8227724|NCT02010632|20288924|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8227725|NCT02010632|20288925|P1|NOT COMPLETED|Second Intervention (7 Days)||1
8227726|NCT02010632|20288924|P2|COMPLETED|Second Intervention (7 Days)||16
8227727|NCT02010632|20288925|P1|COMPLETED|Second Intervention (7 Days)||15
8227728|NCT02010632|20288924|P2|STARTED|Second Intervention (7 Days)||16
8227729|NCT02010632|20288925|P1|STARTED|Second Intervention (7 Days)||16
8227730|NCT02010632|20288924|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
8227731|NCT02010632|20288925|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
8227732|NCT02010632|20288924|P2|COMPLETED|Wash Out Period (14 Days)||16
8227733|NCT02010632|20288925|P1|COMPLETED|Wash Out Period (14 Days)||16
8227734|NCT02010632|20288924|P2|STARTED|Wash Out Period (14 Days)||16
8227735|NCT02010632|20288925|P1|STARTED|Wash Out Period (14 Days)||16
8227736|NCT02010632|20288924|P2|NOT COMPLETED|First Intervention (7 Days)||0
8227737|NCT02010632|20288925|P1|NOT COMPLETED|First Intervention (7 Days)||0
8227738|NCT02010632|20288924|P2|COMPLETED|First Intervention (7 Days)||16
8227739|NCT02010632|20288925|P1|COMPLETED|First Intervention (7 Days)||16
8227740|NCT02010632|20288924|P2|STARTED|First Intervention (7 Days)||16
8227741|NCT02010632|20288925|P1|STARTED|First Intervention (7 Days)||16
8227742|NCT02010567|20288936|P5|NOT COMPLETED|Overall Study||1
8227743|NCT02010567|20288937|P4|NOT COMPLETED|Overall Study||0
8227744|NCT02010567|20288938|P3|NOT COMPLETED|Overall Study||1
8227745|NCT02010567|20288939|P2|NOT COMPLETED|Overall Study||0
8227746|NCT02010567|20288940|P1|NOT COMPLETED|Overall Study||0
8227747|NCT02010567|20288936|P5|COMPLETED|Overall Study||5
8227748|NCT02010567|20288937|P4|COMPLETED|Overall Study||3
8227749|NCT02010567|20288938|P3|COMPLETED|Overall Study||13
8227750|NCT02010567|20288939|P2|COMPLETED|Overall Study||6
8227751|NCT02010567|20288940|P1|COMPLETED|Overall Study||3
8227752|NCT02010567|20288936|P5|STARTED|Overall Study||6
8227753|NCT02010567|20288937|P4|STARTED|Overall Study||3
8227754|NCT02010567|20288938|P3|STARTED|Overall Study||14
8227755|NCT02010567|20288939|P2|STARTED|Overall Study||6
8227756|NCT02010567|20288940|P1|STARTED|Overall Study||3
8227757|NCT02010359|20288957|P2|NOT COMPLETED|Overall Study||2
8227758|NCT02010359|20288958|P1|NOT COMPLETED|Overall Study||2
8227759|NCT02010359|20288957|P2|COMPLETED|Overall Study||12
8227760|NCT02010359|20288958|P1|COMPLETED|Overall Study||13
8227761|NCT02010359|20288957|P2|STARTED|Overall Study||14
8227762|NCT02010359|20288958|P1|STARTED|Overall Study||15
8227763|NCT02010255|20288996|P14|NOT COMPLETED|Overall Study||1
8227764|NCT02010255|20288997|P13|NOT COMPLETED|Overall Study||0
8227765|NCT02010255|20288998|P12|NOT COMPLETED|Overall Study||1
8227766|NCT02010255|20288999|P11|NOT COMPLETED|Overall Study||2
8227767|NCT02010255|20289000|P10|NOT COMPLETED|Overall Study||0
8227768|NCT02010255|20289001|P9|NOT COMPLETED|Overall Study||1
8227769|NCT02010255|20289002|P8|NOT COMPLETED|Overall Study||1
8227770|NCT02010255|20289003|P7|NOT COMPLETED|Overall Study||1
8227771|NCT02010255|20289004|P6|NOT COMPLETED|Overall Study||0
8227772|NCT02010255|20289005|P5|NOT COMPLETED|Overall Study||4
8227773|NCT02010255|20289006|P4|NOT COMPLETED|Overall Study||6
8227774|NCT02010255|20289007|P3|NOT COMPLETED|Overall Study||7
8227775|NCT02010255|20289008|P2|NOT COMPLETED|Overall Study||2
8227776|NCT02010255|20289009|P1|NOT COMPLETED|Overall Study||6
8227777|NCT02010255|20288996|P14|COMPLETED|Overall Study||2
8227778|NCT02010255|20288997|P13|COMPLETED|Overall Study||3
8227779|NCT02010255|20288998|P12|COMPLETED|Overall Study||4
8227780|NCT02010255|20288999|P11|COMPLETED|Overall Study||1
8227781|NCT02010255|20289000|P10|COMPLETED|Overall Study||23
8227782|NCT02010255|20289001|P9|COMPLETED|Overall Study||21
8227783|NCT02010255|20289002|P8|COMPLETED|Overall Study||32
8227784|NCT02010255|20289003|P7|COMPLETED|Overall Study||33
8227785|NCT02010255|20289004|P6|COMPLETED|Overall Study||49
8227786|NCT02010255|20289005|P5|COMPLETED|Overall Study||48
8227787|NCT02010255|20289006|P4|COMPLETED|Overall Study||20
8227788|NCT02010255|20289007|P3|COMPLETED|Overall Study||18
8227789|NCT02010255|20289008|P2|COMPLETED|Overall Study||26
8227790|NCT02010255|20289009|P1|COMPLETED|Overall Study||22
8227791|NCT02010255|20288996|P14|STARTED|Overall Study||3
8227792|NCT02010255|20288997|P13|STARTED|Overall Study||3
8227793|NCT02010255|20288998|P12|STARTED|Overall Study||5
8227794|NCT02010255|20288999|P11|STARTED|Overall Study||3
8227795|NCT02010255|20289000|P10|STARTED|Overall Study||23
8227796|NCT02010255|20289001|P9|STARTED|Overall Study||22
8227797|NCT02010255|20289002|P8|STARTED|Overall Study||33
8227798|NCT02010255|20289003|P7|STARTED|Overall Study||34
8227799|NCT02010255|20289004|P6|STARTED|Overall Study||49
8227800|NCT02010255|20289005|P5|STARTED|Overall Study||52
8227801|NCT02010255|20289006|P4|STARTED|Overall Study||26
8227802|NCT02010255|20289007|P3|STARTED|Overall Study||25
8227803|NCT02010255|20289008|P2|STARTED|Overall Study||28
8227804|NCT02010255|20289009|P1|STARTED|Overall Study||28
8227805|NCT02010216|20289333|P1|NOT COMPLETED|Overall Study||0
8227806|NCT02010216|20289333|P1|COMPLETED|Overall Study||23
8227807|NCT02010216|20289333|P1|STARTED|Overall Study||23
8227808|NCT02010203|20289344|P5|NOT COMPLETED|Overall Study||13
8227809|NCT02010203|20289345|P4|NOT COMPLETED|Overall Study||3
8227810|NCT02010203|20289346|P3|NOT COMPLETED|Overall Study||10
8227811|NCT02010203|20289347|P2|NOT COMPLETED|Overall Study||9
8227812|NCT02010203|20289348|P1|NOT COMPLETED|Overall Study||0
8227813|NCT02010203|20289344|P5|COMPLETED|Overall Study||3
8227814|NCT02010203|20289345|P4|COMPLETED|Overall Study||23
8227815|NCT02010203|20289346|P3|COMPLETED|Overall Study||16
8227816|NCT02010203|20289347|P2|COMPLETED|Overall Study||17
8227817|NCT02010203|20289348|P1|COMPLETED|Overall Study||10
8227818|NCT02010203|20289344|P5|STARTED|Overall Study||16
8227819|NCT02010203|20289345|P4|STARTED|Overall Study||26
8227820|NCT02010203|20289346|P3|STARTED|Overall Study||26
8227821|NCT02010203|20289347|P2|STARTED|Overall Study||26
8227822|NCT02010203|20289348|P1|STARTED|Overall Study||10
8227823|NCT02010151|20289421|P2|NOT COMPLETED|Overall Study||0
8227824|NCT02010151|20289422|P1|NOT COMPLETED|Overall Study||0
8227825|NCT02010151|20289421|P2|COMPLETED|Overall Study|TM sent: 598|1696
8227826|NCT02010151|20289422|P1|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
8227827|NCT02010151|20289421|P2|STARTED|Overall Study|January 2013 to December 2017|1696
8227828|NCT02010151|20289422|P1|STARTED|Overall Study|January 2013 to December 2017|1498
8227829|NCT02010021|20289434|P2|NOT COMPLETED|Overall Study||0
8227830|NCT02010021|20289435|P1|NOT COMPLETED|Overall Study||0
8227831|NCT02010021|20289434|P2|COMPLETED|Overall Study||7
8227832|NCT02010021|20289435|P1|COMPLETED|Overall Study||10
8227833|NCT02010021|20289434|P2|STARTED|Overall Study||7
8227834|NCT02010021|20289435|P1|STARTED|Overall Study||10
8227835|NCT02009982|20289445|P2|NOT COMPLETED|Overall Study||0
8227836|NCT02009982|20289446|P1|NOT COMPLETED|Overall Study||0
8227837|NCT02009982|20289445|P2|COMPLETED|Overall Study||2
8227838|NCT02009982|20289446|P1|COMPLETED|Overall Study||1
8227839|NCT02009982|20289445|P2|STARTED|Overall Study||2
8227840|NCT02009982|20289446|P1|STARTED|Overall Study||1
8227841|NCT02009930|20289454|P1|NOT COMPLETED|Overall Study||5
8227842|NCT02009930|20289454|P1|COMPLETED|Overall Study||107
8227843|NCT02009930|20289454|P1|STARTED|Overall Study|5 withdrawn|112
8227844|NCT02009878|20289479|P3|NOT COMPLETED|Overall Study||0
8227845|NCT02009878|20289480|P2|NOT COMPLETED|Overall Study||1
8227846|NCT02009878|20289481|P1|NOT COMPLETED|Overall Study||0
8227847|NCT02009878|20289479|P3|COMPLETED|Overall Study||9
8227848|NCT02009878|20289480|P2|COMPLETED|Overall Study||10
8227849|NCT02009878|20289481|P1|COMPLETED|Overall Study||10
8227850|NCT02009878|20289479|P3|STARTED|Overall Study||9
8227851|NCT02009878|20289480|P2|STARTED|Overall Study||11
8227852|NCT02009878|20289481|P1|STARTED|Overall Study||10
8227853|NCT02009865|20289515|P2|NOT COMPLETED|Overall Study||5
8227854|NCT02009865|20289516|P1|NOT COMPLETED|Overall Study||1
8227855|NCT02009865|20289515|P2|COMPLETED|Overall Study||76
8227856|NCT02009865|20289516|P1|COMPLETED|Overall Study||80
8227857|NCT02009865|20289515|P2|STARTED|Overall Study||81
8227858|NCT02009865|20289516|P1|STARTED|Overall Study||81
8227859|NCT02009722|20289532|P2|NOT COMPLETED|Overall Study||3
8227860|NCT02009722|20289533|P1|NOT COMPLETED|Overall Study||1
8227861|NCT02009722|20289532|P2|COMPLETED|Overall Study||40
8227862|NCT02009722|20289533|P1|COMPLETED|Overall Study||40
8227863|NCT02009722|20289532|P2|Received Intervention|Overall Study||42
8227864|NCT02009722|20289533|P1|Received Intervention|Overall Study||41
8227865|NCT02009722|20289532|P2|STARTED|Overall Study||43
8227866|NCT02009722|20289533|P1|STARTED|Overall Study||41
8227867|NCT02009696|20289557|P1|NOT COMPLETED|Overall Study||2
8227868|NCT02009696|20289557|P1|COMPLETED|Overall Study||219
8227869|NCT02009696|20289557|P1|STARTED|Overall Study||221
8227870|NCT02009501|20289567|P2|NOT COMPLETED|Overall Study||0
8227871|NCT02009501|20289568|P1|NOT COMPLETED|Overall Study||0
8227872|NCT02009501|20289567|P2|COMPLETED|Overall Study||11
8227873|NCT02009501|20289568|P1|COMPLETED|Overall Study||9
8227874|NCT02009501|20289567|P2|STARTED|Overall Study||11
8227875|NCT02009501|20289568|P1|STARTED|Overall Study||9
8227876|NCT02009163|20289574|P3|NOT COMPLETED|Randomized-withdrawal Period||35
8227877|NCT02009163|20289575|P2|NOT COMPLETED|Randomized-withdrawal Period||88
8227878|NCT02009163|20289576|P1|NOT COMPLETED|Randomized-withdrawal Period||0
8227879|NCT02009163|20289574|P3|COMPLETED|Randomized-withdrawal Period||102
8227880|NCT02009163|20289575|P2|COMPLETED|Randomized-withdrawal Period||50
8227881|NCT02009163|20289576|P1|COMPLETED|Randomized-withdrawal Period||0
8227882|NCT02009163|20289574|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
8227883|NCT02009163|20289575|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
8227884|NCT02009163|20289576|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
8227885|NCT02009163|20289574|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
8227886|NCT02009163|20289575|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
8227887|NCT02009163|20289576|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
8227888|NCT02009163|20289574|P3|COMPLETED|Open-label Period (Non-randomized)||0
8227889|NCT02009163|20289575|P2|COMPLETED|Open-label Period (Non-randomized)||0
8227890|NCT02009163|20289576|P1|COMPLETED|Open-label Period (Non-randomized)||275
8227891|NCT02009163|20289574|P3|STARTED|Open-label Period (Non-randomized)||0
8227892|NCT02009163|20289575|P2|STARTED|Open-label Period (Non-randomized)||0
8227893|NCT02009163|20289576|P1|STARTED|Open-label Period (Non-randomized)||418
8227894|NCT02009046|20289611|P2|NOT COMPLETED|Overall Study||206
8227895|NCT02009046|20289612|P1|NOT COMPLETED|Overall Study||256
8227896|NCT02009046|20289611|P2|COMPLETED|Overall Study||678
8227897|NCT02009046|20289612|P1|COMPLETED|Overall Study||769
8227898|NCT02009046|20289611|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
8227899|NCT02009046|20289612|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
8227900|NCT02009046|20289611|P2|Ctrl Curriculum Only|Overall Study||456
8227901|NCT02009046|20289612|P1|Ctrl Curriculum Only|Overall Study||0
8227902|NCT02009046|20289611|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
8227903|NCT02009046|20289612|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
8227904|NCT02009046|20289611|P2|SEI Curriculum Only|Overall Study||0
8227905|NCT02009046|20289612|P1|SEI Curriculum Only|Overall Study||461
8227906|NCT02009046|20289611|P2|STARTED|Overall Study||884
8227907|NCT02009046|20289612|P1|STARTED|Overall Study||1025
8227908|NCT02008942|20289662|P2|NOT COMPLETED|Second Intervention||0
8227909|NCT02008942|20289663|P1|NOT COMPLETED|Second Intervention||1
8227910|NCT02008942|20289662|P2|COMPLETED|Second Intervention||30
8227911|NCT02008942|20289663|P1|COMPLETED|Second Intervention||25
8227912|NCT02008942|20289662|P2|STARTED|Second Intervention||30
8227913|NCT02008942|20289663|P1|STARTED|Second Intervention||26
8227914|NCT02008942|20289662|P2|NOT COMPLETED|First Intervention||0
8227915|NCT02008942|20289663|P1|NOT COMPLETED|First Intervention||0
8227916|NCT02008942|20289662|P2|COMPLETED|First Intervention||30
8227917|NCT02008942|20289663|P1|COMPLETED|First Intervention||27
8227918|NCT02008942|20289662|P2|STARTED|First Intervention||30
8227919|NCT02008942|20289663|P1|STARTED|First Intervention||27
8227920|NCT02008916|20289672|P3|NOT COMPLETED|Week 16 - 156||10
8227921|NCT02008916|20289673|P2|NOT COMPLETED|Week 16 - 156||13
8227922|NCT02008916|20289674|P1|NOT COMPLETED|Week 16 - 156||19
8227923|NCT02008916|20289672|P3|COMPLETED|Week 16 - 156||63
8227924|NCT02008916|20289673|P2|COMPLETED|Week 16 - 156||62
8227925|NCT02008916|20289674|P1|COMPLETED|Week 16 - 156||55
8227926|NCT02008916|20289672|P3|STARTED|Week 16 - 156||73
8227927|NCT02008916|20289673|P2|STARTED|Week 16 - 156||75
8227928|NCT02008916|20289674|P1|STARTED|Week 16 - 156||74
8227929|NCT02008916|20289672|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
8227930|NCT02008916|20289673|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
8227931|NCT02008916|20289674|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
8227932|NCT02008916|20289672|P3|COMPLETED|Primary Assessment (up to Week 16)||73
8227933|NCT02008916|20289673|P2|COMPLETED|Primary Assessment (up to Week 16)||75
8227934|NCT02008916|20289674|P1|COMPLETED|Primary Assessment (up to Week 16)||74
8227935|NCT02008916|20289672|P3|Safety Set|Primary Assessment (up to Week 16)||75
8227936|NCT02008916|20289673|P2|Safety Set|Primary Assessment (up to Week 16)||76
8227937|NCT02008916|20289674|P1|Safety Set|Primary Assessment (up to Week 16)||74
8227938|NCT02008916|20289672|P3|FAS|Primary Assessment (up to Week 16)||76
8227939|NCT02008916|20289673|P2|FAS|Primary Assessment (up to Week 16)||76
8227940|NCT02008916|20289674|P1|FAS|Primary Assessment (up to Week 16)||74
8227941|NCT02008916|20289672|P3|STARTED|Primary Assessment (up to Week 16)||76
8227942|NCT02008916|20289673|P2|STARTED|Primary Assessment (up to Week 16)||76
8227943|NCT02008916|20289674|P1|STARTED|Primary Assessment (up to Week 16)||74
8227944|NCT02008890|20289710|P5|NOT COMPLETED|Extension Period||4
8227945|NCT02008890|20289711|P4|NOT COMPLETED|Extension Period||4
8227946|NCT02008890|20289712|P3|NOT COMPLETED|Extension Period||0
8227947|NCT02008890|20289713|P2|NOT COMPLETED|Extension Period||5
8227948|NCT02008890|20289714|P1|NOT COMPLETED|Extension Period||5
8227949|NCT02008890|20289710|P5|COMPLETED|Extension Period||13
8227950|NCT02008890|20289711|P4|COMPLETED|Extension Period||6
8227951|NCT02008890|20289712|P3|COMPLETED|Extension Period||0
8227952|NCT02008890|20289713|P2|COMPLETED|Extension Period||31
8227953|NCT02008890|20289714|P1|COMPLETED|Extension Period||26
8227954|NCT02008890|20289710|P5|STARTED|Extension Period||17
8227955|NCT02008890|20289711|P4|STARTED|Extension Period||10
8227956|NCT02008890|20289712|P3|STARTED|Extension Period||0
8227957|NCT02008890|20289713|P2|STARTED|Extension Period||36
8227958|NCT02008890|20289714|P1|STARTED|Extension Period||31
8227959|NCT02008890|20289710|P5|NOT COMPLETED|Period 2||8
8227960|NCT02008890|20289711|P4|NOT COMPLETED|Period 2||14
8227961|NCT02008890|20289712|P3|NOT COMPLETED|Period 2||1
8227962|NCT02008890|20289713|P2|NOT COMPLETED|Period 2||15
8227963|NCT02008890|20289714|P1|NOT COMPLETED|Period 2||27
8227964|NCT02008890|20289710|P5|COMPLETED|Period 2||20
8227965|NCT02008890|20289711|P4|COMPLETED|Period 2||13
8227966|NCT02008890|20289712|P3|COMPLETED|Period 2||9
8227967|NCT02008890|20289713|P2|COMPLETED|Period 2||49
8227968|NCT02008890|20289714|P1|COMPLETED|Period 2||38
8227969|NCT02008890|20289710|P5|STARTED|Period 2||28
8227970|NCT02008890|20289711|P4|STARTED|Period 2||27
8227971|NCT02008890|20289712|P3|STARTED|Period 2||10
8227972|NCT02008890|20289713|P2|STARTED|Period 2||64
8227973|NCT02008890|20289714|P1|STARTED|Period 2||65
8227974|NCT02008890|20289710|P5|NOT COMPLETED|Period 1||0
8227975|NCT02008890|20289711|P4|NOT COMPLETED|Period 1||0
8227976|NCT02008890|20289712|P3|NOT COMPLETED|Period 1||12
8227977|NCT02008890|20289713|P2|NOT COMPLETED|Period 1||15
8227978|NCT02008890|20289714|P1|NOT COMPLETED|Period 1||15
8227979|NCT02008890|20289710|P5|COMPLETED|Period 1||0
8227980|NCT02008890|20289711|P4|COMPLETED|Period 1||0
8227981|NCT02008890|20289712|P3|COMPLETED|Period 1||66
8227982|NCT02008890|20289713|P2|COMPLETED|Period 1||64
8227983|NCT02008890|20289714|P1|COMPLETED|Period 1||65
8227984|NCT02008890|20289710|P5|STARTED|Period 1||0
8227985|NCT02008890|20289711|P4|STARTED|Period 1||0
8227986|NCT02008890|20289712|P3|STARTED|Period 1||78
8227987|NCT02008890|20289713|P2|STARTED|Period 1||79
8227988|NCT02008890|20289714|P1|STARTED|Period 1||80
8227989|NCT02008877|20289750|P3|NOT COMPLETED|Overall Study||0
8227990|NCT02008877|20289751|P2|NOT COMPLETED|Overall Study||1
8227991|NCT02008877|20289752|P1|NOT COMPLETED|Overall Study||0
8227992|NCT02008877|20289750|P3|COMPLETED|Overall Study||10
8227993|NCT02008877|20289751|P2|COMPLETED|Overall Study||6
8227994|NCT02008877|20289752|P1|COMPLETED|Overall Study||3
8227995|NCT02008877|20289750|P3|STARTED|Overall Study||10
8227996|NCT02008877|20289751|P2|STARTED|Overall Study||7
8227997|NCT02008877|20289752|P1|STARTED|Overall Study||3
8227998|NCT02008773|20289771|P4|NOT COMPLETED|Overall Study||12
8227999|NCT02008773|20289772|P3|NOT COMPLETED|Overall Study||14
8228000|NCT02008773|20289773|P2|NOT COMPLETED|Overall Study||9
8228001|NCT02008773|20289774|P1|NOT COMPLETED|Overall Study||13
8228002|NCT02008773|20289771|P4|COMPLETED|Overall Study||38
8228003|NCT02008773|20289772|P3|COMPLETED|Overall Study||32
8228004|NCT02008773|20289773|P2|COMPLETED|Overall Study||25
8228005|NCT02008773|20289774|P1|COMPLETED|Overall Study||27
8228006|NCT02008773|20289771|P4|STARTED|Overall Study||50
8228007|NCT02008773|20289772|P3|STARTED|Overall Study||46
8228008|NCT02008773|20289773|P2|STARTED|Overall Study||34
8228009|NCT02008773|20289774|P1|STARTED|Overall Study||40
8228010|NCT02008682|20289804|P2|NOT COMPLETED|Overall Study||14
8228011|NCT02008682|20289805|P1|NOT COMPLETED|Overall Study||27
8228012|NCT02008682|20289804|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
8228013|NCT02008682|20289805|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
8228014|NCT02008682|20289804|P2|Exposed|Overall Study||184
8228015|NCT02008682|20289805|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
8228016|NCT02008682|20289804|P2|STARTED|Overall Study||184
8228017|NCT02008682|20289805|P1|STARTED|Overall Study||184
8228018|NCT02008617|20289823|P2|NOT COMPLETED|Overall Study||0
8228019|NCT02008617|20289824|P1|NOT COMPLETED|Overall Study||0
8228020|NCT02008617|20289823|P2|COMPLETED|Overall Study||10
8228021|NCT02008617|20289824|P1|COMPLETED|Overall Study||8
8228022|NCT02008617|20289823|P2|STARTED|Overall Study||10
8228023|NCT02008617|20289824|P1|STARTED|Overall Study||8
8228024|NCT02008565|20289840|P4|NOT COMPLETED|Overall Study||0
8228025|NCT02008565|20289841|P3|NOT COMPLETED|Overall Study||2
8228026|NCT02008565|20289842|P2|NOT COMPLETED|Overall Study||1
8228027|NCT02008565|20289843|P1|NOT COMPLETED|Overall Study||1
8228028|NCT02008565|20289840|P4|COMPLETED|Overall Study||42
8228029|NCT02008565|20289841|P3|COMPLETED|Overall Study||86
8228030|NCT02008565|20289842|P2|COMPLETED|Overall Study||83
8228031|NCT02008565|20289843|P1|COMPLETED|Overall Study||85
8228032|NCT02008565|20289840|P4|STARTED|Overall Study||42
8228033|NCT02008565|20289841|P3|STARTED|Overall Study||88
8228034|NCT02008565|20289842|P2|STARTED|Overall Study||84
8228035|NCT02008565|20289843|P1|STARTED|Overall Study||86
8228036|NCT02008526|20289904|P3|NOT COMPLETED|Overall Study||9
8228037|NCT02008526|20289905|P2|NOT COMPLETED|Overall Study||14
8228038|NCT02008526|20289906|P1|NOT COMPLETED|Overall Study||8
8228039|NCT02008526|20289904|P3|COMPLETED|Overall Study||84
8228040|NCT02008526|20289905|P2|COMPLETED|Overall Study||85
8228041|NCT02008526|20289906|P1|COMPLETED|Overall Study||86
8228042|NCT02008526|20289904|P3|STARTED|Overall Study||93
8228043|NCT02008526|20289905|P2|STARTED|Overall Study||99
8228044|NCT02008526|20289906|P1|STARTED|Overall Study||94
8228045|NCT02008396|20289919|P2|NOT COMPLETED|Overall Study||1
8228046|NCT02008396|20289920|P1|NOT COMPLETED|Overall Study||0
8228047|NCT02008396|20289919|P2|COMPLETED|Overall Study||7
8228048|NCT02008396|20289920|P1|COMPLETED|Overall Study||4
8228049|NCT02008396|20289919|P2|STARTED|Overall Study||8
8228050|NCT02008396|20289920|P1|STARTED|Overall Study||4
8228051|NCT02008370|20289930|P1|NOT COMPLETED|Overall Study||7
8228052|NCT02008370|20289930|P1|COMPLETED|Overall Study||0
8228053|NCT02008370|20289930|P1|STARTED|Overall Study||7
8228054|NCT02008318|20289938|P2|NOT COMPLETED|Overall Study||1
8228055|NCT02008318|20289939|P1|NOT COMPLETED|Overall Study||12
8228056|NCT02008318|20289938|P2|COMPLETED|Overall Study||1
8228057|NCT02008318|20289939|P1|COMPLETED|Overall Study||29
8228058|NCT02008318|20289938|P2|Received At Least 1 Dose of Study Drug|Overall Study||2
8228059|NCT02008318|20289939|P1|Received At Least 1 Dose of Study Drug|Overall Study||41
8228060|NCT02008318|20289938|P2|STARTED|Overall Study||2
8228061|NCT02008318|20289939|P1|STARTED|Overall Study||41
8228062|NCT02008227|20289960|P2|NOT COMPLETED|Overall Study||613
8228063|NCT02008227|20289961|P1|NOT COMPLETED|Overall Study||612
8228064|NCT02008227|20289960|P2|COMPLETED|Overall Study||0
8228065|NCT02008227|20289961|P1|COMPLETED|Overall Study||0
8228066|NCT02008227|20289960|P2|Treated|Overall Study||608
8228067|NCT02008227|20289961|P1|Treated|Overall Study||579
8228068|NCT02008227|20289960|P2|STARTED|Overall Study||613
8228069|NCT02008227|20289961|P1|STARTED|Overall Study||612
8228070|NCT02008149|20290039|P3|NOT COMPLETED|Overall Study||0
8228071|NCT02008149|20290040|P2|NOT COMPLETED|Overall Study||1
8228072|NCT02008149|20290041|P1|NOT COMPLETED|Overall Study||3
8228073|NCT02008149|20290039|P3|COMPLETED|Overall Study||1
8228074|NCT02008149|20290040|P2|COMPLETED|Overall Study||0
8228075|NCT02008149|20290041|P1|COMPLETED|Overall Study||4
8228076|NCT02008149|20290039|P3|STARTED|Overall Study||1
8228077|NCT02008149|20290040|P2|STARTED|Overall Study||1
8228078|NCT02008149|20290041|P1|STARTED|Overall Study||7
8228079|NCT02007954|20290049|P1|NOT COMPLETED|Overall Study||7
8228080|NCT02007954|20290049|P1|COMPLETED|Overall Study||17
8228081|NCT02007954|20290049|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
8228082|NCT02007954|20290049|P1|Completed First TACE|Overall Study||24
8228083|NCT02007954|20290049|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
8228084|NCT02007863|20290062|P1|NOT COMPLETED|Overall Study||0
8228085|NCT02007863|20290062|P1|COMPLETED|Overall Study||2
8228086|NCT02007863|20290062|P1|STARTED|Overall Study||2
8228087|NCT02007720|20290068|P2|NOT COMPLETED|Overall Study||72
8228088|NCT02007720|20290069|P1|NOT COMPLETED|Overall Study||82
8228089|NCT02007720|20290068|P2|COMPLETED|Overall Study||368
8228090|NCT02007720|20290069|P1|COMPLETED|Overall Study||354
8228091|NCT02007720|20290068|P2|Safety Set|Overall Study||432
8228092|NCT02007720|20290069|P1|Safety Set|Overall Study||426
8228093|NCT02007720|20290068|P2|Full Analysis Set|Overall Study||437
8228094|NCT02007720|20290069|P1|Full Analysis Set|Overall Study||433
8228095|NCT02007720|20290068|P2|STARTED|Overall Study||440
8228096|NCT02007720|20290069|P1|STARTED|Overall Study||436
8228097|NCT02007577|20290104|P2|NOT COMPLETED|Overall Study||1
8228098|NCT02007577|20290105|P1|NOT COMPLETED|Overall Study||1
8228099|NCT02007577|20290104|P2|COMPLETED|Overall Study||13
8228100|NCT02007577|20290105|P1|COMPLETED|Overall Study||26
8228101|NCT02007577|20290104|P2|STARTED|Overall Study||14
8228102|NCT02007577|20290105|P1|STARTED|Overall Study||27
8228103|NCT02007512|20290117|P4|NOT COMPLETED|Open Label Treatment Period||12
8228104|NCT02007512|20290118|P3|NOT COMPLETED|Open Label Treatment Period||0
8228105|NCT02007512|20290119|P2|NOT COMPLETED|Open Label Treatment Period||21
8228106|NCT02007512|20290120|P1|NOT COMPLETED|Open Label Treatment Period||0
8228107|NCT02007512|20290117|P4|COMPLETED|Open Label Treatment Period||0
8228108|NCT02007512|20290118|P3|COMPLETED|Open Label Treatment Period||0
8228109|NCT02007512|20290119|P2|COMPLETED|Open Label Treatment Period||0
8228110|NCT02007512|20290120|P1|COMPLETED|Open Label Treatment Period||0
8228111|NCT02007512|20290117|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
8228112|NCT02007512|20290118|P3|STARTED|Open Label Treatment Period||0
8228113|NCT02007512|20290119|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
8228114|NCT02007512|20290120|P1|STARTED|Open Label Treatment Period||0
8228115|NCT02007512|20290117|P4|NOT COMPLETED|Double Blind Treatment Period||60
8228116|NCT02007512|20290118|P3|NOT COMPLETED|Double Blind Treatment Period||60
8228117|NCT02007512|20290119|P2|NOT COMPLETED|Double Blind Treatment Period||64
8228118|NCT02007512|20290120|P1|NOT COMPLETED|Double Blind Treatment Period||63
8228119|NCT02007512|20290117|P4|COMPLETED|Double Blind Treatment Period||0
8228120|NCT02007512|20290118|P3|COMPLETED|Double Blind Treatment Period||0
8228121|NCT02007512|20290119|P2|COMPLETED|Double Blind Treatment Period||0
8228122|NCT02007512|20290120|P1|COMPLETED|Double Blind Treatment Period||0
8228123|NCT02007512|20290117|P4|Treated|Double Blind Treatment Period||60
8228124|NCT02007512|20290118|P3|Treated|Double Blind Treatment Period||60
8228125|NCT02007512|20290119|P2|Treated|Double Blind Treatment Period||63
8228126|NCT02007512|20290120|P1|Treated|Double Blind Treatment Period||62
8228127|NCT02007512|20290117|P4|STARTED|Double Blind Treatment Period||60
8228128|NCT02007512|20290118|P3|STARTED|Double Blind Treatment Period||60
8228129|NCT02007512|20290119|P2|STARTED|Double Blind Treatment Period||64
8228130|NCT02007512|20290120|P1|STARTED|Double Blind Treatment Period||63
8228131|NCT02007434|20290198|P8|NOT COMPLETED|Overall Study||0
8228132|NCT02007434|20290199|P7|NOT COMPLETED|Overall Study||0
8228133|NCT02007434|20290200|P6|NOT COMPLETED|Overall Study||0
8228134|NCT02007434|20290201|P5|NOT COMPLETED|Overall Study||0
8228135|NCT02007434|20290202|P4|NOT COMPLETED|Overall Study||0
8228136|NCT02007434|20290203|P3|NOT COMPLETED|Overall Study||1
8228137|NCT02007434|20290204|P2|NOT COMPLETED|Overall Study||1
8228138|NCT02007434|20290205|P1|NOT COMPLETED|Overall Study||1
8228139|NCT02007434|20290198|P8|COMPLETED|Overall Study||4
8228140|NCT02007434|20290199|P7|COMPLETED|Overall Study||18
8228141|NCT02007434|20290200|P6|COMPLETED|Overall Study||4
8228142|NCT02007434|20290201|P5|COMPLETED|Overall Study||16
8228143|NCT02007434|20290202|P4|COMPLETED|Overall Study||4
8228144|NCT02007434|20290203|P3|COMPLETED|Overall Study||16
8228145|NCT02007434|20290204|P2|COMPLETED|Overall Study||3
8228146|NCT02007434|20290205|P1|COMPLETED|Overall Study||16
8228147|NCT02007434|20290198|P8|Received Treatment|Overall Study||4
8228148|NCT02007434|20290199|P7|Received Treatment|Overall Study||18
8228149|NCT02007434|20290200|P6|Received Treatment|Overall Study||4
8228150|NCT02007434|20290201|P5|Received Treatment|Overall Study||16
8228151|NCT02007434|20290202|P4|Received Treatment|Overall Study||4
8228152|NCT02007434|20290203|P3|Received Treatment|Overall Study||17
8228153|NCT02007434|20290204|P2|Received Treatment|Overall Study||3
8228154|NCT02007434|20290205|P1|Received Treatment|Overall Study||17
8228155|NCT02007434|20290198|P8|STARTED|Overall Study||4
8228156|NCT02007434|20290199|P7|STARTED|Overall Study||18
8228157|NCT02007434|20290200|P6|STARTED|Overall Study||4
8228158|NCT02007434|20290201|P5|STARTED|Overall Study||16
8228159|NCT02007434|20290202|P4|STARTED|Overall Study||4
8228160|NCT02007434|20290203|P3|STARTED|Overall Study||17
8228161|NCT02007434|20290204|P2|STARTED|Overall Study||4
8228162|NCT02007434|20290205|P1|STARTED|Overall Study||17
8228163|NCT02007369|20290306|P3|NOT COMPLETED|Overall Study||0
8228164|NCT02007369|20290307|P2|NOT COMPLETED|Overall Study||0
8228165|NCT02007369|20290308|P1|NOT COMPLETED|Overall Study||0
8228166|NCT02007369|20290306|P3|COMPLETED|Overall Study||54
8228167|NCT02007369|20290307|P2|COMPLETED|Overall Study||40
8228168|NCT02007369|20290308|P1|COMPLETED|Overall Study||42
8228169|NCT02007369|20290306|P3|STARTED|Overall Study||54
8228170|NCT02007369|20290307|P2|STARTED|Overall Study||40
8228171|NCT02007369|20290308|P1|STARTED|Overall Study||42
8228172|NCT02007291|20290325|P2|NOT COMPLETED|Overall Study||0
8228173|NCT02007291|20290326|P1|NOT COMPLETED|Overall Study||0
8228174|NCT02007291|20290325|P2|COMPLETED|Overall Study||23
8228175|NCT02007291|20290326|P1|COMPLETED|Overall Study||48
8228176|NCT02007291|20290325|P2|STARTED|Overall Study||23
8228177|NCT02007291|20290326|P1|STARTED|Overall Study||48
8228178|NCT02007278|20290336|P2|NOT COMPLETED|Overall Study||3
8228179|NCT02007278|20290337|P1|NOT COMPLETED|Overall Study||2
8228180|NCT02007278|20290336|P2|COMPLETED|Overall Study||17
8228181|NCT02007278|20290337|P1|COMPLETED|Overall Study||18
8228182|NCT02007278|20290336|P2|STARTED|Overall Study||20
8228183|NCT02007278|20290337|P1|STARTED|Overall Study||20
8228184|NCT02007252|20290359|P2|NOT COMPLETED|Overall Study||11
8228185|NCT02007252|20290360|P1|NOT COMPLETED|Overall Study||11
8228186|NCT02007252|20290359|P2|COMPLETED|Overall Study||22
8228187|NCT02007252|20290360|P1|COMPLETED|Overall Study||20
8228188|NCT02007252|20290359|P2|Pharmacodynamic Analysis Set|Overall Study||33
8228189|NCT02007252|20290360|P1|Pharmacodynamic Analysis Set|Overall Study||31
8228190|NCT02007252|20290359|P2|Safety Analysis Set|Overall Study||33
8228191|NCT02007252|20290360|P1|Safety Analysis Set|Overall Study||31
8228192|NCT02007252|20290359|P2|STARTED|Overall Study||33
8228193|NCT02007252|20290360|P1|STARTED|Overall Study||31
8228194|NCT02007200|20290366|P1|NOT COMPLETED|Overall Study||0
8228195|NCT02007200|20290366|P1|COMPLETED|Overall Study||55
8228196|NCT02007200|20290366|P1|STARTED|Overall Study||55
8228197|NCT02007109|20290373|P1|NOT COMPLETED|Overall Study||111
8228198|NCT02007109|20290373|P1|COMPLETED|Overall Study||82
8228199|NCT02007109|20290373|P1|PACU Analysis|Overall Study||184
8228200|NCT02007109|20290373|P1|STARTED|Overall Study||193
8228201|NCT02007096|20290382|P2|NOT COMPLETED|Overall Study||16
8228202|NCT02007096|20290383|P1|NOT COMPLETED|Overall Study||11
8228203|NCT02007096|20290382|P2|COMPLETED|Overall Study||48
8228204|NCT02007096|20290383|P1|COMPLETED|Overall Study||52
8228205|NCT02007096|20290382|P2|STARTED|Overall Study||64
8228206|NCT02007096|20290383|P1|STARTED|Overall Study||63
8228207|NCT02007070|20290395|P1|NOT COMPLETED|Overall Study||33
8228208|NCT02007070|20290395|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
8228209|NCT02007070|20290395|P1|STARTED|Overall Study||38
8228210|NCT02006979|20290416|P2|NOT COMPLETED|Overall Study||2
8228211|NCT02006979|20290417|P1|NOT COMPLETED|Overall Study||1
8228212|NCT02006979|20290416|P2|COMPLETED|Overall Study||11
8228213|NCT02006979|20290417|P1|COMPLETED|Overall Study||13
8228214|NCT02006979|20290416|P2|STARTED|Overall Study||13
8228215|NCT02006979|20290417|P1|STARTED|Overall Study||14
8228216|NCT02006927|20290429|P1|NOT COMPLETED|Overall Study||3
8228217|NCT02006927|20290429|P1|COMPLETED|Overall Study||0
8228218|NCT02006927|20290429|P1|STARTED|Overall Study||3
8228219|NCT02006888|20290437|P3|NOT COMPLETED|Overall Study||22
8228220|NCT02006888|20290438|P2|NOT COMPLETED|Overall Study||34
8228221|NCT02006888|20290439|P1|NOT COMPLETED|Overall Study||36
8228222|NCT02006888|20290437|P3|COMPLETED|Overall Study||58
8228223|NCT02006888|20290438|P2|COMPLETED|Overall Study||122
8228224|NCT02006888|20290439|P1|COMPLETED|Overall Study||122
8228225|NCT02006888|20290437|P3|STARTED|Overall Study||80
8228226|NCT02006888|20290438|P2|STARTED|Overall Study||156
8228227|NCT02006888|20290439|P1|STARTED|Overall Study||158
8228228|NCT02006836|20290450|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8228229|NCT02006836|20290451|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8228230|NCT02006836|20290452|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8228231|NCT02006836|20290450|P3|COMPLETED|Self-control Period: Month 7-month 12||19
8228232|NCT02006836|20290451|P2|COMPLETED|Self-control Period: Month 7-month 12||0
8228233|NCT02006836|20290452|P1|COMPLETED|Self-control Period: Month 7-month 12||0
8228234|NCT02006836|20290450|P3|STARTED|Self-control Period: Month 7-month 12||19
8228235|NCT02006836|20290451|P2|STARTED|Self-control Period: Month 7-month 12||0
8228236|NCT02006836|20290452|P1|STARTED|Self-control Period: Month 7-month 12||0
8228237|NCT02006836|20290450|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8228238|NCT02006836|20290451|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8228239|NCT02006836|20290452|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8228240|NCT02006836|20290450|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
8228241|NCT02006836|20290451|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
8228242|NCT02006836|20290452|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
8228243|NCT02006836|20290450|P3|STARTED|Case-control Period: Month 1- Month 6||0
8228244|NCT02006836|20290451|P2|STARTED|Case-control Period: Month 1- Month 6||20
8228245|NCT02006836|20290452|P1|STARTED|Case-control Period: Month 1- Month 6||20
8228246|NCT02006758|20290468|P1|NOT COMPLETED|Overall Study||13
8228247|NCT02006758|20290468|P1|COMPLETED|Overall Study||55
8228248|NCT02006758|20290468|P1|12-month Follow up|Overall Study|12-month follow up completed|55
8228249|NCT02006758|20290468|P1|6-month Follow up|Overall Study|6-month follow up completed|60
8228250|NCT02006758|20290468|P1|1-month Follow up|Overall Study|1-month follow up completed|66
8228251|NCT02006758|20290468|P1|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
8228252|NCT02006758|20290468|P1|STARTED|Overall Study|Total number of enrolled participants|68
8228253|NCT02006732|20290499|P4|NOT COMPLETED|Overall Study||4
8228254|NCT02006732|20290500|P3|NOT COMPLETED|Overall Study||9
8228255|NCT02006732|20290501|P2|NOT COMPLETED|Overall Study||12
8228256|NCT02006732|20290502|P1|NOT COMPLETED|Overall Study||20
8228257|NCT02006732|20290499|P4|COMPLETED|Overall Study||198
8228258|NCT02006732|20290500|P3|COMPLETED|Overall Study||193
8228259|NCT02006732|20290501|P2|COMPLETED|Overall Study||191
8228260|NCT02006732|20290502|P1|COMPLETED|Overall Study||182
8228261|NCT02006732|20290499|P4|STARTED|Overall Study||202
8228262|NCT02006732|20290500|P3|STARTED|Overall Study||202
8228263|NCT02006732|20290501|P2|STARTED|Overall Study||203
8228264|NCT02006732|20290502|P1|STARTED|Overall Study||202
8228265|NCT02006719|20290542|P2|NOT COMPLETED|Overall Study||5
8228266|NCT02006719|20290543|P1|NOT COMPLETED|Overall Study||18
8228267|NCT02006719|20290542|P2|COMPLETED|Overall Study||80
8228268|NCT02006719|20290543|P1|COMPLETED|Overall Study||219
8228269|NCT02006719|20290542|P2|STARTED|Overall Study||85
8228270|NCT02006719|20290543|P1|STARTED|Overall Study||237
8228271|NCT02006706|20290573|P1|NOT COMPLETED|Overall Study||1
8228272|NCT02006706|20290573|P1|COMPLETED|Overall Study||14
8228273|NCT02006706|20290573|P1|STARTED|Overall Study||15
8228274|NCT02006693|20290580|P2|NOT COMPLETED|Overall Study||13
8228275|NCT02006693|20290581|P1|NOT COMPLETED|Overall Study||28
8228276|NCT02006693|20290580|P2|COMPLETED|Overall Study||74
8228277|NCT02006693|20290581|P1|COMPLETED|Overall Study||84
8228278|NCT02006693|20290580|P2|STARTED|Overall Study||87
8228279|NCT02006693|20290581|P1|STARTED|Overall Study||112
8228280|NCT02006667|20290593|P1|NOT COMPLETED|Overall Study||6
8228281|NCT02006667|20290593|P1|COMPLETED|Overall Study||7
8228282|NCT02006667|20290593|P1|STARTED|Overall Study||13
8228283|NCT02006654|20290605|P2|NOT COMPLETED|Overall Study||44
8228284|NCT02006654|20290606|P1|NOT COMPLETED|Overall Study||45
8228285|NCT02006654|20290605|P2|COMPLETED|Overall Study||321
8228286|NCT02006654|20290606|P1|COMPLETED|Overall Study||324
8228287|NCT02006654|20290605|P2|Treated|Overall Study||363
8228288|NCT02006654|20290606|P1|Treated|Overall Study||365
8228289|NCT02006654|20290605|P2|STARTED|Overall Study||365
8228290|NCT02006654|20290606|P1|STARTED|Overall Study||369
8228291|NCT02006641|20290635|P3|NOT COMPLETED|Overall Study||36
8228292|NCT02006641|20290636|P2|NOT COMPLETED|Overall Study||33
8228293|NCT02006641|20290637|P1|NOT COMPLETED|Overall Study||26
8228294|NCT02006641|20290635|P3|COMPLETED|Overall Study||248
8228295|NCT02006641|20290636|P2|COMPLETED|Overall Study||257
8228296|NCT02006641|20290637|P1|COMPLETED|Overall Study||258
8228297|NCT02006641|20290635|P3|Treated|Overall Study||281
8228298|NCT02006641|20290636|P2|Treated|Overall Study||285
8228299|NCT02006641|20290637|P1|Treated|Overall Study||282
8228300|NCT02006641|20290635|P3|STARTED|Overall Study||284
8228301|NCT02006641|20290636|P2|STARTED|Overall Study||290
8228302|NCT02006641|20290637|P1|STARTED|Overall Study||284
8228303|NCT02006628|20290677|P2|NOT COMPLETED|Overall Study||2
8228304|NCT02006628|20290678|P1|NOT COMPLETED|Overall Study||3
8228305|NCT02006628|20290677|P2|COMPLETED|Overall Study||43
8228306|NCT02006628|20290678|P1|COMPLETED|Overall Study||40
8228307|NCT02006628|20290677|P2|Intention to Treat (ITT) Analysis Set|Overall Study||44
8228308|NCT02006628|20290678|P1|Intention to Treat (ITT) Analysis Set|Overall Study||42
8228309|NCT02006628|20290677|P2|Received at Least 1 Dose of Study Drug|Overall Study||45
8228310|NCT02006628|20290678|P1|Received at Least 1 Dose of Study Drug|Overall Study||43
8228311|NCT02006628|20290677|P2|STARTED|Overall Study||45
8228312|NCT02006628|20290678|P1|STARTED|Overall Study||43
8228313|NCT02006576|20290703|P3|NOT COMPLETED|Overall Study||17
8228314|NCT02006576|20290704|P2|NOT COMPLETED|Overall Study||7
8228315|NCT02006576|20290705|P1|NOT COMPLETED|Overall Study||18
8228316|NCT02006576|20290703|P3|COMPLETED|Overall Study||15
8228317|NCT02006576|20290704|P2|COMPLETED|Overall Study||44
8228318|NCT02006576|20290705|P1|COMPLETED|Overall Study||17
8228319|NCT02006576|20290703|P3|STARTED|Overall Study||32
8228320|NCT02006576|20290704|P2|STARTED|Overall Study||51
8228321|NCT02006576|20290705|P1|STARTED|Overall Study||35
8228322|NCT02006420|20290718|P2|NOT COMPLETED|Overall Study||0
8228323|NCT02006420|20290719|P1|NOT COMPLETED|Overall Study||0
8228324|NCT02006420|20290718|P2|COMPLETED|Overall Study||21
8228325|NCT02006420|20290719|P1|COMPLETED|Overall Study||24
8228326|NCT02006420|20290718|P2|STARTED|Overall Study||21
8228327|NCT02006420|20290719|P1|STARTED|Overall Study||24
8228328|NCT02006407|20290733|P1|NOT COMPLETED|Overall Study||0
8228329|NCT02006407|20290733|P1|COMPLETED|Overall Study||5
8228330|NCT02006407|20290733|P1|STARTED|Overall Study||5
8228331|NCT02006342|20290741|P2|NOT COMPLETED|Overall Study||0
8228332|NCT02006342|20290742|P1|NOT COMPLETED|Overall Study||1
8228333|NCT02006342|20290741|P2|COMPLETED|Overall Study||20
8228334|NCT02006342|20290742|P1|COMPLETED|Overall Study||19
8228335|NCT02006342|20290741|P2|STARTED|Overall Study||20
8228336|NCT02006342|20290742|P1|STARTED|Overall Study||20
8228337|NCT02006264|20290758|P2|NOT COMPLETED|Overall Study||0
8228338|NCT02006264|20290759|P1|NOT COMPLETED|Overall Study||1
8228339|NCT02006264|20290758|P2|COMPLETED|Overall Study||15
8228340|NCT02006264|20290759|P1|COMPLETED|Overall Study||14
8228341|NCT02006264|20290758|P2|STARTED|Overall Study||15
8228342|NCT02006264|20290759|P1|STARTED|Overall Study||15
8228343|NCT02006160|20290779|P2|NOT COMPLETED|Overall Study||0
8228344|NCT02006160|20290780|P1|NOT COMPLETED|Overall Study||4
8228345|NCT02006160|20290779|P2|COMPLETED|Overall Study||16
8228346|NCT02006160|20290780|P1|COMPLETED|Overall Study||41
8228347|NCT02006160|20290779|P2|STARTED|Overall Study||16
8228348|NCT02006160|20290780|P1|STARTED|Overall Study||45
8228349|NCT02006121|20290788|P2|NOT COMPLETED|Open Label Phase||0
8228350|NCT02006121|20290789|P1|NOT COMPLETED|Open Label Phase||25
8228351|NCT02006121|20290788|P2|COMPLETED|Open Label Phase||0
8228352|NCT02006121|20290789|P1|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
8228353|NCT02006121|20290788|P2|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
8228354|NCT02006121|20290789|P1|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
8228355|NCT02006121|20290788|P2|NOT COMPLETED|Double Blind Phase||24
8228356|NCT02006121|20290789|P1|NOT COMPLETED|Double Blind Phase||12
8228357|NCT02006121|20290788|P2|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
8228358|NCT02006121|20290789|P1|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
8228359|NCT02006121|20290788|P2|STARTED|Double Blind Phase||53
8228360|NCT02006121|20290789|P1|STARTED|Double Blind Phase||54
8228361|NCT02006108|20290803|P1|NOT COMPLETED|Overall Study||2
8228362|NCT02006108|20290803|P1|COMPLETED|Overall Study||19
8228363|NCT02006108|20290803|P1|MR Imaging|Overall Study||19
8228364|NCT02006108|20290803|P1|STARTED|Overall Study||21
8228365|NCT02006056|20290810|P2|NOT COMPLETED|Overall Study||0
8228366|NCT02006056|20290811|P1|NOT COMPLETED|Overall Study||0
8228367|NCT02006056|20290810|P2|COMPLETED|Overall Study||4
8228368|NCT02006056|20290811|P1|COMPLETED|Overall Study||26
8228369|NCT02006056|20290810|P2|STARTED|Overall Study||4
8228370|NCT02006056|20290811|P1|STARTED|Overall Study||26
8228371|NCT02005887|20290822|P2|NOT COMPLETED|Overall Study||2
8228372|NCT02005887|20290823|P1|NOT COMPLETED|Overall Study||0
8228373|NCT02005887|20290822|P2|COMPLETED|Overall Study||23
8228374|NCT02005887|20290823|P1|COMPLETED|Overall Study||26
8228375|NCT02005887|20290822|P2|STARTED|Overall Study||25
8228376|NCT02005887|20290823|P1|STARTED|Overall Study||26
8228377|NCT02005692|20290841|P1|NOT COMPLETED|Overall Study||7
8228378|NCT02005692|20290841|P1|COMPLETED|Overall Study||63
8228379|NCT02005692|20290841|P1|STARTED|Overall Study||70
8228380|NCT02005666|20290849|P3|NOT COMPLETED|Overall Study||9
8228381|NCT02005666|20290850|P2|NOT COMPLETED|Overall Study||44
8228382|NCT02005666|20290851|P1|NOT COMPLETED|Overall Study||27
8228383|NCT02005666|20290849|P3|COMPLETED|Overall Study||160
8228384|NCT02005666|20290850|P2|COMPLETED|Overall Study||299
8228385|NCT02005666|20290851|P1|COMPLETED|Overall Study||311
8228386|NCT02005666|20290849|P3|STARTED|Overall Study||169
8228387|NCT02005666|20290850|P2|STARTED|Overall Study||343
8228388|NCT02005666|20290851|P1|STARTED|Overall Study||338
8228389|NCT02005627|20290867|P2|NOT COMPLETED|Overall Study||4
8228390|NCT02005627|20290868|P1|NOT COMPLETED|Overall Study||2
8228391|NCT02005627|20290867|P2|COMPLETED|Overall Study||19
8228392|NCT02005627|20290868|P1|COMPLETED|Overall Study||21
8228393|NCT02005627|20290867|P2|STARTED|Overall Study||23
8228394|NCT02005627|20290868|P1|STARTED|Overall Study||23
8228395|NCT02005601|20290884|P2|NOT COMPLETED|Overall Study||0
8228396|NCT02005601|20290885|P1|NOT COMPLETED|Overall Study||0
8228397|NCT02005601|20290884|P2|COMPLETED|Overall Study||53
8228398|NCT02005601|20290885|P1|COMPLETED|Overall Study||53
8228399|NCT02005601|20290884|P2|STARTED|Overall Study||53
8228400|NCT02005601|20290885|P1|STARTED|Overall Study||53
8228401|NCT02005562|20290897|P2|NOT COMPLETED|Overall Study||15
8228402|NCT02005562|20290898|P1|NOT COMPLETED|Overall Study||12
8228403|NCT02005562|20290897|P2|COMPLETED|Overall Study||110
8228404|NCT02005562|20290898|P1|COMPLETED|Overall Study||115
8228405|NCT02005562|20290897|P2|Transplanted|Overall Study||121
8228406|NCT02005562|20290898|P1|Transplanted|Overall Study||126
8228407|NCT02005562|20290897|P2|STARTED|Overall Study||125
8228408|NCT02005562|20290898|P1|STARTED|Overall Study||127
8228409|NCT02005549|20290926|P1|NOT COMPLETED|Overall Study||0
8228410|NCT02005549|20290926|P1|COMPLETED|Overall Study||18
8228411|NCT02005549|20290926|P1|STARTED|Overall Study||18
8228412|NCT02005536|20290932|P1|NOT COMPLETED|Overall Study||0
8228413|NCT02005536|20290932|P1|COMPLETED|Overall Study||60
8228414|NCT02005536|20290932|P1|STARTED|Overall Study||60
8228415|NCT02005510|20290942|P2|NOT COMPLETED|Rerandomized (Round 3)||0
8228416|NCT02005510|20290943|P1|NOT COMPLETED|Rerandomized (Round 3)||0
8228417|NCT02005510|20290942|P2|COMPLETED|Rerandomized (Round 3)||195
8228418|NCT02005510|20290943|P1|COMPLETED|Rerandomized (Round 3)||209
8228419|NCT02005510|20290942|P2|STARTED|Rerandomized (Round 3)||195
8228420|NCT02005510|20290943|P1|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
8228421|NCT02005510|20290942|P2|NOT COMPLETED|Rerandomized (Round 2)||0
8228422|NCT02005510|20290943|P1|NOT COMPLETED|Rerandomized (Round 2)||0
8228423|NCT02005510|20290942|P2|COMPLETED|Rerandomized (Round 2)||1585
8228424|NCT02005510|20290943|P1|COMPLETED|Rerandomized (Round 2)||1631
8228425|NCT02005510|20290942|P2|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
8228426|NCT02005510|20290943|P1|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
8228427|NCT02005510|20290942|P2|NOT COMPLETED|Randomized (Round 1)||0
8228428|NCT02005510|20290943|P1|NOT COMPLETED|Randomized (Round 1)||0
8228429|NCT02005510|20290942|P2|COMPLETED|Randomized (Round 1)||8111
8228430|NCT02005510|20290943|P1|COMPLETED|Randomized (Round 1)||8120
8228431|NCT02005510|20290942|P2|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
8228432|NCT02005510|20290943|P1|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
8228433|NCT02005484|20290959|P1|NOT COMPLETED|Overall Study||4
8228434|NCT02005484|20290959|P1|COMPLETED|Overall Study||2
8228435|NCT02005484|20290959|P1|STARTED|Overall Study||6
8228444|NCT02005445|20291027|P2|NOT COMPLETED|Overall Study||1
8228445|NCT02005445|20291028|P1|NOT COMPLETED|Overall Study||0
8228446|NCT02005445|20291027|P2|COMPLETED|Overall Study||1
8228447|NCT02005445|20291028|P1|COMPLETED|Overall Study||2
8228448|NCT02005445|20291027|P2|STARTED|Overall Study||2
8228449|NCT02005445|20291028|P1|STARTED|Overall Study||2
8228450|NCT02005393|20291034|P1|NOT COMPLETED|Overall Study||0
8228451|NCT02005393|20291034|P1|COMPLETED|Overall Study||20
8228452|NCT02005393|20291034|P1|STARTED|Overall Study||20
8228453|NCT02005354|20291040|P2|NOT COMPLETED|Overall Study||0
8228454|NCT02005354|20291041|P1|NOT COMPLETED|Overall Study||0
8228455|NCT02005354|20291040|P2|COMPLETED|Overall Study||35
8228456|NCT02005354|20291041|P1|COMPLETED|Overall Study||35
8228457|NCT02005354|20291040|P2|STARTED|Overall Study||35
8228458|NCT02005354|20291041|P1|STARTED|Overall Study||35
8228459|NCT02005276|20291051|P4|NOT COMPLETED|Overall Study||3
8228460|NCT02005276|20291052|P3|NOT COMPLETED|Overall Study||3
8228461|NCT02005276|20291053|P2|NOT COMPLETED|Overall Study||2
8228462|NCT02005276|20291054|P1|NOT COMPLETED|Overall Study||5
8228463|NCT02005276|20291051|P4|COMPLETED|Overall Study||41
8228464|NCT02005276|20291052|P3|COMPLETED|Overall Study||56
8228465|NCT02005276|20291053|P2|COMPLETED|Overall Study||39
8228466|NCT02005276|20291054|P1|COMPLETED|Overall Study||60
8228467|NCT02005276|20291051|P4|Completed Intervention|Overall Study||42
8228468|NCT02005276|20291052|P3|Completed Intervention|Overall Study||56
8228469|NCT02005276|20291053|P2|Completed Intervention|Overall Study||39
8228470|NCT02005276|20291054|P1|Completed Intervention|Overall Study||61
8228471|NCT02005276|20291051|P4|STARTED|Overall Study||44
8228472|NCT02005276|20291052|P3|STARTED|Overall Study||59
8228473|NCT02005276|20291053|P2|STARTED|Overall Study||41
8228474|NCT02005276|20291054|P1|STARTED|Overall Study||65
8228475|NCT02005250|20291070|P2|NOT COMPLETED|Overall Study||5
8228476|NCT02005250|20291071|P1|NOT COMPLETED|Overall Study||15
8228477|NCT02005250|20291070|P2|COMPLETED|Overall Study||27
8228478|NCT02005250|20291071|P1|COMPLETED|Overall Study||46
8228479|NCT02005250|20291070|P2|STARTED|Overall Study||32
8228480|NCT02005250|20291071|P1|STARTED|Overall Study||61
8228481|NCT02005211|20291084|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228482|NCT02005211|20291085|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228483|NCT02005211|20291086|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
8228484|NCT02005211|20291087|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228485|NCT02005211|20291088|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228486|NCT02005211|20291089|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228487|NCT02005211|20291090|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228488|NCT02005211|20291084|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
8228489|NCT02005211|20291085|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8228490|NCT02005211|20291086|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
8228491|NCT02005211|20291087|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228492|NCT02005211|20291088|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228493|NCT02005211|20291089|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228494|NCT02005211|20291090|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228495|NCT02005211|20291084|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
8228496|NCT02005211|20291085|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8228497|NCT02005211|20291086|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8228498|NCT02005211|20291087|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228499|NCT02005211|20291088|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228500|NCT02005211|20291089|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228501|NCT02005211|20291090|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228502|NCT02005211|20291084|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228503|NCT02005211|20291085|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228504|NCT02005211|20291086|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228505|NCT02005211|20291087|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228506|NCT02005211|20291088|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228507|NCT02005211|20291089|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228508|NCT02005211|20291090|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228509|NCT02005211|20291084|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228510|NCT02005211|20291085|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228511|NCT02005211|20291086|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228512|NCT02005211|20291087|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228513|NCT02005211|20291088|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228514|NCT02005211|20291089|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228515|NCT02005211|20291090|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228516|NCT02005211|20291084|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228517|NCT02005211|20291085|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228518|NCT02005211|20291086|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228519|NCT02005211|20291087|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228520|NCT02005211|20291088|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228521|NCT02005211|20291089|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228522|NCT02005211|20291090|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228523|NCT02005029|20291125|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8228524|NCT02005029|20291126|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8228525|NCT02005029|20291125|P2|COMPLETED|Second Intervention (1 Day)||5
8228526|NCT02005029|20291126|P1|COMPLETED|Second Intervention (1 Day)||4
8228527|NCT02005029|20291125|P2|STARTED|Second Intervention (1 Day)||5
8228528|NCT02005029|20291126|P1|STARTED|Second Intervention (1 Day)||4
8228529|NCT02005029|20291125|P2|NOT COMPLETED|Washout (2 Weeks)||0
8228530|NCT02005029|20291126|P1|NOT COMPLETED|Washout (2 Weeks)||0
8228531|NCT02005029|20291125|P2|COMPLETED|Washout (2 Weeks)||5
8228532|NCT02005029|20291126|P1|COMPLETED|Washout (2 Weeks)||4
8228533|NCT02005029|20291125|P2|STARTED|Washout (2 Weeks)||5
8228534|NCT02005029|20291126|P1|STARTED|Washout (2 Weeks)||4
8228535|NCT02005029|20291125|P2|NOT COMPLETED|First Intervention (1 Day)||0
8228536|NCT02005029|20291126|P1|NOT COMPLETED|First Intervention (1 Day)||1
8228537|NCT02005029|20291125|P2|COMPLETED|First Intervention (1 Day)||5
8228538|NCT02005029|20291126|P1|COMPLETED|First Intervention (1 Day)||4
8228539|NCT02005029|20291125|P2|STARTED|First Intervention (1 Day)||5
8228540|NCT02005029|20291126|P1|STARTED|First Intervention (1 Day)||5
8228541|NCT02005016|20291152|P1|NOT COMPLETED|Overall Study||2
8228542|NCT02005016|20291152|P1|COMPLETED|Overall Study||44
8228543|NCT02005016|20291152|P1|STARTED|Overall Study||46
8228544|NCT02004990|20291157|P1|NOT COMPLETED|Overall Study||0
8228545|NCT02004990|20291157|P1|COMPLETED|Overall Study||12
8228546|NCT02004990|20291157|P1|STARTED|Overall Study||12
8228547|NCT02004977|20291164|P2|NOT COMPLETED|Overall Study||5
8228548|NCT02004977|20291165|P1|NOT COMPLETED|Overall Study||54
8228549|NCT02004977|20291164|P2|COMPLETED|Overall Study||436
8228550|NCT02004977|20291165|P1|COMPLETED|Overall Study||409
8228551|NCT02004977|20291164|P2|STARTED|Overall Study||441
8228552|NCT02004977|20291165|P1|STARTED|Overall Study||463
8228553|NCT02004886|20291183|P4|NOT COMPLETED|Overall Study||0
8228554|NCT02004886|20291184|P3|NOT COMPLETED|Overall Study||0
8228555|NCT02004886|20291185|P2|NOT COMPLETED|Overall Study||1
8228556|NCT02004886|20291186|P1|NOT COMPLETED|Overall Study||1
8228557|NCT02004886|20291183|P4|COMPLETED|Overall Study||19
8228558|NCT02004886|20291184|P3|COMPLETED|Overall Study||18
8228559|NCT02004886|20291185|P2|COMPLETED|Overall Study||17
8228560|NCT02004886|20291186|P1|COMPLETED|Overall Study||18
8228561|NCT02004886|20291183|P4|STARTED|Overall Study||19
8228562|NCT02004886|20291184|P3|STARTED|Overall Study||18
8228563|NCT02004886|20291185|P2|STARTED|Overall Study||18
8228564|NCT02004886|20291186|P1|STARTED|Overall Study||19
8228565|NCT02004873|20291236|P1|NOT COMPLETED|Overall Study||424
8228566|NCT02004873|20291236|P1|COMPLETED|Overall Study|6-Month Follow-up|301
8228567|NCT02004873|20291236|P1|Micra Implant Success|Overall Study||719
8228568|NCT02004873|20291236|P1|STARTED|Overall Study|Micra Implant Attempt|725
8228569|NCT02004847|20291245|P2|NOT COMPLETED|Overall Study||1
8228570|NCT02004847|20291246|P1|NOT COMPLETED|Overall Study||1
8228571|NCT02004847|20291245|P2|COMPLETED|Overall Study||22
8228572|NCT02004847|20291246|P1|COMPLETED|Overall Study||23
8228573|NCT02004847|20291245|P2|STARTED|Overall Study||23
8228574|NCT02004847|20291246|P1|STARTED|Overall Study||24
8228575|NCT02004522|20291292|P2|NOT COMPLETED|Overall Study||159
8228576|NCT02004522|20291293|P1|NOT COMPLETED|Overall Study||126
8228577|NCT02004522|20291292|P2|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
8228578|NCT02004522|20291293|P1|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
8228579|NCT02004522|20291292|P2|Number of Subjects Treated|Overall Study||155
8228580|NCT02004522|20291293|P1|Number of Subjects Treated|Overall Study||158
8228581|NCT02004522|20291292|P2|STARTED|Overall Study||159
8228582|NCT02004522|20291293|P1|STARTED|Overall Study||160
8228583|NCT02004366|20291317|P5|NOT COMPLETED|On Discharge||0
8228584|NCT02004366|20291318|P4|NOT COMPLETED|On Discharge||0
8228585|NCT02004366|20291319|P3|NOT COMPLETED|On Discharge||0
8228586|NCT02004366|20291320|P2|NOT COMPLETED|On Discharge||0
8228587|NCT02004366|20291321|P1|NOT COMPLETED|On Discharge||0
8228588|NCT02004366|20291317|P5|COMPLETED|On Discharge||39
8228589|NCT02004366|20291318|P4|COMPLETED|On Discharge||93
8228590|NCT02004366|20291319|P3|COMPLETED|On Discharge||92
8228591|NCT02004366|20291320|P2|COMPLETED|On Discharge||0
8228592|NCT02004366|20291321|P1|COMPLETED|On Discharge||0
8228593|NCT02004366|20291317|P5|STARTED|On Discharge||39
8228594|NCT02004366|20291318|P4|STARTED|On Discharge||93
8228595|NCT02004366|20291319|P3|STARTED|On Discharge||92
8228596|NCT02004366|20291320|P2|STARTED|On Discharge||0
8228597|NCT02004366|20291321|P1|STARTED|On Discharge||0
8228598|NCT02004366|20291317|P5|NOT COMPLETED|In-hospital||0
8228599|NCT02004366|20291318|P4|NOT COMPLETED|In-hospital||0
8228600|NCT02004366|20291319|P3|NOT COMPLETED|In-hospital||0
8228601|NCT02004366|20291320|P2|NOT COMPLETED|In-hospital||0
8228602|NCT02004366|20291321|P1|NOT COMPLETED|In-hospital||0
8228603|NCT02004366|20291317|P5|COMPLETED|In-hospital||0
8228604|NCT02004366|20291318|P4|COMPLETED|In-hospital||0
8228605|NCT02004366|20291319|P3|COMPLETED|In-hospital||0
8228606|NCT02004366|20291320|P2|COMPLETED|In-hospital||122
8228607|NCT02004366|20291321|P1|COMPLETED|In-hospital||128
8228608|NCT02004366|20291317|P5|STARTED|In-hospital||0
8228609|NCT02004366|20291318|P4|STARTED|In-hospital||0
8228610|NCT02004366|20291319|P3|STARTED|In-hospital||0
8228611|NCT02004366|20291320|P2|STARTED|In-hospital||122
8228612|NCT02004366|20291321|P1|STARTED|In-hospital||128
8228613|NCT02004262|20291414|P6|NOT COMPLETED|Overall Study||30
8228614|NCT02004262|20291415|P5|NOT COMPLETED|Overall Study||31
8228615|NCT02004262|20291416|P4|NOT COMPLETED|Overall Study||29
8228616|NCT02004262|20291417|P3|NOT COMPLETED|Overall Study||72
8228617|NCT02004262|20291418|P2|NOT COMPLETED|Overall Study||68
8228618|NCT02004262|20291419|P1|NOT COMPLETED|Overall Study||73
8228619|NCT02004262|20291414|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228620|NCT02004262|20291415|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228621|NCT02004262|20291416|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228622|NCT02004262|20291417|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228623|NCT02004262|20291418|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228624|NCT02004262|20291419|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228625|NCT02004262|20291414|P6|Treated|Overall Study||11
8228626|NCT02004262|20291415|P5|Treated|Overall Study||29
8228627|NCT02004262|20291416|P4|Treated|Overall Study||26
8228628|NCT02004262|20291417|P3|Treated|Overall Study||43
8228629|NCT02004262|20291418|P2|Treated|Overall Study||58
8228630|NCT02004262|20291419|P1|Treated|Overall Study||68
8228631|NCT02004262|20291414|P6|STARTED|Overall Study||30
8228632|NCT02004262|20291415|P5|STARTED|Overall Study||31
8228633|NCT02004262|20291416|P4|STARTED|Overall Study||29
8228634|NCT02004262|20291417|P3|STARTED|Overall Study||72
8228635|NCT02004262|20291418|P2|STARTED|Overall Study||68
8228636|NCT02004262|20291419|P1|STARTED|Overall Study||73
8228637|NCT02004236|20291439|P3|NOT COMPLETED|Overall Study||16
8228638|NCT02004236|20291440|P2|NOT COMPLETED|Overall Study||0
8228639|NCT02004236|20291441|P1|NOT COMPLETED|Overall Study||0
8228640|NCT02004236|20291439|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
8228641|NCT02004236|20291440|P2|COMPLETED|Overall Study||75
8228642|NCT02004236|20291441|P1|COMPLETED|Overall Study||75
8228643|NCT02004236|20291439|P3|STARTED|Overall Study||75
8228644|NCT02004236|20291440|P2|STARTED|Overall Study||75
8228645|NCT02004236|20291441|P1|STARTED|Overall Study||75
8228646|NCT02004158|20291485|P1|NOT COMPLETED|Overall Study||3
8228647|NCT02004158|20291485|P1|COMPLETED|Overall Study||20
8228648|NCT02004158|20291485|P1|STARTED|Overall Study||23
8228649|NCT02004132|20291493|P1|NOT COMPLETED|Overall Study||0
8228650|NCT02004132|20291493|P1|COMPLETED|Overall Study||12
8228651|NCT02004132|20291493|P1|Received Study Drug|Overall Study||12
8228652|NCT02004132|20291493|P1|STARTED|Overall Study||12
8228653|NCT02004093|20291501|P2|NOT COMPLETED|Overall Study||73
8228654|NCT02004093|20291502|P1|NOT COMPLETED|Overall Study||74
8228655|NCT02004093|20291501|P2|COMPLETED|Overall Study||1
8228656|NCT02004093|20291502|P1|COMPLETED|Overall Study||1
8228657|NCT02004093|20291501|P2|STARTED|Overall Study||74
8228658|NCT02004093|20291502|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
8228659|NCT02003963|20291534|P2|NOT COMPLETED|Overall Study||1
8228660|NCT02003963|20291535|P1|NOT COMPLETED|Overall Study||2
8228661|NCT02003963|20291534|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
8228662|NCT02003963|20291535|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
8228663|NCT02003963|20291534|P2|STARTED|Overall Study||19
8228664|NCT02003963|20291535|P1|STARTED|Overall Study||22
8228698|NCT02003911|20291660|P2|NOT COMPLETED|Overall Study||7
8228699|NCT02003911|20291661|P1|NOT COMPLETED|Overall Study||2
8228700|NCT02003911|20291660|P2|COMPLETED|Overall Study||72
8228701|NCT02003911|20291661|P1|COMPLETED|Overall Study||78
8228702|NCT02003911|20291660|P2|STARTED|Overall Study||79
8228703|NCT02003911|20291661|P1|STARTED|Overall Study||80
8228704|NCT02003898|20291681|P1|NOT COMPLETED|Overall Study||67
8228705|NCT02003898|20291681|P1|COMPLETED|Overall Study||305
8228706|NCT02003898|20291681|P1|STARTED|Overall Study||372
8228707|NCT02003638|20291690|P2|NOT COMPLETED|Overall Study||0
8228708|NCT02003638|20291691|P1|NOT COMPLETED|Overall Study||1
8228709|NCT02003638|20291690|P2|COMPLETED|Overall Study||3
8228710|NCT02003638|20291691|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
8228711|NCT02003638|20291690|P2|STARTED|Overall Study||3
8228712|NCT02003638|20291691|P1|STARTED|Overall Study||6
8228713|NCT02003625|20291699|P2|NOT COMPLETED|Overall Study||3
8228714|NCT02003625|20291700|P1|NOT COMPLETED|Overall Study||1
8228715|NCT02003625|20291699|P2|COMPLETED|Overall Study||12
8228716|NCT02003625|20291700|P1|COMPLETED|Overall Study||14
8228717|NCT02003625|20291699|P2|Received Transplant|Overall Study||12
8228718|NCT02003625|20291700|P1|Received Transplant|Overall Study||14
8228719|NCT02003625|20291699|P2|STARTED|Overall Study||15
8228720|NCT02003625|20291700|P1|STARTED|Overall Study||15
8228721|NCT02003573|20291721|P3|NOT COMPLETED|Overall Study||6
8228722|NCT02003573|20291722|P2|NOT COMPLETED|Overall Study||4
8228723|NCT02003573|20291723|P1|NOT COMPLETED|Overall Study||3
8228724|NCT02003573|20291721|P3|COMPLETED|Overall Study||0
8228725|NCT02003573|20291722|P2|COMPLETED|Overall Study||0
8228726|NCT02003573|20291723|P1|COMPLETED|Overall Study||0
8228727|NCT02003573|20291721|P3|STARTED|Overall Study|Started are treated patients|6
8228728|NCT02003573|20291722|P2|STARTED|Overall Study|Started are treated patients|4
8228729|NCT02003573|20291723|P1|STARTED|Overall Study|Started are treated patients|3
8228730|NCT02003534|20291733|P1|NOT COMPLETED|Overall Study||47
8228731|NCT02003534|20291733|P1|COMPLETED|Overall Study||329
8228732|NCT02003534|20291733|P1|STARTED|Overall Study||376
8228733|NCT02003508|20291739|P2|NOT COMPLETED|Overall Study||0
8228734|NCT02003508|20291740|P1|NOT COMPLETED|Overall Study||0
8228735|NCT02003508|20291739|P2|COMPLETED|Overall Study||166
8228736|NCT02003508|20291740|P1|COMPLETED|Overall Study||179
8228737|NCT02003508|20291739|P2|STARTED|Overall Study||166
8228738|NCT02003508|20291740|P1|STARTED|Overall Study||179
8228739|NCT02003404|20291746|P1|NOT COMPLETED|Overall Study||0
8228740|NCT02003404|20291746|P1|COMPLETED|Overall Study||17
8228741|NCT02003404|20291746|P1|STARTED|Overall Study||17
8228742|NCT02003391|20291754|P2|NOT COMPLETED|Overall Study||2
8228743|NCT02003391|20291755|P1|NOT COMPLETED|Overall Study||3
8228744|NCT02003391|20291754|P2|COMPLETED|Overall Study||73
8228745|NCT02003391|20291755|P1|COMPLETED|Overall Study||78
8228746|NCT02003391|20291754|P2|Intent to Treat Population|Overall Study||73
8228747|NCT02003391|20291755|P1|Intent to Treat Population|Overall Study||78
8228748|NCT02003391|20291754|P2|Safety Population|Overall Study||75
8228749|NCT02003391|20291755|P1|Safety Population|Overall Study||81
8228750|NCT02003391|20291754|P2|STARTED|Overall Study||75
8228751|NCT02003391|20291755|P1|STARTED|Overall Study||81
8228752|NCT02003365|20291768|P3|NOT COMPLETED|Overall Study||1
8228753|NCT02003365|20291769|P2|NOT COMPLETED|Overall Study||0
8228754|NCT02003365|20291770|P1|NOT COMPLETED|Overall Study||0
8228755|NCT02003365|20291768|P3|COMPLETED|Overall Study||9
8228756|NCT02003365|20291769|P2|COMPLETED|Overall Study||30
8228757|NCT02003365|20291770|P1|COMPLETED|Overall Study||10
8228758|NCT02003365|20291768|P3|STARTED|Overall Study||10
8228759|NCT02003365|20291769|P2|STARTED|Overall Study||30
8228760|NCT02003365|20291770|P1|STARTED|Overall Study||10
8228761|NCT02003352|20291781|P1|NOT COMPLETED|Overall Study||0
8228762|NCT02003352|20291781|P1|COMPLETED|Overall Study||98
8228763|NCT02003352|20291781|P1|STARTED|Overall Study||98
8228764|NCT02003183|20291787|P2|NOT COMPLETED|Overall Study||2
8228765|NCT02003183|20291788|P1|NOT COMPLETED|Overall Study||0
8228766|NCT02003183|20291787|P2|COMPLETED|Overall Study||15
8228767|NCT02003183|20291788|P1|COMPLETED|Overall Study||7
8228768|NCT02003183|20291787|P2|STARTED|Overall Study||17
8228769|NCT02003183|20291788|P1|STARTED|Overall Study||7
8228770|NCT02003053|20291796|P2|NOT COMPLETED|Overall Study||0
8228771|NCT02003053|20291797|P1|NOT COMPLETED|Overall Study||0
8228772|NCT02003053|20291796|P2|COMPLETED|Overall Study||3
8228773|NCT02003053|20291797|P1|COMPLETED|Overall Study||4
8228774|NCT02003053|20291796|P2|STARTED|Overall Study||3
8228775|NCT02003053|20291797|P1|STARTED|Overall Study||4
8228776|NCT02003014|20291803|P1|NOT COMPLETED|Overall Study||19
8228777|NCT02003014|20291803|P1|COMPLETED|Overall Study||880
8228778|NCT02003014|20291803|P1|STARTED|Overall Study||899
8228779|NCT02002975|20291813|P1|NOT COMPLETED|Overall Study||572
8228780|NCT02002975|20291813|P1|COMPLETED|Overall Study||17651
8228781|NCT02002975|20291813|P1|STARTED|Overall Study||18223
8228782|NCT02002936|20291829|P1|NOT COMPLETED|Overall Study||0
8228783|NCT02002936|20291829|P1|COMPLETED|Overall Study||1
8228784|NCT02002936|20291829|P1|STARTED|Overall Study||1
8228785|NCT02002884|20291841|P4|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
8228786|NCT02002884|20291842|P3|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8228787|NCT02002884|20291843|P2|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8228788|NCT02002884|20291844|P1|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8228789|NCT02002884|20291841|P4|COMPLETED|Open-Label Extension Period (OLEX)||281
8228790|NCT02002884|20291842|P3|COMPLETED|Open-Label Extension Period (OLEX)||0
8228791|NCT02002884|20291843|P2|COMPLETED|Open-Label Extension Period (OLEX)||0
8228792|NCT02002884|20291844|P1|COMPLETED|Open-Label Extension Period (OLEX)||0
8228793|NCT02002884|20291841|P4|STARTED|Open-Label Extension Period (OLEX)||331
8228794|NCT02002884|20291842|P3|STARTED|Open-Label Extension Period (OLEX)||0
8228795|NCT02002884|20291843|P2|STARTED|Open-Label Extension Period (OLEX)||0
8228796|NCT02002884|20291844|P1|STARTED|Open-Label Extension Period (OLEX)||0
8228797|NCT02002884|20291841|P4|NOT COMPLETED|Main Period (MP)||0
8228798|NCT02002884|20291842|P3|NOT COMPLETED|Main Period (MP)||8
8228799|NCT02002884|20291843|P2|NOT COMPLETED|Main Period (MP)||6
8228800|NCT02002884|20291844|P1|NOT COMPLETED|Main Period (MP)||6
8228801|NCT02002884|20291841|P4|COMPLETED|Main Period (MP)||0
8228802|NCT02002884|20291842|P3|COMPLETED|Main Period (MP)||168
8228803|NCT02002884|20291843|P2|COMPLETED|Main Period (MP)||82
8228804|NCT02002884|20291844|P1|COMPLETED|Main Period (MP)||81
8228805|NCT02002884|20291841|P4|Treated|Main Period (MP)||0
8228806|NCT02002884|20291842|P3|Treated|Main Period (MP)||176
8228807|NCT02002884|20291843|P2|Treated|Main Period (MP)||87
8228808|NCT02002884|20291844|P1|Treated|Main Period (MP)||87
8228809|NCT02002884|20291841|P4|STARTED|Main Period (MP)||0
8228810|NCT02002884|20291842|P3|STARTED|Main Period (MP)||176
8228811|NCT02002884|20291843|P2|STARTED|Main Period (MP)||88
8228812|NCT02002884|20291844|P1|STARTED|Main Period (MP)||87
8228813|NCT02002871|20291903|P1|NOT COMPLETED|Overall Study||1
8228814|NCT02002871|20291903|P1|COMPLETED|Overall Study||20
8228815|NCT02002871|20291903|P1|STARTED|Overall Study||21
8228816|NCT02002832|20291931|P2|NOT COMPLETED|Overall Study||26
8228817|NCT02002832|20291932|P1|NOT COMPLETED|Overall Study||28
8228818|NCT02002832|20291931|P2|COMPLETED|Overall Study||168
8228819|NCT02002832|20291932|P1|COMPLETED|Overall Study||166
8228820|NCT02002832|20291931|P2|STARTED|Overall Study||194
8228821|NCT02002832|20291932|P1|STARTED|Overall Study||194
8228822|NCT02002767|20291942|P2|NOT COMPLETED|Overall Study||0
8228823|NCT02002767|20291943|P1|NOT COMPLETED|Overall Study||0
8228824|NCT02002767|20291942|P2|COMPLETED|Overall Study||10
8228825|NCT02002767|20291943|P1|COMPLETED|Overall Study||9
8228826|NCT02002767|20291942|P2|STARTED|Overall Study||10
8228827|NCT02002767|20291943|P1|STARTED|Overall Study||9
8228828|NCT02002702|20291962|P3|NOT COMPLETED|Overall Study||0
8228829|NCT02002702|20291963|P2|NOT COMPLETED|Overall Study||0
8228830|NCT02002702|20291964|P1|NOT COMPLETED|Overall Study||0
8228831|NCT02002702|20291962|P3|COMPLETED|Overall Study||15
8228832|NCT02002702|20291963|P2|COMPLETED|Overall Study||15
8228833|NCT02002702|20291964|P1|COMPLETED|Overall Study||16
8228834|NCT02002702|20291962|P3|STARTED|Overall Study||15
8228835|NCT02002702|20291963|P2|STARTED|Overall Study||15
8228836|NCT02002702|20291964|P1|STARTED|Overall Study||16
8228837|NCT02002689|20291996|P1|NOT COMPLETED|Overall Study||10
8228838|NCT02002689|20291996|P1|COMPLETED|Overall Study||0
8228839|NCT02002689|20291996|P1|STARTED|Overall Study||10
8228840|NCT02002650|20292004|P2|NOT COMPLETED|Overall Study||0
8228841|NCT02002650|20292005|P1|NOT COMPLETED|Overall Study||0
8228842|NCT02002650|20292004|P2|COMPLETED|Overall Study||1303
8228843|NCT02002650|20292005|P1|COMPLETED|Overall Study||1297
8228844|NCT02002650|20292004|P2|STARTED|Overall Study||1303
8228845|NCT02002650|20292005|P1|STARTED|Overall Study||1297
8228846|NCT02002533|20292015|P2|NOT COMPLETED|Overall Study||18
8228847|NCT02002533|20292016|P1|NOT COMPLETED|Overall Study||6
8228848|NCT02002533|20292015|P2|COMPLETED|Overall Study||19
8228849|NCT02002533|20292016|P1|COMPLETED|Overall Study||28
8228850|NCT02002533|20292015|P2|STARTED|Overall Study||37
8228851|NCT02002533|20292016|P1|STARTED|Overall Study||34
8228852|NCT02002494|20292039|P1|NOT COMPLETED|Overall Study||0
8228853|NCT02002494|20292039|P1|COMPLETED|Overall Study||27
8228854|NCT02002494|20292039|P1|STARTED|Overall Study||27
8228855|NCT02002221|20292056|P2|NOT COMPLETED|Overall Study||3
8228856|NCT02002221|20292057|P1|NOT COMPLETED|Overall Study||2
8228857|NCT02002221|20292056|P2|COMPLETED|Overall Study||75
8228858|NCT02002221|20292057|P1|COMPLETED|Overall Study||76
8228859|NCT02002221|20292056|P2|STARTED|Overall Study||78
8228860|NCT02002221|20292057|P1|STARTED|Overall Study||78
8228861|NCT02002208|20292073|P2|NOT COMPLETED|Overall Study||40
8228862|NCT02002208|20292074|P1|NOT COMPLETED|Overall Study||37
8228863|NCT02002208|20292073|P2|COMPLETED|Overall Study||30
8228864|NCT02002208|20292074|P1|COMPLETED|Overall Study||32
8228865|NCT02002208|20292073|P2|STARTED|Overall Study||70
8228866|NCT02002208|20292074|P1|STARTED|Overall Study||69
8228867|NCT02002182|20292084|P2|NOT COMPLETED|Overall Study||1
8228868|NCT02002182|20292085|P1|NOT COMPLETED|Overall Study||5
8228869|NCT02002182|20292084|P2|COMPLETED|Overall Study||5
8228870|NCT02002182|20292085|P1|COMPLETED|Overall Study||4
8228871|NCT02002182|20292084|P2|STARTED|Overall Study||6
8228872|NCT02002182|20292085|P1|STARTED|Overall Study||9
8228873|NCT02002091|20292097|P2|NOT COMPLETED|One Year Follow up||0
8228874|NCT02002091|20292098|P1|NOT COMPLETED|One Year Follow up||0
8228875|NCT02002091|20292097|P2|COMPLETED|One Year Follow up||191
8228876|NCT02002091|20292098|P1|COMPLETED|One Year Follow up||109
8228877|NCT02002091|20292097|P2|STARTED|One Year Follow up||191
8228878|NCT02002091|20292098|P1|STARTED|One Year Follow up||109
8228879|NCT02002091|20292097|P2|NOT COMPLETED|Screening||14
8228880|NCT02002091|20292098|P1|NOT COMPLETED|Screening||13
8228881|NCT02002091|20292097|P2|COMPLETED|Screening||191
8228882|NCT02002091|20292098|P1|COMPLETED|Screening||109
8228883|NCT02002091|20292097|P2|STARTED|Screening||205
8228884|NCT02002091|20292098|P1|STARTED|Screening||122
8228885|NCT02001987|20292133|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
8228886|NCT02001987|20292133|P1|COMPLETED|LTE Period (52 Weeks)||107
8228887|NCT02001987|20292133|P1|STARTED|LTE Period (52 Weeks)||116
8228888|NCT02001987|20292133|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
8228889|NCT02001987|20292133|P1|COMPLETED|Core Study Period (24 Weeks)||116
8228890|NCT02001987|20292133|P1|STARTED|Core Study Period (24 Weeks)||139
8228891|NCT02001714|20292209|P2|NOT COMPLETED|Overall Study||12
8228892|NCT02001714|20292210|P1|NOT COMPLETED|Overall Study||22
8228893|NCT02001714|20292209|P2|COMPLETED|Overall Study||219
8228894|NCT02001714|20292210|P1|COMPLETED|Overall Study||210
8228895|NCT02001714|20292209|P2|STARTED|Overall Study||231
8228896|NCT02001714|20292210|P1|STARTED|Overall Study||232
8228897|NCT02001688|20292219|P3|NOT COMPLETED|Overall Study||1
8228898|NCT02001688|20292220|P2|NOT COMPLETED|Overall Study||1
8228899|NCT02001688|20292221|P1|NOT COMPLETED|Overall Study||0
8228900|NCT02001688|20292219|P3|COMPLETED|Overall Study||11
8228901|NCT02001688|20292220|P2|COMPLETED|Overall Study||11
8228902|NCT02001688|20292221|P1|COMPLETED|Overall Study||12
8228903|NCT02001688|20292219|P3|STARTED|Overall Study||12
8228904|NCT02001688|20292220|P2|STARTED|Overall Study||12
8228905|NCT02001688|20292221|P1|STARTED|Overall Study||12
8228906|NCT02001558|20292240|P2|NOT COMPLETED|Overall Study||14
8228907|NCT02001558|20292241|P1|NOT COMPLETED|Overall Study||8
8228908|NCT02001558|20292240|P2|COMPLETED|Overall Study||19
8228909|NCT02001558|20292241|P1|COMPLETED|Overall Study||24
8228910|NCT02001558|20292240|P2|STARTED|Overall Study||33
8228911|NCT02001558|20292241|P1|STARTED|Overall Study||32
8228912|NCT02001194|20292277|P4|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
8228913|NCT02001194|20292278|P3|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
8228914|NCT02001194|20292279|P2|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
8228915|NCT02001194|20292280|P1|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
8228916|NCT02001194|20292277|P4|COMPLETED|Follow-Up Period (13 Weeks)||78
8228917|NCT02001194|20292278|P3|COMPLETED|Follow-Up Period (13 Weeks)||73
8228918|NCT02001194|20292279|P2|COMPLETED|Follow-Up Period (13 Weeks)||78
8228919|NCT02001194|20292280|P1|COMPLETED|Follow-Up Period (13 Weeks)||64
8228920|NCT02001194|20292277|P4|STARTED|Follow-Up Period (13 Weeks)||78
8228921|NCT02001194|20292278|P3|STARTED|Follow-Up Period (13 Weeks)||74
8228922|NCT02001194|20292279|P2|STARTED|Follow-Up Period (13 Weeks)||80
8228923|NCT02001194|20292280|P1|STARTED|Follow-Up Period (13 Weeks)||67
8228924|NCT02001194|20292277|P4|NOT COMPLETED|Intervention Period (13 Weeks)||2
8228925|NCT02001194|20292278|P3|NOT COMPLETED|Intervention Period (13 Weeks)||2
8228926|NCT02001194|20292279|P2|NOT COMPLETED|Intervention Period (13 Weeks)||0
8228927|NCT02001194|20292280|P1|NOT COMPLETED|Intervention Period (13 Weeks)||1
8228928|NCT02001194|20292277|P4|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
8228929|NCT02001194|20292278|P3|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
8228930|NCT02001194|20292279|P2|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
8228931|NCT02001194|20292280|P1|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
8228932|NCT02001194|20292277|P4|STARTED|Intervention Period (13 Weeks)|20 teams|80
8228933|NCT02001194|20292278|P3|STARTED|Intervention Period (13 Weeks)|19 teams|76
8228934|NCT02001194|20292279|P2|STARTED|Intervention Period (13 Weeks)|20 teams|80
8228935|NCT02001194|20292280|P1|STARTED|Intervention Period (13 Weeks)|17 teams|68
8228936|NCT02001181|20292296|P2|NOT COMPLETED|Overall Study||3
8228937|NCT02001181|20292297|P1|NOT COMPLETED|Overall Study||1
8228938|NCT02001181|20292296|P2|COMPLETED|Overall Study||31
8228939|NCT02001181|20292297|P1|COMPLETED|Overall Study||34
8228940|NCT02001181|20292296|P2|STARTED|Overall Study||34
8228941|NCT02001181|20292297|P1|STARTED|Overall Study||35
8228942|NCT02001051|20292313|P2|NOT COMPLETED|Overall Study||1
8228943|NCT02001051|20292314|P1|NOT COMPLETED|Overall Study||0
8228944|NCT02001051|20292313|P2|COMPLETED|Overall Study||1
8228945|NCT02001051|20292314|P1|COMPLETED|Overall Study||2
8228946|NCT02001051|20292313|P2|STARTED|Overall Study||2
8228947|NCT02001051|20292314|P1|STARTED|Overall Study||2
8228948|NCT02000973|20292338|P4|NOT COMPLETED|Overall Study||0
8228949|NCT02000973|20292339|P3|NOT COMPLETED|Overall Study||0
8228950|NCT02000973|20292340|P2|NOT COMPLETED|Overall Study||0
8228951|NCT02000973|20292341|P1|NOT COMPLETED|Overall Study||0
8228952|NCT02000973|20292338|P4|COMPLETED|Overall Study||20
8228953|NCT02000973|20292339|P3|COMPLETED|Overall Study||20
8228954|NCT02000973|20292340|P2|COMPLETED|Overall Study||20
8228955|NCT02000973|20292341|P1|COMPLETED|Overall Study||20
8228956|NCT02000973|20292338|P4|STARTED|Overall Study||20
8228957|NCT02000973|20292339|P3|STARTED|Overall Study||20
8228958|NCT02000973|20292340|P2|STARTED|Overall Study||20
8228959|NCT02000973|20292341|P1|STARTED|Overall Study||20
8228960|NCT02000921|20292366|P3|NOT COMPLETED|Overall Study||10
8228961|NCT02000921|20292367|P2|NOT COMPLETED|Overall Study||16
8228962|NCT02000921|20292368|P1|NOT COMPLETED|Overall Study||5
8228963|NCT02000921|20292366|P3|COMPLETED|Overall Study||46
8228964|NCT02000921|20292367|P2|COMPLETED|Overall Study||37
8228965|NCT02000921|20292368|P1|COMPLETED|Overall Study||22
8228966|NCT02000921|20292366|P3|STARTED|Overall Study||56
8228967|NCT02000921|20292367|P2|STARTED|Overall Study||53
8228968|NCT02000921|20292368|P1|STARTED|Overall Study||27
8228969|NCT02000908|20292387|P2|NOT COMPLETED|Overall Study||4
8228970|NCT02000908|20292388|P1|NOT COMPLETED|Overall Study||2
8228971|NCT02000908|20292387|P2|COMPLETED|Overall Study||36
8228972|NCT02000908|20292388|P1|COMPLETED|Overall Study||28
8228973|NCT02000908|20292387|P2|STARTED|Overall Study||40
8228974|NCT02000908|20292388|P1|STARTED|Overall Study||30
8228975|NCT02000817|20292398|P4|NOT COMPLETED|Overall Study||0
8228976|NCT02000817|20292399|P3|NOT COMPLETED|Overall Study||1
8228977|NCT02000817|20292400|P2|NOT COMPLETED|Overall Study||1
8228978|NCT02000817|20292401|P1|NOT COMPLETED|Overall Study||2
8228979|NCT02000817|20292398|P4|COMPLETED|Overall Study||7
8228980|NCT02000817|20292399|P3|COMPLETED|Overall Study||7
8228981|NCT02000817|20292400|P2|COMPLETED|Overall Study||8
8228982|NCT02000817|20292401|P1|COMPLETED|Overall Study||4
8228983|NCT02000817|20292398|P4|STARTED|Overall Study||7
8228984|NCT02000817|20292399|P3|STARTED|Overall Study||8
8228985|NCT02000817|20292400|P2|STARTED|Overall Study||9
8228986|NCT02000817|20292401|P1|STARTED|Overall Study||6
8228987|NCT02000752|20292496|P2|NOT COMPLETED|Overall Study||13
8228988|NCT02000752|20292497|P1|NOT COMPLETED|Overall Study||31
8228989|NCT02000752|20292496|P2|COMPLETED|Overall Study||47
8228990|NCT02000752|20292497|P1|COMPLETED|Overall Study||29
8228991|NCT02000752|20292496|P2|STARTED|Overall Study||60
8228992|NCT02000752|20292497|P1|STARTED|Overall Study||60
8228993|NCT02000622|20292511|P2|NOT COMPLETED|Overall Study||80
8228994|NCT02000622|20292512|P1|NOT COMPLETED|Overall Study||169
8228995|NCT02000622|20292511|P2|COMPLETED|Overall Study||17
8228996|NCT02000622|20292512|P1|COMPLETED|Overall Study||36
8228997|NCT02000622|20292511|P2|STARTED|Overall Study||97
8228998|NCT02000622|20292512|P1|STARTED|Overall Study||205
8228999|NCT02000583|20292542|P2|NOT COMPLETED|Overall Study||5
8229000|NCT02000583|20292543|P1|NOT COMPLETED|Overall Study||3
8229001|NCT02000583|20292542|P2|COMPLETED|Overall Study||34
8229002|NCT02000583|20292543|P1|COMPLETED|Overall Study||75
8229003|NCT02000583|20292542|P2|STARTED|Overall Study||39
8229004|NCT02000583|20292543|P1|STARTED|Overall Study||78
8229005|NCT02000531|20292555|P2|NOT COMPLETED|Overall Study||8
8229006|NCT02000531|20292556|P1|NOT COMPLETED|Overall Study||4
8229007|NCT02000531|20292555|P2|COMPLETED|Overall Study||16
8229008|NCT02000531|20292556|P1|COMPLETED|Overall Study||17
8229009|NCT02000531|20292555|P2|Safety Population|Overall Study||24
8229010|NCT02000531|20292556|P1|Safety Population|Overall Study||21
8229011|NCT02000531|20292555|P2|STARTED|Overall Study||24
8229012|NCT02000531|20292556|P1|STARTED|Overall Study||21
8229013|NCT02000440|20292564|P1|NOT COMPLETED|Overall Study||4
8229014|NCT02000440|20292564|P1|COMPLETED|Overall Study||13
8229015|NCT02000440|20292564|P1|STARTED|Overall Study||17
8229016|NCT02000427|20292584|P1|NOT COMPLETED|Overall Study||22
8229017|NCT02000427|20292584|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
8229018|NCT02000427|20292584|P1|STARTED|Overall Study||45
8229019|NCT02000180|20292601|P2|NOT COMPLETED|Overall Study||0
8229020|NCT02000180|20292602|P1|NOT COMPLETED|Overall Study||0
8229021|NCT02000180|20292601|P2|COMPLETED|Overall Study||19
8229022|NCT02000180|20292602|P1|COMPLETED|Overall Study||18
8229023|NCT02000180|20292601|P2|STARTED|Overall Study||19
8229024|NCT02000180|20292602|P1|STARTED|Overall Study||18
8229025|NCT02000154|20292614|P1|NOT COMPLETED|Overall Study||0
8229026|NCT02000154|20292614|P1|COMPLETED|Overall Study||1
8229027|NCT02000154|20292614|P1|STARTED|Overall Study||1
8229028|NCT02000115|20292625|P4|NOT COMPLETED|Overall Study||53
8229029|NCT02000115|20292626|P3|NOT COMPLETED|Overall Study||1
8229030|NCT02000115|20292627|P2|NOT COMPLETED|Overall Study||68
8229031|NCT02000115|20292628|P1|NOT COMPLETED|Overall Study||79
8229032|NCT02000115|20292625|P4|COMPLETED|Overall Study||0
8229033|NCT02000115|20292626|P3|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
8229034|NCT02000115|20292627|P2|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
8229035|NCT02000115|20292628|P1|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
8229036|NCT02000115|20292625|P4|STARTED|Overall Study||53
8229037|NCT02000115|20292626|P3|STARTED|Overall Study||100
8229038|NCT02000115|20292627|P2|STARTED|Overall Study||369
8229039|NCT02000115|20292628|P1|STARTED|Overall Study||381
8229040|NCT01999985|20292646|P3|NOT COMPLETED|Overall Study||0
8229041|NCT01999985|20292647|P2|NOT COMPLETED|Overall Study||0
8229042|NCT01999985|20292648|P1|NOT COMPLETED|Overall Study||0
8229043|NCT01999985|20292646|P3|COMPLETED|Overall Study||14
8229044|NCT01999985|20292647|P2|COMPLETED|Overall Study||3
8229045|NCT01999985|20292648|P1|COMPLETED|Overall Study||8
8229046|NCT01999985|20292646|P3|STARTED|Overall Study||14
8229047|NCT01999985|20292647|P2|STARTED|Overall Study||3
8229048|NCT01999985|20292648|P1|STARTED|Overall Study||8
8229049|NCT01999972|20292662|P6|NOT COMPLETED|Dose Expansion Part||7
8229050|NCT01999972|20292663|P5|NOT COMPLETED|Dose Expansion Part||21
8229051|NCT01999972|20292664|P4|NOT COMPLETED|Dose Expansion Part||0
8229052|NCT01999972|20292665|P3|NOT COMPLETED|Dose Expansion Part||0
8229053|NCT01999972|20292666|P2|NOT COMPLETED|Dose Expansion Part||0
8229054|NCT01999972|20292667|P1|NOT COMPLETED|Dose Expansion Part||0
8229055|NCT01999972|20292662|P6|COMPLETED|Dose Expansion Part||0
8229056|NCT01999972|20292663|P5|COMPLETED|Dose Expansion Part||0
8229057|NCT01999972|20292664|P4|COMPLETED|Dose Expansion Part||0
8229058|NCT01999972|20292665|P3|COMPLETED|Dose Expansion Part||0
8229059|NCT01999972|20292666|P2|COMPLETED|Dose Expansion Part||0
8229060|NCT01999972|20292667|P1|COMPLETED|Dose Expansion Part||0
8229061|NCT01999972|20292662|P6|Treated|Dose Expansion Part||7
8229062|NCT01999972|20292663|P5|Treated|Dose Expansion Part||21
8229063|NCT01999972|20292664|P4|Treated|Dose Expansion Part||0
8229064|NCT01999972|20292665|P3|Treated|Dose Expansion Part||0
8229065|NCT01999972|20292666|P2|Treated|Dose Expansion Part||0
8229066|NCT01999972|20292667|P1|Treated|Dose Expansion Part||0
8229067|NCT01999972|20292662|P6|STARTED|Dose Expansion Part||7
8229068|NCT01999972|20292663|P5|STARTED|Dose Expansion Part||21
8229069|NCT01999972|20292664|P4|STARTED|Dose Expansion Part||0
8229070|NCT01999972|20292665|P3|STARTED|Dose Expansion Part||0
8229071|NCT01999972|20292666|P2|STARTED|Dose Expansion Part||0
8229072|NCT01999972|20292667|P1|STARTED|Dose Expansion Part||0
8229073|NCT01999972|20292662|P6|NOT COMPLETED|Dose Escalation Part||0
8229074|NCT01999972|20292663|P5|NOT COMPLETED|Dose Escalation Part||0
8229075|NCT01999972|20292664|P4|NOT COMPLETED|Dose Escalation Part||11
8229076|NCT01999972|20292665|P3|NOT COMPLETED|Dose Escalation Part||5
8229077|NCT01999972|20292666|P2|NOT COMPLETED|Dose Escalation Part||3
8229078|NCT01999972|20292667|P1|NOT COMPLETED|Dose Escalation Part||5
8229079|NCT01999972|20292662|P6|COMPLETED|Dose Escalation Part||0
8229080|NCT01999972|20292663|P5|COMPLETED|Dose Escalation Part||0
8229081|NCT01999972|20292664|P4|COMPLETED|Dose Escalation Part||0
8229082|NCT01999972|20292665|P3|COMPLETED|Dose Escalation Part||0
8229083|NCT01999972|20292666|P2|COMPLETED|Dose Escalation Part||0
8229084|NCT01999972|20292667|P1|COMPLETED|Dose Escalation Part||0
8229085|NCT01999972|20292662|P6|Treated|Dose Escalation Part||0
8229086|NCT01999972|20292663|P5|Treated|Dose Escalation Part||0
8229087|NCT01999972|20292664|P4|Treated|Dose Escalation Part||10
8229088|NCT01999972|20292665|P3|Treated|Dose Escalation Part||4
8229089|NCT01999972|20292666|P2|Treated|Dose Escalation Part||3
8229090|NCT01999972|20292667|P1|Treated|Dose Escalation Part||5
8229091|NCT01999972|20292662|P6|STARTED|Dose Escalation Part||0
8229092|NCT01999972|20292663|P5|STARTED|Dose Escalation Part||0
8229093|NCT01999972|20292664|P4|STARTED|Dose Escalation Part||11
8229094|NCT01999972|20292665|P3|STARTED|Dose Escalation Part||5
8229095|NCT01999972|20292666|P2|STARTED|Dose Escalation Part||3
8229096|NCT01999972|20292667|P1|STARTED|Dose Escalation Part||5
8229097|NCT01999946|20292782|P3|NOT COMPLETED|Overall Study||79
8229098|NCT01999946|20292783|P2|NOT COMPLETED|Overall Study||2
8229099|NCT01999946|20292784|P1|NOT COMPLETED|Overall Study||2
8229100|NCT01999946|20292782|P3|COMPLETED|Overall Study||0
8229101|NCT01999946|20292783|P2|COMPLETED|Overall Study||56
8229102|NCT01999946|20292784|P1|COMPLETED|Overall Study||59
8229103|NCT01999946|20292782|P3|STARTED|Overall Study||79
8229104|NCT01999946|20292783|P2|STARTED|Overall Study||58
8229105|NCT01999946|20292784|P1|STARTED|Overall Study||61
8229106|NCT01999920|20292793|P2|NOT COMPLETED|Overall Study||2
8229107|NCT01999920|20292794|P1|NOT COMPLETED|Overall Study||6
8229108|NCT01999920|20292793|P2|COMPLETED|Overall Study||9
8229109|NCT01999920|20292794|P1|COMPLETED|Overall Study||7
8229110|NCT01999920|20292793|P2|STARTED|Overall Study||11
8229111|NCT01999920|20292794|P1|STARTED|Overall Study||13
8229112|NCT01999894|20292810|P1|NOT COMPLETED|Overall Study||36
8229113|NCT01999894|20292810|P1|COMPLETED|Overall Study||66
8229114|NCT01999894|20292810|P1|STARTED|Overall Study||102
8229115|NCT01999868|20292818|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
8229116|NCT01999868|20292819|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
8229117|NCT01999868|20292820|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
8229118|NCT01999868|20292818|P3|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
8229119|NCT01999868|20292819|P2|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
8229120|NCT01999868|20292820|P1|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
8229121|NCT01999868|20292818|P3|STARTED|Blinded Observation Phase (Week 40 - 88)||0
8229122|NCT01999868|20292819|P2|STARTED|Blinded Observation Phase (Week 40 - 88)||35
8229123|NCT01999868|20292820|P1|STARTED|Blinded Observation Phase (Week 40 - 88)||27
8229124|NCT01999868|20292818|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
8229125|NCT01999868|20292819|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
8229126|NCT01999868|20292820|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
8229127|NCT01999868|20292818|P3|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
8229128|NCT01999868|20292819|P2|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
8229129|NCT01999868|20292820|P1|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
8229130|NCT01999868|20292818|P3|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
8229131|NCT01999868|20292819|P2|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
8229132|NCT01999868|20292820|P1|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
8229133|NCT01999868|20292818|P3|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
8229134|NCT01999868|20292819|P2|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
8229135|NCT01999868|20292820|P1|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
8229136|NCT01999868|20292818|P3|COMPLETED|Lead-in Phase (Week 0 - 12)||12
8229137|NCT01999868|20292819|P2|COMPLETED|Lead-in Phase (Week 0 - 12)||46
8229138|NCT01999868|20292820|P1|COMPLETED|Lead-in Phase (Week 0 - 12)||45
8229139|NCT01999868|20292818|P3|STARTED|Lead-in Phase (Week 0 - 12)||17
8229140|NCT01999868|20292819|P2|STARTED|Lead-in Phase (Week 0 - 12)||46
8229141|NCT01999868|20292820|P1|STARTED|Lead-in Phase (Week 0 - 12)||45
8229142|NCT01999777|20292847|P2|NOT COMPLETED|Overall Study||0
8229143|NCT01999777|20292848|P1|NOT COMPLETED|Overall Study||0
8229144|NCT01999777|20292847|P2|COMPLETED|Overall Study||31
8229145|NCT01999777|20292848|P1|COMPLETED|Overall Study||31
8229146|NCT01999777|20292847|P2|STARTED|Overall Study||31
8229147|NCT01999777|20292848|P1|STARTED|Overall Study||31
8229148|NCT01999530|20292856|P1|NOT COMPLETED|Overall Study||13
8229149|NCT01999530|20292856|P1|COMPLETED|Overall Study||7
8229150|NCT01999530|20292856|P1|STARTED|Overall Study||20
8229151|NCT01999517|20292862|P2|NOT COMPLETED|Overall Study||0
8229152|NCT01999517|20292863|P1|NOT COMPLETED|Overall Study||0
8229153|NCT01999517|20292862|P2|COMPLETED|Overall Study||54
8229154|NCT01999517|20292863|P1|COMPLETED|Overall Study||68
8229155|NCT01999517|20292862|P2|STARTED|Overall Study||54
8229156|NCT01999517|20292863|P1|STARTED|Overall Study||68
8229157|NCT01999465|20292871|P2|NOT COMPLETED|Overall Study||3
8229158|NCT01999465|20292872|P1|NOT COMPLETED|Overall Study||0
8229159|NCT01999465|20292871|P2|COMPLETED|Overall Study||7
8229160|NCT01999465|20292872|P1|COMPLETED|Overall Study||10
8229161|NCT01999465|20292871|P2|STARTED|Overall Study||10
8229162|NCT01999465|20292872|P1|STARTED|Overall Study||10
8229163|NCT01999400|20292880|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229164|NCT01999400|20292881|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229165|NCT01999400|20292882|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229166|NCT01999400|20292883|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229167|NCT01999400|20292884|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229168|NCT01999400|20292885|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229169|NCT01999400|20292880|P6|COMPLETED|Fourth Intervention (1 Day)||0
8229170|NCT01999400|20292881|P5|COMPLETED|Fourth Intervention (1 Day)||0
8229171|NCT01999400|20292882|P4|COMPLETED|Fourth Intervention (1 Day)||0
8229172|NCT01999400|20292883|P3|COMPLETED|Fourth Intervention (1 Day)||1
8229173|NCT01999400|20292884|P2|COMPLETED|Fourth Intervention (1 Day)||0
8229174|NCT01999400|20292885|P1|COMPLETED|Fourth Intervention (1 Day)||1
8229175|NCT01999400|20292880|P6|STARTED|Fourth Intervention (1 Day)||0
8229176|NCT01999400|20292881|P5|STARTED|Fourth Intervention (1 Day)||0
8229177|NCT01999400|20292882|P4|STARTED|Fourth Intervention (1 Day)||0
8229178|NCT01999400|20292883|P3|STARTED|Fourth Intervention (1 Day)||1
8229179|NCT01999400|20292884|P2|STARTED|Fourth Intervention (1 Day)||0
8229180|NCT01999400|20292885|P1|STARTED|Fourth Intervention (1 Day)||1
8229181|NCT01999400|20292880|P6|NOT COMPLETED|Washout (10 Days)||0
8229182|NCT01999400|20292881|P5|NOT COMPLETED|Washout (10 Days)||0
8229183|NCT01999400|20292882|P4|NOT COMPLETED|Washout (10 Days)||0
8229184|NCT01999400|20292883|P3|NOT COMPLETED|Washout (10 Days)||0
8229185|NCT01999400|20292884|P2|NOT COMPLETED|Washout (10 Days)||0
8229186|NCT01999400|20292885|P1|NOT COMPLETED|Washout (10 Days)||0
8229187|NCT01999400|20292880|P6|COMPLETED|Washout (10 Days)||0
8229188|NCT01999400|20292881|P5|COMPLETED|Washout (10 Days)||0
8229189|NCT01999400|20292882|P4|COMPLETED|Washout (10 Days)||0
8229190|NCT01999400|20292883|P3|COMPLETED|Washout (10 Days)||1
8229191|NCT01999400|20292884|P2|COMPLETED|Washout (10 Days)||0
8229192|NCT01999400|20292885|P1|COMPLETED|Washout (10 Days)||1
8229193|NCT01999400|20292880|P6|STARTED|Washout (10 Days)||0
8229194|NCT01999400|20292881|P5|STARTED|Washout (10 Days)||0
8229195|NCT01999400|20292882|P4|STARTED|Washout (10 Days)||0
8229196|NCT01999400|20292883|P3|STARTED|Washout (10 Days)||1
8229197|NCT01999400|20292884|P2|STARTED|Washout (10 Days)||0
8229198|NCT01999400|20292885|P1|STARTED|Washout (10 Days)||1
8229199|NCT01999400|20292880|P6|NOT COMPLETED|Third Intervention (1 Day)||1
8229200|NCT01999400|20292881|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8229201|NCT01999400|20292882|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8229202|NCT01999400|20292883|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8229203|NCT01999400|20292884|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8229204|NCT01999400|20292885|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8229205|NCT01999400|20292880|P6|COMPLETED|Third Intervention (1 Day)||0
8229206|NCT01999400|20292881|P5|COMPLETED|Third Intervention (1 Day)||1
8229207|NCT01999400|20292882|P4|COMPLETED|Third Intervention (1 Day)||1
8229208|NCT01999400|20292883|P3|COMPLETED|Third Intervention (1 Day)||1
8229209|NCT01999400|20292884|P2|COMPLETED|Third Intervention (1 Day)||0
8229210|NCT01999400|20292885|P1|COMPLETED|Third Intervention (1 Day)||2
8229211|NCT01999400|20292880|P6|STARTED|Third Intervention (1 Day)||1
8229212|NCT01999400|20292881|P5|STARTED|Third Intervention (1 Day)||1
8229213|NCT01999400|20292882|P4|STARTED|Third Intervention (1 Day)||1
8229214|NCT01999400|20292883|P3|STARTED|Third Intervention (1 Day)||1
8229215|NCT01999400|20292884|P2|STARTED|Third Intervention (1 Day)||0
8229216|NCT01999400|20292885|P1|STARTED|Third Intervention (1 Day)||2
8229217|NCT01999400|20292880|P6|NOT COMPLETED|Washout (10 Days)||0
8229218|NCT01999400|20292881|P5|NOT COMPLETED|Washout (10 Days)||0
8229219|NCT01999400|20292882|P4|NOT COMPLETED|Washout (10 Days)||0
8229220|NCT01999400|20292883|P3|NOT COMPLETED|Washout (10 Days)||0
8229221|NCT01999400|20292884|P2|NOT COMPLETED|Washout (10 Days)||0
8229222|NCT01999400|20292885|P1|NOT COMPLETED|Washout (10 Days)||0
8229223|NCT01999400|20292880|P6|COMPLETED|Washout (10 Days)||1
8229224|NCT01999400|20292881|P5|COMPLETED|Washout (10 Days)||1
8229225|NCT01999400|20292882|P4|COMPLETED|Washout (10 Days)||1
8229226|NCT01999400|20292883|P3|COMPLETED|Washout (10 Days)||1
8229227|NCT01999400|20292884|P2|COMPLETED|Washout (10 Days)||0
8229228|NCT01999400|20292885|P1|COMPLETED|Washout (10 Days)||2
8229229|NCT01999400|20292880|P6|STARTED|Washout (10 Days)||1
8229230|NCT01999400|20292881|P5|STARTED|Washout (10 Days)||1
8229231|NCT01999400|20292882|P4|STARTED|Washout (10 Days)||1
8229232|NCT01999400|20292883|P3|STARTED|Washout (10 Days)||1
8229233|NCT01999400|20292884|P2|STARTED|Washout (10 Days)||0
8229234|NCT01999400|20292885|P1|STARTED|Washout (10 Days)||2
8229235|NCT01999400|20292880|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8229236|NCT01999400|20292881|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8229237|NCT01999400|20292882|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8229238|NCT01999400|20292883|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8229239|NCT01999400|20292884|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8229240|NCT01999400|20292885|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8229241|NCT01999400|20292880|P6|COMPLETED|Second Intervention (1 Day)||3
8229242|NCT01999400|20292881|P5|COMPLETED|Second Intervention (1 Day)||3
8229243|NCT01999400|20292882|P4|COMPLETED|Second Intervention (1 Day)||2
8229244|NCT01999400|20292883|P3|COMPLETED|Second Intervention (1 Day)||3
8229245|NCT01999400|20292884|P2|COMPLETED|Second Intervention (1 Day)||4
8229246|NCT01999400|20292885|P1|COMPLETED|Second Intervention (1 Day)||5
8229247|NCT01999400|20292880|P6|STARTED|Second Intervention (1 Day)||3
8229248|NCT01999400|20292881|P5|STARTED|Second Intervention (1 Day)||3
8229249|NCT01999400|20292882|P4|STARTED|Second Intervention (1 Day)||2
8229250|NCT01999400|20292883|P3|STARTED|Second Intervention (1 Day)||3
8229251|NCT01999400|20292884|P2|STARTED|Second Intervention (1 Day)||4
8229252|NCT01999400|20292885|P1|STARTED|Second Intervention (1 Day)||5
8229253|NCT01999400|20292880|P6|NOT COMPLETED|Washout (10 Days)||0
8229254|NCT01999400|20292881|P5|NOT COMPLETED|Washout (10 Days)||0
8229255|NCT01999400|20292882|P4|NOT COMPLETED|Washout (10 Days)||0
8229256|NCT01999400|20292883|P3|NOT COMPLETED|Washout (10 Days)||0
8229257|NCT01999400|20292884|P2|NOT COMPLETED|Washout (10 Days)||0
8229258|NCT01999400|20292885|P1|NOT COMPLETED|Washout (10 Days)||0
8229259|NCT01999400|20292880|P6|COMPLETED|Washout (10 Days)||3
8229260|NCT01999400|20292881|P5|COMPLETED|Washout (10 Days)||3
8229261|NCT01999400|20292882|P4|COMPLETED|Washout (10 Days)||2
8229262|NCT01999400|20292883|P3|COMPLETED|Washout (10 Days)||3
8229263|NCT01999400|20292884|P2|COMPLETED|Washout (10 Days)||4
8229264|NCT01999400|20292885|P1|COMPLETED|Washout (10 Days)||5
8229265|NCT01999400|20292880|P6|STARTED|Washout (10 Days)||3
8229266|NCT01999400|20292881|P5|STARTED|Washout (10 Days)||3
8229267|NCT01999400|20292882|P4|STARTED|Washout (10 Days)||2
8229268|NCT01999400|20292883|P3|STARTED|Washout (10 Days)||3
8229269|NCT01999400|20292884|P2|STARTED|Washout (10 Days)||4
8229270|NCT01999400|20292885|P1|STARTED|Washout (10 Days)||5
8229271|NCT01999400|20292880|P6|NOT COMPLETED|First Intervention (1 Day)||1
8229272|NCT01999400|20292881|P5|NOT COMPLETED|First Intervention (1 Day)||0
8229273|NCT01999400|20292882|P4|NOT COMPLETED|First Intervention (1 Day)||3
8229274|NCT01999400|20292883|P3|NOT COMPLETED|First Intervention (1 Day)||2
8229275|NCT01999400|20292884|P2|NOT COMPLETED|First Intervention (1 Day)||2
8229276|NCT01999400|20292885|P1|NOT COMPLETED|First Intervention (1 Day)||2
8229277|NCT01999400|20292880|P6|COMPLETED|First Intervention (1 Day)||3
8229278|NCT01999400|20292881|P5|COMPLETED|First Intervention (1 Day)||4
8229279|NCT01999400|20292882|P4|COMPLETED|First Intervention (1 Day)||2
8229280|NCT01999400|20292883|P3|COMPLETED|First Intervention (1 Day)||3
8229281|NCT01999400|20292884|P2|COMPLETED|First Intervention (1 Day)||4
8229282|NCT01999400|20292885|P1|COMPLETED|First Intervention (1 Day)||4
8229283|NCT01999400|20292880|P6|STARTED|First Intervention (1 Day)||4
8229284|NCT01999400|20292881|P5|STARTED|First Intervention (1 Day)||4
8229285|NCT01999400|20292882|P4|STARTED|First Intervention (1 Day)||5
8229286|NCT01999400|20292883|P3|STARTED|First Intervention (1 Day)||5
8229287|NCT01999400|20292884|P2|STARTED|First Intervention (1 Day)||6
8229288|NCT01999400|20292885|P1|STARTED|First Intervention (1 Day)||6
8229289|NCT01999348|20292905|P1|NOT COMPLETED|Overall Study||120
8229290|NCT01999348|20292905|P1|COMPLETED|Overall Study||1433
8229291|NCT01999348|20292905|P1|STARTED|Overall Study||1553
8229292|NCT01999322|20292917|P2|NOT COMPLETED|Overall Study||0
8229293|NCT01999322|20292918|P1|NOT COMPLETED|Overall Study||1
8229294|NCT01999322|20292917|P2|COMPLETED|Overall Study||12
8229295|NCT01999322|20292918|P1|COMPLETED|Overall Study||24
8229296|NCT01999322|20292917|P2|STARTED|Overall Study||12
8229297|NCT01999322|20292918|P1|STARTED|Overall Study||25
8229298|NCT01999231|20292934|P4|NOT COMPLETED|Overall Study||0
8229299|NCT01999231|20292935|P3|NOT COMPLETED|Overall Study||0
8229300|NCT01999231|20292936|P2|NOT COMPLETED|Overall Study||0
8229301|NCT01999231|20292937|P1|NOT COMPLETED|Overall Study||0
8229302|NCT01999231|20292934|P4|COMPLETED|Overall Study||6
8229303|NCT01999231|20292935|P3|COMPLETED|Overall Study||6
8229304|NCT01999231|20292936|P2|COMPLETED|Overall Study||6
8229305|NCT01999231|20292937|P1|COMPLETED|Overall Study||6
8229306|NCT01999231|20292934|P4|STARTED|Overall Study||6
8229307|NCT01999231|20292935|P3|STARTED|Overall Study||6
8229308|NCT01999231|20292936|P2|STARTED|Overall Study||6
8229309|NCT01999231|20292937|P1|STARTED|Overall Study||6
8229310|NCT01999218|20292970|P3|NOT COMPLETED|Overall Study||110
8229311|NCT01999218|20292971|P2|NOT COMPLETED|Overall Study||101
8229312|NCT01999218|20292972|P1|NOT COMPLETED|Overall Study||109
8229313|NCT01999218|20292970|P3|COMPLETED|Overall Study||327
8229314|NCT01999218|20292971|P2|COMPLETED|Overall Study||340
8229315|NCT01999218|20292972|P1|COMPLETED|Overall Study||339
8229316|NCT01999218|20292970|P3|Site Issue|Overall Study||435
8229317|NCT01999218|20292971|P2|Site Issue|Overall Study||435
8229318|NCT01999218|20292972|P1|Site Issue|Overall Study||445
8229319|NCT01999218|20292970|P3|Treated|Overall Study||437
8229320|NCT01999218|20292971|P2|Treated|Overall Study||440
8229321|NCT01999218|20292972|P1|Treated|Overall Study||448
8229322|NCT01999218|20292970|P3|STARTED|Overall Study||437
8229323|NCT01999218|20292971|P2|STARTED|Overall Study||441
8229324|NCT01999218|20292972|P1|STARTED|Overall Study||448
8229325|NCT01999192|20292999|P4|NOT COMPLETED|Extension Phase||0
8229326|NCT01999192|20293000|P3|NOT COMPLETED|Extension Phase||24
8229327|NCT01999192|20293001|P2|NOT COMPLETED|Extension Phase||18
8229328|NCT01999192|20293002|P1|NOT COMPLETED|Extension Phase||13
8229329|NCT01999192|20292999|P4|COMPLETED|Extension Phase||0
8229330|NCT01999192|20293000|P3|COMPLETED|Extension Phase||44
8229331|NCT01999192|20293001|P2|COMPLETED|Extension Phase||38
8229332|NCT01999192|20293002|P1|COMPLETED|Extension Phase||41
8229333|NCT01999192|20292999|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
8229334|NCT01999192|20293000|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
8229335|NCT01999192|20293001|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
8229336|NCT01999192|20293002|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
8229337|NCT01999192|20292999|P4|NOT COMPLETED|Main Phase II||1
8229338|NCT01999192|20293000|P3|NOT COMPLETED|Main Phase II||22
8229339|NCT01999192|20293001|P2|NOT COMPLETED|Main Phase II||9
8229340|NCT01999192|20293002|P1|NOT COMPLETED|Main Phase II||9
8229341|NCT01999192|20292999|P4|COMPLETED|Main Phase II||43
8229342|NCT01999192|20293000|P3|COMPLETED|Main Phase II||76
8229343|NCT01999192|20293001|P2|COMPLETED|Main Phase II||66
8229344|NCT01999192|20293002|P1|COMPLETED|Main Phase II||55
8229345|NCT01999192|20292999|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
8229346|NCT01999192|20293000|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
8229347|NCT01999192|20293001|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
8229348|NCT01999192|20293002|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
8229349|NCT01999192|20292999|P4|NOT COMPLETED|Main Phase I||8
8229350|NCT01999192|20293000|P3|NOT COMPLETED|Main Phase I||8
8229351|NCT01999192|20293001|P2|NOT COMPLETED|Main Phase I||10
8229352|NCT01999192|20293002|P1|NOT COMPLETED|Main Phase I||11
8229353|NCT01999192|20292999|P4|COMPLETED|Main Phase I||72
8229354|NCT01999192|20293000|P3|COMPLETED|Main Phase I||70
8229355|NCT01999192|20293001|P2|COMPLETED|Main Phase I||70
8229356|NCT01999192|20293002|P1|COMPLETED|Main Phase I||72
8229357|NCT01999192|20292999|P4|STARTED|Main Phase I||80
8229358|NCT01999192|20293000|P3|STARTED|Main Phase I||78
8229359|NCT01999192|20293001|P2|STARTED|Main Phase I||80
8229360|NCT01999192|20293002|P1|STARTED|Main Phase I||83
8229361|NCT01999114|20293017|P5|NOT COMPLETED|Overall Study||4
8229362|NCT01999114|20293018|P4|NOT COMPLETED|Overall Study||3
8229363|NCT01999114|20293019|P3|NOT COMPLETED|Overall Study||5
8229364|NCT01999114|20293020|P2|NOT COMPLETED|Overall Study||7
8229365|NCT01999114|20293021|P1|NOT COMPLETED|Overall Study||8
8229366|NCT01999114|20293017|P5|COMPLETED|Overall Study||61
8229367|NCT01999114|20293018|P4|COMPLETED|Overall Study||62
8229368|NCT01999114|20293019|P3|COMPLETED|Overall Study||61
8229369|NCT01999114|20293020|P2|COMPLETED|Overall Study||59
8229370|NCT01999114|20293021|P1|COMPLETED|Overall Study||58
8229371|NCT01999114|20293017|P5|STARTED|Overall Study||65
8229372|NCT01999114|20293018|P4|STARTED|Overall Study||65
8229373|NCT01999114|20293019|P3|STARTED|Overall Study||66
8229374|NCT01999114|20293020|P2|STARTED|Overall Study||66
8229375|NCT01999114|20293021|P1|STARTED|Overall Study||66
8229376|NCT01998984|20293089|P4|NOT COMPLETED|Overall Study||3
8229377|NCT01998984|20293090|P3|NOT COMPLETED|Overall Study||1
8229378|NCT01998984|20293091|P2|NOT COMPLETED|Overall Study||1
8229379|NCT01998984|20293092|P1|NOT COMPLETED|Overall Study||0
8229380|NCT01998984|20293089|P4|COMPLETED|Overall Study||58
8229381|NCT01998984|20293090|P3|COMPLETED|Overall Study||48
8229382|NCT01998984|20293091|P2|COMPLETED|Overall Study||58
8229383|NCT01998984|20293092|P1|COMPLETED|Overall Study||55
8229384|NCT01998984|20293089|P4|STARTED|Overall Study||61
8229385|NCT01998984|20293090|P3|STARTED|Overall Study||49
8229386|NCT01998984|20293091|P2|STARTED|Overall Study||59
8229387|NCT01998984|20293092|P1|STARTED|Overall Study||55
8229388|NCT01998958|20293117|P32|NOT COMPLETED|Follow-up Phase||0
8229389|NCT01998958|20293118|P31|NOT COMPLETED|Follow-up Phase||0
8229390|NCT01998958|20293119|P30|NOT COMPLETED|Follow-up Phase||0
8229391|NCT01998958|20293120|P29|NOT COMPLETED|Follow-up Phase||0
8229392|NCT01998958|20293121|P28|NOT COMPLETED|Follow-up Phase||0
8229393|NCT01998958|20293122|P27|NOT COMPLETED|Follow-up Phase||0
8229394|NCT01998958|20293123|P26|NOT COMPLETED|Follow-up Phase||0
8229395|NCT01998958|20293124|P25|NOT COMPLETED|Follow-up Phase||0
8229396|NCT01998958|20293125|P24|NOT COMPLETED|Follow-up Phase||0
8229397|NCT01998958|20293126|P23|NOT COMPLETED|Follow-up Phase||0
8229398|NCT01998958|20293127|P22|NOT COMPLETED|Follow-up Phase||0
8229399|NCT01998958|20293128|P21|NOT COMPLETED|Follow-up Phase||0
8229400|NCT01998958|20293129|P20|NOT COMPLETED|Follow-up Phase||0
8229401|NCT01998958|20293130|P19|NOT COMPLETED|Follow-up Phase||0
8229402|NCT01998958|20293131|P18|NOT COMPLETED|Follow-up Phase||0
8229403|NCT01998958|20293132|P17|NOT COMPLETED|Follow-up Phase||0
8229404|NCT01998958|20293133|P16|NOT COMPLETED|Follow-up Phase||0
8229405|NCT01998958|20293134|P15|NOT COMPLETED|Follow-up Phase||0
8229406|NCT01998958|20293135|P14|NOT COMPLETED|Follow-up Phase||0
8229407|NCT01998958|20293136|P13|NOT COMPLETED|Follow-up Phase||0
8229408|NCT01998958|20293137|P12|NOT COMPLETED|Follow-up Phase||0
8229409|NCT01998958|20293138|P11|NOT COMPLETED|Follow-up Phase||0
8229410|NCT01998958|20293139|P10|NOT COMPLETED|Follow-up Phase||0
8229411|NCT01998958|20293140|P9|NOT COMPLETED|Follow-up Phase||0
8229412|NCT01998958|20293141|P8|NOT COMPLETED|Follow-up Phase||0
8229413|NCT01998958|20293142|P7|NOT COMPLETED|Follow-up Phase||0
8229414|NCT01998958|20293143|P6|NOT COMPLETED|Follow-up Phase||0
8229415|NCT01998958|20293144|P5|NOT COMPLETED|Follow-up Phase||0
8229416|NCT01998958|20293145|P4|NOT COMPLETED|Follow-up Phase||0
8229417|NCT01998958|20293146|P3|NOT COMPLETED|Follow-up Phase||0
8229418|NCT01998958|20293147|P2|NOT COMPLETED|Follow-up Phase||0
8229419|NCT01998958|20293148|P1|NOT COMPLETED|Follow-up Phase||0
8229420|NCT01998958|20293117|P32|COMPLETED|Follow-up Phase||42
8229421|NCT01998958|20293118|P31|COMPLETED|Follow-up Phase||39
8229422|NCT01998958|20293119|P30|COMPLETED|Follow-up Phase||12
8229423|NCT01998958|20293120|P29|COMPLETED|Follow-up Phase||4
8229424|NCT01998958|20293121|P28|COMPLETED|Follow-up Phase||1
8229425|NCT01998958|20293122|P27|COMPLETED|Follow-up Phase||0
8229426|NCT01998958|20293123|P26|COMPLETED|Follow-up Phase||0
8229427|NCT01998958|20293124|P25|COMPLETED|Follow-up Phase||0
8229428|NCT01998958|20293125|P24|COMPLETED|Follow-up Phase||0
8229429|NCT01998958|20293126|P23|COMPLETED|Follow-up Phase||0
8229430|NCT01998958|20293127|P22|COMPLETED|Follow-up Phase||0
8229431|NCT01998958|20293128|P21|COMPLETED|Follow-up Phase||0
8229432|NCT01998958|20293129|P20|COMPLETED|Follow-up Phase||0
8229433|NCT01998958|20293130|P19|COMPLETED|Follow-up Phase||0
8229434|NCT01998958|20293131|P18|COMPLETED|Follow-up Phase||0
8229435|NCT01998958|20293132|P17|COMPLETED|Follow-up Phase||0
8229436|NCT01998958|20293133|P16|COMPLETED|Follow-up Phase||0
8229437|NCT01998958|20293134|P15|COMPLETED|Follow-up Phase||0
8229438|NCT01998958|20293135|P14|COMPLETED|Follow-up Phase||0
8229439|NCT01998958|20293136|P13|COMPLETED|Follow-up Phase||0
8229440|NCT01998958|20293137|P12|COMPLETED|Follow-up Phase||0
8229441|NCT01998958|20293138|P11|COMPLETED|Follow-up Phase||0
8229442|NCT01998958|20293139|P10|COMPLETED|Follow-up Phase||0
8229443|NCT01998958|20293140|P9|COMPLETED|Follow-up Phase||0
8229444|NCT01998958|20293141|P8|COMPLETED|Follow-up Phase||0
8229445|NCT01998958|20293142|P7|COMPLETED|Follow-up Phase||0
8229446|NCT01998958|20293143|P6|COMPLETED|Follow-up Phase||0
8229447|NCT01998958|20293144|P5|COMPLETED|Follow-up Phase||0
8229448|NCT01998958|20293145|P4|COMPLETED|Follow-up Phase||0
8229449|NCT01998958|20293146|P3|COMPLETED|Follow-up Phase||0
8229450|NCT01998958|20293147|P2|COMPLETED|Follow-up Phase||0
8229451|NCT01998958|20293148|P1|COMPLETED|Follow-up Phase||0
8229452|NCT01998958|20293117|P32|STARTED|Follow-up Phase||42
8229453|NCT01998958|20293118|P31|STARTED|Follow-up Phase||39
8229454|NCT01998958|20293119|P30|STARTED|Follow-up Phase||12
8229455|NCT01998958|20293120|P29|STARTED|Follow-up Phase||4
8229456|NCT01998958|20293121|P28|STARTED|Follow-up Phase||1
8229457|NCT01998958|20293122|P27|STARTED|Follow-up Phase||0
8229458|NCT01998958|20293123|P26|STARTED|Follow-up Phase||0
8229459|NCT01998958|20293124|P25|STARTED|Follow-up Phase||0
8229460|NCT01998958|20293125|P24|STARTED|Follow-up Phase||0
8229461|NCT01998958|20293126|P23|STARTED|Follow-up Phase||0
8229462|NCT01998958|20293127|P22|STARTED|Follow-up Phase||0
8229463|NCT01998958|20293128|P21|STARTED|Follow-up Phase||0
8229464|NCT01998958|20293129|P20|STARTED|Follow-up Phase||0
8229465|NCT01998958|20293130|P19|STARTED|Follow-up Phase||0
8229466|NCT01998958|20293131|P18|STARTED|Follow-up Phase||0
8229467|NCT01998958|20293132|P17|STARTED|Follow-up Phase||0
8229468|NCT01998958|20293133|P16|STARTED|Follow-up Phase||0
8229469|NCT01998958|20293134|P15|STARTED|Follow-up Phase||0
8229470|NCT01998958|20293135|P14|STARTED|Follow-up Phase||0
8229471|NCT01998958|20293136|P13|STARTED|Follow-up Phase||0
8229472|NCT01998958|20293137|P12|STARTED|Follow-up Phase||0
8229473|NCT01998958|20293138|P11|STARTED|Follow-up Phase||0
8229474|NCT01998958|20293139|P10|STARTED|Follow-up Phase||0
8229475|NCT01998958|20293140|P9|STARTED|Follow-up Phase||0
8229476|NCT01998958|20293141|P8|STARTED|Follow-up Phase||0
8229477|NCT01998958|20293142|P7|STARTED|Follow-up Phase||0
8229478|NCT01998958|20293143|P6|STARTED|Follow-up Phase||0
8229479|NCT01998958|20293144|P5|STARTED|Follow-up Phase||0
8229480|NCT01998958|20293145|P4|STARTED|Follow-up Phase||0
8229481|NCT01998958|20293146|P3|STARTED|Follow-up Phase||0
8229482|NCT01998958|20293147|P2|STARTED|Follow-up Phase||0
8229483|NCT01998958|20293148|P1|STARTED|Follow-up Phase||0
8229484|NCT01998958|20293117|P32|NOT COMPLETED|Open Label Phase (Optional)||0
8229485|NCT01998958|20293118|P31|NOT COMPLETED|Open Label Phase (Optional)||0
8229486|NCT01998958|20293119|P30|NOT COMPLETED|Open Label Phase (Optional)||0
8229487|NCT01998958|20293120|P29|NOT COMPLETED|Open Label Phase (Optional)||0
8229488|NCT01998958|20293121|P28|NOT COMPLETED|Open Label Phase (Optional)||0
8229489|NCT01998958|20293122|P27|NOT COMPLETED|Open Label Phase (Optional)||0
8229490|NCT01998958|20293123|P26|NOT COMPLETED|Open Label Phase (Optional)||0
8229491|NCT01998958|20293124|P25|NOT COMPLETED|Open Label Phase (Optional)||0
8229492|NCT01998958|20293125|P24|NOT COMPLETED|Open Label Phase (Optional)||4
8229493|NCT01998958|20293126|P23|NOT COMPLETED|Open Label Phase (Optional)||9
8229494|NCT01998958|20293127|P22|NOT COMPLETED|Open Label Phase (Optional)||3
8229495|NCT01998958|20293128|P21|NOT COMPLETED|Open Label Phase (Optional)||0
8229496|NCT01998958|20293129|P20|NOT COMPLETED|Open Label Phase (Optional)||0
8229497|NCT01998958|20293130|P19|NOT COMPLETED|Open Label Phase (Optional)||0
8229498|NCT01998958|20293131|P18|NOT COMPLETED|Open Label Phase (Optional)||0
8229499|NCT01998958|20293132|P17|NOT COMPLETED|Open Label Phase (Optional)||0
8229500|NCT01998958|20293133|P16|NOT COMPLETED|Open Label Phase (Optional)||0
8229501|NCT01998958|20293134|P15|NOT COMPLETED|Open Label Phase (Optional)||0
8229502|NCT01998958|20293135|P14|NOT COMPLETED|Open Label Phase (Optional)||0
8229503|NCT01998958|20293136|P13|NOT COMPLETED|Open Label Phase (Optional)||0
8229504|NCT01998958|20293137|P12|NOT COMPLETED|Open Label Phase (Optional)||0
8229505|NCT01998958|20293138|P11|NOT COMPLETED|Open Label Phase (Optional)||0
8229506|NCT01998958|20293139|P10|NOT COMPLETED|Open Label Phase (Optional)||0
8229507|NCT01998958|20293140|P9|NOT COMPLETED|Open Label Phase (Optional)||0
8229508|NCT01998958|20293141|P8|NOT COMPLETED|Open Label Phase (Optional)||0
8229509|NCT01998958|20293142|P7|NOT COMPLETED|Open Label Phase (Optional)||0
8229510|NCT01998958|20293143|P6|NOT COMPLETED|Open Label Phase (Optional)||0
8229511|NCT01998958|20293144|P5|NOT COMPLETED|Open Label Phase (Optional)||0
8229512|NCT01998958|20293145|P4|NOT COMPLETED|Open Label Phase (Optional)||0
8229513|NCT01998958|20293146|P3|NOT COMPLETED|Open Label Phase (Optional)||0
8229514|NCT01998958|20293147|P2|NOT COMPLETED|Open Label Phase (Optional)||0
8229515|NCT01998958|20293148|P1|NOT COMPLETED|Open Label Phase (Optional)||0
8229516|NCT01998958|20293117|P32|COMPLETED|Open Label Phase (Optional)||0
8229517|NCT01998958|20293118|P31|COMPLETED|Open Label Phase (Optional)||0
8229518|NCT01998958|20293119|P30|COMPLETED|Open Label Phase (Optional)||0
8229519|NCT01998958|20293120|P29|COMPLETED|Open Label Phase (Optional)||0
8229520|NCT01998958|20293121|P28|COMPLETED|Open Label Phase (Optional)||0
8229521|NCT01998958|20293122|P27|COMPLETED|Open Label Phase (Optional)||19
8229522|NCT01998958|20293123|P26|COMPLETED|Open Label Phase (Optional)||7
8229523|NCT01998958|20293124|P25|COMPLETED|Open Label Phase (Optional)||13
8229524|NCT01998958|20293125|P24|COMPLETED|Open Label Phase (Optional)||23
8229525|NCT01998958|20293126|P23|COMPLETED|Open Label Phase (Optional)||11
8229526|NCT01998958|20293127|P22|COMPLETED|Open Label Phase (Optional)||7
8229527|NCT01998958|20293128|P21|COMPLETED|Open Label Phase (Optional)||0
8229528|NCT01998958|20293129|P20|COMPLETED|Open Label Phase (Optional)||0
8229529|NCT01998958|20293130|P19|COMPLETED|Open Label Phase (Optional)||0
8229530|NCT01998958|20293131|P18|COMPLETED|Open Label Phase (Optional)||0
8229531|NCT01998958|20293132|P17|COMPLETED|Open Label Phase (Optional)||0
8229532|NCT01998958|20293133|P16|COMPLETED|Open Label Phase (Optional)||0
8229533|NCT01998958|20293134|P15|COMPLETED|Open Label Phase (Optional)||0
8229534|NCT01998958|20293135|P14|COMPLETED|Open Label Phase (Optional)||0
8229535|NCT01998958|20293136|P13|COMPLETED|Open Label Phase (Optional)||0
8229536|NCT01998958|20293137|P12|COMPLETED|Open Label Phase (Optional)||0
8229537|NCT01998958|20293138|P11|COMPLETED|Open Label Phase (Optional)||0
8229538|NCT01998958|20293139|P10|COMPLETED|Open Label Phase (Optional)||0
8229539|NCT01998958|20293140|P9|COMPLETED|Open Label Phase (Optional)||0
8229540|NCT01998958|20293141|P8|COMPLETED|Open Label Phase (Optional)||0
8229541|NCT01998958|20293142|P7|COMPLETED|Open Label Phase (Optional)||0
8229542|NCT01998958|20293143|P6|COMPLETED|Open Label Phase (Optional)||0
8229543|NCT01998958|20293144|P5|COMPLETED|Open Label Phase (Optional)||0
8229544|NCT01998958|20293145|P4|COMPLETED|Open Label Phase (Optional)||0
8229545|NCT01998958|20293146|P3|COMPLETED|Open Label Phase (Optional)||0
8229546|NCT01998958|20293147|P2|COMPLETED|Open Label Phase (Optional)||0
8229547|NCT01998958|20293148|P1|COMPLETED|Open Label Phase (Optional)||0
8229548|NCT01998958|20293117|P32|STARTED|Open Label Phase (Optional)||0
8229549|NCT01998958|20293118|P31|STARTED|Open Label Phase (Optional)||0
8229550|NCT01998958|20293119|P30|STARTED|Open Label Phase (Optional)||0
8229551|NCT01998958|20293120|P29|STARTED|Open Label Phase (Optional)||0
8229552|NCT01998958|20293121|P28|STARTED|Open Label Phase (Optional)||0
8229553|NCT01998958|20293122|P27|STARTED|Open Label Phase (Optional)||19
8229554|NCT01998958|20293123|P26|STARTED|Open Label Phase (Optional)||7
8229555|NCT01998958|20293124|P25|STARTED|Open Label Phase (Optional)||13
8229556|NCT01998958|20293125|P24|STARTED|Open Label Phase (Optional)||27
8229557|NCT01998958|20293126|P23|STARTED|Open Label Phase (Optional)||20
8229558|NCT01998958|20293127|P22|STARTED|Open Label Phase (Optional)||10
8229559|NCT01998958|20293128|P21|STARTED|Open Label Phase (Optional)||0
8229560|NCT01998958|20293129|P20|STARTED|Open Label Phase (Optional)||0
8229561|NCT01998958|20293130|P19|STARTED|Open Label Phase (Optional)||0
8229562|NCT01998958|20293131|P18|STARTED|Open Label Phase (Optional)||0
8229563|NCT01998958|20293132|P17|STARTED|Open Label Phase (Optional)||0
8229564|NCT01998958|20293133|P16|STARTED|Open Label Phase (Optional)||0
8229565|NCT01998958|20293134|P15|STARTED|Open Label Phase (Optional)||0
8229566|NCT01998958|20293135|P14|STARTED|Open Label Phase (Optional)||0
8229567|NCT01998958|20293136|P13|STARTED|Open Label Phase (Optional)||0
8229568|NCT01998958|20293137|P12|STARTED|Open Label Phase (Optional)||0
8229569|NCT01998958|20293138|P11|STARTED|Open Label Phase (Optional)||0
8229570|NCT01998958|20293139|P10|STARTED|Open Label Phase (Optional)||0
8229571|NCT01998958|20293140|P9|STARTED|Open Label Phase (Optional)||0
8229572|NCT01998958|20293141|P8|STARTED|Open Label Phase (Optional)||0
8229573|NCT01998958|20293142|P7|STARTED|Open Label Phase (Optional)||0
8229574|NCT01998958|20293143|P6|STARTED|Open Label Phase (Optional)||0
8229575|NCT01998958|20293144|P5|STARTED|Open Label Phase (Optional)||0
8229576|NCT01998958|20293145|P4|STARTED|Open Label Phase (Optional)||0
8229577|NCT01998958|20293146|P3|STARTED|Open Label Phase (Optional)||0
8229578|NCT01998958|20293147|P2|STARTED|Open Label Phase (Optional)||0
8229579|NCT01998958|20293148|P1|STARTED|Open Label Phase (Optional)||0
8229580|NCT01998958|20293117|P32|NOT COMPLETED|Period 2 (Panel A and B)||0
8229581|NCT01998958|20293118|P31|NOT COMPLETED|Period 2 (Panel A and B)||0
8229582|NCT01998958|20293119|P30|NOT COMPLETED|Period 2 (Panel A and B)||0
8229583|NCT01998958|20293120|P29|NOT COMPLETED|Period 2 (Panel A and B)||0
8229584|NCT01998958|20293121|P28|NOT COMPLETED|Period 2 (Panel A and B)||0
8229585|NCT01998958|20293122|P27|NOT COMPLETED|Period 2 (Panel A and B)||0
8229586|NCT01998958|20293123|P26|NOT COMPLETED|Period 2 (Panel A and B)||0
8229587|NCT01998958|20293124|P25|NOT COMPLETED|Period 2 (Panel A and B)||0
8229588|NCT01998958|20293125|P24|NOT COMPLETED|Period 2 (Panel A and B)||0
8229589|NCT01998958|20293126|P23|NOT COMPLETED|Period 2 (Panel A and B)||0
8229590|NCT01998958|20293127|P22|NOT COMPLETED|Period 2 (Panel A and B)||0
8229591|NCT01998958|20293128|P21|NOT COMPLETED|Period 2 (Panel A and B)||0
8229592|NCT01998958|20293129|P20|NOT COMPLETED|Period 2 (Panel A and B)||0
8229593|NCT01998958|20293130|P19|NOT COMPLETED|Period 2 (Panel A and B)||1
8229594|NCT01998958|20293131|P18|NOT COMPLETED|Period 2 (Panel A and B)||0
8229595|NCT01998958|20293132|P17|NOT COMPLETED|Period 2 (Panel A and B)||0
8229596|NCT01998958|20293133|P16|NOT COMPLETED|Period 2 (Panel A and B)||0
8229597|NCT01998958|20293134|P15|NOT COMPLETED|Period 2 (Panel A and B)||2
8229598|NCT01998958|20293135|P14|NOT COMPLETED|Period 2 (Panel A and B)||0
8229599|NCT01998958|20293136|P13|NOT COMPLETED|Period 2 (Panel A and B)||0
8229600|NCT01998958|20293137|P12|NOT COMPLETED|Period 2 (Panel A and B)||0
8229601|NCT01998958|20293138|P11|NOT COMPLETED|Period 2 (Panel A and B)||1
8229602|NCT01998958|20293139|P10|NOT COMPLETED|Period 2 (Panel A and B)||0
8229603|NCT01998958|20293140|P9|NOT COMPLETED|Period 2 (Panel A and B)||0
8229604|NCT01998958|20293141|P8|NOT COMPLETED|Period 2 (Panel A and B)||0
8229605|NCT01998958|20293142|P7|NOT COMPLETED|Period 2 (Panel A and B)||0
8229606|NCT01998958|20293143|P6|NOT COMPLETED|Period 2 (Panel A and B)||0
8229607|NCT01998958|20293144|P5|NOT COMPLETED|Period 2 (Panel A and B)||0
8229608|NCT01998958|20293145|P4|NOT COMPLETED|Period 2 (Panel A and B)||0
8229609|NCT01998958|20293146|P3|NOT COMPLETED|Period 2 (Panel A and B)||0
8229610|NCT01998958|20293147|P2|NOT COMPLETED|Period 2 (Panel A and B)||0
8229611|NCT01998958|20293148|P1|NOT COMPLETED|Period 2 (Panel A and B)||0
8229612|NCT01998958|20293117|P32|COMPLETED|Period 2 (Panel A and B)||0
8229613|NCT01998958|20293118|P31|COMPLETED|Period 2 (Panel A and B)||0
8229614|NCT01998958|20293119|P30|COMPLETED|Period 2 (Panel A and B)||0
8229615|NCT01998958|20293120|P29|COMPLETED|Period 2 (Panel A and B)||0
8229616|NCT01998958|20293121|P28|COMPLETED|Period 2 (Panel A and B)||0
8229617|NCT01998958|20293122|P27|COMPLETED|Period 2 (Panel A and B)||0
8229618|NCT01998958|20293123|P26|COMPLETED|Period 2 (Panel A and B)||0
8229619|NCT01998958|20293124|P25|COMPLETED|Period 2 (Panel A and B)||0
8229620|NCT01998958|20293125|P24|COMPLETED|Period 2 (Panel A and B)||0
8229621|NCT01998958|20293126|P23|COMPLETED|Period 2 (Panel A and B)||0
8229622|NCT01998958|20293127|P22|COMPLETED|Period 2 (Panel A and B)||0
8229623|NCT01998958|20293128|P21|COMPLETED|Period 2 (Panel A and B)||9
8229624|NCT01998958|20293129|P20|COMPLETED|Period 2 (Panel A and B)||11
8229625|NCT01998958|20293130|P19|COMPLETED|Period 2 (Panel A and B)||2
8229626|NCT01998958|20293131|P18|COMPLETED|Period 2 (Panel A and B)||5
8229627|NCT01998958|20293132|P17|COMPLETED|Period 2 (Panel A and B)||8
8229628|NCT01998958|20293133|P16|COMPLETED|Period 2 (Panel A and B)||5
8229629|NCT01998958|20293134|P15|COMPLETED|Period 2 (Panel A and B)||10
8229630|NCT01998958|20293135|P14|COMPLETED|Period 2 (Panel A and B)||11
8229631|NCT01998958|20293136|P13|COMPLETED|Period 2 (Panel A and B)||8
8229632|NCT01998958|20293137|P12|COMPLETED|Period 2 (Panel A and B)||5
8229633|NCT01998958|20293138|P11|COMPLETED|Period 2 (Panel A and B)||8
8229634|NCT01998958|20293139|P10|COMPLETED|Period 2 (Panel A and B)||8
8229635|NCT01998958|20293140|P9|COMPLETED|Period 2 (Panel A and B)||4
8229636|NCT01998958|20293141|P8|COMPLETED|Period 2 (Panel A and B)||6
8229637|NCT01998958|20293142|P7|COMPLETED|Period 2 (Panel A and B)||0
8229638|NCT01998958|20293143|P6|COMPLETED|Period 2 (Panel A and B)||0
8229639|NCT01998958|20293144|P5|COMPLETED|Period 2 (Panel A and B)||0
8229640|NCT01998958|20293145|P4|COMPLETED|Period 2 (Panel A and B)||0
8229641|NCT01998958|20293146|P3|COMPLETED|Period 2 (Panel A and B)||0
8229642|NCT01998958|20293147|P2|COMPLETED|Period 2 (Panel A and B)||0
8229643|NCT01998958|20293148|P1|COMPLETED|Period 2 (Panel A and B)||0
8229644|NCT01998958|20293117|P32|STARTED|Period 2 (Panel A and B)||0
8229645|NCT01998958|20293118|P31|STARTED|Period 2 (Panel A and B)||0
8229646|NCT01998958|20293119|P30|STARTED|Period 2 (Panel A and B)||0
8229647|NCT01998958|20293120|P29|STARTED|Period 2 (Panel A and B)||0
8229648|NCT01998958|20293121|P28|STARTED|Period 2 (Panel A and B)||0
8229649|NCT01998958|20293122|P27|STARTED|Period 2 (Panel A and B)||0
8229650|NCT01998958|20293123|P26|STARTED|Period 2 (Panel A and B)||0
8229651|NCT01998958|20293124|P25|STARTED|Period 2 (Panel A and B)||0
8229652|NCT01998958|20293125|P24|STARTED|Period 2 (Panel A and B)||0
8229653|NCT01998958|20293126|P23|STARTED|Period 2 (Panel A and B)||0
8229654|NCT01998958|20293127|P22|STARTED|Period 2 (Panel A and B)||0
8229655|NCT01998958|20293128|P21|STARTED|Period 2 (Panel A and B)||9
8229656|NCT01998958|20293129|P20|STARTED|Period 2 (Panel A and B)||11
8229657|NCT01998958|20293130|P19|STARTED|Period 2 (Panel A and B)||3
8229658|NCT01998958|20293131|P18|STARTED|Period 2 (Panel A and B)||5
8229659|NCT01998958|20293132|P17|STARTED|Period 2 (Panel A and B)||8
8229660|NCT01998958|20293133|P16|STARTED|Period 2 (Panel A and B)||5
8229661|NCT01998958|20293134|P15|STARTED|Period 2 (Panel A and B)||12
8229662|NCT01998958|20293135|P14|STARTED|Period 2 (Panel A and B)||11
8229663|NCT01998958|20293136|P13|STARTED|Period 2 (Panel A and B)||8
8229664|NCT01998958|20293137|P12|STARTED|Period 2 (Panel A and B)||5
8229665|NCT01998958|20293138|P11|STARTED|Period 2 (Panel A and B)||9
8229666|NCT01998958|20293139|P10|STARTED|Period 2 (Panel A and B)||8
8229667|NCT01998958|20293140|P9|STARTED|Period 2 (Panel A and B)||4
8229668|NCT01998958|20293141|P8|STARTED|Period 2 (Panel A and B)||6
8229669|NCT01998958|20293142|P7|STARTED|Period 2 (Panel A and B)||0
8229670|NCT01998958|20293143|P6|STARTED|Period 2 (Panel A and B)||0
8229671|NCT01998958|20293144|P5|STARTED|Period 2 (Panel A and B)||0
8229672|NCT01998958|20293145|P4|STARTED|Period 2 (Panel A and B)||0
8229673|NCT01998958|20293146|P3|STARTED|Period 2 (Panel A and B)||0
8229674|NCT01998958|20293147|P2|STARTED|Period 2 (Panel A and B)||0
8229675|NCT01998958|20293148|P1|STARTED|Period 2 (Panel A and B)||0
8229676|NCT01998958|20293117|P32|NOT COMPLETED|Period 1 (Panel A and B)||0
8229677|NCT01998958|20293118|P31|NOT COMPLETED|Period 1 (Panel A and B)||0
8229678|NCT01998958|20293119|P30|NOT COMPLETED|Period 1 (Panel A and B)||0
8229679|NCT01998958|20293120|P29|NOT COMPLETED|Period 1 (Panel A and B)||0
8229680|NCT01998958|20293121|P28|NOT COMPLETED|Period 1 (Panel A and B)||0
8229681|NCT01998958|20293122|P27|NOT COMPLETED|Period 1 (Panel A and B)||0
8229682|NCT01998958|20293123|P26|NOT COMPLETED|Period 1 (Panel A and B)||0
8229683|NCT01998958|20293124|P25|NOT COMPLETED|Period 1 (Panel A and B)||0
8229684|NCT01998958|20293125|P24|NOT COMPLETED|Period 1 (Panel A and B)||0
8229685|NCT01998958|20293126|P23|NOT COMPLETED|Period 1 (Panel A and B)||0
8229686|NCT01998958|20293127|P22|NOT COMPLETED|Period 1 (Panel A and B)||0
8229687|NCT01998958|20293128|P21|NOT COMPLETED|Period 1 (Panel A and B)||0
8229688|NCT01998958|20293129|P20|NOT COMPLETED|Period 1 (Panel A and B)||0
8229689|NCT01998958|20293130|P19|NOT COMPLETED|Period 1 (Panel A and B)||0
8229690|NCT01998958|20293131|P18|NOT COMPLETED|Period 1 (Panel A and B)||0
8229691|NCT01998958|20293132|P17|NOT COMPLETED|Period 1 (Panel A and B)||0
8229692|NCT01998958|20293133|P16|NOT COMPLETED|Period 1 (Panel A and B)||0
8229693|NCT01998958|20293134|P15|NOT COMPLETED|Period 1 (Panel A and B)||0
8229694|NCT01998958|20293135|P14|NOT COMPLETED|Period 1 (Panel A and B)||0
8229695|NCT01998958|20293136|P13|NOT COMPLETED|Period 1 (Panel A and B)||0
8229696|NCT01998958|20293137|P12|NOT COMPLETED|Period 1 (Panel A and B)||0
8229697|NCT01998958|20293138|P11|NOT COMPLETED|Period 1 (Panel A and B)||0
8229698|NCT01998958|20293139|P10|NOT COMPLETED|Period 1 (Panel A and B)||0
8229699|NCT01998958|20293140|P9|NOT COMPLETED|Period 1 (Panel A and B)||0
8229700|NCT01998958|20293141|P8|NOT COMPLETED|Period 1 (Panel A and B)||0
8229701|NCT01998958|20293142|P7|NOT COMPLETED|Period 1 (Panel A and B)||0
8229702|NCT01998958|20293143|P6|NOT COMPLETED|Period 1 (Panel A and B)||0
8229703|NCT01998958|20293144|P5|NOT COMPLETED|Period 1 (Panel A and B)||0
8229704|NCT01998958|20293145|P4|NOT COMPLETED|Period 1 (Panel A and B)||0
8229705|NCT01998958|20293146|P3|NOT COMPLETED|Period 1 (Panel A and B)||0
8229706|NCT01998958|20293147|P2|NOT COMPLETED|Period 1 (Panel A and B)||3
8229707|NCT01998958|20293148|P1|NOT COMPLETED|Period 1 (Panel A and B)||1
8229708|NCT01998958|20293117|P32|COMPLETED|Period 1 (Panel A and B)||0
8229709|NCT01998958|20293118|P31|COMPLETED|Period 1 (Panel A and B)||0
8229710|NCT01998958|20293119|P30|COMPLETED|Period 1 (Panel A and B)||0
8229711|NCT01998958|20293120|P29|COMPLETED|Period 1 (Panel A and B)||0
8229712|NCT01998958|20293121|P28|COMPLETED|Period 1 (Panel A and B)||0
8229713|NCT01998958|20293122|P27|COMPLETED|Period 1 (Panel A and B)||0
8229714|NCT01998958|20293123|P26|COMPLETED|Period 1 (Panel A and B)||0
8229715|NCT01998958|20293124|P25|COMPLETED|Period 1 (Panel A and B)||0
8229716|NCT01998958|20293125|P24|COMPLETED|Period 1 (Panel A and B)||0
8229717|NCT01998958|20293126|P23|COMPLETED|Period 1 (Panel A and B)||0
8229718|NCT01998958|20293127|P22|COMPLETED|Period 1 (Panel A and B)||0
8229719|NCT01998958|20293128|P21|COMPLETED|Period 1 (Panel A and B)||0
8229720|NCT01998958|20293129|P20|COMPLETED|Period 1 (Panel A and B)||0
8229721|NCT01998958|20293130|P19|COMPLETED|Period 1 (Panel A and B)||0
8229722|NCT01998958|20293131|P18|COMPLETED|Period 1 (Panel A and B)||0
8229723|NCT01998958|20293132|P17|COMPLETED|Period 1 (Panel A and B)||0
8229724|NCT01998958|20293133|P16|COMPLETED|Period 1 (Panel A and B)||0
8229725|NCT01998958|20293134|P15|COMPLETED|Period 1 (Panel A and B)||0
8229726|NCT01998958|20293135|P14|COMPLETED|Period 1 (Panel A and B)||0
8229727|NCT01998958|20293136|P13|COMPLETED|Period 1 (Panel A and B)||0
8229728|NCT01998958|20293137|P12|COMPLETED|Period 1 (Panel A and B)||0
8229729|NCT01998958|20293138|P11|COMPLETED|Period 1 (Panel A and B)||0
8229730|NCT01998958|20293139|P10|COMPLETED|Period 1 (Panel A and B)||0
8229731|NCT01998958|20293140|P9|COMPLETED|Period 1 (Panel A and B)||0
8229732|NCT01998958|20293141|P8|COMPLETED|Period 1 (Panel A and B)||0
8229733|NCT01998958|20293142|P7|COMPLETED|Period 1 (Panel A and B)||9
8229734|NCT01998958|20293143|P6|COMPLETED|Period 1 (Panel A and B)||11
8229735|NCT01998958|20293144|P5|COMPLETED|Period 1 (Panel A and B)||21
8229736|NCT01998958|20293145|P4|COMPLETED|Period 1 (Panel A and B)||12
8229737|NCT01998958|20293146|P3|COMPLETED|Period 1 (Panel A and B)||11
8229738|NCT01998958|20293147|P2|COMPLETED|Period 1 (Panel A and B)||8
8229739|NCT01998958|20293148|P1|COMPLETED|Period 1 (Panel A and B)||32
8229740|NCT01998958|20293117|P32|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229741|NCT01998958|20293118|P31|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229742|NCT01998958|20293119|P30|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229743|NCT01998958|20293120|P29|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229744|NCT01998958|20293121|P28|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229745|NCT01998958|20293122|P27|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229746|NCT01998958|20293123|P26|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229747|NCT01998958|20293124|P25|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229748|NCT01998958|20293125|P24|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229749|NCT01998958|20293126|P23|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229750|NCT01998958|20293127|P22|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229751|NCT01998958|20293128|P21|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229752|NCT01998958|20293129|P20|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229753|NCT01998958|20293130|P19|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229754|NCT01998958|20293131|P18|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229755|NCT01998958|20293132|P17|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229756|NCT01998958|20293133|P16|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229757|NCT01998958|20293134|P15|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229758|NCT01998958|20293135|P14|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229759|NCT01998958|20293136|P13|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229760|NCT01998958|20293137|P12|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229761|NCT01998958|20293138|P11|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229762|NCT01998958|20293139|P10|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229763|NCT01998958|20293140|P9|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229764|NCT01998958|20293141|P8|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229765|NCT01998958|20293142|P7|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229766|NCT01998958|20293143|P6|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229767|NCT01998958|20293144|P5|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229768|NCT01998958|20293145|P4|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229769|NCT01998958|20293146|P3|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229770|NCT01998958|20293147|P2|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229771|NCT01998958|20293148|P1|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
8229772|NCT01998958|20293117|P32|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229773|NCT01998958|20293118|P31|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229774|NCT01998958|20293119|P30|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229775|NCT01998958|20293120|P29|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229776|NCT01998958|20293121|P28|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229777|NCT01998958|20293122|P27|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229778|NCT01998958|20293123|P26|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229852|NCT01998958|20293133|P16|STARTED|Period 1 (Panel A and B)||0
8229779|NCT01998958|20293124|P25|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229780|NCT01998958|20293125|P24|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229781|NCT01998958|20293126|P23|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229782|NCT01998958|20293127|P22|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229783|NCT01998958|20293128|P21|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229784|NCT01998958|20293129|P20|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229785|NCT01998958|20293130|P19|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229786|NCT01998958|20293131|P18|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229787|NCT01998958|20293132|P17|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229788|NCT01998958|20293133|P16|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229789|NCT01998958|20293134|P15|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229790|NCT01998958|20293135|P14|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229791|NCT01998958|20293136|P13|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229792|NCT01998958|20293137|P12|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229793|NCT01998958|20293138|P11|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229794|NCT01998958|20293139|P10|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229795|NCT01998958|20293140|P9|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229796|NCT01998958|20293141|P8|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229797|NCT01998958|20293142|P7|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229798|NCT01998958|20293143|P6|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229799|NCT01998958|20293144|P5|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229800|NCT01998958|20293145|P4|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229801|NCT01998958|20293146|P3|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229802|NCT01998958|20293147|P2|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229803|NCT01998958|20293148|P1|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
8229804|NCT01998958|20293117|P32|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229805|NCT01998958|20293118|P31|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229806|NCT01998958|20293119|P30|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229807|NCT01998958|20293120|P29|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229808|NCT01998958|20293121|P28|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229809|NCT01998958|20293122|P27|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229810|NCT01998958|20293123|P26|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229811|NCT01998958|20293124|P25|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229812|NCT01998958|20293125|P24|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229813|NCT01998958|20293126|P23|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229814|NCT01998958|20293127|P22|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229815|NCT01998958|20293128|P21|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229816|NCT01998958|20293129|P20|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229817|NCT01998958|20293130|P19|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229818|NCT01998958|20293131|P18|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229819|NCT01998958|20293132|P17|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229820|NCT01998958|20293133|P16|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229821|NCT01998958|20293134|P15|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229822|NCT01998958|20293135|P14|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229823|NCT01998958|20293136|P13|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229824|NCT01998958|20293137|P12|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229825|NCT01998958|20293138|P11|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229826|NCT01998958|20293139|P10|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229827|NCT01998958|20293140|P9|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229828|NCT01998958|20293141|P8|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229829|NCT01998958|20293142|P7|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229830|NCT01998958|20293143|P6|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229831|NCT01998958|20293144|P5|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229832|NCT01998958|20293145|P4|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229833|NCT01998958|20293146|P3|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229834|NCT01998958|20293147|P2|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229835|NCT01998958|20293148|P1|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
8229836|NCT01998958|20293117|P32|STARTED|Period 1 (Panel A and B)||0
8229837|NCT01998958|20293118|P31|STARTED|Period 1 (Panel A and B)||0
8229838|NCT01998958|20293119|P30|STARTED|Period 1 (Panel A and B)||0
8229839|NCT01998958|20293120|P29|STARTED|Period 1 (Panel A and B)||0
8229840|NCT01998958|20293121|P28|STARTED|Period 1 (Panel A and B)||0
8229841|NCT01998958|20293122|P27|STARTED|Period 1 (Panel A and B)||0
8229842|NCT01998958|20293123|P26|STARTED|Period 1 (Panel A and B)||0
8229843|NCT01998958|20293124|P25|STARTED|Period 1 (Panel A and B)||0
8229844|NCT01998958|20293125|P24|STARTED|Period 1 (Panel A and B)||0
8229845|NCT01998958|20293126|P23|STARTED|Period 1 (Panel A and B)||0
8229846|NCT01998958|20293127|P22|STARTED|Period 1 (Panel A and B)||0
8229847|NCT01998958|20293128|P21|STARTED|Period 1 (Panel A and B)||0
8229848|NCT01998958|20293129|P20|STARTED|Period 1 (Panel A and B)||0
8229849|NCT01998958|20293130|P19|STARTED|Period 1 (Panel A and B)||0
8229850|NCT01998958|20293131|P18|STARTED|Period 1 (Panel A and B)||0
8229851|NCT01998958|20293132|P17|STARTED|Period 1 (Panel A and B)||0
8229853|NCT01998958|20293134|P15|STARTED|Period 1 (Panel A and B)||0
8229854|NCT01998958|20293135|P14|STARTED|Period 1 (Panel A and B)||0
8229855|NCT01998958|20293136|P13|STARTED|Period 1 (Panel A and B)||0
8229856|NCT01998958|20293137|P12|STARTED|Period 1 (Panel A and B)||0
8229857|NCT01998958|20293138|P11|STARTED|Period 1 (Panel A and B)||0
8229858|NCT01998958|20293139|P10|STARTED|Period 1 (Panel A and B)||0
8229859|NCT01998958|20293140|P9|STARTED|Period 1 (Panel A and B)||0
8229860|NCT01998958|20293141|P8|STARTED|Period 1 (Panel A and B)||0
8229861|NCT01998958|20293142|P7|STARTED|Period 1 (Panel A and B)||9
8229862|NCT01998958|20293143|P6|STARTED|Period 1 (Panel A and B)||11
8229863|NCT01998958|20293144|P5|STARTED|Period 1 (Panel A and B)||21
8229864|NCT01998958|20293145|P4|STARTED|Period 1 (Panel A and B)||12
8229865|NCT01998958|20293146|P3|STARTED|Period 1 (Panel A and B)||11
8229866|NCT01998958|20293147|P2|STARTED|Period 1 (Panel A and B)||11
8229867|NCT01998958|20293148|P1|STARTED|Period 1 (Panel A and B)||33
8229868|NCT01998919|20293287|P2|NOT COMPLETED|Overall Study||35
8229869|NCT01998919|20293288|P1|NOT COMPLETED|Overall Study||42
8229870|NCT01998919|20293287|P2|COMPLETED|Overall Study||39
8229871|NCT01998919|20293288|P1|COMPLETED|Overall Study||37
8229872|NCT01998919|20293287|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
8229873|NCT01998919|20293288|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
8229874|NCT01998919|20293287|P2|STARTED|Overall Study||74
8229875|NCT01998919|20293288|P1|STARTED|Overall Study||79
8229876|NCT01998906|20293309|P3|NOT COMPLETED|Overall Study||98
8229877|NCT01998906|20293310|P2|NOT COMPLETED|Overall Study||114
8229878|NCT01998906|20293311|P1|NOT COMPLETED|Overall Study||114
8229879|NCT01998906|20293309|P3|COMPLETED|Overall Study||1
8229880|NCT01998906|20293310|P2|COMPLETED|Overall Study||2
8229881|NCT01998906|20293311|P1|COMPLETED|Overall Study||1
8229882|NCT01998906|20293309|P3|STARTED|Overall Study||99
8229883|NCT01998906|20293310|P2|STARTED|Overall Study||116
8229884|NCT01998906|20293311|P1|STARTED|Overall Study||115
8229885|NCT01998893|20293355|P1|NOT COMPLETED|Overall Study||17
8229886|NCT01998893|20293355|P1|COMPLETED|Overall Study||21
8229887|NCT01998893|20293355|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
8229888|NCT01998893|20293355|P1|2nd Treatment Cycle Started|Overall Study||5
8229889|NCT01998893|20293355|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
8229890|NCT01998893|20293355|P1|STARTED|Overall Study||38
8229891|NCT01998880|20293367|P2|NOT COMPLETED|Overall Study||40
8229892|NCT01998880|20293368|P1|NOT COMPLETED|Overall Study||28
8229893|NCT01998880|20293367|P2|COMPLETED|Overall Study||78
8229894|NCT01998880|20293368|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
8229895|NCT01998880|20293367|P2|Received Study Drug|Overall Study||116
8229896|NCT01998880|20293368|P1|Received Study Drug|Overall Study||230
8229897|NCT01998880|20293367|P2|STARTED|Overall Study||118
8229898|NCT01998880|20293368|P1|STARTED|Overall Study||233
8229899|NCT01998737|20293400|P2|NOT COMPLETED|Overall Study||0
8229900|NCT01998737|20293401|P1|NOT COMPLETED|Overall Study||23
8229901|NCT01998737|20293400|P2|COMPLETED|Overall Study||100
8229902|NCT01998737|20293401|P1|COMPLETED|Overall Study||888
8229903|NCT01998737|20293400|P2|STARTED|Overall Study||100
8229904|NCT01998737|20293401|P1|STARTED|Overall Study||911
8229905|NCT01998633|20293413|P1|NOT COMPLETED|Overall Study||1
8229906|NCT01998633|20293413|P1|COMPLETED|Overall Study||46
8229907|NCT01998633|20293413|P1|STARTED|Overall Study||47
8229908|NCT01998581|20293431|P2|NOT COMPLETED|Overall Study||12
8229909|NCT01998581|20293432|P1|NOT COMPLETED|Overall Study||46
8229910|NCT01998581|20293431|P2|COMPLETED|Overall Study||44
8229911|NCT01998581|20293432|P1|COMPLETED|Overall Study||123
8229912|NCT01998581|20293431|P2|STARTED|Overall Study||56
8229913|NCT01998581|20293432|P1|STARTED|Overall Study||169
8229914|NCT01998477|20293445|P2|NOT COMPLETED|Overall Study||5
8229915|NCT01998477|20293446|P1|NOT COMPLETED|Overall Study||10
8229916|NCT01998477|20293445|P2|COMPLETED|Overall Study||143
8229917|NCT01998477|20293446|P1|COMPLETED|Overall Study||272
8229918|NCT01998477|20293445|P2|STARTED|Overall Study||148
8229919|NCT01998477|20293446|P1|STARTED|Overall Study||282
8229920|NCT01998438|20293480|P3|NOT COMPLETED|Overall Study||0
8229921|NCT01998438|20293481|P2|NOT COMPLETED|Overall Study||0
8229922|NCT01998438|20293482|P1|NOT COMPLETED|Overall Study||0
8229923|NCT01998438|20293480|P3|COMPLETED|Overall Study||318
8229924|NCT01998438|20293481|P2|COMPLETED|Overall Study||318
8229925|NCT01998438|20293482|P1|COMPLETED|Overall Study||319
8229926|NCT01998438|20293480|P3|STARTED|Overall Study||318
8229927|NCT01998438|20293481|P2|STARTED|Overall Study||318
8229928|NCT01998438|20293482|P1|STARTED|Overall Study||319
8229929|NCT01998399|20293492|P2|NOT COMPLETED|Overall Study||9
8229930|NCT01998399|20293493|P1|NOT COMPLETED|Overall Study||8
8229931|NCT01998399|20293492|P2|COMPLETED|Overall Study||4
8229932|NCT01998399|20293493|P1|COMPLETED|Overall Study||4
8229933|NCT01998399|20293492|P2|STARTED|Overall Study||13
8229934|NCT01998399|20293493|P1|STARTED|Overall Study||12
8229935|NCT01998360|20293527|P2|NOT COMPLETED|Overall Study||0
8229936|NCT01998360|20293528|P1|NOT COMPLETED|Overall Study||0
8229937|NCT01998360|20293527|P2|COMPLETED|Overall Study||50
8229938|NCT01998360|20293528|P1|COMPLETED|Overall Study||50
8229939|NCT01998360|20293527|P2|STARTED|Overall Study||50
8229940|NCT01998360|20293528|P1|STARTED|Overall Study||50
8229941|NCT01998269|20293542|P1|NOT COMPLETED|Overall Study||0
8229942|NCT01998269|20293542|P1|COMPLETED|Overall Study||193
8229943|NCT01998269|20293542|P1|STARTED|Overall Study||193
8229944|NCT01998243|20293548|P2|NOT COMPLETED|Overall Study||7
8229945|NCT01998243|20293549|P1|NOT COMPLETED|Overall Study||8
8229946|NCT01998243|20293548|P2|COMPLETED|Overall Study||32
8229947|NCT01998243|20293549|P1|COMPLETED|Overall Study||34
8229948|NCT01998243|20293548|P2|STARTED|Overall Study||39
8229949|NCT01998243|20293549|P1|STARTED|Overall Study||42
8229950|NCT01997905|20293563|P1|NOT COMPLETED|Overall Study||3
8229951|NCT01997905|20293563|P1|COMPLETED|Overall Study||10
8229952|NCT01997905|20293563|P1|Baseline Completed|Overall Study||11
8229953|NCT01997905|20293563|P1|STARTED|Overall Study||13
8229954|NCT01997892|20293572|P1|NOT COMPLETED|Overall Study||68
8229955|NCT01997892|20293572|P1|COMPLETED|Overall Study||959
8229956|NCT01997892|20293572|P1|Received Darbepoetin Alfa|Overall Study||987
8229957|NCT01997892|20293572|P1|STARTED|Overall Study||1027
8229958|NCT01997723|20293584|P1|NOT COMPLETED|Overall Study||0
8229959|NCT01997723|20293584|P1|COMPLETED|Overall Study||75
8229960|NCT01997723|20293584|P1|STARTED|Overall Study||75
8229961|NCT01997567|20293592|P2|NOT COMPLETED|Overall Study||0
8229962|NCT01997567|20293593|P1|NOT COMPLETED|Overall Study||0
8229963|NCT01997567|20293592|P2|COMPLETED|Overall Study||0
8229964|NCT01997567|20293593|P1|COMPLETED|Overall Study||0
8229965|NCT01997567|20293592|P2|STARTED|Overall Study||0
8229966|NCT01997567|20293593|P1|STARTED|Overall Study||0
8229967|NCT01997515|20293613|P2|NOT COMPLETED|Overall Study||5
8229968|NCT01997515|20293614|P1|NOT COMPLETED|Overall Study||4
8229969|NCT01997515|20293613|P2|COMPLETED|Overall Study||35
8229970|NCT01997515|20293614|P1|COMPLETED|Overall Study||36
8229971|NCT01997515|20293613|P2|STARTED|Overall Study||40
8229972|NCT01997515|20293614|P1|STARTED|Overall Study||40
8229973|NCT01997437|20293626|P1|NOT COMPLETED|Overall Study||0
8229974|NCT01997437|20293626|P1|COMPLETED|Overall Study||6
8229975|NCT01997437|20293626|P1|STARTED|Overall Study||6
8229976|NCT01997411|20293638|P8|NOT COMPLETED|Overall Study||0
8229977|NCT01997411|20293639|P7|NOT COMPLETED|Overall Study||0
8229978|NCT01997411|20293640|P6|NOT COMPLETED|Overall Study||1
8229979|NCT01997411|20293641|P5|NOT COMPLETED|Overall Study||0
8229980|NCT01997411|20293642|P4|NOT COMPLETED|Overall Study||0
8229981|NCT01997411|20293643|P3|NOT COMPLETED|Overall Study||0
8229982|NCT01997411|20293644|P2|NOT COMPLETED|Overall Study||0
8229983|NCT01997411|20293645|P1|NOT COMPLETED|Overall Study||0
8229984|NCT01997411|20293638|P8|COMPLETED|Overall Study||6
8229985|NCT01997411|20293639|P7|COMPLETED|Overall Study||6
8229986|NCT01997411|20293640|P6|COMPLETED|Overall Study||5
8229987|NCT01997411|20293641|P5|COMPLETED|Overall Study||6
8229988|NCT01997411|20293642|P4|COMPLETED|Overall Study||6
8229989|NCT01997411|20293643|P3|COMPLETED|Overall Study||6
8229990|NCT01997411|20293644|P2|COMPLETED|Overall Study||6
8229991|NCT01997411|20293645|P1|COMPLETED|Overall Study||6
8229992|NCT01997411|20293638|P8|STARTED|Overall Study||6
8229993|NCT01997411|20293639|P7|STARTED|Overall Study||6
8229994|NCT01997411|20293640|P6|STARTED|Overall Study||6
8229995|NCT01997411|20293641|P5|STARTED|Overall Study||6
8229996|NCT01997411|20293642|P4|STARTED|Overall Study||6
8229997|NCT01997411|20293643|P3|STARTED|Overall Study||6
8229998|NCT01997411|20293644|P2|STARTED|Overall Study||6
8229999|NCT01997411|20293645|P1|STARTED|Overall Study||6
8230000|NCT01997398|20293735|P1|NOT COMPLETED|Overall Study||1
8230001|NCT01997398|20293735|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
8230002|NCT01997398|20293735|P1|STARTED|Overall Study||35
8230003|NCT01997333|20293746|P2|NOT COMPLETED|Survival Follow up||14
8230004|NCT01997333|20293747|P1|NOT COMPLETED|Survival Follow up||16
8230005|NCT01997333|20293746|P2|COMPLETED|Survival Follow up||199
8230006|NCT01997333|20293747|P1|COMPLETED|Survival Follow up||76
8230007|NCT01997333|20293746|P2|STARTED|Survival Follow up||213
8230008|NCT01997333|20293747|P1|STARTED|Survival Follow up||92
8230009|NCT01997333|20293746|P2|NOT COMPLETED|Randomization and Treatment||203
8230010|NCT01997333|20293747|P1|NOT COMPLETED|Randomization and Treatment||103
8230011|NCT01997333|20293746|P2|COMPLETED|Randomization and Treatment||15
8230012|NCT01997333|20293747|P1|COMPLETED|Randomization and Treatment||6
8230013|NCT01997333|20293746|P2|STARTED|Randomization and Treatment||218
8230014|NCT01997333|20293747|P1|STARTED|Randomization and Treatment||109
8230015|NCT01997281|20293764|P2|NOT COMPLETED|Overall Study||0
8230016|NCT01997281|20293765|P1|NOT COMPLETED|Overall Study||1
8230017|NCT01997281|20293764|P2|COMPLETED|Overall Study||7
8230018|NCT01997281|20293765|P1|COMPLETED|Overall Study||6
8230019|NCT01997281|20293764|P2|Withdrawal|Overall Study||0
8230020|NCT01997281|20293765|P1|Withdrawal|Overall Study||1
8230021|NCT01997281|20293764|P2|STARTED|Overall Study||7
8230022|NCT01997281|20293765|P1|STARTED|Overall Study||7
8230023|NCT01997229|20293773|P2|NOT COMPLETED|Overall Study||2
8230024|NCT01997229|20293774|P1|NOT COMPLETED|Overall Study||5
8230025|NCT01997229|20293773|P2|COMPLETED|Overall Study||61
8230026|NCT01997229|20293774|P1|COMPLETED|Overall Study||57
8230027|NCT01997229|20293773|P2|STARTED|Overall Study||63
8230028|NCT01997229|20293774|P1|STARTED|Overall Study||62
8230029|NCT01997216|20293780|P2|NOT COMPLETED|Second 9 Hours||0
8230030|NCT01997216|20293781|P1|NOT COMPLETED|Second 9 Hours||0
8230031|NCT01997216|20293780|P2|COMPLETED|Second 9 Hours||21
8230032|NCT01997216|20293781|P1|COMPLETED|Second 9 Hours||19
8230033|NCT01997216|20293780|P2|STARTED|Second 9 Hours||21
8230034|NCT01997216|20293781|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
8230035|NCT01997216|20293780|P2|NOT COMPLETED|First 9 Hours||0
8230036|NCT01997216|20293781|P1|NOT COMPLETED|First 9 Hours||0
8230037|NCT01997216|20293780|P2|COMPLETED|First 9 Hours||21
8230038|NCT01997216|20293781|P1|COMPLETED|First 9 Hours||18
8230039|NCT01997216|20293780|P2|STARTED|First 9 Hours||21
8230040|NCT01997216|20293781|P1|STARTED|First 9 Hours||18
8230041|NCT01996982|20293791|P1|NOT COMPLETED|Overall Study||7
8230042|NCT01996982|20293791|P1|COMPLETED|Overall Study||0
8230043|NCT01996982|20293791|P1|STARTED|Overall Study||7
8230044|NCT01996917|20293796|P1|NOT COMPLETED|Overall Study||0
8230045|NCT01996917|20293796|P1|COMPLETED|Overall Study||21
8230046|NCT01996917|20293796|P1|STARTED|Overall Study||21
8230047|NCT01996904|20293807|P2|NOT COMPLETED|Overall Study||27
8230048|NCT01996904|20293808|P1|NOT COMPLETED|Overall Study||38
8230049|NCT01996904|20293807|P2|COMPLETED|Overall Study||90
8230050|NCT01996904|20293808|P1|COMPLETED|Overall Study||101
8230051|NCT01996904|20293807|P2|STARTED|Overall Study||117
8230052|NCT01996904|20293808|P1|STARTED|Overall Study||139
8230053|NCT01996852|20293817|P3|NOT COMPLETED|Overall Study||0
8230054|NCT01996852|20293818|P2|NOT COMPLETED|Overall Study||0
8230055|NCT01996852|20293819|P1|NOT COMPLETED|Overall Study||0
8230056|NCT01996852|20293817|P3|COMPLETED|Overall Study||0
8230057|NCT01996852|20293818|P2|COMPLETED|Overall Study||0
8230058|NCT01996852|20293819|P1|COMPLETED|Overall Study||0
8230059|NCT01996852|20293817|P3|STARTED|Overall Study||0
8230060|NCT01996852|20293818|P2|STARTED|Overall Study||0
8230061|NCT01996852|20293819|P1|STARTED|Overall Study||0
8230062|NCT01996839|20293866|P3|NOT COMPLETED|Overall Study||32
8230063|NCT01996839|20293867|P2|NOT COMPLETED|Overall Study||38
8230064|NCT01996839|20293868|P1|NOT COMPLETED|Overall Study||92
8230065|NCT01996839|20293866|P3|COMPLETED|Overall Study||139
8230066|NCT01996839|20293867|P2|COMPLETED|Overall Study||133
8230067|NCT01996839|20293868|P1|COMPLETED|Overall Study||80
8230068|NCT01996839|20293866|P3|STARTED|Overall Study||171
8230069|NCT01996839|20293867|P2|STARTED|Overall Study||171
8230070|NCT01996839|20293868|P1|STARTED|Overall Study||172
8230071|NCT01996826|20293893|P2|NOT COMPLETED|Overall Study||3
8230072|NCT01996826|20293894|P1|NOT COMPLETED|Overall Study||7
8230073|NCT01996826|20293893|P2|COMPLETED|Overall Study||33
8230074|NCT01996826|20293894|P1|COMPLETED|Overall Study||32
8230075|NCT01996826|20293893|P2|STARTED|Overall Study||36
8230076|NCT01996826|20293894|P1|STARTED|Overall Study||39
8230077|NCT01996813|20293906|P2|NOT COMPLETED|Overall Study||0
8230078|NCT01996813|20293907|P1|NOT COMPLETED|Overall Study||0
8230079|NCT01996813|20293906|P2|COMPLETED|Overall Study||24
8230080|NCT01996813|20293907|P1|COMPLETED|Overall Study||23
8230081|NCT01996813|20293906|P2|STARTED|Overall Study||24
8230082|NCT01996813|20293907|P1|STARTED|Overall Study||23
8230083|NCT01996748|20293917|P2|NOT COMPLETED|Overall Study||6
8230084|NCT01996748|20293918|P1|NOT COMPLETED|Overall Study||8
8230085|NCT01996748|20293917|P2|COMPLETED|Overall Study||63
8230086|NCT01996748|20293918|P1|COMPLETED|Overall Study||58
8230087|NCT01996748|20293917|P2|STARTED|Overall Study||69
8230088|NCT01996748|20293918|P1|STARTED|Overall Study||66
8230089|NCT01996709|20293932|P2|NOT COMPLETED|Overall Study||1
8230090|NCT01996709|20293933|P1|NOT COMPLETED|Overall Study||5
8230091|NCT01996709|20293932|P2|COMPLETED|Overall Study||67
8230092|NCT01996709|20293933|P1|COMPLETED|Overall Study||61
8230093|NCT01996709|20293932|P2|STARTED|Overall Study||68
8230094|NCT01996709|20293933|P1|STARTED|Overall Study||66
8230095|NCT01996657|20293950|P3|NOT COMPLETED|Overall Study||14
8230096|NCT01996657|20293951|P2|NOT COMPLETED|Overall Study||11
8230097|NCT01996657|20293952|P1|NOT COMPLETED|Overall Study||13
8230098|NCT01996657|20293950|P3|COMPLETED|Overall Study||234
8230099|NCT01996657|20293951|P2|COMPLETED|Overall Study||239
8230100|NCT01996657|20293952|P1|COMPLETED|Overall Study||237
8230101|NCT01996657|20293950|P3|STARTED|Overall Study||248
8230102|NCT01996657|20293951|P2|STARTED|Overall Study||250
8230103|NCT01996657|20293952|P1|STARTED|Overall Study||250
8230104|NCT01996644|20293968|P2|NOT COMPLETED|Overall Study||0
8230105|NCT01996644|20293969|P1|NOT COMPLETED|Overall Study||0
8230106|NCT01996644|20293968|P2|COMPLETED|Overall Study||16
8230107|NCT01996644|20293969|P1|COMPLETED|Overall Study||20
8230108|NCT01996644|20293968|P2|STARTED|Overall Study||16
8230109|NCT01996644|20293969|P1|STARTED|Overall Study||20
8230110|NCT01996592|20293980|P1|NOT COMPLETED|Overall Study||45
8230111|NCT01996592|20293980|P1|COMPLETED|Overall Study||530
8230112|NCT01996592|20293980|P1|STARTED|Overall Study||575
8230113|NCT01996410|20293997|P8|NOT COMPLETED|Overall Study||0
8230114|NCT01996410|20293998|P7|NOT COMPLETED|Overall Study||0
8230115|NCT01996410|20293999|P6|NOT COMPLETED|Overall Study||0
8230116|NCT01996410|20294000|P5|NOT COMPLETED|Overall Study||0
8230117|NCT01996410|20294001|P4|NOT COMPLETED|Overall Study||0
8230118|NCT01996410|20294002|P3|NOT COMPLETED|Overall Study||0
8230119|NCT01996410|20294003|P2|NOT COMPLETED|Overall Study||0
8230120|NCT01996410|20294004|P1|NOT COMPLETED|Overall Study||0
8230121|NCT01996410|20293997|P8|COMPLETED|Overall Study||0
8230122|NCT01996410|20293998|P7|COMPLETED|Overall Study||0
8230123|NCT01996410|20293999|P6|COMPLETED|Overall Study||2
8230124|NCT01996410|20294000|P5|COMPLETED|Overall Study||2
8230125|NCT01996410|20294001|P4|COMPLETED|Overall Study||0
8230126|NCT01996410|20294002|P3|COMPLETED|Overall Study||0
8230127|NCT01996410|20294003|P2|COMPLETED|Overall Study||3
8230128|NCT01996410|20294004|P1|COMPLETED|Overall Study||3
8230129|NCT01996410|20293997|P8|STARTED|Overall Study||0
8230130|NCT01996410|20293998|P7|STARTED|Overall Study||0
8230131|NCT01996410|20293999|P6|STARTED|Overall Study||2
8230132|NCT01996410|20294000|P5|STARTED|Overall Study||2
8230133|NCT01996410|20294001|P4|STARTED|Overall Study||0
8230134|NCT01996410|20294002|P3|STARTED|Overall Study||0
8230135|NCT01996410|20294003|P2|STARTED|Overall Study||3
8230136|NCT01996410|20294004|P1|STARTED|Overall Study||3
8230137|NCT01996332|20294016|P1|NOT COMPLETED|Overall Study||1805
8230138|NCT01996332|20294016|P1|COMPLETED|Overall Study||0
8230139|NCT01996332|20294016|P1|STARTED|Overall Study||1805
8230140|NCT01996319|20294024|P2|NOT COMPLETED|Overall Study||3
8230141|NCT01996319|20294025|P1|NOT COMPLETED|Overall Study||8
8230142|NCT01996319|20294024|P2|COMPLETED|Overall Study||95
8230143|NCT01996319|20294025|P1|COMPLETED|Overall Study||88
8230144|NCT01996319|20294024|P2|STARTED|Overall Study||98
8230145|NCT01996319|20294025|P1|STARTED|Overall Study||96
8230146|NCT01996254|20294047|P3|NOT COMPLETED|Overall Study||8
8230147|NCT01996254|20294048|P2|NOT COMPLETED|Overall Study||5
8230148|NCT01996254|20294049|P1|NOT COMPLETED|Overall Study||1
8230149|NCT01996254|20294047|P3|COMPLETED|Overall Study||6
8230150|NCT01996254|20294048|P2|COMPLETED|Overall Study||9
8230151|NCT01996254|20294049|P1|COMPLETED|Overall Study||4
8230152|NCT01996254|20294047|P3|Per Protocol Set|Overall Study||13
8230153|NCT01996254|20294048|P2|Per Protocol Set|Overall Study||10
8230154|NCT01996254|20294049|P1|Per Protocol Set|Overall Study||0
8230155|NCT01996254|20294047|P3|Long Term Analysis Set|Overall Study||14
8230156|NCT01996254|20294048|P2|Long Term Analysis Set|Overall Study||12
8230157|NCT01996254|20294049|P1|Long Term Analysis Set|Overall Study||0
8230158|NCT01996254|20294047|P3|Full Analysis Set|Overall Study||14
8230159|NCT01996254|20294048|P2|Full Analysis Set|Overall Study||12
8230160|NCT01996254|20294049|P1|Full Analysis Set|Overall Study||0
8230161|NCT01996254|20294047|P3|Safety Set|Overall Study||14
8230162|NCT01996254|20294048|P2|Safety Set|Overall Study||14
8230163|NCT01996254|20294049|P1|Safety Set|Overall Study||5
8230164|NCT01996254|20294047|P3|STARTED|Overall Study||14
8230165|NCT01996254|20294048|P2|STARTED|Overall Study||14
8230166|NCT01996254|20294049|P1|STARTED|Overall Study||5
8230167|NCT01996241|20294077|P2|NOT COMPLETED|Overall Study||235
8230168|NCT01996241|20294078|P1|NOT COMPLETED|Overall Study||252
8230169|NCT01996241|20294077|P2|COMPLETED|Overall Study||876
8230170|NCT01996241|20294078|P1|COMPLETED|Overall Study||912
8230171|NCT01996241|20294077|P2|STARTED|Overall Study||1111
8230172|NCT01996241|20294078|P1|STARTED|Overall Study||1164
8230173|NCT01996033|20294094|P1|NOT COMPLETED|Overall Study||9
8230174|NCT01996033|20294094|P1|COMPLETED|Overall Study||16
8230175|NCT01996033|20294094|P1|STARTED|Overall Study||25
8230176|NCT01995838|20294114|P7|NOT COMPLETED|Overall Study||5
8230177|NCT01995838|20294115|P6|NOT COMPLETED|Overall Study||2
8230178|NCT01995838|20294116|P5|NOT COMPLETED|Overall Study||2
8230179|NCT01995838|20294117|P4|NOT COMPLETED|Overall Study||2
8230180|NCT01995838|20294118|P3|NOT COMPLETED|Overall Study||0
8230181|NCT01995838|20294119|P2|NOT COMPLETED|Overall Study||2
8230182|NCT01995838|20294120|P1|NOT COMPLETED|Overall Study||5
8230183|NCT01995838|20294114|P7|COMPLETED|Overall Study||45
8230184|NCT01995838|20294115|P6|COMPLETED|Overall Study||54
8230185|NCT01995838|20294116|P5|COMPLETED|Overall Study||30
8230186|NCT01995838|20294117|P4|COMPLETED|Overall Study||36
8230187|NCT01995838|20294118|P3|COMPLETED|Overall Study||27
8230188|NCT01995838|20294119|P2|COMPLETED|Overall Study||30
8230189|NCT01995838|20294120|P1|COMPLETED|Overall Study||51
8230190|NCT01995838|20294114|P7|STARTED|Overall Study||50
8230191|NCT01995838|20294115|P6|STARTED|Overall Study||56
8230192|NCT01995838|20294116|P5|STARTED|Overall Study||32
8230193|NCT01995838|20294117|P4|STARTED|Overall Study||38
8230194|NCT01995838|20294118|P3|STARTED|Overall Study||27
8230195|NCT01995838|20294119|P2|STARTED|Overall Study||32
8230196|NCT01995838|20294120|P1|STARTED|Overall Study||56
8230197|NCT01995825|20294221|P2|NOT COMPLETED|Overall Study||0
8230198|NCT01995825|20294222|P1|NOT COMPLETED|Overall Study||1
8230199|NCT01995825|20294221|P2|COMPLETED|Overall Study||17
8230200|NCT01995825|20294222|P1|COMPLETED|Overall Study||17
8230201|NCT01995825|20294221|P2|STARTED|Overall Study||17
8230202|NCT01995825|20294222|P1|STARTED|Overall Study||18
8230203|NCT01995552|20294230|P1|NOT COMPLETED|Overall Study||17
8230204|NCT01995552|20294230|P1|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
8230205|NCT01995552|20294230|P1|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
8230206|NCT01995539|20294236|P1|NOT COMPLETED|Overall Study||33
8230207|NCT01995539|20294236|P1|COMPLETED|Overall Study||148
8230208|NCT01995539|20294236|P1|STARTED|Overall Study||181
8230209|NCT01995526|20294241|P1|NOT COMPLETED|Overall Study||1
8230210|NCT01995526|20294241|P1|COMPLETED|Overall Study||10
8230211|NCT01995526|20294241|P1|Received One Dose of Study Drug|Overall Study||11
8230212|NCT01995526|20294241|P1|STARTED|Overall Study||11
8230213|NCT01995513|20294249|P3|NOT COMPLETED|Double Blind Treatment Period||125
8230214|NCT01995513|20294250|P2|NOT COMPLETED|Double Blind Treatment Period||126
8230215|NCT01995513|20294251|P1|NOT COMPLETED|Double Blind Treatment Period||0
8230216|NCT01995513|20294249|P3|COMPLETED|Double Blind Treatment Period||0
8230217|NCT01995513|20294250|P2|COMPLETED|Double Blind Treatment Period||0
8230218|NCT01995513|20294251|P1|COMPLETED|Double Blind Treatment Period||0
8230219|NCT01995513|20294249|P3|Treated|Double Blind Treatment Period||124
8230220|NCT01995513|20294250|P2|Treated|Double Blind Treatment Period||125
8230221|NCT01995513|20294251|P1|Treated|Double Blind Treatment Period||0
8230222|NCT01995513|20294249|P3|STARTED|Double Blind Treatment Period||125
8230223|NCT01995513|20294250|P2|STARTED|Double Blind Treatment Period||126
8230224|NCT01995513|20294251|P1|STARTED|Double Blind Treatment Period||0
8230225|NCT01995513|20294249|P3|NOT COMPLETED|Open Label Treatment Period||0
8230226|NCT01995513|20294250|P2|NOT COMPLETED|Open Label Treatment Period||0
8230227|NCT01995513|20294251|P1|NOT COMPLETED|Open Label Treatment Period||258
8230228|NCT01995513|20294249|P3|COMPLETED|Open Label Treatment Period||0
8230229|NCT01995513|20294250|P2|COMPLETED|Open Label Treatment Period||0
8230230|NCT01995513|20294251|P1|COMPLETED|Open Label Treatment Period||251
8230231|NCT01995513|20294249|P3|STARTED|Open Label Treatment Period||0
8230232|NCT01995513|20294250|P2|STARTED|Open Label Treatment Period||0
8230233|NCT01995513|20294251|P1|STARTED|Open Label Treatment Period||509
8230234|NCT01995461|20294294|P1|NOT COMPLETED|Overall Study||5
8230235|NCT01995461|20294294|P1|COMPLETED|Overall Study||21
8230236|NCT01995461|20294294|P1|STARTED|Overall Study||26
8230237|NCT01995357|20294300|P6|NOT COMPLETED|Period 5||0
8230238|NCT01995357|20294301|P5|NOT COMPLETED|Period 5||0
8230239|NCT01995357|20294302|P4|NOT COMPLETED|Period 5||0
8230240|NCT01995357|20294303|P3|NOT COMPLETED|Period 5||1
8230241|NCT01995357|20294304|P2|NOT COMPLETED|Period 5||0
8230242|NCT01995357|20294305|P1|NOT COMPLETED|Period 5||2
8230243|NCT01995357|20294300|P6|COMPLETED|Period 5||4
8230244|NCT01995357|20294301|P5|COMPLETED|Period 5||4
8230245|NCT01995357|20294302|P4|COMPLETED|Period 5||3
8230246|NCT01995357|20294303|P3|COMPLETED|Period 5||3
8230247|NCT01995357|20294304|P2|COMPLETED|Period 5||3
8230248|NCT01995357|20294305|P1|COMPLETED|Period 5||2
8230249|NCT01995357|20294300|P6|STARTED|Period 5||4
8230250|NCT01995357|20294301|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
8230251|NCT01995357|20294302|P4|STARTED|Period 5||3
8230252|NCT01995357|20294303|P3|STARTED|Period 5||4
8230253|NCT01995357|20294304|P2|STARTED|Period 5||3
8230254|NCT01995357|20294305|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
8230255|NCT01995357|20294300|P6|NOT COMPLETED|Period 4||0
8230256|NCT01995357|20294301|P5|NOT COMPLETED|Period 4||0
8230257|NCT01995357|20294302|P4|NOT COMPLETED|Period 4||0
8230258|NCT01995357|20294303|P3|NOT COMPLETED|Period 4||0
8230259|NCT01995357|20294304|P2|NOT COMPLETED|Period 4||0
8230260|NCT01995357|20294305|P1|NOT COMPLETED|Period 4||0
8230261|NCT01995357|20294300|P6|COMPLETED|Period 4||4
8230262|NCT01995357|20294301|P5|COMPLETED|Period 4||4
8230263|NCT01995357|20294302|P4|COMPLETED|Period 4||3
8230264|NCT01995357|20294303|P3|COMPLETED|Period 4||4
8230265|NCT01995357|20294304|P2|COMPLETED|Period 4||3
8230266|NCT01995357|20294305|P1|COMPLETED|Period 4||4
8230267|NCT01995357|20294300|P6|STARTED|Period 4||4
8230268|NCT01995357|20294301|P5|STARTED|Period 4||4
8230269|NCT01995357|20294302|P4|STARTED|Period 4||3
8230270|NCT01995357|20294303|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
8230271|NCT01995357|20294304|P2|STARTED|Period 4||3
8230272|NCT01995357|20294305|P1|STARTED|Period 4||4
8230273|NCT01995357|20294300|P6|NOT COMPLETED|Period 3||0
8230274|NCT01995357|20294301|P5|NOT COMPLETED|Period 3||0
8230275|NCT01995357|20294302|P4|NOT COMPLETED|Period 3||0
8230276|NCT01995357|20294303|P3|NOT COMPLETED|Period 3||0
8230277|NCT01995357|20294304|P2|NOT COMPLETED|Period 3||0
8230278|NCT01995357|20294305|P1|NOT COMPLETED|Period 3||0
8230279|NCT01995357|20294300|P6|COMPLETED|Period 3||4
8230280|NCT01995357|20294301|P5|COMPLETED|Period 3||4
8230281|NCT01995357|20294302|P4|COMPLETED|Period 3||3
8230282|NCT01995357|20294303|P3|COMPLETED|Period 3||4
8230283|NCT01995357|20294304|P2|COMPLETED|Period 3||3
8230284|NCT01995357|20294305|P1|COMPLETED|Period 3||4
8230285|NCT01995357|20294300|P6|STARTED|Period 3||4
8230286|NCT01995357|20294301|P5|STARTED|Period 3||4
8230287|NCT01995357|20294302|P4|STARTED|Period 3||3
8230288|NCT01995357|20294303|P3|STARTED|Period 3||4
8230289|NCT01995357|20294304|P2|STARTED|Period 3||3
8230290|NCT01995357|20294305|P1|STARTED|Period 3||4
8230291|NCT01995357|20294300|P6|NOT COMPLETED|Period 2||0
8230292|NCT01995357|20294301|P5|NOT COMPLETED|Period 2||0
8230293|NCT01995357|20294302|P4|NOT COMPLETED|Period 2||0
8230294|NCT01995357|20294303|P3|NOT COMPLETED|Period 2||0
8230295|NCT01995357|20294304|P2|NOT COMPLETED|Period 2||0
8230296|NCT01995357|20294305|P1|NOT COMPLETED|Period 2||0
8230297|NCT01995357|20294300|P6|COMPLETED|Period 2||4
8230298|NCT01995357|20294301|P5|COMPLETED|Period 2||4
8230299|NCT01995357|20294302|P4|COMPLETED|Period 2||3
8230300|NCT01995357|20294303|P3|COMPLETED|Period 2||4
8230301|NCT01995357|20294304|P2|COMPLETED|Period 2||3
8230302|NCT01995357|20294305|P1|COMPLETED|Period 2||4
8230303|NCT01995357|20294300|P6|STARTED|Period 2||4
8230304|NCT01995357|20294301|P5|STARTED|Period 2||4
8230305|NCT01995357|20294302|P4|STARTED|Period 2||3
8230306|NCT01995357|20294303|P3|STARTED|Period 2||4
8230307|NCT01995357|20294304|P2|STARTED|Period 2||3
8230308|NCT01995357|20294305|P1|STARTED|Period 2||4
8230309|NCT01995357|20294300|P6|NOT COMPLETED|Period 1||0
8230310|NCT01995357|20294301|P5|NOT COMPLETED|Period 1||0
8230311|NCT01995357|20294302|P4|NOT COMPLETED|Period 1||0
8230312|NCT01995357|20294303|P3|NOT COMPLETED|Period 1||0
8230313|NCT01995357|20294304|P2|NOT COMPLETED|Period 1||0
8230314|NCT01995357|20294305|P1|NOT COMPLETED|Period 1||0
8230315|NCT01995357|20294300|P6|COMPLETED|Period 1||4
8230316|NCT01995357|20294301|P5|COMPLETED|Period 1||4
8230317|NCT01995357|20294302|P4|COMPLETED|Period 1||3
8230318|NCT01995357|20294303|P3|COMPLETED|Period 1||4
8230319|NCT01995357|20294304|P2|COMPLETED|Period 1||3
8230320|NCT01995357|20294305|P1|COMPLETED|Period 1||4
8230321|NCT01995357|20294300|P6|STARTED|Period 1||4
8230322|NCT01995357|20294301|P5|STARTED|Period 1||4
8230323|NCT01995357|20294302|P4|STARTED|Period 1||3
8230324|NCT01995357|20294303|P3|STARTED|Period 1||4
8230325|NCT01995357|20294304|P2|STARTED|Period 1||3
8230326|NCT01995357|20294305|P1|STARTED|Period 1||4
8230327|NCT01995266|20294321|P1|NOT COMPLETED|Overall Study||9
8230328|NCT01995266|20294321|P1|COMPLETED|Overall Study||150
8230329|NCT01995266|20294321|P1|STARTED|Overall Study||159
8230330|NCT01995201|20294336|P7|NOT COMPLETED|From Week 24 Until Week 48||2
8230331|NCT01995201|20294337|P6|NOT COMPLETED|From Week 24 Until Week 48||8
8230332|NCT01995201|20294338|P5|NOT COMPLETED|From Week 24 Until Week 48||6
8230333|NCT01995201|20294339|P4|NOT COMPLETED|From Week 24 Until Week 48||1
8230334|NCT01995201|20294340|P3|NOT COMPLETED|From Week 24 Until Week 48||5
8230335|NCT01995201|20294341|P2|NOT COMPLETED|From Week 24 Until Week 48||0
8230336|NCT01995201|20294342|P1|NOT COMPLETED|From Week 24 Until Week 48||0
8230337|NCT01995201|20294336|P7|COMPLETED|From Week 24 Until Week 48||0
8230338|NCT01995201|20294337|P6|COMPLETED|From Week 24 Until Week 48||59
8230339|NCT01995201|20294338|P5|COMPLETED|From Week 24 Until Week 48||89
8230340|NCT01995201|20294339|P4|COMPLETED|From Week 24 Until Week 48||89
8230341|NCT01995201|20294340|P3|COMPLETED|From Week 24 Until Week 48||84
8230342|NCT01995201|20294341|P2|COMPLETED|From Week 24 Until Week 48||0
8230343|NCT01995201|20294342|P1|COMPLETED|From Week 24 Until Week 48||0
8230344|NCT01995201|20294336|P7|STARTED|From Week 24 Until Week 48||2
8230345|NCT01995201|20294337|P6|STARTED|From Week 24 Until Week 48||67
8230346|NCT01995201|20294338|P5|STARTED|From Week 24 Until Week 48||95
8230347|NCT01995201|20294339|P4|STARTED|From Week 24 Until Week 48||90
8230348|NCT01995201|20294340|P3|STARTED|From Week 24 Until Week 48||89
8230349|NCT01995201|20294341|P2|STARTED|From Week 24 Until Week 48||0
8230350|NCT01995201|20294342|P1|STARTED|From Week 24 Until Week 48||0
8230351|NCT01995201|20294336|P7|NOT COMPLETED|From Baseline Until Week 24||0
8230352|NCT01995201|20294337|P6|NOT COMPLETED|From Baseline Until Week 24||0
8230353|NCT01995201|20294338|P5|NOT COMPLETED|From Baseline Until Week 24||0
8230354|NCT01995201|20294339|P4|NOT COMPLETED|From Baseline Until Week 24||0
8230355|NCT01995201|20294340|P3|NOT COMPLETED|From Baseline Until Week 24||0
8230356|NCT01995201|20294341|P2|NOT COMPLETED|From Baseline Until Week 24||46
8230357|NCT01995201|20294342|P1|NOT COMPLETED|From Baseline Until Week 24||10
8230358|NCT01995201|20294336|P7|COMPLETED|From Baseline Until Week 24||0
8230359|NCT01995201|20294337|P6|COMPLETED|From Baseline Until Week 24||0
8230360|NCT01995201|20294338|P5|COMPLETED|From Baseline Until Week 24||0
8230361|NCT01995201|20294339|P4|COMPLETED|From Baseline Until Week 24||0
8230362|NCT01995201|20294340|P3|COMPLETED|From Baseline Until Week 24||0
8230363|NCT01995201|20294341|P2|COMPLETED|From Baseline Until Week 24||281
8230364|NCT01995201|20294342|P1|COMPLETED|From Baseline Until Week 24||64
8230365|NCT01995201|20294336|P7|STARTED|From Baseline Until Week 24||0
8230366|NCT01995201|20294337|P6|STARTED|From Baseline Until Week 24||0
8230367|NCT01995201|20294338|P5|STARTED|From Baseline Until Week 24||0
8230368|NCT01995201|20294339|P4|STARTED|From Baseline Until Week 24||0
8230369|NCT01995201|20294340|P3|STARTED|From Baseline Until Week 24||0
8230370|NCT01995201|20294341|P2|STARTED|From Baseline Until Week 24||327
8230371|NCT01995201|20294342|P1|STARTED|From Baseline Until Week 24||74
8230375|NCT01995136|20294466|P1|NOT COMPLETED|Overall Study||1
8230376|NCT01995136|20294466|P1|COMPLETED|Overall Study||31
8230377|NCT01995136|20294466|P1|STARTED|Overall Study||32
8230378|NCT01995123|20294472|P2|NOT COMPLETED|Overall Study||15
8230379|NCT01995123|20294473|P1|NOT COMPLETED|Overall Study||18
8230380|NCT01995123|20294472|P2|COMPLETED|Overall Study||46
8230381|NCT01995123|20294473|P1|COMPLETED|Overall Study||45
8230382|NCT01995123|20294472|P2|STARTED|Overall Study||61
8230383|NCT01995123|20294473|P1|STARTED|Overall Study||63
8230384|NCT01995071|20294495|P12|NOT COMPLETED|Overall Study||0
8230385|NCT01995071|20294496|P11|NOT COMPLETED|Overall Study||1
8230386|NCT01995071|20294497|P10|NOT COMPLETED|Overall Study||0
8230387|NCT01995071|20294498|P9|NOT COMPLETED|Overall Study||1
8230388|NCT01995071|20294499|P8|NOT COMPLETED|Overall Study||2
8230389|NCT01995071|20294500|P7|NOT COMPLETED|Overall Study||1
8230390|NCT01995071|20294501|P6|NOT COMPLETED|Overall Study||0
8230391|NCT01995071|20294502|P5|NOT COMPLETED|Overall Study||1
8230392|NCT01995071|20294503|P4|NOT COMPLETED|Overall Study||0
8230393|NCT01995071|20294504|P3|NOT COMPLETED|Overall Study||1
8230394|NCT01995071|20294505|P2|NOT COMPLETED|Overall Study||0
8230395|NCT01995071|20294506|P1|NOT COMPLETED|Overall Study||1
8230396|NCT01995071|20294495|P12|COMPLETED|Overall Study||0
8230397|NCT01995071|20294496|P11|COMPLETED|Overall Study||7
8230398|NCT01995071|20294497|P10|COMPLETED|Overall Study||8
8230399|NCT01995071|20294498|P9|COMPLETED|Overall Study||7
8230400|NCT01995071|20294499|P8|COMPLETED|Overall Study||6
8230401|NCT01995071|20294500|P7|COMPLETED|Overall Study||7
8230402|NCT01995071|20294501|P6|COMPLETED|Overall Study||8
8230403|NCT01995071|20294502|P5|COMPLETED|Overall Study||7
8230404|NCT01995071|20294503|P4|COMPLETED|Overall Study||8
8230405|NCT01995071|20294504|P3|COMPLETED|Overall Study||8
8230406|NCT01995071|20294505|P2|COMPLETED|Overall Study||8
8230407|NCT01995071|20294506|P1|COMPLETED|Overall Study||7
8230408|NCT01995071|20294495|P12|STARTED|Overall Study||0
8230409|NCT01995071|20294496|P11|STARTED|Overall Study||8
8230410|NCT01995071|20294497|P10|STARTED|Overall Study||8
8230411|NCT01995071|20294498|P9|STARTED|Overall Study||8
8230412|NCT01995071|20294499|P8|STARTED|Overall Study||8
8230413|NCT01995071|20294500|P7|STARTED|Overall Study||8
8230414|NCT01995071|20294501|P6|STARTED|Overall Study||8
8230415|NCT01995071|20294502|P5|STARTED|Overall Study||8
8230416|NCT01995071|20294503|P4|STARTED|Overall Study||8
8230417|NCT01995071|20294504|P3|STARTED|Overall Study||9
8230418|NCT01995071|20294505|P2|STARTED|Overall Study||8
8230419|NCT01995071|20294506|P1|STARTED|Overall Study||8
8230420|NCT01995045|20294567|P2|NOT COMPLETED|Overall Study||0
8230421|NCT01995045|20294568|P1|NOT COMPLETED|Overall Study||0
8230422|NCT01995045|20294567|P2|COMPLETED|Overall Study||28
8230423|NCT01995045|20294568|P1|COMPLETED|Overall Study||29
8230424|NCT01995045|20294567|P2|STARTED|Overall Study||28
8230425|NCT01995045|20294568|P1|STARTED|Overall Study||29
8230426|NCT01994993|20294585|P5|NOT COMPLETED|Overall Study||2
8230427|NCT01994993|20294586|P4|NOT COMPLETED|Overall Study||46
8230428|NCT01994993|20294587|P3|NOT COMPLETED|Overall Study||47
8230429|NCT01994993|20294588|P2|NOT COMPLETED|Overall Study||35
8230430|NCT01994993|20294589|P1|NOT COMPLETED|Overall Study||35
8230431|NCT01994993|20294585|P5|COMPLETED|Overall Study||22
8230432|NCT01994993|20294586|P4|COMPLETED|Overall Study||9
8230433|NCT01994993|20294587|P3|COMPLETED|Overall Study||23
8230434|NCT01994993|20294588|P2|COMPLETED|Overall Study||12
8230435|NCT01994993|20294589|P1|COMPLETED|Overall Study||28
8230436|NCT01994993|20294585|P5|STARTED|Overall Study||24
8230437|NCT01994993|20294586|P4|STARTED|Overall Study||55
8230438|NCT01994993|20294587|P3|STARTED|Overall Study||70
8230439|NCT01994993|20294588|P2|STARTED|Overall Study||47
8230440|NCT01994993|20294589|P1|STARTED|Overall Study||63
8230441|NCT01994954|20294643|P2|NOT COMPLETED|Overall Study||30
8230442|NCT01994954|20294644|P1|NOT COMPLETED|Overall Study||25
8230443|NCT01994954|20294643|P2|COMPLETED|Overall Study||67
8230444|NCT01994954|20294644|P1|COMPLETED|Overall Study||74
8230445|NCT01994954|20294643|P2|STARTED|Overall Study||97
8230446|NCT01994954|20294644|P1|STARTED|Overall Study||99
8230447|NCT01994902|20294662|P2|NOT COMPLETED|Test Period 2||6
8230448|NCT01994902|20294663|P1|NOT COMPLETED|Test Period 2||0
8230449|NCT01994902|20294662|P2|COMPLETED|Test Period 2||55
8230450|NCT01994902|20294663|P1|COMPLETED|Test Period 2||57
8230451|NCT01994902|20294662|P2|STARTED|Test Period 2||61
8230452|NCT01994902|20294663|P1|STARTED|Test Period 2||57
8230453|NCT01994902|20294662|P2|NOT COMPLETED|Test Period 1||3
8230454|NCT01994902|20294663|P1|NOT COMPLETED|Test Period 1||6
8230455|NCT01994902|20294662|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
8230456|NCT01994902|20294663|P1|COMPLETED|Test Period 1||57
8230457|NCT01994902|20294662|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
8230458|NCT01994902|20294663|P1|STARTED|Test Period 1||63
8230459|NCT01994889|20294672|P3|NOT COMPLETED|Overall Study||92
8230460|NCT01994889|20294673|P2|NOT COMPLETED|Overall Study||63
8230461|NCT01994889|20294674|P1|NOT COMPLETED|Overall Study||28
8230462|NCT01994889|20294672|P3|COMPLETED|Overall Study||85
8230463|NCT01994889|20294673|P2|COMPLETED|Overall Study||113
8230464|NCT01994889|20294674|P1|COMPLETED|Overall Study||60
8230465|NCT01994889|20294672|P3|STARTED|Overall Study||177
8230466|NCT01994889|20294673|P2|STARTED|Overall Study||176
8230467|NCT01994889|20294674|P1|STARTED|Overall Study||88
8230468|NCT01994876|20294693|P2|NOT COMPLETED|Test Period 2||1
8230469|NCT01994876|20294694|P1|NOT COMPLETED|Test Period 2||1
8230470|NCT01994876|20294693|P2|COMPLETED|Test Period 2||6
8230471|NCT01994876|20294694|P1|COMPLETED|Test Period 2||8
8230472|NCT01994876|20294693|P2|STARTED|Test Period 2||7
8230473|NCT01994876|20294694|P1|STARTED|Test Period 2||9
8230474|NCT01994876|20294693|P2|NOT COMPLETED|Test Period 1||2
8230475|NCT01994876|20294694|P1|NOT COMPLETED|Test Period 1||0
8230476|NCT01994876|20294693|P2|COMPLETED|Test Period 1||7
8230477|NCT01994876|20294694|P1|COMPLETED|Test Period 1||9
8230478|NCT01994876|20294693|P2|STARTED|Test Period 1||9
8230479|NCT01994876|20294694|P1|STARTED|Test Period 1||9
8230480|NCT01994876|20294693|P2|NOT COMPLETED|Baseline - Own Product||0
8230481|NCT01994876|20294694|P1|NOT COMPLETED|Baseline - Own Product||0
8230482|NCT01994876|20294693|P2|COMPLETED|Baseline - Own Product||9
8230483|NCT01994876|20294694|P1|COMPLETED|Baseline - Own Product||9
8230484|NCT01994876|20294693|P2|STARTED|Baseline - Own Product||9
8230485|NCT01994876|20294694|P1|STARTED|Baseline - Own Product||9
8230486|NCT01994863|20294702|P2|NOT COMPLETED|Period 2||4
8230487|NCT01994863|20294703|P1|NOT COMPLETED|Period 2||1
8230488|NCT01994863|20294702|P2|COMPLETED|Period 2||5
8230489|NCT01994863|20294703|P1|COMPLETED|Period 2||7
8230490|NCT01994863|20294702|P2|STARTED|Period 2||9
8230491|NCT01994863|20294703|P1|STARTED|Period 2||8
8230492|NCT01994863|20294702|P2|NOT COMPLETED|Period 1||3
8230493|NCT01994863|20294703|P1|NOT COMPLETED|Period 1||7
8230494|NCT01994863|20294702|P2|COMPLETED|Period 1||9
8230495|NCT01994863|20294703|P1|COMPLETED|Period 1||4
8230496|NCT01994863|20294702|P2|STARTED|Period 1||12
8230497|NCT01994863|20294703|P1|STARTED|Period 1||11
8230498|NCT01994850|20294709|P1|NOT COMPLETED|Overall Study||2
8230499|NCT01994850|20294709|P1|COMPLETED|Overall Study||30
8230500|NCT01994850|20294709|P1|STARTED|Overall Study||32
8230501|NCT01994837|20294714|P1|NOT COMPLETED|Overall Study||32
8230502|NCT01994837|20294714|P1|COMPLETED|Overall Study||0
8230503|NCT01994837|20294714|P1|Treated|Overall Study||32
8230504|NCT01994837|20294714|P1|STARTED|Overall Study||32
8230505|NCT01994785|20294731|P4|NOT COMPLETED|Overall Study||3
8230506|NCT01994785|20294732|P3|NOT COMPLETED|Overall Study||0
8230507|NCT01994785|20294733|P2|NOT COMPLETED|Overall Study||1
8230508|NCT01994785|20294734|P1|NOT COMPLETED|Overall Study||8
8230509|NCT01994785|20294731|P4|COMPLETED|Overall Study||114
8230510|NCT01994785|20294732|P3|COMPLETED|Overall Study||117
8230511|NCT01994785|20294733|P2|COMPLETED|Overall Study||108
8230512|NCT01994785|20294734|P1|COMPLETED|Overall Study||101
8230513|NCT01994785|20294731|P4|STARTED|Overall Study||117
8230514|NCT01994785|20294732|P3|STARTED|Overall Study||117
8230515|NCT01994785|20294733|P2|STARTED|Overall Study||109
8230516|NCT01994785|20294734|P1|STARTED|Overall Study||109
8230517|NCT01994746|20294744|P2|NOT COMPLETED|Second Visit||0
8230518|NCT01994746|20294745|P1|NOT COMPLETED|Second Visit||0
8230519|NCT01994746|20294744|P2|COMPLETED|Second Visit||38
8230520|NCT01994746|20294745|P1|COMPLETED|Second Visit||38
8230521|NCT01994746|20294744|P2|Completed Both Dosing Visits|Second Visit||38
8230522|NCT01994746|20294745|P1|Completed Both Dosing Visits|Second Visit||38
8230523|NCT01994746|20294744|P2|STARTED|Second Visit||38
8230524|NCT01994746|20294745|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
8230525|NCT01994746|20294744|P2|NOT COMPLETED|First Visit||0
8230526|NCT01994746|20294745|P1|NOT COMPLETED|First Visit||0
8230527|NCT01994746|20294744|P2|COMPLETED|First Visit||38
8230528|NCT01994746|20294745|P1|COMPLETED|First Visit||39
8230529|NCT01994746|20294744|P2|Received At Least 1 Dose|First Visit||38
8230530|NCT01994746|20294745|P1|Received At Least 1 Dose|First Visit||39
8230531|NCT01994746|20294744|P2|STARTED|First Visit||38
8230532|NCT01994746|20294745|P1|STARTED|First Visit||39
8230533|NCT01994720|20294771|P2|NOT COMPLETED|Overall Study||56
8230534|NCT01994720|20294772|P1|NOT COMPLETED|Overall Study||46
8230535|NCT01994720|20294771|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
8230536|NCT01994720|20294772|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
8230537|NCT01994720|20294771|P2|STARTED|Overall Study||6610
8230538|NCT01994720|20294772|P1|STARTED|Overall Study||6589
8230539|NCT01994629|20294814|P2|NOT COMPLETED|Overall Study||3
8230540|NCT01994629|20294815|P1|NOT COMPLETED|Overall Study||1
8230541|NCT01994629|20294814|P2|COMPLETED|Overall Study||99
8230542|NCT01994629|20294815|P1|COMPLETED|Overall Study||99
8230543|NCT01994629|20294814|P2|STARTED|Overall Study||102
8230544|NCT01994629|20294815|P1|STARTED|Overall Study||100
8230545|NCT01994590|20294839|P1|NOT COMPLETED|Overall Study||2
8230546|NCT01994590|20294839|P1|COMPLETED|Overall Study||2
8230547|NCT01994590|20294839|P1|STARTED|Overall Study||4
8230548|NCT01994538|20294845|P2|NOT COMPLETED|Overall Study||0
8230549|NCT01994538|20294846|P1|NOT COMPLETED|Overall Study||0
8230550|NCT01994538|20294845|P2|COMPLETED|Overall Study||136
8230551|NCT01994538|20294846|P1|COMPLETED|Overall Study||136
8230552|NCT01994538|20294845|P2|STARTED|Overall Study||136
8230553|NCT01994538|20294846|P1|STARTED|Overall Study||136
8230554|NCT01994486|20294856|P1|NOT COMPLETED|Overall Study||0
8230555|NCT01994486|20294856|P1|COMPLETED|Overall Study||20
8230556|NCT01994486|20294856|P1|STARTED|Overall Study||20
8230557|NCT01994395|20294867|P2|NOT COMPLETED|Overall Study||2
8230558|NCT01994395|20294868|P1|NOT COMPLETED|Overall Study||1
8230559|NCT01994395|20294867|P2|COMPLETED|Overall Study||25
8230560|NCT01994395|20294868|P1|COMPLETED|Overall Study||25
8230561|NCT01994395|20294867|P2|STARTED|Overall Study||27
8230562|NCT01994395|20294868|P1|STARTED|Overall Study||26
8230563|NCT01994291|20294893|P3|NOT COMPLETED|Overall Study||9
8230564|NCT01994291|20294894|P2|NOT COMPLETED|Overall Study||7
8230565|NCT01994291|20294895|P1|NOT COMPLETED|Overall Study||15
8230566|NCT01994291|20294893|P3|COMPLETED|Overall Study||47
8230567|NCT01994291|20294894|P2|COMPLETED|Overall Study||36
8230568|NCT01994291|20294895|P1|COMPLETED|Overall Study||84
8230569|NCT01994291|20294893|P3|Received Treatment|Overall Study||56
8230570|NCT01994291|20294894|P2|Received Treatment|Overall Study||43
8230571|NCT01994291|20294895|P1|Received Treatment|Overall Study||99
8230572|NCT01994291|20294893|P3|STARTED|Overall Study||56
8230573|NCT01994291|20294894|P2|STARTED|Overall Study||43
8230574|NCT01994291|20294895|P1|STARTED|Overall Study||99
8230575|NCT01994226|20294951|P2|NOT COMPLETED|Overall Study||21
8230576|NCT01994226|20294952|P1|NOT COMPLETED|Overall Study||19
8230577|NCT01994226|20294951|P2|COMPLETED|Overall Study||179
8230578|NCT01994226|20294952|P1|COMPLETED|Overall Study||180
8230579|NCT01994226|20294951|P2|STARTED|Overall Study||200
8230580|NCT01994226|20294952|P1|STARTED|Overall Study||199
8230581|NCT01994109|20294961|P4|NOT COMPLETED|Open-label Phase (Part B)||42
8230582|NCT01994109|20294962|P3|NOT COMPLETED|Open-label Phase (Part B)||0
8230583|NCT01994109|20294963|P2|NOT COMPLETED|Open-label Phase (Part B)||0
8230584|NCT01994109|20294964|P1|NOT COMPLETED|Open-label Phase (Part B)||0
8230585|NCT01994109|20294961|P4|COMPLETED|Open-label Phase (Part B)||128
8230586|NCT01994109|20294962|P3|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
8230587|NCT01994109|20294963|P2|COMPLETED|Open-label Phase (Part B)||0
8230588|NCT01994109|20294964|P1|COMPLETED|Open-label Phase (Part B)||0
8230589|NCT01994109|20294961|P4|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
8230590|NCT01994109|20294962|P3|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
8230591|NCT01994109|20294963|P2|STARTED|Open-label Phase (Part B)||0
8230592|NCT01994109|20294964|P1|STARTED|Open-label Phase (Part B)||0
8230593|NCT01994109|20294961|P4|NOT COMPLETED|Double-blind Phase (Part A)||0
8230594|NCT01994109|20294962|P3|NOT COMPLETED|Double-blind Phase (Part A)||7
8230595|NCT01994109|20294963|P2|NOT COMPLETED|Double-blind Phase (Part A)||3
8230596|NCT01994109|20294964|P1|NOT COMPLETED|Double-blind Phase (Part A)||1
8230597|NCT01994109|20294961|P4|COMPLETED|Double-blind Phase (Part A)||0
8230598|NCT01994109|20294962|P3|COMPLETED|Double-blind Phase (Part A)||53
8230599|NCT01994109|20294963|P2|COMPLETED|Double-blind Phase (Part A)||61
8230600|NCT01994109|20294964|P1|COMPLETED|Double-blind Phase (Part A)||62
8230601|NCT01994109|20294961|P4|STARTED|Double-blind Phase (Part A)||0
8230602|NCT01994109|20294962|P3|STARTED|Double-blind Phase (Part A)||60
8230603|NCT01994109|20294963|P2|STARTED|Double-blind Phase (Part A)||64
8230604|NCT01994109|20294964|P1|STARTED|Double-blind Phase (Part A)||63
8230605|NCT01993940|20294978|P2|NOT COMPLETED|Overall Study||44
8230606|NCT01993940|20294979|P1|NOT COMPLETED|Overall Study||40
8230607|NCT01993940|20294978|P2|COMPLETED|Overall Study||232
8230608|NCT01993940|20294979|P1|COMPLETED|Overall Study||237
8230609|NCT01993940|20294978|P2|Received Treatment|Overall Study||276
8230610|NCT01993940|20294979|P1|Received Treatment|Overall Study||272
8230611|NCT01993940|20294978|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
8230612|NCT01993940|20294979|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
8230613|NCT01993927|20294993|P1|NOT COMPLETED|Overall Study||29
8230614|NCT01993927|20294993|P1|COMPLETED|Overall Study||713
8230615|NCT01993927|20294993|P1|STARTED|Overall Study||742
8230616|NCT01993888|20295001|P2|NOT COMPLETED|Overall Study||3
8230617|NCT01993888|20295002|P1|NOT COMPLETED|Overall Study||2
8230618|NCT01993888|20295001|P2|COMPLETED|Overall Study||49
8230619|NCT01993888|20295002|P1|COMPLETED|Overall Study||48
8230620|NCT01993888|20295001|P2|STARTED|Overall Study||52
8230621|NCT01993888|20295002|P1|STARTED|Overall Study||50
8230622|NCT01993875|20295020|P2|NOT COMPLETED|Overall Study||6
8230623|NCT01993875|20295021|P1|NOT COMPLETED|Overall Study||7
8230624|NCT01993875|20295020|P2|COMPLETED|Overall Study||76
8230625|NCT01993875|20295021|P1|COMPLETED|Overall Study||75
8230626|NCT01993875|20295020|P2|STARTED|Overall Study||82
8230627|NCT01993875|20295021|P1|STARTED|Overall Study||82
8230628|NCT01993849|20295039|P2|NOT COMPLETED|Overall Study||2
8230629|NCT01993849|20295040|P1|NOT COMPLETED|Overall Study||3
8230630|NCT01993849|20295039|P2|COMPLETED|Overall Study||9
8230631|NCT01993849|20295040|P1|COMPLETED|Overall Study||9
8230632|NCT01993849|20295039|P2|STARTED|Overall Study||11
8230633|NCT01993849|20295040|P1|STARTED|Overall Study||12
8230634|NCT01993836|20295051|P3|NOT COMPLETED|Overall Study||5
8230635|NCT01993836|20295052|P2|NOT COMPLETED|Overall Study||13
8230636|NCT01993836|20295053|P1|NOT COMPLETED|Overall Study||17
8230637|NCT01993836|20295051|P3|COMPLETED|Overall Study||46
8230638|NCT01993836|20295052|P2|COMPLETED|Overall Study||55
8230639|NCT01993836|20295053|P1|COMPLETED|Overall Study||55
8230640|NCT01993836|20295051|P3|STARTED|Overall Study||51
8230641|NCT01993836|20295052|P2|STARTED|Overall Study||68
8230642|NCT01993836|20295053|P1|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
8230643|NCT01993823|20295069|P2|NOT COMPLETED|Overall Study||16
8230644|NCT01993823|20295070|P1|NOT COMPLETED|Overall Study||7
8230645|NCT01993823|20295069|P2|COMPLETED|Overall Study||79
8230646|NCT01993823|20295070|P1|COMPLETED|Overall Study||88
8230647|NCT01993823|20295069|P2|STARTED|Overall Study||95
8230648|NCT01993823|20295070|P1|STARTED|Overall Study||95
8230649|NCT01993667|20295080|P2|NOT COMPLETED|Overall Study||19
8230650|NCT01993667|20295081|P1|NOT COMPLETED|Overall Study||21
8230651|NCT01993667|20295080|P2|COMPLETED|Overall Study||47
8230652|NCT01993667|20295081|P1|COMPLETED|Overall Study||43
8230653|NCT01993667|20295080|P2|STARTED|Overall Study||66
8230654|NCT01993667|20295081|P1|STARTED|Overall Study||64
8230655|NCT01993615|20295091|P2|NOT COMPLETED|Overall Study||0
8230656|NCT01993615|20295092|P1|NOT COMPLETED|Overall Study||1
8230657|NCT01993615|20295091|P2|COMPLETED|Overall Study||40
8230658|NCT01993615|20295092|P1|COMPLETED|Overall Study||39
8230659|NCT01993615|20295091|P2|STARTED|Overall Study||40
8230660|NCT01993615|20295092|P1|STARTED|Overall Study||40
8230661|NCT01993238|20295104|P1|NOT COMPLETED|Overall Study||0
8230662|NCT01993238|20295104|P1|COMPLETED|Overall Study||11
8230663|NCT01993238|20295104|P1|STARTED|Overall Study||11
8230664|NCT01993186|20295111|P2|NOT COMPLETED|Open-Label Extension Period||6
8230665|NCT01993186|20295112|P1|NOT COMPLETED|Open-Label Extension Period||7
8230666|NCT01993186|20295111|P2|COMPLETED|Open-Label Extension Period||5
8230667|NCT01993186|20295112|P1|COMPLETED|Open-Label Extension Period||16
8230668|NCT01993186|20295111|P2|STARTED|Open-Label Extension Period||11
8230669|NCT01993186|20295112|P1|STARTED|Open-Label Extension Period||23
8230670|NCT01993186|20295111|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
8230671|NCT01993186|20295112|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
8230672|NCT01993186|20295111|P2|COMPLETED|Double-Blind Placebo-Controlled Period||11
8230673|NCT01993186|20295112|P1|COMPLETED|Double-Blind Placebo-Controlled Period||23
8230674|NCT01993186|20295111|P2|STARTED|Double-Blind Placebo-Controlled Period||11
8230675|NCT01993186|20295112|P1|STARTED|Double-Blind Placebo-Controlled Period||25
8230676|NCT01993108|20295157|P2|NOT COMPLETED|Overall Study||0
8230677|NCT01993108|20295158|P1|NOT COMPLETED|Overall Study||0
8230678|NCT01993108|20295157|P2|COMPLETED|Overall Study||12
8230679|NCT01993108|20295158|P1|COMPLETED|Overall Study||11
8230680|NCT01993108|20295157|P2|STARTED|Overall Study||12
8230681|NCT01993108|20295158|P1|STARTED|Overall Study||11
8230682|NCT01993030|20295189|P2|NOT COMPLETED|Overall Study||4
8230683|NCT01993030|20295190|P1|NOT COMPLETED|Overall Study||0
8230684|NCT01993030|20295189|P2|COMPLETED|Overall Study||31
8230685|NCT01993030|20295190|P1|COMPLETED|Overall Study||36
8230686|NCT01993030|20295189|P2|STARTED|Overall Study||35
8230687|NCT01993030|20295190|P1|STARTED|Overall Study||36
8230688|NCT01993017|20295207|P3|NOT COMPLETED|Overall Study||79
8230689|NCT01993017|20295208|P2|NOT COMPLETED|Overall Study||90
8230690|NCT01993017|20295209|P1|NOT COMPLETED|Overall Study||106
8230691|NCT01993017|20295207|P3|COMPLETED|Overall Study||421
8230692|NCT01993017|20295208|P2|COMPLETED|Overall Study||411
8230693|NCT01993017|20295209|P1|COMPLETED|Overall Study||393
8230694|NCT01993017|20295207|P3|STARTED|Overall Study||500
8230695|NCT01993017|20295208|P2|STARTED|Overall Study||501
8230696|NCT01993017|20295209|P1|STARTED|Overall Study||499
8230697|NCT01992874|20295220|P3|NOT COMPLETED|Part B||0
8230698|NCT01992874|20295221|P2|NOT COMPLETED|Part B||0
8230699|NCT01992874|20295222|P1|NOT COMPLETED|Part B||0
8230700|NCT01992874|20295220|P3|COMPLETED|Part B||38
8230701|NCT01992874|20295221|P2|COMPLETED|Part B||0
8230702|NCT01992874|20295222|P1|COMPLETED|Part B||0
8230703|NCT01992874|20295220|P3|STARTED|Part B||38
8230704|NCT01992874|20295221|P2|STARTED|Part B||0
8230705|NCT01992874|20295222|P1|STARTED|Part B||0
8230706|NCT01992874|20295220|P3|NOT COMPLETED|Part A||0
8230707|NCT01992874|20295221|P2|NOT COMPLETED|Part A||0
8230708|NCT01992874|20295222|P1|NOT COMPLETED|Part A||0
8230709|NCT01992874|20295220|P3|COMPLETED|Part A||0
8230710|NCT01992874|20295221|P2|COMPLETED|Part A||17
8230711|NCT01992874|20295222|P1|COMPLETED|Part A||21
8230712|NCT01992874|20295220|P3|STARTED|Part A||0
8230713|NCT01992874|20295221|P2|STARTED|Part A||17
8230714|NCT01992874|20295222|P1|STARTED|Part A||21
8230715|NCT01992757|20295250|P1|NOT COMPLETED|Overall Study||2
8230716|NCT01992757|20295250|P1|COMPLETED|Overall Study||49
8230717|NCT01992757|20295250|P1|STARTED|Overall Study||51
8230718|NCT01992653|20295263|P8|NOT COMPLETED|Overall Study||4
8230719|NCT01992653|20295264|P7|NOT COMPLETED|Overall Study||8
8230720|NCT01992653|20295265|P6|NOT COMPLETED|Overall Study||0
8230721|NCT01992653|20295266|P5|NOT COMPLETED|Overall Study||1
8230722|NCT01992653|20295267|P4|NOT COMPLETED|Overall Study||0
8230723|NCT01992653|20295268|P3|NOT COMPLETED|Overall Study||1
8230724|NCT01992653|20295269|P2|NOT COMPLETED|Overall Study||0
8230725|NCT01992653|20295270|P1|NOT COMPLETED|Overall Study||0
8230726|NCT01992653|20295263|P8|COMPLETED|Overall Study||13
8230727|NCT01992653|20295264|P7|COMPLETED|Overall Study||32
8230728|NCT01992653|20295265|P6|COMPLETED|Overall Study||6
8230729|NCT01992653|20295266|P5|COMPLETED|Overall Study||5
8230730|NCT01992653|20295267|P4|COMPLETED|Overall Study||1
8230731|NCT01992653|20295268|P3|COMPLETED|Overall Study||5
8230732|NCT01992653|20295269|P2|COMPLETED|Overall Study||3
8230733|NCT01992653|20295270|P1|COMPLETED|Overall Study||3
8230734|NCT01992653|20295263|P8|STARTED|Overall Study||17
8230735|NCT01992653|20295264|P7|STARTED|Overall Study||40
8230736|NCT01992653|20295265|P6|STARTED|Overall Study||6
8230737|NCT01992653|20295266|P5|STARTED|Overall Study||6
8230738|NCT01992653|20295267|P4|STARTED|Overall Study||1
8230739|NCT01992653|20295268|P3|STARTED|Overall Study||6
8230740|NCT01992653|20295269|P2|STARTED|Overall Study||3
8230741|NCT01992653|20295270|P1|STARTED|Overall Study||3
8230742|NCT01992549|20295496|P1|NOT COMPLETED|Overall Study||4
8230743|NCT01992549|20295496|P1|COMPLETED|Overall Study||44
8230744|NCT01992549|20295496|P1|SURG Population|Overall Study||3
8230745|NCT01992549|20295496|P1|BLEED Population|Overall Study||29
8230746|NCT01992549|20295496|P1|PROPH Population|Overall Study||47
8230747|NCT01992549|20295496|P1|ITT Population|Overall Study||47
8230748|NCT01992549|20295496|P1|SAF Population|Overall Study||48
8230749|NCT01992549|20295496|P1|STARTED|Overall Study||48
8230750|NCT01992536|20295516|P10|NOT COMPLETED|Overall Study||1
8230751|NCT01992536|20295517|P9|NOT COMPLETED|Overall Study||1
8230752|NCT01992536|20295518|P8|NOT COMPLETED|Overall Study||0
8230753|NCT01992536|20295519|P7|NOT COMPLETED|Overall Study||7
8230754|NCT01992536|20295520|P6|NOT COMPLETED|Overall Study||1
8230755|NCT01992536|20295521|P5|NOT COMPLETED|Overall Study||0
8230756|NCT01992536|20295522|P4|NOT COMPLETED|Overall Study||2
8230757|NCT01992536|20295523|P3|NOT COMPLETED|Overall Study||1
8230758|NCT01992536|20295524|P2|NOT COMPLETED|Overall Study||3
8230759|NCT01992536|20295525|P1|NOT COMPLETED|Overall Study||4
8230760|NCT01992536|20295516|P10|COMPLETED|Overall Study||18
8230761|NCT01992536|20295517|P9|COMPLETED|Overall Study||18
8230762|NCT01992536|20295518|P8|COMPLETED|Overall Study||21
8230763|NCT01992536|20295519|P7|COMPLETED|Overall Study||0
8230764|NCT01992536|20295520|P6|COMPLETED|Overall Study||20
8230765|NCT01992536|20295521|P5|COMPLETED|Overall Study||11
8230766|NCT01992536|20295522|P4|COMPLETED|Overall Study||22
8230767|NCT01992536|20295523|P3|COMPLETED|Overall Study||16
8230768|NCT01992536|20295524|P2|COMPLETED|Overall Study||22
8230769|NCT01992536|20295525|P1|COMPLETED|Overall Study||22
8230770|NCT01992536|20295516|P10|STARTED|Overall Study||19
8230771|NCT01992536|20295517|P9|STARTED|Overall Study||19
8230772|NCT01992536|20295518|P8|STARTED|Overall Study||21
8230773|NCT01992536|20295519|P7|STARTED|Overall Study||7
8230774|NCT01992536|20295520|P6|STARTED|Overall Study||21
8230775|NCT01992536|20295521|P5|STARTED|Overall Study||11
8230776|NCT01992536|20295522|P4|STARTED|Overall Study||24
8230777|NCT01992536|20295523|P3|STARTED|Overall Study||17
8230778|NCT01992536|20295524|P2|STARTED|Overall Study||25
8230779|NCT01992536|20295525|P1|STARTED|Overall Study||26
8230780|NCT01992523|20295742|P2|NOT COMPLETED|Overall Study||0
8230781|NCT01992523|20295743|P1|NOT COMPLETED|Overall Study||0
8230782|NCT01992523|20295742|P2|COMPLETED|Overall Study||41
8230783|NCT01992523|20295743|P1|COMPLETED|Overall Study||41
8230784|NCT01992523|20295742|P2|STARTED|Overall Study||41
8230785|NCT01992523|20295743|P1|STARTED|Overall Study||41
8230786|NCT01992380|20295758|P3|NOT COMPLETED|Overall Study||0
8230787|NCT01992380|20295759|P2|NOT COMPLETED|Overall Study||0
8230788|NCT01992380|20295760|P1|NOT COMPLETED|Overall Study||0
8230789|NCT01992380|20295758|P3|COMPLETED|Overall Study||10
8230790|NCT01992380|20295759|P2|COMPLETED|Overall Study||8
8230791|NCT01992380|20295760|P1|COMPLETED|Overall Study||6
8230792|NCT01992380|20295758|P3|STARTED|Overall Study||10
8230793|NCT01992380|20295759|P2|STARTED|Overall Study||8
8230794|NCT01992380|20295760|P1|STARTED|Overall Study||6
8230795|NCT01992354|20295767|P1|NOT COMPLETED|Overall Study||0
8230796|NCT01992354|20295767|P1|COMPLETED|Overall Study||4
8230797|NCT01992354|20295767|P1|STARTED|Overall Study||4
8230798|NCT01992185|20295774|P2|NOT COMPLETED|Overall Study||0
8230799|NCT01992185|20295775|P1|NOT COMPLETED|Overall Study||0
8230800|NCT01992185|20295774|P2|COMPLETED|Overall Study||8
8230801|NCT01992185|20295775|P1|COMPLETED|Overall Study||7
8230802|NCT01992185|20295774|P2|STARTED|Overall Study||8
8230803|NCT01992185|20295775|P1|STARTED|Overall Study||7
8230804|NCT01992172|20295783|P2|NOT COMPLETED|Overall Study||0
8230805|NCT01992172|20295784|P1|NOT COMPLETED|Overall Study||0
8230806|NCT01992172|20295783|P2|COMPLETED|Overall Study||0
8230807|NCT01992172|20295784|P1|COMPLETED|Overall Study||7
8230808|NCT01992172|20295783|P2|STARTED|Overall Study||0
8230809|NCT01992172|20295784|P1|STARTED|Overall Study||7
8230810|NCT01992159|20295794|P4|NOT COMPLETED|Overall Study||4
8230811|NCT01992159|20295795|P3|NOT COMPLETED|Overall Study||1
8230812|NCT01992159|20295796|P2|NOT COMPLETED|Overall Study||8
8230813|NCT01992159|20295797|P1|NOT COMPLETED|Overall Study||4
8230814|NCT01992159|20295794|P4|COMPLETED|Overall Study||59
8230815|NCT01992159|20295795|P3|COMPLETED|Overall Study||62
8230816|NCT01992159|20295796|P2|COMPLETED|Overall Study||55
8230817|NCT01992159|20295797|P1|COMPLETED|Overall Study||59
8230818|NCT01992159|20295794|P4|Completed First 12 Months of Study|Overall Study||59
8230819|NCT01992159|20295795|P3|Completed First 12 Months of Study|Overall Study||63
8230820|NCT01992159|20295796|P2|Completed First 12 Months of Study|Overall Study||56
8230821|NCT01992159|20295797|P1|Completed First 12 Months of Study|Overall Study||59
8230822|NCT01992159|20295794|P4|Received Treatment|Overall Study||63
8230823|NCT01992159|20295795|P3|Received Treatment|Overall Study||63
8230824|NCT01992159|20295796|P2|Received Treatment|Overall Study||63
8230825|NCT01992159|20295797|P1|Received Treatment|Overall Study||63
8230826|NCT01992159|20295794|P4|STARTED|Overall Study||63
8230827|NCT01992159|20295795|P3|STARTED|Overall Study||63
8230828|NCT01992159|20295796|P2|STARTED|Overall Study||63
8230829|NCT01992159|20295797|P1|STARTED|Overall Study||63
8230830|NCT01992107|20295850|P3|NOT COMPLETED|Overall Study||36
8230831|NCT01992107|20295851|P2|NOT COMPLETED|Overall Study||33
8230832|NCT01992107|20295852|P1|NOT COMPLETED|Overall Study||68
8230833|NCT01992107|20295850|P3|COMPLETED|Overall Study||545
8230834|NCT01992107|20295851|P2|COMPLETED|Overall Study||560
8230835|NCT01992107|20295852|P1|COMPLETED|Overall Study||1091
8230836|NCT01992107|20295850|P3|STARTED|Overall Study||581
8230837|NCT01992107|20295851|P2|STARTED|Overall Study||593
8230838|NCT01992107|20295852|P1|STARTED|Overall Study||1159
8230839|NCT01992094|20295908|P3|NOT COMPLETED|Overall Study||21
8230840|NCT01992094|20295909|P2|NOT COMPLETED|Overall Study||24
8230841|NCT01992094|20295910|P1|NOT COMPLETED|Overall Study||50
8230842|NCT01992094|20295908|P3|COMPLETED|Overall Study||648
8230843|NCT01992094|20295909|P2|COMPLETED|Overall Study||652
8230844|NCT01992094|20295910|P1|COMPLETED|Overall Study||1285
8230845|NCT01992094|20295908|P3|STARTED|Overall Study||669
8230846|NCT01992094|20295909|P2|STARTED|Overall Study||676
8230847|NCT01992094|20295910|P1|STARTED|Overall Study||1335
8230848|NCT01992016|20295968|P2|NOT COMPLETED|Overall Study||0
8230849|NCT01992016|20295969|P1|NOT COMPLETED|Overall Study||0
8230850|NCT01992016|20295968|P2|COMPLETED|Overall Study||7
8230851|NCT01992016|20295969|P1|COMPLETED|Overall Study||4
8230852|NCT01992016|20295968|P2|STARTED|Overall Study||7
8230853|NCT01992016|20295969|P1|STARTED|Overall Study||4
8230854|NCT01991990|20295977|P2|NOT COMPLETED|Overall Study||0
8230855|NCT01991990|20295978|P1|NOT COMPLETED|Overall Study||0
8230856|NCT01991990|20295977|P2|COMPLETED|Overall Study||12
8230857|NCT01991990|20295978|P1|COMPLETED|Overall Study||6
8230858|NCT01991990|20295977|P2|STARTED|Overall Study||12
8230859|NCT01991990|20295978|P1|STARTED|Overall Study||6
8230860|NCT01991977|20296018|P1|NOT COMPLETED|Overall Study||12
8230861|NCT01991977|20296018|P1|COMPLETED|Overall Study||79
8230862|NCT01991977|20296018|P1|Evaluable for the Primary Outcome|Overall Study||39
8230863|NCT01991977|20296018|P1|Received IMRT Treatment|Overall Study||79
8230864|NCT01991977|20296018|P1|Received PET Tracer|Overall Study||84
8230865|NCT01991977|20296018|P1|STARTED|Overall Study||91
8230866|NCT01991860|20296024|P2|NOT COMPLETED|Overall Study||2
8230867|NCT01991860|20296025|P1|NOT COMPLETED|Overall Study||4
8230868|NCT01991860|20296024|P2|COMPLETED|Overall Study||164
8230869|NCT01991860|20296025|P1|COMPLETED|Overall Study||172
8230870|NCT01991860|20296024|P2|STARTED|Overall Study||166
8230871|NCT01991860|20296025|P1|STARTED|Overall Study||176
8230872|NCT01991821|20296045|P2|NOT COMPLETED|Overall Study||167
8230873|NCT01991821|20296046|P1|NOT COMPLETED|Overall Study||163
8230874|NCT01991821|20296045|P2|COMPLETED|Overall Study||11
8230875|NCT01991821|20296046|P1|COMPLETED|Overall Study||6
8230876|NCT01991821|20296045|P2|STARTED|Overall Study||178
8230877|NCT01991821|20296046|P1|STARTED|Overall Study||169
8230878|NCT01991808|20296064|P1|NOT COMPLETED|Overall Study||0
8230879|NCT01991808|20296064|P1|COMPLETED|Overall Study||16
8230880|NCT01991808|20296064|P1|STARTED|Overall Study||16
8230881|NCT01991795|20296070|P2|NOT COMPLETED|Overall Study||123
8230882|NCT01991795|20296071|P1|NOT COMPLETED|Overall Study||149
8230883|NCT01991795|20296070|P2|COMPLETED|Overall Study||9503
8230884|NCT01991795|20296071|P1|COMPLETED|Overall Study||9496
8230885|NCT01991795|20296070|P2|STARTED|Overall Study||9626
8230886|NCT01991795|20296071|P1|STARTED|Overall Study||9645
8230887|NCT01991743|20296097|P4|NOT COMPLETED|Overall Study||0
8230888|NCT01991743|20296098|P3|NOT COMPLETED|Overall Study||1
8230889|NCT01991743|20296099|P2|NOT COMPLETED|Overall Study||0
8230890|NCT01991743|20296100|P1|NOT COMPLETED|Overall Study||0
8230891|NCT01991743|20296097|P4|COMPLETED|Overall Study||60
8230892|NCT01991743|20296098|P3|COMPLETED|Overall Study||59
8230893|NCT01991743|20296099|P2|COMPLETED|Overall Study||60
8230894|NCT01991743|20296100|P1|COMPLETED|Overall Study||60
8230895|NCT01991743|20296097|P4|STARTED|Overall Study||60
8230896|NCT01991743|20296098|P3|STARTED|Overall Study||60
8230897|NCT01991743|20296099|P2|STARTED|Overall Study||60
8230898|NCT01991743|20296100|P1|STARTED|Overall Study||60
8230899|NCT01991548|20296126|P1|NOT COMPLETED|Overall Study||1
8230900|NCT01991548|20296126|P1|COMPLETED|Overall Study||39
8230901|NCT01991548|20296126|P1|STARTED|Overall Study||40
8230902|NCT01991522|20296132|P2|NOT COMPLETED|Overall Study||0
8230903|NCT01991522|20296133|P1|NOT COMPLETED|Overall Study||0
8230904|NCT01991522|20296132|P2|COMPLETED|Overall Study||17
8230905|NCT01991522|20296133|P1|COMPLETED|Overall Study||16
8230906|NCT01991522|20296132|P2|STARTED|Overall Study||17
8230907|NCT01991522|20296133|P1|STARTED|Overall Study||16
8230908|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level 1000 mg||1
8230909|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level 1000 mg||0
8230910|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level 1000 mg||0
8230911|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level 1000 mg||0
8230912|NCT01991483|20296145|P4|COMPLETED|Dose Level 1000 mg||3
8230913|NCT01991483|20296146|P3|COMPLETED|Dose Level 1000 mg||0
8230914|NCT01991483|20296147|P2|COMPLETED|Dose Level 1000 mg||0
8230915|NCT01991483|20296148|P1|COMPLETED|Dose Level 1000 mg||0
8230916|NCT01991483|20296145|P4|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
8230917|NCT01991483|20296146|P3|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8230918|NCT01991483|20296147|P2|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8230919|NCT01991483|20296148|P1|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8230920|NCT01991483|20296145|P4|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
8230921|NCT01991483|20296146|P3|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8230922|NCT01991483|20296147|P2|STARTED|Dose Level 1000 mg||0
8230923|NCT01991483|20296148|P1|STARTED|Dose Level 1000 mg||0
8230924|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level 600 mg||0
8230925|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level 600 mg||2
8230926|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level 600 mg||0
8230927|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level 600 mg||0
8230928|NCT01991483|20296145|P4|COMPLETED|Dose Level 600 mg||0
8230929|NCT01991483|20296146|P3|COMPLETED|Dose Level 600 mg||9
8230930|NCT01991483|20296147|P2|COMPLETED|Dose Level 600 mg||0
8230931|NCT01991483|20296148|P1|COMPLETED|Dose Level 600 mg||0
8230932|NCT01991483|20296145|P4|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8230933|NCT01991483|20296146|P3|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
8230934|NCT01991483|20296147|P2|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8230935|NCT01991483|20296148|P1|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8230936|NCT01991483|20296145|P4|STARTED|Dose Level 600 mg||0
8230937|NCT01991483|20296146|P3|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
8230938|NCT01991483|20296147|P2|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8230939|NCT01991483|20296148|P1|STARTED|Dose Level 600 mg||0
8230940|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level 300 mg||0
8230941|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level 300 mg||0
8230942|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level 300 mg||0
8230943|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level 300 mg||0
8230944|NCT01991483|20296145|P4|COMPLETED|Dose Level 300 mg||0
8230945|NCT01991483|20296146|P3|COMPLETED|Dose Level 300 mg||0
8230946|NCT01991483|20296147|P2|COMPLETED|Dose Level 300 mg||6
8230947|NCT01991483|20296148|P1|COMPLETED|Dose Level 300 mg||0
8230948|NCT01991483|20296145|P4|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8230949|NCT01991483|20296146|P3|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8230950|NCT01991483|20296147|P2|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
8230951|NCT01991483|20296148|P1|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8230952|NCT01991483|20296145|P4|STARTED|Dose Level 300 mg||0
8230953|NCT01991483|20296146|P3|STARTED|Dose Level 300 mg||0
8230954|NCT01991483|20296147|P2|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
8230955|NCT01991483|20296148|P1|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8230956|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level: Placebo||0
8230957|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level: Placebo||0
8230958|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level: Placebo||0
8230959|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level: Placebo||0
8230960|NCT01991483|20296145|P4|COMPLETED|Dose Level: Placebo||0
8230961|NCT01991483|20296146|P3|COMPLETED|Dose Level: Placebo||0
8230962|NCT01991483|20296147|P2|COMPLETED|Dose Level: Placebo||0
8230963|NCT01991483|20296148|P1|COMPLETED|Dose Level: Placebo||7
8230964|NCT01991483|20296145|P4|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8230965|NCT01991483|20296146|P3|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8230966|NCT01991483|20296147|P2|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8230967|NCT01991483|20296148|P1|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
8230968|NCT01991483|20296145|P4|STARTED|Dose Level: Placebo||0
8230969|NCT01991483|20296146|P3|STARTED|Dose Level: Placebo||0
8230970|NCT01991483|20296147|P2|STARTED|Dose Level: Placebo||0
8230971|NCT01991483|20296148|P1|STARTED|Dose Level: Placebo||7
8230972|NCT01991470|20296214|P1|NOT COMPLETED|Enlite 3 Period||12
8230973|NCT01991470|20296214|P1|COMPLETED|Enlite 3 Period||146
8230974|NCT01991470|20296214|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
8230975|NCT01991470|20296214|P1|NOT COMPLETED|Enlite 1 Period||20
8230976|NCT01991470|20296214|P1|COMPLETED|Enlite 1 Period||141
8230977|NCT01991470|20296214|P1|STARTED|Enlite 1 Period||161
8230978|NCT01991314|20296228|P2|NOT COMPLETED|Overall Study||11
8230979|NCT01991314|20296229|P1|NOT COMPLETED|Overall Study||11
8230980|NCT01991314|20296228|P2|COMPLETED|Overall Study||32
8230981|NCT01991314|20296229|P1|COMPLETED|Overall Study||34
8230982|NCT01991314|20296228|P2|STARTED|Overall Study||43
8230983|NCT01991314|20296229|P1|STARTED|Overall Study||45
8230984|NCT01991197|20296249|P2|NOT COMPLETED|Overall Study||3
8230985|NCT01991197|20296250|P1|NOT COMPLETED|Overall Study||3
8230986|NCT01991197|20296249|P2|COMPLETED|Overall Study||8
8230987|NCT01991197|20296250|P1|COMPLETED|Overall Study||6
8230988|NCT01991197|20296249|P2|STARTED|Overall Study||11
8230989|NCT01991197|20296250|P1|STARTED|Overall Study||9
8230990|NCT01991067|20296288|P2|NOT COMPLETED|Overall Study||5
8230991|NCT01991067|20296289|P1|NOT COMPLETED|Overall Study||6
8230992|NCT01991067|20296288|P2|COMPLETED|Overall Study||10
8230993|NCT01991067|20296289|P1|COMPLETED|Overall Study||13
8230994|NCT01991067|20296288|P2|STARTED|Overall Study||15
8230995|NCT01991067|20296289|P1|STARTED|Overall Study||19
8230996|NCT01990898|20296299|P1|NOT COMPLETED|Overall Study||4
8230997|NCT01990898|20296299|P1|COMPLETED|Overall Study||22
8230998|NCT01990898|20296299|P1|3 Months|Overall Study||22
8230999|NCT01990898|20296299|P1|STARTED|Overall Study||26
8231000|NCT01990859|20296303|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
8231001|NCT01990859|20296303|P1|COMPLETED|90 Day Follow Up for All Participants||20
8231002|NCT01990859|20296303|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
8231003|NCT01990859|20296303|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
8231004|NCT01990859|20296303|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
8231005|NCT01990859|20296303|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
8231006|NCT01990859|20296303|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
8231007|NCT01990859|20296303|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
8231008|NCT01990859|20296303|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
8231009|NCT01990820|20296316|P2|NOT COMPLETED|Overall Study||0
8231010|NCT01990820|20296317|P1|NOT COMPLETED|Overall Study||0
8231011|NCT01990820|20296316|P2|COMPLETED|Overall Study||12
8231012|NCT01990820|20296317|P1|COMPLETED|Overall Study||13
8231013|NCT01990820|20296316|P2|STARTED|Overall Study||12
8231014|NCT01990820|20296317|P1|STARTED|Overall Study||13
8231015|NCT01990794|20296323|P1|NOT COMPLETED|Overall Study||3
8231016|NCT01990794|20296323|P1|COMPLETED|Overall Study||10
8231017|NCT01990794|20296323|P1|One Month Into Study|Overall Study||10
8231018|NCT01990794|20296323|P1|STARTED|Overall Study||13
8231019|NCT01990768|20296438|P3|NOT COMPLETED|6-Month Follow-up||58
8231020|NCT01990768|20296439|P2|NOT COMPLETED|6-Month Follow-up||51
8231021|NCT01990768|20296440|P1|NOT COMPLETED|6-Month Follow-up||39
8231022|NCT01990768|20296438|P3|COMPLETED|6-Month Follow-up||288
8231023|NCT01990768|20296439|P2|COMPLETED|6-Month Follow-up||261
8231024|NCT01990768|20296440|P1|COMPLETED|6-Month Follow-up||270
8231025|NCT01990768|20296438|P3|STARTED|6-Month Follow-up||346
8231026|NCT01990768|20296439|P2|STARTED|6-Month Follow-up||312
8231027|NCT01990768|20296440|P1|STARTED|6-Month Follow-up||309
8231028|NCT01990768|20296438|P3|NOT COMPLETED|In-Hospital Study Drug Infusion||80
8231029|NCT01990768|20296439|P2|NOT COMPLETED|In-Hospital Study Drug Infusion||83
8231030|NCT01990768|20296440|P1|NOT COMPLETED|In-Hospital Study Drug Infusion||95
8231031|NCT01990768|20296438|P3|COMPLETED|In-Hospital Study Drug Infusion||266
8231032|NCT01990768|20296439|P2|COMPLETED|In-Hospital Study Drug Infusion||229
8231033|NCT01990768|20296440|P1|COMPLETED|In-Hospital Study Drug Infusion||214
8231034|NCT01990768|20296438|P3|STARTED|In-Hospital Study Drug Infusion||346
8231035|NCT01990768|20296439|P2|STARTED|In-Hospital Study Drug Infusion||312
8231036|NCT01990768|20296440|P1|STARTED|In-Hospital Study Drug Infusion||309
8231037|NCT01990768|20296438|P3|NOT COMPLETED|Prehospital Study Drug Infusion||19
8231038|NCT01990768|20296439|P2|NOT COMPLETED|Prehospital Study Drug Infusion||27
8231039|NCT01990768|20296440|P1|NOT COMPLETED|Prehospital Study Drug Infusion||19
8231040|NCT01990768|20296438|P3|COMPLETED|Prehospital Study Drug Infusion||327
8231041|NCT01990768|20296439|P2|COMPLETED|Prehospital Study Drug Infusion||285
8231042|NCT01990768|20296440|P1|COMPLETED|Prehospital Study Drug Infusion||290
8231043|NCT01990768|20296438|P3|STARTED|Prehospital Study Drug Infusion||346
8231044|NCT01990768|20296439|P2|STARTED|Prehospital Study Drug Infusion||312
8231045|NCT01990768|20296440|P1|STARTED|Prehospital Study Drug Infusion||309
8231046|NCT01990768|20296438|P3|NOT COMPLETED|Intervention Started||27
8231047|NCT01990768|20296439|P2|NOT COMPLETED|Intervention Started||33
8231048|NCT01990768|20296440|P1|NOT COMPLETED|Intervention Started||36
8231049|NCT01990768|20296438|P3|COMPLETED|Intervention Started||346
8231050|NCT01990768|20296439|P2|COMPLETED|Intervention Started||312
8231051|NCT01990768|20296440|P1|COMPLETED|Intervention Started||309
8231052|NCT01990768|20296438|P3|STARTED|Intervention Started||373
8231053|NCT01990768|20296439|P2|STARTED|Intervention Started||345
8231054|NCT01990768|20296440|P1|STARTED|Intervention Started||345
8231055|NCT01990742|20296505|P2|NOT COMPLETED|Overall Study||1353
8231056|NCT01990742|20296506|P1|NOT COMPLETED|Overall Study||407
8231057|NCT01990742|20296505|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
8231058|NCT01990742|20296506|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
8231059|NCT01990742|20296505|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
8231060|NCT01990742|20296506|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
8231061|NCT01990703|20296518|P2|NOT COMPLETED|Overall Study||45
8231062|NCT01990703|20296519|P1|NOT COMPLETED|Overall Study||39
8231063|NCT01990703|20296518|P2|COMPLETED|Overall Study||93
8231064|NCT01990703|20296519|P1|COMPLETED|Overall Study||108
8231065|NCT01990703|20296518|P2|STARTED|Overall Study||138
8231066|NCT01990703|20296519|P1|STARTED|Overall Study||147
8231067|NCT01990677|20296529|P2|NOT COMPLETED|Overall Study||1
8231068|NCT01990677|20296530|P1|NOT COMPLETED|Overall Study||2
8231069|NCT01990677|20296529|P2|COMPLETED|Overall Study||5
8231070|NCT01990677|20296530|P1|COMPLETED|Overall Study||10
8231071|NCT01990677|20296529|P2|STARTED|Overall Study||6
8231072|NCT01990677|20296530|P1|STARTED|Overall Study||12
8231073|NCT01990664|20296542|P2|NOT COMPLETED|Overall Study||11
8231074|NCT01990664|20296543|P1|NOT COMPLETED|Overall Study||7
8231075|NCT01990664|20296542|P2|COMPLETED|Overall Study||79
8231076|NCT01990664|20296543|P1|COMPLETED|Overall Study||95
8231077|NCT01990664|20296542|P2|STARTED|Overall Study||90
8231078|NCT01990664|20296543|P1|STARTED|Overall Study||102
8231079|NCT01990612|20296551|P2|NOT COMPLETED|Overall Study||3
8231080|NCT01990612|20296552|P1|NOT COMPLETED|Overall Study||7
8231081|NCT01990612|20296551|P2|COMPLETED|Overall Study||3059
8231082|NCT01990612|20296552|P1|COMPLETED|Overall Study||3037
8231083|NCT01990612|20296551|P2|STARTED|Overall Study||3062
8231084|NCT01990612|20296552|P1|STARTED|Overall Study||3044
8231085|NCT01990573|20296633|P3|NOT COMPLETED|Overall Study||1
8231086|NCT01990573|20296634|P2|NOT COMPLETED|Overall Study||0
8231087|NCT01990573|20296635|P1|NOT COMPLETED|Overall Study||0
8231088|NCT01990573|20296633|P3|COMPLETED|Overall Study||16
8231089|NCT01990573|20296634|P2|COMPLETED|Overall Study||14
8231090|NCT01990573|20296635|P1|COMPLETED|Overall Study||20
8231091|NCT01990573|20296633|P3|STARTED|Overall Study||17
8231092|NCT01990573|20296634|P2|STARTED|Overall Study||14
8231093|NCT01990573|20296635|P1|STARTED|Overall Study||20
8231094|NCT01990560|20296648|P1|NOT COMPLETED|Overall Study||1
8231095|NCT01990560|20296648|P1|COMPLETED|Overall Study||7
8231096|NCT01990560|20296648|P1|STARTED|Overall Study||8
8231097|NCT01990534|20296662|P1|NOT COMPLETED|Overall Study||60
8231098|NCT01990534|20296662|P1|COMPLETED|Overall Study||0
8231099|NCT01990534|20296662|P1|Ongoing|Overall Study||36
8231100|NCT01990534|20296662|P1|STARTED|Overall Study||60
8231101|NCT01990495|20296680|P2|NOT COMPLETED|Overall Study||4
8231102|NCT01990495|20296681|P1|NOT COMPLETED|Overall Study||5
8231103|NCT01990495|20296680|P2|COMPLETED|Overall Study||15
8231104|NCT01990495|20296681|P1|COMPLETED|Overall Study||13
8231105|NCT01990495|20296680|P2|STARTED|Overall Study||19
8231106|NCT01990495|20296681|P1|STARTED|Overall Study||18
8231107|NCT01990339|20296691|P1|NOT COMPLETED|Overall Study||2312
8231108|NCT01990339|20296691|P1|COMPLETED|Overall Study||12653
8231109|NCT01990339|20296691|P1|STARTED|Overall Study||14965
8231110|NCT01990313|20296696|P1|NOT COMPLETED|Overall Study||1
8231111|NCT01990313|20296696|P1|COMPLETED|Overall Study||14
8231112|NCT01990313|20296696|P1|STARTED|Overall Study||15
8231113|NCT01990300|20296701|P1|NOT COMPLETED|Overall Study||142
8231114|NCT01990300|20296701|P1|COMPLETED|Overall Study||3139
8231115|NCT01990300|20296701|P1|STARTED|Overall Study||3281
8231116|NCT01990261|20296707|P1|NOT COMPLETED|Overall Study||25
8231117|NCT01990261|20296707|P1|COMPLETED|Overall Study||8
8231118|NCT01990261|20296707|P1|Treated|Overall Study||29
8231119|NCT01990261|20296707|P1|STARTED|Overall Study||33
8231120|NCT01989975|20296717|P1|NOT COMPLETED|Overall Study||0
8231121|NCT01989975|20296717|P1|COMPLETED|Overall Study||40
8231122|NCT01989975|20296717|P1|STARTED|Overall Study||40
8231123|NCT01989910|20296726|P2|NOT COMPLETED|Overall Study||0
8231124|NCT01989910|20296727|P1|NOT COMPLETED|Overall Study||2
8231125|NCT01989910|20296726|P2|COMPLETED|Overall Study||54
8231126|NCT01989910|20296727|P1|COMPLETED|Overall Study||51
8231127|NCT01989910|20296726|P2|STARTED|Overall Study||54
8231128|NCT01989910|20296727|P1|STARTED|Overall Study||53
8231129|NCT01989793|20296739|P2|NOT COMPLETED|Overall Study||4
8231130|NCT01989793|20296740|P1|NOT COMPLETED|Overall Study||8
8231131|NCT01989793|20296739|P2|COMPLETED|Overall Study||15
8231132|NCT01989793|20296740|P1|COMPLETED|Overall Study||10
8231133|NCT01989793|20296739|P2|STARTED|Overall Study||19
8231134|NCT01989793|20296740|P1|STARTED|Overall Study||18
8231135|NCT01989754|20296764|P2|NOT COMPLETED|Overall Study||35
8231136|NCT01989754|20296765|P1|NOT COMPLETED|Overall Study||39
8231137|NCT01989754|20296764|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
8231138|NCT01989754|20296765|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
8231139|NCT01989754|20296764|P2|Treated|Overall Study||2904
8231140|NCT01989754|20296765|P1|Treated|Overall Study||2903
8231141|NCT01989754|20296764|P2|STARTED|Overall Study||2907
8231142|NCT01989754|20296765|P1|STARTED|Overall Study||2905
8231143|NCT01989689|20296777|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
8231144|NCT01989689|20296778|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
8231145|NCT01989689|20296777|P2|COMPLETED|Treatment Period ( 3 Months)||10
8231146|NCT01989689|20296778|P1|COMPLETED|Treatment Period ( 3 Months)||11
8231147|NCT01989689|20296777|P2|STARTED|Treatment Period ( 3 Months)||10
8231148|NCT01989689|20296778|P1|STARTED|Treatment Period ( 3 Months)||11
8231149|NCT01989689|20296777|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
8231150|NCT01989689|20296778|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
8231151|NCT01989689|20296777|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
8231152|NCT01989689|20296778|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
8231153|NCT01989689|20296777|P2|STARTED|Treatment Period 1 ( 3 Months)||13
8231154|NCT01989689|20296778|P1|STARTED|Treatment Period 1 ( 3 Months)||11
8231155|NCT01989689|20296777|P2|NOT COMPLETED|Baseline||0
8231156|NCT01989689|20296778|P1|NOT COMPLETED|Baseline||0
8231157|NCT01989689|20296777|P2|COMPLETED|Baseline||13
8231158|NCT01989689|20296778|P1|COMPLETED|Baseline||11
8231159|NCT01989689|20296777|P2|STARTED|Baseline||13
8231160|NCT01989689|20296778|P1|STARTED|Baseline||11
8231161|NCT01989676|20296790|P2|NOT COMPLETED|Overall Study||347
8231162|NCT01989676|20296791|P1|NOT COMPLETED|Overall Study||338
8231163|NCT01989676|20296790|P2|COMPLETED|Overall Study||6
8231164|NCT01989676|20296791|P1|COMPLETED|Overall Study||11
8231165|NCT01989676|20296790|P2|STARTED|Overall Study|Treated (355 randomized)|353
8231166|NCT01989676|20296791|P1|STARTED|Overall Study|Treated (352 randomized)|349
8231167|NCT01989572|20296817|P6|NOT COMPLETED|Overall Study||110
8231168|NCT01989572|20296818|P5|NOT COMPLETED|Overall Study||98
8231169|NCT01989572|20296819|P4|NOT COMPLETED|Overall Study||51
8231170|NCT01989572|20296820|P3|NOT COMPLETED|Overall Study||62
8231171|NCT01989572|20296821|P2|NOT COMPLETED|Overall Study||58
8231172|NCT01989572|20296822|P1|NOT COMPLETED|Overall Study||55
8231173|NCT01989572|20296817|P6|COMPLETED|Overall Study||79
8231174|NCT01989572|20296818|P5|COMPLETED|Overall Study||92
8231175|NCT01989572|20296819|P4|COMPLETED|Overall Study||56
8231176|NCT01989572|20296820|P3|COMPLETED|Overall Study||47
8231177|NCT01989572|20296821|P2|COMPLETED|Overall Study||53
8231178|NCT01989572|20296822|P1|COMPLETED|Overall Study||54
8231179|NCT01989572|20296817|P6|Treated|Overall Study||171
8231180|NCT01989572|20296818|P5|Treated|Overall Study||186
8231181|NCT01989572|20296819|P4|Treated|Overall Study||104
8231182|NCT01989572|20296820|P3|Treated|Overall Study||107
8231183|NCT01989572|20296821|P2|Treated|Overall Study||110
8231184|NCT01989572|20296822|P1|Treated|Overall Study||104
8231185|NCT01989572|20296817|P6|STARTED|Overall Study||189
8231186|NCT01989572|20296818|P5|STARTED|Overall Study||190
8231187|NCT01989572|20296819|P4|STARTED|Overall Study||107
8231188|NCT01989572|20296820|P3|STARTED|Overall Study||109
8231189|NCT01989572|20296821|P2|STARTED|Overall Study||111
8231190|NCT01989572|20296822|P1|STARTED|Overall Study||109
8231194|NCT01989468|20296859|P5|NOT COMPLETED|Overall Study||8
8231195|NCT01989468|20296860|P4|NOT COMPLETED|Overall Study||16
8231196|NCT01989468|20296861|P3|NOT COMPLETED|Overall Study||19
8231197|NCT01989468|20296862|P2|NOT COMPLETED|Overall Study||37
8231198|NCT01989468|20296863|P1|NOT COMPLETED|Overall Study||47
8231199|NCT01989468|20296859|P5|COMPLETED|Overall Study||0
8231200|NCT01989468|20296860|P4|COMPLETED|Overall Study||49
8231201|NCT01989468|20296861|P3|COMPLETED|Overall Study||45
8231202|NCT01989468|20296862|P2|COMPLETED|Overall Study||102
8231203|NCT01989468|20296863|P1|COMPLETED|Overall Study||91
8231204|NCT01989468|20296859|P5|STARTED|Overall Study||8
8231205|NCT01989468|20296860|P4|STARTED|Overall Study||65
8231206|NCT01989468|20296861|P3|STARTED|Overall Study||64
8231207|NCT01989468|20296862|P2|STARTED|Overall Study||139
8231208|NCT01989468|20296863|P1|STARTED|Overall Study||138
8231209|NCT01989455|20296905|P5|NOT COMPLETED|Overall Study||1
8231210|NCT01989455|20296906|P4|NOT COMPLETED|Overall Study||0
8231211|NCT01989455|20296907|P3|NOT COMPLETED|Overall Study||1
8231212|NCT01989455|20296908|P2|NOT COMPLETED|Overall Study||2
8231213|NCT01989455|20296909|P1|NOT COMPLETED|Overall Study||0
8231214|NCT01989455|20296905|P5|COMPLETED|Overall Study||7
8231215|NCT01989455|20296906|P4|COMPLETED|Overall Study||14
8231216|NCT01989455|20296907|P3|COMPLETED|Overall Study||13
8231217|NCT01989455|20296908|P2|COMPLETED|Overall Study||12
8231218|NCT01989455|20296909|P1|COMPLETED|Overall Study||14
8231219|NCT01989455|20296905|P5|STARTED|Overall Study||8
8231220|NCT01989455|20296906|P4|STARTED|Overall Study||14
8231221|NCT01989455|20296907|P3|STARTED|Overall Study||14
8231222|NCT01989455|20296908|P2|STARTED|Overall Study||14
8231223|NCT01989455|20296909|P1|STARTED|Overall Study||14
8231224|NCT01989208|20296945|P2|NOT COMPLETED|800 mg (7 Days)||0
8231225|NCT01989208|20296946|P1|NOT COMPLETED|800 mg (7 Days)||0
8231226|NCT01989208|20296945|P2|COMPLETED|800 mg (7 Days)||11
8231227|NCT01989208|20296946|P1|COMPLETED|800 mg (7 Days)||4
8231228|NCT01989208|20296945|P2|STARTED|800 mg (7 Days)||11
8231229|NCT01989208|20296946|P1|STARTED|800 mg (7 Days)||4
8231230|NCT01989208|20296945|P2|NOT COMPLETED|400 mg (7 Days)||0
8231231|NCT01989208|20296946|P1|NOT COMPLETED|400 mg (7 Days)||0
8231232|NCT01989208|20296945|P2|COMPLETED|400 mg (7 Days)||11
8231233|NCT01989208|20296946|P1|COMPLETED|400 mg (7 Days)||4
8231234|NCT01989208|20296945|P2|STARTED|400 mg (7 Days)||11
8231235|NCT01989208|20296946|P1|STARTED|400 mg (7 Days)||4
8231236|NCT01989208|20296945|P2|NOT COMPLETED|200 mg (7 Days)||1
8231237|NCT01989208|20296946|P1|NOT COMPLETED|200 mg (7 Days)||0
8231238|NCT01989208|20296945|P2|COMPLETED|200 mg (7 Days)||11
8231239|NCT01989208|20296946|P1|COMPLETED|200 mg (7 Days)||4
8231240|NCT01989208|20296945|P2|STARTED|200 mg (7 Days)||12
8231241|NCT01989208|20296946|P1|STARTED|200 mg (7 Days)||4
8231242|NCT01989195|20296964|P1|NOT COMPLETED|Overall Study||0
8231243|NCT01989195|20296964|P1|COMPLETED|Overall Study||6
8231244|NCT01989195|20296964|P1|STARTED|Overall Study||6
8231245|NCT01989169|20296974|P2|NOT COMPLETED|Period 2||1
8231246|NCT01989169|20296975|P1|NOT COMPLETED|Period 2||0
8231247|NCT01989169|20296974|P2|COMPLETED|Period 2||14
8231248|NCT01989169|20296975|P1|COMPLETED|Period 2||15
8231249|NCT01989169|20296974|P2|STARTED|Period 2||15
8231250|NCT01989169|20296975|P1|STARTED|Period 2||15
8231251|NCT01989169|20296974|P2|NOT COMPLETED|Period 1||0
8231252|NCT01989169|20296975|P1|NOT COMPLETED|Period 1||0
8231253|NCT01989169|20296974|P2|COMPLETED|Period 1||15
8231254|NCT01989169|20296975|P1|COMPLETED|Period 1||15
8231255|NCT01989169|20296974|P2|STARTED|Period 1||15
8231256|NCT01989169|20296975|P1|STARTED|Period 1||15
8231257|NCT01989156|20296988|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
8231258|NCT01989156|20296989|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
8231259|NCT01989156|20296990|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
8231260|NCT01989156|20296988|P3|COMPLETED|End of Study (Population at Day 90)||31
8231261|NCT01989156|20296989|P2|COMPLETED|End of Study (Population at Day 90)||35
8231262|NCT01989156|20296990|P1|COMPLETED|End of Study (Population at Day 90)||73
8231263|NCT01989156|20296988|P3|STARTED|End of Study (Population at Day 90)||34
8231264|NCT01989156|20296989|P2|STARTED|End of Study (Population at Day 90)||40
8231265|NCT01989156|20296990|P1|STARTED|End of Study (Population at Day 90)||80
8231266|NCT01989156|20296988|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
8231267|NCT01989156|20296989|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8231268|NCT01989156|20296990|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
8231269|NCT01989156|20296988|P3|COMPLETED|Confinement Period (Population at Day 5)||34
8231270|NCT01989156|20296989|P2|COMPLETED|Confinement Period (Population at Day 5)||40
8231271|NCT01989156|20296990|P1|COMPLETED|Confinement Period (Population at Day 5)||80
8231272|NCT01989156|20296988|P3|STARTED|Confinement Period (Population at Day 5)||39
8231273|NCT01989156|20296989|P2|STARTED|Confinement Period (Population at Day 5)||41
8231274|NCT01989156|20296990|P1|STARTED|Confinement Period (Population at Day 5)||80
8231275|NCT01989130|20297012|P2|NOT COMPLETED|Overall Study||0
8231276|NCT01989130|20297013|P1|NOT COMPLETED|Overall Study||0
8231277|NCT01989130|20297012|P2|COMPLETED|Overall Study||27
8231278|NCT01989130|20297013|P1|COMPLETED|Overall Study||43
8231279|NCT01989130|20297012|P2|STARTED|Overall Study||27
8231280|NCT01989130|20297013|P1|STARTED|Overall Study||43
8231281|NCT01988922|20297028|P3|NOT COMPLETED|Overall Study||0
8231282|NCT01988922|20297029|P2|NOT COMPLETED|Overall Study||0
8231283|NCT01988922|20297030|P1|NOT COMPLETED|Overall Study||0
8231284|NCT01988922|20297028|P3|COMPLETED|Overall Study||10
8231285|NCT01988922|20297029|P2|COMPLETED|Overall Study||10
8231286|NCT01988922|20297030|P1|COMPLETED|Overall Study||10
8231287|NCT01988922|20297028|P3|STARTED|Overall Study||10
8231288|NCT01988922|20297029|P2|STARTED|Overall Study||10
8231289|NCT01988922|20297030|P1|STARTED|Overall Study||10
8231290|NCT01988857|20297041|P1|NOT COMPLETED|Overall Study||0
8231291|NCT01988857|20297041|P1|COMPLETED|Overall Study||300
8231292|NCT01988857|20297041|P1|STARTED|Overall Study||300
8231293|NCT01988779|20297050|P2|NOT COMPLETED|Overall Study||2
8231294|NCT01988779|20297051|P1|NOT COMPLETED|Overall Study||3
8231295|NCT01988779|20297050|P2|COMPLETED|Overall Study||11
8231296|NCT01988779|20297051|P1|COMPLETED|Overall Study||9
8231297|NCT01988779|20297050|P2|STARTED|Overall Study||13
8231298|NCT01988779|20297051|P1|STARTED|Overall Study||12
8231299|NCT01988662|20297067|P2|NOT COMPLETED|Overall Study||2
8231300|NCT01988662|20297068|P1|NOT COMPLETED|Overall Study||4
8231301|NCT01988662|20297067|P2|COMPLETED|Overall Study||99
8231302|NCT01988662|20297068|P1|COMPLETED|Overall Study||100
8231303|NCT01988662|20297067|P2|STARTED|Overall Study||101
8231304|NCT01988662|20297068|P1|STARTED|Overall Study||104
8231305|NCT01988493|20297090|P5|NOT COMPLETED|Overall Study||1
8231306|NCT01988493|20297091|P4|NOT COMPLETED|Overall Study||2
8231307|NCT01988493|20297092|P3|NOT COMPLETED|Overall Study||0
8231308|NCT01988493|20297093|P2|NOT COMPLETED|Overall Study||0
8231309|NCT01988493|20297094|P1|NOT COMPLETED|Overall Study||0
8231310|NCT01988493|20297090|P5|COMPLETED|Overall Study||44
8231311|NCT01988493|20297091|P4|COMPLETED|Overall Study||43
8231312|NCT01988493|20297092|P3|COMPLETED|Overall Study||6
8231313|NCT01988493|20297093|P2|COMPLETED|Overall Study||14
8231314|NCT01988493|20297094|P1|COMPLETED|Overall Study||7
8231315|NCT01988493|20297090|P5|Safety Population|Overall Study||44
8231316|NCT01988493|20297091|P4|Safety Population|Overall Study||45
8231317|NCT01988493|20297092|P3|Safety Population|Overall Study||6
8231318|NCT01988493|20297093|P2|Safety Population|Overall Study||14
8231319|NCT01988493|20297094|P1|Safety Population|Overall Study||7
8231320|NCT01988493|20297090|P5|Treated|Overall Study||44
8231321|NCT01988493|20297091|P4|Treated|Overall Study||45
8231322|NCT01988493|20297092|P3|Treated|Overall Study||6
8231323|NCT01988493|20297093|P2|Treated|Overall Study||14
8231324|NCT01988493|20297094|P1|Treated|Overall Study||7
8231325|NCT01988493|20297090|P5|STARTED|Overall Study||45
8231326|NCT01988493|20297091|P4|STARTED|Overall Study||45
8231327|NCT01988493|20297092|P3|STARTED|Overall Study||6
8231328|NCT01988493|20297093|P2|STARTED|Overall Study||14
8231329|NCT01988493|20297094|P1|STARTED|Overall Study||7
8231330|NCT01988415|20297163|P1|NOT COMPLETED|Overall Study||0
8231331|NCT01988415|20297163|P1|COMPLETED|Overall Study||26
8231332|NCT01988415|20297163|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
8231333|NCT01988402|20297173|P2|NOT COMPLETED|Overall Study||2
8231334|NCT01988402|20297174|P1|NOT COMPLETED|Overall Study||2
8231335|NCT01988402|20297173|P2|COMPLETED|Overall Study||17
8231336|NCT01988402|20297174|P1|COMPLETED|Overall Study||14
8231337|NCT01988402|20297173|P2|STARTED|Overall Study||19
8231338|NCT01988402|20297174|P1|STARTED|Overall Study||16
8231339|NCT01988376|20297188|P2|NOT COMPLETED|Overall Study||0
8231340|NCT01988376|20297189|P1|NOT COMPLETED|Overall Study||0
8231341|NCT01988376|20297188|P2|COMPLETED|Overall Study||129
8231342|NCT01988376|20297189|P1|COMPLETED|Overall Study||129
8231343|NCT01988376|20297188|P2|STARTED|Overall Study||129
8231344|NCT01988376|20297189|P1|STARTED|Overall Study||129
8231345|NCT01988246|20297197|P2|NOT COMPLETED|Overall Study||0
8231346|NCT01988246|20297198|P1|NOT COMPLETED|Overall Study||1
8231347|NCT01988246|20297197|P2|COMPLETED|Overall Study||15
8231348|NCT01988246|20297198|P1|COMPLETED|Overall Study||14
8231349|NCT01988246|20297197|P2|STARTED|Overall Study||15
8231350|NCT01988246|20297198|P1|STARTED|Overall Study||15
8231351|NCT01988129|20297210|P2|NOT COMPLETED|Overall Study||0
8231352|NCT01988129|20297211|P1|NOT COMPLETED|Overall Study||0
8231353|NCT01988129|20297210|P2|COMPLETED|Overall Study||588
8231354|NCT01988129|20297211|P1|COMPLETED|Overall Study||601
8231355|NCT01988129|20297210|P2|Completed 1-year Follow-up Survey|Overall Study||4
8231356|NCT01988129|20297211|P1|Completed 1-year Follow-up Survey|Overall Study||100
8231357|NCT01988129|20297210|P2|Screened for Sleep Disorders|Overall Study||15
8231358|NCT01988129|20297211|P1|Screened for Sleep Disorders|Overall Study||416
8231359|NCT01988129|20297210|P2|Attended Education Session|Overall Study||18
8231360|NCT01988129|20297211|P1|Attended Education Session|Overall Study||542
8231361|NCT01988129|20297210|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
8231362|NCT01988129|20297211|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
8231363|NCT01988103|20297241|P5|NOT COMPLETED|Observational Follow-up Phase||0
8231364|NCT01988103|20297242|P4|NOT COMPLETED|Observational Follow-up Phase||0
8231365|NCT01988103|20297243|P3|NOT COMPLETED|Observational Follow-up Phase||1
8231366|NCT01988103|20297244|P2|NOT COMPLETED|Observational Follow-up Phase||3
8231367|NCT01988103|20297245|P1|NOT COMPLETED|Observational Follow-up Phase||0
8231368|NCT01988103|20297241|P5|COMPLETED|Observational Follow-up Phase||33
8231369|NCT01988103|20297242|P4|COMPLETED|Observational Follow-up Phase||36
8231370|NCT01988103|20297243|P3|COMPLETED|Observational Follow-up Phase||82
8231371|NCT01988103|20297244|P2|COMPLETED|Observational Follow-up Phase||79
8231372|NCT01988103|20297245|P1|COMPLETED|Observational Follow-up Phase||12
8231373|NCT01988103|20297241|P5|STARTED|Observational Follow-up Phase||33
8231374|NCT01988103|20297242|P4|STARTED|Observational Follow-up Phase||36
8231375|NCT01988103|20297243|P3|STARTED|Observational Follow-up Phase||83
8231376|NCT01988103|20297244|P2|STARTED|Observational Follow-up Phase||82
8231377|NCT01988103|20297245|P1|STARTED|Observational Follow-up Phase||12
8231378|NCT01988103|20297241|P5|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
8231379|NCT01988103|20297242|P4|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
8231380|NCT01988103|20297243|P3|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
8231381|NCT01988103|20297244|P2|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
8231382|NCT01988103|20297245|P1|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
8231383|NCT01988103|20297241|P5|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
8231384|NCT01988103|20297242|P4|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
8231385|NCT01988103|20297243|P3|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
8231386|NCT01988103|20297244|P2|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
8231387|NCT01988103|20297245|P1|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
8231388|NCT01988103|20297241|P5|STARTED|Active Treatment Phase (Weeks 16-68)||35
8231389|NCT01988103|20297242|P4|STARTED|Active Treatment Phase (Weeks 16-68)||36
8231390|NCT01988103|20297243|P3|STARTED|Active Treatment Phase (Weeks 16-68)||76
8231391|NCT01988103|20297244|P2|STARTED|Active Treatment Phase (Weeks 16-68)||69
8231392|NCT01988103|20297245|P1|STARTED|Active Treatment Phase (Weeks 16-68)||0
8231393|NCT01988103|20297241|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231394|NCT01988103|20297242|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231395|NCT01988103|20297243|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
8231396|NCT01988103|20297244|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
8231397|NCT01988103|20297245|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
8231398|NCT01988103|20297241|P5|COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231399|NCT01988103|20297242|P4|COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231400|NCT01988103|20297243|P3|COMPLETED|Placebo-Controlled Phase Week 0-16||76
8231401|NCT01988103|20297244|P2|COMPLETED|Placebo-Controlled Phase Week 0-16||69
8231402|NCT01988103|20297245|P1|COMPLETED|Placebo-Controlled Phase Week 0-16||72
8231403|NCT01988103|20297241|P5|STARTED|Placebo-Controlled Phase Week 0-16||0
8231404|NCT01988103|20297242|P4|STARTED|Placebo-Controlled Phase Week 0-16||0
8231405|NCT01988103|20297243|P3|STARTED|Placebo-Controlled Phase Week 0-16||85
8231406|NCT01988103|20297244|P2|STARTED|Placebo-Controlled Phase Week 0-16||85
8231407|NCT01988103|20297245|P1|STARTED|Placebo-Controlled Phase Week 0-16||84
8231408|NCT01988090|20297292|P2|NOT COMPLETED|Complete Study After Start||1
8231409|NCT01988090|20297293|P1|NOT COMPLETED|Complete Study After Start||3
8231410|NCT01988090|20297292|P2|COMPLETED|Complete Study After Start||42
8231411|NCT01988090|20297293|P1|COMPLETED|Complete Study After Start||41
8231412|NCT01988090|20297292|P2|STARTED|Complete Study After Start||43
8231413|NCT01988090|20297293|P1|STARTED|Complete Study After Start||44
8231414|NCT01988090|20297292|P2|NOT COMPLETED|Start Treament After Randomization||4
8231415|NCT01988090|20297293|P1|NOT COMPLETED|Start Treament After Randomization||2
8231416|NCT01988090|20297292|P2|COMPLETED|Start Treament After Randomization||43
8231417|NCT01988090|20297293|P1|COMPLETED|Start Treament After Randomization||44
8231418|NCT01988090|20297292|P2|STARTED|Start Treament After Randomization||47
8231419|NCT01988090|20297293|P1|STARTED|Start Treament After Randomization||46
8231420|NCT01988012|20297303|P1|NOT COMPLETED|Overall Study||15
8231421|NCT01988012|20297303|P1|COMPLETED|Overall Study||85
8231422|NCT01988012|20297303|P1|STARTED|Overall Study||100
8231423|NCT01987986|20297329|P4|NOT COMPLETED|Overall Study||0
8231424|NCT01987986|20297330|P3|NOT COMPLETED|Overall Study||2
8231425|NCT01987986|20297331|P2|NOT COMPLETED|Overall Study||0
8231426|NCT01987986|20297332|P1|NOT COMPLETED|Overall Study||2
8231427|NCT01987986|20297329|P4|COMPLETED|Overall Study||24
8231428|NCT01987986|20297330|P3|COMPLETED|Overall Study||38
8231429|NCT01987986|20297331|P2|COMPLETED|Overall Study||43
8231430|NCT01987986|20297332|P1|COMPLETED|Overall Study||41
8231431|NCT01987986|20297329|P4|STARTED|Overall Study||24
8231432|NCT01987986|20297330|P3|STARTED|Overall Study||40
8231433|NCT01987986|20297331|P2|STARTED|Overall Study||43
8231434|NCT01987986|20297332|P1|STARTED|Overall Study||43
8231435|NCT01987960|20297372|P4|NOT COMPLETED|Period 3||71
8231436|NCT01987960|20297373|P3|NOT COMPLETED|Period 3||0
8231437|NCT01987960|20297374|P2|NOT COMPLETED|Period 3||0
8231438|NCT01987960|20297375|P1|NOT COMPLETED|Period 3||0
8231439|NCT01987960|20297372|P4|COMPLETED|Period 3||119
8231440|NCT01987960|20297373|P3|COMPLETED|Period 3||0
8231441|NCT01987960|20297374|P2|COMPLETED|Period 3||0
8231442|NCT01987960|20297375|P1|COMPLETED|Period 3||0
8231443|NCT01987960|20297372|P4|STARTED|Period 3||190
8231444|NCT01987960|20297373|P3|STARTED|Period 3||0
8231445|NCT01987960|20297374|P2|STARTED|Period 3||0
8231446|NCT01987960|20297375|P1|STARTED|Period 3||0
8231447|NCT01987960|20297372|P4|NOT COMPLETED|Period 2||0
8231448|NCT01987960|20297373|P3|NOT COMPLETED|Period 2||9
8231449|NCT01987960|20297374|P2|NOT COMPLETED|Period 2||5
8231450|NCT01987960|20297375|P1|NOT COMPLETED|Period 2||0
8231451|NCT01987960|20297372|P4|COMPLETED|Period 2||0
8231452|NCT01987960|20297373|P3|COMPLETED|Period 2||14
8231453|NCT01987960|20297374|P2|COMPLETED|Period 2||12
8231454|NCT01987960|20297375|P1|COMPLETED|Period 2||0
8231455|NCT01987960|20297372|P4|STARTED|Period 2||0
8231456|NCT01987960|20297373|P3|STARTED|Period 2||23
8231457|NCT01987960|20297374|P2|STARTED|Period 2||17
8231458|NCT01987960|20297375|P1|STARTED|Period 2||0
8231459|NCT01987960|20297372|P4|NOT COMPLETED|Period 1||0
8231460|NCT01987960|20297373|P3|NOT COMPLETED|Period 1||0
8231461|NCT01987960|20297374|P2|NOT COMPLETED|Period 1||0
8231462|NCT01987960|20297375|P1|NOT COMPLETED|Period 1||186
8231463|NCT01987960|20297372|P4|COMPLETED|Period 1||0
8231464|NCT01987960|20297373|P3|COMPLETED|Period 1||0
8231465|NCT01987960|20297374|P2|COMPLETED|Period 1||0
8231466|NCT01987960|20297375|P1|COMPLETED|Period 1||231
8231467|NCT01987960|20297372|P4|STARTED|Period 1||0
8231468|NCT01987960|20297373|P3|STARTED|Period 1||0
8231469|NCT01987960|20297374|P2|STARTED|Period 1||0
8231470|NCT01987960|20297375|P1|STARTED|Period 1||417
8231471|NCT01987908|20297387|P3|NOT COMPLETED|Post-Treatment Observation Period||0
8231472|NCT01987908|20297388|P2|NOT COMPLETED|Post-Treatment Observation Period||3
8231473|NCT01987908|20297389|P1|NOT COMPLETED|Post-Treatment Observation Period||0
8231474|NCT01987908|20297387|P3|COMPLETED|Post-Treatment Observation Period||2
8231475|NCT01987908|20297388|P2|COMPLETED|Post-Treatment Observation Period||7
8231476|NCT01987908|20297389|P1|COMPLETED|Post-Treatment Observation Period||0
8231477|NCT01987908|20297387|P3|STARTED|Post-Treatment Observation Period||2
8231478|NCT01987908|20297388|P2|STARTED|Post-Treatment Observation Period||10
8231479|NCT01987908|20297389|P1|STARTED|Post-Treatment Observation Period||0
8231480|NCT01987908|20297387|P3|NOT COMPLETED|Treatment Period||1
8231481|NCT01987908|20297388|P2|NOT COMPLETED|Treatment Period||1
8231482|NCT01987908|20297389|P1|NOT COMPLETED|Treatment Period||0
8231483|NCT01987908|20297387|P3|COMPLETED|Treatment Period||2
8231484|NCT01987908|20297388|P2|COMPLETED|Treatment Period||10
8231485|NCT01987908|20297389|P1|COMPLETED|Treatment Period||0
8231486|NCT01987908|20297387|P3|STARTED|Treatment Period||3
8231487|NCT01987908|20297388|P2|STARTED|Treatment Period||11
8231488|NCT01987908|20297389|P1|STARTED|Treatment Period||0
8231489|NCT01987908|20297387|P3|NOT COMPLETED|Placebo Lead-in Period||0
8231490|NCT01987908|20297388|P2|NOT COMPLETED|Placebo Lead-in Period||0
8231491|NCT01987908|20297389|P1|NOT COMPLETED|Placebo Lead-in Period||9
8231492|NCT01987908|20297387|P3|COMPLETED|Placebo Lead-in Period||0
8231493|NCT01987908|20297388|P2|COMPLETED|Placebo Lead-in Period||0
8231494|NCT01987908|20297389|P1|COMPLETED|Placebo Lead-in Period||14
8231495|NCT01987908|20297387|P3|STARTED|Placebo Lead-in Period||0
8231496|NCT01987908|20297388|P2|STARTED|Placebo Lead-in Period||0
8231497|NCT01987908|20297389|P1|STARTED|Placebo Lead-in Period||23
8231498|NCT01987895|20297472|P2|NOT COMPLETED|Overall Study||30
8231499|NCT01987895|20297473|P1|NOT COMPLETED|Overall Study||30
8231500|NCT01987895|20297472|P2|COMPLETED|Overall Study||296
8231501|NCT01987895|20297473|P1|COMPLETED|Overall Study||276
8231502|NCT01987895|20297472|P2|STARTED|Overall Study||326
8231503|NCT01987895|20297473|P1|STARTED|Overall Study||306
8231504|NCT01987830|20297497|P1|NOT COMPLETED|Overall Study||1
8231505|NCT01987830|20297497|P1|COMPLETED|Overall Study||12
8231506|NCT01987830|20297497|P1|STARTED|Overall Study||13
8231507|NCT01987765|20297501|P1|NOT COMPLETED|Overall Study||102
8231508|NCT01987765|20297501|P1|COMPLETED|Overall Study||745
8231509|NCT01987765|20297501|P1|STARTED|Overall Study||847
8231510|NCT01987752|20297506|P1|NOT COMPLETED|Overall Study||0
8231511|NCT01987752|20297506|P1|COMPLETED|Overall Study||732
8231512|NCT01987752|20297506|P1|STARTED|Overall Study||732
8231513|NCT01987609|20297511|P1|NOT COMPLETED|Overall Study||1
8231514|NCT01987609|20297511|P1|COMPLETED|Overall Study||6
8231515|NCT01987609|20297511|P1|Normal Saline Injected in Arm|Overall Study||6
8231516|NCT01987609|20297511|P1|Hylenex Injected in Arm|Overall Study||6
8231517|NCT01987609|20297511|P1|STARTED|Overall Study|one arm on one patient|7
8231518|NCT01987596|20297544|P2|NOT COMPLETED|Overall Study||1
8231519|NCT01987596|20297545|P1|NOT COMPLETED|Overall Study||1
8231520|NCT01987596|20297544|P2|COMPLETED|Overall Study||10
8231521|NCT01987596|20297545|P1|COMPLETED|Overall Study||11
8231522|NCT01987596|20297544|P2|STARTED|Overall Study||11
8231523|NCT01987596|20297545|P1|STARTED|Overall Study||12
8231524|NCT01987583|20297559|P2|NOT COMPLETED|Overall Study||2
8231525|NCT01987583|20297560|P1|NOT COMPLETED|Overall Study||3
8231526|NCT01987583|20297559|P2|COMPLETED|Overall Study||38
8231527|NCT01987583|20297560|P1|COMPLETED|Overall Study||37
8231528|NCT01987583|20297559|P2|STARTED|Overall Study||40
8231529|NCT01987583|20297560|P1|STARTED|Overall Study||40
8231530|NCT01987557|20297571|P3|NOT COMPLETED|Overall Study||3
8231531|NCT01987557|20297572|P2|NOT COMPLETED|Overall Study||3
8231532|NCT01987557|20297573|P1|NOT COMPLETED|Overall Study||3
8231533|NCT01987557|20297571|P3|COMPLETED|Overall Study||13
8231534|NCT01987557|20297572|P2|COMPLETED|Overall Study||13
8231535|NCT01987557|20297573|P1|COMPLETED|Overall Study||13
8231536|NCT01987557|20297571|P3|STARTED|Overall Study||16
8231537|NCT01987557|20297572|P2|STARTED|Overall Study||16
8231538|NCT01987557|20297573|P1|STARTED|Overall Study||16
8231539|NCT01987505|20297583|P1|NOT COMPLETED|Overall Study||34
8231540|NCT01987505|20297583|P1|COMPLETED|Overall Study||106
8231541|NCT01987505|20297583|P1|STARTED|Overall Study||140
8231542|NCT01987479|20297613|P1|NOT COMPLETED|Overall Study||17
8231543|NCT01987479|20297613|P1|COMPLETED|Overall Study||133
8231544|NCT01987479|20297613|P1|STARTED|Overall Study||150
8231545|NCT01987453|20297641|P3|NOT COMPLETED|Overall Study||1
8231546|NCT01987453|20297642|P2|NOT COMPLETED|Overall Study||12
8231547|NCT01987453|20297643|P1|NOT COMPLETED|Overall Study||1
8231548|NCT01987453|20297641|P3|COMPLETED|Overall Study||7
8231549|NCT01987453|20297642|P2|COMPLETED|Overall Study||29
8231550|NCT01987453|20297643|P1|COMPLETED|Overall Study||50
8231551|NCT01987453|20297641|P3|STARTED|Overall Study||8
8231552|NCT01987453|20297642|P2|STARTED|Overall Study||41
8231553|NCT01987453|20297643|P1|STARTED|Overall Study||51
8231554|NCT01987427|20297669|P3|NOT COMPLETED|Overall Study||20
8231555|NCT01987427|20297670|P2|NOT COMPLETED|Overall Study||10
8231556|NCT01987427|20297671|P1|NOT COMPLETED|Overall Study||14
8231557|NCT01987427|20297669|P3|COMPLETED|Overall Study||59
8231558|NCT01987427|20297670|P2|COMPLETED|Overall Study||68
8231559|NCT01987427|20297671|P1|COMPLETED|Overall Study||64
8231560|NCT01987427|20297669|P3|STARTED|Overall Study||79
8231561|NCT01987427|20297670|P2|STARTED|Overall Study||78
8231562|NCT01987427|20297671|P1|STARTED|Overall Study||78
8231563|NCT01987414|20297702|P2|NOT COMPLETED|Overall Study||2
8231564|NCT01987414|20297703|P1|NOT COMPLETED|Overall Study||2
8231565|NCT01987414|20297702|P2|COMPLETED|Overall Study||6
8231566|NCT01987414|20297703|P1|COMPLETED|Overall Study||8
8231567|NCT01987414|20297702|P2|STARTED|Overall Study||8
8231568|NCT01987414|20297703|P1|STARTED|Overall Study||10
8231569|NCT01987401|20297752|P3|NOT COMPLETED|Overall Study||44
8231570|NCT01987401|20297753|P2|NOT COMPLETED|Overall Study||470
8231571|NCT01987401|20297754|P1|NOT COMPLETED|Overall Study||454
8231572|NCT01987401|20297752|P3|COMPLETED|Overall Study||16
8231573|NCT01987401|20297753|P2|COMPLETED|Overall Study||121
8231574|NCT01987401|20297754|P1|COMPLETED|Overall Study||137
8231575|NCT01987401|20297752|P3|STARTED|Overall Study||60
8231576|NCT01987401|20297753|P2|STARTED|Overall Study||591
8231577|NCT01987401|20297754|P1|STARTED|Overall Study||591
8231578|NCT01987349|20297770|P8|NOT COMPLETED|Overall Study||1
8231579|NCT01987349|20297771|P7|NOT COMPLETED|Overall Study||0
8231580|NCT01987349|20297772|P6|NOT COMPLETED|Overall Study||0
8231581|NCT01987349|20297773|P5|NOT COMPLETED|Overall Study||0
8231582|NCT01987349|20297774|P4|NOT COMPLETED|Overall Study||0
8231583|NCT01987349|20297775|P3|NOT COMPLETED|Overall Study||0
8231584|NCT01987349|20297776|P2|NOT COMPLETED|Overall Study||0
8231585|NCT01987349|20297777|P1|NOT COMPLETED|Overall Study||0
8231586|NCT01987349|20297770|P8|COMPLETED|Overall Study||24
8231587|NCT01987349|20297771|P7|COMPLETED|Overall Study||10
8231588|NCT01987349|20297772|P6|COMPLETED|Overall Study||6
8231589|NCT01987349|20297773|P5|COMPLETED|Overall Study||6
8231590|NCT01987349|20297774|P4|COMPLETED|Overall Study||6
8231591|NCT01987349|20297775|P3|COMPLETED|Overall Study||8
8231592|NCT01987349|20297776|P2|COMPLETED|Overall Study||6
8231593|NCT01987349|20297777|P1|COMPLETED|Overall Study||6
8231594|NCT01987349|20297770|P8|STARTED|Overall Study||25
8231595|NCT01987349|20297771|P7|STARTED|Overall Study||10
8231596|NCT01987349|20297772|P6|STARTED|Overall Study||6
8231597|NCT01987349|20297773|P5|STARTED|Overall Study||6
8231598|NCT01987349|20297774|P4|STARTED|Overall Study||6
8231599|NCT01987349|20297775|P3|STARTED|Overall Study||8
8231600|NCT01987349|20297776|P2|STARTED|Overall Study||6
8231601|NCT01987349|20297777|P1|STARTED|Overall Study||6
8231602|NCT01987232|20297808|P5|NOT COMPLETED|Overall Study||0
8231603|NCT01987232|20297809|P4|NOT COMPLETED|Overall Study||1
8231604|NCT01987232|20297810|P3|NOT COMPLETED|Overall Study||0
8231605|NCT01987232|20297811|P2|NOT COMPLETED|Overall Study||0
8231606|NCT01987232|20297812|P1|NOT COMPLETED|Overall Study||0
8231607|NCT01987232|20297808|P5|COMPLETED|Overall Study||6
8231608|NCT01987232|20297809|P4|COMPLETED|Overall Study||14
8231609|NCT01987232|20297810|P3|COMPLETED|Overall Study||3
8231610|NCT01987232|20297811|P2|COMPLETED|Overall Study||3
8231611|NCT01987232|20297812|P1|COMPLETED|Overall Study||5
8231612|NCT01987232|20297808|P5|STARTED|Overall Study||6
8231613|NCT01987232|20297809|P4|STARTED|Overall Study||15
8231614|NCT01987232|20297810|P3|STARTED|Overall Study||3
8231615|NCT01987232|20297811|P2|STARTED|Overall Study||3
8231616|NCT01987232|20297812|P1|STARTED|Overall Study||5
8231617|NCT01987219|20297877|P6|NOT COMPLETED|Overall Study||0
8231618|NCT01987219|20297878|P5|NOT COMPLETED|Overall Study||0
8231619|NCT01987219|20297879|P4|NOT COMPLETED|Overall Study||0
8231620|NCT01987219|20297880|P3|NOT COMPLETED|Overall Study||1
8231621|NCT01987219|20297881|P2|NOT COMPLETED|Overall Study||0
8231622|NCT01987219|20297882|P1|NOT COMPLETED|Overall Study||0
8231623|NCT01987219|20297877|P6|COMPLETED|Overall Study||1
8231624|NCT01987219|20297878|P5|COMPLETED|Overall Study||1
8231625|NCT01987219|20297879|P4|COMPLETED|Overall Study||2
8231626|NCT01987219|20297880|P3|COMPLETED|Overall Study||6
8231627|NCT01987219|20297881|P2|COMPLETED|Overall Study||2
8231628|NCT01987219|20297882|P1|COMPLETED|Overall Study||2
8231629|NCT01987219|20297877|P6|STARTED|Overall Study||1
8231630|NCT01987219|20297878|P5|STARTED|Overall Study||1
8231631|NCT01987219|20297879|P4|STARTED|Overall Study||2
8231632|NCT01987219|20297880|P3|STARTED|Overall Study||7
8231633|NCT01987219|20297881|P2|STARTED|Overall Study||2
8231634|NCT01987219|20297882|P1|STARTED|Overall Study||2
8231635|NCT01987102|20297901|P2|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
8231636|NCT01987102|20297902|P1|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
8231637|NCT01987102|20297901|P2|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
8231638|NCT01987102|20297902|P1|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
8231639|NCT01987102|20297901|P2|STARTED|2 Courses of HDMTX With MOD Rescue||4
8231640|NCT01987102|20297902|P1|STARTED|2 Courses of HDMTX With MOD Rescue||4
8231641|NCT01987102|20297901|P2|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
8231642|NCT01987102|20297902|P1|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8231643|NCT01987102|20297901|P2|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8231644|NCT01987102|20297902|P1|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8231645|NCT01987102|20297901|P2|STARTED|2 Courses of HDMTX With SOC Rescue||10
8231646|NCT01987102|20297902|P1|STARTED|2 Courses of HDMTX With SOC Rescue||8
8231647|NCT01987089|20297936|P2|NOT COMPLETED|Overall Study||4
8231648|NCT01987089|20297937|P1|NOT COMPLETED|Overall Study||1
8231649|NCT01987089|20297936|P2|COMPLETED|Overall Study||28
8231650|NCT01987089|20297937|P1|COMPLETED|Overall Study||30
8231651|NCT01987089|20297936|P2|STARTED|Overall Study||32
8231652|NCT01987089|20297937|P1|STARTED|Overall Study||31
8231653|NCT01986985|20297949|P1|NOT COMPLETED|Overall Study||7
8231654|NCT01986985|20297949|P1|COMPLETED|Overall Study||51
8231655|NCT01986985|20297949|P1|STARTED|Overall Study||58
8231656|NCT01986946|20297955|P2|NOT COMPLETED|Overall Study||0
8231657|NCT01986946|20297956|P1|NOT COMPLETED|Overall Study||0
8231658|NCT01986946|20297955|P2|COMPLETED|Overall Study||9
8231659|NCT01986946|20297956|P1|COMPLETED|Overall Study||5
8231660|NCT01986946|20297955|P2|STARTED|Overall Study||9
8231661|NCT01986946|20297956|P1|STARTED|Overall Study||5
8231662|NCT01986920|20297986|P4|NOT COMPLETED|Placebo||1
8231663|NCT01986920|20297987|P3|NOT COMPLETED|Placebo||0
8231664|NCT01986920|20297988|P2|NOT COMPLETED|Placebo||0
8231665|NCT01986920|20297989|P1|NOT COMPLETED|Placebo||0
8231666|NCT01986920|20297986|P4|COMPLETED|Placebo||34
8231667|NCT01986920|20297987|P3|COMPLETED|Placebo||0
8231668|NCT01986920|20297988|P2|COMPLETED|Placebo||0
8231669|NCT01986920|20297989|P1|COMPLETED|Placebo||0
8231670|NCT01986920|20297986|P4|STARTED|Placebo||35
8231671|NCT01986920|20297987|P3|STARTED|Placebo||0
8231672|NCT01986920|20297988|P2|STARTED|Placebo||0
8231673|NCT01986920|20297989|P1|STARTED|Placebo||0
8231674|NCT01986920|20297986|P4|NOT COMPLETED|A-101 40%||0
8231675|NCT01986920|20297987|P3|NOT COMPLETED|A-101 40%||1
8231676|NCT01986920|20297988|P2|NOT COMPLETED|A-101 40%||0
8231677|NCT01986920|20297989|P1|NOT COMPLETED|A-101 40%||0
8231678|NCT01986920|20297986|P4|COMPLETED|A-101 40%||0
8231679|NCT01986920|20297987|P3|COMPLETED|A-101 40%||34
8231680|NCT01986920|20297988|P2|COMPLETED|A-101 40%||0
8231681|NCT01986920|20297989|P1|COMPLETED|A-101 40%||0
8231682|NCT01986920|20297986|P4|STARTED|A-101 40%||0
8231683|NCT01986920|20297987|P3|STARTED|A-101 40%||35
8231684|NCT01986920|20297988|P2|STARTED|A-101 40%||0
8231685|NCT01986920|20297989|P1|STARTED|A-101 40%||0
8231686|NCT01986920|20297986|P4|NOT COMPLETED|A-101 32.5%||0
8231687|NCT01986920|20297987|P3|NOT COMPLETED|A-101 32.5%||0
8231688|NCT01986920|20297988|P2|NOT COMPLETED|A-101 32.5%||1
8231689|NCT01986920|20297989|P1|NOT COMPLETED|A-101 32.5%||0
8231690|NCT01986920|20297986|P4|COMPLETED|A-101 32.5%||0
8231691|NCT01986920|20297987|P3|COMPLETED|A-101 32.5%||0
8231692|NCT01986920|20297988|P2|COMPLETED|A-101 32.5%||34
8231693|NCT01986920|20297989|P1|COMPLETED|A-101 32.5%||0
8231694|NCT01986920|20297986|P4|STARTED|A-101 32.5%||0
8231695|NCT01986920|20297987|P3|STARTED|A-101 32.5%||0
8231696|NCT01986920|20297988|P2|STARTED|A-101 32.5%||35
8231697|NCT01986920|20297989|P1|STARTED|A-101 32.5%||0
8231698|NCT01986920|20297986|P4|NOT COMPLETED|A- 101 25%||0
8231699|NCT01986920|20297987|P3|NOT COMPLETED|A- 101 25%||0
8231700|NCT01986920|20297988|P2|NOT COMPLETED|A- 101 25%||0
8231701|NCT01986920|20297989|P1|NOT COMPLETED|A- 101 25%||1
8231702|NCT01986920|20297986|P4|COMPLETED|A- 101 25%||0
8231703|NCT01986920|20297987|P3|COMPLETED|A- 101 25%||0
8231704|NCT01986920|20297988|P2|COMPLETED|A- 101 25%||0
8231705|NCT01986920|20297989|P1|COMPLETED|A- 101 25%||34
8231706|NCT01986920|20297986|P4|STARTED|A- 101 25%||0
8231707|NCT01986920|20297987|P3|STARTED|A- 101 25%||0
8231708|NCT01986920|20297988|P2|STARTED|A- 101 25%||0
8231709|NCT01986920|20297989|P1|STARTED|A- 101 25%||35
8231710|NCT01986907|20298003|P1|NOT COMPLETED|Overall Study||162
8231711|NCT01986907|20298003|P1|COMPLETED|Overall Study||774
8231712|NCT01986907|20298003|P1|STARTED|Overall Study||936
8231713|NCT01986855|20298016|P3|NOT COMPLETED|Overall Study||11
8231714|NCT01986855|20298017|P2|NOT COMPLETED|Overall Study||14
8231715|NCT01986855|20298018|P1|NOT COMPLETED|Overall Study||13
8231716|NCT01986855|20298016|P3|COMPLETED|Overall Study||143
8231717|NCT01986855|20298017|P2|COMPLETED|Overall Study||142
8231718|NCT01986855|20298018|P1|COMPLETED|Overall Study||145
8231719|NCT01986855|20298016|P3|Treated|Overall Study||154
8231720|NCT01986855|20298017|P2|Treated|Overall Study||155
8231721|NCT01986855|20298018|P1|Treated|Overall Study||158
8231722|NCT01986855|20298016|P3|STARTED|Overall Study||154
8231723|NCT01986855|20298017|P2|STARTED|Overall Study||156
8231724|NCT01986855|20298018|P1|STARTED|Overall Study||158
8231725|NCT01986829|20298047|P1|NOT COMPLETED|Overall Study||1
8231726|NCT01986829|20298047|P1|COMPLETED|Overall Study||8
8231727|NCT01986829|20298047|P1|STARTED|Overall Study||9
8231728|NCT01986790|20298077|P3|NOT COMPLETED|Overall Study||0
8231729|NCT01986790|20298078|P2|NOT COMPLETED|Overall Study||0
8231730|NCT01986790|20298079|P1|NOT COMPLETED|Overall Study||0
8231731|NCT01986790|20298077|P3|COMPLETED|Overall Study||98
8231732|NCT01986790|20298078|P2|COMPLETED|Overall Study||154
8231733|NCT01986790|20298079|P1|COMPLETED|Overall Study||91
8231734|NCT01986790|20298077|P3|STARTED|Overall Study||98
8231735|NCT01986790|20298078|P2|STARTED|Overall Study||154
8231736|NCT01986790|20298079|P1|STARTED|Overall Study||91
8231737|NCT01986751|20298095|P2|NOT COMPLETED|Overall Study||2
8231738|NCT01986751|20298096|P1|NOT COMPLETED|Overall Study||10
8231739|NCT01986751|20298095|P2|COMPLETED|Overall Study||2
8231740|NCT01986751|20298096|P1|COMPLETED|Overall Study||0
8231741|NCT01986751|20298095|P2|STARTED|Overall Study||4
8231742|NCT01986751|20298096|P1|STARTED|Overall Study||10
8231743|NCT01986686|20298118|P2|NOT COMPLETED|Overall Study||0
8231744|NCT01986686|20298119|P1|NOT COMPLETED|Overall Study||0
8231745|NCT01986686|20298118|P2|COMPLETED|Overall Study||26
8231746|NCT01986686|20298119|P1|COMPLETED|Overall Study||81
8231747|NCT01986686|20298118|P2|STARTED|Overall Study||26
8231748|NCT01986686|20298119|P1|STARTED|Overall Study||81
8231749|NCT01986647|20298129|P4|NOT COMPLETED|Overall Study||11
8231750|NCT01986647|20298130|P3|NOT COMPLETED|Overall Study||12
8231751|NCT01986647|20298131|P2|NOT COMPLETED|Overall Study||7
8231752|NCT01986647|20298132|P1|NOT COMPLETED|Overall Study||10
8231753|NCT01986647|20298129|P4|COMPLETED|Overall Study||66
8231754|NCT01986647|20298130|P3|COMPLETED|Overall Study||37
8231755|NCT01986647|20298131|P2|COMPLETED|Overall Study||139
8231756|NCT01986647|20298132|P1|COMPLETED|Overall Study||142
8231757|NCT01986647|20298129|P4|STARTED|Overall Study||77
8231758|NCT01986647|20298130|P3|STARTED|Overall Study||49
8231759|NCT01986647|20298131|P2|STARTED|Overall Study||146
8231760|NCT01986647|20298132|P1|STARTED|Overall Study||152
8231761|NCT01986361|20298204|P2|NOT COMPLETED|Overall Study||0
8231762|NCT01986361|20298205|P1|NOT COMPLETED|Overall Study||0
8231763|NCT01986361|20298204|P2|COMPLETED|Overall Study||21
8231764|NCT01986361|20298205|P1|COMPLETED|Overall Study||101
8231765|NCT01986361|20298204|P2|STARTED|Overall Study||21
8231766|NCT01986361|20298205|P1|STARTED|Overall Study||101
8231767|NCT01986231|20298227|P1|NOT COMPLETED|Overall Study||1
8231768|NCT01986231|20298227|P1|COMPLETED|Overall Study||11
8231769|NCT01986231|20298227|P1|STARTED|Overall Study||12
8231770|NCT01986140|20298234|P2|NOT COMPLETED|Overall Study||28
8231771|NCT01986140|20298235|P1|NOT COMPLETED|Overall Study||35
8231772|NCT01986140|20298234|P2|COMPLETED|Overall Study||51
8231773|NCT01986140|20298235|P1|COMPLETED|Overall Study||122
8231774|NCT01986140|20298234|P2|STARTED|Overall Study||79
8231775|NCT01986140|20298235|P1|STARTED|Overall Study||157
8231776|NCT01986114|20298241|P1|NOT COMPLETED|Overall Study||156
8231777|NCT01986114|20298241|P1|COMPLETED|Overall Study||339
8231778|NCT01986114|20298241|P1|STARTED|Overall Study||495
8231779|NCT01986101|20298256|P3|NOT COMPLETED|Overall Study||32
8231780|NCT01986101|20298257|P2|NOT COMPLETED|Overall Study||27
8231781|NCT01986101|20298258|P1|NOT COMPLETED|Overall Study||33
8231782|NCT01986101|20298256|P3|COMPLETED|Overall Study||137
8231783|NCT01986101|20298257|P2|COMPLETED|Overall Study||157
8231784|NCT01986101|20298258|P1|COMPLETED|Overall Study||139
8231785|NCT01986101|20298256|P3|Safety Population|Overall Study||169
8231786|NCT01986101|20298257|P2|Safety Population|Overall Study||184
8231787|NCT01986101|20298258|P1|Safety Population|Overall Study||172
8231788|NCT01986101|20298256|P3|Intent-to-Treat Population|Overall Study||169
8231789|NCT01986101|20298257|P2|Intent-to-Treat Population|Overall Study||182
8231790|NCT01986101|20298258|P1|Intent-to-Treat Population|Overall Study||171
8231791|NCT01986101|20298256|P3|STARTED|Overall Study||169
8231792|NCT01986101|20298257|P2|STARTED|Overall Study||184
8231793|NCT01986101|20298258|P1|STARTED|Overall Study||172
8231794|NCT01986062|20298280|P2|NOT COMPLETED|Overall Study||1
8231795|NCT01986062|20298281|P1|NOT COMPLETED|Overall Study||1
8231796|NCT01986062|20298280|P2|COMPLETED|Overall Study||49
8231797|NCT01986062|20298281|P1|COMPLETED|Overall Study||46
8231798|NCT01986062|20298280|P2|STARTED|Overall Study||50
8231799|NCT01986062|20298281|P1|STARTED|Overall Study||47
8231800|NCT01985971|20298297|P1|NOT COMPLETED|Overall Study||1
8231801|NCT01985971|20298297|P1|COMPLETED|Overall Study||1
8231802|NCT01985971|20298297|P1|STARTED|Overall Study||2
8231803|NCT01985958|20298301|P1|NOT COMPLETED|Overall Study||1
8231804|NCT01985958|20298301|P1|COMPLETED|Overall Study||3
8231805|NCT01985958|20298301|P1|STARTED|Overall Study||4
8231806|NCT01985932|20298305|P1|NOT COMPLETED|Overall Study||0
8231807|NCT01985932|20298305|P1|COMPLETED|Overall Study||15
8231808|NCT01985932|20298305|P1|STARTED|Overall Study||15
8231809|NCT01985763|20298309|P1|NOT COMPLETED|Overall Study||0
8231810|NCT01985763|20298309|P1|COMPLETED|Overall Study||13
8231811|NCT01985763|20298309|P1|STARTED|Overall Study||13
8231812|NCT01985685|20298324|P2|NOT COMPLETED|Overall Study||0
8231813|NCT01985685|20298325|P1|NOT COMPLETED|Overall Study||0
8231814|NCT01985685|20298324|P2|COMPLETED|Overall Study||29
8231815|NCT01985685|20298325|P1|COMPLETED|Overall Study||27
8231816|NCT01985685|20298324|P2|STARTED|Overall Study||29
8231817|NCT01985685|20298325|P1|STARTED|Overall Study||27
8231818|NCT01985581|20298337|P2|NOT COMPLETED|Second Intervention||4
8231819|NCT01985581|20298338|P1|NOT COMPLETED|Second Intervention||2
8231820|NCT01985581|20298337|P2|COMPLETED|Second Intervention||19
8231821|NCT01985581|20298338|P1|COMPLETED|Second Intervention||20
8231822|NCT01985581|20298337|P2|STARTED|Second Intervention||23
8231823|NCT01985581|20298338|P1|STARTED|Second Intervention||22
8231824|NCT01985581|20298337|P2|NOT COMPLETED|First Intervention||2
8231825|NCT01985581|20298338|P1|NOT COMPLETED|First Intervention||3
8231826|NCT01985581|20298337|P2|COMPLETED|First Intervention||23
8231827|NCT01985581|20298338|P1|COMPLETED|First Intervention||22
8231828|NCT01985581|20298337|P2|STARTED|First Intervention||25
8231829|NCT01985581|20298338|P1|STARTED|First Intervention||25
8231830|NCT01985425|20298358|P2|NOT COMPLETED|Overall Study||0
8231831|NCT01985425|20298359|P1|NOT COMPLETED|Overall Study||0
8231832|NCT01985425|20298358|P2|COMPLETED|Overall Study||51
8231833|NCT01985425|20298359|P1|COMPLETED|Overall Study||49
8231834|NCT01985425|20298358|P2|STARTED|Overall Study||51
8231835|NCT01985425|20298359|P1|STARTED|Overall Study||49
8231836|NCT01985360|20298379|P2|NOT COMPLETED|Overall Study||3
8231837|NCT01985360|20298380|P1|NOT COMPLETED|Overall Study||9
8231838|NCT01985360|20298379|P2|COMPLETED|Overall Study||386
8231839|NCT01985360|20298380|P1|COMPLETED|Overall Study||379
8231840|NCT01985360|20298379|P2|STARTED|Overall Study||389
8231841|NCT01985360|20298380|P1|STARTED|Overall Study||388
8231842|NCT01985334|20298396|P8|NOT COMPLETED|Overall Study||121
8231843|NCT01985334|20298397|P7|NOT COMPLETED|Overall Study||37
8231844|NCT01985334|20298398|P6|NOT COMPLETED|Overall Study||156
8231845|NCT01985334|20298399|P5|NOT COMPLETED|Overall Study||40
8231846|NCT01985334|20298400|P4|NOT COMPLETED|Overall Study||229
8231847|NCT01985334|20298401|P3|NOT COMPLETED|Overall Study||53
8231848|NCT01985334|20298402|P2|NOT COMPLETED|Overall Study||84
8231849|NCT01985334|20298403|P1|NOT COMPLETED|Overall Study||23
8231850|NCT01985334|20298396|P8|COMPLETED|Overall Study||699
8231851|NCT01985334|20298397|P7|COMPLETED|Overall Study||237
8231852|NCT01985334|20298398|P6|COMPLETED|Overall Study||666
8231853|NCT01985334|20298399|P5|COMPLETED|Overall Study||234
8231854|NCT01985334|20298400|P4|COMPLETED|Overall Study||1033
8231855|NCT01985334|20298401|P3|COMPLETED|Overall Study||367
8231856|NCT01985334|20298402|P2|COMPLETED|Overall Study||303
8231857|NCT01985334|20298403|P1|COMPLETED|Overall Study||107
8231858|NCT01985334|20298396|P8|The Intention-to-treat (ITT) Population|Overall Study||811
8231859|NCT01985334|20298397|P7|The Intention-to-treat (ITT) Population|Overall Study||268
8231860|NCT01985334|20298398|P6|The Intention-to-treat (ITT) Population|Overall Study||811
8231861|NCT01985334|20298399|P5|The Intention-to-treat (ITT) Population|Overall Study||269
8231862|NCT01985334|20298400|P4|The Intention-to-treat (ITT) Population|Overall Study||1254
8231863|NCT01985334|20298401|P3|The Intention-to-treat (ITT) Population|Overall Study||420
8231864|NCT01985334|20298402|P2|The Intention-to-treat (ITT) Population|Overall Study||369
8231865|NCT01985334|20298403|P1|The Intention-to-treat (ITT) Population|Overall Study||122
8231866|NCT01985334|20298396|P8|STARTED|Overall Study||820
8231867|NCT01985334|20298397|P7|STARTED|Overall Study||274
8231868|NCT01985334|20298398|P6|STARTED|Overall Study||822
8231869|NCT01985334|20298399|P5|STARTED|Overall Study||274
8231870|NCT01985334|20298400|P4|STARTED|Overall Study||1262
8231871|NCT01985334|20298401|P3|STARTED|Overall Study||420
8231872|NCT01985334|20298402|P2|STARTED|Overall Study||387
8231873|NCT01985334|20298403|P1|STARTED|Overall Study||130
8231874|NCT01985321|20298471|P2|NOT COMPLETED|Overall Study||5
8231875|NCT01985321|20298472|P1|NOT COMPLETED|Overall Study||11
8231876|NCT01985321|20298471|P2|COMPLETED|Overall Study||78
8231877|NCT01985321|20298472|P1|COMPLETED|Overall Study||79
8231878|NCT01985321|20298471|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
8231879|NCT01985321|20298472|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
8231880|NCT01985126|20298482|P2|NOT COMPLETED|Overall Study||106
8231881|NCT01985126|20298483|P1|NOT COMPLETED|Overall Study||18
8231882|NCT01985126|20298482|P2|COMPLETED|Overall Study||0
8231883|NCT01985126|20298483|P1|COMPLETED|Overall Study||0
8231884|NCT01985126|20298482|P2|STARTED|Overall Study||106
8231885|NCT01985126|20298483|P1|STARTED|Overall Study||18
8231886|NCT01984892|20298501|P1|NOT COMPLETED|Overall Study||7
8231887|NCT01984892|20298501|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
8231888|NCT01984892|20298501|P1|STARTED|Overall Study||8
8231889|NCT01984697|20298512|P5|NOT COMPLETED|Overall Study||35
8231890|NCT01984697|20298513|P4|NOT COMPLETED|Overall Study||21
8231891|NCT01984697|20298514|P3|NOT COMPLETED|Overall Study||29
8231892|NCT01984697|20298515|P2|NOT COMPLETED|Overall Study||31
8231893|NCT01984697|20298516|P1|NOT COMPLETED|Overall Study||43
8231894|NCT01984697|20298512|P5|COMPLETED|Overall Study||279
8231895|NCT01984697|20298513|P4|COMPLETED|Overall Study||280
8231896|NCT01984697|20298514|P3|COMPLETED|Overall Study||272
8231897|NCT01984697|20298515|P2|COMPLETED|Overall Study||270
8231898|NCT01984697|20298516|P1|COMPLETED|Overall Study||258
8231899|NCT01984697|20298512|P5|Month 36 Vaccination|Overall Study||31
8231900|NCT01984697|20298513|P4|Month 36 Vaccination|Overall Study||9
8231901|NCT01984697|20298514|P3|Month 36 Vaccination|Overall Study||280
8231902|NCT01984697|20298515|P2|Month 36 Vaccination|Overall Study||281
8231903|NCT01984697|20298516|P1|Month 36 Vaccination|Overall Study||270
8231904|NCT01984697|20298512|P5|Vaccination 3|Overall Study||311
8231905|NCT01984697|20298513|P4|Vaccination 3|Overall Study||293
8231906|NCT01984697|20298514|P3|Vaccination 3|Overall Study||0
8231907|NCT01984697|20298515|P2|Vaccination 3|Overall Study||0
8231908|NCT01984697|20298516|P1|Vaccination 3|Overall Study||0
8231909|NCT01984697|20298512|P5|Vaccination 2|Overall Study||313
8231910|NCT01984697|20298513|P4|Vaccination 2|Overall Study||298
8231911|NCT01984697|20298514|P3|Vaccination 2|Overall Study||291
8231912|NCT01984697|20298515|P2|Vaccination 2|Overall Study||296
8231913|NCT01984697|20298516|P1|Vaccination 2|Overall Study||293
8231914|NCT01984697|20298512|P5|Vaccination 1|Overall Study||314
8231915|NCT01984697|20298513|P4|Vaccination 1|Overall Study||300
8231916|NCT01984697|20298514|P3|Vaccination 1|Overall Study||300
8231917|NCT01984697|20298515|P2|Vaccination 1|Overall Study||301
8231918|NCT01984697|20298516|P1|Vaccination 1|Overall Study||301
8231919|NCT01984697|20298512|P5|STARTED|Overall Study||314
8231920|NCT01984697|20298513|P4|STARTED|Overall Study||301
8231921|NCT01984697|20298514|P3|STARTED|Overall Study||301
8231922|NCT01984697|20298515|P2|STARTED|Overall Study||301
8231923|NCT01984697|20298516|P1|STARTED|Overall Study||301
8231924|NCT01984684|20298635|P2|NOT COMPLETED|Overall Study||59
8231925|NCT01984684|20298636|P1|NOT COMPLETED|Overall Study||57
8231926|NCT01984684|20298635|P2|COMPLETED|Overall Study||368
8231927|NCT01984684|20298636|P1|COMPLETED|Overall Study||366
8231928|NCT01984684|20298635|P2|STARTED|Overall Study||427
8231929|NCT01984684|20298636|P1|STARTED|Overall Study||423
8231930|NCT01984515|20298646|P1|NOT COMPLETED|Overall Study||19
8231931|NCT01984515|20298646|P1|COMPLETED|Overall Study||40
8231932|NCT01984515|20298646|P1|Received CBT Session|Overall Study||40
8231933|NCT01984515|20298646|P1|STARTED|Overall Study||59
8231934|NCT01984424|20298654|P2|NOT COMPLETED|Overall Study||7
8231935|NCT01984424|20298655|P1|NOT COMPLETED|Overall Study||3
8231936|NCT01984424|20298654|P2|COMPLETED|Overall Study||138
8231937|NCT01984424|20298655|P1|COMPLETED|Overall Study||70
8231938|NCT01984424|20298654|P2|STARTED|Overall Study||145
8231939|NCT01984424|20298655|P1|STARTED|Overall Study||73
8231940|NCT01984398|20298709|P4|NOT COMPLETED|Treatment Period 2||0
8231941|NCT01984398|20298710|P3|NOT COMPLETED|Treatment Period 2||0
8231942|NCT01984398|20298711|P2|NOT COMPLETED|Treatment Period 2||0
8231943|NCT01984398|20298712|P1|NOT COMPLETED|Treatment Period 2||0
8231944|NCT01984398|20298709|P4|COMPLETED|Treatment Period 2||4
8231945|NCT01984398|20298710|P3|COMPLETED|Treatment Period 2||4
8231946|NCT01984398|20298711|P2|COMPLETED|Treatment Period 2||4
8231947|NCT01984398|20298712|P1|COMPLETED|Treatment Period 2||4
8231948|NCT01984398|20298709|P4|STARTED|Treatment Period 2||4
8231949|NCT01984398|20298710|P3|STARTED|Treatment Period 2||4
8231950|NCT01984398|20298711|P2|STARTED|Treatment Period 2||4
8231951|NCT01984398|20298712|P1|STARTED|Treatment Period 2||4
8231952|NCT01984398|20298709|P4|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231953|NCT01984398|20298710|P3|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231954|NCT01984398|20298711|P2|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231955|NCT01984398|20298712|P1|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231956|NCT01984398|20298709|P4|COMPLETED|Washout Period of 5 to 7 Days||4
8231957|NCT01984398|20298710|P3|COMPLETED|Washout Period of 5 to 7 Days||4
8231958|NCT01984398|20298711|P2|COMPLETED|Washout Period of 5 to 7 Days||4
8231959|NCT01984398|20298712|P1|COMPLETED|Washout Period of 5 to 7 Days||4
8231960|NCT01984398|20298709|P4|STARTED|Washout Period of 5 to 7 Days||4
8231961|NCT01984398|20298710|P3|STARTED|Washout Period of 5 to 7 Days||4
8231962|NCT01984398|20298711|P2|STARTED|Washout Period of 5 to 7 Days||4
8231963|NCT01984398|20298712|P1|STARTED|Washout Period of 5 to 7 Days||4
8231964|NCT01984398|20298709|P4|NOT COMPLETED|Treatment Period 1||0
8231965|NCT01984398|20298710|P3|NOT COMPLETED|Treatment Period 1||0
8231966|NCT01984398|20298711|P2|NOT COMPLETED|Treatment Period 1||0
8231967|NCT01984398|20298712|P1|NOT COMPLETED|Treatment Period 1||0
8231968|NCT01984398|20298709|P4|COMPLETED|Treatment Period 1||4
8231969|NCT01984398|20298710|P3|COMPLETED|Treatment Period 1||4
8231970|NCT01984398|20298711|P2|COMPLETED|Treatment Period 1||4
8231971|NCT01984398|20298712|P1|COMPLETED|Treatment Period 1||4
8231972|NCT01984398|20298709|P4|STARTED|Treatment Period 1||4
8231973|NCT01984398|20298710|P3|STARTED|Treatment Period 1||4
8231974|NCT01984398|20298711|P2|STARTED|Treatment Period 1||4
8231975|NCT01984398|20298712|P1|STARTED|Treatment Period 1||4
8231976|NCT01984294|20298725|P3|NOT COMPLETED|Overall Study||7
8231977|NCT01984294|20298726|P2|NOT COMPLETED|Overall Study||3
8231978|NCT01984294|20298727|P1|NOT COMPLETED|Overall Study||4
8231979|NCT01984294|20298725|P3|COMPLETED|Overall Study||27
8231980|NCT01984294|20298726|P2|COMPLETED|Overall Study||29
8231981|NCT01984294|20298727|P1|COMPLETED|Overall Study||31
8231982|NCT01984294|20298725|P3|STARTED|Overall Study||34
8231983|NCT01984294|20298726|P2|STARTED|Overall Study||32
8231984|NCT01984294|20298727|P1|STARTED|Overall Study||35
8231985|NCT01984268|20298747|P1|NOT COMPLETED|Overall Study||15
8231986|NCT01984268|20298747|P1|COMPLETED|Overall Study||0
8231987|NCT01984268|20298747|P1|STARTED|Overall Study||15
8231988|NCT01984242|20298759|P3|NOT COMPLETED|Overall Study||101
8231989|NCT01984242|20298760|P2|NOT COMPLETED|Overall Study||103
8231990|NCT01984242|20298761|P1|NOT COMPLETED|Overall Study||101
8231991|NCT01984242|20298759|P3|COMPLETED|Overall Study||0
8231992|NCT01984242|20298760|P2|COMPLETED|Overall Study||0
8231993|NCT01984242|20298761|P1|COMPLETED|Overall Study||0
8231994|NCT01984242|20298759|P3|Treated|Overall Study||100
8231995|NCT01984242|20298760|P2|Treated|Overall Study||103
8231996|NCT01984242|20298761|P1|Treated|Overall Study||101
8231997|NCT01984242|20298759|P3|STARTED|Overall Study||101
8231998|NCT01984242|20298760|P2|STARTED|Overall Study||103
8231999|NCT01984242|20298761|P1|STARTED|Overall Study||101
8232000|NCT01984229|20298911|P2|NOT COMPLETED|Safety Follow-up Period||1
8232001|NCT01984229|20298912|P1|NOT COMPLETED|Safety Follow-up Period||2
8232002|NCT01984229|20298911|P2|COMPLETED|Safety Follow-up Period||16
8232003|NCT01984229|20298912|P1|COMPLETED|Safety Follow-up Period||4
8232004|NCT01984229|20298911|P2|STARTED|Safety Follow-up Period||17
8232005|NCT01984229|20298912|P1|STARTED|Safety Follow-up Period||6
8232006|NCT01984229|20298911|P2|NOT COMPLETED|Period 3||0
8232007|NCT01984229|20298912|P1|NOT COMPLETED|Period 3||0
8232008|NCT01984229|20298911|P2|COMPLETED|Period 3||17
8232009|NCT01984229|20298912|P1|COMPLETED|Period 3||6
8232010|NCT01984229|20298911|P2|STARTED|Period 3||17
8232011|NCT01984229|20298912|P1|STARTED|Period 3||6
8232012|NCT01984229|20298911|P2|NOT COMPLETED|Period 2||0
8232013|NCT01984229|20298912|P1|NOT COMPLETED|Period 2||0
8232014|NCT01984229|20298911|P2|COMPLETED|Period 2||17
8232015|NCT01984229|20298912|P1|COMPLETED|Period 2||6
8232016|NCT01984229|20298911|P2|STARTED|Period 2||17
8232017|NCT01984229|20298912|P1|STARTED|Period 2||6
8232018|NCT01984229|20298911|P2|NOT COMPLETED|Period 1||0
8232019|NCT01984229|20298912|P1|NOT COMPLETED|Period 1||0
8232020|NCT01984229|20298911|P2|COMPLETED|Period 1||17
8232021|NCT01984229|20298912|P1|COMPLETED|Period 1||6
8232022|NCT01984229|20298911|P2|STARTED|Period 1||17
8232023|NCT01984229|20298912|P1|STARTED|Period 1||6
8232024|NCT01983969|20298965|P3|NOT COMPLETED|Overall Study||0
8232025|NCT01983969|20298966|P2|NOT COMPLETED|Overall Study||1
8232026|NCT01983969|20298967|P1|NOT COMPLETED|Overall Study||0
8232027|NCT01983969|20298965|P3|COMPLETED|Overall Study||5
8232028|NCT01983969|20298966|P2|COMPLETED|Overall Study||18
8232029|NCT01983969|20298967|P1|COMPLETED|Overall Study||37
8232030|NCT01983969|20298965|P3|STARTED|Overall Study||5
8232031|NCT01983969|20298966|P2|STARTED|Overall Study||19
8232032|NCT01983969|20298967|P1|STARTED|Overall Study||37
8232033|NCT01983930|20298981|P2|NOT COMPLETED|Overall Study||9
8232034|NCT01983930|20298982|P1|NOT COMPLETED|Overall Study||9
8232035|NCT01983930|20298981|P2|COMPLETED|Overall Study||29
8232036|NCT01983930|20298982|P1|COMPLETED|Overall Study||32
8232037|NCT01983930|20298981|P2|STARTED|Overall Study||38
8232038|NCT01983930|20298982|P1|STARTED|Overall Study||41
8232039|NCT01983878|20298994|P1|NOT COMPLETED|Overall Study||0
8232040|NCT01983878|20298994|P1|COMPLETED|Overall Study||36
8232041|NCT01983878|20298994|P1|Received At Least One Dose of Study Drug|Overall Study||36
8232042|NCT01983878|20298994|P1|STARTED|Overall Study||36
8232043|NCT01983839|20299005|P1|NOT COMPLETED|Overall Study||0
8232044|NCT01983839|20299005|P1|COMPLETED|Overall Study||18
8232045|NCT01983839|20299005|P1|STARTED|Overall Study||18
8232046|NCT01983826|20299012|P2|NOT COMPLETED|Overall Study||0
8232047|NCT01983826|20299013|P1|NOT COMPLETED|Overall Study||0
8232048|NCT01983826|20299012|P2|COMPLETED|Overall Study||8
8232049|NCT01983826|20299013|P1|COMPLETED|Overall Study||13
8232050|NCT01983826|20299012|P2|STARTED|Overall Study||8
8232051|NCT01983826|20299013|P1|STARTED|Overall Study||13
8232052|NCT01983787|20299031|P1|NOT COMPLETED|Overall Study||0
8232053|NCT01983787|20299031|P1|COMPLETED|Overall Study||10
8232054|NCT01983787|20299031|P1|STARTED|Overall Study||10
8232055|NCT01983683|20299056|P2|NOT COMPLETED|Overall Study||51
8232056|NCT01983683|20299057|P1|NOT COMPLETED|Overall Study||38
8232057|NCT01983683|20299056|P2|COMPLETED|Overall Study||260
8232058|NCT01983683|20299057|P1|COMPLETED|Overall Study||260
8232059|NCT01983683|20299056|P2|STARTED|Overall Study||311
8232060|NCT01983683|20299057|P1|STARTED|Overall Study||298
8232061|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 4||0
8232062|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 4||0
8232063|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 4||0
8232064|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 4||0
8232065|NCT01983566|20299085|P4|COMPLETED|Test Period 4||0
8232066|NCT01983566|20299086|P3|COMPLETED|Test Period 4||0
8232067|NCT01983566|20299087|P2|COMPLETED|Test Period 4||0
8232068|NCT01983566|20299088|P1|COMPLETED|Test Period 4||0
8232069|NCT01983566|20299085|P4|STARTED|Test Period 4||0
8232070|NCT01983566|20299086|P3|STARTED|Test Period 4||0
8232071|NCT01983566|20299087|P2|STARTED|Test Period 4||0
8232072|NCT01983566|20299088|P1|STARTED|Test Period 4||0
8232073|NCT01983566|20299085|P4|NOT COMPLETED|Wash-Out 3||0
8232074|NCT01983566|20299086|P3|NOT COMPLETED|Wash-Out 3||0
8232075|NCT01983566|20299087|P2|NOT COMPLETED|Wash-Out 3||0
8232076|NCT01983566|20299088|P1|NOT COMPLETED|Wash-Out 3||0
8232077|NCT01983566|20299085|P4|COMPLETED|Wash-Out 3||0
8232078|NCT01983566|20299086|P3|COMPLETED|Wash-Out 3||0
8232079|NCT01983566|20299087|P2|COMPLETED|Wash-Out 3||0
8232080|NCT01983566|20299088|P1|COMPLETED|Wash-Out 3||0
8232081|NCT01983566|20299085|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232082|NCT01983566|20299086|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232083|NCT01983566|20299087|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232084|NCT01983566|20299088|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232085|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 3||0
8232086|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 3||0
8232087|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 3||0
8232088|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 3||0
8232089|NCT01983566|20299085|P4|COMPLETED|Test Period 3||4
8232090|NCT01983566|20299086|P3|COMPLETED|Test Period 3||2
8232091|NCT01983566|20299087|P2|COMPLETED|Test Period 3||3
8232092|NCT01983566|20299088|P1|COMPLETED|Test Period 3||2
8232093|NCT01983566|20299085|P4|STARTED|Test Period 3||4
8232094|NCT01983566|20299086|P3|STARTED|Test Period 3||2
8232095|NCT01983566|20299087|P2|STARTED|Test Period 3||3
8232096|NCT01983566|20299088|P1|STARTED|Test Period 3||2
8232097|NCT01983566|20299085|P4|NOT COMPLETED|Wash-Out 2||0
8232098|NCT01983566|20299086|P3|NOT COMPLETED|Wash-Out 2||0
8232099|NCT01983566|20299087|P2|NOT COMPLETED|Wash-Out 2||0
8232100|NCT01983566|20299088|P1|NOT COMPLETED|Wash-Out 2||0
8232101|NCT01983566|20299085|P4|COMPLETED|Wash-Out 2||4
8232102|NCT01983566|20299086|P3|COMPLETED|Wash-Out 2||2
8232103|NCT01983566|20299087|P2|COMPLETED|Wash-Out 2||3
8232104|NCT01983566|20299088|P1|COMPLETED|Wash-Out 2||2
8232105|NCT01983566|20299085|P4|STARTED|Wash-Out 2||4
8232106|NCT01983566|20299086|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
8232107|NCT01983566|20299087|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
8232108|NCT01983566|20299088|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
8232109|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 2||0
8232110|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 2||0
8232111|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 2||0
8232112|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 2||0
8232113|NCT01983566|20299085|P4|COMPLETED|Test Period 2||4
8232114|NCT01983566|20299086|P3|COMPLETED|Test Period 2||4
8232115|NCT01983566|20299087|P2|COMPLETED|Test Period 2||4
8232116|NCT01983566|20299088|P1|COMPLETED|Test Period 2||4
8232117|NCT01983566|20299085|P4|STARTED|Test Period 2||4
8232118|NCT01983566|20299086|P3|STARTED|Test Period 2||4
8232119|NCT01983566|20299087|P2|STARTED|Test Period 2||4
8232120|NCT01983566|20299088|P1|STARTED|Test Period 2||4
8232121|NCT01983566|20299085|P4|NOT COMPLETED|Wash-Out 1||0
8232122|NCT01983566|20299086|P3|NOT COMPLETED|Wash-Out 1||0
8232123|NCT01983566|20299087|P2|NOT COMPLETED|Wash-Out 1||0
8232124|NCT01983566|20299088|P1|NOT COMPLETED|Wash-Out 1||0
8232125|NCT01983566|20299085|P4|COMPLETED|Wash-Out 1||4
8232126|NCT01983566|20299086|P3|COMPLETED|Wash-Out 1||4
8232127|NCT01983566|20299087|P2|COMPLETED|Wash-Out 1||4
8232128|NCT01983566|20299088|P1|COMPLETED|Wash-Out 1||4
8232129|NCT01983566|20299085|P4|STARTED|Wash-Out 1||4
8232130|NCT01983566|20299086|P3|STARTED|Wash-Out 1||4
8232131|NCT01983566|20299087|P2|STARTED|Wash-Out 1||4
8232132|NCT01983566|20299088|P1|STARTED|Wash-Out 1||4
8232133|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 1||0
8232134|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 1||0
8232135|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 1||0
8232136|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 1||0
8232137|NCT01983566|20299085|P4|COMPLETED|Test Period 1||4
8232138|NCT01983566|20299086|P3|COMPLETED|Test Period 1||4
8232139|NCT01983566|20299087|P2|COMPLETED|Test Period 1||4
8232140|NCT01983566|20299088|P1|COMPLETED|Test Period 1||4
8232141|NCT01983566|20299085|P4|STARTED|Test Period 1||4
8232142|NCT01983566|20299086|P3|STARTED|Test Period 1||4
8232143|NCT01983566|20299087|P2|STARTED|Test Period 1||4
8232144|NCT01983566|20299088|P1|STARTED|Test Period 1||4
8232145|NCT01983553|20299109|P2|NOT COMPLETED|Overall Study||0
8232146|NCT01983553|20299110|P1|NOT COMPLETED|Overall Study||0
8232147|NCT01983553|20299109|P2|COMPLETED|Overall Study||1072
8232148|NCT01983553|20299110|P1|COMPLETED|Overall Study||2131
8232149|NCT01983553|20299109|P2|STARTED|Overall Study||1072
8232150|NCT01983553|20299110|P1|STARTED|Overall Study||2131
8232151|NCT01983293|20299144|P2|NOT COMPLETED|Overall Study||19
8232152|NCT01983293|20299145|P1|NOT COMPLETED|Overall Study||33
8232153|NCT01983293|20299144|P2|COMPLETED|Overall Study||62
8232154|NCT01983293|20299145|P1|COMPLETED|Overall Study||128
8232155|NCT01983293|20299144|P2|STARTED|Overall Study||81
8232156|NCT01983293|20299145|P1|STARTED|Overall Study||161
8232157|NCT01983254|20299153|P2|NOT COMPLETED|Overall Study||30
8232158|NCT01983254|20299154|P1|NOT COMPLETED|Overall Study||34
8232159|NCT01983254|20299153|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
8232160|NCT01983254|20299154|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
8232161|NCT01983254|20299153|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
8232162|NCT01983254|20299154|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
8232163|NCT01983254|20299153|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
8232164|NCT01983254|20299154|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
8232165|NCT01983254|20299153|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
8232166|NCT01983254|20299154|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
8232167|NCT01983254|20299153|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
8232168|NCT01983254|20299154|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
8232169|NCT01983111|20299166|P2|NOT COMPLETED|Overall Study||7
8232170|NCT01983111|20299167|P1|NOT COMPLETED|Overall Study||12
8232171|NCT01983111|20299166|P2|COMPLETED|Overall Study||59
8232172|NCT01983111|20299167|P1|COMPLETED|Overall Study||58
8232173|NCT01983111|20299166|P2|STARTED|Overall Study||66
8232174|NCT01983111|20299167|P1|STARTED|Overall Study||70
8232175|NCT01983020|20299187|P4|NOT COMPLETED|Overall Study||0
8232176|NCT01983020|20299188|P3|NOT COMPLETED|Overall Study||0
8232177|NCT01983020|20299189|P2|NOT COMPLETED|Overall Study||0
8232178|NCT01983020|20299190|P1|NOT COMPLETED|Overall Study||0
8232179|NCT01983020|20299187|P4|COMPLETED|Overall Study||11
8232180|NCT01983020|20299188|P3|COMPLETED|Overall Study||12
8232181|NCT01983020|20299189|P2|COMPLETED|Overall Study||11
8232182|NCT01983020|20299190|P1|COMPLETED|Overall Study||12
8232183|NCT01983020|20299187|P4|STARTED|Overall Study||11
8232184|NCT01983020|20299188|P3|STARTED|Overall Study||12
8232185|NCT01983020|20299189|P2|STARTED|Overall Study||11
8232186|NCT01983020|20299190|P1|STARTED|Overall Study||12
8232187|NCT01982955|20299205|P5|NOT COMPLETED|Overall Study||0
8232188|NCT01982955|20299206|P4|NOT COMPLETED|Overall Study||1
8232189|NCT01982955|20299207|P3|NOT COMPLETED|Overall Study||4
8232190|NCT01982955|20299208|P2|NOT COMPLETED|Overall Study||0
8232191|NCT01982955|20299209|P1|NOT COMPLETED|Overall Study||0
8232192|NCT01982955|20299205|P5|COMPLETED|Overall Study||15
8232193|NCT01982955|20299206|P4|COMPLETED|Overall Study||23
8232194|NCT01982955|20299207|P3|COMPLETED|Overall Study||27
8232195|NCT01982955|20299208|P2|COMPLETED|Overall Study||12
8232196|NCT01982955|20299209|P1|COMPLETED|Overall Study||6
8232197|NCT01982955|20299205|P5|Treated|Overall Study||15
8232198|NCT01982955|20299206|P4|Treated|Overall Study||23
8232199|NCT01982955|20299207|P3|Treated|Overall Study||31
8232200|NCT01982955|20299208|P2|Treated|Overall Study||12
8232201|NCT01982955|20299209|P1|Treated|Overall Study||6
8232202|NCT01982955|20299205|P5|STARTED|Overall Study||15
8232203|NCT01982955|20299206|P4|STARTED|Overall Study||24
8232204|NCT01982955|20299207|P3|STARTED|Overall Study||31
8232205|NCT01982955|20299208|P2|STARTED|Overall Study||12
8232206|NCT01982955|20299209|P1|STARTED|Overall Study||6
8232207|NCT01982942|20299311|P2|NOT COMPLETED|Overall Study||14
8232208|NCT01982942|20299312|P1|NOT COMPLETED|Overall Study||21
8232209|NCT01982942|20299311|P2|COMPLETED|Overall Study||112
8232210|NCT01982942|20299312|P1|COMPLETED|Overall Study||108
8232211|NCT01982942|20299311|P2|STARTED|Overall Study||126
8232212|NCT01982942|20299312|P1|STARTED|Overall Study||129
8232213|NCT01982812|20299330|P2|NOT COMPLETED|Overall Study||10
8232214|NCT01982812|20299331|P1|NOT COMPLETED|Overall Study||1
8232215|NCT01982812|20299330|P2|COMPLETED|Overall Study||11
8232216|NCT01982812|20299331|P1|COMPLETED|Overall Study||22
8232217|NCT01982812|20299330|P2|STARTED|Overall Study||21
8232218|NCT01982812|20299331|P1|STARTED|Overall Study||23
8232219|NCT01982786|20299345|P2|NOT COMPLETED|Overall Study||0
8232220|NCT01982786|20299346|P1|NOT COMPLETED|Overall Study||0
8232221|NCT01982786|20299345|P2|COMPLETED|Overall Study||28
8232222|NCT01982786|20299346|P1|COMPLETED|Overall Study||29
8232223|NCT01982786|20299345|P2|STARTED|Overall Study||28
8232224|NCT01982786|20299346|P1|STARTED|Overall Study||29
8232225|NCT01982773|20299360|P2|NOT COMPLETED|Overall Study||4
8232226|NCT01982773|20299361|P1|NOT COMPLETED|Overall Study||8
8232227|NCT01982773|20299360|P2|COMPLETED|Overall Study||56
8232228|NCT01982773|20299361|P1|COMPLETED|Overall Study||50
8232229|NCT01982773|20299360|P2|STARTED|Overall Study||60
8232230|NCT01982773|20299361|P1|STARTED|Overall Study||58
8232231|NCT01982695|20299375|P2|NOT COMPLETED|Overall Study||1
8232232|NCT01982695|20299376|P1|NOT COMPLETED|Overall Study||0
8232233|NCT01982695|20299375|P2|COMPLETED|Overall Study||10
8232234|NCT01982695|20299376|P1|COMPLETED|Overall Study||12
8232235|NCT01982695|20299375|P2|STARTED|Overall Study||11
8232236|NCT01982695|20299376|P1|STARTED|Overall Study||12
8232237|NCT01982682|20299382|P1|NOT COMPLETED|Overall Study||1
8232238|NCT01982682|20299382|P1|COMPLETED|Overall Study||40
8232239|NCT01982682|20299382|P1|STARTED|Overall Study||41
8232240|NCT01982643|20299390|P1|NOT COMPLETED|Overall Study||12
8232241|NCT01982643|20299390|P1|COMPLETED|Overall Study||37
8232242|NCT01982643|20299390|P1|STARTED|Overall Study||49
8232243|NCT01982539|20299394|P1|NOT COMPLETED|Overall Study||0
8232244|NCT01982539|20299394|P1|COMPLETED|Overall Study||25
8232245|NCT01982539|20299394|P1|STARTED|Overall Study||25
8232246|NCT01982435|20299402|P2|NOT COMPLETED|Overall Study||0
8232247|NCT01982435|20299403|P1|NOT COMPLETED|Overall Study||1
8232248|NCT01982435|20299402|P2|COMPLETED|Overall Study||12
8232249|NCT01982435|20299403|P1|COMPLETED|Overall Study||14
8232250|NCT01982435|20299402|P2|STARTED|Overall Study||12
8232251|NCT01982435|20299403|P1|STARTED|Overall Study||15
8232252|NCT01982383|20299433|P2|NOT COMPLETED|Overall Study||0
8232253|NCT01982383|20299434|P1|NOT COMPLETED|Overall Study||0
8232254|NCT01982383|20299433|P2|COMPLETED|Overall Study||0
8232255|NCT01982383|20299434|P1|COMPLETED|Overall Study||2
8232256|NCT01982383|20299433|P2|STARTED|Overall Study||0
8232257|NCT01982383|20299434|P1|STARTED|Overall Study||2
8232258|NCT01982331|20299442|P2|NOT COMPLETED|Completed Study (Day 112)||0
8232259|NCT01982331|20299443|P1|NOT COMPLETED|Completed Study (Day 112)||2
8232260|NCT01982331|20299442|P2|COMPLETED|Completed Study (Day 112)||7
8232261|NCT01982331|20299443|P1|COMPLETED|Completed Study (Day 112)||25
8232262|NCT01982331|20299442|P2|STARTED|Completed Study (Day 112)||7
8232263|NCT01982331|20299443|P1|STARTED|Completed Study (Day 112)||27
8232264|NCT01982331|20299442|P2|NOT COMPLETED|Received Vaccination 2||3
8232265|NCT01982331|20299443|P1|NOT COMPLETED|Received Vaccination 2||1
8232266|NCT01982331|20299442|P2|COMPLETED|Received Vaccination 2||7
8232267|NCT01982331|20299443|P1|COMPLETED|Received Vaccination 2||27
8232268|NCT01982331|20299442|P2|STARTED|Received Vaccination 2||10
8232269|NCT01982331|20299443|P1|STARTED|Received Vaccination 2||28
8232270|NCT01982331|20299442|P2|NOT COMPLETED|Received Vaccination 1||0
8232271|NCT01982331|20299443|P1|NOT COMPLETED|Received Vaccination 1||0
8232272|NCT01982331|20299442|P2|COMPLETED|Received Vaccination 1||10
8232273|NCT01982331|20299443|P1|COMPLETED|Received Vaccination 1||28
8232274|NCT01982331|20299442|P2|STARTED|Received Vaccination 1||10
8232275|NCT01982331|20299443|P1|STARTED|Received Vaccination 1||28
8232276|NCT01982292|20299479|P2|NOT COMPLETED|Overall Study||1
8232277|NCT01982292|20299480|P1|NOT COMPLETED|Overall Study||12
8232278|NCT01982292|20299479|P2|COMPLETED|Overall Study||107
8232279|NCT01982292|20299480|P1|COMPLETED|Overall Study||203
8232280|NCT01982292|20299479|P2|Safety Set|Overall Study||108
8232281|NCT01982292|20299480|P1|Safety Set|Overall Study||212
8232282|NCT01982292|20299479|P2|Full Analaysis Set (FAS)|Overall Study||108
8232283|NCT01982292|20299480|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
8232284|NCT01982292|20299479|P2|STARTED|Overall Study||108
8232285|NCT01982292|20299480|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
8232286|NCT01982253|20299501|P3|NOT COMPLETED|Overall Study||4
8232287|NCT01982253|20299502|P2|NOT COMPLETED|Overall Study||4
8232288|NCT01982253|20299503|P1|NOT COMPLETED|Overall Study||2
8232289|NCT01982253|20299501|P3|COMPLETED|Overall Study||0
8232290|NCT01982253|20299502|P2|COMPLETED|Overall Study||0
8232291|NCT01982253|20299503|P1|COMPLETED|Overall Study||0
8232292|NCT01982253|20299501|P3|STARTED|Overall Study||4
8232293|NCT01982253|20299502|P2|STARTED|Overall Study||4
8232294|NCT01982253|20299503|P1|STARTED|Overall Study||2
8232295|NCT01982240|20299517|P3|NOT COMPLETED|Overall Study||70
8232296|NCT01982240|20299518|P2|NOT COMPLETED|Overall Study||69
8232297|NCT01982240|20299519|P1|NOT COMPLETED|Overall Study||67
8232298|NCT01982240|20299517|P3|COMPLETED|Overall Study||371
8232299|NCT01982240|20299518|P2|COMPLETED|Overall Study||384
8232300|NCT01982240|20299519|P1|COMPLETED|Overall Study||385
8232301|NCT01982240|20299517|P3|STARTED|Overall Study||441
8232302|NCT01982240|20299518|P2|STARTED|Overall Study||453
8232303|NCT01982240|20299519|P1|STARTED|Overall Study||452
8232304|NCT01982123|20299539|P1|NOT COMPLETED|Overall Study||0
8232305|NCT01982123|20299539|P1|COMPLETED|Overall Study||12
8232306|NCT01982123|20299539|P1|STARTED|Overall Study||12
8232307|NCT01981967|20299546|P2|NOT COMPLETED|Overall Study||0
8232308|NCT01981967|20299547|P1|NOT COMPLETED|Overall Study||0
8232309|NCT01981967|20299546|P2|COMPLETED|Overall Study||3149
8232310|NCT01981967|20299547|P1|COMPLETED|Overall Study||6851
8232311|NCT01981967|20299546|P2|STARTED|Overall Study||3149
8232312|NCT01981967|20299547|P1|STARTED|Overall Study||6851
8232313|NCT01981954|20299557|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
8232314|NCT01981954|20299557|P1|COMPLETED|Fixed-Dose Assessment Period||21
8232315|NCT01981954|20299557|P1|Treated|Fixed-Dose Assessment Period||22
8232316|NCT01981954|20299557|P1|STARTED|Fixed-Dose Assessment Period||22
8232317|NCT01981954|20299557|P1|NOT COMPLETED|Titration Period||1
8232318|NCT01981954|20299557|P1|COMPLETED|Titration Period||22
8232319|NCT01981954|20299557|P1|Treated|Titration Period||23
8232320|NCT01981954|20299557|P1|STARTED|Titration Period||23
8232321|NCT01981863|20299604|P2|NOT COMPLETED|Overall Study||0
8232322|NCT01981863|20299605|P1|NOT COMPLETED|Overall Study||0
8232323|NCT01981863|20299604|P2|COMPLETED|Overall Study||20
8232324|NCT01981863|20299605|P1|COMPLETED|Overall Study||20
8232325|NCT01981863|20299604|P2|STARTED|Overall Study||20
8232326|NCT01981863|20299605|P1|STARTED|Overall Study||20
8232327|NCT01981772|20299617|P2|NOT COMPLETED|Overall Study||0
8232328|NCT01981772|20299618|P1|NOT COMPLETED|Overall Study||0
8232329|NCT01981772|20299617|P2|COMPLETED|Overall Study||43
8232330|NCT01981772|20299618|P1|COMPLETED|Overall Study||45
8232331|NCT01981772|20299617|P2|STARTED|Overall Study||43
8232332|NCT01981772|20299618|P1|STARTED|Overall Study||45
8232333|NCT01981759|20299628|P2|NOT COMPLETED|Overall Study||11
8232334|NCT01981759|20299629|P1|NOT COMPLETED|Overall Study||7
8232335|NCT01981759|20299628|P2|COMPLETED|Overall Study||19
8232336|NCT01981759|20299629|P1|COMPLETED|Overall Study||21
8232337|NCT01981759|20299628|P2|Completed Week 12|Overall Study||22
8232338|NCT01981759|20299629|P1|Completed Week 12|Overall Study||22
8232339|NCT01981759|20299628|P2|Randomization (Week 3)|Overall Study||30
8232340|NCT01981759|20299629|P1|Randomization (Week 3)|Overall Study||28
8232341|NCT01981759|20299628|P2|Baseline (Week 1)|Overall Study||30
8232342|NCT01981759|20299629|P1|Baseline (Week 1)|Overall Study||28
8232343|NCT01981759|20299628|P2|STARTED|Overall Study||30
8232344|NCT01981759|20299629|P1|STARTED|Overall Study||28
8232345|NCT01981616|20299641|P2|NOT COMPLETED|Overall Study||1
8232346|NCT01981616|20299642|P1|NOT COMPLETED|Overall Study||1
8232347|NCT01981616|20299641|P2|COMPLETED|Overall Study||62
8232348|NCT01981616|20299642|P1|COMPLETED|Overall Study||63
8232349|NCT01981616|20299641|P2|STARTED|Overall Study||63
8232350|NCT01981616|20299642|P1|STARTED|Overall Study||64
8232351|NCT01981590|20299654|P1|NOT COMPLETED|Overall Study||0
8232352|NCT01981590|20299654|P1|COMPLETED|Overall Study||15
8232353|NCT01981590|20299654|P1|STARTED|Overall Study||15
8232354|NCT01981564|20299663|P2|NOT COMPLETED|Overall Study||9
8232355|NCT01981564|20299664|P1|NOT COMPLETED|Overall Study||9
8232356|NCT01981564|20299663|P2|COMPLETED|Overall Study||106
8232357|NCT01981564|20299664|P1|COMPLETED|Overall Study||98
8232358|NCT01981564|20299663|P2|STARTED|Overall Study||115
8232359|NCT01981564|20299664|P1|STARTED|Overall Study||107
8232360|NCT01981551|20299672|P1|NOT COMPLETED|Overall Study||9
8232361|NCT01981551|20299672|P1|COMPLETED|Overall Study||8
8232362|NCT01981551|20299672|P1|STARTED|Overall Study||17
8232363|NCT01981473|20299682|P3|NOT COMPLETED|Overall Study||8
8232364|NCT01981473|20299683|P2|NOT COMPLETED|Overall Study||0
8232365|NCT01981473|20299684|P1|NOT COMPLETED|Overall Study||2
8232366|NCT01981473|20299682|P3|COMPLETED|Overall Study||196
8232367|NCT01981473|20299683|P2|COMPLETED|Overall Study||199
8232368|NCT01981473|20299684|P1|COMPLETED|Overall Study||200
8232369|NCT01981473|20299682|P3|STARTED|Overall Study||204
8232370|NCT01981473|20299683|P2|STARTED|Overall Study||199
8232371|NCT01981473|20299684|P1|STARTED|Overall Study||202
8232372|NCT01981356|20299725|P2|NOT COMPLETED|Overall Study||2
8232373|NCT01981356|20299726|P1|NOT COMPLETED|Overall Study||7
8232374|NCT01981356|20299725|P2|COMPLETED|Overall Study||4
8232375|NCT01981356|20299726|P1|COMPLETED|Overall Study||5
8232376|NCT01981356|20299725|P2|STARTED|Overall Study||6
8232377|NCT01981356|20299726|P1|STARTED|Overall Study||12
8232378|NCT01981122|20299753|P2|NOT COMPLETED|Overall Study||20
8232379|NCT01981122|20299754|P1|NOT COMPLETED|Overall Study||14
8232380|NCT01981122|20299753|P2|COMPLETED|Overall Study||7
8232381|NCT01981122|20299754|P1|COMPLETED|Overall Study||11
8232382|NCT01981122|20299753|P2|STARTED|Overall Study||27
8232383|NCT01981122|20299754|P1|STARTED|Overall Study||25
8232384|NCT01981109|20299760|P1|NOT COMPLETED|Overall Study||224
8232385|NCT01981109|20299760|P1|COMPLETED|Overall Study||1
8232386|NCT01981109|20299760|P1|STARTED|Overall Study||225
8232387|NCT01981096|20299767|P2|NOT COMPLETED|Overall Study||1
8232388|NCT01981096|20299768|P1|NOT COMPLETED|Overall Study||3
8232389|NCT01981096|20299767|P2|COMPLETED|Overall Study||19
8232390|NCT01981096|20299768|P1|COMPLETED|Overall Study||17
8232391|NCT01981096|20299767|P2|Post-treatment|Overall Study||19
8232392|NCT01981096|20299768|P1|Post-treatment|Overall Study||17
8232393|NCT01981096|20299767|P2|STARTED|Overall Study||20
8232394|NCT01981096|20299768|P1|STARTED|Overall Study||20
8232395|NCT01981057|20299780|P2|NOT COMPLETED|Overall Study||0
8232396|NCT01981057|20299781|P1|NOT COMPLETED|Overall Study||0
8232397|NCT01981057|20299780|P2|COMPLETED|Overall Study||50
8232398|NCT01981057|20299781|P1|COMPLETED|Overall Study||50
8232399|NCT01981057|20299780|P2|STARTED|Overall Study||50
8232400|NCT01981057|20299781|P1|STARTED|Overall Study||50
8232401|NCT01980992|20299789|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
8232402|NCT01980992|20299790|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
8232403|NCT01980992|20299789|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
8232404|NCT01980992|20299790|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
8232405|NCT01980992|20299789|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
8232406|NCT01980992|20299790|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
8232407|NCT01980992|20299789|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
8232408|NCT01980992|20299790|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
8232409|NCT01980992|20299789|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
8232410|NCT01980992|20299790|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
8232411|NCT01980992|20299789|P2|STARTED|52 Weeks Blinded Study Treatment||23
8232412|NCT01980992|20299790|P1|STARTED|52 Weeks Blinded Study Treatment||23
8232413|NCT01980940|20299815|P8|NOT COMPLETED|Overall Study||0
8232414|NCT01980940|20299816|P7|NOT COMPLETED|Overall Study||0
8232415|NCT01980940|20299817|P6|NOT COMPLETED|Overall Study||2
8232416|NCT01980940|20299818|P5|NOT COMPLETED|Overall Study||0
8232417|NCT01980940|20299819|P4|NOT COMPLETED|Overall Study||0
8232418|NCT01980940|20299820|P3|NOT COMPLETED|Overall Study||0
8232419|NCT01980940|20299821|P2|NOT COMPLETED|Overall Study||0
8232420|NCT01980940|20299822|P1|NOT COMPLETED|Overall Study||0
8232421|NCT01980940|20299815|P8|COMPLETED|Overall Study||24
8232422|NCT01980940|20299816|P7|COMPLETED|Overall Study||24
8232423|NCT01980940|20299817|P6|COMPLETED|Overall Study||0
8232424|NCT01980940|20299818|P5|COMPLETED|Overall Study||2
8232425|NCT01980940|20299819|P4|COMPLETED|Overall Study||3
8232426|NCT01980940|20299820|P3|COMPLETED|Overall Study||5
8232427|NCT01980940|20299821|P2|COMPLETED|Overall Study||5
8232428|NCT01980940|20299822|P1|COMPLETED|Overall Study||5
8232429|NCT01980940|20299815|P8|Treated|Overall Study||24
8232430|NCT01980940|20299816|P7|Treated|Overall Study||24
8232431|NCT01980940|20299817|P6|Treated|Overall Study||2
8232432|NCT01980940|20299818|P5|Treated|Overall Study||2
8232433|NCT01980940|20299819|P4|Treated|Overall Study||3
8232434|NCT01980940|20299820|P3|Treated|Overall Study||5
8232435|NCT01980940|20299821|P2|Treated|Overall Study||5
8232436|NCT01980940|20299822|P1|Treated|Overall Study||5
8232437|NCT01980940|20299815|P8|STARTED|Overall Study||24
8232438|NCT01980940|20299816|P7|STARTED|Overall Study||24
8232439|NCT01980940|20299817|P6|STARTED|Overall Study||2
8232440|NCT01980940|20299818|P5|STARTED|Overall Study||2
8232441|NCT01980940|20299819|P4|STARTED|Overall Study||3
8232442|NCT01980940|20299820|P3|STARTED|Overall Study||5
8232443|NCT01980940|20299821|P2|STARTED|Overall Study||5
8232444|NCT01980940|20299822|P1|STARTED|Overall Study||5
8232445|NCT01980914|20299874|P1|NOT COMPLETED|Overall Study||0
8232446|NCT01980914|20299874|P1|COMPLETED|Overall Study||11
8232447|NCT01980914|20299874|P1|STARTED|Overall Study||11
8232448|NCT01980888|20299881|P2|NOT COMPLETED|Overall Study||133
8232449|NCT01980888|20299882|P1|NOT COMPLETED|Overall Study||144
8232450|NCT01980888|20299881|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
8232451|NCT01980888|20299882|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
8232452|NCT01980888|20299881|P2|STARTED|Overall Study||154
8232453|NCT01980888|20299882|P1|STARTED|Overall Study||157
8232454|NCT01980875|20299901|P3|NOT COMPLETED|Overall Study||24
8232455|NCT01980875|20299902|P2|NOT COMPLETED|Overall Study||25
8232456|NCT01980875|20299903|P1|NOT COMPLETED|Overall Study||8
8232457|NCT01980875|20299901|P3|COMPLETED|Overall Study||0
8232458|NCT01980875|20299902|P2|COMPLETED|Overall Study||0
8232459|NCT01980875|20299903|P1|COMPLETED|Overall Study||0
8232460|NCT01980875|20299901|P3|STARTED|Overall Study||24
8232461|NCT01980875|20299902|P2|STARTED|Overall Study||25
8232462|NCT01980875|20299903|P1|STARTED|Overall Study||8
8232463|NCT01980771|20299928|P2|NOT COMPLETED|Overall Study||119
8232464|NCT01980771|20299929|P1|NOT COMPLETED|Overall Study||84
8232465|NCT01980771|20299928|P2|COMPLETED|Overall Study||305
8232466|NCT01980771|20299929|P1|COMPLETED|Overall Study||352
8232467|NCT01980771|20299928|P2|STARTED|Overall Study||424
8232468|NCT01980771|20299929|P1|STARTED|Overall Study||436
8232469|NCT01980706|20299938|P3|NOT COMPLETED|Overall Study||13
8232470|NCT01980706|20299939|P2|NOT COMPLETED|Overall Study||17
8232471|NCT01980706|20299940|P1|NOT COMPLETED|Overall Study||17
8232472|NCT01980706|20299938|P3|COMPLETED|Overall Study||24
8232473|NCT01980706|20299939|P2|COMPLETED|Overall Study||26
8232474|NCT01980706|20299940|P1|COMPLETED|Overall Study||23
8232475|NCT01980706|20299938|P3|STARTED|Overall Study||37
8232476|NCT01980706|20299939|P2|STARTED|Overall Study||43
8232477|NCT01980706|20299940|P1|STARTED|Overall Study||40
8232478|NCT01980654|20299965|P2|NOT COMPLETED|Overall Study||0
8232479|NCT01980654|20299966|P1|NOT COMPLETED|Overall Study||0
8232480|NCT01980654|20299965|P2|COMPLETED|Overall Study||20
8232481|NCT01980654|20299966|P1|COMPLETED|Overall Study||60
8232482|NCT01980654|20299965|P2|STARTED|Overall Study||20
8232483|NCT01980654|20299966|P1|STARTED|Overall Study||60
8232484|NCT01980628|20299980|P1|NOT COMPLETED|Overall Study||63
8232485|NCT01980628|20299980|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
8232486|NCT01980628|20299980|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
8232487|NCT01980589|20299988|P3|NOT COMPLETED|Overall Study||0
8232488|NCT01980589|20299989|P2|NOT COMPLETED|Overall Study||0
8232489|NCT01980589|20299990|P1|NOT COMPLETED|Overall Study||0
8232490|NCT01980589|20299988|P3|COMPLETED|Overall Study||16
8232491|NCT01980589|20299989|P2|COMPLETED|Overall Study||3
8232492|NCT01980589|20299990|P1|COMPLETED|Overall Study||3
8232493|NCT01980589|20299988|P3|STARTED|Overall Study||16
8232494|NCT01980589|20299989|P2|STARTED|Overall Study||3
8232495|NCT01980589|20299990|P1|STARTED|Overall Study||3
8232496|NCT01980524|20300007|P2|NOT COMPLETED|Study Day 2||0
8232497|NCT01980524|20300008|P1|NOT COMPLETED|Study Day 2||0
8232498|NCT01980524|20300007|P2|COMPLETED|Study Day 2||4
8232499|NCT01980524|20300008|P1|COMPLETED|Study Day 2||4
8232500|NCT01980524|20300007|P2|STARTED|Study Day 2||4
8232501|NCT01980524|20300008|P1|STARTED|Study Day 2||4
8232502|NCT01980524|20300007|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
8232503|NCT01980524|20300008|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
8232504|NCT01980524|20300007|P2|COMPLETED|Washout (at Least 2 Weeks)||4
8232505|NCT01980524|20300008|P1|COMPLETED|Washout (at Least 2 Weeks)||4
8232506|NCT01980524|20300007|P2|STARTED|Washout (at Least 2 Weeks)||4
8232507|NCT01980524|20300008|P1|STARTED|Washout (at Least 2 Weeks)||4
8232508|NCT01980524|20300007|P2|NOT COMPLETED|Study Day 1||0
8232509|NCT01980524|20300008|P1|NOT COMPLETED|Study Day 1||0
8232510|NCT01980524|20300007|P2|COMPLETED|Study Day 1||4
8232511|NCT01980524|20300008|P1|COMPLETED|Study Day 1||4
8232512|NCT01980524|20300007|P2|STARTED|Study Day 1||4
8232513|NCT01980524|20300008|P1|STARTED|Study Day 1||4
8232514|NCT01980485|20300020|P2|NOT COMPLETED|Overall Study||25
8232515|NCT01980485|20300021|P1|NOT COMPLETED|Overall Study||36
8232516|NCT01980485|20300020|P2|COMPLETED|Overall Study||80
8232517|NCT01980485|20300021|P1|COMPLETED|Overall Study||84
8232518|NCT01980485|20300020|P2|STARTED|Overall Study||105
8232519|NCT01980485|20300021|P1|STARTED|Overall Study||120
8232520|NCT01980342|20300029|P1|NOT COMPLETED|Overall Study||1
8232521|NCT01980342|20300029|P1|COMPLETED|Overall Study||0
8232522|NCT01980342|20300029|P1|STARTED|Overall Study||1
8232523|NCT01980095|20300039|P2|NOT COMPLETED|Overall Study||11
8232524|NCT01980095|20300040|P1|NOT COMPLETED|Overall Study||15
8232525|NCT01980095|20300039|P2|COMPLETED|Overall Study||30
8232526|NCT01980095|20300040|P1|COMPLETED|Overall Study||63
8232527|NCT01980095|20300039|P2|Treated|Overall Study||41
8232528|NCT01980095|20300040|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
8232529|NCT01980095|20300039|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
8232530|NCT01980095|20300040|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
8232531|NCT01980056|20300051|P3|NOT COMPLETED|Overall Study||0
8232532|NCT01980056|20300052|P2|NOT COMPLETED|Overall Study||1
8232533|NCT01980056|20300053|P1|NOT COMPLETED|Overall Study||1
8232534|NCT01980056|20300051|P3|COMPLETED|Overall Study||2
8232535|NCT01980056|20300052|P2|COMPLETED|Overall Study||3
8232536|NCT01980056|20300053|P1|COMPLETED|Overall Study||3
8232537|NCT01980056|20300051|P3|STARTED|Overall Study||2
8232538|NCT01980056|20300052|P2|STARTED|Overall Study||4
8232539|NCT01980056|20300053|P1|STARTED|Overall Study||4
8232540|NCT01979952|20300067|P2|NOT COMPLETED|Overall Study||6
8232541|NCT01979952|20300068|P1|NOT COMPLETED|Overall Study||8
8232542|NCT01979952|20300067|P2|COMPLETED|Overall Study||51
8232543|NCT01979952|20300068|P1|COMPLETED|Overall Study||48
8232544|NCT01979952|20300067|P2|STARTED|Overall Study||57
8232545|NCT01979952|20300068|P1|STARTED|Overall Study||56
8232546|NCT01979835|20300096|P1|NOT COMPLETED|Follow-up||32
8232547|NCT01979835|20300096|P1|COMPLETED|Follow-up||980
8232548|NCT01979835|20300096|P1|STARTED|Follow-up||1012
8232549|NCT01979835|20300096|P1|NOT COMPLETED|Primary Outcome SA Measurment||18
8232550|NCT01979835|20300096|P1|COMPLETED|Primary Outcome SA Measurment||1012
8232551|NCT01979835|20300096|P1|STARTED|Primary Outcome SA Measurment||1030
8232552|NCT01979614|20300103|P2|NOT COMPLETED|Overall Study||1
8232553|NCT01979614|20300104|P1|NOT COMPLETED|Overall Study||1
8232554|NCT01979614|20300103|P2|COMPLETED|Overall Study||27
8232555|NCT01979614|20300104|P1|COMPLETED|Overall Study||29
8232556|NCT01979614|20300103|P2|PD Analysis Set|Overall Study||26
8232557|NCT01979614|20300104|P1|PD Analysis Set|Overall Study||25
8232558|NCT01979614|20300103|P2|PK Analysis Set|Overall Study||0
8232559|NCT01979614|20300104|P1|PK Analysis Set|Overall Study||30
8232560|NCT01979614|20300103|P2|Safety Analysis Set|Overall Study||28
8232561|NCT01979614|20300104|P1|Safety Analysis Set|Overall Study||30
8232562|NCT01979614|20300103|P2|STARTED|Overall Study||28
8232563|NCT01979614|20300104|P1|STARTED|Overall Study||30
8232564|NCT01979523|20300126|P2|NOT COMPLETED|Overall Study||0
8232565|NCT01979523|20300127|P1|NOT COMPLETED|Overall Study||1
8232566|NCT01979523|20300126|P2|COMPLETED|Overall Study||21
8232567|NCT01979523|20300127|P1|COMPLETED|Overall Study||20
8232568|NCT01979523|20300126|P2|STARTED|Overall Study||21
8232569|NCT01979523|20300127|P1|STARTED|Overall Study||21
8232570|NCT01979445|20300150|P4|NOT COMPLETED|Overall Study||0
8232571|NCT01979445|20300151|P3|NOT COMPLETED|Overall Study||0
8232572|NCT01979445|20300152|P2|NOT COMPLETED|Overall Study||0
8232573|NCT01979445|20300153|P1|NOT COMPLETED|Overall Study||0
8232574|NCT01979445|20300150|P4|COMPLETED|Overall Study||3
8232575|NCT01979445|20300151|P3|COMPLETED|Overall Study||6
8232576|NCT01979445|20300152|P2|COMPLETED|Overall Study||3
8232577|NCT01979445|20300153|P1|COMPLETED|Overall Study||3
8232578|NCT01979445|20300150|P4|ITT Population|Overall Study||3
8232579|NCT01979445|20300151|P3|ITT Population|Overall Study||6
8232580|NCT01979445|20300152|P2|ITT Population|Overall Study||3
8232581|NCT01979445|20300153|P1|ITT Population|Overall Study||3
8232582|NCT01979445|20300150|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8232583|NCT01979445|20300151|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8232584|NCT01979445|20300152|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8232585|NCT01979445|20300153|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8232586|NCT01979445|20300150|P4|STARTED|Overall Study||3
8232587|NCT01979445|20300151|P3|STARTED|Overall Study||6
8232588|NCT01979445|20300152|P2|STARTED|Overall Study||3
8232589|NCT01979445|20300153|P1|STARTED|Overall Study||3
8232590|NCT01979276|20300179|P1|NOT COMPLETED|Overall Study||0
8232591|NCT01979276|20300179|P1|COMPLETED|Overall Study||2
8232592|NCT01979276|20300179|P1|STARTED|Overall Study||2
8232593|NCT01979185|20300187|P2|NOT COMPLETED|Period 2||1
8232594|NCT01979185|20300188|P1|NOT COMPLETED|Period 2||0
8232595|NCT01979185|20300187|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
8232596|NCT01979185|20300188|P1|COMPLETED|Period 2||15
8232597|NCT01979185|20300187|P2|STARTED|Period 2||15
8232598|NCT01979185|20300188|P1|STARTED|Period 2||15
8232599|NCT01979185|20300187|P2|NOT COMPLETED|Period 1||0
8232600|NCT01979185|20300188|P1|NOT COMPLETED|Period 1||0
8232601|NCT01979185|20300187|P2|COMPLETED|Period 1||15
8232602|NCT01979185|20300188|P1|COMPLETED|Period 1||15
8232603|NCT01979185|20300187|P2|STARTED|Period 1||15
8232604|NCT01979185|20300188|P1|STARTED|Period 1||15
8232605|NCT01979159|20300198|P1|NOT COMPLETED|Overall Study||0
8232606|NCT01979159|20300198|P1|COMPLETED|Overall Study||4
8232607|NCT01979159|20300198|P1|STARTED|Overall Study||4
8232608|NCT01979133|20300204|P1|NOT COMPLETED|Overall Study||3
8232609|NCT01979133|20300204|P1|COMPLETED|Overall Study||7
8232610|NCT01979133|20300204|P1|STARTED|Overall Study||10
8232611|NCT01979029|20300223|P2|NOT COMPLETED|Overall Study||0
8232612|NCT01979029|20300224|P1|NOT COMPLETED|Overall Study||0
8232613|NCT01979029|20300223|P2|COMPLETED|Overall Study||28
8232614|NCT01979029|20300224|P1|COMPLETED|Overall Study||29
8232615|NCT01979029|20300223|P2|STARTED|Overall Study||28
8232616|NCT01979029|20300224|P1|STARTED|Overall Study||29
8232617|NCT01979016|20300236|P2|NOT COMPLETED|Overall Study||1
8232618|NCT01979016|20300237|P1|NOT COMPLETED|Overall Study||2
8232619|NCT01979016|20300236|P2|COMPLETED|Overall Study||26
8232620|NCT01979016|20300237|P1|COMPLETED|Overall Study||25
8232621|NCT01979016|20300236|P2|STARTED|Overall Study||27
8232622|NCT01979016|20300237|P1|STARTED|Overall Study||27
8232623|NCT01978938|20300271|P2|NOT COMPLETED|Overall Study||14
8232624|NCT01978938|20300272|P1|NOT COMPLETED|Overall Study||23
8232625|NCT01978938|20300271|P2|COMPLETED|Overall Study||439
8232626|NCT01978938|20300272|P1|COMPLETED|Overall Study||432
8232627|NCT01978938|20300271|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
8232628|NCT01978938|20300272|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
8232629|NCT01978938|20300271|P2|STARTED|Overall Study||453
8232630|NCT01978938|20300272|P1|STARTED|Overall Study||455
8232631|NCT01978912|20300286|P4|NOT COMPLETED|Overall Study||3
8232632|NCT01978912|20300287|P3|NOT COMPLETED|Overall Study||3
8232633|NCT01978912|20300288|P2|NOT COMPLETED|Overall Study||3
8232634|NCT01978912|20300289|P1|NOT COMPLETED|Overall Study||3
8232635|NCT01978912|20300286|P4|COMPLETED|Overall Study||3
8232636|NCT01978912|20300287|P3|COMPLETED|Overall Study||3
8232637|NCT01978912|20300288|P2|COMPLETED|Overall Study||3
8232638|NCT01978912|20300289|P1|COMPLETED|Overall Study||3
8232639|NCT01978912|20300286|P4|STARTED|Overall Study||6
8232640|NCT01978912|20300287|P3|STARTED|Overall Study||6
8232641|NCT01978912|20300288|P2|STARTED|Overall Study||6
8232642|NCT01978912|20300289|P1|STARTED|Overall Study||6
8232643|NCT01978743|20300335|P1|NOT COMPLETED|Overall Study||0
8232644|NCT01978743|20300335|P1|COMPLETED|Overall Study||10
8232645|NCT01978743|20300335|P1|STARTED|Overall Study||10
8232646|NCT01978600|20300349|P2|NOT COMPLETED|Overall Study||0
8232647|NCT01978600|20300350|P1|NOT COMPLETED|Overall Study||0
8232648|NCT01978600|20300349|P2|COMPLETED|Overall Study||42
8232649|NCT01978600|20300350|P1|COMPLETED|Overall Study||44
8232650|NCT01978600|20300349|P2|STARTED|Overall Study||42
8232651|NCT01978600|20300350|P1|STARTED|Overall Study||44
8232652|NCT01978535|20300362|P2|NOT COMPLETED|Overall Study||0
8232653|NCT01978535|20300363|P1|NOT COMPLETED|Overall Study||0
8232654|NCT01978535|20300362|P2|COMPLETED|Overall Study||2
8232655|NCT01978535|20300363|P1|COMPLETED|Overall Study||1
8232656|NCT01978535|20300362|P2|STARTED|Overall Study||2
8232657|NCT01978535|20300363|P1|STARTED|Overall Study||1
8232658|NCT01978509|20300372|P3|NOT COMPLETED|Overall Study||0
8232659|NCT01978509|20300373|P2|NOT COMPLETED|Overall Study||5
8232660|NCT01978509|20300374|P1|NOT COMPLETED|Overall Study||2
8232661|NCT01978509|20300372|P3|COMPLETED|Overall Study||9
8232662|NCT01978509|20300373|P2|COMPLETED|Overall Study||8
8232663|NCT01978509|20300374|P1|COMPLETED|Overall Study||8
8232664|NCT01978509|20300372|P3|STARTED|Overall Study||9
8232665|NCT01978509|20300373|P2|STARTED|Overall Study||13
8232666|NCT01978509|20300374|P1|STARTED|Overall Study||10
8232667|NCT01978314|20300396|P5|NOT COMPLETED|Overall Study||0
8232668|NCT01978314|20300397|P4|NOT COMPLETED|Overall Study||0
8232669|NCT01978314|20300398|P3|NOT COMPLETED|Overall Study||0
8232670|NCT01978314|20300399|P2|NOT COMPLETED|Overall Study||0
8232671|NCT01978314|20300400|P1|NOT COMPLETED|Overall Study||0
8232672|NCT01978314|20300396|P5|COMPLETED|Overall Study||8
8232673|NCT01978314|20300397|P4|COMPLETED|Overall Study||1
8232674|NCT01978314|20300398|P3|COMPLETED|Overall Study||8
8232675|NCT01978314|20300399|P2|COMPLETED|Overall Study||8
8232676|NCT01978314|20300400|P1|COMPLETED|Overall Study||8
8232677|NCT01978314|20300396|P5|STARTED|Overall Study||8
8232678|NCT01978314|20300397|P4|STARTED|Overall Study||1
8232679|NCT01978314|20300398|P3|STARTED|Overall Study||8
8232680|NCT01978314|20300399|P2|STARTED|Overall Study||8
8232681|NCT01978314|20300400|P1|STARTED|Overall Study||8
8232682|NCT01978262|20300482|P1|NOT COMPLETED|Overall Study||11
8232683|NCT01978262|20300482|P1|COMPLETED|Overall Study||92
8232684|NCT01978262|20300482|P1|STARTED|Overall Study||103
8232685|NCT01978236|20300487|P1|NOT COMPLETED|Overall Study||2
8232686|NCT01978236|20300487|P1|COMPLETED|Overall Study||4
8232687|NCT01978236|20300487|P1|STARTED|Overall Study||6
8232688|NCT01978184|20300508|P2|NOT COMPLETED|Overall Study||20
8232689|NCT01978184|20300509|P1|NOT COMPLETED|Overall Study||13
8232690|NCT01978184|20300508|P2|COMPLETED|Overall Study||41
8232691|NCT01978184|20300509|P1|COMPLETED|Overall Study||30
8232692|NCT01978184|20300508|P2|STARTED|Overall Study||61
8232693|NCT01978184|20300509|P1|STARTED|Overall Study||43
8232694|NCT01978145|20300535|P2|NOT COMPLETED|Treatment Period 2||14
8232695|NCT01978145|20300536|P1|NOT COMPLETED|Treatment Period 2||19
8232696|NCT01978145|20300535|P2|COMPLETED|Treatment Period 2||179
8232697|NCT01978145|20300536|P1|COMPLETED|Treatment Period 2||185
8232698|NCT01978145|20300535|P2|STARTED|Treatment Period 2||193
8232699|NCT01978145|20300536|P1|STARTED|Treatment Period 2||204
8232700|NCT01978145|20300535|P2|NOT COMPLETED|Washout Period 1||3
8232701|NCT01978145|20300536|P1|NOT COMPLETED|Washout Period 1||1
8232702|NCT01978145|20300535|P2|COMPLETED|Washout Period 1||193
8232703|NCT01978145|20300536|P1|COMPLETED|Washout Period 1||204
8232704|NCT01978145|20300535|P2|STARTED|Washout Period 1||196
8232705|NCT01978145|20300536|P1|STARTED|Washout Period 1||205
8232706|NCT01978145|20300535|P2|NOT COMPLETED|Treatment Period 1||16
8232707|NCT01978145|20300536|P1|NOT COMPLETED|Treatment Period 1||9
8232708|NCT01978145|20300535|P2|COMPLETED|Treatment Period 1||196
8232709|NCT01978145|20300536|P1|COMPLETED|Treatment Period 1||205
8232710|NCT01978145|20300535|P2|STARTED|Treatment Period 1||212
8232711|NCT01978145|20300536|P1|STARTED|Treatment Period 1||214
8232712|NCT01978119|20300552|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
8232713|NCT01978119|20300553|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
8232714|NCT01978119|20300552|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
8232715|NCT01978119|20300553|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
8232716|NCT01978119|20300552|P2|STARTED|Treatment Period 2 (12 Weeks)||42
8232717|NCT01978119|20300553|P1|STARTED|Treatment Period 2 (12 Weeks)||38
8232718|NCT01978119|20300552|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
8232719|NCT01978119|20300553|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
8232720|NCT01978119|20300552|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
8232721|NCT01978119|20300553|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
8232722|NCT01978119|20300552|P2|STARTED|Washout Period 1 (3 Weeks)||42
8232723|NCT01978119|20300553|P1|STARTED|Washout Period 1 (3 Weeks)||38
8232724|NCT01978119|20300552|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
8232725|NCT01978119|20300553|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
8232726|NCT01978119|20300552|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
8232727|NCT01978119|20300553|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
8232728|NCT01978119|20300552|P2|STARTED|Treatment Period 1 (12 Weeks)||42
8232729|NCT01978119|20300553|P1|STARTED|Treatment Period 1 (12 Weeks)||40
8232730|NCT01978093|20300579|P2|NOT COMPLETED|Overall Study||73
8232731|NCT01978093|20300580|P1|NOT COMPLETED|Overall Study||65
8232732|NCT01978093|20300579|P2|COMPLETED|Overall Study||230
8232733|NCT01978093|20300580|P1|COMPLETED|Overall Study||232
8232734|NCT01978093|20300579|P2|STARTED|Overall Study||303
8232735|NCT01978093|20300580|P1|STARTED|Overall Study||297
8232736|NCT01977937|20300624|P2|NOT COMPLETED|Overall Study||2
8232737|NCT01977937|20300625|P1|NOT COMPLETED|Overall Study||3
8232738|NCT01977937|20300624|P2|COMPLETED|Overall Study||26
8232739|NCT01977937|20300625|P1|COMPLETED|Overall Study||24
8232740|NCT01977937|20300624|P2|STARTED|Overall Study||28
8232741|NCT01977937|20300625|P1|STARTED|Overall Study||27
8232742|NCT01977846|20300635|P2|NOT COMPLETED|Total Study - Prospective||29
8232743|NCT01977846|20300636|P1|NOT COMPLETED|Total Study - Prospective||0
8232744|NCT01977846|20300635|P2|COMPLETED|Total Study - Prospective||230
8232745|NCT01977846|20300636|P1|COMPLETED|Total Study - Prospective||0
8232746|NCT01977846|20300635|P2|STARTED|Total Study - Prospective||259
8232747|NCT01977846|20300636|P1|STARTED|Total Study - Prospective||0
8232748|NCT01977846|20300635|P2|NOT COMPLETED|Total Study - Retrospective||0
8232749|NCT01977846|20300636|P1|NOT COMPLETED|Total Study - Retrospective||0
8232750|NCT01977846|20300635|P2|COMPLETED|Total Study - Retrospective||0
8232751|NCT01977846|20300636|P1|COMPLETED|Total Study - Retrospective||251
8232752|NCT01977846|20300635|P2|STARTED|Total Study - Retrospective||0
8232753|NCT01977846|20300636|P1|STARTED|Total Study - Retrospective||251
8232754|NCT01977820|20300654|P2|NOT COMPLETED|Overall Study||1
8232755|NCT01977820|20300655|P1|NOT COMPLETED|Overall Study||1
8232756|NCT01977820|20300654|P2|COMPLETED|Overall Study||0
8232757|NCT01977820|20300655|P1|COMPLETED|Overall Study||0
8232758|NCT01977820|20300654|P2|STARTED|Overall Study||1
8232759|NCT01977820|20300655|P1|STARTED|Overall Study||1
8232760|NCT01977794|20300663|P2|NOT COMPLETED|Overall Study||6
8232761|NCT01977794|20300664|P1|NOT COMPLETED|Overall Study||8
8232762|NCT01977794|20300663|P2|COMPLETED|Overall Study||94
8232763|NCT01977794|20300664|P1|COMPLETED|Overall Study||92
8232764|NCT01977794|20300663|P2|STARTED|Overall Study||100
8232765|NCT01977794|20300664|P1|STARTED|Overall Study||100
8232766|NCT01977781|20300680|P2|NOT COMPLETED|Overall Study||1
8232767|NCT01977781|20300681|P1|NOT COMPLETED|Overall Study||6
8232768|NCT01977781|20300680|P2|COMPLETED|Overall Study||15
8232769|NCT01977781|20300681|P1|COMPLETED|Overall Study||18
8232770|NCT01977781|20300680|P2|STARTED|Overall Study||16
8232771|NCT01977781|20300681|P1|STARTED|Overall Study||24
8232772|NCT01977729|20300699|P1|NOT COMPLETED|Overall Study||1
8232773|NCT01977729|20300699|P1|COMPLETED|Overall Study||0
8232774|NCT01977729|20300699|P1|STARTED|Overall Study||1
8232775|NCT01977690|20300711|P2|NOT COMPLETED|Overall Study||4
8232776|NCT01977690|20300712|P1|NOT COMPLETED|Overall Study||0
8232777|NCT01977690|20300711|P2|COMPLETED|Overall Study||11
8232778|NCT01977690|20300712|P1|COMPLETED|Overall Study||15
8232779|NCT01977690|20300711|P2|STARTED|Overall Study||15
8232780|NCT01977690|20300712|P1|STARTED|Overall Study||15
8232781|NCT01977677|20300721|P3|NOT COMPLETED|Overall Study||1
8232782|NCT01977677|20300722|P2|NOT COMPLETED|Overall Study||0
8232783|NCT01977677|20300723|P1|NOT COMPLETED|Overall Study||0
8232784|NCT01977677|20300721|P3|COMPLETED|Overall Study||20
8232785|NCT01977677|20300722|P2|COMPLETED|Overall Study||6
8232786|NCT01977677|20300723|P1|COMPLETED|Overall Study||3
8232787|NCT01977677|20300721|P3|STARTED|Overall Study||21
8232788|NCT01977677|20300722|P2|STARTED|Overall Study||6
8232789|NCT01977677|20300723|P1|STARTED|Overall Study||3
8232790|NCT01977651|20300734|P1|NOT COMPLETED|Post 1 Year Extension Period||144
8232791|NCT01977651|20300734|P1|COMPLETED|Post 1 Year Extension Period||1
8232792|NCT01977651|20300734|P1|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
8232793|NCT01977651|20300734|P1|NOT COMPLETED|1 Year Extension Period||130
8232794|NCT01977651|20300734|P1|COMPLETED|1 Year Extension Period||157
8232795|NCT01977651|20300734|P1|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
8232796|NCT01977651|20300734|P1|NOT COMPLETED|4 Month Treatment Period||101
8232797|NCT01977651|20300734|P1|COMPLETED|4 Month Treatment Period||322
8232798|NCT01977651|20300734|P1|STARTED|4 Month Treatment Period||423
8232799|NCT01977625|20300738|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8232800|NCT01977625|20300739|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8232801|NCT01977625|20300738|P2|COMPLETED|Second Intervention (4 Weeks)||7
8232802|NCT01977625|20300739|P1|COMPLETED|Second Intervention (4 Weeks)||7
8232803|NCT01977625|20300738|P2|STARTED|Second Intervention (4 Weeks)||7
8232804|NCT01977625|20300739|P1|STARTED|Second Intervention (4 Weeks)||8
8232805|NCT01977625|20300738|P2|NOT COMPLETED|Washout (2 Weeks)||0
8232806|NCT01977625|20300739|P1|NOT COMPLETED|Washout (2 Weeks)||0
8232807|NCT01977625|20300738|P2|COMPLETED|Washout (2 Weeks)||7
8232808|NCT01977625|20300739|P1|COMPLETED|Washout (2 Weeks)||8
8232809|NCT01977625|20300738|P2|STARTED|Washout (2 Weeks)||7
8232810|NCT01977625|20300739|P1|STARTED|Washout (2 Weeks)||8
8232811|NCT01977625|20300738|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8232812|NCT01977625|20300739|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
8232813|NCT01977625|20300738|P2|COMPLETED|First Intervention (4 Weeks)||7
8232814|NCT01977625|20300739|P1|COMPLETED|First Intervention (4 Weeks)||8
8232815|NCT01977625|20300738|P2|STARTED|First Intervention (4 Weeks)||7
8232816|NCT01977625|20300739|P1|STARTED|First Intervention (4 Weeks)||11
8232817|NCT01977612|20300749|P2|NOT COMPLETED|Overall Study||1
8232818|NCT01977612|20300750|P1|NOT COMPLETED|Overall Study||1
8232819|NCT01977612|20300749|P2|COMPLETED|Overall Study||79
8232820|NCT01977612|20300750|P1|COMPLETED|Overall Study||84
8232821|NCT01977612|20300749|P2|STARTED|Overall Study||80
8232822|NCT01977612|20300750|P1|STARTED|Overall Study||85
8232823|NCT01977573|20300772|P4|NOT COMPLETED|Overall Study||3
8232824|NCT01977573|20300773|P3|NOT COMPLETED|Overall Study||4
8232825|NCT01977573|20300774|P2|NOT COMPLETED|Overall Study||3
8232826|NCT01977573|20300775|P1|NOT COMPLETED|Overall Study||20
8232827|NCT01977573|20300772|P4|COMPLETED|Overall Study||33
8232828|NCT01977573|20300773|P3|COMPLETED|Overall Study||32
8232829|NCT01977573|20300774|P2|COMPLETED|Overall Study||41
8232830|NCT01977573|20300775|P1|COMPLETED|Overall Study||116
8232831|NCT01977573|20300772|P4|STARTED|Overall Study||36
8232832|NCT01977573|20300773|P3|STARTED|Overall Study||36
8232833|NCT01977573|20300774|P2|STARTED|Overall Study||44
8232834|NCT01977573|20300775|P1|STARTED|Overall Study||136
8232835|NCT01977482|20300889|P6|NOT COMPLETED|Overall Study||5
8232836|NCT01977482|20300890|P5|NOT COMPLETED|Overall Study||3
8232837|NCT01977482|20300891|P4|NOT COMPLETED|Overall Study||4
8232838|NCT01977482|20300892|P3|NOT COMPLETED|Overall Study||5
8232839|NCT01977482|20300893|P2|NOT COMPLETED|Overall Study||9
8232840|NCT01977482|20300894|P1|NOT COMPLETED|Overall Study||3
8232841|NCT01977482|20300889|P6|COMPLETED|Overall Study||14
8232842|NCT01977482|20300890|P5|COMPLETED|Overall Study||37
8232843|NCT01977482|20300891|P4|COMPLETED|Overall Study||35
8232844|NCT01977482|20300892|P3|COMPLETED|Overall Study||35
8232845|NCT01977482|20300893|P2|COMPLETED|Overall Study||30
8232846|NCT01977482|20300894|P1|COMPLETED|Overall Study||36
8232847|NCT01977482|20300889|P6|STARTED|Overall Study||19
8232848|NCT01977482|20300890|P5|STARTED|Overall Study||40
8232849|NCT01977482|20300891|P4|STARTED|Overall Study||39
8232850|NCT01977482|20300892|P3|STARTED|Overall Study||40
8232851|NCT01977482|20300893|P2|STARTED|Overall Study||39
8232852|NCT01977482|20300894|P1|STARTED|Overall Study||39
8232853|NCT01977456|20301009|P1|NOT COMPLETED|Overall Study||5
8232854|NCT01977456|20301009|P1|COMPLETED|Overall Study||22
8232855|NCT01977456|20301009|P1|STARTED|Overall Study||27
8232856|NCT01977352|20301018|P2|NOT COMPLETED|Overall Study||2
8232857|NCT01977352|20301019|P1|NOT COMPLETED|Overall Study||1
8232858|NCT01977352|20301018|P2|COMPLETED|Overall Study||19
8232859|NCT01977352|20301019|P1|COMPLETED|Overall Study||20
8232860|NCT01977352|20301018|P2|STARTED|Overall Study||21
8232861|NCT01977352|20301019|P1|STARTED|Overall Study||21
8232862|NCT01977222|20301037|P1|NOT COMPLETED|Overall Study||1
8232863|NCT01977222|20301037|P1|COMPLETED|Overall Study||11
8232864|NCT01977222|20301037|P1|STARTED|Overall Study||12
8232865|NCT01977092|20301050|P2|NOT COMPLETED|Overall Study||30
8232866|NCT01977092|20301051|P1|NOT COMPLETED|Overall Study||31
8232867|NCT01977092|20301050|P2|COMPLETED|Overall Study||151
8232868|NCT01977092|20301051|P1|COMPLETED|Overall Study||118
8232869|NCT01977092|20301050|P2|STARTED|Overall Study||181
8232870|NCT01977092|20301051|P1|STARTED|Overall Study||149
8232871|NCT01977040|20301061|P1|NOT COMPLETED|Overall Study||2
8232872|NCT01977040|20301061|P1|COMPLETED|Overall Study||66
8232873|NCT01977040|20301061|P1|STARTED|Overall Study||68
8232874|NCT01976988|20301073|P2|NOT COMPLETED|Overall Study||18
8232875|NCT01976988|20301074|P1|NOT COMPLETED|Overall Study||16
8232876|NCT01976988|20301073|P2|COMPLETED|Overall Study||184
8232877|NCT01976988|20301074|P1|COMPLETED|Overall Study||192
8232878|NCT01976988|20301073|P2|STARTED|Overall Study||202
8232879|NCT01976988|20301074|P1|STARTED|Overall Study||208
8232880|NCT01976975|20301092|P2|NOT COMPLETED|Overall Study||12
8232881|NCT01976975|20301093|P1|NOT COMPLETED|Overall Study||147
8232882|NCT01976975|20301092|P2|COMPLETED|Overall Study||32
8232883|NCT01976975|20301093|P1|COMPLETED|Overall Study||79
8232884|NCT01976975|20301092|P2|STARTED|Overall Study||44
8232885|NCT01976975|20301093|P1|STARTED|Overall Study||226
8232886|NCT01976871|20301103|P1|NOT COMPLETED|Overall Study||1
8232887|NCT01976871|20301103|P1|COMPLETED|Overall Study||20
8232888|NCT01976871|20301103|P1|STARTED|Overall Study||21
8232889|NCT01976845|20301115|P3|NOT COMPLETED|Overall Study||3
8232890|NCT01976845|20301116|P2|NOT COMPLETED|Overall Study||8
8232891|NCT01976845|20301117|P1|NOT COMPLETED|Overall Study||8
8232892|NCT01976845|20301115|P3|COMPLETED|Overall Study||40
8232893|NCT01976845|20301116|P2|COMPLETED|Overall Study||40
8232894|NCT01976845|20301117|P1|COMPLETED|Overall Study||40
8232895|NCT01976845|20301115|P3|STARTED|Overall Study||43
8232896|NCT01976845|20301116|P2|STARTED|Overall Study||48
8232897|NCT01976845|20301117|P1|STARTED|Overall Study||48
8232898|NCT01976819|20301131|P1|NOT COMPLETED|Overall Study||5
8232899|NCT01976819|20301131|P1|COMPLETED|Overall Study||11
8232900|NCT01976819|20301131|P1|STARTED|Overall Study||16
8232901|NCT01976806|20301142|P2|NOT COMPLETED|Overall Study||6
8232902|NCT01976806|20301143|P1|NOT COMPLETED|Overall Study||3
8232903|NCT01976806|20301142|P2|COMPLETED|Overall Study||22
8232904|NCT01976806|20301143|P1|COMPLETED|Overall Study||24
8232905|NCT01976806|20301142|P2|STARTED|Overall Study||28
8232906|NCT01976806|20301143|P1|STARTED|Overall Study||27
8232907|NCT01976741|20301181|P10|NOT COMPLETED|Overall Study||4
8232908|NCT01976741|20301182|P9|NOT COMPLETED|Overall Study||1
8232909|NCT01976741|20301183|P8|NOT COMPLETED|Overall Study||12
8232910|NCT01976741|20301184|P7|NOT COMPLETED|Overall Study||4
8232911|NCT01976741|20301185|P6|NOT COMPLETED|Overall Study||0
8232912|NCT01976741|20301186|P5|NOT COMPLETED|Overall Study||0
8232913|NCT01976741|20301187|P4|NOT COMPLETED|Overall Study||1
8232914|NCT01976741|20301188|P3|NOT COMPLETED|Overall Study||3
8232915|NCT01976741|20301189|P2|NOT COMPLETED|Overall Study||0
8232916|NCT01976741|20301190|P1|NOT COMPLETED|Overall Study||1
8232917|NCT01976741|20301181|P10|COMPLETED|Overall Study||36
8232918|NCT01976741|20301182|P9|COMPLETED|Overall Study||7
8232919|NCT01976741|20301183|P8|COMPLETED|Overall Study||62
8232920|NCT01976741|20301184|P7|COMPLETED|Overall Study||19
8232921|NCT01976741|20301185|P6|COMPLETED|Overall Study||4
8232922|NCT01976741|20301186|P5|COMPLETED|Overall Study||4
8232923|NCT01976741|20301187|P4|COMPLETED|Overall Study||2
8232924|NCT01976741|20301188|P3|COMPLETED|Overall Study||1
8232925|NCT01976741|20301189|P2|COMPLETED|Overall Study||4
8232926|NCT01976741|20301190|P1|COMPLETED|Overall Study||3
8232927|NCT01976741|20301181|P10|STARTED|Overall Study||40
8232928|NCT01976741|20301182|P9|STARTED|Overall Study||8
8232929|NCT01976741|20301183|P8|STARTED|Overall Study||74
8232930|NCT01976741|20301184|P7|STARTED|Overall Study||23
8232931|NCT01976741|20301185|P6|STARTED|Overall Study||4
8232932|NCT01976741|20301186|P5|STARTED|Overall Study||4
8232933|NCT01976741|20301187|P4|STARTED|Overall Study||3
8232934|NCT01976741|20301188|P3|STARTED|Overall Study||4
8232935|NCT01976741|20301189|P2|STARTED|Overall Study||4
8232936|NCT01976741|20301190|P1|STARTED|Overall Study||4
8232937|NCT01976663|20301428|P1|NOT COMPLETED|Overall Study||42
8232938|NCT01976663|20301428|P1|COMPLETED|Overall Study||84
8232939|NCT01976663|20301428|P1|Received Repeat Treatment|Overall Study||85
8232940|NCT01976663|20301428|P1|Received Asymmetry Correction|Overall Study||45
8232941|NCT01976663|20301428|P1|Received Touch-up Treatment|Overall Study||63
8232942|NCT01976663|20301428|P1|STARTED|Overall Study||126
8232943|NCT01976650|20301442|P1|NOT COMPLETED|Overall Study||6
8232944|NCT01976650|20301442|P1|COMPLETED|Overall Study||718
8232945|NCT01976650|20301442|P1|STARTED|Overall Study||724
8232946|NCT01976624|20301447|P1|NOT COMPLETED|Overall Study||14
8232947|NCT01976624|20301447|P1|COMPLETED|Overall Study||742
8232948|NCT01976624|20301447|P1|STARTED|Overall Study||756
8232949|NCT01976572|20301452|P3|NOT COMPLETED|Overall Study||0
8232950|NCT01976572|20301453|P2|NOT COMPLETED|Overall Study||0
8232951|NCT01976572|20301454|P1|NOT COMPLETED|Overall Study||0
8232952|NCT01976572|20301452|P3|COMPLETED|Overall Study||6
8232953|NCT01976572|20301453|P2|COMPLETED|Overall Study||6
8232954|NCT01976572|20301454|P1|COMPLETED|Overall Study||6
8232955|NCT01976572|20301452|P3|STARTED|Overall Study||6
8232956|NCT01976572|20301453|P2|STARTED|Overall Study||6
8232957|NCT01976572|20301454|P1|STARTED|Overall Study||6
8232958|NCT01976507|20301475|P1|NOT COMPLETED|Overall Study||7
8232959|NCT01976507|20301475|P1|COMPLETED|Overall Study||94
8232960|NCT01976507|20301475|P1|Received Initial Dose of Dabigatran|Overall Study||100
8232961|NCT01976507|20301475|P1|STARTED|Overall Study||101
8232962|NCT01976442|20301484|P2|NOT COMPLETED|Overall Study||0
8232963|NCT01976442|20301485|P1|NOT COMPLETED|Overall Study||0
8232964|NCT01976442|20301484|P2|COMPLETED|Overall Study||31
8232965|NCT01976442|20301485|P1|COMPLETED|Overall Study||69
8232966|NCT01976442|20301484|P2|STARTED|Overall Study||31
8232967|NCT01976442|20301485|P1|STARTED|Overall Study||69
8232968|NCT01976416|20301499|P2|NOT COMPLETED|Overall Study||2
8232969|NCT01976416|20301500|P1|NOT COMPLETED|Overall Study||2
8232970|NCT01976416|20301499|P2|COMPLETED|Overall Study||102
8232971|NCT01976416|20301500|P1|COMPLETED|Overall Study||102
8232972|NCT01976416|20301499|P2|STARTED|Overall Study||104
8232973|NCT01976416|20301500|P1|STARTED|Overall Study||104
8232974|NCT01976364|20301506|P3|NOT COMPLETED|Sub-study (12 Months)||5
8232975|NCT01976364|20301507|P2|NOT COMPLETED|Sub-study (12 Months)||6
8232976|NCT01976364|20301508|P1|NOT COMPLETED|Sub-study (12 Months)||0
8232977|NCT01976364|20301506|P3|COMPLETED|Sub-study (12 Months)||85
8232978|NCT01976364|20301507|P2|COMPLETED|Sub-study (12 Months)||83
8232979|NCT01976364|20301508|P1|COMPLETED|Sub-study (12 Months)||0
8232980|NCT01976364|20301506|P3|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
8232981|NCT01976364|20301507|P2|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
8232982|NCT01976364|20301508|P1|STARTED|Sub-study (12 Months)||0
8232983|NCT01976364|20301506|P3|NOT COMPLETED|Main Study (36 Months)||0
8232984|NCT01976364|20301507|P2|NOT COMPLETED|Main Study (36 Months)||0
8232985|NCT01976364|20301508|P1|NOT COMPLETED|Main Study (36 Months)||221
8232986|NCT01976364|20301506|P3|COMPLETED|Main Study (36 Months)||0
8232987|NCT01976364|20301507|P2|COMPLETED|Main Study (36 Months)||0
8232988|NCT01976364|20301508|P1|COMPLETED|Main Study (36 Months)||465
8232989|NCT01976364|20301506|P3|STARTED|Main Study (36 Months)||0
8232990|NCT01976364|20301507|P2|STARTED|Main Study (36 Months)||0
8232991|NCT01976364|20301508|P1|STARTED|Main Study (36 Months)||686
8232992|NCT01976338|20301628|P2|NOT COMPLETED|Overall Study||4
8232993|NCT01976338|20301629|P1|NOT COMPLETED|Overall Study||13
8232994|NCT01976338|20301628|P2|COMPLETED|Overall Study|12 months|89
8232995|NCT01976338|20301629|P1|COMPLETED|Overall Study|12 months|177
8232996|NCT01976338|20301628|P2|Discontinued Study Prior to 6 Months|Overall Study||2
8232997|NCT01976338|20301629|P1|Discontinued Study Prior to 6 Months|Overall Study||5
8232998|NCT01976338|20301628|P2|Completed 6 Months|Overall Study||91
8232999|NCT01976338|20301629|P1|Completed 6 Months|Overall Study||185
8233000|NCT01976338|20301628|P2|STARTED|Overall Study||93
8233001|NCT01976338|20301629|P1|STARTED|Overall Study||190
8233002|NCT01976312|20301656|P2|NOT COMPLETED|Overall Study||9
8233003|NCT01976312|20301657|P1|NOT COMPLETED|Overall Study||17
8233004|NCT01976312|20301656|P2|COMPLETED|Overall Study|Completed study at 12 months|53
8233005|NCT01976312|20301657|P1|COMPLETED|Overall Study|Completed study at 12 months|173
8233006|NCT01976312|20301656|P2|Discontinued Study Prior to 3 Months|Overall Study||2
8233007|NCT01976312|20301657|P1|Discontinued Study Prior to 3 Months|Overall Study||4
8233008|NCT01976312|20301656|P2|Completed 3 Months|Overall Study||60
8233009|NCT01976312|20301657|P1|Completed 3 Months|Overall Study||186
8233010|NCT01976312|20301656|P2|STARTED|Overall Study||62
8233011|NCT01976312|20301657|P1|STARTED|Overall Study||190
8233012|NCT01976299|20301678|P2|NOT COMPLETED|Overall Study||6
8233013|NCT01976299|20301679|P1|NOT COMPLETED|Overall Study||23
8233014|NCT01976299|20301678|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
8233015|NCT01976299|20301679|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
8233016|NCT01976299|20301678|P2|Completed Procedure|Overall Study||284
8233017|NCT01976299|20301679|P1|Completed Procedure|Overall Study||283
8233018|NCT01976299|20301678|P2|STARTED|Overall Study||286
8233019|NCT01976299|20301679|P1|STARTED|Overall Study||292
8233020|NCT01976273|20301695|P2|NOT COMPLETED|Overall Study||1
8233021|NCT01976273|20301696|P1|NOT COMPLETED|Overall Study||1
8233022|NCT01976273|20301695|P2|COMPLETED|Overall Study||9
8233023|NCT01976273|20301696|P1|COMPLETED|Overall Study||9
8233024|NCT01976273|20301695|P2|STARTED|Overall Study||10
8233025|NCT01976273|20301696|P1|STARTED|Overall Study||10
8233026|NCT01976104|20301706|P4|NOT COMPLETED|Overall Study||3
8233027|NCT01976104|20301707|P3|NOT COMPLETED|Overall Study||2
8233028|NCT01976104|20301708|P2|NOT COMPLETED|Overall Study||2
8233029|NCT01976104|20301709|P1|NOT COMPLETED|Overall Study||6
8233030|NCT01976104|20301706|P4|COMPLETED|Overall Study||55
8233031|NCT01976104|20301707|P3|COMPLETED|Overall Study||31
8233032|NCT01976104|20301708|P2|COMPLETED|Overall Study||68
8233033|NCT01976104|20301709|P1|COMPLETED|Overall Study||37
8233034|NCT01976104|20301706|P4|STARTED|Overall Study||58
8233035|NCT01976104|20301707|P3|STARTED|Overall Study||33
8233036|NCT01976104|20301708|P2|STARTED|Overall Study||70
8233037|NCT01976104|20301709|P1|STARTED|Overall Study||43
8233038|NCT01975974|20301735|P1|NOT COMPLETED|Overall Study||0
8233039|NCT01975974|20301735|P1|COMPLETED|Overall Study||100
8233040|NCT01975974|20301735|P1|STARTED|Overall Study||100
8233041|NCT01975948|20301743|P4|NOT COMPLETED|Overall Study||6
8233042|NCT01975948|20301744|P3|NOT COMPLETED|Overall Study||7
8233043|NCT01975948|20301745|P2|NOT COMPLETED|Overall Study||21
8233044|NCT01975948|20301746|P1|NOT COMPLETED|Overall Study||17
8233045|NCT01975948|20301743|P4|COMPLETED|Overall Study||51
8233046|NCT01975948|20301744|P3|COMPLETED|Overall Study||65
8233047|NCT01975948|20301745|P2|COMPLETED|Overall Study||34
8233048|NCT01975948|20301746|P1|COMPLETED|Overall Study||39
8233049|NCT01975948|20301743|P4|STARTED|Overall Study||57
8233050|NCT01975948|20301744|P3|STARTED|Overall Study||72
8233051|NCT01975948|20301745|P2|STARTED|Overall Study||55
8233052|NCT01975948|20301746|P1|STARTED|Overall Study||56
8233053|NCT01975935|20301772|P2|NOT COMPLETED|Overall Study||1
8233054|NCT01975935|20301773|P1|NOT COMPLETED|Overall Study||3
8233055|NCT01975935|20301772|P2|COMPLETED|Overall Study||20
8233056|NCT01975935|20301773|P1|COMPLETED|Overall Study||18
8233057|NCT01975935|20301772|P2|STARTED|Overall Study||21
8233058|NCT01975935|20301773|P1|STARTED|Overall Study||21
8233059|NCT01975922|20301785|P2|NOT COMPLETED|Overall Study||9
8233060|NCT01975922|20301786|P1|NOT COMPLETED|Overall Study||0
8233061|NCT01975922|20301785|P2|COMPLETED|Overall Study||43
8233062|NCT01975922|20301786|P1|COMPLETED|Overall Study||45
8233063|NCT01975922|20301785|P2|STARTED|Overall Study||52
8233064|NCT01975922|20301786|P1|STARTED|Overall Study||45
8233065|NCT01975909|20301796|P2|NOT COMPLETED|Overall Study||0
8233066|NCT01975909|20301797|P1|NOT COMPLETED|Overall Study||0
8233067|NCT01975909|20301796|P2|COMPLETED|Overall Study||10
8233068|NCT01975909|20301797|P1|COMPLETED|Overall Study||10
8233069|NCT01975909|20301796|P2|STARTED|Overall Study||10
8233070|NCT01975909|20301797|P1|STARTED|Overall Study||10
8233071|NCT01975831|20301822|P9|NOT COMPLETED|Overall Study||12
8233072|NCT01975831|20301823|P8|NOT COMPLETED|Overall Study||15
8233073|NCT01975831|20301824|P7|NOT COMPLETED|Overall Study||16
8233074|NCT01975831|20301825|P6|NOT COMPLETED|Overall Study||14
8233075|NCT01975831|20301826|P5|NOT COMPLETED|Overall Study||18
8233076|NCT01975831|20301827|P4|NOT COMPLETED|Overall Study||4
8233077|NCT01975831|20301828|P3|NOT COMPLETED|Overall Study||4
8233078|NCT01975831|20301829|P2|NOT COMPLETED|Overall Study||9
8233079|NCT01975831|20301830|P1|NOT COMPLETED|Overall Study||3
8233080|NCT01975831|20301822|P9|COMPLETED|Overall Study||3
8233081|NCT01975831|20301823|P8|COMPLETED|Overall Study||1
8233082|NCT01975831|20301824|P7|COMPLETED|Overall Study||0
8233083|NCT01975831|20301825|P6|COMPLETED|Overall Study||2
8233084|NCT01975831|20301826|P5|COMPLETED|Overall Study||1
8233085|NCT01975831|20301827|P4|COMPLETED|Overall Study||0
8233086|NCT01975831|20301828|P3|COMPLETED|Overall Study||0
8233087|NCT01975831|20301829|P2|COMPLETED|Overall Study||2
8233088|NCT01975831|20301830|P1|COMPLETED|Overall Study||0
8233089|NCT01975831|20301822|P9|STARTED|Overall Study||15
8233090|NCT01975831|20301823|P8|STARTED|Overall Study||16
8233091|NCT01975831|20301824|P7|STARTED|Overall Study||16
8233092|NCT01975831|20301825|P6|STARTED|Overall Study||16
8233093|NCT01975831|20301826|P5|STARTED|Overall Study||19
8233094|NCT01975831|20301827|P4|STARTED|Overall Study||4
8233095|NCT01975831|20301828|P3|STARTED|Overall Study||4
8233096|NCT01975831|20301829|P2|STARTED|Overall Study||11
8233097|NCT01975831|20301830|P1|STARTED|Overall Study||3
8233098|NCT01975701|20301895|P1|NOT COMPLETED|Overall Study||25
8233099|NCT01975701|20301895|P1|COMPLETED|Overall Study||1
8233100|NCT01975701|20301895|P1|STARTED|Overall Study||26
8233101|NCT01975675|20301906|P4|NOT COMPLETED|Overall Study||0
8233102|NCT01975675|20301907|P3|NOT COMPLETED|Overall Study||0
8233103|NCT01975675|20301908|P2|NOT COMPLETED|Overall Study||1
8233104|NCT01975675|20301909|P1|NOT COMPLETED|Overall Study||0
8233105|NCT01975675|20301906|P4|COMPLETED|Overall Study||87
8233106|NCT01975675|20301907|P3|COMPLETED|Overall Study||88
8233107|NCT01975675|20301908|P2|COMPLETED|Overall Study||82
8233108|NCT01975675|20301909|P1|COMPLETED|Overall Study||83
8233109|NCT01975675|20301906|P4|STARTED|Overall Study||87
8233110|NCT01975675|20301907|P3|STARTED|Overall Study||88
8233111|NCT01975675|20301908|P2|STARTED|Overall Study||83
8233112|NCT01975675|20301909|P1|STARTED|Overall Study||83
8233113|NCT01975519|20301931|P2|NOT COMPLETED|Overall Study||0
8233114|NCT01975519|20301932|P1|NOT COMPLETED|Overall Study||0
8233115|NCT01975519|20301931|P2|COMPLETED|Overall Study||108
8233116|NCT01975519|20301932|P1|COMPLETED|Overall Study||3
8233117|NCT01975519|20301931|P2|Phase 2a Angiosarcoma Cohort|Overall Study||22
8233118|NCT01975519|20301932|P1|Phase 2a Angiosarcoma Cohort|Overall Study||0
8233119|NCT01975519|20301931|P2|Phase 2a Soft Tissue Sarcoma|Overall Study||63
8233120|NCT01975519|20301932|P1|Phase 2a Soft Tissue Sarcoma|Overall Study||0
8233121|NCT01975519|20301931|P2|Phase 1b|Overall Study||23
8233122|NCT01975519|20301932|P1|Phase 1b|Overall Study||3
8233123|NCT01975519|20301931|P2|STARTED|Overall Study||108
8233124|NCT01975519|20301932|P1|STARTED|Overall Study||3
8233125|NCT01975467|20301949|P2|NOT COMPLETED|Overall Study||0
8233126|NCT01975467|20301950|P1|NOT COMPLETED|Overall Study||0
8233127|NCT01975467|20301949|P2|COMPLETED|Overall Study||0
8233128|NCT01975467|20301950|P1|COMPLETED|Overall Study||0
8233129|NCT01975467|20301949|P2|STARTED|Overall Study|Study terminated before enrollment|0
8233130|NCT01975467|20301950|P1|STARTED|Overall Study|Study terminated before enrollment|0
8233131|NCT01975389|20301960|P2|NOT COMPLETED|Overall Study||236
8233132|NCT01975389|20301961|P1|NOT COMPLETED|Overall Study||252
8233133|NCT01975389|20301960|P2|COMPLETED|Overall Study||5045
8233134|NCT01975389|20301961|P1|COMPLETED|Overall Study||5031
8233135|NCT01975389|20301960|P2|Treated|Overall Study||5276
8233136|NCT01975389|20301961|P1|Treated|Overall Study||5279
8233137|NCT01975389|20301960|P2|STARTED|Overall Study||5281
8233138|NCT01975389|20301961|P1|STARTED|Overall Study||5283
8233139|NCT01975376|20302021|P2|NOT COMPLETED|Overall Study||217
8233140|NCT01975376|20302022|P1|NOT COMPLETED|Overall Study||226
8233141|NCT01975376|20302021|P2|COMPLETED|Overall Study||8177
8233142|NCT01975376|20302022|P1|COMPLETED|Overall Study||8164
8233143|NCT01975376|20302021|P2|Treated|Overall Study||8386
8233144|NCT01975376|20302022|P1|Treated|Overall Study||8374
8233145|NCT01975376|20302021|P2|STARTED|Overall Study||8394
8233146|NCT01975376|20302022|P1|STARTED|Overall Study||8390
8233147|NCT01975285|20302082|P2|NOT COMPLETED|Overall Study||2
8233148|NCT01975285|20302083|P1|NOT COMPLETED|Overall Study||2
8233149|NCT01975285|20302082|P2|COMPLETED|Overall Study||28
8233150|NCT01975285|20302083|P1|COMPLETED|Overall Study||28
8233151|NCT01975285|20302082|P2|STARTED|Overall Study||30
8233152|NCT01975285|20302083|P1|STARTED|Overall Study||30
8233153|NCT01975246|20302099|P2|NOT COMPLETED|Overall Study||2
8233154|NCT01975246|20302100|P1|NOT COMPLETED|Overall Study||4
8233155|NCT01975246|20302099|P2|COMPLETED|Overall Study||158
8233156|NCT01975246|20302100|P1|COMPLETED|Overall Study||145
8233157|NCT01975246|20302099|P2|STARTED|Overall Study||160
8233158|NCT01975246|20302100|P1|STARTED|Overall Study||149
8233159|NCT01975220|20302113|P6|NOT COMPLETED|Test Period 2||0
8233160|NCT01975220|20302114|P5|NOT COMPLETED|Test Period 2||0
8233161|NCT01975220|20302115|P4|NOT COMPLETED|Test Period 2||0
8233162|NCT01975220|20302116|P3|NOT COMPLETED|Test Period 2||0
8233163|NCT01975220|20302117|P2|NOT COMPLETED|Test Period 2||0
8233164|NCT01975220|20302118|P1|NOT COMPLETED|Test Period 2||0
8233165|NCT01975220|20302113|P6|COMPLETED|Test Period 2||12
8233166|NCT01975220|20302114|P5|COMPLETED|Test Period 2||12
8233167|NCT01975220|20302115|P4|COMPLETED|Test Period 2||12
8233168|NCT01975220|20302116|P3|COMPLETED|Test Period 2||12
8233169|NCT01975220|20302117|P2|COMPLETED|Test Period 2||11
8233170|NCT01975220|20302118|P1|COMPLETED|Test Period 2||12
8233171|NCT01975220|20302113|P6|STARTED|Test Period 2||12
8233172|NCT01975220|20302114|P5|STARTED|Test Period 2||12
8233173|NCT01975220|20302115|P4|STARTED|Test Period 2||12
8233174|NCT01975220|20302116|P3|STARTED|Test Period 2||12
8233175|NCT01975220|20302117|P2|STARTED|Test Period 2||11
8233176|NCT01975220|20302118|P1|STARTED|Test Period 2||12
8233177|NCT01975220|20302113|P6|NOT COMPLETED|Test Period 1||0
8233178|NCT01975220|20302114|P5|NOT COMPLETED|Test Period 1||0
8233179|NCT01975220|20302115|P4|NOT COMPLETED|Test Period 1||0
8233180|NCT01975220|20302116|P3|NOT COMPLETED|Test Period 1||0
8233181|NCT01975220|20302117|P2|NOT COMPLETED|Test Period 1||1
8233182|NCT01975220|20302118|P1|NOT COMPLETED|Test Period 1||0
8233183|NCT01975220|20302113|P6|COMPLETED|Test Period 1||12
8233184|NCT01975220|20302114|P5|COMPLETED|Test Period 1||12
8233185|NCT01975220|20302115|P4|COMPLETED|Test Period 1||12
8233186|NCT01975220|20302116|P3|COMPLETED|Test Period 1||12
8233187|NCT01975220|20302117|P2|COMPLETED|Test Period 1||11
8233188|NCT01975220|20302118|P1|COMPLETED|Test Period 1||12
8233189|NCT01975220|20302113|P6|STARTED|Test Period 1||12
8233190|NCT01975220|20302114|P5|STARTED|Test Period 1||12
8233191|NCT01975220|20302115|P4|STARTED|Test Period 1||12
8233192|NCT01975220|20302116|P3|STARTED|Test Period 1||12
8233193|NCT01975220|20302117|P2|STARTED|Test Period 1||12
8233194|NCT01975220|20302118|P1|STARTED|Test Period 1||12
8233195|NCT01975090|20302162|P1|NOT COMPLETED|Overall Study||12
8233196|NCT01975090|20302162|P1|COMPLETED|Overall Study||117
8233197|NCT01975090|20302162|P1|6-month Follow-up|Overall Study||117
8233198|NCT01975090|20302162|P1|STARTED|Overall Study||129
8233199|NCT01974895|20302174|P2|NOT COMPLETED|Overall Study||15
8233200|NCT01974895|20302175|P1|NOT COMPLETED|Overall Study||15
8233201|NCT01974895|20302174|P2|COMPLETED|Overall Study||141
8233202|NCT01974895|20302175|P1|COMPLETED|Overall Study||143
8233203|NCT01974895|20302174|P2|STARTED|Overall Study||156
8233204|NCT01974895|20302175|P1|STARTED|Overall Study||158
8233205|NCT01974817|20302205|P1|NOT COMPLETED|Overall Study||8
8233206|NCT01974817|20302205|P1|COMPLETED|Overall Study||17
8233207|NCT01974817|20302205|P1|STARTED|Overall Study||25
8233208|NCT01974752|20302211|P2|NOT COMPLETED|Overall Study||15
8233209|NCT01974752|20302212|P1|NOT COMPLETED|Overall Study||37
8233210|NCT01974752|20302211|P2|COMPLETED|Overall Study||17
8233211|NCT01974752|20302212|P1|COMPLETED|Overall Study||60
8233212|NCT01974752|20302211|P2|STARTED|Overall Study||32
8233213|NCT01974752|20302212|P1|STARTED|Overall Study||97
8233214|NCT01974700|20302226|P2|NOT COMPLETED|Overall Study||0
8233215|NCT01974700|20302227|P1|NOT COMPLETED|Overall Study||0
8233216|NCT01974700|20302226|P2|COMPLETED|Overall Study||3
8233217|NCT01974700|20302227|P1|COMPLETED|Overall Study||5
8233218|NCT01974700|20302226|P2|STARTED|Overall Study||3
8233219|NCT01974700|20302227|P1|STARTED|Overall Study||5
8233220|NCT01974687|20302262|P25|NOT COMPLETED|Overall Study||0
8233221|NCT01974687|20302263|P24|NOT COMPLETED|Overall Study||0
8233222|NCT01974687|20302264|P23|NOT COMPLETED|Overall Study||0
8233223|NCT01974687|20302265|P22|NOT COMPLETED|Overall Study||0
8233224|NCT01974687|20302266|P21|NOT COMPLETED|Overall Study||0
8233225|NCT01974687|20302267|P20|NOT COMPLETED|Overall Study||0
8233226|NCT01974687|20302268|P19|NOT COMPLETED|Overall Study||0
8233227|NCT01974687|20302269|P18|NOT COMPLETED|Overall Study||3
8233228|NCT01974687|20302270|P17|NOT COMPLETED|Overall Study||1
8233229|NCT01974687|20302271|P16|NOT COMPLETED|Overall Study||1
8233230|NCT01974687|20302272|P15|NOT COMPLETED|Overall Study||1
8233231|NCT01974687|20302273|P14|NOT COMPLETED|Overall Study||2
8233232|NCT01974687|20302274|P13|NOT COMPLETED|Overall Study||3
8233233|NCT01974687|20302275|P12|NOT COMPLETED|Overall Study||2
8233234|NCT01974687|20302276|P11|NOT COMPLETED|Overall Study||0
8233235|NCT01974687|20302277|P10|NOT COMPLETED|Overall Study||0
8233236|NCT01974687|20302278|P9|NOT COMPLETED|Overall Study||0
8233237|NCT01974687|20302279|P8|NOT COMPLETED|Overall Study||0
8233238|NCT01974687|20302280|P7|NOT COMPLETED|Overall Study||0
8233239|NCT01974687|20302281|P6|NOT COMPLETED|Overall Study||0
8233240|NCT01974687|20302282|P5|NOT COMPLETED|Overall Study||0
8233241|NCT01974687|20302283|P4|NOT COMPLETED|Overall Study||0
8233242|NCT01974687|20302284|P3|NOT COMPLETED|Overall Study||0
8233243|NCT01974687|20302285|P2|NOT COMPLETED|Overall Study||0
8233244|NCT01974687|20302286|P1|NOT COMPLETED|Overall Study||0
8233245|NCT01974687|20302262|P25|COMPLETED|Overall Study||10
8233246|NCT01974687|20302263|P24|COMPLETED|Overall Study||6
8233247|NCT01974687|20302264|P23|COMPLETED|Overall Study||8
8233248|NCT01974687|20302265|P22|COMPLETED|Overall Study||8
8233249|NCT01974687|20302266|P21|COMPLETED|Overall Study||3
8233250|NCT01974687|20302267|P20|COMPLETED|Overall Study||3
8233251|NCT01974687|20302268|P19|COMPLETED|Overall Study||9
8233252|NCT01974687|20302269|P18|COMPLETED|Overall Study||8
8233253|NCT01974687|20302270|P17|COMPLETED|Overall Study||8
8233254|NCT01974687|20302271|P16|COMPLETED|Overall Study||8
8233255|NCT01974687|20302272|P15|COMPLETED|Overall Study||18
8233256|NCT01974687|20302273|P14|COMPLETED|Overall Study||8
8233257|NCT01974687|20302274|P13|COMPLETED|Overall Study||10
8233258|NCT01974687|20302275|P12|COMPLETED|Overall Study||11
8233259|NCT01974687|20302276|P11|COMPLETED|Overall Study||3
8233260|NCT01974687|20302277|P10|COMPLETED|Overall Study||3
8233261|NCT01974687|20302278|P9|COMPLETED|Overall Study||3
8233262|NCT01974687|20302279|P8|COMPLETED|Overall Study||3
8233263|NCT01974687|20302280|P7|COMPLETED|Overall Study||3
8233264|NCT01974687|20302281|P6|COMPLETED|Overall Study||6
8233265|NCT01974687|20302282|P5|COMPLETED|Overall Study||2
8233266|NCT01974687|20302283|P4|COMPLETED|Overall Study||6
8233267|NCT01974687|20302284|P3|COMPLETED|Overall Study||6
8233268|NCT01974687|20302285|P2|COMPLETED|Overall Study||6
8233269|NCT01974687|20302286|P1|COMPLETED|Overall Study||6
8233270|NCT01974687|20302262|P25|Treated|Overall Study||10
8233271|NCT01974687|20302263|P24|Treated|Overall Study||6
8233272|NCT01974687|20302264|P23|Treated|Overall Study||8
8233273|NCT01974687|20302265|P22|Treated|Overall Study||8
8233274|NCT01974687|20302266|P21|Treated|Overall Study||3
8233275|NCT01974687|20302267|P20|Treated|Overall Study||3
8233276|NCT01974687|20302268|P19|Treated|Overall Study||9
8233277|NCT01974687|20302269|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
8233278|NCT01974687|20302270|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
8233279|NCT01974687|20302271|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
8233280|NCT01974687|20302272|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
8233281|NCT01974687|20302273|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
8233282|NCT01974687|20302274|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
8233283|NCT01974687|20302275|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
8233284|NCT01974687|20302276|P11|Treated|Overall Study||3
8233285|NCT01974687|20302277|P10|Treated|Overall Study||3
8233286|NCT01974687|20302278|P9|Treated|Overall Study||3
8233287|NCT01974687|20302279|P8|Treated|Overall Study||3
8233288|NCT01974687|20302280|P7|Treated|Overall Study||3
8233289|NCT01974687|20302281|P6|Treated|Overall Study||6
8233290|NCT01974687|20302282|P5|Treated|Overall Study||2
8233291|NCT01974687|20302283|P4|Treated|Overall Study||6
8233292|NCT01974687|20302284|P3|Treated|Overall Study||6
8233293|NCT01974687|20302285|P2|Treated|Overall Study||6
8233294|NCT01974687|20302286|P1|Treated|Overall Study||6
8233295|NCT01974687|20302262|P25|STARTED|Overall Study||10
8233296|NCT01974687|20302263|P24|STARTED|Overall Study||6
8233297|NCT01974687|20302264|P23|STARTED|Overall Study||8
8233298|NCT01974687|20302265|P22|STARTED|Overall Study||8
8233299|NCT01974687|20302266|P21|STARTED|Overall Study||3
8233300|NCT01974687|20302267|P20|STARTED|Overall Study||3
8233301|NCT01974687|20302268|P19|STARTED|Overall Study||9
8233302|NCT01974687|20302269|P18|STARTED|Overall Study||11
8233303|NCT01974687|20302270|P17|STARTED|Overall Study||9
8233304|NCT01974687|20302271|P16|STARTED|Overall Study||9
8233305|NCT01974687|20302272|P15|STARTED|Overall Study||19
8233306|NCT01974687|20302273|P14|STARTED|Overall Study||10
8233307|NCT01974687|20302274|P13|STARTED|Overall Study||13
8233308|NCT01974687|20302275|P12|STARTED|Overall Study||13
8233309|NCT01974687|20302276|P11|STARTED|Overall Study||3
8233310|NCT01974687|20302277|P10|STARTED|Overall Study||3
8233311|NCT01974687|20302278|P9|STARTED|Overall Study||3
8233312|NCT01974687|20302279|P8|STARTED|Overall Study||3
8233313|NCT01974687|20302280|P7|STARTED|Overall Study||3
8233314|NCT01974687|20302281|P6|STARTED|Overall Study||6
8233315|NCT01974687|20302282|P5|STARTED|Overall Study||2
8233316|NCT01974687|20302283|P4|STARTED|Overall Study||6
8233317|NCT01974687|20302284|P3|STARTED|Overall Study||6
8233318|NCT01974687|20302285|P2|STARTED|Overall Study||6
8233319|NCT01974687|20302286|P1|STARTED|Overall Study||6
8233320|NCT01974635|20302633|P1|NOT COMPLETED|Overall Study||0
8233321|NCT01974635|20302633|P1|COMPLETED|Overall Study||2
8233322|NCT01974635|20302633|P1|STARTED|Overall Study||2
8233323|NCT01974323|20302640|P2|NOT COMPLETED|Overall Study||93
8233324|NCT01974323|20302641|P1|NOT COMPLETED|Overall Study||92
8233325|NCT01974323|20302640|P2|COMPLETED|Overall Study||1027
8233326|NCT01974323|20302641|P1|COMPLETED|Overall Study||1026
8233327|NCT01974323|20302640|P2|STARTED|Overall Study||1120
8233328|NCT01974323|20302641|P1|STARTED|Overall Study||1118
8233329|NCT01974284|20302663|P1|NOT COMPLETED|Overall Study||7
8233330|NCT01974284|20302663|P1|COMPLETED|Overall Study||0
8233331|NCT01974284|20302663|P1|STARTED|Overall Study||7
8233332|NCT01974245|20302672|P2|NOT COMPLETED|Overall Study||8
8233333|NCT01974245|20302673|P1|NOT COMPLETED|Overall Study||9
8233334|NCT01974245|20302672|P2|COMPLETED|Overall Study||20
8233335|NCT01974245|20302673|P1|COMPLETED|Overall Study||18
8233336|NCT01974245|20302672|P2|STARTED|Overall Study||28
8233337|NCT01974245|20302673|P1|STARTED|Overall Study||27
8233338|NCT01974141|20302681|P2|NOT COMPLETED|Overall Study||82
8233339|NCT01974141|20302682|P1|NOT COMPLETED|Overall Study||96
8233340|NCT01974141|20302681|P2|COMPLETED|Overall Study||976
8233341|NCT01974141|20302682|P1|COMPLETED|Overall Study||948
8233342|NCT01974141|20302681|P2|STARTED|Overall Study||1058
8233343|NCT01974141|20302682|P1|STARTED|Overall Study||1044
8233344|NCT01974089|20302706|P2|NOT COMPLETED|Overall Study||0
8233345|NCT01974089|20302707|P1|NOT COMPLETED|Overall Study||0
8233346|NCT01974089|20302706|P2|COMPLETED|Overall Study||101
8233347|NCT01974089|20302707|P1|COMPLETED|Overall Study||53
8233348|NCT01974089|20302706|P2|STARTED|Overall Study||101
8233349|NCT01974089|20302707|P1|STARTED|Overall Study||53
8233350|NCT01974050|20302717|P1|NOT COMPLETED|Overall Study||25
8233351|NCT01974050|20302717|P1|COMPLETED|Overall Study||141
8233352|NCT01974050|20302717|P1|STARTED|Overall Study||166
8233353|NCT01973998|20302726|P2|NOT COMPLETED|Overall Study||2
8233354|NCT01973998|20302727|P1|NOT COMPLETED|Overall Study||2
8233355|NCT01973998|20302726|P2|COMPLETED|Overall Study||33
8233356|NCT01973998|20302727|P1|COMPLETED|Overall Study||31
8233357|NCT01973998|20302726|P2|STARTED|Overall Study||35
8233358|NCT01973998|20302727|P1|STARTED|Overall Study||33
8233359|NCT01973972|20302739|P2|NOT COMPLETED|Overall Study||19
8233360|NCT01973972|20302740|P1|NOT COMPLETED|Overall Study||18
8233361|NCT01973972|20302739|P2|COMPLETED|Overall Study||117
8233362|NCT01973972|20302740|P1|COMPLETED|Overall Study||109
8233363|NCT01973972|20302739|P2|STARTED|Overall Study||136
8233364|NCT01973972|20302740|P1|STARTED|Overall Study||127
8233365|NCT01973777|20302754|P1|NOT COMPLETED|Overall Study||7
8233366|NCT01973777|20302754|P1|COMPLETED|Overall Study||44
8233367|NCT01973777|20302754|P1|One Year Follow-up|Overall Study||44
8233368|NCT01973777|20302754|P1|STARTED|Overall Study|January 2014|51
8233369|NCT01973608|20302764|P4|NOT COMPLETED|Overall Study||0
8233370|NCT01973608|20302765|P3|NOT COMPLETED|Overall Study||0
8233371|NCT01973608|20302766|P2|NOT COMPLETED|Overall Study||0
8233372|NCT01973608|20302767|P1|NOT COMPLETED|Overall Study||0
8233373|NCT01973608|20302764|P4|COMPLETED|Overall Study||2
8233374|NCT01973608|20302765|P3|COMPLETED|Overall Study||6
8233375|NCT01973608|20302766|P2|COMPLETED|Overall Study||2
8233376|NCT01973608|20302767|P1|COMPLETED|Overall Study||2
8233377|NCT01973608|20302764|P4|STARTED|Overall Study||2
8233378|NCT01973608|20302765|P3|STARTED|Overall Study||6
8233379|NCT01973608|20302766|P2|STARTED|Overall Study||2
8233380|NCT01973608|20302767|P1|STARTED|Overall Study||2
8233381|NCT01973595|20302789|P4|NOT COMPLETED|Intervention Phase 2||0
8233382|NCT01973595|20302790|P3|NOT COMPLETED|Intervention Phase 2||0
8233383|NCT01973595|20302791|P2|NOT COMPLETED|Intervention Phase 2||0
8233384|NCT01973595|20302792|P1|NOT COMPLETED|Intervention Phase 2||0
8233385|NCT01973595|20302789|P4|COMPLETED|Intervention Phase 2||14
8233386|NCT01973595|20302790|P3|COMPLETED|Intervention Phase 2||14
8233387|NCT01973595|20302791|P2|COMPLETED|Intervention Phase 2||14
8233388|NCT01973595|20302792|P1|COMPLETED|Intervention Phase 2||14
8233389|NCT01973595|20302789|P4|STARTED|Intervention Phase 2||14
8233390|NCT01973595|20302790|P3|STARTED|Intervention Phase 2||14
8233391|NCT01973595|20302791|P2|STARTED|Intervention Phase 2||14
8233392|NCT01973595|20302792|P1|STARTED|Intervention Phase 2||14
8233393|NCT01973595|20302789|P4|NOT COMPLETED|Washout||0
8233394|NCT01973595|20302790|P3|NOT COMPLETED|Washout||1
8233395|NCT01973595|20302791|P2|NOT COMPLETED|Washout||0
8233396|NCT01973595|20302792|P1|NOT COMPLETED|Washout||1
8233397|NCT01973595|20302789|P4|COMPLETED|Washout||14
8233398|NCT01973595|20302790|P3|COMPLETED|Washout||14
8233399|NCT01973595|20302791|P2|COMPLETED|Washout||14
8233400|NCT01973595|20302792|P1|COMPLETED|Washout||14
8233401|NCT01973595|20302789|P4|STARTED|Washout||14
8233402|NCT01973595|20302790|P3|STARTED|Washout||15
8233403|NCT01973595|20302791|P2|STARTED|Washout||14
8233404|NCT01973595|20302792|P1|STARTED|Washout||15
8233405|NCT01973595|20302789|P4|NOT COMPLETED|Intervention Phase 1||0
8233406|NCT01973595|20302790|P3|NOT COMPLETED|Intervention Phase 1||0
8233407|NCT01973595|20302791|P2|NOT COMPLETED|Intervention Phase 1||0
8233408|NCT01973595|20302792|P1|NOT COMPLETED|Intervention Phase 1||0
8233409|NCT01973595|20302789|P4|COMPLETED|Intervention Phase 1||14
8233410|NCT01973595|20302790|P3|COMPLETED|Intervention Phase 1||15
8233411|NCT01973595|20302791|P2|COMPLETED|Intervention Phase 1||14
8233412|NCT01973595|20302792|P1|COMPLETED|Intervention Phase 1||15
8233413|NCT01973595|20302789|P4|STARTED|Intervention Phase 1||14
8233414|NCT01973595|20302790|P3|STARTED|Intervention Phase 1||15
8233415|NCT01973595|20302791|P2|STARTED|Intervention Phase 1||14
8233416|NCT01973595|20302792|P1|STARTED|Intervention Phase 1||15
8233417|NCT01973569|20302809|P3|NOT COMPLETED|Overall Study||18
8233418|NCT01973569|20302810|P2|NOT COMPLETED|Overall Study||25
8233419|NCT01973569|20302811|P1|NOT COMPLETED|Overall Study||29
8233420|NCT01973569|20302809|P3|COMPLETED|Overall Study||208
8233421|NCT01973569|20302810|P2|COMPLETED|Overall Study||200
8233422|NCT01973569|20302811|P1|COMPLETED|Overall Study||199
8233423|NCT01973569|20302809|P3|Discontinued Study|Overall Study||15
8233424|NCT01973569|20302810|P2|Discontinued Study|Overall Study||22
8233425|NCT01973569|20302811|P1|Discontinued Study|Overall Study||23
8233426|NCT01973569|20302809|P3|Discontinued Study Treatment|Overall Study||15
8233427|NCT01973569|20302810|P2|Discontinued Study Treatment|Overall Study||22
8233428|NCT01973569|20302811|P1|Discontinued Study Treatment|Overall Study||23
8233429|NCT01973569|20302809|P3|Did Not Receive Study Drug|Overall Study||3
8233430|NCT01973569|20302810|P2|Did Not Receive Study Drug|Overall Study||3
8233431|NCT01973569|20302811|P1|Did Not Receive Study Drug|Overall Study||6
8233432|NCT01973569|20302809|P3|Received Study Drug|Overall Study||223
8233433|NCT01973569|20302810|P2|Received Study Drug|Overall Study||222
8233434|NCT01973569|20302811|P1|Received Study Drug|Overall Study||222
8233435|NCT01973569|20302809|P3|STARTED|Overall Study||226
8233436|NCT01973569|20302810|P2|STARTED|Overall Study||225
8233437|NCT01973569|20302811|P1|STARTED|Overall Study||228
8233438|NCT01973491|20302837|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
8233439|NCT01973491|20302837|P1|COMPLETED|Treatment Period (16 Weeks)||18
8233440|NCT01973491|20302837|P1|STARTED|Treatment Period (16 Weeks)||19
8233441|NCT01973491|20302837|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
8233442|NCT01973491|20302837|P1|COMPLETED|Titration Period(4 Weeks)||19
8233443|NCT01973491|20302837|P1|STARTED|Titration Period(4 Weeks)||19
8233444|NCT01973491|20302837|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
8233445|NCT01973491|20302837|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
8233446|NCT01973491|20302837|P1|STARTED|Baseline Control Period (8 Weeks)||37
8233447|NCT01973439|20302853|P1|NOT COMPLETED|Overall Study||5
8233448|NCT01973439|20302853|P1|COMPLETED|Overall Study||18
8233449|NCT01973439|20302853|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
8233450|NCT01973439|20302853|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
8233451|NCT01973439|20302853|P1|STARTED|Overall Study||23
8233452|NCT01973413|20302862|P2|NOT COMPLETED|Overall Study||0
8233453|NCT01973413|20302863|P1|NOT COMPLETED|Overall Study||1
8233454|NCT01973413|20302862|P2|COMPLETED|Overall Study||20
8233455|NCT01973413|20302863|P1|COMPLETED|Overall Study||11
8233456|NCT01973413|20302862|P2|STARTED|Overall Study||20
8233457|NCT01973413|20302863|P1|STARTED|Overall Study||12
8233458|NCT01973387|20302875|P2|NOT COMPLETED|Overall Study||18
8233459|NCT01973387|20302876|P1|NOT COMPLETED|Overall Study||106
8233460|NCT01973387|20302875|P2|COMPLETED|Overall Study||36
8233461|NCT01973387|20302876|P1|COMPLETED|Overall Study||0
8233462|NCT01973387|20302875|P2|Treated|Overall Study||52
8233463|NCT01973387|20302876|P1|Treated|Overall Study||104
8233464|NCT01973387|20302875|P2|STARTED|Overall Study||54
8233465|NCT01973387|20302876|P1|STARTED|Overall Study||106
8233466|NCT01973348|20302894|P4|NOT COMPLETED|Overall Study||0
8233467|NCT01973348|20302895|P3|NOT COMPLETED|Overall Study||0
8233468|NCT01973348|20302896|P2|NOT COMPLETED|Overall Study||3
8233469|NCT01973348|20302897|P1|NOT COMPLETED|Overall Study||8
8233470|NCT01973348|20302894|P4|COMPLETED|Overall Study||0
8233471|NCT01973348|20302895|P3|COMPLETED|Overall Study||0
8233472|NCT01973348|20302896|P2|COMPLETED|Overall Study||15
8233473|NCT01973348|20302897|P1|COMPLETED|Overall Study||19
8233474|NCT01973348|20302894|P4|STARTED|Overall Study||0
8233475|NCT01973348|20302895|P3|STARTED|Overall Study||0
8233476|NCT01973348|20302896|P2|STARTED|Overall Study||18
8233477|NCT01973348|20302897|P1|STARTED|Overall Study||27
8233478|NCT01973335|20302919|P4|NOT COMPLETED|Overall Study||0
8233479|NCT01973335|20302920|P3|NOT COMPLETED|Overall Study||0
8233480|NCT01973335|20302921|P2|NOT COMPLETED|Overall Study||0
8233481|NCT01973335|20302922|P1|NOT COMPLETED|Overall Study||0
8233482|NCT01973335|20302919|P4|COMPLETED|Overall Study||9
8233483|NCT01973335|20302920|P3|COMPLETED|Overall Study||9
8233484|NCT01973335|20302921|P2|COMPLETED|Overall Study||7
8233485|NCT01973335|20302922|P1|COMPLETED|Overall Study||9
8233486|NCT01973335|20302919|P4|STARTED|Overall Study||9
8233487|NCT01973335|20302920|P3|STARTED|Overall Study||9
8233488|NCT01973335|20302921|P2|STARTED|Overall Study||7
8233489|NCT01973335|20302922|P1|STARTED|Overall Study||9
8233490|NCT01973231|20302958|P2|NOT COMPLETED|Overall Study||12
8233491|NCT01973231|20302959|P1|NOT COMPLETED|Overall Study||11
8233492|NCT01973231|20302958|P2|COMPLETED|Overall Study||190
8233493|NCT01973231|20302959|P1|COMPLETED|Overall Study||191
8233494|NCT01973231|20302958|P2|STARTED|Overall Study||202
8233495|NCT01973231|20302959|P1|STARTED|Overall Study||202
8233496|NCT01973218|20302979|P2|NOT COMPLETED|Overall Study||0
8233497|NCT01973218|20302980|P1|NOT COMPLETED|Overall Study||2
8233498|NCT01973218|20302979|P2|COMPLETED|Overall Study||88
8233499|NCT01973218|20302980|P1|COMPLETED|Overall Study||174
8233500|NCT01973218|20302979|P2|STARTED|Overall Study||88
8233501|NCT01973218|20302980|P1|STARTED|Overall Study||176
8233502|NCT01973205|20303003|P2|NOT COMPLETED|Overall Study||22
8233503|NCT01973205|20303004|P1|NOT COMPLETED|Overall Study||30
8233504|NCT01973205|20303003|P2|COMPLETED|Overall Study||425
8233505|NCT01973205|20303004|P1|COMPLETED|Overall Study||423
8233506|NCT01973205|20303003|P2|STARTED|Overall Study||447
8233507|NCT01973205|20303004|P1|STARTED|Overall Study||453
8233508|NCT01973062|20303016|P1|NOT COMPLETED|Overall Study||0
8233509|NCT01973062|20303016|P1|COMPLETED|Overall Study||1
8233510|NCT01973062|20303016|P1|STARTED|Overall Study||1
8233511|NCT01973036|20303026|P2|NOT COMPLETED|Overall Study||0
8233512|NCT01973036|20303027|P1|NOT COMPLETED|Overall Study||0
8233513|NCT01973036|20303026|P2|COMPLETED|Overall Study||93
8233514|NCT01973036|20303027|P1|COMPLETED|Overall Study||108
8233515|NCT01973036|20303026|P2|Received Assigned Intervention|Overall Study||88
8233516|NCT01973036|20303027|P1|Received Assigned Intervention|Overall Study||113
8233517|NCT01973036|20303026|P2|STARTED|Overall Study||93
8233518|NCT01973036|20303027|P1|STARTED|Overall Study||108
8233519|NCT01972841|20303073|P6|NOT COMPLETED|Overall Study||85
8233520|NCT01972841|20303074|P5|NOT COMPLETED|Overall Study||83
8233521|NCT01972841|20303075|P4|NOT COMPLETED|Overall Study||37
8233522|NCT01972841|20303076|P3|NOT COMPLETED|Overall Study||50
8233523|NCT01972841|20303077|P2|NOT COMPLETED|Overall Study||44
8233524|NCT01972841|20303078|P1|NOT COMPLETED|Overall Study||43
8233525|NCT01972841|20303073|P6|COMPLETED|Overall Study||798
8233526|NCT01972841|20303074|P5|COMPLETED|Overall Study||802
8233527|NCT01972841|20303075|P4|COMPLETED|Overall Study||397
8233528|NCT01972841|20303076|P3|COMPLETED|Overall Study||387
8233529|NCT01972841|20303077|P2|COMPLETED|Overall Study||397
8233530|NCT01972841|20303078|P1|COMPLETED|Overall Study||404
8233531|NCT01972841|20303073|P6|STARTED|Overall Study||883
8233532|NCT01972841|20303074|P5|STARTED|Overall Study||885
8233533|NCT01972841|20303075|P4|STARTED|Overall Study||434
8233534|NCT01972841|20303076|P3|STARTED|Overall Study||437
8233535|NCT01972841|20303077|P2|STARTED|Overall Study||441
8233536|NCT01972841|20303078|P1|STARTED|Overall Study||447
8233537|NCT01972789|20303508|P2|NOT COMPLETED|Overall Study||30
8233538|NCT01972789|20303509|P1|NOT COMPLETED|Overall Study||40
8233539|NCT01972789|20303508|P2|COMPLETED|Overall Study||145
8233540|NCT01972789|20303509|P1|COMPLETED|Overall Study||134
8233541|NCT01972789|20303508|P2|STARTED|Overall Study||175
8233542|NCT01972789|20303509|P1|STARTED|Overall Study||174
8233543|NCT01972776|20303543|P6|NOT COMPLETED|Part 2||7
8233544|NCT01972776|20303544|P5|NOT COMPLETED|Part 2||13
8233545|NCT01972776|20303545|P4|NOT COMPLETED|Part 2||0
8233546|NCT01972776|20303546|P3|NOT COMPLETED|Part 2||0
8233547|NCT01972776|20303547|P2|NOT COMPLETED|Part 2||0
8233548|NCT01972776|20303548|P1|NOT COMPLETED|Part 2||0
8233549|NCT01972776|20303543|P6|COMPLETED|Part 2||0
8233550|NCT01972776|20303544|P5|COMPLETED|Part 2||1
8233551|NCT01972776|20303545|P4|COMPLETED|Part 2||0
8233552|NCT01972776|20303546|P3|COMPLETED|Part 2||0
8233553|NCT01972776|20303547|P2|COMPLETED|Part 2||0
8233554|NCT01972776|20303548|P1|COMPLETED|Part 2||0
8233555|NCT01972776|20303543|P6|STARTED|Part 2||7
8233556|NCT01972776|20303544|P5|STARTED|Part 2||14
8233557|NCT01972776|20303545|P4|STARTED|Part 2||0
8233558|NCT01972776|20303546|P3|STARTED|Part 2||0
8233559|NCT01972776|20303547|P2|STARTED|Part 2||0
8233560|NCT01972776|20303548|P1|STARTED|Part 2||0
8233561|NCT01972776|20303543|P6|NOT COMPLETED|Part 1||0
8233562|NCT01972776|20303544|P5|NOT COMPLETED|Part 1||0
8233563|NCT01972776|20303545|P4|NOT COMPLETED|Part 1||1
8233564|NCT01972776|20303546|P3|NOT COMPLETED|Part 1||2
8233565|NCT01972776|20303547|P2|NOT COMPLETED|Part 1||0
8233566|NCT01972776|20303548|P1|NOT COMPLETED|Part 1||0
8233567|NCT01972776|20303543|P6|COMPLETED|Part 1||0
8233568|NCT01972776|20303544|P5|COMPLETED|Part 1||0
8233569|NCT01972776|20303545|P4|COMPLETED|Part 1||6
8233570|NCT01972776|20303546|P3|COMPLETED|Part 1||6
8233571|NCT01972776|20303547|P2|COMPLETED|Part 1||6
8233572|NCT01972776|20303548|P1|COMPLETED|Part 1||6
8233573|NCT01972776|20303543|P6|STARTED|Part 1||0
8233574|NCT01972776|20303544|P5|STARTED|Part 1||0
8233575|NCT01972776|20303545|P4|STARTED|Part 1||7
8233576|NCT01972776|20303546|P3|STARTED|Part 1||8
8233577|NCT01972776|20303547|P2|STARTED|Part 1||6
8233578|NCT01972776|20303548|P1|STARTED|Part 1||6
8233579|NCT01972724|20303619|P3|NOT COMPLETED|Open-Label||5
8233580|NCT01972724|20303620|P2|NOT COMPLETED|Open-Label||0
8233581|NCT01972724|20303621|P1|NOT COMPLETED|Open-Label||0
8233582|NCT01972724|20303619|P3|COMPLETED|Open-Label||72
8233583|NCT01972724|20303620|P2|COMPLETED|Open-Label||0
8233584|NCT01972724|20303621|P1|COMPLETED|Open-Label||0
8233585|NCT01972724|20303619|P3|STARTED|Open-Label||77
8233586|NCT01972724|20303620|P2|STARTED|Open-Label||0
8233587|NCT01972724|20303621|P1|STARTED|Open-Label||0
8233588|NCT01972724|20303619|P3|NOT COMPLETED|Double-Blind||0
8233589|NCT01972724|20303620|P2|NOT COMPLETED|Double-Blind||9
8233590|NCT01972724|20303621|P1|NOT COMPLETED|Double-Blind||9
8233591|NCT01972724|20303619|P3|COMPLETED|Double-Blind||0
8233592|NCT01972724|20303620|P2|COMPLETED|Double-Blind||9
8233593|NCT01972724|20303621|P1|COMPLETED|Double-Blind||10
8233594|NCT01972724|20303619|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
8233595|NCT01972724|20303620|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
8233596|NCT01972724|20303621|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
8233597|NCT01972724|20303619|P3|STARTED|Double-Blind||0
8233598|NCT01972724|20303620|P2|STARTED|Double-Blind||18
8233599|NCT01972724|20303621|P1|STARTED|Double-Blind||19
8233600|NCT01972659|20303634|P2|NOT COMPLETED|Overall Study||3
8233601|NCT01972659|20303635|P1|NOT COMPLETED|Overall Study||4
8233602|NCT01972659|20303634|P2|COMPLETED|Overall Study||37
8233603|NCT01972659|20303635|P1|COMPLETED|Overall Study||36
8233604|NCT01972659|20303634|P2|STARTED|Overall Study||40
8233605|NCT01972659|20303635|P1|STARTED|Overall Study||40
8233606|NCT01972568|20303644|P3|NOT COMPLETED|Overall Study||16
8233607|NCT01972568|20303645|P2|NOT COMPLETED|Overall Study||12
8233608|NCT01972568|20303646|P1|NOT COMPLETED|Overall Study||16
8233609|NCT01972568|20303644|P3|COMPLETED|Overall Study||84
8233610|NCT01972568|20303645|P2|COMPLETED|Overall Study||92
8233611|NCT01972568|20303646|P1|COMPLETED|Overall Study||86
8233612|NCT01972568|20303644|P3|STARTED|Overall Study||100
8233613|NCT01972568|20303645|P2|STARTED|Overall Study||104
8233614|NCT01972568|20303646|P1|STARTED|Overall Study||102
8233615|NCT01972529|20303685|P4|NOT COMPLETED|Overall Study||4
8233616|NCT01972529|20303686|P3|NOT COMPLETED|Overall Study||2
8233617|NCT01972529|20303687|P2|NOT COMPLETED|Overall Study||5
8233618|NCT01972529|20303688|P1|NOT COMPLETED|Overall Study||2
8233619|NCT01972529|20303685|P4|COMPLETED|Overall Study||55
8233620|NCT01972529|20303686|P3|COMPLETED|Overall Study||32
8233621|NCT01972529|20303687|P2|COMPLETED|Overall Study||85
8233622|NCT01972529|20303688|P1|COMPLETED|Overall Study||46
8233623|NCT01972529|20303685|P4|STARTED|Overall Study||59
8233624|NCT01972529|20303686|P3|STARTED|Overall Study||34
8233625|NCT01972529|20303687|P2|STARTED|Overall Study||90
8233626|NCT01972529|20303688|P1|STARTED|Overall Study||48
8233627|NCT01972516|20303716|P2|NOT COMPLETED|Overall Study||0
8233628|NCT01972516|20303717|P1|NOT COMPLETED|Overall Study||0
8233629|NCT01972516|20303716|P2|COMPLETED|Overall Study||1
8233630|NCT01972516|20303717|P1|COMPLETED|Overall Study||3
8233631|NCT01972516|20303716|P2|STARTED|Overall Study||1
8233632|NCT01972516|20303717|P1|STARTED|Overall Study||3
8233633|NCT01972464|20303733|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
8233634|NCT01972464|20303734|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
8233635|NCT01972464|20303733|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
8233636|NCT01972464|20303734|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
8233637|NCT01972464|20303733|P2|STARTED|3-Month Follow-Up (Week 20)||18
8233638|NCT01972464|20303734|P1|STARTED|3-Month Follow-Up (Week 20)||16
8233639|NCT01972464|20303733|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
8233640|NCT01972464|20303734|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
8233641|NCT01972464|20303733|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
8233642|NCT01972464|20303734|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
8233643|NCT01972464|20303733|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
8233644|NCT01972464|20303734|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
8233645|NCT01972438|20303750|P2|NOT COMPLETED|Post Month 12 Study Period||4
8233646|NCT01972438|20303751|P1|NOT COMPLETED|Post Month 12 Study Period||3
8233647|NCT01972438|20303750|P2|COMPLETED|Post Month 12 Study Period||0
8233648|NCT01972438|20303751|P1|COMPLETED|Post Month 12 Study Period||0
8233649|NCT01972438|20303750|P2|STARTED|Post Month 12 Study Period||4
8233650|NCT01972438|20303751|P1|STARTED|Post Month 12 Study Period||3
8233651|NCT01972438|20303750|P2|NOT COMPLETED|Months 6-12 Study Period||2
8233652|NCT01972438|20303751|P1|NOT COMPLETED|Months 6-12 Study Period||3
8233653|NCT01972438|20303750|P2|COMPLETED|Months 6-12 Study Period||4
8233654|NCT01972438|20303751|P1|COMPLETED|Months 6-12 Study Period||3
8233655|NCT01972438|20303750|P2|STARTED|Months 6-12 Study Period||6
8233656|NCT01972438|20303751|P1|STARTED|Months 6-12 Study Period||6
8233657|NCT01972438|20303750|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
8233658|NCT01972438|20303751|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
8233659|NCT01972438|20303750|P2|COMPLETED|Months 3-6 Crossover Period||6
8233660|NCT01972438|20303751|P1|COMPLETED|Months 3-6 Crossover Period||6
8233661|NCT01972438|20303750|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
8233662|NCT01972438|20303751|P1|STARTED|Months 3-6 Crossover Period||6
8233663|NCT01972438|20303750|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
8233664|NCT01972438|20303751|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
8233665|NCT01972438|20303750|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
8233666|NCT01972438|20303751|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
8233667|NCT01972438|20303750|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
8233668|NCT01972438|20303751|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
8233669|NCT01972308|20303805|P2|NOT COMPLETED|Overall Study||8
8233670|NCT01972308|20303806|P1|NOT COMPLETED|Overall Study||8
8233671|NCT01972308|20303805|P2|COMPLETED|Overall Study||148
8233672|NCT01972308|20303806|P1|COMPLETED|Overall Study||148
8233673|NCT01972308|20303805|P2|STARTED|Overall Study||156
8233674|NCT01972308|20303806|P1|STARTED|Overall Study||156
8233675|NCT01972282|20303822|P1|NOT COMPLETED|Overall Study||15
8233676|NCT01972282|20303822|P1|COMPLETED|Overall Study||1005
8233677|NCT01972282|20303822|P1|STARTED|Overall Study||1020
8233678|NCT01972217|20303832|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
8233679|NCT01972217|20303833|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
8233680|NCT01972217|20303834|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
8233681|NCT01972217|20303835|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
8233682|NCT01972217|20303832|P4|COMPLETED|Part B Double-blind, Randomised Period||24
8233683|NCT01972217|20303833|P3|COMPLETED|Part B Double-blind, Randomised Period||25
8233684|NCT01972217|20303834|P2|COMPLETED|Part B Double-blind, Randomised Period||0
8233685|NCT01972217|20303835|P1|COMPLETED|Part B Double-blind, Randomised Period||0
8233686|NCT01972217|20303832|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
8233687|NCT01972217|20303833|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
8233688|NCT01972217|20303834|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
8233689|NCT01972217|20303835|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
8233690|NCT01972217|20303832|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
8233691|NCT01972217|20303833|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
8233692|NCT01972217|20303834|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
8233693|NCT01972217|20303835|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
8233694|NCT01972217|20303832|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
8233695|NCT01972217|20303833|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
8233696|NCT01972217|20303834|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
8233697|NCT01972217|20303835|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
8233698|NCT01972217|20303832|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
8233699|NCT01972217|20303833|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
8233700|NCT01972217|20303834|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
8233701|NCT01972217|20303835|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
8233702|NCT01972217|20303832|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
8233703|NCT01972217|20303833|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
8233704|NCT01972217|20303834|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
8233705|NCT01972217|20303835|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
8233706|NCT01972217|20303832|P4|STARTED|Part A: Open-label Safety Run-in Period||0
8233707|NCT01972217|20303833|P3|STARTED|Part A: Open-label Safety Run-in Period||0
8233708|NCT01972217|20303834|P2|STARTED|Part A: Open-label Safety Run-in Period||13
8233709|NCT01972217|20303835|P1|STARTED|Part A: Open-label Safety Run-in Period||3
8233710|NCT01972204|20303883|P2|NOT COMPLETED|Overall Study||4
8233711|NCT01972204|20303884|P1|NOT COMPLETED|Overall Study||4
8233712|NCT01972204|20303883|P2|COMPLETED|Overall Study||59
8233713|NCT01972204|20303884|P1|COMPLETED|Overall Study||58
8233714|NCT01972204|20303883|P2|STARTED|Overall Study||63
8233715|NCT01972204|20303884|P1|STARTED|Overall Study||62
8233716|NCT01972152|20303896|P6|NOT COMPLETED|Third Treatment Visit||0
8233717|NCT01972152|20303897|P5|NOT COMPLETED|Third Treatment Visit||0
8233718|NCT01972152|20303898|P4|NOT COMPLETED|Third Treatment Visit||0
8233719|NCT01972152|20303899|P3|NOT COMPLETED|Third Treatment Visit||0
8233720|NCT01972152|20303900|P2|NOT COMPLETED|Third Treatment Visit||0
8233721|NCT01972152|20303901|P1|NOT COMPLETED|Third Treatment Visit||0
8233722|NCT01972152|20303896|P6|COMPLETED|Third Treatment Visit||5
8233723|NCT01972152|20303897|P5|COMPLETED|Third Treatment Visit||5
8233724|NCT01972152|20303898|P4|COMPLETED|Third Treatment Visit||5
8233725|NCT01972152|20303899|P3|COMPLETED|Third Treatment Visit||5
8233726|NCT01972152|20303900|P2|COMPLETED|Third Treatment Visit||3
8233727|NCT01972152|20303901|P1|COMPLETED|Third Treatment Visit||5
8233728|NCT01972152|20303896|P6|STARTED|Third Treatment Visit||5
8233729|NCT01972152|20303897|P5|STARTED|Third Treatment Visit||5
8233730|NCT01972152|20303898|P4|STARTED|Third Treatment Visit||5
8233731|NCT01972152|20303899|P3|STARTED|Third Treatment Visit||5
8233732|NCT01972152|20303900|P2|STARTED|Third Treatment Visit||3
8233733|NCT01972152|20303901|P1|STARTED|Third Treatment Visit||5
8233734|NCT01972152|20303896|P6|NOT COMPLETED|Second Treatment Visit||0
8233735|NCT01972152|20303897|P5|NOT COMPLETED|Second Treatment Visit||0
8233736|NCT01972152|20303898|P4|NOT COMPLETED|Second Treatment Visit||0
8233737|NCT01972152|20303899|P3|NOT COMPLETED|Second Treatment Visit||0
8233738|NCT01972152|20303900|P2|NOT COMPLETED|Second Treatment Visit||1
8233739|NCT01972152|20303901|P1|NOT COMPLETED|Second Treatment Visit||0
8233740|NCT01972152|20303896|P6|COMPLETED|Second Treatment Visit||5
8233741|NCT01972152|20303897|P5|COMPLETED|Second Treatment Visit||5
8233742|NCT01972152|20303898|P4|COMPLETED|Second Treatment Visit||5
8233743|NCT01972152|20303899|P3|COMPLETED|Second Treatment Visit||5
8233744|NCT01972152|20303900|P2|COMPLETED|Second Treatment Visit||3
8233745|NCT01972152|20303901|P1|COMPLETED|Second Treatment Visit||5
8233746|NCT01972152|20303896|P6|STARTED|Second Treatment Visit||5
8233747|NCT01972152|20303897|P5|STARTED|Second Treatment Visit||5
8233748|NCT01972152|20303898|P4|STARTED|Second Treatment Visit||5
8233749|NCT01972152|20303899|P3|STARTED|Second Treatment Visit||5
8233750|NCT01972152|20303900|P2|STARTED|Second Treatment Visit||4
8233751|NCT01972152|20303901|P1|STARTED|Second Treatment Visit||5
8233752|NCT01972152|20303896|P6|NOT COMPLETED|First Treatment Visit||0
8233753|NCT01972152|20303897|P5|NOT COMPLETED|First Treatment Visit||0
8233754|NCT01972152|20303898|P4|NOT COMPLETED|First Treatment Visit||0
8233755|NCT01972152|20303899|P3|NOT COMPLETED|First Treatment Visit||0
8233756|NCT01972152|20303900|P2|NOT COMPLETED|First Treatment Visit||1
8233757|NCT01972152|20303901|P1|NOT COMPLETED|First Treatment Visit||0
8233758|NCT01972152|20303896|P6|COMPLETED|First Treatment Visit||5
8233759|NCT01972152|20303897|P5|COMPLETED|First Treatment Visit||5
8233760|NCT01972152|20303898|P4|COMPLETED|First Treatment Visit||5
8233761|NCT01972152|20303899|P3|COMPLETED|First Treatment Visit||5
8233762|NCT01972152|20303900|P2|COMPLETED|First Treatment Visit||4
8233763|NCT01972152|20303901|P1|COMPLETED|First Treatment Visit||5
8233764|NCT01972152|20303896|P6|STARTED|First Treatment Visit||5
8233765|NCT01972152|20303897|P5|STARTED|First Treatment Visit||5
8233766|NCT01972152|20303898|P4|STARTED|First Treatment Visit||5
8233767|NCT01972152|20303899|P3|STARTED|First Treatment Visit||5
8233768|NCT01972152|20303900|P2|STARTED|First Treatment Visit||5
8233769|NCT01972152|20303901|P1|STARTED|First Treatment Visit||5
8233770|NCT01972074|20303939|P3|NOT COMPLETED|Overall Study||3
8233771|NCT01972074|20303940|P2|NOT COMPLETED|Overall Study||4
8233772|NCT01972074|20303941|P1|NOT COMPLETED|Overall Study||6
8233773|NCT01972074|20303939|P3|COMPLETED|Overall Study||15
8233774|NCT01972074|20303940|P2|COMPLETED|Overall Study||17
8233775|NCT01972074|20303941|P1|COMPLETED|Overall Study||16
8233776|NCT01972074|20303939|P3|STARTED|Overall Study||18
8233777|NCT01972074|20303940|P2|STARTED|Overall Study||21
8233778|NCT01972074|20303941|P1|STARTED|Overall Study||22
8233779|NCT01972061|20303951|P3|NOT COMPLETED|Overall Study||0
8233780|NCT01972061|20303952|P2|NOT COMPLETED|Overall Study||0
8233781|NCT01972061|20303953|P1|NOT COMPLETED|Overall Study||0
8233782|NCT01972061|20303951|P3|COMPLETED|Overall Study||20
8233783|NCT01972061|20303952|P2|COMPLETED|Overall Study||23
8233784|NCT01972061|20303953|P1|COMPLETED|Overall Study||1
8233785|NCT01972061|20303951|P3|STARTED|Overall Study||20
8233786|NCT01972061|20303952|P2|STARTED|Overall Study||23
8233787|NCT01972061|20303953|P1|STARTED|Overall Study||1
8233788|NCT01971853|20303967|P2|NOT COMPLETED|Overall Study||0
8233789|NCT01971853|20303968|P1|NOT COMPLETED|Overall Study||0
8233790|NCT01971853|20303967|P2|COMPLETED|Overall Study||0
8233791|NCT01971853|20303968|P1|COMPLETED|Overall Study||0
8233792|NCT01971853|20303967|P2|STARTED|Overall Study||0
8233793|NCT01971853|20303968|P1|STARTED|Overall Study||0
8233794|NCT01971723|20303986|P2|NOT COMPLETED|Overall Study||3
8233795|NCT01971723|20303987|P1|NOT COMPLETED|Overall Study||2
8233796|NCT01971723|20303986|P2|COMPLETED|Overall Study||13
8233797|NCT01971723|20303987|P1|COMPLETED|Overall Study||14
8233798|NCT01971723|20303986|P2|STARTED|Overall Study||16
8233799|NCT01971723|20303987|P1|STARTED|Overall Study||16
8233800|NCT01971645|20304020|P3|NOT COMPLETED|Overall Study||2
8233801|NCT01971645|20304021|P2|NOT COMPLETED|Overall Study||0
8233802|NCT01971645|20304022|P1|NOT COMPLETED|Overall Study||2
8233803|NCT01971645|20304020|P3|COMPLETED|Overall Study||23
8233804|NCT01971645|20304021|P2|COMPLETED|Overall Study||27
8233805|NCT01971645|20304022|P1|COMPLETED|Overall Study||23
8233806|NCT01971645|20304020|P3|STARTED|Overall Study||25
8233807|NCT01971645|20304021|P2|STARTED|Overall Study||27
8233808|NCT01971645|20304022|P1|STARTED|Overall Study||25
8233809|NCT01971593|20304033|P2|NOT COMPLETED|Overall Study||4
8233810|NCT01971593|20304034|P1|NOT COMPLETED|Overall Study||5
8233811|NCT01971593|20304033|P2|COMPLETED|Overall Study||8
8233812|NCT01971593|20304034|P1|COMPLETED|Overall Study||9
8233813|NCT01971593|20304033|P2|STARTED|Overall Study||12
8233814|NCT01971593|20304034|P1|STARTED|Overall Study||14
8233815|NCT01971580|20304045|P2|NOT COMPLETED|Overall Study||5
8233816|NCT01971580|20304046|P1|NOT COMPLETED|Overall Study||4
8233817|NCT01971580|20304045|P2|COMPLETED|Overall Study||9
8233818|NCT01971580|20304046|P1|COMPLETED|Overall Study||10
8233819|NCT01971580|20304045|P2|STARTED|Overall Study||14
8233820|NCT01971580|20304046|P1|STARTED|Overall Study||14
8233821|NCT01971567|20304056|P2|NOT COMPLETED|Overall Study||2
8233822|NCT01971567|20304057|P1|NOT COMPLETED|Overall Study||4
8233823|NCT01971567|20304056|P2|COMPLETED|Overall Study||49
8233824|NCT01971567|20304057|P1|COMPLETED|Overall Study||52
8233825|NCT01971567|20304056|P2|STARTED|Overall Study||51
8233826|NCT01971567|20304057|P1|STARTED|Overall Study||56
8233827|NCT01971554|20304083|P4|NOT COMPLETED|Overall Study||0
8233828|NCT01971554|20304084|P3|NOT COMPLETED|Overall Study||0
8233829|NCT01971554|20304085|P2|NOT COMPLETED|Overall Study||0
8233830|NCT01971554|20304086|P1|NOT COMPLETED|Overall Study||1
8233831|NCT01971554|20304083|P4|COMPLETED|Overall Study||18
8233832|NCT01971554|20304084|P3|COMPLETED|Overall Study||18
8233833|NCT01971554|20304085|P2|COMPLETED|Overall Study||18
8233834|NCT01971554|20304086|P1|COMPLETED|Overall Study||8
8233835|NCT01971554|20304083|P4|STARTED|Overall Study||18
8233836|NCT01971554|20304084|P3|STARTED|Overall Study||18
8233837|NCT01971554|20304085|P2|STARTED|Overall Study||18
8233838|NCT01971554|20304086|P1|STARTED|Overall Study||9
8233839|NCT01971476|20304123|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
8233840|NCT01971476|20304124|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
8233841|NCT01971476|20304125|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
8233842|NCT01971476|20304123|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
8233843|NCT01971476|20304124|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
8233844|NCT01971476|20304125|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
8233845|NCT01971476|20304123|P3|STARTED|Cohort 2: 12 to <18 Years||0
8233846|NCT01971476|20304124|P2|STARTED|Cohort 2: 12 to <18 Years||4
8233847|NCT01971476|20304125|P1|STARTED|Cohort 2: 12 to <18 Years||6
8233848|NCT01971476|20304123|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
8233849|NCT01971476|20304124|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
8233850|NCT01971476|20304125|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
8233851|NCT01971476|20304123|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
8233852|NCT01971476|20304124|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
8233853|NCT01971476|20304125|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
8233854|NCT01971476|20304123|P3|STARTED|Cohort 1: 2 to <12 Years||6
8233855|NCT01971476|20304124|P2|STARTED|Cohort 1: 2 to <12 Years||3
8233856|NCT01971476|20304125|P1|STARTED|Cohort 1: 2 to <12 Years||3
8233857|NCT01971463|20304202|P1|NOT COMPLETED|Overall Study||0
8233858|NCT01971463|20304202|P1|COMPLETED|Overall Study||81
8233859|NCT01971463|20304202|P1|STARTED|Overall Study||81
8233860|NCT01971385|20304210|P3|NOT COMPLETED|Overall Study||4
8233861|NCT01971385|20304211|P2|NOT COMPLETED|Overall Study||5
8233862|NCT01971385|20304212|P1|NOT COMPLETED|Overall Study||3
8233863|NCT01971385|20304210|P3|COMPLETED|Overall Study||15
8233864|NCT01971385|20304211|P2|COMPLETED|Overall Study||13
8233865|NCT01971385|20304212|P1|COMPLETED|Overall Study||14
8233866|NCT01971385|20304210|P3|STARTED|Overall Study||19
8233867|NCT01971385|20304211|P2|STARTED|Overall Study||18
8233868|NCT01971385|20304212|P1|STARTED|Overall Study||17
8233869|NCT01971346|20304219|P1|NOT COMPLETED|Overall Study||8
8233870|NCT01971346|20304219|P1|COMPLETED|Overall Study||42
8233871|NCT01971346|20304219|P1|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
8233872|NCT01971255|20304233|P2|NOT COMPLETED|Overall Study||2
8233873|NCT01971255|20304234|P1|NOT COMPLETED|Overall Study||1
8233874|NCT01971255|20304233|P2|COMPLETED|Overall Study||40
8233875|NCT01971255|20304234|P1|COMPLETED|Overall Study||31
8233876|NCT01971255|20304233|P2|STARTED|Overall Study||42
8233877|NCT01971255|20304234|P1|STARTED|Overall Study||32
8233878|NCT01971203|20304252|P2|NOT COMPLETED|Overall Study||8
8233879|NCT01971203|20304253|P1|NOT COMPLETED|Overall Study||9
8233880|NCT01971203|20304252|P2|COMPLETED|Overall Study||21
8233881|NCT01971203|20304253|P1|COMPLETED|Overall Study||17
8233882|NCT01971203|20304252|P2|STARTED|Overall Study||29
8233883|NCT01971203|20304253|P1|STARTED|Overall Study||26
8233884|NCT01971086|20304265|P1|NOT COMPLETED|Overall Study||0
8233885|NCT01971086|20304265|P1|COMPLETED|Overall Study||300
8233886|NCT01971086|20304265|P1|STARTED|Overall Study||300
8233887|NCT01970995|20304280|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
8233888|NCT01970995|20304281|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
8233889|NCT01970995|20304282|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
8233890|NCT01970995|20304280|P3|COMPLETED|End of Study (Population at Day 90)||38
8233891|NCT01970995|20304281|P2|COMPLETED|End of Study (Population at Day 90)||41
8233892|NCT01970995|20304282|P1|COMPLETED|End of Study (Population at Day 90)||76
8233893|NCT01970995|20304280|P3|STARTED|End of Study (Population at Day 90)||39
8233894|NCT01970995|20304281|P2|STARTED|End of Study (Population at Day 90)||41
8233895|NCT01970995|20304282|P1|STARTED|End of Study (Population at Day 90)||77
8233896|NCT01970995|20304280|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8233897|NCT01970995|20304281|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8233898|NCT01970995|20304282|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8233899|NCT01970995|20304280|P3|COMPLETED|Confinement Period (Population at Day 5)||39
8233900|NCT01970995|20304281|P2|COMPLETED|Confinement Period (Population at Day 5)||41
8233901|NCT01970995|20304282|P1|COMPLETED|Confinement Period (Population at Day 5)||77
8233902|NCT01970995|20304280|P3|STARTED|Confinement Period (Population at Day 5)||40
8233903|NCT01970995|20304281|P2|STARTED|Confinement Period (Population at Day 5)||42
8233904|NCT01970995|20304282|P1|STARTED|Confinement Period (Population at Day 5)||78
8233905|NCT01970982|20304305|P3|NOT COMPLETED|Overall Study||2
8233906|NCT01970982|20304306|P2|NOT COMPLETED|Overall Study||0
8233907|NCT01970982|20304307|P1|NOT COMPLETED|Overall Study||0
8233908|NCT01970982|20304305|P3|COMPLETED|Overall Study||38
8233909|NCT01970982|20304306|P2|COMPLETED|Overall Study||40
8233910|NCT01970982|20304307|P1|COMPLETED|Overall Study||80
8233911|NCT01970982|20304305|P3|STARTED|Overall Study||40
8233912|NCT01970982|20304306|P2|STARTED|Overall Study||40
8233913|NCT01970982|20304307|P1|STARTED|Overall Study||80
8233914|NCT01970943|20304325|P2|NOT COMPLETED|Overall Study||1
8233915|NCT01970943|20304326|P1|NOT COMPLETED|Overall Study||3
8233916|NCT01970943|20304325|P2|COMPLETED|Overall Study||11
8233917|NCT01970943|20304326|P1|COMPLETED|Overall Study||8
8233918|NCT01970943|20304325|P2|STARTED|Overall Study||12
8233919|NCT01970943|20304326|P1|STARTED|Overall Study||11
8233920|NCT01970878|20304342|P4|NOT COMPLETED|Overall Study||24
8233921|NCT01970878|20304343|P3|NOT COMPLETED|Overall Study||26
8233922|NCT01970878|20304344|P2|NOT COMPLETED|Overall Study||27
8233923|NCT01970878|20304345|P1|NOT COMPLETED|Overall Study||37
8233924|NCT01970878|20304342|P4|COMPLETED|Overall Study||147
8233925|NCT01970878|20304343|P3|COMPLETED|Overall Study||187
8233926|NCT01970878|20304344|P2|COMPLETED|Overall Study||191
8233927|NCT01970878|20304345|P1|COMPLETED|Overall Study||253
8233928|NCT01970878|20304342|P4|STARTED|Overall Study||171
8233929|NCT01970878|20304343|P3|STARTED|Overall Study||213
8233930|NCT01970878|20304344|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
8233931|NCT01970878|20304345|P1|STARTED|Overall Study||290
8234000|NCT01970787|20304828|P1|NOT COMPLETED|Overall Study||1
8234001|NCT01970787|20304828|P1|COMPLETED|Overall Study||21
8234002|NCT01970787|20304828|P1|STARTED|Overall Study||22
8234003|NCT01970592|20304836|P1|NOT COMPLETED|Overall Study||6
8234004|NCT01970592|20304836|P1|COMPLETED|Overall Study||50
8234005|NCT01970592|20304836|P1|STARTED|Overall Study|Completed all training sessions|56
8234006|NCT01970540|20304844|P3|NOT COMPLETED|Overall Study||19
8234007|NCT01970540|20304845|P2|NOT COMPLETED|Overall Study||28
8234008|NCT01970540|20304846|P1|NOT COMPLETED|Overall Study||73
8234009|NCT01970540|20304844|P3|COMPLETED|Overall Study||0
8234010|NCT01970540|20304845|P2|COMPLETED|Overall Study||0
8234011|NCT01970540|20304846|P1|COMPLETED|Overall Study||0
8234012|NCT01970540|20304844|P3|STARTED|Overall Study||19
8234013|NCT01970540|20304845|P2|STARTED|Overall Study||28
8234014|NCT01970540|20304846|P1|STARTED|Overall Study||73
8234015|NCT01970527|20304877|P2|NOT COMPLETED|Follow-up Clinic Visit||3
8234016|NCT01970527|20304878|P1|NOT COMPLETED|Follow-up Clinic Visit||1
8234017|NCT01970527|20304877|P2|COMPLETED|Follow-up Clinic Visit||8
8234018|NCT01970527|20304878|P1|COMPLETED|Follow-up Clinic Visit||7
8234019|NCT01970527|20304877|P2|STARTED|Follow-up Clinic Visit||11
8234020|NCT01970527|20304878|P1|STARTED|Follow-up Clinic Visit||8
8234021|NCT01970527|20304877|P2|NOT COMPLETED|Treatment||3
8234022|NCT01970527|20304878|P1|NOT COMPLETED|Treatment||0
8234023|NCT01970527|20304877|P2|COMPLETED|Treatment||11
8234024|NCT01970527|20304878|P1|COMPLETED|Treatment||8
8234025|NCT01970527|20304877|P2|STARTED|Treatment||14
8234026|NCT01970527|20304878|P1|STARTED|Treatment||8
8234027|NCT01970527|20304877|P2|NOT COMPLETED|Pre-treatment/Baseline||0
8234028|NCT01970527|20304878|P1|NOT COMPLETED|Pre-treatment/Baseline||1
8234029|NCT01970527|20304877|P2|COMPLETED|Pre-treatment/Baseline||14
8234030|NCT01970527|20304878|P1|COMPLETED|Pre-treatment/Baseline||8
8234031|NCT01970527|20304877|P2|STARTED|Pre-treatment/Baseline||14
8234032|NCT01970527|20304878|P1|STARTED|Pre-treatment/Baseline||9
8234033|NCT01970488|20304891|P5|NOT COMPLETED|Part 2: Post Week 16||8
8234034|NCT01970488|20304892|P4|NOT COMPLETED|Part 2: Post Week 16||8
8234035|NCT01970488|20304893|P3|NOT COMPLETED|Part 2: Post Week 16||17
8234036|NCT01970488|20304894|P2|NOT COMPLETED|Part 2: Post Week 16||0
8234037|NCT01970488|20304895|P1|NOT COMPLETED|Part 2: Post Week 16||0
8234038|NCT01970488|20304891|P5|COMPLETED|Part 2: Post Week 16||69
8234039|NCT01970488|20304892|P4|COMPLETED|Part 2: Post Week 16||71
8234040|NCT01970488|20304893|P3|COMPLETED|Part 2: Post Week 16||135
8234041|NCT01970488|20304894|P2|COMPLETED|Part 2: Post Week 16||0
8234042|NCT01970488|20304895|P1|COMPLETED|Part 2: Post Week 16||0
8234043|NCT01970488|20304891|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
8234044|NCT01970488|20304892|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
8234045|NCT01970488|20304893|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
8234046|NCT01970488|20304894|P2|STARTED|Part 2: Post Week 16||0
8234047|NCT01970488|20304895|P1|STARTED|Part 2: Post Week 16||0
8234048|NCT01970488|20304891|P5|NOT COMPLETED|Part 1: Through Week 16||0
8234049|NCT01970488|20304892|P4|NOT COMPLETED|Part 1: Through Week 16||0
8234050|NCT01970488|20304893|P3|NOT COMPLETED|Part 1: Through Week 16||0
8234051|NCT01970488|20304894|P2|NOT COMPLETED|Part 1: Through Week 16||13
8234052|NCT01970488|20304895|P1|NOT COMPLETED|Part 1: Through Week 16||11
8234053|NCT01970488|20304891|P5|COMPLETED|Part 1: Through Week 16||0
8234054|NCT01970488|20304892|P4|COMPLETED|Part 1: Through Week 16||0
8234055|NCT01970488|20304893|P3|COMPLETED|Part 1: Through Week 16||0
8234056|NCT01970488|20304894|P2|COMPLETED|Part 1: Through Week 16||162
8234057|NCT01970488|20304895|P1|COMPLETED|Part 1: Through Week 16||164
8234058|NCT01970488|20304891|P5|Received Treatment|Part 1: Through Week 16||0
8234059|NCT01970488|20304892|P4|Received Treatment|Part 1: Through Week 16||0
8234060|NCT01970488|20304893|P3|Received Treatment|Part 1: Through Week 16||0
8234061|NCT01970488|20304894|P2|Received Treatment|Part 1: Through Week 16||173
8234062|NCT01970488|20304895|P1|Received Treatment|Part 1: Through Week 16||174
8234063|NCT01970488|20304891|P5|STARTED|Part 1: Through Week 16||0
8234064|NCT01970488|20304892|P4|STARTED|Part 1: Through Week 16||0
8234065|NCT01970488|20304893|P3|STARTED|Part 1: Through Week 16||0
8234066|NCT01970488|20304894|P2|STARTED|Part 1: Through Week 16||175
8234067|NCT01970488|20304895|P1|STARTED|Part 1: Through Week 16||175
8234068|NCT01970475|20304962|P2|NOT COMPLETED|Overall Study||11
8234069|NCT01970475|20304963|P1|NOT COMPLETED|Overall Study||21
8234070|NCT01970475|20304962|P2|COMPLETED|Overall Study||251
8234071|NCT01970475|20304963|P1|COMPLETED|Overall Study||243
8234072|NCT01970475|20304962|P2|STARTED|Overall Study||262
8234073|NCT01970475|20304963|P1|STARTED|Overall Study||264
8234074|NCT01970462|20304983|P2|NOT COMPLETED|Overall Study||2
8234075|NCT01970462|20304984|P1|NOT COMPLETED|Overall Study||0
8234076|NCT01970462|20304983|P2|COMPLETED|Overall Study||2
8234077|NCT01970462|20304984|P1|COMPLETED|Overall Study||1
8234078|NCT01970462|20304983|P2|STARTED|Overall Study||4
8234079|NCT01970462|20304984|P1|STARTED|Overall Study||1
8234080|NCT01970397|20304998|P2|NOT COMPLETED|Overall Study||5
8234081|NCT01970397|20304999|P1|NOT COMPLETED|Overall Study||2
8234082|NCT01970397|20304998|P2|COMPLETED|Overall Study||64
8234083|NCT01970397|20304999|P1|COMPLETED|Overall Study||67
8234084|NCT01970397|20304998|P2|STARTED|Overall Study||69
8234085|NCT01970397|20304999|P1|STARTED|Overall Study||69
8234086|NCT01970371|20305012|P3|NOT COMPLETED|Overall Study||13
8234087|NCT01970371|20305013|P2|NOT COMPLETED|Overall Study||13
8234088|NCT01970371|20305014|P1|NOT COMPLETED|Overall Study||8
8234089|NCT01970371|20305012|P3|COMPLETED|Overall Study||17
8234090|NCT01970371|20305013|P2|COMPLETED|Overall Study||8
8234091|NCT01970371|20305014|P1|COMPLETED|Overall Study||10
8234092|NCT01970371|20305012|P3|STARTED|Overall Study||30
8234093|NCT01970371|20305013|P2|STARTED|Overall Study||21
8234094|NCT01970371|20305014|P1|STARTED|Overall Study||18
8234095|NCT01970241|20305039|P2|NOT COMPLETED|Overall Study||8
8234096|NCT01970241|20305040|P1|NOT COMPLETED|Overall Study||17
8234097|NCT01970241|20305039|P2|COMPLETED|Overall Study||31
8234098|NCT01970241|20305040|P1|COMPLETED|Overall Study||29
8234099|NCT01970241|20305039|P2|STARTED|Overall Study||39
8234100|NCT01970241|20305040|P1|STARTED|Overall Study||46
8234101|NCT01970176|20305082|P2|NOT COMPLETED|Overall Study||0
8234102|NCT01970176|20305083|P1|NOT COMPLETED|Overall Study||0
8234103|NCT01970176|20305082|P2|COMPLETED|Overall Study||6
8234104|NCT01970176|20305083|P1|COMPLETED|Overall Study||14
8234105|NCT01970176|20305082|P2|STARTED|Overall Study||6
8234106|NCT01970176|20305083|P1|STARTED|Overall Study||14
8234110|NCT01969851|20305100|P3|NOT COMPLETED|Overall Study||7
8234111|NCT01969851|20305101|P2|NOT COMPLETED|Overall Study||3
8234112|NCT01969851|20305102|P1|NOT COMPLETED|Overall Study||1
8234113|NCT01969851|20305100|P3|COMPLETED|Overall Study||14
8234114|NCT01969851|20305101|P2|COMPLETED|Overall Study||21
8234115|NCT01969851|20305102|P1|COMPLETED|Overall Study||9
8234116|NCT01969851|20305100|P3|STARTED|Overall Study||21
8234117|NCT01969851|20305101|P2|STARTED|Overall Study||24
8234118|NCT01969851|20305102|P1|STARTED|Overall Study||10
8234119|NCT01969799|20305124|P2|NOT COMPLETED|Overall Study||14
8234120|NCT01969799|20305125|P1|NOT COMPLETED|Overall Study||17
8234121|NCT01969799|20305124|P2|COMPLETED|Overall Study||58
8234122|NCT01969799|20305125|P1|COMPLETED|Overall Study||54
8234123|NCT01969799|20305124|P2|STARTED|Overall Study||72
8234124|NCT01969799|20305125|P1|STARTED|Overall Study||71
8234125|NCT01969747|20305149|P4|NOT COMPLETED|Overall Study||0
8234126|NCT01969747|20305150|P3|NOT COMPLETED|Overall Study||0
8234127|NCT01969747|20305151|P2|NOT COMPLETED|Overall Study||0
8234128|NCT01969747|20305152|P1|NOT COMPLETED|Overall Study||0
8234129|NCT01969747|20305149|P4|COMPLETED|Overall Study||18
8234130|NCT01969747|20305150|P3|COMPLETED|Overall Study||19
8234131|NCT01969747|20305151|P2|COMPLETED|Overall Study||19
8234132|NCT01969747|20305152|P1|COMPLETED|Overall Study||19
8234133|NCT01969747|20305149|P4|STARTED|Overall Study||18
8234134|NCT01969747|20305150|P3|STARTED|Overall Study||19
8234135|NCT01969747|20305151|P2|STARTED|Overall Study||19
8234136|NCT01969747|20305152|P1|STARTED|Overall Study||19
8234137|NCT01969721|20305162|P4|NOT COMPLETED|Overall Study||6
8234138|NCT01969721|20305163|P3|NOT COMPLETED|Overall Study||5
8234139|NCT01969721|20305164|P2|NOT COMPLETED|Overall Study||12
8234140|NCT01969721|20305165|P1|NOT COMPLETED|Overall Study||4
8234141|NCT01969721|20305162|P4|COMPLETED|Overall Study||46
8234142|NCT01969721|20305163|P3|COMPLETED|Overall Study||45
8234143|NCT01969721|20305164|P2|COMPLETED|Overall Study||57
8234144|NCT01969721|20305165|P1|COMPLETED|Overall Study||54
8234145|NCT01969721|20305162|P4|STARTED|Overall Study||52
8234146|NCT01969721|20305163|P3|STARTED|Overall Study||50
8234147|NCT01969721|20305164|P2|STARTED|Overall Study||69
8234148|NCT01969721|20305165|P1|STARTED|Overall Study||58
8234149|NCT01969708|20305193|P2|NOT COMPLETED|Overall Study||9
8234150|NCT01969708|20305194|P1|NOT COMPLETED|Overall Study||5
8234151|NCT01969708|20305193|P2|COMPLETED|Overall Study||173
8234152|NCT01969708|20305194|P1|COMPLETED|Overall Study||175
8234153|NCT01969708|20305193|P2|STARTED|Overall Study||182
8234154|NCT01969708|20305194|P1|STARTED|Overall Study||180
8234155|NCT01969565|20305210|P1|NOT COMPLETED|Overall Study||1
8234156|NCT01969565|20305210|P1|COMPLETED|Overall Study||0
8234157|NCT01969565|20305210|P1|STARTED|Overall Study||1
8234158|NCT01969539|20305216|P1|NOT COMPLETED|Overall Study||0
8234159|NCT01969539|20305216|P1|COMPLETED|Overall Study||11
8234160|NCT01969539|20305216|P1|STARTED|Overall Study||11
8234161|NCT01969500|20305224|P2|NOT COMPLETED|Overall Study||2
8234162|NCT01969500|20305225|P1|NOT COMPLETED|Overall Study||1
8234163|NCT01969500|20305224|P2|COMPLETED|Overall Study||24
8234164|NCT01969500|20305225|P1|COMPLETED|Overall Study||24
8234165|NCT01969500|20305224|P2|STARTED|Overall Study||26
8234166|NCT01969500|20305225|P1|STARTED|Overall Study||25
8234167|NCT01969448|20305240|P3|NOT COMPLETED|Overall Study||0
8234168|NCT01969448|20305241|P2|NOT COMPLETED|Overall Study||0
8234169|NCT01969448|20305242|P1|NOT COMPLETED|Overall Study||0
8234170|NCT01969448|20305240|P3|COMPLETED|Overall Study||0
8234171|NCT01969448|20305241|P2|COMPLETED|Overall Study||24
8234172|NCT01969448|20305242|P1|COMPLETED|Overall Study||55
8234173|NCT01969448|20305240|P3|STARTED|Overall Study||0
8234174|NCT01969448|20305241|P2|STARTED|Overall Study||24
8234175|NCT01969448|20305242|P1|STARTED|Overall Study||55
8234176|NCT01969435|20305265|P1|NOT COMPLETED|Overall Study||0
8234177|NCT01969435|20305265|P1|COMPLETED|Overall Study||50
8234178|NCT01969435|20305265|P1|STARTED|Overall Study||50
8234179|NCT01969240|20305281|P2|NOT COMPLETED|Overall Study||0
8234180|NCT01969240|20305282|P1|NOT COMPLETED|Overall Study||0
8234181|NCT01969240|20305281|P2|COMPLETED|Overall Study||447
8234182|NCT01969240|20305282|P1|COMPLETED|Overall Study||451
8234183|NCT01969240|20305281|P2|STARTED|Overall Study||447
8234184|NCT01969240|20305282|P1|STARTED|Overall Study||451
8234185|NCT01969214|20305300|P1|NOT COMPLETED|Overall Study||15
8234186|NCT01969214|20305300|P1|COMPLETED|Overall Study||86
8234187|NCT01969214|20305300|P1|STARTED|Overall Study||101
8234188|NCT01969201|20305319|P2|NOT COMPLETED|Overall Study||45
8234189|NCT01969201|20305320|P1|NOT COMPLETED|Overall Study||45
8234190|NCT01969201|20305319|P2|COMPLETED|Overall Study||313
8234191|NCT01969201|20305320|P1|COMPLETED|Overall Study||307
8234192|NCT01969201|20305319|P2|STARTED|Overall Study||358
8234193|NCT01969201|20305320|P1|STARTED|Overall Study||352
8234194|NCT01969162|20305340|P1|NOT COMPLETED|Overall Study||0
8234195|NCT01969162|20305340|P1|COMPLETED|Overall Study||35
8234196|NCT01969162|20305340|P1|STARTED|Overall Study||35
8234197|NCT01969084|20305346|P2|NOT COMPLETED|Overall Study||1
8234198|NCT01969084|20305347|P1|NOT COMPLETED|Overall Study||0
8234199|NCT01969084|20305346|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
8234200|NCT01969084|20305347|P1|COMPLETED|Overall Study||19
8234201|NCT01969084|20305346|P2|STARTED|Overall Study||22
8234202|NCT01969084|20305347|P1|STARTED|Overall Study||19
8234203|NCT01969058|20305363|P2|NOT COMPLETED|Overall Study||0
8234204|NCT01969058|20305364|P1|NOT COMPLETED|Overall Study||3
8234205|NCT01969058|20305363|P2|COMPLETED|Overall Study||26
8234206|NCT01969058|20305364|P1|COMPLETED|Overall Study||47
8234207|NCT01969058|20305363|P2|STARTED|Overall Study||26
8234208|NCT01969058|20305364|P1|STARTED|Overall Study||50
8234209|NCT01968980|20305408|P2|NOT COMPLETED|Overall Study||14
8234210|NCT01968980|20305409|P1|NOT COMPLETED|Overall Study||16
8234211|NCT01968980|20305408|P2|COMPLETED|Overall Study||171
8234212|NCT01968980|20305409|P1|COMPLETED|Overall Study||169
8234213|NCT01968980|20305408|P2|STARTED|Overall Study||185
8234214|NCT01968980|20305409|P1|STARTED|Overall Study||185
8234215|NCT01968967|20305471|P5|NOT COMPLETED|Extension Period||5
8234216|NCT01968967|20305472|P4|NOT COMPLETED|Extension Period||0
8234217|NCT01968967|20305473|P3|NOT COMPLETED|Extension Period||2
8234218|NCT01968967|20305474|P2|NOT COMPLETED|Extension Period||0
8234219|NCT01968967|20305475|P1|NOT COMPLETED|Extension Period||0
8234220|NCT01968967|20305471|P5|COMPLETED|Extension Period||34
8234221|NCT01968967|20305472|P4|COMPLETED|Extension Period||19
8234222|NCT01968967|20305473|P3|COMPLETED|Extension Period||45
8234223|NCT01968967|20305474|P2|COMPLETED|Extension Period||0
8234224|NCT01968967|20305475|P1|COMPLETED|Extension Period||0
8234225|NCT01968967|20305471|P5|STARTED|Extension Period||39
8234226|NCT01968967|20305472|P4|STARTED|Extension Period||19
8234227|NCT01968967|20305473|P3|STARTED|Extension Period||47
8234228|NCT01968967|20305474|P2|STARTED|Extension Period||0
8234229|NCT01968967|20305475|P1|STARTED|Extension Period||0
8234230|NCT01968967|20305471|P5|NOT COMPLETED|Treatment Period||0
8234231|NCT01968967|20305472|P4|NOT COMPLETED|Treatment Period||0
8234232|NCT01968967|20305473|P3|NOT COMPLETED|Treatment Period||0
8234233|NCT01968967|20305474|P2|NOT COMPLETED|Treatment Period||134
8234234|NCT01968967|20305475|P1|NOT COMPLETED|Treatment Period||146
8234235|NCT01968967|20305471|P5|COMPLETED|Treatment Period||0
8234236|NCT01968967|20305472|P4|COMPLETED|Treatment Period||0
8234237|NCT01968967|20305473|P3|COMPLETED|Treatment Period||0
8234238|NCT01968967|20305474|P2|COMPLETED|Treatment Period||934
8234239|NCT01968967|20305475|P1|COMPLETED|Treatment Period||925
8234240|NCT01968967|20305471|P5|Treated|Treatment Period||0
8234241|NCT01968967|20305472|P4|Treated|Treatment Period||0
8234242|NCT01968967|20305473|P3|Treated|Treatment Period||0
8234243|NCT01968967|20305474|P2|Treated|Treatment Period||1063
8234244|NCT01968967|20305475|P1|Treated|Treatment Period||1065
8234245|NCT01968967|20305471|P5|STARTED|Treatment Period||0
8234246|NCT01968967|20305472|P4|STARTED|Treatment Period||0
8234247|NCT01968967|20305473|P3|STARTED|Treatment Period||0
8234248|NCT01968967|20305474|P2|STARTED|Treatment Period||1068
8234249|NCT01968967|20305475|P1|STARTED|Treatment Period||1071
8234250|NCT01968954|20305544|P2|NOT COMPLETED|Overall Study||43
8234251|NCT01968954|20305545|P1|NOT COMPLETED|Overall Study||40
8234252|NCT01968954|20305544|P2|COMPLETED|Overall Study||314
8234253|NCT01968954|20305545|P1|COMPLETED|Overall Study||314
8234254|NCT01968954|20305544|P2|Treated|Overall Study||356
8234255|NCT01968954|20305545|P1|Treated|Overall Study||353
8234256|NCT01968954|20305544|P2|STARTED|Overall Study||357
8234257|NCT01968954|20305545|P1|STARTED|Overall Study||354
8234258|NCT01968811|20305609|P1|NOT COMPLETED|Overall Study||5
8234259|NCT01968811|20305609|P1|COMPLETED|Overall Study||5
8234260|NCT01968811|20305609|P1|STARTED|Overall Study||10
8234261|NCT01968694|20305616|P2|NOT COMPLETED|Visit 2 (1 Day)||0
8234262|NCT01968694|20305617|P1|NOT COMPLETED|Visit 2 (1 Day)||0
8234263|NCT01968694|20305616|P2|COMPLETED|Visit 2 (1 Day)||8
8234264|NCT01968694|20305617|P1|COMPLETED|Visit 2 (1 Day)||10
8234265|NCT01968694|20305616|P2|STARTED|Visit 2 (1 Day)||8
8234266|NCT01968694|20305617|P1|STARTED|Visit 2 (1 Day)||10
8234267|NCT01968694|20305616|P2|NOT COMPLETED|Washout (1 Month)||1
8234268|NCT01968694|20305617|P1|NOT COMPLETED|Washout (1 Month)||0
8234269|NCT01968694|20305616|P2|COMPLETED|Washout (1 Month)||8
8234270|NCT01968694|20305617|P1|COMPLETED|Washout (1 Month)||10
8234271|NCT01968694|20305616|P2|STARTED|Washout (1 Month)||9
8234272|NCT01968694|20305617|P1|STARTED|Washout (1 Month)||10
8234273|NCT01968694|20305616|P2|NOT COMPLETED|Visit 1 (1 Day)||0
8234274|NCT01968694|20305617|P1|NOT COMPLETED|Visit 1 (1 Day)||0
8234275|NCT01968694|20305616|P2|COMPLETED|Visit 1 (1 Day)||9
8234276|NCT01968694|20305617|P1|COMPLETED|Visit 1 (1 Day)||10
8234277|NCT01968694|20305616|P2|STARTED|Visit 1 (1 Day)||9
8234278|NCT01968694|20305617|P1|STARTED|Visit 1 (1 Day)||10
8234279|NCT01968551|20305634|P3|NOT COMPLETED|Extension Phase||4
8234280|NCT01968551|20305635|P2|NOT COMPLETED|Extension Phase||1
8234281|NCT01968551|20305636|P1|NOT COMPLETED|Extension Phase||1
8234282|NCT01968551|20305634|P3|COMPLETED|Extension Phase||30
8234283|NCT01968551|20305635|P2|COMPLETED|Extension Phase||86
8234284|NCT01968551|20305636|P1|COMPLETED|Extension Phase||19
8234285|NCT01968551|20305634|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
8234286|NCT01968551|20305635|P2|STARTED|Extension Phase||87
8234287|NCT01968551|20305636|P1|STARTED|Extension Phase||20
8234288|NCT01968551|20305634|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
8234289|NCT01968551|20305635|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
8234290|NCT01968551|20305636|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
8234291|NCT01968551|20305634|P3|COMPLETED|Open Label Phase (48 Weeks)||41
8234292|NCT01968551|20305635|P2|COMPLETED|Open Label Phase (48 Weeks)||87
8234293|NCT01968551|20305636|P1|COMPLETED|Open Label Phase (48 Weeks)||20
8234294|NCT01968551|20305634|P3|STARTED|Open Label Phase (48 Weeks)||46
8234295|NCT01968551|20305635|P2|STARTED|Open Label Phase (48 Weeks)||90
8234296|NCT01968551|20305636|P1|STARTED|Open Label Phase (48 Weeks)||22
8234297|NCT01968447|20305652|P2|NOT COMPLETED|Overall Study||0
8234298|NCT01968447|20305653|P1|NOT COMPLETED|Overall Study||0
8234299|NCT01968447|20305652|P2|COMPLETED|Overall Study||20
8234300|NCT01968447|20305653|P1|COMPLETED|Overall Study||20
8234301|NCT01968447|20305652|P2|STARTED|Overall Study||20
8234302|NCT01968447|20305653|P1|STARTED|Overall Study||20
8234303|NCT01968434|20305673|P2|NOT COMPLETED|Overall Study||6
8234304|NCT01968434|20305674|P1|NOT COMPLETED|Overall Study||3
8234305|NCT01968434|20305673|P2|COMPLETED|Overall Study||66
8234306|NCT01968434|20305674|P1|COMPLETED|Overall Study||75
8234307|NCT01968434|20305673|P2|STARTED|Overall Study||72
8234308|NCT01968434|20305674|P1|STARTED|Overall Study||78
8234309|NCT01968421|20305686|P2|NOT COMPLETED|Overall Study||0
8234310|NCT01968421|20305687|P1|NOT COMPLETED|Overall Study||0
8234311|NCT01968421|20305686|P2|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
8234312|NCT01968421|20305687|P1|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
8234313|NCT01968421|20305686|P2|Starting Trial|Overall Study||97
8234314|NCT01968421|20305687|P1|Starting Trial|Overall Study||99
8234315|NCT01968421|20305686|P2|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
8234316|NCT01968421|20305687|P1|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
8234317|NCT01968382|20305696|P3|NOT COMPLETED|Overall Study||0
8234318|NCT01968382|20305697|P2|NOT COMPLETED|Overall Study||0
8234319|NCT01968382|20305698|P1|NOT COMPLETED|Overall Study||0
8234320|NCT01968382|20305696|P3|COMPLETED|Overall Study||20
8234321|NCT01968382|20305697|P2|COMPLETED|Overall Study||19
8234322|NCT01968382|20305698|P1|COMPLETED|Overall Study||18
8234323|NCT01968382|20305696|P3|STARTED|Overall Study||20
8234324|NCT01968382|20305697|P2|STARTED|Overall Study||19
8234325|NCT01968382|20305698|P1|STARTED|Overall Study||18
8234326|NCT01968226|20305742|P1|NOT COMPLETED|Overall Study||2
8234327|NCT01968226|20305742|P1|COMPLETED|Overall Study||1
8234328|NCT01968226|20305742|P1|STARTED|Overall Study||3
8234329|NCT01968213|20305748|P2|NOT COMPLETED|Overall Study||9
8234330|NCT01968213|20305749|P1|NOT COMPLETED|Overall Study||90
8234331|NCT01968213|20305748|P2|COMPLETED|Overall Study||180
8234332|NCT01968213|20305749|P1|COMPLETED|Overall Study||285
8234333|NCT01968213|20305748|P2|STARTED|Overall Study||189
8234334|NCT01968213|20305749|P1|STARTED|Overall Study||375
8234335|NCT01968135|20305760|P2|NOT COMPLETED|Overall Study||0
8234336|NCT01968135|20305761|P1|NOT COMPLETED|Overall Study||0
8234337|NCT01968135|20305760|P2|COMPLETED|Overall Study||16
8234338|NCT01968135|20305761|P1|COMPLETED|Overall Study||16
8234339|NCT01968135|20305760|P2|STARTED|Overall Study||16
8234340|NCT01968135|20305761|P1|STARTED|Overall Study||16
8234341|NCT01968070|20305791|P18|NOT COMPLETED|Period 3||0
8234342|NCT01968070|20305792|P17|NOT COMPLETED|Period 3||0
8234343|NCT01968070|20305793|P16|NOT COMPLETED|Period 3||0
8234344|NCT01968070|20305794|P15|NOT COMPLETED|Period 3||0
8234345|NCT01968070|20305795|P14|NOT COMPLETED|Period 3||0
8234346|NCT01968070|20305796|P13|NOT COMPLETED|Period 3||0
8234347|NCT01968070|20305797|P12|NOT COMPLETED|Period 3||0
8234348|NCT01968070|20305798|P11|NOT COMPLETED|Period 3||0
8234349|NCT01968070|20305799|P10|NOT COMPLETED|Period 3||0
8234350|NCT01968070|20305800|P9|NOT COMPLETED|Period 3||0
8234351|NCT01968070|20305801|P8|NOT COMPLETED|Period 3||0
8234352|NCT01968070|20305802|P7|NOT COMPLETED|Period 3||0
8234353|NCT01968070|20305803|P6|NOT COMPLETED|Period 3||0
8234354|NCT01968070|20305804|P5|NOT COMPLETED|Period 3||0
8234355|NCT01968070|20305805|P4|NOT COMPLETED|Period 3||0
8234356|NCT01968070|20305806|P3|NOT COMPLETED|Period 3||0
8234357|NCT01968070|20305807|P2|NOT COMPLETED|Period 3||0
8234358|NCT01968070|20305808|P1|NOT COMPLETED|Period 3||0
8234359|NCT01968070|20305791|P18|COMPLETED|Period 3||0
8234360|NCT01968070|20305792|P17|COMPLETED|Period 3||0
8234361|NCT01968070|20305793|P16|COMPLETED|Period 3||0
8234362|NCT01968070|20305794|P15|COMPLETED|Period 3||0
8234363|NCT01968070|20305795|P14|COMPLETED|Period 3||0
8234364|NCT01968070|20305796|P13|COMPLETED|Period 3||0
8234365|NCT01968070|20305797|P12|COMPLETED|Period 3||0
8234366|NCT01968070|20305798|P11|COMPLETED|Period 3||0
8234367|NCT01968070|20305799|P10|COMPLETED|Period 3||0
8234368|NCT01968070|20305800|P9|COMPLETED|Period 3||0
8234369|NCT01968070|20305801|P8|COMPLETED|Period 3||0
8234370|NCT01968070|20305802|P7|COMPLETED|Period 3||0
8234371|NCT01968070|20305803|P6|COMPLETED|Period 3||4
8234372|NCT01968070|20305804|P5|COMPLETED|Period 3||3
8234373|NCT01968070|20305805|P4|COMPLETED|Period 3||4
8234374|NCT01968070|20305806|P3|COMPLETED|Period 3||4
8234375|NCT01968070|20305807|P2|COMPLETED|Period 3||4
8234376|NCT01968070|20305808|P1|COMPLETED|Period 3||4
8234377|NCT01968070|20305791|P18|STARTED|Period 3||0
8234378|NCT01968070|20305792|P17|STARTED|Period 3||0
8234379|NCT01968070|20305793|P16|STARTED|Period 3||0
8234380|NCT01968070|20305794|P15|STARTED|Period 3||0
8234381|NCT01968070|20305795|P14|STARTED|Period 3||0
8234382|NCT01968070|20305796|P13|STARTED|Period 3||0
8234383|NCT01968070|20305797|P12|STARTED|Period 3||0
8234384|NCT01968070|20305798|P11|STARTED|Period 3||0
8234385|NCT01968070|20305799|P10|STARTED|Period 3||0
8234386|NCT01968070|20305800|P9|STARTED|Period 3||0
8234387|NCT01968070|20305801|P8|STARTED|Period 3||0
8234388|NCT01968070|20305802|P7|STARTED|Period 3||0
8234389|NCT01968070|20305803|P6|STARTED|Period 3||4
8234390|NCT01968070|20305804|P5|STARTED|Period 3||3
8234391|NCT01968070|20305805|P4|STARTED|Period 3||4
8234392|NCT01968070|20305806|P3|STARTED|Period 3||4
8234393|NCT01968070|20305807|P2|STARTED|Period 3||4
8234394|NCT01968070|20305808|P1|STARTED|Period 3||4
8234395|NCT01968070|20305791|P18|NOT COMPLETED|Period 2||0
8234396|NCT01968070|20305792|P17|NOT COMPLETED|Period 2||0
8234397|NCT01968070|20305793|P16|NOT COMPLETED|Period 2||0
8234398|NCT01968070|20305794|P15|NOT COMPLETED|Period 2||0
8234399|NCT01968070|20305795|P14|NOT COMPLETED|Period 2||0
8234400|NCT01968070|20305796|P13|NOT COMPLETED|Period 2||0
8234401|NCT01968070|20305797|P12|NOT COMPLETED|Period 2||0
8234402|NCT01968070|20305798|P11|NOT COMPLETED|Period 2||0
8234403|NCT01968070|20305799|P10|NOT COMPLETED|Period 2||0
8234404|NCT01968070|20305800|P9|NOT COMPLETED|Period 2||0
8234405|NCT01968070|20305801|P8|NOT COMPLETED|Period 2||0
8234406|NCT01968070|20305802|P7|NOT COMPLETED|Period 2||0
8234407|NCT01968070|20305803|P6|NOT COMPLETED|Period 2||0
8234408|NCT01968070|20305804|P5|NOT COMPLETED|Period 2||1
8234409|NCT01968070|20305805|P4|NOT COMPLETED|Period 2||0
8234410|NCT01968070|20305806|P3|NOT COMPLETED|Period 2||0
8234411|NCT01968070|20305807|P2|NOT COMPLETED|Period 2||0
8234412|NCT01968070|20305808|P1|NOT COMPLETED|Period 2||0
8234413|NCT01968070|20305791|P18|COMPLETED|Period 2||0
8234414|NCT01968070|20305792|P17|COMPLETED|Period 2||0
8234415|NCT01968070|20305793|P16|COMPLETED|Period 2||0
8234416|NCT01968070|20305794|P15|COMPLETED|Period 2||0
8234417|NCT01968070|20305795|P14|COMPLETED|Period 2||0
8234418|NCT01968070|20305796|P13|COMPLETED|Period 2||0
8234419|NCT01968070|20305797|P12|COMPLETED|Period 2||0
8234420|NCT01968070|20305798|P11|COMPLETED|Period 2||0
8234421|NCT01968070|20305799|P10|COMPLETED|Period 2||0
8234422|NCT01968070|20305800|P9|COMPLETED|Period 2||0
8234423|NCT01968070|20305801|P8|COMPLETED|Period 2||0
8234424|NCT01968070|20305802|P7|COMPLETED|Period 2||0
8234425|NCT01968070|20305803|P6|COMPLETED|Period 2||4
8234426|NCT01968070|20305804|P5|COMPLETED|Period 2||2
8234427|NCT01968070|20305805|P4|COMPLETED|Period 2||4
8234428|NCT01968070|20305806|P3|COMPLETED|Period 2||4
8234429|NCT01968070|20305807|P2|COMPLETED|Period 2||4
8234430|NCT01968070|20305808|P1|COMPLETED|Period 2||4
8234431|NCT01968070|20305791|P18|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234432|NCT01968070|20305792|P17|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234433|NCT01968070|20305793|P16|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234434|NCT01968070|20305794|P15|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234435|NCT01968070|20305795|P14|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234436|NCT01968070|20305796|P13|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234437|NCT01968070|20305797|P12|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234438|NCT01968070|20305798|P11|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234439|NCT01968070|20305799|P10|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234440|NCT01968070|20305800|P9|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234441|NCT01968070|20305801|P8|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234442|NCT01968070|20305802|P7|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234443|NCT01968070|20305803|P6|STARTED|Period 2||4
8234444|NCT01968070|20305804|P5|STARTED|Period 2||3
8234445|NCT01968070|20305805|P4|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
8234446|NCT01968070|20305806|P3|STARTED|Period 2||4
8234447|NCT01968070|20305807|P2|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
8234448|NCT01968070|20305808|P1|STARTED|Period 2||4
8234449|NCT01968070|20305791|P18|NOT COMPLETED|Period 1||0
8234450|NCT01968070|20305792|P17|NOT COMPLETED|Period 1||0
8234451|NCT01968070|20305793|P16|NOT COMPLETED|Period 1||1
8234452|NCT01968070|20305794|P15|NOT COMPLETED|Period 1||0
8234453|NCT01968070|20305795|P14|NOT COMPLETED|Period 1||0
8234454|NCT01968070|20305796|P13|NOT COMPLETED|Period 1||0
8234455|NCT01968070|20305797|P12|NOT COMPLETED|Period 1||1
8234456|NCT01968070|20305798|P11|NOT COMPLETED|Period 1||0
8234457|NCT01968070|20305799|P10|NOT COMPLETED|Period 1||0
8234458|NCT01968070|20305800|P9|NOT COMPLETED|Period 1||0
8234459|NCT01968070|20305801|P8|NOT COMPLETED|Period 1||0
8234460|NCT01968070|20305802|P7|NOT COMPLETED|Period 1||2
8234461|NCT01968070|20305803|P6|NOT COMPLETED|Period 1||0
8234462|NCT01968070|20305804|P5|NOT COMPLETED|Period 1||1
8234463|NCT01968070|20305805|P4|NOT COMPLETED|Period 1||2
8234464|NCT01968070|20305806|P3|NOT COMPLETED|Period 1||0
8234465|NCT01968070|20305807|P2|NOT COMPLETED|Period 1||1
8234466|NCT01968070|20305808|P1|NOT COMPLETED|Period 1||0
8234467|NCT01968070|20305791|P18|COMPLETED|Period 1||2
8234468|NCT01968070|20305792|P17|COMPLETED|Period 1||2
8234469|NCT01968070|20305793|P16|COMPLETED|Period 1||8
8234470|NCT01968070|20305794|P15|COMPLETED|Period 1||2
8234471|NCT01968070|20305795|P14|COMPLETED|Period 1||2
8234472|NCT01968070|20305796|P13|COMPLETED|Period 1||9
8234473|NCT01968070|20305797|P12|COMPLETED|Period 1||1
8234474|NCT01968070|20305798|P11|COMPLETED|Period 1||2
8234475|NCT01968070|20305799|P10|COMPLETED|Period 1||9
8234476|NCT01968070|20305800|P9|COMPLETED|Period 1||2
8234477|NCT01968070|20305801|P8|COMPLETED|Period 1||2
8234478|NCT01968070|20305802|P7|COMPLETED|Period 1||8
8234479|NCT01968070|20305803|P6|COMPLETED|Period 1||4
8234480|NCT01968070|20305804|P5|COMPLETED|Period 1||3
8234481|NCT01968070|20305805|P4|COMPLETED|Period 1||2
8234482|NCT01968070|20305806|P3|COMPLETED|Period 1||4
8234483|NCT01968070|20305807|P2|COMPLETED|Period 1||3
8234484|NCT01968070|20305808|P1|COMPLETED|Period 1||4
8234485|NCT01968070|20305791|P18|STARTED|Period 1||2
8234486|NCT01968070|20305792|P17|STARTED|Period 1||2
8234487|NCT01968070|20305793|P16|STARTED|Period 1||9
8234488|NCT01968070|20305794|P15|STARTED|Period 1||2
8234489|NCT01968070|20305795|P14|STARTED|Period 1||2
8234490|NCT01968070|20305796|P13|STARTED|Period 1||9
8234491|NCT01968070|20305797|P12|STARTED|Period 1||2
8234492|NCT01968070|20305798|P11|STARTED|Period 1||2
8234493|NCT01968070|20305799|P10|STARTED|Period 1||9
8234494|NCT01968070|20305800|P9|STARTED|Period 1||2
8234495|NCT01968070|20305801|P8|STARTED|Period 1||2
8234496|NCT01968070|20305802|P7|STARTED|Period 1||10
8234497|NCT01968070|20305803|P6|STARTED|Period 1||4
8234498|NCT01968070|20305804|P5|STARTED|Period 1||4
8234499|NCT01968070|20305805|P4|STARTED|Period 1||4
8234500|NCT01968070|20305806|P3|STARTED|Period 1||4
8234501|NCT01968070|20305807|P2|STARTED|Period 1||4
8234502|NCT01968070|20305808|P1|STARTED|Period 1||4
8234503|NCT01968057|20305866|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
8234504|NCT01968057|20305866|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
8234505|NCT01968057|20305866|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
8234506|NCT01968057|20305866|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
8234507|NCT01968057|20305866|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
8234508|NCT01968057|20305866|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
8234509|NCT01968057|20305866|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
8234510|NCT01968057|20305866|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
8234511|NCT01968031|20305879|P3|NOT COMPLETED|Overall Study||29
8234512|NCT01968031|20305880|P2|NOT COMPLETED|Overall Study||20
8234513|NCT01968031|20305881|P1|NOT COMPLETED|Overall Study||18
8234514|NCT01968031|20305879|P3|COMPLETED|Overall Study||178
8234515|NCT01968031|20305880|P2|COMPLETED|Overall Study||182
8234516|NCT01968031|20305881|P1|COMPLETED|Overall Study||186
8234517|NCT01968031|20305879|P3|Completed Week 10|Overall Study||181
8234518|NCT01968031|20305880|P2|Completed Week 10|Overall Study||181
8234519|NCT01968031|20305881|P1|Completed Week 10|Overall Study||187
8234520|NCT01968031|20305879|P3|Completed Week 6|Overall Study||187
8234521|NCT01968031|20305880|P2|Completed Week 6|Overall Study||183
8234522|NCT01968031|20305881|P1|Completed Week 6|Overall Study||191
8234523|NCT01968031|20305879|P3|Completed Week 2|Overall Study||199
8234524|NCT01968031|20305880|P2|Completed Week 2|Overall Study||190
8234525|NCT01968031|20305881|P1|Completed Week 2|Overall Study||197
8234526|NCT01968031|20305879|P3|STARTED|Overall Study||207
8234527|NCT01968031|20305880|P2|STARTED|Overall Study||202
8234528|NCT01968031|20305881|P1|STARTED|Overall Study||204
8234529|NCT01967940|20305925|P4|NOT COMPLETED|Part 2||3
8234530|NCT01967940|20305926|P3|NOT COMPLETED|Part 2||0
8234531|NCT01967940|20305927|P2|NOT COMPLETED|Part 2||0
8234532|NCT01967940|20305928|P1|NOT COMPLETED|Part 2||0
8234533|NCT01967940|20305925|P4|COMPLETED|Part 2||35
8234534|NCT01967940|20305926|P3|COMPLETED|Part 2||0
8234535|NCT01967940|20305927|P2|COMPLETED|Part 2||0
8234536|NCT01967940|20305928|P1|COMPLETED|Part 2||0
8234537|NCT01967940|20305925|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
8234538|NCT01967940|20305926|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
8234539|NCT01967940|20305927|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
8234540|NCT01967940|20305928|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
8234541|NCT01967940|20305925|P4|NOT COMPLETED|Part 1||0
8234542|NCT01967940|20305926|P3|NOT COMPLETED|Part 1||0
8234543|NCT01967940|20305927|P2|NOT COMPLETED|Part 1||0
8234544|NCT01967940|20305928|P1|NOT COMPLETED|Part 1||0
8234545|NCT01967940|20305925|P4|COMPLETED|Part 1||0
8234546|NCT01967940|20305926|P3|COMPLETED|Part 1||15
8234547|NCT01967940|20305927|P2|COMPLETED|Part 1||28
8234548|NCT01967940|20305928|P1|COMPLETED|Part 1||12
8234549|NCT01967940|20305925|P4|STARTED|Part 1||0
8234550|NCT01967940|20305926|P3|STARTED|Part 1||15
8234551|NCT01967940|20305927|P2|STARTED|Part 1||28
8234552|NCT01967940|20305928|P1|STARTED|Part 1||12
8234553|NCT01967888|20305956|P2|NOT COMPLETED|Overall Study||7
8234554|NCT01967888|20305957|P1|NOT COMPLETED|Overall Study||10
8234555|NCT01967888|20305956|P2|COMPLETED|Overall Study||45
8234556|NCT01967888|20305957|P1|COMPLETED|Overall Study||42
8234557|NCT01967888|20305956|P2|STARTED|Overall Study||52
8234558|NCT01967888|20305957|P1|STARTED|Overall Study||52
8234559|NCT01967862|20306025|P1|NOT COMPLETED|Overall Study||0
8234560|NCT01967862|20306025|P1|COMPLETED|Overall Study||54
8234561|NCT01967862|20306025|P1|STARTED|Overall Study||54
8234562|NCT01967836|20306029|P1|NOT COMPLETED|Overall Study||9
8234563|NCT01967836|20306029|P1|COMPLETED|Overall Study||11
8234564|NCT01967836|20306029|P1|STARTED|Overall Study||20
8234565|NCT01967784|20306035|P1|NOT COMPLETED|Overall Study||0
8234566|NCT01967784|20306035|P1|COMPLETED|Overall Study||100
8234567|NCT01967784|20306035|P1|STARTED|Overall Study||100
8234568|NCT01967732|20306045|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8234569|NCT01967732|20306046|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8234570|NCT01967732|20306047|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8234571|NCT01967732|20306048|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8234572|NCT01967732|20306045|P4|COMPLETED|Second Intervention (Day 3)||9
8234573|NCT01967732|20306046|P3|COMPLETED|Second Intervention (Day 3)||9
8234574|NCT01967732|20306047|P2|COMPLETED|Second Intervention (Day 3)||20
8234575|NCT01967732|20306048|P1|COMPLETED|Second Intervention (Day 3)||22
8234576|NCT01967732|20306045|P4|STARTED|Second Intervention (Day 3)||9
8234577|NCT01967732|20306046|P3|STARTED|Second Intervention (Day 3)||9
8234578|NCT01967732|20306047|P2|STARTED|Second Intervention (Day 3)||20
8234579|NCT01967732|20306048|P1|STARTED|Second Intervention (Day 3)||22
8234580|NCT01967732|20306045|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234581|NCT01967732|20306046|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234582|NCT01967732|20306047|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234583|NCT01967732|20306048|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234584|NCT01967732|20306045|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234585|NCT01967732|20306046|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234586|NCT01967732|20306047|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
8234587|NCT01967732|20306048|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
8234588|NCT01967732|20306045|P4|STARTED|Washout Period of 1 Day (Day 2)||9
8234589|NCT01967732|20306046|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8234590|NCT01967732|20306047|P2|STARTED|Washout Period of 1 Day (Day 2)||20
8234591|NCT01967732|20306048|P1|STARTED|Washout Period of 1 Day (Day 2)||22
8234592|NCT01967732|20306045|P4|NOT COMPLETED|First Intervention (Day 1)||0
8234593|NCT01967732|20306046|P3|NOT COMPLETED|First Intervention (Day 1)||0
8234594|NCT01967732|20306047|P2|NOT COMPLETED|First Intervention (Day 1)||1
8234595|NCT01967732|20306048|P1|NOT COMPLETED|First Intervention (Day 1)||0
8234596|NCT01967732|20306045|P4|COMPLETED|First Intervention (Day 1)||9
8234597|NCT01967732|20306046|P3|COMPLETED|First Intervention (Day 1)||9
8234598|NCT01967732|20306047|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
8234599|NCT01967732|20306048|P1|COMPLETED|First Intervention (Day 1)||22
8234600|NCT01967732|20306045|P4|STARTED|First Intervention (Day 1)||9
8234601|NCT01967732|20306046|P3|STARTED|First Intervention (Day 1)||9
8234602|NCT01967732|20306047|P2|STARTED|First Intervention (Day 1)||21
8234603|NCT01967732|20306048|P1|STARTED|First Intervention (Day 1)||22
8234604|NCT01967732|20306045|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234605|NCT01967732|20306046|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234606|NCT01967732|20306047|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
8234607|NCT01967732|20306048|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234608|NCT01967732|20306045|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234609|NCT01967732|20306046|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234610|NCT01967732|20306047|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
8234611|NCT01967732|20306048|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234612|NCT01967732|20306045|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8234613|NCT01967732|20306046|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8234614|NCT01967732|20306047|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8234615|NCT01967732|20306048|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8234616|NCT01967719|20306062|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8234617|NCT01967719|20306063|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8234618|NCT01967719|20306064|P2|NOT COMPLETED|Second Intervention (Day 3)||1
8234619|NCT01967719|20306065|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8234620|NCT01967719|20306062|P4|COMPLETED|Second Intervention (Day 3)||8
8234621|NCT01967719|20306063|P3|COMPLETED|Second Intervention (Day 3)||9
8234622|NCT01967719|20306064|P2|COMPLETED|Second Intervention (Day 3)||20
8234623|NCT01967719|20306065|P1|COMPLETED|Second Intervention (Day 3)||22
8234624|NCT01967719|20306062|P4|STARTED|Second Intervention (Day 3)||8
8234625|NCT01967719|20306063|P3|STARTED|Second Intervention (Day 3)||9
8234626|NCT01967719|20306064|P2|STARTED|Second Intervention (Day 3)||21
8234627|NCT01967719|20306065|P1|STARTED|Second Intervention (Day 3)||22
8234628|NCT01967719|20306062|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234629|NCT01967719|20306063|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234630|NCT01967719|20306064|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234631|NCT01967719|20306065|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234632|NCT01967719|20306062|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
8234633|NCT01967719|20306063|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234634|NCT01967719|20306064|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
8234635|NCT01967719|20306065|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
8234636|NCT01967719|20306062|P4|STARTED|Washout Period of 1 Day (Day 2)||8
8234637|NCT01967719|20306063|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8234638|NCT01967719|20306064|P2|STARTED|Washout Period of 1 Day (Day 2)||21
8234639|NCT01967719|20306065|P1|STARTED|Washout Period of 1 Day (Day 2)||22
8234640|NCT01967719|20306062|P4|NOT COMPLETED|First Intervention (Day 1)||1
8234641|NCT01967719|20306063|P3|NOT COMPLETED|First Intervention (Day 1)||0
8234642|NCT01967719|20306064|P2|NOT COMPLETED|First Intervention (Day 1)||1
8234643|NCT01967719|20306065|P1|NOT COMPLETED|First Intervention (Day 1)||0
8234644|NCT01967719|20306062|P4|COMPLETED|First Intervention (Day 1)||8
8234645|NCT01967719|20306063|P3|COMPLETED|First Intervention (Day 1)||9
8234646|NCT01967719|20306064|P2|COMPLETED|First Intervention (Day 1)||21
8234647|NCT01967719|20306065|P1|COMPLETED|First Intervention (Day 1)||22
8234648|NCT01967719|20306062|P4|STARTED|First Intervention (Day 1)||9
8234649|NCT01967719|20306063|P3|STARTED|First Intervention (Day 1)||9
8234650|NCT01967719|20306064|P2|STARTED|First Intervention (Day 1)||22
8234651|NCT01967719|20306065|P1|STARTED|First Intervention (Day 1)||22
8234652|NCT01967719|20306062|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234653|NCT01967719|20306063|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234654|NCT01967719|20306064|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234655|NCT01967719|20306065|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234656|NCT01967719|20306062|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234657|NCT01967719|20306063|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234658|NCT01967719|20306064|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234659|NCT01967719|20306065|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234660|NCT01967719|20306062|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8234661|NCT01967719|20306063|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8234662|NCT01967719|20306064|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8234663|NCT01967719|20306065|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8234664|NCT01967706|20306080|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8234665|NCT01967706|20306081|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8234666|NCT01967706|20306082|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8234667|NCT01967706|20306083|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8234668|NCT01967706|20306080|P4|COMPLETED|Second Intervention (Day 3)||9
8234669|NCT01967706|20306081|P3|COMPLETED|Second Intervention (Day 3)||9
8234670|NCT01967706|20306082|P2|COMPLETED|Second Intervention (Day 3)||22
8234671|NCT01967706|20306083|P1|COMPLETED|Second Intervention (Day 3)||21
8234672|NCT01967706|20306080|P4|STARTED|Second Intervention (Day 3)||9
8234673|NCT01967706|20306081|P3|STARTED|Second Intervention (Day 3)||9
8234674|NCT01967706|20306082|P2|STARTED|Second Intervention (Day 3)||22
8234675|NCT01967706|20306083|P1|STARTED|Second Intervention (Day 3)||21
8234676|NCT01967706|20306080|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234677|NCT01967706|20306081|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234678|NCT01967706|20306082|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234679|NCT01967706|20306083|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234680|NCT01967706|20306080|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234681|NCT01967706|20306081|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234682|NCT01967706|20306082|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
8234683|NCT01967706|20306083|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
8234684|NCT01967706|20306080|P4|STARTED|Washout Period of 1 Day (Day 2)||9
8234685|NCT01967706|20306081|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8234686|NCT01967706|20306082|P2|STARTED|Washout Period of 1 Day (Day 2)||22
8234687|NCT01967706|20306083|P1|STARTED|Washout Period of 1 Day (Day 2)||21
8234688|NCT01967706|20306080|P4|NOT COMPLETED|First Intervention (Day 1)||0
8234689|NCT01967706|20306081|P3|NOT COMPLETED|First Intervention (Day 1)||0
8234690|NCT01967706|20306082|P2|NOT COMPLETED|First Intervention (Day 1)||0
8234691|NCT01967706|20306083|P1|NOT COMPLETED|First Intervention (Day 1)||1
8234692|NCT01967706|20306080|P4|COMPLETED|First Intervention (Day 1)||9
8234693|NCT01967706|20306081|P3|COMPLETED|First Intervention (Day 1)||9
8234694|NCT01967706|20306082|P2|COMPLETED|First Intervention (Day 1)||22
8234695|NCT01967706|20306083|P1|COMPLETED|First Intervention (Day 1)||21
8234696|NCT01967706|20306080|P4|STARTED|First Intervention (Day 1)||9
8234697|NCT01967706|20306081|P3|STARTED|First Intervention (Day 1)||9
8234698|NCT01967706|20306082|P2|STARTED|First Intervention (Day 1)||22
8234699|NCT01967706|20306083|P1|STARTED|First Intervention (Day 1)||22
8234700|NCT01967706|20306080|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234701|NCT01967706|20306081|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234702|NCT01967706|20306082|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234703|NCT01967706|20306083|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234704|NCT01967706|20306080|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234705|NCT01967706|20306081|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234706|NCT01967706|20306082|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234707|NCT01967706|20306083|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234708|NCT01967706|20306080|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8234709|NCT01967706|20306081|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8234710|NCT01967706|20306082|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8234711|NCT01967706|20306083|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8234712|NCT01967641|20306096|P1|NOT COMPLETED|12-week Outpatient Phase||13
8234713|NCT01967641|20306096|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
8234714|NCT01967641|20306096|P1|STARTED|12-week Outpatient Phase||31
8234715|NCT01967641|20306096|P1|NOT COMPLETED|Admission to Inpatient Phase||12
8234716|NCT01967641|20306096|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
8234717|NCT01967641|20306096|P1|STARTED|Admission to Inpatient Phase||43
8234718|NCT01967641|20306096|P1|NOT COMPLETED|Randomized||8
8234719|NCT01967641|20306096|P1|COMPLETED|Randomized|Completed week 12|43
8234720|NCT01967641|20306096|P1|STARTED|Randomized||51
8234721|NCT01967628|20306104|P2|NOT COMPLETED|Overall Study||31
8234722|NCT01967628|20306105|P1|NOT COMPLETED|Overall Study||27
8234723|NCT01967628|20306104|P2|COMPLETED|Overall Study||19
8234724|NCT01967628|20306105|P1|COMPLETED|Overall Study||21
8234725|NCT01967628|20306104|P2|STARTED|Overall Study||50
8234726|NCT01967628|20306105|P1|STARTED|Overall Study||48
8234727|NCT01967576|20306111|P1|NOT COMPLETED|Overall Study||7
8234728|NCT01967576|20306111|P1|COMPLETED|Overall Study||7
8234729|NCT01967576|20306111|P1|STARTED|Overall Study||14
8234730|NCT01967550|20306122|P2|NOT COMPLETED|Overall Study||2
8234731|NCT01967550|20306123|P1|NOT COMPLETED|Overall Study||5
8234732|NCT01967550|20306122|P2|COMPLETED|Overall Study||149
8234733|NCT01967550|20306123|P1|COMPLETED|Overall Study||148
8234734|NCT01967550|20306122|P2|STARTED|Overall Study||151
8234735|NCT01967550|20306123|P1|STARTED|Overall Study||153
8234736|NCT01967537|20306129|P1|NOT COMPLETED|Overall Study||60
8234737|NCT01967537|20306129|P1|COMPLETED|Overall Study||281
8234738|NCT01967537|20306129|P1|STARTED|Overall Study||341
8234739|NCT01967433|20306140|P2|NOT COMPLETED|Overall Study||1
8234740|NCT01967433|20306141|P1|NOT COMPLETED|Overall Study||0
8234741|NCT01967433|20306140|P2|COMPLETED|Overall Study||58
8234742|NCT01967433|20306141|P1|COMPLETED|Overall Study||61
8234743|NCT01967433|20306140|P2|STARTED|Overall Study||59
8234744|NCT01967433|20306141|P1|STARTED|Overall Study||61
8234745|NCT01967342|20306162|P3|NOT COMPLETED|Overall Study||29
8234746|NCT01967342|20306163|P2|NOT COMPLETED|Overall Study||25
8234747|NCT01967342|20306164|P1|NOT COMPLETED|Overall Study||27
8234748|NCT01967342|20306162|P3|COMPLETED|Overall Study||68
8234749|NCT01967342|20306163|P2|COMPLETED|Overall Study||70
8234750|NCT01967342|20306164|P1|COMPLETED|Overall Study||71
8234751|NCT01967342|20306162|P3|10-week Follow-up|Overall Study||80
8234752|NCT01967342|20306163|P2|10-week Follow-up|Overall Study||83
8234753|NCT01967342|20306164|P1|10-week Follow-up|Overall Study||78
8234754|NCT01967342|20306162|P3|5-week Follow-up|Overall Study||76
8234755|NCT01967342|20306163|P2|5-week Follow-up|Overall Study||78
8234756|NCT01967342|20306164|P1|5-week Follow-up|Overall Study||83
8234757|NCT01967342|20306162|P3|STARTED|Overall Study||97
8234758|NCT01967342|20306163|P2|STARTED|Overall Study||95
8234759|NCT01967342|20306164|P1|STARTED|Overall Study||98
8234760|NCT01967277|20306183|P2|NOT COMPLETED|Overall Study||3
8234761|NCT01967277|20306184|P1|NOT COMPLETED|Overall Study||1
8234762|NCT01967277|20306183|P2|COMPLETED|Overall Study||19
8234763|NCT01967277|20306184|P1|COMPLETED|Overall Study||21
8234764|NCT01967277|20306183|P2|STARTED|Overall Study||22
8234765|NCT01967277|20306184|P1|STARTED|Overall Study||22
8234766|NCT01967225|20306196|P2|NOT COMPLETED|Overall Study||3
8234767|NCT01967225|20306197|P1|NOT COMPLETED|Overall Study||12
8234768|NCT01967225|20306196|P2|COMPLETED|Overall Study||38
8234769|NCT01967225|20306197|P1|COMPLETED|Overall Study||72
8234770|NCT01967225|20306196|P2|Participants Received Treatment|Overall Study||41
8234771|NCT01967225|20306197|P1|Participants Received Treatment|Overall Study||83
8234772|NCT01967225|20306196|P2|STARTED|Overall Study||41
8234773|NCT01967225|20306197|P1|STARTED|Overall Study||84
8234774|NCT01967173|20306229|P8|NOT COMPLETED|Overall Study||24
8234775|NCT01967173|20306230|P7|NOT COMPLETED|Overall Study||18
8234776|NCT01967173|20306231|P6|NOT COMPLETED|Overall Study||23
8234777|NCT01967173|20306232|P5|NOT COMPLETED|Overall Study||17
8234778|NCT01967173|20306233|P4|NOT COMPLETED|Overall Study||14
8234779|NCT01967173|20306234|P3|NOT COMPLETED|Overall Study||16
8234780|NCT01967173|20306235|P2|NOT COMPLETED|Overall Study||17
8234781|NCT01967173|20306236|P1|NOT COMPLETED|Overall Study||24
8234782|NCT01967173|20306229|P8|COMPLETED|Overall Study||50
8234783|NCT01967173|20306230|P7|COMPLETED|Overall Study||57
8234784|NCT01967173|20306231|P6|COMPLETED|Overall Study||49
8234785|NCT01967173|20306232|P5|COMPLETED|Overall Study||56
8234786|NCT01967173|20306233|P4|COMPLETED|Overall Study||57
8234787|NCT01967173|20306234|P3|COMPLETED|Overall Study||55
8234788|NCT01967173|20306235|P2|COMPLETED|Overall Study||52
8234789|NCT01967173|20306236|P1|COMPLETED|Overall Study||45
8234790|NCT01967173|20306229|P8|Completed 4th Period|Overall Study||50
8234791|NCT01967173|20306230|P7|Completed 4th Period|Overall Study||57
8234792|NCT01967173|20306231|P6|Completed 4th Period|Overall Study||49
8234793|NCT01967173|20306232|P5|Completed 4th Period|Overall Study||56
8234794|NCT01967173|20306233|P4|Completed 4th Period|Overall Study||57
8234795|NCT01967173|20306234|P3|Completed 4th Period|Overall Study||55
8234796|NCT01967173|20306235|P2|Completed 4th Period|Overall Study||52
8234797|NCT01967173|20306236|P1|Completed 4th Period|Overall Study||45
8234798|NCT01967173|20306229|P8|Completed 3rd Period|Overall Study||56
8234799|NCT01967173|20306230|P7|Completed 3rd Period|Overall Study||59
8234800|NCT01967173|20306231|P6|Completed 3rd Period|Overall Study||56
8234801|NCT01967173|20306232|P5|Completed 3rd Period|Overall Study||59
8234802|NCT01967173|20306233|P4|Completed 3rd Period|Overall Study||61
8234803|NCT01967173|20306234|P3|Completed 3rd Period|Overall Study||60
8234804|NCT01967173|20306235|P2|Completed 3rd Period|Overall Study||54
8234805|NCT01967173|20306236|P1|Completed 3rd Period|Overall Study||48
8234806|NCT01967173|20306229|P8|Completed 2nd Period|Overall Study||61
8234807|NCT01967173|20306230|P7|Completed 2nd Period|Overall Study||63
8234808|NCT01967173|20306231|P6|Completed 2nd Period|Overall Study||57
8234809|NCT01967173|20306232|P5|Completed 2nd Period|Overall Study||63
8234810|NCT01967173|20306233|P4|Completed 2nd Period|Overall Study||62
8234811|NCT01967173|20306234|P3|Completed 2nd Period|Overall Study||63
8234812|NCT01967173|20306235|P2|Completed 2nd Period|Overall Study||58
8234813|NCT01967173|20306236|P1|Completed 2nd Period|Overall Study||52
8234814|NCT01967173|20306229|P8|Completed 1st Period|Overall Study||69
8234815|NCT01967173|20306230|P7|Completed 1st Period|Overall Study||67
8234816|NCT01967173|20306231|P6|Completed 1st Period|Overall Study||62
8234817|NCT01967173|20306232|P5|Completed 1st Period|Overall Study||64
8234818|NCT01967173|20306233|P4|Completed 1st Period|Overall Study||65
8234819|NCT01967173|20306234|P3|Completed 1st Period|Overall Study||67
8234820|NCT01967173|20306235|P2|Completed 1st Period|Overall Study||60
8234821|NCT01967173|20306236|P1|Completed 1st Period|Overall Study||58
8234822|NCT01967173|20306229|P8|STARTED|Overall Study||74
8234823|NCT01967173|20306230|P7|STARTED|Overall Study||75
8234824|NCT01967173|20306231|P6|STARTED|Overall Study||72
8234825|NCT01967173|20306232|P5|STARTED|Overall Study||73
8234826|NCT01967173|20306233|P4|STARTED|Overall Study||71
8234827|NCT01967173|20306234|P3|STARTED|Overall Study||71
8234828|NCT01967173|20306235|P2|STARTED|Overall Study||69
8234829|NCT01967173|20306236|P1|STARTED|Overall Study||69
8234830|NCT01967147|20306250|P2|NOT COMPLETED|Overall Study||20
8234831|NCT01967147|20306251|P1|NOT COMPLETED|Overall Study||13
8234832|NCT01967147|20306250|P2|COMPLETED|Overall Study||82
8234833|NCT01967147|20306251|P1|COMPLETED|Overall Study||99
8234834|NCT01967147|20306250|P2|STARTED|Overall Study||102
8234835|NCT01967147|20306251|P1|STARTED|Overall Study||112
8234836|NCT01967134|20306269|P3|NOT COMPLETED|Overall Study||0
8234837|NCT01967134|20306270|P2|NOT COMPLETED|Overall Study||1
8234838|NCT01967134|20306271|P1|NOT COMPLETED|Overall Study||0
8234839|NCT01967134|20306269|P3|COMPLETED|Overall Study||9
8234840|NCT01967134|20306270|P2|COMPLETED|Overall Study||7
8234841|NCT01967134|20306271|P1|COMPLETED|Overall Study||8
8234842|NCT01967134|20306269|P3|STARTED|Overall Study||9
8234843|NCT01967134|20306270|P2|STARTED|Overall Study||8
8234844|NCT01967134|20306271|P1|STARTED|Overall Study||8
8234845|NCT01967121|20306294|P3|NOT COMPLETED|Overall Study||0
8234846|NCT01967121|20306295|P2|NOT COMPLETED|Overall Study||0
8234847|NCT01967121|20306296|P1|NOT COMPLETED|Overall Study||0
8234848|NCT01967121|20306294|P3|COMPLETED|Overall Study||25
8234849|NCT01967121|20306295|P2|COMPLETED|Overall Study||25
8234850|NCT01967121|20306296|P1|COMPLETED|Overall Study||25
8234851|NCT01967121|20306294|P3|STARTED|Overall Study||25
8234852|NCT01967121|20306295|P2|STARTED|Overall Study||25
8234853|NCT01967121|20306296|P1|STARTED|Overall Study||25
8234854|NCT01967069|20306306|P2|NOT COMPLETED|Overall Study||8
8234855|NCT01967069|20306307|P1|NOT COMPLETED|Overall Study||8
8234856|NCT01967069|20306306|P2|COMPLETED|Overall Study||87
8234857|NCT01967069|20306307|P1|COMPLETED|Overall Study||174
8234858|NCT01967069|20306306|P2|STARTED|Overall Study||95
8234859|NCT01967069|20306307|P1|STARTED|Overall Study||182
8234860|NCT01966978|20306315|P2|NOT COMPLETED|Overall Study||13
8234861|NCT01966978|20306316|P1|NOT COMPLETED|Overall Study||17
8234862|NCT01966978|20306315|P2|COMPLETED|Overall Study||46
8234863|NCT01966978|20306316|P1|COMPLETED|Overall Study||44
8234864|NCT01966978|20306315|P2|STARTED|Overall Study||59
8234865|NCT01966978|20306316|P1|STARTED|Overall Study||61
8234866|NCT01966926|20306338|P2|NOT COMPLETED|Overall Study||0
8234867|NCT01966926|20306339|P1|NOT COMPLETED|Overall Study||0
8234868|NCT01966926|20306338|P2|COMPLETED|Overall Study||15
8234869|NCT01966926|20306339|P1|COMPLETED|Overall Study||15
8234870|NCT01966926|20306338|P2|STARTED|Overall Study||15
8234871|NCT01966926|20306339|P1|STARTED|Overall Study||15
8234872|NCT01966900|20306357|P2|NOT COMPLETED|Overall Study||0
8234873|NCT01966900|20306358|P1|NOT COMPLETED|Overall Study||2
8234874|NCT01966900|20306357|P2|COMPLETED|Overall Study||6
8234875|NCT01966900|20306358|P1|COMPLETED|Overall Study||6
8234876|NCT01966900|20306357|P2|STARTED|Overall Study||6
8234877|NCT01966900|20306358|P1|STARTED|Overall Study||8
8234878|NCT01966809|20306368|P1|NOT COMPLETED|Overall Study||0
8234879|NCT01966809|20306368|P1|COMPLETED|Overall Study||1
8234880|NCT01966809|20306368|P1|STARTED|Overall Study||1
8234881|NCT01966796|20306379|P4|NOT COMPLETED|Overall Study||0
8234882|NCT01966796|20306380|P3|NOT COMPLETED|Overall Study||0
8234883|NCT01966796|20306381|P2|NOT COMPLETED|Overall Study||0
8234884|NCT01966796|20306382|P1|NOT COMPLETED|Overall Study||0
8234885|NCT01966796|20306379|P4|COMPLETED|Overall Study||269
8234886|NCT01966796|20306380|P3|COMPLETED|Overall Study||195
8234887|NCT01966796|20306381|P2|COMPLETED|Overall Study||51
8234888|NCT01966796|20306382|P1|COMPLETED|Overall Study||15
8234889|NCT01966796|20306379|P4|STARTED|Overall Study||269
8234890|NCT01966796|20306380|P3|STARTED|Overall Study||195
8234891|NCT01966796|20306381|P2|STARTED|Overall Study||51
8234892|NCT01966796|20306382|P1|STARTED|Overall Study||15
8234893|NCT01966770|20306396|P1|NOT COMPLETED|Overall Study||0
8234894|NCT01966770|20306396|P1|COMPLETED|Overall Study||20
8234895|NCT01966770|20306396|P1|STARTED|Overall Study||20
8234896|NCT01966731|20306505|P1|NOT COMPLETED|Overall Study||635
8234897|NCT01966731|20306505|P1|COMPLETED|Overall Study||0
8234898|NCT01966731|20306505|P1|Completed Study|Overall Study||0
8234899|NCT01966731|20306505|P1|Completed 3 Months of Treatment|Overall Study||600
8234900|NCT01966731|20306505|P1|Initiated Hydroxyurea|Overall Study||606
8234901|NCT01966731|20306505|P1|STARTED|Overall Study||635
8234902|NCT01966718|20306509|P1|NOT COMPLETED|Overall Study||0
8234903|NCT01966718|20306509|P1|COMPLETED|Overall Study||8
8234904|NCT01966718|20306509|P1|STARTED|Overall Study||8
8234905|NCT01966471|20306519|P2|NOT COMPLETED|Overall Study||113
8234906|NCT01966471|20306520|P1|NOT COMPLETED|Overall Study||103
8234907|NCT01966471|20306519|P2|COMPLETED|Overall Study||815
8234908|NCT01966471|20306520|P1|COMPLETED|Overall Study||815
8234909|NCT01966471|20306519|P2|STARTED|Overall Study||928
8234910|NCT01966471|20306520|P1|STARTED|Overall Study||918
8234911|NCT01966458|20306538|P2|NOT COMPLETED|Overall Study||2
8234912|NCT01966458|20306539|P1|NOT COMPLETED|Overall Study||4
8234913|NCT01966458|20306538|P2|COMPLETED|Overall Study||155
8234914|NCT01966458|20306539|P1|COMPLETED|Overall Study||304
8234915|NCT01966458|20306538|P2|STARTED|Overall Study||157
8234916|NCT01966458|20306539|P1|STARTED|Overall Study||308
8234917|NCT01966445|20306554|P7|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
8234918|NCT01966445|20306555|P6|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234919|NCT01966445|20306556|P5|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234920|NCT01966445|20306557|P4|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234921|NCT01966445|20306558|P3|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234922|NCT01966445|20306559|P2|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234923|NCT01966445|20306560|P1|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234924|NCT01966445|20306554|P7|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
8234925|NCT01966445|20306555|P6|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234926|NCT01966445|20306556|P5|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234927|NCT01966445|20306557|P4|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234928|NCT01966445|20306558|P3|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234929|NCT01966445|20306559|P2|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234930|NCT01966445|20306560|P1|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234931|NCT01966445|20306554|P7|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
8234932|NCT01966445|20306555|P6|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234933|NCT01966445|20306556|P5|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234934|NCT01966445|20306557|P4|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234935|NCT01966445|20306558|P3|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234936|NCT01966445|20306559|P2|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234937|NCT01966445|20306560|P1|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234938|NCT01966445|20306554|P7|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8234939|NCT01966445|20306555|P6|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234940|NCT01966445|20306556|P5|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
8234941|NCT01966445|20306557|P4|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
8234942|NCT01966445|20306558|P3|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234943|NCT01966445|20306559|P2|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
8234944|NCT01966445|20306560|P1|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8234945|NCT01966445|20306554|P7|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8234946|NCT01966445|20306555|P6|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
8234947|NCT01966445|20306556|P5|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234948|NCT01966445|20306557|P4|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
8234949|NCT01966445|20306558|P3|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234950|NCT01966445|20306559|P2|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234951|NCT01966445|20306560|P1|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234952|NCT01966445|20306554|P7|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
8234953|NCT01966445|20306555|P6|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
8234954|NCT01966445|20306556|P5|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
8234955|NCT01966445|20306557|P4|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
8234956|NCT01966445|20306558|P3|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
8234957|NCT01966445|20306559|P2|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
8234958|NCT01966445|20306560|P1|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
8234959|NCT01966432|20306670|P3|NOT COMPLETED|Overall Study||26
8234960|NCT01966432|20306671|P2|NOT COMPLETED|Overall Study||13
8234961|NCT01966432|20306672|P1|NOT COMPLETED|Overall Study||5
8234962|NCT01966432|20306670|P3|COMPLETED|Overall Study||28
8234963|NCT01966432|20306671|P2|COMPLETED|Overall Study||21
8234964|NCT01966432|20306672|P1|COMPLETED|Overall Study||5
8234965|NCT01966432|20306670|P3|STARTED|Overall Study||54
8234966|NCT01966432|20306671|P2|STARTED|Overall Study||34
8234967|NCT01966432|20306672|P1|STARTED|Overall Study||10
8234968|NCT01966380|20306692|P2|NOT COMPLETED|Overall Study||1
8234969|NCT01966380|20306693|P1|NOT COMPLETED|Overall Study||0
8234970|NCT01966380|20306692|P2|COMPLETED|Overall Study||2
8234971|NCT01966380|20306693|P1|COMPLETED|Overall Study||3
8234972|NCT01966380|20306692|P2|STARTED|Overall Study||3
8234973|NCT01966380|20306693|P1|STARTED|Overall Study||3
8234974|NCT01966354|20306702|P3|NOT COMPLETED|Overall Study||0
8234975|NCT01966354|20306703|P2|NOT COMPLETED|Overall Study||0
8234976|NCT01966354|20306704|P1|NOT COMPLETED|Overall Study||0
8234977|NCT01966354|20306702|P3|COMPLETED|Overall Study||72
8234978|NCT01966354|20306703|P2|COMPLETED|Overall Study||73
8234979|NCT01966354|20306704|P1|COMPLETED|Overall Study||75
8234980|NCT01966354|20306702|P3|STARTED|Overall Study||72
8234981|NCT01966354|20306703|P2|STARTED|Overall Study||73
8234982|NCT01966354|20306704|P1|STARTED|Overall Study||75
8234983|NCT01966159|20306729|P2|NOT COMPLETED|Overall Study||0
8234984|NCT01966159|20306730|P1|NOT COMPLETED|Overall Study||0
8234985|NCT01966159|20306729|P2|COMPLETED|Overall Study||207
8234986|NCT01966159|20306730|P1|COMPLETED|Overall Study||205
8234987|NCT01966159|20306729|P2|STARTED|Overall Study||207
8234988|NCT01966159|20306730|P1|STARTED|Overall Study||205
8234989|NCT01966120|20306742|P2|NOT COMPLETED|Overall Study||6
8234990|NCT01966120|20306743|P1|NOT COMPLETED|Overall Study||1
8234991|NCT01966120|20306742|P2|COMPLETED|Overall Study||26
8234992|NCT01966120|20306743|P1|COMPLETED|Overall Study||54
8234993|NCT01966120|20306742|P2|STARTED|Overall Study||32
8234994|NCT01966120|20306743|P1|STARTED|Overall Study||55
8234995|NCT01966107|20306767|P2|NOT COMPLETED|Overall Study||881
8234996|NCT01966107|20306768|P1|NOT COMPLETED|Overall Study||802
8234997|NCT01966107|20306767|P2|COMPLETED|Overall Study||937
8234998|NCT01966107|20306768|P1|COMPLETED|Overall Study||1010
8234999|NCT01966107|20306767|P2|Full Analysis Set|Overall Study||1798
8235000|NCT01966107|20306768|P1|Full Analysis Set|Overall Study||1791
8235001|NCT01966107|20306767|P2|STARTED|Overall Study||1818
8235002|NCT01966107|20306768|P1|STARTED|Overall Study||1812
8235003|NCT01966068|20306782|P1|NOT COMPLETED|Overall Study||138
8235004|NCT01966068|20306782|P1|COMPLETED|Overall Study||156
8235005|NCT01966068|20306782|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
8235006|NCT01966068|20306782|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
8235007|NCT01966068|20306782|P1|STARTED|Overall Study||294
8235008|NCT01966042|20306787|P1|NOT COMPLETED|Overall Study||2
8235009|NCT01966042|20306787|P1|COMPLETED|Overall Study||11
8235010|NCT01966042|20306787|P1|STARTED|Overall Study||13
8235011|NCT01966003|20306796|P2|NOT COMPLETED|Overall Study||270
8235012|NCT01966003|20306797|P1|NOT COMPLETED|Overall Study||270
8235013|NCT01966003|20306796|P2|COMPLETED|Overall Study||44
8235014|NCT01966003|20306797|P1|COMPLETED|Overall Study||58
8235015|NCT01966003|20306796|P2|Received Study Drug|Overall Study||309
8235016|NCT01966003|20306797|P1|Received Study Drug|Overall Study||324
8235017|NCT01966003|20306796|P2|STARTED|Overall Study||314
8235018|NCT01966003|20306797|P1|STARTED|Overall Study||328
8235019|NCT01965938|20306815|P2|NOT COMPLETED|Overall Study||0
8235020|NCT01965938|20306816|P1|NOT COMPLETED|Overall Study||1
8235021|NCT01965938|20306815|P2|COMPLETED|Overall Study||20
8235022|NCT01965938|20306816|P1|COMPLETED|Overall Study||20
8235023|NCT01965938|20306815|P2|STARTED|Overall Study||20
8235024|NCT01965938|20306816|P1|STARTED|Overall Study||21
8235025|NCT01965899|20306836|P1|NOT COMPLETED|Overall Study||6
8235026|NCT01965899|20306836|P1|COMPLETED|Overall Study||145
8235027|NCT01965899|20306836|P1|STARTED|Overall Study||151
8235028|NCT01965834|20306847|P1|NOT COMPLETED|Overall Study||4
8235029|NCT01965834|20306847|P1|COMPLETED|Overall Study||2
8235030|NCT01965834|20306847|P1|STARTED|Overall Study||6
8235031|NCT01965782|20306853|P1|NOT COMPLETED|Overall Study||0
8235032|NCT01965782|20306853|P1|COMPLETED|Overall Study||0
8235033|NCT01965782|20306853|P1|STARTED|Overall Study||0
8235034|NCT01965756|20306865|P2|NOT COMPLETED|Overall Study||0
8235035|NCT01965756|20306866|P1|NOT COMPLETED|Overall Study||0
8235036|NCT01965756|20306865|P2|COMPLETED|Overall Study||10
8235037|NCT01965756|20306866|P1|COMPLETED|Overall Study||10
8235038|NCT01965756|20306865|P2|STARTED|Overall Study||10
8235039|NCT01965756|20306866|P1|STARTED|Overall Study||10
8235040|NCT01965665|20306880|P1|NOT COMPLETED|Overall Study||1
8235041|NCT01965665|20306880|P1|COMPLETED|Overall Study||19
8235042|NCT01965665|20306880|P1|STARTED|Overall Study||20
8235043|NCT01965652|20306888|P2|NOT COMPLETED|Overall Study||210
8235044|NCT01965652|20306889|P1|NOT COMPLETED|Overall Study||210
8235045|NCT01965652|20306888|P2|COMPLETED|Overall Study||413
8235046|NCT01965652|20306889|P1|COMPLETED|Overall Study||413
8235047|NCT01965652|20306888|P2|Received Treatment|Overall Study||623
8235048|NCT01965652|20306889|P1|Received Treatment|Overall Study||622
8235049|NCT01965652|20306888|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
8235050|NCT01965652|20306889|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
8235051|NCT01965600|20306919|P4|NOT COMPLETED|Second Intervention||2
8235052|NCT01965600|20306920|P3|NOT COMPLETED|Second Intervention||2
8235053|NCT01965600|20306921|P2|NOT COMPLETED|Second Intervention||0
8235054|NCT01965600|20306922|P1|NOT COMPLETED|Second Intervention||0
8235055|NCT01965600|20306919|P4|COMPLETED|Second Intervention||0
8235056|NCT01965600|20306920|P3|COMPLETED|Second Intervention||1
8235057|NCT01965600|20306921|P2|COMPLETED|Second Intervention||4
8235058|NCT01965600|20306922|P1|COMPLETED|Second Intervention||4
8235059|NCT01965600|20306919|P4|STARTED|Second Intervention||2
8235060|NCT01965600|20306920|P3|STARTED|Second Intervention||3
8235061|NCT01965600|20306921|P2|STARTED|Second Intervention||4
8235062|NCT01965600|20306922|P1|STARTED|Second Intervention||4
8235063|NCT01965600|20306919|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8235064|NCT01965600|20306920|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8235065|NCT01965600|20306921|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
8235066|NCT01965600|20306922|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8235067|NCT01965600|20306919|P4|COMPLETED|Washout Period of Approximately 15 Days||2
8235068|NCT01965600|20306920|P3|COMPLETED|Washout Period of Approximately 15 Days||3
8235069|NCT01965600|20306921|P2|COMPLETED|Washout Period of Approximately 15 Days||4
8235070|NCT01965600|20306922|P1|COMPLETED|Washout Period of Approximately 15 Days||4
8235071|NCT01965600|20306919|P4|STARTED|Washout Period of Approximately 15 Days||4
8235072|NCT01965600|20306920|P3|STARTED|Washout Period of Approximately 15 Days||5
8235073|NCT01965600|20306921|P2|STARTED|Washout Period of Approximately 15 Days||8
8235074|NCT01965600|20306922|P1|STARTED|Washout Period of Approximately 15 Days||6
8235075|NCT01965600|20306919|P4|NOT COMPLETED|First Intervention||0
8235076|NCT01965600|20306920|P3|NOT COMPLETED|First Intervention||0
8235077|NCT01965600|20306921|P2|NOT COMPLETED|First Intervention||0
8235078|NCT01965600|20306922|P1|NOT COMPLETED|First Intervention||0
8235079|NCT01965600|20306919|P4|COMPLETED|First Intervention||4
8235080|NCT01965600|20306920|P3|COMPLETED|First Intervention||5
8235081|NCT01965600|20306921|P2|COMPLETED|First Intervention||8
8235082|NCT01965600|20306922|P1|COMPLETED|First Intervention||6
8235083|NCT01965600|20306919|P4|Received at Least One Dose of Drug|First Intervention||4
8235084|NCT01965600|20306920|P3|Received at Least One Dose of Drug|First Intervention||5
8235085|NCT01965600|20306921|P2|Received at Least One Dose of Drug|First Intervention||8
8235086|NCT01965600|20306922|P1|Received at Least One Dose of Drug|First Intervention||6
8235087|NCT01965600|20306919|P4|STARTED|First Intervention||4
8235088|NCT01965600|20306920|P3|STARTED|First Intervention||5
8235089|NCT01965600|20306921|P2|STARTED|First Intervention||8
8235090|NCT01965600|20306922|P1|STARTED|First Intervention||6
8235091|NCT01965561|20306966|P1|NOT COMPLETED|Overall Study||0
8235092|NCT01965561|20306966|P1|COMPLETED|Overall Study||10
8235093|NCT01965561|20306966|P1|STARTED|Overall Study||10
8235094|NCT01965535|20306979|P2|NOT COMPLETED|Overall Study||1
8235095|NCT01965535|20306980|P1|NOT COMPLETED|Overall Study||2
8235096|NCT01965535|20306979|P2|COMPLETED|Overall Study||76
8235097|NCT01965535|20306980|P1|COMPLETED|Overall Study||76
8235098|NCT01965535|20306979|P2|STARTED|Overall Study||77
8235099|NCT01965535|20306980|P1|STARTED|Overall Study||78
8235100|NCT01965431|20306994|P6|NOT COMPLETED|Overall Study||6
8235101|NCT01965431|20306995|P5|NOT COMPLETED|Overall Study||6
8235102|NCT01965431|20306996|P4|NOT COMPLETED|Overall Study||6
8235103|NCT01965431|20306997|P3|NOT COMPLETED|Overall Study||6
8235104|NCT01965431|20306998|P2|NOT COMPLETED|Overall Study||6
8235105|NCT01965431|20306999|P1|NOT COMPLETED|Overall Study||6
8235106|NCT01965431|20306994|P6|COMPLETED|Overall Study||2
8235107|NCT01965431|20306995|P5|COMPLETED|Overall Study||2
8235108|NCT01965431|20306996|P4|COMPLETED|Overall Study||2
8235109|NCT01965431|20306997|P3|COMPLETED|Overall Study||2
8235110|NCT01965431|20306998|P2|COMPLETED|Overall Study||2
8235111|NCT01965431|20306999|P1|COMPLETED|Overall Study||2
8235112|NCT01965431|20306994|P6|STARTED|Overall Study||8
8235113|NCT01965431|20306995|P5|STARTED|Overall Study||8
8235114|NCT01965431|20306996|P4|STARTED|Overall Study||8
8235115|NCT01965431|20306997|P3|STARTED|Overall Study||8
8235116|NCT01965431|20306998|P2|STARTED|Overall Study||8
8235117|NCT01965431|20306999|P1|STARTED|Overall Study|Started are actually Treated subjects|8
8235118|NCT01965366|20307014|P2|NOT COMPLETED|Overall Study||5
8235119|NCT01965366|20307015|P1|NOT COMPLETED|Overall Study||10
8235120|NCT01965366|20307014|P2|COMPLETED|Overall Study||9
8235121|NCT01965366|20307015|P1|COMPLETED|Overall Study||3
8235122|NCT01965366|20307014|P2|STARTED|Overall Study||14
8235123|NCT01965366|20307015|P1|STARTED|Overall Study||13
8235124|NCT01965327|20307023|P1|NOT COMPLETED|Overall Study||2
8235125|NCT01965327|20307023|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
8235126|NCT01965327|20307023|P1|STARTED|Overall Study||12
8235127|NCT01965288|20307030|P2|NOT COMPLETED|Overall Study||0
8235128|NCT01965288|20307031|P1|NOT COMPLETED|Overall Study||0
8235129|NCT01965288|20307030|P2|COMPLETED|Overall Study||30
8235130|NCT01965288|20307031|P1|COMPLETED|Overall Study||30
8235131|NCT01965288|20307030|P2|STARTED|Overall Study||30
8235132|NCT01965288|20307031|P1|STARTED|Overall Study||30
8235133|NCT01965262|20307237|P2|NOT COMPLETED|Second Intervention (7 Days)||10
8235134|NCT01965262|20307238|P1|NOT COMPLETED|Second Intervention (7 Days)||1
8235135|NCT01965262|20307237|P2|COMPLETED|Second Intervention (7 Days)||5
8235136|NCT01965262|20307238|P1|COMPLETED|Second Intervention (7 Days)||14
8235137|NCT01965262|20307237|P2|STARTED|Second Intervention (7 Days)||15
8235138|NCT01965262|20307238|P1|STARTED|Second Intervention (7 Days)||15
8235139|NCT01965262|20307237|P2|NOT COMPLETED|First Intervention (7 Days)||0
8235140|NCT01965262|20307238|P1|NOT COMPLETED|First Intervention (7 Days)||0
8235141|NCT01965262|20307237|P2|COMPLETED|First Intervention (7 Days)||15
8235142|NCT01965262|20307238|P1|COMPLETED|First Intervention (7 Days)||15
8235143|NCT01965262|20307237|P2|STARTED|First Intervention (7 Days)||15
8235144|NCT01965262|20307238|P1|STARTED|First Intervention (7 Days)||15
8235145|NCT01965158|20307302|P2|NOT COMPLETED|Overall Study||35
8235146|NCT01965158|20307303|P1|NOT COMPLETED|Overall Study||41
8235147|NCT01965158|20307302|P2|COMPLETED|Overall Study||238
8235148|NCT01965158|20307303|P1|COMPLETED|Overall Study||233
8235149|NCT01965158|20307302|P2|Received Treatment|Overall Study||273
8235150|NCT01965158|20307303|P1|Received Treatment|Overall Study||272
8235151|NCT01965158|20307302|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
8235152|NCT01965158|20307303|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
8235153|NCT01965067|20307319|P2|NOT COMPLETED|Overall Study||0
8235154|NCT01965067|20307320|P1|NOT COMPLETED|Overall Study||0
8235155|NCT01965067|20307319|P2|COMPLETED|Overall Study||30
8235156|NCT01965067|20307320|P1|COMPLETED|Overall Study||30
8235157|NCT01965067|20307319|P2|STARTED|Overall Study||30
8235158|NCT01965067|20307320|P1|STARTED|Overall Study||30
8235159|NCT01965002|20307336|P1|NOT COMPLETED|Overall Study||0
8235160|NCT01965002|20307336|P1|COMPLETED|Overall Study||5
8235161|NCT01965002|20307336|P1|STARTED|Overall Study||5
8235162|NCT01964976|20307344|P1|NOT COMPLETED|Overall Study||31
8235163|NCT01964976|20307344|P1|COMPLETED|Overall Study||1065
8235164|NCT01964976|20307344|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
8235165|NCT01964963|20307356|P1|NOT COMPLETED|Overall Study||943
8235166|NCT01964963|20307356|P1|COMPLETED|Overall Study||18249
8235167|NCT01964963|20307356|P1|STARTED|Overall Study||19192
8235168|NCT01964950|20307364|P1|NOT COMPLETED|Overall Study||25
8235169|NCT01964950|20307364|P1|COMPLETED|Overall Study||1076
8235170|NCT01964950|20307364|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
8235171|NCT01964924|20307376|P2|NOT COMPLETED|Trametinib + GSK2141||0
8235172|NCT01964924|20307377|P1|NOT COMPLETED|Trametinib + GSK2141||0
8235173|NCT01964924|20307376|P2|COMPLETED|Trametinib + GSK2141||19
8235174|NCT01964924|20307377|P1|COMPLETED|Trametinib + GSK2141||0
8235175|NCT01964924|20307376|P2|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
8235176|NCT01964924|20307377|P1|STARTED|Trametinib + GSK2141||0
8235177|NCT01964924|20307376|P2|NOT COMPLETED|Trametinib Monotherapy||0
8235178|NCT01964924|20307377|P1|NOT COMPLETED|Trametinib Monotherapy||19
8235179|NCT01964924|20307376|P2|COMPLETED|Trametinib Monotherapy||0
8235180|NCT01964924|20307377|P1|COMPLETED|Trametinib Monotherapy||18
8235181|NCT01964924|20307376|P2|STARTED|Trametinib Monotherapy||0
8235182|NCT01964924|20307377|P1|STARTED|Trametinib Monotherapy||37
8235183|NCT01964898|20307401|P2|NOT COMPLETED|Overall Study||7
8235184|NCT01964898|20307402|P1|NOT COMPLETED|Overall Study||7
8235185|NCT01964898|20307401|P2|COMPLETED|Overall Study||26
8235186|NCT01964898|20307402|P1|COMPLETED|Overall Study||24
8235187|NCT01964898|20307401|P2|12 Week Assessment|Overall Study||30
8235188|NCT01964898|20307402|P1|12 Week Assessment|Overall Study||25
8235189|NCT01964898|20307401|P2|STARTED|Overall Study||33
8235190|NCT01964898|20307402|P1|STARTED|Overall Study||31
8235191|NCT01964755|20307422|P1|NOT COMPLETED|Overall Study||2
8235192|NCT01964755|20307422|P1|COMPLETED|Overall Study||4
8235193|NCT01964755|20307422|P1|Cycle 5|Overall Study||4
8235194|NCT01964755|20307422|P1|Cycle 4|Overall Study||4
8235195|NCT01964755|20307422|P1|Cycle 3|Overall Study||4
8235196|NCT01964755|20307422|P1|Cycle 2|Overall Study||5
8235197|NCT01964755|20307422|P1|STARTED|Overall Study||6
8235198|NCT01964716|20307437|P2|NOT COMPLETED|Overall Study||6
8235199|NCT01964716|20307438|P1|NOT COMPLETED|Overall Study||5
8235200|NCT01964716|20307437|P2|COMPLETED|Overall Study||244
8235201|NCT01964716|20307438|P1|COMPLETED|Overall Study||245
8235202|NCT01964716|20307437|P2|Vaccinated Dose 3|Overall Study||244
8235203|NCT01964716|20307438|P1|Vaccinated Dose 3|Overall Study||247
8235204|NCT01964716|20307437|P2|Vaccinated Dose 2|Overall Study||248
8235205|NCT01964716|20307438|P1|Vaccinated Dose 2|Overall Study||249
8235206|NCT01964716|20307437|P2|Vaccinated Dose 1|Overall Study||250
8235207|NCT01964716|20307438|P1|Vaccinated Dose 1|Overall Study||250
8235208|NCT01964716|20307437|P2|STARTED|Overall Study||250
8235209|NCT01964716|20307438|P1|STARTED|Overall Study||250
8235210|NCT01964547|20307476|P2|NOT COMPLETED|Overall Study||11
8235211|NCT01964547|20307477|P1|NOT COMPLETED|Overall Study||12
8235212|NCT01964547|20307476|P2|COMPLETED|Overall Study||48
8235213|NCT01964547|20307477|P1|COMPLETED|Overall Study||50
8235214|NCT01964547|20307476|P2|STARTED|Overall Study||59
8235215|NCT01964547|20307477|P1|STARTED|Overall Study||62
8235216|NCT01964521|20307501|P1|NOT COMPLETED|Overall Study||4
8235217|NCT01964521|20307501|P1|COMPLETED|Overall Study||20
8235218|NCT01964521|20307501|P1|STARTED|Overall Study||24
8235219|NCT01964430|20307508|P2|NOT COMPLETED|Overall Study||124
8235220|NCT01964430|20307509|P1|NOT COMPLETED|Overall Study||145
8235221|NCT01964430|20307508|P2|COMPLETED|Overall Study||310
8235222|NCT01964430|20307509|P1|COMPLETED|Overall Study||287
8235223|NCT01964430|20307508|P2|Treated Population|Overall Study||423
8235224|NCT01964430|20307509|P1|Treated Population|Overall Study||429
8235225|NCT01964430|20307508|P2|STARTED|Overall Study||434
8235226|NCT01964430|20307509|P1|STARTED|Overall Study||432
8235227|NCT01964378|20307521|P2|NOT COMPLETED|Overall Study||21
8235228|NCT01964378|20307522|P1|NOT COMPLETED|Overall Study||25
8235229|NCT01964378|20307521|P2|COMPLETED|Overall Study||45
8235230|NCT01964378|20307522|P1|COMPLETED|Overall Study||41
8235231|NCT01964378|20307521|P2|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
8235232|NCT01964378|20307522|P1|Participants Treated (Safety Set)|Overall Study||65
8235233|NCT01964378|20307521|P2|STARTED|Overall Study||66
8235234|NCT01964378|20307522|P1|STARTED|Overall Study||66
8235235|NCT01964352|20307558|P4|NOT COMPLETED|Overall Study||8
8235236|NCT01964352|20307559|P3|NOT COMPLETED|Overall Study||6
8235237|NCT01964352|20307560|P2|NOT COMPLETED|Overall Study||11
8235238|NCT01964352|20307561|P1|NOT COMPLETED|Overall Study||26
8235239|NCT01964352|20307558|P4|COMPLETED|Overall Study||195
8235240|NCT01964352|20307559|P3|COMPLETED|Overall Study||196
8235241|NCT01964352|20307560|P2|COMPLETED|Overall Study||192
8235242|NCT01964352|20307561|P1|COMPLETED|Overall Study||178
8235243|NCT01964352|20307558|P4|STARTED|Overall Study||203
8235244|NCT01964352|20307559|P3|STARTED|Overall Study||202
8235245|NCT01964352|20307560|P2|STARTED|Overall Study||203
8235246|NCT01964352|20307561|P1|STARTED|Overall Study||204
8235250|NCT01964300|20307600|P2|NOT COMPLETED|Overall Study||11
8235251|NCT01964300|20307601|P1|NOT COMPLETED|Overall Study||6
8235252|NCT01964300|20307600|P2|COMPLETED|Overall Study||1
8235253|NCT01964300|20307601|P1|COMPLETED|Overall Study||1
8235254|NCT01964300|20307600|P2|STARTED|Overall Study||12
8235255|NCT01964300|20307601|P1|STARTED|Overall Study||7
8235256|NCT01964222|20307615|P2|NOT COMPLETED|Overall Study||11
8235257|NCT01964222|20307616|P1|NOT COMPLETED|Overall Study||15
8235258|NCT01964222|20307615|P2|COMPLETED|Overall Study||89
8235259|NCT01964222|20307616|P1|COMPLETED|Overall Study||86
8235260|NCT01964222|20307615|P2|STARTED|Overall Study||100
8235261|NCT01964222|20307616|P1|STARTED|Overall Study||101
8235262|NCT01964105|20307633|P3|NOT COMPLETED|Overall Study||0
8235263|NCT01964105|20307634|P2|NOT COMPLETED|Overall Study||13
8235264|NCT01964105|20307635|P1|NOT COMPLETED|Overall Study||2
8235265|NCT01964105|20307633|P3|COMPLETED|Overall Study||10
8235266|NCT01964105|20307634|P2|COMPLETED|Overall Study||62
8235267|NCT01964105|20307635|P1|COMPLETED|Overall Study||13
8235268|NCT01964105|20307633|P3|STARTED|Overall Study||10
8235269|NCT01964105|20307634|P2|STARTED|Overall Study||75
8235270|NCT01964105|20307635|P1|STARTED|Overall Study||15
8235271|NCT01964092|20307645|P2|NOT COMPLETED|Overall Study||0
8235272|NCT01964092|20307646|P1|NOT COMPLETED|Overall Study||2
8235273|NCT01964092|20307645|P2|COMPLETED|Overall Study||181
8235274|NCT01964092|20307646|P1|COMPLETED|Overall Study||227
8235275|NCT01964092|20307645|P2|STARTED|Overall Study||181
8235276|NCT01964092|20307646|P1|STARTED|Overall Study||229
8235277|NCT01963923|20307654|P2|NOT COMPLETED|3 Months Post-surgery||1
8235278|NCT01963923|20307655|P1|NOT COMPLETED|3 Months Post-surgery||2
8235279|NCT01963923|20307654|P2|COMPLETED|3 Months Post-surgery||9
8235280|NCT01963923|20307655|P1|COMPLETED|3 Months Post-surgery||10
8235281|NCT01963923|20307654|P2|STARTED|3 Months Post-surgery||10
8235282|NCT01963923|20307655|P1|STARTED|3 Months Post-surgery||12
8235283|NCT01963923|20307654|P2|NOT COMPLETED|3 Weeks Post-surgery||10
8235284|NCT01963923|20307655|P1|NOT COMPLETED|3 Weeks Post-surgery||8
8235285|NCT01963923|20307654|P2|COMPLETED|3 Weeks Post-surgery||10
8235286|NCT01963923|20307655|P1|COMPLETED|3 Weeks Post-surgery||12
8235287|NCT01963923|20307654|P2|STARTED|3 Weeks Post-surgery||20
8235288|NCT01963923|20307655|P1|STARTED|3 Weeks Post-surgery||20
8235289|NCT01963845|20307677|P2|NOT COMPLETED|Overall Study||0
8235290|NCT01963845|20307678|P1|NOT COMPLETED|Overall Study||0
8235291|NCT01963845|20307677|P2|COMPLETED|Overall Study||25
8235292|NCT01963845|20307678|P1|COMPLETED|Overall Study||25
8235293|NCT01963845|20307677|P2|STARTED|Overall Study||25
8235294|NCT01963845|20307678|P1|STARTED|Overall Study||25
8235295|NCT01963767|20307694|P2|NOT COMPLETED|Overall Study||2
8235296|NCT01963767|20307695|P1|NOT COMPLETED|Overall Study||6
8235297|NCT01963767|20307694|P2|COMPLETED|Overall Study||53
8235298|NCT01963767|20307695|P1|COMPLETED|Overall Study||52
8235299|NCT01963767|20307694|P2|STARTED|Overall Study||55
8235300|NCT01963767|20307695|P1|STARTED|Overall Study||58
8235301|NCT01963676|20307705|P2|NOT COMPLETED|Overall Study||0
8235302|NCT01963676|20307706|P1|NOT COMPLETED|Overall Study||1
8235303|NCT01963676|20307705|P2|COMPLETED|Overall Study||13
8235304|NCT01963676|20307706|P1|COMPLETED|Overall Study||13
8235305|NCT01963676|20307705|P2|STARTED|Overall Study||13
8235306|NCT01963676|20307706|P1|STARTED|Overall Study||14
8235307|NCT01963611|20307719|P5|NOT COMPLETED|Overall Study||51
8235308|NCT01963611|20307720|P4|NOT COMPLETED|Overall Study||52
8235309|NCT01963611|20307721|P3|NOT COMPLETED|Overall Study||52
8235310|NCT01963611|20307722|P2|NOT COMPLETED|Overall Study||49
8235311|NCT01963611|20307723|P1|NOT COMPLETED|Overall Study||51
8235312|NCT01963611|20307719|P5|COMPLETED|Overall Study||0
8235313|NCT01963611|20307720|P4|COMPLETED|Overall Study||0
8235314|NCT01963611|20307721|P3|COMPLETED|Overall Study||0
8235315|NCT01963611|20307722|P2|COMPLETED|Overall Study||0
8235316|NCT01963611|20307723|P1|COMPLETED|Overall Study||0
8235317|NCT01963611|20307719|P5|Safety Analysis Set|Overall Study||50
8235318|NCT01963611|20307720|P4|Safety Analysis Set|Overall Study||52
8235319|NCT01963611|20307721|P3|Safety Analysis Set|Overall Study||52
8235320|NCT01963611|20307722|P2|Safety Analysis Set|Overall Study||49
8235321|NCT01963611|20307723|P1|Safety Analysis Set|Overall Study||51
8235322|NCT01963611|20307719|P5|STARTED|Overall Study||51
8235323|NCT01963611|20307720|P4|STARTED|Overall Study||52
8235324|NCT01963611|20307721|P3|STARTED|Overall Study||52
8235325|NCT01963611|20307722|P2|STARTED|Overall Study||49
8235326|NCT01963611|20307723|P1|STARTED|Overall Study||51
8235327|NCT01963481|20307780|P1|NOT COMPLETED|Overall Study||0
8235328|NCT01963481|20307780|P1|COMPLETED|Overall Study||23
8235329|NCT01963481|20307780|P1|STARTED|Overall Study||23
8235330|NCT01963403|20307788|P2|NOT COMPLETED|Overall Study||4
8235331|NCT01963403|20307789|P1|NOT COMPLETED|Overall Study||2
8235332|NCT01963403|20307788|P2|COMPLETED|Overall Study|Follow-up over three months|9
8235333|NCT01963403|20307789|P1|COMPLETED|Overall Study|Follow-up over three months|11
8235334|NCT01963403|20307788|P2|STARTED|Overall Study||13
8235335|NCT01963403|20307789|P1|STARTED|Overall Study||13
8235336|NCT01963260|20307811|P10|NOT COMPLETED|Overall Study||0
8235337|NCT01963260|20307812|P9|NOT COMPLETED|Overall Study||0
8235338|NCT01963260|20307813|P8|NOT COMPLETED|Overall Study||0
8235339|NCT01963260|20307814|P7|NOT COMPLETED|Overall Study||0
8235340|NCT01963260|20307815|P6|NOT COMPLETED|Overall Study||0
8235341|NCT01963260|20307816|P5|NOT COMPLETED|Overall Study||2
8235342|NCT01963260|20307817|P4|NOT COMPLETED|Overall Study||1
8235343|NCT01963260|20307818|P3|NOT COMPLETED|Overall Study||0
8235344|NCT01963260|20307819|P2|NOT COMPLETED|Overall Study||0
8235345|NCT01963260|20307820|P1|NOT COMPLETED|Overall Study||2
8235346|NCT01963260|20307811|P10|COMPLETED|Overall Study||4
8235347|NCT01963260|20307812|P9|COMPLETED|Overall Study||1
8235348|NCT01963260|20307813|P8|COMPLETED|Overall Study||2
8235349|NCT01963260|20307814|P7|COMPLETED|Overall Study||3
8235350|NCT01963260|20307815|P6|COMPLETED|Overall Study||10
8235351|NCT01963260|20307816|P5|COMPLETED|Overall Study||4
8235352|NCT01963260|20307817|P4|COMPLETED|Overall Study||5
8235353|NCT01963260|20307818|P3|COMPLETED|Overall Study||6
8235354|NCT01963260|20307819|P2|COMPLETED|Overall Study||6
8235355|NCT01963260|20307820|P1|COMPLETED|Overall Study||4
8235356|NCT01963260|20307811|P10|Treated|Overall Study||4
8235357|NCT01963260|20307812|P9|Treated|Overall Study||1
8235358|NCT01963260|20307813|P8|Treated|Overall Study||2
8235359|NCT01963260|20307814|P7|Treated|Overall Study||3
8235360|NCT01963260|20307815|P6|Treated|Overall Study||10
8235361|NCT01963260|20307816|P5|Treated|Overall Study||6
8235362|NCT01963260|20307817|P4|Treated|Overall Study||6
8235363|NCT01963260|20307818|P3|Treated|Overall Study||6
8235364|NCT01963260|20307819|P2|Treated|Overall Study||6
8235365|NCT01963260|20307820|P1|Treated|Overall Study||6
8235366|NCT01963260|20307811|P10|STARTED|Overall Study||4
8235367|NCT01963260|20307812|P9|STARTED|Overall Study||1
8235368|NCT01963260|20307813|P8|STARTED|Overall Study||2
8235369|NCT01963260|20307814|P7|STARTED|Overall Study||3
8235370|NCT01963260|20307815|P6|STARTED|Overall Study||10
8235371|NCT01963260|20307816|P5|STARTED|Overall Study||6
8235372|NCT01963260|20307817|P4|STARTED|Overall Study||6
8235373|NCT01963260|20307818|P3|STARTED|Overall Study||6
8235374|NCT01963260|20307819|P2|STARTED|Overall Study||6
8235375|NCT01963260|20307820|P1|STARTED|Overall Study||6
8235376|NCT01963234|20307875|P2|NOT COMPLETED|Overall Study||0
8235377|NCT01963234|20307876|P1|NOT COMPLETED|Overall Study||61
8235378|NCT01963234|20307875|P2|COMPLETED|Overall Study||171
8235379|NCT01963234|20307876|P1|COMPLETED|Overall Study||207
8235380|NCT01963234|20307875|P2|STARTED|Overall Study||171
8235381|NCT01963234|20307876|P1|STARTED|Overall Study||268
8235382|NCT01963169|20307903|P3|NOT COMPLETED|Overall Study||26
8235383|NCT01963169|20307904|P2|NOT COMPLETED|Overall Study||82
8235384|NCT01963169|20307905|P1|NOT COMPLETED|Overall Study||59
8235385|NCT01963169|20307903|P3|COMPLETED|Overall Study||237
8235386|NCT01963169|20307904|P2|COMPLETED|Overall Study||220
8235387|NCT01963169|20307905|P1|COMPLETED|Overall Study||242
8235388|NCT01963169|20307903|P3|STARTED|Overall Study||263
8235389|NCT01963169|20307904|P2|STARTED|Overall Study||302
8235390|NCT01963169|20307905|P1|STARTED|Overall Study||301
8235391|NCT01963143|20307922|P3|NOT COMPLETED|Overall Study||1
8235392|NCT01963143|20307923|P2|NOT COMPLETED|Overall Study||1
8235393|NCT01963143|20307924|P1|NOT COMPLETED|Overall Study||0
8235394|NCT01963143|20307922|P3|COMPLETED|Overall Study||14
8235395|NCT01963143|20307923|P2|COMPLETED|Overall Study||18
8235396|NCT01963143|20307924|P1|COMPLETED|Overall Study||14
8235397|NCT01963143|20307922|P3|STARTED|Overall Study||15
8235398|NCT01963143|20307923|P2|STARTED|Overall Study||19
8235399|NCT01963143|20307924|P1|STARTED|Overall Study||14
8235400|NCT01963117|20307934|P1|NOT COMPLETED|Overall Study||1
8235401|NCT01963117|20307934|P1|COMPLETED|Overall Study||10
8235402|NCT01963117|20307934|P1|STARTED|Overall Study||11
8235403|NCT01963091|20307945|P2|NOT COMPLETED|Overall Study||0
8235404|NCT01963091|20307946|P1|NOT COMPLETED|Overall Study||0
8235405|NCT01963091|20307945|P2|COMPLETED|Overall Study||16
8235406|NCT01963091|20307946|P1|COMPLETED|Overall Study||17
8235407|NCT01963091|20307945|P2|STARTED|Overall Study||16
8235408|NCT01963091|20307946|P1|STARTED|Overall Study||17
8235409|NCT01963078|20307960|P4|NOT COMPLETED|Overall Study||2
8235410|NCT01963078|20307961|P3|NOT COMPLETED|Overall Study||1
8235411|NCT01963078|20307962|P2|NOT COMPLETED|Overall Study||1
8235412|NCT01963078|20307963|P1|NOT COMPLETED|Overall Study||1
8235413|NCT01963078|20307960|P4|COMPLETED|Overall Study||7
8235414|NCT01963078|20307961|P3|COMPLETED|Overall Study||9
8235415|NCT01963078|20307962|P2|COMPLETED|Overall Study||9
8235416|NCT01963078|20307963|P1|COMPLETED|Overall Study||8
8235417|NCT01963078|20307960|P4|STARTED|Overall Study||9
8235418|NCT01963078|20307961|P3|STARTED|Overall Study||10
8235419|NCT01963078|20307962|P2|STARTED|Overall Study||10
8235420|NCT01963078|20307963|P1|STARTED|Overall Study||9
8235421|NCT01962987|20307976|P3|NOT COMPLETED|Overall Study||12
8235422|NCT01962987|20307977|P2|NOT COMPLETED|Overall Study||28
8235423|NCT01962987|20307978|P1|NOT COMPLETED|Overall Study||30
8235424|NCT01962987|20307976|P3|COMPLETED|Overall Study||83
8235425|NCT01962987|20307977|P2|COMPLETED|Overall Study||163
8235426|NCT01962987|20307978|P1|COMPLETED|Overall Study||160
8235427|NCT01962987|20307976|P3|STARTED|Overall Study||95
8235428|NCT01962987|20307977|P2|STARTED|Overall Study||191
8235429|NCT01962987|20307978|P1|STARTED|Overall Study||190
8235430|NCT01962974|20307986|P1|NOT COMPLETED|Overall Study||7
8235431|NCT01962974|20307986|P1|COMPLETED|Overall Study||0
8235432|NCT01962974|20307986|P1|STARTED|Overall Study||7
8235433|NCT01962961|20307995|P3|NOT COMPLETED|Overall Study||1
8235434|NCT01962961|20307996|P2|NOT COMPLETED|Overall Study||1
8235435|NCT01962961|20307997|P1|NOT COMPLETED|Overall Study||0
8235436|NCT01962961|20307995|P3|COMPLETED|Overall Study||6
8235437|NCT01962961|20307996|P2|COMPLETED|Overall Study||7
8235438|NCT01962961|20307997|P1|COMPLETED|Overall Study||9
8235439|NCT01962961|20307995|P3|STARTED|Overall Study||7
8235440|NCT01962961|20307996|P2|STARTED|Overall Study||8
8235441|NCT01962961|20307997|P1|STARTED|Overall Study||9
8235442|NCT01962922|20308013|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
8235443|NCT01962922|20308014|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
8235444|NCT01962922|20308013|P2|COMPLETED|Extendion Portion (up to Month 6)||20
8235445|NCT01962922|20308014|P1|COMPLETED|Extendion Portion (up to Month 6)||18
8235446|NCT01962922|20308013|P2|STARTED|Extendion Portion (up to Month 6)||23
8235447|NCT01962922|20308014|P1|STARTED|Extendion Portion (up to Month 6)||23
8235448|NCT01962922|20308013|P2|NOT COMPLETED|PK Portion Day 21||0
8235449|NCT01962922|20308014|P1|NOT COMPLETED|PK Portion Day 21||0
8235450|NCT01962922|20308013|P2|COMPLETED|PK Portion Day 21||23
8235451|NCT01962922|20308014|P1|COMPLETED|PK Portion Day 21||23
8235452|NCT01962922|20308013|P2|STARTED|PK Portion Day 21||23
8235453|NCT01962922|20308014|P1|STARTED|PK Portion Day 21||23
8235454|NCT01962922|20308013|P2|NOT COMPLETED|PK Portion Day 14||0
8235455|NCT01962922|20308014|P1|NOT COMPLETED|PK Portion Day 14||0
8235456|NCT01962922|20308013|P2|COMPLETED|PK Portion Day 14||23
8235457|NCT01962922|20308014|P1|COMPLETED|PK Portion Day 14||23
8235458|NCT01962922|20308013|P2|STARTED|PK Portion Day 14||23
8235459|NCT01962922|20308014|P1|STARTED|PK Portion Day 14||23
8235460|NCT01962922|20308013|P2|NOT COMPLETED|PK Portion Day 7||0
8235461|NCT01962922|20308014|P1|NOT COMPLETED|PK Portion Day 7||4
8235462|NCT01962922|20308013|P2|COMPLETED|PK Portion Day 7||23
8235463|NCT01962922|20308014|P1|COMPLETED|PK Portion Day 7||23
8235464|NCT01962922|20308013|P2|STARTED|PK Portion Day 7||23
8235465|NCT01962922|20308014|P1|STARTED|PK Portion Day 7||27
8235466|NCT01962896|20308036|P1|NOT COMPLETED|Overall Study||4
8235467|NCT01962896|20308036|P1|COMPLETED|Overall Study||0
8235468|NCT01962896|20308036|P1|STARTED|Overall Study||4
8235469|NCT01962870|20308045|P2|NOT COMPLETED|Overall Study||0
8235470|NCT01962870|20308046|P1|NOT COMPLETED|Overall Study||0
8235471|NCT01962870|20308045|P2|COMPLETED|Overall Study||17
8235472|NCT01962870|20308046|P1|COMPLETED|Overall Study||13
8235473|NCT01962870|20308045|P2|STARTED|Overall Study||17
8235474|NCT01962870|20308046|P1|STARTED|Overall Study||13
8235475|NCT01962714|20308094|P2|NOT COMPLETED|Overall Study||33
8235476|NCT01962714|20308095|P1|NOT COMPLETED|Overall Study||30
8235477|NCT01962714|20308094|P2|COMPLETED|Overall Study||60
8235478|NCT01962714|20308095|P1|COMPLETED|Overall Study||61
8235479|NCT01962714|20308094|P2|3-month Follow-up|Overall Study||56
8235480|NCT01962714|20308095|P1|3-month Follow-up|Overall Study||58
8235481|NCT01962714|20308094|P2|Immediate Post-treatment Assessment|Overall Study||57
8235482|NCT01962714|20308095|P1|Immediate Post-treatment Assessment|Overall Study||63
8235483|NCT01962714|20308094|P2|STARTED|Overall Study||93
8235484|NCT01962714|20308095|P1|STARTED|Overall Study||91
8235485|NCT01962688|20308105|P2|NOT COMPLETED|Overall Study||0
8235486|NCT01962688|20308106|P1|NOT COMPLETED|Overall Study||0
8235487|NCT01962688|20308105|P2|COMPLETED|Overall Study||18
8235488|NCT01962688|20308106|P1|COMPLETED|Overall Study||19
8235489|NCT01962688|20308105|P2|STARTED|Overall Study||18
8235490|NCT01962688|20308106|P1|STARTED|Overall Study||19
8235491|NCT01962675|20308124|P2|NOT COMPLETED|Overall Study||0
8235492|NCT01962675|20308125|P1|NOT COMPLETED|Overall Study||0
8235493|NCT01962675|20308124|P2|COMPLETED|Overall Study||7
8235494|NCT01962675|20308125|P1|COMPLETED|Overall Study||7
8235495|NCT01962675|20308124|P2|STARTED|Overall Study||7
8235496|NCT01962675|20308125|P1|STARTED|Overall Study||7
8235497|NCT01962558|20308139|P2|NOT COMPLETED|Overall Study||0
8235498|NCT01962558|20308140|P1|NOT COMPLETED|Overall Study||0
8235499|NCT01962558|20308139|P2|COMPLETED|Overall Study||14
8235500|NCT01962558|20308140|P1|COMPLETED|Overall Study||16
8235501|NCT01962558|20308139|P2|12-Weeks|Overall Study||14
8235502|NCT01962558|20308140|P1|12-Weeks|Overall Study||16
8235503|NCT01962558|20308139|P2|Acute Study|Overall Study||14
8235504|NCT01962558|20308140|P1|Acute Study|Overall Study||16
8235505|NCT01962558|20308139|P2|STARTED|Overall Study||14
8235506|NCT01962558|20308140|P1|STARTED|Overall Study||16
8235507|NCT01962493|20308158|P2|NOT COMPLETED|Overall Study||5
8235508|NCT01962493|20308159|P1|NOT COMPLETED|Overall Study||5
8235509|NCT01962493|20308158|P2|COMPLETED|Overall Study||77
8235510|NCT01962493|20308159|P1|COMPLETED|Overall Study||73
8235511|NCT01962493|20308158|P2|STARTED|Overall Study||82
8235512|NCT01962493|20308159|P1|STARTED|Overall Study||78
8235513|NCT01962441|20308182|P3|NOT COMPLETED|Retreatment Substudy||0
8235514|NCT01962441|20308183|P2|NOT COMPLETED|Retreatment Substudy||0
8235515|NCT01962441|20308184|P1|NOT COMPLETED|Retreatment Substudy||2
8235516|NCT01962441|20308182|P3|COMPLETED|Retreatment Substudy||0
8235517|NCT01962441|20308183|P2|COMPLETED|Retreatment Substudy||10
8235518|NCT01962441|20308184|P1|COMPLETED|Retreatment Substudy||18
8235519|NCT01962441|20308182|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
8235520|NCT01962441|20308183|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
8235521|NCT01962441|20308184|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
8235522|NCT01962441|20308182|P3|NOT COMPLETED|Randomized Period||11
8235523|NCT01962441|20308183|P2|NOT COMPLETED|Randomized Period||11
8235524|NCT01962441|20308184|P1|NOT COMPLETED|Randomized Period||10
8235525|NCT01962441|20308182|P3|COMPLETED|Randomized Period||189
8235526|NCT01962441|20308183|P2|COMPLETED|Randomized Period||190
8235527|NCT01962441|20308184|P1|COMPLETED|Randomized Period||190
8235528|NCT01962441|20308182|P3|STARTED|Randomized Period||200
8235529|NCT01962441|20308183|P2|STARTED|Randomized Period||201
8235530|NCT01962441|20308184|P1|STARTED|Randomized Period||200
8235531|NCT01962428|20308216|P2|NOT COMPLETED|Overall Study||6
8235532|NCT01962428|20308217|P1|NOT COMPLETED|Overall Study||10
8235533|NCT01962428|20308216|P2|COMPLETED|Overall Study||133
8235534|NCT01962428|20308217|P1|COMPLETED|Overall Study||129
8235535|NCT01962428|20308216|P2|STARTED|Overall Study||139
8235536|NCT01962428|20308217|P1|STARTED|Overall Study||139
8235537|NCT01962298|20308228|P5|NOT COMPLETED|Overall Study||6
8235538|NCT01962298|20308229|P4|NOT COMPLETED|Overall Study||2
8235539|NCT01962298|20308230|P3|NOT COMPLETED|Overall Study||5
8235540|NCT01962298|20308231|P2|NOT COMPLETED|Overall Study||4
8235541|NCT01962298|20308232|P1|NOT COMPLETED|Overall Study||3
8235542|NCT01962298|20308228|P5|COMPLETED|Overall Study||9
8235543|NCT01962298|20308229|P4|COMPLETED|Overall Study||13
8235544|NCT01962298|20308230|P3|COMPLETED|Overall Study||10
8235545|NCT01962298|20308231|P2|COMPLETED|Overall Study||11
8235546|NCT01962298|20308232|P1|COMPLETED|Overall Study||12
8235547|NCT01962298|20308228|P5|Received Intervention|Overall Study||15
8235548|NCT01962298|20308229|P4|Received Intervention|Overall Study||15
8235549|NCT01962298|20308230|P3|Received Intervention|Overall Study||15
8235550|NCT01962298|20308231|P2|Received Intervention|Overall Study||15
8235551|NCT01962298|20308232|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
8235552|NCT01962298|20308228|P5|STARTED|Overall Study||15
8235553|NCT01962298|20308229|P4|STARTED|Overall Study||15
8235554|NCT01962298|20308230|P3|STARTED|Overall Study||15
8235555|NCT01962298|20308231|P2|STARTED|Overall Study||15
8235556|NCT01962298|20308232|P1|STARTED|Overall Study||15
8235557|NCT01962207|20308253|P4|NOT COMPLETED|Booster Phase (6 Months)||0
8235558|NCT01962207|20308254|P3|NOT COMPLETED|Booster Phase (6 Months)||0
8235559|NCT01962207|20308255|P2|NOT COMPLETED|Booster Phase (6 Months)||0
8235560|NCT01962207|20308256|P1|NOT COMPLETED|Booster Phase (6 Months)||0
8235561|NCT01962207|20308253|P4|COMPLETED|Booster Phase (6 Months)||21
8235562|NCT01962207|20308254|P3|COMPLETED|Booster Phase (6 Months)||77
8235563|NCT01962207|20308255|P2|COMPLETED|Booster Phase (6 Months)||16
8235564|NCT01962207|20308256|P1|COMPLETED|Booster Phase (6 Months)||67
8235565|NCT01962207|20308253|P4|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
8235566|NCT01962207|20308254|P3|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
8235567|NCT01962207|20308255|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
8235568|NCT01962207|20308256|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
8235569|NCT01962207|20308253|P4|NOT COMPLETED|Persistence Phase (5 Years)||12
8235570|NCT01962207|20308254|P3|NOT COMPLETED|Persistence Phase (5 Years)||44
8235571|NCT01962207|20308255|P2|NOT COMPLETED|Persistence Phase (5 Years)||13
8235572|NCT01962207|20308256|P1|NOT COMPLETED|Persistence Phase (5 Years)||29
8235573|NCT01962207|20308253|P4|COMPLETED|Persistence Phase (5 Years)||17
8235574|NCT01962207|20308254|P3|COMPLETED|Persistence Phase (5 Years)||71
8235575|NCT01962207|20308255|P2|COMPLETED|Persistence Phase (5 Years)||10
8235576|NCT01962207|20308256|P1|COMPLETED|Persistence Phase (5 Years)||47
8235577|NCT01962207|20308253|P4|STARTED|Persistence Phase (5 Years)||29
8235578|NCT01962207|20308254|P3|STARTED|Persistence Phase (5 Years)||115
8235579|NCT01962207|20308255|P2|STARTED|Persistence Phase (5 Years)||23
8235580|NCT01962207|20308256|P1|STARTED|Persistence Phase (5 Years)||76
8235581|NCT01962103|20308367|P9|NOT COMPLETED|Phase 2||14
8235582|NCT01962103|20308368|P8|NOT COMPLETED|Phase 2||14
8235583|NCT01962103|20308369|P7|NOT COMPLETED|Phase 2||14
8235584|NCT01962103|20308370|P6|NOT COMPLETED|Phase 2||0
8235585|NCT01962103|20308371|P5|NOT COMPLETED|Phase 2||0
8235586|NCT01962103|20308372|P4|NOT COMPLETED|Phase 2||0
8235587|NCT01962103|20308373|P3|NOT COMPLETED|Phase 2||0
8235588|NCT01962103|20308374|P2|NOT COMPLETED|Phase 2||0
8235589|NCT01962103|20308375|P1|NOT COMPLETED|Phase 2||0
8235590|NCT01962103|20308367|P9|COMPLETED|Phase 2|completed treatment|0
8235591|NCT01962103|20308368|P8|COMPLETED|Phase 2|completed treatment|0
8235592|NCT01962103|20308369|P7|COMPLETED|Phase 2|completed treatment|0
8235593|NCT01962103|20308370|P6|COMPLETED|Phase 2||0
8235594|NCT01962103|20308371|P5|COMPLETED|Phase 2||0
8235595|NCT01962103|20308372|P4|COMPLETED|Phase 2||0
8235596|NCT01962103|20308373|P3|COMPLETED|Phase 2||0
8235597|NCT01962103|20308374|P2|COMPLETED|Phase 2||0
8235598|NCT01962103|20308375|P1|COMPLETED|Phase 2||0
8235599|NCT01962103|20308367|P9|STARTED|Phase 2||14
8235600|NCT01962103|20308368|P8|STARTED|Phase 2||14
8235601|NCT01962103|20308369|P7|STARTED|Phase 2||14
8235602|NCT01962103|20308370|P6|STARTED|Phase 2||0
8235603|NCT01962103|20308371|P5|STARTED|Phase 2||0
8235604|NCT01962103|20308372|P4|STARTED|Phase 2||0
8235605|NCT01962103|20308373|P3|STARTED|Phase 2||0
8235606|NCT01962103|20308374|P2|STARTED|Phase 2||0
8235607|NCT01962103|20308375|P1|STARTED|Phase 2||0
8235608|NCT01962103|20308367|P9|NOT COMPLETED|Phase 1||0
8235609|NCT01962103|20308368|P8|NOT COMPLETED|Phase 1||0
8235610|NCT01962103|20308369|P7|NOT COMPLETED|Phase 1||0
8235611|NCT01962103|20308370|P6|NOT COMPLETED|Phase 1||7
8235612|NCT01962103|20308371|P5|NOT COMPLETED|Phase 1||8
8235613|NCT01962103|20308372|P4|NOT COMPLETED|Phase 1||11
8235614|NCT01962103|20308373|P3|NOT COMPLETED|Phase 1||14
8235615|NCT01962103|20308374|P2|NOT COMPLETED|Phase 1||8
8235616|NCT01962103|20308375|P1|NOT COMPLETED|Phase 1||16
8235617|NCT01962103|20308367|P9|COMPLETED|Phase 1||0
8235618|NCT01962103|20308368|P8|COMPLETED|Phase 1||0
8235619|NCT01962103|20308369|P7|COMPLETED|Phase 1||0
8235620|NCT01962103|20308370|P6|COMPLETED|Phase 1||0
8235621|NCT01962103|20308371|P5|COMPLETED|Phase 1||0
8235622|NCT01962103|20308372|P4|COMPLETED|Phase 1||0
8235623|NCT01962103|20308373|P3|COMPLETED|Phase 1||0
8235624|NCT01962103|20308374|P2|COMPLETED|Phase 1||0
8235625|NCT01962103|20308375|P1|COMPLETED|Phase 1||0
8235626|NCT01962103|20308367|P9|STARTED|Phase 1||0
8235627|NCT01962103|20308368|P8|STARTED|Phase 1||0
8235628|NCT01962103|20308369|P7|STARTED|Phase 1||0
8235629|NCT01962103|20308370|P6|STARTED|Phase 1||7
8235630|NCT01962103|20308371|P5|STARTED|Phase 1||8
8235631|NCT01962103|20308372|P4|STARTED|Phase 1||11
8235632|NCT01962103|20308373|P3|STARTED|Phase 1||14
8235633|NCT01962103|20308374|P2|STARTED|Phase 1||8
8235634|NCT01962103|20308375|P1|STARTED|Phase 1||16
8235635|NCT01962025|20308477|P2|NOT COMPLETED|Overall Study||0
8235636|NCT01962025|20308478|P1|NOT COMPLETED|Overall Study||0
8235637|NCT01962025|20308477|P2|COMPLETED|Overall Study||6
8235638|NCT01962025|20308478|P1|COMPLETED|Overall Study||8
8235639|NCT01962025|20308477|P2|STARTED|Overall Study||6
8235640|NCT01962025|20308478|P1|STARTED|Overall Study||8
8235641|NCT01961921|20308492|P1|NOT COMPLETED|Overall Study||2
8235642|NCT01961921|20308492|P1|COMPLETED|Overall Study||25
8235643|NCT01961921|20308492|P1|STARTED|Overall Study||27
8235644|NCT01961687|20308502|P1|NOT COMPLETED|Overall Study||61
8235645|NCT01961687|20308502|P1|COMPLETED|Overall Study||60
8235646|NCT01961687|20308502|P1|STARTED|Overall Study||121
8235647|NCT01961609|20308516|P4|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
8235648|NCT01961609|20308517|P3|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
8235649|NCT01961609|20308518|P2|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
8235650|NCT01961609|20308519|P1|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
8235651|NCT01961609|20308516|P4|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
8235652|NCT01961609|20308517|P3|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
8235653|NCT01961609|20308518|P2|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
8235654|NCT01961609|20308519|P1|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
8235655|NCT01961609|20308516|P4|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
8235656|NCT01961609|20308517|P3|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
8235657|NCT01961609|20308518|P2|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
8235658|NCT01961609|20308519|P1|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
8235659|NCT01961609|20308516|P4|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
8235660|NCT01961609|20308517|P3|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
8235661|NCT01961609|20308518|P2|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
8235662|NCT01961609|20308519|P1|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
8235663|NCT01961609|20308516|P4|STARTED|Maintanence 2 (Weeks 49 - 72)||24
8235664|NCT01961609|20308517|P3|STARTED|Maintanence 2 (Weeks 49 - 72)||16
8235665|NCT01961609|20308518|P2|STARTED|Maintanence 2 (Weeks 49 - 72)||31
8235666|NCT01961609|20308519|P1|STARTED|Maintanence 2 (Weeks 49 - 72)||83
8235667|NCT01961609|20308516|P4|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
8235668|NCT01961609|20308517|P3|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
8235669|NCT01961609|20308518|P2|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
8235670|NCT01961609|20308519|P1|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
8235671|NCT01961609|20308516|P4|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
8235672|NCT01961609|20308517|P3|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
8235673|NCT01961609|20308518|P2|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
8235674|NCT01961609|20308519|P1|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
8235675|NCT01961609|20308516|P4|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
8235676|NCT01961609|20308517|P3|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
8235677|NCT01961609|20308518|P2|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
8235678|NCT01961609|20308519|P1|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
8235679|NCT01961609|20308516|P4|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
8235680|NCT01961609|20308517|P3|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
8235681|NCT01961609|20308518|P2|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
8235682|NCT01961609|20308519|P1|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
8235683|NCT01961609|20308516|P4|STARTED|Maintenance 1 (Weeks 17 - 48)||0
8235684|NCT01961609|20308517|P3|STARTED|Maintenance 1 (Weeks 17 - 48)||37
8235685|NCT01961609|20308518|P2|STARTED|Maintenance 1 (Weeks 17 - 48)||66
8235686|NCT01961609|20308519|P1|STARTED|Maintenance 1 (Weeks 17 - 48)||107
8235687|NCT01961609|20308516|P4|NOT COMPLETED|Initiation||0
8235688|NCT01961609|20308517|P3|NOT COMPLETED|Initiation||0
8235689|NCT01961609|20308518|P2|NOT COMPLETED|Initiation||13
8235690|NCT01961609|20308519|P1|NOT COMPLETED|Initiation||12
8235691|NCT01961609|20308516|P4|COMPLETED|Initiation||0
8235692|NCT01961609|20308517|P3|COMPLETED|Initiation||0
8235693|NCT01961609|20308518|P2|COMPLETED|Initiation||103
8235694|NCT01961609|20308519|P1|COMPLETED|Initiation||107
8235695|NCT01961609|20308516|P4|Full Analysis Set|Initiation||0
8235696|NCT01961609|20308517|P3|Full Analysis Set|Initiation||0
8235697|NCT01961609|20308518|P2|Full Analysis Set|Initiation||115
8235698|NCT01961609|20308519|P1|Full Analysis Set|Initiation||118
8235699|NCT01961609|20308516|P4|Safety Set|Initiation||0
8235700|NCT01961609|20308517|P3|Safety Set|Initiation||0
8235701|NCT01961609|20308518|P2|Safety Set|Initiation||115
8235702|NCT01961609|20308519|P1|Safety Set|Initiation||118
8235703|NCT01961609|20308516|P4|STARTED|Initiation||0
8235704|NCT01961609|20308517|P3|STARTED|Initiation||0
8235705|NCT01961609|20308518|P2|STARTED|Initiation||116
8235706|NCT01961609|20308519|P1|STARTED|Initiation||119
8235707|NCT01961544|20308571|P1|NOT COMPLETED|Overall Study||13
8235708|NCT01961544|20308571|P1|COMPLETED|Overall Study||88
8235709|NCT01961544|20308571|P1|STARTED|Overall Study||101
8235710|NCT01961531|20308576|P1|NOT COMPLETED|Overall Study||0
8235711|NCT01961531|20308576|P1|COMPLETED|Overall Study||40
8235712|NCT01961531|20308576|P1|STARTED|Overall Study||40
8235713|NCT01961362|20308581|P1|NOT COMPLETED|Overall Study||0
8235714|NCT01961362|20308581|P1|COMPLETED|Overall Study||19
8235715|NCT01961362|20308581|P1|STARTED|Overall Study||19
8235716|NCT01961349|20308590|P3|NOT COMPLETED|Overall Study||2
8235717|NCT01961349|20308591|P2|NOT COMPLETED|Overall Study||6
8235718|NCT01961349|20308592|P1|NOT COMPLETED|Overall Study||3
8235719|NCT01961349|20308590|P3|COMPLETED|Overall Study||109
8235720|NCT01961349|20308591|P2|COMPLETED|Overall Study||101
8235721|NCT01961349|20308592|P1|COMPLETED|Overall Study||51
8235722|NCT01961349|20308590|P3|STARTED|Overall Study||111
8235723|NCT01961349|20308591|P2|STARTED|Overall Study||107
8235724|NCT01961349|20308592|P1|STARTED|Overall Study||54
8235725|NCT01961323|20308603|P1|NOT COMPLETED|Overall Study||49
8235726|NCT01961323|20308603|P1|COMPLETED|Overall Study||21
8235727|NCT01961323|20308603|P1|STARTED|Overall Study||70
8235728|NCT01961297|20308611|P2|NOT COMPLETED|Overall Study||1
8235729|NCT01961297|20308612|P1|NOT COMPLETED|Overall Study||2
8235730|NCT01961297|20308611|P2|COMPLETED|Overall Study||22
8235731|NCT01961297|20308612|P1|COMPLETED|Overall Study||28
8235732|NCT01961297|20308611|P2|STARTED|Overall Study||23
8235733|NCT01961297|20308612|P1|STARTED|Overall Study||30
8235734|NCT01961271|20308626|P1|NOT COMPLETED|Overall Study||50
8235735|NCT01961271|20308626|P1|COMPLETED|Overall Study||64
8235736|NCT01961271|20308626|P1|STARTED|Overall Study||114
8235737|NCT01961167|20308635|P1|NOT COMPLETED|Overall Study||0
8235738|NCT01961167|20308635|P1|COMPLETED|Overall Study||27
8235739|NCT01961167|20308635|P1|STARTED|Overall Study||27
8235740|NCT01961115|20308676|P3|NOT COMPLETED|Overall Study||4
8235741|NCT01961115|20308677|P2|NOT COMPLETED|Overall Study||0
8235742|NCT01961115|20308678|P1|NOT COMPLETED|Overall Study||2
8235743|NCT01961115|20308676|P3|COMPLETED|Overall Study||5
8235744|NCT01961115|20308677|P2|COMPLETED|Overall Study||0
8235745|NCT01961115|20308678|P1|COMPLETED|Overall Study||0
8235746|NCT01961115|20308676|P3|STARTED|Overall Study||9
8235747|NCT01961115|20308677|P2|STARTED|Overall Study||0
8235748|NCT01961115|20308678|P1|STARTED|Overall Study||2
8235749|NCT01961089|20308713|P1|NOT COMPLETED|Overall Study||0
8235750|NCT01961089|20308713|P1|COMPLETED|Overall Study||40
8235751|NCT01961089|20308713|P1|STARTED|Overall Study||40
8235752|NCT01960907|20308721|P2|NOT COMPLETED|Overall Study||45
8235753|NCT01960907|20308722|P1|NOT COMPLETED|Overall Study||36
8235754|NCT01960907|20308721|P2|COMPLETED|Overall Study||109
8235755|NCT01960907|20308722|P1|COMPLETED|Overall Study||122
8235756|NCT01960907|20308721|P2|STARTED|Overall Study||154
8235757|NCT01960907|20308722|P1|STARTED|Overall Study||158
8235758|NCT01960855|20308737|P5|NOT COMPLETED|Overall Study||5
8235759|NCT01960855|20308738|P4|NOT COMPLETED|Overall Study||4
8235760|NCT01960855|20308739|P3|NOT COMPLETED|Overall Study||9
8235761|NCT01960855|20308740|P2|NOT COMPLETED|Overall Study||4
8235762|NCT01960855|20308741|P1|NOT COMPLETED|Overall Study||11
8235763|NCT01960855|20308737|P5|COMPLETED|Overall Study||50
8235764|NCT01960855|20308738|P4|COMPLETED|Overall Study||51
8235765|NCT01960855|20308739|P3|COMPLETED|Overall Study||46
8235766|NCT01960855|20308740|P2|COMPLETED|Overall Study||51
8235767|NCT01960855|20308741|P1|COMPLETED|Overall Study||45
8235768|NCT01960855|20308737|P5|STARTED|Overall Study||55
8235769|NCT01960855|20308738|P4|STARTED|Overall Study||55
8235770|NCT01960855|20308739|P3|STARTED|Overall Study||55
8235771|NCT01960855|20308740|P2|STARTED|Overall Study||55
8235772|NCT01960855|20308741|P1|STARTED|Overall Study||56
8235773|NCT01960842|20308773|P1|NOT COMPLETED|Overall Study||3
8235774|NCT01960842|20308773|P1|COMPLETED|Overall Study||28
8235775|NCT01960842|20308773|P1|STARTED|Overall Study||31
8235776|NCT01960816|20308796|P1|NOT COMPLETED|Overall Study||1
8235777|NCT01960816|20308796|P1|COMPLETED|Overall Study||32
8235778|NCT01960816|20308796|P1|STARTED|Overall Study||33
8235779|NCT01960790|20308802|P1|NOT COMPLETED|Overall Study||11
8235780|NCT01960790|20308802|P1|COMPLETED|Overall Study||462
8235781|NCT01960790|20308802|P1|STARTED|Overall Study||473
8235782|NCT01960725|20308814|P2|NOT COMPLETED|Overall Study||5
8235783|NCT01960725|20308815|P1|NOT COMPLETED|Overall Study||6
8235784|NCT01960725|20308814|P2|COMPLETED|Overall Study||28
8235785|NCT01960725|20308815|P1|COMPLETED|Overall Study||27
8235786|NCT01960725|20308814|P2|Received Third Vaccine|Overall Study||32
8235787|NCT01960725|20308815|P1|Received Third Vaccine|Overall Study||32
8235788|NCT01960725|20308814|P2|Recieved Second Vaccine|Overall Study||33
8235789|NCT01960725|20308815|P1|Recieved Second Vaccine|Overall Study||33
8235790|NCT01960725|20308814|P2|Received First Vaccine|Overall Study||33
8235791|NCT01960725|20308815|P1|Received First Vaccine|Overall Study||33
8235792|NCT01960725|20308814|P2|STARTED|Overall Study||33
8235793|NCT01960725|20308815|P1|STARTED|Overall Study||33
8235794|NCT01960530|20308837|P1|NOT COMPLETED|Overall Study||0
8235795|NCT01960530|20308837|P1|COMPLETED|Overall Study||14
8235796|NCT01960530|20308837|P1|STARTED|Overall Study||14
8235797|NCT01960465|20308872|P2|NOT COMPLETED|Overall Study||9
8235798|NCT01960465|20308873|P1|NOT COMPLETED|Overall Study||20
8235799|NCT01960465|20308872|P2|COMPLETED|Overall Study||73
8235800|NCT01960465|20308873|P1|COMPLETED|Overall Study||118
8235801|NCT01960465|20308872|P2|STARTED|Overall Study||82
8235802|NCT01960465|20308873|P1|STARTED|Overall Study||138
8235803|NCT01960413|20308885|P2|NOT COMPLETED|Overall Study||1
8235804|NCT01960413|20308886|P1|NOT COMPLETED|Overall Study||4
8235805|NCT01960413|20308885|P2|COMPLETED|Overall Study||21
8235806|NCT01960413|20308886|P1|COMPLETED|Overall Study||20
8235807|NCT01960413|20308885|P2|STARTED|Overall Study||22
8235808|NCT01960413|20308886|P1|STARTED|Overall Study||24
8235809|NCT01960400|20308894|P2|NOT COMPLETED|Overall Study||0
8235810|NCT01960400|20308895|P1|NOT COMPLETED|Overall Study||0
8235811|NCT01960400|20308894|P2|COMPLETED|Overall Study||11
8235812|NCT01960400|20308895|P1|COMPLETED|Overall Study||11
8235813|NCT01960400|20308894|P2|STARTED|Overall Study||11
8235814|NCT01960400|20308895|P1|STARTED|Overall Study||11
8235815|NCT01960387|20308907|P1|NOT COMPLETED|Overall Study||0
8235816|NCT01960387|20308907|P1|COMPLETED|Overall Study||2
8235817|NCT01960387|20308907|P1|STARTED|Overall Study||2
8235818|NCT01960348|20308916|P2|NOT COMPLETED|Overall Study||22
8235819|NCT01960348|20308917|P1|NOT COMPLETED|Overall Study||10
8235820|NCT01960348|20308916|P2|COMPLETED|Overall Study||55
8235821|NCT01960348|20308917|P1|COMPLETED|Overall Study||138
8235822|NCT01960348|20308916|P2|STARTED|Overall Study||77
8235823|NCT01960348|20308917|P1|STARTED|Overall Study||148
8235824|NCT01960296|20308937|P2|NOT COMPLETED|Overall Study||3
8235825|NCT01960296|20308938|P1|NOT COMPLETED|Overall Study||2
8235826|NCT01960296|20308937|P2|COMPLETED|Overall Study||22
8235827|NCT01960296|20308938|P1|COMPLETED|Overall Study||21
8235828|NCT01960296|20308937|P2|STARTED|Overall Study||25
8235829|NCT01960296|20308938|P1|STARTED|Overall Study||23
8235830|NCT01960140|20308958|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
8235831|NCT01960140|20308958|P1|COMPLETED|Period 2 (Days 3-18)||38
8235832|NCT01960140|20308958|P1|Received Simvastatin|Period 2 (Days 3-18)||38
8235833|NCT01960140|20308958|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
8235834|NCT01960140|20308958|P1|STARTED|Period 2 (Days 3-18)||40
8235835|NCT01960140|20308958|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
8235836|NCT01960140|20308958|P1|COMPLETED|Period 1 (Days 1-2)||40
8235837|NCT01960140|20308958|P1|Received Simvastatin|Period 1 (Days 1-2)||40
8235838|NCT01960140|20308958|P1|STARTED|Period 1 (Days 1-2)||40
8235839|NCT01960114|20308969|P2|NOT COMPLETED|Overall Study||1
8235840|NCT01960114|20308970|P1|NOT COMPLETED|Overall Study||1
8235841|NCT01960114|20308969|P2|COMPLETED|Overall Study||268
8235842|NCT01960114|20308970|P1|COMPLETED|Overall Study||133
8235843|NCT01960114|20308969|P2|STARTED|Overall Study||269
8235844|NCT01960114|20308970|P1|STARTED|Overall Study||134
8235845|NCT01960075|20308987|P3|NOT COMPLETED|Overall Study||7
8235846|NCT01960075|20308988|P2|NOT COMPLETED|Overall Study||3
8235847|NCT01960075|20308989|P1|NOT COMPLETED|Overall Study||8
8235848|NCT01960075|20308987|P3|COMPLETED|Overall Study||173
8235849|NCT01960075|20308988|P2|COMPLETED|Overall Study||146
8235850|NCT01960075|20308989|P1|COMPLETED|Overall Study||141
8235851|NCT01960075|20308987|P3|STARTED|Overall Study||180
8235852|NCT01960075|20308988|P2|STARTED|Overall Study||149
8235853|NCT01960075|20308989|P1|STARTED|Overall Study||149
8235854|NCT01959945|20309049|P4|NOT COMPLETED|Overall Study||16
8235855|NCT01959945|20309050|P3|NOT COMPLETED|Overall Study||19
8235856|NCT01959945|20309051|P2|NOT COMPLETED|Overall Study||3
8235857|NCT01959945|20309052|P1|NOT COMPLETED|Overall Study||4
8235858|NCT01959945|20309049|P4|COMPLETED|Overall Study||15
8235859|NCT01959945|20309050|P3|COMPLETED|Overall Study||9
8235860|NCT01959945|20309051|P2|COMPLETED|Overall Study||75
8235861|NCT01959945|20309052|P1|COMPLETED|Overall Study||76
8235862|NCT01959945|20309049|P4|STARTED|Overall Study||31
8235863|NCT01959945|20309050|P3|STARTED|Overall Study||28
8235864|NCT01959945|20309051|P2|STARTED|Overall Study||78
8235865|NCT01959945|20309052|P1|STARTED|Overall Study||80
8235866|NCT01959932|20309077|P3|NOT COMPLETED|Overall Study||0
8235867|NCT01959932|20309078|P2|NOT COMPLETED|Overall Study||0
8235868|NCT01959932|20309079|P1|NOT COMPLETED|Overall Study||1
8235869|NCT01959932|20309077|P3|COMPLETED|Overall Study||39
8235870|NCT01959932|20309078|P2|COMPLETED|Overall Study||41
8235871|NCT01959932|20309079|P1|COMPLETED|Overall Study||79
8235872|NCT01959932|20309077|P3|STARTED|Overall Study||39
8235873|NCT01959932|20309078|P2|STARTED|Overall Study||41
8235874|NCT01959932|20309079|P1|STARTED|Overall Study||80
8235875|NCT01959919|20309097|P1|NOT COMPLETED|Overall Study||2
8235876|NCT01959919|20309097|P1|COMPLETED|Overall Study||84
8235877|NCT01959919|20309097|P1|STARTED|Overall Study||86
8235878|NCT01959880|20309111|P4|NOT COMPLETED|Overall Study||181
8235879|NCT01959880|20309112|P3|NOT COMPLETED|Overall Study||208
8235880|NCT01959880|20309113|P2|NOT COMPLETED|Overall Study||369
8235881|NCT01959880|20309114|P1|NOT COMPLETED|Overall Study||1132
8235882|NCT01959880|20309111|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8235883|NCT01959880|20309112|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
8235884|NCT01959880|20309113|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8235885|NCT01959880|20309114|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8235886|NCT01959880|20309111|P4|STARTED|Overall Study||181
8235887|NCT01959880|20309112|P3|STARTED|Overall Study||209
8235888|NCT01959880|20309113|P2|STARTED|Overall Study||369
8235889|NCT01959880|20309114|P1|STARTED|Overall Study||1132
8235890|NCT01959841|20309139|P3|NOT COMPLETED|Overall Study||43
8235891|NCT01959841|20309140|P2|NOT COMPLETED|Overall Study||57
8235892|NCT01959841|20309141|P1|NOT COMPLETED|Overall Study||43
8235893|NCT01959841|20309139|P3|COMPLETED|Overall Study||206
8235894|NCT01959841|20309140|P2|COMPLETED|Overall Study||193
8235895|NCT01959841|20309141|P1|COMPLETED|Overall Study||209
8235896|NCT01959841|20309139|P3|Reason FAS Excluding 3|Overall Study||0
8235897|NCT01959841|20309140|P2|Reason FAS Excluding 3|Overall Study||1
8235898|NCT01959841|20309141|P1|Reason FAS Excluding 3|Overall Study||0
8235899|NCT01959841|20309139|P3|Reason FAS Excluding 2|Overall Study||0
8235900|NCT01959841|20309140|P2|Reason FAS Excluding 2|Overall Study||1
8235901|NCT01959841|20309141|P1|Reason FAS Excluding 2|Overall Study||0
8235902|NCT01959841|20309139|P3|Reason FAS Excluding 1|Overall Study||4
8235903|NCT01959841|20309140|P2|Reason FAS Excluding 1|Overall Study||5
8235904|NCT01959841|20309141|P1|Reason FAS Excluding 1|Overall Study||5
8235905|NCT01959841|20309139|P3|Full Analysis Set Excluded|Overall Study||4
8235906|NCT01959841|20309140|P2|Full Analysis Set Excluded|Overall Study||7
8235907|NCT01959841|20309141|P1|Full Analysis Set Excluded|Overall Study||5
8235908|NCT01959841|20309139|P3|Full Analysis Set Included|Overall Study||245
8235909|NCT01959841|20309140|P2|Full Analysis Set Included|Overall Study||243
8235910|NCT01959841|20309141|P1|Full Analysis Set Included|Overall Study||247
8235911|NCT01959841|20309139|P3|STARTED|Overall Study||249
8235912|NCT01959841|20309140|P2|STARTED|Overall Study||250
8235913|NCT01959841|20309141|P1|STARTED|Overall Study||252
8235914|NCT01959685|20309164|P1|NOT COMPLETED|Overall Study||0
8235915|NCT01959685|20309164|P1|COMPLETED|Overall Study||9
8235916|NCT01959685|20309164|P1|STARTED|Overall Study||9
8235917|NCT01959672|20309169|P1|NOT COMPLETED|Overall Study||1
8235918|NCT01959672|20309169|P1|COMPLETED|Overall Study||10
8235919|NCT01959672|20309169|P1|STARTED|Overall Study||11
8235920|NCT01959607|20309180|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8235921|NCT01959607|20309181|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8235922|NCT01959607|20309182|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8235923|NCT01959607|20309183|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8235924|NCT01959607|20309180|P4|COMPLETED|Second Intervention (Day 3)||9
8235925|NCT01959607|20309181|P3|COMPLETED|Second Intervention (Day 3)||9
8235926|NCT01959607|20309182|P2|COMPLETED|Second Intervention (Day 3)||21
8235927|NCT01959607|20309183|P1|COMPLETED|Second Intervention (Day 3)||21
8235928|NCT01959607|20309180|P4|STARTED|Second Intervention (Day 3)||9
8235929|NCT01959607|20309181|P3|STARTED|Second Intervention (Day 3)||9
8235930|NCT01959607|20309182|P2|STARTED|Second Intervention (Day 3)||21
8235931|NCT01959607|20309183|P1|STARTED|Second Intervention (Day 3)||21
8235932|NCT01959607|20309180|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235933|NCT01959607|20309181|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235934|NCT01959607|20309182|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235935|NCT01959607|20309183|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235936|NCT01959607|20309180|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
8235937|NCT01959607|20309181|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8235938|NCT01959607|20309182|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
8235939|NCT01959607|20309183|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
8235940|NCT01959607|20309180|P4|STARTED|Washout Period of 1 Day (Day 2)||9
8235941|NCT01959607|20309181|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8235942|NCT01959607|20309182|P2|STARTED|Washout Period of 1 Day (Day 2)||21
8235943|NCT01959607|20309183|P1|STARTED|Washout Period of 1 Day (Day 2)||21
8235944|NCT01959607|20309180|P4|NOT COMPLETED|First Intervention (Day 1)||0
8235945|NCT01959607|20309181|P3|NOT COMPLETED|First Intervention (Day 1)||0
8235946|NCT01959607|20309182|P2|NOT COMPLETED|First Intervention (Day 1)||1
8235947|NCT01959607|20309183|P1|NOT COMPLETED|First Intervention (Day 1)||1
8235948|NCT01959607|20309180|P4|COMPLETED|First Intervention (Day 1)||9
8235949|NCT01959607|20309181|P3|COMPLETED|First Intervention (Day 1)||9
8235950|NCT01959607|20309182|P2|COMPLETED|First Intervention (Day 1)||21
8235951|NCT01959607|20309183|P1|COMPLETED|First Intervention (Day 1)||21
8235952|NCT01959607|20309180|P4|STARTED|First Intervention (Day 1)||9
8235953|NCT01959607|20309181|P3|STARTED|First Intervention (Day 1)||9
8235954|NCT01959607|20309182|P2|STARTED|First Intervention (Day 1)||22
8235955|NCT01959607|20309183|P1|STARTED|First Intervention (Day 1)||22
8235956|NCT01959607|20309180|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235957|NCT01959607|20309181|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235958|NCT01959607|20309182|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235959|NCT01959607|20309183|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235960|NCT01959607|20309180|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8235961|NCT01959607|20309181|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8235962|NCT01959607|20309182|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
8235963|NCT01959607|20309183|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8235964|NCT01959607|20309180|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8235965|NCT01959607|20309181|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8235966|NCT01959607|20309182|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8235967|NCT01959607|20309183|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8235968|NCT01959581|20309196|P1|NOT COMPLETED|Overall Study||5
8235969|NCT01959581|20309196|P1|COMPLETED|Overall Study||25
8235970|NCT01959581|20309196|P1|STARTED|Overall Study||30
8235971|NCT01959542|20309200|P1|NOT COMPLETED|Overall Study||3
8235972|NCT01959542|20309200|P1|COMPLETED|Overall Study||12
8235973|NCT01959542|20309200|P1|Evaluable at Visit 2|Overall Study||12
8235974|NCT01959542|20309200|P1|Evaluable at Visit 1|Overall Study||12
8235975|NCT01959542|20309200|P1|STARTED|Overall Study||15
8235976|NCT01959529|20309207|P2|NOT COMPLETED|Overall Study||72
8235977|NCT01959529|20309208|P1|NOT COMPLETED|Overall Study||76
8235978|NCT01959529|20309207|P2|COMPLETED|Overall Study||3747
8235979|NCT01959529|20309208|P1|COMPLETED|Overall Study||3742
8235980|NCT01959529|20309207|P2|Exposed|Overall Study||3806
8235981|NCT01959529|20309208|P1|Exposed|Overall Study||3809
8235982|NCT01959529|20309207|P2|STARTED|Overall Study||3819
8235983|NCT01959529|20309208|P1|STARTED|Overall Study||3818
8235984|NCT01959516|20309220|P2|NOT COMPLETED|Epoch 2||1
8235985|NCT01959516|20309221|P1|NOT COMPLETED|Epoch 2||2
8235986|NCT01959516|20309220|P2|COMPLETED|Epoch 2||62
8235987|NCT01959516|20309221|P1|COMPLETED|Epoch 2||61
8235988|NCT01959516|20309220|P2|STARTED|Epoch 2||63
8235989|NCT01959516|20309221|P1|STARTED|Epoch 2||63
8235990|NCT01959516|20309220|P2|NOT COMPLETED|Epoch 1||5
8235991|NCT01959516|20309221|P1|NOT COMPLETED|Epoch 1||10
8235992|NCT01959516|20309220|P2|COMPLETED|Epoch 1||58
8235993|NCT01959516|20309221|P1|COMPLETED|Epoch 1||53
8235994|NCT01959516|20309220|P2|ITT Population|Epoch 1||62
8235995|NCT01959516|20309221|P1|ITT Population|Epoch 1||62
8235996|NCT01959516|20309220|P2|Safety Population|Epoch 1||62
8235997|NCT01959516|20309221|P1|Safety Population|Epoch 1||62
8235998|NCT01959516|20309220|P2|STARTED|Epoch 1||63
8235999|NCT01959516|20309221|P1|STARTED|Epoch 1||63
8236000|NCT01959503|20309231|P2|NOT COMPLETED|Overall Study||2
8236001|NCT01959503|20309232|P1|NOT COMPLETED|Overall Study||3
8236002|NCT01959503|20309231|P2|COMPLETED|Overall Study||49
8236003|NCT01959503|20309232|P1|COMPLETED|Overall Study||104
8236004|NCT01959503|20309231|P2|STARTED|Overall Study||51
8236005|NCT01959503|20309232|P1|STARTED|Overall Study||107
8236006|NCT01959490|20309255|P3|NOT COMPLETED|Overall Study||0
8236007|NCT01959490|20309256|P2|NOT COMPLETED|Overall Study||0
8236008|NCT01959490|20309257|P1|NOT COMPLETED|Overall Study||0
8236009|NCT01959490|20309255|P3|COMPLETED|Overall Study||5
8236010|NCT01959490|20309256|P2|COMPLETED|Overall Study||6
8236011|NCT01959490|20309257|P1|COMPLETED|Overall Study||5
8236012|NCT01959490|20309255|P3|STARTED|Overall Study||5
8236013|NCT01959490|20309256|P2|STARTED|Overall Study||6
8236014|NCT01959490|20309257|P1|STARTED|Overall Study||5
8236015|NCT01959425|20309285|P2|NOT COMPLETED|Overall Study||8
8236016|NCT01959425|20309286|P1|NOT COMPLETED|Overall Study||12
8236017|NCT01959425|20309285|P2|COMPLETED|Overall Study||23
8236018|NCT01959425|20309286|P1|COMPLETED|Overall Study||20
8236019|NCT01959425|20309285|P2|STARTED|Overall Study||31
8236020|NCT01959425|20309286|P1|STARTED|Overall Study||32
8236021|NCT01959412|20309306|P6|NOT COMPLETED|Overall Study||0
8236022|NCT01959412|20309307|P5|NOT COMPLETED|Overall Study||3
8236023|NCT01959412|20309308|P4|NOT COMPLETED|Overall Study||2
8236024|NCT01959412|20309309|P3|NOT COMPLETED|Overall Study||0
8236025|NCT01959412|20309310|P2|NOT COMPLETED|Overall Study||1
8236026|NCT01959412|20309311|P1|NOT COMPLETED|Overall Study||1
8236027|NCT01959412|20309306|P6|COMPLETED|Overall Study||15
8236028|NCT01959412|20309307|P5|COMPLETED|Overall Study||13
8236029|NCT01959412|20309308|P4|COMPLETED|Overall Study||13
8236030|NCT01959412|20309309|P3|COMPLETED|Overall Study||15
8236031|NCT01959412|20309310|P2|COMPLETED|Overall Study||14
8236032|NCT01959412|20309311|P1|COMPLETED|Overall Study||14
8236033|NCT01959412|20309306|P6|STARTED|Overall Study||15
8236034|NCT01959412|20309307|P5|STARTED|Overall Study||16
8236035|NCT01959412|20309308|P4|STARTED|Overall Study||15
8236036|NCT01959412|20309309|P3|STARTED|Overall Study||15
8236037|NCT01959412|20309310|P2|STARTED|Overall Study||15
8236038|NCT01959412|20309311|P1|STARTED|Overall Study||15
8236039|NCT01959347|20309351|P2|NOT COMPLETED|Overall Study||7
8236040|NCT01959347|20309352|P1|NOT COMPLETED|Overall Study||9
8236041|NCT01959347|20309351|P2|COMPLETED|Overall Study||235
8236042|NCT01959347|20309352|P1|COMPLETED|Overall Study||229
8236043|NCT01959347|20309351|P2|STARTED|Overall Study||242
8236044|NCT01959347|20309352|P1|STARTED|Overall Study||238
8236045|NCT01959334|20309458|P2|NOT COMPLETED|Third Dose||1
8236046|NCT01959334|20309459|P1|NOT COMPLETED|Third Dose||0
8236047|NCT01959334|20309458|P2|COMPLETED|Third Dose||48
8236048|NCT01959334|20309459|P1|COMPLETED|Third Dose||25
8236049|NCT01959334|20309458|P2|STARTED|Third Dose||49
8236050|NCT01959334|20309459|P1|STARTED|Third Dose||25
8236051|NCT01959334|20309458|P2|NOT COMPLETED|Second Dose||0
8236052|NCT01959334|20309459|P1|NOT COMPLETED|Second Dose||1
8236053|NCT01959334|20309458|P2|COMPLETED|Second Dose||49
8236054|NCT01959334|20309459|P1|COMPLETED|Second Dose||25
8236055|NCT01959334|20309458|P2|STARTED|Second Dose||49
8236056|NCT01959334|20309459|P1|STARTED|Second Dose||26
8236057|NCT01959334|20309458|P2|NOT COMPLETED|First Dose||0
8236058|NCT01959334|20309459|P1|NOT COMPLETED|First Dose||0
8236059|NCT01959334|20309458|P2|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
8236060|NCT01959334|20309459|P1|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
8236061|NCT01959334|20309458|P2|STARTED|First Dose||49
8236062|NCT01959334|20309459|P1|STARTED|First Dose||26
8236063|NCT01959243|20309471|P2|NOT COMPLETED|Overall Study||4
8236064|NCT01959243|20309472|P1|NOT COMPLETED|Overall Study||13
8236065|NCT01959243|20309471|P2|COMPLETED|Overall Study||166
8236066|NCT01959243|20309472|P1|COMPLETED|Overall Study||324
8236067|NCT01959243|20309471|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
8236068|NCT01959243|20309472|P1|Received at Least 1 Dose of Study Drug|Overall Study||337
8236069|NCT01959243|20309471|P2|STARTED|Overall Study||170
8236070|NCT01959243|20309472|P1|STARTED|Overall Study||337
8236071|NCT01959230|20309484|P2|NOT COMPLETED|Overall Study||1
8236072|NCT01959230|20309485|P1|NOT COMPLETED|Overall Study||4
8236073|NCT01959230|20309484|P2|COMPLETED|Overall Study||19
8236074|NCT01959230|20309485|P1|COMPLETED|Overall Study||36
8236075|NCT01959230|20309484|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
8236076|NCT01959230|20309485|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
8236077|NCT01959230|20309484|P2|STARTED|Overall Study||20
8236078|NCT01959230|20309485|P1|STARTED|Overall Study||40
8236079|NCT01959178|20309495|P2|NOT COMPLETED|Overall Study||2
8236080|NCT01959178|20309496|P1|NOT COMPLETED|Overall Study||2
8236081|NCT01959178|20309495|P2|COMPLETED|Overall Study||71
8236082|NCT01959178|20309496|P1|COMPLETED|Overall Study||71
8236083|NCT01959178|20309495|P2|STARTED|Overall Study||73
8236084|NCT01959178|20309496|P1|STARTED|Overall Study||73
8236085|NCT01959165|20309508|P4|NOT COMPLETED|Overall Study||2
8236086|NCT01959165|20309509|P3|NOT COMPLETED|Overall Study||0
8236087|NCT01959165|20309510|P2|NOT COMPLETED|Overall Study||1
8236088|NCT01959165|20309511|P1|NOT COMPLETED|Overall Study||1
8236089|NCT01959165|20309508|P4|COMPLETED|Overall Study||7
8236090|NCT01959165|20309509|P3|COMPLETED|Overall Study||12
8236091|NCT01959165|20309510|P2|COMPLETED|Overall Study||10
8236092|NCT01959165|20309511|P1|COMPLETED|Overall Study||12
8236093|NCT01959165|20309508|P4|STARTED|Overall Study||9
8236094|NCT01959165|20309509|P3|STARTED|Overall Study||12
8236095|NCT01959165|20309510|P2|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
8236096|NCT01959165|20309511|P1|STARTED|Overall Study||13
8236097|NCT01959139|20309537|P4|NOT COMPLETED|Phase II||55
8236098|NCT01959139|20309538|P3|NOT COMPLETED|Phase II||56
8236099|NCT01959139|20309539|P2|NOT COMPLETED|Phase II||0
8236100|NCT01959139|20309540|P1|NOT COMPLETED|Phase II||0
8236101|NCT01959139|20309537|P4|COMPLETED|Phase II||0
8236102|NCT01959139|20309538|P3|COMPLETED|Phase II||0
8236103|NCT01959139|20309539|P2|COMPLETED|Phase II||0
8236104|NCT01959139|20309540|P1|COMPLETED|Phase II||0
8236105|NCT01959139|20309537|P4|Assessed for AEs|Phase II||51
8236106|NCT01959139|20309538|P3|Assessed for AEs|Phase II||54
8236107|NCT01959139|20309539|P2|Assessed for AEs|Phase II||0
8236108|NCT01959139|20309540|P1|Assessed for AEs|Phase II||0
8236109|NCT01959139|20309537|P4|STARTED|Phase II||55
8236110|NCT01959139|20309538|P3|STARTED|Phase II||56
8236111|NCT01959139|20309539|P2|STARTED|Phase II||0
8236112|NCT01959139|20309540|P1|STARTED|Phase II||0
8236113|NCT01959139|20309537|P4|NOT COMPLETED|Phase I: Cohort 2||0
8236114|NCT01959139|20309538|P3|NOT COMPLETED|Phase I: Cohort 2||0
8236115|NCT01959139|20309539|P2|NOT COMPLETED|Phase I: Cohort 2||0
8236116|NCT01959139|20309540|P1|NOT COMPLETED|Phase I: Cohort 2||0
8236117|NCT01959139|20309537|P4|COMPLETED|Phase I: Cohort 2||0
8236118|NCT01959139|20309538|P3|COMPLETED|Phase I: Cohort 2||0
8236119|NCT01959139|20309539|P2|COMPLETED|Phase I: Cohort 2||6
8236120|NCT01959139|20309540|P1|COMPLETED|Phase I: Cohort 2||0
8236121|NCT01959139|20309537|P4|STARTED|Phase I: Cohort 2||0
8236122|NCT01959139|20309538|P3|STARTED|Phase I: Cohort 2||0
8236123|NCT01959139|20309539|P2|STARTED|Phase I: Cohort 2||6
8236124|NCT01959139|20309540|P1|STARTED|Phase I: Cohort 2||0
8236125|NCT01959139|20309537|P4|NOT COMPLETED|Phase I: Cohort 1||0
8236126|NCT01959139|20309538|P3|NOT COMPLETED|Phase I: Cohort 1||0
8236127|NCT01959139|20309539|P2|NOT COMPLETED|Phase I: Cohort 1||0
8236128|NCT01959139|20309540|P1|NOT COMPLETED|Phase I: Cohort 1||0
8236129|NCT01959139|20309537|P4|COMPLETED|Phase I: Cohort 1||0
8236130|NCT01959139|20309538|P3|COMPLETED|Phase I: Cohort 1||0
8236131|NCT01959139|20309539|P2|COMPLETED|Phase I: Cohort 1||0
8236132|NCT01959139|20309540|P1|COMPLETED|Phase I: Cohort 1||5
8236133|NCT01959139|20309537|P4|STARTED|Phase I: Cohort 1||0
8236134|NCT01959139|20309538|P3|STARTED|Phase I: Cohort 1||0
8236135|NCT01959139|20309539|P2|STARTED|Phase I: Cohort 1||0
8236136|NCT01959139|20309540|P1|STARTED|Phase I: Cohort 1||5
8236137|NCT01959113|20309559|P1|NOT COMPLETED|Overall Study||0
8236138|NCT01959113|20309559|P1|COMPLETED|Overall Study||5
8236139|NCT01959113|20309559|P1|STARTED|Overall Study||5
8236140|NCT01959048|20309565|P1|NOT COMPLETED|Overall Study||0
8236141|NCT01959048|20309565|P1|COMPLETED|Overall Study||3
8236142|NCT01959048|20309565|P1|STARTED|Overall Study||3
8236143|NCT01959035|20309573|P1|NOT COMPLETED|Overall Study||11
8236144|NCT01959035|20309573|P1|COMPLETED|Overall Study||77
8236145|NCT01959035|20309573|P1|STARTED|Overall Study||88
8236146|NCT01958918|20309601|P2|NOT COMPLETED|Overall Study||42
8236147|NCT01958918|20309602|P1|NOT COMPLETED|Overall Study||43
8236148|NCT01958918|20309601|P2|COMPLETED|Overall Study||314
8236149|NCT01958918|20309602|P1|COMPLETED|Overall Study||313
8236150|NCT01958918|20309601|P2|Full Analysis Set|Overall Study||354
8236151|NCT01958918|20309602|P1|Full Analysis Set|Overall Study||353
8236152|NCT01958918|20309601|P2|STARTED|Overall Study||356
8236153|NCT01958918|20309602|P1|STARTED|Overall Study||356
8236154|NCT01958827|20309616|P1|NOT COMPLETED|Overall Study||10
8236155|NCT01958827|20309616|P1|COMPLETED|Overall Study||18
8236156|NCT01958827|20309616|P1|STARTED|Overall Study||28
8236157|NCT01958788|20309634|P1|NOT COMPLETED|Overall Study||0
8236158|NCT01958788|20309634|P1|COMPLETED|Overall Study||7
8236159|NCT01958788|20309634|P1|STARTED|Overall Study||7
8236160|NCT01958671|20309647|P3|NOT COMPLETED|Overall Study||32
8236161|NCT01958671|20309648|P2|NOT COMPLETED|Overall Study||24
8236162|NCT01958671|20309649|P1|NOT COMPLETED|Overall Study||19
8236163|NCT01958671|20309647|P3|COMPLETED|Overall Study||121
8236164|NCT01958671|20309648|P2|COMPLETED|Overall Study||128
8236165|NCT01958671|20309649|P1|COMPLETED|Overall Study||137
8236166|NCT01958671|20309647|P3|STARTED|Overall Study||153
8236167|NCT01958671|20309648|P2|STARTED|Overall Study||152
8236168|NCT01958671|20309649|P1|STARTED|Overall Study||156
8236169|NCT01958645|20309693|P3|NOT COMPLETED|Overall Study||0
8236170|NCT01958645|20309694|P2|NOT COMPLETED|Overall Study||0
8236171|NCT01958645|20309695|P1|NOT COMPLETED|Overall Study||0
8236172|NCT01958645|20309693|P3|COMPLETED|Overall Study||4
8236173|NCT01958645|20309694|P2|COMPLETED|Overall Study||4
8236174|NCT01958645|20309695|P1|COMPLETED|Overall Study||4
8236175|NCT01958645|20309693|P3|STARTED|Overall Study||4
8236176|NCT01958645|20309694|P2|STARTED|Overall Study||4
8236177|NCT01958645|20309695|P1|STARTED|Overall Study||4
8236178|NCT01958619|20309723|P4|NOT COMPLETED|Overall Study||0
8236179|NCT01958619|20309724|P3|NOT COMPLETED|Overall Study||1
8236180|NCT01958619|20309725|P2|NOT COMPLETED|Overall Study||0
8236181|NCT01958619|20309726|P1|NOT COMPLETED|Overall Study||2
8236182|NCT01958619|20309723|P4|COMPLETED|Overall Study||12
8236183|NCT01958619|20309724|P3|COMPLETED|Overall Study||13
8236184|NCT01958619|20309725|P2|COMPLETED|Overall Study||14
8236185|NCT01958619|20309726|P1|COMPLETED|Overall Study||13
8236186|NCT01958619|20309723|P4|STARTED|Overall Study||12
8236187|NCT01958619|20309724|P3|STARTED|Overall Study||14
8236188|NCT01958619|20309725|P2|STARTED|Overall Study||14
8236189|NCT01958619|20309726|P1|STARTED|Overall Study||15
8236190|NCT01958606|20309748|P2|NOT COMPLETED|Overall Study||0
8236191|NCT01958606|20309749|P1|NOT COMPLETED|Overall Study||2
8236192|NCT01958606|20309748|P2|COMPLETED|Overall Study||5
8236193|NCT01958606|20309749|P1|COMPLETED|Overall Study||11
8236194|NCT01958606|20309748|P2|STARTED|Overall Study||5
8236195|NCT01958606|20309749|P1|STARTED|Overall Study||13
8236196|NCT01958489|20309787|P2|NOT COMPLETED|Period 2||1
8236197|NCT01958489|20309788|P1|NOT COMPLETED|Period 2||0
8236198|NCT01958489|20309787|P2|COMPLETED|Period 2||23
8236199|NCT01958489|20309788|P1|COMPLETED|Period 2||0
8236200|NCT01958489|20309787|P2|Received at Least 1 Dose of Study Drug|Period 2||24
8236201|NCT01958489|20309788|P1|Received at Least 1 Dose of Study Drug|Period 2||0
8236202|NCT01958489|20309787|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
8236203|NCT01958489|20309788|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
8236204|NCT01958489|20309787|P2|NOT COMPLETED|Period 1||0
8236205|NCT01958489|20309788|P1|NOT COMPLETED|Period 1||0
8236206|NCT01958489|20309787|P2|COMPLETED|Period 1||0
8236207|NCT01958489|20309788|P1|COMPLETED|Period 1||24
8236208|NCT01958489|20309787|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8236209|NCT01958489|20309788|P1|Received at Least 1 Dose of Study Drug|Period 1||24
8236210|NCT01958489|20309787|P2|STARTED|Period 1||0
8236211|NCT01958489|20309788|P1|STARTED|Period 1||24
8236212|NCT01958476|20309804|P2|NOT COMPLETED|Overall Study||0
8236213|NCT01958476|20309805|P1|NOT COMPLETED|Overall Study||1
8236214|NCT01958476|20309804|P2|COMPLETED|Overall Study||58
8236215|NCT01958476|20309805|P1|COMPLETED|Overall Study||58
8236216|NCT01958476|20309804|P2|STARTED|Overall Study||58
8236217|NCT01958476|20309805|P1|STARTED|Overall Study||59
8236218|NCT01958437|20309835|P4|NOT COMPLETED|Overall Study||1
8236219|NCT01958437|20309836|P3|NOT COMPLETED|Overall Study||1
8236220|NCT01958437|20309837|P2|NOT COMPLETED|Overall Study||0
8236221|NCT01958437|20309838|P1|NOT COMPLETED|Overall Study||0
8236222|NCT01958437|20309835|P4|COMPLETED|Overall Study||10
8236223|NCT01958437|20309836|P3|COMPLETED|Overall Study||10
8236224|NCT01958437|20309837|P2|COMPLETED|Overall Study||11
8236225|NCT01958437|20309838|P1|COMPLETED|Overall Study||11
8236226|NCT01958437|20309835|P4|STARTED|Overall Study||11
8236227|NCT01958437|20309836|P3|STARTED|Overall Study||11
8236228|NCT01958437|20309837|P2|STARTED|Overall Study||11
8236229|NCT01958437|20309838|P1|STARTED|Overall Study||11
8236230|NCT01958346|20309862|P2|NOT COMPLETED|Overall Study||0
8236231|NCT01958346|20309863|P1|NOT COMPLETED|Overall Study||0
8236232|NCT01958346|20309862|P2|COMPLETED|Overall Study||39
8236233|NCT01958346|20309863|P1|COMPLETED|Overall Study||39
8236234|NCT01958346|20309862|P2|STARTED|Overall Study||39
8236235|NCT01958346|20309863|P1|STARTED|Overall Study||39
8236236|NCT01958320|20309873|P2|NOT COMPLETED|Overall Study||0
8236237|NCT01958320|20309874|P1|NOT COMPLETED|Overall Study||0
8236238|NCT01958320|20309873|P2|COMPLETED|Overall Study||98
8236239|NCT01958320|20309874|P1|COMPLETED|Overall Study||104
8236240|NCT01958320|20309873|P2|STARTED|Overall Study||98
8236241|NCT01958320|20309874|P1|STARTED|Overall Study||104
8236242|NCT01958294|20309902|P1|NOT COMPLETED|Overall Study||2
8236243|NCT01958294|20309902|P1|COMPLETED|Overall Study||10
8236244|NCT01958294|20309902|P1|STARTED|Overall Study||12
8236245|NCT01958281|20309911|P3|NOT COMPLETED|Overall Study||0
8236246|NCT01958281|20309912|P2|NOT COMPLETED|Overall Study||4
8236247|NCT01958281|20309913|P1|NOT COMPLETED|Overall Study||6
8236248|NCT01958281|20309911|P3|COMPLETED|Overall Study||18
8236249|NCT01958281|20309912|P2|COMPLETED|Overall Study||6
8236250|NCT01958281|20309913|P1|COMPLETED|Overall Study||4
8236251|NCT01958281|20309911|P3|STARTED|Overall Study||18
8236252|NCT01958281|20309912|P2|STARTED|Overall Study||10
8236253|NCT01958281|20309913|P1|STARTED|Overall Study||10
8236254|NCT01958164|20309989|P2|NOT COMPLETED|Overall Study||5
8236255|NCT01958164|20309990|P1|NOT COMPLETED|Overall Study||2
8236256|NCT01958164|20309989|P2|COMPLETED|Overall Study||5
8236257|NCT01958164|20309990|P1|COMPLETED|Overall Study||4
8236258|NCT01958164|20309989|P2|STARTED|Overall Study|Randomised and treated|10
8236259|NCT01958164|20309990|P1|STARTED|Overall Study|Randomised and treated|6
8236260|NCT01958125|20310005|P2|NOT COMPLETED|Overall Study||8
8236261|NCT01958125|20310006|P1|NOT COMPLETED|Overall Study||2
8236262|NCT01958125|20310005|P2|COMPLETED|Overall Study||44
8236263|NCT01958125|20310006|P1|COMPLETED|Overall Study||48
8236264|NCT01958125|20310005|P2|STARTED|Overall Study||52
8236265|NCT01958125|20310006|P1|STARTED|Overall Study||50
8236266|NCT01958112|20310020|P1|NOT COMPLETED|Overall Study||0
8236267|NCT01958112|20310020|P1|COMPLETED|Overall Study||14
8236268|NCT01958112|20310020|P1|STARTED|Overall Study||14
8236269|NCT01958073|20310030|P5|NOT COMPLETED|Open Label Period||0
8236270|NCT01958073|20310031|P4|NOT COMPLETED|Open Label Period||0
8236271|NCT01958073|20310032|P3|NOT COMPLETED|Open Label Period||0
8236272|NCT01958073|20310033|P2|NOT COMPLETED|Open Label Period||0
8236273|NCT01958073|20310034|P1|NOT COMPLETED|Open Label Period||0
8236274|NCT01958073|20310030|P5|COMPLETED|Open Label Period||17
8236275|NCT01958073|20310031|P4|COMPLETED|Open Label Period||5
8236276|NCT01958073|20310032|P3|COMPLETED|Open Label Period||0
8236277|NCT01958073|20310033|P2|COMPLETED|Open Label Period||0
8236278|NCT01958073|20310034|P1|COMPLETED|Open Label Period||0
8236279|NCT01958073|20310030|P5|STARTED|Open Label Period||17
8236280|NCT01958073|20310031|P4|STARTED|Open Label Period||5
8236281|NCT01958073|20310032|P3|STARTED|Open Label Period||0
8236282|NCT01958073|20310033|P2|STARTED|Open Label Period||0
8236283|NCT01958073|20310034|P1|STARTED|Open Label Period||0
8236284|NCT01958073|20310030|P5|NOT COMPLETED|Randomized Period||0
8236285|NCT01958073|20310031|P4|NOT COMPLETED|Randomized Period||0
8236286|NCT01958073|20310032|P3|NOT COMPLETED|Randomized Period||6
8236287|NCT01958073|20310033|P2|NOT COMPLETED|Randomized Period||1
8236288|NCT01958073|20310034|P1|NOT COMPLETED|Randomized Period||2
8236289|NCT01958073|20310030|P5|COMPLETED|Randomized Period||0
8236290|NCT01958073|20310031|P4|COMPLETED|Randomized Period||0
8236291|NCT01958073|20310032|P3|COMPLETED|Randomized Period||11
8236292|NCT01958073|20310033|P2|COMPLETED|Randomized Period||8
8236293|NCT01958073|20310034|P1|COMPLETED|Randomized Period||7
8236294|NCT01958073|20310030|P5|STARTED|Randomized Period||0
8236295|NCT01958073|20310031|P4|STARTED|Randomized Period||0
8236296|NCT01958073|20310032|P3|STARTED|Randomized Period||17
8236297|NCT01958073|20310033|P2|STARTED|Randomized Period||9
8236298|NCT01958073|20310034|P1|STARTED|Randomized Period||9
8236299|NCT01958060|20310069|P6|NOT COMPLETED|Overall Study||0
8236300|NCT01958060|20310070|P5|NOT COMPLETED|Overall Study||1
8236301|NCT01958060|20310071|P4|NOT COMPLETED|Overall Study||0
8236302|NCT01958060|20310072|P3|NOT COMPLETED|Overall Study||0
8236303|NCT01958060|20310073|P2|NOT COMPLETED|Overall Study||0
8236304|NCT01958060|20310074|P1|NOT COMPLETED|Overall Study||2
8236305|NCT01958060|20310069|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
8236306|NCT01958060|20310070|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
8236307|NCT01958060|20310071|P4|COMPLETED|Overall Study||5
8236308|NCT01958060|20310072|P3|COMPLETED|Overall Study||6
8236309|NCT01958060|20310073|P2|COMPLETED|Overall Study||6
8236310|NCT01958060|20310074|P1|COMPLETED|Overall Study||8
8236311|NCT01958060|20310069|P6|STARTED|Overall Study||1
8236312|NCT01958060|20310070|P5|STARTED|Overall Study||7
8236313|NCT01958060|20310071|P4|STARTED|Overall Study||5
8236314|NCT01958060|20310072|P3|STARTED|Overall Study||6
8236315|NCT01958060|20310073|P2|STARTED|Overall Study||6
8236316|NCT01958060|20310074|P1|STARTED|Overall Study||10
8236317|NCT01958021|20310099|P2|NOT COMPLETED|Overall Study||180
8236318|NCT01958021|20310100|P1|NOT COMPLETED|Overall Study||139
8236319|NCT01958021|20310099|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
8236320|NCT01958021|20310100|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
8236321|NCT01958021|20310099|P2|Patients Treated|Overall Study||330
8236322|NCT01958021|20310100|P1|Patients Treated|Overall Study||334
8236323|NCT01958021|20310099|P2|Patients Untreated|Overall Study||4
8236324|NCT01958021|20310100|P1|Patients Untreated|Overall Study||0
8236325|NCT01958021|20310099|P2|STARTED|Overall Study||334
8236326|NCT01958021|20310100|P1|STARTED|Overall Study||334
8236327|NCT01958008|20310112|P4|NOT COMPLETED|Overall Study||0
8236328|NCT01958008|20310113|P3|NOT COMPLETED|Overall Study||1
8236329|NCT01958008|20310114|P2|NOT COMPLETED|Overall Study||0
8236330|NCT01958008|20310115|P1|NOT COMPLETED|Overall Study||1
8236331|NCT01958008|20310112|P4|COMPLETED|Overall Study||21
8236332|NCT01958008|20310113|P3|COMPLETED|Overall Study||20
8236333|NCT01958008|20310114|P2|COMPLETED|Overall Study||21
8236334|NCT01958008|20310115|P1|COMPLETED|Overall Study||20
8236335|NCT01958008|20310112|P4|STARTED|Overall Study||21
8236336|NCT01958008|20310113|P3|STARTED|Overall Study||21
8236337|NCT01958008|20310114|P2|STARTED|Overall Study||21
8236338|NCT01958008|20310115|P1|STARTED|Overall Study||21
8236339|NCT01957930|20310146|P3|NOT COMPLETED|Overall Study||0
8236340|NCT01957930|20310147|P2|NOT COMPLETED|Overall Study||0
8236341|NCT01957930|20310148|P1|NOT COMPLETED|Overall Study||0
8236342|NCT01957930|20310146|P3|COMPLETED|Overall Study||19
8236343|NCT01957930|20310147|P2|COMPLETED|Overall Study||37
8236344|NCT01957930|20310148|P1|COMPLETED|Overall Study||35
8236345|NCT01957930|20310146|P3|STARTED|Overall Study||19
8236346|NCT01957930|20310147|P2|STARTED|Overall Study||37
8236347|NCT01957930|20310148|P1|STARTED|Overall Study||35
8236348|NCT01957865|20310158|P3|NOT COMPLETED|Overall Study||3
8236349|NCT01957865|20310159|P2|NOT COMPLETED|Overall Study||2
8236350|NCT01957865|20310160|P1|NOT COMPLETED|Overall Study||0
8236351|NCT01957865|20310158|P3|COMPLETED|Overall Study||19
8236352|NCT01957865|20310159|P2|COMPLETED|Overall Study||18
8236353|NCT01957865|20310160|P1|COMPLETED|Overall Study||21
8236354|NCT01957865|20310158|P3|STARTED|Overall Study||22
8236355|NCT01957865|20310159|P2|STARTED|Overall Study||20
8236356|NCT01957865|20310160|P1|STARTED|Overall Study||21
8236357|NCT01957787|20310171|P1|NOT COMPLETED|Overall Study||36
8236358|NCT01957787|20310171|P1|COMPLETED|Overall Study||95
8236359|NCT01957787|20310171|P1|Modified ITT (mITT) Population|Overall Study||128
8236360|NCT01957787|20310171|P1|Intent-to-Treat (ITT) Population|Overall Study||130
8236361|NCT01957787|20310171|P1|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
8236362|NCT01957761|20310186|P1|NOT COMPLETED|Overall Study||0
8236363|NCT01957761|20310186|P1|COMPLETED|Overall Study||189
8236364|NCT01957761|20310186|P1|STARTED|Overall Study||189
8236365|NCT01957709|20310190|P1|NOT COMPLETED|Overall Study||1
8236366|NCT01957709|20310190|P1|COMPLETED|Overall Study||7
8236367|NCT01957709|20310190|P1|STARTED|Overall Study||8
8236368|NCT01957657|20310196|P1|NOT COMPLETED|Overall Study||0
8236369|NCT01957657|20310196|P1|COMPLETED|Overall Study||4
8236370|NCT01957657|20310196|P1|STARTED|Overall Study||4
8236371|NCT01957644|20310215|P5|NOT COMPLETED|Overall Study||1
8236372|NCT01957644|20310216|P4|NOT COMPLETED|Overall Study||2
8236373|NCT01957644|20310217|P3|NOT COMPLETED|Overall Study||1
8236374|NCT01957644|20310218|P2|NOT COMPLETED|Overall Study||6
8236375|NCT01957644|20310219|P1|NOT COMPLETED|Overall Study||6
8236376|NCT01957644|20310215|P5|COMPLETED|Overall Study||0
8236377|NCT01957644|20310216|P4|COMPLETED|Overall Study||0
8236378|NCT01957644|20310217|P3|COMPLETED|Overall Study||0
8236379|NCT01957644|20310218|P2|COMPLETED|Overall Study||0
8236380|NCT01957644|20310219|P1|COMPLETED|Overall Study||0
8236381|NCT01957644|20310215|P5|STARTED|Overall Study||1
8236382|NCT01957644|20310216|P4|STARTED|Overall Study||2
8236383|NCT01957644|20310217|P3|STARTED|Overall Study||1
8236384|NCT01957644|20310218|P2|STARTED|Overall Study||6
8236385|NCT01957644|20310219|P1|STARTED|Overall Study||6
8236386|NCT01957579|20310243|P4|NOT COMPLETED|Overall Study||0
8236387|NCT01957579|20310244|P3|NOT COMPLETED|Overall Study||2
8236388|NCT01957579|20310245|P2|NOT COMPLETED|Overall Study||1
8236389|NCT01957579|20310246|P1|NOT COMPLETED|Overall Study||0
8236390|NCT01957579|20310243|P4|COMPLETED|Overall Study||6
8236391|NCT01957579|20310244|P3|COMPLETED|Overall Study||2
8236392|NCT01957579|20310245|P2|COMPLETED|Overall Study||6
8236393|NCT01957579|20310246|P1|COMPLETED|Overall Study||3
8236394|NCT01957579|20310243|P4|STARTED|Overall Study||6
8236395|NCT01957579|20310244|P3|STARTED|Overall Study||4
8236396|NCT01957579|20310245|P2|STARTED|Overall Study||7
8236397|NCT01957579|20310246|P1|STARTED|Overall Study||3
8236398|NCT01957553|20310313|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
8236399|NCT01957553|20310314|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
8236400|NCT01957553|20310313|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
8236401|NCT01957553|20310314|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
8236402|NCT01957553|20310313|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
8236403|NCT01957553|20310314|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
8236404|NCT01957553|20310313|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
8236405|NCT01957553|20310314|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
8236406|NCT01957553|20310313|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
8236407|NCT01957553|20310314|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
8236408|NCT01957553|20310313|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
8236409|NCT01957553|20310314|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
8236410|NCT01957488|20310320|P6|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236411|NCT01957488|20310321|P5|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236412|NCT01957488|20310322|P4|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236413|NCT01957488|20310323|P3|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236414|NCT01957488|20310324|P2|NOT COMPLETED|Test Period 3 (2 Weeks)||1
8236415|NCT01957488|20310325|P1|NOT COMPLETED|Test Period 3 (2 Weeks)||1
8236416|NCT01957488|20310320|P6|COMPLETED|Test Period 3 (2 Weeks)||23
8236417|NCT01957488|20310321|P5|COMPLETED|Test Period 3 (2 Weeks)||25
8236418|NCT01957488|20310322|P4|COMPLETED|Test Period 3 (2 Weeks)||28
8236419|NCT01957488|20310323|P3|COMPLETED|Test Period 3 (2 Weeks)||25
8236420|NCT01957488|20310324|P2|COMPLETED|Test Period 3 (2 Weeks)||26
8236421|NCT01957488|20310325|P1|COMPLETED|Test Period 3 (2 Weeks)||23
8236422|NCT01957488|20310320|P6|STARTED|Test Period 3 (2 Weeks)||23
8236423|NCT01957488|20310321|P5|STARTED|Test Period 3 (2 Weeks)||25
8236424|NCT01957488|20310322|P4|STARTED|Test Period 3 (2 Weeks)||28
8236425|NCT01957488|20310323|P3|STARTED|Test Period 3 (2 Weeks)||25
8236426|NCT01957488|20310324|P2|STARTED|Test Period 3 (2 Weeks)||27
8236427|NCT01957488|20310325|P1|STARTED|Test Period 3 (2 Weeks)||24
8236428|NCT01957488|20310320|P6|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236429|NCT01957488|20310321|P5|NOT COMPLETED|Test Period 2 (2 Weeks)||2
8236430|NCT01957488|20310322|P4|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236431|NCT01957488|20310323|P3|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236432|NCT01957488|20310324|P2|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236433|NCT01957488|20310325|P1|NOT COMPLETED|Test Period 2 (2 Weeks)||3
8236434|NCT01957488|20310320|P6|COMPLETED|Test Period 2 (2 Weeks)||23
8236435|NCT01957488|20310321|P5|COMPLETED|Test Period 2 (2 Weeks)||25
8236436|NCT01957488|20310322|P4|COMPLETED|Test Period 2 (2 Weeks)||28
8236437|NCT01957488|20310323|P3|COMPLETED|Test Period 2 (2 Weeks)||25
8236438|NCT01957488|20310324|P2|COMPLETED|Test Period 2 (2 Weeks)||27
8236439|NCT01957488|20310325|P1|COMPLETED|Test Period 2 (2 Weeks)||24
8236440|NCT01957488|20310320|P6|STARTED|Test Period 2 (2 Weeks)||24
8236441|NCT01957488|20310321|P5|STARTED|Test Period 2 (2 Weeks)||27
8236442|NCT01957488|20310322|P4|STARTED|Test Period 2 (2 Weeks)||29
8236443|NCT01957488|20310323|P3|STARTED|Test Period 2 (2 Weeks)||26
8236444|NCT01957488|20310324|P2|STARTED|Test Period 2 (2 Weeks)||28
8236445|NCT01957488|20310325|P1|STARTED|Test Period 2 (2 Weeks)||27
8236446|NCT01957488|20310320|P6|NOT COMPLETED|Test Period 1 (2 Weeks)||6
8236447|NCT01957488|20310321|P5|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236448|NCT01957488|20310322|P4|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236449|NCT01957488|20310323|P3|NOT COMPLETED|Test Period 1 (2 Weeks)||4
8236450|NCT01957488|20310324|P2|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236451|NCT01957488|20310325|P1|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236452|NCT01957488|20310320|P6|COMPLETED|Test Period 1 (2 Weeks)||24
8236453|NCT01957488|20310321|P5|COMPLETED|Test Period 1 (2 Weeks)||27
8236454|NCT01957488|20310322|P4|COMPLETED|Test Period 1 (2 Weeks)||29
8236455|NCT01957488|20310323|P3|COMPLETED|Test Period 1 (2 Weeks)||26
8236456|NCT01957488|20310324|P2|COMPLETED|Test Period 1 (2 Weeks)||28
8236457|NCT01957488|20310325|P1|COMPLETED|Test Period 1 (2 Weeks)||27
8236458|NCT01957488|20310320|P6|STARTED|Test Period 1 (2 Weeks)||30
8236459|NCT01957488|20310321|P5|STARTED|Test Period 1 (2 Weeks)||30
8236460|NCT01957488|20310322|P4|STARTED|Test Period 1 (2 Weeks)||32
8236461|NCT01957488|20310323|P3|STARTED|Test Period 1 (2 Weeks)||30
8236462|NCT01957488|20310324|P2|STARTED|Test Period 1 (2 Weeks)||31
8236463|NCT01957488|20310325|P1|STARTED|Test Period 1 (2 Weeks)||30
8236464|NCT01957475|20310333|P2|NOT COMPLETED|Test Period 2||0
8236465|NCT01957475|20310334|P1|NOT COMPLETED|Test Period 2||1
8236466|NCT01957475|20310333|P2|COMPLETED|Test Period 2||8
8236467|NCT01957475|20310334|P1|COMPLETED|Test Period 2||8
8236468|NCT01957475|20310333|P2|STARTED|Test Period 2||8
8236469|NCT01957475|20310334|P1|STARTED|Test Period 2||9
8236470|NCT01957475|20310333|P2|NOT COMPLETED|Test Period 1||1
8236471|NCT01957475|20310334|P1|NOT COMPLETED|Test Period 1||2
8236472|NCT01957475|20310333|P2|COMPLETED|Test Period 1||9
8236473|NCT01957475|20310334|P1|COMPLETED|Test Period 1||8
8236474|NCT01957475|20310333|P2|STARTED|Test Period 1||10
8236475|NCT01957475|20310334|P1|STARTED|Test Period 1||10
8236476|NCT01957462|20310340|P2|NOT COMPLETED|Test Period 2||0
8236477|NCT01957462|20310341|P1|NOT COMPLETED|Test Period 2||0
8236478|NCT01957462|20310340|P2|COMPLETED|Test Period 2||15
8236479|NCT01957462|20310341|P1|COMPLETED|Test Period 2||14
8236480|NCT01957462|20310340|P2|STARTED|Test Period 2||15
8236481|NCT01957462|20310341|P1|STARTED|Test Period 2||14
8236482|NCT01957462|20310340|P2|NOT COMPLETED|Test Period 1||0
8236483|NCT01957462|20310341|P1|NOT COMPLETED|Test Period 1||2
8236484|NCT01957462|20310340|P2|COMPLETED|Test Period 1||15
8236485|NCT01957462|20310341|P1|COMPLETED|Test Period 1||14
8236486|NCT01957462|20310340|P2|STARTED|Test Period 1||15
8236487|NCT01957462|20310341|P1|STARTED|Test Period 1||16
8236488|NCT01957410|20310347|P1|NOT COMPLETED|Optional Open Label||0
8236489|NCT01957410|20310347|P1|COMPLETED|Optional Open Label||13
8236490|NCT01957410|20310347|P1|STARTED|Optional Open Label||13
8236491|NCT01957410|20310347|P1|NOT COMPLETED|Open Label||0
8236492|NCT01957410|20310347|P1|COMPLETED|Open Label||13
8236493|NCT01957410|20310347|P1|STARTED|Open Label||13
8236494|NCT01957397|20310352|P2|NOT COMPLETED|Test Period 3||2
8236495|NCT01957397|20310353|P1|NOT COMPLETED|Test Period 3||2
8236496|NCT01957397|20310352|P2|COMPLETED|Test Period 3||9
8236497|NCT01957397|20310353|P1|COMPLETED|Test Period 3||9
8236498|NCT01957397|20310352|P2|STARTED|Test Period 3||11
8236499|NCT01957397|20310353|P1|STARTED|Test Period 3||11
8236500|NCT01957397|20310352|P2|NOT COMPLETED|Test Period 2||1
8236501|NCT01957397|20310353|P1|NOT COMPLETED|Test Period 2||0
8236502|NCT01957397|20310352|P2|COMPLETED|Test Period 2||11
8236503|NCT01957397|20310353|P1|COMPLETED|Test Period 2||11
8236504|NCT01957397|20310352|P2|STARTED|Test Period 2||12
8236505|NCT01957397|20310353|P1|STARTED|Test Period 2||11
8236506|NCT01957397|20310352|P2|NOT COMPLETED|Test Period 1||1
8236507|NCT01957397|20310353|P1|NOT COMPLETED|Test Period 1||2
8236508|NCT01957397|20310352|P2|COMPLETED|Test Period 1||12
8236509|NCT01957397|20310353|P1|COMPLETED|Test Period 1||11
8236510|NCT01957397|20310352|P2|STARTED|Test Period 1||13
8236511|NCT01957397|20310353|P1|STARTED|Test Period 1||13
8236512|NCT01957397|20310352|P2|NOT COMPLETED|Baseline Own Product||0
8236513|NCT01957397|20310353|P1|NOT COMPLETED|Baseline Own Product||0
8236514|NCT01957397|20310352|P2|COMPLETED|Baseline Own Product||13
8236515|NCT01957397|20310353|P1|COMPLETED|Baseline Own Product||13
8236516|NCT01957397|20310352|P2|STARTED|Baseline Own Product||13
8236517|NCT01957397|20310353|P1|STARTED|Baseline Own Product||13
8236518|NCT01957384|20310363|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
8236519|NCT01957384|20310364|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
8236520|NCT01957384|20310365|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
8236521|NCT01957384|20310366|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
8236522|NCT01957384|20310367|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
8236523|NCT01957384|20310368|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
8236524|NCT01957384|20310363|P6|COMPLETED|Test Period 3 (14 Days)||3
8236525|NCT01957384|20310364|P5|COMPLETED|Test Period 3 (14 Days)||3
8236526|NCT01957384|20310365|P4|COMPLETED|Test Period 3 (14 Days)||4
8236527|NCT01957384|20310366|P3|COMPLETED|Test Period 3 (14 Days)||4
8236528|NCT01957384|20310367|P2|COMPLETED|Test Period 3 (14 Days)||4
8236529|NCT01957384|20310368|P1|COMPLETED|Test Period 3 (14 Days)||4
8236530|NCT01957384|20310363|P6|STARTED|Test Period 3 (14 Days)||3
8236531|NCT01957384|20310364|P5|STARTED|Test Period 3 (14 Days)||3
8236532|NCT01957384|20310365|P4|STARTED|Test Period 3 (14 Days)||4
8236533|NCT01957384|20310366|P3|STARTED|Test Period 3 (14 Days)||4
8236534|NCT01957384|20310367|P2|STARTED|Test Period 3 (14 Days)||4
8236535|NCT01957384|20310368|P1|STARTED|Test Period 3 (14 Days)||4
8236536|NCT01957384|20310363|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
8236537|NCT01957384|20310364|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
8236538|NCT01957384|20310365|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
8236539|NCT01957384|20310366|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
8236540|NCT01957384|20310367|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
8236541|NCT01957384|20310368|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
8236542|NCT01957384|20310363|P6|COMPLETED|Test Period 2 (14 Days)||3
8236543|NCT01957384|20310364|P5|COMPLETED|Test Period 2 (14 Days)||3
8236544|NCT01957384|20310365|P4|COMPLETED|Test Period 2 (14 Days)||4
8236545|NCT01957384|20310366|P3|COMPLETED|Test Period 2 (14 Days)||4
8236546|NCT01957384|20310367|P2|COMPLETED|Test Period 2 (14 Days)||4
8236547|NCT01957384|20310368|P1|COMPLETED|Test Period 2 (14 Days)||4
8236548|NCT01957384|20310363|P6|STARTED|Test Period 2 (14 Days)||3
8236549|NCT01957384|20310364|P5|STARTED|Test Period 2 (14 Days)||3
8236550|NCT01957384|20310365|P4|STARTED|Test Period 2 (14 Days)||4
8236551|NCT01957384|20310366|P3|STARTED|Test Period 2 (14 Days)||4
8236552|NCT01957384|20310367|P2|STARTED|Test Period 2 (14 Days)||4
8236553|NCT01957384|20310368|P1|STARTED|Test Period 2 (14 Days)||4
8236554|NCT01957384|20310363|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
8236555|NCT01957384|20310364|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
8236556|NCT01957384|20310365|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
8236557|NCT01957384|20310366|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
8236558|NCT01957384|20310367|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
8236559|NCT01957384|20310368|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
8236560|NCT01957384|20310363|P6|COMPLETED|Test Period 1 (14 Days)||3
8236561|NCT01957384|20310364|P5|COMPLETED|Test Period 1 (14 Days)||3
8236562|NCT01957384|20310365|P4|COMPLETED|Test Period 1 (14 Days)||4
8236563|NCT01957384|20310366|P3|COMPLETED|Test Period 1 (14 Days)||4
8236564|NCT01957384|20310367|P2|COMPLETED|Test Period 1 (14 Days)||4
8236565|NCT01957384|20310368|P1|COMPLETED|Test Period 1 (14 Days)||4
8236566|NCT01957384|20310363|P6|STARTED|Test Period 1 (14 Days)||3
8236567|NCT01957384|20310364|P5|STARTED|Test Period 1 (14 Days)||3
8236568|NCT01957384|20310365|P4|STARTED|Test Period 1 (14 Days)||4
8236569|NCT01957384|20310366|P3|STARTED|Test Period 1 (14 Days)||4
8236570|NCT01957384|20310367|P2|STARTED|Test Period 1 (14 Days)||4
8236571|NCT01957384|20310368|P1|STARTED|Test Period 1 (14 Days)||4
8236572|NCT01957215|20310378|P2|NOT COMPLETED|Overall Study||12
8236573|NCT01957215|20310379|P1|NOT COMPLETED|Overall Study||13
8236574|NCT01957215|20310378|P2|COMPLETED|Overall Study||123
8236575|NCT01957215|20310379|P1|COMPLETED|Overall Study||122
8236576|NCT01957215|20310378|P2|STARTED|Overall Study||135
8236577|NCT01957215|20310379|P1|STARTED|Overall Study||135
8236578|NCT01957202|20310407|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236579|NCT01957202|20310408|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
8236580|NCT01957202|20310409|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236581|NCT01957202|20310410|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236582|NCT01957202|20310411|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236583|NCT01957202|20310412|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236584|NCT01957202|20310413|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236585|NCT01957202|20310414|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236586|NCT01957202|20310415|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236587|NCT01957202|20310416|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236588|NCT01957202|20310417|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236589|NCT01957202|20310418|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236590|NCT01957202|20310419|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236591|NCT01957202|20310420|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236592|NCT01957202|20310421|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236593|NCT01957202|20310422|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236594|NCT01957202|20310423|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236595|NCT01957202|20310424|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236596|NCT01957202|20310407|P18|COMPLETED|Treatment Period 3 (8 Days)||3
8236597|NCT01957202|20310408|P17|COMPLETED|Treatment Period 3 (8 Days)||4
8236598|NCT01957202|20310409|P16|COMPLETED|Treatment Period 3 (8 Days)||3
8236599|NCT01957202|20310410|P15|COMPLETED|Treatment Period 3 (8 Days)||6
8236600|NCT01957202|20310411|P14|COMPLETED|Treatment Period 3 (8 Days)||3
8236601|NCT01957202|20310412|P13|COMPLETED|Treatment Period 3 (8 Days)||3
8236602|NCT01957202|20310413|P12|COMPLETED|Treatment Period 3 (8 Days)||6
8236603|NCT01957202|20310414|P11|COMPLETED|Treatment Period 3 (8 Days)||3
8236604|NCT01957202|20310415|P10|COMPLETED|Treatment Period 3 (8 Days)||6
8236605|NCT01957202|20310416|P9|COMPLETED|Treatment Period 3 (8 Days)||3
8236606|NCT01957202|20310417|P8|COMPLETED|Treatment Period 3 (8 Days)||3
8236607|NCT01957202|20310418|P7|COMPLETED|Treatment Period 3 (8 Days)||3
8236608|NCT01957202|20310419|P6|COMPLETED|Treatment Period 3 (8 Days)||2
8236609|NCT01957202|20310420|P5|COMPLETED|Treatment Period 3 (8 Days)||3
8236610|NCT01957202|20310421|P4|COMPLETED|Treatment Period 3 (8 Days)||3
8236611|NCT01957202|20310422|P3|COMPLETED|Treatment Period 3 (8 Days)||6
8236612|NCT01957202|20310423|P2|COMPLETED|Treatment Period 3 (8 Days)||5
8236613|NCT01957202|20310424|P1|COMPLETED|Treatment Period 3 (8 Days)||3
8236614|NCT01957202|20310407|P18|STARTED|Treatment Period 3 (8 Days)||3
8236615|NCT01957202|20310408|P17|STARTED|Treatment Period 3 (8 Days)||5
8236616|NCT01957202|20310409|P16|STARTED|Treatment Period 3 (8 Days)||3
8236617|NCT01957202|20310410|P15|STARTED|Treatment Period 3 (8 Days)||6
8236618|NCT01957202|20310411|P14|STARTED|Treatment Period 3 (8 Days)||3
8236619|NCT01957202|20310412|P13|STARTED|Treatment Period 3 (8 Days)||3
8236620|NCT01957202|20310413|P12|STARTED|Treatment Period 3 (8 Days)||6
8236621|NCT01957202|20310414|P11|STARTED|Treatment Period 3 (8 Days)||3
8236622|NCT01957202|20310415|P10|STARTED|Treatment Period 3 (8 Days)||6
8236623|NCT01957202|20310416|P9|STARTED|Treatment Period 3 (8 Days)||3
8236624|NCT01957202|20310417|P8|STARTED|Treatment Period 3 (8 Days)||3
8236625|NCT01957202|20310418|P7|STARTED|Treatment Period 3 (8 Days)||3
8236626|NCT01957202|20310419|P6|STARTED|Treatment Period 3 (8 Days)||2
8236627|NCT01957202|20310420|P5|STARTED|Treatment Period 3 (8 Days)||3
8236628|NCT01957202|20310421|P4|STARTED|Treatment Period 3 (8 Days)||3
8236629|NCT01957202|20310422|P3|STARTED|Treatment Period 3 (8 Days)||6
8236630|NCT01957202|20310423|P2|STARTED|Treatment Period 3 (8 Days)||5
8236631|NCT01957202|20310424|P1|STARTED|Treatment Period 3 (8 Days)||3
8236632|NCT01957202|20310407|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236633|NCT01957202|20310408|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236634|NCT01957202|20310409|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236635|NCT01957202|20310410|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236636|NCT01957202|20310411|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236637|NCT01957202|20310412|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236638|NCT01957202|20310413|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236639|NCT01957202|20310414|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236640|NCT01957202|20310415|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236641|NCT01957202|20310416|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236642|NCT01957202|20310417|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236643|NCT01957202|20310418|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236644|NCT01957202|20310419|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236645|NCT01957202|20310420|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236646|NCT01957202|20310421|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236647|NCT01957202|20310422|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236648|NCT01957202|20310423|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236649|NCT01957202|20310424|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236650|NCT01957202|20310407|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236651|NCT01957202|20310408|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
8236652|NCT01957202|20310409|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236653|NCT01957202|20310410|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236654|NCT01957202|20310411|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236655|NCT01957202|20310412|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236656|NCT01957202|20310413|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236657|NCT01957202|20310414|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236658|NCT01957202|20310415|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236659|NCT01957202|20310416|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236660|NCT01957202|20310417|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236661|NCT01957202|20310418|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236662|NCT01957202|20310419|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
8236663|NCT01957202|20310420|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236664|NCT01957202|20310421|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236665|NCT01957202|20310422|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236666|NCT01957202|20310423|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
8236667|NCT01957202|20310424|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236668|NCT01957202|20310407|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
8236669|NCT01957202|20310408|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
8236670|NCT01957202|20310409|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
8236671|NCT01957202|20310410|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
8236672|NCT01957202|20310411|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
8236673|NCT01957202|20310412|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
8236674|NCT01957202|20310413|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
8236675|NCT01957202|20310414|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
8236676|NCT01957202|20310415|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
8236677|NCT01957202|20310416|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
8236678|NCT01957202|20310417|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
8236679|NCT01957202|20310418|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
8236680|NCT01957202|20310419|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
8236681|NCT01957202|20310420|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
8236682|NCT01957202|20310421|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
8236683|NCT01957202|20310422|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
8236684|NCT01957202|20310423|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
8236685|NCT01957202|20310424|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
8236686|NCT01957202|20310407|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236687|NCT01957202|20310408|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
8236688|NCT01957202|20310409|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236689|NCT01957202|20310410|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236690|NCT01957202|20310411|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236691|NCT01957202|20310412|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236692|NCT01957202|20310413|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236693|NCT01957202|20310414|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236694|NCT01957202|20310415|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236695|NCT01957202|20310416|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236696|NCT01957202|20310417|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236697|NCT01957202|20310418|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236698|NCT01957202|20310419|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236699|NCT01957202|20310420|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236700|NCT01957202|20310421|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236701|NCT01957202|20310422|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236702|NCT01957202|20310423|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
8236703|NCT01957202|20310424|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236704|NCT01957202|20310407|P18|COMPLETED|Treatment Period 2 (8 Days)||3
8236705|NCT01957202|20310408|P17|COMPLETED|Treatment Period 2 (8 Days)||5
8236706|NCT01957202|20310409|P16|COMPLETED|Treatment Period 2 (8 Days)||3
8236707|NCT01957202|20310410|P15|COMPLETED|Treatment Period 2 (8 Days)||6
8236708|NCT01957202|20310411|P14|COMPLETED|Treatment Period 2 (8 Days)||3
8236709|NCT01957202|20310412|P13|COMPLETED|Treatment Period 2 (8 Days)||3
8236710|NCT01957202|20310413|P12|COMPLETED|Treatment Period 2 (8 Days)||6
8236711|NCT01957202|20310414|P11|COMPLETED|Treatment Period 2 (8 Days)||3
8236712|NCT01957202|20310415|P10|COMPLETED|Treatment Period 2 (8 Days)||6
8236713|NCT01957202|20310416|P9|COMPLETED|Treatment Period 2 (8 Days)||3
8236714|NCT01957202|20310417|P8|COMPLETED|Treatment Period 2 (8 Days)||3
8236715|NCT01957202|20310418|P7|COMPLETED|Treatment Period 2 (8 Days)||3
8236716|NCT01957202|20310419|P6|COMPLETED|Treatment Period 2 (8 Days)||2
8236717|NCT01957202|20310420|P5|COMPLETED|Treatment Period 2 (8 Days)||3
8236718|NCT01957202|20310421|P4|COMPLETED|Treatment Period 2 (8 Days)||3
8236719|NCT01957202|20310422|P3|COMPLETED|Treatment Period 2 (8 Days)||6
8236720|NCT01957202|20310423|P2|COMPLETED|Treatment Period 2 (8 Days)||5
8236721|NCT01957202|20310424|P1|COMPLETED|Treatment Period 2 (8 Days)||3
8236722|NCT01957202|20310407|P18|STARTED|Treatment Period 2 (8 Days)||3
8236723|NCT01957202|20310408|P17|STARTED|Treatment Period 2 (8 Days)||6
8236724|NCT01957202|20310409|P16|STARTED|Treatment Period 2 (8 Days)||3
8236725|NCT01957202|20310410|P15|STARTED|Treatment Period 2 (8 Days)||6
8236726|NCT01957202|20310411|P14|STARTED|Treatment Period 2 (8 Days)||3
8236727|NCT01957202|20310412|P13|STARTED|Treatment Period 2 (8 Days)||3
8236728|NCT01957202|20310413|P12|STARTED|Treatment Period 2 (8 Days)||6
8236729|NCT01957202|20310414|P11|STARTED|Treatment Period 2 (8 Days)||3
8236730|NCT01957202|20310415|P10|STARTED|Treatment Period 2 (8 Days)||6
8236731|NCT01957202|20310416|P9|STARTED|Treatment Period 2 (8 Days)||3
8236732|NCT01957202|20310417|P8|STARTED|Treatment Period 2 (8 Days)||3
8236733|NCT01957202|20310418|P7|STARTED|Treatment Period 2 (8 Days)||3
8236734|NCT01957202|20310419|P6|STARTED|Treatment Period 2 (8 Days)||2
8236735|NCT01957202|20310420|P5|STARTED|Treatment Period 2 (8 Days)||3
8236736|NCT01957202|20310421|P4|STARTED|Treatment Period 2 (8 Days)||3
8236737|NCT01957202|20310422|P3|STARTED|Treatment Period 2 (8 Days)||6
8236738|NCT01957202|20310423|P2|STARTED|Treatment Period 2 (8 Days)||6
8236739|NCT01957202|20310424|P1|STARTED|Treatment Period 2 (8 Days)||3
8236740|NCT01957202|20310407|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236741|NCT01957202|20310408|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236742|NCT01957202|20310409|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236743|NCT01957202|20310410|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236744|NCT01957202|20310411|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236745|NCT01957202|20310412|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236746|NCT01957202|20310413|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236747|NCT01957202|20310414|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236748|NCT01957202|20310415|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236749|NCT01957202|20310416|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236750|NCT01957202|20310417|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236751|NCT01957202|20310418|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236752|NCT01957202|20310419|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236753|NCT01957202|20310420|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236754|NCT01957202|20310421|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236755|NCT01957202|20310422|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236756|NCT01957202|20310423|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236757|NCT01957202|20310424|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236758|NCT01957202|20310407|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236759|NCT01957202|20310408|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236760|NCT01957202|20310409|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236761|NCT01957202|20310410|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236762|NCT01957202|20310411|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236763|NCT01957202|20310412|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236764|NCT01957202|20310413|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236765|NCT01957202|20310414|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236766|NCT01957202|20310415|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236767|NCT01957202|20310416|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236768|NCT01957202|20310417|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236769|NCT01957202|20310418|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236770|NCT01957202|20310419|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
8236771|NCT01957202|20310420|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236772|NCT01957202|20310421|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236773|NCT01957202|20310422|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236774|NCT01957202|20310423|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236775|NCT01957202|20310424|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236776|NCT01957202|20310407|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
8236777|NCT01957202|20310408|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
8236778|NCT01957202|20310409|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
8236779|NCT01957202|20310410|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
8236780|NCT01957202|20310411|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
8236781|NCT01957202|20310412|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
8236782|NCT01957202|20310413|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
8236783|NCT01957202|20310414|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
8236784|NCT01957202|20310415|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
8236785|NCT01957202|20310416|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
8236786|NCT01957202|20310417|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
8236787|NCT01957202|20310418|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
8236788|NCT01957202|20310419|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
8236789|NCT01957202|20310420|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
8236790|NCT01957202|20310421|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
8236791|NCT01957202|20310422|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
8236792|NCT01957202|20310423|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
8236793|NCT01957202|20310424|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
8236794|NCT01957202|20310407|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236795|NCT01957202|20310408|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236796|NCT01957202|20310409|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236797|NCT01957202|20310410|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236798|NCT01957202|20310411|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236799|NCT01957202|20310412|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236800|NCT01957202|20310413|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236801|NCT01957202|20310414|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236802|NCT01957202|20310415|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236803|NCT01957202|20310416|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236804|NCT01957202|20310417|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236805|NCT01957202|20310418|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236806|NCT01957202|20310419|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236807|NCT01957202|20310420|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236808|NCT01957202|20310421|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236809|NCT01957202|20310422|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236810|NCT01957202|20310423|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236811|NCT01957202|20310424|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236812|NCT01957202|20310407|P18|COMPLETED|Treatment Period 1 (8 Days)||3
8236813|NCT01957202|20310408|P17|COMPLETED|Treatment Period 1 (8 Days)||6
8236814|NCT01957202|20310409|P16|COMPLETED|Treatment Period 1 (8 Days)||3
8236815|NCT01957202|20310410|P15|COMPLETED|Treatment Period 1 (8 Days)||6
8236816|NCT01957202|20310411|P14|COMPLETED|Treatment Period 1 (8 Days)||3
8236817|NCT01957202|20310412|P13|COMPLETED|Treatment Period 1 (8 Days)||3
8236818|NCT01957202|20310413|P12|COMPLETED|Treatment Period 1 (8 Days)||6
8236819|NCT01957202|20310414|P11|COMPLETED|Treatment Period 1 (8 Days)||3
8236820|NCT01957202|20310415|P10|COMPLETED|Treatment Period 1 (8 Days)||6
8236821|NCT01957202|20310416|P9|COMPLETED|Treatment Period 1 (8 Days)||3
8236822|NCT01957202|20310417|P8|COMPLETED|Treatment Period 1 (8 Days)||3
8236823|NCT01957202|20310418|P7|COMPLETED|Treatment Period 1 (8 Days)||3
8236824|NCT01957202|20310419|P6|COMPLETED|Treatment Period 1 (8 Days)||2
8236825|NCT01957202|20310420|P5|COMPLETED|Treatment Period 1 (8 Days)||3
8236826|NCT01957202|20310421|P4|COMPLETED|Treatment Period 1 (8 Days)||3
8236827|NCT01957202|20310422|P3|COMPLETED|Treatment Period 1 (8 Days)||6
8236828|NCT01957202|20310423|P2|COMPLETED|Treatment Period 1 (8 Days)||6
8236829|NCT01957202|20310424|P1|COMPLETED|Treatment Period 1 (8 Days)||3
8236830|NCT01957202|20310407|P18|STARTED|Treatment Period 1 (8 Days)||3
8236831|NCT01957202|20310408|P17|STARTED|Treatment Period 1 (8 Days)||6
8236832|NCT01957202|20310409|P16|STARTED|Treatment Period 1 (8 Days)||3
8236833|NCT01957202|20310410|P15|STARTED|Treatment Period 1 (8 Days)||6
8236834|NCT01957202|20310411|P14|STARTED|Treatment Period 1 (8 Days)||3
8236835|NCT01957202|20310412|P13|STARTED|Treatment Period 1 (8 Days)||3
8236836|NCT01957202|20310413|P12|STARTED|Treatment Period 1 (8 Days)||6
8236837|NCT01957202|20310414|P11|STARTED|Treatment Period 1 (8 Days)||3
8236838|NCT01957202|20310415|P10|STARTED|Treatment Period 1 (8 Days)||6
8236839|NCT01957202|20310416|P9|STARTED|Treatment Period 1 (8 Days)||3
8236840|NCT01957202|20310417|P8|STARTED|Treatment Period 1 (8 Days)||3
8236841|NCT01957202|20310418|P7|STARTED|Treatment Period 1 (8 Days)||3
8236842|NCT01957202|20310419|P6|STARTED|Treatment Period 1 (8 Days)||2
8236843|NCT01957202|20310420|P5|STARTED|Treatment Period 1 (8 Days)||3
8236844|NCT01957202|20310421|P4|STARTED|Treatment Period 1 (8 Days)||3
8236845|NCT01957202|20310422|P3|STARTED|Treatment Period 1 (8 Days)||6
8236846|NCT01957202|20310423|P2|STARTED|Treatment Period 1 (8 Days)||6
8236847|NCT01957202|20310424|P1|STARTED|Treatment Period 1 (8 Days)||3
8236848|NCT01957163|20310449|P3|NOT COMPLETED|Overall Study||18
8236849|NCT01957163|20310450|P2|NOT COMPLETED|Overall Study||11
8236850|NCT01957163|20310451|P1|NOT COMPLETED|Overall Study||15
8236851|NCT01957163|20310449|P3|COMPLETED|Overall Study||189
8236852|NCT01957163|20310450|P2|COMPLETED|Overall Study||195
8236853|NCT01957163|20310451|P1|COMPLETED|Overall Study||191
8236854|NCT01957163|20310449|P3|STARTED|Overall Study||207
8236855|NCT01957163|20310450|P2|STARTED|Overall Study||206
8236856|NCT01957163|20310451|P1|STARTED|Overall Study||206
8236857|NCT01957150|20310464|P2|NOT COMPLETED|Overall Study||58
8236858|NCT01957150|20310465|P1|NOT COMPLETED|Overall Study||55
8236859|NCT01957150|20310464|P2|COMPLETED|Overall Study||83
8236860|NCT01957150|20310465|P1|COMPLETED|Overall Study||87
8236861|NCT01957150|20310464|P2|STARTED|Overall Study||141
8236862|NCT01957150|20310465|P1|STARTED|Overall Study||142
8236863|NCT01957137|20310481|P1|NOT COMPLETED|No Stimulation||0
8236864|NCT01957137|20310481|P1|COMPLETED|No Stimulation||28
8236865|NCT01957137|20310481|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
8236866|NCT01957137|20310481|P1|NOT COMPLETED|Randomized Portion||2
8236867|NCT01957137|20310481|P1|COMPLETED|Randomized Portion||28
8236868|NCT01957137|20310481|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
8236869|NCT01957137|20310481|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
8236870|NCT01957137|20310481|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
8236871|NCT01957137|20310481|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
8236872|NCT01957137|20310481|P1|STARTED|Randomized Portion||30
8236873|NCT01957111|20310511|P2|NOT COMPLETED|Overall Study||1
8236874|NCT01957111|20310512|P1|NOT COMPLETED|Overall Study||1
8236875|NCT01957111|20310511|P2|COMPLETED|Overall Study||15
8236876|NCT01957111|20310512|P1|COMPLETED|Overall Study||15
8236877|NCT01957111|20310511|P2|STARTED|Overall Study||16
8236878|NCT01957111|20310512|P1|STARTED|Overall Study||16
8236879|NCT01957085|20310520|P1|NOT COMPLETED|Overall Study||0
8236880|NCT01957085|20310520|P1|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
8236881|NCT01957085|20310520|P1|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
8236882|NCT01956773|20310531|P2|NOT COMPLETED|Overall Study||1
8236883|NCT01956773|20310532|P1|NOT COMPLETED|Overall Study||628
8236884|NCT01956773|20310531|P2|COMPLETED|Overall Study||99
8236885|NCT01956773|20310532|P1|COMPLETED|Overall Study||1892
8236886|NCT01956773|20310531|P2|STARTED|Overall Study||100
8236887|NCT01956773|20310532|P1|STARTED|Overall Study||2520
8236888|NCT01956669|20310550|P7|NOT COMPLETED|Overall Study||6
8236889|NCT01956669|20310551|P6|NOT COMPLETED|Overall Study||4
8236890|NCT01956669|20310552|P5|NOT COMPLETED|Overall Study||4
8236891|NCT01956669|20310553|P4|NOT COMPLETED|Overall Study||10
8236892|NCT01956669|20310554|P3|NOT COMPLETED|Overall Study||10
8236893|NCT01956669|20310555|P2|NOT COMPLETED|Overall Study||11
8236894|NCT01956669|20310556|P1|NOT COMPLETED|Overall Study||12
8236895|NCT01956669|20310550|P7|COMPLETED|Overall Study||0
8236896|NCT01956669|20310551|P6|COMPLETED|Overall Study||0
8236897|NCT01956669|20310552|P5|COMPLETED|Overall Study||0
8236898|NCT01956669|20310553|P4|COMPLETED|Overall Study||0
8236899|NCT01956669|20310554|P3|COMPLETED|Overall Study||0
8236900|NCT01956669|20310555|P2|COMPLETED|Overall Study||0
8236901|NCT01956669|20310556|P1|COMPLETED|Overall Study||0
8236902|NCT01956669|20310550|P7|Per Protocol Set (PP Set)|Overall Study||5
8236903|NCT01956669|20310551|P6|Per Protocol Set (PP Set)|Overall Study||4
8236904|NCT01956669|20310552|P5|Per Protocol Set (PP Set)|Overall Study||4
8236905|NCT01956669|20310553|P4|Per Protocol Set (PP Set)|Overall Study||9
8236906|NCT01956669|20310554|P3|Per Protocol Set (PP Set)|Overall Study||6
8236907|NCT01956669|20310555|P2|Per Protocol Set (PP Set)|Overall Study||10
8236908|NCT01956669|20310556|P1|Per Protocol Set (PP Set)|Overall Study||9
8236909|NCT01956669|20310550|P7|Biomarker Set|Overall Study||3
8236910|NCT01956669|20310551|P6|Biomarker Set|Overall Study||4
8236911|NCT01956669|20310552|P5|Biomarker Set|Overall Study||3
8236912|NCT01956669|20310553|P4|Biomarker Set|Overall Study||9
8236913|NCT01956669|20310554|P3|Biomarker Set|Overall Study||9
8236914|NCT01956669|20310555|P2|Biomarker Set|Overall Study||11
8236915|NCT01956669|20310556|P1|Biomarker Set|Overall Study||12
8236916|NCT01956669|20310550|P7|PKES Set|Overall Study||5
8236917|NCT01956669|20310551|P6|PKES Set|Overall Study||1
8236918|NCT01956669|20310552|P5|PKES Set|Overall Study||1
8236919|NCT01956669|20310553|P4|PKES Set|Overall Study||0
8236920|NCT01956669|20310554|P3|PKES Set|Overall Study||3
8236921|NCT01956669|20310555|P2|PKES Set|Overall Study||0
8236922|NCT01956669|20310556|P1|PKES Set|Overall Study||4
8236923|NCT01956669|20310550|P7|PK Set|Overall Study||6
8236924|NCT01956669|20310551|P6|PK Set|Overall Study||4
8236925|NCT01956669|20310552|P5|PK Set|Overall Study||4
8236926|NCT01956669|20310553|P4|PK Set|Overall Study||10
8236927|NCT01956669|20310554|P3|PK Set|Overall Study||10
8236928|NCT01956669|20310555|P2|PK Set|Overall Study||11
8236929|NCT01956669|20310556|P1|PK Set|Overall Study||11
8236930|NCT01956669|20310550|P7|STARTED|Overall Study||6
8236931|NCT01956669|20310551|P6|STARTED|Overall Study||4
8236932|NCT01956669|20310552|P5|STARTED|Overall Study||4
8236933|NCT01956669|20310553|P4|STARTED|Overall Study||10
8236934|NCT01956669|20310554|P3|STARTED|Overall Study||10
8236935|NCT01956669|20310555|P2|STARTED|Overall Study||11
8236936|NCT01956669|20310556|P1|STARTED|Overall Study||12
8236937|NCT01956435|20310651|P2|NOT COMPLETED|Overall Study||0
8236938|NCT01956435|20310652|P1|NOT COMPLETED|Overall Study||0
8236939|NCT01956435|20310651|P2|COMPLETED|Overall Study||3
8236940|NCT01956435|20310652|P1|COMPLETED|Overall Study||3
8236941|NCT01956435|20310651|P2|STARTED|Overall Study||3
8236942|NCT01956435|20310652|P1|STARTED|Overall Study||3
8236943|NCT01956279|20310661|P2|NOT COMPLETED|Overall Study||14
8236944|NCT01956279|20310662|P1|NOT COMPLETED|Overall Study||14
8236945|NCT01956279|20310661|P2|COMPLETED|Overall Study||74
8236946|NCT01956279|20310662|P1|COMPLETED|Overall Study||68
8236947|NCT01956279|20310661|P2|STARTED|Overall Study||88
8236948|NCT01956279|20310662|P1|STARTED|Overall Study||82
8236949|NCT01956240|20310678|P2|NOT COMPLETED|Overall Study||24
8236950|NCT01956240|20310679|P1|NOT COMPLETED|Overall Study||23
8236951|NCT01956240|20310678|P2|COMPLETED|Overall Study||25
8236952|NCT01956240|20310679|P1|COMPLETED|Overall Study||25
8236953|NCT01956240|20310678|P2|STARTED|Overall Study||49
8236954|NCT01956240|20310679|P1|STARTED|Overall Study||48
8236955|NCT01956123|20310689|P4|NOT COMPLETED|COS Cycle 3||2
8236956|NCT01956123|20310690|P3|NOT COMPLETED|COS Cycle 3||6
8236957|NCT01956123|20310691|P2|NOT COMPLETED|COS Cycle 3||0
8236958|NCT01956123|20310692|P1|NOT COMPLETED|COS Cycle 3||0
8236959|NCT01956123|20310689|P4|COMPLETED|COS Cycle 3||91
8236960|NCT01956123|20310690|P3|COMPLETED|COS Cycle 3||89
8236961|NCT01956123|20310691|P2|COMPLETED|COS Cycle 3||0
8236962|NCT01956123|20310692|P1|COMPLETED|COS Cycle 3||0
8236963|NCT01956123|20310689|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
8236964|NCT01956123|20310690|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
8236965|NCT01956123|20310691|P2|STARTED|COS Cycle 3||0
8236966|NCT01956123|20310692|P1|STARTED|COS Cycle 3||0
8236967|NCT01956123|20310689|P4|NOT COMPLETED|COS Cycle 2||0
8236968|NCT01956123|20310690|P3|NOT COMPLETED|COS Cycle 2||0
8236969|NCT01956123|20310691|P2|NOT COMPLETED|COS Cycle 2||7
8236970|NCT01956123|20310692|P1|NOT COMPLETED|COS Cycle 2||14
8236971|NCT01956123|20310689|P4|COMPLETED|COS Cycle 2||0
8236972|NCT01956123|20310690|P3|COMPLETED|COS Cycle 2||0
8236973|NCT01956123|20310691|P2|COMPLETED|COS Cycle 2||254
8236974|NCT01956123|20310692|P1|COMPLETED|COS Cycle 2||238
8236975|NCT01956123|20310689|P4|STARTED|COS Cycle 2||0
8236976|NCT01956123|20310690|P3|STARTED|COS Cycle 2||0
8236977|NCT01956123|20310691|P2|STARTED|COS Cycle 2||261
8236978|NCT01956123|20310692|P1|STARTED|COS Cycle 2||252
8236979|NCT01956110|20310744|P2|NOT COMPLETED|Overall Study||22
8236980|NCT01956110|20310745|P1|NOT COMPLETED|Overall Study||35
8236981|NCT01956110|20310744|P2|COMPLETED|Overall Study||639
8236982|NCT01956110|20310745|P1|COMPLETED|Overall Study||630
8236983|NCT01956110|20310744|P2|STARTED|Overall Study||661
8236984|NCT01956110|20310745|P1|STARTED|Overall Study||665
8236985|NCT01956097|20310798|P3|NOT COMPLETED|Overall Study||0
8236986|NCT01956097|20310799|P2|NOT COMPLETED|Overall Study||2
8236987|NCT01956097|20310800|P1|NOT COMPLETED|Overall Study||6
8236988|NCT01956097|20310798|P3|COMPLETED|Overall Study||15
8236989|NCT01956097|20310799|P2|COMPLETED|Overall Study||28
8236990|NCT01956097|20310800|P1|COMPLETED|Overall Study||24
8236991|NCT01956097|20310798|P3|STARTED|Overall Study||15
8236992|NCT01956097|20310799|P2|STARTED|Overall Study||30
8236993|NCT01956097|20310800|P1|STARTED|Overall Study||30
8236994|NCT01956071|20310817|P1|NOT COMPLETED|Overall Study||0
8236995|NCT01956071|20310817|P1|COMPLETED|Overall Study||44
8236996|NCT01956071|20310817|P1|STARTED|Overall Study||44
8236997|NCT01956032|20310821|P1|NOT COMPLETED|Overall Study||0
8236998|NCT01956032|20310821|P1|COMPLETED|Overall Study||15
8236999|NCT01956032|20310821|P1|STARTED|Overall Study||15
8237000|NCT01955954|20310868|P1|NOT COMPLETED|Overall Study||36
8237001|NCT01955954|20310868|P1|COMPLETED|Overall Study|12-months|33
8237002|NCT01955954|20310868|P1|Completed 6-month Assessement|Overall Study||42
8237003|NCT01955954|20310868|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
8237004|NCT01955954|20310868|P1|Completed Post-treatment Assessement|Overall Study||48
8237005|NCT01955954|20310868|P1|Completed Treatment|Overall Study||53
8237006|NCT01955954|20310868|P1|Received Treatment|Overall Study||66
8237007|NCT01955954|20310868|P1|STARTED|Overall Study||69
8237008|NCT01955837|20310879|P2|NOT COMPLETED|Overall Study||0
8237009|NCT01955837|20310880|P1|NOT COMPLETED|Overall Study||0
8237010|NCT01955837|20310879|P2|COMPLETED|Overall Study||135
8237011|NCT01955837|20310880|P1|COMPLETED|Overall Study||271
8237012|NCT01955837|20310879|P2|STARTED|Overall Study||135
8237013|NCT01955837|20310880|P1|STARTED|Overall Study||271
8237014|NCT01955733|20310911|P3|NOT COMPLETED|Period 2||21
8237015|NCT01955733|20310912|P2|NOT COMPLETED|Period 2||19
8237016|NCT01955733|20310913|P1|NOT COMPLETED|Period 2||12
8237017|NCT01955733|20310911|P3|COMPLETED|Period 2||8
8237018|NCT01955733|20310912|P2|COMPLETED|Period 2||10
8237019|NCT01955733|20310913|P1|COMPLETED|Period 2||20
8237020|NCT01955733|20310911|P3|STARTED|Period 2||29
8237021|NCT01955733|20310912|P2|STARTED|Period 2||29
8237022|NCT01955733|20310913|P1|STARTED|Period 2||32
8237023|NCT01955733|20310911|P3|NOT COMPLETED|Period 1||0
8237024|NCT01955733|20310912|P2|NOT COMPLETED|Period 1||0
8237025|NCT01955733|20310913|P1|NOT COMPLETED|Period 1||1
8237026|NCT01955733|20310911|P3|COMPLETED|Period 1||29
8237027|NCT01955733|20310912|P2|COMPLETED|Period 1||29
8237028|NCT01955733|20310913|P1|COMPLETED|Period 1||32
8237029|NCT01955733|20310911|P3|STARTED|Period 1||29
8237030|NCT01955733|20310912|P2|STARTED|Period 1||29
8237031|NCT01955733|20310913|P1|STARTED|Period 1||33
8237032|NCT01955720|20310933|P6|NOT COMPLETED|Overall Study||0
8237033|NCT01955720|20310934|P5|NOT COMPLETED|Overall Study||0
8237034|NCT01955720|20310935|P4|NOT COMPLETED|Overall Study||0
8237035|NCT01955720|20310936|P3|NOT COMPLETED|Overall Study||0
8237036|NCT01955720|20310937|P2|NOT COMPLETED|Overall Study||0
8237037|NCT01955720|20310938|P1|NOT COMPLETED|Overall Study||0
8237038|NCT01955720|20310933|P6|COMPLETED|Overall Study||7
8237039|NCT01955720|20310934|P5|COMPLETED|Overall Study||7
8237040|NCT01955720|20310935|P4|COMPLETED|Overall Study||3
8237041|NCT01955720|20310936|P3|COMPLETED|Overall Study||3
8237042|NCT01955720|20310937|P2|COMPLETED|Overall Study||13
8237043|NCT01955720|20310938|P1|COMPLETED|Overall Study||13
8237044|NCT01955720|20310933|P6|Subjects With Moderate Renal Impairment|Overall Study||0
8237045|NCT01955720|20310934|P5|Subjects With Moderate Renal Impairment|Overall Study||0
8237046|NCT01955720|20310935|P4|Subjects With Moderate Renal Impairment|Overall Study||0
8237047|NCT01955720|20310936|P3|Subjects With Moderate Renal Impairment|Overall Study||0
8237048|NCT01955720|20310937|P2|Subjects With Moderate Renal Impairment|Overall Study||3
8237049|NCT01955720|20310938|P1|Subjects With Moderate Renal Impairment|Overall Study||3
8237050|NCT01955720|20310933|P6|Subjects With Mild Renal Impairment|Overall Study||3
8237051|NCT01955720|20310934|P5|Subjects With Mild Renal Impairment|Overall Study||3
8237052|NCT01955720|20310935|P4|Subjects With Mild Renal Impairment|Overall Study||0
8237053|NCT01955720|20310936|P3|Subjects With Mild Renal Impairment|Overall Study||0
8237054|NCT01955720|20310937|P2|Subjects With Mild Renal Impairment|Overall Study||3
8237055|NCT01955720|20310938|P1|Subjects With Mild Renal Impairment|Overall Study||3
8237056|NCT01955720|20310933|P6|Healthy Subjects Aged 65-80|Overall Study||4
8237057|NCT01955720|20310934|P5|Healthy Subjects Aged 65-80|Overall Study||4
8237058|NCT01955720|20310935|P4|Healthy Subjects Aged 65-80|Overall Study||0
8237059|NCT01955720|20310936|P3|Healthy Subjects Aged 65-80|Overall Study||0
8237060|NCT01955720|20310937|P2|Healthy Subjects Aged 65-80|Overall Study||4
8237061|NCT01955720|20310938|P1|Healthy Subjects Aged 65-80|Overall Study||4
8237062|NCT01955720|20310933|P6|Healthy Subjects Aged 45-64|Overall Study||0
8237063|NCT01955720|20310934|P5|Healthy Subjects Aged 45-64|Overall Study||0
8237064|NCT01955720|20310935|P4|Healthy Subjects Aged 45-64|Overall Study||3
8237065|NCT01955720|20310936|P3|Healthy Subjects Aged 45-64|Overall Study||3
8237066|NCT01955720|20310937|P2|Healthy Subjects Aged 45-64|Overall Study||3
8237067|NCT01955720|20310938|P1|Healthy Subjects Aged 45-64|Overall Study||3
8237068|NCT01955720|20310933|P6|STARTED|Overall Study||7
8237069|NCT01955720|20310934|P5|STARTED|Overall Study||7
8237070|NCT01955720|20310935|P4|STARTED|Overall Study||3
8237071|NCT01955720|20310936|P3|STARTED|Overall Study||3
8237072|NCT01955720|20310937|P2|STARTED|Overall Study||13
8237073|NCT01955720|20310938|P1|STARTED|Overall Study||13
8237074|NCT01955707|20311006|P2|NOT COMPLETED|Overall Study||22
8237075|NCT01955707|20311007|P1|NOT COMPLETED|Overall Study||20
8237076|NCT01955707|20311006|P2|COMPLETED|Overall Study||57
8237077|NCT01955707|20311007|P1|COMPLETED|Overall Study||62
8237078|NCT01955707|20311006|P2|Received Total Volume of Study Drug|Overall Study||77
8237079|NCT01955707|20311007|P1|Received Total Volume of Study Drug|Overall Study||82
8237080|NCT01955707|20311006|P2|Dosed|Overall Study||78
8237081|NCT01955707|20311007|P1|Dosed|Overall Study||82
8237082|NCT01955707|20311006|P2|Withdrew Prior to Dosing|Overall Study||1
8237083|NCT01955707|20311007|P1|Withdrew Prior to Dosing|Overall Study||0
8237084|NCT01955707|20311006|P2|STARTED|Overall Study||79
8237085|NCT01955707|20311007|P1|STARTED|Overall Study||82
8237086|NCT01955629|20311031|P1|NOT COMPLETED|Overall Study||0
8237087|NCT01955629|20311031|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
8237088|NCT01955629|20311031|P1|STARTED|Overall Study||4
8237089|NCT01955564|20311050|P7|NOT COMPLETED|Overall Study||0
8237090|NCT01955564|20311051|P6|NOT COMPLETED|Overall Study||0
8237091|NCT01955564|20311052|P5|NOT COMPLETED|Overall Study||0
8237092|NCT01955564|20311053|P4|NOT COMPLETED|Overall Study||0
8237093|NCT01955564|20311054|P3|NOT COMPLETED|Overall Study||0
8237094|NCT01955564|20311055|P2|NOT COMPLETED|Overall Study||0
8237095|NCT01955564|20311056|P1|NOT COMPLETED|Overall Study||0
8237096|NCT01955564|20311050|P7|COMPLETED|Overall Study||6
8237097|NCT01955564|20311051|P6|COMPLETED|Overall Study||6
8237098|NCT01955564|20311052|P5|COMPLETED|Overall Study||6
8237099|NCT01955564|20311053|P4|COMPLETED|Overall Study||6
8237100|NCT01955564|20311054|P3|COMPLETED|Overall Study||6
8237101|NCT01955564|20311055|P2|COMPLETED|Overall Study||6
8237102|NCT01955564|20311056|P1|COMPLETED|Overall Study||18
8237103|NCT01955564|20311050|P7|STARTED|Overall Study||6
8237104|NCT01955564|20311051|P6|STARTED|Overall Study||6
8237105|NCT01955564|20311052|P5|STARTED|Overall Study||6
8237106|NCT01955564|20311053|P4|STARTED|Overall Study||6
8237107|NCT01955564|20311054|P3|STARTED|Overall Study||6
8237108|NCT01955564|20311055|P2|STARTED|Overall Study||6
8237109|NCT01955564|20311056|P1|STARTED|Overall Study||18
8237110|NCT01955473|20311089|P5|NOT COMPLETED|Overall Study||0
8237111|NCT01955473|20311090|P4|NOT COMPLETED|Overall Study||0
8237112|NCT01955473|20311091|P3|NOT COMPLETED|Overall Study||0
8237113|NCT01955473|20311092|P2|NOT COMPLETED|Overall Study||0
8237114|NCT01955473|20311093|P1|NOT COMPLETED|Overall Study||0
8237115|NCT01955473|20311089|P5|COMPLETED|Overall Study||30
8237116|NCT01955473|20311090|P4|COMPLETED|Overall Study||6
8237117|NCT01955473|20311091|P3|COMPLETED|Overall Study||6
8237118|NCT01955473|20311092|P2|COMPLETED|Overall Study||6
8237119|NCT01955473|20311093|P1|COMPLETED|Overall Study||3
8237120|NCT01955473|20311089|P5|STARTED|Overall Study||30
8237121|NCT01955473|20311090|P4|STARTED|Overall Study||6
8237122|NCT01955473|20311091|P3|STARTED|Overall Study||6
8237123|NCT01955473|20311092|P2|STARTED|Overall Study||6
8237124|NCT01955473|20311093|P1|STARTED|Overall Study||3
8237125|NCT01955434|20311247|P1|NOT COMPLETED|Overall Study||0
8237126|NCT01955434|20311247|P1|COMPLETED|Overall Study||25
8237127|NCT01955434|20311247|P1|STARTED|Overall Study||25
8237128|NCT01955382|20311257|P2|NOT COMPLETED|Overall Study||0
8237129|NCT01955382|20311258|P1|NOT COMPLETED|Overall Study||0
8237130|NCT01955382|20311257|P2|COMPLETED|Overall Study||35
8237131|NCT01955382|20311258|P1|COMPLETED|Overall Study||35
8237132|NCT01955382|20311257|P2|STARTED|Overall Study||35
8237133|NCT01955382|20311258|P1|STARTED|Overall Study||35
8237134|NCT01955369|20311266|P1|NOT COMPLETED|Overall Study||0
8237135|NCT01955369|20311266|P1|COMPLETED|Overall Study||200
8237136|NCT01955369|20311266|P1|STARTED|Overall Study||200
8237137|NCT01955161|20311275|P3|NOT COMPLETED|Overall Study||35
8237138|NCT01955161|20311276|P2|NOT COMPLETED|Overall Study||25
8237139|NCT01955161|20311277|P1|NOT COMPLETED|Overall Study||27
8237140|NCT01955161|20311275|P3|COMPLETED|Overall Study||275
8237141|NCT01955161|20311276|P2|COMPLETED|Overall Study||288
8237142|NCT01955161|20311277|P1|COMPLETED|Overall Study||283
8237143|NCT01955161|20311275|P3|Treated|Overall Study||309
8237144|NCT01955161|20311276|P2|Treated|Overall Study||313
8237145|NCT01955161|20311277|P1|Treated|Overall Study||308
8237146|NCT01955161|20311275|P3|STARTED|Overall Study||310
8237147|NCT01955161|20311276|P2|STARTED|Overall Study||313
8237148|NCT01955161|20311277|P1|STARTED|Overall Study||310
8237149|NCT01955122|20311317|P2|NOT COMPLETED|Overall Study||5
8237150|NCT01955122|20311318|P1|NOT COMPLETED|Overall Study||5
8237151|NCT01955122|20311317|P2|COMPLETED|Overall Study||57
8237152|NCT01955122|20311318|P1|COMPLETED|Overall Study||59
8237153|NCT01955122|20311317|P2|No. Patients Completed Double Procedure|Overall Study||57
8237154|NCT01955122|20311318|P1|No. Patients Completed Double Procedure|Overall Study||59
8237155|NCT01955122|20311317|P2|No.Patients Enrolled|Overall Study||62
8237156|NCT01955122|20311318|P1|No.Patients Enrolled|Overall Study||64
8237157|NCT01955122|20311317|P2|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 57)"|62
8237158|NCT01955122|20311318|P1|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 59)"|64
8237159|NCT01955083|20311338|P2|NOT COMPLETED|Overall Study||1
8237160|NCT01955083|20311339|P1|NOT COMPLETED|Overall Study||1
8237161|NCT01955083|20311338|P2|COMPLETED|Overall Study||14
8237162|NCT01955083|20311339|P1|COMPLETED|Overall Study||14
8237163|NCT01955083|20311338|P2|STARTED|Overall Study||15
8237164|NCT01955083|20311339|P1|STARTED|Overall Study||15
8237165|NCT01955044|20311372|P3|NOT COMPLETED|Overall Study||0
8237166|NCT01955044|20311373|P2|NOT COMPLETED|Overall Study||1
8237167|NCT01955044|20311374|P1|NOT COMPLETED|Overall Study||1
8237168|NCT01955044|20311372|P3|COMPLETED|Overall Study||10
8237169|NCT01955044|20311373|P2|COMPLETED|Overall Study||9
8237170|NCT01955044|20311374|P1|COMPLETED|Overall Study||9
8237171|NCT01955044|20311372|P3|STARTED|Overall Study||10
8237172|NCT01955044|20311373|P2|STARTED|Overall Study||10
8237173|NCT01955044|20311374|P1|STARTED|Overall Study||10
8237174|NCT01955005|20311387|P2|NOT COMPLETED|Overall Study||5
8237175|NCT01955005|20311388|P1|NOT COMPLETED|Overall Study||3
8237176|NCT01955005|20311387|P2|COMPLETED|Overall Study||25
8237177|NCT01955005|20311388|P1|COMPLETED|Overall Study||27
8237178|NCT01955005|20311387|P2|STARTED|Overall Study||30
8237179|NCT01955005|20311388|P1|STARTED|Overall Study||30
8237180|NCT01954927|20311400|P2|NOT COMPLETED|Overall Study||1
8237181|NCT01954927|20311401|P1|NOT COMPLETED|Overall Study||3
8237182|NCT01954927|20311400|P2|COMPLETED|Overall Study||44
8237183|NCT01954927|20311401|P1|COMPLETED|Overall Study||42
8237184|NCT01954927|20311400|P2|STARTED|Overall Study||45
8237185|NCT01954927|20311401|P1|STARTED|Overall Study||45
8237186|NCT01954771|20311422|P3|NOT COMPLETED|Overall Study||3
8237187|NCT01954771|20311423|P2|NOT COMPLETED|Overall Study||3
8237188|NCT01954771|20311424|P1|NOT COMPLETED|Overall Study||7
8237189|NCT01954771|20311422|P3|COMPLETED|Overall Study||25
8237190|NCT01954771|20311423|P2|COMPLETED|Overall Study||29
8237191|NCT01954771|20311424|P1|COMPLETED|Overall Study||22
8237192|NCT01954771|20311422|P3|STARTED|Overall Study||28
8237193|NCT01954771|20311423|P2|STARTED|Overall Study||32
8237194|NCT01954771|20311424|P1|STARTED|Overall Study||29
8237195|NCT01954745|20311441|P1|NOT COMPLETED|Overall Study||19
8237196|NCT01954745|20311441|P1|COMPLETED|Overall Study||0
8237197|NCT01954745|20311441|P1|STARTED|Overall Study||19
8237198|NCT01954628|20311450|P2|NOT COMPLETED|Overall Study||27
8237199|NCT01954628|20311451|P1|NOT COMPLETED|Overall Study||31
8237200|NCT01954628|20311450|P2|COMPLETED|Overall Study||173
8237201|NCT01954628|20311451|P1|COMPLETED|Overall Study||169
8237202|NCT01954628|20311450|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
8237203|NCT01954628|20311451|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
8237204|NCT01954628|20311450|P2|Pharmacokinetic Population|Overall Study||0
8237205|NCT01954628|20311451|P1|Pharmacokinetic Population|Overall Study||181
8237206|NCT01954628|20311450|P2|Safety Set|Overall Study||200
8237207|NCT01954628|20311451|P1|Safety Set|Overall Study||200
8237208|NCT01954628|20311450|P2|Full Analysis Set (FAS)|Overall Study||198
8237209|NCT01954628|20311451|P1|Full Analysis Set (FAS)|Overall Study||200
8237210|NCT01954628|20311450|P2|STARTED|Overall Study||200
8237211|NCT01954628|20311451|P1|STARTED|Overall Study||200
8237212|NCT01954394|20311472|P2|NOT COMPLETED|Overall Study||57
8237213|NCT01954394|20311473|P1|NOT COMPLETED|Overall Study||30
8237214|NCT01954394|20311472|P2|COMPLETED|Overall Study||598
8237215|NCT01954394|20311473|P1|COMPLETED|Overall Study||301
8237216|NCT01954394|20311472|P2|Treated|Overall Study|Safety population|655
8237217|NCT01954394|20311473|P1|Treated|Overall Study|Safety population|330
8237218|NCT01954394|20311472|P2|STARTED|Overall Study|Enrolled|655
8237219|NCT01954394|20311473|P1|STARTED|Overall Study|Enrolled|331
8237220|NCT01954342|20311527|P4|NOT COMPLETED|Overall Study||18
8237221|NCT01954342|20311528|P3|NOT COMPLETED|Overall Study||0
8237222|NCT01954342|20311529|P2|NOT COMPLETED|Overall Study||0
8237223|NCT01954342|20311530|P1|NOT COMPLETED|Overall Study||0
8237224|NCT01954342|20311527|P4|COMPLETED|Overall Study||0
8237225|NCT01954342|20311528|P3|COMPLETED|Overall Study||10
8237226|NCT01954342|20311529|P2|COMPLETED|Overall Study||8
8237227|NCT01954342|20311530|P1|COMPLETED|Overall Study||36
8237228|NCT01954342|20311527|P4|STARTED|Overall Study||18
8237229|NCT01954342|20311528|P3|STARTED|Overall Study||10
8237230|NCT01954342|20311529|P2|STARTED|Overall Study||8
8237231|NCT01954342|20311530|P1|STARTED|Overall Study||36
8237232|NCT01954264|20311580|P1|NOT COMPLETED|Overall Study||0
8237233|NCT01954264|20311580|P1|COMPLETED|Overall Study||2421
8237234|NCT01954264|20311580|P1|STARTED|Overall Study||2421
8237235|NCT01954251|20311632|P2|NOT COMPLETED|Overall Study||19
8237236|NCT01954251|20311633|P1|NOT COMPLETED|Overall Study||13
8237237|NCT01954251|20311632|P2|COMPLETED|Overall Study||396
8237238|NCT01954251|20311633|P1|COMPLETED|Overall Study||400
8237239|NCT01954251|20311632|P2|STARTED|Overall Study||415
8237240|NCT01954251|20311633|P1|STARTED|Overall Study||413
8237241|NCT01954160|20311669|P2|NOT COMPLETED|Overall Study||0
8237242|NCT01954160|20311670|P1|NOT COMPLETED|Overall Study||5
8237243|NCT01954160|20311669|P2|COMPLETED|Overall Study||0
8237244|NCT01954160|20311670|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
8237245|NCT01954160|20311669|P2|STARTED|Overall Study|Not started|0
8237246|NCT01954160|20311670|P1|STARTED|Overall Study||5
8237247|NCT01954121|20311730|P2|NOT COMPLETED|Overall Study||91
8237248|NCT01954121|20311731|P1|NOT COMPLETED|Overall Study||127
8237249|NCT01954121|20311730|P2|COMPLETED|Overall Study||125
8237250|NCT01954121|20311731|P1|COMPLETED|Overall Study||93
8237251|NCT01954121|20311730|P2|STARTED|Overall Study||216
8237252|NCT01954121|20311731|P1|STARTED|Overall Study||220
8237253|NCT01954082|20311747|P2|NOT COMPLETED|Overall Study||57
8237254|NCT01954082|20311748|P1|NOT COMPLETED|Overall Study||68
8237255|NCT01954082|20311747|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
8237256|NCT01954082|20311748|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
8237257|NCT01954082|20311747|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
8237258|NCT01954082|20311748|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
8237259|NCT01954082|20311747|P2|STARTED|Overall Study||321
8237260|NCT01954082|20311748|P1|STARTED|Overall Study||317
8237261|NCT01954056|20311768|P2|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
8237262|NCT01954056|20311769|P1|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
8237263|NCT01954056|20311768|P2|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
8237264|NCT01954056|20311769|P1|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
8237265|NCT01954056|20311768|P2|STARTED|Birth to 22-26 Mos. Corrected GA||6
8237266|NCT01954056|20311769|P1|STARTED|Birth to 22-26 Mos. Corrected GA||6
8237267|NCT01954056|20311768|P2|NOT COMPLETED|Birth to 60 Days of Life||0
8237268|NCT01954056|20311769|P1|NOT COMPLETED|Birth to 60 Days of Life||0
8237269|NCT01954056|20311768|P2|COMPLETED|Birth to 60 Days of Life||6
8237270|NCT01954056|20311769|P1|COMPLETED|Birth to 60 Days of Life||6
8237271|NCT01954056|20311768|P2|STARTED|Birth to 60 Days of Life||6
8237272|NCT01954056|20311769|P1|STARTED|Birth to 60 Days of Life||6
8237273|NCT01954017|20311814|P3|NOT COMPLETED|Overall Study||13
8237274|NCT01954017|20311815|P2|NOT COMPLETED|Overall Study||8
8237275|NCT01954017|20311816|P1|NOT COMPLETED|Overall Study||5
8237276|NCT01954017|20311814|P3|COMPLETED|Overall Study||21
8237277|NCT01954017|20311815|P2|COMPLETED|Overall Study||25
8237278|NCT01954017|20311816|P1|COMPLETED|Overall Study||31
8237279|NCT01954017|20311814|P3|STARTED|Overall Study||34
8237280|NCT01954017|20311815|P2|STARTED|Overall Study||33
8237281|NCT01954017|20311816|P1|STARTED|Overall Study||36
8237282|NCT01953913|20312042|P1|NOT COMPLETED|Overall Study||542
8237283|NCT01953913|20312042|P1|COMPLETED|Overall Study||0
8237284|NCT01953913|20312042|P1|Treated|Overall Study||541
8237285|NCT01953913|20312042|P1|STARTED|Overall Study||542
8237286|NCT01953874|20312050|P2|NOT COMPLETED|Overall Study||0
8237287|NCT01953874|20312051|P1|NOT COMPLETED|Overall Study||0
8237288|NCT01953874|20312050|P2|COMPLETED|Overall Study||61
8237289|NCT01953874|20312051|P1|COMPLETED|Overall Study||65
8237290|NCT01953874|20312050|P2|STARTED|Overall Study||61
8237291|NCT01953874|20312051|P1|STARTED|Overall Study||65
8237292|NCT01953783|20312094|P1|NOT COMPLETED|Overall Study||2
8237293|NCT01953783|20312094|P1|COMPLETED|Overall Study||5
8237294|NCT01953783|20312094|P1|STARTED|Overall Study||7
8237295|NCT01953601|20312119|P3|NOT COMPLETED|Part 2 (Extension Study)||204
8237296|NCT01953601|20312120|P2|NOT COMPLETED|Part 2 (Extension Study)||191
8237297|NCT01953601|20312121|P1|NOT COMPLETED|Part 2 (Extension Study)||198
8237298|NCT01953601|20312119|P3|COMPLETED|Part 2 (Extension Study)||0
8237299|NCT01953601|20312120|P2|COMPLETED|Part 2 (Extension Study)||0
8237300|NCT01953601|20312121|P1|COMPLETED|Part 2 (Extension Study)||0
8237301|NCT01953601|20312119|P3|Treated|Part 2 (Extension Study)||204
8237302|NCT01953601|20312120|P2|Treated|Part 2 (Extension Study)||191
8237303|NCT01953601|20312121|P1|Treated|Part 2 (Extension Study)||197
8237304|NCT01953601|20312119|P3|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
8237305|NCT01953601|20312120|P2|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
8237306|NCT01953601|20312121|P1|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
8237307|NCT01953601|20312119|P3|NOT COMPLETED|Part 1 (Base Study)||246
8237308|NCT01953601|20312120|P2|NOT COMPLETED|Part 1 (Base Study)||253
8237309|NCT01953601|20312121|P1|NOT COMPLETED|Part 1 (Base Study)||251
8237310|NCT01953601|20312119|P3|COMPLETED|Part 1 (Base Study)||239
8237311|NCT01953601|20312120|P2|COMPLETED|Part 1 (Base Study)||231
8237312|NCT01953601|20312121|P1|COMPLETED|Part 1 (Base Study)||234
8237313|NCT01953601|20312119|P3|Treated|Part 1 (Base Study)||484
8237314|NCT01953601|20312120|P2|Treated|Part 1 (Base Study)||484
8237315|NCT01953601|20312121|P1|Treated|Part 1 (Base Study)||483
8237316|NCT01953601|20312119|P3|STARTED|Part 1 (Base Study)||485
8237317|NCT01953601|20312120|P2|STARTED|Part 1 (Base Study)||484
8237318|NCT01953601|20312121|P1|STARTED|Part 1 (Base Study)||485
8237319|NCT01953575|20312171|P3|NOT COMPLETED|Overall Study||0
8237320|NCT01953575|20312172|P2|NOT COMPLETED|Overall Study||0
8237321|NCT01953575|20312173|P1|NOT COMPLETED|Overall Study||0
8237322|NCT01953575|20312171|P3|COMPLETED|Overall Study||10
8237323|NCT01953575|20312172|P2|COMPLETED|Overall Study||10
8237324|NCT01953575|20312173|P1|COMPLETED|Overall Study||10
8237325|NCT01953575|20312171|P3|STARTED|Overall Study||10
8237326|NCT01953575|20312172|P2|STARTED|Overall Study||10
8237327|NCT01953575|20312173|P1|STARTED|Overall Study||10
8237328|NCT01953432|20312183|P2|NOT COMPLETED|Overall Study||15
8237329|NCT01953432|20312184|P1|NOT COMPLETED|Overall Study||14
8237330|NCT01953432|20312183|P2|COMPLETED|Overall Study||6
8237331|NCT01953432|20312184|P1|COMPLETED|Overall Study||8
8237332|NCT01953432|20312183|P2|STARTED|Overall Study||21
8237333|NCT01953432|20312184|P1|STARTED|Overall Study||22
8237334|NCT01953354|20312192|P2|NOT COMPLETED|Overall Study||2
8237335|NCT01953354|20312193|P1|NOT COMPLETED|Overall Study||1
8237336|NCT01953354|20312192|P2|COMPLETED|Overall Study||5
8237337|NCT01953354|20312193|P1|COMPLETED|Overall Study||8
8237338|NCT01953354|20312192|P2|STARTED|Overall Study||7
8237339|NCT01953354|20312193|P1|STARTED|Overall Study||9
8237340|NCT01953328|20312221|P8|NOT COMPLETED|Overall Study||0
8237341|NCT01953328|20312222|P7|NOT COMPLETED|Overall Study||0
8237342|NCT01953328|20312223|P6|NOT COMPLETED|Overall Study||0
8237343|NCT01953328|20312224|P5|NOT COMPLETED|Overall Study||2
8237344|NCT01953328|20312225|P4|NOT COMPLETED|Overall Study||0
8237345|NCT01953328|20312226|P3|NOT COMPLETED|Overall Study||0
8237346|NCT01953328|20312227|P2|NOT COMPLETED|Overall Study||0
8237347|NCT01953328|20312228|P1|NOT COMPLETED|Overall Study||0
8237348|NCT01953328|20312221|P8|COMPLETED|Overall Study||51
8237349|NCT01953328|20312222|P7|COMPLETED|Overall Study||51
8237350|NCT01953328|20312223|P6|COMPLETED|Overall Study||51
8237351|NCT01953328|20312224|P5|COMPLETED|Overall Study||50
8237352|NCT01953328|20312225|P4|COMPLETED|Overall Study||50
8237353|NCT01953328|20312226|P3|COMPLETED|Overall Study||50
8237354|NCT01953328|20312227|P2|COMPLETED|Overall Study||50
8237355|NCT01953328|20312228|P1|COMPLETED|Overall Study||49
8237356|NCT01953328|20312221|P8|Received Treatment|Overall Study||51
8237357|NCT01953328|20312222|P7|Received Treatment|Overall Study||51
8237358|NCT01953328|20312223|P6|Received Treatment|Overall Study||51
8237359|NCT01953328|20312224|P5|Received Treatment|Overall Study||52
8237360|NCT01953328|20312225|P4|Received Treatment|Overall Study||50
8237361|NCT01953328|20312226|P3|Received Treatment|Overall Study||50
8237362|NCT01953328|20312227|P2|Received Treatment|Overall Study||50
8237363|NCT01953328|20312228|P1|Received Treatment|Overall Study||49
8237364|NCT01953328|20312221|P8|STARTED|Overall Study||51
8237365|NCT01953328|20312222|P7|STARTED|Overall Study||51
8237366|NCT01953328|20312223|P6|STARTED|Overall Study||51
8237367|NCT01953328|20312224|P5|STARTED|Overall Study||52
8237368|NCT01953328|20312225|P4|STARTED|Overall Study||50
8237369|NCT01953328|20312226|P3|STARTED|Overall Study||50
8237370|NCT01953328|20312227|P2|STARTED|Overall Study||50
8237371|NCT01953328|20312228|P1|STARTED|Overall Study||49
8237372|NCT01953237|20312432|P2|NOT COMPLETED|Overall Study||0
8237373|NCT01953237|20312433|P1|NOT COMPLETED|Overall Study||0
8237374|NCT01953237|20312432|P2|COMPLETED|Overall Study||21
8237375|NCT01953237|20312433|P1|COMPLETED|Overall Study||10
8237376|NCT01953237|20312432|P2|STARTED|Overall Study||21
8237377|NCT01953237|20312433|P1|STARTED|Overall Study||10
8237378|NCT01953224|20312441|P2|NOT COMPLETED|Overall Study||3
8237379|NCT01953224|20312442|P1|NOT COMPLETED|Overall Study||2
8237380|NCT01953224|20312441|P2|COMPLETED|Overall Study||17
8237381|NCT01953224|20312442|P1|COMPLETED|Overall Study||18
8237382|NCT01953224|20312441|P2|STARTED|Overall Study||20
8237383|NCT01953224|20312442|P1|STARTED|Overall Study||20
8237384|NCT01953211|20312458|P1|NOT COMPLETED|Overall Study||0
8237385|NCT01953211|20312458|P1|COMPLETED|Overall Study|completed prior to clinical trials submission|64
8237386|NCT01953211|20312458|P1|STARTED|Overall Study|completed prior to clinical trials submission|64
8237387|NCT01953081|20312466|P2|NOT COMPLETED|Overall Study||3
8237388|NCT01953081|20312467|P1|NOT COMPLETED|Overall Study||2
8237389|NCT01953081|20312466|P2|COMPLETED|Overall Study||3
8237390|NCT01953081|20312467|P1|COMPLETED|Overall Study||5
8237391|NCT01953081|20312466|P2|STARTED|Overall Study||6
8237392|NCT01953081|20312467|P1|STARTED|Overall Study||7
8237393|NCT01953003|20312491|P2|NOT COMPLETED|Overall Study||55
8237394|NCT01953003|20312492|P1|NOT COMPLETED|Overall Study||56
8237395|NCT01953003|20312491|P2|COMPLETED|Overall Study||1
8237396|NCT01953003|20312492|P1|COMPLETED|Overall Study||0
8237397|NCT01953003|20312491|P2|STARTED|Overall Study||56
8237398|NCT01953003|20312492|P1|STARTED|Overall Study||56
8237399|NCT01952834|20312498|P1|NOT COMPLETED|Overall Study||1
8237400|NCT01952834|20312498|P1|COMPLETED|Overall Study||20
8237401|NCT01952834|20312498|P1|STARTED|Overall Study||21
8237402|NCT01952691|20312505|P1|NOT COMPLETED|Overall Study||2
8237403|NCT01952691|20312505|P1|COMPLETED|Overall Study||20
8237404|NCT01952691|20312505|P1|STARTED|Overall Study||22
8237405|NCT01952678|20312513|P2|NOT COMPLETED|Overall Study||0
8237406|NCT01952678|20312514|P1|NOT COMPLETED|Overall Study||0
8237407|NCT01952678|20312513|P2|COMPLETED|Overall Study||102
8237408|NCT01952678|20312514|P1|COMPLETED|Overall Study||102
8237409|NCT01952678|20312513|P2|STARTED|Overall Study||102
8237410|NCT01952678|20312514|P1|STARTED|Overall Study||102
8237411|NCT01952665|20312532|P2|NOT COMPLETED|Overall Study||6
8237412|NCT01952665|20312533|P1|NOT COMPLETED|Overall Study||6
8237413|NCT01952665|20312532|P2|COMPLETED|Overall Study||20
8237414|NCT01952665|20312533|P1|COMPLETED|Overall Study||31
8237415|NCT01952665|20312532|P2|STARTED|Overall Study||26
8237416|NCT01952665|20312533|P1|STARTED|Overall Study||37
8237417|NCT01952600|20312674|P3|NOT COMPLETED|Overall Study||7
8237418|NCT01952600|20312675|P2|NOT COMPLETED|Overall Study||13
8237419|NCT01952600|20312676|P1|NOT COMPLETED|Overall Study||15
8237420|NCT01952600|20312674|P3|COMPLETED|Overall Study||38
8237421|NCT01952600|20312675|P2|COMPLETED|Overall Study||77
8237422|NCT01952600|20312676|P1|COMPLETED|Overall Study||65
8237423|NCT01952600|20312674|P3|STARTED|Overall Study||45
8237424|NCT01952600|20312675|P2|STARTED|Overall Study||90
8237425|NCT01952600|20312676|P1|STARTED|Overall Study||80
8237426|NCT01952574|20312688|P7|NOT COMPLETED|Clinical Home Use Substudy||1
8237427|NCT01952574|20312689|P6|NOT COMPLETED|Clinical Home Use Substudy||3
8237428|NCT01952574|20312690|P5|NOT COMPLETED|Clinical Home Use Substudy||0
8237429|NCT01952574|20312691|P4|NOT COMPLETED|Clinical Home Use Substudy||0
8237430|NCT01952574|20312692|P3|NOT COMPLETED|Clinical Home Use Substudy||0
8237431|NCT01952574|20312693|P2|NOT COMPLETED|Clinical Home Use Substudy||0
8237432|NCT01952574|20312694|P1|NOT COMPLETED|Clinical Home Use Substudy||0
8237433|NCT01952574|20312688|P7|COMPLETED|Clinical Home Use Substudy||40
8237434|NCT01952574|20312689|P6|COMPLETED|Clinical Home Use Substudy||39
8237435|NCT01952574|20312690|P5|COMPLETED|Clinical Home Use Substudy||0
8237436|NCT01952574|20312691|P4|COMPLETED|Clinical Home Use Substudy||0
8237437|NCT01952574|20312692|P3|COMPLETED|Clinical Home Use Substudy||0
8237438|NCT01952574|20312693|P2|COMPLETED|Clinical Home Use Substudy||0
8237439|NCT01952574|20312694|P1|COMPLETED|Clinical Home Use Substudy||0
8237440|NCT01952574|20312688|P7|STARTED|Clinical Home Use Substudy||41
8237441|NCT01952574|20312689|P6|STARTED|Clinical Home Use Substudy||42
8237442|NCT01952574|20312690|P5|STARTED|Clinical Home Use Substudy||0
8237443|NCT01952574|20312691|P4|STARTED|Clinical Home Use Substudy||0
8237444|NCT01952574|20312692|P3|STARTED|Clinical Home Use Substudy||0
8237445|NCT01952574|20312693|P2|STARTED|Clinical Home Use Substudy||0
8237446|NCT01952574|20312694|P1|STARTED|Clinical Home Use Substudy||0
8237447|NCT01952574|20312688|P7|NOT COMPLETED|Open-label Treatment Phase||0
8237448|NCT01952574|20312689|P6|NOT COMPLETED|Open-label Treatment Phase||0
8237449|NCT01952574|20312690|P5|NOT COMPLETED|Open-label Treatment Phase||162
8237450|NCT01952574|20312691|P4|NOT COMPLETED|Open-label Treatment Phase||0
8237451|NCT01952574|20312692|P3|NOT COMPLETED|Open-label Treatment Phase||0
8237452|NCT01952574|20312693|P2|NOT COMPLETED|Open-label Treatment Phase||0
8237453|NCT01952574|20312694|P1|NOT COMPLETED|Open-label Treatment Phase||0
8237454|NCT01952574|20312688|P7|COMPLETED|Open-label Treatment Phase||0
8237455|NCT01952574|20312689|P6|COMPLETED|Open-label Treatment Phase||0
8237456|NCT01952574|20312690|P5|COMPLETED|Open-label Treatment Phase||221
8237457|NCT01952574|20312691|P4|COMPLETED|Open-label Treatment Phase||0
8237458|NCT01952574|20312692|P3|COMPLETED|Open-label Treatment Phase||0
8237459|NCT01952574|20312693|P2|COMPLETED|Open-label Treatment Phase||0
8237460|NCT01952574|20312694|P1|COMPLETED|Open-label Treatment Phase||0
8237461|NCT01952574|20312688|P7|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237462|NCT01952574|20312689|P6|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237463|NCT01952574|20312690|P5|Received 140 mg Erenumab|Open-label Treatment Phase||250
8237464|NCT01952574|20312691|P4|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237465|NCT01952574|20312692|P3|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237466|NCT01952574|20312693|P2|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237467|NCT01952574|20312694|P1|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237468|NCT01952574|20312688|P7|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237469|NCT01952574|20312689|P6|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237470|NCT01952574|20312690|P5|Received 70 mg Erenumab|Open-label Treatment Phase||383
8237471|NCT01952574|20312691|P4|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237472|NCT01952574|20312692|P3|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237473|NCT01952574|20312693|P2|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237474|NCT01952574|20312694|P1|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237475|NCT01952574|20312688|P7|STARTED|Open-label Treatment Phase||0
8237476|NCT01952574|20312689|P6|STARTED|Open-label Treatment Phase||0
8237477|NCT01952574|20312690|P5|STARTED|Open-label Treatment Phase||383
8237478|NCT01952574|20312691|P4|STARTED|Open-label Treatment Phase||0
8237479|NCT01952574|20312692|P3|STARTED|Open-label Treatment Phase||0
8237480|NCT01952574|20312693|P2|STARTED|Open-label Treatment Phase||0
8237481|NCT01952574|20312694|P1|STARTED|Open-label Treatment Phase||0
8237482|NCT01952574|20312688|P7|NOT COMPLETED|Double-blind Treatment Phase||0
8237483|NCT01952574|20312689|P6|NOT COMPLETED|Double-blind Treatment Phase||0
8237484|NCT01952574|20312690|P5|NOT COMPLETED|Double-blind Treatment Phase||0
8237485|NCT01952574|20312691|P4|NOT COMPLETED|Double-blind Treatment Phase||6
8237486|NCT01952574|20312692|P3|NOT COMPLETED|Double-blind Treatment Phase||9
8237487|NCT01952574|20312693|P2|NOT COMPLETED|Double-blind Treatment Phase||3
8237488|NCT01952574|20312694|P1|NOT COMPLETED|Double-blind Treatment Phase||17
8237489|NCT01952574|20312688|P7|COMPLETED|Double-blind Treatment Phase||0
8237490|NCT01952574|20312689|P6|COMPLETED|Double-blind Treatment Phase||0
8237491|NCT01952574|20312690|P5|COMPLETED|Double-blind Treatment Phase||0
8237492|NCT01952574|20312691|P4|COMPLETED|Double-blind Treatment Phase||101
8237493|NCT01952574|20312692|P3|COMPLETED|Double-blind Treatment Phase||99
8237494|NCT01952574|20312693|P2|COMPLETED|Double-blind Treatment Phase||105
8237495|NCT01952574|20312694|P1|COMPLETED|Double-blind Treatment Phase||143
8237496|NCT01952574|20312688|P7|Received Study Drug|Double-blind Treatment Phase||0
8237497|NCT01952574|20312689|P6|Received Study Drug|Double-blind Treatment Phase||0
8237498|NCT01952574|20312690|P5|Received Study Drug|Double-blind Treatment Phase||0
8237499|NCT01952574|20312691|P4|Received Study Drug|Double-blind Treatment Phase||106
8237500|NCT01952574|20312692|P3|Received Study Drug|Double-blind Treatment Phase||105
8237501|NCT01952574|20312693|P2|Received Study Drug|Double-blind Treatment Phase||108
8237502|NCT01952574|20312694|P1|Received Study Drug|Double-blind Treatment Phase||153
8237503|NCT01952574|20312688|P7|STARTED|Double-blind Treatment Phase||0
8237504|NCT01952574|20312689|P6|STARTED|Double-blind Treatment Phase||0
8237505|NCT01952574|20312690|P5|STARTED|Double-blind Treatment Phase||0
8237506|NCT01952574|20312691|P4|STARTED|Double-blind Treatment Phase||107
8237507|NCT01952574|20312692|P3|STARTED|Double-blind Treatment Phase||108
8237508|NCT01952574|20312693|P2|STARTED|Double-blind Treatment Phase||108
8237509|NCT01952574|20312694|P1|STARTED|Double-blind Treatment Phase||160
8237510|NCT01952470|20312739|P2|NOT COMPLETED|Overall Study||3
8237511|NCT01952470|20312740|P1|NOT COMPLETED|Overall Study||3
8237512|NCT01952470|20312739|P2|COMPLETED|Overall Study||13
8237513|NCT01952470|20312740|P1|COMPLETED|Overall Study||13
8237514|NCT01952470|20312739|P2|Missing 3 Month LCI 2% Data.|Overall Study||0
8237515|NCT01952470|20312740|P1|Missing 3 Month LCI 2% Data.|Overall Study||1
8237516|NCT01952470|20312739|P2|Missing 1+3 Month LCI 2% Data.|Overall Study||1
8237517|NCT01952470|20312740|P1|Missing 1+3 Month LCI 2% Data.|Overall Study||2
8237518|NCT01952470|20312739|P2|Missing Baseline LCI 2% Data.|Overall Study||2
8237519|NCT01952470|20312740|P1|Missing Baseline LCI 2% Data.|Overall Study||0
8237520|NCT01952470|20312739|P2|Death|Overall Study||1
8237521|NCT01952470|20312740|P1|Death|Overall Study||1
8237522|NCT01952470|20312739|P2|Discontinued Intervention|Overall Study||1
8237523|NCT01952470|20312740|P1|Discontinued Intervention|Overall Study||2
8237524|NCT01952470|20312739|P2|ITT Analysis|Overall Study||16
8237525|NCT01952470|20312740|P1|ITT Analysis|Overall Study||16
8237526|NCT01952470|20312739|P2|STARTED|Overall Study||16
8237527|NCT01952470|20312740|P1|STARTED|Overall Study||16
8237528|NCT01952444|20312778|P2|NOT COMPLETED|Overall Study||1
8237529|NCT01952444|20312779|P1|NOT COMPLETED|Overall Study||0
8237530|NCT01952444|20312778|P2|COMPLETED|Overall Study||19
8237531|NCT01952444|20312779|P1|COMPLETED|Overall Study||20
8237532|NCT01952444|20312778|P2|STARTED|Overall Study||20
8237533|NCT01952444|20312779|P1|STARTED|Overall Study||20
8237534|NCT01952418|20312805|P2|NOT COMPLETED|Overall Study||0
8237535|NCT01952418|20312806|P1|NOT COMPLETED|Overall Study||0
8237536|NCT01952418|20312805|P2|COMPLETED|Overall Study||895
8237537|NCT01952418|20312806|P1|COMPLETED|Overall Study||910
8237538|NCT01952418|20312805|P2|STARTED|Overall Study||895
8237539|NCT01952418|20312806|P1|STARTED|Overall Study||910
8237540|NCT01952366|20312818|P1|NOT COMPLETED|Overall Study||31
8237541|NCT01952366|20312818|P1|COMPLETED|Overall Study||138
8237542|NCT01952366|20312818|P1|STARTED|Overall Study||169
8237543|NCT01952301|20312825|P1|NOT COMPLETED|Overall Study||0
8237544|NCT01952301|20312825|P1|COMPLETED|Overall Study||30
8237545|NCT01952301|20312825|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
8237546|NCT01952145|20312833|P2|NOT COMPLETED|Overall Study||14
8237547|NCT01952145|20312834|P1|NOT COMPLETED|Overall Study||28
8237548|NCT01952145|20312833|P2|COMPLETED|Overall Study||265
8237549|NCT01952145|20312834|P1|COMPLETED|Overall Study||250
8237550|NCT01952145|20312833|P2|STARTED|Overall Study||279
8237551|NCT01952145|20312834|P1|STARTED|Overall Study||278
8237552|NCT01952080|20312848|P4|NOT COMPLETED|Overall Study||1
8237553|NCT01952080|20312849|P3|NOT COMPLETED|Overall Study||0
8237554|NCT01952080|20312850|P2|NOT COMPLETED|Overall Study||1
8237555|NCT01952080|20312851|P1|NOT COMPLETED|Overall Study||0
8237556|NCT01952080|20312848|P4|COMPLETED|Overall Study||14
8237557|NCT01952080|20312849|P3|COMPLETED|Overall Study||14
8237558|NCT01952080|20312850|P2|COMPLETED|Overall Study||7
8237559|NCT01952080|20312851|P1|COMPLETED|Overall Study||5
8237560|NCT01952080|20312848|P4|Treated|Overall Study||15
8237561|NCT01952080|20312849|P3|Treated|Overall Study||14
8237562|NCT01952080|20312850|P2|Treated|Overall Study||8
8237563|NCT01952080|20312851|P1|Treated|Overall Study||5
8237564|NCT01952080|20312848|P4|STARTED|Overall Study||15
8237565|NCT01952080|20312849|P3|STARTED|Overall Study||14
8237566|NCT01952080|20312850|P2|STARTED|Overall Study||8
8237567|NCT01952080|20312851|P1|STARTED|Overall Study||5
8237568|NCT01952054|20312897|P1|NOT COMPLETED|Overall Study||1
8237569|NCT01952054|20312897|P1|COMPLETED|Overall Study||5
8237570|NCT01952054|20312897|P1|STARTED|Overall Study||6
8237571|NCT01952041|20312905|P2|NOT COMPLETED|Overall Study||21
8237572|NCT01952041|20312906|P1|NOT COMPLETED|Overall Study||17
8237573|NCT01952041|20312905|P2|COMPLETED|Overall Study||43
8237574|NCT01952041|20312906|P1|COMPLETED|Overall Study||45
8237575|NCT01952041|20312905|P2|STARTED|Overall Study||64
8237576|NCT01952041|20312906|P1|STARTED|Overall Study||62
8237577|NCT01952015|20312920|P1|NOT COMPLETED|Treatment Period 3||9
8237578|NCT01952015|20312920|P1|COMPLETED|Treatment Period 3||0
8237579|NCT01952015|20312920|P1|STARTED|Treatment Period 3||9
8237580|NCT01952015|20312920|P1|NOT COMPLETED|Maintenance||2
8237581|NCT01952015|20312920|P1|COMPLETED|Maintenance||9
8237582|NCT01952015|20312920|P1|STARTED|Maintenance||11
8237583|NCT01952015|20312920|P1|NOT COMPLETED|Induction||1
8237584|NCT01952015|20312920|P1|COMPLETED|Induction||11
8237585|NCT01952015|20312920|P1|STARTED|Induction||12
8237586|NCT01951963|20312943|P2|NOT COMPLETED|Overall Study||0
8237587|NCT01951963|20312944|P1|NOT COMPLETED|Overall Study||0
8237588|NCT01951963|20312943|P2|COMPLETED|Overall Study||32
8237589|NCT01951963|20312944|P1|COMPLETED|Overall Study||31
8237590|NCT01951963|20312943|P2|STARTED|Overall Study||32
8237591|NCT01951963|20312944|P1|STARTED|Overall Study||31
8237592|NCT01951950|20312956|P2|NOT COMPLETED|Overall Study||6
8237593|NCT01951950|20312957|P1|NOT COMPLETED|Overall Study||6
8237594|NCT01951950|20312956|P2|COMPLETED|Overall Study||20
8237595|NCT01951950|20312957|P1|COMPLETED|Overall Study||20
8237596|NCT01951950|20312956|P2|STARTED|Overall Study||26
8237597|NCT01951950|20312957|P1|STARTED|Overall Study||26
8237598|NCT01951820|20312965|P2|NOT COMPLETED|Overall Study||0
8237599|NCT01951820|20312966|P1|NOT COMPLETED|Overall Study||0
8237600|NCT01951820|20312965|P2|COMPLETED|Overall Study||30
8237601|NCT01951820|20312966|P1|COMPLETED|Overall Study||34
8237602|NCT01951820|20312965|P2|STARTED|Overall Study||30
8237603|NCT01951820|20312966|P1|STARTED|Overall Study||34
8237604|NCT01951768|20312974|P2|NOT COMPLETED|Overall Study||0
8237605|NCT01951768|20312975|P1|NOT COMPLETED|Overall Study||0
8237606|NCT01951768|20312974|P2|COMPLETED|Overall Study|45 patients|45
8237607|NCT01951768|20312975|P1|COMPLETED|Overall Study|43 patients|43
8237608|NCT01951768|20312974|P2|STARTED|Overall Study||45
8237609|NCT01951768|20312975|P1|STARTED|Overall Study||43
8237610|NCT01951703|20312987|P2|NOT COMPLETED|Second Intervention||2
8237611|NCT01951703|20312988|P1|NOT COMPLETED|Second Intervention||0
8237612|NCT01951703|20312987|P2|COMPLETED|Second Intervention||60
8237613|NCT01951703|20312988|P1|COMPLETED|Second Intervention||61
8237614|NCT01951703|20312987|P2|STARTED|Second Intervention||62
8237615|NCT01951703|20312988|P1|STARTED|Second Intervention||61
8237616|NCT01951703|20312987|P2|NOT COMPLETED|First Intervention||1
8237617|NCT01951703|20312988|P1|NOT COMPLETED|First Intervention||3
8237618|NCT01951703|20312987|P2|COMPLETED|First Intervention||62
8237619|NCT01951703|20312988|P1|COMPLETED|First Intervention||61
8237620|NCT01951703|20312987|P2|STARTED|First Intervention||63
8237621|NCT01951703|20312988|P1|STARTED|First Intervention||64
8237622|NCT01951651|20312998|P2|NOT COMPLETED|Overall Study||2
8237623|NCT01951651|20312999|P1|NOT COMPLETED|Overall Study||4
8237624|NCT01951651|20312998|P2|COMPLETED|Overall Study||10
8237625|NCT01951651|20312999|P1|COMPLETED|Overall Study||8
8237626|NCT01951651|20312998|P2|STARTED|Overall Study||12
8237627|NCT01951651|20312999|P1|STARTED|Overall Study||12
8237628|NCT01951586|20313013|P2|NOT COMPLETED|Overall Study||148
8237629|NCT01951586|20313014|P1|NOT COMPLETED|Overall Study||78
8237630|NCT01951586|20313013|P2|COMPLETED|Overall Study||0
8237631|NCT01951586|20313014|P1|COMPLETED|Overall Study||0
8237632|NCT01951586|20313013|P2|Received Study Drug|Overall Study||145
8237633|NCT01951586|20313014|P1|Received Study Drug|Overall Study||76
8237634|NCT01951586|20313013|P2|STARTED|Overall Study||148
8237635|NCT01951586|20313014|P1|STARTED|Overall Study||78
8237636|NCT01951573|20313038|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
8237637|NCT01951573|20313039|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
8237638|NCT01951573|20313038|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
8237639|NCT01951573|20313039|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
8237640|NCT01951573|20313038|P2|STARTED|Period 2, Second 9 Hours of Wear||16
8237641|NCT01951573|20313039|P1|STARTED|Period 2, Second 9 Hours of Wear||17
8237642|NCT01951573|20313038|P2|NOT COMPLETED|Washout Period||1
8237643|NCT01951573|20313039|P1|NOT COMPLETED|Washout Period||0
8237644|NCT01951573|20313038|P2|COMPLETED|Washout Period||16
8237645|NCT01951573|20313039|P1|COMPLETED|Washout Period||17
8237646|NCT01951573|20313038|P2|STARTED|Washout Period||17
8237647|NCT01951573|20313039|P1|STARTED|Washout Period||17
8237648|NCT01951573|20313038|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
8237649|NCT01951573|20313039|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
8237650|NCT01951573|20313038|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
8237651|NCT01951573|20313039|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
8237652|NCT01951573|20313038|P2|STARTED|Period 1, First 9 Hours of Wear||17
8237653|NCT01951573|20313039|P1|STARTED|Period 1, First 9 Hours of Wear||17
8237654|NCT01951417|20313049|P1|NOT COMPLETED|Overall Study||9
8237655|NCT01951417|20313049|P1|COMPLETED|Overall Study||72
8237656|NCT01951417|20313049|P1|STARTED|Overall Study||81
8237657|NCT01951391|20313074|P2|NOT COMPLETED|Overall Study||0
8237658|NCT01951391|20313075|P1|NOT COMPLETED|Overall Study||0
8237659|NCT01951391|20313074|P2|COMPLETED|Overall Study||5
8237660|NCT01951391|20313075|P1|COMPLETED|Overall Study||5
8237661|NCT01951391|20313074|P2|STARTED|Overall Study||5
8237662|NCT01951391|20313075|P1|STARTED|Overall Study||5
8237663|NCT01951378|20313085|P2|NOT COMPLETED|Overall Study||17
8237664|NCT01951378|20313086|P1|NOT COMPLETED|Overall Study||23
8237665|NCT01951378|20313085|P2|COMPLETED|Overall Study||0
8237666|NCT01951378|20313086|P1|COMPLETED|Overall Study||0
8237667|NCT01951378|20313085|P2|STARTED|Overall Study||17
8237668|NCT01951378|20313086|P1|STARTED|Overall Study||23
8237669|NCT01951352|20313094|P1|NOT COMPLETED|Overall Study||0
8237670|NCT01951352|20313094|P1|COMPLETED|Overall Study||10
8237671|NCT01951352|20313094|P1|STARTED|Overall Study||10
8237672|NCT01951339|20313103|P2|NOT COMPLETED|Overall Study||1
8237673|NCT01951339|20313104|P1|NOT COMPLETED|Overall Study||2
8237674|NCT01951339|20313103|P2|COMPLETED|Overall Study||14
8237675|NCT01951339|20313104|P1|COMPLETED|Overall Study||13
8237676|NCT01951339|20313103|P2|STARTED|Overall Study||15
8237677|NCT01951339|20313104|P1|STARTED|Overall Study||15
8237678|NCT01951326|20313128|P2|NOT COMPLETED|Overall Study||78
8237679|NCT01951326|20313129|P1|NOT COMPLETED|Overall Study||79
8237680|NCT01951326|20313128|P2|COMPLETED|Overall Study||87
8237681|NCT01951326|20313129|P1|COMPLETED|Overall Study||87
8237682|NCT01951326|20313128|P2|STARTED|Overall Study||165
8237683|NCT01951326|20313129|P1|STARTED|Overall Study||166
8237684|NCT01951261|20313163|P2|NOT COMPLETED|Overall Study||6
8237685|NCT01951261|20313164|P1|NOT COMPLETED|Overall Study||9
8237686|NCT01951261|20313163|P2|COMPLETED|Overall Study||52
8237687|NCT01951261|20313164|P1|COMPLETED|Overall Study||49
8237688|NCT01951261|20313163|P2|Discontinued|Overall Study|"2-readmission when was at home
~1-new home hospitalitation 3-missing"|6
8237689|NCT01951261|20313164|P1|Discontinued|Overall Study|"2-readmission when was at home
~1-monitor failure
~1-new home hospitalitation 4-missing
~1-death"|9
8237690|NCT01951261|20313163|P2|STARTED|Overall Study||58
8237691|NCT01951261|20313164|P1|STARTED|Overall Study||58
8237692|NCT01951170|20313182|P1|NOT COMPLETED|Overall Study||1
8237693|NCT01951170|20313182|P1|COMPLETED|Overall Study||51
8237694|NCT01951170|20313182|P1|STARTED|Overall Study||52
8237695|NCT01951157|20313208|P3|NOT COMPLETED|Overall Study||25
8237696|NCT01951157|20313209|P2|NOT COMPLETED|Overall Study||22
8237697|NCT01951157|20313210|P1|NOT COMPLETED|Overall Study||22
8237698|NCT01951157|20313208|P3|COMPLETED|Overall Study||0
8237699|NCT01951157|20313209|P2|COMPLETED|Overall Study||0
8237700|NCT01951157|20313210|P1|COMPLETED|Overall Study||0
8237701|NCT01951157|20313208|P3|STARTED|Overall Study||25
8237702|NCT01951157|20313209|P2|STARTED|Overall Study||22
8237703|NCT01951157|20313210|P1|STARTED|Overall Study||22
8237704|NCT01951118|20313239|P1|NOT COMPLETED|Overall Study||27
8237705|NCT01951118|20313239|P1|COMPLETED|Overall Study||94
8237706|NCT01951118|20313239|P1|STARTED|Overall Study||121
8237707|NCT01951105|20313261|P3|NOT COMPLETED|Overall Study||2
8237708|NCT01951105|20313262|P2|NOT COMPLETED|Overall Study||10
8237709|NCT01951105|20313263|P1|NOT COMPLETED|Overall Study||1
8237710|NCT01951105|20313261|P3|COMPLETED|Overall Study||28
8237711|NCT01951105|20313262|P2|COMPLETED|Overall Study||21
8237712|NCT01951105|20313263|P1|COMPLETED|Overall Study||10
8237713|NCT01951105|20313261|P3|Completed 12 Weeks Treatment|Overall Study||28
8237714|NCT01951105|20313262|P2|Completed 12 Weeks Treatment|Overall Study||24
8237715|NCT01951105|20313263|P1|Completed 12 Weeks Treatment|Overall Study||10
8237716|NCT01951105|20313261|P3|STARTED|Overall Study||30
8237717|NCT01951105|20313262|P2|STARTED|Overall Study||31
8237718|NCT01951105|20313263|P1|STARTED|Overall Study||11
8237719|NCT01951092|20313277|P1|NOT COMPLETED|Overall Study||12
8237720|NCT01951092|20313277|P1|COMPLETED|Overall Study||20
8237721|NCT01951092|20313277|P1|STARTED|Overall Study||32
8237722|NCT01951066|20313282|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
8237723|NCT01951066|20313283|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
8237724|NCT01951066|20313282|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
8237725|NCT01951066|20313283|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
8237726|NCT01951066|20313282|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
8237727|NCT01951066|20313283|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
8237728|NCT01951066|20313282|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
8237729|NCT01951066|20313283|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
8237730|NCT01951066|20313282|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
8237731|NCT01951066|20313283|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
8237732|NCT01951066|20313282|P2|STARTED|First Intervention (Baseline to Week 16)||10
8237733|NCT01951066|20313283|P1|STARTED|First Intervention (Baseline to Week 16)||10
8237734|NCT01950819|20313290|P2|NOT COMPLETED|Overall Study||134
8237735|NCT01950819|20313291|P1|NOT COMPLETED|Overall Study||129
8237736|NCT01950819|20313290|P2|COMPLETED|Overall Study||881
8237737|NCT01950819|20313291|P1|COMPLETED|Overall Study||893
8237738|NCT01950819|20313290|P2|STARTED|Overall Study||1015
8237739|NCT01950819|20313291|P1|STARTED|Overall Study||1022
8237740|NCT01950780|20313339|P1|NOT COMPLETED|Overall Study||0
8237741|NCT01950780|20313339|P1|COMPLETED|Overall Study||12
8237742|NCT01950780|20313339|P1|STARTED|Overall Study||12
8237743|NCT01950741|20313344|P1|NOT COMPLETED|Overall Study||3
8237744|NCT01950741|20313344|P1|COMPLETED|Overall Study||45
8237745|NCT01950741|20313344|P1|STARTED|Overall Study||48
8237746|NCT01950663|20313353|P1|NOT COMPLETED|Overall Study||1
8237747|NCT01950663|20313353|P1|COMPLETED|Overall Study||467
8237748|NCT01950663|20313353|P1|STARTED|Overall Study||468
8237749|NCT01950364|20313359|P2|NOT COMPLETED|Overall Study||10
8237750|NCT01950364|20313360|P1|NOT COMPLETED|Overall Study||10
8237751|NCT01950364|20313359|P2|COMPLETED|Overall Study||0
8237752|NCT01950364|20313360|P1|COMPLETED|Overall Study||0
8237753|NCT01950364|20313359|P2|STARTED|Overall Study||10
8237754|NCT01950364|20313360|P1|STARTED|Overall Study||10
8237755|NCT01950299|20313461|P3|NOT COMPLETED|Overall Study||7
8237756|NCT01950299|20313462|P2|NOT COMPLETED|Overall Study||4
8237757|NCT01950299|20313463|P1|NOT COMPLETED|Overall Study||11
8237758|NCT01950299|20313461|P3|COMPLETED|Overall Study||28
8237759|NCT01950299|20313462|P2|COMPLETED|Overall Study||27
8237760|NCT01950299|20313463|P1|COMPLETED|Overall Study||22
8237761|NCT01950299|20313461|P3|STARTED|Overall Study||35
8237762|NCT01950299|20313462|P2|STARTED|Overall Study||31
8237763|NCT01950299|20313463|P1|STARTED|Overall Study||33
8237764|NCT01950273|20313482|P2|NOT COMPLETED|Overall Study||0
8237765|NCT01950273|20313483|P1|NOT COMPLETED|Overall Study||4
8237766|NCT01950273|20313482|P2|COMPLETED|Overall Study||46
8237767|NCT01950273|20313483|P1|COMPLETED|Overall Study||45
8237768|NCT01950273|20313482|P2|STARTED|Overall Study||46
8237769|NCT01950273|20313483|P1|STARTED|Overall Study||49
8237770|NCT01950260|20313505|P2|NOT COMPLETED|Overall Study||0
8237771|NCT01950260|20313506|P1|NOT COMPLETED|Overall Study||0
8237772|NCT01950260|20313505|P2|COMPLETED|Overall Study||31
8237773|NCT01950260|20313506|P1|COMPLETED|Overall Study||30
8237774|NCT01950260|20313505|P2|STARTED|Overall Study||31
8237775|NCT01950260|20313506|P1|STARTED|Overall Study||30
8237776|NCT01950078|20313518|P2|NOT COMPLETED|Overall Study||12
8237777|NCT01950078|20313519|P1|NOT COMPLETED|Overall Study||20
8237778|NCT01950078|20313518|P2|COMPLETED|Overall Study||496
8237779|NCT01950078|20313519|P1|COMPLETED|Overall Study||1005
8237780|NCT01950078|20313518|P2|STARTED|Overall Study||508
8237781|NCT01950078|20313519|P1|STARTED|Overall Study||1025
8237782|NCT01950013|20313530|P3|NOT COMPLETED|Overall Study||0
8237783|NCT01950013|20313531|P2|NOT COMPLETED|Overall Study||2
8237784|NCT01950013|20313532|P1|NOT COMPLETED|Overall Study||0
8237785|NCT01950013|20313530|P3|COMPLETED|Overall Study||15
8237786|NCT01950013|20313531|P2|COMPLETED|Overall Study||13
8237787|NCT01950013|20313532|P1|COMPLETED|Overall Study||15
8237788|NCT01950013|20313530|P3|STARTED|Overall Study||15
8237789|NCT01950013|20313531|P2|STARTED|Overall Study||15
8237790|NCT01950013|20313532|P1|STARTED|Overall Study||15
8237791|NCT01949870|20313543|P1|NOT COMPLETED|Overall Study||6
8237792|NCT01949870|20313543|P1|COMPLETED|Overall Study||0
8237793|NCT01949870|20313543|P1|Received Treatment|Overall Study||4
8237794|NCT01949870|20313543|P1|STARTED|Overall Study||6
8237795|NCT01949844|20313547|P1|NOT COMPLETED|Overall Study||0
8237796|NCT01949844|20313547|P1|COMPLETED|Overall Study||44
8237797|NCT01949844|20313547|P1|STARTED|Overall Study||44
8237798|NCT01949779|20313551|P1|NOT COMPLETED|Overall Study||2
8237799|NCT01949779|20313551|P1|COMPLETED|Overall Study||79
8237800|NCT01949779|20313551|P1|STARTED|Overall Study||81
8237801|NCT01949662|20313559|P2|NOT COMPLETED|Overall Study||14
8237802|NCT01949662|20313560|P1|NOT COMPLETED|Overall Study||18
8237803|NCT01949662|20313559|P2|COMPLETED|Overall Study||29
8237804|NCT01949662|20313560|P1|COMPLETED|Overall Study||29
8237805|NCT01949662|20313559|P2|STARTED|Overall Study||43
8237806|NCT01949662|20313560|P1|STARTED|Overall Study||47
8237807|NCT01949545|20313576|P4|NOT COMPLETED|Overall Study||0
8237808|NCT01949545|20313577|P3|NOT COMPLETED|Overall Study||0
8237809|NCT01949545|20313578|P2|NOT COMPLETED|Overall Study||0
8237810|NCT01949545|20313579|P1|NOT COMPLETED|Overall Study||0
8237811|NCT01949545|20313576|P4|COMPLETED|Overall Study||4
8237812|NCT01949545|20313577|P3|COMPLETED|Overall Study||14
8237813|NCT01949545|20313578|P2|COMPLETED|Overall Study||17
8237814|NCT01949545|20313579|P1|COMPLETED|Overall Study||11
8237815|NCT01949545|20313576|P4|STARTED|Overall Study||4
8237816|NCT01949545|20313577|P3|STARTED|Overall Study||14
8237817|NCT01949545|20313578|P2|STARTED|Overall Study||17
8237818|NCT01949545|20313579|P1|STARTED|Overall Study||11
8237819|NCT01949532|20313727|P2|NOT COMPLETED|Overall Study||3
8237820|NCT01949532|20313728|P1|NOT COMPLETED|Overall Study||3
8237821|NCT01949532|20313727|P2|COMPLETED|Overall Study||8
8237822|NCT01949532|20313728|P1|COMPLETED|Overall Study||12
8237823|NCT01949532|20313727|P2|STARTED|Overall Study||11
8237824|NCT01949532|20313728|P1|STARTED|Overall Study||15
8237825|NCT01949480|20313798|P2|NOT COMPLETED|Overall Study||8
8237826|NCT01949480|20313799|P1|NOT COMPLETED|Overall Study||5
8237827|NCT01949480|20313798|P2|COMPLETED|Overall Study||14
8237828|NCT01949480|20313799|P1|COMPLETED|Overall Study||15
8237829|NCT01949480|20313798|P2|STARTED|Overall Study||22
8237830|NCT01949480|20313799|P1|STARTED|Overall Study||20
8237831|NCT01949389|20313827|P1|NOT COMPLETED|Overall Study||0
8237832|NCT01949389|20313827|P1|COMPLETED|Overall Study||51
8237833|NCT01949389|20313827|P1|STARTED|Overall Study||51
8237834|NCT01949337|20313834|P2|NOT COMPLETED|Overall Study||0
8237835|NCT01949337|20313835|P1|NOT COMPLETED|Overall Study||0
8237836|NCT01949337|20313834|P2|COMPLETED|Overall Study||654
8237837|NCT01949337|20313835|P1|COMPLETED|Overall Study||657
8237838|NCT01949337|20313834|P2|STARTED|Overall Study||654
8237839|NCT01949337|20313835|P1|STARTED|Overall Study||657
8237840|NCT01949155|20313845|P2|NOT COMPLETED|Overall Study||0
8237841|NCT01949155|20313846|P1|NOT COMPLETED|Overall Study||2
8237842|NCT01949155|20313845|P2|COMPLETED|Overall Study||88
8237843|NCT01949155|20313846|P1|COMPLETED|Overall Study||176
8237844|NCT01949155|20313845|P2|STARTED|Overall Study||88
8237845|NCT01949155|20313846|P1|STARTED|Overall Study||178
8237846|NCT01949142|20313858|P2|NOT COMPLETED|Overall Study||1
8237847|NCT01949142|20313859|P1|NOT COMPLETED|Overall Study||3
8237848|NCT01949142|20313858|P2|COMPLETED|Overall Study||86
8237849|NCT01949142|20313859|P1|COMPLETED|Overall Study||176
8237850|NCT01949142|20313858|P2|STARTED|Overall Study||87
8237851|NCT01949142|20313859|P1|STARTED|Overall Study||179
8237852|NCT01949116|20313871|P2|NOT COMPLETED|Overall Study||6
8237853|NCT01949116|20313872|P1|NOT COMPLETED|Overall Study||8
8237854|NCT01949116|20313871|P2|COMPLETED|Overall Study||84
8237855|NCT01949116|20313872|P1|COMPLETED|Overall Study||78
8237856|NCT01949116|20313871|P2|STARTED|Overall Study||90
8237857|NCT01949116|20313872|P1|STARTED|Overall Study||86
8237858|NCT01949090|20313909|P5|NOT COMPLETED|Overall Study||4
8237859|NCT01949090|20313910|P4|NOT COMPLETED|Overall Study||1
8237860|NCT01949090|20313911|P3|NOT COMPLETED|Overall Study||2
8237861|NCT01949090|20313912|P2|NOT COMPLETED|Overall Study||2
8237862|NCT01949090|20313913|P1|NOT COMPLETED|Overall Study||4
8237863|NCT01949090|20313909|P5|COMPLETED|Overall Study||116
8237864|NCT01949090|20313910|P4|COMPLETED|Overall Study||59
8237865|NCT01949090|20313911|P3|COMPLETED|Overall Study||58
8237866|NCT01949090|20313912|P2|COMPLETED|Overall Study||58
8237867|NCT01949090|20313913|P1|COMPLETED|Overall Study||56
8237868|NCT01949090|20313909|P5|STARTED|Overall Study||120
8237869|NCT01949090|20313910|P4|STARTED|Overall Study||60
8237870|NCT01949090|20313911|P3|STARTED|Overall Study||60
8237871|NCT01949090|20313912|P2|STARTED|Overall Study||60
8237872|NCT01949090|20313913|P1|STARTED|Overall Study||60
8237873|NCT01949051|20314090|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237874|NCT01949051|20314091|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237875|NCT01949051|20314092|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237876|NCT01949051|20314093|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237877|NCT01949051|20314094|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237878|NCT01949051|20314095|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237879|NCT01949051|20314090|P6|COMPLETED|Treatment Period 3 (7 Days)||12
8237880|NCT01949051|20314091|P5|COMPLETED|Treatment Period 3 (7 Days)||13
8237881|NCT01949051|20314092|P4|COMPLETED|Treatment Period 3 (7 Days)||12
8237882|NCT01949051|20314093|P3|COMPLETED|Treatment Period 3 (7 Days)||12
8237883|NCT01949051|20314094|P2|COMPLETED|Treatment Period 3 (7 Days)||12
8237884|NCT01949051|20314095|P1|COMPLETED|Treatment Period 3 (7 Days)||11
8237885|NCT01949051|20314090|P6|STARTED|Treatment Period 3 (7 Days)||12
8237886|NCT01949051|20314091|P5|STARTED|Treatment Period 3 (7 Days)||13
8237887|NCT01949051|20314092|P4|STARTED|Treatment Period 3 (7 Days)||12
8237888|NCT01949051|20314093|P3|STARTED|Treatment Period 3 (7 Days)||12
8237889|NCT01949051|20314094|P2|STARTED|Treatment Period 3 (7 Days)||12
8237890|NCT01949051|20314095|P1|STARTED|Treatment Period 3 (7 Days)||11
8237891|NCT01949051|20314090|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237892|NCT01949051|20314091|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237893|NCT01949051|20314092|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237894|NCT01949051|20314093|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237895|NCT01949051|20314094|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237896|NCT01949051|20314095|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237897|NCT01949051|20314090|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237898|NCT01949051|20314091|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
8237899|NCT01949051|20314092|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237900|NCT01949051|20314093|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237901|NCT01949051|20314094|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237902|NCT01949051|20314095|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
8237903|NCT01949051|20314090|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
8237904|NCT01949051|20314091|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
8237905|NCT01949051|20314092|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
8237906|NCT01949051|20314093|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
8237907|NCT01949051|20314094|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
8237908|NCT01949051|20314095|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
8237909|NCT01949051|20314090|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8237910|NCT01949051|20314091|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8237911|NCT01949051|20314092|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8237912|NCT01949051|20314093|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8237913|NCT01949051|20314094|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8237914|NCT01949051|20314095|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8237915|NCT01949051|20314090|P6|COMPLETED|Treatment Period 2 (7 Days)||12
8237916|NCT01949051|20314091|P5|COMPLETED|Treatment Period 2 (7 Days)||13
8237917|NCT01949051|20314092|P4|COMPLETED|Treatment Period 2 (7 Days)||12
8237918|NCT01949051|20314093|P3|COMPLETED|Treatment Period 2 (7 Days)||12
8237919|NCT01949051|20314094|P2|COMPLETED|Treatment Period 2 (7 Days)||12
8237920|NCT01949051|20314095|P1|COMPLETED|Treatment Period 2 (7 Days)||11
8237921|NCT01949051|20314090|P6|STARTED|Treatment Period 2 (7 Days)||13
8237922|NCT01949051|20314091|P5|STARTED|Treatment Period 2 (7 Days)||13
8237923|NCT01949051|20314092|P4|STARTED|Treatment Period 2 (7 Days)||12
8237924|NCT01949051|20314093|P3|STARTED|Treatment Period 2 (7 Days)||13
8237925|NCT01949051|20314094|P2|STARTED|Treatment Period 2 (7 Days)||13
8237926|NCT01949051|20314095|P1|STARTED|Treatment Period 2 (7 Days)||11
8237927|NCT01949051|20314090|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237928|NCT01949051|20314091|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237929|NCT01949051|20314092|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237930|NCT01949051|20314093|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237931|NCT01949051|20314094|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237932|NCT01949051|20314095|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237933|NCT01949051|20314090|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237934|NCT01949051|20314091|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237935|NCT01949051|20314092|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
8237936|NCT01949051|20314093|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237937|NCT01949051|20314094|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237938|NCT01949051|20314095|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
8237939|NCT01949051|20314090|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
8237940|NCT01949051|20314091|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
8237941|NCT01949051|20314092|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
8237942|NCT01949051|20314093|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
8237943|NCT01949051|20314094|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
8237944|NCT01949051|20314095|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
8237945|NCT01949051|20314090|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237946|NCT01949051|20314091|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237947|NCT01949051|20314092|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
8237948|NCT01949051|20314093|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237949|NCT01949051|20314094|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237950|NCT01949051|20314095|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8237951|NCT01949051|20314090|P6|COMPLETED|Treatment Period 1 (7 Days)||13
8237952|NCT01949051|20314091|P5|COMPLETED|Treatment Period 1 (7 Days)||13
8237953|NCT01949051|20314092|P4|COMPLETED|Treatment Period 1 (7 Days)||12
8237954|NCT01949051|20314093|P3|COMPLETED|Treatment Period 1 (7 Days)||13
8237955|NCT01949051|20314094|P2|COMPLETED|Treatment Period 1 (7 Days)||13
8237956|NCT01949051|20314095|P1|COMPLETED|Treatment Period 1 (7 Days)||11
8237957|NCT01949051|20314090|P6|STARTED|Treatment Period 1 (7 Days)||13
8237958|NCT01949051|20314091|P5|STARTED|Treatment Period 1 (7 Days)||13
8237959|NCT01949051|20314092|P4|STARTED|Treatment Period 1 (7 Days)||13
8237960|NCT01949051|20314093|P3|STARTED|Treatment Period 1 (7 Days)||13
8237961|NCT01949051|20314094|P2|STARTED|Treatment Period 1 (7 Days)||13
8237962|NCT01949051|20314095|P1|STARTED|Treatment Period 1 (7 Days)||13
8237963|NCT01948986|20314111|P5|NOT COMPLETED|Overall Study||0
8237964|NCT01948986|20314112|P4|NOT COMPLETED|Overall Study||0
8237965|NCT01948986|20314113|P3|NOT COMPLETED|Overall Study||0
8237966|NCT01948986|20314114|P2|NOT COMPLETED|Overall Study||0
8237967|NCT01948986|20314115|P1|NOT COMPLETED|Overall Study||0
8237968|NCT01948986|20314111|P5|COMPLETED|Overall Study||8
8237969|NCT01948986|20314112|P4|COMPLETED|Overall Study||6
8237970|NCT01948986|20314113|P3|COMPLETED|Overall Study||8
8237971|NCT01948986|20314114|P2|COMPLETED|Overall Study||8
8237972|NCT01948986|20314115|P1|COMPLETED|Overall Study||6
8237973|NCT01948986|20314111|P5|STARTED|Overall Study||8
8237974|NCT01948986|20314112|P4|STARTED|Overall Study||6
8237975|NCT01948986|20314113|P3|STARTED|Overall Study||8
8237976|NCT01948986|20314114|P2|STARTED|Overall Study||8
8237977|NCT01948986|20314115|P1|STARTED|Overall Study||6
8237978|NCT01948947|20314274|P2|NOT COMPLETED|Overall Study||0
8237979|NCT01948947|20314275|P1|NOT COMPLETED|Overall Study||0
8237980|NCT01948947|20314274|P2|COMPLETED|Overall Study||15
8237981|NCT01948947|20314275|P1|COMPLETED|Overall Study||14
8237982|NCT01948947|20314274|P2|STARTED|Overall Study||15
8237983|NCT01948947|20314275|P1|STARTED|Overall Study||14
8237984|NCT01948908|20314290|P3|NOT COMPLETED|Overall Study||2
8237985|NCT01948908|20314291|P2|NOT COMPLETED|Overall Study||0
8237986|NCT01948908|20314292|P1|NOT COMPLETED|Overall Study||1
8237987|NCT01948908|20314290|P3|COMPLETED|Overall Study||31
8237988|NCT01948908|20314291|P2|COMPLETED|Overall Study||33
8237989|NCT01948908|20314292|P1|COMPLETED|Overall Study||32
8237990|NCT01948908|20314290|P3|STARTED|Overall Study||33
8237991|NCT01948908|20314291|P2|STARTED|Overall Study||33
8237992|NCT01948908|20314292|P1|STARTED|Overall Study||33
8237993|NCT01948830|20314308|P2|NOT COMPLETED|Overall Study||32
8237994|NCT01948830|20314309|P1|NOT COMPLETED|Overall Study||33
8237995|NCT01948830|20314308|P2|COMPLETED|Overall Study||295
8237996|NCT01948830|20314309|P1|COMPLETED|Overall Study||290
8237997|NCT01948830|20314308|P2|Safety Set|Overall Study||326
8237998|NCT01948830|20314309|P1|Safety Set|Overall Study||323
8237999|NCT01948830|20314308|P2|STARTED|Overall Study||327
8238000|NCT01948830|20314309|P1|STARTED|Overall Study||323
8238001|NCT01948791|20314341|P1|NOT COMPLETED|Overall Study||71
8238002|NCT01948791|20314341|P1|COMPLETED|Overall Study||151
8238003|NCT01948791|20314341|P1|STARTED|Overall Study||222
8238004|NCT01948518|20314349|P1|NOT COMPLETED|Overall Study||0
8238005|NCT01948518|20314349|P1|COMPLETED|Overall Study||15
8238006|NCT01948518|20314349|P1|STARTED|Overall Study||15
8238007|NCT01948388|20314356|P2|NOT COMPLETED|Overall Study||1
8238008|NCT01948388|20314357|P1|NOT COMPLETED|Overall Study||2
8238009|NCT01948388|20314356|P2|COMPLETED|Overall Study||9
8238010|NCT01948388|20314357|P1|COMPLETED|Overall Study||8
8238011|NCT01948388|20314356|P2|STARTED|Overall Study||10
8238012|NCT01948388|20314357|P1|STARTED|Overall Study||10
8238013|NCT01948375|20314373|P2|NOT COMPLETED|Overall Study||0
8238014|NCT01948375|20314374|P1|NOT COMPLETED|Overall Study||0
8238015|NCT01948375|20314373|P2|COMPLETED|Overall Study||30
8238016|NCT01948375|20314374|P1|COMPLETED|Overall Study||30
8238017|NCT01948375|20314373|P2|STARTED|Overall Study||30
8238018|NCT01948375|20314374|P1|STARTED|Overall Study||30
8238019|NCT01948310|20314390|P2|NOT COMPLETED|Overall Study||5
8238020|NCT01948310|20314391|P1|NOT COMPLETED|Overall Study||3
8238021|NCT01948310|20314390|P2|COMPLETED|Overall Study||13
8238022|NCT01948310|20314391|P1|COMPLETED|Overall Study||16
8238023|NCT01948310|20314390|P2|STARTED|Overall Study||18
8238024|NCT01948310|20314391|P1|STARTED|Overall Study||19
8238025|NCT01948258|20314401|P1|NOT COMPLETED|Overall Study||162
8238026|NCT01948258|20314401|P1|COMPLETED|Overall Study||233
8238027|NCT01948258|20314401|P1|STARTED|Overall Study||395
8238028|NCT01948193|20314407|P1|NOT COMPLETED|Overall Study||9
8238029|NCT01948193|20314407|P1|COMPLETED|Overall Study||168
8238030|NCT01948193|20314407|P1|STARTED|Overall Study||177
8238031|NCT01948141|20314416|P1|NOT COMPLETED|Overall Study||0
8238032|NCT01948141|20314416|P1|COMPLETED|Overall Study||6
8238033|NCT01948141|20314416|P1|STARTED|Overall Study||6
8238034|NCT01948076|20314429|P2|NOT COMPLETED|Overall Study||1
8238035|NCT01948076|20314430|P1|NOT COMPLETED|Overall Study||0
8238036|NCT01948076|20314429|P2|COMPLETED|Overall Study||19
8238037|NCT01948076|20314430|P1|COMPLETED|Overall Study||20
8238038|NCT01948076|20314429|P2|STARTED|Overall Study||20
8238039|NCT01948076|20314430|P1|STARTED|Overall Study||20
8238040|NCT01948063|20314440|P2|NOT COMPLETED|Overall Study||2
8238041|NCT01948063|20314441|P1|NOT COMPLETED|Overall Study||1
8238042|NCT01948063|20314440|P2|COMPLETED|Overall Study||19
8238043|NCT01948063|20314441|P1|COMPLETED|Overall Study||19
8238044|NCT01948063|20314440|P2|STARTED|Overall Study||21
8238045|NCT01948063|20314441|P1|STARTED|Overall Study||20
8238046|NCT01948050|20314449|P2|NOT COMPLETED|Overall Study||1
8238047|NCT01948050|20314450|P1|NOT COMPLETED|Overall Study||0
8238048|NCT01948050|20314449|P2|COMPLETED|Overall Study||7
8238049|NCT01948050|20314450|P1|COMPLETED|Overall Study||16
8238050|NCT01948050|20314449|P2|STARTED|Overall Study||8
8238051|NCT01948050|20314450|P1|STARTED|Overall Study||16
8238052|NCT01947946|20314459|P3|NOT COMPLETED|Overall Study||5
8238053|NCT01947946|20314460|P2|NOT COMPLETED|Overall Study||5
8238054|NCT01947946|20314461|P1|NOT COMPLETED|Overall Study||3
8238055|NCT01947946|20314459|P3|COMPLETED|Overall Study||0
8238056|NCT01947946|20314460|P2|COMPLETED|Overall Study||0
8238057|NCT01947946|20314461|P1|COMPLETED|Overall Study|Study Stopped|0
8238058|NCT01947946|20314459|P3|STARTED|Overall Study||5
8238059|NCT01947946|20314460|P2|STARTED|Overall Study||5
8238060|NCT01947946|20314461|P1|STARTED|Overall Study||3
8238061|NCT01947907|20314473|P4|NOT COMPLETED|Overall Study||0
8238062|NCT01947907|20314474|P3|NOT COMPLETED|Overall Study||0
8238063|NCT01947907|20314475|P2|NOT COMPLETED|Overall Study||0
8238064|NCT01947907|20314476|P1|NOT COMPLETED|Overall Study||0
8238065|NCT01947907|20314473|P4|COMPLETED|Overall Study||13
8238066|NCT01947907|20314474|P3|COMPLETED|Overall Study||14
8238067|NCT01947907|20314475|P2|COMPLETED|Overall Study||14
8238068|NCT01947907|20314476|P1|COMPLETED|Overall Study||12
8238069|NCT01947907|20314473|P4|STARTED|Overall Study||13
8238070|NCT01947907|20314474|P3|STARTED|Overall Study||14
8238071|NCT01947907|20314475|P2|STARTED|Overall Study||14
8238072|NCT01947907|20314476|P1|STARTED|Overall Study||12
8238073|NCT01947894|20314518|P3|NOT COMPLETED|Overall Study||27
8238074|NCT01947894|20314519|P2|NOT COMPLETED|Overall Study||18
8238075|NCT01947894|20314520|P1|NOT COMPLETED|Overall Study||87
8238076|NCT01947894|20314518|P3|COMPLETED|Overall Study||61
8238077|NCT01947894|20314519|P2|COMPLETED|Overall Study||24
8238078|NCT01947894|20314520|P1|COMPLETED|Overall Study||160
8238079|NCT01947894|20314518|P3|Treated|Overall Study||87
8238080|NCT01947894|20314519|P2|Treated|Overall Study||41
8238081|NCT01947894|20314520|P1|Treated|Overall Study||246
8238082|NCT01947894|20314518|P3|STARTED|Overall Study||88
8238083|NCT01947894|20314519|P2|STARTED|Overall Study||42
8238084|NCT01947894|20314520|P1|STARTED|Overall Study||247
8238085|NCT01947855|20314585|P3|NOT COMPLETED|Overall Study||0
8238086|NCT01947855|20314586|P2|NOT COMPLETED|Overall Study||0
8238087|NCT01947855|20314587|P1|NOT COMPLETED|Overall Study||1
8238088|NCT01947855|20314585|P3|COMPLETED|Overall Study||19
8238089|NCT01947855|20314586|P2|COMPLETED|Overall Study||20
8238090|NCT01947855|20314587|P1|COMPLETED|Overall Study||20
8238091|NCT01947855|20314585|P3|STARTED|Overall Study||19
8238092|NCT01947855|20314586|P2|STARTED|Overall Study||20
8238093|NCT01947855|20314587|P1|STARTED|Overall Study||21
8238094|NCT01947816|20314595|P1|NOT COMPLETED|Overall Study||70
8238095|NCT01947816|20314595|P1|COMPLETED|Overall Study||1523
8238096|NCT01947816|20314595|P1|STARTED|Overall Study||1593
8238097|NCT01947647|20314605|P2|NOT COMPLETED|6-month Followup Phase||8
8238098|NCT01947647|20314606|P1|NOT COMPLETED|6-month Followup Phase||9
8238099|NCT01947647|20314605|P2|COMPLETED|6-month Followup Phase||13
8238100|NCT01947647|20314606|P1|COMPLETED|6-month Followup Phase||20
8238101|NCT01947647|20314605|P2|STARTED|6-month Followup Phase||21
8238102|NCT01947647|20314606|P1|STARTED|6-month Followup Phase||29
8238103|NCT01947647|20314605|P2|NOT COMPLETED|Treatment Phase||26
8238104|NCT01947647|20314606|P1|NOT COMPLETED|Treatment Phase||17
8238105|NCT01947647|20314605|P2|COMPLETED|Treatment Phase||21
8238106|NCT01947647|20314606|P1|COMPLETED|Treatment Phase||29
8238107|NCT01947647|20314605|P2|STARTED|Treatment Phase||47
8238108|NCT01947647|20314606|P1|STARTED|Treatment Phase||46
8238109|NCT01947582|20314622|P1|NOT COMPLETED|Overall Study||1
8238110|NCT01947582|20314622|P1|COMPLETED|Overall Study||1
8238111|NCT01947582|20314622|P1|STARTED|Overall Study||2
8238112|NCT01947517|20314631|P2|NOT COMPLETED|Overall Study||1
8238113|NCT01947517|20314632|P1|NOT COMPLETED|Overall Study||1
8238114|NCT01947517|20314631|P2|COMPLETED|Overall Study||25
8238115|NCT01947517|20314632|P1|COMPLETED|Overall Study||25
8238116|NCT01947517|20314631|P2|STARTED|Overall Study||26
8238117|NCT01947517|20314632|P1|STARTED|Overall Study||26
8238118|NCT01947491|20314650|P4|NOT COMPLETED|Overall Study||5
8238119|NCT01947491|20314651|P3|NOT COMPLETED|Overall Study||2
8238120|NCT01947491|20314652|P2|NOT COMPLETED|Overall Study||6
8238121|NCT01947491|20314653|P1|NOT COMPLETED|Overall Study||8
8238122|NCT01947491|20314650|P4|COMPLETED|Overall Study||38
8238123|NCT01947491|20314651|P3|COMPLETED|Overall Study||88
8238124|NCT01947491|20314652|P2|COMPLETED|Overall Study||81
8238125|NCT01947491|20314653|P1|COMPLETED|Overall Study||166
8238126|NCT01947491|20314650|P4|STARTED|Overall Study||43
8238127|NCT01947491|20314651|P3|STARTED|Overall Study||90
8238128|NCT01947491|20314652|P2|STARTED|Overall Study||87
8238129|NCT01947491|20314653|P1|STARTED|Overall Study||174
8238130|NCT01947335|20314665|P2|NOT COMPLETED|Overall Study||0
8238131|NCT01947335|20314666|P1|NOT COMPLETED|Overall Study||0
8238132|NCT01947335|20314665|P2|COMPLETED|Overall Study||41
8238133|NCT01947335|20314666|P1|COMPLETED|Overall Study||42
8238134|NCT01947335|20314665|P2|STARTED|Overall Study||41
8238135|NCT01947335|20314666|P1|STARTED|Overall Study||42
8238136|NCT01947283|20314683|P7|NOT COMPLETED|Overall Study||8
8238137|NCT01947283|20314684|P6|NOT COMPLETED|Overall Study||7
8238138|NCT01947283|20314685|P5|NOT COMPLETED|Overall Study||0
8238139|NCT01947283|20314686|P4|NOT COMPLETED|Overall Study||17
8238140|NCT01947283|20314687|P3|NOT COMPLETED|Overall Study||21
8238141|NCT01947283|20314688|P2|NOT COMPLETED|Overall Study||23
8238142|NCT01947283|20314689|P1|NOT COMPLETED|Overall Study||29
8238143|NCT01947283|20314683|P7|COMPLETED|Overall Study||32
8238144|NCT01947283|20314684|P6|COMPLETED|Overall Study||27
8238145|NCT01947283|20314685|P5|COMPLETED|Overall Study||95
8238146|NCT01947283|20314686|P4|COMPLETED|Overall Study||55
8238147|NCT01947283|20314687|P3|COMPLETED|Overall Study||62
8238148|NCT01947283|20314688|P2|COMPLETED|Overall Study||45
8238149|NCT01947283|20314689|P1|COMPLETED|Overall Study||60
8238150|NCT01947283|20314683|P7|Completed NRCT Baseline Assessment|Overall Study||0
8238151|NCT01947283|20314684|P6|Completed NRCT Baseline Assessment|Overall Study||0
8238152|NCT01947283|20314685|P5|Completed NRCT Baseline Assessment|Overall Study||95
8238153|NCT01947283|20314686|P4|Completed NRCT Baseline Assessment|Overall Study||0
8238154|NCT01947283|20314687|P3|Completed NRCT Baseline Assessment|Overall Study||0
8238155|NCT01947283|20314688|P2|Completed NRCT Baseline Assessment|Overall Study||0
8238156|NCT01947283|20314689|P1|Completed NRCT Baseline Assessment|Overall Study||0
8238157|NCT01947283|20314683|P7|In Analysis|Overall Study||38
8238158|NCT01947283|20314684|P6|In Analysis|Overall Study||30
8238159|NCT01947283|20314685|P5|In Analysis|Overall Study||95
8238160|NCT01947283|20314686|P4|In Analysis|Overall Study||72
8238161|NCT01947283|20314687|P3|In Analysis|Overall Study||83
8238162|NCT01947283|20314688|P2|In Analysis|Overall Study||68
8238163|NCT01947283|20314689|P1|In Analysis|Overall Study||89
8238164|NCT01947283|20314683|P7|End-of-Intervention Assessment|Overall Study||33
8238165|NCT01947283|20314684|P6|End-of-Intervention Assessment|Overall Study||32
8238166|NCT01947283|20314685|P5|End-of-Intervention Assessment|Overall Study||0
8238167|NCT01947283|20314686|P4|End-of-Intervention Assessment|Overall Study||66
8238168|NCT01947283|20314687|P3|End-of-Intervention Assessment|Overall Study||73
8238169|NCT01947283|20314688|P2|End-of-Intervention Assessment|Overall Study||53
8238170|NCT01947283|20314689|P1|End-of-Intervention Assessment|Overall Study||74
8238171|NCT01947283|20314683|P7|Clinical Recording|Overall Study||0
8238172|NCT01947283|20314684|P6|Clinical Recording|Overall Study||0
8238173|NCT01947283|20314685|P5|Clinical Recording|Overall Study||0
8238174|NCT01947283|20314686|P4|Clinical Recording|Overall Study||57
8238175|NCT01947283|20314687|P3|Clinical Recording|Overall Study||68
8238176|NCT01947283|20314688|P2|Clinical Recording|Overall Study||54
8238177|NCT01947283|20314689|P1|Clinical Recording|Overall Study||65
8238178|NCT01947283|20314683|P7|Follow-up Assessment|Overall Study||36
8238179|NCT01947283|20314684|P6|Follow-up Assessment|Overall Study||27
8238180|NCT01947283|20314685|P5|Follow-up Assessment|Overall Study||0
8238181|NCT01947283|20314686|P4|Follow-up Assessment|Overall Study||59
8238182|NCT01947283|20314687|P3|Follow-up Assessment|Overall Study||65
8238183|NCT01947283|20314688|P2|Follow-up Assessment|Overall Study||51
8238184|NCT01947283|20314689|P1|Follow-up Assessment|Overall Study||64
8238185|NCT01947283|20314683|P7|Baseline Assessment|Overall Study||40
8238186|NCT01947283|20314684|P6|Baseline Assessment|Overall Study||34
8238187|NCT01947283|20314685|P5|Baseline Assessment|Overall Study||0
8238188|NCT01947283|20314686|P4|Baseline Assessment|Overall Study||72
8238189|NCT01947283|20314687|P3|Baseline Assessment|Overall Study||83
8238190|NCT01947283|20314688|P2|Baseline Assessment|Overall Study||68
8238191|NCT01947283|20314689|P1|Baseline Assessment|Overall Study||89
8238192|NCT01947283|20314683|P7|STARTED|Overall Study||40
8238193|NCT01947283|20314684|P6|STARTED|Overall Study||34
8238194|NCT01947283|20314685|P5|STARTED|Overall Study||95
8238195|NCT01947283|20314686|P4|STARTED|Overall Study||72
8238196|NCT01947283|20314687|P3|STARTED|Overall Study||83
8238197|NCT01947283|20314688|P2|STARTED|Overall Study||68
8238198|NCT01947283|20314689|P1|STARTED|Overall Study||89
8238199|NCT01947153|20314740|P2|NOT COMPLETED|Test Period 2||0
8238200|NCT01947153|20314741|P1|NOT COMPLETED|Test Period 2||0
8238201|NCT01947153|20314740|P2|COMPLETED|Test Period 2||18
8238202|NCT01947153|20314741|P1|COMPLETED|Test Period 2||18
8238203|NCT01947153|20314740|P2|STARTED|Test Period 2||18
8238204|NCT01947153|20314741|P1|STARTED|Test Period 2||18
8238205|NCT01947153|20314740|P2|NOT COMPLETED|Test Period 1||0
8238206|NCT01947153|20314741|P1|NOT COMPLETED|Test Period 1||0
8238207|NCT01947153|20314740|P2|COMPLETED|Test Period 1||18
8238208|NCT01947153|20314741|P1|COMPLETED|Test Period 1||18
8238209|NCT01947153|20314740|P2|STARTED|Test Period 1||18
8238210|NCT01947153|20314741|P1|STARTED|Test Period 1||18
8238211|NCT01947127|20314761|P2|NOT COMPLETED|Overall Study||43
8238212|NCT01947127|20314762|P1|NOT COMPLETED|Overall Study||23
8238213|NCT01947127|20314761|P2|COMPLETED|Overall Study||249
8238214|NCT01947127|20314762|P1|COMPLETED|Overall Study||143
8238215|NCT01947127|20314761|P2|STARTED|Overall Study||292
8238216|NCT01947127|20314762|P1|STARTED|Overall Study||166
8238217|NCT01946880|20314774|P2|NOT COMPLETED|Overall Study||3
8238218|NCT01946880|20314775|P1|NOT COMPLETED|Overall Study||7
8238219|NCT01946880|20314774|P2|COMPLETED|Overall Study||49
8238220|NCT01946880|20314775|P1|COMPLETED|Overall Study||43
8238221|NCT01946880|20314774|P2|STARTED|Overall Study||52
8238222|NCT01946880|20314775|P1|STARTED|Overall Study||50
8238223|NCT01946542|20314853|P2|NOT COMPLETED|Testing Visit 2||0
8238224|NCT01946542|20314854|P1|NOT COMPLETED|Testing Visit 2||0
8238225|NCT01946542|20314853|P2|COMPLETED|Testing Visit 2||1
8238226|NCT01946542|20314854|P1|COMPLETED|Testing Visit 2||1
8238227|NCT01946542|20314853|P2|STARTED|Testing Visit 2||1
8238228|NCT01946542|20314854|P1|STARTED|Testing Visit 2||1
8238229|NCT01946542|20314853|P2|NOT COMPLETED|Testing Visit 1||0
8238230|NCT01946542|20314854|P1|NOT COMPLETED|Testing Visit 1||0
8238231|NCT01946542|20314853|P2|COMPLETED|Testing Visit 1||1
8238232|NCT01946542|20314854|P1|COMPLETED|Testing Visit 1||1
8238233|NCT01946542|20314853|P2|STARTED|Testing Visit 1||1
8238234|NCT01946542|20314854|P1|STARTED|Testing Visit 1||1
8238235|NCT01946529|20314865|P3|NOT COMPLETED|Completion of All Therapy||6
8238236|NCT01946529|20314866|P2|NOT COMPLETED|Completion of All Therapy||16
8238237|NCT01946529|20314867|P1|NOT COMPLETED|Completion of All Therapy||1
8238238|NCT01946529|20314865|P3|COMPLETED|Completion of All Therapy||0
8238239|NCT01946529|20314866|P2|COMPLETED|Completion of All Therapy||0
8238240|NCT01946529|20314867|P1|COMPLETED|Completion of All Therapy||0
8238241|NCT01946529|20314865|P3|STARTED|Completion of All Therapy||6
8238242|NCT01946529|20314866|P2|STARTED|Completion of All Therapy||16
8238243|NCT01946529|20314867|P1|STARTED|Completion of All Therapy||1
8238244|NCT01946529|20314865|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
8238245|NCT01946529|20314866|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
8238246|NCT01946529|20314867|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
8238247|NCT01946529|20314865|P3|COMPLETED|End of Window Therapy (2 Courses)||6
8238248|NCT01946529|20314866|P2|COMPLETED|End of Window Therapy (2 Courses)||16
8238249|NCT01946529|20314867|P1|COMPLETED|End of Window Therapy (2 Courses)||1
8238250|NCT01946529|20314865|P3|STARTED|End of Window Therapy (2 Courses)||6
8238251|NCT01946529|20314866|P2|STARTED|End of Window Therapy (2 Courses)||17
8238252|NCT01946529|20314867|P1|STARTED|End of Window Therapy (2 Courses)||1
8238253|NCT01946438|20314878|P4|NOT COMPLETED|Overall Study||1
8238254|NCT01946438|20314879|P3|NOT COMPLETED|Overall Study||1
8238255|NCT01946438|20314880|P2|NOT COMPLETED|Overall Study||0
8238256|NCT01946438|20314881|P1|NOT COMPLETED|Overall Study||2
8238257|NCT01946438|20314878|P4|COMPLETED|Overall Study||51
8238258|NCT01946438|20314879|P3|COMPLETED|Overall Study||51
8238259|NCT01946438|20314880|P2|COMPLETED|Overall Study||52
8238260|NCT01946438|20314881|P1|COMPLETED|Overall Study||50
8238261|NCT01946438|20314878|P4|STARTED|Overall Study||52
8238262|NCT01946438|20314879|P3|STARTED|Overall Study||52
8238263|NCT01946438|20314880|P2|STARTED|Overall Study||52
8238264|NCT01946438|20314881|P1|STARTED|Overall Study||52
8238265|NCT01946425|20314909|P2|NOT COMPLETED|Overall Study||0
8238266|NCT01946425|20314910|P1|NOT COMPLETED|Overall Study||2
8238267|NCT01946425|20314909|P2|COMPLETED|Overall Study||30
8238268|NCT01946425|20314910|P1|COMPLETED|Overall Study||28
8238269|NCT01946425|20314909|P2|STARTED|Overall Study||30
8238270|NCT01946425|20314910|P1|STARTED|Overall Study||30
8238271|NCT01946412|20314924|P1|NOT COMPLETED|Overall Study||5
8238272|NCT01946412|20314924|P1|COMPLETED|Overall Study||28
8238273|NCT01946412|20314924|P1|STARTED|Overall Study||33
8238274|NCT01946282|20314949|P3|NOT COMPLETED|Year 3||30
8238275|NCT01946282|20314950|P2|NOT COMPLETED|Year 3||43
8238276|NCT01946282|20314951|P1|NOT COMPLETED|Year 3||288
8238277|NCT01946282|20314949|P3|COMPLETED|Year 3||140
8238278|NCT01946282|20314950|P2|COMPLETED|Year 3||141
8238279|NCT01946282|20314951|P1|COMPLETED|Year 3||856
8238280|NCT01946282|20314949|P3|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
8238281|NCT01946282|20314950|P2|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
8238282|NCT01946282|20314951|P1|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
8238283|NCT01946282|20314949|P3|NOT COMPLETED|Year 2||115
8238284|NCT01946282|20314950|P2|NOT COMPLETED|Year 2||131
8238285|NCT01946282|20314951|P1|NOT COMPLETED|Year 2||803
8238286|NCT01946282|20314949|P3|COMPLETED|Year 2||184
8238287|NCT01946282|20314950|P2|COMPLETED|Year 2||210
8238288|NCT01946282|20314951|P1|COMPLETED|Year 2||1248
8238289|NCT01946282|20314949|P3|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
8238290|NCT01946282|20314950|P2|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
8238291|NCT01946282|20314951|P1|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
8238292|NCT01946282|20314949|P3|NOT COMPLETED|Year 1||654
8238293|NCT01946282|20314950|P2|NOT COMPLETED|Year 1||608
8238294|NCT01946282|20314951|P1|NOT COMPLETED|Year 1||4186
8238295|NCT01946282|20314949|P3|COMPLETED|Year 1||346
8238296|NCT01946282|20314950|P2|COMPLETED|Year 1||392
8238297|NCT01946282|20314951|P1|COMPLETED|Year 1||2379
8238298|NCT01946282|20314949|P3|STARTED|Year 1||1000
8238299|NCT01946282|20314950|P2|STARTED|Year 1||1000
8238300|NCT01946282|20314951|P1|STARTED|Year 1||6565
8238301|NCT01946243|20314961|P1|NOT COMPLETED|Overall Study||0
8238302|NCT01946243|20314961|P1|COMPLETED|Overall Study||96
8238303|NCT01946243|20314961|P1|STARTED|Overall Study||96
8238304|NCT01946204|20314984|P2|NOT COMPLETED|Overall Study||806
8238305|NCT01946204|20314985|P1|NOT COMPLETED|Overall Study||401
8238306|NCT01946204|20314984|P2|COMPLETED|Overall Study||0
8238307|NCT01946204|20314985|P1|COMPLETED|Overall Study||0
8238308|NCT01946204|20314984|P2|Treated|Overall Study||803
8238309|NCT01946204|20314985|P1|Treated|Overall Study||398
8238310|NCT01946204|20314984|P2|STARTED|Overall Study||806
8238311|NCT01946204|20314985|P1|STARTED|Overall Study||401
8238312|NCT01946191|20315003|P2|NOT COMPLETED|Primary Outcome Analysis||18
8238313|NCT01946191|20315004|P1|NOT COMPLETED|Primary Outcome Analysis||18
8238314|NCT01946191|20315003|P2|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
8238315|NCT01946191|20315004|P1|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
8238316|NCT01946191|20315003|P2|STARTED|Primary Outcome Analysis||95
8238317|NCT01946191|20315004|P1|STARTED|Primary Outcome Analysis||98
8238318|NCT01946191|20315003|P2|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
8238319|NCT01946191|20315004|P1|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
8238320|NCT01946191|20315003|P2|COMPLETED|Follow-Up, 24-mo Endpoint||77
8238321|NCT01946191|20315004|P1|COMPLETED|Follow-Up, 24-mo Endpoint||80
8238322|NCT01946191|20315003|P2|STARTED|Follow-Up, 24-mo Endpoint||95
8238323|NCT01946191|20315004|P1|STARTED|Follow-Up, 24-mo Endpoint||97
8238324|NCT01946191|20315003|P2|NOT COMPLETED|Allocation||1
8238325|NCT01946191|20315004|P1|NOT COMPLETED|Allocation||1
8238326|NCT01946191|20315003|P2|COMPLETED|Allocation||95
8238327|NCT01946191|20315004|P1|COMPLETED|Allocation||97
8238328|NCT01946191|20315003|P2|STARTED|Allocation||96
8238329|NCT01946191|20315004|P1|STARTED|Allocation||98
8238330|NCT01946178|20315030|P1|NOT COMPLETED|Overall Study||2
8238331|NCT01946178|20315030|P1|COMPLETED|Overall Study||71
8238332|NCT01946178|20315030|P1|STARTED|Overall Study||73
8238333|NCT01946165|20315040|P2|NOT COMPLETED|Overall Study||2
8238334|NCT01946165|20315041|P1|NOT COMPLETED|Overall Study||2
8238335|NCT01946165|20315040|P2|COMPLETED|Overall Study||21
8238336|NCT01946165|20315041|P1|COMPLETED|Overall Study||43
8238337|NCT01946165|20315040|P2|STARTED|Overall Study||23
8238338|NCT01946165|20315041|P1|STARTED|Overall Study||45
8238339|NCT01946126|20315051|P2|NOT COMPLETED|Overall Study||0
8238340|NCT01946126|20315052|P1|NOT COMPLETED|Overall Study||0
8238341|NCT01946126|20315051|P2|COMPLETED|Overall Study||275
8238342|NCT01946126|20315052|P1|COMPLETED|Overall Study||184
8238343|NCT01946126|20315051|P2|STARTED|Overall Study||275
8238344|NCT01946126|20315052|P1|STARTED|Overall Study||184
8238345|NCT01945996|20315068|P2|NOT COMPLETED|Overall Study||5
8238346|NCT01945996|20315069|P1|NOT COMPLETED|Overall Study||3
8238347|NCT01945996|20315068|P2|COMPLETED|Overall Study||17
8238348|NCT01945996|20315069|P1|COMPLETED|Overall Study||19
8238349|NCT01945996|20315068|P2|STARTED|Overall Study||22
8238350|NCT01945996|20315069|P1|STARTED|Overall Study||22
8238351|NCT01945970|20315101|P6|NOT COMPLETED|Overall Study||0
8238352|NCT01945970|20315102|P5|NOT COMPLETED|Overall Study||0
8238353|NCT01945970|20315103|P4|NOT COMPLETED|Overall Study||0
8238354|NCT01945970|20315104|P3|NOT COMPLETED|Overall Study||0
8238355|NCT01945970|20315105|P2|NOT COMPLETED|Overall Study||0
8238356|NCT01945970|20315106|P1|NOT COMPLETED|Overall Study||0
8238357|NCT01945970|20315101|P6|COMPLETED|Overall Study||5
8238358|NCT01945970|20315102|P5|COMPLETED|Overall Study||5
8238359|NCT01945970|20315103|P4|COMPLETED|Overall Study||5
8238360|NCT01945970|20315104|P3|COMPLETED|Overall Study||5
8238361|NCT01945970|20315105|P2|COMPLETED|Overall Study||5
8238362|NCT01945970|20315106|P1|COMPLETED|Overall Study||5
8238363|NCT01945970|20315101|P6|STARTED|Overall Study||5
8238364|NCT01945970|20315102|P5|STARTED|Overall Study||5
8238365|NCT01945970|20315103|P4|STARTED|Overall Study||5
8238366|NCT01945970|20315104|P3|STARTED|Overall Study||5
8238367|NCT01945970|20315105|P2|STARTED|Overall Study||5
8238368|NCT01945970|20315106|P1|STARTED|Overall Study||5
8238369|NCT01945944|20315145|P2|NOT COMPLETED|Overall Study||3
8238370|NCT01945944|20315146|P1|NOT COMPLETED|Overall Study||1
8238371|NCT01945944|20315145|P2|COMPLETED|Overall Study||6
8238372|NCT01945944|20315146|P1|COMPLETED|Overall Study||8
8238373|NCT01945944|20315145|P2|STARTED|Overall Study||9
8238374|NCT01945944|20315146|P1|STARTED|Overall Study||9
8238375|NCT01945866|20315170|P2|NOT COMPLETED|Overall Study||0
8238376|NCT01945866|20315171|P1|NOT COMPLETED|Overall Study||2
8238377|NCT01945866|20315170|P2|COMPLETED|Overall Study||64
8238378|NCT01945866|20315171|P1|COMPLETED|Overall Study||63
8238379|NCT01945866|20315170|P2|STARTED|Overall Study||64
8238380|NCT01945866|20315171|P1|STARTED|Overall Study||65
8238389|NCT01945710|20315229|P7|NOT COMPLETED|Overall Study||23
8238390|NCT01945710|20315230|P6|NOT COMPLETED|Overall Study||3
8238391|NCT01945710|20315231|P5|NOT COMPLETED|Overall Study||9
8238392|NCT01945710|20315232|P4|NOT COMPLETED|Overall Study||3
8238393|NCT01945710|20315233|P3|NOT COMPLETED|Overall Study||7
8238394|NCT01945710|20315234|P2|NOT COMPLETED|Overall Study||6
8238395|NCT01945710|20315235|P1|NOT COMPLETED|Overall Study||7
8238396|NCT01945710|20315229|P7|COMPLETED|Overall Study||0
8238397|NCT01945710|20315230|P6|COMPLETED|Overall Study||0
8238398|NCT01945710|20315231|P5|COMPLETED|Overall Study||0
8238399|NCT01945710|20315232|P4|COMPLETED|Overall Study||0
8238400|NCT01945710|20315233|P3|COMPLETED|Overall Study||0
8238401|NCT01945710|20315234|P2|COMPLETED|Overall Study||0
8238402|NCT01945710|20315235|P1|COMPLETED|Overall Study||0
8238403|NCT01945710|20315229|P7|STARTED|Overall Study||23
8238404|NCT01945710|20315230|P6|STARTED|Overall Study||3
8238405|NCT01945710|20315231|P5|STARTED|Overall Study||9
8238406|NCT01945710|20315232|P4|STARTED|Overall Study||3
8238407|NCT01945710|20315233|P3|STARTED|Overall Study||7
8238408|NCT01945710|20315234|P2|STARTED|Overall Study||6
8238409|NCT01945710|20315235|P1|STARTED|Overall Study||7
8238410|NCT01945593|20315354|P4|NOT COMPLETED|Overall Study||20
8238411|NCT01945593|20315355|P3|NOT COMPLETED|Overall Study||3
8238412|NCT01945593|20315356|P2|NOT COMPLETED|Overall Study||8
8238413|NCT01945593|20315357|P1|NOT COMPLETED|Overall Study||0
8238414|NCT01945593|20315354|P4|COMPLETED|Overall Study||105
8238415|NCT01945593|20315355|P3|COMPLETED|Overall Study||23
8238416|NCT01945593|20315356|P2|COMPLETED|Overall Study||56
8238417|NCT01945593|20315357|P1|COMPLETED|Overall Study||3
8238418|NCT01945593|20315354|P4|STARTED|Overall Study||125
8238419|NCT01945593|20315355|P3|STARTED|Overall Study||26
8238420|NCT01945593|20315356|P2|STARTED|Overall Study||64
8238421|NCT01945593|20315357|P1|STARTED|Overall Study||3
8238422|NCT01945489|20315439|P2|NOT COMPLETED|Cycle 2||1
8238423|NCT01945489|20315440|P1|NOT COMPLETED|Cycle 2||1
8238424|NCT01945489|20315439|P2|COMPLETED|Cycle 2||106
8238425|NCT01945489|20315440|P1|COMPLETED|Cycle 2||87
8238426|NCT01945489|20315439|P2|STARTED|Cycle 2||107
8238427|NCT01945489|20315440|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
8238428|NCT01945489|20315439|P2|NOT COMPLETED|Cycle 1||4
8238429|NCT01945489|20315440|P1|NOT COMPLETED|Cycle 1||13
8238430|NCT01945489|20315439|P2|COMPLETED|Cycle 1||121
8238431|NCT01945489|20315440|P1|COMPLETED|Cycle 1||116
8238432|NCT01945489|20315439|P2|STARTED|Cycle 1||125
8238433|NCT01945489|20315440|P1|STARTED|Cycle 1||129
8238434|NCT01945294|20315460|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
8238435|NCT01945294|20315461|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
8238436|NCT01945294|20315462|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
8238437|NCT01945294|20315463|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
8238438|NCT01945294|20315460|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
8238439|NCT01945294|20315461|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
8238440|NCT01945294|20315462|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
8238441|NCT01945294|20315463|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
8238442|NCT01945294|20315460|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
8238443|NCT01945294|20315461|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
8238444|NCT01945294|20315462|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
8238445|NCT01945294|20315463|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
8238446|NCT01945294|20315460|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238447|NCT01945294|20315461|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238448|NCT01945294|20315462|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238449|NCT01945294|20315463|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
8238450|NCT01945294|20315460|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238451|NCT01945294|20315461|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238452|NCT01945294|20315462|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238453|NCT01945294|20315463|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
8238454|NCT01945294|20315460|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8238455|NCT01945294|20315461|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8238456|NCT01945294|20315462|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8238457|NCT01945294|20315463|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
8238458|NCT01945281|20315494|P2|NOT COMPLETED|Overall Study||4
8238459|NCT01945281|20315495|P1|NOT COMPLETED|Overall Study||6
8238460|NCT01945281|20315494|P2|COMPLETED|Overall Study||13
8238461|NCT01945281|20315495|P1|COMPLETED|Overall Study||28
8238462|NCT01945281|20315494|P2|Treated|Overall Study||16
8238463|NCT01945281|20315495|P1|Treated|Overall Study||33
8238464|NCT01945281|20315494|P2|STARTED|Overall Study||17
8238465|NCT01945281|20315495|P1|STARTED|Overall Study||34
8238466|NCT01945242|20315507|P2|NOT COMPLETED|Overall Study||3
8238467|NCT01945242|20315508|P1|NOT COMPLETED|Overall Study||3
8238468|NCT01945242|20315507|P2|COMPLETED|Overall Study||120
8238469|NCT01945242|20315508|P1|COMPLETED|Overall Study||1248
8238470|NCT01945242|20315507|P2|STARTED|Overall Study||123
8238471|NCT01945242|20315508|P1|STARTED|Overall Study||1251
8238472|NCT01945216|20315523|P1|NOT COMPLETED|Overall Study||99
8238473|NCT01945216|20315523|P1|COMPLETED|Overall Study||3218
8238474|NCT01945216|20315523|P1|STARTED|Overall Study||3317
8238475|NCT01945138|20315537|P2|NOT COMPLETED|Overall Study||0
8238476|NCT01945138|20315538|P1|NOT COMPLETED|Overall Study||0
8238477|NCT01945138|20315537|P2|COMPLETED|Overall Study||7
8238478|NCT01945138|20315538|P1|COMPLETED|Overall Study||7
8238479|NCT01945138|20315537|P2|STARTED|Overall Study||7
8238480|NCT01945138|20315538|P1|STARTED|Overall Study||7
8238481|NCT01945112|20315572|P2|NOT COMPLETED|Overall Study||0
8238482|NCT01945112|20315573|P1|NOT COMPLETED|Overall Study||0
8238483|NCT01945112|20315572|P2|COMPLETED|Overall Study||51
8238484|NCT01945112|20315573|P1|COMPLETED|Overall Study||77
8238485|NCT01945112|20315572|P2|STARTED|Overall Study|total number of sites where tape was applied|51
8238486|NCT01945112|20315573|P1|STARTED|Overall Study|total number of sites where tape was applied|77
8238487|NCT01945086|20315581|P3|NOT COMPLETED|Overall Study||2
8238488|NCT01945086|20315582|P2|NOT COMPLETED|Overall Study||0
8238489|NCT01945086|20315583|P1|NOT COMPLETED|Overall Study||1
8238490|NCT01945086|20315581|P3|COMPLETED|Overall Study||26
8238491|NCT01945086|20315582|P2|COMPLETED|Overall Study||24
8238492|NCT01945086|20315583|P1|COMPLETED|Overall Study||26
8238493|NCT01945086|20315581|P3|STARTED|Overall Study||28
8238494|NCT01945086|20315582|P2|STARTED|Overall Study||24
8238495|NCT01945086|20315583|P1|STARTED|Overall Study||27
8238496|NCT01945034|20315627|P3|NOT COMPLETED|Overall Study||7
8238497|NCT01945034|20315628|P2|NOT COMPLETED|Overall Study||5
8238498|NCT01945034|20315629|P1|NOT COMPLETED|Overall Study||1
8238499|NCT01945034|20315627|P3|COMPLETED|Overall Study||145
8238500|NCT01945034|20315628|P2|COMPLETED|Overall Study||80
8238501|NCT01945034|20315629|P1|COMPLETED|Overall Study||66
8238502|NCT01945034|20315627|P3|STARTED|Overall Study||152
8238503|NCT01945034|20315628|P2|STARTED|Overall Study||85
8238504|NCT01945034|20315629|P1|STARTED|Overall Study||67
8238511|NCT01944969|20315693|P1|NOT COMPLETED|Overall Study||26
8238512|NCT01944969|20315693|P1|COMPLETED|Overall Study||0
8238513|NCT01944969|20315693|P1|STARTED|Overall Study||26
8238514|NCT01944930|20315706|P2|NOT COMPLETED|Overall Study||1
8238515|NCT01944930|20315707|P1|NOT COMPLETED|Overall Study||2
8238516|NCT01944930|20315706|P2|COMPLETED|Overall Study||10
8238517|NCT01944930|20315707|P1|COMPLETED|Overall Study||10
8238518|NCT01944930|20315706|P2|STARTED|Overall Study||11
8238519|NCT01944930|20315707|P1|STARTED|Overall Study||12
8238520|NCT01944878|20315715|P2|NOT COMPLETED|Overall Study||0
8238521|NCT01944878|20315716|P1|NOT COMPLETED|Overall Study||0
8238522|NCT01944878|20315715|P2|COMPLETED|Overall Study||328
8238523|NCT01944878|20315716|P1|COMPLETED|Overall Study||127
8238524|NCT01944878|20315715|P2|STARTED|Overall Study||328
8238525|NCT01944878|20315716|P1|STARTED|Overall Study||127
8238526|NCT01944839|20315726|P2|NOT COMPLETED|Overall Study||28
8238527|NCT01944839|20315727|P1|NOT COMPLETED|Overall Study||22
8238528|NCT01944839|20315726|P2|COMPLETED|Overall Study||282
8238529|NCT01944839|20315727|P1|COMPLETED|Overall Study||287
8238530|NCT01944839|20315726|P2|STARTED|Overall Study||310
8238531|NCT01944839|20315727|P1|STARTED|Overall Study||309
8238532|NCT01944774|20315736|P3|NOT COMPLETED|Overall Study||8
8238533|NCT01944774|20315737|P2|NOT COMPLETED|Overall Study||8
8238534|NCT01944774|20315738|P1|NOT COMPLETED|Overall Study||6
8238535|NCT01944774|20315736|P3|COMPLETED|Overall Study||62
8238536|NCT01944774|20315737|P2|COMPLETED|Overall Study||60
8238537|NCT01944774|20315738|P1|COMPLETED|Overall Study||63
8238538|NCT01944774|20315736|P3|Received Treatment|Overall Study||70
8238539|NCT01944774|20315737|P2|Received Treatment|Overall Study||67
8238540|NCT01944774|20315738|P1|Received Treatment|Overall Study||68
8238541|NCT01944774|20315736|P3|STARTED|Overall Study||70
8238542|NCT01944774|20315737|P2|STARTED|Overall Study||68
8238543|NCT01944774|20315738|P1|STARTED|Overall Study||69
8238544|NCT01944722|20315781|P1|NOT COMPLETED|Overall Study||9515
8238545|NCT01944722|20315781|P1|COMPLETED|Overall Study||24343
8238546|NCT01944722|20315781|P1|STARTED|Overall Study||33858
8238547|NCT01944670|20315815|P1|NOT COMPLETED|Overall Study||2
8238548|NCT01944670|20315815|P1|COMPLETED|Overall Study||24
8238549|NCT01944670|20315815|P1|STARTED|Overall Study||26
8238550|NCT01944644|20315822|P2|NOT COMPLETED|Overall Study||0
8238551|NCT01944644|20315823|P1|NOT COMPLETED|Overall Study||0
8238552|NCT01944644|20315822|P2|COMPLETED|Overall Study||32
8238553|NCT01944644|20315823|P1|COMPLETED|Overall Study||34
8238554|NCT01944644|20315822|P2|STARTED|Overall Study||32
8238555|NCT01944644|20315823|P1|STARTED|Overall Study||34
8238556|NCT01944631|20315837|P2|NOT COMPLETED|Overall Study||2
8238557|NCT01944631|20315838|P1|NOT COMPLETED|Overall Study||4
8238558|NCT01944631|20315837|P2|COMPLETED|Overall Study||98
8238559|NCT01944631|20315838|P1|COMPLETED|Overall Study||96
8238560|NCT01944631|20315837|P2|STARTED|Overall Study||100
8238561|NCT01944631|20315838|P1|STARTED|Overall Study||100
8238562|NCT01944462|20315854|P1|NOT COMPLETED|Optional Vaccination||0
8238563|NCT01944462|20315854|P1|COMPLETED|Optional Vaccination||20
8238564|NCT01944462|20315854|P1|STARTED|Optional Vaccination||20
8238565|NCT01944462|20315854|P1|NOT COMPLETED|PPPP Educational Program||60
8238566|NCT01944462|20315854|P1|COMPLETED|PPPP Educational Program||143
8238567|NCT01944462|20315854|P1|3 Month Follow-Up|PPPP Educational Program||143
8238568|NCT01944462|20315854|P1|Post-Test|PPPP Educational Program||187
8238569|NCT01944462|20315854|P1|Baseline|PPPP Educational Program||203
8238570|NCT01944462|20315854|P1|STARTED|PPPP Educational Program||203
8238571|NCT01944371|20315866|P3|NOT COMPLETED|Overall Study||0
8238572|NCT01944371|20315867|P2|NOT COMPLETED|Overall Study||0
8238573|NCT01944371|20315868|P1|NOT COMPLETED|Overall Study||0
8238574|NCT01944371|20315866|P3|COMPLETED|Overall Study||10
8238575|NCT01944371|20315867|P2|COMPLETED|Overall Study||10
8238576|NCT01944371|20315868|P1|COMPLETED|Overall Study||10
8238577|NCT01944371|20315866|P3|STARTED|Overall Study||10
8238578|NCT01944371|20315867|P2|STARTED|Overall Study||10
8238579|NCT01944371|20315868|P1|STARTED|Overall Study||10
8238580|NCT01944345|20315885|P1|NOT COMPLETED|Overall Study||0
8238581|NCT01944345|20315885|P1|COMPLETED|Overall Study||69
8238582|NCT01944345|20315885|P1|STARTED|Overall Study||69
8238583|NCT01944319|20315893|P2|NOT COMPLETED|Overall Study||0
8238584|NCT01944319|20315894|P1|NOT COMPLETED|Overall Study||0
8238585|NCT01944319|20315893|P2|COMPLETED|Overall Study||39
8238586|NCT01944319|20315894|P1|COMPLETED|Overall Study||40
8238587|NCT01944319|20315893|P2|STARTED|Overall Study||39
8238588|NCT01944319|20315894|P1|STARTED|Overall Study||40
8238589|NCT01944293|20315906|P2|NOT COMPLETED|Overall Study||0
8238590|NCT01944293|20315907|P1|NOT COMPLETED|Overall Study||0
8238591|NCT01944293|20315906|P2|COMPLETED|Overall Study||9
8238592|NCT01944293|20315907|P1|COMPLETED|Overall Study||7
8238593|NCT01944293|20315906|P2|STARTED|Overall Study||9
8238594|NCT01944293|20315907|P1|STARTED|Overall Study||7
8238595|NCT01944098|20315917|P2|NOT COMPLETED|Overall Study||0
8238596|NCT01944098|20315918|P1|NOT COMPLETED|Overall Study||1
8238597|NCT01944098|20315917|P2|COMPLETED|Overall Study||10
8238598|NCT01944098|20315918|P1|COMPLETED|Overall Study||9
8238599|NCT01944098|20315917|P2|STARTED|Overall Study||10
8238600|NCT01944098|20315918|P1|STARTED|Overall Study||10
8238601|NCT01944059|20315930|P1|NOT COMPLETED|Overall Study||7
8238602|NCT01944059|20315930|P1|COMPLETED|Overall Study||24
8238603|NCT01944059|20315930|P1|STARTED|Overall Study||31
8238604|NCT01944046|20315941|P2|NOT COMPLETED|Open Label Eligible and Consented||8
8238605|NCT01944046|20315942|P1|NOT COMPLETED|Open Label Eligible and Consented||14
8238606|NCT01944046|20315941|P2|COMPLETED|Open Label Eligible and Consented||116
8238607|NCT01944046|20315942|P1|COMPLETED|Open Label Eligible and Consented||110
8238608|NCT01944046|20315941|P2|STARTED|Open Label Eligible and Consented||124
8238609|NCT01944046|20315942|P1|STARTED|Open Label Eligible and Consented||124
8238610|NCT01944046|20315941|P2|NOT COMPLETED|Randomized to DB||19
8238611|NCT01944046|20315942|P1|NOT COMPLETED|Randomized to DB||21
8238612|NCT01944046|20315941|P2|COMPLETED|Randomized to DB||125
8238613|NCT01944046|20315942|P1|COMPLETED|Randomized to DB||125
8238614|NCT01944046|20315941|P2|STARTED|Randomized to DB||144
8238615|NCT01944046|20315942|P1|STARTED|Randomized to DB||146
8238616|NCT01943864|20315980|P1|NOT COMPLETED|Overall Study||0
8238617|NCT01943864|20315980|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
8238618|NCT01943864|20315980|P1|STARTED|Overall Study||20
8238619|NCT01943825|20316012|P4|NOT COMPLETED|Overall Study||11
8238620|NCT01943825|20316013|P3|NOT COMPLETED|Overall Study||15
8238621|NCT01943825|20316014|P2|NOT COMPLETED|Overall Study||4
8238622|NCT01943825|20316015|P1|NOT COMPLETED|Overall Study||10
8238623|NCT01943825|20316012|P4|COMPLETED|Overall Study||14
8238624|NCT01943825|20316013|P3|COMPLETED|Overall Study||10
8238625|NCT01943825|20316014|P2|COMPLETED|Overall Study||11
8238626|NCT01943825|20316015|P1|COMPLETED|Overall Study||15
8238627|NCT01943825|20316012|P4|STARTED|Overall Study||25
8238628|NCT01943825|20316013|P3|STARTED|Overall Study||25
8238629|NCT01943825|20316014|P2|STARTED|Overall Study||15
8238630|NCT01943825|20316015|P1|STARTED|Overall Study||25
8238631|NCT01943799|20316057|P4|NOT COMPLETED|Overall Study||0
8238632|NCT01943799|20316058|P3|NOT COMPLETED|Overall Study||2
8238633|NCT01943799|20316059|P2|NOT COMPLETED|Overall Study||3
8238634|NCT01943799|20316060|P1|NOT COMPLETED|Overall Study||5
8238635|NCT01943799|20316057|P4|COMPLETED|Overall Study||50
8238636|NCT01943799|20316058|P3|COMPLETED|Overall Study||49
8238637|NCT01943799|20316059|P2|COMPLETED|Overall Study||47
8238638|NCT01943799|20316060|P1|COMPLETED|Overall Study||22
8238639|NCT01943799|20316057|P4|STARTED|Overall Study||50
8238640|NCT01943799|20316058|P3|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
8238641|NCT01943799|20316059|P2|STARTED|Overall Study||50
8238642|NCT01943799|20316060|P1|STARTED|Overall Study||27
8238643|NCT01943591|20316100|P2|NOT COMPLETED|Overall Study||11
8238644|NCT01943591|20316101|P1|NOT COMPLETED|Overall Study||5
8238645|NCT01943591|20316100|P2|COMPLETED|Overall Study||95
8238646|NCT01943591|20316101|P1|COMPLETED|Overall Study||99
8238647|NCT01943591|20316100|P2|STARTED|Overall Study||106
8238648|NCT01943591|20316101|P1|STARTED|Overall Study||104
8238649|NCT01943565|20316126|P3|NOT COMPLETED|Overall Study||0
8238650|NCT01943565|20316127|P2|NOT COMPLETED|Overall Study||0
8238651|NCT01943565|20316128|P1|NOT COMPLETED|Overall Study||0
8238652|NCT01943565|20316126|P3|COMPLETED|Overall Study||9
8238653|NCT01943565|20316127|P2|COMPLETED|Overall Study||9
8238654|NCT01943565|20316128|P1|COMPLETED|Overall Study||11
8238655|NCT01943565|20316126|P3|STARTED|Overall Study||9
8238656|NCT01943565|20316127|P2|STARTED|Overall Study||9
8238657|NCT01943565|20316128|P1|STARTED|Overall Study||11
8238658|NCT01943552|20316159|P2|NOT COMPLETED|Overall Study||25
8238659|NCT01943552|20316160|P1|NOT COMPLETED|Overall Study||25
8238660|NCT01943552|20316159|P2|COMPLETED|Overall Study||69
8238661|NCT01943552|20316160|P1|COMPLETED|Overall Study||71
8238662|NCT01943552|20316159|P2|STARTED|Overall Study||94
8238663|NCT01943552|20316160|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
8238664|NCT01943539|20316176|P2|NOT COMPLETED|Overall Study||0
8238665|NCT01943539|20316177|P1|NOT COMPLETED|Overall Study||4
8238666|NCT01943539|20316176|P2|COMPLETED|Overall Study||40
8238667|NCT01943539|20316177|P1|COMPLETED|Overall Study||40
8238668|NCT01943539|20316176|P2|STARTED|Overall Study||40
8238669|NCT01943539|20316177|P1|STARTED|Overall Study||44
8238670|NCT01943474|20316188|P2|NOT COMPLETED|Overall Study||0
8238671|NCT01943474|20316189|P1|NOT COMPLETED|Overall Study||0
8238672|NCT01943474|20316188|P2|COMPLETED|Overall Study||125
8238673|NCT01943474|20316189|P1|COMPLETED|Overall Study||123
8238674|NCT01943474|20316188|P2|STARTED|Overall Study||125
8238675|NCT01943474|20316189|P1|STARTED|Overall Study||123
8238676|NCT01943461|20316214|P4|NOT COMPLETED|Overall Study||0
8238677|NCT01943461|20316215|P3|NOT COMPLETED|Overall Study||0
8238678|NCT01943461|20316216|P2|NOT COMPLETED|Overall Study||0
8238679|NCT01943461|20316217|P1|NOT COMPLETED|Overall Study||0
8238680|NCT01943461|20316214|P4|COMPLETED|Overall Study||40
8238681|NCT01943461|20316215|P3|COMPLETED|Overall Study||6
8238682|NCT01943461|20316216|P2|COMPLETED|Overall Study||6
8238683|NCT01943461|20316217|P1|COMPLETED|Overall Study||5
8238684|NCT01943461|20316214|P4|STARTED|Overall Study||40
8238685|NCT01943461|20316215|P3|STARTED|Overall Study||6
8238686|NCT01943461|20316216|P2|STARTED|Overall Study||6
8238687|NCT01943461|20316217|P1|STARTED|Overall Study||5
8238688|NCT01943435|20316274|P3|NOT COMPLETED|6 Month Follow up||15
8238689|NCT01943435|20316275|P2|NOT COMPLETED|6 Month Follow up||7
8238690|NCT01943435|20316276|P1|NOT COMPLETED|6 Month Follow up||12
8238691|NCT01943435|20316274|P3|COMPLETED|6 Month Follow up||65
8238692|NCT01943435|20316275|P2|COMPLETED|6 Month Follow up||59
8238693|NCT01943435|20316276|P1|COMPLETED|6 Month Follow up||67
8238694|NCT01943435|20316274|P3|STARTED|6 Month Follow up||80
8238695|NCT01943435|20316275|P2|STARTED|6 Month Follow up||66
8238696|NCT01943435|20316276|P1|STARTED|6 Month Follow up||79
8238697|NCT01943435|20316274|P3|NOT COMPLETED|2 Month Follow up||0
8238698|NCT01943435|20316275|P2|NOT COMPLETED|2 Month Follow up||3
8238699|NCT01943435|20316276|P1|NOT COMPLETED|2 Month Follow up||2
8238700|NCT01943435|20316274|P3|COMPLETED|2 Month Follow up||80
8238701|NCT01943435|20316275|P2|COMPLETED|2 Month Follow up||66
8238702|NCT01943435|20316276|P1|COMPLETED|2 Month Follow up||79
8238703|NCT01943435|20316274|P3|STARTED|2 Month Follow up||80
8238704|NCT01943435|20316275|P2|STARTED|2 Month Follow up||69
8238705|NCT01943435|20316276|P1|STARTED|2 Month Follow up||81
8238706|NCT01943435|20316274|P3|NOT COMPLETED|Intervention Period||4
8238707|NCT01943435|20316275|P2|NOT COMPLETED|Intervention Period||3
8238708|NCT01943435|20316276|P1|NOT COMPLETED|Intervention Period||3
8238709|NCT01943435|20316274|P3|COMPLETED|Intervention Period||80
8238710|NCT01943435|20316275|P2|COMPLETED|Intervention Period||69
8238711|NCT01943435|20316276|P1|COMPLETED|Intervention Period||81
8238712|NCT01943435|20316274|P3|STARTED|Intervention Period||84
8238713|NCT01943435|20316275|P2|STARTED|Intervention Period||72
8238714|NCT01943435|20316276|P1|STARTED|Intervention Period||84
8238715|NCT01943435|20316274|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
8238716|NCT01943435|20316275|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
8238717|NCT01943435|20316276|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
8238718|NCT01943435|20316274|P3|COMPLETED|Baseline Eligibility and Randomization||84
8238719|NCT01943435|20316275|P2|COMPLETED|Baseline Eligibility and Randomization||72
8238720|NCT01943435|20316276|P1|COMPLETED|Baseline Eligibility and Randomization||84
8238721|NCT01943435|20316274|P3|STARTED|Baseline Eligibility and Randomization||87
8238722|NCT01943435|20316275|P2|STARTED|Baseline Eligibility and Randomization||84
8238723|NCT01943435|20316276|P1|STARTED|Baseline Eligibility and Randomization||88
8238724|NCT01943344|20316290|P1|NOT COMPLETED|Overall Study||3
8238725|NCT01943344|20316290|P1|COMPLETED|Overall Study||9
8238726|NCT01943344|20316290|P1|STARTED|Overall Study||12
8238727|NCT01943292|20316299|P3|NOT COMPLETED|Overall Study||0
8238728|NCT01943292|20316300|P2|NOT COMPLETED|Overall Study||0
8238729|NCT01943292|20316301|P1|NOT COMPLETED|Overall Study||1
8238730|NCT01943292|20316299|P3|COMPLETED|Overall Study||3
8238731|NCT01943292|20316300|P2|COMPLETED|Overall Study||3
8238732|NCT01943292|20316301|P1|COMPLETED|Overall Study||2
8238733|NCT01943292|20316299|P3|Completed Follow-Up|Overall Study||3
8238734|NCT01943292|20316300|P2|Completed Follow-Up|Overall Study||3
8238735|NCT01943292|20316301|P1|Completed Follow-Up|Overall Study||2
8238736|NCT01943292|20316299|P3|Completed Treatment|Overall Study||3
8238737|NCT01943292|20316300|P2|Completed Treatment|Overall Study||3
8238738|NCT01943292|20316301|P1|Completed Treatment|Overall Study||3
8238739|NCT01943292|20316299|P3|Completed Cycle 1|Overall Study||3
8238740|NCT01943292|20316300|P2|Completed Cycle 1|Overall Study||3
8238741|NCT01943292|20316301|P1|Completed Cycle 1|Overall Study||3
8238742|NCT01943292|20316299|P3|STARTED|Overall Study||3
8238743|NCT01943292|20316300|P2|STARTED|Overall Study||3
8238744|NCT01943292|20316301|P1|STARTED|Overall Study||3
8238745|NCT01943227|20316314|P2|NOT COMPLETED|Overall Study||0
8238746|NCT01943227|20316315|P1|NOT COMPLETED|Overall Study||0
8238747|NCT01943227|20316314|P2|COMPLETED|Overall Study||10
8238748|NCT01943227|20316315|P1|COMPLETED|Overall Study||10
8238749|NCT01943227|20316314|P2|STARTED|Overall Study||10
8238750|NCT01943227|20316315|P1|STARTED|Overall Study||10
8238751|NCT01943110|20316321|P1|NOT COMPLETED|Overall Study||0
8238752|NCT01943110|20316321|P1|COMPLETED|Overall Study||30
8238753|NCT01943110|20316321|P1|STARTED|Overall Study||30
8238754|NCT01942993|20316337|P1|NOT COMPLETED|Overall Study||2
8238755|NCT01942993|20316337|P1|COMPLETED|Overall Study||1
8238756|NCT01942993|20316337|P1|STARTED|Overall Study||3
8238757|NCT01942785|20316354|P1|NOT COMPLETED|Overall Study||4
8238758|NCT01942785|20316354|P1|COMPLETED|Overall Study||50
8238759|NCT01942785|20316354|P1|STARTED|Overall Study||54
8238760|NCT01942733|20316383|P1|NOT COMPLETED|Overall Study||3
8238761|NCT01942733|20316383|P1|COMPLETED|Overall Study||41
8238762|NCT01942733|20316383|P1|STARTED|Overall Study||44
8238763|NCT01942720|20316412|P1|NOT COMPLETED|Overall Study||21
8238764|NCT01942720|20316412|P1|COMPLETED|Overall Study||53
8238765|NCT01942720|20316412|P1|STARTED|Overall Study||74
8238766|NCT01942707|20316422|P2|NOT COMPLETED|Overall Study||0
8238767|NCT01942707|20316423|P1|NOT COMPLETED|Overall Study||0
8238768|NCT01942707|20316422|P2|COMPLETED|Overall Study||23
8238769|NCT01942707|20316423|P1|COMPLETED|Overall Study||23
8238770|NCT01942707|20316422|P2|STARTED|Overall Study||23
8238771|NCT01942707|20316423|P1|STARTED|Overall Study||23
8238772|NCT01942694|20316435|P2|NOT COMPLETED|Overall Study||0
8238773|NCT01942694|20316436|P1|NOT COMPLETED|Overall Study||1
8238774|NCT01942694|20316435|P2|COMPLETED|Overall Study||1211
8238775|NCT01942694|20316436|P1|COMPLETED|Overall Study||1211
8238776|NCT01942694|20316435|P2|STARTED|Overall Study||1211
8238777|NCT01942694|20316436|P1|STARTED|Overall Study||1212
8238778|NCT01942668|20316461|P5|NOT COMPLETED|Overall Study||59
8238779|NCT01942668|20316462|P4|NOT COMPLETED|Overall Study||146
8238780|NCT01942668|20316463|P3|NOT COMPLETED|Overall Study||110
8238781|NCT01942668|20316464|P2|NOT COMPLETED|Overall Study||121
8238782|NCT01942668|20316465|P1|NOT COMPLETED|Overall Study||134
8238783|NCT01942668|20316461|P5|COMPLETED|Overall Study||93
8238784|NCT01942668|20316462|P4|COMPLETED|Overall Study||281
8238785|NCT01942668|20316463|P3|COMPLETED|Overall Study||312
8238786|NCT01942668|20316464|P2|COMPLETED|Overall Study||305
8238787|NCT01942668|20316465|P1|COMPLETED|Overall Study||284
8238788|NCT01942668|20316461|P5|STARTED|Overall Study||152
8238789|NCT01942668|20316462|P4|STARTED|Overall Study||427
8238790|NCT01942668|20316463|P3|STARTED|Overall Study||422
8238791|NCT01942668|20316464|P2|STARTED|Overall Study||426
8238792|NCT01942668|20316465|P1|STARTED|Overall Study||418
8238793|NCT01942590|20317524|P2|NOT COMPLETED|Overall Study||1
8238794|NCT01942590|20317525|P1|NOT COMPLETED|Overall Study||1
8238795|NCT01942590|20317524|P2|COMPLETED|Overall Study||4
8238796|NCT01942590|20317525|P1|COMPLETED|Overall Study||7
8238797|NCT01942590|20317524|P2|STARTED|Overall Study||5
8238798|NCT01942590|20317525|P1|STARTED|Overall Study||8
8238799|NCT01942486|20317555|P1|NOT COMPLETED|Overall Study||27
8238800|NCT01942486|20317555|P1|COMPLETED|Overall Study||8
8238801|NCT01942486|20317555|P1|STARTED|Overall Study||35
8238802|NCT01942161|20317562|P3|NOT COMPLETED|Overall Study||6
8238803|NCT01942161|20317563|P2|NOT COMPLETED|Overall Study||6
8238804|NCT01942161|20317564|P1|NOT COMPLETED|Overall Study||8
8238805|NCT01942161|20317562|P3|COMPLETED|Overall Study||35
8238806|NCT01942161|20317563|P2|COMPLETED|Overall Study||24
8238807|NCT01942161|20317564|P1|COMPLETED|Overall Study||27
8238808|NCT01942161|20317562|P3|STARTED|Overall Study||41
8238809|NCT01942161|20317563|P2|STARTED|Overall Study||30
8238810|NCT01942161|20317564|P1|STARTED|Overall Study||35
8238811|NCT01942148|20317584|P1|NOT COMPLETED|Overall Study||27
8238812|NCT01942148|20317584|P1|COMPLETED|Overall Study||41
8238813|NCT01942148|20317584|P1|STARTED|Overall Study||68
8238814|NCT01942135|20317592|P2|NOT COMPLETED|Overall Study||174
8238815|NCT01942135|20317593|P1|NOT COMPLETED|Overall Study||347
8238816|NCT01942135|20317592|P2|COMPLETED|Overall Study||0
8238817|NCT01942135|20317593|P1|COMPLETED|Overall Study||0
8238818|NCT01942135|20317592|P2|STARTED|Overall Study||174
8238819|NCT01942135|20317593|P1|STARTED|Overall Study||347
8238820|NCT01941940|20317630|P1|NOT COMPLETED|Overall Study||33
8238821|NCT01941940|20317630|P1|COMPLETED|Overall Study||194
8238822|NCT01941940|20317630|P1|STARTED|Overall Study||227
8238823|NCT01941927|20317672|P2|NOT COMPLETED|Overall Study||0
8238824|NCT01941927|20317673|P1|NOT COMPLETED|Overall Study||0
8238825|NCT01941927|20317672|P2|COMPLETED|Overall Study||10
8238826|NCT01941927|20317673|P1|COMPLETED|Overall Study||10
8238827|NCT01941927|20317672|P2|STARTED|Overall Study||10
8238828|NCT01941927|20317673|P1|STARTED|Overall Study||10
8238829|NCT01941745|20317689|P4|NOT COMPLETED|Overall Study||0
8238830|NCT01941745|20317690|P3|NOT COMPLETED|Overall Study||0
8238831|NCT01941745|20317691|P2|NOT COMPLETED|Overall Study||0
8238832|NCT01941745|20317692|P1|NOT COMPLETED|Overall Study||0
8238833|NCT01941745|20317689|P4|COMPLETED|Overall Study||23
8238834|NCT01941745|20317690|P3|COMPLETED|Overall Study||21
8238835|NCT01941745|20317691|P2|COMPLETED|Overall Study||22
8238836|NCT01941745|20317692|P1|COMPLETED|Overall Study||22
8238837|NCT01941745|20317689|P4|STARTED|Overall Study||23
8238838|NCT01941745|20317690|P3|STARTED|Overall Study||21
8238839|NCT01941745|20317691|P2|STARTED|Overall Study||22
8238840|NCT01941745|20317692|P1|STARTED|Overall Study||22
8238841|NCT01941628|20317716|P2|NOT COMPLETED|Overall Study||0
8238842|NCT01941628|20317717|P1|NOT COMPLETED|Overall Study||1
8238843|NCT01941628|20317716|P2|COMPLETED|Overall Study||45
8238844|NCT01941628|20317717|P1|COMPLETED|Overall Study||45
8238845|NCT01941628|20317716|P2|STARTED|Overall Study||45
8238846|NCT01941628|20317717|P1|STARTED|Overall Study||46
8238847|NCT01941615|20317727|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
8238848|NCT01941615|20317727|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
8238849|NCT01941615|20317727|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
8238850|NCT01941615|20317727|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
8238851|NCT01941615|20317727|P1|COMPLETED|Reference Treatment: Microgynon®||0
8238852|NCT01941615|20317727|P1|STARTED|Reference Treatment: Microgynon®||0
8238853|NCT01941615|20317727|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
8238854|NCT01941615|20317727|P1|COMPLETED|Run in Treatment: Microgynon®||16
8238855|NCT01941615|20317727|P1|STARTED|Run in Treatment: Microgynon®||16
8238856|NCT01941537|20317738|P2|NOT COMPLETED|Overall Study||3
8238857|NCT01941537|20317739|P1|NOT COMPLETED|Overall Study||4
8238858|NCT01941537|20317738|P2|COMPLETED|Overall Study||17
8238859|NCT01941537|20317739|P1|COMPLETED|Overall Study||36
8238860|NCT01941537|20317738|P2|STARTED|Overall Study||20
8238861|NCT01941537|20317739|P1|STARTED|Overall Study||40
8238862|NCT01941498|20317751|P1|NOT COMPLETED|Overall Study||1
8238863|NCT01941498|20317751|P1|COMPLETED|Overall Study||96
8238864|NCT01941498|20317751|P1|STARTED|Overall Study||97
8238865|NCT01941485|20317797|P1|NOT COMPLETED|Overall Study||0
8238866|NCT01941485|20317797|P1|COMPLETED|Overall Study||59
8238867|NCT01941485|20317797|P1|STARTED|Overall Study||59
8238868|NCT01941472|20317863|P1|NOT COMPLETED|Overall Study||0
8238869|NCT01941472|20317863|P1|COMPLETED|Overall Study||40
8238870|NCT01941472|20317863|P1|STARTED|Overall Study||40
8238871|NCT01941186|20317869|P2|NOT COMPLETED|Follow-up||0
8238872|NCT01941186|20317870|P1|NOT COMPLETED|Follow-up||1
8238873|NCT01941186|20317869|P2|COMPLETED|Follow-up||33
8238874|NCT01941186|20317870|P1|COMPLETED|Follow-up||30
8238875|NCT01941186|20317869|P2|STARTED|Follow-up||33
8238876|NCT01941186|20317870|P1|STARTED|Follow-up||31
8238877|NCT01941186|20317869|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
8238878|NCT01941186|20317870|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
8238879|NCT01941186|20317869|P2|COMPLETED|Randomization/Allocation to Study Group||33
8238880|NCT01941186|20317870|P1|COMPLETED|Randomization/Allocation to Study Group||31
8238881|NCT01941186|20317869|P2|STARTED|Randomization/Allocation to Study Group||33
8238882|NCT01941186|20317870|P1|STARTED|Randomization/Allocation to Study Group||31
8238883|NCT01941095|20317896|P1|NOT COMPLETED|Overall Study||56
8238884|NCT01941095|20317896|P1|COMPLETED|Overall Study||41
8238885|NCT01941095|20317896|P1|STARTED|Overall Study||97
8238886|NCT01941030|20317921|P2|NOT COMPLETED|Overall Study||13
8238887|NCT01941030|20317922|P1|NOT COMPLETED|Overall Study||13
8238888|NCT01941030|20317921|P2|COMPLETED|Overall Study||13
8238889|NCT01941030|20317922|P1|COMPLETED|Overall Study||12
8238890|NCT01941030|20317921|P2|STARTED|Overall Study||26
8238891|NCT01941030|20317922|P1|STARTED|Overall Study||25
8238892|NCT01940939|20317944|P2|NOT COMPLETED|Overall Study||8
8238893|NCT01940939|20317945|P1|NOT COMPLETED|Overall Study||2
8238894|NCT01940939|20317944|P2|COMPLETED|Overall Study||27
8238895|NCT01940939|20317945|P1|COMPLETED|Overall Study||33
8238896|NCT01940939|20317944|P2|STARTED|Overall Study||35
8238897|NCT01940939|20317945|P1|STARTED|Overall Study||35
8238898|NCT01940900|20317957|P2|NOT COMPLETED|Overall Study||31
8238899|NCT01940900|20317958|P1|NOT COMPLETED|Overall Study||29
8238900|NCT01940900|20317957|P2|COMPLETED|Overall Study||284
8238901|NCT01940900|20317958|P1|COMPLETED|Overall Study||282
8238902|NCT01940900|20317957|P2|STARTED|Overall Study||315
8238903|NCT01940900|20317958|P1|STARTED|Overall Study||311
8238904|NCT01940887|20317966|P2|NOT COMPLETED|Year 2||222
8238905|NCT01940887|20317967|P1|NOT COMPLETED|Year 2||217
8238906|NCT01940887|20317966|P2|COMPLETED|Year 2||75
8238907|NCT01940887|20317967|P1|COMPLETED|Year 2||66
8238908|NCT01940887|20317966|P2|STARTED|Year 2||297
8238909|NCT01940887|20317967|P1|STARTED|Year 2||283
8238910|NCT01940887|20317966|P2|NOT COMPLETED|Year 1||23
8238911|NCT01940887|20317967|P1|NOT COMPLETED|Year 1||39
8238912|NCT01940887|20317966|P2|COMPLETED|Year 1||297
8238913|NCT01940887|20317967|P1|COMPLETED|Year 1||283
8238914|NCT01940887|20317966|P2|STARTED|Year 1||320
8238915|NCT01940887|20317967|P1|STARTED|Year 1||322
8238916|NCT01940705|20317977|P4|NOT COMPLETED|Overall Study||4
8238917|NCT01940705|20317978|P3|NOT COMPLETED|Overall Study||8
8238918|NCT01940705|20317979|P2|NOT COMPLETED|Overall Study||8
8238919|NCT01940705|20317980|P1|NOT COMPLETED|Overall Study||4
8238920|NCT01940705|20317977|P4|COMPLETED|Overall Study||63
8238921|NCT01940705|20317978|P3|COMPLETED|Overall Study||61
8238922|NCT01940705|20317979|P2|COMPLETED|Overall Study||59
8238923|NCT01940705|20317980|P1|COMPLETED|Overall Study||62
8238924|NCT01940705|20317977|P4|STARTED|Overall Study||67
8238925|NCT01940705|20317978|P3|STARTED|Overall Study||69
8238926|NCT01940705|20317979|P2|STARTED|Overall Study||67
8238927|NCT01940705|20317980|P1|STARTED|Overall Study||66
8238928|NCT01940523|20318000|P2|NOT COMPLETED|Overall Study||0
8238929|NCT01940523|20318001|P1|NOT COMPLETED|Overall Study||0
8238930|NCT01940523|20318000|P2|COMPLETED|Overall Study||320
8238931|NCT01940523|20318001|P1|COMPLETED|Overall Study||320
8238932|NCT01940523|20318000|P2|STARTED|Overall Study||320
8238933|NCT01940523|20318001|P1|STARTED|Overall Study||320
8238934|NCT01940510|20318011|P1|NOT COMPLETED|Overall Study||0
8238935|NCT01940510|20318011|P1|COMPLETED|Overall Study||24
8238936|NCT01940510|20318011|P1|STARTED|Overall Study||24
8238937|NCT01940497|20318044|P2|NOT COMPLETED|Overall Study||18
8238938|NCT01940497|20318045|P1|NOT COMPLETED|Overall Study||21
8238939|NCT01940497|20318044|P2|COMPLETED|Overall Study||101
8238940|NCT01940497|20318045|P1|COMPLETED|Overall Study||100
8238941|NCT01940497|20318044|P2|Treated: Neoadjuvant|Overall Study||21
8238942|NCT01940497|20318045|P1|Treated: Neoadjuvant|Overall Study||20
8238943|NCT01940497|20318044|P2|Treated: Adjuvant|Overall Study||92
8238944|NCT01940497|20318045|P1|Treated: Adjuvant|Overall Study||95
8238945|NCT01940497|20318044|P2|Treated|Overall Study||113
8238946|NCT01940497|20318045|P1|Treated|Overall Study||115
8238947|NCT01940497|20318044|P2|STARTED|Overall Study||119
8238948|NCT01940497|20318045|P1|STARTED|Overall Study||121
8238949|NCT01940484|20318086|P1|NOT COMPLETED|Overall Study||10
8238950|NCT01940484|20318086|P1|COMPLETED|Overall Study||88
8238951|NCT01940484|20318086|P1|STARTED|Overall Study||98
8238964|NCT01940354|20318125|P2|NOT COMPLETED|Overall Study||2
8238965|NCT01940354|20318126|P1|NOT COMPLETED|Overall Study||4
8238966|NCT01940354|20318125|P2|COMPLETED|Overall Study||108
8238967|NCT01940354|20318126|P1|COMPLETED|Overall Study||106
8238968|NCT01940354|20318125|P2|STARTED|Overall Study||110
8238969|NCT01940354|20318126|P1|STARTED|Overall Study||110
8238970|NCT01940341|20318138|P2|NOT COMPLETED|Open-label Extension Phase||1
8238971|NCT01940341|20318139|P1|NOT COMPLETED|Open-label Extension Phase||4
8238972|NCT01940341|20318138|P2|COMPLETED|Open-label Extension Phase||0
8238973|NCT01940341|20318139|P1|COMPLETED|Open-label Extension Phase||0
8238974|NCT01940341|20318138|P2|STARTED|Open-label Extension Phase||1
8238975|NCT01940341|20318139|P1|STARTED|Open-label Extension Phase||4
8238976|NCT01940341|20318138|P2|NOT COMPLETED|Double-Blind Phase||140
8238977|NCT01940341|20318139|P1|NOT COMPLETED|Double-Blind Phase||281
8238978|NCT01940341|20318138|P2|COMPLETED|Double-Blind Phase||1
8238979|NCT01940341|20318139|P1|COMPLETED|Double-Blind Phase||4
8238980|NCT01940341|20318138|P2|STARTED|Double-Blind Phase||141
8238981|NCT01940341|20318139|P1|STARTED|Double-Blind Phase||285
8238982|NCT01940276|20318155|P2|NOT COMPLETED|Overall Study||0
8238983|NCT01940276|20318156|P1|NOT COMPLETED|Overall Study||0
8238984|NCT01940276|20318155|P2|COMPLETED|Overall Study||50
8238985|NCT01940276|20318156|P1|COMPLETED|Overall Study||50
8238986|NCT01940276|20318155|P2|STARTED|Overall Study||50
8238987|NCT01940276|20318156|P1|STARTED|Overall Study||50
8238988|NCT01940146|20318176|P4|NOT COMPLETED|Overall Study||2
8238989|NCT01940146|20318177|P3|NOT COMPLETED|Overall Study||1
8238990|NCT01940146|20318178|P2|NOT COMPLETED|Overall Study||0
8238991|NCT01940146|20318179|P1|NOT COMPLETED|Overall Study||1
8238992|NCT01940146|20318176|P4|COMPLETED|Overall Study||53
8238993|NCT01940146|20318177|P3|COMPLETED|Overall Study||55
8238994|NCT01940146|20318178|P2|COMPLETED|Overall Study||55
8238995|NCT01940146|20318179|P1|COMPLETED|Overall Study||55
8238996|NCT01940146|20318176|P4|STARTED|Overall Study||55
8238997|NCT01940146|20318177|P3|STARTED|Overall Study||56
8238998|NCT01940146|20318178|P2|STARTED|Overall Study||55
8238999|NCT01940146|20318179|P1|STARTED|Overall Study||56
8239000|NCT01940120|20318189|P1|NOT COMPLETED|Overall Study||48
8239001|NCT01940120|20318189|P1|COMPLETED|Overall Study||30
8239002|NCT01940120|20318189|P1|STARTED|Overall Study||78
8239003|NCT01939977|20318345|P2|NOT COMPLETED|Overall Study||7
8239004|NCT01939977|20318346|P1|NOT COMPLETED|Overall Study||9
8239005|NCT01939977|20318345|P2|COMPLETED|Overall Study||41
8239006|NCT01939977|20318346|P1|COMPLETED|Overall Study||37
8239007|NCT01939977|20318345|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
8239008|NCT01939977|20318346|P1|STARTED|Overall Study||46
8239009|NCT01939938|20318382|P1|NOT COMPLETED|Overall Study||0
8239010|NCT01939938|20318382|P1|COMPLETED|Overall Study||10
8239011|NCT01939938|20318382|P1|STARTED|Overall Study||10
8239012|NCT01939899|20318393|P5|NOT COMPLETED|Phase 2||1
8239013|NCT01939899|20318394|P4|NOT COMPLETED|Phase 2||11
8239014|NCT01939899|20318395|P3|NOT COMPLETED|Phase 2||0
8239015|NCT01939899|20318396|P2|NOT COMPLETED|Phase 2||0
8239016|NCT01939899|20318397|P1|NOT COMPLETED|Phase 2||0
8239017|NCT01939899|20318393|P5|COMPLETED|Phase 2||0
8239018|NCT01939899|20318394|P4|COMPLETED|Phase 2||1
8239019|NCT01939899|20318395|P3|COMPLETED|Phase 2||0
8239020|NCT01939899|20318396|P2|COMPLETED|Phase 2||0
8239021|NCT01939899|20318397|P1|COMPLETED|Phase 2||0
8239022|NCT01939899|20318393|P5|STARTED|Phase 2||1
8239023|NCT01939899|20318394|P4|STARTED|Phase 2||12
8239024|NCT01939899|20318395|P3|STARTED|Phase 2||0
8239025|NCT01939899|20318396|P2|STARTED|Phase 2||0
8239026|NCT01939899|20318397|P1|STARTED|Phase 2||0
8239027|NCT01939899|20318393|P5|NOT COMPLETED|Lead-in Dose Finding Phase||0
8239028|NCT01939899|20318394|P4|NOT COMPLETED|Lead-in Dose Finding Phase||0
8239029|NCT01939899|20318395|P3|NOT COMPLETED|Lead-in Dose Finding Phase||5
8239030|NCT01939899|20318396|P2|NOT COMPLETED|Lead-in Dose Finding Phase||7
8239031|NCT01939899|20318397|P1|NOT COMPLETED|Lead-in Dose Finding Phase||2
8239032|NCT01939899|20318393|P5|COMPLETED|Lead-in Dose Finding Phase||0
8239033|NCT01939899|20318394|P4|COMPLETED|Lead-in Dose Finding Phase||0
8239034|NCT01939899|20318395|P3|COMPLETED|Lead-in Dose Finding Phase||1
8239035|NCT01939899|20318396|P2|COMPLETED|Lead-in Dose Finding Phase||0
8239036|NCT01939899|20318397|P1|COMPLETED|Lead-in Dose Finding Phase||1
8239037|NCT01939899|20318393|P5|STARTED|Lead-in Dose Finding Phase||0
8239038|NCT01939899|20318394|P4|STARTED|Lead-in Dose Finding Phase||0
8239039|NCT01939899|20318395|P3|STARTED|Lead-in Dose Finding Phase||6
8239040|NCT01939899|20318396|P2|STARTED|Lead-in Dose Finding Phase||7
8239041|NCT01939899|20318397|P1|STARTED|Lead-in Dose Finding Phase||3
8239042|NCT01939548|20318444|P3|NOT COMPLETED|Overall Study||30
8239043|NCT01939548|20318445|P2|NOT COMPLETED|Overall Study||49
8239044|NCT01939548|20318446|P1|NOT COMPLETED|Overall Study||37
8239045|NCT01939548|20318444|P3|COMPLETED|Overall Study||50
8239046|NCT01939548|20318445|P2|COMPLETED|Overall Study||33
8239047|NCT01939548|20318446|P1|COMPLETED|Overall Study||41
8239048|NCT01939548|20318444|P3|STARTED|Overall Study||80
8239049|NCT01939548|20318445|P2|STARTED|Overall Study||82
8239050|NCT01939548|20318446|P1|STARTED|Overall Study||78
8239051|NCT01939496|20318520|P3|NOT COMPLETED|Overall Study||2
8239052|NCT01939496|20318521|P2|NOT COMPLETED|Overall Study||3
8239053|NCT01939496|20318522|P1|NOT COMPLETED|Overall Study||9
8239054|NCT01939496|20318520|P3|COMPLETED|Overall Study||54
8239055|NCT01939496|20318521|P2|COMPLETED|Overall Study||54
8239056|NCT01939496|20318522|P1|COMPLETED|Overall Study||47
8239057|NCT01939496|20318520|P3|STARTED|Overall Study||56
8239058|NCT01939496|20318521|P2|STARTED|Overall Study||57
8239059|NCT01939496|20318522|P1|STARTED|Overall Study||56
8239060|NCT01939405|20318574|P2|NOT COMPLETED|Overall Study||2
8239061|NCT01939405|20318575|P1|NOT COMPLETED|Overall Study||3
8239062|NCT01939405|20318574|P2|COMPLETED|Overall Study||28
8239063|NCT01939405|20318575|P1|COMPLETED|Overall Study||27
8239064|NCT01939405|20318574|P2|STARTED|Overall Study||30
8239065|NCT01939405|20318575|P1|STARTED|Overall Study||30
8239066|NCT01939366|20318592|P5|NOT COMPLETED|Overall Study||18
8239067|NCT01939366|20318593|P4|NOT COMPLETED|Overall Study||17
8239068|NCT01939366|20318594|P3|NOT COMPLETED|Overall Study||38
8239069|NCT01939366|20318595|P2|NOT COMPLETED|Overall Study||23
8239070|NCT01939366|20318596|P1|NOT COMPLETED|Overall Study||14
8239071|NCT01939366|20318592|P5|COMPLETED|Overall Study||48
8239072|NCT01939366|20318593|P4|COMPLETED|Overall Study||51
8239073|NCT01939366|20318594|P3|COMPLETED|Overall Study||27
8239074|NCT01939366|20318595|P2|COMPLETED|Overall Study||41
8239075|NCT01939366|20318596|P1|COMPLETED|Overall Study||52
8239076|NCT01939366|20318592|P5|Per Protocol Set|Overall Study||49
8239077|NCT01939366|20318593|P4|Per Protocol Set|Overall Study||51
8239078|NCT01939366|20318594|P3|Per Protocol Set|Overall Study||50
8239079|NCT01939366|20318595|P2|Per Protocol Set|Overall Study||55
8239080|NCT01939366|20318596|P1|Per Protocol Set|Overall Study||58
8239081|NCT01939366|20318592|P5|Full Analysis Set|Overall Study||62
8239082|NCT01939366|20318593|P4|Full Analysis Set|Overall Study||65
8239083|NCT01939366|20318594|P3|Full Analysis Set|Overall Study||61
8239084|NCT01939366|20318595|P2|Full Analysis Set|Overall Study||60
8239085|NCT01939366|20318596|P1|Full Analysis Set|Overall Study||64
8239086|NCT01939366|20318592|P5|Safety Set|Overall Study||62
8239087|NCT01939366|20318593|P4|Safety Set|Overall Study||65
8239088|NCT01939366|20318594|P3|Safety Set|Overall Study||62
8239089|NCT01939366|20318595|P2|Safety Set|Overall Study||61
8239090|NCT01939366|20318596|P1|Safety Set|Overall Study||64
8239091|NCT01939366|20318592|P5|Allocated Set Excl. Non-compliant Sites|Overall Study||63
8239092|NCT01939366|20318593|P4|Allocated Set Excl. Non-compliant Sites|Overall Study||65
8239093|NCT01939366|20318594|P3|Allocated Set Excl. Non-compliant Sites|Overall Study||63
8239094|NCT01939366|20318595|P2|Allocated Set Excl. Non-compliant Sites|Overall Study||61
8239095|NCT01939366|20318596|P1|Allocated Set Excl. Non-compliant Sites|Overall Study||64
8239096|NCT01939366|20318592|P5|STARTED|Overall Study||66
8239097|NCT01939366|20318593|P4|STARTED|Overall Study||68
8239098|NCT01939366|20318594|P3|STARTED|Overall Study||65
8239099|NCT01939366|20318595|P2|STARTED|Overall Study||64
8239100|NCT01939366|20318596|P1|STARTED|Overall Study||66
8239101|NCT01939314|20318610|P2|NOT COMPLETED|Overall Study||8
8239102|NCT01939314|20318611|P1|NOT COMPLETED|Overall Study||9
8239103|NCT01939314|20318610|P2|COMPLETED|Overall Study||40
8239104|NCT01939314|20318611|P1|COMPLETED|Overall Study||36
8239105|NCT01939314|20318610|P2|24 Hour Endpoint|Overall Study||40
8239106|NCT01939314|20318611|P1|24 Hour Endpoint|Overall Study||36
8239107|NCT01939314|20318610|P2|15 Minute Endpoint|Overall Study||46
8239108|NCT01939314|20318611|P1|15 Minute Endpoint|Overall Study||41
8239109|NCT01939314|20318610|P2|STARTED|Overall Study||48
8239110|NCT01939314|20318611|P1|STARTED|Overall Study||45
8239111|NCT01939301|20318623|P2|NOT COMPLETED|Overall Study||1
8239112|NCT01939301|20318624|P1|NOT COMPLETED|Overall Study||1
8239113|NCT01939301|20318623|P2|COMPLETED|Overall Study||38
8239114|NCT01939301|20318624|P1|COMPLETED|Overall Study||38
8239115|NCT01939301|20318623|P2|STARTED|Overall Study||39
8239116|NCT01939301|20318624|P1|STARTED|Overall Study||39
8239117|NCT01939288|20318632|P2|NOT COMPLETED|Overall Study||0
8239118|NCT01939288|20318633|P1|NOT COMPLETED|Overall Study||0
8239119|NCT01939288|20318632|P2|COMPLETED|Overall Study||5
8239120|NCT01939288|20318633|P1|COMPLETED|Overall Study||5
8239121|NCT01939288|20318632|P2|STARTED|Overall Study||5
8239122|NCT01939288|20318633|P1|STARTED|Overall Study||5
8239123|NCT01939275|20318639|P1|NOT COMPLETED|Overall Study||0
8239124|NCT01939275|20318639|P1|COMPLETED|Overall Study||8
8239125|NCT01939275|20318639|P1|STARTED|Overall Study||8
8239126|NCT01939223|20318645|P2|NOT COMPLETED|Overall Study||11
8239127|NCT01939223|20318646|P1|NOT COMPLETED|Overall Study||13
8239128|NCT01939223|20318645|P2|COMPLETED|Overall Study||0
8239129|NCT01939223|20318646|P1|COMPLETED|Overall Study||1
8239130|NCT01939223|20318645|P2|Participants Received Treatment|Overall Study||11
8239131|NCT01939223|20318646|P1|Participants Received Treatment|Overall Study||14
8239132|NCT01939223|20318645|P2|STARTED|Overall Study||11
8239133|NCT01939223|20318646|P1|STARTED|Overall Study||14
8239134|NCT01939197|20318661|P7|NOT COMPLETED|Overall Study||2
8239135|NCT01939197|20318662|P6|NOT COMPLETED|Overall Study||1
8239136|NCT01939197|20318663|P5|NOT COMPLETED|Overall Study||4
8239137|NCT01939197|20318664|P4|NOT COMPLETED|Overall Study||1
8239138|NCT01939197|20318665|P3|NOT COMPLETED|Overall Study||0
8239139|NCT01939197|20318666|P2|NOT COMPLETED|Overall Study||1
8239140|NCT01939197|20318667|P1|NOT COMPLETED|Overall Study||1
8239141|NCT01939197|20318661|P7|COMPLETED|Overall Study||26
8239142|NCT01939197|20318662|P6|COMPLETED|Overall Study||4
8239143|NCT01939197|20318663|P5|COMPLETED|Overall Study||196
8239144|NCT01939197|20318664|P4|COMPLETED|Overall Study||11
8239145|NCT01939197|20318665|P3|COMPLETED|Overall Study||10
8239146|NCT01939197|20318666|P2|COMPLETED|Overall Study||31
8239147|NCT01939197|20318667|P1|COMPLETED|Overall Study||30
8239148|NCT01939197|20318661|P7|STARTED|Overall Study||28
8239149|NCT01939197|20318662|P6|STARTED|Overall Study||5
8239150|NCT01939197|20318663|P5|STARTED|Overall Study||200
8239151|NCT01939197|20318664|P4|STARTED|Overall Study||12
8239152|NCT01939197|20318665|P3|STARTED|Overall Study||10
8239153|NCT01939197|20318666|P2|STARTED|Overall Study||32
8239154|NCT01939197|20318667|P1|STARTED|Overall Study||31
8239155|NCT01939145|20318727|P2|NOT COMPLETED|Overall Study||7
8239156|NCT01939145|20318728|P1|NOT COMPLETED|Overall Study||2
8239157|NCT01939145|20318727|P2|COMPLETED|Overall Study||44
8239158|NCT01939145|20318728|P1|COMPLETED|Overall Study||47
8239159|NCT01939145|20318727|P2|STARTED|Overall Study||51
8239160|NCT01939145|20318728|P1|STARTED|Overall Study||49
8239161|NCT01939028|20318736|P1|NOT COMPLETED|Overall Study||12
8239162|NCT01939028|20318736|P1|COMPLETED|Overall Study||46
8239163|NCT01939028|20318736|P1|STARTED|Overall Study||58
8239164|NCT01939002|20318749|P2|NOT COMPLETED|Overall Study||18
8239165|NCT01939002|20318750|P1|NOT COMPLETED|Overall Study||19
8239166|NCT01939002|20318749|P2|COMPLETED|Overall Study||80
8239167|NCT01939002|20318750|P1|COMPLETED|Overall Study||84
8239168|NCT01939002|20318749|P2|STARTED|Overall Study||98
8239169|NCT01939002|20318750|P1|STARTED|Overall Study||103
8239170|NCT01938989|20318816|P2|NOT COMPLETED|Overall Study||0
8239171|NCT01938989|20318817|P1|NOT COMPLETED|Overall Study||0
8239172|NCT01938989|20318816|P2|COMPLETED|Overall Study||77
8239173|NCT01938989|20318817|P1|COMPLETED|Overall Study||77
8239174|NCT01938989|20318816|P2|STARTED|Overall Study||77
8239175|NCT01938989|20318817|P1|STARTED|Overall Study||77
8239176|NCT01938846|20318826|P3|NOT COMPLETED|Overall Study||24
8239177|NCT01938846|20318827|P2|NOT COMPLETED|Overall Study||25
8239178|NCT01938846|20318828|P1|NOT COMPLETED|Overall Study||41
8239179|NCT01938846|20318826|P3|COMPLETED|Overall Study||0
8239180|NCT01938846|20318827|P2|COMPLETED|Overall Study||0
8239181|NCT01938846|20318828|P1|COMPLETED|Overall Study||0
8239182|NCT01938846|20318826|P3|STARTED|Overall Study||24
8239183|NCT01938846|20318827|P2|STARTED|Overall Study||25
8239184|NCT01938846|20318828|P1|STARTED|Overall Study||41
8239185|NCT01938833|20319020|P1|NOT COMPLETED|Overall Study||0
8239186|NCT01938833|20319020|P1|COMPLETED|Overall Study||9
8239187|NCT01938833|20319020|P1|STARTED|Overall Study||9
8239188|NCT01938716|20319028|P1|NOT COMPLETED|Overall Study||4
8239189|NCT01938716|20319028|P1|COMPLETED|Overall Study||8
8239190|NCT01938716|20319028|P1|STARTED|Overall Study||12
8239191|NCT01938664|20319038|P2|NOT COMPLETED|Overall Study||10
8239192|NCT01938664|20319039|P1|NOT COMPLETED|Overall Study||15
8239193|NCT01938664|20319038|P2|COMPLETED|Overall Study||0
8239194|NCT01938664|20319039|P1|COMPLETED|Overall Study||5
8239195|NCT01938664|20319038|P2|STARTED|Overall Study||10
8239196|NCT01938664|20319039|P1|STARTED|Overall Study||20
8239197|NCT01938625|20319051|P2|NOT COMPLETED|Overall Study||2
8239198|NCT01938625|20319052|P1|NOT COMPLETED|Overall Study||0
8239199|NCT01938625|20319051|P2|COMPLETED|Overall Study||23
8239200|NCT01938625|20319052|P1|COMPLETED|Overall Study||10
8239201|NCT01938625|20319051|P2|STARTED|Overall Study||25
8239202|NCT01938625|20319052|P1|STARTED|Overall Study||10
8239203|NCT01938573|20319072|P2|NOT COMPLETED|Overall Study||0
8239204|NCT01938573|20319073|P1|NOT COMPLETED|Overall Study||2
8239205|NCT01938573|20319072|P2|COMPLETED|Overall Study||6
8239206|NCT01938573|20319073|P1|COMPLETED|Overall Study||13
8239207|NCT01938573|20319072|P2|STARTED|Overall Study||6
8239208|NCT01938573|20319073|P1|STARTED|Overall Study||15
8239209|NCT01938430|20319093|P14|NOT COMPLETED|Overall Study||1
8239210|NCT01938430|20319094|P13|NOT COMPLETED|Overall Study||0
8239211|NCT01938430|20319095|P12|NOT COMPLETED|Overall Study||1
8239212|NCT01938430|20319096|P11|NOT COMPLETED|Overall Study||3
8239213|NCT01938430|20319097|P10|NOT COMPLETED|Overall Study||3
8239214|NCT01938430|20319098|P9|NOT COMPLETED|Overall Study||4
8239215|NCT01938430|20319099|P8|NOT COMPLETED|Overall Study||1
8239216|NCT01938430|20319100|P7|NOT COMPLETED|Overall Study||2
8239217|NCT01938430|20319101|P6|NOT COMPLETED|Overall Study||1
8239218|NCT01938430|20319102|P5|NOT COMPLETED|Overall Study||0
8239219|NCT01938430|20319103|P4|NOT COMPLETED|Overall Study||2
8239220|NCT01938430|20319104|P3|NOT COMPLETED|Overall Study||5
8239221|NCT01938430|20319105|P2|NOT COMPLETED|Overall Study||3
8239222|NCT01938430|20319106|P1|NOT COMPLETED|Overall Study||4
8239223|NCT01938430|20319093|P14|COMPLETED|Overall Study||2
8239224|NCT01938430|20319094|P13|COMPLETED|Overall Study||4
8239225|NCT01938430|20319095|P12|COMPLETED|Overall Study||3
8239226|NCT01938430|20319096|P11|COMPLETED|Overall Study||3
8239227|NCT01938430|20319097|P10|COMPLETED|Overall Study||23
8239228|NCT01938430|20319098|P9|COMPLETED|Overall Study||22
8239229|NCT01938430|20319099|P8|COMPLETED|Overall Study||24
8239230|NCT01938430|20319100|P7|COMPLETED|Overall Study||24
8239231|NCT01938430|20319101|P6|COMPLETED|Overall Study||55
8239232|NCT01938430|20319102|P5|COMPLETED|Overall Study||55
8239233|NCT01938430|20319103|P4|COMPLETED|Overall Study||24
8239234|NCT01938430|20319104|P3|COMPLETED|Overall Study||18
8239235|NCT01938430|20319105|P2|COMPLETED|Overall Study||26
8239236|NCT01938430|20319106|P1|COMPLETED|Overall Study||26
8239237|NCT01938430|20319093|P14|STARTED|Overall Study||3
8239238|NCT01938430|20319094|P13|STARTED|Overall Study||4
8239239|NCT01938430|20319095|P12|STARTED|Overall Study||4
8239240|NCT01938430|20319096|P11|STARTED|Overall Study||6
8239241|NCT01938430|20319097|P10|STARTED|Overall Study||26
8239242|NCT01938430|20319098|P9|STARTED|Overall Study||26
8239243|NCT01938430|20319099|P8|STARTED|Overall Study||25
8239244|NCT01938430|20319100|P7|STARTED|Overall Study||26
8239245|NCT01938430|20319101|P6|STARTED|Overall Study||56
8239246|NCT01938430|20319102|P5|STARTED|Overall Study||55
8239247|NCT01938430|20319103|P4|STARTED|Overall Study||26
8239248|NCT01938430|20319104|P3|STARTED|Overall Study||23
8239249|NCT01938430|20319105|P2|STARTED|Overall Study||29
8239250|NCT01938430|20319106|P1|STARTED|Overall Study||30
8239251|NCT01938391|20319431|P1|NOT COMPLETED|12 Month Follow up||2
8239252|NCT01938391|20319431|P1|COMPLETED|12 Month Follow up||22
8239253|NCT01938391|20319431|P1|STARTED|12 Month Follow up||24
8239254|NCT01938391|20319431|P1|NOT COMPLETED|6 Month Follow up||1
8239255|NCT01938391|20319431|P1|COMPLETED|6 Month Follow up||24
8239256|NCT01938391|20319431|P1|STARTED|6 Month Follow up||25
8239257|NCT01938391|20319431|P1|NOT COMPLETED|2 Week Follow up||0
8239258|NCT01938391|20319431|P1|COMPLETED|2 Week Follow up||25
8239259|NCT01938391|20319431|P1|STARTED|2 Week Follow up||25
8239260|NCT01938391|20319431|P1|NOT COMPLETED|Baseline||0
8239261|NCT01938391|20319431|P1|COMPLETED|Baseline||25
8239262|NCT01938391|20319431|P1|STARTED|Baseline||25
8239263|NCT01938378|20319444|P1|NOT COMPLETED|Overall Study||0
8239264|NCT01938378|20319444|P1|COMPLETED|Overall Study||41
8239265|NCT01938378|20319444|P1|STARTED|Overall Study||41
8239266|NCT01938170|20319509|P1|NOT COMPLETED|Overall Study||0
8239267|NCT01938170|20319509|P1|COMPLETED|Overall Study||41
8239268|NCT01938170|20319509|P1|STARTED|Overall Study||41
8239269|NCT01938079|20319516|P2|NOT COMPLETED|Overall Study||0
8239270|NCT01938079|20319517|P1|NOT COMPLETED|Overall Study||0
8239271|NCT01938079|20319516|P2|COMPLETED|Overall Study||10
8239272|NCT01938079|20319517|P1|COMPLETED|Overall Study||10
8239273|NCT01938079|20319516|P2|STARTED|Overall Study||10
8239274|NCT01938079|20319517|P1|STARTED|Overall Study||10
8239275|NCT01938066|20319525|P2|NOT COMPLETED|Overall Study||2
8239276|NCT01938066|20319526|P1|NOT COMPLETED|Overall Study||1
8239277|NCT01938066|20319525|P2|COMPLETED|Overall Study||13
8239278|NCT01938066|20319526|P1|COMPLETED|Overall Study||14
8239279|NCT01938066|20319525|P2|STARTED|Overall Study||15
8239280|NCT01938066|20319526|P1|STARTED|Overall Study||15
8239281|NCT01938040|20319536|P2|NOT COMPLETED|Overall Study||0
8239282|NCT01938040|20319537|P1|NOT COMPLETED|Overall Study||0
8239283|NCT01938040|20319536|P2|COMPLETED|Overall Study||27
8239284|NCT01938040|20319537|P1|COMPLETED|Overall Study||28
8239285|NCT01938040|20319536|P2|Behavior Metrics|Overall Study||27
8239286|NCT01938040|20319537|P1|Behavior Metrics|Overall Study||28
8239287|NCT01938040|20319536|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
8239288|NCT01938040|20319537|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
8239289|NCT01938040|20319536|P2|STARTED|Overall Study||27
8239290|NCT01938040|20319537|P1|STARTED|Overall Study||28
8239301|NCT01937975|20319593|P3|NOT COMPLETED|Overall Study||0
8239302|NCT01937975|20319594|P2|NOT COMPLETED|Overall Study||0
8239303|NCT01937975|20319595|P1|NOT COMPLETED|Overall Study||0
8239304|NCT01937975|20319593|P3|COMPLETED|Overall Study||8
8239305|NCT01937975|20319594|P2|COMPLETED|Overall Study||8
8239306|NCT01937975|20319595|P1|COMPLETED|Overall Study||8
8239307|NCT01937975|20319593|P3|STARTED|Overall Study||8
8239308|NCT01937975|20319594|P2|STARTED|Overall Study||8
8239309|NCT01937975|20319595|P1|STARTED|Overall Study||8
8239310|NCT01937871|20319645|P3|NOT COMPLETED|Overall Study||11
8239311|NCT01937871|20319646|P2|NOT COMPLETED|Overall Study||17
8239312|NCT01937871|20319647|P1|NOT COMPLETED|Overall Study||24
8239313|NCT01937871|20319645|P3|COMPLETED|Overall Study||174
8239314|NCT01937871|20319646|P2|COMPLETED|Overall Study||346
8239315|NCT01937871|20319647|P1|COMPLETED|Overall Study||337
8239316|NCT01937871|20319645|P3|Received at Least One Dose of Study Drug|Overall Study||185
8239317|NCT01937871|20319646|P2|Received at Least One Dose of Study Drug|Overall Study||362
8239318|NCT01937871|20319647|P1|Received at Least One Dose of Study Drug|Overall Study||361
8239319|NCT01937871|20319645|P3|STARTED|Overall Study||185
8239320|NCT01937871|20319646|P2|STARTED|Overall Study||363
8239321|NCT01937871|20319647|P1|STARTED|Overall Study||361
8239322|NCT01937715|20319723|P5|NOT COMPLETED|Overall Study||2
8239323|NCT01937715|20319724|P4|NOT COMPLETED|Overall Study||4
8239324|NCT01937715|20319725|P3|NOT COMPLETED|Overall Study||0
8239325|NCT01937715|20319726|P2|NOT COMPLETED|Overall Study||1
8239326|NCT01937715|20319727|P1|NOT COMPLETED|Overall Study||0
8239327|NCT01937715|20319723|P5|COMPLETED|Overall Study||1
8239328|NCT01937715|20319724|P4|COMPLETED|Overall Study||1
8239329|NCT01937715|20319725|P3|COMPLETED|Overall Study||3
8239330|NCT01937715|20319726|P2|COMPLETED|Overall Study||3
8239331|NCT01937715|20319727|P1|COMPLETED|Overall Study||3
8239332|NCT01937715|20319723|P5|STARTED|Overall Study||3
8239333|NCT01937715|20319724|P4|STARTED|Overall Study||5
8239334|NCT01937715|20319725|P3|STARTED|Overall Study||3
8239335|NCT01937715|20319726|P2|STARTED|Overall Study||4
8239336|NCT01937715|20319727|P1|STARTED|Overall Study||3
8239337|NCT01937624|20319849|P1|NOT COMPLETED|Overall Study||0
8239338|NCT01937624|20319849|P1|COMPLETED|Overall Study||51
8239339|NCT01937624|20319849|P1|STARTED|Overall Study||51
8239340|NCT01937598|20319853|P2|NOT COMPLETED|Overall Study||0
8239341|NCT01937598|20319854|P1|NOT COMPLETED|Overall Study||0
8239342|NCT01937598|20319853|P2|COMPLETED|Overall Study||8
8239343|NCT01937598|20319854|P1|COMPLETED|Overall Study||8
8239344|NCT01937598|20319853|P2|STARTED|Overall Study||8
8239345|NCT01937598|20319854|P1|STARTED|Overall Study||8
8239346|NCT01937559|20319879|P3|NOT COMPLETED|Overall Study||0
8239347|NCT01937559|20319880|P2|NOT COMPLETED|Overall Study||11
8239348|NCT01937559|20319881|P1|NOT COMPLETED|Overall Study||11
8239349|NCT01937559|20319879|P3|COMPLETED|Overall Study||66
8239350|NCT01937559|20319880|P2|COMPLETED|Overall Study||50
8239351|NCT01937559|20319881|P1|COMPLETED|Overall Study||50
8239352|NCT01937559|20319879|P3|STARTED|Overall Study||66
8239353|NCT01937559|20319880|P2|STARTED|Overall Study||61
8239354|NCT01937559|20319881|P1|STARTED|Overall Study||61
8239355|NCT01937520|20319907|P2|NOT COMPLETED|Overall Study||0
8239356|NCT01937520|20319908|P1|NOT COMPLETED|Overall Study||0
8239357|NCT01937520|20319907|P2|COMPLETED|Overall Study||9
8239358|NCT01937520|20319908|P1|COMPLETED|Overall Study||11
8239359|NCT01937520|20319907|P2|STARTED|Overall Study||9
8239360|NCT01937520|20319908|P1|STARTED|Overall Study||11
8239361|NCT01937507|20319944|P1|NOT COMPLETED|Overall Study||2
8239362|NCT01937507|20319944|P1|COMPLETED|Overall Study||0
8239363|NCT01937507|20319944|P1|STARTED|Overall Study||2
8239364|NCT01937390|20319951|P1|NOT COMPLETED|Overall Study||35
8239365|NCT01937390|20319951|P1|COMPLETED|Overall Study||550
8239366|NCT01937390|20319951|P1|STARTED|Overall Study||585
8239367|NCT01937364|20319961|P2|NOT COMPLETED|Overall Study||1
8239368|NCT01937364|20319962|P1|NOT COMPLETED|Overall Study||2
8239369|NCT01937364|20319961|P2|COMPLETED|Overall Study||7
8239370|NCT01937364|20319962|P1|COMPLETED|Overall Study||7
8239371|NCT01937364|20319961|P2|STARTED|Overall Study||8
8239372|NCT01937364|20319962|P1|STARTED|Overall Study||9
8239373|NCT01937351|20319974|P2|NOT COMPLETED|Overall Study||2
8239374|NCT01937351|20319975|P1|NOT COMPLETED|Overall Study||9
8239375|NCT01937351|20319974|P2|COMPLETED|Overall Study||26
8239376|NCT01937351|20319975|P1|COMPLETED|Overall Study||125
8239377|NCT01937351|20319974|P2|6-Month Follow-up|Overall Study||26
8239378|NCT01937351|20319975|P1|6-Month Follow-up|Overall Study||125
8239379|NCT01937351|20319974|P2|30-Day Follow-up|Overall Study||27
8239380|NCT01937351|20319975|P1|30-Day Follow-up|Overall Study||128
8239381|NCT01937351|20319974|P2|Treated w Study Device|Overall Study||28
8239382|NCT01937351|20319975|P1|Treated w Study Device|Overall Study||130
8239383|NCT01937351|20319974|P2|STARTED|Overall Study||28
8239384|NCT01937351|20319975|P1|STARTED|Overall Study||134
8239385|NCT01937312|20319983|P2|NOT COMPLETED|Overall Study||3
8239386|NCT01937312|20319984|P1|NOT COMPLETED|Overall Study||11
8239387|NCT01937312|20319983|P2|COMPLETED|Overall Study||92
8239388|NCT01937312|20319984|P1|COMPLETED|Overall Study||83
8239389|NCT01937312|20319983|P2|Treated|Overall Study||95
8239390|NCT01937312|20319984|P1|Treated|Overall Study||93
8239391|NCT01937312|20319983|P2|STARTED|Overall Study||95
8239392|NCT01937312|20319984|P1|STARTED|Overall Study||94
8239393|NCT01937299|20319999|P2|NOT COMPLETED|Overall Study||4
8239394|NCT01937299|20320000|P1|NOT COMPLETED|Overall Study||14
8239395|NCT01937299|20319999|P2|COMPLETED|Overall Study||112
8239396|NCT01937299|20320000|P1|COMPLETED|Overall Study||103
8239397|NCT01937299|20319999|P2|STARTED|Overall Study||116
8239398|NCT01937299|20320000|P1|STARTED|Overall Study||117
8239399|NCT01937260|20320013|P2|NOT COMPLETED|Overall Study||0
8239400|NCT01937260|20320014|P1|NOT COMPLETED|Overall Study||1
8239401|NCT01937260|20320013|P2|COMPLETED|Overall Study||10
8239402|NCT01937260|20320014|P1|COMPLETED|Overall Study||20
8239403|NCT01937260|20320013|P2|STARTED|Overall Study||10
8239404|NCT01937260|20320014|P1|STARTED|Overall Study||21
8239405|NCT01937195|20320021|P1|NOT COMPLETED|Overall Study||0
8239406|NCT01937195|20320021|P1|COMPLETED|Overall Study||95
8239407|NCT01937195|20320021|P1|STARTED|Overall Study||95
8239408|NCT01937130|20320035|P4|NOT COMPLETED|Overall Study||2
8239409|NCT01937130|20320036|P3|NOT COMPLETED|Overall Study||3
8239410|NCT01937130|20320037|P2|NOT COMPLETED|Overall Study||4
8239411|NCT01937130|20320038|P1|NOT COMPLETED|Overall Study||5
8239412|NCT01937130|20320035|P4|COMPLETED|Overall Study||2
8239413|NCT01937130|20320036|P3|COMPLETED|Overall Study||2
8239414|NCT01937130|20320037|P2|COMPLETED|Overall Study||3
8239415|NCT01937130|20320038|P1|COMPLETED|Overall Study||0
8239416|NCT01937130|20320035|P4|STARTED|Overall Study||4
8239417|NCT01937130|20320036|P3|STARTED|Overall Study||5
8239418|NCT01937130|20320037|P2|STARTED|Overall Study||7
8239419|NCT01937130|20320038|P1|STARTED|Overall Study||5
8239420|NCT01937117|20320065|P1|NOT COMPLETED|Overall Study||13
8239421|NCT01937117|20320065|P1|COMPLETED|Overall Study||75
8239422|NCT01937117|20320065|P1|STARTED|Overall Study||88
8239423|NCT01937026|20320069|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
8239424|NCT01937026|20320069|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
8239425|NCT01937026|20320069|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
8239426|NCT01937026|20320069|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
8239427|NCT01937026|20320069|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
8239428|NCT01937026|20320069|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
8239429|NCT01937026|20320069|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
8239430|NCT01937026|20320069|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
8239431|NCT01937026|20320069|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
8239432|NCT01936974|20320080|P2|NOT COMPLETED|Overall Study||5
8239433|NCT01936974|20320081|P1|NOT COMPLETED|Overall Study||2
8239434|NCT01936974|20320080|P2|COMPLETED|Overall Study||0
8239435|NCT01936974|20320081|P1|COMPLETED|Overall Study||0
8239436|NCT01936974|20320080|P2|STARTED|Overall Study||5
8239437|NCT01936974|20320081|P1|STARTED|Overall Study||2
8239438|NCT01936909|20320090|P3|NOT COMPLETED|Overall Study||6
8239439|NCT01936909|20320091|P2|NOT COMPLETED|Overall Study||8
8239440|NCT01936909|20320092|P1|NOT COMPLETED|Overall Study||10
8239441|NCT01936909|20320090|P3|COMPLETED|Overall Study||14
8239442|NCT01936909|20320091|P2|COMPLETED|Overall Study||12
8239443|NCT01936909|20320092|P1|COMPLETED|Overall Study||10
8239444|NCT01936909|20320090|P3|STARTED|Overall Study||20
8239445|NCT01936909|20320091|P2|STARTED|Overall Study||20
8239446|NCT01936909|20320092|P1|STARTED|Overall Study||20
8239447|NCT01936896|20320106|P1|NOT COMPLETED|Overall Study||0
8239448|NCT01936896|20320106|P1|COMPLETED|Overall Study||10
8239449|NCT01936896|20320106|P1|STARTED|Overall Study||10
8239450|NCT01936870|20320111|P1|NOT COMPLETED|Overall Study||189
8239451|NCT01936870|20320111|P1|COMPLETED|Overall Study||2303
8239452|NCT01936870|20320111|P1|STARTED|Overall Study||2492
8239453|NCT01936857|20320126|P2|NOT COMPLETED|Overall Study||25
8239454|NCT01936857|20320127|P1|NOT COMPLETED|Overall Study||34
8239455|NCT01936857|20320126|P2|COMPLETED|Overall Study||115
8239456|NCT01936857|20320127|P1|COMPLETED|Overall Study||107
8239457|NCT01936857|20320126|P2|STARTED|Overall Study||140
8239458|NCT01936857|20320127|P1|STARTED|Overall Study||141
8239459|NCT01936844|20320135|P2|NOT COMPLETED|Overall Study||7
8239460|NCT01936844|20320136|P1|NOT COMPLETED|Overall Study||6
8239461|NCT01936844|20320135|P2|COMPLETED|Overall Study||8
8239462|NCT01936844|20320136|P1|COMPLETED|Overall Study||9
8239463|NCT01936844|20320135|P2|STARTED|Overall Study||15
8239464|NCT01936844|20320136|P1|STARTED|Overall Study||15
8239465|NCT01936662|20320148|P2|NOT COMPLETED|Overall Study||0
8239466|NCT01936662|20320149|P1|NOT COMPLETED|Overall Study||0
8239467|NCT01936662|20320148|P2|COMPLETED|Overall Study||42
8239468|NCT01936662|20320149|P1|COMPLETED|Overall Study||42
8239469|NCT01936662|20320148|P2|STARTED|Overall Study||42
8239470|NCT01936662|20320149|P1|STARTED|Overall Study||42
8239471|NCT01936649|20320157|P1|NOT COMPLETED|Overall Study||13
8239472|NCT01936649|20320157|P1|COMPLETED|Overall Study||50
8239473|NCT01936649|20320157|P1|Treated|Overall Study||51
8239474|NCT01936649|20320157|P1|STARTED|Overall Study||63
8239475|NCT01936623|20320164|P2|NOT COMPLETED|Overall Study||5
8239476|NCT01936623|20320165|P1|NOT COMPLETED|Overall Study||0
8239477|NCT01936623|20320164|P2|COMPLETED|Overall Study||35
8239478|NCT01936623|20320165|P1|COMPLETED|Overall Study||40
8239479|NCT01936623|20320164|P2|STARTED|Overall Study||40
8239480|NCT01936623|20320165|P1|STARTED|Overall Study||40
8239481|NCT01936467|20320179|P2|NOT COMPLETED|Overall Study||0
8239482|NCT01936467|20320180|P1|NOT COMPLETED|Overall Study||0
8239483|NCT01936467|20320179|P2|COMPLETED|Overall Study||61
8239484|NCT01936467|20320180|P1|COMPLETED|Overall Study||60
8239485|NCT01936467|20320179|P2|STARTED|Overall Study||61
8239486|NCT01936467|20320180|P1|STARTED|Overall Study||60
8239487|NCT01936389|20320200|P2|NOT COMPLETED|Overall Study||0
8239488|NCT01936389|20320201|P1|NOT COMPLETED|Overall Study||1
8239489|NCT01936389|20320200|P2|COMPLETED|Overall Study||5
8239490|NCT01936389|20320201|P1|COMPLETED|Overall Study||4
8239491|NCT01936389|20320200|P2|STARTED|Overall Study||5
8239492|NCT01936389|20320201|P1|STARTED|Overall Study||5
8239493|NCT01936363|20320209|P2|NOT COMPLETED|Overall Study||0
8239494|NCT01936363|20320210|P1|NOT COMPLETED|Overall Study||0
8239495|NCT01936363|20320209|P2|COMPLETED|Overall Study||33
8239496|NCT01936363|20320210|P1|COMPLETED|Overall Study||32
8239497|NCT01936363|20320209|P2|STARTED|Overall Study||33
8239498|NCT01936363|20320210|P1|STARTED|Overall Study||32
8239499|NCT01936324|20320237|P3|NOT COMPLETED|Overall Study||5
8239500|NCT01936324|20320238|P2|NOT COMPLETED|Overall Study||6
8239501|NCT01936324|20320239|P1|NOT COMPLETED|Overall Study||0
8239502|NCT01936324|20320237|P3|COMPLETED|Overall Study||50
8239503|NCT01936324|20320238|P2|COMPLETED|Overall Study||47
8239504|NCT01936324|20320239|P1|COMPLETED|Overall Study||6
8239505|NCT01936324|20320237|P3|STARTED|Overall Study||55
8239506|NCT01936324|20320238|P2|STARTED|Overall Study||53
8239507|NCT01936324|20320239|P1|STARTED|Overall Study||6
8239508|NCT01936259|20320252|P2|NOT COMPLETED|Overall Study||20
8239509|NCT01936259|20320253|P1|NOT COMPLETED|Overall Study||12
8239510|NCT01936259|20320252|P2|COMPLETED|Overall Study||111
8239511|NCT01936259|20320253|P1|COMPLETED|Overall Study||118
8239512|NCT01936259|20320252|P2|STARTED|Overall Study||131
8239513|NCT01936259|20320253|P1|STARTED|Overall Study||130
8239514|NCT01936181|20320273|P4|NOT COMPLETED|Transition-extension||5
8239515|NCT01936181|20320274|P3|NOT COMPLETED|Transition-extension||6
8239516|NCT01936181|20320275|P2|NOT COMPLETED|Transition-extension||0
8239517|NCT01936181|20320276|P1|NOT COMPLETED|Transition-extension||15
8239518|NCT01936181|20320273|P4|COMPLETED|Transition-extension||96
8239519|NCT01936181|20320274|P3|COMPLETED|Transition-extension||88
8239520|NCT01936181|20320275|P2|COMPLETED|Transition-extension||0
8239521|NCT01936181|20320276|P1|COMPLETED|Transition-extension||186
8239522|NCT01936181|20320273|P4|STARTED|Transition-extension||101
8239523|NCT01936181|20320274|P3|STARTED|Transition-extension||94
8239524|NCT01936181|20320275|P2|STARTED|Transition-extension||0
8239525|NCT01936181|20320276|P1|STARTED|Transition-extension||201
8239526|NCT01936181|20320273|P4|NOT COMPLETED|Randomised, Double-blind||0
8239527|NCT01936181|20320274|P3|NOT COMPLETED|Randomised, Double-blind||0
8239528|NCT01936181|20320275|P2|NOT COMPLETED|Randomised, Double-blind||68
8239529|NCT01936181|20320276|P1|NOT COMPLETED|Randomised, Double-blind||64
8239530|NCT01936181|20320273|P4|COMPLETED|Randomised, Double-blind||0
8239531|NCT01936181|20320274|P3|COMPLETED|Randomised, Double-blind||0
8239532|NCT01936181|20320275|P2|COMPLETED|Randomised, Double-blind||225
8239533|NCT01936181|20320276|P1|COMPLETED|Randomised, Double-blind||227
8239534|NCT01936181|20320273|P4|STARTED|Randomised, Double-blind||0
8239535|NCT01936181|20320274|P3|STARTED|Randomised, Double-blind||0
8239536|NCT01936181|20320275|P2|STARTED|Randomised, Double-blind||293
8239537|NCT01936181|20320276|P1|STARTED|Randomised, Double-blind||291
8239538|NCT01935947|20320290|P3|NOT COMPLETED|Overall Study||2
8239539|NCT01935947|20320291|P2|NOT COMPLETED|Overall Study||4
8239540|NCT01935947|20320292|P1|NOT COMPLETED|Overall Study||3
8239541|NCT01935947|20320290|P3|COMPLETED|Overall Study||0
8239542|NCT01935947|20320291|P2|COMPLETED|Overall Study||0
8239543|NCT01935947|20320292|P1|COMPLETED|Overall Study||1
8239544|NCT01935947|20320290|P3|Cytotoxic Therapy|Overall Study||2
8239545|NCT01935947|20320291|P2|Cytotoxic Therapy|Overall Study||3
8239546|NCT01935947|20320292|P1|Cytotoxic Therapy|Overall Study||3
8239547|NCT01935947|20320290|P3|Epigenetic Therapy|Overall Study||0
8239548|NCT01935947|20320291|P2|Epigenetic Therapy|Overall Study||4
8239549|NCT01935947|20320292|P1|Epigenetic Therapy|Overall Study||4
8239550|NCT01935947|20320290|P3|STARTED|Overall Study||2
8239551|NCT01935947|20320291|P2|STARTED|Overall Study||4
8239552|NCT01935947|20320292|P1|STARTED|Overall Study||4
8239553|NCT01935934|20320317|P2|NOT COMPLETED|Overall Study||0
8239554|NCT01935934|20320318|P1|NOT COMPLETED|Overall Study||0
8239555|NCT01935934|20320317|P2|COMPLETED|Overall Study||32
8239556|NCT01935934|20320318|P1|COMPLETED|Overall Study||70
8239557|NCT01935934|20320317|P2|STARTED|Overall Study||32
8239558|NCT01935934|20320318|P1|STARTED|Overall Study||70
8239559|NCT01935700|20320327|P2|NOT COMPLETED|Overall Study||0
8239560|NCT01935700|20320328|P1|NOT COMPLETED|Overall Study||5
8239561|NCT01935700|20320327|P2|COMPLETED|Overall Study||86
8239562|NCT01935700|20320328|P1|COMPLETED|Overall Study||9
8239563|NCT01935700|20320327|P2|STARTED|Overall Study||86
8239564|NCT01935700|20320328|P1|STARTED|Overall Study||14
8239565|NCT01935622|20320339|P3|NOT COMPLETED|Overall Study||0
8239566|NCT01935622|20320340|P2|NOT COMPLETED|Overall Study||2
8239567|NCT01935622|20320341|P1|NOT COMPLETED|Overall Study||2
8239568|NCT01935622|20320339|P3|COMPLETED|Overall Study||4
8239569|NCT01935622|20320340|P2|COMPLETED|Overall Study||1
8239570|NCT01935622|20320341|P1|COMPLETED|Overall Study||1
8239571|NCT01935622|20320339|P3|STARTED|Overall Study||4
8239572|NCT01935622|20320340|P2|STARTED|Overall Study||3
8239573|NCT01935622|20320341|P1|STARTED|Overall Study||3
8239574|NCT01935180|20320351|P2|NOT COMPLETED|Overall Study||14
8239575|NCT01935180|20320352|P1|NOT COMPLETED|Overall Study||21
8239576|NCT01935180|20320351|P2|COMPLETED|Overall Study||561
8239577|NCT01935180|20320352|P1|COMPLETED|Overall Study||552
8239578|NCT01935180|20320351|P2|STARTED|Overall Study||575
8239579|NCT01935180|20320352|P1|STARTED|Overall Study||573
8239580|NCT01934972|20320372|P2|NOT COMPLETED|Overall Study||6
8239581|NCT01934972|20320373|P1|NOT COMPLETED|Overall Study||9
8239582|NCT01934972|20320372|P2|COMPLETED|Overall Study||5
8239583|NCT01934972|20320373|P1|COMPLETED|Overall Study||4
8239584|NCT01934972|20320372|P2|STARTED|Overall Study||11
8239585|NCT01934972|20320373|P1|STARTED|Overall Study||13
8239586|NCT01934894|20320403|P2|NOT COMPLETED|Overall Study||5
8239587|NCT01934894|20320404|P1|NOT COMPLETED|Overall Study||6
8239588|NCT01934894|20320403|P2|COMPLETED|Overall Study||0
8239589|NCT01934894|20320404|P1|COMPLETED|Overall Study||0
8239590|NCT01934894|20320403|P2|STARTED|Overall Study||5
8239591|NCT01934894|20320404|P1|STARTED|Overall Study||6
8239592|NCT01934790|20320419|P1|NOT COMPLETED|Long Term Follow up||0
8239593|NCT01934790|20320419|P1|COMPLETED|Long Term Follow up||12
8239594|NCT01934790|20320419|P1|STARTED|Long Term Follow up||12
8239595|NCT01934790|20320419|P1|NOT COMPLETED|Active Follow up||24
8239596|NCT01934790|20320419|P1|COMPLETED|Active Follow up||10
8239597|NCT01934790|20320419|P1|STARTED|Active Follow up||34
8239598|NCT01934790|20320419|P1|NOT COMPLETED|Treatment||16
8239599|NCT01934790|20320419|P1|COMPLETED|Treatment||29
8239600|NCT01934790|20320419|P1|Participants Received Study Treatment|Treatment||44
8239601|NCT01934790|20320419|P1|STARTED|Treatment|Eligible for treatment|45
8239602|NCT01934647|20320450|P3|NOT COMPLETED|Overall Study||0
8239603|NCT01934647|20320451|P2|NOT COMPLETED|Overall Study||0
8239604|NCT01934647|20320452|P1|NOT COMPLETED|Overall Study||0
8239605|NCT01934647|20320450|P3|COMPLETED|Overall Study||3
8239606|NCT01934647|20320451|P2|COMPLETED|Overall Study||2
8239607|NCT01934647|20320452|P1|COMPLETED|Overall Study||2
8239608|NCT01934647|20320450|P3|STARTED|Overall Study||3
8239609|NCT01934647|20320451|P2|STARTED|Overall Study||2
8239610|NCT01934647|20320452|P1|STARTED|Overall Study||2
8239611|NCT01934582|20320460|P1|NOT COMPLETED|Overall Study||0
8239612|NCT01934582|20320460|P1|COMPLETED|Overall Study||13
8239613|NCT01934582|20320460|P1|STARTED|Overall Study||13
8239614|NCT01934556|20320477|P3|NOT COMPLETED|Overall Study||10
8239615|NCT01934556|20320478|P2|NOT COMPLETED|Overall Study||16
8239616|NCT01934556|20320479|P1|NOT COMPLETED|Overall Study||5
8239617|NCT01934556|20320477|P3|COMPLETED|Overall Study||50
8239618|NCT01934556|20320478|P2|COMPLETED|Overall Study||44
8239619|NCT01934556|20320479|P1|COMPLETED|Overall Study||25
8239620|NCT01934556|20320477|P3|STARTED|Overall Study||60
8239621|NCT01934556|20320478|P2|STARTED|Overall Study||60
8239622|NCT01934556|20320479|P1|STARTED|Overall Study||30
8239623|NCT01934517|20320511|P1|NOT COMPLETED|Overall Study||0
8239624|NCT01934517|20320511|P1|COMPLETED|Overall Study||25
8239625|NCT01934517|20320511|P1|STARTED|Overall Study||25
8239626|NCT01934504|20320523|P4|NOT COMPLETED|Overall Study||7
8239627|NCT01934504|20320524|P3|NOT COMPLETED|Overall Study||5
8239628|NCT01934504|20320525|P2|NOT COMPLETED|Overall Study||0
8239629|NCT01934504|20320526|P1|NOT COMPLETED|Overall Study||1
8239630|NCT01934504|20320523|P4|COMPLETED|Overall Study||1
8239631|NCT01934504|20320524|P3|COMPLETED|Overall Study||11
8239632|NCT01934504|20320525|P2|COMPLETED|Overall Study||3
8239633|NCT01934504|20320526|P1|COMPLETED|Overall Study||5
8239634|NCT01934504|20320523|P4|STARTED|Overall Study||8
8239635|NCT01934504|20320524|P3|STARTED|Overall Study||16
8239636|NCT01934504|20320525|P2|STARTED|Overall Study||3
8239637|NCT01934504|20320526|P1|STARTED|Overall Study||6
8239638|NCT01934231|20320548|P1|NOT COMPLETED|Overall Study||0
8239639|NCT01934231|20320548|P1|COMPLETED|Overall Study||27
8239640|NCT01934231|20320548|P1|STARTED|Overall Study||27
8239641|NCT01934218|20320559|P2|NOT COMPLETED|Open-Label Phase||24
8239642|NCT01934218|20320560|P1|NOT COMPLETED|Open-Label Phase||26
8239643|NCT01934218|20320559|P2|COMPLETED|Open-Label Phase||304
8239644|NCT01934218|20320560|P1|COMPLETED|Open-Label Phase||290
8239645|NCT01934218|20320559|P2|STARTED|Open-Label Phase||328
8239646|NCT01934218|20320560|P1|STARTED|Open-Label Phase||316
8239647|NCT01934218|20320559|P2|NOT COMPLETED|Double-blind Phase||54
8239648|NCT01934218|20320560|P1|NOT COMPLETED|Double-blind Phase||48
8239649|NCT01934218|20320559|P2|COMPLETED|Double-blind Phase||356
8239650|NCT01934218|20320560|P1|COMPLETED|Double-blind Phase||356
8239651|NCT01934218|20320559|P2|Analyzed Participants|Double-blind Phase||407
8239652|NCT01934218|20320560|P1|Analyzed Participants|Double-blind Phase||402
8239653|NCT01934218|20320559|P2|STARTED|Double-blind Phase||410
8239654|NCT01934218|20320560|P1|STARTED|Double-blind Phase||404
8239655|NCT01934192|20320571|P4|NOT COMPLETED|Overall Study||1
8239656|NCT01934192|20320572|P3|NOT COMPLETED|Overall Study||1
8239657|NCT01934192|20320573|P2|NOT COMPLETED|Overall Study||7
8239658|NCT01934192|20320574|P1|NOT COMPLETED|Overall Study||9
8239659|NCT01934192|20320571|P4|COMPLETED|Overall Study||3
8239660|NCT01934192|20320572|P3|COMPLETED|Overall Study||3
8239661|NCT01934192|20320573|P2|COMPLETED|Overall Study||37
8239662|NCT01934192|20320574|P1|COMPLETED|Overall Study||31
8239663|NCT01934192|20320571|P4|STARTED|Overall Study||4
8239664|NCT01934192|20320572|P3|STARTED|Overall Study||4
8239665|NCT01934192|20320573|P2|STARTED|Overall Study||44
8239666|NCT01934192|20320574|P1|STARTED|Overall Study||40
8239667|NCT01934140|20320710|P2|NOT COMPLETED|Booster Phase (6 Months)||3
8239668|NCT01934140|20320711|P1|NOT COMPLETED|Booster Phase (6 Months)||5
8239669|NCT01934140|20320710|P2|COMPLETED|Booster Phase (6 Months)||53
8239670|NCT01934140|20320711|P1|COMPLETED|Booster Phase (6 Months)||159
8239671|NCT01934140|20320710|P2|Vaccinated|Booster Phase (6 Months)||56
8239672|NCT01934140|20320711|P1|Vaccinated|Booster Phase (6 Months)||164
8239673|NCT01934140|20320710|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
8239674|NCT01934140|20320711|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
8239675|NCT01934140|20320710|P2|NOT COMPLETED|Persistence Phase (Year 6-10)||25
8239676|NCT01934140|20320711|P1|NOT COMPLETED|Persistence Phase (Year 6-10)||83
8239677|NCT01934140|20320710|P2|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
8239678|NCT01934140|20320711|P1|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
8239679|NCT01934140|20320710|P2|STARTED|Persistence Phase (Year 6-10)||76
8239680|NCT01934140|20320711|P1|STARTED|Persistence Phase (Year 6-10)||235
8239681|NCT01934010|20320762|P3|NOT COMPLETED|Overall Study||2
8239682|NCT01934010|20320763|P2|NOT COMPLETED|Overall Study||11
8239683|NCT01934010|20320764|P1|NOT COMPLETED|Overall Study||23
8239684|NCT01934010|20320762|P3|COMPLETED|Overall Study||74
8239685|NCT01934010|20320763|P2|COMPLETED|Overall Study||56
8239686|NCT01934010|20320764|P1|COMPLETED|Overall Study||91
8239687|NCT01934010|20320762|P3|STARTED|Overall Study||76
8239688|NCT01934010|20320763|P2|STARTED|Overall Study||67
8239689|NCT01934010|20320764|P1|STARTED|Overall Study||114
8239690|NCT01933984|20320783|P2|NOT COMPLETED|Overall Study||0
8239691|NCT01933984|20320784|P1|NOT COMPLETED|Overall Study||0
8239692|NCT01933984|20320783|P2|COMPLETED|Overall Study||25
8239693|NCT01933984|20320784|P1|COMPLETED|Overall Study||26
8239694|NCT01933984|20320783|P2|STARTED|Overall Study||25
8239695|NCT01933984|20320784|P1|STARTED|Overall Study||26
8239696|NCT01933932|20320806|P2|NOT COMPLETED|Overall Study||178
8239697|NCT01933932|20320807|P1|NOT COMPLETED|Overall Study||184
8239698|NCT01933932|20320806|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
8239699|NCT01933932|20320807|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
8239700|NCT01933932|20320806|P2|STARTED|Overall Study||256
8239701|NCT01933932|20320807|P1|STARTED|Overall Study||254
8239702|NCT01933919|20320825|P2|NOT COMPLETED|Open-label Long-term Phase||6
8239703|NCT01933919|20320826|P1|NOT COMPLETED|Open-label Long-term Phase||7
8239704|NCT01933919|20320825|P2|COMPLETED|Open-label Long-term Phase||9
8239705|NCT01933919|20320826|P1|COMPLETED|Open-label Long-term Phase||12
8239706|NCT01933919|20320825|P2|STARTED|Open-label Long-term Phase||15
8239707|NCT01933919|20320826|P1|STARTED|Open-label Long-term Phase||19
8239708|NCT01933919|20320825|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
8239709|NCT01933919|20320826|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
8239710|NCT01933919|20320825|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
8239711|NCT01933919|20320826|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
8239712|NCT01933919|20320825|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
8239713|NCT01933919|20320826|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
8239714|NCT01933919|20320825|P2|STARTED|Double-blind Placebo-controlled Phase||19
8239715|NCT01933919|20320826|P1|STARTED|Double-blind Placebo-controlled Phase||19
8239716|NCT01933880|20320862|P2|NOT COMPLETED|Overall Study||1
8239717|NCT01933880|20320863|P1|NOT COMPLETED|Overall Study||30
8239718|NCT01933880|20320862|P2|COMPLETED|Overall Study||40
8239719|NCT01933880|20320863|P1|COMPLETED|Overall Study||123
8239720|NCT01933880|20320862|P2|STARTED|Overall Study||41
8239721|NCT01933880|20320863|P1|STARTED|Overall Study||153
8239722|NCT01933789|20320937|P9|NOT COMPLETED|Overall Study||0
8239723|NCT01933789|20320938|P8|NOT COMPLETED|Overall Study||14
8239724|NCT01933789|20320939|P7|NOT COMPLETED|Overall Study||15
8239725|NCT01933789|20320940|P6|NOT COMPLETED|Overall Study||67
8239726|NCT01933789|20320941|P5|NOT COMPLETED|Overall Study||59
8239727|NCT01933789|20320942|P4|NOT COMPLETED|Overall Study||1
8239728|NCT01933789|20320943|P3|NOT COMPLETED|Overall Study||0
8239729|NCT01933789|20320944|P2|NOT COMPLETED|Overall Study||1
8239730|NCT01933789|20320945|P1|NOT COMPLETED|Overall Study||6
8239731|NCT01933789|20320937|P9|COMPLETED|Overall Study||25
8239732|NCT01933789|20320938|P8|COMPLETED|Overall Study||47
8239733|NCT01933789|20320939|P7|COMPLETED|Overall Study||43
8239734|NCT01933789|20320940|P6|COMPLETED|Overall Study||221
8239735|NCT01933789|20320941|P5|COMPLETED|Overall Study||190
8239736|NCT01933789|20320942|P4|COMPLETED|Overall Study||1
8239737|NCT01933789|20320943|P3|COMPLETED|Overall Study||2
8239738|NCT01933789|20320944|P2|COMPLETED|Overall Study||66
8239739|NCT01933789|20320945|P1|COMPLETED|Overall Study||59
8239740|NCT01933789|20320937|P9|Qualitative Interviews|Overall Study||25
8239741|NCT01933789|20320938|P8|Qualitative Interviews|Overall Study||0
8239742|NCT01933789|20320939|P7|Qualitative Interviews|Overall Study||0
8239743|NCT01933789|20320940|P6|Qualitative Interviews|Overall Study||0
8239744|NCT01933789|20320941|P5|Qualitative Interviews|Overall Study||0
8239745|NCT01933789|20320942|P4|Qualitative Interviews|Overall Study||0
8239746|NCT01933789|20320943|P3|Qualitative Interviews|Overall Study||0
8239747|NCT01933789|20320944|P2|Qualitative Interviews|Overall Study||0
8239748|NCT01933789|20320945|P1|Qualitative Interviews|Overall Study||0
8239749|NCT01933789|20320937|P9|Completed 6-Month Survey|Overall Study||0
8239750|NCT01933789|20320938|P8|Completed 6-Month Survey|Overall Study||40
8239751|NCT01933789|20320939|P7|Completed 6-Month Survey|Overall Study||35
8239752|NCT01933789|20320940|P6|Completed 6-Month Survey|Overall Study||188
8239753|NCT01933789|20320941|P5|Completed 6-Month Survey|Overall Study||160
8239754|NCT01933789|20320942|P4|Completed 6-Month Survey|Overall Study||0
8239755|NCT01933789|20320943|P3|Completed 6-Month Survey|Overall Study||0
8239756|NCT01933789|20320944|P2|Completed 6-Month Survey|Overall Study||0
8239757|NCT01933789|20320945|P1|Completed 6-Month Survey|Overall Study||0
8239758|NCT01933789|20320937|P9|Completed 3-Month Survey|Overall Study||0
8239759|NCT01933789|20320938|P8|Completed 3-Month Survey|Overall Study||43
8239760|NCT01933789|20320939|P7|Completed 3-Month Survey|Overall Study||37
8239761|NCT01933789|20320940|P6|Completed 3-Month Survey|Overall Study||211
8239762|NCT01933789|20320941|P5|Completed 3-Month Survey|Overall Study||176
8239763|NCT01933789|20320942|P4|Completed 3-Month Survey|Overall Study||0
8239764|NCT01933789|20320943|P3|Completed 3-Month Survey|Overall Study||0
8239765|NCT01933789|20320944|P2|Completed 3-Month Survey|Overall Study||0
8239766|NCT01933789|20320945|P1|Completed 3-Month Survey|Overall Study||0
8239767|NCT01933789|20320937|P9|Completed 2-Week Survey|Overall Study||0
8239768|NCT01933789|20320938|P8|Completed 2-Week Survey|Overall Study||0
8239769|NCT01933789|20320939|P7|Completed 2-Week Survey|Overall Study||0
8239770|NCT01933789|20320940|P6|Completed 2-Week Survey|Overall Study||215
8239771|NCT01933789|20320941|P5|Completed 2-Week Survey|Overall Study||184
8239772|NCT01933789|20320942|P4|Completed 2-Week Survey|Overall Study||0
8239773|NCT01933789|20320943|P3|Completed 2-Week Survey|Overall Study||0
8239774|NCT01933789|20320944|P2|Completed 2-Week Survey|Overall Study||0
8239775|NCT01933789|20320945|P1|Completed 2-Week Survey|Overall Study||0
8239776|NCT01933789|20320937|P9|Completed After-visit Survey|Overall Study||0
8239777|NCT01933789|20320938|P8|Completed After-visit Survey|Overall Study||0
8239778|NCT01933789|20320939|P7|Completed After-visit Survey|Overall Study||0
8239779|NCT01933789|20320940|P6|Completed After-visit Survey|Overall Study||0
8239780|NCT01933789|20320941|P5|Completed After-visit Survey|Overall Study||0
8239781|NCT01933789|20320942|P4|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
8239782|NCT01933789|20320943|P3|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
8239783|NCT01933789|20320944|P2|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
8239784|NCT01933789|20320945|P1|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
8239785|NCT01933789|20320937|P9|Had Target Visit|Overall Study||0
8239786|NCT01933789|20320938|P8|Had Target Visit|Overall Study||0
8239787|NCT01933789|20320939|P7|Had Target Visit|Overall Study||0
8239788|NCT01933789|20320940|P6|Had Target Visit|Overall Study||266
8239789|NCT01933789|20320941|P5|Had Target Visit|Overall Study||228
8239790|NCT01933789|20320942|P4|Had Target Visit|Overall Study||2
8239791|NCT01933789|20320943|P3|Had Target Visit|Overall Study||2
8239792|NCT01933789|20320944|P2|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
8239793|NCT01933789|20320945|P1|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
8239794|NCT01933789|20320937|P9|STARTED|Overall Study||25
8239795|NCT01933789|20320938|P8|STARTED|Overall Study||61
8239796|NCT01933789|20320939|P7|STARTED|Overall Study||58
8239797|NCT01933789|20320940|P6|STARTED|Overall Study||288
8239798|NCT01933789|20320941|P5|STARTED|Overall Study||249
8239799|NCT01933789|20320942|P4|STARTED|Overall Study||2
8239800|NCT01933789|20320943|P3|STARTED|Overall Study||2
8239801|NCT01933789|20320944|P2|STARTED|Overall Study||67
8239802|NCT01933789|20320945|P1|STARTED|Overall Study||65
8239803|NCT01933776|20321246|P2|NOT COMPLETED|Overall Study||0
8239804|NCT01933776|20321247|P1|NOT COMPLETED|Overall Study||0
8239805|NCT01933776|20321246|P2|COMPLETED|Overall Study||20
8239806|NCT01933776|20321247|P1|COMPLETED|Overall Study||20
8239807|NCT01933776|20321246|P2|STARTED|Overall Study||20
8239808|NCT01933776|20321247|P1|STARTED|Overall Study||20
8239809|NCT01933672|20321255|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239810|NCT01933672|20321256|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239811|NCT01933672|20321257|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239812|NCT01933672|20321258|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
8239813|NCT01933672|20321259|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239814|NCT01933672|20321260|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
8239815|NCT01933672|20321261|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239816|NCT01933672|20321255|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
8239817|NCT01933672|20321256|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
8239818|NCT01933672|20321257|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
8239819|NCT01933672|20321258|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
8239820|NCT01933672|20321259|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
8239821|NCT01933672|20321260|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
8239822|NCT01933672|20321261|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
8239823|NCT01933672|20321255|P7|STARTED|Third Intervention Period (12-16 Days)||6
8239824|NCT01933672|20321256|P6|STARTED|Third Intervention Period (12-16 Days)||4
8239825|NCT01933672|20321257|P5|STARTED|Third Intervention Period (12-16 Days)||6
8239826|NCT01933672|20321258|P4|STARTED|Third Intervention Period (12-16 Days)||5
8239827|NCT01933672|20321259|P3|STARTED|Third Intervention Period (12-16 Days)||1
8239828|NCT01933672|20321260|P2|STARTED|Third Intervention Period (12-16 Days)||6
8239829|NCT01933672|20321261|P1|STARTED|Third Intervention Period (12-16 Days)||0
8239830|NCT01933672|20321255|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239831|NCT01933672|20321256|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239832|NCT01933672|20321257|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239833|NCT01933672|20321258|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239834|NCT01933672|20321259|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239835|NCT01933672|20321260|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239836|NCT01933672|20321261|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239837|NCT01933672|20321255|P7|COMPLETED|Second Washout Period (7-14 Days)||6
8239838|NCT01933672|20321256|P6|COMPLETED|Second Washout Period (7-14 Days)||4
8239839|NCT01933672|20321257|P5|COMPLETED|Second Washout Period (7-14 Days)||6
8239840|NCT01933672|20321258|P4|COMPLETED|Second Washout Period (7-14 Days)||5
8239841|NCT01933672|20321259|P3|COMPLETED|Second Washout Period (7-14 Days)||1
8239842|NCT01933672|20321260|P2|COMPLETED|Second Washout Period (7-14 Days)||6
8239843|NCT01933672|20321261|P1|COMPLETED|Second Washout Period (7-14 Days)||0
8239844|NCT01933672|20321255|P7|STARTED|Second Washout Period (7-14 Days)||6
8239845|NCT01933672|20321256|P6|STARTED|Second Washout Period (7-14 Days)||4
8239846|NCT01933672|20321257|P5|STARTED|Second Washout Period (7-14 Days)||6
8239847|NCT01933672|20321258|P4|STARTED|Second Washout Period (7-14 Days)||5
8239848|NCT01933672|20321259|P3|STARTED|Second Washout Period (7-14 Days)||1
8239849|NCT01933672|20321260|P2|STARTED|Second Washout Period (7-14 Days)||6
8239850|NCT01933672|20321261|P1|STARTED|Second Washout Period (7-14 Days)||0
8239851|NCT01933672|20321255|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239852|NCT01933672|20321256|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239853|NCT01933672|20321257|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239854|NCT01933672|20321258|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239855|NCT01933672|20321259|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
8239856|NCT01933672|20321260|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
8239857|NCT01933672|20321261|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239858|NCT01933672|20321255|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
8239859|NCT01933672|20321256|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
8239860|NCT01933672|20321257|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
8239861|NCT01933672|20321258|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
8239862|NCT01933672|20321259|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
8239863|NCT01933672|20321260|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
8239864|NCT01933672|20321261|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
8239865|NCT01933672|20321255|P7|STARTED|Second Intervention Period (12-16 Days)||6
8239866|NCT01933672|20321256|P6|STARTED|Second Intervention Period (12-16 Days)||4
8239867|NCT01933672|20321257|P5|STARTED|Second Intervention Period (12-16 Days)||6
8239868|NCT01933672|20321258|P4|STARTED|Second Intervention Period (12-16 Days)||5
8239869|NCT01933672|20321259|P3|STARTED|Second Intervention Period (12-16 Days)||2
8239870|NCT01933672|20321260|P2|STARTED|Second Intervention Period (12-16 Days)||7
8239871|NCT01933672|20321261|P1|STARTED|Second Intervention Period (12-16 Days)||0
8239872|NCT01933672|20321255|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239873|NCT01933672|20321256|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239874|NCT01933672|20321257|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239875|NCT01933672|20321258|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239876|NCT01933672|20321259|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239877|NCT01933672|20321260|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239878|NCT01933672|20321261|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239879|NCT01933672|20321255|P7|COMPLETED|First Washout Period (7-14 Days)||6
8239880|NCT01933672|20321256|P6|COMPLETED|First Washout Period (7-14 Days)||4
8239881|NCT01933672|20321257|P5|COMPLETED|First Washout Period (7-14 Days)||6
8239882|NCT01933672|20321258|P4|COMPLETED|First Washout Period (7-14 Days)||5
8239883|NCT01933672|20321259|P3|COMPLETED|First Washout Period (7-14 Days)||2
8239884|NCT01933672|20321260|P2|COMPLETED|First Washout Period (7-14 Days)||7
8239885|NCT01933672|20321261|P1|COMPLETED|First Washout Period (7-14 Days)||0
8239886|NCT01933672|20321255|P7|STARTED|First Washout Period (7-14 Days)||6
8239887|NCT01933672|20321256|P6|STARTED|First Washout Period (7-14 Days)||4
8239888|NCT01933672|20321257|P5|STARTED|First Washout Period (7-14 Days)||6
8239889|NCT01933672|20321258|P4|STARTED|First Washout Period (7-14 Days)||5
8239890|NCT01933672|20321259|P3|STARTED|First Washout Period (7-14 Days)||2
8239891|NCT01933672|20321260|P2|STARTED|First Washout Period (7-14 Days)||7
8239892|NCT01933672|20321261|P1|STARTED|First Washout Period (7-14 Days)||0
8239893|NCT01933672|20321255|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239894|NCT01933672|20321256|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8239895|NCT01933672|20321257|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8239896|NCT01933672|20321258|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239897|NCT01933672|20321259|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8239898|NCT01933672|20321260|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239899|NCT01933672|20321261|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239900|NCT01933672|20321255|P7|COMPLETED|First Intervention Period (12-16 Days)||6
8239901|NCT01933672|20321256|P6|COMPLETED|First Intervention Period (12-16 Days)||4
8239902|NCT01933672|20321257|P5|COMPLETED|First Intervention Period (12-16 Days)||6
8239903|NCT01933672|20321258|P4|COMPLETED|First Intervention Period (12-16 Days)||5
8239904|NCT01933672|20321259|P3|COMPLETED|First Intervention Period (12-16 Days)||2
8239905|NCT01933672|20321260|P2|COMPLETED|First Intervention Period (12-16 Days)||7
8239906|NCT01933672|20321261|P1|COMPLETED|First Intervention Period (12-16 Days)||0
8239907|NCT01933672|20321255|P7|STARTED|First Intervention Period (12-16 Days)||6
8239908|NCT01933672|20321256|P6|STARTED|First Intervention Period (12-16 Days)||5
8239909|NCT01933672|20321257|P5|STARTED|First Intervention Period (12-16 Days)||7
8239910|NCT01933672|20321258|P4|STARTED|First Intervention Period (12-16 Days)||5
8239911|NCT01933672|20321259|P3|STARTED|First Intervention Period (12-16 Days)||3
8239912|NCT01933672|20321260|P2|STARTED|First Intervention Period (12-16 Days)||7
8239913|NCT01933672|20321261|P1|STARTED|First Intervention Period (12-16 Days)||0
8239914|NCT01933672|20321255|P7|NOT COMPLETED|Metformin Run-in Period||0
8239915|NCT01933672|20321256|P6|NOT COMPLETED|Metformin Run-in Period||0
8239916|NCT01933672|20321257|P5|NOT COMPLETED|Metformin Run-in Period||0
8239917|NCT01933672|20321258|P4|NOT COMPLETED|Metformin Run-in Period||0
8239918|NCT01933672|20321259|P3|NOT COMPLETED|Metformin Run-in Period||0
8239919|NCT01933672|20321260|P2|NOT COMPLETED|Metformin Run-in Period||0
8239920|NCT01933672|20321261|P1|NOT COMPLETED|Metformin Run-in Period||10
8239921|NCT01933672|20321255|P7|COMPLETED|Metformin Run-in Period||0
8239922|NCT01933672|20321256|P6|COMPLETED|Metformin Run-in Period||0
8239923|NCT01933672|20321257|P5|COMPLETED|Metformin Run-in Period||0
8239924|NCT01933672|20321258|P4|COMPLETED|Metformin Run-in Period||0
8239925|NCT01933672|20321259|P3|COMPLETED|Metformin Run-in Period||0
8239926|NCT01933672|20321260|P2|COMPLETED|Metformin Run-in Period||0
8239927|NCT01933672|20321261|P1|COMPLETED|Metformin Run-in Period||33
8239928|NCT01933672|20321255|P7|Received Treatment|Metformin Run-in Period||0
8239929|NCT01933672|20321256|P6|Received Treatment|Metformin Run-in Period||0
8239930|NCT01933672|20321257|P5|Received Treatment|Metformin Run-in Period||0
8239931|NCT01933672|20321258|P4|Received Treatment|Metformin Run-in Period||0
8239932|NCT01933672|20321259|P3|Received Treatment|Metformin Run-in Period||0
8239933|NCT01933672|20321260|P2|Received Treatment|Metformin Run-in Period||0
8239934|NCT01933672|20321261|P1|Received Treatment|Metformin Run-in Period||43
8239935|NCT01933672|20321255|P7|STARTED|Metformin Run-in Period||0
8239936|NCT01933672|20321256|P6|STARTED|Metformin Run-in Period||0
8239937|NCT01933672|20321257|P5|STARTED|Metformin Run-in Period||0
8239938|NCT01933672|20321258|P4|STARTED|Metformin Run-in Period||0
8239939|NCT01933672|20321259|P3|STARTED|Metformin Run-in Period||0
8239940|NCT01933672|20321260|P2|STARTED|Metformin Run-in Period||0
8239941|NCT01933672|20321261|P1|STARTED|Metformin Run-in Period||43
8239942|NCT01933594|20321313|P6|NOT COMPLETED|Overall Study||0
8239943|NCT01933594|20321314|P5|NOT COMPLETED|Overall Study||2
8239944|NCT01933594|20321315|P4|NOT COMPLETED|Overall Study||0
8239945|NCT01933594|20321316|P3|NOT COMPLETED|Overall Study||0
8239946|NCT01933594|20321317|P2|NOT COMPLETED|Overall Study||0
8239947|NCT01933594|20321318|P1|NOT COMPLETED|Overall Study||1
8239948|NCT01933594|20321313|P6|COMPLETED|Overall Study||3
8239949|NCT01933594|20321314|P5|COMPLETED|Overall Study||11
8239950|NCT01933594|20321315|P4|COMPLETED|Overall Study||7
8239951|NCT01933594|20321316|P3|COMPLETED|Overall Study||12
8239952|NCT01933594|20321317|P2|COMPLETED|Overall Study||12
8239953|NCT01933594|20321318|P1|COMPLETED|Overall Study||11
8239954|NCT01933594|20321313|P6|STARTED|Overall Study||3
8239955|NCT01933594|20321314|P5|STARTED|Overall Study||13
8239956|NCT01933594|20321315|P4|STARTED|Overall Study||7
8239957|NCT01933594|20321316|P3|STARTED|Overall Study||12
8239958|NCT01933594|20321317|P2|STARTED|Overall Study||12
8239959|NCT01933594|20321318|P1|STARTED|Overall Study||12
8239960|NCT01933464|20321410|P2|NOT COMPLETED|Overall Study||0
8239961|NCT01933464|20321411|P1|NOT COMPLETED|Overall Study||0
8239962|NCT01933464|20321410|P2|COMPLETED|Overall Study||5
8239963|NCT01933464|20321411|P1|COMPLETED|Overall Study||5
8239964|NCT01933464|20321410|P2|STARTED|Overall Study||5
8239965|NCT01933464|20321411|P1|STARTED|Overall Study||5
8239966|NCT01933425|20321423|P2|NOT COMPLETED|Overall Study||0
8239967|NCT01933425|20321424|P1|NOT COMPLETED|Overall Study||0
8239968|NCT01933425|20321423|P2|COMPLETED|Overall Study||7
8239969|NCT01933425|20321424|P1|COMPLETED|Overall Study||7
8239970|NCT01933425|20321423|P2|STARTED|Overall Study||7
8239971|NCT01933425|20321424|P1|STARTED|Overall Study||7
8239972|NCT01933399|20321437|P3|NOT COMPLETED|Overall Study||0
8239973|NCT01933399|20321438|P2|NOT COMPLETED|Overall Study||0
8239974|NCT01933399|20321439|P1|NOT COMPLETED|Overall Study||0
8239975|NCT01933399|20321437|P3|COMPLETED|Overall Study||37
8239976|NCT01933399|20321438|P2|COMPLETED|Overall Study||32
8239977|NCT01933399|20321439|P1|COMPLETED|Overall Study||29
8239978|NCT01933399|20321437|P3|STARTED|Overall Study||37
8239979|NCT01933399|20321438|P2|STARTED|Overall Study||32
8239980|NCT01933399|20321439|P1|STARTED|Overall Study||29
8239981|NCT01933334|20321452|P2|NOT COMPLETED|Overall Study||2
8239982|NCT01933334|20321453|P1|NOT COMPLETED|Overall Study||5
8239983|NCT01933334|20321452|P2|COMPLETED|Overall Study||29
8239984|NCT01933334|20321453|P1|COMPLETED|Overall Study||27
8239985|NCT01933334|20321452|P2|STARTED|Overall Study||31
8239986|NCT01933334|20321453|P1|STARTED|Overall Study||32
8239987|NCT01933243|20321465|P2|NOT COMPLETED|Overall Study||4
8239988|NCT01933243|20321466|P1|NOT COMPLETED|Overall Study||2
8239989|NCT01933243|20321465|P2|COMPLETED|Overall Study||8
8239990|NCT01933243|20321466|P1|COMPLETED|Overall Study||10
8239991|NCT01933243|20321465|P2|STARTED|Overall Study||12
8239992|NCT01933243|20321466|P1|STARTED|Overall Study||12
8239993|NCT01933230|20321476|P1|NOT COMPLETED|Overall Study||0
8239994|NCT01933230|20321476|P1|COMPLETED|Overall Study||2
8239995|NCT01933230|20321476|P1|STARTED|Overall Study||2
8239996|NCT01933217|20321482|P2|NOT COMPLETED|Crossover (4 Weeks)||0
8239997|NCT01933217|20321483|P1|NOT COMPLETED|Crossover (4 Weeks)||0
8239998|NCT01933217|20321482|P2|COMPLETED|Crossover (4 Weeks)||10
8239999|NCT01933217|20321483|P1|COMPLETED|Crossover (4 Weeks)||10
8240000|NCT01933217|20321482|P2|STARTED|Crossover (4 Weeks)||10
8240001|NCT01933217|20321483|P1|STARTED|Crossover (4 Weeks)||10
8240002|NCT01933217|20321482|P2|NOT COMPLETED|Randomization (4 Weeks)||4
8240003|NCT01933217|20321483|P1|NOT COMPLETED|Randomization (4 Weeks)||2
8240004|NCT01933217|20321482|P2|COMPLETED|Randomization (4 Weeks)||10
8240005|NCT01933217|20321483|P1|COMPLETED|Randomization (4 Weeks)||10
8240006|NCT01933217|20321482|P2|STARTED|Randomization (4 Weeks)||14
8240007|NCT01933217|20321483|P1|STARTED|Randomization (4 Weeks)||12
8240008|NCT01933113|20321495|P1|NOT COMPLETED|Overall Study||1
8240009|NCT01933113|20321495|P1|COMPLETED|Overall Study||2
8240010|NCT01933113|20321495|P1|STARTED|Overall Study||3
8240011|NCT01933048|20321501|P2|NOT COMPLETED|Overall Study||28
8240012|NCT01933048|20321502|P1|NOT COMPLETED|Overall Study||25
8240013|NCT01933048|20321501|P2|COMPLETED|Overall Study||501
8240014|NCT01933048|20321502|P1|COMPLETED|Overall Study||523
8240015|NCT01933048|20321501|P2|STARTED|Overall Study||529
8240016|NCT01933048|20321502|P1|STARTED|Overall Study||548
8240017|NCT01932996|20321517|P2|NOT COMPLETED|Overall Study||0
8240018|NCT01932996|20321518|P1|NOT COMPLETED|Overall Study||2
8240019|NCT01932996|20321517|P2|COMPLETED|Overall Study||180
8240020|NCT01932996|20321518|P1|COMPLETED|Overall Study||170
8240021|NCT01932996|20321517|P2|STARTED|Overall Study||180
8240022|NCT01932996|20321518|P1|STARTED|Overall Study||172
8240023|NCT01932970|20321528|P1|NOT COMPLETED|Overall Study||18
8240024|NCT01932970|20321528|P1|COMPLETED|Overall Study||140
8240025|NCT01932970|20321528|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
8240026|NCT01932970|20321528|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
8240027|NCT01932788|20321538|P2|NOT COMPLETED|Overall Study||51
8240028|NCT01932788|20321539|P1|NOT COMPLETED|Overall Study||38
8240029|NCT01932788|20321538|P2|COMPLETED|Overall Study||118
8240030|NCT01932788|20321539|P1|COMPLETED|Overall Study||135
8240031|NCT01932788|20321538|P2|STARTED|Overall Study||169
8240032|NCT01932788|20321539|P1|STARTED|Overall Study||173
8240045|NCT01932697|20321588|P2|NOT COMPLETED|Overall Study||0
8240046|NCT01932697|20321589|P1|NOT COMPLETED|Overall Study||2
8240047|NCT01932697|20321588|P2|COMPLETED|Overall Study||43
8240048|NCT01932697|20321589|P1|COMPLETED|Overall Study||36
8240049|NCT01932697|20321588|P2|STARTED|Overall Study||43
8240050|NCT01932697|20321589|P1|STARTED|Overall Study||38
8240051|NCT01932606|20321603|P2|NOT COMPLETED|Overall Study||0
8240052|NCT01932606|20321604|P1|NOT COMPLETED|Overall Study||0
8240053|NCT01932606|20321603|P2|COMPLETED|Overall Study||14
8240054|NCT01932606|20321604|P1|COMPLETED|Overall Study||14
8240055|NCT01932606|20321603|P2|STARTED|Overall Study||14
8240056|NCT01932606|20321604|P1|STARTED|Overall Study||14
8240057|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
8240058|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240059|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240060|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240061|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240062|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240063|NCT01932437|20321656|P6|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
8240064|NCT01932437|20321657|P5|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240065|NCT01932437|20321658|P4|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240066|NCT01932437|20321659|P3|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240067|NCT01932437|20321660|P2|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240068|NCT01932437|20321661|P1|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
8240069|NCT01932437|20321656|P6|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
8240070|NCT01932437|20321657|P5|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240071|NCT01932437|20321658|P4|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240072|NCT01932437|20321659|P3|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240073|NCT01932437|20321660|P2|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240074|NCT01932437|20321661|P1|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
8240075|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240076|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240077|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240078|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240079|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240080|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240081|NCT01932437|20321656|P6|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240082|NCT01932437|20321657|P5|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
8240083|NCT01932437|20321658|P4|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240084|NCT01932437|20321659|P3|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240085|NCT01932437|20321660|P2|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240086|NCT01932437|20321661|P1|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
8240087|NCT01932437|20321656|P6|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240088|NCT01932437|20321657|P5|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
8240089|NCT01932437|20321658|P4|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240090|NCT01932437|20321659|P3|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240091|NCT01932437|20321660|P2|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240092|NCT01932437|20321661|P1|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
8240093|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240094|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240095|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240096|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240097|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240098|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240099|NCT01932437|20321656|P6|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240100|NCT01932437|20321657|P5|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240101|NCT01932437|20321658|P4|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
8240102|NCT01932437|20321659|P3|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240103|NCT01932437|20321660|P2|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240104|NCT01932437|20321661|P1|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
8240105|NCT01932437|20321656|P6|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240106|NCT01932437|20321657|P5|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240107|NCT01932437|20321658|P4|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
8240108|NCT01932437|20321659|P3|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240109|NCT01932437|20321660|P2|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240110|NCT01932437|20321661|P1|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
8240111|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240112|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240113|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240114|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240115|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240116|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240117|NCT01932437|20321656|P6|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240118|NCT01932437|20321657|P5|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240119|NCT01932437|20321658|P4|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240120|NCT01932437|20321659|P3|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
8240121|NCT01932437|20321660|P2|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240122|NCT01932437|20321661|P1|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
8240123|NCT01932437|20321656|P6|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240124|NCT01932437|20321657|P5|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240125|NCT01932437|20321658|P4|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240126|NCT01932437|20321659|P3|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
8240127|NCT01932437|20321660|P2|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240128|NCT01932437|20321661|P1|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
8240129|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240130|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240131|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240132|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240133|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240134|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240135|NCT01932437|20321656|P6|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240136|NCT01932437|20321657|P5|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240137|NCT01932437|20321658|P4|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240138|NCT01932437|20321659|P3|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240139|NCT01932437|20321660|P2|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
8240140|NCT01932437|20321661|P1|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
8240141|NCT01932437|20321656|P6|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240142|NCT01932437|20321657|P5|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240143|NCT01932437|20321658|P4|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240144|NCT01932437|20321659|P3|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240145|NCT01932437|20321660|P2|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
8240146|NCT01932437|20321661|P1|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
8240147|NCT01932294|20321711|P1|NOT COMPLETED|Overall Study||99
8240148|NCT01932294|20321711|P1|COMPLETED|Overall Study||72
8240149|NCT01932294|20321711|P1|STARTED|Overall Study||171
8240150|NCT01932242|20321719|P2|NOT COMPLETED|Overall Study||5
8240151|NCT01932242|20321720|P1|NOT COMPLETED|Overall Study||5
8240152|NCT01932242|20321719|P2|COMPLETED|Overall Study||30
8240153|NCT01932242|20321720|P1|COMPLETED|Overall Study||30
8240154|NCT01932242|20321719|P2|STARTED|Overall Study||35
8240155|NCT01932242|20321720|P1|STARTED|Overall Study||35
8240156|NCT01932164|20321764|P1|NOT COMPLETED|Overall Study||0
8240157|NCT01932164|20321764|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
8240158|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
8240159|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
8240160|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
8240161|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
8240162|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
8240163|NCT01932164|20321764|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
8240164|NCT01932112|20321769|P1|NOT COMPLETED|Overall Study||0
8240165|NCT01932112|20321769|P1|COMPLETED|Overall Study||378
8240166|NCT01932112|20321769|P1|STARTED|Overall Study||378
8240167|NCT01932060|20321775|P2|NOT COMPLETED|Overall Study||0
8240168|NCT01932060|20321776|P1|NOT COMPLETED|Overall Study||0
8240169|NCT01932060|20321775|P2|COMPLETED|Overall Study||24
8240170|NCT01932060|20321776|P1|COMPLETED|Overall Study||27
8240171|NCT01932060|20321775|P2|STARTED|Overall Study||24
8240172|NCT01932060|20321776|P1|STARTED|Overall Study||27
8240173|NCT01931956|20321788|P4|NOT COMPLETED|Overall Study||133
8240174|NCT01931956|20321789|P3|NOT COMPLETED|Overall Study||487
8240175|NCT01931956|20321790|P2|NOT COMPLETED|Overall Study||7
8240176|NCT01931956|20321791|P1|NOT COMPLETED|Overall Study||51
8240177|NCT01931956|20321788|P4|COMPLETED|Overall Study||138
8240178|NCT01931956|20321789|P3|COMPLETED|Overall Study||141
8240179|NCT01931956|20321790|P2|COMPLETED|Overall Study||0
8240180|NCT01931956|20321791|P1|COMPLETED|Overall Study||8
8240181|NCT01931956|20321788|P4|STARTED|Overall Study||271
8240182|NCT01931956|20321789|P3|STARTED|Overall Study||628
8240183|NCT01931956|20321790|P2|STARTED|Overall Study||7
8240184|NCT01931956|20321791|P1|STARTED|Overall Study||59
8240185|NCT01931878|20322147|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
8240186|NCT01931878|20322148|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
8240187|NCT01931878|20322147|P2|COMPLETED|Second Intervention (After 3 Months)||12
8240188|NCT01931878|20322148|P1|COMPLETED|Second Intervention (After 3 Months)||9
8240189|NCT01931878|20322147|P2|STARTED|Second Intervention (After 3 Months)||14
8240190|NCT01931878|20322148|P1|STARTED|Second Intervention (After 3 Months)||9
8240191|NCT01931878|20322147|P2|NOT COMPLETED|First Intervention||0
8240192|NCT01931878|20322148|P1|NOT COMPLETED|First Intervention||1
8240193|NCT01931878|20322147|P2|COMPLETED|First Intervention||14
8240194|NCT01931878|20322148|P1|COMPLETED|First Intervention||9
8240195|NCT01931878|20322147|P2|STARTED|First Intervention||14
8240196|NCT01931878|20322148|P1|STARTED|First Intervention||10
8240197|NCT01931865|20322158|P1|NOT COMPLETED|Overall Study||4
8240198|NCT01931865|20322158|P1|COMPLETED|Overall Study||8
8240199|NCT01931865|20322158|P1|STARTED|Overall Study||12
8240200|NCT01931839|20322171|P7|NOT COMPLETED|Overall Study||4
8240201|NCT01931839|20322172|P6|NOT COMPLETED|Overall Study||5
8240202|NCT01931839|20322173|P5|NOT COMPLETED|Overall Study||1
8240203|NCT01931839|20322174|P4|NOT COMPLETED|Overall Study||14
8240204|NCT01931839|20322175|P3|NOT COMPLETED|Overall Study||39
8240205|NCT01931839|20322176|P2|NOT COMPLETED|Overall Study||26
8240206|NCT01931839|20322177|P1|NOT COMPLETED|Overall Study||41
8240207|NCT01931839|20322171|P7|COMPLETED|Overall Study||56
8240208|NCT01931839|20322172|P6|COMPLETED|Overall Study||50
8240209|NCT01931839|20322173|P5|COMPLETED|Overall Study||18
8240210|NCT01931839|20322174|P4|COMPLETED|Overall Study||162
8240211|NCT01931839|20322175|P3|COMPLETED|Overall Study||301
8240212|NCT01931839|20322176|P2|COMPLETED|Overall Study||152
8240213|NCT01931839|20322177|P1|COMPLETED|Overall Study||294
8240214|NCT01931839|20322171|P7|Safety Analysis Set (As Dosed)|Overall Study||60
8240215|NCT01931839|20322172|P6|Safety Analysis Set (As Dosed)|Overall Study||55
8240216|NCT01931839|20322173|P5|Safety Analysis Set (As Dosed)|Overall Study||19
8240217|NCT01931839|20322174|P4|Safety Analysis Set (As Dosed)|Overall Study||176
8240218|NCT01931839|20322175|P3|Safety Analysis Set (As Dosed)|Overall Study||340
8240219|NCT01931839|20322176|P2|Safety Analysis Set (As Dosed)|Overall Study||178
8240220|NCT01931839|20322177|P1|Safety Analysis Set (As Dosed)|Overall Study||335
8240221|NCT01931839|20322171|P7|Full Analysis Set (As Randomized)|Overall Study||60
8240222|NCT01931839|20322172|P6|Full Analysis Set (As Randomized)|Overall Study||55
8240223|NCT01931839|20322173|P5|Full Analysis Set (As Randomized)|Overall Study||19
8240224|NCT01931839|20322174|P4|Full Analysis Set (As Randomized)|Overall Study||176
8240225|NCT01931839|20322175|P3|Full Analysis Set (As Randomized)|Overall Study||340
8240226|NCT01931839|20322176|P2|Full Analysis Set (As Randomized)|Overall Study||179
8240227|NCT01931839|20322177|P1|Full Analysis Set (As Randomized)|Overall Study||334
8240228|NCT01931839|20322171|P7|STARTED|Overall Study||60
8240229|NCT01931839|20322172|P6|STARTED|Overall Study||55
8240230|NCT01931839|20322173|P5|STARTED|Overall Study||19
8240231|NCT01931839|20322174|P4|STARTED|Overall Study||176
8240232|NCT01931839|20322175|P3|STARTED|Overall Study||340
8240233|NCT01931839|20322176|P2|STARTED|Overall Study||178
8240234|NCT01931839|20322177|P1|STARTED|Overall Study||335
8240235|NCT01931735|20322249|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
8240236|NCT01931735|20322250|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
8240237|NCT01931735|20322251|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
8240238|NCT01931735|20322252|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
8240239|NCT01931735|20322249|P4|COMPLETED|Observational Non-Randomized Phase||9
8240240|NCT01931735|20322250|P3|COMPLETED|Observational Non-Randomized Phase||0
8240241|NCT01931735|20322251|P2|COMPLETED|Observational Non-Randomized Phase||1
8240242|NCT01931735|20322252|P1|COMPLETED|Observational Non-Randomized Phase||2
8240243|NCT01931735|20322249|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
8240244|NCT01931735|20322250|P3|STARTED|Observational Non-Randomized Phase||0
8240245|NCT01931735|20322251|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
8240246|NCT01931735|20322252|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
8240247|NCT01931735|20322249|P4|NOT COMPLETED|Randomized Phase||0
8240248|NCT01931735|20322250|P3|NOT COMPLETED|Randomized Phase||5
8240249|NCT01931735|20322251|P2|NOT COMPLETED|Randomized Phase||2
8240250|NCT01931735|20322252|P1|NOT COMPLETED|Randomized Phase||2
8240251|NCT01931735|20322249|P4|COMPLETED|Randomized Phase||0
8240252|NCT01931735|20322250|P3|COMPLETED|Randomized Phase||4
8240253|NCT01931735|20322251|P2|COMPLETED|Randomized Phase||1
8240254|NCT01931735|20322252|P1|COMPLETED|Randomized Phase||2
8240255|NCT01931735|20322249|P4|STARTED|Randomized Phase||0
8240256|NCT01931735|20322250|P3|STARTED|Randomized Phase||9
8240257|NCT01931735|20322251|P2|STARTED|Randomized Phase||3
8240258|NCT01931735|20322252|P1|STARTED|Randomized Phase||4
8240259|NCT01931709|20322286|P1|NOT COMPLETED|Overall Study||0
8240260|NCT01931709|20322286|P1|COMPLETED|Overall Study||35
8240261|NCT01931709|20322286|P1|STARTED|Overall Study||35
8240262|NCT01931670|20322299|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
8240263|NCT01931670|20322300|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
8240264|NCT01931670|20322301|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
8240265|NCT01931670|20322299|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
8240266|NCT01931670|20322300|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
8240267|NCT01931670|20322301|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
8240268|NCT01931670|20322299|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
8240269|NCT01931670|20322300|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
8240270|NCT01931670|20322301|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
8240271|NCT01931670|20322299|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
8240272|NCT01931670|20322300|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
8240273|NCT01931670|20322301|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
8240274|NCT01931670|20322299|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
8240275|NCT01931670|20322300|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
8240276|NCT01931670|20322301|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
8240277|NCT01931670|20322299|P3|NOT COMPLETED|Treatment Period||45
8240278|NCT01931670|20322300|P2|NOT COMPLETED|Treatment Period||48
8240279|NCT01931670|20322301|P1|NOT COMPLETED|Treatment Period||90
8240280|NCT01931670|20322299|P3|COMPLETED|Treatment Period||184
8240281|NCT01931670|20322300|P2|COMPLETED|Treatment Period||178
8240282|NCT01931670|20322301|P1|COMPLETED|Treatment Period||270
8240283|NCT01931670|20322299|P3|STARTED|Treatment Period||229
8240284|NCT01931670|20322300|P2|STARTED|Treatment Period||226
8240285|NCT01931670|20322301|P1|STARTED|Treatment Period||360
8240286|NCT01931566|20322402|P3|NOT COMPLETED|Overall Study||1506
8240287|NCT01931566|20322403|P2|NOT COMPLETED|Overall Study||1476
8240288|NCT01931566|20322404|P1|NOT COMPLETED|Overall Study||429
8240289|NCT01931566|20322402|P3|COMPLETED|Overall Study||39
8240290|NCT01931566|20322403|P2|COMPLETED|Overall Study||40
8240291|NCT01931566|20322404|P1|COMPLETED|Overall Study||4
8240292|NCT01931566|20322402|P3|Treated|Overall Study||1531
8240293|NCT01931566|20322403|P2|Treated|Overall Study||1507
8240294|NCT01931566|20322404|P1|Treated|Overall Study||427
8240295|NCT01931566|20322402|P3|STARTED|Overall Study||1545
8240296|NCT01931566|20322403|P2|STARTED|Overall Study||1516
8240297|NCT01931566|20322404|P1|STARTED|Overall Study||433
8240298|NCT01931527|20322419|P2|NOT COMPLETED|Overall Study||0
8240299|NCT01931527|20322420|P1|NOT COMPLETED|Overall Study||0
8240300|NCT01931527|20322419|P2|COMPLETED|Overall Study||15
8240301|NCT01931527|20322420|P1|COMPLETED|Overall Study||16
8240302|NCT01931527|20322419|P2|STARTED|Overall Study||15
8240303|NCT01931527|20322420|P1|STARTED|Overall Study||16
8240304|NCT01931475|20322442|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
8240305|NCT01931475|20322443|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
8240306|NCT01931475|20322442|P2|COMPLETED|Period 2: Extension Treatment Phase||157
8240307|NCT01931475|20322443|P1|COMPLETED|Period 2: Extension Treatment Phase||162
8240308|NCT01931475|20322442|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
8240309|NCT01931475|20322443|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
8240310|NCT01931475|20322442|P2|STARTED|Period 2: Extension Treatment Phase||176
8240311|NCT01931475|20322443|P1|STARTED|Period 2: Extension Treatment Phase||166
8240312|NCT01931475|20322442|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
8240313|NCT01931475|20322443|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
8240314|NCT01931475|20322442|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
8240315|NCT01931475|20322443|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
8240316|NCT01931475|20322442|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
8240317|NCT01931475|20322443|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
8240318|NCT01931475|20322442|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
8240319|NCT01931475|20322443|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
8240320|NCT01931462|20322470|P1|NOT COMPLETED|Overall Study||1
8240321|NCT01931462|20322470|P1|COMPLETED|Overall Study||1
8240322|NCT01931462|20322470|P1|STARTED|Overall Study||2
8240323|NCT01931397|20322481|P1|NOT COMPLETED|Overall Study||11
8240324|NCT01931397|20322481|P1|COMPLETED|Overall Study||19
8240325|NCT01931397|20322481|P1|STARTED|Overall Study||30
8240326|NCT01931202|20322493|P3|NOT COMPLETED|Overall Study||4
8240327|NCT01931202|20322494|P2|NOT COMPLETED|Overall Study||5
8240328|NCT01931202|20322495|P1|NOT COMPLETED|Overall Study||0
8240329|NCT01931202|20322493|P3|COMPLETED|Overall Study||45
8240330|NCT01931202|20322494|P2|COMPLETED|Overall Study||46
8240331|NCT01931202|20322495|P1|COMPLETED|Overall Study||8
8240332|NCT01931202|20322493|P3|STARTED|Overall Study||49
8240333|NCT01931202|20322494|P2|STARTED|Overall Study||51
8240334|NCT01931202|20322495|P1|STARTED|Overall Study||8
8240335|NCT01931150|20322541|P2|NOT COMPLETED|Overall Study||2
8240336|NCT01931150|20322542|P1|NOT COMPLETED|Overall Study||1
8240337|NCT01931150|20322541|P2|COMPLETED|Overall Study||4
8240338|NCT01931150|20322542|P1|COMPLETED|Overall Study||4
8240339|NCT01931150|20322541|P2|STARTED|Overall Study||6
8240340|NCT01931150|20322542|P1|STARTED|Overall Study||5
8240341|NCT01931098|20322550|P2|NOT COMPLETED|Overall Study||4
8240342|NCT01931098|20322551|P1|NOT COMPLETED|Overall Study||0
8240343|NCT01931098|20322550|P2|COMPLETED|Overall Study||22
8240344|NCT01931098|20322551|P1|COMPLETED|Overall Study||9
8240345|NCT01931098|20322550|P2|STARTED|Overall Study||26
8240346|NCT01931098|20322551|P1|STARTED|Overall Study||9
8240347|NCT01931059|20322567|P2|NOT COMPLETED|Day3||0
8240348|NCT01931059|20322568|P1|NOT COMPLETED|Day3||1
8240349|NCT01931059|20322567|P2|COMPLETED|Day3||4
8240350|NCT01931059|20322568|P1|COMPLETED|Day3||5
8240351|NCT01931059|20322567|P2|STARTED|Day3||4
8240352|NCT01931059|20322568|P1|STARTED|Day3||6
8240353|NCT01931059|20322567|P2|NOT COMPLETED|Day2||0
8240354|NCT01931059|20322568|P1|NOT COMPLETED|Day2||0
8240355|NCT01931059|20322567|P2|COMPLETED|Day2||4
8240356|NCT01931059|20322568|P1|COMPLETED|Day2||6
8240357|NCT01931059|20322567|P2|STARTED|Day2||4
8240358|NCT01931059|20322568|P1|STARTED|Day2||6
8240359|NCT01931059|20322567|P2|NOT COMPLETED|Day 1||1
8240360|NCT01931059|20322568|P1|NOT COMPLETED|Day 1||0
8240361|NCT01931059|20322567|P2|COMPLETED|Day 1||4
8240362|NCT01931059|20322568|P1|COMPLETED|Day 1||6
8240363|NCT01931059|20322567|P2|STARTED|Day 1||5
8240364|NCT01931059|20322568|P1|STARTED|Day 1||6
8240365|NCT01930890|20322584|P4|NOT COMPLETED|Overall Study||27
8240366|NCT01930890|20322585|P3|NOT COMPLETED|Overall Study||13
8240367|NCT01930890|20322586|P2|NOT COMPLETED|Overall Study||33
8240368|NCT01930890|20322587|P1|NOT COMPLETED|Overall Study||14
8240369|NCT01930890|20322584|P4|COMPLETED|Overall Study||0
8240370|NCT01930890|20322585|P3|COMPLETED|Overall Study||0
8240371|NCT01930890|20322586|P2|COMPLETED|Overall Study||0
8240372|NCT01930890|20322587|P1|COMPLETED|Overall Study||0
8240373|NCT01930890|20322584|P4|STARTED|Overall Study||27
8240374|NCT01930890|20322585|P3|STARTED|Overall Study||13
8240375|NCT01930890|20322586|P2|STARTED|Overall Study||33
8240376|NCT01930890|20322587|P1|STARTED|Overall Study||14
8240377|NCT01930799|20322601|P1|NOT COMPLETED|Overall Study||8
8240378|NCT01930799|20322601|P1|COMPLETED|Overall Study||112
8240379|NCT01930799|20322601|P1|STARTED|Overall Study||120
8240380|NCT01930747|20322609|P3|NOT COMPLETED|Overall Study||0
8240381|NCT01930747|20322610|P2|NOT COMPLETED|Overall Study||0
8240382|NCT01930747|20322611|P1|NOT COMPLETED|Overall Study||0
8240383|NCT01930747|20322609|P3|COMPLETED|Overall Study||12
8240384|NCT01930747|20322610|P2|COMPLETED|Overall Study||14
8240385|NCT01930747|20322611|P1|COMPLETED|Overall Study||16
8240386|NCT01930747|20322609|P3|STARTED|Overall Study||12
8240387|NCT01930747|20322610|P2|STARTED|Overall Study||14
8240388|NCT01930747|20322611|P1|STARTED|Overall Study||16
8240389|NCT01930643|20322627|P2|NOT COMPLETED|Overall Study||0
8240390|NCT01930643|20322628|P1|NOT COMPLETED|Overall Study||0
8240391|NCT01930643|20322627|P2|COMPLETED|Overall Study||6
8240392|NCT01930643|20322628|P1|COMPLETED|Overall Study||7
8240393|NCT01930643|20322627|P2|STARTED|Overall Study||6
8240394|NCT01930643|20322628|P1|STARTED|Overall Study||7
8240395|NCT01930487|20322634|P2|NOT COMPLETED|Second Intervention (30 Days)||0
8240396|NCT01930487|20322635|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8240397|NCT01930487|20322634|P2|COMPLETED|Second Intervention (30 Days)||23
8240398|NCT01930487|20322635|P1|COMPLETED|Second Intervention (30 Days)||19
8240399|NCT01930487|20322634|P2|STARTED|Second Intervention (30 Days)||23
8240400|NCT01930487|20322635|P1|STARTED|Second Intervention (30 Days)||19
8240401|NCT01930487|20322634|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
8240402|NCT01930487|20322635|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
8240403|NCT01930487|20322634|P2|COMPLETED|Washout Period (3 Weeks)||23
8240404|NCT01930487|20322635|P1|COMPLETED|Washout Period (3 Weeks)||19
8240405|NCT01930487|20322634|P2|STARTED|Washout Period (3 Weeks)||23
8240406|NCT01930487|20322635|P1|STARTED|Washout Period (3 Weeks)||19
8240407|NCT01930487|20322634|P2|NOT COMPLETED|First Intervention (30 Days)||2
8240408|NCT01930487|20322635|P1|NOT COMPLETED|First Intervention (30 Days)||2
8240409|NCT01930487|20322634|P2|COMPLETED|First Intervention (30 Days)||23
8240410|NCT01930487|20322635|P1|COMPLETED|First Intervention (30 Days)||19
8240411|NCT01930487|20322634|P2|STARTED|First Intervention (30 Days)||25
8240412|NCT01930487|20322635|P1|STARTED|First Intervention (30 Days)||21
8240413|NCT01930435|20322729|P1|NOT COMPLETED|Overall Study||0
8240414|NCT01930435|20322729|P1|COMPLETED|Overall Study||20
8240415|NCT01930435|20322729|P1|STARTED|Overall Study||20
8240416|NCT01930214|20322740|P3|NOT COMPLETED|Overall Study||25
8240417|NCT01930214|20322741|P2|NOT COMPLETED|Overall Study||21
8240418|NCT01930214|20322742|P1|NOT COMPLETED|Overall Study||20
8240419|NCT01930214|20322740|P3|COMPLETED|Overall Study||108
8240420|NCT01930214|20322741|P2|COMPLETED|Overall Study||96
8240421|NCT01930214|20322742|P1|COMPLETED|Overall Study||80
8240422|NCT01930214|20322740|P3|STARTED|Overall Study||133
8240423|NCT01930214|20322741|P2|STARTED|Overall Study||117
8240424|NCT01930214|20322742|P1|STARTED|Overall Study||100
8240425|NCT01930188|20322762|P3|NOT COMPLETED|Overall Study||19
8240426|NCT01930188|20322763|P2|NOT COMPLETED|Overall Study||21
8240427|NCT01930188|20322764|P1|NOT COMPLETED|Overall Study||22
8240428|NCT01930188|20322762|P3|COMPLETED|Overall Study||388
8240429|NCT01930188|20322763|P2|COMPLETED|Overall Study||388
8240430|NCT01930188|20322764|P1|COMPLETED|Overall Study||387
8240431|NCT01930188|20322762|P3|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
8240432|NCT01930188|20322763|P2|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
8240433|NCT01930188|20322764|P1|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
8240434|NCT01930188|20322762|P3|STARTED|Overall Study||407
8240435|NCT01930188|20322763|P2|STARTED|Overall Study||409
8240436|NCT01930188|20322764|P1|STARTED|Overall Study||409
8240437|NCT01930175|20322791|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240438|NCT01930175|20322792|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240439|NCT01930175|20322793|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240440|NCT01930175|20322791|P3|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
8240441|NCT01930175|20322792|P2|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240442|NCT01930175|20322793|P1|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240443|NCT01930175|20322791|P3|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
8240444|NCT01930175|20322792|P2|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
8240445|NCT01930175|20322793|P1|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
8240446|NCT01930175|20322791|P3|NOT COMPLETED|Core Study||1
8240447|NCT01930175|20322792|P2|NOT COMPLETED|Core Study||1
8240448|NCT01930175|20322793|P1|NOT COMPLETED|Core Study||0
8240449|NCT01930175|20322791|P3|COMPLETED|Core Study||3
8240450|NCT01930175|20322792|P2|COMPLETED|Core Study||1
8240451|NCT01930175|20322793|P1|COMPLETED|Core Study||7
8240452|NCT01930175|20322791|P3|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
8240453|NCT01930175|20322792|P2|Pharmacokinetics (PK) Analysis Set|Core Study||2
8240454|NCT01930175|20322793|P1|Pharmacokinetics (PK) Analysis Set|Core Study||7
8240455|NCT01930175|20322791|P3|Safety Analysis Set|Core Study||4
8240456|NCT01930175|20322792|P2|Safety Analysis Set|Core Study||2
8240457|NCT01930175|20322793|P1|Safety Analysis Set|Core Study||7
8240458|NCT01930175|20322791|P3|STARTED|Core Study||4
8240459|NCT01930175|20322792|P2|STARTED|Core Study||2
8240460|NCT01930175|20322793|P1|STARTED|Core Study||7
8240461|NCT01930162|20322823|P1|NOT COMPLETED|Overall Study||5
8240462|NCT01930162|20322823|P1|COMPLETED|Overall Study||4
8240463|NCT01930162|20322823|P1|STARTED|Overall Study||9
8240464|NCT01930058|20322835|P3|NOT COMPLETED|Overall Study||0
8240465|NCT01930058|20322836|P2|NOT COMPLETED|Overall Study||0
8240466|NCT01930058|20322837|P1|NOT COMPLETED|Overall Study||0
8240467|NCT01930058|20322835|P3|COMPLETED|Overall Study||3
8240468|NCT01930058|20322836|P2|COMPLETED|Overall Study||3
8240469|NCT01930058|20322837|P1|COMPLETED|Overall Study||3
8240470|NCT01930058|20322835|P3|STARTED|Overall Study||3
8240471|NCT01930058|20322836|P2|STARTED|Overall Study||3
8240472|NCT01930058|20322837|P1|STARTED|Overall Study||3
8240473|NCT01930045|20322859|P6|NOT COMPLETED|Part 2 - Period 5||0
8240474|NCT01930045|20322860|P5|NOT COMPLETED|Part 2 - Period 5||0
8240475|NCT01930045|20322861|P4|NOT COMPLETED|Part 2 - Period 5||0
8240476|NCT01930045|20322862|P3|NOT COMPLETED|Part 2 - Period 5||0
8240477|NCT01930045|20322863|P2|NOT COMPLETED|Part 2 - Period 5||0
8240478|NCT01930045|20322864|P1|NOT COMPLETED|Part 2 - Period 5||0
8240479|NCT01930045|20322859|P6|COMPLETED|Part 2 - Period 5||1
8240480|NCT01930045|20322860|P5|COMPLETED|Part 2 - Period 5||3
8240481|NCT01930045|20322861|P4|COMPLETED|Part 2 - Period 5||3
8240482|NCT01930045|20322862|P3|COMPLETED|Part 2 - Period 5||3
8240483|NCT01930045|20322863|P2|COMPLETED|Part 2 - Period 5||3
8240484|NCT01930045|20322864|P1|COMPLETED|Part 2 - Period 5||3
8240485|NCT01930045|20322859|P6|STARTED|Part 2 - Period 5||1
8240486|NCT01930045|20322860|P5|STARTED|Part 2 - Period 5||3
8240487|NCT01930045|20322861|P4|STARTED|Part 2 - Period 5||3
8240488|NCT01930045|20322862|P3|STARTED|Part 2 - Period 5||3
8240489|NCT01930045|20322863|P2|STARTED|Part 2 - Period 5||3
8240490|NCT01930045|20322864|P1|STARTED|Part 2 - Period 5||3
8240491|NCT01930045|20322859|P6|NOT COMPLETED|Part 2 - Period 4||0
8240492|NCT01930045|20322860|P5|NOT COMPLETED|Part 2 - Period 4||0
8240493|NCT01930045|20322861|P4|NOT COMPLETED|Part 2 - Period 4||0
8240494|NCT01930045|20322862|P3|NOT COMPLETED|Part 2 - Period 4||0
8240495|NCT01930045|20322863|P2|NOT COMPLETED|Part 2 - Period 4||0
8240496|NCT01930045|20322864|P1|NOT COMPLETED|Part 2 - Period 4||0
8240497|NCT01930045|20322859|P6|COMPLETED|Part 2 - Period 4||1
8240498|NCT01930045|20322860|P5|COMPLETED|Part 2 - Period 4||3
8240499|NCT01930045|20322861|P4|COMPLETED|Part 2 - Period 4||3
8240500|NCT01930045|20322862|P3|COMPLETED|Part 2 - Period 4||3
8240501|NCT01930045|20322863|P2|COMPLETED|Part 2 - Period 4||3
8240502|NCT01930045|20322864|P1|COMPLETED|Part 2 - Period 4||3
8240503|NCT01930045|20322859|P6|STARTED|Part 2 - Period 4||1
8240504|NCT01930045|20322860|P5|STARTED|Part 2 - Period 4||3
8240505|NCT01930045|20322861|P4|STARTED|Part 2 - Period 4||3
8240506|NCT01930045|20322862|P3|STARTED|Part 2 - Period 4||3
8240507|NCT01930045|20322863|P2|STARTED|Part 2 - Period 4||3
8240508|NCT01930045|20322864|P1|STARTED|Part 2 - Period 4||3
8240509|NCT01930045|20322859|P6|NOT COMPLETED|Pause (up to 37 Days)||2
8240510|NCT01930045|20322860|P5|NOT COMPLETED|Pause (up to 37 Days)||0
8240511|NCT01930045|20322861|P4|NOT COMPLETED|Pause (up to 37 Days)||0
8240512|NCT01930045|20322862|P3|NOT COMPLETED|Pause (up to 37 Days)||0
8240513|NCT01930045|20322863|P2|NOT COMPLETED|Pause (up to 37 Days)||0
8240514|NCT01930045|20322864|P1|NOT COMPLETED|Pause (up to 37 Days)||0
8240515|NCT01930045|20322859|P6|COMPLETED|Pause (up to 37 Days)||1
8240516|NCT01930045|20322860|P5|COMPLETED|Pause (up to 37 Days)||3
8240517|NCT01930045|20322861|P4|COMPLETED|Pause (up to 37 Days)||3
8240518|NCT01930045|20322862|P3|COMPLETED|Pause (up to 37 Days)||3
8240519|NCT01930045|20322863|P2|COMPLETED|Pause (up to 37 Days)||3
8240520|NCT01930045|20322864|P1|COMPLETED|Pause (up to 37 Days)||3
8240521|NCT01930045|20322859|P6|STARTED|Pause (up to 37 Days)||3
8240522|NCT01930045|20322860|P5|STARTED|Pause (up to 37 Days)||3
8240523|NCT01930045|20322861|P4|STARTED|Pause (up to 37 Days)||3
8240524|NCT01930045|20322862|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
8240525|NCT01930045|20322863|P2|STARTED|Pause (up to 37 Days)||3
8240526|NCT01930045|20322864|P1|STARTED|Pause (up to 37 Days)||3
8240527|NCT01930045|20322859|P6|NOT COMPLETED|Part 1 - Period 3||0
8240528|NCT01930045|20322860|P5|NOT COMPLETED|Part 1 - Period 3||0
8240529|NCT01930045|20322861|P4|NOT COMPLETED|Part 1 - Period 3||0
8240530|NCT01930045|20322862|P3|NOT COMPLETED|Part 1 - Period 3||0
8240531|NCT01930045|20322863|P2|NOT COMPLETED|Part 1 - Period 3||0
8240532|NCT01930045|20322864|P1|NOT COMPLETED|Part 1 - Period 3||0
8240533|NCT01930045|20322859|P6|COMPLETED|Part 1 - Period 3||3
8240534|NCT01930045|20322860|P5|COMPLETED|Part 1 - Period 3||3
8240535|NCT01930045|20322861|P4|COMPLETED|Part 1 - Period 3||3
8240536|NCT01930045|20322862|P3|COMPLETED|Part 1 - Period 3||2
8240537|NCT01930045|20322863|P2|COMPLETED|Part 1 - Period 3||3
8240538|NCT01930045|20322864|P1|COMPLETED|Part 1 - Period 3||3
8240539|NCT01930045|20322859|P6|STARTED|Part 1 - Period 3||3
8240540|NCT01930045|20322860|P5|STARTED|Part 1 - Period 3||3
8240541|NCT01930045|20322861|P4|STARTED|Part 1 - Period 3||3
8240542|NCT01930045|20322862|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
8240543|NCT01930045|20322863|P2|STARTED|Part 1 - Period 3||3
8240544|NCT01930045|20322864|P1|STARTED|Part 1 - Period 3||3
8240545|NCT01930045|20322859|P6|NOT COMPLETED|Part 1 - Period 2||0
8240546|NCT01930045|20322860|P5|NOT COMPLETED|Part 1 - Period 2||0
8240547|NCT01930045|20322861|P4|NOT COMPLETED|Part 1 - Period 2||0
8240548|NCT01930045|20322862|P3|NOT COMPLETED|Part 1 - Period 2||0
8240549|NCT01930045|20322863|P2|NOT COMPLETED|Part 1 - Period 2||0
8240550|NCT01930045|20322864|P1|NOT COMPLETED|Part 1 - Period 2||0
8240551|NCT01930045|20322859|P6|COMPLETED|Part 1 - Period 2||3
8240552|NCT01930045|20322860|P5|COMPLETED|Part 1 - Period 2||3
8240553|NCT01930045|20322861|P4|COMPLETED|Part 1 - Period 2||3
8240554|NCT01930045|20322862|P3|COMPLETED|Part 1 - Period 2||3
8240555|NCT01930045|20322863|P2|COMPLETED|Part 1 - Period 2||3
8240556|NCT01930045|20322864|P1|COMPLETED|Part 1 - Period 2||3
8240557|NCT01930045|20322859|P6|STARTED|Part 1 - Period 2||3
8240558|NCT01930045|20322860|P5|STARTED|Part 1 - Period 2||3
8240559|NCT01930045|20322861|P4|STARTED|Part 1 - Period 2||3
8240560|NCT01930045|20322862|P3|STARTED|Part 1 - Period 2||3
8240561|NCT01930045|20322863|P2|STARTED|Part 1 - Period 2||3
8240562|NCT01930045|20322864|P1|STARTED|Part 1 - Period 2||3
8240563|NCT01930045|20322859|P6|NOT COMPLETED|Part 1 - Period 1||0
8240564|NCT01930045|20322860|P5|NOT COMPLETED|Part 1 - Period 1||0
8240565|NCT01930045|20322861|P4|NOT COMPLETED|Part 1 - Period 1||0
8240566|NCT01930045|20322862|P3|NOT COMPLETED|Part 1 - Period 1||0
8240567|NCT01930045|20322863|P2|NOT COMPLETED|Part 1 - Period 1||0
8240568|NCT01930045|20322864|P1|NOT COMPLETED|Part 1 - Period 1||0
8240569|NCT01930045|20322859|P6|COMPLETED|Part 1 - Period 1||3
8240570|NCT01930045|20322860|P5|COMPLETED|Part 1 - Period 1||3
8240571|NCT01930045|20322861|P4|COMPLETED|Part 1 - Period 1||3
8240572|NCT01930045|20322862|P3|COMPLETED|Part 1 - Period 1||3
8240573|NCT01930045|20322863|P2|COMPLETED|Part 1 - Period 1||3
8240574|NCT01930045|20322864|P1|COMPLETED|Part 1 - Period 1||3
8240575|NCT01930045|20322859|P6|STARTED|Part 1 - Period 1||3
8240576|NCT01930045|20322860|P5|STARTED|Part 1 - Period 1||3
8240577|NCT01930045|20322861|P4|STARTED|Part 1 - Period 1||3
8240578|NCT01930045|20322862|P3|STARTED|Part 1 - Period 1||3
8240579|NCT01930045|20322863|P2|STARTED|Part 1 - Period 1||3
8240580|NCT01930045|20322864|P1|STARTED|Part 1 - Period 1||3
8240581|NCT01929993|20322891|P2|NOT COMPLETED|Overall Study||28
8240582|NCT01929993|20322892|P1|NOT COMPLETED|Overall Study||30
8240583|NCT01929993|20322891|P2|COMPLETED|Overall Study||54
8240584|NCT01929993|20322892|P1|COMPLETED|Overall Study||52
8240585|NCT01929993|20322891|P2|STARTED|Overall Study||82
8240586|NCT01929993|20322892|P1|STARTED|Overall Study||82
8240587|NCT01929980|20322898|P1|NOT COMPLETED|Overall Study||1
8240588|NCT01929980|20322898|P1|COMPLETED|Overall Study||3
8240589|NCT01929980|20322898|P1|STARTED|Overall Study||4
8240590|NCT01929889|20322902|P1|NOT COMPLETED|Overall Study||5
8240591|NCT01929889|20322902|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
8240592|NCT01929889|20322902|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
8240593|NCT01929876|20322906|P1|NOT COMPLETED|Period 2||1
8240594|NCT01929876|20322906|P1|COMPLETED|Period 2||15
8240595|NCT01929876|20322906|P1|STARTED|Period 2||16
8240596|NCT01929876|20322906|P1|NOT COMPLETED|Period 1||0
8240597|NCT01929876|20322906|P1|COMPLETED|Period 1||16
8240598|NCT01929876|20322906|P1|STARTED|Period 1||16
8240599|NCT01929863|20322919|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240600|NCT01929863|20322920|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240601|NCT01929863|20322919|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
8240602|NCT01929863|20322920|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
8240603|NCT01929863|20322919|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240604|NCT01929863|20322920|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240605|NCT01929863|20322919|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
8240606|NCT01929863|20322920|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
8240607|NCT01929863|20322919|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
8240608|NCT01929863|20322920|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
8240609|NCT01929863|20322919|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
8240610|NCT01929863|20322920|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
8240611|NCT01929863|20322919|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
8240612|NCT01929863|20322920|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
8240613|NCT01929863|20322919|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
8240614|NCT01929863|20322920|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
8240615|NCT01929863|20322919|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
8240616|NCT01929863|20322920|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
8240617|NCT01929863|20322919|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
8240618|NCT01929863|20322920|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
8240619|NCT01929863|20322919|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
8240620|NCT01929863|20322920|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
8240621|NCT01929863|20322919|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
8240622|NCT01929863|20322920|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
8240623|NCT01929759|20322963|P1|NOT COMPLETED|Overall Study||0
8240624|NCT01929759|20322963|P1|COMPLETED|Overall Study||10
8240625|NCT01929759|20322963|P1|STARTED|Overall Study||10
8240626|NCT01929707|20322975|P8|NOT COMPLETED|Intervention Period 2||0
8240627|NCT01929707|20322976|P7|NOT COMPLETED|Intervention Period 2||0
8240628|NCT01929707|20322977|P6|NOT COMPLETED|Intervention Period 2||2
8240629|NCT01929707|20322978|P5|NOT COMPLETED|Intervention Period 2||0
8240630|NCT01929707|20322979|P4|NOT COMPLETED|Intervention Period 2||0
8240631|NCT01929707|20322980|P3|NOT COMPLETED|Intervention Period 2||0
8240632|NCT01929707|20322981|P2|NOT COMPLETED|Intervention Period 2||0
8240633|NCT01929707|20322982|P1|NOT COMPLETED|Intervention Period 2||0
8240634|NCT01929707|20322975|P8|COMPLETED|Intervention Period 2||4
8240635|NCT01929707|20322976|P7|COMPLETED|Intervention Period 2||12
8240636|NCT01929707|20322977|P6|COMPLETED|Intervention Period 2||6
8240637|NCT01929707|20322978|P5|COMPLETED|Intervention Period 2||6
8240638|NCT01929707|20322979|P4|COMPLETED|Intervention Period 2||5
8240639|NCT01929707|20322980|P3|COMPLETED|Intervention Period 2||0
8240640|NCT01929707|20322981|P2|COMPLETED|Intervention Period 2||0
8240641|NCT01929707|20322982|P1|COMPLETED|Intervention Period 2||0
8240642|NCT01929707|20322975|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
8240643|NCT01929707|20322976|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
8240644|NCT01929707|20322977|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
8240645|NCT01929707|20322978|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
8240646|NCT01929707|20322979|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
8240647|NCT01929707|20322980|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
8240648|NCT01929707|20322981|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
8240649|NCT01929707|20322982|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
8240650|NCT01929707|20322975|P8|NOT COMPLETED|Washout Period ≥7 Days||0
8240651|NCT01929707|20322976|P7|NOT COMPLETED|Washout Period ≥7 Days||0
8240652|NCT01929707|20322977|P6|NOT COMPLETED|Washout Period ≥7 Days||0
8240653|NCT01929707|20322978|P5|NOT COMPLETED|Washout Period ≥7 Days||0
8240654|NCT01929707|20322979|P4|NOT COMPLETED|Washout Period ≥7 Days||0
8240655|NCT01929707|20322980|P3|NOT COMPLETED|Washout Period ≥7 Days||0
8240656|NCT01929707|20322981|P2|NOT COMPLETED|Washout Period ≥7 Days||0
8240657|NCT01929707|20322982|P1|NOT COMPLETED|Washout Period ≥7 Days||0
8240658|NCT01929707|20322975|P8|COMPLETED|Washout Period ≥7 Days||0
8240659|NCT01929707|20322976|P7|COMPLETED|Washout Period ≥7 Days||0
8240660|NCT01929707|20322977|P6|COMPLETED|Washout Period ≥7 Days||0
8240661|NCT01929707|20322978|P5|COMPLETED|Washout Period ≥7 Days||0
8240662|NCT01929707|20322979|P4|COMPLETED|Washout Period ≥7 Days||7
8240663|NCT01929707|20322980|P3|COMPLETED|Washout Period ≥7 Days||12
8240664|NCT01929707|20322981|P2|COMPLETED|Washout Period ≥7 Days||8
8240665|NCT01929707|20322982|P1|COMPLETED|Washout Period ≥7 Days||6
8240666|NCT01929707|20322975|P8|STARTED|Washout Period ≥7 Days||0
8240667|NCT01929707|20322976|P7|STARTED|Washout Period ≥7 Days||0
8240668|NCT01929707|20322977|P6|STARTED|Washout Period ≥7 Days||0
8240669|NCT01929707|20322978|P5|STARTED|Washout Period ≥7 Days||0
8240670|NCT01929707|20322979|P4|STARTED|Washout Period ≥7 Days||7
8240671|NCT01929707|20322980|P3|STARTED|Washout Period ≥7 Days||12
8240672|NCT01929707|20322981|P2|STARTED|Washout Period ≥7 Days||8
8240673|NCT01929707|20322982|P1|STARTED|Washout Period ≥7 Days||6
8240674|NCT01929707|20322975|P8|NOT COMPLETED|Intervention Period 1||0
8240675|NCT01929707|20322976|P7|NOT COMPLETED|Intervention Period 1||0
8240676|NCT01929707|20322977|P6|NOT COMPLETED|Intervention Period 1||0
8240677|NCT01929707|20322978|P5|NOT COMPLETED|Intervention Period 1||0
8240678|NCT01929707|20322979|P4|NOT COMPLETED|Intervention Period 1||3
8240679|NCT01929707|20322980|P3|NOT COMPLETED|Intervention Period 1||0
8240680|NCT01929707|20322981|P2|NOT COMPLETED|Intervention Period 1||0
8240681|NCT01929707|20322982|P1|NOT COMPLETED|Intervention Period 1||0
8240682|NCT01929707|20322975|P8|COMPLETED|Intervention Period 1||0
8240683|NCT01929707|20322976|P7|COMPLETED|Intervention Period 1||0
8240684|NCT01929707|20322977|P6|COMPLETED|Intervention Period 1||0
8240685|NCT01929707|20322978|P5|COMPLETED|Intervention Period 1||0
8240686|NCT01929707|20322979|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
8240687|NCT01929707|20322980|P3|COMPLETED|Intervention Period 1||12
8240688|NCT01929707|20322981|P2|COMPLETED|Intervention Period 1||8
8240689|NCT01929707|20322982|P1|COMPLETED|Intervention Period 1||6
8240690|NCT01929707|20322975|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240691|NCT01929707|20322976|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240692|NCT01929707|20322977|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240693|NCT01929707|20322978|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240694|NCT01929707|20322979|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
8240695|NCT01929707|20322980|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
8240696|NCT01929707|20322981|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
8240697|NCT01929707|20322982|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
8240698|NCT01929707|20322975|P8|STARTED|Intervention Period 1||0
8240699|NCT01929707|20322976|P7|STARTED|Intervention Period 1||0
8240700|NCT01929707|20322977|P6|STARTED|Intervention Period 1||0
8240701|NCT01929707|20322978|P5|STARTED|Intervention Period 1||0
8240702|NCT01929707|20322979|P4|STARTED|Intervention Period 1||10
8240703|NCT01929707|20322980|P3|STARTED|Intervention Period 1||12
8240704|NCT01929707|20322981|P2|STARTED|Intervention Period 1||8
8240705|NCT01929707|20322982|P1|STARTED|Intervention Period 1||6
8240706|NCT01929681|20323014|P2|NOT COMPLETED|Overall Study||1
8240707|NCT01929681|20323015|P1|NOT COMPLETED|Overall Study||2
8240708|NCT01929681|20323014|P2|COMPLETED|Overall Study||24
8240709|NCT01929681|20323015|P1|COMPLETED|Overall Study||26
8240710|NCT01929681|20323014|P2|STARTED|Overall Study||25
8240711|NCT01929681|20323015|P1|STARTED|Overall Study||28
8240712|NCT01929473|20323029|P1|NOT COMPLETED|Overall Study||587
8240713|NCT01929473|20323029|P1|COMPLETED|Overall Study||3243
8240714|NCT01929473|20323029|P1|365 Day|Overall Study||3589
8240715|NCT01929473|20323029|P1|STARTED|Overall Study|0 day|3830
8240716|NCT01929460|20323035|P2|NOT COMPLETED|Overall Study||0
8240717|NCT01929460|20323036|P1|NOT COMPLETED|Overall Study||0
8240718|NCT01929460|20323035|P2|COMPLETED|Overall Study||13
8240719|NCT01929460|20323036|P1|COMPLETED|Overall Study||13
8240720|NCT01929460|20323035|P2|STARTED|Overall Study||13
8240721|NCT01929460|20323036|P1|STARTED|Overall Study||13
8240722|NCT01929408|20323058|P1|NOT COMPLETED|Overall Study||8
8240723|NCT01929408|20323058|P1|COMPLETED|Overall Study||695
8240724|NCT01929408|20323058|P1|STARTED|Overall Study||703
8240725|NCT01929395|20323066|P3|NOT COMPLETED|Overall Study||1
8240726|NCT01929395|20323067|P2|NOT COMPLETED|Overall Study||1
8240727|NCT01929395|20323068|P1|NOT COMPLETED|Overall Study||1
8240728|NCT01929395|20323066|P3|COMPLETED|Overall Study||69
8240729|NCT01929395|20323067|P2|COMPLETED|Overall Study||69
8240730|NCT01929395|20323068|P1|COMPLETED|Overall Study||18
8240731|NCT01929395|20323066|P3|STARTED|Overall Study||70
8240732|NCT01929395|20323067|P2|STARTED|Overall Study||70
8240733|NCT01929395|20323068|P1|STARTED|Overall Study||19
8240734|NCT01929343|20323081|P3|NOT COMPLETED|Overall Study||0
8240735|NCT01929343|20323082|P2|NOT COMPLETED|Overall Study||2
8240736|NCT01929343|20323083|P1|NOT COMPLETED|Overall Study||1
8240737|NCT01929343|20323081|P3|COMPLETED|Overall Study||12
8240738|NCT01929343|20323082|P2|COMPLETED|Overall Study||7
8240739|NCT01929343|20323083|P1|COMPLETED|Overall Study||11
8240740|NCT01929343|20323081|P3|STARTED|Overall Study||12
8240741|NCT01929343|20323082|P2|STARTED|Overall Study||9
8240742|NCT01929343|20323083|P1|STARTED|Overall Study||12
8240743|NCT01929317|20323111|P2|NOT COMPLETED|Long-term Phase||4
8240744|NCT01929317|20323112|P1|NOT COMPLETED|Long-term Phase||19
8240745|NCT01929317|20323111|P2|COMPLETED|Long-term Phase||14
8240746|NCT01929317|20323112|P1|COMPLETED|Long-term Phase||25
8240747|NCT01929317|20323111|P2|STARTED|Long-term Phase||18
8240748|NCT01929317|20323112|P1|STARTED|Long-term Phase||44
8240749|NCT01929317|20323111|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
8240750|NCT01929317|20323112|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
8240751|NCT01929317|20323111|P2|COMPLETED|Dose Increase Effect Verification Phase||19
8240752|NCT01929317|20323112|P1|COMPLETED|Dose Increase Effect Verification Phase||52
8240753|NCT01929317|20323111|P2|STARTED|Dose Increase Effect Verification Phase||20
8240754|NCT01929317|20323112|P1|STARTED|Dose Increase Effect Verification Phase||61
8240755|NCT01929291|20323179|P1|NOT COMPLETED|Overall Study||0
8240756|NCT01929291|20323179|P1|COMPLETED|Overall Study||672
8240757|NCT01929291|20323179|P1|STARTED|Overall Study||672
8240758|NCT01929226|20323187|P2|NOT COMPLETED|Overall Study||1
8240759|NCT01929226|20323188|P1|NOT COMPLETED|Overall Study||5
8240760|NCT01929226|20323187|P2|COMPLETED|Overall Study||69
8240761|NCT01929226|20323188|P1|COMPLETED|Overall Study||205
8240762|NCT01929226|20323187|P2|STARTED|Overall Study||70
8240763|NCT01929226|20323188|P1|STARTED|Overall Study||210
8240764|NCT01929135|20323214|P2|NOT COMPLETED|Overall Study||1
8240765|NCT01929135|20323215|P1|NOT COMPLETED|Overall Study||1
8240766|NCT01929135|20323214|P2|COMPLETED|Overall Study||18
8240767|NCT01929135|20323215|P1|COMPLETED|Overall Study||18
8240768|NCT01929135|20323214|P2|STARTED|Overall Study||19
8240769|NCT01929135|20323215|P1|STARTED|Overall Study||19
8240770|NCT01929109|20323234|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240771|NCT01929109|20323235|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240772|NCT01929109|20323236|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240773|NCT01929109|20323237|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240774|NCT01929109|20323238|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240775|NCT01929109|20323234|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
8240776|NCT01929109|20323235|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240777|NCT01929109|20323236|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240778|NCT01929109|20323237|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240779|NCT01929109|20323238|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240780|NCT01929109|20323234|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
8240781|NCT01929109|20323235|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240782|NCT01929109|20323236|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240783|NCT01929109|20323237|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240784|NCT01929109|20323238|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240785|NCT01929109|20323234|P5|NOT COMPLETED|Period 1 (All Groups)||0
8240786|NCT01929109|20323235|P4|NOT COMPLETED|Period 1 (All Groups)||0
8240787|NCT01929109|20323236|P3|NOT COMPLETED|Period 1 (All Groups)||1
8240788|NCT01929109|20323237|P2|NOT COMPLETED|Period 1 (All Groups)||0
8240789|NCT01929109|20323238|P1|NOT COMPLETED|Period 1 (All Groups)||0
8240790|NCT01929109|20323234|P5|COMPLETED|Period 1 (All Groups)||8
8240791|NCT01929109|20323235|P4|COMPLETED|Period 1 (All Groups)||8
8240792|NCT01929109|20323236|P3|COMPLETED|Period 1 (All Groups)||8
8240793|NCT01929109|20323237|P2|COMPLETED|Period 1 (All Groups)||8
8240794|NCT01929109|20323238|P1|COMPLETED|Period 1 (All Groups)||14
8240795|NCT01929109|20323234|P5|STARTED|Period 1 (All Groups)||8
8240796|NCT01929109|20323235|P4|STARTED|Period 1 (All Groups)||8
8240797|NCT01929109|20323236|P3|STARTED|Period 1 (All Groups)||9
8240798|NCT01929109|20323237|P2|STARTED|Period 1 (All Groups)||8
8240799|NCT01929109|20323238|P1|STARTED|Period 1 (All Groups)||14
8240800|NCT01929083|20323257|P2|NOT COMPLETED|Intervention 2||1
8240801|NCT01929083|20323258|P1|NOT COMPLETED|Intervention 2||0
8240802|NCT01929083|20323257|P2|COMPLETED|Intervention 2||8
8240803|NCT01929083|20323258|P1|COMPLETED|Intervention 2||7
8240804|NCT01929083|20323257|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
8240805|NCT01929083|20323258|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
8240806|NCT01929083|20323257|P2|STARTED|Intervention 2||9
8240807|NCT01929083|20323258|P1|STARTED|Intervention 2||7
8240808|NCT01929083|20323257|P2|NOT COMPLETED|Intervention 1||0
8240809|NCT01929083|20323258|P1|NOT COMPLETED|Intervention 1||3
8240810|NCT01929083|20323257|P2|COMPLETED|Intervention 1||9
8240811|NCT01929083|20323258|P1|COMPLETED|Intervention 1||7
8240812|NCT01929083|20323257|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
8240813|NCT01929083|20323258|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
8240814|NCT01929083|20323257|P2|STARTED|Intervention 1||9
8240815|NCT01929083|20323258|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
8240816|NCT01929057|20323284|P2|NOT COMPLETED|Overall Study||0
8240817|NCT01929057|20323285|P1|NOT COMPLETED|Overall Study||0
8240818|NCT01929057|20323284|P2|COMPLETED|Overall Study||3
8240819|NCT01929057|20323285|P1|COMPLETED|Overall Study||31
8240820|NCT01929057|20323284|P2|STARTED|Overall Study||3
8240821|NCT01929057|20323285|P1|STARTED|Overall Study||31
8240822|NCT01929044|20323295|P2|NOT COMPLETED|Overall Study||17
8240823|NCT01929044|20323296|P1|NOT COMPLETED|Overall Study||11
8240824|NCT01929044|20323295|P2|COMPLETED|Overall Study||129
8240825|NCT01929044|20323296|P1|COMPLETED|Overall Study||142
8240826|NCT01929044|20323295|P2|STARTED|Overall Study||146
8240827|NCT01929044|20323296|P1|STARTED|Overall Study||153
8240828|NCT01929031|20323318|P6|NOT COMPLETED|Overall Study||1
8240829|NCT01929031|20323319|P5|NOT COMPLETED|Overall Study||1
8240830|NCT01929031|20323320|P4|NOT COMPLETED|Overall Study||0
8240831|NCT01929031|20323321|P3|NOT COMPLETED|Overall Study||1
8240832|NCT01929031|20323322|P2|NOT COMPLETED|Overall Study||2
8240833|NCT01929031|20323323|P1|NOT COMPLETED|Overall Study||4
8240834|NCT01929031|20323318|P6|COMPLETED|Overall Study||35
8240835|NCT01929031|20323319|P5|COMPLETED|Overall Study||33
8240836|NCT01929031|20323320|P4|COMPLETED|Overall Study||35
8240837|NCT01929031|20323321|P3|COMPLETED|Overall Study||34
8240838|NCT01929031|20323322|P2|COMPLETED|Overall Study||207
8240839|NCT01929031|20323323|P1|COMPLETED|Overall Study||209
8240840|NCT01929031|20323318|P6|STARTED|Overall Study||36
8240841|NCT01929031|20323319|P5|STARTED|Overall Study||34
8240842|NCT01929031|20323320|P4|STARTED|Overall Study||35
8240843|NCT01929031|20323321|P3|STARTED|Overall Study||35
8240844|NCT01929031|20323322|P2|STARTED|Overall Study||209
8240845|NCT01929031|20323323|P1|STARTED|Overall Study||213
8240846|NCT01929018|20323347|P2|NOT COMPLETED|Overall Study||1
8240847|NCT01929018|20323348|P1|NOT COMPLETED|Overall Study||1
8240848|NCT01929018|20323347|P2|COMPLETED|Overall Study||18
8240849|NCT01929018|20323348|P1|COMPLETED|Overall Study||18
8240850|NCT01929018|20323347|P2|STARTED|Overall Study||19
8240851|NCT01929018|20323348|P1|STARTED|Overall Study||19
8240852|NCT01928940|20323372|P2|NOT COMPLETED|Overall Study||1
8240853|NCT01928940|20323373|P1|NOT COMPLETED|Overall Study||0
8240854|NCT01928940|20323372|P2|COMPLETED|Overall Study||5
8240855|NCT01928940|20323373|P1|COMPLETED|Overall Study||6
8240856|NCT01928940|20323372|P2|STARTED|Overall Study||6
8240857|NCT01928940|20323373|P1|STARTED|Overall Study||6
8240858|NCT01928927|20323416|P2|NOT COMPLETED|Overall Study||1
8240859|NCT01928927|20323417|P1|NOT COMPLETED|Overall Study||2
8240860|NCT01928927|20323416|P2|COMPLETED|Overall Study||14
8240861|NCT01928927|20323417|P1|COMPLETED|Overall Study||27
8240862|NCT01928927|20323416|P2|STARTED|Overall Study||15
8240863|NCT01928927|20323417|P1|STARTED|Overall Study||29
8240864|NCT01928862|20323558|P5|NOT COMPLETED|Overall Study||1
8240865|NCT01928862|20323559|P4|NOT COMPLETED|Overall Study||0
8240866|NCT01928862|20323560|P3|NOT COMPLETED|Overall Study||0
8240867|NCT01928862|20323561|P2|NOT COMPLETED|Overall Study||0
8240868|NCT01928862|20323562|P1|NOT COMPLETED|Overall Study||1
8240869|NCT01928862|20323558|P5|COMPLETED|Overall Study||13
8240870|NCT01928862|20323559|P4|COMPLETED|Overall Study||16
8240871|NCT01928862|20323560|P3|COMPLETED|Overall Study||16
8240872|NCT01928862|20323561|P2|COMPLETED|Overall Study||16
8240873|NCT01928862|20323562|P1|COMPLETED|Overall Study||15
8240874|NCT01928862|20323558|P5|STARTED|Overall Study||14
8240875|NCT01928862|20323559|P4|STARTED|Overall Study||16
8240876|NCT01928862|20323560|P3|STARTED|Overall Study||16
8240877|NCT01928862|20323561|P2|STARTED|Overall Study||16
8240878|NCT01928862|20323562|P1|STARTED|Overall Study||16
8240879|NCT01928849|20323601|P2|NOT COMPLETED|Overall Study||7
8240880|NCT01928849|20323602|P1|NOT COMPLETED|Overall Study||14
8240881|NCT01928849|20323601|P2|COMPLETED|Overall Study||55
8240882|NCT01928849|20323602|P1|COMPLETED|Overall Study||52
8240883|NCT01928849|20323601|P2|STARTED|Overall Study||62
8240884|NCT01928849|20323602|P1|STARTED|Overall Study||66
8240885|NCT01928797|20323622|P2|NOT COMPLETED|Overall Study||0
8240886|NCT01928797|20323623|P1|NOT COMPLETED|Overall Study||0
8240887|NCT01928797|20323622|P2|COMPLETED|Overall Study||30
8240888|NCT01928797|20323623|P1|COMPLETED|Overall Study||30
8240889|NCT01928797|20323622|P2|STARTED|Overall Study||30
8240890|NCT01928797|20323623|P1|STARTED|Overall Study||30
8240891|NCT01928771|20323636|P3|NOT COMPLETED|Overall Study||40
8240892|NCT01928771|20323637|P2|NOT COMPLETED|Overall Study||40
8240893|NCT01928771|20323638|P1|NOT COMPLETED|Overall Study||46
8240894|NCT01928771|20323636|P3|COMPLETED|Overall Study||367
8240895|NCT01928771|20323637|P2|COMPLETED|Overall Study||358
8240896|NCT01928771|20323638|P1|COMPLETED|Overall Study||354
8240897|NCT01928771|20323636|P3|Received Treatment|Overall Study||407
8240898|NCT01928771|20323637|P2|Received Treatment|Overall Study||398
8240899|NCT01928771|20323638|P1|Received Treatment|Overall Study||399
8240900|NCT01928771|20323636|P3|STARTED|Overall Study||407
8240901|NCT01928771|20323637|P2|STARTED|Overall Study||398
8240902|NCT01928771|20323638|P1|STARTED|Overall Study||400
8240903|NCT01928758|20323717|P2|NOT COMPLETED|Overall Study||20
8240904|NCT01928758|20323718|P1|NOT COMPLETED|Overall Study||25
8240905|NCT01928758|20323717|P2|COMPLETED|Overall Study||74
8240906|NCT01928758|20323718|P1|COMPLETED|Overall Study||69
8240907|NCT01928758|20323717|P2|STARTED|Overall Study||94
8240908|NCT01928758|20323718|P1|STARTED|Overall Study||94
8240909|NCT01928719|20323736|P2|NOT COMPLETED|Overall Study||19
8240910|NCT01928719|20323737|P1|NOT COMPLETED|Overall Study||52
8240911|NCT01928719|20323736|P2|COMPLETED|Overall Study||104
8240912|NCT01928719|20323737|P1|COMPLETED|Overall Study||70
8240913|NCT01928719|20323736|P2|STARTED|Overall Study||123
8240914|NCT01928719|20323737|P1|STARTED|Overall Study||122
8240915|NCT01928693|20323757|P3|NOT COMPLETED|Overall Study||0
8240916|NCT01928693|20323758|P2|NOT COMPLETED|Overall Study||0
8240917|NCT01928693|20323759|P1|NOT COMPLETED|Overall Study||0
8240918|NCT01928693|20323757|P3|COMPLETED|Overall Study||1
8240919|NCT01928693|20323758|P2|COMPLETED|Overall Study||1
8240920|NCT01928693|20323759|P1|COMPLETED|Overall Study||0
8240921|NCT01928693|20323757|P3|STARTED|Overall Study||1
8240922|NCT01928693|20323758|P2|STARTED|Overall Study||1
8240923|NCT01928693|20323759|P1|STARTED|Overall Study||0
8240924|NCT01928680|20323785|P1|NOT COMPLETED|Overall Study||0
8240925|NCT01928680|20323785|P1|COMPLETED|Overall Study||33
8240926|NCT01928680|20323785|P1|STARTED|Overall Study||33
8240927|NCT01928615|20323789|P1|NOT COMPLETED|Overall Study||2
8240928|NCT01928615|20323789|P1|COMPLETED|Overall Study||0
8240929|NCT01928615|20323789|P1|STARTED|Overall Study||2
8240930|NCT01928485|20323806|P2|NOT COMPLETED|Overall Study||1
8240931|NCT01928485|20323807|P1|NOT COMPLETED|Overall Study||0
8240932|NCT01928485|20323806|P2|COMPLETED|Overall Study||1
8240933|NCT01928485|20323807|P1|COMPLETED|Overall Study||4
8240934|NCT01928485|20323806|P2|STARTED|Overall Study||2
8240935|NCT01928485|20323807|P1|STARTED|Overall Study||4
8240936|NCT01928472|20323859|P4|NOT COMPLETED|Overall Study||2
8240937|NCT01928472|20323860|P3|NOT COMPLETED|Overall Study||7
8240938|NCT01928472|20323861|P2|NOT COMPLETED|Overall Study||8
8240939|NCT01928472|20323862|P1|NOT COMPLETED|Overall Study||8
8240940|NCT01928472|20323859|P4|COMPLETED|Overall Study||100
8240941|NCT01928472|20323860|P3|COMPLETED|Overall Study||91
8240942|NCT01928472|20323861|P2|COMPLETED|Overall Study||96
8240943|NCT01928472|20323862|P1|COMPLETED|Overall Study||90
8240944|NCT01928472|20323859|P4|STARTED|Overall Study||102
8240945|NCT01928472|20323860|P3|STARTED|Overall Study||98
8240946|NCT01928472|20323861|P2|STARTED|Overall Study||104
8240947|NCT01928472|20323862|P1|STARTED|Overall Study||98
8240948|NCT01928433|20323932|P3|NOT COMPLETED|Overall Study||28
8240949|NCT01928433|20323933|P2|NOT COMPLETED|Overall Study||21
8240950|NCT01928433|20323934|P1|NOT COMPLETED|Overall Study||20
8240951|NCT01928433|20323932|P3|COMPLETED|Overall Study||46
8240952|NCT01928433|20323933|P2|COMPLETED|Overall Study||54
8240953|NCT01928433|20323934|P1|COMPLETED|Overall Study||56
8240954|NCT01928433|20323932|P3|STARTED|Overall Study||74
8240955|NCT01928433|20323933|P2|STARTED|Overall Study||75
8240956|NCT01928433|20323934|P1|STARTED|Overall Study||76
8240957|NCT01928394|20323980|P23|NOT COMPLETED|Follow-up Period||6
8240958|NCT01928394|20323981|P22|NOT COMPLETED|Follow-up Period||9
8240959|NCT01928394|20323982|P21|NOT COMPLETED|Follow-up Period||9
8240960|NCT01928394|20323983|P20|NOT COMPLETED|Follow-up Period||21
8240961|NCT01928394|20323984|P19|NOT COMPLETED|Follow-up Period||16
8240962|NCT01928394|20323985|P18|NOT COMPLETED|Follow-up Period||8
8240963|NCT01928394|20323986|P17|NOT COMPLETED|Follow-up Period||14
8240964|NCT01928394|20323987|P16|NOT COMPLETED|Follow-up Period||0
8240965|NCT01928394|20323988|P15|NOT COMPLETED|Follow-up Period||30
8240966|NCT01928394|20323989|P14|NOT COMPLETED|Follow-up Period||38
8240967|NCT01928394|20323990|P13|NOT COMPLETED|Follow-up Period||14
8240968|NCT01928394|20323991|P12|NOT COMPLETED|Follow-up Period||22
8240969|NCT01928394|20323992|P11|NOT COMPLETED|Follow-up Period||11
8240970|NCT01928394|20323993|P10|NOT COMPLETED|Follow-up Period||2
8240971|NCT01928394|20323994|P9|NOT COMPLETED|Follow-up Period||1
8240972|NCT01928394|20323995|P8|NOT COMPLETED|Follow-up Period||6
8240973|NCT01928394|20323996|P7|NOT COMPLETED|Follow-up Period||12
8240974|NCT01928394|20323997|P6|NOT COMPLETED|Follow-up Period||8
8240975|NCT01928394|20323998|P5|NOT COMPLETED|Follow-up Period||0
8240976|NCT01928394|20323999|P4|NOT COMPLETED|Follow-up Period||10
8240977|NCT01928394|20324000|P3|NOT COMPLETED|Follow-up Period||3
8240978|NCT01928394|20324001|P2|NOT COMPLETED|Follow-up Period||0
8240979|NCT01928394|20324002|P1|NOT COMPLETED|Follow-up Period||3
8240980|NCT01928394|20323980|P23|COMPLETED|Follow-up Period||36
8240981|NCT01928394|20323981|P22|COMPLETED|Follow-up Period||34
8240982|NCT01928394|20323982|P21|COMPLETED|Follow-up Period||32
8240983|NCT01928394|20323983|P20|COMPLETED|Follow-up Period||83
8240984|NCT01928394|20323984|P19|COMPLETED|Follow-up Period||76
8240985|NCT01928394|20323985|P18|COMPLETED|Follow-up Period||50
8240986|NCT01928394|20323986|P17|COMPLETED|Follow-up Period||41
8240987|NCT01928394|20323987|P16|COMPLETED|Follow-up Period||3
8240988|NCT01928394|20323988|P15|COMPLETED|Follow-up Period||66
8240989|NCT01928394|20323989|P14|COMPLETED|Follow-up Period||107
8240990|NCT01928394|20323990|P13|COMPLETED|Follow-up Period||47
8240991|NCT01928394|20323991|P12|COMPLETED|Follow-up Period||59
8240992|NCT01928394|20323992|P11|COMPLETED|Follow-up Period||19
8240993|NCT01928394|20323993|P10|COMPLETED|Follow-up Period||16
8240994|NCT01928394|20323994|P9|COMPLETED|Follow-up Period||2
8240995|NCT01928394|20323995|P8|COMPLETED|Follow-up Period||10
8240996|NCT01928394|20323996|P7|COMPLETED|Follow-up Period||40
8240997|NCT01928394|20323997|P6|COMPLETED|Follow-up Period||41
8240998|NCT01928394|20323998|P5|COMPLETED|Follow-up Period||3
8240999|NCT01928394|20323999|P4|COMPLETED|Follow-up Period||40
8241000|NCT01928394|20324000|P3|COMPLETED|Follow-up Period||15
8241001|NCT01928394|20324001|P2|COMPLETED|Follow-up Period||3
8241002|NCT01928394|20324002|P1|COMPLETED|Follow-up Period||12
8241003|NCT01928394|20323980|P23|STARTED|Follow-up Period||42
8241004|NCT01928394|20323981|P22|STARTED|Follow-up Period||43
8241005|NCT01928394|20323982|P21|STARTED|Follow-up Period||41
8241006|NCT01928394|20323983|P20|STARTED|Follow-up Period||104
8241007|NCT01928394|20323984|P19|STARTED|Follow-up Period||92
8241008|NCT01928394|20323985|P18|STARTED|Follow-up Period||58
8241009|NCT01928394|20323986|P17|STARTED|Follow-up Period||55
8241010|NCT01928394|20323987|P16|STARTED|Follow-up Period||3
8241011|NCT01928394|20323988|P15|STARTED|Follow-up Period||96
8241012|NCT01928394|20323989|P14|STARTED|Follow-up Period||145
8241013|NCT01928394|20323990|P13|STARTED|Follow-up Period||61
8241014|NCT01928394|20323991|P12|STARTED|Follow-up Period||81
8241015|NCT01928394|20323992|P11|STARTED|Follow-up Period||30
8241016|NCT01928394|20323993|P10|STARTED|Follow-up Period||18
8241017|NCT01928394|20323994|P9|STARTED|Follow-up Period||3
8241018|NCT01928394|20323995|P8|STARTED|Follow-up Period||16
8241019|NCT01928394|20323996|P7|STARTED|Follow-up Period||52
8241020|NCT01928394|20323997|P6|STARTED|Follow-up Period||49
8241021|NCT01928394|20323998|P5|STARTED|Follow-up Period||3
8241022|NCT01928394|20323999|P4|STARTED|Follow-up Period||50
8241023|NCT01928394|20324000|P3|STARTED|Follow-up Period||18
8241024|NCT01928394|20324001|P2|STARTED|Follow-up Period||3
8241025|NCT01928394|20324002|P1|STARTED|Follow-up Period||15
8241026|NCT01928394|20323980|P23|NOT COMPLETED|Treatment Period||39
8241027|NCT01928394|20323981|P22|NOT COMPLETED|Treatment Period||42
8241028|NCT01928394|20323982|P21|NOT COMPLETED|Treatment Period||40
8241029|NCT01928394|20323983|P20|NOT COMPLETED|Treatment Period||96
8241030|NCT01928394|20323984|P19|NOT COMPLETED|Treatment Period||70
8241031|NCT01928394|20323985|P18|NOT COMPLETED|Treatment Period||71
8241032|NCT01928394|20323986|P17|NOT COMPLETED|Treatment Period||50
8241033|NCT01928394|20323987|P16|NOT COMPLETED|Treatment Period||2
8241034|NCT01928394|20323988|P15|NOT COMPLETED|Treatment Period||88
8241035|NCT01928394|20323989|P14|NOT COMPLETED|Treatment Period||139
8241036|NCT01928394|20323990|P13|NOT COMPLETED|Treatment Period||55
8241037|NCT01928394|20323991|P12|NOT COMPLETED|Treatment Period||93
8241038|NCT01928394|20323992|P11|NOT COMPLETED|Treatment Period||30
8241039|NCT01928394|20323993|P10|NOT COMPLETED|Treatment Period||18
8241040|NCT01928394|20323994|P9|NOT COMPLETED|Treatment Period||3
8241041|NCT01928394|20323995|P8|NOT COMPLETED|Treatment Period||18
8241042|NCT01928394|20323996|P7|NOT COMPLETED|Treatment Period||49
8241043|NCT01928394|20323997|P6|NOT COMPLETED|Treatment Period||43
8241044|NCT01928394|20323998|P5|NOT COMPLETED|Treatment Period||3
8241045|NCT01928394|20323999|P4|NOT COMPLETED|Treatment Period||56
8241046|NCT01928394|20324000|P3|NOT COMPLETED|Treatment Period||18
8241047|NCT01928394|20324001|P2|NOT COMPLETED|Treatment Period||3
8241048|NCT01928394|20324002|P1|NOT COMPLETED|Treatment Period||18
8241049|NCT01928394|20323980|P23|COMPLETED|Treatment Period||3
8241050|NCT01928394|20323981|P22|COMPLETED|Treatment Period||1
8241051|NCT01928394|20323982|P21|COMPLETED|Treatment Period||1
8241052|NCT01928394|20323983|P20|COMPLETED|Treatment Period||8
8241053|NCT01928394|20323984|P19|COMPLETED|Treatment Period||22
8241054|NCT01928394|20323985|P18|COMPLETED|Treatment Period||7
8241055|NCT01928394|20323986|P17|COMPLETED|Treatment Period||5
8241056|NCT01928394|20323987|P16|COMPLETED|Treatment Period||1
8241057|NCT01928394|20323988|P15|COMPLETED|Treatment Period||8
8241058|NCT01928394|20323989|P14|COMPLETED|Treatment Period||8
8241059|NCT01928394|20323990|P13|COMPLETED|Treatment Period||6
8241060|NCT01928394|20323991|P12|COMPLETED|Treatment Period||5
8241061|NCT01928394|20323992|P11|COMPLETED|Treatment Period||0
8241062|NCT01928394|20323993|P10|COMPLETED|Treatment Period||0
8241063|NCT01928394|20323994|P9|COMPLETED|Treatment Period||0
8241064|NCT01928394|20323995|P8|COMPLETED|Treatment Period||0
8241065|NCT01928394|20323996|P7|COMPLETED|Treatment Period||3
8241066|NCT01928394|20323997|P6|COMPLETED|Treatment Period||6
8241067|NCT01928394|20323998|P5|COMPLETED|Treatment Period||0
8241068|NCT01928394|20323999|P4|COMPLETED|Treatment Period||3
8241069|NCT01928394|20324000|P3|COMPLETED|Treatment Period||0
8241070|NCT01928394|20324001|P2|COMPLETED|Treatment Period||0
8241071|NCT01928394|20324002|P1|COMPLETED|Treatment Period||0
8241072|NCT01928394|20323980|P23|Transition- Continued|Treatment Period||0
8241073|NCT01928394|20323981|P22|Transition- Continued|Treatment Period||0
8241074|NCT01928394|20323982|P21|Transition- Continued|Treatment Period||0
8241075|NCT01928394|20323983|P20|Transition- Continued|Treatment Period||19
8241076|NCT01928394|20323984|P19|Transition- Continued|Treatment Period||1
8241077|NCT01928394|20323985|P18|Transition- Continued|Treatment Period||0
8241078|NCT01928394|20323986|P17|Transition- Continued|Treatment Period||0
8241079|NCT01928394|20323987|P16|Transition- Continued|Treatment Period||0
8241080|NCT01928394|20323988|P15|Transition- Continued|Treatment Period||2
8241081|NCT01928394|20323989|P14|Transition- Continued|Treatment Period||0
8241082|NCT01928394|20323990|P13|Transition- Continued|Treatment Period||17
8241083|NCT01928394|20323991|P12|Transition- Continued|Treatment Period||0
8241084|NCT01928394|20323992|P11|Transition- Continued|Treatment Period||0
8241085|NCT01928394|20323993|P10|Transition- Continued|Treatment Period||1
8241086|NCT01928394|20323994|P9|Transition- Continued|Treatment Period||1
8241087|NCT01928394|20323995|P8|Transition- Continued|Treatment Period||0
8241088|NCT01928394|20323996|P7|Transition- Continued|Treatment Period||6
8241089|NCT01928394|20323997|P6|Transition- Continued|Treatment Period||3
8241090|NCT01928394|20323998|P5|Transition- Continued|Treatment Period||0
8241091|NCT01928394|20323999|P4|Transition- Continued|Treatment Period||0
8241092|NCT01928394|20324000|P3|Transition- Continued|Treatment Period||3
8241093|NCT01928394|20324001|P2|Transition- Continued|Treatment Period||0
8241094|NCT01928394|20324002|P1|Transition- Continued|Treatment Period||0
8241095|NCT01928394|20323980|P23|Transition|Treatment Period||0
8241096|NCT01928394|20323981|P22|Transition|Treatment Period||0
8241097|NCT01928394|20323982|P21|Transition|Treatment Period||0
8241098|NCT01928394|20323983|P20|Transition|Treatment Period||0
8241099|NCT01928394|20323984|P19|Transition|Treatment Period||0
8241100|NCT01928394|20323985|P18|Transition|Treatment Period||20
8241101|NCT01928394|20323986|P17|Transition|Treatment Period||0
8241102|NCT01928394|20323987|P16|Transition|Treatment Period||0
8241103|NCT01928394|20323988|P15|Transition|Treatment Period||0
8241104|NCT01928394|20323989|P14|Transition|Treatment Period||2
8241105|NCT01928394|20323990|P13|Transition|Treatment Period||0
8241106|NCT01928394|20323991|P12|Transition|Treatment Period||17
8241107|NCT01928394|20323992|P11|Transition|Treatment Period||0
8241108|NCT01928394|20323993|P10|Transition|Treatment Period||0
8241109|NCT01928394|20323994|P9|Transition|Treatment Period||0
8241110|NCT01928394|20323995|P8|Transition|Treatment Period||2
8241111|NCT01928394|20323996|P7|Transition|Treatment Period||0
8241112|NCT01928394|20323997|P6|Transition|Treatment Period||0
8241113|NCT01928394|20323998|P5|Transition|Treatment Period||0
8241114|NCT01928394|20323999|P4|Transition|Treatment Period||9
8241115|NCT01928394|20324000|P3|Transition|Treatment Period||0
8241116|NCT01928394|20324001|P2|Transition|Treatment Period||0
8241117|NCT01928394|20324002|P1|Transition|Treatment Period||3
8241118|NCT01928394|20323980|P23|STARTED|Treatment Period||42
8241119|NCT01928394|20323981|P22|STARTED|Treatment Period||43
8241120|NCT01928394|20323982|P21|STARTED|Treatment Period||41
8241121|NCT01928394|20323983|P20|STARTED|Treatment Period||104
8241122|NCT01928394|20323984|P19|STARTED|Treatment Period||92
8241123|NCT01928394|20323985|P18|STARTED|Treatment Period||78
8241124|NCT01928394|20323986|P17|STARTED|Treatment Period||55
8241125|NCT01928394|20323987|P16|STARTED|Treatment Period||3
8241126|NCT01928394|20323988|P15|STARTED|Treatment Period||96
8241127|NCT01928394|20323989|P14|STARTED|Treatment Period||147
8241128|NCT01928394|20323990|P13|STARTED|Treatment Period||61
8241129|NCT01928394|20323991|P12|STARTED|Treatment Period||98
8241130|NCT01928394|20323992|P11|STARTED|Treatment Period||30
8241131|NCT01928394|20323993|P10|STARTED|Treatment Period||18
8241132|NCT01928394|20323994|P9|STARTED|Treatment Period||3
8241133|NCT01928394|20323995|P8|STARTED|Treatment Period||18
8241134|NCT01928394|20323996|P7|STARTED|Treatment Period||52
8241135|NCT01928394|20323997|P6|STARTED|Treatment Period||49
8241136|NCT01928394|20323998|P5|STARTED|Treatment Period||3
8241137|NCT01928394|20323999|P4|STARTED|Treatment Period||59
8241138|NCT01928394|20324000|P3|STARTED|Treatment Period||18
8241139|NCT01928394|20324001|P2|STARTED|Treatment Period||3
8241140|NCT01928394|20324002|P1|STARTED|Treatment Period||18
8241141|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241142|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241143|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241144|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241145|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
8241146|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241147|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241148|NCT01928381|20324050|P7|COMPLETED|Part 2 - Post Third Intervention||5
8241149|NCT01928381|20324051|P6|COMPLETED|Part 2 - Post Third Intervention||5
8241150|NCT01928381|20324052|P5|COMPLETED|Part 2 - Post Third Intervention||3
8241151|NCT01928381|20324053|P4|COMPLETED|Part 2 - Post Third Intervention||4
8241152|NCT01928381|20324054|P3|COMPLETED|Part 2 - Post Third Intervention||3
8241153|NCT01928381|20324055|P2|COMPLETED|Part 2 - Post Third Intervention||5
8241154|NCT01928381|20324056|P1|COMPLETED|Part 2 - Post Third Intervention||0
8241155|NCT01928381|20324050|P7|STARTED|Part 2 - Post Third Intervention||5
8241156|NCT01928381|20324051|P6|STARTED|Part 2 - Post Third Intervention||5
8241157|NCT01928381|20324052|P5|STARTED|Part 2 - Post Third Intervention||3
8241158|NCT01928381|20324053|P4|STARTED|Part 2 - Post Third Intervention||4
8241159|NCT01928381|20324054|P3|STARTED|Part 2 - Post Third Intervention||4
8241160|NCT01928381|20324055|P2|STARTED|Part 2 - Post Third Intervention||5
8241161|NCT01928381|20324056|P1|STARTED|Part 2 - Post Third Intervention||0
8241162|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - Third Intervention||0
8241163|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - Third Intervention||0
8241164|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - Third Intervention||0
8241165|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - Third Intervention||0
8241166|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - Third Intervention||0
8241167|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - Third Intervention||0
8241168|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - Third Intervention||0
8241169|NCT01928381|20324050|P7|COMPLETED|Part 2 - Third Intervention||5
8241170|NCT01928381|20324051|P6|COMPLETED|Part 2 - Third Intervention||5
8241171|NCT01928381|20324052|P5|COMPLETED|Part 2 - Third Intervention||3
8241172|NCT01928381|20324053|P4|COMPLETED|Part 2 - Third Intervention||4
8241173|NCT01928381|20324054|P3|COMPLETED|Part 2 - Third Intervention||4
8241174|NCT01928381|20324055|P2|COMPLETED|Part 2 - Third Intervention||5
8241175|NCT01928381|20324056|P1|COMPLETED|Part 2 - Third Intervention||0
8241176|NCT01928381|20324050|P7|STARTED|Part 2 - Third Intervention||5
8241177|NCT01928381|20324051|P6|STARTED|Part 2 - Third Intervention||5
8241178|NCT01928381|20324052|P5|STARTED|Part 2 - Third Intervention||3
8241179|NCT01928381|20324053|P4|STARTED|Part 2 - Third Intervention||4
8241180|NCT01928381|20324054|P3|STARTED|Part 2 - Third Intervention||4
8241181|NCT01928381|20324055|P2|STARTED|Part 2 - Third Intervention||5
8241182|NCT01928381|20324056|P1|STARTED|Part 2 - Third Intervention||0
8241183|NCT01928381|20324050|P7|NOT COMPLETED|Washout Second Intervention||0
8241184|NCT01928381|20324051|P6|NOT COMPLETED|Washout Second Intervention||0
8241185|NCT01928381|20324052|P5|NOT COMPLETED|Washout Second Intervention||0
8241186|NCT01928381|20324053|P4|NOT COMPLETED|Washout Second Intervention||0
8241187|NCT01928381|20324054|P3|NOT COMPLETED|Washout Second Intervention||0
8241188|NCT01928381|20324055|P2|NOT COMPLETED|Washout Second Intervention||0
8241189|NCT01928381|20324056|P1|NOT COMPLETED|Washout Second Intervention||0
8241190|NCT01928381|20324050|P7|COMPLETED|Washout Second Intervention||5
8241191|NCT01928381|20324051|P6|COMPLETED|Washout Second Intervention||5
8241192|NCT01928381|20324052|P5|COMPLETED|Washout Second Intervention||3
8241193|NCT01928381|20324053|P4|COMPLETED|Washout Second Intervention||4
8241194|NCT01928381|20324054|P3|COMPLETED|Washout Second Intervention||4
8241195|NCT01928381|20324055|P2|COMPLETED|Washout Second Intervention||5
8241196|NCT01928381|20324056|P1|COMPLETED|Washout Second Intervention||0
8241197|NCT01928381|20324050|P7|STARTED|Washout Second Intervention||5
8241198|NCT01928381|20324051|P6|STARTED|Washout Second Intervention||5
8241199|NCT01928381|20324052|P5|STARTED|Washout Second Intervention||3
8241200|NCT01928381|20324053|P4|STARTED|Washout Second Intervention||4
8241201|NCT01928381|20324054|P3|STARTED|Washout Second Intervention||4
8241202|NCT01928381|20324055|P2|STARTED|Washout Second Intervention||5
8241203|NCT01928381|20324056|P1|STARTED|Washout Second Intervention||0
8241204|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - Second Intervention||0
8241205|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - Second Intervention||0
8241206|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - Second Intervention||0
8241207|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - Second Intervention||1
8241208|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - Second Intervention||0
8241209|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - Second Intervention||1
8241210|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - Second Intervention||0
8241211|NCT01928381|20324050|P7|COMPLETED|Part 2 - Second Intervention||5
8241212|NCT01928381|20324051|P6|COMPLETED|Part 2 - Second Intervention||5
8241213|NCT01928381|20324052|P5|COMPLETED|Part 2 - Second Intervention||3
8241214|NCT01928381|20324053|P4|COMPLETED|Part 2 - Second Intervention||4
8241215|NCT01928381|20324054|P3|COMPLETED|Part 2 - Second Intervention||4
8241216|NCT01928381|20324055|P2|COMPLETED|Part 2 - Second Intervention||5
8241217|NCT01928381|20324056|P1|COMPLETED|Part 2 - Second Intervention||0
8241218|NCT01928381|20324050|P7|STARTED|Part 2 - Second Intervention||5
8241219|NCT01928381|20324051|P6|STARTED|Part 2 - Second Intervention||5
8241220|NCT01928381|20324052|P5|STARTED|Part 2 - Second Intervention||3
8241221|NCT01928381|20324053|P4|STARTED|Part 2 - Second Intervention||5
8241222|NCT01928381|20324054|P3|STARTED|Part 2 - Second Intervention||4
8241223|NCT01928381|20324055|P2|STARTED|Part 2 - Second Intervention||6
8241224|NCT01928381|20324056|P1|STARTED|Part 2 - Second Intervention||0
8241225|NCT01928381|20324050|P7|NOT COMPLETED|Washout First Intervention||0
8241226|NCT01928381|20324051|P6|NOT COMPLETED|Washout First Intervention||0
8241227|NCT01928381|20324052|P5|NOT COMPLETED|Washout First Intervention||1
8241228|NCT01928381|20324053|P4|NOT COMPLETED|Washout First Intervention||0
8241229|NCT01928381|20324054|P3|NOT COMPLETED|Washout First Intervention||0
8241230|NCT01928381|20324055|P2|NOT COMPLETED|Washout First Intervention||0
8241231|NCT01928381|20324056|P1|NOT COMPLETED|Washout First Intervention||0
8241232|NCT01928381|20324050|P7|COMPLETED|Washout First Intervention||5
8241233|NCT01928381|20324051|P6|COMPLETED|Washout First Intervention||5
8241234|NCT01928381|20324052|P5|COMPLETED|Washout First Intervention||3
8241235|NCT01928381|20324053|P4|COMPLETED|Washout First Intervention||5
8241236|NCT01928381|20324054|P3|COMPLETED|Washout First Intervention||4
8241237|NCT01928381|20324055|P2|COMPLETED|Washout First Intervention||6
8241238|NCT01928381|20324056|P1|COMPLETED|Washout First Intervention||0
8241239|NCT01928381|20324050|P7|STARTED|Washout First Intervention||5
8241240|NCT01928381|20324051|P6|STARTED|Washout First Intervention||5
8241241|NCT01928381|20324052|P5|STARTED|Washout First Intervention||4
8241242|NCT01928381|20324053|P4|STARTED|Washout First Intervention||5
8241243|NCT01928381|20324054|P3|STARTED|Washout First Intervention||4
8241244|NCT01928381|20324055|P2|STARTED|Washout First Intervention||6
8241245|NCT01928381|20324056|P1|STARTED|Washout First Intervention||0
8241246|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - First Intervention||1
8241247|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - First Intervention||1
8241248|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - First Intervention||0
8241249|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - First Intervention||1
8241250|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - First Intervention||2
8241251|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - First Intervention||0
8241252|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - First Intervention||0
8241253|NCT01928381|20324050|P7|COMPLETED|Part 2 - First Intervention||5
8241254|NCT01928381|20324051|P6|COMPLETED|Part 2 - First Intervention||5
8241255|NCT01928381|20324052|P5|COMPLETED|Part 2 - First Intervention||4
8241256|NCT01928381|20324053|P4|COMPLETED|Part 2 - First Intervention||5
8241257|NCT01928381|20324054|P3|COMPLETED|Part 2 - First Intervention||4
8241258|NCT01928381|20324055|P2|COMPLETED|Part 2 - First Intervention||6
8241259|NCT01928381|20324056|P1|COMPLETED|Part 2 - First Intervention||0
8241260|NCT01928381|20324050|P7|STARTED|Part 2 - First Intervention||6
8241261|NCT01928381|20324051|P6|STARTED|Part 2 - First Intervention||6
8241262|NCT01928381|20324052|P5|STARTED|Part 2 - First Intervention||4
8241263|NCT01928381|20324053|P4|STARTED|Part 2 - First Intervention||6
8241264|NCT01928381|20324054|P3|STARTED|Part 2 - First Intervention||6
8241265|NCT01928381|20324055|P2|STARTED|Part 2 - First Intervention||6
8241266|NCT01928381|20324056|P1|STARTED|Part 2 - First Intervention||0
8241267|NCT01928381|20324050|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241268|NCT01928381|20324051|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241269|NCT01928381|20324052|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241270|NCT01928381|20324053|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241271|NCT01928381|20324054|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241272|NCT01928381|20324055|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241273|NCT01928381|20324056|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
8241274|NCT01928381|20324050|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241275|NCT01928381|20324051|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241276|NCT01928381|20324052|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241277|NCT01928381|20324053|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241278|NCT01928381|20324054|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241279|NCT01928381|20324055|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241280|NCT01928381|20324056|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
8241281|NCT01928381|20324050|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
8241282|NCT01928381|20324051|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
8241283|NCT01928381|20324052|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
8241284|NCT01928381|20324053|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
8241285|NCT01928381|20324054|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
8241286|NCT01928381|20324055|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
8241287|NCT01928381|20324056|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
8241288|NCT01928381|20324050|P7|NOT COMPLETED|Part 1 - Pain Training||0
8241289|NCT01928381|20324051|P6|NOT COMPLETED|Part 1 - Pain Training||0
8241290|NCT01928381|20324052|P5|NOT COMPLETED|Part 1 - Pain Training||0
8241291|NCT01928381|20324053|P4|NOT COMPLETED|Part 1 - Pain Training||0
8241292|NCT01928381|20324054|P3|NOT COMPLETED|Part 1 - Pain Training||0
8241293|NCT01928381|20324055|P2|NOT COMPLETED|Part 1 - Pain Training||0
8241294|NCT01928381|20324056|P1|NOT COMPLETED|Part 1 - Pain Training||35
8241295|NCT01928381|20324050|P7|COMPLETED|Part 1 - Pain Training||0
8241296|NCT01928381|20324051|P6|COMPLETED|Part 1 - Pain Training||0
8241297|NCT01928381|20324052|P5|COMPLETED|Part 1 - Pain Training||0
8241298|NCT01928381|20324053|P4|COMPLETED|Part 1 - Pain Training||0
8241299|NCT01928381|20324054|P3|COMPLETED|Part 1 - Pain Training||0
8241300|NCT01928381|20324055|P2|COMPLETED|Part 1 - Pain Training||0
8241301|NCT01928381|20324056|P1|COMPLETED|Part 1 - Pain Training||48
8241302|NCT01928381|20324050|P7|STARTED|Part 1 - Pain Training||0
8241303|NCT01928381|20324051|P6|STARTED|Part 1 - Pain Training||0
8241304|NCT01928381|20324052|P5|STARTED|Part 1 - Pain Training||0
8241305|NCT01928381|20324053|P4|STARTED|Part 1 - Pain Training||0
8241306|NCT01928381|20324054|P3|STARTED|Part 1 - Pain Training||0
8241307|NCT01928381|20324055|P2|STARTED|Part 1 - Pain Training||0
8241308|NCT01928381|20324056|P1|STARTED|Part 1 - Pain Training||83
8241309|NCT01928381|20324050|P7|NOT COMPLETED|Screening for Pain Training||0
8241310|NCT01928381|20324051|P6|NOT COMPLETED|Screening for Pain Training||0
8241311|NCT01928381|20324052|P5|NOT COMPLETED|Screening for Pain Training||0
8241312|NCT01928381|20324053|P4|NOT COMPLETED|Screening for Pain Training||0
8241313|NCT01928381|20324054|P3|NOT COMPLETED|Screening for Pain Training||0
8241314|NCT01928381|20324055|P2|NOT COMPLETED|Screening for Pain Training||0
8241315|NCT01928381|20324056|P1|NOT COMPLETED|Screening for Pain Training||60
8241316|NCT01928381|20324050|P7|COMPLETED|Screening for Pain Training||0
8241317|NCT01928381|20324051|P6|COMPLETED|Screening for Pain Training||0
8241318|NCT01928381|20324052|P5|COMPLETED|Screening for Pain Training||0
8241319|NCT01928381|20324053|P4|COMPLETED|Screening for Pain Training||0
8241320|NCT01928381|20324054|P3|COMPLETED|Screening for Pain Training||0
8241321|NCT01928381|20324055|P2|COMPLETED|Screening for Pain Training||0
8241322|NCT01928381|20324056|P1|COMPLETED|Screening for Pain Training||83
8241323|NCT01928381|20324050|P7|STARTED|Screening for Pain Training||0
8241324|NCT01928381|20324051|P6|STARTED|Screening for Pain Training||0
8241325|NCT01928381|20324052|P5|STARTED|Screening for Pain Training||0
8241326|NCT01928381|20324053|P4|STARTED|Screening for Pain Training||0
8241327|NCT01928381|20324054|P3|STARTED|Screening for Pain Training||0
8241328|NCT01928381|20324055|P2|STARTED|Screening for Pain Training||0
8241329|NCT01928381|20324056|P1|STARTED|Screening for Pain Training||143
8241330|NCT01928329|20324071|P2|NOT COMPLETED|Overall Study||14
8241331|NCT01928329|20324072|P1|NOT COMPLETED|Overall Study||12
8241332|NCT01928329|20324071|P2|COMPLETED|Overall Study||25
8241333|NCT01928329|20324072|P1|COMPLETED|Overall Study||28
8241334|NCT01928329|20324071|P2|STARTED|Overall Study||39
8241335|NCT01928329|20324072|P1|STARTED|Overall Study||40
8241336|NCT01928290|20324086|P2|NOT COMPLETED|Overall Study||0
8241337|NCT01928290|20324087|P1|NOT COMPLETED|Overall Study||0
8241338|NCT01928290|20324086|P2|COMPLETED|Overall Study||26
8241339|NCT01928290|20324087|P1|COMPLETED|Overall Study||41
8241340|NCT01928290|20324086|P2|STARTED|Overall Study||26
8241341|NCT01928290|20324087|P1|STARTED|Overall Study||41
8241342|NCT01928225|20324107|P2|NOT COMPLETED|Overall Study||3
8241343|NCT01928225|20324108|P1|NOT COMPLETED|Overall Study||3
8241344|NCT01928225|20324107|P2|COMPLETED|Overall Study||87
8241345|NCT01928225|20324108|P1|COMPLETED|Overall Study||87
8241346|NCT01928225|20324107|P2|STARTED|Overall Study||90
8241347|NCT01928225|20324108|P1|STARTED|Overall Study||90
8241348|NCT01928186|20324116|P1|NOT COMPLETED|Overall Study||0
8241349|NCT01928186|20324116|P1|COMPLETED|Overall Study||28
8241350|NCT01928186|20324116|P1|STARTED|Overall Study||28
8241351|NCT01928082|20324130|P1|NOT COMPLETED|Overall Study||1
8241352|NCT01928082|20324130|P1|COMPLETED|Overall Study||0
8241353|NCT01928082|20324130|P1|STARTED|Overall Study||1
8241354|NCT01928030|20324148|P3|NOT COMPLETED|Overall Study||0
8241355|NCT01928030|20324149|P2|NOT COMPLETED|Overall Study||0
8241356|NCT01928030|20324150|P1|NOT COMPLETED|Overall Study||0
8241357|NCT01928030|20324148|P3|COMPLETED|Overall Study||0
8241358|NCT01928030|20324149|P2|COMPLETED|Overall Study||0
8241359|NCT01928030|20324150|P1|COMPLETED|Overall Study||3
8241360|NCT01928030|20324148|P3|STARTED|Overall Study||0
8241361|NCT01928030|20324149|P2|STARTED|Overall Study||0
8241362|NCT01928030|20324150|P1|STARTED|Overall Study||3
8241363|NCT01927887|20324157|P1|NOT COMPLETED|Overall Study||0
8241364|NCT01927887|20324157|P1|COMPLETED|Overall Study||12
8241365|NCT01927887|20324157|P1|STARTED|Overall Study||12
8241366|NCT01927861|20324164|P2|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
8241367|NCT01927861|20324165|P1|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
8241368|NCT01927861|20324164|P2|COMPLETED|Extended Treatment Phase (26 Weeks)||14
8241369|NCT01927861|20324165|P1|COMPLETED|Extended Treatment Phase (26 Weeks)||15
8241370|NCT01927861|20324164|P2|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
8241371|NCT01927861|20324165|P1|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
8241372|NCT01927861|20324164|P2|NOT COMPLETED|Extension Phase (104 Weeks)||3
8241373|NCT01927861|20324165|P1|NOT COMPLETED|Extension Phase (104 Weeks)||0
8241374|NCT01927861|20324164|P2|COMPLETED|Extension Phase (104 Weeks)||23
8241375|NCT01927861|20324165|P1|COMPLETED|Extension Phase (104 Weeks)||25
8241376|NCT01927861|20324164|P2|STARTED|Extension Phase (104 Weeks)||26
8241377|NCT01927861|20324165|P1|STARTED|Extension Phase (104 Weeks)||25
8241378|NCT01927861|20324164|P2|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
8241379|NCT01927861|20324165|P1|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
8241380|NCT01927861|20324164|P2|COMPLETED|Pivotal Phase (104 Weeks)||26
8241381|NCT01927861|20324165|P1|COMPLETED|Pivotal Phase (104 Weeks)||25
8241382|NCT01927861|20324164|P2|STARTED|Pivotal Phase (104 Weeks)||26
8241383|NCT01927861|20324165|P1|STARTED|Pivotal Phase (104 Weeks)||25
8241384|NCT01927757|20324303|P1|NOT COMPLETED|Overall Study||23
8241385|NCT01927757|20324303|P1|COMPLETED|Overall Study||67
8241386|NCT01927757|20324303|P1|Received Etanercept|Overall Study||88
8241387|NCT01927757|20324303|P1|STARTED|Overall Study||90
8241388|NCT01927718|20324321|P1|NOT COMPLETED|Overall Study||0
8241389|NCT01927718|20324321|P1|COMPLETED|Overall Study||10
8241390|NCT01927718|20324321|P1|STARTED|Overall Study||10
8241391|NCT01927627|20324325|P1|NOT COMPLETED|Overall Study||5
8241392|NCT01927627|20324325|P1|COMPLETED|Overall Study||37
8241393|NCT01927627|20324325|P1|STARTED|Overall Study||42
8241394|NCT01927575|20324330|P1|NOT COMPLETED|Overall Study||0
8241395|NCT01927575|20324330|P1|COMPLETED|Overall Study||1
8241396|NCT01927575|20324330|P1|STARTED|Overall Study||1
8241397|NCT01927562|20324338|P1|NOT COMPLETED|Overall Study||38
8241398|NCT01927562|20324338|P1|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
8241399|NCT01927562|20324338|P1|STARTED|Overall Study||57
8241400|NCT01927419|20324344|P2|NOT COMPLETED|Overall Study||28
8241401|NCT01927419|20324345|P1|NOT COMPLETED|Overall Study||70
8241402|NCT01927419|20324344|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
8241403|NCT01927419|20324345|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
8241404|NCT01927419|20324344|P2|Received Treatment|Overall Study||46
8241405|NCT01927419|20324345|P1|Received Treatment|Overall Study||94
8241406|NCT01927419|20324344|P2|STARTED|Overall Study||47
8241407|NCT01927419|20324345|P1|STARTED|Overall Study||95
8241414|NCT01927120|20324378|P1|NOT COMPLETED|Overall Study||10
8241415|NCT01927120|20324378|P1|COMPLETED|Overall Study||10
8241416|NCT01927120|20324378|P1|STARTED|Overall Study||20
8241417|NCT01927055|20324396|P3|NOT COMPLETED|Double-Blind||13
8241418|NCT01927055|20324397|P2|NOT COMPLETED|Double-Blind||11
8241419|NCT01927055|20324398|P1|NOT COMPLETED|Double-Blind||0
8241420|NCT01927055|20324396|P3|COMPLETED|Double-Blind||10
8241421|NCT01927055|20324397|P2|COMPLETED|Double-Blind||11
8241422|NCT01927055|20324398|P1|COMPLETED|Double-Blind||0
8241423|NCT01927055|20324396|P3|STARTED|Double-Blind||23
8241424|NCT01927055|20324397|P2|STARTED|Double-Blind||22
8241425|NCT01927055|20324398|P1|STARTED|Double-Blind||0
8241426|NCT01927055|20324396|P3|NOT COMPLETED|Open-label||0
8241427|NCT01927055|20324397|P2|NOT COMPLETED|Open-label||0
8241428|NCT01927055|20324398|P1|NOT COMPLETED|Open-label||16
8241429|NCT01927055|20324396|P3|COMPLETED|Open-label||0
8241430|NCT01927055|20324397|P2|COMPLETED|Open-label||0
8241431|NCT01927055|20324398|P1|COMPLETED|Open-label||45
8241432|NCT01927055|20324396|P3|STARTED|Open-label||0
8241433|NCT01927055|20324397|P2|STARTED|Open-label||0
8241434|NCT01927055|20324398|P1|STARTED|Open-label||61
8241435|NCT01926977|20324407|P2|NOT COMPLETED|Overall Study||0
8241436|NCT01926977|20324408|P1|NOT COMPLETED|Overall Study||0
8241437|NCT01926977|20324407|P2|COMPLETED|Overall Study||53
8241438|NCT01926977|20324408|P1|COMPLETED|Overall Study||47
8241439|NCT01926977|20324407|P2|STARTED|Overall Study||53
8241440|NCT01926977|20324408|P1|STARTED|Overall Study||47
8241441|NCT01926886|20324416|P2|NOT COMPLETED|Overall Study||0
8241442|NCT01926886|20324417|P1|NOT COMPLETED|Overall Study||32
8241443|NCT01926886|20324416|P2|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
8241444|NCT01926886|20324417|P1|COMPLETED|Overall Study||70
8241445|NCT01926886|20324416|P2|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
8241446|NCT01926886|20324417|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
8241447|NCT01926886|20324416|P2|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
8241448|NCT01926886|20324417|P1|STARTED|Overall Study||102
8241449|NCT01926782|20324436|P6|NOT COMPLETED|Overall Study||41
8241450|NCT01926782|20324437|P5|NOT COMPLETED|Overall Study||8
8241451|NCT01926782|20324438|P4|NOT COMPLETED|Overall Study||20
8241452|NCT01926782|20324439|P3|NOT COMPLETED|Overall Study||40
8241453|NCT01926782|20324440|P2|NOT COMPLETED|Overall Study||13
8241454|NCT01926782|20324441|P1|NOT COMPLETED|Overall Study||28
8241455|NCT01926782|20324436|P6|COMPLETED|Overall Study||105
8241456|NCT01926782|20324437|P5|COMPLETED|Overall Study||29
8241457|NCT01926782|20324438|P4|COMPLETED|Overall Study||53
8241458|NCT01926782|20324439|P3|COMPLETED|Overall Study||272
8241459|NCT01926782|20324440|P2|COMPLETED|Overall Study||65
8241460|NCT01926782|20324441|P1|COMPLETED|Overall Study||129
8241461|NCT01926782|20324436|P6|Completed 24 Weeks Treatment Period|Overall Study||120
8241462|NCT01926782|20324437|P5|Completed 24 Weeks Treatment Period|Overall Study||31
8241463|NCT01926782|20324438|P4|Completed 24 Weeks Treatment Period|Overall Study||58
8241464|NCT01926782|20324439|P3|Completed 24 Weeks Treatment Period|Overall Study||285
8241465|NCT01926782|20324440|P2|Completed 24 Weeks Treatment Period|Overall Study||68
8241466|NCT01926782|20324441|P1|Completed 24 Weeks Treatment Period|Overall Study||137
8241467|NCT01926782|20324436|P6|Treated|Overall Study||146
8241468|NCT01926782|20324437|P5|Treated|Overall Study||37
8241469|NCT01926782|20324438|P4|Treated|Overall Study||72
8241470|NCT01926782|20324439|P3|Treated|Overall Study||312
8241471|NCT01926782|20324440|P2|Treated|Overall Study||78
8241472|NCT01926782|20324441|P1|Treated|Overall Study||157
8241473|NCT01926782|20324436|P6|STARTED|Overall Study||146
8241474|NCT01926782|20324437|P5|STARTED|Overall Study||37
8241475|NCT01926782|20324438|P4|STARTED|Overall Study||73
8241476|NCT01926782|20324439|P3|STARTED|Overall Study||312
8241477|NCT01926782|20324440|P2|STARTED|Overall Study||78
8241478|NCT01926782|20324441|P1|STARTED|Overall Study||157
8241479|NCT01926626|20324590|P1|NOT COMPLETED|Overall Study||22
8241480|NCT01926626|20324590|P1|COMPLETED|Overall Study||16
8241481|NCT01926626|20324590|P1|Received Moclobemide|Overall Study||37
8241482|NCT01926626|20324590|P1|STARTED|Overall Study||38
8241483|NCT01926509|20324604|P4|NOT COMPLETED|Overall Study||0
8241484|NCT01926509|20324605|P3|NOT COMPLETED|Overall Study||0
8241485|NCT01926509|20324606|P2|NOT COMPLETED|Overall Study||0
8241486|NCT01926509|20324607|P1|NOT COMPLETED|Overall Study||1
8241487|NCT01926509|20324604|P4|COMPLETED|Overall Study||6
8241488|NCT01926509|20324605|P3|COMPLETED|Overall Study||5
8241489|NCT01926509|20324606|P2|COMPLETED|Overall Study||6
8241490|NCT01926509|20324607|P1|COMPLETED|Overall Study||5
8241491|NCT01926509|20324604|P4|STARTED|Overall Study||6
8241492|NCT01926509|20324605|P3|STARTED|Overall Study||5
8241493|NCT01926509|20324606|P2|STARTED|Overall Study||6
8241494|NCT01926509|20324607|P1|STARTED|Overall Study||6
8241495|NCT01926496|20324626|P2|NOT COMPLETED|Overall Study||48
8241496|NCT01926496|20324627|P1|NOT COMPLETED|Overall Study||37
8241497|NCT01926496|20324626|P2|COMPLETED|Overall Study||197
8241498|NCT01926496|20324627|P1|COMPLETED|Overall Study||203
8241499|NCT01926496|20324626|P2|STARTED|Overall Study||245
8241500|NCT01926496|20324627|P1|STARTED|Overall Study||240
8241501|NCT01926444|20324647|P4|NOT COMPLETED|Overall Study||2
8241502|NCT01926444|20324648|P3|NOT COMPLETED|Overall Study||4
8241503|NCT01926444|20324649|P2|NOT COMPLETED|Overall Study||0
8241504|NCT01926444|20324650|P1|NOT COMPLETED|Overall Study||0
8241505|NCT01926444|20324647|P4|COMPLETED|Overall Study||101
8241506|NCT01926444|20324648|P3|COMPLETED|Overall Study||53
8241507|NCT01926444|20324649|P2|COMPLETED|Overall Study||52
8241508|NCT01926444|20324650|P1|COMPLETED|Overall Study||56
8241509|NCT01926444|20324647|P4|STARTED|Overall Study||103
8241510|NCT01926444|20324648|P3|STARTED|Overall Study||57
8241511|NCT01926444|20324649|P2|STARTED|Overall Study||52
8241512|NCT01926444|20324650|P1|STARTED|Overall Study||56
8241513|NCT01926119|20324692|P1|NOT COMPLETED|Overall Study||1
8241514|NCT01926119|20324692|P1|COMPLETED|Overall Study||3
8241515|NCT01926119|20324692|P1|STARTED|Overall Study||4
8241516|NCT01926028|20324705|P3|NOT COMPLETED|Overall Study||2
8241517|NCT01926028|20324706|P2|NOT COMPLETED|Overall Study||22
8241518|NCT01926028|20324707|P1|NOT COMPLETED|Overall Study||21
8241519|NCT01926028|20324705|P3|COMPLETED|Overall Study||12
8241520|NCT01926028|20324706|P2|COMPLETED|Overall Study||67
8241521|NCT01926028|20324707|P1|COMPLETED|Overall Study||64
8241522|NCT01926028|20324705|P3|STARTED|Overall Study||14
8241523|NCT01926028|20324706|P2|STARTED|Overall Study||89
8241524|NCT01926028|20324707|P1|STARTED|Overall Study||85
8241525|NCT01926015|20324743|P2|NOT COMPLETED|Overall Study||1
8241526|NCT01926015|20324744|P1|NOT COMPLETED|Overall Study||2
8241527|NCT01926015|20324743|P2|COMPLETED|Overall Study||95
8241528|NCT01926015|20324744|P1|COMPLETED|Overall Study||94
8241529|NCT01926015|20324743|P2|Received >=1 Vaccination|Overall Study||96
8241530|NCT01926015|20324744|P1|Received >=1 Vaccination|Overall Study||94
8241531|NCT01926015|20324743|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
8241532|NCT01926015|20324744|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
8241533|NCT01925989|20324776|P3|NOT COMPLETED|Period 2||0
8241534|NCT01925989|20324777|P2|NOT COMPLETED|Period 2||0
8241535|NCT01925989|20324778|P1|NOT COMPLETED|Period 2||0
8241536|NCT01925989|20324776|P3|COMPLETED|Period 2||12
8241537|NCT01925989|20324777|P2|COMPLETED|Period 2||6
8241538|NCT01925989|20324778|P1|COMPLETED|Period 2||6
8241539|NCT01925989|20324776|P3|STARTED|Period 2||12
8241540|NCT01925989|20324777|P2|STARTED|Period 2||6
8241541|NCT01925989|20324778|P1|STARTED|Period 2||6
8241542|NCT01925989|20324776|P3|NOT COMPLETED|Period 1||0
8241543|NCT01925989|20324777|P2|NOT COMPLETED|Period 1||2
8241544|NCT01925989|20324778|P1|NOT COMPLETED|Period 1||1
8241545|NCT01925989|20324776|P3|COMPLETED|Period 1||12
8241546|NCT01925989|20324777|P2|COMPLETED|Period 1||6
8241547|NCT01925989|20324778|P1|COMPLETED|Period 1||6
8241548|NCT01925989|20324776|P3|Received at Least 1 Dose of Study Drug|Period 1||0
8241549|NCT01925989|20324777|P2|Received at Least 1 Dose of Study Drug|Period 1||8
8241550|NCT01925989|20324778|P1|Received at Least 1 Dose of Study Drug|Period 1||7
8241551|NCT01925989|20324776|P3|STARTED|Period 1||12
8241552|NCT01925989|20324777|P2|STARTED|Period 1||8
8241553|NCT01925989|20324778|P1|STARTED|Period 1||7
8241554|NCT01925950|20324798|P2|NOT COMPLETED|Part 2||0
8241555|NCT01925950|20324799|P1|NOT COMPLETED|Part 2||1
8241556|NCT01925950|20324798|P2|COMPLETED|Part 2||0
8241557|NCT01925950|20324799|P1|COMPLETED|Part 2||0
8241558|NCT01925950|20324798|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
8241559|NCT01925950|20324799|P1|STARTED|Part 2||1
8241560|NCT01925950|20324798|P2|NOT COMPLETED|Part 1||0
8241561|NCT01925950|20324799|P1|NOT COMPLETED|Part 1||0
8241562|NCT01925950|20324798|P2|COMPLETED|Part 1||1
8241563|NCT01925950|20324799|P1|COMPLETED|Part 1||1
8241564|NCT01925950|20324798|P2|STARTED|Part 1||1
8241565|NCT01925950|20324799|P1|STARTED|Part 1||1
8241566|NCT01925781|20324807|P2|NOT COMPLETED|Overall Study||4
8241567|NCT01925781|20324808|P1|NOT COMPLETED|Overall Study||2
8241568|NCT01925781|20324807|P2|COMPLETED|Overall Study||1
8241569|NCT01925781|20324808|P1|COMPLETED|Overall Study||3
8241570|NCT01925781|20324807|P2|STARTED|Overall Study||5
8241571|NCT01925781|20324808|P1|STARTED|Overall Study||5
8241572|NCT01925768|20324818|P2|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
8241573|NCT01925768|20324819|P1|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
8241574|NCT01925768|20324818|P2|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
8241575|NCT01925768|20324819|P1|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
8241576|NCT01925768|20324818|P2|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
8241577|NCT01925768|20324819|P1|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
8241578|NCT01925768|20324818|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
8241579|NCT01925768|20324819|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
8241580|NCT01925768|20324818|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
8241581|NCT01925768|20324819|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
8241582|NCT01925768|20324818|P2|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
8241583|NCT01925768|20324819|P1|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
8241584|NCT01925768|20324818|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
8241585|NCT01925768|20324819|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
8241586|NCT01925768|20324818|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
8241587|NCT01925768|20324819|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
8241588|NCT01925768|20324818|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
8241589|NCT01925768|20324819|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
8241590|NCT01925703|20324867|P1|NOT COMPLETED|Overall Study||4
8241591|NCT01925703|20324867|P1|COMPLETED|Overall Study||9
8241592|NCT01925703|20324867|P1|Follow-up Completed|Overall Study||9
8241593|NCT01925703|20324867|P1|Full Iron Repletion Achieved|Overall Study||11
8241594|NCT01925703|20324867|P1|Dosing Regimen Completed|Overall Study||12
8241595|NCT01925703|20324867|P1|STARTED|Overall Study||13
8241596|NCT01925677|20324873|P1|NOT COMPLETED|Overall Study||0
8241597|NCT01925677|20324873|P1|COMPLETED|Overall Study||3
8241598|NCT01925677|20324873|P1|STARTED|Overall Study||3
8241599|NCT01925612|20324885|P5|NOT COMPLETED|Overall Study||2
8241600|NCT01925612|20324886|P4|NOT COMPLETED|Overall Study||1
8241601|NCT01925612|20324887|P3|NOT COMPLETED|Overall Study||1
8241602|NCT01925612|20324888|P2|NOT COMPLETED|Overall Study||4
8241603|NCT01925612|20324889|P1|NOT COMPLETED|Overall Study||4
8241604|NCT01925612|20324885|P5|COMPLETED|Overall Study||10
8241605|NCT01925612|20324886|P4|COMPLETED|Overall Study||10
8241606|NCT01925612|20324887|P3|COMPLETED|Overall Study||10
8241607|NCT01925612|20324888|P2|COMPLETED|Overall Study||18
8241608|NCT01925612|20324889|P1|COMPLETED|Overall Study||25
8241609|NCT01925612|20324885|P5|STARTED|Overall Study||12
8241610|NCT01925612|20324886|P4|STARTED|Overall Study||11
8241611|NCT01925612|20324887|P3|STARTED|Overall Study||11
8241612|NCT01925612|20324888|P2|STARTED|Overall Study||22
8241613|NCT01925612|20324889|P1|STARTED|Overall Study||29
8241614|NCT01925469|20324928|P2|NOT COMPLETED|Overall Study||0
8241615|NCT01925469|20324929|P1|NOT COMPLETED|Overall Study||1
8241616|NCT01925469|20324928|P2|COMPLETED|Overall Study||15
8241617|NCT01925469|20324929|P1|COMPLETED|Overall Study||14
8241618|NCT01925469|20324928|P2|STARTED|Overall Study||15
8241619|NCT01925469|20324929|P1|STARTED|Overall Study||15
8241620|NCT01925417|20324939|P1|NOT COMPLETED|Overall Study||3
8241621|NCT01925417|20324939|P1|COMPLETED|Overall Study||31
8241622|NCT01925417|20324939|P1|STARTED|Overall Study||34
8241623|NCT01925404|20324951|P4|NOT COMPLETED|Overall Study||0
8241624|NCT01925404|20324952|P3|NOT COMPLETED|Overall Study||0
8241625|NCT01925404|20324953|P2|NOT COMPLETED|Overall Study||0
8241626|NCT01925404|20324954|P1|NOT COMPLETED|Overall Study||0
8241627|NCT01925404|20324951|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241628|NCT01925404|20324952|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241629|NCT01925404|20324953|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241630|NCT01925404|20324954|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241631|NCT01925404|20324951|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
8241632|NCT01925404|20324952|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
8241633|NCT01925404|20324953|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
8241634|NCT01925404|20324954|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.
~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
8241635|NCT01925339|20324970|P2|NOT COMPLETED|Overall Study||0
8241636|NCT01925339|20324971|P1|NOT COMPLETED|Overall Study||2
8241637|NCT01925339|20324970|P2|COMPLETED|Overall Study||20
8241638|NCT01925339|20324971|P1|COMPLETED|Overall Study||18
8241639|NCT01925339|20324970|P2|STARTED|Overall Study||20
8241640|NCT01925339|20324971|P1|STARTED|Overall Study||20
8241641|NCT01925274|20324982|P3|NOT COMPLETED|Overall Study||6
8241642|NCT01925274|20324983|P2|NOT COMPLETED|Overall Study||6
8241643|NCT01925274|20324984|P1|NOT COMPLETED|Overall Study||7
8241644|NCT01925274|20324982|P3|COMPLETED|Overall Study||0
8241645|NCT01925274|20324983|P2|COMPLETED|Overall Study||0
8241646|NCT01925274|20324984|P1|COMPLETED|Overall Study||0
8241647|NCT01925274|20324982|P3|STARTED|Overall Study||6
8241648|NCT01925274|20324983|P2|STARTED|Overall Study||6
8241649|NCT01925274|20324984|P1|STARTED|Overall Study||7
8241650|NCT01925209|20325065|P4|NOT COMPLETED|Follow-up||4
8241651|NCT01925209|20325066|P3|NOT COMPLETED|Follow-up||1
8241652|NCT01925209|20325067|P2|NOT COMPLETED|Follow-up||6
8241653|NCT01925209|20325068|P1|NOT COMPLETED|Follow-up||1
8241654|NCT01925209|20325065|P4|COMPLETED|Follow-up||54
8241655|NCT01925209|20325066|P3|COMPLETED|Follow-up||55
8241656|NCT01925209|20325067|P2|COMPLETED|Follow-up||55
8241657|NCT01925209|20325068|P1|COMPLETED|Follow-up||56
8241658|NCT01925209|20325065|P4|STARTED|Follow-up||58
8241659|NCT01925209|20325066|P3|STARTED|Follow-up||56
8241660|NCT01925209|20325067|P2|STARTED|Follow-up||61
8241661|NCT01925209|20325068|P1|STARTED|Follow-up||57
8241662|NCT01925209|20325065|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
8241663|NCT01925209|20325066|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
8241664|NCT01925209|20325067|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
8241665|NCT01925209|20325068|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
8241666|NCT01925209|20325065|P4|COMPLETED|Maintenance Treatment Epoch||48
8241667|NCT01925209|20325066|P3|COMPLETED|Maintenance Treatment Epoch||50
8241668|NCT01925209|20325067|P2|COMPLETED|Maintenance Treatment Epoch||45
8241669|NCT01925209|20325068|P1|COMPLETED|Maintenance Treatment Epoch||49
8241670|NCT01925209|20325065|P4|STARTED|Maintenance Treatment Epoch||50
8241671|NCT01925209|20325066|P3|STARTED|Maintenance Treatment Epoch||52
8241672|NCT01925209|20325067|P2|STARTED|Maintenance Treatment Epoch||46
8241673|NCT01925209|20325068|P1|STARTED|Maintenance Treatment Epoch||49
8241674|NCT01925209|20325065|P4|NOT COMPLETED|Treatment Epoch||5
8241675|NCT01925209|20325066|P3|NOT COMPLETED|Treatment Epoch||7
8241676|NCT01925209|20325067|P2|NOT COMPLETED|Treatment Epoch||8
8241677|NCT01925209|20325068|P1|NOT COMPLETED|Treatment Epoch||9
8241678|NCT01925209|20325065|P4|COMPLETED|Treatment Epoch||57
8241679|NCT01925209|20325066|P3|COMPLETED|Treatment Epoch||56
8241680|NCT01925209|20325067|P2|COMPLETED|Treatment Epoch||55
8241681|NCT01925209|20325068|P1|COMPLETED|Treatment Epoch||54
8241682|NCT01925209|20325065|P4|Full Analysis Set|Treatment Epoch||62
8241683|NCT01925209|20325066|P3|Full Analysis Set|Treatment Epoch||63
8241684|NCT01925209|20325067|P2|Full Analysis Set|Treatment Epoch||63
8241685|NCT01925209|20325068|P1|Full Analysis Set|Treatment Epoch||63
8241686|NCT01925209|20325065|P4|STARTED|Treatment Epoch||62
8241687|NCT01925209|20325066|P3|STARTED|Treatment Epoch||63
8241688|NCT01925209|20325067|P2|STARTED|Treatment Epoch||63
8241689|NCT01925209|20325068|P1|STARTED|Treatment Epoch||63
8241690|NCT01925183|20325100|P2|NOT COMPLETED|Overall Study||0
8241691|NCT01925183|20325101|P1|NOT COMPLETED|Overall Study||1
8241692|NCT01925183|20325100|P2|COMPLETED|Overall Study||3
8241693|NCT01925183|20325101|P1|COMPLETED|Overall Study||2
8241694|NCT01925183|20325100|P2|STARTED|Overall Study||3
8241695|NCT01925183|20325101|P1|STARTED|Overall Study||3
8241696|NCT01925170|20325109|P1|NOT COMPLETED|Overall Study||53
8241697|NCT01925170|20325109|P1|COMPLETED|Overall Study||1585
8241698|NCT01925170|20325109|P1|STARTED|Overall Study||1638
8241699|NCT01925144|20325127|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
8241700|NCT01925144|20325127|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
8241701|NCT01925144|20325127|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
8241702|NCT01925144|20325127|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
8241703|NCT01925144|20325127|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
8241704|NCT01925144|20325127|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
8241705|NCT01925144|20325127|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
8241706|NCT01925144|20325127|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
8241707|NCT01925144|20325127|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
8241708|NCT01925014|20325140|P2|NOT COMPLETED|Overall Study||19
8241709|NCT01925014|20325141|P1|NOT COMPLETED|Overall Study||9
8241710|NCT01925014|20325140|P2|COMPLETED|Overall Study||1520
8241711|NCT01925014|20325141|P1|COMPLETED|Overall Study||1526
8241712|NCT01925014|20325140|P2|STARTED|Overall Study||1539
8241713|NCT01925014|20325141|P1|STARTED|Overall Study||1535
8241714|NCT01924988|20325175|P1|NOT COMPLETED|Overall Study||0
8241715|NCT01924988|20325175|P1|COMPLETED|Overall Study||15
8241716|NCT01924988|20325175|P1|STARTED|Overall Study||15
8241717|NCT01924975|20325187|P2|NOT COMPLETED|Overall Study||0
8241718|NCT01924975|20325188|P1|NOT COMPLETED|Overall Study||0
8241719|NCT01924975|20325187|P2|COMPLETED|Overall Study||51
8241720|NCT01924975|20325188|P1|COMPLETED|Overall Study||51
8241721|NCT01924975|20325187|P2|STARTED|Overall Study||51
8241722|NCT01924975|20325188|P1|STARTED|Overall Study||51
8241723|NCT01924949|20325198|P1|NOT COMPLETED|Overall Study||0
8241724|NCT01924949|20325198|P1|COMPLETED|Overall Study||5
8241725|NCT01924949|20325198|P1|STARTED|Overall Study||5
8241726|NCT01924871|20325209|P2|NOT COMPLETED|Overall Study||2
8241727|NCT01924871|20325210|P1|NOT COMPLETED|Overall Study||6
8241728|NCT01924871|20325209|P2|COMPLETED|Overall Study||29
8241729|NCT01924871|20325210|P1|COMPLETED|Overall Study||25
8241730|NCT01924871|20325209|P2|STARTED|Overall Study||31
8241731|NCT01924871|20325210|P1|STARTED|Overall Study||31
8241732|NCT01924845|20325216|P1|NOT COMPLETED|Overall Study||6
8241733|NCT01924845|20325216|P1|COMPLETED|Overall Study||18
8241734|NCT01924845|20325216|P1|STARTED|Overall Study||24
8241735|NCT01924806|20325226|P2|NOT COMPLETED|Overall Study||1
8241736|NCT01924806|20325227|P1|NOT COMPLETED|Overall Study||2
8241737|NCT01924806|20325226|P2|COMPLETED|Overall Study||3
8241738|NCT01924806|20325227|P1|COMPLETED|Overall Study||3
8241739|NCT01924806|20325226|P2|STARTED|Overall Study||4
8241740|NCT01924806|20325227|P1|STARTED|Overall Study||5
8241741|NCT01924767|20325244|P5|NOT COMPLETED|Overall Study||0
8241742|NCT01924767|20325245|P4|NOT COMPLETED|Overall Study||0
8241743|NCT01924767|20325246|P3|NOT COMPLETED|Overall Study||1
8241744|NCT01924767|20325247|P2|NOT COMPLETED|Overall Study||0
8241745|NCT01924767|20325248|P1|NOT COMPLETED|Overall Study||1
8241746|NCT01924767|20325244|P5|COMPLETED|Overall Study||9
8241747|NCT01924767|20325245|P4|COMPLETED|Overall Study||9
8241748|NCT01924767|20325246|P3|COMPLETED|Overall Study||8
8241749|NCT01924767|20325247|P2|COMPLETED|Overall Study||9
8241750|NCT01924767|20325248|P1|COMPLETED|Overall Study||11
8241751|NCT01924767|20325244|P5|STARTED|Overall Study||9
8241752|NCT01924767|20325245|P4|STARTED|Overall Study||9
8241753|NCT01924767|20325246|P3|STARTED|Overall Study||9
8241754|NCT01924767|20325247|P2|STARTED|Overall Study||9
8241755|NCT01924767|20325248|P1|STARTED|Overall Study||12
8241756|NCT01924689|20325354|P6|NOT COMPLETED|Overall Study||2
8241757|NCT01924689|20325355|P5|NOT COMPLETED|Overall Study||6
8241758|NCT01924689|20325356|P4|NOT COMPLETED|Overall Study||6
8241759|NCT01924689|20325357|P3|NOT COMPLETED|Overall Study||4
8241760|NCT01924689|20325358|P2|NOT COMPLETED|Overall Study||3
8241761|NCT01924689|20325359|P1|NOT COMPLETED|Overall Study||3
8241762|NCT01924689|20325354|P6|COMPLETED|Overall Study||0
8241763|NCT01924689|20325355|P5|COMPLETED|Overall Study||0
8241764|NCT01924689|20325356|P4|COMPLETED|Overall Study||0
8241765|NCT01924689|20325357|P3|COMPLETED|Overall Study||0
8241766|NCT01924689|20325358|P2|COMPLETED|Overall Study||0
8241767|NCT01924689|20325359|P1|COMPLETED|Overall Study||0
8241768|NCT01924689|20325354|P6|STARTED|Overall Study||2
8241769|NCT01924689|20325355|P5|STARTED|Overall Study||6
8241770|NCT01924689|20325356|P4|STARTED|Overall Study||6
8241771|NCT01924689|20325357|P3|STARTED|Overall Study||4
8241772|NCT01924689|20325358|P2|STARTED|Overall Study||3
8241773|NCT01924689|20325359|P1|STARTED|Overall Study||3
8241774|NCT01924559|20325417|P1|NOT COMPLETED|Overall Study||0
8241775|NCT01924559|20325417|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
8241776|NCT01924559|20325417|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
8241777|NCT01924533|20325433|P2|NOT COMPLETED|Overall Study||205
8241778|NCT01924533|20325434|P1|NOT COMPLETED|Overall Study||189
8241779|NCT01924533|20325433|P2|COMPLETED|Overall Study||57
8241780|NCT01924533|20325434|P1|COMPLETED|Overall Study||74
8241781|NCT01924533|20325433|P2|STARTED|Overall Study||262
8241782|NCT01924533|20325434|P1|STARTED|Overall Study||263
8241783|NCT01924442|20325464|P2|NOT COMPLETED|Overall Study||137
8241784|NCT01924442|20325465|P1|NOT COMPLETED|Overall Study||40
8241785|NCT01924442|20325464|P2|COMPLETED|Overall Study||967
8241786|NCT01924442|20325465|P1|COMPLETED|Overall Study||1059
8241787|NCT01924442|20325464|P2|STARTED|Overall Study||1104
8241788|NCT01924442|20325465|P1|STARTED|Overall Study||1099
8241789|NCT01924429|20325475|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
8241790|NCT01924429|20325476|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
8241791|NCT01924429|20325475|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
8241792|NCT01924429|20325476|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
8241793|NCT01924429|20325475|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
8241794|NCT01924429|20325476|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
8241795|NCT01924429|20325475|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
8241796|NCT01924429|20325476|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
8241797|NCT01924429|20325475|P2|COMPLETED|Washout Period (2 Weeks)||11
8241798|NCT01924429|20325476|P1|COMPLETED|Washout Period (2 Weeks)||14
8241799|NCT01924429|20325475|P2|STARTED|Washout Period (2 Weeks)||13
8241800|NCT01924429|20325476|P1|STARTED|Washout Period (2 Weeks)||17
8241801|NCT01924429|20325475|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
8241802|NCT01924429|20325476|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
8241803|NCT01924429|20325475|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
8241804|NCT01924429|20325476|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
8241805|NCT01924429|20325475|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
8241806|NCT01924429|20325476|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
8241807|NCT01924390|20325508|P2|NOT COMPLETED|Overall Study||1
8241808|NCT01924390|20325509|P1|NOT COMPLETED|Overall Study||1
8241809|NCT01924390|20325508|P2|COMPLETED|Overall Study||21
8241810|NCT01924390|20325509|P1|COMPLETED|Overall Study||21
8241811|NCT01924390|20325508|P2|STARTED|Overall Study||22
8241812|NCT01924390|20325509|P1|STARTED|Overall Study||22
8241813|NCT01924364|20325519|P1|NOT COMPLETED|Overall Study||3
8241814|NCT01924364|20325519|P1|COMPLETED|Overall Study||4
8241815|NCT01924364|20325519|P1|STARTED|Overall Study||7
8241816|NCT01924299|20325536|P2|NOT COMPLETED|Period 2||1
8241817|NCT01924299|20325537|P1|NOT COMPLETED|Period 2||1
8241818|NCT01924299|20325536|P2|COMPLETED|Period 2||17
8241819|NCT01924299|20325537|P1|COMPLETED|Period 2||17
8241820|NCT01924299|20325536|P2|Received Baricitinib|Period 2||17
8241821|NCT01924299|20325537|P1|Received Baricitinib|Period 2||17
8241822|NCT01924299|20325536|P2|Received at Least 1 Dose of Study Drug|Period 2||18
8241823|NCT01924299|20325537|P1|Received at Least 1 Dose of Study Drug|Period 2||18
8241824|NCT01924299|20325536|P2|STARTED|Period 2||18
8241825|NCT01924299|20325537|P1|STARTED|Period 2||18
8241826|NCT01924299|20325536|P2|NOT COMPLETED|Period 1||0
8241827|NCT01924299|20325537|P1|NOT COMPLETED|Period 1||0
8241828|NCT01924299|20325536|P2|COMPLETED|Period 1||18
8241829|NCT01924299|20325537|P1|COMPLETED|Period 1||18
8241830|NCT01924299|20325536|P2|Received Baricitinib|Period 1||18
8241831|NCT01924299|20325537|P1|Received Baricitinib|Period 1||18
8241832|NCT01924299|20325536|P2|STARTED|Period 1||18
8241833|NCT01924299|20325537|P1|STARTED|Period 1||18
8241834|NCT01924182|20325559|P2|NOT COMPLETED|Overall Study||0
8241835|NCT01924182|20325560|P1|NOT COMPLETED|Overall Study||1
8241836|NCT01924182|20325559|P2|COMPLETED|Overall Study||0
8241837|NCT01924182|20325560|P1|COMPLETED|Overall Study||2
8241838|NCT01924182|20325559|P2|STARTED|Overall Study||0
8241839|NCT01924182|20325560|P1|STARTED|Overall Study||3
8241840|NCT01924169|20325572|P1|NOT COMPLETED|Overall Study||0
8241841|NCT01924169|20325572|P1|COMPLETED|Overall Study||3
8241842|NCT01924169|20325572|P1|STARTED|Overall Study||3
8241843|NCT01923961|20325580|P3|NOT COMPLETED|Third Intervention||0
8241844|NCT01923961|20325581|P2|NOT COMPLETED|Third Intervention||0
8241845|NCT01923961|20325582|P1|NOT COMPLETED|Third Intervention||0
8241846|NCT01923961|20325580|P3|COMPLETED|Third Intervention||2
8241847|NCT01923961|20325581|P2|COMPLETED|Third Intervention||3
8241848|NCT01923961|20325582|P1|COMPLETED|Third Intervention||3
8241849|NCT01923961|20325580|P3|STARTED|Third Intervention||2
8241850|NCT01923961|20325581|P2|STARTED|Third Intervention||3
8241851|NCT01923961|20325582|P1|STARTED|Third Intervention||3
8241852|NCT01923961|20325580|P3|NOT COMPLETED|Washout (1 Week)||0
8241853|NCT01923961|20325581|P2|NOT COMPLETED|Washout (1 Week)||0
8241854|NCT01923961|20325582|P1|NOT COMPLETED|Washout (1 Week)||0
8241855|NCT01923961|20325580|P3|COMPLETED|Washout (1 Week)||2
8241856|NCT01923961|20325581|P2|COMPLETED|Washout (1 Week)||3
8241857|NCT01923961|20325582|P1|COMPLETED|Washout (1 Week)||3
8241858|NCT01923961|20325580|P3|STARTED|Washout (1 Week)||2
8241859|NCT01923961|20325581|P2|STARTED|Washout (1 Week)||3
8241860|NCT01923961|20325582|P1|STARTED|Washout (1 Week)||3
8241861|NCT01923961|20325580|P3|NOT COMPLETED|Second Intervention||0
8241862|NCT01923961|20325581|P2|NOT COMPLETED|Second Intervention||0
8241863|NCT01923961|20325582|P1|NOT COMPLETED|Second Intervention||0
8241864|NCT01923961|20325580|P3|COMPLETED|Second Intervention||2
8241865|NCT01923961|20325581|P2|COMPLETED|Second Intervention||3
8241866|NCT01923961|20325582|P1|COMPLETED|Second Intervention||3
8241867|NCT01923961|20325580|P3|STARTED|Second Intervention||2
8241868|NCT01923961|20325581|P2|STARTED|Second Intervention||3
8241869|NCT01923961|20325582|P1|STARTED|Second Intervention||3
8241870|NCT01923961|20325580|P3|NOT COMPLETED|Washout (1 Week)||0
8241871|NCT01923961|20325581|P2|NOT COMPLETED|Washout (1 Week)||0
8241872|NCT01923961|20325582|P1|NOT COMPLETED|Washout (1 Week)||0
8241873|NCT01923961|20325580|P3|COMPLETED|Washout (1 Week)||2
8241874|NCT01923961|20325581|P2|COMPLETED|Washout (1 Week)||3
8241875|NCT01923961|20325582|P1|COMPLETED|Washout (1 Week)||3
8241876|NCT01923961|20325580|P3|STARTED|Washout (1 Week)||2
8241877|NCT01923961|20325581|P2|STARTED|Washout (1 Week)||3
8241878|NCT01923961|20325582|P1|STARTED|Washout (1 Week)||3
8241879|NCT01923961|20325580|P3|NOT COMPLETED|First Intervention||0
8241880|NCT01923961|20325581|P2|NOT COMPLETED|First Intervention||0
8241881|NCT01923961|20325582|P1|NOT COMPLETED|First Intervention||0
8241882|NCT01923961|20325580|P3|COMPLETED|First Intervention||2
8241883|NCT01923961|20325581|P2|COMPLETED|First Intervention||3
8241884|NCT01923961|20325582|P1|COMPLETED|First Intervention||3
8241885|NCT01923961|20325580|P3|STARTED|First Intervention||2
8241886|NCT01923961|20325581|P2|STARTED|First Intervention||3
8241887|NCT01923961|20325582|P1|STARTED|First Intervention||3
8241888|NCT01923896|20325601|P2|NOT COMPLETED|Overall Study||0
8241889|NCT01923896|20325602|P1|NOT COMPLETED|Overall Study||1
8241890|NCT01923896|20325601|P2|COMPLETED|Overall Study||8
8241891|NCT01923896|20325602|P1|COMPLETED|Overall Study||7
8241892|NCT01923896|20325601|P2|STARTED|Overall Study||8
8241893|NCT01923896|20325602|P1|STARTED|Overall Study||8
8241894|NCT01923805|20325616|P2|NOT COMPLETED|Overall Study||5
8241895|NCT01923805|20325617|P1|NOT COMPLETED|Overall Study||3
8241896|NCT01923805|20325616|P2|COMPLETED|Overall Study||0
8241897|NCT01923805|20325617|P1|COMPLETED|Overall Study||0
8241898|NCT01923805|20325616|P2|STARTED|Overall Study|early termination|5
8241899|NCT01923805|20325617|P1|STARTED|Overall Study|early termination|3
8241900|NCT01923740|20325625|P2|NOT COMPLETED|Overall Study||9
8241901|NCT01923740|20325626|P1|NOT COMPLETED|Overall Study||6
8241902|NCT01923740|20325625|P2|COMPLETED|Overall Study||223
8241903|NCT01923740|20325626|P1|COMPLETED|Overall Study||221
8241904|NCT01923740|20325625|P2|STARTED|Overall Study||232
8241905|NCT01923740|20325626|P1|STARTED|Overall Study||227
8241906|NCT01923480|20325891|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241907|NCT01923480|20325892|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241908|NCT01923480|20325893|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241909|NCT01923480|20325894|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241910|NCT01923480|20325895|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241911|NCT01923480|20325896|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241912|NCT01923480|20325891|P6|COMPLETED|Period 2 (Hours 1-7)||2
8241913|NCT01923480|20325892|P5|COMPLETED|Period 2 (Hours 1-7)||2
8241914|NCT01923480|20325893|P4|COMPLETED|Period 2 (Hours 1-7)||2
8241915|NCT01923480|20325894|P3|COMPLETED|Period 2 (Hours 1-7)||2
8241916|NCT01923480|20325895|P2|COMPLETED|Period 2 (Hours 1-7)||1
8241917|NCT01923480|20325896|P1|COMPLETED|Period 2 (Hours 1-7)||1
8241918|NCT01923480|20325891|P6|STARTED|Period 2 (Hours 1-7)||2
8241919|NCT01923480|20325892|P5|STARTED|Period 2 (Hours 1-7)||2
8241920|NCT01923480|20325893|P4|STARTED|Period 2 (Hours 1-7)||2
8241921|NCT01923480|20325894|P3|STARTED|Period 2 (Hours 1-7)||2
8241922|NCT01923480|20325895|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
8241923|NCT01923480|20325896|P1|STARTED|Period 2 (Hours 1-7)||1
8241924|NCT01923480|20325891|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241925|NCT01923480|20325892|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241926|NCT01923480|20325893|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241927|NCT01923480|20325894|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241928|NCT01923480|20325895|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241929|NCT01923480|20325896|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241930|NCT01923480|20325891|P6|COMPLETED|Period 1 (Hours 1-7)||2
8241931|NCT01923480|20325892|P5|COMPLETED|Period 1 (Hours 1-7)||2
8241932|NCT01923480|20325893|P4|COMPLETED|Period 1 (Hours 1-7)||2
8241933|NCT01923480|20325894|P3|COMPLETED|Period 1 (Hours 1-7)||2
8241934|NCT01923480|20325895|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
8241935|NCT01923480|20325896|P1|COMPLETED|Period 1 (Hours 1-7)||1
8241936|NCT01923480|20325891|P6|STARTED|Period 1 (Hours 1-7)||2
8241937|NCT01923480|20325892|P5|STARTED|Period 1 (Hours 1-7)||2
8241938|NCT01923480|20325893|P4|STARTED|Period 1 (Hours 1-7)||2
8241939|NCT01923480|20325894|P3|STARTED|Period 1 (Hours 1-7)||2
8241940|NCT01923480|20325895|P2|STARTED|Period 1 (Hours 1-7)||2
8241941|NCT01923480|20325896|P1|STARTED|Period 1 (Hours 1-7)||1
8241942|NCT01923467|20326051|P1|NOT COMPLETED|Overall Study||541
8241943|NCT01923467|20326051|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
8241944|NCT01923467|20326051|P1|Baseline Completed, Enrolled|Overall Study||288
8241945|NCT01923467|20326051|P1|STARTED|Overall Study|Offered stop smoking program|767
8241946|NCT01923428|20326059|P4|NOT COMPLETED|Overall Study||10
8241947|NCT01923428|20326060|P3|NOT COMPLETED|Overall Study||11
8241948|NCT01923428|20326061|P2|NOT COMPLETED|Overall Study||12
8241949|NCT01923428|20326062|P1|NOT COMPLETED|Overall Study||19
8241950|NCT01923428|20326059|P4|COMPLETED|Overall Study||80
8241951|NCT01923428|20326060|P3|COMPLETED|Overall Study||78
8241952|NCT01923428|20326061|P2|COMPLETED|Overall Study||77
8241953|NCT01923428|20326062|P1|COMPLETED|Overall Study||69
8241954|NCT01923428|20326059|P4|STARTED|Overall Study||90
8241955|NCT01923428|20326060|P3|STARTED|Overall Study||89
8241956|NCT01923428|20326061|P2|STARTED|Overall Study||89
8241957|NCT01923428|20326062|P1|STARTED|Overall Study||88
8241958|NCT01923389|20326074|P2|NOT COMPLETED|Overall Study||0
8241959|NCT01923389|20326075|P1|NOT COMPLETED|Overall Study||1
8241960|NCT01923389|20326074|P2|COMPLETED|Overall Study||2
8241961|NCT01923389|20326075|P1|COMPLETED|Overall Study||1
8241962|NCT01923389|20326074|P2|STARTED|Overall Study||2
8241963|NCT01923389|20326075|P1|STARTED|Overall Study||2
8241964|NCT01923363|20326097|P1|NOT COMPLETED|Overall Study||1
8241965|NCT01923363|20326097|P1|COMPLETED|Overall Study||28
8241966|NCT01923363|20326097|P1|STARTED|Overall Study||29
8241967|NCT01923311|20326106|P2|NOT COMPLETED|Overall Study||1
8241968|NCT01923311|20326107|P1|NOT COMPLETED|Overall Study||17
8241969|NCT01923311|20326106|P2|COMPLETED|Overall Study||13
8241970|NCT01923311|20326107|P1|COMPLETED|Overall Study||0
8241971|NCT01923311|20326106|P2|STARTED|Overall Study||14
8241972|NCT01923311|20326107|P1|STARTED|Overall Study||17
8241973|NCT01923285|20326152|P2|NOT COMPLETED|Overall Study||6
8241974|NCT01923285|20326153|P1|NOT COMPLETED|Overall Study||7
8241975|NCT01923285|20326152|P2|COMPLETED|Overall Study||70
8241976|NCT01923285|20326153|P1|COMPLETED|Overall Study||69
8241977|NCT01923285|20326152|P2|Modified Intent-to-treat|Overall Study||73
8241978|NCT01923285|20326153|P1|Modified Intent-to-treat|Overall Study||73
8241979|NCT01923285|20326152|P2|STARTED|Overall Study||76
8241980|NCT01923285|20326153|P1|STARTED|Overall Study||76
8241981|NCT01923181|20326174|P9|NOT COMPLETED|Overall Study||3
8241982|NCT01923181|20326175|P8|NOT COMPLETED|Overall Study||8
8241983|NCT01923181|20326176|P7|NOT COMPLETED|Overall Study||8
8241984|NCT01923181|20326177|P6|NOT COMPLETED|Overall Study||4
8241985|NCT01923181|20326178|P5|NOT COMPLETED|Overall Study||8
8241986|NCT01923181|20326179|P4|NOT COMPLETED|Overall Study||5
8241987|NCT01923181|20326180|P3|NOT COMPLETED|Overall Study||2
8241988|NCT01923181|20326181|P2|NOT COMPLETED|Overall Study||6
8241989|NCT01923181|20326182|P1|NOT COMPLETED|Overall Study||3
8241990|NCT01923181|20326174|P9|COMPLETED|Overall Study||68
8241991|NCT01923181|20326175|P8|COMPLETED|Overall Study||61
8241992|NCT01923181|20326176|P7|COMPLETED|Overall Study||62
8241993|NCT01923181|20326177|P6|COMPLETED|Overall Study||66
8241994|NCT01923181|20326178|P5|COMPLETED|Overall Study||63
8241995|NCT01923181|20326179|P4|COMPLETED|Overall Study||65
8241996|NCT01923181|20326180|P3|COMPLETED|Overall Study||67
8241997|NCT01923181|20326181|P2|COMPLETED|Overall Study||64
8241998|NCT01923181|20326182|P1|COMPLETED|Overall Study||67
8241999|NCT01923181|20326174|P9|Safety Analysis Set (SAS)|Overall Study||71
8242000|NCT01923181|20326175|P8|Safety Analysis Set (SAS)|Overall Study||69
8242001|NCT01923181|20326176|P7|Safety Analysis Set (SAS)|Overall Study||70
8242002|NCT01923181|20326177|P6|Safety Analysis Set (SAS)|Overall Study||70
8242003|NCT01923181|20326178|P5|Safety Analysis Set (SAS)|Overall Study||71
8242004|NCT01923181|20326179|P4|Safety Analysis Set (SAS)|Overall Study||70
8242005|NCT01923181|20326180|P3|Safety Analysis Set (SAS)|Overall Study||69
8242006|NCT01923181|20326181|P2|Safety Analysis Set (SAS)|Overall Study||70
8242007|NCT01923181|20326182|P1|Safety Analysis Set (SAS)|Overall Study||70
8242008|NCT01923181|20326174|P9|Full Analysis Set (FAS)|Overall Study||71
8242009|NCT01923181|20326175|P8|Full Analysis Set (FAS)|Overall Study||69
8242010|NCT01923181|20326176|P7|Full Analysis Set (FAS)|Overall Study||70
8242011|NCT01923181|20326177|P6|Full Analysis Set (FAS)|Overall Study||70
8242012|NCT01923181|20326178|P5|Full Analysis Set (FAS)|Overall Study||71
8242013|NCT01923181|20326179|P4|Full Analysis Set (FAS)|Overall Study||70
8242014|NCT01923181|20326180|P3|Full Analysis Set (FAS)|Overall Study||69
8242015|NCT01923181|20326181|P2|Full Analysis Set (FAS)|Overall Study||70
8242016|NCT01923181|20326182|P1|Full Analysis Set (FAS)|Overall Study||70
8242017|NCT01923181|20326174|P9|STARTED|Overall Study||71
8242018|NCT01923181|20326175|P8|STARTED|Overall Study||69
8242019|NCT01923181|20326176|P7|STARTED|Overall Study||70
8242020|NCT01923181|20326177|P6|STARTED|Overall Study||70
8242021|NCT01923181|20326178|P5|STARTED|Overall Study||71
8242022|NCT01923181|20326179|P4|STARTED|Overall Study||70
8242023|NCT01923181|20326180|P3|STARTED|Overall Study||69
8242024|NCT01923181|20326181|P2|STARTED|Overall Study||70
8242025|NCT01923181|20326182|P1|STARTED|Overall Study||70
8242026|NCT01923168|20326260|P3|NOT COMPLETED|Overall Study||17
8242027|NCT01923168|20326261|P2|NOT COMPLETED|Overall Study||39
8242028|NCT01923168|20326262|P1|NOT COMPLETED|Overall Study||37
8242029|NCT01923168|20326260|P3|COMPLETED|Overall Study||109
8242030|NCT01923168|20326261|P2|COMPLETED|Overall Study||44
8242031|NCT01923168|20326262|P1|COMPLETED|Overall Study||94
8242032|NCT01923168|20326260|P3|STARTED|Overall Study||126
8242033|NCT01923168|20326261|P2|STARTED|Overall Study||83
8242034|NCT01923168|20326262|P1|STARTED|Overall Study||131
8242035|NCT01923129|20326321|P2|NOT COMPLETED|Overall Study||0
8242036|NCT01923129|20326322|P1|NOT COMPLETED|Overall Study||0
8242037|NCT01923129|20326321|P2|COMPLETED|Overall Study||71
8242038|NCT01923129|20326322|P1|COMPLETED|Overall Study||71
8242039|NCT01923129|20326321|P2|STARTED|Overall Study||71
8242040|NCT01923129|20326322|P1|STARTED|Overall Study||71
8242041|NCT01922986|20326332|P2|NOT COMPLETED|Overall Study||0
8242042|NCT01922986|20326333|P1|NOT COMPLETED|Overall Study||0
8242043|NCT01922986|20326332|P2|COMPLETED|Overall Study||2
8242044|NCT01922986|20326333|P1|COMPLETED|Overall Study||2
8242045|NCT01922986|20326332|P2|STARTED|Overall Study||2
8242046|NCT01922986|20326333|P1|STARTED|Overall Study||2
8242047|NCT01922934|20326345|P2|NOT COMPLETED|Visit 12 / Final Visits||290
8242048|NCT01922934|20326346|P1|NOT COMPLETED|Visit 12 / Final Visits||6
8242049|NCT01922934|20326345|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
8242050|NCT01922934|20326346|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
8242051|NCT01922934|20326345|P2|STARTED|Visit 12 / Final Visits||2930
8242052|NCT01922934|20326346|P1|STARTED|Visit 12 / Final Visits||119
8242053|NCT01922934|20326345|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
8242054|NCT01922934|20326346|P1|NOT COMPLETED|Visit 1- Weight Measured||21
8242055|NCT01922934|20326345|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
8242056|NCT01922934|20326346|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
8242057|NCT01922934|20326345|P2|STARTED|Visit 1- Weight Measured||4214
8242058|NCT01922934|20326346|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
8242059|NCT01922934|20326345|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
8242060|NCT01922934|20326346|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
8242061|NCT01922934|20326345|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
8242062|NCT01922934|20326346|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
8242063|NCT01922934|20326345|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
8242064|NCT01922934|20326346|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
8242065|NCT01922934|20326345|P2|NOT COMPLETED|Eligible Patients||88
8242066|NCT01922934|20326346|P1|NOT COMPLETED|Eligible Patients||53
8242067|NCT01922934|20326345|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
8242068|NCT01922934|20326346|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
8242069|NCT01922934|20326345|P2|STARTED|Eligible Patients||4302
8242070|NCT01922934|20326346|P1|STARTED|Eligible Patients||428
8242071|NCT01922739|20326358|P1|NOT COMPLETED|Open-label Treatment Period||34
8242072|NCT01922739|20326358|P1|COMPLETED|Open-label Treatment Period||136
8242073|NCT01922739|20326358|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
8242074|NCT01922739|20326358|P1|STARTED|Open-label Treatment Period||170
8242075|NCT01922739|20326358|P1|NOT COMPLETED|Titration/Adjustment Period||12
8242076|NCT01922739|20326358|P1|COMPLETED|Titration/Adjustment Period||170
8242077|NCT01922739|20326358|P1|Safety Analysis Set|Titration/Adjustment Period||182
8242078|NCT01922739|20326358|P1|STARTED|Titration/Adjustment Period||182
8242079|NCT01922349|20326387|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
8242080|NCT01922349|20326388|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8242081|NCT01922349|20326389|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8242082|NCT01922349|20326390|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8242083|NCT01922349|20326387|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
8242084|NCT01922349|20326388|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
8242085|NCT01922349|20326389|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
8242086|NCT01922349|20326390|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
8242087|NCT01922349|20326387|P4|STARTED|Multiple Rising Dose (MRD) Period||27
8242088|NCT01922349|20326388|P3|STARTED|Multiple Rising Dose (MRD) Period||18
8242089|NCT01922349|20326389|P2|STARTED|Multiple Rising Dose (MRD) Period||27
8242090|NCT01922349|20326390|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
8242091|NCT01922349|20326387|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242092|NCT01922349|20326388|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242093|NCT01922349|20326389|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242094|NCT01922349|20326390|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242095|NCT01922349|20326387|P4|COMPLETED|Single Rising Dose (SRD) Period||27
8242096|NCT01922349|20326388|P3|COMPLETED|Single Rising Dose (SRD) Period||18
8242097|NCT01922349|20326389|P2|COMPLETED|Single Rising Dose (SRD) Period||27
8242098|NCT01922349|20326390|P1|COMPLETED|Single Rising Dose (SRD) Period||25
8242099|NCT01922349|20326387|P4|STARTED|Single Rising Dose (SRD) Period||27
8242100|NCT01922349|20326388|P3|STARTED|Single Rising Dose (SRD) Period||18
8242101|NCT01922349|20326389|P2|STARTED|Single Rising Dose (SRD) Period||27
8242102|NCT01922349|20326390|P1|STARTED|Single Rising Dose (SRD) Period||25
8242103|NCT01922336|20326498|P3|NOT COMPLETED|Overall Study||0
8242104|NCT01922336|20326499|P2|NOT COMPLETED|Overall Study||0
8242105|NCT01922336|20326500|P1|NOT COMPLETED|Overall Study||0
8242106|NCT01922336|20326498|P3|COMPLETED|Overall Study||53
8242107|NCT01922336|20326499|P2|COMPLETED|Overall Study||53
8242108|NCT01922336|20326500|P1|COMPLETED|Overall Study||53
8242109|NCT01922336|20326498|P3|STARTED|Overall Study||53
8242110|NCT01922336|20326499|P2|STARTED|Overall Study||53
8242111|NCT01922336|20326500|P1|STARTED|Overall Study||53
8242112|NCT01922271|20326519|P2|NOT COMPLETED|PERIOD 2||0
8242113|NCT01922271|20326520|P1|NOT COMPLETED|PERIOD 2||0
8242114|NCT01922271|20326519|P2|COMPLETED|PERIOD 2||76
8242115|NCT01922271|20326520|P1|COMPLETED|PERIOD 2||75
8242116|NCT01922271|20326519|P2|STARTED|PERIOD 2||76
8242117|NCT01922271|20326520|P1|STARTED|PERIOD 2||75
8242118|NCT01922271|20326519|P2|NOT COMPLETED|WASHOUT Period||0
8242119|NCT01922271|20326520|P1|NOT COMPLETED|WASHOUT Period||1
8242120|NCT01922271|20326519|P2|COMPLETED|WASHOUT Period||76
8242121|NCT01922271|20326520|P1|COMPLETED|WASHOUT Period||75
8242122|NCT01922271|20326519|P2|STARTED|WASHOUT Period||76
8242123|NCT01922271|20326520|P1|STARTED|WASHOUT Period||76
8242124|NCT01922271|20326519|P2|NOT COMPLETED|PERIOD 1||0
8242125|NCT01922271|20326520|P1|NOT COMPLETED|PERIOD 1||0
8242126|NCT01922271|20326519|P2|COMPLETED|PERIOD 1||76
8242127|NCT01922271|20326520|P1|COMPLETED|PERIOD 1||76
8242128|NCT01922271|20326519|P2|STARTED|PERIOD 1||76
8242129|NCT01922271|20326520|P1|STARTED|PERIOD 1||76
8242130|NCT01922258|20326540|P2|NOT COMPLETED|Overall Study||16
8242131|NCT01922258|20326541|P1|NOT COMPLETED|Overall Study||16
8242132|NCT01922258|20326540|P2|COMPLETED|Overall Study||121
8242133|NCT01922258|20326541|P1|COMPLETED|Overall Study||117
8242134|NCT01922258|20326540|P2|STARTED|Overall Study||137
8242135|NCT01922258|20326541|P1|STARTED|Overall Study||133
8242136|NCT01922219|20326549|P1|NOT COMPLETED|Overall Study||9
8242137|NCT01922219|20326549|P1|COMPLETED|Overall Study||28
8242138|NCT01922219|20326549|P1|STARTED|Overall Study||37
8242139|NCT01922115|20326557|P2|NOT COMPLETED|Overall Study||7
8242140|NCT01922115|20326558|P1|NOT COMPLETED|Overall Study||7
8242141|NCT01922115|20326557|P2|COMPLETED|Overall Study||24
8242142|NCT01922115|20326558|P1|COMPLETED|Overall Study||21
8242143|NCT01922115|20326557|P2|STARTED|Overall Study||31
8242144|NCT01922115|20326558|P1|STARTED|Overall Study||28
8242145|NCT01922102|20326573|P3|NOT COMPLETED|Overall Study||8
8242146|NCT01922102|20326574|P2|NOT COMPLETED|Overall Study||9
8242147|NCT01922102|20326575|P1|NOT COMPLETED|Overall Study||9
8242148|NCT01922102|20326573|P3|COMPLETED|Overall Study||83
8242149|NCT01922102|20326574|P2|COMPLETED|Overall Study||175
8242150|NCT01922102|20326575|P1|COMPLETED|Overall Study||173
8242151|NCT01922102|20326573|P3|STARTED|Overall Study||91
8242152|NCT01922102|20326574|P2|STARTED|Overall Study||184
8242153|NCT01922102|20326575|P1|STARTED|Overall Study||182
8242154|NCT01922089|20326611|P2|NOT COMPLETED|Overall Study||30
8242155|NCT01922089|20326612|P1|NOT COMPLETED|Overall Study||39
8242156|NCT01922089|20326611|P2|COMPLETED|Overall Study||221
8242157|NCT01922089|20326612|P1|COMPLETED|Overall Study||208
8242158|NCT01922089|20326611|P2|Safety Set|Overall Study||251
8242159|NCT01922089|20326612|P1|Safety Set|Overall Study||246
8242160|NCT01922089|20326611|P2|STARTED|Overall Study||251
8242161|NCT01922089|20326612|P1|STARTED|Overall Study||247
8242162|NCT01922050|20326636|P14|NOT COMPLETED|Part 2 Double-blind Phase||3
8242163|NCT01922050|20326637|P13|NOT COMPLETED|Part 2 Double-blind Phase||0
8242164|NCT01922050|20326638|P12|NOT COMPLETED|Part 2 Double-blind Phase||2
8242165|NCT01922050|20326639|P11|NOT COMPLETED|Part 2 Double-blind Phase||1
8242166|NCT01922050|20326640|P10|NOT COMPLETED|Part 2 Double-blind Phase||0
8242167|NCT01922050|20326641|P9|NOT COMPLETED|Part 2 Double-blind Phase||0
8242168|NCT01922050|20326642|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
8242169|NCT01922050|20326643|P7|NOT COMPLETED|Part 2 Double-blind Phase||0
8242170|NCT01922050|20326644|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
8242171|NCT01922050|20326645|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
8242172|NCT01922050|20326646|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
8242173|NCT01922050|20326647|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
8242174|NCT01922050|20326648|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
8242175|NCT01922050|20326649|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
8242176|NCT01922050|20326636|P14|COMPLETED|Part 2 Double-blind Phase||56
8242177|NCT01922050|20326637|P13|COMPLETED|Part 2 Double-blind Phase||62
8242178|NCT01922050|20326638|P12|COMPLETED|Part 2 Double-blind Phase||58
8242179|NCT01922050|20326639|P11|COMPLETED|Part 2 Double-blind Phase||61
8242180|NCT01922050|20326640|P10|COMPLETED|Part 2 Double-blind Phase||0
8242181|NCT01922050|20326641|P9|COMPLETED|Part 2 Double-blind Phase||0
8242182|NCT01922050|20326642|P8|COMPLETED|Part 2 Double-blind Phase||0
8242183|NCT01922050|20326643|P7|COMPLETED|Part 2 Double-blind Phase||0
8242184|NCT01922050|20326644|P6|COMPLETED|Part 2 Double-blind Phase||0
8242185|NCT01922050|20326645|P5|COMPLETED|Part 2 Double-blind Phase||0
8242186|NCT01922050|20326646|P4|COMPLETED|Part 2 Double-blind Phase||0
8242187|NCT01922050|20326647|P3|COMPLETED|Part 2 Double-blind Phase||0
8242188|NCT01922050|20326648|P2|COMPLETED|Part 2 Double-blind Phase||0
8242189|NCT01922050|20326649|P1|COMPLETED|Part 2 Double-blind Phase||0
8242190|NCT01922050|20326636|P14|STARTED|Part 2 Double-blind Phase||59
8242191|NCT01922050|20326637|P13|STARTED|Part 2 Double-blind Phase||62
8242192|NCT01922050|20326638|P12|STARTED|Part 2 Double-blind Phase||60
8242193|NCT01922050|20326639|P11|STARTED|Part 2 Double-blind Phase||62
8242194|NCT01922050|20326640|P10|STARTED|Part 2 Double-blind Phase||0
8242195|NCT01922050|20326641|P9|STARTED|Part 2 Double-blind Phase||0
8242196|NCT01922050|20326642|P8|STARTED|Part 2 Double-blind Phase||0
8242197|NCT01922050|20326643|P7|STARTED|Part 2 Double-blind Phase||0
8242198|NCT01922050|20326644|P6|STARTED|Part 2 Double-blind Phase||0
8242199|NCT01922050|20326645|P5|STARTED|Part 2 Double-blind Phase||0
8242200|NCT01922050|20326646|P4|STARTED|Part 2 Double-blind Phase||0
8242201|NCT01922050|20326647|P3|STARTED|Part 2 Double-blind Phase||0
8242202|NCT01922050|20326648|P2|STARTED|Part 2 Double-blind Phase||0
8242203|NCT01922050|20326649|P1|STARTED|Part 2 Double-blind Phase||0
8242204|NCT01922050|20326636|P14|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242205|NCT01922050|20326637|P13|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242206|NCT01922050|20326638|P12|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242207|NCT01922050|20326639|P11|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242208|NCT01922050|20326640|P10|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242209|NCT01922050|20326641|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242210|NCT01922050|20326642|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242211|NCT01922050|20326643|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242212|NCT01922050|20326644|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242213|NCT01922050|20326645|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242214|NCT01922050|20326646|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242215|NCT01922050|20326647|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242216|NCT01922050|20326648|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242217|NCT01922050|20326649|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242218|NCT01922050|20326636|P14|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242219|NCT01922050|20326637|P13|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242220|NCT01922050|20326638|P12|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242221|NCT01922050|20326639|P11|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242222|NCT01922050|20326640|P10|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8242223|NCT01922050|20326641|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8242224|NCT01922050|20326642|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242225|NCT01922050|20326643|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242226|NCT01922050|20326644|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
8242227|NCT01922050|20326645|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
8242228|NCT01922050|20326646|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8242229|NCT01922050|20326647|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8242230|NCT01922050|20326648|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242231|NCT01922050|20326649|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242232|NCT01922050|20326636|P14|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242233|NCT01922050|20326637|P13|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242234|NCT01922050|20326638|P12|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242235|NCT01922050|20326639|P11|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242236|NCT01922050|20326640|P10|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8242237|NCT01922050|20326641|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8242238|NCT01922050|20326642|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242239|NCT01922050|20326643|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242240|NCT01922050|20326644|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||18
8242241|NCT01922050|20326645|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||17
8242242|NCT01922050|20326646|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8242243|NCT01922050|20326647|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8242244|NCT01922050|20326648|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242245|NCT01922050|20326649|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242246|NCT01922037|20326689|P2|NOT COMPLETED|Overall Study||174
8242247|NCT01922037|20326690|P1|NOT COMPLETED|Overall Study||10
8242248|NCT01922037|20326689|P2|COMPLETED|Overall Study||563
8242249|NCT01922037|20326690|P1|COMPLETED|Overall Study||59
8242250|NCT01922037|20326689|P2|Treated|Overall Study||732
8242251|NCT01922037|20326690|P1|Treated|Overall Study||69
8242252|NCT01922037|20326689|P2|STARTED|Overall Study||737
8242253|NCT01922037|20326690|P1|STARTED|Overall Study||69
8242254|NCT01922024|20326784|P2|NOT COMPLETED|Overall Study||0
8242255|NCT01922024|20326785|P1|NOT COMPLETED|Overall Study||0
8242256|NCT01922024|20326784|P2|COMPLETED|Overall Study||471
8242257|NCT01922024|20326785|P1|COMPLETED|Overall Study||1653
8242258|NCT01922024|20326784|P2|STARTED|Overall Study||471
8242259|NCT01922024|20326785|P1|STARTED|Overall Study||1653
8242260|NCT01922011|20326793|P2|NOT COMPLETED|Overall Study||5
8242261|NCT01922011|20326794|P1|NOT COMPLETED|Overall Study||6
8242262|NCT01922011|20326793|P2|COMPLETED|Overall Study||69
8242263|NCT01922011|20326794|P1|COMPLETED|Overall Study||69
8242264|NCT01922011|20326793|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
8242265|NCT01922011|20326794|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
8242266|NCT01922011|20326793|P2|Treated|Overall Study|Treated Participants|73
8242267|NCT01922011|20326794|P1|Treated|Overall Study|Treated Participants|73
8242268|NCT01922011|20326793|P2|STARTED|Overall Study|Randomized participants|74
8242269|NCT01922011|20326794|P1|STARTED|Overall Study|Randomized participants|75
8242270|NCT01921894|20326837|P3|NOT COMPLETED|Overall Study||0
8242271|NCT01921894|20326838|P2|NOT COMPLETED|Overall Study||0
8242272|NCT01921894|20326839|P1|NOT COMPLETED|Overall Study||0
8242273|NCT01921894|20326837|P3|COMPLETED|Overall Study||8
8242274|NCT01921894|20326838|P2|COMPLETED|Overall Study||8
8242275|NCT01921894|20326839|P1|COMPLETED|Overall Study||8
8242276|NCT01921894|20326837|P3|STARTED|Overall Study||8
8242277|NCT01921894|20326838|P2|STARTED|Overall Study||8
8242278|NCT01921894|20326839|P1|STARTED|Overall Study||8
8242279|NCT01921829|20326861|P2|NOT COMPLETED|Overall Study||1
8242280|NCT01921829|20326862|P1|NOT COMPLETED|Overall Study||0
8242281|NCT01921829|20326861|P2|COMPLETED|Overall Study||8
8242282|NCT01921829|20326862|P1|COMPLETED|Overall Study||10
8242283|NCT01921829|20326861|P2|STARTED|Overall Study||9
8242284|NCT01921829|20326862|P1|STARTED|Overall Study||10
8242285|NCT01921751|20326911|P3|NOT COMPLETED|Overall Study||0
8242286|NCT01921751|20326912|P2|NOT COMPLETED|Overall Study||0
8242287|NCT01921751|20326913|P1|NOT COMPLETED|Overall Study||0
8242288|NCT01921751|20326911|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
8242289|NCT01921751|20326912|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
8242290|NCT01921751|20326913|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
8242291|NCT01921751|20326911|P3|STARTED|Overall Study||5
8242292|NCT01921751|20326912|P2|STARTED|Overall Study||4
8242293|NCT01921751|20326913|P1|STARTED|Overall Study||4
8242294|NCT01921634|20326931|P1|NOT COMPLETED|Overall Study||0
8242295|NCT01921634|20326931|P1|COMPLETED|Overall Study||300
8242296|NCT01921634|20326931|P1|STARTED|Overall Study||300
8242297|NCT01921517|20326938|P2|NOT COMPLETED|Overall Study||9
8242298|NCT01921517|20326939|P1|NOT COMPLETED|Overall Study||15
8242299|NCT01921517|20326938|P2|COMPLETED|Overall Study||29
8242300|NCT01921517|20326939|P1|COMPLETED|Overall Study||27
8242301|NCT01921517|20326938|P2|STARTED|Overall Study||38
8242302|NCT01921517|20326939|P1|STARTED|Overall Study||42
8242303|NCT01921452|20326945|P1|NOT COMPLETED|Overall Study||0
8242304|NCT01921452|20326945|P1|COMPLETED|Overall Study||283
8242305|NCT01921452|20326945|P1|STARTED|Overall Study||283
8242306|NCT01921387|20326950|P1|NOT COMPLETED|Overall Study||1
8242307|NCT01921387|20326950|P1|COMPLETED|Overall Study||19
8242308|NCT01921387|20326950|P1|STARTED|Overall Study||20
8242309|NCT01921348|20326959|P2|NOT COMPLETED|Overall Study||2
8242310|NCT01921348|20326960|P1|NOT COMPLETED|Overall Study||1
8242311|NCT01921348|20326959|P2|COMPLETED|Overall Study||7
8242312|NCT01921348|20326960|P1|COMPLETED|Overall Study||8
8242313|NCT01921348|20326959|P2|STARTED|Overall Study||9
8242314|NCT01921348|20326960|P1|STARTED|Overall Study||9
8242315|NCT01921322|20326972|P2|NOT COMPLETED|Overall Study||17
8242316|NCT01921322|20326973|P1|NOT COMPLETED|Overall Study||15
8242317|NCT01921322|20326972|P2|COMPLETED|Overall Study||44
8242318|NCT01921322|20326973|P1|COMPLETED|Overall Study||42
8242319|NCT01921322|20326972|P2|STARTED|Overall Study||61
8242320|NCT01921322|20326973|P1|STARTED|Overall Study||57
8242321|NCT01921296|20326981|P1|NOT COMPLETED|Overall Study||0
8242322|NCT01921296|20326981|P1|COMPLETED|Overall Study||2
8242323|NCT01921296|20326981|P1|STARTED|Overall Study||2
8242324|NCT01921270|20326989|P1|NOT COMPLETED|Overall Study||1
8242325|NCT01921270|20326989|P1|COMPLETED|Overall Study||17
8242326|NCT01921270|20326989|P1|STARTED|Overall Study||18
8242327|NCT01921257|20327005|P1|NOT COMPLETED|Overall Study||3
8242328|NCT01921257|20327005|P1|COMPLETED|Overall Study||13
8242329|NCT01921257|20327005|P1|Active Treatment|Overall Study||13
8242330|NCT01921257|20327005|P1|Placebo run-in|Overall Study||16
8242331|NCT01921257|20327005|P1|STARTED|Overall Study||16
8242332|NCT01921218|20327012|P2|NOT COMPLETED|Overall Study||4
8242333|NCT01921218|20327013|P1|NOT COMPLETED|Overall Study||3
8242334|NCT01921218|20327012|P2|COMPLETED|Overall Study||3
8242335|NCT01921218|20327013|P1|COMPLETED|Overall Study||3
8242336|NCT01921218|20327012|P2|STARTED|Overall Study||7
8242337|NCT01921218|20327013|P1|STARTED|Overall Study||6
8242338|NCT01921205|20327029|P2|NOT COMPLETED|Overall Study||20
8242339|NCT01921205|20327030|P1|NOT COMPLETED|Overall Study||21
8242340|NCT01921205|20327029|P2|COMPLETED|Overall Study||151
8242341|NCT01921205|20327030|P1|COMPLETED|Overall Study||151
8242342|NCT01921205|20327029|P2|STARTED|Overall Study||171
8242343|NCT01921205|20327030|P1|STARTED|Overall Study||172
8242344|NCT01921179|20327060|P2|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
8242345|NCT01921179|20327061|P1|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
8242346|NCT01921179|20327060|P2|COMPLETED|Long Term Follow-up After GOALS Training||0
8242347|NCT01921179|20327061|P1|COMPLETED|Long Term Follow-up After GOALS Training||32
8242348|NCT01921179|20327060|P2|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
8242349|NCT01921179|20327061|P1|STARTED|Long Term Follow-up After GOALS Training||34
8242350|NCT01921179|20327060|P2|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
8242351|NCT01921179|20327061|P1|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
8242352|NCT01921179|20327060|P2|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
8242353|NCT01921179|20327061|P1|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
8242354|NCT01921179|20327060|P2|STARTED|5 Week Randomized GOALS vs EDU Training||22
8242355|NCT01921179|20327061|P1|STARTED|5 Week Randomized GOALS vs EDU Training||24
8242356|NCT01921166|20327076|P2|NOT COMPLETED|Overall Study||0
8242357|NCT01921166|20327077|P1|NOT COMPLETED|Overall Study||0
8242358|NCT01921166|20327076|P2|COMPLETED|Overall Study||15
8242359|NCT01921166|20327077|P1|COMPLETED|Overall Study||8
8242360|NCT01921166|20327076|P2|STARTED|Overall Study||15
8242361|NCT01921166|20327077|P1|STARTED|Overall Study||8
8242362|NCT01921114|20327087|P2|NOT COMPLETED|Overall Study||0
8242363|NCT01921114|20327088|P1|NOT COMPLETED|Overall Study||0
8242364|NCT01921114|20327087|P2|COMPLETED|Overall Study||0
8242365|NCT01921114|20327088|P1|COMPLETED|Overall Study||0
8242366|NCT01921114|20327087|P2|STARTED|Overall Study||0
8242367|NCT01921114|20327088|P1|STARTED|Overall Study||0
8242368|NCT01921101|20327098|P2|NOT COMPLETED|Overall Study||6
8242369|NCT01921101|20327099|P1|NOT COMPLETED|Overall Study||16
8242370|NCT01921101|20327098|P2|COMPLETED|Overall Study||32
8242371|NCT01921101|20327099|P1|COMPLETED|Overall Study||24
8242372|NCT01921101|20327098|P2|STARTED|Overall Study||38
8242373|NCT01921101|20327099|P1|STARTED|Overall Study||40
8242374|NCT01920958|20327107|P1|NOT COMPLETED|Overall Study||5
8242375|NCT01920958|20327107|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
8242376|NCT01920958|20327107|P1|STARTED|Overall Study||233
8242377|NCT01920893|20327125|P2|NOT COMPLETED|Overall Study||2
8242378|NCT01920893|20327126|P1|NOT COMPLETED|Overall Study||7
8242379|NCT01920893|20327125|P2|COMPLETED|Overall Study||28
8242380|NCT01920893|20327126|P1|COMPLETED|Overall Study||23
8242381|NCT01920893|20327125|P2|Treated (Safety Population)|Overall Study||30
8242382|NCT01920893|20327126|P1|Treated (Safety Population)|Overall Study||30
8242383|NCT01920893|20327125|P2|STARTED|Overall Study||30
8242384|NCT01920893|20327126|P1|STARTED|Overall Study||30
8242385|NCT01920854|20327159|P7|NOT COMPLETED|Overall Study||1
8242386|NCT01920854|20327160|P6|NOT COMPLETED|Overall Study||0
8242387|NCT01920854|20327161|P5|NOT COMPLETED|Overall Study||1
8242388|NCT01920854|20327162|P4|NOT COMPLETED|Overall Study||0
8242389|NCT01920854|20327163|P3|NOT COMPLETED|Overall Study||0
8242390|NCT01920854|20327164|P2|NOT COMPLETED|Overall Study||0
8242391|NCT01920854|20327165|P1|NOT COMPLETED|Overall Study||1
8242392|NCT01920854|20327159|P7|COMPLETED|Overall Study||5
8242393|NCT01920854|20327160|P6|COMPLETED|Overall Study||6
8242394|NCT01920854|20327161|P5|COMPLETED|Overall Study||5
8242395|NCT01920854|20327162|P4|COMPLETED|Overall Study||6
8242396|NCT01920854|20327163|P3|COMPLETED|Overall Study||6
8242397|NCT01920854|20327164|P2|COMPLETED|Overall Study||6
8242398|NCT01920854|20327165|P1|COMPLETED|Overall Study||11
8242399|NCT01920854|20327159|P7|STARTED|Overall Study||6
8242400|NCT01920854|20327160|P6|STARTED|Overall Study||6
8242401|NCT01920854|20327161|P5|STARTED|Overall Study||6
8242402|NCT01920854|20327162|P4|STARTED|Overall Study||6
8242403|NCT01920854|20327163|P3|STARTED|Overall Study||6
8242404|NCT01920854|20327164|P2|STARTED|Overall Study||6
8242405|NCT01920854|20327165|P1|STARTED|Overall Study||12
8242406|NCT01920802|20327292|P3|NOT COMPLETED|Overall Study||1
8242407|NCT01920802|20327293|P2|NOT COMPLETED|Overall Study||2
8242408|NCT01920802|20327294|P1|NOT COMPLETED|Overall Study||4
8242409|NCT01920802|20327292|P3|COMPLETED|Overall Study||10
8242410|NCT01920802|20327293|P2|COMPLETED|Overall Study||7
8242411|NCT01920802|20327294|P1|COMPLETED|Overall Study||7
8242412|NCT01920802|20327292|P3|STARTED|Overall Study||11
8242413|NCT01920802|20327293|P2|STARTED|Overall Study||9
8242414|NCT01920802|20327294|P1|STARTED|Overall Study||11
8242415|NCT01920711|20327325|P2|NOT COMPLETED|Overall Study||373
8242416|NCT01920711|20327326|P1|NOT COMPLETED|Overall Study||364
8242417|NCT01920711|20327325|P2|COMPLETED|Overall Study||2030
8242418|NCT01920711|20327326|P1|COMPLETED|Overall Study||2055
8242419|NCT01920711|20327325|P2|STARTED|Overall Study||2403
8242420|NCT01920711|20327326|P1|STARTED|Overall Study||2419
8242421|NCT01920594|20327343|P2|NOT COMPLETED|Overall Study||3
8242422|NCT01920594|20327344|P1|NOT COMPLETED|Overall Study||7
8242423|NCT01920594|20327343|P2|COMPLETED|Overall Study||25
8242424|NCT01920594|20327344|P1|COMPLETED|Overall Study||20
8242425|NCT01920594|20327343|P2|STARTED|Overall Study||28
8242426|NCT01920594|20327344|P1|STARTED|Overall Study||27
8242427|NCT01920568|20327394|P2|NOT COMPLETED|Overall Study||84
8242428|NCT01920568|20327395|P1|NOT COMPLETED|Overall Study||151
8242429|NCT01920568|20327394|P2|COMPLETED|Overall Study||75
8242430|NCT01920568|20327395|P1|COMPLETED|Overall Study||175
8242431|NCT01920568|20327394|P2|STARTED|Overall Study||159
8242432|NCT01920568|20327395|P1|STARTED|Overall Study||326
8242433|NCT01920555|20327421|P5|NOT COMPLETED|Overall Study||1
8242434|NCT01920555|20327422|P4|NOT COMPLETED|Overall Study||3
8242435|NCT01920555|20327423|P3|NOT COMPLETED|Overall Study||1
8242436|NCT01920555|20327424|P2|NOT COMPLETED|Overall Study||4
8242437|NCT01920555|20327425|P1|NOT COMPLETED|Overall Study||4
8242438|NCT01920555|20327421|P5|COMPLETED|Overall Study||18
8242439|NCT01920555|20327422|P4|COMPLETED|Overall Study||17
8242440|NCT01920555|20327423|P3|COMPLETED|Overall Study||21
8242441|NCT01920555|20327424|P2|COMPLETED|Overall Study||16
8242442|NCT01920555|20327425|P1|COMPLETED|Overall Study||14
8242443|NCT01920555|20327421|P5|STARTED|Overall Study||19
8242444|NCT01920555|20327422|P4|STARTED|Overall Study||20
8242445|NCT01920555|20327423|P3|STARTED|Overall Study||22
8242446|NCT01920555|20327424|P2|STARTED|Overall Study||20
8242447|NCT01920555|20327425|P1|STARTED|Overall Study||18
8242448|NCT01920477|20327484|P2|NOT COMPLETED|Overall Study||17
8242449|NCT01920477|20327485|P1|NOT COMPLETED|Overall Study||15
8242450|NCT01920477|20327484|P2|COMPLETED|Overall Study||1
8242451|NCT01920477|20327485|P1|COMPLETED|Overall Study||2
8242452|NCT01920477|20327484|P2|Requiried Individualized Follow-up|Overall Study||0
8242453|NCT01920477|20327485|P1|Requiried Individualized Follow-up|Overall Study||1
8242454|NCT01920477|20327484|P2|STARTED|Overall Study||18
8242455|NCT01920477|20327485|P1|STARTED|Overall Study||17
8242456|NCT01920282|20327519|P3|NOT COMPLETED|Overall Study||0
8242457|NCT01920282|20327520|P2|NOT COMPLETED|Overall Study||0
8242458|NCT01920282|20327521|P1|NOT COMPLETED|Overall Study||0
8242459|NCT01920282|20327519|P3|COMPLETED|Overall Study||15
8242460|NCT01920282|20327520|P2|COMPLETED|Overall Study||15
8242461|NCT01920282|20327521|P1|COMPLETED|Overall Study||15
8242462|NCT01920282|20327519|P3|STARTED|Overall Study||15
8242463|NCT01920282|20327520|P2|STARTED|Overall Study||15
8242464|NCT01920282|20327521|P1|STARTED|Overall Study||15
8242465|NCT01920178|20327534|P2|NOT COMPLETED|Overall Study||1
8242466|NCT01920178|20327535|P1|NOT COMPLETED|Overall Study||2
8242467|NCT01920178|20327534|P2|COMPLETED|Overall Study||1
8242468|NCT01920178|20327535|P1|COMPLETED|Overall Study||3
8242469|NCT01920178|20327534|P2|STARTED|Overall Study||2
8242470|NCT01920178|20327535|P1|STARTED|Overall Study||5
8242477|NCT01919996|20327584|P1|NOT COMPLETED|Overall Study||0
8242478|NCT01919996|20327584|P1|COMPLETED|Overall Study||8
8242479|NCT01919996|20327584|P1|STARTED|Overall Study||8
8242480|NCT01919970|20327592|P2|NOT COMPLETED|Overall Study||0
8242481|NCT01919970|20327593|P1|NOT COMPLETED|Overall Study||3
8242482|NCT01919970|20327592|P2|COMPLETED|Overall Study||18
8242483|NCT01919970|20327593|P1|COMPLETED|Overall Study||11
8242484|NCT01919970|20327592|P2|STARTED|Overall Study||18
8242485|NCT01919970|20327593|P1|STARTED|Overall Study||14
8242486|NCT01919814|20327601|P2|NOT COMPLETED|Overall Study||0
8242487|NCT01919814|20327602|P1|NOT COMPLETED|Overall Study||3
8242488|NCT01919814|20327601|P2|COMPLETED|Overall Study||30
8242489|NCT01919814|20327602|P1|COMPLETED|Overall Study||27
8242490|NCT01919814|20327601|P2|STARTED|Overall Study||30
8242491|NCT01919814|20327602|P1|STARTED|Overall Study||30
8242492|NCT01919801|20327614|P2|NOT COMPLETED|Overall Study||3
8242493|NCT01919801|20327615|P1|NOT COMPLETED|Overall Study||1
8242494|NCT01919801|20327614|P2|COMPLETED|Overall Study||57
8242495|NCT01919801|20327615|P1|COMPLETED|Overall Study||60
8242496|NCT01919801|20327614|P2|STARTED|Overall Study||60
8242497|NCT01919801|20327615|P1|STARTED|Overall Study||61
8242498|NCT01919723|20327640|P2|NOT COMPLETED|Overall Study||2
8242499|NCT01919723|20327641|P1|NOT COMPLETED|Overall Study||2
8242500|NCT01919723|20327640|P2|COMPLETED|Overall Study||33
8242501|NCT01919723|20327641|P1|COMPLETED|Overall Study||33
8242502|NCT01919723|20327640|P2|STARTED|Overall Study||35
8242503|NCT01919723|20327641|P1|STARTED|Overall Study||35
8242504|NCT01919697|20327655|P2|NOT COMPLETED|Overall Study||385
8242505|NCT01919697|20327656|P1|NOT COMPLETED|Overall Study||53
8242506|NCT01919697|20327655|P2|COMPLETED|Overall Study||1761
8242507|NCT01919697|20327656|P1|COMPLETED|Overall Study||171
8242508|NCT01919697|20327655|P2|STARTED|Overall Study||2146
8242509|NCT01919697|20327656|P1|STARTED|Overall Study||224
8242510|NCT01919606|20327686|P2|NOT COMPLETED|Overall Study||0
8242511|NCT01919606|20327687|P1|NOT COMPLETED|Overall Study||0
8242512|NCT01919606|20327686|P2|COMPLETED|Overall Study||0
8242513|NCT01919606|20327687|P1|COMPLETED|Overall Study||1
8242514|NCT01919606|20327686|P2|STARTED|Overall Study||0
8242515|NCT01919606|20327687|P1|STARTED|Overall Study||1
8242516|NCT01919450|20327699|P4|NOT COMPLETED|Overall Study||1
8242517|NCT01919450|20327700|P3|NOT COMPLETED|Overall Study||0
8242518|NCT01919450|20327701|P2|NOT COMPLETED|Overall Study||0
8242519|NCT01919450|20327702|P1|NOT COMPLETED|Overall Study||0
8242520|NCT01919450|20327699|P4|COMPLETED|Overall Study||19
8242521|NCT01919450|20327700|P3|COMPLETED|Overall Study||20
8242522|NCT01919450|20327701|P2|COMPLETED|Overall Study||20
8242523|NCT01919450|20327702|P1|COMPLETED|Overall Study||20
8242524|NCT01919450|20327699|P4|STARTED|Overall Study||20
8242525|NCT01919450|20327700|P3|STARTED|Overall Study||20
8242526|NCT01919450|20327701|P2|STARTED|Overall Study||20
8242527|NCT01919450|20327702|P1|STARTED|Overall Study||20
8242528|NCT01919411|20327714|P2|NOT COMPLETED|Overall Study||5
8242529|NCT01919411|20327715|P1|NOT COMPLETED|Overall Study||5
8242530|NCT01919411|20327714|P2|COMPLETED|Overall Study||41
8242531|NCT01919411|20327715|P1|COMPLETED|Overall Study||38
8242532|NCT01919411|20327714|P2|STARTED|Overall Study||46
8242533|NCT01919411|20327715|P1|STARTED|Overall Study||43
8242534|NCT01919398|20327734|P3|NOT COMPLETED|Overall Study||4
8242535|NCT01919398|20327735|P2|NOT COMPLETED|Overall Study||0
8242536|NCT01919398|20327736|P1|NOT COMPLETED|Overall Study||0
8242537|NCT01919398|20327734|P3|COMPLETED|Overall Study||9
8242538|NCT01919398|20327735|P2|COMPLETED|Overall Study||3
8242539|NCT01919398|20327736|P1|COMPLETED|Overall Study||3
8242540|NCT01919398|20327734|P3|Received at Least One Dose of Study Drug|Overall Study||13
8242541|NCT01919398|20327735|P2|Received at Least One Dose of Study Drug|Overall Study||3
8242542|NCT01919398|20327736|P1|Received at Least One Dose of Study Drug|Overall Study||3
8242543|NCT01919398|20327734|P3|STARTED|Overall Study||13
8242544|NCT01919398|20327735|P2|STARTED|Overall Study||3
8242545|NCT01919398|20327736|P1|STARTED|Overall Study||3
8242546|NCT01919307|20327756|P1|NOT COMPLETED|Overall Study||9
8242547|NCT01919307|20327756|P1|COMPLETED|Overall Study||20
8242548|NCT01919307|20327756|P1|STARTED|Overall Study||29
8242549|NCT01919229|20327766|P3|NOT COMPLETED|Overall Study||1
8242550|NCT01919229|20327767|P2|NOT COMPLETED|Overall Study||0
8242551|NCT01919229|20327768|P1|NOT COMPLETED|Overall Study||0
8242552|NCT01919229|20327766|P3|COMPLETED|Overall Study||3
8242553|NCT01919229|20327767|P2|COMPLETED|Overall Study||6
8242554|NCT01919229|20327768|P1|COMPLETED|Overall Study||4
8242555|NCT01919229|20327766|P3|STARTED|Overall Study||4
8242556|NCT01919229|20327767|P2|STARTED|Overall Study||6
8242557|NCT01919229|20327768|P1|STARTED|Overall Study||4
8242558|NCT01919216|20327800|P3|NOT COMPLETED|Overall Study||1
8242559|NCT01919216|20327801|P2|NOT COMPLETED|Overall Study||1
8242560|NCT01919216|20327802|P1|NOT COMPLETED|Overall Study||2
8242561|NCT01919216|20327800|P3|COMPLETED|Overall Study||4
8242562|NCT01919216|20327801|P2|COMPLETED|Overall Study||20
8242563|NCT01919216|20327802|P1|COMPLETED|Overall Study||26
8242564|NCT01919216|20327800|P3|STARTED|Overall Study||5
8242565|NCT01919216|20327801|P2|STARTED|Overall Study||21
8242566|NCT01919216|20327802|P1|STARTED|Overall Study||28
8242567|NCT01919164|20327815|P5|NOT COMPLETED|Overall Study||33
8242568|NCT01919164|20327816|P4|NOT COMPLETED|Overall Study||28
8242569|NCT01919164|20327817|P3|NOT COMPLETED|Overall Study||37
8242570|NCT01919164|20327818|P2|NOT COMPLETED|Overall Study||30
8242571|NCT01919164|20327819|P1|NOT COMPLETED|Overall Study||43
8242572|NCT01919164|20327815|P5|COMPLETED|Overall Study||77
8242573|NCT01919164|20327816|P4|COMPLETED|Overall Study||82
8242574|NCT01919164|20327817|P3|COMPLETED|Overall Study||74
8242575|NCT01919164|20327818|P2|COMPLETED|Overall Study||80
8242576|NCT01919164|20327819|P1|COMPLETED|Overall Study||65
8242577|NCT01919164|20327815|P5|Safety Analysis Set|Overall Study||109
8242578|NCT01919164|20327816|P4|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
8242579|NCT01919164|20327817|P3|Safety Analysis Set|Overall Study||111
8242580|NCT01919164|20327818|P2|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
8242581|NCT01919164|20327819|P1|Safety Analysis Set|Overall Study||107
8242582|NCT01919164|20327815|P5|STARTED|Overall Study||110
8242583|NCT01919164|20327816|P4|STARTED|Overall Study||110
8242584|NCT01919164|20327817|P3|STARTED|Overall Study||111
8242585|NCT01919164|20327818|P2|STARTED|Overall Study||110
8242586|NCT01919164|20327819|P1|STARTED|Overall Study||108
8242587|NCT01919112|20327874|P3|NOT COMPLETED|Secondary Analysis-day 30||1
8242588|NCT01919112|20327875|P2|NOT COMPLETED|Secondary Analysis-day 30||1
8242589|NCT01919112|20327876|P1|NOT COMPLETED|Secondary Analysis-day 30||2
8242590|NCT01919112|20327874|P3|COMPLETED|Secondary Analysis-day 30||14
8242591|NCT01919112|20327875|P2|COMPLETED|Secondary Analysis-day 30||12
8242592|NCT01919112|20327876|P1|COMPLETED|Secondary Analysis-day 30||12
8242593|NCT01919112|20327874|P3|STARTED|Secondary Analysis-day 30||15
8242594|NCT01919112|20327875|P2|STARTED|Secondary Analysis-day 30||13
8242595|NCT01919112|20327876|P1|STARTED|Secondary Analysis-day 30||14
8242596|NCT01919112|20327874|P3|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8242597|NCT01919112|20327875|P2|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8242598|NCT01919112|20327876|P1|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8242599|NCT01919112|20327874|P3|COMPLETED|Primary Analysis-day 5 of Intervention||15
8242600|NCT01919112|20327875|P2|COMPLETED|Primary Analysis-day 5 of Intervention||13
8242601|NCT01919112|20327876|P1|COMPLETED|Primary Analysis-day 5 of Intervention||14
8242602|NCT01919112|20327874|P3|STARTED|Primary Analysis-day 5 of Intervention||15
8242603|NCT01919112|20327875|P2|STARTED|Primary Analysis-day 5 of Intervention||13
8242604|NCT01919112|20327876|P1|STARTED|Primary Analysis-day 5 of Intervention||14
8242605|NCT01918800|20327916|P2|NOT COMPLETED|Overall Study||5
8242606|NCT01918800|20327917|P1|NOT COMPLETED|Overall Study||9
8242607|NCT01918800|20327916|P2|COMPLETED|Overall Study||104
8242608|NCT01918800|20327917|P1|COMPLETED|Overall Study||100
8242609|NCT01918800|20327916|P2|STARTED|Overall Study||109
8242610|NCT01918800|20327917|P1|STARTED|Overall Study||109
8242611|NCT01918774|20327935|P1|NOT COMPLETED|Overall Study||5
8242612|NCT01918774|20327935|P1|COMPLETED|Overall Study||52
8242613|NCT01918774|20327935|P1|STARTED|Overall Study||57
8242614|NCT01918761|20327950|P1|NOT COMPLETED|Overall Study||0
8242615|NCT01918761|20327950|P1|COMPLETED|Overall Study||5
8242616|NCT01918761|20327950|P1|STARTED|Overall Study||5
8242617|NCT01918371|20327959|P2|NOT COMPLETED|Overall Study||1
8242618|NCT01918371|20327960|P1|NOT COMPLETED|Overall Study||1
8242619|NCT01918371|20327959|P2|COMPLETED|Overall Study||156
8242620|NCT01918371|20327960|P1|COMPLETED|Overall Study||165
8242621|NCT01918371|20327959|P2|Participants With Complete Data|Overall Study||156
8242622|NCT01918371|20327960|P1|Participants With Complete Data|Overall Study||165
8242623|NCT01918371|20327959|P2|STARTED|Overall Study||157
8242624|NCT01918371|20327960|P1|STARTED|Overall Study||166
8242625|NCT01918332|20328038|P4|NOT COMPLETED|Overall Study||7
8242626|NCT01918332|20328039|P3|NOT COMPLETED|Overall Study||9
8242627|NCT01918332|20328040|P2|NOT COMPLETED|Overall Study||5
8242628|NCT01918332|20328041|P1|NOT COMPLETED|Overall Study||8
8242629|NCT01918332|20328038|P4|COMPLETED|Overall Study||38
8242630|NCT01918332|20328039|P3|COMPLETED|Overall Study||30
8242631|NCT01918332|20328040|P2|COMPLETED|Overall Study||36
8242632|NCT01918332|20328041|P1|COMPLETED|Overall Study||35
8242633|NCT01918332|20328038|P4|STARTED|Overall Study||45
8242634|NCT01918332|20328039|P3|STARTED|Overall Study||39
8242635|NCT01918332|20328040|P2|STARTED|Overall Study||41
8242636|NCT01918332|20328041|P1|STARTED|Overall Study||43
8242637|NCT01918306|20328053|P4|NOT COMPLETED|Overall Study||3
8242638|NCT01918306|20328054|P3|NOT COMPLETED|Overall Study||2
8242639|NCT01918306|20328055|P2|NOT COMPLETED|Overall Study||0
8242640|NCT01918306|20328056|P1|NOT COMPLETED|Overall Study||6
8242641|NCT01918306|20328053|P4|COMPLETED|Overall Study||0
8242642|NCT01918306|20328054|P3|COMPLETED|Overall Study||0
8242643|NCT01918306|20328055|P2|COMPLETED|Overall Study||0
8242644|NCT01918306|20328056|P1|COMPLETED|Overall Study||0
8242645|NCT01918306|20328053|P4|STARTED|Overall Study||3
8242646|NCT01918306|20328054|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
8242647|NCT01918306|20328055|P2|STARTED|Overall Study|No patients enrolled|0
8242648|NCT01918306|20328056|P1|STARTED|Overall Study||6
8242649|NCT01918189|20328076|P1|NOT COMPLETED|Overall Study||18
8242650|NCT01918189|20328076|P1|COMPLETED|Overall Study||41
8242651|NCT01918189|20328076|P1|Completed Follow-up Assessment|Overall Study||41
8242652|NCT01918189|20328076|P1|Completed Baseline Assessment|Overall Study||58
8242653|NCT01918189|20328076|P1|STARTED|Overall Study||59
8242654|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
8242655|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
8242656|NCT01918085|20328087|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
8242657|NCT01918085|20328088|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
8242658|NCT01918085|20328087|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
8242659|NCT01918085|20328088|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
8242660|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
8242661|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
8242662|NCT01918085|20328087|P2|COMPLETED|Test Period 2: Strata Strip||11
8242663|NCT01918085|20328088|P1|COMPLETED|Test Period 2: Strata Strip||10
8242664|NCT01918085|20328087|P2|STARTED|Test Period 2: Strata Strip||11
8242665|NCT01918085|20328088|P1|STARTED|Test Period 2: Strata Strip||10
8242666|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
8242667|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
8242668|NCT01918085|20328087|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
8242669|NCT01918085|20328088|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
8242670|NCT01918085|20328087|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
8242671|NCT01918085|20328088|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
8242672|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
8242673|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
8242674|NCT01918085|20328087|P2|COMPLETED|Test Period 1: Strata Strip||11
8242675|NCT01918085|20328088|P1|COMPLETED|Test Period 1: Strata Strip||10
8242676|NCT01918085|20328087|P2|STARTED|Test Period 1: Strata Strip||12
8242677|NCT01918085|20328088|P1|STARTED|Test Period 1: Strata Strip||10
8242678|NCT01918072|20328096|P3|NOT COMPLETED|Quality Assessment Period||0
8242679|NCT01918072|20328097|P2|NOT COMPLETED|Quality Assessment Period||0
8242680|NCT01918072|20328098|P1|NOT COMPLETED|Quality Assessment Period||0
8242681|NCT01918072|20328096|P3|COMPLETED|Quality Assessment Period||202
8242682|NCT01918072|20328097|P2|COMPLETED|Quality Assessment Period||0
8242683|NCT01918072|20328098|P1|COMPLETED|Quality Assessment Period||0
8242684|NCT01918072|20328096|P3|STARTED|Quality Assessment Period||202
8242685|NCT01918072|20328097|P2|STARTED|Quality Assessment Period||0
8242686|NCT01918072|20328098|P1|STARTED|Quality Assessment Period||0
8242687|NCT01918072|20328096|P3|NOT COMPLETED|E-consult Assessment Period||0
8242688|NCT01918072|20328097|P2|NOT COMPLETED|E-consult Assessment Period||0
8242689|NCT01918072|20328098|P1|NOT COMPLETED|E-consult Assessment Period||0
8242690|NCT01918072|20328096|P3|COMPLETED|E-consult Assessment Period||0
8242691|NCT01918072|20328097|P2|COMPLETED|E-consult Assessment Period||42
8242692|NCT01918072|20328098|P1|COMPLETED|E-consult Assessment Period||0
8242693|NCT01918072|20328096|P3|STARTED|E-consult Assessment Period||0
8242694|NCT01918072|20328097|P2|STARTED|E-consult Assessment Period||42
8242695|NCT01918072|20328098|P1|STARTED|E-consult Assessment Period||0
8242696|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8242697|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8242698|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8242699|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Five - Four Months||0
8242700|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Five - Four Months||0
8242701|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Five - Four Months||11
8242702|NCT01918072|20328096|P3|Control|Controlled Trial Step Five - Four Months||0
8242703|NCT01918072|20328097|P2|Control|Controlled Trial Step Five - Four Months||0
8242704|NCT01918072|20328098|P1|Control|Controlled Trial Step Five - Four Months||0
8242705|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Five - Four Months||0
8242706|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Five - Four Months||0
8242707|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Five - Four Months||11
8242708|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Five - Four Months||0
8242709|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Five - Four Months||0
8242710|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Five - Four Months||11
8242711|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8242712|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8242713|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8242714|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Four - Six Months||0
8242715|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Four - Six Months||0
8242716|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Four - Six Months||11
8242717|NCT01918072|20328096|P3|Control|Controlled Trial Step Four - Six Months||0
8242718|NCT01918072|20328097|P2|Control|Controlled Trial Step Four - Six Months||0
8242719|NCT01918072|20328098|P1|Control|Controlled Trial Step Four - Six Months||0
8242720|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Four - Six Months||0
8242721|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Four - Six Months||0
8242722|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Four - Six Months||11
8242723|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Four - Six Months||0
8242724|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Four - Six Months||0
8242725|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Four - Six Months||11
8242726|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8242727|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8242728|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8242729|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Three - Six Months||0
8242730|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Three - Six Months||0
8242731|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Three - Six Months||11
8242732|NCT01918072|20328096|P3|Control|Controlled Trial Step Three - Six Months||0
8242733|NCT01918072|20328097|P2|Control|Controlled Trial Step Three - Six Months||0
8242734|NCT01918072|20328098|P1|Control|Controlled Trial Step Three - Six Months||2
8242735|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Three - Six Months||0
8242736|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Three - Six Months||0
8242737|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Three - Six Months||9
8242738|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Three - Six Months||0
8242739|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Three - Six Months||0
8242740|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Three - Six Months||11
8242741|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8242742|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8242743|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8242744|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Two - Six Months||0
8242745|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Two - Six Months||0
8242746|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Two - Six Months||11
8242747|NCT01918072|20328096|P3|Control|Controlled Trial Step Two - Six Months||0
8242748|NCT01918072|20328097|P2|Control|Controlled Trial Step Two - Six Months||0
8242749|NCT01918072|20328098|P1|Control|Controlled Trial Step Two - Six Months||4
8242750|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Two - Six Months||0
8242751|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Two - Six Months||0
8242752|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Two - Six Months||7
8242753|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Two - Six Months||0
8242754|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Two - Six Months||0
8242755|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Two - Six Months||11
8242756|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8242757|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8242758|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8242759|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step One - Six Months||0
8242760|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step One - Six Months||0
8242761|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step One - Six Months||11
8242762|NCT01918072|20328096|P3|Control|Controlled Trial Step One - Six Months||0
8242763|NCT01918072|20328097|P2|Control|Controlled Trial Step One - Six Months||0
8242764|NCT01918072|20328098|P1|Control|Controlled Trial Step One - Six Months||10
8242765|NCT01918072|20328096|P3|Intervention|Controlled Trial Step One - Six Months||0
8242766|NCT01918072|20328097|P2|Intervention|Controlled Trial Step One - Six Months||0
8242767|NCT01918072|20328098|P1|Intervention|Controlled Trial Step One - Six Months||1
8242768|NCT01918072|20328096|P3|STARTED|Controlled Trial Step One - Six Months||0
8242769|NCT01918072|20328097|P2|STARTED|Controlled Trial Step One - Six Months||0
8242770|NCT01918072|20328098|P1|STARTED|Controlled Trial Step One - Six Months||11
8242771|NCT01918033|20328112|P3|NOT COMPLETED|Overall Study||3
8242772|NCT01918033|20328113|P2|NOT COMPLETED|Overall Study||2
8242773|NCT01918033|20328114|P1|NOT COMPLETED|Overall Study||5
8242774|NCT01918033|20328112|P3|COMPLETED|Overall Study||199
8242775|NCT01918033|20328113|P2|COMPLETED|Overall Study||201
8242776|NCT01918033|20328114|P1|COMPLETED|Overall Study||198
8242777|NCT01918033|20328112|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
8242778|NCT01918033|20328113|P2|Treated|Overall Study||203
8242779|NCT01918033|20328114|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
8242780|NCT01918033|20328112|P3|STARTED|Overall Study||202
8242781|NCT01918033|20328113|P2|STARTED|Overall Study||203
8242782|NCT01918033|20328114|P1|STARTED|Overall Study||203
8242783|NCT01917812|20328155|P3|NOT COMPLETED|Overall Study||0
8242784|NCT01917812|20328156|P2|NOT COMPLETED|Overall Study||0
8242785|NCT01917812|20328157|P1|NOT COMPLETED|Overall Study||1
8242786|NCT01917812|20328155|P3|COMPLETED|Overall Study||16
8242787|NCT01917812|20328156|P2|COMPLETED|Overall Study||16
8242788|NCT01917812|20328157|P1|COMPLETED|Overall Study||15
8242789|NCT01917812|20328155|P3|STARTED|Overall Study||16
8242790|NCT01917812|20328156|P2|STARTED|Overall Study||16
8242791|NCT01917812|20328157|P1|STARTED|Overall Study||16
8242792|NCT01917773|20328177|P1|NOT COMPLETED|Overall Study||0
8242793|NCT01917773|20328177|P1|COMPLETED|Overall Study||13
8242794|NCT01917773|20328177|P1|STARTED|Overall Study||13
8242795|NCT01917747|20328185|P2|NOT COMPLETED|Overall Study||11
8242796|NCT01917747|20328186|P1|NOT COMPLETED|Overall Study||19
8242797|NCT01917747|20328185|P2|COMPLETED|Overall Study||35
8242798|NCT01917747|20328186|P1|COMPLETED|Overall Study||41
8242799|NCT01917747|20328185|P2|STARTED|Overall Study||46
8242800|NCT01917747|20328186|P1|STARTED|Overall Study||60
8242801|NCT01917682|20328198|P1|NOT COMPLETED|Overall Study||0
8242802|NCT01917682|20328198|P1|COMPLETED|Overall Study||754
8242803|NCT01917682|20328198|P1|STARTED|Overall Study||754
8242804|NCT01917656|20328215|P2|NOT COMPLETED|Overall Study||24
8242805|NCT01917656|20328216|P1|NOT COMPLETED|Overall Study||26
8242806|NCT01917656|20328215|P2|COMPLETED|Overall Study||147
8242807|NCT01917656|20328216|P1|COMPLETED|Overall Study||146
8242808|NCT01917656|20328215|P2|Exposed During Ramadan (Fasting)|Overall Study||163
8242809|NCT01917656|20328216|P1|Exposed During Ramadan (Fasting)|Overall Study||152
8242810|NCT01917656|20328215|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
8242811|NCT01917656|20328216|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
8242812|NCT01917656|20328215|P2|STARTED|Overall Study||171
8242813|NCT01917656|20328216|P1|STARTED|Overall Study||172
8242814|NCT01917526|20328242|P2|NOT COMPLETED|Overall Study||1
8242815|NCT01917526|20328243|P1|NOT COMPLETED|Overall Study||1
8242816|NCT01917526|20328242|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
8242817|NCT01917526|20328243|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
8242818|NCT01917526|20328242|P2|STARTED|Overall Study||250
8242819|NCT01917526|20328243|P1|STARTED|Overall Study||250
8242820|NCT01917513|20328253|P2|NOT COMPLETED|Overall Study||102
8242821|NCT01917513|20328254|P1|NOT COMPLETED|Overall Study||95
8242822|NCT01917513|20328253|P2|COMPLETED|Overall Study||396
8242823|NCT01917513|20328254|P1|COMPLETED|Overall Study||407
8242824|NCT01917513|20328253|P2|STARTED|Overall Study||498
8242825|NCT01917513|20328254|P1|STARTED|Overall Study||502
8242826|NCT01917344|20328260|P1|NOT COMPLETED|Overall Study||1
8242827|NCT01917344|20328260|P1|COMPLETED|Overall Study||9
8242828|NCT01917344|20328260|P1|STARTED|Overall Study||10
8242829|NCT01917318|20328266|P2|NOT COMPLETED|Second Treatment||0
8242830|NCT01917318|20328267|P1|NOT COMPLETED|Second Treatment||0
8242831|NCT01917318|20328266|P2|COMPLETED|Second Treatment||0
8242832|NCT01917318|20328267|P1|COMPLETED|Second Treatment||0
8242833|NCT01917318|20328266|P2|STARTED|Second Treatment||0
8242834|NCT01917318|20328267|P1|STARTED|Second Treatment||0
8242835|NCT01917318|20328266|P2|NOT COMPLETED|First Treatment||1
8242836|NCT01917318|20328267|P1|NOT COMPLETED|First Treatment||0
8242837|NCT01917318|20328266|P2|COMPLETED|First Treatment||0
8242838|NCT01917318|20328267|P1|COMPLETED|First Treatment||0
8242839|NCT01917318|20328266|P2|STARTED|First Treatment||1
8242840|NCT01917318|20328267|P1|STARTED|First Treatment||0
8242841|NCT01917214|20328287|P1|NOT COMPLETED|Overall Study||0
8242842|NCT01917214|20328287|P1|COMPLETED|Overall Study||212
8242843|NCT01917214|20328287|P1|STARTED|Overall Study||212
8242844|NCT01917188|20328299|P3|NOT COMPLETED|Overall Study||9
8242845|NCT01917188|20328300|P2|NOT COMPLETED|Overall Study||6
8242846|NCT01917188|20328301|P1|NOT COMPLETED|Overall Study||12
8242847|NCT01917188|20328299|P3|COMPLETED|Overall Study||11
8242848|NCT01917188|20328300|P2|COMPLETED|Overall Study||17
8242849|NCT01917188|20328301|P1|COMPLETED|Overall Study||17
8242850|NCT01917188|20328299|P3|STARTED|Overall Study||20
8242851|NCT01917188|20328300|P2|STARTED|Overall Study||23
8242852|NCT01917188|20328301|P1|STARTED|Overall Study||29
8242853|NCT01917136|20328309|P1|NOT COMPLETED|Overall Study||0
8242854|NCT01917136|20328309|P1|COMPLETED|Overall Study||21
8242855|NCT01917136|20328309|P1|STARTED|Overall Study||21
8242856|NCT01917084|20328313|P1|NOT COMPLETED|Overall Study||1
8242857|NCT01917084|20328313|P1|COMPLETED|Overall Study||19
8242858|NCT01917084|20328313|P1|STARTED|Overall Study||20
8242859|NCT01917006|20328326|P8|NOT COMPLETED|Open-label Period||2
8242860|NCT01917006|20328327|P7|NOT COMPLETED|Open-label Period||0
8242861|NCT01917006|20328328|P6|NOT COMPLETED|Open-label Period||0
8242862|NCT01917006|20328329|P5|NOT COMPLETED|Open-label Period||0
8242863|NCT01917006|20328330|P4|NOT COMPLETED|Open-label Period||0
8242864|NCT01917006|20328331|P3|NOT COMPLETED|Open-label Period||0
8242865|NCT01917006|20328332|P2|NOT COMPLETED|Open-label Period||0
8242866|NCT01917006|20328333|P1|NOT COMPLETED|Open-label Period||0
8242867|NCT01917006|20328326|P8|COMPLETED|Open-label Period||6
8242868|NCT01917006|20328327|P7|COMPLETED|Open-label Period||0
8242869|NCT01917006|20328328|P6|COMPLETED|Open-label Period||0
8242870|NCT01917006|20328329|P5|COMPLETED|Open-label Period||0
8242871|NCT01917006|20328330|P4|COMPLETED|Open-label Period||0
8242872|NCT01917006|20328331|P3|COMPLETED|Open-label Period||0
8242873|NCT01917006|20328332|P2|COMPLETED|Open-label Period||0
8242874|NCT01917006|20328333|P1|COMPLETED|Open-label Period||0
8242875|NCT01917006|20328326|P8|STARTED|Open-label Period||8
8242876|NCT01917006|20328327|P7|STARTED|Open-label Period||0
8242877|NCT01917006|20328328|P6|STARTED|Open-label Period||0
8242878|NCT01917006|20328329|P5|STARTED|Open-label Period||0
8242879|NCT01917006|20328330|P4|STARTED|Open-label Period||0
8242880|NCT01917006|20328331|P3|STARTED|Open-label Period||0
8242881|NCT01917006|20328332|P2|STARTED|Open-label Period||0
8242882|NCT01917006|20328333|P1|STARTED|Open-label Period||0
8242883|NCT01917006|20328326|P8|NOT COMPLETED|Randomized-treatment Period||0
8242884|NCT01917006|20328327|P7|NOT COMPLETED|Randomized-treatment Period||1
8242885|NCT01917006|20328328|P6|NOT COMPLETED|Randomized-treatment Period||1
8242886|NCT01917006|20328329|P5|NOT COMPLETED|Randomized-treatment Period||0
8242887|NCT01917006|20328330|P4|NOT COMPLETED|Randomized-treatment Period||1
8242888|NCT01917006|20328331|P3|NOT COMPLETED|Randomized-treatment Period||0
8242889|NCT01917006|20328332|P2|NOT COMPLETED|Randomized-treatment Period||0
8242890|NCT01917006|20328333|P1|NOT COMPLETED|Randomized-treatment Period||2
8242891|NCT01917006|20328326|P8|COMPLETED|Randomized-treatment Period||0
8242892|NCT01917006|20328327|P7|COMPLETED|Randomized-treatment Period||14
8242893|NCT01917006|20328328|P6|COMPLETED|Randomized-treatment Period||7
8242894|NCT01917006|20328329|P5|COMPLETED|Randomized-treatment Period||8
8242895|NCT01917006|20328330|P4|COMPLETED|Randomized-treatment Period||7
8242896|NCT01917006|20328331|P3|COMPLETED|Randomized-treatment Period||8
8242897|NCT01917006|20328332|P2|COMPLETED|Randomized-treatment Period||7
8242898|NCT01917006|20328333|P1|COMPLETED|Randomized-treatment Period||3
8242899|NCT01917006|20328326|P8|STARTED|Randomized-treatment Period||0
8242900|NCT01917006|20328327|P7|STARTED|Randomized-treatment Period||15
8242901|NCT01917006|20328328|P6|STARTED|Randomized-treatment Period||8
8242902|NCT01917006|20328329|P5|STARTED|Randomized-treatment Period||8
8242903|NCT01917006|20328330|P4|STARTED|Randomized-treatment Period||8
8242904|NCT01917006|20328331|P3|STARTED|Randomized-treatment Period||8
8242905|NCT01917006|20328332|P2|STARTED|Randomized-treatment Period||7
8242906|NCT01917006|20328333|P1|STARTED|Randomized-treatment Period||5
8242907|NCT01916980|20328366|P2|NOT COMPLETED|Overall Study||4
8242908|NCT01916980|20328367|P1|NOT COMPLETED|Overall Study||7
8242909|NCT01916980|20328366|P2|COMPLETED|Overall Study||25
8242910|NCT01916980|20328367|P1|COMPLETED|Overall Study||58
8242911|NCT01916980|20328366|P2|STARTED|Overall Study||29
8242912|NCT01916980|20328367|P1|STARTED|Overall Study||65
8242913|NCT01916967|20328386|P3|NOT COMPLETED|Overall Study||9
8242914|NCT01916967|20328387|P2|NOT COMPLETED|Overall Study||1
8242915|NCT01916967|20328388|P1|NOT COMPLETED|Overall Study||0
8242916|NCT01916967|20328386|P3|COMPLETED|Overall Study||71
8242917|NCT01916967|20328387|P2|COMPLETED|Overall Study||78
8242918|NCT01916967|20328388|P1|COMPLETED|Overall Study||80
8242919|NCT01916967|20328386|P3|STARTED|Overall Study||80
8242920|NCT01916967|20328387|P2|STARTED|Overall Study||79
8242921|NCT01916967|20328388|P1|STARTED|Overall Study||80
8242922|NCT01916941|20328431|P2|NOT COMPLETED|Overall Study||4
8242923|NCT01916941|20328432|P1|NOT COMPLETED|Overall Study||5
8242924|NCT01916941|20328431|P2|COMPLETED|Overall Study||14
8242925|NCT01916941|20328432|P1|COMPLETED|Overall Study||13
8242926|NCT01916941|20328431|P2|STARTED|Overall Study||18
8242927|NCT01916941|20328432|P1|STARTED|Overall Study||18
8242928|NCT01916928|20328438|P1|NOT COMPLETED|Overall Study||0
8242929|NCT01916928|20328438|P1|COMPLETED|Overall Study||50
8242930|NCT01916928|20328438|P1|STARTED|Overall Study||50
8242931|NCT01916824|20328444|P2|NOT COMPLETED|Overall Study||9
8242932|NCT01916824|20328445|P1|NOT COMPLETED|Overall Study||7
8242933|NCT01916824|20328444|P2|COMPLETED|Overall Study||20
8242934|NCT01916824|20328445|P1|COMPLETED|Overall Study||17
8242935|NCT01916824|20328444|P2|STARTED|Overall Study||29
8242936|NCT01916824|20328445|P1|STARTED|Overall Study||24
8242937|NCT01916681|20328455|P4|NOT COMPLETED|Overall Study||0
8242938|NCT01916681|20328456|P3|NOT COMPLETED|Overall Study||0
8242939|NCT01916681|20328457|P2|NOT COMPLETED|Overall Study||0
8242940|NCT01916681|20328458|P1|NOT COMPLETED|Overall Study||0
8242941|NCT01916681|20328455|P4|COMPLETED|Overall Study||125
8242942|NCT01916681|20328456|P3|COMPLETED|Overall Study||123
8242943|NCT01916681|20328457|P2|COMPLETED|Overall Study||120
8242944|NCT01916681|20328458|P1|COMPLETED|Overall Study||123
8242945|NCT01916681|20328455|P4|STARTED|Overall Study||125
8242946|NCT01916681|20328456|P3|STARTED|Overall Study||123
8242947|NCT01916681|20328457|P2|STARTED|Overall Study||120
8242948|NCT01916681|20328458|P1|STARTED|Overall Study||123
8242949|NCT01916655|20328499|P3|NOT COMPLETED|Overall Study||29
8242950|NCT01916655|20328500|P2|NOT COMPLETED|Overall Study||20
8242951|NCT01916655|20328501|P1|NOT COMPLETED|Overall Study||15
8242952|NCT01916655|20328499|P3|COMPLETED|Overall Study||91
8242953|NCT01916655|20328500|P2|COMPLETED|Overall Study||89
8242954|NCT01916655|20328501|P1|COMPLETED|Overall Study||116
8242955|NCT01916655|20328499|P3|STARTED|Overall Study||120
8242956|NCT01916655|20328500|P2|STARTED|Overall Study||109
8242957|NCT01916655|20328501|P1|STARTED|Overall Study||131
8242958|NCT01916629|20328511|P2|NOT COMPLETED|Overall Study||0
8242959|NCT01916629|20328512|P1|NOT COMPLETED|Overall Study||0
8242960|NCT01916629|20328511|P2|COMPLETED|Overall Study||5
8242961|NCT01916629|20328512|P1|COMPLETED|Overall Study||7
8242962|NCT01916629|20328511|P2|STARTED|Overall Study||5
8242963|NCT01916629|20328512|P1|STARTED|Overall Study||7
8242964|NCT01916590|20328520|P2|NOT COMPLETED|Overall Study||0
8242965|NCT01916590|20328521|P1|NOT COMPLETED|Overall Study||0
8242966|NCT01916590|20328520|P2|COMPLETED|Overall Study||3
8242967|NCT01916590|20328521|P1|COMPLETED|Overall Study||4
8242968|NCT01916590|20328520|P2|STARTED|Overall Study||3
8242969|NCT01916590|20328521|P1|STARTED|Overall Study||4
8242970|NCT01916304|20328527|P1|NOT COMPLETED|Overall Study||17
8242971|NCT01916304|20328527|P1|COMPLETED|Overall Study||84
8242972|NCT01916304|20328527|P1|Intent-to-Treat Set|Overall Study||84
8242973|NCT01916304|20328527|P1|Safety Set|Overall Study||101
8242974|NCT01916304|20328527|P1|STARTED|Overall Study||101
8242975|NCT01916226|20328539|P4|NOT COMPLETED|Overall Study||4
8242976|NCT01916226|20328540|P3|NOT COMPLETED|Overall Study||3
8242977|NCT01916226|20328541|P2|NOT COMPLETED|Overall Study||1
8242978|NCT01916226|20328542|P1|NOT COMPLETED|Overall Study||1
8242979|NCT01916226|20328539|P4|COMPLETED|Overall Study||167
8242980|NCT01916226|20328540|P3|COMPLETED|Overall Study||168
8242981|NCT01916226|20328541|P2|COMPLETED|Overall Study||169
8242982|NCT01916226|20328542|P1|COMPLETED|Overall Study||169
8242983|NCT01916226|20328539|P4|STARTED|Overall Study||171
8242984|NCT01916226|20328540|P3|STARTED|Overall Study||171
8242985|NCT01916226|20328541|P2|STARTED|Overall Study||170
8242986|NCT01916226|20328542|P1|STARTED|Overall Study||170
8242987|NCT01916109|20328576|P1|NOT COMPLETED|Overall Study||1
8242988|NCT01916109|20328576|P1|COMPLETED|Overall Study||3
8242989|NCT01916109|20328576|P1|STARTED|Overall Study||4
8242990|NCT01915940|20328582|P3|NOT COMPLETED|Treatment Period||4
8242991|NCT01915940|20328583|P2|NOT COMPLETED|Treatment Period||11
8242992|NCT01915940|20328584|P1|NOT COMPLETED|Treatment Period||0
8242993|NCT01915940|20328582|P3|COMPLETED|Treatment Period||62
8242994|NCT01915940|20328583|P2|COMPLETED|Treatment Period||53
8242995|NCT01915940|20328584|P1|COMPLETED|Treatment Period||0
8242996|NCT01915940|20328582|P3|STARTED|Treatment Period||66
8242997|NCT01915940|20328583|P2|STARTED|Treatment Period||64
8242998|NCT01915940|20328584|P1|STARTED|Treatment Period||0
8242999|NCT01915940|20328582|P3|NOT COMPLETED|Pre-randomization Washout Period||0
8243000|NCT01915940|20328583|P2|NOT COMPLETED|Pre-randomization Washout Period||0
8243001|NCT01915940|20328584|P1|NOT COMPLETED|Pre-randomization Washout Period||39
8243002|NCT01915940|20328582|P3|COMPLETED|Pre-randomization Washout Period||0
8243003|NCT01915940|20328583|P2|COMPLETED|Pre-randomization Washout Period||0
8243004|NCT01915940|20328584|P1|COMPLETED|Pre-randomization Washout Period||130
8243005|NCT01915940|20328582|P3|STARTED|Pre-randomization Washout Period||0
8243006|NCT01915940|20328583|P2|STARTED|Pre-randomization Washout Period||0
8243007|NCT01915940|20328584|P1|STARTED|Pre-randomization Washout Period||169
8243008|NCT01915914|20328600|P4|NOT COMPLETED|Follow-up Phase||2
8243009|NCT01915914|20328601|P3|NOT COMPLETED|Follow-up Phase||0
8243010|NCT01915914|20328602|P2|NOT COMPLETED|Follow-up Phase||0
8243011|NCT01915914|20328603|P1|NOT COMPLETED|Follow-up Phase||0
8243012|NCT01915914|20328600|P4|COMPLETED|Follow-up Phase||64
8243013|NCT01915914|20328601|P3|COMPLETED|Follow-up Phase||0
8243014|NCT01915914|20328602|P2|COMPLETED|Follow-up Phase||0
8243015|NCT01915914|20328603|P1|COMPLETED|Follow-up Phase||0
8243016|NCT01915914|20328600|P4|STARTED|Follow-up Phase||66
8243017|NCT01915914|20328601|P3|STARTED|Follow-up Phase||0
8243018|NCT01915914|20328602|P2|STARTED|Follow-up Phase||0
8243019|NCT01915914|20328603|P1|STARTED|Follow-up Phase||0
8243020|NCT01915914|20328600|P4|NOT COMPLETED|Maintenance Phase||0
8243021|NCT01915914|20328601|P3|NOT COMPLETED|Maintenance Phase||2
8243022|NCT01915914|20328602|P2|NOT COMPLETED|Maintenance Phase||6
8243023|NCT01915914|20328603|P1|NOT COMPLETED|Maintenance Phase||0
8243024|NCT01915914|20328600|P4|COMPLETED|Maintenance Phase||0
8243025|NCT01915914|20328601|P3|COMPLETED|Maintenance Phase||51
8243026|NCT01915914|20328602|P2|COMPLETED|Maintenance Phase||48
8243027|NCT01915914|20328603|P1|COMPLETED|Maintenance Phase||0
8243028|NCT01915914|20328600|P4|STARTED|Maintenance Phase||0
8243029|NCT01915914|20328601|P3|STARTED|Maintenance Phase||53
8243030|NCT01915914|20328602|P2|STARTED|Maintenance Phase||54
8243031|NCT01915914|20328603|P1|STARTED|Maintenance Phase||0
8243032|NCT01915914|20328600|P4|NOT COMPLETED|Acute Phase||0
8243033|NCT01915914|20328601|P3|NOT COMPLETED|Acute Phase||0
8243034|NCT01915914|20328602|P2|NOT COMPLETED|Acute Phase||0
8243035|NCT01915914|20328603|P1|NOT COMPLETED|Acute Phase||12
8243036|NCT01915914|20328600|P4|COMPLETED|Acute Phase||0
8243037|NCT01915914|20328601|P3|COMPLETED|Acute Phase||0
8243038|NCT01915914|20328602|P2|COMPLETED|Acute Phase||0
8243039|NCT01915914|20328603|P1|COMPLETED|Acute Phase||111
8243040|NCT01915914|20328600|P4|Completed-Not Entered Maintenance Phase|Acute Phase||0
8243041|NCT01915914|20328601|P3|Completed-Not Entered Maintenance Phase|Acute Phase||0
8243042|NCT01915914|20328602|P2|Completed-Not Entered Maintenance Phase|Acute Phase||0
8243043|NCT01915914|20328603|P1|Completed-Not Entered Maintenance Phase|Acute Phase||4
8243044|NCT01915914|20328600|P4|STARTED|Acute Phase||0
8243045|NCT01915914|20328601|P3|STARTED|Acute Phase||0
8243046|NCT01915914|20328602|P2|STARTED|Acute Phase||0
8243047|NCT01915914|20328603|P1|STARTED|Acute Phase||123
8243048|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243049|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243050|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243051|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243052|NCT01915849|20328635|P4|COMPLETED|Treatment Period 4 (4 Days)||3
8243053|NCT01915849|20328636|P3|COMPLETED|Treatment Period 4 (4 Days)||3
8243054|NCT01915849|20328637|P2|COMPLETED|Treatment Period 4 (4 Days)||3
8243055|NCT01915849|20328638|P1|COMPLETED|Treatment Period 4 (4 Days)||3
8243056|NCT01915849|20328635|P4|STARTED|Treatment Period 4 (4 Days)||3
8243057|NCT01915849|20328636|P3|STARTED|Treatment Period 4 (4 Days)||3
8243058|NCT01915849|20328637|P2|STARTED|Treatment Period 4 (4 Days)||3
8243059|NCT01915849|20328638|P1|STARTED|Treatment Period 4 (4 Days)||3
8243060|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243061|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243062|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243063|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243064|NCT01915849|20328635|P4|COMPLETED|Treatment Period 3 (4 Days)||3
8243065|NCT01915849|20328636|P3|COMPLETED|Treatment Period 3 (4 Days)||3
8243066|NCT01915849|20328637|P2|COMPLETED|Treatment Period 3 (4 Days)||3
8243067|NCT01915849|20328638|P1|COMPLETED|Treatment Period 3 (4 Days)||3
8243068|NCT01915849|20328635|P4|STARTED|Treatment Period 3 (4 Days)||3
8243069|NCT01915849|20328636|P3|STARTED|Treatment Period 3 (4 Days)||3
8243070|NCT01915849|20328637|P2|STARTED|Treatment Period 3 (4 Days)||3
8243071|NCT01915849|20328638|P1|STARTED|Treatment Period 3 (4 Days)||3
8243072|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243073|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243074|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243075|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243076|NCT01915849|20328635|P4|COMPLETED|Treatment Period 2 (4 Days)||3
8243077|NCT01915849|20328636|P3|COMPLETED|Treatment Period 2 (4 Days)||3
8243078|NCT01915849|20328637|P2|COMPLETED|Treatment Period 2 (4 Days)||3
8243079|NCT01915849|20328638|P1|COMPLETED|Treatment Period 2 (4 Days)||3
8243080|NCT01915849|20328635|P4|STARTED|Treatment Period 2 (4 Days)||3
8243081|NCT01915849|20328636|P3|STARTED|Treatment Period 2 (4 Days)||3
8243082|NCT01915849|20328637|P2|STARTED|Treatment Period 2 (4 Days)||3
8243083|NCT01915849|20328638|P1|STARTED|Treatment Period 2 (4 Days)||3
8243084|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8243085|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8243086|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8243087|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
8243088|NCT01915849|20328635|P4|COMPLETED|Treatment Period 1 (4 Days)||3
8243089|NCT01915849|20328636|P3|COMPLETED|Treatment Period 1 (4 Days)||3
8243090|NCT01915849|20328637|P2|COMPLETED|Treatment Period 1 (4 Days)||3
8243091|NCT01915849|20328638|P1|COMPLETED|Treatment Period 1 (4 Days)||3
8243092|NCT01915849|20328635|P4|STARTED|Treatment Period 1 (4 Days)||3
8243093|NCT01915849|20328636|P3|STARTED|Treatment Period 1 (4 Days)||3
8243094|NCT01915849|20328637|P2|STARTED|Treatment Period 1 (4 Days)||3
8243095|NCT01915849|20328638|P1|STARTED|Treatment Period 1 (4 Days)||5
8243096|NCT01915823|20328650|P2|NOT COMPLETED|Overall Study||2
8243097|NCT01915823|20328651|P1|NOT COMPLETED|Overall Study||2
8243098|NCT01915823|20328650|P2|COMPLETED|Overall Study||173
8243099|NCT01915823|20328651|P1|COMPLETED|Overall Study||171
8243100|NCT01915823|20328650|P2|STARTED|Overall Study||175
8243101|NCT01915823|20328651|P1|STARTED|Overall Study||173
8243102|NCT01915771|20328661|P1|NOT COMPLETED|Day 15||1
8243103|NCT01915771|20328661|P1|COMPLETED|Day 15||13
8243104|NCT01915771|20328661|P1|STARTED|Day 15||14
8243105|NCT01915771|20328661|P1|NOT COMPLETED|Day 1||1
8243106|NCT01915771|20328661|P1|COMPLETED|Day 1||14
8243107|NCT01915771|20328661|P1|STARTED|Day 1||15
8243108|NCT01915732|20328685|P2|NOT COMPLETED|Overall Study||71
8243109|NCT01915732|20328686|P1|NOT COMPLETED|Overall Study||70
8243110|NCT01915732|20328685|P2|COMPLETED|Overall Study||445
8243111|NCT01915732|20328686|P1|COMPLETED|Overall Study||430
8243112|NCT01915732|20328685|P2|STARTED|Overall Study||516
8243113|NCT01915732|20328686|P1|STARTED|Overall Study||500
8243114|NCT01915563|20328712|P2|NOT COMPLETED|Overall Study||0
8243115|NCT01915563|20328713|P1|NOT COMPLETED|Overall Study||0
8243116|NCT01915563|20328712|P2|COMPLETED|Overall Study||227
8243117|NCT01915563|20328713|P1|COMPLETED|Overall Study||243
8243118|NCT01915563|20328712|P2|STARTED|Overall Study||227
8243119|NCT01915563|20328713|P1|STARTED|Overall Study||243
8243120|NCT01915498|20328739|P19|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
8243121|NCT01915498|20328740|P18|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243122|NCT01915498|20328741|P17|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243123|NCT01915498|20328742|P16|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243124|NCT01915498|20328743|P15|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243125|NCT01915498|20328744|P14|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243126|NCT01915498|20328745|P13|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243127|NCT01915498|20328746|P12|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243128|NCT01915498|20328747|P11|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243129|NCT01915498|20328748|P10|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243130|NCT01915498|20328749|P9|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243131|NCT01915498|20328750|P8|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243132|NCT01915498|20328751|P7|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243133|NCT01915498|20328752|P6|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243134|NCT01915498|20328753|P5|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243135|NCT01915498|20328754|P4|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243136|NCT01915498|20328755|P3|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243137|NCT01915498|20328756|P2|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243138|NCT01915498|20328757|P1|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243139|NCT01915498|20328739|P19|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
8243140|NCT01915498|20328740|P18|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243141|NCT01915498|20328741|P17|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243142|NCT01915498|20328742|P16|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243143|NCT01915498|20328743|P15|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243144|NCT01915498|20328744|P14|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243145|NCT01915498|20328745|P13|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243146|NCT01915498|20328746|P12|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243147|NCT01915498|20328747|P11|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243148|NCT01915498|20328748|P10|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243149|NCT01915498|20328749|P9|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243150|NCT01915498|20328750|P8|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243151|NCT01915498|20328751|P7|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243152|NCT01915498|20328752|P6|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243153|NCT01915498|20328753|P5|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243154|NCT01915498|20328754|P4|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243155|NCT01915498|20328755|P3|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243156|NCT01915498|20328756|P2|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243157|NCT01915498|20328757|P1|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243158|NCT01915498|20328739|P19|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
8243159|NCT01915498|20328740|P18|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243160|NCT01915498|20328741|P17|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243161|NCT01915498|20328742|P16|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243162|NCT01915498|20328743|P15|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243163|NCT01915498|20328744|P14|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243164|NCT01915498|20328745|P13|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243165|NCT01915498|20328746|P12|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243166|NCT01915498|20328747|P11|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243167|NCT01915498|20328748|P10|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243168|NCT01915498|20328749|P9|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243169|NCT01915498|20328750|P8|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243170|NCT01915498|20328751|P7|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243171|NCT01915498|20328752|P6|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243172|NCT01915498|20328753|P5|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243173|NCT01915498|20328754|P4|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243174|NCT01915498|20328755|P3|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243254|NCT01915108|20329337|P2|NOT COMPLETED|Overall Study||3
8243175|NCT01915498|20328756|P2|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243176|NCT01915498|20328757|P1|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243177|NCT01915498|20328739|P19|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243178|NCT01915498|20328740|P18|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
8243179|NCT01915498|20328741|P17|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
8243180|NCT01915498|20328742|P16|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
8243181|NCT01915498|20328743|P15|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
8243182|NCT01915498|20328744|P14|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
8243183|NCT01915498|20328745|P13|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243184|NCT01915498|20328746|P12|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
8243185|NCT01915498|20328747|P11|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
8243186|NCT01915498|20328748|P10|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
8243187|NCT01915498|20328749|P9|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
8243188|NCT01915498|20328750|P8|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
8243189|NCT01915498|20328751|P7|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243190|NCT01915498|20328752|P6|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
8243191|NCT01915498|20328753|P5|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
8243192|NCT01915498|20328754|P4|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
8243193|NCT01915498|20328755|P3|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243194|NCT01915498|20328756|P2|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243195|NCT01915498|20328757|P1|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243196|NCT01915498|20328739|P19|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243197|NCT01915498|20328740|P18|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
8243198|NCT01915498|20328741|P17|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
8243199|NCT01915498|20328742|P16|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
8243200|NCT01915498|20328743|P15|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243201|NCT01915498|20328744|P14|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
8243202|NCT01915498|20328745|P13|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243203|NCT01915498|20328746|P12|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
8243204|NCT01915498|20328747|P11|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243205|NCT01915498|20328748|P10|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243206|NCT01915498|20328749|P9|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243207|NCT01915498|20328750|P8|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
8243208|NCT01915498|20328751|P7|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243209|NCT01915498|20328752|P6|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243210|NCT01915498|20328753|P5|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243211|NCT01915498|20328754|P4|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243212|NCT01915498|20328755|P3|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243213|NCT01915498|20328756|P2|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243214|NCT01915498|20328757|P1|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243215|NCT01915498|20328739|P19|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
8243216|NCT01915498|20328740|P18|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
8243217|NCT01915498|20328741|P17|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
8243218|NCT01915498|20328742|P16|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
8243219|NCT01915498|20328743|P15|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
8243220|NCT01915498|20328744|P14|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
8243221|NCT01915498|20328745|P13|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243222|NCT01915498|20328746|P12|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
8243223|NCT01915498|20328747|P11|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
8243224|NCT01915498|20328748|P10|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
8243225|NCT01915498|20328749|P9|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
8243226|NCT01915498|20328750|P8|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
8243227|NCT01915498|20328751|P7|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243228|NCT01915498|20328752|P6|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
8243229|NCT01915498|20328753|P5|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
8243230|NCT01915498|20328754|P4|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
8243231|NCT01915498|20328755|P3|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243232|NCT01915498|20328756|P2|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243233|NCT01915498|20328757|P1|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243234|NCT01915303|20329281|P1|NOT COMPLETED|Extension Phase||17
8243235|NCT01915303|20329281|P1|COMPLETED|Extension Phase||12
8243236|NCT01915303|20329281|P1|STARTED|Extension Phase||29
8243237|NCT01915303|20329281|P1|NOT COMPLETED|Core Phase||16
8243238|NCT01915303|20329281|P1|COMPLETED|Core Phase||52
8243239|NCT01915303|20329281|P1|STARTED|Core Phase||68
8243240|NCT01915173|20329310|P4|NOT COMPLETED|Overall Study||0
8243241|NCT01915173|20329311|P3|NOT COMPLETED|Overall Study||0
8243242|NCT01915173|20329312|P2|NOT COMPLETED|Overall Study||0
8243243|NCT01915173|20329313|P1|NOT COMPLETED|Overall Study||0
8243244|NCT01915173|20329310|P4|COMPLETED|Overall Study||6
8243245|NCT01915173|20329311|P3|COMPLETED|Overall Study||6
8243246|NCT01915173|20329312|P2|COMPLETED|Overall Study||6
8243247|NCT01915173|20329313|P1|COMPLETED|Overall Study||6
8243248|NCT01915173|20329310|P4|STARTED|Overall Study||6
8243249|NCT01915173|20329311|P3|STARTED|Overall Study||6
8243250|NCT01915173|20329312|P2|STARTED|Overall Study||6
8243251|NCT01915173|20329313|P1|STARTED|Overall Study||6
8243252|NCT01915108|20329335|P4|NOT COMPLETED|Overall Study||2
8243253|NCT01915108|20329336|P3|NOT COMPLETED|Overall Study||1
8243255|NCT01915108|20329338|P1|NOT COMPLETED|Overall Study||2
8243256|NCT01915108|20329335|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
8243257|NCT01915108|20329336|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
8243258|NCT01915108|20329337|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
8243259|NCT01915108|20329338|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
8243260|NCT01915108|20329335|P4|STARTED|Overall Study||32
8243261|NCT01915108|20329336|P3|STARTED|Overall Study||32
8243262|NCT01915108|20329337|P2|STARTED|Overall Study||32
8243263|NCT01915108|20329338|P1|STARTED|Overall Study||32
8243264|NCT01915095|20329355|P5|NOT COMPLETED|Overall Study||6
8243265|NCT01915095|20329356|P4|NOT COMPLETED|Overall Study||4
8243266|NCT01915095|20329357|P3|NOT COMPLETED|Overall Study||0
8243267|NCT01915095|20329358|P2|NOT COMPLETED|Overall Study||0
8243268|NCT01915095|20329359|P1|NOT COMPLETED|Overall Study||0
8243269|NCT01915095|20329355|P5|COMPLETED|Overall Study||3
8243270|NCT01915095|20329356|P4|COMPLETED|Overall Study||4
8243271|NCT01915095|20329357|P3|COMPLETED|Overall Study||5
8243272|NCT01915095|20329358|P2|COMPLETED|Overall Study||10
8243273|NCT01915095|20329359|P1|COMPLETED|Overall Study||10
8243274|NCT01915095|20329355|P5|Control|Overall Study||0
8243275|NCT01915095|20329356|P4|Control|Overall Study||0
8243276|NCT01915095|20329357|P3|Control|Overall Study||0
8243277|NCT01915095|20329358|P2|Control|Overall Study||5
8243278|NCT01915095|20329359|P1|Control|Overall Study||5
8243279|NCT01915095|20329355|P5|SCI|Overall Study||9
8243280|NCT01915095|20329356|P4|SCI|Overall Study||8
8243281|NCT01915095|20329357|P3|SCI|Overall Study||5
8243282|NCT01915095|20329358|P2|SCI|Overall Study||5
8243283|NCT01915095|20329359|P1|SCI|Overall Study||5
8243284|NCT01915095|20329355|P5|STARTED|Overall Study||9
8243285|NCT01915095|20329356|P4|STARTED|Overall Study||8
8243286|NCT01915095|20329357|P3|STARTED|Overall Study||5
8243287|NCT01915095|20329358|P2|STARTED|Overall Study||10
8243288|NCT01915095|20329359|P1|STARTED|Overall Study||10
8243289|NCT01914926|20329382|P2|NOT COMPLETED|Overall Study||1
8243290|NCT01914926|20329383|P1|NOT COMPLETED|Overall Study||1
8243291|NCT01914926|20329382|P2|COMPLETED|Overall Study||24
8243292|NCT01914926|20329383|P1|COMPLETED|Overall Study||28
8243293|NCT01914926|20329382|P2|STARTED|Overall Study||25
8243294|NCT01914926|20329383|P1|STARTED|Overall Study||29
8243295|NCT01914757|20329392|P3|NOT COMPLETED|Overall Study||38
8243296|NCT01914757|20329393|P2|NOT COMPLETED|Overall Study||51
8243297|NCT01914757|20329394|P1|NOT COMPLETED|Overall Study||36
8243298|NCT01914757|20329392|P3|COMPLETED|Overall Study||402
8243299|NCT01914757|20329393|P2|COMPLETED|Overall Study||390
8243300|NCT01914757|20329394|P1|COMPLETED|Overall Study||389
8243301|NCT01914757|20329392|P3|STARTED|Overall Study||440
8243302|NCT01914757|20329393|P2|STARTED|Overall Study||441
8243303|NCT01914757|20329394|P1|STARTED|Overall Study||425
8243304|NCT01914679|20329468|P1|NOT COMPLETED|Overall Study||5
8243305|NCT01914679|20329468|P1|COMPLETED|Overall Study||12
8243306|NCT01914679|20329468|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
8243307|NCT01914679|20329468|P1|STARTED|Overall Study||17
8243308|NCT01914666|20329475|P3|NOT COMPLETED|Tapering Period||0
8243309|NCT01914666|20329476|P2|NOT COMPLETED|Tapering Period||0
8243310|NCT01914666|20329477|P1|NOT COMPLETED|Tapering Period||0
8243311|NCT01914666|20329475|P3|COMPLETED|Tapering Period||40
8243312|NCT01914666|20329476|P2|COMPLETED|Tapering Period||39
8243313|NCT01914666|20329477|P1|COMPLETED|Tapering Period||59
8243314|NCT01914666|20329475|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
8243315|NCT01914666|20329476|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
8243316|NCT01914666|20329477|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
8243317|NCT01914666|20329475|P3|NOT COMPLETED|Treatment Period||8
8243318|NCT01914666|20329476|P2|NOT COMPLETED|Treatment Period||6
8243319|NCT01914666|20329477|P1|NOT COMPLETED|Treatment Period||13
8243320|NCT01914666|20329475|P3|COMPLETED|Treatment Period||33
8243321|NCT01914666|20329476|P2|COMPLETED|Treatment Period||36
8243322|NCT01914666|20329477|P1|COMPLETED|Treatment Period||55
8243323|NCT01914666|20329475|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
8243324|NCT01914666|20329476|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
8243325|NCT01914666|20329477|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
8243326|NCT01914666|20329475|P3|STARTED|Treatment Period||41
8243327|NCT01914666|20329476|P2|STARTED|Treatment Period||42
8243328|NCT01914666|20329477|P1|STARTED|Treatment Period||68
8243329|NCT01914510|20329510|P1|NOT COMPLETED|Overall Study||2
8243330|NCT01914510|20329510|P1|COMPLETED|Overall Study||38
8243331|NCT01914510|20329510|P1|STARTED|Overall Study||40
8243332|NCT01914393|20329520|P3|NOT COMPLETED|Overall Study||138
8243333|NCT01914393|20329521|P2|NOT COMPLETED|Overall Study||71
8243334|NCT01914393|20329522|P1|NOT COMPLETED|Overall Study||115
8243335|NCT01914393|20329520|P3|COMPLETED|Overall Study||168
8243336|NCT01914393|20329521|P2|COMPLETED|Overall Study||54
8243337|NCT01914393|20329522|P1|COMPLETED|Overall Study||156
8243338|NCT01914393|20329520|P3|STARTED|Overall Study||306
8243339|NCT01914393|20329521|P2|STARTED|Overall Study||125
8243340|NCT01914393|20329522|P1|STARTED|Overall Study||271
8243341|NCT01914159|20329554|P1|NOT COMPLETED|Overall Study||3
8243342|NCT01914159|20329554|P1|COMPLETED|Overall Study||21
8243343|NCT01914159|20329554|P1|STARTED|Overall Study||24
8243344|NCT01914003|20329562|P2|NOT COMPLETED|Overall Study||12
8243345|NCT01914003|20329563|P1|NOT COMPLETED|Overall Study||8
8243346|NCT01914003|20329562|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
8243347|NCT01914003|20329563|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
8243348|NCT01914003|20329562|P2|STARTED|Overall Study||26
8243349|NCT01914003|20329563|P1|STARTED|Overall Study||27
8243350|NCT01913795|20329573|P4|NOT COMPLETED|Overall Study||1
8243351|NCT01913795|20329574|P3|NOT COMPLETED|Overall Study||0
8243352|NCT01913795|20329575|P2|NOT COMPLETED|Overall Study||3
8243353|NCT01913795|20329576|P1|NOT COMPLETED|Overall Study||0
8243354|NCT01913795|20329573|P4|COMPLETED|Overall Study||5
8243355|NCT01913795|20329574|P3|COMPLETED|Overall Study||9
8243356|NCT01913795|20329575|P2|COMPLETED|Overall Study||7
8243357|NCT01913795|20329576|P1|COMPLETED|Overall Study||4
8243358|NCT01913795|20329573|P4|STARTED|Overall Study||6
8243359|NCT01913795|20329574|P3|STARTED|Overall Study||9
8243360|NCT01913795|20329575|P2|STARTED|Overall Study||10
8243361|NCT01913795|20329576|P1|STARTED|Overall Study||4
8243362|NCT01913639|20329590|P1|NOT COMPLETED|Overall Study||3
8243363|NCT01913639|20329590|P1|COMPLETED|Overall Study||36
8243364|NCT01913639|20329590|P1|STARTED|Overall Study||39
8243365|NCT01913600|20329597|P1|NOT COMPLETED|Overall Study||1
8243366|NCT01913600|20329597|P1|COMPLETED|Overall Study||55
8243367|NCT01913600|20329597|P1|STARTED|Overall Study||56
8243368|NCT01913535|20329619|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243369|NCT01913535|20329620|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243370|NCT01913535|20329621|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243371|NCT01913535|20329622|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243372|NCT01913535|20329623|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243373|NCT01913535|20329619|P5|COMPLETED|Phase 2 (Days 3-5)||1
8243374|NCT01913535|20329620|P4|COMPLETED|Phase 2 (Days 3-5)||2
8243375|NCT01913535|20329621|P3|COMPLETED|Phase 2 (Days 3-5)||1
8243376|NCT01913535|20329622|P2|COMPLETED|Phase 2 (Days 3-5)||2
8243377|NCT01913535|20329623|P1|COMPLETED|Phase 2 (Days 3-5)||2
8243378|NCT01913535|20329619|P5|STARTED|Phase 2 (Days 3-5)||1
8243379|NCT01913535|20329620|P4|STARTED|Phase 2 (Days 3-5)||2
8243380|NCT01913535|20329621|P3|STARTED|Phase 2 (Days 3-5)||1
8243381|NCT01913535|20329622|P2|STARTED|Phase 2 (Days 3-5)||2
8243382|NCT01913535|20329623|P1|STARTED|Phase 2 (Days 3-5)||2
8243383|NCT01913535|20329619|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243384|NCT01913535|20329620|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243385|NCT01913535|20329621|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243386|NCT01913535|20329622|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243387|NCT01913535|20329623|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243388|NCT01913535|20329619|P5|COMPLETED|Phase 1 (Days 0-2)||1
8243389|NCT01913535|20329620|P4|COMPLETED|Phase 1 (Days 0-2)||2
8243390|NCT01913535|20329621|P3|COMPLETED|Phase 1 (Days 0-2)||1
8243391|NCT01913535|20329622|P2|COMPLETED|Phase 1 (Days 0-2)||2
8243392|NCT01913535|20329623|P1|COMPLETED|Phase 1 (Days 0-2)||2
8243393|NCT01913535|20329619|P5|STARTED|Phase 1 (Days 0-2)||1
8243394|NCT01913535|20329620|P4|STARTED|Phase 1 (Days 0-2)||2
8243395|NCT01913535|20329621|P3|STARTED|Phase 1 (Days 0-2)||1
8243396|NCT01913535|20329622|P2|STARTED|Phase 1 (Days 0-2)||2
8243397|NCT01913535|20329623|P1|STARTED|Phase 1 (Days 0-2)||2
8243398|NCT01913483|20329656|P2|NOT COMPLETED|Overall Study||22
8243399|NCT01913483|20329657|P1|NOT COMPLETED|Overall Study||21
8243400|NCT01913483|20329656|P2|COMPLETED|Overall Study||343
8243401|NCT01913483|20329657|P1|COMPLETED|Overall Study||346
8243402|NCT01913483|20329656|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
8243403|NCT01913483|20329657|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
8243404|NCT01913483|20329656|P2|STARTED|Overall Study||365
8243405|NCT01913483|20329657|P1|STARTED|Overall Study||367
8243406|NCT01913470|20329669|P2|NOT COMPLETED|Overall Study||3
8243407|NCT01913470|20329670|P1|NOT COMPLETED|Overall Study||0
8243408|NCT01913470|20329669|P2|COMPLETED|Overall Study||4
8243409|NCT01913470|20329670|P1|COMPLETED|Overall Study||5
8243410|NCT01913470|20329669|P2|STARTED|Overall Study||7
8243411|NCT01913470|20329670|P1|STARTED|Overall Study||5
8243412|NCT01913405|20329688|P1|NOT COMPLETED|Overall Study||2
8243413|NCT01913405|20329688|P1|COMPLETED|Overall Study||20
8243414|NCT01913405|20329688|P1|STARTED|Overall Study||22
8243415|NCT01913353|20329744|P2|NOT COMPLETED|Overall Study||15
8243416|NCT01913353|20329745|P1|NOT COMPLETED|Overall Study||32
8243417|NCT01913353|20329744|P2|COMPLETED|Overall Study||204
8243418|NCT01913353|20329745|P1|COMPLETED|Overall Study||189
8243419|NCT01913353|20329744|P2|STARTED|Overall Study||219
8243420|NCT01913353|20329745|P1|STARTED|Overall Study||221
8243421|NCT01913340|20329815|P2|NOT COMPLETED|Overall Study||6
8243422|NCT01913340|20329816|P1|NOT COMPLETED|Overall Study||3
8243423|NCT01913340|20329815|P2|COMPLETED|Overall Study||20
8243424|NCT01913340|20329816|P1|COMPLETED|Overall Study||21
8243425|NCT01913340|20329815|P2|STARTED|Overall Study||26
8243426|NCT01913340|20329816|P1|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
8243427|NCT01913327|20329840|P2|NOT COMPLETED|Overall Study||1
8243428|NCT01913327|20329841|P1|NOT COMPLETED|Overall Study||0
8243429|NCT01913327|20329840|P2|COMPLETED|Overall Study||1
8243430|NCT01913327|20329841|P1|COMPLETED|Overall Study||1
8243431|NCT01913327|20329840|P2|STARTED|Overall Study||2
8243432|NCT01913327|20329841|P1|STARTED|Overall Study||1
8243433|NCT01913314|20329853|P1|NOT COMPLETED|Overall Study||0
8243434|NCT01913314|20329853|P1|COMPLETED|Overall Study||6
8243435|NCT01913314|20329853|P1|Received Study Drug|Overall Study||6
8243436|NCT01913314|20329853|P1|STARTED|Overall Study||6
8243437|NCT01913041|20329866|P1|NOT COMPLETED|Overall Study||39
8243438|NCT01913041|20329866|P1|COMPLETED|Overall Study||830
8243439|NCT01913041|20329866|P1|STARTED|Overall Study||869
8243440|NCT01912963|20329873|P3|NOT COMPLETED|Overall Study||7
8243441|NCT01912963|20329874|P2|NOT COMPLETED|Overall Study||19
8243442|NCT01912963|20329875|P1|NOT COMPLETED|Overall Study||6
8243443|NCT01912963|20329873|P3|COMPLETED|Overall Study||0
8243444|NCT01912963|20329874|P2|COMPLETED|Overall Study||0
8243445|NCT01912963|20329875|P1|COMPLETED|Overall Study||0
8243446|NCT01912963|20329873|P3|STARTED|Overall Study||7
8243447|NCT01912963|20329874|P2|STARTED|Overall Study||19
8243448|NCT01912963|20329875|P1|STARTED|Overall Study||6
8243449|NCT01912872|20329898|P4|NOT COMPLETED|Overall Study||12
8243450|NCT01912872|20329899|P3|NOT COMPLETED|Overall Study||10
8243451|NCT01912872|20329900|P2|NOT COMPLETED|Overall Study||4
8243452|NCT01912872|20329901|P1|NOT COMPLETED|Overall Study||5
8243453|NCT01912872|20329898|P4|COMPLETED|Overall Study||27
8243454|NCT01912872|20329899|P3|COMPLETED|Overall Study||30
8243455|NCT01912872|20329900|P2|COMPLETED|Overall Study||13
8243456|NCT01912872|20329901|P1|COMPLETED|Overall Study||11
8243457|NCT01912872|20329898|P4|Discontinued Treatment Prior to Month 12|Overall Study||11
8243458|NCT01912872|20329899|P3|Discontinued Treatment Prior to Month 12|Overall Study||10
8243459|NCT01912872|20329900|P2|Discontinued Treatment Prior to Month 12|Overall Study||4
8243460|NCT01912872|20329901|P1|Discontinued Treatment Prior to Month 12|Overall Study||5
8243461|NCT01912872|20329898|P4|Completed Study Treatment at Month 12|Overall Study||27
8243462|NCT01912872|20329899|P3|Completed Study Treatment at Month 12|Overall Study||30
8243463|NCT01912872|20329900|P2|Completed Study Treatment at Month 12|Overall Study||13
8243464|NCT01912872|20329901|P1|Completed Study Treatment at Month 12|Overall Study||11
8243465|NCT01912872|20329898|P4|STARTED|Overall Study||39
8243466|NCT01912872|20329899|P3|STARTED|Overall Study||40
8243467|NCT01912872|20329900|P2|STARTED|Overall Study||17
8243468|NCT01912872|20329901|P1|STARTED|Overall Study||16
8243469|NCT01912781|20329945|P2|NOT COMPLETED|Overall Study||0
8243470|NCT01912781|20329946|P1|NOT COMPLETED|Overall Study||2
8243471|NCT01912781|20329945|P2|COMPLETED|Overall Study||35
8243472|NCT01912781|20329946|P1|COMPLETED|Overall Study||69
8243473|NCT01912781|20329945|P2|STARTED|Overall Study||35
8243474|NCT01912781|20329946|P1|STARTED|Overall Study||71
8243475|NCT01912768|20329977|P2|NOT COMPLETED|Overall Study||4
8243476|NCT01912768|20329978|P1|NOT COMPLETED|Overall Study||10
8243477|NCT01912768|20329977|P2|COMPLETED|Overall Study||109
8243478|NCT01912768|20329978|P1|COMPLETED|Overall Study||229
8243479|NCT01912768|20329977|P2|STARTED|Overall Study||113
8243480|NCT01912768|20329978|P1|STARTED|Overall Study||239
8243481|NCT01912729|20330009|P2|NOT COMPLETED|Overall Study||1
8243482|NCT01912729|20330010|P1|NOT COMPLETED|Overall Study||0
8243483|NCT01912729|20330009|P2|COMPLETED|Overall Study||19
8243484|NCT01912729|20330010|P1|COMPLETED|Overall Study||20
8243485|NCT01912729|20330009|P2|STARTED|Overall Study||20
8243486|NCT01912729|20330010|P1|STARTED|Overall Study||20
8243487|NCT01912716|20330022|P2|NOT COMPLETED|Overall Study||0
8243488|NCT01912716|20330023|P1|NOT COMPLETED|Overall Study||0
8243489|NCT01912716|20330022|P2|COMPLETED|Overall Study||515
8243490|NCT01912716|20330023|P1|COMPLETED|Overall Study||522
8243491|NCT01912716|20330022|P2|3-day Follow-up|Overall Study||513
8243492|NCT01912716|20330023|P1|3-day Follow-up|Overall Study||521
8243493|NCT01912716|20330022|P2|5-day Follow-up|Overall Study||515
8243494|NCT01912716|20330023|P1|5-day Follow-up|Overall Study||522
8243495|NCT01912716|20330022|P2|Receipt of 2nd Dose|Overall Study||503
8243496|NCT01912716|20330023|P1|Receipt of 2nd Dose|Overall Study||511
8243497|NCT01912716|20330022|P2|STARTED|Overall Study||515
8243498|NCT01912716|20330023|P1|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
8243499|NCT01912612|20330033|P3|NOT COMPLETED|Overall Study||3
8243500|NCT01912612|20330034|P2|NOT COMPLETED|Overall Study||0
8243501|NCT01912612|20330035|P1|NOT COMPLETED|Overall Study||5
8243502|NCT01912612|20330033|P3|COMPLETED|Overall Study||0
8243503|NCT01912612|20330034|P2|COMPLETED|Overall Study||40
8243504|NCT01912612|20330035|P1|COMPLETED|Overall Study||31
8243505|NCT01912612|20330033|P3|STARTED|Overall Study||3
8243506|NCT01912612|20330034|P2|STARTED|Overall Study||40
8243507|NCT01912612|20330035|P1|STARTED|Overall Study||36
8243508|NCT01912599|20330079|P2|NOT COMPLETED|Overall Study||1
8243509|NCT01912599|20330080|P1|NOT COMPLETED|Overall Study||0
8243510|NCT01912599|20330079|P2|COMPLETED|Overall Study||15
8243511|NCT01912599|20330080|P1|COMPLETED|Overall Study||20
8243512|NCT01912599|20330079|P2|STARTED|Overall Study||16
8243513|NCT01912599|20330080|P1|STARTED|Overall Study||20
8243514|NCT01912495|20330094|P1|NOT COMPLETED|Overall Study||0
8243515|NCT01912495|20330094|P1|COMPLETED|Overall Study||57
8243516|NCT01912495|20330094|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
8243517|NCT01912404|20330105|P2|NOT COMPLETED|Overall Study||0
8243518|NCT01912404|20330106|P1|NOT COMPLETED|Overall Study||1
8243519|NCT01912404|20330105|P2|COMPLETED|Overall Study||2
8243520|NCT01912404|20330106|P1|COMPLETED|Overall Study||2
8243521|NCT01912404|20330105|P2|STARTED|Overall Study||2
8243522|NCT01912404|20330106|P1|STARTED|Overall Study||3
8243523|NCT01912352|20330112|P1|NOT COMPLETED|Overall Study||5
8243524|NCT01912352|20330112|P1|COMPLETED|Overall Study||78
8243525|NCT01912352|20330112|P1|STARTED|Overall Study||83
8243526|NCT01912339|20330119|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
8243527|NCT01912339|20330120|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243528|NCT01912339|20330121|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
8243529|NCT01912339|20330119|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243530|NCT01912339|20330120|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243531|NCT01912339|20330121|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243532|NCT01912339|20330119|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
8243533|NCT01912339|20330120|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
8243534|NCT01912339|20330121|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
8243535|NCT01912339|20330119|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
8243536|NCT01912339|20330120|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
8243537|NCT01912339|20330121|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
8243538|NCT01912339|20330119|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
8243539|NCT01912339|20330120|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
8243540|NCT01912339|20330121|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
8243541|NCT01912339|20330119|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
8243542|NCT01912339|20330120|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
8243543|NCT01912339|20330121|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
8243544|NCT01912339|20330119|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
8243545|NCT01912339|20330120|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
8243546|NCT01912339|20330121|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
8243547|NCT01912339|20330119|P3|COMPLETED|Blinded (0 to 3 Months)||0
8243548|NCT01912339|20330120|P2|COMPLETED|Blinded (0 to 3 Months)||61
8243549|NCT01912339|20330121|P1|COMPLETED|Blinded (0 to 3 Months)||134
8243550|NCT01912339|20330119|P3|STARTED|Blinded (0 to 3 Months)||0
8243551|NCT01912339|20330120|P2|STARTED|Blinded (0 to 3 Months)||61
8243552|NCT01912339|20330121|P1|STARTED|Blinded (0 to 3 Months)||136
8243553|NCT01912287|20330138|P3|NOT COMPLETED|Overall Study||15
8243554|NCT01912287|20330139|P2|NOT COMPLETED|Overall Study||23
8243555|NCT01912287|20330140|P1|NOT COMPLETED|Overall Study||33
8243556|NCT01912287|20330138|P3|COMPLETED|Overall Study||28
8243557|NCT01912287|20330139|P2|COMPLETED|Overall Study||67
8243558|NCT01912287|20330140|P1|COMPLETED|Overall Study||60
8243559|NCT01912287|20330138|P3|STARTED|Overall Study||43
8243560|NCT01912287|20330139|P2|STARTED|Overall Study||90
8243561|NCT01912287|20330140|P1|STARTED|Overall Study||93
8243562|NCT01912222|20330151|P3|NOT COMPLETED|Part B: Treatment Period||20
8243563|NCT01912222|20330152|P2|NOT COMPLETED|Part B: Treatment Period||15
8243564|NCT01912222|20330153|P1|NOT COMPLETED|Part B: Treatment Period||13
8243565|NCT01912222|20330151|P3|COMPLETED|Part B: Treatment Period||0
8243566|NCT01912222|20330152|P2|COMPLETED|Part B: Treatment Period||0
8243567|NCT01912222|20330153|P1|COMPLETED|Part B: Treatment Period||0
8243568|NCT01912222|20330151|P3|STARTED|Part B: Treatment Period||20
8243569|NCT01912222|20330152|P2|STARTED|Part B: Treatment Period||15
8243570|NCT01912222|20330153|P1|STARTED|Part B: Treatment Period||13
8243571|NCT01912222|20330151|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
8243572|NCT01912222|20330152|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
8243573|NCT01912222|20330153|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
8243574|NCT01912222|20330151|P3|COMPLETED|Part A: Pharmacokinetic Period||18
8243575|NCT01912222|20330152|P2|COMPLETED|Part A: Pharmacokinetic Period||13
8243576|NCT01912222|20330153|P1|COMPLETED|Part A: Pharmacokinetic Period||12
8243577|NCT01912222|20330151|P3|STARTED|Part A: Pharmacokinetic Period||20
8243578|NCT01912222|20330152|P2|STARTED|Part A: Pharmacokinetic Period||15
8243579|NCT01912222|20330153|P1|STARTED|Part A: Pharmacokinetic Period||13
8243580|NCT01911910|20330178|P2|NOT COMPLETED|Overall Study||11
8243581|NCT01911910|20330179|P1|NOT COMPLETED|Overall Study||13
8243582|NCT01911910|20330178|P2|COMPLETED|Overall Study||194
8243583|NCT01911910|20330179|P1|COMPLETED|Overall Study||184
8243584|NCT01911910|20330178|P2|STARTED|Overall Study||205
8243585|NCT01911910|20330179|P1|STARTED|Overall Study||197
8243586|NCT01911845|20330211|P1|NOT COMPLETED|Overall Study||6
8243587|NCT01911845|20330211|P1|COMPLETED|Overall Study||32
8243588|NCT01911845|20330211|P1|Completed Study Drug|Overall Study||37
8243589|NCT01911845|20330211|P1|STARTED|Overall Study||38
8243590|NCT01911819|20330228|P3|NOT COMPLETED|Overall Study||0
8243591|NCT01911819|20330229|P2|NOT COMPLETED|Overall Study||2
8243592|NCT01911819|20330230|P1|NOT COMPLETED|Overall Study||1
8243593|NCT01911819|20330228|P3|COMPLETED|Overall Study||10
8243594|NCT01911819|20330229|P2|COMPLETED|Overall Study||9
8243595|NCT01911819|20330230|P1|COMPLETED|Overall Study||9
8243596|NCT01911819|20330228|P3|STARTED|Overall Study||10
8243597|NCT01911819|20330229|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
8243598|NCT01911819|20330230|P1|STARTED|Overall Study||10
8243599|NCT01911793|20330243|P2|NOT COMPLETED|Overall Study||5
8243600|NCT01911793|20330244|P1|NOT COMPLETED|Overall Study||1
8243601|NCT01911793|20330243|P2|COMPLETED|Overall Study||0
8243602|NCT01911793|20330244|P1|COMPLETED|Overall Study||0
8243603|NCT01911793|20330243|P2|STARTED|Overall Study||5
8243604|NCT01911793|20330244|P1|STARTED|Overall Study||1
8243605|NCT01911780|20330268|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
8243606|NCT01911780|20330269|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
8243607|NCT01911780|20330268|P2|COMPLETED|Extension Period (52 Weeks)||58
8243608|NCT01911780|20330269|P1|COMPLETED|Extension Period (52 Weeks)||61
8243609|NCT01911780|20330268|P2|STARTED|Extension Period (52 Weeks)||61
8243610|NCT01911780|20330269|P1|STARTED|Extension Period (52 Weeks)||65
8243611|NCT01911780|20330268|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
8243612|NCT01911780|20330269|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
8243613|NCT01911780|20330268|P2|COMPLETED|Double-blind Period (8 Weeks)||61
8243614|NCT01911780|20330269|P1|COMPLETED|Double-blind Period (8 Weeks)||65
8243615|NCT01911780|20330268|P2|STARTED|Double-blind Period (8 Weeks)||64
8243616|NCT01911780|20330269|P1|STARTED|Double-blind Period (8 Weeks)||68
8243617|NCT01911689|20330289|P2|NOT COMPLETED|Overall Study||0
8243618|NCT01911689|20330290|P1|NOT COMPLETED|Overall Study||0
8243619|NCT01911689|20330289|P2|COMPLETED|Overall Study||51
8243620|NCT01911689|20330290|P1|COMPLETED|Overall Study||117
8243621|NCT01911689|20330289|P2|STARTED|Overall Study||51
8243622|NCT01911689|20330290|P1|STARTED|Overall Study||117
8243623|NCT01911546|20330303|P1|NOT COMPLETED|Overall Study||6
8243624|NCT01911546|20330303|P1|COMPLETED|Overall Study||14
8243625|NCT01911546|20330303|P1|STARTED|Overall Study||20
8243626|NCT01911442|20330313|P3|NOT COMPLETED|Overall Study||12
8243627|NCT01911442|20330314|P2|NOT COMPLETED|Overall Study||4
8243628|NCT01911442|20330315|P1|NOT COMPLETED|Overall Study||6
8243629|NCT01911442|20330313|P3|COMPLETED|Overall Study||38
8243630|NCT01911442|20330314|P2|COMPLETED|Overall Study||47
8243631|NCT01911442|20330315|P1|COMPLETED|Overall Study||43
8243632|NCT01911442|20330313|P3|STARTED|Overall Study||50
8243633|NCT01911442|20330314|P2|STARTED|Overall Study||51
8243634|NCT01911442|20330315|P1|STARTED|Overall Study||49
8243635|NCT01911429|20330344|P3|NOT COMPLETED|Overall Study||20
8243636|NCT01911429|20330345|P2|NOT COMPLETED|Overall Study||10
8243637|NCT01911429|20330346|P1|NOT COMPLETED|Overall Study||12
8243638|NCT01911429|20330344|P3|COMPLETED|Overall Study||93
8243639|NCT01911429|20330345|P2|COMPLETED|Overall Study||96
8243640|NCT01911429|20330346|P1|COMPLETED|Overall Study||96
8243641|NCT01911429|20330344|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
8243642|NCT01911429|20330345|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
8243643|NCT01911429|20330346|P1|STARTED|Overall Study||108
8243644|NCT01911403|20330380|P2|NOT COMPLETED|Overall Study||3
8243645|NCT01911403|20330381|P1|NOT COMPLETED|Overall Study||9
8243646|NCT01911403|20330380|P2|COMPLETED|Overall Study||59
8243647|NCT01911403|20330381|P1|COMPLETED|Overall Study||52
8243648|NCT01911403|20330380|P2|STARTED|Overall Study||62
8243649|NCT01911403|20330381|P1|STARTED|Overall Study||61
8243650|NCT01911390|20330402|P4|NOT COMPLETED|Overall Study||1
8243651|NCT01911390|20330403|P3|NOT COMPLETED|Overall Study||1
8243652|NCT01911390|20330404|P2|NOT COMPLETED|Overall Study||0
8243653|NCT01911390|20330405|P1|NOT COMPLETED|Overall Study||1
8243654|NCT01911390|20330402|P4|COMPLETED|Overall Study||10
8243655|NCT01911390|20330403|P3|COMPLETED|Overall Study||9
8243656|NCT01911390|20330404|P2|COMPLETED|Overall Study||10
8243657|NCT01911390|20330405|P1|COMPLETED|Overall Study||9
8243658|NCT01911390|20330402|P4|STARTED|Overall Study||11
8243659|NCT01911390|20330403|P3|STARTED|Overall Study||10
8243660|NCT01911390|20330404|P2|STARTED|Overall Study||10
8243661|NCT01911390|20330405|P1|STARTED|Overall Study||10
8243662|NCT01911351|20330421|P2|NOT COMPLETED|Overall Study||0
8243663|NCT01911351|20330422|P1|NOT COMPLETED|Overall Study||0
8243664|NCT01911351|20330421|P2|COMPLETED|Overall Study||43
8243665|NCT01911351|20330422|P1|COMPLETED|Overall Study||39
8243666|NCT01911351|20330421|P2|STARTED|Overall Study||43
8243667|NCT01911351|20330422|P1|STARTED|Overall Study||39
8243668|NCT01911273|20330438|P2|NOT COMPLETED|Overall Study||2
8243669|NCT01911273|20330439|P1|NOT COMPLETED|Overall Study||1
8243670|NCT01911273|20330438|P2|COMPLETED|Overall Study||0
8243671|NCT01911273|20330439|P1|COMPLETED|Overall Study||0
8243672|NCT01911273|20330438|P2|STARTED|Overall Study||2
8243673|NCT01911273|20330439|P1|STARTED|Overall Study||1
8243674|NCT01911260|20330473|P4|NOT COMPLETED|Follow-up Period||12
8243675|NCT01911260|20330474|P3|NOT COMPLETED|Follow-up Period||15
8243676|NCT01911260|20330475|P2|NOT COMPLETED|Follow-up Period||20
8243677|NCT01911260|20330476|P1|NOT COMPLETED|Follow-up Period||13
8243678|NCT01911260|20330473|P4|COMPLETED|Follow-up Period||30
8243679|NCT01911260|20330474|P3|COMPLETED|Follow-up Period||24
8243680|NCT01911260|20330475|P2|COMPLETED|Follow-up Period||18
8243681|NCT01911260|20330476|P1|COMPLETED|Follow-up Period||27
8243682|NCT01911260|20330473|P4|STARTED|Follow-up Period||42
8243683|NCT01911260|20330474|P3|STARTED|Follow-up Period||39
8243684|NCT01911260|20330475|P2|STARTED|Follow-up Period||38
8243685|NCT01911260|20330476|P1|STARTED|Follow-up Period||40
8243686|NCT01911260|20330473|P4|NOT COMPLETED|Supplementation Period||8
8243687|NCT01911260|20330474|P3|NOT COMPLETED|Supplementation Period||10
8243688|NCT01911260|20330475|P2|NOT COMPLETED|Supplementation Period||12
8243689|NCT01911260|20330476|P1|NOT COMPLETED|Supplementation Period||10
8243690|NCT01911260|20330473|P4|COMPLETED|Supplementation Period||42
8243691|NCT01911260|20330474|P3|COMPLETED|Supplementation Period||39
8243692|NCT01911260|20330475|P2|COMPLETED|Supplementation Period||38
8243693|NCT01911260|20330476|P1|COMPLETED|Supplementation Period||40
8243694|NCT01911260|20330473|P4|STARTED|Supplementation Period||50
8243695|NCT01911260|20330474|P3|STARTED|Supplementation Period||49
8243696|NCT01911260|20330475|P2|STARTED|Supplementation Period||50
8243697|NCT01911260|20330476|P1|STARTED|Supplementation Period||50
8243698|NCT01911221|20330486|P1|NOT COMPLETED|Overall Study||0
8243699|NCT01911221|20330486|P1|COMPLETED|Overall Study||13
8243700|NCT01911221|20330486|P1|STARTED|Overall Study||13
8243701|NCT01911169|20330502|P2|NOT COMPLETED|Overall Study||0
8243702|NCT01911169|20330503|P1|NOT COMPLETED|Overall Study||0
8243703|NCT01911169|20330502|P2|COMPLETED|Overall Study||3
8243704|NCT01911169|20330503|P1|COMPLETED|Overall Study||6
8243705|NCT01911169|20330502|P2|STARTED|Overall Study||3
8243706|NCT01911169|20330503|P1|STARTED|Overall Study||6
8243707|NCT01911065|20330513|P2|NOT COMPLETED|Overall Study||0
8243708|NCT01911065|20330514|P1|NOT COMPLETED|Overall Study||0
8243709|NCT01911065|20330513|P2|COMPLETED|Overall Study||9
8243710|NCT01911065|20330514|P1|COMPLETED|Overall Study||45
8243711|NCT01911065|20330513|P2|STARTED|Overall Study||9
8243712|NCT01911065|20330514|P1|STARTED|Overall Study||45
8243713|NCT01910831|20330522|P1|NOT COMPLETED|Overall Study||1
8243714|NCT01910831|20330522|P1|COMPLETED|Overall Study||19
8243715|NCT01910831|20330522|P1|STARTED|Overall Study||20
8243716|NCT01910792|20330531|P2|NOT COMPLETED|Overall Study||0
8243717|NCT01910792|20330532|P1|NOT COMPLETED|Overall Study||0
8243718|NCT01910792|20330531|P2|COMPLETED|Overall Study||10
8243719|NCT01910792|20330532|P1|COMPLETED|Overall Study||9
8243720|NCT01910792|20330531|P2|STARTED|Overall Study||10
8243721|NCT01910792|20330532|P1|STARTED|Overall Study||9
8243722|NCT01910688|20330538|P1|NOT COMPLETED|Overall Study||5
8243723|NCT01910688|20330538|P1|COMPLETED|Overall Study||20
8243724|NCT01910688|20330538|P1|12months|Overall Study||22
8243725|NCT01910688|20330538|P1|3rd RFA Treatment|Overall Study||18
8243726|NCT01910688|20330538|P1|7.5months|Overall Study||24
8243727|NCT01910688|20330538|P1|2nd RFA Treatment|Overall Study||22
8243728|NCT01910688|20330538|P1|3.5month|Overall Study||25
8243729|NCT01910688|20330538|P1|STARTED|Overall Study||25
8243730|NCT01910636|20330547|P2|NOT COMPLETED|Overall Study||0
8243731|NCT01910636|20330548|P1|NOT COMPLETED|Overall Study||0
8243732|NCT01910636|20330547|P2|COMPLETED|Overall Study||63
8243733|NCT01910636|20330548|P1|COMPLETED|Overall Study||90
8243734|NCT01910636|20330547|P2|STARTED|Overall Study||63
8243735|NCT01910636|20330548|P1|STARTED|Overall Study||90
8243736|NCT01910519|20330562|P2|NOT COMPLETED|Overall Study||0
8243737|NCT01910519|20330563|P1|NOT COMPLETED|Overall Study||4
8243738|NCT01910519|20330562|P2|COMPLETED|Overall Study||15
8243739|NCT01910519|20330563|P1|COMPLETED|Overall Study||31
8243740|NCT01910519|20330562|P2|STARTED|Overall Study||15
8243741|NCT01910519|20330563|P1|STARTED|Overall Study||35
8243742|NCT01910441|20330589|P2|NOT COMPLETED|Overall Study||10
8243743|NCT01910441|20330590|P1|NOT COMPLETED|Overall Study||7
8243744|NCT01910441|20330589|P2|COMPLETED|Overall Study||37
8243745|NCT01910441|20330590|P1|COMPLETED|Overall Study||41
8243746|NCT01910441|20330589|P2|STARTED|Overall Study||47
8243747|NCT01910441|20330590|P1|STARTED|Overall Study||48
8243748|NCT01910402|20330598|P2|NOT COMPLETED|Continuation Phase||0
8243749|NCT01910402|20330599|P1|NOT COMPLETED|Continuation Phase||90
8243750|NCT01910402|20330598|P2|COMPLETED|Continuation Phase||0
8243751|NCT01910402|20330599|P1|COMPLETED|Continuation Phase||30
8243752|NCT01910402|20330598|P2|STARTED|Continuation Phase||0
8243753|NCT01910402|20330599|P1|STARTED|Continuation Phase||120
8243754|NCT01910402|20330598|P2|NOT COMPLETED|Randomized Phase||55
8243755|NCT01910402|20330599|P1|NOT COMPLETED|Randomized Phase||42
8243756|NCT01910402|20330598|P2|COMPLETED|Randomized Phase||192
8243757|NCT01910402|20330599|P1|COMPLETED|Randomized Phase||206
8243758|NCT01910402|20330598|P2|STARTED|Randomized Phase||247
8243759|NCT01910402|20330599|P1|STARTED|Randomized Phase||248
8243760|NCT01910389|20330669|P2|NOT COMPLETED|Overall Study||8
8243761|NCT01910389|20330670|P1|NOT COMPLETED|Overall Study||15
8243762|NCT01910389|20330669|P2|COMPLETED|Overall Study||0
8243763|NCT01910389|20330670|P1|COMPLETED|Overall Study||0
8243764|NCT01910389|20330669|P2|STARTED|Overall Study||8
8243765|NCT01910389|20330670|P1|STARTED|Overall Study||15
8243766|NCT01910311|20330700|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
8243767|NCT01910311|20330700|P1|COMPLETED|Period 2 (Days 3-32)||18
8243768|NCT01910311|20330700|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
8243769|NCT01910311|20330700|P1|Received Baricitinib|Period 2 (Days 3-32)||18
8243770|NCT01910311|20330700|P1|STARTED|Period 2 (Days 3-32)||18
8243771|NCT01910311|20330700|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
8243772|NCT01910311|20330700|P1|COMPLETED|Period 1 (Days 1-2)||18
8243773|NCT01910311|20330700|P1|Received Baricitinib|Period 1 (Days 1-2)||18
8243774|NCT01910311|20330700|P1|STARTED|Period 1 (Days 1-2)||18
8243775|NCT01910298|20330713|P2|NOT COMPLETED|Overall Study||32
8243776|NCT01910298|20330714|P1|NOT COMPLETED|Overall Study||5
8243777|NCT01910298|20330713|P2|COMPLETED|Overall Study||23
8243778|NCT01910298|20330714|P1|COMPLETED|Overall Study||71
8243779|NCT01910298|20330713|P2|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
8243780|NCT01910298|20330714|P1|Safety Set|Overall Study||76
8243781|NCT01910298|20330713|P2|STARTED|Overall Study||55
8243782|NCT01910298|20330714|P1|STARTED|Overall Study||76
8243783|NCT01910181|20330732|P1|NOT COMPLETED|Overall Study||46
8243784|NCT01910181|20330732|P1|COMPLETED|Overall Study||0
8243785|NCT01910181|20330732|P1|Expansion Cohort|Overall Study||26
8243786|NCT01910181|20330732|P1|PK Cohort|Overall Study||20
8243787|NCT01910181|20330732|P1|STARTED|Overall Study||46
8243788|NCT01910129|20330759|P3|NOT COMPLETED|Randomized Phase 3||0
8243789|NCT01910129|20330760|P2|NOT COMPLETED|Randomized Phase 3||1
8243790|NCT01910129|20330761|P1|NOT COMPLETED|Randomized Phase 3||0
8243791|NCT01910129|20330759|P3|COMPLETED|Randomized Phase 3||0
8243792|NCT01910129|20330760|P2|COMPLETED|Randomized Phase 3||4
8243793|NCT01910129|20330761|P1|COMPLETED|Randomized Phase 3||5
8243794|NCT01910129|20330759|P3|STARTED|Randomized Phase 3||0
8243795|NCT01910129|20330760|P2|STARTED|Randomized Phase 3||5
8243796|NCT01910129|20330761|P1|STARTED|Randomized Phase 3||5
8243797|NCT01910129|20330759|P3|NOT COMPLETED|Randomized Phase 2||0
8243798|NCT01910129|20330760|P2|NOT COMPLETED|Randomized Phase 2||1
8243799|NCT01910129|20330761|P1|NOT COMPLETED|Randomized Phase 2||2
8243800|NCT01910129|20330759|P3|COMPLETED|Randomized Phase 2||0
8243801|NCT01910129|20330760|P2|COMPLETED|Randomized Phase 2||5
8243802|NCT01910129|20330761|P1|COMPLETED|Randomized Phase 2||5
8243803|NCT01910129|20330759|P3|STARTED|Randomized Phase 2||0
8243804|NCT01910129|20330760|P2|STARTED|Randomized Phase 2||6
8243805|NCT01910129|20330761|P1|STARTED|Randomized Phase 2||7
8243806|NCT01910129|20330759|P3|NOT COMPLETED|Run-in Period Phase 1||0
8243807|NCT01910129|20330760|P2|NOT COMPLETED|Run-in Period Phase 1||0
8243808|NCT01910129|20330761|P1|NOT COMPLETED|Run-in Period Phase 1||0
8243809|NCT01910129|20330759|P3|COMPLETED|Run-in Period Phase 1||13
8243810|NCT01910129|20330760|P2|COMPLETED|Run-in Period Phase 1||0
8243811|NCT01910129|20330761|P1|COMPLETED|Run-in Period Phase 1||0
8243812|NCT01910129|20330759|P3|STARTED|Run-in Period Phase 1||13
8243813|NCT01910129|20330760|P2|STARTED|Run-in Period Phase 1||0
8243814|NCT01910129|20330761|P1|STARTED|Run-in Period Phase 1||0
8243815|NCT01910116|20330785|P2|NOT COMPLETED|Overall Study||16
8243816|NCT01910116|20330786|P1|NOT COMPLETED|Overall Study||14
8243817|NCT01910116|20330785|P2|COMPLETED|Overall Study||94
8243818|NCT01910116|20330786|P1|COMPLETED|Overall Study||96
8243819|NCT01910116|20330785|P2|Week 16|Overall Study||94
8243820|NCT01910116|20330786|P1|Week 16|Overall Study||96
8243821|NCT01910116|20330785|P2|Week 12|Overall Study||96
8243822|NCT01910116|20330786|P1|Week 12|Overall Study||97
8243823|NCT01910116|20330785|P2|Week 8|Overall Study||99
8243824|NCT01910116|20330786|P1|Week 8|Overall Study||98
8243825|NCT01910116|20330785|P2|Week 4|Overall Study||102
8243826|NCT01910116|20330786|P1|Week 4|Overall Study||106
8243827|NCT01910116|20330785|P2|STARTED|Overall Study||110
8243828|NCT01910116|20330786|P1|STARTED|Overall Study||110
8243829|NCT01910064|20330862|P1|NOT COMPLETED|Overall Study||45
8243830|NCT01910064|20330862|P1|COMPLETED|Overall Study||391
8243831|NCT01910064|20330862|P1|STARTED|Overall Study||436
8243832|NCT01909973|20330873|P2|NOT COMPLETED|Overall Study||0
8243833|NCT01909973|20330874|P1|NOT COMPLETED|Overall Study||1
8243834|NCT01909973|20330873|P2|COMPLETED|Overall Study||7
8243835|NCT01909973|20330874|P1|COMPLETED|Overall Study||7
8243836|NCT01909973|20330873|P2|STARTED|Overall Study||7
8243837|NCT01909973|20330874|P1|STARTED|Overall Study||8
8243838|NCT01909804|20330894|P12|NOT COMPLETED|Overall Study||3
8243839|NCT01909804|20330895|P11|NOT COMPLETED|Overall Study||1
8243840|NCT01909804|20330896|P10|NOT COMPLETED|Overall Study||1
8243841|NCT01909804|20330897|P9|NOT COMPLETED|Overall Study||0
8243842|NCT01909804|20330898|P8|NOT COMPLETED|Overall Study||1
8243843|NCT01909804|20330899|P7|NOT COMPLETED|Overall Study||2
8243844|NCT01909804|20330900|P6|NOT COMPLETED|Overall Study||4
8243845|NCT01909804|20330901|P5|NOT COMPLETED|Overall Study||8
8243846|NCT01909804|20330902|P4|NOT COMPLETED|Overall Study||0
8243847|NCT01909804|20330903|P3|NOT COMPLETED|Overall Study||0
8243848|NCT01909804|20330904|P2|NOT COMPLETED|Overall Study||1
8243849|NCT01909804|20330905|P1|NOT COMPLETED|Overall Study||4
8243850|NCT01909804|20330894|P12|COMPLETED|Overall Study||26
8243851|NCT01909804|20330895|P11|COMPLETED|Overall Study||26
8243852|NCT01909804|20330896|P10|COMPLETED|Overall Study||28
8243853|NCT01909804|20330897|P9|COMPLETED|Overall Study||27
8243854|NCT01909804|20330898|P8|COMPLETED|Overall Study||25
8243855|NCT01909804|20330899|P7|COMPLETED|Overall Study||25
8243856|NCT01909804|20330900|P6|COMPLETED|Overall Study||21
8243857|NCT01909804|20330901|P5|COMPLETED|Overall Study||18
8243858|NCT01909804|20330902|P4|COMPLETED|Overall Study||26
8243859|NCT01909804|20330903|P3|COMPLETED|Overall Study||27
8243860|NCT01909804|20330904|P2|COMPLETED|Overall Study||27
8243861|NCT01909804|20330905|P1|COMPLETED|Overall Study||22
8243862|NCT01909804|20330894|P12|STARTED|Overall Study||29
8243863|NCT01909804|20330895|P11|STARTED|Overall Study||27
8243864|NCT01909804|20330896|P10|STARTED|Overall Study||29
8243865|NCT01909804|20330897|P9|STARTED|Overall Study||27
8243866|NCT01909804|20330898|P8|STARTED|Overall Study||26
8243867|NCT01909804|20330899|P7|STARTED|Overall Study||27
8243868|NCT01909804|20330900|P6|STARTED|Overall Study||25
8243869|NCT01909804|20330901|P5|STARTED|Overall Study||26
8243870|NCT01909804|20330902|P4|STARTED|Overall Study||26
8243871|NCT01909804|20330903|P3|STARTED|Overall Study||27
8243872|NCT01909804|20330904|P2|STARTED|Overall Study||28
8243873|NCT01909804|20330905|P1|STARTED|Overall Study||26
8243874|NCT01909791|20330954|P3|NOT COMPLETED|Overall Study||28
8243875|NCT01909791|20330955|P2|NOT COMPLETED|Overall Study||28
8243876|NCT01909791|20330956|P1|NOT COMPLETED|Overall Study||21
8243877|NCT01909791|20330954|P3|COMPLETED|Overall Study||208
8243878|NCT01909791|20330955|P2|COMPLETED|Overall Study||212
8243879|NCT01909791|20330956|P1|COMPLETED|Overall Study||205
8243880|NCT01909791|20330954|P3|STARTED|Overall Study||236
8243881|NCT01909791|20330955|P2|STARTED|Overall Study||240
8243882|NCT01909791|20330956|P1|STARTED|Overall Study||226
8243883|NCT01909778|20331014|P1|NOT COMPLETED|Overall Study||1
8243884|NCT01909778|20331014|P1|COMPLETED|Overall Study||1
8243885|NCT01909778|20331014|P1|STARTED|Overall Study||2
8243886|NCT01909713|20331038|P1|NOT COMPLETED|Overall Study||0
8243887|NCT01909713|20331038|P1|COMPLETED|Overall Study||35
8243888|NCT01909713|20331038|P1|STARTED|Overall Study||35
8243889|NCT01909674|20331093|P2|NOT COMPLETED|Overall Study||2
8243890|NCT01909674|20331094|P1|NOT COMPLETED|Overall Study||5
8243891|NCT01909674|20331093|P2|COMPLETED|Overall Study||7
8243892|NCT01909674|20331094|P1|COMPLETED|Overall Study||7
8243893|NCT01909674|20331093|P2|STARTED|Overall Study||9
8243894|NCT01909674|20331094|P1|STARTED|Overall Study||12
8243895|NCT01909570|20331102|P2|NOT COMPLETED|Overall Study||27
8243896|NCT01909570|20331103|P1|NOT COMPLETED|Overall Study||27
8243897|NCT01909570|20331102|P2|COMPLETED|Overall Study||64
8243898|NCT01909570|20331103|P1|COMPLETED|Overall Study||57
8243899|NCT01909570|20331102|P2|STARTED|Overall Study||91
8243900|NCT01909570|20331103|P1|STARTED|Overall Study||84
8243901|NCT01909466|20331113|P2|NOT COMPLETED|Overall Study||23
8243902|NCT01909466|20331114|P1|NOT COMPLETED|Overall Study||22
8243903|NCT01909466|20331113|P2|COMPLETED|Overall Study||50
8243904|NCT01909466|20331114|P1|COMPLETED|Overall Study||46
8243905|NCT01909466|20331113|P2|STARTED|Overall Study||73
8243906|NCT01909466|20331114|P1|STARTED|Overall Study||68
8243907|NCT01909336|20331137|P3|NOT COMPLETED|Overall Study||3
8243908|NCT01909336|20331138|P2|NOT COMPLETED|Overall Study||3
8243909|NCT01909336|20331139|P1|NOT COMPLETED|Overall Study||4
8243910|NCT01909336|20331137|P3|COMPLETED|Overall Study||52
8243911|NCT01909336|20331138|P2|COMPLETED|Overall Study||50
8243912|NCT01909336|20331139|P1|COMPLETED|Overall Study||49
8243913|NCT01909336|20331137|P3|STARTED|Overall Study||55
8243914|NCT01909336|20331138|P2|STARTED|Overall Study||53
8243915|NCT01909336|20331139|P1|STARTED|Overall Study||53
8243916|NCT01909180|20331153|P1|NOT COMPLETED|Overall Study||0
8243917|NCT01909180|20331153|P1|COMPLETED|Overall Study||49
8243918|NCT01909180|20331153|P1|STARTED|Overall Study||49
8243919|NCT01909154|20331159|P1|NOT COMPLETED|Overall Study||0
8243920|NCT01909154|20331159|P1|COMPLETED|Overall Study||12
8243921|NCT01909154|20331159|P1|STARTED|Overall Study||12
8243922|NCT01909141|20331170|P2|NOT COMPLETED|Overall Study||0
8243923|NCT01909141|20331171|P1|NOT COMPLETED|Overall Study||0
8243924|NCT01909141|20331170|P2|COMPLETED|Overall Study||50
8243925|NCT01909141|20331171|P1|COMPLETED|Overall Study||50
8243926|NCT01909141|20331170|P2|STARTED|Overall Study||50
8243927|NCT01909141|20331171|P1|STARTED|Overall Study||50
8243928|NCT01909011|20331187|P2|NOT COMPLETED|Overall Study||0
8243929|NCT01909011|20331188|P1|NOT COMPLETED|Overall Study||0
8243930|NCT01909011|20331187|P2|COMPLETED|Overall Study||9
8243931|NCT01909011|20331188|P1|COMPLETED|Overall Study||7
8243932|NCT01909011|20331187|P2|STARTED|Overall Study||9
8243933|NCT01909011|20331188|P1|STARTED|Overall Study||7
8243934|NCT01908972|20331200|P2|NOT COMPLETED|Overall Study||0
8243935|NCT01908972|20331201|P1|NOT COMPLETED|Overall Study||2
8243936|NCT01908972|20331200|P2|COMPLETED|Overall Study||17
8243937|NCT01908972|20331201|P1|COMPLETED|Overall Study||15
8243938|NCT01908972|20331200|P2|STARTED|Overall Study||17
8243939|NCT01908972|20331201|P1|STARTED|Overall Study||17
8243940|NCT01908907|20331237|P2|NOT COMPLETED|Overall Study||0
8243941|NCT01908907|20331238|P1|NOT COMPLETED|Overall Study||2
8243942|NCT01908907|20331237|P2|COMPLETED|Overall Study||29
8243943|NCT01908907|20331238|P1|COMPLETED|Overall Study||29
8243944|NCT01908907|20331237|P2|STARTED|Overall Study||29
8243945|NCT01908907|20331238|P1|STARTED|Overall Study||31
8243946|NCT01908842|20331260|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
8243947|NCT01908842|20331261|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
8243948|NCT01908842|20331260|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
8243949|NCT01908842|20331261|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
8243950|NCT01908842|20331260|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
8243951|NCT01908842|20331261|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
8243952|NCT01908842|20331260|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
8243953|NCT01908842|20331261|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
8243954|NCT01908842|20331260|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
8243955|NCT01908842|20331261|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
8243956|NCT01908842|20331260|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
8243957|NCT01908842|20331261|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
8243958|NCT01908842|20331260|P2|NOT COMPLETED|Induction||31
8243959|NCT01908842|20331261|P1|NOT COMPLETED|Induction||26
8243960|NCT01908842|20331260|P2|COMPLETED|Induction||344
8243961|NCT01908842|20331261|P1|COMPLETED|Induction||357
8243962|NCT01908842|20331260|P2|STARTED|Induction||375
8243963|NCT01908842|20331261|P1|STARTED|Induction||383
8243964|NCT01908829|20331282|P3|NOT COMPLETED|Overall Study||39
8243965|NCT01908829|20331283|P2|NOT COMPLETED|Overall Study||49
8243966|NCT01908829|20331284|P1|NOT COMPLETED|Overall Study||49
8243967|NCT01908829|20331282|P3|COMPLETED|Overall Study||680
8243968|NCT01908829|20331283|P2|COMPLETED|Overall Study||679
8243969|NCT01908829|20331284|P1|COMPLETED|Overall Study||678
8243970|NCT01908829|20331282|P3|Treated With Double-blind Drug|Overall Study||719
8243971|NCT01908829|20331283|P2|Treated With Double-blind Drug|Overall Study||728
8243972|NCT01908829|20331284|P1|Treated With Double-blind Drug|Overall Study||725
8243973|NCT01908829|20331282|P3|STARTED|Overall Study||719
8243974|NCT01908829|20331283|P2|STARTED|Overall Study||728
8243975|NCT01908829|20331284|P1|STARTED|Overall Study||727
8243976|NCT01908816|20331401|P4|NOT COMPLETED|Overall Study||35
8243977|NCT01908816|20331402|P3|NOT COMPLETED|Overall Study||58
8243978|NCT01908816|20331403|P2|NOT COMPLETED|Overall Study||84
8243979|NCT01908816|20331404|P1|NOT COMPLETED|Overall Study||93
8243980|NCT01908816|20331401|P4|COMPLETED|Overall Study||0
8243981|NCT01908816|20331402|P3|COMPLETED|Overall Study||0
8243982|NCT01908816|20331403|P2|COMPLETED|Overall Study||0
8243983|NCT01908816|20331404|P1|COMPLETED|Overall Study||0
8243984|NCT01908816|20331401|P4|STARTED|Overall Study||35
8243985|NCT01908816|20331402|P3|STARTED|Overall Study||58
8243986|NCT01908816|20331403|P2|STARTED|Overall Study||84
8243987|NCT01908816|20331404|P1|STARTED|Overall Study||93
8243988|NCT01908803|20331429|P2|NOT COMPLETED|Overall Study||1
8243989|NCT01908803|20331430|P1|NOT COMPLETED|Overall Study||4
8243990|NCT01908803|20331429|P2|COMPLETED|Overall Study||23
8243991|NCT01908803|20331430|P1|COMPLETED|Overall Study||42
8243992|NCT01908803|20331429|P2|Treated|Overall Study||24
8243993|NCT01908803|20331430|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
8243994|NCT01908803|20331429|P2|STARTED|Overall Study||24
8243995|NCT01908803|20331430|P1|STARTED|Overall Study||46
8243996|NCT01908751|20331445|P4|NOT COMPLETED|Overall Study||4
8243997|NCT01908751|20331446|P3|NOT COMPLETED|Overall Study||5
8243998|NCT01908751|20331447|P2|NOT COMPLETED|Overall Study||5
8243999|NCT01908751|20331448|P1|NOT COMPLETED|Overall Study||5
8244000|NCT01908751|20331445|P4|COMPLETED|Overall Study||16
8244001|NCT01908751|20331446|P3|COMPLETED|Overall Study||16
8244002|NCT01908751|20331447|P2|COMPLETED|Overall Study||18
8244003|NCT01908751|20331448|P1|COMPLETED|Overall Study||17
8244004|NCT01908751|20331445|P4|STARTED|Overall Study||20
8244005|NCT01908751|20331446|P3|STARTED|Overall Study||21
8244006|NCT01908751|20331447|P2|STARTED|Overall Study||23
8244007|NCT01908751|20331448|P1|STARTED|Overall Study||22
8244008|NCT01908699|20331484|P2|NOT COMPLETED|Overall Study||78
8244009|NCT01908699|20331485|P1|NOT COMPLETED|Overall Study||75
8244010|NCT01908699|20331484|P2|COMPLETED|Overall Study||58
8244011|NCT01908699|20331485|P1|COMPLETED|Overall Study||62
8244012|NCT01908699|20331484|P2|Received at Least 1 Dose of Study Drug|Overall Study||135
8244013|NCT01908699|20331485|P1|Received at Least 1 Dose of Study Drug|Overall Study||136
8244014|NCT01908699|20331484|P2|STARTED|Overall Study||136
8244015|NCT01908699|20331485|P1|STARTED|Overall Study||137
8244016|NCT01908582|20331501|P1|NOT COMPLETED|Period 2||2
8244017|NCT01908582|20331501|P1|COMPLETED|Period 2||24
8244018|NCT01908582|20331501|P1|STARTED|Period 2||26
8244019|NCT01908582|20331501|P1|NOT COMPLETED|Period 1||0
8244020|NCT01908582|20331501|P1|COMPLETED|Period 1||26
8244021|NCT01908582|20331501|P1|Received at Least One Dose of Study Drug|Period 1||26
8244022|NCT01908582|20331501|P1|STARTED|Period 1||26
8244023|NCT01908530|20331515|P3|NOT COMPLETED|Overall Study||0
8244024|NCT01908530|20331516|P2|NOT COMPLETED|Overall Study||0
8244025|NCT01908530|20331517|P1|NOT COMPLETED|Overall Study||0
8244026|NCT01908530|20331515|P3|COMPLETED|Overall Study||10
8244027|NCT01908530|20331516|P2|COMPLETED|Overall Study||8
8244028|NCT01908530|20331517|P1|COMPLETED|Overall Study||8
8244029|NCT01908530|20331515|P3|STARTED|Overall Study||10
8244030|NCT01908530|20331516|P2|STARTED|Overall Study||8
8244031|NCT01908530|20331517|P1|STARTED|Overall Study||8
8244032|NCT01908426|20331545|P2|NOT COMPLETED|Overall Study||211
8244033|NCT01908426|20331546|P1|NOT COMPLETED|Overall Study||397
8244034|NCT01908426|20331545|P2|COMPLETED|Overall Study||26
8244035|NCT01908426|20331546|P1|COMPLETED|Overall Study||73
8244036|NCT01908426|20331545|P2|STARTED|Overall Study||237
8244037|NCT01908426|20331546|P1|STARTED|Overall Study||470
8244038|NCT01908205|20331558|P2|NOT COMPLETED|Overall Study||1
8244039|NCT01908205|20331559|P1|NOT COMPLETED|Overall Study||5
8244040|NCT01908205|20331558|P2|COMPLETED|Overall Study||29
8244041|NCT01908205|20331559|P1|COMPLETED|Overall Study||25
8244042|NCT01908205|20331558|P2|STARTED|Overall Study||30
8244043|NCT01908205|20331559|P1|STARTED|Overall Study||30
8244044|NCT01908140|20331587|P2|NOT COMPLETED|Overall Study||79
8244045|NCT01908140|20331588|P1|NOT COMPLETED|Overall Study||66
8244046|NCT01908140|20331587|P2|COMPLETED|Overall Study||386
8244047|NCT01908140|20331588|P1|COMPLETED|Overall Study||402
8244048|NCT01908140|20331587|P2|STARTED|Overall Study||465
8244049|NCT01908140|20331588|P1|STARTED|Overall Study||468
8244050|NCT01908127|20331598|P2|NOT COMPLETED|Overall Study||0
8244051|NCT01908127|20331599|P1|NOT COMPLETED|Overall Study||1
8244052|NCT01908127|20331598|P2|COMPLETED|Overall Study||23
8244053|NCT01908127|20331599|P1|COMPLETED|Overall Study||22
8244054|NCT01908127|20331598|P2|STARTED|Overall Study||23
8244055|NCT01908127|20331599|P1|STARTED|Overall Study||23
8244056|NCT01908101|20331607|P1|NOT COMPLETED|Overall Study||9
8244057|NCT01908101|20331607|P1|COMPLETED|Overall Study||59
8244058|NCT01908101|20331607|P1|STARTED|Overall Study||68
8244059|NCT01908062|20331613|P2|NOT COMPLETED|Overall Study||3
8244060|NCT01908062|20331614|P1|NOT COMPLETED|Overall Study||2
8244061|NCT01908062|20331613|P2|COMPLETED|Overall Study||22
8244062|NCT01908062|20331614|P1|COMPLETED|Overall Study||24
8244063|NCT01908062|20331613|P2|STARTED|Overall Study||25
8244064|NCT01908062|20331614|P1|STARTED|Overall Study||26
8244065|NCT01907906|20331641|P2|NOT COMPLETED|Overall Study||1
8244066|NCT01907906|20331642|P1|NOT COMPLETED|Overall Study||4
8244067|NCT01907906|20331641|P2|COMPLETED|Overall Study||12
8244068|NCT01907906|20331642|P1|COMPLETED|Overall Study||12
8244069|NCT01907906|20331641|P2|STARTED|Overall Study||13
8244070|NCT01907906|20331642|P1|STARTED|Overall Study||16
8244071|NCT01907854|20331722|P2|NOT COMPLETED|Overall Study||13
8244072|NCT01907854|20331723|P1|NOT COMPLETED|Overall Study||16
8244073|NCT01907854|20331722|P2|COMPLETED|Overall Study||191
8244074|NCT01907854|20331723|P1|COMPLETED|Overall Study||187
8244075|NCT01907854|20331722|P2|Exposed|Overall Study||204
8244076|NCT01907854|20331723|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
8244077|NCT01907854|20331722|P2|STARTED|Overall Study||204
8244078|NCT01907854|20331723|P1|STARTED|Overall Study||203
8244079|NCT01907828|20331743|P2|NOT COMPLETED|Overall Study||6
8244080|NCT01907828|20331744|P1|NOT COMPLETED|Overall Study||7
8244081|NCT01907828|20331743|P2|COMPLETED|Overall Study||16
8244082|NCT01907828|20331744|P1|COMPLETED|Overall Study||32
8244083|NCT01907828|20331743|P2|24-month Follow-up|Overall Study||16
8244084|NCT01907828|20331744|P1|24-month Follow-up|Overall Study|2 participants terminated early|32
8244085|NCT01907828|20331743|P2|12-month Follow-up|Overall Study||16
8244086|NCT01907828|20331744|P1|12-month Follow-up|Overall Study|1 participant terminated early|34
8244087|NCT01907828|20331743|P2|6-month Follow-up|Overall Study||16
8244088|NCT01907828|20331744|P1|6-month Follow-up|Overall Study|1 participant terminated early|35
8244089|NCT01907828|20331743|P2|3-month Follow-up|Overall Study|1 participant terminated early|16
8244090|NCT01907828|20331744|P1|3-month Follow-up|Overall Study|1 participant terminated early|36
8244091|NCT01907828|20331743|P2|1-month Follow-up|Overall Study|3 participants terminated early|17
8244092|NCT01907828|20331744|P1|1-month Follow-up|Overall Study|2 participants terminated early|37
8244093|NCT01907828|20331743|P2|Underwent Procedure|Overall Study|2 participants terminated early|20
8244094|NCT01907828|20331744|P1|Underwent Procedure|Overall Study||39
8244095|NCT01907828|20331743|P2|STARTED|Overall Study||22
8244096|NCT01907828|20331744|P1|STARTED|Overall Study||39
8244097|NCT01907815|20331772|P2|NOT COMPLETED|Overall Study||0
8244098|NCT01907815|20331773|P1|NOT COMPLETED|Overall Study||1
8244099|NCT01907815|20331772|P2|COMPLETED|Overall Study||7
8244100|NCT01907815|20331773|P1|COMPLETED|Overall Study||16
8244101|NCT01907815|20331772|P2|STARTED|Overall Study||7
8244102|NCT01907815|20331773|P1|STARTED|Overall Study||17
8244103|NCT01907737|20331787|P1|NOT COMPLETED|Overall Study||1
8244104|NCT01907737|20331787|P1|COMPLETED|Overall Study||21
8244105|NCT01907737|20331787|P1|STARTED|Overall Study||22
8244106|NCT01907607|20331797|P1|NOT COMPLETED|Overall Study||0
8244107|NCT01907607|20331797|P1|COMPLETED|Overall Study||29
8244108|NCT01907607|20331797|P1|STARTED|Overall Study||29
8244109|NCT01907516|20331806|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8244110|NCT01907516|20331807|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8244111|NCT01907516|20331806|P2|COMPLETED|Second Intervention (3 Weeks)||34
8244112|NCT01907516|20331807|P1|COMPLETED|Second Intervention (3 Weeks)||40
8244113|NCT01907516|20331806|P2|STARTED|Second Intervention (3 Weeks)||34
8244114|NCT01907516|20331807|P1|STARTED|Second Intervention (3 Weeks)||40
8244115|NCT01907516|20331806|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
8244116|NCT01907516|20331807|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
8244117|NCT01907516|20331806|P2|COMPLETED|First Intervention (3 Weeks)||34
8244118|NCT01907516|20331807|P1|COMPLETED|First Intervention (3 Weeks)||40
8244119|NCT01907516|20331806|P2|STARTED|First Intervention (3 Weeks)||50
8244120|NCT01907516|20331807|P1|STARTED|First Intervention (3 Weeks)||50
8244121|NCT01907490|20331814|P1|NOT COMPLETED|Overall Study||0
8244122|NCT01907490|20331814|P1|COMPLETED|Overall Study||38
8244123|NCT01907490|20331814|P1|STARTED|Overall Study||38
8244124|NCT01907334|20331821|P2|NOT COMPLETED|Overall Study||0
8244125|NCT01907334|20331822|P1|NOT COMPLETED|Overall Study||0
8244126|NCT01907334|20331821|P2|COMPLETED|Overall Study||4
8244127|NCT01907334|20331822|P1|COMPLETED|Overall Study||6
8244128|NCT01907334|20331821|P2|STARTED|Overall Study||4
8244129|NCT01907334|20331822|P1|STARTED|Overall Study||6
8244130|NCT01907321|20331827|P1|NOT COMPLETED|Overall Study||2
8244131|NCT01907321|20331827|P1|COMPLETED|Overall Study||12
8244132|NCT01907321|20331827|P1|STARTED|Overall Study||14
8244133|NCT01907269|20331834|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
8244134|NCT01907269|20331835|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
8244135|NCT01907269|20331834|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
8244136|NCT01907269|20331835|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
8244137|NCT01907269|20331834|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
8244138|NCT01907269|20331835|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
8244139|NCT01907269|20331834|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
8244140|NCT01907269|20331835|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
8244141|NCT01907269|20331834|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
8244142|NCT01907269|20331835|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
8244143|NCT01907269|20331834|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
8244144|NCT01907269|20331835|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
8244145|NCT01907217|20331851|P2|NOT COMPLETED|Overall Study||2
8244146|NCT01907217|20331852|P1|NOT COMPLETED|Overall Study||0
8244147|NCT01907217|20331851|P2|COMPLETED|Overall Study||67
8244148|NCT01907217|20331852|P1|COMPLETED|Overall Study||69
8244149|NCT01907217|20331851|P2|STARTED|Overall Study||69
8244150|NCT01907217|20331852|P1|STARTED|Overall Study||69
8244151|NCT01907113|20331869|P5|NOT COMPLETED|Overall Study||0
8244152|NCT01907113|20331870|P4|NOT COMPLETED|Overall Study||0
8244153|NCT01907113|20331871|P3|NOT COMPLETED|Overall Study||0
8244154|NCT01907113|20331872|P2|NOT COMPLETED|Overall Study||0
8244155|NCT01907113|20331873|P1|NOT COMPLETED|Overall Study||0
8244156|NCT01907113|20331869|P5|COMPLETED|Overall Study||8
8244157|NCT01907113|20331870|P4|COMPLETED|Overall Study||8
8244158|NCT01907113|20331871|P3|COMPLETED|Overall Study||7
8244159|NCT01907113|20331872|P2|COMPLETED|Overall Study||9
8244160|NCT01907113|20331873|P1|COMPLETED|Overall Study||8
8244161|NCT01907113|20331869|P5|STARTED|Overall Study||8
8244162|NCT01907113|20331870|P4|STARTED|Overall Study||8
8244163|NCT01907113|20331871|P3|STARTED|Overall Study||7
8244164|NCT01907113|20331872|P2|STARTED|Overall Study||9
8244165|NCT01907113|20331873|P1|STARTED|Overall Study||8
8244166|NCT01907100|20331964|P4|NOT COMPLETED|Overall Study||146
8244167|NCT01907100|20331965|P3|NOT COMPLETED|Overall Study||147
8244168|NCT01907100|20331966|P2|NOT COMPLETED|Overall Study||40
8244169|NCT01907100|20331967|P1|NOT COMPLETED|Overall Study||42
8244170|NCT01907100|20331964|P4|COMPLETED|Overall Study||83
8244171|NCT01907100|20331965|P3|COMPLETED|Overall Study||82
8244172|NCT01907100|20331966|P2|COMPLETED|Overall Study||4
8244173|NCT01907100|20331967|P1|COMPLETED|Overall Study||1
8244174|NCT01907100|20331964|P4|Treated Patients|Overall Study||227
8244175|NCT01907100|20331965|P3|Treated Patients|Overall Study||228
8244176|NCT01907100|20331966|P2|Treated Patients|Overall Study||44
8244177|NCT01907100|20331967|P1|Treated Patients|Overall Study||41
8244178|NCT01907100|20331964|P4|STARTED|Overall Study||229
8244179|NCT01907100|20331965|P3|STARTED|Overall Study||229
8244180|NCT01907100|20331966|P2|STARTED|Overall Study||44
8244181|NCT01907100|20331967|P1|STARTED|Overall Study||43
8244182|NCT01907087|20331981|P1|NOT COMPLETED|Overall Study||1
8244183|NCT01907087|20331981|P1|COMPLETED|Overall Study||23
8244184|NCT01907087|20331981|P1|STARTED|Overall Study||24
8244185|NCT01906866|20331992|P2|NOT COMPLETED|Overall Study||21
8244186|NCT01906866|20331993|P1|NOT COMPLETED|Overall Study||9
8244187|NCT01906866|20331992|P2|COMPLETED|Overall Study||44
8244188|NCT01906866|20331993|P1|COMPLETED|Overall Study||51
8244189|NCT01906866|20331992|P2|STARTED|Overall Study||65
8244190|NCT01906866|20331993|P1|STARTED|Overall Study||60
8244191|NCT01906658|20332006|P4|NOT COMPLETED|Overall Study||0
8244192|NCT01906658|20332007|P3|NOT COMPLETED|Overall Study||3
8244193|NCT01906658|20332008|P2|NOT COMPLETED|Overall Study||1
8244194|NCT01906658|20332009|P1|NOT COMPLETED|Overall Study||2
8244195|NCT01906658|20332006|P4|COMPLETED|Overall Study||11
8244196|NCT01906658|20332007|P3|COMPLETED|Overall Study||7
8244197|NCT01906658|20332008|P2|COMPLETED|Overall Study||10
8244198|NCT01906658|20332009|P1|COMPLETED|Overall Study||9
8244199|NCT01906658|20332006|P4|STARTED|Overall Study||11
8244200|NCT01906658|20332007|P3|STARTED|Overall Study||10
8244201|NCT01906658|20332008|P2|STARTED|Overall Study||11
8244202|NCT01906658|20332009|P1|STARTED|Overall Study||11
8244203|NCT01906515|20332033|P2|NOT COMPLETED|Overall Study||0
8244204|NCT01906515|20332034|P1|NOT COMPLETED|Overall Study||0
8244205|NCT01906515|20332033|P2|COMPLETED|Overall Study||61
8244206|NCT01906515|20332034|P1|COMPLETED|Overall Study||45
8244207|NCT01906515|20332033|P2|STARTED|Overall Study||61
8244208|NCT01906515|20332034|P1|STARTED|Overall Study||45
8244209|NCT01906476|20332044|P2|NOT COMPLETED|Overall Study||16
8244210|NCT01906476|20332045|P1|NOT COMPLETED|Overall Study||17
8244211|NCT01906476|20332044|P2|COMPLETED|Overall Study||139
8244212|NCT01906476|20332045|P1|COMPLETED|Overall Study||140
8244213|NCT01906476|20332044|P2|STARTED|Overall Study||155
8244214|NCT01906476|20332045|P1|STARTED|Overall Study||157
8244215|NCT01906372|20332053|P1|NOT COMPLETED|Overall Study||2
8244216|NCT01906372|20332053|P1|COMPLETED|Overall Study||10
8244217|NCT01906372|20332053|P1|Visit 10: Follow up Phase Completed|Overall Study||8
8244218|NCT01906372|20332053|P1|Visit 7: Treatment Phase Completed|Overall Study||10
8244219|NCT01906372|20332053|P1|STARTED|Overall Study||12
8244220|NCT01906346|20332058|P1|NOT COMPLETED|Overall Study||1
8244221|NCT01906346|20332058|P1|COMPLETED|Overall Study||8
8244222|NCT01906346|20332058|P1|STARTED|Overall Study||9
8244223|NCT01906008|20332066|P2|NOT COMPLETED|Overall Study||27
8244224|NCT01906008|20332067|P1|NOT COMPLETED|Overall Study||27
8244225|NCT01906008|20332066|P2|COMPLETED|Overall Study||34
8244226|NCT01906008|20332067|P1|COMPLETED|Overall Study||32
8244227|NCT01906008|20332066|P2|STARTED|Overall Study||61
8244228|NCT01906008|20332067|P1|STARTED|Overall Study||59
8244229|NCT01905956|20332077|P2|NOT COMPLETED|Overall Study||11
8244230|NCT01905956|20332078|P1|NOT COMPLETED|Overall Study||6
8244231|NCT01905956|20332077|P2|COMPLETED|Overall Study|Per-protocol population|48
8244232|NCT01905956|20332078|P1|COMPLETED|Overall Study|Per-protocol population|54
8244233|NCT01905956|20332077|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
8244234|NCT01905956|20332078|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
8244235|NCT01905956|20332077|P2|STARTED|Overall Study|Randomized|59
8244236|NCT01905956|20332078|P1|STARTED|Overall Study|Randomized|60
8244237|NCT01905943|20332100|P1|NOT COMPLETED|Overall Study||314
8244238|NCT01905943|20332100|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|658
8244239|NCT01905943|20332100|P1|STARTED|Overall Study||972
8244240|NCT01905683|20332217|P1|NOT COMPLETED|Overall Study||51
8244241|NCT01905683|20332217|P1|COMPLETED|Overall Study||319
8244242|NCT01905683|20332217|P1|STARTED|Overall Study||370
8244243|NCT01905657|20332233|P3|NOT COMPLETED|Overall Study||328
8244244|NCT01905657|20332234|P2|NOT COMPLETED|Overall Study||346
8244245|NCT01905657|20332235|P1|NOT COMPLETED|Overall Study||345
8244246|NCT01905657|20332233|P3|COMPLETED|Overall Study||15
8244247|NCT01905657|20332234|P2|COMPLETED|Overall Study||0
8244248|NCT01905657|20332235|P1|COMPLETED|Overall Study||0
8244249|NCT01905657|20332233|P3|Treated|Overall Study||309
8244250|NCT01905657|20332234|P2|Treated|Overall Study||343
8244251|NCT01905657|20332235|P1|Treated|Overall Study||339
8244252|NCT01905657|20332233|P3|STARTED|Overall Study||343
8244253|NCT01905657|20332234|P2|STARTED|Overall Study||346
8244254|NCT01905657|20332235|P1|STARTED|Overall Study||345
8244255|NCT01905592|20332260|P2|NOT COMPLETED|Overall Study||135
8244256|NCT01905592|20332261|P1|NOT COMPLETED|Overall Study||71
8244257|NCT01905592|20332260|P2|COMPLETED|Overall Study||0
8244258|NCT01905592|20332261|P1|COMPLETED|Overall Study||0
8244259|NCT01905592|20332260|P2|STARTED|Overall Study||135
8244260|NCT01905592|20332261|P1|STARTED|Overall Study||71
8244261|NCT01905553|20332275|P2|NOT COMPLETED|Period 2||0
8244262|NCT01905553|20332276|P1|NOT COMPLETED|Period 2||1
8244263|NCT01905553|20332275|P2|COMPLETED|Period 2||4
8244264|NCT01905553|20332276|P1|COMPLETED|Period 2||4
8244265|NCT01905553|20332275|P2|STARTED|Period 2||4
8244266|NCT01905553|20332276|P1|STARTED|Period 2||5
8244267|NCT01905553|20332275|P2|NOT COMPLETED|Period 1||0
8244268|NCT01905553|20332276|P1|NOT COMPLETED|Period 1||0
8244269|NCT01905553|20332275|P2|COMPLETED|Period 1||4
8244270|NCT01905553|20332276|P1|COMPLETED|Period 1||5
8244271|NCT01905553|20332275|P2|STARTED|Period 1||4
8244272|NCT01905553|20332276|P1|STARTED|Period 1||5
8244273|NCT01905540|20332290|P4|NOT COMPLETED|Period 3||1
8244274|NCT01905540|20332291|P3|NOT COMPLETED|Period 3||1
8244275|NCT01905540|20332292|P2|NOT COMPLETED|Period 3||0
8244276|NCT01905540|20332293|P1|NOT COMPLETED|Period 3||1
8244277|NCT01905540|20332290|P4|COMPLETED|Period 3||6
8244278|NCT01905540|20332291|P3|COMPLETED|Period 3||6
8244279|NCT01905540|20332292|P2|COMPLETED|Period 3||7
8244280|NCT01905540|20332293|P1|COMPLETED|Period 3||6
8244281|NCT01905540|20332290|P4|STARTED|Period 3||7
8244282|NCT01905540|20332291|P3|STARTED|Period 3||7
8244283|NCT01905540|20332292|P2|STARTED|Period 3||7
8244284|NCT01905540|20332293|P1|STARTED|Period 3||7
8244285|NCT01905540|20332290|P4|NOT COMPLETED|Period 2||0
8244286|NCT01905540|20332291|P3|NOT COMPLETED|Period 2||0
8244287|NCT01905540|20332292|P2|NOT COMPLETED|Period 2||0
8244288|NCT01905540|20332293|P1|NOT COMPLETED|Period 2||0
8244289|NCT01905540|20332290|P4|COMPLETED|Period 2||7
8244290|NCT01905540|20332291|P3|COMPLETED|Period 2||7
8244291|NCT01905540|20332292|P2|COMPLETED|Period 2||7
8244292|NCT01905540|20332293|P1|COMPLETED|Period 2||7
8244293|NCT01905540|20332290|P4|STARTED|Period 2||7
8244294|NCT01905540|20332291|P3|STARTED|Period 2||7
8244295|NCT01905540|20332292|P2|STARTED|Period 2||7
8244296|NCT01905540|20332293|P1|STARTED|Period 2||7
8244297|NCT01905540|20332290|P4|NOT COMPLETED|Period 1||0
8244298|NCT01905540|20332291|P3|NOT COMPLETED|Period 1||0
8244299|NCT01905540|20332292|P2|NOT COMPLETED|Period 1||0
8244300|NCT01905540|20332293|P1|NOT COMPLETED|Period 1||0
8244301|NCT01905540|20332290|P4|COMPLETED|Period 1||7
8244302|NCT01905540|20332291|P3|COMPLETED|Period 1||7
8244303|NCT01905540|20332292|P2|COMPLETED|Period 1||7
8244304|NCT01905540|20332293|P1|COMPLETED|Period 1||7
8244305|NCT01905540|20332290|P4|STARTED|Period 1||7
8244306|NCT01905540|20332291|P3|STARTED|Period 1||7
8244307|NCT01905540|20332292|P2|STARTED|Period 1||7
8244308|NCT01905540|20332293|P1|STARTED|Period 1||7
8244309|NCT01905423|20332316|P5|NOT COMPLETED|Overall Study||0
8244310|NCT01905423|20332317|P4|NOT COMPLETED|Overall Study||0
8244311|NCT01905423|20332318|P3|NOT COMPLETED|Overall Study||0
8244312|NCT01905423|20332319|P2|NOT COMPLETED|Overall Study||0
8244313|NCT01905423|20332320|P1|NOT COMPLETED|Overall Study||0
8244314|NCT01905423|20332316|P5|COMPLETED|Overall Study||2487
8244315|NCT01905423|20332317|P4|COMPLETED|Overall Study||2757
8244316|NCT01905423|20332318|P3|COMPLETED|Overall Study||4111
8244317|NCT01905423|20332319|P2|COMPLETED|Overall Study||3297
8244318|NCT01905423|20332320|P1|COMPLETED|Overall Study||4456
8244319|NCT01905423|20332316|P5|Year 3 Follow-up|Overall Study||0
8244320|NCT01905423|20332317|P4|Year 3 Follow-up|Overall Study||0
8244321|NCT01905423|20332318|P3|Year 3 Follow-up|Overall Study||1028
8244322|NCT01905423|20332319|P2|Year 3 Follow-up|Overall Study||871
8244323|NCT01905423|20332320|P1|Year 3 Follow-up|Overall Study||905
8244324|NCT01905423|20332316|P5|Year 2 Follow-up|Overall Study||0
8244325|NCT01905423|20332317|P4|Year 2 Follow-up|Overall Study||0
8244326|NCT01905423|20332318|P3|Year 2 Follow-up|Overall Study||1043
8244327|NCT01905423|20332319|P2|Year 2 Follow-up|Overall Study||858
8244328|NCT01905423|20332320|P1|Year 2 Follow-up|Overall Study||1114
8244329|NCT01905423|20332316|P5|Year 1 Follow-up|Overall Study||1161
8244330|NCT01905423|20332317|P4|Year 1 Follow-up|Overall Study||1275
8244331|NCT01905423|20332318|P3|Year 1 Follow-up|Overall Study||1007
8244332|NCT01905423|20332319|P2|Year 1 Follow-up|Overall Study||846
8244333|NCT01905423|20332320|P1|Year 1 Follow-up|Overall Study||994
8244334|NCT01905423|20332316|P5|Baseline|Overall Study||1326
8244335|NCT01905423|20332317|P4|Baseline|Overall Study||1482
8244336|NCT01905423|20332318|P3|Baseline|Overall Study||1033
8244337|NCT01905423|20332319|P2|Baseline|Overall Study||722
8244338|NCT01905423|20332320|P1|Baseline|Overall Study||1443
8244339|NCT01905423|20332316|P5|STARTED|Overall Study||2487
8244340|NCT01905423|20332317|P4|STARTED|Overall Study||2757
8244341|NCT01905423|20332318|P3|STARTED|Overall Study||4111
8244342|NCT01905423|20332319|P2|STARTED|Overall Study||3297
8244343|NCT01905423|20332320|P1|STARTED|Overall Study||4456
8244344|NCT01905267|20332359|P2|NOT COMPLETED|Overall Study||2
8244345|NCT01905267|20332360|P1|NOT COMPLETED|Overall Study||2
8244346|NCT01905267|20332359|P2|COMPLETED|Overall Study||14
8244347|NCT01905267|20332360|P1|COMPLETED|Overall Study||15
8244348|NCT01905267|20332359|P2|STARTED|Overall Study||16
8244349|NCT01905267|20332360|P1|STARTED|Overall Study||17
8244350|NCT01905254|20332368|P1|NOT COMPLETED|Overall Study||0
8244351|NCT01905254|20332368|P1|COMPLETED|Overall Study||34
8244352|NCT01905254|20332368|P1|STARTED|Overall Study||34
8244353|NCT01904864|20332374|P2|NOT COMPLETED|Overall Study||12
8244354|NCT01904864|20332375|P1|NOT COMPLETED|Overall Study||9
8244355|NCT01904864|20332374|P2|COMPLETED|Overall Study||28
8244356|NCT01904864|20332375|P1|COMPLETED|Overall Study||31
8244357|NCT01904864|20332374|P2|STARTED|Overall Study||40
8244358|NCT01904864|20332375|P1|STARTED|Overall Study||40
8244359|NCT01904773|20332381|P9|NOT COMPLETED|Sixth Intervention||0
8244360|NCT01904773|20332382|P8|NOT COMPLETED|Sixth Intervention||0
8244361|NCT01904773|20332383|P7|NOT COMPLETED|Sixth Intervention||0
8244362|NCT01904773|20332384|P6|NOT COMPLETED|Sixth Intervention||0
8244363|NCT01904773|20332385|P5|NOT COMPLETED|Sixth Intervention||0
8244364|NCT01904773|20332386|P4|NOT COMPLETED|Sixth Intervention||0
8244365|NCT01904773|20332387|P3|NOT COMPLETED|Sixth Intervention||0
8244366|NCT01904773|20332388|P2|NOT COMPLETED|Sixth Intervention||0
8244367|NCT01904773|20332389|P1|NOT COMPLETED|Sixth Intervention||0
8244368|NCT01904773|20332381|P9|COMPLETED|Sixth Intervention||4
8244369|NCT01904773|20332382|P8|COMPLETED|Sixth Intervention||2
8244370|NCT01904773|20332383|P7|COMPLETED|Sixth Intervention||3
8244371|NCT01904773|20332384|P6|COMPLETED|Sixth Intervention||4
8244372|NCT01904773|20332385|P5|COMPLETED|Sixth Intervention||3
8244373|NCT01904773|20332386|P4|COMPLETED|Sixth Intervention||2
8244374|NCT01904773|20332387|P3|COMPLETED|Sixth Intervention||1
8244375|NCT01904773|20332388|P2|COMPLETED|Sixth Intervention||0
8244376|NCT01904773|20332389|P1|COMPLETED|Sixth Intervention||0
8244377|NCT01904773|20332381|P9|STARTED|Sixth Intervention||4
8244378|NCT01904773|20332382|P8|STARTED|Sixth Intervention||2
8244379|NCT01904773|20332383|P7|STARTED|Sixth Intervention||3
8244380|NCT01904773|20332384|P6|STARTED|Sixth Intervention||4
8244381|NCT01904773|20332385|P5|STARTED|Sixth Intervention||3
8244382|NCT01904773|20332386|P4|STARTED|Sixth Intervention||2
8244383|NCT01904773|20332387|P3|STARTED|Sixth Intervention||1
8244384|NCT01904773|20332388|P2|STARTED|Sixth Intervention||0
8244385|NCT01904773|20332389|P1|STARTED|Sixth Intervention||0
8244386|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244387|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244388|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244389|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244390|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244391|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244392|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244393|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
8244394|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244395|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Fifth Intervention||4
8244396|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Fifth Intervention||2
8244397|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Fifth Intervention||3
8244398|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Fifth Intervention||4
8244399|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Fifth Intervention||3
8244400|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Fifth Intervention||2
8244401|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Fifth Intervention||1
8244402|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Fifth Intervention||0
8244403|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Fifth Intervention||0
8244404|NCT01904773|20332381|P9|STARTED|Placebo Washout Fifth Intervention||4
8244405|NCT01904773|20332382|P8|STARTED|Placebo Washout Fifth Intervention||2
8244406|NCT01904773|20332383|P7|STARTED|Placebo Washout Fifth Intervention||3
8244407|NCT01904773|20332384|P6|STARTED|Placebo Washout Fifth Intervention||4
8244408|NCT01904773|20332385|P5|STARTED|Placebo Washout Fifth Intervention||3
8244409|NCT01904773|20332386|P4|STARTED|Placebo Washout Fifth Intervention||2
8244410|NCT01904773|20332387|P3|STARTED|Placebo Washout Fifth Intervention||1
8244411|NCT01904773|20332388|P2|STARTED|Placebo Washout Fifth Intervention||1
8244412|NCT01904773|20332389|P1|STARTED|Placebo Washout Fifth Intervention||0
8244413|NCT01904773|20332381|P9|NOT COMPLETED|Fifth Intervention||0
8244414|NCT01904773|20332382|P8|NOT COMPLETED|Fifth Intervention||1
8244415|NCT01904773|20332383|P7|NOT COMPLETED|Fifth Intervention||0
8244416|NCT01904773|20332384|P6|NOT COMPLETED|Fifth Intervention||0
8244417|NCT01904773|20332385|P5|NOT COMPLETED|Fifth Intervention||0
8244418|NCT01904773|20332386|P4|NOT COMPLETED|Fifth Intervention||0
8244419|NCT01904773|20332387|P3|NOT COMPLETED|Fifth Intervention||0
8244420|NCT01904773|20332388|P2|NOT COMPLETED|Fifth Intervention||0
8244421|NCT01904773|20332389|P1|NOT COMPLETED|Fifth Intervention||0
8244422|NCT01904773|20332381|P9|COMPLETED|Fifth Intervention||4
8244423|NCT01904773|20332382|P8|COMPLETED|Fifth Intervention||2
8244424|NCT01904773|20332383|P7|COMPLETED|Fifth Intervention||3
8244425|NCT01904773|20332384|P6|COMPLETED|Fifth Intervention||4
8244426|NCT01904773|20332385|P5|COMPLETED|Fifth Intervention||3
8244427|NCT01904773|20332386|P4|COMPLETED|Fifth Intervention||2
8244428|NCT01904773|20332387|P3|COMPLETED|Fifth Intervention||1
8244429|NCT01904773|20332388|P2|COMPLETED|Fifth Intervention||1
8244430|NCT01904773|20332389|P1|COMPLETED|Fifth Intervention||0
8244431|NCT01904773|20332381|P9|STARTED|Fifth Intervention||4
8244432|NCT01904773|20332382|P8|STARTED|Fifth Intervention||3
8244433|NCT01904773|20332383|P7|STARTED|Fifth Intervention||3
8244434|NCT01904773|20332384|P6|STARTED|Fifth Intervention||4
8244435|NCT01904773|20332385|P5|STARTED|Fifth Intervention||3
8244436|NCT01904773|20332386|P4|STARTED|Fifth Intervention||2
8244437|NCT01904773|20332387|P3|STARTED|Fifth Intervention||1
8244438|NCT01904773|20332388|P2|STARTED|Fifth Intervention||1
8244439|NCT01904773|20332389|P1|STARTED|Fifth Intervention||0
8244440|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244441|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244442|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244443|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244444|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244445|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244446|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244447|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244448|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244449|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Fourth Intervention||4
8244450|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Fourth Intervention||3
8244451|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Fourth Intervention||3
8244452|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Fourth Intervention||4
8244453|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Fourth Intervention||3
8244454|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Fourth Intervention||2
8244455|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Fourth Intervention||1
8244456|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Fourth Intervention||1
8244457|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Fourth Intervention||0
8244458|NCT01904773|20332381|P9|STARTED|Placebo Washout Fourth Intervention||4
8244459|NCT01904773|20332382|P8|STARTED|Placebo Washout Fourth Intervention||3
8244460|NCT01904773|20332383|P7|STARTED|Placebo Washout Fourth Intervention||3
8244461|NCT01904773|20332384|P6|STARTED|Placebo Washout Fourth Intervention||4
8244462|NCT01904773|20332385|P5|STARTED|Placebo Washout Fourth Intervention||3
8244463|NCT01904773|20332386|P4|STARTED|Placebo Washout Fourth Intervention||2
8244464|NCT01904773|20332387|P3|STARTED|Placebo Washout Fourth Intervention||1
8244465|NCT01904773|20332388|P2|STARTED|Placebo Washout Fourth Intervention||1
8244466|NCT01904773|20332389|P1|STARTED|Placebo Washout Fourth Intervention||0
8244467|NCT01904773|20332381|P9|NOT COMPLETED|Fourth Intervention||0
8244468|NCT01904773|20332382|P8|NOT COMPLETED|Fourth Intervention||0
8244469|NCT01904773|20332383|P7|NOT COMPLETED|Fourth Intervention||0
8244470|NCT01904773|20332384|P6|NOT COMPLETED|Fourth Intervention||0
8244471|NCT01904773|20332385|P5|NOT COMPLETED|Fourth Intervention||0
8244472|NCT01904773|20332386|P4|NOT COMPLETED|Fourth Intervention||0
8244473|NCT01904773|20332387|P3|NOT COMPLETED|Fourth Intervention||0
8244474|NCT01904773|20332388|P2|NOT COMPLETED|Fourth Intervention||0
8244475|NCT01904773|20332389|P1|NOT COMPLETED|Fourth Intervention||0
8244476|NCT01904773|20332381|P9|COMPLETED|Fourth Intervention||4
8244477|NCT01904773|20332382|P8|COMPLETED|Fourth Intervention||3
8244478|NCT01904773|20332383|P7|COMPLETED|Fourth Intervention||3
8244479|NCT01904773|20332384|P6|COMPLETED|Fourth Intervention||4
8244480|NCT01904773|20332385|P5|COMPLETED|Fourth Intervention||3
8244481|NCT01904773|20332386|P4|COMPLETED|Fourth Intervention||2
8244482|NCT01904773|20332387|P3|COMPLETED|Fourth Intervention||1
8244483|NCT01904773|20332388|P2|COMPLETED|Fourth Intervention||1
8244484|NCT01904773|20332389|P1|COMPLETED|Fourth Intervention||0
8244485|NCT01904773|20332381|P9|STARTED|Fourth Intervention||4
8244486|NCT01904773|20332382|P8|STARTED|Fourth Intervention||3
8244487|NCT01904773|20332383|P7|STARTED|Fourth Intervention||3
8244488|NCT01904773|20332384|P6|STARTED|Fourth Intervention||4
8244489|NCT01904773|20332385|P5|STARTED|Fourth Intervention||3
8244490|NCT01904773|20332386|P4|STARTED|Fourth Intervention||2
8244491|NCT01904773|20332387|P3|STARTED|Fourth Intervention||1
8244492|NCT01904773|20332388|P2|STARTED|Fourth Intervention||1
8244493|NCT01904773|20332389|P1|STARTED|Fourth Intervention||0
8244494|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
8244495|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
8244496|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
8244497|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
8244498|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
8244499|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
8244500|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
8244501|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
8244502|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
8244503|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Third Intervention||4
8244504|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Third Intervention||3
8244505|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Third Intervention||3
8244506|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Third Intervention||4
8244507|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Third Intervention||3
8244508|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Third Intervention||2
8244509|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Third Intervention||1
8244510|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Third Intervention||1
8244511|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Third Intervention||0
8244512|NCT01904773|20332381|P9|STARTED|Placebo Washout Third Intervention||4
8244513|NCT01904773|20332382|P8|STARTED|Placebo Washout Third Intervention||3
8244514|NCT01904773|20332383|P7|STARTED|Placebo Washout Third Intervention||3
8244515|NCT01904773|20332384|P6|STARTED|Placebo Washout Third Intervention||4
8244516|NCT01904773|20332385|P5|STARTED|Placebo Washout Third Intervention||3
8244517|NCT01904773|20332386|P4|STARTED|Placebo Washout Third Intervention||2
8244518|NCT01904773|20332387|P3|STARTED|Placebo Washout Third Intervention||1
8244519|NCT01904773|20332388|P2|STARTED|Placebo Washout Third Intervention||1
8244520|NCT01904773|20332389|P1|STARTED|Placebo Washout Third Intervention||0
8244521|NCT01904773|20332381|P9|NOT COMPLETED|Third Intervention||0
8244522|NCT01904773|20332382|P8|NOT COMPLETED|Third Intervention||0
8244523|NCT01904773|20332383|P7|NOT COMPLETED|Third Intervention||0
8244524|NCT01904773|20332384|P6|NOT COMPLETED|Third Intervention||0
8244525|NCT01904773|20332385|P5|NOT COMPLETED|Third Intervention||0
8244526|NCT01904773|20332386|P4|NOT COMPLETED|Third Intervention||0
8244527|NCT01904773|20332387|P3|NOT COMPLETED|Third Intervention||0
8244528|NCT01904773|20332388|P2|NOT COMPLETED|Third Intervention||0
8244529|NCT01904773|20332389|P1|NOT COMPLETED|Third Intervention||0
8244530|NCT01904773|20332381|P9|COMPLETED|Third Intervention||4
8244531|NCT01904773|20332382|P8|COMPLETED|Third Intervention||3
8244532|NCT01904773|20332383|P7|COMPLETED|Third Intervention||3
8244533|NCT01904773|20332384|P6|COMPLETED|Third Intervention||4
8244534|NCT01904773|20332385|P5|COMPLETED|Third Intervention||3
8244535|NCT01904773|20332386|P4|COMPLETED|Third Intervention||2
8244536|NCT01904773|20332387|P3|COMPLETED|Third Intervention||1
8244537|NCT01904773|20332388|P2|COMPLETED|Third Intervention||1
8244538|NCT01904773|20332389|P1|COMPLETED|Third Intervention||0
8244539|NCT01904773|20332381|P9|STARTED|Third Intervention||4
8244540|NCT01904773|20332382|P8|STARTED|Third Intervention||3
8244541|NCT01904773|20332383|P7|STARTED|Third Intervention||3
8244542|NCT01904773|20332384|P6|STARTED|Third Intervention||4
8244543|NCT01904773|20332385|P5|STARTED|Third Intervention||3
8244544|NCT01904773|20332386|P4|STARTED|Third Intervention||2
8244545|NCT01904773|20332387|P3|STARTED|Third Intervention||1
8244546|NCT01904773|20332388|P2|STARTED|Third Intervention||1
8244547|NCT01904773|20332389|P1|STARTED|Third Intervention||0
8244548|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
8244549|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
8244550|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
8244551|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
8244552|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
8244553|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
8244554|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
8244555|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
8244556|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
8244557|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Second Intervention||4
8244558|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Second Intervention||3
8244559|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Second Intervention||3
8244560|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Second Intervention||4
8244561|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Second Intervention||3
8244562|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Second Intervention||2
8244563|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Second Intervention||1
8244564|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Second Intervention||1
8244565|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Second Intervention||0
8244566|NCT01904773|20332381|P9|STARTED|Placebo Washout Second Intervention||4
8244567|NCT01904773|20332382|P8|STARTED|Placebo Washout Second Intervention||3
8244568|NCT01904773|20332383|P7|STARTED|Placebo Washout Second Intervention||3
8244569|NCT01904773|20332384|P6|STARTED|Placebo Washout Second Intervention||4
8244570|NCT01904773|20332385|P5|STARTED|Placebo Washout Second Intervention||3
8244571|NCT01904773|20332386|P4|STARTED|Placebo Washout Second Intervention||2
8244572|NCT01904773|20332387|P3|STARTED|Placebo Washout Second Intervention||1
8244573|NCT01904773|20332388|P2|STARTED|Placebo Washout Second Intervention||1
8244574|NCT01904773|20332389|P1|STARTED|Placebo Washout Second Intervention||0
8244575|NCT01904773|20332381|P9|NOT COMPLETED|Second Intervention||0
8244576|NCT01904773|20332382|P8|NOT COMPLETED|Second Intervention||0
8244577|NCT01904773|20332383|P7|NOT COMPLETED|Second Intervention||0
8244578|NCT01904773|20332384|P6|NOT COMPLETED|Second Intervention||0
8244579|NCT01904773|20332385|P5|NOT COMPLETED|Second Intervention||0
8244580|NCT01904773|20332386|P4|NOT COMPLETED|Second Intervention||0
8244581|NCT01904773|20332387|P3|NOT COMPLETED|Second Intervention||0
8244582|NCT01904773|20332388|P2|NOT COMPLETED|Second Intervention||0
8244583|NCT01904773|20332389|P1|NOT COMPLETED|Second Intervention||0
8244584|NCT01904773|20332381|P9|COMPLETED|Second Intervention||4
8244585|NCT01904773|20332382|P8|COMPLETED|Second Intervention||3
8244586|NCT01904773|20332383|P7|COMPLETED|Second Intervention||3
8244587|NCT01904773|20332384|P6|COMPLETED|Second Intervention||4
8244588|NCT01904773|20332385|P5|COMPLETED|Second Intervention||3
8244589|NCT01904773|20332386|P4|COMPLETED|Second Intervention||2
8244590|NCT01904773|20332387|P3|COMPLETED|Second Intervention||1
8244591|NCT01904773|20332388|P2|COMPLETED|Second Intervention||1
8244592|NCT01904773|20332389|P1|COMPLETED|Second Intervention||0
8244593|NCT01904773|20332381|P9|STARTED|Second Intervention||4
8244594|NCT01904773|20332382|P8|STARTED|Second Intervention||3
8244595|NCT01904773|20332383|P7|STARTED|Second Intervention||3
8244596|NCT01904773|20332384|P6|STARTED|Second Intervention||4
8244597|NCT01904773|20332385|P5|STARTED|Second Intervention||3
8244598|NCT01904773|20332386|P4|STARTED|Second Intervention||2
8244599|NCT01904773|20332387|P3|STARTED|Second Intervention||1
8244600|NCT01904773|20332388|P2|STARTED|Second Intervention||1
8244601|NCT01904773|20332389|P1|STARTED|Second Intervention||0
8244602|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout First Intervention||0
8244603|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout First Intervention||0
8244604|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout First Intervention||0
8244605|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout First Intervention||0
8244606|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout First Intervention||0
8244607|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout First Intervention||0
8244608|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout First Intervention||0
8244609|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout First Intervention||1
8244610|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout First Intervention||0
8244611|NCT01904773|20332381|P9|COMPLETED|Placebo Washout First Intervention||4
8244612|NCT01904773|20332382|P8|COMPLETED|Placebo Washout First Intervention||3
8244613|NCT01904773|20332383|P7|COMPLETED|Placebo Washout First Intervention||3
8244614|NCT01904773|20332384|P6|COMPLETED|Placebo Washout First Intervention||4
8244615|NCT01904773|20332385|P5|COMPLETED|Placebo Washout First Intervention||3
8244616|NCT01904773|20332386|P4|COMPLETED|Placebo Washout First Intervention||2
8244617|NCT01904773|20332387|P3|COMPLETED|Placebo Washout First Intervention||1
8244618|NCT01904773|20332388|P2|COMPLETED|Placebo Washout First Intervention||1
8244619|NCT01904773|20332389|P1|COMPLETED|Placebo Washout First Intervention||0
8244620|NCT01904773|20332381|P9|STARTED|Placebo Washout First Intervention||4
8244621|NCT01904773|20332382|P8|STARTED|Placebo Washout First Intervention||3
8244622|NCT01904773|20332383|P7|STARTED|Placebo Washout First Intervention||3
8244623|NCT01904773|20332384|P6|STARTED|Placebo Washout First Intervention||4
8244624|NCT01904773|20332385|P5|STARTED|Placebo Washout First Intervention||3
8244625|NCT01904773|20332386|P4|STARTED|Placebo Washout First Intervention||2
8244626|NCT01904773|20332387|P3|STARTED|Placebo Washout First Intervention||1
8244627|NCT01904773|20332388|P2|STARTED|Placebo Washout First Intervention||2
8244628|NCT01904773|20332389|P1|STARTED|Placebo Washout First Intervention||0
8244629|NCT01904773|20332381|P9|NOT COMPLETED|First Intervention||0
8244630|NCT01904773|20332382|P8|NOT COMPLETED|First Intervention||0
8244631|NCT01904773|20332383|P7|NOT COMPLETED|First Intervention||1
8244632|NCT01904773|20332384|P6|NOT COMPLETED|First Intervention||0
8244633|NCT01904773|20332385|P5|NOT COMPLETED|First Intervention||0
8244634|NCT01904773|20332386|P4|NOT COMPLETED|First Intervention||0
8244635|NCT01904773|20332387|P3|NOT COMPLETED|First Intervention||0
8244636|NCT01904773|20332388|P2|NOT COMPLETED|First Intervention||0
8244637|NCT01904773|20332389|P1|NOT COMPLETED|First Intervention||0
8244638|NCT01904773|20332381|P9|COMPLETED|First Intervention||4
8244639|NCT01904773|20332382|P8|COMPLETED|First Intervention||3
8244640|NCT01904773|20332383|P7|COMPLETED|First Intervention||3
8244641|NCT01904773|20332384|P6|COMPLETED|First Intervention||4
8244642|NCT01904773|20332385|P5|COMPLETED|First Intervention||3
8244643|NCT01904773|20332386|P4|COMPLETED|First Intervention||2
8244644|NCT01904773|20332387|P3|COMPLETED|First Intervention||1
8244645|NCT01904773|20332388|P2|COMPLETED|First Intervention||2
8244646|NCT01904773|20332389|P1|COMPLETED|First Intervention||0
8244647|NCT01904773|20332381|P9|STARTED|First Intervention||4
8244648|NCT01904773|20332382|P8|STARTED|First Intervention||3
8244649|NCT01904773|20332383|P7|STARTED|First Intervention||4
8244650|NCT01904773|20332384|P6|STARTED|First Intervention||4
8244651|NCT01904773|20332385|P5|STARTED|First Intervention||3
8244652|NCT01904773|20332386|P4|STARTED|First Intervention||2
8244653|NCT01904773|20332387|P3|STARTED|First Intervention||1
8244654|NCT01904773|20332388|P2|STARTED|First Intervention||2
8244655|NCT01904773|20332389|P1|STARTED|First Intervention||0
8244656|NCT01904773|20332381|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244657|NCT01904773|20332382|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244658|NCT01904773|20332383|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244659|NCT01904773|20332384|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244660|NCT01904773|20332385|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244661|NCT01904773|20332386|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244662|NCT01904773|20332387|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244663|NCT01904773|20332388|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244664|NCT01904773|20332389|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
8244665|NCT01904773|20332381|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244666|NCT01904773|20332382|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244667|NCT01904773|20332383|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244668|NCT01904773|20332384|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244669|NCT01904773|20332385|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244670|NCT01904773|20332386|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244671|NCT01904773|20332387|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244672|NCT01904773|20332388|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244673|NCT01904773|20332389|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
8244674|NCT01904773|20332381|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244675|NCT01904773|20332382|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244676|NCT01904773|20332383|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244677|NCT01904773|20332384|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244678|NCT01904773|20332385|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244679|NCT01904773|20332386|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244680|NCT01904773|20332387|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244681|NCT01904773|20332388|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244682|NCT01904773|20332389|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
8244683|NCT01904773|20332381|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244684|NCT01904773|20332382|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244685|NCT01904773|20332383|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244686|NCT01904773|20332384|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244687|NCT01904773|20332385|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244688|NCT01904773|20332386|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244689|NCT01904773|20332387|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244690|NCT01904773|20332388|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244691|NCT01904773|20332389|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
8244692|NCT01904773|20332381|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244693|NCT01904773|20332382|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244694|NCT01904773|20332383|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244695|NCT01904773|20332384|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244696|NCT01904773|20332385|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244697|NCT01904773|20332386|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244698|NCT01904773|20332387|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244699|NCT01904773|20332388|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244700|NCT01904773|20332389|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
8244701|NCT01904773|20332381|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244702|NCT01904773|20332382|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244703|NCT01904773|20332383|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244704|NCT01904773|20332384|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244705|NCT01904773|20332385|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244706|NCT01904773|20332386|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244707|NCT01904773|20332387|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244708|NCT01904773|20332388|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244709|NCT01904773|20332389|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244710|NCT01904773|20332381|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244711|NCT01904773|20332382|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244712|NCT01904773|20332383|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244713|NCT01904773|20332384|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244714|NCT01904773|20332385|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244715|NCT01904773|20332386|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244716|NCT01904773|20332387|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244717|NCT01904773|20332388|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244718|NCT01904773|20332389|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
8244719|NCT01904773|20332381|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244720|NCT01904773|20332382|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244721|NCT01904773|20332383|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244722|NCT01904773|20332384|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244723|NCT01904773|20332385|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244724|NCT01904773|20332386|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244725|NCT01904773|20332387|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244726|NCT01904773|20332388|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244727|NCT01904773|20332389|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
8244728|NCT01904773|20332381|P9|NOT COMPLETED|Screen||0
8244729|NCT01904773|20332382|P8|NOT COMPLETED|Screen||0
8244730|NCT01904773|20332383|P7|NOT COMPLETED|Screen||0
8244731|NCT01904773|20332384|P6|NOT COMPLETED|Screen||0
8244732|NCT01904773|20332385|P5|NOT COMPLETED|Screen||0
8244733|NCT01904773|20332386|P4|NOT COMPLETED|Screen||0
8244734|NCT01904773|20332387|P3|NOT COMPLETED|Screen||0
8244735|NCT01904773|20332388|P2|NOT COMPLETED|Screen||0
8244736|NCT01904773|20332389|P1|NOT COMPLETED|Screen||4
8244737|NCT01904773|20332381|P9|COMPLETED|Screen||0
8244738|NCT01904773|20332382|P8|COMPLETED|Screen||0
8244739|NCT01904773|20332383|P7|COMPLETED|Screen||0
8244740|NCT01904773|20332384|P6|COMPLETED|Screen||0
8244741|NCT01904773|20332385|P5|COMPLETED|Screen||0
8244742|NCT01904773|20332386|P4|COMPLETED|Screen||0
8244743|NCT01904773|20332387|P3|COMPLETED|Screen||0
8244744|NCT01904773|20332388|P2|COMPLETED|Screen||0
8244745|NCT01904773|20332389|P1|COMPLETED|Screen||24
8244746|NCT01904773|20332381|P9|STARTED|Screen||0
8244747|NCT01904773|20332382|P8|STARTED|Screen||0
8244748|NCT01904773|20332383|P7|STARTED|Screen||0
8244749|NCT01904773|20332384|P6|STARTED|Screen||0
8244750|NCT01904773|20332385|P5|STARTED|Screen||0
8244751|NCT01904773|20332386|P4|STARTED|Screen||0
8244752|NCT01904773|20332387|P3|STARTED|Screen||0
8244753|NCT01904773|20332388|P2|STARTED|Screen||0
8244754|NCT01904773|20332389|P1|STARTED|Screen||28
8244755|NCT01904760|20332406|P2|NOT COMPLETED|Overall Study||0
8244756|NCT01904760|20332407|P1|NOT COMPLETED|Overall Study||1
8244757|NCT01904760|20332406|P2|COMPLETED|Overall Study||40
8244758|NCT01904760|20332407|P1|COMPLETED|Overall Study||39
8244759|NCT01904760|20332406|P2|STARTED|Overall Study||40
8244760|NCT01904760|20332407|P1|STARTED|Overall Study||40
8244761|NCT01904721|20332422|P7|NOT COMPLETED|Overall Study||7
8244762|NCT01904721|20332423|P6|NOT COMPLETED|Overall Study||9
8244763|NCT01904721|20332424|P5|NOT COMPLETED|Overall Study||8
8244764|NCT01904721|20332425|P4|NOT COMPLETED|Overall Study||1
8244765|NCT01904721|20332426|P3|NOT COMPLETED|Overall Study||1
8244766|NCT01904721|20332427|P2|NOT COMPLETED|Overall Study||0
8244767|NCT01904721|20332428|P1|NOT COMPLETED|Overall Study||0
8244768|NCT01904721|20332422|P7|COMPLETED|Overall Study||57
8244769|NCT01904721|20332423|P6|COMPLETED|Overall Study||56
8244770|NCT01904721|20332424|P5|COMPLETED|Overall Study||57
8244771|NCT01904721|20332425|P4|COMPLETED|Overall Study||11
8244772|NCT01904721|20332426|P3|COMPLETED|Overall Study||11
8244773|NCT01904721|20332427|P2|COMPLETED|Overall Study||13
8244774|NCT01904721|20332428|P1|COMPLETED|Overall Study||13
8244775|NCT01904721|20332422|P7|STARTED|Overall Study||64
8244776|NCT01904721|20332423|P6|STARTED|Overall Study||65
8244777|NCT01904721|20332424|P5|STARTED|Overall Study||65
8244778|NCT01904721|20332425|P4|STARTED|Overall Study||12
8244779|NCT01904721|20332426|P3|STARTED|Overall Study||12
8244780|NCT01904721|20332427|P2|STARTED|Overall Study||13
8244781|NCT01904721|20332428|P1|STARTED|Overall Study||13
8244782|NCT01904604|20332458|P3|NOT COMPLETED|Overall Study||2
8244783|NCT01904604|20332459|P2|NOT COMPLETED|Overall Study||7
8244784|NCT01904604|20332460|P1|NOT COMPLETED|Overall Study||7
8244785|NCT01904604|20332458|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
8244786|NCT01904604|20332459|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
8244787|NCT01904604|20332460|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
8244788|NCT01904604|20332458|P3|Completed Week 130 OFC|Overall Study||23
8244789|NCT01904604|20332459|P2|Completed Week 130 OFC|Overall Study||18
8244790|NCT01904604|20332460|P1|Completed Week 130 OFC|Overall Study||18
8244791|NCT01904604|20332458|P3|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
8244792|NCT01904604|20332459|P2|Began Crossover Treatment|Overall Study||21
8244793|NCT01904604|20332460|P1|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
8244794|NCT01904604|20332458|P3|Completed Week 52 OFC|Overall Study||25
8244795|NCT01904604|20332459|P2|Completed Week 52 OFC|Overall Study||21
8244796|NCT01904604|20332460|P1|Completed Week 52 OFC|Overall Study||22
8244797|NCT01904604|20332458|P3|STARTED|Overall Study||25
8244798|NCT01904604|20332459|P2|STARTED|Overall Study||25
8244799|NCT01904604|20332460|P1|STARTED|Overall Study||25
8244800|NCT01904526|20332489|P1|NOT COMPLETED|Overall Study||0
8244801|NCT01904526|20332489|P1|COMPLETED|Overall Study||5
8244802|NCT01904526|20332489|P1|STARTED|Overall Study||5
8244803|NCT01904448|20332503|P1|NOT COMPLETED|Overall Study||0
8244804|NCT01904448|20332503|P1|COMPLETED|Overall Study||5
8244805|NCT01904448|20332503|P1|STARTED|Overall Study||5
8244806|NCT01904383|20332525|P1|NOT COMPLETED|Overall Study||1774
8244807|NCT01904383|20332525|P1|COMPLETED|Overall Study||2283
8244808|NCT01904383|20332525|P1|Treated|Overall Study||3940
8244809|NCT01904383|20332525|P1|STARTED|Overall Study||4057
8244810|NCT01904279|20332532|P2|NOT COMPLETED|Overall Study||3
8244811|NCT01904279|20332533|P1|NOT COMPLETED|Overall Study||3
8244812|NCT01904279|20332532|P2|COMPLETED|Overall Study||22
8244813|NCT01904279|20332533|P1|COMPLETED|Overall Study||24
8244814|NCT01904279|20332532|P2|STARTED|Overall Study||25
8244815|NCT01904279|20332533|P1|STARTED|Overall Study||27
8244816|NCT01904149|20332559|P6|NOT COMPLETED|Overall Study||3
8244817|NCT01904149|20332560|P5|NOT COMPLETED|Overall Study||5
8244818|NCT01904149|20332561|P4|NOT COMPLETED|Overall Study||4
8244819|NCT01904149|20332562|P3|NOT COMPLETED|Overall Study||2
8244820|NCT01904149|20332563|P2|NOT COMPLETED|Overall Study||11
8244821|NCT01904149|20332564|P1|NOT COMPLETED|Overall Study||5
8244822|NCT01904149|20332559|P6|COMPLETED|Overall Study||48
8244823|NCT01904149|20332560|P5|COMPLETED|Overall Study||46
8244824|NCT01904149|20332561|P4|COMPLETED|Overall Study||47
8244825|NCT01904149|20332562|P3|COMPLETED|Overall Study||148
8244826|NCT01904149|20332563|P2|COMPLETED|Overall Study||140
8244827|NCT01904149|20332564|P1|COMPLETED|Overall Study||147
8244828|NCT01904149|20332559|P6|Multiple-dose Phase|Overall Study||49
8244829|NCT01904149|20332560|P5|Multiple-dose Phase|Overall Study||48
8244830|NCT01904149|20332561|P4|Multiple-dose Phase|Overall Study||48
8244831|NCT01904149|20332562|P3|Multiple-dose Phase|Overall Study||149
8244832|NCT01904149|20332563|P2|Multiple-dose Phase|Overall Study||146
8244833|NCT01904149|20332564|P1|Multiple-dose Phase|Overall Study||150
8244834|NCT01904149|20332559|P6|Single-dose Phase|Overall Study||51
8244835|NCT01904149|20332560|P5|Single-dose Phase|Overall Study||51
8244836|NCT01904149|20332561|P4|Single-dose Phase|Overall Study||51
8244837|NCT01904149|20332562|P3|Single-dose Phase|Overall Study||150
8244838|NCT01904149|20332563|P2|Single-dose Phase|Overall Study||151
8244839|NCT01904149|20332564|P1|Single-dose Phase|Overall Study||152
8244840|NCT01904149|20332559|P6|STARTED|Overall Study||51
8244841|NCT01904149|20332560|P5|STARTED|Overall Study||51
8244842|NCT01904149|20332561|P4|STARTED|Overall Study||51
8244843|NCT01904149|20332562|P3|STARTED|Overall Study||150
8244844|NCT01904149|20332563|P2|STARTED|Overall Study||151
8244845|NCT01904149|20332564|P1|STARTED|Overall Study||152
8244846|NCT01904071|20332589|P3|NOT COMPLETED|Overall Study||0
8244847|NCT01904071|20332590|P2|NOT COMPLETED|Overall Study||0
8244848|NCT01904071|20332591|P1|NOT COMPLETED|Overall Study||0
8244849|NCT01904071|20332589|P3|COMPLETED|Overall Study||20
8244850|NCT01904071|20332590|P2|COMPLETED|Overall Study||20
8244851|NCT01904071|20332591|P1|COMPLETED|Overall Study||24
8244852|NCT01904071|20332589|P3|STARTED|Overall Study||20
8244853|NCT01904071|20332590|P2|STARTED|Overall Study||20
8244854|NCT01904071|20332591|P1|STARTED|Overall Study||24
8244855|NCT01904058|20332615|P4|NOT COMPLETED|Overall Study||1
8244856|NCT01904058|20332616|P3|NOT COMPLETED|Overall Study||1
8244857|NCT01904058|20332617|P2|NOT COMPLETED|Overall Study||0
8244858|NCT01904058|20332618|P1|NOT COMPLETED|Overall Study||3
8244859|NCT01904058|20332615|P4|COMPLETED|Overall Study||12
8244860|NCT01904058|20332616|P3|COMPLETED|Overall Study||10
8244861|NCT01904058|20332617|P2|COMPLETED|Overall Study||21
8244862|NCT01904058|20332618|P1|COMPLETED|Overall Study||18
8244863|NCT01904058|20332615|P4|STARTED|Overall Study||13
8244864|NCT01904058|20332616|P3|STARTED|Overall Study||11
8244865|NCT01904058|20332617|P2|STARTED|Overall Study||21
8244866|NCT01904058|20332618|P1|STARTED|Overall Study||21
8244867|NCT01903993|20332658|P2|NOT COMPLETED|Overall Study||144
8244868|NCT01903993|20332659|P1|NOT COMPLETED|Overall Study||143
8244869|NCT01903993|20332658|P2|COMPLETED|Overall Study||0
8244870|NCT01903993|20332659|P1|COMPLETED|Overall Study||0
8244871|NCT01903993|20332658|P2|Received Treatment|Overall Study||142
8244872|NCT01903993|20332659|P1|Received Treatment|Overall Study||135
8244873|NCT01903993|20332658|P2|STARTED|Overall Study||144
8244874|NCT01903993|20332659|P1|STARTED|Overall Study||143
8244875|NCT01903876|20332676|P2|NOT COMPLETED|Six-Month Follow-up Period||145
8244876|NCT01903876|20332677|P1|NOT COMPLETED|Six-Month Follow-up Period||91
8244877|NCT01903876|20332676|P2|COMPLETED|Six-Month Follow-up Period||123
8244878|NCT01903876|20332677|P1|COMPLETED|Six-Month Follow-up Period||92
8244879|NCT01903876|20332676|P2|STARTED|Six-Month Follow-up Period||268
8244880|NCT01903876|20332677|P1|STARTED|Six-Month Follow-up Period||183
8244881|NCT01903876|20332676|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
8244882|NCT01903876|20332677|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
8244883|NCT01903876|20332676|P2|COMPLETED|Baseline to Post-Intervention Period||268
8244884|NCT01903876|20332677|P1|COMPLETED|Baseline to Post-Intervention Period||183
8244885|NCT01903876|20332676|P2|STARTED|Baseline to Post-Intervention Period||376
8244886|NCT01903876|20332677|P1|STARTED|Baseline to Post-Intervention Period||367
8244887|NCT01903863|20332687|P2|NOT COMPLETED|Overall Study||0
8244888|NCT01903863|20332688|P1|NOT COMPLETED|Overall Study||2
8244889|NCT01903863|20332687|P2|COMPLETED|Overall Study||16
8244890|NCT01903863|20332688|P1|COMPLETED|Overall Study||13
8244891|NCT01903863|20332687|P2|STARTED|Overall Study||16
8244892|NCT01903863|20332688|P1|STARTED|Overall Study||15
8244893|NCT01903811|20332710|P2|NOT COMPLETED|Overall Study||14
8244894|NCT01903811|20332711|P1|NOT COMPLETED|Overall Study||8
8244895|NCT01903811|20332710|P2|COMPLETED|Overall Study||57
8244896|NCT01903811|20332711|P1|COMPLETED|Overall Study||64
8244897|NCT01903811|20332710|P2|Crossover to Arm II|Overall Study||0
8244898|NCT01903811|20332711|P1|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
8244899|NCT01903811|20332710|P2|STARTED|Overall Study||71
8244900|NCT01903811|20332711|P1|STARTED|Overall Study||72
8244901|NCT01903798|20332728|P4|NOT COMPLETED|Overall Study||0
8244902|NCT01903798|20332729|P3|NOT COMPLETED|Overall Study||0
8244903|NCT01903798|20332730|P2|NOT COMPLETED|Overall Study||0
8244904|NCT01903798|20332731|P1|NOT COMPLETED|Overall Study||0
8244905|NCT01903798|20332728|P4|COMPLETED|Overall Study||1
8244906|NCT01903798|20332729|P3|COMPLETED|Overall Study||1
8244907|NCT01903798|20332730|P2|COMPLETED|Overall Study||0
8244908|NCT01903798|20332731|P1|COMPLETED|Overall Study||2
8244909|NCT01903798|20332728|P4|STARTED|Overall Study||1
8244910|NCT01903798|20332729|P3|STARTED|Overall Study||1
8244911|NCT01903798|20332730|P2|STARTED|Overall Study||0
8244912|NCT01903798|20332731|P1|STARTED|Overall Study||2
8244913|NCT01903720|20332745|P1|NOT COMPLETED|Overall Study||12
8244914|NCT01903720|20332745|P1|COMPLETED|Overall Study||59
8244915|NCT01903720|20332745|P1|STARTED|Overall Study||71
8244916|NCT01903564|20332762|P2|NOT COMPLETED|Overall Study||0
8244917|NCT01903564|20332763|P1|NOT COMPLETED|Overall Study||0
8244918|NCT01903564|20332762|P2|COMPLETED|Overall Study||29
8244919|NCT01903564|20332763|P1|COMPLETED|Overall Study||10
8244920|NCT01903564|20332762|P2|STARTED|Overall Study||29
8244921|NCT01903564|20332763|P1|STARTED|Overall Study||10
8244922|NCT01903525|20332781|P2|NOT COMPLETED|Overall Study||10
8244923|NCT01903525|20332782|P1|NOT COMPLETED|Overall Study||5
8244924|NCT01903525|20332781|P2|COMPLETED|Overall Study||10
8244925|NCT01903525|20332782|P1|COMPLETED|Overall Study||15
8244926|NCT01903525|20332781|P2|STARTED|Overall Study||20
8244927|NCT01903525|20332782|P1|STARTED|Overall Study||20
8244928|NCT01903460|20332798|P4|NOT COMPLETED|Overall Study||1
8244929|NCT01903460|20332799|P3|NOT COMPLETED|Overall Study||0
8244930|NCT01903460|20332800|P2|NOT COMPLETED|Overall Study||0
8244931|NCT01903460|20332801|P1|NOT COMPLETED|Overall Study||0
8244932|NCT01903460|20332798|P4|COMPLETED|Overall Study||2
8244933|NCT01903460|20332799|P3|COMPLETED|Overall Study||3
8244934|NCT01903460|20332800|P2|COMPLETED|Overall Study||8
8244935|NCT01903460|20332801|P1|COMPLETED|Overall Study||6
8244936|NCT01903460|20332798|P4|STARTED|Overall Study||3
8244937|NCT01903460|20332799|P3|STARTED|Overall Study||3
8244938|NCT01903460|20332800|P2|STARTED|Overall Study||8
8244939|NCT01903460|20332801|P1|STARTED|Overall Study||6
8244940|NCT01903434|20332818|P2|NOT COMPLETED|Treatment Period 3||0
8244941|NCT01903434|20332819|P1|NOT COMPLETED|Treatment Period 3||0
8244942|NCT01903434|20332818|P2|COMPLETED|Treatment Period 3||28
8244943|NCT01903434|20332819|P1|COMPLETED|Treatment Period 3||29
8244944|NCT01903434|20332818|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
8244945|NCT01903434|20332819|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
8244946|NCT01903434|20332818|P2|STARTED|Treatment Period 3||28
8244947|NCT01903434|20332819|P1|STARTED|Treatment Period 3||29
8244948|NCT01903434|20332818|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8244949|NCT01903434|20332819|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8244950|NCT01903434|20332818|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
8244951|NCT01903434|20332819|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
8244952|NCT01903434|20332818|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
8244953|NCT01903434|20332819|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
8244954|NCT01903434|20332818|P2|NOT COMPLETED|Treatment Period 2||0
8244955|NCT01903434|20332819|P1|NOT COMPLETED|Treatment Period 2||0
8244956|NCT01903434|20332818|P2|COMPLETED|Treatment Period 2||28
8244957|NCT01903434|20332819|P1|COMPLETED|Treatment Period 2||29
8244958|NCT01903434|20332818|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
8244959|NCT01903434|20332819|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
8244960|NCT01903434|20332818|P2|STARTED|Treatment Period 2||28
8244961|NCT01903434|20332819|P1|STARTED|Treatment Period 2||29
8244962|NCT01903434|20332818|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
8244963|NCT01903434|20332819|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
8244964|NCT01903434|20332818|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
8244965|NCT01903434|20332819|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
8244966|NCT01903434|20332818|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
8244967|NCT01903434|20332819|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
8244968|NCT01903434|20332818|P2|NOT COMPLETED|Treatment Period 1||0
8244969|NCT01903434|20332819|P1|NOT COMPLETED|Treatment Period 1||0
8244970|NCT01903434|20332818|P2|COMPLETED|Treatment Period 1||30
8244971|NCT01903434|20332819|P1|COMPLETED|Treatment Period 1||30
8244972|NCT01903434|20332818|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
8244973|NCT01903434|20332819|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
8244974|NCT01903434|20332818|P2|STARTED|Treatment Period 1||30
8244975|NCT01903434|20332819|P1|STARTED|Treatment Period 1||30
8244976|NCT01903356|20332827|P1|NOT COMPLETED|Overall Study||15
8244977|NCT01903356|20332827|P1|COMPLETED|Overall Study||709
8244978|NCT01903356|20332827|P1|STARTED|Overall Study||724
8244979|NCT01903265|20332837|P2|NOT COMPLETED|Overall Study||17
8244980|NCT01903265|20332838|P1|NOT COMPLETED|Overall Study||14
8244981|NCT01903265|20332837|P2|COMPLETED|Overall Study||85
8244982|NCT01903265|20332838|P1|COMPLETED|Overall Study||89
8244983|NCT01903265|20332837|P2|STARTED|Overall Study||102
8244984|NCT01903265|20332838|P1|STARTED|Overall Study||103
8244985|NCT01903252|20332854|P6|NOT COMPLETED|Maintenance, Open-Label||18
8244986|NCT01903252|20332855|P5|NOT COMPLETED|Maintenance, Open-Label||21
8244987|NCT01903252|20332856|P4|NOT COMPLETED|Maintenance, Open-Label||6
8244988|NCT01903252|20332857|P3|NOT COMPLETED|Maintenance, Open-Label||0
8244989|NCT01903252|20332858|P2|NOT COMPLETED|Maintenance, Open-Label||0
8244990|NCT01903252|20332859|P1|NOT COMPLETED|Maintenance, Open-Label||0
8244991|NCT01903252|20332854|P6|COMPLETED|Maintenance, Open-Label||181
8244992|NCT01903252|20332855|P5|COMPLETED|Maintenance, Open-Label||253
8244993|NCT01903252|20332856|P4|COMPLETED|Maintenance, Open-Label||196
8244994|NCT01903252|20332857|P3|COMPLETED|Maintenance, Open-Label||0
8244995|NCT01903252|20332858|P2|COMPLETED|Maintenance, Open-Label||0
8244996|NCT01903252|20332859|P1|COMPLETED|Maintenance, Open-Label||0
8244997|NCT01903252|20332854|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
8244998|NCT01903252|20332855|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
8244999|NCT01903252|20332856|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
8245000|NCT01903252|20332857|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
8245001|NCT01903252|20332858|P2|STARTED|Maintenance, Open-Label||0
8245002|NCT01903252|20332859|P1|STARTED|Maintenance, Open-Label||0
8245003|NCT01903252|20332854|P6|NOT COMPLETED|Extended Induction, Open-Label||0
8245004|NCT01903252|20332855|P5|NOT COMPLETED|Extended Induction, Open-Label||0
8245005|NCT01903252|20332856|P4|NOT COMPLETED|Extended Induction, Open-Label||0
8245006|NCT01903252|20332857|P3|NOT COMPLETED|Extended Induction, Open-Label||23
8245007|NCT01903252|20332858|P2|NOT COMPLETED|Extended Induction, Open-Label||0
8245008|NCT01903252|20332859|P1|NOT COMPLETED|Extended Induction, Open-Label||0
8245009|NCT01903252|20332854|P6|COMPLETED|Extended Induction, Open-Label||0
8245010|NCT01903252|20332855|P5|COMPLETED|Extended Induction, Open-Label||0
8245011|NCT01903252|20332856|P4|COMPLETED|Extended Induction, Open-Label||0
8245012|NCT01903252|20332857|P3|COMPLETED|Extended Induction, Open-Label||220
8245013|NCT01903252|20332858|P2|COMPLETED|Extended Induction, Open-Label||0
8245014|NCT01903252|20332859|P1|COMPLETED|Extended Induction, Open-Label||0
8245015|NCT01903252|20332854|P6|STARTED|Extended Induction, Open-Label||0
8245016|NCT01903252|20332855|P5|STARTED|Extended Induction, Open-Label||0
8245017|NCT01903252|20332856|P4|STARTED|Extended Induction, Open-Label||0
8245018|NCT01903252|20332857|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
8245019|NCT01903252|20332858|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
8245020|NCT01903252|20332859|P1|STARTED|Extended Induction, Open-Label||0
8245021|NCT01903252|20332854|P6|NOT COMPLETED|Double-Blind Induction||0
8245022|NCT01903252|20332855|P5|NOT COMPLETED|Double-Blind Induction||0
8245023|NCT01903252|20332856|P4|NOT COMPLETED|Double-Blind Induction||0
8245024|NCT01903252|20332857|P3|NOT COMPLETED|Double-Blind Induction||0
8245025|NCT01903252|20332858|P2|NOT COMPLETED|Double-Blind Induction||41
8245026|NCT01903252|20332859|P1|NOT COMPLETED|Double-Blind Induction||39
8245027|NCT01903252|20332854|P6|COMPLETED|Double-Blind Induction||0
8245028|NCT01903252|20332855|P5|COMPLETED|Double-Blind Induction||0
8245029|NCT01903252|20332856|P4|COMPLETED|Double-Blind Induction||0
8245030|NCT01903252|20332857|P3|COMPLETED|Double-Blind Induction||0
8245031|NCT01903252|20332858|P2|COMPLETED|Double-Blind Induction||367
8245032|NCT01903252|20332859|P1|COMPLETED|Double-Blind Induction||370
8245033|NCT01903252|20332854|P6|STARTED|Double-Blind Induction||0
8245034|NCT01903252|20332855|P5|STARTED|Double-Blind Induction||0
8245035|NCT01903252|20332856|P4|STARTED|Double-Blind Induction||0
8245036|NCT01903252|20332857|P3|STARTED|Double-Blind Induction||0
8245037|NCT01903252|20332858|P2|STARTED|Double-Blind Induction||408
8245038|NCT01903252|20332859|P1|STARTED|Double-Blind Induction||409
8245039|NCT01903187|20332938|P2|NOT COMPLETED|12 Month||0
8245040|NCT01903187|20332939|P1|NOT COMPLETED|12 Month||0
8245041|NCT01903187|20332938|P2|COMPLETED|12 Month||0
8245042|NCT01903187|20332939|P1|COMPLETED|12 Month||2
8245043|NCT01903187|20332938|P2|STARTED|12 Month||0
8245044|NCT01903187|20332939|P1|STARTED|12 Month||2
8245045|NCT01903187|20332938|P2|NOT COMPLETED|6 Month||0
8245046|NCT01903187|20332939|P1|NOT COMPLETED|6 Month||0
8245047|NCT01903187|20332938|P2|COMPLETED|6 Month||0
8245048|NCT01903187|20332939|P1|COMPLETED|6 Month||2
8245049|NCT01903187|20332938|P2|STARTED|6 Month||0
8245050|NCT01903187|20332939|P1|STARTED|6 Month||2
8245051|NCT01903187|20332938|P2|NOT COMPLETED|3 Month||0
8245052|NCT01903187|20332939|P1|NOT COMPLETED|3 Month||0
8245053|NCT01903187|20332938|P2|COMPLETED|3 Month||0
8245054|NCT01903187|20332939|P1|COMPLETED|3 Month||2
8245055|NCT01903187|20332938|P2|STARTED|3 Month||0
8245056|NCT01903187|20332939|P1|STARTED|3 Month||2
8245057|NCT01903187|20332938|P2|NOT COMPLETED|1 Month||0
8245058|NCT01903187|20332939|P1|NOT COMPLETED|1 Month||0
8245059|NCT01903187|20332938|P2|COMPLETED|1 Month||2
8245060|NCT01903187|20332939|P1|COMPLETED|1 Month||2
8245061|NCT01903187|20332938|P2|STARTED|1 Month||2
8245062|NCT01903187|20332939|P1|STARTED|1 Month||2
8245063|NCT01903187|20332938|P2|NOT COMPLETED|Procedure||0
8245064|NCT01903187|20332939|P1|NOT COMPLETED|Procedure||0
8245065|NCT01903187|20332938|P2|COMPLETED|Procedure||2
8245066|NCT01903187|20332939|P1|COMPLETED|Procedure||2
8245067|NCT01903187|20332938|P2|STARTED|Procedure||2
8245068|NCT01903187|20332939|P1|STARTED|Procedure||2
8245069|NCT01903148|20332953|P1|NOT COMPLETED|Overall Study||0
8245070|NCT01903148|20332953|P1|COMPLETED|Overall Study||441
8245071|NCT01903148|20332953|P1|STARTED|Overall Study||441
8245072|NCT01903031|20332972|P3|NOT COMPLETED|Overall Study||5
8245073|NCT01903031|20332973|P2|NOT COMPLETED|Overall Study||3
8245074|NCT01903031|20332974|P1|NOT COMPLETED|Overall Study||2
8245075|NCT01903031|20332972|P3|COMPLETED|Overall Study||24
8245076|NCT01903031|20332973|P2|COMPLETED|Overall Study||25
8245077|NCT01903031|20332974|P1|COMPLETED|Overall Study||25
8245078|NCT01903031|20332972|P3|STARTED|Overall Study||29
8245079|NCT01903031|20332973|P2|STARTED|Overall Study||28
8245080|NCT01903031|20332974|P1|STARTED|Overall Study||27
8245081|NCT01903005|20333016|P1|NOT COMPLETED|Overall Study||373
8245082|NCT01903005|20333016|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
8245083|NCT01903005|20333016|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
8245084|NCT01902953|20333030|P1|NOT COMPLETED|Overall Study||0
8245085|NCT01902953|20333030|P1|COMPLETED|Overall Study||16
8245086|NCT01902953|20333030|P1|STARTED|Overall Study||16
8245087|NCT01902901|20333037|P2|NOT COMPLETED|Overall Study||2
8245088|NCT01902901|20333038|P1|NOT COMPLETED|Overall Study||0
8245089|NCT01902901|20333037|P2|COMPLETED|Overall Study||201
8245090|NCT01902901|20333038|P1|COMPLETED|Overall Study||180
8245091|NCT01902901|20333037|P2|STARTED|Overall Study||203
8245092|NCT01902901|20333038|P1|STARTED|Overall Study||180
8245093|NCT01902888|20333048|P1|NOT COMPLETED|Overall Study||3
8245094|NCT01902888|20333048|P1|COMPLETED|Overall Study||0
8245095|NCT01902888|20333048|P1|STARTED|Overall Study||3
8245096|NCT01902758|20333055|P2|NOT COMPLETED|Overall Study||0
8245097|NCT01902758|20333056|P1|NOT COMPLETED|Overall Study||0
8245098|NCT01902758|20333055|P2|COMPLETED|Overall Study||14
8245099|NCT01902758|20333056|P1|COMPLETED|Overall Study||14
8245100|NCT01902758|20333055|P2|STARTED|Overall Study||14
8245101|NCT01902758|20333056|P1|STARTED|Overall Study||14
8245102|NCT01902628|20333062|P1|NOT COMPLETED|Overall Study||83
8245103|NCT01902628|20333062|P1|COMPLETED|Overall Study||354
8245104|NCT01902628|20333062|P1|STARTED|Overall Study||437
8245105|NCT01902459|20333071|P2|NOT COMPLETED|Overall Study||0
8245106|NCT01902459|20333072|P1|NOT COMPLETED|Overall Study||0
8245107|NCT01902459|20333071|P2|COMPLETED|Overall Study||75
8245108|NCT01902459|20333072|P1|COMPLETED|Overall Study||75
8245109|NCT01902459|20333071|P2|STARTED|Overall Study||75
8245110|NCT01902459|20333072|P1|STARTED|Overall Study||75
8245111|NCT01902303|20333090|P2|NOT COMPLETED|Overall Study||24
8245112|NCT01902303|20333091|P1|NOT COMPLETED|Overall Study||23
8245113|NCT01902303|20333090|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
8245114|NCT01902303|20333091|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
8245115|NCT01902303|20333090|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
8245116|NCT01902303|20333091|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
8245117|NCT01902303|20333090|P2|STARTED|Overall Study|Allocated to active treatment|81
8245118|NCT01902303|20333091|P1|STARTED|Overall Study|Allocated to placebo|77
8245119|NCT01902173|20333105|P6|NOT COMPLETED|Phase II||0
8245120|NCT01902173|20333106|P5|NOT COMPLETED|Phase II||0
8245121|NCT01902173|20333107|P4|NOT COMPLETED|Phase II||0
8245122|NCT01902173|20333108|P3|NOT COMPLETED|Phase II||0
8245123|NCT01902173|20333109|P2|NOT COMPLETED|Phase II||0
8245124|NCT01902173|20333110|P1|NOT COMPLETED|Phase II||0
8245125|NCT01902173|20333105|P6|COMPLETED|Phase II||0
8245126|NCT01902173|20333106|P5|COMPLETED|Phase II||0
8245127|NCT01902173|20333107|P4|COMPLETED|Phase II||0
8245128|NCT01902173|20333108|P3|COMPLETED|Phase II||0
8245129|NCT01902173|20333109|P2|COMPLETED|Phase II||0
8245130|NCT01902173|20333110|P1|COMPLETED|Phase II||0
8245131|NCT01902173|20333105|P6|STARTED|Phase II||0
8245132|NCT01902173|20333106|P5|STARTED|Phase II||0
8245133|NCT01902173|20333107|P4|STARTED|Phase II||0
8245134|NCT01902173|20333108|P3|STARTED|Phase II||0
8245135|NCT01902173|20333109|P2|STARTED|Phase II||0
8245136|NCT01902173|20333110|P1|STARTED|Phase II||0
8245137|NCT01902173|20333105|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
8245138|NCT01902173|20333106|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245139|NCT01902173|20333107|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245140|NCT01902173|20333108|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245141|NCT01902173|20333109|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245142|NCT01902173|20333110|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245143|NCT01902173|20333105|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245144|NCT01902173|20333106|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245145|NCT01902173|20333107|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245146|NCT01902173|20333108|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245147|NCT01902173|20333109|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245148|NCT01902173|20333110|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8245149|NCT01902173|20333105|P6|STARTED|Phase 1 Triplet Regimen Cohort 4||5
8245150|NCT01902173|20333106|P5|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8245151|NCT01902173|20333107|P4|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8245152|NCT01902173|20333108|P3|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8245153|NCT01902173|20333109|P2|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8245154|NCT01902173|20333110|P1|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8245155|NCT01902173|20333105|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245156|NCT01902173|20333106|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
8245157|NCT01902173|20333107|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245158|NCT01902173|20333108|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245159|NCT01902173|20333109|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245160|NCT01902173|20333110|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245161|NCT01902173|20333105|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245162|NCT01902173|20333106|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245163|NCT01902173|20333107|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245164|NCT01902173|20333108|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245165|NCT01902173|20333109|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245166|NCT01902173|20333110|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8245167|NCT01902173|20333105|P6|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8245168|NCT01902173|20333106|P5|STARTED|Phase 1 Triplet Regimen Cohort 3||3
8245169|NCT01902173|20333107|P4|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8245170|NCT01902173|20333108|P3|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8245171|NCT01902173|20333109|P2|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8245172|NCT01902173|20333110|P1|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8245173|NCT01902173|20333105|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245174|NCT01902173|20333106|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245175|NCT01902173|20333107|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
8245176|NCT01902173|20333108|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245177|NCT01902173|20333109|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245178|NCT01902173|20333110|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245179|NCT01902173|20333105|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245180|NCT01902173|20333106|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245181|NCT01902173|20333107|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245182|NCT01902173|20333108|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245183|NCT01902173|20333109|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245184|NCT01902173|20333110|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8245185|NCT01902173|20333105|P6|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8245186|NCT01902173|20333106|P5|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8245187|NCT01902173|20333107|P4|STARTED|Phase 1 Triplet Regimen Cohort 2||3
8245188|NCT01902173|20333108|P3|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8245189|NCT01902173|20333109|P2|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8245190|NCT01902173|20333110|P1|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8245191|NCT01902173|20333105|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245192|NCT01902173|20333106|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245193|NCT01902173|20333107|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245194|NCT01902173|20333108|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
8245195|NCT01902173|20333109|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245196|NCT01902173|20333110|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245197|NCT01902173|20333105|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245198|NCT01902173|20333106|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245199|NCT01902173|20333107|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245200|NCT01902173|20333108|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245201|NCT01902173|20333109|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245202|NCT01902173|20333110|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8245203|NCT01902173|20333105|P6|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8245204|NCT01902173|20333106|P5|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8245205|NCT01902173|20333107|P4|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8245206|NCT01902173|20333108|P3|STARTED|Phase 1 Triplet Regimen Cohort 1||4
8245207|NCT01902173|20333109|P2|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8245208|NCT01902173|20333110|P1|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8245209|NCT01902173|20333105|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245210|NCT01902173|20333106|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245211|NCT01902173|20333107|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245212|NCT01902173|20333108|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245213|NCT01902173|20333109|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
8245214|NCT01902173|20333110|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245215|NCT01902173|20333105|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245216|NCT01902173|20333106|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245217|NCT01902173|20333107|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245218|NCT01902173|20333108|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245219|NCT01902173|20333109|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245220|NCT01902173|20333110|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8245221|NCT01902173|20333105|P6|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8245222|NCT01902173|20333106|P5|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8245223|NCT01902173|20333107|P4|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8245224|NCT01902173|20333108|P3|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8245225|NCT01902173|20333109|P2|STARTED|Phase 1 Doublet Regimen Cohort 2||9
8245226|NCT01902173|20333110|P1|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8245227|NCT01902173|20333105|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245228|NCT01902173|20333106|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245229|NCT01902173|20333107|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245230|NCT01902173|20333108|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245231|NCT01902173|20333109|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245232|NCT01902173|20333110|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
8245233|NCT01902173|20333105|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245234|NCT01902173|20333106|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245235|NCT01902173|20333107|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245236|NCT01902173|20333108|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245237|NCT01902173|20333109|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245238|NCT01902173|20333110|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8245239|NCT01902173|20333105|P6|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8245240|NCT01902173|20333106|P5|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8245241|NCT01902173|20333107|P4|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8245242|NCT01902173|20333108|P3|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8245243|NCT01902173|20333109|P2|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8245244|NCT01902173|20333110|P1|STARTED|Phase 1 Doublet Regimen Cohort 1||3
8245245|NCT01902134|20333133|P6|NOT COMPLETED|Overall Study||9
8245246|NCT01902134|20333134|P5|NOT COMPLETED|Overall Study||7
8245247|NCT01902134|20333135|P4|NOT COMPLETED|Overall Study||2
8245248|NCT01902134|20333136|P3|NOT COMPLETED|Overall Study||15
8245249|NCT01902134|20333137|P2|NOT COMPLETED|Overall Study||11
8245250|NCT01902134|20333138|P1|NOT COMPLETED|Overall Study||8
8245251|NCT01902134|20333133|P6|COMPLETED|Overall Study||45
8245252|NCT01902134|20333134|P5|COMPLETED|Overall Study||46
8245253|NCT01902134|20333135|P4|COMPLETED|Overall Study||52
8245254|NCT01902134|20333136|P3|COMPLETED|Overall Study||145
8245255|NCT01902134|20333137|P2|COMPLETED|Overall Study||150
8245256|NCT01902134|20333138|P1|COMPLETED|Overall Study||151
8245257|NCT01902134|20333133|P6|Multiple-dose Phase|Overall Study||52
8245258|NCT01902134|20333134|P5|Multiple-dose Phase|Overall Study||53
8245259|NCT01902134|20333135|P4|Multiple-dose Phase|Overall Study||54
8245260|NCT01902134|20333136|P3|Multiple-dose Phase|Overall Study||160
8245261|NCT01902134|20333137|P2|Multiple-dose Phase|Overall Study||160
8245262|NCT01902134|20333138|P1|Multiple-dose Phase|Overall Study||159
8245263|NCT01902134|20333133|P6|Single-dose Phase|Overall Study||54
8245264|NCT01902134|20333134|P5|Single-dose Phase|Overall Study||53
8245265|NCT01902134|20333135|P4|Single-dose Phase|Overall Study||54
8245266|NCT01902134|20333136|P3|Single-dose Phase|Overall Study||160
8245267|NCT01902134|20333137|P2|Single-dose Phase|Overall Study||161
8245268|NCT01902134|20333138|P1|Single-dose Phase|Overall Study||159
8245269|NCT01902134|20333133|P6|STARTED|Overall Study||54
8245270|NCT01902134|20333134|P5|STARTED|Overall Study||53
8245271|NCT01902134|20333135|P4|STARTED|Overall Study||54
8245272|NCT01902134|20333136|P3|STARTED|Overall Study||160
8245273|NCT01902134|20333137|P2|STARTED|Overall Study||161
8245274|NCT01902134|20333138|P1|STARTED|Overall Study||159
8245275|NCT01902004|20333162|P2|NOT COMPLETED|Overall Study||18
8245276|NCT01902004|20333163|P1|NOT COMPLETED|Overall Study||15
8245277|NCT01902004|20333162|P2|COMPLETED|Overall Study||29
8245278|NCT01902004|20333163|P1|COMPLETED|Overall Study||33
8245279|NCT01902004|20333162|P2|STARTED|Overall Study||47
8245280|NCT01902004|20333163|P1|STARTED|Overall Study||48
8245281|NCT01901874|20333175|P1|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
8245282|NCT01901874|20333175|P1|COMPLETED|1-Year (365-Day) MAE Evaluation||244
8245283|NCT01901874|20333175|P1|STARTED|1-Year (365-Day) MAE Evaluation||264
8245284|NCT01901874|20333175|P1|NOT COMPLETED|30-Day MAE Evaluation||1
8245285|NCT01901874|20333175|P1|COMPLETED|30-Day MAE Evaluation||264
8245286|NCT01901874|20333175|P1|STARTED|30-Day MAE Evaluation||265
8245287|NCT01901874|20333175|P1|NOT COMPLETED|Screening Committee Retrospective Review||47
8245288|NCT01901874|20333175|P1|COMPLETED|Screening Committee Retrospective Review||265
8245289|NCT01901874|20333175|P1|STARTED|Screening Committee Retrospective Review||312
8245290|NCT01901874|20333175|P1|NOT COMPLETED|Procedure||0
8245291|NCT01901874|20333175|P1|COMPLETED|Procedure||312
8245292|NCT01901874|20333175|P1|STARTED|Procedure||312
8245293|NCT01901848|20333190|P2|NOT COMPLETED|Removed From Analyses||0
8245294|NCT01901848|20333191|P1|NOT COMPLETED|Removed From Analyses||10
8245295|NCT01901848|20333190|P2|COMPLETED|Removed From Analyses||19
8245296|NCT01901848|20333191|P1|COMPLETED|Removed From Analyses||12
8245297|NCT01901848|20333190|P2|STARTED|Removed From Analyses||19
8245298|NCT01901848|20333191|P1|STARTED|Removed From Analyses||22
8245299|NCT01901848|20333190|P2|NOT COMPLETED|Randomized and Treated||6
8245300|NCT01901848|20333191|P1|NOT COMPLETED|Randomized and Treated||3
8245301|NCT01901848|20333190|P2|COMPLETED|Randomized and Treated||19
8245302|NCT01901848|20333191|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
8245303|NCT01901848|20333190|P2|STARTED|Randomized and Treated||25
8245304|NCT01901848|20333191|P1|STARTED|Randomized and Treated||25
8245305|NCT01901809|20333203|P4|NOT COMPLETED|Overall Study||2
8245306|NCT01901809|20333204|P3|NOT COMPLETED|Overall Study||3
8245307|NCT01901809|20333205|P2|NOT COMPLETED|Overall Study||0
8245308|NCT01901809|20333206|P1|NOT COMPLETED|Overall Study||0
8245309|NCT01901809|20333203|P4|COMPLETED|Overall Study||22
8245310|NCT01901809|20333204|P3|COMPLETED|Overall Study||21
8245311|NCT01901809|20333205|P2|COMPLETED|Overall Study||23
8245312|NCT01901809|20333206|P1|COMPLETED|Overall Study||19
8245313|NCT01901809|20333203|P4|STARTED|Overall Study||24
8245314|NCT01901809|20333204|P3|STARTED|Overall Study||24
8245315|NCT01901809|20333205|P2|STARTED|Overall Study||23
8245316|NCT01901809|20333206|P1|STARTED|Overall Study||19
8245317|NCT01901653|20333233|P13|NOT COMPLETED|Overall Study||5
8245318|NCT01901653|20333234|P12|NOT COMPLETED|Overall Study||16
8245319|NCT01901653|20333235|P11|NOT COMPLETED|Overall Study||2
8245320|NCT01901653|20333236|P10|NOT COMPLETED|Overall Study||18
8245321|NCT01901653|20333237|P9|NOT COMPLETED|Overall Study||1
8245322|NCT01901653|20333238|P8|NOT COMPLETED|Overall Study||10
8245323|NCT01901653|20333239|P7|NOT COMPLETED|Overall Study||7
8245324|NCT01901653|20333240|P6|NOT COMPLETED|Overall Study||3
8245325|NCT01901653|20333241|P5|NOT COMPLETED|Overall Study||2
8245326|NCT01901653|20333242|P4|NOT COMPLETED|Overall Study||3
8245327|NCT01901653|20333243|P3|NOT COMPLETED|Overall Study||11
8245328|NCT01901653|20333244|P2|NOT COMPLETED|Overall Study||1
8245329|NCT01901653|20333245|P1|NOT COMPLETED|Overall Study||3
8245330|NCT01901653|20333233|P13|COMPLETED|Overall Study||0
8245331|NCT01901653|20333234|P12|COMPLETED|Overall Study||0
8245332|NCT01901653|20333235|P11|COMPLETED|Overall Study||0
8245333|NCT01901653|20333236|P10|COMPLETED|Overall Study||0
8245334|NCT01901653|20333237|P9|COMPLETED|Overall Study||0
8245335|NCT01901653|20333238|P8|COMPLETED|Overall Study||0
8245336|NCT01901653|20333239|P7|COMPLETED|Overall Study||0
8245337|NCT01901653|20333240|P6|COMPLETED|Overall Study||0
8245338|NCT01901653|20333241|P5|COMPLETED|Overall Study||0
8245339|NCT01901653|20333242|P4|COMPLETED|Overall Study||0
8245340|NCT01901653|20333243|P3|COMPLETED|Overall Study||0
8245341|NCT01901653|20333244|P2|COMPLETED|Overall Study||0
8245342|NCT01901653|20333245|P1|COMPLETED|Overall Study||0
8245343|NCT01901653|20333233|P13|STARTED|Overall Study||5
8245344|NCT01901653|20333234|P12|STARTED|Overall Study||16
8245345|NCT01901653|20333235|P11|STARTED|Overall Study||2
8245346|NCT01901653|20333236|P10|STARTED|Overall Study||18
8245347|NCT01901653|20333237|P9|STARTED|Overall Study||1
8245348|NCT01901653|20333238|P8|STARTED|Overall Study||10
8245349|NCT01901653|20333239|P7|STARTED|Overall Study||7
8245350|NCT01901653|20333240|P6|STARTED|Overall Study||3
8245351|NCT01901653|20333241|P5|STARTED|Overall Study||2
8245352|NCT01901653|20333242|P4|STARTED|Overall Study||3
8245353|NCT01901653|20333243|P3|STARTED|Overall Study||11
8245354|NCT01901653|20333244|P2|STARTED|Overall Study||1
8245355|NCT01901653|20333245|P1|STARTED|Overall Study||3
8245356|NCT01901614|20333289|P2|NOT COMPLETED|Overall Study||1
8245357|NCT01901614|20333290|P1|NOT COMPLETED|Overall Study||2
8245358|NCT01901614|20333289|P2|COMPLETED|Overall Study||1
8245359|NCT01901614|20333290|P1|COMPLETED|Overall Study||1
8245360|NCT01901614|20333289|P2|STARTED|Overall Study||2
8245361|NCT01901614|20333290|P1|STARTED|Overall Study||3
8245362|NCT01901588|20333298|P2|NOT COMPLETED|Overall Study||0
8245363|NCT01901588|20333299|P1|NOT COMPLETED|Overall Study||0
8245364|NCT01901588|20333298|P2|COMPLETED|Overall Study||31
8245365|NCT01901588|20333299|P1|COMPLETED|Overall Study||32
8245366|NCT01901588|20333298|P2|STARTED|Overall Study||31
8245367|NCT01901588|20333299|P1|STARTED|Overall Study||32
8245368|NCT01901575|20333315|P1|NOT COMPLETED|Overall Study||0
8245369|NCT01901575|20333315|P1|COMPLETED|Overall Study||16
8245370|NCT01901575|20333315|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
8245371|NCT01901432|20333325|P5|NOT COMPLETED|Overall Study||9
8245372|NCT01901432|20333326|P4|NOT COMPLETED|Overall Study||0
8245373|NCT01901432|20333327|P3|NOT COMPLETED|Overall Study||2
8245374|NCT01901432|20333328|P2|NOT COMPLETED|Overall Study||1
8245375|NCT01901432|20333329|P1|NOT COMPLETED|Overall Study||0
8245376|NCT01901432|20333325|P5|COMPLETED|Overall Study||27
8245377|NCT01901432|20333326|P4|COMPLETED|Overall Study||3
8245378|NCT01901432|20333327|P3|COMPLETED|Overall Study||1
8245379|NCT01901432|20333328|P2|COMPLETED|Overall Study||2
8245380|NCT01901432|20333329|P1|COMPLETED|Overall Study||3
8245381|NCT01901432|20333325|P5|Received Study Drug|Overall Study||35
8245382|NCT01901432|20333326|P4|Received Study Drug|Overall Study||3
8245383|NCT01901432|20333327|P3|Received Study Drug|Overall Study||3
8245384|NCT01901432|20333328|P2|Received Study Drug|Overall Study||3
8245385|NCT01901432|20333329|P1|Received Study Drug|Overall Study||3
8245386|NCT01901432|20333325|P5|STARTED|Overall Study||36
8245387|NCT01901432|20333326|P4|STARTED|Overall Study||3
8245388|NCT01901432|20333327|P3|STARTED|Overall Study||3
8245389|NCT01901432|20333328|P2|STARTED|Overall Study||3
8245390|NCT01901432|20333329|P1|STARTED|Overall Study||3
8245391|NCT01901419|20333381|P2|NOT COMPLETED|Overall Study||9
8245392|NCT01901419|20333382|P1|NOT COMPLETED|Overall Study||8
8245393|NCT01901419|20333381|P2|COMPLETED|Overall Study||31
8245394|NCT01901419|20333382|P1|COMPLETED|Overall Study||32
8245395|NCT01901419|20333381|P2|STARTED|Overall Study||40
8245396|NCT01901419|20333382|P1|STARTED|Overall Study||40
8245397|NCT01901393|20333448|P2|NOT COMPLETED|Overall Study||0
8245398|NCT01901393|20333449|P1|NOT COMPLETED|Overall Study||1
8245399|NCT01901393|20333448|P2|COMPLETED|Overall Study||49
8245400|NCT01901393|20333449|P1|COMPLETED|Overall Study||50
8245401|NCT01901393|20333448|P2|STARTED|Overall Study||49
8245402|NCT01901393|20333449|P1|STARTED|Overall Study||51
8245403|NCT01901341|20333467|P2|NOT COMPLETED|Overall Study||21
8245404|NCT01901341|20333468|P1|NOT COMPLETED|Overall Study||20
8245405|NCT01901341|20333467|P2|COMPLETED|Overall Study||1
8245406|NCT01901341|20333468|P1|COMPLETED|Overall Study||2
8245407|NCT01901341|20333467|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
8245408|NCT01901341|20333468|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
8245409|NCT01901341|20333467|P2|STARTED|Overall Study||22
8245410|NCT01901341|20333468|P1|STARTED|Overall Study||22
8245411|NCT01901328|20333482|P2|NOT COMPLETED|Overall Study||21
8245412|NCT01901328|20333483|P1|NOT COMPLETED|Overall Study||22
8245413|NCT01901328|20333482|P2|COMPLETED|Overall Study||2
8245414|NCT01901328|20333483|P1|COMPLETED|Overall Study||4
8245415|NCT01901328|20333482|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
8245416|NCT01901328|20333483|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
8245417|NCT01901328|20333482|P2|STARTED|Overall Study||23
8245418|NCT01901328|20333483|P1|STARTED|Overall Study||26
8245419|NCT01901302|20333497|P2|NOT COMPLETED|Overall Study||23
8245420|NCT01901302|20333498|P1|NOT COMPLETED|Overall Study||27
8245421|NCT01901302|20333497|P2|COMPLETED|Overall Study||7
8245422|NCT01901302|20333498|P1|COMPLETED|Overall Study||4
8245423|NCT01901302|20333497|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
8245424|NCT01901302|20333498|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8245425|NCT01901302|20333497|P2|STARTED|Overall Study||30
8245426|NCT01901302|20333498|P1|STARTED|Overall Study||31
8245427|NCT01901289|20333510|P1|NOT COMPLETED|Overall Study||200
8245428|NCT01901289|20333510|P1|COMPLETED|Overall Study||0
8245429|NCT01901289|20333510|P1|12-Month Follow-up|Overall Study||175
8245430|NCT01901289|20333510|P1|STARTED|Overall Study||200
8245431|NCT01901250|20333516|P2|NOT COMPLETED|Overall Study||126
8245432|NCT01901250|20333517|P1|NOT COMPLETED|Overall Study||138
8245433|NCT01901250|20333516|P2|COMPLETED|Overall Study||139
8245434|NCT01901250|20333517|P1|COMPLETED|Overall Study||122
8245435|NCT01901250|20333516|P2|End of 1st Grade|Overall Study||151
8245436|NCT01901250|20333517|P1|End of 1st Grade|Overall Study||143
8245437|NCT01901250|20333516|P2|Start of 1st Grade|Overall Study||176
8245438|NCT01901250|20333517|P1|Start of 1st Grade|Overall Study||173
8245439|NCT01901250|20333516|P2|End of Kidergarten|Overall Study||212
8245440|NCT01901250|20333517|P1|End of Kidergarten|Overall Study||215
8245441|NCT01901250|20333516|P2|STARTED|Overall Study||265
8245442|NCT01901250|20333517|P1|STARTED|Overall Study||260
8245443|NCT01901224|20333523|P1|NOT COMPLETED|Overall Study||2
8245444|NCT01901224|20333523|P1|COMPLETED|Overall Study||0
8245445|NCT01901224|20333523|P1|STARTED|Overall Study||2
8245446|NCT01901211|20333534|P2|NOT COMPLETED|Second Ten-week Period||0
8245447|NCT01901211|20333535|P1|NOT COMPLETED|Second Ten-week Period||0
8245448|NCT01901211|20333534|P2|COMPLETED|Second Ten-week Period||5
8245449|NCT01901211|20333535|P1|COMPLETED|Second Ten-week Period||6
8245450|NCT01901211|20333534|P2|STARTED|Second Ten-week Period||5
8245451|NCT01901211|20333535|P1|STARTED|Second Ten-week Period||6
8245452|NCT01901211|20333534|P2|NOT COMPLETED|Washout (6 Weeks)||0
8245453|NCT01901211|20333535|P1|NOT COMPLETED|Washout (6 Weeks)||0
8245454|NCT01901211|20333534|P2|COMPLETED|Washout (6 Weeks)||5
8245455|NCT01901211|20333535|P1|COMPLETED|Washout (6 Weeks)||6
8245456|NCT01901211|20333534|P2|STARTED|Washout (6 Weeks)||5
8245457|NCT01901211|20333535|P1|STARTED|Washout (6 Weeks)||6
8245458|NCT01901211|20333534|P2|NOT COMPLETED|First Ten-week Period||0
8245459|NCT01901211|20333535|P1|NOT COMPLETED|First Ten-week Period||0
8245460|NCT01901211|20333534|P2|COMPLETED|First Ten-week Period||5
8245461|NCT01901211|20333535|P1|COMPLETED|First Ten-week Period||6
8245462|NCT01901211|20333534|P2|STARTED|First Ten-week Period||5
8245463|NCT01901211|20333535|P1|STARTED|First Ten-week Period||6
8245464|NCT01901185|20333558|P1|NOT COMPLETED|Overall Study||2
8245465|NCT01901185|20333558|P1|COMPLETED|Overall Study||75
8245466|NCT01901185|20333558|P1|Received Etanercept With Autoinjector A|Overall Study||75
8245467|NCT01901185|20333558|P1|STARTED|Overall Study||77
8245468|NCT01901146|20333567|P5|NOT COMPLETED|Adjuvant Phase||14
8245469|NCT01901146|20333568|P4|NOT COMPLETED|Adjuvant Phase||7
8245470|NCT01901146|20333569|P3|NOT COMPLETED|Adjuvant Phase||26
8245471|NCT01901146|20333570|P2|NOT COMPLETED|Adjuvant Phase||0
8245472|NCT01901146|20333571|P1|NOT COMPLETED|Adjuvant Phase||0
8245473|NCT01901146|20333567|P5|COMPLETED|Adjuvant Phase||157
8245474|NCT01901146|20333568|P4|COMPLETED|Adjuvant Phase||164
8245475|NCT01901146|20333569|P3|COMPLETED|Adjuvant Phase||323
8245476|NCT01901146|20333570|P2|COMPLETED|Adjuvant Phase||0
8245477|NCT01901146|20333571|P1|COMPLETED|Adjuvant Phase||0
8245478|NCT01901146|20333567|P5|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
8245479|NCT01901146|20333568|P4|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
8245480|NCT01901146|20333569|P3|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
8245481|NCT01901146|20333570|P2|STARTED|Adjuvant Phase||0
8245482|NCT01901146|20333571|P1|STARTED|Adjuvant Phase||0
8245483|NCT01901146|20333567|P5|NOT COMPLETED|Neoadjuvant Phase||0
8245484|NCT01901146|20333568|P4|NOT COMPLETED|Neoadjuvant Phase||0
8245485|NCT01901146|20333569|P3|NOT COMPLETED|Neoadjuvant Phase||0
8245486|NCT01901146|20333570|P2|NOT COMPLETED|Neoadjuvant Phase||14
8245487|NCT01901146|20333571|P1|NOT COMPLETED|Neoadjuvant Phase||6
8245488|NCT01901146|20333567|P5|COMPLETED|Neoadjuvant Phase||0
8245489|NCT01901146|20333568|P4|COMPLETED|Neoadjuvant Phase||0
8245490|NCT01901146|20333569|P3|COMPLETED|Neoadjuvant Phase||0
8245491|NCT01901146|20333570|P2|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
8245492|NCT01901146|20333571|P1|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
8245493|NCT01901146|20333567|P5|STARTED|Neoadjuvant Phase||0
8245494|NCT01901146|20333568|P4|STARTED|Neoadjuvant Phase||0
8245495|NCT01901146|20333569|P3|STARTED|Neoadjuvant Phase||0
8245496|NCT01901146|20333570|P2|STARTED|Neoadjuvant Phase||361
8245497|NCT01901146|20333571|P1|STARTED|Neoadjuvant Phase||364
8245498|NCT01900899|20333586|P2|NOT COMPLETED|Overall Study||1
8245499|NCT01900899|20333587|P1|NOT COMPLETED|Overall Study||9
8245500|NCT01900899|20333586|P2|COMPLETED|Overall Study||24
8245501|NCT01900899|20333587|P1|COMPLETED|Overall Study||150
8245502|NCT01900899|20333586|P2|STARTED|Overall Study||25
8245503|NCT01900899|20333587|P1|STARTED|Overall Study||159
8245504|NCT01900730|20333613|P2|NOT COMPLETED|Overall Study||0
8245505|NCT01900730|20333614|P1|NOT COMPLETED|Overall Study||2
8245506|NCT01900730|20333613|P2|COMPLETED|Overall Study||0
8245507|NCT01900730|20333614|P1|COMPLETED|Overall Study||1
8245508|NCT01900730|20333613|P2|STARTED|Overall Study||0
8245509|NCT01900730|20333614|P1|STARTED|Overall Study||3
8245510|NCT01900704|20333623|P3|NOT COMPLETED|Overall Study||33
8245511|NCT01900704|20333624|P2|NOT COMPLETED|Overall Study||35
8245512|NCT01900704|20333625|P1|NOT COMPLETED|Overall Study||41
8245513|NCT01900704|20333623|P3|COMPLETED|Overall Study||237
8245514|NCT01900704|20333624|P2|COMPLETED|Overall Study||235
8245515|NCT01900704|20333625|P1|COMPLETED|Overall Study||229
8245516|NCT01900704|20333623|P3|STARTED|Overall Study||270
8245517|NCT01900704|20333624|P2|STARTED|Overall Study||270
8245518|NCT01900704|20333625|P1|STARTED|Overall Study||270
8245519|NCT01900665|20333638|P2|NOT COMPLETED|Open Label Period||859
8245520|NCT01900665|20333639|P1|NOT COMPLETED|Open Label Period||881
8245521|NCT01900665|20333638|P2|COMPLETED|Open Label Period||0
8245522|NCT01900665|20333639|P1|COMPLETED|Open Label Period||0
8245523|NCT01900665|20333638|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
8245524|NCT01900665|20333639|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
8245525|NCT01900665|20333638|P2|NOT COMPLETED|Placebo Controlled Period||164
8245526|NCT01900665|20333639|P1|NOT COMPLETED|Placebo Controlled Period||143
8245527|NCT01900665|20333638|P2|COMPLETED|Placebo Controlled Period||908
8245528|NCT01900665|20333639|P1|COMPLETED|Placebo Controlled Period||914
8245529|NCT01900665|20333638|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
8245530|NCT01900665|20333639|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
8245531|NCT01900665|20333638|P2|STARTED|Placebo Controlled Period||1072
8245532|NCT01900665|20333639|P1|STARTED|Placebo Controlled Period||1057
8245533|NCT01900652|20333682|P2|NOT COMPLETED|Overall Study||3
8245534|NCT01900652|20333683|P1|NOT COMPLETED|Overall Study||8
8245535|NCT01900652|20333682|P2|COMPLETED|Overall Study||25
8245536|NCT01900652|20333683|P1|COMPLETED|Overall Study||75
8245537|NCT01900652|20333682|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
8245538|NCT01900652|20333683|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
8245539|NCT01900652|20333682|P2|STARTED|Overall Study||28
8245540|NCT01900652|20333683|P1|STARTED|Overall Study||83
8245541|NCT01900626|20333719|P2|NOT COMPLETED|Overall Study||1
8245542|NCT01900626|20333720|P1|NOT COMPLETED|Overall Study||1
8245543|NCT01900626|20333719|P2|COMPLETED|Overall Study||0
8245544|NCT01900626|20333720|P1|COMPLETED|Overall Study||0
8245545|NCT01900626|20333719|P2|STARTED|Overall Study||1
8245546|NCT01900626|20333720|P1|STARTED|Overall Study||1
8245547|NCT01900561|20333738|P2|NOT COMPLETED|Overall Study||9
8245548|NCT01900561|20333739|P1|NOT COMPLETED|Overall Study||17
8245549|NCT01900561|20333738|P2|COMPLETED|Overall Study||269
8245550|NCT01900561|20333739|P1|COMPLETED|Overall Study||261
8245551|NCT01900561|20333738|P2|STARTED|Overall Study||278
8245552|NCT01900561|20333739|P1|STARTED|Overall Study||278
8245553|NCT01900444|20333799|P1|NOT COMPLETED|Overall Study||3
8245554|NCT01900444|20333799|P1|COMPLETED|Overall Study||116
8245555|NCT01900444|20333799|P1|STARTED|Overall Study||119
8245556|NCT01900431|20333812|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
8245557|NCT01900431|20333813|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
8245558|NCT01900431|20333814|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
8245559|NCT01900431|20333812|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
8245560|NCT01900431|20333813|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
8245561|NCT01900431|20333814|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
8245562|NCT01900431|20333812|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
8245563|NCT01900431|20333813|P2|STARTED|Open-Label Treatment Period (Part C)||0
8245564|NCT01900431|20333814|P1|STARTED|Open-Label Treatment Period (Part C)||0
8245565|NCT01900431|20333812|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
8245566|NCT01900431|20333813|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
8245567|NCT01900431|20333814|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
8245568|NCT01900431|20333812|P3|COMPLETED|Extended Treatment Period (Part B)||0
8245569|NCT01900431|20333813|P2|COMPLETED|Extended Treatment Period (Part B)||12
8245570|NCT01900431|20333814|P1|COMPLETED|Extended Treatment Period (Part B)||7
8245571|NCT01900431|20333812|P3|STARTED|Extended Treatment Period (Part B)||0
8245572|NCT01900431|20333813|P2|STARTED|Extended Treatment Period (Part B)||22
8245573|NCT01900431|20333814|P1|STARTED|Extended Treatment Period (Part B)||8
8245574|NCT01900431|20333812|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
8245575|NCT01900431|20333813|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
8245576|NCT01900431|20333814|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
8245577|NCT01900431|20333812|P3|COMPLETED|Principal Treatment Period (Part A)||0
8245578|NCT01900431|20333813|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
8245579|NCT01900431|20333814|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
8245580|NCT01900431|20333812|P3|STARTED|Principal Treatment Period (Part A)||0
8245581|NCT01900431|20333813|P2|STARTED|Principal Treatment Period (Part A)||38
8245582|NCT01900431|20333814|P1|STARTED|Principal Treatment Period (Part A)||20
8245583|NCT01900392|20333841|P3|NOT COMPLETED|Overall Study||0
8245584|NCT01900392|20333842|P2|NOT COMPLETED|Overall Study||1
8245585|NCT01900392|20333843|P1|NOT COMPLETED|Overall Study||1
8245586|NCT01900392|20333841|P3|COMPLETED|Overall Study||77
8245587|NCT01900392|20333842|P2|COMPLETED|Overall Study||74
8245588|NCT01900392|20333843|P1|COMPLETED|Overall Study||38
8245589|NCT01900392|20333841|P3|STARTED|Overall Study||77
8245590|NCT01900392|20333842|P2|STARTED|Overall Study||75
8245591|NCT01900392|20333843|P1|STARTED|Overall Study||39
8245592|NCT01900314|20333856|P2|NOT COMPLETED|Overall Study||4
8245593|NCT01900314|20333857|P1|NOT COMPLETED|Overall Study||4
8245594|NCT01900314|20333856|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
8245595|NCT01900314|20333857|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
8245596|NCT01900314|20333856|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
8245597|NCT01900314|20333857|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
8245598|NCT01900314|20333856|P2|STARTED|Overall Study||20
8245599|NCT01900314|20333857|P1|STARTED|Overall Study||20
8245600|NCT01900249|20333868|P3|NOT COMPLETED|Overall Study||4
8245601|NCT01900249|20333869|P2|NOT COMPLETED|Overall Study||5
8245602|NCT01900249|20333870|P1|NOT COMPLETED|Overall Study||3
8245603|NCT01900249|20333868|P3|COMPLETED|Overall Study||65
8245604|NCT01900249|20333869|P2|COMPLETED|Overall Study||63
8245605|NCT01900249|20333870|P1|COMPLETED|Overall Study||64
8245606|NCT01900249|20333868|P3|STARTED|Overall Study||69
8245607|NCT01900249|20333869|P2|STARTED|Overall Study||68
8245608|NCT01900249|20333870|P1|STARTED|Overall Study||67
8245609|NCT01900067|20333880|P2|NOT COMPLETED|Overall Study||13
8245610|NCT01900067|20333881|P1|NOT COMPLETED|Overall Study||12
8245611|NCT01900067|20333880|P2|COMPLETED|Overall Study||124
8245612|NCT01900067|20333881|P1|COMPLETED|Overall Study||122
8245613|NCT01900067|20333880|P2|STARTED|Overall Study||137
8245614|NCT01900067|20333881|P1|STARTED|Overall Study||134
8245615|NCT01900054|20333887|P1|NOT COMPLETED|Overall Study||2
8245616|NCT01900054|20333887|P1|COMPLETED|Overall Study||56
8245617|NCT01900054|20333887|P1|STARTED|Overall Study||58
8245618|NCT01899911|20333892|P1|NOT COMPLETED|Overall Study||0
8245619|NCT01899911|20333892|P1|COMPLETED|Overall Study||12
8245620|NCT01899911|20333892|P1|STARTED|Overall Study||12
8245621|NCT01899768|20333896|P1|NOT COMPLETED|Part C||0
8245622|NCT01899768|20333896|P1|COMPLETED|Part C||11
8245623|NCT01899768|20333896|P1|STARTED|Part C||11
8245624|NCT01899768|20333896|P1|NOT COMPLETED|Part B||2
8245625|NCT01899768|20333896|P1|COMPLETED|Part B||11
8245626|NCT01899768|20333896|P1|STARTED|Part B||13
8245627|NCT01899768|20333896|P1|NOT COMPLETED|Part A||3
8245628|NCT01899768|20333896|P1|COMPLETED|Part A||13
8245629|NCT01899768|20333896|P1|STARTED|Part A||16
8245630|NCT01899742|20333970|P2|NOT COMPLETED|Overall Study||16
8245631|NCT01899742|20333971|P1|NOT COMPLETED|Overall Study||17
8245632|NCT01899742|20333970|P2|COMPLETED|Overall Study||231
8245633|NCT01899742|20333971|P1|COMPLETED|Overall Study||230
8245634|NCT01899742|20333970|P2|STARTED|Overall Study||247
8245635|NCT01899742|20333971|P1|STARTED|Overall Study||247
8245636|NCT01899729|20333984|P5|NOT COMPLETED|Overall Study||2
8245637|NCT01899729|20333985|P4|NOT COMPLETED|Overall Study||0
8245638|NCT01899729|20333986|P3|NOT COMPLETED|Overall Study||2
8245639|NCT01899729|20333987|P2|NOT COMPLETED|Overall Study||2
8245640|NCT01899729|20333988|P1|NOT COMPLETED|Overall Study||2
8245641|NCT01899729|20333984|P5|COMPLETED|Overall Study||9
8245642|NCT01899729|20333985|P4|COMPLETED|Overall Study||9
8245643|NCT01899729|20333986|P3|COMPLETED|Overall Study||6
8245644|NCT01899729|20333987|P2|COMPLETED|Overall Study||7
8245645|NCT01899729|20333988|P1|COMPLETED|Overall Study||7
8245646|NCT01899729|20333984|P5|STARTED|Overall Study||11
8245647|NCT01899729|20333985|P4|STARTED|Overall Study||9
8245648|NCT01899729|20333986|P3|STARTED|Overall Study||8
8245649|NCT01899729|20333987|P2|STARTED|Overall Study||9
8245650|NCT01899729|20333988|P1|STARTED|Overall Study||9
8245651|NCT01899677|20334002|P2|NOT COMPLETED|Overall Study||7
8245652|NCT01899677|20334003|P1|NOT COMPLETED|Overall Study||10
8245653|NCT01899677|20334002|P2|COMPLETED|Overall Study||28
8245654|NCT01899677|20334003|P1|COMPLETED|Overall Study||25
8245655|NCT01899677|20334002|P2|STARTED|Overall Study||35
8245656|NCT01899677|20334003|P1|STARTED|Overall Study||35
8245657|NCT01899261|20334031|P1|NOT COMPLETED|Overall Study||0
8245658|NCT01899261|20334031|P1|COMPLETED|Overall Study||20
8245659|NCT01899261|20334031|P1|STARTED|Overall Study||20
8245660|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 5||1
8245661|NCT01899144|20334035|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
8245662|NCT01899144|20334035|P1|STARTED|Treatment Period 5||58
8245663|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 4||0
8245664|NCT01899144|20334035|P1|COMPLETED|Treatment Period 4||58
8245665|NCT01899144|20334035|P1|STARTED|Treatment Period 4||58
8245666|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 3||2
8245667|NCT01899144|20334035|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
8245668|NCT01899144|20334035|P1|STARTED|Treatment Period 3||60
8245669|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 2||1
8245670|NCT01899144|20334035|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
8245671|NCT01899144|20334035|P1|STARTED|Treatment Period 2||61
8245672|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 1||0
8245673|NCT01899144|20334035|P1|COMPLETED|Treatment Period 1||61
8245674|NCT01899144|20334035|P1|STARTED|Treatment Period 1||61
8245675|NCT01899053|20334071|P14|NOT COMPLETED|Overall Study||20
8245676|NCT01899053|20334072|P13|NOT COMPLETED|Overall Study||14
8245677|NCT01899053|20334073|P12|NOT COMPLETED|Overall Study||7
8245678|NCT01899053|20334074|P11|NOT COMPLETED|Overall Study||16
8245679|NCT01899053|20334075|P10|NOT COMPLETED|Overall Study||3
8245680|NCT01899053|20334076|P9|NOT COMPLETED|Overall Study||6
8245681|NCT01899053|20334077|P8|NOT COMPLETED|Overall Study||3
8245682|NCT01899053|20334078|P7|NOT COMPLETED|Overall Study||3
8245683|NCT01899053|20334079|P6|NOT COMPLETED|Overall Study||3
8245684|NCT01899053|20334080|P5|NOT COMPLETED|Overall Study||6
8245685|NCT01899053|20334081|P4|NOT COMPLETED|Overall Study||3
8245686|NCT01899053|20334082|P3|NOT COMPLETED|Overall Study||7
8245687|NCT01899053|20334083|P2|NOT COMPLETED|Overall Study||3
8245688|NCT01899053|20334084|P1|NOT COMPLETED|Overall Study||7
8245689|NCT01899053|20334071|P14|COMPLETED|Overall Study||0
8245690|NCT01899053|20334072|P13|COMPLETED|Overall Study||0
8245691|NCT01899053|20334073|P12|COMPLETED|Overall Study||0
8245692|NCT01899053|20334074|P11|COMPLETED|Overall Study||0
8245693|NCT01899053|20334075|P10|COMPLETED|Overall Study||0
8245694|NCT01899053|20334076|P9|COMPLETED|Overall Study||0
8245695|NCT01899053|20334077|P8|COMPLETED|Overall Study||0
8245696|NCT01899053|20334078|P7|COMPLETED|Overall Study||0
8245697|NCT01899053|20334079|P6|COMPLETED|Overall Study||0
8245698|NCT01899053|20334080|P5|COMPLETED|Overall Study||0
8245699|NCT01899053|20334081|P4|COMPLETED|Overall Study||0
8245700|NCT01899053|20334082|P3|COMPLETED|Overall Study||0
8245701|NCT01899053|20334083|P2|COMPLETED|Overall Study||0
8245702|NCT01899053|20334084|P1|COMPLETED|Overall Study||0
8245703|NCT01899053|20334071|P14|STARTED|Overall Study||20
8245704|NCT01899053|20334072|P13|STARTED|Overall Study||14
8245705|NCT01899053|20334073|P12|STARTED|Overall Study||7
8245706|NCT01899053|20334074|P11|STARTED|Overall Study||16
8245707|NCT01899053|20334075|P10|STARTED|Overall Study||3
8245708|NCT01899053|20334076|P9|STARTED|Overall Study||6
8245709|NCT01899053|20334077|P8|STARTED|Overall Study||3
8245710|NCT01899053|20334078|P7|STARTED|Overall Study||3
8245711|NCT01899053|20334079|P6|STARTED|Overall Study||3
8245712|NCT01899053|20334080|P5|STARTED|Overall Study||6
8245713|NCT01899053|20334081|P4|STARTED|Overall Study||3
8245714|NCT01899053|20334082|P3|STARTED|Overall Study||7
8245715|NCT01899053|20334083|P2|STARTED|Overall Study||3
8245716|NCT01899053|20334084|P1|STARTED|Overall Study||7
8245717|NCT01898884|20334341|P9|NOT COMPLETED|Multiple Dose Period||1
8245718|NCT01898884|20334342|P8|NOT COMPLETED|Multiple Dose Period||0
8245719|NCT01898884|20334343|P7|NOT COMPLETED|Multiple Dose Period||1
8245720|NCT01898884|20334344|P6|NOT COMPLETED|Multiple Dose Period||0
8245721|NCT01898884|20334345|P5|NOT COMPLETED|Multiple Dose Period||0
8245722|NCT01898884|20334346|P4|NOT COMPLETED|Multiple Dose Period||0
8245723|NCT01898884|20334347|P3|NOT COMPLETED|Multiple Dose Period||0
8245724|NCT01898884|20334348|P2|NOT COMPLETED|Multiple Dose Period||0
8245725|NCT01898884|20334349|P1|NOT COMPLETED|Multiple Dose Period||0
8245726|NCT01898884|20334341|P9|COMPLETED|Multiple Dose Period||5
8245727|NCT01898884|20334342|P8|COMPLETED|Multiple Dose Period||6
8245728|NCT01898884|20334343|P7|COMPLETED|Multiple Dose Period||5
8245729|NCT01898884|20334344|P6|COMPLETED|Multiple Dose Period||6
8245730|NCT01898884|20334345|P5|COMPLETED|Multiple Dose Period||0
8245731|NCT01898884|20334346|P4|COMPLETED|Multiple Dose Period||0
8245732|NCT01898884|20334347|P3|COMPLETED|Multiple Dose Period||0
8245733|NCT01898884|20334348|P2|COMPLETED|Multiple Dose Period||0
8245734|NCT01898884|20334349|P1|COMPLETED|Multiple Dose Period||0
8245735|NCT01898884|20334341|P9|Treated|Multiple Dose Period||5
8245736|NCT01898884|20334342|P8|Treated|Multiple Dose Period||6
8245737|NCT01898884|20334343|P7|Treated|Multiple Dose Period||6
8245738|NCT01898884|20334344|P6|Treated|Multiple Dose Period||6
8245739|NCT01898884|20334345|P5|Treated|Multiple Dose Period||0
8245740|NCT01898884|20334346|P4|Treated|Multiple Dose Period||0
8245741|NCT01898884|20334347|P3|Treated|Multiple Dose Period||0
8245742|NCT01898884|20334348|P2|Treated|Multiple Dose Period||0
8245743|NCT01898884|20334349|P1|Treated|Multiple Dose Period||0
8245744|NCT01898884|20334341|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8245745|NCT01898884|20334342|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8245746|NCT01898884|20334343|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8245747|NCT01898884|20334344|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8245748|NCT01898884|20334345|P5|STARTED|Multiple Dose Period||0
8245749|NCT01898884|20334346|P4|STARTED|Multiple Dose Period||0
8245750|NCT01898884|20334347|P3|STARTED|Multiple Dose Period||0
8245751|NCT01898884|20334348|P2|STARTED|Multiple Dose Period||0
8245752|NCT01898884|20334349|P1|STARTED|Multiple Dose Period||0
8245753|NCT01898884|20334341|P9|NOT COMPLETED|Single Dose Period||0
8245754|NCT01898884|20334342|P8|NOT COMPLETED|Single Dose Period||0
8245755|NCT01898884|20334343|P7|NOT COMPLETED|Single Dose Period||0
8245756|NCT01898884|20334344|P6|NOT COMPLETED|Single Dose Period||0
8245757|NCT01898884|20334345|P5|NOT COMPLETED|Single Dose Period||0
8245758|NCT01898884|20334346|P4|NOT COMPLETED|Single Dose Period||0
8245759|NCT01898884|20334347|P3|NOT COMPLETED|Single Dose Period||0
8245760|NCT01898884|20334348|P2|NOT COMPLETED|Single Dose Period||0
8245761|NCT01898884|20334349|P1|NOT COMPLETED|Single Dose Period||0
8245762|NCT01898884|20334341|P9|COMPLETED|Single Dose Period||0
8245763|NCT01898884|20334342|P8|COMPLETED|Single Dose Period||0
8245764|NCT01898884|20334343|P7|COMPLETED|Single Dose Period||0
8245765|NCT01898884|20334344|P6|COMPLETED|Single Dose Period||0
8245766|NCT01898884|20334345|P5|COMPLETED|Single Dose Period||6
8245767|NCT01898884|20334346|P4|COMPLETED|Single Dose Period||6
8245768|NCT01898884|20334347|P3|COMPLETED|Single Dose Period||6
8245769|NCT01898884|20334348|P2|COMPLETED|Single Dose Period||6
8245770|NCT01898884|20334349|P1|COMPLETED|Single Dose Period||8
8245771|NCT01898884|20334341|P9|STARTED|Single Dose Period||0
8245772|NCT01898884|20334342|P8|STARTED|Single Dose Period||0
8245773|NCT01898884|20334343|P7|STARTED|Single Dose Period||0
8245774|NCT01898884|20334344|P6|STARTED|Single Dose Period||0
8245775|NCT01898884|20334345|P5|STARTED|Single Dose Period||6
8245776|NCT01898884|20334346|P4|STARTED|Single Dose Period||6
8245777|NCT01898884|20334347|P3|STARTED|Single Dose Period||6
8245778|NCT01898884|20334348|P2|STARTED|Single Dose Period||6
8245779|NCT01898884|20334349|P1|STARTED|Single Dose Period||8
8245780|NCT01898806|20334499|P1|NOT COMPLETED|Overall Study||3
8245781|NCT01898806|20334499|P1|COMPLETED|Overall Study||8
8245782|NCT01898806|20334499|P1|STARTED|Overall Study||11
8245783|NCT01898611|20334506|P2|NOT COMPLETED|Overall Study||1
8245784|NCT01898611|20334507|P1|NOT COMPLETED|Overall Study||0
8245785|NCT01898611|20334506|P2|COMPLETED|Overall Study||10
8245786|NCT01898611|20334507|P1|COMPLETED|Overall Study||5
8245787|NCT01898611|20334506|P2|STARTED|Overall Study||11
8245788|NCT01898611|20334507|P1|STARTED|Overall Study||5
8245789|NCT01898598|20334529|P2|NOT COMPLETED|Overall Study||2
8245790|NCT01898598|20334530|P1|NOT COMPLETED|Overall Study||4
8245791|NCT01898598|20334529|P2|COMPLETED|Overall Study||4
8245792|NCT01898598|20334530|P1|COMPLETED|Overall Study||8
8245793|NCT01898598|20334529|P2|Treated|Overall Study||5
8245794|NCT01898598|20334530|P1|Treated|Overall Study||11
8245795|NCT01898598|20334529|P2|STARTED|Overall Study||6
8245796|NCT01898598|20334530|P1|STARTED|Overall Study||12
8245797|NCT01898442|20334549|P3|NOT COMPLETED|Overall Study||3
8245798|NCT01898442|20334550|P2|NOT COMPLETED|Overall Study||2
8245799|NCT01898442|20334551|P1|NOT COMPLETED|Overall Study||1
8245800|NCT01898442|20334549|P3|COMPLETED|Overall Study||15
8245801|NCT01898442|20334550|P2|COMPLETED|Overall Study||15
8245802|NCT01898442|20334551|P1|COMPLETED|Overall Study||16
8245803|NCT01898442|20334549|P3|STARTED|Overall Study||18
8245804|NCT01898442|20334550|P2|STARTED|Overall Study||17
8245805|NCT01898442|20334551|P1|STARTED|Overall Study||17
8245806|NCT01898429|20334574|P3|NOT COMPLETED|Phase 3||0
8245807|NCT01898429|20334575|P2|NOT COMPLETED|Phase 3||0
8245808|NCT01898429|20334576|P1|NOT COMPLETED|Phase 3||0
8245809|NCT01898429|20334574|P3|COMPLETED|Phase 3||5
8245810|NCT01898429|20334575|P2|COMPLETED|Phase 3||0
8245811|NCT01898429|20334576|P1|COMPLETED|Phase 3||0
8245812|NCT01898429|20334574|P3|STARTED|Phase 3||5
8245813|NCT01898429|20334575|P2|STARTED|Phase 3||0
8245814|NCT01898429|20334576|P1|STARTED|Phase 3||0
8245815|NCT01898429|20334574|P3|NOT COMPLETED|Phase 2||0
8245816|NCT01898429|20334575|P2|NOT COMPLETED|Phase 2||0
8245817|NCT01898429|20334576|P1|NOT COMPLETED|Phase 2||0
8245818|NCT01898429|20334574|P3|COMPLETED|Phase 2||0
8245819|NCT01898429|20334575|P2|COMPLETED|Phase 2||5
8245820|NCT01898429|20334576|P1|COMPLETED|Phase 2||0
8245821|NCT01898429|20334574|P3|STARTED|Phase 2||0
8245822|NCT01898429|20334575|P2|STARTED|Phase 2||5
8245823|NCT01898429|20334576|P1|STARTED|Phase 2||0
8245824|NCT01898429|20334574|P3|NOT COMPLETED|Phase 1||0
8245825|NCT01898429|20334575|P2|NOT COMPLETED|Phase 1||0
8245826|NCT01898429|20334576|P1|NOT COMPLETED|Phase 1||0
8245827|NCT01898429|20334574|P3|COMPLETED|Phase 1||0
8245828|NCT01898429|20334575|P2|COMPLETED|Phase 1||0
8245829|NCT01898429|20334576|P1|COMPLETED|Phase 1||5
8245830|NCT01898429|20334574|P3|STARTED|Phase 1||0
8245831|NCT01898429|20334575|P2|STARTED|Phase 1||0
8245832|NCT01898429|20334576|P1|STARTED|Phase 1||5
8245833|NCT01898403|20334580|P1|NOT COMPLETED|Overall Study||0
8245834|NCT01898403|20334580|P1|COMPLETED|Overall Study||50
8245835|NCT01898403|20334580|P1|STARTED|Overall Study||50
8245836|NCT01898299|20334588|P2|NOT COMPLETED|Post Treatment (One Month)||4
8245837|NCT01898299|20334589|P1|NOT COMPLETED|Post Treatment (One Month)||3
8245838|NCT01898299|20334588|P2|COMPLETED|Post Treatment (One Month)||38
8245839|NCT01898299|20334589|P1|COMPLETED|Post Treatment (One Month)||44
8245840|NCT01898299|20334588|P2|STARTED|Post Treatment (One Month)||42
8245841|NCT01898299|20334589|P1|STARTED|Post Treatment (One Month)||47
8245842|NCT01898299|20334588|P2|NOT COMPLETED|Post Treatment (One Week)||0
8245843|NCT01898299|20334589|P1|NOT COMPLETED|Post Treatment (One Week)||0
8245844|NCT01898299|20334588|P2|COMPLETED|Post Treatment (One Week)||42
8245845|NCT01898299|20334589|P1|COMPLETED|Post Treatment (One Week)||47
8245846|NCT01898299|20334588|P2|STARTED|Post Treatment (One Week)||42
8245847|NCT01898299|20334589|P1|STARTED|Post Treatment (One Week)||47
8245848|NCT01898286|20334595|P1|NOT COMPLETED|Overall Study||3
8245849|NCT01898286|20334595|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
8245850|NCT01898286|20334595|P1|STARTED|Overall Study||38
8245851|NCT01898208|20334605|P3|NOT COMPLETED|Overall Study||37
8245852|NCT01898208|20334606|P2|NOT COMPLETED|Overall Study||49
8245853|NCT01898208|20334607|P1|NOT COMPLETED|Overall Study||40
8245854|NCT01898208|20334605|P3|COMPLETED|Overall Study||212
8245855|NCT01898208|20334606|P2|COMPLETED|Overall Study||198
8245856|NCT01898208|20334607|P1|COMPLETED|Overall Study||207
8245857|NCT01898208|20334605|P3|STARTED|Overall Study||249
8245858|NCT01898208|20334606|P2|STARTED|Overall Study||247
8245859|NCT01898208|20334607|P1|STARTED|Overall Study||247
8245860|NCT01898195|20334654|P3|NOT COMPLETED|Smoking Abstinence||36
8245861|NCT01898195|20334655|P2|NOT COMPLETED|Smoking Abstinence||38
8245862|NCT01898195|20334656|P1|NOT COMPLETED|Smoking Abstinence||35
8245863|NCT01898195|20334654|P3|COMPLETED|Smoking Abstinence||15
8245864|NCT01898195|20334655|P2|COMPLETED|Smoking Abstinence||16
8245865|NCT01898195|20334656|P1|COMPLETED|Smoking Abstinence||18
8245866|NCT01898195|20334654|P3|STARTED|Smoking Abstinence||51
8245867|NCT01898195|20334655|P2|STARTED|Smoking Abstinence||54
8245868|NCT01898195|20334656|P1|STARTED|Smoking Abstinence||53
8245869|NCT01898195|20334654|P3|NOT COMPLETED|Varenicline Adherence||36
8245870|NCT01898195|20334655|P2|NOT COMPLETED|Varenicline Adherence||38
8245871|NCT01898195|20334656|P1|NOT COMPLETED|Varenicline Adherence||35
8245872|NCT01898195|20334654|P3|COMPLETED|Varenicline Adherence||15
8245873|NCT01898195|20334655|P2|COMPLETED|Varenicline Adherence||16
8245874|NCT01898195|20334656|P1|COMPLETED|Varenicline Adherence||18
8245875|NCT01898195|20334654|P3|STARTED|Varenicline Adherence||51
8245876|NCT01898195|20334655|P2|STARTED|Varenicline Adherence||54
8245877|NCT01898195|20334656|P1|STARTED|Varenicline Adherence||53
8245878|NCT01898130|20334667|P1|NOT COMPLETED|Follow up Until PD or Death||1
8245879|NCT01898130|20334667|P1|COMPLETED|Follow up Until PD or Death||26
8245880|NCT01898130|20334667|P1|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
8245881|NCT01898130|20334667|P1|NOT COMPLETED|Treatment||6
8245882|NCT01898130|20334667|P1|COMPLETED|Treatment||21
8245883|NCT01898130|20334667|P1|Went on to Start Cycle 3|Treatment||21
8245884|NCT01898130|20334667|P1|Reached 1st Response/2 Cycles|Treatment||24
8245885|NCT01898130|20334667|P1|STARTED|Treatment||27
8245886|NCT01898091|20334682|P2|NOT COMPLETED|Overall Study||6
8245887|NCT01898091|20334683|P1|NOT COMPLETED|Overall Study||2
8245888|NCT01898091|20334682|P2|COMPLETED|Overall Study||19
8245889|NCT01898091|20334683|P1|COMPLETED|Overall Study||23
8245890|NCT01898091|20334682|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
8245891|NCT01898091|20334683|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
8245892|NCT01898078|20334691|P2|NOT COMPLETED|Overall Study||8
8245893|NCT01898078|20334692|P1|NOT COMPLETED|Overall Study||6
8245894|NCT01898078|20334691|P2|COMPLETED|Overall Study|Completed treatment|5
8245895|NCT01898078|20334692|P1|COMPLETED|Overall Study|Completed treatment|7
8245896|NCT01898078|20334691|P2|STARTED|Overall Study||13
8245897|NCT01898078|20334692|P1|STARTED|Overall Study||13
8245898|NCT01898013|20334710|P2|NOT COMPLETED|Visit 6||5
8245899|NCT01898013|20334711|P1|NOT COMPLETED|Visit 6||3
8245900|NCT01898013|20334710|P2|COMPLETED|Visit 6||42
8245901|NCT01898013|20334711|P1|COMPLETED|Visit 6||41
8245902|NCT01898013|20334710|P2|STARTED|Visit 6||47
8245903|NCT01898013|20334711|P1|STARTED|Visit 6||44
8245904|NCT01898013|20334710|P2|NOT COMPLETED|Visit 5||1
8245905|NCT01898013|20334711|P1|NOT COMPLETED|Visit 5||1
8245906|NCT01898013|20334710|P2|COMPLETED|Visit 5||47
8245907|NCT01898013|20334711|P1|COMPLETED|Visit 5||44
8245908|NCT01898013|20334710|P2|STARTED|Visit 5||48
8245909|NCT01898013|20334711|P1|STARTED|Visit 5||45
8245910|NCT01898013|20334710|P2|NOT COMPLETED|Visit 4||1
8245911|NCT01898013|20334711|P1|NOT COMPLETED|Visit 4||0
8245912|NCT01898013|20334710|P2|COMPLETED|Visit 4||48
8245913|NCT01898013|20334711|P1|COMPLETED|Visit 4||45
8245914|NCT01898013|20334710|P2|STARTED|Visit 4||49
8245915|NCT01898013|20334711|P1|STARTED|Visit 4||45
8245916|NCT01898013|20334710|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
8245917|NCT01898013|20334711|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
8245918|NCT01898013|20334710|P2|COMPLETED|Visit 3 (Randomization Visit)||49
8245919|NCT01898013|20334711|P1|COMPLETED|Visit 3 (Randomization Visit)||45
8245920|NCT01898013|20334710|P2|STARTED|Visit 3 (Randomization Visit)||49
8245921|NCT01898013|20334711|P1|STARTED|Visit 3 (Randomization Visit)||45
8245922|NCT01897896|20334729|P2|NOT COMPLETED|Overall Study||12
8245923|NCT01897896|20334730|P1|NOT COMPLETED|Overall Study||26
8245924|NCT01897896|20334729|P2|COMPLETED|Overall Study||25
8245925|NCT01897896|20334730|P1|COMPLETED|Overall Study||56
8245926|NCT01897896|20334729|P2|STARTED|Overall Study||37
8245927|NCT01897896|20334730|P1|STARTED|Overall Study||82
8245928|NCT01897792|20334812|P2|NOT COMPLETED|Overall Study||0
8245929|NCT01897792|20334813|P1|NOT COMPLETED|Overall Study||0
8245930|NCT01897792|20334812|P2|COMPLETED|Overall Study||5
8245931|NCT01897792|20334813|P1|COMPLETED|Overall Study||6
8245932|NCT01897792|20334812|P2|STARTED|Overall Study||5
8245933|NCT01897792|20334813|P1|STARTED|Overall Study||6
8245934|NCT01897766|20334837|P1|NOT COMPLETED|Overall Study||0
8245935|NCT01897766|20334837|P1|COMPLETED|Overall Study||482
8245936|NCT01897766|20334837|P1|STARTED|Overall Study||482
8245937|NCT01897727|20334862|P2|NOT COMPLETED|Overall Study||1
8245938|NCT01897727|20334863|P1|NOT COMPLETED|Overall Study||0
8245939|NCT01897727|20334862|P2|COMPLETED|Overall Study||8
8245940|NCT01897727|20334863|P1|COMPLETED|Overall Study||8
8245941|NCT01897727|20334862|P2|STARTED|Overall Study||9
8245942|NCT01897727|20334863|P1|STARTED|Overall Study||8
8245943|NCT01897714|20334875|P6|NOT COMPLETED|Phase II (MTD)||11
8245944|NCT01897714|20334876|P5|NOT COMPLETED|Phase II (MTD)||30
8245945|NCT01897714|20334877|P4|NOT COMPLETED|Phase II (MTD)||0
8245946|NCT01897714|20334878|P3|NOT COMPLETED|Phase II (MTD)||0
8245947|NCT01897714|20334879|P2|NOT COMPLETED|Phase II (MTD)||0
8245948|NCT01897714|20334880|P1|NOT COMPLETED|Phase II (MTD)||0
8245949|NCT01897714|20334875|P6|COMPLETED|Phase II (MTD)||2
8245950|NCT01897714|20334876|P5|COMPLETED|Phase II (MTD)||15
8245951|NCT01897714|20334877|P4|COMPLETED|Phase II (MTD)||0
8245952|NCT01897714|20334878|P3|COMPLETED|Phase II (MTD)||0
8245953|NCT01897714|20334879|P2|COMPLETED|Phase II (MTD)||0
8245954|NCT01897714|20334880|P1|COMPLETED|Phase II (MTD)||0
8245955|NCT01897714|20334875|P6|STARTED|Phase II (MTD)||13
8245956|NCT01897714|20334876|P5|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
8245957|NCT01897714|20334877|P4|STARTED|Phase II (MTD)||0
8245958|NCT01897714|20334878|P3|STARTED|Phase II (MTD)||0
8245959|NCT01897714|20334879|P2|STARTED|Phase II (MTD)||0
8245960|NCT01897714|20334880|P1|STARTED|Phase II (MTD)||0
8245961|NCT01897714|20334875|P6|NOT COMPLETED|Phase I (Dose Escalation)||0
8245962|NCT01897714|20334876|P5|NOT COMPLETED|Phase I (Dose Escalation)||0
8245963|NCT01897714|20334877|P4|NOT COMPLETED|Phase I (Dose Escalation)||6
8245964|NCT01897714|20334878|P3|NOT COMPLETED|Phase I (Dose Escalation)||5
8245965|NCT01897714|20334879|P2|NOT COMPLETED|Phase I (Dose Escalation)||7
8245966|NCT01897714|20334880|P1|NOT COMPLETED|Phase I (Dose Escalation)||3
8245967|NCT01897714|20334875|P6|COMPLETED|Phase I (Dose Escalation)||0
8245968|NCT01897714|20334876|P5|COMPLETED|Phase I (Dose Escalation)||0
8245969|NCT01897714|20334877|P4|COMPLETED|Phase I (Dose Escalation)||0
8245970|NCT01897714|20334878|P3|COMPLETED|Phase I (Dose Escalation)||1
8245971|NCT01897714|20334879|P2|COMPLETED|Phase I (Dose Escalation)||0
8245972|NCT01897714|20334880|P1|COMPLETED|Phase I (Dose Escalation)||1
8245973|NCT01897714|20334875|P6|STARTED|Phase I (Dose Escalation)||0
8245974|NCT01897714|20334876|P5|STARTED|Phase I (Dose Escalation)||0
8245975|NCT01897714|20334877|P4|STARTED|Phase I (Dose Escalation)||6
8245976|NCT01897714|20334878|P3|STARTED|Phase I (Dose Escalation)||6
8245977|NCT01897714|20334879|P2|STARTED|Phase I (Dose Escalation)||7
8245978|NCT01897714|20334880|P1|STARTED|Phase I (Dose Escalation)||4
8245979|NCT01897532|20334926|P2|NOT COMPLETED|Discontinuation From Trial||41
8245980|NCT01897532|20334927|P1|NOT COMPLETED|Discontinuation From Trial||62
8245981|NCT01897532|20334926|P2|COMPLETED|Discontinuation From Trial||3458
8245982|NCT01897532|20334927|P1|COMPLETED|Discontinuation From Trial||3430
8245983|NCT01897532|20334926|P2|Treated|Discontinuation From Trial||3494
8245984|NCT01897532|20334927|P1|Treated|Discontinuation From Trial||3485
8245985|NCT01897532|20334926|P2|STARTED|Discontinuation From Trial||3499
8245986|NCT01897532|20334927|P1|STARTED|Discontinuation From Trial||3492
8245987|NCT01897532|20334926|P2|NOT COMPLETED|Discontinuation From Treatment||839
8245988|NCT01897532|20334927|P1|NOT COMPLETED|Discontinuation From Treatment||962
8245989|NCT01897532|20334926|P2|COMPLETED|Discontinuation From Treatment||2660
8245990|NCT01897532|20334927|P1|COMPLETED|Discontinuation From Treatment||2530
8245991|NCT01897532|20334926|P2|Treated|Discontinuation From Treatment||3494
8245992|NCT01897532|20334927|P1|Treated|Discontinuation From Treatment||3485
8245993|NCT01897532|20334926|P2|STARTED|Discontinuation From Treatment||3499
8245994|NCT01897532|20334927|P1|STARTED|Discontinuation From Treatment||3492
8245995|NCT01897493|20334935|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
8245996|NCT01897493|20334935|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
8245997|NCT01897493|20334935|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
8245998|NCT01897493|20334935|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
8245999|NCT01897493|20334935|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
8246000|NCT01897493|20334935|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
8246093|NCT01896726|20335113|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
8246001|NCT01897493|20334935|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
8246002|NCT01897493|20334935|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
8246003|NCT01897402|20334950|P2|NOT COMPLETED|Overall Study||16
8246004|NCT01897402|20334951|P1|NOT COMPLETED|Overall Study||19
8246005|NCT01897402|20334950|P2|COMPLETED|Overall Study||244
8246006|NCT01897402|20334951|P1|COMPLETED|Overall Study||246
8246007|NCT01897402|20334950|P2|STARTED|Overall Study||260
8246008|NCT01897402|20334951|P1|STARTED|Overall Study||265
8246009|NCT01897285|20334963|P1|NOT COMPLETED|Overall Study||0
8246010|NCT01897285|20334963|P1|COMPLETED|Overall Study||20
8246011|NCT01897285|20334963|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
8246012|NCT01897233|20334971|P1|NOT COMPLETED|Part B (24 Weeks)||4
8246013|NCT01897233|20334971|P1|COMPLETED|Part B (24 Weeks)||54
8246014|NCT01897233|20334971|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
8246015|NCT01897233|20334971|P1|NOT COMPLETED|Part A (14 Days)||0
8246016|NCT01897233|20334971|P1|COMPLETED|Part A (14 Days)||10
8246017|NCT01897233|20334971|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
8246018|NCT01897233|20334971|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
8246019|NCT01897233|20334971|P1|STARTED|Part A (14 Days)||10
8246020|NCT01897077|20334995|P2|NOT COMPLETED|Overall Study||0
8246021|NCT01897077|20334996|P1|NOT COMPLETED|Overall Study||0
8246022|NCT01897077|20334995|P2|COMPLETED|Overall Study||5
8246023|NCT01897077|20334996|P1|COMPLETED|Overall Study||0
8246024|NCT01897077|20334995|P2|STARTED|Overall Study||5
8246025|NCT01897077|20334996|P1|STARTED|Overall Study||0
8246026|NCT01897025|20335014|P2|NOT COMPLETED|Overall Study||0
8246027|NCT01897025|20335015|P1|NOT COMPLETED|Overall Study||0
8246028|NCT01897025|20335014|P2|COMPLETED|Overall Study||9
8246029|NCT01897025|20335015|P1|COMPLETED|Overall Study||10
8246030|NCT01897025|20335014|P2|STARTED|Overall Study||9
8246031|NCT01897025|20335015|P1|STARTED|Overall Study||10
8246032|NCT01896986|20335023|P2|NOT COMPLETED|Overall Study||23
8246033|NCT01896986|20335024|P1|NOT COMPLETED|Overall Study||14
8246034|NCT01896986|20335023|P2|COMPLETED|Overall Study||0
8246035|NCT01896986|20335024|P1|COMPLETED|Overall Study||0
8246036|NCT01896986|20335023|P2|STARTED|Overall Study||23
8246037|NCT01896986|20335024|P1|STARTED|Overall Study||14
8246038|NCT01896934|20335030|P1|NOT COMPLETED|Overall Study||2
8246039|NCT01896934|20335030|P1|COMPLETED|Overall Study||19
8246040|NCT01896934|20335030|P1|STARTED|Overall Study||21
8246041|NCT01896921|20335036|P1|NOT COMPLETED|Overall Study||2
8246042|NCT01896921|20335036|P1|COMPLETED|Overall Study||5
8246043|NCT01896921|20335036|P1|STARTED|Overall Study||7
8246044|NCT01896895|20335043|P4|NOT COMPLETED|OLEX Period||0
8246045|NCT01896895|20335044|P3|NOT COMPLETED|OLEX Period||0
8246046|NCT01896895|20335045|P2|NOT COMPLETED|OLEX Period||0
8246047|NCT01896895|20335046|P1|NOT COMPLETED|OLEX Period||0
8246048|NCT01896895|20335043|P4|COMPLETED|OLEX Period||39
8246049|NCT01896895|20335044|P3|COMPLETED|OLEX Period||0
8246050|NCT01896895|20335045|P2|COMPLETED|OLEX Period||0
8246051|NCT01896895|20335046|P1|COMPLETED|OLEX Period||0
8246052|NCT01896895|20335043|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
8246053|NCT01896895|20335044|P3|STARTED|OLEX Period||0
8246054|NCT01896895|20335045|P2|STARTED|OLEX Period||0
8246055|NCT01896895|20335046|P1|STARTED|OLEX Period||0
8246056|NCT01896895|20335043|P4|NOT COMPLETED|Double-blind MP||0
8246057|NCT01896895|20335044|P3|NOT COMPLETED|Double-blind MP||3
8246058|NCT01896895|20335045|P2|NOT COMPLETED|Double-blind MP||2
8246059|NCT01896895|20335046|P1|NOT COMPLETED|Double-blind MP||1
8246060|NCT01896895|20335043|P4|COMPLETED|Double-blind MP||0
8246061|NCT01896895|20335044|P3|COMPLETED|Double-blind MP||16
8246062|NCT01896895|20335045|P2|COMPLETED|Double-blind MP||20
8246063|NCT01896895|20335046|P1|COMPLETED|Double-blind MP||19
8246064|NCT01896895|20335043|P4|STARTED|Double-blind MP||0
8246065|NCT01896895|20335044|P3|STARTED|Double-blind MP||19
8246066|NCT01896895|20335045|P2|STARTED|Double-blind MP||22
8246067|NCT01896895|20335046|P1|STARTED|Double-blind MP||20
8246068|NCT01896869|20335063|P2|NOT COMPLETED|Overall Study||6
8246069|NCT01896869|20335064|P1|NOT COMPLETED|Overall Study||1
8246070|NCT01896869|20335063|P2|COMPLETED|Overall Study||36
8246071|NCT01896869|20335064|P1|COMPLETED|Overall Study||40
8246072|NCT01896869|20335063|P2|STARTED|Overall Study||42
8246073|NCT01896869|20335064|P1|STARTED|Overall Study||41
8246074|NCT01896856|20335089|P6|NOT COMPLETED|Overall Study||0
8246075|NCT01896856|20335090|P5|NOT COMPLETED|Overall Study||0
8246076|NCT01896856|20335091|P4|NOT COMPLETED|Overall Study||0
8246077|NCT01896856|20335092|P3|NOT COMPLETED|Overall Study||1
8246078|NCT01896856|20335093|P2|NOT COMPLETED|Overall Study||0
8246079|NCT01896856|20335094|P1|NOT COMPLETED|Overall Study||0
8246080|NCT01896856|20335089|P6|COMPLETED|Overall Study||34
8246081|NCT01896856|20335090|P5|COMPLETED|Overall Study||62
8246082|NCT01896856|20335091|P4|COMPLETED|Overall Study||6
8246083|NCT01896856|20335092|P3|COMPLETED|Overall Study||6
8246084|NCT01896856|20335093|P2|COMPLETED|Overall Study||3
8246085|NCT01896856|20335094|P1|COMPLETED|Overall Study||6
8246086|NCT01896856|20335089|P6|STARTED|Overall Study||34
8246087|NCT01896856|20335090|P5|STARTED|Overall Study||62
8246088|NCT01896856|20335091|P4|STARTED|Overall Study||6
8246089|NCT01896856|20335092|P3|STARTED|Overall Study||7
8246090|NCT01896856|20335093|P2|STARTED|Overall Study||3
8246091|NCT01896856|20335094|P1|STARTED|Overall Study||6
8246092|NCT01896726|20335113|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
8246094|NCT01896726|20335113|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
8246095|NCT01896726|20335113|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
8246096|NCT01896726|20335113|P1|STARTED|Treatment Period 2 (Days 23-31)||20
8246097|NCT01896726|20335113|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
8246098|NCT01896726|20335113|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
8246099|NCT01896726|20335113|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
8246100|NCT01896726|20335113|P1|STARTED|Treatment Period 1 (Days 1-22)||20
8246101|NCT01896700|20335128|P2|NOT COMPLETED|Overall Study||6
8246102|NCT01896700|20335129|P1|NOT COMPLETED|Overall Study||4
8246103|NCT01896700|20335128|P2|COMPLETED|Overall Study||6
8246104|NCT01896700|20335129|P1|COMPLETED|Overall Study||8
8246105|NCT01896700|20335128|P2|STARTED|Overall Study||12
8246106|NCT01896700|20335129|P1|STARTED|Overall Study||12
8246107|NCT01896687|20335151|P2|NOT COMPLETED|Overall Study||0
8246108|NCT01896687|20335152|P1|NOT COMPLETED|Overall Study||0
8246109|NCT01896687|20335151|P2|COMPLETED|Overall Study||15
8246110|NCT01896687|20335152|P1|COMPLETED|Overall Study||15
8246111|NCT01896687|20335151|P2|STARTED|Overall Study||15
8246112|NCT01896687|20335152|P1|STARTED|Overall Study||15
8246113|NCT01896557|20335160|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
8246114|NCT01896557|20335161|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
8246115|NCT01896557|20335160|P2|COMPLETED|Clopidogrel + GI Protector||44
8246116|NCT01896557|20335161|P1|COMPLETED|Clopidogrel + GI Protector||41
8246117|NCT01896557|20335160|P2|STARTED|Clopidogrel + GI Protector||48
8246118|NCT01896557|20335161|P1|STARTED|Clopidogrel + GI Protector||43
8246119|NCT01896557|20335160|P2|NOT COMPLETED|Clopidogrel Alone||0
8246120|NCT01896557|20335161|P1|NOT COMPLETED|Clopidogrel Alone||1
8246121|NCT01896557|20335160|P2|COMPLETED|Clopidogrel Alone||48
8246122|NCT01896557|20335161|P1|COMPLETED|Clopidogrel Alone||43
8246123|NCT01896557|20335160|P2|STARTED|Clopidogrel Alone||48
8246124|NCT01896557|20335161|P1|STARTED|Clopidogrel Alone||44
8246125|NCT01896544|20335176|P3|NOT COMPLETED|Overall Study||0
8246126|NCT01896544|20335177|P2|NOT COMPLETED|Overall Study||0
8246127|NCT01896544|20335178|P1|NOT COMPLETED|Overall Study||0
8246128|NCT01896544|20335176|P3|COMPLETED|Overall Study||10
8246129|NCT01896544|20335177|P2|COMPLETED|Overall Study||10
8246130|NCT01896544|20335178|P1|COMPLETED|Overall Study||10
8246131|NCT01896544|20335176|P3|STARTED|Overall Study||10
8246132|NCT01896544|20335177|P2|STARTED|Overall Study||10
8246133|NCT01896544|20335178|P1|STARTED|Overall Study||10
8246134|NCT01896297|20335198|P1|NOT COMPLETED|Overall Study||1
8246135|NCT01896297|20335198|P1|COMPLETED|Overall Study||59
8246136|NCT01896297|20335198|P1|STARTED|Overall Study||60
8246137|NCT01896232|20335205|P2|NOT COMPLETED|Overall Study||53
8246138|NCT01896232|20335206|P1|NOT COMPLETED|Overall Study||49
8246139|NCT01896232|20335205|P2|COMPLETED|Overall Study||287
8246140|NCT01896232|20335206|P1|COMPLETED|Overall Study||294
8246141|NCT01896232|20335205|P2|Received Treatment|Overall Study||338
8246142|NCT01896232|20335206|P1|Received Treatment|Overall Study||341
8246143|NCT01896232|20335205|P2|STARTED|Overall Study||340
8246144|NCT01896232|20335206|P1|STARTED|Overall Study||343
8246145|NCT01896206|20335226|P1|NOT COMPLETED|Overall Study||0
8246146|NCT01896206|20335226|P1|COMPLETED|Overall Study||21
8246147|NCT01896206|20335226|P1|STARTED|Overall Study||21
8246148|NCT01896193|20335234|P2|NOT COMPLETED|Overall Study||12
8246149|NCT01896193|20335235|P1|NOT COMPLETED|Overall Study||21
8246150|NCT01896193|20335234|P2|COMPLETED|Overall Study||53
8246151|NCT01896193|20335235|P1|COMPLETED|Overall Study||41
8246152|NCT01896193|20335234|P2|STARTED|Overall Study||65
8246153|NCT01896193|20335235|P1|STARTED|Overall Study||62
8246154|NCT01896128|20335261|P2|NOT COMPLETED|Overall Study||3
8246155|NCT01896128|20335262|P1|NOT COMPLETED|Overall Study||3
8246156|NCT01896128|20335261|P2|COMPLETED|Overall Study||8
8246157|NCT01896128|20335262|P1|COMPLETED|Overall Study||5
8246158|NCT01896128|20335261|P2|STARTED|Overall Study||11
8246159|NCT01896128|20335262|P1|STARTED|Overall Study||8
8246160|NCT01896115|20335278|P2|NOT COMPLETED|Overall Study||0
8246161|NCT01896115|20335279|P1|NOT COMPLETED|Overall Study||1
8246162|NCT01896115|20335278|P2|COMPLETED|Overall Study||24
8246163|NCT01896115|20335279|P1|COMPLETED|Overall Study||15
8246164|NCT01896115|20335278|P2|Phase 2 Steering|Overall Study||24
8246165|NCT01896115|20335279|P1|Phase 2 Steering|Overall Study||0
8246166|NCT01896115|20335278|P2|Phase 2 Single Contact|Overall Study||24
8246167|NCT01896115|20335279|P1|Phase 2 Single Contact|Overall Study||0
8246168|NCT01896115|20335278|P2|Phase 1 Ventral Steering|Overall Study||0
8246169|NCT01896115|20335279|P1|Phase 1 Ventral Steering|Overall Study||15
8246170|NCT01896115|20335278|P2|Phase 1 Dorsal Steering|Overall Study||0
8246171|NCT01896115|20335279|P1|Phase 1 Dorsal Steering|Overall Study||15
8246172|NCT01896115|20335278|P2|Phase 1 Conventional PW|Overall Study||0
8246173|NCT01896115|20335279|P1|Phase 1 Conventional PW|Overall Study||15
8246174|NCT01896115|20335278|P2|Phase 1 Short PW|Overall Study||0
8246175|NCT01896115|20335279|P1|Phase 1 Short PW|Overall Study||15
8246176|NCT01896115|20335278|P2|STARTED|Overall Study||24
8246177|NCT01896115|20335279|P1|STARTED|Overall Study||16
8246178|NCT01896050|20335304|P2|NOT COMPLETED|Overall Study||2
8246179|NCT01896050|20335305|P1|NOT COMPLETED|Overall Study||38
8246180|NCT01896050|20335304|P2|COMPLETED|Overall Study||20
8246181|NCT01896050|20335305|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
8246182|NCT01896050|20335304|P2|STARTED|Overall Study||22
8246183|NCT01896050|20335305|P1|STARTED|Overall Study||93
8246184|NCT01895972|20335315|P1|NOT COMPLETED|Overall Study||9
8246185|NCT01895972|20335315|P1|COMPLETED|Overall Study||121
8246186|NCT01895972|20335315|P1|STARTED|Overall Study||130
8246187|NCT01895959|20335320|P1|NOT COMPLETED|Overall Study||2
8246188|NCT01895959|20335320|P1|COMPLETED|Overall Study||10
8246189|NCT01895959|20335320|P1|STARTED|Overall Study||12
8246190|NCT01895946|20335328|P2|NOT COMPLETED|Overall Study||0
8246191|NCT01895946|20335329|P1|NOT COMPLETED|Overall Study||0
8246192|NCT01895946|20335328|P2|COMPLETED|Overall Study||12
8246193|NCT01895946|20335329|P1|COMPLETED|Overall Study||18
8246194|NCT01895946|20335328|P2|STARTED|Overall Study||12
8246195|NCT01895946|20335329|P1|STARTED|Overall Study||18
8246196|NCT01895777|20335349|P2|NOT COMPLETED|Overall Study||5
8246197|NCT01895777|20335350|P1|NOT COMPLETED|Overall Study||9
8246198|NCT01895777|20335349|P2|COMPLETED|Overall Study||85
8246199|NCT01895777|20335350|P1|COMPLETED|Overall Study||168
8246200|NCT01895777|20335349|P2|Treated|Overall Study||90
8246201|NCT01895777|20335350|P1|Treated|Overall Study||176
8246202|NCT01895777|20335349|P2|STARTED|Overall Study||90
8246203|NCT01895777|20335350|P1|STARTED|Overall Study||177
8246204|NCT01895647|20335378|P3|NOT COMPLETED|Overall Study||0
8246205|NCT01895647|20335379|P2|NOT COMPLETED|Overall Study||0
8246206|NCT01895647|20335380|P1|NOT COMPLETED|Overall Study||0
8246207|NCT01895647|20335378|P3|COMPLETED|Overall Study||7
8246208|NCT01895647|20335379|P2|COMPLETED|Overall Study||10
8246209|NCT01895647|20335380|P1|COMPLETED|Overall Study||8
8246210|NCT01895647|20335378|P3|STARTED|Overall Study||7
8246211|NCT01895647|20335379|P2|STARTED|Overall Study||10
8246212|NCT01895647|20335380|P1|STARTED|Overall Study||8
8246213|NCT01895634|20335394|P1|NOT COMPLETED|Overall Study||3
8246214|NCT01895634|20335394|P1|COMPLETED|Overall Study||46
8246215|NCT01895634|20335394|P1|STARTED|Overall Study||49
8246216|NCT01895608|20335406|P4|NOT COMPLETED|Overall Study||0
8246217|NCT01895608|20335407|P3|NOT COMPLETED|Overall Study||3
8246218|NCT01895608|20335408|P2|NOT COMPLETED|Overall Study||1
8246219|NCT01895608|20335409|P1|NOT COMPLETED|Overall Study||0
8246220|NCT01895608|20335406|P4|COMPLETED|Overall Study||6
8246221|NCT01895608|20335407|P3|COMPLETED|Overall Study||8
8246222|NCT01895608|20335408|P2|COMPLETED|Overall Study||6
8246223|NCT01895608|20335409|P1|COMPLETED|Overall Study||10
8246224|NCT01895608|20335406|P4|STARTED|Overall Study||6
8246225|NCT01895608|20335407|P3|STARTED|Overall Study||11
8246226|NCT01895608|20335408|P2|STARTED|Overall Study||7
8246227|NCT01895608|20335409|P1|STARTED|Overall Study||10
8246228|NCT01895543|20335439|P1|NOT COMPLETED|Overall Study||129
8246229|NCT01895543|20335439|P1|COMPLETED|Overall Study||282
8246230|NCT01895543|20335439|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
8246231|NCT01895543|20335439|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
8246232|NCT01895543|20335439|P1|STARTED|Overall Study||411
8246233|NCT01895452|20335455|P2|NOT COMPLETED|Overall Study||28
8246234|NCT01895452|20335456|P1|NOT COMPLETED|Overall Study||4
8246235|NCT01895452|20335455|P2|COMPLETED|Overall Study||198
8246236|NCT01895452|20335456|P1|COMPLETED|Overall Study||61
8246237|NCT01895452|20335455|P2|STARTED|Overall Study||226
8246238|NCT01895452|20335456|P1|STARTED|Overall Study||65
8246239|NCT01895361|20335469|P3|NOT COMPLETED|Overall Study||24
8246240|NCT01895361|20335470|P2|NOT COMPLETED|Overall Study||21
8246241|NCT01895361|20335471|P1|NOT COMPLETED|Overall Study||24
8246242|NCT01895361|20335469|P3|COMPLETED|Overall Study||41
8246243|NCT01895361|20335470|P2|COMPLETED|Overall Study||45
8246244|NCT01895361|20335471|P1|COMPLETED|Overall Study||43
8246245|NCT01895361|20335469|P3|STARTED|Overall Study||65
8246246|NCT01895361|20335470|P2|STARTED|Overall Study||66
8246247|NCT01895361|20335471|P1|STARTED|Overall Study||67
8246248|NCT01895335|20335500|P1|NOT COMPLETED|Overall Study||215
8246249|NCT01895335|20335500|P1|COMPLETED|Overall Study||786
8246250|NCT01895335|20335500|P1|Treated|Overall Study||1000
8246251|NCT01895335|20335500|P1|STARTED|Overall Study||1001
8246252|NCT01895322|20335517|P1|NOT COMPLETED|Overall Study||13
8246253|NCT01895322|20335517|P1|COMPLETED|Overall Study||7
8246254|NCT01895322|20335517|P1|STARTED|Overall Study||20
8246255|NCT01895309|20335526|P2|NOT COMPLETED|Overall Study||51
8246256|NCT01895309|20335527|P1|NOT COMPLETED|Overall Study||40
8246257|NCT01895309|20335526|P2|COMPLETED|Overall Study||246
8246258|NCT01895309|20335527|P1|COMPLETED|Overall Study||259
8246259|NCT01895309|20335526|P2|STARTED|Overall Study||297
8246260|NCT01895309|20335527|P1|STARTED|Overall Study||299
8246261|NCT01895270|20335541|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
8246262|NCT01895270|20335542|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
8246263|NCT01895270|20335541|P2|COMPLETED|Isradipine Taper (W7-8)||0
8246264|NCT01895270|20335542|P1|COMPLETED|Isradipine Taper (W7-8)||2
8246265|NCT01895270|20335541|P2|STARTED|Isradipine Taper (W7-8)||2
8246266|NCT01895270|20335542|P1|STARTED|Isradipine Taper (W7-8)||2
8246267|NCT01895270|20335541|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
8246268|NCT01895270|20335542|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
8246269|NCT01895270|20335541|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
8246270|NCT01895270|20335542|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
8246271|NCT01895270|20335541|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
8246272|NCT01895270|20335542|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
8246273|NCT01895270|20335541|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
8246274|NCT01895270|20335542|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
8246275|NCT01895270|20335541|P2|COMPLETED|Study Medications Induction (W1-4)||8
8246276|NCT01895270|20335542|P1|COMPLETED|Study Medications Induction (W1-4)||5
8246277|NCT01895270|20335541|P2|STARTED|Study Medications Induction (W1-4)||14
8246278|NCT01895270|20335542|P1|STARTED|Study Medications Induction (W1-4)||11
8246279|NCT01895127|20335550|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
8246280|NCT01895127|20335551|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
8246281|NCT01895127|20335550|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
8246282|NCT01895127|20335551|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
8246283|NCT01895127|20335550|P2|STARTED|Long Term Follow-up (Month 3-12)||7
8246284|NCT01895127|20335551|P1|STARTED|Long Term Follow-up (Month 3-12)||3
8246285|NCT01895127|20335550|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
8246286|NCT01895127|20335551|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
8246287|NCT01895127|20335550|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
8246288|NCT01895127|20335551|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
8246289|NCT01895127|20335550|P2|STARTED|Month 3 Follow-up & Biopsy||7
8246290|NCT01895127|20335551|P1|STARTED|Month 3 Follow-up & Biopsy||3
8246291|NCT01895127|20335550|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
8246292|NCT01895127|20335551|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
8246293|NCT01895127|20335550|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
8246294|NCT01895127|20335551|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
8246295|NCT01895127|20335550|P2|STARTED|Treatment Period (Week 0-Month 3)||7
8246296|NCT01895127|20335551|P1|STARTED|Treatment Period (Week 0-Month 3)||3
8246297|NCT01895127|20335550|P2|NOT COMPLETED|Screening||0
8246298|NCT01895127|20335551|P1|NOT COMPLETED|Screening||0
8246299|NCT01895127|20335550|P2|COMPLETED|Screening||7
8246300|NCT01895127|20335551|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
8246301|NCT01895127|20335550|P2|STARTED|Screening||7
8246302|NCT01895127|20335551|P1|STARTED|Screening||4
8246303|NCT01895101|20335561|P3|NOT COMPLETED|Overall Study||5
8246304|NCT01895101|20335562|P2|NOT COMPLETED|Overall Study||5
8246305|NCT01895101|20335563|P1|NOT COMPLETED|Overall Study||1
8246306|NCT01895101|20335561|P3|COMPLETED|Overall Study||245
8246307|NCT01895101|20335562|P2|COMPLETED|Overall Study||245
8246308|NCT01895101|20335563|P1|COMPLETED|Overall Study||249
8246309|NCT01895101|20335561|P3|STARTED|Overall Study||250
8246310|NCT01895101|20335562|P2|STARTED|Overall Study||250
8246311|NCT01895101|20335563|P1|STARTED|Overall Study||250
8246312|NCT01895088|20335577|P1|NOT COMPLETED|Overall Study||18
8246313|NCT01895088|20335577|P1|COMPLETED|Overall Study||253
8246314|NCT01895088|20335577|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
8246315|NCT01895062|20335583|P2|NOT COMPLETED|Overall Study||0
8246316|NCT01895062|20335584|P1|NOT COMPLETED|Overall Study||0
8246317|NCT01895062|20335583|P2|COMPLETED|Overall Study||24
8246318|NCT01895062|20335584|P1|COMPLETED|Overall Study||30
8246319|NCT01895062|20335583|P2|STARTED|Overall Study||24
8246320|NCT01895062|20335584|P1|STARTED|Overall Study||30
8246321|NCT01895036|20335592|P1|NOT COMPLETED|Overall Study||0
8246322|NCT01895036|20335592|P1|COMPLETED|Overall Study||6
8246323|NCT01895036|20335592|P1|STARTED|Overall Study||6
8246324|NCT01894984|20335598|P2|NOT COMPLETED|Overall Study||175
8246325|NCT01894984|20335599|P1|NOT COMPLETED|Overall Study||314
8246326|NCT01894984|20335598|P2|COMPLETED|Overall Study||69
8246327|NCT01894984|20335599|P1|COMPLETED|Overall Study||82
8246328|NCT01894984|20335598|P2|STARTED|Overall Study||244
8246329|NCT01894984|20335599|P1|STARTED|Overall Study||396
8246330|NCT01894919|20335628|P13|NOT COMPLETED|Overall Study||0
8246331|NCT01894919|20335629|P12|NOT COMPLETED|Overall Study||0
8246332|NCT01894919|20335630|P11|NOT COMPLETED|Overall Study||2
8246333|NCT01894919|20335631|P10|NOT COMPLETED|Overall Study||1
8246334|NCT01894919|20335632|P9|NOT COMPLETED|Overall Study||0
8246335|NCT01894919|20335633|P8|NOT COMPLETED|Overall Study||0
8246336|NCT01894919|20335634|P7|NOT COMPLETED|Overall Study||0
8246337|NCT01894919|20335635|P6|NOT COMPLETED|Overall Study||0
8246338|NCT01894919|20335636|P5|NOT COMPLETED|Overall Study||3
8246339|NCT01894919|20335637|P4|NOT COMPLETED|Overall Study||0
8246340|NCT01894919|20335638|P3|NOT COMPLETED|Overall Study||0
8246341|NCT01894919|20335639|P2|NOT COMPLETED|Overall Study||0
8246342|NCT01894919|20335640|P1|NOT COMPLETED|Overall Study||2
8246343|NCT01894919|20335628|P13|COMPLETED|Overall Study||50
8246344|NCT01894919|20335629|P12|COMPLETED|Overall Study||55
8246345|NCT01894919|20335630|P11|COMPLETED|Overall Study||98
8246346|NCT01894919|20335631|P10|COMPLETED|Overall Study||89
8246347|NCT01894919|20335632|P9|COMPLETED|Overall Study||91
8246348|NCT01894919|20335633|P8|COMPLETED|Overall Study||36
8246349|NCT01894919|20335634|P7|COMPLETED|Overall Study||32
8246350|NCT01894919|20335635|P6|COMPLETED|Overall Study||39
8246351|NCT01894919|20335636|P5|COMPLETED|Overall Study||78
8246352|NCT01894919|20335637|P4|COMPLETED|Overall Study||43
8246353|NCT01894919|20335638|P3|COMPLETED|Overall Study||89
8246354|NCT01894919|20335639|P2|COMPLETED|Overall Study||47
8246355|NCT01894919|20335640|P1|COMPLETED|Overall Study||96
8246356|NCT01894919|20335628|P13|STARTED|Overall Study||50
8246357|NCT01894919|20335629|P12|STARTED|Overall Study||55
8246358|NCT01894919|20335630|P11|STARTED|Overall Study||100
8246359|NCT01894919|20335631|P10|STARTED|Overall Study||90
8246360|NCT01894919|20335632|P9|STARTED|Overall Study||91
8246361|NCT01894919|20335633|P8|STARTED|Overall Study||36
8246362|NCT01894919|20335634|P7|STARTED|Overall Study||32
8246363|NCT01894919|20335635|P6|STARTED|Overall Study||39
8246364|NCT01894919|20335636|P5|STARTED|Overall Study||81
8246365|NCT01894919|20335637|P4|STARTED|Overall Study||43
8246366|NCT01894919|20335638|P3|STARTED|Overall Study||89
8246367|NCT01894919|20335639|P2|STARTED|Overall Study||47
8246368|NCT01894919|20335640|P1|STARTED|Overall Study||98
8246369|NCT01894906|20335762|P2|NOT COMPLETED|Overall Study||0
8246370|NCT01894906|20335763|P1|NOT COMPLETED|Overall Study||0
8246371|NCT01894906|20335762|P2|COMPLETED|Overall Study||6
8246372|NCT01894906|20335763|P1|COMPLETED|Overall Study||6
8246373|NCT01894906|20335762|P2|Treatment F|Overall Study||6
8246374|NCT01894906|20335763|P1|Treatment F|Overall Study||6
8246375|NCT01894906|20335762|P2|Treatment E|Overall Study||6
8246376|NCT01894906|20335763|P1|Treatment E|Overall Study||6
8246377|NCT01894906|20335762|P2|Treatment D|Overall Study||6
8246378|NCT01894906|20335763|P1|Treatment D|Overall Study||6
8246379|NCT01894906|20335762|P2|Treatment C|Overall Study||6
8246380|NCT01894906|20335763|P1|Treatment C|Overall Study||6
8246381|NCT01894906|20335762|P2|Treatment B|Overall Study||6
8246382|NCT01894906|20335763|P1|Treatment B|Overall Study||6
8246383|NCT01894906|20335762|P2|Treatment A|Overall Study||6
8246384|NCT01894906|20335763|P1|Treatment A|Overall Study||6
8246385|NCT01894906|20335762|P2|STARTED|Overall Study||6
8246386|NCT01894906|20335763|P1|STARTED|Overall Study||6
8246387|NCT01894841|20335795|P2|NOT COMPLETED|Overall Study||9
8246388|NCT01894841|20335796|P1|NOT COMPLETED|Overall Study||18
8246389|NCT01894841|20335795|P2|COMPLETED|Overall Study||44
8246390|NCT01894841|20335796|P1|COMPLETED|Overall Study||34
8246391|NCT01894841|20335795|P2|STARTED|Overall Study||53
8246392|NCT01894841|20335796|P1|STARTED|Overall Study||52
8246393|NCT01894776|20335812|P1|NOT COMPLETED|Overall Study||1
8246394|NCT01894776|20335812|P1|COMPLETED|Overall Study||14
8246395|NCT01894776|20335812|P1|STARTED|Overall Study||15
8246396|NCT01894672|20335818|P1|NOT COMPLETED|Overall Study||0
8246397|NCT01894672|20335818|P1|COMPLETED|Overall Study||7
8246398|NCT01894672|20335818|P1|STARTED|Overall Study||7
8246405|NCT01894607|20335835|P1|NOT COMPLETED|Overall Study||1
8246406|NCT01894607|20335835|P1|COMPLETED|Overall Study||10
8246407|NCT01894607|20335835|P1|STARTED|Overall Study||11
8246408|NCT01894581|20335842|P2|NOT COMPLETED|Overall Study||7
8246409|NCT01894581|20335843|P1|NOT COMPLETED|Overall Study||5
8246410|NCT01894581|20335842|P2|COMPLETED|Overall Study||12
8246411|NCT01894581|20335843|P1|COMPLETED|Overall Study||15
8246412|NCT01894581|20335842|P2|STARTED|Overall Study||19
8246413|NCT01894581|20335843|P1|STARTED|Overall Study||20
8246414|NCT01894568|20335851|P2|NOT COMPLETED|Overall Study||10
8246415|NCT01894568|20335852|P1|NOT COMPLETED|Overall Study||10
8246416|NCT01894568|20335851|P2|COMPLETED|Overall Study||186
8246417|NCT01894568|20335852|P1|COMPLETED|Overall Study||182
8246418|NCT01894568|20335851|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
8246419|NCT01894568|20335852|P1|Received at Least 1 Dose of Study Drug|Overall Study||192
8246420|NCT01894568|20335851|P2|STARTED|Overall Study||196
8246421|NCT01894568|20335852|P1|STARTED|Overall Study||192
8246422|NCT01894555|20335892|P1|NOT COMPLETED|Overall Study||0
8246423|NCT01894555|20335892|P1|COMPLETED|Overall Study||33
8246424|NCT01894555|20335892|P1|STARTED|Overall Study||33
8246425|NCT01894516|20335900|P4|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
8246426|NCT01894516|20335901|P3|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
8246427|NCT01894516|20335902|P2|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8246428|NCT01894516|20335903|P1|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
8246429|NCT01894516|20335900|P4|COMPLETED|Period 2 (Week 13 to Week 24)||65
8246430|NCT01894516|20335901|P3|COMPLETED|Period 2 (Week 13 to Week 24)||142
8246431|NCT01894516|20335902|P2|COMPLETED|Period 2 (Week 13 to Week 24)||50
8246432|NCT01894516|20335903|P1|COMPLETED|Period 2 (Week 13 to Week 24)||0
8246433|NCT01894516|20335900|P4|STARTED|Period 2 (Week 13 to Week 24)||66
8246434|NCT01894516|20335901|P3|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
8246435|NCT01894516|20335902|P2|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
8246436|NCT01894516|20335903|P1|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
8246437|NCT01894516|20335900|P4|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8246438|NCT01894516|20335901|P3|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8246439|NCT01894516|20335902|P2|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
8246440|NCT01894516|20335903|P1|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
8246441|NCT01894516|20335900|P4|COMPLETED|Period 1 (Baseline up to Week 12)||66
8246442|NCT01894516|20335901|P3|COMPLETED|Period 1 (Baseline up to Week 12)||67
8246443|NCT01894516|20335902|P2|COMPLETED|Period 1 (Baseline up to Week 12)||67
8246444|NCT01894516|20335903|P1|COMPLETED|Period 1 (Baseline up to Week 12)||65
8246445|NCT01894516|20335900|P4|STARTED|Period 1 (Baseline up to Week 12)||69
8246446|NCT01894516|20335901|P3|STARTED|Period 1 (Baseline up to Week 12)||70
8246447|NCT01894516|20335902|P2|STARTED|Period 1 (Baseline up to Week 12)||72
8246448|NCT01894516|20335903|P1|STARTED|Period 1 (Baseline up to Week 12)||72
8246449|NCT01894503|20335952|P1|NOT COMPLETED|Overall Study||0
8246450|NCT01894503|20335952|P1|COMPLETED|Overall Study||5
8246451|NCT01894503|20335952|P1|STARTED|Overall Study||5
8246452|NCT01894477|20335959|P2|NOT COMPLETED|Overall Study||2
8246453|NCT01894477|20335960|P1|NOT COMPLETED|Overall Study||0
8246454|NCT01894477|20335959|P2|COMPLETED|Overall Study||65
8246455|NCT01894477|20335960|P1|COMPLETED|Overall Study||35
8246456|NCT01894477|20335959|P2|STARTED|Overall Study||67
8246457|NCT01894477|20335960|P1|STARTED|Overall Study||35
8246458|NCT01894256|20335971|P3|NOT COMPLETED|Part B||14
8246459|NCT01894256|20335972|P2|NOT COMPLETED|Part B||14
8246460|NCT01894256|20335973|P1|NOT COMPLETED|Part B||15
8246461|NCT01894256|20335971|P3|COMPLETED|Part B||0
8246462|NCT01894256|20335972|P2|COMPLETED|Part B||0
8246463|NCT01894256|20335973|P1|COMPLETED|Part B||0
8246464|NCT01894256|20335971|P3|STARTED|Part B||14
8246465|NCT01894256|20335972|P2|STARTED|Part B||14
8246466|NCT01894256|20335973|P1|STARTED|Part B||15
8246467|NCT01894256|20335971|P3|NOT COMPLETED|Part A||0
8246468|NCT01894256|20335972|P2|NOT COMPLETED|Part A||1
8246469|NCT01894256|20335973|P1|NOT COMPLETED|Part A||0
8246470|NCT01894256|20335971|P3|COMPLETED|Part A||14
8246471|NCT01894256|20335972|P2|COMPLETED|Part A||14
8246472|NCT01894256|20335973|P1|COMPLETED|Part A||15
8246473|NCT01894256|20335971|P3|STARTED|Part A||14
8246474|NCT01894256|20335972|P2|STARTED|Part A||15
8246475|NCT01894256|20335973|P1|STARTED|Part A||15
8246476|NCT01894243|20336020|P3|NOT COMPLETED|Overall Study||8
8246477|NCT01894243|20336021|P2|NOT COMPLETED|Overall Study||10
8246478|NCT01894243|20336022|P1|NOT COMPLETED|Overall Study||13
8246479|NCT01894243|20336020|P3|COMPLETED|Overall Study||0
8246480|NCT01894243|20336021|P2|COMPLETED|Overall Study||0
8246481|NCT01894243|20336022|P1|COMPLETED|Overall Study||0
8246482|NCT01894243|20336020|P3|Ongoing Into Part B|Overall Study||8
8246483|NCT01894243|20336021|P2|Ongoing Into Part B|Overall Study||10
8246484|NCT01894243|20336022|P1|Ongoing Into Part B|Overall Study||13
8246485|NCT01894243|20336020|P3|Completed Treatment in Part A|Overall Study||8
8246486|NCT01894243|20336021|P2|Completed Treatment in Part A|Overall Study||10
8246487|NCT01894243|20336022|P1|Completed Treatment in Part A|Overall Study||13
8246488|NCT01894243|20336020|P3|STARTED|Overall Study||8
8246489|NCT01894243|20336021|P2|STARTED|Overall Study||10
8246490|NCT01894243|20336022|P1|STARTED|Overall Study||13
8246491|NCT01894230|20336061|P2|NOT COMPLETED|Overall Study||7
8246492|NCT01894230|20336062|P1|NOT COMPLETED|Overall Study||7
8246493|NCT01894230|20336061|P2|COMPLETED|Overall Study||69
8246494|NCT01894230|20336062|P1|COMPLETED|Overall Study||76
8246495|NCT01894230|20336061|P2|STARTED|Overall Study||76
8246496|NCT01894230|20336062|P1|STARTED|Overall Study||83
8246497|NCT01894178|20336088|P2|NOT COMPLETED|Overall Study||0
8246498|NCT01894178|20336089|P1|NOT COMPLETED|Overall Study||0
8246499|NCT01894178|20336088|P2|COMPLETED|Overall Study||30
8246500|NCT01894178|20336089|P1|COMPLETED|Overall Study||30
8246501|NCT01894178|20336088|P2|STARTED|Overall Study||30
8246502|NCT01894178|20336089|P1|STARTED|Overall Study||30
8246503|NCT01894152|20336097|P1|NOT COMPLETED|Overall Study||151
8246504|NCT01894152|20336097|P1|COMPLETED|Overall Study||1851
8246505|NCT01894152|20336097|P1|STARTED|Overall Study||2002
8246506|NCT01894100|20336140|P2|NOT COMPLETED|Overall Study||1
8246507|NCT01894100|20336141|P1|NOT COMPLETED|Overall Study||3
8246508|NCT01894100|20336140|P2|COMPLETED|Overall Study||14
8246509|NCT01894100|20336141|P1|COMPLETED|Overall Study||12
8246510|NCT01894100|20336140|P2|STARTED|Overall Study||15
8246511|NCT01894100|20336141|P1|STARTED|Overall Study||15
8246512|NCT01894087|20336151|P2|NOT COMPLETED|Overall Study||0
8246513|NCT01894087|20336152|P1|NOT COMPLETED|Overall Study||6
8246514|NCT01894087|20336151|P2|COMPLETED|Overall Study||102
8246515|NCT01894087|20336152|P1|COMPLETED|Overall Study||96
8246516|NCT01894087|20336151|P2|STARTED|Overall Study||102
8246517|NCT01894087|20336152|P1|STARTED|Overall Study||102
8246518|NCT01894022|20336166|P2|NOT COMPLETED|Overall Study||10
8246519|NCT01894022|20336167|P1|NOT COMPLETED|Overall Study||9
8246520|NCT01894022|20336166|P2|COMPLETED|Overall Study||0
8246521|NCT01894022|20336167|P1|COMPLETED|Overall Study||0
8246522|NCT01894022|20336166|P2|STARTED|Overall Study||10
8246523|NCT01894022|20336167|P1|STARTED|Overall Study||9
8246524|NCT01893983|20336221|P2|NOT COMPLETED|Overall Study||6
8246525|NCT01893983|20336222|P1|NOT COMPLETED|Overall Study||10
8246526|NCT01893983|20336221|P2|COMPLETED|Overall Study||134
8246527|NCT01893983|20336222|P1|COMPLETED|Overall Study||130
8246528|NCT01893983|20336221|P2|STARTED|Overall Study||140
8246529|NCT01893983|20336222|P1|STARTED|Overall Study||140
8246530|NCT01893905|20336236|P2|NOT COMPLETED|Overall Study||14
8246531|NCT01893905|20336237|P1|NOT COMPLETED|Overall Study||25
8246532|NCT01893905|20336236|P2|COMPLETED|Overall Study||64
8246533|NCT01893905|20336237|P1|COMPLETED|Overall Study||55
8246534|NCT01893905|20336236|P2|STARTED|Overall Study||78
8246535|NCT01893905|20336237|P1|STARTED|Overall Study||80
8246536|NCT01893879|20336245|P2|NOT COMPLETED|Overall Study||3
8246537|NCT01893879|20336246|P1|NOT COMPLETED|Overall Study||2
8246538|NCT01893879|20336245|P2|COMPLETED|Overall Study||4
8246539|NCT01893879|20336246|P1|COMPLETED|Overall Study||5
8246540|NCT01893879|20336245|P2|STARTED|Overall Study||7
8246541|NCT01893879|20336246|P1|STARTED|Overall Study||7
8246542|NCT01893827|20336254|P2|NOT COMPLETED|Overall Study||26
8246543|NCT01893827|20336255|P1|NOT COMPLETED|Overall Study||19
8246544|NCT01893827|20336254|P2|COMPLETED|Overall Study||94
8246545|NCT01893827|20336255|P1|COMPLETED|Overall Study||98
8246546|NCT01893827|20336254|P2|STARTED|Overall Study||120
8246547|NCT01893827|20336255|P1|STARTED|Overall Study||117
8246548|NCT01893801|20336261|P1|NOT COMPLETED|Overall Study||0
8246549|NCT01893801|20336261|P1|COMPLETED|Overall Study||25
8246550|NCT01893801|20336261|P1|STARTED|Overall Study||25
8246551|NCT01893632|20336271|P2|NOT COMPLETED|Overall Study||0
8246552|NCT01893632|20336272|P1|NOT COMPLETED|Overall Study||0
8246553|NCT01893632|20336271|P2|COMPLETED|Overall Study||1
8246554|NCT01893632|20336272|P1|COMPLETED|Overall Study||1
8246555|NCT01893632|20336271|P2|STARTED|Overall Study||1
8246556|NCT01893632|20336272|P1|STARTED|Overall Study||1
8246557|NCT01893567|20336278|P1|NOT COMPLETED|Overall Study||0
8246558|NCT01893567|20336278|P1|COMPLETED|Overall Study||28
8246559|NCT01893567|20336278|P1|STARTED|Overall Study||28
8246560|NCT01893411|20336285|P3|NOT COMPLETED|Overall Study||9
8246561|NCT01893411|20336286|P2|NOT COMPLETED|Overall Study||7
8246562|NCT01893411|20336287|P1|NOT COMPLETED|Overall Study||17
8246563|NCT01893411|20336285|P3|COMPLETED|Overall Study||69
8246564|NCT01893411|20336286|P2|COMPLETED|Overall Study||70
8246565|NCT01893411|20336287|P1|COMPLETED|Overall Study||139
8246566|NCT01893411|20336285|P3|STARTED|Overall Study||78
8246567|NCT01893411|20336286|P2|STARTED|Overall Study||77
8246568|NCT01893411|20336287|P1|STARTED|Overall Study||156
8246569|NCT01893372|20336351|P2|NOT COMPLETED|Overall Study||0
8246570|NCT01893372|20336352|P1|NOT COMPLETED|Overall Study||0
8246571|NCT01893372|20336351|P2|COMPLETED|Overall Study||22
8246572|NCT01893372|20336352|P1|COMPLETED|Overall Study||7
8246573|NCT01893372|20336351|P2|STARTED|Overall Study||22
8246574|NCT01893372|20336352|P1|STARTED|Overall Study||7
8246575|NCT01893359|20336367|P3|NOT COMPLETED|Overall Study||0
8246576|NCT01893359|20336368|P2|NOT COMPLETED|Overall Study||0
8246577|NCT01893359|20336369|P1|NOT COMPLETED|Overall Study||0
8246578|NCT01893359|20336367|P3|COMPLETED|Overall Study||0
8246579|NCT01893359|20336368|P2|COMPLETED|Overall Study||2
8246580|NCT01893359|20336369|P1|COMPLETED|Overall Study||0
8246581|NCT01893359|20336367|P3|STARTED|Overall Study||0
8246582|NCT01893359|20336368|P2|STARTED|Overall Study||2
8246583|NCT01893359|20336369|P1|STARTED|Overall Study||0
8246584|NCT01893346|20336384|P4|NOT COMPLETED|Overall Study||0
8246585|NCT01893346|20336385|P3|NOT COMPLETED|Overall Study||0
8246586|NCT01893346|20336386|P2|NOT COMPLETED|Overall Study||1
8246587|NCT01893346|20336387|P1|NOT COMPLETED|Overall Study||3
8246588|NCT01893346|20336384|P4|COMPLETED|Overall Study||8
8246589|NCT01893346|20336385|P3|COMPLETED|Overall Study||8
8246590|NCT01893346|20336386|P2|COMPLETED|Overall Study||7
8246591|NCT01893346|20336387|P1|COMPLETED|Overall Study||8
8246592|NCT01893346|20336384|P4|Patients Who Received Full Infusion|Overall Study||8
8246593|NCT01893346|20336385|P3|Patients Who Received Full Infusion|Overall Study||8
8246594|NCT01893346|20336386|P2|Patients Who Received Full Infusion|Overall Study||8
8246595|NCT01893346|20336387|P1|Patients Who Received Full Infusion|Overall Study||8
8246596|NCT01893346|20336384|P4|STARTED|Overall Study||8
8246597|NCT01893346|20336385|P3|STARTED|Overall Study||8
8246598|NCT01893346|20336386|P2|STARTED|Overall Study||8
8246599|NCT01893346|20336387|P1|STARTED|Overall Study||11
8246600|NCT01893281|20336401|P1|NOT COMPLETED|Overall Study||3
8246601|NCT01893281|20336401|P1|COMPLETED|Overall Study||75
8246602|NCT01893281|20336401|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
8246603|NCT01893281|20336401|P1|STARTED|Overall Study||78
8246604|NCT01893203|20336408|P1|NOT COMPLETED|Overall Study||1
8246605|NCT01893203|20336408|P1|COMPLETED|Overall Study||13
8246606|NCT01893203|20336408|P1|STARTED|Overall Study||14
8246607|NCT01892865|20336417|P2|NOT COMPLETED|Overall Study||0
8246608|NCT01892865|20336418|P1|NOT COMPLETED|Overall Study||0
8246609|NCT01892865|20336417|P2|COMPLETED|Overall Study||379
8246610|NCT01892865|20336418|P1|COMPLETED|Overall Study||356
8246611|NCT01892865|20336417|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
8246612|NCT01892865|20336418|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
8246613|NCT01892722|20336432|P2|NOT COMPLETED|Overall Study||20
8246614|NCT01892722|20336433|P1|NOT COMPLETED|Overall Study||7
8246615|NCT01892722|20336432|P2|COMPLETED|Overall Study||88
8246616|NCT01892722|20336433|P1|COMPLETED|Overall Study||100
8246617|NCT01892722|20336432|P2|Full Analysis Set|Overall Study||107
8246618|NCT01892722|20336433|P1|Full Analysis Set|Overall Study||107
8246619|NCT01892722|20336432|P2|STARTED|Overall Study||108
8246620|NCT01892722|20336433|P1|STARTED|Overall Study||107
8246621|NCT01892709|20336439|P1|NOT COMPLETED|Overall Study||0
8246622|NCT01892709|20336439|P1|COMPLETED|Overall Study||215
8246623|NCT01892709|20336439|P1|STARTED|Overall Study||215
8246624|NCT01892657|20336449|P1|NOT COMPLETED|Overall Study||18
8246625|NCT01892657|20336449|P1|COMPLETED|Overall Study||110
8246626|NCT01892657|20336449|P1|STARTED|Overall Study||128
8246627|NCT01892540|20336468|P3|NOT COMPLETED|Overall Study||3
8246628|NCT01892540|20336469|P2|NOT COMPLETED|Overall Study||0
8246629|NCT01892540|20336470|P1|NOT COMPLETED|Overall Study||0
8246630|NCT01892540|20336468|P3|COMPLETED|Overall Study||25
8246631|NCT01892540|20336469|P2|COMPLETED|Overall Study||0
8246632|NCT01892540|20336470|P1|COMPLETED|Overall Study||15
8246633|NCT01892540|20336468|P3|STARTED|Overall Study||28
8246634|NCT01892540|20336469|P2|STARTED|Overall Study||0
8246635|NCT01892540|20336470|P1|STARTED|Overall Study||15
8246636|NCT01892436|20336491|P4|NOT COMPLETED|Overall Study||14
8246637|NCT01892436|20336492|P3|NOT COMPLETED|Overall Study||11
8246638|NCT01892436|20336493|P2|NOT COMPLETED|Overall Study||29
8246639|NCT01892436|20336494|P1|NOT COMPLETED|Overall Study||23
8246640|NCT01892436|20336491|P4|COMPLETED|Overall Study||61
8246641|NCT01892436|20336492|P3|COMPLETED|Overall Study||63
8246642|NCT01892436|20336493|P2|COMPLETED|Overall Study||132
8246643|NCT01892436|20336494|P1|COMPLETED|Overall Study||124
8246644|NCT01892436|20336491|P4|STARTED|Overall Study||75
8246645|NCT01892436|20336492|P3|STARTED|Overall Study||74
8246646|NCT01892436|20336493|P2|STARTED|Overall Study||161
8246647|NCT01892436|20336494|P1|STARTED|Overall Study||147
8246648|NCT01892345|20336534|P2|NOT COMPLETED|Overall Study||3
8246649|NCT01892345|20336535|P1|NOT COMPLETED|Overall Study||16
8246650|NCT01892345|20336534|P2|COMPLETED|Overall Study||44
8246651|NCT01892345|20336535|P1|COMPLETED|Overall Study||80
8246652|NCT01892345|20336534|P2|Received At Least 1 Dose Of Study Drug|Overall Study||47
8246653|NCT01892345|20336535|P1|Received At Least 1 Dose Of Study Drug|Overall Study||96
8246654|NCT01892345|20336534|P2|STARTED|Overall Study||47
8246655|NCT01892345|20336535|P1|STARTED|Overall Study||96
8246656|NCT01892306|20336555|P2|NOT COMPLETED|Overall Study||6
8246657|NCT01892306|20336556|P1|NOT COMPLETED|Overall Study||5
8246658|NCT01892306|20336555|P2|COMPLETED|Overall Study||10
8246659|NCT01892306|20336556|P1|COMPLETED|Overall Study||8
8246660|NCT01892306|20336555|P2|STARTED|Overall Study||16
8246661|NCT01892306|20336556|P1|STARTED|Overall Study||13
8246662|NCT01892293|20336576|P1|NOT COMPLETED|Overall Study||4
8246663|NCT01892293|20336576|P1|COMPLETED|Overall Study||2
8246664|NCT01892293|20336576|P1|Received T-cell|Overall Study||2
8246665|NCT01892293|20336576|P1|STARTED|Overall Study||6
8246666|NCT01892267|20336584|P2|NOT COMPLETED|Overall Study||0
8246667|NCT01892267|20336585|P1|NOT COMPLETED|Overall Study||0
8246668|NCT01892267|20336584|P2|COMPLETED|Overall Study||10
8246669|NCT01892267|20336585|P1|COMPLETED|Overall Study||9
8246670|NCT01892267|20336584|P2|STARTED|Overall Study||10
8246671|NCT01892267|20336585|P1|STARTED|Overall Study||9
8246672|NCT01892189|20336620|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246673|NCT01892189|20336621|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246674|NCT01892189|20336622|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246675|NCT01892189|20336623|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246676|NCT01892189|20336624|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246677|NCT01892189|20336625|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246678|NCT01892189|20336626|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246679|NCT01892189|20336627|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246680|NCT01892189|20336628|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246681|NCT01892189|20336620|P9|COMPLETED|Third Intervention Period (1 Day)||1
8246682|NCT01892189|20336621|P8|COMPLETED|Third Intervention Period (1 Day)||3
8246683|NCT01892189|20336622|P7|COMPLETED|Third Intervention Period (1 Day)||2
8246684|NCT01892189|20336623|P6|COMPLETED|Third Intervention Period (1 Day)||2
8246685|NCT01892189|20336624|P5|COMPLETED|Third Intervention Period (1 Day)||3
8246686|NCT01892189|20336625|P4|COMPLETED|Third Intervention Period (1 Day)||2
8246687|NCT01892189|20336626|P3|COMPLETED|Third Intervention Period (1 Day)||1
8246688|NCT01892189|20336627|P2|COMPLETED|Third Intervention Period (1 Day)||3
8246689|NCT01892189|20336628|P1|COMPLETED|Third Intervention Period (1 Day)||3
8246690|NCT01892189|20336620|P9|STARTED|Third Intervention Period (1 Day)||1
8246691|NCT01892189|20336621|P8|STARTED|Third Intervention Period (1 Day)||3
8246692|NCT01892189|20336622|P7|STARTED|Third Intervention Period (1 Day)||2
8246693|NCT01892189|20336623|P6|STARTED|Third Intervention Period (1 Day)||2
8246694|NCT01892189|20336624|P5|STARTED|Third Intervention Period (1 Day)||3
8246695|NCT01892189|20336625|P4|STARTED|Third Intervention Period (1 Day)||2
8246696|NCT01892189|20336626|P3|STARTED|Third Intervention Period (1 Day)||1
8246697|NCT01892189|20336627|P2|STARTED|Third Intervention Period (1 Day)||3
8246698|NCT01892189|20336628|P1|STARTED|Third Intervention Period (1 Day)||3
8246699|NCT01892189|20336620|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246700|NCT01892189|20336621|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246701|NCT01892189|20336622|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246702|NCT01892189|20336623|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246703|NCT01892189|20336624|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246704|NCT01892189|20336625|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246705|NCT01892189|20336626|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246706|NCT01892189|20336627|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246707|NCT01892189|20336628|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246708|NCT01892189|20336620|P9|COMPLETED|Washout Period 2 (7 Days)||1
8246709|NCT01892189|20336621|P8|COMPLETED|Washout Period 2 (7 Days)||3
8246710|NCT01892189|20336622|P7|COMPLETED|Washout Period 2 (7 Days)||2
8246711|NCT01892189|20336623|P6|COMPLETED|Washout Period 2 (7 Days)||2
8246712|NCT01892189|20336624|P5|COMPLETED|Washout Period 2 (7 Days)||3
8246713|NCT01892189|20336625|P4|COMPLETED|Washout Period 2 (7 Days)||2
8246714|NCT01892189|20336626|P3|COMPLETED|Washout Period 2 (7 Days)||1
8246715|NCT01892189|20336627|P2|COMPLETED|Washout Period 2 (7 Days)||3
8246716|NCT01892189|20336628|P1|COMPLETED|Washout Period 2 (7 Days)||3
8246717|NCT01892189|20336620|P9|STARTED|Washout Period 2 (7 Days)||1
8246718|NCT01892189|20336621|P8|STARTED|Washout Period 2 (7 Days)||3
8246719|NCT01892189|20336622|P7|STARTED|Washout Period 2 (7 Days)||2
8246720|NCT01892189|20336623|P6|STARTED|Washout Period 2 (7 Days)||2
8246721|NCT01892189|20336624|P5|STARTED|Washout Period 2 (7 Days)||3
8246722|NCT01892189|20336625|P4|STARTED|Washout Period 2 (7 Days)||2
8246723|NCT01892189|20336626|P3|STARTED|Washout Period 2 (7 Days)||1
8246724|NCT01892189|20336627|P2|STARTED|Washout Period 2 (7 Days)||3
8246725|NCT01892189|20336628|P1|STARTED|Washout Period 2 (7 Days)||3
8246726|NCT01892189|20336620|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246727|NCT01892189|20336621|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246728|NCT01892189|20336622|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246729|NCT01892189|20336623|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246730|NCT01892189|20336624|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246731|NCT01892189|20336625|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246732|NCT01892189|20336626|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246733|NCT01892189|20336627|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246734|NCT01892189|20336628|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246735|NCT01892189|20336620|P9|COMPLETED|Second Intervention Period (1 Day)||1
8246736|NCT01892189|20336621|P8|COMPLETED|Second Intervention Period (1 Day)||3
8246737|NCT01892189|20336622|P7|COMPLETED|Second Intervention Period (1 Day)||2
8246738|NCT01892189|20336623|P6|COMPLETED|Second Intervention Period (1 Day)||2
8246739|NCT01892189|20336624|P5|COMPLETED|Second Intervention Period (1 Day)||3
8246740|NCT01892189|20336625|P4|COMPLETED|Second Intervention Period (1 Day)||2
8246741|NCT01892189|20336626|P3|COMPLETED|Second Intervention Period (1 Day)||1
8246742|NCT01892189|20336627|P2|COMPLETED|Second Intervention Period (1 Day)||3
8246743|NCT01892189|20336628|P1|COMPLETED|Second Intervention Period (1 Day)||3
8246744|NCT01892189|20336620|P9|STARTED|Second Intervention Period (1 Day)||1
8246745|NCT01892189|20336621|P8|STARTED|Second Intervention Period (1 Day)||3
8246746|NCT01892189|20336622|P7|STARTED|Second Intervention Period (1 Day)||2
8246747|NCT01892189|20336623|P6|STARTED|Second Intervention Period (1 Day)||2
8246748|NCT01892189|20336624|P5|STARTED|Second Intervention Period (1 Day)||3
8246749|NCT01892189|20336625|P4|STARTED|Second Intervention Period (1 Day)||2
8246750|NCT01892189|20336626|P3|STARTED|Second Intervention Period (1 Day)||1
8246751|NCT01892189|20336627|P2|STARTED|Second Intervention Period (1 Day)||3
8246752|NCT01892189|20336628|P1|STARTED|Second Intervention Period (1 Day)||3
8246753|NCT01892189|20336620|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
8246754|NCT01892189|20336621|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246755|NCT01892189|20336622|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
8246756|NCT01892189|20336623|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
8246757|NCT01892189|20336624|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246758|NCT01892189|20336625|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8246759|NCT01892189|20336626|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
8246760|NCT01892189|20336627|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246761|NCT01892189|20336628|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246762|NCT01892189|20336620|P9|COMPLETED|Washout Period 1 (7 Days)||1
8246763|NCT01892189|20336621|P8|COMPLETED|Washout Period 1 (7 Days)||3
8246764|NCT01892189|20336622|P7|COMPLETED|Washout Period 1 (7 Days)||2
8246765|NCT01892189|20336623|P6|COMPLETED|Washout Period 1 (7 Days)||2
8246766|NCT01892189|20336624|P5|COMPLETED|Washout Period 1 (7 Days)||3
8246767|NCT01892189|20336625|P4|COMPLETED|Washout Period 1 (7 Days)||2
8246768|NCT01892189|20336626|P3|COMPLETED|Washout Period 1 (7 Days)||1
8246769|NCT01892189|20336627|P2|COMPLETED|Washout Period 1 (7 Days)||3
8246770|NCT01892189|20336628|P1|COMPLETED|Washout Period 1 (7 Days)||3
8246771|NCT01892189|20336620|P9|STARTED|Washout Period 1 (7 Days)||3
8246772|NCT01892189|20336621|P8|STARTED|Washout Period 1 (7 Days)||3
8246773|NCT01892189|20336622|P7|STARTED|Washout Period 1 (7 Days)||3
8246774|NCT01892189|20336623|P6|STARTED|Washout Period 1 (7 Days)||3
8246775|NCT01892189|20336624|P5|STARTED|Washout Period 1 (7 Days)||3
8246776|NCT01892189|20336625|P4|STARTED|Washout Period 1 (7 Days)||3
8246777|NCT01892189|20336626|P3|STARTED|Washout Period 1 (7 Days)||3
8246778|NCT01892189|20336627|P2|STARTED|Washout Period 1 (7 Days)||3
8246779|NCT01892189|20336628|P1|STARTED|Washout Period 1 (7 Days)||3
8246780|NCT01892189|20336620|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
8246781|NCT01892189|20336621|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
8246782|NCT01892189|20336622|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
8246783|NCT01892189|20336623|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
8246784|NCT01892189|20336624|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
8246785|NCT01892189|20336625|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
8246786|NCT01892189|20336626|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
8246787|NCT01892189|20336627|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
8246788|NCT01892189|20336628|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
8246789|NCT01892189|20336620|P9|COMPLETED|First Intervention Period (1 Day)||3
8246790|NCT01892189|20336621|P8|COMPLETED|First Intervention Period (1 Day)||3
8246791|NCT01892189|20336622|P7|COMPLETED|First Intervention Period (1 Day)||3
8246792|NCT01892189|20336623|P6|COMPLETED|First Intervention Period (1 Day)||3
8246793|NCT01892189|20336624|P5|COMPLETED|First Intervention Period (1 Day)||3
8246794|NCT01892189|20336625|P4|COMPLETED|First Intervention Period (1 Day)||3
8246795|NCT01892189|20336626|P3|COMPLETED|First Intervention Period (1 Day)||3
8246796|NCT01892189|20336627|P2|COMPLETED|First Intervention Period (1 Day)||3
8246797|NCT01892189|20336628|P1|COMPLETED|First Intervention Period (1 Day)||3
8246798|NCT01892189|20336620|P9|STARTED|First Intervention Period (1 Day)||3
8246799|NCT01892189|20336621|P8|STARTED|First Intervention Period (1 Day)||3
8246800|NCT01892189|20336622|P7|STARTED|First Intervention Period (1 Day)||3
8246801|NCT01892189|20336623|P6|STARTED|First Intervention Period (1 Day)||3
8246802|NCT01892189|20336624|P5|STARTED|First Intervention Period (1 Day)||3
8246803|NCT01892189|20336625|P4|STARTED|First Intervention Period (1 Day)||3
8246804|NCT01892189|20336626|P3|STARTED|First Intervention Period (1 Day)||3
8246805|NCT01892189|20336627|P2|STARTED|First Intervention Period (1 Day)||3
8246806|NCT01892189|20336628|P1|STARTED|First Intervention Period (1 Day)||3
8246807|NCT01892163|20336670|P2|NOT COMPLETED|Overall Study||1
8246808|NCT01892163|20336671|P1|NOT COMPLETED|Overall Study||2
8246809|NCT01892163|20336670|P2|COMPLETED|Overall Study||49
8246810|NCT01892163|20336671|P1|COMPLETED|Overall Study||48
8246811|NCT01892163|20336670|P2|STARTED|Overall Study||50
8246812|NCT01892163|20336671|P1|STARTED|Overall Study||50
8246813|NCT01892020|20336683|P2|NOT COMPLETED|Period 2||0
8246814|NCT01892020|20336684|P1|NOT COMPLETED|Period 2||1
8246815|NCT01892020|20336683|P2|COMPLETED|Period 2||74
8246816|NCT01892020|20336684|P1|COMPLETED|Period 2||77
8246817|NCT01892020|20336683|P2|STARTED|Period 2||74
8246818|NCT01892020|20336684|P1|STARTED|Period 2||78
8246819|NCT01892020|20336683|P2|NOT COMPLETED|Period 1||6
8246820|NCT01892020|20336684|P1|NOT COMPLETED|Period 1||3
8246821|NCT01892020|20336683|P2|COMPLETED|Period 1||74
8246822|NCT01892020|20336684|P1|COMPLETED|Period 1||78
8246823|NCT01892020|20336683|P2|STARTED|Period 1||80
8246824|NCT01892020|20336684|P1|STARTED|Period 1||81
8246825|NCT01892007|20336704|P2|NOT COMPLETED|Overall Study||0
8246826|NCT01892007|20336705|P1|NOT COMPLETED|Overall Study||0
8246827|NCT01892007|20336704|P2|COMPLETED|Overall Study||30
8246828|NCT01892007|20336705|P1|COMPLETED|Overall Study||27
8246829|NCT01892007|20336704|P2|STARTED|Overall Study||30
8246830|NCT01892007|20336705|P1|STARTED|Overall Study||27
8246831|NCT01891994|20336731|P1|NOT COMPLETED|Overall Study||0
8246832|NCT01891994|20336731|P1|COMPLETED|Overall Study||40
8246833|NCT01891994|20336731|P1|STARTED|Overall Study||40
8246834|NCT01891968|20336735|P1|NOT COMPLETED|Overall Study||0
8246835|NCT01891968|20336735|P1|COMPLETED|Overall Study||15
8246836|NCT01891968|20336735|P1|STARTED|Overall Study||15
8246837|NCT01891890|20336742|P3|NOT COMPLETED|Overall Study||7
8246838|NCT01891890|20336743|P2|NOT COMPLETED|Overall Study||3
8246839|NCT01891890|20336744|P1|NOT COMPLETED|Overall Study||7
8246840|NCT01891890|20336742|P3|COMPLETED|Overall Study||14
8246841|NCT01891890|20336743|P2|COMPLETED|Overall Study||24
8246842|NCT01891890|20336744|P1|COMPLETED|Overall Study||17
8246843|NCT01891890|20336742|P3|STARTED|Overall Study||21
8246844|NCT01891890|20336743|P2|STARTED|Overall Study||27
8246845|NCT01891890|20336744|P1|STARTED|Overall Study||24
8246846|NCT01891864|20336787|P6|NOT COMPLETED|Extension Period||0
8246847|NCT01891864|20336788|P5|NOT COMPLETED|Extension Period||7
8246848|NCT01891864|20336789|P4|NOT COMPLETED|Extension Period||5
8246849|NCT01891864|20336790|P3|NOT COMPLETED|Extension Period||8
8246850|NCT01891864|20336791|P2|NOT COMPLETED|Extension Period||0
8246851|NCT01891864|20336792|P1|NOT COMPLETED|Extension Period||0
8246852|NCT01891864|20336787|P6|COMPLETED|Extension Period||90
8246853|NCT01891864|20336788|P5|COMPLETED|Extension Period||88
8246854|NCT01891864|20336789|P4|COMPLETED|Extension Period||137
8246855|NCT01891864|20336790|P3|COMPLETED|Extension Period||132
8246856|NCT01891864|20336791|P2|COMPLETED|Extension Period||0
8246857|NCT01891864|20336792|P1|COMPLETED|Extension Period||0
8246858|NCT01891864|20336787|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
8246859|NCT01891864|20336788|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
8246860|NCT01891864|20336789|P4|STARTED|Extension Period||142
8246861|NCT01891864|20336790|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
8246862|NCT01891864|20336791|P2|STARTED|Extension Period||0
8246863|NCT01891864|20336792|P1|STARTED|Extension Period||0
8246864|NCT01891864|20336787|P6|NOT COMPLETED|Treatment Period 2||5
8246865|NCT01891864|20336788|P5|NOT COMPLETED|Treatment Period 2||4
8246866|NCT01891864|20336789|P4|NOT COMPLETED|Treatment Period 2||9
8246867|NCT01891864|20336790|P3|NOT COMPLETED|Treatment Period 2||7
8246868|NCT01891864|20336791|P2|NOT COMPLETED|Treatment Period 2||0
8246869|NCT01891864|20336792|P1|NOT COMPLETED|Treatment Period 2||0
8246870|NCT01891864|20336787|P6|COMPLETED|Treatment Period 2||91
8246871|NCT01891864|20336788|P5|COMPLETED|Treatment Period 2||96
8246872|NCT01891864|20336789|P4|COMPLETED|Treatment Period 2||142
8246873|NCT01891864|20336790|P3|COMPLETED|Treatment Period 2||143
8246874|NCT01891864|20336791|P2|COMPLETED|Treatment Period 2||0
8246875|NCT01891864|20336792|P1|COMPLETED|Treatment Period 2||0
8246876|NCT01891864|20336787|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
8246877|NCT01891864|20336788|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
8246878|NCT01891864|20336789|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
8246879|NCT01891864|20336790|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
8246880|NCT01891864|20336791|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8246881|NCT01891864|20336792|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8246882|NCT01891864|20336787|P6|NOT COMPLETED|Treatment Period 1||0
8246883|NCT01891864|20336788|P5|NOT COMPLETED|Treatment Period 1||0
8246884|NCT01891864|20336789|P4|NOT COMPLETED|Treatment Period 1||0
8246885|NCT01891864|20336790|P3|NOT COMPLETED|Treatment Period 1||0
8246886|NCT01891864|20336791|P2|NOT COMPLETED|Treatment Period 1||12
8246887|NCT01891864|20336792|P1|NOT COMPLETED|Treatment Period 1||8
8246888|NCT01891864|20336787|P6|COMPLETED|Treatment Period 1||0
8246889|NCT01891864|20336788|P5|COMPLETED|Treatment Period 1||0
8246890|NCT01891864|20336789|P4|COMPLETED|Treatment Period 1||0
8246891|NCT01891864|20336790|P3|COMPLETED|Treatment Period 1||0
8246892|NCT01891864|20336791|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
8246893|NCT01891864|20336792|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
8246894|NCT01891864|20336787|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246895|NCT01891864|20336788|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246896|NCT01891864|20336789|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246897|NCT01891864|20336790|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246898|NCT01891864|20336791|P2|STARTED|Treatment Period 1||267
8246899|NCT01891864|20336792|P1|STARTED|Treatment Period 1||264
8246900|NCT01891734|20336814|P2|NOT COMPLETED|Overall Study||3
8246901|NCT01891734|20336815|P1|NOT COMPLETED|Overall Study||3
8246902|NCT01891734|20336814|P2|COMPLETED|Overall Study||13
8246903|NCT01891734|20336815|P1|COMPLETED|Overall Study||14
8246904|NCT01891734|20336814|P2|STARTED|Overall Study||16
8246905|NCT01891734|20336815|P1|STARTED|Overall Study||17
8246906|NCT01891721|20336828|P3|NOT COMPLETED|Overall Study||1
8246907|NCT01891721|20336829|P2|NOT COMPLETED|Overall Study||5
8246908|NCT01891721|20336830|P1|NOT COMPLETED|Overall Study||10
8246909|NCT01891721|20336828|P3|COMPLETED|Overall Study||19
8246910|NCT01891721|20336829|P2|COMPLETED|Overall Study||35
8246911|NCT01891721|20336830|P1|COMPLETED|Overall Study||29
8246912|NCT01891721|20336828|P3|STARTED|Overall Study||20
8246913|NCT01891721|20336829|P2|STARTED|Overall Study||40
8246914|NCT01891721|20336830|P1|STARTED|Overall Study||39
8246915|NCT01891669|20336854|P10|NOT COMPLETED|Overall Study||2
8246916|NCT01891669|20336855|P9|NOT COMPLETED|Overall Study||1
8246917|NCT01891669|20336856|P8|NOT COMPLETED|Overall Study||4
8246918|NCT01891669|20336857|P7|NOT COMPLETED|Overall Study||1
8246919|NCT01891669|20336858|P6|NOT COMPLETED|Overall Study||0
8246920|NCT01891669|20336859|P5|NOT COMPLETED|Overall Study||0
8246921|NCT01891669|20336860|P4|NOT COMPLETED|Overall Study||0
8246922|NCT01891669|20336861|P3|NOT COMPLETED|Overall Study||0
8246923|NCT01891669|20336862|P2|NOT COMPLETED|Overall Study||1
8246924|NCT01891669|20336863|P1|NOT COMPLETED|Overall Study||2
8246925|NCT01891669|20336854|P10|COMPLETED|Overall Study||1
8246926|NCT01891669|20336855|P9|COMPLETED|Overall Study||2
8246927|NCT01891669|20336856|P8|COMPLETED|Overall Study||2
8246928|NCT01891669|20336857|P7|COMPLETED|Overall Study||1
8246929|NCT01891669|20336858|P6|COMPLETED|Overall Study||2
8246930|NCT01891669|20336859|P5|COMPLETED|Overall Study||2
8246931|NCT01891669|20336860|P4|COMPLETED|Overall Study||2
8246932|NCT01891669|20336861|P3|COMPLETED|Overall Study||2
8246933|NCT01891669|20336862|P2|COMPLETED|Overall Study||1
8246934|NCT01891669|20336863|P1|COMPLETED|Overall Study||0
8246935|NCT01891669|20336854|P10|STARTED|Overall Study||3
8246936|NCT01891669|20336855|P9|STARTED|Overall Study||3
8246937|NCT01891669|20336856|P8|STARTED|Overall Study||6
8246938|NCT01891669|20336857|P7|STARTED|Overall Study||2
8246939|NCT01891669|20336858|P6|STARTED|Overall Study||2
8246940|NCT01891669|20336859|P5|STARTED|Overall Study||2
8246941|NCT01891669|20336860|P4|STARTED|Overall Study||2
8246942|NCT01891669|20336861|P3|STARTED|Overall Study||2
8246943|NCT01891669|20336862|P2|STARTED|Overall Study||2
8246944|NCT01891669|20336863|P1|STARTED|Overall Study||2
8246945|NCT01891357|20337014|P1|NOT COMPLETED|Overall Study||3
8246946|NCT01891357|20337014|P1|COMPLETED|Overall Study||61
8246947|NCT01891357|20337014|P1|STARTED|Overall Study||64
8246948|NCT01891331|20337025|P4|NOT COMPLETED|Overall Study||2
8246949|NCT01891331|20337026|P3|NOT COMPLETED|Overall Study||1
8246950|NCT01891331|20337027|P2|NOT COMPLETED|Overall Study||2
8246951|NCT01891331|20337028|P1|NOT COMPLETED|Overall Study||2
8246952|NCT01891331|20337025|P4|COMPLETED|Overall Study||13
8246953|NCT01891331|20337026|P3|COMPLETED|Overall Study||13
8246954|NCT01891331|20337027|P2|COMPLETED|Overall Study||10
8246955|NCT01891331|20337028|P1|COMPLETED|Overall Study||12
8246956|NCT01891331|20337025|P4|STARTED|Overall Study||15
8246957|NCT01891331|20337026|P3|STARTED|Overall Study||14
8246958|NCT01891331|20337027|P2|STARTED|Overall Study||12
8246959|NCT01891331|20337028|P1|STARTED|Overall Study||14
8246960|NCT01891305|20337042|P4|NOT COMPLETED|Overall Study||0
8246961|NCT01891305|20337043|P3|NOT COMPLETED|Overall Study||3
8246962|NCT01891305|20337044|P2|NOT COMPLETED|Overall Study||1
8246963|NCT01891305|20337045|P1|NOT COMPLETED|Overall Study||3
8246964|NCT01891305|20337042|P4|COMPLETED|Overall Study||12
8246965|NCT01891305|20337043|P3|COMPLETED|Overall Study||11
8246966|NCT01891305|20337044|P2|COMPLETED|Overall Study||11
8246967|NCT01891305|20337045|P1|COMPLETED|Overall Study||9
8246968|NCT01891305|20337042|P4|STARTED|Overall Study||12
8246969|NCT01891305|20337043|P3|STARTED|Overall Study||14
8246970|NCT01891305|20337044|P2|STARTED|Overall Study||12
8246971|NCT01891305|20337045|P1|STARTED|Overall Study||12
8246972|NCT01890967|20337061|P6|NOT COMPLETED|Overall Study||13
8246973|NCT01890967|20337062|P5|NOT COMPLETED|Overall Study||10
8246974|NCT01890967|20337063|P4|NOT COMPLETED|Overall Study||11
8246975|NCT01890967|20337064|P3|NOT COMPLETED|Overall Study||10
8246976|NCT01890967|20337065|P2|NOT COMPLETED|Overall Study||11
8246977|NCT01890967|20337066|P1|NOT COMPLETED|Overall Study||10
8246978|NCT01890967|20337061|P6|COMPLETED|Overall Study||75
8246979|NCT01890967|20337062|P5|COMPLETED|Overall Study||77
8246980|NCT01890967|20337063|P4|COMPLETED|Overall Study||77
8246981|NCT01890967|20337064|P3|COMPLETED|Overall Study||78
8246982|NCT01890967|20337065|P2|COMPLETED|Overall Study||77
8246983|NCT01890967|20337066|P1|COMPLETED|Overall Study||78
8246984|NCT01890967|20337061|P6|Received at Least One Dose of Study Drug|Overall Study||87
8246985|NCT01890967|20337062|P5|Received at Least One Dose of Study Drug|Overall Study||86
8246986|NCT01890967|20337063|P4|Received at Least One Dose of Study Drug|Overall Study||86
8246987|NCT01890967|20337064|P3|Received at Least One Dose of Study Drug|Overall Study||86
8246988|NCT01890967|20337065|P2|Received at Least One Dose of Study Drug|Overall Study||87
8246989|NCT01890967|20337066|P1|Received at Least One Dose of Study Drug|Overall Study||87
8246990|NCT01890967|20337061|P6|STARTED|Overall Study||88
8246991|NCT01890967|20337062|P5|STARTED|Overall Study||87
8246992|NCT01890967|20337063|P4|STARTED|Overall Study||88
8246993|NCT01890967|20337064|P3|STARTED|Overall Study||88
8246994|NCT01890967|20337065|P2|STARTED|Overall Study||88
8246995|NCT01890967|20337066|P1|STARTED|Overall Study||88
8246996|NCT01890954|20337135|P2|NOT COMPLETED|Overall Study||0
8246997|NCT01890954|20337136|P1|NOT COMPLETED|Overall Study||1
8246998|NCT01890954|20337135|P2|COMPLETED|Overall Study||8
8246999|NCT01890954|20337136|P1|COMPLETED|Overall Study||8
8247000|NCT01890954|20337135|P2|STARTED|Overall Study||8
8247001|NCT01890954|20337136|P1|STARTED|Overall Study||9
8247002|NCT01890915|20337144|P2|NOT COMPLETED|Overall Study||1
8247003|NCT01890915|20337145|P1|NOT COMPLETED|Overall Study||3
8247004|NCT01890915|20337144|P2|COMPLETED|Overall Study||9
8247005|NCT01890915|20337145|P1|COMPLETED|Overall Study||8
8247006|NCT01890915|20337144|P2|STARTED|Overall Study||10
8247007|NCT01890915|20337145|P1|STARTED|Overall Study||11
8247008|NCT01890785|20337161|P6|NOT COMPLETED|Third Intervention||0
8247009|NCT01890785|20337162|P5|NOT COMPLETED|Third Intervention||0
8247010|NCT01890785|20337163|P4|NOT COMPLETED|Third Intervention||0
8247011|NCT01890785|20337164|P3|NOT COMPLETED|Third Intervention||0
8247012|NCT01890785|20337165|P2|NOT COMPLETED|Third Intervention||1
8247013|NCT01890785|20337166|P1|NOT COMPLETED|Third Intervention||0
8247014|NCT01890785|20337161|P6|COMPLETED|Third Intervention||5
8247015|NCT01890785|20337162|P5|COMPLETED|Third Intervention||5
8247016|NCT01890785|20337163|P4|COMPLETED|Third Intervention||5
8247017|NCT01890785|20337164|P3|COMPLETED|Third Intervention||5
8247018|NCT01890785|20337165|P2|COMPLETED|Third Intervention||4
8247019|NCT01890785|20337166|P1|COMPLETED|Third Intervention||5
8247020|NCT01890785|20337161|P6|STARTED|Third Intervention||5
8247021|NCT01890785|20337162|P5|STARTED|Third Intervention||5
8247022|NCT01890785|20337163|P4|STARTED|Third Intervention||5
8247023|NCT01890785|20337164|P3|STARTED|Third Intervention||5
8247024|NCT01890785|20337165|P2|STARTED|Third Intervention||5
8247025|NCT01890785|20337166|P1|STARTED|Third Intervention||5
8247026|NCT01890785|20337161|P6|NOT COMPLETED|Second Intervention||0
8247027|NCT01890785|20337162|P5|NOT COMPLETED|Second Intervention||0
8247028|NCT01890785|20337163|P4|NOT COMPLETED|Second Intervention||0
8247029|NCT01890785|20337164|P3|NOT COMPLETED|Second Intervention||0
8247030|NCT01890785|20337165|P2|NOT COMPLETED|Second Intervention||0
8247031|NCT01890785|20337166|P1|NOT COMPLETED|Second Intervention||0
8247032|NCT01890785|20337161|P6|COMPLETED|Second Intervention||5
8247033|NCT01890785|20337162|P5|COMPLETED|Second Intervention||5
8247034|NCT01890785|20337163|P4|COMPLETED|Second Intervention||5
8247035|NCT01890785|20337164|P3|COMPLETED|Second Intervention||5
8247036|NCT01890785|20337165|P2|COMPLETED|Second Intervention||5
8247037|NCT01890785|20337166|P1|COMPLETED|Second Intervention||5
8247038|NCT01890785|20337161|P6|STARTED|Second Intervention||5
8247039|NCT01890785|20337162|P5|STARTED|Second Intervention||5
8247040|NCT01890785|20337163|P4|STARTED|Second Intervention||5
8247041|NCT01890785|20337164|P3|STARTED|Second Intervention||5
8247042|NCT01890785|20337165|P2|STARTED|Second Intervention||5
8247043|NCT01890785|20337166|P1|STARTED|Second Intervention||5
8247044|NCT01890785|20337161|P6|NOT COMPLETED|First Intervention||0
8247045|NCT01890785|20337162|P5|NOT COMPLETED|First Intervention||0
8247046|NCT01890785|20337163|P4|NOT COMPLETED|First Intervention||0
8247047|NCT01890785|20337164|P3|NOT COMPLETED|First Intervention||0
8247048|NCT01890785|20337165|P2|NOT COMPLETED|First Intervention||0
8247049|NCT01890785|20337166|P1|NOT COMPLETED|First Intervention||0
8247050|NCT01890785|20337161|P6|COMPLETED|First Intervention||5
8247051|NCT01890785|20337162|P5|COMPLETED|First Intervention||5
8247052|NCT01890785|20337163|P4|COMPLETED|First Intervention||5
8247053|NCT01890785|20337164|P3|COMPLETED|First Intervention||5
8247054|NCT01890785|20337165|P2|COMPLETED|First Intervention||5
8247055|NCT01890785|20337166|P1|COMPLETED|First Intervention||5
8247056|NCT01890785|20337161|P6|STARTED|First Intervention||5
8247057|NCT01890785|20337162|P5|STARTED|First Intervention||5
8247058|NCT01890785|20337163|P4|STARTED|First Intervention||5
8247059|NCT01890785|20337164|P3|STARTED|First Intervention||5
8247060|NCT01890785|20337165|P2|STARTED|First Intervention||5
8247061|NCT01890785|20337166|P1|STARTED|First Intervention||5
8247062|NCT01890759|20337185|P2|NOT COMPLETED|Overall Study||12
8247063|NCT01890759|20337186|P1|NOT COMPLETED|Overall Study||2
8247064|NCT01890759|20337185|P2|COMPLETED|Overall Study||188
8247065|NCT01890759|20337186|P1|COMPLETED|Overall Study||98
8247066|NCT01890759|20337185|P2|STARTED|Overall Study||200
8247067|NCT01890759|20337186|P1|STARTED|Overall Study||100
8247068|NCT01890746|20337220|P2|NOT COMPLETED|Overall Study||41
8247069|NCT01890746|20337221|P1|NOT COMPLETED|Overall Study||52
8247070|NCT01890746|20337220|P2|COMPLETED|Overall Study||33
8247071|NCT01890746|20337221|P1|COMPLETED|Overall Study||22
8247072|NCT01890746|20337220|P2|STARTED|Overall Study||74
8247073|NCT01890746|20337221|P1|STARTED|Overall Study||74
8247074|NCT01890707|20337307|P2|NOT COMPLETED|Overall Study||1
8247075|NCT01890707|20337308|P1|NOT COMPLETED|Overall Study||1
8247076|NCT01890707|20337307|P2|COMPLETED|Overall Study||7
8247077|NCT01890707|20337308|P1|COMPLETED|Overall Study||10
8247078|NCT01890707|20337307|P2|STARTED|Overall Study||8
8247079|NCT01890707|20337308|P1|STARTED|Overall Study||11
8247080|NCT01890694|20337316|P2|NOT COMPLETED|Overall Study||1
8247081|NCT01890694|20337317|P1|NOT COMPLETED|Overall Study||1
8247082|NCT01890694|20337316|P2|COMPLETED|Overall Study||0
8247083|NCT01890694|20337317|P1|COMPLETED|Overall Study||0
8247084|NCT01890694|20337316|P2|STARTED|Overall Study||1
8247085|NCT01890694|20337317|P1|STARTED|Overall Study||1
8247086|NCT01890642|20337352|P3|NOT COMPLETED|Overall Study||0
8247087|NCT01890642|20337353|P2|NOT COMPLETED|Overall Study||0
8247088|NCT01890642|20337354|P1|NOT COMPLETED|Overall Study||0
8247089|NCT01890642|20337352|P3|COMPLETED|Overall Study||96
8247090|NCT01890642|20337353|P2|COMPLETED|Overall Study||53
8247091|NCT01890642|20337354|P1|COMPLETED|Overall Study||56
8247092|NCT01890642|20337352|P3|STARTED|Overall Study||96
8247093|NCT01890642|20337353|P2|STARTED|Overall Study||53
8247094|NCT01890642|20337354|P1|STARTED|Overall Study||56
8247095|NCT01890577|20337374|P1|NOT COMPLETED|Overall Study||28
8247096|NCT01890577|20337374|P1|COMPLETED|Overall Study||0
8247097|NCT01890577|20337374|P1|STARTED|Overall Study||28
8247098|NCT01890512|20337387|P1|NOT COMPLETED|Overall Study||3
8247099|NCT01890512|20337387|P1|COMPLETED|Overall Study||17
8247100|NCT01890512|20337387|P1|STARTED|Overall Study||20
8247101|NCT01890473|20337393|P2|NOT COMPLETED|Overall Study||0
8247102|NCT01890473|20337394|P1|NOT COMPLETED|Overall Study||2
8247103|NCT01890473|20337393|P2|COMPLETED|Overall Study||113
8247104|NCT01890473|20337394|P1|COMPLETED|Overall Study||109
8247105|NCT01890473|20337393|P2|STARTED|Overall Study||113
8247106|NCT01890473|20337394|P1|STARTED|Overall Study||111
8247107|NCT01890434|20337420|P1|NOT COMPLETED|Overall Study||20
8247108|NCT01890434|20337420|P1|COMPLETED|Overall Study||458
8247109|NCT01890434|20337420|P1|Evaluated for Efficacy|Overall Study||389
8247110|NCT01890434|20337420|P1|STARTED|Overall Study||478
8247111|NCT01890421|20337450|P1|NOT COMPLETED|Overall Study||11
8247112|NCT01890421|20337450|P1|COMPLETED|Overall Study||415
8247113|NCT01890421|20337450|P1|STARTED|Overall Study||426
8247114|NCT01890343|20337476|P3|NOT COMPLETED|Overall Study||0
8247115|NCT01890343|20337477|P2|NOT COMPLETED|Overall Study||0
8247116|NCT01890343|20337478|P1|NOT COMPLETED|Overall Study||0
8247117|NCT01890343|20337476|P3|COMPLETED|Overall Study||10
8247118|NCT01890343|20337477|P2|COMPLETED|Overall Study||10
8247119|NCT01890343|20337478|P1|COMPLETED|Overall Study||8
8247120|NCT01890343|20337476|P3|STARTED|Overall Study||10
8247121|NCT01890343|20337477|P2|STARTED|Overall Study||10
8247122|NCT01890343|20337478|P1|STARTED|Overall Study||8
8247123|NCT01890265|20337495|P6|NOT COMPLETED|Overall Study||0
8247124|NCT01890265|20337496|P5|NOT COMPLETED|Overall Study||2
8247125|NCT01890265|20337497|P4|NOT COMPLETED|Overall Study||0
8247126|NCT01890265|20337498|P3|NOT COMPLETED|Overall Study||4
8247127|NCT01890265|20337499|P2|NOT COMPLETED|Overall Study||13
8247128|NCT01890265|20337500|P1|NOT COMPLETED|Overall Study||10
8247129|NCT01890265|20337495|P6|COMPLETED|Overall Study||6
8247130|NCT01890265|20337496|P5|COMPLETED|Overall Study||13
8247131|NCT01890265|20337497|P4|COMPLETED|Overall Study||12
8247132|NCT01890265|20337498|P3|COMPLETED|Overall Study||20
8247133|NCT01890265|20337499|P2|COMPLETED|Overall Study||40
8247134|NCT01890265|20337500|P1|COMPLETED|Overall Study||40
8247135|NCT01890265|20337495|P6|Intent-to-Treat (ITT) Population|Overall Study||6
8247136|NCT01890265|20337496|P5|Intent-to-Treat (ITT) Population|Overall Study||15
8247137|NCT01890265|20337497|P4|Intent-to-Treat (ITT) Population|Overall Study||12
8247138|NCT01890265|20337498|P3|Intent-to-Treat (ITT) Population|Overall Study||24
8247139|NCT01890265|20337499|P2|Intent-to-Treat (ITT) Population|Overall Study||51
8247140|NCT01890265|20337500|P1|Intent-to-Treat (ITT) Population|Overall Study||50
8247141|NCT01890265|20337495|P6|Safety Population|Overall Study||6
8247142|NCT01890265|20337496|P5|Safety Population|Overall Study||15
8247143|NCT01890265|20337497|P4|Safety Population|Overall Study||12
8247144|NCT01890265|20337498|P3|Safety Population|Overall Study||24
8247145|NCT01890265|20337499|P2|Safety Population|Overall Study||53
8247146|NCT01890265|20337500|P1|Safety Population|Overall Study||50
8247147|NCT01890265|20337495|P6|STARTED|Overall Study||6
8247148|NCT01890265|20337496|P5|STARTED|Overall Study||15
8247149|NCT01890265|20337497|P4|STARTED|Overall Study||12
8247150|NCT01890265|20337498|P3|STARTED|Overall Study||24
8247151|NCT01890265|20337499|P2|STARTED|Overall Study||53
8247152|NCT01890265|20337500|P1|STARTED|Overall Study||50
8247153|NCT01890226|20337524|P2|NOT COMPLETED|Overall Study||0
8247154|NCT01890226|20337525|P1|NOT COMPLETED|Overall Study||0
8247155|NCT01890226|20337524|P2|COMPLETED|Overall Study||156
8247156|NCT01890226|20337525|P1|COMPLETED|Overall Study||155
8247157|NCT01890226|20337524|P2|STARTED|Overall Study||156
8247158|NCT01890226|20337525|P1|STARTED|Overall Study||155
8247159|NCT01890148|20337537|P1|NOT COMPLETED|Overall Study||1
8247160|NCT01890148|20337537|P1|COMPLETED|Overall Study||4
8247161|NCT01890148|20337537|P1|STARTED|Overall Study||5
8247162|NCT01890122|20337557|P4|NOT COMPLETED|Overall Study||59
8247163|NCT01890122|20337558|P3|NOT COMPLETED|Overall Study||13
8247164|NCT01890122|20337559|P2|NOT COMPLETED|Overall Study||37
8247165|NCT01890122|20337560|P1|NOT COMPLETED|Overall Study||27
8247166|NCT01890122|20337557|P4|COMPLETED|Overall Study||104
8247167|NCT01890122|20337558|P3|COMPLETED|Overall Study||146
8247168|NCT01890122|20337559|P2|COMPLETED|Overall Study||126
8247169|NCT01890122|20337560|P1|COMPLETED|Overall Study||135
8247170|NCT01890122|20337557|P4|Treated|Overall Study||163
8247171|NCT01890122|20337558|P3|Treated|Overall Study||159
8247172|NCT01890122|20337559|P2|Treated|Overall Study||162
8247173|NCT01890122|20337560|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
8247174|NCT01890122|20337557|P4|STARTED|Overall Study||163
8247175|NCT01890122|20337558|P3|STARTED|Overall Study||159
8247176|NCT01890122|20337559|P2|STARTED|Overall Study||163
8247177|NCT01890122|20337560|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
8247178|NCT01890109|20337624|P2|NOT COMPLETED|Overall Study||5
8247179|NCT01890109|20337625|P1|NOT COMPLETED|Overall Study||1
8247180|NCT01890109|20337624|P2|COMPLETED|Overall Study||46
8247181|NCT01890109|20337625|P1|COMPLETED|Overall Study||51
8247182|NCT01890109|20337624|P2|Received Study Treatment|Overall Study||50
8247183|NCT01890109|20337625|P1|Received Study Treatment|Overall Study||52
8247184|NCT01890109|20337624|P2|STARTED|Overall Study||51
8247185|NCT01890109|20337625|P1|STARTED|Overall Study||52
8247186|NCT01890031|20337649|P5|NOT COMPLETED|Overall Study||0
8247187|NCT01890031|20337650|P4|NOT COMPLETED|Overall Study||0
8247188|NCT01890031|20337651|P3|NOT COMPLETED|Overall Study||0
8247189|NCT01890031|20337652|P2|NOT COMPLETED|Overall Study||0
8247190|NCT01890031|20337653|P1|NOT COMPLETED|Overall Study||0
8247191|NCT01890031|20337649|P5|COMPLETED|Overall Study||8
8247192|NCT01890031|20337650|P4|COMPLETED|Overall Study||11
8247193|NCT01890031|20337651|P3|COMPLETED|Overall Study||12
8247194|NCT01890031|20337652|P2|COMPLETED|Overall Study||50
8247195|NCT01890031|20337653|P1|COMPLETED|Overall Study||50
8247196|NCT01890031|20337649|P5|STARTED|Overall Study||8
8247197|NCT01890031|20337650|P4|STARTED|Overall Study||11
8247198|NCT01890031|20337651|P3|STARTED|Overall Study||12
8247199|NCT01890031|20337652|P2|STARTED|Overall Study||50
8247200|NCT01890031|20337653|P1|STARTED|Overall Study||50
8247201|NCT01889862|20337674|P4|NOT COMPLETED|Overall Study||0
8247202|NCT01889862|20337675|P3|NOT COMPLETED|Overall Study||1
8247203|NCT01889862|20337676|P2|NOT COMPLETED|Overall Study||0
8247204|NCT01889862|20337677|P1|NOT COMPLETED|Overall Study||0
8247205|NCT01889862|20337674|P4|COMPLETED|Overall Study||14
8247206|NCT01889862|20337675|P3|COMPLETED|Overall Study||31
8247207|NCT01889862|20337676|P2|COMPLETED|Overall Study||15
8247208|NCT01889862|20337677|P1|COMPLETED|Overall Study||34
8247209|NCT01889862|20337674|P4|STARTED|Overall Study||14
8247210|NCT01889862|20337675|P3|STARTED|Overall Study||32
8247211|NCT01889862|20337676|P2|STARTED|Overall Study||15
8247212|NCT01889862|20337677|P1|STARTED|Overall Study||34
8247213|NCT01889797|20337689|P2|NOT COMPLETED|Overall Study||0
8247214|NCT01889797|20337690|P1|NOT COMPLETED|Overall Study||0
8247215|NCT01889797|20337689|P2|COMPLETED|Overall Study||16
8247216|NCT01889797|20337690|P1|COMPLETED|Overall Study||16
8247217|NCT01889797|20337689|P2|STARTED|Overall Study||16
8247218|NCT01889797|20337690|P1|STARTED|Overall Study||16
8247219|NCT01889667|20337705|P3|NOT COMPLETED|Overall Study||0
8247220|NCT01889667|20337706|P2|NOT COMPLETED|Overall Study||0
8247221|NCT01889667|20337707|P1|NOT COMPLETED|Overall Study||0
8247222|NCT01889667|20337705|P3|COMPLETED|Overall Study||10
8247223|NCT01889667|20337706|P2|COMPLETED|Overall Study||10
8247224|NCT01889667|20337707|P1|COMPLETED|Overall Study||10
8247225|NCT01889667|20337705|P3|STARTED|Overall Study||10
8247226|NCT01889667|20337706|P2|STARTED|Overall Study||10
8247227|NCT01889667|20337707|P1|STARTED|Overall Study||10
8247228|NCT01889602|20337730|P3|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8247229|NCT01889602|20337731|P2|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8247230|NCT01889602|20337732|P1|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8247231|NCT01889602|20337730|P3|COMPLETED|Third Washout Period of at Least 2 Weeks||16
8247232|NCT01889602|20337731|P2|COMPLETED|Third Washout Period of at Least 2 Weeks||15
8247233|NCT01889602|20337732|P1|COMPLETED|Third Washout Period of at Least 2 Weeks||15
8247234|NCT01889602|20337730|P3|STARTED|Third Washout Period of at Least 2 Weeks||16
8247235|NCT01889602|20337731|P2|STARTED|Third Washout Period of at Least 2 Weeks||15
8247236|NCT01889602|20337732|P1|STARTED|Third Washout Period of at Least 2 Weeks||15
8247237|NCT01889602|20337730|P3|NOT COMPLETED|Third Intervention||0
8247238|NCT01889602|20337731|P2|NOT COMPLETED|Third Intervention||2
8247239|NCT01889602|20337732|P1|NOT COMPLETED|Third Intervention||3
8247240|NCT01889602|20337730|P3|COMPLETED|Third Intervention||16
8247241|NCT01889602|20337731|P2|COMPLETED|Third Intervention||15
8247242|NCT01889602|20337732|P1|COMPLETED|Third Intervention||15
8247243|NCT01889602|20337730|P3|STARTED|Third Intervention||16
8247244|NCT01889602|20337731|P2|STARTED|Third Intervention||17
8247245|NCT01889602|20337732|P1|STARTED|Third Intervention||18
8247246|NCT01889602|20337730|P3|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8247247|NCT01889602|20337731|P2|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8247248|NCT01889602|20337732|P1|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8247249|NCT01889602|20337730|P3|COMPLETED|Second Washout Period of at Least 2 Week||16
8247250|NCT01889602|20337731|P2|COMPLETED|Second Washout Period of at Least 2 Week||17
8247251|NCT01889602|20337732|P1|COMPLETED|Second Washout Period of at Least 2 Week||18
8247252|NCT01889602|20337730|P3|STARTED|Second Washout Period of at Least 2 Week||16
8247253|NCT01889602|20337731|P2|STARTED|Second Washout Period of at Least 2 Week||17
8247254|NCT01889602|20337732|P1|STARTED|Second Washout Period of at Least 2 Week||18
8247255|NCT01889602|20337730|P3|NOT COMPLETED|Second Intervention||2
8247256|NCT01889602|20337731|P2|NOT COMPLETED|Second Intervention||0
8247257|NCT01889602|20337732|P1|NOT COMPLETED|Second Intervention||1
8247258|NCT01889602|20337730|P3|COMPLETED|Second Intervention||16
8247259|NCT01889602|20337731|P2|COMPLETED|Second Intervention||17
8247260|NCT01889602|20337732|P1|COMPLETED|Second Intervention||18
8247261|NCT01889602|20337730|P3|STARTED|Second Intervention||18
8247262|NCT01889602|20337731|P2|STARTED|Second Intervention||17
8247263|NCT01889602|20337732|P1|STARTED|Second Intervention||19
8247264|NCT01889602|20337730|P3|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8247265|NCT01889602|20337731|P2|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8247266|NCT01889602|20337732|P1|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8247267|NCT01889602|20337730|P3|COMPLETED|First Washout Period of at Least 2 Weeks||18
8247268|NCT01889602|20337731|P2|COMPLETED|First Washout Period of at Least 2 Weeks||17
8247269|NCT01889602|20337732|P1|COMPLETED|First Washout Period of at Least 2 Weeks||19
8247270|NCT01889602|20337730|P3|STARTED|First Washout Period of at Least 2 Weeks||18
8247271|NCT01889602|20337731|P2|STARTED|First Washout Period of at Least 2 Weeks||17
8247272|NCT01889602|20337732|P1|STARTED|First Washout Period of at Least 2 Weeks||19
8247273|NCT01889602|20337730|P3|NOT COMPLETED|First Intervention||2
8247274|NCT01889602|20337731|P2|NOT COMPLETED|First Intervention||3
8247275|NCT01889602|20337732|P1|NOT COMPLETED|First Intervention||1
8247276|NCT01889602|20337730|P3|COMPLETED|First Intervention||18
8247277|NCT01889602|20337731|P2|COMPLETED|First Intervention||17
8247278|NCT01889602|20337732|P1|COMPLETED|First Intervention||19
8247279|NCT01889602|20337730|P3|STARTED|First Intervention||20
8247280|NCT01889602|20337731|P2|STARTED|First Intervention||20
8247281|NCT01889602|20337732|P1|STARTED|First Intervention||20
8247282|NCT01889563|20337759|P2|NOT COMPLETED|Overall Study||5
8247283|NCT01889563|20337760|P1|NOT COMPLETED|Overall Study||7
8247284|NCT01889563|20337759|P2|COMPLETED|Overall Study||10
8247285|NCT01889563|20337760|P1|COMPLETED|Overall Study||10
8247286|NCT01889563|20337759|P2|STARTED|Overall Study||15
8247287|NCT01889563|20337760|P1|STARTED|Overall Study||17
8247288|NCT01889420|20337768|P1|NOT COMPLETED|Overall Study||0
8247289|NCT01889420|20337768|P1|COMPLETED|Overall Study||1
8247290|NCT01889420|20337768|P1|STARTED|Overall Study||1
8247291|NCT01889355|20337774|P1|NOT COMPLETED|Overall Study||2
8247292|NCT01889355|20337774|P1|COMPLETED|Overall Study||113
8247293|NCT01889355|20337774|P1|STARTED|Overall Study||115
8247294|NCT01889251|20337780|P2|NOT COMPLETED|Overall Study||0
8247295|NCT01889251|20337781|P1|NOT COMPLETED|Overall Study||1
8247296|NCT01889251|20337780|P2|COMPLETED|Overall Study||57
8247297|NCT01889251|20337781|P1|COMPLETED|Overall Study||114
8247298|NCT01889251|20337780|P2|STARTED|Overall Study||57
8247299|NCT01889251|20337781|P1|STARTED|Overall Study||115
8247300|NCT01889238|20337787|P1|NOT COMPLETED|Overall Study||9
8247301|NCT01889238|20337787|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
8247302|NCT01889238|20337787|P1|STARTED|Overall Study||118
8247303|NCT01889069|20337806|P1|NOT COMPLETED|Overall Study||45
8247304|NCT01889069|20337806|P1|COMPLETED|Overall Study||113
8247305|NCT01889069|20337806|P1|STARTED|Overall Study||158
8247306|NCT01888965|20337851|P1|NOT COMPLETED|Overall Study||9
8247307|NCT01888965|20337851|P1|COMPLETED|Overall Study||0
8247308|NCT01888965|20337851|P1|STARTED|Overall Study||9
8247309|NCT01888952|20337857|P1|NOT COMPLETED|Overall Study||0
8247310|NCT01888952|20337857|P1|COMPLETED|Overall Study||10
8247311|NCT01888952|20337857|P1|STARTED|Overall Study||10
8247312|NCT01888900|20337863|P2|NOT COMPLETED|Overall Study||2
8247313|NCT01888900|20337864|P1|NOT COMPLETED|Overall Study||0
8247314|NCT01888900|20337863|P2|COMPLETED|Overall Study||11
8247315|NCT01888900|20337864|P1|COMPLETED|Overall Study||22
8247316|NCT01888900|20337863|P2|STARTED|Overall Study||13
8247317|NCT01888900|20337864|P1|STARTED|Overall Study||22
8247318|NCT01888874|20337891|P7|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247319|NCT01888874|20337892|P6|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247320|NCT01888874|20337893|P5|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247321|NCT01888874|20337894|P4|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8247322|NCT01888874|20337895|P3|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
8247323|NCT01888874|20337896|P2|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8247324|NCT01888874|20337897|P1|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247325|NCT01888874|20337891|P7|COMPLETED|Period 2 (Week 13 to Week 24)||80
8247326|NCT01888874|20337892|P6|COMPLETED|Period 2 (Week 13 to Week 24)||109
8247327|NCT01888874|20337893|P5|COMPLETED|Period 2 (Week 13 to Week 24)||57
8247328|NCT01888874|20337894|P4|COMPLETED|Period 2 (Week 13 to Week 24)||78
8247329|NCT01888874|20337895|P3|COMPLETED|Period 2 (Week 13 to Week 24)||104
8247330|NCT01888874|20337896|P2|COMPLETED|Period 2 (Week 13 to Week 24)||55
8247331|NCT01888874|20337897|P1|COMPLETED|Period 2 (Week 13 to Week 24)||50
8247332|NCT01888874|20337891|P7|STARTED|Period 2 (Week 13 to Week 24)||83
8247333|NCT01888874|20337892|P6|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
8247334|NCT01888874|20337893|P5|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
8247335|NCT01888874|20337894|P4|STARTED|Period 2 (Week 13 to Week 24)||80
8247336|NCT01888874|20337895|P3|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
8247337|NCT01888874|20337896|P2|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
8247338|NCT01888874|20337897|P1|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
8247339|NCT01888874|20337891|P7|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
8247340|NCT01888874|20337892|P6|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
8247341|NCT01888874|20337893|P5|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
8247342|NCT01888874|20337894|P4|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
8247343|NCT01888874|20337895|P3|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
8247344|NCT01888874|20337896|P2|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
8247345|NCT01888874|20337897|P1|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8247346|NCT01888874|20337891|P7|COMPLETED|Period 1 (Baseline up to Week 12)||83
8247347|NCT01888874|20337892|P6|COMPLETED|Period 1 (Baseline up to Week 12)||80
8247348|NCT01888874|20337893|P5|COMPLETED|Period 1 (Baseline up to Week 12)||77
8247349|NCT01888874|20337894|P4|COMPLETED|Period 1 (Baseline up to Week 12)||80
8247350|NCT01888874|20337895|P3|COMPLETED|Period 1 (Baseline up to Week 12)||78
8247351|NCT01888874|20337896|P2|COMPLETED|Period 1 (Baseline up to Week 12)||76
8247352|NCT01888874|20337897|P1|COMPLETED|Period 1 (Baseline up to Week 12)||83
8247353|NCT01888874|20337891|P7|STARTED|Period 1 (Baseline up to Week 12)||84
8247354|NCT01888874|20337892|P6|STARTED|Period 1 (Baseline up to Week 12)||85
8247355|NCT01888874|20337893|P5|STARTED|Period 1 (Baseline up to Week 12)||86
8247356|NCT01888874|20337894|P4|STARTED|Period 1 (Baseline up to Week 12)||86
8247357|NCT01888874|20337895|P3|STARTED|Period 1 (Baseline up to Week 12)||85
8247358|NCT01888874|20337896|P2|STARTED|Period 1 (Baseline up to Week 12)||82
8247359|NCT01888874|20337897|P1|STARTED|Period 1 (Baseline up to Week 12)||86
8247360|NCT01888640|20337986|P3|NOT COMPLETED|Overall Study||5
8247361|NCT01888640|20337987|P2|NOT COMPLETED|Overall Study||31
8247362|NCT01888640|20337988|P1|NOT COMPLETED|Overall Study||27
8247363|NCT01888640|20337986|P3|COMPLETED|Overall Study||94
8247364|NCT01888640|20337987|P2|COMPLETED|Overall Study||68
8247365|NCT01888640|20337988|P1|COMPLETED|Overall Study||76
8247366|NCT01888640|20337986|P3|STARTED|Overall Study||99
8247367|NCT01888640|20337987|P2|STARTED|Overall Study||99
8247368|NCT01888640|20337988|P1|STARTED|Overall Study||103
8247369|NCT01888432|20338044|P2|NOT COMPLETED|36-month Analysis (Extension)||0
8247370|NCT01888432|20338045|P1|NOT COMPLETED|36-month Analysis (Extension)||1
8247371|NCT01888432|20338044|P2|COMPLETED|36-month Analysis (Extension)||5
8247372|NCT01888432|20338045|P1|COMPLETED|36-month Analysis (Extension)||12
8247373|NCT01888432|20338044|P2|STARTED|36-month Analysis (Extension)||5
8247374|NCT01888432|20338045|P1|STARTED|36-month Analysis (Extension)||13
8247375|NCT01888432|20338044|P2|NOT COMPLETED|24-month Analysis (FAS)||17
8247376|NCT01888432|20338045|P1|NOT COMPLETED|24-month Analysis (FAS)||17
8247377|NCT01888432|20338044|P2|COMPLETED|24-month Analysis (FAS)||125
8247378|NCT01888432|20338045|P1|COMPLETED|24-month Analysis (FAS)||125
8247379|NCT01888432|20338044|P2|STARTED|24-month Analysis (FAS)||142
8247380|NCT01888432|20338045|P1|STARTED|24-month Analysis (FAS)||142
8247381|NCT01888432|20338044|P2|NOT COMPLETED|12-month Analysis (FAS)||9
8247382|NCT01888432|20338045|P1|NOT COMPLETED|12-month Analysis (FAS)||11
8247383|NCT01888432|20338044|P2|COMPLETED|12-month Analysis (FAS)||133
8247384|NCT01888432|20338045|P1|COMPLETED|12-month Analysis (FAS)||131
8247385|NCT01888432|20338044|P2|STARTED|12-month Analysis (FAS)||142
8247386|NCT01888432|20338045|P1|STARTED|12-month Analysis (FAS)||142
8247387|NCT01888367|20338086|P3|NOT COMPLETED|Overall Study||5
8247388|NCT01888367|20338087|P2|NOT COMPLETED|Overall Study||5
8247389|NCT01888367|20338088|P1|NOT COMPLETED|Overall Study||8
8247390|NCT01888367|20338086|P3|COMPLETED|Overall Study||73
8247391|NCT01888367|20338087|P2|COMPLETED|Overall Study||66
8247392|NCT01888367|20338088|P1|COMPLETED|Overall Study||288
8247393|NCT01888367|20338086|P3|STARTED|Overall Study||78
8247394|NCT01888367|20338087|P2|STARTED|Overall Study||71
8247395|NCT01888367|20338088|P1|STARTED|Overall Study||296
8247396|NCT01888003|20338108|P3|NOT COMPLETED|Overall Study||40
8247397|NCT01888003|20338109|P2|NOT COMPLETED|Overall Study||6
8247398|NCT01888003|20338110|P1|NOT COMPLETED|Overall Study||5
8247399|NCT01888003|20338108|P3|COMPLETED|Overall Study||0
8247400|NCT01888003|20338109|P2|COMPLETED|Overall Study||0
8247401|NCT01888003|20338110|P1|COMPLETED|Overall Study||0
8247402|NCT01888003|20338108|P3|STARTED|Overall Study||40
8247403|NCT01888003|20338109|P2|STARTED|Overall Study||6
8247404|NCT01888003|20338110|P1|STARTED|Overall Study||5
8247405|NCT01887990|20338131|P4|NOT COMPLETED|Overall Study||0
8247406|NCT01887990|20338132|P3|NOT COMPLETED|Overall Study||0
8247407|NCT01887990|20338133|P2|NOT COMPLETED|Overall Study||0
8247408|NCT01887990|20338134|P1|NOT COMPLETED|Overall Study||0
8247409|NCT01887990|20338131|P4|COMPLETED|Overall Study||2
8247410|NCT01887990|20338132|P3|COMPLETED|Overall Study||2
8247411|NCT01887990|20338133|P2|COMPLETED|Overall Study||7
8247412|NCT01887990|20338134|P1|COMPLETED|Overall Study||7
8247413|NCT01887990|20338131|P4|STARTED|Overall Study||2
8247414|NCT01887990|20338132|P3|STARTED|Overall Study||2
8247415|NCT01887990|20338133|P2|STARTED|Overall Study||7
8247416|NCT01887990|20338134|P1|STARTED|Overall Study||7
8247417|NCT01887912|20338150|P2|NOT COMPLETED|Overall Study||731
8247418|NCT01887912|20338151|P1|NOT COMPLETED|Overall Study||1392
8247419|NCT01887912|20338150|P2|COMPLETED|Overall Study||2370
8247420|NCT01887912|20338151|P1|COMPLETED|Overall Study||4809
8247421|NCT01887912|20338150|P2|Safety Population|Overall Study||3057
8247422|NCT01887912|20338151|P1|Safety Population|Overall Study||6113
8247423|NCT01887912|20338150|P2|STARTED|Overall Study||3101
8247424|NCT01887912|20338151|P1|STARTED|Overall Study||6201
8247425|NCT01887717|20338179|P2|NOT COMPLETED|Overall Study||11
8247426|NCT01887717|20338180|P1|NOT COMPLETED|Overall Study||6
8247427|NCT01887717|20338179|P2|COMPLETED|Overall Study||8
8247428|NCT01887717|20338180|P1|COMPLETED|Overall Study||11
8247429|NCT01887717|20338179|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8247430|NCT01887717|20338180|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8247431|NCT01887717|20338179|P2|STARTED|Overall Study||19
8247432|NCT01887717|20338180|P1|STARTED|Overall Study||17
8247433|NCT01887678|20338202|P2|NOT COMPLETED|Overall Study||28
8247434|NCT01887678|20338203|P1|NOT COMPLETED|Overall Study||17
8247435|NCT01887678|20338202|P2|COMPLETED|Overall Study||85
8247436|NCT01887678|20338203|P1|COMPLETED|Overall Study||102
8247437|NCT01887678|20338202|P2|STARTED|Overall Study||113
8247438|NCT01887678|20338203|P1|STARTED|Overall Study||119
8247447|NCT01887587|20338358|P1|NOT COMPLETED|Overall Study||0
8247448|NCT01887587|20338358|P1|COMPLETED|Overall Study||5
8247449|NCT01887587|20338358|P1|STARTED|Overall Study||5
8247450|NCT01887470|20338367|P4|NOT COMPLETED|Overall Study||0
8247451|NCT01887470|20338368|P3|NOT COMPLETED|Overall Study||0
8247452|NCT01887470|20338369|P2|NOT COMPLETED|Overall Study||0
8247453|NCT01887470|20338370|P1|NOT COMPLETED|Overall Study||0
8247454|NCT01887470|20338367|P4|COMPLETED|Overall Study||10
8247455|NCT01887470|20338368|P3|COMPLETED|Overall Study||10
8247456|NCT01887470|20338369|P2|COMPLETED|Overall Study||10
8247457|NCT01887470|20338370|P1|COMPLETED|Overall Study||10
8247458|NCT01887470|20338367|P4|STARTED|Overall Study||10
8247459|NCT01887470|20338368|P3|STARTED|Overall Study||10
8247460|NCT01887470|20338369|P2|STARTED|Overall Study||10
8247461|NCT01887470|20338370|P1|STARTED|Overall Study||10
8247462|NCT01887418|20338389|P3|NOT COMPLETED|Overall Study||1
8247463|NCT01887418|20338390|P2|NOT COMPLETED|Overall Study||0
8247464|NCT01887418|20338391|P1|NOT COMPLETED|Overall Study||0
8247465|NCT01887418|20338389|P3|COMPLETED|Overall Study||9
8247466|NCT01887418|20338390|P2|COMPLETED|Overall Study||14
8247467|NCT01887418|20338391|P1|COMPLETED|Overall Study||15
8247468|NCT01887418|20338389|P3|STARTED|Overall Study||10
8247469|NCT01887418|20338390|P2|STARTED|Overall Study||14
8247470|NCT01887418|20338391|P1|STARTED|Overall Study||15
8247471|NCT01887353|20338410|P2|NOT COMPLETED|Overall Study||3
8247472|NCT01887353|20338411|P1|NOT COMPLETED|Overall Study||4
8247473|NCT01887353|20338410|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
8247474|NCT01887353|20338411|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
8247475|NCT01887353|20338410|P2|STARTED|Overall Study||4
8247476|NCT01887353|20338411|P1|STARTED|Overall Study||4
8247477|NCT01887327|20338420|P3|NOT COMPLETED|Overall Study||3
8247478|NCT01887327|20338421|P2|NOT COMPLETED|Overall Study||4
8247479|NCT01887327|20338422|P1|NOT COMPLETED|Overall Study||1
8247480|NCT01887327|20338420|P3|COMPLETED|Overall Study||27
8247481|NCT01887327|20338421|P2|COMPLETED|Overall Study||27
8247482|NCT01887327|20338422|P1|COMPLETED|Overall Study||29
8247483|NCT01887327|20338420|P3|STARTED|Overall Study||30
8247484|NCT01887327|20338421|P2|STARTED|Overall Study||31
8247485|NCT01887327|20338422|P1|STARTED|Overall Study||30
8247486|NCT01887288|20338439|P1|NOT COMPLETED|Overall Study||16
8247487|NCT01887288|20338439|P1|COMPLETED|Overall Study||0
8247488|NCT01887288|20338439|P1|STARTED|Overall Study||16
8247489|NCT01887210|20338446|P2|NOT COMPLETED|Overall Study||4
8247490|NCT01887210|20338447|P1|NOT COMPLETED|Overall Study||1
8247491|NCT01887210|20338446|P2|COMPLETED|Overall Study||29
8247492|NCT01887210|20338447|P1|COMPLETED|Overall Study||32
8247493|NCT01887210|20338446|P2|STARTED|Overall Study||33
8247494|NCT01887210|20338447|P1|STARTED|Overall Study||33
8247495|NCT01887171|20338461|P2|NOT COMPLETED|Overall Study||0
8247496|NCT01887171|20338462|P1|NOT COMPLETED|Overall Study||0
8247497|NCT01887171|20338461|P2|COMPLETED|Overall Study||43
8247498|NCT01887171|20338462|P1|COMPLETED|Overall Study||43
8247499|NCT01887171|20338461|P2|STARTED|Overall Study||43
8247500|NCT01887171|20338462|P1|STARTED|Overall Study||43
8247501|NCT01887132|20338468|P1|NOT COMPLETED|Overall Study||0
8247502|NCT01887132|20338468|P1|COMPLETED|Overall Study||4
8247503|NCT01887132|20338468|P1|STARTED|Overall Study||4
8247504|NCT01886963|20338475|P2|NOT COMPLETED|Overall Study||4
8247505|NCT01886963|20338476|P1|NOT COMPLETED|Overall Study||5
8247506|NCT01886963|20338475|P2|COMPLETED|Overall Study||49
8247507|NCT01886963|20338476|P1|COMPLETED|Overall Study||46
8247508|NCT01886963|20338475|P2|12 Week Follow Up|Overall Study||22
8247509|NCT01886963|20338476|P1|12 Week Follow Up|Overall Study||24
8247510|NCT01886963|20338475|P2|4 Week Follow Up|Overall Study||26
8247511|NCT01886963|20338476|P1|4 Week Follow Up|Overall Study||24
8247512|NCT01886963|20338475|P2|2 Week Follow Up|Overall Study||35
8247513|NCT01886963|20338476|P1|2 Week Follow Up|Overall Study||38
8247514|NCT01886963|20338475|P2|STARTED|Overall Study||53
8247515|NCT01886963|20338476|P1|STARTED|Overall Study||51
8247516|NCT01886937|20338484|P2|NOT COMPLETED|Overall Study||0
8247517|NCT01886937|20338485|P1|NOT COMPLETED|Overall Study||0
8247518|NCT01886937|20338484|P2|COMPLETED|Overall Study||6
8247519|NCT01886937|20338485|P1|COMPLETED|Overall Study||7
8247520|NCT01886937|20338484|P2|STARTED|Overall Study||6
8247521|NCT01886937|20338485|P1|STARTED|Overall Study||7
8247522|NCT01886872|20338494|P3|NOT COMPLETED|Overall Study||12
8247523|NCT01886872|20338495|P2|NOT COMPLETED|Overall Study||4
8247524|NCT01886872|20338496|P1|NOT COMPLETED|Overall Study||7
8247525|NCT01886872|20338494|P3|COMPLETED|Overall Study||170
8247526|NCT01886872|20338495|P2|COMPLETED|Overall Study||178
8247527|NCT01886872|20338496|P1|COMPLETED|Overall Study||176
8247528|NCT01886872|20338494|P3|Crossover Cohort|Overall Study||0
8247529|NCT01886872|20338495|P2|Crossover Cohort|Overall Study||0
8247530|NCT01886872|20338496|P1|Crossover Cohort|Overall Study||30
8247531|NCT01886872|20338494|P3|Evaluable for Adverse Events|Overall Study||181
8247532|NCT01886872|20338495|P2|Evaluable for Adverse Events|Overall Study||180
8247533|NCT01886872|20338496|P1|Evaluable for Adverse Events|Overall Study||176
8247534|NCT01886872|20338494|P3|Evaluable for Secondary Endpoints|Overall Study||182
8247535|NCT01886872|20338495|P2|Evaluable for Secondary Endpoints|Overall Study||182
8247536|NCT01886872|20338496|P1|Evaluable for Secondary Endpoints|Overall Study||183
8247537|NCT01886872|20338494|P3|STARTED|Overall Study||182
8247538|NCT01886872|20338495|P2|STARTED|Overall Study||182
8247539|NCT01886872|20338496|P1|STARTED|Overall Study||183
8247540|NCT01886833|20338529|P1|NOT COMPLETED|Overall Study||204
8247541|NCT01886833|20338529|P1|COMPLETED|Overall Study||216
8247542|NCT01886833|20338529|P1|STARTED|Overall Study||420
8247543|NCT01886807|20338540|P3|NOT COMPLETED|Overall Study||10
8247544|NCT01886807|20338541|P2|NOT COMPLETED|Overall Study||10
8247545|NCT01886807|20338542|P1|NOT COMPLETED|Overall Study||5
8247546|NCT01886807|20338540|P3|COMPLETED|Overall Study||153
8247547|NCT01886807|20338541|P2|COMPLETED|Overall Study||145
8247548|NCT01886807|20338542|P1|COMPLETED|Overall Study||159
8247549|NCT01886807|20338540|P3|STARTED|Overall Study||163
8247550|NCT01886807|20338541|P2|STARTED|Overall Study||155
8247551|NCT01886807|20338542|P1|STARTED|Overall Study||164
8247552|NCT01886781|20338561|P2|NOT COMPLETED|Overall Study||2
8247553|NCT01886781|20338562|P1|NOT COMPLETED|Overall Study||14
8247554|NCT01886781|20338561|P2|COMPLETED|Overall Study||25
8247555|NCT01886781|20338562|P1|COMPLETED|Overall Study||40
8247556|NCT01886781|20338561|P2|STARTED|Overall Study||27
8247557|NCT01886781|20338562|P1|STARTED|Overall Study||54
8247558|NCT01886716|20338572|P4|NOT COMPLETED|1-Month Post Follow-Up||0
8247559|NCT01886716|20338573|P3|NOT COMPLETED|1-Month Post Follow-Up||0
8247560|NCT01886716|20338574|P2|NOT COMPLETED|1-Month Post Follow-Up||0
8247561|NCT01886716|20338575|P1|NOT COMPLETED|1-Month Post Follow-Up||0
8247562|NCT01886716|20338572|P4|COMPLETED|1-Month Post Follow-Up||14
8247563|NCT01886716|20338573|P3|COMPLETED|1-Month Post Follow-Up||19
8247564|NCT01886716|20338574|P2|COMPLETED|1-Month Post Follow-Up||17
8247565|NCT01886716|20338575|P1|COMPLETED|1-Month Post Follow-Up||20
8247566|NCT01886716|20338572|P4|STARTED|1-Month Post Follow-Up||14
8247567|NCT01886716|20338573|P3|STARTED|1-Month Post Follow-Up||19
8247568|NCT01886716|20338574|P2|STARTED|1-Month Post Follow-Up||17
8247569|NCT01886716|20338575|P1|STARTED|1-Month Post Follow-Up||20
8247570|NCT01886716|20338572|P4|NOT COMPLETED|1-Week Post Follow-Up||0
8247571|NCT01886716|20338573|P3|NOT COMPLETED|1-Week Post Follow-Up||0
8247572|NCT01886716|20338574|P2|NOT COMPLETED|1-Week Post Follow-Up||0
8247573|NCT01886716|20338575|P1|NOT COMPLETED|1-Week Post Follow-Up||0
8247574|NCT01886716|20338572|P4|COMPLETED|1-Week Post Follow-Up||14
8247575|NCT01886716|20338573|P3|COMPLETED|1-Week Post Follow-Up||19
8247576|NCT01886716|20338574|P2|COMPLETED|1-Week Post Follow-Up||17
8247577|NCT01886716|20338575|P1|COMPLETED|1-Week Post Follow-Up||20
8247578|NCT01886716|20338572|P4|STARTED|1-Week Post Follow-Up||14
8247579|NCT01886716|20338573|P3|STARTED|1-Week Post Follow-Up||19
8247580|NCT01886716|20338574|P2|STARTED|1-Week Post Follow-Up||17
8247581|NCT01886716|20338575|P1|STARTED|1-Week Post Follow-Up||20
8247582|NCT01886716|20338572|P4|NOT COMPLETED|Week 4||0
8247583|NCT01886716|20338573|P3|NOT COMPLETED|Week 4||0
8247584|NCT01886716|20338574|P2|NOT COMPLETED|Week 4||0
8247585|NCT01886716|20338575|P1|NOT COMPLETED|Week 4||0
8247586|NCT01886716|20338572|P4|COMPLETED|Week 4||14
8247587|NCT01886716|20338573|P3|COMPLETED|Week 4||19
8247588|NCT01886716|20338574|P2|COMPLETED|Week 4||17
8247589|NCT01886716|20338575|P1|COMPLETED|Week 4||20
8247590|NCT01886716|20338572|P4|STARTED|Week 4||14
8247591|NCT01886716|20338573|P3|STARTED|Week 4||19
8247592|NCT01886716|20338574|P2|STARTED|Week 4||17
8247593|NCT01886716|20338575|P1|STARTED|Week 4||20
8247594|NCT01886716|20338572|P4|NOT COMPLETED|Week 3||1
8247595|NCT01886716|20338573|P3|NOT COMPLETED|Week 3||0
8247596|NCT01886716|20338574|P2|NOT COMPLETED|Week 3||1
8247597|NCT01886716|20338575|P1|NOT COMPLETED|Week 3||1
8247598|NCT01886716|20338572|P4|COMPLETED|Week 3||14
8247599|NCT01886716|20338573|P3|COMPLETED|Week 3||19
8247600|NCT01886716|20338574|P2|COMPLETED|Week 3||17
8247601|NCT01886716|20338575|P1|COMPLETED|Week 3||20
8247602|NCT01886716|20338572|P4|STARTED|Week 3||15
8247603|NCT01886716|20338573|P3|STARTED|Week 3||19
8247604|NCT01886716|20338574|P2|STARTED|Week 3||18
8247605|NCT01886716|20338575|P1|STARTED|Week 3||21
8247606|NCT01886716|20338572|P4|NOT COMPLETED|Week 2||3
8247607|NCT01886716|20338573|P3|NOT COMPLETED|Week 2||1
8247608|NCT01886716|20338574|P2|NOT COMPLETED|Week 2||2
8247609|NCT01886716|20338575|P1|NOT COMPLETED|Week 2||3
8247610|NCT01886716|20338572|P4|COMPLETED|Week 2||15
8247611|NCT01886716|20338573|P3|COMPLETED|Week 2||19
8247612|NCT01886716|20338574|P2|COMPLETED|Week 2||18
8247613|NCT01886716|20338575|P1|COMPLETED|Week 2||21
8247614|NCT01886716|20338572|P4|STARTED|Week 2||18
8247615|NCT01886716|20338573|P3|STARTED|Week 2||20
8247616|NCT01886716|20338574|P2|STARTED|Week 2||20
8247617|NCT01886716|20338575|P1|STARTED|Week 2||24
8247618|NCT01886716|20338572|P4|NOT COMPLETED|Week 1||2
8247619|NCT01886716|20338573|P3|NOT COMPLETED|Week 1||2
8247620|NCT01886716|20338574|P2|NOT COMPLETED|Week 1||0
8247621|NCT01886716|20338575|P1|NOT COMPLETED|Week 1||0
8247622|NCT01886716|20338572|P4|COMPLETED|Week 1||18
8247623|NCT01886716|20338573|P3|COMPLETED|Week 1||20
8247624|NCT01886716|20338574|P2|COMPLETED|Week 1||20
8247625|NCT01886716|20338575|P1|COMPLETED|Week 1||24
8247626|NCT01886716|20338572|P4|STARTED|Week 1||20
8247627|NCT01886716|20338573|P3|STARTED|Week 1||22
8247628|NCT01886716|20338574|P2|STARTED|Week 1||20
8247629|NCT01886716|20338575|P1|STARTED|Week 1||24
8247630|NCT01886690|20338591|P2|NOT COMPLETED|Overall Study||2
8247631|NCT01886690|20338592|P1|NOT COMPLETED|Overall Study||0
8247632|NCT01886690|20338591|P2|COMPLETED|Overall Study||71
8247633|NCT01886690|20338592|P1|COMPLETED|Overall Study||75
8247634|NCT01886690|20338591|P2|STARTED|Overall Study||73
8247635|NCT01886690|20338592|P1|STARTED|Overall Study||75
8247636|NCT01886313|20338608|P2|NOT COMPLETED|Overall Study||1
8247637|NCT01886313|20338609|P1|NOT COMPLETED|Overall Study||1
8247638|NCT01886313|20338608|P2|COMPLETED|Overall Study||4
8247639|NCT01886313|20338609|P1|COMPLETED|Overall Study||5
8247640|NCT01886313|20338608|P2|STARTED|Overall Study||5
8247641|NCT01886313|20338609|P1|STARTED|Overall Study||6
8247642|NCT01886300|20338615|P1|NOT COMPLETED|Overall Study||16
8247643|NCT01886300|20338615|P1|COMPLETED|Overall Study||0
8247644|NCT01886300|20338615|P1|STARTED|Overall Study||16
8247645|NCT01886287|20338626|P1|NOT COMPLETED|Overall Study||2
8247646|NCT01886287|20338626|P1|COMPLETED|Overall Study||0
8247647|NCT01886287|20338626|P1|STARTED|Overall Study||2
8247648|NCT01886235|20338631|P1|NOT COMPLETED|Overall Study||0
8247649|NCT01886235|20338631|P1|COMPLETED|Overall Study||10
8247650|NCT01886235|20338631|P1|STARTED|Overall Study||10
8247651|NCT01886105|20338642|P1|NOT COMPLETED|Overall Study||3
8247652|NCT01886105|20338642|P1|COMPLETED|Overall Study||1
8247653|NCT01886105|20338642|P1|STARTED|Overall Study||4
8247654|NCT01885936|20338649|P2|NOT COMPLETED|Overall Study||0
8247655|NCT01885936|20338650|P1|NOT COMPLETED|Overall Study||1
8247656|NCT01885936|20338649|P2|COMPLETED|Overall Study||5
8247657|NCT01885936|20338650|P1|COMPLETED|Overall Study||7
8247658|NCT01885936|20338649|P2|STARTED|Overall Study||5
8247659|NCT01885936|20338650|P1|STARTED|Overall Study||8
8247660|NCT01885910|20338660|P1|NOT COMPLETED|Overall Study||8
8247661|NCT01885910|20338660|P1|COMPLETED|Overall Study||24
8247662|NCT01885910|20338660|P1|STARTED|Overall Study||32
8247663|NCT01885897|20338680|P6|NOT COMPLETED|Overall Study||0
8247664|NCT01885897|20338681|P5|NOT COMPLETED|Overall Study||0
8247665|NCT01885897|20338682|P4|NOT COMPLETED|Overall Study||0
8247666|NCT01885897|20338683|P3|NOT COMPLETED|Overall Study||0
8247667|NCT01885897|20338684|P2|NOT COMPLETED|Overall Study||0
8247668|NCT01885897|20338685|P1|NOT COMPLETED|Overall Study||0
8247669|NCT01885897|20338680|P6|COMPLETED|Overall Study||9
8247670|NCT01885897|20338681|P5|COMPLETED|Overall Study||8
8247671|NCT01885897|20338682|P4|COMPLETED|Overall Study||3
8247672|NCT01885897|20338683|P3|COMPLETED|Overall Study||4
8247673|NCT01885897|20338684|P2|COMPLETED|Overall Study||3
8247674|NCT01885897|20338685|P1|COMPLETED|Overall Study||6
8247675|NCT01885897|20338680|P6|STARTED|Overall Study||9
8247676|NCT01885897|20338681|P5|STARTED|Overall Study||8
8247677|NCT01885897|20338682|P4|STARTED|Overall Study||3
8247678|NCT01885897|20338683|P3|STARTED|Overall Study||4
8247679|NCT01885897|20338684|P2|STARTED|Overall Study||3
8247680|NCT01885897|20338685|P1|STARTED|Overall Study||6
8247681|NCT01885871|20338723|P1|NOT COMPLETED|Overall Study||0
8247682|NCT01885871|20338723|P1|COMPLETED|Overall Study||20
8247683|NCT01885871|20338723|P1|STARTED|Overall Study||20
8247684|NCT01885559|20338733|P2|NOT COMPLETED|Overall Study||36
8247685|NCT01885559|20338734|P1|NOT COMPLETED|Overall Study||24
8247686|NCT01885559|20338733|P2|COMPLETED|Overall Study||208
8247687|NCT01885559|20338734|P1|COMPLETED|Overall Study||218
8247688|NCT01885559|20338733|P2|STARTED|Overall Study||244
8247689|NCT01885559|20338734|P1|STARTED|Overall Study||242
8247690|NCT01885208|20338756|P2|NOT COMPLETED|Overall Study||38
8247691|NCT01885208|20338757|P1|NOT COMPLETED|Overall Study||32
8247692|NCT01885208|20338756|P2|COMPLETED|Overall Study||369
8247693|NCT01885208|20338757|P1|COMPLETED|Overall Study||374
8247694|NCT01885208|20338756|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
8247695|NCT01885208|20338757|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
8247696|NCT01885208|20338756|P2|Exposed|Overall Study||405
8247697|NCT01885208|20338757|P1|Exposed|Overall Study||404
8247698|NCT01885208|20338756|P2|STARTED|Overall Study||407
8247699|NCT01885208|20338757|P1|STARTED|Overall Study||406
8247700|NCT01885182|20338775|P2|NOT COMPLETED|Overall Study||22
8247701|NCT01885182|20338776|P1|NOT COMPLETED|Overall Study||34
8247702|NCT01885182|20338775|P2|COMPLETED|Overall Study||93
8247703|NCT01885182|20338776|P1|COMPLETED|Overall Study||83
8247704|NCT01885182|20338775|P2|FAP Population|Overall Study||106
8247705|NCT01885182|20338776|P1|FAP Population|Overall Study||107
8247706|NCT01885182|20338775|P2|Safety Population|Overall Study||111
8247707|NCT01885182|20338776|P1|Safety Population|Overall Study||114
8247708|NCT01885182|20338775|P2|STARTED|Overall Study||115
8247709|NCT01885182|20338776|P1|STARTED|Overall Study||117
8247710|NCT01885117|20338800|P2|NOT COMPLETED|Overall Study||0
8247711|NCT01885117|20338801|P1|NOT COMPLETED|Overall Study||0
8247712|NCT01885117|20338800|P2|COMPLETED|Overall Study||64
8247713|NCT01885117|20338801|P1|COMPLETED|Overall Study||61
8247714|NCT01885117|20338800|P2|STARTED|Overall Study||64
8247715|NCT01885117|20338801|P1|STARTED|Overall Study||61
8247716|NCT01885104|20338823|P2|NOT COMPLETED|Overall Study||1
8247717|NCT01885104|20338824|P1|NOT COMPLETED|Overall Study||2
8247718|NCT01885104|20338823|P2|COMPLETED|Overall Study||33
8247719|NCT01885104|20338824|P1|COMPLETED|Overall Study||29
8247720|NCT01885104|20338823|P2|STARTED|Overall Study||34
8247721|NCT01885104|20338824|P1|STARTED|Overall Study||31
8247722|NCT01885000|20338834|P2|NOT COMPLETED|Overall Study||2
8247723|NCT01885000|20338835|P1|NOT COMPLETED|Overall Study||2
8247724|NCT01885000|20338834|P2|COMPLETED|Overall Study||42
8247725|NCT01885000|20338835|P1|COMPLETED|Overall Study||46
8247726|NCT01885000|20338834|P2|STARTED|Overall Study||44
8247727|NCT01885000|20338835|P1|STARTED|Overall Study||48
8247728|NCT01884844|20338849|P2|NOT COMPLETED|Overall Study||5
8247729|NCT01884844|20338850|P1|NOT COMPLETED|Overall Study||3
8247730|NCT01884844|20338849|P2|COMPLETED|Overall Study||12
8247731|NCT01884844|20338850|P1|COMPLETED|Overall Study||13
8247732|NCT01884844|20338849|P2|STARTED|Overall Study||17
8247733|NCT01884844|20338850|P1|STARTED|Overall Study||16
8247734|NCT01884688|20338856|P1|NOT COMPLETED|Overall Study||2
8247735|NCT01884688|20338856|P1|COMPLETED|Overall Study||1
8247736|NCT01884688|20338856|P1|STARTED|Overall Study||3
8247737|NCT01884675|20338862|P2|NOT COMPLETED|Overall Study||2
8247738|NCT01884675|20338863|P1|NOT COMPLETED|Overall Study||3
8247739|NCT01884675|20338862|P2|COMPLETED|Overall Study||15
8247740|NCT01884675|20338863|P1|COMPLETED|Overall Study||13
8247741|NCT01884675|20338862|P2|STARTED|Overall Study||17
8247742|NCT01884675|20338863|P1|STARTED|Overall Study||16
8247743|NCT01884597|20338906|P3|NOT COMPLETED|Overall Study||1
8247744|NCT01884597|20338907|P2|NOT COMPLETED|Overall Study||1
8247745|NCT01884597|20338908|P1|NOT COMPLETED|Overall Study||1
8247746|NCT01884597|20338906|P3|COMPLETED|Overall Study||15
8247747|NCT01884597|20338907|P2|COMPLETED|Overall Study||2
8247748|NCT01884597|20338908|P1|COMPLETED|Overall Study||4
8247749|NCT01884597|20338906|P3|STARTED|Overall Study||16
8247750|NCT01884597|20338907|P2|STARTED|Overall Study||3
8247751|NCT01884597|20338908|P1|STARTED|Overall Study||5
8247752|NCT01884571|20338937|P1|NOT COMPLETED|Overall Study||8
8247753|NCT01884571|20338937|P1|COMPLETED|Overall Study||23
8247754|NCT01884571|20338937|P1|STARTED|Overall Study||31
8247755|NCT01884545|20338952|P4|NOT COMPLETED|Overall Study||9
8247756|NCT01884545|20338953|P3|NOT COMPLETED|Overall Study||14
8247757|NCT01884545|20338954|P2|NOT COMPLETED|Overall Study||18
8247758|NCT01884545|20338955|P1|NOT COMPLETED|Overall Study||13
8247759|NCT01884545|20338952|P4|COMPLETED|Overall Study||43
8247760|NCT01884545|20338953|P3|COMPLETED|Overall Study||35
8247761|NCT01884545|20338954|P2|COMPLETED|Overall Study||31
8247762|NCT01884545|20338955|P1|COMPLETED|Overall Study||37
8247763|NCT01884545|20338952|P4|STARTED|Overall Study||52
8247764|NCT01884545|20338953|P3|STARTED|Overall Study||49
8247765|NCT01884545|20338954|P2|STARTED|Overall Study||49
8247766|NCT01884545|20338955|P1|STARTED|Overall Study||50
8247767|NCT01884519|20339063|P2|NOT COMPLETED|Overall Study||0
8247768|NCT01884519|20339064|P1|NOT COMPLETED|Overall Study||0
8247769|NCT01884519|20339063|P2|COMPLETED|Overall Study||60
8247770|NCT01884519|20339064|P1|COMPLETED|Overall Study||60
8247771|NCT01884519|20339063|P2|STARTED|Overall Study||60
8247772|NCT01884519|20339064|P1|STARTED|Overall Study||60
8247773|NCT01884350|20339108|P3|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
8247774|NCT01884350|20339109|P2|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
8247775|NCT01884350|20339110|P1|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
8247776|NCT01884350|20339108|P3|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
8247777|NCT01884350|20339109|P2|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
8247778|NCT01884350|20339110|P1|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
8247779|NCT01884350|20339108|P3|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
8247780|NCT01884350|20339109|P2|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
8247781|NCT01884350|20339110|P1|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
8247782|NCT01884350|20339108|P3|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
8247783|NCT01884350|20339109|P2|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
8247784|NCT01884350|20339110|P1|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
8247785|NCT01884350|20339108|P3|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
8247786|NCT01884350|20339109|P2|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
8247787|NCT01884350|20339110|P1|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
8247788|NCT01884350|20339108|P3|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
8247789|NCT01884350|20339109|P2|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
8247790|NCT01884350|20339110|P1|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
8247791|NCT01884350|20339108|P3|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
8247792|NCT01884350|20339109|P2|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
8247793|NCT01884350|20339110|P1|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
8247794|NCT01884350|20339108|P3|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
8247795|NCT01884350|20339109|P2|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
8247796|NCT01884350|20339110|P1|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
8247797|NCT01884337|20339133|P2|NOT COMPLETED|Follow-up Period||1
8247798|NCT01884337|20339134|P1|NOT COMPLETED|Follow-up Period||1
8247799|NCT01884337|20339133|P2|COMPLETED|Follow-up Period||170
8247800|NCT01884337|20339134|P1|COMPLETED|Follow-up Period||323
8247801|NCT01884337|20339133|P2|STARTED|Follow-up Period||171
8247802|NCT01884337|20339134|P1|STARTED|Follow-up Period||324
8247803|NCT01884337|20339133|P2|NOT COMPLETED|Treatment||2
8247804|NCT01884337|20339134|P1|NOT COMPLETED|Treatment||4
8247805|NCT01884337|20339133|P2|COMPLETED|Treatment||170
8247806|NCT01884337|20339134|P1|COMPLETED|Treatment||322
8247807|NCT01884337|20339133|P2|Continuing Into Follow-up Period|Treatment||171
8247808|NCT01884337|20339134|P1|Continuing Into Follow-up Period|Treatment||324
8247809|NCT01884337|20339133|P2|STARTED|Treatment||172
8247810|NCT01884337|20339134|P1|STARTED|Treatment||326
8247811|NCT01884311|20339142|P1|NOT COMPLETED|Overall Study||5
8247812|NCT01884311|20339142|P1|COMPLETED|Overall Study||33
8247813|NCT01884311|20339142|P1|STARTED|Overall Study||38
8247814|NCT01884077|20339152|P2|NOT COMPLETED|Overall Study||10
8247815|NCT01884077|20339153|P1|NOT COMPLETED|Overall Study||8
8247816|NCT01884077|20339152|P2|COMPLETED|Overall Study||1
8247817|NCT01884077|20339153|P1|COMPLETED|Overall Study||0
8247818|NCT01884077|20339152|P2|STARTED|Overall Study||11
8247819|NCT01884077|20339153|P1|STARTED|Overall Study||8
8247820|NCT01884064|20339165|P2|NOT COMPLETED|Overall Study||0
8247821|NCT01884064|20339166|P1|NOT COMPLETED|Overall Study||0
8247822|NCT01884064|20339165|P2|COMPLETED|Overall Study||5
8247823|NCT01884064|20339166|P1|COMPLETED|Overall Study||12
8247824|NCT01884064|20339165|P2|STARTED|Overall Study||5
8247825|NCT01884064|20339166|P1|STARTED|Overall Study||12
8247826|NCT01884025|20339174|P2|NOT COMPLETED|Overall Study||4
8247827|NCT01884025|20339175|P1|NOT COMPLETED|Overall Study||3
8247828|NCT01884025|20339174|P2|COMPLETED|Overall Study||10
8247829|NCT01884025|20339175|P1|COMPLETED|Overall Study||10
8247830|NCT01884025|20339174|P2|STARTED|Overall Study||14
8247831|NCT01884025|20339175|P1|STARTED|Overall Study||13
8247832|NCT01883999|20339203|P1|NOT COMPLETED|Overall Study||3
8247833|NCT01883999|20339203|P1|COMPLETED|Overall Study||61
8247834|NCT01883999|20339203|P1|STARTED|Overall Study||64
8247835|NCT01883986|20339211|P2|NOT COMPLETED|Overall Study||1
8247836|NCT01883986|20339212|P1|NOT COMPLETED|Overall Study||3
8247837|NCT01883986|20339211|P2|COMPLETED|Overall Study|Completed study|19
8247838|NCT01883986|20339212|P1|COMPLETED|Overall Study|Received allocated intervention|17
8247839|NCT01883986|20339211|P2|Did Not Complete Study|Overall Study|Did not completed study|1
8247840|NCT01883986|20339212|P1|Did Not Complete Study|Overall Study||3
8247841|NCT01883986|20339211|P2|STARTED|Overall Study|Allocated to usual care arm|20
8247842|NCT01883986|20339212|P1|STARTED|Overall Study|Allocated to intervention arm|20
8247843|NCT01883908|20339226|P2|NOT COMPLETED|Overall Study||0
8247844|NCT01883908|20339227|P1|NOT COMPLETED|Overall Study||0
8247845|NCT01883908|20339226|P2|COMPLETED|Overall Study||1
8247846|NCT01883908|20339227|P1|COMPLETED|Overall Study||3
8247847|NCT01883908|20339226|P2|STARTED|Overall Study||1
8247848|NCT01883908|20339227|P1|STARTED|Overall Study||3
8247849|NCT01883895|20339235|P1|NOT COMPLETED|Overall Study||2
8247850|NCT01883895|20339235|P1|COMPLETED|Overall Study||32
8247851|NCT01883895|20339235|P1|STARTED|Overall Study||34
8247852|NCT01883856|20339242|P2|NOT COMPLETED|Overall Study||0
8247853|NCT01883856|20339243|P1|NOT COMPLETED|Overall Study||0
8247854|NCT01883856|20339242|P2|COMPLETED|Overall Study||26
8247855|NCT01883856|20339243|P1|COMPLETED|Overall Study||26
8247856|NCT01883856|20339242|P2|STARTED|Overall Study||26
8247857|NCT01883856|20339243|P1|STARTED|Overall Study||26
8247858|NCT01883804|20339253|P1|NOT COMPLETED|Overall Study||5
8247859|NCT01883804|20339253|P1|COMPLETED|Overall Study||20
8247860|NCT01883804|20339253|P1|STARTED|Overall Study||25
8247861|NCT01883635|20339262|P2|NOT COMPLETED|Overall Study||0
8247862|NCT01883635|20339263|P1|NOT COMPLETED|Overall Study||4
8247863|NCT01883635|20339262|P2|COMPLETED|Overall Study||20
8247864|NCT01883635|20339263|P1|COMPLETED|Overall Study||20
8247865|NCT01883635|20339262|P2|STARTED|Overall Study||20
8247866|NCT01883635|20339263|P1|STARTED|Overall Study||24
8247867|NCT01883492|20339277|P2|NOT COMPLETED|Overall Study||11
8247868|NCT01883492|20339278|P1|NOT COMPLETED|Overall Study||13
8247869|NCT01883492|20339277|P2|COMPLETED|Overall Study||67
8247870|NCT01883492|20339278|P1|COMPLETED|Overall Study||62
8247871|NCT01883492|20339277|P2|STARTED|Overall Study||78
8247872|NCT01883492|20339278|P1|STARTED|Overall Study||75
8247873|NCT01883453|20339310|P2|NOT COMPLETED|Overall Study||23
8247874|NCT01883453|20339311|P1|NOT COMPLETED|Overall Study||25
8247875|NCT01883453|20339310|P2|COMPLETED|Overall Study||50
8247876|NCT01883453|20339311|P1|COMPLETED|Overall Study||48
8247877|NCT01883453|20339310|P2|STARTED|Overall Study||73
8247878|NCT01883453|20339311|P1|STARTED|Overall Study||73
8247879|NCT01883440|20339319|P2|NOT COMPLETED|Overall Study||0
8247880|NCT01883440|20339320|P1|NOT COMPLETED|Overall Study||3
8247881|NCT01883440|20339319|P2|COMPLETED|Overall Study||45
8247882|NCT01883440|20339320|P1|COMPLETED|Overall Study||42
8247883|NCT01883440|20339319|P2|STARTED|Overall Study||45
8247884|NCT01883440|20339320|P1|STARTED|Overall Study||45
8247885|NCT01883427|20339330|P2|NOT COMPLETED|Overall Study||0
8247886|NCT01883427|20339331|P1|NOT COMPLETED|Overall Study||0
8247887|NCT01883427|20339330|P2|COMPLETED|Overall Study||20
8247888|NCT01883427|20339331|P1|COMPLETED|Overall Study||20
8247889|NCT01883427|20339330|P2|STARTED|Overall Study||20
8247890|NCT01883427|20339331|P1|STARTED|Overall Study||20
8247891|NCT01883141|20339337|P1|NOT COMPLETED|Overall Study||0
8247892|NCT01883141|20339337|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
8247893|NCT01883141|20339337|P1|Multivein|Overall Study||23
8247894|NCT01883141|20339337|P1|Biv Pacing-Posterior|Overall Study||22
8247895|NCT01883141|20339337|P1|BiV Pacing-Anterior|Overall Study||23
8247896|NCT01883141|20339337|P1|Multispot-pacing|Overall Study||24
8247897|NCT01883141|20339337|P1|BiV Pacing-Standard Therapy|Overall Study||26
8247898|NCT01883141|20339337|P1|BiV Pacing-Mid|Overall Study||25
8247899|NCT01883141|20339337|P1|BiV Pacing-Distal|Overall Study||24
8247900|NCT01883141|20339337|P1|Usable EP Data|Overall Study||26
8247901|NCT01883141|20339337|P1|EP Study Performed|Overall Study||30
8247902|NCT01883141|20339337|P1|Passing Eligibility|Overall Study||30
8247903|NCT01883141|20339337|P1|STARTED|Overall Study||31
8247904|NCT01882985|20339346|P1|NOT COMPLETED|Overall Study||2
8247905|NCT01882985|20339346|P1|COMPLETED|Overall Study||12
8247906|NCT01882985|20339346|P1|STARTED|Overall Study||14
8247907|NCT01882907|20339355|P2|NOT COMPLETED|Overall Study||28
8247908|NCT01882907|20339356|P1|NOT COMPLETED|Overall Study||14
8247909|NCT01882907|20339355|P2|COMPLETED|Overall Study||83
8247910|NCT01882907|20339356|P1|COMPLETED|Overall Study||103
8247911|NCT01882907|20339355|P2|STARTED|Overall Study||111
8247912|NCT01882907|20339356|P1|STARTED|Overall Study||117
8247913|NCT01882868|20339372|P1|NOT COMPLETED|Overall Study||0
8247914|NCT01882868|20339372|P1|COMPLETED|Overall Study||62
8247915|NCT01882868|20339372|P1|STARTED|Overall Study||62
8247916|NCT01882829|20339402|P1|NOT COMPLETED|Overall Study||6
8247917|NCT01882829|20339402|P1|COMPLETED|Overall Study||14
8247918|NCT01882829|20339402|P1|STARTED|Overall Study||20
8247919|NCT01882803|20339416|P1|NOT COMPLETED|Overall Study||94
8247920|NCT01882803|20339416|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
8247921|NCT01882803|20339416|P1|STARTED|Overall Study||129
8247922|NCT01882764|20339429|P2|NOT COMPLETED|Overall Study||18
8247923|NCT01882764|20339430|P1|NOT COMPLETED|Overall Study||47
8247924|NCT01882764|20339429|P2|COMPLETED|Overall Study||1
8247925|NCT01882764|20339430|P1|COMPLETED|Overall Study||0
8247926|NCT01882764|20339429|P2|STARTED|Overall Study||19
8247927|NCT01882764|20339430|P1|STARTED|Overall Study||47
8247928|NCT01882725|20339436|P1|NOT COMPLETED|Overall Study||0
8247929|NCT01882725|20339436|P1|COMPLETED|Overall Study||14
8247930|NCT01882725|20339436|P1|STARTED|Overall Study||14
8247931|NCT01882647|20339443|P2|NOT COMPLETED|Overall Study||6
8247932|NCT01882647|20339444|P1|NOT COMPLETED|Overall Study||2
8247933|NCT01882647|20339443|P2|COMPLETED|Overall Study||106
8247934|NCT01882647|20339444|P1|COMPLETED|Overall Study||108
8247935|NCT01882647|20339443|P2|STARTED|Overall Study||112
8247936|NCT01882647|20339444|P1|STARTED|Overall Study||110
8247937|NCT01882543|20339462|P2|NOT COMPLETED|Overall Study||3
8247938|NCT01882543|20339463|P1|NOT COMPLETED|Overall Study||4
8247939|NCT01882543|20339462|P2|COMPLETED|Overall Study||29
8247940|NCT01882543|20339463|P1|COMPLETED|Overall Study||33
8247941|NCT01882543|20339462|P2|STARTED|Overall Study||32
8247942|NCT01882543|20339463|P1|STARTED|Overall Study||37
8247943|NCT01882465|20339484|P7|NOT COMPLETED|Period 3||0
8247944|NCT01882465|20339485|P6|NOT COMPLETED|Period 3||0
8247945|NCT01882465|20339486|P5|NOT COMPLETED|Period 3||0
8247946|NCT01882465|20339487|P4|NOT COMPLETED|Period 3||0
8247947|NCT01882465|20339488|P3|NOT COMPLETED|Period 3||0
8247948|NCT01882465|20339489|P2|NOT COMPLETED|Period 3||0
8247949|NCT01882465|20339490|P1|NOT COMPLETED|Period 3||0
8247950|NCT01882465|20339484|P7|COMPLETED|Period 3||0
8247951|NCT01882465|20339485|P6|COMPLETED|Period 3||5
8247952|NCT01882465|20339486|P5|COMPLETED|Period 3||4
8247953|NCT01882465|20339487|P4|COMPLETED|Period 3||5
8247954|NCT01882465|20339488|P3|COMPLETED|Period 3||5
8247955|NCT01882465|20339489|P2|COMPLETED|Period 3||6
8247956|NCT01882465|20339490|P1|COMPLETED|Period 3||6
8247957|NCT01882465|20339484|P7|STARTED|Period 3||0
8247958|NCT01882465|20339485|P6|STARTED|Period 3||5
8247959|NCT01882465|20339486|P5|STARTED|Period 3||4
8247960|NCT01882465|20339487|P4|STARTED|Period 3||5
8247961|NCT01882465|20339488|P3|STARTED|Period 3||5
8247962|NCT01882465|20339489|P2|STARTED|Period 3||6
8247963|NCT01882465|20339490|P1|STARTED|Period 3||6
8247964|NCT01882465|20339484|P7|NOT COMPLETED|Period 2||0
8247965|NCT01882465|20339485|P6|NOT COMPLETED|Period 2||0
8247966|NCT01882465|20339486|P5|NOT COMPLETED|Period 2||1
8247967|NCT01882465|20339487|P4|NOT COMPLETED|Period 2||0
8247968|NCT01882465|20339488|P3|NOT COMPLETED|Period 2||0
8247969|NCT01882465|20339489|P2|NOT COMPLETED|Period 2||0
8247970|NCT01882465|20339490|P1|NOT COMPLETED|Period 2||0
8247971|NCT01882465|20339484|P7|COMPLETED|Period 2||0
8247972|NCT01882465|20339485|P6|COMPLETED|Period 2||5
8247973|NCT01882465|20339486|P5|COMPLETED|Period 2||4
8247974|NCT01882465|20339487|P4|COMPLETED|Period 2||5
8247975|NCT01882465|20339488|P3|COMPLETED|Period 2||5
8247976|NCT01882465|20339489|P2|COMPLETED|Period 2||6
8247977|NCT01882465|20339490|P1|COMPLETED|Period 2||6
8247978|NCT01882465|20339484|P7|STARTED|Period 2||0
8247979|NCT01882465|20339485|P6|STARTED|Period 2||5
8247980|NCT01882465|20339486|P5|STARTED|Period 2||5
8247981|NCT01882465|20339487|P4|STARTED|Period 2||5
8247982|NCT01882465|20339488|P3|STARTED|Period 2||5
8247983|NCT01882465|20339489|P2|STARTED|Period 2||6
8247984|NCT01882465|20339490|P1|STARTED|Period 2||6
8247985|NCT01882465|20339484|P7|NOT COMPLETED|Period 1||1
8247986|NCT01882465|20339485|P6|NOT COMPLETED|Period 1||0
8247987|NCT01882465|20339486|P5|NOT COMPLETED|Period 1||0
8247988|NCT01882465|20339487|P4|NOT COMPLETED|Period 1||1
8247989|NCT01882465|20339488|P3|NOT COMPLETED|Period 1||0
8247990|NCT01882465|20339489|P2|NOT COMPLETED|Period 1||0
8247991|NCT01882465|20339490|P1|NOT COMPLETED|Period 1||0
8247992|NCT01882465|20339484|P7|COMPLETED|Period 1||0
8247993|NCT01882465|20339485|P6|COMPLETED|Period 1||5
8247994|NCT01882465|20339486|P5|COMPLETED|Period 1||5
8247995|NCT01882465|20339487|P4|COMPLETED|Period 1||5
8247996|NCT01882465|20339488|P3|COMPLETED|Period 1||5
8247997|NCT01882465|20339489|P2|COMPLETED|Period 1||6
8247998|NCT01882465|20339490|P1|COMPLETED|Period 1||6
8247999|NCT01882465|20339484|P7|STARTED|Period 1||1
8248000|NCT01882465|20339485|P6|STARTED|Period 1||5
8248001|NCT01882465|20339486|P5|STARTED|Period 1||5
8248002|NCT01882465|20339487|P4|STARTED|Period 1||6
8248003|NCT01882465|20339488|P3|STARTED|Period 1||5
8248004|NCT01882465|20339489|P2|STARTED|Period 1||6
8248005|NCT01882465|20339490|P1|STARTED|Period 1||6
8248006|NCT01882439|20339502|P4|NOT COMPLETED|Overall Study||9
8248007|NCT01882439|20339503|P3|NOT COMPLETED|Overall Study||10
8248008|NCT01882439|20339504|P2|NOT COMPLETED|Overall Study||21
8248009|NCT01882439|20339505|P1|NOT COMPLETED|Overall Study||9
8248010|NCT01882439|20339502|P4|COMPLETED|Overall Study||56
8248011|NCT01882439|20339503|P3|COMPLETED|Overall Study||56
8248012|NCT01882439|20339504|P2|COMPLETED|Overall Study||111
8248013|NCT01882439|20339505|P1|COMPLETED|Overall Study||122
8248014|NCT01882439|20339502|P4|STARTED|Overall Study|Received treatment|65
8248015|NCT01882439|20339503|P3|STARTED|Overall Study|Received treatment|66
8248016|NCT01882439|20339504|P2|STARTED|Overall Study|Received treatment|132
8248017|NCT01882439|20339505|P1|STARTED|Overall Study|Received treatment|131
8248018|NCT01882413|20339685|P1|NOT COMPLETED|Overall Study||0
8248019|NCT01882413|20339685|P1|COMPLETED|Overall Study||204
8248020|NCT01882413|20339685|P1|STARTED|Overall Study||204
8248021|NCT01882257|20339702|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
8248022|NCT01882257|20339703|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
8248023|NCT01882257|20339704|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
8248024|NCT01882257|20339702|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
8248025|NCT01882257|20339703|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
8248026|NCT01882257|20339704|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
8248027|NCT01882257|20339702|P3|STARTED|Therapy Portion of Study (12 Months)||22
8248028|NCT01882257|20339703|P2|STARTED|Therapy Portion of Study (12 Months)||38
8248029|NCT01882257|20339704|P1|STARTED|Therapy Portion of Study (12 Months)||11
8248030|NCT01882257|20339702|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
8248031|NCT01882257|20339703|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
8248032|NCT01882257|20339704|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
8248033|NCT01882257|20339702|P3|COMPLETED|Study Origination to Beginning Therapy||22
8248034|NCT01882257|20339703|P2|COMPLETED|Study Origination to Beginning Therapy||38
8248035|NCT01882257|20339704|P1|COMPLETED|Study Origination to Beginning Therapy||11
8248036|NCT01882257|20339702|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
8248037|NCT01882257|20339703|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
8248038|NCT01882257|20339704|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
8248039|NCT01882257|20339702|P3|STARTED|Study Origination to Beginning Therapy||23
8248040|NCT01882257|20339703|P2|STARTED|Study Origination to Beginning Therapy||40
8248041|NCT01882257|20339704|P1|STARTED|Study Origination to Beginning Therapy||11
8248042|NCT01882088|20339711|P1|NOT COMPLETED|Overall Study||5
8248043|NCT01882088|20339711|P1|COMPLETED|Overall Study||30
8248044|NCT01882088|20339711|P1|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
8248045|NCT01882062|20339724|P1|NOT COMPLETED|Overall Study||0
8248046|NCT01882062|20339724|P1|COMPLETED|Overall Study|18th of july 2013|10
8248047|NCT01882062|20339724|P1|STARTED|Overall Study|16th of may 2013|10
8248048|NCT01881984|20339728|P1|NOT COMPLETED|Overall Study||0
8248049|NCT01881984|20339728|P1|COMPLETED|Overall Study||4
8248050|NCT01881984|20339728|P1|STARTED|Overall Study||4
8248051|NCT01881932|20339736|P3|NOT COMPLETED|Overall Study||0
8248052|NCT01881932|20339737|P2|NOT COMPLETED|Overall Study||0
8248053|NCT01881932|20339738|P1|NOT COMPLETED|Overall Study||0
8248054|NCT01881932|20339736|P3|COMPLETED|Overall Study||13
8248055|NCT01881932|20339737|P2|COMPLETED|Overall Study||4
8248056|NCT01881932|20339738|P1|COMPLETED|Overall Study||2
8248057|NCT01881932|20339736|P3|STARTED|Overall Study||13
8248058|NCT01881932|20339737|P2|STARTED|Overall Study||4
8248059|NCT01881932|20339738|P1|STARTED|Overall Study||2
8248060|NCT01881867|20339748|P2|NOT COMPLETED|Overall Study||13
8248061|NCT01881867|20339749|P1|NOT COMPLETED|Overall Study||12
8248062|NCT01881867|20339748|P2|COMPLETED|Overall Study||15
8248063|NCT01881867|20339749|P1|COMPLETED|Overall Study||14
8248064|NCT01881867|20339748|P2|STARTED|Overall Study||28
8248065|NCT01881867|20339749|P1|STARTED|Overall Study||26
8248066|NCT01881828|20339769|P2|NOT COMPLETED|Overall Study||0
8248067|NCT01881828|20339770|P1|NOT COMPLETED|Overall Study||0
8248068|NCT01881828|20339769|P2|COMPLETED|Overall Study||69
8248069|NCT01881828|20339770|P1|COMPLETED|Overall Study||71
8248070|NCT01881828|20339769|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
8248071|NCT01881828|20339770|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
8248072|NCT01881776|20339793|P3|NOT COMPLETED|Overall Study||2
8248073|NCT01881776|20339794|P2|NOT COMPLETED|Overall Study||4
8248074|NCT01881776|20339795|P1|NOT COMPLETED|Overall Study||1
8248075|NCT01881776|20339793|P3|COMPLETED|Overall Study||20
8248076|NCT01881776|20339794|P2|COMPLETED|Overall Study||20
8248077|NCT01881776|20339795|P1|COMPLETED|Overall Study||23
8248078|NCT01881776|20339793|P3|STARTED|Overall Study||22
8248079|NCT01881776|20339794|P2|STARTED|Overall Study||24
8248080|NCT01881776|20339795|P1|STARTED|Overall Study||24
8248081|NCT01881750|20339823|P2|NOT COMPLETED|Overall Study||4
8248082|NCT01881750|20339824|P1|NOT COMPLETED|Overall Study||2
8248083|NCT01881750|20339823|P2|COMPLETED|Overall Study||22
8248084|NCT01881750|20339824|P1|COMPLETED|Overall Study||25
8248085|NCT01881750|20339823|P2|STARTED|Overall Study||26
8248086|NCT01881750|20339824|P1|STARTED|Overall Study||27
8248087|NCT01881737|20339842|P1|NOT COMPLETED|Overall Study||5
8248088|NCT01881737|20339842|P1|COMPLETED|Overall Study||10
8248089|NCT01881737|20339842|P1|Number Screened|Overall Study||15
8248090|NCT01881737|20339842|P1|STARTED|Overall Study|This is a pilot study|15
8248091|NCT01881620|20339851|P1|NOT COMPLETED|Overall Study||4
8248092|NCT01881620|20339851|P1|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
8248093|NCT01881620|20339851|P1|STARTED|Overall Study||109
8248094|NCT01881412|20339862|P2|NOT COMPLETED|Overall Study||2
8248095|NCT01881412|20339863|P1|NOT COMPLETED|Overall Study||10
8248096|NCT01881412|20339862|P2|COMPLETED|Overall Study||57
8248097|NCT01881412|20339863|P1|COMPLETED|Overall Study||49
8248098|NCT01881412|20339862|P2|STARTED|Overall Study||59
8248099|NCT01881412|20339863|P1|STARTED|Overall Study||59
8248100|NCT01881373|20339882|P3|NOT COMPLETED|24 Months||0
8248101|NCT01881373|20339883|P2|NOT COMPLETED|24 Months||0
8248102|NCT01881373|20339884|P1|NOT COMPLETED|24 Months||0
8248103|NCT01881373|20339882|P3|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
8248104|NCT01881373|20339883|P2|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
8248105|NCT01881373|20339884|P1|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
8248106|NCT01881373|20339882|P3|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
8248107|NCT01881373|20339883|P2|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
8248108|NCT01881373|20339884|P1|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
8248109|NCT01881373|20339882|P3|NOT COMPLETED|Baseline||0
8248110|NCT01881373|20339883|P2|NOT COMPLETED|Baseline||0
8248111|NCT01881373|20339884|P1|NOT COMPLETED|Baseline||0
8248112|NCT01881373|20339882|P3|COMPLETED|Baseline|Cross-sectional sample|1321
8248113|NCT01881373|20339883|P2|COMPLETED|Baseline|Cross-sectional sample|1491
8248114|NCT01881373|20339884|P1|COMPLETED|Baseline|Cross-sectional sample|1517
8248115|NCT01881373|20339882|P3|STARTED|Baseline|Cross-sectional sample|1321
8248116|NCT01881373|20339883|P2|STARTED|Baseline|Cross-sectional sample|1491
8248117|NCT01881373|20339884|P1|STARTED|Baseline|Cross-sectional sample|1517
8248118|NCT01881230|20339931|P3|NOT COMPLETED|Overall Study||66
8248119|NCT01881230|20339932|P2|NOT COMPLETED|Overall Study||64
8248120|NCT01881230|20339933|P1|NOT COMPLETED|Overall Study||61
8248121|NCT01881230|20339931|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
8248122|NCT01881230|20339932|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
8248123|NCT01881230|20339933|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
8248124|NCT01881230|20339931|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
8248125|NCT01881230|20339932|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
8248126|NCT01881230|20339933|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
8248127|NCT01881230|20339931|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
8248128|NCT01881230|20339932|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
8248129|NCT01881230|20339933|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
8248130|NCT01881230|20339931|P3|STARTED|Overall Study||66
8248131|NCT01881230|20339932|P2|STARTED|Overall Study||64
8248132|NCT01881230|20339933|P1|STARTED|Overall Study||61
8248133|NCT01881126|20339961|P2|NOT COMPLETED|Overall Study||2
8248134|NCT01881126|20339962|P1|NOT COMPLETED|Overall Study||1
8248135|NCT01881126|20339961|P2|COMPLETED|Overall Study||44
8248136|NCT01881126|20339962|P1|COMPLETED|Overall Study||46
8248137|NCT01881126|20339961|P2|STARTED|Overall Study||46
8248138|NCT01881126|20339962|P1|STARTED|Overall Study||47
8248139|NCT01881113|20339970|P2|NOT COMPLETED|Overall Study||6
8248140|NCT01881113|20339971|P1|NOT COMPLETED|Overall Study||8
8248141|NCT01881113|20339970|P2|COMPLETED|Overall Study||44
8248142|NCT01881113|20339971|P1|COMPLETED|Overall Study||43
8248143|NCT01881113|20339970|P2|STARTED|Overall Study||50
8248144|NCT01881113|20339971|P1|STARTED|Overall Study||51
8248145|NCT01881087|20340028|P3|NOT COMPLETED|Overall Study||2
8248146|NCT01881087|20340029|P2|NOT COMPLETED|Overall Study||0
8248147|NCT01881087|20340030|P1|NOT COMPLETED|Overall Study||1
8248148|NCT01881087|20340028|P3|COMPLETED|Overall Study||60
8248149|NCT01881087|20340029|P2|COMPLETED|Overall Study||61
8248150|NCT01881087|20340030|P1|COMPLETED|Overall Study||59
8248151|NCT01881087|20340028|P3|STARTED|Overall Study||62
8248152|NCT01881087|20340029|P2|STARTED|Overall Study||61
8248153|NCT01881087|20340030|P1|STARTED|Overall Study||60
8248154|NCT01881009|20340043|P2|NOT COMPLETED|Summer Camp Session (6 Days)||1
8248155|NCT01881009|20340044|P1|NOT COMPLETED|Summer Camp Session (6 Days)||0
8248156|NCT01881009|20340043|P2|COMPLETED|Summer Camp Session (6 Days)||21
8248157|NCT01881009|20340044|P1|COMPLETED|Summer Camp Session (6 Days)||0
8248158|NCT01881009|20340043|P2|STARTED|Summer Camp Session (6 Days)||22
8248159|NCT01881009|20340044|P1|STARTED|Summer Camp Session (6 Days)||0
8248160|NCT01881009|20340043|P2|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
8248161|NCT01881009|20340044|P1|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
8248162|NCT01881009|20340043|P2|COMPLETED|Inpatient Safety Testing (22 Hours)||0
8248163|NCT01881009|20340044|P1|COMPLETED|Inpatient Safety Testing (22 Hours)||16
8248164|NCT01881009|20340043|P2|STARTED|Inpatient Safety Testing (22 Hours)||0
8248165|NCT01881009|20340044|P1|STARTED|Inpatient Safety Testing (22 Hours)||16
8248166|NCT01880840|20340055|P2|NOT COMPLETED|Overall Study||5
8248167|NCT01880840|20340056|P1|NOT COMPLETED|Overall Study||8
8248168|NCT01880840|20340055|P2|COMPLETED|Overall Study||91
8248169|NCT01880840|20340056|P1|COMPLETED|Overall Study||87
8248170|NCT01880840|20340055|P2|STARTED|Overall Study||96
8248171|NCT01880840|20340056|P1|STARTED|Overall Study||95
8248172|NCT01880736|20340066|P4|NOT COMPLETED|Overall Study||6
8248173|NCT01880736|20340067|P3|NOT COMPLETED|Overall Study||1
8248174|NCT01880736|20340068|P2|NOT COMPLETED|Overall Study||2
8248175|NCT01880736|20340069|P1|NOT COMPLETED|Overall Study||1
8248176|NCT01880736|20340066|P4|COMPLETED|Overall Study||108
8248177|NCT01880736|20340067|P3|COMPLETED|Overall Study||114
8248178|NCT01880736|20340068|P2|COMPLETED|Overall Study||113
8248179|NCT01880736|20340069|P1|COMPLETED|Overall Study||113
8248180|NCT01880736|20340066|P4|STARTED|Overall Study||114
8248181|NCT01880736|20340067|P3|STARTED|Overall Study||115
8248182|NCT01880736|20340068|P2|STARTED|Overall Study||115
8248183|NCT01880736|20340069|P1|STARTED|Overall Study||114
8248184|NCT01880723|20340113|P2|NOT COMPLETED|Overall Study||0
8248185|NCT01880723|20340114|P1|NOT COMPLETED|Overall Study||0
8248186|NCT01880723|20340113|P2|COMPLETED|Overall Study||16
8248187|NCT01880723|20340114|P1|COMPLETED|Overall Study||16
8248188|NCT01880723|20340113|P2|STARTED|Overall Study||16
8248189|NCT01880723|20340114|P1|STARTED|Overall Study||16
8248190|NCT01880697|20340130|P2|NOT COMPLETED|Overall Study||1
8248191|NCT01880697|20340131|P1|NOT COMPLETED|Overall Study||0
8248192|NCT01880697|20340130|P2|COMPLETED|Overall Study||62
8248193|NCT01880697|20340131|P1|COMPLETED|Overall Study||63
8248194|NCT01880697|20340130|P2|STARTED|Overall Study||63
8248195|NCT01880697|20340131|P1|STARTED|Overall Study||63
8248196|NCT01880593|20340153|P2|NOT COMPLETED|Overall Study||6
8248197|NCT01880593|20340154|P1|NOT COMPLETED|Overall Study||8
8248198|NCT01880593|20340153|P2|COMPLETED|Overall Study||10
8248199|NCT01880593|20340154|P1|COMPLETED|Overall Study||10
8248200|NCT01880593|20340153|P2|STARTED|Overall Study||16
8248201|NCT01880593|20340154|P1|STARTED|Overall Study||18
8248202|NCT01880528|20340174|P2|NOT COMPLETED|Overall Study||1
8248203|NCT01880528|20340175|P1|NOT COMPLETED|Overall Study||1
8248204|NCT01880528|20340174|P2|COMPLETED|Overall Study||10
8248205|NCT01880528|20340175|P1|COMPLETED|Overall Study||11
8248206|NCT01880528|20340174|P2|STARTED|Overall Study||11
8248207|NCT01880528|20340175|P1|STARTED|Overall Study||12
8248208|NCT01880515|20340191|P2|NOT COMPLETED|Overall Study||9
8248209|NCT01880515|20340192|P1|NOT COMPLETED|Overall Study||8
8248210|NCT01880515|20340191|P2|COMPLETED|Overall Study||45
8248211|NCT01880515|20340192|P1|COMPLETED|Overall Study||45
8248212|NCT01880515|20340191|P2|STARTED|Overall Study||54
8248213|NCT01880515|20340192|P1|STARTED|Overall Study||53
8248214|NCT01880437|20340203|P3|NOT COMPLETED|Overall Study||19
8248215|NCT01880437|20340204|P2|NOT COMPLETED|Overall Study||4
8248216|NCT01880437|20340205|P1|NOT COMPLETED|Overall Study||15
8248217|NCT01880437|20340203|P3|COMPLETED|Overall Study||0
8248218|NCT01880437|20340204|P2|COMPLETED|Overall Study||0
8248219|NCT01880437|20340205|P1|COMPLETED|Overall Study||0
8248220|NCT01880437|20340203|P3|STARTED|Overall Study||19
8248221|NCT01880437|20340204|P2|STARTED|Overall Study||4
8248222|NCT01880437|20340205|P1|STARTED|Overall Study||15
8248223|NCT01880424|20340231|P2|NOT COMPLETED|Overall Study||55
8248224|NCT01880424|20340232|P1|NOT COMPLETED|Overall Study||33
8248225|NCT01880424|20340231|P2|COMPLETED|Overall Study||367
8248226|NCT01880424|20340232|P1|COMPLETED|Overall Study||384
8248227|NCT01880424|20340231|P2|STARTED|Overall Study||422
8248228|NCT01880424|20340232|P1|STARTED|Overall Study||417
8248229|NCT01880320|20340257|P3|NOT COMPLETED|Overall Study||8
8248230|NCT01880320|20340258|P2|NOT COMPLETED|Overall Study||25
8248231|NCT01880320|20340259|P1|NOT COMPLETED|Overall Study||20
8248232|NCT01880320|20340257|P3|COMPLETED|Overall Study||61
8248233|NCT01880320|20340258|P2|COMPLETED|Overall Study||192
8248234|NCT01880320|20340259|P1|COMPLETED|Overall Study||197
8248235|NCT01880320|20340257|P3|STARTED|Overall Study||69
8248236|NCT01880320|20340258|P2|STARTED|Overall Study||217
8248237|NCT01880320|20340259|P1|STARTED|Overall Study||217
8248238|NCT01880099|20340276|P3|NOT COMPLETED|Overall Study||7
8248239|NCT01880099|20340277|P2|NOT COMPLETED|Overall Study||10
8248240|NCT01880099|20340278|P1|NOT COMPLETED|Overall Study||8
8248241|NCT01880099|20340276|P3|COMPLETED|Overall Study||15
8248242|NCT01880099|20340277|P2|COMPLETED|Overall Study||11
8248243|NCT01880099|20340278|P1|COMPLETED|Overall Study||9
8248244|NCT01880099|20340276|P3|STARTED|Overall Study||22
8248245|NCT01880099|20340277|P2|STARTED|Overall Study||21
8248246|NCT01880099|20340278|P1|STARTED|Overall Study||17
8248247|NCT01880086|20340288|P2|NOT COMPLETED|Overall Study||1
8248248|NCT01880086|20340289|P1|NOT COMPLETED|Overall Study||1
8248249|NCT01880086|20340288|P2|COMPLETED|Overall Study||6
8248250|NCT01880086|20340289|P1|COMPLETED|Overall Study||5
8248251|NCT01880086|20340288|P2|STARTED|Overall Study||7
8248252|NCT01880086|20340289|P1|STARTED|Overall Study||6
8248253|NCT01880073|20340307|P1|NOT COMPLETED|Overall Study||0
8248254|NCT01880073|20340307|P1|COMPLETED|Overall Study||24
8248255|NCT01880073|20340307|P1|STARTED|Overall Study||24
8248256|NCT01880047|20340318|P4|NOT COMPLETED|Extension Phase - 18 Months||2
8248257|NCT01880047|20340319|P3|NOT COMPLETED|Extension Phase - 18 Months||1
8248258|NCT01880047|20340320|P2|NOT COMPLETED|Extension Phase - 18 Months||3
8248259|NCT01880047|20340321|P1|NOT COMPLETED|Extension Phase - 18 Months||9
8248260|NCT01880047|20340318|P4|COMPLETED|Extension Phase - 18 Months||0
8248261|NCT01880047|20340319|P3|COMPLETED|Extension Phase - 18 Months||3
8248262|NCT01880047|20340320|P2|COMPLETED|Extension Phase - 18 Months||3
8248263|NCT01880047|20340321|P1|COMPLETED|Extension Phase - 18 Months||6
8248264|NCT01880047|20340318|P4|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
8248265|NCT01880047|20340319|P3|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
8248266|NCT01880047|20340320|P2|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
8248267|NCT01880047|20340321|P1|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
8248268|NCT01880047|20340318|P4|NOT COMPLETED|Weeks 5-8||0
8248269|NCT01880047|20340319|P3|NOT COMPLETED|Weeks 5-8||0
8248270|NCT01880047|20340320|P2|NOT COMPLETED|Weeks 5-8||1
8248271|NCT01880047|20340321|P1|NOT COMPLETED|Weeks 5-8||2
8248272|NCT01880047|20340318|P4|COMPLETED|Weeks 5-8||2
8248273|NCT01880047|20340319|P3|COMPLETED|Weeks 5-8||4
8248274|NCT01880047|20340320|P2|COMPLETED|Weeks 5-8||6
8248275|NCT01880047|20340321|P1|COMPLETED|Weeks 5-8||15
8248276|NCT01880047|20340318|P4|STARTED|Weeks 5-8||2
8248277|NCT01880047|20340319|P3|STARTED|Weeks 5-8||4
8248278|NCT01880047|20340320|P2|STARTED|Weeks 5-8||7
8248279|NCT01880047|20340321|P1|STARTED|Weeks 5-8||17
8248280|NCT01880047|20340318|P4|NOT COMPLETED|Weeks 3-4||0
8248281|NCT01880047|20340319|P3|NOT COMPLETED|Weeks 3-4||0
8248282|NCT01880047|20340320|P2|NOT COMPLETED|Weeks 3-4||1
8248283|NCT01880047|20340321|P1|NOT COMPLETED|Weeks 3-4||0
8248284|NCT01880047|20340318|P4|COMPLETED|Weeks 3-4||2
8248285|NCT01880047|20340319|P3|COMPLETED|Weeks 3-4||4
8248286|NCT01880047|20340320|P2|COMPLETED|Weeks 3-4||7
8248287|NCT01880047|20340321|P1|COMPLETED|Weeks 3-4||17
8248288|NCT01880047|20340318|P4|STARTED|Weeks 3-4||2
8248289|NCT01880047|20340319|P3|STARTED|Weeks 3-4||4
8248290|NCT01880047|20340320|P2|STARTED|Weeks 3-4||8
8248291|NCT01880047|20340321|P1|STARTED|Weeks 3-4||17
8248292|NCT01880047|20340318|P4|NOT COMPLETED|Weeks 0-2||1
8248293|NCT01880047|20340319|P3|NOT COMPLETED|Weeks 0-2||1
8248294|NCT01880047|20340320|P2|NOT COMPLETED|Weeks 0-2||1
8248295|NCT01880047|20340321|P1|NOT COMPLETED|Weeks 0-2||0
8248296|NCT01880047|20340318|P4|COMPLETED|Weeks 0-2||2
8248297|NCT01880047|20340319|P3|COMPLETED|Weeks 0-2||4
8248298|NCT01880047|20340320|P2|COMPLETED|Weeks 0-2||8
8248299|NCT01880047|20340321|P1|COMPLETED|Weeks 0-2||17
8248300|NCT01880047|20340318|P4|STARTED|Weeks 0-2||3
8248301|NCT01880047|20340319|P3|STARTED|Weeks 0-2||5
8248302|NCT01880047|20340320|P2|STARTED|Weeks 0-2||9
8248303|NCT01880047|20340321|P1|STARTED|Weeks 0-2||17
8248304|NCT01879852|20340344|P2|NOT COMPLETED|Overall Study||0
8248305|NCT01879852|20340345|P1|NOT COMPLETED|Overall Study||2
8248306|NCT01879852|20340344|P2|COMPLETED|Overall Study||13
8248307|NCT01879852|20340345|P1|COMPLETED|Overall Study||12
8248308|NCT01879852|20340344|P2|STARTED|Overall Study||13
8248309|NCT01879852|20340345|P1|STARTED|Overall Study||14
8248310|NCT01879826|20340359|P2|NOT COMPLETED|Overall Study||0
8248311|NCT01879826|20340360|P1|NOT COMPLETED|Overall Study||0
8248312|NCT01879826|20340359|P2|COMPLETED|Overall Study||40
8248313|NCT01879826|20340360|P1|COMPLETED|Overall Study||41
8248314|NCT01879826|20340359|P2|STARTED|Overall Study||40
8248315|NCT01879826|20340360|P1|STARTED|Overall Study||41
8248316|NCT01879800|20340370|P2|NOT COMPLETED|Overall Study||4
8248317|NCT01879800|20340371|P1|NOT COMPLETED|Overall Study||0
8248318|NCT01879800|20340370|P2|COMPLETED|Overall Study||26
8248319|NCT01879800|20340371|P1|COMPLETED|Overall Study||14
8248320|NCT01879800|20340370|P2|STARTED|Overall Study||30
8248321|NCT01879800|20340371|P1|STARTED|Overall Study||14
8248322|NCT01879735|20340383|P2|NOT COMPLETED|Overall Study||0
8248323|NCT01879735|20340384|P1|NOT COMPLETED|Overall Study||0
8248324|NCT01879735|20340383|P2|COMPLETED|Overall Study||16
8248325|NCT01879735|20340384|P1|COMPLETED|Overall Study||6
8248326|NCT01879735|20340383|P2|STARTED|Overall Study||16
8248327|NCT01879735|20340384|P1|STARTED|Overall Study||6
8248328|NCT01879722|20340400|P10|NOT COMPLETED|Overall Study||0
8248329|NCT01879722|20340401|P9|NOT COMPLETED|Overall Study||2
8248330|NCT01879722|20340402|P8|NOT COMPLETED|Overall Study||1
8248331|NCT01879722|20340403|P7|NOT COMPLETED|Overall Study||0
8248332|NCT01879722|20340404|P6|NOT COMPLETED|Overall Study||0
8248333|NCT01879722|20340405|P5|NOT COMPLETED|Overall Study||1
8248334|NCT01879722|20340406|P4|NOT COMPLETED|Overall Study||1
8248335|NCT01879722|20340407|P3|NOT COMPLETED|Overall Study||0
8248336|NCT01879722|20340408|P2|NOT COMPLETED|Overall Study||1
8248337|NCT01879722|20340409|P1|NOT COMPLETED|Overall Study||0
8248338|NCT01879722|20340400|P10|COMPLETED|Overall Study||6
8248339|NCT01879722|20340401|P9|COMPLETED|Overall Study||6
8248340|NCT01879722|20340402|P8|COMPLETED|Overall Study||7
8248341|NCT01879722|20340403|P7|COMPLETED|Overall Study||8
8248342|NCT01879722|20340404|P6|COMPLETED|Overall Study||9
8248343|NCT01879722|20340405|P5|COMPLETED|Overall Study||7
8248344|NCT01879722|20340406|P4|COMPLETED|Overall Study||7
8248345|NCT01879722|20340407|P3|COMPLETED|Overall Study||7
8248346|NCT01879722|20340408|P2|COMPLETED|Overall Study||7
8248347|NCT01879722|20340409|P1|COMPLETED|Overall Study||7
8248348|NCT01879722|20340400|P10|STARTED|Overall Study||6
8248349|NCT01879722|20340401|P9|STARTED|Overall Study||8
8248350|NCT01879722|20340402|P8|STARTED|Overall Study||8
8248351|NCT01879722|20340403|P7|STARTED|Overall Study||8
8248352|NCT01879722|20340404|P6|STARTED|Overall Study||9
8248353|NCT01879722|20340405|P5|STARTED|Overall Study||8
8248354|NCT01879722|20340406|P4|STARTED|Overall Study||8
8248355|NCT01879722|20340407|P3|STARTED|Overall Study||7
8248356|NCT01879722|20340408|P2|STARTED|Overall Study||8
8248357|NCT01879722|20340409|P1|STARTED|Overall Study||7
8248358|NCT01879683|20340557|P1|NOT COMPLETED|Overall Study||1
8248359|NCT01879683|20340557|P1|COMPLETED|Overall Study||9
8248360|NCT01879683|20340557|P1|STARTED|Overall Study||10
8248361|NCT01879618|20340564|P1|NOT COMPLETED|Overall Study||21
8248362|NCT01879618|20340564|P1|COMPLETED|Overall Study||131
8248363|NCT01879618|20340564|P1|STARTED|Overall Study||152
8248364|NCT01879579|20340571|P2|NOT COMPLETED|Overall Study||2
8248365|NCT01879579|20340572|P1|NOT COMPLETED|Overall Study||5
8248366|NCT01879579|20340571|P2|COMPLETED|Overall Study||26
8248367|NCT01879579|20340572|P1|COMPLETED|Overall Study||28
8248368|NCT01879579|20340571|P2|STARTED|Overall Study||28
8248369|NCT01879579|20340572|P1|STARTED|Overall Study||33
8248370|NCT01879553|20340602|P2|NOT COMPLETED|Overall Study||0
8248371|NCT01879553|20340603|P1|NOT COMPLETED|Overall Study||1
8248372|NCT01879553|20340602|P2|COMPLETED|Overall Study||63
8248373|NCT01879553|20340603|P1|COMPLETED|Overall Study||62
8248374|NCT01879553|20340602|P2|STARTED|Overall Study||63
8248375|NCT01879553|20340603|P1|STARTED|Overall Study||63
8248376|NCT01879540|20340624|P1|NOT COMPLETED|Overall Study||0
8248377|NCT01879540|20340624|P1|COMPLETED|Overall Study||63
8248378|NCT01879540|20340624|P1|STARTED|Overall Study||63
8248379|NCT01879410|20340637|P2|NOT COMPLETED|Overall Study||38
8248380|NCT01879410|20340638|P1|NOT COMPLETED|Overall Study||24
8248381|NCT01879410|20340637|P2|COMPLETED|Overall Study||312
8248382|NCT01879410|20340638|P1|COMPLETED|Overall Study||326
8248383|NCT01879410|20340637|P2|Intent-to-Treat Population|Overall Study||348
8248384|NCT01879410|20340638|P1|Intent-to-Treat Population|Overall Study||349
8248385|NCT01879410|20340637|P2|STARTED|Overall Study||350
8248386|NCT01879410|20340638|P1|STARTED|Overall Study||350
8248387|NCT01879371|20340652|P6|NOT COMPLETED|Overall Study||0
8248388|NCT01879371|20340653|P5|NOT COMPLETED|Overall Study||0
8248389|NCT01879371|20340654|P4|NOT COMPLETED|Overall Study||0
8248390|NCT01879371|20340655|P3|NOT COMPLETED|Overall Study||0
8248391|NCT01879371|20340656|P2|NOT COMPLETED|Overall Study||0
8248392|NCT01879371|20340657|P1|NOT COMPLETED|Overall Study||0
8248393|NCT01879371|20340652|P6|COMPLETED|Overall Study||6
8248394|NCT01879371|20340653|P5|COMPLETED|Overall Study||6
8248395|NCT01879371|20340654|P4|COMPLETED|Overall Study||6
8248396|NCT01879371|20340655|P3|COMPLETED|Overall Study||6
8248397|NCT01879371|20340656|P2|COMPLETED|Overall Study||6
8248398|NCT01879371|20340657|P1|COMPLETED|Overall Study||6
8248399|NCT01879371|20340652|P6|STARTED|Overall Study||6
8248400|NCT01879371|20340653|P5|STARTED|Overall Study||6
8248401|NCT01879371|20340654|P4|STARTED|Overall Study||6
8248402|NCT01879371|20340655|P3|STARTED|Overall Study||6
8248403|NCT01879371|20340656|P2|STARTED|Overall Study||6
8248404|NCT01879371|20340657|P1|STARTED|Overall Study||6
8248405|NCT01879345|20340674|P3|NOT COMPLETED|7-day Multiple-dose Period||0
8248406|NCT01879345|20340675|P2|NOT COMPLETED|7-day Multiple-dose Period||0
8248407|NCT01879345|20340676|P1|NOT COMPLETED|7-day Multiple-dose Period||0
8248408|NCT01879345|20340674|P3|COMPLETED|7-day Multiple-dose Period||6
8248409|NCT01879345|20340675|P2|COMPLETED|7-day Multiple-dose Period||6
8248410|NCT01879345|20340676|P1|COMPLETED|7-day Multiple-dose Period||6
8248411|NCT01879345|20340674|P3|STARTED|7-day Multiple-dose Period||6
8248412|NCT01879345|20340675|P2|STARTED|7-day Multiple-dose Period||6
8248413|NCT01879345|20340676|P1|STARTED|7-day Multiple-dose Period||6
8248414|NCT01879345|20340674|P3|NOT COMPLETED|Single-dose Period||0
8248415|NCT01879345|20340675|P2|NOT COMPLETED|Single-dose Period||0
8248416|NCT01879345|20340676|P1|NOT COMPLETED|Single-dose Period||0
8248417|NCT01879345|20340674|P3|COMPLETED|Single-dose Period||6
8248418|NCT01879345|20340675|P2|COMPLETED|Single-dose Period||6
8248419|NCT01879345|20340676|P1|COMPLETED|Single-dose Period||6
8248420|NCT01879345|20340674|P3|STARTED|Single-dose Period||6
8248421|NCT01879345|20340675|P2|STARTED|Single-dose Period||6
8248422|NCT01879345|20340676|P1|STARTED|Single-dose Period||6
8248423|NCT01879332|20340693|P3|NOT COMPLETED|Overall Study||4
8248424|NCT01879332|20340694|P2|NOT COMPLETED|Overall Study||6
8248425|NCT01879332|20340695|P1|NOT COMPLETED|Overall Study||6
8248426|NCT01879332|20340693|P3|COMPLETED|Overall Study||0
8248427|NCT01879332|20340694|P2|COMPLETED|Overall Study||0
8248428|NCT01879332|20340695|P1|COMPLETED|Overall Study||0
8248429|NCT01879332|20340693|P3|STARTED|Overall Study||4
8248430|NCT01879332|20340694|P2|STARTED|Overall Study||6
8248431|NCT01879332|20340695|P1|STARTED|Overall Study||6
8248432|NCT01879319|20340705|P2|NOT COMPLETED|Overall Study||5
8248433|NCT01879319|20340706|P1|NOT COMPLETED|Overall Study||2
8248434|NCT01879319|20340705|P2|COMPLETED|Overall Study||77
8248435|NCT01879319|20340706|P1|COMPLETED|Overall Study||80
8248436|NCT01879319|20340705|P2|Received Treatment|Overall Study||82
8248437|NCT01879319|20340706|P1|Received Treatment|Overall Study||82
8248438|NCT01879319|20340705|P2|STARTED|Overall Study||82
8248439|NCT01879319|20340706|P1|STARTED|Overall Study||82
8248440|NCT01879176|20340716|P2|NOT COMPLETED|Overall Study||6
8248441|NCT01879176|20340717|P1|NOT COMPLETED|Overall Study||8
8248442|NCT01879176|20340716|P2|COMPLETED|Overall Study||16
8248443|NCT01879176|20340717|P1|COMPLETED|Overall Study||16
8248444|NCT01879176|20340716|P2|STARTED|Overall Study||22
8248445|NCT01879176|20340717|P1|STARTED|Overall Study||24
8248446|NCT01879072|20340723|P1|NOT COMPLETED|Overall Study||151
8248447|NCT01879072|20340723|P1|COMPLETED|Overall Study||1709
8248448|NCT01879072|20340723|P1|STARTED|Overall Study||1860
8248449|NCT01879059|20340727|P1|NOT COMPLETED|Overall Study||0
8248450|NCT01879059|20340727|P1|COMPLETED|Overall Study||13
8248451|NCT01879059|20340727|P1|STARTED|Overall Study||13
8248452|NCT01878890|20340735|P4|NOT COMPLETED|Overall Study||0
8248453|NCT01878890|20340736|P3|NOT COMPLETED|Overall Study||0
8248454|NCT01878890|20340737|P2|NOT COMPLETED|Overall Study||1
8248455|NCT01878890|20340738|P1|NOT COMPLETED|Overall Study||0
8248456|NCT01878890|20340735|P4|COMPLETED|Overall Study||5
8248457|NCT01878890|20340736|P3|COMPLETED|Overall Study||4
8248458|NCT01878890|20340737|P2|COMPLETED|Overall Study||10
8248459|NCT01878890|20340738|P1|COMPLETED|Overall Study||5
8248460|NCT01878890|20340735|P4|STARTED|Overall Study||5
8248461|NCT01878890|20340736|P3|STARTED|Overall Study||4
8248462|NCT01878890|20340737|P2|STARTED|Overall Study||11
8248463|NCT01878890|20340738|P1|STARTED|Overall Study||5
8248464|NCT01878825|20340753|P2|NOT COMPLETED|Overall Study||0
8248465|NCT01878825|20340754|P1|NOT COMPLETED|Overall Study||0
8248466|NCT01878825|20340753|P2|COMPLETED|Overall Study||60
8248467|NCT01878825|20340754|P1|COMPLETED|Overall Study||60
8248468|NCT01878825|20340753|P2|STARTED|Overall Study||60
8248469|NCT01878825|20340754|P1|STARTED|Overall Study||60
8248470|NCT01878812|20340792|P2|NOT COMPLETED|Overall Study||0
8248471|NCT01878812|20340793|P1|NOT COMPLETED|Overall Study||0
8248472|NCT01878812|20340792|P2|COMPLETED|Overall Study||57
8248473|NCT01878812|20340793|P1|COMPLETED|Overall Study||60
8248474|NCT01878812|20340792|P2|STARTED|Overall Study||57
8248475|NCT01878812|20340793|P1|STARTED|Overall Study||60
8248476|NCT01878799|20340829|P2|NOT COMPLETED|Overall Study||0
8248477|NCT01878799|20340830|P1|NOT COMPLETED|Overall Study||1
8248478|NCT01878799|20340829|P2|COMPLETED|Overall Study||13
8248479|NCT01878799|20340830|P1|COMPLETED|Overall Study||36
8248480|NCT01878799|20340829|P2|STARTED|Overall Study||13
8248481|NCT01878799|20340830|P1|STARTED|Overall Study||37
8248482|NCT01878786|20340839|P3|NOT COMPLETED|Overall Study||7
8248483|NCT01878786|20340840|P2|NOT COMPLETED|Overall Study||9
8248484|NCT01878786|20340841|P1|NOT COMPLETED|Overall Study||9
8248485|NCT01878786|20340839|P3|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
8248486|NCT01878786|20340840|P2|COMPLETED|Overall Study|Study closed prematurely|0
8248487|NCT01878786|20340841|P1|COMPLETED|Overall Study|Study closed prematurely|0
8248488|NCT01878786|20340839|P3|STARTED|Overall Study||7
8248489|NCT01878786|20340840|P2|STARTED|Overall Study||9
8248490|NCT01878786|20340841|P1|STARTED|Overall Study||9
8248491|NCT01878656|20340857|P2|NOT COMPLETED|Overall Study||0
8248492|NCT01878656|20340858|P1|NOT COMPLETED|Overall Study||0
8248493|NCT01878656|20340857|P2|COMPLETED|Overall Study||72
8248494|NCT01878656|20340858|P1|COMPLETED|Overall Study||72
8248495|NCT01878656|20340857|P2|STARTED|Overall Study||72
8248496|NCT01878656|20340858|P1|STARTED|Overall Study||72
8248497|NCT01878604|20340864|P1|NOT COMPLETED|Overall Study||0
8248498|NCT01878604|20340864|P1|COMPLETED|Overall Study||5
8248499|NCT01878604|20340864|P1|STARTED|Overall Study||5
8248500|NCT01878526|20340871|P2|NOT COMPLETED|Overall Study||2
8248501|NCT01878526|20340872|P1|NOT COMPLETED|Overall Study||3
8248502|NCT01878526|20340871|P2|COMPLETED|Overall Study||38
8248503|NCT01878526|20340872|P1|COMPLETED|Overall Study||37
8248504|NCT01878526|20340871|P2|STARTED|Overall Study||40
8248505|NCT01878526|20340872|P1|STARTED|Overall Study||40
8248506|NCT01878383|20340887|P2|NOT COMPLETED|Overall Study||1499
8248507|NCT01878383|20340888|P1|NOT COMPLETED|Overall Study||0
8248508|NCT01878383|20340887|P2|COMPLETED|Overall Study||11001
8248509|NCT01878383|20340888|P1|COMPLETED|Overall Study||50
8248510|NCT01878383|20340887|P2|STARTED|Overall Study||12500
8248511|NCT01878383|20340888|P1|STARTED|Overall Study||50
8248512|NCT01878292|20340898|P3|NOT COMPLETED|Double-blind Down-Taper Period||4
8248513|NCT01878292|20340899|P2|NOT COMPLETED|Double-blind Down-Taper Period||8
8248514|NCT01878292|20340900|P1|NOT COMPLETED|Double-blind Down-Taper Period||5
8248515|NCT01878292|20340898|P3|COMPLETED|Double-blind Down-Taper Period||142
8248516|NCT01878292|20340899|P2|COMPLETED|Double-blind Down-Taper Period||132
8248517|NCT01878292|20340900|P1|COMPLETED|Double-blind Down-Taper Period||122
8248518|NCT01878292|20340898|P3|STARTED|Double-blind Down-Taper Period||146
8248519|NCT01878292|20340899|P2|STARTED|Double-blind Down-Taper Period||140
8248520|NCT01878292|20340900|P1|STARTED|Double-blind Down-Taper Period||127
8248521|NCT01878292|20340898|P3|NOT COMPLETED|Double-blind Treatment Period||19
8248522|NCT01878292|20340899|P2|NOT COMPLETED|Double-blind Treatment Period||26
8248523|NCT01878292|20340900|P1|NOT COMPLETED|Double-blind Treatment Period||29
8248524|NCT01878292|20340898|P3|COMPLETED|Double-blind Treatment Period||161
8248525|NCT01878292|20340899|P2|COMPLETED|Double-blind Treatment Period||149
8248526|NCT01878292|20340900|P1|COMPLETED|Double-blind Treatment Period||142
8248527|NCT01878292|20340898|P3|STARTED|Double-blind Treatment Period||180
8248528|NCT01878292|20340899|P2|STARTED|Double-blind Treatment Period||175
8248529|NCT01878292|20340900|P1|STARTED|Double-blind Treatment Period||171
8248530|NCT01878292|20340898|P3|NOT COMPLETED|Randomized||0
8248531|NCT01878292|20340899|P2|NOT COMPLETED|Randomized||0
8248532|NCT01878292|20340900|P1|NOT COMPLETED|Randomized||3
8248533|NCT01878292|20340898|P3|COMPLETED|Randomized||180
8248534|NCT01878292|20340899|P2|COMPLETED|Randomized||175
8248535|NCT01878292|20340900|P1|COMPLETED|Randomized||171
8248536|NCT01878292|20340898|P3|STARTED|Randomized||180
8248537|NCT01878292|20340899|P2|STARTED|Randomized||175
8248538|NCT01878292|20340900|P1|STARTED|Randomized||174
8248539|NCT01878253|20340911|P1|NOT COMPLETED|Overall Study||9
8248540|NCT01878253|20340911|P1|COMPLETED|Overall Study||86
8248541|NCT01878253|20340911|P1|2 Year|Overall Study||86
8248542|NCT01878253|20340911|P1|1 Year|Overall Study||88
8248543|NCT01878253|20340911|P1|6 Months|Overall Study||90
8248544|NCT01878253|20340911|P1|6 Weeks|Overall Study||95
8248545|NCT01878253|20340911|P1|Pre-Operative|Overall Study||95
8248546|NCT01878253|20340911|P1|STARTED|Overall Study||95
8248547|NCT01878214|20340922|P2|NOT COMPLETED|Overall Study||44
8248548|NCT01878214|20340923|P1|NOT COMPLETED|Overall Study||53
8248549|NCT01878214|20340922|P2|COMPLETED|Overall Study||175
8248550|NCT01878214|20340923|P1|COMPLETED|Overall Study||170
8248551|NCT01878214|20340922|P2|STARTED|Overall Study||219
8248552|NCT01878214|20340923|P1|STARTED|Overall Study||223
8248553|NCT01878175|20340937|P1|NOT COMPLETED|Overall Study||2
8248554|NCT01878175|20340937|P1|COMPLETED|Overall Study||13
8248555|NCT01878175|20340937|P1|STARTED|Overall Study||15
8248556|NCT01878149|20340956|P2|NOT COMPLETED|Overall Study||2
8248557|NCT01878149|20340957|P1|NOT COMPLETED|Overall Study||2
8248558|NCT01878149|20340956|P2|COMPLETED|Overall Study||15
8248559|NCT01878149|20340957|P1|COMPLETED|Overall Study||19
8248560|NCT01878149|20340956|P2|STARTED|Overall Study||17
8248561|NCT01878149|20340957|P1|STARTED|Overall Study||21
8248562|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 4||3007
8248563|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 4||3604
8248564|NCT01878097|20340965|P2|COMPLETED|Implementation Year 4||6607
8248565|NCT01878097|20340966|P1|COMPLETED|Implementation Year 4||6981
8248566|NCT01878097|20340965|P2|STARTED|Implementation Year 4||9614
8248567|NCT01878097|20340966|P1|STARTED|Implementation Year 4||10585
8248568|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 3||2980
8248569|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 3||3494
8248570|NCT01878097|20340965|P2|COMPLETED|Implementation Year 3||6770
8248571|NCT01878097|20340966|P1|COMPLETED|Implementation Year 3||7046
8248572|NCT01878097|20340965|P2|STARTED|Implementation Year 3||9750
8248573|NCT01878097|20340966|P1|STARTED|Implementation Year 3||10540
8248574|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 2||2841
8248575|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 2||3281
8248576|NCT01878097|20340965|P2|COMPLETED|Implementation Year 2||6770
8248577|NCT01878097|20340966|P1|COMPLETED|Implementation Year 2||8286
8248578|NCT01878097|20340965|P2|STARTED|Implementation Year 2||9611
8248579|NCT01878097|20340966|P1|STARTED|Implementation Year 2||11567
8248580|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 1||2549
8248581|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 1||3202
8248582|NCT01878097|20340965|P2|COMPLETED|Implementation Year 1||7317
8248583|NCT01878097|20340966|P1|COMPLETED|Implementation Year 1||8540
8248584|NCT01878097|20340965|P2|STARTED|Implementation Year 1||9866
8248585|NCT01878097|20340966|P1|STARTED|Implementation Year 1||11742
8248586|NCT01878097|20340965|P2|NOT COMPLETED|Baseline||1800
8248587|NCT01878097|20340966|P1|NOT COMPLETED|Baseline||2497
8248588|NCT01878097|20340965|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
8248589|NCT01878097|20340966|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
8248590|NCT01878097|20340965|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
8248591|NCT01878097|20340966|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
8248592|NCT01878084|20340974|P1|NOT COMPLETED|Overall Study||2
8248593|NCT01878084|20340974|P1|COMPLETED|Overall Study||7
8248594|NCT01878084|20340974|P1|Control (Sockets Were Left Empty)|Overall Study||7
8248595|NCT01878084|20340974|P1|Test(Received TAMP Bioglass) s|Overall Study||7
8248596|NCT01878084|20340974|P1|STARTED|Overall Study||9
8248597|NCT01878006|20340979|P2|NOT COMPLETED|Study Session 2||0
8248598|NCT01878006|20340980|P1|NOT COMPLETED|Study Session 2||0
8248599|NCT01878006|20340979|P2|COMPLETED|Study Session 2||5
8248600|NCT01878006|20340980|P1|COMPLETED|Study Session 2||5
8248601|NCT01878006|20340979|P2|STARTED|Study Session 2||5
8248602|NCT01878006|20340980|P1|STARTED|Study Session 2||5
8248603|NCT01878006|20340979|P2|NOT COMPLETED|Study Session 1||0
8248604|NCT01878006|20340980|P1|NOT COMPLETED|Study Session 1||0
8248605|NCT01878006|20340979|P2|COMPLETED|Study Session 1||5
8248606|NCT01878006|20340980|P1|COMPLETED|Study Session 1||5
8248607|NCT01878006|20340979|P2|STARTED|Study Session 1||5
8248608|NCT01878006|20340980|P1|STARTED|Study Session 1||5
8248609|NCT01877941|20341000|P1|NOT COMPLETED|Overall Study||0
8248610|NCT01877941|20341000|P1|COMPLETED|Overall Study||39
8248611|NCT01877941|20341000|P1|STARTED|Overall Study||39
8248612|NCT01877915|20341008|P2|NOT COMPLETED|Overall Study||68
8248613|NCT01877915|20341009|P1|NOT COMPLETED|Overall Study||54
8248614|NCT01877915|20341008|P2|COMPLETED|Overall Study||2447
8248615|NCT01877915|20341009|P1|COMPLETED|Overall Study||2453
8248616|NCT01877915|20341008|P2|STARTED|Overall Study||2515
8248617|NCT01877915|20341009|P1|STARTED|Overall Study||2507
8248618|NCT01877720|20341031|P2|NOT COMPLETED|Overall Study||0
8248619|NCT01877720|20341032|P1|NOT COMPLETED|Overall Study||1
8248620|NCT01877720|20341031|P2|COMPLETED|Overall Study||8
8248621|NCT01877720|20341032|P1|COMPLETED|Overall Study||7
8248622|NCT01877720|20341031|P2|2nd Intervention|Overall Study||8
8248623|NCT01877720|20341032|P1|2nd Intervention|Overall Study||7
8248624|NCT01877720|20341031|P2|1st Intervention|Overall Study||8
8248625|NCT01877720|20341032|P1|1st Intervention|Overall Study||7
8248626|NCT01877720|20341031|P2|STARTED|Overall Study||8
8248627|NCT01877720|20341032|P1|STARTED|Overall Study||8
8248628|NCT01877668|20341061|P5|NOT COMPLETED|Overall Study||10
8248629|NCT01877668|20341062|P4|NOT COMPLETED|Overall Study||8
8248630|NCT01877668|20341063|P3|NOT COMPLETED|Overall Study||12
8248631|NCT01877668|20341064|P2|NOT COMPLETED|Overall Study||8
8248632|NCT01877668|20341065|P1|NOT COMPLETED|Overall Study||11
8248633|NCT01877668|20341061|P5|COMPLETED|Overall Study||43
8248634|NCT01877668|20341062|P4|COMPLETED|Overall Study||44
8248635|NCT01877668|20341063|P3|COMPLETED|Overall Study||94
8248636|NCT01877668|20341064|P2|COMPLETED|Overall Study||96
8248637|NCT01877668|20341065|P1|COMPLETED|Overall Study||96
8248638|NCT01877668|20341061|P5|STARTED|Overall Study|Received treatment|53
8248639|NCT01877668|20341062|P4|STARTED|Overall Study|Received treatment|52
8248640|NCT01877668|20341063|P3|STARTED|Overall Study|Received treatment|106
8248641|NCT01877668|20341064|P2|STARTED|Overall Study|Received treatment|104
8248642|NCT01877668|20341065|P1|STARTED|Overall Study|Received treatment|107
8248643|NCT01877655|20341296|P2|NOT COMPLETED|Overall Study||97
8248644|NCT01877655|20341297|P1|NOT COMPLETED|Overall Study||98
8248645|NCT01877655|20341296|P2|COMPLETED|Overall Study||154
8248646|NCT01877655|20341297|P1|COMPLETED|Overall Study||165
8248647|NCT01877655|20341296|P2|Received Treatment|Overall Study||246
8248648|NCT01877655|20341297|P1|Received Treatment|Overall Study||255
8248649|NCT01877655|20341296|P2|STARTED|Overall Study||251
8248650|NCT01877655|20341297|P1|STARTED|Overall Study||263
8248651|NCT01877642|20341315|P7|NOT COMPLETED|Overall Study||0
8248652|NCT01877642|20341316|P6|NOT COMPLETED|Overall Study||0
8248653|NCT01877642|20341317|P5|NOT COMPLETED|Overall Study||0
8248654|NCT01877642|20341318|P4|NOT COMPLETED|Overall Study||0
8248655|NCT01877642|20341319|P3|NOT COMPLETED|Overall Study||0
8248656|NCT01877642|20341320|P2|NOT COMPLETED|Overall Study||0
8248657|NCT01877642|20341321|P1|NOT COMPLETED|Overall Study||0
8248658|NCT01877642|20341315|P7|COMPLETED|Overall Study||3
8248659|NCT01877642|20341316|P6|COMPLETED|Overall Study||3
8248660|NCT01877642|20341317|P5|COMPLETED|Overall Study||3
8248661|NCT01877642|20341318|P4|COMPLETED|Overall Study||3
8248662|NCT01877642|20341319|P3|COMPLETED|Overall Study||3
8248663|NCT01877642|20341320|P2|COMPLETED|Overall Study||3
8248664|NCT01877642|20341321|P1|COMPLETED|Overall Study||4
8248665|NCT01877642|20341315|P7|STARTED|Overall Study||3
8248666|NCT01877642|20341316|P6|STARTED|Overall Study||3
8248667|NCT01877642|20341317|P5|STARTED|Overall Study||3
8248668|NCT01877642|20341318|P4|STARTED|Overall Study||3
8248669|NCT01877642|20341319|P3|STARTED|Overall Study||3
8248670|NCT01877642|20341320|P2|STARTED|Overall Study||3
8248671|NCT01877642|20341321|P1|STARTED|Overall Study||4
8248672|NCT01877564|20341344|P2|NOT COMPLETED|Overall Study||0
8248673|NCT01877564|20341345|P1|NOT COMPLETED|Overall Study||0
8248674|NCT01877564|20341344|P2|COMPLETED|Overall Study||4
8248675|NCT01877564|20341345|P1|COMPLETED|Overall Study||6
8248676|NCT01877564|20341344|P2|STARTED|Overall Study||4
8248677|NCT01877564|20341345|P1|STARTED|Overall Study||6
8248678|NCT01877551|20341353|P2|NOT COMPLETED|Overall Study||1
8248679|NCT01877551|20341354|P1|NOT COMPLETED|Overall Study||0
8248680|NCT01877551|20341353|P2|COMPLETED|Overall Study||13
8248681|NCT01877551|20341354|P1|COMPLETED|Overall Study||13
8248682|NCT01877551|20341353|P2|STARTED|Overall Study||14
8248683|NCT01877551|20341354|P1|STARTED|Overall Study||13
8248684|NCT01877538|20341366|P1|NOT COMPLETED|Overall Study||0
8248685|NCT01877538|20341366|P1|COMPLETED|Overall Study||7
8248686|NCT01877538|20341366|P1|STARTED|Overall Study||7
8248687|NCT01877421|20341403|P18|NOT COMPLETED|Phase 2||0
8248688|NCT01877421|20341404|P17|NOT COMPLETED|Phase 2||0
8248689|NCT01877421|20341405|P16|NOT COMPLETED|Phase 2||1
8248690|NCT01877421|20341406|P15|NOT COMPLETED|Phase 2||0
8248691|NCT01877421|20341407|P14|NOT COMPLETED|Phase 2||0
8248692|NCT01877421|20341408|P13|NOT COMPLETED|Phase 2||1
8248693|NCT01877421|20341409|P12|NOT COMPLETED|Phase 2||0
8248694|NCT01877421|20341410|P11|NOT COMPLETED|Phase 2||2
8248695|NCT01877421|20341411|P10|NOT COMPLETED|Phase 2||0
8248696|NCT01877421|20341412|P9|NOT COMPLETED|Phase 2||1
8248697|NCT01877421|20341413|P8|NOT COMPLETED|Phase 2||0
8248698|NCT01877421|20341414|P7|NOT COMPLETED|Phase 2||1
8248699|NCT01877421|20341415|P6|NOT COMPLETED|Phase 2||0
8248700|NCT01877421|20341416|P5|NOT COMPLETED|Phase 2||0
8248701|NCT01877421|20341417|P4|NOT COMPLETED|Phase 2||0
8248702|NCT01877421|20341418|P3|NOT COMPLETED|Phase 2||0
8248703|NCT01877421|20341419|P2|NOT COMPLETED|Phase 2||0
8248704|NCT01877421|20341420|P1|NOT COMPLETED|Phase 2||0
8248705|NCT01877421|20341403|P18|COMPLETED|Phase 2||0
8248706|NCT01877421|20341404|P17|COMPLETED|Phase 2||0
8248707|NCT01877421|20341405|P16|COMPLETED|Phase 2||2
8248708|NCT01877421|20341406|P15|COMPLETED|Phase 2||7
8248709|NCT01877421|20341407|P14|COMPLETED|Phase 2||3
8248710|NCT01877421|20341408|P13|COMPLETED|Phase 2||6
8248711|NCT01877421|20341409|P12|COMPLETED|Phase 2||3
8248712|NCT01877421|20341410|P11|COMPLETED|Phase 2||5
8248713|NCT01877421|20341411|P10|COMPLETED|Phase 2||3
8248714|NCT01877421|20341412|P9|COMPLETED|Phase 2||5
8248715|NCT01877421|20341413|P8|COMPLETED|Phase 2||2
8248716|NCT01877421|20341414|P7|COMPLETED|Phase 2||6
8248717|NCT01877421|20341415|P6|COMPLETED|Phase 2||3
8248718|NCT01877421|20341416|P5|COMPLETED|Phase 2||7
8248719|NCT01877421|20341417|P4|COMPLETED|Phase 2||2
8248720|NCT01877421|20341418|P3|COMPLETED|Phase 2||4
8248721|NCT01877421|20341419|P2|COMPLETED|Phase 2||0
8248722|NCT01877421|20341420|P1|COMPLETED|Phase 2||0
8248723|NCT01877421|20341403|P18|STARTED|Phase 2||0
8248724|NCT01877421|20341404|P17|STARTED|Phase 2||0
8248725|NCT01877421|20341405|P16|STARTED|Phase 2||3
8248726|NCT01877421|20341406|P15|STARTED|Phase 2||7
8248727|NCT01877421|20341407|P14|STARTED|Phase 2||3
8248728|NCT01877421|20341408|P13|STARTED|Phase 2||7
8248729|NCT01877421|20341409|P12|STARTED|Phase 2||3
8248730|NCT01877421|20341410|P11|STARTED|Phase 2||7
8248731|NCT01877421|20341411|P10|STARTED|Phase 2||3
8248732|NCT01877421|20341412|P9|STARTED|Phase 2||6
8248733|NCT01877421|20341413|P8|STARTED|Phase 2||2
8248734|NCT01877421|20341414|P7|STARTED|Phase 2||7
8248735|NCT01877421|20341415|P6|STARTED|Phase 2||3
8248736|NCT01877421|20341416|P5|STARTED|Phase 2||7
8248737|NCT01877421|20341417|P4|STARTED|Phase 2||2
8248738|NCT01877421|20341418|P3|STARTED|Phase 2||4
8248739|NCT01877421|20341419|P2|STARTED|Phase 2||0
8248740|NCT01877421|20341420|P1|STARTED|Phase 2||0
8248741|NCT01877421|20341403|P18|NOT COMPLETED|Phase 1||0
8248742|NCT01877421|20341404|P17|NOT COMPLETED|Phase 1||0
8248743|NCT01877421|20341405|P16|NOT COMPLETED|Phase 1||0
8248744|NCT01877421|20341406|P15|NOT COMPLETED|Phase 1||0
8248745|NCT01877421|20341407|P14|NOT COMPLETED|Phase 1||0
8248746|NCT01877421|20341408|P13|NOT COMPLETED|Phase 1||0
8248747|NCT01877421|20341409|P12|NOT COMPLETED|Phase 1||0
8248748|NCT01877421|20341410|P11|NOT COMPLETED|Phase 1||0
8248749|NCT01877421|20341411|P10|NOT COMPLETED|Phase 1||0
8248750|NCT01877421|20341412|P9|NOT COMPLETED|Phase 1||0
8248751|NCT01877421|20341413|P8|NOT COMPLETED|Phase 1||0
8248752|NCT01877421|20341414|P7|NOT COMPLETED|Phase 1||0
8248753|NCT01877421|20341415|P6|NOT COMPLETED|Phase 1||0
8248754|NCT01877421|20341416|P5|NOT COMPLETED|Phase 1||0
8248755|NCT01877421|20341417|P4|NOT COMPLETED|Phase 1||0
8248756|NCT01877421|20341418|P3|NOT COMPLETED|Phase 1||0
8248757|NCT01877421|20341419|P2|NOT COMPLETED|Phase 1||0
8248758|NCT01877421|20341420|P1|NOT COMPLETED|Phase 1||0
8248759|NCT01877421|20341403|P18|COMPLETED|Phase 1||3
8248760|NCT01877421|20341404|P17|COMPLETED|Phase 1||7
8248761|NCT01877421|20341405|P16|COMPLETED|Phase 1||3
8248762|NCT01877421|20341406|P15|COMPLETED|Phase 1||7
8248763|NCT01877421|20341407|P14|COMPLETED|Phase 1||3
8248764|NCT01877421|20341408|P13|COMPLETED|Phase 1||7
8248765|NCT01877421|20341409|P12|COMPLETED|Phase 1||3
8248766|NCT01877421|20341410|P11|COMPLETED|Phase 1||7
8248767|NCT01877421|20341411|P10|COMPLETED|Phase 1||3
8248768|NCT01877421|20341412|P9|COMPLETED|Phase 1||7
8248769|NCT01877421|20341413|P8|COMPLETED|Phase 1||2
8248770|NCT01877421|20341414|P7|COMPLETED|Phase 1||4
8248771|NCT01877421|20341415|P6|COMPLETED|Phase 1||2
8248772|NCT01877421|20341416|P5|COMPLETED|Phase 1||4
8248773|NCT01877421|20341417|P4|COMPLETED|Phase 1||2
8248774|NCT01877421|20341418|P3|COMPLETED|Phase 1||4
8248775|NCT01877421|20341419|P2|COMPLETED|Phase 1||1
8248776|NCT01877421|20341420|P1|COMPLETED|Phase 1||2
8248777|NCT01877421|20341403|P18|STARTED|Phase 1||3
8248778|NCT01877421|20341404|P17|STARTED|Phase 1||7
8248779|NCT01877421|20341405|P16|STARTED|Phase 1||3
8248780|NCT01877421|20341406|P15|STARTED|Phase 1||7
8248781|NCT01877421|20341407|P14|STARTED|Phase 1||3
8248782|NCT01877421|20341408|P13|STARTED|Phase 1||7
8248783|NCT01877421|20341409|P12|STARTED|Phase 1||3
8248784|NCT01877421|20341410|P11|STARTED|Phase 1||7
8248785|NCT01877421|20341411|P10|STARTED|Phase 1||3
8248786|NCT01877421|20341412|P9|STARTED|Phase 1||7
8248787|NCT01877421|20341413|P8|STARTED|Phase 1||2
8248788|NCT01877421|20341414|P7|STARTED|Phase 1||4
8248789|NCT01877421|20341415|P6|STARTED|Phase 1||2
8248790|NCT01877421|20341416|P5|STARTED|Phase 1||4
8248791|NCT01877421|20341417|P4|STARTED|Phase 1||2
8248792|NCT01877421|20341418|P3|STARTED|Phase 1||4
8248793|NCT01877421|20341419|P2|STARTED|Phase 1||1
8248794|NCT01877421|20341420|P1|STARTED|Phase 1||2
8248795|NCT01877408|20341530|P2|NOT COMPLETED|Overall Study||2
8248796|NCT01877408|20341531|P1|NOT COMPLETED|Overall Study||0
8248797|NCT01877408|20341530|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
8248798|NCT01877408|20341531|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
8248799|NCT01877408|20341530|P2|STARTED|Overall Study||100
8248800|NCT01877408|20341531|P1|STARTED|Overall Study||50
8248801|NCT01877343|20341551|P7|NOT COMPLETED|Overall Study||0
8248802|NCT01877343|20341552|P6|NOT COMPLETED|Overall Study||0
8248803|NCT01877343|20341553|P5|NOT COMPLETED|Overall Study||0
8248804|NCT01877343|20341554|P4|NOT COMPLETED|Overall Study||0
8248805|NCT01877343|20341555|P3|NOT COMPLETED|Overall Study||0
8248806|NCT01877343|20341556|P2|NOT COMPLETED|Overall Study||0
8248807|NCT01877343|20341557|P1|NOT COMPLETED|Overall Study||0
8248808|NCT01877343|20341551|P7|COMPLETED|Overall Study||0
8248809|NCT01877343|20341552|P6|COMPLETED|Overall Study||5
8248810|NCT01877343|20341553|P5|COMPLETED|Overall Study||0
8248811|NCT01877343|20341554|P4|COMPLETED|Overall Study||0
8248812|NCT01877343|20341555|P3|COMPLETED|Overall Study||0
8248813|NCT01877343|20341556|P2|COMPLETED|Overall Study||3
8248814|NCT01877343|20341557|P1|COMPLETED|Overall Study||2
8248815|NCT01877343|20341551|P7|STARTED|Overall Study||0
8248816|NCT01877343|20341552|P6|STARTED|Overall Study||5
8248817|NCT01877343|20341553|P5|STARTED|Overall Study||0
8248818|NCT01877343|20341554|P4|STARTED|Overall Study||0
8248819|NCT01877343|20341555|P3|STARTED|Overall Study||0
8248820|NCT01877343|20341556|P2|STARTED|Overall Study||3
8248821|NCT01877343|20341557|P1|STARTED|Overall Study||2
8248822|NCT01877278|20341564|P2|NOT COMPLETED|Overall Study||3
8248823|NCT01877278|20341565|P1|NOT COMPLETED|Overall Study||3
8248824|NCT01877278|20341564|P2|COMPLETED|Overall Study||30
8248825|NCT01877278|20341565|P1|COMPLETED|Overall Study||30
8248826|NCT01877278|20341564|P2|STARTED|Overall Study||33
8248827|NCT01877278|20341565|P1|STARTED|Overall Study||33
8248828|NCT01877265|20341573|P6|NOT COMPLETED|Treatment Period 3||0
8248829|NCT01877265|20341574|P5|NOT COMPLETED|Treatment Period 3||0
8248830|NCT01877265|20341575|P4|NOT COMPLETED|Treatment Period 3||0
8248831|NCT01877265|20341576|P3|NOT COMPLETED|Treatment Period 3||0
8248832|NCT01877265|20341577|P2|NOT COMPLETED|Treatment Period 3||0
8248833|NCT01877265|20341578|P1|NOT COMPLETED|Treatment Period 3||1
8248834|NCT01877265|20341573|P6|COMPLETED|Treatment Period 3||2
8248835|NCT01877265|20341574|P5|COMPLETED|Treatment Period 3||3
8248836|NCT01877265|20341575|P4|COMPLETED|Treatment Period 3||3
8248837|NCT01877265|20341576|P3|COMPLETED|Treatment Period 3||2
8248838|NCT01877265|20341577|P2|COMPLETED|Treatment Period 3||3
8248839|NCT01877265|20341578|P1|COMPLETED|Treatment Period 3||2
8248840|NCT01877265|20341573|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
8248841|NCT01877265|20341574|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248842|NCT01877265|20341575|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248843|NCT01877265|20341576|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
8248844|NCT01877265|20341577|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248845|NCT01877265|20341578|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248846|NCT01877265|20341573|P6|STARTED|Treatment Period 3||2
8248847|NCT01877265|20341574|P5|STARTED|Treatment Period 3||3
8248848|NCT01877265|20341575|P4|STARTED|Treatment Period 3||3
8248849|NCT01877265|20341576|P3|STARTED|Treatment Period 3||2
8248850|NCT01877265|20341577|P2|STARTED|Treatment Period 3||3
8248851|NCT01877265|20341578|P1|STARTED|Treatment Period 3||3
8248852|NCT01877265|20341573|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
8248853|NCT01877265|20341574|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248854|NCT01877265|20341575|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248855|NCT01877265|20341576|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248856|NCT01877265|20341577|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248857|NCT01877265|20341578|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248858|NCT01877265|20341573|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
8248859|NCT01877265|20341574|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248860|NCT01877265|20341575|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248861|NCT01877265|20341576|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
8248862|NCT01877265|20341577|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248863|NCT01877265|20341578|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248864|NCT01877265|20341573|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
8248865|NCT01877265|20341574|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
8248866|NCT01877265|20341575|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
8248867|NCT01877265|20341576|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
8248868|NCT01877265|20341577|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
8248869|NCT01877265|20341578|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
8248870|NCT01877265|20341573|P6|NOT COMPLETED|Treatment Period 2||0
8248871|NCT01877265|20341574|P5|NOT COMPLETED|Treatment Period 2||0
8248872|NCT01877265|20341575|P4|NOT COMPLETED|Treatment Period 2||0
8248873|NCT01877265|20341576|P3|NOT COMPLETED|Treatment Period 2||0
8248874|NCT01877265|20341577|P2|NOT COMPLETED|Treatment Period 2||0
8248875|NCT01877265|20341578|P1|NOT COMPLETED|Treatment Period 2||0
8248876|NCT01877265|20341573|P6|COMPLETED|Treatment Period 2||3
8248877|NCT01877265|20341574|P5|COMPLETED|Treatment Period 2||3
8248878|NCT01877265|20341575|P4|COMPLETED|Treatment Period 2||3
8248879|NCT01877265|20341576|P3|COMPLETED|Treatment Period 2||2
8248880|NCT01877265|20341577|P2|COMPLETED|Treatment Period 2||3
8248881|NCT01877265|20341578|P1|COMPLETED|Treatment Period 2||3
8248882|NCT01877265|20341573|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248883|NCT01877265|20341574|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248884|NCT01877265|20341575|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248885|NCT01877265|20341576|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
8248886|NCT01877265|20341577|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248887|NCT01877265|20341578|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248888|NCT01877265|20341573|P6|STARTED|Treatment Period 2||3
8248889|NCT01877265|20341574|P5|STARTED|Treatment Period 2||3
8248890|NCT01877265|20341575|P4|STARTED|Treatment Period 2||3
8248891|NCT01877265|20341576|P3|STARTED|Treatment Period 2||2
8248892|NCT01877265|20341577|P2|STARTED|Treatment Period 2||3
8248893|NCT01877265|20341578|P1|STARTED|Treatment Period 2||3
8248894|NCT01877265|20341573|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248895|NCT01877265|20341574|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248896|NCT01877265|20341575|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248897|NCT01877265|20341576|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248898|NCT01877265|20341577|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248899|NCT01877265|20341578|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248900|NCT01877265|20341573|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248901|NCT01877265|20341574|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248902|NCT01877265|20341575|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248903|NCT01877265|20341576|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
8248904|NCT01877265|20341577|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248905|NCT01877265|20341578|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248906|NCT01877265|20341573|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
8248907|NCT01877265|20341574|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
8248908|NCT01877265|20341575|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
8248909|NCT01877265|20341576|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
8248910|NCT01877265|20341577|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
8248911|NCT01877265|20341578|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
8248912|NCT01877265|20341573|P6|NOT COMPLETED|Treatment Period 1||0
8248913|NCT01877265|20341574|P5|NOT COMPLETED|Treatment Period 1||0
8248914|NCT01877265|20341575|P4|NOT COMPLETED|Treatment Period 1||0
8248915|NCT01877265|20341576|P3|NOT COMPLETED|Treatment Period 1||1
8248916|NCT01877265|20341577|P2|NOT COMPLETED|Treatment Period 1||0
8248917|NCT01877265|20341578|P1|NOT COMPLETED|Treatment Period 1||0
8248918|NCT01877265|20341573|P6|COMPLETED|Treatment Period 1||3
8248919|NCT01877265|20341574|P5|COMPLETED|Treatment Period 1||3
8248920|NCT01877265|20341575|P4|COMPLETED|Treatment Period 1||3
8248921|NCT01877265|20341576|P3|COMPLETED|Treatment Period 1||2
8248922|NCT01877265|20341577|P2|COMPLETED|Treatment Period 1||3
8248923|NCT01877265|20341578|P1|COMPLETED|Treatment Period 1||3
8248924|NCT01877265|20341573|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248925|NCT01877265|20341574|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248926|NCT01877265|20341575|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248927|NCT01877265|20341576|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248928|NCT01877265|20341577|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248929|NCT01877265|20341578|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248930|NCT01877265|20341573|P6|STARTED|Treatment Period 1||3
8248931|NCT01877265|20341574|P5|STARTED|Treatment Period 1||3
8248932|NCT01877265|20341575|P4|STARTED|Treatment Period 1||3
8248933|NCT01877265|20341576|P3|STARTED|Treatment Period 1||3
8248934|NCT01877265|20341577|P2|STARTED|Treatment Period 1||3
8248935|NCT01877265|20341578|P1|STARTED|Treatment Period 1||3
8248936|NCT01877239|20341595|P1|NOT COMPLETED|Overall Study||50
8248937|NCT01877239|20341595|P1|COMPLETED|Overall Study||61
8248938|NCT01877239|20341595|P1|Treated|Overall Study||76
8248939|NCT01877239|20341595|P1|STARTED|Overall Study||111
8248940|NCT01877187|20341601|P1|NOT COMPLETED|Overall Study||22
8248941|NCT01877187|20341601|P1|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
8248942|NCT01877187|20341601|P1|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
8248943|NCT01877187|20341601|P1|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
8248944|NCT01877187|20341601|P1|STARTED|Overall Study|21 HCC, 18 non-HCC|39
8248945|NCT01877161|20341630|P1|NOT COMPLETED|Third Session of Stimulation||0
8248946|NCT01877161|20341630|P1|COMPLETED|Third Session of Stimulation||12
8248947|NCT01877161|20341630|P1|STARTED|Third Session of Stimulation||12
8248948|NCT01877161|20341630|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
8248949|NCT01877161|20341630|P1|COMPLETED|Washout (at Least 3 Days)||12
8248950|NCT01877161|20341630|P1|STARTED|Washout (at Least 3 Days)||12
8248951|NCT01877161|20341630|P1|NOT COMPLETED|Second Session of Stimulation||0
8248952|NCT01877161|20341630|P1|COMPLETED|Second Session of Stimulation||12
8248953|NCT01877161|20341630|P1|STARTED|Second Session of Stimulation||12
8248954|NCT01877161|20341630|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
8248955|NCT01877161|20341630|P1|COMPLETED|Washout (at Least 3 Days)||12
8248956|NCT01877161|20341630|P1|STARTED|Washout (at Least 3 Days)||12
8248957|NCT01877161|20341630|P1|NOT COMPLETED|First Session of Stimulation||0
8248958|NCT01877161|20341630|P1|COMPLETED|First Session of Stimulation||12
8248959|NCT01877161|20341630|P1|STARTED|First Session of Stimulation||12
8248960|NCT01877148|20341640|P2|NOT COMPLETED|Overall Study||1
8248961|NCT01877148|20341641|P1|NOT COMPLETED|Overall Study||1
8248962|NCT01877148|20341640|P2|COMPLETED|Overall Study||5
8248963|NCT01877148|20341641|P1|COMPLETED|Overall Study||5
8248964|NCT01877148|20341640|P2|STARTED|Overall Study||6
8248965|NCT01877148|20341641|P1|STARTED|Overall Study||6
8248966|NCT01877083|20341653|P1|NOT COMPLETED|Extension Phase||5
8248967|NCT01877083|20341653|P1|COMPLETED|Extension Phase||0
8248968|NCT01877083|20341653|P1|STARTED|Extension Phase||5
8248969|NCT01877083|20341653|P1|NOT COMPLETED|Treatment Phase||20
8248970|NCT01877083|20341653|P1|COMPLETED|Treatment Phase||5
8248971|NCT01877083|20341653|P1|STARTED|Treatment Phase||25
8248972|NCT01876992|20341662|P2|NOT COMPLETED|Overall Study||0
8248973|NCT01876992|20341663|P1|NOT COMPLETED|Overall Study||0
8248974|NCT01876992|20341662|P2|COMPLETED|Overall Study||5
8248975|NCT01876992|20341663|P1|COMPLETED|Overall Study||5
8248976|NCT01876992|20341662|P2|STARTED|Overall Study||5
8248977|NCT01876992|20341663|P1|STARTED|Overall Study||5
8248978|NCT01876979|20341677|P2|NOT COMPLETED|Overall Study||3
8248979|NCT01876979|20341678|P1|NOT COMPLETED|Overall Study||2
8248980|NCT01876979|20341677|P2|COMPLETED|Overall Study||0
8248981|NCT01876979|20341678|P1|COMPLETED|Overall Study||0
8248982|NCT01876979|20341677|P2|STARTED|Overall Study||3
8248983|NCT01876979|20341678|P1|STARTED|Overall Study||2
8248984|NCT01876823|20341684|P1|NOT COMPLETED|Overall Study||9
8248985|NCT01876823|20341684|P1|COMPLETED|Overall Study||26
8248986|NCT01876823|20341684|P1|STARTED|Overall Study||35
8248987|NCT01876810|20341697|P2|NOT COMPLETED|Overall Study||1
8248988|NCT01876810|20341698|P1|NOT COMPLETED|Overall Study||0
8248989|NCT01876810|20341697|P2|COMPLETED|Overall Study||13
8248990|NCT01876810|20341698|P1|COMPLETED|Overall Study||14
8248991|NCT01876810|20341697|P2|STARTED|Overall Study||14
8248992|NCT01876810|20341698|P1|STARTED|Overall Study||14
8248993|NCT01876784|20341710|P2|NOT COMPLETED|Overall Study||119
8248994|NCT01876784|20341711|P1|NOT COMPLETED|Overall Study||119
8248995|NCT01876784|20341710|P2|COMPLETED|Overall Study||0
8248996|NCT01876784|20341711|P1|COMPLETED|Overall Study||0
8248997|NCT01876784|20341710|P2|Treated|Overall Study||118
8248998|NCT01876784|20341711|P1|Treated|Overall Study||117
8248999|NCT01876784|20341710|P2|STARTED|Overall Study||119
8249000|NCT01876784|20341711|P1|STARTED|Overall Study||119
8249001|NCT01876732|20341717|P1|NOT COMPLETED|Overall Study||75
8249002|NCT01876732|20341717|P1|COMPLETED|Overall Study||57
8249003|NCT01876732|20341717|P1|STARTED|Overall Study||132
8249004|NCT01876706|20341722|P1|NOT COMPLETED|Overall Study||25
8249005|NCT01876706|20341722|P1|COMPLETED|Overall Study||26
8249006|NCT01876706|20341722|P1|60 Months|Overall Study||26
8249007|NCT01876706|20341722|P1|48 Months|Overall Study||31
8249008|NCT01876706|20341722|P1|36 Months|Overall Study||32
8249009|NCT01876706|20341722|P1|24 Months|Overall Study||35
8249010|NCT01876706|20341722|P1|12 Months|Overall Study||42
8249011|NCT01876706|20341722|P1|6 Months|Overall Study||46
8249012|NCT01876706|20341722|P1|3 Months|Overall Study||51
8249013|NCT01876706|20341722|P1|1 Month|Overall Study||51
8249014|NCT01876706|20341722|P1|STARTED|Overall Study||51
8249015|NCT01876511|20341742|P3|NOT COMPLETED|Overall Study||31
8249016|NCT01876511|20341743|P2|NOT COMPLETED|Overall Study||25
8249017|NCT01876511|20341744|P1|NOT COMPLETED|Overall Study||23
8249018|NCT01876511|20341742|P3|COMPLETED|Overall Study||16
8249019|NCT01876511|20341743|P2|COMPLETED|Overall Study||0
8249020|NCT01876511|20341744|P1|COMPLETED|Overall Study||18
8249021|NCT01876511|20341742|P3|Stages 1 and 2|Overall Study||21
8249022|NCT01876511|20341743|P2|Stages 1 and 2|Overall Study||25
8249023|NCT01876511|20341744|P1|Stages 1 and 2|Overall Study||24
8249024|NCT01876511|20341742|P3|STARTED|Overall Study||47
8249025|NCT01876511|20341743|P2|STARTED|Overall Study||25
8249026|NCT01876511|20341744|P1|STARTED|Overall Study||41
8249027|NCT01876485|20341781|P2|NOT COMPLETED|Overall Study||26
8249028|NCT01876485|20341782|P1|NOT COMPLETED|Overall Study||24
8249029|NCT01876485|20341781|P2|COMPLETED|Overall Study||114
8249030|NCT01876485|20341782|P1|COMPLETED|Overall Study||116
8249031|NCT01876485|20341781|P2|Maintenance|Overall Study||114
8249032|NCT01876485|20341782|P1|Maintenance|Overall Study||116
8249033|NCT01876485|20341781|P2|Post-Intervention|Overall Study||129
8249034|NCT01876485|20341782|P1|Post-Intervention|Overall Study||125
8249035|NCT01876485|20341781|P2|STARTED|Overall Study||140
8249036|NCT01876485|20341782|P1|STARTED|Overall Study||140
8249037|NCT01876446|20341792|P2|NOT COMPLETED|Overall Study||6
8249038|NCT01876446|20341793|P1|NOT COMPLETED|Overall Study||2
8249039|NCT01876446|20341792|P2|COMPLETED|Overall Study||12
8249040|NCT01876446|20341793|P1|COMPLETED|Overall Study||18
8249041|NCT01876446|20341792|P2|STARTED|Overall Study||18
8249042|NCT01876446|20341793|P1|STARTED|Overall Study||20
8249043|NCT01876420|20341809|P1|NOT COMPLETED|Overall Study||1
8249044|NCT01876420|20341809|P1|COMPLETED|Overall Study||59
8249045|NCT01876420|20341809|P1|STARTED|Overall Study||60
8249046|NCT01876381|20341821|P1|NOT COMPLETED|Overall Study||7
8249047|NCT01876381|20341821|P1|COMPLETED|Overall Study||16
8249048|NCT01876381|20341821|P1|STARTED|Overall Study||23
8249049|NCT01876368|20341828|P2|NOT COMPLETED|Overall Study||13
8249050|NCT01876368|20341829|P1|NOT COMPLETED|Overall Study||9
8249051|NCT01876368|20341828|P2|COMPLETED|Overall Study||175
8249052|NCT01876368|20341829|P1|COMPLETED|Overall Study||179
8249053|NCT01876368|20341828|P2|Safety Set (SAF)|Overall Study||187
8249054|NCT01876368|20341829|P1|Safety Set (SAF)|Overall Study||188
8249055|NCT01876368|20341828|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
8249056|NCT01876368|20341829|P1|Full Analysis Set (FAS)|Overall Study||188
8249057|NCT01876368|20341828|P2|STARTED|Overall Study||188
8249058|NCT01876368|20341829|P1|STARTED|Overall Study||188
8249059|NCT01876329|20341858|P3|NOT COMPLETED|Overall Study||0
8249060|NCT01876329|20341859|P2|NOT COMPLETED|Overall Study||0
8249061|NCT01876329|20341860|P1|NOT COMPLETED|Overall Study||0
8249062|NCT01876329|20341858|P3|COMPLETED|Overall Study||44
8249063|NCT01876329|20341859|P2|COMPLETED|Overall Study||36
8249064|NCT01876329|20341860|P1|COMPLETED|Overall Study||45
8249065|NCT01876329|20341858|P3|STARTED|Overall Study||44
8249066|NCT01876329|20341859|P2|STARTED|Overall Study||36
8249067|NCT01876329|20341860|P1|STARTED|Overall Study||45
8249068|NCT01876251|20341874|P3|NOT COMPLETED|Overall Study||11
8249069|NCT01876251|20341875|P2|NOT COMPLETED|Overall Study||3
8249070|NCT01876251|20341876|P1|NOT COMPLETED|Overall Study||15
8249071|NCT01876251|20341874|P3|COMPLETED|Overall Study||0
8249072|NCT01876251|20341875|P2|COMPLETED|Overall Study||0
8249073|NCT01876251|20341876|P1|COMPLETED|Overall Study||0
8249074|NCT01876251|20341874|P3|STARTED|Overall Study||11
8249075|NCT01876251|20341875|P2|STARTED|Overall Study||3
8249076|NCT01876251|20341876|P1|STARTED|Overall Study||15
8249077|NCT01876212|20341935|P2|NOT COMPLETED|Overall Study||0
8249078|NCT01876212|20341936|P1|NOT COMPLETED|Overall Study||0
8249079|NCT01876212|20341935|P2|COMPLETED|Overall Study||6
8249080|NCT01876212|20341936|P1|COMPLETED|Overall Study||9
8249081|NCT01876212|20341935|P2|STARTED|Overall Study||6
8249082|NCT01876212|20341936|P1|STARTED|Overall Study||9
8249083|NCT01876043|20341980|P1|NOT COMPLETED|Overall Study||2
8249084|NCT01876043|20341980|P1|COMPLETED|Overall Study||22
8249085|NCT01876043|20341980|P1|Interim Analysis Population|Overall Study||17
8249086|NCT01876043|20341980|P1|STARTED|Overall Study||24
8249087|NCT01875991|20341992|P2|NOT COMPLETED|Overall Study||6
8249088|NCT01875991|20341993|P1|NOT COMPLETED|Overall Study||7
8249089|NCT01875991|20341992|P2|COMPLETED|Overall Study||103
8249090|NCT01875991|20341993|P1|COMPLETED|Overall Study||101
8249091|NCT01875991|20341992|P2|Received Etanercept in Period 2|Overall Study||103
8249092|NCT01875991|20341993|P1|Received Etanercept in Period 2|Overall Study||102
8249093|NCT01875991|20341992|P2|Received Etanercept in Period 1|Overall Study||108
8249094|NCT01875991|20341993|P1|Received Etanercept in Period 1|Overall Study||108
8249095|NCT01875991|20341992|P2|STARTED|Overall Study||109
8249096|NCT01875991|20341993|P1|STARTED|Overall Study||108
8249097|NCT01875978|20342016|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
8249098|NCT01875978|20342017|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
8249099|NCT01875978|20342016|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249100|NCT01875978|20342017|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249101|NCT01875978|20342016|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249102|NCT01875978|20342017|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249103|NCT01875978|20342016|P2|NOT COMPLETED|Study 4weeks||0
8249104|NCT01875978|20342017|P1|NOT COMPLETED|Study 4weeks||0
8249105|NCT01875978|20342016|P2|COMPLETED|Study 4weeks||20
8249106|NCT01875978|20342017|P1|COMPLETED|Study 4weeks||20
8249107|NCT01875978|20342016|P2|STARTED|Study 4weeks||20
8249108|NCT01875978|20342017|P1|STARTED|Study 4weeks||20
8249109|NCT01875874|20342029|P1|NOT COMPLETED|Overall Study||3
8249110|NCT01875874|20342029|P1|COMPLETED|Overall Study||5
8249111|NCT01875874|20342029|P1|STARTED|Overall Study||8
8249112|NCT01875861|20342036|P2|NOT COMPLETED|Sustainability||0
8249113|NCT01875861|20342037|P1|NOT COMPLETED|Sustainability||0
8249114|NCT01875861|20342036|P2|COMPLETED|Sustainability||3444
8249115|NCT01875861|20342037|P1|COMPLETED|Sustainability||4306
8249116|NCT01875861|20342036|P2|STARTED|Sustainability||3444
8249117|NCT01875861|20342037|P1|STARTED|Sustainability||4306
8249118|NCT01875861|20342036|P2|NOT COMPLETED|Implementation||0
8249119|NCT01875861|20342037|P1|NOT COMPLETED|Implementation||0
8249120|NCT01875861|20342036|P2|COMPLETED|Implementation||3444
8249121|NCT01875861|20342037|P1|COMPLETED|Implementation||4546
8249122|NCT01875861|20342036|P2|STARTED|Implementation||3444
8249123|NCT01875861|20342037|P1|STARTED|Implementation||4546
8249124|NCT01875861|20342036|P2|NOT COMPLETED|Pre-implementation||0
8249125|NCT01875861|20342037|P1|NOT COMPLETED|Pre-implementation||0
8249126|NCT01875861|20342036|P2|COMPLETED|Pre-implementation||3714
8249127|NCT01875861|20342037|P1|COMPLETED|Pre-implementation||4779
8249128|NCT01875861|20342036|P2|STARTED|Pre-implementation||3714
8249129|NCT01875861|20342037|P1|STARTED|Pre-implementation||4779
8249130|NCT01875848|20342049|P2|NOT COMPLETED|Overall Study||0
8249131|NCT01875848|20342050|P1|NOT COMPLETED|Overall Study||2
8249132|NCT01875848|20342049|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
8249133|NCT01875848|20342050|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
8249134|NCT01875848|20342049|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
8249135|NCT01875848|20342050|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
8249136|NCT01875783|20342058|P1|NOT COMPLETED|Overall Study||0
8249137|NCT01875783|20342058|P1|COMPLETED|Overall Study||385
8249138|NCT01875783|20342058|P1|STARTED|Overall Study||385
8249139|NCT01875731|20342067|P2|NOT COMPLETED|Overall Study||0
8249140|NCT01875731|20342068|P1|NOT COMPLETED|Overall Study||1
8249141|NCT01875731|20342067|P2|COMPLETED|Overall Study||32
8249142|NCT01875731|20342068|P1|COMPLETED|Overall Study||33
8249143|NCT01875731|20342067|P2|STARTED|Overall Study||32
8249144|NCT01875731|20342068|P1|STARTED|Overall Study||34
8249145|NCT01875510|20342078|P2|NOT COMPLETED|Overall Study||0
8249146|NCT01875510|20342079|P1|NOT COMPLETED|Overall Study||0
8249147|NCT01875510|20342078|P2|COMPLETED|Overall Study||40
8249148|NCT01875510|20342079|P1|COMPLETED|Overall Study||40
8249149|NCT01875510|20342078|P2|STARTED|Overall Study||40
8249150|NCT01875510|20342079|P1|STARTED|Overall Study||40
8249151|NCT01875471|20342087|P2|NOT COMPLETED|Overall Study||1
8249152|NCT01875471|20342088|P1|NOT COMPLETED|Overall Study||1
8249153|NCT01875471|20342087|P2|COMPLETED|Overall Study||137
8249154|NCT01875471|20342088|P1|COMPLETED|Overall Study||136
8249155|NCT01875471|20342087|P2|Completed Per Protocol|Overall Study||123
8249156|NCT01875471|20342088|P1|Completed Per Protocol|Overall Study||127
8249157|NCT01875471|20342087|P2|STARTED|Overall Study||138
8249158|NCT01875471|20342088|P1|STARTED|Overall Study||137
8249159|NCT01875445|20342096|P2|NOT COMPLETED|Overall Study||0
8249160|NCT01875445|20342097|P1|NOT COMPLETED|Overall Study||7
8249161|NCT01875445|20342096|P2|COMPLETED|Overall Study||19
8249162|NCT01875445|20342097|P1|COMPLETED|Overall Study||12
8249163|NCT01875445|20342096|P2|STARTED|Overall Study||19
8249164|NCT01875445|20342097|P1|STARTED|Overall Study||19
8249165|NCT01875250|20342107|P2|NOT COMPLETED|Overall Study||0
8249166|NCT01875250|20342108|P1|NOT COMPLETED|Overall Study||2
8249167|NCT01875250|20342107|P2|COMPLETED|Overall Study||19
8249168|NCT01875250|20342108|P1|COMPLETED|Overall Study||17
8249169|NCT01875250|20342107|P2|STARTED|Overall Study||19
8249170|NCT01875250|20342108|P1|STARTED|Overall Study||19
8249171|NCT01875237|20342123|P2|NOT COMPLETED|Overall Study||0
8249172|NCT01875237|20342124|P1|NOT COMPLETED|Overall Study||2
8249173|NCT01875237|20342123|P2|COMPLETED|Overall Study||1
8249174|NCT01875237|20342124|P1|COMPLETED|Overall Study||0
8249175|NCT01875237|20342123|P2|STARTED|Overall Study||1
8249176|NCT01875237|20342124|P1|STARTED|Overall Study||2
8249177|NCT01875185|20342150|P2|NOT COMPLETED|Overall Study||48
8249178|NCT01875185|20342151|P1|NOT COMPLETED|Overall Study||52
8249179|NCT01875185|20342150|P2|COMPLETED|Overall Study||0
8249180|NCT01875185|20342151|P1|COMPLETED|Overall Study||0
8249181|NCT01875185|20342150|P2|STARTED|Overall Study||48
8249182|NCT01875185|20342151|P1|STARTED|Overall Study||52
8249183|NCT01875159|20342165|P2|NOT COMPLETED|Overall Study||0
8249184|NCT01875159|20342166|P1|NOT COMPLETED|Overall Study||3
8249185|NCT01875159|20342165|P2|COMPLETED|Overall Study||53
8249186|NCT01875159|20342166|P1|COMPLETED|Overall Study||42
8249187|NCT01875159|20342165|P2|STARTED|Overall Study||53
8249188|NCT01875159|20342166|P1|STARTED|Overall Study||45
8249189|NCT01874951|20342176|P2|NOT COMPLETED|Overall Study||0
8249190|NCT01874951|20342177|P1|NOT COMPLETED|Overall Study||0
8249191|NCT01874951|20342176|P2|COMPLETED|Overall Study||6
8249192|NCT01874951|20342177|P1|COMPLETED|Overall Study||6
8249193|NCT01874951|20342176|P2|STARTED|Overall Study||6
8249194|NCT01874951|20342177|P1|STARTED|Overall Study||6
8249195|NCT01874756|20342201|P4|NOT COMPLETED|Overall Study||6
8249196|NCT01874756|20342202|P3|NOT COMPLETED|Overall Study||2
8249197|NCT01874756|20342203|P2|NOT COMPLETED|Overall Study||0
8249198|NCT01874756|20342204|P1|NOT COMPLETED|Overall Study||1
8249199|NCT01874756|20342201|P4|COMPLETED|Overall Study||21
8249200|NCT01874756|20342202|P3|COMPLETED|Overall Study||27
8249201|NCT01874756|20342203|P2|COMPLETED|Overall Study||10
8249202|NCT01874756|20342204|P1|COMPLETED|Overall Study||28
8249203|NCT01874756|20342201|P4|STARTED|Overall Study||27
8249204|NCT01874756|20342202|P3|STARTED|Overall Study||29
8249205|NCT01874756|20342203|P2|STARTED|Overall Study||10
8249206|NCT01874756|20342204|P1|STARTED|Overall Study||29
8249207|NCT01874665|20342236|P2|NOT COMPLETED|Overall Study||15
8249208|NCT01874665|20342237|P1|NOT COMPLETED|Overall Study||30
8249209|NCT01874665|20342236|P2|COMPLETED|Overall Study||0
8249210|NCT01874665|20342237|P1|COMPLETED|Overall Study||0
8249211|NCT01874665|20342236|P2|STARTED|Overall Study||15
8249212|NCT01874665|20342237|P1|STARTED|Overall Study||30
8249213|NCT01874535|20342265|P2|NOT COMPLETED|Overall Study||44
8249214|NCT01874535|20342266|P1|NOT COMPLETED|Overall Study||55
8249215|NCT01874535|20342265|P2|COMPLETED|Overall Study||157
8249216|NCT01874535|20342266|P1|COMPLETED|Overall Study||152
8249217|NCT01874535|20342265|P2|STARTED|Overall Study||201
8249218|NCT01874535|20342266|P1|STARTED|Overall Study||207
8249225|NCT01874340|20342302|P4|NOT COMPLETED|Overall Study||5
8249226|NCT01874340|20342303|P3|NOT COMPLETED|Overall Study||8
8249227|NCT01874340|20342304|P2|NOT COMPLETED|Overall Study||8
8249228|NCT01874340|20342305|P1|NOT COMPLETED|Overall Study||6
8249229|NCT01874340|20342302|P4|COMPLETED|Overall Study||1
8249230|NCT01874340|20342303|P3|COMPLETED|Overall Study||0
8249231|NCT01874340|20342304|P2|COMPLETED|Overall Study||0
8249232|NCT01874340|20342305|P1|COMPLETED|Overall Study||0
8249233|NCT01874340|20342302|P4|STARTED|Overall Study||6
8249234|NCT01874340|20342303|P3|STARTED|Overall Study||8
8249235|NCT01874340|20342304|P2|STARTED|Overall Study||8
8249236|NCT01874340|20342305|P1|STARTED|Overall Study||6
8249237|NCT01874288|20342336|P5|NOT COMPLETED|Overall Study||2
8249238|NCT01874288|20342337|P4|NOT COMPLETED|Overall Study||7
8249239|NCT01874288|20342338|P3|NOT COMPLETED|Overall Study||5
8249240|NCT01874288|20342339|P2|NOT COMPLETED|Overall Study||0
8249241|NCT01874288|20342340|P1|NOT COMPLETED|Overall Study||3
8249242|NCT01874288|20342336|P5|COMPLETED|Overall Study||0
8249243|NCT01874288|20342337|P4|COMPLETED|Overall Study||0
8249244|NCT01874288|20342338|P3|COMPLETED|Overall Study||4
8249245|NCT01874288|20342339|P2|COMPLETED|Overall Study||3
8249246|NCT01874288|20342340|P1|COMPLETED|Overall Study||0
8249247|NCT01874288|20342336|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
8249248|NCT01874288|20342337|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8249249|NCT01874288|20342338|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8249250|NCT01874288|20342339|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8249251|NCT01874288|20342340|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8249252|NCT01874288|20342336|P5|STARTED|Overall Study||2
8249253|NCT01874288|20342337|P4|STARTED|Overall Study||7
8249254|NCT01874288|20342338|P3|STARTED|Overall Study||9
8249255|NCT01874288|20342339|P2|STARTED|Overall Study||3
8249256|NCT01874288|20342340|P1|STARTED|Overall Study||3
8249257|NCT01874275|20342375|P2|NOT COMPLETED|Overall Study||0
8249258|NCT01874275|20342376|P1|NOT COMPLETED|Overall Study||1
8249259|NCT01874275|20342375|P2|COMPLETED|Overall Study||2
8249260|NCT01874275|20342376|P1|COMPLETED|Overall Study||3
8249261|NCT01874275|20342375|P2|STARTED|Overall Study||2
8249262|NCT01874275|20342376|P1|STARTED|Overall Study||4
8249263|NCT01874262|20342390|P2|NOT COMPLETED|Overall Study||3
8249264|NCT01874262|20342391|P1|NOT COMPLETED|Overall Study||5
8249265|NCT01874262|20342390|P2|COMPLETED|Overall Study||80
8249266|NCT01874262|20342391|P1|COMPLETED|Overall Study||86
8249267|NCT01874262|20342390|P2|Not Included Due to Tehnical Issues|Overall Study||3
8249268|NCT01874262|20342391|P1|Not Included Due to Tehnical Issues|Overall Study||3
8249269|NCT01874262|20342390|P2|Not Correctly Randomised|Overall Study||0
8249270|NCT01874262|20342391|P1|Not Correctly Randomised|Overall Study||2
8249271|NCT01874262|20342390|P2|STARTED|Overall Study||83
8249272|NCT01874262|20342391|P1|STARTED|Overall Study||91
8249273|NCT01874145|20342399|P2|NOT COMPLETED|Extension Period||4
8249274|NCT01874145|20342400|P1|NOT COMPLETED|Extension Period||6
8249275|NCT01874145|20342399|P2|COMPLETED|Extension Period||97
8249276|NCT01874145|20342400|P1|COMPLETED|Extension Period||91
8249277|NCT01874145|20342399|P2|Full Analysis Set|Extension Period||101
8249278|NCT01874145|20342400|P1|Full Analysis Set|Extension Period||95
8249279|NCT01874145|20342399|P2|STARTED|Extension Period|Non-Switchers|101
8249280|NCT01874145|20342400|P1|STARTED|Extension Period|Switchers|97
8249281|NCT01874145|20342399|P2|NOT COMPLETED|Core Period||7
8249282|NCT01874145|20342400|P1|NOT COMPLETED|Core Period||3
8249283|NCT01874145|20342399|P2|COMPLETED|Core Period||101
8249284|NCT01874145|20342400|P1|COMPLETED|Core Period||98
8249285|NCT01874145|20342399|P2|Full Analysis Set|Core Period||108
8249286|NCT01874145|20342400|P1|Full Analysis Set|Core Period||100
8249287|NCT01874145|20342399|P2|STARTED|Core Period||108
8249288|NCT01874145|20342400|P1|STARTED|Core Period||101
8249289|NCT01874132|20342439|P3|NOT COMPLETED|Overall Study||3
8249290|NCT01874132|20342440|P2|NOT COMPLETED|Overall Study||4
8249291|NCT01874132|20342441|P1|NOT COMPLETED|Overall Study||4
8249292|NCT01874132|20342439|P3|COMPLETED|Overall Study||19
8249293|NCT01874132|20342440|P2|COMPLETED|Overall Study||18
8249294|NCT01874132|20342441|P1|COMPLETED|Overall Study||18
8249295|NCT01874132|20342439|P3|STARTED|Overall Study||22
8249296|NCT01874132|20342440|P2|STARTED|Overall Study||22
8249297|NCT01874132|20342441|P1|STARTED|Overall Study||22
8249298|NCT01874119|20342452|P2|NOT COMPLETED|Second Intervention (6 Days)||0
8249299|NCT01874119|20342453|P1|NOT COMPLETED|Second Intervention (6 Days)||0
8249300|NCT01874119|20342452|P2|COMPLETED|Second Intervention (6 Days)||3
8249301|NCT01874119|20342453|P1|COMPLETED|Second Intervention (6 Days)||4
8249302|NCT01874119|20342452|P2|STARTED|Second Intervention (6 Days)||3
8249303|NCT01874119|20342453|P1|STARTED|Second Intervention (6 Days)||4
8249304|NCT01874119|20342452|P2|NOT COMPLETED|Washout (7 Days)||2
8249305|NCT01874119|20342453|P1|NOT COMPLETED|Washout (7 Days)||3
8249306|NCT01874119|20342452|P2|COMPLETED|Washout (7 Days)||3
8249307|NCT01874119|20342453|P1|COMPLETED|Washout (7 Days)||4
8249308|NCT01874119|20342452|P2|STARTED|Washout (7 Days)||5
8249309|NCT01874119|20342453|P1|STARTED|Washout (7 Days)||7
8249310|NCT01874119|20342452|P2|NOT COMPLETED|First Intervention (6 Days)||0
8249311|NCT01874119|20342453|P1|NOT COMPLETED|First Intervention (6 Days)||1
8249312|NCT01874119|20342452|P2|COMPLETED|First Intervention (6 Days)||5
8249313|NCT01874119|20342453|P1|COMPLETED|First Intervention (6 Days)||7
8249314|NCT01874119|20342452|P2|STARTED|First Intervention (6 Days)||5
8249315|NCT01874119|20342453|P1|STARTED|First Intervention (6 Days)||8
8249316|NCT01874054|20342459|P1|NOT COMPLETED|Overall Study||55
8249317|NCT01874054|20342459|P1|COMPLETED|Overall Study||0
8249318|NCT01874054|20342459|P1|Completed 16 Cycles of BV Treatment|Overall Study||17
8249319|NCT01874054|20342459|P1|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
8249320|NCT01874054|20342459|P1|STARTED|Overall Study||55
8249321|NCT01873989|20342470|P2|NOT COMPLETED|Overall Study||1
8249322|NCT01873989|20342471|P1|NOT COMPLETED|Overall Study||1
8249323|NCT01873989|20342470|P2|COMPLETED|Overall Study||6
8249324|NCT01873989|20342471|P1|COMPLETED|Overall Study||7
8249325|NCT01873989|20342470|P2|STARTED|Overall Study||7
8249326|NCT01873989|20342471|P1|STARTED|Overall Study||8
8249327|NCT01873950|20342481|P5|NOT COMPLETED|Period 5||0
8249328|NCT01873950|20342482|P4|NOT COMPLETED|Period 5||1
8249329|NCT01873950|20342483|P3|NOT COMPLETED|Period 5||0
8249330|NCT01873950|20342484|P2|NOT COMPLETED|Period 5||0
8249331|NCT01873950|20342485|P1|NOT COMPLETED|Period 5||0
8249332|NCT01873950|20342481|P5|COMPLETED|Period 5||4
8249333|NCT01873950|20342482|P4|COMPLETED|Period 5||3
8249334|NCT01873950|20342483|P3|COMPLETED|Period 5||4
8249335|NCT01873950|20342484|P2|COMPLETED|Period 5||5
8249336|NCT01873950|20342485|P1|COMPLETED|Period 5||4
8249337|NCT01873950|20342481|P5|STARTED|Period 5||4
8249338|NCT01873950|20342482|P4|STARTED|Period 5||4
8249339|NCT01873950|20342483|P3|STARTED|Period 5||4
8249340|NCT01873950|20342484|P2|STARTED|Period 5||5
8249341|NCT01873950|20342485|P1|STARTED|Period 5||4
8249342|NCT01873950|20342481|P5|NOT COMPLETED|Period 4||0
8249343|NCT01873950|20342482|P4|NOT COMPLETED|Period 4||0
8249344|NCT01873950|20342483|P3|NOT COMPLETED|Period 4||0
8249345|NCT01873950|20342484|P2|NOT COMPLETED|Period 4||0
8249346|NCT01873950|20342485|P1|NOT COMPLETED|Period 4||0
8249347|NCT01873950|20342481|P5|COMPLETED|Period 4||5
8249348|NCT01873950|20342482|P4|COMPLETED|Period 4||4
8249349|NCT01873950|20342483|P3|COMPLETED|Period 4||4
8249350|NCT01873950|20342484|P2|COMPLETED|Period 4||5
8249351|NCT01873950|20342485|P1|COMPLETED|Period 4||4
8249352|NCT01873950|20342481|P5|STARTED|Period 4||5
8249353|NCT01873950|20342482|P4|STARTED|Period 4||4
8249354|NCT01873950|20342483|P3|STARTED|Period 4||4
8249355|NCT01873950|20342484|P2|STARTED|Period 4||5
8249356|NCT01873950|20342485|P1|STARTED|Period 4||4
8249357|NCT01873950|20342481|P5|NOT COMPLETED|Period 3||0
8249358|NCT01873950|20342482|P4|NOT COMPLETED|Period 3||0
8249359|NCT01873950|20342483|P3|NOT COMPLETED|Period 3||0
8249360|NCT01873950|20342484|P2|NOT COMPLETED|Period 3||0
8249361|NCT01873950|20342485|P1|NOT COMPLETED|Period 3||0
8249362|NCT01873950|20342481|P5|COMPLETED|Period 3||4
8249363|NCT01873950|20342482|P4|COMPLETED|Period 3||5
8249364|NCT01873950|20342483|P3|COMPLETED|Period 3||5
8249365|NCT01873950|20342484|P2|COMPLETED|Period 3||4
8249366|NCT01873950|20342485|P1|COMPLETED|Period 3||4
8249367|NCT01873950|20342481|P5|STARTED|Period 3||4
8249368|NCT01873950|20342482|P4|STARTED|Period 3||5
8249369|NCT01873950|20342483|P3|STARTED|Period 3||5
8249370|NCT01873950|20342484|P2|STARTED|Period 3||4
8249371|NCT01873950|20342485|P1|STARTED|Period 3||4
8249372|NCT01873950|20342481|P5|NOT COMPLETED|Period 2||0
8249373|NCT01873950|20342482|P4|NOT COMPLETED|Period 2||0
8249374|NCT01873950|20342483|P3|NOT COMPLETED|Period 2||0
8249375|NCT01873950|20342484|P2|NOT COMPLETED|Period 2||0
8249376|NCT01873950|20342485|P1|NOT COMPLETED|Period 2||0
8249377|NCT01873950|20342481|P5|COMPLETED|Period 2||5
8249378|NCT01873950|20342482|P4|COMPLETED|Period 2||4
8249379|NCT01873950|20342483|P3|COMPLETED|Period 2||4
8249380|NCT01873950|20342484|P2|COMPLETED|Period 2||4
8249381|NCT01873950|20342485|P1|COMPLETED|Period 2||5
8249382|NCT01873950|20342481|P5|STARTED|Period 2||5
8249383|NCT01873950|20342482|P4|STARTED|Period 2||4
8249384|NCT01873950|20342483|P3|STARTED|Period 2||4
8249385|NCT01873950|20342484|P2|STARTED|Period 2||4
8249386|NCT01873950|20342485|P1|STARTED|Period 2||5
8249387|NCT01873950|20342481|P5|NOT COMPLETED|Period 1||0
8249388|NCT01873950|20342482|P4|NOT COMPLETED|Period 1||0
8249389|NCT01873950|20342483|P3|NOT COMPLETED|Period 1||0
8249390|NCT01873950|20342484|P2|NOT COMPLETED|Period 1||0
8249391|NCT01873950|20342485|P1|NOT COMPLETED|Period 1||0
8249392|NCT01873950|20342481|P5|COMPLETED|Period 1||4
8249393|NCT01873950|20342482|P4|COMPLETED|Period 1||4
8249394|NCT01873950|20342483|P3|COMPLETED|Period 1||5
8249395|NCT01873950|20342484|P2|COMPLETED|Period 1||4
8249396|NCT01873950|20342485|P1|COMPLETED|Period 1||5
8249397|NCT01873950|20342481|P5|STARTED|Period 1||4
8249398|NCT01873950|20342482|P4|STARTED|Period 1||4
8249399|NCT01873950|20342483|P3|STARTED|Period 1||5
8249400|NCT01873950|20342484|P2|STARTED|Period 1||4
8249401|NCT01873950|20342485|P1|STARTED|Period 1||5
8249402|NCT01873859|20342522|P2|NOT COMPLETED|Overall Study||4
8249403|NCT01873859|20342523|P1|NOT COMPLETED|Overall Study||0
8249404|NCT01873859|20342522|P2|COMPLETED|Overall Study||79
8249405|NCT01873859|20342523|P1|COMPLETED|Overall Study||83
8249406|NCT01873859|20342522|P2|STARTED|Overall Study||83
8249407|NCT01873859|20342523|P1|STARTED|Overall Study||83
8249408|NCT01873846|20342531|P1|NOT COMPLETED|Overall Study||12
8249409|NCT01873846|20342531|P1|COMPLETED|Overall Study||388
8249410|NCT01873846|20342531|P1|Eligble Participants Dispensed Lenses|Overall Study||396
8249411|NCT01873846|20342531|P1|STARTED|Overall Study||400
8249412|NCT01873742|20342541|P2|NOT COMPLETED|Overall Study||76
8249413|NCT01873742|20342542|P1|NOT COMPLETED|Overall Study||68
8249414|NCT01873742|20342541|P2|COMPLETED|Overall Study||87
8249415|NCT01873742|20342542|P1|COMPLETED|Overall Study||97
8249416|NCT01873742|20342541|P2|STARTED|Overall Study||163
8249417|NCT01873742|20342542|P1|STARTED|Overall Study||165
8249418|NCT01873729|20342548|P1|NOT COMPLETED|Overall Study||1
8249419|NCT01873729|20342548|P1|COMPLETED|Overall Study||2
8249420|NCT01873729|20342548|P1|STARTED|Overall Study||3
8249421|NCT01873586|20342553|P1|NOT COMPLETED|Overall Study||3
8249422|NCT01873586|20342553|P1|COMPLETED|Overall Study||26
8249423|NCT01873586|20342553|P1|STARTED|Overall Study||29
8249424|NCT01873495|20342566|P1|NOT COMPLETED|Overall Study||7
8249425|NCT01873495|20342566|P1|COMPLETED|Overall Study||0
8249426|NCT01873495|20342566|P1|STARTED|Overall Study||7
8249427|NCT01873417|20342574|P1|NOT COMPLETED|Overall Study||35
8249428|NCT01873417|20342574|P1|COMPLETED|Overall Study||202
8249429|NCT01873417|20342574|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
8249430|NCT01873417|20342574|P1|STARTED|Overall Study||237
8249431|NCT01873287|20342587|P2|NOT COMPLETED|Overall Study||174
8249432|NCT01873287|20342588|P1|NOT COMPLETED|Overall Study||305
8249433|NCT01873287|20342587|P2|COMPLETED|Overall Study||883
8249434|NCT01873287|20342588|P1|COMPLETED|Overall Study||1701
8249435|NCT01873287|20342587|P2|STARTED|Overall Study||1057
8249436|NCT01873287|20342588|P1|STARTED|Overall Study||2006
8249437|NCT01872910|20342602|P6|NOT COMPLETED|Overall Study||0
8249438|NCT01872910|20342603|P5|NOT COMPLETED|Overall Study||0
8249439|NCT01872910|20342604|P4|NOT COMPLETED|Overall Study||0
8249440|NCT01872910|20342605|P3|NOT COMPLETED|Overall Study||2
8249441|NCT01872910|20342606|P2|NOT COMPLETED|Overall Study||0
8249442|NCT01872910|20342607|P1|NOT COMPLETED|Overall Study||2
8249443|NCT01872910|20342602|P6|COMPLETED|Overall Study||3
8249444|NCT01872910|20342603|P5|COMPLETED|Overall Study||15
8249445|NCT01872910|20342604|P4|COMPLETED|Overall Study||15
8249446|NCT01872910|20342605|P3|COMPLETED|Overall Study||28
8249447|NCT01872910|20342606|P2|COMPLETED|Overall Study||31
8249448|NCT01872910|20342607|P1|COMPLETED|Overall Study||28
8249449|NCT01872910|20342602|P6|Received Any Study Drug|Overall Study||3
8249450|NCT01872910|20342603|P5|Received Any Study Drug|Overall Study||15
8249451|NCT01872910|20342604|P4|Received Any Study Drug|Overall Study||15
8249452|NCT01872910|20342605|P3|Received Any Study Drug|Overall Study||30
8249453|NCT01872910|20342606|P2|Received Any Study Drug|Overall Study||31
8249454|NCT01872910|20342607|P1|Received Any Study Drug|Overall Study||30
8249455|NCT01872910|20342602|P6|STARTED|Overall Study||3
8249456|NCT01872910|20342603|P5|STARTED|Overall Study||15
8249457|NCT01872910|20342604|P4|STARTED|Overall Study||15
8249458|NCT01872910|20342605|P3|STARTED|Overall Study||30
8249459|NCT01872910|20342606|P2|STARTED|Overall Study||31
8249460|NCT01872910|20342607|P1|STARTED|Overall Study||30
8249461|NCT01872819|20342647|P1|NOT COMPLETED|Overall Study||0
8249462|NCT01872819|20342647|P1|COMPLETED|Overall Study||14
8249463|NCT01872819|20342647|P1|STARTED|Overall Study||14
8249464|NCT01872715|20342652|P1|NOT COMPLETED|Overall Study||4
8249465|NCT01872715|20342652|P1|COMPLETED|Overall Study||20
8249466|NCT01872715|20342652|P1|STARTED|Overall Study||24
8249467|NCT01872689|20342671|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249468|NCT01872689|20342672|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249469|NCT01872689|20342673|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
8249470|NCT01872689|20342674|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
8249471|NCT01872689|20342671|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249472|NCT01872689|20342672|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249473|NCT01872689|20342673|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
8249474|NCT01872689|20342674|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
8249475|NCT01872689|20342671|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
8249476|NCT01872689|20342672|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
8249477|NCT01872689|20342673|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
8249478|NCT01872689|20342674|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
8249479|NCT01872689|20342671|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
8249480|NCT01872689|20342672|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
8249481|NCT01872689|20342673|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
8249482|NCT01872689|20342674|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
8249483|NCT01872689|20342671|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
8249484|NCT01872689|20342672|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
8249485|NCT01872689|20342673|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
8249486|NCT01872689|20342674|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
8249487|NCT01872689|20342671|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
8249488|NCT01872689|20342672|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
8249489|NCT01872689|20342673|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
8249490|NCT01872689|20342674|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
8249491|NCT01872611|20342750|P2|NOT COMPLETED|Overall Study||12
8249492|NCT01872611|20342751|P1|NOT COMPLETED|Overall Study||24
8249493|NCT01872611|20342750|P2|COMPLETED|Overall Study||292
8249494|NCT01872611|20342751|P1|COMPLETED|Overall Study||277
8249495|NCT01872611|20342750|P2|Full Analysis Set|Overall Study||293
8249496|NCT01872611|20342751|P1|Full Analysis Set|Overall Study||289
8249497|NCT01872611|20342750|P2|Treated (Safety Analysis Set)|Overall Study||295
8249498|NCT01872611|20342751|P1|Treated (Safety Analysis Set)|Overall Study||293
8249499|NCT01872611|20342750|P2|Randomized|Overall Study||304
8249500|NCT01872611|20342751|P1|Randomized|Overall Study||301
8249501|NCT01872611|20342750|P2|STARTED|Overall Study||304
8249502|NCT01872611|20342751|P1|STARTED|Overall Study||301
8249503|NCT01872338|20342771|P2|NOT COMPLETED|Overall Study||0
8249504|NCT01872338|20342772|P1|NOT COMPLETED|Overall Study||20
8249505|NCT01872338|20342771|P2|COMPLETED|Overall Study||69
8249506|NCT01872338|20342772|P1|COMPLETED|Overall Study||46
8249507|NCT01872338|20342771|P2|STARTED|Overall Study||69
8249508|NCT01872338|20342772|P1|STARTED|Overall Study||66
8249509|NCT01872325|20342786|P2|NOT COMPLETED|Overall Study||0
8249510|NCT01872325|20342787|P1|NOT COMPLETED|Overall Study||0
8249511|NCT01872325|20342786|P2|COMPLETED|Overall Study||387
8249512|NCT01872325|20342787|P1|COMPLETED|Overall Study||689
8249513|NCT01872325|20342786|P2|STARTED|Overall Study||387
8249514|NCT01872325|20342787|P1|STARTED|Overall Study||689
8249515|NCT01872078|20342803|P4|NOT COMPLETED|Overall Study||2
8249516|NCT01872078|20342804|P3|NOT COMPLETED|Overall Study||3
8249517|NCT01872078|20342805|P2|NOT COMPLETED|Overall Study||0
8249518|NCT01872078|20342806|P1|NOT COMPLETED|Overall Study||0
8249519|NCT01872078|20342803|P4|COMPLETED|Overall Study||15
8249520|NCT01872078|20342804|P3|COMPLETED|Overall Study||14
8249521|NCT01872078|20342805|P2|COMPLETED|Overall Study||15
8249522|NCT01872078|20342806|P1|COMPLETED|Overall Study||16
8249523|NCT01872078|20342803|P4|STARTED|Overall Study||17
8249524|NCT01872078|20342804|P3|STARTED|Overall Study||17
8249525|NCT01872078|20342805|P2|STARTED|Overall Study||15
8249526|NCT01872078|20342806|P1|STARTED|Overall Study||16
8249527|NCT01871870|20342816|P1|NOT COMPLETED|Overall Study||9
8249528|NCT01871870|20342816|P1|COMPLETED|Overall Study||11
8249529|NCT01871870|20342816|P1|STARTED|Overall Study||20
8249530|NCT01871805|20342827|P6|NOT COMPLETED|Phase II||87
8249531|NCT01871805|20342828|P5|NOT COMPLETED|Phase II||0
8249532|NCT01871805|20342829|P4|NOT COMPLETED|Phase II||0
8249533|NCT01871805|20342830|P3|NOT COMPLETED|Phase II||0
8249534|NCT01871805|20342831|P2|NOT COMPLETED|Phase II||0
8249535|NCT01871805|20342832|P1|NOT COMPLETED|Phase II||0
8249536|NCT01871805|20342827|P6|COMPLETED|Phase II||0
8249537|NCT01871805|20342828|P5|COMPLETED|Phase II||0
8249538|NCT01871805|20342829|P4|COMPLETED|Phase II||0
8249539|NCT01871805|20342830|P3|COMPLETED|Phase II||0
8249540|NCT01871805|20342831|P2|COMPLETED|Phase II||0
8249541|NCT01871805|20342832|P1|COMPLETED|Phase II||0
8249542|NCT01871805|20342827|P6|STARTED|Phase II||87
8249543|NCT01871805|20342828|P5|STARTED|Phase II||0
8249544|NCT01871805|20342829|P4|STARTED|Phase II||0
8249545|NCT01871805|20342830|P3|STARTED|Phase II||0
8249546|NCT01871805|20342831|P2|STARTED|Phase II||0
8249547|NCT01871805|20342832|P1|STARTED|Phase II||0
8249548|NCT01871805|20342827|P6|NOT COMPLETED|Phase I||0
8249549|NCT01871805|20342828|P5|NOT COMPLETED|Phase I||13
8249550|NCT01871805|20342829|P4|NOT COMPLETED|Phase I||7
8249551|NCT01871805|20342830|P3|NOT COMPLETED|Phase I||13
8249552|NCT01871805|20342831|P2|NOT COMPLETED|Phase I||7
8249553|NCT01871805|20342832|P1|NOT COMPLETED|Phase I||7
8249554|NCT01871805|20342827|P6|COMPLETED|Phase I||0
8249555|NCT01871805|20342828|P5|COMPLETED|Phase I||0
8249556|NCT01871805|20342829|P4|COMPLETED|Phase I||0
8249557|NCT01871805|20342830|P3|COMPLETED|Phase I||0
8249558|NCT01871805|20342831|P2|COMPLETED|Phase I||0
8249559|NCT01871805|20342832|P1|COMPLETED|Phase I||0
8249560|NCT01871805|20342827|P6|STARTED|Phase I||0
8249561|NCT01871805|20342828|P5|STARTED|Phase I||13
8249562|NCT01871805|20342829|P4|STARTED|Phase I||7
8249563|NCT01871805|20342830|P3|STARTED|Phase I||13
8249564|NCT01871805|20342831|P2|STARTED|Phase I||7
8249565|NCT01871805|20342832|P1|STARTED|Phase I||7
8249566|NCT01871558|20342904|P2|NOT COMPLETED|Overall Study||2
8249567|NCT01871558|20342905|P1|NOT COMPLETED|Overall Study||3
8249568|NCT01871558|20342904|P2|COMPLETED|Overall Study||19
8249569|NCT01871558|20342905|P1|COMPLETED|Overall Study||18
8249570|NCT01871558|20342904|P2|STARTED|Overall Study||21
8249571|NCT01871558|20342905|P1|STARTED|Overall Study||21
8249572|NCT01871545|20342925|P2|NOT COMPLETED|Overall Study||3
8249573|NCT01871545|20342926|P1|NOT COMPLETED|Overall Study||17
8249574|NCT01871545|20342925|P2|COMPLETED|Overall Study||8
8249575|NCT01871545|20342926|P1|COMPLETED|Overall Study||56
8249576|NCT01871545|20342925|P2|STARTED|Overall Study||11
8249577|NCT01871545|20342926|P1|STARTED|Overall Study||73
8249578|NCT01871532|20342967|P2|NOT COMPLETED|Overall Study||2
8249579|NCT01871532|20342968|P1|NOT COMPLETED|Overall Study||1
8249580|NCT01871532|20342967|P2|COMPLETED|Overall Study||10
8249581|NCT01871532|20342968|P1|COMPLETED|Overall Study||11
8249582|NCT01871532|20342967|P2|Subjects Received hCG Treatment|Overall Study||9
8249583|NCT01871532|20342968|P1|Subjects Received hCG Treatment|Overall Study||11
8249584|NCT01871532|20342967|P2|STARTED|Overall Study||12
8249585|NCT01871532|20342968|P1|STARTED|Overall Study||12
8249586|NCT01871519|20343002|P1|NOT COMPLETED|Overall Study||90
8249587|NCT01871519|20343002|P1|COMPLETED|Overall Study||260
8249588|NCT01871519|20343002|P1|STARTED|Overall Study||350
8249589|NCT01871506|20343025|P2|NOT COMPLETED|Overall Study||0
8249590|NCT01871506|20343026|P1|NOT COMPLETED|Overall Study||0
8249591|NCT01871506|20343025|P2|COMPLETED|Overall Study||153
8249592|NCT01871506|20343026|P1|COMPLETED|Overall Study||150
8249593|NCT01871506|20343025|P2|STARTED|Overall Study||153
8249594|NCT01871506|20343026|P1|STARTED|Overall Study||150
8249595|NCT01871441|20343050|P1|NOT COMPLETED|Overall Study||0
8249596|NCT01871441|20343050|P1|COMPLETED|Overall Study||4
8249597|NCT01871441|20343050|P1|STARTED|Overall Study||4
8249598|NCT01871402|20343059|P2|NOT COMPLETED|Overall Study||3
8249599|NCT01871402|20343060|P1|NOT COMPLETED|Overall Study||1
8249600|NCT01871402|20343059|P2|COMPLETED|Overall Study||108
8249601|NCT01871402|20343060|P1|COMPLETED|Overall Study||109
8249602|NCT01871402|20343059|P2|STARTED|Overall Study||111
8249603|NCT01871402|20343060|P1|STARTED|Overall Study||110
8249604|NCT01871285|20343078|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8249605|NCT01871285|20343079|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8249606|NCT01871285|20343080|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8249607|NCT01871285|20343081|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8249608|NCT01871285|20343078|P4|COMPLETED|Second Intervention (1 Day)||2
8249609|NCT01871285|20343079|P3|COMPLETED|Second Intervention (1 Day)||3
8249610|NCT01871285|20343080|P2|COMPLETED|Second Intervention (1 Day)||14
8249611|NCT01871285|20343081|P1|COMPLETED|Second Intervention (1 Day)||17
8249612|NCT01871285|20343078|P4|STARTED|Second Intervention (1 Day)||2
8249613|NCT01871285|20343079|P3|STARTED|Second Intervention (1 Day)||3
8249614|NCT01871285|20343080|P2|STARTED|Second Intervention (1 Day)||14
8249615|NCT01871285|20343081|P1|STARTED|Second Intervention (1 Day)||17
8249616|NCT01871285|20343078|P4|NOT COMPLETED|First Intervention (1 Day)||0
8249617|NCT01871285|20343079|P3|NOT COMPLETED|First Intervention (1 Day)||1
8249618|NCT01871285|20343080|P2|NOT COMPLETED|First Intervention (1 Day)||1
8249619|NCT01871285|20343081|P1|NOT COMPLETED|First Intervention (1 Day)||1
8249620|NCT01871285|20343078|P4|COMPLETED|First Intervention (1 Day)||2
8249621|NCT01871285|20343079|P3|COMPLETED|First Intervention (1 Day)||3
8249622|NCT01871285|20343080|P2|COMPLETED|First Intervention (1 Day)||14
8249623|NCT01871285|20343081|P1|COMPLETED|First Intervention (1 Day)||17
8249624|NCT01871285|20343078|P4|STARTED|First Intervention (1 Day)||2
8249625|NCT01871285|20343079|P3|STARTED|First Intervention (1 Day)||4
8249626|NCT01871285|20343080|P2|STARTED|First Intervention (1 Day)||15
8249627|NCT01871285|20343081|P1|STARTED|First Intervention (1 Day)||18
8249628|NCT01871142|20343107|P1|NOT COMPLETED|Overall Study||1
8249629|NCT01871142|20343107|P1|COMPLETED|Overall Study||11
8249630|NCT01871142|20343107|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
8249631|NCT01871142|20343107|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
8249632|NCT01871142|20343107|P1|Received Placebo + Hypoxia|Overall Study||12
8249633|NCT01871142|20343107|P1|Received Placebo + Normoixa|Overall Study||11
8249634|NCT01871142|20343107|P1|STARTED|Overall Study||12
8249635|NCT01871090|20343123|P2|NOT COMPLETED|Overall Study||23
8249636|NCT01871090|20343124|P1|NOT COMPLETED|Overall Study||2
8249637|NCT01871090|20343123|P2|COMPLETED|Overall Study||25
8249638|NCT01871090|20343124|P1|COMPLETED|Overall Study||33
8249639|NCT01871090|20343123|P2|STARTED|Overall Study||48
8249640|NCT01871090|20343124|P1|STARTED|Overall Study||35
8249641|NCT01871077|20343134|P1|NOT COMPLETED|Overall Study||0
8249642|NCT01871077|20343134|P1|COMPLETED|Overall Study||30
8249643|NCT01871077|20343134|P1|STARTED|Overall Study||30
8249644|NCT01870999|20343144|P3|NOT COMPLETED|Overall Study||7
8249645|NCT01870999|20343145|P2|NOT COMPLETED|Overall Study||8
8249646|NCT01870999|20343146|P1|NOT COMPLETED|Overall Study||4
8249647|NCT01870999|20343144|P3|COMPLETED|Overall Study||4
8249648|NCT01870999|20343145|P2|COMPLETED|Overall Study||8
8249649|NCT01870999|20343146|P1|COMPLETED|Overall Study||10
8249650|NCT01870999|20343144|P3|Safety Population; Received Study Drug|Overall Study||10
8249651|NCT01870999|20343145|P2|Safety Population; Received Study Drug|Overall Study||15
8249652|NCT01870999|20343146|P1|Safety Population; Received Study Drug|Overall Study||14
8249653|NCT01870999|20343144|P3|STARTED|Overall Study||11
8249654|NCT01870999|20343145|P2|STARTED|Overall Study||16
8249655|NCT01870999|20343146|P1|STARTED|Overall Study||14
8249656|NCT01870973|20343204|P2|NOT COMPLETED|Overall Study||3
8249657|NCT01870973|20343205|P1|NOT COMPLETED|Overall Study||10
8249658|NCT01870973|20343204|P2|COMPLETED|Overall Study||49
8249659|NCT01870973|20343205|P1|COMPLETED|Overall Study||46
8249660|NCT01870973|20343204|P2|STARTED|Overall Study||52
8249661|NCT01870973|20343205|P1|STARTED|Overall Study||56
8249662|NCT01870921|20343211|P1|NOT COMPLETED|Overall Study||90
8249663|NCT01870921|20343211|P1|COMPLETED|Overall Study||1914
8249664|NCT01870921|20343211|P1|STARTED|Overall Study||2004
8249665|NCT01870869|20343221|P4|NOT COMPLETED|Overall Study||30
8249666|NCT01870869|20343222|P3|NOT COMPLETED|Overall Study||130
8249667|NCT01870869|20343223|P2|NOT COMPLETED|Overall Study||14
8249668|NCT01870869|20343224|P1|NOT COMPLETED|Overall Study||28
8249669|NCT01870869|20343221|P4|COMPLETED|Overall Study||205
8249670|NCT01870869|20343222|P3|COMPLETED|Overall Study||1092
8249671|NCT01870869|20343223|P2|COMPLETED|Overall Study||192
8249672|NCT01870869|20343224|P1|COMPLETED|Overall Study||260
8249673|NCT01870869|20343221|P4|STARTED|Overall Study||235
8249674|NCT01870869|20343222|P3|STARTED|Overall Study||1222
8249675|NCT01870869|20343223|P2|STARTED|Overall Study||206
8249676|NCT01870869|20343224|P1|STARTED|Overall Study||288
8249677|NCT01870856|20343252|P2|NOT COMPLETED|Overall Study||0
8249678|NCT01870856|20343253|P1|NOT COMPLETED|Overall Study||0
8249679|NCT01870856|20343252|P2|COMPLETED|Overall Study||27
8249680|NCT01870856|20343253|P1|COMPLETED|Overall Study||25
8249681|NCT01870856|20343252|P2|STARTED|Overall Study||27
8249682|NCT01870856|20343253|P1|STARTED|Overall Study||25
8249683|NCT01870843|20343263|P1|NOT COMPLETED|Overall Study||53
8249684|NCT01870843|20343263|P1|COMPLETED|Overall Study||208
8249685|NCT01870843|20343263|P1|STARTED|Overall Study||261
8249686|NCT01870778|20343278|P2|NOT COMPLETED|Overall Study||9
8249687|NCT01870778|20343279|P1|NOT COMPLETED|Overall Study||8
8249688|NCT01870778|20343278|P2|COMPLETED|Overall Study||3262
8249689|NCT01870778|20343279|P1|COMPLETED|Overall Study||3266
8249690|NCT01870778|20343278|P2|Biomarker Analysis Set|Overall Study||510
8249691|NCT01870778|20343279|P1|Biomarker Analysis Set|Overall Study||521
8249692|NCT01870778|20343278|P2|Full Analysis Set|Overall Study||3271
8249693|NCT01870778|20343279|P1|Full Analysis Set|Overall Study||3274
8249694|NCT01870778|20343278|P2|Safety Set|Overall Study||3248
8249695|NCT01870778|20343279|P1|Safety Set|Overall Study||3257
8249696|NCT01870778|20343278|P2|STARTED|Overall Study||3271
8249697|NCT01870778|20343279|P1|STARTED|Overall Study||3274
8249698|NCT01870739|20343305|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
8249699|NCT01870739|20343306|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
8249700|NCT01870739|20343305|P2|COMPLETED|Add-on Period (40 Weeks)||51
8249701|NCT01870739|20343306|P1|COMPLETED|Add-on Period (40 Weeks)||51
8249702|NCT01870739|20343305|P2|STARTED|Add-on Period (40 Weeks)||53
8249703|NCT01870739|20343306|P1|STARTED|Add-on Period (40 Weeks)||54
8249704|NCT01870739|20343305|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
8249705|NCT01870739|20343306|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
8249706|NCT01870739|20343305|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
8249707|NCT01870739|20343306|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
8249708|NCT01870739|20343305|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
8249709|NCT01870739|20343306|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
8249710|NCT01870739|20343305|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
8249711|NCT01870739|20343306|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
8249712|NCT01870739|20343305|P2|STARTED|Single Drug Treatment (12 Weeks)||57
8249713|NCT01870739|20343306|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
8249714|NCT01870726|20343345|P7|NOT COMPLETED|Overall Study||10
8249715|NCT01870726|20343346|P6|NOT COMPLETED|Overall Study||5
8249716|NCT01870726|20343347|P5|NOT COMPLETED|Overall Study||7
8249717|NCT01870726|20343348|P4|NOT COMPLETED|Overall Study||6
8249718|NCT01870726|20343349|P3|NOT COMPLETED|Overall Study||4
8249719|NCT01870726|20343350|P2|NOT COMPLETED|Overall Study||6
8249720|NCT01870726|20343351|P1|NOT COMPLETED|Overall Study||5
8249721|NCT01870726|20343345|P7|COMPLETED|Overall Study||0
8249722|NCT01870726|20343346|P6|COMPLETED|Overall Study||0
8249723|NCT01870726|20343347|P5|COMPLETED|Overall Study||0
8249724|NCT01870726|20343348|P4|COMPLETED|Overall Study||0
8249725|NCT01870726|20343349|P3|COMPLETED|Overall Study||0
8249726|NCT01870726|20343350|P2|COMPLETED|Overall Study||0
8249727|NCT01870726|20343351|P1|COMPLETED|Overall Study||0
8249728|NCT01870726|20343345|P7|STARTED|Overall Study||10
8249729|NCT01870726|20343346|P6|STARTED|Overall Study||5
8249730|NCT01870726|20343347|P5|STARTED|Overall Study||7
8249731|NCT01870726|20343348|P4|STARTED|Overall Study||6
8249732|NCT01870726|20343349|P3|STARTED|Overall Study||4
8249733|NCT01870726|20343350|P2|STARTED|Overall Study||6
8249734|NCT01870726|20343351|P1|STARTED|Overall Study||5
8249735|NCT01870596|20343436|P2|NOT COMPLETED|Overall Study||0
8249736|NCT01870596|20343437|P1|NOT COMPLETED|Overall Study||0
8249737|NCT01870596|20343436|P2|COMPLETED|Overall Study||18
8249738|NCT01870596|20343437|P1|COMPLETED|Overall Study||14
8249739|NCT01870596|20343436|P2|STARTED|Overall Study||18
8249740|NCT01870596|20343437|P1|STARTED|Overall Study||14
8249741|NCT01870583|20343446|P3|NOT COMPLETED|Overall Study||8
8249742|NCT01870583|20343447|P2|NOT COMPLETED|Overall Study||18
8249743|NCT01870583|20343448|P1|NOT COMPLETED|Overall Study||11
8249744|NCT01870583|20343446|P3|COMPLETED|Overall Study||455
8249745|NCT01870583|20343447|P2|COMPLETED|Overall Study||456
8249746|NCT01870583|20343448|P1|COMPLETED|Overall Study||456
8249747|NCT01870583|20343446|P3|STARTED|Overall Study||463
8249748|NCT01870583|20343447|P2|STARTED|Overall Study||474
8249749|NCT01870583|20343448|P1|STARTED|Overall Study||467
8249750|NCT01870401|20343458|P2|NOT COMPLETED|Overall Study||96
8249751|NCT01870401|20343459|P1|NOT COMPLETED|Overall Study||150
8249752|NCT01870401|20343458|P2|COMPLETED|Overall Study||59
8249753|NCT01870401|20343459|P1|COMPLETED|Overall Study||137
8249754|NCT01870401|20343458|P2|STARTED|Overall Study||155
8249755|NCT01870401|20343459|P1|STARTED|Overall Study||287
8249756|NCT01870388|20343519|P2|NOT COMPLETED|Overall Study||0
8249757|NCT01870388|20343520|P1|NOT COMPLETED|Overall Study||0
8249758|NCT01870388|20343519|P2|COMPLETED|Overall Study||8
8249759|NCT01870388|20343520|P1|COMPLETED|Overall Study||8
8249760|NCT01870388|20343519|P2|Received 1 Dose of Study Drug|Overall Study||8
8249761|NCT01870388|20343520|P1|Received 1 Dose of Study Drug|Overall Study||8
8249762|NCT01870388|20343519|P2|STARTED|Overall Study||8
8249763|NCT01870388|20343520|P1|STARTED|Overall Study||8
8249764|NCT01870297|20343535|P7|NOT COMPLETED|Overall Study||2
8249765|NCT01870297|20343536|P6|NOT COMPLETED|Overall Study||1
8249766|NCT01870297|20343537|P5|NOT COMPLETED|Overall Study||3
8249767|NCT01870297|20343538|P4|NOT COMPLETED|Overall Study||0
8249768|NCT01870297|20343539|P3|NOT COMPLETED|Overall Study||1
8249769|NCT01870297|20343540|P2|NOT COMPLETED|Overall Study||7
8249770|NCT01870297|20343541|P1|NOT COMPLETED|Overall Study||0
8249771|NCT01870297|20343535|P7|COMPLETED|Overall Study||8
8249772|NCT01870297|20343536|P6|COMPLETED|Overall Study||8
8249773|NCT01870297|20343537|P5|COMPLETED|Overall Study||7
8249774|NCT01870297|20343538|P4|COMPLETED|Overall Study||9
8249775|NCT01870297|20343539|P3|COMPLETED|Overall Study||7
8249776|NCT01870297|20343540|P2|COMPLETED|Overall Study||8
8249777|NCT01870297|20343541|P1|COMPLETED|Overall Study||11
8249778|NCT01870297|20343535|P7|STARTED|Overall Study||10
8249779|NCT01870297|20343536|P6|STARTED|Overall Study||9
8249780|NCT01870297|20343537|P5|STARTED|Overall Study||10
8249781|NCT01870297|20343538|P4|STARTED|Overall Study||9
8249782|NCT01870297|20343539|P3|STARTED|Overall Study||8
8249783|NCT01870297|20343540|P2|STARTED|Overall Study||15
8249784|NCT01870297|20343541|P1|STARTED|Overall Study||11
8249785|NCT01870076|20343585|P4|NOT COMPLETED|Overall Study||0
8249786|NCT01870076|20343586|P3|NOT COMPLETED|Overall Study||1
8249787|NCT01870076|20343587|P2|NOT COMPLETED|Overall Study||0
8249788|NCT01870076|20343588|P1|NOT COMPLETED|Overall Study||1
8249789|NCT01870076|20343585|P4|COMPLETED|Overall Study||11
8249790|NCT01870076|20343586|P3|COMPLETED|Overall Study||7
8249791|NCT01870076|20343587|P2|COMPLETED|Overall Study||12
8249792|NCT01870076|20343588|P1|COMPLETED|Overall Study||9
8249793|NCT01870076|20343585|P4|STARTED|Overall Study||11
8249794|NCT01870076|20343586|P3|STARTED|Overall Study||8
8249795|NCT01870076|20343587|P2|STARTED|Overall Study||12
8249796|NCT01870076|20343588|P1|STARTED|Overall Study||10
8249797|NCT01869959|20343606|P5|NOT COMPLETED|Treatment Period||0
8249798|NCT01869959|20343607|P4|NOT COMPLETED|Treatment Period||2
8249799|NCT01869959|20343608|P3|NOT COMPLETED|Treatment Period||3
8249800|NCT01869959|20343609|P2|NOT COMPLETED|Treatment Period||2
8249801|NCT01869959|20343610|P1|NOT COMPLETED|Treatment Period||1
8249802|NCT01869959|20343606|P5|COMPLETED|Treatment Period||0
8249803|NCT01869959|20343607|P4|COMPLETED|Treatment Period||8
8249804|NCT01869959|20343608|P3|COMPLETED|Treatment Period||12
8249805|NCT01869959|20343609|P2|COMPLETED|Treatment Period||8
8249806|NCT01869959|20343610|P1|COMPLETED|Treatment Period||10
8249807|NCT01869959|20343606|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
8249808|NCT01869959|20343607|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
8249809|NCT01869959|20343608|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
8249810|NCT01869959|20343609|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
8249811|NCT01869959|20343610|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
8249812|NCT01869959|20343606|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
8249813|NCT01869959|20343607|P4|STARTED|Treatment Period||10
8249814|NCT01869959|20343608|P3|STARTED|Treatment Period||15
8249815|NCT01869959|20343609|P2|STARTED|Treatment Period||10
8249816|NCT01869959|20343610|P1|STARTED|Treatment Period||11
8249817|NCT01869959|20343606|P5|NOT COMPLETED|Randomization Period||1
8249818|NCT01869959|20343607|P4|NOT COMPLETED|Randomization Period||0
8249819|NCT01869959|20343608|P3|NOT COMPLETED|Randomization Period||0
8249820|NCT01869959|20343609|P2|NOT COMPLETED|Randomization Period||0
8249821|NCT01869959|20343610|P1|NOT COMPLETED|Randomization Period||0
8249822|NCT01869959|20343606|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
8249823|NCT01869959|20343607|P4|COMPLETED|Randomization Period||0
8249824|NCT01869959|20343608|P3|COMPLETED|Randomization Period||0
8249825|NCT01869959|20343609|P2|COMPLETED|Randomization Period||0
8249826|NCT01869959|20343610|P1|COMPLETED|Randomization Period||0
8249827|NCT01869959|20343606|P5|STARTED|Randomization Period||47
8249828|NCT01869959|20343607|P4|STARTED|Randomization Period||0
8249829|NCT01869959|20343608|P3|STARTED|Randomization Period||0
8249830|NCT01869959|20343609|P2|STARTED|Randomization Period||0
8249831|NCT01869959|20343610|P1|STARTED|Randomization Period||0
8249832|NCT01869777|20343678|P1|NOT COMPLETED|Overall Study||1
8249833|NCT01869777|20343678|P1|COMPLETED|Overall Study||101
8249834|NCT01869777|20343678|P1|STARTED|Overall Study||102
8249835|NCT01869764|20343691|P2|NOT COMPLETED|Overall Study||2
8249836|NCT01869764|20343692|P1|NOT COMPLETED|Overall Study||0
8249837|NCT01869764|20343691|P2|COMPLETED|Overall Study||27
8249838|NCT01869764|20343692|P1|COMPLETED|Overall Study||28
8249839|NCT01869764|20343691|P2|STARTED|Overall Study||29
8249840|NCT01869764|20343692|P1|STARTED|Overall Study||28
8249841|NCT01869699|20343710|P2|NOT COMPLETED|Overall Study||0
8249842|NCT01869699|20343711|P1|NOT COMPLETED|Overall Study||1
8249843|NCT01869699|20343710|P2|COMPLETED|Overall Study||20
8249844|NCT01869699|20343711|P1|COMPLETED|Overall Study||20
8249845|NCT01869699|20343710|P2|STARTED|Overall Study||20
8249846|NCT01869699|20343711|P1|STARTED|Overall Study||21
8249847|NCT01869686|20343729|P1|NOT COMPLETED|Overall Study||0
8249848|NCT01869686|20343729|P1|COMPLETED|Overall Study||12
8249849|NCT01869686|20343729|P1|STARTED|Overall Study||12
8249850|NCT01869647|20343744|P3|NOT COMPLETED|Overall Study||0
8249851|NCT01869647|20343745|P2|NOT COMPLETED|Overall Study||6
8249852|NCT01869647|20343746|P1|NOT COMPLETED|Overall Study||1
8249853|NCT01869647|20343744|P3|COMPLETED|Overall Study||62
8249854|NCT01869647|20343745|P2|COMPLETED|Overall Study||130
8249855|NCT01869647|20343746|P1|COMPLETED|Overall Study||65
8249856|NCT01869647|20343744|P3|STARTED|Overall Study||62
8249857|NCT01869647|20343745|P2|STARTED|Overall Study||136
8249858|NCT01869647|20343746|P1|STARTED|Overall Study||66
8249859|NCT01869634|20343759|P2|NOT COMPLETED|Overall Study||0
8249860|NCT01869634|20343760|P1|NOT COMPLETED|Overall Study||2
8249861|NCT01869634|20343759|P2|COMPLETED|Overall Study||17
8249862|NCT01869634|20343760|P1|COMPLETED|Overall Study||18
8249863|NCT01869634|20343759|P2|STARTED|Overall Study||17
8249864|NCT01869634|20343760|P1|STARTED|Overall Study||20
8249865|NCT01869478|20343772|P2|NOT COMPLETED|Overall Study||0
8249866|NCT01869478|20343773|P1|NOT COMPLETED|Overall Study||0
8249867|NCT01869478|20343772|P2|COMPLETED|Overall Study||1
8249868|NCT01869478|20343773|P1|COMPLETED|Overall Study||0
8249869|NCT01869478|20343772|P2|STARTED|Overall Study||1
8249870|NCT01869478|20343773|P1|STARTED|Overall Study||0
8249871|NCT01869439|20343781|P1|NOT COMPLETED|Overall Study||0
8249872|NCT01869439|20343781|P1|COMPLETED|Overall Study||40
8249873|NCT01869439|20343781|P1|STARTED|Overall Study||40
8249874|NCT01869374|20343787|P2|NOT COMPLETED|Overall Study||1
8249875|NCT01869374|20343788|P1|NOT COMPLETED|Overall Study||0
8249876|NCT01869374|20343787|P2|COMPLETED|Overall Study||8
8249877|NCT01869374|20343788|P1|COMPLETED|Overall Study||9
8249878|NCT01869374|20343787|P2|STARTED|Overall Study||9
8249879|NCT01869374|20343788|P1|STARTED|Overall Study||9
8249880|NCT01869348|20343796|P2|NOT COMPLETED|Overall Study||1
8249881|NCT01869348|20343797|P1|NOT COMPLETED|Overall Study||1
8249882|NCT01869348|20343796|P2|COMPLETED|Overall Study||19
8249883|NCT01869348|20343797|P1|COMPLETED|Overall Study||19
8249884|NCT01869348|20343796|P2|STARTED|Overall Study||20
8249885|NCT01869348|20343797|P1|STARTED|Overall Study||20
8249886|NCT01869192|20343805|P2|NOT COMPLETED|Postoperative Chemotherapy||2
8249887|NCT01869192|20343806|P1|NOT COMPLETED|Postoperative Chemotherapy||0
8249888|NCT01869192|20343805|P2|COMPLETED|Postoperative Chemotherapy||31
8249889|NCT01869192|20343806|P1|COMPLETED|Postoperative Chemotherapy||32
8249890|NCT01869192|20343805|P2|STARTED|Postoperative Chemotherapy||33
8249891|NCT01869192|20343806|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
8249892|NCT01869192|20343805|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
8249893|NCT01869192|20343806|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
8249894|NCT01869192|20343805|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
8249895|NCT01869192|20343806|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
8249896|NCT01869192|20343805|P2|STARTED|Preoperative Chemotherapy to Surgery||35
8249897|NCT01869192|20343806|P1|STARTED|Preoperative Chemotherapy to Surgery||37
8249898|NCT01869075|20343820|P6|NOT COMPLETED|Phase 2||0
8249899|NCT01869075|20343821|P5|NOT COMPLETED|Phase 2||0
8249900|NCT01869075|20343822|P4|NOT COMPLETED|Phase 2||0
8249901|NCT01869075|20343823|P3|NOT COMPLETED|Phase 2||0
8249902|NCT01869075|20343824|P2|NOT COMPLETED|Phase 2||0
8249903|NCT01869075|20343825|P1|NOT COMPLETED|Phase 2||0
8249904|NCT01869075|20343820|P6|COMPLETED|Phase 2||45
8249905|NCT01869075|20343821|P5|COMPLETED|Phase 2||75
8249906|NCT01869075|20343822|P4|COMPLETED|Phase 2||45
8249907|NCT01869075|20343823|P3|COMPLETED|Phase 2||75
8249908|NCT01869075|20343824|P2|COMPLETED|Phase 2||30
8249909|NCT01869075|20343825|P1|COMPLETED|Phase 2||90
8249910|NCT01869075|20343820|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
8249911|NCT01869075|20343821|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
8249912|NCT01869075|20343822|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
8249913|NCT01869075|20343823|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
8249914|NCT01869075|20343824|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
8249915|NCT01869075|20343825|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
8249916|NCT01869075|20343820|P6|NOT COMPLETED|Phase 1||0
8249917|NCT01869075|20343821|P5|NOT COMPLETED|Phase 1||0
8249918|NCT01869075|20343822|P4|NOT COMPLETED|Phase 1||0
8249919|NCT01869075|20343823|P3|NOT COMPLETED|Phase 1||0
8249920|NCT01869075|20343824|P2|NOT COMPLETED|Phase 1||0
8249921|NCT01869075|20343825|P1|NOT COMPLETED|Phase 1||0
8249922|NCT01869075|20343820|P6|COMPLETED|Phase 1||90
8249923|NCT01869075|20343821|P5|COMPLETED|Phase 1||30
8249924|NCT01869075|20343822|P4|COMPLETED|Phase 1||75
8249925|NCT01869075|20343823|P3|COMPLETED|Phase 1||45
8249926|NCT01869075|20343824|P2|COMPLETED|Phase 1||75
8249927|NCT01869075|20343825|P1|COMPLETED|Phase 1||45
8249928|NCT01869075|20343820|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
8249929|NCT01869075|20343821|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
8249930|NCT01869075|20343822|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
8249931|NCT01869075|20343823|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
8249932|NCT01869075|20343824|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
8249933|NCT01869075|20343825|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
8249934|NCT01869075|20343820|P6|NOT COMPLETED|Phase 0 (Baseline)||0
8249935|NCT01869075|20343821|P5|NOT COMPLETED|Phase 0 (Baseline)||0
8249936|NCT01869075|20343822|P4|NOT COMPLETED|Phase 0 (Baseline)||0
8249937|NCT01869075|20343823|P3|NOT COMPLETED|Phase 0 (Baseline)||0
8249938|NCT01869075|20343824|P2|NOT COMPLETED|Phase 0 (Baseline)||0
8249939|NCT01869075|20343825|P1|NOT COMPLETED|Phase 0 (Baseline)||0
8249940|NCT01869075|20343820|P6|COMPLETED|Phase 0 (Baseline)||341
8249941|NCT01869075|20343821|P5|COMPLETED|Phase 0 (Baseline)||0
8249942|NCT01869075|20343822|P4|COMPLETED|Phase 0 (Baseline)||416
8249943|NCT01869075|20343823|P3|COMPLETED|Phase 0 (Baseline)||0
8249944|NCT01869075|20343824|P2|COMPLETED|Phase 0 (Baseline)||418
8249945|NCT01869075|20343825|P1|COMPLETED|Phase 0 (Baseline)||0
8249946|NCT01869075|20343820|P6|STARTED|Phase 0 (Baseline)||341
8249947|NCT01869075|20343821|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8249948|NCT01869075|20343822|P4|STARTED|Phase 0 (Baseline)||416
8249949|NCT01869075|20343823|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8249950|NCT01869075|20343824|P2|STARTED|Phase 0 (Baseline)||418
8249951|NCT01869075|20343825|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8249952|NCT01868997|20343841|P2|NOT COMPLETED|Overall Study||6
8249953|NCT01868997|20343842|P1|NOT COMPLETED|Overall Study||7
8249954|NCT01868997|20343841|P2|COMPLETED|Overall Study||36
8249955|NCT01868997|20343842|P1|COMPLETED|Overall Study||38
8249956|NCT01868997|20343841|P2|STARTED|Overall Study|randomized and treated|42
8249957|NCT01868997|20343842|P1|STARTED|Overall Study|randomized and treated|45
8249958|NCT01868893|20343858|P1|NOT COMPLETED|Overall Study||20
8249959|NCT01868893|20343858|P1|COMPLETED|Overall Study||0
8249960|NCT01868893|20343858|P1|STARTED|Overall Study||20
8249961|NCT01868789|20343867|P2|NOT COMPLETED|Overall Study||2
8249962|NCT01868789|20343868|P1|NOT COMPLETED|Overall Study||2
8249963|NCT01868789|20343867|P2|COMPLETED|Overall Study||12
8249964|NCT01868789|20343868|P1|COMPLETED|Overall Study||7
8249965|NCT01868789|20343867|P2|STARTED|Overall Study||14
8249966|NCT01868789|20343868|P1|STARTED|Overall Study||9
8249967|NCT01868776|20343878|P2|NOT COMPLETED|Overall Study||0
8249968|NCT01868776|20343879|P1|NOT COMPLETED|Overall Study||0
8249969|NCT01868776|20343878|P2|COMPLETED|Overall Study||50
8249970|NCT01868776|20343879|P1|COMPLETED|Overall Study||50
8249971|NCT01868776|20343878|P2|STARTED|Overall Study||50
8249972|NCT01868776|20343879|P1|STARTED|Overall Study||50
8249973|NCT01868646|20343889|P2|NOT COMPLETED|Overall Study||5
8249974|NCT01868646|20343890|P1|NOT COMPLETED|Overall Study||3
8249975|NCT01868646|20343889|P2|COMPLETED|Overall Study||67
8249976|NCT01868646|20343890|P1|COMPLETED|Overall Study||73
8249977|NCT01868646|20343889|P2|STARTED|Overall Study||72
8249978|NCT01868646|20343890|P1|STARTED|Overall Study||76
8249979|NCT01868633|20343918|P2|NOT COMPLETED|Overall Study||0
8249980|NCT01868633|20343919|P1|NOT COMPLETED|Overall Study||0
8249981|NCT01868633|20343918|P2|COMPLETED|Overall Study||26
8249982|NCT01868633|20343919|P1|COMPLETED|Overall Study||26
8249983|NCT01868633|20343918|P2|STARTED|Overall Study||26
8249984|NCT01868633|20343919|P1|STARTED|Overall Study||26
8249985|NCT01868594|20343935|P2|NOT COMPLETED|Overall Study||3
8249986|NCT01868594|20343936|P1|NOT COMPLETED|Overall Study||4
8249987|NCT01868594|20343935|P2|COMPLETED|Overall Study||72
8249988|NCT01868594|20343936|P1|COMPLETED|Overall Study||72
8249989|NCT01868594|20343935|P2|STARTED|Overall Study||75
8249990|NCT01868594|20343936|P1|STARTED|Overall Study||76
8249991|NCT01868542|20343956|P2|NOT COMPLETED|Overall Study||2
8249992|NCT01868542|20343957|P1|NOT COMPLETED|Overall Study||0
8249993|NCT01868542|20343956|P2|COMPLETED|Overall Study||21
8249994|NCT01868542|20343957|P1|COMPLETED|Overall Study||23
8249995|NCT01868542|20343956|P2|STARTED|Overall Study||23
8249996|NCT01868542|20343957|P1|STARTED|Overall Study||23
8249997|NCT01868503|20343975|P1|NOT COMPLETED|Overall Study||2
8249998|NCT01868503|20343975|P1|COMPLETED|Overall Study||5
8249999|NCT01868503|20343975|P1|STARTED|Overall Study||7
8250000|NCT01868477|20343985|P2|NOT COMPLETED|Overall Study||5
8250001|NCT01868477|20343986|P1|NOT COMPLETED|Overall Study||4
8250002|NCT01868477|20343985|P2|COMPLETED|Overall Study||6
8250003|NCT01868477|20343986|P1|COMPLETED|Overall Study||8
8250004|NCT01868477|20343985|P2|Not Switched to EPO+DFX|Overall Study||0
8250005|NCT01868477|20343986|P1|Not Switched to EPO+DFX|Overall Study||7
8250006|NCT01868477|20343985|P2|Switched to EPO+DFX|Overall Study||0
8250007|NCT01868477|20343986|P1|Switched to EPO+DFX|Overall Study||5
8250008|NCT01868477|20343985|P2|STARTED|Overall Study||11
8250009|NCT01868477|20343986|P1|STARTED|Overall Study||12
8250010|NCT01868425|20344012|P2|NOT COMPLETED|Overall Study||0
8250011|NCT01868425|20344013|P1|NOT COMPLETED|Overall Study||0
8250012|NCT01868425|20344012|P2|COMPLETED|Overall Study||57
8250013|NCT01868425|20344013|P1|COMPLETED|Overall Study||55
8250014|NCT01868425|20344012|P2|STARTED|Overall Study||57
8250015|NCT01868425|20344013|P1|STARTED|Overall Study||55
8250016|NCT01868334|20344047|P4|NOT COMPLETED|Year 2 Pre-post Study||0
8250017|NCT01868334|20344048|P3|NOT COMPLETED|Year 2 Pre-post Study||0
8250018|NCT01868334|20344049|P2|NOT COMPLETED|Year 2 Pre-post Study||0
8250019|NCT01868334|20344050|P1|NOT COMPLETED|Year 2 Pre-post Study||0
8250020|NCT01868334|20344047|P4|COMPLETED|Year 2 Pre-post Study||19274
8250021|NCT01868334|20344048|P3|COMPLETED|Year 2 Pre-post Study||20904
8250022|NCT01868334|20344049|P2|COMPLETED|Year 2 Pre-post Study||8047
8250023|NCT01868334|20344050|P1|COMPLETED|Year 2 Pre-post Study||22324
8250024|NCT01868334|20344047|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
8250025|NCT01868334|20344048|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
8250026|NCT01868334|20344049|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
8250027|NCT01868334|20344050|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
8250028|NCT01868334|20344047|P4|NOT COMPLETED|Year 1 RCCT Study||0
8250029|NCT01868334|20344048|P3|NOT COMPLETED|Year 1 RCCT Study||0
8250030|NCT01868334|20344049|P2|NOT COMPLETED|Year 1 RCCT Study||0
8250031|NCT01868334|20344050|P1|NOT COMPLETED|Year 1 RCCT Study||0
8250032|NCT01868334|20344047|P4|COMPLETED|Year 1 RCCT Study||20904
8250033|NCT01868334|20344048|P3|COMPLETED|Year 1 RCCT Study||19274
8250034|NCT01868334|20344049|P2|COMPLETED|Year 1 RCCT Study||17185
8250035|NCT01868334|20344050|P1|COMPLETED|Year 1 RCCT Study||13186
8250036|NCT01868334|20344047|P4|STARTED|Year 1 RCCT Study||20904
8250037|NCT01868334|20344048|P3|STARTED|Year 1 RCCT Study||19274
8250038|NCT01868334|20344049|P2|STARTED|Year 1 RCCT Study||17185
8250039|NCT01868334|20344050|P1|STARTED|Year 1 RCCT Study||13186
8250040|NCT01868243|20344090|P2|NOT COMPLETED|Overall Study||1
8250041|NCT01868243|20344091|P1|NOT COMPLETED|Overall Study||0
8250042|NCT01868243|20344090|P2|COMPLETED|Overall Study||11
8250043|NCT01868243|20344091|P1|COMPLETED|Overall Study||15
8250044|NCT01868243|20344090|P2|STARTED|Overall Study||12
8250045|NCT01868243|20344091|P1|STARTED|Overall Study||15
8250046|NCT01868165|20344099|P1|NOT COMPLETED|Overall Study||45
8250047|NCT01868165|20344099|P1|COMPLETED|Overall Study||292
8250048|NCT01868165|20344099|P1|STARTED|Overall Study||337
8250049|NCT01868139|20344103|P1|NOT COMPLETED|Overall Study||1
8250050|NCT01868139|20344103|P1|COMPLETED|Overall Study||0
8250051|NCT01868139|20344103|P1|STARTED|Overall Study||1
8250052|NCT01868074|20344115|P2|NOT COMPLETED|Overall Study||4
8250053|NCT01868074|20344116|P1|NOT COMPLETED|Overall Study||7
8250054|NCT01868074|20344115|P2|COMPLETED|Overall Study||32
8250055|NCT01868074|20344116|P1|COMPLETED|Overall Study||29
8250056|NCT01868074|20344115|P2|STARTED|Overall Study||36
8250057|NCT01868074|20344116|P1|STARTED|Overall Study||36
8250058|NCT01868035|20344126|P1|NOT COMPLETED|Overall Study||7
8250059|NCT01868035|20344126|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
8250060|NCT01868035|20344126|P1|STARTED|Overall Study||15
8250061|NCT01868022|20344151|P9|NOT COMPLETED|Overall Study||2
8250062|NCT01868022|20344152|P8|NOT COMPLETED|Overall Study||9
8250063|NCT01868022|20344153|P7|NOT COMPLETED|Overall Study||0
8250064|NCT01868022|20344154|P6|NOT COMPLETED|Overall Study||1
8250065|NCT01868022|20344155|P5|NOT COMPLETED|Overall Study||2
8250066|NCT01868022|20344156|P4|NOT COMPLETED|Overall Study||1
8250067|NCT01868022|20344157|P3|NOT COMPLETED|Overall Study||1
8250068|NCT01868022|20344158|P2|NOT COMPLETED|Overall Study||0
8250069|NCT01868022|20344159|P1|NOT COMPLETED|Overall Study||0
8250070|NCT01868022|20344151|P9|COMPLETED|Overall Study||6
8250071|NCT01868022|20344152|P8|COMPLETED|Overall Study||16
8250072|NCT01868022|20344153|P7|COMPLETED|Overall Study||3
8250073|NCT01868022|20344154|P6|COMPLETED|Overall Study||2
8250074|NCT01868022|20344155|P5|COMPLETED|Overall Study||1
8250075|NCT01868022|20344156|P4|COMPLETED|Overall Study||2
8250076|NCT01868022|20344157|P3|COMPLETED|Overall Study||13
8250077|NCT01868022|20344158|P2|COMPLETED|Overall Study||3
8250078|NCT01868022|20344159|P1|COMPLETED|Overall Study||3
8250079|NCT01868022|20344151|P9|STARTED|Overall Study||8
8250080|NCT01868022|20344152|P8|STARTED|Overall Study||25
8250081|NCT01868022|20344153|P7|STARTED|Overall Study||3
8250082|NCT01868022|20344154|P6|STARTED|Overall Study||3
8250083|NCT01868022|20344155|P5|STARTED|Overall Study||3
8250084|NCT01868022|20344156|P4|STARTED|Overall Study||3
8250085|NCT01868022|20344157|P3|STARTED|Overall Study||14
8250086|NCT01868022|20344158|P2|STARTED|Overall Study||3
8250087|NCT01868022|20344159|P1|STARTED|Overall Study||3
8250088|NCT01868009|20344365|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
8250089|NCT01868009|20344366|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
8250090|NCT01868009|20344365|P2|COMPLETED|Period 2 (5-9 Days)||142
8250091|NCT01868009|20344366|P1|COMPLETED|Period 2 (5-9 Days)||141
8250092|NCT01868009|20344365|P2|STARTED|Period 2 (5-9 Days)||142
8250093|NCT01868009|20344366|P1|STARTED|Period 2 (5-9 Days)||143
8250094|NCT01868009|20344365|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
8250095|NCT01868009|20344366|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
8250096|NCT01868009|20344365|P2|COMPLETED|Period 1 (5-9 Days)||142
8250097|NCT01868009|20344366|P1|COMPLETED|Period 1 (5-9 Days)||143
8250098|NCT01868009|20344365|P2|STARTED|Period 1 (5-9 Days)||144
8250099|NCT01868009|20344366|P1|STARTED|Period 1 (5-9 Days)||143
8250100|NCT01867710|20344380|P4|NOT COMPLETED|Overall Study||42
8250101|NCT01867710|20344381|P3|NOT COMPLETED|Overall Study||40
8250102|NCT01867710|20344382|P2|NOT COMPLETED|Overall Study||41
8250103|NCT01867710|20344383|P1|NOT COMPLETED|Overall Study||41
8250104|NCT01867710|20344380|P4|COMPLETED|Overall Study||0
8250105|NCT01867710|20344381|P3|COMPLETED|Overall Study||0
8250106|NCT01867710|20344382|P2|COMPLETED|Overall Study||0
8250107|NCT01867710|20344383|P1|COMPLETED|Overall Study||0
8250108|NCT01867710|20344380|P4|Treated|Overall Study||42
8250109|NCT01867710|20344381|P3|Treated|Overall Study||39
8250110|NCT01867710|20344382|P2|Treated|Overall Study||41
8250111|NCT01867710|20344383|P1|Treated|Overall Study||41
8250112|NCT01867710|20344380|P4|STARTED|Overall Study||42
8250113|NCT01867710|20344381|P3|STARTED|Overall Study||40
8250114|NCT01867710|20344382|P2|STARTED|Overall Study||41
8250115|NCT01867710|20344383|P1|STARTED|Overall Study||41
8250116|NCT01867671|20344451|P2|NOT COMPLETED|Overall Study||28
8250117|NCT01867671|20344452|P1|NOT COMPLETED|Overall Study||29
8250118|NCT01867671|20344451|P2|COMPLETED|Overall Study||22
8250119|NCT01867671|20344452|P1|COMPLETED|Overall Study||67
8250120|NCT01867671|20344451|P2|STARTED|Overall Study||50
8250121|NCT01867671|20344452|P1|STARTED|Overall Study||96
8250122|NCT01867658|20344465|P1|NOT COMPLETED|Overall Study||9
8250123|NCT01867658|20344465|P1|COMPLETED|Overall Study||103
8250124|NCT01867658|20344465|P1|STARTED|Overall Study||112
8250125|NCT01867632|20344478|P2|NOT COMPLETED|Overall Study||0
8250126|NCT01867632|20344479|P1|NOT COMPLETED|Overall Study||0
8250127|NCT01867632|20344478|P2|COMPLETED|Overall Study||66
8250128|NCT01867632|20344479|P1|COMPLETED|Overall Study||65
8250129|NCT01867632|20344478|P2|STARTED|Overall Study||66
8250130|NCT01867632|20344479|P1|STARTED|Overall Study||65
8250131|NCT01867606|20344489|P2|NOT COMPLETED|Overall Study||15
8250132|NCT01867606|20344490|P1|NOT COMPLETED|Overall Study||10
8250133|NCT01867606|20344489|P2|COMPLETED|Overall Study||17
8250134|NCT01867606|20344490|P1|COMPLETED|Overall Study||16
8250135|NCT01867606|20344489|P2|STARTED|Overall Study||32
8250136|NCT01867606|20344490|P1|STARTED|Overall Study||26
8250137|NCT01867580|20344508|P2|NOT COMPLETED|Overall Study||24
8250138|NCT01867580|20344509|P1|NOT COMPLETED|Overall Study||28
8250139|NCT01867580|20344508|P2|COMPLETED|Overall Study||64
8250140|NCT01867580|20344509|P1|COMPLETED|Overall Study||65
8250141|NCT01867580|20344508|P2|STARTED|Overall Study||88
8250142|NCT01867580|20344509|P1|STARTED|Overall Study||93
8250143|NCT01867515|20344522|P3|NOT COMPLETED|Overall Study||11
8250144|NCT01867515|20344523|P2|NOT COMPLETED|Overall Study||1
8250145|NCT01867515|20344524|P1|NOT COMPLETED|Overall Study||0
8250146|NCT01867515|20344522|P3|COMPLETED|Overall Study||14
8250147|NCT01867515|20344523|P2|COMPLETED|Overall Study||11
8250148|NCT01867515|20344524|P1|COMPLETED|Overall Study||13
8250149|NCT01867515|20344522|P3|STARTED|Overall Study||25
8250150|NCT01867515|20344523|P2|STARTED|Overall Study||12
8250151|NCT01867515|20344524|P1|STARTED|Overall Study||13
8250152|NCT01867424|20344534|P2|NOT COMPLETED|Overall Study||1
8250153|NCT01867424|20344535|P1|NOT COMPLETED|Overall Study||2
8250154|NCT01867424|20344534|P2|COMPLETED|Overall Study||11
8250155|NCT01867424|20344535|P1|COMPLETED|Overall Study||10
8250156|NCT01867424|20344534|P2|STARTED|Overall Study||12
8250157|NCT01867424|20344535|P1|STARTED|Overall Study||12
8250158|NCT01867307|20344549|P2|NOT COMPLETED|Overall Study||3
8250159|NCT01867307|20344550|P1|NOT COMPLETED|Overall Study||3
8250160|NCT01867307|20344549|P2|COMPLETED|Overall Study||16
8250161|NCT01867307|20344550|P1|COMPLETED|Overall Study||15
8250162|NCT01867307|20344549|P2|STARTED|Overall Study|Started are the treated patients|19
8250163|NCT01867307|20344550|P1|STARTED|Overall Study|Started are the treated patients|18
8250164|NCT01867294|20344560|P4|NOT COMPLETED|Overall Study||0
8250165|NCT01867294|20344561|P3|NOT COMPLETED|Overall Study||0
8250166|NCT01867294|20344562|P2|NOT COMPLETED|Overall Study||1
8250167|NCT01867294|20344563|P1|NOT COMPLETED|Overall Study||1
8250168|NCT01867294|20344560|P4|COMPLETED|Overall Study||0
8250169|NCT01867294|20344561|P3|COMPLETED|Overall Study||0
8250170|NCT01867294|20344562|P2|COMPLETED|Overall Study||9
8250171|NCT01867294|20344563|P1|COMPLETED|Overall Study||8
8250172|NCT01867294|20344560|P4|STARTED|Overall Study||0
8250173|NCT01867294|20344561|P3|STARTED|Overall Study||0
8250174|NCT01867294|20344562|P2|STARTED|Overall Study||10
8250175|NCT01867294|20344563|P1|STARTED|Overall Study||9
8250176|NCT01867216|20344610|P7|NOT COMPLETED|Overall Study||1
8250177|NCT01867216|20344611|P6|NOT COMPLETED|Overall Study||0
8250178|NCT01867216|20344612|P5|NOT COMPLETED|Overall Study||1
8250179|NCT01867216|20344613|P4|NOT COMPLETED|Overall Study||0
8250180|NCT01867216|20344614|P3|NOT COMPLETED|Overall Study||0
8250181|NCT01867216|20344615|P2|NOT COMPLETED|Overall Study||0
8250182|NCT01867216|20344616|P1|NOT COMPLETED|Overall Study||4
8250183|NCT01867216|20344610|P7|COMPLETED|Overall Study||8
8250184|NCT01867216|20344611|P6|COMPLETED|Overall Study||8
8250185|NCT01867216|20344612|P5|COMPLETED|Overall Study||8
8250186|NCT01867216|20344613|P4|COMPLETED|Overall Study||8
8250187|NCT01867216|20344614|P3|COMPLETED|Overall Study||8
8250188|NCT01867216|20344615|P2|COMPLETED|Overall Study||8
8250189|NCT01867216|20344616|P1|COMPLETED|Overall Study||12
8250190|NCT01867216|20344610|P7|Received Study Drug|Overall Study||9
8250191|NCT01867216|20344611|P6|Received Study Drug|Overall Study||8
8250192|NCT01867216|20344612|P5|Received Study Drug|Overall Study||9
8250193|NCT01867216|20344613|P4|Received Study Drug|Overall Study||8
8250194|NCT01867216|20344614|P3|Received Study Drug|Overall Study||8
8250195|NCT01867216|20344615|P2|Received Study Drug|Overall Study||8
8250196|NCT01867216|20344616|P1|Received Study Drug|Overall Study||14
8250197|NCT01867216|20344610|P7|STARTED|Overall Study||9
8250198|NCT01867216|20344611|P6|STARTED|Overall Study||8
8250199|NCT01867216|20344612|P5|STARTED|Overall Study||9
8250200|NCT01867216|20344613|P4|STARTED|Overall Study||8
8250201|NCT01867216|20344614|P3|STARTED|Overall Study||8
8250202|NCT01867216|20344615|P2|STARTED|Overall Study||8
8250203|NCT01867216|20344616|P1|STARTED|Overall Study||16
8250204|NCT01867164|20344673|P2|NOT COMPLETED|Overall Study||0
8250205|NCT01867164|20344674|P1|NOT COMPLETED|Overall Study||0
8250206|NCT01867164|20344673|P2|COMPLETED|Overall Study||79
8250207|NCT01867164|20344674|P1|COMPLETED|Overall Study||81
8250208|NCT01867164|20344673|P2|STARTED|Overall Study||79
8250209|NCT01867164|20344674|P1|STARTED|Overall Study||81
8250210|NCT01867086|20344688|P1|NOT COMPLETED|Overall Study||1
8250211|NCT01867086|20344688|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
8250212|NCT01867086|20344688|P1|STARTED|Overall Study||1
8250213|NCT01867047|20344697|P2|NOT COMPLETED|Overall Study||5
8250214|NCT01867047|20344698|P1|NOT COMPLETED|Overall Study||8
8250215|NCT01867047|20344697|P2|COMPLETED|Overall Study||23
8250216|NCT01867047|20344698|P1|COMPLETED|Overall Study||23
8250217|NCT01867047|20344697|P2|STARTED|Overall Study||28
8250218|NCT01867047|20344698|P1|STARTED|Overall Study||31
8250219|NCT01867021|20344718|P2|NOT COMPLETED|Overall Study||10
8250220|NCT01867021|20344719|P1|NOT COMPLETED|Overall Study||2
8250221|NCT01867021|20344718|P2|COMPLETED|Overall Study||1440
8250222|NCT01867021|20344719|P1|COMPLETED|Overall Study||1450
8250223|NCT01867021|20344718|P2|STARTED|Overall Study||1450
8250224|NCT01867021|20344719|P1|STARTED|Overall Study||1452
8250225|NCT01867008|20344738|P1|NOT COMPLETED|Overall Study||1
8250226|NCT01867008|20344738|P1|COMPLETED|Overall Study||54
8250227|NCT01867008|20344738|P1|STARTED|Overall Study||55
8250228|NCT01866943|20344742|P2|NOT COMPLETED|Overall Study||22
8250229|NCT01866943|20344743|P1|NOT COMPLETED|Overall Study||19
8250230|NCT01866943|20344742|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
8250231|NCT01866943|20344743|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
8250232|NCT01866943|20344742|P2|STARTED|Overall Study||22
8250233|NCT01866943|20344743|P1|STARTED|Overall Study||19
8250234|NCT01866917|20344754|P2|NOT COMPLETED|Overall Study||6
8250235|NCT01866917|20344755|P1|NOT COMPLETED|Overall Study||4
8250236|NCT01866917|20344754|P2|COMPLETED|Overall Study||12
8250237|NCT01866917|20344755|P1|COMPLETED|Overall Study||13
8250238|NCT01866917|20344754|P2|STARTED|Overall Study||18
8250239|NCT01866917|20344755|P1|STARTED|Overall Study||17
8250240|NCT01866839|20344763|P1|NOT COMPLETED|Overall Study||10
8250241|NCT01866839|20344763|P1|COMPLETED|Overall Study||30
8250242|NCT01866839|20344763|P1|STARTED|Overall Study||40
8250243|NCT01866826|20344779|P2|NOT COMPLETED|Second Intervention - 4 Weeks||0
8250244|NCT01866826|20344780|P1|NOT COMPLETED|Second Intervention - 4 Weeks||0
8250245|NCT01866826|20344779|P2|COMPLETED|Second Intervention - 4 Weeks||20
8250246|NCT01866826|20344780|P1|COMPLETED|Second Intervention - 4 Weeks||22
8250247|NCT01866826|20344779|P2|STARTED|Second Intervention - 4 Weeks||20
8250248|NCT01866826|20344780|P1|STARTED|Second Intervention - 4 Weeks||22
8250249|NCT01866826|20344779|P2|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
8250250|NCT01866826|20344780|P1|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
8250251|NCT01866826|20344779|P2|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
8250252|NCT01866826|20344780|P1|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
8250253|NCT01866826|20344779|P2|STARTED|Wash-Out Period - 4 -6 Weeks||23
8250254|NCT01866826|20344780|P1|STARTED|Wash-Out Period - 4 -6 Weeks||22
8250255|NCT01866826|20344779|P2|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
8250256|NCT01866826|20344780|P1|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
8250257|NCT01866826|20344779|P2|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
8250258|NCT01866826|20344780|P1|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
8250259|NCT01866826|20344779|P2|STARTED|Phase I -Initial Randomization - 4 Weeks||23
8250260|NCT01866826|20344780|P1|STARTED|Phase I -Initial Randomization - 4 Weeks||23
8250261|NCT01866709|20344796|P2|NOT COMPLETED|Overall Study||0
8250262|NCT01866709|20344797|P1|NOT COMPLETED|Overall Study||1
8250263|NCT01866709|20344796|P2|COMPLETED|Overall Study||17
8250264|NCT01866709|20344797|P1|COMPLETED|Overall Study||14
8250265|NCT01866709|20344796|P2|STARTED|Overall Study||17
8250266|NCT01866709|20344797|P1|STARTED|Overall Study||15
8250267|NCT01866592|20344805|P1|NOT COMPLETED|Overall Study||23
8250268|NCT01866592|20344805|P1|COMPLETED|Overall Study||58
8250269|NCT01866592|20344805|P1|STARTED|Overall Study||81
8250270|NCT01866423|20344838|P1|NOT COMPLETED|Overall Study||4
8250271|NCT01866423|20344838|P1|COMPLETED|Overall Study||0
8250272|NCT01866423|20344838|P1|STARTED|Overall Study||4
8250273|NCT01866410|20344848|P1|NOT COMPLETED|Overall Study||0
8250274|NCT01866410|20344848|P1|COMPLETED|Overall Study||37
8250275|NCT01866410|20344848|P1|STARTED|Overall Study||37
8250276|NCT01866319|20344866|P3|NOT COMPLETED|Overall Study||180
8250277|NCT01866319|20344867|P2|NOT COMPLETED|Overall Study||178
8250278|NCT01866319|20344868|P1|NOT COMPLETED|Overall Study||207
8250279|NCT01866319|20344866|P3|COMPLETED|Overall Study||97
8250280|NCT01866319|20344867|P2|COMPLETED|Overall Study||101
8250281|NCT01866319|20344868|P1|COMPLETED|Overall Study||71
8250282|NCT01866319|20344866|P3|Treated|Overall Study||277
8250283|NCT01866319|20344867|P2|Treated|Overall Study||278
8250284|NCT01866319|20344868|P1|Treated|Overall Study||256
8250285|NCT01866319|20344866|P3|STARTED|Overall Study||277
8250286|NCT01866319|20344867|P2|STARTED|Overall Study||279
8250287|NCT01866319|20344868|P1|STARTED|Overall Study||278
8250288|NCT01866306|20344889|P7|NOT COMPLETED|Overall Study||0
8250289|NCT01866306|20344890|P6|NOT COMPLETED|Overall Study||0
8250290|NCT01866306|20344891|P5|NOT COMPLETED|Overall Study||0
8250291|NCT01866306|20344892|P4|NOT COMPLETED|Overall Study||0
8250292|NCT01866306|20344893|P3|NOT COMPLETED|Overall Study||0
8250293|NCT01866306|20344894|P2|NOT COMPLETED|Overall Study||0
8250294|NCT01866306|20344895|P1|NOT COMPLETED|Overall Study||0
8250295|NCT01866306|20344889|P7|COMPLETED|Overall Study||23
8250296|NCT01866306|20344890|P6|COMPLETED|Overall Study||6
8250297|NCT01866306|20344891|P5|COMPLETED|Overall Study||6
8250298|NCT01866306|20344892|P4|COMPLETED|Overall Study||6
8250299|NCT01866306|20344893|P3|COMPLETED|Overall Study||6
8250300|NCT01866306|20344894|P2|COMPLETED|Overall Study||6
8250301|NCT01866306|20344895|P1|COMPLETED|Overall Study||6
8250302|NCT01866306|20344889|P7|STARTED|Overall Study||23
8250303|NCT01866306|20344890|P6|STARTED|Overall Study||6
8250304|NCT01866306|20344891|P5|STARTED|Overall Study||6
8250305|NCT01866306|20344892|P4|STARTED|Overall Study||6
8250306|NCT01866306|20344893|P3|STARTED|Overall Study||6
8250307|NCT01866306|20344894|P2|STARTED|Overall Study||6
8250308|NCT01866306|20344895|P1|STARTED|Overall Study||6
8250309|NCT01866293|20344967|P1|NOT COMPLETED|Overall Study||2
8250310|NCT01866293|20344967|P1|COMPLETED|Overall Study||9
8250311|NCT01866293|20344967|P1|STARTED|Overall Study||11
8250312|NCT01866163|20344977|P2|NOT COMPLETED|Overall Study||4
8250313|NCT01866163|20344978|P1|NOT COMPLETED|Overall Study||10
8250314|NCT01866163|20344977|P2|COMPLETED|Overall Study||99
8250315|NCT01866163|20344978|P1|COMPLETED|Overall Study||313
8250316|NCT01866163|20344977|P2|STARTED|Overall Study||103
8250317|NCT01866163|20344978|P1|STARTED|Overall Study||323
8250318|NCT01866150|20344988|P1|NOT COMPLETED|Overall Study||0
8250319|NCT01866150|20344988|P1|COMPLETED|Overall Study||450
8250320|NCT01866150|20344988|P1|STARTED|Overall Study||450
8250321|NCT01866098|20345012|P3|NOT COMPLETED|Overall Study||21
8250322|NCT01866098|20345013|P2|NOT COMPLETED|Overall Study||27
8250323|NCT01866098|20345014|P1|NOT COMPLETED|Overall Study||19
8250324|NCT01866098|20345012|P3|COMPLETED|Overall Study||25
8250325|NCT01866098|20345013|P2|COMPLETED|Overall Study||20
8250326|NCT01866098|20345014|P1|COMPLETED|Overall Study||32
8250327|NCT01866098|20345012|P3|STARTED|Overall Study||46
8250328|NCT01866098|20345013|P2|STARTED|Overall Study||47
8250329|NCT01866098|20345014|P1|STARTED|Overall Study||51
8250330|NCT01865812|20345043|P1|NOT COMPLETED|Overall Study||2
8250331|NCT01865812|20345043|P1|COMPLETED|Overall Study||24
8250332|NCT01865812|20345043|P1|STARTED|Overall Study||26
8250333|NCT01865747|20345051|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
8250334|NCT01865747|20345052|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
8250335|NCT01865747|20345051|P2|COMPLETED|Primary Intent to Treat (PITT)||36
8250336|NCT01865747|20345052|P1|COMPLETED|Primary Intent to Treat (PITT)||56
8250337|NCT01865747|20345051|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
8250338|NCT01865747|20345052|P1|STARTED|Primary Intent to Treat (PITT)||187
8250339|NCT01865747|20345051|P2|NOT COMPLETED|Overall Study (ITT)||255
8250340|NCT01865747|20345052|P1|NOT COMPLETED|Overall Study (ITT)||198
8250341|NCT01865747|20345051|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
8250342|NCT01865747|20345052|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
8250343|NCT01865747|20345051|P2|STARTED|Overall Study (ITT)||328
8250344|NCT01865747|20345052|P1|STARTED|Overall Study (ITT)||330
8250345|NCT01865708|20345062|P1|NOT COMPLETED|Overall Study||0
8250346|NCT01865708|20345062|P1|COMPLETED|Overall Study||10
8250347|NCT01865708|20345062|P1|STARTED|Overall Study||10
8250348|NCT01865552|20345073|P6|NOT COMPLETED|Period 2||0
8250349|NCT01865552|20345074|P5|NOT COMPLETED|Period 2||0
8250350|NCT01865552|20345075|P4|NOT COMPLETED|Period 2||0
8250351|NCT01865552|20345076|P3|NOT COMPLETED|Period 2||0
8250352|NCT01865552|20345077|P2|NOT COMPLETED|Period 2||0
8250353|NCT01865552|20345078|P1|NOT COMPLETED|Period 2||0
8250354|NCT01865552|20345073|P6|COMPLETED|Period 2||22
8250355|NCT01865552|20345074|P5|COMPLETED|Period 2||20
8250356|NCT01865552|20345075|P4|COMPLETED|Period 2||22
8250357|NCT01865552|20345076|P3|COMPLETED|Period 2||23
8250358|NCT01865552|20345077|P2|COMPLETED|Period 2||23
8250359|NCT01865552|20345078|P1|COMPLETED|Period 2||22
8250360|NCT01865552|20345073|P6|STARTED|Period 2||22
8250361|NCT01865552|20345074|P5|STARTED|Period 2||20
8250362|NCT01865552|20345075|P4|STARTED|Period 2||22
8250363|NCT01865552|20345076|P3|STARTED|Period 2||23
8250364|NCT01865552|20345077|P2|STARTED|Period 2||23
8250365|NCT01865552|20345078|P1|STARTED|Period 2||22
8250366|NCT01865552|20345073|P6|NOT COMPLETED|Period 1||1
8250367|NCT01865552|20345074|P5|NOT COMPLETED|Period 1||3
8250368|NCT01865552|20345075|P4|NOT COMPLETED|Period 1||1
8250369|NCT01865552|20345076|P3|NOT COMPLETED|Period 1||0
8250370|NCT01865552|20345077|P2|NOT COMPLETED|Period 1||0
8250371|NCT01865552|20345078|P1|NOT COMPLETED|Period 1||1
8250372|NCT01865552|20345073|P6|COMPLETED|Period 1||22
8250373|NCT01865552|20345074|P5|COMPLETED|Period 1||20
8250374|NCT01865552|20345075|P4|COMPLETED|Period 1||22
8250375|NCT01865552|20345076|P3|COMPLETED|Period 1||23
8250376|NCT01865552|20345077|P2|COMPLETED|Period 1||23
8250377|NCT01865552|20345078|P1|COMPLETED|Period 1||22
8250378|NCT01865552|20345073|P6|Discontinued From Period 1|Period 1||1
8250379|NCT01865552|20345074|P5|Discontinued From Period 1|Period 1||3
8250380|NCT01865552|20345075|P4|Discontinued From Period 1|Period 1||1
8250381|NCT01865552|20345076|P3|Discontinued From Period 1|Period 1||0
8250382|NCT01865552|20345077|P2|Discontinued From Period 1|Period 1||0
8250383|NCT01865552|20345078|P1|Discontinued From Period 1|Period 1||1
8250384|NCT01865552|20345073|P6|STARTED|Period 1||23
8250385|NCT01865552|20345074|P5|STARTED|Period 1||23
8250386|NCT01865552|20345075|P4|STARTED|Period 1||23
8250387|NCT01865552|20345076|P3|STARTED|Period 1||23
8250388|NCT01865552|20345077|P2|STARTED|Period 1||23
8250389|NCT01865552|20345078|P1|STARTED|Period 1||23
8250390|NCT01865487|20345116|P10|NOT COMPLETED|Overall Study||0
8250391|NCT01865487|20345117|P9|NOT COMPLETED|Overall Study||0
8250392|NCT01865487|20345118|P8|NOT COMPLETED|Overall Study||0
8250393|NCT01865487|20345119|P7|NOT COMPLETED|Overall Study||1
8250394|NCT01865487|20345120|P6|NOT COMPLETED|Overall Study||0
8250395|NCT01865487|20345121|P5|NOT COMPLETED|Overall Study||1
8250396|NCT01865487|20345122|P4|NOT COMPLETED|Overall Study||1
8250397|NCT01865487|20345123|P3|NOT COMPLETED|Overall Study||0
8250398|NCT01865487|20345124|P2|NOT COMPLETED|Overall Study||0
8250399|NCT01865487|20345125|P1|NOT COMPLETED|Overall Study||0
8250400|NCT01865487|20345116|P10|COMPLETED|Overall Study||4
8250401|NCT01865487|20345117|P9|COMPLETED|Overall Study||12
8250402|NCT01865487|20345118|P8|COMPLETED|Overall Study||4
8250403|NCT01865487|20345119|P7|COMPLETED|Overall Study||11
8250404|NCT01865487|20345120|P6|COMPLETED|Overall Study||4
8250405|NCT01865487|20345121|P5|COMPLETED|Overall Study||11
8250406|NCT01865487|20345122|P4|COMPLETED|Overall Study||4
8250407|NCT01865487|20345123|P3|COMPLETED|Overall Study||15
8250408|NCT01865487|20345124|P2|COMPLETED|Overall Study||15
8250409|NCT01865487|20345125|P1|COMPLETED|Overall Study||15
8250410|NCT01865487|20345116|P10|STARTED|Overall Study||4
8250411|NCT01865487|20345117|P9|STARTED|Overall Study||12
8250412|NCT01865487|20345118|P8|STARTED|Overall Study||4
8250413|NCT01865487|20345119|P7|STARTED|Overall Study||12
8250414|NCT01865487|20345120|P6|STARTED|Overall Study||4
8250415|NCT01865487|20345121|P5|STARTED|Overall Study||12
8250416|NCT01865487|20345122|P4|STARTED|Overall Study||5
8250417|NCT01865487|20345123|P3|STARTED|Overall Study||15
8250418|NCT01865487|20345124|P2|STARTED|Overall Study||15
8250419|NCT01865487|20345125|P1|STARTED|Overall Study||15
8250420|NCT01865448|20345164|P2|NOT COMPLETED|Overall Study||3
8250421|NCT01865448|20345165|P1|NOT COMPLETED|Overall Study||2
8250422|NCT01865448|20345164|P2|COMPLETED|Overall Study||14
8250423|NCT01865448|20345165|P1|COMPLETED|Overall Study||15
8250424|NCT01865448|20345164|P2|STARTED|Overall Study||17
8250425|NCT01865448|20345165|P1|STARTED|Overall Study||17
8250426|NCT01865084|20345276|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
8250427|NCT01865084|20345277|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
8250428|NCT01865084|20345278|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
8250429|NCT01865084|20345276|P3|COMPLETED|Open Label Extension (OLE) Period||158
8250430|NCT01865084|20345277|P2|COMPLETED|Open Label Extension (OLE) Period||139
8250431|NCT01865084|20345278|P1|COMPLETED|Open Label Extension (OLE) Period||0
8250432|NCT01865084|20345276|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
8250433|NCT01865084|20345277|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
8250434|NCT01865084|20345278|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
8250435|NCT01865084|20345276|P3|NOT COMPLETED|Double Blind Period (DB)||6
8250436|NCT01865084|20345277|P2|NOT COMPLETED|Double Blind Period (DB)||4
8250437|NCT01865084|20345278|P1|NOT COMPLETED|Double Blind Period (DB)||5
8250438|NCT01865084|20345276|P3|COMPLETED|Double Blind Period (DB)||107
8250439|NCT01865084|20345277|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
8250440|NCT01865084|20345278|P1|COMPLETED|Double Blind Period (DB)||111
8250441|NCT01865084|20345276|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
8250442|NCT01865084|20345277|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
8250443|NCT01865084|20345278|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
8250444|NCT01865084|20345276|P3|STARTED|Double Blind Period (DB)||113
8250445|NCT01865084|20345277|P2|STARTED|Double Blind Period (DB)||102
8250446|NCT01865084|20345278|P1|STARTED|Double Blind Period (DB)||116
8250447|NCT01864564|20345306|P2|NOT COMPLETED|Overall Study||95
8250448|NCT01864564|20345307|P1|NOT COMPLETED|Overall Study||37
8250449|NCT01864564|20345306|P2|COMPLETED|Overall Study||387
8250450|NCT01864564|20345307|P1|COMPLETED|Overall Study||443
8250451|NCT01864564|20345306|P2|STARTED|Overall Study||482
8250452|NCT01864564|20345307|P1|STARTED|Overall Study||480
8250453|NCT01864538|20345333|P1|NOT COMPLETED|Overall Study||11
8250454|NCT01864538|20345333|P1|COMPLETED|Overall Study||0
8250455|NCT01864538|20345333|P1|STARTED|Overall Study||11
8250456|NCT01864525|20345339|P2|NOT COMPLETED|Overall Study||0
8250457|NCT01864525|20345340|P1|NOT COMPLETED|Overall Study||1
8250458|NCT01864525|20345339|P2|COMPLETED|Overall Study||7
8250459|NCT01864525|20345340|P1|COMPLETED|Overall Study||9
8250460|NCT01864525|20345339|P2|STARTED|Overall Study||7
8250461|NCT01864525|20345340|P1|STARTED|Overall Study||10
8250462|NCT01864434|20345350|P2|NOT COMPLETED|Overall Study||0
8250463|NCT01864434|20345351|P1|NOT COMPLETED|Overall Study||0
8250464|NCT01864434|20345350|P2|COMPLETED|Overall Study||25
8250465|NCT01864434|20345351|P1|COMPLETED|Overall Study||25
8250466|NCT01864434|20345350|P2|STARTED|Overall Study||25
8250467|NCT01864434|20345351|P1|STARTED|Overall Study||25
8250468|NCT01864291|20345361|P1|NOT COMPLETED|Overall Study||2
8250469|NCT01864291|20345361|P1|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
8250470|NCT01864291|20345361|P1|STARTED|Overall Study||9
8250471|NCT01864200|20345369|P2|NOT COMPLETED|Overall Study||3
8250472|NCT01864200|20345370|P1|NOT COMPLETED|Overall Study||2
8250473|NCT01864200|20345369|P2|COMPLETED|Overall Study||26
8250474|NCT01864200|20345370|P1|COMPLETED|Overall Study||43
8250475|NCT01864200|20345369|P2|STARTED|Overall Study||29
8250476|NCT01864200|20345370|P1|STARTED|Overall Study||45
8250477|NCT01864174|20345378|P2|NOT COMPLETED|Off Treatment Follow-Up||0
8250478|NCT01864174|20345379|P1|NOT COMPLETED|Off Treatment Follow-Up||3
8250479|NCT01864174|20345378|P2|COMPLETED|Off Treatment Follow-Up||1
8250480|NCT01864174|20345379|P1|COMPLETED|Off Treatment Follow-Up||6
8250481|NCT01864174|20345378|P2|STARTED|Off Treatment Follow-Up||1
8250482|NCT01864174|20345379|P1|STARTED|Off Treatment Follow-Up||9
8250483|NCT01864174|20345378|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
8250484|NCT01864174|20345379|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
8250485|NCT01864174|20345378|P2|COMPLETED|Double Blind - Compliant Randomized||245
8250486|NCT01864174|20345379|P1|COMPLETED|Double Blind - Compliant Randomized||245
8250487|NCT01864174|20345378|P2|STARTED|Double Blind - Compliant Randomized||271
8250488|NCT01864174|20345379|P1|STARTED|Double Blind - Compliant Randomized||268
8250489|NCT01864174|20345378|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
8250490|NCT01864174|20345379|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
8250491|NCT01864174|20345378|P2|COMPLETED|Double Blind Treatment - All Treated||271
8250492|NCT01864174|20345379|P1|COMPLETED|Double Blind Treatment - All Treated||268
8250493|NCT01864174|20345378|P2|STARTED|Double Blind Treatment - All Treated||285
8250494|NCT01864174|20345379|P1|STARTED|Double Blind Treatment - All Treated||283
8250495|NCT01864148|20345398|P5|NOT COMPLETED|Overall Study||23
8250496|NCT01864148|20345399|P4|NOT COMPLETED|Overall Study||26
8250497|NCT01864148|20345400|P3|NOT COMPLETED|Overall Study||11
8250498|NCT01864148|20345401|P2|NOT COMPLETED|Overall Study||5
8250499|NCT01864148|20345402|P1|NOT COMPLETED|Overall Study||20
8250500|NCT01864148|20345398|P5|COMPLETED|Overall Study||69
8250501|NCT01864148|20345399|P4|COMPLETED|Overall Study||68
8250502|NCT01864148|20345400|P3|COMPLETED|Overall Study||84
8250503|NCT01864148|20345401|P2|COMPLETED|Overall Study||40
8250504|NCT01864148|20345402|P1|COMPLETED|Overall Study||73
8250505|NCT01864148|20345398|P5|Randomized and Dosed|Overall Study||92
8250506|NCT01864148|20345399|P4|Randomized and Dosed|Overall Study||93
8250507|NCT01864148|20345400|P3|Randomized and Dosed|Overall Study||95
8250508|NCT01864148|20345401|P2|Randomized and Dosed|Overall Study||45
8250509|NCT01864148|20345402|P1|Randomized and Dosed|Overall Study||93
8250510|NCT01864148|20345398|P5|STARTED|Overall Study||92
8250511|NCT01864148|20345399|P4|STARTED|Overall Study||94
8250512|NCT01864148|20345400|P3|STARTED|Overall Study||95
8250513|NCT01864148|20345401|P2|STARTED|Overall Study||45
8250514|NCT01864148|20345402|P1|STARTED|Overall Study||93
8250515|NCT01864005|20345431|P2|NOT COMPLETED|Overall Study||6
8250516|NCT01864005|20345432|P1|NOT COMPLETED|Overall Study||3
8250517|NCT01864005|20345431|P2|COMPLETED|Overall Study||25
8250518|NCT01864005|20345432|P1|COMPLETED|Overall Study||26
8250519|NCT01864005|20345431|P2|STARTED|Overall Study||31
8250520|NCT01864005|20345432|P1|STARTED|Overall Study||29
8250521|NCT01863953|20345449|P3|NOT COMPLETED|Overall Study||1
8250522|NCT01863953|20345450|P2|NOT COMPLETED|Overall Study||0
8250523|NCT01863953|20345451|P1|NOT COMPLETED|Overall Study||0
8250524|NCT01863953|20345449|P3|COMPLETED|Overall Study||37
8250525|NCT01863953|20345450|P2|COMPLETED|Overall Study||36
8250526|NCT01863953|20345451|P1|COMPLETED|Overall Study||38
8250527|NCT01863953|20345449|P3|STARTED|Overall Study||38
8250528|NCT01863953|20345450|P2|STARTED|Overall Study||36
8250529|NCT01863953|20345451|P1|STARTED|Overall Study||38
8250530|NCT01863771|20345465|P4|NOT COMPLETED|Maintenance Phase||43
8250531|NCT01863771|20345466|P3|NOT COMPLETED|Maintenance Phase||12
8250532|NCT01863771|20345467|P2|NOT COMPLETED|Maintenance Phase||5
8250533|NCT01863771|20345468|P1|NOT COMPLETED|Maintenance Phase||0
8250534|NCT01863771|20345465|P4|COMPLETED|Maintenance Phase||17
8250535|NCT01863771|20345466|P3|COMPLETED|Maintenance Phase||19
8250536|NCT01863771|20345467|P2|COMPLETED|Maintenance Phase||27
8250537|NCT01863771|20345468|P1|COMPLETED|Maintenance Phase||0
8250538|NCT01863771|20345465|P4|STARTED|Maintenance Phase||60
8250539|NCT01863771|20345466|P3|STARTED|Maintenance Phase||31
8250540|NCT01863771|20345467|P2|STARTED|Maintenance Phase||32
8250541|NCT01863771|20345468|P1|STARTED|Maintenance Phase||0
8250542|NCT01863771|20345465|P4|NOT COMPLETED|Induction Phase||0
8250543|NCT01863771|20345466|P3|NOT COMPLETED|Induction Phase||0
8250544|NCT01863771|20345467|P2|NOT COMPLETED|Induction Phase||0
8250545|NCT01863771|20345468|P1|NOT COMPLETED|Induction Phase||21
8250546|NCT01863771|20345465|P4|COMPLETED|Induction Phase||0
8250547|NCT01863771|20345466|P3|COMPLETED|Induction Phase||0
8250548|NCT01863771|20345467|P2|COMPLETED|Induction Phase||0
8250549|NCT01863771|20345468|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
8250550|NCT01863771|20345465|P4|STARTED|Induction Phase||0
8250551|NCT01863771|20345466|P3|STARTED|Induction Phase||0
8250552|NCT01863771|20345467|P2|STARTED|Induction Phase||0
8250553|NCT01863771|20345468|P1|STARTED|Induction Phase||144
8250554|NCT01863758|20345480|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
8250555|NCT01863758|20345480|P1|COMPLETED|Prophylactic Treatment-Phase II||64
8250556|NCT01863758|20345480|P1|STARTED|Prophylactic Treatment-Phase II||66
8250557|NCT01863758|20345480|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
8250558|NCT01863758|20345480|P1|COMPLETED|Prophylactic Treatment-Phase I||66
8250559|NCT01863758|20345480|P1|STARTED|Prophylactic Treatment-Phase I||66
8250560|NCT01863758|20345480|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
8250561|NCT01863758|20345480|P1|COMPLETED|Pharmacokinetic Assessment||66
8250562|NCT01863758|20345480|P1|STARTED|Pharmacokinetic Assessment||66
8250563|NCT01863732|20345492|P4|NOT COMPLETED|Overall Study||8
8250564|NCT01863732|20345493|P3|NOT COMPLETED|Overall Study||11
8250565|NCT01863732|20345494|P2|NOT COMPLETED|Overall Study||12
8250566|NCT01863732|20345495|P1|NOT COMPLETED|Overall Study||13
8250567|NCT01863732|20345492|P4|COMPLETED|Overall Study||33
8250568|NCT01863732|20345493|P3|COMPLETED|Overall Study||35
8250569|NCT01863732|20345494|P2|COMPLETED|Overall Study||75
8250570|NCT01863732|20345495|P1|COMPLETED|Overall Study||87
8250571|NCT01863732|20345492|P4|STARTED|Overall Study||41
8250572|NCT01863732|20345493|P3|STARTED|Overall Study||46
8250573|NCT01863732|20345494|P2|STARTED|Overall Study||87
8250574|NCT01863732|20345495|P1|STARTED|Overall Study||100
8250575|NCT01863680|20345508|P1|NOT COMPLETED|Overall Study||57
8250576|NCT01863680|20345508|P1|COMPLETED|Overall Study||121
8250577|NCT01863680|20345508|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
8250578|NCT01863680|20345508|P1|Subjects Received Study Drug|Overall Study||149
8250579|NCT01863680|20345508|P1|Subjects Received hCG Injection|Overall Study||162
8250580|NCT01863680|20345508|P1|Subjects Started COS Treatment|Overall Study||169
8250581|NCT01863680|20345508|P1|STARTED|Overall Study||178
8250582|NCT01863667|20345516|P2|NOT COMPLETED|Overall Study||32
8250583|NCT01863667|20345517|P1|NOT COMPLETED|Overall Study||33
8250584|NCT01863667|20345516|P2|COMPLETED|Overall Study||0
8250585|NCT01863667|20345517|P1|COMPLETED|Overall Study||0
8250586|NCT01863667|20345516|P2|STARTED|Overall Study||32
8250587|NCT01863667|20345517|P1|STARTED|Overall Study||33
8250588|NCT01863563|20345537|P1|NOT COMPLETED|Overall Study||0
8250589|NCT01863563|20345537|P1|COMPLETED|Overall Study||100
8250590|NCT01863563|20345537|P1|STARTED|Overall Study||100
8250591|NCT01863498|20345543|P2|NOT COMPLETED|Overall Study||0
8250592|NCT01863498|20345544|P1|NOT COMPLETED|Overall Study||0
8250593|NCT01863498|20345543|P2|COMPLETED|Overall Study||32
8250594|NCT01863498|20345544|P1|COMPLETED|Overall Study||33
8250595|NCT01863498|20345543|P2|STARTED|Overall Study||32
8250596|NCT01863498|20345544|P1|STARTED|Overall Study||33
8250597|NCT01863433|20345554|P1|NOT COMPLETED|Overall Study||1
8250598|NCT01863433|20345554|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
8250599|NCT01863433|20345554|P1|STARTED|Overall Study||120
8250600|NCT01863368|20345564|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
8250601|NCT01863368|20345565|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
8250602|NCT01863368|20345564|P2|COMPLETED|Phase II, Day 35 to Day 90||41
8250603|NCT01863368|20345565|P1|COMPLETED|Phase II, Day 35 to Day 90||41
8250604|NCT01863368|20345564|P2|STARTED|Phase II, Day 35 to Day 90||41
8250605|NCT01863368|20345565|P1|STARTED|Phase II, Day 35 to Day 90||43
8250606|NCT01863368|20345564|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
8250607|NCT01863368|20345565|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
8250608|NCT01863368|20345564|P2|COMPLETED|Phase I, Day 0 to Day 35||41
8250609|NCT01863368|20345565|P1|COMPLETED|Phase I, Day 0 to Day 35||43
8250610|NCT01863368|20345564|P2|Treated|Phase I, Day 0 to Day 35||47
8250611|NCT01863368|20345565|P1|Treated|Phase I, Day 0 to Day 35||46
8250612|NCT01863368|20345564|P2|STARTED|Phase I, Day 0 to Day 35||48
8250613|NCT01863368|20345565|P1|STARTED|Phase I, Day 0 to Day 35||46
8250614|NCT01863134|20345580|P2|NOT COMPLETED|Overall Study||0
8250615|NCT01863134|20345581|P1|NOT COMPLETED|Overall Study||0
8250616|NCT01863134|20345580|P2|COMPLETED|Overall Study||68
8250617|NCT01863134|20345581|P1|COMPLETED|Overall Study||72
8250618|NCT01863134|20345580|P2|STARTED|Overall Study||68
8250619|NCT01863134|20345581|P1|STARTED|Overall Study||72
8250620|NCT01863030|20345587|P1|NOT COMPLETED|Follow up||18
8250621|NCT01863030|20345587|P1|COMPLETED|Follow up||13
8250622|NCT01863030|20345587|P1|24 Months|Follow up||13
8250623|NCT01863030|20345587|P1|12 Months|Follow up||26
8250624|NCT01863030|20345587|P1|6 Months|Follow up||29
8250625|NCT01863030|20345587|P1|3 Months|Follow up||28
8250626|NCT01863030|20345587|P1|2 Weeks|Follow up||31
8250627|NCT01863030|20345587|P1|STARTED|Follow up||31
8250628|NCT01863030|20345587|P1|NOT COMPLETED|Baseline||0
8250629|NCT01863030|20345587|P1|COMPLETED|Baseline||31
8250630|NCT01863030|20345587|P1|STARTED|Baseline||31
8250631|NCT01863017|20345605|P2|NOT COMPLETED|Overall Study||0
8250632|NCT01863017|20345606|P1|NOT COMPLETED|Overall Study||0
8250633|NCT01863017|20345605|P2|COMPLETED|Overall Study||19
8250634|NCT01863017|20345606|P1|COMPLETED|Overall Study||12
8250635|NCT01863017|20345605|P2|Participants With PWS|Overall Study||7
8250636|NCT01863017|20345606|P1|Participants With PWS|Overall Study||3
8250637|NCT01863017|20345605|P2|Obese Participants|Overall Study||7
8250638|NCT01863017|20345606|P1|Obese Participants|Overall Study||4
8250639|NCT01863017|20345605|P2|Normal Weight Participants|Overall Study||5
8250640|NCT01863017|20345606|P1|Normal Weight Participants|Overall Study||5
8250641|NCT01863017|20345605|P2|STARTED|Overall Study||19
8250642|NCT01863017|20345606|P1|STARTED|Overall Study||12
8250643|NCT01862991|20345619|P3|NOT COMPLETED|Overall Study||1
8250644|NCT01862991|20345620|P2|NOT COMPLETED|Overall Study||1
8250645|NCT01862991|20345621|P1|NOT COMPLETED|Overall Study||3
8250646|NCT01862991|20345619|P3|COMPLETED|Overall Study||27
8250647|NCT01862991|20345620|P2|COMPLETED|Overall Study||27
8250648|NCT01862991|20345621|P1|COMPLETED|Overall Study||21
8250649|NCT01862991|20345619|P3|STARTED|Overall Study||28
8250650|NCT01862991|20345620|P2|STARTED|Overall Study||28
8250651|NCT01862991|20345621|P1|STARTED|Overall Study||24
8250652|NCT01862874|20345634|P2|NOT COMPLETED|Overall Study||77
8250653|NCT01862874|20345635|P1|NOT COMPLETED|Overall Study||79
8250654|NCT01862874|20345634|P2|COMPLETED|Overall Study||485
8250655|NCT01862874|20345635|P1|COMPLETED|Overall Study||483
8250656|NCT01862874|20345634|P2|Vaccination 3|Overall Study||532
8250657|NCT01862874|20345635|P1|Vaccination 3|Overall Study||530
8250658|NCT01862874|20345634|P2|Vaccination 2|Overall Study||542
8250659|NCT01862874|20345635|P1|Vaccination 2|Overall Study||539
8250660|NCT01862874|20345634|P2|Vaccination 1|Overall Study||562
8250661|NCT01862874|20345635|P1|Vaccination 1|Overall Study||561
8250662|NCT01862874|20345634|P2|STARTED|Overall Study|Randomized participants|562
8250663|NCT01862874|20345635|P1|STARTED|Overall Study|Randomized participants|562
8250664|NCT01862796|20345654|P3|NOT COMPLETED|Overall Study||1
8250665|NCT01862796|20345655|P2|NOT COMPLETED|Overall Study||0
8250666|NCT01862796|20345656|P1|NOT COMPLETED|Overall Study||0
8250667|NCT01862796|20345654|P3|COMPLETED|Overall Study||23
8250668|NCT01862796|20345655|P2|COMPLETED|Overall Study||18
8250669|NCT01862796|20345656|P1|COMPLETED|Overall Study||19
8250670|NCT01862796|20345654|P3|STARTED|Overall Study||24
8250671|NCT01862796|20345655|P2|STARTED|Overall Study||18
8250672|NCT01862796|20345656|P1|STARTED|Overall Study||19
8250673|NCT01862640|20345671|P4|NOT COMPLETED|Overall Study||15
8250674|NCT01862640|20345672|P3|NOT COMPLETED|Overall Study||18
8250675|NCT01862640|20345673|P2|NOT COMPLETED|Overall Study||16
8250676|NCT01862640|20345674|P1|NOT COMPLETED|Overall Study||7
8250677|NCT01862640|20345671|P4|COMPLETED|Overall Study||121
8250678|NCT01862640|20345672|P3|COMPLETED|Overall Study||122
8250679|NCT01862640|20345673|P2|COMPLETED|Overall Study||121
8250680|NCT01862640|20345674|P1|COMPLETED|Overall Study||13
8250681|NCT01862640|20345671|P4|STARTED|Overall Study||136
8250682|NCT01862640|20345672|P3|STARTED|Overall Study||140
8250683|NCT01862640|20345673|P2|STARTED|Overall Study||137
8250684|NCT01862640|20345674|P1|STARTED|Overall Study||20
8250685|NCT01862614|20345686|P2|NOT COMPLETED|Second Appointment.||0
8250686|NCT01862614|20345687|P1|NOT COMPLETED|Second Appointment.||0
8250687|NCT01862614|20345686|P2|COMPLETED|Second Appointment.||40
8250688|NCT01862614|20345687|P1|COMPLETED|Second Appointment.||40
8250689|NCT01862614|20345686|P2|STARTED|Second Appointment.|Received articaine at second appointment.|40
8250690|NCT01862614|20345687|P1|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
8250691|NCT01862614|20345686|P2|NOT COMPLETED|2 Week Washout Period.||0
8250692|NCT01862614|20345687|P1|NOT COMPLETED|2 Week Washout Period.||0
8250693|NCT01862614|20345686|P2|COMPLETED|2 Week Washout Period.||40
8250694|NCT01862614|20345687|P1|COMPLETED|2 Week Washout Period.||40
8250695|NCT01862614|20345686|P2|STARTED|2 Week Washout Period.||40
8250696|NCT01862614|20345687|P1|STARTED|2 Week Washout Period.||40
8250697|NCT01862614|20345686|P2|NOT COMPLETED|First Appointment.||0
8250698|NCT01862614|20345687|P1|NOT COMPLETED|First Appointment.||0
8250699|NCT01862614|20345686|P2|COMPLETED|First Appointment.||40
8250700|NCT01862614|20345687|P1|COMPLETED|First Appointment.||40
8250701|NCT01862614|20345686|P2|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
8250702|NCT01862614|20345687|P1|STARTED|First Appointment.|Received articaine injection at first appointment.|40
8250703|NCT01862484|20345695|P2|NOT COMPLETED|Overall Study||8
8250704|NCT01862484|20345696|P1|NOT COMPLETED|Overall Study||2
8250705|NCT01862484|20345695|P2|COMPLETED|Overall Study||6
8250706|NCT01862484|20345696|P1|COMPLETED|Overall Study||13
8250707|NCT01862484|20345695|P2|STARTED|Overall Study||14
8250708|NCT01862484|20345696|P1|STARTED|Overall Study||15
8250709|NCT01862419|20345704|P2|NOT COMPLETED|Overall Study||0
8250710|NCT01862419|20345705|P1|NOT COMPLETED|Overall Study||0
8250711|NCT01862419|20345704|P2|COMPLETED|Overall Study||1192
8250712|NCT01862419|20345705|P1|COMPLETED|Overall Study||1201
8250713|NCT01862419|20345704|P2|STARTED|Overall Study||1192
8250714|NCT01862419|20345705|P1|STARTED|Overall Study||1201
8250715|NCT01862328|20345722|P7|NOT COMPLETED|Overall Study||10
8250716|NCT01862328|20345723|P6|NOT COMPLETED|Overall Study||7
8250717|NCT01862328|20345724|P5|NOT COMPLETED|Overall Study||12
8250718|NCT01862328|20345725|P4|NOT COMPLETED|Overall Study||7
8250719|NCT01862328|20345726|P3|NOT COMPLETED|Overall Study||6
8250720|NCT01862328|20345727|P2|NOT COMPLETED|Overall Study||18
8250721|NCT01862328|20345728|P1|NOT COMPLETED|Overall Study||4
8250722|NCT01862328|20345722|P7|COMPLETED|Overall Study||0
8250723|NCT01862328|20345723|P6|COMPLETED|Overall Study||0
8250724|NCT01862328|20345724|P5|COMPLETED|Overall Study||0
8250725|NCT01862328|20345725|P4|COMPLETED|Overall Study||0
8250726|NCT01862328|20345726|P3|COMPLETED|Overall Study||0
8250727|NCT01862328|20345727|P2|COMPLETED|Overall Study||0
8250728|NCT01862328|20345728|P1|COMPLETED|Overall Study||0
8250729|NCT01862328|20345722|P7|STARTED|Overall Study||10
8250730|NCT01862328|20345723|P6|STARTED|Overall Study||7
8250731|NCT01862328|20345724|P5|STARTED|Overall Study||12
8250732|NCT01862328|20345725|P4|STARTED|Overall Study||7
8250733|NCT01862328|20345726|P3|STARTED|Overall Study||6
8250734|NCT01862328|20345727|P2|STARTED|Overall Study||18
8250735|NCT01862328|20345728|P1|STARTED|Overall Study||4
8250736|NCT01862250|20345780|P1|NOT COMPLETED|Overall Study||4
8250737|NCT01862250|20345780|P1|COMPLETED|Overall Study||8
8250738|NCT01862250|20345780|P1|STARTED|Overall Study||12
8250739|NCT01862159|20345787|P1|NOT COMPLETED|Overall Study||0
8250740|NCT01862159|20345787|P1|COMPLETED|Overall Study||25038
8250741|NCT01862159|20345787|P1|STARTED|Overall Study||25038
8250742|NCT01862133|20345794|P2|NOT COMPLETED|Overall Study||0
8250743|NCT01862133|20345795|P1|NOT COMPLETED|Overall Study||0
8250744|NCT01862133|20345794|P2|COMPLETED|Overall Study||31
8250745|NCT01862133|20345795|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
8250746|NCT01862133|20345794|P2|Returned During 6 mo Study|Overall Study||31
8250747|NCT01862133|20345795|P1|Returned During 6 mo Study|Overall Study||92
8250748|NCT01862133|20345794|P2|STARTED|Overall Study||31
8250749|NCT01862133|20345795|P1|STARTED|Overall Study||105
8250750|NCT01862029|20345801|P1|NOT COMPLETED|Overall Study||1
8250751|NCT01862029|20345801|P1|COMPLETED|Overall Study||8
8250752|NCT01862029|20345801|P1|STARTED|Overall Study||9
8250753|NCT01861925|20345809|P3|NOT COMPLETED|Overall Study||0
8250754|NCT01861925|20345810|P2|NOT COMPLETED|Overall Study||0
8250755|NCT01861925|20345811|P1|NOT COMPLETED|Overall Study||0
8250756|NCT01861925|20345809|P3|COMPLETED|Overall Study||8
8250757|NCT01861925|20345810|P2|COMPLETED|Overall Study||8
8250758|NCT01861925|20345811|P1|COMPLETED|Overall Study||34
8250759|NCT01861925|20345809|P3|STARTED|Overall Study||8
8250760|NCT01861925|20345810|P2|STARTED|Overall Study||8
8250761|NCT01861925|20345811|P1|STARTED|Overall Study||34
8250762|NCT01861756|20345834|P2|NOT COMPLETED|Overall Study||18
8250763|NCT01861756|20345835|P1|NOT COMPLETED|Overall Study||13
8250764|NCT01861756|20345834|P2|COMPLETED|Overall Study||85
8250765|NCT01861756|20345835|P1|COMPLETED|Overall Study||88
8250766|NCT01861756|20345834|P2|STARTED|Overall Study||103
8250767|NCT01861756|20345835|P1|STARTED|Overall Study||101
8250768|NCT01861704|20345843|P2|NOT COMPLETED|Overall Study||3
8250769|NCT01861704|20345844|P1|NOT COMPLETED|Overall Study||3
8250770|NCT01861704|20345843|P2|COMPLETED|Overall Study||104
8250771|NCT01861704|20345844|P1|COMPLETED|Overall Study||67
8250772|NCT01861704|20345843|P2|STARTED|Overall Study||107
8250773|NCT01861704|20345844|P1|STARTED|Overall Study||70
8250774|NCT01861665|20345852|P2|NOT COMPLETED|Overall Study||0
8250775|NCT01861665|20345853|P1|NOT COMPLETED|Overall Study||0
8250776|NCT01861665|20345852|P2|COMPLETED|Overall Study||17
8250777|NCT01861665|20345853|P1|COMPLETED|Overall Study||10
8250778|NCT01861665|20345852|P2|STARTED|Overall Study||17
8250779|NCT01861665|20345853|P1|STARTED|Overall Study||10
8250780|NCT01861587|20345861|P2|NOT COMPLETED|Overall Study||0
8250781|NCT01861587|20345862|P1|NOT COMPLETED|Overall Study||0
8250782|NCT01861587|20345861|P2|COMPLETED|Overall Study||13
8250783|NCT01861587|20345862|P1|COMPLETED|Overall Study||14
8250784|NCT01861587|20345861|P2|STARTED|Overall Study||13
8250785|NCT01861587|20345862|P1|STARTED|Overall Study||14
8250786|NCT01861574|20345878|P4|NOT COMPLETED|Overall Study||0
8250787|NCT01861574|20345879|P3|NOT COMPLETED|Overall Study||0
8250788|NCT01861574|20345880|P2|NOT COMPLETED|Overall Study||0
8250789|NCT01861574|20345881|P1|NOT COMPLETED|Overall Study||0
8250790|NCT01861574|20345878|P4|COMPLETED|Overall Study||28
8250791|NCT01861574|20345879|P3|COMPLETED|Overall Study||27
8250792|NCT01861574|20345880|P2|COMPLETED|Overall Study||25
8250793|NCT01861574|20345881|P1|COMPLETED|Overall Study||28
8250794|NCT01861574|20345878|P4|STARTED|Overall Study||28
8250795|NCT01861574|20345879|P3|STARTED|Overall Study||27
8250796|NCT01861574|20345880|P2|STARTED|Overall Study||25
8250797|NCT01861574|20345881|P1|STARTED|Overall Study||28
8250798|NCT01861522|20345904|P2|NOT COMPLETED|Overall Study||0
8250799|NCT01861522|20345905|P1|NOT COMPLETED|Overall Study||3
8250800|NCT01861522|20345904|P2|COMPLETED|Overall Study||232
8250801|NCT01861522|20345905|P1|COMPLETED|Overall Study||237
8250802|NCT01861522|20345904|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
8250803|NCT01861522|20345905|P1|STARTED|Overall Study||240
8250804|NCT01861457|20345913|P2|NOT COMPLETED|Overall Study||0
8250805|NCT01861457|20345914|P1|NOT COMPLETED|Overall Study||0
8250806|NCT01861457|20345913|P2|COMPLETED|Overall Study||19
8250807|NCT01861457|20345914|P1|COMPLETED|Overall Study||20
8250808|NCT01861457|20345913|P2|STARTED|Overall Study||19
8250809|NCT01861457|20345914|P1|STARTED|Overall Study||20
8250810|NCT01861301|20345922|P1|NOT COMPLETED|Overall Study||0
8250811|NCT01861301|20345922|P1|COMPLETED|Overall Study||18
8250812|NCT01861301|20345922|P1|STARTED|Overall Study||18
8250813|NCT01861028|20345929|P1|NOT COMPLETED|Overall Study||0
8250814|NCT01861028|20345929|P1|COMPLETED|Overall Study||44
8250815|NCT01861028|20345929|P1|STARTED|Overall Study||44
8250816|NCT01860989|20345934|P1|NOT COMPLETED|Overall Study||5
8250817|NCT01860989|20345934|P1|COMPLETED|Overall Study||6
8250818|NCT01860989|20345934|P1|STARTED|Overall Study||11
8250819|NCT01860976|20345940|P2|NOT COMPLETED|Long Term Extension||107
8250820|NCT01860976|20345941|P1|NOT COMPLETED|Long Term Extension||113
8250821|NCT01860976|20345940|P2|COMPLETED|Long Term Extension||8
8250822|NCT01860976|20345941|P1|COMPLETED|Long Term Extension||0
8250823|NCT01860976|20345940|P2|STARTED|Long Term Extension||115
8250824|NCT01860976|20345941|P1|STARTED|Long Term Extension||113
8250825|NCT01860976|20345940|P2|NOT COMPLETED|Open-Label||64
8250826|NCT01860976|20345941|P1|NOT COMPLETED|Open-Label||74
8250827|NCT01860976|20345940|P2|COMPLETED|Open-Label||121
8250828|NCT01860976|20345941|P1|COMPLETED|Open-Label||123
8250829|NCT01860976|20345940|P2|STARTED|Open-Label||185
8250830|NCT01860976|20345941|P1|STARTED|Open-Label||197
8250831|NCT01860976|20345940|P2|NOT COMPLETED|Blinded Treatment||113
8250832|NCT01860976|20345941|P1|NOT COMPLETED|Blinded Treatment||88
8250833|NCT01860976|20345940|P2|COMPLETED|Blinded Treatment||98
8250834|NCT01860976|20345941|P1|COMPLETED|Blinded Treatment||125
8250835|NCT01860976|20345940|P2|STARTED|Blinded Treatment||211
8250836|NCT01860976|20345941|P1|STARTED|Blinded Treatment||213
8250837|NCT01860950|20345969|P6|NOT COMPLETED|Overall Study||0
8250838|NCT01860950|20345970|P5|NOT COMPLETED|Overall Study||0
8250839|NCT01860950|20345971|P4|NOT COMPLETED|Overall Study||0
8250840|NCT01860950|20345972|P3|NOT COMPLETED|Overall Study||0
8250841|NCT01860950|20345973|P2|NOT COMPLETED|Overall Study||0
8250842|NCT01860950|20345974|P1|NOT COMPLETED|Overall Study||0
8250843|NCT01860950|20345969|P6|COMPLETED|Overall Study||13
8250844|NCT01860950|20345970|P5|COMPLETED|Overall Study||14
8250845|NCT01860950|20345971|P4|COMPLETED|Overall Study||13
8250846|NCT01860950|20345972|P3|COMPLETED|Overall Study||10
8250847|NCT01860950|20345973|P2|COMPLETED|Overall Study||15
8250848|NCT01860950|20345974|P1|COMPLETED|Overall Study||14
8250849|NCT01860950|20345969|P6|STARTED|Overall Study||13
8250850|NCT01860950|20345970|P5|STARTED|Overall Study||14
8250851|NCT01860950|20345971|P4|STARTED|Overall Study||13
8250852|NCT01860950|20345972|P3|STARTED|Overall Study||10
8250853|NCT01860950|20345973|P2|STARTED|Overall Study||15
8250854|NCT01860950|20345974|P1|STARTED|Overall Study||14
8250855|NCT01860846|20345995|P1|NOT COMPLETED|Overall Study||33
8250856|NCT01860846|20345995|P1|COMPLETED|Overall Study||73
8250857|NCT01860846|20345995|P1|Month 12|Overall Study||73
8250858|NCT01860846|20345995|P1|Month 6|Overall Study||85
8250859|NCT01860846|20345995|P1|Month 4|Overall Study||82
8250860|NCT01860846|20345995|P1|Month 2|Overall Study||83
8250861|NCT01860846|20345995|P1|Month 1|Overall Study||97
8250862|NCT01860846|20345995|P1|STARTED|Overall Study||106
8250863|NCT01860807|20346008|P2|NOT COMPLETED|Overall Study||29
8250864|NCT01860807|20346009|P1|NOT COMPLETED|Overall Study||30
8250865|NCT01860807|20346008|P2|COMPLETED|Overall Study||32
8250866|NCT01860807|20346009|P1|COMPLETED|Overall Study||34
8250867|NCT01860807|20346008|P2|STARTED|Overall Study||61
8250868|NCT01860807|20346009|P1|STARTED|Overall Study||64
8250869|NCT01860703|20346015|P4|NOT COMPLETED|Overall Study||2
8250870|NCT01860703|20346016|P3|NOT COMPLETED|Overall Study||1
8250871|NCT01860703|20346017|P2|NOT COMPLETED|Overall Study||5
8250872|NCT01860703|20346018|P1|NOT COMPLETED|Overall Study||2
8250873|NCT01860703|20346015|P4|COMPLETED|Overall Study||10
8250874|NCT01860703|20346016|P3|COMPLETED|Overall Study||11
8250875|NCT01860703|20346017|P2|COMPLETED|Overall Study||8
8250876|NCT01860703|20346018|P1|COMPLETED|Overall Study||11
8250877|NCT01860703|20346015|P4|STARTED|Overall Study||12
8250878|NCT01860703|20346016|P3|STARTED|Overall Study||12
8250879|NCT01860703|20346017|P2|STARTED|Overall Study||13
8250880|NCT01860703|20346018|P1|STARTED|Overall Study||13
8250881|NCT01860677|20346050|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8250882|NCT01860677|20346051|P1|NOT COMPLETED|Second Intervention (1 Day)||7
8250883|NCT01860677|20346050|P2|COMPLETED|Second Intervention (1 Day)||0
8250884|NCT01860677|20346051|P1|COMPLETED|Second Intervention (1 Day)||1
8250885|NCT01860677|20346050|P2|STARTED|Second Intervention (1 Day)||0
8250886|NCT01860677|20346051|P1|STARTED|Second Intervention (1 Day)||8
8250887|NCT01860677|20346050|P2|NOT COMPLETED|First Intervention (1 Day)||0
8250888|NCT01860677|20346051|P1|NOT COMPLETED|First Intervention (1 Day)||0
8250889|NCT01860677|20346050|P2|COMPLETED|First Intervention (1 Day)||0
8250890|NCT01860677|20346051|P1|COMPLETED|First Intervention (1 Day)||8
8250891|NCT01860677|20346050|P2|STARTED|First Intervention (1 Day)||0
8250892|NCT01860677|20346051|P1|STARTED|First Intervention (1 Day)||8
8250893|NCT01860651|20346062|P2|NOT COMPLETED|Overall Study||8
8250894|NCT01860651|20346063|P1|NOT COMPLETED|Overall Study||25
8250895|NCT01860651|20346062|P2|COMPLETED|Overall Study||39
8250896|NCT01860651|20346063|P1|COMPLETED|Overall Study||31
8250897|NCT01860651|20346062|P2|STARTED|Overall Study||47
8250898|NCT01860651|20346063|P1|STARTED|Overall Study||56
8250899|NCT01860586|20346079|P1|NOT COMPLETED|Overall Study||0
8250900|NCT01860586|20346079|P1|COMPLETED|Overall Study||20
8250901|NCT01860586|20346079|P1|STARTED|Overall Study||20
8250902|NCT01860573|20346087|P2|NOT COMPLETED|Overall Study||0
8250903|NCT01860573|20346088|P1|NOT COMPLETED|Overall Study||0
8250904|NCT01860573|20346087|P2|COMPLETED|Overall Study||85
8250905|NCT01860573|20346088|P1|COMPLETED|Overall Study||83
8250906|NCT01860573|20346087|P2|STARTED|Overall Study||85
8250907|NCT01860573|20346088|P1|STARTED|Overall Study||83
8250908|NCT01860534|20346108|P2|NOT COMPLETED|ROP #2||0
8250909|NCT01860534|20346109|P1|NOT COMPLETED|ROP #2||1
8250910|NCT01860534|20346108|P2|COMPLETED|ROP #2||13
8250911|NCT01860534|20346109|P1|COMPLETED|ROP #2||13
8250912|NCT01860534|20346108|P2|STARTED|ROP #2||13
8250913|NCT01860534|20346109|P1|STARTED|ROP #2||14
8250914|NCT01860534|20346108|P2|NOT COMPLETED|ROP #1||1
8250915|NCT01860534|20346109|P1|NOT COMPLETED|ROP #1||0
8250916|NCT01860534|20346108|P2|COMPLETED|ROP #1||13
8250917|NCT01860534|20346109|P1|COMPLETED|ROP #1||14
8250918|NCT01860534|20346108|P2|STARTED|ROP #1||14
8250919|NCT01860534|20346109|P1|STARTED|ROP #1||14
8250920|NCT01860521|20346123|P2|NOT COMPLETED|Overall Study||0
8250921|NCT01860521|20346124|P1|NOT COMPLETED|Overall Study||0
8250922|NCT01860521|20346123|P2|COMPLETED|Overall Study|June 2013|52
8250923|NCT01860521|20346124|P1|COMPLETED|Overall Study|June 2013|52
8250924|NCT01860521|20346123|P2|STARTED|Overall Study|September 2011|52
8250925|NCT01860521|20346124|P1|STARTED|Overall Study|September 2011|52
8250926|NCT01860287|20346139|P3|NOT COMPLETED|Overall Study||0
8250927|NCT01860287|20346140|P2|NOT COMPLETED|Overall Study||0
8250928|NCT01860287|20346141|P1|NOT COMPLETED|Overall Study||0
8250929|NCT01860287|20346139|P3|COMPLETED|Overall Study||15
8250930|NCT01860287|20346140|P2|COMPLETED|Overall Study||15
8250931|NCT01860287|20346141|P1|COMPLETED|Overall Study||18
8250932|NCT01860287|20346139|P3|STARTED|Overall Study||15
8250933|NCT01860287|20346140|P2|STARTED|Overall Study||15
8250934|NCT01860287|20346141|P1|STARTED|Overall Study||18
8250935|NCT01860170|20346152|P3|NOT COMPLETED|Overall Study||0
8250936|NCT01860170|20346153|P2|NOT COMPLETED|Overall Study||0
8250937|NCT01860170|20346154|P1|NOT COMPLETED|Overall Study||0
8250938|NCT01860170|20346152|P3|COMPLETED|Overall Study||22
8250939|NCT01860170|20346153|P2|COMPLETED|Overall Study||3
8250940|NCT01860170|20346154|P1|COMPLETED|Overall Study||3
8250941|NCT01860170|20346152|P3|STARTED|Overall Study||22
8250942|NCT01860170|20346153|P2|STARTED|Overall Study||3
8250943|NCT01860170|20346154|P1|STARTED|Overall Study||3
8250944|NCT01860079|20346170|P2|NOT COMPLETED|Overall Study||22
8250945|NCT01860079|20346171|P1|NOT COMPLETED|Overall Study||14
8250946|NCT01860079|20346170|P2|COMPLETED|Overall Study||363
8250947|NCT01860079|20346171|P1|COMPLETED|Overall Study||370
8250948|NCT01860079|20346170|P2|STARTED|Overall Study||385
8250949|NCT01860079|20346171|P1|STARTED|Overall Study||384
8250950|NCT01860040|20346179|P2|NOT COMPLETED|Overall Study||0
8250951|NCT01860040|20346180|P1|NOT COMPLETED|Overall Study||1
8250952|NCT01860040|20346179|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
8250953|NCT01860040|20346180|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
8250954|NCT01860040|20346179|P2|STARTED|Overall Study|did not meet recruitment goal|0
8250955|NCT01860040|20346180|P1|STARTED|Overall Study|did not meet recruitment goal|1
8250956|NCT01859988|20346191|P6|NOT COMPLETED|Overall Study||19
8250957|NCT01859988|20346192|P5|NOT COMPLETED|Overall Study||23
8250958|NCT01859988|20346193|P4|NOT COMPLETED|Overall Study||10
8250959|NCT01859988|20346194|P3|NOT COMPLETED|Overall Study||28
8250960|NCT01859988|20346195|P2|NOT COMPLETED|Overall Study||12
8250961|NCT01859988|20346196|P1|NOT COMPLETED|Overall Study||11
8250962|NCT01859988|20346191|P6|COMPLETED|Overall Study||42
8250963|NCT01859988|20346192|P5|COMPLETED|Overall Study||42
8250964|NCT01859988|20346193|P4|COMPLETED|Overall Study||55
8250965|NCT01859988|20346194|P3|COMPLETED|Overall Study||34
8250966|NCT01859988|20346195|P2|COMPLETED|Overall Study||52
8250967|NCT01859988|20346196|P1|COMPLETED|Overall Study||52
8250968|NCT01859988|20346191|P6|Treated|Overall Study||61
8250969|NCT01859988|20346192|P5|Treated|Overall Study||65
8250970|NCT01859988|20346193|P4|Treated|Overall Study||65
8250971|NCT01859988|20346194|P3|Treated|Overall Study||61
8250972|NCT01859988|20346195|P2|Treated|Overall Study||64
8250973|NCT01859988|20346196|P1|Treated|Overall Study||63
8250974|NCT01859988|20346191|P6|STARTED|Overall Study||61
8250975|NCT01859988|20346192|P5|STARTED|Overall Study||65
8250976|NCT01859988|20346193|P4|STARTED|Overall Study||65
8250977|NCT01859988|20346194|P3|STARTED|Overall Study||62
8250978|NCT01859988|20346195|P2|STARTED|Overall Study||64
8250979|NCT01859988|20346196|P1|STARTED|Overall Study||63
8250980|NCT01859949|20346290|P2|NOT COMPLETED|Overall Study||17
8250981|NCT01859949|20346291|P1|NOT COMPLETED|Overall Study||14
8250982|NCT01859949|20346290|P2|COMPLETED|Overall Study||15
8250983|NCT01859949|20346291|P1|COMPLETED|Overall Study||15
8250984|NCT01859949|20346290|P2|STARTED|Overall Study|Treated participants|32
8250985|NCT01859949|20346291|P1|STARTED|Overall Study|Treated participants|29
8250986|NCT01859923|20346311|P4|NOT COMPLETED|Overall Study||1
8250987|NCT01859923|20346312|P3|NOT COMPLETED|Overall Study||1
8250988|NCT01859923|20346313|P2|NOT COMPLETED|Overall Study||0
8250989|NCT01859923|20346314|P1|NOT COMPLETED|Overall Study||0
8250990|NCT01859923|20346311|P4|COMPLETED|Overall Study||11
8250991|NCT01859923|20346312|P3|COMPLETED|Overall Study||11
8250992|NCT01859923|20346313|P2|COMPLETED|Overall Study||6
8250993|NCT01859923|20346314|P1|COMPLETED|Overall Study||7
8250994|NCT01859923|20346311|P4|STARTED|Overall Study||12
8250995|NCT01859923|20346312|P3|STARTED|Overall Study||12
8250996|NCT01859923|20346313|P2|STARTED|Overall Study||6
8250997|NCT01859923|20346314|P1|STARTED|Overall Study||7
8250998|NCT01859793|20346368|P2|NOT COMPLETED|2nd Intervention Period||0
8250999|NCT01859793|20346369|P1|NOT COMPLETED|2nd Intervention Period||0
8251000|NCT01859793|20346368|P2|COMPLETED|2nd Intervention Period||16
8251001|NCT01859793|20346369|P1|COMPLETED|2nd Intervention Period||14
8251002|NCT01859793|20346368|P2|STARTED|2nd Intervention Period||16
8251003|NCT01859793|20346369|P1|STARTED|2nd Intervention Period||14
8251004|NCT01859793|20346368|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
8251005|NCT01859793|20346369|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
8251006|NCT01859793|20346368|P2|COMPLETED|Washout Period (4 Weeks)||16
8251007|NCT01859793|20346369|P1|COMPLETED|Washout Period (4 Weeks)||14
8251008|NCT01859793|20346368|P2|STARTED|Washout Period (4 Weeks)||17
8251009|NCT01859793|20346369|P1|STARTED|Washout Period (4 Weeks)||15
8251010|NCT01859793|20346368|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
8251011|NCT01859793|20346369|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
8251012|NCT01859793|20346368|P2|COMPLETED|First Intervention (8 Weeks)||17
8251013|NCT01859793|20346369|P1|COMPLETED|First Intervention (8 Weeks)||15
8251014|NCT01859793|20346368|P2|STARTED|First Intervention (8 Weeks)||18
8251015|NCT01859793|20346369|P1|STARTED|First Intervention (8 Weeks)||20
8251016|NCT01859741|20346387|P8|NOT COMPLETED|Overall Study||70
8251017|NCT01859741|20346388|P7|NOT COMPLETED|Overall Study||70
8251018|NCT01859741|20346389|P6|NOT COMPLETED|Overall Study||6
8251019|NCT01859741|20346390|P5|NOT COMPLETED|Overall Study||6
8251020|NCT01859741|20346391|P4|NOT COMPLETED|Overall Study||3
8251021|NCT01859741|20346392|P3|NOT COMPLETED|Overall Study||6
8251022|NCT01859741|20346393|P2|NOT COMPLETED|Overall Study||3
8251023|NCT01859741|20346394|P1|NOT COMPLETED|Overall Study||3
8251024|NCT01859741|20346387|P8|COMPLETED|Overall Study||3
8251025|NCT01859741|20346388|P7|COMPLETED|Overall Study||2
8251026|NCT01859741|20346389|P6|COMPLETED|Overall Study||0
8251027|NCT01859741|20346390|P5|COMPLETED|Overall Study||0
8251028|NCT01859741|20346391|P4|COMPLETED|Overall Study||0
8251029|NCT01859741|20346392|P3|COMPLETED|Overall Study||0
8251030|NCT01859741|20346393|P2|COMPLETED|Overall Study||0
8251031|NCT01859741|20346394|P1|COMPLETED|Overall Study||0
8251032|NCT01859741|20346387|P8|STARTED|Overall Study||73
8251033|NCT01859741|20346388|P7|STARTED|Overall Study||72
8251034|NCT01859741|20346389|P6|STARTED|Overall Study||6
8251035|NCT01859741|20346390|P5|STARTED|Overall Study||6
8251036|NCT01859741|20346391|P4|STARTED|Overall Study||3
8251037|NCT01859741|20346392|P3|STARTED|Overall Study||6
8251038|NCT01859741|20346393|P2|STARTED|Overall Study||3
8251039|NCT01859741|20346394|P1|STARTED|Overall Study||3
8251040|NCT01859715|20346423|P3|NOT COMPLETED|Overall Study||23
8251041|NCT01859715|20346424|P2|NOT COMPLETED|Overall Study||8
8251042|NCT01859715|20346425|P1|NOT COMPLETED|Overall Study||16
8251043|NCT01859715|20346423|P3|COMPLETED|Overall Study||93
8251044|NCT01859715|20346424|P2|COMPLETED|Overall Study||83
8251045|NCT01859715|20346425|P1|COMPLETED|Overall Study||125
8251046|NCT01859715|20346423|P3|STARTED|Overall Study||116
8251047|NCT01859715|20346424|P2|STARTED|Overall Study||91
8251048|NCT01859715|20346425|P1|STARTED|Overall Study||141
8251049|NCT01859702|20346436|P1|NOT COMPLETED|Overall Study||5
8251050|NCT01859702|20346436|P1|COMPLETED|Overall Study||31
8251051|NCT01859702|20346436|P1|STARTED|Overall Study||36
8251052|NCT01859637|20346440|P1|NOT COMPLETED|Overall Study||0
8251053|NCT01859637|20346440|P1|COMPLETED|Overall Study||6
8251054|NCT01859637|20346440|P1|STARTED|Overall Study||6
8251055|NCT01859611|20346446|P1|NOT COMPLETED|Overall Study||8
8251056|NCT01859611|20346446|P1|COMPLETED|Overall Study||43
8251057|NCT01859611|20346446|P1|STARTED|Overall Study||51
8251058|NCT01859598|20346450|P1|NOT COMPLETED|Visit 3 at 6 Months||912
8251059|NCT01859598|20346450|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
8251060|NCT01859598|20346450|P1|STARTED|Visit 3 at 6 Months||17253
8251061|NCT01859598|20346450|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
8251062|NCT01859598|20346450|P1|COMPLETED|Visit 2 at 3 Months||17253
8251063|NCT01859598|20346450|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
8251064|NCT01859507|20346458|P1|NOT COMPLETED|Overall Study||4
8251065|NCT01859507|20346458|P1|COMPLETED|Overall Study||28
8251066|NCT01859507|20346458|P1|STARTED|Overall Study||32
8251067|NCT01859494|20346463|P1|NOT COMPLETED|Overall Study||1
8251068|NCT01859494|20346463|P1|COMPLETED|Overall Study||218
8251069|NCT01859494|20346463|P1|STARTED|Overall Study||219
8251070|NCT01859390|20346474|P2|NOT COMPLETED|Overall Study||7
8251071|NCT01859390|20346475|P1|NOT COMPLETED|Overall Study||1
8251072|NCT01859390|20346474|P2|COMPLETED|Overall Study||30
8251073|NCT01859390|20346475|P1|COMPLETED|Overall Study||35
8251074|NCT01859390|20346474|P2|Withdrawals|Overall Study||2
8251075|NCT01859390|20346475|P1|Withdrawals|Overall Study||2
8251076|NCT01859390|20346474|P2|STARTED|Overall Study||37
8251077|NCT01859390|20346475|P1|STARTED|Overall Study||36
8251078|NCT01859325|20346499|P3|NOT COMPLETED|Overall Study||0
8251079|NCT01859325|20346500|P2|NOT COMPLETED|Overall Study||4
8251080|NCT01859325|20346501|P1|NOT COMPLETED|Overall Study||3
8251081|NCT01859325|20346499|P3|COMPLETED|Overall Study||2
8251082|NCT01859325|20346500|P2|COMPLETED|Overall Study||12
8251083|NCT01859325|20346501|P1|COMPLETED|Overall Study||12
8251084|NCT01859325|20346499|P3|STARTED|Overall Study||2
8251085|NCT01859325|20346500|P2|STARTED|Overall Study||16
8251086|NCT01859325|20346501|P1|STARTED|Overall Study||15
8251087|NCT01859312|20346509|P1|NOT COMPLETED|Overall Study||0
8251088|NCT01859312|20346509|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
8251089|NCT01859312|20346509|P1|STARTED|Overall Study||8
8251090|NCT01859247|20346564|P8|NOT COMPLETED|Overall Study||0
8251091|NCT01859247|20346565|P7|NOT COMPLETED|Overall Study||0
8251092|NCT01859247|20346566|P6|NOT COMPLETED|Overall Study||0
8251093|NCT01859247|20346567|P5|NOT COMPLETED|Overall Study||0
8251094|NCT01859247|20346568|P4|NOT COMPLETED|Overall Study||0
8251095|NCT01859247|20346569|P3|NOT COMPLETED|Overall Study||0
8251096|NCT01859247|20346570|P2|NOT COMPLETED|Overall Study||0
8251097|NCT01859247|20346571|P1|NOT COMPLETED|Overall Study||0
8251098|NCT01859247|20346564|P8|COMPLETED|Overall Study||1
8251099|NCT01859247|20346565|P7|COMPLETED|Overall Study||1
8251100|NCT01859247|20346566|P6|COMPLETED|Overall Study||1
8251101|NCT01859247|20346567|P5|COMPLETED|Overall Study||1
8251102|NCT01859247|20346568|P4|COMPLETED|Overall Study||1
8251103|NCT01859247|20346569|P3|COMPLETED|Overall Study||1
8251104|NCT01859247|20346570|P2|COMPLETED|Overall Study||1
8251105|NCT01859247|20346571|P1|COMPLETED|Overall Study||1
8251106|NCT01859247|20346564|P8|STARTED|Overall Study||1
8251107|NCT01859247|20346565|P7|STARTED|Overall Study||1
8251108|NCT01859247|20346566|P6|STARTED|Overall Study||1
8251109|NCT01859247|20346567|P5|STARTED|Overall Study||1
8251110|NCT01859247|20346568|P4|STARTED|Overall Study||1
8251111|NCT01859247|20346569|P3|STARTED|Overall Study||1
8251112|NCT01859247|20346570|P2|STARTED|Overall Study||1
8251113|NCT01859247|20346571|P1|STARTED|Overall Study||1
8251114|NCT01859195|20346598|P2|NOT COMPLETED|Overall Study||0
8251115|NCT01859195|20346599|P1|NOT COMPLETED|Overall Study||0
8251116|NCT01859195|20346598|P2|COMPLETED|Overall Study||12
8251117|NCT01859195|20346599|P1|COMPLETED|Overall Study||24
8251118|NCT01859195|20346598|P2|STARTED|Overall Study||12
8251119|NCT01859195|20346599|P1|STARTED|Overall Study||24
8251120|NCT01859143|20346609|P2|NOT COMPLETED|Overall Study||0
8251121|NCT01859143|20346610|P1|NOT COMPLETED|Overall Study||2
8251122|NCT01859143|20346609|P2|COMPLETED|Overall Study||60
8251123|NCT01859143|20346610|P1|COMPLETED|Overall Study||238
8251124|NCT01859143|20346609|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
8251125|NCT01859143|20346610|P1|STARTED|Overall Study||240
8251126|NCT01859078|20346624|P1|NOT COMPLETED|Overall Study||0
8251127|NCT01859078|20346624|P1|COMPLETED|Overall Study||28
8251128|NCT01859078|20346624|P1|STARTED|Overall Study||28
8251129|NCT01859013|20346640|P2|NOT COMPLETED|Overall Study||5
8251130|NCT01859013|20346641|P1|NOT COMPLETED|Overall Study||4
8251131|NCT01859013|20346640|P2|COMPLETED|Overall Study||9
8251132|NCT01859013|20346641|P1|COMPLETED|Overall Study||12
8251133|NCT01859013|20346640|P2|STARTED|Overall Study||14
8251134|NCT01859013|20346641|P1|STARTED|Overall Study||16
8251135|NCT01858766|20346666|P19|NOT COMPLETED|Overall Study||4
8251136|NCT01858766|20346667|P18|NOT COMPLETED|Overall Study||4
8251137|NCT01858766|20346668|P17|NOT COMPLETED|Overall Study||3
8251138|NCT01858766|20346669|P16|NOT COMPLETED|Overall Study||6
8251139|NCT01858766|20346670|P15|NOT COMPLETED|Overall Study||8
8251140|NCT01858766|20346671|P14|NOT COMPLETED|Overall Study||3
8251141|NCT01858766|20346672|P13|NOT COMPLETED|Overall Study||5
8251142|NCT01858766|20346673|P12|NOT COMPLETED|Overall Study||5
8251143|NCT01858766|20346674|P11|NOT COMPLETED|Overall Study||0
8251144|NCT01858766|20346675|P10|NOT COMPLETED|Overall Study||0
8251145|NCT01858766|20346676|P9|NOT COMPLETED|Overall Study||0
8251146|NCT01858766|20346677|P8|NOT COMPLETED|Overall Study||2
8251147|NCT01858766|20346678|P7|NOT COMPLETED|Overall Study||0
8251148|NCT01858766|20346679|P6|NOT COMPLETED|Overall Study||4
8251149|NCT01858766|20346680|P5|NOT COMPLETED|Overall Study||1
8251150|NCT01858766|20346681|P4|NOT COMPLETED|Overall Study||0
8251151|NCT01858766|20346682|P3|NOT COMPLETED|Overall Study||1
8251152|NCT01858766|20346683|P2|NOT COMPLETED|Overall Study||0
8251153|NCT01858766|20346684|P1|NOT COMPLETED|Overall Study||1
8251154|NCT01858766|20346666|P19|COMPLETED|Overall Study||22
8251155|NCT01858766|20346667|P18|COMPLETED|Overall Study||23
8251156|NCT01858766|20346668|P17|COMPLETED|Overall Study||22
8251157|NCT01858766|20346669|P16|COMPLETED|Overall Study||20
8251158|NCT01858766|20346670|P15|COMPLETED|Overall Study||23
8251159|NCT01858766|20346671|P14|COMPLETED|Overall Study||26
8251160|NCT01858766|20346672|P13|COMPLETED|Overall Study||25
8251161|NCT01858766|20346673|P12|COMPLETED|Overall Study||25
8251162|NCT01858766|20346674|P11|COMPLETED|Overall Study||5
8251163|NCT01858766|20346675|P10|COMPLETED|Overall Study||4
8251164|NCT01858766|20346676|P9|COMPLETED|Overall Study||1
8251165|NCT01858766|20346677|P8|COMPLETED|Overall Study||5
8251166|NCT01858766|20346678|P7|COMPLETED|Overall Study||7
8251167|NCT01858766|20346679|P6|COMPLETED|Overall Study||24
8251168|NCT01858766|20346680|P5|COMPLETED|Overall Study||26
8251169|NCT01858766|20346681|P4|COMPLETED|Overall Study||10
8251170|NCT01858766|20346682|P3|COMPLETED|Overall Study||10
8251171|NCT01858766|20346683|P2|COMPLETED|Overall Study||28
8251172|NCT01858766|20346684|P1|COMPLETED|Overall Study||26
8251173|NCT01858766|20346666|P19|STARTED|Overall Study||26
8251174|NCT01858766|20346667|P18|STARTED|Overall Study||27
8251175|NCT01858766|20346668|P17|STARTED|Overall Study||25
8251176|NCT01858766|20346669|P16|STARTED|Overall Study||26
8251177|NCT01858766|20346670|P15|STARTED|Overall Study||31
8251178|NCT01858766|20346671|P14|STARTED|Overall Study||29
8251179|NCT01858766|20346672|P13|STARTED|Overall Study||30
8251180|NCT01858766|20346673|P12|STARTED|Overall Study||30
8251181|NCT01858766|20346674|P11|STARTED|Overall Study||5
8251182|NCT01858766|20346675|P10|STARTED|Overall Study||4
8251183|NCT01858766|20346676|P9|STARTED|Overall Study||1
8251184|NCT01858766|20346677|P8|STARTED|Overall Study||7
8251185|NCT01858766|20346678|P7|STARTED|Overall Study||7
8251186|NCT01858766|20346679|P6|STARTED|Overall Study||28
8251187|NCT01858766|20346680|P5|STARTED|Overall Study||27
8251188|NCT01858766|20346681|P4|STARTED|Overall Study||10
8251189|NCT01858766|20346682|P3|STARTED|Overall Study||11
8251190|NCT01858766|20346683|P2|STARTED|Overall Study||28
8251191|NCT01858766|20346684|P1|STARTED|Overall Study||27
8251192|NCT01858701|20346755|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8251193|NCT01858701|20346756|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8251194|NCT01858701|20346755|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
8251195|NCT01858701|20346756|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
8251196|NCT01858701|20346755|P2|STARTED|Period 2, Second 30 Days of Wear||17
8251197|NCT01858701|20346756|P1|STARTED|Period 2, Second 30 Days of Wear||18
8251198|NCT01858701|20346755|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
8251199|NCT01858701|20346756|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
8251200|NCT01858701|20346755|P2|COMPLETED|Washout Period, 1-13 Days||17
8251201|NCT01858701|20346756|P1|COMPLETED|Washout Period, 1-13 Days||18
8251202|NCT01858701|20346755|P2|STARTED|Washout Period, 1-13 Days||19
8251203|NCT01858701|20346756|P1|STARTED|Washout Period, 1-13 Days||20
8251204|NCT01858701|20346755|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
8251205|NCT01858701|20346756|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8251206|NCT01858701|20346755|P2|COMPLETED|Period 1, First 30 Days of Wear||19
8251207|NCT01858701|20346756|P1|COMPLETED|Period 1, First 30 Days of Wear||20
8251208|NCT01858701|20346755|P2|STARTED|Period 1, First 30 Days of Wear||20
8251209|NCT01858701|20346756|P1|STARTED|Period 1, First 30 Days of Wear||20
8251210|NCT01858636|20346762|P1|NOT COMPLETED|Overall Study||28
8251211|NCT01858636|20346762|P1|COMPLETED|Overall Study||207
8251212|NCT01858636|20346762|P1|Device Deployment|Overall Study||211
8251213|NCT01858636|20346762|P1|STARTED|Overall Study|Subjects consented|235
8251214|NCT01858558|20346769|P2|NOT COMPLETED|Overall Study||2
8251215|NCT01858558|20346770|P1|NOT COMPLETED|Overall Study||9
8251216|NCT01858558|20346769|P2|COMPLETED|Overall Study||29
8251217|NCT01858558|20346770|P1|COMPLETED|Overall Study||61
8251218|NCT01858558|20346769|P2|STARTED|Overall Study||31
8251219|NCT01858558|20346770|P1|STARTED|Overall Study||70
8251220|NCT01858545|20346781|P2|NOT COMPLETED|Overall Study||6
8251221|NCT01858545|20346782|P1|NOT COMPLETED|Overall Study||4
8251222|NCT01858545|20346781|P2|COMPLETED|Overall Study||23
8251223|NCT01858545|20346782|P1|COMPLETED|Overall Study||23
8251224|NCT01858545|20346781|P2|STARTED|Overall Study||29
8251225|NCT01858545|20346782|P1|STARTED|Overall Study||27
8251226|NCT01858532|20346792|P4|NOT COMPLETED|Overall Study||93
8251227|NCT01858532|20346793|P3|NOT COMPLETED|Overall Study||98
8251228|NCT01858532|20346794|P2|NOT COMPLETED|Overall Study||192
8251229|NCT01858532|20346795|P1|NOT COMPLETED|Overall Study||181
8251230|NCT01858532|20346792|P4|COMPLETED|Overall Study||418
8251231|NCT01858532|20346793|P3|COMPLETED|Overall Study||411
8251232|NCT01858532|20346794|P2|COMPLETED|Overall Study||1131
8251233|NCT01858532|20346795|P1|COMPLETED|Overall Study||1144
8251234|NCT01858532|20346792|P4|STARTED|Overall Study||511
8251235|NCT01858532|20346793|P3|STARTED|Overall Study||509
8251236|NCT01858532|20346794|P2|STARTED|Overall Study||1323
8251237|NCT01858532|20346795|P1|STARTED|Overall Study||1325
8251238|NCT01858428|20346812|P2|NOT COMPLETED|Overall Study||10
8251239|NCT01858428|20346813|P1|NOT COMPLETED|Overall Study||1
8251240|NCT01858428|20346812|P2|COMPLETED|Overall Study||190
8251241|NCT01858428|20346813|P1|COMPLETED|Overall Study||99
8251242|NCT01858428|20346812|P2|STARTED|Overall Study||200
8251243|NCT01858428|20346813|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
8251244|NCT01858389|20346849|P2|NOT COMPLETED|Overall Study||25
8251245|NCT01858389|20346850|P1|NOT COMPLETED|Overall Study||16
8251246|NCT01858389|20346849|P2|COMPLETED|Overall Study||0
8251247|NCT01858389|20346850|P1|COMPLETED|Overall Study||0
8251248|NCT01858389|20346849|P2|Received Treatment|Overall Study||22
8251249|NCT01858389|20346850|P1|Received Treatment|Overall Study||16
8251250|NCT01858389|20346849|P2|STARTED|Overall Study|Enrolled|25
8251251|NCT01858389|20346850|P1|STARTED|Overall Study|Enrolled|16
8251252|NCT01858376|20346865|P1|NOT COMPLETED|Overall Study||4
8251253|NCT01858376|20346865|P1|COMPLETED|Overall Study||20
8251254|NCT01858376|20346865|P1|STARTED|Overall Study||24
8251255|NCT01858194|20346874|P2|NOT COMPLETED|Overall Study||2
8251256|NCT01858194|20346875|P1|NOT COMPLETED|Overall Study||0
8251257|NCT01858194|20346874|P2|COMPLETED|Overall Study||7
8251258|NCT01858194|20346875|P1|COMPLETED|Overall Study|All patients in Control arm completed.|8
8251259|NCT01858194|20346874|P2|STARTED|Overall Study||9
8251260|NCT01858194|20346875|P1|STARTED|Overall Study||8
8251261|NCT01857986|20346917|P2|NOT COMPLETED|Overall Study||7
8251262|NCT01857986|20346918|P1|NOT COMPLETED|Overall Study||5
8251263|NCT01857986|20346917|P2|COMPLETED|Overall Study||30
8251264|NCT01857986|20346918|P1|COMPLETED|Overall Study||34
8251265|NCT01857986|20346917|P2|STARTED|Overall Study||37
8251266|NCT01857986|20346918|P1|STARTED|Overall Study||39
8251267|NCT01857973|20346928|P1|NOT COMPLETED|Overall Study||5
8251268|NCT01857973|20346928|P1|COMPLETED|Overall Study||73
8251269|NCT01857973|20346928|P1|Phase 7|Overall Study||4
8251270|NCT01857973|20346928|P1|Phase 6|Overall Study||4
8251271|NCT01857973|20346928|P1|Phase 4|Overall Study||10
8251272|NCT01857973|20346928|P1|Phase 3|Overall Study||10
8251273|NCT01857973|20346928|P1|Phase 2|Overall Study||14
8251274|NCT01857973|20346928|P1|Phase 1|Overall Study||17
8251275|NCT01857973|20346928|P1|Xploratory B Phase|Overall Study||9
8251276|NCT01857973|20346928|P1|Exploratory A Phase|Overall Study||9
8251277|NCT01857973|20346928|P1|STARTED|Overall Study||78
8251278|NCT01857882|20346941|P2|NOT COMPLETED|Overall Study||0
8251279|NCT01857882|20346942|P1|NOT COMPLETED|Overall Study||0
8251280|NCT01857882|20346941|P2|COMPLETED|Overall Study||20
8251281|NCT01857882|20346942|P1|COMPLETED|Overall Study||21
8251282|NCT01857882|20346941|P2|STARTED|Overall Study||20
8251283|NCT01857882|20346942|P1|STARTED|Overall Study||21
8251284|NCT01857869|20346958|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
8251285|NCT01857869|20346959|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
8251286|NCT01857869|20346960|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
8251287|NCT01857869|20346961|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
8251288|NCT01857869|20346962|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
8251289|NCT01857869|20346963|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
8251290|NCT01857869|20346964|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
8251291|NCT01857869|20346965|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
8251292|NCT01857869|20346966|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
8251293|NCT01857869|20346967|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
8251294|NCT01857869|20346958|P10|COMPLETED|Booster/Rechallenge Phase||6
8251295|NCT01857869|20346959|P9|COMPLETED|Booster/Rechallenge Phase||3
8251296|NCT01857869|20346960|P8|COMPLETED|Booster/Rechallenge Phase||4
8251297|NCT01857869|20346961|P7|COMPLETED|Booster/Rechallenge Phase||5
8251298|NCT01857869|20346962|P6|COMPLETED|Booster/Rechallenge Phase||2
8251299|NCT01857869|20346963|P5|COMPLETED|Booster/Rechallenge Phase||10
8251300|NCT01857869|20346964|P4|COMPLETED|Booster/Rechallenge Phase||7
8251301|NCT01857869|20346965|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251302|NCT01857869|20346966|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251303|NCT01857869|20346967|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251304|NCT01857869|20346958|P10|STARTED|Booster/Rechallenge Phase||6
8251305|NCT01857869|20346959|P9|STARTED|Booster/Rechallenge Phase||3
8251306|NCT01857869|20346960|P8|STARTED|Booster/Rechallenge Phase||4
8251307|NCT01857869|20346961|P7|STARTED|Booster/Rechallenge Phase||5
8251308|NCT01857869|20346962|P6|STARTED|Booster/Rechallenge Phase||2
8251309|NCT01857869|20346963|P5|STARTED|Booster/Rechallenge Phase||10
8251310|NCT01857869|20346964|P4|STARTED|Booster/Rechallenge Phase||9
8251311|NCT01857869|20346965|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251312|NCT01857869|20346966|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251313|NCT01857869|20346967|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251314|NCT01857869|20346958|P10|NOT COMPLETED|Primary/Challenge Phase||0
8251315|NCT01857869|20346959|P9|NOT COMPLETED|Primary/Challenge Phase||0
8251316|NCT01857869|20346960|P8|NOT COMPLETED|Primary/Challenge Phase||0
8251317|NCT01857869|20346961|P7|NOT COMPLETED|Primary/Challenge Phase||0
8251318|NCT01857869|20346962|P6|NOT COMPLETED|Primary/Challenge Phase||0
8251319|NCT01857869|20346963|P5|NOT COMPLETED|Primary/Challenge Phase||0
8251320|NCT01857869|20346964|P4|NOT COMPLETED|Primary/Challenge Phase||0
8251321|NCT01857869|20346965|P3|NOT COMPLETED|Primary/Challenge Phase||0
8251322|NCT01857869|20346966|P2|NOT COMPLETED|Primary/Challenge Phase||1
8251323|NCT01857869|20346967|P1|NOT COMPLETED|Primary/Challenge Phase||5
8251324|NCT01857869|20346958|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251325|NCT01857869|20346959|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251326|NCT01857869|20346960|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251327|NCT01857869|20346961|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251328|NCT01857869|20346962|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251329|NCT01857869|20346963|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251330|NCT01857869|20346964|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251331|NCT01857869|20346965|P3|COMPLETED|Primary/Challenge Phase||12
8251332|NCT01857869|20346966|P2|COMPLETED|Primary/Challenge Phase||16
8251333|NCT01857869|20346967|P1|COMPLETED|Primary/Challenge Phase||29
8251334|NCT01857869|20346958|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251335|NCT01857869|20346959|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251336|NCT01857869|20346960|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251337|NCT01857869|20346961|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251338|NCT01857869|20346962|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251339|NCT01857869|20346963|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251340|NCT01857869|20346964|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251341|NCT01857869|20346965|P3|STARTED|Primary/Challenge Phase||12
8251342|NCT01857869|20346966|P2|STARTED|Primary/Challenge Phase||17
8251343|NCT01857869|20346967|P1|STARTED|Primary/Challenge Phase||34
8251344|NCT01857713|20347047|P1|NOT COMPLETED|Overall Study||6
8251345|NCT01857713|20347047|P1|COMPLETED|Overall Study||89
8251346|NCT01857713|20347047|P1|STARTED|Overall Study||95
8251347|NCT01857622|20347057|P3|NOT COMPLETED|Overall Study||2
8251348|NCT01857622|20347058|P2|NOT COMPLETED|Overall Study||1
8251349|NCT01857622|20347059|P1|NOT COMPLETED|Overall Study||11
8251350|NCT01857622|20347057|P3|COMPLETED|Overall Study||19
8251351|NCT01857622|20347058|P2|COMPLETED|Overall Study||21
8251352|NCT01857622|20347059|P1|COMPLETED|Overall Study||39
8251353|NCT01857622|20347057|P3|STARTED|Overall Study||21
8251354|NCT01857622|20347058|P2|STARTED|Overall Study||22
8251355|NCT01857622|20347059|P1|STARTED|Overall Study||50
8251356|NCT01857583|20347071|P4|NOT COMPLETED|Overall Study||4
8251357|NCT01857583|20347072|P3|NOT COMPLETED|Overall Study||3
8251358|NCT01857583|20347073|P2|NOT COMPLETED|Overall Study||1
8251359|NCT01857583|20347074|P1|NOT COMPLETED|Overall Study||1
8251360|NCT01857583|20347071|P4|COMPLETED|Overall Study||17
8251361|NCT01857583|20347072|P3|COMPLETED|Overall Study||19
8251362|NCT01857583|20347073|P2|COMPLETED|Overall Study||6
8251363|NCT01857583|20347074|P1|COMPLETED|Overall Study||29
8251364|NCT01857583|20347071|P4|Safety Analysis Population|Overall Study||20
8251365|NCT01857583|20347072|P3|Safety Analysis Population|Overall Study||22
8251366|NCT01857583|20347073|P2|Safety Analysis Population|Overall Study||7
8251367|NCT01857583|20347074|P1|Safety Analysis Population|Overall Study||30
8251368|NCT01857583|20347071|P4|STARTED|Overall Study||21
8251369|NCT01857583|20347072|P3|STARTED|Overall Study||22
8251370|NCT01857583|20347073|P2|STARTED|Overall Study||7
8251371|NCT01857583|20347074|P1|STARTED|Overall Study||30
8251372|NCT01857531|20347084|P1|NOT COMPLETED|Overall Study||4
8251373|NCT01857531|20347084|P1|COMPLETED|Overall Study||12
8251374|NCT01857531|20347084|P1|STARTED|Overall Study||16
8251375|NCT01857362|20347093|P2|NOT COMPLETED|Overall Study||0
8251376|NCT01857362|20347094|P1|NOT COMPLETED|Overall Study||0
8251377|NCT01857362|20347093|P2|COMPLETED|Overall Study||6
8251378|NCT01857362|20347094|P1|COMPLETED|Overall Study||6
8251379|NCT01857362|20347093|P2|STARTED|Overall Study||6
8251380|NCT01857362|20347094|P1|STARTED|Overall Study||6
8251381|NCT01857323|20347102|P1|NOT COMPLETED|Overall Study||64
8251382|NCT01857323|20347102|P1|COMPLETED|Overall Study||253
8251383|NCT01857323|20347102|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
8251384|NCT01857323|20347102|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
8251385|NCT01857310|20347113|P2|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
8251386|NCT01857310|20347114|P1|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
8251387|NCT01857310|20347113|P2|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
8251388|NCT01857310|20347114|P1|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
8251389|NCT01857310|20347113|P2|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
8251390|NCT01857310|20347114|P1|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
8251391|NCT01857310|20347113|P2|NOT COMPLETED|Primary Analysis: Live Birth||0
8251392|NCT01857310|20347114|P1|NOT COMPLETED|Primary Analysis: Live Birth||0
8251393|NCT01857310|20347113|P2|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
8251394|NCT01857310|20347114|P1|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
8251395|NCT01857310|20347113|P2|STARTED|Primary Analysis: Live Birth|Male partner|1185
8251396|NCT01857310|20347114|P1|STARTED|Primary Analysis: Live Birth|Male partner|1185
8251397|NCT01857297|20347194|P2|NOT COMPLETED|Overall Study||0
8251398|NCT01857297|20347195|P1|NOT COMPLETED|Overall Study||0
8251399|NCT01857297|20347194|P2|COMPLETED|Overall Study||60
8251400|NCT01857297|20347195|P1|COMPLETED|Overall Study||60
8251401|NCT01857297|20347194|P2|STARTED|Overall Study||60
8251402|NCT01857297|20347195|P1|STARTED|Overall Study||60
8251403|NCT01857271|20347209|P1|NOT COMPLETED|Overall Study||1
8251404|NCT01857271|20347209|P1|COMPLETED|Overall Study||2
8251405|NCT01857271|20347209|P1|STARTED|Overall Study||3
8251406|NCT01857258|20347213|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
8251407|NCT01857258|20347214|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
8251408|NCT01857258|20347213|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
8251409|NCT01857258|20347214|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
8251410|NCT01857258|20347213|P2|STARTED|Second Intervention (3 h Postprandially)||7
8251411|NCT01857258|20347214|P1|STARTED|Second Intervention (3 h Postprandially)||8
8251412|NCT01857258|20347213|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
8251413|NCT01857258|20347214|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
8251414|NCT01857258|20347213|P2|COMPLETED|Wash-out Period (7 Days)||7
8251415|NCT01857258|20347214|P1|COMPLETED|Wash-out Period (7 Days)||8
8251416|NCT01857258|20347213|P2|STARTED|Wash-out Period (7 Days)||7
8251417|NCT01857258|20347214|P1|STARTED|Wash-out Period (7 Days)||8
8251418|NCT01857258|20347213|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
8251419|NCT01857258|20347214|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
8251420|NCT01857258|20347213|P2|COMPLETED|First Intervention (3 h Postprandially)||7
8251421|NCT01857258|20347214|P1|COMPLETED|First Intervention (3 h Postprandially)||8
8251422|NCT01857258|20347213|P2|STARTED|First Intervention (3 h Postprandially)||7
8251423|NCT01857258|20347214|P1|STARTED|First Intervention (3 h Postprandially)||8
8251424|NCT01857232|20347239|P5|NOT COMPLETED|Overall Study||6
8251425|NCT01857232|20347240|P4|NOT COMPLETED|Overall Study||2
8251426|NCT01857232|20347241|P3|NOT COMPLETED|Overall Study||4
8251427|NCT01857232|20347242|P2|NOT COMPLETED|Overall Study||2
8251428|NCT01857232|20347243|P1|NOT COMPLETED|Overall Study||8
8251429|NCT01857232|20347239|P5|COMPLETED|Overall Study||63
8251430|NCT01857232|20347240|P4|COMPLETED|Overall Study||68
8251431|NCT01857232|20347241|P3|COMPLETED|Overall Study||63
8251432|NCT01857232|20347242|P2|COMPLETED|Overall Study||65
8251433|NCT01857232|20347243|P1|COMPLETED|Overall Study||61
8251434|NCT01857232|20347239|P5|Evaluable ITT|Overall Study||65
8251435|NCT01857232|20347240|P4|Evaluable ITT|Overall Study||68
8251436|NCT01857232|20347241|P3|Evaluable ITT|Overall Study||63
8251437|NCT01857232|20347242|P2|Evaluable ITT|Overall Study||66
8251438|NCT01857232|20347243|P1|Evaluable ITT|Overall Study||66
8251439|NCT01857232|20347239|P5|STARTED|Overall Study||69
8251440|NCT01857232|20347240|P4|STARTED|Overall Study||70
8251441|NCT01857232|20347241|P3|STARTED|Overall Study||67
8251442|NCT01857232|20347242|P2|STARTED|Overall Study||67
8251443|NCT01857232|20347243|P1|STARTED|Overall Study||69
8251444|NCT01857206|20347262|P2|NOT COMPLETED|Overall Study||10
8251445|NCT01857206|20347263|P1|NOT COMPLETED|Overall Study||13
8251446|NCT01857206|20347262|P2|COMPLETED|Overall Study||673
8251447|NCT01857206|20347263|P1|COMPLETED|Overall Study||1359
8251448|NCT01857206|20347262|P2|STARTED|Overall Study||683
8251449|NCT01857206|20347263|P1|STARTED|Overall Study||1372
8251450|NCT01857102|20347281|P2|NOT COMPLETED|Period 2||0
8251451|NCT01857102|20347282|P1|NOT COMPLETED|Period 2||2
8251452|NCT01857102|20347281|P2|COMPLETED|Period 2||51
8251453|NCT01857102|20347282|P1|COMPLETED|Period 2||53
8251454|NCT01857102|20347281|P2|Neophytes|Period 2||4
8251455|NCT01857102|20347282|P1|Neophytes|Period 2||7
8251456|NCT01857102|20347281|P2|Habitual Users|Period 2||47
8251457|NCT01857102|20347282|P1|Habitual Users|Period 2||48
8251458|NCT01857102|20347281|P2|STARTED|Period 2||51
8251459|NCT01857102|20347282|P1|STARTED|Period 2||55
8251460|NCT01857102|20347281|P2|NOT COMPLETED|Period 1||5
8251461|NCT01857102|20347282|P1|NOT COMPLETED|Period 1||3
8251462|NCT01857102|20347281|P2|COMPLETED|Period 1||51
8251463|NCT01857102|20347282|P1|COMPLETED|Period 1||55
8251464|NCT01857102|20347281|P2|Neophtyes|Period 1||4
8251465|NCT01857102|20347282|P1|Neophtyes|Period 1||7
8251466|NCT01857102|20347281|P2|Habitual Users|Period 1||52
8251467|NCT01857102|20347282|P1|Habitual Users|Period 1||51
8251468|NCT01857102|20347281|P2|STARTED|Period 1||56
8251469|NCT01857102|20347282|P1|STARTED|Period 1||58
8251470|NCT01857063|20347292|P2|NOT COMPLETED|Period 2 (7 Days)||2
8251471|NCT01857063|20347293|P1|NOT COMPLETED|Period 2 (7 Days)||4
8251472|NCT01857063|20347292|P2|COMPLETED|Period 2 (7 Days)||104
8251473|NCT01857063|20347293|P1|COMPLETED|Period 2 (7 Days)||104
8251474|NCT01857063|20347292|P2|STARTED|Period 2 (7 Days)||106
8251475|NCT01857063|20347293|P1|STARTED|Period 2 (7 Days)||108
8251476|NCT01857063|20347292|P2|NOT COMPLETED|Period 1 (7 Days)||4
8251477|NCT01857063|20347293|P1|NOT COMPLETED|Period 1 (7 Days)||2
8251478|NCT01857063|20347292|P2|COMPLETED|Period 1 (7 Days)||106
8251479|NCT01857063|20347293|P1|COMPLETED|Period 1 (7 Days)||108
8251480|NCT01857063|20347292|P2|STARTED|Period 1 (7 Days)||110
8251481|NCT01857063|20347293|P1|STARTED|Period 1 (7 Days)||110
8251482|NCT01856933|20347319|P1|NOT COMPLETED|Overall Study||0
8251483|NCT01856933|20347319|P1|COMPLETED|Overall Study||6
8251484|NCT01856933|20347319|P1|STARTED|Overall Study||6
8251485|NCT01856907|20347327|P3|NOT COMPLETED|Overall Study||0
8251486|NCT01856907|20347328|P2|NOT COMPLETED|Overall Study||3
8251487|NCT01856907|20347329|P1|NOT COMPLETED|Overall Study||0
8251488|NCT01856907|20347327|P3|COMPLETED|Overall Study||12
8251489|NCT01856907|20347328|P2|COMPLETED|Overall Study||9
8251490|NCT01856907|20347329|P1|COMPLETED|Overall Study||12
8251491|NCT01856907|20347327|P3|STARTED|Overall Study||12
8251492|NCT01856907|20347328|P2|STARTED|Overall Study||12
8251493|NCT01856907|20347329|P1|STARTED|Overall Study||12
8251494|NCT01856790|20347367|P1|NOT COMPLETED|Closed Loop Control + Liraglutide||2
8251495|NCT01856790|20347367|P1|COMPLETED|Closed Loop Control + Liraglutide||11
8251496|NCT01856790|20347367|P1|STARTED|Closed Loop Control + Liraglutide||13
8251497|NCT01856790|20347367|P1|NOT COMPLETED|Closed Loop Control||2
8251498|NCT01856790|20347367|P1|COMPLETED|Closed Loop Control||13
8251499|NCT01856790|20347367|P1|STARTED|Closed Loop Control||15
8251500|NCT01856764|20347393|P2|NOT COMPLETED|Overall Study||0
8251501|NCT01856764|20347394|P1|NOT COMPLETED|Overall Study||0
8251502|NCT01856764|20347393|P2|COMPLETED|Overall Study||20
8251503|NCT01856764|20347394|P1|COMPLETED|Overall Study||20
8251504|NCT01856764|20347393|P2|STARTED|Overall Study||20
8251505|NCT01856764|20347394|P1|STARTED|Overall Study||20
8251506|NCT01856712|20347406|P2|NOT COMPLETED|Overall Study||3
8251507|NCT01856712|20347407|P1|NOT COMPLETED|Overall Study||7
8251508|NCT01856712|20347406|P2|COMPLETED|Overall Study||19
8251509|NCT01856712|20347407|P1|COMPLETED|Overall Study||16
8251510|NCT01856712|20347406|P2|Lost to 45 Day Follow up|Overall Study||1
8251511|NCT01856712|20347407|P1|Lost to 45 Day Follow up|Overall Study||1
8251512|NCT01856712|20347406|P2|Lost to 14 Day Follow up|Overall Study||2
8251513|NCT01856712|20347407|P1|Lost to 14 Day Follow up|Overall Study||6
8251514|NCT01856712|20347406|P2|STARTED|Overall Study|1 received oral in error thus randomized.|22
8251515|NCT01856712|20347407|P1|STARTED|Overall Study||23
8251516|NCT01856686|20347421|P2|NOT COMPLETED|Overall Study||11
8251517|NCT01856686|20347422|P1|NOT COMPLETED|Overall Study||5
8251518|NCT01856686|20347421|P2|COMPLETED|Overall Study||22
8251519|NCT01856686|20347422|P1|COMPLETED|Overall Study||26
8251520|NCT01856686|20347421|P2|STARTED|Overall Study||33
8251521|NCT01856686|20347422|P1|STARTED|Overall Study||31
8251522|NCT01856673|20347465|P3|NOT COMPLETED|Overall Study||34
8251523|NCT01856673|20347466|P2|NOT COMPLETED|Overall Study||85
8251524|NCT01856673|20347467|P1|NOT COMPLETED|Overall Study||98
8251525|NCT01856673|20347465|P3|COMPLETED|Overall Study||137
8251526|NCT01856673|20347466|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
8251527|NCT01856673|20347467|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
8251528|NCT01856673|20347465|P3|Quibdó Participants|Overall Study||83
8251529|NCT01856673|20347466|P2|Quibdó Participants|Overall Study||86
8251530|NCT01856673|20347467|P1|Quibdó Participants|Overall Study||83
8251531|NCT01856673|20347465|P3|Buenaventura Participants|Overall Study||88
8251532|NCT01856673|20347466|P2|Buenaventura Participants|Overall Study||89
8251533|NCT01856673|20347467|P1|Buenaventura Participants|Overall Study||92
8251534|NCT01856673|20347465|P3|STARTED|Overall Study||171
8251535|NCT01856673|20347466|P2|STARTED|Overall Study||175
8251536|NCT01856673|20347467|P1|STARTED|Overall Study||175
8251537|NCT01856595|20347487|P9|NOT COMPLETED|Overall Study||0
8251538|NCT01856595|20347488|P8|NOT COMPLETED|Overall Study||0
8251539|NCT01856595|20347489|P7|NOT COMPLETED|Overall Study||1
8251540|NCT01856595|20347490|P6|NOT COMPLETED|Overall Study||0
8251541|NCT01856595|20347491|P5|NOT COMPLETED|Overall Study||0
8251542|NCT01856595|20347492|P4|NOT COMPLETED|Overall Study||0
8251543|NCT01856595|20347493|P3|NOT COMPLETED|Overall Study||0
8251544|NCT01856595|20347494|P2|NOT COMPLETED|Overall Study||1
8251545|NCT01856595|20347495|P1|NOT COMPLETED|Overall Study||0
8251546|NCT01856595|20347487|P9|COMPLETED|Overall Study||14
8251547|NCT01856595|20347488|P8|COMPLETED|Overall Study||10
8251548|NCT01856595|20347489|P7|COMPLETED|Overall Study||12
8251549|NCT01856595|20347490|P6|COMPLETED|Overall Study||12
8251550|NCT01856595|20347491|P5|COMPLETED|Overall Study||14
8251551|NCT01856595|20347492|P4|COMPLETED|Overall Study||12
8251552|NCT01856595|20347493|P3|COMPLETED|Overall Study||12
8251553|NCT01856595|20347494|P2|COMPLETED|Overall Study||11
8251554|NCT01856595|20347495|P1|COMPLETED|Overall Study||18
8251555|NCT01856595|20347487|P9|STARTED|Overall Study||14
8251556|NCT01856595|20347488|P8|STARTED|Overall Study||10
8251557|NCT01856595|20347489|P7|STARTED|Overall Study||13
8251558|NCT01856595|20347490|P6|STARTED|Overall Study||12
8251559|NCT01856595|20347491|P5|STARTED|Overall Study||14
8251560|NCT01856595|20347492|P4|STARTED|Overall Study||12
8251561|NCT01856595|20347493|P3|STARTED|Overall Study||12
8251562|NCT01856595|20347494|P2|STARTED|Overall Study||12
8251563|NCT01856595|20347495|P1|STARTED|Overall Study||18
8251564|NCT01856582|20347728|P1|NOT COMPLETED|Overall Study||1
8251565|NCT01856582|20347728|P1|COMPLETED|Overall Study||22
8251566|NCT01856582|20347728|P1|STARTED|Overall Study||23
8251567|NCT01856569|20347732|P1|NOT COMPLETED|Overall Study||13
8251568|NCT01856569|20347732|P1|COMPLETED|Overall Study||139
8251569|NCT01856569|20347732|P1|Full Analysis Set|Overall Study||144
8251570|NCT01856569|20347732|P1|STARTED|Overall Study||152
8251571|NCT01856543|20347743|P2|NOT COMPLETED|Overall Study||6
8251572|NCT01856543|20347744|P1|NOT COMPLETED|Overall Study||13
8251573|NCT01856543|20347743|P2|COMPLETED|Overall Study||64
8251574|NCT01856543|20347744|P1|COMPLETED|Overall Study||60
8251575|NCT01856543|20347743|P2|STARTED|Overall Study||70
8251576|NCT01856543|20347744|P1|STARTED|Overall Study||73
8251577|NCT01856530|20347756|P2|NOT COMPLETED|Overall Study||0
8251578|NCT01856530|20347757|P1|NOT COMPLETED|Overall Study||0
8251579|NCT01856530|20347756|P2|COMPLETED|Overall Study||27
8251580|NCT01856530|20347757|P1|COMPLETED|Overall Study||27
8251581|NCT01856530|20347756|P2|STARTED|Overall Study||27
8251582|NCT01856530|20347757|P1|STARTED|Overall Study||27
8251583|NCT01856491|20347773|P1|NOT COMPLETED|Overall Study||15
8251584|NCT01856491|20347773|P1|COMPLETED|Overall Study||152
8251585|NCT01856491|20347773|P1|STARTED|Overall Study||167
8251586|NCT01856361|20347784|P2|NOT COMPLETED|Overall Study||0
8251587|NCT01856361|20347785|P1|NOT COMPLETED|Overall Study||0
8251588|NCT01856361|20347784|P2|COMPLETED|Overall Study||1
8251589|NCT01856361|20347785|P1|COMPLETED|Overall Study||1
8251590|NCT01856361|20347784|P2|STARTED|Overall Study||1
8251591|NCT01856361|20347785|P1|STARTED|Overall Study||1
8251592|NCT01856322|20347802|P3|NOT COMPLETED|Overall Study||3
8251593|NCT01856322|20347803|P2|NOT COMPLETED|Overall Study||0
8251594|NCT01856322|20347804|P1|NOT COMPLETED|Overall Study||0
8251595|NCT01856322|20347802|P3|COMPLETED|Overall Study||0
8251596|NCT01856322|20347803|P2|COMPLETED|Overall Study||0
8251597|NCT01856322|20347804|P1|COMPLETED|Overall Study||0
8251598|NCT01856322|20347802|P3|STARTED|Overall Study||3
8251599|NCT01856322|20347803|P2|STARTED|Overall Study||0
8251600|NCT01856322|20347804|P1|STARTED|Overall Study||0
8251601|NCT01856309|20347815|P4|NOT COMPLETED|Overall Study||609
8251602|NCT01856309|20347816|P3|NOT COMPLETED|Overall Study||595
8251603|NCT01856309|20347817|P2|NOT COMPLETED|Overall Study||288
8251604|NCT01856309|20347818|P1|NOT COMPLETED|Overall Study||299
8251605|NCT01856309|20347815|P4|COMPLETED|Overall Study||9
8251606|NCT01856309|20347816|P3|COMPLETED|Overall Study||11
8251607|NCT01856309|20347817|P2|COMPLETED|Overall Study||3
8251608|NCT01856309|20347818|P1|COMPLETED|Overall Study||6
8251609|NCT01856309|20347815|P4|Treated Partcipants|Overall Study||618
8251610|NCT01856309|20347816|P3|Treated Partcipants|Overall Study||605
8251611|NCT01856309|20347817|P2|Treated Partcipants|Overall Study||290
8251612|NCT01856309|20347818|P1|Treated Partcipants|Overall Study||305
8251613|NCT01856309|20347815|P4|Participants From Study CNTO136ARA3003|Overall Study||206
8251614|NCT01856309|20347816|P3|Participants From Study CNTO136ARA3003|Overall Study||201
8251615|NCT01856309|20347817|P2|Participants From Study CNTO136ARA3003|Overall Study||104
8251616|NCT01856309|20347818|P1|Participants From Study CNTO136ARA3003|Overall Study||108
8251617|NCT01856309|20347815|P4|Participants From Study CNTO136ARA3002|Overall Study||412
8251618|NCT01856309|20347816|P3|Participants From Study CNTO136ARA3002|Overall Study||405
8251619|NCT01856309|20347817|P2|Participants From Study CNTO136ARA3002|Overall Study||187
8251620|NCT01856309|20347818|P1|Participants From Study CNTO136ARA3002|Overall Study||197
8251621|NCT01856309|20347815|P4|STARTED|Overall Study||618
8251622|NCT01856309|20347816|P3|STARTED|Overall Study||606
8251623|NCT01856309|20347817|P2|STARTED|Overall Study||291
8251624|NCT01856309|20347818|P1|STARTED|Overall Study||305
8251625|NCT01856270|20347918|P2|NOT COMPLETED|Overall Study||12
8251626|NCT01856270|20347919|P1|NOT COMPLETED|Overall Study||11
8251627|NCT01856270|20347918|P2|COMPLETED|Overall Study||14
8251628|NCT01856270|20347919|P1|COMPLETED|Overall Study||13
8251629|NCT01856270|20347918|P2|STARTED|Overall Study||26
8251630|NCT01856270|20347919|P1|STARTED|Overall Study||24
8251631|NCT01856257|20347942|P4|NOT COMPLETED|Overall Study||2
8251632|NCT01856257|20347943|P3|NOT COMPLETED|Overall Study||0
8251633|NCT01856257|20347944|P2|NOT COMPLETED|Overall Study||1
8251634|NCT01856257|20347945|P1|NOT COMPLETED|Overall Study||3
8251635|NCT01856257|20347942|P4|COMPLETED|Overall Study||0
8251636|NCT01856257|20347943|P3|COMPLETED|Overall Study||11
8251637|NCT01856257|20347944|P2|COMPLETED|Overall Study||28
8251638|NCT01856257|20347945|P1|COMPLETED|Overall Study||26
8251639|NCT01856257|20347942|P4|STARTED|Overall Study||2
8251640|NCT01856257|20347943|P3|STARTED|Overall Study||11
8251641|NCT01856257|20347944|P2|STARTED|Overall Study||29
8251642|NCT01856257|20347945|P1|STARTED|Overall Study||29
8251643|NCT01856218|20348044|P1|NOT COMPLETED|Long-Term Extension Phase||0
8251644|NCT01856218|20348044|P1|COMPLETED|Long-Term Extension Phase||3
8251645|NCT01856218|20348044|P1|STARTED|Long-Term Extension Phase||3
8251646|NCT01856218|20348044|P1|NOT COMPLETED|First Phase||0
8251647|NCT01856218|20348044|P1|COMPLETED|First Phase||3
8251648|NCT01856218|20348044|P1|STARTED|First Phase||3
8251649|NCT01856114|20348060|P2|NOT COMPLETED|Overall Study||0
8251650|NCT01856114|20348061|P1|NOT COMPLETED|Overall Study||2
8251651|NCT01856114|20348060|P2|COMPLETED|Overall Study||11
8251652|NCT01856114|20348061|P1|COMPLETED|Overall Study||9
8251653|NCT01856114|20348060|P2|STARTED|Overall Study||11
8251654|NCT01856114|20348061|P1|STARTED|Overall Study||11
8251655|NCT01855997|20348071|P1|NOT COMPLETED|Overall Study||0
8251656|NCT01855997|20348071|P1|COMPLETED|Overall Study||1669
8251657|NCT01855997|20348071|P1|STARTED|Overall Study||1669
8251658|NCT01855958|20348126|P2|NOT COMPLETED|Overall Study||0
8251659|NCT01855958|20348127|P1|NOT COMPLETED|Overall Study||1
8251660|NCT01855958|20348126|P2|COMPLETED|Overall Study||13
8251661|NCT01855958|20348127|P1|COMPLETED|Overall Study||12
8251662|NCT01855958|20348126|P2|STARTED|Overall Study||13
8251663|NCT01855958|20348127|P1|STARTED|Overall Study||13
8251664|NCT01855945|20348157|P12|NOT COMPLETED|Overall Study||3
8251665|NCT01855945|20348158|P11|NOT COMPLETED|Overall Study||5
8251666|NCT01855945|20348159|P10|NOT COMPLETED|Overall Study||2
8251667|NCT01855945|20348160|P9|NOT COMPLETED|Overall Study||2
8251668|NCT01855945|20348161|P8|NOT COMPLETED|Overall Study||8
8251669|NCT01855945|20348162|P7|NOT COMPLETED|Overall Study||10
8251670|NCT01855945|20348163|P6|NOT COMPLETED|Overall Study||3
8251671|NCT01855945|20348164|P5|NOT COMPLETED|Overall Study||1
8251672|NCT01855945|20348165|P4|NOT COMPLETED|Overall Study||4
8251673|NCT01855945|20348166|P3|NOT COMPLETED|Overall Study||12
8251674|NCT01855945|20348167|P2|NOT COMPLETED|Overall Study||11
8251675|NCT01855945|20348168|P1|NOT COMPLETED|Overall Study||16
8251676|NCT01855945|20348157|P12|COMPLETED|Overall Study||49
8251677|NCT01855945|20348158|P11|COMPLETED|Overall Study||46
8251678|NCT01855945|20348159|P10|COMPLETED|Overall Study||49
8251679|NCT01855945|20348160|P9|COMPLETED|Overall Study||46
8251680|NCT01855945|20348161|P8|COMPLETED|Overall Study||47
8251681|NCT01855945|20348162|P7|COMPLETED|Overall Study||43
8251682|NCT01855945|20348163|P6|COMPLETED|Overall Study||50
8251683|NCT01855945|20348164|P5|COMPLETED|Overall Study||50
8251684|NCT01855945|20348165|P4|COMPLETED|Overall Study||49
8251685|NCT01855945|20348166|P3|COMPLETED|Overall Study||39
8251686|NCT01855945|20348167|P2|COMPLETED|Overall Study||44
8251687|NCT01855945|20348168|P1|COMPLETED|Overall Study||38
8251688|NCT01855945|20348157|P12|STARTED|Overall Study||52
8251689|NCT01855945|20348158|P11|STARTED|Overall Study||51
8251690|NCT01855945|20348159|P10|STARTED|Overall Study||51
8251691|NCT01855945|20348160|P9|STARTED|Overall Study||48
8251692|NCT01855945|20348161|P8|STARTED|Overall Study||55
8251693|NCT01855945|20348162|P7|STARTED|Overall Study||53
8251694|NCT01855945|20348163|P6|STARTED|Overall Study||53
8251695|NCT01855945|20348164|P5|STARTED|Overall Study||51
8251696|NCT01855945|20348165|P4|STARTED|Overall Study||53
8251697|NCT01855945|20348166|P3|STARTED|Overall Study||51
8251698|NCT01855945|20348167|P2|STARTED|Overall Study||55
8251699|NCT01855945|20348168|P1|STARTED|Overall Study||54
8251700|NCT01855919|20348304|P2|NOT COMPLETED|Overall Study||26
8251701|NCT01855919|20348305|P1|NOT COMPLETED|Overall Study||23
8251702|NCT01855919|20348304|P2|COMPLETED|Overall Study||200
8251703|NCT01855919|20348305|P1|COMPLETED|Overall Study||209
8251704|NCT01855919|20348304|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
8251705|NCT01855919|20348305|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
8251706|NCT01855919|20348304|P2|STARTED|Overall Study||226
8251707|NCT01855919|20348305|P1|STARTED|Overall Study||232
8251708|NCT01855828|20348337|P1|NOT COMPLETED|Overall Study||2
8251709|NCT01855828|20348337|P1|COMPLETED|Overall Study||48
8251710|NCT01855828|20348337|P1|STARTED|Overall Study||50
8251711|NCT01855789|20348347|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
8251712|NCT01855789|20348348|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
8251713|NCT01855789|20348349|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
8251714|NCT01855789|20348350|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
8251715|NCT01855789|20348347|P4|COMPLETED|2) Week 24 up to End of Study||250
8251716|NCT01855789|20348348|P3|COMPLETED|2) Week 24 up to End of Study||129
8251717|NCT01855789|20348349|P2|COMPLETED|2) Week 24 up to End of Study||132
8251718|NCT01855789|20348350|P1|COMPLETED|2) Week 24 up to End of Study||0
8251719|NCT01855789|20348347|P4|STARTED|2) Week 24 up to End of Study||308
8251720|NCT01855789|20348348|P3|STARTED|2) Week 24 up to End of Study||147
8251721|NCT01855789|20348349|P2|STARTED|2) Week 24 up to End of Study||147
8251722|NCT01855789|20348350|P1|STARTED|2) Week 24 up to End of Study||0
8251723|NCT01855789|20348347|P4|NOT COMPLETED|1) Baseline up to Week 24||0
8251724|NCT01855789|20348348|P3|NOT COMPLETED|1) Baseline up to Week 24||0
8251725|NCT01855789|20348349|P2|NOT COMPLETED|1) Baseline up to Week 24||0
8251726|NCT01855789|20348350|P1|NOT COMPLETED|1) Baseline up to Week 24||116
8251727|NCT01855789|20348347|P4|COMPLETED|1) Baseline up to Week 24||0
8251728|NCT01855789|20348348|P3|COMPLETED|1) Baseline up to Week 24||0
8251729|NCT01855789|20348349|P2|COMPLETED|1) Baseline up to Week 24||0
8251730|NCT01855789|20348350|P1|COMPLETED|1) Baseline up to Week 24||602
8251731|NCT01855789|20348347|P4|STARTED|1) Baseline up to Week 24||0
8251732|NCT01855789|20348348|P3|STARTED|1) Baseline up to Week 24||0
8251733|NCT01855789|20348349|P2|STARTED|1) Baseline up to Week 24||0
8251734|NCT01855789|20348350|P1|STARTED|1) Baseline up to Week 24||718
8251735|NCT01855750|20348374|P2|NOT COMPLETED|Overall Study||419
8251736|NCT01855750|20348375|P1|NOT COMPLETED|Overall Study||419
8251737|NCT01855750|20348374|P2|COMPLETED|Overall Study||0
8251738|NCT01855750|20348375|P1|COMPLETED|Overall Study||0
8251739|NCT01855750|20348374|P2|Treated|Overall Study|1 participant not treated: withdrew consent.|418
8251740|NCT01855750|20348375|P1|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
8251741|NCT01855750|20348374|P2|STARTED|Overall Study||419
8251742|NCT01855750|20348375|P1|STARTED|Overall Study||419
8251743|NCT01855425|20348391|P1|NOT COMPLETED|Overall Study||20
8251744|NCT01855425|20348391|P1|COMPLETED|Overall Study||76
8251745|NCT01855425|20348391|P1|STARTED|Overall Study||96
8251746|NCT01855399|20348397|P2|NOT COMPLETED|12 Month||11
8251747|NCT01855399|20348398|P1|NOT COMPLETED|12 Month||7
8251748|NCT01855399|20348397|P2|COMPLETED|12 Month||118
8251749|NCT01855399|20348398|P1|COMPLETED|12 Month||119
8251750|NCT01855399|20348397|P2|STARTED|12 Month||129
8251751|NCT01855399|20348398|P1|STARTED|12 Month||126
8251752|NCT01855399|20348397|P2|NOT COMPLETED|6 Month||15
8251753|NCT01855399|20348398|P1|NOT COMPLETED|6 Month||20
8251754|NCT01855399|20348397|P2|COMPLETED|6 Month||129
8251755|NCT01855399|20348398|P1|COMPLETED|6 Month||126
8251756|NCT01855399|20348397|P2|STARTED|6 Month||144
8251757|NCT01855399|20348398|P1|STARTED|6 Month||146
8251758|NCT01855360|20348404|P1|NOT COMPLETED|Overall Study||10
8251759|NCT01855360|20348404|P1|COMPLETED|Overall Study||30
8251760|NCT01855360|20348404|P1|STARTED|Overall Study||40
8251761|NCT01855243|20348412|P3|NOT COMPLETED|Overall Study||0
8251762|NCT01855243|20348413|P2|NOT COMPLETED|Overall Study||0
8251763|NCT01855243|20348414|P1|NOT COMPLETED|Overall Study||1
8251764|NCT01855243|20348412|P3|COMPLETED|Overall Study||22
8251765|NCT01855243|20348413|P2|COMPLETED|Overall Study||21
8251766|NCT01855243|20348414|P1|COMPLETED|Overall Study||19
8251767|NCT01855243|20348412|P3|STARTED|Overall Study||22
8251768|NCT01855243|20348413|P2|STARTED|Overall Study||21
8251769|NCT01855243|20348414|P1|STARTED|Overall Study||20
8251770|NCT01855126|20348436|P2|NOT COMPLETED|Second Intervention (8 Weeks)||2
8251771|NCT01855126|20348437|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
8251772|NCT01855126|20348436|P2|COMPLETED|Second Intervention (8 Weeks)||14
8251773|NCT01855126|20348437|P1|COMPLETED|Second Intervention (8 Weeks)||18
8251774|NCT01855126|20348436|P2|STARTED|Second Intervention (8 Weeks)||16
8251775|NCT01855126|20348437|P1|STARTED|Second Intervention (8 Weeks)||20
8251776|NCT01855126|20348436|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8251777|NCT01855126|20348437|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8251778|NCT01855126|20348436|P2|COMPLETED|Washout Period (2 Weeks)||16
8251779|NCT01855126|20348437|P1|COMPLETED|Washout Period (2 Weeks)||20
8251780|NCT01855126|20348436|P2|STARTED|Washout Period (2 Weeks)||16
8251781|NCT01855126|20348437|P1|STARTED|Washout Period (2 Weeks)||20
8251782|NCT01855126|20348436|P2|NOT COMPLETED|First Intervention (8 Weeks)||6
8251783|NCT01855126|20348437|P1|NOT COMPLETED|First Intervention (8 Weeks)||4
8251784|NCT01855126|20348436|P2|COMPLETED|First Intervention (8 Weeks)||16
8251785|NCT01855126|20348437|P1|COMPLETED|First Intervention (8 Weeks)||20
8251786|NCT01855126|20348436|P2|STARTED|First Intervention (8 Weeks)||22
8251787|NCT01855126|20348437|P1|STARTED|First Intervention (8 Weeks)||24
8251788|NCT01855074|20348449|P1|NOT COMPLETED|Overall Study||14
8251789|NCT01855074|20348449|P1|COMPLETED|Overall Study||66
8251790|NCT01855074|20348449|P1|Treated|Overall Study||79
8251791|NCT01855074|20348449|P1|STARTED|Overall Study||80
8251792|NCT01854944|20348461|P3|NOT COMPLETED|Overall Study||1
8251793|NCT01854944|20348462|P2|NOT COMPLETED|Overall Study||0
8251794|NCT01854944|20348463|P1|NOT COMPLETED|Overall Study||0
8251795|NCT01854944|20348461|P3|COMPLETED|Overall Study||3
8251796|NCT01854944|20348462|P2|COMPLETED|Overall Study||4
8251797|NCT01854944|20348463|P1|COMPLETED|Overall Study||4
8251798|NCT01854944|20348461|P3|STARTED|Overall Study||4
8251799|NCT01854944|20348462|P2|STARTED|Overall Study||4
8251800|NCT01854944|20348463|P1|STARTED|Overall Study||4
8251801|NCT01854918|20348515|P2|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
8251802|NCT01854918|20348516|P1|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
8251803|NCT01854918|20348515|P2|COMPLETED|All-IP Period (Years 2 and 3)||2196
8251804|NCT01854918|20348516|P1|COMPLETED|All-IP Period (Years 2 and 3)||1079
8251805|NCT01854918|20348515|P2|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
8251806|NCT01854918|20348516|P1|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
8251807|NCT01854918|20348515|P2|STARTED|All-IP Period (Years 2 and 3)||2391
8251808|NCT01854918|20348516|P1|STARTED|All-IP Period (Years 2 and 3)||1197
8251809|NCT01854918|20348515|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||63
8251810|NCT01854918|20348516|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||30
8251811|NCT01854918|20348515|P2|COMPLETED|SOC-controlled Period (Year 1)||2391
8251812|NCT01854918|20348516|P1|COMPLETED|SOC-controlled Period (Year 1)||1197
8251813|NCT01854918|20348515|P2|Received Evolocumab|SOC-controlled Period (Year 1)||2452
8251814|NCT01854918|20348516|P1|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
8251815|NCT01854918|20348515|P2|STARTED|SOC-controlled Period (Year 1)||2454
8251816|NCT01854918|20348516|P1|STARTED|SOC-controlled Period (Year 1)||1227
8251817|NCT01854905|20348531|P1|NOT COMPLETED|Overall Study||0
8251818|NCT01854905|20348531|P1|COMPLETED|Overall Study||400
8251819|NCT01854905|20348531|P1|STARTED|Overall Study||400
8251820|NCT01854879|20348535|P1|NOT COMPLETED|Overall Study||5
8251821|NCT01854879|20348535|P1|COMPLETED|Overall Study|92 had matched endpoint data|92
8251822|NCT01854879|20348535|P1|STARTED|Overall Study|97 consented|97
8251823|NCT01854827|20348539|P1|NOT COMPLETED|Overall Study||1
8251824|NCT01854827|20348539|P1|COMPLETED|Overall Study||29
8251825|NCT01854827|20348539|P1|STARTED|Overall Study||30
8251826|NCT01854710|20348551|P6|NOT COMPLETED|Overall Study||2
8251827|NCT01854710|20348552|P5|NOT COMPLETED|Overall Study||2
8251828|NCT01854710|20348553|P4|NOT COMPLETED|Overall Study||2
8251829|NCT01854710|20348554|P3|NOT COMPLETED|Overall Study||2
8251830|NCT01854710|20348555|P2|NOT COMPLETED|Overall Study||3
8251831|NCT01854710|20348556|P1|NOT COMPLETED|Overall Study||4
8251832|NCT01854710|20348551|P6|COMPLETED|Overall Study||8
8251833|NCT01854710|20348552|P5|COMPLETED|Overall Study||8
8251834|NCT01854710|20348553|P4|COMPLETED|Overall Study||8
8251835|NCT01854710|20348554|P3|COMPLETED|Overall Study||8
8251836|NCT01854710|20348555|P2|COMPLETED|Overall Study||7
8251837|NCT01854710|20348556|P1|COMPLETED|Overall Study||6
8251838|NCT01854710|20348551|P6|STARTED|Overall Study||10
8251839|NCT01854710|20348552|P5|STARTED|Overall Study||10
8251840|NCT01854710|20348553|P4|STARTED|Overall Study||10
8251841|NCT01854710|20348554|P3|STARTED|Overall Study||10
8251842|NCT01854710|20348555|P2|STARTED|Overall Study||10
8251843|NCT01854710|20348556|P1|STARTED|Overall Study||10
8251844|NCT01854697|20348577|P5|NOT COMPLETED|Overall Study||2
8251845|NCT01854697|20348578|P4|NOT COMPLETED|Overall Study||3
8251846|NCT01854697|20348579|P3|NOT COMPLETED|Overall Study||2
8251847|NCT01854697|20348580|P2|NOT COMPLETED|Overall Study||3
8251848|NCT01854697|20348581|P1|NOT COMPLETED|Overall Study||6
8251849|NCT01854697|20348577|P5|COMPLETED|Overall Study||39
8251850|NCT01854697|20348578|P4|COMPLETED|Overall Study||80
8251851|NCT01854697|20348579|P3|COMPLETED|Overall Study||82
8251852|NCT01854697|20348580|P2|COMPLETED|Overall Study||31
8251853|NCT01854697|20348581|P1|COMPLETED|Overall Study||63
8251854|NCT01854697|20348577|P5|STARTED|Overall Study||41
8251855|NCT01854697|20348578|P4|STARTED|Overall Study||83
8251856|NCT01854697|20348579|P3|STARTED|Overall Study||84
8251857|NCT01854697|20348580|P2|STARTED|Overall Study||34
8251858|NCT01854697|20348581|P1|STARTED|Overall Study||69
8251859|NCT01854658|20348625|P4|NOT COMPLETED|Overall Study||59
8251860|NCT01854658|20348626|P3|NOT COMPLETED|Overall Study||80
8251861|NCT01854658|20348627|P2|NOT COMPLETED|Overall Study||75
8251862|NCT01854658|20348628|P1|NOT COMPLETED|Overall Study||93
8251863|NCT01854658|20348625|P4|COMPLETED|Overall Study||165
8251864|NCT01854658|20348626|P3|COMPLETED|Overall Study||432
8251865|NCT01854658|20348627|P2|COMPLETED|Overall Study||365
8251866|NCT01854658|20348628|P1|COMPLETED|Overall Study||346
8251867|NCT01854658|20348625|P4|STARTED|Overall Study||224
8251868|NCT01854658|20348626|P3|STARTED|Overall Study||512
8251869|NCT01854658|20348627|P2|STARTED|Overall Study||440
8251870|NCT01854658|20348628|P1|STARTED|Overall Study||439
8251871|NCT01854645|20348663|P5|NOT COMPLETED|Overall Study||60
8251872|NCT01854645|20348664|P4|NOT COMPLETED|Overall Study||62
8251873|NCT01854645|20348665|P3|NOT COMPLETED|Overall Study||82
8251874|NCT01854645|20348666|P2|NOT COMPLETED|Overall Study||106
8251875|NCT01854645|20348667|P1|NOT COMPLETED|Overall Study||98
8251876|NCT01854645|20348663|P5|COMPLETED|Overall Study||160
8251877|NCT01854645|20348664|P4|COMPLETED|Overall Study||391
8251878|NCT01854645|20348665|P3|COMPLETED|Overall Study||370
8251879|NCT01854645|20348666|P2|COMPLETED|Overall Study||345
8251880|NCT01854645|20348667|P1|COMPLETED|Overall Study||429
8251881|NCT01854645|20348663|P5|STARTED|Overall Study||220
8251882|NCT01854645|20348664|P4|STARTED|Overall Study||453
8251883|NCT01854645|20348665|P3|STARTED|Overall Study||452
8251884|NCT01854645|20348666|P2|STARTED|Overall Study||451
8251885|NCT01854645|20348667|P1|STARTED|Overall Study||527
8251886|NCT01854632|20348706|P2|NOT COMPLETED|Overall Study||13
8251887|NCT01854632|20348707|P1|NOT COMPLETED|Overall Study||26
8251888|NCT01854632|20348706|P2|COMPLETED|Overall Study||574
8251889|NCT01854632|20348707|P1|COMPLETED|Overall Study||1148
8251890|NCT01854632|20348706|P2|STARTED|Overall Study||587
8251891|NCT01854632|20348707|P1|STARTED|Overall Study||1174
8251892|NCT01854593|20348715|P2|NOT COMPLETED|Overall Study||1
8251893|NCT01854593|20348716|P1|NOT COMPLETED|Overall Study||2
8251894|NCT01854593|20348715|P2|COMPLETED|Overall Study||34
8251895|NCT01854593|20348716|P1|COMPLETED|Overall Study||32
8251896|NCT01854593|20348715|P2|STARTED|Overall Study||35
8251897|NCT01854593|20348716|P1|STARTED|Overall Study||34
8251898|NCT01854528|20348748|P2|NOT COMPLETED|Overall Study||15
8251899|NCT01854528|20348749|P1|NOT COMPLETED|Overall Study||0
8251900|NCT01854528|20348748|P2|COMPLETED|Overall Study||32
8251901|NCT01854528|20348749|P1|COMPLETED|Overall Study||101
8251902|NCT01854528|20348748|P2|STARTED|Overall Study||47
8251903|NCT01854528|20348749|P1|STARTED|Overall Study||101
8251904|NCT01854281|20348769|P4|NOT COMPLETED|Overall Study||0
8251905|NCT01854281|20348770|P3|NOT COMPLETED|Overall Study||0
8251906|NCT01854281|20348771|P2|NOT COMPLETED|Overall Study||0
8251907|NCT01854281|20348772|P1|NOT COMPLETED|Overall Study||0
8251908|NCT01854281|20348769|P4|COMPLETED|Overall Study||8
8251909|NCT01854281|20348770|P3|COMPLETED|Overall Study||5
8251910|NCT01854281|20348771|P2|COMPLETED|Overall Study||19
8251911|NCT01854281|20348772|P1|COMPLETED|Overall Study||15
8251912|NCT01854281|20348769|P4|STARTED|Overall Study||8
8251913|NCT01854281|20348770|P3|STARTED|Overall Study||5
8251914|NCT01854281|20348771|P2|STARTED|Overall Study||19
8251915|NCT01854281|20348772|P1|STARTED|Overall Study||15
8251916|NCT01854268|20348782|P1|NOT COMPLETED|Overall Study||0
8251917|NCT01854268|20348782|P1|COMPLETED|Overall Study||25
8251918|NCT01854268|20348782|P1|STARTED|Overall Study||25
8251919|NCT01854242|20348788|P1|NOT COMPLETED|Overall Study||0
8251920|NCT01854242|20348788|P1|COMPLETED|Overall Study||50
8251921|NCT01854242|20348788|P1|STARTED|Overall Study||50
8251922|NCT01854177|20348792|P1|NOT COMPLETED|Overall Study||0
8251923|NCT01854177|20348792|P1|COMPLETED|Overall Study||10
8251924|NCT01854177|20348792|P1|STARTED|Overall Study||10
8251925|NCT01854138|20348802|P2|NOT COMPLETED|Overall Study||52
8251926|NCT01854138|20348803|P1|NOT COMPLETED|Overall Study||0
8251927|NCT01854138|20348802|P2|COMPLETED|Overall Study||196
8251928|NCT01854138|20348803|P1|COMPLETED|Overall Study||400
8251929|NCT01854138|20348802|P2|STARTED|Overall Study||248
8251930|NCT01854138|20348803|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
8251931|NCT01854047|20348820|P5|NOT COMPLETED|Overall Study||19
8251932|NCT01854047|20348821|P4|NOT COMPLETED|Overall Study||15
8251933|NCT01854047|20348822|P3|NOT COMPLETED|Overall Study||13
8251934|NCT01854047|20348823|P2|NOT COMPLETED|Overall Study||8
8251935|NCT01854047|20348824|P1|NOT COMPLETED|Overall Study||12
8251936|NCT01854047|20348820|P5|COMPLETED|Overall Study||135
8251937|NCT01854047|20348821|P4|COMPLETED|Overall Study||142
8251938|NCT01854047|20348822|P3|COMPLETED|Overall Study||137
8251939|NCT01854047|20348823|P2|COMPLETED|Overall Study||149
8251940|NCT01854047|20348824|P1|COMPLETED|Overall Study||146
8251941|NCT01854047|20348820|P5|Completed 12-week Study Treatment|Overall Study||143
8251942|NCT01854047|20348821|P4|Completed 12-week Study Treatment|Overall Study||146
8251943|NCT01854047|20348822|P3|Completed 12-week Study Treatment|Overall Study||141
8251944|NCT01854047|20348823|P2|Completed 12-week Study Treatment|Overall Study||149
8251945|NCT01854047|20348824|P1|Completed 12-week Study Treatment|Overall Study||153
8251946|NCT01854047|20348820|P5|Treated|Overall Study||150
8251947|NCT01854047|20348821|P4|Treated|Overall Study||157
8251948|NCT01854047|20348822|P3|Treated|Overall Study||148
8251949|NCT01854047|20348823|P2|Treated|Overall Study||156
8251950|NCT01854047|20348824|P1|Treated|Overall Study||158
8251951|NCT01854047|20348820|P5|STARTED|Overall Study||154
8251952|NCT01854047|20348821|P4|STARTED|Overall Study||157
8251953|NCT01854047|20348822|P3|STARTED|Overall Study||150
8251954|NCT01854047|20348823|P2|STARTED|Overall Study||157
8251955|NCT01854047|20348824|P1|STARTED|Overall Study||158
8251956|NCT01854034|20348946|P1|NOT COMPLETED|Overall Study||0
8251957|NCT01854034|20348946|P1|COMPLETED|Overall Study||29
8251958|NCT01854034|20348946|P1|STARTED|Overall Study||29
8251959|NCT01853982|20348955|P2|NOT COMPLETED|Overall Study||1
8251960|NCT01853982|20348956|P1|NOT COMPLETED|Overall Study||2
8251961|NCT01853982|20348955|P2|COMPLETED|Overall Study||1
8251962|NCT01853982|20348956|P1|COMPLETED|Overall Study||0
8251963|NCT01853982|20348955|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8251964|NCT01853982|20348956|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8251965|NCT01853982|20348955|P2|STARTED|Overall Study||2
8251966|NCT01853982|20348956|P1|STARTED|Overall Study||2
8251967|NCT01853930|20348964|P2|NOT COMPLETED|Overall Study||0
8251968|NCT01853930|20348965|P1|NOT COMPLETED|Overall Study||0
8251969|NCT01853930|20348964|P2|COMPLETED|Overall Study||8
8251970|NCT01853930|20348965|P1|COMPLETED|Overall Study||25
8251971|NCT01853930|20348964|P2|STARTED|Overall Study||8
8251972|NCT01853930|20348965|P1|STARTED|Overall Study||25
8251973|NCT01853878|20348973|P2|NOT COMPLETED|Overall Study||44
8251974|NCT01853878|20348974|P1|NOT COMPLETED|Overall Study||63
8251975|NCT01853878|20348973|P2|COMPLETED|Overall Study||3
8251976|NCT01853878|20348974|P1|COMPLETED|Overall Study||23
8251977|NCT01853878|20348973|P2|STARTED|Overall Study||47
8251978|NCT01853878|20348974|P1|STARTED|Overall Study||86
8251979|NCT01853839|20348998|P1|NOT COMPLETED|Overall Study||429
8251980|NCT01853839|20348998|P1|COMPLETED|Overall Study||1663
8251981|NCT01853839|20348998|P1|STARTED|Overall Study||2092
8251982|NCT01853774|20349020|P2|NOT COMPLETED|Overall Study||28
8251983|NCT01853774|20349021|P1|NOT COMPLETED|Overall Study||46
8251984|NCT01853774|20349020|P2|COMPLETED|Overall Study||134
8251985|NCT01853774|20349021|P1|COMPLETED|Overall Study||211
8251986|NCT01853774|20349020|P2|STARTED|Overall Study||162
8251987|NCT01853774|20349021|P1|STARTED|Overall Study||257
8251988|NCT01853696|20349031|P2|NOT COMPLETED|Overall Study||5
8251989|NCT01853696|20349032|P1|NOT COMPLETED|Overall Study||6
8251990|NCT01853696|20349031|P2|COMPLETED|Overall Study||78
8251991|NCT01853696|20349032|P1|COMPLETED|Overall Study||78
8251992|NCT01853696|20349031|P2|STARTED|Overall Study||83
8251993|NCT01853696|20349032|P1|STARTED|Overall Study||84
8251994|NCT01853644|20349040|P1|NOT COMPLETED|Follow up for 3 Years or Until Death||3
8251995|NCT01853644|20349040|P1|COMPLETED|Follow up for 3 Years or Until Death||26
8251996|NCT01853644|20349040|P1|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|29
8251997|NCT01853644|20349040|P1|NOT COMPLETED|Continued Treatment After First Response||12
8251998|NCT01853644|20349040|P1|COMPLETED|Continued Treatment After First Response||12
8251999|NCT01853644|20349040|P1|STARTED|Continued Treatment After First Response||24
8252000|NCT01853644|20349040|P1|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
8252001|NCT01853644|20349040|P1|COMPLETED|Reached First Response/Complete 2 Cycles||24
8252002|NCT01853644|20349040|P1|STARTED|Reached First Response/Complete 2 Cycles||30
8252003|NCT01853644|20349040|P1|NOT COMPLETED|Registration and Treatment Start||1
8252004|NCT01853644|20349040|P1|COMPLETED|Registration and Treatment Start||30
8252005|NCT01853644|20349040|P1|Started Treatment|Registration and Treatment Start||30
8252006|NCT01853644|20349040|P1|Registered|Registration and Treatment Start||31
8252007|NCT01853644|20349040|P1|STARTED|Registration and Treatment Start||31
8252008|NCT01853618|20349054|P5|NOT COMPLETED|Overall Study||3
8252009|NCT01853618|20349055|P4|NOT COMPLETED|Overall Study||1
8252010|NCT01853618|20349056|P3|NOT COMPLETED|Overall Study||2
8252011|NCT01853618|20349057|P2|NOT COMPLETED|Overall Study||2
8252012|NCT01853618|20349058|P1|NOT COMPLETED|Overall Study||2
8252013|NCT01853618|20349054|P5|COMPLETED|Overall Study||17
8252014|NCT01853618|20349055|P4|COMPLETED|Overall Study||8
8252015|NCT01853618|20349056|P3|COMPLETED|Overall Study||10
8252016|NCT01853618|20349057|P2|COMPLETED|Overall Study||10
8252017|NCT01853618|20349058|P1|COMPLETED|Overall Study||6
8252018|NCT01853618|20349054|P5|STARTED|Overall Study||20
8252019|NCT01853618|20349055|P4|STARTED|Overall Study||9
8252020|NCT01853618|20349056|P3|STARTED|Overall Study||12
8252021|NCT01853618|20349057|P2|STARTED|Overall Study||12
8252022|NCT01853618|20349058|P1|STARTED|Overall Study||8
8252023|NCT01853605|20349089|P4|NOT COMPLETED|Overall Study||0
8252024|NCT01853605|20349090|P3|NOT COMPLETED|Overall Study||0
8252025|NCT01853605|20349091|P2|NOT COMPLETED|Overall Study||0
8252026|NCT01853605|20349092|P1|NOT COMPLETED|Overall Study||0
8252027|NCT01853605|20349089|P4|COMPLETED|Overall Study||428
8252028|NCT01853605|20349090|P3|COMPLETED|Overall Study||751
8252029|NCT01853605|20349091|P2|COMPLETED|Overall Study||693
8252030|NCT01853605|20349092|P1|COMPLETED|Overall Study||1939
8252031|NCT01853605|20349089|P4|STARTED|Overall Study||428
8252032|NCT01853605|20349090|P3|STARTED|Overall Study||751
8252033|NCT01853605|20349091|P2|STARTED|Overall Study||693
8252034|NCT01853605|20349092|P1|STARTED|Overall Study||1939
8252035|NCT01853553|20349112|P2|NOT COMPLETED|Overall Study||0
8252036|NCT01853553|20349113|P1|NOT COMPLETED|Overall Study||1
8252037|NCT01853553|20349112|P2|COMPLETED|Overall Study||32
8252038|NCT01853553|20349113|P1|COMPLETED|Overall Study||28
8252039|NCT01853553|20349112|P2|STARTED|Overall Study||32
8252040|NCT01853553|20349113|P1|STARTED|Overall Study||29
8252041|NCT01853475|20349124|P3|NOT COMPLETED|Overall Study||0
8252042|NCT01853475|20349125|P2|NOT COMPLETED|Overall Study||1
8252043|NCT01853475|20349126|P1|NOT COMPLETED|Overall Study||0
8252044|NCT01853475|20349124|P3|COMPLETED|Overall Study||8
8252045|NCT01853475|20349125|P2|COMPLETED|Overall Study||7
8252046|NCT01853475|20349126|P1|COMPLETED|Overall Study||8
8252047|NCT01853475|20349124|P3|STARTED|Overall Study||8
8252048|NCT01853475|20349125|P2|STARTED|Overall Study||8
8252049|NCT01853475|20349126|P1|STARTED|Overall Study||8
8252050|NCT01853462|20349145|P2|NOT COMPLETED|Overall Study||1
8252051|NCT01853462|20349146|P1|NOT COMPLETED|Overall Study||1
8252052|NCT01853462|20349145|P2|COMPLETED|Overall Study||10
8252053|NCT01853462|20349146|P1|COMPLETED|Overall Study||10
8252054|NCT01853462|20349145|P2|STARTED|Overall Study||11
8252055|NCT01853462|20349146|P1|STARTED|Overall Study||11
8252056|NCT01853397|20349216|P4|NOT COMPLETED|Overall Study||2
8252057|NCT01853397|20349217|P3|NOT COMPLETED|Overall Study||0
8252058|NCT01853397|20349218|P2|NOT COMPLETED|Overall Study||0
8252059|NCT01853397|20349219|P1|NOT COMPLETED|Overall Study||0
8252060|NCT01853397|20349216|P4|COMPLETED|Overall Study||15
8252061|NCT01853397|20349217|P3|COMPLETED|Overall Study||17
8252062|NCT01853397|20349218|P2|COMPLETED|Overall Study||20
8252063|NCT01853397|20349219|P1|COMPLETED|Overall Study||18
8252064|NCT01853397|20349216|P4|STARTED|Overall Study||17
8252065|NCT01853397|20349217|P3|STARTED|Overall Study||17
8252066|NCT01853397|20349218|P2|STARTED|Overall Study||20
8252067|NCT01853397|20349219|P1|STARTED|Overall Study||18
8252068|NCT01853384|20349247|P2|NOT COMPLETED|Completed Follow up Visit 2||3
8252069|NCT01853384|20349248|P1|NOT COMPLETED|Completed Follow up Visit 2||3
8252070|NCT01853384|20349247|P2|COMPLETED|Completed Follow up Visit 2||91
8252071|NCT01853384|20349248|P1|COMPLETED|Completed Follow up Visit 2||93
8252072|NCT01853384|20349247|P2|STARTED|Completed Follow up Visit 2||94
8252073|NCT01853384|20349248|P1|STARTED|Completed Follow up Visit 2||96
8252074|NCT01853384|20349247|P2|NOT COMPLETED|Completed Follow up Visit 1||9
8252075|NCT01853384|20349248|P1|NOT COMPLETED|Completed Follow up Visit 1||14
8252076|NCT01853384|20349247|P2|COMPLETED|Completed Follow up Visit 1||85
8252077|NCT01853384|20349248|P1|COMPLETED|Completed Follow up Visit 1||82
8252078|NCT01853384|20349247|P2|STARTED|Completed Follow up Visit 1||94
8252079|NCT01853384|20349248|P1|STARTED|Completed Follow up Visit 1||96
8252080|NCT01853384|20349247|P2|NOT COMPLETED|Enrolled in Follow up Period||0
8252081|NCT01853384|20349248|P1|NOT COMPLETED|Enrolled in Follow up Period||0
8252082|NCT01853384|20349247|P2|COMPLETED|Enrolled in Follow up Period||94
8252083|NCT01853384|20349248|P1|COMPLETED|Enrolled in Follow up Period||96
8252178|NCT01852825|20349547|P2|COMPLETED|Overall Study||7
8252084|NCT01853384|20349247|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
8252085|NCT01853384|20349248|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
8252086|NCT01853384|20349247|P2|STARTED|Enrolled in Follow up Period||94
8252087|NCT01853384|20349248|P1|STARTED|Enrolled in Follow up Period||96
8252088|NCT01853384|20349247|P2|NOT COMPLETED|Randomized||46
8252089|NCT01853384|20349248|P1|NOT COMPLETED|Randomized||62
8252090|NCT01853384|20349247|P2|COMPLETED|Randomized||75
8252091|NCT01853384|20349248|P1|COMPLETED|Randomized||69
8252092|NCT01853384|20349247|P2|STARTED|Randomized||121
8252093|NCT01853384|20349248|P1|STARTED|Randomized||131
8252094|NCT01853371|20349268|P2|NOT COMPLETED|Overall Study||2
8252095|NCT01853371|20349269|P1|NOT COMPLETED|Overall Study||0
8252096|NCT01853371|20349268|P2|COMPLETED|Overall Study||8
8252097|NCT01853371|20349269|P1|COMPLETED|Overall Study||10
8252098|NCT01853371|20349268|P2|STARTED|Overall Study||10
8252099|NCT01853371|20349269|P1|STARTED|Overall Study||10
8252100|NCT01853332|20349277|P1|NOT COMPLETED|Overall Study||59
8252101|NCT01853332|20349277|P1|COMPLETED|Overall Study||151
8252102|NCT01853332|20349277|P1|STARTED|Overall Study||210
8252103|NCT01853280|20349288|P2|NOT COMPLETED|Overall Study||6
8252104|NCT01853280|20349289|P1|NOT COMPLETED|Overall Study||2
8252105|NCT01853280|20349288|P2|COMPLETED|Overall Study||16
8252106|NCT01853280|20349289|P1|COMPLETED|Overall Study||20
8252107|NCT01853280|20349288|P2|STARTED|Overall Study||22
8252108|NCT01853280|20349289|P1|STARTED|Overall Study||22
8252109|NCT01853254|20349295|P1|NOT COMPLETED|Overall Study||104
8252110|NCT01853254|20349295|P1|COMPLETED|Overall Study||168
8252111|NCT01853254|20349295|P1|STARTED|Overall Study||272
8252112|NCT01853228|20349299|P2|NOT COMPLETED|Phase 2||8
8252113|NCT01853228|20349300|P1|NOT COMPLETED|Phase 2||0
8252114|NCT01853228|20349299|P2|COMPLETED|Phase 2||0
8252115|NCT01853228|20349300|P1|COMPLETED|Phase 2||0
8252116|NCT01853228|20349299|P2|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
8252117|NCT01853228|20349300|P1|STARTED|Phase 2||0
8252118|NCT01853228|20349299|P2|NOT COMPLETED|Phase 1||0
8252119|NCT01853228|20349300|P1|NOT COMPLETED|Phase 1||9
8252120|NCT01853228|20349299|P2|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
8252121|NCT01853228|20349300|P1|COMPLETED|Phase 1||0
8252122|NCT01853228|20349299|P2|STARTED|Phase 1||7
8252123|NCT01853228|20349300|P1|STARTED|Phase 1||9
8252124|NCT01853215|20349317|P1|NOT COMPLETED|Overall Study||0
8252125|NCT01853215|20349317|P1|COMPLETED|Overall Study||24
8252126|NCT01853215|20349317|P1|STARTED|Overall Study||24
8252127|NCT01853176|20349330|P2|NOT COMPLETED|Overall Study||0
8252128|NCT01853176|20349331|P1|NOT COMPLETED|Overall Study||4
8252129|NCT01853176|20349330|P2|COMPLETED|Overall Study||0
8252130|NCT01853176|20349331|P1|COMPLETED|Overall Study||0
8252131|NCT01853176|20349330|P2|STARTED|Overall Study||0
8252132|NCT01853176|20349331|P1|STARTED|Overall Study||4
8252133|NCT01853137|20349339|P2|NOT COMPLETED|Overall Study||1
8252134|NCT01853137|20349340|P1|NOT COMPLETED|Overall Study||4
8252135|NCT01853137|20349339|P2|COMPLETED|Overall Study||17
8252136|NCT01853137|20349340|P1|COMPLETED|Overall Study||21
8252137|NCT01853137|20349339|P2|STARTED|Overall Study||18
8252138|NCT01853137|20349340|P1|STARTED|Overall Study||25
8252139|NCT01853085|20349348|P1|NOT COMPLETED|Overall Study||235
8252140|NCT01853085|20349348|P1|COMPLETED|Overall Study||1595
8252141|NCT01853085|20349348|P1|STARTED|Overall Study||1830
8252142|NCT01853072|20349361|P2|NOT COMPLETED|Overall Study||21
8252143|NCT01853072|20349362|P1|NOT COMPLETED|Overall Study||12
8252144|NCT01853072|20349361|P2|COMPLETED|Overall Study||286
8252145|NCT01853072|20349362|P1|COMPLETED|Overall Study||296
8252146|NCT01853072|20349361|P2|Full Analysis Set|Overall Study||300
8252147|NCT01853072|20349362|P1|Full Analysis Set|Overall Study||298
8252148|NCT01853072|20349361|P2|Treated (Safety Analysis Set)|Overall Study||302
8252149|NCT01853072|20349362|P1|Treated (Safety Analysis Set)|Overall Study||301
8252150|NCT01853072|20349361|P2|Randomized|Overall Study||307
8252151|NCT01853072|20349362|P1|Randomized|Overall Study||308
8252152|NCT01853072|20349361|P2|STARTED|Overall Study||307
8252153|NCT01853072|20349362|P1|STARTED|Overall Study||308
8252154|NCT01853046|20349382|P2|NOT COMPLETED|Overall Study||6
8252155|NCT01853046|20349383|P1|NOT COMPLETED|Overall Study||18
8252156|NCT01853046|20349382|P2|COMPLETED|Overall Study||0
8252157|NCT01853046|20349383|P1|COMPLETED|Overall Study||0
8252158|NCT01853046|20349382|P2|Received Treatment|Overall Study||6
8252159|NCT01853046|20349383|P1|Received Treatment|Overall Study||18
8252160|NCT01853046|20349382|P2|STARTED|Overall Study||6
8252161|NCT01853046|20349383|P1|STARTED|Overall Study||18
8252162|NCT01852955|20349437|P2|NOT COMPLETED|Overall Study||3
8252163|NCT01852955|20349438|P1|NOT COMPLETED|Overall Study||2
8252164|NCT01852955|20349437|P2|COMPLETED|Overall Study||32
8252165|NCT01852955|20349438|P1|COMPLETED|Overall Study||33
8252166|NCT01852955|20349437|P2|STARTED|Overall Study||35
8252167|NCT01852955|20349438|P1|STARTED|Overall Study||35
8252168|NCT01852942|20349450|P2|NOT COMPLETED|Overall Study||6
8252169|NCT01852942|20349451|P1|NOT COMPLETED|Overall Study||5
8252170|NCT01852942|20349450|P2|COMPLETED|Overall Study||21
8252171|NCT01852942|20349451|P1|COMPLETED|Overall Study||20
8252172|NCT01852942|20349450|P2|STARTED|Overall Study||27
8252173|NCT01852942|20349451|P1|STARTED|Overall Study||25
8252174|NCT01852825|20349546|P3|NOT COMPLETED|Overall Study||0
8252175|NCT01852825|20349547|P2|NOT COMPLETED|Overall Study||0
8252176|NCT01852825|20349548|P1|NOT COMPLETED|Overall Study||2
8252177|NCT01852825|20349546|P3|COMPLETED|Overall Study||3
8252179|NCT01852825|20349548|P1|COMPLETED|Overall Study||14
8252180|NCT01852825|20349546|P3|STARTED|Overall Study||3
8252181|NCT01852825|20349547|P2|STARTED|Overall Study||7
8252182|NCT01852825|20349548|P1|STARTED|Overall Study||16
8252183|NCT01852812|20349574|P3|NOT COMPLETED|Overall Study||1
8252184|NCT01852812|20349575|P2|NOT COMPLETED|Overall Study||1
8252185|NCT01852812|20349576|P1|NOT COMPLETED|Overall Study||0
8252186|NCT01852812|20349574|P3|COMPLETED|Overall Study||17
8252187|NCT01852812|20349575|P2|COMPLETED|Overall Study||17
8252188|NCT01852812|20349576|P1|COMPLETED|Overall Study||51
8252189|NCT01852812|20349574|P3|STARTED|Overall Study||18
8252190|NCT01852812|20349575|P2|STARTED|Overall Study||18
8252191|NCT01852812|20349576|P1|STARTED|Overall Study||51
8252192|NCT01852799|20349596|P1|NOT COMPLETED|Overall Study||18
8252193|NCT01852799|20349596|P1|COMPLETED|Overall Study||0
8252194|NCT01852799|20349596|P1|STARTED|Overall Study||18
8252195|NCT01852669|20349607|P2|NOT COMPLETED|Overall Study||1
8252196|NCT01852669|20349608|P1|NOT COMPLETED|Overall Study||0
8252197|NCT01852669|20349607|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
8252198|NCT01852669|20349608|P1|COMPLETED|Overall Study||71
8252199|NCT01852669|20349607|P2|STARTED|Overall Study||69
8252200|NCT01852669|20349608|P1|STARTED|Overall Study||71
8252201|NCT01852591|20349614|P1|NOT COMPLETED|Overall Study||3
8252202|NCT01852591|20349614|P1|COMPLETED|Overall Study||5
8252203|NCT01852591|20349614|P1|STARTED|Overall Study||8
8252204|NCT01852513|20349623|P2|NOT COMPLETED|Overall Study||0
8252205|NCT01852513|20349624|P1|NOT COMPLETED|Overall Study||0
8252206|NCT01852513|20349623|P2|COMPLETED|Overall Study||19
8252207|NCT01852513|20349624|P1|COMPLETED|Overall Study||20
8252208|NCT01852513|20349623|P2|STARTED|Overall Study||19
8252209|NCT01852513|20349624|P1|STARTED|Overall Study||20
8252210|NCT01852383|20349634|P1|NOT COMPLETED|Overall Study||11
8252211|NCT01852383|20349634|P1|COMPLETED|Overall Study||19
8252212|NCT01852383|20349634|P1|STARTED|Overall Study||30
8252213|NCT01852344|20349645|P4|NOT COMPLETED|Overall Study||0
8252214|NCT01852344|20349646|P3|NOT COMPLETED|Overall Study||0
8252215|NCT01852344|20349647|P2|NOT COMPLETED|Overall Study||0
8252216|NCT01852344|20349648|P1|NOT COMPLETED|Overall Study||0
8252217|NCT01852344|20349645|P4|COMPLETED|Overall Study||27
8252218|NCT01852344|20349646|P3|COMPLETED|Overall Study||27
8252219|NCT01852344|20349647|P2|COMPLETED|Overall Study||27
8252220|NCT01852344|20349648|P1|COMPLETED|Overall Study||27
8252221|NCT01852344|20349645|P4|Actual Participation in First Assignment|Overall Study||27
8252222|NCT01852344|20349646|P3|Actual Participation in First Assignment|Overall Study||27
8252223|NCT01852344|20349647|P2|Actual Participation in First Assignment|Overall Study||27
8252224|NCT01852344|20349648|P1|Actual Participation in First Assignment|Overall Study||27
8252225|NCT01852344|20349645|P4|STARTED|Overall Study||27
8252226|NCT01852344|20349646|P3|STARTED|Overall Study||27
8252227|NCT01852344|20349647|P2|STARTED|Overall Study||27
8252228|NCT01852344|20349648|P1|STARTED|Overall Study||27
8252229|NCT01852292|20349668|P2|NOT COMPLETED|Overall Study||79
8252230|NCT01852292|20349669|P1|NOT COMPLETED|Overall Study||79
8252231|NCT01852292|20349668|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
8252232|NCT01852292|20349669|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
8252233|NCT01852292|20349668|P2|STARTED|Overall Study||79
8252234|NCT01852292|20349669|P1|STARTED|Overall Study||79
8252235|NCT01852214|20349693|P2|NOT COMPLETED|Period 2||0
8252236|NCT01852214|20349694|P1|NOT COMPLETED|Period 2||0
8252237|NCT01852214|20349693|P2|COMPLETED|Period 2||20
8252238|NCT01852214|20349694|P1|COMPLETED|Period 2||25
8252239|NCT01852214|20349693|P2|STARTED|Period 2||20
8252240|NCT01852214|20349694|P1|STARTED|Period 2||25
8252241|NCT01852214|20349693|P2|NOT COMPLETED|Washout Period||1
8252242|NCT01852214|20349694|P1|NOT COMPLETED|Washout Period||0
8252243|NCT01852214|20349693|P2|COMPLETED|Washout Period||20
8252244|NCT01852214|20349694|P1|COMPLETED|Washout Period||25
8252245|NCT01852214|20349693|P2|STARTED|Washout Period||21
8252246|NCT01852214|20349694|P1|STARTED|Washout Period||25
8252247|NCT01852214|20349693|P2|NOT COMPLETED|Period 1||3
8252248|NCT01852214|20349694|P1|NOT COMPLETED|Period 1||1
8252249|NCT01852214|20349693|P2|COMPLETED|Period 1||21
8252250|NCT01852214|20349694|P1|COMPLETED|Period 1||25
8252251|NCT01852214|20349693|P2|STARTED|Period 1||24
8252252|NCT01852214|20349694|P1|STARTED|Period 1||26
8252253|NCT01852201|20349708|P2|NOT COMPLETED|Overall Study||0
8252254|NCT01852201|20349709|P1|NOT COMPLETED|Overall Study||0
8252255|NCT01852201|20349708|P2|COMPLETED|Overall Study||12
8252256|NCT01852201|20349709|P1|COMPLETED|Overall Study||21
8252257|NCT01852201|20349708|P2|STARTED|Overall Study||12
8252258|NCT01852201|20349709|P1|STARTED|Overall Study||21
8252259|NCT01852175|20349733|P2|NOT COMPLETED|Overall Study||0
8252260|NCT01852175|20349734|P1|NOT COMPLETED|Overall Study||0
8252261|NCT01852175|20349733|P2|COMPLETED|Overall Study||55
8252262|NCT01852175|20349734|P1|COMPLETED|Overall Study||55
8252263|NCT01852175|20349733|P2|STARTED|Overall Study||55
8252264|NCT01852175|20349734|P1|STARTED|Overall Study||55
8252265|NCT01852162|20349746|P2|NOT COMPLETED|Overall Study||1
8252266|NCT01852162|20349747|P1|NOT COMPLETED|Overall Study||4
8252267|NCT01852162|20349746|P2|COMPLETED|Overall Study||16
8252268|NCT01852162|20349747|P1|COMPLETED|Overall Study||14
8252269|NCT01852162|20349746|P2|STARTED|Overall Study||17
8252270|NCT01852162|20349747|P1|STARTED|Overall Study||18
8252271|NCT01852110|20349763|P6|NOT COMPLETED|Overall Study||0
8252272|NCT01852110|20349764|P5|NOT COMPLETED|Overall Study||0
8252273|NCT01852110|20349765|P4|NOT COMPLETED|Overall Study||0
8252274|NCT01852110|20349766|P3|NOT COMPLETED|Overall Study||0
8252275|NCT01852110|20349767|P2|NOT COMPLETED|Overall Study||46
8252276|NCT01852110|20349768|P1|NOT COMPLETED|Overall Study||50
8252277|NCT01852110|20349763|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252278|NCT01852110|20349764|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252279|NCT01852110|20349765|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252280|NCT01852110|20349766|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252281|NCT01852110|20349767|P2|COMPLETED|Overall Study||74
8252282|NCT01852110|20349768|P1|COMPLETED|Overall Study||70
8252283|NCT01852110|20349763|P6|Treated|Overall Study||0
8252284|NCT01852110|20349764|P5|Treated|Overall Study||0
8252285|NCT01852110|20349765|P4|Treated|Overall Study||0
8252286|NCT01852110|20349766|P3|Treated|Overall Study||0
8252287|NCT01852110|20349767|P2|Treated|Overall Study||120
8252288|NCT01852110|20349768|P1|Treated|Overall Study||119
8252289|NCT01852110|20349763|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252290|NCT01852110|20349764|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252291|NCT01852110|20349765|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252292|NCT01852110|20349766|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252293|NCT01852110|20349767|P2|STARTED|Overall Study||120
8252294|NCT01852110|20349768|P1|STARTED|Overall Study||120
8252295|NCT01852084|20349800|P4|NOT COMPLETED|Overall Study||0
8252296|NCT01852084|20349801|P3|NOT COMPLETED|Overall Study||2
8252297|NCT01852084|20349802|P2|NOT COMPLETED|Overall Study||0
8252298|NCT01852084|20349803|P1|NOT COMPLETED|Overall Study||0
8252299|NCT01852084|20349800|P4|COMPLETED|Overall Study||12
8252300|NCT01852084|20349801|P3|COMPLETED|Overall Study||18
8252301|NCT01852084|20349802|P2|COMPLETED|Overall Study||80
8252302|NCT01852084|20349803|P1|COMPLETED|Overall Study||79
8252303|NCT01852084|20349800|P4|STARTED|Overall Study||12
8252304|NCT01852084|20349801|P3|STARTED|Overall Study||20
8252305|NCT01852084|20349802|P2|STARTED|Overall Study||80
8252306|NCT01852084|20349803|P1|STARTED|Overall Study||79
8252307|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252308|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252309|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252310|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252311|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252312|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252313|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252314|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252315|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252316|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252317|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252318|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252319|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
8252320|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
8252321|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
8252322|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252323|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252324|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252325|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252326|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252327|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252328|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252329|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252330|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252331|NCT01852058|20349832|P12|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
8252332|NCT01852058|20349833|P11|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
8252333|NCT01852058|20349834|P10|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
8252334|NCT01852058|20349835|P9|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252335|NCT01852058|20349836|P8|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252336|NCT01852058|20349837|P7|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252337|NCT01852058|20349838|P6|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252338|NCT01852058|20349839|P5|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252339|NCT01852058|20349840|P4|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252340|NCT01852058|20349841|P3|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252341|NCT01852058|20349842|P2|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252342|NCT01852058|20349843|P1|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252343|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252344|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252345|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252346|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
8252347|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
8252511|NCT01851863|20350011|P2|COMPLETED|Overall Study||57
8252348|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252349|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252350|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252351|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252352|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252353|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252354|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252355|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252356|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252357|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252358|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
8252359|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
8252360|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
8252361|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252362|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252363|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252364|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252365|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252366|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252367|NCT01852058|20349832|P12|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252368|NCT01852058|20349833|P11|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252369|NCT01852058|20349834|P10|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252370|NCT01852058|20349835|P9|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
8252371|NCT01852058|20349836|P8|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
8252372|NCT01852058|20349837|P7|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
8252373|NCT01852058|20349838|P6|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252374|NCT01852058|20349839|P5|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252375|NCT01852058|20349840|P4|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252376|NCT01852058|20349841|P3|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252377|NCT01852058|20349842|P2|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252378|NCT01852058|20349843|P1|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252379|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252380|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252381|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252382|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252383|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252384|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252385|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
8252386|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
8252387|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
8252388|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252389|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252390|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252391|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252392|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252393|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252394|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252395|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252396|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252397|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
8252398|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
8252399|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
8252400|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252401|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252402|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252403|NCT01852058|20349832|P12|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252404|NCT01852058|20349833|P11|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252405|NCT01852058|20349834|P10|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252406|NCT01852058|20349835|P9|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252407|NCT01852058|20349836|P8|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252408|NCT01852058|20349837|P7|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252409|NCT01852058|20349838|P6|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
8252410|NCT01852058|20349839|P5|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
8252411|NCT01852058|20349840|P4|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
8252412|NCT01852058|20349841|P3|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252413|NCT01852058|20349842|P2|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252414|NCT01852058|20349843|P1|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252415|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252416|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252417|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252418|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252419|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252420|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252421|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252422|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252423|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252424|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252425|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252426|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
8252427|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252428|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252429|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252430|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252431|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252432|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252433|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252434|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252435|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252436|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
8252437|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
8252438|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
8252439|NCT01852058|20349832|P12|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252440|NCT01852058|20349833|P11|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252441|NCT01852058|20349834|P10|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252442|NCT01852058|20349835|P9|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252443|NCT01852058|20349836|P8|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252444|NCT01852058|20349837|P7|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252445|NCT01852058|20349838|P6|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252446|NCT01852058|20349839|P5|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252447|NCT01852058|20349840|P4|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252448|NCT01852058|20349841|P3|STARTED|Treatment Cycle 1, Occurred in Study 120||25
8252449|NCT01852058|20349842|P2|STARTED|Treatment Cycle 1, Occurred in Study 120||39
8252450|NCT01852058|20349843|P1|STARTED|Treatment Cycle 1, Occurred in Study 120||31
8252451|NCT01852045|20349923|P3|NOT COMPLETED|Overall Study||4
8252452|NCT01852045|20349924|P2|NOT COMPLETED|Overall Study||4
8252453|NCT01852045|20349925|P1|NOT COMPLETED|Overall Study||6
8252454|NCT01852045|20349923|P3|COMPLETED|Overall Study||26
8252455|NCT01852045|20349924|P2|COMPLETED|Overall Study||41
8252456|NCT01852045|20349925|P1|COMPLETED|Overall Study||33
8252457|NCT01852045|20349923|P3|Safety Population|Overall Study||30
8252458|NCT01852045|20349924|P2|Safety Population|Overall Study||45
8252459|NCT01852045|20349925|P1|Safety Population|Overall Study||38
8252460|NCT01852045|20349923|P3|mITT Population|Overall Study||30
8252461|NCT01852045|20349924|P2|mITT Population|Overall Study||45
8252462|NCT01852045|20349925|P1|mITT Population|Overall Study||38
8252463|NCT01852045|20349923|P3|STARTED|Overall Study||30
8252464|NCT01852045|20349924|P2|STARTED|Overall Study||45
8252465|NCT01852045|20349925|P1|STARTED|Overall Study||39
8252466|NCT01852032|20349963|P1|NOT COMPLETED|Overall Study||0
8252467|NCT01852032|20349963|P1|COMPLETED|Overall Study||23
8252468|NCT01852032|20349963|P1|STARTED|Overall Study||23
8252469|NCT01852019|20349973|P5|NOT COMPLETED|Day 8||0
8252470|NCT01852019|20349974|P4|NOT COMPLETED|Day 8||0
8252471|NCT01852019|20349975|P3|NOT COMPLETED|Day 8||0
8252472|NCT01852019|20349976|P2|NOT COMPLETED|Day 8||0
8252473|NCT01852019|20349977|P1|NOT COMPLETED|Day 8||0
8252474|NCT01852019|20349973|P5|COMPLETED|Day 8||6
8252475|NCT01852019|20349974|P4|COMPLETED|Day 8||6
8252476|NCT01852019|20349975|P3|COMPLETED|Day 8||0
8252477|NCT01852019|20349976|P2|COMPLETED|Day 8||0
8252478|NCT01852019|20349977|P1|COMPLETED|Day 8||0
8252479|NCT01852019|20349973|P5|STARTED|Day 8||6
8252480|NCT01852019|20349974|P4|STARTED|Day 8||6
8252481|NCT01852019|20349975|P3|STARTED|Day 8||0
8252482|NCT01852019|20349976|P2|STARTED|Day 8||0
8252483|NCT01852019|20349977|P1|STARTED|Day 8||0
8252484|NCT01852019|20349973|P5|NOT COMPLETED|Day 1||0
8252485|NCT01852019|20349974|P4|NOT COMPLETED|Day 1||0
8252486|NCT01852019|20349975|P3|NOT COMPLETED|Day 1||0
8252487|NCT01852019|20349976|P2|NOT COMPLETED|Day 1||0
8252488|NCT01852019|20349977|P1|NOT COMPLETED|Day 1||0
8252489|NCT01852019|20349973|P5|COMPLETED|Day 1||0
8252490|NCT01852019|20349974|P4|COMPLETED|Day 1||0
8252491|NCT01852019|20349975|P3|COMPLETED|Day 1||6
8252492|NCT01852019|20349976|P2|COMPLETED|Day 1||3
8252493|NCT01852019|20349977|P1|COMPLETED|Day 1||3
8252494|NCT01852019|20349973|P5|STARTED|Day 1||0
8252495|NCT01852019|20349974|P4|STARTED|Day 1||0
8252496|NCT01852019|20349975|P3|STARTED|Day 1||6
8252497|NCT01852019|20349976|P2|STARTED|Day 1||3
8252498|NCT01852019|20349977|P1|STARTED|Day 1||3
8252499|NCT01851876|20349998|P2|NOT COMPLETED|Overall Study||0
8252500|NCT01851876|20349999|P1|NOT COMPLETED|Overall Study||0
8252501|NCT01851876|20349998|P2|COMPLETED|Overall Study||62
8252502|NCT01851876|20349999|P1|COMPLETED|Overall Study||56
8252503|NCT01851876|20349998|P2|STARTED|Overall Study||62
8252504|NCT01851876|20349999|P1|STARTED|Overall Study||56
8252505|NCT01851863|20350009|P4|NOT COMPLETED|Overall Study||3
8252506|NCT01851863|20350010|P3|NOT COMPLETED|Overall Study||5
8252507|NCT01851863|20350011|P2|NOT COMPLETED|Overall Study||9
8252508|NCT01851863|20350012|P1|NOT COMPLETED|Overall Study||5
8252509|NCT01851863|20350009|P4|COMPLETED|Overall Study||63
8252510|NCT01851863|20350010|P3|COMPLETED|Overall Study||60
8252512|NCT01851863|20350012|P1|COMPLETED|Overall Study||60
8252513|NCT01851863|20350009|P4|STARTED|Overall Study||66
8252514|NCT01851863|20350010|P3|STARTED|Overall Study||65
8252515|NCT01851863|20350011|P2|STARTED|Overall Study||66
8252516|NCT01851863|20350012|P1|STARTED|Overall Study||65
8252517|NCT01851772|20350033|P1|NOT COMPLETED|Overall Study||0
8252518|NCT01851772|20350033|P1|COMPLETED|Overall Study||3
8252519|NCT01851772|20350033|P1|STARTED|Overall Study||3
8252520|NCT01851720|20350041|P2|NOT COMPLETED|Overall Study||1
8252521|NCT01851720|20350042|P1|NOT COMPLETED|Overall Study||0
8252522|NCT01851720|20350041|P2|COMPLETED|Overall Study||0
8252523|NCT01851720|20350042|P1|COMPLETED|Overall Study||0
8252524|NCT01851720|20350041|P2|STARTED|Overall Study||1
8252525|NCT01851720|20350042|P1|STARTED|Overall Study||0
8252526|NCT01851655|20350050|P2|NOT COMPLETED|Overall Study||0
8252527|NCT01851655|20350051|P1|NOT COMPLETED|Overall Study||0
8252528|NCT01851655|20350050|P2|COMPLETED|Overall Study||12
8252529|NCT01851655|20350051|P1|COMPLETED|Overall Study||12
8252530|NCT01851655|20350050|P2|STARTED|Overall Study||12
8252531|NCT01851655|20350051|P1|STARTED|Overall Study||12
8252532|NCT01851590|20350072|P3|NOT COMPLETED|Overall Study||3
8252533|NCT01851590|20350073|P2|NOT COMPLETED|Overall Study||1
8252534|NCT01851590|20350074|P1|NOT COMPLETED|Overall Study||0
8252535|NCT01851590|20350072|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
8252536|NCT01851590|20350073|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
8252537|NCT01851590|20350074|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
8252538|NCT01851590|20350072|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
8252539|NCT01851590|20350073|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
8252540|NCT01851590|20350074|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
8252541|NCT01851590|20350072|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
8252542|NCT01851590|20350073|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
8252543|NCT01851590|20350074|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
8252544|NCT01851590|20350072|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
8252545|NCT01851590|20350073|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
8252546|NCT01851590|20350074|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
8252547|NCT01851590|20350072|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
8252548|NCT01851590|20350073|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
8252549|NCT01851590|20350074|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
8252550|NCT01851590|20350072|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
8252551|NCT01851590|20350073|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
8252552|NCT01851590|20350074|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
8252553|NCT01851330|20350097|P3|NOT COMPLETED|Overall Study||12
8252554|NCT01851330|20350098|P2|NOT COMPLETED|Overall Study||16
8252555|NCT01851330|20350099|P1|NOT COMPLETED|Overall Study||13
8252556|NCT01851330|20350097|P3|COMPLETED|Overall Study||204
8252557|NCT01851330|20350098|P2|COMPLETED|Overall Study||200
8252558|NCT01851330|20350099|P1|COMPLETED|Overall Study||202
8252559|NCT01851330|20350097|P3|STARTED|Overall Study||216
8252560|NCT01851330|20350098|P2|STARTED|Overall Study||216
8252561|NCT01851330|20350099|P1|STARTED|Overall Study||215
8252562|NCT01851174|20350134|P1|NOT COMPLETED|Overall Study||0
8252563|NCT01851174|20350134|P1|COMPLETED|Overall Study||15
8252564|NCT01851174|20350134|P1|STARTED|Overall Study||15
8252565|NCT01850823|20350142|P3|NOT COMPLETED|Overall Study||10
8252566|NCT01850823|20350143|P2|NOT COMPLETED|Overall Study||3
8252567|NCT01850823|20350144|P1|NOT COMPLETED|Overall Study||3
8252568|NCT01850823|20350142|P3|COMPLETED|Overall Study||345
8252569|NCT01850823|20350143|P2|COMPLETED|Overall Study||347
8252570|NCT01850823|20350144|P1|COMPLETED|Overall Study||172
8252571|NCT01850823|20350142|P3|STARTED|Overall Study||355
8252572|NCT01850823|20350143|P2|STARTED|Overall Study||350
8252573|NCT01850823|20350144|P1|STARTED|Overall Study||175
8252574|NCT01850745|20350157|P3|NOT COMPLETED|Overall Study||0
8252575|NCT01850745|20350158|P2|NOT COMPLETED|Overall Study||0
8252576|NCT01850745|20350159|P1|NOT COMPLETED|Overall Study||0
8252577|NCT01850745|20350157|P3|COMPLETED|Overall Study||131
8252578|NCT01850745|20350158|P2|COMPLETED|Overall Study||169
8252579|NCT01850745|20350159|P1|COMPLETED|Overall Study||147
8252580|NCT01850745|20350157|P3|STARTED|Overall Study||131
8252581|NCT01850745|20350158|P2|STARTED|Overall Study||169
8252582|NCT01850745|20350159|P1|STARTED|Overall Study||147
8252583|NCT01850641|20350167|P1|NOT COMPLETED|Overall Study||5
8252584|NCT01850641|20350167|P1|COMPLETED|Overall Study||30
8252585|NCT01850641|20350167|P1|STARTED|Overall Study||35
8252586|NCT01850615|20350181|P2|NOT COMPLETED|Overall Study||5
8252587|NCT01850615|20350182|P1|NOT COMPLETED|Overall Study||9
8252588|NCT01850615|20350181|P2|COMPLETED|Overall Study||115
8252589|NCT01850615|20350182|P1|COMPLETED|Overall Study||107
8252590|NCT01850615|20350181|P2|Exposed|Overall Study||120
8252591|NCT01850615|20350182|P1|Exposed|Overall Study||115
8252592|NCT01850615|20350181|P2|STARTED|Overall Study||120
8252593|NCT01850615|20350182|P1|STARTED|Overall Study||116
8252594|NCT01850602|20350200|P2|NOT COMPLETED|Overall Study||18
8252595|NCT01850602|20350201|P1|NOT COMPLETED|Overall Study||14
8252596|NCT01850602|20350200|P2|COMPLETED|Overall Study||87
8252597|NCT01850602|20350201|P1|COMPLETED|Overall Study||94
8252598|NCT01850602|20350200|P2|STARTED|Overall Study||105
8252599|NCT01850602|20350201|P1|STARTED|Overall Study||108
8252600|NCT01850589|20350215|P2|NOT COMPLETED|Overall Study||0
8252601|NCT01850589|20350216|P1|NOT COMPLETED|Overall Study||8
8252602|NCT01850589|20350215|P2|COMPLETED|Overall Study||22
8252603|NCT01850589|20350216|P1|COMPLETED|Overall Study||14
8252604|NCT01850589|20350215|P2|STARTED|Overall Study||22
8252605|NCT01850589|20350216|P1|STARTED|Overall Study||22
8252606|NCT01850550|20350224|P2|NOT COMPLETED|Overall Study||3
8252607|NCT01850550|20350225|P1|NOT COMPLETED|Overall Study||0
8252608|NCT01850550|20350224|P2|COMPLETED|Overall Study||37
8252609|NCT01850550|20350225|P1|COMPLETED|Overall Study||40
8252610|NCT01850550|20350224|P2|STARTED|Overall Study||40
8252611|NCT01850550|20350225|P1|STARTED|Overall Study||40
8252612|NCT01850485|20350235|P2|NOT COMPLETED|Overall Study||0
8252613|NCT01850485|20350236|P1|NOT COMPLETED|Overall Study||0
8252614|NCT01850485|20350235|P2|COMPLETED|Overall Study||13
8252615|NCT01850485|20350236|P1|COMPLETED|Overall Study||9
8252616|NCT01850485|20350235|P2|STARTED|Overall Study||13
8252617|NCT01850485|20350236|P1|STARTED|Overall Study||9
8252618|NCT01850446|20350256|P2|NOT COMPLETED|Overall Study||2
8252619|NCT01850446|20350257|P1|NOT COMPLETED|Overall Study||5
8252620|NCT01850446|20350256|P2|COMPLETED|Overall Study||90
8252621|NCT01850446|20350257|P1|COMPLETED|Overall Study||87
8252622|NCT01850446|20350256|P2|STARTED|Overall Study||92
8252623|NCT01850446|20350257|P1|STARTED|Overall Study||92
8252624|NCT01850394|20350292|P3|NOT COMPLETED|Overall Study||0
8252625|NCT01850394|20350293|P2|NOT COMPLETED|Overall Study||0
8252626|NCT01850394|20350294|P1|NOT COMPLETED|Overall Study||0
8252627|NCT01850394|20350292|P3|COMPLETED|Overall Study||45
8252628|NCT01850394|20350293|P2|COMPLETED|Overall Study||45
8252629|NCT01850394|20350294|P1|COMPLETED|Overall Study||45
8252630|NCT01850394|20350292|P3|STARTED|Overall Study||45
8252631|NCT01850394|20350293|P2|STARTED|Overall Study||45
8252632|NCT01850394|20350294|P1|STARTED|Overall Study||45
8252633|NCT01850030|20350316|P2|NOT COMPLETED|Overall Study||369
8252634|NCT01850030|20350317|P1|NOT COMPLETED|Overall Study||347
8252635|NCT01850030|20350316|P2|COMPLETED|Overall Study||142
8252636|NCT01850030|20350317|P1|COMPLETED|Overall Study||173
8252637|NCT01850030|20350316|P2|STARTED|Overall Study||511
8252638|NCT01850030|20350317|P1|STARTED|Overall Study||520
8252639|NCT01850004|20350329|P1|NOT COMPLETED|Overall Study||8
8252640|NCT01850004|20350329|P1|COMPLETED|Overall Study||76
8252641|NCT01850004|20350329|P1|STARTED|Overall Study||84
8252642|NCT01849848|20350336|P1|NOT COMPLETED|Overall Study||4
8252643|NCT01849848|20350336|P1|COMPLETED|Overall Study||13
8252644|NCT01849848|20350336|P1|STARTED|Overall Study||17
8252645|NCT01849770|20350353|P3|NOT COMPLETED|Overall Study||1
8252646|NCT01849770|20350354|P2|NOT COMPLETED|Overall Study||4
8252647|NCT01849770|20350355|P1|NOT COMPLETED|Overall Study||0
8252648|NCT01849770|20350353|P3|COMPLETED|Overall Study||19
8252649|NCT01849770|20350354|P2|COMPLETED|Overall Study||15
8252650|NCT01849770|20350355|P1|COMPLETED|Overall Study||20
8252651|NCT01849770|20350353|P3|STARTED|Overall Study||20
8252652|NCT01849770|20350354|P2|STARTED|Overall Study||19
8252653|NCT01849770|20350355|P1|STARTED|Overall Study||20
8252654|NCT01849692|20350398|P8|NOT COMPLETED|Overall Study||0
8252655|NCT01849692|20350399|P7|NOT COMPLETED|Overall Study||0
8252656|NCT01849692|20350400|P6|NOT COMPLETED|Overall Study||0
8252657|NCT01849692|20350401|P5|NOT COMPLETED|Overall Study||0
8252658|NCT01849692|20350402|P4|NOT COMPLETED|Overall Study||0
8252659|NCT01849692|20350403|P3|NOT COMPLETED|Overall Study||0
8252660|NCT01849692|20350404|P2|NOT COMPLETED|Overall Study||0
8252661|NCT01849692|20350405|P1|NOT COMPLETED|Overall Study||0
8252662|NCT01849692|20350398|P8|COMPLETED|Overall Study||3
8252663|NCT01849692|20350399|P7|COMPLETED|Overall Study||10
8252664|NCT01849692|20350400|P6|COMPLETED|Overall Study||3
8252665|NCT01849692|20350401|P5|COMPLETED|Overall Study||10
8252666|NCT01849692|20350402|P4|COMPLETED|Overall Study||3
8252667|NCT01849692|20350403|P3|COMPLETED|Overall Study||10
8252668|NCT01849692|20350404|P2|COMPLETED|Overall Study||3
8252669|NCT01849692|20350405|P1|COMPLETED|Overall Study||10
8252670|NCT01849692|20350398|P8|STARTED|Overall Study||3
8252671|NCT01849692|20350399|P7|STARTED|Overall Study||10
8252672|NCT01849692|20350400|P6|STARTED|Overall Study||3
8252673|NCT01849692|20350401|P5|STARTED|Overall Study||10
8252674|NCT01849692|20350402|P4|STARTED|Overall Study||3
8252675|NCT01849692|20350403|P3|STARTED|Overall Study||10
8252676|NCT01849692|20350404|P2|STARTED|Overall Study||3
8252677|NCT01849692|20350405|P1|STARTED|Overall Study||10
8252678|NCT01849588|20350434|P1|NOT COMPLETED|Overall Study||3
8252679|NCT01849588|20350434|P1|COMPLETED|Overall Study||0
8252680|NCT01849588|20350434|P1|STARTED|Overall Study||3
8252681|NCT01849575|20350443|P2|NOT COMPLETED|Overall Study||207
8252682|NCT01849575|20350444|P1|NOT COMPLETED|Overall Study||150
8252683|NCT01849575|20350443|P2|COMPLETED|Overall Study||1576
8252684|NCT01849575|20350444|P1|COMPLETED|Overall Study||1599
8252685|NCT01849575|20350443|P2|STARTED|Overall Study||1783
8252686|NCT01849575|20350444|P1|STARTED|Overall Study||1749
8252687|NCT01849562|20350453|P3|NOT COMPLETED|Overall Study||0
8252688|NCT01849562|20350454|P2|NOT COMPLETED|Overall Study||0
8252689|NCT01849562|20350455|P1|NOT COMPLETED|Overall Study||2
8252690|NCT01849562|20350453|P3|COMPLETED|Overall Study||10
8252691|NCT01849562|20350454|P2|COMPLETED|Overall Study||10
8252692|NCT01849562|20350455|P1|COMPLETED|Overall Study||8
8252693|NCT01849562|20350453|P3|STARTED|Overall Study||10
8252694|NCT01849562|20350454|P2|STARTED|Overall Study||10
8252695|NCT01849562|20350455|P1|STARTED|Overall Study||10
8252696|NCT01849497|20350468|P2|NOT COMPLETED|Overall Study||4
8252697|NCT01849497|20350469|P1|NOT COMPLETED|Overall Study||1
8252698|NCT01849497|20350468|P2|COMPLETED|Overall Study||70
8252699|NCT01849497|20350469|P1|COMPLETED|Overall Study||74
8252700|NCT01849497|20350468|P2|Received Treatment|Overall Study||74
8252701|NCT01849497|20350469|P1|Received Treatment|Overall Study||75
8252702|NCT01849497|20350468|P2|STARTED|Overall Study||74
8252703|NCT01849497|20350469|P1|STARTED|Overall Study||75
8252704|NCT01849458|20350477|P1|NOT COMPLETED|Overall Study||4
8252705|NCT01849458|20350477|P1|COMPLETED|Overall Study||46
8252706|NCT01849458|20350477|P1|6 Months Follow-up|Overall Study||50
8252707|NCT01849458|20350477|P1|STARTED|Overall Study||50
8252708|NCT01849419|20350487|P1|NOT COMPLETED|Overall Study||0
8252709|NCT01849419|20350487|P1|COMPLETED|Overall Study||65
8252710|NCT01849419|20350487|P1|STARTED|Overall Study||65
8252711|NCT01849289|20350516|P2|NOT COMPLETED|Overall Study||24
8252712|NCT01849289|20350517|P1|NOT COMPLETED|Overall Study||32
8252713|NCT01849289|20350516|P2|COMPLETED|Overall Study||254
8252714|NCT01849289|20350517|P1|COMPLETED|Overall Study||523
8252715|NCT01849289|20350516|P2|Exposed|Overall Study||278
8252716|NCT01849289|20350517|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
8252717|NCT01849289|20350516|P2|STARTED|Overall Study||278
8252718|NCT01849289|20350517|P1|STARTED|Overall Study||555
8252719|NCT01849276|20350533|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
8252720|NCT01849276|20350533|P1|COMPLETED|Followed for Survival for 5 Years||0
8252721|NCT01849276|20350533|P1|STARTED|Followed for Survival for 5 Years||2
8252722|NCT01849276|20350533|P1|NOT COMPLETED|Completed Treatment||0
8252723|NCT01849276|20350533|P1|COMPLETED|Completed Treatment||2
8252724|NCT01849276|20350533|P1|STARTED|Completed Treatment||2
8252725|NCT01849276|20350533|P1|NOT COMPLETED|Registered to the Study||0
8252726|NCT01849276|20350533|P1|COMPLETED|Registered to the Study||2
8252727|NCT01849276|20350533|P1|STARTED|Registered to the Study||2
8252728|NCT01849263|20350545|P1|NOT COMPLETED|Overall Study||0
8252729|NCT01849263|20350545|P1|COMPLETED|Overall Study||40
8252730|NCT01849263|20350545|P1|STARTED|Overall Study||40
8252731|NCT01849172|20350557|P2|NOT COMPLETED|Overall Study||6
8252732|NCT01849172|20350558|P1|NOT COMPLETED|Overall Study||7
8252733|NCT01849172|20350557|P2|COMPLETED|Overall Study||174
8252734|NCT01849172|20350558|P1|COMPLETED|Overall Study||173
8252735|NCT01849172|20350557|P2|STARTED|Overall Study||180
8252736|NCT01849172|20350558|P1|STARTED|Overall Study||180
8252737|NCT01849068|20350596|P2|NOT COMPLETED|Overall Study||0
8252738|NCT01849068|20350597|P1|NOT COMPLETED|Overall Study||0
8252739|NCT01849068|20350596|P2|COMPLETED|Overall Study||10
8252740|NCT01849068|20350597|P1|COMPLETED|Overall Study||10
8252741|NCT01849068|20350596|P2|STARTED|Overall Study||10
8252742|NCT01849068|20350597|P1|STARTED|Overall Study||10
8252743|NCT01849055|20350615|P6|NOT COMPLETED|Overall Study||0
8252744|NCT01849055|20350616|P5|NOT COMPLETED|Overall Study||0
8252745|NCT01849055|20350617|P4|NOT COMPLETED|Overall Study||0
8252746|NCT01849055|20350618|P3|NOT COMPLETED|Overall Study||1
8252747|NCT01849055|20350619|P2|NOT COMPLETED|Overall Study||0
8252748|NCT01849055|20350620|P1|NOT COMPLETED|Overall Study||0
8252749|NCT01849055|20350615|P6|COMPLETED|Overall Study||8
8252750|NCT01849055|20350616|P5|COMPLETED|Overall Study||8
8252751|NCT01849055|20350617|P4|COMPLETED|Overall Study||8
8252752|NCT01849055|20350618|P3|COMPLETED|Overall Study||7
8252753|NCT01849055|20350619|P2|COMPLETED|Overall Study||8
8252754|NCT01849055|20350620|P1|COMPLETED|Overall Study||8
8252755|NCT01849055|20350615|P6|STARTED|Overall Study||8
8252756|NCT01849055|20350616|P5|STARTED|Overall Study||8
8252757|NCT01849055|20350617|P4|STARTED|Overall Study||8
8252758|NCT01849055|20350618|P3|STARTED|Overall Study||8
8252759|NCT01849055|20350619|P2|STARTED|Overall Study||8
8252760|NCT01849055|20350620|P1|STARTED|Overall Study||8
8252761|NCT01848990|20350655|P3|NOT COMPLETED|Overall Study||16
8252762|NCT01848990|20350656|P2|NOT COMPLETED|Overall Study||20
8252763|NCT01848990|20350657|P1|NOT COMPLETED|Overall Study||46
8252764|NCT01848990|20350655|P3|COMPLETED|Overall Study||98
8252765|NCT01848990|20350656|P2|COMPLETED|Overall Study||95
8252766|NCT01848990|20350657|P1|COMPLETED|Overall Study||181
8252767|NCT01848990|20350655|P3|Completed Month 6|Overall Study||103
8252768|NCT01848990|20350656|P2|Completed Month 6|Overall Study||106
8252769|NCT01848990|20350657|P1|Completed Month 6|Overall Study||194
8252770|NCT01848990|20350655|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
8252771|NCT01848990|20350656|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
8252772|NCT01848990|20350657|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
8252773|NCT01848990|20350655|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
8252774|NCT01848990|20350656|P2|STARTED|Overall Study||115
8252775|NCT01848990|20350657|P1|STARTED|Overall Study||227
8252776|NCT01848977|20350716|P1|NOT COMPLETED|Overall Study||0
8252777|NCT01848977|20350716|P1|COMPLETED|Overall Study||20
8252778|NCT01848977|20350716|P1|STARTED|Overall Study||20
8252779|NCT01848938|20350727|P2|NOT COMPLETED|Overall Study||1
8252780|NCT01848938|20350728|P1|NOT COMPLETED|Overall Study||1
8252781|NCT01848938|20350727|P2|COMPLETED|Overall Study||60
8252782|NCT01848938|20350728|P1|COMPLETED|Overall Study||61
8252783|NCT01848938|20350727|P2|STARTED|Overall Study||61
8252784|NCT01848938|20350728|P1|STARTED|Overall Study||62
8252785|NCT01848899|20350746|P2|NOT COMPLETED|Overall Study||0
8252786|NCT01848899|20350747|P1|NOT COMPLETED|Overall Study||0
8252787|NCT01848899|20350746|P2|COMPLETED|Overall Study||50
8252788|NCT01848899|20350747|P1|COMPLETED|Overall Study||50
8252789|NCT01848899|20350746|P2|STARTED|Overall Study||50
8252790|NCT01848899|20350747|P1|STARTED|Overall Study||50
8252791|NCT01848847|20350763|P2|NOT COMPLETED|Overall Study||3
8252792|NCT01848847|20350764|P1|NOT COMPLETED|Overall Study||2
8252793|NCT01848847|20350763|P2|COMPLETED|Overall Study||48
8252794|NCT01848847|20350764|P1|COMPLETED|Overall Study||49
8252795|NCT01848847|20350763|P2|STARTED|Overall Study||51
8252796|NCT01848847|20350764|P1|STARTED|Overall Study||51
8252797|NCT01848834|20350777|P5|NOT COMPLETED|Overall Study||132
8252798|NCT01848834|20350778|P4|NOT COMPLETED|Overall Study||37
8252799|NCT01848834|20350779|P3|NOT COMPLETED|Overall Study||32
8252800|NCT01848834|20350780|P2|NOT COMPLETED|Overall Study||60
8252801|NCT01848834|20350781|P1|NOT COMPLETED|Overall Study||30
8252802|NCT01848834|20350777|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
8252803|NCT01848834|20350778|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
8252804|NCT01848834|20350779|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
8252805|NCT01848834|20350780|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
8252806|NCT01848834|20350781|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
8252807|NCT01848834|20350777|P5|Treated|Overall Study||132
8252808|NCT01848834|20350778|P4|Treated|Overall Study||39
8252809|NCT01848834|20350779|P3|Treated|Overall Study||33
8252810|NCT01848834|20350780|P2|Treated|Overall Study||60
8252811|NCT01848834|20350781|P1|Treated|Overall Study||32
8252812|NCT01848834|20350777|P5|STARTED|Overall Study||132
8252813|NCT01848834|20350778|P4|STARTED|Overall Study||39
8252814|NCT01848834|20350779|P3|STARTED|Overall Study||33
8252815|NCT01848834|20350780|P2|STARTED|Overall Study||61
8252816|NCT01848834|20350781|P1|STARTED|Overall Study||32
8252817|NCT01848821|20350818|P2|NOT COMPLETED|Overall Study||0
8252818|NCT01848821|20350819|P1|NOT COMPLETED|Overall Study||0
8252819|NCT01848821|20350818|P2|COMPLETED|Overall Study||7
8252820|NCT01848821|20350819|P1|COMPLETED|Overall Study||7
8252821|NCT01848821|20350818|P2|STARTED|Overall Study||7
8252822|NCT01848821|20350819|P1|STARTED|Overall Study||7
8252823|NCT01848756|20350829|P1|NOT COMPLETED|Overall Study||3
8252824|NCT01848756|20350829|P1|COMPLETED|Overall Study|Cycle 1|12
8252825|NCT01848756|20350829|P1|STARTED|Overall Study||15
8252826|NCT01848483|20350841|P2|NOT COMPLETED|Overall Study||11
8252827|NCT01848483|20350842|P1|NOT COMPLETED|Overall Study||11
8252828|NCT01848483|20350841|P2|COMPLETED|Overall Study||49
8252829|NCT01848483|20350842|P1|COMPLETED|Overall Study||50
8252830|NCT01848483|20350841|P2|STARTED|Overall Study||60
8252831|NCT01848483|20350842|P1|STARTED|Overall Study||61
8252832|NCT01848457|20350860|P4|NOT COMPLETED|Overall Study||0
8252833|NCT01848457|20350861|P3|NOT COMPLETED|Overall Study||0
8252834|NCT01848457|20350862|P2|NOT COMPLETED|Overall Study||0
8252835|NCT01848457|20350863|P1|NOT COMPLETED|Overall Study||1
8252836|NCT01848457|20350860|P4|COMPLETED|Overall Study||3
8252837|NCT01848457|20350861|P3|COMPLETED|Overall Study||3
8252838|NCT01848457|20350862|P2|COMPLETED|Overall Study||3
8252839|NCT01848457|20350863|P1|COMPLETED|Overall Study||3
8252840|NCT01848457|20350860|P4|Cycle 4|Overall Study||3
8252841|NCT01848457|20350861|P3|Cycle 4|Overall Study||3
8252842|NCT01848457|20350862|P2|Cycle 4|Overall Study||3
8252843|NCT01848457|20350863|P1|Cycle 4|Overall Study||3
8252844|NCT01848457|20350860|P4|Cycle 3|Overall Study||3
8252845|NCT01848457|20350861|P3|Cycle 3|Overall Study||3
8252846|NCT01848457|20350862|P2|Cycle 3|Overall Study||3
8252847|NCT01848457|20350863|P1|Cycle 3|Overall Study||3
8252848|NCT01848457|20350860|P4|Cycle 2|Overall Study||3
8252849|NCT01848457|20350861|P3|Cycle 2|Overall Study||3
8252850|NCT01848457|20350862|P2|Cycle 2|Overall Study||3
8252851|NCT01848457|20350863|P1|Cycle 2|Overall Study||3
8252852|NCT01848457|20350860|P4|Cycle 1|Overall Study||3
8252853|NCT01848457|20350861|P3|Cycle 1|Overall Study||3
8252854|NCT01848457|20350862|P2|Cycle 1|Overall Study||3
8252855|NCT01848457|20350863|P1|Cycle 1|Overall Study||4
8252856|NCT01848457|20350860|P4|Baseline|Overall Study||3
8252857|NCT01848457|20350861|P3|Baseline|Overall Study||3
8252858|NCT01848457|20350862|P2|Baseline|Overall Study||3
8252859|NCT01848457|20350863|P1|Baseline|Overall Study||4
8252860|NCT01848457|20350860|P4|STARTED|Overall Study||3
8252861|NCT01848457|20350861|P3|STARTED|Overall Study||3
8252862|NCT01848457|20350862|P2|STARTED|Overall Study||3
8252863|NCT01848457|20350863|P1|STARTED|Overall Study||4
8252864|NCT01848366|20350887|P1|NOT COMPLETED|Overall Study||0
8252865|NCT01848366|20350887|P1|COMPLETED|Overall Study||8
8252866|NCT01848366|20350887|P1|STARTED|Overall Study||8
8252867|NCT01848353|20350895|P4|NOT COMPLETED|Phase 3||0
8252868|NCT01848353|20350896|P3|NOT COMPLETED|Phase 3||0
8252869|NCT01848353|20350897|P2|NOT COMPLETED|Phase 3||1
8252870|NCT01848353|20350898|P1|NOT COMPLETED|Phase 3||1
8252871|NCT01848353|20350895|P4|COMPLETED|Phase 3||0
8252872|NCT01848353|20350896|P3|COMPLETED|Phase 3||0
8252873|NCT01848353|20350897|P2|COMPLETED|Phase 3||9
8252874|NCT01848353|20350898|P1|COMPLETED|Phase 3||4
8252875|NCT01848353|20350895|P4|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
8252876|NCT01848353|20350896|P3|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
8252877|NCT01848353|20350897|P2|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
8252878|NCT01848353|20350898|P1|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
8252879|NCT01848353|20350895|P4|NOT COMPLETED|Phase 2||0
8252880|NCT01848353|20350896|P3|NOT COMPLETED|Phase 2||0
8252881|NCT01848353|20350897|P2|NOT COMPLETED|Phase 2||2
8252882|NCT01848353|20350898|P1|NOT COMPLETED|Phase 2||3
8252883|NCT01848353|20350895|P4|COMPLETED|Phase 2||0
8252884|NCT01848353|20350896|P3|COMPLETED|Phase 2||0
8252885|NCT01848353|20350897|P2|COMPLETED|Phase 2||26
8252886|NCT01848353|20350898|P1|COMPLETED|Phase 2||20
8252887|NCT01848353|20350895|P4|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
8252888|NCT01848353|20350896|P3|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
8252889|NCT01848353|20350897|P2|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
8252890|NCT01848353|20350898|P1|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
8252891|NCT01848353|20350895|P4|NOT COMPLETED|Phase 1||0
8252892|NCT01848353|20350896|P3|NOT COMPLETED|Phase 1||0
8252893|NCT01848353|20350897|P2|NOT COMPLETED|Phase 1||1
8252894|NCT01848353|20350898|P1|NOT COMPLETED|Phase 1||3
8252895|NCT01848353|20350895|P4|COMPLETED|Phase 1||19
8252896|NCT01848353|20350896|P3|COMPLETED|Phase 1||20
8252897|NCT01848353|20350897|P2|COMPLETED|Phase 1||42
8252898|NCT01848353|20350898|P1|COMPLETED|Phase 1||35
8252899|NCT01848353|20350895|P4|STARTED|Phase 1||19
8252900|NCT01848353|20350896|P3|STARTED|Phase 1||20
8252901|NCT01848353|20350897|P2|STARTED|Phase 1||43
8252902|NCT01848353|20350898|P1|STARTED|Phase 1||38
8252903|NCT01848288|20350954|P1|NOT COMPLETED|Overall Study||3
8252904|NCT01848288|20350954|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
8252905|NCT01848288|20350954|P1|STARTED|Overall Study||100
8252906|NCT01848210|20350965|P2|NOT COMPLETED|Overall Study||78
8252907|NCT01848210|20350966|P1|NOT COMPLETED|Overall Study||88
8252908|NCT01848210|20350965|P2|COMPLETED|Overall Study||340
8252909|NCT01848210|20350966|P1|COMPLETED|Overall Study||323
8252910|NCT01848210|20350965|P2|Per Protocol Population|Overall Study||245
8252911|NCT01848210|20350966|P1|Per Protocol Population|Overall Study||222
8252912|NCT01848210|20350965|P2|Intent-to-Treat (ITT) Population|Overall Study||388
8252913|NCT01848210|20350966|P1|Intent-to-Treat (ITT) Population|Overall Study||383
8252914|NCT01848210|20350965|P2|Safety Population-Received Study Drug|Overall Study||398
8252915|NCT01848210|20350966|P1|Safety Population-Received Study Drug|Overall Study||394
8252916|NCT01848210|20350965|P2|STARTED|Overall Study||418
8252917|NCT01848210|20350966|P1|STARTED|Overall Study||411
8252918|NCT01848184|20350978|P1|NOT COMPLETED|Overall Study||26
8252919|NCT01848184|20350978|P1|COMPLETED|Overall Study||100
8252920|NCT01848184|20350978|P1|STARTED|Overall Study||126
8252921|NCT01848158|20350990|P2|NOT COMPLETED|Overall Study||0
8252922|NCT01848158|20350991|P1|NOT COMPLETED|Overall Study||0
8252923|NCT01848158|20350990|P2|COMPLETED|Overall Study||7
8252924|NCT01848158|20350991|P1|COMPLETED|Overall Study||10
8252925|NCT01848158|20350990|P2|STARTED|Overall Study||7
8252926|NCT01848158|20350991|P1|STARTED|Overall Study||10
8252927|NCT01848145|20351015|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
8252928|NCT01848145|20351015|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
8252929|NCT01848145|20351015|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
8252930|NCT01848145|20351015|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
8252931|NCT01848145|20351015|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
8252932|NCT01848145|20351015|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
8252933|NCT01848145|20351015|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
8252934|NCT01848145|20351015|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
8252935|NCT01848145|20351015|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
8252936|NCT01848145|20351015|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
8252937|NCT01848145|20351015|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
8252938|NCT01848145|20351015|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
8252939|NCT01848145|20351015|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
8252940|NCT01848145|20351015|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
8252941|NCT01848145|20351015|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
8252942|NCT01848067|20351024|P1|NOT COMPLETED|Overall Study||0
8252943|NCT01848067|20351024|P1|COMPLETED|Overall Study||9
8252944|NCT01848067|20351024|P1|STARTED|Overall Study||9
8252945|NCT01848054|20351032|P2|NOT COMPLETED|Stabilization/Maintenance||40
8252946|NCT01848054|20351033|P1|NOT COMPLETED|Stabilization/Maintenance||40
8252947|NCT01848054|20351032|P2|COMPLETED|Stabilization/Maintenance||107
8252948|NCT01848054|20351033|P1|COMPLETED|Stabilization/Maintenance||92
8252949|NCT01848054|20351032|P2|STARTED|Stabilization/Maintenance||147
8252950|NCT01848054|20351033|P1|STARTED|Stabilization/Maintenance||132
8252951|NCT01848054|20351032|P2|NOT COMPLETED|Induction Phase||8
8252952|NCT01848054|20351033|P1|NOT COMPLETED|Induction Phase||23
8252953|NCT01848054|20351032|P2|COMPLETED|Induction Phase||147
8252954|NCT01848054|20351033|P1|COMPLETED|Induction Phase||132
8252955|NCT01848054|20351032|P2|STARTED|Induction Phase||155
8252956|NCT01848054|20351033|P1|STARTED|Induction Phase||155
8252957|NCT01847885|20351055|P3|NOT COMPLETED|Randomization||2
8252958|NCT01847885|20351056|P2|NOT COMPLETED|Randomization||4
8252959|NCT01847885|20351057|P1|NOT COMPLETED|Randomization||0
8252960|NCT01847885|20351055|P3|COMPLETED|Randomization||13
8252961|NCT01847885|20351056|P2|COMPLETED|Randomization||27
8252962|NCT01847885|20351057|P1|COMPLETED|Randomization||0
8252963|NCT01847885|20351055|P3|Per Protocol Set|Randomization||13
8252964|NCT01847885|20351056|P2|Per Protocol Set|Randomization||27
8252965|NCT01847885|20351057|P1|Per Protocol Set|Randomization||0
8252966|NCT01847885|20351055|P3|Safety Set|Randomization||13
8252967|NCT01847885|20351056|P2|Safety Set|Randomization||28
8252968|NCT01847885|20351057|P1|Safety Set|Randomization||0
8252969|NCT01847885|20351055|P3|Full Analysis Set|Randomization||15
8252970|NCT01847885|20351056|P2|Full Analysis Set|Randomization||28
8252971|NCT01847885|20351057|P1|Full Analysis Set|Randomization||0
8252972|NCT01847885|20351055|P3|STARTED|Randomization||15
8252973|NCT01847885|20351056|P2|STARTED|Randomization||31
8252974|NCT01847885|20351057|P1|STARTED|Randomization||0
8252975|NCT01847885|20351055|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
8252976|NCT01847885|20351056|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
8252977|NCT01847885|20351057|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
8252978|NCT01847885|20351055|P3|COMPLETED|Initial Enrollment (Consented)||0
8252979|NCT01847885|20351056|P2|COMPLETED|Initial Enrollment (Consented)||0
8252980|NCT01847885|20351057|P1|COMPLETED|Initial Enrollment (Consented)||40
8252981|NCT01847885|20351055|P3|Per Protocol Set|Initial Enrollment (Consented)||0
8252982|NCT01847885|20351056|P2|Per Protocol Set|Initial Enrollment (Consented)||0
8252983|NCT01847885|20351057|P1|Per Protocol Set|Initial Enrollment (Consented)||40
8252984|NCT01847885|20351055|P3|Safety Set|Initial Enrollment (Consented)||0
8252985|NCT01847885|20351056|P2|Safety Set|Initial Enrollment (Consented)||0
8252986|NCT01847885|20351057|P1|Safety Set|Initial Enrollment (Consented)||41
8252987|NCT01847885|20351055|P3|Full Analysis Set|Initial Enrollment (Consented)||0
8252988|NCT01847885|20351056|P2|Full Analysis Set|Initial Enrollment (Consented)||0
8252989|NCT01847885|20351057|P1|Full Analysis Set|Initial Enrollment (Consented)||43
8252990|NCT01847885|20351055|P3|Randomized|Initial Enrollment (Consented)||0
8252991|NCT01847885|20351056|P2|Randomized|Initial Enrollment (Consented)||0
8252992|NCT01847885|20351057|P1|Randomized|Initial Enrollment (Consented)||46
8252993|NCT01847885|20351055|P3|STARTED|Initial Enrollment (Consented)||0
8252994|NCT01847885|20351056|P2|STARTED|Initial Enrollment (Consented)||0
8252995|NCT01847885|20351057|P1|STARTED|Initial Enrollment (Consented)||88
8252996|NCT01847638|20351091|P2|NOT COMPLETED|Overall Study||0
8252997|NCT01847638|20351092|P1|NOT COMPLETED|Overall Study||0
8252998|NCT01847638|20351091|P2|COMPLETED|Overall Study||25
8252999|NCT01847638|20351092|P1|COMPLETED|Overall Study||25
8253000|NCT01847638|20351091|P2|STARTED|Overall Study||25
8253001|NCT01847638|20351092|P1|STARTED|Overall Study||25
8253002|NCT01847560|20351112|P10|NOT COMPLETED|Overall Study||0
8253003|NCT01847560|20351113|P9|NOT COMPLETED|Overall Study||0
8253004|NCT01847560|20351114|P8|NOT COMPLETED|Overall Study||0
8253005|NCT01847560|20351115|P7|NOT COMPLETED|Overall Study||0
8253006|NCT01847560|20351116|P6|NOT COMPLETED|Overall Study||0
8253007|NCT01847560|20351117|P5|NOT COMPLETED|Overall Study||0
8253008|NCT01847560|20351118|P4|NOT COMPLETED|Overall Study||0
8253009|NCT01847560|20351119|P3|NOT COMPLETED|Overall Study||0
8253010|NCT01847560|20351120|P2|NOT COMPLETED|Overall Study||0
8253011|NCT01847560|20351121|P1|NOT COMPLETED|Overall Study||0
8253012|NCT01847560|20351112|P10|COMPLETED|Overall Study||39438
8253013|NCT01847560|20351113|P9|COMPLETED|Overall Study||77547
8253014|NCT01847560|20351114|P8|COMPLETED|Overall Study||19829
8253015|NCT01847560|20351115|P7|COMPLETED|Overall Study||40971
8253016|NCT01847560|20351116|P6|COMPLETED|Overall Study||28343
8253017|NCT01847560|20351117|P5|COMPLETED|Overall Study||27731
8253018|NCT01847560|20351118|P4|COMPLETED|Overall Study||56655
8253019|NCT01847560|20351119|P3|COMPLETED|Overall Study||9731
8253020|NCT01847560|20351120|P2|COMPLETED|Overall Study||19955
8253021|NCT01847560|20351121|P1|COMPLETED|Overall Study||13464
8253022|NCT01847560|20351112|P10|STARTED|Overall Study||39438
8253023|NCT01847560|20351113|P9|STARTED|Overall Study||77547
8253024|NCT01847560|20351114|P8|STARTED|Overall Study||19829
8253025|NCT01847560|20351115|P7|STARTED|Overall Study||40971
8253026|NCT01847560|20351116|P6|STARTED|Overall Study||28343
8253027|NCT01847560|20351117|P5|STARTED|Overall Study||27731
8253028|NCT01847560|20351118|P4|STARTED|Overall Study||56655
8253029|NCT01847560|20351119|P3|STARTED|Overall Study||9731
8253030|NCT01847560|20351120|P2|STARTED|Overall Study||19955
8253031|NCT01847560|20351121|P1|STARTED|Overall Study||13464
8253032|NCT01847547|20351165|P2|NOT COMPLETED|Overall Study||0
8253033|NCT01847547|20351166|P1|NOT COMPLETED|Overall Study||0
8253034|NCT01847547|20351165|P2|COMPLETED|Overall Study||2991
8253035|NCT01847547|20351166|P1|COMPLETED|Overall Study||2991
8253036|NCT01847547|20351165|P2|STARTED|Overall Study||2991
8253037|NCT01847547|20351166|P1|STARTED|Overall Study||2991
8253038|NCT01847469|20351210|P2|NOT COMPLETED|Overall Study||3
8253039|NCT01847469|20351211|P1|NOT COMPLETED|Overall Study||9
8253040|NCT01847469|20351210|P2|COMPLETED|Overall Study||3
8253041|NCT01847469|20351211|P1|COMPLETED|Overall Study||9
8253042|NCT01847469|20351210|P2|STARTED|Overall Study||6
8253043|NCT01847469|20351211|P1|STARTED|Overall Study||18
8253044|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 4||0
8253045|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 4||0
8253046|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 4||0
8253047|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 4||0
8253048|NCT01847443|20351221|P4|COMPLETED|Study Period 4||21
8253049|NCT01847443|20351222|P3|COMPLETED|Study Period 4||21
8253050|NCT01847443|20351223|P2|COMPLETED|Study Period 4||19
8253051|NCT01847443|20351224|P1|COMPLETED|Study Period 4||16
8253052|NCT01847443|20351221|P4|STARTED|Study Period 4||21
8253053|NCT01847443|20351222|P3|STARTED|Study Period 4||21
8253054|NCT01847443|20351223|P2|STARTED|Study Period 4||19
8253055|NCT01847443|20351224|P1|STARTED|Study Period 4||16
8253056|NCT01847443|20351221|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
8253057|NCT01847443|20351222|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
8253058|NCT01847443|20351223|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
8253059|NCT01847443|20351224|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
8253060|NCT01847443|20351221|P4|COMPLETED|Washout Period Before Study Period 4||21
8253061|NCT01847443|20351222|P3|COMPLETED|Washout Period Before Study Period 4||21
8253062|NCT01847443|20351223|P2|COMPLETED|Washout Period Before Study Period 4||19
8253063|NCT01847443|20351224|P1|COMPLETED|Washout Period Before Study Period 4||16
8253064|NCT01847443|20351221|P4|STARTED|Washout Period Before Study Period 4||21
8253065|NCT01847443|20351222|P3|STARTED|Washout Period Before Study Period 4||21
8253066|NCT01847443|20351223|P2|STARTED|Washout Period Before Study Period 4||19
8253067|NCT01847443|20351224|P1|STARTED|Washout Period Before Study Period 4||18
8253068|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 3||0
8253069|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 3||0
8253070|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 3||0
8253071|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 3||0
8253072|NCT01847443|20351221|P4|COMPLETED|Study Period 3||21
8253073|NCT01847443|20351222|P3|COMPLETED|Study Period 3||21
8253074|NCT01847443|20351223|P2|COMPLETED|Study Period 3||19
8253075|NCT01847443|20351224|P1|COMPLETED|Study Period 3||18
8253076|NCT01847443|20351221|P4|STARTED|Study Period 3||21
8253077|NCT01847443|20351222|P3|STARTED|Study Period 3||21
8253078|NCT01847443|20351223|P2|STARTED|Study Period 3||19
8253079|NCT01847443|20351224|P1|STARTED|Study Period 3||18
8253080|NCT01847443|20351221|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
8253081|NCT01847443|20351222|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
8253082|NCT01847443|20351223|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
8253083|NCT01847443|20351224|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
8253084|NCT01847443|20351221|P4|COMPLETED|Washout Period Before Study Period 3||21
8253085|NCT01847443|20351222|P3|COMPLETED|Washout Period Before Study Period 3||21
8253086|NCT01847443|20351223|P2|COMPLETED|Washout Period Before Study Period 3||19
8253087|NCT01847443|20351224|P1|COMPLETED|Washout Period Before Study Period 3||18
8253088|NCT01847443|20351221|P4|STARTED|Washout Period Before Study Period 3||21
8253089|NCT01847443|20351222|P3|STARTED|Washout Period Before Study Period 3||21
8253090|NCT01847443|20351223|P2|STARTED|Washout Period Before Study Period 3||19
8253091|NCT01847443|20351224|P1|STARTED|Washout Period Before Study Period 3||19
8253092|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 2||0
8253093|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 2||0
8253094|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 2||0
8253095|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 2||0
8253096|NCT01847443|20351221|P4|COMPLETED|Study Period 2||21
8253097|NCT01847443|20351222|P3|COMPLETED|Study Period 2||21
8253098|NCT01847443|20351223|P2|COMPLETED|Study Period 2||19
8253099|NCT01847443|20351224|P1|COMPLETED|Study Period 2||19
8253100|NCT01847443|20351221|P4|STARTED|Study Period 2||21
8253101|NCT01847443|20351222|P3|STARTED|Study Period 2||21
8253102|NCT01847443|20351223|P2|STARTED|Study Period 2||19
8253103|NCT01847443|20351224|P1|STARTED|Study Period 2||19
8253104|NCT01847443|20351221|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
8253105|NCT01847443|20351222|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
8253106|NCT01847443|20351223|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
8253107|NCT01847443|20351224|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
8253108|NCT01847443|20351221|P4|COMPLETED|Washout Period Before Study Period 2||21
8253109|NCT01847443|20351222|P3|COMPLETED|Washout Period Before Study Period 2||21
8253110|NCT01847443|20351223|P2|COMPLETED|Washout Period Before Study Period 2||19
8253111|NCT01847443|20351224|P1|COMPLETED|Washout Period Before Study Period 2||19
8253112|NCT01847443|20351221|P4|STARTED|Washout Period Before Study Period 2||21
8253113|NCT01847443|20351222|P3|STARTED|Washout Period Before Study Period 2||21
8253114|NCT01847443|20351223|P2|STARTED|Washout Period Before Study Period 2||20
8253115|NCT01847443|20351224|P1|STARTED|Washout Period Before Study Period 2||21
8253116|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 1||0
8253117|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 1||0
8253118|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 1||1
8253119|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 1||0
8253120|NCT01847443|20351221|P4|COMPLETED|Study Period 1||21
8253121|NCT01847443|20351222|P3|COMPLETED|Study Period 1||21
8253122|NCT01847443|20351223|P2|COMPLETED|Study Period 1||20
8253123|NCT01847443|20351224|P1|COMPLETED|Study Period 1||21
8253124|NCT01847443|20351221|P4|STARTED|Study Period 1||21
8253125|NCT01847443|20351222|P3|STARTED|Study Period 1||21
8253126|NCT01847443|20351223|P2|STARTED|Study Period 1||21
8253127|NCT01847443|20351224|P1|STARTED|Study Period 1||21
8253128|NCT01847430|20351254|P1|NOT COMPLETED|Overall Study||0
8253129|NCT01847430|20351254|P1|COMPLETED|Overall Study||302
8253130|NCT01847430|20351254|P1|STARTED|Overall Study||302
8253131|NCT01847313|20351267|P2|NOT COMPLETED|Overall Study||2
8253132|NCT01847313|20351268|P1|NOT COMPLETED|Overall Study||0
8253133|NCT01847313|20351267|P2|COMPLETED|Overall Study||8
8253134|NCT01847313|20351268|P1|COMPLETED|Overall Study||10
8253135|NCT01847313|20351267|P2|STARTED|Overall Study||10
8253136|NCT01847313|20351268|P1|STARTED|Overall Study||10
8253137|NCT01847274|20351284|P4|NOT COMPLETED|Overall Study||104
8253138|NCT01847274|20351285|P3|NOT COMPLETED|Overall Study||188
8253139|NCT01847274|20351286|P2|NOT COMPLETED|Overall Study||61
8253140|NCT01847274|20351287|P1|NOT COMPLETED|Overall Study||91
8253141|NCT01847274|20351284|P4|COMPLETED|Overall Study||12
8253142|NCT01847274|20351285|P3|COMPLETED|Overall Study||46
8253143|NCT01847274|20351286|P2|COMPLETED|Overall Study||4
8253144|NCT01847274|20351287|P1|COMPLETED|Overall Study||47
8253145|NCT01847274|20351284|P4|STARTED|Overall Study||116
8253146|NCT01847274|20351285|P3|STARTED|Overall Study||234
8253147|NCT01847274|20351286|P2|STARTED|Overall Study||65
8253148|NCT01847274|20351287|P1|STARTED|Overall Study||138
8253149|NCT01847209|20351341|P1|NOT COMPLETED|Overall Study||2
8253150|NCT01847209|20351341|P1|COMPLETED|Overall Study||23
8253151|NCT01847209|20351341|P1|STARTED|Overall Study||25
8253152|NCT01847196|20351346|P1|NOT COMPLETED|Overall Study||0
8253153|NCT01847196|20351346|P1|COMPLETED|Overall Study||5
8253154|NCT01847196|20351346|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
8253155|NCT01847131|20351353|P2|NOT COMPLETED|Overall Study||0
8253156|NCT01847131|20351354|P1|NOT COMPLETED|Overall Study||0
8253157|NCT01847131|20351353|P2|COMPLETED|Overall Study||25
8253158|NCT01847131|20351354|P1|COMPLETED|Overall Study||25
8253159|NCT01847131|20351353|P2|STARTED|Overall Study||25
8253160|NCT01847131|20351354|P1|STARTED|Overall Study||25
8253161|NCT01847092|20351364|P2|NOT COMPLETED|Overall Study||11
8253162|NCT01847092|20351365|P1|NOT COMPLETED|Overall Study||26
8253163|NCT01847092|20351364|P2|COMPLETED|Overall Study||66
8253164|NCT01847092|20351365|P1|COMPLETED|Overall Study||51
8253165|NCT01847092|20351364|P2|STARTED|Overall Study||77
8253166|NCT01847092|20351365|P1|STARTED|Overall Study||77
8253167|NCT01847027|20351375|P2|NOT COMPLETED|Overall Study||2
8253168|NCT01847027|20351376|P1|NOT COMPLETED|Overall Study||1
8253169|NCT01847027|20351375|P2|COMPLETED|Overall Study||10
8253170|NCT01847027|20351376|P1|COMPLETED|Overall Study||10
8253171|NCT01847027|20351375|P2|STARTED|Overall Study||12
8253172|NCT01847027|20351376|P1|STARTED|Overall Study||11
8253173|NCT01847014|20351386|P1|NOT COMPLETED|Completion of Extension Study||4
8253174|NCT01847014|20351386|P1|COMPLETED|Completion of Extension Study||0
8253175|NCT01847014|20351386|P1|STARTED|Completion of Extension Study||4
8253176|NCT01847014|20351386|P1|NOT COMPLETED|Baseline Extension Visit||0
8253177|NCT01847014|20351386|P1|COMPLETED|Baseline Extension Visit||4
8253178|NCT01847014|20351386|P1|STARTED|Baseline Extension Visit||4
8253179|NCT01847001|20351390|P1|NOT COMPLETED|Overall Study||0
8253180|NCT01847001|20351390|P1|COMPLETED|Overall Study||10
8253181|NCT01847001|20351390|P1|STARTED|Overall Study||10
8253182|NCT01846871|20351394|P1|NOT COMPLETED|Overall Study||0
8253183|NCT01846871|20351394|P1|COMPLETED|Overall Study||10
8253184|NCT01846871|20351394|P1|STARTED|Overall Study||10
8253185|NCT01846741|20351419|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
8253186|NCT01846741|20351419|P1|COMPLETED|Implantation to 18-Month/End of Study||20
8253187|NCT01846741|20351419|P1|STARTED|Implantation to 18-Month/End of Study||20
8253188|NCT01846741|20351419|P1|NOT COMPLETED|Baseline Visit||2
8253189|NCT01846741|20351419|P1|COMPLETED|Baseline Visit||20
8253190|NCT01846741|20351419|P1|STARTED|Baseline Visit||22
8253191|NCT01846728|20351475|P1|NOT COMPLETED|Overall Study||0
8253192|NCT01846728|20351475|P1|COMPLETED|Overall Study||6
8253193|NCT01846728|20351475|P1|STARTED|Overall Study||6
8253194|NCT01846702|20351490|P7|NOT COMPLETED|Overall Study||0
8253195|NCT01846702|20351491|P6|NOT COMPLETED|Overall Study||0
8253196|NCT01846702|20351492|P5|NOT COMPLETED|Overall Study||0
8253197|NCT01846702|20351493|P4|NOT COMPLETED|Overall Study||0
8253198|NCT01846702|20351494|P3|NOT COMPLETED|Overall Study||1
8253199|NCT01846702|20351495|P2|NOT COMPLETED|Overall Study||0
8253200|NCT01846702|20351496|P1|NOT COMPLETED|Overall Study||0
8253201|NCT01846702|20351490|P7|COMPLETED|Overall Study||6
8253202|NCT01846702|20351491|P6|COMPLETED|Overall Study||6
8253203|NCT01846702|20351492|P5|COMPLETED|Overall Study||6
8253204|NCT01846702|20351493|P4|COMPLETED|Overall Study||6
8253205|NCT01846702|20351494|P3|COMPLETED|Overall Study||6
8253206|NCT01846702|20351495|P2|COMPLETED|Overall Study||6
8253207|NCT01846702|20351496|P1|COMPLETED|Overall Study||6
8253208|NCT01846702|20351490|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8253209|NCT01846702|20351491|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
8253210|NCT01846702|20351492|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8253211|NCT01846702|20351493|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8253212|NCT01846702|20351494|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8253213|NCT01846702|20351495|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8253214|NCT01846702|20351496|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8253215|NCT01846702|20351490|P7|STARTED|Overall Study||6
8253216|NCT01846702|20351491|P6|STARTED|Overall Study||6
8253217|NCT01846702|20351492|P5|STARTED|Overall Study||6
8253218|NCT01846702|20351493|P4|STARTED|Overall Study||6
8253219|NCT01846702|20351494|P3|STARTED|Overall Study||7
8253220|NCT01846702|20351495|P2|STARTED|Overall Study||6
8253221|NCT01846702|20351496|P1|STARTED|Overall Study||6
8253222|NCT01846624|20351575|P1|NOT COMPLETED|Overall Study||1
8253223|NCT01846624|20351575|P1|COMPLETED|Overall Study||12
8253224|NCT01846624|20351575|P1|STARTED|Overall Study||13
8253225|NCT01846611|20351585|P2|NOT COMPLETED|Overall Study||43
8253226|NCT01846611|20351586|P1|NOT COMPLETED|Overall Study||38
8253227|NCT01846611|20351585|P2|COMPLETED|Overall Study||244
8253228|NCT01846611|20351586|P1|COMPLETED|Overall Study||251
8253229|NCT01846611|20351585|P2|Treated|Overall Study||282
8253230|NCT01846611|20351586|P1|Treated|Overall Study||286
8253231|NCT01846611|20351585|P2|STARTED|Overall Study||287
8253232|NCT01846611|20351586|P1|STARTED|Overall Study||289
8253233|NCT01846507|20351596|P1|NOT COMPLETED|Overall Study||7
8253234|NCT01846507|20351596|P1|COMPLETED|Overall Study||25
8253235|NCT01846507|20351596|P1|STARTED|Overall Study||32
8253236|NCT01846494|20351615|P2|NOT COMPLETED|Overall Study||38
8253237|NCT01846494|20351616|P1|NOT COMPLETED|Overall Study||30
8253238|NCT01846494|20351615|P2|COMPLETED|Overall Study||25
8253239|NCT01846494|20351616|P1|COMPLETED|Overall Study||20
8253240|NCT01846494|20351615|P2|STARTED|Overall Study||63
8253241|NCT01846494|20351616|P1|STARTED|Overall Study||50
8253242|NCT01846455|20351629|P5|NOT COMPLETED|Overall Study||0
8253243|NCT01846455|20351630|P4|NOT COMPLETED|Overall Study||0
8253244|NCT01846455|20351631|P3|NOT COMPLETED|Overall Study||0
8253245|NCT01846455|20351632|P2|NOT COMPLETED|Overall Study||0
8253246|NCT01846455|20351633|P1|NOT COMPLETED|Overall Study||0
8253247|NCT01846455|20351629|P5|COMPLETED|Overall Study||8
8253248|NCT01846455|20351630|P4|COMPLETED|Overall Study||10
8253249|NCT01846455|20351631|P3|COMPLETED|Overall Study||8
8253250|NCT01846455|20351632|P2|COMPLETED|Overall Study||8
8253251|NCT01846455|20351633|P1|COMPLETED|Overall Study||9
8253252|NCT01846455|20351629|P5|PK Population|Overall Study||8
8253253|NCT01846455|20351630|P4|PK Population|Overall Study||6
8253254|NCT01846455|20351631|P3|PK Population|Overall Study||6
8253255|NCT01846455|20351632|P2|PK Population|Overall Study||7
8253256|NCT01846455|20351633|P1|PK Population|Overall Study||6
8253257|NCT01846455|20351629|P5|STARTED|Overall Study||8
8253258|NCT01846455|20351630|P4|STARTED|Overall Study||10
8253259|NCT01846455|20351631|P3|STARTED|Overall Study||8
8253260|NCT01846455|20351632|P2|STARTED|Overall Study||8
8253261|NCT01846455|20351633|P1|STARTED|Overall Study||9
8253262|NCT01846442|20351694|P4|NOT COMPLETED|Overall Study||3
8253263|NCT01846442|20351695|P3|NOT COMPLETED|Overall Study||4
8253264|NCT01846442|20351696|P2|NOT COMPLETED|Overall Study||6
8253265|NCT01846442|20351697|P1|NOT COMPLETED|Overall Study||6
8253266|NCT01846442|20351694|P4|COMPLETED|Overall Study||51
8253267|NCT01846442|20351695|P3|COMPLETED|Overall Study||52
8253268|NCT01846442|20351696|P2|COMPLETED|Overall Study||48
8253269|NCT01846442|20351697|P1|COMPLETED|Overall Study||48
8253270|NCT01846442|20351694|P4|ITT Population|Overall Study||54
8253271|NCT01846442|20351695|P3|ITT Population|Overall Study||56
8253272|NCT01846442|20351696|P2|ITT Population|Overall Study||53
8253273|NCT01846442|20351697|P1|ITT Population|Overall Study||53
8253274|NCT01846442|20351694|P4|Safety Population|Overall Study||54
8253275|NCT01846442|20351695|P3|Safety Population|Overall Study||56
8253276|NCT01846442|20351696|P2|Safety Population|Overall Study||53
8253277|NCT01846442|20351697|P1|Safety Population|Overall Study||54
8253278|NCT01846442|20351694|P4|STARTED|Overall Study||54
8253279|NCT01846442|20351695|P3|STARTED|Overall Study||56
8253280|NCT01846442|20351696|P2|STARTED|Overall Study||54
8253281|NCT01846442|20351697|P1|STARTED|Overall Study||54
8253282|NCT01846416|20351738|P3|NOT COMPLETED|Survival Follow-up||12
8253283|NCT01846416|20351739|P2|NOT COMPLETED|Survival Follow-up||80
8253284|NCT01846416|20351740|P1|NOT COMPLETED|Survival Follow-up||28
8253285|NCT01846416|20351738|P3|COMPLETED|Survival Follow-up||0
8253286|NCT01846416|20351739|P2|COMPLETED|Survival Follow-up||0
8253287|NCT01846416|20351740|P1|COMPLETED|Survival Follow-up||0
8253288|NCT01846416|20351738|P3|STARTED|Survival Follow-up||12
8253289|NCT01846416|20351739|P2|STARTED|Survival Follow-up||80
8253290|NCT01846416|20351740|P1|STARTED|Survival Follow-up||28
8253291|NCT01846416|20351738|P3|NOT COMPLETED|Treatment Phase||13
8253292|NCT01846416|20351739|P2|NOT COMPLETED|Treatment Phase||93
8253293|NCT01846416|20351740|P1|NOT COMPLETED|Treatment Phase||31
8253294|NCT01846416|20351738|P3|COMPLETED|Treatment Phase||0
8253295|NCT01846416|20351739|P2|COMPLETED|Treatment Phase||0
8253296|NCT01846416|20351740|P1|COMPLETED|Treatment Phase||0
8253297|NCT01846416|20351738|P3|STARTED|Treatment Phase||13
8253298|NCT01846416|20351739|P2|STARTED|Treatment Phase||93
8253299|NCT01846416|20351740|P1|STARTED|Treatment Phase||31
8253300|NCT01846299|20351785|P2|NOT COMPLETED|Overall Study||10
8253301|NCT01846299|20351786|P1|NOT COMPLETED|Overall Study||12
8253302|NCT01846299|20351785|P2|COMPLETED|Overall Study||50
8253303|NCT01846299|20351786|P1|COMPLETED|Overall Study||106
8253304|NCT01846299|20351785|P2|Safety Set|Overall Study||58
8253305|NCT01846299|20351786|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
8253306|NCT01846299|20351785|P2|Full Analysis Set|Overall Study||60
8253307|NCT01846299|20351786|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
8253308|NCT01846299|20351785|P2|STARTED|Overall Study||60
8253309|NCT01846299|20351786|P1|STARTED|Overall Study||118
8253310|NCT01846273|20351825|P3|NOT COMPLETED|Overall Study||0
8253311|NCT01846273|20351826|P2|NOT COMPLETED|Overall Study||26
8253312|NCT01846273|20351827|P1|NOT COMPLETED|Overall Study||22
8253313|NCT01846273|20351825|P3|COMPLETED|Overall Study||41
8253314|NCT01846273|20351826|P2|COMPLETED|Overall Study||87
8253315|NCT01846273|20351827|P1|COMPLETED|Overall Study||146
8253316|NCT01846273|20351825|P3|Safety Analysis Set|Overall Study||14
8253317|NCT01846273|20351826|P2|Safety Analysis Set|Overall Study||135
8253318|NCT01846273|20351827|P1|Safety Analysis Set|Overall Study||172
8253319|NCT01846273|20351825|P3|STARTED|Overall Study||41
8253320|NCT01846273|20351826|P2|STARTED|Overall Study||113
8253321|NCT01846273|20351827|P1|STARTED|Overall Study||168
8253322|NCT01846221|20351883|P2|NOT COMPLETED|Overall Study||0
8253323|NCT01846221|20351884|P1|NOT COMPLETED|Overall Study||3
8253324|NCT01846221|20351883|P2|COMPLETED|Overall Study||51
8253325|NCT01846221|20351884|P1|COMPLETED|Overall Study||47
8253326|NCT01846221|20351883|P2|STARTED|Overall Study||51
8253327|NCT01846221|20351884|P1|STARTED|Overall Study||50
8253328|NCT01846208|20351901|P3|NOT COMPLETED|Overall Study||8
8253329|NCT01846208|20351902|P2|NOT COMPLETED|Overall Study||4
8253330|NCT01846208|20351903|P1|NOT COMPLETED|Overall Study||9
8253331|NCT01846208|20351901|P3|COMPLETED|Overall Study||32
8253332|NCT01846208|20351902|P2|COMPLETED|Overall Study||20
8253333|NCT01846208|20351903|P1|COMPLETED|Overall Study||19
8253334|NCT01846208|20351901|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
8253335|NCT01846208|20351902|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
8253336|NCT01846208|20351903|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
8253337|NCT01846208|20351901|P3|Year 2 Desensitization OFC|Overall Study||33
8253338|NCT01846208|20351902|P2|Year 2 Desensitization OFC|Overall Study||20
8253339|NCT01846208|20351903|P1|Year 2 Desensitization OFC|Overall Study||19
8253340|NCT01846208|20351901|P3|Year 1 Desensitization OFC|Overall Study||34
8253341|NCT01846208|20351902|P2|Year 1 Desensitization OFC|Overall Study||20
8253342|NCT01846208|20351903|P1|Year 1 Desensitization OFC|Overall Study||23
8253343|NCT01846208|20351901|P3|Initiatiated Treatment|Overall Study||39
8253344|NCT01846208|20351902|P2|Initiatiated Treatment|Overall Study||23
8253345|NCT01846208|20351903|P1|Initiatiated Treatment|Overall Study||27
8253346|NCT01846208|20351901|P3|STARTED|Overall Study||40
8253347|NCT01846208|20351902|P2|STARTED|Overall Study||24
8253348|NCT01846208|20351903|P1|STARTED|Overall Study||28
8253349|NCT01846104|20351923|P1|NOT COMPLETED|Overall Study||1
8253350|NCT01846104|20351923|P1|COMPLETED|Overall Study||3
8253351|NCT01846104|20351923|P1|STARTED|Overall Study||4
8253352|NCT01846039|20351929|P1|NOT COMPLETED|Overall Study||2
8253353|NCT01846039|20351929|P1|COMPLETED|Overall Study||27
8253354|NCT01846039|20351929|P1|STARTED|Overall Study||29
8253355|NCT01845974|20351941|P2|NOT COMPLETED|Overall Study||0
8253356|NCT01845974|20351942|P1|NOT COMPLETED|Overall Study||1
8253357|NCT01845974|20351941|P2|COMPLETED|Overall Study||9
8253358|NCT01845974|20351942|P1|COMPLETED|Overall Study||3
8253359|NCT01845974|20351941|P2|STARTED|Overall Study||9
8253360|NCT01845974|20351942|P1|STARTED|Overall Study||4
8253361|NCT01845831|20351950|P5|NOT COMPLETED|Outpatient Phase||0
8253362|NCT01845831|20351951|P4|NOT COMPLETED|Outpatient Phase||0
8253363|NCT01845831|20351952|P3|NOT COMPLETED|Outpatient Phase||0
8253364|NCT01845831|20351953|P2|NOT COMPLETED|Outpatient Phase||0
8253365|NCT01845831|20351954|P1|NOT COMPLETED|Outpatient Phase||0
8253366|NCT01845831|20351950|P5|COMPLETED|Outpatient Phase||87
8253367|NCT01845831|20351951|P4|COMPLETED|Outpatient Phase||98
8253368|NCT01845831|20351952|P3|COMPLETED|Outpatient Phase||68
8253369|NCT01845831|20351953|P2|COMPLETED|Outpatient Phase||0
8253370|NCT01845831|20351954|P1|COMPLETED|Outpatient Phase||0
8253371|NCT01845831|20351950|P5|STARTED|Outpatient Phase||87
8253372|NCT01845831|20351951|P4|STARTED|Outpatient Phase||98
8253373|NCT01845831|20351952|P3|STARTED|Outpatient Phase||68
8253374|NCT01845831|20351953|P2|STARTED|Outpatient Phase||0
8253375|NCT01845831|20351954|P1|STARTED|Outpatient Phase||0
8253376|NCT01845831|20351950|P5|NOT COMPLETED|Inpatient Phase||0
8253377|NCT01845831|20351951|P4|NOT COMPLETED|Inpatient Phase||0
8253378|NCT01845831|20351952|P3|NOT COMPLETED|Inpatient Phase||0
8253379|NCT01845831|20351953|P2|NOT COMPLETED|Inpatient Phase||1
8253380|NCT01845831|20351954|P1|NOT COMPLETED|Inpatient Phase||1
8253381|NCT01845831|20351950|P5|COMPLETED|Inpatient Phase||0
8253382|NCT01845831|20351951|P4|COMPLETED|Inpatient Phase||0
8253383|NCT01845831|20351952|P3|COMPLETED|Inpatient Phase||0
8253384|NCT01845831|20351953|P2|COMPLETED|Inpatient Phase||138
8253385|NCT01845831|20351954|P1|COMPLETED|Inpatient Phase||139
8253386|NCT01845831|20351950|P5|STARTED|Inpatient Phase||0
8253387|NCT01845831|20351951|P4|STARTED|Inpatient Phase||0
8253388|NCT01845831|20351952|P3|STARTED|Inpatient Phase||0
8253389|NCT01845831|20351953|P2|STARTED|Inpatient Phase||139
8253390|NCT01845831|20351954|P1|STARTED|Inpatient Phase||140
8253391|NCT01845818|20351983|P2|NOT COMPLETED|Overall Study||17
8253392|NCT01845818|20351984|P1|NOT COMPLETED|Overall Study||45
8253393|NCT01845818|20351983|P2|COMPLETED|Overall Study||40
8253394|NCT01845818|20351984|P1|COMPLETED|Overall Study||81
8253395|NCT01845818|20351983|P2|STARTED|Overall Study||57
8253396|NCT01845818|20351984|P1|STARTED|Overall Study||126
8253397|NCT01845792|20352025|P2|NOT COMPLETED|Overall Study||0
8253398|NCT01845792|20352026|P1|NOT COMPLETED|Overall Study||0
8253399|NCT01845792|20352025|P2|COMPLETED|Overall Study||2
8253400|NCT01845792|20352026|P1|COMPLETED|Overall Study||5
8253401|NCT01845792|20352025|P2|STARTED|Overall Study||2
8253402|NCT01845792|20352026|P1|STARTED|Overall Study||5
8253403|NCT01845636|20352034|P1|NOT COMPLETED|Overall Study||4
8253404|NCT01845636|20352034|P1|COMPLETED|Overall Study||37
8253405|NCT01845636|20352034|P1|STARTED|Overall Study||41
8253406|NCT01845220|20352042|P2|NOT COMPLETED|Overall Study||0
8253407|NCT01845220|20352043|P1|NOT COMPLETED|Overall Study||0
8253408|NCT01845220|20352042|P2|COMPLETED|Overall Study||30
8253409|NCT01845220|20352043|P1|COMPLETED|Overall Study||30
8253410|NCT01845220|20352042|P2|STARTED|Overall Study||30
8253411|NCT01845220|20352043|P1|STARTED|Overall Study||30
8253412|NCT01845155|20352051|P2|NOT COMPLETED|Overall Study||0
8253413|NCT01845155|20352052|P1|NOT COMPLETED|Overall Study||1
8253414|NCT01845155|20352051|P2|COMPLETED|Overall Study||144
8253415|NCT01845155|20352052|P1|COMPLETED|Overall Study||145
8253416|NCT01845155|20352051|P2|STARTED|Overall Study||144
8253417|NCT01845155|20352052|P1|STARTED|Overall Study||146
8253418|NCT01845103|20352060|P1|NOT COMPLETED|Overall Study||0
8253419|NCT01845103|20352060|P1|COMPLETED|Overall Study||1
8253420|NCT01845103|20352060|P1|STARTED|Overall Study||1
8253421|NCT01845077|20352068|P6|NOT COMPLETED|Treatment Period 2||0
8253422|NCT01845077|20352069|P5|NOT COMPLETED|Treatment Period 2||0
8253423|NCT01845077|20352070|P4|NOT COMPLETED|Treatment Period 2||0
8253424|NCT01845077|20352071|P3|NOT COMPLETED|Treatment Period 2||0
8253425|NCT01845077|20352072|P2|NOT COMPLETED|Treatment Period 2||0
8253426|NCT01845077|20352073|P1|NOT COMPLETED|Treatment Period 2||0
8253427|NCT01845077|20352068|P6|COMPLETED|Treatment Period 2||11
8253428|NCT01845077|20352069|P5|COMPLETED|Treatment Period 2||11
8253429|NCT01845077|20352070|P4|COMPLETED|Treatment Period 2||10
8253430|NCT01845077|20352071|P3|COMPLETED|Treatment Period 2||11
8253431|NCT01845077|20352072|P2|COMPLETED|Treatment Period 2||11
8253432|NCT01845077|20352073|P1|COMPLETED|Treatment Period 2||11
8253433|NCT01845077|20352068|P6|STARTED|Treatment Period 2||11
8253434|NCT01845077|20352069|P5|STARTED|Treatment Period 2||11
8253435|NCT01845077|20352070|P4|STARTED|Treatment Period 2||10
8253436|NCT01845077|20352071|P3|STARTED|Treatment Period 2||11
8253437|NCT01845077|20352072|P2|STARTED|Treatment Period 2||11
8253438|NCT01845077|20352073|P1|STARTED|Treatment Period 2||11
8253439|NCT01845077|20352068|P6|NOT COMPLETED|Washout Period||1
8253440|NCT01845077|20352069|P5|NOT COMPLETED|Washout Period||1
8253441|NCT01845077|20352070|P4|NOT COMPLETED|Washout Period||2
8253442|NCT01845077|20352071|P3|NOT COMPLETED|Washout Period||1
8253443|NCT01845077|20352072|P2|NOT COMPLETED|Washout Period||1
8253444|NCT01845077|20352073|P1|NOT COMPLETED|Washout Period||1
8253445|NCT01845077|20352068|P6|COMPLETED|Washout Period||11
8253446|NCT01845077|20352069|P5|COMPLETED|Washout Period||11
8253447|NCT01845077|20352070|P4|COMPLETED|Washout Period||10
8253448|NCT01845077|20352071|P3|COMPLETED|Washout Period||11
8253449|NCT01845077|20352072|P2|COMPLETED|Washout Period||11
8253450|NCT01845077|20352073|P1|COMPLETED|Washout Period||11
8253451|NCT01845077|20352068|P6|STARTED|Washout Period||12
8253452|NCT01845077|20352069|P5|STARTED|Washout Period||12
8253453|NCT01845077|20352070|P4|STARTED|Washout Period||12
8253454|NCT01845077|20352071|P3|STARTED|Washout Period||12
8253455|NCT01845077|20352072|P2|STARTED|Washout Period||12
8253456|NCT01845077|20352073|P1|STARTED|Washout Period||12
8253457|NCT01845077|20352068|P6|NOT COMPLETED|Treatment Period 1||0
8253458|NCT01845077|20352069|P5|NOT COMPLETED|Treatment Period 1||0
8253459|NCT01845077|20352070|P4|NOT COMPLETED|Treatment Period 1||0
8253460|NCT01845077|20352071|P3|NOT COMPLETED|Treatment Period 1||0
8253461|NCT01845077|20352072|P2|NOT COMPLETED|Treatment Period 1||0
8253462|NCT01845077|20352073|P1|NOT COMPLETED|Treatment Period 1||0
8253463|NCT01845077|20352068|P6|COMPLETED|Treatment Period 1||12
8253464|NCT01845077|20352069|P5|COMPLETED|Treatment Period 1||12
8253465|NCT01845077|20352070|P4|COMPLETED|Treatment Period 1||12
8253466|NCT01845077|20352071|P3|COMPLETED|Treatment Period 1||12
8253467|NCT01845077|20352072|P2|COMPLETED|Treatment Period 1||12
8253468|NCT01845077|20352073|P1|COMPLETED|Treatment Period 1||12
8253469|NCT01845077|20352068|P6|STARTED|Treatment Period 1||12
8253470|NCT01845077|20352069|P5|STARTED|Treatment Period 1||12
8253471|NCT01845077|20352070|P4|STARTED|Treatment Period 1||12
8253472|NCT01845077|20352071|P3|STARTED|Treatment Period 1||12
8253473|NCT01845077|20352072|P2|STARTED|Treatment Period 1||12
8253474|NCT01845077|20352073|P1|STARTED|Treatment Period 1||12
8253475|NCT01845025|20352119|P2|NOT COMPLETED|Overall Study||77
8253476|NCT01845025|20352120|P1|NOT COMPLETED|Overall Study||85
8253477|NCT01845025|20352119|P2|COMPLETED|Overall Study||332
8253478|NCT01845025|20352120|P1|COMPLETED|Overall Study||326
8253479|NCT01845025|20352119|P2|STARTED|Overall Study||409
8253480|NCT01845025|20352120|P1|STARTED|Overall Study||411
8253487|NCT01844895|20352167|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
8253488|NCT01844895|20352167|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
8253489|NCT01844895|20352167|P1|STARTED|Day 29 - Day113 - Autoinjector||117
8253490|NCT01844895|20352167|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
8253491|NCT01844895|20352167|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
8253492|NCT01844895|20352167|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
8253493|NCT01844856|20352185|P2|NOT COMPLETED|Overall Study||16
8253494|NCT01844856|20352186|P1|NOT COMPLETED|Overall Study||24
8253495|NCT01844856|20352185|P2|COMPLETED|Overall Study||255
8253496|NCT01844856|20352186|P1|COMPLETED|Overall Study||246
8253497|NCT01844856|20352185|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
8253498|NCT01844856|20352186|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
8253499|NCT01844856|20352185|P2|STARTED|Overall Study||271
8253500|NCT01844856|20352186|P1|STARTED|Overall Study||270
8253501|NCT01844830|20352198|P2|NOT COMPLETED|Overall Study||0
8253502|NCT01844830|20352199|P1|NOT COMPLETED|Overall Study||1
8253503|NCT01844830|20352198|P2|COMPLETED|Overall Study||30
8253504|NCT01844830|20352199|P1|COMPLETED|Overall Study||59
8253505|NCT01844830|20352198|P2|400 µL Dose|Overall Study||10
8253506|NCT01844830|20352199|P1|400 µL Dose|Overall Study||20
8253507|NCT01844830|20352198|P2|200 µL Dose|Overall Study||12
8253508|NCT01844830|20352199|P1|200 µL Dose|Overall Study||24
8253509|NCT01844830|20352198|P2|100 µL Dose|Overall Study||8
8253510|NCT01844830|20352199|P1|100 µL Dose|Overall Study||16
8253511|NCT01844830|20352198|P2|STARTED|Overall Study||30
8253512|NCT01844830|20352199|P1|STARTED|Overall Study||60
8253513|NCT01844817|20352229|P2|NOT COMPLETED|Treatment||63
8253514|NCT01844817|20352230|P1|NOT COMPLETED|Treatment||64
8253515|NCT01844817|20352229|P2|COMPLETED|Treatment||0
8253516|NCT01844817|20352230|P1|COMPLETED|Treatment||0
8253517|NCT01844817|20352229|P2|STARTED|Treatment||63
8253518|NCT01844817|20352230|P1|STARTED|Treatment||64
8253519|NCT01844817|20352229|P2|NOT COMPLETED|Enrolled and Randomized||3
8253520|NCT01844817|20352230|P1|NOT COMPLETED|Enrolled and Randomized||2
8253521|NCT01844817|20352229|P2|COMPLETED|Enrolled and Randomized||63
8253522|NCT01844817|20352230|P1|COMPLETED|Enrolled and Randomized||64
8253523|NCT01844817|20352229|P2|STARTED|Enrolled and Randomized||66
8253524|NCT01844817|20352230|P1|STARTED|Enrolled and Randomized||66
8253525|NCT01844778|20352243|P3|NOT COMPLETED|Overall Study||4
8253526|NCT01844778|20352244|P2|NOT COMPLETED|Overall Study||3
8253527|NCT01844778|20352245|P1|NOT COMPLETED|Overall Study||2
8253528|NCT01844778|20352243|P3|COMPLETED|Overall Study||14
8253529|NCT01844778|20352244|P2|COMPLETED|Overall Study||25
8253530|NCT01844778|20352245|P1|COMPLETED|Overall Study||12
8253531|NCT01844778|20352243|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
8253532|NCT01844778|20352244|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
8253533|NCT01844778|20352245|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
8253534|NCT01844778|20352243|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
8253535|NCT01844778|20352244|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
8253536|NCT01844778|20352245|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
8253537|NCT01844778|20352243|P3|STARTED|Overall Study||18
8253538|NCT01844778|20352244|P2|STARTED|Overall Study||28
8253539|NCT01844778|20352245|P1|STARTED|Overall Study||14
8253540|NCT01844765|20352271|P2|NOT COMPLETED|Overall Study||6
8253541|NCT01844765|20352272|P1|NOT COMPLETED|Overall Study||9
8253542|NCT01844765|20352271|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
8253543|NCT01844765|20352272|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
8253544|NCT01844765|20352271|P2|Untreated|Overall Study||0
8253545|NCT01844765|20352272|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
8253546|NCT01844765|20352271|P2|Treated|Overall Study||25
8253547|NCT01844765|20352272|P1|Treated|Overall Study||33
8253548|NCT01844765|20352271|P2|STARTED|Overall Study||25
8253549|NCT01844765|20352272|P1|STARTED|Overall Study||34
8253550|NCT01844700|20352292|P2|NOT COMPLETED|Overall Study||1
8253551|NCT01844700|20352293|P1|NOT COMPLETED|Overall Study||3
8253552|NCT01844700|20352292|P2|COMPLETED|Overall Study||2
8253553|NCT01844700|20352293|P1|COMPLETED|Overall Study||1
8253554|NCT01844700|20352292|P2|STARTED|Overall Study||3
8253555|NCT01844700|20352293|P1|STARTED|Overall Study||4
8253556|NCT01844687|20352305|P1|NOT COMPLETED|Visit 8||0
8253557|NCT01844687|20352305|P1|COMPLETED|Visit 8||31
8253558|NCT01844687|20352305|P1|STARTED|Visit 8||31
8253559|NCT01844687|20352305|P1|NOT COMPLETED|Visit 7||0
8253560|NCT01844687|20352305|P1|COMPLETED|Visit 7||31
8253561|NCT01844687|20352305|P1|STARTED|Visit 7||31
8253562|NCT01844687|20352305|P1|NOT COMPLETED|Visit 6||0
8253563|NCT01844687|20352305|P1|COMPLETED|Visit 6||31
8253564|NCT01844687|20352305|P1|STARTED|Visit 6||31
8253565|NCT01844687|20352305|P1|NOT COMPLETED|Visit 5||0
8253566|NCT01844687|20352305|P1|COMPLETED|Visit 5||31
8253567|NCT01844687|20352305|P1|STARTED|Visit 5||31
8253568|NCT01844687|20352305|P1|NOT COMPLETED|Visit 4||4
8253569|NCT01844687|20352305|P1|COMPLETED|Visit 4||31
8253570|NCT01844687|20352305|P1|STARTED|Visit 4||35
8253571|NCT01844687|20352305|P1|NOT COMPLETED|Visit 3||5
8253572|NCT01844687|20352305|P1|COMPLETED|Visit 3||35
8253573|NCT01844687|20352305|P1|STARTED|Visit 3||40
8253574|NCT01844687|20352305|P1|NOT COMPLETED|Visit 2||2
8253575|NCT01844687|20352305|P1|COMPLETED|Visit 2||40
8253576|NCT01844687|20352305|P1|STARTED|Visit 2||42
8253577|NCT01844687|20352305|P1|NOT COMPLETED|Visit 1||8
8253578|NCT01844687|20352305|P1|COMPLETED|Visit 1||42
8253579|NCT01844687|20352305|P1|STARTED|Visit 1||50
8253580|NCT01844583|20352366|P2|NOT COMPLETED|Overall Study||10
8253581|NCT01844583|20352367|P1|NOT COMPLETED|Overall Study||8
8253582|NCT01844583|20352366|P2|COMPLETED|Overall Study||19
8253583|NCT01844583|20352367|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
8253584|NCT01844583|20352366|P2|STARTED|Overall Study||29
8253585|NCT01844583|20352367|P1|STARTED|Overall Study||26
8253586|NCT01844531|20352399|P4|NOT COMPLETED|Overall Study||0
8253587|NCT01844531|20352400|P3|NOT COMPLETED|Overall Study||0
8253588|NCT01844531|20352401|P2|NOT COMPLETED|Overall Study||1
8253589|NCT01844531|20352402|P1|NOT COMPLETED|Overall Study||0
8253590|NCT01844531|20352399|P4|COMPLETED|Overall Study||6
8253591|NCT01844531|20352400|P3|COMPLETED|Overall Study||6
8253592|NCT01844531|20352401|P2|COMPLETED|Overall Study||5
8253593|NCT01844531|20352402|P1|COMPLETED|Overall Study||6
8253594|NCT01844531|20352399|P4|STARTED|Overall Study||6
8253595|NCT01844531|20352400|P3|STARTED|Overall Study||6
8253596|NCT01844531|20352401|P2|STARTED|Overall Study||6
8253597|NCT01844531|20352402|P1|STARTED|Overall Study||6
8253598|NCT01844518|20352432|P1|NOT COMPLETED|Long-Term Extension||157
8253599|NCT01844518|20352432|P1|COMPLETED|Long-Term Extension|Study is on-going|0
8253600|NCT01844518|20352432|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
8253601|NCT01844518|20352432|P1|NOT COMPLETED|Short-Term (ST) Period||9
8253602|NCT01844518|20352432|P1|COMPLETED|Short-Term (ST) Period||164
8253603|NCT01844518|20352432|P1|STARTED|Short-Term (ST) Period||173
8253604|NCT01844505|20352449|P3|NOT COMPLETED|Overall Study||295
8253605|NCT01844505|20352450|P2|NOT COMPLETED|Overall Study||269
8253606|NCT01844505|20352451|P1|NOT COMPLETED|Overall Study||249
8253607|NCT01844505|20352449|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
8253608|NCT01844505|20352450|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
8253609|NCT01844505|20352451|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
8253610|NCT01844505|20352449|P3|STARTED|Overall Study||311
8253611|NCT01844505|20352450|P2|STARTED|Overall Study||313
8253612|NCT01844505|20352451|P1|STARTED|Overall Study||313
8253613|NCT01844479|20352501|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
8253614|NCT01844479|20352502|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
8253615|NCT01844479|20352501|P2|COMPLETED|Second Intervention up to 30 Minutes||13
8253616|NCT01844479|20352502|P1|COMPLETED|Second Intervention up to 30 Minutes||14
8253617|NCT01844479|20352501|P2|STARTED|Second Intervention up to 30 Minutes||13
8253618|NCT01844479|20352502|P1|STARTED|Second Intervention up to 30 Minutes||14
8253619|NCT01844479|20352501|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
8253620|NCT01844479|20352502|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
8253621|NCT01844479|20352501|P2|COMPLETED|First Intervention up to 30 Minutes||13
8253622|NCT01844479|20352502|P1|COMPLETED|First Intervention up to 30 Minutes||14
8253623|NCT01844479|20352501|P2|STARTED|First Intervention up to 30 Minutes||13
8253624|NCT01844479|20352502|P1|STARTED|First Intervention up to 30 Minutes||14
8253625|NCT01844388|20352532|P2|NOT COMPLETED|Overall Study||7
8253626|NCT01844388|20352533|P1|NOT COMPLETED|Overall Study||8
8253627|NCT01844388|20352532|P2|COMPLETED|Overall Study||114
8253628|NCT01844388|20352533|P1|COMPLETED|Overall Study||236
8253629|NCT01844388|20352532|P2|STARTED|Overall Study||121
8253630|NCT01844388|20352533|P1|STARTED|Overall Study||244
8253631|NCT01844375|20352545|P2|NOT COMPLETED|Overall Study||1
8253632|NCT01844375|20352546|P1|NOT COMPLETED|Overall Study||1
8253633|NCT01844375|20352545|P2|COMPLETED|Overall Study||34
8253634|NCT01844375|20352546|P1|COMPLETED|Overall Study||34
8253635|NCT01844375|20352545|P2|STARTED|Overall Study||35
8253636|NCT01844375|20352546|P1|STARTED|Overall Study||35
8253637|NCT01844284|20352558|P2|NOT COMPLETED|Overall Study||7
8253638|NCT01844284|20352559|P1|NOT COMPLETED|Overall Study||12
8253639|NCT01844284|20352558|P2|COMPLETED|Overall Study||127
8253640|NCT01844284|20352559|P1|COMPLETED|Overall Study||254
8253641|NCT01844284|20352558|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|134
8253642|NCT01844284|20352559|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|266
8253643|NCT01844206|20352769|P2|NOT COMPLETED|Overall Study||1
8253644|NCT01844206|20352770|P1|NOT COMPLETED|Overall Study||0
8253645|NCT01844206|20352769|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
8253646|NCT01844206|20352770|P1|COMPLETED|Overall Study||2
8253647|NCT01844206|20352769|P2|STARTED|Overall Study||3
8253648|NCT01844206|20352770|P1|STARTED|Overall Study||2
8253649|NCT01844115|20352778|P2|NOT COMPLETED|Overall Study||58
8253650|NCT01844115|20352779|P1|NOT COMPLETED|Overall Study||39
8253651|NCT01844115|20352778|P2|COMPLETED|Overall Study||144
8253652|NCT01844115|20352779|P1|COMPLETED|Overall Study||163
8253653|NCT01844115|20352778|P2|STARTED|Overall Study||202
8253654|NCT01844115|20352779|P1|STARTED|Overall Study||202
8253655|NCT01843972|20352797|P10|NOT COMPLETED|Overall Study||0
8253656|NCT01843972|20352798|P9|NOT COMPLETED|Overall Study||0
8253657|NCT01843972|20352799|P8|NOT COMPLETED|Overall Study||0
8253658|NCT01843972|20352800|P7|NOT COMPLETED|Overall Study||0
8253659|NCT01843972|20352801|P6|NOT COMPLETED|Overall Study||0
8253660|NCT01843972|20352802|P5|NOT COMPLETED|Overall Study||1
8253661|NCT01843972|20352803|P4|NOT COMPLETED|Overall Study||0
8253662|NCT01843972|20352804|P3|NOT COMPLETED|Overall Study||0
8253663|NCT01843972|20352805|P2|NOT COMPLETED|Overall Study||0
8253664|NCT01843972|20352806|P1|NOT COMPLETED|Overall Study||0
8253665|NCT01843972|20352797|P10|COMPLETED|Overall Study||12
8253666|NCT01843972|20352798|P9|COMPLETED|Overall Study||17
8253667|NCT01843972|20352799|P8|COMPLETED|Overall Study||5
8253668|NCT01843972|20352800|P7|COMPLETED|Overall Study||5
8253669|NCT01843972|20352801|P6|COMPLETED|Overall Study||6
8253670|NCT01843972|20352802|P5|COMPLETED|Overall Study||5
8253671|NCT01843972|20352803|P4|COMPLETED|Overall Study||6
8253672|NCT01843972|20352804|P3|COMPLETED|Overall Study||5
8253673|NCT01843972|20352805|P2|COMPLETED|Overall Study||6
8253674|NCT01843972|20352806|P1|COMPLETED|Overall Study||13
8253675|NCT01843972|20352797|P10|STARTED|Overall Study||12
8253676|NCT01843972|20352798|P9|STARTED|Overall Study||17
8253677|NCT01843972|20352799|P8|STARTED|Overall Study||5
8253678|NCT01843972|20352800|P7|STARTED|Overall Study||5
8253679|NCT01843972|20352801|P6|STARTED|Overall Study||6
8253680|NCT01843972|20352802|P5|STARTED|Overall Study||6
8253681|NCT01843972|20352803|P4|STARTED|Overall Study||6
8253682|NCT01843972|20352804|P3|STARTED|Overall Study||5
8253683|NCT01843972|20352805|P2|STARTED|Overall Study||6
8253684|NCT01843972|20352806|P1|STARTED|Overall Study||13
8253685|NCT01843933|20352876|P2|NOT COMPLETED|Overall Study||4
8253686|NCT01843933|20352877|P1|NOT COMPLETED|Overall Study||6
8253687|NCT01843933|20352876|P2|COMPLETED|Overall Study||103
8253688|NCT01843933|20352877|P1|COMPLETED|Overall Study||98
8253689|NCT01843933|20352876|P2|STARTED|Overall Study||107
8253690|NCT01843933|20352877|P1|STARTED|Overall Study||104
8253691|NCT01843920|20352885|P2|NOT COMPLETED|Overall Study||0
8253692|NCT01843920|20352886|P1|NOT COMPLETED|Overall Study||0
8253693|NCT01843920|20352885|P2|COMPLETED|Overall Study||9
8253694|NCT01843920|20352886|P1|COMPLETED|Overall Study||12
8253695|NCT01843920|20352885|P2|STARTED|Overall Study||9
8253696|NCT01843920|20352886|P1|STARTED|Overall Study||12
8253697|NCT01843842|20352896|P2|NOT COMPLETED|Overall Study||1
8253698|NCT01843842|20352897|P1|NOT COMPLETED|Overall Study||1
8253699|NCT01843842|20352896|P2|COMPLETED|Overall Study||151
8253700|NCT01843842|20352897|P1|COMPLETED|Overall Study||153
8253701|NCT01843842|20352896|P2|STARTED|Overall Study||152
8253702|NCT01843842|20352897|P1|STARTED|Overall Study||154
8253703|NCT01843803|20352919|P2|NOT COMPLETED|Overall Study||3
8253704|NCT01843803|20352920|P1|NOT COMPLETED|Overall Study||1
8253705|NCT01843803|20352919|P2|COMPLETED|Overall Study||136
8253706|NCT01843803|20352920|P1|COMPLETED|Overall Study||136
8253707|NCT01843803|20352919|P2|STARTED|Overall Study||139
8253708|NCT01843803|20352920|P1|STARTED|Overall Study||137
8253709|NCT01843777|20352934|P2|NOT COMPLETED|Overall Study||0
8253710|NCT01843777|20352935|P1|NOT COMPLETED|Overall Study||1
8253711|NCT01843777|20352934|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
8253712|NCT01843777|20352935|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
8253713|NCT01843777|20352934|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
8253714|NCT01843777|20352935|P1|Per Protocol Population|Overall Study||11
8253715|NCT01843777|20352934|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
8253716|NCT01843777|20352935|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
8253717|NCT01843751|20352945|P2|NOT COMPLETED|Overall Study||7
8253718|NCT01843751|20352946|P1|NOT COMPLETED|Overall Study||11
8253719|NCT01843751|20352945|P2|COMPLETED|Overall Study||3
8253720|NCT01843751|20352946|P1|COMPLETED|Overall Study||0
8253721|NCT01843751|20352945|P2|STARTED|Overall Study||10
8253722|NCT01843751|20352946|P1|STARTED|Overall Study||11
8253723|NCT01843673|20352960|P1|NOT COMPLETED|Overall Study||6
8253724|NCT01843673|20352960|P1|COMPLETED|Overall Study||10
8253725|NCT01843673|20352960|P1|STARTED|Overall Study||16
8253726|NCT01843660|20352972|P1|NOT COMPLETED|Overall Study||30
8253727|NCT01843660|20352972|P1|COMPLETED|Overall Study||1029
8253728|NCT01843660|20352972|P1|STARTED|Overall Study||1059
8253729|NCT01843621|20352990|P1|NOT COMPLETED|Overall Study||0
8253730|NCT01843621|20352990|P1|COMPLETED|Overall Study||7
8253731|NCT01843621|20352990|P1|STARTED|Overall Study||7
8253732|NCT01843465|20353007|P1|NOT COMPLETED|Overall Study||0
8253733|NCT01843465|20353007|P1|COMPLETED|Overall Study||34
8253734|NCT01843465|20353007|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
8253743|NCT01843348|20353041|P3|NOT COMPLETED|Overall Study||41
8253744|NCT01843348|20353042|P2|NOT COMPLETED|Overall Study||40
8253745|NCT01843348|20353043|P1|NOT COMPLETED|Overall Study||23
8253746|NCT01843348|20353041|P3|COMPLETED|Overall Study||158
8253747|NCT01843348|20353042|P2|COMPLETED|Overall Study||168
8253748|NCT01843348|20353043|P1|COMPLETED|Overall Study||182
8253749|NCT01843348|20353041|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
8253750|NCT01843348|20353042|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
8253751|NCT01843348|20353043|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
8253752|NCT01843348|20353041|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
8253753|NCT01843348|20353042|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
8253754|NCT01843348|20353043|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
8253755|NCT01843348|20353041|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
8253756|NCT01843348|20353042|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
8253846|NCT01842620|20353327|P2|NOT COMPLETED|Period 1||0
8253847|NCT01842620|20353328|P1|NOT COMPLETED|Period 1||1
8253757|NCT01843348|20353043|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
8253758|NCT01843348|20353041|P3|STARTED|Overall Study||199
8253759|NCT01843348|20353042|P2|STARTED|Overall Study||208
8253760|NCT01843348|20353043|P1|STARTED|Overall Study||205
8253761|NCT01843205|20353083|P2|NOT COMPLETED|Second Treatment (11 Days)||0
8253762|NCT01843205|20353084|P1|NOT COMPLETED|Second Treatment (11 Days)||0
8253763|NCT01843205|20353083|P2|COMPLETED|Second Treatment (11 Days)||4
8253764|NCT01843205|20353084|P1|COMPLETED|Second Treatment (11 Days)||4
8253765|NCT01843205|20353083|P2|STARTED|Second Treatment (11 Days)||4
8253766|NCT01843205|20353084|P1|STARTED|Second Treatment (11 Days)||4
8253767|NCT01843205|20353083|P2|NOT COMPLETED|First Treatment (11 Days)||0
8253768|NCT01843205|20353084|P1|NOT COMPLETED|First Treatment (11 Days)||1
8253769|NCT01843205|20353083|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
8253770|NCT01843205|20353084|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
8253771|NCT01843205|20353083|P2|STARTED|First Treatment (11 Days)||4
8253772|NCT01843205|20353084|P1|STARTED|First Treatment (11 Days)||5
8253773|NCT01843192|20353145|P3|NOT COMPLETED|Overall Study||2
8253774|NCT01843192|20353146|P2|NOT COMPLETED|Overall Study||6
8253775|NCT01843192|20353147|P1|NOT COMPLETED|Overall Study||2
8253776|NCT01843192|20353145|P3|COMPLETED|Overall Study||9
8253777|NCT01843192|20353146|P2|COMPLETED|Overall Study||28
8253778|NCT01843192|20353147|P1|COMPLETED|Overall Study||24
8253779|NCT01843192|20353145|P3|STARTED|Overall Study||11
8253780|NCT01843192|20353146|P2|STARTED|Overall Study||34
8253781|NCT01843192|20353147|P1|STARTED|Overall Study||26
8253782|NCT01843062|20353178|P2|NOT COMPLETED|Overall Study||9
8253783|NCT01843062|20353179|P1|NOT COMPLETED|Overall Study||22
8253784|NCT01843062|20353178|P2|COMPLETED|Overall Study||69
8253785|NCT01843062|20353179|P1|COMPLETED|Overall Study||133
8253786|NCT01843062|20353178|P2|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
8253787|NCT01843062|20353179|P1|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
8253788|NCT01843062|20353178|P2|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
8253789|NCT01843062|20353179|P1|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
8253790|NCT01843062|20353178|P2|Safety Analysis Set|Overall Study||77
8253791|NCT01843062|20353179|P1|Safety Analysis Set|Overall Study||154
8253792|NCT01843062|20353178|P2|Intention to Treat (ITT) Analysis Set|Overall Study||78
8253793|NCT01843062|20353179|P1|Intention to Treat (ITT) Analysis Set|Overall Study||155
8253794|NCT01843062|20353178|P2|STARTED|Overall Study||78
8253795|NCT01843062|20353179|P1|STARTED|Overall Study||155
8253796|NCT01842958|20353193|P2|NOT COMPLETED|Overall Study||1
8253797|NCT01842958|20353194|P1|NOT COMPLETED|Overall Study||1
8253798|NCT01842958|20353193|P2|COMPLETED|Overall Study||24
8253799|NCT01842958|20353194|P1|COMPLETED|Overall Study||24
8253800|NCT01842958|20353193|P2|Randomized|Overall Study||25
8253801|NCT01842958|20353194|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
8253802|NCT01842958|20353193|P2|STARTED|Overall Study||25
8253803|NCT01842958|20353194|P1|STARTED|Overall Study||25
8253804|NCT01842906|20353214|P2|NOT COMPLETED|Overall Study||0
8253805|NCT01842906|20353215|P1|NOT COMPLETED|Overall Study||0
8253806|NCT01842906|20353214|P2|COMPLETED|Overall Study||104
8253807|NCT01842906|20353215|P1|COMPLETED|Overall Study||115
8253808|NCT01842906|20353214|P2|STARTED|Overall Study||104
8253809|NCT01842906|20353215|P1|STARTED|Overall Study||115
8253810|NCT01842841|20353227|P1|NOT COMPLETED|Overall Study||0
8253811|NCT01842841|20353227|P1|COMPLETED|Overall Study||5
8253812|NCT01842841|20353227|P1|STARTED|Overall Study||5
8253813|NCT01842815|20353246|P1|NOT COMPLETED|Overall Study||4
8253814|NCT01842815|20353246|P1|COMPLETED|Overall Study||16
8253815|NCT01842815|20353246|P1|STARTED|Overall Study||20
8253816|NCT01842789|20353257|P2|NOT COMPLETED|Overall Study||0
8253817|NCT01842789|20353258|P1|NOT COMPLETED|Overall Study||0
8253818|NCT01842789|20353257|P2|COMPLETED|Overall Study||8
8253819|NCT01842789|20353258|P1|COMPLETED|Overall Study||10
8253820|NCT01842789|20353257|P2|STARTED|Overall Study||8
8253821|NCT01842789|20353258|P1|STARTED|Overall Study||10
8253822|NCT01842646|20353267|P1|NOT COMPLETED|Overall Study||0
8253823|NCT01842646|20353267|P1|COMPLETED|Overall Study||35
8253824|NCT01842646|20353267|P1|STARTED|Overall Study||35
8253825|NCT01842633|20353278|P3|NOT COMPLETED|Overall Study||0
8253826|NCT01842633|20353279|P2|NOT COMPLETED|Overall Study||2
8253827|NCT01842633|20353280|P1|NOT COMPLETED|Overall Study||3
8253828|NCT01842633|20353278|P3|COMPLETED|Overall Study||34
8253829|NCT01842633|20353279|P2|COMPLETED|Overall Study||64
8253830|NCT01842633|20353280|P1|COMPLETED|Overall Study||62
8253831|NCT01842633|20353278|P3|STARTED|Overall Study||34
8253832|NCT01842633|20353279|P2|STARTED|Overall Study||66
8253833|NCT01842633|20353280|P1|STARTED|Overall Study||65
8253834|NCT01842620|20353327|P2|NOT COMPLETED|Period 2||0
8253835|NCT01842620|20353328|P1|NOT COMPLETED|Period 2||0
8253836|NCT01842620|20353327|P2|COMPLETED|Period 2||12
8253837|NCT01842620|20353328|P1|COMPLETED|Period 2||12
8253838|NCT01842620|20353327|P2|STARTED|Period 2||12
8253839|NCT01842620|20353328|P1|STARTED|Period 2||12
8253840|NCT01842620|20353327|P2|NOT COMPLETED|Washout Period||0
8253841|NCT01842620|20353328|P1|NOT COMPLETED|Washout Period||0
8253842|NCT01842620|20353327|P2|COMPLETED|Washout Period||12
8253843|NCT01842620|20353328|P1|COMPLETED|Washout Period||12
8253844|NCT01842620|20353327|P2|STARTED|Washout Period||12
8253845|NCT01842620|20353328|P1|STARTED|Washout Period||12
8253848|NCT01842620|20353327|P2|COMPLETED|Period 1||12
8253849|NCT01842620|20353328|P1|COMPLETED|Period 1||12
8253850|NCT01842620|20353327|P2|STARTED|Period 1||12
8253851|NCT01842620|20353328|P1|STARTED|Period 1||13
8253852|NCT01842607|20353344|P1|NOT COMPLETED|Overall Study||66
8253853|NCT01842607|20353344|P1|COMPLETED|Overall Study||585
8253854|NCT01842607|20353344|P1|STARTED|Overall Study||651
8253855|NCT01842594|20353363|P1|NOT COMPLETED|Overall Study||3
8253856|NCT01842594|20353363|P1|COMPLETED|Overall Study||10
8253857|NCT01842594|20353363|P1|STARTED|Overall Study||13
8253858|NCT01842581|20353370|P2|NOT COMPLETED|Overall Study||30
8253859|NCT01842581|20353371|P1|NOT COMPLETED|Overall Study||44
8253860|NCT01842581|20353370|P2|COMPLETED|Overall Study||79
8253861|NCT01842581|20353371|P1|COMPLETED|Overall Study||69
8253862|NCT01842581|20353370|P2|Received at Least 1 Dose of Study Drug|Overall Study||108
8253863|NCT01842581|20353371|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
8253864|NCT01842581|20353370|P2|STARTED|Overall Study||109
8253865|NCT01842581|20353371|P1|STARTED|Overall Study||113
8253866|NCT01842464|20353387|P1|NOT COMPLETED|Overall Study||0
8253867|NCT01842464|20353387|P1|COMPLETED|Overall Study||44
8253868|NCT01842464|20353387|P1|STARTED|Overall Study||44
8253869|NCT01842438|20353395|P2|NOT COMPLETED|T2: 6month Follow-up||4
8253870|NCT01842438|20353396|P1|NOT COMPLETED|T2: 6month Follow-up||4
8253871|NCT01842438|20353395|P2|COMPLETED|T2: 6month Follow-up||32
8253872|NCT01842438|20353396|P1|COMPLETED|T2: 6month Follow-up||32
8253873|NCT01842438|20353395|P2|STARTED|T2: 6month Follow-up||36
8253874|NCT01842438|20353396|P1|STARTED|T2: 6month Follow-up||36
8253875|NCT01842438|20353395|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
8253876|NCT01842438|20353396|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
8253877|NCT01842438|20353395|P2|COMPLETED|T1: Immediately After the Intervention||36
8253878|NCT01842438|20353396|P1|COMPLETED|T1: Immediately After the Intervention||36
8253879|NCT01842438|20353395|P2|STARTED|T1: Immediately After the Intervention||44
8253880|NCT01842438|20353396|P1|STARTED|T1: Immediately After the Intervention||42
8253881|NCT01842334|20353410|P2|NOT COMPLETED|Overall Study||4
8253882|NCT01842334|20353411|P1|NOT COMPLETED|Overall Study||3
8253883|NCT01842334|20353410|P2|COMPLETED|Overall Study||3
8253884|NCT01842334|20353411|P1|COMPLETED|Overall Study||2
8253885|NCT01842334|20353410|P2|STARTED|Overall Study||7
8253886|NCT01842334|20353411|P1|STARTED|Overall Study||5
8253887|NCT01842308|20353422|P5|NOT COMPLETED|Overall Study||1
8253888|NCT01842308|20353423|P4|NOT COMPLETED|Overall Study||0
8253889|NCT01842308|20353424|P3|NOT COMPLETED|Overall Study||0
8253890|NCT01842308|20353425|P2|NOT COMPLETED|Overall Study||0
8253891|NCT01842308|20353426|P1|NOT COMPLETED|Overall Study||0
8253892|NCT01842308|20353422|P5|COMPLETED|Overall Study||35
8253893|NCT01842308|20353423|P4|COMPLETED|Overall Study||2
8253894|NCT01842308|20353424|P3|COMPLETED|Overall Study||3
8253895|NCT01842308|20353425|P2|COMPLETED|Overall Study||3
8253896|NCT01842308|20353426|P1|COMPLETED|Overall Study||6
8253897|NCT01842308|20353422|P5|STARTED|Overall Study||36
8253898|NCT01842308|20353423|P4|STARTED|Overall Study||2
8253899|NCT01842308|20353424|P3|STARTED|Overall Study||3
8253900|NCT01842308|20353425|P2|STARTED|Overall Study||3
8253901|NCT01842308|20353426|P1|STARTED|Overall Study||6
8253902|NCT01841970|20353445|P1|NOT COMPLETED|Overall Study||11
8253903|NCT01841970|20353445|P1|COMPLETED|Overall Study||9
8253904|NCT01841970|20353445|P1|STARTED|Overall Study||20
8253905|NCT01841931|20353461|P1|NOT COMPLETED|Overall Study||4
8253906|NCT01841931|20353461|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
8253907|NCT01841931|20353461|P1|STARTED|Overall Study||4
8253908|NCT01841762|20353469|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
8253909|NCT01841762|20353469|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
8253910|NCT01841762|20353469|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
8253911|NCT01841762|20353469|P1|NOT COMPLETED|Treatment Period||32
8253912|NCT01841762|20353469|P1|COMPLETED|Treatment Period||252
8253913|NCT01841762|20353469|P1|STARTED|Treatment Period||284
8253914|NCT01841762|20353469|P1|NOT COMPLETED|Screening Period||51
8253915|NCT01841762|20353469|P1|COMPLETED|Screening Period||284
8253916|NCT01841762|20353469|P1|STARTED|Screening Period||335
8253925|NCT01841697|20353493|P2|NOT COMPLETED|Overall Study||18
8253926|NCT01841697|20353494|P1|NOT COMPLETED|Overall Study||20
8253927|NCT01841697|20353493|P2|COMPLETED|Overall Study||302
8253928|NCT01841697|20353494|P1|COMPLETED|Overall Study||302
8253929|NCT01841697|20353493|P2|STARTED|Overall Study||320
8253930|NCT01841697|20353494|P1|STARTED|Overall Study||322
8253931|NCT01841632|20353510|P1|NOT COMPLETED|Overall Study||0
8253932|NCT01841632|20353510|P1|COMPLETED|Overall Study||3
8253933|NCT01841632|20353510|P1|STARTED|Overall Study||3
8253934|NCT01841619|20353515|P1|NOT COMPLETED|Overall Study||0
8253935|NCT01841619|20353515|P1|COMPLETED|Overall Study||16
8253936|NCT01841619|20353515|P1|STARTED|Overall Study||16
8253937|NCT01841606|20353525|P2|NOT COMPLETED|Overall Study||0
8253938|NCT01841606|20353526|P1|NOT COMPLETED|Overall Study||0
8253939|NCT01841606|20353525|P2|COMPLETED|Overall Study||27
8253940|NCT01841606|20353526|P1|COMPLETED|Overall Study||25
8253941|NCT01841606|20353525|P2|STARTED|Overall Study||27
8253942|NCT01841606|20353526|P1|STARTED|Overall Study||25
8253943|NCT01841593|20353534|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
8253944|NCT01841593|20353535|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
8253945|NCT01841593|20353534|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
8253946|NCT01841593|20353535|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
8253947|NCT01841593|20353534|P2|STARTED|Third Intervention (Days 15 to 21)||6
8253948|NCT01841593|20353535|P1|STARTED|Third Intervention (Days 15 to 21)||11
8253949|NCT01841593|20353534|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
8253950|NCT01841593|20353535|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
8253951|NCT01841593|20353534|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
8253952|NCT01841593|20353535|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
8253953|NCT01841593|20353534|P2|STARTED|Second Intervention (Days 8 to 14)||6
8253954|NCT01841593|20353535|P1|STARTED|Second Intervention (Days 8 to 14)||12
8253955|NCT01841593|20353534|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
8253956|NCT01841593|20353535|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
8253957|NCT01841593|20353534|P2|COMPLETED|First Intervention (Days 1 to 7)||6
8253958|NCT01841593|20353535|P1|COMPLETED|First Intervention (Days 1 to 7)||12
8253959|NCT01841593|20353534|P2|STARTED|First Intervention (Days 1 to 7)||7
8253960|NCT01841593|20353535|P1|STARTED|First Intervention (Days 1 to 7)||12
8253961|NCT01841567|20353551|P1|NOT COMPLETED|Overall Study||3
8253962|NCT01841567|20353551|P1|COMPLETED|Overall Study||57
8253963|NCT01841567|20353551|P1|STARTED|Overall Study||60
8253964|NCT01841554|20353556|P1|NOT COMPLETED|Overall Study||19
8253965|NCT01841554|20353556|P1|COMPLETED|Overall Study||42
8253966|NCT01841554|20353556|P1|1 Year Follow Up|Overall Study||42
8253967|NCT01841554|20353556|P1|Implanted|Overall Study||60
8253968|NCT01841554|20353556|P1|STARTED|Overall Study||61
8253969|NCT01841281|20353569|P4|NOT COMPLETED|Second Intervention (12 Weeks)||0
8253970|NCT01841281|20353570|P3|NOT COMPLETED|Second Intervention (12 Weeks)||0
8253971|NCT01841281|20353571|P2|NOT COMPLETED|Second Intervention (12 Weeks)||3
8253972|NCT01841281|20353572|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8253973|NCT01841281|20353569|P4|COMPLETED|Second Intervention (12 Weeks)||13
8253974|NCT01841281|20353570|P3|COMPLETED|Second Intervention (12 Weeks)||10
8253975|NCT01841281|20353571|P2|COMPLETED|Second Intervention (12 Weeks)||6
8253976|NCT01841281|20353572|P1|COMPLETED|Second Intervention (12 Weeks)||9
8253977|NCT01841281|20353569|P4|STARTED|Second Intervention (12 Weeks)||13
8253978|NCT01841281|20353570|P3|STARTED|Second Intervention (12 Weeks)||10
8253979|NCT01841281|20353571|P2|STARTED|Second Intervention (12 Weeks)||9
8253980|NCT01841281|20353572|P1|STARTED|Second Intervention (12 Weeks)||9
8253981|NCT01841281|20353569|P4|NOT COMPLETED|Washout (6 Weeks)||1
8253982|NCT01841281|20353570|P3|NOT COMPLETED|Washout (6 Weeks)||3
8253983|NCT01841281|20353571|P2|NOT COMPLETED|Washout (6 Weeks)||3
8253984|NCT01841281|20353572|P1|NOT COMPLETED|Washout (6 Weeks)||2
8253985|NCT01841281|20353569|P4|COMPLETED|Washout (6 Weeks)||13
8253986|NCT01841281|20353570|P3|COMPLETED|Washout (6 Weeks)||10
8253987|NCT01841281|20353571|P2|COMPLETED|Washout (6 Weeks)||9
8253988|NCT01841281|20353572|P1|COMPLETED|Washout (6 Weeks)||9
8253989|NCT01841281|20353569|P4|STARTED|Washout (6 Weeks)||14
8253990|NCT01841281|20353570|P3|STARTED|Washout (6 Weeks)||13
8253991|NCT01841281|20353571|P2|STARTED|Washout (6 Weeks)||12
8253992|NCT01841281|20353572|P1|STARTED|Washout (6 Weeks)||11
8253993|NCT01841281|20353569|P4|NOT COMPLETED|First Intervention (12 Weeks)||0
8253994|NCT01841281|20353570|P3|NOT COMPLETED|First Intervention (12 Weeks)||0
8253995|NCT01841281|20353571|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
8253996|NCT01841281|20353572|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8253997|NCT01841281|20353569|P4|COMPLETED|First Intervention (12 Weeks)||14
8253998|NCT01841281|20353570|P3|COMPLETED|First Intervention (12 Weeks)||13
8253999|NCT01841281|20353571|P2|COMPLETED|First Intervention (12 Weeks)||12
8254000|NCT01841281|20353572|P1|COMPLETED|First Intervention (12 Weeks)||11
8254001|NCT01841281|20353569|P4|STARTED|First Intervention (12 Weeks)||14
8254002|NCT01841281|20353570|P3|STARTED|First Intervention (12 Weeks)||13
8254003|NCT01841281|20353571|P2|STARTED|First Intervention (12 Weeks)||12
8254004|NCT01841281|20353572|P1|STARTED|First Intervention (12 Weeks)||11
8254005|NCT01841216|20353594|P2|NOT COMPLETED|Overall Study||0
8254006|NCT01841216|20353595|P1|NOT COMPLETED|Overall Study||0
8254007|NCT01841216|20353594|P2|COMPLETED|Overall Study||15
8254008|NCT01841216|20353595|P1|COMPLETED|Overall Study||15
8254009|NCT01841216|20353594|P2|STARTED|Overall Study||15
8254010|NCT01841216|20353595|P1|STARTED|Overall Study||15
8254011|NCT01841073|20353605|P2|NOT COMPLETED|Overall Study||3
8254012|NCT01841073|20353606|P1|NOT COMPLETED|Overall Study||2
8254013|NCT01841073|20353605|P2|COMPLETED|Overall Study||19
8254014|NCT01841073|20353606|P1|COMPLETED|Overall Study||20
8254015|NCT01841073|20353605|P2|STARTED|Overall Study||22
8254016|NCT01841073|20353606|P1|STARTED|Overall Study||22
8254017|NCT01841060|20353616|P1|NOT COMPLETED|Overall Study||10
8254018|NCT01841060|20353616|P1|COMPLETED|Overall Study||32
8254019|NCT01841060|20353616|P1|STARTED|Overall Study||42
8254020|NCT01841021|20353623|P1|NOT COMPLETED|Overall Study||0
8254021|NCT01841021|20353623|P1|COMPLETED|Overall Study||1
8254022|NCT01841021|20353623|P1|STARTED|Overall Study||1
8254023|NCT01840943|20353635|P2|NOT COMPLETED|Overall Study||12
8254024|NCT01840943|20353636|P1|NOT COMPLETED|Overall Study||13
8254025|NCT01840943|20353635|P2|COMPLETED|Overall Study||0
8254026|NCT01840943|20353636|P1|COMPLETED|Overall Study||1
8254027|NCT01840943|20353635|P2|STARTED|Overall Study||12
8254028|NCT01840943|20353636|P1|STARTED|Overall Study||14
8254029|NCT01840722|20353672|P2|NOT COMPLETED|Overall Study||69
8254030|NCT01840722|20353673|P1|NOT COMPLETED|Overall Study||0
8254031|NCT01840722|20353672|P2|COMPLETED|Overall Study||130
8254032|NCT01840722|20353673|P1|COMPLETED|Overall Study||201
8254033|NCT01840722|20353672|P2|STARTED|Overall Study||199
8254034|NCT01840722|20353673|P1|STARTED|Overall Study||201
8254035|NCT01840605|20353685|P2|NOT COMPLETED|Overall Study||2
8254036|NCT01840605|20353686|P1|NOT COMPLETED|Overall Study||2
8254037|NCT01840605|20353685|P2|COMPLETED|Overall Study||150
8254038|NCT01840605|20353686|P1|COMPLETED|Overall Study||149
8254039|NCT01840605|20353685|P2|STARTED|Overall Study||152
8254040|NCT01840605|20353686|P1|STARTED|Overall Study||151
8254041|NCT01840410|20353700|P2|NOT COMPLETED|Overall Study||4
8254042|NCT01840410|20353701|P1|NOT COMPLETED|Overall Study||7
8254043|NCT01840410|20353700|P2|COMPLETED|Overall Study||55
8254044|NCT01840410|20353701|P1|COMPLETED|Overall Study||112
8254045|NCT01840410|20353700|P2|Full Analysis Set|Overall Study||59
8254046|NCT01840410|20353701|P1|Full Analysis Set|Overall Study||119
8254047|NCT01840410|20353700|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
8254048|NCT01840410|20353701|P1|Safety Set|Overall Study||119
8254049|NCT01840410|20353700|P2|STARTED|Overall Study||59
8254050|NCT01840410|20353701|P1|STARTED|Overall Study||119
8254051|NCT01840345|20353737|P1|NOT COMPLETED|Overall Study||1
8254052|NCT01840345|20353737|P1|COMPLETED|Overall Study||10
8254053|NCT01840345|20353737|P1|STARTED|Overall Study||11
8254054|NCT01840319|20353744|P1|NOT COMPLETED|Overall Study||0
8254055|NCT01840319|20353744|P1|COMPLETED|Overall Study||156
8254056|NCT01840319|20353744|P1|STARTED|Overall Study||156
8254057|NCT01840228|20353750|P2|NOT COMPLETED|Overall Study||1
8254058|NCT01840228|20353751|P1|NOT COMPLETED|Overall Study||1
8254059|NCT01840228|20353750|P2|COMPLETED|Overall Study||18
8254060|NCT01840228|20353751|P1|COMPLETED|Overall Study||18
8254061|NCT01840228|20353750|P2|STARTED|Overall Study||19
8254062|NCT01840228|20353751|P1|STARTED|Overall Study||19
8254063|NCT01840163|20353779|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
8254064|NCT01840163|20353780|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
8254065|NCT01840163|20353779|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
8254066|NCT01840163|20353780|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
8254067|NCT01840163|20353779|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
8254068|NCT01840163|20353780|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
8254069|NCT01840163|20353779|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
8254070|NCT01840163|20353780|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
8254071|NCT01840163|20353779|P2|COMPLETED|First Follow up -Primary Outcome||254
8254072|NCT01840163|20353780|P1|COMPLETED|First Follow up -Primary Outcome||248
8254073|NCT01840163|20353779|P2|STARTED|First Follow up -Primary Outcome||270
8254074|NCT01840163|20353780|P1|STARTED|First Follow up -Primary Outcome||267
8254075|NCT01840072|20353802|P2|NOT COMPLETED|Overall Study||47
8254076|NCT01840072|20353803|P1|NOT COMPLETED|Overall Study||7
8254077|NCT01840072|20353802|P2|COMPLETED|Overall Study||1986
8254078|NCT01840072|20353803|P1|COMPLETED|Overall Study||2031
8254079|NCT01840072|20353802|P2|STARTED|Overall Study||2033
8254080|NCT01840072|20353803|P1|STARTED|Overall Study||2038
8254081|NCT01839916|20353825|P1|NOT COMPLETED|Overall Study||41
8254082|NCT01839916|20353825|P1|COMPLETED|Overall Study||36
8254083|NCT01839916|20353825|P1|STARTED|Overall Study||77
8254084|NCT01839708|20353836|P2|NOT COMPLETED|Overall Study||67
8254085|NCT01839708|20353837|P1|NOT COMPLETED|Overall Study||76
8254086|NCT01839708|20353836|P2|COMPLETED|Overall Study||115
8254087|NCT01839708|20353837|P1|COMPLETED|Overall Study||311
8254088|NCT01839708|20353836|P2|STARTED|Overall Study||182
8254089|NCT01839708|20353837|P1|STARTED|Overall Study||387
8254090|NCT01839695|20353869|P1|NOT COMPLETED|Overall Study||0
8254091|NCT01839695|20353869|P1|COMPLETED|Overall Study||9
8254092|NCT01839695|20353869|P1|STARTED|Overall Study||9
8254101|NCT01839604|20353904|P5|NOT COMPLETED|Overall Study||0
8254102|NCT01839604|20353905|P4|NOT COMPLETED|Overall Study||0
8254103|NCT01839604|20353906|P3|NOT COMPLETED|Overall Study||0
8254104|NCT01839604|20353907|P2|NOT COMPLETED|Overall Study||0
8254105|NCT01839604|20353908|P1|NOT COMPLETED|Overall Study||0
8254106|NCT01839604|20353904|P5|COMPLETED|Overall Study||15
8254107|NCT01839604|20353905|P4|COMPLETED|Overall Study||5
8254108|NCT01839604|20353906|P3|COMPLETED|Overall Study||7
8254109|NCT01839604|20353907|P2|COMPLETED|Overall Study||6
8254110|NCT01839604|20353908|P1|COMPLETED|Overall Study||6
8254111|NCT01839604|20353904|P5|STARTED|Overall Study||15
8254112|NCT01839604|20353905|P4|STARTED|Overall Study||5
8254113|NCT01839604|20353906|P3|STARTED|Overall Study||7
8254114|NCT01839604|20353907|P2|STARTED|Overall Study||6
8254115|NCT01839604|20353908|P1|STARTED|Overall Study||6
8254116|NCT01839487|20353937|P6|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
8254117|NCT01839487|20353938|P5|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
8254118|NCT01839487|20353939|P4|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
8254119|NCT01839487|20353940|P3|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
8254120|NCT01839487|20353941|P2|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254121|NCT01839487|20353942|P1|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254122|NCT01839487|20353937|P6|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254123|NCT01839487|20353938|P5|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
8254124|NCT01839487|20353939|P4|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254125|NCT01839487|20353940|P3|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254126|NCT01839487|20353941|P2|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254127|NCT01839487|20353942|P1|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254128|NCT01839487|20353937|P6|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
8254129|NCT01839487|20353938|P5|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
8254130|NCT01839487|20353939|P4|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
8254131|NCT01839487|20353940|P3|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
8254132|NCT01839487|20353941|P2|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
8254133|NCT01839487|20353942|P1|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
8254134|NCT01839487|20353937|P6|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254135|NCT01839487|20353938|P5|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254136|NCT01839487|20353939|P4|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254137|NCT01839487|20353940|P3|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254138|NCT01839487|20353941|P2|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
8254139|NCT01839487|20353942|P1|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
8254140|NCT01839487|20353937|P6|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254141|NCT01839487|20353938|P5|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254142|NCT01839487|20353939|P4|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254143|NCT01839487|20353940|P3|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254144|NCT01839487|20353941|P2|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254145|NCT01839487|20353942|P1|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254146|NCT01839487|20353937|P6|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254147|NCT01839487|20353938|P5|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254148|NCT01839487|20353939|P4|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254149|NCT01839487|20353940|P3|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254150|NCT01839487|20353941|P2|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
8254151|NCT01839487|20353942|P1|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
8254152|NCT01839396|20353965|P2|NOT COMPLETED|Overall Study||0
8254153|NCT01839396|20353966|P1|NOT COMPLETED|Overall Study||0
8254154|NCT01839396|20353965|P2|COMPLETED|Overall Study||39
8254155|NCT01839396|20353966|P1|COMPLETED|Overall Study||121
8254156|NCT01839396|20353965|P2|STARTED|Overall Study||39
8254157|NCT01839396|20353966|P1|STARTED|Overall Study||121
8254158|NCT01839318|20353974|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
8254159|NCT01839318|20353975|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
8254160|NCT01839318|20353976|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
8254161|NCT01839318|20353977|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
8254162|NCT01839318|20353978|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
8254163|NCT01839318|20353979|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
8254164|NCT01839318|20353974|P6|COMPLETED|Period 3, Third Day of Wear||2
8254165|NCT01839318|20353975|P5|COMPLETED|Period 3, Third Day of Wear||7
8254166|NCT01839318|20353976|P4|COMPLETED|Period 3, Third Day of Wear||6
8254167|NCT01839318|20353977|P3|COMPLETED|Period 3, Third Day of Wear||5
8254168|NCT01839318|20353978|P2|COMPLETED|Period 3, Third Day of Wear||4
8254169|NCT01839318|20353979|P1|COMPLETED|Period 3, Third Day of Wear||4
8254170|NCT01839318|20353974|P6|STARTED|Period 3, Third Day of Wear||2
8254171|NCT01839318|20353975|P5|STARTED|Period 3, Third Day of Wear||7
8254172|NCT01839318|20353976|P4|STARTED|Period 3, Third Day of Wear||6
8254173|NCT01839318|20353977|P3|STARTED|Period 3, Third Day of Wear||5
8254174|NCT01839318|20353978|P2|STARTED|Period 3, Third Day of Wear||4
8254175|NCT01839318|20353979|P1|STARTED|Period 3, Third Day of Wear||4
8254176|NCT01839318|20353974|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
8254177|NCT01839318|20353975|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
8254178|NCT01839318|20353976|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
8254179|NCT01839318|20353977|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
8254180|NCT01839318|20353978|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
8254181|NCT01839318|20353979|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
8254182|NCT01839318|20353974|P6|COMPLETED|Period 2, Second Day of Wear||2
8254183|NCT01839318|20353975|P5|COMPLETED|Period 2, Second Day of Wear||7
8254184|NCT01839318|20353976|P4|COMPLETED|Period 2, Second Day of Wear||6
8254185|NCT01839318|20353977|P3|COMPLETED|Period 2, Second Day of Wear||5
8254186|NCT01839318|20353978|P2|COMPLETED|Period 2, Second Day of Wear||4
8254187|NCT01839318|20353979|P1|COMPLETED|Period 2, Second Day of Wear||4
8254188|NCT01839318|20353974|P6|STARTED|Period 2, Second Day of Wear||2
8254189|NCT01839318|20353975|P5|STARTED|Period 2, Second Day of Wear||7
8254190|NCT01839318|20353976|P4|STARTED|Period 2, Second Day of Wear||6
8254191|NCT01839318|20353977|P3|STARTED|Period 2, Second Day of Wear||5
8254192|NCT01839318|20353978|P2|STARTED|Period 2, Second Day of Wear||4
8254193|NCT01839318|20353979|P1|STARTED|Period 2, Second Day of Wear||4
8254194|NCT01839318|20353974|P6|NOT COMPLETED|Period 1, First Day of Wear||0
8254195|NCT01839318|20353975|P5|NOT COMPLETED|Period 1, First Day of Wear||0
8254196|NCT01839318|20353976|P4|NOT COMPLETED|Period 1, First Day of Wear||0
8254197|NCT01839318|20353977|P3|NOT COMPLETED|Period 1, First Day of Wear||0
8254198|NCT01839318|20353978|P2|NOT COMPLETED|Period 1, First Day of Wear||0
8254199|NCT01839318|20353979|P1|NOT COMPLETED|Period 1, First Day of Wear||0
8254200|NCT01839318|20353974|P6|COMPLETED|Period 1, First Day of Wear||2
8254201|NCT01839318|20353975|P5|COMPLETED|Period 1, First Day of Wear||7
8254202|NCT01839318|20353976|P4|COMPLETED|Period 1, First Day of Wear||6
8254203|NCT01839318|20353977|P3|COMPLETED|Period 1, First Day of Wear||5
8254204|NCT01839318|20353978|P2|COMPLETED|Period 1, First Day of Wear||4
8254205|NCT01839318|20353979|P1|COMPLETED|Period 1, First Day of Wear||4
8254206|NCT01839318|20353974|P6|STARTED|Period 1, First Day of Wear||2
8254207|NCT01839318|20353975|P5|STARTED|Period 1, First Day of Wear||7
8254208|NCT01839318|20353976|P4|STARTED|Period 1, First Day of Wear||6
8254209|NCT01839318|20353977|P3|STARTED|Period 1, First Day of Wear||5
8254210|NCT01839318|20353978|P2|STARTED|Period 1, First Day of Wear||4
8254211|NCT01839318|20353979|P1|STARTED|Period 1, First Day of Wear||4
8254212|NCT01839279|20353993|P3|NOT COMPLETED|Overall Study||2
8254213|NCT01839279|20353994|P2|NOT COMPLETED|Overall Study||2
8254214|NCT01839279|20353995|P1|NOT COMPLETED|Overall Study||13
8254215|NCT01839279|20353993|P3|COMPLETED|Overall Study||30
8254216|NCT01839279|20353994|P2|COMPLETED|Overall Study||30
8254217|NCT01839279|20353995|P1|COMPLETED|Overall Study||59
8254218|NCT01839279|20353993|P3|PK/QTc Analysis Set|Overall Study||0
8254219|NCT01839279|20353994|P2|PK/QTc Analysis Set|Overall Study||0
8254220|NCT01839279|20353995|P1|PK/QTc Analysis Set|Overall Study||70
8254221|NCT01839279|20353993|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
8254222|NCT01839279|20353994|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
8254223|NCT01839279|20353995|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
8254224|NCT01839279|20353993|P3|PK Analysis Set|Overall Study||0
8254225|NCT01839279|20353994|P2|PK Analysis Set|Overall Study||0
8254226|NCT01839279|20353995|P1|PK Analysis Set|Overall Study||70
8254227|NCT01839279|20353993|P3|QT/QTc Analysis Set|Overall Study||32
8254228|NCT01839279|20353994|P2|QT/QTc Analysis Set|Overall Study||32
8254229|NCT01839279|20353995|P1|QT/QTc Analysis Set|Overall Study||72
8254230|NCT01839279|20353993|P3|STARTED|Overall Study||32
8254231|NCT01839279|20353994|P2|STARTED|Overall Study||32
8254232|NCT01839279|20353995|P1|STARTED|Overall Study||72
8254233|NCT01839188|20354014|P1|NOT COMPLETED|Overall Study||1
8254234|NCT01839188|20354014|P1|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
8254235|NCT01839188|20354014|P1|Treated|Overall Study||385
8254236|NCT01839188|20354014|P1|STARTED|Overall Study||385
8254237|NCT01839110|20354057|P3|NOT COMPLETED|Overall Study||3
8254238|NCT01839110|20354058|P2|NOT COMPLETED|Overall Study||2
8254239|NCT01839110|20354059|P1|NOT COMPLETED|Overall Study||3
8254240|NCT01839110|20354057|P3|COMPLETED|Overall Study||6
8254241|NCT01839110|20354058|P2|COMPLETED|Overall Study||4
8254242|NCT01839110|20354059|P1|COMPLETED|Overall Study||4
8254243|NCT01839110|20354057|P3|STARTED|Overall Study||9
8254244|NCT01839110|20354058|P2|STARTED|Overall Study||6
8254245|NCT01839110|20354059|P1|STARTED|Overall Study||7
8254246|NCT01839058|20354069|P2|NOT COMPLETED|Overall Study||3
8254247|NCT01839058|20354070|P1|NOT COMPLETED|Overall Study||4
8254248|NCT01839058|20354069|P2|COMPLETED|Overall Study||16
8254249|NCT01839058|20354070|P1|COMPLETED|Overall Study||17
8254250|NCT01839058|20354069|P2|STARTED|Overall Study||19
8254251|NCT01839058|20354070|P1|STARTED|Overall Study||21
8254252|NCT01838980|20354082|P1|NOT COMPLETED|Overall Study||0
8254253|NCT01838980|20354082|P1|COMPLETED|Overall Study||15
8254254|NCT01838980|20354082|P1|STARTED|Overall Study||15
8254255|NCT01838941|20354086|P1|NOT COMPLETED|Overall Study||2
8254256|NCT01838941|20354086|P1|COMPLETED|Overall Study||10
8254257|NCT01838941|20354086|P1|STARTED|Overall Study||12
8254258|NCT01838876|20354091|P1|NOT COMPLETED|Overall Study||233
8254259|NCT01838876|20354091|P1|COMPLETED|Overall Study||209
8254260|NCT01838876|20354091|P1|Entered Safety Follow-up Period|Overall Study||287
8254261|NCT01838876|20354091|P1|Safety Population; Received Study Drug|Overall Study||345
8254262|NCT01838876|20354091|P1|STARTED|Overall Study||442
8254263|NCT01838863|20354106|P2|NOT COMPLETED|Overall Study||9
8254264|NCT01838863|20354107|P1|NOT COMPLETED|Overall Study||10
8254265|NCT01838863|20354106|P2|COMPLETED|Overall Study||60
8254266|NCT01838863|20354107|P1|COMPLETED|Overall Study||65
8254267|NCT01838863|20354106|P2|STARTED|Overall Study||69
8254268|NCT01838863|20354107|P1|STARTED|Overall Study||75
8254269|NCT01838785|20354193|P1|NOT COMPLETED|Overall Study||0
8254270|NCT01838785|20354193|P1|COMPLETED|Overall Study||25
8254271|NCT01838785|20354193|P1|STARTED|Overall Study||25
8254272|NCT01838694|20354200|P2|NOT COMPLETED|Overall Study||1
8254273|NCT01838694|20354201|P1|NOT COMPLETED|Overall Study||0
8254274|NCT01838694|20354200|P2|COMPLETED|Overall Study||21
8254275|NCT01838694|20354201|P1|COMPLETED|Overall Study||8
8254276|NCT01838694|20354200|P2|STARTED|Overall Study||22
8254277|NCT01838694|20354201|P1|STARTED|Overall Study||8
8254278|NCT01838681|20354210|P4|NOT COMPLETED|Period B/A+||117
8254279|NCT01838681|20354211|P3|NOT COMPLETED|Period B/A+||95
8254280|NCT01838681|20354212|P2|NOT COMPLETED|Period B/A+||62
8254281|NCT01838681|20354213|P1|NOT COMPLETED|Period B/A+||0
8254282|NCT01838681|20354210|P4|COMPLETED|Period B/A+||653
8254283|NCT01838681|20354211|P3|COMPLETED|Period B/A+||349
8254284|NCT01838681|20354212|P2|COMPLETED|Period B/A+||380
8254285|NCT01838681|20354213|P1|COMPLETED|Period B/A+||0
8254286|NCT01838681|20354210|P4|STARTED|Period B/A+||770
8254287|NCT01838681|20354211|P3|STARTED|Period B/A+||444
8254288|NCT01838681|20354212|P2|STARTED|Period B/A+||442
8254289|NCT01838681|20354213|P1|STARTED|Period B/A+||0
8254290|NCT01838681|20354210|P4|NOT COMPLETED|Period A||0
8254291|NCT01838681|20354211|P3|NOT COMPLETED|Period A||0
8254292|NCT01838681|20354212|P2|NOT COMPLETED|Period A||0
8254293|NCT01838681|20354213|P1|NOT COMPLETED|Period A||325
8254294|NCT01838681|20354210|P4|COMPLETED|Period A||0
8254295|NCT01838681|20354211|P3|COMPLETED|Period A||0
8254296|NCT01838681|20354212|P2|COMPLETED|Period A||0
8254297|NCT01838681|20354213|P1|COMPLETED|Period A||1661
8254298|NCT01838681|20354210|P4|STARTED|Period A||0
8254299|NCT01838681|20354211|P3|STARTED|Period A||0
8254300|NCT01838681|20354212|P2|STARTED|Period A||0
8254301|NCT01838681|20354213|P1|STARTED|Period A||1986
8254302|NCT01838655|20354253|P1|NOT COMPLETED|Overall Study||0
8254303|NCT01838655|20354253|P1|COMPLETED|Overall Study||5
8254304|NCT01838655|20354253|P1|STARTED|Overall Study||5
8254305|NCT01838642|20354321|P1|NOT COMPLETED|Overall Study||1
8254306|NCT01838642|20354321|P1|COMPLETED|Overall Study||2
8254307|NCT01838642|20354321|P1|STARTED|Overall Study||3
8254308|NCT01838616|20354334|P2|NOT COMPLETED|Pick-up Arm||0
8254309|NCT01838616|20354335|P1|NOT COMPLETED|Pick-up Arm||15
8254310|NCT01838616|20354334|P2|COMPLETED|Pick-up Arm||0
8254311|NCT01838616|20354335|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
8254312|NCT01838616|20354334|P2|Full Analysis Set|Pick-up Arm||0
8254313|NCT01838616|20354335|P1|Full Analysis Set|Pick-up Arm||49
8254314|NCT01838616|20354334|P2|STARTED|Pick-up Arm||0
8254315|NCT01838616|20354335|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
8254316|NCT01838616|20354334|P2|NOT COMPLETED|Continuation Period||14
8254317|NCT01838616|20354335|P1|NOT COMPLETED|Continuation Period||14
8254318|NCT01838616|20354334|P2|COMPLETED|Continuation Period||48
8254319|NCT01838616|20354335|P1|COMPLETED|Continuation Period||86
8254320|NCT01838616|20354334|P2|Switched to Pick-up Arm|Continuation Period||7
8254321|NCT01838616|20354335|P1|Switched to Pick-up Arm|Continuation Period||0
8254322|NCT01838616|20354334|P2|STARTED|Continuation Period||62
8254323|NCT01838616|20354335|P1|STARTED|Continuation Period||100
8254324|NCT01838616|20354334|P2|NOT COMPLETED|Titration Period||66
8254325|NCT01838616|20354335|P1|NOT COMPLETED|Titration Period||30
8254326|NCT01838616|20354334|P2|COMPLETED|Titration Period||62
8254327|NCT01838616|20354335|P1|COMPLETED|Titration Period||100
8254328|NCT01838616|20354334|P2|Per Protocol Set|Titration Period||112
8254329|NCT01838616|20354335|P1|Per Protocol Set|Titration Period||117
8254330|NCT01838616|20354334|P2|Full Analysis Set|Titration Period||128
8254331|NCT01838616|20354335|P1|Full Analysis Set|Titration Period||130
8254332|NCT01838616|20354334|P2|Switched to Pick-up Arm|Titration Period||43
8254333|NCT01838616|20354335|P1|Switched to Pick-up Arm|Titration Period||0
8254334|NCT01838616|20354334|P2|Major Protocol Deviations|Titration Period||16
8254335|NCT01838616|20354335|P1|Major Protocol Deviations|Titration Period||13
8254336|NCT01838616|20354334|P2|No Post Baseline Pain Intensity Values|Titration Period||2
8254337|NCT01838616|20354335|P1|No Post Baseline Pain Intensity Values|Titration Period||0
8254338|NCT01838616|20354334|P2|STARTED|Titration Period||128
8254339|NCT01838616|20354335|P1|STARTED|Titration Period||130
8254340|NCT01838590|20354406|P2|NOT COMPLETED|Overall Study||5
8254341|NCT01838590|20354407|P1|NOT COMPLETED|Overall Study||12
8254342|NCT01838590|20354406|P2|COMPLETED|Overall Study||46
8254343|NCT01838590|20354407|P1|COMPLETED|Overall Study||40
8254344|NCT01838590|20354406|P2|STARTED|Overall Study||51
8254345|NCT01838590|20354407|P1|STARTED|Overall Study||52
8254346|NCT01838499|20354431|P2|NOT COMPLETED|Overall Study||17
8254347|NCT01838499|20354432|P1|NOT COMPLETED|Overall Study||24
8254348|NCT01838499|20354431|P2|COMPLETED|Overall Study||37
8254349|NCT01838499|20354432|P1|COMPLETED|Overall Study||31
8254350|NCT01838499|20354431|P2|STARTED|Overall Study||54
8254351|NCT01838499|20354432|P1|STARTED|Overall Study||55
8254352|NCT01838447|20354444|P2|NOT COMPLETED|Overall Study||3
8254353|NCT01838447|20354445|P1|NOT COMPLETED|Overall Study||2
8254354|NCT01838447|20354444|P2|COMPLETED|Overall Study||21
8254355|NCT01838447|20354445|P1|COMPLETED|Overall Study||20
8254356|NCT01838447|20354444|P2|STARTED|Overall Study||24
8254357|NCT01838447|20354445|P1|STARTED|Overall Study||22
8254358|NCT01838304|20354465|P2|NOT COMPLETED|Overall Study||0
8254359|NCT01838304|20354466|P1|NOT COMPLETED|Overall Study||1
8254360|NCT01838304|20354465|P2|COMPLETED|Overall Study||20
8254361|NCT01838304|20354466|P1|COMPLETED|Overall Study||19
8254362|NCT01838304|20354465|P2|STARTED|Overall Study||20
8254363|NCT01838304|20354466|P1|STARTED|Overall Study||20
8254364|NCT01838226|20354480|P2|NOT COMPLETED|Overall Study||71
8254365|NCT01838226|20354481|P1|NOT COMPLETED|Overall Study||76
8254366|NCT01838226|20354480|P2|COMPLETED|Overall Study||128
8254367|NCT01838226|20354481|P1|COMPLETED|Overall Study||126
8254368|NCT01838226|20354480|P2|STARTED|Overall Study||199
8254369|NCT01838226|20354481|P1|STARTED|Overall Study||202
8254370|NCT01838213|20354493|P2|NOT COMPLETED|Overall Study||191
8254371|NCT01838213|20354494|P1|NOT COMPLETED|Overall Study||166
8254372|NCT01838213|20354493|P2|COMPLETED|Overall Study||262
8254373|NCT01838213|20354494|P1|COMPLETED|Overall Study||81
8254374|NCT01838213|20354493|P2|STARTED|Overall Study||453
8254375|NCT01838213|20354494|P1|STARTED|Overall Study||247
8254376|NCT01838200|20354502|P2|NOT COMPLETED|Overall Study||2
8254377|NCT01838200|20354503|P1|NOT COMPLETED|Overall Study||3
8254378|NCT01838200|20354502|P2|COMPLETED|Overall Study||0
8254379|NCT01838200|20354503|P1|COMPLETED|Overall Study||0
8254380|NCT01838200|20354502|P2|STARTED|Overall Study||2
8254381|NCT01838200|20354503|P1|STARTED|Overall Study||3
8254382|NCT01837966|20354515|P2|NOT COMPLETED|Overall Study||1
8254383|NCT01837966|20354516|P1|NOT COMPLETED|Overall Study||2
8254384|NCT01837966|20354515|P2|COMPLETED|Overall Study||45
8254385|NCT01837966|20354516|P1|COMPLETED|Overall Study||45
8254386|NCT01837966|20354515|P2|STARTED|Overall Study||46
8254387|NCT01837966|20354516|P1|STARTED|Overall Study||47
8254388|NCT01837823|20354522|P1|NOT COMPLETED|Overall Study||6
8254389|NCT01837823|20354522|P1|COMPLETED|Overall Study||85
8254390|NCT01837823|20354522|P1|STARTED|Overall Study||91
8254391|NCT01837797|20354553|P5|NOT COMPLETED|Period 3||23
8254392|NCT01837797|20354554|P4|NOT COMPLETED|Period 3||0
8254393|NCT01837797|20354555|P3|NOT COMPLETED|Period 3||0
8254394|NCT01837797|20354556|P2|NOT COMPLETED|Period 3||0
8254395|NCT01837797|20354557|P1|NOT COMPLETED|Period 3||0
8254396|NCT01837797|20354553|P5|COMPLETED|Period 3||24
8254397|NCT01837797|20354554|P4|COMPLETED|Period 3||0
8254398|NCT01837797|20354555|P3|COMPLETED|Period 3||0
8254399|NCT01837797|20354556|P2|COMPLETED|Period 3||0
8254400|NCT01837797|20354557|P1|COMPLETED|Period 3||0
8254401|NCT01837797|20354553|P5|STARTED|Period 3||47
8254402|NCT01837797|20354554|P4|STARTED|Period 3||0
8254403|NCT01837797|20354555|P3|STARTED|Period 3||0
8254404|NCT01837797|20354556|P2|STARTED|Period 3||0
8254405|NCT01837797|20354557|P1|STARTED|Period 3||0
8254406|NCT01837797|20354553|P5|NOT COMPLETED|Period 2||0
8254407|NCT01837797|20354554|P4|NOT COMPLETED|Period 2||5
8254408|NCT01837797|20354555|P3|NOT COMPLETED|Period 2||2
8254409|NCT01837797|20354556|P2|NOT COMPLETED|Period 2||5
8254410|NCT01837797|20354557|P1|NOT COMPLETED|Period 2||0
8254411|NCT01837797|20354553|P5|COMPLETED|Period 2||0
8254412|NCT01837797|20354554|P4|COMPLETED|Period 2||1
8254413|NCT01837797|20354555|P3|COMPLETED|Period 2||1
8254414|NCT01837797|20354556|P2|COMPLETED|Period 2||1
8254415|NCT01837797|20354557|P1|COMPLETED|Period 2||0
8254416|NCT01837797|20354553|P5|STARTED|Period 2||0
8254417|NCT01837797|20354554|P4|STARTED|Period 2||6
8254418|NCT01837797|20354555|P3|STARTED|Period 2||3
8254419|NCT01837797|20354556|P2|STARTED|Period 2||6
8254420|NCT01837797|20354557|P1|STARTED|Period 2||0
8254421|NCT01837797|20354553|P5|NOT COMPLETED|Period 1||0
8254422|NCT01837797|20354554|P4|NOT COMPLETED|Period 1||0
8254423|NCT01837797|20354555|P3|NOT COMPLETED|Period 1||0
8254424|NCT01837797|20354556|P2|NOT COMPLETED|Period 1||0
8254425|NCT01837797|20354557|P1|NOT COMPLETED|Period 1||102
8254426|NCT01837797|20354553|P5|COMPLETED|Period 1||0
8254427|NCT01837797|20354554|P4|COMPLETED|Period 1||0
8254428|NCT01837797|20354555|P3|COMPLETED|Period 1||0
8254429|NCT01837797|20354556|P2|COMPLETED|Period 1||0
8254430|NCT01837797|20354557|P1|COMPLETED|Period 1||27
8254431|NCT01837797|20354553|P5|STARTED|Period 1||0
8254432|NCT01837797|20354554|P4|STARTED|Period 1||0
8254433|NCT01837797|20354555|P3|STARTED|Period 1||0
8254434|NCT01837797|20354556|P2|STARTED|Period 1||0
8254435|NCT01837797|20354557|P1|STARTED|Period 1||129
8254436|NCT01837719|20354592|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
8254437|NCT01837719|20354592|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
8254438|NCT01837719|20354592|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
8254439|NCT01837719|20354592|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
8254440|NCT01837719|20354592|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
8254441|NCT01837719|20354592|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
8254442|NCT01837719|20354592|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
8254443|NCT01837719|20354592|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
8254444|NCT01837719|20354592|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
8254445|NCT01837719|20354592|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
8254446|NCT01837719|20354592|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
8254447|NCT01837719|20354592|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
8254448|NCT01837719|20354592|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
8254449|NCT01837719|20354592|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
8254450|NCT01837719|20354592|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
8254451|NCT01837680|20354661|P2|NOT COMPLETED|Overall Study||8
8254452|NCT01837680|20354662|P1|NOT COMPLETED|Overall Study||10
8254453|NCT01837680|20354661|P2|COMPLETED|Overall Study||45
8254454|NCT01837680|20354662|P1|COMPLETED|Overall Study||42
8254455|NCT01837680|20354661|P2|STARTED|Overall Study||53
8254456|NCT01837680|20354662|P1|STARTED|Overall Study||52
8254457|NCT01837654|20354700|P2|NOT COMPLETED|Overall Study||0
8254458|NCT01837654|20354701|P1|NOT COMPLETED|Overall Study||0
8254459|NCT01837654|20354700|P2|COMPLETED|Overall Study||11
8254460|NCT01837654|20354701|P1|COMPLETED|Overall Study||11
8254461|NCT01837654|20354700|P2|STARTED|Overall Study||11
8254462|NCT01837654|20354701|P1|STARTED|Overall Study||11
8254463|NCT01837550|20354711|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
8254464|NCT01837550|20354712|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
8254465|NCT01837550|20354711|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
8254466|NCT01837550|20354712|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
8254467|NCT01837550|20354711|P2|STARTED|T0-T2, 6 Months Follow-up||37
8254468|NCT01837550|20354712|P1|STARTED|T0-T2, 6 Months Follow-up||37
8254469|NCT01837550|20354711|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
8254470|NCT01837550|20354712|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
8254471|NCT01837550|20354711|P2|COMPLETED|T0-T1, 5 Weeks||37
8254472|NCT01837550|20354712|P1|COMPLETED|T0-T1, 5 Weeks||37
8254473|NCT01837550|20354711|P2|STARTED|T0-T1, 5 Weeks||37
8254474|NCT01837550|20354712|P1|STARTED|T0-T1, 5 Weeks||37
8254475|NCT01837537|20354724|P1|NOT COMPLETED|Overall Study||0
8254476|NCT01837537|20354724|P1|COMPLETED|Overall Study||90
8254477|NCT01837537|20354724|P1|STARTED|Overall Study||90
8254478|NCT01837524|20354731|P2|NOT COMPLETED|Overall Study||2
8254479|NCT01837524|20354732|P1|NOT COMPLETED|Overall Study||3
8254480|NCT01837524|20354731|P2|COMPLETED|Overall Study||25
8254481|NCT01837524|20354732|P1|COMPLETED|Overall Study||25
8254482|NCT01837524|20354731|P2|STARTED|Overall Study||27
8254483|NCT01837524|20354732|P1|STARTED|Overall Study||28
8254484|NCT01837069|20354740|P2|NOT COMPLETED|Overall Study||0
8254485|NCT01837069|20354741|P1|NOT COMPLETED|Overall Study||0
8254486|NCT01837069|20354740|P2|COMPLETED|Overall Study||95
8254487|NCT01837069|20354741|P1|COMPLETED|Overall Study||103
8254488|NCT01837069|20354740|P2|STARTED|Overall Study||95
8254489|NCT01837069|20354741|P1|STARTED|Overall Study||103
8254490|NCT01836809|20354757|P4|NOT COMPLETED|Overall Study||2
8254491|NCT01836809|20354758|P3|NOT COMPLETED|Overall Study||0
8254492|NCT01836809|20354759|P2|NOT COMPLETED|Overall Study||0
8254493|NCT01836809|20354760|P1|NOT COMPLETED|Overall Study||0
8254494|NCT01836809|20354757|P4|COMPLETED|Overall Study||0
8254495|NCT01836809|20354758|P3|COMPLETED|Overall Study||0
8254496|NCT01836809|20354759|P2|COMPLETED|Overall Study||0
8254497|NCT01836809|20354760|P1|COMPLETED|Overall Study||0
8254498|NCT01836809|20354757|P4|STARTED|Overall Study||2
8254499|NCT01836809|20354758|P3|STARTED|Overall Study||0
8254500|NCT01836809|20354759|P2|STARTED|Overall Study||0
8254501|NCT01836809|20354760|P1|STARTED|Overall Study||0
8254502|NCT01836549|20354796|P7|NOT COMPLETED|Overall Study||1
8254503|NCT01836549|20354797|P6|NOT COMPLETED|Overall Study||0
8254504|NCT01836549|20354798|P5|NOT COMPLETED|Overall Study||0
8254505|NCT01836549|20354799|P4|NOT COMPLETED|Overall Study||1
8254506|NCT01836549|20354800|P3|NOT COMPLETED|Overall Study||1
8254507|NCT01836549|20354801|P2|NOT COMPLETED|Overall Study||0
8254508|NCT01836549|20354802|P1|NOT COMPLETED|Overall Study||0
8254509|NCT01836549|20354796|P7|COMPLETED|Overall Study||8
8254510|NCT01836549|20354797|P6|COMPLETED|Overall Study||4
8254511|NCT01836549|20354798|P5|COMPLETED|Overall Study||18
8254512|NCT01836549|20354799|P4|COMPLETED|Overall Study||8
8254513|NCT01836549|20354800|P3|COMPLETED|Overall Study||0
8254514|NCT01836549|20354801|P2|COMPLETED|Overall Study||1
8254515|NCT01836549|20354802|P1|COMPLETED|Overall Study||1
8254516|NCT01836549|20354796|P7|STARTED|Overall Study||9
8254517|NCT01836549|20354797|P6|STARTED|Overall Study||4
8254518|NCT01836549|20354798|P5|STARTED|Overall Study||18
8254519|NCT01836549|20354799|P4|STARTED|Overall Study||9
8254520|NCT01836549|20354800|P3|STARTED|Overall Study||1
8254521|NCT01836549|20354801|P2|STARTED|Overall Study||1
8254522|NCT01836549|20354802|P1|STARTED|Overall Study||1
8254523|NCT01836523|20354826|P4|NOT COMPLETED|Overall Study||74
8254524|NCT01836523|20354827|P3|NOT COMPLETED|Overall Study||91
8254525|NCT01836523|20354828|P2|NOT COMPLETED|Overall Study||85
8254526|NCT01836523|20354829|P1|NOT COMPLETED|Overall Study||51
8254527|NCT01836523|20354826|P4|COMPLETED|Overall Study||274
8254528|NCT01836523|20354827|P3|COMPLETED|Overall Study||258
8254529|NCT01836523|20354828|P2|COMPLETED|Overall Study||265
8254530|NCT01836523|20354829|P1|COMPLETED|Overall Study||300
8254531|NCT01836523|20354826|P4|Exposed|Overall Study||348
8254532|NCT01836523|20354827|P3|Exposed|Overall Study||347
8254533|NCT01836523|20354828|P2|Exposed|Overall Study||348
8254534|NCT01836523|20354829|P1|Exposed|Overall Study||350
8254535|NCT01836523|20354826|P4|STARTED|Overall Study||348
8254536|NCT01836523|20354827|P3|STARTED|Overall Study||349
8254537|NCT01836523|20354828|P2|STARTED|Overall Study||350
8254538|NCT01836523|20354829|P1|STARTED|Overall Study||351
8254539|NCT01836471|20354856|P5|NOT COMPLETED|Overall Study||5
8254540|NCT01836471|20354857|P4|NOT COMPLETED|Overall Study||2
8254541|NCT01836471|20354858|P3|NOT COMPLETED|Overall Study||2
8254542|NCT01836471|20354859|P2|NOT COMPLETED|Overall Study||9
8254543|NCT01836471|20354860|P1|NOT COMPLETED|Overall Study||11
8254544|NCT01836471|20354856|P5|COMPLETED|Overall Study||49
8254545|NCT01836471|20354857|P4|COMPLETED|Overall Study||40
8254546|NCT01836471|20354858|P3|COMPLETED|Overall Study||49
8254547|NCT01836471|20354859|P2|COMPLETED|Overall Study||85
8254548|NCT01836471|20354860|P1|COMPLETED|Overall Study||82
8254549|NCT01836471|20354856|P5|STARTED|Overall Study||54
8254550|NCT01836471|20354857|P4|STARTED|Overall Study||42
8254551|NCT01836471|20354858|P3|STARTED|Overall Study||51
8254552|NCT01836471|20354859|P2|STARTED|Overall Study||94
8254553|NCT01836471|20354860|P1|STARTED|Overall Study||93
8254554|NCT01836458|20354889|P4|NOT COMPLETED|Overall Study||6
8254555|NCT01836458|20354890|P3|NOT COMPLETED|Overall Study||5
8254556|NCT01836458|20354891|P2|NOT COMPLETED|Overall Study||2
8254557|NCT01836458|20354892|P1|NOT COMPLETED|Overall Study||3
8254558|NCT01836458|20354889|P4|COMPLETED|Overall Study||1
8254559|NCT01836458|20354890|P3|COMPLETED|Overall Study||2
8254560|NCT01836458|20354891|P2|COMPLETED|Overall Study||2
8254561|NCT01836458|20354892|P1|COMPLETED|Overall Study||4
8254562|NCT01836458|20354889|P4|STARTED|Overall Study||7
8254563|NCT01836458|20354890|P3|STARTED|Overall Study||7
8254564|NCT01836458|20354891|P2|STARTED|Overall Study||4
8254565|NCT01836458|20354892|P1|STARTED|Overall Study||7
8254566|NCT01836445|20354916|P2|NOT COMPLETED|12 Month STI Testing||77
8254567|NCT01836445|20354917|P1|NOT COMPLETED|12 Month STI Testing||80
8254568|NCT01836445|20354916|P2|COMPLETED|12 Month STI Testing||378
8254569|NCT01836445|20354917|P1|COMPLETED|12 Month STI Testing||365
8254570|NCT01836445|20354916|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8254571|NCT01836445|20354917|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254572|NCT01836445|20354916|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
8254573|NCT01836445|20354917|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
8254574|NCT01836445|20354916|P2|COMPLETED|12 Month Follow-up Assessment||391
8254575|NCT01836445|20354917|P1|COMPLETED|12 Month Follow-up Assessment||370
8254576|NCT01836445|20354916|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8254577|NCT01836445|20354917|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254578|NCT01836445|20354916|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
8254579|NCT01836445|20354917|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
8254580|NCT01836445|20354916|P2|COMPLETED|6 Month Follow-up Assessment||380
8254581|NCT01836445|20354917|P1|COMPLETED|6 Month Follow-up Assessment||342
8254582|NCT01836445|20354916|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8254583|NCT01836445|20354917|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254584|NCT01836445|20354916|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
8254585|NCT01836445|20354917|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
8254586|NCT01836445|20354916|P2|COMPLETED|3 Month Follow-up Assessment||409
8254587|NCT01836445|20354917|P1|COMPLETED|3 Month Follow-up Assessment||348
8254588|NCT01836445|20354916|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
8254589|NCT01836445|20354917|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254590|NCT01836445|20354916|P2|NOT COMPLETED|Intervention Modules||22
8254591|NCT01836445|20354917|P1|NOT COMPLETED|Intervention Modules||70
8254592|NCT01836445|20354916|P2|COMPLETED|Intervention Modules||434
8254593|NCT01836445|20354917|P1|COMPLETED|Intervention Modules||375
8254594|NCT01836445|20354916|P2|STARTED|Intervention Modules||456
8254595|NCT01836445|20354917|P1|STARTED|Intervention Modules||445
8254596|NCT01836276|20354977|P2|NOT COMPLETED|Overall Study||51
8254597|NCT01836276|20354978|P1|NOT COMPLETED|Overall Study||28
8254598|NCT01836276|20354977|P2|COMPLETED|Overall Study||174
8254599|NCT01836276|20354978|P1|COMPLETED|Overall Study||196
8254600|NCT01836276|20354977|P2|Week 12|Overall Study||165
8254601|NCT01836276|20354978|P1|Week 12|Overall Study||183
8254602|NCT01836276|20354977|P2|Week 4|Overall Study||186
8254603|NCT01836276|20354978|P1|Week 4|Overall Study||198
8254604|NCT01836276|20354977|P2|STARTED|Overall Study||225
8254605|NCT01836276|20354978|P1|STARTED|Overall Study||224
8254606|NCT01836198|20354986|P3|NOT COMPLETED|Part B||0
8254607|NCT01836198|20354987|P2|NOT COMPLETED|Part B||0
8254608|NCT01836198|20354988|P1|NOT COMPLETED|Part B||0
8254609|NCT01836198|20354986|P3|COMPLETED|Part B||12
8254610|NCT01836198|20354987|P2|COMPLETED|Part B||0
8254611|NCT01836198|20354988|P1|COMPLETED|Part B||0
8254612|NCT01836198|20354986|P3|Received at Least 1 Dose of Study Drug|Part B||12
8254613|NCT01836198|20354987|P2|Received at Least 1 Dose of Study Drug|Part B||0
8254614|NCT01836198|20354988|P1|Received at Least 1 Dose of Study Drug|Part B||0
8254615|NCT01836198|20354986|P3|STARTED|Part B||12
8254616|NCT01836198|20354987|P2|STARTED|Part B||0
8254617|NCT01836198|20354988|P1|STARTED|Part B||0
8254618|NCT01836198|20354986|P3|NOT COMPLETED|Part A, Period 2||0
8254619|NCT01836198|20354987|P2|NOT COMPLETED|Part A, Period 2||1
8254620|NCT01836198|20354988|P1|NOT COMPLETED|Part A, Period 2||0
8254621|NCT01836198|20354986|P3|COMPLETED|Part A, Period 2||0
8254622|NCT01836198|20354987|P2|COMPLETED|Part A, Period 2||14
8254623|NCT01836198|20354988|P1|COMPLETED|Part A, Period 2||15
8254624|NCT01836198|20354986|P3|Completed Part A, Entered Part B|Part A, Period 2||0
8254625|NCT01836198|20354987|P2|Completed Part A, Entered Part B|Part A, Period 2||6
8254626|NCT01836198|20354988|P1|Completed Part A, Entered Part B|Part A, Period 2||6
8254627|NCT01836198|20354986|P3|STARTED|Part A, Period 2||0
8254628|NCT01836198|20354987|P2|STARTED|Part A, Period 2||15
8254629|NCT01836198|20354988|P1|STARTED|Part A, Period 2||15
8254630|NCT01836198|20354986|P3|NOT COMPLETED|Part A, Period 1||0
8254631|NCT01836198|20354987|P2|NOT COMPLETED|Part A, Period 1||0
8254632|NCT01836198|20354988|P1|NOT COMPLETED|Part A, Period 1||0
8254633|NCT01836198|20354986|P3|COMPLETED|Part A, Period 1||0
8254634|NCT01836198|20354987|P2|COMPLETED|Part A, Period 1||15
8254635|NCT01836198|20354988|P1|COMPLETED|Part A, Period 1||15
8254636|NCT01836198|20354986|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8254637|NCT01836198|20354987|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
8254638|NCT01836198|20354988|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
8254639|NCT01836198|20354986|P3|STARTED|Part A, Period 1||0
8254640|NCT01836198|20354987|P2|STARTED|Part A, Period 1||15
8254641|NCT01836198|20354988|P1|STARTED|Part A, Period 1||15
8254642|NCT01836185|20355014|P4|NOT COMPLETED|Overall Study||0
8254643|NCT01836185|20355015|P3|NOT COMPLETED|Overall Study||0
8254644|NCT01836185|20355016|P2|NOT COMPLETED|Overall Study||0
8254645|NCT01836185|20355017|P1|NOT COMPLETED|Overall Study||0
8254646|NCT01836185|20355014|P4|COMPLETED|Overall Study||6
8254647|NCT01836185|20355015|P3|COMPLETED|Overall Study||8
8254648|NCT01836185|20355016|P2|COMPLETED|Overall Study||8
8254649|NCT01836185|20355017|P1|COMPLETED|Overall Study||10
8254650|NCT01836185|20355014|P4|Received Single Dose of Study Treatment|Overall Study||6
8254651|NCT01836185|20355015|P3|Received Single Dose of Study Treatment|Overall Study||8
8254652|NCT01836185|20355016|P2|Received Single Dose of Study Treatment|Overall Study||8
8254653|NCT01836185|20355017|P1|Received Single Dose of Study Treatment|Overall Study||10
8254654|NCT01836185|20355014|P4|STARTED|Overall Study||6
8254655|NCT01836185|20355015|P3|STARTED|Overall Study||8
8254656|NCT01836185|20355016|P2|STARTED|Overall Study||8
8254657|NCT01836185|20355017|P1|STARTED|Overall Study||10
8254658|NCT01836133|20355035|P1|NOT COMPLETED|Overall Study||0
8254659|NCT01836133|20355035|P1|COMPLETED|Overall Study||70
8254660|NCT01836133|20355035|P1|STARTED|Overall Study||70
8254661|NCT01836042|20355044|P3|NOT COMPLETED|Overall Study||0
8254662|NCT01836042|20355045|P2|NOT COMPLETED|Overall Study||0
8254663|NCT01836042|20355046|P1|NOT COMPLETED|Overall Study||0
8254664|NCT01836042|20355044|P3|COMPLETED|Overall Study||22
8254665|NCT01836042|20355045|P2|COMPLETED|Overall Study||35
8254666|NCT01836042|20355046|P1|COMPLETED|Overall Study||51
8254667|NCT01836042|20355044|P3|STARTED|Overall Study||22
8254668|NCT01836042|20355045|P2|STARTED|Overall Study||35
8254669|NCT01836042|20355046|P1|STARTED|Overall Study||51
8254670|NCT01836029|20355056|P2|NOT COMPLETED|Overall Study||0
8254671|NCT01836029|20355057|P1|NOT COMPLETED|Overall Study||0
8254672|NCT01836029|20355056|P2|COMPLETED|Overall Study||95
8254673|NCT01836029|20355057|P1|COMPLETED|Overall Study||100
8254674|NCT01836029|20355056|P2|STARTED|Overall Study||95
8254675|NCT01836029|20355057|P1|STARTED|Overall Study||100
8254676|NCT01835912|20355069|P1|NOT COMPLETED|Overall Study||0
8254677|NCT01835912|20355069|P1|COMPLETED|Overall Study||10
8254678|NCT01835912|20355069|P1|Chronic Placebo|Overall Study||10
8254679|NCT01835912|20355069|P1|Chronic|Overall Study||10
8254680|NCT01835912|20355069|P1|Acute Placebo|Overall Study||10
8254681|NCT01835912|20355069|P1|Acute|Overall Study||10
8254682|NCT01835912|20355069|P1|STARTED|Overall Study||10
8254683|NCT01835899|20355090|P3|NOT COMPLETED|Overall Study||1
8254684|NCT01835899|20355091|P2|NOT COMPLETED|Overall Study||1
8254685|NCT01835899|20355092|P1|NOT COMPLETED|Overall Study||0
8254686|NCT01835899|20355090|P3|COMPLETED|Overall Study||8
8254687|NCT01835899|20355091|P2|COMPLETED|Overall Study||8
8254688|NCT01835899|20355092|P1|COMPLETED|Overall Study||6
8254689|NCT01835899|20355090|P3|STARTED|Overall Study||9
8254690|NCT01835899|20355091|P2|STARTED|Overall Study||9
8254691|NCT01835899|20355092|P1|STARTED|Overall Study||6
8254692|NCT01835756|20355112|P2|NOT COMPLETED|Overall Study||0
8254693|NCT01835756|20355113|P1|NOT COMPLETED|Overall Study||0
8254694|NCT01835756|20355112|P2|COMPLETED|Overall Study||31
8254695|NCT01835756|20355113|P1|COMPLETED|Overall Study||31
8254696|NCT01835756|20355112|P2|STARTED|Overall Study||31
8254697|NCT01835756|20355113|P1|STARTED|Overall Study||31
8254698|NCT01835743|20355125|P2|NOT COMPLETED|Overall Study||0
8254699|NCT01835743|20355126|P1|NOT COMPLETED|Overall Study||0
8254700|NCT01835743|20355125|P2|COMPLETED|Overall Study||32
8254701|NCT01835743|20355126|P1|COMPLETED|Overall Study||37
8254702|NCT01835743|20355125|P2|STARTED|Overall Study||32
8254703|NCT01835743|20355126|P1|STARTED|Overall Study||37
8254704|NCT01835626|20355134|P1|NOT COMPLETED|Overall Study||0
8254705|NCT01835626|20355134|P1|COMPLETED|Overall Study||24
8254706|NCT01835626|20355134|P1|STARTED|Overall Study||24
8254707|NCT01835587|20355149|P4|NOT COMPLETED|Overall Study||9
8254708|NCT01835587|20355150|P3|NOT COMPLETED|Overall Study||2
8254709|NCT01835587|20355151|P2|NOT COMPLETED|Overall Study||4
8254710|NCT01835587|20355152|P1|NOT COMPLETED|Overall Study||2
8254711|NCT01835587|20355149|P4|COMPLETED|Overall Study||10
8254712|NCT01835587|20355150|P3|COMPLETED|Overall Study||2
8254713|NCT01835587|20355151|P2|COMPLETED|Overall Study||0
8254714|NCT01835587|20355152|P1|COMPLETED|Overall Study||1
8254715|NCT01835587|20355149|P4|STARTED|Overall Study||19
8254716|NCT01835587|20355150|P3|STARTED|Overall Study||4
8254717|NCT01835587|20355151|P2|STARTED|Overall Study||4
8254718|NCT01835587|20355152|P1|STARTED|Overall Study||3
8254719|NCT01835548|20355213|P3|NOT COMPLETED|Double-Blind Treatment Period||0
8254720|NCT01835548|20355214|P2|NOT COMPLETED|Double-Blind Treatment Period||2
8254721|NCT01835548|20355215|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8254722|NCT01835548|20355213|P3|COMPLETED|Double-Blind Treatment Period||0
8254723|NCT01835548|20355214|P2|COMPLETED|Double-Blind Treatment Period||39
8254724|NCT01835548|20355215|P1|COMPLETED|Double-Blind Treatment Period||44
8254725|NCT01835548|20355213|P3|STARTED|Double-Blind Treatment Period||0
8254726|NCT01835548|20355214|P2|STARTED|Double-Blind Treatment Period||41
8254727|NCT01835548|20355215|P1|STARTED|Double-Blind Treatment Period||44
8254728|NCT01835548|20355213|P3|NOT COMPLETED|Dose Stabilization Period||0
8254729|NCT01835548|20355214|P2|NOT COMPLETED|Dose Stabilization Period||0
8254730|NCT01835548|20355215|P1|NOT COMPLETED|Dose Stabilization Period||0
8254731|NCT01835548|20355213|P3|COMPLETED|Dose Stabilization Period||85
8254732|NCT01835548|20355214|P2|COMPLETED|Dose Stabilization Period||0
8254733|NCT01835548|20355215|P1|COMPLETED|Dose Stabilization Period||0
8254734|NCT01835548|20355213|P3|STARTED|Dose Stabilization Period||85
8254735|NCT01835548|20355214|P2|STARTED|Dose Stabilization Period||0
8254736|NCT01835548|20355215|P1|STARTED|Dose Stabilization Period||0
8254737|NCT01835548|20355213|P3|NOT COMPLETED|Dose Optimization Period||2
8254738|NCT01835548|20355214|P2|NOT COMPLETED|Dose Optimization Period||0
8254739|NCT01835548|20355215|P1|NOT COMPLETED|Dose Optimization Period||0
8254740|NCT01835548|20355213|P3|COMPLETED|Dose Optimization Period||85
8254741|NCT01835548|20355214|P2|COMPLETED|Dose Optimization Period||0
8254742|NCT01835548|20355215|P1|COMPLETED|Dose Optimization Period||0
8254743|NCT01835548|20355213|P3|STARTED|Dose Optimization Period||87
8254744|NCT01835548|20355214|P2|STARTED|Dose Optimization Period||0
8254745|NCT01835548|20355215|P1|STARTED|Dose Optimization Period||0
8254746|NCT01835548|20355213|P3|NOT COMPLETED|Screening/Washout Period||0
8254747|NCT01835548|20355214|P2|NOT COMPLETED|Screening/Washout Period||0
8254748|NCT01835548|20355215|P1|NOT COMPLETED|Screening/Washout Period||0
8254749|NCT01835548|20355213|P3|COMPLETED|Screening/Washout Period||87
8254750|NCT01835548|20355214|P2|COMPLETED|Screening/Washout Period||0
8254751|NCT01835548|20355215|P1|COMPLETED|Screening/Washout Period||0
8254752|NCT01835548|20355213|P3|STARTED|Screening/Washout Period||87
8254753|NCT01835548|20355214|P2|STARTED|Screening/Washout Period||0
8254754|NCT01835548|20355215|P1|STARTED|Screening/Washout Period||0
8254755|NCT01835496|20355235|P1|NOT COMPLETED|Overall Study||0
8254756|NCT01835496|20355235|P1|COMPLETED|Overall Study||8
8254757|NCT01835496|20355235|P1|STARTED|Overall Study||8
8254764|NCT01835431|20355256|P2|NOT COMPLETED|Overall Study||12
8254765|NCT01835431|20355257|P1|NOT COMPLETED|Overall Study||8
8254766|NCT01835431|20355256|P2|COMPLETED|Overall Study||168
8254767|NCT01835431|20355257|P1|COMPLETED|Overall Study||174
8254768|NCT01835431|20355256|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
8254769|NCT01835431|20355257|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
8254770|NCT01835431|20355256|P2|STARTED|Overall Study||180
8254771|NCT01835431|20355257|P1|STARTED|Overall Study||182
8254772|NCT01835379|20355277|P2|NOT COMPLETED|Overall Study||0
8254773|NCT01835379|20355278|P1|NOT COMPLETED|Overall Study||0
8254774|NCT01835379|20355277|P2|COMPLETED|Overall Study||41
8254775|NCT01835379|20355278|P1|COMPLETED|Overall Study||41
8254776|NCT01835379|20355277|P2|STARTED|Overall Study||41
8254777|NCT01835379|20355278|P1|STARTED|Overall Study||41
8254778|NCT01835262|20355288|P2|NOT COMPLETED|Overall Study||0
8254779|NCT01835262|20355289|P1|NOT COMPLETED|Overall Study||0
8254780|NCT01835262|20355288|P2|COMPLETED|Overall Study||45
8254781|NCT01835262|20355289|P1|COMPLETED|Overall Study||45
8254782|NCT01835262|20355288|P2|STARTED|Overall Study||45
8254783|NCT01835262|20355289|P1|STARTED|Overall Study||45
8254784|NCT01835223|20355297|P2|NOT COMPLETED|Overall Study||1
8254785|NCT01835223|20355298|P1|NOT COMPLETED|Overall Study||9
8254786|NCT01835223|20355297|P2|COMPLETED|Overall Study||2
8254787|NCT01835223|20355298|P1|COMPLETED|Overall Study||21
8254788|NCT01835223|20355297|P2|STARTED|Overall Study||3
8254789|NCT01835223|20355298|P1|STARTED|Overall Study||30
8254796|NCT01835145|20355331|P2|NOT COMPLETED|Overall Study||0
8254797|NCT01835145|20355332|P1|NOT COMPLETED|Overall Study||1
8254798|NCT01835145|20355331|P2|COMPLETED|Overall Study||15
8254799|NCT01835145|20355332|P1|COMPLETED|Overall Study||31
8254800|NCT01835145|20355331|P2|STARTED|Overall Study||15
8254801|NCT01835145|20355332|P1|STARTED|Overall Study||32
8254802|NCT01835132|20355347|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
8254803|NCT01835132|20355347|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
8254804|NCT01835132|20355347|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
8254805|NCT01835132|20355347|P1|NOT COMPLETED|1st Extension Phase||0
8254806|NCT01835132|20355347|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
8254807|NCT01835132|20355347|P1|STARTED|1st Extension Phase||6
8254808|NCT01835132|20355347|P1|NOT COMPLETED|Initial Phase||2
8254809|NCT01835132|20355347|P1|COMPLETED|Initial Phase||6
8254810|NCT01835132|20355347|P1|STARTED|Initial Phase||8
8254811|NCT01835015|20355392|P5|NOT COMPLETED|Overall Study||0
8254812|NCT01835015|20355393|P4|NOT COMPLETED|Overall Study||0
8254813|NCT01835015|20355394|P3|NOT COMPLETED|Overall Study||1
8254814|NCT01835015|20355395|P2|NOT COMPLETED|Overall Study||0
8254815|NCT01835015|20355396|P1|NOT COMPLETED|Overall Study||0
8254816|NCT01835015|20355392|P5|COMPLETED|Overall Study||6
8254817|NCT01835015|20355393|P4|COMPLETED|Overall Study||6
8254818|NCT01835015|20355394|P3|COMPLETED|Overall Study||6
8254819|NCT01835015|20355395|P2|COMPLETED|Overall Study||6
8254820|NCT01835015|20355396|P1|COMPLETED|Overall Study||6
8254821|NCT01835015|20355392|P5|STARTED|Overall Study||6
8254822|NCT01835015|20355393|P4|STARTED|Overall Study||6
8254823|NCT01835015|20355394|P3|STARTED|Overall Study||7
8254824|NCT01835015|20355395|P2|STARTED|Overall Study||6
8254825|NCT01835015|20355396|P1|STARTED|Overall Study||6
8254826|NCT01834729|20355473|P4|NOT COMPLETED|Overall Study||2
8254827|NCT01834729|20355474|P3|NOT COMPLETED|Overall Study||3
8254828|NCT01834729|20355475|P2|NOT COMPLETED|Overall Study||1
8254829|NCT01834729|20355476|P1|NOT COMPLETED|Overall Study||1
8254830|NCT01834729|20355473|P4|COMPLETED|Overall Study||16
8254831|NCT01834729|20355474|P3|COMPLETED|Overall Study||15
8254832|NCT01834729|20355475|P2|COMPLETED|Overall Study||19
8254833|NCT01834729|20355476|P1|COMPLETED|Overall Study||17
8254834|NCT01834729|20355473|P4|STARTED|Overall Study||18
8254835|NCT01834729|20355474|P3|STARTED|Overall Study||18
8254836|NCT01834729|20355475|P2|STARTED|Overall Study||20
8254837|NCT01834729|20355476|P1|STARTED|Overall Study||18
8254838|NCT01834716|20355492|P2|NOT COMPLETED|Overall Study||1
8254839|NCT01834716|20355493|P1|NOT COMPLETED|Overall Study||0
8254840|NCT01834716|20355492|P2|COMPLETED|Overall Study||11
8254841|NCT01834716|20355493|P1|COMPLETED|Overall Study||4
8254842|NCT01834716|20355492|P2|STARTED|Overall Study||12
8254843|NCT01834716|20355493|P1|STARTED|Overall Study||4
8254844|NCT01834651|20355499|P1|NOT COMPLETED|Overall Study||1
8254845|NCT01834651|20355499|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
8254846|NCT01834651|20355499|P1|STARTED|Overall Study||17
8254847|NCT01834586|20355509|P1|NOT COMPLETED|Overall Study||1
8254848|NCT01834586|20355509|P1|COMPLETED|Overall Study||29
8254849|NCT01834586|20355509|P1|STARTED|Overall Study||30
8254850|NCT01834404|20355516|P2|NOT COMPLETED|Overall Study||0
8254851|NCT01834404|20355517|P1|NOT COMPLETED|Overall Study||0
8254852|NCT01834404|20355516|P2|COMPLETED|Overall Study||12
8254853|NCT01834404|20355517|P1|COMPLETED|Overall Study||12
8254854|NCT01834404|20355516|P2|STARTED|Overall Study||12
8254855|NCT01834404|20355517|P1|STARTED|Overall Study||12
8254856|NCT01834274|20355549|P2|NOT COMPLETED|Overall Study||41
8254857|NCT01834274|20355550|P1|NOT COMPLETED|Overall Study||47
8254858|NCT01834274|20355549|P2|COMPLETED|Overall Study||5
8254859|NCT01834274|20355550|P1|COMPLETED|Overall Study||3
8254860|NCT01834274|20355549|P2|STARTED|Overall Study||46
8254861|NCT01834274|20355550|P1|STARTED|Overall Study||50
8254862|NCT01834261|20355562|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
8254863|NCT01834261|20355563|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
8254864|NCT01834261|20355562|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
8254865|NCT01834261|20355563|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
8254866|NCT01834261|20355562|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
8254867|NCT01834261|20355563|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
8254868|NCT01834261|20355562|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
8254869|NCT01834261|20355563|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
8254870|NCT01834261|20355562|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
8254871|NCT01834261|20355563|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
8254872|NCT01834261|20355562|P2|STARTED|MIT fMRI and MEG Resting State Study||10
8254873|NCT01834261|20355563|P1|STARTED|MIT fMRI and MEG Resting State Study||11
8254874|NCT01834222|20355573|P1|NOT COMPLETED|Overall Study||1
8254875|NCT01834222|20355573|P1|COMPLETED|Overall Study||658
8254876|NCT01834222|20355573|P1|Treated|Overall Study||658
8254877|NCT01834222|20355573|P1|STARTED|Overall Study||659
8254878|NCT01834144|20355584|P2|NOT COMPLETED|Overall Study||1
8254879|NCT01834144|20355585|P1|NOT COMPLETED|Overall Study||0
8254880|NCT01834144|20355584|P2|COMPLETED|Overall Study||2
8254881|NCT01834144|20355585|P1|COMPLETED|Overall Study||1
8254882|NCT01834144|20355584|P2|STARTED|Overall Study||3
8254883|NCT01834144|20355585|P1|STARTED|Overall Study||1
8254884|NCT01834027|20355593|P2|NOT COMPLETED|Overall Study||0
8254885|NCT01834027|20355594|P1|NOT COMPLETED|Overall Study||0
8254886|NCT01834027|20355593|P2|COMPLETED|Overall Study||28
8254887|NCT01834027|20355594|P1|COMPLETED|Overall Study||28
8254888|NCT01834027|20355593|P2|STARTED|Overall Study||28
8254889|NCT01834027|20355594|P1|STARTED|Overall Study||28
8254890|NCT01833988|20355604|P2|NOT COMPLETED|Overall Study||0
8254891|NCT01833988|20355605|P1|NOT COMPLETED|Overall Study||0
8254892|NCT01833988|20355604|P2|COMPLETED|Overall Study||16
8254893|NCT01833988|20355605|P1|COMPLETED|Overall Study||16
8254894|NCT01833988|20355604|P2|STARTED|Overall Study||16
8254895|NCT01833988|20355605|P1|STARTED|Overall Study||16
8254896|NCT01833936|20355661|P2|NOT COMPLETED|Overall Study||2
8254897|NCT01833936|20355662|P1|NOT COMPLETED|Overall Study||4
8254898|NCT01833936|20355661|P2|COMPLETED|Overall Study||18
8254899|NCT01833936|20355662|P1|COMPLETED|Overall Study||16
8254900|NCT01833936|20355661|P2|STARTED|Overall Study||20
8254901|NCT01833936|20355662|P1|STARTED|Overall Study||20
8254902|NCT01833897|20355668|P1|NOT COMPLETED|Overall Study||1
8254903|NCT01833897|20355668|P1|COMPLETED|Overall Study||7
8254904|NCT01833897|20355668|P1|STARTED|Overall Study||8
8254905|NCT01833845|20355676|P1|NOT COMPLETED|Overall Study||0
8254906|NCT01833845|20355676|P1|COMPLETED|Overall Study||4
8254907|NCT01833845|20355676|P1|STARTED|Overall Study||4
8254908|NCT01833832|20355680|P1|NOT COMPLETED|Overall Study||1
8254909|NCT01833832|20355680|P1|COMPLETED|Overall Study||10
8254910|NCT01833832|20355680|P1|STARTED|Overall Study||11
8254911|NCT01833754|20355691|P3|NOT COMPLETED|Overall Study||0
8254912|NCT01833754|20355692|P2|NOT COMPLETED|Overall Study||0
8254913|NCT01833754|20355693|P1|NOT COMPLETED|Overall Study||0
8254914|NCT01833754|20355691|P3|COMPLETED|Overall Study||8
8254915|NCT01833754|20355692|P2|COMPLETED|Overall Study||8
8254916|NCT01833754|20355693|P1|COMPLETED|Overall Study||8
8254917|NCT01833754|20355691|P3|STARTED|Overall Study||8
8254918|NCT01833754|20355692|P2|STARTED|Overall Study||8
8254919|NCT01833754|20355693|P1|STARTED|Overall Study||8
8254920|NCT01833741|20355722|P1|NOT COMPLETED|Overall Study||140
8254921|NCT01833741|20355722|P1|COMPLETED|Overall Study||997
8254922|NCT01833741|20355722|P1|STARTED|Overall Study||1137
8254923|NCT01833546|20355739|P4|NOT COMPLETED|Overall Study||0
8254924|NCT01833546|20355740|P3|NOT COMPLETED|Overall Study||0
8254925|NCT01833546|20355741|P2|NOT COMPLETED|Overall Study||0
8254926|NCT01833546|20355742|P1|NOT COMPLETED|Overall Study||0
8254927|NCT01833546|20355739|P4|COMPLETED|Overall Study||6
8254928|NCT01833546|20355740|P3|COMPLETED|Overall Study||8
8254929|NCT01833546|20355741|P2|COMPLETED|Overall Study||3
8254930|NCT01833546|20355742|P1|COMPLETED|Overall Study||3
8254931|NCT01833546|20355739|P4|STARTED|Overall Study||6
8254932|NCT01833546|20355740|P3|STARTED|Overall Study||8
8254933|NCT01833546|20355741|P2|STARTED|Overall Study||3
8254934|NCT01833546|20355742|P1|STARTED|Overall Study||3
8254935|NCT01833533|20355835|P2|NOT COMPLETED|Overall Study||21
8254936|NCT01833533|20355836|P1|NOT COMPLETED|Overall Study||6
8254937|NCT01833533|20355835|P2|COMPLETED|Overall Study||184
8254938|NCT01833533|20355836|P1|COMPLETED|Overall Study||94
8254939|NCT01833533|20355835|P2|STARTED|Overall Study||205
8254940|NCT01833533|20355836|P1|STARTED|Overall Study||100
8254941|NCT01833494|20355850|P1|NOT COMPLETED|Overall Study||45
8254942|NCT01833494|20355850|P1|COMPLETED|Overall Study||116
8254943|NCT01833494|20355850|P1|STARTED|Overall Study||161
8254944|NCT01833481|20355860|P3|NOT COMPLETED|Overall Study||0
8254945|NCT01833481|20355861|P2|NOT COMPLETED|Overall Study||0
8254946|NCT01833481|20355862|P1|NOT COMPLETED|Overall Study||0
8254947|NCT01833481|20355860|P3|COMPLETED|Overall Study||10
8254948|NCT01833481|20355861|P2|COMPLETED|Overall Study||10
8254949|NCT01833481|20355862|P1|COMPLETED|Overall Study||10
8254950|NCT01833481|20355860|P3|STARTED|Overall Study||10
8254951|NCT01833481|20355861|P2|STARTED|Overall Study||10
8254952|NCT01833481|20355862|P1|STARTED|Overall Study||10
8254953|NCT01833455|20355878|P2|NOT COMPLETED|Overall Study||0
8254954|NCT01833455|20355879|P1|NOT COMPLETED|Overall Study||1
8254955|NCT01833455|20355878|P2|COMPLETED|Overall Study||4
8254956|NCT01833455|20355879|P1|COMPLETED|Overall Study||3
8254957|NCT01833455|20355878|P2|Completed 2nd Baseline (Washout)|Overall Study||4
8254958|NCT01833455|20355879|P1|Completed 2nd Baseline (Washout)|Overall Study||3
8254959|NCT01833455|20355878|P2|Completed 1st Intervention|Overall Study||4
8254960|NCT01833455|20355879|P1|Completed 1st Intervention|Overall Study||3
8254961|NCT01833455|20355878|P2|Completed 1st Baseline|Overall Study||4
8254962|NCT01833455|20355879|P1|Completed 1st Baseline|Overall Study||4
8254963|NCT01833455|20355878|P2|STARTED|Overall Study||4
8254964|NCT01833455|20355879|P1|STARTED|Overall Study||4
8254965|NCT01833403|20355897|P1|NOT COMPLETED|Overall Study||0
8254966|NCT01833403|20355897|P1|COMPLETED|Overall Study||4
8254967|NCT01833403|20355897|P1|STARTED|Overall Study||4
8254968|NCT01833247|20355902|P1|NOT COMPLETED|Overall Study||0
8254969|NCT01833247|20355902|P1|COMPLETED|Overall Study||12
8254970|NCT01833247|20355902|P1|STARTED|Overall Study||12
8254971|NCT01833169|20355908|P1|NOT COMPLETED|Overall Study||146
8254972|NCT01833169|20355908|P1|COMPLETED|Overall Study||0
8254973|NCT01833169|20355908|P1|Consented to be Followed for Survival|Overall Study||128
8254974|NCT01833169|20355908|P1|STARTED|Overall Study||146
8254975|NCT01833143|20355919|P1|NOT COMPLETED|Overall Study||1
8254976|NCT01833143|20355919|P1|COMPLETED|Overall Study||16
8254977|NCT01833143|20355919|P1|STARTED|Overall Study||17
8254978|NCT01833130|20355928|P2|NOT COMPLETED|Overall Study||19
8254979|NCT01833130|20355929|P1|NOT COMPLETED|Overall Study||10
8254980|NCT01833130|20355928|P2|COMPLETED|Overall Study||8
8254981|NCT01833130|20355929|P1|COMPLETED|Overall Study||15
8254982|NCT01833130|20355928|P2|STARTED|Overall Study||27
8254983|NCT01833130|20355929|P1|STARTED|Overall Study||25
8254984|NCT01833117|20355967|P2|NOT COMPLETED|Overall Study||0
8254985|NCT01833117|20355968|P1|NOT COMPLETED|Overall Study||0
8254986|NCT01833117|20355967|P2|COMPLETED|Overall Study||19
8254987|NCT01833117|20355968|P1|COMPLETED|Overall Study||43
8254988|NCT01833117|20355967|P2|STARTED|Overall Study||19
8254989|NCT01833117|20355968|P1|STARTED|Overall Study||43
8254990|NCT01833078|20355976|P1|NOT COMPLETED|Overall Study||0
8254991|NCT01833078|20355976|P1|COMPLETED|Overall Study||5
8254992|NCT01833078|20355976|P1|STARTED|Overall Study||5
8254993|NCT01833065|20355984|P5|NOT COMPLETED|Overall Study||36
8254994|NCT01833065|20355985|P4|NOT COMPLETED|Overall Study||9
8254995|NCT01833065|20355986|P3|NOT COMPLETED|Overall Study||12
8254996|NCT01833065|20355987|P2|NOT COMPLETED|Overall Study||13
8254997|NCT01833065|20355988|P1|NOT COMPLETED|Overall Study||24
8254998|NCT01833065|20355984|P5|COMPLETED|Overall Study||74
8254999|NCT01833065|20355985|P4|COMPLETED|Overall Study||41
8255000|NCT01833065|20355986|P3|COMPLETED|Overall Study||23
8255001|NCT01833065|20355987|P2|COMPLETED|Overall Study||40
8255002|NCT01833065|20355988|P1|COMPLETED|Overall Study||41
8255003|NCT01833065|20355984|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
8255004|NCT01833065|20355985|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8255005|NCT01833065|20355986|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8255006|NCT01833065|20355987|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
8255007|NCT01833065|20355988|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8255008|NCT01833065|20355984|P5|STARTED|Overall Study|Randomized patients - As treated|110
8255009|NCT01833065|20355985|P4|STARTED|Overall Study|Randomized patients - As treated|50
8255010|NCT01833065|20355986|P3|STARTED|Overall Study|Randomized patients - As treated|35
8255011|NCT01833065|20355987|P2|STARTED|Overall Study|Randomized patients - As treated|53
8255012|NCT01833065|20355988|P1|STARTED|Overall Study|Randomized patients - As treated|65
8255013|NCT01833026|20356021|P2|NOT COMPLETED|Overall Study||0
8255014|NCT01833026|20356022|P1|NOT COMPLETED|Overall Study||0
8255015|NCT01833026|20356021|P2|COMPLETED|Overall Study||34
8255016|NCT01833026|20356022|P1|COMPLETED|Overall Study||22
8255017|NCT01833026|20356021|P2|STARTED|Overall Study||34
8255018|NCT01833026|20356022|P1|STARTED|Overall Study||22
8255019|NCT01832961|20356028|P2|NOT COMPLETED|Third Intervention||0
8255020|NCT01832961|20356029|P1|NOT COMPLETED|Third Intervention||0
8255021|NCT01832961|20356028|P2|COMPLETED|Third Intervention||7
8255022|NCT01832961|20356029|P1|COMPLETED|Third Intervention||8
8255023|NCT01832961|20356028|P2|STARTED|Third Intervention||7
8255024|NCT01832961|20356029|P1|STARTED|Third Intervention||8
8255025|NCT01832961|20356028|P2|NOT COMPLETED|Second Intervention||0
8255026|NCT01832961|20356029|P1|NOT COMPLETED|Second Intervention||0
8255027|NCT01832961|20356028|P2|COMPLETED|Second Intervention||7
8255028|NCT01832961|20356029|P1|COMPLETED|Second Intervention||8
8255029|NCT01832961|20356028|P2|STARTED|Second Intervention||7
8255030|NCT01832961|20356029|P1|STARTED|Second Intervention||8
8255031|NCT01832961|20356028|P2|NOT COMPLETED|Washout||0
8255032|NCT01832961|20356029|P1|NOT COMPLETED|Washout||0
8255033|NCT01832961|20356028|P2|COMPLETED|Washout||7
8255034|NCT01832961|20356029|P1|COMPLETED|Washout||8
8255035|NCT01832961|20356028|P2|STARTED|Washout||7
8255036|NCT01832961|20356029|P1|STARTED|Washout||8
8255037|NCT01832961|20356028|P2|NOT COMPLETED|First Intervention||0
8255038|NCT01832961|20356029|P1|NOT COMPLETED|First Intervention||0
8255039|NCT01832961|20356028|P2|COMPLETED|First Intervention||7
8255040|NCT01832961|20356029|P1|COMPLETED|First Intervention||8
8255041|NCT01832961|20356028|P2|STARTED|First Intervention||7
8255042|NCT01832961|20356029|P1|STARTED|First Intervention||8
8255043|NCT01832818|20356057|P1|NOT COMPLETED|Overall Study||6
8255044|NCT01832818|20356057|P1|COMPLETED|Overall Study||8
8255045|NCT01832818|20356057|P1|STARTED|Overall Study||14
8255046|NCT01832766|20356066|P2|NOT COMPLETED|Second Intervention||0
8255047|NCT01832766|20356067|P1|NOT COMPLETED|Second Intervention||0
8255048|NCT01832766|20356066|P2|COMPLETED|Second Intervention||5
8255049|NCT01832766|20356067|P1|COMPLETED|Second Intervention||7
8255050|NCT01832766|20356066|P2|STARTED|Second Intervention||5
8255051|NCT01832766|20356067|P1|STARTED|Second Intervention||7
8255052|NCT01832766|20356066|P2|NOT COMPLETED|Washout||1
8255053|NCT01832766|20356067|P1|NOT COMPLETED|Washout||0
8255054|NCT01832766|20356066|P2|COMPLETED|Washout||5
8255055|NCT01832766|20356067|P1|COMPLETED|Washout||7
8255056|NCT01832766|20356066|P2|STARTED|Washout||6
8255057|NCT01832766|20356067|P1|STARTED|Washout||7
8255058|NCT01832766|20356066|P2|NOT COMPLETED|First Intervention||0
8255059|NCT01832766|20356067|P1|NOT COMPLETED|First Intervention||0
8255060|NCT01832766|20356066|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
8255061|NCT01832766|20356067|P1|COMPLETED|First Intervention||7
8255062|NCT01832766|20356066|P2|STARTED|First Intervention||6
8255063|NCT01832766|20356067|P1|STARTED|First Intervention||7
8255064|NCT01832753|20356080|P3|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255065|NCT01832753|20356081|P2|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255066|NCT01832753|20356082|P1|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255067|NCT01832753|20356080|P3|COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255068|NCT01832753|20356081|P2|COMPLETED|Open Label Dose Phase (Months 12-18)||3
8255069|NCT01832753|20356082|P1|COMPLETED|Open Label Dose Phase (Months 12-18)||3
8255070|NCT01832753|20356080|P3|STARTED|Open Label Dose Phase (Months 12-18)||0
8255071|NCT01832753|20356081|P2|STARTED|Open Label Dose Phase (Months 12-18)||3
8255072|NCT01832753|20356082|P1|STARTED|Open Label Dose Phase (Months 12-18)||3
8255073|NCT01832753|20356080|P3|NOT COMPLETED|Randomization Phase (Months 6-12)||0
8255074|NCT01832753|20356081|P2|NOT COMPLETED|Randomization Phase (Months 6-12)||1
8255075|NCT01832753|20356082|P1|NOT COMPLETED|Randomization Phase (Months 6-12)||1
8255076|NCT01832753|20356080|P3|COMPLETED|Randomization Phase (Months 6-12)||0
8255077|NCT01832753|20356081|P2|COMPLETED|Randomization Phase (Months 6-12)||3
8255078|NCT01832753|20356082|P1|COMPLETED|Randomization Phase (Months 6-12)||4
8255079|NCT01832753|20356080|P3|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
8255080|NCT01832753|20356081|P2|STARTED|Randomization Phase (Months 6-12)||4
8255081|NCT01832753|20356082|P1|STARTED|Randomization Phase (Months 6-12)||5
8255082|NCT01832753|20356080|P3|NOT COMPLETED|Observation Phase (Months 0-6)||2
8255083|NCT01832753|20356081|P2|NOT COMPLETED|Observation Phase (Months 0-6)||0
8255084|NCT01832753|20356082|P1|NOT COMPLETED|Observation Phase (Months 0-6)||0
8255085|NCT01832753|20356080|P3|COMPLETED|Observation Phase (Months 0-6)||1
8255086|NCT01832753|20356081|P2|COMPLETED|Observation Phase (Months 0-6)||4
8255087|NCT01832753|20356082|P1|COMPLETED|Observation Phase (Months 0-6)||5
8255088|NCT01832753|20356080|P3|STARTED|Observation Phase (Months 0-6)||3
8255089|NCT01832753|20356081|P2|STARTED|Observation Phase (Months 0-6)||4
8255090|NCT01832753|20356082|P1|STARTED|Observation Phase (Months 0-6)||5
8255091|NCT01832727|20356103|P9|NOT COMPLETED|Overall Study||18
8255092|NCT01832727|20356104|P8|NOT COMPLETED|Overall Study||6
8255093|NCT01832727|20356105|P7|NOT COMPLETED|Overall Study||8
8255094|NCT01832727|20356106|P6|NOT COMPLETED|Overall Study||6
8255095|NCT01832727|20356107|P5|NOT COMPLETED|Overall Study||4
8255096|NCT01832727|20356108|P4|NOT COMPLETED|Overall Study||4
8255097|NCT01832727|20356109|P3|NOT COMPLETED|Overall Study||3
8255098|NCT01832727|20356110|P2|NOT COMPLETED|Overall Study||7
8255099|NCT01832727|20356111|P1|NOT COMPLETED|Overall Study||9
8255100|NCT01832727|20356103|P9|COMPLETED|Overall Study||0
8255101|NCT01832727|20356104|P8|COMPLETED|Overall Study||0
8255102|NCT01832727|20356105|P7|COMPLETED|Overall Study||0
8255103|NCT01832727|20356106|P6|COMPLETED|Overall Study||0
8255104|NCT01832727|20356107|P5|COMPLETED|Overall Study||0
8255105|NCT01832727|20356108|P4|COMPLETED|Overall Study||0
8255106|NCT01832727|20356109|P3|COMPLETED|Overall Study||0
8255107|NCT01832727|20356110|P2|COMPLETED|Overall Study||0
8255108|NCT01832727|20356111|P1|COMPLETED|Overall Study||0
8255109|NCT01832727|20356103|P9|STARTED|Overall Study||18
8255110|NCT01832727|20356104|P8|STARTED|Overall Study||6
8255111|NCT01832727|20356105|P7|STARTED|Overall Study||8
8255112|NCT01832727|20356106|P6|STARTED|Overall Study||6
8255113|NCT01832727|20356107|P5|STARTED|Overall Study||4
8255114|NCT01832727|20356108|P4|STARTED|Overall Study||4
8255115|NCT01832727|20356109|P3|STARTED|Overall Study||3
8255116|NCT01832727|20356110|P2|STARTED|Overall Study||7
8255117|NCT01832727|20356111|P1|STARTED|Overall Study||9
8255118|NCT01832610|20356211|P1|NOT COMPLETED|Overall Study||4
8255119|NCT01832610|20356211|P1|COMPLETED|Overall Study||97
8255120|NCT01832610|20356211|P1|STARTED|Overall Study||101
8255121|NCT01832532|20356224|P2|NOT COMPLETED|Overall Study||2
8255122|NCT01832532|20356225|P1|NOT COMPLETED|Overall Study||5
8255123|NCT01832532|20356224|P2|COMPLETED|Overall Study||9
8255124|NCT01832532|20356225|P1|COMPLETED|Overall Study||18
8255125|NCT01832532|20356224|P2|STARTED|Overall Study||11
8255126|NCT01832532|20356225|P1|STARTED|Overall Study||23
8255127|NCT01832506|20356234|P3|NOT COMPLETED|Overall Study||0
8255128|NCT01832506|20356235|P2|NOT COMPLETED|Overall Study||0
8255129|NCT01832506|20356236|P1|NOT COMPLETED|Overall Study||0
8255130|NCT01832506|20356234|P3|COMPLETED|Overall Study||6
8255131|NCT01832506|20356235|P2|COMPLETED|Overall Study||3
8255132|NCT01832506|20356236|P1|COMPLETED|Overall Study||3
8255133|NCT01832506|20356234|P3|STARTED|Overall Study||6
8255134|NCT01832506|20356235|P2|STARTED|Overall Study||3
8255135|NCT01832506|20356236|P1|STARTED|Overall Study||3
8255136|NCT01832493|20356287|P1|NOT COMPLETED|Overall Study||8
8255137|NCT01832493|20356287|P1|COMPLETED|Overall Study||42
8255138|NCT01832493|20356287|P1|STARTED|Overall Study||50
8255139|NCT01832480|20356296|P2|NOT COMPLETED|Overall Study||42
8255140|NCT01832480|20356297|P1|NOT COMPLETED|Overall Study||41
8255141|NCT01832480|20356296|P2|COMPLETED|Overall Study||270
8255142|NCT01832480|20356297|P1|COMPLETED|Overall Study||270
8255143|NCT01832480|20356296|P2|STARTED|Overall Study||312
8255144|NCT01832480|20356297|P1|STARTED|Overall Study||311
8255145|NCT01832402|20356305|P2|NOT COMPLETED|Overall Study||4
8255146|NCT01832402|20356306|P1|NOT COMPLETED|Overall Study||7
8255147|NCT01832402|20356305|P2|COMPLETED|Overall Study||12
8255148|NCT01832402|20356306|P1|COMPLETED|Overall Study||12
8255149|NCT01832402|20356305|P2|Completed Study With Incorrect Dose|Overall Study||3
8255150|NCT01832402|20356306|P1|Completed Study With Incorrect Dose|Overall Study||2
8255151|NCT01832402|20356305|P2|Completed Study With Correct Dose|Overall Study||9
8255152|NCT01832402|20356306|P1|Completed Study With Correct Dose|Overall Study||10
8255153|NCT01832402|20356305|P2|Received Allocated Medication|Overall Study||12
8255154|NCT01832402|20356306|P1|Received Allocated Medication|Overall Study||12
8255155|NCT01832402|20356305|P2|STARTED|Overall Study||16
8255156|NCT01832402|20356306|P1|STARTED|Overall Study||19
8255157|NCT01832259|20356320|P2|NOT COMPLETED|Overall Study||0
8255158|NCT01832259|20356321|P1|NOT COMPLETED|Overall Study||0
8255159|NCT01832259|20356320|P2|COMPLETED|Overall Study||15
8255160|NCT01832259|20356321|P1|COMPLETED|Overall Study||15
8255161|NCT01832259|20356320|P2|STARTED|Overall Study||15
8255162|NCT01832259|20356321|P1|STARTED|Overall Study||15
8255163|NCT01832155|20356333|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
8255164|NCT01832155|20356334|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
8255165|NCT01832155|20356333|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
8255166|NCT01832155|20356334|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
8255167|NCT01832155|20356333|P2|STARTED|End of Study: 4 - 8 Weeks||18
8255168|NCT01832155|20356334|P1|STARTED|End of Study: 4 - 8 Weeks||16
8255169|NCT01832155|20356333|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
8255170|NCT01832155|20356334|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
8255171|NCT01832155|20356333|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
8255172|NCT01832155|20356334|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
8255173|NCT01832155|20356333|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
8255174|NCT01832155|20356334|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
8255175|NCT01832155|20356333|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
8255176|NCT01832155|20356334|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
8255177|NCT01832155|20356333|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
8255178|NCT01832155|20356334|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
8255179|NCT01832155|20356333|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
8255180|NCT01832155|20356334|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
8255181|NCT01832090|20356357|P2|NOT COMPLETED|Overall Study||1
8255182|NCT01832090|20356358|P1|NOT COMPLETED|Overall Study||6
8255183|NCT01832090|20356357|P2|COMPLETED|Overall Study||28
8255184|NCT01832090|20356358|P1|COMPLETED|Overall Study||83
8255185|NCT01832090|20356357|P2|STARTED|Overall Study||29
8255186|NCT01832090|20356358|P1|STARTED|Overall Study||89
8255187|NCT01832038|20356401|P1|NOT COMPLETED|Overall Study||235
8255188|NCT01832038|20356401|P1|COMPLETED|Overall Study||238
8255189|NCT01832038|20356401|P1|STARTED|Overall Study||473
8255190|NCT01831960|20356410|P2|NOT COMPLETED|Overall Study||0
8255191|NCT01831960|20356411|P1|NOT COMPLETED|Overall Study||0
8255192|NCT01831960|20356410|P2|COMPLETED|Overall Study||22
8255193|NCT01831960|20356411|P1|COMPLETED|Overall Study||20
8255194|NCT01831960|20356410|P2|STARTED|Overall Study||22
8255195|NCT01831960|20356411|P1|STARTED|Overall Study||20
8255196|NCT01831934|20356425|P2|NOT COMPLETED|Overall Study||0
8255197|NCT01831934|20356426|P1|NOT COMPLETED|Overall Study||1
8255198|NCT01831934|20356425|P2|COMPLETED|Overall Study||10
8255199|NCT01831934|20356426|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
8255200|NCT01831934|20356425|P2|STARTED|Overall Study||10
8255201|NCT01831934|20356426|P1|STARTED|Overall Study||12
8255202|NCT01831921|20356434|P2|NOT COMPLETED|Overall Study||39
8255203|NCT01831921|20356435|P1|NOT COMPLETED|Overall Study||84
8255204|NCT01831921|20356434|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
8255205|NCT01831921|20356435|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
8255206|NCT01831921|20356434|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
8255207|NCT01831921|20356435|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
8255208|NCT01831921|20356434|P2|12 Months|Overall Study||62
8255209|NCT01831921|20356435|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
8255210|NCT01831921|20356434|P2|6 Months|Overall Study||63
8255211|NCT01831921|20356435|P1|6 Months|Overall Study||122
8255212|NCT01831921|20356434|P2|STARTED|Overall Study||75
8255213|NCT01831921|20356435|P1|STARTED|Overall Study||150
8255214|NCT01831856|20356459|P2|NOT COMPLETED|Overall Study||37
8255215|NCT01831856|20356460|P1|NOT COMPLETED|Overall Study||34
8255216|NCT01831856|20356459|P2|COMPLETED|Overall Study||30
8255217|NCT01831856|20356460|P1|COMPLETED|Overall Study||33
8255218|NCT01831856|20356459|P2|STARTED|Overall Study||67
8255219|NCT01831856|20356460|P1|STARTED|Overall Study||67
8255220|NCT01831817|20356470|P4|NOT COMPLETED|Overall Study||0
8255221|NCT01831817|20356471|P3|NOT COMPLETED|Overall Study||0
8255222|NCT01831817|20356472|P2|NOT COMPLETED|Overall Study||0
8255223|NCT01831817|20356473|P1|NOT COMPLETED|Overall Study||4
8255224|NCT01831817|20356470|P4|COMPLETED|Overall Study||36
8255225|NCT01831817|20356471|P3|COMPLETED|Overall Study||35
8255226|NCT01831817|20356472|P2|COMPLETED|Overall Study||34
8255227|NCT01831817|20356473|P1|COMPLETED|Overall Study||31
8255228|NCT01831817|20356470|P4|STARTED|Overall Study||36
8255229|NCT01831817|20356471|P3|STARTED|Overall Study||35
8255230|NCT01831817|20356472|P2|STARTED|Overall Study||34
8255231|NCT01831817|20356473|P1|STARTED|Overall Study||35
8255232|NCT01831804|20356520|P9|NOT COMPLETED|Overall Study||2
8255233|NCT01831804|20356521|P8|NOT COMPLETED|Overall Study||3
8255234|NCT01831804|20356522|P7|NOT COMPLETED|Overall Study||1
8255235|NCT01831804|20356523|P6|NOT COMPLETED|Overall Study||0
8255236|NCT01831804|20356524|P5|NOT COMPLETED|Overall Study||2
8255237|NCT01831804|20356525|P4|NOT COMPLETED|Overall Study||0
8255238|NCT01831804|20356526|P3|NOT COMPLETED|Overall Study||6
8255239|NCT01831804|20356527|P2|NOT COMPLETED|Overall Study||2
8255240|NCT01831804|20356528|P1|NOT COMPLETED|Overall Study||1
8255241|NCT01831804|20356520|P9|COMPLETED|Overall Study||2
8255242|NCT01831804|20356521|P8|COMPLETED|Overall Study||23
8255243|NCT01831804|20356522|P7|COMPLETED|Overall Study||3
8255244|NCT01831804|20356523|P6|COMPLETED|Overall Study||3
8255245|NCT01831804|20356524|P5|COMPLETED|Overall Study||3
8255246|NCT01831804|20356525|P4|COMPLETED|Overall Study||5
8255247|NCT01831804|20356526|P3|COMPLETED|Overall Study||3
8255248|NCT01831804|20356527|P2|COMPLETED|Overall Study||1
8255249|NCT01831804|20356528|P1|COMPLETED|Overall Study||3
8255250|NCT01831804|20356520|P9|STARTED|Overall Study||4
8255251|NCT01831804|20356521|P8|STARTED|Overall Study||26
8255252|NCT01831804|20356522|P7|STARTED|Overall Study||4
8255253|NCT01831804|20356523|P6|STARTED|Overall Study||3
8255254|NCT01831804|20356524|P5|STARTED|Overall Study||5
8255255|NCT01831804|20356525|P4|STARTED|Overall Study||5
8255256|NCT01831804|20356526|P3|STARTED|Overall Study||9
8255257|NCT01831804|20356527|P2|STARTED|Overall Study||3
8255258|NCT01831804|20356528|P1|STARTED|Overall Study||4
8255259|NCT01831791|20356623|P1|NOT COMPLETED|Overall Study||10
8255260|NCT01831791|20356623|P1|COMPLETED|Overall Study||110
8255261|NCT01831791|20356623|P1|STARTED|Overall Study||120
8255262|NCT01831765|20356652|P3|NOT COMPLETED|Overall Study||42
8255263|NCT01831765|20356653|P2|NOT COMPLETED|Overall Study||27
8255264|NCT01831765|20356654|P1|NOT COMPLETED|Overall Study||44
8255265|NCT01831765|20356652|P3|COMPLETED|Overall Study||338
8255266|NCT01831765|20356653|P2|COMPLETED|Overall Study||355
8255267|NCT01831765|20356654|P1|COMPLETED|Overall Study||337
8255268|NCT01831765|20356652|P3|Completed 52 Weeks|Overall Study||338
8255269|NCT01831765|20356653|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
8255270|NCT01831765|20356654|P1|Completed 52 Weeks|Overall Study||337
8255271|NCT01831765|20356652|P3|Completed 26 Weeks|Overall Study||356
8255272|NCT01831765|20356653|P2|Completed 26 Weeks|Overall Study||355
8255273|NCT01831765|20356654|P1|Completed 26 Weeks|Overall Study||351
8255274|NCT01831765|20356652|P3|STARTED|Overall Study||380
8255275|NCT01831765|20356653|P2|STARTED|Overall Study||382
8255276|NCT01831765|20356654|P1|STARTED|Overall Study||381
8255277|NCT01831726|20356680|P1|NOT COMPLETED|Overall Study||80
8255278|NCT01831726|20356680|P1|COMPLETED|Overall Study||0
8255279|NCT01831726|20356680|P1|STARTED|Overall Study||80
8255280|NCT01831596|20356687|P1|NOT COMPLETED|Overall Study||8
8255281|NCT01831596|20356687|P1|COMPLETED|Overall Study||51
8255282|NCT01831596|20356687|P1|STARTED|Overall Study||59
8255283|NCT01831544|20356691|P1|NOT COMPLETED|Overall Study||3
8255284|NCT01831544|20356691|P1|COMPLETED|Overall Study||8
8255285|NCT01831544|20356691|P1|STARTED|Overall Study||11
8255286|NCT01831466|20356720|P12|NOT COMPLETED|Overall Study||4
8255287|NCT01831466|20356721|P11|NOT COMPLETED|Overall Study||2
8255288|NCT01831466|20356722|P10|NOT COMPLETED|Overall Study||5
8255289|NCT01831466|20356723|P9|NOT COMPLETED|Overall Study||3
8255290|NCT01831466|20356724|P8|NOT COMPLETED|Overall Study||2
8255291|NCT01831466|20356725|P7|NOT COMPLETED|Overall Study||1
8255292|NCT01831466|20356726|P6|NOT COMPLETED|Overall Study||26
8255293|NCT01831466|20356727|P5|NOT COMPLETED|Overall Study||17
8255294|NCT01831466|20356728|P4|NOT COMPLETED|Overall Study||19
8255295|NCT01831466|20356729|P3|NOT COMPLETED|Overall Study||23
8255296|NCT01831466|20356730|P2|NOT COMPLETED|Overall Study||18
8255297|NCT01831466|20356731|P1|NOT COMPLETED|Overall Study||16
8255298|NCT01831466|20356720|P12|COMPLETED|Overall Study||3
8255299|NCT01831466|20356721|P11|COMPLETED|Overall Study||4
8255300|NCT01831466|20356722|P10|COMPLETED|Overall Study||2
8255301|NCT01831466|20356723|P9|COMPLETED|Overall Study||4
8255302|NCT01831466|20356724|P8|COMPLETED|Overall Study||5
8255303|NCT01831466|20356725|P7|COMPLETED|Overall Study||6
8255304|NCT01831466|20356726|P6|COMPLETED|Overall Study||48
8255305|NCT01831466|20356727|P5|COMPLETED|Overall Study||57
8255306|NCT01831466|20356728|P4|COMPLETED|Overall Study||51
8255307|NCT01831466|20356729|P3|COMPLETED|Overall Study||48
8255308|NCT01831466|20356730|P2|COMPLETED|Overall Study||52
8255309|NCT01831466|20356731|P1|COMPLETED|Overall Study||55
8255310|NCT01831466|20356720|P12|STARTED|Overall Study|Treated|7
8255311|NCT01831466|20356721|P11|STARTED|Overall Study|Treated|6
8255312|NCT01831466|20356722|P10|STARTED|Overall Study|Treated|7
8255313|NCT01831466|20356723|P9|STARTED|Overall Study|Treated|7
8255314|NCT01831466|20356724|P8|STARTED|Overall Study|Treated|7
8255315|NCT01831466|20356725|P7|STARTED|Overall Study|Treated|7
8255316|NCT01831466|20356726|P6|STARTED|Overall Study|Treated|74
8255317|NCT01831466|20356727|P5|STARTED|Overall Study|Treated|74
8255318|NCT01831466|20356728|P4|STARTED|Overall Study|Treated|70
8255319|NCT01831466|20356729|P3|STARTED|Overall Study|Treated|71
8255320|NCT01831466|20356730|P2|STARTED|Overall Study|Treated|70
8255321|NCT01831466|20356731|P1|STARTED|Overall Study|Treated|71
8255322|NCT01831258|20356853|P2|NOT COMPLETED|Overall Study||3
8255323|NCT01831258|20356854|P1|NOT COMPLETED|Overall Study||5
8255324|NCT01831258|20356853|P2|COMPLETED|Overall Study||32
8255325|NCT01831258|20356854|P1|COMPLETED|Overall Study||30
8255326|NCT01831258|20356853|P2|STARTED|Overall Study||35
8255327|NCT01831258|20356854|P1|STARTED|Overall Study||35
8255328|NCT01831232|20356880|P1|NOT COMPLETED|Overall Study||0
8255329|NCT01831232|20356880|P1|COMPLETED|Overall Study||24
8255330|NCT01831232|20356880|P1|STARTED|Overall Study||24
8255331|NCT01831219|20356891|P2|NOT COMPLETED|Overall Study||24
8255332|NCT01831219|20356892|P1|NOT COMPLETED|Overall Study||33
8255333|NCT01831219|20356891|P2|COMPLETED|Overall Study||21
8255334|NCT01831219|20356892|P1|COMPLETED|Overall Study||40
8255335|NCT01831219|20356891|P2|STARTED|Overall Study||45
8255336|NCT01831219|20356892|P1|STARTED|Overall Study||73
8255337|NCT01831154|20356913|P3|NOT COMPLETED|Overall Study||0
8255338|NCT01831154|20356914|P2|NOT COMPLETED|Overall Study||0
8255339|NCT01831154|20356915|P1|NOT COMPLETED|Overall Study||0
8255340|NCT01831154|20356913|P3|COMPLETED|Overall Study||11
8255341|NCT01831154|20356914|P2|COMPLETED|Overall Study||11
8255342|NCT01831154|20356915|P1|COMPLETED|Overall Study||15
8255343|NCT01831154|20356913|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
8255344|NCT01831154|20356914|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
8255345|NCT01831154|20356915|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
8255346|NCT01831089|20356944|P6|NOT COMPLETED|Cohort B: Arm B||14
8255347|NCT01831089|20356945|P5|NOT COMPLETED|Cohort B: Arm B||0
8255348|NCT01831089|20356946|P4|NOT COMPLETED|Cohort B: Arm B||0
8255349|NCT01831089|20356947|P3|NOT COMPLETED|Cohort B: Arm B||0
8255350|NCT01831089|20356948|P2|NOT COMPLETED|Cohort B: Arm B||0
8255351|NCT01831089|20356949|P1|NOT COMPLETED|Cohort B: Arm B||0
8255352|NCT01831089|20356944|P6|COMPLETED|Cohort B: Arm B||0
8255353|NCT01831089|20356945|P5|COMPLETED|Cohort B: Arm B||0
8255354|NCT01831089|20356946|P4|COMPLETED|Cohort B: Arm B||0
8255355|NCT01831089|20356947|P3|COMPLETED|Cohort B: Arm B||0
8255356|NCT01831089|20356948|P2|COMPLETED|Cohort B: Arm B||0
8255357|NCT01831089|20356949|P1|COMPLETED|Cohort B: Arm B||0
8255358|NCT01831089|20356944|P6|STARTED|Cohort B: Arm B||14
8255359|NCT01831089|20356945|P5|STARTED|Cohort B: Arm B||0
8255360|NCT01831089|20356946|P4|STARTED|Cohort B: Arm B||0
8255361|NCT01831089|20356947|P3|STARTED|Cohort B: Arm B||0
8255362|NCT01831089|20356948|P2|STARTED|Cohort B: Arm B||0
8255363|NCT01831089|20356949|P1|STARTED|Cohort B: Arm B||0
8255364|NCT01831089|20356944|P6|NOT COMPLETED|Cohort V: Dose Level 5||0
8255365|NCT01831089|20356945|P5|NOT COMPLETED|Cohort V: Dose Level 5||37
8255366|NCT01831089|20356946|P4|NOT COMPLETED|Cohort V: Dose Level 5||0
8255367|NCT01831089|20356947|P3|NOT COMPLETED|Cohort V: Dose Level 5||0
8255368|NCT01831089|20356948|P2|NOT COMPLETED|Cohort V: Dose Level 5||0
8255369|NCT01831089|20356949|P1|NOT COMPLETED|Cohort V: Dose Level 5||0
8255370|NCT01831089|20356944|P6|COMPLETED|Cohort V: Dose Level 5||0
8255371|NCT01831089|20356945|P5|COMPLETED|Cohort V: Dose Level 5||0
8255372|NCT01831089|20356946|P4|COMPLETED|Cohort V: Dose Level 5||0
8255373|NCT01831089|20356947|P3|COMPLETED|Cohort V: Dose Level 5||0
8255374|NCT01831089|20356948|P2|COMPLETED|Cohort V: Dose Level 5||0
8255375|NCT01831089|20356949|P1|COMPLETED|Cohort V: Dose Level 5||0
8255376|NCT01831089|20356944|P6|STARTED|Cohort V: Dose Level 5||0
8255377|NCT01831089|20356945|P5|STARTED|Cohort V: Dose Level 5||37
8255378|NCT01831089|20356946|P4|STARTED|Cohort V: Dose Level 5||0
8255379|NCT01831089|20356947|P3|STARTED|Cohort V: Dose Level 5||0
8255380|NCT01831089|20356948|P2|STARTED|Cohort V: Dose Level 5||0
8255381|NCT01831089|20356949|P1|STARTED|Cohort V: Dose Level 5||0
8255382|NCT01831089|20356944|P6|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255383|NCT01831089|20356945|P5|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255384|NCT01831089|20356946|P4|NOT COMPLETED|Cohort IV: Dose Level 4||6
8255385|NCT01831089|20356947|P3|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255386|NCT01831089|20356948|P2|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255387|NCT01831089|20356949|P1|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255388|NCT01831089|20356944|P6|COMPLETED|Cohort IV: Dose Level 4||0
8255389|NCT01831089|20356945|P5|COMPLETED|Cohort IV: Dose Level 4||0
8255390|NCT01831089|20356946|P4|COMPLETED|Cohort IV: Dose Level 4||0
8255391|NCT01831089|20356947|P3|COMPLETED|Cohort IV: Dose Level 4||0
8255392|NCT01831089|20356948|P2|COMPLETED|Cohort IV: Dose Level 4||0
8255393|NCT01831089|20356949|P1|COMPLETED|Cohort IV: Dose Level 4||0
8255394|NCT01831089|20356944|P6|STARTED|Cohort IV: Dose Level 4||0
8255395|NCT01831089|20356945|P5|STARTED|Cohort IV: Dose Level 4||0
8255396|NCT01831089|20356946|P4|STARTED|Cohort IV: Dose Level 4||6
8255397|NCT01831089|20356947|P3|STARTED|Cohort IV: Dose Level 4||0
8255398|NCT01831089|20356948|P2|STARTED|Cohort IV: Dose Level 4||0
8255399|NCT01831089|20356949|P1|STARTED|Cohort IV: Dose Level 4||0
8255400|NCT01831089|20356944|P6|NOT COMPLETED|Cohort III: Dose Level 3||0
8255401|NCT01831089|20356945|P5|NOT COMPLETED|Cohort III: Dose Level 3||0
8255402|NCT01831089|20356946|P4|NOT COMPLETED|Cohort III: Dose Level 3||0
8255403|NCT01831089|20356947|P3|NOT COMPLETED|Cohort III: Dose Level 3||6
8255404|NCT01831089|20356948|P2|NOT COMPLETED|Cohort III: Dose Level 3||0
8255405|NCT01831089|20356949|P1|NOT COMPLETED|Cohort III: Dose Level 3||0
8255406|NCT01831089|20356944|P6|COMPLETED|Cohort III: Dose Level 3||0
8255407|NCT01831089|20356945|P5|COMPLETED|Cohort III: Dose Level 3||0
8255408|NCT01831089|20356946|P4|COMPLETED|Cohort III: Dose Level 3||0
8255409|NCT01831089|20356947|P3|COMPLETED|Cohort III: Dose Level 3||0
8255410|NCT01831089|20356948|P2|COMPLETED|Cohort III: Dose Level 3||0
8255411|NCT01831089|20356949|P1|COMPLETED|Cohort III: Dose Level 3||0
8255412|NCT01831089|20356944|P6|STARTED|Cohort III: Dose Level 3||0
8255413|NCT01831089|20356945|P5|STARTED|Cohort III: Dose Level 3||0
8255414|NCT01831089|20356946|P4|STARTED|Cohort III: Dose Level 3||0
8255415|NCT01831089|20356947|P3|STARTED|Cohort III: Dose Level 3||6
8255416|NCT01831089|20356948|P2|STARTED|Cohort III: Dose Level 3||0
8255417|NCT01831089|20356949|P1|STARTED|Cohort III: Dose Level 3||0
8255418|NCT01831089|20356944|P6|NOT COMPLETED|Cohort II: Dose Level 2||0
8255419|NCT01831089|20356945|P5|NOT COMPLETED|Cohort II: Dose Level 2||0
8255420|NCT01831089|20356946|P4|NOT COMPLETED|Cohort II: Dose Level 2||0
8255421|NCT01831089|20356947|P3|NOT COMPLETED|Cohort II: Dose Level 2||0
8255422|NCT01831089|20356948|P2|NOT COMPLETED|Cohort II: Dose Level 2||3
8255423|NCT01831089|20356949|P1|NOT COMPLETED|Cohort II: Dose Level 2||0
8255424|NCT01831089|20356944|P6|COMPLETED|Cohort II: Dose Level 2||0
8255425|NCT01831089|20356945|P5|COMPLETED|Cohort II: Dose Level 2||0
8255426|NCT01831089|20356946|P4|COMPLETED|Cohort II: Dose Level 2||0
8255427|NCT01831089|20356947|P3|COMPLETED|Cohort II: Dose Level 2||0
8255428|NCT01831089|20356948|P2|COMPLETED|Cohort II: Dose Level 2||0
8255429|NCT01831089|20356949|P1|COMPLETED|Cohort II: Dose Level 2||0
8255430|NCT01831089|20356944|P6|STARTED|Cohort II: Dose Level 2||0
8255431|NCT01831089|20356945|P5|STARTED|Cohort II: Dose Level 2||0
8255432|NCT01831089|20356946|P4|STARTED|Cohort II: Dose Level 2||0
8255433|NCT01831089|20356947|P3|STARTED|Cohort II: Dose Level 2||0
8255434|NCT01831089|20356948|P2|STARTED|Cohort II: Dose Level 2||3
8255435|NCT01831089|20356949|P1|STARTED|Cohort II: Dose Level 2||0
8255436|NCT01831089|20356944|P6|NOT COMPLETED|Cohort I: Dose Level 1||0
8255437|NCT01831089|20356945|P5|NOT COMPLETED|Cohort I: Dose Level 1||0
8255438|NCT01831089|20356946|P4|NOT COMPLETED|Cohort I: Dose Level 1||0
8255439|NCT01831089|20356947|P3|NOT COMPLETED|Cohort I: Dose Level 1||0
8255440|NCT01831089|20356948|P2|NOT COMPLETED|Cohort I: Dose Level 1||0
8255441|NCT01831089|20356949|P1|NOT COMPLETED|Cohort I: Dose Level 1||3
8255442|NCT01831089|20356944|P6|COMPLETED|Cohort I: Dose Level 1||0
8255443|NCT01831089|20356945|P5|COMPLETED|Cohort I: Dose Level 1||0
8255444|NCT01831089|20356946|P4|COMPLETED|Cohort I: Dose Level 1||0
8255445|NCT01831089|20356947|P3|COMPLETED|Cohort I: Dose Level 1||0
8255446|NCT01831089|20356948|P2|COMPLETED|Cohort I: Dose Level 1||0
8255447|NCT01831089|20356949|P1|COMPLETED|Cohort I: Dose Level 1||0
8255448|NCT01831089|20356944|P6|STARTED|Cohort I: Dose Level 1||0
8255449|NCT01831089|20356945|P5|STARTED|Cohort I: Dose Level 1||0
8255450|NCT01831089|20356946|P4|STARTED|Cohort I: Dose Level 1||0
8255451|NCT01831089|20356947|P3|STARTED|Cohort I: Dose Level 1||0
8255452|NCT01831089|20356948|P2|STARTED|Cohort I: Dose Level 1||0
8255453|NCT01831089|20356949|P1|STARTED|Cohort I: Dose Level 1||3
8255454|NCT01831076|20356991|P2|NOT COMPLETED|Overall Study||1
8255455|NCT01831076|20356992|P1|NOT COMPLETED|Overall Study||1
8255456|NCT01831076|20356991|P2|COMPLETED|Overall Study||4
8255457|NCT01831076|20356992|P1|COMPLETED|Overall Study||30
8255458|NCT01831076|20356991|P2|STARTED|Overall Study||5
8255459|NCT01831076|20356992|P1|STARTED|Overall Study||31
8255460|NCT01830972|20357000|P2|NOT COMPLETED|Part IV||1
8255461|NCT01830972|20357001|P1|NOT COMPLETED|Part IV||3
8255462|NCT01830972|20357000|P2|COMPLETED|Part IV||10
8255463|NCT01830972|20357001|P1|COMPLETED|Part IV||39
8255464|NCT01830972|20357000|P2|STARTED|Part IV||11
8255465|NCT01830972|20357001|P1|STARTED|Part IV||42
8255466|NCT01830972|20357000|P2|NOT COMPLETED|Part III||0
8255467|NCT01830972|20357001|P1|NOT COMPLETED|Part III||2
8255468|NCT01830972|20357000|P2|COMPLETED|Part III||11
8255469|NCT01830972|20357001|P1|COMPLETED|Part III||42
8255470|NCT01830972|20357000|P2|STARTED|Part III||11
8255471|NCT01830972|20357001|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
8255472|NCT01830972|20357000|P2|NOT COMPLETED|Part II||2
8255473|NCT01830972|20357001|P1|NOT COMPLETED|Part II||2
8255474|NCT01830972|20357000|P2|COMPLETED|Part II||11
8255475|NCT01830972|20357001|P1|COMPLETED|Part II||44
8255476|NCT01830972|20357000|P2|STARTED|Part II|Entered study at Part 2|13
8255477|NCT01830972|20357001|P1|STARTED|Part II||46
8255478|NCT01830972|20357000|P2|NOT COMPLETED|Part I||0
8255479|NCT01830972|20357001|P1|NOT COMPLETED|Part I||0
8255480|NCT01830972|20357000|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
8255481|NCT01830972|20357001|P1|COMPLETED|Part I||46
8255482|NCT01830972|20357000|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
8255483|NCT01830972|20357001|P1|STARTED|Part I||46
8255484|NCT01830933|20357027|P2|NOT COMPLETED|Overall Study||232
8255485|NCT01830933|20357028|P1|NOT COMPLETED|Overall Study||168
8255486|NCT01830933|20357027|P2|COMPLETED|Overall Study||580
8255487|NCT01830933|20357028|P1|COMPLETED|Overall Study||655
8255488|NCT01830933|20357027|P2|Completed Meet-up|Overall Study||603
8255489|NCT01830933|20357028|P1|Completed Meet-up|Overall Study||675
8255490|NCT01830933|20357027|P2|STARTED|Overall Study||812
8255491|NCT01830933|20357028|P1|STARTED|Overall Study||823
8255492|NCT01830920|20357045|P5|NOT COMPLETED|Overall Study||8
8255493|NCT01830920|20357046|P4|NOT COMPLETED|Overall Study||16
8255494|NCT01830920|20357047|P3|NOT COMPLETED|Overall Study||8
8255495|NCT01830920|20357048|P2|NOT COMPLETED|Overall Study||6
8255496|NCT01830920|20357049|P1|NOT COMPLETED|Overall Study||21
8255497|NCT01830920|20357045|P5|COMPLETED|Overall Study||99
8255498|NCT01830920|20357046|P4|COMPLETED|Overall Study||109
8255499|NCT01830920|20357047|P3|COMPLETED|Overall Study||40
8255500|NCT01830920|20357048|P2|COMPLETED|Overall Study||40
8255501|NCT01830920|20357049|P1|COMPLETED|Overall Study||105
8255502|NCT01830920|20357045|P5|Received Allocated Drug|Overall Study||105
8255503|NCT01830920|20357046|P4|Received Allocated Drug|Overall Study||119
8255504|NCT01830920|20357047|P3|Received Allocated Drug|Overall Study||47
8255505|NCT01830920|20357048|P2|Received Allocated Drug|Overall Study||45
8255506|NCT01830920|20357049|P1|Received Allocated Drug|Overall Study||115
8255507|NCT01830920|20357045|P5|STARTED|Overall Study||107
8255508|NCT01830920|20357046|P4|STARTED|Overall Study||125
8255509|NCT01830920|20357047|P3|STARTED|Overall Study||48
8255510|NCT01830920|20357048|P2|STARTED|Overall Study||46
8255511|NCT01830920|20357049|P1|STARTED|Overall Study||126
8255512|NCT01830881|20357088|P2|NOT COMPLETED|Overall Study||1
8255513|NCT01830881|20357089|P1|NOT COMPLETED|Overall Study||0
8255514|NCT01830881|20357088|P2|COMPLETED|Overall Study||61
8255515|NCT01830881|20357089|P1|COMPLETED|Overall Study||62
8255516|NCT01830881|20357088|P2|STARTED|Overall Study||62
8255517|NCT01830881|20357089|P1|STARTED|Overall Study||62
8255518|NCT01830855|20357137|P4|NOT COMPLETED|Overall Study||82
8255519|NCT01830855|20357138|P3|NOT COMPLETED|Overall Study||66
8255520|NCT01830855|20357139|P2|NOT COMPLETED|Overall Study||61
8255521|NCT01830855|20357140|P1|NOT COMPLETED|Overall Study||155
8255522|NCT01830855|20357137|P4|COMPLETED|Overall Study||815
8255523|NCT01830855|20357138|P3|COMPLETED|Overall Study||521
8255524|NCT01830855|20357139|P2|COMPLETED|Overall Study||537
8255525|NCT01830855|20357140|P1|COMPLETED|Overall Study||1353
8255526|NCT01830855|20357137|P4|STARTED|Overall Study||897
8255527|NCT01830855|20357138|P3|STARTED|Overall Study||587
8255528|NCT01830855|20357139|P2|STARTED|Overall Study||598
8255529|NCT01830855|20357140|P1|STARTED|Overall Study||1508
8255530|NCT01830842|20357246|P2|NOT COMPLETED|Overall Study||2
8255531|NCT01830842|20357247|P1|NOT COMPLETED|Overall Study||5
8255532|NCT01830842|20357246|P2|COMPLETED|Overall Study||22
8255533|NCT01830842|20357247|P1|COMPLETED|Overall Study||25
8255534|NCT01830842|20357246|P2|STARTED|Overall Study||24
8255535|NCT01830842|20357247|P1|STARTED|Overall Study||30
8255536|NCT01830816|20357256|P3|NOT COMPLETED|Overall Study||7
8255537|NCT01830816|20357257|P2|NOT COMPLETED|Overall Study||14
8255538|NCT01830816|20357258|P1|NOT COMPLETED|Overall Study||20
8255539|NCT01830816|20357256|P3|COMPLETED|Overall Study||0
8255540|NCT01830816|20357257|P2|COMPLETED|Overall Study||0
8255541|NCT01830816|20357258|P1|COMPLETED|Overall Study||0
8255542|NCT01830816|20357256|P3|Pharmacokinetic-Evaluable Population|Overall Study||6
8255543|NCT01830816|20357257|P2|Pharmacokinetic-Evaluable Population|Overall Study||14
8255544|NCT01830816|20357258|P1|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
8255545|NCT01830816|20357256|P3|STARTED|Overall Study||7
8255546|NCT01830816|20357257|P2|STARTED|Overall Study||14
8255547|NCT01830816|20357258|P1|STARTED|Overall Study||20
8255548|NCT01830790|20357283|P2|NOT COMPLETED|Overall Study||0
8255549|NCT01830790|20357284|P1|NOT COMPLETED|Overall Study||0
8255550|NCT01830790|20357283|P2|COMPLETED|Overall Study||10
8255551|NCT01830790|20357284|P1|COMPLETED|Overall Study||0
8255552|NCT01830790|20357283|P2|STARTED|Overall Study||10
8255553|NCT01830790|20357284|P1|STARTED|Overall Study||0
8255554|NCT01830699|20357294|P2|NOT COMPLETED|Overall Study||0
8255555|NCT01830699|20357295|P1|NOT COMPLETED|Overall Study||0
8255556|NCT01830699|20357294|P2|COMPLETED|Overall Study||20
8255557|NCT01830699|20357295|P1|COMPLETED|Overall Study||13
8255558|NCT01830699|20357294|P2|STARTED|Overall Study||20
8255559|NCT01830699|20357295|P1|STARTED|Overall Study||13
8255560|NCT01830621|20357307|P2|NOT COMPLETED|Overall Study||0
8255561|NCT01830621|20357308|P1|NOT COMPLETED|Overall Study||0
8255562|NCT01830621|20357307|P2|COMPLETED|Overall Study||144
8255563|NCT01830621|20357308|P1|COMPLETED|Overall Study||138
8255564|NCT01830621|20357307|P2|STARTED|Overall Study||144
8255565|NCT01830621|20357308|P1|STARTED|Overall Study||138
8255566|NCT01830595|20357322|P2|NOT COMPLETED|Second Period||0
8255567|NCT01830595|20357323|P1|NOT COMPLETED|Second Period||0
8255568|NCT01830595|20357322|P2|COMPLETED|Second Period||23
8255569|NCT01830595|20357323|P1|COMPLETED|Second Period||23
8255570|NCT01830595|20357322|P2|STARTED|Second Period||23
8255571|NCT01830595|20357323|P1|STARTED|Second Period||23
8255572|NCT01830595|20357322|P2|NOT COMPLETED|Washout||2
8255573|NCT01830595|20357323|P1|NOT COMPLETED|Washout||2
8255574|NCT01830595|20357322|P2|COMPLETED|Washout||23
8255575|NCT01830595|20357323|P1|COMPLETED|Washout||23
8255576|NCT01830595|20357322|P2|STARTED|Washout||25
8255577|NCT01830595|20357323|P1|STARTED|Washout||25
8255578|NCT01830595|20357322|P2|NOT COMPLETED|First Period||3
8255579|NCT01830595|20357323|P1|NOT COMPLETED|First Period||1
8255580|NCT01830595|20357322|P2|COMPLETED|First Period||25
8255581|NCT01830595|20357323|P1|COMPLETED|First Period||25
8255582|NCT01830595|20357322|P2|Received at Least One Dose|First Period||28
8255583|NCT01830595|20357323|P1|Received at Least One Dose|First Period||26
8255584|NCT01830595|20357322|P2|STARTED|First Period||28
8255585|NCT01830595|20357323|P1|STARTED|First Period||26
8255586|NCT01830543|20357340|P3|NOT COMPLETED|Overall Study||214
8255587|NCT01830543|20357341|P2|NOT COMPLETED|Overall Study||152
8255588|NCT01830543|20357342|P1|NOT COMPLETED|Overall Study||159
8255589|NCT01830543|20357340|P3|COMPLETED|Overall Study||492
8255590|NCT01830543|20357341|P2|COMPLETED|Overall Study||557
8255591|NCT01830543|20357342|P1|COMPLETED|Overall Study||550
8255592|NCT01830543|20357340|P3|Treated|Overall Study||697
8255593|NCT01830543|20357341|P2|Treated|Overall Study||706
8255594|NCT01830543|20357342|P1|Treated|Overall Study||696
8255595|NCT01830543|20357340|P3|STARTED|Overall Study||706
8255596|NCT01830543|20357341|P2|STARTED|Overall Study||709
8255597|NCT01830543|20357342|P1|STARTED|Overall Study||709
8255598|NCT01830205|20357378|P4|NOT COMPLETED|Overall Study||0
8255599|NCT01830205|20357379|P3|NOT COMPLETED|Overall Study||0
8255600|NCT01830205|20357380|P2|NOT COMPLETED|Overall Study||0
8255601|NCT01830205|20357381|P1|NOT COMPLETED|Overall Study||0
8255602|NCT01830205|20357378|P4|COMPLETED|Overall Study||12
8255603|NCT01830205|20357379|P3|COMPLETED|Overall Study||6
8255604|NCT01830205|20357380|P2|COMPLETED|Overall Study||6
8255605|NCT01830205|20357381|P1|COMPLETED|Overall Study||12
8255606|NCT01830205|20357378|P4|STARTED|Overall Study||12
8255607|NCT01830205|20357379|P3|STARTED|Overall Study||6
8255608|NCT01830205|20357380|P2|STARTED|Overall Study||6
8255609|NCT01830205|20357381|P1|STARTED|Overall Study||12
8255610|NCT01830140|20357465|P2|NOT COMPLETED|Overall Study||4
8255611|NCT01830140|20357466|P1|NOT COMPLETED|Overall Study||7
8255612|NCT01830140|20357465|P2|COMPLETED|Overall Study||229
8255613|NCT01830140|20357466|P1|COMPLETED|Overall Study||226
8255614|NCT01830140|20357465|P2|STARTED|Overall Study||233
8255615|NCT01830140|20357466|P1|STARTED|Overall Study||233
8255616|NCT01830127|20357474|P2|NOT COMPLETED|Overall Study||9
8255617|NCT01830127|20357475|P1|NOT COMPLETED|Overall Study||5
8255618|NCT01830127|20357474|P2|COMPLETED|Overall Study||8
8255619|NCT01830127|20357475|P1|COMPLETED|Overall Study||13
8255620|NCT01830127|20357474|P2|STARTED|Overall Study||17
8255621|NCT01830127|20357475|P1|STARTED|Overall Study||18
8255622|NCT01829997|20357483|P1|NOT COMPLETED|Overall Study||6
8255623|NCT01829997|20357483|P1|COMPLETED|Overall Study||16
8255624|NCT01829997|20357483|P1|STARTED|Overall Study||22
8255625|NCT01829919|20357492|P1|NOT COMPLETED|Overall Study||0
8255626|NCT01829919|20357492|P1|COMPLETED|Overall Study||24
8255627|NCT01829919|20357492|P1|STARTED|Overall Study||24
8255628|NCT01829711|20357508|P1|NOT COMPLETED|Overall Study||43
8255629|NCT01829711|20357508|P1|COMPLETED|Overall Study||37
8255630|NCT01829711|20357508|P1|STARTED|Overall Study||80
8255631|NCT01829516|20357539|P2|NOT COMPLETED|2nd Intervention||0
8255632|NCT01829516|20357540|P1|NOT COMPLETED|2nd Intervention||0
8255633|NCT01829516|20357539|P2|COMPLETED|2nd Intervention||14
8255634|NCT01829516|20357540|P1|COMPLETED|2nd Intervention||18
8255635|NCT01829516|20357539|P2|STARTED|2nd Intervention||14
8255636|NCT01829516|20357540|P1|STARTED|2nd Intervention||18
8255637|NCT01829516|20357539|P2|NOT COMPLETED|Washout Period - 1 Week||0
8255638|NCT01829516|20357540|P1|NOT COMPLETED|Washout Period - 1 Week||0
8255639|NCT01829516|20357539|P2|COMPLETED|Washout Period - 1 Week||14
8255640|NCT01829516|20357540|P1|COMPLETED|Washout Period - 1 Week||18
8255641|NCT01829516|20357539|P2|STARTED|Washout Period - 1 Week||14
8255642|NCT01829516|20357540|P1|STARTED|Washout Period - 1 Week||18
8255643|NCT01829516|20357539|P2|NOT COMPLETED|First Intervention||0
8255644|NCT01829516|20357540|P1|NOT COMPLETED|First Intervention||0
8255645|NCT01829516|20357539|P2|COMPLETED|First Intervention||14
8255646|NCT01829516|20357540|P1|COMPLETED|First Intervention||18
8255647|NCT01829516|20357539|P2|STARTED|First Intervention||14
8255648|NCT01829516|20357540|P1|STARTED|First Intervention||18
8255649|NCT01829503|20357548|P1|NOT COMPLETED|Overall Study||0
8255650|NCT01829503|20357548|P1|COMPLETED|Overall Study||44
8255651|NCT01829503|20357548|P1|STARTED|Overall Study||44
8255652|NCT01829477|20357565|P2|NOT COMPLETED|Overall Study||15
8255653|NCT01829477|20357566|P1|NOT COMPLETED|Overall Study||16
8255654|NCT01829477|20357565|P2|COMPLETED|Overall Study||1
8255655|NCT01829477|20357566|P1|COMPLETED|Overall Study||1
8255656|NCT01829477|20357565|P2|STARTED|Overall Study||16
8255657|NCT01829477|20357566|P1|STARTED|Overall Study||17
8255658|NCT01829464|20357579|P3|NOT COMPLETED|Overall Study||26
8255659|NCT01829464|20357580|P2|NOT COMPLETED|Overall Study||29
8255660|NCT01829464|20357581|P1|NOT COMPLETED|Overall Study||28
8255661|NCT01829464|20357579|P3|COMPLETED|Overall Study||3
8255662|NCT01829464|20357580|P2|COMPLETED|Overall Study||2
8255663|NCT01829464|20357581|P1|COMPLETED|Overall Study||2
8255664|NCT01829464|20357579|P3|STARTED|Overall Study||29
8255665|NCT01829464|20357580|P2|STARTED|Overall Study||31
8255666|NCT01829464|20357581|P1|STARTED|Overall Study||30
8255667|NCT01829425|20357597|P2|NOT COMPLETED|Overall Study||4
8255668|NCT01829425|20357598|P1|NOT COMPLETED|Overall Study||6
8255669|NCT01829425|20357597|P2|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
8255670|NCT01829425|20357598|P1|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
8255671|NCT01829425|20357597|P2|STARTED|Overall Study||74
8255672|NCT01829425|20357598|P1|STARTED|Overall Study||78
8255673|NCT01829399|20357628|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
8255674|NCT01829399|20357629|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
8255675|NCT01829399|20357628|P2|COMPLETED|Visit 2 (One Month Later)||12
8255676|NCT01829399|20357629|P1|COMPLETED|Visit 2 (One Month Later)||12
8255677|NCT01829399|20357628|P2|STARTED|Visit 2 (One Month Later)||12
8255678|NCT01829399|20357629|P1|STARTED|Visit 2 (One Month Later)||12
8255679|NCT01829399|20357628|P2|NOT COMPLETED|Visit 1||0
8255680|NCT01829399|20357629|P1|NOT COMPLETED|Visit 1||0
8255681|NCT01829399|20357628|P2|COMPLETED|Visit 1||12
8255682|NCT01829399|20357629|P1|COMPLETED|Visit 1||12
8255683|NCT01829399|20357628|P2|STARTED|Visit 1||12
8255684|NCT01829399|20357629|P1|STARTED|Visit 1||12
8255685|NCT01829360|20357641|P4|NOT COMPLETED|Overall Study||0
8255686|NCT01829360|20357642|P3|NOT COMPLETED|Overall Study||1
8255687|NCT01829360|20357643|P2|NOT COMPLETED|Overall Study||0
8255688|NCT01829360|20357644|P1|NOT COMPLETED|Overall Study||0
8255689|NCT01829360|20357641|P4|COMPLETED|Overall Study||8
8255690|NCT01829360|20357642|P3|COMPLETED|Overall Study||9
8255691|NCT01829360|20357643|P2|COMPLETED|Overall Study||9
8255692|NCT01829360|20357644|P1|COMPLETED|Overall Study||8
8255693|NCT01829360|20357641|P4|STARTED|Overall Study||8
8255694|NCT01829360|20357642|P3|STARTED|Overall Study||10
8255695|NCT01829360|20357643|P2|STARTED|Overall Study||9
8255696|NCT01829360|20357644|P1|STARTED|Overall Study||8
8255697|NCT01829347|20357664|P2|NOT COMPLETED|VTI-210E||6
8255698|NCT01829347|20357665|P1|NOT COMPLETED|VTI-210E||3
8255699|NCT01829347|20357664|P2|COMPLETED|VTI-210E||0
8255700|NCT01829347|20357665|P1|COMPLETED|VTI-210E||0
8255701|NCT01829347|20357664|P2|STARTED|VTI-210E||6
8255702|NCT01829347|20357665|P1|STARTED|VTI-210E||3
8255703|NCT01829347|20357664|P2|NOT COMPLETED|VTI-210||3
8255704|NCT01829347|20357665|P1|NOT COMPLETED|VTI-210||6
8255705|NCT01829347|20357664|P2|COMPLETED|VTI-210||6
8255706|NCT01829347|20357665|P1|COMPLETED|VTI-210||3
8255707|NCT01829347|20357664|P2|STARTED|VTI-210||9
8255708|NCT01829347|20357665|P1|STARTED|VTI-210||9
8255709|NCT01829295|20357675|P4|NOT COMPLETED|6-12 Months||13
8255710|NCT01829295|20357676|P3|NOT COMPLETED|6-12 Months||12
8255711|NCT01829295|20357677|P2|NOT COMPLETED|6-12 Months||2
8255712|NCT01829295|20357678|P1|NOT COMPLETED|6-12 Months||4
8255713|NCT01829295|20357675|P4|COMPLETED|6-12 Months||29
8255714|NCT01829295|20357676|P3|COMPLETED|6-12 Months||20
8255715|NCT01829295|20357677|P2|COMPLETED|6-12 Months||54
8255716|NCT01829295|20357678|P1|COMPLETED|6-12 Months||60
8255717|NCT01829295|20357675|P4|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
8255718|NCT01829295|20357676|P3|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
8255719|NCT01829295|20357677|P2|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
8255720|NCT01829295|20357678|P1|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
8255721|NCT01829295|20357675|P4|NOT COMPLETED|0-6 Months||0
8255722|NCT01829295|20357676|P3|NOT COMPLETED|0-6 Months||0
8255723|NCT01829295|20357677|P2|NOT COMPLETED|0-6 Months||11
8255724|NCT01829295|20357678|P1|NOT COMPLETED|0-6 Months||11
8255725|NCT01829295|20357675|P4|COMPLETED|0-6 Months||0
8255726|NCT01829295|20357676|P3|COMPLETED|0-6 Months||0
8255727|NCT01829295|20357677|P2|COMPLETED|0-6 Months||98
8255728|NCT01829295|20357678|P1|COMPLETED|0-6 Months||96
8255729|NCT01829295|20357675|P4|STARTED|0-6 Months||0
8255730|NCT01829295|20357676|P3|STARTED|0-6 Months||0
8255731|NCT01829295|20357677|P2|STARTED|0-6 Months||109
8255732|NCT01829295|20357678|P1|STARTED|0-6 Months||107
8255733|NCT01829243|20357688|P2|NOT COMPLETED|Second Intervention||0
8255734|NCT01829243|20357689|P1|NOT COMPLETED|Second Intervention||0
8255735|NCT01829243|20357688|P2|COMPLETED|Second Intervention||13
8255736|NCT01829243|20357689|P1|COMPLETED|Second Intervention||7
8255737|NCT01829243|20357688|P2|STARTED|Second Intervention||13
8255738|NCT01829243|20357689|P1|STARTED|Second Intervention||7
8255739|NCT01829243|20357688|P2|NOT COMPLETED|Washout Period of 1 Week||0
8255740|NCT01829243|20357689|P1|NOT COMPLETED|Washout Period of 1 Week||0
8255741|NCT01829243|20357688|P2|COMPLETED|Washout Period of 1 Week||13
8255742|NCT01829243|20357689|P1|COMPLETED|Washout Period of 1 Week||7
8255743|NCT01829243|20357688|P2|STARTED|Washout Period of 1 Week||13
8255744|NCT01829243|20357689|P1|STARTED|Washout Period of 1 Week||7
8255745|NCT01829243|20357688|P2|NOT COMPLETED|First Intervention||2
8255746|NCT01829243|20357689|P1|NOT COMPLETED|First Intervention||4
8255747|NCT01829243|20357688|P2|COMPLETED|First Intervention||13
8255748|NCT01829243|20357689|P1|COMPLETED|First Intervention||7
8255749|NCT01829243|20357688|P2|STARTED|First Intervention||15
8255750|NCT01829243|20357689|P1|STARTED|First Intervention||11
8255751|NCT01829230|20357703|P2|NOT COMPLETED|Overall Study||4
8255752|NCT01829230|20357704|P1|NOT COMPLETED|Overall Study||1
8255753|NCT01829230|20357703|P2|COMPLETED|Overall Study||38
8255754|NCT01829230|20357704|P1|COMPLETED|Overall Study||39
8255755|NCT01829230|20357703|P2|STARTED|Overall Study||42
8255756|NCT01829230|20357704|P1|STARTED|Overall Study||40
8255757|NCT01829217|20357712|P1|NOT COMPLETED|Overall Study||0
8255758|NCT01829217|20357712|P1|COMPLETED|Overall Study||13
8255759|NCT01829217|20357712|P1|STARTED|Overall Study||13
8255760|NCT01829191|20357718|P2|NOT COMPLETED|Overall Study||14
8255761|NCT01829191|20357719|P1|NOT COMPLETED|Overall Study||7
8255762|NCT01829191|20357718|P2|COMPLETED|Overall Study||50
8255763|NCT01829191|20357719|P1|COMPLETED|Overall Study||56
8255764|NCT01829191|20357718|P2|STARTED|Overall Study||64
8255765|NCT01829191|20357719|P1|STARTED|Overall Study||63
8255766|NCT01829165|20357728|P2|NOT COMPLETED|Overall Study||0
8255767|NCT01829165|20357729|P1|NOT COMPLETED|Overall Study||2
8255768|NCT01829165|20357728|P2|COMPLETED|Overall Study||13
8255769|NCT01829165|20357729|P1|COMPLETED|Overall Study||18
8255770|NCT01829165|20357728|P2|STARTED|Overall Study||13
8255771|NCT01829165|20357729|P1|STARTED|Overall Study||20
8255772|NCT01829113|20357737|P2|NOT COMPLETED|Overall Study||78
8255773|NCT01829113|20357738|P1|NOT COMPLETED|Overall Study||77
8255774|NCT01829113|20357737|P2|COMPLETED|Overall Study||0
8255775|NCT01829113|20357738|P1|COMPLETED|Overall Study||0
8255776|NCT01829113|20357737|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
8255777|NCT01829113|20357738|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
8255778|NCT01829048|20357755|P5|NOT COMPLETED|Overall Study||0
8255779|NCT01829048|20357756|P4|NOT COMPLETED|Overall Study||2
8255780|NCT01829048|20357757|P3|NOT COMPLETED|Overall Study||0
8255781|NCT01829048|20357758|P2|NOT COMPLETED|Overall Study||0
8255782|NCT01829048|20357759|P1|NOT COMPLETED|Overall Study||0
8255783|NCT01829048|20357755|P5|COMPLETED|Overall Study||2
8255784|NCT01829048|20357756|P4|COMPLETED|Overall Study||12
8255785|NCT01829048|20357757|P3|COMPLETED|Overall Study||7
8255786|NCT01829048|20357758|P2|COMPLETED|Overall Study||8
8255787|NCT01829048|20357759|P1|COMPLETED|Overall Study||6
8255788|NCT01829048|20357755|P5|STARTED|Overall Study||2
8255789|NCT01829048|20357756|P4|STARTED|Overall Study||14
8255790|NCT01829048|20357757|P3|STARTED|Overall Study||7
8255791|NCT01829048|20357758|P2|STARTED|Overall Study||8
8255792|NCT01829048|20357759|P1|STARTED|Overall Study||6
8255793|NCT01828983|20357833|P2|NOT COMPLETED|Overall Study||0
8255794|NCT01828983|20357834|P1|NOT COMPLETED|Overall Study||0
8255795|NCT01828983|20357833|P2|COMPLETED|Overall Study||81
8255796|NCT01828983|20357834|P1|COMPLETED|Overall Study||80
8255797|NCT01828983|20357833|P2|STARTED|Overall Study||81
8255798|NCT01828983|20357834|P1|STARTED|Overall Study||80
8255799|NCT01828593|20357847|P3|NOT COMPLETED|Placebo-Free Phase||6
8255800|NCT01828593|20357848|P2|NOT COMPLETED|Placebo-Free Phase||6
8255801|NCT01828593|20357849|P1|NOT COMPLETED|Placebo-Free Phase||0
8255802|NCT01828593|20357847|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
8255803|NCT01828593|20357848|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
8255804|NCT01828593|20357849|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
8255805|NCT01828593|20357847|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
8255806|NCT01828593|20357848|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
8255807|NCT01828593|20357849|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
8255808|NCT01828593|20357847|P3|NOT COMPLETED|Placebo-Controlled Phase||1
8255809|NCT01828593|20357848|P2|NOT COMPLETED|Placebo-Controlled Phase||0
8255810|NCT01828593|20357849|P1|NOT COMPLETED|Placebo-Controlled Phase||0
8255811|NCT01828593|20357847|P3|COMPLETED|Placebo-Controlled Phase||32
8255812|NCT01828593|20357848|P2|COMPLETED|Placebo-Controlled Phase||34
8255813|NCT01828593|20357849|P1|COMPLETED|Placebo-Controlled Phase||36
8255814|NCT01828593|20357847|P3|STARTED|Placebo-Controlled Phase||33
8255815|NCT01828593|20357848|P2|STARTED|Placebo-Controlled Phase||34
8255816|NCT01828593|20357849|P1|STARTED|Placebo-Controlled Phase||36
8255817|NCT01828567|20357872|P2|NOT COMPLETED|Overall Study||10
8255818|NCT01828567|20357873|P1|NOT COMPLETED|Overall Study||31
8255819|NCT01828567|20357872|P2|COMPLETED|Overall Study||199
8255820|NCT01828567|20357873|P1|COMPLETED|Overall Study||177
8255821|NCT01828567|20357872|P2|1 Month|Overall Study||192
8255822|NCT01828567|20357873|P1|1 Month|Overall Study||172
8255823|NCT01828567|20357872|P2|STARTED|Overall Study||209
8255824|NCT01828567|20357873|P1|STARTED|Overall Study||208
8255825|NCT01828554|20357889|P1|NOT COMPLETED|Overall Study||0
8255826|NCT01828554|20357889|P1|COMPLETED|Overall Study||8
8255827|NCT01828554|20357889|P1|STARTED|Overall Study||8
8255828|NCT01828515|20357896|P2|NOT COMPLETED|Second Intervention (19 Days)||3
8255829|NCT01828515|20357897|P1|NOT COMPLETED|Second Intervention (19 Days)||0
8255830|NCT01828515|20357896|P2|COMPLETED|Second Intervention (19 Days)||5
8255831|NCT01828515|20357897|P1|COMPLETED|Second Intervention (19 Days)||6
8255832|NCT01828515|20357896|P2|STARTED|Second Intervention (19 Days)||8
8255833|NCT01828515|20357897|P1|STARTED|Second Intervention (19 Days)||6
8255834|NCT01828515|20357896|P2|NOT COMPLETED|Washout (23 Days)||1
8255835|NCT01828515|20357897|P1|NOT COMPLETED|Washout (23 Days)||5
8255836|NCT01828515|20357896|P2|COMPLETED|Washout (23 Days)||8
8255837|NCT01828515|20357897|P1|COMPLETED|Washout (23 Days)||6
8255838|NCT01828515|20357896|P2|STARTED|Washout (23 Days)||9
8255839|NCT01828515|20357897|P1|STARTED|Washout (23 Days)||11
8255840|NCT01828515|20357896|P2|NOT COMPLETED|First Intervention (19 Days)||2
8255841|NCT01828515|20357897|P1|NOT COMPLETED|First Intervention (19 Days)||2
8255842|NCT01828515|20357896|P2|COMPLETED|First Intervention (19 Days)||9
8255843|NCT01828515|20357897|P1|COMPLETED|First Intervention (19 Days)||11
8255844|NCT01828515|20357896|P2|STARTED|First Intervention (19 Days)||11
8255845|NCT01828515|20357897|P1|STARTED|First Intervention (19 Days)||13
8255846|NCT01828476|20357905|P2|NOT COMPLETED|Overall Study||0
8255847|NCT01828476|20357906|P1|NOT COMPLETED|Overall Study||0
8255848|NCT01828476|20357905|P2|COMPLETED|Overall Study||0
8255849|NCT01828476|20357906|P1|COMPLETED|Overall Study||13
8255850|NCT01828476|20357905|P2|STARTED|Overall Study||0
8255851|NCT01828476|20357906|P1|STARTED|Overall Study||13
8255852|NCT01828281|20357928|P2|NOT COMPLETED|Overall Study||0
8255853|NCT01828281|20357929|P1|NOT COMPLETED|Overall Study||1
8255854|NCT01828281|20357928|P2|COMPLETED|Overall Study||45
8255855|NCT01828281|20357929|P1|COMPLETED|Overall Study||44
8255856|NCT01828281|20357928|P2|STARTED|Overall Study||45
8255857|NCT01828281|20357929|P1|STARTED|Overall Study||45
8255858|NCT01828255|20357941|P2|NOT COMPLETED|Overall Study||0
8255859|NCT01828255|20357942|P1|NOT COMPLETED|Overall Study||0
8255860|NCT01828255|20357941|P2|COMPLETED|Overall Study||20
8255861|NCT01828255|20357942|P1|COMPLETED|Overall Study||20
8255862|NCT01828255|20357941|P2|STARTED|Overall Study||20
8255863|NCT01828255|20357942|P1|STARTED|Overall Study||20
8255864|NCT01828216|20357958|P2|NOT COMPLETED|Overall Study||0
8255865|NCT01828216|20357959|P1|NOT COMPLETED|Overall Study||0
8255866|NCT01828216|20357958|P2|COMPLETED|Overall Study||157
8255867|NCT01828216|20357959|P1|COMPLETED|Overall Study||159
8255868|NCT01828216|20357958|P2|STARTED|Overall Study||157
8255869|NCT01828216|20357959|P1|STARTED|Overall Study||159
8255870|NCT01828164|20357967|P1|NOT COMPLETED|Overall Study||17
8255871|NCT01828164|20357967|P1|COMPLETED|Overall Study||32
8255872|NCT01828164|20357967|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
8255873|NCT01828112|20357979|P2|NOT COMPLETED|Overall Study||108
8255874|NCT01828112|20357980|P1|NOT COMPLETED|Overall Study||82
8255875|NCT01828112|20357979|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
8255876|NCT01828112|20357980|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
8255877|NCT01828112|20357979|P2|Treated|Overall Study||113
8255878|NCT01828112|20357980|P1|Treated|Overall Study||115
8255879|NCT01828112|20357979|P2|Untreated|Overall Study||3
8255880|NCT01828112|20357980|P1|Untreated|Overall Study||0
8255881|NCT01828112|20357979|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
8255882|NCT01828112|20357980|P1|Untreated Patients|Overall Study||0
8255883|NCT01828112|20357979|P2|Discontinued From Study|Overall Study||10
8255884|NCT01828112|20357980|P1|Discontinued From Study|Overall Study||14
8255885|NCT01828112|20357979|P2|Entered Survival Follow-up Phase|Overall Study||19
8255886|NCT01828112|20357980|P1|Entered Survival Follow-up Phase|Overall Study||61
8255887|NCT01828112|20357979|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
8255888|NCT01828112|20357980|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
8255889|NCT01828112|20357979|P2|Entered Extension Treatment Phase|Overall Study||74
8255890|NCT01828112|20357980|P1|Entered Extension Treatment Phase|Overall Study||0
8255891|NCT01828112|20357979|P2|STARTED|Overall Study||116
8255892|NCT01828112|20357980|P1|STARTED|Overall Study||115
8255893|NCT01828099|20357988|P2|NOT COMPLETED|Overall Study||157
8255894|NCT01828099|20357989|P1|NOT COMPLETED|Overall Study||94
8255895|NCT01828099|20357988|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
8255896|NCT01828099|20357989|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
8255897|NCT01828099|20357988|P2|Discontinued From Study|Overall Study||29
8255898|NCT01828099|20357989|P1|Discontinued From Study|Overall Study||20
8255899|NCT01828099|20357988|P2|Entered Survival Follow-up Phase|Overall Study||31
8255900|NCT01828099|20357989|P1|Entered Survival Follow-up Phase|Overall Study||64
8255901|NCT01828099|20357988|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
8255902|NCT01828099|20357989|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
8255903|NCT01828099|20357988|P2|Entered Extension-treatment Phase|Overall Study||81
8255904|NCT01828099|20357989|P1|Entered Extension-treatment Phase|Overall Study||0
8255905|NCT01828099|20357988|P2|Discontinued From Treatment Phase|Overall Study||157
8255906|NCT01828099|20357989|P1|Discontinued From Treatment Phase|Overall Study||94
8255907|NCT01828099|20357988|P2|Treated|Overall Study||175
8255908|NCT01828099|20357989|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
8255909|NCT01828099|20357988|P2|Untreated Patients|Overall Study||12
8255910|NCT01828099|20357989|P1|Untreated Patients|Overall Study||0
8255911|NCT01828099|20357988|P2|STARTED|Overall Study||187
8255912|NCT01828099|20357989|P1|STARTED|Overall Study||189
8255913|NCT01828073|20357997|P2|NOT COMPLETED|Overall Study||2
8255914|NCT01828073|20357998|P1|NOT COMPLETED|Overall Study||1
8255915|NCT01828073|20357997|P2|COMPLETED|Overall Study||16
8255916|NCT01828073|20357998|P1|COMPLETED|Overall Study||21
8255917|NCT01828073|20357997|P2|STARTED|Overall Study||18
8255918|NCT01828073|20357998|P1|STARTED|Overall Study||22
8255919|NCT01828034|20358022|P4|NOT COMPLETED|Overall Study||1
8255920|NCT01828034|20358023|P3|NOT COMPLETED|Overall Study||0
8255921|NCT01828034|20358024|P2|NOT COMPLETED|Overall Study||0
8255922|NCT01828034|20358025|P1|NOT COMPLETED|Overall Study||0
8255923|NCT01828034|20358022|P4|COMPLETED|Overall Study||29
8255924|NCT01828034|20358023|P3|COMPLETED|Overall Study||3
8255925|NCT01828034|20358024|P2|COMPLETED|Overall Study||6
8255926|NCT01828034|20358025|P1|COMPLETED|Overall Study||3
8255927|NCT01828034|20358022|P4|STARTED|Overall Study||30
8255928|NCT01828034|20358023|P3|STARTED|Overall Study||3
8255929|NCT01828034|20358024|P2|STARTED|Overall Study||6
8255930|NCT01828034|20358025|P1|STARTED|Overall Study||3
8255931|NCT01828021|20358037|P1|NOT COMPLETED|Overall Study||25
8255932|NCT01828021|20358037|P1|COMPLETED|Overall Study||0
8255933|NCT01828021|20358037|P1|STARTED|Overall Study||25
8255934|NCT01827930|20358045|P3|NOT COMPLETED|Overall Study||0
8255935|NCT01827930|20358046|P2|NOT COMPLETED|Overall Study||0
8255936|NCT01827930|20358047|P1|NOT COMPLETED|Overall Study||0
8255937|NCT01827930|20358045|P3|COMPLETED|Overall Study||19
8255938|NCT01827930|20358046|P2|COMPLETED|Overall Study||25
8255939|NCT01827930|20358047|P1|COMPLETED|Overall Study||24
8255940|NCT01827930|20358045|P3|STARTED|Overall Study||19
8255941|NCT01827930|20358046|P2|STARTED|Overall Study||25
8255942|NCT01827930|20358047|P1|STARTED|Overall Study||24
8255943|NCT01827839|20358076|P1|NOT COMPLETED|Overall Study||3
8255944|NCT01827839|20358076|P1|COMPLETED|Overall Study||93
8255945|NCT01827839|20358076|P1|STARTED|Overall Study||96
8255946|NCT01827787|20358100|P2|NOT COMPLETED|Overall Study||0
8255947|NCT01827787|20358101|P1|NOT COMPLETED|Overall Study||0
8255948|NCT01827787|20358100|P2|COMPLETED|Overall Study||38
8255949|NCT01827787|20358101|P1|COMPLETED|Overall Study||45
8255950|NCT01827787|20358100|P2|STARTED|Overall Study||38
8255951|NCT01827787|20358101|P1|STARTED|Overall Study||45
8255952|NCT01827670|20358121|P2|NOT COMPLETED|Overall Study||3
8255953|NCT01827670|20358122|P1|NOT COMPLETED|Overall Study||3
8255954|NCT01827670|20358121|P2|COMPLETED|Overall Study||56
8255955|NCT01827670|20358122|P1|COMPLETED|Overall Study||57
8255956|NCT01827670|20358121|P2|STARTED|Overall Study||59
8255957|NCT01827670|20358122|P1|STARTED|Overall Study||60
8255958|NCT01827592|20358141|P3|NOT COMPLETED|Overall Study||76
8255959|NCT01827592|20358142|P2|NOT COMPLETED|Overall Study||80
8255960|NCT01827592|20358143|P1|NOT COMPLETED|Overall Study||74
8255961|NCT01827592|20358141|P3|COMPLETED|Overall Study||48
8255962|NCT01827592|20358142|P2|COMPLETED|Overall Study||46
8255963|NCT01827592|20358143|P1|COMPLETED|Overall Study||52
8255964|NCT01827592|20358141|P3|Safety Analysis Set|Overall Study||124
8255965|NCT01827592|20358142|P2|Safety Analysis Set|Overall Study||126
8255966|NCT01827592|20358143|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
8255967|NCT01827592|20358141|P3|STARTED|Overall Study|Randomized patients.|124
8255968|NCT01827592|20358142|P2|STARTED|Overall Study|Randomized patients.|126
8255969|NCT01827592|20358143|P1|STARTED|Overall Study|Randomized patients.|126
8255970|NCT01827475|20358175|P3|NOT COMPLETED|Overall Study||0
8255971|NCT01827475|20358176|P2|NOT COMPLETED|Overall Study||0
8255972|NCT01827475|20358177|P1|NOT COMPLETED|Overall Study||0
8255973|NCT01827475|20358175|P3|COMPLETED|Overall Study||30
8255974|NCT01827475|20358176|P2|COMPLETED|Overall Study||30
8255975|NCT01827475|20358177|P1|COMPLETED|Overall Study||30
8255976|NCT01827475|20358175|P3|STARTED|Overall Study||30
8255977|NCT01827475|20358176|P2|STARTED|Overall Study||30
8255978|NCT01827475|20358177|P1|STARTED|Overall Study||30
8255979|NCT01827462|20358191|P3|NOT COMPLETED|Overall Study||28
8255980|NCT01827462|20358192|P2|NOT COMPLETED|Overall Study||18
8255981|NCT01827462|20358193|P1|NOT COMPLETED|Overall Study||41
8255982|NCT01827462|20358191|P3|COMPLETED|Overall Study||12
8255983|NCT01827462|20358192|P2|COMPLETED|Overall Study||19
8255984|NCT01827462|20358193|P1|COMPLETED|Overall Study||18
8255985|NCT01827462|20358191|P3|STARTED|Overall Study||40
8255986|NCT01827462|20358192|P2|STARTED|Overall Study||37
8255987|NCT01827462|20358193|P1|STARTED|Overall Study||59
8255988|NCT01827371|20358208|P4|NOT COMPLETED|Overall Study||23
8255989|NCT01827371|20358209|P3|NOT COMPLETED|Overall Study||11
8255990|NCT01827371|20358210|P2|NOT COMPLETED|Overall Study||7
8255991|NCT01827371|20358211|P1|NOT COMPLETED|Overall Study||13
8255992|NCT01827371|20358208|P4|COMPLETED|Overall Study||97
8255993|NCT01827371|20358209|P3|COMPLETED|Overall Study||93
8255994|NCT01827371|20358210|P2|COMPLETED|Overall Study||89
8255995|NCT01827371|20358211|P1|COMPLETED|Overall Study||102
8255996|NCT01827371|20358208|P4|STARTED|Overall Study||120
8255997|NCT01827371|20358209|P3|STARTED|Overall Study||104
8255998|NCT01827371|20358210|P2|STARTED|Overall Study||96
8255999|NCT01827371|20358211|P1|STARTED|Overall Study||115
8256000|NCT01827358|20358235|P2|NOT COMPLETED|Overall Study||31
8256001|NCT01827358|20358236|P1|NOT COMPLETED|Overall Study||35
8256002|NCT01827358|20358235|P2|COMPLETED|Overall Study||44
8256003|NCT01827358|20358236|P1|COMPLETED|Overall Study||45
8256004|NCT01827358|20358235|P2|STARTED|Overall Study||75
8256005|NCT01827358|20358236|P1|STARTED|Overall Study||80
8256006|NCT01827332|20358270|P2|NOT COMPLETED|Overall Study||1
8256007|NCT01827332|20358271|P1|NOT COMPLETED|Overall Study||2
8256008|NCT01827332|20358270|P2|COMPLETED|Overall Study||7
8256009|NCT01827332|20358271|P1|COMPLETED|Overall Study||6
8256010|NCT01827332|20358270|P2|STARTED|Overall Study||8
8256011|NCT01827332|20358271|P1|STARTED|Overall Study||8
8256012|NCT01827319|20358279|P1|NOT COMPLETED|Overall Study||3
8256013|NCT01827319|20358279|P1|COMPLETED|Overall Study||200
8256014|NCT01827319|20358279|P1|STARTED|Overall Study||203
8256015|NCT01827306|20358287|P2|NOT COMPLETED|Overall Study||5
8256016|NCT01827306|20358288|P1|NOT COMPLETED|Overall Study||11
8256017|NCT01827306|20358287|P2|COMPLETED|Overall Study||8
8256018|NCT01827306|20358288|P1|COMPLETED|Overall Study||10
8256019|NCT01827306|20358287|P2|STARTED|Overall Study||13
8256020|NCT01827306|20358288|P1|STARTED|Overall Study||21
8256021|NCT01827267|20358302|P2|NOT COMPLETED|Overall Study||12
8256022|NCT01827267|20358303|P1|NOT COMPLETED|Overall Study||5
8256023|NCT01827267|20358302|P2|COMPLETED|Overall Study||32
8256024|NCT01827267|20358303|P1|COMPLETED|Overall Study||13
8256025|NCT01827267|20358302|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
8256026|NCT01827267|20358303|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
8256027|NCT01827267|20358302|P2|Received Study Drug|Overall Study||43
8256028|NCT01827267|20358303|P1|Received Study Drug|Overall Study||17
8256029|NCT01827267|20358302|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
8256030|NCT01827267|20358303|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
8256031|NCT01827254|20358318|P1|NOT COMPLETED|Overall Study||59
8256032|NCT01827254|20358318|P1|COMPLETED|Overall Study||2
8256033|NCT01827254|20358318|P1|Evaluable Population|Overall Study||52
8256034|NCT01827254|20358318|P1|STARTED|Overall Study||61
8256035|NCT01827163|20358328|P1|NOT COMPLETED|Overall Study||11
8256036|NCT01827163|20358328|P1|COMPLETED|Overall Study||9
8256037|NCT01827163|20358328|P1|STARTED|Overall Study||20
8256038|NCT01827046|20358335|P2|NOT COMPLETED|Overall Study||9
8256039|NCT01827046|20358336|P1|NOT COMPLETED|Overall Study||1
8256040|NCT01827046|20358335|P2|COMPLETED|Overall Study||240
8256041|NCT01827046|20358336|P1|COMPLETED|Overall Study||249
8256042|NCT01827046|20358335|P2|STARTED|Overall Study||249
8256043|NCT01827046|20358336|P1|STARTED|Overall Study||250
8256044|NCT01826981|20358391|P15|NOT COMPLETED|Overall Study||0
8256045|NCT01826981|20358392|P14|NOT COMPLETED|Overall Study||5
8256046|NCT01826981|20358393|P13|NOT COMPLETED|Overall Study||1
8256047|NCT01826981|20358394|P12|NOT COMPLETED|Overall Study||2
8256048|NCT01826981|20358395|P11|NOT COMPLETED|Overall Study||2
8256049|NCT01826981|20358396|P10|NOT COMPLETED|Overall Study||1
8256050|NCT01826981|20358397|P9|NOT COMPLETED|Overall Study||7
8256051|NCT01826981|20358398|P8|NOT COMPLETED|Overall Study||11
8256052|NCT01826981|20358399|P7|NOT COMPLETED|Overall Study||1
8256053|NCT01826981|20358400|P6|NOT COMPLETED|Overall Study||1
8256054|NCT01826981|20358401|P5|NOT COMPLETED|Overall Study||7
8256055|NCT01826981|20358402|P4|NOT COMPLETED|Overall Study||0
8256056|NCT01826981|20358403|P3|NOT COMPLETED|Overall Study||0
8256057|NCT01826981|20358404|P2|NOT COMPLETED|Overall Study||1
8256058|NCT01826981|20358405|P1|NOT COMPLETED|Overall Study||0
8256059|NCT01826981|20358391|P15|COMPLETED|Overall Study||8
8256060|NCT01826981|20358392|P14|COMPLETED|Overall Study||15
8256061|NCT01826981|20358393|P13|COMPLETED|Overall Study||25
8256062|NCT01826981|20358394|P12|COMPLETED|Overall Study||25
8256063|NCT01826981|20358395|P11|COMPLETED|Overall Study||22
8256064|NCT01826981|20358396|P10|COMPLETED|Overall Study||26
8256065|NCT01826981|20358397|P9|COMPLETED|Overall Study||13
8256066|NCT01826981|20358398|P8|COMPLETED|Overall Study||40
8256067|NCT01826981|20358399|P7|COMPLETED|Overall Study||24
8256068|NCT01826981|20358400|P6|COMPLETED|Overall Study||25
8256069|NCT01826981|20358401|P5|COMPLETED|Overall Study||18
8256070|NCT01826981|20358402|P4|COMPLETED|Overall Study||26
8256071|NCT01826981|20358403|P3|COMPLETED|Overall Study||25
8256072|NCT01826981|20358404|P2|COMPLETED|Overall Study||9
8256073|NCT01826981|20358405|P1|COMPLETED|Overall Study||19
8256074|NCT01826981|20358391|P15|STARTED|Overall Study||8
8256075|NCT01826981|20358392|P14|STARTED|Overall Study||20
8256076|NCT01826981|20358393|P13|STARTED|Overall Study||26
8256077|NCT01826981|20358394|P12|STARTED|Overall Study||27
8256078|NCT01826981|20358395|P11|STARTED|Overall Study||24
8256079|NCT01826981|20358396|P10|STARTED|Overall Study||27
8256080|NCT01826981|20358397|P9|STARTED|Overall Study||20
8256081|NCT01826981|20358398|P8|STARTED|Overall Study||51
8256082|NCT01826981|20358399|P7|STARTED|Overall Study||25
8256083|NCT01826981|20358400|P6|STARTED|Overall Study||26
8256084|NCT01826981|20358401|P5|STARTED|Overall Study||25
8256085|NCT01826981|20358402|P4|STARTED|Overall Study||26
8256086|NCT01826981|20358403|P3|STARTED|Overall Study||25
8256087|NCT01826981|20358404|P2|STARTED|Overall Study||10
8256088|NCT01826981|20358405|P1|STARTED|Overall Study||19
8256089|NCT01826851|20358553|P2|NOT COMPLETED|Overall Study||0
8256090|NCT01826851|20358554|P1|NOT COMPLETED|Overall Study||0
8256091|NCT01826851|20358553|P2|COMPLETED|Overall Study||41
8256092|NCT01826851|20358554|P1|COMPLETED|Overall Study||38
8256093|NCT01826851|20358553|P2|STARTED|Overall Study||41
8256094|NCT01826851|20358554|P1|STARTED|Overall Study||38
8256095|NCT01826812|20358574|P2|NOT COMPLETED|Overall Study||1
8256096|NCT01826812|20358575|P1|NOT COMPLETED|Overall Study||0
8256097|NCT01826812|20358574|P2|COMPLETED|Overall Study||32
8256098|NCT01826812|20358575|P1|COMPLETED|Overall Study||167
8256099|NCT01826812|20358574|P2|STARTED|Overall Study||33
8256100|NCT01826812|20358575|P1|STARTED|Overall Study||167
8256101|NCT01826604|20358591|P2|NOT COMPLETED|Overall Study||9
8256102|NCT01826604|20358592|P1|NOT COMPLETED|Overall Study||8
8256103|NCT01826604|20358591|P2|COMPLETED|Overall Study||148
8256104|NCT01826604|20358592|P1|COMPLETED|Overall Study||136
8256105|NCT01826604|20358591|P2|STARTED|Overall Study||157
8256106|NCT01826604|20358592|P1|STARTED|Overall Study||144
8256107|NCT01826513|20358603|P3|NOT COMPLETED|Overall Study||0
8256108|NCT01826513|20358604|P2|NOT COMPLETED|Overall Study||0
8256109|NCT01826513|20358605|P1|NOT COMPLETED|Overall Study||0
8256110|NCT01826513|20358603|P3|COMPLETED|Overall Study||10
8256111|NCT01826513|20358604|P2|COMPLETED|Overall Study||10
8256112|NCT01826513|20358605|P1|COMPLETED|Overall Study||5
8256113|NCT01826513|20358603|P3|STARTED|Overall Study||10
8256114|NCT01826513|20358604|P2|STARTED|Overall Study||10
8256115|NCT01826513|20358605|P1|STARTED|Overall Study||5
8256116|NCT01826487|20358636|P2|NOT COMPLETED|Overall Study||5
8256117|NCT01826487|20358637|P1|NOT COMPLETED|Overall Study||4
8256118|NCT01826487|20358636|P2|COMPLETED|Overall Study||110
8256119|NCT01826487|20358637|P1|COMPLETED|Overall Study||111
8256120|NCT01826487|20358636|P2|ITT Population|Overall Study||114
8256121|NCT01826487|20358637|P1|ITT Population|Overall Study||114
8256122|NCT01826487|20358636|P2|As-treated Population|Overall Study||115
8256123|NCT01826487|20358637|P1|As-treated Population|Overall Study||115
8256124|NCT01826487|20358636|P2|STARTED|Overall Study||115
8256125|NCT01826487|20358637|P1|STARTED|Overall Study||115
8256126|NCT01826448|20358664|P2|NOT COMPLETED|Overall Study||9
8256127|NCT01826448|20358665|P1|NOT COMPLETED|Overall Study||4
8256128|NCT01826448|20358664|P2|COMPLETED|Overall Study||0
8256129|NCT01826448|20358665|P1|COMPLETED|Overall Study||0
8256130|NCT01826448|20358664|P2|STARTED|Overall Study||9
8256131|NCT01826448|20358665|P1|STARTED|Overall Study||4
8256132|NCT01826422|20358673|P2|NOT COMPLETED|Overall Study||3
8256133|NCT01826422|20358674|P1|NOT COMPLETED|Overall Study||1
8256134|NCT01826422|20358673|P2|COMPLETED|Overall Study||19
8256135|NCT01826422|20358674|P1|COMPLETED|Overall Study||17
8256136|NCT01826422|20358673|P2|STARTED|Overall Study||22
8256137|NCT01826422|20358674|P1|STARTED|Overall Study||18
8256138|NCT01826370|20358718|P1|NOT COMPLETED|Overall Study||20
8256139|NCT01826370|20358718|P1|COMPLETED|Overall Study||658
8256140|NCT01826370|20358718|P1|STARTED|Overall Study||678
8256141|NCT01826227|20358724|P1|NOT COMPLETED|Overall Study||0
8256142|NCT01826227|20358724|P1|COMPLETED|Overall Study||5
8256143|NCT01826227|20358724|P1|STARTED|Overall Study||5
8256144|NCT01826214|20358730|P2|NOT COMPLETED|Overall Study||34
8256145|NCT01826214|20358731|P1|NOT COMPLETED|Overall Study||35
8256146|NCT01826214|20358730|P2|COMPLETED|Overall Study||0
8256147|NCT01826214|20358731|P1|COMPLETED|Overall Study||0
8256148|NCT01826214|20358730|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
8256149|NCT01826214|20358731|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
8256150|NCT01826214|20358730|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
8256151|NCT01826214|20358731|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
8256152|NCT01826214|20358730|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
8256153|NCT01826214|20358731|P1|STARTED|Overall Study||35
8256154|NCT01826201|20358749|P1|NOT COMPLETED|Overall Study||4
8256155|NCT01826201|20358749|P1|COMPLETED|Overall Study||17
8256156|NCT01826201|20358749|P1|STARTED|Overall Study|Subjects in each arm are same|21
8256157|NCT01825941|20358757|P2|NOT COMPLETED|Overall Study||1
8256158|NCT01825941|20358758|P1|NOT COMPLETED|Overall Study||4
8256159|NCT01825941|20358757|P2|COMPLETED|Overall Study||103
8256160|NCT01825941|20358758|P1|COMPLETED|Overall Study||100
8256161|NCT01825941|20358757|P2|STARTED|Overall Study||104
8256162|NCT01825941|20358758|P1|STARTED|Overall Study||104
8256163|NCT01825889|20358766|P2|NOT COMPLETED|Overall Study||0
8256164|NCT01825889|20358767|P1|NOT COMPLETED|Overall Study||0
8256165|NCT01825889|20358766|P2|COMPLETED|Overall Study||10
8256166|NCT01825889|20358767|P1|COMPLETED|Overall Study||10
8256167|NCT01825889|20358766|P2|Received One Dose of Study Drug|Overall Study||10
8256168|NCT01825889|20358767|P1|Received One Dose of Study Drug|Overall Study||10
8256169|NCT01825889|20358766|P2|STARTED|Overall Study||10
8256170|NCT01825889|20358767|P1|STARTED|Overall Study||10
8256171|NCT01825876|20358777|P2|NOT COMPLETED|Period 2||1
8256172|NCT01825876|20358778|P1|NOT COMPLETED|Period 2||0
8256173|NCT01825876|20358777|P2|COMPLETED|Period 2||16
8256174|NCT01825876|20358778|P1|COMPLETED|Period 2||0
8256175|NCT01825876|20358777|P2|Received 1 Dose of Study Drug|Period 2||17
8256176|NCT01825876|20358778|P1|Received 1 Dose of Study Drug|Period 2||0
8256177|NCT01825876|20358777|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
8256178|NCT01825876|20358778|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
8256179|NCT01825876|20358777|P2|NOT COMPLETED|Period 1||0
8256180|NCT01825876|20358778|P1|NOT COMPLETED|Period 1||0
8256181|NCT01825876|20358777|P2|COMPLETED|Period 1||0
8256182|NCT01825876|20358778|P1|COMPLETED|Period 1||17
8256183|NCT01825876|20358777|P2|Received 1 Dose of Study Drug|Period 1||0
8256184|NCT01825876|20358778|P1|Received 1 Dose of Study Drug|Period 1||17
8256185|NCT01825876|20358777|P2|STARTED|Period 1||0
8256186|NCT01825876|20358778|P1|STARTED|Period 1||17
8256187|NCT01825837|20358799|P4|NOT COMPLETED|PART II||0
8256188|NCT01825837|20358800|P3|NOT COMPLETED|PART II||19
8256189|NCT01825837|20358801|P2|NOT COMPLETED|PART II||14
8256190|NCT01825837|20358802|P1|NOT COMPLETED|PART II||19
8256191|NCT01825837|20358799|P4|COMPLETED|PART II||0
8256192|NCT01825837|20358800|P3|COMPLETED|PART II||7
8256193|NCT01825837|20358801|P2|COMPLETED|PART II||12
8256194|NCT01825837|20358802|P1|COMPLETED|PART II||16
8256195|NCT01825837|20358799|P4|Per-Protocol Population|PART II||0
8256196|NCT01825837|20358800|P3|Per-Protocol Population|PART II||24
8256197|NCT01825837|20358801|P2|Per-Protocol Population|PART II||23
8256198|NCT01825837|20358802|P1|Per-Protocol Population|PART II||32
8256199|NCT01825837|20358799|P4|Intent-to-Treat Population|PART II||0
8256200|NCT01825837|20358800|P3|Intent-to-Treat Population|PART II||26
8256201|NCT01825837|20358801|P2|Intent-to-Treat Population|PART II||25
8256202|NCT01825837|20358802|P1|Intent-to-Treat Population|PART II||34
8256203|NCT01825837|20358799|P4|Safety Population (Double-Blind)|PART II||0
8256204|NCT01825837|20358800|P3|Safety Population (Double-Blind)|PART II||26
8256205|NCT01825837|20358801|P2|Safety Population (Double-Blind)|PART II||26
8256206|NCT01825837|20358802|P1|Safety Population (Double-Blind)|PART II||35
8256207|NCT01825837|20358799|P4|Randomized Patients|PART II||0
8256208|NCT01825837|20358800|P3|Randomized Patients|PART II||26
8256209|NCT01825837|20358801|P2|Randomized Patients|PART II||26
8256210|NCT01825837|20358802|P1|Randomized Patients|PART II||35
8256211|NCT01825837|20358799|P4|STARTED|PART II||0
8256212|NCT01825837|20358800|P3|STARTED|PART II||26
8256213|NCT01825837|20358801|P2|STARTED|PART II||26
8256214|NCT01825837|20358802|P1|STARTED|PART II||35
8256215|NCT01825837|20358799|P4|NOT COMPLETED|PART I||17
8256216|NCT01825837|20358800|P3|NOT COMPLETED|PART I||0
8256217|NCT01825837|20358801|P2|NOT COMPLETED|PART I||0
8256218|NCT01825837|20358802|P1|NOT COMPLETED|PART I||0
8256219|NCT01825837|20358799|P4|COMPLETED|PART I||87
8256220|NCT01825837|20358800|P3|COMPLETED|PART I||0
8256221|NCT01825837|20358801|P2|COMPLETED|PART I||0
8256222|NCT01825837|20358802|P1|COMPLETED|PART I||0
8256223|NCT01825837|20358799|P4|Safety Population (Open-Label)|PART I||104
8256224|NCT01825837|20358800|P3|Safety Population (Open-Label)|PART I||0
8256225|NCT01825837|20358801|P2|Safety Population (Open-Label)|PART I||0
8256226|NCT01825837|20358802|P1|Safety Population (Open-Label)|PART I||0
8256227|NCT01825837|20358799|P4|Enrolled|PART I||104
8256228|NCT01825837|20358800|P3|Enrolled|PART I||0
8256229|NCT01825837|20358801|P2|Enrolled|PART I||0
8256230|NCT01825837|20358802|P1|Enrolled|PART I||0
8256231|NCT01825837|20358799|P4|STARTED|PART I||104
8256232|NCT01825837|20358800|P3|STARTED|PART I||0
8256233|NCT01825837|20358801|P2|STARTED|PART I||0
8256234|NCT01825837|20358802|P1|STARTED|PART I||0
8256235|NCT01825798|20358812|P2|NOT COMPLETED|Overall Study||5
8256236|NCT01825798|20358813|P1|NOT COMPLETED|Overall Study||2
8256237|NCT01825798|20358812|P2|COMPLETED|Overall Study||23
8256238|NCT01825798|20358813|P1|COMPLETED|Overall Study||30
8256239|NCT01825798|20358812|P2|STARTED|Overall Study||28
8256240|NCT01825798|20358813|P1|STARTED|Overall Study||32
8256241|NCT01825785|20358848|P7|NOT COMPLETED|Overall Study||0
8256242|NCT01825785|20358849|P6|NOT COMPLETED|Overall Study||1
8256243|NCT01825785|20358850|P5|NOT COMPLETED|Overall Study||2
8256244|NCT01825785|20358851|P4|NOT COMPLETED|Overall Study||0
8256245|NCT01825785|20358852|P3|NOT COMPLETED|Overall Study||0
8256246|NCT01825785|20358853|P2|NOT COMPLETED|Overall Study||0
8256247|NCT01825785|20358854|P1|NOT COMPLETED|Overall Study||0
8256248|NCT01825785|20358848|P7|COMPLETED|Overall Study||6
8256249|NCT01825785|20358849|P6|COMPLETED|Overall Study||5
8256250|NCT01825785|20358850|P5|COMPLETED|Overall Study||4
8256251|NCT01825785|20358851|P4|COMPLETED|Overall Study||6
8256252|NCT01825785|20358852|P3|COMPLETED|Overall Study||6
8256253|NCT01825785|20358853|P2|COMPLETED|Overall Study||6
8256254|NCT01825785|20358854|P1|COMPLETED|Overall Study||12
8256255|NCT01825785|20358848|P7|STARTED|Overall Study||6
8256256|NCT01825785|20358849|P6|STARTED|Overall Study||6
8256257|NCT01825785|20358850|P5|STARTED|Overall Study||6
8256258|NCT01825785|20358851|P4|STARTED|Overall Study||6
8256259|NCT01825785|20358852|P3|STARTED|Overall Study||6
8256260|NCT01825785|20358853|P2|STARTED|Overall Study||6
8256261|NCT01825785|20358854|P1|STARTED|Overall Study||12
8256262|NCT01825655|20359000|P2|NOT COMPLETED|Overall Study||0
8256263|NCT01825655|20359001|P1|NOT COMPLETED|Overall Study||0
8256264|NCT01825655|20359000|P2|COMPLETED|Overall Study||2
8256265|NCT01825655|20359001|P1|COMPLETED|Overall Study||0
8256266|NCT01825655|20359000|P2|STARTED|Overall Study||2
8256267|NCT01825655|20359001|P1|STARTED|Overall Study||0
8256268|NCT01825577|20359007|P1|NOT COMPLETED|Overall Study||8
8256269|NCT01825577|20359007|P1|COMPLETED|Overall Study||6
8256270|NCT01825577|20359007|P1|STARTED|Overall Study||14
8256271|NCT01825408|20359016|P4|NOT COMPLETED|Overall Study||0
8256272|NCT01825408|20359017|P3|NOT COMPLETED|Overall Study||0
8256273|NCT01825408|20359018|P2|NOT COMPLETED|Overall Study||0
8256274|NCT01825408|20359019|P1|NOT COMPLETED|Overall Study||0
8256275|NCT01825408|20359016|P4|COMPLETED|Overall Study||12
8256276|NCT01825408|20359017|P3|COMPLETED|Overall Study||14
8256277|NCT01825408|20359018|P2|COMPLETED|Overall Study||7
8256278|NCT01825408|20359019|P1|COMPLETED|Overall Study||7
8256279|NCT01825408|20359016|P4|STARTED|Overall Study||12
8256280|NCT01825408|20359017|P3|STARTED|Overall Study||14
8256281|NCT01825408|20359018|P2|STARTED|Overall Study||7
8256282|NCT01825408|20359019|P1|STARTED|Overall Study||7
8256283|NCT01825200|20359031|P2|NOT COMPLETED|Overall Study||7
8256284|NCT01825200|20359032|P1|NOT COMPLETED|Overall Study||5
8256285|NCT01825200|20359031|P2|COMPLETED|Overall Study||1314
8256286|NCT01825200|20359032|P1|COMPLETED|Overall Study||1314
8256287|NCT01825200|20359031|P2|STARTED|Overall Study||1321
8256288|NCT01825200|20359032|P1|STARTED|Overall Study||1319
8256289|NCT01825122|20359046|P2|NOT COMPLETED|Overall Study||19
8256290|NCT01825122|20359047|P1|NOT COMPLETED|Overall Study||10
8256291|NCT01825122|20359046|P2|COMPLETED|Overall Study||59
8256292|NCT01825122|20359047|P1|COMPLETED|Overall Study||67
8256293|NCT01825122|20359046|P2|STARTED|Overall Study||78
8256294|NCT01825122|20359047|P1|STARTED|Overall Study||77
8256295|NCT01824979|20359055|P2|NOT COMPLETED|Overall Study||13
8256296|NCT01824979|20359056|P1|NOT COMPLETED|Overall Study||13
8256297|NCT01824979|20359055|P2|COMPLETED|Overall Study||37
8256298|NCT01824979|20359056|P1|COMPLETED|Overall Study||37
8256299|NCT01824979|20359055|P2|STARTED|Overall Study||50
8256300|NCT01824979|20359056|P1|STARTED|Overall Study||50
8256301|NCT01824901|20359064|P4|NOT COMPLETED|Overall Study||0
8256302|NCT01824901|20359065|P3|NOT COMPLETED|Overall Study||0
8256303|NCT01824901|20359066|P2|NOT COMPLETED|Overall Study||0
8256304|NCT01824901|20359067|P1|NOT COMPLETED|Overall Study||0
8256305|NCT01824901|20359064|P4|COMPLETED|Overall Study||0
8256306|NCT01824901|20359065|P3|COMPLETED|Overall Study||0
8256307|NCT01824901|20359066|P2|COMPLETED|Overall Study||0
8256308|NCT01824901|20359067|P1|COMPLETED|Overall Study||2
8256309|NCT01824901|20359064|P4|STARTED|Overall Study||0
8256310|NCT01824901|20359065|P3|STARTED|Overall Study||0
8256311|NCT01824901|20359066|P2|STARTED|Overall Study||0
8256312|NCT01824901|20359067|P1|STARTED|Overall Study||2
8256313|NCT01824823|20359073|P2|NOT COMPLETED|Overall Study||1
8256314|NCT01824823|20359074|P1|NOT COMPLETED|Overall Study||2
8256315|NCT01824823|20359073|P2|COMPLETED|Overall Study||0
8256316|NCT01824823|20359074|P1|COMPLETED|Overall Study||0
8256317|NCT01824823|20359073|P2|STARTED|Overall Study||1
8256318|NCT01824823|20359074|P1|STARTED|Overall Study||2
8256319|NCT01824693|20359083|P3|NOT COMPLETED|Overall Study||15
8256320|NCT01824693|20359084|P2|NOT COMPLETED|Overall Study||7
8256321|NCT01824693|20359085|P1|NOT COMPLETED|Overall Study||1
8256322|NCT01824693|20359083|P3|COMPLETED|Overall Study||0
8256323|NCT01824693|20359084|P2|COMPLETED|Overall Study||2
8256324|NCT01824693|20359085|P1|COMPLETED|Overall Study||5
8256325|NCT01824693|20359083|P3|STARTED|Overall Study||15
8256326|NCT01824693|20359084|P2|STARTED|Overall Study||9
8256327|NCT01824693|20359085|P1|STARTED|Overall Study||6
8256328|NCT01824602|20359102|P4|NOT COMPLETED|Overall Study||5
8256329|NCT01824602|20359103|P3|NOT COMPLETED|Overall Study||4
8256330|NCT01824602|20359104|P2|NOT COMPLETED|Overall Study||0
8256331|NCT01824602|20359105|P1|NOT COMPLETED|Overall Study||1
8256332|NCT01824602|20359102|P4|COMPLETED|Overall Study||5
8256333|NCT01824602|20359103|P3|COMPLETED|Overall Study||5
8256334|NCT01824602|20359104|P2|COMPLETED|Overall Study||8
8256335|NCT01824602|20359105|P1|COMPLETED|Overall Study||10
8256336|NCT01824602|20359102|P4|Intent-to-treat Population|Overall Study||9
8256337|NCT01824602|20359103|P3|Intent-to-treat Population|Overall Study||9
8256338|NCT01824602|20359104|P2|Intent-to-treat Population|Overall Study||8
8256339|NCT01824602|20359105|P1|Intent-to-treat Population|Overall Study||11
8256340|NCT01824602|20359102|P4|Safety Population|Overall Study||10
8256341|NCT01824602|20359103|P3|Safety Population|Overall Study||9
8256342|NCT01824602|20359104|P2|Safety Population|Overall Study||8
8256343|NCT01824602|20359105|P1|Safety Population|Overall Study||11
8256344|NCT01824602|20359102|P4|STARTED|Overall Study||10
8256345|NCT01824602|20359103|P3|STARTED|Overall Study||9
8256346|NCT01824602|20359104|P2|STARTED|Overall Study||8
8256347|NCT01824602|20359105|P1|STARTED|Overall Study||11
8256348|NCT01824589|20359119|P4|NOT COMPLETED|Overall Study||0
8256349|NCT01824589|20359120|P3|NOT COMPLETED|Overall Study||0
8256350|NCT01824589|20359121|P2|NOT COMPLETED|Overall Study||0
8256351|NCT01824589|20359122|P1|NOT COMPLETED|Overall Study||0
8256352|NCT01824589|20359119|P4|COMPLETED|Overall Study||0
8256353|NCT01824589|20359120|P3|COMPLETED|Overall Study||0
8256354|NCT01824589|20359121|P2|COMPLETED|Overall Study||0
8256355|NCT01824589|20359122|P1|COMPLETED|Overall Study||1
8256356|NCT01824589|20359119|P4|STARTED|Overall Study||0
8256357|NCT01824589|20359120|P3|STARTED|Overall Study||0
8256358|NCT01824589|20359121|P2|STARTED|Overall Study||0
8256359|NCT01824589|20359122|P1|STARTED|Overall Study||1
8256360|NCT01824576|20359144|P1|NOT COMPLETED|Overall Study||2
8256361|NCT01824576|20359144|P1|COMPLETED|Overall Study||7
8256362|NCT01824576|20359144|P1|STARTED|Overall Study||9
8256363|NCT01824498|20359162|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256364|NCT01824498|20359163|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256365|NCT01824498|20359164|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256366|NCT01824498|20359165|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256367|NCT01824498|20359166|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256368|NCT01824498|20359167|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256369|NCT01824498|20359162|P6|COMPLETED|3rd Intervention (8 Weeks)||4
8256370|NCT01824498|20359163|P5|COMPLETED|3rd Intervention (8 Weeks)||3
8256371|NCT01824498|20359164|P4|COMPLETED|3rd Intervention (8 Weeks)||2
8256372|NCT01824498|20359165|P3|COMPLETED|3rd Intervention (8 Weeks)||4
8256373|NCT01824498|20359166|P2|COMPLETED|3rd Intervention (8 Weeks)||2
8256374|NCT01824498|20359167|P1|COMPLETED|3rd Intervention (8 Weeks)||3
8256375|NCT01824498|20359162|P6|STARTED|3rd Intervention (8 Weeks)||4
8256376|NCT01824498|20359163|P5|STARTED|3rd Intervention (8 Weeks)||3
8256377|NCT01824498|20359164|P4|STARTED|3rd Intervention (8 Weeks)||2
8256378|NCT01824498|20359165|P3|STARTED|3rd Intervention (8 Weeks)||4
8256379|NCT01824498|20359166|P2|STARTED|3rd Intervention (8 Weeks)||2
8256380|NCT01824498|20359167|P1|STARTED|3rd Intervention (8 Weeks)||3
8256381|NCT01824498|20359162|P6|NOT COMPLETED|Washout (8 Weeks)||0
8256382|NCT01824498|20359163|P5|NOT COMPLETED|Washout (8 Weeks)||0
8256383|NCT01824498|20359164|P4|NOT COMPLETED|Washout (8 Weeks)||0
8256384|NCT01824498|20359165|P3|NOT COMPLETED|Washout (8 Weeks)||0
8256385|NCT01824498|20359166|P2|NOT COMPLETED|Washout (8 Weeks)||0
8256386|NCT01824498|20359167|P1|NOT COMPLETED|Washout (8 Weeks)||0
8256387|NCT01824498|20359162|P6|COMPLETED|Washout (8 Weeks)||4
8256388|NCT01824498|20359163|P5|COMPLETED|Washout (8 Weeks)||3
8256389|NCT01824498|20359164|P4|COMPLETED|Washout (8 Weeks)||2
8256390|NCT01824498|20359165|P3|COMPLETED|Washout (8 Weeks)||4
8256391|NCT01824498|20359166|P2|COMPLETED|Washout (8 Weeks)||2
8256392|NCT01824498|20359167|P1|COMPLETED|Washout (8 Weeks)||3
8256393|NCT01824498|20359162|P6|STARTED|Washout (8 Weeks)||4
8256394|NCT01824498|20359163|P5|STARTED|Washout (8 Weeks)||3
8256395|NCT01824498|20359164|P4|STARTED|Washout (8 Weeks)||2
8256396|NCT01824498|20359165|P3|STARTED|Washout (8 Weeks)||4
8256397|NCT01824498|20359166|P2|STARTED|Washout (8 Weeks)||2
8256398|NCT01824498|20359167|P1|STARTED|Washout (8 Weeks)||3
8256399|NCT01824498|20359162|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256400|NCT01824498|20359163|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256401|NCT01824498|20359164|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256402|NCT01824498|20359165|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256403|NCT01824498|20359166|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256404|NCT01824498|20359167|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256405|NCT01824498|20359162|P6|COMPLETED|2nd Intervention (8 Weeks)||4
8256406|NCT01824498|20359163|P5|COMPLETED|2nd Intervention (8 Weeks)||3
8256407|NCT01824498|20359164|P4|COMPLETED|2nd Intervention (8 Weeks)||2
8256408|NCT01824498|20359165|P3|COMPLETED|2nd Intervention (8 Weeks)||4
8256409|NCT01824498|20359166|P2|COMPLETED|2nd Intervention (8 Weeks)||2
8256410|NCT01824498|20359167|P1|COMPLETED|2nd Intervention (8 Weeks)||3
8256411|NCT01824498|20359162|P6|STARTED|2nd Intervention (8 Weeks)||4
8256412|NCT01824498|20359163|P5|STARTED|2nd Intervention (8 Weeks)||3
8256413|NCT01824498|20359164|P4|STARTED|2nd Intervention (8 Weeks)||2
8256414|NCT01824498|20359165|P3|STARTED|2nd Intervention (8 Weeks)||4
8256415|NCT01824498|20359166|P2|STARTED|2nd Intervention (8 Weeks)||2
8256416|NCT01824498|20359167|P1|STARTED|2nd Intervention (8 Weeks)||3
8256417|NCT01824498|20359162|P6|NOT COMPLETED|Washout (8 Weeks)||0
8256418|NCT01824498|20359163|P5|NOT COMPLETED|Washout (8 Weeks)||1
8256419|NCT01824498|20359164|P4|NOT COMPLETED|Washout (8 Weeks)||1
8256420|NCT01824498|20359165|P3|NOT COMPLETED|Washout (8 Weeks)||2
8256421|NCT01824498|20359166|P2|NOT COMPLETED|Washout (8 Weeks)||0
8256422|NCT01824498|20359167|P1|NOT COMPLETED|Washout (8 Weeks)||2
8256423|NCT01824498|20359162|P6|COMPLETED|Washout (8 Weeks)||4
8256424|NCT01824498|20359163|P5|COMPLETED|Washout (8 Weeks)||3
8256425|NCT01824498|20359164|P4|COMPLETED|Washout (8 Weeks)||2
8256426|NCT01824498|20359165|P3|COMPLETED|Washout (8 Weeks)||4
8256427|NCT01824498|20359166|P2|COMPLETED|Washout (8 Weeks)||2
8256428|NCT01824498|20359167|P1|COMPLETED|Washout (8 Weeks)||3
8256429|NCT01824498|20359162|P6|STARTED|Washout (8 Weeks)||4
8256430|NCT01824498|20359163|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
8256431|NCT01824498|20359164|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
8256432|NCT01824498|20359165|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
8256433|NCT01824498|20359166|P2|STARTED|Washout (8 Weeks)||2
8256434|NCT01824498|20359167|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
8256435|NCT01824498|20359162|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256436|NCT01824498|20359163|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256437|NCT01824498|20359164|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256438|NCT01824498|20359165|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256439|NCT01824498|20359166|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256440|NCT01824498|20359167|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256441|NCT01824498|20359162|P6|COMPLETED|1st Intervention (8 Weeks)||4
8256442|NCT01824498|20359163|P5|COMPLETED|1st Intervention (8 Weeks)||4
8256443|NCT01824498|20359164|P4|COMPLETED|1st Intervention (8 Weeks)||3
8256444|NCT01824498|20359165|P3|COMPLETED|1st Intervention (8 Weeks)||6
8256445|NCT01824498|20359166|P2|COMPLETED|1st Intervention (8 Weeks)||2
8256446|NCT01824498|20359167|P1|COMPLETED|1st Intervention (8 Weeks)||5
8256447|NCT01824498|20359162|P6|STARTED|1st Intervention (8 Weeks)||4
8256448|NCT01824498|20359163|P5|STARTED|1st Intervention (8 Weeks)||4
8256449|NCT01824498|20359164|P4|STARTED|1st Intervention (8 Weeks)||3
8256450|NCT01824498|20359165|P3|STARTED|1st Intervention (8 Weeks)||6
8256451|NCT01824498|20359166|P2|STARTED|1st Intervention (8 Weeks)||2
8256452|NCT01824498|20359167|P1|STARTED|1st Intervention (8 Weeks)||5
8256453|NCT01824472|20359178|P3|NOT COMPLETED|Overall Study||4
8256454|NCT01824472|20359179|P2|NOT COMPLETED|Overall Study||7
8256455|NCT01824472|20359180|P1|NOT COMPLETED|Overall Study||1
8256456|NCT01824472|20359178|P3|COMPLETED|Overall Study||11
8256457|NCT01824472|20359179|P2|COMPLETED|Overall Study||6
8256458|NCT01824472|20359180|P1|COMPLETED|Overall Study||16
8256459|NCT01824472|20359178|P3|STARTED|Overall Study||15
8256460|NCT01824472|20359179|P2|STARTED|Overall Study||13
8256461|NCT01824472|20359180|P1|STARTED|Overall Study||17
8256462|NCT01824446|20359188|P1|NOT COMPLETED|Overall Study||0
8256463|NCT01824446|20359188|P1|COMPLETED|Overall Study||6
8256464|NCT01824446|20359188|P1|STARTED|Overall Study||6
8256465|NCT01824394|20359214|P3|NOT COMPLETED|Overall Study||74
8256466|NCT01824394|20359215|P2|NOT COMPLETED|Overall Study||116
8256467|NCT01824394|20359216|P1|NOT COMPLETED|Overall Study||119
8256468|NCT01824394|20359214|P3|COMPLETED|Overall Study||51
8256469|NCT01824394|20359215|P2|COMPLETED|Overall Study||53
8256470|NCT01824394|20359216|P1|COMPLETED|Overall Study||55
8256471|NCT01824394|20359214|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
8256472|NCT01824394|20359215|P2|Per-Protocol Population|Overall Study||148
8256473|NCT01824394|20359216|P1|Per-Protocol Population|Overall Study||150
8256474|NCT01824394|20359214|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
8256475|NCT01824394|20359215|P2|Safety Population|Overall Study||149
8256476|NCT01824394|20359216|P1|Safety Population|Overall Study||151
8256477|NCT01824394|20359214|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
8256478|NCT01824394|20359215|P2|Intent to Treat Population|Overall Study||149
8256479|NCT01824394|20359216|P1|Intent to Treat Population|Overall Study||151
8256480|NCT01824394|20359214|P3|STARTED|Overall Study||125
8256481|NCT01824394|20359215|P2|STARTED|Overall Study||169
8256482|NCT01824394|20359216|P1|STARTED|Overall Study||174
8256483|NCT01824355|20359226|P1|NOT COMPLETED|Overall Study||3
8256484|NCT01824355|20359226|P1|COMPLETED|Overall Study||110
8256485|NCT01824355|20359226|P1|STARTED|Overall Study||113
8256486|NCT01824342|20359237|P2|NOT COMPLETED|Overall Study||5
8256487|NCT01824342|20359238|P1|NOT COMPLETED|Overall Study||9
8256488|NCT01824342|20359237|P2|COMPLETED|Overall Study||2
8256489|NCT01824342|20359238|P1|COMPLETED|Overall Study||2
8256490|NCT01824342|20359237|P2|STARTED|Overall Study||7
8256491|NCT01824342|20359238|P1|STARTED|Overall Study||11
8256492|NCT01824303|20359252|P2|NOT COMPLETED|Open Label Extension||0
8256493|NCT01824303|20359253|P1|NOT COMPLETED|Open Label Extension||0
8256494|NCT01824303|20359252|P2|COMPLETED|Open Label Extension||11
8256495|NCT01824303|20359253|P1|COMPLETED|Open Label Extension||12
8256496|NCT01824303|20359252|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
8256497|NCT01824303|20359253|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
8256498|NCT01824303|20359252|P2|NOT COMPLETED|Randomized Study||1
8256499|NCT01824303|20359253|P1|NOT COMPLETED|Randomized Study||2
8256500|NCT01824303|20359252|P2|COMPLETED|Randomized Study||13
8256501|NCT01824303|20359253|P1|COMPLETED|Randomized Study||14
8256502|NCT01824303|20359252|P2|STARTED|Randomized Study||14
8256503|NCT01824303|20359253|P1|STARTED|Randomized Study||16
8256504|NCT01824290|20359279|P2|NOT COMPLETED|Overall Study||2
8256505|NCT01824290|20359280|P1|NOT COMPLETED|Overall Study||3
8256506|NCT01824290|20359279|P2|COMPLETED|Overall Study||15
8256507|NCT01824290|20359280|P1|COMPLETED|Overall Study||15
8256508|NCT01824290|20359279|P2|Received 40 mg|Overall Study||13
8256509|NCT01824290|20359280|P1|Received 40 mg|Overall Study||0
8256510|NCT01824290|20359279|P2|Received 20 mg|Overall Study||4
8256511|NCT01824290|20359280|P1|Received 20 mg|Overall Study||0
8256512|NCT01824290|20359279|P2|Received at Least One Dose of Study Drug|Overall Study||17
8256513|NCT01824290|20359280|P1|Received at Least One Dose of Study Drug|Overall Study||18
8256514|NCT01824290|20359279|P2|STARTED|Overall Study||17
8256515|NCT01824290|20359280|P1|STARTED|Overall Study||18
8256516|NCT01824160|20359292|P1|NOT COMPLETED|Overall Study||0
8256517|NCT01824160|20359292|P1|COMPLETED|Overall Study||50
8256518|NCT01824160|20359292|P1|STARTED|Overall Study||50
8256519|NCT01823991|20359298|P2|NOT COMPLETED|Overall Study||5
8256520|NCT01823991|20359299|P1|NOT COMPLETED|Overall Study||8
8256521|NCT01823991|20359298|P2|COMPLETED|Overall Study||13
8256522|NCT01823991|20359299|P1|COMPLETED|Overall Study||10
8256523|NCT01823991|20359298|P2|STARTED|Overall Study||18
8256524|NCT01823991|20359299|P1|STARTED|Overall Study||18
8256525|NCT01823861|20359333|P2|NOT COMPLETED|12 Month Follow up||61
8256526|NCT01823861|20359334|P1|NOT COMPLETED|12 Month Follow up||42
8256527|NCT01823861|20359333|P2|COMPLETED|12 Month Follow up||159
8256528|NCT01823861|20359334|P1|COMPLETED|12 Month Follow up||169
8256529|NCT01823861|20359333|P2|STARTED|12 Month Follow up||220
8256530|NCT01823861|20359334|P1|STARTED|12 Month Follow up||211
8256531|NCT01823861|20359333|P2|NOT COMPLETED|4 Month Follow up||31
8256532|NCT01823861|20359334|P1|NOT COMPLETED|4 Month Follow up||38
8256533|NCT01823861|20359333|P2|COMPLETED|4 Month Follow up||220
8256534|NCT01823861|20359334|P1|COMPLETED|4 Month Follow up||211
8256535|NCT01823861|20359333|P2|STARTED|4 Month Follow up||251
8256536|NCT01823861|20359334|P1|STARTED|4 Month Follow up||249
8256537|NCT01823679|20359340|P1|NOT COMPLETED|Overall Study||1
8256538|NCT01823679|20359340|P1|COMPLETED|Overall Study||1
8256539|NCT01823679|20359340|P1|STARTED|Overall Study||2
8256540|NCT01823653|20359348|P1|NOT COMPLETED|Overall Study||0
8256541|NCT01823653|20359348|P1|COMPLETED|Overall Study||60
8256542|NCT01823653|20359348|P1|STARTED|Overall Study||60
8256543|NCT01823614|20359362|P6|NOT COMPLETED|Overall Study||0
8256544|NCT01823614|20359363|P5|NOT COMPLETED|Overall Study||0
8256545|NCT01823614|20359364|P4|NOT COMPLETED|Overall Study||0
8256546|NCT01823614|20359365|P3|NOT COMPLETED|Overall Study||0
8256547|NCT01823614|20359366|P2|NOT COMPLETED|Overall Study||0
8256548|NCT01823614|20359367|P1|NOT COMPLETED|Overall Study||0
8256549|NCT01823614|20359362|P6|COMPLETED|Overall Study||154
8256550|NCT01823614|20359363|P5|COMPLETED|Overall Study||172
8256551|NCT01823614|20359364|P4|COMPLETED|Overall Study||122
8256552|NCT01823614|20359365|P3|COMPLETED|Overall Study||176
8256553|NCT01823614|20359366|P2|COMPLETED|Overall Study||140
8256554|NCT01823614|20359367|P1|COMPLETED|Overall Study||179
8256555|NCT01823614|20359362|P6|STARTED|Overall Study||154
8256556|NCT01823614|20359363|P5|STARTED|Overall Study||172
8256557|NCT01823614|20359364|P4|STARTED|Overall Study||122
8256558|NCT01823614|20359365|P3|STARTED|Overall Study||176
8256559|NCT01823614|20359366|P2|STARTED|Overall Study||140
8256560|NCT01823614|20359367|P1|STARTED|Overall Study||179
8256561|NCT01823536|20359393|P6|NOT COMPLETED|Overall Study||0
8256562|NCT01823536|20359394|P5|NOT COMPLETED|Overall Study||2
8256563|NCT01823536|20359395|P4|NOT COMPLETED|Overall Study||2
8256564|NCT01823536|20359396|P3|NOT COMPLETED|Overall Study||1
8256565|NCT01823536|20359397|P2|NOT COMPLETED|Overall Study||2
8256566|NCT01823536|20359398|P1|NOT COMPLETED|Overall Study||2
8256567|NCT01823536|20359393|P6|COMPLETED|Overall Study||2
8256568|NCT01823536|20359394|P5|COMPLETED|Overall Study||99
8256569|NCT01823536|20359395|P4|COMPLETED|Overall Study||64
8256570|NCT01823536|20359396|P3|COMPLETED|Overall Study||119
8256571|NCT01823536|20359397|P2|COMPLETED|Overall Study||101
8256572|NCT01823536|20359398|P1|COMPLETED|Overall Study||71
8256573|NCT01823536|20359393|P6|STARTED|Overall Study||2
8256574|NCT01823536|20359394|P5|STARTED|Overall Study||101
8256575|NCT01823536|20359395|P4|STARTED|Overall Study||66
8256576|NCT01823536|20359396|P3|STARTED|Overall Study||120
8256577|NCT01823536|20359397|P2|STARTED|Overall Study||103
8256578|NCT01823536|20359398|P1|STARTED|Overall Study||73
8256579|NCT01823510|20359436|P2|NOT COMPLETED|Days 22-28||0
8256580|NCT01823510|20359437|P1|NOT COMPLETED|Days 22-28||0
8256581|NCT01823510|20359436|P2|COMPLETED|Days 22-28||10
8256582|NCT01823510|20359437|P1|COMPLETED|Days 22-28||10
8256583|NCT01823510|20359436|P2|STARTED|Days 22-28||10
8256584|NCT01823510|20359437|P1|STARTED|Days 22-28||10
8256585|NCT01823510|20359436|P2|NOT COMPLETED|Days 8-21||0
8256586|NCT01823510|20359437|P1|NOT COMPLETED|Days 8-21||0
8256587|NCT01823510|20359436|P2|COMPLETED|Days 8-21||10
8256588|NCT01823510|20359437|P1|COMPLETED|Days 8-21||10
8256589|NCT01823510|20359436|P2|STARTED|Days 8-21||10
8256590|NCT01823510|20359437|P1|STARTED|Days 8-21||10
8256591|NCT01823510|20359436|P2|NOT COMPLETED|Days 1-7||0
8256592|NCT01823510|20359437|P1|NOT COMPLETED|Days 1-7||0
8256593|NCT01823510|20359436|P2|COMPLETED|Days 1-7||10
8256594|NCT01823510|20359437|P1|COMPLETED|Days 1-7||10
8256595|NCT01823510|20359436|P2|STARTED|Days 1-7||10
8256596|NCT01823510|20359437|P1|STARTED|Days 1-7||10
8256597|NCT01823497|20359451|P2|NOT COMPLETED|Overall Study||8
8256598|NCT01823497|20359452|P1|NOT COMPLETED|Overall Study||3
8256599|NCT01823497|20359451|P2|COMPLETED|Overall Study||9
8256600|NCT01823497|20359452|P1|COMPLETED|Overall Study||16
8256601|NCT01823497|20359451|P2|STARTED|Overall Study||17
8256602|NCT01823497|20359452|P1|STARTED|Overall Study||19
8256603|NCT01823341|20359460|P1|NOT COMPLETED|Overall Study||15
8256604|NCT01823341|20359460|P1|COMPLETED|Overall Study||82
8256605|NCT01823341|20359460|P1|STARTED|Overall Study||97
8256606|NCT01823328|20359505|P2|NOT COMPLETED|Overall Study||6
8256607|NCT01823328|20359506|P1|NOT COMPLETED|Overall Study||8
8256608|NCT01823328|20359505|P2|COMPLETED|Overall Study||67
8256609|NCT01823328|20359506|P1|COMPLETED|Overall Study||62
8256610|NCT01823328|20359505|P2|STARTED|Overall Study||73
8256611|NCT01823328|20359506|P1|STARTED|Overall Study||70
8256612|NCT01823289|20359526|P1|NOT COMPLETED|Overall Study||24
8256613|NCT01823289|20359526|P1|COMPLETED|Overall Study||47
8256614|NCT01823289|20359526|P1|STARTED|Overall Study||71
8256615|NCT01823224|20359534|P2|NOT COMPLETED|Overall Study||11
8256616|NCT01823224|20359535|P1|NOT COMPLETED|Overall Study||6
8256617|NCT01823224|20359534|P2|COMPLETED|Overall Study||22
8256618|NCT01823224|20359535|P1|COMPLETED|Overall Study||28
8256619|NCT01823224|20359534|P2|STARTED|Overall Study||33
8256620|NCT01823224|20359535|P1|STARTED|Overall Study||34
8256621|NCT01823146|20359545|P2|NOT COMPLETED|Overall Study||2
8256622|NCT01823146|20359546|P1|NOT COMPLETED|Overall Study||2
8256623|NCT01823146|20359545|P2|COMPLETED|Overall Study||49
8256624|NCT01823146|20359546|P1|COMPLETED|Overall Study||53
8256625|NCT01823146|20359545|P2|STARTED|Overall Study||51
8256626|NCT01823146|20359546|P1|STARTED|Overall Study||55
8256627|NCT01823107|20359556|P1|NOT COMPLETED|Overall Study||1
8256628|NCT01823107|20359556|P1|COMPLETED|Overall Study||24
8256629|NCT01823107|20359556|P1|STARTED|Overall Study||25
8256630|NCT01822925|20359566|P4|NOT COMPLETED|Overall Study||5
8256631|NCT01822925|20359567|P3|NOT COMPLETED|Overall Study||3
8256632|NCT01822925|20359568|P2|NOT COMPLETED|Overall Study||2
8256633|NCT01822925|20359569|P1|NOT COMPLETED|Overall Study||6
8256634|NCT01822925|20359566|P4|COMPLETED|Overall Study||27
8256635|NCT01822925|20359567|P3|COMPLETED|Overall Study||29
8256636|NCT01822925|20359568|P2|COMPLETED|Overall Study||30
8256637|NCT01822925|20359569|P1|COMPLETED|Overall Study||26
8256638|NCT01822925|20359566|P4|STARTED|Overall Study||32
8256639|NCT01822925|20359567|P3|STARTED|Overall Study||32
8256640|NCT01822925|20359568|P2|STARTED|Overall Study||32
8256641|NCT01822925|20359569|P1|STARTED|Overall Study||32
8256642|NCT01822899|20359621|P2|NOT COMPLETED|Overall Study||18
8256643|NCT01822899|20359622|P1|NOT COMPLETED|Overall Study||24
8256644|NCT01822899|20359621|P2|COMPLETED|Overall Study||340
8256645|NCT01822899|20359622|P1|COMPLETED|Overall Study||334
8256646|NCT01822899|20359621|P2|STARTED|Overall Study||358
8256647|NCT01822899|20359622|P1|STARTED|Overall Study||358
8256648|NCT01822886|20359630|P1|NOT COMPLETED|Overall Study||15
8256649|NCT01822886|20359630|P1|COMPLETED|Overall Study||5
8256650|NCT01822886|20359630|P1|STARTED|Overall Study||20
8256651|NCT01822821|20359640|P2|NOT COMPLETED|Overall Study||1
8256652|NCT01822821|20359641|P1|NOT COMPLETED|Overall Study||2
8256653|NCT01822821|20359640|P2|COMPLETED|Overall Study||74
8256654|NCT01822821|20359641|P1|COMPLETED|Overall Study||73
8256655|NCT01822821|20359640|P2|STARTED|Overall Study||75
8256656|NCT01822821|20359641|P1|STARTED|Overall Study||75
8256657|NCT01822756|20359670|P5|NOT COMPLETED|Overall Study||7
8256658|NCT01822756|20359671|P4|NOT COMPLETED|Overall Study||4
8256659|NCT01822756|20359672|P3|NOT COMPLETED|Overall Study||10
8256660|NCT01822756|20359673|P2|NOT COMPLETED|Overall Study||4
8256661|NCT01822756|20359674|P1|NOT COMPLETED|Overall Study||16
8256662|NCT01822756|20359670|P5|COMPLETED|Overall Study||1
8256663|NCT01822756|20359671|P4|COMPLETED|Overall Study||0
8256664|NCT01822756|20359672|P3|COMPLETED|Overall Study||0
8256665|NCT01822756|20359673|P2|COMPLETED|Overall Study||0
8256666|NCT01822756|20359674|P1|COMPLETED|Overall Study||0
8256667|NCT01822756|20359670|P5|Discontinued From the Study|Overall Study||7
8256668|NCT01822756|20359671|P4|Discontinued From the Study|Overall Study||4
8256669|NCT01822756|20359672|P3|Discontinued From the Study|Overall Study||10
8256670|NCT01822756|20359673|P2|Discontinued From the Study|Overall Study||4
8256671|NCT01822756|20359674|P1|Discontinued From the Study|Overall Study||16
8256672|NCT01822756|20359670|P5|STARTED|Overall Study||8
8256673|NCT01822756|20359671|P4|STARTED|Overall Study||4
8256674|NCT01822756|20359672|P3|STARTED|Overall Study||10
8256675|NCT01822756|20359673|P2|STARTED|Overall Study||4
8256676|NCT01822756|20359674|P1|STARTED|Overall Study||16
8256677|NCT01822691|20359716|P1|NOT COMPLETED|Overall Study||2
8256678|NCT01822691|20359716|P1|COMPLETED|Overall Study||13
8256679|NCT01822691|20359716|P1|STARTED|Overall Study||15
8256680|NCT01822678|20359727|P3|NOT COMPLETED|Overall Study||11
8256681|NCT01822678|20359728|P2|NOT COMPLETED|Overall Study||15
8256682|NCT01822678|20359729|P1|NOT COMPLETED|Overall Study||12
8256683|NCT01822678|20359727|P3|COMPLETED|Overall Study||29
8256684|NCT01822678|20359728|P2|COMPLETED|Overall Study||49
8256685|NCT01822678|20359729|P1|COMPLETED|Overall Study||45
8256686|NCT01822678|20359727|P3|Per Protocol Population|Overall Study||34
8256687|NCT01822678|20359728|P2|Per Protocol Population|Overall Study||52
8256688|NCT01822678|20359729|P1|Per Protocol Population|Overall Study||45
8256689|NCT01822678|20359727|P3|Intention-to-Treat Population (ITT)|Overall Study||40
8256690|NCT01822678|20359728|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
8256691|NCT01822678|20359729|P1|Intention-to-Treat Population (ITT)|Overall Study||57
8256692|NCT01822678|20359727|P3|Safety Population|Overall Study||40
8256693|NCT01822678|20359728|P2|Safety Population|Overall Study||64
8256694|NCT01822678|20359729|P1|Safety Population|Overall Study||57
8256695|NCT01822678|20359727|P3|Treated|Overall Study||40
8256696|NCT01822678|20359728|P2|Treated|Overall Study||64
8256697|NCT01822678|20359729|P1|Treated|Overall Study||57
8256698|NCT01822678|20359727|P3|STARTED|Overall Study||40
8256699|NCT01822678|20359728|P2|STARTED|Overall Study||64
8256700|NCT01822678|20359729|P1|STARTED|Overall Study||57
8256701|NCT01822665|20359737|P1|NOT COMPLETED|Overall Study||8
8256702|NCT01822665|20359737|P1|COMPLETED|Overall Study||20
8256703|NCT01822665|20359737|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
8256704|NCT01822665|20359737|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
8256705|NCT01822665|20359737|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
8256706|NCT01822665|20359737|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
8256707|NCT01822665|20359737|P1|STARTED|Overall Study||28
8256708|NCT01822587|20359764|P3|NOT COMPLETED|Overall Study||18
8256709|NCT01822587|20359765|P2|NOT COMPLETED|Overall Study||15
8256710|NCT01822587|20359766|P1|NOT COMPLETED|Overall Study||16
8256711|NCT01822587|20359764|P3|COMPLETED|Overall Study||44
8256712|NCT01822587|20359765|P2|COMPLETED|Overall Study||45
8256713|NCT01822587|20359766|P1|COMPLETED|Overall Study||43
8256714|NCT01822587|20359764|P3|STARTED|Overall Study||62
8256715|NCT01822587|20359765|P2|STARTED|Overall Study||60
8256716|NCT01822587|20359766|P1|STARTED|Overall Study||59
8256717|NCT01822574|20359789|P3|NOT COMPLETED|Overall Study||0
8256718|NCT01822574|20359790|P2|NOT COMPLETED|Overall Study||0
8256719|NCT01822574|20359791|P1|NOT COMPLETED|Overall Study||0
8256720|NCT01822574|20359789|P3|COMPLETED|Overall Study||30
8256721|NCT01822574|20359790|P2|COMPLETED|Overall Study||30
8256722|NCT01822574|20359791|P1|COMPLETED|Overall Study||30
8256723|NCT01822574|20359789|P3|STARTED|Overall Study||30
8256724|NCT01822574|20359790|P2|STARTED|Overall Study||30
8256725|NCT01822574|20359791|P1|STARTED|Overall Study||30
8256726|NCT01822561|20359805|P1|NOT COMPLETED|Overall Study||2
8256727|NCT01822561|20359805|P1|COMPLETED|Overall Study||13
8256728|NCT01822561|20359805|P1|STARTED|Overall Study||15
8256729|NCT01822548|20359815|P2|NOT COMPLETED|Overall Study||0
8256730|NCT01822548|20359816|P1|NOT COMPLETED|Overall Study||0
8256731|NCT01822548|20359815|P2|COMPLETED|Overall Study||24
8256732|NCT01822548|20359816|P1|COMPLETED|Overall Study||40
8256733|NCT01822548|20359815|P2|Discontinued Intervention|Overall Study||5
8256734|NCT01822548|20359816|P1|Discontinued Intervention|Overall Study||0
8256735|NCT01822548|20359815|P2|STARTED|Overall Study||24
8256736|NCT01822548|20359816|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
8256737|NCT01822535|20359826|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
8256738|NCT01822535|20359827|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
8256739|NCT01822535|20359826|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
8256740|NCT01822535|20359827|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
8256741|NCT01822535|20359826|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
8256742|NCT01822535|20359827|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
8256743|NCT01822535|20359826|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
8256744|NCT01822535|20359827|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
8256745|NCT01822535|20359826|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
8256746|NCT01822535|20359827|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
8256747|NCT01822535|20359826|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
8256748|NCT01822535|20359827|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
8256749|NCT01822496|20359843|P4|NOT COMPLETED|Overall Study||4
8256750|NCT01822496|20359844|P3|NOT COMPLETED|Overall Study||0
8256751|NCT01822496|20359845|P2|NOT COMPLETED|Overall Study||2
8256752|NCT01822496|20359846|P1|NOT COMPLETED|Overall Study||2
8256753|NCT01822496|20359843|P4|COMPLETED|Overall Study||7
8256754|NCT01822496|20359844|P3|COMPLETED|Overall Study||9
8256755|NCT01822496|20359845|P2|COMPLETED|Overall Study||21
8256756|NCT01822496|20359846|P1|COMPLETED|Overall Study||14
8256757|NCT01822496|20359843|P4|Eligible and Started Study Treatment|Overall Study||7
8256758|NCT01822496|20359844|P3|Eligible and Started Study Treatment|Overall Study||9
8256759|NCT01822496|20359845|P2|Eligible and Started Study Treatment|Overall Study||20
8256760|NCT01822496|20359846|P1|Eligible and Started Study Treatment|Overall Study||14
8256761|NCT01822496|20359843|P4|Eligible With Disease Assessment|Overall Study||4
8256762|NCT01822496|20359844|P3|Eligible With Disease Assessment|Overall Study||6
8256763|NCT01822496|20359845|P2|Eligible With Disease Assessment|Overall Study||15
8256764|NCT01822496|20359846|P1|Eligible With Disease Assessment|Overall Study||10
8256765|NCT01822496|20359843|P4|Eligible|Overall Study||7
8256766|NCT01822496|20359844|P3|Eligible|Overall Study||9
8256767|NCT01822496|20359845|P2|Eligible|Overall Study||21
8256768|NCT01822496|20359846|P1|Eligible|Overall Study||14
8256769|NCT01822496|20359843|P4|STARTED|Overall Study||11
8256770|NCT01822496|20359844|P3|STARTED|Overall Study||9
8256771|NCT01822496|20359845|P2|STARTED|Overall Study||23
8256772|NCT01822496|20359846|P1|STARTED|Overall Study||16
8256773|NCT01822457|20359882|P2|NOT COMPLETED|Overall Study||5
8256774|NCT01822457|20359883|P1|NOT COMPLETED|Overall Study||4
8256775|NCT01822457|20359882|P2|COMPLETED|Overall Study||12
8256776|NCT01822457|20359883|P1|COMPLETED|Overall Study||16
8256777|NCT01822457|20359882|P2|STARTED|Overall Study||17
8256778|NCT01822457|20359883|P1|STARTED|Overall Study||20
8256779|NCT01822366|20359899|P4|NOT COMPLETED|Overall Study||22
8256780|NCT01822366|20359900|P3|NOT COMPLETED|Overall Study||5
8256781|NCT01822366|20359901|P2|NOT COMPLETED|Overall Study||22
8256782|NCT01822366|20359902|P1|NOT COMPLETED|Overall Study||5
8256783|NCT01822366|20359899|P4|COMPLETED|Overall Study||298
8256784|NCT01822366|20359900|P3|COMPLETED|Overall Study||315
8256785|NCT01822366|20359901|P2|COMPLETED|Overall Study||298
8256786|NCT01822366|20359902|P1|COMPLETED|Overall Study||315
8256787|NCT01822366|20359899|P4|STARTED|Overall Study||320
8256788|NCT01822366|20359900|P3|STARTED|Overall Study||320
8256789|NCT01822366|20359901|P2|STARTED|Overall Study||320
8256790|NCT01822366|20359902|P1|STARTED|Overall Study||320
8256800|NCT01822301|20359943|P1|NOT COMPLETED|Overall Study||0
8256801|NCT01822301|20359943|P1|COMPLETED|Overall Study||5
8256802|NCT01822301|20359943|P1|STARTED|Overall Study||5
8256803|NCT01822223|20359955|P2|NOT COMPLETED|Overall Study||1
8256804|NCT01822223|20359956|P1|NOT COMPLETED|Overall Study||0
8256805|NCT01822223|20359955|P2|COMPLETED|Overall Study||9
8256806|NCT01822223|20359956|P1|COMPLETED|Overall Study||10
8256807|NCT01822223|20359955|P2|STARTED|Overall Study||10
8256808|NCT01822223|20359956|P1|STARTED|Overall Study||10
8256809|NCT01822197|20359972|P1|NOT COMPLETED|Overall Study||0
8256810|NCT01822197|20359972|P1|COMPLETED|Overall Study||30
8256811|NCT01822197|20359972|P1|STARTED|Overall Study||30
8256812|NCT01822132|20359980|P2|NOT COMPLETED|Overall Study||2
8256813|NCT01822132|20359981|P1|NOT COMPLETED|Overall Study||4
8256814|NCT01822132|20359980|P2|COMPLETED|Overall Study||25
8256815|NCT01822132|20359981|P1|COMPLETED|Overall Study||21
8256816|NCT01822132|20359980|P2|STARTED|Overall Study||27
8256817|NCT01822132|20359981|P1|STARTED|Overall Study||25
8256818|NCT01822119|20359995|P1|NOT COMPLETED|Overall Study||0
8256819|NCT01822119|20359995|P1|COMPLETED|Overall Study||27
8256820|NCT01822119|20359995|P1|STARTED|Overall Study||27
8256821|NCT01821963|20360018|P1|NOT COMPLETED|Overall Study||1
8256822|NCT01821963|20360018|P1|COMPLETED|Overall Study||0
8256823|NCT01821963|20360018|P1|STARTED|Overall Study||1
8256824|NCT01821937|20360024|P2|NOT COMPLETED|Overall Study||3
8256825|NCT01821937|20360025|P1|NOT COMPLETED|Overall Study||0
8256826|NCT01821937|20360024|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
8256827|NCT01821937|20360025|P1|COMPLETED|Overall Study||10
8256828|NCT01821937|20360024|P2|STARTED|Overall Study||15
8256829|NCT01821937|20360025|P1|STARTED|Overall Study||10
8256830|NCT01821898|20360045|P2|NOT COMPLETED|Overall Study||1
8256831|NCT01821898|20360046|P1|NOT COMPLETED|Overall Study||2
8256832|NCT01821898|20360045|P2|COMPLETED|Overall Study||0
8256833|NCT01821898|20360046|P1|COMPLETED|Overall Study||0
8256834|NCT01821898|20360045|P2|STARTED|Overall Study||1
8256835|NCT01821898|20360046|P1|STARTED|Overall Study||2
8256836|NCT01821859|20360058|P1|NOT COMPLETED|Overall Study||5
8256837|NCT01821859|20360058|P1|COMPLETED|Overall Study||0
8256838|NCT01821859|20360058|P1|STARTED|Overall Study||5
8256839|NCT01821807|20360064|P2|NOT COMPLETED|Overall Study||1
8256840|NCT01821807|20360065|P1|NOT COMPLETED|Overall Study||3
8256841|NCT01821807|20360064|P2|COMPLETED|Overall Study||109
8256842|NCT01821807|20360065|P1|COMPLETED|Overall Study||147
8256843|NCT01821807|20360064|P2|STARTED|Overall Study||110
8256844|NCT01821807|20360065|P1|STARTED|Overall Study||150
8256845|NCT01821729|20360073|P1|NOT COMPLETED|Overall Study||1
8256846|NCT01821729|20360073|P1|COMPLETED|Overall Study||49
8256847|NCT01821729|20360073|P1|Underwent Attempted Surgery|Overall Study||42
8256848|NCT01821729|20360073|P1|Received Chemoradiotherapy|Overall Study||45
8256849|NCT01821729|20360073|P1|STARTED|Overall Study||50
8256850|NCT01821625|20360078|P1|NOT COMPLETED|Overall Study||6
8256851|NCT01821625|20360078|P1|COMPLETED|Overall Study||1
8256852|NCT01821625|20360078|P1|STARTED|Overall Study||7
8256853|NCT01821560|20360084|P2|NOT COMPLETED|Overall Study||7
8256854|NCT01821560|20360085|P1|NOT COMPLETED|Overall Study||6
8256855|NCT01821560|20360084|P2|COMPLETED|Overall Study||15
8256856|NCT01821560|20360085|P1|COMPLETED|Overall Study||16
8256857|NCT01821560|20360084|P2|STARTED|Overall Study||22
8256858|NCT01821560|20360085|P1|STARTED|Overall Study||22
8256859|NCT01821534|20360091|P1|NOT COMPLETED|Overall Study||0
8256860|NCT01821534|20360091|P1|COMPLETED|Overall Study||201
8256861|NCT01821534|20360091|P1|STARTED|Overall Study||201
8256862|NCT01821417|20360100|P2|NOT COMPLETED|Overall Study||0
8256863|NCT01821417|20360101|P1|NOT COMPLETED|Overall Study||0
8256864|NCT01821417|20360100|P2|COMPLETED|Overall Study||31
8256865|NCT01821417|20360101|P1|COMPLETED|Overall Study||37
8256866|NCT01821417|20360100|P2|STARTED|Overall Study||31
8256867|NCT01821417|20360101|P1|STARTED|Overall Study||37
8256874|NCT01821378|20360125|P3|NOT COMPLETED|Overall Study||42
8256875|NCT01821378|20360126|P2|NOT COMPLETED|Overall Study||54
8256876|NCT01821378|20360127|P1|NOT COMPLETED|Overall Study||27
8256877|NCT01821378|20360125|P3|COMPLETED|Overall Study||70
8256878|NCT01821378|20360126|P2|COMPLETED|Overall Study||145
8256879|NCT01821378|20360127|P1|COMPLETED|Overall Study||74
8256880|NCT01821378|20360125|P3|STARTED|Overall Study||112
8256881|NCT01821378|20360126|P2|STARTED|Overall Study||199
8256882|NCT01821378|20360127|P1|STARTED|Overall Study||101
8256883|NCT01821352|20360165|P2|NOT COMPLETED|Overall Study||0
8256884|NCT01821352|20360166|P1|NOT COMPLETED|Overall Study||0
8256885|NCT01821352|20360165|P2|COMPLETED|Overall Study||25
8256886|NCT01821352|20360166|P1|COMPLETED|Overall Study||28
8256887|NCT01821352|20360165|P2|STARTED|Overall Study||25
8256888|NCT01821352|20360166|P1|STARTED|Overall Study||28
8256889|NCT01821326|20360176|P1|NOT COMPLETED|Overall Study||0
8256890|NCT01821326|20360176|P1|COMPLETED|Overall Study||339
8256891|NCT01821326|20360176|P1|STARTED|Overall Study||339
8256892|NCT01821300|20360182|P2|NOT COMPLETED|Overall Study||0
8256893|NCT01821300|20360183|P1|NOT COMPLETED|Overall Study||0
8256894|NCT01821300|20360182|P2|COMPLETED|Overall Study||103
8256895|NCT01821300|20360183|P1|COMPLETED|Overall Study||154
8256896|NCT01821300|20360182|P2|STARTED|Overall Study||103
8256897|NCT01821300|20360183|P1|STARTED|Overall Study||154
8256898|NCT01821118|20360217|P2|NOT COMPLETED|Overall Study||1
8256899|NCT01821118|20360218|P1|NOT COMPLETED|Overall Study||0
8256900|NCT01821118|20360217|P2|COMPLETED|Overall Study||11
8256901|NCT01821118|20360218|P1|COMPLETED|Overall Study||24
8256902|NCT01821118|20360217|P2|STARTED|Overall Study||12
8256903|NCT01821118|20360218|P1|STARTED|Overall Study||24
8256904|NCT01821105|20360251|P1|NOT COMPLETED|Overall Study||0
8256905|NCT01821105|20360251|P1|COMPLETED|Overall Study||21
8256906|NCT01821105|20360251|P1|STARTED|Overall Study||21
8256910|NCT01820637|20360265|P1|NOT COMPLETED|Overall Study||3
8256911|NCT01820637|20360265|P1|COMPLETED|Overall Study||54
8256912|NCT01820637|20360265|P1|STARTED|Overall Study||57
8256913|NCT01820585|20360274|P4|NOT COMPLETED|Overall Study||49
8256914|NCT01820585|20360275|P3|NOT COMPLETED|Overall Study||34
8256915|NCT01820585|20360276|P2|NOT COMPLETED|Overall Study||32
8256916|NCT01820585|20360277|P1|NOT COMPLETED|Overall Study||27
8256917|NCT01820585|20360274|P4|COMPLETED|Overall Study||83
8256918|NCT01820585|20360275|P3|COMPLETED|Overall Study||101
8256919|NCT01820585|20360276|P2|COMPLETED|Overall Study||98
8256920|NCT01820585|20360277|P1|COMPLETED|Overall Study||104
8256921|NCT01820585|20360274|P4|Completed Maintenance Period|Overall Study||84
8256922|NCT01820585|20360275|P3|Completed Maintenance Period|Overall Study||101
8256923|NCT01820585|20360276|P2|Completed Maintenance Period|Overall Study||98
8256924|NCT01820585|20360277|P1|Completed Maintenance Period|Overall Study||105
8256925|NCT01820585|20360274|P4|Entered Maintenance Period|Overall Study||123
8256926|NCT01820585|20360275|P3|Entered Maintenance Period|Overall Study||131
8256927|NCT01820585|20360276|P2|Entered Maintenance Period|Overall Study||124
8256928|NCT01820585|20360277|P1|Entered Maintenance Period|Overall Study||128
8256929|NCT01820585|20360274|P4|Completed Titration Period|Overall Study||126
8256930|NCT01820585|20360275|P3|Completed Titration Period|Overall Study||131
8256931|NCT01820585|20360276|P2|Completed Titration Period|Overall Study||125
8256932|NCT01820585|20360277|P1|Completed Titration Period|Overall Study||128
8256933|NCT01820585|20360274|P4|Full Analysis Set|Overall Study||129
8256934|NCT01820585|20360275|P3|Full Analysis Set|Overall Study||135
8256935|NCT01820585|20360276|P2|Full Analysis Set|Overall Study||130
8256936|NCT01820585|20360277|P1|Full Analysis Set|Overall Study||131
8256937|NCT01820585|20360274|P4|Randomized and Treated|Overall Study||132
8256938|NCT01820585|20360275|P3|Randomized and Treated|Overall Study||135
8256939|NCT01820585|20360276|P2|Randomized and Treated|Overall Study||130
8256940|NCT01820585|20360277|P1|Randomized and Treated|Overall Study||131
8256941|NCT01820585|20360274|P4|STARTED|Overall Study||132
8256942|NCT01820585|20360275|P3|STARTED|Overall Study||135
8256943|NCT01820585|20360276|P2|STARTED|Overall Study||130
8256944|NCT01820585|20360277|P1|STARTED|Overall Study||131
8256945|NCT01820572|20360289|P2|NOT COMPLETED|Treatment Period||36
8256946|NCT01820572|20360290|P1|NOT COMPLETED|Treatment Period||26
8256947|NCT01820572|20360289|P2|COMPLETED|Treatment Period||186
8256948|NCT01820572|20360290|P1|COMPLETED|Treatment Period||195
8256949|NCT01820572|20360289|P2|STARTED|Treatment Period||222
8256950|NCT01820572|20360290|P1|STARTED|Treatment Period||221
8256951|NCT01820572|20360289|P2|NOT COMPLETED|Randomization||1
8256952|NCT01820572|20360290|P1|NOT COMPLETED|Randomization||2
8256953|NCT01820572|20360289|P2|COMPLETED|Randomization||222
8256954|NCT01820572|20360290|P1|COMPLETED|Randomization||221
8256955|NCT01820572|20360289|P2|STARTED|Randomization||223
8256956|NCT01820572|20360290|P1|STARTED|Randomization||223
8256957|NCT01820559|20360333|P3|NOT COMPLETED|Overall Study||29
8256958|NCT01820559|20360334|P2|NOT COMPLETED|Overall Study||13
8256959|NCT01820559|20360335|P1|NOT COMPLETED|Overall Study||14
8256960|NCT01820559|20360333|P3|COMPLETED|Overall Study||110
8256961|NCT01820559|20360334|P2|COMPLETED|Overall Study||122
8256962|NCT01820559|20360335|P1|COMPLETED|Overall Study||122
8256963|NCT01820559|20360333|P3|Completed Maintenance Period|Overall Study||110
8256964|NCT01820559|20360334|P2|Completed Maintenance Period|Overall Study||123
8256965|NCT01820559|20360335|P1|Completed Maintenance Period|Overall Study||122
8256966|NCT01820559|20360333|P3|Entered Maintenance Period|Overall Study||129
8256967|NCT01820559|20360334|P2|Entered Maintenance Period|Overall Study||133
8256968|NCT01820559|20360335|P1|Entered Maintenance Period|Overall Study||129
8256969|NCT01820559|20360333|P3|Completed Tutration Period|Overall Study||131
8256970|NCT01820559|20360334|P2|Completed Tutration Period|Overall Study||134
8256971|NCT01820559|20360335|P1|Completed Tutration Period|Overall Study||130
8256972|NCT01820559|20360333|P3|Randomized and Treated|Overall Study||139
8256973|NCT01820559|20360334|P2|Randomized and Treated|Overall Study||135
8256974|NCT01820559|20360335|P1|Randomized and Treated|Overall Study||136
8256975|NCT01820559|20360333|P3|STARTED|Overall Study||139
8256976|NCT01820559|20360334|P2|STARTED|Overall Study||135
8256977|NCT01820559|20360335|P1|STARTED|Overall Study||136
8256978|NCT01820416|20360346|P3|NOT COMPLETED|Overall Study||0
8256979|NCT01820416|20360347|P2|NOT COMPLETED|Overall Study||2
8256980|NCT01820416|20360348|P1|NOT COMPLETED|Overall Study||3
8256981|NCT01820416|20360346|P3|COMPLETED|Overall Study||11
8256982|NCT01820416|20360347|P2|COMPLETED|Overall Study||10
8256983|NCT01820416|20360348|P1|COMPLETED|Overall Study||9
8256984|NCT01820416|20360346|P3|STARTED|Overall Study||11
8256985|NCT01820416|20360347|P2|STARTED|Overall Study||12
8256986|NCT01820416|20360348|P1|STARTED|Overall Study||12
8256987|NCT01820364|20360356|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
8256988|NCT01820364|20360357|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
8256989|NCT01820364|20360356|P2|COMPLETED|Part II: LGX818 + MEK162||0
8256990|NCT01820364|20360357|P1|COMPLETED|Part II: LGX818 + MEK162||0
8256991|NCT01820364|20360356|P2|STARTED|Part II: LGX818 + MEK162||1
8256992|NCT01820364|20360357|P1|STARTED|Part II: LGX818 + MEK162||0
8256993|NCT01820364|20360356|P2|NOT COMPLETED|Part I: LGX818||0
8256994|NCT01820364|20360357|P1|NOT COMPLETED|Part I: LGX818||14
8256995|NCT01820364|20360356|P2|COMPLETED|Part I: LGX818||0
8256996|NCT01820364|20360357|P1|COMPLETED|Part I: LGX818||1
8256997|NCT01820364|20360356|P2|STARTED|Part I: LGX818||0
8256998|NCT01820364|20360357|P1|STARTED|Part I: LGX818||15
8256999|NCT01819935|20360371|P2|NOT COMPLETED|Overall Study||0
8257000|NCT01819935|20360372|P1|NOT COMPLETED|Overall Study||0
8257001|NCT01819935|20360371|P2|COMPLETED|Overall Study||4943
8257002|NCT01819935|20360372|P1|COMPLETED|Overall Study||328
8257003|NCT01819935|20360371|P2|STARTED|Overall Study||4943
8257004|NCT01819935|20360372|P1|STARTED|Overall Study||328
8257005|NCT01819922|20360392|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
8257006|NCT01819922|20360393|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
8257007|NCT01819922|20360392|P2|COMPLETED|Second Intervention Period (1 Day)||6
8257008|NCT01819922|20360393|P1|COMPLETED|Second Intervention Period (1 Day)||6
8257009|NCT01819922|20360392|P2|STARTED|Second Intervention Period (1 Day)||6
8257010|NCT01819922|20360393|P1|STARTED|Second Intervention Period (1 Day)||6
8257011|NCT01819922|20360392|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
8257012|NCT01819922|20360393|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
8257013|NCT01819922|20360392|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
8257014|NCT01819922|20360393|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
8257015|NCT01819922|20360392|P2|STARTED|Washout Period (at Least 7-10 Days)||6
8257016|NCT01819922|20360393|P1|STARTED|Washout Period (at Least 7-10 Days)||6
8257017|NCT01819922|20360392|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
8257018|NCT01819922|20360393|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
8257019|NCT01819922|20360392|P2|COMPLETED|First Intervention Period (1 Day)||6
8257020|NCT01819922|20360393|P1|COMPLETED|First Intervention Period (1 Day)||6
8257021|NCT01819922|20360392|P2|STARTED|First Intervention Period (1 Day)||6
8257022|NCT01819922|20360393|P1|STARTED|First Intervention Period (1 Day)||6
8257023|NCT01819883|20360479|P2|NOT COMPLETED|Overall Study||0
8257024|NCT01819883|20360480|P1|NOT COMPLETED|Overall Study||4
8257025|NCT01819883|20360479|P2|COMPLETED|Overall Study||20
8257026|NCT01819883|20360480|P1|COMPLETED|Overall Study||16
8257027|NCT01819883|20360479|P2|STARTED|Overall Study||20
8257028|NCT01819883|20360480|P1|STARTED|Overall Study||20
8257029|NCT01819844|20360486|P1|NOT COMPLETED|Overall Study||0
8257030|NCT01819844|20360486|P1|COMPLETED|Overall Study||12
8257031|NCT01819844|20360486|P1|STARTED|Overall Study||12
8257032|NCT01819727|20360501|P2|NOT COMPLETED|Overall Study||28
8257033|NCT01819727|20360502|P1|NOT COMPLETED|Overall Study||20
8257034|NCT01819727|20360501|P2|COMPLETED|Overall Study||102
8257035|NCT01819727|20360502|P1|COMPLETED|Overall Study||111
8257036|NCT01819727|20360501|P2|STARTED|Overall Study||130
8257037|NCT01819727|20360502|P1|STARTED|Overall Study||131
8257038|NCT01819597|20360512|P1|NOT COMPLETED|Overall Study||0
8257039|NCT01819597|20360512|P1|COMPLETED|Overall Study||52
8257040|NCT01819597|20360512|P1|STARTED|Overall Study||52
8257041|NCT01819506|20360524|P2|NOT COMPLETED|Overall Study||5
8257042|NCT01819506|20360525|P1|NOT COMPLETED|Overall Study||8
8257043|NCT01819506|20360524|P2|COMPLETED|Overall Study||47
8257044|NCT01819506|20360525|P1|COMPLETED|Overall Study||43
8257045|NCT01819506|20360524|P2|STARTED|Overall Study||52
8257046|NCT01819506|20360525|P1|STARTED|Overall Study||51
8257047|NCT01819415|20360539|P4|NOT COMPLETED|Overall Study||2
8257048|NCT01819415|20360540|P3|NOT COMPLETED|Overall Study||1
8257049|NCT01819415|20360541|P2|NOT COMPLETED|Overall Study||4
8257050|NCT01819415|20360542|P1|NOT COMPLETED|Overall Study||3
8257051|NCT01819415|20360539|P4|COMPLETED|Overall Study||8
8257052|NCT01819415|20360540|P3|COMPLETED|Overall Study||9
8257053|NCT01819415|20360541|P2|COMPLETED|Overall Study||6
8257054|NCT01819415|20360542|P1|COMPLETED|Overall Study||7
8257055|NCT01819415|20360539|P4|STARTED|Overall Study||10
8257056|NCT01819415|20360540|P3|STARTED|Overall Study||10
8257057|NCT01819415|20360541|P2|STARTED|Overall Study||10
8257058|NCT01819415|20360542|P1|STARTED|Overall Study||10
8257059|NCT01819311|20360554|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
8257060|NCT01819311|20360555|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
8257061|NCT01819311|20360554|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
8257062|NCT01819311|20360555|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
8257063|NCT01819311|20360554|P2|STARTED|Follow-up Phase (8 Weeks)||30
8257064|NCT01819311|20360555|P1|STARTED|Follow-up Phase (8 Weeks)||31
8257065|NCT01819311|20360554|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
8257066|NCT01819311|20360555|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
8257067|NCT01819311|20360554|P2|COMPLETED|Treatment Phase (4 Weeks)||30
8257068|NCT01819311|20360555|P1|COMPLETED|Treatment Phase (4 Weeks)||31
8257069|NCT01819311|20360554|P2|STARTED|Treatment Phase (4 Weeks)||31
8257070|NCT01819311|20360555|P1|STARTED|Treatment Phase (4 Weeks)||33
8257071|NCT01819272|20360577|P6|NOT COMPLETED|Overall Study||7
8257072|NCT01819272|20360578|P5|NOT COMPLETED|Overall Study||4
8257073|NCT01819272|20360579|P4|NOT COMPLETED|Overall Study||5
8257074|NCT01819272|20360580|P3|NOT COMPLETED|Overall Study||3
8257075|NCT01819272|20360581|P2|NOT COMPLETED|Overall Study||3
8257076|NCT01819272|20360582|P1|NOT COMPLETED|Overall Study||6
8257077|NCT01819272|20360577|P6|COMPLETED|Overall Study||33
8257078|NCT01819272|20360578|P5|COMPLETED|Overall Study||36
8257079|NCT01819272|20360579|P4|COMPLETED|Overall Study||35
8257080|NCT01819272|20360580|P3|COMPLETED|Overall Study||37
8257081|NCT01819272|20360581|P2|COMPLETED|Overall Study||36
8257082|NCT01819272|20360582|P1|COMPLETED|Overall Study||35
8257083|NCT01819272|20360577|P6|STARTED|Overall Study||40
8257084|NCT01819272|20360578|P5|STARTED|Overall Study||40
8257085|NCT01819272|20360579|P4|STARTED|Overall Study||40
8257086|NCT01819272|20360580|P3|STARTED|Overall Study||40
8257087|NCT01819272|20360581|P2|STARTED|Overall Study||39
8257088|NCT01819272|20360582|P1|STARTED|Overall Study||41
8257089|NCT01819233|20360608|P1|NOT COMPLETED|Overall Study||6
8257090|NCT01819233|20360608|P1|COMPLETED|Overall Study||32
8257091|NCT01819233|20360608|P1|STARTED|Overall Study||38
8257092|NCT01819194|20360620|P1|NOT COMPLETED|Overall Study||2
8257093|NCT01819194|20360620|P1|COMPLETED|Overall Study||60
8257094|NCT01819194|20360620|P1|STARTED|Overall Study||62
8257095|NCT01819129|20360627|P2|NOT COMPLETED|Overall Study||39
8257096|NCT01819129|20360628|P1|NOT COMPLETED|Overall Study||44
8257097|NCT01819129|20360627|P2|COMPLETED|Overall Study||305
8257098|NCT01819129|20360628|P1|COMPLETED|Overall Study||301
8257099|NCT01819129|20360627|P2|Exposed|Overall Study||341
8257100|NCT01819129|20360628|P1|Exposed|Overall Study||341
8257101|NCT01819129|20360627|P2|STARTED|Overall Study||344
8257102|NCT01819129|20360628|P1|STARTED|Overall Study||345
8257103|NCT01818804|20360642|P2|NOT COMPLETED|Overall Study||7
8257104|NCT01818804|20360643|P1|NOT COMPLETED|Overall Study||5
8257105|NCT01818804|20360642|P2|COMPLETED|Overall Study||65
8257106|NCT01818804|20360643|P1|COMPLETED|Overall Study||68
8257107|NCT01818804|20360642|P2|STARTED|Overall Study||72
8257108|NCT01818804|20360643|P1|STARTED|Overall Study||73
8257109|NCT01818765|20360653|P1|NOT COMPLETED|Overall Study||2
8257110|NCT01818765|20360653|P1|COMPLETED|Overall Study||18
8257111|NCT01818765|20360653|P1|STARTED|Overall Study||20
8257112|NCT01818752|20360666|P2|NOT COMPLETED|Overall Study||198
8257113|NCT01818752|20360667|P1|NOT COMPLETED|Overall Study||187
8257114|NCT01818752|20360666|P2|COMPLETED|Overall Study|Completed treatment|280
8257115|NCT01818752|20360667|P1|COMPLETED|Overall Study|Completed treatment|290
8257116|NCT01818752|20360666|P2|Received Treatment|Overall Study||474
8257117|NCT01818752|20360667|P1|Received Treatment|Overall Study||470
8257118|NCT01818752|20360666|P2|STARTED|Overall Study||478
8257119|NCT01818752|20360667|P1|STARTED|Overall Study||477
8257120|NCT01818726|20360687|P2|NOT COMPLETED|Overall Study||2
8257121|NCT01818726|20360688|P1|NOT COMPLETED|Overall Study||6
8257122|NCT01818726|20360687|P2|COMPLETED|Overall Study||3
8257123|NCT01818726|20360688|P1|COMPLETED|Overall Study||4
8257124|NCT01818726|20360687|P2|STARTED|Overall Study||5
8257125|NCT01818726|20360688|P1|STARTED|Overall Study||10
8257126|NCT01818700|20360698|P1|NOT COMPLETED|Overall Study||104
8257127|NCT01818700|20360698|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
8257128|NCT01818700|20360698|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
8257129|NCT01818700|20360698|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
8257130|NCT01818700|20360698|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
8257131|NCT01818700|20360698|P1|STARTED|Overall Study|The No. of enrolled patients|245
8257132|NCT01818596|20360709|P2|NOT COMPLETED|Overall Study||0
8257133|NCT01818596|20360710|P1|NOT COMPLETED|Overall Study||31
8257134|NCT01818596|20360709|P2|COMPLETED|Overall Study||6
8257135|NCT01818596|20360710|P1|COMPLETED|Overall Study||215
8257136|NCT01818596|20360709|P2|STARTED|Overall Study||6
8257137|NCT01818596|20360710|P1|STARTED|Overall Study||246
8257138|NCT01818531|20360749|P2|NOT COMPLETED|Overall Study||2
8257139|NCT01818531|20360750|P1|NOT COMPLETED|Overall Study||1
8257140|NCT01818531|20360749|P2|COMPLETED|Overall Study||73
8257141|NCT01818531|20360750|P1|COMPLETED|Overall Study||74
8257142|NCT01818531|20360749|P2|STARTED|Overall Study||75
8257143|NCT01818531|20360750|P1|STARTED|Overall Study||75
8257144|NCT01818518|20360770|P6|NOT COMPLETED|Overall Study||0
8257145|NCT01818518|20360771|P5|NOT COMPLETED|Overall Study||0
8257146|NCT01818518|20360772|P4|NOT COMPLETED|Overall Study||0
8257147|NCT01818518|20360773|P3|NOT COMPLETED|Overall Study||0
8257148|NCT01818518|20360774|P2|NOT COMPLETED|Overall Study||0
8257149|NCT01818518|20360775|P1|NOT COMPLETED|Overall Study||0
8257150|NCT01818518|20360770|P6|COMPLETED|Overall Study||37
8257151|NCT01818518|20360771|P5|COMPLETED|Overall Study||38
8257152|NCT01818518|20360772|P4|COMPLETED|Overall Study||59
8257153|NCT01818518|20360773|P3|COMPLETED|Overall Study||288
8257154|NCT01818518|20360774|P2|COMPLETED|Overall Study||263
8257155|NCT01818518|20360775|P1|COMPLETED|Overall Study||310
8257156|NCT01818518|20360770|P6|STARTED|Overall Study||37
8257157|NCT01818518|20360771|P5|STARTED|Overall Study||38
8257158|NCT01818518|20360772|P4|STARTED|Overall Study||59
8257159|NCT01818518|20360773|P3|STARTED|Overall Study||288
8257160|NCT01818518|20360774|P2|STARTED|Overall Study||263
8257161|NCT01818518|20360775|P1|STARTED|Overall Study||310
8257162|NCT01818492|20360789|P1|NOT COMPLETED|Overall Study||10
8257163|NCT01818492|20360789|P1|COMPLETED|Overall Study||35
8257164|NCT01818492|20360789|P1|STARTED|Overall Study||45
8257165|NCT01818427|20360806|P2|NOT COMPLETED|Overall Study||13
8257166|NCT01818427|20360807|P1|NOT COMPLETED|Overall Study||9
8257167|NCT01818427|20360806|P2|COMPLETED|Overall Study||271
8257168|NCT01818427|20360807|P1|COMPLETED|Overall Study||230
8257169|NCT01818427|20360806|P2|STARTED|Overall Study||284
8257170|NCT01818427|20360807|P1|STARTED|Overall Study||239
8257171|NCT01818414|20360823|P2|NOT COMPLETED|Overall Study||0
8257172|NCT01818414|20360824|P1|NOT COMPLETED|Overall Study||0
8257173|NCT01818414|20360823|P2|COMPLETED|Overall Study||15
8257174|NCT01818414|20360824|P1|COMPLETED|Overall Study||14
8257175|NCT01818414|20360823|P2|STARTED|Overall Study||15
8257176|NCT01818414|20360824|P1|STARTED|Overall Study||14
8257177|NCT01818336|20360838|P2|NOT COMPLETED|Overall Study||12
8257178|NCT01818336|20360839|P1|NOT COMPLETED|Overall Study||0
8257179|NCT01818336|20360838|P2|COMPLETED|Overall Study||47
8257180|NCT01818336|20360839|P1|COMPLETED|Overall Study||391
8257181|NCT01818336|20360838|P2|STARTED|Overall Study||59
8257182|NCT01818336|20360839|P1|STARTED|Overall Study||391
8257183|NCT01818297|20360847|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
8257184|NCT01818297|20360848|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
8257185|NCT01818297|20360847|P2|COMPLETED|Open Label Phase (3-12 Months)||19
8257186|NCT01818297|20360848|P1|COMPLETED|Open Label Phase (3-12 Months)||14
8257187|NCT01818297|20360847|P2|STARTED|Open Label Phase (3-12 Months)||29
8257188|NCT01818297|20360848|P1|STARTED|Open Label Phase (3-12 Months)||32
8257189|NCT01818297|20360847|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
8257190|NCT01818297|20360848|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
8257191|NCT01818297|20360847|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
8257192|NCT01818297|20360848|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
8257193|NCT01818297|20360847|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
8257194|NCT01818297|20360848|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
8257195|NCT01818297|20360847|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
8257196|NCT01818297|20360848|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
8257197|NCT01818297|20360847|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
8257198|NCT01818297|20360848|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
8257199|NCT01818284|20360866|P2|NOT COMPLETED|Overall Study||6
8257200|NCT01818284|20360867|P1|NOT COMPLETED|Overall Study||4
8257201|NCT01818284|20360866|P2|COMPLETED|Overall Study||5
8257202|NCT01818284|20360867|P1|COMPLETED|Overall Study||7
8257203|NCT01818284|20360866|P2|STARTED|Overall Study||11
8257204|NCT01818284|20360867|P1|STARTED|Overall Study||11
8257205|NCT01818245|20360875|P2|NOT COMPLETED|Intervention C||0
8257206|NCT01818245|20360876|P1|NOT COMPLETED|Intervention C||0
8257207|NCT01818245|20360875|P2|COMPLETED|Intervention C||0
8257208|NCT01818245|20360876|P1|COMPLETED|Intervention C||30
8257209|NCT01818245|20360875|P2|STARTED|Intervention C||0
8257210|NCT01818245|20360876|P1|STARTED|Intervention C||30
8257211|NCT01818245|20360875|P2|NOT COMPLETED|Washout (16-28 Days)||0
8257212|NCT01818245|20360876|P1|NOT COMPLETED|Washout (16-28 Days)||0
8257213|NCT01818245|20360875|P2|COMPLETED|Washout (16-28 Days)||0
8257214|NCT01818245|20360876|P1|COMPLETED|Washout (16-28 Days)||30
8257215|NCT01818245|20360875|P2|STARTED|Washout (16-28 Days)||0
8257216|NCT01818245|20360876|P1|STARTED|Washout (16-28 Days)||30
8257217|NCT01818245|20360875|P2|NOT COMPLETED|Intervention B||0
8257218|NCT01818245|20360876|P1|NOT COMPLETED|Intervention B||0
8257219|NCT01818245|20360875|P2|COMPLETED|Intervention B||0
8257220|NCT01818245|20360876|P1|COMPLETED|Intervention B||30
8257221|NCT01818245|20360875|P2|STARTED|Intervention B||0
8257222|NCT01818245|20360876|P1|STARTED|Intervention B||30
8257223|NCT01818245|20360875|P2|NOT COMPLETED|Washout (16-28 Days)||0
8257224|NCT01818245|20360876|P1|NOT COMPLETED|Washout (16-28 Days)||0
8257225|NCT01818245|20360875|P2|COMPLETED|Washout (16-28 Days)||0
8257226|NCT01818245|20360876|P1|COMPLETED|Washout (16-28 Days)||30
8257227|NCT01818245|20360875|P2|STARTED|Washout (16-28 Days)||0
8257228|NCT01818245|20360876|P1|STARTED|Washout (16-28 Days)||30
8257229|NCT01818245|20360875|P2|NOT COMPLETED|Intervention A||0
8257230|NCT01818245|20360876|P1|NOT COMPLETED|Intervention A||0
8257231|NCT01818245|20360875|P2|COMPLETED|Intervention A||22
8257232|NCT01818245|20360876|P1|COMPLETED|Intervention A||30
8257233|NCT01818245|20360875|P2|Received One Dose of Study Drug|Intervention A||22
8257234|NCT01818245|20360876|P1|Received One Dose of Study Drug|Intervention A||30
8257235|NCT01818245|20360875|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
8257236|NCT01818245|20360876|P1|STARTED|Intervention A||30
8257237|NCT01818141|20360900|P2|NOT COMPLETED|Overall Study||3
8257238|NCT01818141|20360901|P1|NOT COMPLETED|Overall Study||3
8257239|NCT01818141|20360900|P2|COMPLETED|Overall Study||13
8257240|NCT01818141|20360901|P1|COMPLETED|Overall Study||15
8257241|NCT01818141|20360900|P2|STARTED|Overall Study||16
8257242|NCT01818141|20360901|P1|STARTED|Overall Study||18
8257243|NCT01818063|20360911|P2|NOT COMPLETED|Overall Study||0
8257244|NCT01818063|20360912|P1|NOT COMPLETED|Overall Study||0
8257245|NCT01818063|20360911|P2|COMPLETED|Overall Study||4
8257246|NCT01818063|20360912|P1|COMPLETED|Overall Study||5
8257247|NCT01818063|20360911|P2|STARTED|Overall Study||4
8257248|NCT01818063|20360912|P1|STARTED|Overall Study||5
8257255|NCT01817907|20360971|P2|NOT COMPLETED|Second Intervention||0
8257256|NCT01817907|20360972|P1|NOT COMPLETED|Second Intervention||0
8257257|NCT01817907|20360971|P2|COMPLETED|Second Intervention||7
8257258|NCT01817907|20360972|P1|COMPLETED|Second Intervention||8
8257259|NCT01817907|20360971|P2|STARTED|Second Intervention||7
8257260|NCT01817907|20360972|P1|STARTED|Second Intervention||8
8257261|NCT01817907|20360971|P2|NOT COMPLETED|Washout Period||0
8257262|NCT01817907|20360972|P1|NOT COMPLETED|Washout Period||0
8257263|NCT01817907|20360971|P2|COMPLETED|Washout Period||7
8257264|NCT01817907|20360972|P1|COMPLETED|Washout Period||8
8257265|NCT01817907|20360971|P2|STARTED|Washout Period||7
8257266|NCT01817907|20360972|P1|STARTED|Washout Period||8
8257267|NCT01817907|20360971|P2|NOT COMPLETED|First Intervention||0
8257268|NCT01817907|20360972|P1|NOT COMPLETED|First Intervention||0
8257269|NCT01817907|20360971|P2|COMPLETED|First Intervention||7
8257270|NCT01817907|20360972|P1|COMPLETED|First Intervention||8
8257271|NCT01817907|20360971|P2|STARTED|First Intervention||7
8257272|NCT01817907|20360972|P1|STARTED|First Intervention||8
8257273|NCT01817855|20360984|P4|NOT COMPLETED|Overall Study||0
8257274|NCT01817855|20360985|P3|NOT COMPLETED|Overall Study||2
8257275|NCT01817855|20360986|P2|NOT COMPLETED|Overall Study||2
8257276|NCT01817855|20360987|P1|NOT COMPLETED|Overall Study||0
8257277|NCT01817855|20360984|P4|COMPLETED|Overall Study||5
8257278|NCT01817855|20360985|P3|COMPLETED|Overall Study||9
8257279|NCT01817855|20360986|P2|COMPLETED|Overall Study||6
8257280|NCT01817855|20360987|P1|COMPLETED|Overall Study||23
8257281|NCT01817855|20360984|P4|STARTED|Overall Study||5
8257282|NCT01817855|20360985|P3|STARTED|Overall Study||11
8257283|NCT01817855|20360986|P2|STARTED|Overall Study||8
8257284|NCT01817855|20360987|P1|STARTED|Overall Study||23
8257285|NCT01817790|20361017|P2|NOT COMPLETED|Overall Study||8
8257286|NCT01817790|20361018|P1|NOT COMPLETED|Overall Study||4
8257287|NCT01817790|20361017|P2|COMPLETED|Overall Study||304
8257288|NCT01817790|20361018|P1|COMPLETED|Overall Study||310
8257289|NCT01817790|20361017|P2|STARTED|Overall Study||312
8257290|NCT01817790|20361018|P1|STARTED|Overall Study||314
8257291|NCT01817777|20361062|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
8257292|NCT01817777|20361063|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
8257293|NCT01817777|20361064|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
8257294|NCT01817777|20361062|P3|COMPLETED|Interventional Phase (20 Weeks)||10
8257295|NCT01817777|20361063|P2|COMPLETED|Interventional Phase (20 Weeks)||11
8257296|NCT01817777|20361064|P1|COMPLETED|Interventional Phase (20 Weeks)||0
8257297|NCT01817777|20361062|P3|STARTED|Interventional Phase (20 Weeks)||15
8257298|NCT01817777|20361063|P2|STARTED|Interventional Phase (20 Weeks)||16
8257299|NCT01817777|20361064|P1|STARTED|Interventional Phase (20 Weeks)||0
8257300|NCT01817777|20361062|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
8257301|NCT01817777|20361063|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
8257302|NCT01817777|20361064|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
8257303|NCT01817777|20361062|P3|COMPLETED|Observational Phase (8 Weeks)||0
8257304|NCT01817777|20361063|P2|COMPLETED|Observational Phase (8 Weeks)||0
8257305|NCT01817777|20361064|P1|COMPLETED|Observational Phase (8 Weeks)||31
8257306|NCT01817777|20361062|P3|STARTED|Observational Phase (8 Weeks)||0
8257307|NCT01817777|20361063|P2|STARTED|Observational Phase (8 Weeks)||0
8257308|NCT01817777|20361064|P1|STARTED|Observational Phase (8 Weeks)||36
8257309|NCT01817764|20361088|P2|NOT COMPLETED|Overall Study||38
8257310|NCT01817764|20361089|P1|NOT COMPLETED|Overall Study||34
8257311|NCT01817764|20361088|P2|COMPLETED|Overall Study||315
8257312|NCT01817764|20361089|P1|COMPLETED|Overall Study||319
8257313|NCT01817764|20361088|P2|STARTED|Overall Study||353
8257314|NCT01817764|20361089|P1|STARTED|Overall Study||353
8257315|NCT01817725|20361097|P1|NOT COMPLETED|Overall Study||1
8257316|NCT01817725|20361097|P1|COMPLETED|Overall Study||19
8257317|NCT01817725|20361097|P1|STARTED|Overall Study||20
8257318|NCT01817712|20361104|P2|NOT COMPLETED|Overall Study||30
8257319|NCT01817712|20361105|P1|NOT COMPLETED|Overall Study||21
8257320|NCT01817712|20361104|P2|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
8257321|NCT01817712|20361105|P1|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
8257322|NCT01817712|20361104|P2|STARTED|Overall Study||270
8257323|NCT01817712|20361105|P1|STARTED|Overall Study||271
8257324|NCT01817582|20361118|P3|NOT COMPLETED|Overall Study||0
8257325|NCT01817582|20361119|P2|NOT COMPLETED|Overall Study||1
8257326|NCT01817582|20361120|P1|NOT COMPLETED|Overall Study||2
8257327|NCT01817582|20361118|P3|COMPLETED|Overall Study||33
8257328|NCT01817582|20361119|P2|COMPLETED|Overall Study||35
8257329|NCT01817582|20361120|P1|COMPLETED|Overall Study||31
8257330|NCT01817582|20361118|P3|Received at Least 1 Dose of Study Drug|Overall Study||33
8257331|NCT01817582|20361119|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
8257332|NCT01817582|20361120|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
8257333|NCT01817582|20361118|P3|STARTED|Overall Study||33
8257334|NCT01817582|20361119|P2|STARTED|Overall Study||36
8257335|NCT01817582|20361120|P1|STARTED|Overall Study||33
8257336|NCT01817530|20361190|P8|NOT COMPLETED|Overall Study||24
8257337|NCT01817530|20361191|P7|NOT COMPLETED|Overall Study||23
8257338|NCT01817530|20361192|P6|NOT COMPLETED|Overall Study||19
8257339|NCT01817530|20361193|P5|NOT COMPLETED|Overall Study||11
8257340|NCT01817530|20361194|P4|NOT COMPLETED|Overall Study||13
8257341|NCT01817530|20361195|P3|NOT COMPLETED|Overall Study||11
8257342|NCT01817530|20361196|P2|NOT COMPLETED|Overall Study||13
8257343|NCT01817530|20361197|P1|NOT COMPLETED|Overall Study||15
8257344|NCT01817530|20361190|P8|COMPLETED|Overall Study||53
8257345|NCT01817530|20361191|P7|COMPLETED|Overall Study||53
8257346|NCT01817530|20361192|P6|COMPLETED|Overall Study||58
8257347|NCT01817530|20361193|P5|COMPLETED|Overall Study||67
8257348|NCT01817530|20361194|P4|COMPLETED|Overall Study||52
8257349|NCT01817530|20361195|P3|COMPLETED|Overall Study||53
8257350|NCT01817530|20361196|P2|COMPLETED|Overall Study||52
8257351|NCT01817530|20361197|P1|COMPLETED|Overall Study||50
8257352|NCT01817530|20361190|P8|STARTED|Overall Study||77
8257353|NCT01817530|20361191|P7|STARTED|Overall Study||76
8257354|NCT01817530|20361192|P6|STARTED|Overall Study||77
8257355|NCT01817530|20361193|P5|STARTED|Overall Study||78
8257356|NCT01817530|20361194|P4|STARTED|Overall Study||65
8257357|NCT01817530|20361195|P3|STARTED|Overall Study||64
8257358|NCT01817530|20361196|P2|STARTED|Overall Study||65
8257359|NCT01817530|20361197|P1|STARTED|Overall Study||65
8257360|NCT01817491|20361361|P2|NOT COMPLETED|Overall Study||0
8257361|NCT01817491|20361362|P1|NOT COMPLETED|Overall Study||4
8257362|NCT01817491|20361361|P2|COMPLETED|Overall Study||28
8257363|NCT01817491|20361362|P1|COMPLETED|Overall Study||28
8257364|NCT01817491|20361361|P2|STARTED|Overall Study||28
8257365|NCT01817491|20361362|P1|STARTED|Overall Study||32
8257366|NCT01817374|20361408|P1|NOT COMPLETED|Overall Study||0
8257367|NCT01817374|20361408|P1|COMPLETED|Overall Study||6
8257368|NCT01817374|20361408|P1|STARTED|Overall Study||6
8257369|NCT01817075|20361422|P2|NOT COMPLETED|Overall Study||35
8257370|NCT01817075|20361423|P1|NOT COMPLETED|Overall Study||47
8257371|NCT01817075|20361422|P2|COMPLETED|Overall Study||54
8257372|NCT01817075|20361423|P1|COMPLETED|Overall Study||41
8257373|NCT01817075|20361422|P2|STARTED|Overall Study||89
8257374|NCT01817075|20361423|P1|STARTED|Overall Study||88
8257375|NCT01816984|20361435|P1|NOT COMPLETED|Overall Study||1
8257376|NCT01816984|20361435|P1|COMPLETED|Overall Study||11
8257377|NCT01816984|20361435|P1|STARTED|Overall Study||12
8257378|NCT01816906|20361448|P2|NOT COMPLETED|12 Months||5
8257379|NCT01816906|20361449|P1|NOT COMPLETED|12 Months||4
8257380|NCT01816906|20361448|P2|COMPLETED|12 Months||14
8257381|NCT01816906|20361449|P1|COMPLETED|12 Months||16
8257382|NCT01816906|20361448|P2|STARTED|12 Months||19
8257383|NCT01816906|20361449|P1|STARTED|12 Months||20
8257384|NCT01816906|20361448|P2|NOT COMPLETED|Six Months||22
8257385|NCT01816906|20361449|P1|NOT COMPLETED|Six Months||21
8257386|NCT01816906|20361448|P2|COMPLETED|Six Months||19
8257387|NCT01816906|20361449|P1|COMPLETED|Six Months||20
8257388|NCT01816906|20361448|P2|STARTED|Six Months||41
8257389|NCT01816906|20361449|P1|STARTED|Six Months||41
8257390|NCT01816893|20361467|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
8257391|NCT01816893|20361468|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
8257392|NCT01816893|20361467|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
8257393|NCT01816893|20361468|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
8257394|NCT01816893|20361467|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
8257395|NCT01816893|20361468|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
8257396|NCT01816893|20361467|P2|NOT COMPLETED|Washout Period||0
8257397|NCT01816893|20361468|P1|NOT COMPLETED|Washout Period||2
8257398|NCT01816893|20361467|P2|COMPLETED|Washout Period||11
8257399|NCT01816893|20361468|P1|COMPLETED|Washout Period||9
8257400|NCT01816893|20361467|P2|STARTED|Washout Period||11
8257401|NCT01816893|20361468|P1|STARTED|Washout Period||11
8257402|NCT01816893|20361467|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
8257403|NCT01816893|20361468|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
8257404|NCT01816893|20361467|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257405|NCT01816893|20361468|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257406|NCT01816893|20361467|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257407|NCT01816893|20361468|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257408|NCT01816776|20361480|P2|NOT COMPLETED|Overall Study||8
8257409|NCT01816776|20361481|P1|NOT COMPLETED|Overall Study||13
8257410|NCT01816776|20361480|P2|COMPLETED|Overall Study||70
8257411|NCT01816776|20361481|P1|COMPLETED|Overall Study||60
8257412|NCT01816776|20361480|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
8257413|NCT01816776|20361481|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
8257414|NCT01816776|20361480|P2|STARTED|Overall Study||78
8257415|NCT01816776|20361481|P1|STARTED|Overall Study||73
8257416|NCT01816763|20361504|P3|NOT COMPLETED|Overall Study||11
8257417|NCT01816763|20361505|P2|NOT COMPLETED|Overall Study||15
8257418|NCT01816763|20361506|P1|NOT COMPLETED|Overall Study||4
8257419|NCT01816763|20361504|P3|COMPLETED|Overall Study||169
8257420|NCT01816763|20361505|P2|COMPLETED|Overall Study||179
8257421|NCT01816763|20361506|P1|COMPLETED|Overall Study||191
8257422|NCT01816763|20361504|P3|STARTED|Overall Study||180
8257423|NCT01816763|20361505|P2|STARTED|Overall Study||194
8257424|NCT01816763|20361506|P1|STARTED|Overall Study||195
8257425|NCT01816711|20361522|P2|NOT COMPLETED|Overall Study||0
8257426|NCT01816711|20361523|P1|NOT COMPLETED|Overall Study||0
8257427|NCT01816711|20361522|P2|COMPLETED|Overall Study||83
8257428|NCT01816711|20361523|P1|COMPLETED|Overall Study||121
8257429|NCT01816711|20361522|P2|STARTED|Overall Study||83
8257430|NCT01816711|20361523|P1|STARTED|Overall Study||121
8257431|NCT01816685|20361531|P2|NOT COMPLETED|Overall Study||11
8257432|NCT01816685|20361532|P1|NOT COMPLETED|Overall Study||10
8257433|NCT01816685|20361531|P2|COMPLETED|Overall Study||56
8257434|NCT01816685|20361532|P1|COMPLETED|Overall Study||58
8257435|NCT01816685|20361531|P2|STARTED|Overall Study||67
8257436|NCT01816685|20361532|P1|STARTED|Overall Study||68
8257437|NCT01816594|20361542|P2|NOT COMPLETED|Overall Study||2
8257438|NCT01816594|20361543|P1|NOT COMPLETED|Overall Study||11
8257439|NCT01816594|20361542|P2|COMPLETED|Overall Study||23
8257440|NCT01816594|20361543|P1|COMPLETED|Overall Study||14
8257441|NCT01816594|20361542|P2|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
8257442|NCT01816594|20361543|P1|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
8257443|NCT01816594|20361542|P2|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
8257444|NCT01816594|20361543|P1|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
8257445|NCT01816594|20361542|P2|STARTED|Overall Study||25
8257446|NCT01816594|20361543|P1|STARTED|Overall Study||25
8257447|NCT01816477|20361581|P2|NOT COMPLETED|Overall Study||1
8257448|NCT01816477|20361582|P1|NOT COMPLETED|Overall Study||16
8257449|NCT01816477|20361581|P2|COMPLETED|Overall Study||41
8257450|NCT01816477|20361582|P1|COMPLETED|Overall Study||27
8257451|NCT01816477|20361581|P2|STARTED|Overall Study||42
8257452|NCT01816477|20361582|P1|STARTED|Overall Study||43
8257453|NCT01816451|20361595|P3|NOT COMPLETED|Overall Study||0
8257454|NCT01816451|20361596|P2|NOT COMPLETED|Overall Study||0
8257455|NCT01816451|20361597|P1|NOT COMPLETED|Overall Study||0
8257456|NCT01816451|20361595|P3|COMPLETED|Overall Study||8
8257457|NCT01816451|20361596|P2|COMPLETED|Overall Study||11
8257458|NCT01816451|20361597|P1|COMPLETED|Overall Study||13
8257459|NCT01816451|20361595|P3|STARTED|Overall Study||8
8257460|NCT01816451|20361596|P2|STARTED|Overall Study||11
8257461|NCT01816451|20361597|P1|STARTED|Overall Study||13
8257462|NCT01816295|20361636|P2|NOT COMPLETED|OLE Phase||56
8257463|NCT01816295|20361637|P1|NOT COMPLETED|OLE Phase||53
8257464|NCT01816295|20361636|P2|COMPLETED|OLE Phase||227
8257465|NCT01816295|20361637|P1|COMPLETED|OLE Phase||222
8257466|NCT01816295|20361636|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
8257467|NCT01816295|20361637|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
8257468|NCT01816295|20361636|P2|NOT COMPLETED|Double Blind Phase||56
8257469|NCT01816295|20361637|P1|NOT COMPLETED|Double Blind Phase||63
8257470|NCT01816295|20361636|P2|COMPLETED|Double Blind Phase||302
8257471|NCT01816295|20361637|P1|COMPLETED|Double Blind Phase||294
8257472|NCT01816295|20361636|P2|Received Study Drug|Double Blind Phase||354
8257473|NCT01816295|20361637|P1|Received Study Drug|Double Blind Phase||356
8257474|NCT01816295|20361636|P2|STARTED|Double Blind Phase||358
8257475|NCT01816295|20361637|P1|STARTED|Double Blind Phase||357
8257476|NCT01816243|20361652|P1|NOT COMPLETED|Overall Study||12
8257477|NCT01816243|20361652|P1|COMPLETED|Overall Study||27
8257478|NCT01816243|20361652|P1|STARTED|Overall Study||39
8257479|NCT01816230|20361659|P1|NOT COMPLETED|Overall Study||0
8257480|NCT01816230|20361659|P1|COMPLETED|Overall Study||36
8257481|NCT01816230|20361659|P1|STARTED|Overall Study||36
8257482|NCT01816074|20361667|P4|NOT COMPLETED|Phase 2||1
8257483|NCT01816074|20361668|P3|NOT COMPLETED|Phase 2||0
8257484|NCT01816074|20361669|P2|NOT COMPLETED|Phase 2||2
8257485|NCT01816074|20361670|P1|NOT COMPLETED|Phase 2||2
8257486|NCT01816074|20361667|P4|COMPLETED|Phase 2||9
8257487|NCT01816074|20361668|P3|COMPLETED|Phase 2||10
8257488|NCT01816074|20361669|P2|COMPLETED|Phase 2||7
8257489|NCT01816074|20361670|P1|COMPLETED|Phase 2||9
8257490|NCT01816074|20361667|P4|STARTED|Phase 2||10
8257491|NCT01816074|20361668|P3|STARTED|Phase 2||10
8257492|NCT01816074|20361669|P2|STARTED|Phase 2||9
8257493|NCT01816074|20361670|P1|STARTED|Phase 2||11
8257494|NCT01816074|20361667|P4|NOT COMPLETED|Phase 1||0
8257495|NCT01816074|20361668|P3|NOT COMPLETED|Phase 1||1
8257496|NCT01816074|20361669|P2|NOT COMPLETED|Phase 1||0
8257497|NCT01816074|20361670|P1|NOT COMPLETED|Phase 1||0
8257498|NCT01816074|20361667|P4|COMPLETED|Phase 1||10
8257499|NCT01816074|20361668|P3|COMPLETED|Phase 1||10
8257500|NCT01816074|20361669|P2|COMPLETED|Phase 1||9
8257501|NCT01816074|20361670|P1|COMPLETED|Phase 1||11
8257502|NCT01816074|20361667|P4|STARTED|Phase 1||10
8257503|NCT01816074|20361668|P3|STARTED|Phase 1||11
8257504|NCT01816074|20361669|P2|STARTED|Phase 1||9
8257505|NCT01816074|20361670|P1|STARTED|Phase 1||11
8257506|NCT01816061|20361700|P2|NOT COMPLETED|Overall Study||24
8257507|NCT01816061|20361701|P1|NOT COMPLETED|Overall Study||13
8257508|NCT01816061|20361700|P2|COMPLETED|Overall Study||27
8257509|NCT01816061|20361701|P1|COMPLETED|Overall Study||27
8257510|NCT01816061|20361700|P2|STARTED|Overall Study||51
8257511|NCT01816061|20361701|P1|STARTED|Overall Study||40
8257512|NCT01816048|20361709|P1|NOT COMPLETED|Overall Study||6
8257513|NCT01816048|20361709|P1|COMPLETED|Overall Study||2
8257514|NCT01816048|20361709|P1|STARTED|Overall Study||8
8257515|NCT01815918|20361724|P2|NOT COMPLETED|Overall Study||19
8257516|NCT01815918|20361725|P1|NOT COMPLETED|Overall Study||18
8257517|NCT01815918|20361724|P2|COMPLETED|Overall Study||11
8257518|NCT01815918|20361725|P1|COMPLETED|Overall Study||12
8257519|NCT01815918|20361724|P2|STARTED|Overall Study||30
8257520|NCT01815918|20361725|P1|STARTED|Overall Study||30
8257521|NCT01815840|20361741|P2|NOT COMPLETED|Overall Study||63
8257522|NCT01815840|20361742|P1|NOT COMPLETED|Overall Study||59
8257523|NCT01815840|20361741|P2|COMPLETED|Overall Study||50
8257524|NCT01815840|20361742|P1|COMPLETED|Overall Study||57
8257525|NCT01815840|20361741|P2|STARTED|Overall Study||113
8257526|NCT01815840|20361742|P1|STARTED|Overall Study||116
8257527|NCT01815736|20361772|P2|NOT COMPLETED|Overall Study||478
8257528|NCT01815736|20361773|P1|NOT COMPLETED|Overall Study||961
8257529|NCT01815736|20361772|P2|COMPLETED|Overall Study||2
8257530|NCT01815736|20361773|P1|COMPLETED|Overall Study||2
8257531|NCT01815736|20361772|P2|STARTED|Overall Study||480
8257532|NCT01815736|20361773|P1|STARTED|Overall Study||963
8257533|NCT01815671|20361789|P2|NOT COMPLETED|Overall Study||0
8257534|NCT01815671|20361790|P1|NOT COMPLETED|Overall Study||0
8257535|NCT01815671|20361789|P2|COMPLETED|Overall Study||85
8257536|NCT01815671|20361790|P1|COMPLETED|Overall Study||88
8257537|NCT01815671|20361789|P2|STARTED|Overall Study||85
8257538|NCT01815671|20361790|P1|STARTED|Overall Study||88
8257539|NCT01815645|20361802|P2|NOT COMPLETED|Overall Study||0
8257540|NCT01815645|20361803|P1|NOT COMPLETED|Overall Study||0
8257541|NCT01815645|20361802|P2|COMPLETED|Overall Study||33
8257542|NCT01815645|20361803|P1|COMPLETED|Overall Study||32
8257543|NCT01815645|20361802|P2|STARTED|Overall Study||33
8257544|NCT01815645|20361803|P1|STARTED|Overall Study||32
8257545|NCT01815515|20361819|P1|NOT COMPLETED|Overall Study||0
8257546|NCT01815515|20361819|P1|COMPLETED|Overall Study||17
8257547|NCT01815515|20361819|P1|STARTED|Overall Study||17
8257548|NCT01815502|20361826|P2|NOT COMPLETED|Overall Study||0
8257549|NCT01815502|20361827|P1|NOT COMPLETED|Overall Study||0
8257550|NCT01815502|20361826|P2|COMPLETED|Overall Study||10
8257551|NCT01815502|20361827|P1|COMPLETED|Overall Study||10
8257552|NCT01815502|20361826|P2|STARTED|Overall Study||10
8257553|NCT01815502|20361827|P1|STARTED|Overall Study||10
8257554|NCT01815424|20361842|P5|NOT COMPLETED|Week 16 to 52||3
8257555|NCT01815424|20361843|P4|NOT COMPLETED|Week 16 to 52||3
8257556|NCT01815424|20361844|P3|NOT COMPLETED|Week 16 to 52||0
8257557|NCT01815424|20361845|P2|NOT COMPLETED|Week 16 to 52||5
8257558|NCT01815424|20361846|P1|NOT COMPLETED|Week 16 to 52||2
8257559|NCT01815424|20361842|P5|COMPLETED|Week 16 to 52||36
8257560|NCT01815424|20361843|P4|COMPLETED|Week 16 to 52||35
8257561|NCT01815424|20361844|P3|COMPLETED|Week 16 to 52||0
8257562|NCT01815424|20361845|P2|COMPLETED|Week 16 to 52||79
8257563|NCT01815424|20361846|P1|COMPLETED|Week 16 to 52||81
8257564|NCT01815424|20361842|P5|STARTED|Week 16 to 52||39
8257565|NCT01815424|20361843|P4|STARTED|Week 16 to 52||38
8257566|NCT01815424|20361844|P3|STARTED|Week 16 to 52||0
8257567|NCT01815424|20361845|P2|STARTED|Week 16 to 52||84
8257568|NCT01815424|20361846|P1|STARTED|Week 16 to 52||83
8257569|NCT01815424|20361842|P5|NOT COMPLETED|Week 0 to 16||0
8257570|NCT01815424|20361843|P4|NOT COMPLETED|Week 0 to 16||0
8257571|NCT01815424|20361844|P3|NOT COMPLETED|Week 0 to 16||11
8257572|NCT01815424|20361845|P2|NOT COMPLETED|Week 0 to 16||4
8257573|NCT01815424|20361846|P1|NOT COMPLETED|Week 0 to 16||7
8257574|NCT01815424|20361842|P5|COMPLETED|Week 0 to 16||0
8257575|NCT01815424|20361843|P4|COMPLETED|Week 0 to 16||0
8257576|NCT01815424|20361844|P3|COMPLETED|Week 0 to 16||77
8257577|NCT01815424|20361845|P2|COMPLETED|Week 0 to 16||84
8257578|NCT01815424|20361846|P1|COMPLETED|Week 0 to 16||83
8257579|NCT01815424|20361842|P5|STARTED|Week 0 to 16||0
8257580|NCT01815424|20361843|P4|STARTED|Week 0 to 16||0
8257581|NCT01815424|20361844|P3|STARTED|Week 0 to 16||88
8257582|NCT01815424|20361845|P2|STARTED|Week 0 to 16||88
8257583|NCT01815424|20361846|P1|STARTED|Week 0 to 16||90
8257584|NCT01815333|20362042|P1|NOT COMPLETED|Overall Study||0
8257585|NCT01815333|20362042|P1|COMPLETED|Overall Study||10
8257586|NCT01815333|20362042|P1|STARTED|Overall Study||10
8257587|NCT01815229|20362049|P3|NOT COMPLETED|Overall Study||51
8257588|NCT01815229|20362050|P2|NOT COMPLETED|Overall Study||0
8257589|NCT01815229|20362051|P1|NOT COMPLETED|Overall Study||0
8257590|NCT01815229|20362049|P3|COMPLETED|Overall Study||0
8257591|NCT01815229|20362050|P2|COMPLETED|Overall Study||18
8257592|NCT01815229|20362051|P1|COMPLETED|Overall Study||13
8257593|NCT01815229|20362049|P3|STARTED|Overall Study||51
8257594|NCT01815229|20362050|P2|STARTED|Overall Study||18
8257595|NCT01815229|20362051|P1|STARTED|Overall Study||13
8257596|NCT01815138|20362062|P2|NOT COMPLETED|Overall Study||6
8257597|NCT01815138|20362063|P1|NOT COMPLETED|Overall Study||8
8257598|NCT01815138|20362062|P2|COMPLETED|Overall Study||31
8257599|NCT01815138|20362063|P1|COMPLETED|Overall Study||26
8257600|NCT01815138|20362062|P2|STARTED|Overall Study||37
8257601|NCT01815138|20362063|P1|STARTED|Overall Study||34
8257602|NCT01815099|20362075|P1|NOT COMPLETED|Overall Study||2
8257603|NCT01815099|20362075|P1|COMPLETED|Overall Study||2
8257604|NCT01815099|20362075|P1|Began rTMS Treatment|Overall Study||3
8257605|NCT01815099|20362075|P1|STARTED|Overall Study||4
8257606|NCT01815008|20362080|P1|NOT COMPLETED|Overall Study||4
8257607|NCT01815008|20362080|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
8257608|NCT01815008|20362080|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
8257609|NCT01814878|20362089|P2|NOT COMPLETED|Overall Study||30
8257610|NCT01814878|20362090|P1|NOT COMPLETED|Overall Study||46
8257611|NCT01814878|20362089|P2|COMPLETED|Overall Study||128
8257612|NCT01814878|20362090|P1|COMPLETED|Overall Study||116
8257613|NCT01814878|20362089|P2|STARTED|Overall Study||158
8257614|NCT01814878|20362090|P1|STARTED|Overall Study||162
8257615|NCT01814826|20362113|P3|NOT COMPLETED|Overall Study||3
8257616|NCT01814826|20362114|P2|NOT COMPLETED|Overall Study||29
8257617|NCT01814826|20362115|P1|NOT COMPLETED|Overall Study||32
8257618|NCT01814826|20362113|P3|COMPLETED|Overall Study||0
8257619|NCT01814826|20362114|P2|COMPLETED|Overall Study||0
8257620|NCT01814826|20362115|P1|COMPLETED|Overall Study||0
8257621|NCT01814826|20362113|P3|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
8257622|NCT01814826|20362114|P2|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
8257623|NCT01814826|20362115|P1|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
8257624|NCT01814813|20362191|P3|NOT COMPLETED|Overall Study||0
8257625|NCT01814813|20362192|P2|NOT COMPLETED|Overall Study||0
8257626|NCT01814813|20362193|P1|NOT COMPLETED|Overall Study||0
8257627|NCT01814813|20362191|P3|COMPLETED|Overall Study||31
8257628|NCT01814813|20362192|P2|COMPLETED|Overall Study||30
8257629|NCT01814813|20362193|P1|COMPLETED|Overall Study||29
8257630|NCT01814813|20362191|P3|STARTED|Overall Study||31
8257631|NCT01814813|20362192|P2|STARTED|Overall Study||30
8257632|NCT01814813|20362193|P1|STARTED|Overall Study||29
8257633|NCT01814800|20362207|P1|NOT COMPLETED|Overall Study||5
8257634|NCT01814800|20362207|P1|COMPLETED|Overall Study||54
8257635|NCT01814800|20362207|P1|STARTED|Overall Study||59
8257636|NCT01814787|20362246|P2|NOT COMPLETED|Overall Study||0
8257637|NCT01814787|20362247|P1|NOT COMPLETED|Overall Study||0
8257638|NCT01814787|20362246|P2|COMPLETED|Overall Study||684
8257639|NCT01814787|20362247|P1|COMPLETED|Overall Study||685
8257640|NCT01814787|20362246|P2|STARTED|Overall Study||684
8257641|NCT01814787|20362247|P1|STARTED|Overall Study||685
8257642|NCT01814774|20362253|P1|NOT COMPLETED|Overall Study||0
8257643|NCT01814774|20362253|P1|COMPLETED|Overall Study||48
8257644|NCT01814774|20362253|P1|STARTED|Overall Study||48
8257645|NCT01814761|20362267|P2|NOT COMPLETED|Overall Study||30
8257646|NCT01814761|20362268|P1|NOT COMPLETED|Overall Study||8
8257647|NCT01814761|20362267|P2|COMPLETED|Overall Study||240
8257648|NCT01814761|20362268|P1|COMPLETED|Overall Study||34
8257649|NCT01814761|20362267|P2|STARTED|Overall Study||270
8257650|NCT01814761|20362268|P1|STARTED|Overall Study||42
8257651|NCT01814748|20362282|P2|NOT COMPLETED|Overall Study||7
8257652|NCT01814748|20362283|P1|NOT COMPLETED|Overall Study||8
8257653|NCT01814748|20362282|P2|COMPLETED|Overall Study||94
8257654|NCT01814748|20362283|P1|COMPLETED|Overall Study||94
8257655|NCT01814748|20362282|P2|STARTED|Overall Study||101
8257656|NCT01814748|20362283|P1|STARTED|Overall Study||102
8257657|NCT01814722|20362306|P3|NOT COMPLETED|Overall Study||0
8257658|NCT01814722|20362307|P2|NOT COMPLETED|Overall Study||0
8257659|NCT01814722|20362308|P1|NOT COMPLETED|Overall Study||0
8257660|NCT01814722|20362306|P3|COMPLETED|Overall Study||6
8257661|NCT01814722|20362307|P2|COMPLETED|Overall Study||21
8257662|NCT01814722|20362308|P1|COMPLETED|Overall Study||36
8257663|NCT01814722|20362306|P3|STARTED|Overall Study||6
8257664|NCT01814722|20362307|P2|STARTED|Overall Study||21
8257665|NCT01814722|20362308|P1|STARTED|Overall Study||36
8257666|NCT01814696|20362327|P2|NOT COMPLETED|Overall Study||0
8257667|NCT01814696|20362328|P1|NOT COMPLETED|Overall Study||2
8257668|NCT01814696|20362327|P2|COMPLETED|Overall Study||11
8257669|NCT01814696|20362328|P1|COMPLETED|Overall Study||13
8257670|NCT01814696|20362327|P2|STARTED|Overall Study||11
8257671|NCT01814696|20362328|P1|STARTED|Overall Study||15
8257672|NCT01814670|20362346|P1|NOT COMPLETED|Overall Study||12
8257673|NCT01814670|20362346|P1|COMPLETED|Overall Study||173
8257674|NCT01814670|20362346|P1|STARTED|Overall Study||185
8257675|NCT01814553|20362356|P2|NOT COMPLETED|Overall Study||22
8257676|NCT01814553|20362357|P1|NOT COMPLETED|Overall Study||18
8257677|NCT01814553|20362356|P2|COMPLETED|Overall Study||0
8257678|NCT01814553|20362357|P1|COMPLETED|Overall Study||0
8257679|NCT01814553|20362356|P2|STARTED|Overall Study||22
8257680|NCT01814553|20362357|P1|STARTED|Overall Study||18
8257681|NCT01814397|20362371|P1|NOT COMPLETED|Overall Study||14
8257682|NCT01814397|20362371|P1|COMPLETED|Overall Study||36
8257683|NCT01814397|20362371|P1|3 Month Evaluation|Overall Study||43
8257684|NCT01814397|20362371|P1|STARTED|Overall Study||50
8257685|NCT01814371|20362380|P2|NOT COMPLETED|Overall Study||27
8257686|NCT01814371|20362381|P1|NOT COMPLETED|Overall Study||30
8257687|NCT01814371|20362380|P2|COMPLETED|Overall Study||199
8257688|NCT01814371|20362381|P1|COMPLETED|Overall Study||218
8257689|NCT01814371|20362380|P2|STARTED|Overall Study||226
8257690|NCT01814371|20362381|P1|STARTED|Overall Study||248
8257691|NCT01814332|20362416|P2|NOT COMPLETED|Overall Study||16
8257692|NCT01814332|20362417|P1|NOT COMPLETED|Overall Study||16
8257693|NCT01814332|20362416|P2|COMPLETED|Overall Study||49
8257694|NCT01814332|20362417|P1|COMPLETED|Overall Study||47
8257695|NCT01814332|20362416|P2|STARTED|Overall Study||65
8257696|NCT01814332|20362417|P1|STARTED|Overall Study||63
8257697|NCT01814241|20362429|P1|NOT COMPLETED|Overall Study||4
8257698|NCT01814241|20362429|P1|COMPLETED|Overall Study||16
8257699|NCT01814241|20362429|P1|STARTED|Overall Study||20
8257700|NCT01814137|20362439|P2|NOT COMPLETED|Overall Study||5
8257701|NCT01814137|20362440|P1|NOT COMPLETED|Overall Study||5
8257702|NCT01814137|20362439|P2|COMPLETED|Overall Study||15
8257703|NCT01814137|20362440|P1|COMPLETED|Overall Study||15
8257704|NCT01814137|20362439|P2|STARTED|Overall Study||20
8257705|NCT01814137|20362440|P1|STARTED|Overall Study||20
8257706|NCT01814072|20362486|P32|NOT COMPLETED|Overall Study||0
8257707|NCT01814072|20362487|P31|NOT COMPLETED|Overall Study||2
8257708|NCT01814072|20362488|P30|NOT COMPLETED|Overall Study||3
8257709|NCT01814072|20362489|P29|NOT COMPLETED|Overall Study||4
8257710|NCT01814072|20362490|P28|NOT COMPLETED|Overall Study||4
8257711|NCT01814072|20362491|P27|NOT COMPLETED|Overall Study||2
8257712|NCT01814072|20362492|P26|NOT COMPLETED|Overall Study||2
8257713|NCT01814072|20362493|P25|NOT COMPLETED|Overall Study||6
8257714|NCT01814072|20362494|P24|NOT COMPLETED|Overall Study||1
8257715|NCT01814072|20362495|P23|NOT COMPLETED|Overall Study||4
8257716|NCT01814072|20362496|P22|NOT COMPLETED|Overall Study||1
8257717|NCT01814072|20362497|P21|NOT COMPLETED|Overall Study||2
8257718|NCT01814072|20362498|P20|NOT COMPLETED|Overall Study||5
8257719|NCT01814072|20362499|P19|NOT COMPLETED|Overall Study||3
8257720|NCT01814072|20362500|P18|NOT COMPLETED|Overall Study||1
8257721|NCT01814072|20362501|P17|NOT COMPLETED|Overall Study||3
8257722|NCT01814072|20362502|P16|NOT COMPLETED|Overall Study||2
8257723|NCT01814072|20362503|P15|NOT COMPLETED|Overall Study||3
8257724|NCT01814072|20362504|P14|NOT COMPLETED|Overall Study||2
8257725|NCT01814072|20362505|P13|NOT COMPLETED|Overall Study||3
8257726|NCT01814072|20362506|P12|NOT COMPLETED|Overall Study||2
8257727|NCT01814072|20362507|P11|NOT COMPLETED|Overall Study||1
8257728|NCT01814072|20362508|P10|NOT COMPLETED|Overall Study||5
8257729|NCT01814072|20362509|P9|NOT COMPLETED|Overall Study||3
8257730|NCT01814072|20362510|P8|NOT COMPLETED|Overall Study||1
8257731|NCT01814072|20362511|P7|NOT COMPLETED|Overall Study||4
8257732|NCT01814072|20362512|P6|NOT COMPLETED|Overall Study||6
8257733|NCT01814072|20362513|P5|NOT COMPLETED|Overall Study||4
8257734|NCT01814072|20362514|P4|NOT COMPLETED|Overall Study||0
8257735|NCT01814072|20362515|P3|NOT COMPLETED|Overall Study||3
8257736|NCT01814072|20362516|P2|NOT COMPLETED|Overall Study||2
8257737|NCT01814072|20362517|P1|NOT COMPLETED|Overall Study||4
8257738|NCT01814072|20362486|P32|COMPLETED|Overall Study||17
8257739|NCT01814072|20362487|P31|COMPLETED|Overall Study||15
8257740|NCT01814072|20362488|P30|COMPLETED|Overall Study||14
8257741|NCT01814072|20362489|P29|COMPLETED|Overall Study||14
8257742|NCT01814072|20362490|P28|COMPLETED|Overall Study||13
8257743|NCT01814072|20362491|P27|COMPLETED|Overall Study||16
8257744|NCT01814072|20362492|P26|COMPLETED|Overall Study||14
8257745|NCT01814072|20362493|P25|COMPLETED|Overall Study||11
8257746|NCT01814072|20362494|P24|COMPLETED|Overall Study||17
8257747|NCT01814072|20362495|P23|COMPLETED|Overall Study||13
8257748|NCT01814072|20362496|P22|COMPLETED|Overall Study||16
8257749|NCT01814072|20362497|P21|COMPLETED|Overall Study||14
8257750|NCT01814072|20362498|P20|COMPLETED|Overall Study||11
8257751|NCT01814072|20362499|P19|COMPLETED|Overall Study||14
8257752|NCT01814072|20362500|P18|COMPLETED|Overall Study||17
8257753|NCT01814072|20362501|P17|COMPLETED|Overall Study||14
8257754|NCT01814072|20362502|P16|COMPLETED|Overall Study||16
8257755|NCT01814072|20362503|P15|COMPLETED|Overall Study||15
8257756|NCT01814072|20362504|P14|COMPLETED|Overall Study||16
8257757|NCT01814072|20362505|P13|COMPLETED|Overall Study||15
8257758|NCT01814072|20362506|P12|COMPLETED|Overall Study||16
8257759|NCT01814072|20362507|P11|COMPLETED|Overall Study||17
8257760|NCT01814072|20362508|P10|COMPLETED|Overall Study||13
8257761|NCT01814072|20362509|P9|COMPLETED|Overall Study||16
8257762|NCT01814072|20362510|P8|COMPLETED|Overall Study||17
8257763|NCT01814072|20362511|P7|COMPLETED|Overall Study||14
8257764|NCT01814072|20362512|P6|COMPLETED|Overall Study||12
8257765|NCT01814072|20362513|P5|COMPLETED|Overall Study||14
8257766|NCT01814072|20362514|P4|COMPLETED|Overall Study||18
8257767|NCT01814072|20362515|P3|COMPLETED|Overall Study||15
8257768|NCT01814072|20362516|P2|COMPLETED|Overall Study||16
8257769|NCT01814072|20362517|P1|COMPLETED|Overall Study||14
8257770|NCT01814072|20362486|P32|Intent to Treat|Overall Study||0
8257771|NCT01814072|20362487|P31|Intent to Treat|Overall Study||2
8257772|NCT01814072|20362488|P30|Intent to Treat|Overall Study||3
8257773|NCT01814072|20362489|P29|Intent to Treat|Overall Study||4
8257774|NCT01814072|20362490|P28|Intent to Treat|Overall Study||4
8257775|NCT01814072|20362491|P27|Intent to Treat|Overall Study||2
8257776|NCT01814072|20362492|P26|Intent to Treat|Overall Study||2
8257777|NCT01814072|20362493|P25|Intent to Treat|Overall Study||6
8257778|NCT01814072|20362494|P24|Intent to Treat|Overall Study||1
8257779|NCT01814072|20362495|P23|Intent to Treat|Overall Study||4
8257780|NCT01814072|20362496|P22|Intent to Treat|Overall Study||1
8257781|NCT01814072|20362497|P21|Intent to Treat|Overall Study||2
8257782|NCT01814072|20362498|P20|Intent to Treat|Overall Study||5
8257783|NCT01814072|20362499|P19|Intent to Treat|Overall Study||3
8257784|NCT01814072|20362500|P18|Intent to Treat|Overall Study||1
8257785|NCT01814072|20362501|P17|Intent to Treat|Overall Study||3
8257786|NCT01814072|20362502|P16|Intent to Treat|Overall Study||2
8257787|NCT01814072|20362503|P15|Intent to Treat|Overall Study||3
8257788|NCT01814072|20362504|P14|Intent to Treat|Overall Study||2
8257789|NCT01814072|20362505|P13|Intent to Treat|Overall Study||3
8257790|NCT01814072|20362506|P12|Intent to Treat|Overall Study||2
8257791|NCT01814072|20362507|P11|Intent to Treat|Overall Study||1
8257792|NCT01814072|20362508|P10|Intent to Treat|Overall Study||5
8257793|NCT01814072|20362509|P9|Intent to Treat|Overall Study||3
8257794|NCT01814072|20362510|P8|Intent to Treat|Overall Study||1
8257795|NCT01814072|20362511|P7|Intent to Treat|Overall Study||4
8257796|NCT01814072|20362512|P6|Intent to Treat|Overall Study||6
8257797|NCT01814072|20362513|P5|Intent to Treat|Overall Study||4
8257798|NCT01814072|20362514|P4|Intent to Treat|Overall Study||0
8257799|NCT01814072|20362515|P3|Intent to Treat|Overall Study||3
8257800|NCT01814072|20362516|P2|Intent to Treat|Overall Study||2
8257801|NCT01814072|20362517|P1|Intent to Treat|Overall Study||4
8257802|NCT01814072|20362486|P32|3-mo Visit|Overall Study||17
8257803|NCT01814072|20362487|P31|3-mo Visit|Overall Study||16
8257804|NCT01814072|20362488|P30|3-mo Visit|Overall Study||16
8257805|NCT01814072|20362489|P29|3-mo Visit|Overall Study||15
8257806|NCT01814072|20362490|P28|3-mo Visit|Overall Study||14
8257807|NCT01814072|20362491|P27|3-mo Visit|Overall Study||17
8257808|NCT01814072|20362492|P26|3-mo Visit|Overall Study||14
8257809|NCT01814072|20362493|P25|3-mo Visit|Overall Study||13
8257810|NCT01814072|20362494|P24|3-mo Visit|Overall Study||18
8257811|NCT01814072|20362495|P23|3-mo Visit|Overall Study||15
8257812|NCT01814072|20362496|P22|3-mo Visit|Overall Study||17
8257813|NCT01814072|20362497|P21|3-mo Visit|Overall Study||15
8257814|NCT01814072|20362498|P20|3-mo Visit|Overall Study||13
8257815|NCT01814072|20362499|P19|3-mo Visit|Overall Study||14
8257816|NCT01814072|20362500|P18|3-mo Visit|Overall Study||16
8257817|NCT01814072|20362501|P17|3-mo Visit|Overall Study||16
8257818|NCT01814072|20362502|P16|3-mo Visit|Overall Study||16
8257819|NCT01814072|20362503|P15|3-mo Visit|Overall Study||16
8257820|NCT01814072|20362504|P14|3-mo Visit|Overall Study||16
8257821|NCT01814072|20362505|P13|3-mo Visit|Overall Study||16
8257822|NCT01814072|20362506|P12|3-mo Visit|Overall Study||17
8257823|NCT01814072|20362507|P11|3-mo Visit|Overall Study||18
8257824|NCT01814072|20362508|P10|3-mo Visit|Overall Study||15
8257825|NCT01814072|20362509|P9|3-mo Visit|Overall Study||18
8257826|NCT01814072|20362510|P8|3-mo Visit|Overall Study||18
8257827|NCT01814072|20362511|P7|3-mo Visit|Overall Study||16
8257828|NCT01814072|20362512|P6|3-mo Visit|Overall Study||15
8257829|NCT01814072|20362513|P5|3-mo Visit|Overall Study||15
8257830|NCT01814072|20362514|P4|3-mo Visit|Overall Study||18
8257831|NCT01814072|20362515|P3|3-mo Visit|Overall Study||16
8257832|NCT01814072|20362516|P2|3-mo Visit|Overall Study||18
8257833|NCT01814072|20362517|P1|3-mo Visit|Overall Study||15
8257834|NCT01814072|20362486|P32|STARTED|Overall Study||17
8257835|NCT01814072|20362487|P31|STARTED|Overall Study||17
8257836|NCT01814072|20362488|P30|STARTED|Overall Study||17
8257837|NCT01814072|20362489|P29|STARTED|Overall Study||18
8257838|NCT01814072|20362490|P28|STARTED|Overall Study||17
8257839|NCT01814072|20362491|P27|STARTED|Overall Study||18
8257840|NCT01814072|20362492|P26|STARTED|Overall Study||16
8257841|NCT01814072|20362493|P25|STARTED|Overall Study||17
8257842|NCT01814072|20362494|P24|STARTED|Overall Study||18
8257843|NCT01814072|20362495|P23|STARTED|Overall Study||17
8257844|NCT01814072|20362496|P22|STARTED|Overall Study||17
8257845|NCT01814072|20362497|P21|STARTED|Overall Study||16
8257846|NCT01814072|20362498|P20|STARTED|Overall Study||16
8257847|NCT01814072|20362499|P19|STARTED|Overall Study||17
8257848|NCT01814072|20362500|P18|STARTED|Overall Study||18
8257849|NCT01814072|20362501|P17|STARTED|Overall Study||17
8257850|NCT01814072|20362502|P16|STARTED|Overall Study||18
8257851|NCT01814072|20362503|P15|STARTED|Overall Study||18
8257852|NCT01814072|20362504|P14|STARTED|Overall Study||18
8257853|NCT01814072|20362505|P13|STARTED|Overall Study||18
8257854|NCT01814072|20362506|P12|STARTED|Overall Study||18
8257855|NCT01814072|20362507|P11|STARTED|Overall Study||18
8257856|NCT01814072|20362508|P10|STARTED|Overall Study||18
8257857|NCT01814072|20362509|P9|STARTED|Overall Study||19
8257858|NCT01814072|20362510|P8|STARTED|Overall Study||18
8257859|NCT01814072|20362511|P7|STARTED|Overall Study||18
8257860|NCT01814072|20362512|P6|STARTED|Overall Study||18
8257861|NCT01814072|20362513|P5|STARTED|Overall Study||18
8257862|NCT01814072|20362514|P4|STARTED|Overall Study||18
8257863|NCT01814072|20362515|P3|STARTED|Overall Study||18
8257864|NCT01814072|20362516|P2|STARTED|Overall Study||18
8257865|NCT01814072|20362517|P1|STARTED|Overall Study||18
8257866|NCT01814046|20362559|P3|NOT COMPLETED|Retreatment||0
8257867|NCT01814046|20362560|P2|NOT COMPLETED|Retreatment||0
8257868|NCT01814046|20362561|P1|NOT COMPLETED|Retreatment||0
8257869|NCT01814046|20362559|P3|COMPLETED|Retreatment||3
8257870|NCT01814046|20362560|P2|COMPLETED|Retreatment||0
8257871|NCT01814046|20362561|P1|COMPLETED|Retreatment||0
8257872|NCT01814046|20362559|P3|STARTED|Retreatment||3
8257873|NCT01814046|20362560|P2|STARTED|Retreatment||0
8257874|NCT01814046|20362561|P1|STARTED|Retreatment||0
8257875|NCT01814046|20362559|P3|NOT COMPLETED|Drug Administration||0
8257876|NCT01814046|20362560|P2|NOT COMPLETED|Drug Administration||0
8257877|NCT01814046|20362561|P1|NOT COMPLETED|Drug Administration||1
8257878|NCT01814046|20362559|P3|COMPLETED|Drug Administration||0
8257879|NCT01814046|20362560|P2|COMPLETED|Drug Administration||2
8257880|NCT01814046|20362561|P1|COMPLETED|Drug Administration||21
8257881|NCT01814046|20362559|P3|STARTED|Drug Administration||0
8257882|NCT01814046|20362560|P2|STARTED|Drug Administration||2
8257883|NCT01814046|20362561|P1|STARTED|Drug Administration||22
8257884|NCT01814007|20362572|P1|NOT COMPLETED|Overall Study||1
8257885|NCT01814007|20362572|P1|COMPLETED|Overall Study||34
8257886|NCT01814007|20362572|P1|STARTED|Overall Study||35
8257887|NCT01813890|20362585|P3|NOT COMPLETED|Overall Study||6
8257888|NCT01813890|20362586|P2|NOT COMPLETED|Overall Study||4
8257889|NCT01813890|20362587|P1|NOT COMPLETED|Overall Study||9
8257890|NCT01813890|20362585|P3|COMPLETED|Overall Study||13
8257891|NCT01813890|20362586|P2|COMPLETED|Overall Study||17
8257892|NCT01813890|20362587|P1|COMPLETED|Overall Study||11
8257893|NCT01813890|20362585|P3|STARTED|Overall Study||19
8257894|NCT01813890|20362586|P2|STARTED|Overall Study||21
8257895|NCT01813890|20362587|P1|STARTED|Overall Study||20
8257896|NCT01813734|20362616|P1|NOT COMPLETED|Overall Study||0
8257897|NCT01813734|20362616|P1|COMPLETED|Overall Study||9
8257898|NCT01813734|20362616|P1|STARTED|Overall Study||9
8257899|NCT01813721|20362624|P1|NOT COMPLETED|Overall Study||64
8257900|NCT01813721|20362624|P1|COMPLETED|Overall Study||943
8257901|NCT01813721|20362624|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
8257902|NCT01813474|20362679|P3|NOT COMPLETED|Overall Study||11
8257903|NCT01813474|20362680|P2|NOT COMPLETED|Overall Study||7
8257904|NCT01813474|20362681|P1|NOT COMPLETED|Overall Study||3
8257905|NCT01813474|20362679|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
8257906|NCT01813474|20362680|P2|COMPLETED|Overall Study||0
8257907|NCT01813474|20362681|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
8257908|NCT01813474|20362679|P3|STARTED|Overall Study||12
8257909|NCT01813474|20362680|P2|STARTED|Overall Study||7
8257910|NCT01813474|20362681|P1|STARTED|Overall Study||4
8257911|NCT01813435|20362705|P2|NOT COMPLETED|Overall Study||1007
8257912|NCT01813435|20362706|P1|NOT COMPLETED|Overall Study||2170
8257913|NCT01813435|20362705|P2|COMPLETED|Overall Study||6981
8257914|NCT01813435|20362706|P1|COMPLETED|Overall Study||5810
8257915|NCT01813435|20362705|P2|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
8257916|NCT01813435|20362706|P1|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
8257917|NCT01813422|20362730|P2|NOT COMPLETED|Overall Study||16
8257918|NCT01813422|20362731|P1|NOT COMPLETED|Overall Study||20
8257919|NCT01813422|20362730|P2|COMPLETED|Overall Study||468
8257920|NCT01813422|20362731|P1|COMPLETED|Overall Study||466
8257921|NCT01813422|20362730|P2|Received Treatment|Overall Study||484
8257922|NCT01813422|20362731|P1|Received Treatment|Overall Study||484
8257923|NCT01813422|20362730|P2|STARTED|Overall Study||484
8257924|NCT01813422|20362731|P1|STARTED|Overall Study||486
8257925|NCT01813357|20362745|P2|NOT COMPLETED|Overall Study||6
8257926|NCT01813357|20362746|P1|NOT COMPLETED|Overall Study||5
8257927|NCT01813357|20362745|P2|COMPLETED|Overall Study||38
8257928|NCT01813357|20362746|P1|COMPLETED|Overall Study||35
8257929|NCT01813357|20362745|P2|STARTED|Overall Study||44
8257930|NCT01813357|20362746|P1|STARTED|Overall Study||40
8257931|NCT01813214|20362756|P2|NOT COMPLETED|Overall Study||0
8257932|NCT01813214|20362757|P1|NOT COMPLETED|Overall Study||0
8257933|NCT01813214|20362756|P2|COMPLETED|Overall Study||2
8257934|NCT01813214|20362757|P1|COMPLETED|Overall Study||3
8257935|NCT01813214|20362756|P2|STARTED|Overall Study||2
8257936|NCT01813214|20362757|P1|STARTED|Overall Study||3
8257937|NCT01813149|20362770|P2|NOT COMPLETED|Overall Study||0
8257938|NCT01813149|20362771|P1|NOT COMPLETED|Overall Study||0
8257939|NCT01813149|20362770|P2|COMPLETED|Overall Study||38
8257940|NCT01813149|20362771|P1|COMPLETED|Overall Study||90
8257941|NCT01813149|20362770|P2|STARTED|Overall Study||38
8257942|NCT01813149|20362771|P1|STARTED|Overall Study||90
8257943|NCT01813110|20362782|P2|NOT COMPLETED|Overall Study||1
8257944|NCT01813110|20362783|P1|NOT COMPLETED|Overall Study||0
8257945|NCT01813110|20362782|P2|COMPLETED|Overall Study||10
8257946|NCT01813110|20362783|P1|COMPLETED|Overall Study||10
8257947|NCT01813110|20362782|P2|STARTED|Overall Study||11
8257948|NCT01813110|20362783|P1|STARTED|Overall Study||10
8257949|NCT01813071|20362802|P9|NOT COMPLETED|Overall Study||3
8257950|NCT01813071|20362803|P8|NOT COMPLETED|Overall Study||5
8257951|NCT01813071|20362804|P7|NOT COMPLETED|Overall Study||3
8257952|NCT01813071|20362805|P6|NOT COMPLETED|Overall Study||7
8257953|NCT01813071|20362806|P5|NOT COMPLETED|Overall Study||1
8257954|NCT01813071|20362807|P4|NOT COMPLETED|Overall Study||0
8257955|NCT01813071|20362808|P3|NOT COMPLETED|Overall Study||0
8257956|NCT01813071|20362809|P2|NOT COMPLETED|Overall Study||0
8257957|NCT01813071|20362810|P1|NOT COMPLETED|Overall Study||0
8257958|NCT01813071|20362802|P9|COMPLETED|Overall Study||13
8257959|NCT01813071|20362803|P8|COMPLETED|Overall Study||7
8257960|NCT01813071|20362804|P7|COMPLETED|Overall Study||9
8257961|NCT01813071|20362805|P6|COMPLETED|Overall Study||5
8257962|NCT01813071|20362806|P5|COMPLETED|Overall Study||11
8257963|NCT01813071|20362807|P4|COMPLETED|Overall Study||9
8257964|NCT01813071|20362808|P3|COMPLETED|Overall Study||10
8257965|NCT01813071|20362809|P2|COMPLETED|Overall Study||10
8257966|NCT01813071|20362810|P1|COMPLETED|Overall Study||10
8257967|NCT01813071|20362802|P9|STARTED|Overall Study||16
8257968|NCT01813071|20362803|P8|STARTED|Overall Study||12
8257969|NCT01813071|20362804|P7|STARTED|Overall Study||12
8257970|NCT01813071|20362805|P6|STARTED|Overall Study||12
8257971|NCT01813071|20362806|P5|STARTED|Overall Study||12
8257972|NCT01813071|20362807|P4|STARTED|Overall Study||9
8257973|NCT01813071|20362808|P3|STARTED|Overall Study||10
8257974|NCT01813071|20362809|P2|STARTED|Overall Study||10
8257975|NCT01813071|20362810|P1|STARTED|Overall Study||10
8257976|NCT01813058|20363277|P2|NOT COMPLETED|Overall Study||4
8257977|NCT01813058|20363278|P1|NOT COMPLETED|Overall Study||5
8257978|NCT01813058|20363277|P2|COMPLETED|Overall Study||56
8257979|NCT01813058|20363278|P1|COMPLETED|Overall Study||55
8257980|NCT01813058|20363277|P2|STARTED|Overall Study||60
8257981|NCT01813058|20363278|P1|STARTED|Overall Study||60
8257982|NCT01813019|20363286|P2|NOT COMPLETED|Overall Study||6
8257983|NCT01813019|20363287|P1|NOT COMPLETED|Overall Study||7
8257984|NCT01813019|20363286|P2|COMPLETED|Overall Study||20
8257985|NCT01813019|20363287|P1|COMPLETED|Overall Study||17
8257986|NCT01813019|20363286|P2|STARTED|Overall Study||26
8257987|NCT01813019|20363287|P1|STARTED|Overall Study||24
8257988|NCT01812837|20363298|P3|NOT COMPLETED|Overall Study||0
8257989|NCT01812837|20363299|P2|NOT COMPLETED|Overall Study||1
8257990|NCT01812837|20363300|P1|NOT COMPLETED|Overall Study||2
8257991|NCT01812837|20363298|P3|COMPLETED|Overall Study||17
8257992|NCT01812837|20363299|P2|COMPLETED|Overall Study||16
8257993|NCT01812837|20363300|P1|COMPLETED|Overall Study||15
8257994|NCT01812837|20363298|P3|STARTED|Overall Study||17
8257995|NCT01812837|20363299|P2|STARTED|Overall Study||17
8257996|NCT01812837|20363300|P1|STARTED|Overall Study||17
8257997|NCT01812759|20363311|P3|NOT COMPLETED|Overall Study||1
8257998|NCT01812759|20363312|P2|NOT COMPLETED|Overall Study||0
8257999|NCT01812759|20363313|P1|NOT COMPLETED|Overall Study||0
8258000|NCT01812759|20363311|P3|COMPLETED|Overall Study||0
8258001|NCT01812759|20363312|P2|COMPLETED|Overall Study||1
8258002|NCT01812759|20363313|P1|COMPLETED|Overall Study||1
8258003|NCT01812759|20363311|P3|STARTED|Overall Study||1
8258004|NCT01812759|20363312|P2|STARTED|Overall Study||1
8258005|NCT01812759|20363313|P1|STARTED|Overall Study||1
8258006|NCT01812707|20363325|P4|NOT COMPLETED|Overall Study||2
8258007|NCT01812707|20363326|P3|NOT COMPLETED|Overall Study||0
8258008|NCT01812707|20363327|P2|NOT COMPLETED|Overall Study||0
8258009|NCT01812707|20363328|P1|NOT COMPLETED|Overall Study||2
8258010|NCT01812707|20363325|P4|COMPLETED|Overall Study||23
8258011|NCT01812707|20363326|P3|COMPLETED|Overall Study||25
8258012|NCT01812707|20363327|P2|COMPLETED|Overall Study||25
8258013|NCT01812707|20363328|P1|COMPLETED|Overall Study||23
8258014|NCT01812707|20363325|P4|Treated|Overall Study||25
8258015|NCT01812707|20363326|P3|Treated|Overall Study||25
8258016|NCT01812707|20363327|P2|Treated|Overall Study||25
8258017|NCT01812707|20363328|P1|Treated|Overall Study||25
8258018|NCT01812707|20363325|P4|STARTED|Overall Study||25
8258019|NCT01812707|20363326|P3|STARTED|Overall Study||25
8258020|NCT01812707|20363327|P2|STARTED|Overall Study||25
8258021|NCT01812707|20363328|P1|STARTED|Overall Study||25
8258022|NCT01812681|20363364|P2|NOT COMPLETED|Overall Study||0
8258023|NCT01812681|20363365|P1|NOT COMPLETED|Overall Study||3
8258024|NCT01812681|20363364|P2|COMPLETED|Overall Study||24
8258025|NCT01812681|20363365|P1|COMPLETED|Overall Study||57
8258026|NCT01812681|20363364|P2|STARTED|Overall Study||24
8258027|NCT01812681|20363365|P1|STARTED|Overall Study||60
8258028|NCT01812655|20363376|P3|NOT COMPLETED|Overall Study||0
8258029|NCT01812655|20363377|P2|NOT COMPLETED|Overall Study||1
8258030|NCT01812655|20363378|P1|NOT COMPLETED|Overall Study||1
8258031|NCT01812655|20363376|P3|COMPLETED|Overall Study||10
8258032|NCT01812655|20363377|P2|COMPLETED|Overall Study||10
8258033|NCT01812655|20363378|P1|COMPLETED|Overall Study||8
8258034|NCT01812655|20363376|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
8258035|NCT01812655|20363377|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
8258129|NCT01811654|20363611|P1|STARTED|Overall Study||14
8258036|NCT01812655|20363378|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
8258037|NCT01812473|20363394|P2|NOT COMPLETED|Overall Study||0
8258038|NCT01812473|20363395|P1|NOT COMPLETED|Overall Study||0
8258039|NCT01812473|20363394|P2|COMPLETED|Overall Study||13
8258040|NCT01812473|20363395|P1|COMPLETED|Overall Study||22
8258041|NCT01812473|20363394|P2|STARTED|Overall Study||13
8258042|NCT01812473|20363395|P1|STARTED|Overall Study||22
8258043|NCT01812057|20363403|P2|NOT COMPLETED|Overall Study||0
8258044|NCT01812057|20363404|P1|NOT COMPLETED|Overall Study||2
8258045|NCT01812057|20363403|P2|COMPLETED|Overall Study||24
8258046|NCT01812057|20363404|P1|COMPLETED|Overall Study||23
8258047|NCT01812057|20363403|P2|STARTED|Overall Study||24
8258048|NCT01812057|20363404|P1|STARTED|Overall Study||25
8258049|NCT01812044|20363445|P3|NOT COMPLETED|Overall Study||0
8258050|NCT01812044|20363446|P2|NOT COMPLETED|Overall Study||0
8258051|NCT01812044|20363447|P1|NOT COMPLETED|Overall Study||0
8258052|NCT01812044|20363445|P3|COMPLETED|Overall Study||16
8258053|NCT01812044|20363446|P2|COMPLETED|Overall Study||17
8258054|NCT01812044|20363447|P1|COMPLETED|Overall Study||17
8258055|NCT01812044|20363445|P3|STARTED|Overall Study||16
8258056|NCT01812044|20363446|P2|STARTED|Overall Study||17
8258057|NCT01812044|20363447|P1|STARTED|Overall Study||17
8258058|NCT01812005|20363478|P2|NOT COMPLETED|Overall Study||0
8258059|NCT01812005|20363479|P1|NOT COMPLETED|Overall Study||0
8258060|NCT01812005|20363478|P2|COMPLETED|Overall Study||13
8258061|NCT01812005|20363479|P1|COMPLETED|Overall Study||1
8258062|NCT01812005|20363478|P2|STARTED|Overall Study||13
8258063|NCT01812005|20363479|P1|STARTED|Overall Study||1
8258064|NCT01811953|20363507|P6|NOT COMPLETED|Overall Study||1
8258065|NCT01811953|20363508|P5|NOT COMPLETED|Overall Study||1
8258066|NCT01811953|20363509|P4|NOT COMPLETED|Overall Study||1
8258067|NCT01811953|20363510|P3|NOT COMPLETED|Overall Study||0
8258068|NCT01811953|20363511|P2|NOT COMPLETED|Overall Study||0
8258069|NCT01811953|20363512|P1|NOT COMPLETED|Overall Study||0
8258070|NCT01811953|20363507|P6|COMPLETED|Overall Study||11
8258071|NCT01811953|20363508|P5|COMPLETED|Overall Study||11
8258072|NCT01811953|20363509|P4|COMPLETED|Overall Study||5
8258073|NCT01811953|20363510|P3|COMPLETED|Overall Study||6
8258074|NCT01811953|20363511|P2|COMPLETED|Overall Study||6
8258075|NCT01811953|20363512|P1|COMPLETED|Overall Study||6
8258076|NCT01811953|20363507|P6|STARTED|Overall Study||12
8258077|NCT01811953|20363508|P5|STARTED|Overall Study||12
8258078|NCT01811953|20363509|P4|STARTED|Overall Study||6
8258079|NCT01811953|20363510|P3|STARTED|Overall Study||6
8258080|NCT01811953|20363511|P2|STARTED|Overall Study||6
8258081|NCT01811953|20363512|P1|STARTED|Overall Study||6
8258082|NCT01811940|20363558|P2|NOT COMPLETED|Overall Study||26
8258083|NCT01811940|20363559|P1|NOT COMPLETED|Overall Study||22
8258084|NCT01811940|20363558|P2|COMPLETED|Overall Study||37
8258085|NCT01811940|20363559|P1|COMPLETED|Overall Study||42
8258086|NCT01811940|20363558|P2|STARTED|Overall Study||63
8258087|NCT01811940|20363559|P1|STARTED|Overall Study||64
8258088|NCT01811732|20363569|P2|NOT COMPLETED|Overall Study||58
8258089|NCT01811732|20363570|P1|NOT COMPLETED|Overall Study||55
8258090|NCT01811732|20363569|P2|COMPLETED|Overall Study||271
8258091|NCT01811732|20363570|P1|COMPLETED|Overall Study||276
8258092|NCT01811732|20363569|P2|STARTED|Overall Study||329
8258093|NCT01811732|20363570|P1|STARTED|Overall Study||331
8258094|NCT01811706|20363580|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8258095|NCT01811706|20363581|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8258096|NCT01811706|20363580|P2|COMPLETED|Second Intervention (4 Weeks)||10
8258097|NCT01811706|20363581|P1|COMPLETED|Second Intervention (4 Weeks)||9
8258098|NCT01811706|20363580|P2|STARTED|Second Intervention (4 Weeks)||10
8258099|NCT01811706|20363581|P1|STARTED|Second Intervention (4 Weeks)||9
8258100|NCT01811706|20363580|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
8258101|NCT01811706|20363581|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
8258102|NCT01811706|20363580|P2|COMPLETED|Washout ( 2 Weeks)||10
8258103|NCT01811706|20363581|P1|COMPLETED|Washout ( 2 Weeks)||9
8258104|NCT01811706|20363580|P2|STARTED|Washout ( 2 Weeks)||10
8258105|NCT01811706|20363581|P1|STARTED|Washout ( 2 Weeks)||9
8258106|NCT01811706|20363580|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
8258107|NCT01811706|20363581|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
8258108|NCT01811706|20363580|P2|COMPLETED|First Intervention ( 4 Weeks)||10
8258109|NCT01811706|20363581|P1|COMPLETED|First Intervention ( 4 Weeks)||9
8258110|NCT01811706|20363580|P2|STARTED|First Intervention ( 4 Weeks)||10
8258111|NCT01811706|20363581|P1|STARTED|First Intervention ( 4 Weeks)||10
8258112|NCT01811693|20363594|P3|NOT COMPLETED|Overall Study||0
8258113|NCT01811693|20363595|P2|NOT COMPLETED|Overall Study||0
8258114|NCT01811693|20363596|P1|NOT COMPLETED|Overall Study||0
8258115|NCT01811693|20363594|P3|COMPLETED|Overall Study||0
8258116|NCT01811693|20363595|P2|COMPLETED|Overall Study||0
8258117|NCT01811693|20363596|P1|COMPLETED|Overall Study||4
8258118|NCT01811693|20363594|P3|STARTED|Overall Study||0
8258119|NCT01811693|20363595|P2|STARTED|Overall Study||0
8258120|NCT01811693|20363596|P1|STARTED|Overall Study||4
8258121|NCT01811680|20363603|P1|NOT COMPLETED|Overall Study||0
8258122|NCT01811680|20363603|P1|COMPLETED|Overall Study||10
8258123|NCT01811680|20363603|P1|STARTED|Overall Study||10
8258124|NCT01811654|20363610|P2|NOT COMPLETED|Overall Study||0
8258125|NCT01811654|20363611|P1|NOT COMPLETED|Overall Study||0
8258126|NCT01811654|20363610|P2|COMPLETED|Overall Study||16
8258127|NCT01811654|20363611|P1|COMPLETED|Overall Study||14
8258128|NCT01811654|20363610|P2|STARTED|Overall Study||16
8258130|NCT01811563|20363621|P2|NOT COMPLETED|Overall Study||3
8258131|NCT01811563|20363622|P1|NOT COMPLETED|Overall Study||5
8258132|NCT01811563|20363621|P2|COMPLETED|Overall Study||20
8258133|NCT01811563|20363622|P1|COMPLETED|Overall Study||20
8258134|NCT01811563|20363621|P2|STARTED|Overall Study||23
8258135|NCT01811563|20363622|P1|STARTED|Overall Study||25
8258136|NCT01811485|20363651|P3|NOT COMPLETED|Overall Study||5
8258137|NCT01811485|20363652|P2|NOT COMPLETED|Overall Study||4
8258138|NCT01811485|20363653|P1|NOT COMPLETED|Overall Study||2
8258139|NCT01811485|20363651|P3|COMPLETED|Overall Study||51
8258140|NCT01811485|20363652|P2|COMPLETED|Overall Study||55
8258141|NCT01811485|20363653|P1|COMPLETED|Overall Study||54
8258142|NCT01811485|20363651|P3|STARTED|Overall Study||56
8258143|NCT01811485|20363652|P2|STARTED|Overall Study||59
8258144|NCT01811485|20363653|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
8258145|NCT01811472|20363673|P3|NOT COMPLETED|Overall Study||5
8258146|NCT01811472|20363674|P2|NOT COMPLETED|Overall Study||0
8258147|NCT01811472|20363675|P1|NOT COMPLETED|Overall Study||2
8258148|NCT01811472|20363673|P3|COMPLETED|Overall Study||16
8258149|NCT01811472|20363674|P2|COMPLETED|Overall Study||11
8258150|NCT01811472|20363675|P1|COMPLETED|Overall Study||18
8258151|NCT01811472|20363673|P3|STARTED|Overall Study||21
8258152|NCT01811472|20363674|P2|STARTED|Overall Study||11
8258153|NCT01811472|20363675|P1|STARTED|Overall Study||20
8258154|NCT01811355|20363720|P2|NOT COMPLETED|Second Dose||0
8258155|NCT01811355|20363721|P1|NOT COMPLETED|Second Dose||0
8258156|NCT01811355|20363720|P2|COMPLETED|Second Dose||12
8258157|NCT01811355|20363721|P1|COMPLETED|Second Dose||9
8258158|NCT01811355|20363720|P2|STARTED|Second Dose||12
8258159|NCT01811355|20363721|P1|STARTED|Second Dose||9
8258160|NCT01811355|20363720|P2|NOT COMPLETED|Washout||0
8258161|NCT01811355|20363721|P1|NOT COMPLETED|Washout||0
8258162|NCT01811355|20363720|P2|COMPLETED|Washout||12
8258163|NCT01811355|20363721|P1|COMPLETED|Washout||9
8258164|NCT01811355|20363720|P2|STARTED|Washout||12
8258165|NCT01811355|20363721|P1|STARTED|Washout||9
8258166|NCT01811355|20363720|P2|NOT COMPLETED|First Dose||0
8258167|NCT01811355|20363721|P1|NOT COMPLETED|First Dose||2
8258168|NCT01811355|20363720|P2|COMPLETED|First Dose||12
8258169|NCT01811355|20363721|P1|COMPLETED|First Dose||9
8258170|NCT01811355|20363720|P2|STARTED|First Dose||12
8258171|NCT01811355|20363721|P1|STARTED|First Dose||11
8258172|NCT01811316|20363732|P3|NOT COMPLETED|Overall Study||0
8258173|NCT01811316|20363733|P2|NOT COMPLETED|Overall Study||0
8258174|NCT01811316|20363734|P1|NOT COMPLETED|Overall Study||3
8258175|NCT01811316|20363732|P3|COMPLETED|Overall Study||19
8258176|NCT01811316|20363733|P2|COMPLETED|Overall Study||22
8258177|NCT01811316|20363734|P1|COMPLETED|Overall Study||18
8258178|NCT01811316|20363732|P3|Visit 12 Weeks|Overall Study||19
8258179|NCT01811316|20363733|P2|Visit 12 Weeks|Overall Study||22
8258180|NCT01811316|20363734|P1|Visit 12 Weeks|Overall Study||18
8258181|NCT01811316|20363732|P3|Visit 4 Weeks|Overall Study||19
8258182|NCT01811316|20363733|P2|Visit 4 Weeks|Overall Study||22
8258183|NCT01811316|20363734|P1|Visit 4 Weeks|Overall Study||19
8258184|NCT01811316|20363732|P3|STARTED|Overall Study||19
8258185|NCT01811316|20363733|P2|STARTED|Overall Study||22
8258186|NCT01811316|20363734|P1|STARTED|Overall Study||21
8258187|NCT01811303|20363751|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258188|NCT01811303|20363752|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258189|NCT01811303|20363753|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258190|NCT01811303|20363754|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258191|NCT01811303|20363751|P4|COMPLETED|Fourth Intervention (1 Day)||2
8258192|NCT01811303|20363752|P3|COMPLETED|Fourth Intervention (1 Day)||4
8258193|NCT01811303|20363753|P2|COMPLETED|Fourth Intervention (1 Day)||4
8258194|NCT01811303|20363754|P1|COMPLETED|Fourth Intervention (1 Day)||4
8258195|NCT01811303|20363751|P4|STARTED|Fourth Intervention (1 Day)||2
8258196|NCT01811303|20363752|P3|STARTED|Fourth Intervention (1 Day)||4
8258197|NCT01811303|20363753|P2|STARTED|Fourth Intervention (1 Day)||4
8258198|NCT01811303|20363754|P1|STARTED|Fourth Intervention (1 Day)||4
8258199|NCT01811303|20363751|P4|NOT COMPLETED|Washout (2 Days or More)||0
8258200|NCT01811303|20363752|P3|NOT COMPLETED|Washout (2 Days or More)||0
8258201|NCT01811303|20363753|P2|NOT COMPLETED|Washout (2 Days or More)||0
8258202|NCT01811303|20363754|P1|NOT COMPLETED|Washout (2 Days or More)||0
8258203|NCT01811303|20363751|P4|COMPLETED|Washout (2 Days or More)||2
8258204|NCT01811303|20363752|P3|COMPLETED|Washout (2 Days or More)||4
8258205|NCT01811303|20363753|P2|COMPLETED|Washout (2 Days or More)||4
8258206|NCT01811303|20363754|P1|COMPLETED|Washout (2 Days or More)||4
8258207|NCT01811303|20363751|P4|STARTED|Washout (2 Days or More)||2
8258208|NCT01811303|20363752|P3|STARTED|Washout (2 Days or More)||4
8258209|NCT01811303|20363753|P2|STARTED|Washout (2 Days or More)||4
8258210|NCT01811303|20363754|P1|STARTED|Washout (2 Days or More)||4
8258211|NCT01811303|20363751|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8258212|NCT01811303|20363752|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8258213|NCT01811303|20363753|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8258214|NCT01811303|20363754|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8258215|NCT01811303|20363751|P4|COMPLETED|Third Intervention (1 Day)||2
8258216|NCT01811303|20363752|P3|COMPLETED|Third Intervention (1 Day)||4
8258217|NCT01811303|20363753|P2|COMPLETED|Third Intervention (1 Day)||4
8258218|NCT01811303|20363754|P1|COMPLETED|Third Intervention (1 Day)||4
8258219|NCT01811303|20363751|P4|STARTED|Third Intervention (1 Day)||2
8258220|NCT01811303|20363752|P3|STARTED|Third Intervention (1 Day)||4
8258221|NCT01811303|20363753|P2|STARTED|Third Intervention (1 Day)||4
8258222|NCT01811303|20363754|P1|STARTED|Third Intervention (1 Day)||4
8258223|NCT01811303|20363751|P4|NOT COMPLETED|Washout (2 Days or More)||0
8258224|NCT01811303|20363752|P3|NOT COMPLETED|Washout (2 Days or More)||0
8258225|NCT01811303|20363753|P2|NOT COMPLETED|Washout (2 Days or More)||0
8258226|NCT01811303|20363754|P1|NOT COMPLETED|Washout (2 Days or More)||0
8258227|NCT01811303|20363751|P4|COMPLETED|Washout (2 Days or More)||2
8258228|NCT01811303|20363752|P3|COMPLETED|Washout (2 Days or More)||4
8258229|NCT01811303|20363753|P2|COMPLETED|Washout (2 Days or More)||4
8258230|NCT01811303|20363754|P1|COMPLETED|Washout (2 Days or More)||4
8258231|NCT01811303|20363751|P4|STARTED|Washout (2 Days or More)||2
8258232|NCT01811303|20363752|P3|STARTED|Washout (2 Days or More)||4
8258233|NCT01811303|20363753|P2|STARTED|Washout (2 Days or More)||4
8258234|NCT01811303|20363754|P1|STARTED|Washout (2 Days or More)||4
8258235|NCT01811303|20363751|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8258236|NCT01811303|20363752|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8258237|NCT01811303|20363753|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8258238|NCT01811303|20363754|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8258239|NCT01811303|20363751|P4|COMPLETED|Second Intervention (1 Day)||2
8258240|NCT01811303|20363752|P3|COMPLETED|Second Intervention (1 Day)||4
8258241|NCT01811303|20363753|P2|COMPLETED|Second Intervention (1 Day)||4
8258242|NCT01811303|20363754|P1|COMPLETED|Second Intervention (1 Day)||4
8258243|NCT01811303|20363751|P4|STARTED|Second Intervention (1 Day)||2
8258244|NCT01811303|20363752|P3|STARTED|Second Intervention (1 Day)||4
8258245|NCT01811303|20363753|P2|STARTED|Second Intervention (1 Day)||4
8258246|NCT01811303|20363754|P1|STARTED|Second Intervention (1 Day)||4
8258247|NCT01811303|20363751|P4|NOT COMPLETED|Washout (2 Days or More)||0
8258248|NCT01811303|20363752|P3|NOT COMPLETED|Washout (2 Days or More)||0
8258249|NCT01811303|20363753|P2|NOT COMPLETED|Washout (2 Days or More)||0
8258250|NCT01811303|20363754|P1|NOT COMPLETED|Washout (2 Days or More)||0
8258251|NCT01811303|20363751|P4|COMPLETED|Washout (2 Days or More)||2
8258252|NCT01811303|20363752|P3|COMPLETED|Washout (2 Days or More)||4
8258253|NCT01811303|20363753|P2|COMPLETED|Washout (2 Days or More)||4
8258254|NCT01811303|20363754|P1|COMPLETED|Washout (2 Days or More)||4
8258255|NCT01811303|20363751|P4|STARTED|Washout (2 Days or More)||2
8258256|NCT01811303|20363752|P3|STARTED|Washout (2 Days or More)||4
8258257|NCT01811303|20363753|P2|STARTED|Washout (2 Days or More)||4
8258258|NCT01811303|20363754|P1|STARTED|Washout (2 Days or More)||4
8258259|NCT01811303|20363751|P4|NOT COMPLETED|First Intervention (1 Day)||0
8258260|NCT01811303|20363752|P3|NOT COMPLETED|First Intervention (1 Day)||0
8258261|NCT01811303|20363753|P2|NOT COMPLETED|First Intervention (1 Day)||0
8258262|NCT01811303|20363754|P1|NOT COMPLETED|First Intervention (1 Day)||0
8258263|NCT01811303|20363751|P4|COMPLETED|First Intervention (1 Day)||2
8258264|NCT01811303|20363752|P3|COMPLETED|First Intervention (1 Day)||4
8258265|NCT01811303|20363753|P2|COMPLETED|First Intervention (1 Day)||4
8258266|NCT01811303|20363754|P1|COMPLETED|First Intervention (1 Day)||4
8258267|NCT01811303|20363751|P4|STARTED|First Intervention (1 Day)||2
8258268|NCT01811303|20363752|P3|STARTED|First Intervention (1 Day)||4
8258269|NCT01811303|20363753|P2|STARTED|First Intervention (1 Day)||4
8258270|NCT01811303|20363754|P1|STARTED|First Intervention (1 Day)||4
8258271|NCT01811238|20363762|P1|NOT COMPLETED|Overall Study||81
8258272|NCT01811238|20363762|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
8258273|NCT01811238|20363762|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
8258274|NCT01811238|20363762|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
8258275|NCT01811238|20363762|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
8258276|NCT01811238|20363762|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
8258277|NCT01811225|20363771|P2|NOT COMPLETED|Treatment Period 2||6
8258278|NCT01811225|20363772|P1|NOT COMPLETED|Treatment Period 2||4
8258279|NCT01811225|20363771|P2|COMPLETED|Treatment Period 2||23
8258280|NCT01811225|20363772|P1|COMPLETED|Treatment Period 2||20
8258281|NCT01811225|20363771|P2|STARTED|Treatment Period 2||29
8258282|NCT01811225|20363772|P1|STARTED|Treatment Period 2||24
8258283|NCT01811225|20363771|P2|NOT COMPLETED|Treatment Period 1||17
8258284|NCT01811225|20363772|P1|NOT COMPLETED|Treatment Period 1||25
8258285|NCT01811225|20363771|P2|COMPLETED|Treatment Period 1||29
8258286|NCT01811225|20363772|P1|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
8258287|NCT01811225|20363771|P2|STARTED|Treatment Period 1||46
8258288|NCT01811225|20363772|P1|STARTED|Treatment Period 1||49
8258289|NCT01811212|20363782|P1|NOT COMPLETED|Overall Study||0
8258290|NCT01811212|20363782|P1|COMPLETED|Overall Study||25
8258291|NCT01811212|20363782|P1|STARTED|Overall Study||25
8258292|NCT01811186|20363797|P2|NOT COMPLETED|Overall Study||62
8258293|NCT01811186|20363798|P1|NOT COMPLETED|Overall Study||71
8258294|NCT01811186|20363797|P2|COMPLETED|Overall Study||64
8258295|NCT01811186|20363798|P1|COMPLETED|Overall Study||61
8258296|NCT01811186|20363797|P2|STARTED|Overall Study||126
8258297|NCT01811186|20363798|P1|STARTED|Overall Study||132
8258298|NCT01811147|20363818|P4|NOT COMPLETED|Overall Study||29
8258299|NCT01811147|20363819|P3|NOT COMPLETED|Overall Study||43
8258300|NCT01811147|20363820|P2|NOT COMPLETED|Overall Study||45
8258301|NCT01811147|20363821|P1|NOT COMPLETED|Overall Study||36
8258302|NCT01811147|20363818|P4|COMPLETED|Overall Study||4
8258303|NCT01811147|20363819|P3|COMPLETED|Overall Study||6
8258304|NCT01811147|20363820|P2|COMPLETED|Overall Study||11
8258305|NCT01811147|20363821|P1|COMPLETED|Overall Study||15
8258306|NCT01811147|20363818|P4|STARTED|Overall Study||33
8258307|NCT01811147|20363819|P3|STARTED|Overall Study||49
8258308|NCT01811147|20363820|P2|STARTED|Overall Study||56
8258309|NCT01811147|20363821|P1|STARTED|Overall Study||51
8258310|NCT01811030|20363835|P1|NOT COMPLETED|Overall Study||13
8258311|NCT01811030|20363835|P1|COMPLETED|Overall Study||20
8258312|NCT01811030|20363835|P1|STARTED|Overall Study||33
8258313|NCT01811004|20363842|P2|NOT COMPLETED|Overall Study||3
8258314|NCT01811004|20363843|P1|NOT COMPLETED|Overall Study||1
8258315|NCT01811004|20363842|P2|COMPLETED|Overall Study||5
8258316|NCT01811004|20363843|P1|COMPLETED|Overall Study||8
8258317|NCT01811004|20363842|P2|STARTED|Overall Study||8
8258318|NCT01811004|20363843|P1|STARTED|Overall Study||9
8258319|NCT01810991|20363860|P1|NOT COMPLETED|Overall Study||2
8258320|NCT01810991|20363860|P1|COMPLETED|Overall Study||17
8258321|NCT01810991|20363860|P1|STARTED|Overall Study||19
8258322|NCT01810952|20363867|P2|NOT COMPLETED|Overall Study||0
8258323|NCT01810952|20363868|P1|NOT COMPLETED|Overall Study||0
8258324|NCT01810952|20363867|P2|COMPLETED|Overall Study||17
8258325|NCT01810952|20363868|P1|COMPLETED|Overall Study||20
8258326|NCT01810952|20363867|P2|STARTED|Overall Study||17
8258327|NCT01810952|20363868|P1|STARTED|Overall Study||20
8258328|NCT01810939|20363882|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
8258329|NCT01810939|20363883|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
8258330|NCT01810939|20363884|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
8258331|NCT01810939|20363882|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
8258332|NCT01810939|20363883|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
8258333|NCT01810939|20363884|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
8258334|NCT01810939|20363882|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
8258335|NCT01810939|20363883|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
8258336|NCT01810939|20363884|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
8258337|NCT01810939|20363882|P3|NOT COMPLETED|Part A Treatment Period||0
8258338|NCT01810939|20363883|P2|NOT COMPLETED|Part A Treatment Period||0
8258339|NCT01810939|20363884|P1|NOT COMPLETED|Part A Treatment Period||24
8258340|NCT01810939|20363882|P3|COMPLETED|Part A Treatment Period||0
8258341|NCT01810939|20363883|P2|COMPLETED|Part A Treatment Period||0
8258342|NCT01810939|20363884|P1|COMPLETED|Part A Treatment Period||219
8258343|NCT01810939|20363882|P3|STARTED|Part A Treatment Period||0
8258344|NCT01810939|20363883|P2|STARTED|Part A Treatment Period||0
8258345|NCT01810939|20363884|P1|STARTED|Part A Treatment Period||243
8258346|NCT01810783|20363897|P1|NOT COMPLETED|Overall Study||109
8258347|NCT01810783|20363897|P1|COMPLETED|Overall Study||101
8258348|NCT01810783|20363897|P1|STARTED|Overall Study||210
8258349|NCT01810692|20363903|P2|NOT COMPLETED|Overall Study||0
8258350|NCT01810692|20363904|P1|NOT COMPLETED|Overall Study||0
8258351|NCT01810692|20363903|P2|COMPLETED|Overall Study||77
8258352|NCT01810692|20363904|P1|COMPLETED|Overall Study||77
8258353|NCT01810692|20363903|P2|STARTED|Overall Study||77
8258354|NCT01810692|20363904|P1|STARTED|Overall Study||77
8258355|NCT01810666|20363916|P1|NOT COMPLETED|Overall Study||0
8258356|NCT01810666|20363916|P1|COMPLETED|Overall Study||30
8258357|NCT01810666|20363916|P1|STARTED|Overall Study||30
8258358|NCT01810432|20363922|P2|NOT COMPLETED|Period 2||2
8258359|NCT01810432|20363923|P1|NOT COMPLETED|Period 2||4
8258360|NCT01810432|20363922|P2|COMPLETED|Period 2||17
8258361|NCT01810432|20363923|P1|COMPLETED|Period 2||15
8258362|NCT01810432|20363922|P2|Received at Least 1 Dose of Study Drug|Period 2||19
8258363|NCT01810432|20363923|P1|Received at Least 1 Dose of Study Drug|Period 2||19
8258364|NCT01810432|20363922|P2|STARTED|Period 2||19
8258365|NCT01810432|20363923|P1|STARTED|Period 2||19
8258366|NCT01810432|20363922|P2|NOT COMPLETED|Washout||1
8258367|NCT01810432|20363923|P1|NOT COMPLETED|Washout||1
8258368|NCT01810432|20363922|P2|COMPLETED|Washout||19
8258369|NCT01810432|20363923|P1|COMPLETED|Washout||19
8258370|NCT01810432|20363922|P2|STARTED|Washout||20
8258371|NCT01810432|20363923|P1|STARTED|Washout||20
8258372|NCT01810432|20363922|P2|NOT COMPLETED|Period 1||0
8258373|NCT01810432|20363923|P1|NOT COMPLETED|Period 1||0
8258374|NCT01810432|20363922|P2|COMPLETED|Period 1||20
8258375|NCT01810432|20363923|P1|COMPLETED|Period 1||20
8258376|NCT01810432|20363922|P2|Received at Least 1 Dose of Study Drug|Period 1||20
8258377|NCT01810432|20363923|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8258378|NCT01810432|20363922|P2|STARTED|Period 1||20
8258379|NCT01810432|20363923|P1|STARTED|Period 1||20
8258380|NCT01810380|20363936|P3|NOT COMPLETED|Overall Study||32
8258381|NCT01810380|20363937|P2|NOT COMPLETED|Overall Study||38
8258382|NCT01810380|20363938|P1|NOT COMPLETED|Overall Study||55
8258383|NCT01810380|20363936|P3|COMPLETED|Overall Study||122
8258384|NCT01810380|20363937|P2|COMPLETED|Overall Study||113
8258385|NCT01810380|20363938|P1|COMPLETED|Overall Study||108
8258386|NCT01810380|20363936|P3|Treated|Overall Study||153
8258387|NCT01810380|20363937|P2|Treated|Overall Study||150
8258388|NCT01810380|20363938|P1|Treated|Overall Study||161
8258389|NCT01810380|20363936|P3|STARTED|Overall Study||154
8258390|NCT01810380|20363937|P2|STARTED|Overall Study||151
8258391|NCT01810380|20363938|P1|STARTED|Overall Study||163
8258392|NCT01810302|20363999|P2|NOT COMPLETED|Overall Study||1
8258393|NCT01810302|20364000|P1|NOT COMPLETED|Overall Study||1
8258394|NCT01810302|20363999|P2|COMPLETED|Overall Study||0
8258395|NCT01810302|20364000|P1|COMPLETED|Overall Study||0
8258396|NCT01810302|20363999|P2|STARTED|Overall Study||1
8258397|NCT01810302|20364000|P1|STARTED|Overall Study||1
8258398|NCT01810289|20364010|P2|NOT COMPLETED|Overall Study||0
8258399|NCT01810289|20364011|P1|NOT COMPLETED|Overall Study||0
8258400|NCT01810289|20364010|P2|COMPLETED|Overall Study||4747
8258401|NCT01810289|20364011|P1|COMPLETED|Overall Study||7277
8258402|NCT01810289|20364010|P2|STARTED|Overall Study||4747
8258403|NCT01810289|20364011|P1|STARTED|Overall Study||7277
8258404|NCT01810263|20364027|P2|NOT COMPLETED|Overall Study||7
8258405|NCT01810263|20364028|P1|NOT COMPLETED|Overall Study||8
8258406|NCT01810263|20364027|P2|COMPLETED|Overall Study||11
8258407|NCT01810263|20364028|P1|COMPLETED|Overall Study|2014 July|8
8258408|NCT01810263|20364027|P2|STARTED|Overall Study||18
8258409|NCT01810263|20364028|P1|STARTED|Overall Study||16
8258410|NCT01810042|20364034|P1|NOT COMPLETED|Overall Study||10
8258411|NCT01810042|20364034|P1|COMPLETED|Overall Study||39
8258412|NCT01810042|20364034|P1|STARTED|Overall Study||49
8258413|NCT01810016|20364044|P3|NOT COMPLETED|Overall Study||1
8258414|NCT01810016|20364045|P2|NOT COMPLETED|Overall Study||1
8258415|NCT01810016|20364046|P1|NOT COMPLETED|Overall Study||1
8258416|NCT01810016|20364044|P3|COMPLETED|Overall Study||0
8258417|NCT01810016|20364045|P2|COMPLETED|Overall Study||1
8258418|NCT01810016|20364046|P1|COMPLETED|Overall Study||4
8258419|NCT01810016|20364044|P3|STARTED|Overall Study||1
8258420|NCT01810016|20364045|P2|STARTED|Overall Study||2
8258421|NCT01810016|20364046|P1|STARTED|Overall Study||5
8258422|NCT01809938|20364057|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
8258423|NCT01809938|20364058|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
8258424|NCT01809938|20364057|P2|COMPLETED|Second Intervention (170 Minutes)||5
8258425|NCT01809938|20364058|P1|COMPLETED|Second Intervention (170 Minutes)||5
8258426|NCT01809938|20364057|P2|STARTED|Second Intervention (170 Minutes)||5
8258427|NCT01809938|20364058|P1|STARTED|Second Intervention (170 Minutes)||5
8258428|NCT01809938|20364057|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
8258429|NCT01809938|20364058|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
8258430|NCT01809938|20364057|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
8258431|NCT01809938|20364058|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
8258432|NCT01809938|20364057|P2|STARTED|Washout (Not Less Than 24 Hours)||5
8258433|NCT01809938|20364058|P1|STARTED|Washout (Not Less Than 24 Hours)||5
8258434|NCT01809938|20364057|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
8258435|NCT01809938|20364058|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
8258436|NCT01809938|20364057|P2|COMPLETED|First Intervention (170 Minutes)||5
8258437|NCT01809938|20364058|P1|COMPLETED|First Intervention (170 Minutes)||5
8258438|NCT01809938|20364057|P2|STARTED|First Intervention (170 Minutes)||5
8258439|NCT01809938|20364058|P1|STARTED|First Intervention (170 Minutes)||5
8258440|NCT01809899|20364067|P2|NOT COMPLETED|Overall Study||0
8258441|NCT01809899|20364068|P1|NOT COMPLETED|Overall Study||0
8258442|NCT01809899|20364067|P2|COMPLETED|Overall Study||4
8258443|NCT01809899|20364068|P1|COMPLETED|Overall Study||8
8258444|NCT01809899|20364067|P2|STARTED|Overall Study||4
8258445|NCT01809899|20364068|P1|STARTED|Overall Study||8
8258446|NCT01809834|20364076|P1|NOT COMPLETED|Overall Study||0
8258447|NCT01809834|20364076|P1|COMPLETED|Overall Study||44
8258448|NCT01809834|20364076|P1|STARTED|Overall Study||44
8258449|NCT01809639|20364104|P2|NOT COMPLETED|Overall Study||0
8258450|NCT01809639|20364105|P1|NOT COMPLETED|Overall Study||0
8258451|NCT01809639|20364104|P2|COMPLETED|Overall Study||7
8258452|NCT01809639|20364105|P1|COMPLETED|Overall Study||18
8258453|NCT01809639|20364104|P2|STARTED|Overall Study||7
8258454|NCT01809639|20364105|P1|STARTED|Overall Study||18
8258455|NCT01809327|20364116|P5|NOT COMPLETED|Overall Study||25
8258456|NCT01809327|20364117|P4|NOT COMPLETED|Overall Study||12
8258457|NCT01809327|20364118|P3|NOT COMPLETED|Overall Study||22
8258458|NCT01809327|20364119|P2|NOT COMPLETED|Overall Study||26
8258459|NCT01809327|20364120|P1|NOT COMPLETED|Overall Study||32
8258460|NCT01809327|20364116|P5|COMPLETED|Overall Study||212
8258461|NCT01809327|20364117|P4|COMPLETED|Overall Study||225
8258462|NCT01809327|20364118|P3|COMPLETED|Overall Study||216
8258463|NCT01809327|20364119|P2|COMPLETED|Overall Study||211
8258464|NCT01809327|20364120|P1|COMPLETED|Overall Study||205
8258465|NCT01809327|20364116|P5|STARTED|Overall Study||237
8258466|NCT01809327|20364117|P4|STARTED|Overall Study||237
8258467|NCT01809327|20364118|P3|STARTED|Overall Study||238
8258468|NCT01809327|20364119|P2|STARTED|Overall Study||237
8258469|NCT01809327|20364120|P1|STARTED|Overall Study||237
8258470|NCT01809314|20364162|P1|NOT COMPLETED|Overall Study||745
8258471|NCT01809314|20364162|P1|COMPLETED|Overall Study||422
8258472|NCT01809314|20364162|P1|STARTED|Overall Study||1167
8258473|NCT01809262|20364168|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258474|NCT01809262|20364169|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258475|NCT01809262|20364170|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258476|NCT01809262|20364171|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258477|NCT01809262|20364172|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258478|NCT01809262|20364173|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258479|NCT01809262|20364174|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258480|NCT01809262|20364175|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258481|NCT01809262|20364176|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258482|NCT01809262|20364177|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258483|NCT01809262|20364168|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258484|NCT01809262|20364169|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258485|NCT01809262|20364170|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258486|NCT01809262|20364171|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258487|NCT01809262|20364172|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258488|NCT01809262|20364173|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258489|NCT01809262|20364174|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258490|NCT01809262|20364175|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258491|NCT01809262|20364176|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258492|NCT01809262|20364177|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258493|NCT01809262|20364168|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
8258494|NCT01809262|20364169|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
8258495|NCT01809262|20364170|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
8258496|NCT01809262|20364171|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
8258497|NCT01809262|20364172|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
8258498|NCT01809262|20364173|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
8258499|NCT01809262|20364174|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
8258500|NCT01809262|20364175|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
8258501|NCT01809262|20364176|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
8258502|NCT01809262|20364177|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
8258503|NCT01809262|20364168|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258504|NCT01809262|20364169|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258505|NCT01809262|20364170|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258506|NCT01809262|20364171|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258507|NCT01809262|20364172|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258508|NCT01809262|20364173|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258509|NCT01809262|20364174|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258510|NCT01809262|20364175|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258511|NCT01809262|20364176|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258512|NCT01809262|20364177|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258513|NCT01809262|20364168|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258514|NCT01809262|20364169|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258515|NCT01809262|20364170|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258516|NCT01809262|20364171|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258517|NCT01809262|20364172|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258518|NCT01809262|20364173|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258519|NCT01809262|20364174|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258520|NCT01809262|20364175|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258521|NCT01809262|20364176|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258522|NCT01809262|20364177|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258523|NCT01809262|20364168|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
8258524|NCT01809262|20364169|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
8258525|NCT01809262|20364170|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
8258526|NCT01809262|20364171|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
8258527|NCT01809262|20364172|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
8258528|NCT01809262|20364173|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
8258529|NCT01809262|20364174|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
8258530|NCT01809262|20364175|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
8258531|NCT01809262|20364176|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
8258532|NCT01809262|20364177|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
8258533|NCT01809262|20364168|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258534|NCT01809262|20364169|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258535|NCT01809262|20364170|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258536|NCT01809262|20364171|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258537|NCT01809262|20364172|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258538|NCT01809262|20364173|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258539|NCT01809262|20364174|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258540|NCT01809262|20364175|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258541|NCT01809262|20364176|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
8258542|NCT01809262|20364177|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258543|NCT01809262|20364168|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
8258544|NCT01809262|20364169|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
8258545|NCT01809262|20364170|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
8258546|NCT01809262|20364171|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
8258547|NCT01809262|20364172|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
8258548|NCT01809262|20364173|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
8258549|NCT01809262|20364174|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
8258550|NCT01809262|20364175|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
8258551|NCT01809262|20364176|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
8258552|NCT01809262|20364177|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
8258553|NCT01809262|20364168|P10|STARTED|Period 3 (Third Dose + Washout)||4
8258554|NCT01809262|20364169|P9|STARTED|Period 3 (Third Dose + Washout)||3
8258555|NCT01809262|20364170|P8|STARTED|Period 3 (Third Dose + Washout)||4
8258556|NCT01809262|20364171|P7|STARTED|Period 3 (Third Dose + Washout)||3
8258557|NCT01809262|20364172|P6|STARTED|Period 3 (Third Dose + Washout)||3
8258558|NCT01809262|20364173|P5|STARTED|Period 3 (Third Dose + Washout)||3
8258559|NCT01809262|20364174|P4|STARTED|Period 3 (Third Dose + Washout)||3
8258560|NCT01809262|20364175|P3|STARTED|Period 3 (Third Dose + Washout)||4
8258561|NCT01809262|20364176|P2|STARTED|Period 3 (Third Dose + Washout)||4
8258562|NCT01809262|20364177|P1|STARTED|Period 3 (Third Dose + Washout)||4
8258563|NCT01809262|20364168|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258564|NCT01809262|20364169|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258565|NCT01809262|20364170|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258566|NCT01809262|20364171|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258567|NCT01809262|20364172|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258568|NCT01809262|20364173|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258569|NCT01809262|20364174|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258570|NCT01809262|20364175|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258571|NCT01809262|20364176|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258572|NCT01809262|20364177|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258573|NCT01809262|20364168|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
8258574|NCT01809262|20364169|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
8258575|NCT01809262|20364170|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
8258576|NCT01809262|20364171|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
8258577|NCT01809262|20364172|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
8258578|NCT01809262|20364173|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
8258579|NCT01809262|20364174|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
8258580|NCT01809262|20364175|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
8258581|NCT01809262|20364176|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
8258582|NCT01809262|20364177|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
8258583|NCT01809262|20364168|P10|STARTED|Period 2 (Second Dose + Washout)||4
8258584|NCT01809262|20364169|P9|STARTED|Period 2 (Second Dose + Washout)||3
8258585|NCT01809262|20364170|P8|STARTED|Period 2 (Second Dose + Washout)||4
8258586|NCT01809262|20364171|P7|STARTED|Period 2 (Second Dose + Washout)||3
8258587|NCT01809262|20364172|P6|STARTED|Period 2 (Second Dose + Washout)||3
8258588|NCT01809262|20364173|P5|STARTED|Period 2 (Second Dose + Washout)||3
8258589|NCT01809262|20364174|P4|STARTED|Period 2 (Second Dose + Washout)||3
8258590|NCT01809262|20364175|P3|STARTED|Period 2 (Second Dose + Washout)||4
8258591|NCT01809262|20364176|P2|STARTED|Period 2 (Second Dose + Washout)||4
8258592|NCT01809262|20364177|P1|STARTED|Period 2 (Second Dose + Washout)||4
8258593|NCT01809262|20364168|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258594|NCT01809262|20364169|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258595|NCT01809262|20364170|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258596|NCT01809262|20364171|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258597|NCT01809262|20364172|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258598|NCT01809262|20364173|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
8258599|NCT01809262|20364174|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258600|NCT01809262|20364175|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258601|NCT01809262|20364176|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258602|NCT01809262|20364177|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258603|NCT01809262|20364168|P10|COMPLETED|Period 1 (First Dose + Washout)||4
8258604|NCT01809262|20364169|P9|COMPLETED|Period 1 (First Dose + Washout)||3
8258605|NCT01809262|20364170|P8|COMPLETED|Period 1 (First Dose + Washout)||4
8258606|NCT01809262|20364171|P7|COMPLETED|Period 1 (First Dose + Washout)||3
8258607|NCT01809262|20364172|P6|COMPLETED|Period 1 (First Dose + Washout)||3
8258608|NCT01809262|20364173|P5|COMPLETED|Period 1 (First Dose + Washout)||3
8258609|NCT01809262|20364174|P4|COMPLETED|Period 1 (First Dose + Washout)||3
8258610|NCT01809262|20364175|P3|COMPLETED|Period 1 (First Dose + Washout)||4
8258611|NCT01809262|20364176|P2|COMPLETED|Period 1 (First Dose + Washout)||4
8258612|NCT01809262|20364177|P1|COMPLETED|Period 1 (First Dose + Washout)||4
8258613|NCT01809262|20364168|P10|STARTED|Period 1 (First Dose + Washout)||4
8258614|NCT01809262|20364169|P9|STARTED|Period 1 (First Dose + Washout)||3
8258615|NCT01809262|20364170|P8|STARTED|Period 1 (First Dose + Washout)||4
8258616|NCT01809262|20364171|P7|STARTED|Period 1 (First Dose + Washout)||3
8258617|NCT01809262|20364172|P6|STARTED|Period 1 (First Dose + Washout)||3
8258618|NCT01809262|20364173|P5|STARTED|Period 1 (First Dose + Washout)||4
8258619|NCT01809262|20364174|P4|STARTED|Period 1 (First Dose + Washout)||3
8258620|NCT01809262|20364175|P3|STARTED|Period 1 (First Dose + Washout)||4
8258621|NCT01809262|20364176|P2|STARTED|Period 1 (First Dose + Washout)||4
8258622|NCT01809262|20364177|P1|STARTED|Period 1 (First Dose + Washout)||4
8258623|NCT01809210|20364251|P7|NOT COMPLETED|Overall Study||5
8258624|NCT01809210|20364252|P6|NOT COMPLETED|Overall Study||3
8258625|NCT01809210|20364253|P5|NOT COMPLETED|Overall Study||2
8258626|NCT01809210|20364254|P4|NOT COMPLETED|Overall Study||1
8258627|NCT01809210|20364255|P3|NOT COMPLETED|Overall Study||3
8258628|NCT01809210|20364256|P2|NOT COMPLETED|Overall Study||1
8258629|NCT01809210|20364257|P1|NOT COMPLETED|Overall Study||1
8258630|NCT01809210|20364251|P7|COMPLETED|Overall Study||7
8258631|NCT01809210|20364252|P6|COMPLETED|Overall Study||12
8258632|NCT01809210|20364253|P5|COMPLETED|Overall Study||4
8258633|NCT01809210|20364254|P4|COMPLETED|Overall Study||2
8258634|NCT01809210|20364255|P3|COMPLETED|Overall Study||4
8258635|NCT01809210|20364256|P2|COMPLETED|Overall Study||8
8258636|NCT01809210|20364257|P1|COMPLETED|Overall Study||2
8258637|NCT01809210|20364251|P7|STARTED|Overall Study||12
8258638|NCT01809210|20364252|P6|STARTED|Overall Study||15
8258639|NCT01809210|20364253|P5|STARTED|Overall Study||6
8258640|NCT01809210|20364254|P4|STARTED|Overall Study||3
8258641|NCT01809210|20364255|P3|STARTED|Overall Study||7
8258642|NCT01809210|20364256|P2|STARTED|Overall Study||9
8258643|NCT01809210|20364257|P1|STARTED|Overall Study||3
8258644|NCT01809197|20364331|P2|NOT COMPLETED|Overall Study||8
8258645|NCT01809197|20364332|P1|NOT COMPLETED|Overall Study||10
8258646|NCT01809197|20364331|P2|COMPLETED|Overall Study||177
8258647|NCT01809197|20364332|P1|COMPLETED|Overall Study||177
8258648|NCT01809197|20364331|P2|STARTED|Overall Study||185
8258649|NCT01809197|20364332|P1|STARTED|Overall Study||187
8258650|NCT01809132|20364341|P3|NOT COMPLETED|Overall Study||1
8258651|NCT01809132|20364342|P2|NOT COMPLETED|Overall Study||0
8258652|NCT01809132|20364343|P1|NOT COMPLETED|Overall Study||0
8258653|NCT01809132|20364341|P3|COMPLETED|Overall Study||0
8258654|NCT01809132|20364342|P2|COMPLETED|Overall Study||50
8258655|NCT01809132|20364343|P1|COMPLETED|Overall Study||53
8258656|NCT01809132|20364341|P3|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
8258657|NCT01809132|20364342|P2|STARTED|Overall Study||50
8258658|NCT01809132|20364343|P1|STARTED|Overall Study||53
8258659|NCT01809106|20364364|P4|NOT COMPLETED|Overall Study||4
8258660|NCT01809106|20364365|P3|NOT COMPLETED|Overall Study||3
8258661|NCT01809106|20364366|P2|NOT COMPLETED|Overall Study||5
8258662|NCT01809106|20364367|P1|NOT COMPLETED|Overall Study||8
8258663|NCT01809106|20364364|P4|COMPLETED|Overall Study||124
8258664|NCT01809106|20364365|P3|COMPLETED|Overall Study||127
8258665|NCT01809106|20364366|P2|COMPLETED|Overall Study||125
8258666|NCT01809106|20364367|P1|COMPLETED|Overall Study||122
8258667|NCT01809106|20364364|P4|STARTED|Overall Study||128
8258668|NCT01809106|20364365|P3|STARTED|Overall Study||130
8258669|NCT01809106|20364366|P2|STARTED|Overall Study||130
8258670|NCT01809106|20364367|P1|STARTED|Overall Study||130
8258671|NCT01809054|20364387|P2|NOT COMPLETED|Overall Study||0
8258672|NCT01809054|20364388|P1|NOT COMPLETED|Overall Study||0
8258673|NCT01809054|20364387|P2|COMPLETED|Overall Study||22
8258674|NCT01809054|20364388|P1|COMPLETED|Overall Study||27
8258675|NCT01809054|20364387|P2|STARTED|Overall Study||22
8258676|NCT01809054|20364388|P1|STARTED|Overall Study||27
8258677|NCT01808963|20364396|P1|NOT COMPLETED|Overall Study||0
8258678|NCT01808963|20364396|P1|COMPLETED|Overall Study||13
8258679|NCT01808963|20364396|P1|STARTED|Overall Study||13
8258680|NCT01808950|20364403|P3|NOT COMPLETED|Overall Study||0
8258681|NCT01808950|20364404|P2|NOT COMPLETED|Overall Study||0
8258682|NCT01808950|20364405|P1|NOT COMPLETED|Overall Study||0
8258683|NCT01808950|20364403|P3|COMPLETED|Overall Study||0
8258684|NCT01808950|20364404|P2|COMPLETED|Overall Study||3
8258685|NCT01808950|20364405|P1|COMPLETED|Overall Study||1
8258686|NCT01808950|20364403|P3|STARTED|Overall Study||0
8258687|NCT01808950|20364404|P2|STARTED|Overall Study||3
8258688|NCT01808950|20364405|P1|STARTED|Overall Study||1
8258689|NCT01808794|20364418|P2|NOT COMPLETED|Overall Study||0
8258690|NCT01808794|20364419|P1|NOT COMPLETED|Overall Study||0
8258691|NCT01808794|20364418|P2|COMPLETED|Overall Study||0
8258692|NCT01808794|20364419|P1|COMPLETED|Overall Study||0
8258693|NCT01808794|20364418|P2|STARTED|Overall Study||0
8258694|NCT01808794|20364419|P1|STARTED|Overall Study||0
8258695|NCT01808755|20364427|P2|NOT COMPLETED|Overall Study||0
8258696|NCT01808755|20364428|P1|NOT COMPLETED|Overall Study||0
8258697|NCT01808755|20364427|P2|COMPLETED|Overall Study||30
8258698|NCT01808755|20364428|P1|COMPLETED|Overall Study||30
8258699|NCT01808755|20364427|P2|STARTED|Overall Study||30
8258700|NCT01808755|20364428|P1|STARTED|Overall Study||30
8258701|NCT01808690|20364435|P2|NOT COMPLETED|Overall Study||2
8258702|NCT01808690|20364436|P1|NOT COMPLETED|Overall Study||1
8258703|NCT01808690|20364435|P2|COMPLETED|Overall Study||21
8258704|NCT01808690|20364436|P1|COMPLETED|Overall Study||24
8258705|NCT01808690|20364435|P2|STARTED|Overall Study||23
8258706|NCT01808690|20364436|P1|STARTED|Overall Study||25
8258707|NCT01808651|20364455|P3|NOT COMPLETED|Study Period 2||0
8258708|NCT01808651|20364456|P2|NOT COMPLETED|Study Period 2||0
8258709|NCT01808651|20364457|P1|NOT COMPLETED|Study Period 2||0
8258710|NCT01808651|20364455|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
8258711|NCT01808651|20364456|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
8258712|NCT01808651|20364457|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
8258713|NCT01808651|20364455|P3|STARTED|Study Period 2||33
8258714|NCT01808651|20364456|P2|STARTED|Study Period 2||52
8258715|NCT01808651|20364457|P1|STARTED|Study Period 2||77
8258716|NCT01808651|20364455|P3|NOT COMPLETED|Study Period 1||5
8258717|NCT01808651|20364456|P2|NOT COMPLETED|Study Period 1||17
8258718|NCT01808651|20364457|P1|NOT COMPLETED|Study Period 1||26
8258719|NCT01808651|20364455|P3|COMPLETED|Study Period 1||31
8258720|NCT01808651|20364456|P2|COMPLETED|Study Period 1||48
8258721|NCT01808651|20364457|P1|COMPLETED|Study Period 1||73
8258722|NCT01808651|20364455|P3|Received at Least One Dose of Study Drug|Study Period 1||36
8258723|NCT01808651|20364456|P2|Received at Least One Dose of Study Drug|Study Period 1||65
8258724|NCT01808651|20364457|P1|Received at Least One Dose of Study Drug|Study Period 1||98
8258725|NCT01808651|20364455|P3|STARTED|Study Period 1||36
8258726|NCT01808651|20364456|P2|STARTED|Study Period 1||65
8258727|NCT01808651|20364457|P1|STARTED|Study Period 1||99
8258728|NCT01808612|20364492|P3|NOT COMPLETED|Discontinuation Period||0
8258729|NCT01808612|20364493|P2|NOT COMPLETED|Discontinuation Period||1
8258730|NCT01808612|20364494|P1|NOT COMPLETED|Discontinuation Period||2
8258731|NCT01808612|20364492|P3|COMPLETED|Discontinuation Period||145
8258732|NCT01808612|20364493|P2|COMPLETED|Discontinuation Period||37
8258733|NCT01808612|20364494|P1|COMPLETED|Discontinuation Period||85
8258734|NCT01808612|20364492|P3|STARTED|Discontinuation Period||145
8258735|NCT01808612|20364493|P2|STARTED|Discontinuation Period||38
8258736|NCT01808612|20364494|P1|STARTED|Discontinuation Period||87
8258737|NCT01808612|20364492|P3|NOT COMPLETED|Treatment Period||14
8258738|NCT01808612|20364493|P2|NOT COMPLETED|Treatment Period||7
8258739|NCT01808612|20364494|P1|NOT COMPLETED|Treatment Period||15
8258740|NCT01808612|20364492|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
8258741|NCT01808612|20364493|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
8258742|NCT01808612|20364494|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
8258743|NCT01808612|20364492|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
8258744|NCT01808612|20364493|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
8258745|NCT01808612|20364494|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
8258746|NCT01808612|20364492|P3|STARTED|Treatment Period||260
8258747|NCT01808612|20364493|P2|STARTED|Treatment Period||84
8258748|NCT01808612|20364494|P1|STARTED|Treatment Period||169
8258749|NCT01808573|20364525|P2|NOT COMPLETED|Overall Study||314
8258750|NCT01808573|20364526|P1|NOT COMPLETED|Overall Study||307
8258751|NCT01808573|20364525|P2|COMPLETED|Overall Study||0
8258752|NCT01808573|20364526|P1|COMPLETED|Overall Study||0
8258753|NCT01808573|20364525|P2|Received Treatment|Overall Study||311
8258754|NCT01808573|20364526|P1|Received Treatment|Overall Study||303
8258755|NCT01808573|20364525|P2|STARTED|Overall Study||314
8258756|NCT01808573|20364526|P1|STARTED|Overall Study||307
8258757|NCT01808560|20364547|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
8258758|NCT01808560|20364548|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
8258759|NCT01808560|20364549|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
8258760|NCT01808560|20364547|P3|COMPLETED|4-Month After Cataract Surgery||13
8258761|NCT01808560|20364548|P2|COMPLETED|4-Month After Cataract Surgery||0
8258762|NCT01808560|20364549|P1|COMPLETED|4-Month After Cataract Surgery||0
8258763|NCT01808560|20364547|P3|STARTED|4-Month After Cataract Surgery||13
8258764|NCT01808560|20364548|P2|STARTED|4-Month After Cataract Surgery||0
8258765|NCT01808560|20364549|P1|STARTED|4-Month After Cataract Surgery||0
8258766|NCT01808560|20364547|P3|NOT COMPLETED|Crossover Treatment||0
8258767|NCT01808560|20364548|P2|NOT COMPLETED|Crossover Treatment||0
8258768|NCT01808560|20364549|P1|NOT COMPLETED|Crossover Treatment||0
8258769|NCT01808560|20364547|P3|COMPLETED|Crossover Treatment||13
8258770|NCT01808560|20364548|P2|COMPLETED|Crossover Treatment||0
8258771|NCT01808560|20364549|P1|COMPLETED|Crossover Treatment||0
8258772|NCT01808560|20364547|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
8258773|NCT01808560|20364548|P2|STARTED|Crossover Treatment||0
8258774|NCT01808560|20364549|P1|STARTED|Crossover Treatment||0
8258775|NCT01808560|20364547|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
8258776|NCT01808560|20364548|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
8258777|NCT01808560|20364549|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
8258778|NCT01808560|20364547|P3|COMPLETED|3-Month After Cataract Surgery||0
8258779|NCT01808560|20364548|P2|COMPLETED|3-Month After Cataract Surgery||13
8258780|NCT01808560|20364549|P1|COMPLETED|3-Month After Cataract Surgery||17
8258781|NCT01808560|20364547|P3|STARTED|3-Month After Cataract Surgery||0
8258782|NCT01808560|20364548|P2|STARTED|3-Month After Cataract Surgery||13
8258783|NCT01808560|20364549|P1|STARTED|3-Month After Cataract Surgery||17
8258784|NCT01808560|20364547|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
8258785|NCT01808560|20364548|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
8258786|NCT01808560|20364549|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
8258787|NCT01808560|20364547|P3|COMPLETED|1-Month After Cataract Surgery||0
8258788|NCT01808560|20364548|P2|COMPLETED|1-Month After Cataract Surgery||13
8258789|NCT01808560|20364549|P1|COMPLETED|1-Month After Cataract Surgery||16
8258790|NCT01808560|20364547|P3|STARTED|1-Month After Cataract Surgery||0
8258791|NCT01808560|20364548|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
8258792|NCT01808560|20364549|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
8258793|NCT01808560|20364547|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
8258794|NCT01808560|20364548|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
8258795|NCT01808560|20364549|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
8258796|NCT01808560|20364547|P3|COMPLETED|Randomization and Treatment Allocation||0
8258797|NCT01808560|20364548|P2|COMPLETED|Randomization and Treatment Allocation||16
8258798|NCT01808560|20364549|P1|COMPLETED|Randomization and Treatment Allocation||18
8258799|NCT01808560|20364547|P3|STARTED|Randomization and Treatment Allocation||0
8258800|NCT01808560|20364548|P2|STARTED|Randomization and Treatment Allocation||16
8258801|NCT01808560|20364549|P1|STARTED|Randomization and Treatment Allocation||18
8258802|NCT01808547|20364574|P2|NOT COMPLETED|Overall Study||46
8258803|NCT01808547|20364575|P1|NOT COMPLETED|Overall Study||37
8258804|NCT01808547|20364574|P2|COMPLETED|Overall Study||48
8258805|NCT01808547|20364575|P1|COMPLETED|Overall Study||137
8258806|NCT01808547|20364574|P2|mITT Population|Overall Study||85
8258807|NCT01808547|20364575|P1|mITT Population|Overall Study||168
8258808|NCT01808547|20364574|P2|Safety Population|Overall Study||85
8258809|NCT01808547|20364575|P1|Safety Population|Overall Study||170
8258810|NCT01808547|20364574|P2|STARTED|Overall Study||94
8258811|NCT01808547|20364575|P1|STARTED|Overall Study||174
8258812|NCT01808534|20364581|P1|NOT COMPLETED|Overall Study||4
8258813|NCT01808534|20364581|P1|COMPLETED|Overall Study||1
8258814|NCT01808534|20364581|P1|STARTED|Overall Study||5
8258815|NCT01808508|20364592|P3|NOT COMPLETED|Overall Study||0
8258816|NCT01808508|20364593|P2|NOT COMPLETED|Overall Study||0
8258817|NCT01808508|20364594|P1|NOT COMPLETED|Overall Study||1
8258818|NCT01808508|20364592|P3|COMPLETED|Overall Study||3
8258819|NCT01808508|20364593|P2|COMPLETED|Overall Study||9
8258820|NCT01808508|20364594|P1|COMPLETED|Overall Study||10
8258821|NCT01808508|20364592|P3|STARTED|Overall Study||3
8258822|NCT01808508|20364593|P2|STARTED|Overall Study||9
8258823|NCT01808508|20364594|P1|STARTED|Overall Study||11
8258824|NCT01808339|20364611|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258825|NCT01808339|20364612|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258826|NCT01808339|20364613|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258827|NCT01808339|20364614|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8258828|NCT01808339|20364615|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258829|NCT01808339|20364616|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258830|NCT01808339|20364611|P6|COMPLETED|Treatment Period 3 (14 Days)||5
8258831|NCT01808339|20364612|P5|COMPLETED|Treatment Period 3 (14 Days)||4
8258832|NCT01808339|20364613|P4|COMPLETED|Treatment Period 3 (14 Days)||2
8258833|NCT01808339|20364614|P3|COMPLETED|Treatment Period 3 (14 Days)||3
8258834|NCT01808339|20364615|P2|COMPLETED|Treatment Period 3 (14 Days)||3
8258835|NCT01808339|20364616|P1|COMPLETED|Treatment Period 3 (14 Days)||4
8258836|NCT01808339|20364611|P6|STARTED|Treatment Period 3 (14 Days)||5
8258837|NCT01808339|20364612|P5|STARTED|Treatment Period 3 (14 Days)||4
8258838|NCT01808339|20364613|P4|STARTED|Treatment Period 3 (14 Days)||2
8258839|NCT01808339|20364614|P3|STARTED|Treatment Period 3 (14 Days)||4
8258840|NCT01808339|20364615|P2|STARTED|Treatment Period 3 (14 Days)||3
8258841|NCT01808339|20364616|P1|STARTED|Treatment Period 3 (14 Days)||4
8258842|NCT01808339|20364611|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258843|NCT01808339|20364612|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258844|NCT01808339|20364613|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258845|NCT01808339|20364614|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258846|NCT01808339|20364615|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258847|NCT01808339|20364616|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258848|NCT01808339|20364611|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
8258849|NCT01808339|20364612|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
8258850|NCT01808339|20364613|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
8258851|NCT01808339|20364614|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
8258852|NCT01808339|20364615|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
8258853|NCT01808339|20364616|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
8258854|NCT01808339|20364611|P6|STARTED|Washout Period 2 (14-21 Days)||5
8258855|NCT01808339|20364612|P5|STARTED|Washout Period 2 (14-21 Days)||4
8258856|NCT01808339|20364613|P4|STARTED|Washout Period 2 (14-21 Days)||2
8258857|NCT01808339|20364614|P3|STARTED|Washout Period 2 (14-21 Days)||4
8258858|NCT01808339|20364615|P2|STARTED|Washout Period 2 (14-21 Days)||3
8258859|NCT01808339|20364616|P1|STARTED|Washout Period 2 (14-21 Days)||4
8258860|NCT01808339|20364611|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258861|NCT01808339|20364612|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258862|NCT01808339|20364613|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258863|NCT01808339|20364614|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258864|NCT01808339|20364615|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258865|NCT01808339|20364616|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258866|NCT01808339|20364611|P6|COMPLETED|Treatment Period 2 (14 Days)||5
8258867|NCT01808339|20364612|P5|COMPLETED|Treatment Period 2 (14 Days)||4
8258868|NCT01808339|20364613|P4|COMPLETED|Treatment Period 2 (14 Days)||2
8258869|NCT01808339|20364614|P3|COMPLETED|Treatment Period 2 (14 Days)||4
8258870|NCT01808339|20364615|P2|COMPLETED|Treatment Period 2 (14 Days)||3
8258871|NCT01808339|20364616|P1|COMPLETED|Treatment Period 2 (14 Days)||4
8258872|NCT01808339|20364611|P6|STARTED|Treatment Period 2 (14 Days)||5
8258873|NCT01808339|20364612|P5|STARTED|Treatment Period 2 (14 Days)||4
8258874|NCT01808339|20364613|P4|STARTED|Treatment Period 2 (14 Days)||2
8258875|NCT01808339|20364614|P3|STARTED|Treatment Period 2 (14 Days)||4
8258876|NCT01808339|20364615|P2|STARTED|Treatment Period 2 (14 Days)||3
8258877|NCT01808339|20364616|P1|STARTED|Treatment Period 2 (14 Days)||4
8258878|NCT01808339|20364611|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258879|NCT01808339|20364612|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258880|NCT01808339|20364613|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258881|NCT01808339|20364614|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258882|NCT01808339|20364615|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258883|NCT01808339|20364616|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258884|NCT01808339|20364611|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
8258885|NCT01808339|20364612|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
8258886|NCT01808339|20364613|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
8258887|NCT01808339|20364614|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
8258888|NCT01808339|20364615|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
8258889|NCT01808339|20364616|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
8258890|NCT01808339|20364611|P6|STARTED|Washout Period 1 (14-21 Days)||5
8258891|NCT01808339|20364612|P5|STARTED|Washout Period 1 (14-21 Days)||4
8258892|NCT01808339|20364613|P4|STARTED|Washout Period 1 (14-21 Days)||2
8258893|NCT01808339|20364614|P3|STARTED|Washout Period 1 (14-21 Days)||4
8258894|NCT01808339|20364615|P2|STARTED|Washout Period 1 (14-21 Days)||3
8258895|NCT01808339|20364616|P1|STARTED|Washout Period 1 (14-21 Days)||4
8258896|NCT01808339|20364611|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8258897|NCT01808339|20364612|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8258898|NCT01808339|20364613|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8258899|NCT01808339|20364614|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8258900|NCT01808339|20364615|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8258901|NCT01808339|20364616|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8258902|NCT01808339|20364611|P6|COMPLETED|Treatment Period 1 (14 Days)||5
8258903|NCT01808339|20364612|P5|COMPLETED|Treatment Period 1 (14 Days)||4
8258904|NCT01808339|20364613|P4|COMPLETED|Treatment Period 1 (14 Days)||2
8258905|NCT01808339|20364614|P3|COMPLETED|Treatment Period 1 (14 Days)||4
8258906|NCT01808339|20364615|P2|COMPLETED|Treatment Period 1 (14 Days)||3
8258907|NCT01808339|20364616|P1|COMPLETED|Treatment Period 1 (14 Days)||4
8258908|NCT01808339|20364611|P6|STARTED|Treatment Period 1 (14 Days)||6
8258909|NCT01808339|20364612|P5|STARTED|Treatment Period 1 (14 Days)||6
8258910|NCT01808339|20364613|P4|STARTED|Treatment Period 1 (14 Days)||4
8258911|NCT01808339|20364614|P3|STARTED|Treatment Period 1 (14 Days)||4
8258912|NCT01808339|20364615|P2|STARTED|Treatment Period 1 (14 Days)||4
8258913|NCT01808339|20364616|P1|STARTED|Treatment Period 1 (14 Days)||4
8258914|NCT01808326|20364633|P1|NOT COMPLETED|Overall Study||0
8258915|NCT01808326|20364633|P1|COMPLETED|Overall Study||5
8258916|NCT01808326|20364633|P1|STARTED|Overall Study||5
8258917|NCT01808313|20364660|P1|NOT COMPLETED|Overall Study||10
8258918|NCT01808313|20364660|P1|COMPLETED|Overall Study||123
8258919|NCT01808313|20364660|P1|STARTED|Overall Study||133
8258920|NCT01808261|20364690|P2|NOT COMPLETED|Overall Study||33
8258921|NCT01808261|20364691|P1|NOT COMPLETED|Overall Study||36
8258922|NCT01808261|20364690|P2|COMPLETED|Overall Study||32
8258923|NCT01808261|20364691|P1|COMPLETED|Overall Study||32
8258924|NCT01808261|20364690|P2|STARTED|Overall Study||65
8258925|NCT01808261|20364691|P1|STARTED|Overall Study||68
8258926|NCT01808248|20364747|P1|NOT COMPLETED|Overall Study||5
8258927|NCT01808248|20364747|P1|COMPLETED|Overall Study||42
8258928|NCT01808248|20364747|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
8258929|NCT01808248|20364747|P1|STARTED|Overall Study||47
8258930|NCT01808222|20364759|P1|NOT COMPLETED|Overall Study||1
8258931|NCT01808222|20364759|P1|COMPLETED|Overall Study||24
8258932|NCT01808222|20364759|P1|Completed mpMR Scan|Overall Study||24
8258933|NCT01808222|20364759|P1|Completed Fluciclovine PET-CT Scan|Overall Study||25
8258934|NCT01808222|20364759|P1|STARTED|Overall Study||25
8258935|NCT01808209|20364766|P2|NOT COMPLETED|Overall Study||1
8258936|NCT01808209|20364767|P1|NOT COMPLETED|Overall Study||0
8258937|NCT01808209|20364766|P2|COMPLETED|Overall Study||26
8258938|NCT01808209|20364767|P1|COMPLETED|Overall Study||33
8258939|NCT01808209|20364766|P2|STARTED|Overall Study||27
8258940|NCT01808209|20364767|P1|STARTED|Overall Study||33
8258941|NCT01808196|20364809|P1|NOT COMPLETED|Overall Study||1
8258942|NCT01808196|20364809|P1|COMPLETED|Overall Study||5
8258943|NCT01808196|20364809|P1|STARTED|Overall Study||6
8258944|NCT01808144|20364817|P2|NOT COMPLETED|Overall Study||48
8258945|NCT01808144|20364818|P1|NOT COMPLETED|Overall Study||40
8258946|NCT01808144|20364817|P2|COMPLETED|Overall Study||51
8258947|NCT01808144|20364818|P1|COMPLETED|Overall Study||57
8258948|NCT01808144|20364817|P2|STARTED|Overall Study||99
8258949|NCT01808144|20364818|P1|STARTED|Overall Study||97
8258950|NCT01808118|20364826|P3|NOT COMPLETED|Period 2||8
8258951|NCT01808118|20364827|P2|NOT COMPLETED|Period 2||13
8258952|NCT01808118|20364828|P1|NOT COMPLETED|Period 2||0
8258953|NCT01808118|20364826|P3|COMPLETED|Period 2||144
8258954|NCT01808118|20364827|P2|COMPLETED|Period 2||140
8258955|NCT01808118|20364828|P1|COMPLETED|Period 2||0
8258956|NCT01808118|20364826|P3|STARTED|Period 2||152
8258957|NCT01808118|20364827|P2|STARTED|Period 2||153
8258958|NCT01808118|20364828|P1|STARTED|Period 2||0
8258959|NCT01808118|20364826|P3|NOT COMPLETED|Period 1||0
8258960|NCT01808118|20364827|P2|NOT COMPLETED|Period 1||0
8258961|NCT01808118|20364828|P1|NOT COMPLETED|Period 1||368
8258962|NCT01808118|20364826|P3|COMPLETED|Period 1||0
8258963|NCT01808118|20364827|P2|COMPLETED|Period 1||0
8258964|NCT01808118|20364828|P1|COMPLETED|Period 1||305
8258965|NCT01808118|20364826|P3|STARTED|Period 1||0
8258966|NCT01808118|20364827|P2|STARTED|Period 1||0
8258967|NCT01808118|20364828|P1|STARTED|Period 1||673
8258968|NCT01808092|20364891|P2|NOT COMPLETED|Overall Study||45
8258969|NCT01808092|20364892|P1|NOT COMPLETED|Overall Study||54
8258970|NCT01808092|20364891|P2|COMPLETED|Overall Study||363
8258971|NCT01808092|20364892|P1|COMPLETED|Overall Study||355
8258972|NCT01808092|20364891|P2|STARTED|Overall Study||408
8258973|NCT01808092|20364892|P1|STARTED|Overall Study||409
8258974|NCT01808066|20364994|P1|NOT COMPLETED|Overall Study||15
8258975|NCT01808066|20364994|P1|COMPLETED|Overall Study||6
8258976|NCT01808066|20364994|P1|STARTED|Overall Study||21
8258977|NCT01807949|20365005|P3|NOT COMPLETED|Overall Study||9
8258978|NCT01807949|20365006|P2|NOT COMPLETED|Overall Study||7
8258979|NCT01807949|20365007|P1|NOT COMPLETED|Overall Study||2
8258980|NCT01807949|20365005|P3|COMPLETED|Overall Study||180
8258981|NCT01807949|20365006|P2|COMPLETED|Overall Study||180
8258982|NCT01807949|20365007|P1|COMPLETED|Overall Study||185
8258983|NCT01807949|20365005|P3|STARTED|Overall Study||189
8258984|NCT01807949|20365006|P2|STARTED|Overall Study||187
8258985|NCT01807949|20365007|P1|STARTED|Overall Study||187
8258986|NCT01807923|20365059|P3|NOT COMPLETED|Overall Study||11
8258987|NCT01807923|20365060|P2|NOT COMPLETED|Overall Study||6
8258988|NCT01807923|20365061|P1|NOT COMPLETED|Overall Study||5
8258989|NCT01807923|20365059|P3|COMPLETED|Overall Study||176
8258990|NCT01807923|20365060|P2|COMPLETED|Overall Study||179
8258991|NCT01807923|20365061|P1|COMPLETED|Overall Study||182
8258992|NCT01807923|20365059|P3|STARTED|Overall Study||187
8258993|NCT01807923|20365060|P2|STARTED|Overall Study||185
8258994|NCT01807923|20365061|P1|STARTED|Overall Study||187
8258995|NCT01807871|20365112|P2|NOT COMPLETED|Overall Study||218
8258996|NCT01807871|20365113|P1|NOT COMPLETED|Overall Study||178
8258997|NCT01807871|20365112|P2|COMPLETED|Overall Study||127
8258998|NCT01807871|20365113|P1|COMPLETED|Overall Study||178
8258999|NCT01807871|20365112|P2|STARTED|Overall Study||345
8259000|NCT01807871|20365113|P1|STARTED|Overall Study||356
8259001|NCT01807650|20365123|P1|NOT COMPLETED|Overall Study||20
8259002|NCT01807650|20365123|P1|COMPLETED|Overall Study||92
8259003|NCT01807650|20365123|P1|STARTED|Overall Study||112
8259004|NCT01807637|20365176|P2|NOT COMPLETED|One Month||0
8259005|NCT01807637|20365177|P1|NOT COMPLETED|One Month||0
8259006|NCT01807637|20365176|P2|COMPLETED|One Month||2
8259007|NCT01807637|20365177|P1|COMPLETED|One Month||4
8259008|NCT01807637|20365176|P2|STARTED|One Month||2
8259009|NCT01807637|20365177|P1|STARTED|One Month||4
8259010|NCT01807637|20365176|P2|NOT COMPLETED|One Week||0
8259011|NCT01807637|20365177|P1|NOT COMPLETED|One Week||0
8259012|NCT01807637|20365176|P2|COMPLETED|One Week||2
8259013|NCT01807637|20365177|P1|COMPLETED|One Week||4
8259014|NCT01807637|20365176|P2|STARTED|One Week||2
8259015|NCT01807637|20365177|P1|STARTED|One Week||4
8259016|NCT01807637|20365176|P2|NOT COMPLETED|Baseline||0
8259017|NCT01807637|20365177|P1|NOT COMPLETED|Baseline||0
8259018|NCT01807637|20365176|P2|COMPLETED|Baseline||2
8259019|NCT01807637|20365177|P1|COMPLETED|Baseline||4
8259020|NCT01807637|20365176|P2|STARTED|Baseline||2
8259021|NCT01807637|20365177|P1|STARTED|Baseline||4
8259022|NCT01807624|20365193|P1|NOT COMPLETED|Overall Study||0
8259023|NCT01807624|20365193|P1|COMPLETED|Overall Study||24
8259024|NCT01807624|20365193|P1|STARTED|Overall Study||24
8259025|NCT01807598|20365209|P1|NOT COMPLETED|Overall Study||6
8259026|NCT01807598|20365209|P1|COMPLETED|Overall Study||4
8259027|NCT01807598|20365209|P1|STARTED|Overall Study||10
8259028|NCT01807585|20365223|P3|NOT COMPLETED|Overall Study||6
8259029|NCT01807585|20365224|P2|NOT COMPLETED|Overall Study||4
8259030|NCT01807585|20365225|P1|NOT COMPLETED|Overall Study||1
8259031|NCT01807585|20365223|P3|COMPLETED|Overall Study||108
8259032|NCT01807585|20365224|P2|COMPLETED|Overall Study||104
8259033|NCT01807585|20365225|P1|COMPLETED|Overall Study||19
8259034|NCT01807585|20365223|P3|3 Mos|Overall Study||113
8259035|NCT01807585|20365224|P2|3 Mos|Overall Study||108
8259036|NCT01807585|20365225|P1|3 Mos|Overall Study||20
8259037|NCT01807585|20365223|P3|STARTED|Overall Study||114
8259038|NCT01807585|20365224|P2|STARTED|Overall Study||108
8259039|NCT01807585|20365225|P1|STARTED|Overall Study||20
8259040|NCT01807520|20365241|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
8259041|NCT01807520|20365242|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
8259042|NCT01807520|20365243|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259043|NCT01807520|20365244|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259044|NCT01807520|20365245|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259045|NCT01807520|20365246|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259046|NCT01807520|20365247|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259047|NCT01807520|20365241|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
8259048|NCT01807520|20365242|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
8259049|NCT01807520|20365243|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259050|NCT01807520|20365244|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259051|NCT01807520|20365245|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
8259052|NCT01807520|20365246|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259053|NCT01807520|20365247|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259054|NCT01807520|20365241|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
8259055|NCT01807520|20365242|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
8259056|NCT01807520|20365243|P5|STARTED|Follow-up Period (132-140 Weeks)||0
8259057|NCT01807520|20365244|P4|STARTED|Follow-up Period (132-140 Weeks)||0
8259058|NCT01807520|20365245|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
8259059|NCT01807520|20365246|P2|STARTED|Follow-up Period (132-140 Weeks)||0
8259060|NCT01807520|20365247|P1|STARTED|Follow-up Period (132-140 Weeks)||0
8259061|NCT01807520|20365241|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259062|NCT01807520|20365242|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259063|NCT01807520|20365243|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
8259064|NCT01807520|20365244|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
8259065|NCT01807520|20365245|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259066|NCT01807520|20365246|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
8259067|NCT01807520|20365247|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
8259068|NCT01807520|20365241|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259069|NCT01807520|20365242|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259070|NCT01807520|20365243|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
8259071|NCT01807520|20365244|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
8259072|NCT01807520|20365245|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259073|NCT01807520|20365246|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
8259074|NCT01807520|20365247|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
8259075|NCT01807520|20365241|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8259076|NCT01807520|20365242|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8259077|NCT01807520|20365243|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
8259078|NCT01807520|20365244|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
8259079|NCT01807520|20365245|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8259080|NCT01807520|20365246|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
8259081|NCT01807520|20365247|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
8259082|NCT01807520|20365241|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8259083|NCT01807520|20365242|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8259084|NCT01807520|20365243|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
8259085|NCT01807520|20365244|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
8259086|NCT01807520|20365245|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8259087|NCT01807520|20365246|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
8259088|NCT01807520|20365247|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
8259089|NCT01807520|20365241|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
8259090|NCT01807520|20365242|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
8259091|NCT01807520|20365243|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
8259092|NCT01807520|20365244|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
8259093|NCT01807520|20365245|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
8259094|NCT01807520|20365246|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
8259095|NCT01807520|20365247|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
8259096|NCT01807520|20365241|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259097|NCT01807520|20365242|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259098|NCT01807520|20365243|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259099|NCT01807520|20365244|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259100|NCT01807520|20365245|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
8259101|NCT01807520|20365246|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
8259102|NCT01807520|20365247|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
8259103|NCT01807520|20365241|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259104|NCT01807520|20365242|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259105|NCT01807520|20365243|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259106|NCT01807520|20365244|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259107|NCT01807520|20365245|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
8259108|NCT01807520|20365246|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
8259109|NCT01807520|20365247|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
8259110|NCT01807520|20365241|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259111|NCT01807520|20365242|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259112|NCT01807520|20365243|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259113|NCT01807520|20365244|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259114|NCT01807520|20365245|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
8259115|NCT01807520|20365246|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
8259116|NCT01807520|20365247|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
8259117|NCT01807520|20365241|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259118|NCT01807520|20365242|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259119|NCT01807520|20365243|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259120|NCT01807520|20365244|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259121|NCT01807520|20365245|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
8259122|NCT01807520|20365246|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
8259123|NCT01807520|20365247|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
8259124|NCT01807520|20365241|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259125|NCT01807520|20365242|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259126|NCT01807520|20365243|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259127|NCT01807520|20365244|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259128|NCT01807520|20365245|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
8259129|NCT01807520|20365246|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
8259130|NCT01807520|20365247|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
8259131|NCT01807455|20365266|P1|NOT COMPLETED|Overall Study||0
8259132|NCT01807455|20365266|P1|COMPLETED|Overall Study||12
8259133|NCT01807455|20365266|P1|STARTED|Overall Study||12
8259134|NCT01807299|20365278|P4|NOT COMPLETED|Overall Study||2
8259135|NCT01807299|20365279|P3|NOT COMPLETED|Overall Study||0
8259136|NCT01807299|20365280|P2|NOT COMPLETED|Overall Study||1
8259137|NCT01807299|20365281|P1|NOT COMPLETED|Overall Study||3
8259138|NCT01807299|20365278|P4|COMPLETED|Overall Study||11
8259139|NCT01807299|20365279|P3|COMPLETED|Overall Study||12
8259140|NCT01807299|20365280|P2|COMPLETED|Overall Study||13
8259141|NCT01807299|20365281|P1|COMPLETED|Overall Study||11
8259142|NCT01807299|20365278|P4|STARTED|Overall Study||13
8259143|NCT01807299|20365279|P3|STARTED|Overall Study||12
8259144|NCT01807299|20365280|P2|STARTED|Overall Study||14
8259145|NCT01807299|20365281|P1|STARTED|Overall Study||14
8259146|NCT01807234|20365297|P6|NOT COMPLETED|Overall Study||4
8259147|NCT01807234|20365298|P5|NOT COMPLETED|Overall Study||4
8259148|NCT01807234|20365299|P4|NOT COMPLETED|Overall Study||2
8259149|NCT01807234|20365300|P3|NOT COMPLETED|Overall Study||2
8259150|NCT01807234|20365301|P2|NOT COMPLETED|Overall Study||6
8259151|NCT01807234|20365302|P1|NOT COMPLETED|Overall Study||5
8259152|NCT01807234|20365297|P6|COMPLETED|Overall Study||8
8259153|NCT01807234|20365298|P5|COMPLETED|Overall Study||8
8259154|NCT01807234|20365299|P4|COMPLETED|Overall Study||10
8259155|NCT01807234|20365300|P3|COMPLETED|Overall Study||10
8259156|NCT01807234|20365301|P2|COMPLETED|Overall Study||6
8259157|NCT01807234|20365302|P1|COMPLETED|Overall Study||7
8259158|NCT01807234|20365297|P6|Completed Only 1 Attack|Overall Study||1
8259159|NCT01807234|20365298|P5|Completed Only 1 Attack|Overall Study||0
8259160|NCT01807234|20365299|P4|Completed Only 1 Attack|Overall Study||1
8259161|NCT01807234|20365300|P3|Completed Only 1 Attack|Overall Study||0
8259162|NCT01807234|20365301|P2|Completed Only 1 Attack|Overall Study||1
8259163|NCT01807234|20365302|P1|Completed Only 1 Attack|Overall Study||2
8259164|NCT01807234|20365297|P6|Randomized, But Did Not Take Drug|Overall Study||3
8259165|NCT01807234|20365298|P5|Randomized, But Did Not Take Drug|Overall Study||4
8259166|NCT01807234|20365299|P4|Randomized, But Did Not Take Drug|Overall Study||1
8259167|NCT01807234|20365300|P3|Randomized, But Did Not Take Drug|Overall Study||2
8259168|NCT01807234|20365301|P2|Randomized, But Did Not Take Drug|Overall Study||5
8259169|NCT01807234|20365302|P1|Randomized, But Did Not Take Drug|Overall Study||3
8259170|NCT01807234|20365297|P6|STARTED|Overall Study||12
8259171|NCT01807234|20365298|P5|STARTED|Overall Study||12
8259172|NCT01807234|20365299|P4|STARTED|Overall Study||12
8259173|NCT01807234|20365300|P3|STARTED|Overall Study||12
8259174|NCT01807234|20365301|P2|STARTED|Overall Study||12
8259175|NCT01807234|20365302|P1|STARTED|Overall Study||12
8259176|NCT01807156|20365337|P1|NOT COMPLETED|Overall Study||1
8259177|NCT01807156|20365337|P1|COMPLETED|Overall Study||6
8259178|NCT01807156|20365337|P1|STARTED|Overall Study||7
8259179|NCT01807104|20365344|P2|NOT COMPLETED|Overall Study||4
8259180|NCT01807104|20365345|P1|NOT COMPLETED|Overall Study||4
8259181|NCT01807104|20365344|P2|COMPLETED|Overall Study||40
8259182|NCT01807104|20365345|P1|COMPLETED|Overall Study||39
8259183|NCT01807104|20365344|P2|STARTED|Overall Study||44
8259184|NCT01807104|20365345|P1|STARTED|Overall Study||43
8259185|NCT01807065|20365353|P2|NOT COMPLETED|Overall Study||1
8259186|NCT01807065|20365354|P1|NOT COMPLETED|Overall Study||1
8259187|NCT01807065|20365353|P2|COMPLETED|Overall Study||25
8259188|NCT01807065|20365354|P1|COMPLETED|Overall Study||24
8259189|NCT01807065|20365353|P2|STARTED|Overall Study||26
8259190|NCT01807065|20365354|P1|STARTED|Overall Study||25
8259191|NCT01807026|20365368|P6|NOT COMPLETED|Overall Study||0
8259192|NCT01807026|20365369|P5|NOT COMPLETED|Overall Study||0
8259193|NCT01807026|20365370|P4|NOT COMPLETED|Overall Study||0
8259194|NCT01807026|20365371|P3|NOT COMPLETED|Overall Study||0
8259195|NCT01807026|20365372|P2|NOT COMPLETED|Overall Study||0
8259196|NCT01807026|20365373|P1|NOT COMPLETED|Overall Study||0
8259197|NCT01807026|20365368|P6|COMPLETED|Overall Study||3
8259198|NCT01807026|20365369|P5|COMPLETED|Overall Study||9
8259199|NCT01807026|20365370|P4|COMPLETED|Overall Study||2
8259200|NCT01807026|20365371|P3|COMPLETED|Overall Study||10
8259201|NCT01807026|20365372|P2|COMPLETED|Overall Study||2
8259202|NCT01807026|20365373|P1|COMPLETED|Overall Study||10
8259203|NCT01807026|20365368|P6|Received at Least One Dose of Study Drug|Overall Study||3
8259204|NCT01807026|20365369|P5|Received at Least One Dose of Study Drug|Overall Study||9
8259205|NCT01807026|20365370|P4|Received at Least One Dose of Study Drug|Overall Study||2
8259206|NCT01807026|20365371|P3|Received at Least One Dose of Study Drug|Overall Study||10
8259207|NCT01807026|20365372|P2|Received at Least One Dose of Study Drug|Overall Study||2
8259208|NCT01807026|20365373|P1|Received at Least One Dose of Study Drug|Overall Study||10
8259209|NCT01807026|20365368|P6|STARTED|Overall Study||3
8259210|NCT01807026|20365369|P5|STARTED|Overall Study||9
8259211|NCT01807026|20365370|P4|STARTED|Overall Study||2
8259212|NCT01807026|20365371|P3|STARTED|Overall Study||10
8259213|NCT01807026|20365372|P2|STARTED|Overall Study||2
8259214|NCT01807026|20365373|P1|STARTED|Overall Study||10
8259215|NCT01807000|20365401|P1|NOT COMPLETED|Overall Study||0
8259216|NCT01807000|20365401|P1|COMPLETED|Overall Study||6
8259217|NCT01807000|20365401|P1|STARTED|Overall Study||6
8259218|NCT01806961|20365420|P1|NOT COMPLETED|Overall Study||16
8259219|NCT01806961|20365420|P1|COMPLETED|Overall Study||0
8259220|NCT01806961|20365420|P1|STARTED|Overall Study||16
8259221|NCT01806896|20365426|P2|NOT COMPLETED|Overall Study||0
8259222|NCT01806896|20365427|P1|NOT COMPLETED|Overall Study||3
8259223|NCT01806896|20365426|P2|COMPLETED|Overall Study||17
8259224|NCT01806896|20365427|P1|COMPLETED|Overall Study||17
8259225|NCT01806896|20365426|P2|Received Treatment|Overall Study||17
8259226|NCT01806896|20365427|P1|Received Treatment|Overall Study||19
8259227|NCT01806896|20365426|P2|STARTED|Overall Study||17
8259228|NCT01806896|20365427|P1|STARTED|Overall Study||20
8259229|NCT01806857|20365455|P2|NOT COMPLETED|Overall Study||0
8259230|NCT01806857|20365456|P1|NOT COMPLETED|Overall Study||1
8259231|NCT01806857|20365455|P2|COMPLETED|Overall Study||29
8259232|NCT01806857|20365456|P1|COMPLETED|Overall Study||30
8259233|NCT01806857|20365455|P2|STARTED|Overall Study||29
8259234|NCT01806857|20365456|P1|STARTED|Overall Study||31
8259235|NCT01806779|20365494|P3|NOT COMPLETED|Overall Study||23
8259236|NCT01806779|20365495|P2|NOT COMPLETED|Overall Study||44
8259237|NCT01806779|20365496|P1|NOT COMPLETED|Overall Study||42
8259238|NCT01806779|20365494|P3|COMPLETED|Overall Study||0
8259239|NCT01806779|20365495|P2|COMPLETED|Overall Study||40
8259240|NCT01806779|20365496|P1|COMPLETED|Overall Study||48
8259241|NCT01806779|20365494|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
8259242|NCT01806779|20365495|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
8259243|NCT01806779|20365496|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
8259244|NCT01806779|20365494|P3|Randomized at Visit 2|Overall Study||0
8259245|NCT01806779|20365495|P2|Randomized at Visit 2|Overall Study||84
8259246|NCT01806779|20365496|P1|Randomized at Visit 2|Overall Study||90
8259247|NCT01806779|20365494|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
8259248|NCT01806779|20365495|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
8259249|NCT01806779|20365496|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
8259250|NCT01806779|20365494|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
8259251|NCT01806779|20365495|P2|STARTED|Overall Study||84
8259252|NCT01806779|20365496|P1|STARTED|Overall Study||90
8259253|NCT01806740|20365509|P1|NOT COMPLETED|Overall Study||6
8259254|NCT01806740|20365509|P1|COMPLETED|Overall Study||31
8259255|NCT01806740|20365509|P1|STARTED|Overall Study||37
8259256|NCT01806714|20365520|P2|NOT COMPLETED|Overall Study||170
8259257|NCT01806714|20365521|P1|NOT COMPLETED|Overall Study||200
8259258|NCT01806714|20365520|P2|COMPLETED|Overall Study||1919
8259259|NCT01806714|20365521|P1|COMPLETED|Overall Study||1893
8259260|NCT01806714|20365520|P2|STARTED|Overall Study||2089
8259261|NCT01806714|20365521|P1|STARTED|Overall Study||2093
8259262|NCT01806675|20365534|P3|NOT COMPLETED|Overall Study||0
8259263|NCT01806675|20365535|P2|NOT COMPLETED|Overall Study||0
8259264|NCT01806675|20365536|P1|NOT COMPLETED|Overall Study||0
8259265|NCT01806675|20365534|P3|COMPLETED|Overall Study||8
8259266|NCT01806675|20365535|P2|COMPLETED|Overall Study||6
8259267|NCT01806675|20365536|P1|COMPLETED|Overall Study||11
8259268|NCT01806675|20365534|P3|STARTED|Overall Study||8
8259269|NCT01806675|20365535|P2|STARTED|Overall Study||6
8259270|NCT01806675|20365536|P1|STARTED|Overall Study||11
8259271|NCT01806662|20365556|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
8259272|NCT01806662|20365557|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
8259273|NCT01806662|20365556|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
8259274|NCT01806662|20365557|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
8259275|NCT01806662|20365556|P2|STARTED|Second Intervention (Weeks 16-32)||15
8259276|NCT01806662|20365557|P1|STARTED|Second Intervention (Weeks 16-32)||12
8259277|NCT01806662|20365556|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
8259278|NCT01806662|20365557|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
8259279|NCT01806662|20365556|P2|COMPLETED|First Intervention (Weeks 0-16)||15
8259280|NCT01806662|20365557|P1|COMPLETED|First Intervention (Weeks 0-16)||12
8259281|NCT01806662|20365556|P2|Received Intervention|First Intervention (Weeks 0-16)||15
8259282|NCT01806662|20365557|P1|Received Intervention|First Intervention (Weeks 0-16)||12
8259283|NCT01806662|20365556|P2|STARTED|First Intervention (Weeks 0-16)||16
8259284|NCT01806662|20365557|P1|STARTED|First Intervention (Weeks 0-16)||16
8259285|NCT01806597|20365566|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
8259286|NCT01806597|20365567|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259287|NCT01806597|20365568|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259288|NCT01806597|20365569|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259289|NCT01806597|20365570|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259290|NCT01806597|20365571|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259291|NCT01806597|20365566|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
8259292|NCT01806597|20365567|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
8259293|NCT01806597|20365568|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259294|NCT01806597|20365569|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259295|NCT01806597|20365570|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259296|NCT01806597|20365571|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259297|NCT01806597|20365566|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
8259298|NCT01806597|20365567|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
8259299|NCT01806597|20365568|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259300|NCT01806597|20365569|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259301|NCT01806597|20365570|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259302|NCT01806597|20365571|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259303|NCT01806597|20365566|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8259304|NCT01806597|20365567|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
8259305|NCT01806597|20365568|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
8259306|NCT01806597|20365569|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
8259307|NCT01806597|20365570|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
8259308|NCT01806597|20365571|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
8259309|NCT01806597|20365566|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8259310|NCT01806597|20365567|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8259311|NCT01806597|20365568|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
8259312|NCT01806597|20365569|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
8259313|NCT01806597|20365570|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
8259314|NCT01806597|20365571|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
8259315|NCT01806597|20365566|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
8259316|NCT01806597|20365567|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
8259317|NCT01806597|20365568|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
8259318|NCT01806597|20365569|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
8259319|NCT01806597|20365570|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
8259320|NCT01806597|20365571|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
8259321|NCT01806597|20365566|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8259322|NCT01806597|20365567|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8259323|NCT01806597|20365568|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8259324|NCT01806597|20365569|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8259325|NCT01806597|20365570|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8259326|NCT01806597|20365571|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8259327|NCT01806597|20365566|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
8259328|NCT01806597|20365567|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
8259329|NCT01806597|20365568|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
8259330|NCT01806597|20365569|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
8259331|NCT01806597|20365570|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
8259332|NCT01806597|20365571|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
8259333|NCT01806597|20365566|P6|STARTED|Period 1 (Baseline to Week 16)||0
8259334|NCT01806597|20365567|P5|STARTED|Period 1 (Baseline to Week 16)||68
8259335|NCT01806597|20365568|P4|STARTED|Period 1 (Baseline to Week 16)||0
8259336|NCT01806597|20365569|P3|STARTED|Period 1 (Baseline to Week 16)||0
8259337|NCT01806597|20365570|P2|STARTED|Period 1 (Baseline to Week 16)||69
8259338|NCT01806597|20365571|P1|STARTED|Period 1 (Baseline to Week 16)||68
8259339|NCT01806584|20365607|P2|NOT COMPLETED|Overall Study||18
8259340|NCT01806584|20365608|P1|NOT COMPLETED|Overall Study||14
8259341|NCT01806584|20365607|P2|COMPLETED|Overall Study||0
8259342|NCT01806584|20365608|P1|COMPLETED|Overall Study||0
8259343|NCT01806584|20365607|P2|STARTED|Overall Study||18
8259344|NCT01806584|20365608|P1|STARTED|Overall Study||14
8259345|NCT01806571|20365620|P1|NOT COMPLETED|Overall Study||0
8259346|NCT01806571|20365620|P1|COMPLETED|Overall Study||34
8259347|NCT01806571|20365620|P1|STARTED|Overall Study||34
8259348|NCT01806545|20365630|P2|NOT COMPLETED|Overall Study||5
8259349|NCT01806545|20365631|P1|NOT COMPLETED|Overall Study||6
8259350|NCT01806545|20365630|P2|COMPLETED|Overall Study||30
8259351|NCT01806545|20365631|P1|COMPLETED|Overall Study||23
8259352|NCT01806545|20365630|P2|STARTED|Overall Study||35
8259353|NCT01806545|20365631|P1|STARTED|Overall Study||29
8259354|NCT01806506|20365655|P2|NOT COMPLETED|Overall Study||1
8259355|NCT01806506|20365656|P1|NOT COMPLETED|Overall Study||2
8259356|NCT01806506|20365655|P2|COMPLETED|Overall Study||35
8259357|NCT01806506|20365656|P1|COMPLETED|Overall Study||34
8259358|NCT01806506|20365655|P2|9 Months|Overall Study|1 patient (reason - lost contact)|35
8259359|NCT01806506|20365656|P1|9 Months|Overall Study||34
8259360|NCT01806506|20365655|P2|6 Months|Overall Study||36
8259361|NCT01806506|20365656|P1|6 Months|Overall Study|1 patient (reason - lost contact)|34
8259362|NCT01806506|20365655|P2|3 Months|Overall Study||36
8259363|NCT01806506|20365656|P1|3 Months|Overall Study|1 patient (reason - lost contact)|35
8259364|NCT01806506|20365655|P2|1 Month|Overall Study||36
8259365|NCT01806506|20365656|P1|1 Month|Overall Study||36
8259366|NCT01806506|20365655|P2|STARTED|Overall Study||36
8259367|NCT01806506|20365656|P1|STARTED|Overall Study||36
8259368|NCT01806389|20365662|P1|NOT COMPLETED|Overall Study||4
8259369|NCT01806389|20365662|P1|COMPLETED|Overall Study||10
8259370|NCT01806389|20365662|P1|STARTED|Overall Study||14
8259371|NCT01806298|20365676|P1|NOT COMPLETED|Overall Study||10
8259372|NCT01806298|20365676|P1|COMPLETED|Overall Study||68
8259373|NCT01806298|20365676|P1|STARTED|Overall Study||78
8259374|NCT01806259|20365688|P2|NOT COMPLETED|Overall Study||0
8259375|NCT01806259|20365689|P1|NOT COMPLETED|Overall Study||0
8259376|NCT01806259|20365688|P2|COMPLETED|Overall Study||107
8259377|NCT01806259|20365689|P1|COMPLETED|Overall Study||96
8259378|NCT01806259|20365688|P2|STARTED|Overall Study||107
8259379|NCT01806259|20365689|P1|STARTED|Overall Study||96
8259380|NCT01806064|20365702|P5|NOT COMPLETED|Overall Study||2
8259381|NCT01806064|20365703|P4|NOT COMPLETED|Overall Study||1
8259382|NCT01806064|20365704|P3|NOT COMPLETED|Overall Study||0
8259383|NCT01806064|20365705|P2|NOT COMPLETED|Overall Study||0
8259384|NCT01806064|20365706|P1|NOT COMPLETED|Overall Study||0
8259385|NCT01806064|20365702|P5|COMPLETED|Overall Study||73
8259386|NCT01806064|20365703|P4|COMPLETED|Overall Study||74
8259387|NCT01806064|20365704|P3|COMPLETED|Overall Study||5
8259388|NCT01806064|20365705|P2|COMPLETED|Overall Study||15
8259389|NCT01806064|20365706|P1|COMPLETED|Overall Study||3
8259390|NCT01806064|20365702|P5|STARTED|Overall Study||75
8259391|NCT01806064|20365703|P4|STARTED|Overall Study||75
8259392|NCT01806064|20365704|P3|STARTED|Overall Study||5
8259393|NCT01806064|20365705|P2|STARTED|Overall Study||15
8259394|NCT01806064|20365706|P1|STARTED|Overall Study||3
8259395|NCT01806051|20365731|P1|NOT COMPLETED|Overall Study||6
8259396|NCT01806051|20365731|P1|COMPLETED|Overall Study||0
8259397|NCT01806051|20365731|P1|STARTED|Overall Study||6
8259398|NCT01805895|20365739|P2|NOT COMPLETED|Overall Study||0
8259399|NCT01805895|20365740|P1|NOT COMPLETED|Overall Study||0
8259400|NCT01805895|20365739|P2|COMPLETED|Overall Study||8
8259401|NCT01805895|20365740|P1|COMPLETED|Overall Study||8
8259402|NCT01805895|20365739|P2|STARTED|Overall Study||8
8259403|NCT01805895|20365740|P1|STARTED|Overall Study||8
8259404|NCT01805882|20365757|P9|NOT COMPLETED|Overall Study||1
8259405|NCT01805882|20365758|P8|NOT COMPLETED|Overall Study||0
8259406|NCT01805882|20365759|P7|NOT COMPLETED|Overall Study||2
8259407|NCT01805882|20365760|P6|NOT COMPLETED|Overall Study||1
8259408|NCT01805882|20365761|P5|NOT COMPLETED|Overall Study||0
8259409|NCT01805882|20365762|P4|NOT COMPLETED|Overall Study||2
8259410|NCT01805882|20365763|P3|NOT COMPLETED|Overall Study||1
8259411|NCT01805882|20365764|P2|NOT COMPLETED|Overall Study||0
8259412|NCT01805882|20365765|P1|NOT COMPLETED|Overall Study||0
8259413|NCT01805882|20365757|P9|COMPLETED|Overall Study||24
8259414|NCT01805882|20365758|P8|COMPLETED|Overall Study||25
8259415|NCT01805882|20365759|P7|COMPLETED|Overall Study||48
8259416|NCT01805882|20365760|P6|COMPLETED|Overall Study||20
8259417|NCT01805882|20365761|P5|COMPLETED|Overall Study||14
8259418|NCT01805882|20365762|P4|COMPLETED|Overall Study||32
8259419|NCT01805882|20365763|P3|COMPLETED|Overall Study||19
8259420|NCT01805882|20365764|P2|COMPLETED|Overall Study||20
8259421|NCT01805882|20365765|P1|COMPLETED|Overall Study||20
8259422|NCT01805882|20365757|P9|STARTED|Overall Study||25
8259423|NCT01805882|20365758|P8|STARTED|Overall Study||25
8259424|NCT01805882|20365759|P7|STARTED|Overall Study||50
8259425|NCT01805882|20365760|P6|STARTED|Overall Study||21
8259426|NCT01805882|20365761|P5|STARTED|Overall Study||14
8259427|NCT01805882|20365762|P4|STARTED|Overall Study||34
8259428|NCT01805882|20365763|P3|STARTED|Overall Study||20
8259429|NCT01805882|20365764|P2|STARTED|Overall Study||20
8259430|NCT01805882|20365765|P1|STARTED|Overall Study||20
8259431|NCT01805791|20365788|P3|NOT COMPLETED|Overall Study||20
8259432|NCT01805791|20365789|P2|NOT COMPLETED|Overall Study||17
8259433|NCT01805791|20365790|P1|NOT COMPLETED|Overall Study||22
8259434|NCT01805791|20365788|P3|COMPLETED|Overall Study||48
8259435|NCT01805791|20365789|P2|COMPLETED|Overall Study||50
8259436|NCT01805791|20365790|P1|COMPLETED|Overall Study||44
8259437|NCT01805791|20365788|P3|STARTED|Overall Study||68
8259438|NCT01805791|20365789|P2|STARTED|Overall Study||67
8259439|NCT01805791|20365790|P1|STARTED|Overall Study||66
8259440|NCT01805687|20365804|P1|NOT COMPLETED|Overall Study||0
8259441|NCT01805687|20365804|P1|COMPLETED|Overall Study||25
8259442|NCT01805687|20365804|P1|STARTED|Overall Study||25
8259443|NCT01805440|20365811|P3|NOT COMPLETED|Overall Study||0
8259444|NCT01805440|20365812|P2|NOT COMPLETED|Overall Study||0
8259445|NCT01805440|20365813|P1|NOT COMPLETED|Overall Study||1
8259446|NCT01805440|20365811|P3|COMPLETED|Overall Study||26
8259447|NCT01805440|20365812|P2|COMPLETED|Overall Study||17
8259448|NCT01805440|20365813|P1|COMPLETED|Overall Study||18
8259449|NCT01805440|20365811|P3|STARTED|Overall Study||26
8259450|NCT01805440|20365812|P2|STARTED|Overall Study||17
8259451|NCT01805440|20365813|P1|STARTED|Overall Study||19
8259452|NCT01805323|20365826|P1|NOT COMPLETED|Overall Study||0
8259453|NCT01805323|20365826|P1|COMPLETED|Overall Study||101
8259454|NCT01805323|20365826|P1|STARTED|Overall Study||101
8259455|NCT01805297|20365833|P2|NOT COMPLETED|Overall Study||3
8259456|NCT01805297|20365834|P1|NOT COMPLETED|Overall Study||2
8259457|NCT01805297|20365833|P2|COMPLETED|Overall Study||3
8259458|NCT01805297|20365834|P1|COMPLETED|Overall Study||4
8259459|NCT01805297|20365833|P2|STARTED|Overall Study||6
8259460|NCT01805297|20365834|P1|STARTED|Overall Study||6
8259461|NCT01805180|20365848|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
8259462|NCT01805180|20365849|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
8259463|NCT01805180|20365850|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
8259464|NCT01805180|20365848|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
8259465|NCT01805180|20365849|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
8259466|NCT01805180|20365850|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
8259467|NCT01805180|20365848|P3|STARTED|Pivotal Randomization Through Study Exit||20
8259468|NCT01805180|20365849|P2|STARTED|Pivotal Randomization Through Study Exit||22
8259469|NCT01805180|20365850|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
8259470|NCT01805180|20365848|P3|NOT COMPLETED|Lead-in Donor Phase||0
8259471|NCT01805180|20365849|P2|NOT COMPLETED|Lead-in Donor Phase||0
8259472|NCT01805180|20365850|P1|NOT COMPLETED|Lead-in Donor Phase||1
8259473|NCT01805180|20365848|P3|COMPLETED|Lead-in Donor Phase||0
8259474|NCT01805180|20365849|P2|COMPLETED|Lead-in Donor Phase||0
8259475|NCT01805180|20365850|P1|COMPLETED|Lead-in Donor Phase||6
8259476|NCT01805180|20365848|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
8259477|NCT01805180|20365849|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
8259478|NCT01805180|20365850|P1|STARTED|Lead-in Donor Phase||7
8259479|NCT01805154|20365873|P1|NOT COMPLETED|Overall Study||354
8259480|NCT01805154|20365873|P1|COMPLETED|Overall Study||1175
8259481|NCT01805154|20365873|P1|STARTED|Overall Study||1529
8259482|NCT01805089|20365883|P2|NOT COMPLETED|Overall Study||4
8259483|NCT01805089|20365884|P1|NOT COMPLETED|Overall Study||5
8259484|NCT01805089|20365883|P2|COMPLETED|Overall Study||43
8259485|NCT01805089|20365884|P1|COMPLETED|Overall Study||43
8259486|NCT01805089|20365883|P2|STARTED|Overall Study||47
8259487|NCT01805089|20365884|P1|STARTED|Overall Study||48
8259488|NCT01805037|20365894|P2|NOT COMPLETED|Follow Up (up to 3 Years)||6
8259489|NCT01805037|20365895|P1|NOT COMPLETED|Follow Up (up to 3 Years)||0
8259490|NCT01805037|20365894|P2|COMPLETED|Follow Up (up to 3 Years)||14
8259491|NCT01805037|20365895|P1|COMPLETED|Follow Up (up to 3 Years)||0
8259492|NCT01805037|20365894|P2|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
8259493|NCT01805037|20365895|P1|STARTED|Follow Up (up to 3 Years)||0
8259494|NCT01805037|20365894|P2|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
8259495|NCT01805037|20365895|P1|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
8259496|NCT01805037|20365894|P2|COMPLETED|2nd Cycle of Maintenance and Beyond||2
8259497|NCT01805037|20365895|P1|COMPLETED|2nd Cycle of Maintenance and Beyond||0
8259498|NCT01805037|20365894|P2|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
8259499|NCT01805037|20365895|P1|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
8259500|NCT01805037|20365894|P2|STARTED|2nd Cycle of Maintenance and Beyond||14
8259501|NCT01805037|20365895|P1|STARTED|2nd Cycle of Maintenance and Beyond||0
8259502|NCT01805037|20365894|P2|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
8259503|NCT01805037|20365895|P1|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
8259504|NCT01805037|20365894|P2|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
8259505|NCT01805037|20365895|P1|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
8259506|NCT01805037|20365894|P2|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
8259507|NCT01805037|20365895|P1|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
8259508|NCT01805037|20365894|P2|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
8259509|NCT01805037|20365895|P1|STARTED|1st Cycle of Maintenance (3 Weeks)||0
8259510|NCT01805037|20365894|P2|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
8259511|NCT01805037|20365895|P1|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
8259512|NCT01805037|20365894|P2|COMPLETED|Consolidation (Optional, 4 Weeks)||6
8259513|NCT01805037|20365895|P1|COMPLETED|Consolidation (Optional, 4 Weeks)||0
8259514|NCT01805037|20365894|P2|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
8259515|NCT01805037|20365895|P1|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
8259516|NCT01805037|20365894|P2|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
8259517|NCT01805037|20365895|P1|STARTED|Consolidation (Optional, 4 Weeks)||0
8259518|NCT01805037|20365894|P2|NOT COMPLETED|Induction (4 Weeks)||0
8259519|NCT01805037|20365895|P1|NOT COMPLETED|Induction (4 Weeks)||0
8259520|NCT01805037|20365894|P2|COMPLETED|Induction (4 Weeks)||20
8259521|NCT01805037|20365895|P1|COMPLETED|Induction (4 Weeks)||0
8259522|NCT01805037|20365894|P2|Received Dose of Study Drug|Induction (4 Weeks)||20
8259523|NCT01805037|20365895|P1|Received Dose of Study Drug|Induction (4 Weeks)||0
8259524|NCT01805037|20365894|P2|STARTED|Induction (4 Weeks)||20
8259525|NCT01805037|20365895|P1|STARTED|Induction (4 Weeks)||0
8259526|NCT01805024|20365913|P4|NOT COMPLETED|Overall Study||0
8259527|NCT01805024|20365914|P3|NOT COMPLETED|Overall Study||0
8259528|NCT01805024|20365915|P2|NOT COMPLETED|Overall Study||0
8259529|NCT01805024|20365916|P1|NOT COMPLETED|Overall Study||0
8259530|NCT01805024|20365913|P4|COMPLETED|Overall Study||8
8259531|NCT01805024|20365914|P3|COMPLETED|Overall Study||4
8259532|NCT01805024|20365915|P2|COMPLETED|Overall Study||4
8259533|NCT01805024|20365916|P1|COMPLETED|Overall Study||4
8259534|NCT01805024|20365913|P4|STARTED|Overall Study||8
8259535|NCT01805024|20365914|P3|STARTED|Overall Study||4
8259536|NCT01805024|20365915|P2|STARTED|Overall Study||4
8259537|NCT01805024|20365916|P1|STARTED|Overall Study||4
8259538|NCT01804946|20365940|P2|NOT COMPLETED|Overall Study||4
8259539|NCT01804946|20365941|P1|NOT COMPLETED|Overall Study||2
8259540|NCT01804946|20365940|P2|COMPLETED|Overall Study||76
8259541|NCT01804946|20365941|P1|COMPLETED|Overall Study||79
8259542|NCT01804946|20365940|P2|STARTED|Overall Study||80
8259543|NCT01804946|20365941|P1|STARTED|Overall Study||81
8259544|NCT01804881|20365965|P2|NOT COMPLETED|Overall Study||4
8259545|NCT01804881|20365966|P1|NOT COMPLETED|Overall Study||5
8259546|NCT01804881|20365965|P2|COMPLETED|Overall Study||10
8259547|NCT01804881|20365966|P1|COMPLETED|Overall Study||11
8259548|NCT01804881|20365965|P2|STARTED|Overall Study||14
8259549|NCT01804881|20365966|P1|STARTED|Overall Study||16
8259550|NCT01804842|20365979|P3|NOT COMPLETED|Overall Study||1
8259551|NCT01804842|20365980|P2|NOT COMPLETED|Overall Study||2
8259552|NCT01804842|20365981|P1|NOT COMPLETED|Overall Study||3
8259553|NCT01804842|20365979|P3|COMPLETED|Overall Study||8
8259554|NCT01804842|20365980|P2|COMPLETED|Overall Study||6
8259555|NCT01804842|20365981|P1|COMPLETED|Overall Study||6
8259556|NCT01804842|20365979|P3|Completed Treatment C|Overall Study||9
8259557|NCT01804842|20365980|P2|Completed Treatment C|Overall Study||7
8259558|NCT01804842|20365981|P1|Completed Treatment C|Overall Study||7
8259559|NCT01804842|20365979|P3|Completed Treatment B|Overall Study||8
8259560|NCT01804842|20365980|P2|Completed Treatment B|Overall Study||8
8259561|NCT01804842|20365981|P1|Completed Treatment B|Overall Study||8
8259562|NCT01804842|20365979|P3|Completed Treatment A|Overall Study||8
8259563|NCT01804842|20365980|P2|Completed Treatment A|Overall Study||6
8259564|NCT01804842|20365981|P1|Completed Treatment A|Overall Study||9
8259565|NCT01804842|20365979|P3|STARTED|Overall Study||9
8259566|NCT01804842|20365980|P2|STARTED|Overall Study||8
8259567|NCT01804842|20365981|P1|STARTED|Overall Study||9
8259574|NCT01804673|20366010|P1|NOT COMPLETED|Overall Study||140
8259575|NCT01804673|20366010|P1|COMPLETED|Overall Study||34
8259576|NCT01804673|20366010|P1|Completed Hour 72|Overall Study||36
8259577|NCT01804673|20366010|P1|Completed Hour 48|Overall Study||79
8259578|NCT01804673|20366010|P1|Completed Hour 24|Overall Study||170
8259579|NCT01804673|20366010|P1|STARTED|Overall Study||174
8259580|NCT01804582|20366028|P2|NOT COMPLETED|Overall Study||56
8259581|NCT01804582|20366029|P1|NOT COMPLETED|Overall Study||49
8259582|NCT01804582|20366028|P2|COMPLETED|Overall Study||117
8259583|NCT01804582|20366029|P1|COMPLETED|Overall Study||128
8259584|NCT01804582|20366028|P2|STARTED|Overall Study||173
8259585|NCT01804582|20366029|P1|STARTED|Overall Study||177
8259592|NCT01804257|20366056|P1|NOT COMPLETED|Overall Study||1
8259593|NCT01804257|20366056|P1|COMPLETED|Overall Study||27
8259594|NCT01804257|20366056|P1|STARTED|Overall Study||28
8259595|NCT01804140|20366060|P1|NOT COMPLETED|Overall Study||114
8259596|NCT01804140|20366060|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
8259597|NCT01804140|20366060|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
8259598|NCT01804101|20366067|P2|NOT COMPLETED|Overall Study||0
8259599|NCT01804101|20366068|P1|NOT COMPLETED|Overall Study||0
8259600|NCT01804101|20366067|P2|COMPLETED|Overall Study||10
8259601|NCT01804101|20366068|P1|COMPLETED|Overall Study||38
8259602|NCT01804101|20366067|P2|STARTED|Overall Study||10
8259603|NCT01804101|20366068|P1|STARTED|Overall Study||38
8259604|NCT01804075|20366078|P2|NOT COMPLETED|Overall Study||0
8259605|NCT01804075|20366079|P1|NOT COMPLETED|Overall Study||0
8259606|NCT01804075|20366078|P2|COMPLETED|Overall Study||16
8259607|NCT01804075|20366079|P1|COMPLETED|Overall Study||15
8259608|NCT01804075|20366078|P2|STARTED|Overall Study||16
8259609|NCT01804075|20366079|P1|STARTED|Overall Study||15
8259610|NCT01804062|20366087|P1|NOT COMPLETED|Overall Study||0
8259611|NCT01804062|20366087|P1|COMPLETED|Overall Study||30
8259612|NCT01804062|20366087|P1|STARTED|Overall Study||30
8259613|NCT01804049|20366094|P2|NOT COMPLETED|Overall Study||32
8259614|NCT01804049|20366095|P1|NOT COMPLETED|Overall Study||11
8259615|NCT01804049|20366094|P2|COMPLETED|Overall Study||45
8259616|NCT01804049|20366095|P1|COMPLETED|Overall Study||32
8259617|NCT01804049|20366094|P2|STARTED|Overall Study||77
8259618|NCT01804049|20366095|P1|STARTED|Overall Study||43
8259619|NCT01804036|20366107|P2|NOT COMPLETED|Overall Study||20
8259620|NCT01804036|20366108|P1|NOT COMPLETED|Overall Study||13
8259621|NCT01804036|20366107|P2|COMPLETED|Overall Study||21
8259622|NCT01804036|20366108|P1|COMPLETED|Overall Study||18
8259623|NCT01804036|20366107|P2|STARTED|Overall Study||41
8259624|NCT01804036|20366108|P1|STARTED|Overall Study||31
8259625|NCT01803880|20366143|P3|NOT COMPLETED|Overall Study||15
8259626|NCT01803880|20366144|P2|NOT COMPLETED|Overall Study||10
8259627|NCT01803880|20366145|P1|NOT COMPLETED|Overall Study||6
8259628|NCT01803880|20366143|P3|COMPLETED|Overall Study||14
8259629|NCT01803880|20366144|P2|COMPLETED|Overall Study||18
8259630|NCT01803880|20366145|P1|COMPLETED|Overall Study||13
8259631|NCT01803880|20366143|P3|STARTED|Overall Study||29
8259632|NCT01803880|20366144|P2|STARTED|Overall Study||28
8259633|NCT01803880|20366145|P1|STARTED|Overall Study||19
8259634|NCT01803737|20366181|P2|NOT COMPLETED|Overall Study||3
8259635|NCT01803737|20366182|P1|NOT COMPLETED|Overall Study||1
8259636|NCT01803737|20366181|P2|COMPLETED|Overall Study||10
8259637|NCT01803737|20366182|P1|COMPLETED|Overall Study||12
8259638|NCT01803737|20366181|P2|STARTED|Overall Study||13
8259639|NCT01803737|20366182|P1|STARTED|Overall Study||13
8259640|NCT01803711|20366206|P2|NOT COMPLETED|Overall Study||1
8259641|NCT01803711|20366207|P1|NOT COMPLETED|Overall Study||1
8259642|NCT01803711|20366206|P2|COMPLETED|Overall Study||2
8259643|NCT01803711|20366207|P1|COMPLETED|Overall Study||1
8259644|NCT01803711|20366206|P2|STARTED|Overall Study||3
8259645|NCT01803711|20366207|P1|STARTED|Overall Study||2
8259646|NCT01803646|20366225|P2|NOT COMPLETED|Overall Study||10
8259647|NCT01803646|20366226|P1|NOT COMPLETED|Overall Study||17
8259648|NCT01803646|20366225|P2|COMPLETED|Overall Study||129
8259649|NCT01803646|20366226|P1|COMPLETED|Overall Study||187
8259650|NCT01803646|20366225|P2|STARTED|Overall Study||139
8259651|NCT01803646|20366226|P1|STARTED|Overall Study||204
8259652|NCT01803607|20366238|P2|NOT COMPLETED|Overall Study||67
8259653|NCT01803607|20366239|P1|NOT COMPLETED|Overall Study||68
8259654|NCT01803607|20366238|P2|COMPLETED|Overall Study||0
8259655|NCT01803607|20366239|P1|COMPLETED|Overall Study||0
8259656|NCT01803607|20366238|P2|STARTED|Overall Study||67
8259657|NCT01803607|20366239|P1|STARTED|Overall Study||68
8259658|NCT01803464|20366263|P4|NOT COMPLETED|Overall Study||0
8259659|NCT01803464|20366264|P3|NOT COMPLETED|Overall Study||4
8259660|NCT01803464|20366265|P2|NOT COMPLETED|Overall Study||0
8259661|NCT01803464|20366266|P1|NOT COMPLETED|Overall Study||1
8259662|NCT01803464|20366263|P4|COMPLETED|Overall Study||10
8259663|NCT01803464|20366264|P3|COMPLETED|Overall Study||6
8259664|NCT01803464|20366265|P2|COMPLETED|Overall Study||4
8259665|NCT01803464|20366266|P1|COMPLETED|Overall Study||4
8259666|NCT01803464|20366263|P4|STARTED|Overall Study||10
8259667|NCT01803464|20366264|P3|STARTED|Overall Study||10
8259668|NCT01803464|20366265|P2|STARTED|Overall Study||4
8259669|NCT01803464|20366266|P1|STARTED|Overall Study||5
8259670|NCT01803282|20366296|P12|NOT COMPLETED|Overall Study||15
8259671|NCT01803282|20366297|P11|NOT COMPLETED|Overall Study||8
8259672|NCT01803282|20366298|P10|NOT COMPLETED|Overall Study||45
8259673|NCT01803282|20366299|P9|NOT COMPLETED|Overall Study||11
8259674|NCT01803282|20366300|P8|NOT COMPLETED|Overall Study||46
8259675|NCT01803282|20366301|P7|NOT COMPLETED|Overall Study||41
8259676|NCT01803282|20366302|P6|NOT COMPLETED|Overall Study||10
8259677|NCT01803282|20366303|P5|NOT COMPLETED|Overall Study||11
8259678|NCT01803282|20366304|P4|NOT COMPLETED|Overall Study||36
8259679|NCT01803282|20366305|P3|NOT COMPLETED|Overall Study||6
8259680|NCT01803282|20366306|P2|NOT COMPLETED|Overall Study||3
8259681|NCT01803282|20366307|P1|NOT COMPLETED|Overall Study||4
8259682|NCT01803282|20366296|P12|COMPLETED|Overall Study||0
8259683|NCT01803282|20366297|P11|COMPLETED|Overall Study||0
8259684|NCT01803282|20366298|P10|COMPLETED|Overall Study||0
8259685|NCT01803282|20366299|P9|COMPLETED|Overall Study||0
8259686|NCT01803282|20366300|P8|COMPLETED|Overall Study||0
8259687|NCT01803282|20366301|P7|COMPLETED|Overall Study||0
8259688|NCT01803282|20366302|P6|COMPLETED|Overall Study||0
8259689|NCT01803282|20366303|P5|COMPLETED|Overall Study||0
8259690|NCT01803282|20366304|P4|COMPLETED|Overall Study||0
8259691|NCT01803282|20366305|P3|COMPLETED|Overall Study||0
8259692|NCT01803282|20366306|P2|COMPLETED|Overall Study||0
8259693|NCT01803282|20366307|P1|COMPLETED|Overall Study||0
8259694|NCT01803282|20366296|P12|STARTED|Overall Study||15
8259695|NCT01803282|20366297|P11|STARTED|Overall Study||8
8259696|NCT01803282|20366298|P10|STARTED|Overall Study||45
8259697|NCT01803282|20366299|P9|STARTED|Overall Study||11
8259698|NCT01803282|20366300|P8|STARTED|Overall Study||46
8259699|NCT01803282|20366301|P7|STARTED|Overall Study||41
8259700|NCT01803282|20366302|P6|STARTED|Overall Study||10
8259701|NCT01803282|20366303|P5|STARTED|Overall Study||11
8259702|NCT01803282|20366304|P4|STARTED|Overall Study||36
8259703|NCT01803282|20366305|P3|STARTED|Overall Study||6
8259704|NCT01803282|20366306|P2|STARTED|Overall Study||3
8259705|NCT01803282|20366307|P1|STARTED|Overall Study||4
8259706|NCT01803269|20366348|P3|NOT COMPLETED|Overall Study||0
8259707|NCT01803269|20366349|P2|NOT COMPLETED|Overall Study||0
8259708|NCT01803269|20366350|P1|NOT COMPLETED|Overall Study||3
8259709|NCT01803269|20366348|P3|COMPLETED|Overall Study||14
8259710|NCT01803269|20366349|P2|COMPLETED|Overall Study||8
8259711|NCT01803269|20366350|P1|COMPLETED|Overall Study||4
8259712|NCT01803269|20366348|P3|STARTED|Overall Study||14
8259713|NCT01803269|20366349|P2|STARTED|Overall Study||8
8259714|NCT01803269|20366350|P1|STARTED|Overall Study||7
8259715|NCT01803204|20366372|P2|NOT COMPLETED|Overall Study||0
8259716|NCT01803204|20366373|P1|NOT COMPLETED|Overall Study||0
8259717|NCT01803204|20366372|P2|COMPLETED|Overall Study||20
8259718|NCT01803204|20366373|P1|COMPLETED|Overall Study||20
8259719|NCT01803204|20366372|P2|STARTED|Overall Study||20
8259720|NCT01803204|20366373|P1|STARTED|Overall Study||20
8259721|NCT01803074|20366397|P14|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259722|NCT01803074|20366398|P13|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259723|NCT01803074|20366399|P12|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259724|NCT01803074|20366400|P11|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259725|NCT01803074|20366401|P10|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259726|NCT01803074|20366402|P9|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259727|NCT01803074|20366403|P8|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259728|NCT01803074|20366404|P7|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259729|NCT01803074|20366405|P6|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259730|NCT01803074|20366406|P5|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259731|NCT01803074|20366407|P4|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259732|NCT01803074|20366408|P3|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259733|NCT01803074|20366409|P2|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259734|NCT01803074|20366410|P1|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259735|NCT01803074|20366397|P14|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
8259736|NCT01803074|20366398|P13|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
8259737|NCT01803074|20366399|P12|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
8259738|NCT01803074|20366400|P11|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259739|NCT01803074|20366401|P10|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259740|NCT01803074|20366402|P9|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259741|NCT01803074|20366403|P8|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259742|NCT01803074|20366404|P7|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259743|NCT01803074|20366405|P6|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259744|NCT01803074|20366406|P5|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259745|NCT01803074|20366407|P4|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259746|NCT01803074|20366408|P3|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259747|NCT01803074|20366409|P2|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259748|NCT01803074|20366410|P1|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259749|NCT01803074|20366397|P14|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
8259750|NCT01803074|20366398|P13|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
8259751|NCT01803074|20366399|P12|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
8259752|NCT01803074|20366400|P11|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259753|NCT01803074|20366401|P10|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259754|NCT01803074|20366402|P9|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259755|NCT01803074|20366403|P8|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259756|NCT01803074|20366404|P7|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259757|NCT01803074|20366405|P6|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259758|NCT01803074|20366406|P5|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259759|NCT01803074|20366407|P4|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259760|NCT01803074|20366408|P3|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259761|NCT01803074|20366409|P2|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259762|NCT01803074|20366410|P1|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259763|NCT01803074|20366397|P14|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259764|NCT01803074|20366398|P13|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259765|NCT01803074|20366399|P12|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259766|NCT01803074|20366400|P11|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259767|NCT01803074|20366401|P10|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259768|NCT01803074|20366402|P9|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259769|NCT01803074|20366403|P8|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259770|NCT01803074|20366404|P7|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259771|NCT01803074|20366405|P6|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259772|NCT01803074|20366406|P5|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259773|NCT01803074|20366407|P4|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259774|NCT01803074|20366408|P3|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259775|NCT01803074|20366409|P2|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259776|NCT01803074|20366410|P1|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259777|NCT01803074|20366397|P14|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259778|NCT01803074|20366398|P13|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259779|NCT01803074|20366399|P12|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259780|NCT01803074|20366400|P11|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8259781|NCT01803074|20366401|P10|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
8259782|NCT01803074|20366402|P9|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8259783|NCT01803074|20366403|P8|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8259784|NCT01803074|20366404|P7|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259785|NCT01803074|20366405|P6|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259786|NCT01803074|20366406|P5|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259787|NCT01803074|20366407|P4|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259788|NCT01803074|20366408|P3|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259789|NCT01803074|20366409|P2|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259790|NCT01803074|20366410|P1|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259791|NCT01803074|20366397|P14|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259792|NCT01803074|20366398|P13|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259793|NCT01803074|20366399|P12|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259794|NCT01803074|20366400|P11|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8259795|NCT01803074|20366401|P10|STARTED|Period 2: Part B (HIV-1 Clade B)||4
8259796|NCT01803074|20366402|P9|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8259797|NCT01803074|20366403|P8|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8259798|NCT01803074|20366404|P7|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259799|NCT01803074|20366405|P6|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259800|NCT01803074|20366406|P5|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259801|NCT01803074|20366407|P4|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259802|NCT01803074|20366408|P3|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259803|NCT01803074|20366409|P2|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259804|NCT01803074|20366410|P1|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259805|NCT01803074|20366397|P14|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259806|NCT01803074|20366398|P13|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259807|NCT01803074|20366399|P12|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259808|NCT01803074|20366400|P11|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259809|NCT01803074|20366401|P10|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259810|NCT01803074|20366402|P9|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259811|NCT01803074|20366403|P8|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259812|NCT01803074|20366404|P7|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259813|NCT01803074|20366405|P6|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259814|NCT01803074|20366406|P5|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259815|NCT01803074|20366407|P4|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259816|NCT01803074|20366408|P3|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259817|NCT01803074|20366409|P2|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259818|NCT01803074|20366410|P1|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259819|NCT01803074|20366397|P14|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259820|NCT01803074|20366398|P13|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259821|NCT01803074|20366399|P12|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259822|NCT01803074|20366400|P11|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259823|NCT01803074|20366401|P10|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259824|NCT01803074|20366402|P9|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259825|NCT01803074|20366403|P8|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259826|NCT01803074|20366404|P7|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
8259827|NCT01803074|20366405|P6|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259828|NCT01803074|20366406|P5|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259829|NCT01803074|20366407|P4|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259830|NCT01803074|20366408|P3|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259831|NCT01803074|20366409|P2|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259832|NCT01803074|20366410|P1|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259833|NCT01803074|20366397|P14|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259834|NCT01803074|20366398|P13|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259835|NCT01803074|20366399|P12|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259836|NCT01803074|20366400|P11|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259837|NCT01803074|20366401|P10|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259838|NCT01803074|20366402|P9|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259839|NCT01803074|20366403|P8|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259840|NCT01803074|20366404|P7|STARTED|Period 1: Part A (HIV-1 Clade B)||12
8259841|NCT01803074|20366405|P6|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259842|NCT01803074|20366406|P5|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259843|NCT01803074|20366407|P4|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259844|NCT01803074|20366408|P3|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259845|NCT01803074|20366409|P2|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259846|NCT01803074|20366410|P1|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259847|NCT01802879|20366664|P1|NOT COMPLETED|Overall Study||8
8259848|NCT01802879|20366664|P1|COMPLETED|Overall Study||0
8259849|NCT01802879|20366664|P1|STARTED|Overall Study||8
8259850|NCT01802775|20366671|P2|NOT COMPLETED|Overall Study||12
8259851|NCT01802775|20366672|P1|NOT COMPLETED|Overall Study||6
8259852|NCT01802775|20366671|P2|COMPLETED|Overall Study||89
8259853|NCT01802775|20366672|P1|COMPLETED|Overall Study||96
8259854|NCT01802775|20366671|P2|Received Drug (Safety Analysis Set)|Overall Study||100
8259855|NCT01802775|20366672|P1|Received Drug (Safety Analysis Set)|Overall Study||101
8259856|NCT01802775|20366671|P2|STARTED|Overall Study||101
8259857|NCT01802775|20366672|P1|STARTED|Overall Study||102
8259858|NCT01802710|20366690|P2|NOT COMPLETED|From T1 to T2||2
8259859|NCT01802710|20366691|P1|NOT COMPLETED|From T1 to T2||2
8259860|NCT01802710|20366690|P2|COMPLETED|From T1 to T2||70
8259861|NCT01802710|20366691|P1|COMPLETED|From T1 to T2||58
8259862|NCT01802710|20366690|P2|STARTED|From T1 to T2||72
8259863|NCT01802710|20366691|P1|STARTED|From T1 to T2||60
8259864|NCT01802710|20366690|P2|NOT COMPLETED|From T0 to T1||10
8259865|NCT01802710|20366691|P1|NOT COMPLETED|From T0 to T1||16
8259866|NCT01802710|20366690|P2|COMPLETED|From T0 to T1||72
8259867|NCT01802710|20366691|P1|COMPLETED|From T0 to T1||60
8259868|NCT01802710|20366690|P2|STARTED|From T0 to T1||82
8259869|NCT01802710|20366691|P1|STARTED|From T0 to T1||76
8259888|NCT01802580|20366728|P2|NOT COMPLETED|Overall Study||11
8259889|NCT01802580|20366729|P1|NOT COMPLETED|Overall Study||9
8259890|NCT01802580|20366728|P2|COMPLETED|Overall Study||9
8259891|NCT01802580|20366729|P1|COMPLETED|Overall Study||11
8259892|NCT01802580|20366728|P2|STARTED|Overall Study||20
8259893|NCT01802580|20366729|P1|STARTED|Overall Study||20
8259894|NCT01802554|20366742|P2|NOT COMPLETED|Overall Study||6
8259895|NCT01802554|20366743|P1|NOT COMPLETED|Overall Study||8
8259896|NCT01802554|20366742|P2|COMPLETED|Overall Study||43
8259897|NCT01802554|20366743|P1|COMPLETED|Overall Study||43
8259898|NCT01802554|20366742|P2|STARTED|Overall Study||49
8259899|NCT01802554|20366743|P1|STARTED|Overall Study||51
8259900|NCT01802515|20366760|P3|NOT COMPLETED|Overall Study||0
8259901|NCT01802515|20366761|P2|NOT COMPLETED|Overall Study||0
8259902|NCT01802515|20366762|P1|NOT COMPLETED|Overall Study||3
8259903|NCT01802515|20366760|P3|COMPLETED|Overall Study||4
8259904|NCT01802515|20366761|P2|COMPLETED|Overall Study||5
8259905|NCT01802515|20366762|P1|COMPLETED|Overall Study||2
8259906|NCT01802515|20366760|P3|STARTED|Overall Study||4
8259907|NCT01802515|20366761|P2|STARTED|Overall Study||5
8259908|NCT01802515|20366762|P1|STARTED|Overall Study||5
8259909|NCT01802437|20366775|P2|NOT COMPLETED|Overall Study||4
8259910|NCT01802437|20366776|P1|NOT COMPLETED|Overall Study||4
8259911|NCT01802437|20366775|P2|COMPLETED|Overall Study||16
8259912|NCT01802437|20366776|P1|COMPLETED|Overall Study||16
8259913|NCT01802437|20366775|P2|STARTED|Overall Study||20
8259914|NCT01802437|20366776|P1|STARTED|Overall Study||20
8259915|NCT01802411|20366788|P2|NOT COMPLETED|Overall Study||21
8259916|NCT01802411|20366789|P1|NOT COMPLETED|Overall Study||14
8259917|NCT01802411|20366788|P2|COMPLETED|Overall Study||74
8259918|NCT01802411|20366789|P1|COMPLETED|Overall Study||82
8259919|NCT01802411|20366788|P2|STARTED|Overall Study||95
8259920|NCT01802411|20366789|P1|STARTED|Overall Study||96
8259921|NCT01802385|20366801|P2|NOT COMPLETED|Overall Study||120
8259922|NCT01802385|20366802|P1|NOT COMPLETED|Overall Study||106
8259923|NCT01802385|20366801|P2|COMPLETED|Overall Study||109
8259924|NCT01802385|20366802|P1|COMPLETED|Overall Study||125
8259925|NCT01802385|20366801|P2|STARTED|Overall Study||229
8259926|NCT01802385|20366802|P1|STARTED|Overall Study||231
8259927|NCT01802333|20366825|P3|NOT COMPLETED|Overall Study||63
8259928|NCT01802333|20366826|P2|NOT COMPLETED|Overall Study||61
8259929|NCT01802333|20366827|P1|NOT COMPLETED|Overall Study||49
8259930|NCT01802333|20366825|P3|COMPLETED|Overall Study||161
8259931|NCT01802333|20366826|P2|COMPLETED|Overall Study||206
8259932|NCT01802333|20366827|P1|COMPLETED|Overall Study||214
8259933|NCT01802333|20366825|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
8259934|NCT01802333|20366826|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
8259935|NCT01802333|20366827|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
8259936|NCT01802333|20366825|P3|Known NPM1 Status at Baseline|Overall Study||142
8259937|NCT01802333|20366826|P2|Known NPM1 Status at Baseline|Overall Study||156
8259938|NCT01802333|20366827|P1|Known NPM1 Status at Baseline|Overall Study||169
8259939|NCT01802333|20366825|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
8259940|NCT01802333|20366826|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
8259941|NCT01802333|20366827|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
8259942|NCT01802333|20366825|P3|High Risk Patients|Overall Study||38
8259943|NCT01802333|20366826|P2|High Risk Patients|Overall Study||61
8259944|NCT01802333|20366827|P1|High Risk Patients|Overall Study||60
8259945|NCT01802333|20366825|P3|STARTED|Overall Study||224
8259946|NCT01802333|20366826|P2|STARTED|Overall Study||267
8259947|NCT01802333|20366827|P1|STARTED|Overall Study||263
8259948|NCT01802320|20366854|P1|NOT COMPLETED|Overall Study||2
8259949|NCT01802320|20366854|P1|COMPLETED|Overall Study||16
8259950|NCT01802320|20366854|P1|STARTED|Overall Study||18
8259951|NCT01802216|20366864|P2|NOT COMPLETED|12 Month Visit||4
8259952|NCT01802216|20366865|P1|NOT COMPLETED|12 Month Visit||3
8259953|NCT01802216|20366864|P2|COMPLETED|12 Month Visit||30
8259954|NCT01802216|20366865|P1|COMPLETED|12 Month Visit||14
8259955|NCT01802216|20366864|P2|STARTED|12 Month Visit||34
8259956|NCT01802216|20366865|P1|STARTED|12 Month Visit||17
8259957|NCT01802216|20366864|P2|NOT COMPLETED|8 Month Visit||5
8259958|NCT01802216|20366865|P1|NOT COMPLETED|8 Month Visit||3
8259959|NCT01802216|20366864|P2|COMPLETED|8 Month Visit||29
8259960|NCT01802216|20366865|P1|COMPLETED|8 Month Visit||14
8259961|NCT01802216|20366864|P2|STARTED|8 Month Visit||34
8259962|NCT01802216|20366865|P1|STARTED|8 Month Visit||17
8259963|NCT01802216|20366864|P2|NOT COMPLETED|4 Month Visit||4
8259964|NCT01802216|20366865|P1|NOT COMPLETED|4 Month Visit||3
8259965|NCT01802216|20366864|P2|COMPLETED|4 Month Visit||30
8259966|NCT01802216|20366865|P1|COMPLETED|4 Month Visit||14
8259967|NCT01802216|20366864|P2|STARTED|4 Month Visit||34
8259968|NCT01802216|20366865|P1|STARTED|4 Month Visit||17
8259969|NCT01802216|20366864|P2|NOT COMPLETED|Baseline||0
8259970|NCT01802216|20366865|P1|NOT COMPLETED|Baseline||0
8259971|NCT01802216|20366864|P2|COMPLETED|Baseline||34
8259972|NCT01802216|20366865|P1|COMPLETED|Baseline||17
8259973|NCT01802216|20366864|P2|STARTED|Baseline||34
8259974|NCT01802216|20366865|P1|STARTED|Baseline||17
8259975|NCT01802151|20366877|P4|NOT COMPLETED|Overall Study||0
8259976|NCT01802151|20366878|P3|NOT COMPLETED|Overall Study||2
8259977|NCT01802151|20366879|P2|NOT COMPLETED|Overall Study||0
8259978|NCT01802151|20366880|P1|NOT COMPLETED|Overall Study||0
8259979|NCT01802151|20366877|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8259980|NCT01802151|20366878|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8259981|NCT01802151|20366879|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
8259982|NCT01802151|20366880|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8259983|NCT01802151|20366877|P4|STARTED|Overall Study||20
8259984|NCT01802151|20366878|P3|STARTED|Overall Study||22
8259985|NCT01802151|20366879|P2|STARTED|Overall Study||21
8259986|NCT01802151|20366880|P1|STARTED|Overall Study||20
8259987|NCT01802073|20366944|P2|NOT COMPLETED|Overall Study||11
8259988|NCT01802073|20366945|P1|NOT COMPLETED|Overall Study||5
8259989|NCT01802073|20366944|P2|COMPLETED|Overall Study||9
8259990|NCT01802073|20366945|P1|COMPLETED|Overall Study||9
8259991|NCT01802073|20366944|P2|STARTED|Overall Study||20
8259992|NCT01802073|20366945|P1|STARTED|Overall Study||14
8259996|NCT01801917|20366975|P4|NOT COMPLETED|Extension - All Active||0
8259997|NCT01801917|20366976|P3|NOT COMPLETED|Extension - All Active||0
8259998|NCT01801917|20366977|P2|NOT COMPLETED|Extension - All Active||0
8259999|NCT01801917|20366978|P1|NOT COMPLETED|Extension - All Active||0
8260000|NCT01801917|20366975|P4|COMPLETED|Extension - All Active||0
8260001|NCT01801917|20366976|P3|COMPLETED|Extension - All Active||3
8260002|NCT01801917|20366977|P2|COMPLETED|Extension - All Active||0
8260003|NCT01801917|20366978|P1|COMPLETED|Extension - All Active||6
8260004|NCT01801917|20366975|P4|STARTED|Extension - All Active||0
8260005|NCT01801917|20366976|P3|STARTED|Extension - All Active||3
8260006|NCT01801917|20366977|P2|STARTED|Extension - All Active||0
8260007|NCT01801917|20366978|P1|STARTED|Extension - All Active||6
8260008|NCT01801917|20366975|P4|NOT COMPLETED|Period 1 - Randomized||0
8260009|NCT01801917|20366976|P3|NOT COMPLETED|Period 1 - Randomized||1
8260010|NCT01801917|20366977|P2|NOT COMPLETED|Period 1 - Randomized||0
8260011|NCT01801917|20366978|P1|NOT COMPLETED|Period 1 - Randomized||1
8260012|NCT01801917|20366975|P4|COMPLETED|Period 1 - Randomized||1
8260013|NCT01801917|20366976|P3|COMPLETED|Period 1 - Randomized||3
8260014|NCT01801917|20366977|P2|COMPLETED|Period 1 - Randomized||2
8260015|NCT01801917|20366978|P1|COMPLETED|Period 1 - Randomized||6
8260016|NCT01801917|20366975|P4|STARTED|Period 1 - Randomized||1
8260017|NCT01801917|20366976|P3|STARTED|Period 1 - Randomized||4
8260018|NCT01801917|20366977|P2|STARTED|Period 1 - Randomized||2
8260019|NCT01801917|20366978|P1|STARTED|Period 1 - Randomized||7
8260020|NCT01801865|20366998|P1|NOT COMPLETED|Overall Study||42
8260021|NCT01801865|20366998|P1|COMPLETED|Overall Study||615
8260022|NCT01801865|20366998|P1|STARTED|Overall Study||657
8260023|NCT01801735|20367003|P1|NOT COMPLETED|Overall Study||210
8260024|NCT01801735|20367003|P1|COMPLETED|Overall Study||390
8260025|NCT01801735|20367003|P1|STARTED|Overall Study||600
8260026|NCT01801475|20367010|P5|NOT COMPLETED|Overall Study||1
8260027|NCT01801475|20367011|P4|NOT COMPLETED|Overall Study||0
8260028|NCT01801475|20367012|P3|NOT COMPLETED|Overall Study||0
8260029|NCT01801475|20367013|P2|NOT COMPLETED|Overall Study||0
8260030|NCT01801475|20367014|P1|NOT COMPLETED|Overall Study||0
8260031|NCT01801475|20367010|P5|COMPLETED|Overall Study||39
8260032|NCT01801475|20367011|P4|COMPLETED|Overall Study||10
8260033|NCT01801475|20367012|P3|COMPLETED|Overall Study||10
8260034|NCT01801475|20367013|P2|COMPLETED|Overall Study||30
8260035|NCT01801475|20367014|P1|COMPLETED|Overall Study||10
8260036|NCT01801475|20367010|P5|STARTED|Overall Study||40
8260037|NCT01801475|20367011|P4|STARTED|Overall Study||10
8260038|NCT01801475|20367012|P3|STARTED|Overall Study||10
8260039|NCT01801475|20367013|P2|STARTED|Overall Study||30
8260040|NCT01801475|20367014|P1|STARTED|Overall Study||10
8260041|NCT01801449|20367025|P1|NOT COMPLETED|Overall Study||0
8260042|NCT01801449|20367025|P1|COMPLETED|Overall Study||6
8260043|NCT01801449|20367025|P1|STARTED|Overall Study||6
8260044|NCT01801436|20367039|P1|NOT COMPLETED|Overall Study||9
8260045|NCT01801436|20367039|P1|COMPLETED|Overall Study||5
8260046|NCT01801436|20367039|P1|STARTED|Overall Study||14
8260047|NCT01801358|20367077|P6|NOT COMPLETED|Overall Study||8
8260048|NCT01801358|20367078|P5|NOT COMPLETED|Overall Study||6
8260049|NCT01801358|20367079|P4|NOT COMPLETED|Overall Study||6
8260050|NCT01801358|20367080|P3|NOT COMPLETED|Overall Study||6
8260051|NCT01801358|20367081|P2|NOT COMPLETED|Overall Study||6
8260052|NCT01801358|20367082|P1|NOT COMPLETED|Overall Study||6
8260053|NCT01801358|20367077|P6|COMPLETED|Overall Study||0
8260054|NCT01801358|20367078|P5|COMPLETED|Overall Study||0
8260055|NCT01801358|20367079|P4|COMPLETED|Overall Study||0
8260056|NCT01801358|20367080|P3|COMPLETED|Overall Study||0
8260057|NCT01801358|20367081|P2|COMPLETED|Overall Study||0
8260058|NCT01801358|20367082|P1|COMPLETED|Overall Study||0
8260059|NCT01801358|20367077|P6|STARTED|Overall Study||8
8260060|NCT01801358|20367078|P5|STARTED|Overall Study||6
8260061|NCT01801358|20367079|P4|STARTED|Overall Study||6
8260062|NCT01801358|20367080|P3|STARTED|Overall Study||6
8260063|NCT01801358|20367081|P2|STARTED|Overall Study||6
8260064|NCT01801358|20367082|P1|STARTED|Overall Study||6
8260065|NCT01801280|20367204|P4|NOT COMPLETED|Period 4||0
8260066|NCT01801280|20367205|P3|NOT COMPLETED|Period 4||1
8260067|NCT01801280|20367206|P2|NOT COMPLETED|Period 4||0
8260068|NCT01801280|20367207|P1|NOT COMPLETED|Period 4||0
8260069|NCT01801280|20367204|P4|COMPLETED|Period 4||5
8260070|NCT01801280|20367205|P3|COMPLETED|Period 4||4
8260071|NCT01801280|20367206|P2|COMPLETED|Period 4||4
8260072|NCT01801280|20367207|P1|COMPLETED|Period 4||4
8260073|NCT01801280|20367204|P4|STARTED|Period 4||5
8260074|NCT01801280|20367205|P3|STARTED|Period 4||5
8260075|NCT01801280|20367206|P2|STARTED|Period 4||4
8260076|NCT01801280|20367207|P1|STARTED|Period 4||4
8260077|NCT01801280|20367204|P4|NOT COMPLETED|Period 3||0
8260078|NCT01801280|20367205|P3|NOT COMPLETED|Period 3||0
8260079|NCT01801280|20367206|P2|NOT COMPLETED|Period 3||0
8260080|NCT01801280|20367207|P1|NOT COMPLETED|Period 3||0
8260081|NCT01801280|20367204|P4|COMPLETED|Period 3||5
8260082|NCT01801280|20367205|P3|COMPLETED|Period 3||5
8260083|NCT01801280|20367206|P2|COMPLETED|Period 3||4
8260084|NCT01801280|20367207|P1|COMPLETED|Period 3||4
8260085|NCT01801280|20367204|P4|STARTED|Period 3||5
8260086|NCT01801280|20367205|P3|STARTED|Period 3||5
8260087|NCT01801280|20367206|P2|STARTED|Period 3||4
8260088|NCT01801280|20367207|P1|STARTED|Period 3||4
8260089|NCT01801280|20367204|P4|NOT COMPLETED|Period 2||0
8260090|NCT01801280|20367205|P3|NOT COMPLETED|Period 2||0
8260091|NCT01801280|20367206|P2|NOT COMPLETED|Period 2||0
8260092|NCT01801280|20367207|P1|NOT COMPLETED|Period 2||1
8260093|NCT01801280|20367204|P4|COMPLETED|Period 2||5
8260094|NCT01801280|20367205|P3|COMPLETED|Period 2||5
8260095|NCT01801280|20367206|P2|COMPLETED|Period 2||4
8260096|NCT01801280|20367207|P1|COMPLETED|Period 2||4
8260097|NCT01801280|20367204|P4|STARTED|Period 2||5
8260098|NCT01801280|20367205|P3|STARTED|Period 2||5
8260099|NCT01801280|20367206|P2|STARTED|Period 2||4
8260100|NCT01801280|20367207|P1|STARTED|Period 2||5
8260101|NCT01801280|20367204|P4|NOT COMPLETED|Period 1||0
8260102|NCT01801280|20367205|P3|NOT COMPLETED|Period 1||0
8260103|NCT01801280|20367206|P2|NOT COMPLETED|Period 1||1
8260104|NCT01801280|20367207|P1|NOT COMPLETED|Period 1||0
8260105|NCT01801280|20367204|P4|COMPLETED|Period 1||5
8260106|NCT01801280|20367205|P3|COMPLETED|Period 1||5
8260107|NCT01801280|20367206|P2|COMPLETED|Period 1||4
8260108|NCT01801280|20367207|P1|COMPLETED|Period 1||5
8260109|NCT01801280|20367204|P4|STARTED|Period 1||5
8260110|NCT01801280|20367205|P3|STARTED|Period 1||5
8260111|NCT01801280|20367206|P2|STARTED|Period 1||5
8260112|NCT01801280|20367207|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
8260113|NCT01801124|20367217|P1|NOT COMPLETED|Overall Study||0
8260114|NCT01801124|20367217|P1|COMPLETED|Overall Study||13
8260115|NCT01801124|20367217|P1|STARTED|Overall Study||13
8260116|NCT01801111|20367222|P1|NOT COMPLETED|Overall Study||138
8260117|NCT01801111|20367222|P1|COMPLETED|Overall Study||0
8260118|NCT01801111|20367222|P1|STARTED|Overall Study||138
8260119|NCT01801007|20367261|P1|NOT COMPLETED|Overall Study||11
8260120|NCT01801007|20367261|P1|COMPLETED|Overall Study||134
8260121|NCT01801007|20367261|P1|STARTED|Overall Study||145
8260122|NCT01800968|20367274|P2|NOT COMPLETED|Overall Study||32
8260123|NCT01800968|20367275|P1|NOT COMPLETED|Overall Study||36
8260124|NCT01800968|20367274|P2|COMPLETED|Overall Study||114
8260125|NCT01800968|20367275|P1|COMPLETED|Overall Study||118
8260126|NCT01800968|20367274|P2|STARTED|Overall Study||146
8260127|NCT01800968|20367275|P1|STARTED|Overall Study||154
8260128|NCT01800916|20367317|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
8260129|NCT01800916|20367318|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
8260130|NCT01800916|20367319|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
8260131|NCT01800916|20367320|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
8260132|NCT01800916|20367321|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
8260133|NCT01800916|20367322|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
8260134|NCT01800916|20367323|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
8260135|NCT01800916|20367324|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
8260136|NCT01800916|20367325|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
8260137|NCT01800916|20367317|P9|COMPLETED|Test Period 3 (1 Week)||7
8260138|NCT01800916|20367318|P8|COMPLETED|Test Period 3 (1 Week)||7
8260139|NCT01800916|20367319|P7|COMPLETED|Test Period 3 (1 Week)||7
8260140|NCT01800916|20367320|P6|COMPLETED|Test Period 3 (1 Week)||7
8260141|NCT01800916|20367321|P5|COMPLETED|Test Period 3 (1 Week)||7
8260142|NCT01800916|20367322|P4|COMPLETED|Test Period 3 (1 Week)||6
8260143|NCT01800916|20367323|P3|COMPLETED|Test Period 3 (1 Week)||7
8260144|NCT01800916|20367324|P2|COMPLETED|Test Period 3 (1 Week)||7
8260145|NCT01800916|20367325|P1|COMPLETED|Test Period 3 (1 Week)||7
8260146|NCT01800916|20367317|P9|STARTED|Test Period 3 (1 Week)||7
8260147|NCT01800916|20367318|P8|STARTED|Test Period 3 (1 Week)||7
8260148|NCT01800916|20367319|P7|STARTED|Test Period 3 (1 Week)||7
8260149|NCT01800916|20367320|P6|STARTED|Test Period 3 (1 Week)||7
8260150|NCT01800916|20367321|P5|STARTED|Test Period 3 (1 Week)||7
8260151|NCT01800916|20367322|P4|STARTED|Test Period 3 (1 Week)||6
8260152|NCT01800916|20367323|P3|STARTED|Test Period 3 (1 Week)||7
8260153|NCT01800916|20367324|P2|STARTED|Test Period 3 (1 Week)||7
8260154|NCT01800916|20367325|P1|STARTED|Test Period 3 (1 Week)||7
8260155|NCT01800916|20367317|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
8260156|NCT01800916|20367318|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
8260157|NCT01800916|20367319|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
8260158|NCT01800916|20367320|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
8260159|NCT01800916|20367321|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
8260160|NCT01800916|20367322|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
8260161|NCT01800916|20367323|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
8260162|NCT01800916|20367324|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
8260163|NCT01800916|20367325|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
8260164|NCT01800916|20367317|P9|COMPLETED|Test Period 2 (1 Week)||7
8260165|NCT01800916|20367318|P8|COMPLETED|Test Period 2 (1 Week)||7
8260166|NCT01800916|20367319|P7|COMPLETED|Test Period 2 (1 Week)||7
8260167|NCT01800916|20367320|P6|COMPLETED|Test Period 2 (1 Week)||7
8260168|NCT01800916|20367321|P5|COMPLETED|Test Period 2 (1 Week)||7
8260169|NCT01800916|20367322|P4|COMPLETED|Test Period 2 (1 Week)||6
8260170|NCT01800916|20367323|P3|COMPLETED|Test Period 2 (1 Week)||7
8260171|NCT01800916|20367324|P2|COMPLETED|Test Period 2 (1 Week)||7
8260172|NCT01800916|20367325|P1|COMPLETED|Test Period 2 (1 Week)||7
8260173|NCT01800916|20367317|P9|STARTED|Test Period 2 (1 Week)||7
8260174|NCT01800916|20367318|P8|STARTED|Test Period 2 (1 Week)||7
8260175|NCT01800916|20367319|P7|STARTED|Test Period 2 (1 Week)||7
8260176|NCT01800916|20367320|P6|STARTED|Test Period 2 (1 Week)||7
8260177|NCT01800916|20367321|P5|STARTED|Test Period 2 (1 Week)||7
8260178|NCT01800916|20367322|P4|STARTED|Test Period 2 (1 Week)||6
8260179|NCT01800916|20367323|P3|STARTED|Test Period 2 (1 Week)||7
8260180|NCT01800916|20367324|P2|STARTED|Test Period 2 (1 Week)||7
8260181|NCT01800916|20367325|P1|STARTED|Test Period 2 (1 Week)||7
8260182|NCT01800916|20367317|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
8260183|NCT01800916|20367318|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
8260184|NCT01800916|20367319|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
8260185|NCT01800916|20367320|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
8260186|NCT01800916|20367321|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
8260187|NCT01800916|20367322|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
8260188|NCT01800916|20367323|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
8260189|NCT01800916|20367324|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
8260190|NCT01800916|20367325|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
8260191|NCT01800916|20367317|P9|COMPLETED|Test Period 1 (1 Week)||7
8260192|NCT01800916|20367318|P8|COMPLETED|Test Period 1 (1 Week)||7
8260193|NCT01800916|20367319|P7|COMPLETED|Test Period 1 (1 Week)||7
8260194|NCT01800916|20367320|P6|COMPLETED|Test Period 1 (1 Week)||7
8260195|NCT01800916|20367321|P5|COMPLETED|Test Period 1 (1 Week)||7
8260196|NCT01800916|20367322|P4|COMPLETED|Test Period 1 (1 Week)||6
8260197|NCT01800916|20367323|P3|COMPLETED|Test Period 1 (1 Week)||7
8260198|NCT01800916|20367324|P2|COMPLETED|Test Period 1 (1 Week)||7
8260199|NCT01800916|20367325|P1|COMPLETED|Test Period 1 (1 Week)||7
8260200|NCT01800916|20367317|P9|STARTED|Test Period 1 (1 Week)||7
8260201|NCT01800916|20367318|P8|STARTED|Test Period 1 (1 Week)||7
8260202|NCT01800916|20367319|P7|STARTED|Test Period 1 (1 Week)||7
8260203|NCT01800916|20367320|P6|STARTED|Test Period 1 (1 Week)||7
8260204|NCT01800916|20367321|P5|STARTED|Test Period 1 (1 Week)||8
8260205|NCT01800916|20367322|P4|STARTED|Test Period 1 (1 Week)||7
8260206|NCT01800916|20367323|P3|STARTED|Test Period 1 (1 Week)||7
8260207|NCT01800916|20367324|P2|STARTED|Test Period 1 (1 Week)||7
8260208|NCT01800916|20367325|P1|STARTED|Test Period 1 (1 Week)||7
8260209|NCT01800903|20367335|P6|NOT COMPLETED|Third Test Period||0
8260210|NCT01800903|20367336|P5|NOT COMPLETED|Third Test Period||0
8260211|NCT01800903|20367337|P4|NOT COMPLETED|Third Test Period||0
8260212|NCT01800903|20367338|P3|NOT COMPLETED|Third Test Period||0
8260213|NCT01800903|20367339|P2|NOT COMPLETED|Third Test Period||0
8260214|NCT01800903|20367340|P1|NOT COMPLETED|Third Test Period||0
8260215|NCT01800903|20367335|P6|COMPLETED|Third Test Period||6
8260216|NCT01800903|20367336|P5|COMPLETED|Third Test Period||6
8260217|NCT01800903|20367337|P4|COMPLETED|Third Test Period||7
8260218|NCT01800903|20367338|P3|COMPLETED|Third Test Period||4
8260219|NCT01800903|20367339|P2|COMPLETED|Third Test Period||6
8260220|NCT01800903|20367340|P1|COMPLETED|Third Test Period||6
8260221|NCT01800903|20367335|P6|STARTED|Third Test Period||6
8260222|NCT01800903|20367336|P5|STARTED|Third Test Period||6
8260223|NCT01800903|20367337|P4|STARTED|Third Test Period||7
8260224|NCT01800903|20367338|P3|STARTED|Third Test Period||4
8260225|NCT01800903|20367339|P2|STARTED|Third Test Period||6
8260226|NCT01800903|20367340|P1|STARTED|Third Test Period||6
8260227|NCT01800903|20367335|P6|NOT COMPLETED|Second Test Period||0
8260228|NCT01800903|20367336|P5|NOT COMPLETED|Second Test Period||0
8260229|NCT01800903|20367337|P4|NOT COMPLETED|Second Test Period||0
8260230|NCT01800903|20367338|P3|NOT COMPLETED|Second Test Period||0
8260231|NCT01800903|20367339|P2|NOT COMPLETED|Second Test Period||0
8260232|NCT01800903|20367340|P1|NOT COMPLETED|Second Test Period||1
8260233|NCT01800903|20367335|P6|COMPLETED|Second Test Period||6
8260234|NCT01800903|20367336|P5|COMPLETED|Second Test Period||6
8260235|NCT01800903|20367337|P4|COMPLETED|Second Test Period||7
8260236|NCT01800903|20367338|P3|COMPLETED|Second Test Period||4
8260237|NCT01800903|20367339|P2|COMPLETED|Second Test Period||6
8260238|NCT01800903|20367340|P1|COMPLETED|Second Test Period||6
8260239|NCT01800903|20367335|P6|STARTED|Second Test Period||6
8260240|NCT01800903|20367336|P5|STARTED|Second Test Period||6
8260241|NCT01800903|20367337|P4|STARTED|Second Test Period||7
8260242|NCT01800903|20367338|P3|STARTED|Second Test Period||4
8260243|NCT01800903|20367339|P2|STARTED|Second Test Period||6
8260244|NCT01800903|20367340|P1|STARTED|Second Test Period||7
8260245|NCT01800903|20367335|P6|NOT COMPLETED|First Test Period||0
8260246|NCT01800903|20367336|P5|NOT COMPLETED|First Test Period||0
8260247|NCT01800903|20367337|P4|NOT COMPLETED|First Test Period||0
8260248|NCT01800903|20367338|P3|NOT COMPLETED|First Test Period||0
8260249|NCT01800903|20367339|P2|NOT COMPLETED|First Test Period||0
8260250|NCT01800903|20367340|P1|NOT COMPLETED|First Test Period||0
8260251|NCT01800903|20367335|P6|COMPLETED|First Test Period||6
8260252|NCT01800903|20367336|P5|COMPLETED|First Test Period||6
8260253|NCT01800903|20367337|P4|COMPLETED|First Test Period||7
8260254|NCT01800903|20367338|P3|COMPLETED|First Test Period||4
8260255|NCT01800903|20367339|P2|COMPLETED|First Test Period||6
8260256|NCT01800903|20367340|P1|COMPLETED|First Test Period||7
8260257|NCT01800903|20367335|P6|STARTED|First Test Period||6
8260258|NCT01800903|20367336|P5|STARTED|First Test Period||6
8260259|NCT01800903|20367337|P4|STARTED|First Test Period||7
8260260|NCT01800903|20367338|P3|STARTED|First Test Period||4
8260261|NCT01800903|20367339|P2|STARTED|First Test Period||6
8260262|NCT01800903|20367340|P1|STARTED|First Test Period||7
8260263|NCT01800890|20367346|P9|NOT COMPLETED|Test Period 3||0
8260264|NCT01800890|20367347|P8|NOT COMPLETED|Test Period 3||0
8260265|NCT01800890|20367348|P7|NOT COMPLETED|Test Period 3||0
8260266|NCT01800890|20367349|P6|NOT COMPLETED|Test Period 3||0
8260267|NCT01800890|20367350|P5|NOT COMPLETED|Test Period 3||0
8260268|NCT01800890|20367351|P4|NOT COMPLETED|Test Period 3||0
8260269|NCT01800890|20367352|P3|NOT COMPLETED|Test Period 3||0
8260270|NCT01800890|20367353|P2|NOT COMPLETED|Test Period 3||0
8260271|NCT01800890|20367354|P1|NOT COMPLETED|Test Period 3||0
8260272|NCT01800890|20367346|P9|COMPLETED|Test Period 3||3
8260273|NCT01800890|20367347|P8|COMPLETED|Test Period 3||3
8260274|NCT01800890|20367348|P7|COMPLETED|Test Period 3||3
8260275|NCT01800890|20367349|P6|COMPLETED|Test Period 3||4
8260276|NCT01800890|20367350|P5|COMPLETED|Test Period 3||4
8260277|NCT01800890|20367351|P4|COMPLETED|Test Period 3||2
8260278|NCT01800890|20367352|P3|COMPLETED|Test Period 3||3
8260279|NCT01800890|20367353|P2|COMPLETED|Test Period 3||3
8260280|NCT01800890|20367354|P1|COMPLETED|Test Period 3||3
8260281|NCT01800890|20367346|P9|STARTED|Test Period 3||3
8260282|NCT01800890|20367347|P8|STARTED|Test Period 3||3
8260283|NCT01800890|20367348|P7|STARTED|Test Period 3||3
8260284|NCT01800890|20367349|P6|STARTED|Test Period 3||4
8260285|NCT01800890|20367350|P5|STARTED|Test Period 3||4
8260286|NCT01800890|20367351|P4|STARTED|Test Period 3||2
8260287|NCT01800890|20367352|P3|STARTED|Test Period 3||3
8260288|NCT01800890|20367353|P2|STARTED|Test Period 3||3
8260289|NCT01800890|20367354|P1|STARTED|Test Period 3||3
8260290|NCT01800890|20367346|P9|NOT COMPLETED|Test Period 2||0
8260291|NCT01800890|20367347|P8|NOT COMPLETED|Test Period 2||0
8260292|NCT01800890|20367348|P7|NOT COMPLETED|Test Period 2||0
8260293|NCT01800890|20367349|P6|NOT COMPLETED|Test Period 2||0
8260294|NCT01800890|20367350|P5|NOT COMPLETED|Test Period 2||0
8260295|NCT01800890|20367351|P4|NOT COMPLETED|Test Period 2||0
8260296|NCT01800890|20367352|P3|NOT COMPLETED|Test Period 2||0
8260297|NCT01800890|20367353|P2|NOT COMPLETED|Test Period 2||0
8260298|NCT01800890|20367354|P1|NOT COMPLETED|Test Period 2||0
8260299|NCT01800890|20367346|P9|COMPLETED|Test Period 2||3
8260300|NCT01800890|20367347|P8|COMPLETED|Test Period 2||3
8260301|NCT01800890|20367348|P7|COMPLETED|Test Period 2||3
8260302|NCT01800890|20367349|P6|COMPLETED|Test Period 2||4
8260303|NCT01800890|20367350|P5|COMPLETED|Test Period 2||4
8260304|NCT01800890|20367351|P4|COMPLETED|Test Period 2||2
8260305|NCT01800890|20367352|P3|COMPLETED|Test Period 2||3
8260306|NCT01800890|20367353|P2|COMPLETED|Test Period 2||3
8260307|NCT01800890|20367354|P1|COMPLETED|Test Period 2||3
8260308|NCT01800890|20367346|P9|STARTED|Test Period 2||3
8260309|NCT01800890|20367347|P8|STARTED|Test Period 2||3
8260310|NCT01800890|20367348|P7|STARTED|Test Period 2||3
8260311|NCT01800890|20367349|P6|STARTED|Test Period 2||4
8260312|NCT01800890|20367350|P5|STARTED|Test Period 2||4
8260313|NCT01800890|20367351|P4|STARTED|Test Period 2||2
8260314|NCT01800890|20367352|P3|STARTED|Test Period 2||3
8260315|NCT01800890|20367353|P2|STARTED|Test Period 2||3
8260316|NCT01800890|20367354|P1|STARTED|Test Period 2||3
8260317|NCT01800890|20367346|P9|NOT COMPLETED|Test Period 1||0
8260318|NCT01800890|20367347|P8|NOT COMPLETED|Test Period 1||0
8260319|NCT01800890|20367348|P7|NOT COMPLETED|Test Period 1||0
8260320|NCT01800890|20367349|P6|NOT COMPLETED|Test Period 1||0
8260321|NCT01800890|20367350|P5|NOT COMPLETED|Test Period 1||0
8260322|NCT01800890|20367351|P4|NOT COMPLETED|Test Period 1||1
8260323|NCT01800890|20367352|P3|NOT COMPLETED|Test Period 1||0
8260324|NCT01800890|20367353|P2|NOT COMPLETED|Test Period 1||0
8260325|NCT01800890|20367354|P1|NOT COMPLETED|Test Period 1||0
8260326|NCT01800890|20367346|P9|COMPLETED|Test Period 1||3
8260327|NCT01800890|20367347|P8|COMPLETED|Test Period 1||3
8260328|NCT01800890|20367348|P7|COMPLETED|Test Period 1||3
8260329|NCT01800890|20367349|P6|COMPLETED|Test Period 1||4
8260330|NCT01800890|20367350|P5|COMPLETED|Test Period 1||4
8260331|NCT01800890|20367351|P4|COMPLETED|Test Period 1||2
8260332|NCT01800890|20367352|P3|COMPLETED|Test Period 1||3
8260333|NCT01800890|20367353|P2|COMPLETED|Test Period 1||3
8260334|NCT01800890|20367354|P1|COMPLETED|Test Period 1||3
8260335|NCT01800890|20367346|P9|STARTED|Test Period 1||3
8260336|NCT01800890|20367347|P8|STARTED|Test Period 1||3
8260337|NCT01800890|20367348|P7|STARTED|Test Period 1||3
8260338|NCT01800890|20367349|P6|STARTED|Test Period 1||4
8260339|NCT01800890|20367350|P5|STARTED|Test Period 1||4
8260340|NCT01800890|20367351|P4|STARTED|Test Period 1||3
8260341|NCT01800890|20367352|P3|STARTED|Test Period 1||3
8260342|NCT01800890|20367353|P2|STARTED|Test Period 1||3
8260343|NCT01800890|20367354|P1|STARTED|Test Period 1||3
8260344|NCT01800877|20367366|P2|NOT COMPLETED|Overall Study||0
8260345|NCT01800877|20367367|P1|NOT COMPLETED|Overall Study||2
8260346|NCT01800877|20367366|P2|COMPLETED|Overall Study||60
8260347|NCT01800877|20367367|P1|COMPLETED|Overall Study||58
8260348|NCT01800877|20367366|P2|STARTED|Overall Study||60
8260349|NCT01800877|20367367|P1|STARTED|Overall Study||60
8260350|NCT01800838|20367377|P4|NOT COMPLETED|Overall Study||0
8260351|NCT01800838|20367378|P3|NOT COMPLETED|Overall Study||0
8260352|NCT01800838|20367379|P2|NOT COMPLETED|Overall Study||0
8260353|NCT01800838|20367380|P1|NOT COMPLETED|Overall Study||0
8260354|NCT01800838|20367377|P4|COMPLETED|Overall Study||2
8260355|NCT01800838|20367378|P3|COMPLETED|Overall Study||7
8260356|NCT01800838|20367379|P2|COMPLETED|Overall Study||1
8260357|NCT01800838|20367380|P1|COMPLETED|Overall Study||1
8260358|NCT01800838|20367377|P4|STARTED|Overall Study||2
8260359|NCT01800838|20367378|P3|STARTED|Overall Study||7
8260360|NCT01800838|20367379|P2|STARTED|Overall Study||1
8260361|NCT01800838|20367380|P1|STARTED|Overall Study||1
8260362|NCT01800786|20367387|P2|NOT COMPLETED|Overall Study||1
8260363|NCT01800786|20367388|P1|NOT COMPLETED|Overall Study||2
8260364|NCT01800786|20367387|P2|COMPLETED|Overall Study||15
8260365|NCT01800786|20367388|P1|COMPLETED|Overall Study||15
8260366|NCT01800786|20367387|P2|STARTED|Overall Study||16
8260367|NCT01800786|20367388|P1|STARTED|Overall Study||17
8260368|NCT01800318|20367398|P4|NOT COMPLETED|Overall Study||1
8260369|NCT01800318|20367399|P3|NOT COMPLETED|Overall Study||1
8260370|NCT01800318|20367400|P2|NOT COMPLETED|Overall Study||5
8260371|NCT01800318|20367401|P1|NOT COMPLETED|Overall Study||2
8260372|NCT01800318|20367398|P4|COMPLETED|Overall Study||39
8260373|NCT01800318|20367399|P3|COMPLETED|Overall Study||40
8260374|NCT01800318|20367400|P2|COMPLETED|Overall Study||37
8260375|NCT01800318|20367401|P1|COMPLETED|Overall Study||37
8260376|NCT01800318|20367398|P4|STARTED|Overall Study||40
8260377|NCT01800318|20367399|P3|STARTED|Overall Study||41
8260378|NCT01800318|20367400|P2|STARTED|Overall Study||42
8260379|NCT01800318|20367401|P1|STARTED|Overall Study||39
8260380|NCT01800201|20367429|P2|NOT COMPLETED|Overall Study||3
8260381|NCT01800201|20367430|P1|NOT COMPLETED|Overall Study||3
8260382|NCT01800201|20367429|P2|COMPLETED|Overall Study||1000
8260383|NCT01800201|20367430|P1|COMPLETED|Overall Study||503
8260384|NCT01800201|20367429|P2|STARTED|Overall Study||1003
8260385|NCT01800201|20367430|P1|STARTED|Overall Study||506
8260386|NCT01800162|20367445|P3|NOT COMPLETED|Overall Study||0
8260387|NCT01800162|20367446|P2|NOT COMPLETED|Overall Study||0
8260388|NCT01800162|20367447|P1|NOT COMPLETED|Overall Study||0
8260389|NCT01800162|20367445|P3|COMPLETED|Overall Study||1
8260390|NCT01800162|20367446|P2|COMPLETED|Overall Study||0
8260391|NCT01800162|20367447|P1|COMPLETED|Overall Study||1
8260392|NCT01800162|20367445|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
8260393|NCT01800162|20367446|P2|STARTED|Overall Study||0
8260394|NCT01800162|20367447|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
8260395|NCT01800058|20367471|P1|NOT COMPLETED|Overall Study||1
8260396|NCT01800058|20367471|P1|COMPLETED|Overall Study||65
8260397|NCT01800058|20367471|P1|STARTED|Overall Study||66
8260398|NCT01799993|20367484|P2|NOT COMPLETED|Overall Study||128
8260399|NCT01799993|20367485|P1|NOT COMPLETED|Overall Study||133
8260400|NCT01799993|20367484|P2|COMPLETED|Overall Study||235
8260401|NCT01799993|20367485|P1|COMPLETED|Overall Study||229
8260402|NCT01799993|20367484|P2|mITT Population|Overall Study||253
8260403|NCT01799993|20367485|P1|mITT Population|Overall Study||255
8260404|NCT01799993|20367484|P2|ITT Population|Overall Study||358
8260405|NCT01799993|20367485|P1|ITT Population|Overall Study||354
8260406|NCT01799993|20367484|P2|STARTED|Overall Study||363
8260407|NCT01799993|20367485|P1|STARTED|Overall Study||362
8260408|NCT01799941|20367517|P1|NOT COMPLETED|Overall Study||96
8260409|NCT01799941|20367517|P1|COMPLETED|Overall Study||271
8260410|NCT01799941|20367517|P1|STARTED|Overall Study||367
8260411|NCT01799889|20367583|P12|NOT COMPLETED|Overall Study||3
8260412|NCT01799889|20367584|P11|NOT COMPLETED|Overall Study||7
8260413|NCT01799889|20367585|P10|NOT COMPLETED|Overall Study||8
8260414|NCT01799889|20367586|P9|NOT COMPLETED|Overall Study||33
8260415|NCT01799889|20367587|P8|NOT COMPLETED|Overall Study||20
8260416|NCT01799889|20367588|P7|NOT COMPLETED|Overall Study||21
8260417|NCT01799889|20367589|P6|NOT COMPLETED|Overall Study||20
8260418|NCT01799889|20367590|P5|NOT COMPLETED|Overall Study||49
8260419|NCT01799889|20367591|P4|NOT COMPLETED|Overall Study||39
8260420|NCT01799889|20367592|P3|NOT COMPLETED|Overall Study||44
8260421|NCT01799889|20367593|P2|NOT COMPLETED|Overall Study||41
8260422|NCT01799889|20367594|P1|NOT COMPLETED|Overall Study||41
8260423|NCT01799889|20367583|P12|COMPLETED|Overall Study||0
8260424|NCT01799889|20367584|P11|COMPLETED|Overall Study||0
8260425|NCT01799889|20367585|P10|COMPLETED|Overall Study||0
8260426|NCT01799889|20367586|P9|COMPLETED|Overall Study||0
8260427|NCT01799889|20367587|P8|COMPLETED|Overall Study||0
8260428|NCT01799889|20367588|P7|COMPLETED|Overall Study||0
8260429|NCT01799889|20367589|P6|COMPLETED|Overall Study||0
8260430|NCT01799889|20367590|P5|COMPLETED|Overall Study||0
8260431|NCT01799889|20367591|P4|COMPLETED|Overall Study||0
8260432|NCT01799889|20367592|P3|COMPLETED|Overall Study||0
8260433|NCT01799889|20367593|P2|COMPLETED|Overall Study||0
8260434|NCT01799889|20367594|P1|COMPLETED|Overall Study||0
8260435|NCT01799889|20367583|P12|STARTED|Overall Study||3
8260436|NCT01799889|20367584|P11|STARTED|Overall Study||7
8260437|NCT01799889|20367585|P10|STARTED|Overall Study||8
8260438|NCT01799889|20367586|P9|STARTED|Overall Study||33
8260439|NCT01799889|20367587|P8|STARTED|Overall Study||20
8260440|NCT01799889|20367588|P7|STARTED|Overall Study||21
8260441|NCT01799889|20367589|P6|STARTED|Overall Study||20
8260442|NCT01799889|20367590|P5|STARTED|Overall Study||49
8260443|NCT01799889|20367591|P4|STARTED|Overall Study||39
8260444|NCT01799889|20367592|P3|STARTED|Overall Study||44
8260445|NCT01799889|20367593|P2|STARTED|Overall Study||41
8260446|NCT01799889|20367594|P1|STARTED|Overall Study||41
8260447|NCT01799720|20367695|P3|NOT COMPLETED|Overall Study||1
8260448|NCT01799720|20367696|P2|NOT COMPLETED|Overall Study||1
8260449|NCT01799720|20367697|P1|NOT COMPLETED|Overall Study||3
8260450|NCT01799720|20367695|P3|COMPLETED|Overall Study||18
8260451|NCT01799720|20367696|P2|COMPLETED|Overall Study||17
8260452|NCT01799720|20367697|P1|COMPLETED|Overall Study||17
8260453|NCT01799720|20367695|P3|Began the Treatment and Finished it|Overall Study||18
8260454|NCT01799720|20367696|P2|Began the Treatment and Finished it|Overall Study||17
8260455|NCT01799720|20367697|P1|Began the Treatment and Finished it|Overall Study||17
8260456|NCT01799720|20367695|P3|Began the Treatment|Overall Study||19
8260457|NCT01799720|20367696|P2|Began the Treatment|Overall Study||18
8260458|NCT01799720|20367697|P1|Began the Treatment|Overall Study||20
8260459|NCT01799720|20367695|P3|STARTED|Overall Study||19
8260460|NCT01799720|20367696|P2|STARTED|Overall Study||18
8260461|NCT01799720|20367697|P1|STARTED|Overall Study||20
8260462|NCT01799590|20367735|P3|NOT COMPLETED|Overall Study||14
8260463|NCT01799590|20367736|P2|NOT COMPLETED|Overall Study||16
8260464|NCT01799590|20367737|P1|NOT COMPLETED|Overall Study||26
8260465|NCT01799590|20367735|P3|COMPLETED|Overall Study||77
8260466|NCT01799590|20367736|P2|COMPLETED|Overall Study||78
8260467|NCT01799590|20367737|P1|COMPLETED|Overall Study||85
8260468|NCT01799590|20367735|P3|STARTED|Overall Study||91
8260469|NCT01799590|20367736|P2|STARTED|Overall Study||94
8260470|NCT01799590|20367737|P1|STARTED|Overall Study||111
8260471|NCT01799278|20367772|P1|NOT COMPLETED|Overall Study||0
8260472|NCT01799278|20367772|P1|COMPLETED|Overall Study||60
8260473|NCT01799278|20367772|P1|STARTED|Overall Study||60
8260474|NCT01799239|20367780|P2|NOT COMPLETED|Period 2 (7 Days)||1
8260475|NCT01799239|20367781|P1|NOT COMPLETED|Period 2 (7 Days)||2
8260476|NCT01799239|20367780|P2|COMPLETED|Period 2 (7 Days)||14
8260477|NCT01799239|20367781|P1|COMPLETED|Period 2 (7 Days)||11
8260478|NCT01799239|20367780|P2|STARTED|Period 2 (7 Days)||15
8260479|NCT01799239|20367781|P1|STARTED|Period 2 (7 Days)||13
8260480|NCT01799239|20367780|P2|NOT COMPLETED|Period 1 (7 Days)||1
8260481|NCT01799239|20367781|P1|NOT COMPLETED|Period 1 (7 Days)||3
8260482|NCT01799239|20367780|P2|COMPLETED|Period 1 (7 Days)||15
8260483|NCT01799239|20367781|P1|COMPLETED|Period 1 (7 Days)||12
8260484|NCT01799239|20367780|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
8260485|NCT01799239|20367781|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
8260486|NCT01799226|20367789|P2|NOT COMPLETED|Overall Study||0
8260487|NCT01799226|20367790|P1|NOT COMPLETED|Overall Study||2
8260488|NCT01799226|20367789|P2|COMPLETED|Overall Study||16
8260489|NCT01799226|20367790|P1|COMPLETED|Overall Study||14
8260490|NCT01799226|20367789|P2|Left Stent Side|Overall Study||8
8260491|NCT01799226|20367790|P1|Left Stent Side|Overall Study||8
8260492|NCT01799226|20367789|P2|Right Stent Side|Overall Study||8
8260493|NCT01799226|20367790|P1|Right Stent Side|Overall Study||8
8260494|NCT01799226|20367789|P2|STARTED|Overall Study||16
8260495|NCT01799226|20367790|P1|STARTED|Overall Study||16
8260496|NCT01799213|20367800|P2|NOT COMPLETED|Overall Study||6
8260497|NCT01799213|20367801|P1|NOT COMPLETED|Overall Study||7
8260498|NCT01799213|20367800|P2|COMPLETED|Overall Study||178
8260499|NCT01799213|20367801|P1|COMPLETED|Overall Study||173
8260500|NCT01799213|20367800|P2|STARTED|Overall Study||184
8260501|NCT01799213|20367801|P1|STARTED|Overall Study||180
8260502|NCT01798992|20367821|P4|NOT COMPLETED|Overall Study||1
8260503|NCT01798992|20367822|P3|NOT COMPLETED|Overall Study||2
8260504|NCT01798992|20367823|P2|NOT COMPLETED|Overall Study||2
8260505|NCT01798992|20367824|P1|NOT COMPLETED|Overall Study||0
8260506|NCT01798992|20367821|P4|COMPLETED|Overall Study||16
8260507|NCT01798992|20367822|P3|COMPLETED|Overall Study||14
8260508|NCT01798992|20367823|P2|COMPLETED|Overall Study||17
8260509|NCT01798992|20367824|P1|COMPLETED|Overall Study||4
8260510|NCT01798992|20367821|P4|STARTED|Overall Study||17
8260511|NCT01798992|20367822|P3|STARTED|Overall Study||16
8260512|NCT01798992|20367823|P2|STARTED|Overall Study||19
8260513|NCT01798992|20367824|P1|STARTED|Overall Study||4
8260514|NCT01798966|20367838|P1|NOT COMPLETED|Overall Study||0
8260515|NCT01798966|20367838|P1|COMPLETED|Overall Study||10
8260516|NCT01798966|20367838|P1|STARTED|Overall Study||10
8260517|NCT01798927|20367844|P1|NOT COMPLETED|Overall Study||1
8260518|NCT01798927|20367844|P1|COMPLETED|Overall Study||3
8260519|NCT01798927|20367844|P1|STARTED|Overall Study||4
8260520|NCT01798849|20367853|P3|NOT COMPLETED|Overall Study||1
8260521|NCT01798849|20367854|P2|NOT COMPLETED|Overall Study||0
8260522|NCT01798849|20367855|P1|NOT COMPLETED|Overall Study||0
8260523|NCT01798849|20367853|P3|COMPLETED|Overall Study||8
8260524|NCT01798849|20367854|P2|COMPLETED|Overall Study||8
8260525|NCT01798849|20367855|P1|COMPLETED|Overall Study||8
8260526|NCT01798849|20367853|P3|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
8260527|NCT01798849|20367854|P2|STARTED|Overall Study||8
8260528|NCT01798849|20367855|P1|STARTED|Overall Study||8
8260529|NCT01798706|20368045|P2|NOT COMPLETED|Overall Study||21
8260530|NCT01798706|20368046|P1|NOT COMPLETED|Overall Study||21
8260531|NCT01798706|20368045|P2|COMPLETED|Overall Study||153
8260532|NCT01798706|20368046|P1|COMPLETED|Overall Study||155
8260533|NCT01798706|20368045|P2|STARTED|Overall Study||174
8260534|NCT01798706|20368046|P1|STARTED|Overall Study||176
8260535|NCT01798641|20368074|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8260536|NCT01798641|20368075|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8260537|NCT01798641|20368074|P2|COMPLETED|Second Intervention (6 Weeks)||19
8260538|NCT01798641|20368075|P1|COMPLETED|Second Intervention (6 Weeks)||19
8260539|NCT01798641|20368074|P2|STARTED|Second Intervention (6 Weeks)||19
8260540|NCT01798641|20368075|P1|STARTED|Second Intervention (6 Weeks)||19
8260541|NCT01798641|20368074|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8260542|NCT01798641|20368075|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8260543|NCT01798641|20368074|P2|COMPLETED|First Intervention (6 Weeks)||19
8260544|NCT01798641|20368075|P1|COMPLETED|First Intervention (6 Weeks)||19
8260545|NCT01798641|20368074|P2|STARTED|First Intervention (6 Weeks)||19
8260546|NCT01798641|20368075|P1|STARTED|First Intervention (6 Weeks)||19
8260547|NCT01798589|20368089|P1|NOT COMPLETED|Overall Study||0
8260548|NCT01798589|20368089|P1|COMPLETED|Overall Study||16
8260549|NCT01798589|20368089|P1|STARTED|Overall Study||16
8260550|NCT01798550|20368100|P2|NOT COMPLETED|Overall Study||6
8260551|NCT01798550|20368101|P1|NOT COMPLETED|Overall Study||2
8260552|NCT01798550|20368100|P2|COMPLETED|Overall Study||26
8260553|NCT01798550|20368101|P1|COMPLETED|Overall Study||28
8260554|NCT01798550|20368100|P2|STARTED|Overall Study||32
8260555|NCT01798550|20368101|P1|STARTED|Overall Study||30
8260556|NCT01798485|20368117|P2|NOT COMPLETED|Overall Study||290
8260557|NCT01798485|20368118|P1|NOT COMPLETED|Overall Study||346
8260558|NCT01798485|20368117|P2|COMPLETED|Overall Study||59
8260559|NCT01798485|20368118|P1|COMPLETED|Overall Study||1
8260560|NCT01798485|20368117|P2|Randomized as of 19 October 2015|Overall Study||337
8260561|NCT01798485|20368118|P1|Randomized as of 19 October 2015|Overall Study||335
8260562|NCT01798485|20368117|P2|Safety Population as of 23 Dec 2015|Overall Study||342
8260563|NCT01798485|20368118|P1|Safety Population as of 23 Dec 2015|Overall Study||338
8260564|NCT01798485|20368117|P2|STARTED|Overall Study||349
8260565|NCT01798485|20368118|P1|STARTED|Overall Study||347
8260566|NCT01798394|20368154|P2|NOT COMPLETED|Overall Study||3
8260567|NCT01798394|20368155|P1|NOT COMPLETED|Overall Study||3
8260568|NCT01798394|20368154|P2|COMPLETED|Overall Study||19
8260569|NCT01798394|20368155|P1|COMPLETED|Overall Study||21
8260570|NCT01798394|20368154|P2|STARTED|Overall Study||22
8260571|NCT01798394|20368155|P1|STARTED|Overall Study||24
8260572|NCT01798316|20368175|P2|NOT COMPLETED|Overall Study||0
8260573|NCT01798316|20368176|P1|NOT COMPLETED|Overall Study||0
8260574|NCT01798316|20368175|P2|COMPLETED|Overall Study||53
8260575|NCT01798316|20368176|P1|COMPLETED|Overall Study||52
8260576|NCT01798316|20368175|P2|STARTED|Overall Study||53
8260577|NCT01798316|20368176|P1|STARTED|Overall Study||52
8260578|NCT01798264|20368198|P4|NOT COMPLETED|Overall Study||4
8260579|NCT01798264|20368199|P3|NOT COMPLETED|Overall Study||0
8260580|NCT01798264|20368200|P2|NOT COMPLETED|Overall Study||0
8260581|NCT01798264|20368201|P1|NOT COMPLETED|Overall Study||1
8260582|NCT01798264|20368198|P4|COMPLETED|Overall Study||7
8260583|NCT01798264|20368199|P3|COMPLETED|Overall Study||10
8260584|NCT01798264|20368200|P2|COMPLETED|Overall Study||11
8260585|NCT01798264|20368201|P1|COMPLETED|Overall Study||11
8260586|NCT01798264|20368198|P4|STARTED|Overall Study||11
8260587|NCT01798264|20368199|P3|STARTED|Overall Study||10
8260588|NCT01798264|20368200|P2|STARTED|Overall Study||11
8260589|NCT01798264|20368201|P1|STARTED|Overall Study||12
8260590|NCT01798225|20368225|P2|NOT COMPLETED|Overall Study||3
8260591|NCT01798225|20368226|P1|NOT COMPLETED|Overall Study||0
8260592|NCT01798225|20368225|P2|COMPLETED|Overall Study||53
8260593|NCT01798225|20368226|P1|COMPLETED|Overall Study||57
8260594|NCT01798225|20368225|P2|STARTED|Overall Study||56
8260595|NCT01798225|20368226|P1|STARTED|Overall Study||57
8260596|NCT01798186|20368238|P4|NOT COMPLETED|Overall Study||0
8260597|NCT01798186|20368239|P3|NOT COMPLETED|Overall Study||0
8260598|NCT01798186|20368240|P2|NOT COMPLETED|Overall Study||0
8260599|NCT01798186|20368241|P1|NOT COMPLETED|Overall Study||0
8260600|NCT01798186|20368238|P4|COMPLETED|Overall Study||8
8260601|NCT01798186|20368239|P3|COMPLETED|Overall Study||6
8260602|NCT01798186|20368240|P2|COMPLETED|Overall Study||6
8260603|NCT01798186|20368241|P1|COMPLETED|Overall Study||6
8260604|NCT01798186|20368238|P4|STARTED|Overall Study||8
8260605|NCT01798186|20368239|P3|STARTED|Overall Study||6
8260606|NCT01798186|20368240|P2|STARTED|Overall Study||6
8260607|NCT01798186|20368241|P1|STARTED|Overall Study||6
8260608|NCT01798134|20368255|P1|NOT COMPLETED|Overall Study||16
8260609|NCT01798134|20368255|P1|COMPLETED|Overall Study||9
8260610|NCT01798134|20368255|P1|STARTED|Overall Study||25
8260611|NCT01798056|20368264|P2|NOT COMPLETED|Overall Study||25
8260612|NCT01798056|20368265|P1|NOT COMPLETED|Overall Study||27
8260613|NCT01798056|20368264|P2|COMPLETED|Overall Study||90
8260614|NCT01798056|20368265|P1|COMPLETED|Overall Study||90
8260615|NCT01798056|20368264|P2|STARTED|Overall Study||115
8260616|NCT01798056|20368265|P1|STARTED|Overall Study||117
8260617|NCT01798004|20368299|P1|NOT COMPLETED|Overall Study||87
8260618|NCT01798004|20368299|P1|COMPLETED|Overall Study||63
8260619|NCT01798004|20368299|P1|STARTED|Overall Study||150
8260620|NCT01797965|20368307|P4|NOT COMPLETED|Overall Study||73
8260621|NCT01797965|20368308|P3|NOT COMPLETED|Overall Study||8
8260622|NCT01797965|20368309|P2|NOT COMPLETED|Overall Study||569
8260623|NCT01797965|20368310|P1|NOT COMPLETED|Overall Study||549
8260624|NCT01797965|20368307|P4|COMPLETED|Overall Study||154
8260625|NCT01797965|20368308|P3|COMPLETED|Overall Study||62
8260626|NCT01797965|20368309|P2|COMPLETED|Overall Study||38
8260627|NCT01797965|20368310|P1|COMPLETED|Overall Study||48
8260628|NCT01797965|20368307|P4|STARTED|Overall Study||227
8260629|NCT01797965|20368308|P3|STARTED|Overall Study||70
8260630|NCT01797965|20368309|P2|STARTED|Overall Study||607
8260631|NCT01797965|20368310|P1|STARTED|Overall Study||597
8260632|NCT01797835|20368444|P2|NOT COMPLETED|Overall Study||27
8260633|NCT01797835|20368445|P1|NOT COMPLETED|Overall Study||31
8260634|NCT01797835|20368444|P2|COMPLETED|Overall Study||114
8260635|NCT01797835|20368445|P1|COMPLETED|Overall Study||122
8260636|NCT01797835|20368444|P2|STARTED|Overall Study||141
8260637|NCT01797835|20368445|P1|STARTED|Overall Study||153
8260638|NCT01797822|20368453|P1|NOT COMPLETED|Overall Study||0
8260639|NCT01797822|20368453|P1|COMPLETED|Overall Study|The protocol is now closed.|20
8260640|NCT01797822|20368453|P1|STARTED|Overall Study||20
8260641|NCT01797783|20368461|P2|NOT COMPLETED|Overall Study||1
8260642|NCT01797783|20368462|P1|NOT COMPLETED|Overall Study||2
8260643|NCT01797783|20368461|P2|COMPLETED|Overall Study||26
8260644|NCT01797783|20368462|P1|COMPLETED|Overall Study||50
8260645|NCT01797783|20368461|P2|STARTED|Overall Study||27
8260646|NCT01797783|20368462|P1|STARTED|Overall Study||52
8260647|NCT01797731|20368486|P2|NOT COMPLETED|Overall Study||3
8260648|NCT01797731|20368487|P1|NOT COMPLETED|Overall Study||3
8260649|NCT01797731|20368486|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
8260650|NCT01797731|20368487|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
8260651|NCT01797731|20368486|P2|STARTED|Overall Study||50
8260652|NCT01797731|20368487|P1|STARTED|Overall Study||50
8260653|NCT01797705|20368495|P1|NOT COMPLETED|Overall Study||5
8260654|NCT01797705|20368495|P1|COMPLETED|Overall Study||28
8260655|NCT01797705|20368495|P1|STARTED|Overall Study||33
8260656|NCT01797575|20368503|P4|NOT COMPLETED|Week 8 Re-Randomization||3
8260657|NCT01797575|20368504|P3|NOT COMPLETED|Week 8 Re-Randomization||1
8260658|NCT01797575|20368505|P2|NOT COMPLETED|Week 8 Re-Randomization||0
8260659|NCT01797575|20368506|P1|NOT COMPLETED|Week 8 Re-Randomization||0
8260660|NCT01797575|20368503|P4|COMPLETED|Week 8 Re-Randomization||7
8260661|NCT01797575|20368504|P3|COMPLETED|Week 8 Re-Randomization||4
8260662|NCT01797575|20368505|P2|COMPLETED|Week 8 Re-Randomization||5
8260663|NCT01797575|20368506|P1|COMPLETED|Week 8 Re-Randomization||4
8260664|NCT01797575|20368503|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
8260665|NCT01797575|20368504|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
8260666|NCT01797575|20368505|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
8260667|NCT01797575|20368506|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
8260668|NCT01797575|20368503|P4|NOT COMPLETED|Baseline Allocation||7
8260669|NCT01797575|20368504|P3|NOT COMPLETED|Baseline Allocation||5
8260670|NCT01797575|20368505|P2|NOT COMPLETED|Baseline Allocation||1
8260671|NCT01797575|20368506|P1|NOT COMPLETED|Baseline Allocation||1
8260672|NCT01797575|20368503|P4|COMPLETED|Baseline Allocation||8
8260673|NCT01797575|20368504|P3|COMPLETED|Baseline Allocation||4
8260674|NCT01797575|20368505|P2|COMPLETED|Baseline Allocation||8
8260675|NCT01797575|20368506|P1|COMPLETED|Baseline Allocation||4
8260676|NCT01797575|20368503|P4|STARTED|Baseline Allocation||15
8260677|NCT01797575|20368504|P3|STARTED|Baseline Allocation||9
8260678|NCT01797575|20368505|P2|STARTED|Baseline Allocation||9
8260679|NCT01797575|20368506|P1|STARTED|Baseline Allocation||5
8260680|NCT01797562|20368556|P1|NOT COMPLETED|Overall Study||5
8260681|NCT01797562|20368556|P1|COMPLETED|Overall Study||111
8260682|NCT01797562|20368556|P1|STARTED|Overall Study||116
8260683|NCT01797536|20368565|P4|NOT COMPLETED|Overall Study||0
8260684|NCT01797536|20368566|P3|NOT COMPLETED|Overall Study||0
8260685|NCT01797536|20368567|P2|NOT COMPLETED|Overall Study||1
8260686|NCT01797536|20368568|P1|NOT COMPLETED|Overall Study||0
8260687|NCT01797536|20368565|P4|COMPLETED|Overall Study||8
8260688|NCT01797536|20368566|P3|COMPLETED|Overall Study||7
8260689|NCT01797536|20368567|P2|COMPLETED|Overall Study||10
8260690|NCT01797536|20368568|P1|COMPLETED|Overall Study||8
8260691|NCT01797536|20368565|P4|STARTED|Overall Study||8
8260692|NCT01797536|20368566|P3|STARTED|Overall Study||7
8260693|NCT01797536|20368567|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
8260694|NCT01797536|20368568|P1|STARTED|Overall Study||8
8260695|NCT01797484|20368600|P2|NOT COMPLETED|Overall Study||0
8260696|NCT01797484|20368601|P1|NOT COMPLETED|Overall Study||0
8260697|NCT01797484|20368600|P2|COMPLETED|Overall Study||10
8260698|NCT01797484|20368601|P1|COMPLETED|Overall Study||10
8260699|NCT01797484|20368600|P2|STARTED|Overall Study||10
8260700|NCT01797484|20368601|P1|STARTED|Overall Study||10
8260701|NCT01797471|20368607|P1|NOT COMPLETED|Overall Study||0
8260702|NCT01797471|20368607|P1|COMPLETED|Overall Study||1
8260703|NCT01797471|20368607|P1|STARTED|Overall Study||1
8260704|NCT01797458|20368619|P3|NOT COMPLETED|Overall Study||7
8260705|NCT01797458|20368620|P2|NOT COMPLETED|Overall Study||9
8260706|NCT01797458|20368621|P1|NOT COMPLETED|Overall Study||12
8260707|NCT01797458|20368619|P3|COMPLETED|Overall Study||58
8260708|NCT01797458|20368620|P2|COMPLETED|Overall Study||43
8260709|NCT01797458|20368621|P1|COMPLETED|Overall Study||40
8260710|NCT01797458|20368619|P3|STARTED|Overall Study||65
8260711|NCT01797458|20368620|P2|STARTED|Overall Study||52
8260712|NCT01797458|20368621|P1|STARTED|Overall Study||52
8260713|NCT01797445|20368640|P2|NOT COMPLETED|Open-Label Extension Phase||0
8260714|NCT01797445|20368641|P1|NOT COMPLETED|Open-Label Extension Phase||1
8260715|NCT01797445|20368640|P2|COMPLETED|Open-Label Extension Phase||119
8260716|NCT01797445|20368641|P1|COMPLETED|Open-Label Extension Phase||140
8260717|NCT01797445|20368640|P2|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
8260718|NCT01797445|20368641|P1|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
8260719|NCT01797445|20368640|P2|NOT COMPLETED|Double-Blind Phase||89
8260720|NCT01797445|20368641|P1|NOT COMPLETED|Double-Blind Phase||87
8260721|NCT01797445|20368640|P2|COMPLETED|Double-Blind Phase||348
8260722|NCT01797445|20368641|P1|COMPLETED|Double-Blind Phase||348
8260723|NCT01797445|20368640|P2|STARTED|Double-Blind Phase||437
8260724|NCT01797445|20368641|P1|STARTED|Double-Blind Phase||435
8260725|NCT01797432|20368681|P1|NOT COMPLETED|Overall Study||4
8260726|NCT01797432|20368681|P1|COMPLETED|Overall Study||10
8260727|NCT01797432|20368681|P1|STARTED|Overall Study||14
8260728|NCT01797380|20368688|P2|NOT COMPLETED|Overall Study||2
8260729|NCT01797380|20368689|P1|NOT COMPLETED|Overall Study||3
8260730|NCT01797380|20368688|P2|COMPLETED|Overall Study||0
8260731|NCT01797380|20368689|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
8260732|NCT01797380|20368688|P2|STARTED|Overall Study||2
8260733|NCT01797380|20368689|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
8260734|NCT01797328|20368697|P2|NOT COMPLETED|Overall Study||0
8260735|NCT01797328|20368698|P1|NOT COMPLETED|Overall Study||2
8260736|NCT01797328|20368697|P2|COMPLETED|Overall Study||12
8260737|NCT01797328|20368698|P1|COMPLETED|Overall Study||14
8260738|NCT01797328|20368697|P2|STARTED|Overall Study||12
8260739|NCT01797328|20368698|P1|STARTED|Overall Study||16
8260740|NCT01797302|20368707|P3|NOT COMPLETED|Overall Study||26
8260741|NCT01797302|20368708|P2|NOT COMPLETED|Overall Study||26
8260742|NCT01797302|20368709|P1|NOT COMPLETED|Overall Study||17
8260743|NCT01797302|20368707|P3|COMPLETED|Overall Study||50
8260744|NCT01797302|20368708|P2|COMPLETED|Overall Study||48
8260745|NCT01797302|20368709|P1|COMPLETED|Overall Study||58
8260746|NCT01797302|20368707|P3|3 Month Visit|Overall Study||57
8260747|NCT01797302|20368708|P2|3 Month Visit|Overall Study||57
8260748|NCT01797302|20368709|P1|3 Month Visit|Overall Study||60
8260749|NCT01797302|20368707|P3|STARTED|Overall Study||76
8260750|NCT01797302|20368708|P2|STARTED|Overall Study||74
8260751|NCT01797302|20368709|P1|STARTED|Overall Study||75
8260752|NCT01797263|20368746|P2|NOT COMPLETED|Overall Study||40
8260753|NCT01797263|20368747|P1|NOT COMPLETED|Overall Study||37
8260754|NCT01797263|20368746|P2|COMPLETED|Overall Study||87
8260755|NCT01797263|20368747|P1|COMPLETED|Overall Study||92
8260756|NCT01797263|20368746|P2|9 Month|Overall Study||87
8260757|NCT01797263|20368747|P1|9 Month|Overall Study||92
8260758|NCT01797263|20368746|P2|6 Month|Overall Study||85
8260759|NCT01797263|20368747|P1|6 Month|Overall Study||90
8260760|NCT01797263|20368746|P2|3 Month|Overall Study||84
8260761|NCT01797263|20368747|P1|3 Month|Overall Study||87
8260762|NCT01797263|20368746|P2|1 Month|Overall Study||87
8260763|NCT01797263|20368747|P1|1 Month|Overall Study||96
8260764|NCT01797263|20368746|P2|STARTED|Overall Study||127
8260765|NCT01797263|20368747|P1|STARTED|Overall Study||129
8260766|NCT01797185|20368782|P3|NOT COMPLETED|Overall Study||12
8260767|NCT01797185|20368783|P2|NOT COMPLETED|Overall Study||38
8260768|NCT01797185|20368784|P1|NOT COMPLETED|Overall Study||28
8260769|NCT01797185|20368782|P3|COMPLETED|Overall Study||38
8260770|NCT01797185|20368783|P2|COMPLETED|Overall Study||125
8260771|NCT01797185|20368784|P1|COMPLETED|Overall Study||134
8260772|NCT01797185|20368782|P3|STARTED|Overall Study||50
8260773|NCT01797185|20368783|P2|STARTED|Overall Study||163
8260774|NCT01797185|20368784|P1|STARTED|Overall Study||162
8260775|NCT01797159|20368792|P1|NOT COMPLETED|Overall Study||0
8260776|NCT01797159|20368792|P1|COMPLETED|Overall Study||20
8260777|NCT01797159|20368792|P1|STARTED|Overall Study||20
8260778|NCT01797120|20368808|P2|NOT COMPLETED|Overall Study||65
8260779|NCT01797120|20368809|P1|NOT COMPLETED|Overall Study||66
8260780|NCT01797120|20368808|P2|COMPLETED|Overall Study||0
8260781|NCT01797120|20368809|P1|COMPLETED|Overall Study||0
8260782|NCT01797120|20368808|P2|STARTED|Overall Study||65
8260783|NCT01797120|20368809|P1|STARTED|Overall Study||66
8260784|NCT01797094|20368823|P2|NOT COMPLETED|Overall Study||2
8260785|NCT01797094|20368824|P1|NOT COMPLETED|Overall Study||6
8260786|NCT01797094|20368823|P2|COMPLETED|Overall Study||51
8260787|NCT01797094|20368824|P1|COMPLETED|Overall Study||42
8260788|NCT01797094|20368823|P2|STARTED|Overall Study||53
8260789|NCT01797094|20368824|P1|STARTED|Overall Study||48
8260790|NCT01797081|20368846|P4|NOT COMPLETED|Overall Study||9
8260791|NCT01797081|20368847|P3|NOT COMPLETED|Overall Study||5
8260792|NCT01797081|20368848|P2|NOT COMPLETED|Overall Study||4
8260793|NCT01797081|20368849|P1|NOT COMPLETED|Overall Study||14
8260794|NCT01797081|20368846|P4|COMPLETED|Overall Study||40
8260795|NCT01797081|20368847|P3|COMPLETED|Overall Study||43
8260796|NCT01797081|20368848|P2|COMPLETED|Overall Study||95
8260797|NCT01797081|20368849|P1|COMPLETED|Overall Study||90
8260798|NCT01797081|20368846|P4|STARTED|Overall Study||49
8260799|NCT01797081|20368847|P3|STARTED|Overall Study||48
8260800|NCT01797081|20368848|P2|STARTED|Overall Study||99
8260801|NCT01797081|20368849|P1|STARTED|Overall Study||104
8260802|NCT01797029|20368868|P2|NOT COMPLETED|Overall Study||61
8260803|NCT01797029|20368869|P1|NOT COMPLETED|Overall Study||159
8260804|NCT01797029|20368868|P2|COMPLETED|Overall Study||526
8260805|NCT01797029|20368869|P1|COMPLETED|Overall Study||1015
8260806|NCT01797029|20368868|P2|STARTED|Overall Study||587
8260807|NCT01797029|20368869|P1|STARTED|Overall Study||1174
8260808|NCT01796977|20368877|P1|NOT COMPLETED|Overall Study||0
8260809|NCT01796977|20368877|P1|COMPLETED|Overall Study||27
8260810|NCT01796977|20368877|P1|STARTED|Overall Study||27
8260811|NCT01796964|20368890|P2|NOT COMPLETED|Overall Study||3
8260812|NCT01796964|20368891|P1|NOT COMPLETED|Overall Study||3
8260813|NCT01796964|20368890|P2|COMPLETED|Overall Study||42
8260814|NCT01796964|20368891|P1|COMPLETED|Overall Study||41
8260815|NCT01796964|20368890|P2|STARTED|Overall Study||45
8260816|NCT01796964|20368891|P1|STARTED|Overall Study||44
8260817|NCT01796912|20368913|P2|NOT COMPLETED|Second Intervention||0
8260818|NCT01796912|20368914|P1|NOT COMPLETED|Second Intervention||0
8260819|NCT01796912|20368913|P2|COMPLETED|Second Intervention||10
8260820|NCT01796912|20368914|P1|COMPLETED|Second Intervention||10
8260821|NCT01796912|20368913|P2|STARTED|Second Intervention||10
8260822|NCT01796912|20368914|P1|STARTED|Second Intervention||10
8260823|NCT01796912|20368913|P2|NOT COMPLETED|Washout||0
8260824|NCT01796912|20368914|P1|NOT COMPLETED|Washout||0
8260825|NCT01796912|20368913|P2|COMPLETED|Washout||10
8260826|NCT01796912|20368914|P1|COMPLETED|Washout||10
8260827|NCT01796912|20368913|P2|STARTED|Washout||10
8260828|NCT01796912|20368914|P1|STARTED|Washout||10
8260829|NCT01796912|20368913|P2|NOT COMPLETED|First Intervention||0
8260830|NCT01796912|20368914|P1|NOT COMPLETED|First Intervention||0
8260831|NCT01796912|20368913|P2|COMPLETED|First Intervention||10
8260832|NCT01796912|20368914|P1|COMPLETED|First Intervention||10
8260833|NCT01796912|20368913|P2|STARTED|First Intervention||10
8260834|NCT01796912|20368914|P1|STARTED|First Intervention||10
8260835|NCT01796860|20368932|P1|NOT COMPLETED|Overall Study||3
8260836|NCT01796860|20368932|P1|COMPLETED|Overall Study||7
8260837|NCT01796860|20368932|P1|STARTED|Overall Study||10
8260838|NCT01796665|20368941|P3|NOT COMPLETED|Overall Study||42
8260839|NCT01796665|20368942|P2|NOT COMPLETED|Overall Study||73
8260840|NCT01796665|20368943|P1|NOT COMPLETED|Overall Study||58
8260841|NCT01796665|20368941|P3|COMPLETED|Overall Study||195
8260842|NCT01796665|20368942|P2|COMPLETED|Overall Study||396
8260843|NCT01796665|20368943|P1|COMPLETED|Overall Study||416
8260844|NCT01796665|20368941|P3|STARTED|Overall Study||237
8260845|NCT01796665|20368942|P2|STARTED|Overall Study||469
8260846|NCT01796665|20368943|P1|STARTED|Overall Study||474
8260847|NCT01796548|20368957|P1|NOT COMPLETED|Overall Study||3
8260848|NCT01796548|20368957|P1|COMPLETED|Overall Study||14
8260849|NCT01796548|20368957|P1|Treated|Overall Study||15
8260850|NCT01796548|20368957|P1|STARTED|Overall Study||17
8260851|NCT01796470|20368974|P5|NOT COMPLETED|Overall Study||8
8260852|NCT01796470|20368975|P4|NOT COMPLETED|Overall Study||3
8260853|NCT01796470|20368976|P3|NOT COMPLETED|Overall Study||6
8260854|NCT01796470|20368977|P2|NOT COMPLETED|Overall Study||14
8260855|NCT01796470|20368978|P1|NOT COMPLETED|Overall Study||35
8260856|NCT01796470|20368974|P5|COMPLETED|Overall Study||0
8260857|NCT01796470|20368975|P4|COMPLETED|Overall Study||0
8260858|NCT01796470|20368976|P3|COMPLETED|Overall Study||0
8260859|NCT01796470|20368977|P2|COMPLETED|Overall Study||0
8260860|NCT01796470|20368978|P1|COMPLETED|Overall Study||0
8260861|NCT01796470|20368974|P5|Entospletinib Monotherapy|Overall Study||0
8260862|NCT01796470|20368975|P4|Entospletinib Monotherapy|Overall Study||0
8260863|NCT01796470|20368976|P3|Entospletinib Monotherapy|Overall Study||0
8260864|NCT01796470|20368977|P2|Entospletinib Monotherapy|Overall Study||4
8260865|NCT01796470|20368978|P1|Entospletinib Monotherapy|Overall Study||4
8260866|NCT01796470|20368974|P5|STARTED|Overall Study||8
8260867|NCT01796470|20368975|P4|STARTED|Overall Study||3
8260868|NCT01796470|20368976|P3|STARTED|Overall Study||6
8260869|NCT01796470|20368977|P2|STARTED|Overall Study||14
8260870|NCT01796470|20368978|P1|STARTED|Overall Study||35
8260871|NCT01796392|20369022|P2|NOT COMPLETED|Overall Study||3
8260872|NCT01796392|20369023|P1|NOT COMPLETED|Overall Study||9
8260873|NCT01796392|20369022|P2|COMPLETED|Overall Study|59 active subjects at 12-months|59
8260874|NCT01796392|20369023|P1|COMPLETED|Overall Study|119 active subjects at 12-months|119
8260875|NCT01796392|20369022|P2|STARTED|Overall Study||62
8260876|NCT01796392|20369023|P1|STARTED|Overall Study||128
8260877|NCT01796301|20369037|P2|NOT COMPLETED|Overall Study||20
8260878|NCT01796301|20369038|P1|NOT COMPLETED|Overall Study||18
8260879|NCT01796301|20369037|P2|COMPLETED|Overall Study||198
8260880|NCT01796301|20369038|P1|COMPLETED|Overall Study||200
8260881|NCT01796301|20369037|P2|Received Treatment|Overall Study||218
8260882|NCT01796301|20369038|P1|Received Treatment|Overall Study||214
8260883|NCT01796301|20369037|P2|STARTED|Overall Study||218
8260884|NCT01796301|20369038|P1|STARTED|Overall Study||218
8260885|NCT01796236|20369074|P2|NOT COMPLETED|Overall Study||2
8260886|NCT01796236|20369075|P1|NOT COMPLETED|Overall Study||2
8260887|NCT01796236|20369074|P2|COMPLETED|Overall Study||50
8260888|NCT01796236|20369075|P1|COMPLETED|Overall Study||49
8260889|NCT01796236|20369074|P2|STARTED|Overall Study||52
8260890|NCT01796236|20369075|P1|STARTED|Overall Study||51
8260891|NCT01795937|20369124|P3|NOT COMPLETED|Overall Study||0
8260892|NCT01795937|20369125|P2|NOT COMPLETED|Overall Study||1
8260893|NCT01795937|20369126|P1|NOT COMPLETED|Overall Study||1
8260894|NCT01795937|20369124|P3|COMPLETED|Overall Study||17
8260895|NCT01795937|20369125|P2|COMPLETED|Overall Study||15
8260896|NCT01795937|20369126|P1|COMPLETED|Overall Study||17
8260897|NCT01795937|20369124|P3|STARTED|Overall Study||17
8260898|NCT01795937|20369125|P2|STARTED|Overall Study||16
8260899|NCT01795937|20369126|P1|STARTED|Overall Study||18
8260900|NCT01795898|20369155|P1|NOT COMPLETED|Overall Study||60
8260901|NCT01795898|20369155|P1|COMPLETED|Overall Study||177
8260902|NCT01795898|20369155|P1|STARTED|Overall Study||237
8260903|NCT01795859|20369165|P2|NOT COMPLETED|Overall Study||2
8260904|NCT01795859|20369166|P1|NOT COMPLETED|Overall Study||1
8260905|NCT01795859|20369165|P2|COMPLETED|Overall Study||43
8260906|NCT01795859|20369166|P1|COMPLETED|Overall Study||44
8260907|NCT01795859|20369165|P2|STARTED|Overall Study||45
8260908|NCT01795859|20369166|P1|STARTED|Overall Study||45
8260909|NCT01795833|20369184|P2|NOT COMPLETED|Overall Study||149
8260910|NCT01795833|20369185|P1|NOT COMPLETED|Overall Study||150
8260911|NCT01795833|20369184|P2|COMPLETED|Overall Study||882
8260912|NCT01795833|20369185|P1|COMPLETED|Overall Study||881
8260913|NCT01795833|20369184|P2|STARTED|Overall Study||1031
8260914|NCT01795833|20369185|P1|STARTED|Overall Study||1031
8260915|NCT01795716|20369205|P2|NOT COMPLETED|Second Intervention (13 Days)||0
8260916|NCT01795716|20369206|P1|NOT COMPLETED|Second Intervention (13 Days)||0
8260917|NCT01795716|20369205|P2|COMPLETED|Second Intervention (13 Days)||11
8260918|NCT01795716|20369206|P1|COMPLETED|Second Intervention (13 Days)||10
8260919|NCT01795716|20369205|P2|STARTED|Second Intervention (13 Days)||11
8260920|NCT01795716|20369206|P1|STARTED|Second Intervention (13 Days)||10
8260921|NCT01795716|20369205|P2|NOT COMPLETED|Washout (10 Days)||0
8260922|NCT01795716|20369206|P1|NOT COMPLETED|Washout (10 Days)||0
8260923|NCT01795716|20369205|P2|COMPLETED|Washout (10 Days)||11
8260924|NCT01795716|20369206|P1|COMPLETED|Washout (10 Days)||10
8260925|NCT01795716|20369205|P2|STARTED|Washout (10 Days)||11
8260926|NCT01795716|20369206|P1|STARTED|Washout (10 Days)||10
8260927|NCT01795716|20369205|P2|NOT COMPLETED|First Intervention (13 Days)||0
8260928|NCT01795716|20369206|P1|NOT COMPLETED|First Intervention (13 Days)||0
8260929|NCT01795716|20369205|P2|COMPLETED|First Intervention (13 Days)||11
8260930|NCT01795716|20369206|P1|COMPLETED|First Intervention (13 Days)||10
8260931|NCT01795716|20369205|P2|STARTED|First Intervention (13 Days)||11
8260932|NCT01795716|20369206|P1|STARTED|First Intervention (13 Days)||10
8260933|NCT01795638|20369214|P2|NOT COMPLETED|Overall Study||11
8260934|NCT01795638|20369215|P1|NOT COMPLETED|Overall Study||13
8260935|NCT01795638|20369214|P2|COMPLETED|Overall Study||15
8260936|NCT01795638|20369215|P1|COMPLETED|Overall Study||14
8260937|NCT01795638|20369214|P2|STARTED|Overall Study||26
8260938|NCT01795638|20369215|P1|STARTED|Overall Study||27
8260939|NCT01795547|20369241|P2|NOT COMPLETED|Overall Study||64
8260940|NCT01795547|20369242|P1|NOT COMPLETED|Overall Study||48
8260941|NCT01795547|20369241|P2|COMPLETED|Overall Study||83
8260942|NCT01795547|20369242|P1|COMPLETED|Overall Study||100
8260943|NCT01795547|20369241|P2|STARTED|Overall Study||147
8260944|NCT01795547|20369242|P1|STARTED|Overall Study||148
8260945|NCT01795534|20369264|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
8260946|NCT01795534|20369265|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
8260947|NCT01795534|20369264|P2|COMPLETED|Second Intervention (Second Shot)||5
8260948|NCT01795534|20369265|P1|COMPLETED|Second Intervention (Second Shot)||5
8260949|NCT01795534|20369264|P2|STARTED|Second Intervention (Second Shot)||5
8260950|NCT01795534|20369265|P1|STARTED|Second Intervention (Second Shot)||5
8260951|NCT01795534|20369264|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
8260952|NCT01795534|20369265|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
8260953|NCT01795534|20369264|P2|COMPLETED|Wash Out Period (4 Days)||5
8260954|NCT01795534|20369265|P1|COMPLETED|Wash Out Period (4 Days)||5
8260955|NCT01795534|20369264|P2|STARTED|Wash Out Period (4 Days)||5
8260956|NCT01795534|20369265|P1|STARTED|Wash Out Period (4 Days)||5
8260957|NCT01795534|20369264|P2|NOT COMPLETED|First Intervention (First Shot)||0
8260958|NCT01795534|20369265|P1|NOT COMPLETED|First Intervention (First Shot)||0
8260959|NCT01795534|20369264|P2|COMPLETED|First Intervention (First Shot)||5
8260960|NCT01795534|20369265|P1|COMPLETED|First Intervention (First Shot)||5
8260961|NCT01795534|20369264|P2|STARTED|First Intervention (First Shot)||5
8260962|NCT01795534|20369265|P1|STARTED|First Intervention (First Shot)||5
8260963|NCT01795495|20369274|P3|NOT COMPLETED|Overall Study||2
8260964|NCT01795495|20369275|P2|NOT COMPLETED|Overall Study||0
8260965|NCT01795495|20369276|P1|NOT COMPLETED|Overall Study||1
8260966|NCT01795495|20369274|P3|COMPLETED|Overall Study||19
8260967|NCT01795495|20369275|P2|COMPLETED|Overall Study||22
8260968|NCT01795495|20369276|P1|COMPLETED|Overall Study||19
8260969|NCT01795495|20369274|P3|STARTED|Overall Study||21
8260970|NCT01795495|20369275|P2|STARTED|Overall Study||22
8260971|NCT01795495|20369276|P1|STARTED|Overall Study||20
8260972|NCT01795105|20369287|P1|NOT COMPLETED|Overall Study||44
8260973|NCT01795105|20369287|P1|COMPLETED|Overall Study||648
8260974|NCT01795105|20369287|P1|STARTED|Overall Study||692
8260975|NCT01794949|20369296|P2|NOT COMPLETED|Overall Study||0
8260976|NCT01794949|20369297|P1|NOT COMPLETED|Overall Study||1
8260977|NCT01794949|20369296|P2|COMPLETED|Overall Study||1
8260978|NCT01794949|20369297|P1|COMPLETED|Overall Study||6
8260979|NCT01794949|20369296|P2|6 Month Follow-up|Overall Study||1
8260980|NCT01794949|20369297|P1|6 Month Follow-up|Overall Study||6
8260981|NCT01794949|20369296|P2|STARTED|Overall Study||1
8260982|NCT01794949|20369297|P1|STARTED|Overall Study||7
8260983|NCT01794936|20369303|P1|NOT COMPLETED|Overall Study||0
8260984|NCT01794936|20369303|P1|COMPLETED|Overall Study||9
8260985|NCT01794936|20369303|P1|STARTED|Overall Study||9
8260986|NCT01794845|20369308|P1|NOT COMPLETED|Overall Study||1
8260987|NCT01794845|20369308|P1|COMPLETED|Overall Study||4
8260988|NCT01794845|20369308|P1|STARTED|Overall Study||5
8260989|NCT01794806|20369317|P2|NOT COMPLETED|Overall Study||1
8260990|NCT01794806|20369318|P1|NOT COMPLETED|Overall Study||5
8260991|NCT01794806|20369317|P2|COMPLETED|Overall Study||27
8260992|NCT01794806|20369318|P1|COMPLETED|Overall Study||26
8260993|NCT01794806|20369317|P2|4 Weeks|Overall Study||27
8260994|NCT01794806|20369318|P1|4 Weeks|Overall Study||26
8260995|NCT01794806|20369317|P2|1 Week|Overall Study||28
8260996|NCT01794806|20369318|P1|1 Week|Overall Study||28
8260997|NCT01794806|20369317|P2|STARTED|Overall Study||28
8260998|NCT01794806|20369318|P1|STARTED|Overall Study||31
8260999|NCT01794780|20369336|P8|NOT COMPLETED|Overall Study||9
8261000|NCT01794780|20369337|P7|NOT COMPLETED|Overall Study||42
8261001|NCT01794780|20369338|P6|NOT COMPLETED|Overall Study||180
8261002|NCT01794780|20369339|P5|NOT COMPLETED|Overall Study||3
8261003|NCT01794780|20369340|P4|NOT COMPLETED|Overall Study||83
8261004|NCT01794780|20369341|P3|NOT COMPLETED|Overall Study||242
8261005|NCT01794780|20369342|P2|NOT COMPLETED|Overall Study||96
8261006|NCT01794780|20369343|P1|NOT COMPLETED|Overall Study||17
8261007|NCT01794780|20369336|P8|COMPLETED|Overall Study||21
8261008|NCT01794780|20369337|P7|COMPLETED|Overall Study||112
8261009|NCT01794780|20369338|P6|COMPLETED|Overall Study||452
8261010|NCT01794780|20369339|P5|COMPLETED|Overall Study||6
8261011|NCT01794780|20369340|P4|COMPLETED|Overall Study||200
8261012|NCT01794780|20369341|P3|COMPLETED|Overall Study||571
8261013|NCT01794780|20369342|P2|COMPLETED|Overall Study||180
8261014|NCT01794780|20369343|P1|COMPLETED|Overall Study||15
8261015|NCT01794780|20369336|P8|STARTED|Overall Study||30
8261016|NCT01794780|20369337|P7|STARTED|Overall Study||154
8261017|NCT01794780|20369338|P6|STARTED|Overall Study||632
8261018|NCT01794780|20369339|P5|STARTED|Overall Study||9
8261019|NCT01794780|20369340|P4|STARTED|Overall Study||283
8261020|NCT01794780|20369341|P3|STARTED|Overall Study||813
8261021|NCT01794780|20369342|P2|STARTED|Overall Study||276
8261022|NCT01794780|20369343|P1|STARTED|Overall Study||32
8261023|NCT01794741|20369393|P2|NOT COMPLETED|Overall Study||9
8261024|NCT01794741|20369394|P1|NOT COMPLETED|Overall Study||19
8261025|NCT01794741|20369393|P2|COMPLETED|Overall Study||92
8261026|NCT01794741|20369394|P1|COMPLETED|Overall Study||285
8261027|NCT01794741|20369393|P2|STARTED|Overall Study||101
8261028|NCT01794741|20369394|P1|STARTED|Overall Study||304
8261029|NCT01794702|20369403|P3|NOT COMPLETED|Overall Study||0
8261030|NCT01794702|20369404|P2|NOT COMPLETED|Overall Study||0
8261031|NCT01794702|20369405|P1|NOT COMPLETED|Overall Study||0
8261032|NCT01794702|20369403|P3|COMPLETED|Overall Study||47
8261033|NCT01794702|20369404|P2|COMPLETED|Overall Study||0
8261034|NCT01794702|20369405|P1|COMPLETED|Overall Study||18
8261035|NCT01794702|20369403|P3|STARTED|Overall Study||47
8261036|NCT01794702|20369404|P2|STARTED|Overall Study||0
8261037|NCT01794702|20369405|P1|STARTED|Overall Study||18
8261038|NCT01794689|20369419|P4|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261039|NCT01794689|20369420|P3|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261040|NCT01794689|20369421|P2|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261041|NCT01794689|20369422|P1|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261042|NCT01794689|20369419|P4|COMPLETED|Intervention 2 (2 Nights)||18
8261043|NCT01794689|20369420|P3|COMPLETED|Intervention 2 (2 Nights)||21
8261044|NCT01794689|20369421|P2|COMPLETED|Intervention 2 (2 Nights)||27
8261045|NCT01794689|20369422|P1|COMPLETED|Intervention 2 (2 Nights)||20
8261046|NCT01794689|20369419|P4|STARTED|Intervention 2 (2 Nights)||18
8261047|NCT01794689|20369420|P3|STARTED|Intervention 2 (2 Nights)||21
8261048|NCT01794689|20369421|P2|STARTED|Intervention 2 (2 Nights)||27
8261049|NCT01794689|20369422|P1|STARTED|Intervention 2 (2 Nights)||20
8261050|NCT01794689|20369419|P4|NOT COMPLETED|Washout (2 Weeks)||0
8261051|NCT01794689|20369420|P3|NOT COMPLETED|Washout (2 Weeks)||0
8261052|NCT01794689|20369421|P2|NOT COMPLETED|Washout (2 Weeks)||0
8261053|NCT01794689|20369422|P1|NOT COMPLETED|Washout (2 Weeks)||0
8261054|NCT01794689|20369419|P4|COMPLETED|Washout (2 Weeks)||18
8261055|NCT01794689|20369420|P3|COMPLETED|Washout (2 Weeks)||21
8261056|NCT01794689|20369421|P2|COMPLETED|Washout (2 Weeks)||27
8261057|NCT01794689|20369422|P1|COMPLETED|Washout (2 Weeks)||20
8261058|NCT01794689|20369419|P4|STARTED|Washout (2 Weeks)||18
8261059|NCT01794689|20369420|P3|STARTED|Washout (2 Weeks)||21
8261060|NCT01794689|20369421|P2|STARTED|Washout (2 Weeks)||27
8261061|NCT01794689|20369422|P1|STARTED|Washout (2 Weeks)||20
8261062|NCT01794689|20369419|P4|NOT COMPLETED|Intervention 1 (2 Nights)||4
8261063|NCT01794689|20369420|P3|NOT COMPLETED|Intervention 1 (2 Nights)||3
8261064|NCT01794689|20369421|P2|NOT COMPLETED|Intervention 1 (2 Nights)||2
8261065|NCT01794689|20369422|P1|NOT COMPLETED|Intervention 1 (2 Nights)||5
8261066|NCT01794689|20369419|P4|COMPLETED|Intervention 1 (2 Nights)||18
8261067|NCT01794689|20369420|P3|COMPLETED|Intervention 1 (2 Nights)||21
8261068|NCT01794689|20369421|P2|COMPLETED|Intervention 1 (2 Nights)||27
8261069|NCT01794689|20369422|P1|COMPLETED|Intervention 1 (2 Nights)||20
8261070|NCT01794689|20369419|P4|STARTED|Intervention 1 (2 Nights)||22
8261071|NCT01794689|20369420|P3|STARTED|Intervention 1 (2 Nights)||24
8261072|NCT01794689|20369421|P2|STARTED|Intervention 1 (2 Nights)||29
8261073|NCT01794689|20369422|P1|STARTED|Intervention 1 (2 Nights)||25
8261074|NCT01794455|20369446|P2|NOT COMPLETED|Overall Study||0
8261075|NCT01794455|20369447|P1|NOT COMPLETED|Overall Study||0
8261076|NCT01794455|20369446|P2|COMPLETED|Overall Study||1
8261077|NCT01794455|20369447|P1|COMPLETED|Overall Study||0
8261078|NCT01794455|20369446|P2|STARTED|Overall Study||1
8261079|NCT01794455|20369447|P1|STARTED|Overall Study||0
8261080|NCT01794312|20369465|P2|NOT COMPLETED|Overall Study||11
8261081|NCT01794312|20369466|P1|NOT COMPLETED|Overall Study||6
8261082|NCT01794312|20369465|P2|COMPLETED|Overall Study||67
8261083|NCT01794312|20369466|P1|COMPLETED|Overall Study||68
8261084|NCT01794312|20369465|P2|STARTED|Overall Study||78
8261085|NCT01794312|20369466|P1|STARTED|Overall Study||74
8261086|NCT01794299|20369476|P1|NOT COMPLETED|Overall Study||22
8261087|NCT01794299|20369476|P1|COMPLETED|Overall Study||9
8261088|NCT01794299|20369476|P1|STARTED|Overall Study||31
8261089|NCT01794039|20369482|P2|NOT COMPLETED|Overall Study||0
8261090|NCT01794039|20369483|P1|NOT COMPLETED|Overall Study||0
8261091|NCT01794039|20369482|P2|COMPLETED|Overall Study||4
8261092|NCT01794039|20369483|P1|COMPLETED|Overall Study||5
8261093|NCT01794039|20369482|P2|STARTED|Overall Study||4
8261094|NCT01794039|20369483|P1|STARTED|Overall Study||5
8261095|NCT01794000|20369495|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8261096|NCT01794000|20369496|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
8261097|NCT01794000|20369495|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
8261098|NCT01794000|20369496|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
8261099|NCT01794000|20369495|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
8261100|NCT01794000|20369496|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
8261101|NCT01794000|20369495|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
8261102|NCT01794000|20369496|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
8261103|NCT01794000|20369495|P2|COMPLETED|Double-Blind Phase (DBP)||4
8261104|NCT01794000|20369496|P1|COMPLETED|Double-Blind Phase (DBP)||2
8261105|NCT01794000|20369495|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
8261106|NCT01794000|20369496|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
8261107|NCT01794000|20369495|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
8261108|NCT01794000|20369496|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
8261109|NCT01794000|20369495|P2|STARTED|Double-Blind Phase (DBP)||170
8261110|NCT01794000|20369496|P1|STARTED|Double-Blind Phase (DBP)||171
8261111|NCT01793935|20369529|P2|NOT COMPLETED|Overall Study||3
8261112|NCT01793935|20369530|P1|NOT COMPLETED|Overall Study||6
8261113|NCT01793935|20369529|P2|COMPLETED|Overall Study||31
8261114|NCT01793935|20369530|P1|COMPLETED|Overall Study||28
8261115|NCT01793935|20369529|P2|STARTED|Overall Study||34
8261116|NCT01793935|20369530|P1|STARTED|Overall Study||34
8261117|NCT01793909|20369566|P2|NOT COMPLETED|Overall Study||5
8261118|NCT01793909|20369567|P1|NOT COMPLETED|Overall Study||10
8261119|NCT01793909|20369566|P2|COMPLETED|Overall Study||20
8261120|NCT01793909|20369567|P1|COMPLETED|Overall Study||20
8261121|NCT01793909|20369566|P2|STARTED|Overall Study||25
8261122|NCT01793909|20369567|P1|STARTED|Overall Study||30
8261123|NCT01793883|20369576|P3|NOT COMPLETED|Overall Study||8
8261124|NCT01793883|20369577|P2|NOT COMPLETED|Overall Study||10
8261125|NCT01793883|20369578|P1|NOT COMPLETED|Overall Study||12
8261126|NCT01793883|20369576|P3|COMPLETED|Overall Study||204
8261127|NCT01793883|20369577|P2|COMPLETED|Overall Study||204
8261128|NCT01793883|20369578|P1|COMPLETED|Overall Study||201
8261129|NCT01793883|20369576|P3|STARTED|Overall Study||212
8261130|NCT01793883|20369577|P2|STARTED|Overall Study||214
8261131|NCT01793883|20369578|P1|STARTED|Overall Study||213
8261132|NCT01793792|20369586|P1|NOT COMPLETED|Overall Study||12
8261133|NCT01793792|20369586|P1|COMPLETED|Overall Study||141
8261134|NCT01793792|20369586|P1|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
8261135|NCT01793792|20369586|P1|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
8261136|NCT01793688|20369591|P1|NOT COMPLETED|Overall Study||2
8261137|NCT01793688|20369591|P1|COMPLETED|Overall Study||980
8261138|NCT01793688|20369591|P1|STARTED|Overall Study||982
8261139|NCT01793610|20369601|P3|NOT COMPLETED|Overall Study||1
8261140|NCT01793610|20369602|P2|NOT COMPLETED|Overall Study||0
8261141|NCT01793610|20369603|P1|NOT COMPLETED|Overall Study||1
8261142|NCT01793610|20369601|P3|COMPLETED|Overall Study||12
8261143|NCT01793610|20369602|P2|COMPLETED|Overall Study||9
8261144|NCT01793610|20369603|P1|COMPLETED|Overall Study||5
8261145|NCT01793610|20369601|P3|STARTED|Overall Study||13
8261146|NCT01793610|20369602|P2|STARTED|Overall Study||9
8261147|NCT01793610|20369603|P1|STARTED|Overall Study||6
8261148|NCT01793285|20369629|P1|NOT COMPLETED|Overall Study||0
8261149|NCT01793285|20369629|P1|COMPLETED|Overall Study||85
8261150|NCT01793285|20369629|P1|STARTED|Overall Study||85
8261151|NCT01793142|20369649|P1|NOT COMPLETED|Overall Study||7
8261152|NCT01793142|20369649|P1|COMPLETED|Overall Study||3423
8261153|NCT01793142|20369649|P1|Treated|Overall Study||3423
8261154|NCT01793142|20369649|P1|STARTED|Overall Study||3430
8261155|NCT01792986|20369660|P1|NOT COMPLETED|Overall Study||0
8261156|NCT01792986|20369660|P1|COMPLETED|Overall Study||12
8261157|NCT01792986|20369660|P1|STARTED|Overall Study||12
8261158|NCT01792830|20369679|P11|NOT COMPLETED|Overall Study||3
8261159|NCT01792830|20369680|P10|NOT COMPLETED|Overall Study||0
8261160|NCT01792830|20369681|P9|NOT COMPLETED|Overall Study||9
8261161|NCT01792830|20369682|P8|NOT COMPLETED|Overall Study||1
8261162|NCT01792830|20369683|P7|NOT COMPLETED|Overall Study||2
8261163|NCT01792830|20369684|P6|NOT COMPLETED|Overall Study||1
8261164|NCT01792830|20369685|P5|NOT COMPLETED|Overall Study||1
8261165|NCT01792830|20369686|P4|NOT COMPLETED|Overall Study||3
8261166|NCT01792830|20369687|P3|NOT COMPLETED|Overall Study||0
8261167|NCT01792830|20369688|P2|NOT COMPLETED|Overall Study||0
8261168|NCT01792830|20369689|P1|NOT COMPLETED|Overall Study||25
8261169|NCT01792830|20369679|P11|COMPLETED|Overall Study||9
8261170|NCT01792830|20369680|P10|COMPLETED|Overall Study||4
8261171|NCT01792830|20369681|P9|COMPLETED|Overall Study||11
8261172|NCT01792830|20369682|P8|COMPLETED|Overall Study||6
8261173|NCT01792830|20369683|P7|COMPLETED|Overall Study||12
8261174|NCT01792830|20369684|P6|COMPLETED|Overall Study||3
8261175|NCT01792830|20369685|P5|COMPLETED|Overall Study||1
8261176|NCT01792830|20369686|P4|COMPLETED|Overall Study||18
8261177|NCT01792830|20369687|P3|COMPLETED|Overall Study||4
8261178|NCT01792830|20369688|P2|COMPLETED|Overall Study||3
8261179|NCT01792830|20369689|P1|COMPLETED|Overall Study||59
8261180|NCT01792830|20369679|P11|STARTED|Overall Study||12
8261181|NCT01792830|20369680|P10|STARTED|Overall Study||4
8261182|NCT01792830|20369681|P9|STARTED|Overall Study||20
8261183|NCT01792830|20369682|P8|STARTED|Overall Study||7
8261184|NCT01792830|20369683|P7|STARTED|Overall Study||14
8261185|NCT01792830|20369684|P6|STARTED|Overall Study||4
8261186|NCT01792830|20369685|P5|STARTED|Overall Study||2
8261187|NCT01792830|20369686|P4|STARTED|Overall Study||21
8261188|NCT01792830|20369687|P3|STARTED|Overall Study||4
8261189|NCT01792830|20369688|P2|STARTED|Overall Study||3
8261190|NCT01792830|20369689|P1|STARTED|Overall Study||84
8261191|NCT01792817|20369758|P3|NOT COMPLETED|Phase 2 Open Label||26
8261192|NCT01792817|20369759|P2|NOT COMPLETED|Phase 2 Open Label||0
8261193|NCT01792817|20369760|P1|NOT COMPLETED|Phase 2 Open Label||0
8261194|NCT01792817|20369758|P3|COMPLETED|Phase 2 Open Label||74
8261195|NCT01792817|20369759|P2|COMPLETED|Phase 2 Open Label||0
8261196|NCT01792817|20369760|P1|COMPLETED|Phase 2 Open Label||0
8261197|NCT01792817|20369758|P3|STARTED|Phase 2 Open Label||100
8261198|NCT01792817|20369759|P2|STARTED|Phase 2 Open Label||0
8261199|NCT01792817|20369760|P1|STARTED|Phase 2 Open Label||0
8261200|NCT01792817|20369758|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
8261201|NCT01792817|20369759|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
8261202|NCT01792817|20369760|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
8261203|NCT01792817|20369758|P3|COMPLETED|Phase 1 Double Blind Period||0
8261204|NCT01792817|20369759|P2|COMPLETED|Phase 1 Double Blind Period||42
8261205|NCT01792817|20369760|P1|COMPLETED|Phase 1 Double Blind Period||58
8261206|NCT01792817|20369758|P3|STARTED|Phase 1 Double Blind Period||0
8261207|NCT01792817|20369759|P2|STARTED|Phase 1 Double Blind Period||73
8261208|NCT01792817|20369760|P1|STARTED|Phase 1 Double Blind Period||77
8261209|NCT01792635|20369776|P3|NOT COMPLETED|Part B||4
8261210|NCT01792635|20369777|P2|NOT COMPLETED|Part B||4
8261211|NCT01792635|20369778|P1|NOT COMPLETED|Part B||0
8261212|NCT01792635|20369776|P3|COMPLETED|Part B||3
8261213|NCT01792635|20369777|P2|COMPLETED|Part B||2
8261214|NCT01792635|20369778|P1|COMPLETED|Part B||0
8261215|NCT01792635|20369776|P3|STARTED|Part B||7
8261216|NCT01792635|20369777|P2|STARTED|Part B||6
8261217|NCT01792635|20369778|P1|STARTED|Part B||0
8261218|NCT01792635|20369776|P3|NOT COMPLETED|Part A||0
8261219|NCT01792635|20369777|P2|NOT COMPLETED|Part A||0
8261220|NCT01792635|20369778|P1|NOT COMPLETED|Part A||0
8261221|NCT01792635|20369776|P3|COMPLETED|Part A||0
8261222|NCT01792635|20369777|P2|COMPLETED|Part A||0
8261223|NCT01792635|20369778|P1|COMPLETED|Part A||6
8261224|NCT01792635|20369776|P3|STARTED|Part A||0
8261225|NCT01792635|20369777|P2|STARTED|Part A||0
8261226|NCT01792635|20369778|P1|STARTED|Part A||6
8261227|NCT01792518|20369806|P2|NOT COMPLETED|Overall Study||7
8261228|NCT01792518|20369807|P1|NOT COMPLETED|Overall Study||8
8261229|NCT01792518|20369806|P2|COMPLETED|Overall Study||175
8261230|NCT01792518|20369807|P1|COMPLETED|Overall Study||170
8261231|NCT01792518|20369806|P2|STARTED|Overall Study||182
8261232|NCT01792518|20369807|P1|STARTED|Overall Study||178
8261233|NCT01792284|20369817|P3|NOT COMPLETED|Randomization Period 2||0
8261234|NCT01792284|20369818|P2|NOT COMPLETED|Randomization Period 2||3
8261235|NCT01792284|20369819|P1|NOT COMPLETED|Randomization Period 2||0
8261236|NCT01792284|20369817|P3|COMPLETED|Randomization Period 2||85
8261237|NCT01792284|20369818|P2|COMPLETED|Randomization Period 2||87
8261238|NCT01792284|20369819|P1|COMPLETED|Randomization Period 2||0
8261239|NCT01792284|20369817|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
8261240|NCT01792284|20369818|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
8261241|NCT01792284|20369819|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
8261242|NCT01792284|20369817|P3|STARTED|Randomization Period 2||85
8261243|NCT01792284|20369818|P2|STARTED|Randomization Period 2||90
8261244|NCT01792284|20369819|P1|STARTED|Randomization Period 2||0
8261245|NCT01792284|20369817|P3|NOT COMPLETED|Randomization Period 1||5
8261246|NCT01792284|20369818|P2|NOT COMPLETED|Randomization Period 1||2
8261247|NCT01792284|20369819|P1|NOT COMPLETED|Randomization Period 1||0
8261248|NCT01792284|20369817|P3|COMPLETED|Randomization Period 1||85
8261249|NCT01792284|20369818|P2|COMPLETED|Randomization Period 1||90
8261250|NCT01792284|20369819|P1|COMPLETED|Randomization Period 1||0
8261251|NCT01792284|20369817|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
8261252|NCT01792284|20369818|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
8261253|NCT01792284|20369819|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
8261254|NCT01792284|20369817|P3|STARTED|Randomization Period 1||90
8261255|NCT01792284|20369818|P2|STARTED|Randomization Period 1||92
8261256|NCT01792284|20369819|P1|STARTED|Randomization Period 1||0
8261257|NCT01792284|20369817|P3|NOT COMPLETED|Lead-in Period||0
8261258|NCT01792284|20369818|P2|NOT COMPLETED|Lead-in Period||0
8261259|NCT01792284|20369819|P1|NOT COMPLETED|Lead-in Period||30
8261260|NCT01792284|20369817|P3|COMPLETED|Lead-in Period||0
8261261|NCT01792284|20369818|P2|COMPLETED|Lead-in Period||0
8261262|NCT01792284|20369819|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
8261263|NCT01792284|20369817|P3|STARTED|Lead-in Period||0
8261264|NCT01792284|20369818|P2|STARTED|Lead-in Period||0
8261265|NCT01792284|20369819|P1|STARTED|Lead-in Period||212
8261266|NCT01792115|20369860|P3|NOT COMPLETED|Overall Study||0
8261267|NCT01792115|20369861|P2|NOT COMPLETED|Overall Study||1
8261268|NCT01792115|20369862|P1|NOT COMPLETED|Overall Study||0
8261269|NCT01792115|20369860|P3|COMPLETED|Overall Study||8
8261270|NCT01792115|20369861|P2|COMPLETED|Overall Study||6
8261271|NCT01792115|20369862|P1|COMPLETED|Overall Study||7
8261272|NCT01792115|20369860|P3|STARTED|Overall Study||8
8261273|NCT01792115|20369861|P2|STARTED|Overall Study||7
8261274|NCT01792115|20369862|P1|STARTED|Overall Study||7
8261275|NCT01792024|20369891|P1|NOT COMPLETED|Overall Study||0
8261276|NCT01792024|20369891|P1|COMPLETED|Overall Study||27
8261277|NCT01792024|20369891|P1|STARTED|Overall Study||27
8261278|NCT01791972|20369901|P2|NOT COMPLETED|Overall Study||0
8261279|NCT01791972|20369902|P1|NOT COMPLETED|Overall Study||0
8261280|NCT01791972|20369901|P2|COMPLETED|Overall Study||19
8261281|NCT01791972|20369902|P1|COMPLETED|Overall Study||19
8261282|NCT01791972|20369901|P2|STARTED|Overall Study||19
8261283|NCT01791972|20369902|P1|STARTED|Overall Study||19
8261284|NCT01791894|20369912|P1|NOT COMPLETED|Overall Study||1
8261285|NCT01791894|20369912|P1|COMPLETED|Overall Study||4
8261286|NCT01791894|20369912|P1|STARTED|Overall Study||5
8261287|NCT01791803|20369923|P4|NOT COMPLETED|Overall Study||5
8261288|NCT01791803|20369924|P3|NOT COMPLETED|Overall Study||2
8261289|NCT01791803|20369925|P2|NOT COMPLETED|Overall Study||2
8261290|NCT01791803|20369926|P1|NOT COMPLETED|Overall Study||0
8261291|NCT01791803|20369923|P4|COMPLETED|Overall Study||37
8261292|NCT01791803|20369924|P3|COMPLETED|Overall Study||38
8261293|NCT01791803|20369925|P2|COMPLETED|Overall Study||39
8261294|NCT01791803|20369926|P1|COMPLETED|Overall Study||41
8261295|NCT01791803|20369923|P4|STARTED|Overall Study||42
8261296|NCT01791803|20369924|P3|STARTED|Overall Study||40
8261297|NCT01791803|20369925|P2|STARTED|Overall Study||41
8261298|NCT01791803|20369926|P1|STARTED|Overall Study||41
8261299|NCT01791725|20369944|P3|NOT COMPLETED|Overall Study||0
8261300|NCT01791725|20369945|P2|NOT COMPLETED|Overall Study||1
8261301|NCT01791725|20369946|P1|NOT COMPLETED|Overall Study||0
8261302|NCT01791725|20369944|P3|COMPLETED|Overall Study||6
8261303|NCT01791725|20369945|P2|COMPLETED|Overall Study||4
8261304|NCT01791725|20369946|P1|COMPLETED|Overall Study||12
8261305|NCT01791725|20369944|P3|STARTED|Overall Study||6
8261306|NCT01791725|20369945|P2|STARTED|Overall Study||5
8261307|NCT01791725|20369946|P1|STARTED|Overall Study||12
8261308|NCT01791517|20369969|P12|NOT COMPLETED|Phase II||1
8261309|NCT01791517|20369970|P11|NOT COMPLETED|Phase II||1
8261310|NCT01791517|20369971|P10|NOT COMPLETED|Phase II||3
8261311|NCT01791517|20369972|P9|NOT COMPLETED|Phase II||2
8261312|NCT01791517|20369973|P8|NOT COMPLETED|Phase II||3
8261313|NCT01791517|20369974|P7|NOT COMPLETED|Phase II||2
8261314|NCT01791517|20369975|P6|NOT COMPLETED|Phase II||4
8261315|NCT01791517|20369976|P5|NOT COMPLETED|Phase II||2
8261316|NCT01791517|20369977|P4|NOT COMPLETED|Phase II||0
8261317|NCT01791517|20369978|P3|NOT COMPLETED|Phase II||1
8261318|NCT01791517|20369979|P2|NOT COMPLETED|Phase II||0
8261319|NCT01791517|20369980|P1|NOT COMPLETED|Phase II||2
8261320|NCT01791517|20369969|P12|COMPLETED|Phase II||17
8261321|NCT01791517|20369970|P11|COMPLETED|Phase II||15
8261322|NCT01791517|20369971|P10|COMPLETED|Phase II||15
8261323|NCT01791517|20369972|P9|COMPLETED|Phase II||17
8261324|NCT01791517|20369973|P8|COMPLETED|Phase II||17
8261325|NCT01791517|20369974|P7|COMPLETED|Phase II||17
8261326|NCT01791517|20369975|P6|COMPLETED|Phase II||14
8261327|NCT01791517|20369976|P5|COMPLETED|Phase II||16
8261328|NCT01791517|20369977|P4|COMPLETED|Phase II||15
8261329|NCT01791517|20369978|P3|COMPLETED|Phase II||15
8261330|NCT01791517|20369979|P2|COMPLETED|Phase II||14
8261331|NCT01791517|20369980|P1|COMPLETED|Phase II||15
8261332|NCT01791517|20369969|P12|STARTED|Phase II||18
8261333|NCT01791517|20369970|P11|STARTED|Phase II||16
8261334|NCT01791517|20369971|P10|STARTED|Phase II||18
8261335|NCT01791517|20369972|P9|STARTED|Phase II||19
8261336|NCT01791517|20369973|P8|STARTED|Phase II||20
8261337|NCT01791517|20369974|P7|STARTED|Phase II||19
8261338|NCT01791517|20369975|P6|STARTED|Phase II||18
8261339|NCT01791517|20369976|P5|STARTED|Phase II||18
8261340|NCT01791517|20369977|P4|STARTED|Phase II||15
8261341|NCT01791517|20369978|P3|STARTED|Phase II||16
8261342|NCT01791517|20369979|P2|STARTED|Phase II||14
8261343|NCT01791517|20369980|P1|STARTED|Phase II||17
8261344|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 4||0
8261345|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 4||0
8261346|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 4||0
8261347|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 4||0
8261348|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 4||0
8261349|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 4||0
8261350|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 4||0
8261351|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 4||0
8261352|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 4||0
8261353|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 4||0
8261354|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 4||0
8261355|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 4||0
8261356|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 4||18
8261357|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 4||16
8261358|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 4||18
8261359|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 4||19
8261360|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 4||20
8261361|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 4||19
8261362|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 4||18
8261363|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 4||18
8261364|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 4||15
8261365|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 4||16
8261366|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 4||14
8261367|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 4||17
8261368|NCT01791517|20369969|P12|STARTED|Phase I: Period 4||18
8261369|NCT01791517|20369970|P11|STARTED|Phase I: Period 4||16
8261370|NCT01791517|20369971|P10|STARTED|Phase I: Period 4||18
8261371|NCT01791517|20369972|P9|STARTED|Phase I: Period 4||19
8261372|NCT01791517|20369973|P8|STARTED|Phase I: Period 4||20
8261373|NCT01791517|20369974|P7|STARTED|Phase I: Period 4||19
8261374|NCT01791517|20369975|P6|STARTED|Phase I: Period 4||18
8261375|NCT01791517|20369976|P5|STARTED|Phase I: Period 4||18
8261376|NCT01791517|20369977|P4|STARTED|Phase I: Period 4||15
8261377|NCT01791517|20369978|P3|STARTED|Phase I: Period 4||16
8261378|NCT01791517|20369979|P2|STARTED|Phase I: Period 4||14
8261379|NCT01791517|20369980|P1|STARTED|Phase I: Period 4||17
8261380|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 3||1
8261381|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 3||0
8261382|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 3||0
8261383|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 3||0
8261384|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 3||0
8261385|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 3||0
8261386|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 3||0
8261387|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 3||1
8261388|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 3||1
8261389|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 3||0
8261390|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 3||1
8261391|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 3||0
8261392|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 3||18
8261393|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 3||16
8261394|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 3||18
8261395|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 3||19
8261396|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 3||20
8261397|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 3||19
8261398|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 3||18
8261399|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 3||18
8261400|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 3||15
8261401|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 3||16
8261402|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 3||14
8261403|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 3||17
8261404|NCT01791517|20369969|P12|STARTED|Phase I: Period 3||19
8261405|NCT01791517|20369970|P11|STARTED|Phase I: Period 3||16
8261406|NCT01791517|20369971|P10|STARTED|Phase I: Period 3||18
8261407|NCT01791517|20369972|P9|STARTED|Phase I: Period 3||19
8261408|NCT01791517|20369973|P8|STARTED|Phase I: Period 3||20
8261409|NCT01791517|20369974|P7|STARTED|Phase I: Period 3||19
8261410|NCT01791517|20369975|P6|STARTED|Phase I: Period 3||18
8261411|NCT01791517|20369976|P5|STARTED|Phase I: Period 3||19
8261412|NCT01791517|20369977|P4|STARTED|Phase I: Period 3||16
8261413|NCT01791517|20369978|P3|STARTED|Phase I: Period 3||16
8261414|NCT01791517|20369979|P2|STARTED|Phase I: Period 3||15
8261415|NCT01791517|20369980|P1|STARTED|Phase I: Period 3||17
8261416|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 2||0
8261417|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 2||2
8261418|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 2||1
8261419|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 2||0
8261420|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 2||0
8261421|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 2||0
8261422|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 2||1
8261423|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 2||0
8261424|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 2||1
8261425|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 2||2
8261426|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 2||3
8261427|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 2||1
8261428|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 2||19
8261429|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 2||16
8261430|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 2||18
8261431|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 2||19
8261432|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 2||20
8261433|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 2||19
8261434|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 2||18
8261435|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 2||19
8261436|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 2||16
8261437|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 2||16
8261438|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 2||15
8261439|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 2||17
8261440|NCT01791517|20369969|P12|STARTED|Phase I: Period 2||19
8261441|NCT01791517|20369970|P11|STARTED|Phase I: Period 2||18
8261442|NCT01791517|20369971|P10|STARTED|Phase I: Period 2||19
8261443|NCT01791517|20369972|P9|STARTED|Phase I: Period 2||19
8261444|NCT01791517|20369973|P8|STARTED|Phase I: Period 2||20
8261445|NCT01791517|20369974|P7|STARTED|Phase I: Period 2||19
8261446|NCT01791517|20369975|P6|STARTED|Phase I: Period 2||19
8261447|NCT01791517|20369976|P5|STARTED|Phase I: Period 2||19
8261448|NCT01791517|20369977|P4|STARTED|Phase I: Period 2||17
8261449|NCT01791517|20369978|P3|STARTED|Phase I: Period 2||18
8261450|NCT01791517|20369979|P2|STARTED|Phase I: Period 2||18
8261451|NCT01791517|20369980|P1|STARTED|Phase I: Period 2||18
8261452|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 1||1
8261453|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 1||0
8261454|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 1||1
8261455|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 1||1
8261456|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 1||0
8261457|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 1||1
8261458|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 1||1
8261459|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 1||1
8261460|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 1||2
8261461|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 1||2
8261462|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 1||2
8261463|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 1||1
8261464|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 1||19
8261465|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 1||18
8261466|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 1||19
8261467|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 1||19
8261468|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 1||20
8261469|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 1||19
8261470|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 1||19
8261471|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 1||19
8261472|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 1||17
8261473|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 1||18
8261474|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 1||18
8261475|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 1||18
8261476|NCT01791517|20369969|P12|STARTED|Phase I: Period 1||20
8261477|NCT01791517|20369970|P11|STARTED|Phase I: Period 1||18
8261478|NCT01791517|20369971|P10|STARTED|Phase I: Period 1||20
8261479|NCT01791517|20369972|P9|STARTED|Phase I: Period 1||20
8261480|NCT01791517|20369973|P8|STARTED|Phase I: Period 1||20
8261481|NCT01791517|20369974|P7|STARTED|Phase I: Period 1||20
8261482|NCT01791517|20369975|P6|STARTED|Phase I: Period 1||20
8261483|NCT01791517|20369976|P5|STARTED|Phase I: Period 1||20
8261484|NCT01791517|20369977|P4|STARTED|Phase I: Period 1||19
8261485|NCT01791517|20369978|P3|STARTED|Phase I: Period 1||20
8261486|NCT01791517|20369979|P2|STARTED|Phase I: Period 1||20
8261487|NCT01791517|20369980|P1|STARTED|Phase I: Period 1||19
8261488|NCT01791491|20370006|P1|NOT COMPLETED|Overall Study||0
8261489|NCT01791491|20370006|P1|COMPLETED|Overall Study||9
8261490|NCT01791491|20370006|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
8261491|NCT01791465|20370018|P1|NOT COMPLETED|Overall Study||0
8261492|NCT01791465|20370018|P1|COMPLETED|Overall Study||6
8261493|NCT01791465|20370018|P1|STARTED|Overall Study||6
8261494|NCT01791413|20370044|P2|NOT COMPLETED|Overall Study||1
8261495|NCT01791413|20370045|P1|NOT COMPLETED|Overall Study||5
8261496|NCT01791413|20370044|P2|COMPLETED|Overall Study||19
8261497|NCT01791413|20370045|P1|COMPLETED|Overall Study||15
8261498|NCT01791413|20370044|P2|STARTED|Overall Study||20
8261499|NCT01791413|20370045|P1|STARTED|Overall Study||20
8261500|NCT01791244|20370054|P2|NOT COMPLETED|Overall Study||18
8261501|NCT01791244|20370055|P1|NOT COMPLETED|Overall Study||15
8261502|NCT01791244|20370054|P2|COMPLETED|Overall Study||29
8261503|NCT01791244|20370055|P1|COMPLETED|Overall Study||31
8261504|NCT01791244|20370054|P2|Intent to Treat (ITT)|Overall Study||39
8261505|NCT01791244|20370055|P1|Intent to Treat (ITT)|Overall Study||38
8261506|NCT01791244|20370054|P2|STARTED|Overall Study||47
8261507|NCT01791244|20370055|P1|STARTED|Overall Study||46
8261508|NCT01791205|20370091|P2|NOT COMPLETED|Phase II||0
8261509|NCT01791205|20370092|P1|NOT COMPLETED|Phase II||12
8261510|NCT01791205|20370091|P2|COMPLETED|Phase II||0
8261511|NCT01791205|20370092|P1|COMPLETED|Phase II||92
8261512|NCT01791205|20370091|P2|STARTED|Phase II||0
8261602|NCT01790594|20370346|P2|COMPLETED|Overall Study||18
8261513|NCT01791205|20370092|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
8261514|NCT01791205|20370091|P2|NOT COMPLETED|Phase I||0
8261515|NCT01791205|20370092|P1|NOT COMPLETED|Phase I||0
8261516|NCT01791205|20370091|P2|COMPLETED|Phase I||152
8261517|NCT01791205|20370092|P1|COMPLETED|Phase I||152
8261518|NCT01791205|20370091|P2|STARTED|Phase I||152
8261519|NCT01791205|20370092|P1|STARTED|Phase I||152
8261520|NCT01791153|20370176|P8|NOT COMPLETED|Part 2: Open-label Period||6
8261521|NCT01791153|20370177|P7|NOT COMPLETED|Part 2: Open-label Period||6
8261522|NCT01791153|20370178|P6|NOT COMPLETED|Part 2: Open-label Period||4
8261523|NCT01791153|20370179|P5|NOT COMPLETED|Part 2: Open-label Period||2
8261524|NCT01791153|20370180|P4|NOT COMPLETED|Part 2: Open-label Period||0
8261525|NCT01791153|20370181|P3|NOT COMPLETED|Part 2: Open-label Period||0
8261526|NCT01791153|20370182|P2|NOT COMPLETED|Part 2: Open-label Period||0
8261527|NCT01791153|20370183|P1|NOT COMPLETED|Part 2: Open-label Period||0
8261528|NCT01791153|20370176|P8|COMPLETED|Part 2: Open-label Period||61
8261529|NCT01791153|20370177|P7|COMPLETED|Part 2: Open-label Period||44
8261530|NCT01791153|20370178|P6|COMPLETED|Part 2: Open-label Period||54
8261531|NCT01791153|20370179|P5|COMPLETED|Part 2: Open-label Period||38
8261532|NCT01791153|20370180|P4|COMPLETED|Part 2: Open-label Period||0
8261533|NCT01791153|20370181|P3|COMPLETED|Part 2: Open-label Period||0
8261534|NCT01791153|20370182|P2|COMPLETED|Part 2: Open-label Period||0
8261535|NCT01791153|20370183|P1|COMPLETED|Part 2: Open-label Period||0
8261536|NCT01791153|20370176|P8|STARTED|Part 2: Open-label Period||67
8261537|NCT01791153|20370177|P7|STARTED|Part 2: Open-label Period||50
8261538|NCT01791153|20370178|P6|STARTED|Part 2: Open-label Period||58
8261539|NCT01791153|20370179|P5|STARTED|Part 2: Open-label Period||40
8261540|NCT01791153|20370180|P4|STARTED|Part 2: Open-label Period||0
8261541|NCT01791153|20370181|P3|STARTED|Part 2: Open-label Period||0
8261542|NCT01791153|20370182|P2|STARTED|Part 2: Open-label Period||0
8261543|NCT01791153|20370183|P1|STARTED|Part 2: Open-label Period||0
8261544|NCT01791153|20370176|P8|NOT COMPLETED|Part 1: Blinded Period||0
8261545|NCT01791153|20370177|P7|NOT COMPLETED|Part 1: Blinded Period||0
8261546|NCT01791153|20370178|P6|NOT COMPLETED|Part 1: Blinded Period||0
8261547|NCT01791153|20370179|P5|NOT COMPLETED|Part 1: Blinded Period||0
8261548|NCT01791153|20370180|P4|NOT COMPLETED|Part 1: Blinded Period||5
8261549|NCT01791153|20370181|P3|NOT COMPLETED|Part 1: Blinded Period||6
8261550|NCT01791153|20370182|P2|NOT COMPLETED|Part 1: Blinded Period||8
8261551|NCT01791153|20370183|P1|NOT COMPLETED|Part 1: Blinded Period||15
8261552|NCT01791153|20370176|P8|COMPLETED|Part 1: Blinded Period||0
8261553|NCT01791153|20370177|P7|COMPLETED|Part 1: Blinded Period||0
8261554|NCT01791153|20370178|P6|COMPLETED|Part 1: Blinded Period||0
8261555|NCT01791153|20370179|P5|COMPLETED|Part 1: Blinded Period||0
8261556|NCT01791153|20370180|P4|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
8261557|NCT01791153|20370181|P3|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
8261558|NCT01791153|20370182|P2|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
8261559|NCT01791153|20370183|P1|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
8261560|NCT01791153|20370176|P8|STARTED|Part 1: Blinded Period||0
8261561|NCT01791153|20370177|P7|STARTED|Part 1: Blinded Period||0
8261562|NCT01791153|20370178|P6|STARTED|Part 1: Blinded Period||0
8261563|NCT01791153|20370179|P5|STARTED|Part 1: Blinded Period||0
8261564|NCT01791153|20370180|P4|STARTED|Part 1: Blinded Period||51
8261565|NCT01791153|20370181|P3|STARTED|Part 1: Blinded Period||50
8261566|NCT01791153|20370182|P2|STARTED|Part 1: Blinded Period||49
8261567|NCT01791153|20370183|P1|STARTED|Part 1: Blinded Period||100
8261568|NCT01791127|20370243|P1|NOT COMPLETED|Overall Study||1472
8261569|NCT01791127|20370243|P1|COMPLETED|Overall Study||286
8261570|NCT01791127|20370243|P1|STARTED|Overall Study||1758
8261571|NCT01790932|20370267|P1|NOT COMPLETED|Overall Study||50
8261572|NCT01790932|20370267|P1|COMPLETED|Overall Study||0
8261573|NCT01790932|20370267|P1|STARTED|Overall Study||50
8261574|NCT01790828|20370273|P1|NOT COMPLETED|Overall Study||34
8261575|NCT01790828|20370273|P1|COMPLETED|Overall Study||8
8261576|NCT01790828|20370273|P1|STARTED|Overall Study||42
8261577|NCT01790750|20370296|P1|NOT COMPLETED|Overall Study||0
8261578|NCT01790750|20370296|P1|COMPLETED|Overall Study||50
8261579|NCT01790750|20370296|P1|STARTED|Overall Study||50
8261580|NCT01790685|20370303|P2|NOT COMPLETED|Overall Study||0
8261581|NCT01790685|20370304|P1|NOT COMPLETED|Overall Study||0
8261582|NCT01790685|20370303|P2|COMPLETED|Overall Study||17
8261583|NCT01790685|20370304|P1|COMPLETED|Overall Study||23
8261584|NCT01790685|20370303|P2|STARTED|Overall Study||17
8261585|NCT01790685|20370304|P1|STARTED|Overall Study||23
8261586|NCT01790659|20370312|P2|NOT COMPLETED|Overall Study||6
8261587|NCT01790659|20370313|P1|NOT COMPLETED|Overall Study||6
8261588|NCT01790659|20370312|P2|COMPLETED|Overall Study||192
8261589|NCT01790659|20370313|P1|COMPLETED|Overall Study||195
8261590|NCT01790659|20370312|P2|STARTED|Overall Study||198
8261591|NCT01790659|20370313|P1|STARTED|Overall Study||201
8261592|NCT01790633|20370331|P2|NOT COMPLETED|Overall Study||5
8261593|NCT01790633|20370332|P1|NOT COMPLETED|Overall Study||48
8261594|NCT01790633|20370331|P2|COMPLETED|Overall Study||159
8261595|NCT01790633|20370332|P1|COMPLETED|Overall Study||115
8261596|NCT01790633|20370331|P2|STARTED|Overall Study||164
8261597|NCT01790633|20370332|P1|STARTED|Overall Study||163
8261598|NCT01790594|20370345|P3|NOT COMPLETED|Overall Study||3
8261599|NCT01790594|20370346|P2|NOT COMPLETED|Overall Study||3
8261600|NCT01790594|20370347|P1|NOT COMPLETED|Overall Study||5
8261601|NCT01790594|20370345|P3|COMPLETED|Overall Study||0
8261603|NCT01790594|20370347|P1|COMPLETED|Overall Study||17
8261604|NCT01790594|20370345|P3|STARTED|Overall Study||3
8261605|NCT01790594|20370346|P2|STARTED|Overall Study||21
8261606|NCT01790594|20370347|P1|STARTED|Overall Study||22
8261607|NCT01790581|20370415|P2|NOT COMPLETED|Overall Study||0
8261608|NCT01790581|20370416|P1|NOT COMPLETED|Overall Study||0
8261609|NCT01790581|20370415|P2|COMPLETED|Overall Study||12
8261610|NCT01790581|20370416|P1|COMPLETED|Overall Study||12
8261611|NCT01790581|20370415|P2|STARTED|Overall Study||12
8261612|NCT01790581|20370416|P1|STARTED|Overall Study||12
8261613|NCT01790568|20370424|P2|NOT COMPLETED|Overall Study||1
8261614|NCT01790568|20370425|P1|NOT COMPLETED|Overall Study||0
8261615|NCT01790568|20370424|P2|COMPLETED|Overall Study||25
8261616|NCT01790568|20370425|P1|COMPLETED|Overall Study||12
8261617|NCT01790568|20370424|P2|STARTED|Overall Study||26
8261618|NCT01790568|20370425|P1|STARTED|Overall Study||12
8261619|NCT01790516|20370433|P2|NOT COMPLETED|Overall Study||0
8261620|NCT01790516|20370434|P1|NOT COMPLETED|Overall Study||1
8261621|NCT01790516|20370433|P2|COMPLETED|Overall Study||1
8261622|NCT01790516|20370434|P1|COMPLETED|Overall Study||0
8261623|NCT01790516|20370433|P2|STARTED|Overall Study||1
8261624|NCT01790516|20370434|P1|STARTED|Overall Study||1
8261625|NCT01790503|20370451|P11|NOT COMPLETED|Overall Study||16
8261626|NCT01790503|20370452|P10|NOT COMPLETED|Overall Study||26
8261627|NCT01790503|20370453|P9|NOT COMPLETED|Overall Study||3
8261628|NCT01790503|20370454|P8|NOT COMPLETED|Overall Study||1
8261629|NCT01790503|20370455|P7|NOT COMPLETED|Overall Study||1
8261630|NCT01790503|20370456|P6|NOT COMPLETED|Overall Study||5
8261631|NCT01790503|20370457|P5|NOT COMPLETED|Overall Study||5
8261632|NCT01790503|20370458|P4|NOT COMPLETED|Overall Study||2
8261633|NCT01790503|20370459|P3|NOT COMPLETED|Overall Study||1
8261634|NCT01790503|20370460|P2|NOT COMPLETED|Overall Study||1
8261635|NCT01790503|20370461|P1|NOT COMPLETED|Overall Study||3
8261636|NCT01790503|20370451|P11|COMPLETED|Overall Study||0
8261637|NCT01790503|20370452|P10|COMPLETED|Overall Study||1
8261638|NCT01790503|20370453|P9|COMPLETED|Overall Study||0
8261639|NCT01790503|20370454|P8|COMPLETED|Overall Study||0
8261640|NCT01790503|20370455|P7|COMPLETED|Overall Study||0
8261641|NCT01790503|20370456|P6|COMPLETED|Overall Study||0
8261642|NCT01790503|20370457|P5|COMPLETED|Overall Study||0
8261643|NCT01790503|20370458|P4|COMPLETED|Overall Study||0
8261644|NCT01790503|20370459|P3|COMPLETED|Overall Study||0
8261645|NCT01790503|20370460|P2|COMPLETED|Overall Study||0
8261646|NCT01790503|20370461|P1|COMPLETED|Overall Study||0
8261647|NCT01790503|20370451|P11|STARTED|Overall Study||16
8261648|NCT01790503|20370452|P10|STARTED|Overall Study||27
8261649|NCT01790503|20370453|P9|STARTED|Overall Study||3
8261650|NCT01790503|20370454|P8|STARTED|Overall Study||1
8261651|NCT01790503|20370455|P7|STARTED|Overall Study||1
8261652|NCT01790503|20370456|P6|STARTED|Overall Study||5
8261653|NCT01790503|20370457|P5|STARTED|Overall Study||5
8261654|NCT01790503|20370458|P4|STARTED|Overall Study||2
8261655|NCT01790503|20370459|P3|STARTED|Overall Study||1
8261656|NCT01790503|20370460|P2|STARTED|Overall Study||1
8261657|NCT01790503|20370461|P1|STARTED|Overall Study||3
8261658|NCT01790490|20370516|P3|NOT COMPLETED|Overall Study||0
8261659|NCT01790490|20370517|P2|NOT COMPLETED|Overall Study||0
8261660|NCT01790490|20370518|P1|NOT COMPLETED|Overall Study||0
8261661|NCT01790490|20370516|P3|COMPLETED|Overall Study||2
8261662|NCT01790490|20370517|P2|COMPLETED|Overall Study||3
8261663|NCT01790490|20370518|P1|COMPLETED|Overall Study||3
8261664|NCT01790490|20370516|P3|STARTED|Overall Study||2
8261665|NCT01790490|20370517|P2|STARTED|Overall Study||3
8261666|NCT01790490|20370518|P1|STARTED|Overall Study||3
8261667|NCT01790438|20370531|P2|NOT COMPLETED|Overall Study||11
8261668|NCT01790438|20370532|P1|NOT COMPLETED|Overall Study||35
8261669|NCT01790438|20370531|P2|COMPLETED|Overall Study||202
8261670|NCT01790438|20370532|P1|COMPLETED|Overall Study||393
8261671|NCT01790438|20370531|P2|Received at Least One Dose of Study Drug|Overall Study||212
8261672|NCT01790438|20370532|P1|Received at Least One Dose of Study Drug|Overall Study||427
8261673|NCT01790438|20370531|P2|STARTED|Overall Study||213
8261674|NCT01790438|20370532|P1|STARTED|Overall Study||428
8261675|NCT01790295|20370582|P1|NOT COMPLETED|Overall Study||11
8261676|NCT01790295|20370582|P1|COMPLETED|Overall Study||10
8261677|NCT01790295|20370582|P1|STARTED|Overall Study||21
8261678|NCT01790243|20370607|P2|NOT COMPLETED|Overall Study||43
8261679|NCT01790243|20370608|P1|NOT COMPLETED|Overall Study||290
8261680|NCT01790243|20370607|P2|COMPLETED|Overall Study||117
8261681|NCT01790243|20370608|P1|COMPLETED|Overall Study||739
8261682|NCT01790243|20370607|P2|STARTED|Overall Study||160
8261683|NCT01790243|20370608|P1|STARTED|Overall Study||1029
8261684|NCT01790178|20370634|P2|NOT COMPLETED|Overall Study||0
8261685|NCT01790178|20370635|P1|NOT COMPLETED|Overall Study||0
8261686|NCT01790178|20370634|P2|COMPLETED|Overall Study||24
8261687|NCT01790178|20370635|P1|COMPLETED|Overall Study||16
8261688|NCT01790178|20370634|P2|STARTED|Overall Study||24
8261689|NCT01790178|20370635|P1|STARTED|Overall Study||16
8261690|NCT01790126|20370652|P3|NOT COMPLETED|Overall Study||31
8261691|NCT01790126|20370653|P2|NOT COMPLETED|Overall Study||29
8261692|NCT01790126|20370654|P1|NOT COMPLETED|Overall Study||30
8261693|NCT01790126|20370652|P3|COMPLETED|Overall Study||0
8261694|NCT01790126|20370653|P2|COMPLETED|Overall Study||0
8261695|NCT01790126|20370654|P1|COMPLETED|Overall Study||0
8261696|NCT01790126|20370652|P3|Treated|Overall Study||31
8261697|NCT01790126|20370653|P2|Treated|Overall Study||29
8261698|NCT01790126|20370654|P1|Treated|Overall Study||29
8261699|NCT01790126|20370652|P3|STARTED|Overall Study||31
8261700|NCT01790126|20370653|P2|STARTED|Overall Study||29
8261701|NCT01790126|20370654|P1|STARTED|Overall Study||30
8261702|NCT01790048|20370711|P2|NOT COMPLETED|Overall Study||17
8261703|NCT01790048|20370712|P1|NOT COMPLETED|Overall Study||12
8261704|NCT01790048|20370711|P2|COMPLETED|Overall Study||1086
8261705|NCT01790048|20370712|P1|COMPLETED|Overall Study||1144
8261706|NCT01790048|20370711|P2|STARTED|Overall Study||1103
8261707|NCT01790048|20370712|P1|STARTED|Overall Study||1156
8261708|NCT01789970|20370730|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
8261709|NCT01789970|20370731|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
8261710|NCT01789970|20370732|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8261711|NCT01789970|20370730|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
8261712|NCT01789970|20370731|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
8261713|NCT01789970|20370732|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8261714|NCT01789970|20370730|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
8261715|NCT01789970|20370731|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
8261716|NCT01789970|20370732|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
8261717|NCT01789970|20370730|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
8261718|NCT01789970|20370731|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
8261719|NCT01789970|20370732|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
8261720|NCT01789970|20370730|P3|NOT COMPLETED|Open-label Titration Period||0
8261721|NCT01789970|20370731|P2|NOT COMPLETED|Open-label Titration Period||0
8261722|NCT01789970|20370732|P1|NOT COMPLETED|Open-label Titration Period||254
8261723|NCT01789970|20370730|P3|COMPLETED|Open-label Titration Period||0
8261724|NCT01789970|20370731|P2|COMPLETED|Open-label Titration Period||0
8261725|NCT01789970|20370732|P1|COMPLETED|Open-label Titration Period||371
8261726|NCT01789970|20370730|P3|Safety Analysis Set|Open-label Titration Period||0
8261727|NCT01789970|20370731|P2|Safety Analysis Set|Open-label Titration Period||0
8261728|NCT01789970|20370732|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
8261729|NCT01789970|20370730|P3|STARTED|Open-label Titration Period||0
8261730|NCT01789970|20370731|P2|STARTED|Open-label Titration Period||0
8261731|NCT01789970|20370732|P1|STARTED|Open-label Titration Period||625
8261732|NCT01789905|20370764|P1|NOT COMPLETED|Overall Study||0
8261733|NCT01789905|20370764|P1|COMPLETED|Overall Study||116
8261734|NCT01789905|20370764|P1|STARTED|Overall Study||116
8261735|NCT01789814|20370772|P2|NOT COMPLETED|Overall Study||0
8261736|NCT01789814|20370773|P1|NOT COMPLETED|Overall Study||0
8261737|NCT01789814|20370772|P2|COMPLETED|Overall Study||12
8261738|NCT01789814|20370773|P1|COMPLETED|Overall Study||12
8261739|NCT01789814|20370772|P2|STARTED|Overall Study||12
8261740|NCT01789814|20370773|P1|STARTED|Overall Study||12
8261741|NCT01789775|20370781|P2|NOT COMPLETED|Overall Study||7
8261742|NCT01789775|20370782|P1|NOT COMPLETED|Overall Study||2
8261743|NCT01789775|20370781|P2|COMPLETED|Overall Study||50
8261744|NCT01789775|20370782|P1|COMPLETED|Overall Study||53
8261745|NCT01789775|20370781|P2|STARTED|Overall Study||57
8261746|NCT01789775|20370782|P1|STARTED|Overall Study||55
8261747|NCT01789606|20370790|P2|NOT COMPLETED|Overall Study||450
8261748|NCT01789606|20370791|P1|NOT COMPLETED|Overall Study||23
8261749|NCT01789606|20370790|P2|COMPLETED|Overall Study||382
8261750|NCT01789606|20370791|P1|COMPLETED|Overall Study||228
8261751|NCT01789606|20370790|P2|STARTED|Overall Study||832
8261752|NCT01789606|20370791|P1|STARTED|Overall Study||251
8261753|NCT01789567|20370809|P1|NOT COMPLETED|Overall Study||6
8261754|NCT01789567|20370809|P1|COMPLETED|Overall Study||14
8261755|NCT01789567|20370809|P1|STARTED|Overall Study||20
8261756|NCT01789476|20370818|P2|NOT COMPLETED|Overall Study||2
8261757|NCT01789476|20370819|P1|NOT COMPLETED|Overall Study||8
8261758|NCT01789476|20370818|P2|COMPLETED|Overall Study||15
8261759|NCT01789476|20370819|P1|COMPLETED|Overall Study||26
8261760|NCT01789476|20370818|P2|STARTED|Overall Study||17
8261761|NCT01789476|20370819|P1|STARTED|Overall Study||34
8261762|NCT01789255|20370829|P1|NOT COMPLETED|Overall Study||0
8261763|NCT01789255|20370829|P1|COMPLETED|Overall Study||12
8261764|NCT01789255|20370829|P1|STARTED|Overall Study||12
8261765|NCT01789203|20370841|P2|NOT COMPLETED|Overall Study||4
8261766|NCT01789203|20370842|P1|NOT COMPLETED|Overall Study||9
8261767|NCT01789203|20370841|P2|COMPLETED|Overall Study||63
8261768|NCT01789203|20370842|P1|COMPLETED|Overall Study||124
8261769|NCT01789203|20370841|P2|STARTED|Overall Study||67
8261770|NCT01789203|20370842|P1|STARTED|Overall Study||133
8261771|NCT01789138|20370872|P2|NOT COMPLETED|Overall Study||52
8261772|NCT01789138|20370873|P1|NOT COMPLETED|Overall Study||41
8261773|NCT01789138|20370872|P2|COMPLETED|Overall Study||206
8261774|NCT01789138|20370873|P1|COMPLETED|Overall Study||213
8261775|NCT01789138|20370872|P2|STARTED|Overall Study||258
8261776|NCT01789138|20370873|P1|STARTED|Overall Study||254
8261777|NCT01789047|20370883|P2|NOT COMPLETED|Overall Study||4
8261778|NCT01789047|20370884|P1|NOT COMPLETED|Overall Study||4
8261779|NCT01789047|20370883|P2|COMPLETED|Overall Study||17
8261780|NCT01789047|20370884|P1|COMPLETED|Overall Study||17
8261781|NCT01789047|20370883|P2|STARTED|Overall Study||21
8261782|NCT01789047|20370884|P1|STARTED|Overall Study||21
8261783|NCT01788943|20370892|P2|NOT COMPLETED|Overall Study||0
8261784|NCT01788943|20370893|P1|NOT COMPLETED|Overall Study||1
8261785|NCT01788943|20370892|P2|COMPLETED|Overall Study||12
8261786|NCT01788943|20370893|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
8261787|NCT01788943|20370892|P2|STARTED|Overall Study||12
8261788|NCT01788943|20370893|P1|STARTED|Overall Study|Recruitment for study began.|13
8261789|NCT01788631|20370903|P2|NOT COMPLETED|Overall Study||1
8261790|NCT01788631|20370904|P1|NOT COMPLETED|Overall Study||3
8261791|NCT01788631|20370903|P2|COMPLETED|Overall Study||43
8261792|NCT01788631|20370904|P1|COMPLETED|Overall Study||49
8261793|NCT01788631|20370903|P2|Randomized|Overall Study||47
8261794|NCT01788631|20370904|P1|Randomized|Overall Study||53
8261795|NCT01788631|20370903|P2|STARTED|Overall Study||44
8261796|NCT01788631|20370904|P1|STARTED|Overall Study||52
8261797|NCT01788566|20370922|P1|NOT COMPLETED|Overall Study||8
8261798|NCT01788566|20370922|P1|COMPLETED|Overall Study||53
8261799|NCT01788566|20370922|P1|STARTED|Overall Study||61
8261800|NCT01788475|20370935|P3|NOT COMPLETED|Overall Study||0
8261801|NCT01788475|20370936|P2|NOT COMPLETED|Overall Study||0
8261802|NCT01788475|20370937|P1|NOT COMPLETED|Overall Study||3
8261803|NCT01788475|20370935|P3|COMPLETED|Overall Study||0
8261804|NCT01788475|20370936|P2|COMPLETED|Overall Study||0
8261805|NCT01788475|20370937|P1|COMPLETED|Overall Study||0
8261806|NCT01788475|20370935|P3|STARTED|Overall Study||0
8261807|NCT01788475|20370936|P2|STARTED|Overall Study||0
8261808|NCT01788475|20370937|P1|STARTED|Overall Study||3
8261809|NCT01788423|20370960|P3|NOT COMPLETED|Overall Study||5
8261810|NCT01788423|20370961|P2|NOT COMPLETED|Overall Study||4
8261811|NCT01788423|20370962|P1|NOT COMPLETED|Overall Study||0
8261812|NCT01788423|20370960|P3|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
8261813|NCT01788423|20370961|P2|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
8261814|NCT01788423|20370962|P1|COMPLETED|Overall Study||53
8261815|NCT01788423|20370960|P3|STARTED|Overall Study||55
8261816|NCT01788423|20370961|P2|STARTED|Overall Study||55
8261817|NCT01788423|20370962|P1|STARTED|Overall Study||53
8261818|NCT01788358|20370973|P1|NOT COMPLETED|Overall Study||98
8261819|NCT01788358|20370973|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
8261820|NCT01788358|20370973|P1|Completed Week 52|Overall Study||193
8261821|NCT01788358|20370973|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
8261822|NCT01788358|20370973|P1|Completed Week 28|Overall Study||417
8261823|NCT01788358|20370973|P1|Treated|Overall Study||508
8261824|NCT01788358|20370973|P1|STARTED|Overall Study||508
8261825|NCT01788228|20370987|P2|NOT COMPLETED|Overall Study||0
8261826|NCT01788228|20370988|P1|NOT COMPLETED|Overall Study||1
8261827|NCT01788228|20370987|P2|COMPLETED|Overall Study||1
8261828|NCT01788228|20370988|P1|COMPLETED|Overall Study||48
8261829|NCT01788228|20370987|P2|STARTED|Overall Study||1
8261830|NCT01788228|20370988|P1|STARTED|Overall Study||49
8261831|NCT01788215|20371021|P2|NOT COMPLETED|Overall Study||1
8261832|NCT01788215|20371022|P1|NOT COMPLETED|Overall Study||2
8261833|NCT01788215|20371021|P2|COMPLETED|Overall Study||4
8261834|NCT01788215|20371022|P1|COMPLETED|Overall Study||3
8261835|NCT01788215|20371021|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
8261836|NCT01788215|20371022|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
8261837|NCT01788215|20371021|P2|STARTED|Overall Study||5
8261838|NCT01788215|20371022|P1|STARTED|Overall Study||5
8261839|NCT01788163|20371051|P9|NOT COMPLETED|Overall Study||16
8261840|NCT01788163|20371052|P8|NOT COMPLETED|Overall Study||48
8261841|NCT01788163|20371053|P7|NOT COMPLETED|Overall Study||1
8261842|NCT01788163|20371054|P6|NOT COMPLETED|Overall Study||7
8261843|NCT01788163|20371055|P5|NOT COMPLETED|Overall Study||0
8261844|NCT01788163|20371056|P4|NOT COMPLETED|Overall Study||0
8261845|NCT01788163|20371057|P3|NOT COMPLETED|Overall Study||0
8261846|NCT01788163|20371058|P2|NOT COMPLETED|Overall Study||0
8261847|NCT01788163|20371059|P1|NOT COMPLETED|Overall Study||55
8261848|NCT01788163|20371051|P9|COMPLETED|Overall Study||956
8261849|NCT01788163|20371052|P8|COMPLETED|Overall Study||254
8261850|NCT01788163|20371053|P7|COMPLETED|Overall Study||49
8261851|NCT01788163|20371054|P6|COMPLETED|Overall Study||95
8261852|NCT01788163|20371055|P5|COMPLETED|Overall Study||94
8261853|NCT01788163|20371056|P4|COMPLETED|Overall Study||71
8261854|NCT01788163|20371057|P3|COMPLETED|Overall Study||62
8261855|NCT01788163|20371058|P2|COMPLETED|Overall Study||271
8261856|NCT01788163|20371059|P1|COMPLETED|Overall Study||1403
8261857|NCT01788163|20371051|P9|STARTED|Overall Study||972
8261858|NCT01788163|20371052|P8|STARTED|Overall Study||302
8261859|NCT01788163|20371053|P7|STARTED|Overall Study||50
8261860|NCT01788163|20371054|P6|STARTED|Overall Study||102
8261861|NCT01788163|20371055|P5|STARTED|Overall Study||94
8261862|NCT01788163|20371056|P4|STARTED|Overall Study||71
8261863|NCT01788163|20371057|P3|STARTED|Overall Study||62
8261864|NCT01788163|20371058|P2|STARTED|Overall Study||271
8261865|NCT01788163|20371059|P1|STARTED|Overall Study||1458
8261866|NCT01788046|20371222|P2|NOT COMPLETED|Overall Study||37
8261867|NCT01788046|20371223|P1|NOT COMPLETED|Overall Study||56
8261868|NCT01788046|20371222|P2|COMPLETED|Overall Study||218
8261869|NCT01788046|20371223|P1|COMPLETED|Overall Study||204
8261870|NCT01788046|20371222|P2|Received Treatment|Overall Study||252
8261871|NCT01788046|20371223|P1|Received Treatment|Overall Study||259
8261872|NCT01788046|20371222|P2|STARTED|Overall Study||255
8261873|NCT01788046|20371223|P1|STARTED|Overall Study||260
8261874|NCT01787916|20371239|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
8261875|NCT01787916|20371240|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
8261876|NCT01787916|20371239|P2|COMPLETED|Second Intervention (24 Weeks)||7
8261877|NCT01787916|20371240|P1|COMPLETED|Second Intervention (24 Weeks)||8
8261878|NCT01787916|20371239|P2|STARTED|Second Intervention (24 Weeks)||7
8261879|NCT01787916|20371240|P1|STARTED|Second Intervention (24 Weeks)||8
8261880|NCT01787916|20371239|P2|NOT COMPLETED|Washout (4 Weeks)||0
8261881|NCT01787916|20371240|P1|NOT COMPLETED|Washout (4 Weeks)||0
8261882|NCT01787916|20371239|P2|COMPLETED|Washout (4 Weeks)||7
8261883|NCT01787916|20371240|P1|COMPLETED|Washout (4 Weeks)||8
8261884|NCT01787916|20371239|P2|STARTED|Washout (4 Weeks)||7
8261885|NCT01787916|20371240|P1|STARTED|Washout (4 Weeks)||8
8261886|NCT01787916|20371239|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
8261887|NCT01787916|20371240|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
8261888|NCT01787916|20371239|P2|COMPLETED|First Intervention (24 Weeks)||7
8261889|NCT01787916|20371240|P1|COMPLETED|First Intervention (24 Weeks)||8
8261890|NCT01787916|20371239|P2|STARTED|First Intervention (24 Weeks)||7
8261891|NCT01787916|20371240|P1|STARTED|First Intervention (24 Weeks)||8
8261892|NCT01787838|20371246|P1|NOT COMPLETED|Overall Study||1413
8261893|NCT01787838|20371246|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
8261894|NCT01787838|20371246|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
8261895|NCT01787825|20371250|P2|NOT COMPLETED|Overall Study||1
8261896|NCT01787825|20371251|P1|NOT COMPLETED|Overall Study||6
8261897|NCT01787825|20371250|P2|COMPLETED|Overall Study||60
8261898|NCT01787825|20371251|P1|COMPLETED|Overall Study||54
8261899|NCT01787825|20371250|P2|STARTED|Overall Study||61
8261900|NCT01787825|20371251|P1|STARTED|Overall Study||60
8261901|NCT01787799|20371262|P1|NOT COMPLETED|Overall Study||0
8261902|NCT01787799|20371262|P1|COMPLETED|Overall Study||100
8261903|NCT01787799|20371262|P1|STARTED|Overall Study||100
8261904|NCT01787760|20371269|P3|NOT COMPLETED|Overall Study||5
8261905|NCT01787760|20371270|P2|NOT COMPLETED|Overall Study||16
8261906|NCT01787760|20371271|P1|NOT COMPLETED|Overall Study||26
8261907|NCT01787760|20371269|P3|COMPLETED|Overall Study||46
8261908|NCT01787760|20371270|P2|COMPLETED|Overall Study||34
8261909|NCT01787760|20371271|P1|COMPLETED|Overall Study||25
8261910|NCT01787760|20371269|P3|STARTED|Overall Study||51
8261911|NCT01787760|20371270|P2|STARTED|Overall Study||50
8261912|NCT01787760|20371271|P1|STARTED|Overall Study||51
8261913|NCT01787604|20371285|P2|NOT COMPLETED|Overall Study||4
8261914|NCT01787604|20371286|P1|NOT COMPLETED|Overall Study||4
8261915|NCT01787604|20371285|P2|COMPLETED|Overall Study||28
8261916|NCT01787604|20371286|P1|COMPLETED|Overall Study||28
8261917|NCT01787604|20371285|P2|STARTED|Overall Study||32
8261918|NCT01787604|20371286|P1|STARTED|Overall Study||32
8261919|NCT01787591|20371296|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261920|NCT01787591|20371297|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261921|NCT01787591|20371298|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261922|NCT01787591|20371299|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261923|NCT01787591|20371296|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261924|NCT01787591|20371297|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261925|NCT01787591|20371298|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261926|NCT01787591|20371299|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261927|NCT01787591|20371296|P4|STARTED|Period 4 (Cross-over Arm 4)||5
8261928|NCT01787591|20371297|P3|STARTED|Period 4 (Cross-over Arm 4)||5
8261929|NCT01787591|20371298|P2|STARTED|Period 4 (Cross-over Arm 4)||5
8261930|NCT01787591|20371299|P1|STARTED|Period 4 (Cross-over Arm 4)||5
8261931|NCT01787591|20371296|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261932|NCT01787591|20371297|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261933|NCT01787591|20371298|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261934|NCT01787591|20371299|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261935|NCT01787591|20371296|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261936|NCT01787591|20371297|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261937|NCT01787591|20371298|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261938|NCT01787591|20371299|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261939|NCT01787591|20371296|P4|STARTED|Period 3 (Cross-over Arm 3)||5
8261940|NCT01787591|20371297|P3|STARTED|Period 3 (Cross-over Arm 3)||5
8261941|NCT01787591|20371298|P2|STARTED|Period 3 (Cross-over Arm 3)||5
8261942|NCT01787591|20371299|P1|STARTED|Period 3 (Cross-over Arm 3)||5
8261943|NCT01787591|20371296|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261944|NCT01787591|20371297|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261945|NCT01787591|20371298|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261946|NCT01787591|20371299|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261947|NCT01787591|20371296|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261948|NCT01787591|20371297|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261949|NCT01787591|20371298|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261950|NCT01787591|20371299|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261951|NCT01787591|20371296|P4|STARTED|Period 2 (Cross-over Arm 2)||5
8261952|NCT01787591|20371297|P3|STARTED|Period 2 (Cross-over Arm 2)||5
8261953|NCT01787591|20371298|P2|STARTED|Period 2 (Cross-over Arm 2)||5
8261954|NCT01787591|20371299|P1|STARTED|Period 2 (Cross-over Arm 2)||5
8261955|NCT01787591|20371296|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
8261956|NCT01787591|20371297|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8261957|NCT01787591|20371298|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8261958|NCT01787591|20371299|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8261959|NCT01787591|20371296|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261960|NCT01787591|20371297|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261961|NCT01787591|20371298|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261962|NCT01787591|20371299|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261963|NCT01787591|20371296|P4|STARTED|Period 1 (Cross-over Arm 1)||6
8261964|NCT01787591|20371297|P3|STARTED|Period 1 (Cross-over Arm 1)||5
8261965|NCT01787591|20371298|P2|STARTED|Period 1 (Cross-over Arm 1)||5
8261966|NCT01787591|20371299|P1|STARTED|Period 1 (Cross-over Arm 1)||5
8261967|NCT01787552|20371329|P4|NOT COMPLETED|Overall Study||27
8261968|NCT01787552|20371330|P3|NOT COMPLETED|Overall Study||5
8261969|NCT01787552|20371331|P2|NOT COMPLETED|Overall Study||9
8261970|NCT01787552|20371332|P1|NOT COMPLETED|Overall Study||8
8261971|NCT01787552|20371329|P4|COMPLETED|Overall Study||0
8261972|NCT01787552|20371330|P3|COMPLETED|Overall Study||0
8261973|NCT01787552|20371331|P2|COMPLETED|Overall Study||1
8261974|NCT01787552|20371332|P1|COMPLETED|Overall Study||0
8261975|NCT01787552|20371329|P4|STARTED|Overall Study||27
8261976|NCT01787552|20371330|P3|STARTED|Overall Study||5
8261977|NCT01787552|20371331|P2|STARTED|Overall Study||10
8261978|NCT01787552|20371332|P1|STARTED|Overall Study||8
8261979|NCT01787461|20371402|P2|NOT COMPLETED|Overall Study||9
8261980|NCT01787461|20371403|P1|NOT COMPLETED|Overall Study||14
8261981|NCT01787461|20371402|P2|COMPLETED|Overall Study||89
8261982|NCT01787461|20371403|P1|COMPLETED|Overall Study||82
8261983|NCT01787461|20371402|P2|STARTED|Overall Study||98
8261984|NCT01787461|20371403|P1|STARTED|Overall Study||96
8261985|NCT01787383|20371431|P2|NOT COMPLETED|Overall Study||22
8261986|NCT01787383|20371432|P1|NOT COMPLETED|Overall Study||9
8261987|NCT01787383|20371431|P2|COMPLETED|Overall Study||76
8261988|NCT01787383|20371432|P1|COMPLETED|Overall Study||92
8261989|NCT01787383|20371431|P2|STARTED|Overall Study||98
8261990|NCT01787383|20371432|P1|STARTED|Overall Study||101
8261991|NCT01787331|20371452|P1|NOT COMPLETED|Overall Study||2
8261992|NCT01787331|20371452|P1|COMPLETED|Overall Study||19
8261993|NCT01787331|20371452|P1|STARTED|Overall Study||21
8261994|NCT01787292|20371464|P2|NOT COMPLETED|Home Based Exercise Program||1
8261995|NCT01787292|20371465|P1|NOT COMPLETED|Home Based Exercise Program||3
8261996|NCT01787292|20371464|P2|COMPLETED|Home Based Exercise Program||13
8261997|NCT01787292|20371465|P1|COMPLETED|Home Based Exercise Program||12
8261998|NCT01787292|20371464|P2|STARTED|Home Based Exercise Program||14
8261999|NCT01787292|20371465|P1|STARTED|Home Based Exercise Program||15
8262000|NCT01787292|20371464|P2|NOT COMPLETED|Crossover Exercise Interventions||2
8262001|NCT01787292|20371465|P1|NOT COMPLETED|Crossover Exercise Interventions||2
8262002|NCT01787292|20371464|P2|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
8262003|NCT01787292|20371465|P1|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
8262004|NCT01787292|20371464|P2|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
8262005|NCT01787292|20371465|P1|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
8262006|NCT01787279|20371482|P1|NOT COMPLETED|Overall Study||3
8262007|NCT01787279|20371482|P1|COMPLETED|Overall Study||56
8262008|NCT01787279|20371482|P1|STARTED|Overall Study||59
8262009|NCT01787240|20371493|P2|NOT COMPLETED|Overall Study||1
8262010|NCT01787240|20371494|P1|NOT COMPLETED|Overall Study||5
8262011|NCT01787240|20371493|P2|COMPLETED|Overall Study||4
8262012|NCT01787240|20371494|P1|COMPLETED|Overall Study||10
8262013|NCT01787240|20371493|P2|STARTED|Overall Study||5
8262014|NCT01787240|20371494|P1|STARTED|Overall Study||15
8262015|NCT01787188|20371508|P3|NOT COMPLETED|Overall Study||18
8262016|NCT01787188|20371509|P2|NOT COMPLETED|Overall Study||18
8262017|NCT01787188|20371510|P1|NOT COMPLETED|Overall Study||17
8262018|NCT01787188|20371508|P3|COMPLETED|Overall Study||116
8262019|NCT01787188|20371509|P2|COMPLETED|Overall Study||112
8262020|NCT01787188|20371510|P1|COMPLETED|Overall Study||122
8262021|NCT01787188|20371508|P3|STARTED|Overall Study||134
8262022|NCT01787188|20371509|P2|STARTED|Overall Study||130
8262023|NCT01787188|20371510|P1|STARTED|Overall Study||139
8262024|NCT01787175|20371565|P2|NOT COMPLETED|Overall Study||0
8262025|NCT01787175|20371566|P1|NOT COMPLETED|Overall Study||0
8262026|NCT01787175|20371565|P2|COMPLETED|Overall Study||28
8262027|NCT01787175|20371566|P1|COMPLETED|Overall Study||30
8262028|NCT01787175|20371565|P2|STARTED|Overall Study||28
8262029|NCT01787175|20371566|P1|STARTED|Overall Study||30
8262030|NCT01787097|20371576|P4|NOT COMPLETED|Overall Study||0
8262031|NCT01787097|20371577|P3|NOT COMPLETED|Overall Study||0
8262032|NCT01787097|20371578|P2|NOT COMPLETED|Overall Study||0
8262033|NCT01787097|20371579|P1|NOT COMPLETED|Overall Study||1
8262034|NCT01787097|20371576|P4|COMPLETED|Overall Study||9
8262035|NCT01787097|20371577|P3|COMPLETED|Overall Study||7
8262036|NCT01787097|20371578|P2|COMPLETED|Overall Study||7
8262037|NCT01787097|20371579|P1|COMPLETED|Overall Study|Study completed|7
8262038|NCT01787097|20371576|P4|STARTED|Overall Study||9
8262039|NCT01787097|20371577|P3|STARTED|Overall Study||7
8262040|NCT01787097|20371578|P2|STARTED|Overall Study||7
8262041|NCT01787097|20371579|P1|STARTED|Overall Study|Study started in 2012/2013|8
8262042|NCT01787032|20371611|P6|NOT COMPLETED|Overall Study||1
8262043|NCT01787032|20371612|P5|NOT COMPLETED|Overall Study||1
8262044|NCT01787032|20371613|P4|NOT COMPLETED|Overall Study||0
8262045|NCT01787032|20371614|P3|NOT COMPLETED|Overall Study||0
8262046|NCT01787032|20371615|P2|NOT COMPLETED|Overall Study||0
8262047|NCT01787032|20371616|P1|NOT COMPLETED|Overall Study||0
8262048|NCT01787032|20371611|P6|COMPLETED|Overall Study||3
8262049|NCT01787032|20371612|P5|COMPLETED|Overall Study||3
8262050|NCT01787032|20371613|P4|COMPLETED|Overall Study||3
8262051|NCT01787032|20371614|P3|COMPLETED|Overall Study||3
8262052|NCT01787032|20371615|P2|COMPLETED|Overall Study||3
8262053|NCT01787032|20371616|P1|COMPLETED|Overall Study||3
8262054|NCT01787032|20371611|P6|Received T2|Overall Study||4
8262055|NCT01787032|20371612|P5|Received T2|Overall Study||4
8262056|NCT01787032|20371613|P4|Received T2|Overall Study||3
8262057|NCT01787032|20371614|P3|Received T2|Overall Study||3
8262058|NCT01787032|20371615|P2|Received T2|Overall Study||3
8262059|NCT01787032|20371616|P1|Received T2|Overall Study||3
8262060|NCT01787032|20371611|P6|Received T1|Overall Study||4
8262061|NCT01787032|20371612|P5|Received T1|Overall Study||3
8262062|NCT01787032|20371613|P4|Received T1|Overall Study||3
8262063|NCT01787032|20371614|P3|Received T1|Overall Study||3
8262064|NCT01787032|20371615|P2|Received T1|Overall Study||3
8262065|NCT01787032|20371616|P1|Received T1|Overall Study||3
8262066|NCT01787032|20371611|P6|Received R|Overall Study||3
8262067|NCT01787032|20371612|P5|Received R|Overall Study||4
8262068|NCT01787032|20371613|P4|Received R|Overall Study||3
8262069|NCT01787032|20371614|P3|Received R|Overall Study||3
8262070|NCT01787032|20371615|P2|Received R|Overall Study||3
8262071|NCT01787032|20371616|P1|Received R|Overall Study||3
8262072|NCT01787032|20371611|P6|STARTED|Overall Study||4
8262073|NCT01787032|20371612|P5|STARTED|Overall Study||4
8262074|NCT01787032|20371613|P4|STARTED|Overall Study||3
8262075|NCT01787032|20371614|P3|STARTED|Overall Study||3
8262076|NCT01787032|20371615|P2|STARTED|Overall Study||3
8262077|NCT01787032|20371616|P1|STARTED|Overall Study||3
8262078|NCT01787006|20371640|P2|NOT COMPLETED|Overall Study||3
8262079|NCT01787006|20371641|P1|NOT COMPLETED|Overall Study||3
8262080|NCT01787006|20371640|P2|COMPLETED|Overall Study||36
8262081|NCT01787006|20371641|P1|COMPLETED|Overall Study||32
8262082|NCT01787006|20371640|P2|STARTED|Overall Study||39
8262083|NCT01787006|20371641|P1|STARTED|Overall Study||35
8262084|NCT01786993|20371669|P2|NOT COMPLETED|Overall Study||10
8262085|NCT01786993|20371670|P1|NOT COMPLETED|Overall Study||12
8262086|NCT01786993|20371669|P2|COMPLETED|Overall Study||170
8262087|NCT01786993|20371670|P1|COMPLETED|Overall Study||189
8262088|NCT01786993|20371669|P2|Per Protocol Population at 9 Months|Overall Study||170
8262089|NCT01786993|20371670|P1|Per Protocol Population at 9 Months|Overall Study||189
8262090|NCT01786993|20371669|P2|STARTED|Overall Study||180
8262091|NCT01786993|20371670|P1|STARTED|Overall Study||201
8262092|NCT01786967|20371677|P1|NOT COMPLETED|Overall Study||0
8262093|NCT01786967|20371677|P1|COMPLETED|Overall Study||61
8262094|NCT01786967|20371677|P1|Metabolizer Status Undetermined|Overall Study||3
8262095|NCT01786967|20371677|P1|Poor Metabolizers|Overall Study||4
8262096|NCT01786967|20371677|P1|Extensive Metabolizers|Overall Study||54
8262097|NCT01786967|20371677|P1|STARTED|Overall Study||61
8262098|NCT01786954|20371686|P2|NOT COMPLETED|Overall Study||0
8262099|NCT01786954|20371687|P1|NOT COMPLETED|Overall Study||0
8262100|NCT01786954|20371686|P2|COMPLETED|Overall Study||34
8262101|NCT01786954|20371687|P1|COMPLETED|Overall Study||34
8262102|NCT01786954|20371686|P2|STARTED|Overall Study||34
8262103|NCT01786954|20371687|P1|STARTED|Overall Study||34
8262104|NCT01786902|20371699|P2|NOT COMPLETED|Overall Study||3
8262105|NCT01786902|20371700|P1|NOT COMPLETED|Overall Study||4
8262106|NCT01786902|20371699|P2|COMPLETED|Overall Study||31
8262107|NCT01786902|20371700|P1|COMPLETED|Overall Study||32
8262108|NCT01786902|20371699|P2|STARTED|Overall Study||34
8262109|NCT01786902|20371700|P1|STARTED|Overall Study||36
8262110|NCT01786876|20371710|P1|NOT COMPLETED|Overall Study||0
8262111|NCT01786876|20371710|P1|COMPLETED|Overall Study||6
8262112|NCT01786876|20371710|P1|STARTED|Overall Study||6
8262113|NCT01786707|20371729|P2|NOT COMPLETED|Overall Study||1
8262114|NCT01786707|20371730|P1|NOT COMPLETED|Overall Study||1
8262115|NCT01786707|20371729|P2|COMPLETED|Overall Study||0
8262116|NCT01786707|20371730|P1|COMPLETED|Overall Study||0
8262117|NCT01786707|20371729|P2|STARTED|Overall Study||1
8262118|NCT01786707|20371730|P1|STARTED|Overall Study||1
8262119|NCT01786668|20371742|P4|NOT COMPLETED|Overall Study||4
8262120|NCT01786668|20371743|P3|NOT COMPLETED|Overall Study||5
8262121|NCT01786668|20371744|P2|NOT COMPLETED|Overall Study||1
8262122|NCT01786668|20371745|P1|NOT COMPLETED|Overall Study||1
8262123|NCT01786668|20371742|P4|COMPLETED|Overall Study||47
8262124|NCT01786668|20371743|P3|COMPLETED|Overall Study||47
8262125|NCT01786668|20371744|P2|COMPLETED|Overall Study||51
8262126|NCT01786668|20371745|P1|COMPLETED|Overall Study||51
8262127|NCT01786668|20371742|P4|STARTED|Overall Study||51
8262128|NCT01786668|20371743|P3|STARTED|Overall Study||52
8262129|NCT01786668|20371744|P2|STARTED|Overall Study||52
8262130|NCT01786668|20371745|P1|STARTED|Overall Study||52
8262131|NCT01786629|20371845|P2|NOT COMPLETED|Overall Study||5
8262132|NCT01786629|20371846|P1|NOT COMPLETED|Overall Study||0
8262133|NCT01786629|20371845|P2|COMPLETED|Overall Study||164
8262134|NCT01786629|20371846|P1|COMPLETED|Overall Study||169
8262135|NCT01786629|20371845|P2|STARTED|Overall Study||169
8262136|NCT01786629|20371846|P1|STARTED|Overall Study||169
8262137|NCT01786603|20371854|P2|NOT COMPLETED|Overall Study||12
8262138|NCT01786603|20371855|P1|NOT COMPLETED|Overall Study||18
8262139|NCT01786603|20371854|P2|COMPLETED|Overall Study||8
8262140|NCT01786603|20371855|P1|COMPLETED|Overall Study||42
8262141|NCT01786603|20371854|P2|STARTED|Overall Study||20
8262142|NCT01786603|20371855|P1|STARTED|Overall Study||60
8262143|NCT01786564|20371873|P1|NOT COMPLETED|Overall Study||64
8262144|NCT01786564|20371873|P1|COMPLETED|Overall Study||56
8262145|NCT01786564|20371873|P1|STARTED|Overall Study||120
8262146|NCT01786551|20371877|P1|NOT COMPLETED|Overall Study||2
8262147|NCT01786551|20371877|P1|COMPLETED|Overall Study||14
8262148|NCT01786551|20371877|P1|STARTED|Overall Study||16
8262149|NCT01786343|20371885|P2|NOT COMPLETED|Overall Study||0
8262150|NCT01786343|20371886|P1|NOT COMPLETED|Overall Study||0
8262151|NCT01786343|20371885|P2|COMPLETED|Overall Study||46
8262152|NCT01786343|20371886|P1|COMPLETED|Overall Study||28
8262153|NCT01786343|20371885|P2|STARTED|Overall Study||46
8262154|NCT01786343|20371886|P1|STARTED|Overall Study||28
8262155|NCT01786330|20371898|P2|NOT COMPLETED|Overall Study||3
8262156|NCT01786330|20371899|P1|NOT COMPLETED|Overall Study||1
8262157|NCT01786330|20371898|P2|COMPLETED|Overall Study||27
8262158|NCT01786330|20371899|P1|COMPLETED|Overall Study||29
8262159|NCT01786330|20371898|P2|STARTED|Overall Study||30
8262160|NCT01786330|20371899|P1|STARTED|Overall Study||30
8262161|NCT01786252|20371913|P2|NOT COMPLETED|Overall Study||0
8262162|NCT01786252|20371914|P1|NOT COMPLETED|Overall Study||0
8262163|NCT01786252|20371913|P2|COMPLETED|Overall Study||8
8262164|NCT01786252|20371914|P1|COMPLETED|Overall Study||7
8262165|NCT01786252|20371913|P2|STARTED|Overall Study||8
8262166|NCT01786252|20371914|P1|STARTED|Overall Study||7
8262167|NCT01786239|20371928|P2|NOT COMPLETED|Overall Study||11
8262168|NCT01786239|20371929|P1|NOT COMPLETED|Overall Study||11
8262169|NCT01786239|20371928|P2|COMPLETED|Overall Study||14
8262170|NCT01786239|20371929|P1|COMPLETED|Overall Study||14
8262171|NCT01786239|20371928|P2|STARTED|Overall Study||25
8262172|NCT01786239|20371929|P1|STARTED|Overall Study||25
8262173|NCT01786187|20371937|P2|NOT COMPLETED|Overall Study||10
8262174|NCT01786187|20371938|P1|NOT COMPLETED|Overall Study||5
8262175|NCT01786187|20371937|P2|COMPLETED|Overall Study||37
8262176|NCT01786187|20371938|P1|COMPLETED|Overall Study||35
8262177|NCT01786187|20371937|P2|STARTED|Overall Study||47
8262178|NCT01786187|20371938|P1|STARTED|Overall Study||40
8262179|NCT01786174|20371951|P2|NOT COMPLETED|Overall Study||0
8262180|NCT01786174|20371952|P1|NOT COMPLETED|Overall Study||2
8262181|NCT01786174|20371951|P2|COMPLETED|Overall Study||10
8262182|NCT01786174|20371952|P1|COMPLETED|Overall Study||16
8262183|NCT01786174|20371951|P2|Randomized|Overall Study||11
8262184|NCT01786174|20371952|P1|Randomized|Overall Study||19
8262185|NCT01786174|20371951|P2|STARTED|Overall Study||10
8262186|NCT01786174|20371952|P1|STARTED|Overall Study||18
8262187|NCT01786161|20371968|P2|NOT COMPLETED|Overall Study||0
8262188|NCT01786161|20371969|P1|NOT COMPLETED|Overall Study||0
8262189|NCT01786161|20371968|P2|COMPLETED|Overall Study||22
8262190|NCT01786161|20371969|P1|COMPLETED|Overall Study||22
8262191|NCT01786161|20371968|P2|STARTED|Overall Study||22
8262192|NCT01786161|20371969|P1|STARTED|Overall Study||22
8262193|NCT01786148|20371981|P2|NOT COMPLETED|Overall Study||22
8262194|NCT01786148|20371982|P1|NOT COMPLETED|Overall Study||22
8262195|NCT01786148|20371981|P2|COMPLETED|Overall Study||50
8262196|NCT01786148|20371982|P1|COMPLETED|Overall Study||55
8262197|NCT01786148|20371981|P2|STARTED|Overall Study||72
8262198|NCT01786148|20371982|P1|STARTED|Overall Study||77
8262199|NCT01786109|20371997|P3|NOT COMPLETED|Overall Study||2
8262200|NCT01786109|20371998|P2|NOT COMPLETED|Overall Study||0
8262201|NCT01786109|20371999|P1|NOT COMPLETED|Overall Study||1
8262202|NCT01786109|20371997|P3|COMPLETED|Overall Study||25
8262203|NCT01786109|20371998|P2|COMPLETED|Overall Study||24
8262204|NCT01786109|20371999|P1|COMPLETED|Overall Study||23
8262205|NCT01786109|20371997|P3|STARTED|Overall Study||27
8262206|NCT01786109|20371998|P2|STARTED|Overall Study||24
8262207|NCT01786109|20371999|P1|STARTED|Overall Study||24
8262208|NCT01785875|20372028|P3|NOT COMPLETED|Overall Study||107
8262209|NCT01785875|20372029|P2|NOT COMPLETED|Overall Study||289
8262210|NCT01785875|20372030|P1|NOT COMPLETED|Overall Study||294
8262211|NCT01785875|20372028|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
8262212|NCT01785875|20372029|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
8262213|NCT01785875|20372030|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
8262214|NCT01785875|20372028|P3|Received Etelcalcetide|Overall Study||123
8262215|NCT01785875|20372029|P2|Received Etelcalcetide|Overall Study||384
8262216|NCT01785875|20372030|P1|Received Etelcalcetide|Overall Study||383
8262217|NCT01785875|20372028|P3|STARTED|Overall Study||123
8262218|NCT01785875|20372029|P2|STARTED|Overall Study||384
8262219|NCT01785875|20372030|P1|STARTED|Overall Study||384
8262220|NCT01785849|20372099|P2|NOT COMPLETED|Overall Study||34
8262221|NCT01785849|20372100|P1|NOT COMPLETED|Overall Study||61
8262222|NCT01785849|20372099|P2|COMPLETED|Overall Study||220
8262223|NCT01785849|20372100|P1|COMPLETED|Overall Study||193
8262224|NCT01785849|20372099|P2|Received Treatment|Overall Study||251
8262225|NCT01785849|20372100|P1|Received Treatment|Overall Study||254
8262226|NCT01785849|20372099|P2|STARTED|Overall Study||254
8262227|NCT01785849|20372100|P1|STARTED|Overall Study||254
8262228|NCT01785810|20372116|P1|NOT COMPLETED|Overall Study||8
8262229|NCT01785810|20372116|P1|COMPLETED|Overall Study||29
8262230|NCT01785810|20372116|P1|STARTED|Overall Study||37
8262231|NCT01785680|20372122|P2|NOT COMPLETED|Overall Study||0
8262232|NCT01785680|20372123|P1|NOT COMPLETED|Overall Study||0
8262233|NCT01785680|20372122|P2|COMPLETED|Overall Study||857
8262234|NCT01785680|20372123|P1|COMPLETED|Overall Study||1100
8262235|NCT01785680|20372122|P2|STARTED|Overall Study||857
8262236|NCT01785680|20372123|P1|STARTED|Overall Study||1100
8262237|NCT01785628|20372137|P2|NOT COMPLETED|Overall Study||3
8262238|NCT01785628|20372138|P1|NOT COMPLETED|Overall Study||2
8262239|NCT01785628|20372137|P2|COMPLETED|Overall Study||12
8262240|NCT01785628|20372138|P1|COMPLETED|Overall Study||13
8262241|NCT01785628|20372137|P2|STARTED|Overall Study||15
8262242|NCT01785628|20372138|P1|STARTED|Overall Study||15
8262243|NCT01785615|20372161|P4|NOT COMPLETED|Atorvastatin Phase||0
8262244|NCT01785615|20372162|P3|NOT COMPLETED|Atorvastatin Phase||0
8262245|NCT01785615|20372163|P2|NOT COMPLETED|Atorvastatin Phase||0
8262246|NCT01785615|20372164|P1|NOT COMPLETED|Atorvastatin Phase||0
8262247|NCT01785615|20372161|P4|COMPLETED|Atorvastatin Phase||0
8262248|NCT01785615|20372162|P3|COMPLETED|Atorvastatin Phase||0
8262249|NCT01785615|20372163|P2|COMPLETED|Atorvastatin Phase||44
8262250|NCT01785615|20372164|P1|COMPLETED|Atorvastatin Phase||44
8262251|NCT01785615|20372161|P4|STARTED|Atorvastatin Phase||0
8262252|NCT01785615|20372162|P3|STARTED|Atorvastatin Phase||0
8262253|NCT01785615|20372163|P2|STARTED|Atorvastatin Phase||44
8262254|NCT01785615|20372164|P1|STARTED|Atorvastatin Phase||44
8262255|NCT01785615|20372161|P4|NOT COMPLETED|Dietary Phase||24
8262256|NCT01785615|20372162|P3|NOT COMPLETED|Dietary Phase||0
8262257|NCT01785615|20372163|P2|NOT COMPLETED|Dietary Phase||0
8262258|NCT01785615|20372164|P1|NOT COMPLETED|Dietary Phase||0
8262259|NCT01785615|20372161|P4|COMPLETED|Dietary Phase||116
8262260|NCT01785615|20372162|P3|COMPLETED|Dietary Phase||35
8262261|NCT01785615|20372163|P2|COMPLETED|Dietary Phase||0
8262262|NCT01785615|20372164|P1|COMPLETED|Dietary Phase||0
8262263|NCT01785615|20372161|P4|STARTED|Dietary Phase||140
8262264|NCT01785615|20372162|P3|STARTED|Dietary Phase||35
8262265|NCT01785615|20372163|P2|STARTED|Dietary Phase||0
8262266|NCT01785615|20372164|P1|STARTED|Dietary Phase||0
8262267|NCT01785602|20372236|P2|NOT COMPLETED|Overall Study||9
8262268|NCT01785602|20372237|P1|NOT COMPLETED|Overall Study||13
8262269|NCT01785602|20372236|P2|COMPLETED|Overall Study||18
8262270|NCT01785602|20372237|P1|COMPLETED|Overall Study||63
8262271|NCT01785602|20372236|P2|STARTED|Overall Study||27
8262272|NCT01785602|20372237|P1|STARTED|Overall Study||76
8262273|NCT01785524|20372247|P2|NOT COMPLETED|Overall Study||2
8262274|NCT01785524|20372248|P1|NOT COMPLETED|Overall Study||2
8262275|NCT01785524|20372247|P2|COMPLETED|Overall Study||2
8262276|NCT01785524|20372248|P1|COMPLETED|Overall Study||5
8262277|NCT01785524|20372247|P2|STARTED|Overall Study||4
8262278|NCT01785524|20372248|P1|STARTED|Overall Study||7
8262279|NCT01785472|20372267|P3|NOT COMPLETED|Overall Study||22
8262280|NCT01785472|20372268|P2|NOT COMPLETED|Overall Study||19
8262281|NCT01785472|20372269|P1|NOT COMPLETED|Overall Study||24
8262282|NCT01785472|20372267|P3|COMPLETED|Overall Study||464
8262283|NCT01785472|20372268|P2|COMPLETED|Overall Study||454
8262284|NCT01785472|20372269|P1|COMPLETED|Overall Study||455
8262285|NCT01785472|20372267|P3|Safety Set (SAF)|Overall Study||484
8262286|NCT01785472|20372268|P2|Safety Set (SAF)|Overall Study||472
8262287|NCT01785472|20372269|P1|Safety Set (SAF)|Overall Study||478
8262288|NCT01785472|20372267|P3|Full Analysis Set (FAS)|Overall Study||484
8262289|NCT01785472|20372268|P2|Full Analysis Set (FAS)|Overall Study||472
8262290|NCT01785472|20372269|P1|Full Analysis Set (FAS)|Overall Study||479
8262291|NCT01785472|20372267|P3|STARTED|Overall Study||486
8262292|NCT01785472|20372268|P2|STARTED|Overall Study||473
8262293|NCT01785472|20372269|P1|STARTED|Overall Study||479
8262294|NCT01785459|20372313|P2|NOT COMPLETED|Overall Study||0
8262295|NCT01785459|20372314|P1|NOT COMPLETED|Overall Study||0
8262296|NCT01785459|20372313|P2|COMPLETED|Overall Study||12
8262297|NCT01785459|20372314|P1|COMPLETED|Overall Study||11
8262298|NCT01785459|20372313|P2|STARTED|Overall Study||12
8262299|NCT01785459|20372314|P1|STARTED|Overall Study||11
8262300|NCT01785186|20372329|P5|NOT COMPLETED|Overall Study||6
8262301|NCT01785186|20372330|P4|NOT COMPLETED|Overall Study||5
8262302|NCT01785186|20372331|P3|NOT COMPLETED|Overall Study||5
8262303|NCT01785186|20372332|P2|NOT COMPLETED|Overall Study||6
8262304|NCT01785186|20372333|P1|NOT COMPLETED|Overall Study||6
8262305|NCT01785186|20372329|P5|COMPLETED|Overall Study||117
8262306|NCT01785186|20372330|P4|COMPLETED|Overall Study||58
8262307|NCT01785186|20372331|P3|COMPLETED|Overall Study||52
8262308|NCT01785186|20372332|P2|COMPLETED|Overall Study||57
8262309|NCT01785186|20372333|P1|COMPLETED|Overall Study||53
8262310|NCT01785186|20372329|P5|STARTED|Overall Study||123
8262311|NCT01785186|20372330|P4|STARTED|Overall Study||63
8262312|NCT01785186|20372331|P3|STARTED|Overall Study||57
8262313|NCT01785186|20372332|P2|STARTED|Overall Study||63
8262314|NCT01785186|20372333|P1|STARTED|Overall Study||59
8262315|NCT01785160|20372355|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
8262316|NCT01785160|20372355|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
8262317|NCT01785160|20372355|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
8262318|NCT01785160|20372355|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
8262319|NCT01785160|20372355|P1|COMPLETED|Washout Period of at Least 7 Days||23
8262320|NCT01785160|20372355|P1|STARTED|Washout Period of at Least 7 Days||24
8262321|NCT01785160|20372355|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
8262322|NCT01785160|20372355|P1|COMPLETED|Treatment Period 1: Raltegravir||24
8262323|NCT01785160|20372355|P1|STARTED|Treatment Period 1: Raltegravir||25
8262324|NCT01785134|20372365|P2|NOT COMPLETED|Overall Study||7
8262325|NCT01785134|20372366|P1|NOT COMPLETED|Overall Study||12
8262326|NCT01785134|20372365|P2|COMPLETED|Overall Study||33
8262327|NCT01785134|20372366|P1|COMPLETED|Overall Study||29
8262328|NCT01785134|20372365|P2|STARTED|Overall Study||40
8262329|NCT01785134|20372366|P1|STARTED|Overall Study||41
8262330|NCT01785095|20372380|P1|NOT COMPLETED|Overall Study||3
8262331|NCT01785095|20372380|P1|COMPLETED|Overall Study||24
8262332|NCT01785095|20372380|P1|STARTED|Overall Study||27
8262333|NCT01785069|20372392|P4|NOT COMPLETED|Overall Study||14
8262334|NCT01785069|20372393|P3|NOT COMPLETED|Overall Study||13
8262335|NCT01785069|20372394|P2|NOT COMPLETED|Overall Study||12
8262336|NCT01785069|20372395|P1|NOT COMPLETED|Overall Study||12
8262337|NCT01785069|20372392|P4|COMPLETED|Overall Study||54
8262338|NCT01785069|20372393|P3|COMPLETED|Overall Study||91
8262339|NCT01785069|20372394|P2|COMPLETED|Overall Study||64
8262340|NCT01785069|20372395|P1|COMPLETED|Overall Study||95
8262341|NCT01785069|20372392|P4|STARTED|Overall Study||68
8262342|NCT01785069|20372393|P3|STARTED|Overall Study||104
8262343|NCT01785069|20372394|P2|STARTED|Overall Study||76
8262344|NCT01785069|20372395|P1|STARTED|Overall Study||107
8262345|NCT01784991|20372423|P2|NOT COMPLETED|Overall Study||0
8262346|NCT01784991|20372424|P1|NOT COMPLETED|Overall Study||0
8262347|NCT01784991|20372423|P2|COMPLETED|Overall Study||0
8262348|NCT01784991|20372424|P1|COMPLETED|Overall Study||0
8262349|NCT01784991|20372423|P2|STARTED|Overall Study||0
8262350|NCT01784991|20372424|P1|STARTED|Overall Study||0
8262351|NCT01784965|20372444|P2|NOT COMPLETED|Overall Study||11
8262352|NCT01784965|20372445|P1|NOT COMPLETED|Overall Study||6
8262353|NCT01784965|20372444|P2|COMPLETED|Overall Study||24
8262354|NCT01784965|20372445|P1|COMPLETED|Overall Study||27
8262355|NCT01784965|20372444|P2|STARTED|Overall Study||35
8262356|NCT01784965|20372445|P1|STARTED|Overall Study||33
8262357|NCT01784926|20372457|P2|NOT COMPLETED|Overall Study||8
8262358|NCT01784926|20372458|P1|NOT COMPLETED|Overall Study||11
8262359|NCT01784926|20372457|P2|COMPLETED|Overall Study||42
8262360|NCT01784926|20372458|P1|COMPLETED|Overall Study||43
8262361|NCT01784926|20372457|P2|STARTED|Overall Study||50
8262362|NCT01784926|20372458|P1|STARTED|Overall Study||54
8262363|NCT01784848|20372476|P2|NOT COMPLETED|Overall Study||3
8262364|NCT01784848|20372477|P1|NOT COMPLETED|Overall Study||1
8262365|NCT01784848|20372476|P2|COMPLETED|Overall Study||47
8262366|NCT01784848|20372477|P1|COMPLETED|Overall Study||49
8262367|NCT01784848|20372476|P2|STARTED|Overall Study||50
8262368|NCT01784848|20372477|P1|STARTED|Overall Study||50
8262369|NCT01784796|20372485|P2|NOT COMPLETED|Overall Study||23
8262370|NCT01784796|20372486|P1|NOT COMPLETED|Overall Study||35
8262371|NCT01784796|20372485|P2|COMPLETED|Overall Study||35
8262372|NCT01784796|20372486|P1|COMPLETED|Overall Study||39
8262373|NCT01784796|20372485|P2|8 wk Data Collection|Overall Study||39
8262374|NCT01784796|20372486|P1|8 wk Data Collection|Overall Study||56
8262375|NCT01784796|20372485|P2|4 Week Data Collection|Overall Study||43
8262376|NCT01784796|20372486|P1|4 Week Data Collection|Overall Study||47
8262377|NCT01784796|20372485|P2|Baseline Data Collected|Overall Study||58
8262378|NCT01784796|20372486|P1|Baseline Data Collected|Overall Study||68
8262379|NCT01784796|20372485|P2|STARTED|Overall Study|These are participants who provided informed consent|58
8262380|NCT01784796|20372486|P1|STARTED|Overall Study|These are participants who provided informed consent|74
8262381|NCT01784770|20372498|P1|NOT COMPLETED|Overall Study||0
8262382|NCT01784770|20372498|P1|COMPLETED|Overall Study||21
8262383|NCT01784770|20372498|P1|STARTED|Overall Study||21
8262384|NCT01784666|20372506|P3|NOT COMPLETED|Overall Study||0
8262385|NCT01784666|20372507|P2|NOT COMPLETED|Overall Study||0
8262386|NCT01784666|20372508|P1|NOT COMPLETED|Overall Study||0
8262387|NCT01784666|20372506|P3|COMPLETED|Overall Study||1
8262388|NCT01784666|20372507|P2|COMPLETED|Overall Study||0
8262389|NCT01784666|20372508|P1|COMPLETED|Overall Study||1
8262390|NCT01784666|20372506|P3|STARTED|Overall Study||1
8262391|NCT01784666|20372507|P2|STARTED|Overall Study||0
8262392|NCT01784666|20372508|P1|STARTED|Overall Study||1
8262393|NCT01784614|20372516|P8|NOT COMPLETED|Period 4||0
8262394|NCT01784614|20372517|P7|NOT COMPLETED|Period 4||0
8262395|NCT01784614|20372518|P6|NOT COMPLETED|Period 4||0
8262396|NCT01784614|20372519|P5|NOT COMPLETED|Period 4||0
8262397|NCT01784614|20372520|P4|NOT COMPLETED|Period 4||0
8262398|NCT01784614|20372521|P3|NOT COMPLETED|Period 4||0
8262399|NCT01784614|20372522|P2|NOT COMPLETED|Period 4||0
8262400|NCT01784614|20372523|P1|NOT COMPLETED|Period 4||0
8262401|NCT01784614|20372516|P8|COMPLETED|Period 4||2
8262402|NCT01784614|20372517|P7|COMPLETED|Period 4||3
8262403|NCT01784614|20372518|P6|COMPLETED|Period 4||3
8262404|NCT01784614|20372519|P5|COMPLETED|Period 4||3
8262405|NCT01784614|20372520|P4|COMPLETED|Period 4||3
8262406|NCT01784614|20372521|P3|COMPLETED|Period 4||3
8262407|NCT01784614|20372522|P2|COMPLETED|Period 4||2
8262408|NCT01784614|20372523|P1|COMPLETED|Period 4||3
8262409|NCT01784614|20372516|P8|STARTED|Period 4||2
8262410|NCT01784614|20372517|P7|STARTED|Period 4||3
8262411|NCT01784614|20372518|P6|STARTED|Period 4||3
8262412|NCT01784614|20372519|P5|STARTED|Period 4||3
8262413|NCT01784614|20372520|P4|STARTED|Period 4||3
8262414|NCT01784614|20372521|P3|STARTED|Period 4||3
8262415|NCT01784614|20372522|P2|STARTED|Period 4||2
8262416|NCT01784614|20372523|P1|STARTED|Period 4||3
8262417|NCT01784614|20372516|P8|NOT COMPLETED|Period 3||0
8262418|NCT01784614|20372517|P7|NOT COMPLETED|Period 3||0
8262419|NCT01784614|20372518|P6|NOT COMPLETED|Period 3||0
8262420|NCT01784614|20372519|P5|NOT COMPLETED|Period 3||0
8262421|NCT01784614|20372520|P4|NOT COMPLETED|Period 3||0
8262422|NCT01784614|20372521|P3|NOT COMPLETED|Period 3||0
8262423|NCT01784614|20372522|P2|NOT COMPLETED|Period 3||0
8262424|NCT01784614|20372523|P1|NOT COMPLETED|Period 3||0
8262425|NCT01784614|20372516|P8|COMPLETED|Period 3||2
8262426|NCT01784614|20372517|P7|COMPLETED|Period 3||3
8262427|NCT01784614|20372518|P6|COMPLETED|Period 3||3
8262428|NCT01784614|20372519|P5|COMPLETED|Period 3||3
8262429|NCT01784614|20372520|P4|COMPLETED|Period 3||3
8262430|NCT01784614|20372521|P3|COMPLETED|Period 3||3
8262431|NCT01784614|20372522|P2|COMPLETED|Period 3||2
8262432|NCT01784614|20372523|P1|COMPLETED|Period 3||3
8262433|NCT01784614|20372516|P8|STARTED|Period 3||2
8262434|NCT01784614|20372517|P7|STARTED|Period 3||3
8262435|NCT01784614|20372518|P6|STARTED|Period 3||3
8262436|NCT01784614|20372519|P5|STARTED|Period 3||3
8262437|NCT01784614|20372520|P4|STARTED|Period 3||3
8262438|NCT01784614|20372521|P3|STARTED|Period 3||3
8262439|NCT01784614|20372522|P2|STARTED|Period 3||2
8262440|NCT01784614|20372523|P1|STARTED|Period 3||3
8262441|NCT01784614|20372516|P8|NOT COMPLETED|Period 2||0
8262442|NCT01784614|20372517|P7|NOT COMPLETED|Period 2||0
8262443|NCT01784614|20372518|P6|NOT COMPLETED|Period 2||0
8262444|NCT01784614|20372519|P5|NOT COMPLETED|Period 2||0
8262445|NCT01784614|20372520|P4|NOT COMPLETED|Period 2||0
8262446|NCT01784614|20372521|P3|NOT COMPLETED|Period 2||0
8262447|NCT01784614|20372522|P2|NOT COMPLETED|Period 2||0
8262448|NCT01784614|20372523|P1|NOT COMPLETED|Period 2||0
8262449|NCT01784614|20372516|P8|COMPLETED|Period 2||2
8262450|NCT01784614|20372517|P7|COMPLETED|Period 2||3
8262451|NCT01784614|20372518|P6|COMPLETED|Period 2||3
8262452|NCT01784614|20372519|P5|COMPLETED|Period 2||3
8262453|NCT01784614|20372520|P4|COMPLETED|Period 2||3
8262454|NCT01784614|20372521|P3|COMPLETED|Period 2||3
8262455|NCT01784614|20372522|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
8262456|NCT01784614|20372523|P1|COMPLETED|Period 2||3
8262457|NCT01784614|20372516|P8|STARTED|Period 2||2
8262458|NCT01784614|20372517|P7|STARTED|Period 2||3
8262459|NCT01784614|20372518|P6|STARTED|Period 2||3
8262460|NCT01784614|20372519|P5|STARTED|Period 2||3
8262461|NCT01784614|20372520|P4|STARTED|Period 2||3
8262462|NCT01784614|20372521|P3|STARTED|Period 2||3
8262463|NCT01784614|20372522|P2|STARTED|Period 2||3
8262464|NCT01784614|20372523|P1|STARTED|Period 2||3
8262465|NCT01784614|20372516|P8|NOT COMPLETED|Period 1||0
8262466|NCT01784614|20372517|P7|NOT COMPLETED|Period 1||0
8262467|NCT01784614|20372518|P6|NOT COMPLETED|Period 1||0
8262468|NCT01784614|20372519|P5|NOT COMPLETED|Period 1||0
8262469|NCT01784614|20372520|P4|NOT COMPLETED|Period 1||0
8262470|NCT01784614|20372521|P3|NOT COMPLETED|Period 1||0
8262471|NCT01784614|20372522|P2|NOT COMPLETED|Period 1||0
8262472|NCT01784614|20372523|P1|NOT COMPLETED|Period 1||0
8262473|NCT01784614|20372516|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
8262474|NCT01784614|20372517|P7|COMPLETED|Period 1||3
8262475|NCT01784614|20372518|P6|COMPLETED|Period 1||3
8262476|NCT01784614|20372519|P5|COMPLETED|Period 1||3
8262477|NCT01784614|20372520|P4|COMPLETED|Period 1||3
8262478|NCT01784614|20372521|P3|COMPLETED|Period 1||3
8262479|NCT01784614|20372522|P2|COMPLETED|Period 1||3
8262480|NCT01784614|20372523|P1|COMPLETED|Period 1||3
8262481|NCT01784614|20372516|P8|Received at Least 1 Dose of Study Drug|Period 1||3
8262482|NCT01784614|20372517|P7|Received at Least 1 Dose of Study Drug|Period 1||3
8262483|NCT01784614|20372518|P6|Received at Least 1 Dose of Study Drug|Period 1||3
8262484|NCT01784614|20372519|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8262485|NCT01784614|20372520|P4|Received at Least 1 Dose of Study Drug|Period 1||3
8262486|NCT01784614|20372521|P3|Received at Least 1 Dose of Study Drug|Period 1||3
8262487|NCT01784614|20372522|P2|Received at Least 1 Dose of Study Drug|Period 1||3
8262488|NCT01784614|20372523|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8262489|NCT01784614|20372516|P8|STARTED|Period 1||3
8262490|NCT01784614|20372517|P7|STARTED|Period 1||3
8262491|NCT01784614|20372518|P6|STARTED|Period 1||3
8262492|NCT01784614|20372519|P5|STARTED|Period 1||3
8262493|NCT01784614|20372520|P4|STARTED|Period 1||3
8262494|NCT01784614|20372521|P3|STARTED|Period 1||3
8262495|NCT01784614|20372522|P2|STARTED|Period 1||3
8262496|NCT01784614|20372523|P1|STARTED|Period 1||3
8262503|NCT01784419|20372566|P1|NOT COMPLETED|Overall Study||3
8262504|NCT01784419|20372566|P1|COMPLETED|Overall Study||7
8262505|NCT01784419|20372566|P1|STARTED|Overall Study||10
8262506|NCT01784211|20372574|P6|NOT COMPLETED|Part B (Days 16-21)||0
8262507|NCT01784211|20372575|P5|NOT COMPLETED|Part B (Days 16-21)||0
8262508|NCT01784211|20372576|P4|NOT COMPLETED|Part B (Days 16-21)||0
8262509|NCT01784211|20372577|P3|NOT COMPLETED|Part B (Days 16-21)||0
8262510|NCT01784211|20372578|P2|NOT COMPLETED|Part B (Days 16-21)||0
8262511|NCT01784211|20372579|P1|NOT COMPLETED|Part B (Days 16-21)||0
8262512|NCT01784211|20372574|P6|COMPLETED|Part B (Days 16-21)||10
8262513|NCT01784211|20372575|P5|COMPLETED|Part B (Days 16-21)||11
8262514|NCT01784211|20372576|P4|COMPLETED|Part B (Days 16-21)||9
8262515|NCT01784211|20372577|P3|COMPLETED|Part B (Days 16-21)||10
8262516|NCT01784211|20372578|P2|COMPLETED|Part B (Days 16-21)||0
8262517|NCT01784211|20372579|P1|COMPLETED|Part B (Days 16-21)||0
8262518|NCT01784211|20372574|P6|STARTED|Part B (Days 16-21)||10
8262519|NCT01784211|20372575|P5|STARTED|Part B (Days 16-21)||11
8262520|NCT01784211|20372576|P4|STARTED|Part B (Days 16-21)||9
8262521|NCT01784211|20372577|P3|STARTED|Part B (Days 16-21)||10
8262522|NCT01784211|20372578|P2|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
8262523|NCT01784211|20372579|P1|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
8262524|NCT01784211|20372574|P6|NOT COMPLETED|Part A (Days 1-15)||0
8262525|NCT01784211|20372575|P5|NOT COMPLETED|Part A (Days 1-15)||0
8262526|NCT01784211|20372576|P4|NOT COMPLETED|Part A (Days 1-15)||0
8262527|NCT01784211|20372577|P3|NOT COMPLETED|Part A (Days 1-15)||0
8262528|NCT01784211|20372578|P2|NOT COMPLETED|Part A (Days 1-15)||2
8262529|NCT01784211|20372579|P1|NOT COMPLETED|Part A (Days 1-15)||3
8262530|NCT01784211|20372574|P6|COMPLETED|Part A (Days 1-15)||0
8262531|NCT01784211|20372575|P5|COMPLETED|Part A (Days 1-15)||0
8262532|NCT01784211|20372576|P4|COMPLETED|Part A (Days 1-15)||0
8262533|NCT01784211|20372577|P3|COMPLETED|Part A (Days 1-15)||0
8262534|NCT01784211|20372578|P2|COMPLETED|Part A (Days 1-15)||36
8262535|NCT01784211|20372579|P1|COMPLETED|Part A (Days 1-15)||35
8262536|NCT01784211|20372574|P6|Entered Part B|Part A (Days 1-15)||0
8262537|NCT01784211|20372575|P5|Entered Part B|Part A (Days 1-15)||0
8262538|NCT01784211|20372576|P4|Entered Part B|Part A (Days 1-15)||0
8262539|NCT01784211|20372577|P3|Entered Part B|Part A (Days 1-15)||0
8262540|NCT01784211|20372578|P2|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
8262541|NCT01784211|20372579|P1|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
8262542|NCT01784211|20372574|P6|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262543|NCT01784211|20372575|P5|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262544|NCT01784211|20372576|P4|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262545|NCT01784211|20372577|P3|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262546|NCT01784211|20372578|P2|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
8262547|NCT01784211|20372579|P1|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
8262548|NCT01784211|20372574|P6|STARTED|Part A (Days 1-15)||0
8262549|NCT01784211|20372575|P5|STARTED|Part A (Days 1-15)||0
8262550|NCT01784211|20372576|P4|STARTED|Part A (Days 1-15)||0
8262551|NCT01784211|20372577|P3|STARTED|Part A (Days 1-15)||0
8262552|NCT01784211|20372578|P2|STARTED|Part A (Days 1-15)||38
8262553|NCT01784211|20372579|P1|STARTED|Part A (Days 1-15)||38
8262566|NCT01784055|20372609|P1|NOT COMPLETED|Overall Study||26
8262567|NCT01784055|20372609|P1|COMPLETED|Overall Study||100
8262568|NCT01784055|20372609|P1|STARTED|Overall Study||126
8262569|NCT01784029|20372616|P3|NOT COMPLETED|Overall Study||22
8262570|NCT01784029|20372617|P2|NOT COMPLETED|Overall Study||20
8262571|NCT01784029|20372618|P1|NOT COMPLETED|Overall Study||19
8262572|NCT01784029|20372616|P3|COMPLETED|Overall Study||41
8262573|NCT01784029|20372617|P2|COMPLETED|Overall Study||39
8262574|NCT01784029|20372618|P1|COMPLETED|Overall Study||42
8262575|NCT01784029|20372616|P3|STARTED|Overall Study||63
8262576|NCT01784029|20372617|P2|STARTED|Overall Study||59
8262577|NCT01784029|20372618|P1|STARTED|Overall Study||61
8262578|NCT01783990|20372628|P2|NOT COMPLETED|Overall Study||2
8262579|NCT01783990|20372629|P1|NOT COMPLETED|Overall Study||5
8262580|NCT01783990|20372628|P2|COMPLETED|Overall Study||18
8262581|NCT01783990|20372629|P1|COMPLETED|Overall Study||125
8262582|NCT01783990|20372628|P2|STARTED|Overall Study||20
8262583|NCT01783990|20372629|P1|STARTED|Overall Study||130
8262584|NCT01783938|20372647|P2|NOT COMPLETED|Overall Study||53
8262585|NCT01783938|20372648|P1|NOT COMPLETED|Overall Study||47
8262586|NCT01783938|20372647|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
8262587|NCT01783938|20372648|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
8262588|NCT01783938|20372647|P2|STARTED|Overall Study||70
8262589|NCT01783938|20372648|P1|STARTED|Overall Study||68
8262590|NCT01783912|20372663|P3|NOT COMPLETED|Overall Study||23
8262591|NCT01783912|20372664|P2|NOT COMPLETED|Overall Study||46
8262592|NCT01783912|20372665|P1|NOT COMPLETED|Overall Study||30
8262593|NCT01783912|20372663|P3|COMPLETED|Overall Study||25
8262594|NCT01783912|20372664|P2|COMPLETED|Overall Study||58
8262595|NCT01783912|20372665|P1|COMPLETED|Overall Study||88
8262596|NCT01783912|20372663|P3|STARTED|Overall Study||48
8262597|NCT01783912|20372664|P2|STARTED|Overall Study||104
8262598|NCT01783912|20372665|P1|STARTED|Overall Study||118
8262599|NCT01783886|20372676|P3|NOT COMPLETED|Overall Study||10
8262600|NCT01783886|20372677|P2|NOT COMPLETED|Overall Study||11
8262601|NCT01783886|20372678|P1|NOT COMPLETED|Overall Study||5
8262602|NCT01783886|20372676|P3|COMPLETED|Overall Study||117
8262603|NCT01783886|20372677|P2|COMPLETED|Overall Study||116
8262604|NCT01783886|20372678|P1|COMPLETED|Overall Study||122
8262605|NCT01783886|20372676|P3|Participants Received Treatment|Overall Study||124
8262606|NCT01783886|20372677|P2|Participants Received Treatment|Overall Study||127
8262607|NCT01783886|20372678|P1|Participants Received Treatment|Overall Study||127
8262608|NCT01783886|20372676|P3|STARTED|Overall Study||127
8262609|NCT01783886|20372677|P2|STARTED|Overall Study||127
8262610|NCT01783886|20372678|P1|STARTED|Overall Study||127
8262611|NCT01783860|20372706|P2|NOT COMPLETED|Overall Study||0
8262612|NCT01783860|20372707|P1|NOT COMPLETED|Overall Study||0
8262613|NCT01783860|20372706|P2|COMPLETED|Overall Study||50
8262614|NCT01783860|20372707|P1|COMPLETED|Overall Study||50
8262615|NCT01783860|20372706|P2|STARTED|Overall Study||50
8262616|NCT01783860|20372707|P1|STARTED|Overall Study||50
8262617|NCT01783847|20372726|P3|NOT COMPLETED|Overall Study||0
8262618|NCT01783847|20372727|P2|NOT COMPLETED|Overall Study||1
8262619|NCT01783847|20372728|P1|NOT COMPLETED|Overall Study||16
8262620|NCT01783847|20372726|P3|COMPLETED|Overall Study||16
8262621|NCT01783847|20372727|P2|COMPLETED|Overall Study||15
8262622|NCT01783847|20372728|P1|COMPLETED|Overall Study||69
8262623|NCT01783847|20372726|P3|STARTED|Overall Study||16
8262624|NCT01783847|20372727|P2|STARTED|Overall Study||16
8262625|NCT01783847|20372728|P1|STARTED|Overall Study||85
8262626|NCT01783821|20372741|P2|NOT COMPLETED|Overall Study||1
8262627|NCT01783821|20372742|P1|NOT COMPLETED|Overall Study||1
8262628|NCT01783821|20372741|P2|COMPLETED|Overall Study||30
8262629|NCT01783821|20372742|P1|COMPLETED|Overall Study||29
8262630|NCT01783821|20372741|P2|STARTED|Overall Study||31
8262631|NCT01783821|20372742|P1|STARTED|Overall Study||30
8262632|NCT01783743|20372760|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
8262633|NCT01783743|20372761|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
8262634|NCT01783743|20372760|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
8262635|NCT01783743|20372761|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
8262636|NCT01783743|20372760|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
8262637|NCT01783743|20372761|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
8262638|NCT01783743|20372760|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
8262639|NCT01783743|20372761|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
8262640|NCT01783743|20372760|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
8262641|NCT01783743|20372761|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
8262642|NCT01783743|20372760|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
8262643|NCT01783743|20372761|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
8262644|NCT01783743|20372760|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
8262645|NCT01783743|20372761|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
8262646|NCT01783743|20372760|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
8262647|NCT01783743|20372761|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
8262648|NCT01783743|20372760|P2|STARTED|Screening of Subjects by CTA During MDA||13964
8262649|NCT01783743|20372761|P1|STARTED|Screening of Subjects by CTA During MDA||13509
8262650|NCT01783730|20372775|P1|NOT COMPLETED|Overall Study||6
8262651|NCT01783730|20372775|P1|COMPLETED|Overall Study||157
8262652|NCT01783730|20372775|P1|STARTED|Overall Study||163
8262653|NCT01783678|20372800|P6|NOT COMPLETED|Overall Study||5
8262654|NCT01783678|20372801|P5|NOT COMPLETED|Overall Study||7
8262655|NCT01783678|20372802|P4|NOT COMPLETED|Overall Study||8
8262656|NCT01783678|20372803|P3|NOT COMPLETED|Overall Study||1
8262657|NCT01783678|20372804|P2|NOT COMPLETED|Overall Study||18
8262658|NCT01783678|20372805|P1|NOT COMPLETED|Overall Study||2
8262659|NCT01783678|20372800|P6|COMPLETED|Overall Study||26
8262660|NCT01783678|20372801|P5|COMPLETED|Overall Study||42
8262661|NCT01783678|20372802|P4|COMPLETED|Overall Study||50
8262662|NCT01783678|20372803|P3|COMPLETED|Overall Study||5
8262663|NCT01783678|20372804|P2|COMPLETED|Overall Study||94
8262664|NCT01783678|20372805|P1|COMPLETED|Overall Study||17
8262665|NCT01783678|20372800|P6|STARTED|Overall Study||31
8262666|NCT01783678|20372801|P5|STARTED|Overall Study||49
8262667|NCT01783678|20372802|P4|STARTED|Overall Study||58
8262668|NCT01783678|20372803|P3|STARTED|Overall Study||6
8262669|NCT01783678|20372804|P2|STARTED|Overall Study||112
8262670|NCT01783678|20372805|P1|STARTED|Overall Study||19
8262671|NCT01783639|20372877|P1|NOT COMPLETED|Overall Study||0
8262672|NCT01783639|20372877|P1|COMPLETED|Overall Study||120
8262673|NCT01783639|20372877|P1|STARTED|Overall Study||120
8262674|NCT01783574|20372883|P2|NOT COMPLETED|Overall Study||9
8262675|NCT01783574|20372884|P1|NOT COMPLETED|Overall Study||5
8262676|NCT01783574|20372883|P2|COMPLETED|Overall Study||41
8262677|NCT01783574|20372884|P1|COMPLETED|Overall Study||46
8262678|NCT01783574|20372883|P2|STARTED|Overall Study||50
8262679|NCT01783574|20372884|P1|STARTED|Overall Study||51
8262680|NCT01783561|20372896|P2|NOT COMPLETED|Overall Study||0
8262681|NCT01783561|20372897|P1|NOT COMPLETED|Overall Study||0
8262682|NCT01783561|20372896|P2|COMPLETED|Overall Study||10
8262683|NCT01783561|20372897|P1|COMPLETED|Overall Study||11
8262684|NCT01783561|20372896|P2|STARTED|Overall Study||10
8262685|NCT01783561|20372897|P1|STARTED|Overall Study||11
8262686|NCT01783548|20372909|P2|NOT COMPLETED|Overall Study||18
8262687|NCT01783548|20372910|P1|NOT COMPLETED|Overall Study||34
8262688|NCT01783548|20372909|P2|COMPLETED|Overall Study||167
8262689|NCT01783548|20372910|P1|COMPLETED|Overall Study||328
8262690|NCT01783548|20372909|P2|Full Analysis Set (FAS)|Overall Study||184
8262691|NCT01783548|20372910|P1|Full Analysis Set (FAS)|Overall Study||358
8262692|NCT01783548|20372909|P2|STARTED|Overall Study|Randomized|185
8262693|NCT01783548|20372910|P1|STARTED|Overall Study|Randomized|362
8262694|NCT01783522|20372924|P2|NOT COMPLETED|Overall Study||0
8262695|NCT01783522|20372925|P1|NOT COMPLETED|Overall Study||0
8262696|NCT01783522|20372924|P2|COMPLETED|Overall Study||5
8262697|NCT01783522|20372925|P1|COMPLETED|Overall Study||4
8262698|NCT01783522|20372924|P2|STARTED|Overall Study||5
8262699|NCT01783522|20372925|P1|STARTED|Overall Study||4
8262700|NCT01783496|20372943|P6|NOT COMPLETED|Overall Study||1
8262701|NCT01783496|20372944|P5|NOT COMPLETED|Overall Study||0
8262702|NCT01783496|20372945|P4|NOT COMPLETED|Overall Study||2
8262703|NCT01783496|20372946|P3|NOT COMPLETED|Overall Study||0
8262704|NCT01783496|20372947|P2|NOT COMPLETED|Overall Study||0
8262705|NCT01783496|20372948|P1|NOT COMPLETED|Overall Study||1
8262706|NCT01783496|20372943|P6|COMPLETED|Overall Study||4
8262707|NCT01783496|20372944|P5|COMPLETED|Overall Study||5
8262708|NCT01783496|20372945|P4|COMPLETED|Overall Study||8
8262709|NCT01783496|20372946|P3|COMPLETED|Overall Study||10
8262710|NCT01783496|20372947|P2|COMPLETED|Overall Study||10
8262711|NCT01783496|20372948|P1|COMPLETED|Overall Study||9
8262712|NCT01783496|20372943|P6|STARTED|Overall Study||5
8262713|NCT01783496|20372944|P5|STARTED|Overall Study||5
8262714|NCT01783496|20372945|P4|STARTED|Overall Study||10
8262715|NCT01783496|20372946|P3|STARTED|Overall Study||10
8262716|NCT01783496|20372947|P2|STARTED|Overall Study||10
8262717|NCT01783496|20372948|P1|STARTED|Overall Study||10
8262718|NCT01783483|20372976|P2|NOT COMPLETED|Overall Study||15
8262719|NCT01783483|20372977|P1|NOT COMPLETED|Overall Study||20
8262720|NCT01783483|20372976|P2|COMPLETED|Overall Study||101
8262721|NCT01783483|20372977|P1|COMPLETED|Overall Study||100
8262722|NCT01783483|20372976|P2|STARTED|Overall Study||116
8262723|NCT01783483|20372977|P1|STARTED|Overall Study||120
8262724|NCT01783470|20373005|P2|NOT COMPLETED|Overall Study||0
8262725|NCT01783470|20373006|P1|NOT COMPLETED|Overall Study||0
8262726|NCT01783470|20373005|P2|COMPLETED|Overall Study||6
8262727|NCT01783470|20373006|P1|COMPLETED|Overall Study||6
8262728|NCT01783470|20373005|P2|STARTED|Overall Study|Single-dose|6
8262729|NCT01783470|20373006|P1|STARTED|Overall Study||6
8262730|NCT01783418|20373015|P2|NOT COMPLETED|Overall Study||0
8262731|NCT01783418|20373016|P1|NOT COMPLETED|Overall Study||1
8262732|NCT01783418|20373015|P2|COMPLETED|Overall Study||6
8262733|NCT01783418|20373016|P1|COMPLETED|Overall Study||7
8262734|NCT01783418|20373015|P2|STARTED|Overall Study||6
8262735|NCT01783418|20373016|P1|STARTED|Overall Study||8
8262736|NCT01783236|20373036|P2|NOT COMPLETED|Overall Study||0
8262737|NCT01783236|20373037|P1|NOT COMPLETED|Overall Study||2
8262738|NCT01783236|20373036|P2|COMPLETED|Overall Study||8
8262739|NCT01783236|20373037|P1|COMPLETED|Overall Study||6
8262740|NCT01783236|20373036|P2|STARTED|Overall Study||8
8262741|NCT01783236|20373037|P1|STARTED|Overall Study||8
8262742|NCT01783080|20373051|P1|NOT COMPLETED|Overall Study||0
8262743|NCT01783080|20373051|P1|COMPLETED|Overall Study||16
8262744|NCT01783080|20373051|P1|STARTED|Overall Study||16
8262745|NCT01783054|20373058|P1|NOT COMPLETED|Overall Study||0
8262746|NCT01783054|20373058|P1|COMPLETED|Overall Study||2
8262747|NCT01783054|20373058|P1|STARTED|Overall Study||2
8262748|NCT01783015|20373069|P3|NOT COMPLETED|Open Label Treatment||6
8262749|NCT01783015|20373070|P2|NOT COMPLETED|Open Label Treatment||0
8262750|NCT01783015|20373071|P1|NOT COMPLETED|Open Label Treatment||0
8262751|NCT01783015|20373069|P3|COMPLETED|Open Label Treatment||5
8262752|NCT01783015|20373070|P2|COMPLETED|Open Label Treatment||0
8262753|NCT01783015|20373071|P1|COMPLETED|Open Label Treatment||0
8262754|NCT01783015|20373069|P3|STARTED|Open Label Treatment||11
8262755|NCT01783015|20373070|P2|STARTED|Open Label Treatment||0
8262756|NCT01783015|20373071|P1|STARTED|Open Label Treatment||0
8262757|NCT01783015|20373069|P3|NOT COMPLETED|Blinded Treatment||0
8262758|NCT01783015|20373070|P2|NOT COMPLETED|Blinded Treatment||3
8262759|NCT01783015|20373071|P1|NOT COMPLETED|Blinded Treatment||2
8262760|NCT01783015|20373069|P3|COMPLETED|Blinded Treatment||0
8262761|NCT01783015|20373070|P2|COMPLETED|Blinded Treatment||2
8262762|NCT01783015|20373071|P1|COMPLETED|Blinded Treatment||9
8262763|NCT01783015|20373069|P3|Treated|Blinded Treatment||0
8262764|NCT01783015|20373070|P2|Treated|Blinded Treatment||5
8262765|NCT01783015|20373071|P1|Treated|Blinded Treatment||11
8262766|NCT01783015|20373069|P3|STARTED|Blinded Treatment||0
8262767|NCT01783015|20373070|P2|STARTED|Blinded Treatment||5
8262768|NCT01783015|20373071|P1|STARTED|Blinded Treatment||11
8262769|NCT01782963|20373156|P1|NOT COMPLETED|Overall Study||0
8262770|NCT01782963|20373156|P1|COMPLETED|Overall Study||50
8262771|NCT01782963|20373156|P1|STARTED|Overall Study||50
8262772|NCT01782898|20373171|P2|NOT COMPLETED|Overall Study||6
8262773|NCT01782898|20373172|P1|NOT COMPLETED|Overall Study||6
8262774|NCT01782898|20373171|P2|COMPLETED|Overall Study||29
8262775|NCT01782898|20373172|P1|COMPLETED|Overall Study||29
8262776|NCT01782898|20373171|P2|STARTED|Overall Study||35
8262777|NCT01782898|20373172|P1|STARTED|Overall Study||35
8262778|NCT01782885|20373184|P2|NOT COMPLETED|Overall Study||6
8262779|NCT01782885|20373185|P1|NOT COMPLETED|Overall Study||4
8262780|NCT01782885|20373184|P2|COMPLETED|Overall Study||33
8262781|NCT01782885|20373185|P1|COMPLETED|Overall Study||32
8262782|NCT01782885|20373184|P2|STARTED|Overall Study||39
8262783|NCT01782885|20373185|P1|STARTED|Overall Study||36
8262784|NCT01782872|20373211|P4|NOT COMPLETED|Overall Study||1
8262785|NCT01782872|20373212|P3|NOT COMPLETED|Overall Study||0
8262786|NCT01782872|20373213|P2|NOT COMPLETED|Overall Study||1
8262787|NCT01782872|20373214|P1|NOT COMPLETED|Overall Study||0
8262788|NCT01782872|20373211|P4|COMPLETED|Overall Study||19
8262789|NCT01782872|20373212|P3|COMPLETED|Overall Study||20
8262790|NCT01782872|20373213|P2|COMPLETED|Overall Study||19
8262791|NCT01782872|20373214|P1|COMPLETED|Overall Study||20
8262792|NCT01782872|20373211|P4|STARTED|Overall Study||20
8262793|NCT01782872|20373212|P3|STARTED|Overall Study||20
8262794|NCT01782872|20373213|P2|STARTED|Overall Study||20
8262795|NCT01782872|20373214|P1|STARTED|Overall Study||20
8262796|NCT01782859|20373238|P2|NOT COMPLETED|Overall Study||7
8262797|NCT01782859|20373239|P1|NOT COMPLETED|Overall Study||6
8262798|NCT01782859|20373238|P2|COMPLETED|Overall Study||13
8262799|NCT01782859|20373239|P1|COMPLETED|Overall Study||14
8262800|NCT01782859|20373238|P2|STARTED|Overall Study||20
8262801|NCT01782859|20373239|P1|STARTED|Overall Study||20
8262802|NCT01782833|20373253|P1|NOT COMPLETED|Overall Study||270
8262803|NCT01782833|20373253|P1|COMPLETED|Overall Study||3365
8262804|NCT01782833|20373253|P1|STARTED|Overall Study||3635
8262805|NCT01782742|20373261|P2|NOT COMPLETED|Open Label Phase||0
8262806|NCT01782742|20373262|P1|NOT COMPLETED|Open Label Phase||0
8262807|NCT01782742|20373261|P2|COMPLETED|Open Label Phase||0
8262808|NCT01782742|20373262|P1|COMPLETED|Open Label Phase||19
8262809|NCT01782742|20373261|P2|STARTED|Open Label Phase||0
8262810|NCT01782742|20373262|P1|STARTED|Open Label Phase||19
8262811|NCT01782742|20373261|P2|NOT COMPLETED|Double-blind Treatment Phase||0
8262812|NCT01782742|20373262|P1|NOT COMPLETED|Double-blind Treatment Phase||1
8262813|NCT01782742|20373261|P2|COMPLETED|Double-blind Treatment Phase||4
8262814|NCT01782742|20373262|P1|COMPLETED|Double-blind Treatment Phase||15
8262815|NCT01782742|20373261|P2|STARTED|Double-blind Treatment Phase||4
8262816|NCT01782742|20373262|P1|STARTED|Double-blind Treatment Phase||16
8262817|NCT01782690|20373295|P1|NOT COMPLETED|Overall Study||299
8262818|NCT01782690|20373295|P1|COMPLETED|Overall Study||39
8262819|NCT01782690|20373295|P1|STARTED|Overall Study||338
8262820|NCT01782664|20373317|P6|NOT COMPLETED|Overall Study||0
8262821|NCT01782664|20373318|P5|NOT COMPLETED|Overall Study||0
8262822|NCT01782664|20373319|P4|NOT COMPLETED|Overall Study||5
8262823|NCT01782664|20373320|P3|NOT COMPLETED|Overall Study||4
8262824|NCT01782664|20373321|P2|NOT COMPLETED|Overall Study||5
8262825|NCT01782664|20373322|P1|NOT COMPLETED|Overall Study||6
8262826|NCT01782664|20373317|P6|COMPLETED|Overall Study||2
8262827|NCT01782664|20373318|P5|COMPLETED|Overall Study||6
8262828|NCT01782664|20373319|P4|COMPLETED|Overall Study||9
8262829|NCT01782664|20373320|P3|COMPLETED|Overall Study||12
8262830|NCT01782664|20373321|P2|COMPLETED|Overall Study||10
8262831|NCT01782664|20373322|P1|COMPLETED|Overall Study||8
8262832|NCT01782664|20373317|P6|STARTED|Overall Study||2
8262833|NCT01782664|20373318|P5|STARTED|Overall Study||6
8262834|NCT01782664|20373319|P4|STARTED|Overall Study||14
8262835|NCT01782664|20373320|P3|STARTED|Overall Study||16
8262836|NCT01782664|20373321|P2|STARTED|Overall Study||15
8262837|NCT01782664|20373322|P1|STARTED|Overall Study||14
8262838|NCT01782495|20373479|P11|NOT COMPLETED|Overall Study||0
8262839|NCT01782495|20373480|P10|NOT COMPLETED|Overall Study||0
8262840|NCT01782495|20373481|P9|NOT COMPLETED|Overall Study||0
8262841|NCT01782495|20373482|P8|NOT COMPLETED|Overall Study||3
8262842|NCT01782495|20373483|P7|NOT COMPLETED|Overall Study||0
8262843|NCT01782495|20373484|P6|NOT COMPLETED|Overall Study||0
8262844|NCT01782495|20373485|P5|NOT COMPLETED|Overall Study||0
8262845|NCT01782495|20373486|P4|NOT COMPLETED|Overall Study||0
8262846|NCT01782495|20373487|P3|NOT COMPLETED|Overall Study||0
8262847|NCT01782495|20373488|P2|NOT COMPLETED|Overall Study||1
8262848|NCT01782495|20373489|P1|NOT COMPLETED|Overall Study||0
8262849|NCT01782495|20373479|P11|COMPLETED|Overall Study||1
8262850|NCT01782495|20373480|P10|COMPLETED|Overall Study||2
8262851|NCT01782495|20373481|P9|COMPLETED|Overall Study||3
8262852|NCT01782495|20373482|P8|COMPLETED|Overall Study||6
8262853|NCT01782495|20373483|P7|COMPLETED|Overall Study||12
8262854|NCT01782495|20373484|P6|COMPLETED|Overall Study||22
8262855|NCT01782495|20373485|P5|COMPLETED|Overall Study||2
8262856|NCT01782495|20373486|P4|COMPLETED|Overall Study||4
8262857|NCT01782495|20373487|P3|COMPLETED|Overall Study||13
8262858|NCT01782495|20373488|P2|COMPLETED|Overall Study||26
8262859|NCT01782495|20373489|P1|COMPLETED|Overall Study||34
8262860|NCT01782495|20373479|P11|STARTED|Overall Study||1
8262861|NCT01782495|20373480|P10|STARTED|Overall Study||2
8262862|NCT01782495|20373481|P9|STARTED|Overall Study||3
8262863|NCT01782495|20373482|P8|STARTED|Overall Study||9
8262864|NCT01782495|20373483|P7|STARTED|Overall Study||12
8262865|NCT01782495|20373484|P6|STARTED|Overall Study||22
8262866|NCT01782495|20373485|P5|STARTED|Overall Study||2
8262867|NCT01782495|20373486|P4|STARTED|Overall Study||4
8262868|NCT01782495|20373487|P3|STARTED|Overall Study||13
8262869|NCT01782495|20373488|P2|STARTED|Overall Study||27
8262870|NCT01782495|20373489|P1|STARTED|Overall Study||34
8262871|NCT01782482|20373548|P2|NOT COMPLETED|Overall Study||10
8262872|NCT01782482|20373549|P1|NOT COMPLETED|Overall Study||10
8262873|NCT01782482|20373548|P2|COMPLETED|Overall Study||270
8262874|NCT01782482|20373549|P1|COMPLETED|Overall Study||271
8262875|NCT01782482|20373548|P2|STARTED|Overall Study||280
8262876|NCT01782482|20373549|P1|STARTED|Overall Study||281
8262877|NCT01782469|20373557|P1|NOT COMPLETED|Overall Study||1
8262878|NCT01782469|20373557|P1|COMPLETED|Overall Study||15
8262879|NCT01782469|20373557|P1|STARTED|Overall Study||16
8262880|NCT01782378|20373567|P2|NOT COMPLETED|Second Series||32
8262881|NCT01782378|20373568|P1|NOT COMPLETED|Second Series||26
8262882|NCT01782378|20373567|P2|COMPLETED|Second Series||0
8262883|NCT01782378|20373568|P1|COMPLETED|Second Series||5
8262884|NCT01782378|20373567|P2|STARTED|Second Series||32
8262885|NCT01782378|20373568|P1|STARTED|Second Series||31
8262886|NCT01782378|20373567|P2|NOT COMPLETED|First Series||8
8262887|NCT01782378|20373568|P1|NOT COMPLETED|First Series||7
8262888|NCT01782378|20373567|P2|COMPLETED|First Series||23
8262889|NCT01782378|20373568|P1|COMPLETED|First Series||25
8262890|NCT01782378|20373567|P2|STARTED|First Series||31
8262891|NCT01782378|20373568|P1|STARTED|First Series||32
8262892|NCT01782326|20373634|P2|NOT COMPLETED|Double-blind Treatment||320
8262893|NCT01782326|20373635|P1|NOT COMPLETED|Double-blind Treatment||278
8262894|NCT01782326|20373634|P2|COMPLETED|Double-blind Treatment||1360
8262895|NCT01782326|20373635|P1|COMPLETED|Double-blind Treatment||1400
8262896|NCT01782326|20373634|P2|STARTED|Double-blind Treatment||1680
8262897|NCT01782326|20373635|P1|STARTED|Double-blind Treatment||1678
8262898|NCT01782326|20373634|P2|NOT COMPLETED|Planned Treatment Epoch||208
8262899|NCT01782326|20373635|P1|NOT COMPLETED|Planned Treatment Epoch||202
8262900|NCT01782326|20373634|P2|COMPLETED|Planned Treatment Epoch||1474
8262901|NCT01782326|20373635|P1|COMPLETED|Planned Treatment Epoch||1478
8262902|NCT01782326|20373634|P2|Urine Cortisol Set|Planned Treatment Epoch||269
8262903|NCT01782326|20373635|P1|Urine Cortisol Set|Planned Treatment Epoch||266
8262904|NCT01782326|20373634|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
8262905|NCT01782326|20373635|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
8262906|NCT01782326|20373634|P2|Serial Spirometry Set|Planned Treatment Epoch||279
8262907|NCT01782326|20373635|P1|Serial Spirometry Set|Planned Treatment Epoch||280
8262908|NCT01782326|20373634|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
8262909|NCT01782326|20373635|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
8262910|NCT01782326|20373634|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
8262911|NCT01782326|20373635|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
8262912|NCT01782326|20373634|P2|STARTED|Planned Treatment Epoch||1682
8262913|NCT01782326|20373635|P1|STARTED|Planned Treatment Epoch||1680
8262914|NCT01782313|20373695|P1|NOT COMPLETED|Survival Follow up||1
8262915|NCT01782313|20373695|P1|COMPLETED|Survival Follow up||57
8262916|NCT01782313|20373695|P1|STARTED|Survival Follow up||58
8262917|NCT01782313|20373695|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
8262918|NCT01782313|20373695|P1|COMPLETED|Continued Treatment After 16 Weeks||18
8262919|NCT01782313|20373695|P1|STARTED|Continued Treatment After 16 Weeks||25
8262920|NCT01782313|20373695|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
8262921|NCT01782313|20373695|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
8262922|NCT01782313|20373695|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
8262923|NCT01782313|20373695|P1|NOT COMPLETED|Treated Cycle 3||21
8262924|NCT01782313|20373695|P1|COMPLETED|Treated Cycle 3||31
8262925|NCT01782313|20373695|P1|STARTED|Treated Cycle 3||52
8262926|NCT01782313|20373695|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
8262927|NCT01782313|20373695|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
8262928|NCT01782313|20373695|P1|STARTED|Reached First Response/Completed 2 Cycle||58
8262929|NCT01782222|20373709|P3|NOT COMPLETED|Overall Study||4
8262930|NCT01782222|20373710|P2|NOT COMPLETED|Overall Study||11
8262931|NCT01782222|20373711|P1|NOT COMPLETED|Overall Study||8
8262932|NCT01782222|20373709|P3|COMPLETED|Overall Study||37
8262933|NCT01782222|20373710|P2|COMPLETED|Overall Study||30
8262934|NCT01782222|20373711|P1|COMPLETED|Overall Study||32
8262935|NCT01782222|20373709|P3|STARTED|Overall Study||41
8262936|NCT01782222|20373710|P2|STARTED|Overall Study||41
8262937|NCT01782222|20373711|P1|STARTED|Overall Study||40
8262938|NCT01782209|20373743|P1|NOT COMPLETED|Overall Study||110
8262939|NCT01782209|20373743|P1|COMPLETED|Overall Study||225
8262940|NCT01782209|20373743|P1|STARTED|Overall Study||335
8262941|NCT01782131|20373749|P2|NOT COMPLETED|Overall Study||115
8262942|NCT01782131|20373750|P1|NOT COMPLETED|Overall Study||109
8262943|NCT01782131|20373749|P2|COMPLETED|Overall Study||177
8262944|NCT01782131|20373750|P1|COMPLETED|Overall Study||184
8262945|NCT01782131|20373749|P2|Treated|Overall Study||287
8262946|NCT01782131|20373750|P1|Treated|Overall Study||288
8262947|NCT01782131|20373749|P2|STARTED|Overall Study||292
8262948|NCT01782131|20373750|P1|STARTED|Overall Study||293
8262949|NCT01781975|20373787|P2|NOT COMPLETED|Overall Study||1
8262950|NCT01781975|20373788|P1|NOT COMPLETED|Overall Study||2
8262951|NCT01781975|20373787|P2|COMPLETED|Overall Study||21
8262952|NCT01781975|20373788|P1|COMPLETED|Overall Study||43
8262953|NCT01781975|20373787|P2|Follow-Up Period|Overall Study||21
8262954|NCT01781975|20373788|P1|Follow-Up Period|Overall Study||43
8262955|NCT01781975|20373787|P2|Treatment Period|Overall Study||22
8262956|NCT01781975|20373788|P1|Treatment Period|Overall Study||44
8262957|NCT01781975|20373787|P2|STARTED|Overall Study||22
8262958|NCT01781975|20373788|P1|STARTED|Overall Study||45
8262959|NCT01781962|20373804|P1|NOT COMPLETED|Overall Study||5
8262960|NCT01781962|20373804|P1|COMPLETED|Overall Study||201
8262961|NCT01781962|20373804|P1|STARTED|Overall Study||206
8262962|NCT01781832|20373810|P1|NOT COMPLETED|Overall Study||1
8262963|NCT01781832|20373810|P1|COMPLETED|Overall Study||25
8262964|NCT01781832|20373810|P1|STARTED|Overall Study||26
8262965|NCT01781806|20373817|P2|NOT COMPLETED|Overall Study||3
8262966|NCT01781806|20373818|P1|NOT COMPLETED|Overall Study||79
8262967|NCT01781806|20373817|P2|COMPLETED|Overall Study||1
8262968|NCT01781806|20373818|P1|COMPLETED|Overall Study||218
8262969|NCT01781806|20373817|P2|Week 48|Overall Study||1
8262970|NCT01781806|20373818|P1|Week 48|Overall Study||222
8262971|NCT01781806|20373817|P2|Week 36|Overall Study||1
8262972|NCT01781806|20373818|P1|Week 36|Overall Study||247
8262973|NCT01781806|20373817|P2|Week 24|Overall Study||1
8262974|NCT01781806|20373818|P1|Week 24|Overall Study||260
8262975|NCT01781806|20373817|P2|Week 12|Overall Study||2
8262976|NCT01781806|20373818|P1|Week 12|Overall Study||272
8262977|NCT01781806|20373817|P2|Week 8|Overall Study||4
8262978|NCT01781806|20373818|P1|Week 8|Overall Study||278
8262979|NCT01781806|20373817|P2|Week 4|Overall Study||4
8262980|NCT01781806|20373818|P1|Week 4|Overall Study||284
8262981|NCT01781806|20373817|P2|Week 0|Overall Study||4
8262982|NCT01781806|20373818|P1|Week 0|Overall Study||297
8262983|NCT01781806|20373817|P2|STARTED|Overall Study||4
8262984|NCT01781806|20373818|P1|STARTED|Overall Study||297
8262985|NCT01781637|20373830|P2|NOT COMPLETED|Overall Study||6
8262986|NCT01781637|20373831|P1|NOT COMPLETED|Overall Study||4
8262987|NCT01781637|20373830|P2|COMPLETED|Overall Study||2
8262988|NCT01781637|20373831|P1|COMPLETED|Overall Study||24
8262989|NCT01781637|20373830|P2|STARTED|Overall Study||8
8262990|NCT01781637|20373831|P1|STARTED|Overall Study||28
8262991|NCT01781611|20373841|P2|NOT COMPLETED|Overall Study||0
8262992|NCT01781611|20373842|P1|NOT COMPLETED|Overall Study||4
8262993|NCT01781611|20373841|P2|COMPLETED|Overall Study||5
8262994|NCT01781611|20373842|P1|COMPLETED|Overall Study||9
8262995|NCT01781611|20373841|P2|STARTED|Overall Study||5
8262996|NCT01781611|20373842|P1|STARTED|Overall Study||13
8262997|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
8262998|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
8262999|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
8263000|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg LEE011 600mg||0
8263001|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg LEE011 600mg||0
8263002|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg LEE011 600mg||0
8263003|NCT01781572|20373863|P3|STARTED|MEK162 45mg LEE011 600mg||0
8263004|NCT01781572|20373864|P2|STARTED|MEK162 45mg LEE011 600mg||6
8263005|NCT01781572|20373865|P1|STARTED|MEK162 45mg LEE011 600mg||0
8263006|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
8263007|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
8263008|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
8263009|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg LEE011 450mg||0
8263010|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg LEE011 450mg||0
8263011|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg LEE011 450mg||0
8263012|NCT01781572|20373863|P3|STARTED|MEK162 45mg LEE011 450mg||0
8263013|NCT01781572|20373864|P2|STARTED|MEK162 45mg LEE011 450mg||9
8263014|NCT01781572|20373865|P1|STARTED|MEK162 45mg LEE011 450mg||0
8263015|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
8263016|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
8263017|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
8263018|NCT01781572|20373863|P3|COMPLETED|MEK162 30mg LEE011 200mg||0
8263019|NCT01781572|20373864|P2|COMPLETED|MEK162 30mg LEE011 200mg||0
8263020|NCT01781572|20373865|P1|COMPLETED|MEK162 30mg LEE011 200mg||0
8263021|NCT01781572|20373863|P3|STARTED|MEK162 30mg LEE011 200mg||0
8263022|NCT01781572|20373864|P2|STARTED|MEK162 30mg LEE011 200mg||5
8263023|NCT01781572|20373865|P1|STARTED|MEK162 30mg LEE011 200mg||0
8263024|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263025|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
8263026|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
8263027|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263028|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263029|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263030|NCT01781572|20373863|P3|STARTED|MEK162 45mg BID+LEE011 300mg||0
8263031|NCT01781572|20373864|P2|STARTED|MEK162 45mg BID+LEE011 300mg||4
8263032|NCT01781572|20373865|P1|STARTED|MEK162 45mg BID+LEE011 300mg||6
8263033|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263034|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
8263035|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
8263036|NCT01781572|20373863|P3|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263037|NCT01781572|20373864|P2|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263038|NCT01781572|20373865|P1|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263039|NCT01781572|20373863|P3|STARTED|MEK162 30mg BID+LEE011 300mg||0
8263040|NCT01781572|20373864|P2|STARTED|MEK162 30mg BID+LEE011 300mg||2
8263041|NCT01781572|20373865|P1|STARTED|MEK162 30mg BID+LEE011 300mg||4
8263042|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263043|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263044|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
8263045|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263046|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263047|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263048|NCT01781572|20373863|P3|STARTED|MEK162 45mg BID+LEE011 250mg||0
8263049|NCT01781572|20373864|P2|STARTED|MEK162 45mg BID+LEE011 250mg||0
8263050|NCT01781572|20373865|P1|STARTED|MEK162 45mg BID+LEE011 250mg||3
8263051|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
8263052|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
8263053|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
8263054|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8263055|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8263056|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8263057|NCT01781572|20373863|P3|STARTED|MEK162 45mg BID+LEE011 200mg||41
8263058|NCT01781572|20373864|P2|STARTED|MEK162 45mg BID+LEE011 200mg||6
8263059|NCT01781572|20373865|P1|STARTED|MEK162 45mg BID+LEE011 200mg||16
8263060|NCT01781481|20374107|P1|NOT COMPLETED|Overall Study||0
8263061|NCT01781481|20374107|P1|COMPLETED|Overall Study||148
8263062|NCT01781481|20374107|P1|STARTED|Overall Study||148
8263063|NCT01781468|20374169|P3|NOT COMPLETED|Overall Study||12
8263064|NCT01781468|20374170|P2|NOT COMPLETED|Overall Study||13
8263065|NCT01781468|20374171|P1|NOT COMPLETED|Overall Study||6
8263066|NCT01781468|20374169|P3|COMPLETED|Overall Study||97
8263067|NCT01781468|20374170|P2|COMPLETED|Overall Study||97
8263068|NCT01781468|20374171|P1|COMPLETED|Overall Study||103
8263069|NCT01781468|20374169|P3|STARTED|Overall Study||109
8263070|NCT01781468|20374170|P2|STARTED|Overall Study||110
8263071|NCT01781468|20374171|P1|STARTED|Overall Study||109
8263072|NCT01781429|20374206|P16|NOT COMPLETED|Overall Study||0
8263073|NCT01781429|20374207|P15|NOT COMPLETED|Overall Study||16
8263074|NCT01781429|20374208|P14|NOT COMPLETED|Overall Study||8
8263075|NCT01781429|20374209|P13|NOT COMPLETED|Overall Study||22
8263076|NCT01781429|20374210|P12|NOT COMPLETED|Overall Study||21
8263077|NCT01781429|20374211|P11|NOT COMPLETED|Overall Study||18
8263078|NCT01781429|20374212|P10|NOT COMPLETED|Overall Study||24
8263079|NCT01781429|20374213|P9|NOT COMPLETED|Overall Study||7
8263080|NCT01781429|20374214|P8|NOT COMPLETED|Overall Study||4
8263081|NCT01781429|20374215|P7|NOT COMPLETED|Overall Study||7
8263082|NCT01781429|20374216|P6|NOT COMPLETED|Overall Study||4
8263083|NCT01781429|20374217|P5|NOT COMPLETED|Overall Study||1
8263084|NCT01781429|20374218|P4|NOT COMPLETED|Overall Study||1
8263085|NCT01781429|20374219|P3|NOT COMPLETED|Overall Study||1
8263086|NCT01781429|20374220|P2|NOT COMPLETED|Overall Study||1
8263087|NCT01781429|20374221|P1|NOT COMPLETED|Overall Study||1
8263088|NCT01781429|20374206|P16|COMPLETED|Overall Study||0
8263089|NCT01781429|20374207|P15|COMPLETED|Overall Study||0
8263090|NCT01781429|20374208|P14|COMPLETED|Overall Study||0
8263091|NCT01781429|20374209|P13|COMPLETED|Overall Study||0
8263092|NCT01781429|20374210|P12|COMPLETED|Overall Study||0
8263093|NCT01781429|20374211|P11|COMPLETED|Overall Study||0
8263094|NCT01781429|20374212|P10|COMPLETED|Overall Study||0
8263095|NCT01781429|20374213|P9|COMPLETED|Overall Study||0
8263096|NCT01781429|20374214|P8|COMPLETED|Overall Study||0
8263097|NCT01781429|20374215|P7|COMPLETED|Overall Study||0
8263098|NCT01781429|20374216|P6|COMPLETED|Overall Study||0
8263099|NCT01781429|20374217|P5|COMPLETED|Overall Study||0
8263100|NCT01781429|20374218|P4|COMPLETED|Overall Study||0
8263101|NCT01781429|20374219|P3|COMPLETED|Overall Study||0
8263102|NCT01781429|20374220|P2|COMPLETED|Overall Study||0
8263103|NCT01781429|20374221|P1|COMPLETED|Overall Study||0
8263104|NCT01781429|20374206|P16|STARTED|Overall Study||0
8263105|NCT01781429|20374207|P15|STARTED|Overall Study||16
8263106|NCT01781429|20374208|P14|STARTED|Overall Study||8
8263107|NCT01781429|20374209|P13|STARTED|Overall Study||22
8263108|NCT01781429|20374210|P12|STARTED|Overall Study||21
8263109|NCT01781429|20374211|P11|STARTED|Overall Study||18
8263110|NCT01781429|20374212|P10|STARTED|Overall Study||24
8263111|NCT01781429|20374213|P9|STARTED|Overall Study||7
8263112|NCT01781429|20374214|P8|STARTED|Overall Study||4
8263113|NCT01781429|20374215|P7|STARTED|Overall Study||7
8263114|NCT01781429|20374216|P6|STARTED|Overall Study||4
8263115|NCT01781429|20374217|P5|STARTED|Overall Study||1
8263116|NCT01781429|20374218|P4|STARTED|Overall Study||1
8263117|NCT01781429|20374219|P3|STARTED|Overall Study||1
8263118|NCT01781429|20374220|P2|STARTED|Overall Study||1
8263119|NCT01781429|20374221|P1|STARTED|Overall Study||1
8263129|NCT01781299|20374298|P2|NOT COMPLETED|Overall Study||1
8263130|NCT01781299|20374299|P1|NOT COMPLETED|Overall Study||0
8263131|NCT01781299|20374298|P2|COMPLETED|Overall Study||4
8263132|NCT01781299|20374299|P1|COMPLETED|Overall Study||4
8263133|NCT01781299|20374298|P2|STARTED|Overall Study||5
8263134|NCT01781299|20374299|P1|STARTED|Overall Study||4
8263135|NCT01781286|20374307|P6|NOT COMPLETED|Overall Study||1
8263136|NCT01781286|20374308|P5|NOT COMPLETED|Overall Study||0
8263137|NCT01781286|20374309|P4|NOT COMPLETED|Overall Study||1
8263138|NCT01781286|20374310|P3|NOT COMPLETED|Overall Study||2
8263139|NCT01781286|20374311|P2|NOT COMPLETED|Overall Study||0
8263140|NCT01781286|20374312|P1|NOT COMPLETED|Overall Study||2
8263141|NCT01781286|20374307|P6|COMPLETED|Overall Study||2
8263142|NCT01781286|20374308|P5|COMPLETED|Overall Study||6
8263143|NCT01781286|20374309|P4|COMPLETED|Overall Study||7
8263144|NCT01781286|20374310|P3|COMPLETED|Overall Study||7
8263145|NCT01781286|20374311|P2|COMPLETED|Overall Study||4
8263146|NCT01781286|20374312|P1|COMPLETED|Overall Study||5
8263147|NCT01781286|20374307|P6|Started 3rd Intervention|Overall Study||2
8263148|NCT01781286|20374308|P5|Started 3rd Intervention|Overall Study||6
8263149|NCT01781286|20374309|P4|Started 3rd Intervention|Overall Study||7
8263150|NCT01781286|20374310|P3|Started 3rd Intervention|Overall Study||7
8263151|NCT01781286|20374311|P2|Started 3rd Intervention|Overall Study||4
8263152|NCT01781286|20374312|P1|Started 3rd Intervention|Overall Study||5
8263153|NCT01781286|20374307|P6|Started 2nd Intervention|Overall Study||2
8263154|NCT01781286|20374308|P5|Started 2nd Intervention|Overall Study||6
8263155|NCT01781286|20374309|P4|Started 2nd Intervention|Overall Study||8
8263156|NCT01781286|20374310|P3|Started 2nd Intervention|Overall Study||9
8263157|NCT01781286|20374311|P2|Started 2nd Intervention|Overall Study||4
8263158|NCT01781286|20374312|P1|Started 2nd Intervention|Overall Study||5
8263159|NCT01781286|20374307|P6|Started 1st Intervention|Overall Study||2
8263160|NCT01781286|20374308|P5|Started 1st Intervention|Overall Study||6
8263161|NCT01781286|20374309|P4|Started 1st Intervention|Overall Study||8
8263162|NCT01781286|20374310|P3|Started 1st Intervention|Overall Study||9
8263163|NCT01781286|20374311|P2|Started 1st Intervention|Overall Study||4
8263164|NCT01781286|20374312|P1|Started 1st Intervention|Overall Study||6
8263165|NCT01781286|20374307|P6|STARTED|Overall Study||3
8263166|NCT01781286|20374308|P5|STARTED|Overall Study||6
8263167|NCT01781286|20374309|P4|STARTED|Overall Study||8
8263168|NCT01781286|20374310|P3|STARTED|Overall Study||9
8263169|NCT01781286|20374311|P2|STARTED|Overall Study||4
8263170|NCT01781286|20374312|P1|STARTED|Overall Study||7
8263171|NCT01781234|20374337|P2|NOT COMPLETED|Overall Study||3
8263172|NCT01781234|20374338|P1|NOT COMPLETED|Overall Study||9
8263173|NCT01781234|20374337|P2|COMPLETED|Overall Study||21
8263174|NCT01781234|20374338|P1|COMPLETED|Overall Study||18
8263175|NCT01781234|20374337|P2|STARTED|Overall Study||24
8263176|NCT01781234|20374338|P1|STARTED|Overall Study||27
8263177|NCT01781208|20374348|P1|NOT COMPLETED|Overall Study||0
8263178|NCT01781208|20374348|P1|COMPLETED|Overall Study||62
8263179|NCT01781208|20374348|P1|Overall Study|Overall Study||62
8263180|NCT01781208|20374348|P1|STARTED|Overall Study||62
8263181|NCT01781169|20374355|P2|NOT COMPLETED|Overall Study||0
8263182|NCT01781169|20374356|P1|NOT COMPLETED|Overall Study||1
8263183|NCT01781169|20374355|P2|COMPLETED|Overall Study||21
8263184|NCT01781169|20374356|P1|COMPLETED|Overall Study||21
8263185|NCT01781169|20374355|P2|STARTED|Overall Study||21
8263186|NCT01781169|20374356|P1|STARTED|Overall Study||22
8263187|NCT01781078|20374364|P3|NOT COMPLETED|Overall Study||16
8263188|NCT01781078|20374365|P2|NOT COMPLETED|Overall Study||5
8263189|NCT01781078|20374366|P1|NOT COMPLETED|Overall Study||12
8263190|NCT01781078|20374364|P3|COMPLETED|Overall Study||0
8263191|NCT01781078|20374365|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
8263192|NCT01781078|20374366|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
8263193|NCT01781078|20374364|P3|STARTED|Overall Study||16
8263194|NCT01781078|20374365|P2|STARTED|Overall Study|Randomized post implantation|118
8263195|NCT01781078|20374366|P1|STARTED|Overall Study|Randomized post implantation|229
8263196|NCT01781026|20374376|P1|NOT COMPLETED|Overall Study||2
8263197|NCT01781026|20374376|P1|COMPLETED|Overall Study||0
8263198|NCT01781026|20374376|P1|STARTED|Overall Study||2
8263199|NCT01780987|20374382|P2|NOT COMPLETED|Overall Study||6
8263200|NCT01780987|20374383|P1|NOT COMPLETED|Overall Study||3
8263201|NCT01780987|20374382|P2|COMPLETED|Overall Study||34
8263202|NCT01780987|20374383|P1|COMPLETED|Overall Study||37
8263203|NCT01780987|20374382|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
8263204|NCT01780987|20374383|P1|STARTED|Overall Study||40
8263205|NCT01780974|20374401|P2|NOT COMPLETED|Overall Study||3
8263206|NCT01780974|20374402|P1|NOT COMPLETED|Overall Study||2
8263207|NCT01780974|20374401|P2|COMPLETED|Overall Study||18
8263208|NCT01780974|20374402|P1|COMPLETED|Overall Study||19
8263209|NCT01780974|20374401|P2|STARTED|Overall Study||21
8263210|NCT01780974|20374402|P1|STARTED|Overall Study||21
8263211|NCT01780935|20374412|P2|NOT COMPLETED|Overall Study||336
8263212|NCT01780935|20374413|P1|NOT COMPLETED|Overall Study||335
8263213|NCT01780935|20374412|P2|COMPLETED|Overall Study||0
8263214|NCT01780935|20374413|P1|COMPLETED|Overall Study||0
8263215|NCT01780935|20374412|P2|Safety Set|Overall Study||336
8263216|NCT01780935|20374413|P1|Safety Set|Overall Study||334
8263217|NCT01780935|20374412|P2|STARTED|Overall Study||336
8263218|NCT01780935|20374413|P1|STARTED|Overall Study||335
8263219|NCT01780922|20374443|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8263220|NCT01780922|20374444|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8263221|NCT01780922|20374445|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8263222|NCT01780922|20374446|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8263223|NCT01780922|20374447|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8263224|NCT01780922|20374448|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8263225|NCT01780922|20374443|P6|COMPLETED|Third Intervention (1 Day)||2
8263226|NCT01780922|20374444|P5|COMPLETED|Third Intervention (1 Day)||2
8263227|NCT01780922|20374445|P4|COMPLETED|Third Intervention (1 Day)||2
8263228|NCT01780922|20374446|P3|COMPLETED|Third Intervention (1 Day)||2
8263229|NCT01780922|20374447|P2|COMPLETED|Third Intervention (1 Day)||2
8263230|NCT01780922|20374448|P1|COMPLETED|Third Intervention (1 Day)||2
8263231|NCT01780922|20374443|P6|STARTED|Third Intervention (1 Day)||2
8263232|NCT01780922|20374444|P5|STARTED|Third Intervention (1 Day)||2
8263233|NCT01780922|20374445|P4|STARTED|Third Intervention (1 Day)||2
8263234|NCT01780922|20374446|P3|STARTED|Third Intervention (1 Day)||2
8263235|NCT01780922|20374447|P2|STARTED|Third Intervention (1 Day)||2
8263236|NCT01780922|20374448|P1|STARTED|Third Intervention (1 Day)||2
8263237|NCT01780922|20374443|P6|NOT COMPLETED|Washout (7 Days)||0
8263238|NCT01780922|20374444|P5|NOT COMPLETED|Washout (7 Days)||0
8263239|NCT01780922|20374445|P4|NOT COMPLETED|Washout (7 Days)||0
8263240|NCT01780922|20374446|P3|NOT COMPLETED|Washout (7 Days)||0
8263241|NCT01780922|20374447|P2|NOT COMPLETED|Washout (7 Days)||0
8263242|NCT01780922|20374448|P1|NOT COMPLETED|Washout (7 Days)||0
8263243|NCT01780922|20374443|P6|COMPLETED|Washout (7 Days)||2
8263244|NCT01780922|20374444|P5|COMPLETED|Washout (7 Days)||2
8263245|NCT01780922|20374445|P4|COMPLETED|Washout (7 Days)||2
8263246|NCT01780922|20374446|P3|COMPLETED|Washout (7 Days)||2
8263247|NCT01780922|20374447|P2|COMPLETED|Washout (7 Days)||2
8263248|NCT01780922|20374448|P1|COMPLETED|Washout (7 Days)||2
8263249|NCT01780922|20374443|P6|STARTED|Washout (7 Days)||2
8263250|NCT01780922|20374444|P5|STARTED|Washout (7 Days)||2
8263251|NCT01780922|20374445|P4|STARTED|Washout (7 Days)||2
8263252|NCT01780922|20374446|P3|STARTED|Washout (7 Days)||2
8263253|NCT01780922|20374447|P2|STARTED|Washout (7 Days)||2
8263254|NCT01780922|20374448|P1|STARTED|Washout (7 Days)||2
8263255|NCT01780922|20374443|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8263256|NCT01780922|20374444|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8263257|NCT01780922|20374445|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8263258|NCT01780922|20374446|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8263259|NCT01780922|20374447|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8263260|NCT01780922|20374448|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8263261|NCT01780922|20374443|P6|COMPLETED|Second Intervention (1 Day)||2
8263262|NCT01780922|20374444|P5|COMPLETED|Second Intervention (1 Day)||2
8263263|NCT01780922|20374445|P4|COMPLETED|Second Intervention (1 Day)||2
8263264|NCT01780922|20374446|P3|COMPLETED|Second Intervention (1 Day)||2
8263265|NCT01780922|20374447|P2|COMPLETED|Second Intervention (1 Day)||2
8263266|NCT01780922|20374448|P1|COMPLETED|Second Intervention (1 Day)||2
8263267|NCT01780922|20374443|P6|STARTED|Second Intervention (1 Day)||2
8263268|NCT01780922|20374444|P5|STARTED|Second Intervention (1 Day)||2
8263269|NCT01780922|20374445|P4|STARTED|Second Intervention (1 Day)||2
8263270|NCT01780922|20374446|P3|STARTED|Second Intervention (1 Day)||2
8263271|NCT01780922|20374447|P2|STARTED|Second Intervention (1 Day)||2
8263272|NCT01780922|20374448|P1|STARTED|Second Intervention (1 Day)||2
8263273|NCT01780922|20374443|P6|NOT COMPLETED|Washout (7 Days)||0
8263274|NCT01780922|20374444|P5|NOT COMPLETED|Washout (7 Days)||0
8263275|NCT01780922|20374445|P4|NOT COMPLETED|Washout (7 Days)||0
8263276|NCT01780922|20374446|P3|NOT COMPLETED|Washout (7 Days)||0
8263277|NCT01780922|20374447|P2|NOT COMPLETED|Washout (7 Days)||0
8263278|NCT01780922|20374448|P1|NOT COMPLETED|Washout (7 Days)||0
8263279|NCT01780922|20374443|P6|COMPLETED|Washout (7 Days)||2
8263280|NCT01780922|20374444|P5|COMPLETED|Washout (7 Days)||2
8263281|NCT01780922|20374445|P4|COMPLETED|Washout (7 Days)||2
8263282|NCT01780922|20374446|P3|COMPLETED|Washout (7 Days)||2
8263283|NCT01780922|20374447|P2|COMPLETED|Washout (7 Days)||2
8263284|NCT01780922|20374448|P1|COMPLETED|Washout (7 Days)||2
8263285|NCT01780922|20374443|P6|STARTED|Washout (7 Days)||2
8263286|NCT01780922|20374444|P5|STARTED|Washout (7 Days)||2
8263287|NCT01780922|20374445|P4|STARTED|Washout (7 Days)||2
8263288|NCT01780922|20374446|P3|STARTED|Washout (7 Days)||2
8263289|NCT01780922|20374447|P2|STARTED|Washout (7 Days)||2
8263290|NCT01780922|20374448|P1|STARTED|Washout (7 Days)||2
8263291|NCT01780922|20374443|P6|NOT COMPLETED|First Intervention (1 Day)||0
8263292|NCT01780922|20374444|P5|NOT COMPLETED|First Intervention (1 Day)||0
8263293|NCT01780922|20374445|P4|NOT COMPLETED|First Intervention (1 Day)||0
8263294|NCT01780922|20374446|P3|NOT COMPLETED|First Intervention (1 Day)||0
8263295|NCT01780922|20374447|P2|NOT COMPLETED|First Intervention (1 Day)||0
8263296|NCT01780922|20374448|P1|NOT COMPLETED|First Intervention (1 Day)||0
8263297|NCT01780922|20374443|P6|COMPLETED|First Intervention (1 Day)||2
8263298|NCT01780922|20374444|P5|COMPLETED|First Intervention (1 Day)||2
8263299|NCT01780922|20374445|P4|COMPLETED|First Intervention (1 Day)||2
8263300|NCT01780922|20374446|P3|COMPLETED|First Intervention (1 Day)||2
8263301|NCT01780922|20374447|P2|COMPLETED|First Intervention (1 Day)||2
8263302|NCT01780922|20374448|P1|COMPLETED|First Intervention (1 Day)||2
8263303|NCT01780922|20374443|P6|STARTED|First Intervention (1 Day)||2
8263304|NCT01780922|20374444|P5|STARTED|First Intervention (1 Day)||2
8263305|NCT01780922|20374445|P4|STARTED|First Intervention (1 Day)||2
8263306|NCT01780922|20374446|P3|STARTED|First Intervention (1 Day)||2
8263307|NCT01780922|20374447|P2|STARTED|First Intervention (1 Day)||2
8263308|NCT01780922|20374448|P1|STARTED|First Intervention (1 Day)||2
8263309|NCT01780870|20374503|P2|NOT COMPLETED|Overall Study||0
8263310|NCT01780870|20374504|P1|NOT COMPLETED|Overall Study||0
8263311|NCT01780870|20374503|P2|COMPLETED|Overall Study||5
8263312|NCT01780870|20374504|P1|COMPLETED|Overall Study||0
8263313|NCT01780870|20374503|P2|STARTED|Overall Study||5
8263314|NCT01780870|20374504|P1|STARTED|Overall Study||0
8263315|NCT01780831|20374518|P4|NOT COMPLETED|Overall Study||1
8263316|NCT01780831|20374519|P3|NOT COMPLETED|Overall Study||4
8263317|NCT01780831|20374520|P2|NOT COMPLETED|Overall Study||0
8263318|NCT01780831|20374521|P1|NOT COMPLETED|Overall Study||0
8263319|NCT01780831|20374518|P4|COMPLETED|Overall Study||9
8263320|NCT01780831|20374519|P3|COMPLETED|Overall Study||22
8263321|NCT01780831|20374520|P2|COMPLETED|Overall Study||6
8263322|NCT01780831|20374521|P1|COMPLETED|Overall Study||10
8263323|NCT01780831|20374518|P4|STARTED|Overall Study||10
8263324|NCT01780831|20374519|P3|STARTED|Overall Study||26
8263325|NCT01780831|20374520|P2|STARTED|Overall Study||6
8263326|NCT01780831|20374521|P1|STARTED|Overall Study||10
8263327|NCT01780662|20374589|P3|NOT COMPLETED|Overall Study||10
8263328|NCT01780662|20374590|P2|NOT COMPLETED|Overall Study||6
8263329|NCT01780662|20374591|P1|NOT COMPLETED|Overall Study||1
8263330|NCT01780662|20374589|P3|COMPLETED|Overall Study||20
8263331|NCT01780662|20374590|P2|COMPLETED|Overall Study||7
8263332|NCT01780662|20374591|P1|COMPLETED|Overall Study||2
8263333|NCT01780662|20374589|P3|STARTED|Overall Study||30
8263334|NCT01780662|20374590|P2|STARTED|Overall Study||13
8263335|NCT01780662|20374591|P1|STARTED|Overall Study||3
8263336|NCT01780584|20374608|P3|NOT COMPLETED|Overall Study||2
8263337|NCT01780584|20374609|P2|NOT COMPLETED|Overall Study||1
8263338|NCT01780584|20374610|P1|NOT COMPLETED|Overall Study||1
8263339|NCT01780584|20374608|P3|COMPLETED|Overall Study||13
8263340|NCT01780584|20374609|P2|COMPLETED|Overall Study||14
8263341|NCT01780584|20374610|P1|COMPLETED|Overall Study||14
8263342|NCT01780584|20374608|P3|STARTED|Overall Study||15
8263343|NCT01780584|20374609|P2|STARTED|Overall Study||15
8263344|NCT01780584|20374610|P1|STARTED|Overall Study||15
8263345|NCT01780545|20374632|P2|NOT COMPLETED|Overall Study||2
8263346|NCT01780545|20374633|P1|NOT COMPLETED|Overall Study||4
8263347|NCT01780545|20374632|P2|COMPLETED|Overall Study||99
8263348|NCT01780545|20374633|P1|COMPLETED|Overall Study||95
8263349|NCT01780545|20374632|P2|STARTED|Overall Study||101
8263350|NCT01780545|20374633|P1|STARTED|Overall Study||99
8263351|NCT01780506|20374651|P2|NOT COMPLETED|Open-Label Extension Phase||1
8263352|NCT01780506|20374652|P1|NOT COMPLETED|Open-Label Extension Phase||0
8263353|NCT01780506|20374651|P2|COMPLETED|Open-Label Extension Phase||94
8263354|NCT01780506|20374652|P1|COMPLETED|Open-Label Extension Phase||90
8263355|NCT01780506|20374651|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
8263356|NCT01780506|20374652|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
8263357|NCT01780506|20374651|P2|NOT COMPLETED|Double-Blind Phase||78
8263358|NCT01780506|20374652|P1|NOT COMPLETED|Double-Blind Phase||70
8263359|NCT01780506|20374651|P2|COMPLETED|Double-Blind Phase||356
8263360|NCT01780506|20374652|P1|COMPLETED|Double-Blind Phase||368
8263361|NCT01780506|20374651|P2|STARTED|Double-Blind Phase||434
8263362|NCT01780506|20374652|P1|STARTED|Double-Blind Phase||438
8263363|NCT01780454|20374706|P1|NOT COMPLETED|Overall Study||0
8263364|NCT01780454|20374706|P1|COMPLETED|Overall Study||2
8263365|NCT01780454|20374706|P1|STARTED|Overall Study||2
8263366|NCT01780389|20374710|P1|NOT COMPLETED|Overall Study||1
8263367|NCT01780389|20374710|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
8263368|NCT01780389|20374710|P1|STARTED|Overall Study||5
8263369|NCT01780350|20374721|P1|NOT COMPLETED|Overall Study||0
8263370|NCT01780350|20374721|P1|COMPLETED|Overall Study||200
8263371|NCT01780350|20374721|P1|STARTED|Overall Study||200
8263372|NCT01780337|20374728|P2|NOT COMPLETED|Overall Study||0
8263373|NCT01780337|20374729|P1|NOT COMPLETED|Overall Study||0
8263374|NCT01780337|20374728|P2|COMPLETED|Overall Study||6
8263375|NCT01780337|20374729|P1|COMPLETED|Overall Study||6
8263376|NCT01780337|20374728|P2|STARTED|Overall Study||6
8263377|NCT01780337|20374729|P1|STARTED|Overall Study||6
8263378|NCT01780324|20374741|P2|NOT COMPLETED|Overall Study||6
8263379|NCT01780324|20374742|P1|NOT COMPLETED|Overall Study||1
8263380|NCT01780324|20374741|P2|COMPLETED|Overall Study||33
8263381|NCT01780324|20374742|P1|COMPLETED|Overall Study||40
8263382|NCT01780324|20374741|P2|STARTED|Overall Study||39
8263383|NCT01780324|20374742|P1|STARTED|Overall Study||41
8263384|NCT01779869|20374748|P1|NOT COMPLETED|Overall Study||2
8263385|NCT01779869|20374748|P1|COMPLETED|Overall Study||14
8263386|NCT01779869|20374748|P1|STARTED|Overall Study||16
8263387|NCT01779700|20374754|P2|NOT COMPLETED|Overall Study||5
8263388|NCT01779700|20374755|P1|NOT COMPLETED|Overall Study||4
8263389|NCT01779700|20374754|P2|COMPLETED|Overall Study||17
8263390|NCT01779700|20374755|P1|COMPLETED|Overall Study||14
8263391|NCT01779700|20374754|P2|STARTED|Overall Study||22
8263392|NCT01779700|20374755|P1|STARTED|Overall Study||18
8263393|NCT01779648|20374795|P2|NOT COMPLETED|Overall Study||0
8263394|NCT01779648|20374796|P1|NOT COMPLETED|Overall Study||1
8263395|NCT01779648|20374795|P2|COMPLETED|Overall Study||27
8263396|NCT01779648|20374796|P1|COMPLETED|Overall Study||27
8263397|NCT01779648|20374795|P2|STARTED|Overall Study||27
8263398|NCT01779648|20374796|P1|STARTED|Overall Study||28
8263399|NCT01779440|20374826|P2|NOT COMPLETED|Overall Study||5
8263400|NCT01779440|20374827|P1|NOT COMPLETED|Overall Study||3
8263401|NCT01779440|20374826|P2|COMPLETED|Overall Study||23
8263402|NCT01779440|20374827|P1|COMPLETED|Overall Study||27
8263403|NCT01779440|20374826|P2|STARTED|Overall Study||28
8263404|NCT01779440|20374827|P1|STARTED|Overall Study||30
8263405|NCT01779375|20374837|P2|NOT COMPLETED|Overall Study||3
8263406|NCT01779375|20374838|P1|NOT COMPLETED|Overall Study||2
8263407|NCT01779375|20374837|P2|COMPLETED|Overall Study||41
8263408|NCT01779375|20374838|P1|COMPLETED|Overall Study||45
8263409|NCT01779375|20374837|P2|STARTED|Overall Study||44
8263410|NCT01779375|20374838|P1|STARTED|Overall Study||47
8263411|NCT01779219|20374854|P2|NOT COMPLETED|Overall Study||0
8263412|NCT01779219|20374855|P1|NOT COMPLETED|Overall Study||0
8263413|NCT01779219|20374854|P2|COMPLETED|Overall Study|First interim analysis|21
8263414|NCT01779219|20374855|P1|COMPLETED|Overall Study|First interim analysis|21
8263415|NCT01779219|20374854|P2|STARTED|Overall Study|First interim analysis|21
8263416|NCT01779219|20374855|P1|STARTED|Overall Study|First interim analysis|21
8263417|NCT01779167|20374867|P1|NOT COMPLETED|Overall Study||1
8263418|NCT01779167|20374867|P1|COMPLETED|Overall Study||3
8263419|NCT01779167|20374867|P1|STARTED|Overall Study||4
8263420|NCT01779141|20374876|P1|NOT COMPLETED|Overall Study||181
8263421|NCT01779141|20374876|P1|COMPLETED|Overall Study||300
8263422|NCT01779141|20374876|P1|STARTED|Overall Study||481
8263423|NCT01779024|20374883|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
8263424|NCT01779024|20374884|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
8263425|NCT01779024|20374883|P2|COMPLETED|2nd Visit - Functional MRI||6
8263426|NCT01779024|20374884|P1|COMPLETED|2nd Visit - Functional MRI||5
8263427|NCT01779024|20374883|P2|STARTED|2nd Visit - Functional MRI||6
8263428|NCT01779024|20374884|P1|STARTED|2nd Visit - Functional MRI||5
8263429|NCT01779024|20374883|P2|NOT COMPLETED|1st Visit - Functional MRI||2
8263430|NCT01779024|20374884|P1|NOT COMPLETED|1st Visit - Functional MRI||2
8263431|NCT01779024|20374883|P2|COMPLETED|1st Visit - Functional MRI||5
8263432|NCT01779024|20374884|P1|COMPLETED|1st Visit - Functional MRI||4
8263433|NCT01779024|20374883|P2|STARTED|1st Visit - Functional MRI||7
8263434|NCT01779024|20374884|P1|STARTED|1st Visit - Functional MRI||6
8263435|NCT01779024|20374883|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
8263436|NCT01779024|20374884|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
8263437|NCT01779024|20374883|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
8263438|NCT01779024|20374884|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
8263439|NCT01779024|20374883|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
8263440|NCT01779024|20374884|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
8263441|NCT01779024|20374883|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
8263442|NCT01779024|20374884|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
8263443|NCT01779024|20374883|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
8263444|NCT01779024|20374884|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
8263445|NCT01779024|20374883|P2|STARTED|1st Visit - Alcohol Self-Administration||9
8263446|NCT01779024|20374884|P1|STARTED|1st Visit - Alcohol Self-Administration||8
8263447|NCT01778985|20374892|P2|NOT COMPLETED|Overall Study||3
8263448|NCT01778985|20374893|P1|NOT COMPLETED|Overall Study||7
8263449|NCT01778985|20374892|P2|COMPLETED|Overall Study||12
8263450|NCT01778985|20374893|P1|COMPLETED|Overall Study||8
8263451|NCT01778985|20374892|P2|STARTED|Overall Study||15
8263452|NCT01778985|20374893|P1|STARTED|Overall Study||15
8263453|NCT01778855|20374939|P2|NOT COMPLETED|Overall Study||1
8263454|NCT01778855|20374940|P1|NOT COMPLETED|Overall Study||0
8263455|NCT01778855|20374939|P2|COMPLETED|Overall Study||3
8263456|NCT01778855|20374940|P1|COMPLETED|Overall Study||2
8263457|NCT01778855|20374939|P2|STARTED|Overall Study||4
8263458|NCT01778855|20374940|P1|STARTED|Overall Study||2
8263459|NCT01778751|20374948|P2|NOT COMPLETED|Overall Study||2
8263460|NCT01778751|20374949|P1|NOT COMPLETED|Overall Study||2
8263461|NCT01778751|20374948|P2|COMPLETED|Overall Study||23
8263462|NCT01778751|20374949|P1|COMPLETED|Overall Study||23
8263463|NCT01778751|20374948|P2|STARTED|Overall Study||25
8263464|NCT01778751|20374949|P1|STARTED|Overall Study||25
8263465|NCT01778634|20374963|P2|NOT COMPLETED|Overall Study||0
8263466|NCT01778634|20374964|P1|NOT COMPLETED|Overall Study||0
8263467|NCT01778634|20374963|P2|COMPLETED|Overall Study||60
8263468|NCT01778634|20374964|P1|COMPLETED|Overall Study||61
8263469|NCT01778634|20374963|P2|STARTED|Overall Study||60
8263470|NCT01778634|20374964|P1|STARTED|Overall Study||61
8263471|NCT01778556|20375006|P2|NOT COMPLETED|Long-term Follow-up||0
8263472|NCT01778556|20375007|P1|NOT COMPLETED|Long-term Follow-up||1
8263473|NCT01778556|20375006|P2|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
8263474|NCT01778556|20375007|P1|COMPLETED|Long-term Follow-up||14
8263475|NCT01778556|20375006|P2|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
8263476|NCT01778556|20375007|P1|STARTED|Long-term Follow-up||15
8263477|NCT01778556|20375006|P2|NOT COMPLETED|Intervention 2 (14 Days)||0
8263478|NCT01778556|20375007|P1|NOT COMPLETED|Intervention 2 (14 Days)||1
8263479|NCT01778556|20375006|P2|COMPLETED|Intervention 2 (14 Days)||8
8263480|NCT01778556|20375007|P1|COMPLETED|Intervention 2 (14 Days)||14
8263481|NCT01778556|20375006|P2|STARTED|Intervention 2 (14 Days)||8
8263482|NCT01778556|20375007|P1|STARTED|Intervention 2 (14 Days)||15
8263483|NCT01778556|20375006|P2|NOT COMPLETED|Intervention 1 (5 Days)||2
8263484|NCT01778556|20375007|P1|NOT COMPLETED|Intervention 1 (5 Days)||0
8263485|NCT01778556|20375006|P2|COMPLETED|Intervention 1 (5 Days)||8
8263486|NCT01778556|20375007|P1|COMPLETED|Intervention 1 (5 Days)||15
8263487|NCT01778556|20375006|P2|STARTED|Intervention 1 (5 Days)||10
8263488|NCT01778556|20375007|P1|STARTED|Intervention 1 (5 Days)||15
8263489|NCT01778530|20375020|P1|NOT COMPLETED|Overall Study||2
8263490|NCT01778530|20375020|P1|COMPLETED|Overall Study||0
8263491|NCT01778530|20375020|P1|STARTED|Overall Study||2
8263492|NCT01778426|20375027|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
8263493|NCT01778426|20375028|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
8263494|NCT01778426|20375027|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
8263495|NCT01778426|20375028|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
8263496|NCT01778426|20375027|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
8263497|NCT01778426|20375028|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
8263498|NCT01778426|20375027|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
8263499|NCT01778426|20375028|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
8263500|NCT01778426|20375027|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
8263501|NCT01778426|20375028|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
8263502|NCT01778426|20375027|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
8263503|NCT01778426|20375028|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
8263504|NCT01778296|20375044|P1|NOT COMPLETED|Overall Study||0
8263505|NCT01778296|20375044|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
8263506|NCT01778296|20375044|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
8263507|NCT01778179|20375050|P2|NOT COMPLETED|Overall Study||3
8263508|NCT01778179|20375051|P1|NOT COMPLETED|Overall Study||2
8263509|NCT01778179|20375050|P2|COMPLETED|Overall Study||22
8263510|NCT01778179|20375051|P1|COMPLETED|Overall Study||23
8263511|NCT01778179|20375050|P2|STARTED|Overall Study||25
8263512|NCT01778179|20375051|P1|STARTED|Overall Study||25
8263513|NCT01778127|20375062|P3|NOT COMPLETED|Overall Study||6
8263514|NCT01778127|20375063|P2|NOT COMPLETED|Overall Study||2
8263515|NCT01778127|20375064|P1|NOT COMPLETED|Overall Study||8
8263516|NCT01778127|20375062|P3|COMPLETED|Overall Study||26
8263517|NCT01778127|20375063|P2|COMPLETED|Overall Study||31
8263518|NCT01778127|20375064|P1|COMPLETED|Overall Study||25
8263519|NCT01778127|20375062|P3|STARTED|Overall Study||32
8263520|NCT01778127|20375063|P2|STARTED|Overall Study||33
8263521|NCT01778127|20375064|P1|STARTED|Overall Study||33
8263522|NCT01778062|20375107|P2|NOT COMPLETED|Overall Study||11
8263523|NCT01778062|20375108|P1|NOT COMPLETED|Overall Study||6
8263524|NCT01778062|20375107|P2|COMPLETED|Overall Study||57
8263525|NCT01778062|20375108|P1|COMPLETED|Overall Study||62
8263526|NCT01778062|20375107|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
8263527|NCT01778062|20375108|P1|Intent to Treat (ITT)|Overall Study||68
8263528|NCT01778062|20375107|P2|Safety Set|Overall Study||68
8263529|NCT01778062|20375108|P1|Safety Set|Overall Study||68
8263530|NCT01778062|20375107|P2|STARTED|Overall Study||68
8263531|NCT01778062|20375108|P1|STARTED|Overall Study||68
8263532|NCT01778049|20375122|P6|NOT COMPLETED|Double Blind Treatment Period||7
8263533|NCT01778049|20375123|P5|NOT COMPLETED|Double Blind Treatment Period||12
8263534|NCT01778049|20375124|P4|NOT COMPLETED|Double Blind Treatment Period||12
8263535|NCT01778049|20375125|P3|NOT COMPLETED|Double Blind Treatment Period||15
8263536|NCT01778049|20375126|P2|NOT COMPLETED|Double Blind Treatment Period||0
8263537|NCT01778049|20375127|P1|NOT COMPLETED|Double Blind Treatment Period||0
8263538|NCT01778049|20375122|P6|COMPLETED|Double Blind Treatment Period||105
8263539|NCT01778049|20375123|P5|COMPLETED|Double Blind Treatment Period||102
8263540|NCT01778049|20375124|P4|COMPLETED|Double Blind Treatment Period||118
8263541|NCT01778049|20375125|P3|COMPLETED|Double Blind Treatment Period||111
8263542|NCT01778049|20375126|P2|COMPLETED|Double Blind Treatment Period||0
8263543|NCT01778049|20375127|P1|COMPLETED|Double Blind Treatment Period||0
8263544|NCT01778049|20375122|P6|STARTED|Double Blind Treatment Period||112
8263545|NCT01778049|20375123|P5|STARTED|Double Blind Treatment Period||114
8263546|NCT01778049|20375124|P4|STARTED|Double Blind Treatment Period||130
8263547|NCT01778049|20375125|P3|STARTED|Double Blind Treatment Period||126
8263548|NCT01778049|20375126|P2|STARTED|Double Blind Treatment Period||0
8263549|NCT01778049|20375127|P1|STARTED|Double Blind Treatment Period||0
8263550|NCT01778049|20375122|P6|NOT COMPLETED|Open Label Treatment Period||0
8263551|NCT01778049|20375123|P5|NOT COMPLETED|Open Label Treatment Period||0
8263552|NCT01778049|20375124|P4|NOT COMPLETED|Open Label Treatment Period||0
8263553|NCT01778049|20375125|P3|NOT COMPLETED|Open Label Treatment Period||0
8263554|NCT01778049|20375126|P2|NOT COMPLETED|Open Label Treatment Period||129
8263555|NCT01778049|20375127|P1|NOT COMPLETED|Open Label Treatment Period||98
8263556|NCT01778049|20375122|P6|COMPLETED|Open Label Treatment Period||0
8263557|NCT01778049|20375123|P5|COMPLETED|Open Label Treatment Period||0
8263558|NCT01778049|20375124|P4|COMPLETED|Open Label Treatment Period||0
8263559|NCT01778049|20375125|P3|COMPLETED|Open Label Treatment Period||0
8263560|NCT01778049|20375126|P2|COMPLETED|Open Label Treatment Period||226
8263561|NCT01778049|20375127|P1|COMPLETED|Open Label Treatment Period||256
8263562|NCT01778049|20375122|P6|STARTED|Open Label Treatment Period||0
8263563|NCT01778049|20375123|P5|STARTED|Open Label Treatment Period||0
8263564|NCT01778049|20375124|P4|STARTED|Open Label Treatment Period||0
8263565|NCT01778049|20375125|P3|STARTED|Open Label Treatment Period||0
8263566|NCT01778049|20375126|P2|STARTED|Open Label Treatment Period||355
8263567|NCT01778049|20375127|P1|STARTED|Open Label Treatment Period||354
8263568|NCT01778023|20375145|P2|NOT COMPLETED|Overall Study||3
8263569|NCT01778023|20375146|P1|NOT COMPLETED|Overall Study||0
8263570|NCT01778023|20375145|P2|COMPLETED|Overall Study||15
8263571|NCT01778023|20375146|P1|COMPLETED|Overall Study||36
8263572|NCT01778023|20375145|P2|Exposed|Overall Study||15
8263573|NCT01778023|20375146|P1|Exposed|Overall Study||36
8263574|NCT01778023|20375145|P2|STARTED|Overall Study||18
8263575|NCT01778023|20375146|P1|STARTED|Overall Study||36
8263576|NCT01778010|20375163|P1|NOT COMPLETED|Overall Study||5
8263577|NCT01778010|20375163|P1|COMPLETED|Overall Study||8
8263578|NCT01778010|20375163|P1|STARTED|Overall Study||13
8263579|NCT01777997|20375204|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
8263580|NCT01777997|20375204|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
8263581|NCT01777997|20375204|P1|STARTED|Weeks 48 to 72/96 on ART||28
8263582|NCT01777997|20375204|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
8263583|NCT01777997|20375204|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
8263584|NCT01777997|20375204|P1|STARTED|Weeks 0 to 24/48 on ART||36
8263585|NCT01777997|20375204|P1|NOT COMPLETED|12 Week lead-in of no ART||2
8263586|NCT01777997|20375204|P1|COMPLETED|12 Week lead-in of no ART||36
8263587|NCT01777997|20375204|P1|STARTED|12 Week lead-in of no ART||38
8263588|NCT01777945|20375216|P1|NOT COMPLETED|Overall Study||0
8263589|NCT01777945|20375216|P1|COMPLETED|Overall Study||46
8263590|NCT01777945|20375216|P1|Evaluable Participants|Overall Study||45
8263591|NCT01777945|20375216|P1|STARTED|Overall Study||46
8263592|NCT01777932|20375226|P1|NOT COMPLETED|Overall Study||205
8263593|NCT01777932|20375226|P1|COMPLETED|Overall Study||15
8263594|NCT01777932|20375226|P1|STARTED|Overall Study||220
8263595|NCT01777854|20375240|P2|NOT COMPLETED|Overall Study||3
8263596|NCT01777854|20375241|P1|NOT COMPLETED|Overall Study||3
8263597|NCT01777854|20375240|P2|COMPLETED|Overall Study||0
8263598|NCT01777854|20375241|P1|COMPLETED|Overall Study||0
8263599|NCT01777854|20375240|P2|STARTED|Overall Study||3
8263600|NCT01777854|20375241|P1|STARTED|Overall Study||3
8263601|NCT01777776|20375249|P4|NOT COMPLETED|Overall Study||4
8263602|NCT01777776|20375250|P3|NOT COMPLETED|Overall Study||6
8263603|NCT01777776|20375251|P2|NOT COMPLETED|Overall Study||12
8263604|NCT01777776|20375252|P1|NOT COMPLETED|Overall Study||6
8263605|NCT01777776|20375249|P4|COMPLETED|Overall Study||0
8263606|NCT01777776|20375250|P3|COMPLETED|Overall Study||0
8263607|NCT01777776|20375251|P2|COMPLETED|Overall Study||0
8263608|NCT01777776|20375252|P1|COMPLETED|Overall Study||0
8263609|NCT01777776|20375249|P4|STARTED|Overall Study||4
8263610|NCT01777776|20375250|P3|STARTED|Overall Study||6
8263611|NCT01777776|20375251|P2|STARTED|Overall Study||12
8263612|NCT01777776|20375252|P1|STARTED|Overall Study||6
8263613|NCT01777763|20375311|P2|NOT COMPLETED|Overall Study||47
8263614|NCT01777763|20375312|P1|NOT COMPLETED|Overall Study||4
8263615|NCT01777763|20375311|P2|COMPLETED|Overall Study||163
8263616|NCT01777763|20375312|P1|COMPLETED|Overall Study||16
8263617|NCT01777763|20375311|P2|STARTED|Overall Study||210
8263618|NCT01777763|20375312|P1|STARTED|Overall Study||20
8263619|NCT01777620|20375336|P2|NOT COMPLETED|Overall Study||0
8263620|NCT01777620|20375337|P1|NOT COMPLETED|Overall Study||1
8263621|NCT01777620|20375336|P2|COMPLETED|Overall Study||62
8263622|NCT01777620|20375337|P1|COMPLETED|Overall Study||62
8263623|NCT01777620|20375336|P2|STARTED|Overall Study||62
8263624|NCT01777620|20375337|P1|STARTED|Overall Study||63
8263625|NCT01777581|20375363|P2|NOT COMPLETED|Overall Study||2
8263626|NCT01777581|20375364|P1|NOT COMPLETED|Overall Study||3
8263627|NCT01777581|20375363|P2|COMPLETED|Overall Study||3
8263628|NCT01777581|20375364|P1|COMPLETED|Overall Study||5
8263629|NCT01777581|20375363|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
8263630|NCT01777581|20375364|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
8263631|NCT01777568|20375384|P2|NOT COMPLETED|Overall Study||0
8263632|NCT01777568|20375385|P1|NOT COMPLETED|Overall Study||0
8263633|NCT01777568|20375384|P2|COMPLETED|Overall Study||2896
8263634|NCT01777568|20375385|P1|COMPLETED|Overall Study||2853
8263635|NCT01777568|20375384|P2|STARTED|Overall Study||2896
8263636|NCT01777568|20375385|P1|STARTED|Overall Study||2853
8263637|NCT01777542|20375393|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
8263638|NCT01777542|20375394|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
8263639|NCT01777542|20375393|P2|COMPLETED|Second Intervention (20 Weeks)||14
8263640|NCT01777542|20375394|P1|COMPLETED|Second Intervention (20 Weeks)||15
8263641|NCT01777542|20375393|P2|STARTED|Second Intervention (20 Weeks)||15
8263642|NCT01777542|20375394|P1|STARTED|Second Intervention (20 Weeks)||15
8263643|NCT01777542|20375393|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
8263644|NCT01777542|20375394|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
8263645|NCT01777542|20375393|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
8263646|NCT01777542|20375394|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
8263647|NCT01777542|20375393|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
8263648|NCT01777542|20375394|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
8263649|NCT01777542|20375393|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
8263650|NCT01777542|20375394|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
8263651|NCT01777542|20375393|P2|COMPLETED|First Intervention (20 Weeks)||15
8263652|NCT01777542|20375394|P1|COMPLETED|First Intervention (20 Weeks)||15
8263653|NCT01777542|20375393|P2|STARTED|First Intervention (20 Weeks)||15
8263654|NCT01777542|20375394|P1|STARTED|First Intervention (20 Weeks)||15
8263655|NCT01777490|20375437|P4|NOT COMPLETED|Overall Study||1
8263656|NCT01777490|20375438|P3|NOT COMPLETED|Overall Study||1
8263657|NCT01777490|20375439|P2|NOT COMPLETED|Overall Study||0
8263658|NCT01777490|20375440|P1|NOT COMPLETED|Overall Study||0
8263659|NCT01777490|20375437|P4|COMPLETED|Overall Study||118
8263660|NCT01777490|20375438|P3|COMPLETED|Overall Study||118
8263661|NCT01777490|20375439|P2|COMPLETED|Overall Study||123
8263662|NCT01777490|20375440|P1|COMPLETED|Overall Study||123
8263663|NCT01777490|20375437|P4|STARTED|Overall Study||119
8263664|NCT01777490|20375438|P3|STARTED|Overall Study||119
8263665|NCT01777490|20375439|P2|STARTED|Overall Study||123
8263666|NCT01777490|20375440|P1|STARTED|Overall Study||123
8263667|NCT01777438|20375458|P2|NOT COMPLETED|Overall Study||0
8263668|NCT01777438|20375459|P1|NOT COMPLETED|Overall Study||0
8263669|NCT01777438|20375458|P2|COMPLETED|Overall Study||82
8263670|NCT01777438|20375459|P1|COMPLETED|Overall Study||352
8263671|NCT01777438|20375458|P2|STARTED|Overall Study||82
8263672|NCT01777438|20375459|P1|STARTED|Overall Study||352
8263673|NCT01777425|20375471|P1|NOT COMPLETED|Overall Study||0
8263674|NCT01777425|20375471|P1|COMPLETED|Overall Study||389
8263675|NCT01777425|20375471|P1|STARTED|Overall Study||389
8263676|NCT01777412|20375477|P1|NOT COMPLETED|Overall Study||0
8263677|NCT01777412|20375477|P1|COMPLETED|Overall Study||10
8263678|NCT01777412|20375477|P1|STARTED|Overall Study||10
8263679|NCT01777334|20375485|P2|NOT COMPLETED|Overall Study||63
8263680|NCT01777334|20375486|P1|NOT COMPLETED|Overall Study||53
8263681|NCT01777334|20375485|P2|COMPLETED|Overall Study||388
8263682|NCT01777334|20375486|P1|COMPLETED|Overall Study||401
8263683|NCT01777334|20375485|P2|STARTED|Overall Study||451
8263684|NCT01777334|20375486|P1|STARTED|Overall Study||454
8263685|NCT01777321|20375496|P2|NOT COMPLETED|Overall Study||1
8263686|NCT01777321|20375497|P1|NOT COMPLETED|Overall Study||0
8263687|NCT01777321|20375496|P2|COMPLETED|Overall Study||29
8263688|NCT01777321|20375497|P1|COMPLETED|Overall Study||30
8263689|NCT01777321|20375496|P2|STARTED|Overall Study||30
8263690|NCT01777321|20375497|P1|STARTED|Overall Study||30
8263691|NCT01777308|20375535|P2|NOT COMPLETED|Overall Study||3
8263692|NCT01777308|20375536|P1|NOT COMPLETED|Overall Study||14
8263693|NCT01777308|20375535|P2|COMPLETED|Overall Study||34
8263694|NCT01777308|20375536|P1|COMPLETED|Overall Study||105
8263695|NCT01777308|20375535|P2|Completed up to Month 73|Overall Study||37
8263696|NCT01777308|20375536|P1|Completed up to Month 73|Overall Study||118
8263697|NCT01777308|20375535|P2|STARTED|Overall Study||37
8263698|NCT01777308|20375536|P1|STARTED|Overall Study||119
8263699|NCT01777295|20375568|P2|NOT COMPLETED|Overall Study||3
8263700|NCT01777295|20375569|P1|NOT COMPLETED|Overall Study||4
8263701|NCT01777295|20375568|P2|COMPLETED|Overall Study||38
8263702|NCT01777295|20375569|P1|COMPLETED|Overall Study||36
8263703|NCT01777295|20375568|P2|STARTED|Overall Study||41
8263704|NCT01777295|20375569|P1|STARTED|Overall Study||40
8263705|NCT01777282|20375776|P5|NOT COMPLETED|Overall Study||7
8263706|NCT01777282|20375777|P4|NOT COMPLETED|Overall Study||2
8263707|NCT01777282|20375778|P3|NOT COMPLETED|Overall Study||6
8263708|NCT01777282|20375779|P2|NOT COMPLETED|Overall Study||4
8263709|NCT01777282|20375780|P1|NOT COMPLETED|Overall Study||11
8263710|NCT01777282|20375776|P5|COMPLETED|Overall Study||54
8263711|NCT01777282|20375777|P4|COMPLETED|Overall Study||59
8263712|NCT01777282|20375778|P3|COMPLETED|Overall Study||59
8263713|NCT01777282|20375779|P2|COMPLETED|Overall Study||63
8263714|NCT01777282|20375780|P1|COMPLETED|Overall Study||109
8263715|NCT01777282|20375776|P5|Completing Follow-up Period|Overall Study||54
8263716|NCT01777282|20375777|P4|Completing Follow-up Period|Overall Study||59
8263717|NCT01777282|20375778|P3|Completing Follow-up Period|Overall Study||59
8263718|NCT01777282|20375779|P2|Completing Follow-up Period|Overall Study||63
8263719|NCT01777282|20375780|P1|Completing Follow-up Period|Overall Study||109
8263720|NCT01777282|20375776|P5|Completing Treatment Period|Overall Study||54
8263721|NCT01777282|20375777|P4|Completing Treatment Period|Overall Study||59
8263722|NCT01777282|20375778|P3|Completing Treatment Period|Overall Study||59
8263723|NCT01777282|20375779|P2|Completing Treatment Period|Overall Study||63
8263724|NCT01777282|20375780|P1|Completing Treatment Period|Overall Study||109
8263725|NCT01777282|20375776|P5|STARTED|Overall Study||61
8263726|NCT01777282|20375777|P4|STARTED|Overall Study||61
8263727|NCT01777282|20375778|P3|STARTED|Overall Study||65
8263728|NCT01777282|20375779|P2|STARTED|Overall Study||67
8263729|NCT01777282|20375780|P1|STARTED|Overall Study||120
8263730|NCT01777269|20375824|P2|NOT COMPLETED|Overall Study||59
8263731|NCT01777269|20375825|P1|NOT COMPLETED|Overall Study||55
8263732|NCT01777269|20375824|P2|COMPLETED|Overall Study||184
8263733|NCT01777269|20375825|P1|COMPLETED|Overall Study||191
8263734|NCT01777269|20375824|P2|STARTED|Overall Study||243
8263735|NCT01777269|20375825|P1|STARTED|Overall Study||246
8263736|NCT01777217|20375853|P2|NOT COMPLETED|Overall Study||0
8263737|NCT01777217|20375854|P1|NOT COMPLETED|Overall Study||0
8263738|NCT01777217|20375853|P2|COMPLETED|Overall Study||4
8263739|NCT01777217|20375854|P1|COMPLETED|Overall Study||4
8263740|NCT01777217|20375853|P2|STARTED|Overall Study||4
8263741|NCT01777217|20375854|P1|STARTED|Overall Study||4
8263742|NCT01777191|20375862|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
8263743|NCT01777191|20375863|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
8263744|NCT01777191|20375862|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
8263745|NCT01777191|20375863|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
8263746|NCT01777191|20375862|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
8263747|NCT01777191|20375863|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
8263748|NCT01777191|20375862|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
8263749|NCT01777191|20375863|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
8263750|NCT01777191|20375862|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
8263751|NCT01777191|20375863|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
8263752|NCT01777191|20375862|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
8263753|NCT01777191|20375863|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
8263754|NCT01777152|20375893|P2|NOT COMPLETED|Overall Study||226
8263755|NCT01777152|20375894|P1|NOT COMPLETED|Overall Study||226
8263756|NCT01777152|20375893|P2|COMPLETED|Overall Study||0
8263757|NCT01777152|20375894|P1|COMPLETED|Overall Study||0
8263758|NCT01777152|20375893|P2|STARTED|Overall Study||226
8263759|NCT01777152|20375894|P1|STARTED|Overall Study||226
8263760|NCT01777139|20375910|P2|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
8263761|NCT01777139|20375911|P1|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
8263762|NCT01777139|20375910|P2|COMPLETED|SFUCP (Up to 1.4 Years)||0
8263763|NCT01777139|20375911|P1|COMPLETED|SFUCP (Up to 1.4 Years)||0
8263764|NCT01777139|20375910|P2|STARTED|SFUCP (Up to 1.4 Years)||4
8263765|NCT01777139|20375911|P1|STARTED|SFUCP (Up to 1.4 Years)||0
8263766|NCT01777139|20375910|P2|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8263767|NCT01777139|20375911|P1|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
8263768|NCT01777139|20375910|P2|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8263769|NCT01777139|20375911|P1|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8263770|NCT01777139|20375910|P2|STARTED|Primary Reporting Phase (Up to 4 Years)||0
8263771|NCT01777139|20375911|P1|STARTED|Primary Reporting Phase (Up to 4 Years)||30
8263772|NCT01777126|20375952|P2|NOT COMPLETED|Overall Study||0
8263773|NCT01777126|20375953|P1|NOT COMPLETED|Overall Study||0
8263774|NCT01777126|20375952|P2|COMPLETED|Overall Study||46
8263775|NCT01777126|20375953|P1|COMPLETED|Overall Study||48
8263776|NCT01777126|20375952|P2|STARTED|Overall Study||46
8263777|NCT01777126|20375953|P1|STARTED|Overall Study||48
8263793|NCT01776645|20376001|P2|NOT COMPLETED|Overall Study||14
8263794|NCT01776645|20376002|P1|NOT COMPLETED|Overall Study||14
8263795|NCT01776645|20376001|P2|COMPLETED|Overall Study||14
8263796|NCT01776645|20376002|P1|COMPLETED|Overall Study||14
8263797|NCT01776645|20376001|P2|STARTED|Overall Study||28
8263798|NCT01776645|20376002|P1|STARTED|Overall Study||28
8263799|NCT01776632|20376010|P2|NOT COMPLETED|Overall Study||29
8263800|NCT01776632|20376011|P1|NOT COMPLETED|Overall Study||27
8263801|NCT01776632|20376010|P2|COMPLETED|Overall Study||190
8263802|NCT01776632|20376011|P1|COMPLETED|Overall Study||190
8263803|NCT01776632|20376010|P2|STARTED|Overall Study||219
8263804|NCT01776632|20376011|P1|STARTED|Overall Study||217
8263805|NCT01776554|20376025|P2|NOT COMPLETED|Overall Study||23
8263806|NCT01776554|20376026|P1|NOT COMPLETED|Overall Study||17
8263807|NCT01776554|20376025|P2|COMPLETED|Overall Study||307
8263808|NCT01776554|20376026|P1|COMPLETED|Overall Study||315
8263809|NCT01776554|20376025|P2|STARTED|Overall Study||330
8263810|NCT01776554|20376026|P1|STARTED|Overall Study||332
8263811|NCT01776541|20376069|P2|NOT COMPLETED|Overall Study||75
8263812|NCT01776541|20376070|P1|NOT COMPLETED|Overall Study||56
8263813|NCT01776541|20376069|P2|COMPLETED|Overall Study||416
8263814|NCT01776541|20376070|P1|COMPLETED|Overall Study||432
8263815|NCT01776541|20376069|P2|STARTED|Overall Study||491
8263816|NCT01776541|20376070|P1|STARTED|Overall Study||488
8263829|NCT01776268|20376116|P2|NOT COMPLETED|Overall Study||0
8263830|NCT01776268|20376117|P1|NOT COMPLETED|Overall Study||0
8263831|NCT01776268|20376116|P2|COMPLETED|Overall Study||51
8263832|NCT01776268|20376117|P1|COMPLETED|Overall Study||48
8263833|NCT01776268|20376116|P2|STARTED|Overall Study||51
8263834|NCT01776268|20376117|P1|STARTED|Overall Study||48
8263835|NCT01776008|20376125|P1|NOT COMPLETED|Overall Study||2
8263836|NCT01776008|20376125|P1|COMPLETED|Overall Study||14
8263837|NCT01776008|20376125|P1|STARTED|Overall Study||16
8263838|NCT01775995|20376139|P2|NOT COMPLETED|Overall Study||1
8263839|NCT01775995|20376140|P1|NOT COMPLETED|Overall Study||1
8263840|NCT01775995|20376139|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
8263841|NCT01775995|20376140|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
8263842|NCT01775995|20376139|P2|STARTED|Overall Study||14
8263843|NCT01775995|20376140|P1|STARTED|Overall Study||21
8263844|NCT01775930|20376200|P1|NOT COMPLETED|Overall Study||1
8263845|NCT01775930|20376200|P1|COMPLETED|Overall Study||9
8263846|NCT01775930|20376200|P1|STARTED|Overall Study||10
8263847|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
8263848|NCT01775904|20376208|P1|COMPLETED|LY2886721 ODT (Water, Fasting)||24
8263849|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
8263850|NCT01775904|20376208|P1|STARTED|LY2886721 ODT (Water, Fasting)||25
8263851|NCT01775904|20376208|P1|NOT COMPLETED|Third Washout (7 Days)||0
8263852|NCT01775904|20376208|P1|COMPLETED|Third Washout (7 Days)||25
8263853|NCT01775904|20376208|P1|STARTED|Third Washout (7 Days)||25
8263854|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
8263855|NCT01775904|20376208|P1|COMPLETED|LY2886721 ODT (Water, Fed)||25
8263856|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
8263857|NCT01775904|20376208|P1|STARTED|LY2886721 ODT (Water, Fed)||25
8263858|NCT01775904|20376208|P1|NOT COMPLETED|Second Washout (7 Days)||0
8263859|NCT01775904|20376208|P1|COMPLETED|Second Washout (7 Days)||25
8263860|NCT01775904|20376208|P1|STARTED|Second Washout (7 Days)||25
8263861|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
8263862|NCT01775904|20376208|P1|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
8263863|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
8263864|NCT01775904|20376208|P1|STARTED|LY2886721 Capsule (Water, Fasting)||26
8263865|NCT01775904|20376208|P1|NOT COMPLETED|First Washout (7 Days)||0
8263866|NCT01775904|20376208|P1|COMPLETED|First Washout (7 Days)||26
8263867|NCT01775904|20376208|P1|STARTED|First Washout (7 Days)||26
8264114|NCT01775189|20376396|P1|STARTED|Drug Discrimination Phase: Day 2||0
8263868|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
8263869|NCT01775904|20376208|P1|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
8263870|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
8263871|NCT01775904|20376208|P1|STARTED|LY2886721 ODT (no Water, Fasting)||26
8263872|NCT01775865|20376233|P3|NOT COMPLETED|Overall Study||0
8263873|NCT01775865|20376234|P2|NOT COMPLETED|Overall Study||1
8263874|NCT01775865|20376235|P1|NOT COMPLETED|Overall Study||3
8263875|NCT01775865|20376233|P3|COMPLETED|Overall Study||17
8263876|NCT01775865|20376234|P2|COMPLETED|Overall Study||13
8263877|NCT01775865|20376235|P1|COMPLETED|Overall Study||11
8263878|NCT01775865|20376233|P3|STARTED|Overall Study||17
8263879|NCT01775865|20376234|P2|STARTED|Overall Study||14
8263880|NCT01775865|20376235|P1|STARTED|Overall Study||14
8263881|NCT01775852|20376251|P2|NOT COMPLETED|Overall Study||1
8263882|NCT01775852|20376252|P1|NOT COMPLETED|Overall Study||0
8263883|NCT01775852|20376251|P2|COMPLETED|Overall Study||13
8263884|NCT01775852|20376252|P1|COMPLETED|Overall Study||31
8263885|NCT01775852|20376251|P2|STARTED|Overall Study||14
8263886|NCT01775852|20376252|P1|STARTED|Overall Study||31
8263887|NCT01775800|20376266|P2|NOT COMPLETED|Overall Study||0
8263888|NCT01775800|20376267|P1|NOT COMPLETED|Overall Study||0
8263889|NCT01775800|20376266|P2|COMPLETED|Overall Study||8
8263890|NCT01775800|20376267|P1|COMPLETED|Overall Study||8
8263891|NCT01775800|20376266|P2|STARTED|Overall Study||8
8263892|NCT01775800|20376267|P1|STARTED|Overall Study||8
8263893|NCT01775787|20376274|P2|NOT COMPLETED|Second 7-10 Days||2
8263894|NCT01775787|20376275|P1|NOT COMPLETED|Second 7-10 Days||0
8263895|NCT01775787|20376274|P2|COMPLETED|Second 7-10 Days||6
8263896|NCT01775787|20376275|P1|COMPLETED|Second 7-10 Days||12
8263897|NCT01775787|20376274|P2|STARTED|Second 7-10 Days||8
8263898|NCT01775787|20376275|P1|STARTED|Second 7-10 Days||12
8263899|NCT01775787|20376274|P2|NOT COMPLETED|First 7-10 Days||6
8263900|NCT01775787|20376275|P1|NOT COMPLETED|First 7-10 Days||1
8263901|NCT01775787|20376274|P2|COMPLETED|First 7-10 Days||8
8263902|NCT01775787|20376275|P1|COMPLETED|First 7-10 Days||12
8263903|NCT01775787|20376274|P2|STARTED|First 7-10 Days||14
8263904|NCT01775787|20376275|P1|STARTED|First 7-10 Days||13
8263905|NCT01775774|20376286|P3|NOT COMPLETED|Overall Study||0
8263906|NCT01775774|20376287|P2|NOT COMPLETED|Overall Study||0
8263907|NCT01775774|20376288|P1|NOT COMPLETED|Overall Study||0
8263908|NCT01775774|20376286|P3|COMPLETED|Overall Study||3
8263909|NCT01775774|20376287|P2|COMPLETED|Overall Study||3
8263910|NCT01775774|20376288|P1|COMPLETED|Overall Study||3
8263911|NCT01775774|20376286|P3|STARTED|Overall Study||3
8263912|NCT01775774|20376287|P2|STARTED|Overall Study||3
8263913|NCT01775774|20376288|P1|STARTED|Overall Study||3
8263914|NCT01775735|20376316|P2|NOT COMPLETED|Open Label (24 Months)||4
8263915|NCT01775735|20376317|P1|NOT COMPLETED|Open Label (24 Months)||1
8263916|NCT01775735|20376316|P2|COMPLETED|Open Label (24 Months)||3
8263917|NCT01775735|20376317|P1|COMPLETED|Open Label (24 Months)||7
8263918|NCT01775735|20376316|P2|STARTED|Open Label (24 Months)||7
8263919|NCT01775735|20376317|P1|STARTED|Open Label (24 Months)||8
8263920|NCT01775735|20376316|P2|NOT COMPLETED|Intervention (6 Months)||0
8263921|NCT01775735|20376317|P1|NOT COMPLETED|Intervention (6 Months)||0
8263922|NCT01775735|20376316|P2|COMPLETED|Intervention (6 Months)||7
8263923|NCT01775735|20376317|P1|COMPLETED|Intervention (6 Months)||8
8263924|NCT01775735|20376316|P2|STARTED|Intervention (6 Months)||7
8263925|NCT01775735|20376317|P1|STARTED|Intervention (6 Months)||8
8263926|NCT01775722|20376323|P1|NOT COMPLETED|Overall Study||2
8263927|NCT01775722|20376323|P1|COMPLETED|Overall Study||20
8263928|NCT01775722|20376323|P1|STARTED|Overall Study||22
8263929|NCT01775670|20376331|P2|NOT COMPLETED|Overall Study||1
8263930|NCT01775670|20376332|P1|NOT COMPLETED|Overall Study||1
8263931|NCT01775670|20376331|P2|COMPLETED|Overall Study||2
8263932|NCT01775670|20376332|P1|COMPLETED|Overall Study||0
8263933|NCT01775670|20376331|P2|STARTED|Overall Study||3
8263934|NCT01775670|20376332|P1|STARTED|Overall Study||1
8263935|NCT01775553|20376358|P1|NOT COMPLETED|Overall Study||13
8263936|NCT01775553|20376358|P1|COMPLETED|Overall Study||0
8263937|NCT01775553|20376358|P1|STARTED|Overall Study||13
8263938|NCT01775501|20376366|P1|NOT COMPLETED|Overall Study||1
8263939|NCT01775501|20376366|P1|COMPLETED|Overall Study||39
8263940|NCT01775501|20376366|P1|STARTED|Overall Study||40
8263941|NCT01775371|20376377|P2|NOT COMPLETED|Overall Study||0
8263942|NCT01775371|20376378|P1|NOT COMPLETED|Overall Study||0
8263943|NCT01775371|20376377|P2|COMPLETED|Overall Study||330
8263944|NCT01775371|20376378|P1|COMPLETED|Overall Study||306
8263945|NCT01775371|20376377|P2|STARTED|Overall Study||330
8263946|NCT01775371|20376378|P1|STARTED|Overall Study||306
8263947|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263948|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263949|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263950|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263951|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263952|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263953|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263954|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
8263955|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
8263956|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
8263957|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
8263958|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
8263959|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
8263960|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
8263961|NCT01775189|20376390|P7|STARTED|Treatment Phase: Fourth Intervention||7
8263962|NCT01775189|20376391|P6|STARTED|Treatment Phase: Fourth Intervention||7
8263963|NCT01775189|20376392|P5|STARTED|Treatment Phase: Fourth Intervention||8
8263964|NCT01775189|20376393|P4|STARTED|Treatment Phase: Fourth Intervention||6
8263965|NCT01775189|20376394|P3|STARTED|Treatment Phase: Fourth Intervention||0
8263966|NCT01775189|20376395|P2|STARTED|Treatment Phase: Fourth Intervention||0
8263967|NCT01775189|20376396|P1|STARTED|Treatment Phase: Fourth Intervention||0
8263968|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
8263969|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263970|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263971|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
8263972|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263973|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263974|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263975|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Washout Period 3||7
8263976|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Washout Period 3||7
8263977|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Washout Period 3||8
8263978|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Washout Period 3||6
8263979|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Washout Period 3||0
8263980|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Washout Period 3||0
8263981|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Washout Period 3||0
8263982|NCT01775189|20376390|P7|STARTED|Treatment Phase: Washout Period 3||8
8263983|NCT01775189|20376391|P6|STARTED|Treatment Phase: Washout Period 3||7
8263984|NCT01775189|20376392|P5|STARTED|Treatment Phase: Washout Period 3||8
8263985|NCT01775189|20376393|P4|STARTED|Treatment Phase: Washout Period 3||7
8263986|NCT01775189|20376394|P3|STARTED|Treatment Phase: Washout Period 3||0
8263987|NCT01775189|20376395|P2|STARTED|Treatment Phase: Washout Period 3||0
8263988|NCT01775189|20376396|P1|STARTED|Treatment Phase: Washout Period 3||0
8263989|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263990|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263991|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263992|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263993|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263994|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263995|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263996|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Third Intervention||8
8263997|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Third Intervention||7
8263998|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Third Intervention||8
8263999|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Third Intervention||7
8264000|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Third Intervention||0
8264001|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Third Intervention||0
8264002|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Third Intervention||0
8264003|NCT01775189|20376390|P7|STARTED|Treatment Phase: Third Intervention||8
8264004|NCT01775189|20376391|P6|STARTED|Treatment Phase: Third Intervention||7
8264005|NCT01775189|20376392|P5|STARTED|Treatment Phase: Third Intervention||8
8264006|NCT01775189|20376393|P4|STARTED|Treatment Phase: Third Intervention||7
8264007|NCT01775189|20376394|P3|STARTED|Treatment Phase: Third Intervention||0
8264008|NCT01775189|20376395|P2|STARTED|Treatment Phase: Third Intervention||0
8264009|NCT01775189|20376396|P1|STARTED|Treatment Phase: Third Intervention||0
8264010|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264011|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264012|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264013|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
8264014|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264015|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264016|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264017|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Washout Period 2||8
8264018|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Washout Period 2||7
8264019|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Washout Period 2||8
8264020|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Washout Period 2||7
8264021|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Washout Period 2||0
8264022|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Washout Period 2||0
8264023|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Washout Period 2||0
8264024|NCT01775189|20376390|P7|STARTED|Treatment Phase: Washout Period 2||8
8264025|NCT01775189|20376391|P6|STARTED|Treatment Phase: Washout Period 2||7
8264026|NCT01775189|20376392|P5|STARTED|Treatment Phase: Washout Period 2||8
8264027|NCT01775189|20376393|P4|STARTED|Treatment Phase: Washout Period 2||8
8264028|NCT01775189|20376394|P3|STARTED|Treatment Phase: Washout Period 2||0
8264029|NCT01775189|20376395|P2|STARTED|Treatment Phase: Washout Period 2||0
8264030|NCT01775189|20376396|P1|STARTED|Treatment Phase: Washout Period 2||0
8264031|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264032|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264033|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264034|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264035|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264036|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264037|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264038|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Second Intervention||8
8264039|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Second Intervention||7
8264040|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Second Intervention||8
8264041|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Second Intervention||8
8264042|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Second Intervention||0
8264043|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Second Intervention||0
8264044|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Second Intervention||0
8264045|NCT01775189|20376390|P7|STARTED|Treatment Phase: Second Intervention||8
8264046|NCT01775189|20376391|P6|STARTED|Treatment Phase: Second Intervention||7
8264047|NCT01775189|20376392|P5|STARTED|Treatment Phase: Second Intervention||8
8264048|NCT01775189|20376393|P4|STARTED|Treatment Phase: Second Intervention||8
8264049|NCT01775189|20376394|P3|STARTED|Treatment Phase: Second Intervention||0
8264050|NCT01775189|20376395|P2|STARTED|Treatment Phase: Second Intervention||0
8264051|NCT01775189|20376396|P1|STARTED|Treatment Phase: Second Intervention||0
8264052|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264053|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
8264054|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264055|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264056|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264057|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264058|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264059|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Washout Period 1||8
8264060|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Washout Period 1||7
8264061|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Washout Period 1||8
8264062|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Washout Period 1||8
8264063|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Washout Period 1||0
8264064|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Washout Period 1||0
8264065|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Washout Period 1||0
8264066|NCT01775189|20376390|P7|STARTED|Treatment Phase: Washout Period 1||8
8264067|NCT01775189|20376391|P6|STARTED|Treatment Phase: Washout Period 1||8
8264068|NCT01775189|20376392|P5|STARTED|Treatment Phase: Washout Period 1||8
8264069|NCT01775189|20376393|P4|STARTED|Treatment Phase: Washout Period 1||8
8264070|NCT01775189|20376394|P3|STARTED|Treatment Phase: Washout Period 1||0
8264071|NCT01775189|20376395|P2|STARTED|Treatment Phase: Washout Period 1||0
8264072|NCT01775189|20376396|P1|STARTED|Treatment Phase: Washout Period 1||0
8264073|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
8264074|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
8264075|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
8264076|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
8264077|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
8264078|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
8264079|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
8264080|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: First Intervention||8
8264081|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: First Intervention||8
8264082|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: First Intervention||8
8264083|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: First Intervention||8
8264084|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: First Intervention||0
8264085|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: First Intervention||0
8264086|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: First Intervention||0
8264087|NCT01775189|20376390|P7|STARTED|Treatment Phase: First Intervention||8
8264088|NCT01775189|20376391|P6|STARTED|Treatment Phase: First Intervention||8
8264089|NCT01775189|20376392|P5|STARTED|Treatment Phase: First Intervention||8
8264090|NCT01775189|20376393|P4|STARTED|Treatment Phase: First Intervention||8
8264091|NCT01775189|20376394|P3|STARTED|Treatment Phase: First Intervention||0
8264092|NCT01775189|20376395|P2|STARTED|Treatment Phase: First Intervention||0
8264093|NCT01775189|20376396|P1|STARTED|Treatment Phase: First Intervention||0
8264094|NCT01775189|20376390|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264095|NCT01775189|20376391|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264096|NCT01775189|20376392|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264097|NCT01775189|20376393|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264098|NCT01775189|20376394|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
8264099|NCT01775189|20376395|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
8264100|NCT01775189|20376396|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264101|NCT01775189|20376390|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
8264102|NCT01775189|20376391|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
8264103|NCT01775189|20376392|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
8264104|NCT01775189|20376393|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
8264105|NCT01775189|20376394|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
8264106|NCT01775189|20376395|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
8264107|NCT01775189|20376396|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
8264108|NCT01775189|20376390|P7|STARTED|Drug Discrimination Phase: Day 2||0
8264109|NCT01775189|20376391|P6|STARTED|Drug Discrimination Phase: Day 2||0
8264110|NCT01775189|20376392|P5|STARTED|Drug Discrimination Phase: Day 2||0
8264111|NCT01775189|20376393|P4|STARTED|Drug Discrimination Phase: Day 2||0
8264112|NCT01775189|20376394|P3|STARTED|Drug Discrimination Phase: Day 2||23
8264113|NCT01775189|20376395|P2|STARTED|Drug Discrimination Phase: Day 2||19
8264115|NCT01775189|20376390|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264116|NCT01775189|20376391|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264117|NCT01775189|20376392|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264118|NCT01775189|20376393|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264119|NCT01775189|20376394|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264120|NCT01775189|20376395|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
8264121|NCT01775189|20376396|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264122|NCT01775189|20376390|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
8264123|NCT01775189|20376391|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
8264124|NCT01775189|20376392|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
8264125|NCT01775189|20376393|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
8264126|NCT01775189|20376394|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
8264127|NCT01775189|20376395|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
8264128|NCT01775189|20376396|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
8264129|NCT01775189|20376390|P7|STARTED|Drug Discrimination Phase: Day 1||0
8264130|NCT01775189|20376391|P6|STARTED|Drug Discrimination Phase: Day 1||0
8264131|NCT01775189|20376392|P5|STARTED|Drug Discrimination Phase: Day 1||0
8264132|NCT01775189|20376393|P4|STARTED|Drug Discrimination Phase: Day 1||0
8264133|NCT01775189|20376394|P3|STARTED|Drug Discrimination Phase: Day 1||23
8264134|NCT01775189|20376395|P2|STARTED|Drug Discrimination Phase: Day 1||22
8264135|NCT01775189|20376396|P1|STARTED|Drug Discrimination Phase: Day 1||0
8264136|NCT01775189|20376390|P7|NOT COMPLETED|Naloxone Challenge Phase||0
8264137|NCT01775189|20376391|P6|NOT COMPLETED|Naloxone Challenge Phase||0
8264138|NCT01775189|20376392|P5|NOT COMPLETED|Naloxone Challenge Phase||0
8264139|NCT01775189|20376393|P4|NOT COMPLETED|Naloxone Challenge Phase||0
8264140|NCT01775189|20376394|P3|NOT COMPLETED|Naloxone Challenge Phase||0
8264141|NCT01775189|20376395|P2|NOT COMPLETED|Naloxone Challenge Phase||0
8264142|NCT01775189|20376396|P1|NOT COMPLETED|Naloxone Challenge Phase||0
8264143|NCT01775189|20376390|P7|COMPLETED|Naloxone Challenge Phase||0
8264144|NCT01775189|20376391|P6|COMPLETED|Naloxone Challenge Phase||0
8264145|NCT01775189|20376392|P5|COMPLETED|Naloxone Challenge Phase||0
8264146|NCT01775189|20376393|P4|COMPLETED|Naloxone Challenge Phase||0
8264147|NCT01775189|20376394|P3|COMPLETED|Naloxone Challenge Phase||0
8264148|NCT01775189|20376395|P2|COMPLETED|Naloxone Challenge Phase||0
8264149|NCT01775189|20376396|P1|COMPLETED|Naloxone Challenge Phase||45
8264150|NCT01775189|20376390|P7|STARTED|Naloxone Challenge Phase||0
8264151|NCT01775189|20376391|P6|STARTED|Naloxone Challenge Phase||0
8264152|NCT01775189|20376392|P5|STARTED|Naloxone Challenge Phase||0
8264153|NCT01775189|20376393|P4|STARTED|Naloxone Challenge Phase||0
8264154|NCT01775189|20376394|P3|STARTED|Naloxone Challenge Phase||0
8264155|NCT01775189|20376395|P2|STARTED|Naloxone Challenge Phase||0
8264156|NCT01775189|20376396|P1|STARTED|Naloxone Challenge Phase||45
8264157|NCT01775137|20376615|P1|NOT COMPLETED|Overall Study||11
8264158|NCT01775137|20376615|P1|COMPLETED|Overall Study||34
8264159|NCT01775137|20376615|P1|STARTED|Overall Study||45
8264160|NCT01775124|20376642|P2|NOT COMPLETED|Extension Period||18
8264161|NCT01775124|20376643|P1|NOT COMPLETED|Extension Period||12
8264162|NCT01775124|20376642|P2|COMPLETED|Extension Period||138
8264163|NCT01775124|20376643|P1|COMPLETED|Extension Period||145
8264164|NCT01775124|20376642|P2|STARTED|Extension Period||156
8264165|NCT01775124|20376643|P1|STARTED|Extension Period||157
8264166|NCT01775124|20376642|P2|NOT COMPLETED|Core Period||10
8264167|NCT01775124|20376643|P1|NOT COMPLETED|Core Period||11
8264168|NCT01775124|20376642|P2|COMPLETED|Core Period||156
8264169|NCT01775124|20376643|P1|COMPLETED|Core Period||157
8264170|NCT01775124|20376642|P2|Safety Set|Core Period||166
8264171|NCT01775124|20376643|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
8264172|NCT01775124|20376642|P2|Per Protocol Set|Core Period||155
8264173|NCT01775124|20376643|P1|Per Protocol Set|Core Period||157
8264174|NCT01775124|20376642|P2|Full Analysis Set|Core Period||166
8264175|NCT01775124|20376643|P1|Full Analysis Set|Core Period||167
8264176|NCT01775124|20376642|P2|STARTED|Core Period||166
8264177|NCT01775124|20376643|P1|STARTED|Core Period||168
8264178|NCT01774981|20376678|P8|NOT COMPLETED|Overall Study||1
8264179|NCT01774981|20376679|P7|NOT COMPLETED|Overall Study||0
8264180|NCT01774981|20376680|P6|NOT COMPLETED|Overall Study||1
8264181|NCT01774981|20376681|P5|NOT COMPLETED|Overall Study||1
8264182|NCT01774981|20376682|P4|NOT COMPLETED|Overall Study||0
8264183|NCT01774981|20376683|P3|NOT COMPLETED|Overall Study||0
8264184|NCT01774981|20376684|P2|NOT COMPLETED|Overall Study||0
8264185|NCT01774981|20376685|P1|NOT COMPLETED|Overall Study||0
8264186|NCT01774981|20376678|P8|COMPLETED|Overall Study||11
8264187|NCT01774981|20376679|P7|COMPLETED|Overall Study||13
8264188|NCT01774981|20376680|P6|COMPLETED|Overall Study||13
8264189|NCT01774981|20376681|P5|COMPLETED|Overall Study||5
8264190|NCT01774981|20376682|P4|COMPLETED|Overall Study||4
8264191|NCT01774981|20376683|P3|COMPLETED|Overall Study||4
8264192|NCT01774981|20376684|P2|COMPLETED|Overall Study||4
8264193|NCT01774981|20376685|P1|COMPLETED|Overall Study||3
8264194|NCT01774981|20376678|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
8264195|NCT01774981|20376679|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
8264196|NCT01774981|20376680|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
8264197|NCT01774981|20376681|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8264198|NCT01774981|20376682|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8264199|NCT01774981|20376683|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
8264290|NCT01774305|20376938|P2|NOT COMPLETED|Overall Study||0
8264200|NCT01774981|20376684|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8264201|NCT01774981|20376685|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8264202|NCT01774981|20376678|P8|STARTED|Overall Study||12
8264203|NCT01774981|20376679|P7|STARTED|Overall Study||13
8264204|NCT01774981|20376680|P6|STARTED|Overall Study||14
8264205|NCT01774981|20376681|P5|STARTED|Overall Study||6
8264206|NCT01774981|20376682|P4|STARTED|Overall Study||4
8264207|NCT01774981|20376683|P3|STARTED|Overall Study||4
8264208|NCT01774981|20376684|P2|STARTED|Overall Study||4
8264209|NCT01774981|20376685|P1|STARTED|Overall Study||3
8264210|NCT01774968|20376717|P2|NOT COMPLETED|Overall Study||35
8264211|NCT01774968|20376718|P1|NOT COMPLETED|Overall Study||30
8264212|NCT01774968|20376717|P2|COMPLETED|Overall Study||128
8264213|NCT01774968|20376718|P1|COMPLETED|Overall Study||132
8264214|NCT01774968|20376717|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
8264215|NCT01774968|20376718|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
8264216|NCT01774968|20376717|P2|STARTED|Overall Study||163
8264217|NCT01774968|20376718|P1|STARTED|Overall Study||162
8264218|NCT01774929|20376752|P1|NOT COMPLETED|Overall Study||3
8264219|NCT01774929|20376752|P1|COMPLETED|Overall Study||32
8264220|NCT01774929|20376752|P1|STARTED|Overall Study||35
8264221|NCT01774903|20376758|P1|NOT COMPLETED|Overall Study||11
8264222|NCT01774903|20376758|P1|COMPLETED|Overall Study||34
8264223|NCT01774903|20376758|P1|STARTED|Overall Study||45
8264224|NCT01774851|20376767|P2|NOT COMPLETED|Overall Study||0
8264225|NCT01774851|20376768|P1|NOT COMPLETED|Overall Study||0
8264226|NCT01774851|20376767|P2|COMPLETED|Overall Study||42
8264227|NCT01774851|20376768|P1|COMPLETED|Overall Study||42
8264228|NCT01774851|20376767|P2|STARTED|Overall Study||42
8264229|NCT01774851|20376768|P1|STARTED|Overall Study||42
8264230|NCT01774799|20376778|P4|NOT COMPLETED|Overall Study||0
8264231|NCT01774799|20376779|P3|NOT COMPLETED|Overall Study||0
8264232|NCT01774799|20376780|P2|NOT COMPLETED|Overall Study||1
8264233|NCT01774799|20376781|P1|NOT COMPLETED|Overall Study||1
8264234|NCT01774799|20376778|P4|COMPLETED|Overall Study||190
8264235|NCT01774799|20376779|P3|COMPLETED|Overall Study||212
8264236|NCT01774799|20376780|P2|COMPLETED|Overall Study||189
8264237|NCT01774799|20376781|P1|COMPLETED|Overall Study||211
8264238|NCT01774799|20376778|P4|STARTED|Overall Study||190
8264239|NCT01774799|20376779|P3|STARTED|Overall Study||212
8264240|NCT01774799|20376780|P2|STARTED|Overall Study||190
8264241|NCT01774799|20376781|P1|STARTED|Overall Study||212
8264242|NCT01774786|20376797|P2|NOT COMPLETED|Overall Study||346
8264243|NCT01774786|20376798|P1|NOT COMPLETED|Overall Study||328
8264244|NCT01774786|20376797|P2|COMPLETED|Overall Study||46
8264245|NCT01774786|20376798|P1|COMPLETED|Overall Study||60
8264246|NCT01774786|20376797|P2|Received Placebo (No Pertuzumab)|Overall Study||388
8264247|NCT01774786|20376798|P1|Received Placebo (No Pertuzumab)|Overall Study||0
8264248|NCT01774786|20376797|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
8264249|NCT01774786|20376798|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
8264250|NCT01774786|20376797|P2|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
8264251|NCT01774786|20376798|P1|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
8264252|NCT01774786|20376797|P2|STARTED|Overall Study||392
8264253|NCT01774786|20376798|P1|STARTED|Overall Study||388
8264254|NCT01774760|20376828|P1|NOT COMPLETED|Overall Study||0
8264255|NCT01774760|20376828|P1|COMPLETED|Overall Study||10
8264256|NCT01774760|20376828|P1|STARTED|Overall Study||10
8264257|NCT01774721|20376834|P2|NOT COMPLETED|Overall Study||225
8264258|NCT01774721|20376835|P1|NOT COMPLETED|Overall Study||227
8264259|NCT01774721|20376834|P2|COMPLETED|Overall Study||0
8264260|NCT01774721|20376835|P1|COMPLETED|Overall Study||0
8264261|NCT01774721|20376834|P2|Treated|Overall Study||224
8264262|NCT01774721|20376835|P1|Treated|Overall Study||227
8264263|NCT01774721|20376834|P2|STARTED|Overall Study||225
8264264|NCT01774721|20376835|P1|STARTED|Overall Study||227
8264265|NCT01774604|20376879|P2|NOT COMPLETED|Overall Study||0
8264266|NCT01774604|20376880|P1|NOT COMPLETED|Overall Study||0
8264267|NCT01774604|20376879|P2|COMPLETED|Overall Study||226
8264268|NCT01774604|20376880|P1|COMPLETED|Overall Study||223
8264269|NCT01774604|20376879|P2|STARTED|Overall Study||226
8264270|NCT01774604|20376880|P1|STARTED|Overall Study||223
8264271|NCT01774591|20376900|P2|NOT COMPLETED|Overall Study||4
8264272|NCT01774591|20376901|P1|NOT COMPLETED|Overall Study||1
8264273|NCT01774591|20376900|P2|COMPLETED|Overall Study||7
8264274|NCT01774591|20376901|P1|COMPLETED|Overall Study||9
8264275|NCT01774591|20376900|P2|STARTED|Overall Study||11
8264276|NCT01774591|20376901|P1|STARTED|Overall Study||10
8264277|NCT01774370|20376911|P1|NOT COMPLETED|Overall Study||129
8264278|NCT01774370|20376911|P1|COMPLETED|Overall Study||3053
8264279|NCT01774370|20376911|P1|STARTED|Overall Study||3182
8264280|NCT01774344|20376919|P2|NOT COMPLETED|Overall Study||121
8264281|NCT01774344|20376920|P1|NOT COMPLETED|Overall Study||62
8264282|NCT01774344|20376919|P2|COMPLETED|Overall Study||258
8264283|NCT01774344|20376920|P1|COMPLETED|Overall Study||132
8264284|NCT01774344|20376919|P2|Entered Survival FU|Overall Study||291
8264285|NCT01774344|20376920|P1|Entered Survival FU|Overall Study||145
8264286|NCT01774344|20376919|P2|Treated|Overall Study||374
8264287|NCT01774344|20376920|P1|Treated|Overall Study||193
8264288|NCT01774344|20376919|P2|STARTED|Overall Study||379
8264289|NCT01774344|20376920|P1|STARTED|Overall Study||194
8264291|NCT01774305|20376939|P1|NOT COMPLETED|Overall Study||1
8264292|NCT01774305|20376938|P2|COMPLETED|Overall Study||71
8264293|NCT01774305|20376939|P1|COMPLETED|Overall Study||70
8264294|NCT01774305|20376938|P2|STARTED|Overall Study||71
8264295|NCT01774305|20376939|P1|STARTED|Overall Study||71
8264296|NCT01774253|20376947|P1|NOT COMPLETED|Overall Study||9
8264297|NCT01774253|20376947|P1|COMPLETED|Overall Study||0
8264298|NCT01774253|20376947|P1|STARTED|Overall Study||9
8264299|NCT01774149|20376957|P2|NOT COMPLETED|Overall Study||3
8264300|NCT01774149|20376958|P1|NOT COMPLETED|Overall Study||1
8264301|NCT01774149|20376957|P2|COMPLETED|Overall Study||12
8264302|NCT01774149|20376958|P1|COMPLETED|Overall Study||14
8264303|NCT01774149|20376957|P2|STARTED|Overall Study||15
8264304|NCT01774149|20376958|P1|STARTED|Overall Study||15
8264305|NCT01774110|20376966|P1|NOT COMPLETED|Overall Study||7
8264306|NCT01774110|20376966|P1|COMPLETED|Overall Study||5
8264307|NCT01774110|20376966|P1|STARTED|Overall Study||12
8264308|NCT01774097|20376974|P2|NOT COMPLETED|Overall Study||2
8264309|NCT01774097|20376975|P1|NOT COMPLETED|Overall Study||2
8264310|NCT01774097|20376974|P2|COMPLETED|Overall Study||40
8264311|NCT01774097|20376975|P1|COMPLETED|Overall Study||38
8264312|NCT01774097|20376974|P2|STARTED|Overall Study||42
8264313|NCT01774097|20376975|P1|STARTED|Overall Study||40
8264314|NCT01774084|20377005|P2|NOT COMPLETED|Overall Study||0
8264315|NCT01774084|20377006|P1|NOT COMPLETED|Overall Study||1
8264316|NCT01774084|20377005|P2|COMPLETED|Overall Study||12
8264317|NCT01774084|20377006|P1|COMPLETED|Overall Study||10
8264318|NCT01774084|20377005|P2|STARTED|Overall Study||12
8264319|NCT01774084|20377006|P1|STARTED|Overall Study||11
8264320|NCT01774045|20377016|P2|NOT COMPLETED|Overall Study||0
8264321|NCT01774045|20377017|P1|NOT COMPLETED|Overall Study||0
8264322|NCT01774045|20377016|P2|COMPLETED|Overall Study||7
8264323|NCT01774045|20377017|P1|COMPLETED|Overall Study||23
8264324|NCT01774045|20377016|P2|STARTED|Overall Study||7
8264325|NCT01774045|20377017|P1|STARTED|Overall Study||23
8264326|NCT01773993|20377031|P1|NOT COMPLETED|Overall Study||35
8264327|NCT01773993|20377031|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
8264328|NCT01773993|20377031|P1|STARTED|Overall Study||534
8264329|NCT01773967|20377050|P2|NOT COMPLETED|Overall Study||13
8264330|NCT01773967|20377051|P1|NOT COMPLETED|Overall Study||15
8264331|NCT01773967|20377050|P2|COMPLETED|Overall Study||475
8264332|NCT01773967|20377051|P1|COMPLETED|Overall Study||468
8264333|NCT01773967|20377050|P2|STARTED|Overall Study||488
8264334|NCT01773967|20377051|P1|STARTED|Overall Study||483
8264335|NCT01773954|20377061|P1|NOT COMPLETED|Overall Study||9
8264336|NCT01773954|20377061|P1|COMPLETED|Overall Study||31
8264337|NCT01773954|20377061|P1|STARTED|Overall Study||40
8264338|NCT01773889|20377066|P1|NOT COMPLETED|Overall Study||2
8264339|NCT01773889|20377066|P1|COMPLETED|Overall Study||0
8264340|NCT01773889|20377066|P1|STARTED|Overall Study||2
8264341|NCT01773473|20377072|P2|NOT COMPLETED|Overall Study||19
8264342|NCT01773473|20377073|P1|NOT COMPLETED|Overall Study||16
8264343|NCT01773473|20377072|P2|COMPLETED|Overall Study||177
8264344|NCT01773473|20377073|P1|COMPLETED|Overall Study||191
8264345|NCT01773473|20377072|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
8264346|NCT01773473|20377073|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
8264347|NCT01773473|20377072|P2|STARTED|Overall Study||196
8264348|NCT01773473|20377073|P1|STARTED|Overall Study||207
8264349|NCT01773421|20377095|P7|NOT COMPLETED|Extension Phase||0
8264350|NCT01773421|20377096|P6|NOT COMPLETED|Extension Phase||2
8264351|NCT01773421|20377097|P5|NOT COMPLETED|Extension Phase||3
8264352|NCT01773421|20377098|P4|NOT COMPLETED|Extension Phase||0
8264353|NCT01773421|20377099|P3|NOT COMPLETED|Extension Phase||0
8264354|NCT01773421|20377100|P2|NOT COMPLETED|Extension Phase||0
8264355|NCT01773421|20377101|P1|NOT COMPLETED|Extension Phase||0
8264356|NCT01773421|20377095|P7|COMPLETED|Extension Phase||0
8264357|NCT01773421|20377096|P6|COMPLETED|Extension Phase||1
8264358|NCT01773421|20377097|P5|COMPLETED|Extension Phase||12
8264359|NCT01773421|20377098|P4|COMPLETED|Extension Phase||0
8264360|NCT01773421|20377099|P3|COMPLETED|Extension Phase||0
8264361|NCT01773421|20377100|P2|COMPLETED|Extension Phase||0
8264362|NCT01773421|20377101|P1|COMPLETED|Extension Phase||0
8264363|NCT01773421|20377095|P7|STARTED|Extension Phase||0
8264364|NCT01773421|20377096|P6|STARTED|Extension Phase||3
8264365|NCT01773421|20377097|P5|STARTED|Extension Phase||15
8264366|NCT01773421|20377098|P4|STARTED|Extension Phase||0
8264367|NCT01773421|20377099|P3|STARTED|Extension Phase||0
8264368|NCT01773421|20377100|P2|STARTED|Extension Phase||0
8264369|NCT01773421|20377101|P1|STARTED|Extension Phase||0
8264370|NCT01773421|20377095|P7|NOT COMPLETED|Treatment Phase||0
8264371|NCT01773421|20377096|P6|NOT COMPLETED|Treatment Phase||0
8264372|NCT01773421|20377097|P5|NOT COMPLETED|Treatment Phase||0
8264373|NCT01773421|20377098|P4|NOT COMPLETED|Treatment Phase||2
8264374|NCT01773421|20377099|P3|NOT COMPLETED|Treatment Phase||6
8264375|NCT01773421|20377100|P2|NOT COMPLETED|Treatment Phase||0
8264376|NCT01773421|20377101|P1|NOT COMPLETED|Treatment Phase||0
8264377|NCT01773421|20377095|P7|COMPLETED|Treatment Phase||0
8264378|NCT01773421|20377096|P6|COMPLETED|Treatment Phase||0
8264379|NCT01773421|20377097|P5|COMPLETED|Treatment Phase||0
8264380|NCT01773421|20377098|P4|COMPLETED|Treatment Phase||5
8264381|NCT01773421|20377099|P3|COMPLETED|Treatment Phase||13
8264382|NCT01773421|20377100|P2|COMPLETED|Treatment Phase||8
8264383|NCT01773421|20377101|P1|COMPLETED|Treatment Phase||7
8264384|NCT01773421|20377095|P7|STARTED|Treatment Phase||0
8264385|NCT01773421|20377096|P6|STARTED|Treatment Phase||0
8264386|NCT01773421|20377097|P5|STARTED|Treatment Phase||0
8264387|NCT01773421|20377098|P4|STARTED|Treatment Phase||7
8264388|NCT01773421|20377099|P3|STARTED|Treatment Phase||19
8264389|NCT01773421|20377100|P2|STARTED|Treatment Phase||8
8264390|NCT01773421|20377101|P1|STARTED|Treatment Phase||7
8264391|NCT01773291|20377132|P3|NOT COMPLETED|Overall Study||1
8264392|NCT01773291|20377133|P2|NOT COMPLETED|Overall Study||0
8264393|NCT01773291|20377134|P1|NOT COMPLETED|Overall Study||1
8264394|NCT01773291|20377132|P3|COMPLETED|Overall Study||6
8264395|NCT01773291|20377133|P2|COMPLETED|Overall Study||9
8264396|NCT01773291|20377134|P1|COMPLETED|Overall Study||7
8264397|NCT01773291|20377132|P3|STARTED|Overall Study||7
8264398|NCT01773291|20377133|P2|STARTED|Overall Study||9
8264399|NCT01773291|20377134|P1|STARTED|Overall Study||8
8264400|NCT01773226|20377145|P1|NOT COMPLETED|Overall Study||1
8264401|NCT01773226|20377145|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
8264402|NCT01773226|20377145|P1|STARTED|Overall Study||11
8264403|NCT01773187|20377155|P2|NOT COMPLETED|Overall Study||32
8264404|NCT01773187|20377156|P1|NOT COMPLETED|Overall Study||53
8264405|NCT01773187|20377155|P2|COMPLETED|Overall Study||75
8264406|NCT01773187|20377156|P1|COMPLETED|Overall Study||167
8264407|NCT01773187|20377155|P2|STARTED|Overall Study||107
8264408|NCT01773187|20377156|P1|STARTED|Overall Study||220
8264409|NCT01773135|20377166|P1|NOT COMPLETED|Overall Study||0
8264410|NCT01773135|20377166|P1|COMPLETED|Overall Study||262
8264411|NCT01773135|20377166|P1|STARTED|Overall Study||262
8264412|NCT01773122|20377175|P4|NOT COMPLETED|Overall Study||1
8264413|NCT01773122|20377176|P3|NOT COMPLETED|Overall Study||0
8264414|NCT01773122|20377177|P2|NOT COMPLETED|Overall Study||1
8264415|NCT01773122|20377178|P1|NOT COMPLETED|Overall Study||3
8264416|NCT01773122|20377175|P4|COMPLETED|Overall Study||18
8264417|NCT01773122|20377176|P3|COMPLETED|Overall Study||19
8264418|NCT01773122|20377177|P2|COMPLETED|Overall Study||18
8264419|NCT01773122|20377178|P1|COMPLETED|Overall Study||17
8264420|NCT01773122|20377175|P4|STARTED|Overall Study||19
8264421|NCT01773122|20377176|P3|STARTED|Overall Study||19
8264422|NCT01773122|20377177|P2|STARTED|Overall Study||19
8264423|NCT01773122|20377178|P1|STARTED|Overall Study||20
8264424|NCT01773109|20377192|P1|NOT COMPLETED|Overall Study||3
8264425|NCT01773109|20377192|P1|COMPLETED|Overall Study||37
8264426|NCT01773109|20377192|P1|STARTED|Overall Study||40
8264427|NCT01773070|20377196|P1|NOT COMPLETED|Overall Study||81
8264428|NCT01773070|20377196|P1|COMPLETED|Overall Study||397
8264429|NCT01773070|20377196|P1|STARTED|Overall Study||478
8264430|NCT01772823|20377206|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
8264431|NCT01772823|20377207|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
8264432|NCT01772823|20377206|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
8264433|NCT01772823|20377207|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
8264434|NCT01772823|20377206|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
8264435|NCT01772823|20377207|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
8264436|NCT01772823|20377206|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
8264437|NCT01772823|20377207|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
8264438|NCT01772823|20377206|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
8264439|NCT01772823|20377207|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
8264440|NCT01772823|20377206|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
8264441|NCT01772823|20377207|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
8264442|NCT01772823|20377206|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
8264443|NCT01772823|20377207|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
8264444|NCT01772823|20377206|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
8264445|NCT01772823|20377207|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
8264446|NCT01772823|20377206|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
8264447|NCT01772823|20377207|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
8264448|NCT01772758|20377307|P4|NOT COMPLETED|Overall Study||0
8264449|NCT01772758|20377308|P3|NOT COMPLETED|Overall Study||0
8264450|NCT01772758|20377309|P2|NOT COMPLETED|Overall Study||0
8264451|NCT01772758|20377310|P1|NOT COMPLETED|Overall Study||0
8264452|NCT01772758|20377307|P4|COMPLETED|Overall Study||17
8264453|NCT01772758|20377308|P3|COMPLETED|Overall Study||12
8264454|NCT01772758|20377309|P2|COMPLETED|Overall Study||17
8264455|NCT01772758|20377310|P1|COMPLETED|Overall Study||18
8264456|NCT01772758|20377307|P4|STARTED|Overall Study||17
8264457|NCT01772758|20377308|P3|STARTED|Overall Study||12
8264458|NCT01772758|20377309|P2|STARTED|Overall Study||17
8264459|NCT01772758|20377310|P1|STARTED|Overall Study||18
8264460|NCT01772719|20377320|P1|NOT COMPLETED|Overall Study||7
8264461|NCT01772719|20377320|P1|COMPLETED|Overall Study||0
8264462|NCT01772719|20377320|P1|STARTED|Overall Study||7
8264463|NCT01772693|20377333|P2|NOT COMPLETED|Overall Study||1
8264464|NCT01772693|20377334|P1|NOT COMPLETED|Overall Study||6
8264465|NCT01772693|20377333|P2|COMPLETED|Overall Study||6
8264466|NCT01772693|20377334|P1|COMPLETED|Overall Study||14
8264467|NCT01772693|20377333|P2|STARTED|Overall Study||7
8264468|NCT01772693|20377334|P1|STARTED|Overall Study||20
8264469|NCT01772654|20377348|P2|NOT COMPLETED|Overall Study||0
8264470|NCT01772654|20377349|P1|NOT COMPLETED|Overall Study||0
8264471|NCT01772654|20377348|P2|COMPLETED|Overall Study||15
8264472|NCT01772654|20377349|P1|COMPLETED|Overall Study||2
8264473|NCT01772654|20377348|P2|STARTED|Overall Study||15
8264474|NCT01772654|20377349|P1|STARTED|Overall Study||2
8264475|NCT01772576|20377355|P1|NOT COMPLETED|Overall Study||34
8264476|NCT01772576|20377355|P1|COMPLETED|Overall Study||133
8264477|NCT01772576|20377355|P1|STARTED|Overall Study||167
8264478|NCT01772550|20377367|P3|NOT COMPLETED|Overall Study||6
8264479|NCT01772550|20377368|P2|NOT COMPLETED|Overall Study||1
8264480|NCT01772550|20377369|P1|NOT COMPLETED|Overall Study||1
8264481|NCT01772550|20377367|P3|COMPLETED|Overall Study||27
8264482|NCT01772550|20377368|P2|COMPLETED|Overall Study||102
8264483|NCT01772550|20377369|P1|COMPLETED|Overall Study||101
8264484|NCT01772550|20377367|P3|CT Cardiac|Overall Study||1
8264485|NCT01772550|20377368|P2|CT Cardiac|Overall Study||7
8264486|NCT01772550|20377369|P1|CT Cardiac|Overall Study||7
8264487|NCT01772550|20377367|P3|CT Kidney|Overall Study||6
8264488|NCT01772550|20377368|P2|CT Kidney|Overall Study||19
8264489|NCT01772550|20377369|P1|CT Kidney|Overall Study||12
8264490|NCT01772550|20377367|P3|CT Liver|Overall Study||8
8264491|NCT01772550|20377368|P2|CT Liver|Overall Study||14
8264492|NCT01772550|20377369|P1|CT Liver|Overall Study||18
8264493|NCT01772550|20377367|P3|CT Angiogram|Overall Study||4
8264494|NCT01772550|20377368|P2|CT Angiogram|Overall Study||25
8264495|NCT01772550|20377369|P1|CT Angiogram|Overall Study||24
8264496|NCT01772550|20377367|P3|CT Pancreas|Overall Study||8
8264497|NCT01772550|20377368|P2|CT Pancreas|Overall Study||36
8264498|NCT01772550|20377369|P1|CT Pancreas|Overall Study||40
8264499|NCT01772550|20377367|P3|STARTED|Overall Study||33
8264500|NCT01772550|20377368|P2|STARTED|Overall Study||103
8264501|NCT01772550|20377369|P1|STARTED|Overall Study||102
8264502|NCT01772537|20377410|P3|NOT COMPLETED|Overall Study||0
8264503|NCT01772537|20377411|P2|NOT COMPLETED|Overall Study||0
8264504|NCT01772537|20377412|P1|NOT COMPLETED|Overall Study||1
8264505|NCT01772537|20377410|P3|COMPLETED|Overall Study||6
8264506|NCT01772537|20377411|P2|COMPLETED|Overall Study||3
8264507|NCT01772537|20377412|P1|COMPLETED|Overall Study||4
8264508|NCT01772537|20377410|P3|STARTED|Overall Study||6
8264509|NCT01772537|20377411|P2|STARTED|Overall Study||3
8264510|NCT01772537|20377412|P1|STARTED|Overall Study||5
8264511|NCT01772472|20377428|P2|NOT COMPLETED|Overall Study||743
8264512|NCT01772472|20377429|P1|NOT COMPLETED|Overall Study||743
8264513|NCT01772472|20377428|P2|COMPLETED|Overall Study||0
8264514|NCT01772472|20377429|P1|COMPLETED|Overall Study||0
8264515|NCT01772472|20377428|P2|STARTED|Overall Study||743
8264516|NCT01772472|20377429|P1|STARTED|Overall Study||743
8264517|NCT01772368|20377441|P1|NOT COMPLETED|Overall Study||7
8264518|NCT01772368|20377441|P1|COMPLETED|Overall Study||65
8264519|NCT01772368|20377441|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
8264520|NCT01772368|20377441|P1|Received FS MDPI 100/50 mcg|Overall Study||68
8264521|NCT01772368|20377441|P1|Received FS MDPI 100/25 mcg|Overall Study||67
8264522|NCT01772368|20377441|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
8264523|NCT01772368|20377441|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
8264524|NCT01772368|20377441|P1|Received Fp MDPI 100 mcg|Overall Study||67
8264525|NCT01772368|20377441|P1|STARTED|Overall Study||72
8264526|NCT01772316|20377487|P1|NOT COMPLETED|Overall Study||7
8264527|NCT01772316|20377487|P1|COMPLETED|Overall Study||40
8264528|NCT01772316|20377487|P1|STARTED|Overall Study||47
8264529|NCT01772160|20377505|P1|NOT COMPLETED|Overall Study||48
8264530|NCT01772160|20377505|P1|COMPLETED|Overall Study||346
8264531|NCT01772160|20377505|P1|STARTED|Overall Study||394
8264532|NCT01772147|20377528|P3|NOT COMPLETED|Overall Study||18
8264533|NCT01772147|20377529|P2|NOT COMPLETED|Overall Study||25
8264534|NCT01772147|20377530|P1|NOT COMPLETED|Overall Study||31
8264535|NCT01772147|20377528|P3|COMPLETED|Overall Study||184
8264536|NCT01772147|20377529|P2|COMPLETED|Overall Study||178
8264537|NCT01772147|20377530|P1|COMPLETED|Overall Study||170
8264538|NCT01772147|20377528|P3|STARTED|Overall Study||202
8264539|NCT01772147|20377529|P2|STARTED|Overall Study||203
8264540|NCT01772147|20377530|P1|STARTED|Overall Study||201
8264541|NCT01772134|20377550|P3|NOT COMPLETED|Overall Study||22
8264542|NCT01772134|20377551|P2|NOT COMPLETED|Overall Study||14
8264543|NCT01772134|20377552|P1|NOT COMPLETED|Overall Study||29
8264544|NCT01772134|20377550|P3|COMPLETED|Overall Study||184
8264545|NCT01772134|20377551|P2|COMPLETED|Overall Study||190
8264546|NCT01772134|20377552|P1|COMPLETED|Overall Study||178
8264547|NCT01772134|20377550|P3|Received Randomized Study Medication|Overall Study||205
8264548|NCT01772134|20377551|P2|Received Randomized Study Medication|Overall Study||204
8264549|NCT01772134|20377552|P1|Received Randomized Study Medication|Overall Study||205
8264550|NCT01772134|20377550|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
8264551|NCT01772134|20377551|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
8264552|NCT01772134|20377552|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
8264553|NCT01771991|20377571|P2|NOT COMPLETED|Overall Study||6
8264554|NCT01771991|20377572|P1|NOT COMPLETED|Overall Study||8
8264555|NCT01771991|20377571|P2|COMPLETED|Overall Study||30
8264556|NCT01771991|20377572|P1|COMPLETED|Overall Study||30
8264557|NCT01771991|20377571|P2|Started Treatment|Overall Study||34
8264558|NCT01771991|20377572|P1|Started Treatment|Overall Study||37
8264559|NCT01771991|20377571|P2|STARTED|Overall Study||36
8264560|NCT01771991|20377572|P1|STARTED|Overall Study||38
8264561|NCT01771965|20377586|P2|NOT COMPLETED|Overall Study||5
8264562|NCT01771965|20377587|P1|NOT COMPLETED|Overall Study||3
8264563|NCT01771965|20377586|P2|COMPLETED|Overall Study||4
8264564|NCT01771965|20377587|P1|COMPLETED|Overall Study||7
8264565|NCT01771965|20377586|P2|STARTED|Overall Study||9
8264566|NCT01771965|20377587|P1|STARTED|Overall Study||10
8264567|NCT01771952|20377595|P2|NOT COMPLETED|Overall Study||3
8264568|NCT01771952|20377596|P1|NOT COMPLETED|Overall Study||3
8264569|NCT01771952|20377595|P2|COMPLETED|Overall Study||38
8264570|NCT01771952|20377596|P1|COMPLETED|Overall Study||42
8264571|NCT01771952|20377595|P2|STARTED|Overall Study||41
8264572|NCT01771952|20377596|P1|STARTED|Overall Study||45
8264573|NCT01771913|20377608|P2|NOT COMPLETED|Overall Study||0
8264574|NCT01771913|20377609|P1|NOT COMPLETED|Overall Study||1
8264575|NCT01771913|20377608|P2|COMPLETED|Overall Study||11
8264576|NCT01771913|20377609|P1|COMPLETED|Overall Study||8
8264577|NCT01771913|20377608|P2|STARTED|Overall Study||11
8264578|NCT01771913|20377609|P1|STARTED|Overall Study||9
8264579|NCT01771809|20377621|P2|NOT COMPLETED|Overall Study||83
8264580|NCT01771809|20377622|P1|NOT COMPLETED|Overall Study||71
8264581|NCT01771809|20377621|P2|COMPLETED|Overall Study||83
8264582|NCT01771809|20377622|P1|COMPLETED|Overall Study||93
8264583|NCT01771809|20377621|P2|STARTED|Overall Study||166
8264584|NCT01771809|20377622|P1|STARTED|Overall Study||164
8264585|NCT01771731|20377638|P2|NOT COMPLETED|Overall Study||2
8264586|NCT01771731|20377639|P1|NOT COMPLETED|Overall Study||2
8264587|NCT01771731|20377638|P2|COMPLETED|Overall Study||12
8264588|NCT01771731|20377639|P1|COMPLETED|Overall Study||11
8264589|NCT01771731|20377638|P2|STARTED|Overall Study||14
8264590|NCT01771731|20377639|P1|STARTED|Overall Study||13
8264591|NCT01771666|20377645|P1|NOT COMPLETED|Overall Study||0
8264592|NCT01771666|20377645|P1|COMPLETED|Overall Study||23
8264593|NCT01771666|20377645|P1|STARTED|Overall Study||23
8264594|NCT01771627|20377652|P2|NOT COMPLETED|Overall Study||50
8264595|NCT01771627|20377653|P1|NOT COMPLETED|Overall Study||108
8264596|NCT01771627|20377652|P2|COMPLETED|Overall Study||50
8264597|NCT01771627|20377653|P1|COMPLETED|Overall Study||92
8264598|NCT01771627|20377652|P2|STARTED|Overall Study||100
8264599|NCT01771627|20377653|P1|STARTED|Overall Study||200
8264600|NCT01771250|20377659|P2|NOT COMPLETED|Period 2||0
8264601|NCT01771250|20377660|P1|NOT COMPLETED|Period 2||0
8264602|NCT01771250|20377659|P2|COMPLETED|Period 2||7
8264603|NCT01771250|20377660|P1|COMPLETED|Period 2||7
8264604|NCT01771250|20377659|P2|STARTED|Period 2||7
8264605|NCT01771250|20377660|P1|STARTED|Period 2||7
8264606|NCT01771250|20377659|P2|NOT COMPLETED|Period 1||0
8264607|NCT01771250|20377660|P1|NOT COMPLETED|Period 1||1
8264608|NCT01771250|20377659|P2|COMPLETED|Period 1||7
8264609|NCT01771250|20377660|P1|COMPLETED|Period 1||7
8264610|NCT01771250|20377659|P2|Received at Least One Dose of Study Drug|Period 1||7
8264611|NCT01771250|20377660|P1|Received at Least One Dose of Study Drug|Period 1||7
8264612|NCT01771250|20377659|P2|STARTED|Period 1||7
8264613|NCT01771250|20377660|P1|STARTED|Period 1||8
8264614|NCT01771172|20377672|P1|NOT COMPLETED|Overall Study||2
8264615|NCT01771172|20377672|P1|COMPLETED|Overall Study||46
8264616|NCT01771172|20377672|P1|STARTED|Overall Study||48
8264617|NCT01770912|20377678|P2|NOT COMPLETED|Overall Study||0
8264618|NCT01770912|20377679|P1|NOT COMPLETED|Overall Study||2
8264619|NCT01770912|20377678|P2|COMPLETED|Overall Study||12
8264620|NCT01770912|20377679|P1|COMPLETED|Overall Study||10
8264621|NCT01770912|20377678|P2|STARTED|Overall Study||12
8264622|NCT01770912|20377679|P1|STARTED|Overall Study||12
8264623|NCT01770860|20377713|P1|NOT COMPLETED|Overall Study||6
8264624|NCT01770860|20377713|P1|COMPLETED|Overall Study||40
8264625|NCT01770860|20377713|P1|Randomization|Overall Study|One participant withdrew before randomization|45
8264626|NCT01770860|20377713|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
8264627|NCT01770743|20377761|P5|NOT COMPLETED|Overall Study||2
8264628|NCT01770743|20377762|P4|NOT COMPLETED|Overall Study||2
8264629|NCT01770743|20377763|P3|NOT COMPLETED|Overall Study||1
8264630|NCT01770743|20377764|P2|NOT COMPLETED|Overall Study||3
8264631|NCT01770743|20377765|P1|NOT COMPLETED|Overall Study||2
8264632|NCT01770743|20377761|P5|COMPLETED|Overall Study||21
8264633|NCT01770743|20377762|P4|COMPLETED|Overall Study||42
8264634|NCT01770743|20377763|P3|COMPLETED|Overall Study||22
8264635|NCT01770743|20377764|P2|COMPLETED|Overall Study||31
8264636|NCT01770743|20377765|P1|COMPLETED|Overall Study||42
8264637|NCT01770743|20377761|P5|Treated|Overall Study||23
8264638|NCT01770743|20377762|P4|Treated|Overall Study||44
8264639|NCT01770743|20377763|P3|Treated|Overall Study||23
8264640|NCT01770743|20377764|P2|Treated|Overall Study||34
8264641|NCT01770743|20377765|P1|Treated|Overall Study||44
8264642|NCT01770743|20377761|P5|STARTED|Overall Study||23
8264643|NCT01770743|20377762|P4|STARTED|Overall Study||44
8264644|NCT01770743|20377763|P3|STARTED|Overall Study||23
8264645|NCT01770743|20377764|P2|STARTED|Overall Study||34
8264646|NCT01770743|20377765|P1|STARTED|Overall Study||44
8264647|NCT01770691|20377817|P1|NOT COMPLETED|Overall Study||0
8264648|NCT01770691|20377817|P1|COMPLETED|Overall Study||7
8264649|NCT01770691|20377817|P1|STARTED|Overall Study||7
8264650|NCT01770652|20377828|P4|NOT COMPLETED|Overall Study||0
8264651|NCT01770652|20377829|P3|NOT COMPLETED|Overall Study||0
8264652|NCT01770652|20377830|P2|NOT COMPLETED|Overall Study||0
8264653|NCT01770652|20377831|P1|NOT COMPLETED|Overall Study||0
8264654|NCT01770652|20377828|P4|COMPLETED|Overall Study||8
8264655|NCT01770652|20377829|P3|COMPLETED|Overall Study||8
8264656|NCT01770652|20377830|P2|COMPLETED|Overall Study||8
8264657|NCT01770652|20377831|P1|COMPLETED|Overall Study||8
8264658|NCT01770652|20377828|P4|STARTED|Overall Study||8
8264659|NCT01770652|20377829|P3|STARTED|Overall Study||8
8264660|NCT01770652|20377830|P2|STARTED|Overall Study||8
8264661|NCT01770652|20377831|P1|STARTED|Overall Study||8
8264662|NCT01770509|20377867|P2|NOT COMPLETED|Overall Study||3
8264663|NCT01770509|20377868|P1|NOT COMPLETED|Overall Study||1
8264664|NCT01770509|20377867|P2|COMPLETED|Overall Study||14
8264665|NCT01770509|20377868|P1|COMPLETED|Overall Study||11
8264666|NCT01770509|20377867|P2|STARTED|Overall Study||17
8264667|NCT01770509|20377868|P1|STARTED|Overall Study||12
8264668|NCT01770483|20377884|P2|NOT COMPLETED|Overall Study||0
8264669|NCT01770483|20377885|P1|NOT COMPLETED|Overall Study||0
8264670|NCT01770483|20377884|P2|COMPLETED|Overall Study||33
8264671|NCT01770483|20377885|P1|COMPLETED|Overall Study||33
8264672|NCT01770483|20377884|P2|STARTED|Overall Study||33
8264673|NCT01770483|20377885|P1|STARTED|Overall Study||33
8264674|NCT01770431|20377895|P2|NOT COMPLETED|Overall Study||32
8264675|NCT01770431|20377896|P1|NOT COMPLETED|Overall Study||10
8264676|NCT01770431|20377895|P2|COMPLETED|Overall Study||316
8264677|NCT01770431|20377896|P1|COMPLETED|Overall Study||686
8264678|NCT01770431|20377895|P2|STARTED|Overall Study||348
8264679|NCT01770431|20377896|P1|STARTED|Overall Study||696
8264680|NCT01770392|20377904|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
8264681|NCT01770392|20377904|P1|COMPLETED|Nintedanib+ Rifampicin||25
8264682|NCT01770392|20377904|P1|STARTED|Nintedanib+ Rifampicin||25
8264683|NCT01770392|20377904|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
8264684|NCT01770392|20377904|P1|COMPLETED|Washout Period of at Least 14 Days||25
8264685|NCT01770392|20377904|P1|STARTED|Washout Period of at Least 14 Days||26
8264686|NCT01770392|20377904|P1|NOT COMPLETED|Nintedanib||0
8264687|NCT01770392|20377904|P1|COMPLETED|Nintedanib||26
8264688|NCT01770392|20377904|P1|STARTED|Nintedanib||26
8264689|NCT01770379|20377919|P3|NOT COMPLETED|Overall Study||42
8264690|NCT01770379|20377920|P2|NOT COMPLETED|Overall Study||44
8264691|NCT01770379|20377921|P1|NOT COMPLETED|Overall Study||39
8264692|NCT01770379|20377919|P3|COMPLETED|Overall Study||39
8264693|NCT01770379|20377920|P2|COMPLETED|Overall Study||37
8264694|NCT01770379|20377921|P1|COMPLETED|Overall Study||41
8264695|NCT01770379|20377919|P3|STARTED|Overall Study||81
8264696|NCT01770379|20377920|P2|STARTED|Overall Study||81
8264697|NCT01770379|20377921|P1|STARTED|Overall Study||80
8264698|NCT01770366|20377940|P2|NOT COMPLETED|Overall Study||2
8264699|NCT01770366|20377941|P1|NOT COMPLETED|Overall Study||2
8264700|NCT01770366|20377940|P2|COMPLETED|Overall Study||4
8264701|NCT01770366|20377941|P1|COMPLETED|Overall Study||2
8264702|NCT01770366|20377940|P2|STARTED|Overall Study||6
8264703|NCT01770366|20377941|P1|STARTED|Overall Study||4
8264704|NCT01770353|20377949|P2|NOT COMPLETED|Overall Study||12
8264705|NCT01770353|20377950|P1|NOT COMPLETED|Overall Study||6
8264706|NCT01770353|20377949|P2|COMPLETED|Overall Study||18
8264707|NCT01770353|20377950|P1|COMPLETED|Overall Study||9
8264708|NCT01770353|20377949|P2|Received FMX and MM-398|Overall Study||29
8264709|NCT01770353|20377950|P1|Received FMX and MM-398|Overall Study||13
8264710|NCT01770353|20377949|P2|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
8264711|NCT01770353|20377950|P1|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
8264712|NCT01770353|20377949|P2|STARTED|Overall Study||30
8264713|NCT01770353|20377950|P1|STARTED|Overall Study||15
8264714|NCT01770314|20378000|P2|NOT COMPLETED|Overall Study||0
8264715|NCT01770314|20378001|P1|NOT COMPLETED|Overall Study||0
8264716|NCT01770314|20378000|P2|COMPLETED|Overall Study||90
8264717|NCT01770314|20378001|P1|COMPLETED|Overall Study||86
8264718|NCT01770314|20378000|P2|Contributed Data to One-month Follow-up|Overall Study||66
8264719|NCT01770314|20378001|P1|Contributed Data to One-month Follow-up|Overall Study||61
8264720|NCT01770314|20378000|P2|Contributed Data to Post-test|Overall Study||67
8264721|NCT01770314|20378001|P1|Contributed Data to Post-test|Overall Study||65
8264722|NCT01770314|20378000|P2|Contributed Data to Baseline|Overall Study||72
8264723|NCT01770314|20378001|P1|Contributed Data to Baseline|Overall Study||68
8264724|NCT01770314|20378000|P2|STARTED|Overall Study||90
8264725|NCT01770314|20378001|P1|STARTED|Overall Study||86
8264726|NCT01770145|20378009|P1|NOT COMPLETED|Treatment||4
8264727|NCT01770145|20378009|P1|COMPLETED|Treatment||97
8264728|NCT01770145|20378009|P1|STARTED|Treatment||101
8264729|NCT01770145|20378009|P1|NOT COMPLETED|Baseline||26
8264730|NCT01770145|20378009|P1|COMPLETED|Baseline||101
8264731|NCT01770145|20378009|P1|STARTED|Baseline||127
8264732|NCT01769612|20378014|P1|NOT COMPLETED|Overall Study||0
8264733|NCT01769612|20378014|P1|COMPLETED|Overall Study||168
8264734|NCT01769612|20378014|P1|STARTED|Overall Study||168
8264735|NCT01769586|20378022|P2|NOT COMPLETED|Overall Study||0
8264736|NCT01769586|20378023|P1|NOT COMPLETED|Overall Study||0
8264737|NCT01769586|20378022|P2|COMPLETED|Overall Study||100
8264738|NCT01769586|20378023|P1|COMPLETED|Overall Study||100
8264739|NCT01769586|20378022|P2|STARTED|Overall Study||100
8264740|NCT01769586|20378023|P1|STARTED|Overall Study||100
8264741|NCT01769573|20378034|P5|NOT COMPLETED|Overall Study||0
8264742|NCT01769573|20378035|P4|NOT COMPLETED|Overall Study||0
8264743|NCT01769573|20378036|P3|NOT COMPLETED|Overall Study||0
8264744|NCT01769573|20378037|P2|NOT COMPLETED|Overall Study||0
8264745|NCT01769573|20378038|P1|NOT COMPLETED|Overall Study||0
8264746|NCT01769573|20378034|P5|COMPLETED|Overall Study||10
8264747|NCT01769573|20378035|P4|COMPLETED|Overall Study||0
8264748|NCT01769573|20378036|P3|COMPLETED|Overall Study||10
8264749|NCT01769573|20378037|P2|COMPLETED|Overall Study||6
8264750|NCT01769573|20378038|P1|COMPLETED|Overall Study||10
8264751|NCT01769573|20378034|P5|STARTED|Overall Study||10
8264752|NCT01769573|20378035|P4|STARTED|Overall Study||0
8264753|NCT01769573|20378036|P3|STARTED|Overall Study||10
8264754|NCT01769573|20378037|P2|STARTED|Overall Study||6
8264755|NCT01769573|20378038|P1|STARTED|Overall Study||10
8264756|NCT01769508|20378065|P1|NOT COMPLETED|Overall Study||6
8264757|NCT01769508|20378065|P1|COMPLETED|Overall Study||6
8264758|NCT01769508|20378065|P1|STARTED|Overall Study||12
8264759|NCT01769469|20378074|P1|NOT COMPLETED|Overall Study||35
8264760|NCT01769469|20378074|P1|COMPLETED|Overall Study||66
8264761|NCT01769469|20378074|P1|STARTED|Overall Study||101
8264762|NCT01769456|20378234|P1|NOT COMPLETED|Overall Study||37
8264763|NCT01769456|20378234|P1|COMPLETED|Overall Study||41
8264764|NCT01769456|20378234|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
8264765|NCT01769443|20378255|P2|NOT COMPLETED|Overall Study||0
8264766|NCT01769443|20378256|P1|NOT COMPLETED|Overall Study||1
8264767|NCT01769443|20378255|P2|COMPLETED|Overall Study||1
8264768|NCT01769443|20378256|P1|COMPLETED|Overall Study||0
8264769|NCT01769443|20378255|P2|STARTED|Overall Study||1
8264770|NCT01769443|20378256|P1|STARTED|Overall Study||1
8264771|NCT01769404|20378298|P2|NOT COMPLETED|Treatment Period 2||0
8264772|NCT01769404|20378299|P1|NOT COMPLETED|Treatment Period 2||7
8264773|NCT01769404|20378298|P2|COMPLETED|Treatment Period 2||13
8264774|NCT01769404|20378299|P1|COMPLETED|Treatment Period 2||0
8264775|NCT01769404|20378298|P2|STARTED|Treatment Period 2||13
8264776|NCT01769404|20378299|P1|STARTED|Treatment Period 2||7
8264777|NCT01769404|20378298|P2|NOT COMPLETED|Treatment Period 1||0
8264778|NCT01769404|20378299|P1|NOT COMPLETED|Treatment Period 1||5
8264779|NCT01769404|20378298|P2|COMPLETED|Treatment Period 1||13
8264780|NCT01769404|20378299|P1|COMPLETED|Treatment Period 1||7
8264781|NCT01769404|20378298|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
8264782|NCT01769404|20378299|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
8264783|NCT01769404|20378298|P2|STARTED|Treatment Period 1||13
8264784|NCT01769404|20378299|P1|STARTED|Treatment Period 1||12
8264785|NCT01769391|20378321|P2|NOT COMPLETED|Overall Study||9
8264786|NCT01769391|20378322|P1|NOT COMPLETED|Overall Study||17
8264787|NCT01769391|20378321|P2|COMPLETED|Overall Study||48
8264788|NCT01769391|20378322|P1|COMPLETED|Overall Study||93
8264789|NCT01769391|20378321|P2|Received at Least One Dose of Study Drug|Overall Study||55
8264790|NCT01769391|20378322|P1|Received at Least One Dose of Study Drug|Overall Study||106
8264791|NCT01769391|20378321|P2|STARTED|Overall Study||57
8264792|NCT01769391|20378322|P1|STARTED|Overall Study||110
8264793|NCT01769378|20378341|P2|NOT COMPLETED|Overall Study||4
8264794|NCT01769378|20378342|P1|NOT COMPLETED|Overall Study||25
8264795|NCT01769378|20378341|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
8264796|NCT01769378|20378342|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
8264797|NCT01769378|20378341|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
8264798|NCT01769378|20378342|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
8264799|NCT01769378|20378341|P2|STARTED|Overall Study||60
8264800|NCT01769378|20378342|P1|STARTED|Overall Study||240
8264801|NCT01769365|20378380|P3|NOT COMPLETED|Overall Study||2
8264802|NCT01769365|20378381|P2|NOT COMPLETED|Overall Study||2
8264803|NCT01769365|20378382|P1|NOT COMPLETED|Overall Study||0
8264804|NCT01769365|20378380|P3|COMPLETED|Overall Study||101
8264805|NCT01769365|20378381|P2|COMPLETED|Overall Study||100
8264806|NCT01769365|20378382|P1|COMPLETED|Overall Study||102
8264807|NCT01769365|20378380|P3|STARTED|Overall Study||103
8264808|NCT01769365|20378381|P2|STARTED|Overall Study||102
8264809|NCT01769365|20378382|P1|STARTED|Overall Study||102
8264810|NCT01769352|20378394|P4|NOT COMPLETED|Overall Study||0
8264811|NCT01769352|20378395|P3|NOT COMPLETED|Overall Study||0
8264812|NCT01769352|20378396|P2|NOT COMPLETED|Overall Study||0
8264813|NCT01769352|20378397|P1|NOT COMPLETED|Overall Study||0
8264814|NCT01769352|20378394|P4|COMPLETED|Overall Study||8
8264815|NCT01769352|20378395|P3|COMPLETED|Overall Study||9
8264816|NCT01769352|20378396|P2|COMPLETED|Overall Study||12
8264817|NCT01769352|20378397|P1|COMPLETED|Overall Study||13
8264818|NCT01769352|20378394|P4|STARTED|Overall Study||8
8264819|NCT01769352|20378395|P3|STARTED|Overall Study||9
8264820|NCT01769352|20378396|P2|STARTED|Overall Study||12
8264821|NCT01769352|20378397|P1|STARTED|Overall Study||13
8264822|NCT01769339|20378422|P1|NOT COMPLETED|Overall Study||43
8264823|NCT01769339|20378422|P1|COMPLETED|Overall Study||72
8264824|NCT01769339|20378422|P1|STARTED|Overall Study||115
8264825|NCT01769326|20378433|P4|NOT COMPLETED|Overall Study||0
8264826|NCT01769326|20378434|P3|NOT COMPLETED|Overall Study||1
8264827|NCT01769326|20378435|P2|NOT COMPLETED|Overall Study||4
8264828|NCT01769326|20378436|P1|NOT COMPLETED|Overall Study||2
8264829|NCT01769326|20378433|P4|COMPLETED|Overall Study||8
8264830|NCT01769326|20378434|P3|COMPLETED|Overall Study||8
8264831|NCT01769326|20378435|P2|COMPLETED|Overall Study||8
8264832|NCT01769326|20378436|P1|COMPLETED|Overall Study||9
8264833|NCT01769326|20378433|P4|STARTED|Overall Study||8
8264834|NCT01769326|20378434|P3|STARTED|Overall Study||9
8264835|NCT01769326|20378435|P2|STARTED|Overall Study||12
8264836|NCT01769326|20378436|P1|STARTED|Overall Study||11
8264837|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8264838|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8264839|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8264840|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session2-Period4||3
8264841|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session2-Period4||2
8264842|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session2-Period4||0
8264843|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session2-Period4||3
8264844|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session2-Period4||2
8264845|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session2-Period4||0
8264846|NCT01769274|20378446|P3|NOT COMPLETED|Washout Period||0
8264847|NCT01769274|20378447|P2|NOT COMPLETED|Washout Period||0
8264848|NCT01769274|20378448|P1|NOT COMPLETED|Washout Period||0
8264849|NCT01769274|20378446|P3|COMPLETED|Washout Period||3
8264850|NCT01769274|20378447|P2|COMPLETED|Washout Period||2
8264851|NCT01769274|20378448|P1|COMPLETED|Washout Period||0
8264852|NCT01769274|20378446|P3|STARTED|Washout Period||3
8264853|NCT01769274|20378447|P2|STARTED|Washout Period||2
8264854|NCT01769274|20378448|P1|STARTED|Washout Period||0
8264855|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8264856|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8264857|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8264858|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session2-Period3||3
8264859|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session2-Period3||2
8264860|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session2-Period3||0
8264861|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session2-Period3||3
8264862|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session2-Period3||2
8264863|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session2-Period3||0
8264864|NCT01769274|20378446|P3|NOT COMPLETED|Washout Period||0
8264865|NCT01769274|20378447|P2|NOT COMPLETED|Washout Period||0
8264866|NCT01769274|20378448|P1|NOT COMPLETED|Washout Period||0
8264867|NCT01769274|20378446|P3|COMPLETED|Washout Period||3
8264868|NCT01769274|20378447|P2|COMPLETED|Washout Period||2
8264869|NCT01769274|20378448|P1|COMPLETED|Washout Period||0
8264870|NCT01769274|20378446|P3|STARTED|Washout Period||3
8264871|NCT01769274|20378447|P2|STARTED|Washout Period||2
8264872|NCT01769274|20378448|P1|STARTED|Washout Period||0
8264873|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8264874|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8264875|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8264876|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session1-Period2||3
8264877|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session1-Period2||2
8264878|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session1-Period2||0
8264879|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session1-Period2||3
8264880|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session1-Period2||2
8264881|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session1-Period2||0
8264882|NCT01769274|20378446|P3|NOT COMPLETED|Washout Period||0
8264883|NCT01769274|20378447|P2|NOT COMPLETED|Washout Period||0
8264884|NCT01769274|20378448|P1|NOT COMPLETED|Washout Period||0
8264885|NCT01769274|20378446|P3|COMPLETED|Washout Period||3
8264886|NCT01769274|20378447|P2|COMPLETED|Washout Period||2
8264887|NCT01769274|20378448|P1|COMPLETED|Washout Period||0
8264888|NCT01769274|20378446|P3|STARTED|Washout Period||3
8264889|NCT01769274|20378447|P2|STARTED|Washout Period||2
8264890|NCT01769274|20378448|P1|STARTED|Washout Period||0
8264891|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8264892|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8264893|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8264894|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session1-Period1||3
8264895|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session1-Period1||2
8264896|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session1-Period1||0
8264897|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session1-Period1||3
8264898|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session1-Period1||2
8264899|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session1-Period1||0
8264900|NCT01769274|20378446|P3|NOT COMPLETED|Part A||0
8264901|NCT01769274|20378447|P2|NOT COMPLETED|Part A||0
8264902|NCT01769274|20378448|P1|NOT COMPLETED|Part A||0
8264903|NCT01769274|20378446|P3|COMPLETED|Part A||0
8264904|NCT01769274|20378447|P2|COMPLETED|Part A||0
8264905|NCT01769274|20378448|P1|COMPLETED|Part A||5
8264906|NCT01769274|20378446|P3|STARTED|Part A||0
8264907|NCT01769274|20378447|P2|STARTED|Part A||0
8264908|NCT01769274|20378448|P1|STARTED|Part A||5
8264909|NCT01769248|20378540|P2|NOT COMPLETED|Overall Study||12
8264910|NCT01769248|20378541|P1|NOT COMPLETED|Overall Study||28
8264911|NCT01769248|20378540|P2|COMPLETED|Overall Study||58
8264912|NCT01769248|20378541|P1|COMPLETED|Overall Study||42
8264913|NCT01769248|20378540|P2|Participants Who Crossed-over|Overall Study||12
8264914|NCT01769248|20378541|P1|Participants Who Crossed-over|Overall Study||28
8264915|NCT01769248|20378540|P2|STARTED|Overall Study||70
8264916|NCT01769248|20378541|P1|STARTED|Overall Study||70
8264917|NCT01769222|20378553|P2|NOT COMPLETED|Overall Study||0
8264918|NCT01769222|20378554|P1|NOT COMPLETED|Overall Study||0
8264919|NCT01769222|20378553|P2|COMPLETED|Overall Study||0
8264920|NCT01769222|20378554|P1|COMPLETED|Overall Study||3
8264921|NCT01769222|20378553|P2|STARTED|Overall Study||0
8264922|NCT01769222|20378554|P1|STARTED|Overall Study||3
8264923|NCT01769209|20378568|P1|NOT COMPLETED|Overall Study||0
8264924|NCT01769209|20378568|P1|COMPLETED|Overall Study||18
8264925|NCT01769209|20378568|P1|STARTED|Overall Study||18
8264926|NCT01769196|20378581|P2|NOT COMPLETED|Overall Study||272
8264927|NCT01769196|20378582|P1|NOT COMPLETED|Overall Study||272
8264928|NCT01769196|20378581|P2|COMPLETED|Overall Study||0
8264929|NCT01769196|20378582|P1|COMPLETED|Overall Study||0
8264930|NCT01769196|20378581|P2|STARTED|Overall Study||272
8264931|NCT01769196|20378582|P1|STARTED|Overall Study||272
8264932|NCT01769170|20378612|P2|NOT COMPLETED|Overall Study||27
8264933|NCT01769170|20378613|P1|NOT COMPLETED|Overall Study||71
8264934|NCT01769170|20378612|P2|COMPLETED|Overall Study||122
8264935|NCT01769170|20378613|P1|COMPLETED|Overall Study||232
8264936|NCT01769170|20378612|P2|STARTED|Overall Study||149
8264937|NCT01769170|20378613|P1|STARTED|Overall Study||303
8264938|NCT01769105|20378623|P2|NOT COMPLETED|Cross-over||0
8264939|NCT01769105|20378624|P1|NOT COMPLETED|Cross-over||5
8264940|NCT01769105|20378623|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
8264941|NCT01769105|20378624|P1|COMPLETED|Cross-over||9
8264942|NCT01769105|20378623|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
8264943|NCT01769105|20378624|P1|STARTED|Cross-over||14
8264944|NCT01769105|20378623|P2|NOT COMPLETED|First Intervention||2
8264945|NCT01769105|20378624|P1|NOT COMPLETED|First Intervention||2
8264946|NCT01769105|20378623|P2|COMPLETED|First Intervention||17
8264947|NCT01769105|20378624|P1|COMPLETED|First Intervention||14
8264948|NCT01769105|20378623|P2|STARTED|First Intervention||19
8264949|NCT01769105|20378624|P1|STARTED|First Intervention||16
8264950|NCT01768858|20378643|P1|NOT COMPLETED|Overall Study||22
8264951|NCT01768858|20378643|P1|COMPLETED|Overall Study||74
8264952|NCT01768858|20378643|P1|STARTED|Overall Study||96
8264953|NCT01768832|20378658|P3|NOT COMPLETED|Overall Study||9
8264954|NCT01768832|20378659|P2|NOT COMPLETED|Overall Study||4
8264955|NCT01768832|20378660|P1|NOT COMPLETED|Overall Study||10
8264956|NCT01768832|20378658|P3|COMPLETED|Overall Study||26
8264957|NCT01768832|20378659|P2|COMPLETED|Overall Study||39
8264958|NCT01768832|20378660|P1|COMPLETED|Overall Study||31
8264959|NCT01768832|20378658|P3|STARTED|Overall Study||35
8264960|NCT01768832|20378659|P2|STARTED|Overall Study||43
8264961|NCT01768832|20378660|P1|STARTED|Overall Study||41
8264962|NCT01768676|20378694|P2|NOT COMPLETED|Overall Study||31
8264963|NCT01768676|20378695|P1|NOT COMPLETED|Overall Study||24
8264964|NCT01768676|20378694|P2|COMPLETED|Overall Study||60
8264965|NCT01768676|20378695|P1|COMPLETED|Overall Study||66
8264966|NCT01768676|20378694|P2|STARTED|Overall Study||91
8264967|NCT01768676|20378695|P1|STARTED|Overall Study||90
8264968|NCT01768637|20378711|P2|NOT COMPLETED|Overall Study||7
8264969|NCT01768637|20378712|P1|NOT COMPLETED|Overall Study||3
8264970|NCT01768637|20378711|P2|COMPLETED|Overall Study||12
8264971|NCT01768637|20378712|P1|COMPLETED|Overall Study||26
8264972|NCT01768637|20378711|P2|Completed Visit 2|Overall Study||13
8264973|NCT01768637|20378712|P1|Completed Visit 2|Overall Study||26
8264974|NCT01768637|20378711|P2|Completed Visit 1|Overall Study||16
8264975|NCT01768637|20378712|P1|Completed Visit 1|Overall Study||28
8264976|NCT01768637|20378711|P2|STARTED|Overall Study||19
8264977|NCT01768637|20378712|P1|STARTED|Overall Study||29
8264978|NCT01768572|20378725|P3|NOT COMPLETED|Overall Study||6
8264979|NCT01768572|20378726|P2|NOT COMPLETED|Overall Study||12
8264980|NCT01768572|20378727|P1|NOT COMPLETED|Overall Study||9
8264981|NCT01768572|20378725|P3|COMPLETED|Overall Study||96
8264982|NCT01768572|20378726|P2|COMPLETED|Overall Study||39
8264983|NCT01768572|20378727|P1|COMPLETED|Overall Study||40
8264984|NCT01768572|20378725|P3|STARTED|Overall Study||102
8264985|NCT01768572|20378726|P2|STARTED|Overall Study||51
8264986|NCT01768572|20378727|P1|STARTED|Overall Study||49
8264987|NCT01768559|20378738|P3|NOT COMPLETED|Overall Study||13
8264988|NCT01768559|20378739|P2|NOT COMPLETED|Overall Study||17
8264989|NCT01768559|20378740|P1|NOT COMPLETED|Overall Study||30
8264990|NCT01768559|20378738|P3|COMPLETED|Overall Study||285
8264991|NCT01768559|20378739|P2|COMPLETED|Overall Study||281
8264992|NCT01768559|20378740|P1|COMPLETED|Overall Study||268
8264993|NCT01768559|20378738|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
8264994|NCT01768559|20378739|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
8264995|NCT01768559|20378740|P1|Treated|Overall Study||298
8264996|NCT01768559|20378738|P3|STARTED|Overall Study||298
8264997|NCT01768559|20378739|P2|STARTED|Overall Study||298
8264998|NCT01768559|20378740|P1|STARTED|Overall Study||298
8264999|NCT01768520|20378791|P3|NOT COMPLETED|Overall Study||9
8265000|NCT01768520|20378792|P2|NOT COMPLETED|Overall Study||26
8265001|NCT01768520|20378793|P1|NOT COMPLETED|Overall Study||32
8265002|NCT01768520|20378791|P3|COMPLETED|Overall Study||30
8265003|NCT01768520|20378792|P2|COMPLETED|Overall Study||121
8265004|NCT01768520|20378793|P1|COMPLETED|Overall Study||120
8265005|NCT01768520|20378791|P3|STARTED|Overall Study||39
8265006|NCT01768520|20378792|P2|STARTED|Overall Study||147
8265007|NCT01768520|20378793|P1|STARTED|Overall Study||152
8265008|NCT01768325|20378806|P2|NOT COMPLETED|Overall Study||0
8265009|NCT01768325|20378807|P1|NOT COMPLETED|Overall Study||0
8265010|NCT01768325|20378806|P2|COMPLETED|Overall Study||41
8265011|NCT01768325|20378807|P1|COMPLETED|Overall Study||37
8265012|NCT01768325|20378806|P2|STARTED|Overall Study||41
8265013|NCT01768325|20378807|P1|STARTED|Overall Study||37
8265014|NCT01768286|20378821|P4|NOT COMPLETED|Overall Study||1
8265015|NCT01768286|20378822|P3|NOT COMPLETED|Overall Study||2
8265016|NCT01768286|20378823|P2|NOT COMPLETED|Overall Study||4
8265017|NCT01768286|20378824|P1|NOT COMPLETED|Overall Study||7
8265018|NCT01768286|20378821|P4|COMPLETED|Overall Study||110
8265019|NCT01768286|20378822|P3|COMPLETED|Overall Study||108
8265020|NCT01768286|20378823|P2|COMPLETED|Overall Study||107
8265021|NCT01768286|20378824|P1|COMPLETED|Overall Study||102
8265022|NCT01768286|20378821|P4|STARTED|Overall Study||111
8265023|NCT01768286|20378822|P3|STARTED|Overall Study||110
8265024|NCT01768286|20378823|P2|STARTED|Overall Study||111
8265025|NCT01768286|20378824|P1|STARTED|Overall Study||109
8265026|NCT01768117|20378886|P1|NOT COMPLETED|Overall Study||6
8265027|NCT01768117|20378886|P1|COMPLETED|Overall Study||7
8265028|NCT01768117|20378886|P1|STARTED|Overall Study||13
8265029|NCT01768013|20378894|P1|NOT COMPLETED|Overall Study||0
8265030|NCT01768013|20378894|P1|COMPLETED|Overall Study||13
8265031|NCT01768013|20378894|P1|STARTED|Overall Study||13
8265032|NCT01768000|20378927|P4|NOT COMPLETED|Overall Study||2
8265033|NCT01768000|20378928|P3|NOT COMPLETED|Overall Study||1
8265034|NCT01768000|20378929|P2|NOT COMPLETED|Overall Study||2
8265035|NCT01768000|20378930|P1|NOT COMPLETED|Overall Study||1
8265036|NCT01768000|20378927|P4|COMPLETED|Overall Study||8
8265037|NCT01768000|20378928|P3|COMPLETED|Overall Study||9
8265038|NCT01768000|20378929|P2|COMPLETED|Overall Study||8
8265039|NCT01768000|20378930|P1|COMPLETED|Overall Study||9
8265040|NCT01768000|20378927|P4|STARTED|Overall Study||10
8265041|NCT01768000|20378928|P3|STARTED|Overall Study||10
8265042|NCT01768000|20378929|P2|STARTED|Overall Study||10
8265043|NCT01768000|20378930|P1|STARTED|Overall Study||10
8265044|NCT01767987|20378950|P2|NOT COMPLETED|Overall Study||1
8265045|NCT01767987|20378951|P1|NOT COMPLETED|Overall Study||4
8265046|NCT01767987|20378950|P2|COMPLETED|Overall Study||1
8265047|NCT01767987|20378951|P1|COMPLETED|Overall Study||0
8265048|NCT01767987|20378950|P2|STARTED|Overall Study||2
8265049|NCT01767987|20378951|P1|STARTED|Overall Study||4
8265050|NCT01767935|20378973|P1|NOT COMPLETED|Overall Study||0
8265051|NCT01767935|20378973|P1|COMPLETED|Overall Study||1
8265052|NCT01767935|20378973|P1|STARTED|Overall Study||1
8265053|NCT01767909|20378983|P2|NOT COMPLETED|Overall Study||12
8265054|NCT01767909|20378984|P1|NOT COMPLETED|Overall Study||13
8265055|NCT01767909|20378983|P2|COMPLETED|Overall Study||107
8265056|NCT01767909|20378984|P1|COMPLETED|Overall Study||108
8265057|NCT01767909|20378983|P2|STARTED|Overall Study||119
8265058|NCT01767909|20378984|P1|STARTED|Overall Study||121
8265062|NCT01767701|20379010|P1|NOT COMPLETED|Overall Study||0
8265063|NCT01767701|20379010|P1|COMPLETED|Overall Study||20
8265064|NCT01767701|20379010|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
8265065|NCT01767688|20379023|P2|NOT COMPLETED|Overall Study||0
8265066|NCT01767688|20379024|P1|NOT COMPLETED|Overall Study||0
8265067|NCT01767688|20379023|P2|COMPLETED|Overall Study||8
8265068|NCT01767688|20379024|P1|COMPLETED|Overall Study||8
8265069|NCT01767688|20379023|P2|STARTED|Overall Study||8
8265070|NCT01767688|20379024|P1|STARTED|Overall Study||8
8265071|NCT01767636|20379044|P1|NOT COMPLETED|Overall Study||3
8265072|NCT01767636|20379044|P1|COMPLETED|Overall Study||35
8265073|NCT01767636|20379044|P1|STARTED|Overall Study||38
8265074|NCT01767597|20379054|P2|NOT COMPLETED|Overall Study||1
8265075|NCT01767597|20379055|P1|NOT COMPLETED|Overall Study||4
8265076|NCT01767597|20379054|P2|COMPLETED|Overall Study||499
8265077|NCT01767597|20379055|P1|COMPLETED|Overall Study||496
8265078|NCT01767597|20379054|P2|STARTED|Overall Study||500
8265079|NCT01767597|20379055|P1|STARTED|Overall Study||500
8265080|NCT01767519|20379064|P3|NOT COMPLETED|Overall Study||5
8265081|NCT01767519|20379065|P2|NOT COMPLETED|Overall Study||13
8265082|NCT01767519|20379066|P1|NOT COMPLETED|Overall Study||14
8265083|NCT01767519|20379064|P3|COMPLETED|Overall Study||55
8265084|NCT01767519|20379065|P2|COMPLETED|Overall Study||138
8265085|NCT01767519|20379066|P1|COMPLETED|Overall Study||131
8265086|NCT01767519|20379064|P3|STARTED|Overall Study||60
8265087|NCT01767519|20379065|P2|STARTED|Overall Study||151
8265088|NCT01767519|20379066|P1|STARTED|Overall Study||145
8265089|NCT01767506|20379094|P2|NOT COMPLETED|Overall Study||0
8265090|NCT01767506|20379095|P1|NOT COMPLETED|Overall Study||0
8265091|NCT01767506|20379094|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
8265092|NCT01767506|20379095|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
8265093|NCT01767506|20379094|P2|STARTED|Overall Study|"26 communities were randomized to control group
~The study was conducted at the community level."|0
8265094|NCT01767506|20379095|P1|STARTED|Overall Study|"26 communities were randomized to intervention group
~The study was conducted at the community level."|0
8265095|NCT01767467|20379107|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
8265096|NCT01767467|20379108|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
8265097|NCT01767467|20379107|P2|COMPLETED|End of Study Phase (up to Month 13)||216
8265098|NCT01767467|20379108|P1|COMPLETED|End of Study Phase (up to Month 13)||236
8265099|NCT01767467|20379107|P2|STARTED|End of Study Phase (up to Month 13)||279
8265100|NCT01767467|20379108|P1|STARTED|End of Study Phase (up to Month 13)||283
8265101|NCT01767467|20379107|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
8265102|NCT01767467|20379108|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
8265103|NCT01767467|20379107|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
8265104|NCT01767467|20379108|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
8265105|NCT01767467|20379107|P2|STARTED|Vaccination Phase (up to Month 2)||279
8265106|NCT01767467|20379108|P1|STARTED|Vaccination Phase (up to Month 2)||283
8265107|NCT01767415|20379156|P1|NOT COMPLETED|Overall Study||0
8265108|NCT01767415|20379156|P1|COMPLETED|Overall Study||10
8265109|NCT01767415|20379156|P1|STARTED|Overall Study||10
8265110|NCT01767376|20379164|P3|NOT COMPLETED|Overall Study||0
8265111|NCT01767376|20379165|P2|NOT COMPLETED|Overall Study||3
8265112|NCT01767376|20379166|P1|NOT COMPLETED|Overall Study||4
8265113|NCT01767376|20379164|P3|COMPLETED|Overall Study||232
8265114|NCT01767376|20379165|P2|COMPLETED|Overall Study||225
8265115|NCT01767376|20379166|P1|COMPLETED|Overall Study||227
8265116|NCT01767376|20379164|P3|STARTED|Overall Study||232
8265117|NCT01767376|20379165|P2|STARTED|Overall Study||228
8265118|NCT01767376|20379166|P1|STARTED|Overall Study||231
8265119|NCT01767285|20379213|P2|NOT COMPLETED|Overall Study||6
8265120|NCT01767285|20379214|P1|NOT COMPLETED|Overall Study||7
8265121|NCT01767285|20379213|P2|COMPLETED|Overall Study||24
8265122|NCT01767285|20379214|P1|COMPLETED|Overall Study||22
8265123|NCT01767285|20379213|P2|STARTED|Overall Study||30
8265124|NCT01767285|20379214|P1|STARTED|Overall Study||29
8265125|NCT01767194|20379232|P2|NOT COMPLETED|Overall Study||43
8265126|NCT01767194|20379233|P1|NOT COMPLETED|Overall Study||18
8265127|NCT01767194|20379232|P2|COMPLETED|Overall Study||11
8265128|NCT01767194|20379233|P1|COMPLETED|Overall Study||1
8265129|NCT01767194|20379232|P2|STARTED|Overall Study||54
8265130|NCT01767194|20379233|P1|STARTED|Overall Study||19
8265131|NCT01767155|20379242|P2|NOT COMPLETED|Overall Study||15
8265132|NCT01767155|20379243|P1|NOT COMPLETED|Overall Study||13
8265133|NCT01767155|20379242|P2|COMPLETED|Overall Study||240
8265134|NCT01767155|20379243|P1|COMPLETED|Overall Study||243
8265135|NCT01767155|20379242|P2|Safety Population (SAF)|Overall Study||249
8265136|NCT01767155|20379243|P1|Safety Population (SAF)|Overall Study||252
8265137|NCT01767155|20379242|P2|Modified ITT (mITT)|Overall Study||249
8265138|NCT01767155|20379243|P1|Modified ITT (mITT)|Overall Study||252
8265139|NCT01767155|20379242|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
8265140|NCT01767155|20379243|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
8265141|NCT01767142|20379255|P1|NOT COMPLETED|Overall Study||3
8265142|NCT01767142|20379255|P1|COMPLETED|Overall Study||37
8265143|NCT01767142|20379255|P1|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
8265144|NCT01767116|20379264|P2|NOT COMPLETED|Overall Study||2
8265145|NCT01767116|20379265|P1|NOT COMPLETED|Overall Study||2
8265146|NCT01767116|20379264|P2|COMPLETED|Overall Study||207
8265147|NCT01767116|20379265|P1|COMPLETED|Overall Study||208
8265148|NCT01767116|20379264|P2|STARTED|Overall Study||209
8265149|NCT01767116|20379265|P1|STARTED|Overall Study||210
8265150|NCT01767103|20379284|P3|NOT COMPLETED|Overall Study||0
8265151|NCT01767103|20379285|P2|NOT COMPLETED|Overall Study||0
8265152|NCT01767103|20379286|P1|NOT COMPLETED|Overall Study||0
8265153|NCT01767103|20379284|P3|COMPLETED|Overall Study||7
8265154|NCT01767103|20379285|P2|COMPLETED|Overall Study||7
8265155|NCT01767103|20379286|P1|COMPLETED|Overall Study||7
8265156|NCT01767103|20379284|P3|STARTED|Overall Study||7
8265157|NCT01767103|20379285|P2|STARTED|Overall Study||7
8265158|NCT01767103|20379286|P1|STARTED|Overall Study||7
8265159|NCT01767064|20379314|P2|NOT COMPLETED|Overall Study||0
8265160|NCT01767064|20379315|P1|NOT COMPLETED|Overall Study||0
8265161|NCT01767064|20379314|P2|COMPLETED|Overall Study||7
8265162|NCT01767064|20379315|P1|COMPLETED|Overall Study||7
8265163|NCT01767064|20379314|P2|STARTED|Overall Study||7
8265164|NCT01767064|20379315|P1|STARTED|Overall Study||7
8265165|NCT01766986|20379324|P3|NOT COMPLETED|Overall Study||0
8265166|NCT01766986|20379325|P2|NOT COMPLETED|Overall Study||0
8265167|NCT01766986|20379326|P1|NOT COMPLETED|Overall Study||0
8265168|NCT01766986|20379324|P3|COMPLETED|Overall Study||38
8265169|NCT01766986|20379325|P2|COMPLETED|Overall Study||51
8265170|NCT01766986|20379326|P1|COMPLETED|Overall Study||41
8265171|NCT01766986|20379324|P3|STARTED|Overall Study||38
8265172|NCT01766986|20379325|P2|STARTED|Overall Study||51
8265173|NCT01766986|20379326|P1|STARTED|Overall Study||41
8265174|NCT01766921|20379336|P2|NOT COMPLETED|Overall Study||17
8265175|NCT01766921|20379337|P1|NOT COMPLETED|Overall Study||24
8265176|NCT01766921|20379336|P2|COMPLETED|Overall Study||676
8265177|NCT01766921|20379337|P1|COMPLETED|Overall Study||676
8265178|NCT01766921|20379336|P2|STARTED|Overall Study||693
8265179|NCT01766921|20379337|P1|STARTED|Overall Study||700
8265180|NCT01766817|20379359|P3|NOT COMPLETED|Overall Study||13
8265181|NCT01766817|20379360|P2|NOT COMPLETED|Overall Study||11
8265182|NCT01766817|20379361|P1|NOT COMPLETED|Overall Study||11
8265183|NCT01766817|20379359|P3|COMPLETED|Overall Study||34
8265184|NCT01766817|20379360|P2|COMPLETED|Overall Study||37
8265185|NCT01766817|20379361|P1|COMPLETED|Overall Study||37
8265186|NCT01766817|20379359|P3|STARTED|Overall Study||47
8265187|NCT01766817|20379360|P2|STARTED|Overall Study||48
8265188|NCT01766817|20379361|P1|STARTED|Overall Study||48
8265189|NCT01766778|20379412|P2|NOT COMPLETED|Overall Study||4
8265190|NCT01766778|20379413|P1|NOT COMPLETED|Overall Study||5
8265191|NCT01766778|20379412|P2|COMPLETED|Overall Study||57
8265192|NCT01766778|20379413|P1|COMPLETED|Overall Study||51
8265193|NCT01766778|20379412|P2|STARTED|Overall Study||61
8265194|NCT01766778|20379413|P1|STARTED|Overall Study|Intent to treat population|56
8265195|NCT01766713|20379431|P2|NOT COMPLETED|Overall Study||3
8265196|NCT01766713|20379432|P1|NOT COMPLETED|Overall Study||2
8265197|NCT01766713|20379431|P2|COMPLETED|Overall Study||22
8265198|NCT01766713|20379432|P1|COMPLETED|Overall Study||23
8265199|NCT01766713|20379431|P2|STARTED|Overall Study||25
8265200|NCT01766713|20379432|P1|STARTED|Overall Study||25
8265201|NCT01766466|20379440|P4|NOT COMPLETED|Day 5||0
8265202|NCT01766466|20379441|P3|NOT COMPLETED|Day 5||0
8265203|NCT01766466|20379442|P2|NOT COMPLETED|Day 5||0
8265204|NCT01766466|20379443|P1|NOT COMPLETED|Day 5||0
8265205|NCT01766466|20379440|P4|COMPLETED|Day 5||6
8265206|NCT01766466|20379441|P3|COMPLETED|Day 5||0
8265207|NCT01766466|20379442|P2|COMPLETED|Day 5||6
8265208|NCT01766466|20379443|P1|COMPLETED|Day 5||0
8265209|NCT01766466|20379440|P4|STARTED|Day 5||6
8265210|NCT01766466|20379441|P3|STARTED|Day 5||0
8265211|NCT01766466|20379442|P2|STARTED|Day 5||6
8265212|NCT01766466|20379443|P1|STARTED|Day 5||0
8265213|NCT01766466|20379440|P4|NOT COMPLETED|Day 1||0
8265214|NCT01766466|20379441|P3|NOT COMPLETED|Day 1||0
8265215|NCT01766466|20379442|P2|NOT COMPLETED|Day 1||0
8265216|NCT01766466|20379443|P1|NOT COMPLETED|Day 1||0
8265217|NCT01766466|20379440|P4|COMPLETED|Day 1||0
8265218|NCT01766466|20379441|P3|COMPLETED|Day 1||6
8265219|NCT01766466|20379442|P2|COMPLETED|Day 1||0
8265220|NCT01766466|20379443|P1|COMPLETED|Day 1||6
8265221|NCT01766466|20379440|P4|STARTED|Day 1||0
8265222|NCT01766466|20379441|P3|STARTED|Day 1||6
8265223|NCT01766466|20379442|P2|STARTED|Day 1||0
8265224|NCT01766466|20379443|P1|STARTED|Day 1||6
8265228|NCT01766401|20379467|P2|NOT COMPLETED|Overall Study||56
8265229|NCT01766401|20379468|P1|NOT COMPLETED|Overall Study||37
8265230|NCT01766401|20379467|P2|COMPLETED|Overall Study||144
8265231|NCT01766401|20379468|P1|COMPLETED|Overall Study||161
8265232|NCT01766401|20379467|P2|STARTED|Overall Study||200
8265233|NCT01766401|20379468|P1|STARTED|Overall Study||198
8265234|NCT01766336|20379478|P2|NOT COMPLETED|Overall Study||75
8265235|NCT01766336|20379479|P1|NOT COMPLETED|Overall Study||90
8265236|NCT01766336|20379478|P2|COMPLETED|Overall Study||71
8265237|NCT01766336|20379479|P1|COMPLETED|Overall Study||60
8265238|NCT01766336|20379478|P2|STARTED|Overall Study||146
8265239|NCT01766336|20379479|P1|STARTED|Overall Study||150
8265240|NCT01766310|20379487|P2|NOT COMPLETED|Overall Study||3
8265241|NCT01766310|20379488|P1|NOT COMPLETED|Overall Study||1
8265242|NCT01766310|20379487|P2|COMPLETED|Overall Study||23
8265243|NCT01766310|20379488|P1|COMPLETED|Overall Study||23
8265244|NCT01766310|20379487|P2|STARTED|Overall Study||26
8265245|NCT01766310|20379488|P1|STARTED|Overall Study||24
8265246|NCT01766219|20379499|P3|NOT COMPLETED|Overall Study||0
8265247|NCT01766219|20379500|P2|NOT COMPLETED|Overall Study||0
8265248|NCT01766219|20379501|P1|NOT COMPLETED|Overall Study||0
8265249|NCT01766219|20379499|P3|COMPLETED|Overall Study||11
8265250|NCT01766219|20379500|P2|COMPLETED|Overall Study||2
8265251|NCT01766219|20379501|P1|COMPLETED|Overall Study||4
8265252|NCT01766219|20379499|P3|STARTED|Overall Study||11
8265253|NCT01766219|20379500|P2|STARTED|Overall Study||2
8265254|NCT01766219|20379501|P1|STARTED|Overall Study||4
8265255|NCT01766206|20379518|P1|NOT COMPLETED|Overall Study||51
8265256|NCT01766206|20379518|P1|COMPLETED|Overall Study||3888
8265257|NCT01766206|20379518|P1|STARTED|Overall Study||3939
8265258|NCT01766102|20379527|P2|NOT COMPLETED|Overall Study||0
8265259|NCT01766102|20379528|P1|NOT COMPLETED|Overall Study||0
8265260|NCT01766102|20379527|P2|COMPLETED|Overall Study||36
8265261|NCT01766102|20379528|P1|COMPLETED|Overall Study||36
8265262|NCT01766102|20379527|P2|STARTED|Overall Study||36
8265263|NCT01766102|20379528|P1|STARTED|Overall Study||36
8265264|NCT01766076|20379538|P2|NOT COMPLETED|Overall Study||0
8265265|NCT01766076|20379539|P1|NOT COMPLETED|Overall Study||0
8265266|NCT01766076|20379538|P2|COMPLETED|Overall Study||15
8265267|NCT01766076|20379539|P1|COMPLETED|Overall Study||15
8265268|NCT01766076|20379538|P2|STARTED|Overall Study||15
8265269|NCT01766076|20379539|P1|STARTED|Overall Study||15
8265270|NCT01766050|20379545|P1|NOT COMPLETED|Overall Study||4
8265271|NCT01766050|20379545|P1|COMPLETED|Overall Study||18
8265272|NCT01766050|20379545|P1|STARTED|Overall Study||22
8265273|NCT01766037|20379680|P2|NOT COMPLETED|Overall Study||29
8265274|NCT01766037|20379681|P1|NOT COMPLETED|Overall Study||29
8265275|NCT01766037|20379680|P2|COMPLETED|Overall Study||31
8265276|NCT01766037|20379681|P1|COMPLETED|Overall Study||82
8265277|NCT01766037|20379680|P2|STARTED|Overall Study||60
8265278|NCT01766037|20379681|P1|STARTED|Overall Study||111
8265279|NCT01766024|20379718|P2|NOT COMPLETED|Overall Study||0
8265280|NCT01766024|20379719|P1|NOT COMPLETED|Overall Study||0
8265281|NCT01766024|20379718|P2|COMPLETED|Overall Study||16
8265282|NCT01766024|20379719|P1|COMPLETED|Overall Study||16
8265283|NCT01766024|20379718|P2|STARTED|Overall Study||16
8265284|NCT01766024|20379719|P1|STARTED|Overall Study||16
8265285|NCT01765972|20379729|P4|NOT COMPLETED|Overall Study||0
8265286|NCT01765972|20379730|P3|NOT COMPLETED|Overall Study||0
8265287|NCT01765972|20379731|P2|NOT COMPLETED|Overall Study||0
8265288|NCT01765972|20379732|P1|NOT COMPLETED|Overall Study||0
8265289|NCT01765972|20379729|P4|COMPLETED|Overall Study||6
8265290|NCT01765972|20379730|P3|COMPLETED|Overall Study||6
8265291|NCT01765972|20379731|P2|COMPLETED|Overall Study||6
8265292|NCT01765972|20379732|P1|COMPLETED|Overall Study||6
8265293|NCT01765972|20379729|P4|STARTED|Overall Study||6
8265294|NCT01765972|20379730|P3|STARTED|Overall Study||6
8265295|NCT01765972|20379731|P2|STARTED|Overall Study||6
8265296|NCT01765972|20379732|P1|STARTED|Overall Study||6
8265297|NCT01765920|20379744|P2|NOT COMPLETED|Overall Study||6
8265298|NCT01765920|20379745|P1|NOT COMPLETED|Overall Study||2
8265299|NCT01765920|20379744|P2|COMPLETED|Overall Study||167
8265300|NCT01765920|20379745|P1|COMPLETED|Overall Study||167
8265301|NCT01765920|20379744|P2|STARTED|Overall Study||173
8265302|NCT01765920|20379745|P1|STARTED|Overall Study||169
8265303|NCT01765803|20379759|P1|NOT COMPLETED|Overall Study||0
8265304|NCT01765803|20379759|P1|COMPLETED|Overall Study||6
8265305|NCT01765803|20379759|P1|STARTED|Overall Study||6
8265306|NCT01765764|20379767|P3|NOT COMPLETED|Post-treatment Period||0
8265307|NCT01765764|20379768|P2|NOT COMPLETED|Post-treatment Period||0
8265308|NCT01765764|20379769|P1|NOT COMPLETED|Post-treatment Period||0
8265309|NCT01765764|20379767|P3|COMPLETED|Post-treatment Period||112
8265310|NCT01765764|20379768|P2|COMPLETED|Post-treatment Period||107
8265311|NCT01765764|20379769|P1|COMPLETED|Post-treatment Period||114
8265312|NCT01765764|20379767|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
8265313|NCT01765764|20379768|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
8265314|NCT01765764|20379769|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
8265315|NCT01765764|20379767|P3|NOT COMPLETED|Treatment Period||6
8265316|NCT01765764|20379768|P2|NOT COMPLETED|Treatment Period||9
8265317|NCT01765764|20379769|P1|NOT COMPLETED|Treatment Period||3
8265318|NCT01765764|20379767|P3|COMPLETED|Treatment Period||115
8265319|NCT01765764|20379768|P2|COMPLETED|Treatment Period||109
8265320|NCT01765764|20379769|P1|COMPLETED|Treatment Period||115
8265321|NCT01765764|20379767|P3|STARTED|Treatment Period||121
8265322|NCT01765764|20379768|P2|STARTED|Treatment Period||118
8265323|NCT01765764|20379769|P1|STARTED|Treatment Period||118
8265324|NCT01765751|20379789|P3|NOT COMPLETED|Overall Study||1
8265325|NCT01765751|20379790|P2|NOT COMPLETED|Overall Study||2
8265326|NCT01765751|20379791|P1|NOT COMPLETED|Overall Study||0
8265327|NCT01765751|20379789|P3|COMPLETED|Overall Study||15
8265328|NCT01765751|20379790|P2|COMPLETED|Overall Study||14
8265329|NCT01765751|20379791|P1|COMPLETED|Overall Study||16
8265330|NCT01765751|20379789|P3|STARTED|Overall Study||16
8265331|NCT01765751|20379790|P2|STARTED|Overall Study||16
8265332|NCT01765751|20379791|P1|STARTED|Overall Study||16
8265333|NCT01765673|20379823|P1|NOT COMPLETED|Overall Study||1
8265334|NCT01765673|20379823|P1|COMPLETED|Overall Study||11
8265335|NCT01765673|20379823|P1|STARTED|Overall Study||12
8265336|NCT01765647|20379846|P1|NOT COMPLETED|Overall Study||0
8265337|NCT01765647|20379846|P1|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
8265338|NCT01765647|20379846|P1|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
8265339|NCT01765582|20379856|P3|NOT COMPLETED|Overall Study||95
8265340|NCT01765582|20379857|P2|NOT COMPLETED|Overall Study||92
8265341|NCT01765582|20379858|P1|NOT COMPLETED|Overall Study||93
8265342|NCT01765582|20379856|P3|COMPLETED|Overall Study||0
8265343|NCT01765582|20379857|P2|COMPLETED|Overall Study||0
8265344|NCT01765582|20379858|P1|COMPLETED|Overall Study||0
8265345|NCT01765582|20379856|P3|STARTED|Overall Study||95
8265346|NCT01765582|20379857|P2|STARTED|Overall Study||92
8265347|NCT01765582|20379858|P1|STARTED|Overall Study||93
8265348|NCT01765569|20379891|P1|NOT COMPLETED|Period C||1
8265349|NCT01765569|20379891|P1|COMPLETED|Period C||27
8265350|NCT01765569|20379891|P1|STARTED|Period C||28
8265351|NCT01765569|20379891|P1|NOT COMPLETED|Period B||1
8265352|NCT01765569|20379891|P1|COMPLETED|Period B||28
8265353|NCT01765569|20379891|P1|STARTED|Period B||29
8265354|NCT01765569|20379891|P1|NOT COMPLETED|Period A||0
8265355|NCT01765569|20379891|P1|COMPLETED|Period A||29
8265356|NCT01765569|20379891|P1|STARTED|Period A||29
8265357|NCT01765543|20379912|P1|NOT COMPLETED|Overall Study||3
8265358|NCT01765543|20379912|P1|COMPLETED|Overall Study||24
8265359|NCT01765543|20379912|P1|STARTED|Overall Study||27
8265360|NCT01765530|20379936|P2|NOT COMPLETED|Overall Study||1
8265361|NCT01765530|20379937|P1|NOT COMPLETED|Overall Study||1
8265362|NCT01765530|20379936|P2|COMPLETED|Overall Study||36
8265363|NCT01765530|20379937|P1|COMPLETED|Overall Study||36
8265364|NCT01765530|20379936|P2|STARTED|Overall Study||37
8265365|NCT01765530|20379937|P1|STARTED|Overall Study||37
8265366|NCT01765465|20379947|P2|NOT COMPLETED|Overall Study||4
8265367|NCT01765465|20379948|P1|NOT COMPLETED|Overall Study||7
8265368|NCT01765465|20379947|P2|COMPLETED|Overall Study||63
8265369|NCT01765465|20379948|P1|COMPLETED|Overall Study||64
8265370|NCT01765465|20379947|P2|STARTED|Overall Study||67
8265371|NCT01765465|20379948|P1|STARTED|Overall Study||71
8265372|NCT01765426|20379964|P4|NOT COMPLETED|Overall Study||0
8265373|NCT01765426|20379965|P3|NOT COMPLETED|Overall Study||0
8265374|NCT01765426|20379966|P2|NOT COMPLETED|Overall Study||1
8265375|NCT01765426|20379967|P1|NOT COMPLETED|Overall Study||0
8265376|NCT01765426|20379964|P4|COMPLETED|Overall Study||15
8265377|NCT01765426|20379965|P3|COMPLETED|Overall Study||17
8265378|NCT01765426|20379966|P2|COMPLETED|Overall Study||16
8265379|NCT01765426|20379967|P1|COMPLETED|Overall Study||18
8265380|NCT01765426|20379964|P4|Completed All Vaccinations|Overall Study||15
8265381|NCT01765426|20379965|P3|Completed All Vaccinations|Overall Study||17
8265382|NCT01765426|20379966|P2|Completed All Vaccinations|Overall Study||16
8265383|NCT01765426|20379967|P1|Completed All Vaccinations|Overall Study||17
8265384|NCT01765426|20379964|P4|STARTED|Overall Study||15
8265385|NCT01765426|20379965|P3|STARTED|Overall Study||17
8265386|NCT01765426|20379966|P2|STARTED|Overall Study||17
8265387|NCT01765426|20379967|P1|STARTED|Overall Study||18
8265388|NCT01765270|20380023|P2|NOT COMPLETED|Overall Study||1
8265389|NCT01765270|20380024|P1|NOT COMPLETED|Overall Study||1
8265390|NCT01765270|20380023|P2|COMPLETED|Overall Study||6
8265391|NCT01765270|20380024|P1|COMPLETED|Overall Study||4
8265392|NCT01765270|20380023|P2|STARTED|Overall Study||7
8265393|NCT01765270|20380024|P1|STARTED|Overall Study||5
8265394|NCT01765192|20380046|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
8265395|NCT01765192|20380047|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
8265396|NCT01765192|20380046|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
8265397|NCT01765192|20380047|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
8265398|NCT01765192|20380046|P2|STARTED|End of Treatment Period 2 to Final Visit||28
8265489|NCT01764945|20380217|P2|COMPLETED|Overall Study||4
8265399|NCT01765192|20380047|P1|STARTED|End of Treatment Period 2 to Final Visit||30
8265400|NCT01765192|20380046|P2|NOT COMPLETED|Treatment Period 2||2
8265401|NCT01765192|20380047|P1|NOT COMPLETED|Treatment Period 2||0
8265402|NCT01765192|20380046|P2|COMPLETED|Treatment Period 2||28
8265403|NCT01765192|20380047|P1|COMPLETED|Treatment Period 2||30
8265404|NCT01765192|20380046|P2|STARTED|Treatment Period 2||30
8265405|NCT01765192|20380047|P1|STARTED|Treatment Period 2||30
8265406|NCT01765192|20380046|P2|NOT COMPLETED|Washout Period||1
8265407|NCT01765192|20380047|P1|NOT COMPLETED|Washout Period||2
8265408|NCT01765192|20380046|P2|COMPLETED|Washout Period||30
8265409|NCT01765192|20380047|P1|COMPLETED|Washout Period||30
8265410|NCT01765192|20380046|P2|STARTED|Washout Period||31
8265411|NCT01765192|20380047|P1|STARTED|Washout Period||32
8265412|NCT01765192|20380046|P2|NOT COMPLETED|Treatment Period 1||1
8265413|NCT01765192|20380047|P1|NOT COMPLETED|Treatment Period 1||0
8265414|NCT01765192|20380046|P2|COMPLETED|Treatment Period 1||31
8265415|NCT01765192|20380047|P1|COMPLETED|Treatment Period 1||32
8265416|NCT01765192|20380046|P2|STARTED|Treatment Period 1||32
8265417|NCT01765192|20380047|P1|STARTED|Treatment Period 1||32
8265418|NCT01765179|20380065|P1|NOT COMPLETED|Overall Study||27
8265419|NCT01765179|20380065|P1|COMPLETED|Overall Study||117
8265420|NCT01765179|20380065|P1|STARTED|Overall Study||144
8265421|NCT01765153|20380072|P2|NOT COMPLETED|Rest Phase 2||1
8265422|NCT01765153|20380073|P1|NOT COMPLETED|Rest Phase 2||2
8265423|NCT01765153|20380072|P2|COMPLETED|Rest Phase 2||7
8265424|NCT01765153|20380073|P1|COMPLETED|Rest Phase 2||8
8265425|NCT01765153|20380072|P2|STARTED|Rest Phase 2||8
8265426|NCT01765153|20380073|P1|STARTED|Rest Phase 2||10
8265427|NCT01765153|20380072|P2|NOT COMPLETED|Training Phase 2||1
8265428|NCT01765153|20380073|P1|NOT COMPLETED|Training Phase 2||0
8265429|NCT01765153|20380072|P2|COMPLETED|Training Phase 2||8
8265430|NCT01765153|20380073|P1|COMPLETED|Training Phase 2||10
8265431|NCT01765153|20380072|P2|STARTED|Training Phase 2||9
8265432|NCT01765153|20380073|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
8265433|NCT01765153|20380072|P2|NOT COMPLETED|Rest Phase 1||1
8265434|NCT01765153|20380073|P1|NOT COMPLETED|Rest Phase 1||0
8265435|NCT01765153|20380072|P2|COMPLETED|Rest Phase 1||9
8265436|NCT01765153|20380073|P1|COMPLETED|Rest Phase 1||9
8265437|NCT01765153|20380072|P2|STARTED|Rest Phase 1||10
8265438|NCT01765153|20380073|P1|STARTED|Rest Phase 1||9
8265439|NCT01765153|20380072|P2|NOT COMPLETED|Training Phase 1||1
8265440|NCT01765153|20380073|P1|NOT COMPLETED|Training Phase 1||1
8265441|NCT01765153|20380072|P2|COMPLETED|Training Phase 1||10
8265442|NCT01765153|20380073|P1|COMPLETED|Training Phase 1||9
8265443|NCT01765153|20380072|P2|STARTED|Training Phase 1||11
8265444|NCT01765153|20380073|P1|STARTED|Training Phase 1||10
8265445|NCT01764997|20380180|P5|NOT COMPLETED|Study Drug Treatment Period||36
8265446|NCT01764997|20380181|P4|NOT COMPLETED|Study Drug Treatment Period||0
8265447|NCT01764997|20380182|P3|NOT COMPLETED|Study Drug Treatment Period||0
8265448|NCT01764997|20380183|P2|NOT COMPLETED|Study Drug Treatment Period||1
8265449|NCT01764997|20380184|P1|NOT COMPLETED|Study Drug Treatment Period||0
8265450|NCT01764997|20380180|P5|COMPLETED|Study Drug Treatment Period||286
8265451|NCT01764997|20380181|P4|COMPLETED|Study Drug Treatment Period||13
8265452|NCT01764997|20380182|P3|COMPLETED|Study Drug Treatment Period||13
8265453|NCT01764997|20380183|P2|COMPLETED|Study Drug Treatment Period||16
8265454|NCT01764997|20380184|P1|COMPLETED|Study Drug Treatment Period||0
8265455|NCT01764997|20380180|P5|STARTED|Study Drug Treatment Period||322
8265456|NCT01764997|20380181|P4|STARTED|Study Drug Treatment Period||13
8265457|NCT01764997|20380182|P3|STARTED|Study Drug Treatment Period||13
8265458|NCT01764997|20380183|P2|STARTED|Study Drug Treatment Period||17
8265459|NCT01764997|20380184|P1|STARTED|Study Drug Treatment Period||0
8265460|NCT01764997|20380180|P5|NOT COMPLETED|Run-in Period||0
8265461|NCT01764997|20380181|P4|NOT COMPLETED|Run-in Period||0
8265462|NCT01764997|20380182|P3|NOT COMPLETED|Run-in Period||0
8265463|NCT01764997|20380183|P2|NOT COMPLETED|Run-in Period||0
8265464|NCT01764997|20380184|P1|NOT COMPLETED|Run-in Period||38
8265465|NCT01764997|20380180|P5|COMPLETED|Run-in Period||0
8265466|NCT01764997|20380181|P4|COMPLETED|Run-in Period||0
8265467|NCT01764997|20380182|P3|COMPLETED|Run-in Period||0
8265468|NCT01764997|20380183|P2|COMPLETED|Run-in Period||0
8265469|NCT01764997|20380184|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
8265470|NCT01764997|20380180|P5|STARTED|Run-in Period||0
8265471|NCT01764997|20380181|P4|STARTED|Run-in Period||0
8265472|NCT01764997|20380182|P3|STARTED|Run-in Period||0
8265473|NCT01764997|20380183|P2|STARTED|Run-in Period||0
8265474|NCT01764997|20380184|P1|STARTED|Run-in Period||776
8265475|NCT01764945|20380211|P8|NOT COMPLETED|Overall Study||0
8265476|NCT01764945|20380212|P7|NOT COMPLETED|Overall Study||1
8265477|NCT01764945|20380213|P6|NOT COMPLETED|Overall Study||0
8265478|NCT01764945|20380214|P5|NOT COMPLETED|Overall Study||0
8265479|NCT01764945|20380215|P4|NOT COMPLETED|Overall Study||0
8265480|NCT01764945|20380216|P3|NOT COMPLETED|Overall Study||0
8265481|NCT01764945|20380217|P2|NOT COMPLETED|Overall Study||1
8265482|NCT01764945|20380218|P1|NOT COMPLETED|Overall Study||0
8265483|NCT01764945|20380211|P8|COMPLETED|Overall Study||9
8265484|NCT01764945|20380212|P7|COMPLETED|Overall Study||8
8265485|NCT01764945|20380213|P6|COMPLETED|Overall Study||8
8265486|NCT01764945|20380214|P5|COMPLETED|Overall Study||10
8265487|NCT01764945|20380215|P4|COMPLETED|Overall Study||5
8265488|NCT01764945|20380216|P3|COMPLETED|Overall Study||5
8265490|NCT01764945|20380218|P1|COMPLETED|Overall Study||5
8265491|NCT01764945|20380211|P8|STARTED|Overall Study||9
8265492|NCT01764945|20380212|P7|STARTED|Overall Study||9
8265493|NCT01764945|20380213|P6|STARTED|Overall Study||8
8265494|NCT01764945|20380214|P5|STARTED|Overall Study||10
8265495|NCT01764945|20380215|P4|STARTED|Overall Study||5
8265496|NCT01764945|20380216|P3|STARTED|Overall Study||5
8265497|NCT01764945|20380217|P2|STARTED|Overall Study||5
8265498|NCT01764945|20380218|P1|STARTED|Overall Study||5
8265499|NCT01764919|20380252|P1|NOT COMPLETED|Overall Study||0
8265500|NCT01764919|20380252|P1|COMPLETED|Overall Study||4
8265501|NCT01764919|20380252|P1|STARTED|Overall Study||4
8265502|NCT01764854|20380264|P4|NOT COMPLETED|Overall Study||2
8265503|NCT01764854|20380265|P3|NOT COMPLETED|Overall Study||6
8265504|NCT01764854|20380266|P2|NOT COMPLETED|Overall Study||0
8265505|NCT01764854|20380267|P1|NOT COMPLETED|Overall Study||0
8265506|NCT01764854|20380264|P4|COMPLETED|Overall Study||33
8265507|NCT01764854|20380265|P3|COMPLETED|Overall Study||31
8265508|NCT01764854|20380266|P2|COMPLETED|Overall Study||8
8265509|NCT01764854|20380267|P1|COMPLETED|Overall Study||8
8265510|NCT01764854|20380264|P4|STARTED|Overall Study||35
8265511|NCT01764854|20380265|P3|STARTED|Overall Study||37
8265512|NCT01764854|20380266|P2|STARTED|Overall Study||8
8265513|NCT01764854|20380267|P1|STARTED|Overall Study||8
8265514|NCT01764841|20380281|P4|NOT COMPLETED|Overall Study||19
8265515|NCT01764841|20380282|P3|NOT COMPLETED|Overall Study||14
8265516|NCT01764841|20380283|P2|NOT COMPLETED|Overall Study||26
8265517|NCT01764841|20380284|P1|NOT COMPLETED|Overall Study||23
8265518|NCT01764841|20380281|P4|COMPLETED|Overall Study||49
8265519|NCT01764841|20380282|P3|COMPLETED|Overall Study||56
8265520|NCT01764841|20380283|P2|COMPLETED|Overall Study||111
8265521|NCT01764841|20380284|P1|COMPLETED|Overall Study||118
8265522|NCT01764841|20380281|P4|Participants Received Treatment|Overall Study|safety population|68
8265523|NCT01764841|20380282|P3|Participants Received Treatment|Overall Study|safety population|69
8265524|NCT01764841|20380283|P2|Participants Received Treatment|Overall Study|safety population|136
8265525|NCT01764841|20380284|P1|Participants Received Treatment|Overall Study|safety population|141
8265526|NCT01764841|20380281|P4|STARTED|Overall Study||68
8265527|NCT01764841|20380282|P3|STARTED|Overall Study||70
8265528|NCT01764841|20380283|P2|STARTED|Overall Study||137
8265529|NCT01764841|20380284|P1|STARTED|Overall Study||141
8265530|NCT01764685|20380318|P2|NOT COMPLETED|Overall Study||1
8265531|NCT01764685|20380319|P1|NOT COMPLETED|Overall Study||0
8265532|NCT01764685|20380318|P2|COMPLETED|Overall Study||3
8265533|NCT01764685|20380319|P1|COMPLETED|Overall Study||0
8265534|NCT01764685|20380318|P2|STARTED|Overall Study||4
8265535|NCT01764685|20380319|P1|STARTED|Overall Study||0
8265536|NCT01764659|20380325|P1|NOT COMPLETED|Overall Study||2
8265537|NCT01764659|20380325|P1|COMPLETED|Overall Study||12
8265538|NCT01764659|20380325|P1|STARTED|Overall Study||14
8265539|NCT01764633|20380339|P2|NOT COMPLETED|Overall Study||93
8265540|NCT01764633|20380340|P1|NOT COMPLETED|Overall Study||118
8265541|NCT01764633|20380339|P2|COMPLETED|Overall Study||13691
8265542|NCT01764633|20380340|P1|COMPLETED|Overall Study||13662
8265543|NCT01764633|20380339|P2|Received Treatment|Overall Study||13769
8265544|NCT01764633|20380340|P1|Received Treatment|Overall Study||13756
8265545|NCT01764633|20380339|P2|STARTED|Overall Study||13784
8265546|NCT01764633|20380340|P1|STARTED|Overall Study||13780
8265547|NCT01764607|20380362|P1|NOT COMPLETED|Overall Study||0
8265548|NCT01764607|20380362|P1|COMPLETED|Overall Study||1
8265549|NCT01764607|20380362|P1|STARTED|Overall Study||1
8265550|NCT01764464|20380369|P2|NOT COMPLETED|Second Intervention (Cross-over)||0
8265551|NCT01764464|20380370|P1|NOT COMPLETED|Second Intervention (Cross-over)||2
8265552|NCT01764464|20380369|P2|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
8265553|NCT01764464|20380370|P1|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
8265554|NCT01764464|20380369|P2|STARTED|Second Intervention (Cross-over)|Started Gralise|13
8265555|NCT01764464|20380370|P1|STARTED|Second Intervention (Cross-over)|Started Placebo|14
8265556|NCT01764464|20380369|P2|NOT COMPLETED|First Intervention||3
8265557|NCT01764464|20380370|P1|NOT COMPLETED|First Intervention||2
8265558|NCT01764464|20380369|P2|COMPLETED|First Intervention|Completed Placebo|13
8265559|NCT01764464|20380370|P1|COMPLETED|First Intervention|Completed Gralise|14
8265560|NCT01764464|20380369|P2|STARTED|First Intervention|Started Placebo|16
8265561|NCT01764464|20380370|P1|STARTED|First Intervention|Started Gralise|16
8265562|NCT01764386|20380388|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
8265563|NCT01764386|20380389|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
8265564|NCT01764386|20380388|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
8265565|NCT01764386|20380389|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
8265566|NCT01764386|20380388|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
8265567|NCT01764386|20380389|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
8265568|NCT01764386|20380388|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
8265569|NCT01764386|20380389|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
8265570|NCT01764386|20380388|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
8265571|NCT01764386|20380389|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
8265572|NCT01764386|20380388|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
8265573|NCT01764386|20380389|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
8265574|NCT01764386|20380388|P2|STARTED|Controlled Treatment Period (CTP)||89
8265575|NCT01764386|20380389|P1|STARTED|Controlled Treatment Period (CTP)||153
8265576|NCT01764256|20380434|P4|NOT COMPLETED|Completed Study||1
8265577|NCT01764256|20380435|P3|NOT COMPLETED|Completed Study||0
8265578|NCT01764256|20380436|P2|NOT COMPLETED|Completed Study||0
8265579|NCT01764256|20380437|P1|NOT COMPLETED|Completed Study||0
8265580|NCT01764256|20380434|P4|COMPLETED|Completed Study||11
8265581|NCT01764256|20380435|P3|COMPLETED|Completed Study||11
8265582|NCT01764256|20380436|P2|COMPLETED|Completed Study||11
8265583|NCT01764256|20380437|P1|COMPLETED|Completed Study||10
8265584|NCT01764256|20380434|P4|STARTED|Completed Study||12
8265585|NCT01764256|20380435|P3|STARTED|Completed Study||11
8265586|NCT01764256|20380436|P2|STARTED|Completed Study||11
8265587|NCT01764256|20380437|P1|STARTED|Completed Study||10
8265588|NCT01764256|20380434|P4|NOT COMPLETED|Received All Vaccinations||0
8265589|NCT01764256|20380435|P3|NOT COMPLETED|Received All Vaccinations||1
8265590|NCT01764256|20380436|P2|NOT COMPLETED|Received All Vaccinations||1
8265591|NCT01764256|20380437|P1|NOT COMPLETED|Received All Vaccinations||2
8265592|NCT01764256|20380434|P4|COMPLETED|Received All Vaccinations||12
8265593|NCT01764256|20380435|P3|COMPLETED|Received All Vaccinations||11
8265594|NCT01764256|20380436|P2|COMPLETED|Received All Vaccinations||11
8265595|NCT01764256|20380437|P1|COMPLETED|Received All Vaccinations||10
8265596|NCT01764256|20380434|P4|STARTED|Received All Vaccinations||12
8265597|NCT01764256|20380435|P3|STARTED|Received All Vaccinations||12
8265598|NCT01764256|20380436|P2|STARTED|Received All Vaccinations||12
8265599|NCT01764256|20380437|P1|STARTED|Received All Vaccinations||12
8265600|NCT01764022|20380480|P2|NOT COMPLETED|Overall Study||14
8265601|NCT01764022|20380481|P1|NOT COMPLETED|Overall Study||8
8265602|NCT01764022|20380480|P2|COMPLETED|Overall Study||96
8265603|NCT01764022|20380481|P1|COMPLETED|Overall Study||107
8265604|NCT01764022|20380480|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
8265605|NCT01764022|20380481|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
8265606|NCT01764022|20380480|P2|STARTED|Overall Study||110
8265607|NCT01764022|20380481|P1|STARTED|Overall Study||115
8265608|NCT01763996|20380513|P2|NOT COMPLETED|Treatment Period 2||1
8265609|NCT01763996|20380514|P1|NOT COMPLETED|Treatment Period 2||0
8265610|NCT01763996|20380513|P2|COMPLETED|Treatment Period 2||14
8265611|NCT01763996|20380514|P1|COMPLETED|Treatment Period 2||15
8265612|NCT01763996|20380513|P2|STARTED|Treatment Period 2||15
8265613|NCT01763996|20380514|P1|STARTED|Treatment Period 2||15
8265614|NCT01763996|20380513|P2|NOT COMPLETED|Treatment Period 1||0
8265615|NCT01763996|20380514|P1|NOT COMPLETED|Treatment Period 1||0
8265616|NCT01763996|20380513|P2|COMPLETED|Treatment Period 1||15
8265617|NCT01763996|20380514|P1|COMPLETED|Treatment Period 1||15
8265618|NCT01763996|20380513|P2|STARTED|Treatment Period 1||15
8265619|NCT01763996|20380514|P1|STARTED|Treatment Period 1||15
8265620|NCT01763970|20380540|P1|NOT COMPLETED|Overall Study||0
8265621|NCT01763970|20380540|P1|COMPLETED|Overall Study||14
8265622|NCT01763970|20380540|P1|STARTED|Overall Study||14
8265623|NCT01763931|20380555|P2|NOT COMPLETED|Overall Study||1
8265624|NCT01763931|20380556|P1|NOT COMPLETED|Overall Study||0
8265625|NCT01763931|20380555|P2|COMPLETED|Overall Study||3
8265626|NCT01763931|20380556|P1|COMPLETED|Overall Study||2
8265627|NCT01763931|20380555|P2|STARTED|Overall Study||4
8265628|NCT01763931|20380556|P1|STARTED|Overall Study||2
8265629|NCT01763918|20380568|P4|NOT COMPLETED|Overall Study||2
8265630|NCT01763918|20380569|P3|NOT COMPLETED|Overall Study||10
8265631|NCT01763918|20380570|P2|NOT COMPLETED|Overall Study||1
8265632|NCT01763918|20380571|P1|NOT COMPLETED|Overall Study||6
8265633|NCT01763918|20380568|P4|COMPLETED|Overall Study||108
8265634|NCT01763918|20380569|P3|COMPLETED|Overall Study||101
8265635|NCT01763918|20380570|P2|COMPLETED|Overall Study||54
8265636|NCT01763918|20380571|P1|COMPLETED|Overall Study||49
8265637|NCT01763918|20380568|P4|Received Treatment|Overall Study||110
8265638|NCT01763918|20380569|P3|Received Treatment|Overall Study||110
8265639|NCT01763918|20380570|P2|Received Treatment|Overall Study||55
8265640|NCT01763918|20380571|P1|Received Treatment|Overall Study||54
8265641|NCT01763918|20380568|P4|STARTED|Overall Study||110
8265642|NCT01763918|20380569|P3|STARTED|Overall Study||111
8265643|NCT01763918|20380570|P2|STARTED|Overall Study||55
8265644|NCT01763918|20380571|P1|STARTED|Overall Study||55
8265645|NCT01763905|20380669|P4|NOT COMPLETED|Overall Study||1
8265646|NCT01763905|20380670|P3|NOT COMPLETED|Overall Study||9
8265647|NCT01763905|20380671|P2|NOT COMPLETED|Overall Study||1
8265648|NCT01763905|20380672|P1|NOT COMPLETED|Overall Study||6
8265649|NCT01763905|20380669|P4|COMPLETED|Overall Study||101
8265650|NCT01763905|20380670|P3|COMPLETED|Overall Study||94
8265651|NCT01763905|20380671|P2|COMPLETED|Overall Study||50
8265652|NCT01763905|20380672|P1|COMPLETED|Overall Study||45
8265653|NCT01763905|20380669|P4|STARTED|Overall Study||102
8265654|NCT01763905|20380670|P3|STARTED|Overall Study||103
8265655|NCT01763905|20380671|P2|STARTED|Overall Study||51
8265656|NCT01763905|20380672|P1|STARTED|Overall Study||51
8265657|NCT01763866|20380790|P24|NOT COMPLETED|Overall Study||2
8265658|NCT01763866|20380791|P23|NOT COMPLETED|Overall Study||3
8265659|NCT01763866|20380792|P22|NOT COMPLETED|Overall Study||1
8265660|NCT01763866|20380793|P21|NOT COMPLETED|Overall Study||4
8265661|NCT01763866|20380794|P20|NOT COMPLETED|Overall Study||2
8265662|NCT01763866|20380795|P19|NOT COMPLETED|Overall Study||6
8265663|NCT01763866|20380796|P18|NOT COMPLETED|Overall Study||1
8265664|NCT01763866|20380797|P17|NOT COMPLETED|Overall Study||1
8265665|NCT01763866|20380798|P16|NOT COMPLETED|Overall Study||3
8265666|NCT01763866|20380799|P15|NOT COMPLETED|Overall Study||12
8265667|NCT01763866|20380800|P14|NOT COMPLETED|Overall Study||0
8265668|NCT01763866|20380801|P13|NOT COMPLETED|Overall Study||4
8265669|NCT01763866|20380802|P12|NOT COMPLETED|Overall Study||2
8265670|NCT01763866|20380803|P11|NOT COMPLETED|Overall Study||8
8265671|NCT01763866|20380804|P10|NOT COMPLETED|Overall Study||1
8265672|NCT01763866|20380805|P9|NOT COMPLETED|Overall Study||3
8265673|NCT01763866|20380806|P8|NOT COMPLETED|Overall Study||0
8265674|NCT01763866|20380807|P7|NOT COMPLETED|Overall Study||7
8265675|NCT01763866|20380808|P6|NOT COMPLETED|Overall Study||3
8265676|NCT01763866|20380809|P5|NOT COMPLETED|Overall Study||2
8265677|NCT01763866|20380810|P4|NOT COMPLETED|Overall Study||0
8265678|NCT01763866|20380811|P3|NOT COMPLETED|Overall Study||5
8265679|NCT01763866|20380812|P2|NOT COMPLETED|Overall Study||1
8265680|NCT01763866|20380813|P1|NOT COMPLETED|Overall Study||2
8265681|NCT01763866|20380790|P24|COMPLETED|Overall Study||113
8265682|NCT01763866|20380791|P23|COMPLETED|Overall Study||109
8265683|NCT01763866|20380792|P22|COMPLETED|Overall Study||54
8265684|NCT01763866|20380793|P21|COMPLETED|Overall Study||52
8265685|NCT01763866|20380794|P20|COMPLETED|Overall Study||110
8265686|NCT01763866|20380795|P19|COMPLETED|Overall Study||105
8265687|NCT01763866|20380796|P18|COMPLETED|Overall Study||55
8265688|NCT01763866|20380797|P17|COMPLETED|Overall Study||55
8265689|NCT01763866|20380798|P16|COMPLETED|Overall Study||112
8265690|NCT01763866|20380799|P15|COMPLETED|Overall Study||102
8265691|NCT01763866|20380800|P14|COMPLETED|Overall Study||57
8265692|NCT01763866|20380801|P13|COMPLETED|Overall Study||54
8265693|NCT01763866|20380802|P12|COMPLETED|Overall Study||108
8265694|NCT01763866|20380803|P11|COMPLETED|Overall Study||102
8265695|NCT01763866|20380804|P10|COMPLETED|Overall Study||53
8265696|NCT01763866|20380805|P9|COMPLETED|Overall Study||53
8265697|NCT01763866|20380806|P8|COMPLETED|Overall Study||55
8265698|NCT01763866|20380807|P7|COMPLETED|Overall Study||48
8265699|NCT01763866|20380808|P6|COMPLETED|Overall Study||107
8265700|NCT01763866|20380809|P5|COMPLETED|Overall Study||108
8265701|NCT01763866|20380810|P4|COMPLETED|Overall Study||55
8265702|NCT01763866|20380811|P3|COMPLETED|Overall Study||51
8265703|NCT01763866|20380812|P2|COMPLETED|Overall Study||54
8265704|NCT01763866|20380813|P1|COMPLETED|Overall Study||54
8265705|NCT01763866|20380790|P24|Received Treatment|Overall Study||115
8265706|NCT01763866|20380791|P23|Received Treatment|Overall Study||112
8265707|NCT01763866|20380792|P22|Received Treatment|Overall Study||55
8265708|NCT01763866|20380793|P21|Received Treatment|Overall Study||56
8265709|NCT01763866|20380794|P20|Received Treatment|Overall Study||112
8265710|NCT01763866|20380795|P19|Received Treatment|Overall Study||111
8265711|NCT01763866|20380796|P18|Received Treatment|Overall Study||55
8265712|NCT01763866|20380797|P17|Received Treatment|Overall Study||56
8265713|NCT01763866|20380798|P16|Received Treatment|Overall Study||115
8265714|NCT01763866|20380799|P15|Received Treatment|Overall Study||113
8265715|NCT01763866|20380800|P14|Received Treatment|Overall Study||57
8265716|NCT01763866|20380801|P13|Received Treatment|Overall Study||58
8265717|NCT01763866|20380802|P12|Received Treatment|Overall Study||110
8265718|NCT01763866|20380803|P11|Received Treatment|Overall Study||109
8265719|NCT01763866|20380804|P10|Received Treatment|Overall Study||54
8265720|NCT01763866|20380805|P9|Received Treatment|Overall Study||56
8265721|NCT01763866|20380806|P8|Received Treatment|Overall Study||55
8265722|NCT01763866|20380807|P7|Received Treatment|Overall Study||55
8265723|NCT01763866|20380808|P6|Received Treatment|Overall Study||110
8265724|NCT01763866|20380809|P5|Received Treatment|Overall Study||110
8265725|NCT01763866|20380810|P4|Received Treatment|Overall Study||55
8265726|NCT01763866|20380811|P3|Received Treatment|Overall Study||56
8265727|NCT01763866|20380812|P2|Received Treatment|Overall Study||55
8265728|NCT01763866|20380813|P1|Received Treatment|Overall Study||56
8265729|NCT01763866|20380790|P24|STARTED|Overall Study||115
8265730|NCT01763866|20380791|P23|STARTED|Overall Study||112
8265731|NCT01763866|20380792|P22|STARTED|Overall Study||55
8265732|NCT01763866|20380793|P21|STARTED|Overall Study||56
8265733|NCT01763866|20380794|P20|STARTED|Overall Study||112
8265734|NCT01763866|20380795|P19|STARTED|Overall Study||111
8265735|NCT01763866|20380796|P18|STARTED|Overall Study||56
8265736|NCT01763866|20380797|P17|STARTED|Overall Study||56
8265737|NCT01763866|20380798|P16|STARTED|Overall Study||115
8265738|NCT01763866|20380799|P15|STARTED|Overall Study||114
8265739|NCT01763866|20380800|P14|STARTED|Overall Study||57
8265740|NCT01763866|20380801|P13|STARTED|Overall Study||58
8265741|NCT01763866|20380802|P12|STARTED|Overall Study||110
8265742|NCT01763866|20380803|P11|STARTED|Overall Study||110
8265743|NCT01763866|20380804|P10|STARTED|Overall Study||54
8265744|NCT01763866|20380805|P9|STARTED|Overall Study||56
8265745|NCT01763866|20380806|P8|STARTED|Overall Study||55
8265746|NCT01763866|20380807|P7|STARTED|Overall Study||55
8265747|NCT01763866|20380808|P6|STARTED|Overall Study||110
8265748|NCT01763866|20380809|P5|STARTED|Overall Study||110
8265749|NCT01763866|20380810|P4|STARTED|Overall Study||55
8265750|NCT01763866|20380811|P3|STARTED|Overall Study||56
8265751|NCT01763866|20380812|P2|STARTED|Overall Study||55
8265752|NCT01763866|20380813|P1|STARTED|Overall Study||56
8265753|NCT01763827|20381373|P6|NOT COMPLETED|Overall Study||2
8265754|NCT01763827|20381374|P5|NOT COMPLETED|Overall Study||6
8265755|NCT01763827|20381375|P4|NOT COMPLETED|Overall Study||1
8265756|NCT01763827|20381376|P3|NOT COMPLETED|Overall Study||4
8265757|NCT01763827|20381377|P2|NOT COMPLETED|Overall Study||1
8265758|NCT01763827|20381378|P1|NOT COMPLETED|Overall Study||3
8265759|NCT01763827|20381373|P6|COMPLETED|Overall Study||151
8265760|NCT01763827|20381374|P5|COMPLETED|Overall Study||147
8265761|NCT01763827|20381375|P4|COMPLETED|Overall Study||76
8265762|NCT01763827|20381376|P3|COMPLETED|Overall Study||73
8265763|NCT01763827|20381377|P2|COMPLETED|Overall Study||77
8265764|NCT01763827|20381378|P1|COMPLETED|Overall Study||74
8265765|NCT01763827|20381373|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
8265766|NCT01763827|20381374|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
8265767|NCT01763827|20381375|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
8265768|NCT01763827|20381376|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
8265769|NCT01763827|20381377|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
8265770|NCT01763827|20381378|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
8265771|NCT01763827|20381373|P6|STARTED|Overall Study||153
8265772|NCT01763827|20381374|P5|STARTED|Overall Study||153
8265773|NCT01763827|20381375|P4|STARTED|Overall Study||77
8265774|NCT01763827|20381376|P3|STARTED|Overall Study||77
8265775|NCT01763827|20381377|P2|STARTED|Overall Study||78
8265776|NCT01763827|20381378|P1|STARTED|Overall Study||77
8265777|NCT01763788|20381522|P4|NOT COMPLETED|Overall Study||0
8265778|NCT01763788|20381523|P3|NOT COMPLETED|Overall Study||1
8265779|NCT01763788|20381524|P2|NOT COMPLETED|Overall Study||0
8265780|NCT01763788|20381525|P1|NOT COMPLETED|Overall Study||0
8265781|NCT01763788|20381522|P4|COMPLETED|Overall Study||92
8265782|NCT01763788|20381523|P3|COMPLETED|Overall Study||90
8265783|NCT01763788|20381524|P2|COMPLETED|Overall Study||6
8265784|NCT01763788|20381525|P1|COMPLETED|Overall Study||3
8265785|NCT01763788|20381522|P4|Received at Least 1dose of Study Drug|Overall Study||91
8265786|NCT01763788|20381523|P3|Received at Least 1dose of Study Drug|Overall Study||90
8265787|NCT01763788|20381524|P2|Received at Least 1dose of Study Drug|Overall Study||6
8265788|NCT01763788|20381525|P1|Received at Least 1dose of Study Drug|Overall Study||3
8265789|NCT01763788|20381522|P4|STARTED|Overall Study||92
8265790|NCT01763788|20381523|P3|STARTED|Overall Study||91
8265791|NCT01763788|20381524|P2|STARTED|Overall Study||6
8265792|NCT01763788|20381525|P1|STARTED|Overall Study||3
8265793|NCT01763645|20381561|P2|NOT COMPLETED|Overall Study||24
8265794|NCT01763645|20381562|P1|NOT COMPLETED|Overall Study||26
8265795|NCT01763645|20381561|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
8265796|NCT01763645|20381562|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
8265797|NCT01763645|20381561|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
8265798|NCT01763645|20381562|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
8265799|NCT01763645|20381561|P2|STARTED|Overall Study||69
8265800|NCT01763645|20381562|P1|STARTED|Overall Study||69
8265801|NCT01763606|20381582|P2|NOT COMPLETED|Overall Study||0
8265802|NCT01763606|20381583|P1|NOT COMPLETED|Overall Study||0
8265803|NCT01763606|20381582|P2|COMPLETED|Overall Study||10
8265804|NCT01763606|20381583|P1|COMPLETED|Overall Study||10
8265805|NCT01763606|20381582|P2|STARTED|Overall Study||10
8265806|NCT01763606|20381583|P1|STARTED|Overall Study||10
8265807|NCT01763567|20381592|P1|NOT COMPLETED|Overall Study||0
8265808|NCT01763567|20381592|P1|COMPLETED|Overall Study||19
8265809|NCT01763567|20381592|P1|STARTED|Overall Study||19
8265810|NCT01763346|20381602|P2|NOT COMPLETED|Overall Study||8
8265811|NCT01763346|20381603|P1|NOT COMPLETED|Overall Study||10
8265812|NCT01763346|20381602|P2|COMPLETED|Overall Study||36
8265813|NCT01763346|20381603|P1|COMPLETED|Overall Study||34
8265814|NCT01763346|20381602|P2|Received Intervention|Overall Study||38
8265815|NCT01763346|20381603|P1|Received Intervention|Overall Study||39
8265816|NCT01763346|20381602|P2|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
8265817|NCT01763346|20381603|P1|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
8265818|NCT01763333|20381627|P14|NOT COMPLETED|Overall Study||0
8265819|NCT01763333|20381628|P13|NOT COMPLETED|Overall Study||0
8265820|NCT01763333|20381629|P12|NOT COMPLETED|Overall Study||0
8265821|NCT01763333|20381630|P11|NOT COMPLETED|Overall Study||0
8265822|NCT01763333|20381631|P10|NOT COMPLETED|Overall Study||0
8265823|NCT01763333|20381632|P9|NOT COMPLETED|Overall Study||0
8265824|NCT01763333|20381633|P8|NOT COMPLETED|Overall Study||0
8265825|NCT01763333|20381634|P7|NOT COMPLETED|Overall Study||0
8265826|NCT01763333|20381635|P6|NOT COMPLETED|Overall Study||0
8265827|NCT01763333|20381636|P5|NOT COMPLETED|Overall Study||0
8265828|NCT01763333|20381637|P4|NOT COMPLETED|Overall Study||0
8265829|NCT01763333|20381638|P3|NOT COMPLETED|Overall Study||0
8265830|NCT01763333|20381639|P2|NOT COMPLETED|Overall Study||0
8265831|NCT01763333|20381640|P1|NOT COMPLETED|Overall Study||0
8265832|NCT01763333|20381627|P14|COMPLETED|Overall Study||3
8265833|NCT01763333|20381628|P13|COMPLETED|Overall Study||3
8265834|NCT01763333|20381629|P12|COMPLETED|Overall Study||3
8265835|NCT01763333|20381630|P11|COMPLETED|Overall Study||3
8265836|NCT01763333|20381631|P10|COMPLETED|Overall Study||18
8265837|NCT01763333|20381632|P9|COMPLETED|Overall Study||5
8265838|NCT01763333|20381633|P8|COMPLETED|Overall Study||6
8265839|NCT01763333|20381634|P7|COMPLETED|Overall Study||5
8265840|NCT01763333|20381635|P6|COMPLETED|Overall Study||6
8265841|NCT01763333|20381636|P5|COMPLETED|Overall Study||4
8265842|NCT01763333|20381637|P4|COMPLETED|Overall Study||6
8265843|NCT01763333|20381638|P3|COMPLETED|Overall Study||6
8265844|NCT01763333|20381639|P2|COMPLETED|Overall Study||6
8265845|NCT01763333|20381640|P1|COMPLETED|Overall Study||6
8265846|NCT01763333|20381627|P14|STARTED|Overall Study||3
8265847|NCT01763333|20381628|P13|STARTED|Overall Study||3
8265848|NCT01763333|20381629|P12|STARTED|Overall Study||3
8265849|NCT01763333|20381630|P11|STARTED|Overall Study||3
8265850|NCT01763333|20381631|P10|STARTED|Overall Study||18
8265851|NCT01763333|20381632|P9|STARTED|Overall Study||5
8265852|NCT01763333|20381633|P8|STARTED|Overall Study||6
8265853|NCT01763333|20381634|P7|STARTED|Overall Study||5
8265854|NCT01763333|20381635|P6|STARTED|Overall Study||6
8265855|NCT01763333|20381636|P5|STARTED|Overall Study||4
8265856|NCT01763333|20381637|P4|STARTED|Overall Study||6
8265857|NCT01763333|20381638|P3|STARTED|Overall Study||6
8265858|NCT01763333|20381639|P2|STARTED|Overall Study||6
8265859|NCT01763333|20381640|P1|STARTED|Overall Study||6
8265860|NCT01763203|20381746|P2|NOT COMPLETED|Overall Study||42
8265861|NCT01763203|20381747|P1|NOT COMPLETED|Overall Study||33
8265862|NCT01763203|20381746|P2|COMPLETED|Overall Study||204
8265863|NCT01763203|20381747|P1|COMPLETED|Overall Study||208
8265864|NCT01763203|20381746|P2|STARTED|Overall Study||246
8265865|NCT01763203|20381747|P1|STARTED|Overall Study||241
8265866|NCT01763047|20381793|P2|NOT COMPLETED|Period 2||5
8265867|NCT01763047|20381794|P1|NOT COMPLETED|Period 2||4
8265868|NCT01763047|20381793|P2|COMPLETED|Period 2||121
8265869|NCT01763047|20381794|P1|COMPLETED|Period 2||126
8265870|NCT01763047|20381793|P2|Hyperopes|Period 2||54
8265871|NCT01763047|20381794|P1|Hyperopes|Period 2||56
8265872|NCT01763047|20381793|P2|Myopes|Period 2||72
8265873|NCT01763047|20381794|P1|Myopes|Period 2||74
8265874|NCT01763047|20381793|P2|STARTED|Period 2||126
8265875|NCT01763047|20381794|P1|STARTED|Period 2||130
8265876|NCT01763047|20381793|P2|NOT COMPLETED|Period 1||11
8265877|NCT01763047|20381794|P1|NOT COMPLETED|Period 1||9
8265878|NCT01763047|20381793|P2|COMPLETED|Period 1||126
8265879|NCT01763047|20381794|P1|COMPLETED|Period 1||130
8265880|NCT01763047|20381793|P2|Hyperopes|Period 1||61
8265881|NCT01763047|20381794|P1|Hyperopes|Period 1||62
8265882|NCT01763047|20381793|P2|Myopes|Period 1||76
8265883|NCT01763047|20381794|P1|Myopes|Period 1||77
8265884|NCT01763047|20381793|P2|STARTED|Period 1||137
8265885|NCT01763047|20381794|P1|STARTED|Period 1||139
8265886|NCT01762982|20381810|P1|NOT COMPLETED|Overall Study||0
8265887|NCT01762982|20381810|P1|COMPLETED|Overall Study||36
8265888|NCT01762982|20381810|P1|Received Empty Finn Chamber|Overall Study||36
8265889|NCT01762982|20381810|P1|Received SLS|Overall Study||36
8265890|NCT01762982|20381810|P1|Received Benzalkonium Chloride|Overall Study||36
8265891|NCT01762982|20381810|P1|Received Saline Water|Overall Study||36
8265892|NCT01762982|20381810|P1|STARTED|Overall Study||36
8265893|NCT01762943|20381833|P2|NOT COMPLETED|Overall Study||2
8265894|NCT01762943|20381834|P1|NOT COMPLETED|Overall Study||4
8265895|NCT01762943|20381833|P2|COMPLETED|Overall Study||15
8265896|NCT01762943|20381834|P1|COMPLETED|Overall Study||15
8265897|NCT01762943|20381833|P2|Withdrawal|Overall Study||15
8265898|NCT01762943|20381834|P1|Withdrawal|Overall Study||15
8265899|NCT01762943|20381833|P2|Addback|Overall Study||15
8265900|NCT01762943|20381834|P1|Addback|Overall Study||16
8265901|NCT01762943|20381833|P2|Hypogonadism|Overall Study||15
8265902|NCT01762943|20381834|P1|Hypogonadism|Overall Study||18
8265903|NCT01762943|20381833|P2|STARTED|Overall Study||17
8265904|NCT01762943|20381834|P1|STARTED|Overall Study||19
8265905|NCT01762904|20381842|P1|NOT COMPLETED|Overall Study||0
8265906|NCT01762904|20381842|P1|COMPLETED|Overall Study|October, 2013|135
8265907|NCT01762904|20381842|P1|STARTED|Overall Study|January, 2013|135
8265908|NCT01762800|20381851|P2|NOT COMPLETED|Overall Study||21
8265909|NCT01762800|20381852|P1|NOT COMPLETED|Overall Study||19
8265910|NCT01762800|20381851|P2|COMPLETED|Overall Study||183
8265911|NCT01762800|20381852|P1|COMPLETED|Overall Study||183
8265912|NCT01762800|20381851|P2|STARTED|Overall Study||204
8265913|NCT01762800|20381852|P1|STARTED|Overall Study||202
8265914|NCT01762761|20381926|P2|NOT COMPLETED|Overall Study||65
8265915|NCT01762761|20381927|P1|NOT COMPLETED|Overall Study||39
8265916|NCT01762761|20381926|P2|COMPLETED|Overall Study||39
8265917|NCT01762761|20381927|P1|COMPLETED|Overall Study||12
8265918|NCT01762761|20381926|P2|STARTED|Overall Study||104
8265919|NCT01762761|20381927|P1|STARTED|Overall Study||51
8265920|NCT01762722|20381983|P2|NOT COMPLETED|Overall Study||0
8265921|NCT01762722|20381984|P1|NOT COMPLETED|Overall Study||0
8265922|NCT01762722|20381983|P2|COMPLETED|Overall Study||11
8265923|NCT01762722|20381984|P1|COMPLETED|Overall Study||12
8265924|NCT01762722|20381983|P2|STARTED|Overall Study||11
8265925|NCT01762722|20381984|P1|STARTED|Overall Study||12
8265926|NCT01762631|20381992|P2|NOT COMPLETED|Overall Study||0
8265927|NCT01762631|20381993|P1|NOT COMPLETED|Overall Study||0
8265928|NCT01762631|20381992|P2|COMPLETED|Overall Study||22
8265929|NCT01762631|20381993|P1|COMPLETED|Overall Study||53
8265930|NCT01762631|20381992|P2|STARTED|Overall Study||22
8265931|NCT01762631|20381993|P1|STARTED|Overall Study||53
8265932|NCT01762501|20382011|P2|NOT COMPLETED|Overall Study||23
8265933|NCT01762501|20382012|P1|NOT COMPLETED|Overall Study||27
8265934|NCT01762501|20382011|P2|COMPLETED|Overall Study||336
8265935|NCT01762501|20382012|P1|COMPLETED|Overall Study||332
8265936|NCT01762501|20382011|P2|STARTED|Overall Study||359
8265937|NCT01762501|20382012|P1|STARTED|Overall Study||359
8265938|NCT01762345|20382026|P1|NOT COMPLETED|Overall Study||7
8265939|NCT01762345|20382026|P1|COMPLETED|Overall Study||76
8265940|NCT01762345|20382026|P1|STARTED|Overall Study||83
8265941|NCT01762059|20382036|P1|NOT COMPLETED|Overall Study||0
8265942|NCT01762059|20382036|P1|COMPLETED|Overall Study||20
8265943|NCT01762059|20382036|P1|STARTED|Overall Study||20
8265944|NCT01761747|20382063|P1|NOT COMPLETED|Overall Study||1
8265945|NCT01761747|20382063|P1|COMPLETED|Overall Study||2
8265946|NCT01761747|20382063|P1|STARTED|Overall Study||3
8265947|NCT01761643|20382076|P2|NOT COMPLETED|Overall Study||42
8265948|NCT01761643|20382077|P1|NOT COMPLETED|Overall Study||32
8265949|NCT01761643|20382076|P2|COMPLETED|Overall Study||158
8265950|NCT01761643|20382077|P1|COMPLETED|Overall Study||166
8265951|NCT01761643|20382076|P2|STARTED|Overall Study||200
8265952|NCT01761643|20382077|P1|STARTED|Overall Study||198
8265953|NCT01761565|20382087|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
8265954|NCT01761565|20382087|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
8265955|NCT01761565|20382087|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
8265956|NCT01761565|20382087|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
8265957|NCT01761565|20382087|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
8265958|NCT01761565|20382087|P1|STARTED|Single Dose of SUF NT 15 mcg||40
8265959|NCT01761292|20382099|P1|NOT COMPLETED|Extension 3||0
8265960|NCT01761292|20382099|P1|COMPLETED|Extension 3||18
8265961|NCT01761292|20382099|P1|STARTED|Extension 3||18
8265962|NCT01761292|20382099|P1|NOT COMPLETED|Extension 2||0
8265963|NCT01761292|20382099|P1|COMPLETED|Extension 2||18
8265964|NCT01761292|20382099|P1|STARTED|Extension 2||18
8265965|NCT01761292|20382099|P1|NOT COMPLETED|Extension 1||1
8265966|NCT01761292|20382099|P1|COMPLETED|Extension 1||18
8265967|NCT01761292|20382099|P1|STARTED|Extension 1||19
8265968|NCT01761292|20382099|P1|NOT COMPLETED|Part 2||0
8265969|NCT01761292|20382099|P1|COMPLETED|Part 2||19
8265970|NCT01761292|20382099|P1|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
8265971|NCT01761292|20382099|P1|NOT COMPLETED|Part 1||2
8265972|NCT01761292|20382099|P1|COMPLETED|Part 1||18
8265973|NCT01761292|20382099|P1|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
8265974|NCT01761292|20382099|P1|STARTED|Part 1||20
8265975|NCT01761279|20382118|P1|NOT COMPLETED|Overall Study||0
8265976|NCT01761279|20382118|P1|COMPLETED|Overall Study||84
8265977|NCT01761279|20382118|P1|STARTED|Overall Study||84
8265978|NCT01761266|20382133|P2|NOT COMPLETED|Overall Study||476
8265979|NCT01761266|20382134|P1|NOT COMPLETED|Overall Study||478
8265980|NCT01761266|20382133|P2|COMPLETED|Overall Study||0
8265981|NCT01761266|20382134|P1|COMPLETED|Overall Study||0
8265982|NCT01761266|20382133|P2|Treated|Overall Study||475
8265983|NCT01761266|20382134|P1|Treated|Overall Study||476
8265984|NCT01761266|20382133|P2|STARTED|Overall Study||476
8265985|NCT01761266|20382134|P1|STARTED|Overall Study||478
8265986|NCT01761175|20382162|P2|NOT COMPLETED|Overall Study||0
8265987|NCT01761175|20382163|P1|NOT COMPLETED|Overall Study||0
8265988|NCT01761175|20382162|P2|COMPLETED|Overall Study||112
8265989|NCT01761175|20382163|P1|COMPLETED|Overall Study||112
8265990|NCT01761175|20382162|P2|STARTED|Overall Study||112
8265991|NCT01761175|20382163|P1|STARTED|Overall Study||112
8265992|NCT01761162|20382191|P1|NOT COMPLETED|Overall Study||3
8265993|NCT01761162|20382191|P1|COMPLETED|Overall Study||226
8265994|NCT01761162|20382191|P1|STARTED|Overall Study||229
8265995|NCT01761084|20382201|P2|NOT COMPLETED|Overall Study||6
8265996|NCT01761084|20382202|P1|NOT COMPLETED|Overall Study||5
8265997|NCT01761084|20382201|P2|COMPLETED|Overall Study||64
8265998|NCT01761084|20382202|P1|COMPLETED|Overall Study||66
8265999|NCT01761084|20382201|P2|STARTED|Overall Study||70
8266000|NCT01761084|20382202|P1|STARTED|Overall Study||71
8266001|NCT01761019|20382251|P1|NOT COMPLETED|Overall Study||0
8266002|NCT01761019|20382251|P1|COMPLETED|Overall Study||8
8266003|NCT01761019|20382251|P1|STARTED|Overall Study||8
8266004|NCT01760993|20382259|P1|NOT COMPLETED|Overall Study||0
8266005|NCT01760993|20382259|P1|COMPLETED|Overall Study||0
8266006|NCT01760993|20382259|P1|STARTED|Overall Study||0
8266007|NCT01760954|20382280|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
8266008|NCT01760954|20382281|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
8266009|NCT01760954|20382282|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
8266010|NCT01760954|20382283|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
8266011|NCT01760954|20382280|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
8266012|NCT01760954|20382281|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
8266013|NCT01760954|20382282|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
8266014|NCT01760954|20382283|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
8266015|NCT01760954|20382280|P4|STARTED|Post-treatment Follow-up (12 Months)||87
8266016|NCT01760954|20382281|P3|STARTED|Post-treatment Follow-up (12 Months)||86
8266017|NCT01760954|20382282|P2|STARTED|Post-treatment Follow-up (12 Months)||118
8266018|NCT01760954|20382283|P1|STARTED|Post-treatment Follow-up (12 Months)||126
8266019|NCT01760954|20382280|P4|NOT COMPLETED|Treatment Period (6 Months)||26
8266020|NCT01760954|20382281|P3|NOT COMPLETED|Treatment Period (6 Months)||21
8266021|NCT01760954|20382282|P2|NOT COMPLETED|Treatment Period (6 Months)||28
8266022|NCT01760954|20382283|P1|NOT COMPLETED|Treatment Period (6 Months)||33
8266023|NCT01760954|20382280|P4|COMPLETED|Treatment Period (6 Months)||83
8266024|NCT01760954|20382281|P3|COMPLETED|Treatment Period (6 Months)||87
8266025|NCT01760954|20382282|P2|COMPLETED|Treatment Period (6 Months)||110
8266026|NCT01760954|20382283|P1|COMPLETED|Treatment Period (6 Months)||116
8266027|NCT01760954|20382280|P4|STARTED|Treatment Period (6 Months)||109
8266028|NCT01760954|20382281|P3|STARTED|Treatment Period (6 Months)||108
8266029|NCT01760954|20382282|P2|STARTED|Treatment Period (6 Months)||138
8266030|NCT01760954|20382283|P1|STARTED|Treatment Period (6 Months)||149
8266031|NCT01760941|20382361|P1|NOT COMPLETED|Overall Study||0
8266032|NCT01760941|20382361|P1|COMPLETED|Overall Study||1
8266033|NCT01760941|20382361|P1|STARTED|Overall Study||1
8266034|NCT01760889|20382371|P3|NOT COMPLETED|Overall Study||0
8266035|NCT01760889|20382372|P2|NOT COMPLETED|Overall Study||0
8266036|NCT01760889|20382373|P1|NOT COMPLETED|Overall Study||0
8266037|NCT01760889|20382371|P3|COMPLETED|Overall Study||0
8266038|NCT01760889|20382372|P2|COMPLETED|Overall Study||0
8266039|NCT01760889|20382373|P1|COMPLETED|Overall Study||0
8266040|NCT01760889|20382371|P3|STARTED|Overall Study||0
8266041|NCT01760889|20382372|P2|STARTED|Overall Study||0
8266042|NCT01760889|20382373|P1|STARTED|Overall Study||0
8266043|NCT01760876|20382420|P1|NOT COMPLETED|Overall Study||6
8266044|NCT01760876|20382420|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
8266045|NCT01760876|20382420|P1|STARTED|Overall Study||106
8266046|NCT01760785|20382426|P2|NOT COMPLETED|Overall Study||0
8266047|NCT01760785|20382427|P1|NOT COMPLETED|Overall Study||0
8266048|NCT01760785|20382426|P2|COMPLETED|Overall Study||27
8266049|NCT01760785|20382427|P1|COMPLETED|Overall Study||23
8266050|NCT01760785|20382426|P2|STARTED|Overall Study||27
8266051|NCT01760785|20382427|P1|STARTED|Overall Study||23
8266052|NCT01760733|20382435|P1|NOT COMPLETED|Transplanted||217
8266053|NCT01760733|20382435|P1|COMPLETED|Transplanted||0
8266054|NCT01760733|20382435|P1|STARTED|Transplanted||217
8266055|NCT01760733|20382435|P1|NOT COMPLETED|Waiting List||72
8266056|NCT01760733|20382435|P1|COMPLETED|Waiting List|217 patients have been transplanted|217
8266057|NCT01760733|20382435|P1|STARTED|Waiting List|All patients included started in the waiting list group.|289
8266058|NCT01760473|20382440|P1|NOT COMPLETED|Overall Study||15
8266059|NCT01760473|20382440|P1|COMPLETED|Overall Study||12
8266060|NCT01760473|20382440|P1|STARTED|Overall Study||27
8266061|NCT01760447|20382465|P4|NOT COMPLETED|Weeks 20-54||4
8266062|NCT01760447|20382466|P3|NOT COMPLETED|Weeks 20-54||3
8266063|NCT01760447|20382467|P2|NOT COMPLETED|Weeks 20-54||2
8266064|NCT01760447|20382468|P1|NOT COMPLETED|Weeks 20-54||3
8266065|NCT01760447|20382465|P4|COMPLETED|Weeks 20-54||43
8266066|NCT01760447|20382466|P3|COMPLETED|Weeks 20-54||39
8266067|NCT01760447|20382467|P2|COMPLETED|Weeks 20-54||28
8266068|NCT01760447|20382468|P1|COMPLETED|Weeks 20-54||25
8266069|NCT01760447|20382465|P4|STARTED|Weeks 20-54||47
8266070|NCT01760447|20382466|P3|STARTED|Weeks 20-54||42
8266071|NCT01760447|20382467|P2|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
8266072|NCT01760447|20382468|P1|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
8266073|NCT01760447|20382465|P4|NOT COMPLETED|Weeks 0-20||4
8266074|NCT01760447|20382466|P3|NOT COMPLETED|Weeks 0-20||5
8266075|NCT01760447|20382467|P2|NOT COMPLETED|Weeks 0-20||0
8266076|NCT01760447|20382468|P1|NOT COMPLETED|Weeks 0-20||3
8266077|NCT01760447|20382465|P4|COMPLETED|Weeks 0-20||47
8266078|NCT01760447|20382466|P3|COMPLETED|Weeks 0-20||42
8266079|NCT01760447|20382467|P2|COMPLETED|Weeks 0-20||62
8266080|NCT01760447|20382468|P1|COMPLETED|Weeks 0-20||59
8266081|NCT01760447|20382465|P4|Treated|Weeks 0-20||51
8266082|NCT01760447|20382466|P3|Treated|Weeks 0-20||45
8266083|NCT01760447|20382467|P2|Treated|Weeks 0-20||62
8266084|NCT01760447|20382468|P1|Treated|Weeks 0-20||62
8266085|NCT01760447|20382465|P4|STARTED|Weeks 0-20||51
8266086|NCT01760447|20382466|P3|STARTED|Weeks 0-20||47
8266087|NCT01760447|20382467|P2|STARTED|Weeks 0-20||62
8266088|NCT01760447|20382468|P1|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
8266089|NCT01760304|20382528|P2|NOT COMPLETED|Overall Study||0
8266090|NCT01760304|20382529|P1|NOT COMPLETED|Overall Study||0
8266091|NCT01760304|20382528|P2|COMPLETED|Overall Study||3
8266092|NCT01760304|20382529|P1|COMPLETED|Overall Study||2
8266093|NCT01760304|20382528|P2|STARTED|Overall Study||3
8266094|NCT01760304|20382529|P1|STARTED|Overall Study||2
8266095|NCT01760239|20382541|P2|NOT COMPLETED|Overall Study||14316
8266096|NCT01760239|20382542|P1|NOT COMPLETED|Overall Study||16741
8266097|NCT01760239|20382541|P2|COMPLETED|Overall Study||226
8266098|NCT01760239|20382542|P1|COMPLETED|Overall Study||296
8266099|NCT01760239|20382541|P2|STARTED|Overall Study||14542
8266100|NCT01760239|20382542|P1|STARTED|Overall Study||17037
8266101|NCT01760187|20382562|P5|NOT COMPLETED|Overall Study||0
8266102|NCT01760187|20382563|P4|NOT COMPLETED|Overall Study||2
8266103|NCT01760187|20382564|P3|NOT COMPLETED|Overall Study||0
8266104|NCT01760187|20382565|P2|NOT COMPLETED|Overall Study||0
8266105|NCT01760187|20382566|P1|NOT COMPLETED|Overall Study||1
8266106|NCT01760187|20382562|P5|COMPLETED|Overall Study||16
8266107|NCT01760187|20382563|P4|COMPLETED|Overall Study||10
8266108|NCT01760187|20382564|P3|COMPLETED|Overall Study||12
8266109|NCT01760187|20382565|P2|COMPLETED|Overall Study||12
8266110|NCT01760187|20382566|P1|COMPLETED|Overall Study||19
8266111|NCT01760187|20382562|P5|STARTED|Overall Study||16
8266112|NCT01760187|20382563|P4|STARTED|Overall Study||12
8266113|NCT01760187|20382564|P3|STARTED|Overall Study||12
8266114|NCT01760187|20382565|P2|STARTED|Overall Study||12
8266115|NCT01760187|20382566|P1|STARTED|Overall Study||20
8266116|NCT01759862|20382796|P2|NOT COMPLETED|Overall Study||2
8266117|NCT01759862|20382797|P1|NOT COMPLETED|Overall Study||3
8266118|NCT01759862|20382796|P2|COMPLETED|Overall Study||25
8266119|NCT01759862|20382797|P1|COMPLETED|Overall Study||20
8266120|NCT01759862|20382796|P2|STARTED|Overall Study||27
8266121|NCT01759862|20382797|P1|STARTED|Overall Study||23
8266122|NCT01759602|20382807|P1|NOT COMPLETED|Overall Study||0
8266123|NCT01759602|20382807|P1|COMPLETED|Overall Study||10
8266124|NCT01759602|20382807|P1|STARTED|Overall Study||10
8266125|NCT01759511|20382815|P1|NOT COMPLETED|Overall Study||34
8266126|NCT01759511|20382815|P1|COMPLETED|Overall Study||0
8266127|NCT01759511|20382815|P1|STARTED|Overall Study||34
8266128|NCT01759446|20382828|P5|NOT COMPLETED|Overall Study||0
8266129|NCT01759446|20382829|P4|NOT COMPLETED|Overall Study||1
8266130|NCT01759446|20382830|P3|NOT COMPLETED|Overall Study||1
8266131|NCT01759446|20382831|P2|NOT COMPLETED|Overall Study||1
8266132|NCT01759446|20382832|P1|NOT COMPLETED|Overall Study||1
8266133|NCT01759446|20382828|P5|COMPLETED|Overall Study||8
8266134|NCT01759446|20382829|P4|COMPLETED|Overall Study||8
8266135|NCT01759446|20382830|P3|COMPLETED|Overall Study||8
8266136|NCT01759446|20382831|P2|COMPLETED|Overall Study||8
8266137|NCT01759446|20382832|P1|COMPLETED|Overall Study||8
8266138|NCT01759446|20382828|P5|STARTED|Overall Study||8
8266139|NCT01759446|20382829|P4|STARTED|Overall Study||9
8266140|NCT01759446|20382830|P3|STARTED|Overall Study||9
8266141|NCT01759446|20382831|P2|STARTED|Overall Study||9
8266142|NCT01759446|20382832|P1|STARTED|Overall Study||9
8266143|NCT01759420|20382844|P1|NOT COMPLETED|Overall Study||6
8266144|NCT01759420|20382844|P1|COMPLETED|Overall Study||22
8266145|NCT01759420|20382844|P1|STARTED|Overall Study||28
8266146|NCT01759407|20382851|P2|NOT COMPLETED|Overall Study||2
8266147|NCT01759407|20382852|P1|NOT COMPLETED|Overall Study||0
8266148|NCT01759407|20382851|P2|COMPLETED|Overall Study||7
8266149|NCT01759407|20382852|P1|COMPLETED|Overall Study||10
8266150|NCT01759407|20382851|P2|STARTED|Overall Study||9
8266151|NCT01759407|20382852|P1|STARTED|Overall Study||10
8266152|NCT01759381|20382864|P2|NOT COMPLETED|Overall Study||0
8266153|NCT01759381|20382865|P1|NOT COMPLETED|Overall Study||1
8266154|NCT01759381|20382864|P2|COMPLETED|Overall Study||11
8266155|NCT01759381|20382865|P1|COMPLETED|Overall Study||7
8266156|NCT01759381|20382864|P2|STARTED|Overall Study||11
8266157|NCT01759381|20382865|P1|STARTED|Overall Study||8
8266158|NCT01759368|20382873|P2|NOT COMPLETED|Overall Study||0
8266159|NCT01759368|20382874|P1|NOT COMPLETED|Overall Study||1
8266160|NCT01759368|20382873|P2|COMPLETED|Overall Study||47
8266161|NCT01759368|20382874|P1|COMPLETED|Overall Study||46
8266162|NCT01759368|20382873|P2|STARTED|Overall Study||47
8266163|NCT01759368|20382874|P1|STARTED|Overall Study||47
8266164|NCT01759290|20382892|P1|NOT COMPLETED|Overall Study||81
8266165|NCT01759290|20382892|P1|COMPLETED|Overall Study||1719
8266166|NCT01759290|20382892|P1|STARTED|Overall Study||1800
8266173|NCT01759264|20382961|P1|NOT COMPLETED|Overall Study||10
8266174|NCT01759264|20382961|P1|COMPLETED|Overall Study||91
8266175|NCT01759264|20382961|P1|STARTED|Overall Study||101
8266176|NCT01759251|20382974|P1|NOT COMPLETED|Follow-up Period||0
8266177|NCT01759251|20382974|P1|COMPLETED|Follow-up Period||305
8266178|NCT01759251|20382974|P1|STARTED|Follow-up Period||305
8266179|NCT01759251|20382974|P1|NOT COMPLETED|60 Days Treatment Period||0
8266180|NCT01759251|20382974|P1|COMPLETED|60 Days Treatment Period||305
8266181|NCT01759251|20382974|P1|STARTED|60 Days Treatment Period||305
8266182|NCT01759251|20382974|P1|NOT COMPLETED|30 Days Treatment Period||4
8266183|NCT01759251|20382974|P1|COMPLETED|30 Days Treatment Period||305
8266184|NCT01759251|20382974|P1|STARTED|30 Days Treatment Period||309
8266185|NCT01759160|20382980|P2|NOT COMPLETED|Overall Study||0
8266186|NCT01759160|20382981|P1|NOT COMPLETED|Overall Study||0
8266187|NCT01759160|20382980|P2|COMPLETED|Overall Study||30
8266188|NCT01759160|20382981|P1|COMPLETED|Overall Study||30
8266189|NCT01759160|20382980|P2|STARTED|Overall Study||30
8266190|NCT01759160|20382981|P1|STARTED|Overall Study||30
8266191|NCT01758900|20382989|P2|NOT COMPLETED|Overall Study||8
8266192|NCT01758900|20382990|P1|NOT COMPLETED|Overall Study||7
8266193|NCT01758900|20382989|P2|COMPLETED|Overall Study||100
8266194|NCT01758900|20382990|P1|COMPLETED|Overall Study||99
8266195|NCT01758900|20382989|P2|STARTED|Overall Study||108
8266196|NCT01758900|20382990|P1|STARTED|Overall Study||106
8266197|NCT01758731|20383008|P1|NOT COMPLETED|Overall Study||1
8266198|NCT01758731|20383008|P1|COMPLETED|Overall Study||16
8266199|NCT01758731|20383008|P1|STARTED|Overall Study||17
8266200|NCT01758588|20383014|P2|NOT COMPLETED|Overall Study||0
8266201|NCT01758588|20383015|P1|NOT COMPLETED|Overall Study||0
8266202|NCT01758588|20383014|P2|COMPLETED|Overall Study||3
8266203|NCT01758588|20383015|P1|COMPLETED|Overall Study||5
8266204|NCT01758588|20383014|P2|STARTED|Overall Study||3
8266205|NCT01758588|20383015|P1|STARTED|Overall Study||5
8266206|NCT01758523|20383027|P2|NOT COMPLETED|Overall Study||14
8266207|NCT01758523|20383028|P1|NOT COMPLETED|Overall Study||21
8266208|NCT01758523|20383027|P2|COMPLETED|Overall Study||54
8266209|NCT01758523|20383028|P1|COMPLETED|Overall Study||53
8266210|NCT01758523|20383027|P2|Attended >/= 1 Visit Post-randomization|Overall Study||67
8266211|NCT01758523|20383028|P1|Attended >/= 1 Visit Post-randomization|Overall Study||68
8266212|NCT01758523|20383027|P2|STARTED|Overall Study||68
8266213|NCT01758523|20383028|P1|STARTED|Overall Study||74
8266214|NCT01758432|20383053|P7|NOT COMPLETED|Overall Study||0
8266215|NCT01758432|20383054|P6|NOT COMPLETED|Overall Study||0
8266216|NCT01758432|20383055|P5|NOT COMPLETED|Overall Study||0
8266217|NCT01758432|20383056|P4|NOT COMPLETED|Overall Study||0
8266218|NCT01758432|20383057|P3|NOT COMPLETED|Overall Study||0
8266219|NCT01758432|20383058|P2|NOT COMPLETED|Overall Study||0
8266220|NCT01758432|20383059|P1|NOT COMPLETED|Overall Study||0
8266221|NCT01758432|20383053|P7|COMPLETED|Overall Study||6
8266222|NCT01758432|20383054|P6|COMPLETED|Overall Study||6
8266223|NCT01758432|20383055|P5|COMPLETED|Overall Study||6
8266224|NCT01758432|20383056|P4|COMPLETED|Overall Study||6
8266225|NCT01758432|20383057|P3|COMPLETED|Overall Study||6
8266226|NCT01758432|20383058|P2|COMPLETED|Overall Study||6
8266227|NCT01758432|20383059|P1|COMPLETED|Overall Study||18
8266228|NCT01758432|20383053|P7|STARTED|Overall Study||6
8266229|NCT01758432|20383054|P6|STARTED|Overall Study||6
8266230|NCT01758432|20383055|P5|STARTED|Overall Study||6
8266231|NCT01758432|20383056|P4|STARTED|Overall Study||6
8266232|NCT01758432|20383057|P3|STARTED|Overall Study||6
8266233|NCT01758432|20383058|P2|STARTED|Overall Study||6
8266234|NCT01758432|20383059|P1|STARTED|Overall Study||18
8266235|NCT01758289|20383131|P1|NOT COMPLETED|Overall Study||53
8266236|NCT01758289|20383131|P1|COMPLETED|Overall Study||52
8266237|NCT01758289|20383131|P1|STARTED|Overall Study||105
8266238|NCT01757964|20383150|P2|NOT COMPLETED|Overall Study||0
8266239|NCT01757964|20383151|P1|NOT COMPLETED|Overall Study||0
8266240|NCT01757964|20383150|P2|COMPLETED|Overall Study||4
8266241|NCT01757964|20383151|P1|COMPLETED|Overall Study||9
8266242|NCT01757964|20383150|P2|STARTED|Overall Study||4
8266243|NCT01757964|20383151|P1|STARTED|Overall Study||9
8266244|NCT01757847|20383157|P2|NOT COMPLETED|Overall Study||4
8266245|NCT01757847|20383158|P1|NOT COMPLETED|Overall Study||3
8266246|NCT01757847|20383157|P2|COMPLETED|Overall Study||42
8266247|NCT01757847|20383158|P1|COMPLETED|Overall Study||41
8266248|NCT01757847|20383157|P2|STARTED|Overall Study||46
8266249|NCT01757847|20383158|P1|STARTED|Overall Study||44
8266250|NCT01757821|20383166|P1|NOT COMPLETED|Overall Study||1
8266251|NCT01757821|20383166|P1|COMPLETED|Overall Study|10 subjects|10
8266252|NCT01757821|20383166|P1|STARTED|Overall Study|11 subjects|11
8266253|NCT01757717|20383174|P1|NOT COMPLETED|Overall Study||0
8266254|NCT01757717|20383174|P1|COMPLETED|Overall Study||3
8266255|NCT01757717|20383174|P1|STARTED|Overall Study||3
8266256|NCT01757704|20383181|P2|NOT COMPLETED|Overall Study||3
8266257|NCT01757704|20383182|P1|NOT COMPLETED|Overall Study||1
8266258|NCT01757704|20383181|P2|COMPLETED|Overall Study||10
8266259|NCT01757704|20383182|P1|COMPLETED|Overall Study||10
8266260|NCT01757704|20383181|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
8266261|NCT01757704|20383182|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
8266262|NCT01757691|20383200|P2|NOT COMPLETED|Overall Study||0
8266263|NCT01757691|20383201|P1|NOT COMPLETED|Overall Study||2
8266264|NCT01757691|20383200|P2|COMPLETED|Overall Study||0
8266265|NCT01757691|20383201|P1|COMPLETED|Overall Study||0
8266266|NCT01757691|20383200|P2|STARTED|Overall Study||0
8266267|NCT01757691|20383201|P1|STARTED|Overall Study||2
8266268|NCT01757678|20383214|P1|NOT COMPLETED|Overall Study||0
8266269|NCT01757678|20383214|P1|COMPLETED|Overall Study||276
8266270|NCT01757678|20383214|P1|STARTED|Overall Study||276
8266271|NCT01757665|20383228|P2|NOT COMPLETED|Overall Study||83
8266272|NCT01757665|20383229|P1|NOT COMPLETED|Overall Study||694
8266273|NCT01757665|20383228|P2|COMPLETED|Overall Study||0
8266274|NCT01757665|20383229|P1|COMPLETED|Overall Study||0
8266275|NCT01757665|20383228|P2|Implanted With Device|Overall Study||82
8266276|NCT01757665|20383229|P1|Implanted With Device|Overall Study||689
8266277|NCT01757665|20383228|P2|STARTED|Overall Study||83
8266278|NCT01757665|20383229|P1|STARTED|Overall Study||694
8266279|NCT01757561|20383382|P4|NOT COMPLETED|Overall Study||9
8266280|NCT01757561|20383383|P3|NOT COMPLETED|Overall Study||7
8266281|NCT01757561|20383384|P2|NOT COMPLETED|Overall Study||6
8266282|NCT01757561|20383385|P1|NOT COMPLETED|Overall Study||6
8266283|NCT01757561|20383382|P4|COMPLETED|Overall Study||25
8266284|NCT01757561|20383383|P3|COMPLETED|Overall Study||31
8266285|NCT01757561|20383384|P2|COMPLETED|Overall Study||28
8266286|NCT01757561|20383385|P1|COMPLETED|Overall Study||32
8266287|NCT01757561|20383382|P4|STARTED|Overall Study||34
8266288|NCT01757561|20383383|P3|STARTED|Overall Study||38
8266289|NCT01757561|20383384|P2|STARTED|Overall Study||34
8266290|NCT01757561|20383385|P1|STARTED|Overall Study||38
8266291|NCT01757535|20383401|P2|NOT COMPLETED|Overall Study||208
8266292|NCT01757535|20383402|P1|NOT COMPLETED|Overall Study||193
8266293|NCT01757535|20383401|P2|COMPLETED|Overall Study||26
8266294|NCT01757535|20383402|P1|COMPLETED|Overall Study||45
8266295|NCT01757535|20383401|P2|Received Treatment|Overall Study||233
8266296|NCT01757535|20383402|P1|Received Treatment|Overall Study||236
8266297|NCT01757535|20383401|P2|STARTED|Overall Study||234
8266298|NCT01757535|20383402|P1|STARTED|Overall Study||238
8266299|NCT01757405|20383434|P2|NOT COMPLETED|Overall Study||2
8266300|NCT01757405|20383435|P1|NOT COMPLETED|Overall Study||1
8266301|NCT01757405|20383434|P2|COMPLETED|Overall Study||18
8266302|NCT01757405|20383435|P1|COMPLETED|Overall Study||17
8266303|NCT01757405|20383434|P2|STARTED|Overall Study||20
8266304|NCT01757405|20383435|P1|STARTED|Overall Study||18
8266308|NCT01757301|20383461|P2|NOT COMPLETED|Overall Study||14
8266309|NCT01757301|20383462|P1|NOT COMPLETED|Overall Study||13
8266310|NCT01757301|20383461|P2|COMPLETED|Overall Study||133
8266311|NCT01757301|20383462|P1|COMPLETED|Overall Study||134
8266312|NCT01757301|20383461|P2|STARTED|Overall Study||147
8266313|NCT01757301|20383462|P1|STARTED|Overall Study||147
8266314|NCT01757275|20383478|P2|NOT COMPLETED|Overall Study||13
8266315|NCT01757275|20383479|P1|NOT COMPLETED|Overall Study||9
8266316|NCT01757275|20383478|P2|COMPLETED|Overall Study||98
8266317|NCT01757275|20383479|P1|COMPLETED|Overall Study||102
8266318|NCT01757275|20383478|P2|STARTED|Overall Study||111
8266319|NCT01757275|20383479|P1|STARTED|Overall Study||111
8266320|NCT01757197|20383501|P1|NOT COMPLETED|Overall Study||2
8266321|NCT01757197|20383501|P1|COMPLETED|Overall Study||0
8266322|NCT01757197|20383501|P1|STARTED|Overall Study||2
8266323|NCT01757184|20383510|P4|NOT COMPLETED|Open-label Period||3
8266324|NCT01757184|20383511|P3|NOT COMPLETED|Open-label Period||4
8266325|NCT01757184|20383512|P2|NOT COMPLETED|Open-label Period||0
8266326|NCT01757184|20383513|P1|NOT COMPLETED|Open-label Period||0
8266327|NCT01757184|20383510|P4|COMPLETED|Open-label Period||27
8266328|NCT01757184|20383511|P3|COMPLETED|Open-label Period||32
8266329|NCT01757184|20383512|P2|COMPLETED|Open-label Period||0
8266330|NCT01757184|20383513|P1|COMPLETED|Open-label Period||0
8266331|NCT01757184|20383510|P4|Received at Least 1 Dose of Study Drug|Open-label Period||30
8266332|NCT01757184|20383511|P3|Received at Least 1 Dose of Study Drug|Open-label Period||36
8266333|NCT01757184|20383512|P2|Received at Least 1 Dose of Study Drug|Open-label Period||0
8266334|NCT01757184|20383513|P1|Received at Least 1 Dose of Study Drug|Open-label Period||0
8266335|NCT01757184|20383510|P4|STARTED|Open-label Period||30
8266336|NCT01757184|20383511|P3|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
8266337|NCT01757184|20383512|P2|STARTED|Open-label Period||0
8266338|NCT01757184|20383513|P1|STARTED|Open-label Period||0
8266339|NCT01757184|20383510|P4|NOT COMPLETED|Double-blind Period||0
8266340|NCT01757184|20383511|P3|NOT COMPLETED|Double-blind Period||0
8266341|NCT01757184|20383512|P2|NOT COMPLETED|Double-blind Period||0
8266342|NCT01757184|20383513|P1|NOT COMPLETED|Double-blind Period||1
8266343|NCT01757184|20383510|P4|COMPLETED|Double-blind Period||0
8266344|NCT01757184|20383511|P3|COMPLETED|Double-blind Period||0
8266345|NCT01757184|20383512|P2|COMPLETED|Double-blind Period||30
8266346|NCT01757184|20383513|P1|COMPLETED|Double-blind Period||35
8266347|NCT01757184|20383510|P4|Received at Least 1 Dose of Study Drug|Double-blind Period||0
8266348|NCT01757184|20383511|P3|Received at Least 1 Dose of Study Drug|Double-blind Period||0
8266349|NCT01757184|20383512|P2|Received at Least 1 Dose of Study Drug|Double-blind Period||30
8266350|NCT01757184|20383513|P1|Received at Least 1 Dose of Study Drug|Double-blind Period||36
8266351|NCT01757184|20383510|P4|STARTED|Double-blind Period||0
8266352|NCT01757184|20383511|P3|STARTED|Double-blind Period||0
8266353|NCT01757184|20383512|P2|STARTED|Double-blind Period||30
8266354|NCT01757184|20383513|P1|STARTED|Double-blind Period||36
8266355|NCT01757171|20383557|P2|NOT COMPLETED|Overall Study||1
8266356|NCT01757171|20383558|P1|NOT COMPLETED|Overall Study||8
8266357|NCT01757171|20383557|P2|COMPLETED|Overall Study||23
8266358|NCT01757171|20383558|P1|COMPLETED|Overall Study||53
8266359|NCT01757171|20383557|P2|STARTED|Overall Study||24
8266360|NCT01757171|20383558|P1|STARTED|Overall Study||61
8266361|NCT01756976|20383572|P2|NOT COMPLETED|Overall Study||0
8266362|NCT01756976|20383573|P1|NOT COMPLETED|Overall Study||3
8266363|NCT01756976|20383572|P2|COMPLETED|Overall Study||8
8266364|NCT01756976|20383573|P1|COMPLETED|Overall Study||73
8266365|NCT01756976|20383572|P2|STARTED|Overall Study||8
8266366|NCT01756976|20383573|P1|STARTED|Overall Study||76
8266367|NCT01756885|20383581|P2|NOT COMPLETED|Overall Study||26
8266368|NCT01756885|20383582|P1|NOT COMPLETED|Overall Study||23
8266369|NCT01756885|20383581|P2|COMPLETED|Overall Study||79
8266370|NCT01756885|20383582|P1|COMPLETED|Overall Study||79
8266371|NCT01756885|20383581|P2|STARTED|Overall Study||105
8266372|NCT01756885|20383582|P1|STARTED|Overall Study||102
8266373|NCT01756846|20383594|P2|NOT COMPLETED|Overall Study||12
8266374|NCT01756846|20383595|P1|NOT COMPLETED|Overall Study||6
8266375|NCT01756846|20383594|P2|COMPLETED|Overall Study||1821
8266376|NCT01756846|20383595|P1|COMPLETED|Overall Study||1827
8266377|NCT01756846|20383594|P2|STARTED|Overall Study||1833
8266378|NCT01756846|20383595|P1|STARTED|Overall Study||1833
8266379|NCT01756586|20383605|P2|NOT COMPLETED|Overall Study||2
8266380|NCT01756586|20383606|P1|NOT COMPLETED|Overall Study||2
8266381|NCT01756586|20383605|P2|COMPLETED|Overall Study||0
8266382|NCT01756586|20383606|P1|COMPLETED|Overall Study||0
8266383|NCT01756586|20383605|P2|STARTED|Overall Study||2
8266384|NCT01756586|20383606|P1|STARTED|Overall Study||2
8266385|NCT01756573|20383615|P3|NOT COMPLETED|Overall Study||0
8266386|NCT01756573|20383616|P2|NOT COMPLETED|Overall Study||0
8266387|NCT01756573|20383617|P1|NOT COMPLETED|Overall Study||0
8266388|NCT01756573|20383615|P3|COMPLETED|Overall Study||1
8266389|NCT01756573|20383616|P2|COMPLETED|Overall Study||1
8266390|NCT01756573|20383617|P1|COMPLETED|Overall Study||3
8266391|NCT01756573|20383615|P3|STARTED|Overall Study||1
8266392|NCT01756573|20383616|P2|STARTED|Overall Study||1
8266393|NCT01756573|20383617|P1|STARTED|Overall Study||3
8266394|NCT01756560|20383627|P2|NOT COMPLETED|Overall Study||0
8266395|NCT01756560|20383628|P1|NOT COMPLETED|Overall Study||2
8266396|NCT01756560|20383627|P2|COMPLETED|Overall Study||0
8266397|NCT01756560|20383628|P1|COMPLETED|Overall Study||0
8266398|NCT01756560|20383627|P2|STARTED|Overall Study||0
8266399|NCT01756560|20383628|P1|STARTED|Overall Study||2
8266400|NCT01756456|20383640|P6|NOT COMPLETED|Follow Up Period Phase I/II||33
8266401|NCT01756456|20383641|P5|NOT COMPLETED|Follow Up Period Phase I/II||26
8266402|NCT01756456|20383642|P4|NOT COMPLETED|Follow Up Period Phase I/II||33
8266403|NCT01756456|20383643|P3|NOT COMPLETED|Follow Up Period Phase I/II||1
8266404|NCT01756456|20383644|P2|NOT COMPLETED|Follow Up Period Phase I/II||1
8266405|NCT01756456|20383645|P1|NOT COMPLETED|Follow Up Period Phase I/II||1
8266406|NCT01756456|20383640|P6|COMPLETED|Follow Up Period Phase I/II||15
8266407|NCT01756456|20383641|P5|COMPLETED|Follow Up Period Phase I/II||13
8266408|NCT01756456|20383642|P4|COMPLETED|Follow Up Period Phase I/II||12
8266409|NCT01756456|20383643|P3|COMPLETED|Follow Up Period Phase I/II||1
8266410|NCT01756456|20383644|P2|COMPLETED|Follow Up Period Phase I/II||5
8266411|NCT01756456|20383645|P1|COMPLETED|Follow Up Period Phase I/II||5
8266412|NCT01756456|20383640|P6|STARTED|Follow Up Period Phase I/II||48
8266413|NCT01756456|20383641|P5|STARTED|Follow Up Period Phase I/II||39
8266414|NCT01756456|20383642|P4|STARTED|Follow Up Period Phase I/II||45
8266415|NCT01756456|20383643|P3|STARTED|Follow Up Period Phase I/II||2
8266416|NCT01756456|20383644|P2|STARTED|Follow Up Period Phase I/II||6
8266417|NCT01756456|20383645|P1|STARTED|Follow Up Period Phase I/II||6
8266418|NCT01756456|20383640|P6|NOT COMPLETED|Treatment Period: Phase I/II||4
8266419|NCT01756456|20383641|P5|NOT COMPLETED|Treatment Period: Phase I/II||13
8266420|NCT01756456|20383642|P4|NOT COMPLETED|Treatment Period: Phase I/II||7
8266421|NCT01756456|20383643|P3|NOT COMPLETED|Treatment Period: Phase I/II||2
8266422|NCT01756456|20383644|P2|NOT COMPLETED|Treatment Period: Phase I/II||1
8266423|NCT01756456|20383645|P1|NOT COMPLETED|Treatment Period: Phase I/II||1
8266424|NCT01756456|20383640|P6|COMPLETED|Treatment Period: Phase I/II||48
8266425|NCT01756456|20383641|P5|COMPLETED|Treatment Period: Phase I/II||39
8266426|NCT01756456|20383642|P4|COMPLETED|Treatment Period: Phase I/II||45
8266427|NCT01756456|20383643|P3|COMPLETED|Treatment Period: Phase I/II||2
8266428|NCT01756456|20383644|P2|COMPLETED|Treatment Period: Phase I/II||6
8266429|NCT01756456|20383645|P1|COMPLETED|Treatment Period: Phase I/II||6
8266430|NCT01756456|20383640|P6|STARTED|Treatment Period: Phase I/II||52
8266431|NCT01756456|20383641|P5|STARTED|Treatment Period: Phase I/II||52
8266432|NCT01756456|20383642|P4|STARTED|Treatment Period: Phase I/II||52
8266433|NCT01756456|20383643|P3|STARTED|Treatment Period: Phase I/II||4
8266434|NCT01756456|20383644|P2|STARTED|Treatment Period: Phase I/II||7
8266435|NCT01756456|20383645|P1|STARTED|Treatment Period: Phase I/II||7
8266436|NCT01756391|20383743|P1|NOT COMPLETED|Overall Study||32
8266437|NCT01756391|20383743|P1|COMPLETED|Overall Study||319
8266438|NCT01756391|20383743|P1|STARTED|Overall Study||351
8266439|NCT01756352|20383747|P1|NOT COMPLETED|Overall Study||1
8266440|NCT01756352|20383747|P1|COMPLETED|Overall Study||12
8266441|NCT01756352|20383747|P1|STARTED|Overall Study||13
8266442|NCT01756300|20383752|P1|NOT COMPLETED|Overall Study||2
8266443|NCT01756300|20383752|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
8266444|NCT01756300|20383752|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
8266445|NCT01756274|20383774|P1|NOT COMPLETED|Overall Study||3
8266446|NCT01756274|20383774|P1|COMPLETED|Overall Study||159
8266447|NCT01756274|20383774|P1|STARTED|Overall Study||162
8266448|NCT01756235|20383781|P1|NOT COMPLETED|Overall Study||2
8266449|NCT01756235|20383781|P1|COMPLETED|Overall Study||460
8266450|NCT01756235|20383781|P1|STARTED|Overall Study||462
8266451|NCT01756209|20383806|P4|NOT COMPLETED|Overall Study||0
8266452|NCT01756209|20383807|P3|NOT COMPLETED|Overall Study||0
8266453|NCT01756209|20383808|P2|NOT COMPLETED|Overall Study||0
8266454|NCT01756209|20383809|P1|NOT COMPLETED|Overall Study||0
8266455|NCT01756209|20383806|P4|COMPLETED|Overall Study||40
8266456|NCT01756209|20383807|P3|COMPLETED|Overall Study||40
8266457|NCT01756209|20383808|P2|COMPLETED|Overall Study||40
8266458|NCT01756209|20383809|P1|COMPLETED|Overall Study||40
8266459|NCT01756209|20383806|P4|STARTED|Overall Study||40
8266460|NCT01756209|20383807|P3|STARTED|Overall Study||40
8266461|NCT01756209|20383808|P2|STARTED|Overall Study||40
8266462|NCT01756209|20383809|P1|STARTED|Overall Study||40
8266463|NCT01756157|20383819|P2|NOT COMPLETED|Second Intervention Period||0
8266464|NCT01756157|20383820|P1|NOT COMPLETED|Second Intervention Period||0
8266465|NCT01756157|20383819|P2|COMPLETED|Second Intervention Period||22
8266466|NCT01756157|20383820|P1|COMPLETED|Second Intervention Period||22
8266467|NCT01756157|20383819|P2|STARTED|Second Intervention Period||22
8266468|NCT01756157|20383820|P1|STARTED|Second Intervention Period||22
8266469|NCT01756157|20383819|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8266470|NCT01756157|20383820|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8266471|NCT01756157|20383819|P2|COMPLETED|Washout Period (at Least 7 Days)||22
8266472|NCT01756157|20383820|P1|COMPLETED|Washout Period (at Least 7 Days)||22
8266473|NCT01756157|20383819|P2|STARTED|Washout Period (at Least 7 Days)||22
8266474|NCT01756157|20383820|P1|STARTED|Washout Period (at Least 7 Days)||22
8266475|NCT01756157|20383819|P2|NOT COMPLETED|First Intervention Period||2
8266476|NCT01756157|20383820|P1|NOT COMPLETED|First Intervention Period||1
8266477|NCT01756157|20383819|P2|COMPLETED|First Intervention Period||22
8266478|NCT01756157|20383820|P1|COMPLETED|First Intervention Period||22
8266479|NCT01756157|20383819|P2|STARTED|First Intervention Period||24
8266480|NCT01756157|20383820|P1|STARTED|First Intervention Period||23
8266481|NCT01756079|20383834|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
8266482|NCT01756079|20383834|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
8266483|NCT01756079|20383834|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
8266484|NCT01756079|20383834|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
8266485|NCT01756079|20383834|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
8266486|NCT01756079|20383834|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
8266487|NCT01756079|20383834|P1|STARTED|Lead-in: Day 0 to Week 4||58
8266488|NCT01756053|20383840|P2|NOT COMPLETED|Period 2 (10 Days)||2
8266489|NCT01756053|20383841|P1|NOT COMPLETED|Period 2 (10 Days)||0
8266490|NCT01756053|20383840|P2|COMPLETED|Period 2 (10 Days)||6
8266491|NCT01756053|20383841|P1|COMPLETED|Period 2 (10 Days)||7
8266492|NCT01756053|20383840|P2|STARTED|Period 2 (10 Days)||8
8266493|NCT01756053|20383841|P1|STARTED|Period 2 (10 Days)||7
8266494|NCT01756053|20383840|P2|NOT COMPLETED|Washout Period (~21 Days)||0
8266495|NCT01756053|20383841|P1|NOT COMPLETED|Washout Period (~21 Days)||0
8266496|NCT01756053|20383840|P2|COMPLETED|Washout Period (~21 Days)||8
8266497|NCT01756053|20383841|P1|COMPLETED|Washout Period (~21 Days)||7
8266498|NCT01756053|20383840|P2|STARTED|Washout Period (~21 Days)||8
8266499|NCT01756053|20383841|P1|STARTED|Washout Period (~21 Days)||7
8266500|NCT01756053|20383840|P2|NOT COMPLETED|Period 1 (10 Days)||1
8266501|NCT01756053|20383841|P1|NOT COMPLETED|Period 1 (10 Days)||1
8266502|NCT01756053|20383840|P2|COMPLETED|Period 1 (10 Days)||8
8266503|NCT01756053|20383841|P1|COMPLETED|Period 1 (10 Days)||7
8266504|NCT01756053|20383840|P2|STARTED|Period 1 (10 Days)||9
8266505|NCT01756053|20383841|P1|STARTED|Period 1 (10 Days)||8
8266506|NCT01755949|20383867|P6|NOT COMPLETED|Overall Study||0
8266507|NCT01755949|20383868|P5|NOT COMPLETED|Overall Study||0
8266508|NCT01755949|20383869|P4|NOT COMPLETED|Overall Study||0
8266509|NCT01755949|20383870|P3|NOT COMPLETED|Overall Study||0
8266510|NCT01755949|20383871|P2|NOT COMPLETED|Overall Study||0
8266511|NCT01755949|20383872|P1|NOT COMPLETED|Overall Study||0
8266512|NCT01755949|20383867|P6|COMPLETED|Overall Study||3
8266513|NCT01755949|20383868|P5|COMPLETED|Overall Study||4
8266514|NCT01755949|20383869|P4|COMPLETED|Overall Study||5
8266515|NCT01755949|20383870|P3|COMPLETED|Overall Study||4
8266516|NCT01755949|20383871|P2|COMPLETED|Overall Study||5
8266517|NCT01755949|20383872|P1|COMPLETED|Overall Study||5
8266518|NCT01755949|20383867|P6|STARTED|Overall Study||3
8266519|NCT01755949|20383868|P5|STARTED|Overall Study||4
8266520|NCT01755949|20383869|P4|STARTED|Overall Study||5
8266521|NCT01755949|20383870|P3|STARTED|Overall Study||4
8266522|NCT01755949|20383871|P2|STARTED|Overall Study||5
8266523|NCT01755949|20383872|P1|STARTED|Overall Study||5
8266524|NCT01755858|20383900|P2|NOT COMPLETED|Overall Study||1
8266525|NCT01755858|20383901|P1|NOT COMPLETED|Overall Study||1
8266526|NCT01755858|20383900|P2|COMPLETED|Overall Study||8
8266527|NCT01755858|20383901|P1|COMPLETED|Overall Study||6
8266528|NCT01755858|20383900|P2|STARTED|Overall Study||9
8266529|NCT01755858|20383901|P1|STARTED|Overall Study||7
8266530|NCT01755767|20383927|P4|NOT COMPLETED|Overall Study||114
8266531|NCT01755767|20383928|P3|NOT COMPLETED|Overall Study||226
8266532|NCT01755767|20383929|P2|NOT COMPLETED|Overall Study||15
8266533|NCT01755767|20383930|P1|NOT COMPLETED|Overall Study||28
8266534|NCT01755767|20383927|P4|COMPLETED|Overall Study||0
8266535|NCT01755767|20383928|P3|COMPLETED|Overall Study||0
8266536|NCT01755767|20383929|P2|COMPLETED|Overall Study||0
8266537|NCT01755767|20383930|P1|COMPLETED|Overall Study||0
8266538|NCT01755767|20383927|P4|STARTED|Overall Study||114
8266539|NCT01755767|20383928|P3|STARTED|Overall Study||226
8266540|NCT01755767|20383929|P2|STARTED|Overall Study||15
8266541|NCT01755767|20383930|P1|STARTED|Overall Study||28
8266542|NCT01755702|20383946|P1|NOT COMPLETED|Period III||0
8266543|NCT01755702|20383946|P1|COMPLETED|Period III||58
8266544|NCT01755702|20383946|P1|Received Ibuprofen|Period III||18
8266545|NCT01755702|20383946|P1|Received Paracetamol/Caffeine|Period III||10
8266546|NCT01755702|20383946|P1|Received Placebo|Period III||13
8266547|NCT01755702|20383946|P1|Received Paracetamol|Period III||17
8266548|NCT01755702|20383946|P1|STARTED|Period III||58
8266549|NCT01755702|20383946|P1|NOT COMPLETED|Washout Period II||5
8266550|NCT01755702|20383946|P1|COMPLETED|Washout Period II||58
8266551|NCT01755702|20383946|P1|STARTED|Washout Period II||63
8266552|NCT01755702|20383946|P1|NOT COMPLETED|Period II||0
8266553|NCT01755702|20383946|P1|COMPLETED|Period II||63
8266554|NCT01755702|20383946|P1|Received Paracetamol|Period II||17
8266555|NCT01755702|20383946|P1|Received Paracetamol/Caffeine|Period II||20
8266556|NCT01755702|20383946|P1|Received Placebo|Period II||15
8266557|NCT01755702|20383946|P1|Received Ibuprofen|Period II||11
8266558|NCT01755702|20383946|P1|STARTED|Period II||63
8266559|NCT01755702|20383946|P1|NOT COMPLETED|Wash Out Period I||3
8266560|NCT01755702|20383946|P1|COMPLETED|Wash Out Period I||63
8266561|NCT01755702|20383946|P1|STARTED|Wash Out Period I||66
8266562|NCT01755702|20383946|P1|NOT COMPLETED|Period I||0
8266563|NCT01755702|20383946|P1|COMPLETED|Period I||66
8266564|NCT01755702|20383946|P1|Received Paracetamol/Caffeine|Period I||17
8266565|NCT01755702|20383946|P1|Received Ibuprofen|Period I||16
8266566|NCT01755702|20383946|P1|Received Placebo|Period I||17
8266567|NCT01755702|20383946|P1|Received Paracetamol|Period I||16
8266568|NCT01755702|20383946|P1|STARTED|Period I||66
8266569|NCT01755689|20383993|P5|NOT COMPLETED|Overall Study||6
8266570|NCT01755689|20383994|P4|NOT COMPLETED|Overall Study||6
8266571|NCT01755689|20383995|P3|NOT COMPLETED|Overall Study||6
8266572|NCT01755689|20383996|P2|NOT COMPLETED|Overall Study||5
8266573|NCT01755689|20383997|P1|NOT COMPLETED|Overall Study||3
8266574|NCT01755689|20383993|P5|COMPLETED|Overall Study||255
8266575|NCT01755689|20383994|P4|COMPLETED|Overall Study||254
8266576|NCT01755689|20383995|P3|COMPLETED|Overall Study||255
8266577|NCT01755689|20383996|P2|COMPLETED|Overall Study||254
8266578|NCT01755689|20383997|P1|COMPLETED|Overall Study||256
8266579|NCT01755689|20383993|P5|STARTED|Overall Study||261
8266580|NCT01755689|20383994|P4|STARTED|Overall Study||260
8266581|NCT01755689|20383995|P3|STARTED|Overall Study||261
8266582|NCT01755689|20383996|P2|STARTED|Overall Study||259
8266583|NCT01755689|20383997|P1|STARTED|Overall Study||259
8266584|NCT01755637|20384072|P2|NOT COMPLETED|Period 2||0
8266585|NCT01755637|20384073|P1|NOT COMPLETED|Period 2||0
8266586|NCT01755637|20384072|P2|COMPLETED|Period 2||27
8266587|NCT01755637|20384073|P1|COMPLETED|Period 2||28
8266588|NCT01755637|20384072|P2|STARTED|Period 2||27
8266589|NCT01755637|20384073|P1|STARTED|Period 2||28
8266590|NCT01755637|20384072|P2|NOT COMPLETED|Period 1||1
8266591|NCT01755637|20384073|P1|NOT COMPLETED|Period 1||0
8266592|NCT01755637|20384072|P2|COMPLETED|Period 1||27
8266593|NCT01755637|20384073|P1|COMPLETED|Period 1||28
8266594|NCT01755637|20384072|P2|STARTED|Period 1||28
8266595|NCT01755637|20384073|P1|STARTED|Period 1||28
8266596|NCT01755598|20384093|P2|NOT COMPLETED|Overall Study||283
8266597|NCT01755598|20384094|P1|NOT COMPLETED|Overall Study||265
8266598|NCT01755598|20384093|P2|COMPLETED|Overall Study||1504
8266599|NCT01755598|20384094|P1|COMPLETED|Overall Study||1521
8266600|NCT01755598|20384093|P2|STARTED|Overall Study||1787
8266601|NCT01755598|20384094|P1|STARTED|Overall Study||1786
8266602|NCT01755546|20384128|P1|NOT COMPLETED|Long Term Treatment||121
8266603|NCT01755546|20384128|P1|COMPLETED|Long Term Treatment||103
8266604|NCT01755546|20384128|P1|STARTED|Long Term Treatment||224
8266605|NCT01755546|20384128|P1|NOT COMPLETED|Titration Phase||70
8266606|NCT01755546|20384128|P1|COMPLETED|Titration Phase||224
8266607|NCT01755546|20384128|P1|STARTED|Titration Phase||294
8266608|NCT01755546|20384128|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
8266609|NCT01755546|20384128|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
8266610|NCT01755546|20384128|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
8266611|NCT01755455|20384132|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8266612|NCT01755455|20384133|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8266613|NCT01755455|20384132|P2|COMPLETED|Second Intervention (6 Weeks)||11
8266614|NCT01755455|20384133|P1|COMPLETED|Second Intervention (6 Weeks)||11
8266615|NCT01755455|20384132|P2|STARTED|Second Intervention (6 Weeks)||11
8266616|NCT01755455|20384133|P1|STARTED|Second Intervention (6 Weeks)||11
8266617|NCT01755455|20384132|P2|NOT COMPLETED|Washout (4 Weeks)||0
8266618|NCT01755455|20384133|P1|NOT COMPLETED|Washout (4 Weeks)||0
8266619|NCT01755455|20384132|P2|COMPLETED|Washout (4 Weeks)||11
8266620|NCT01755455|20384133|P1|COMPLETED|Washout (4 Weeks)||11
8266621|NCT01755455|20384132|P2|STARTED|Washout (4 Weeks)||11
8266622|NCT01755455|20384133|P1|STARTED|Washout (4 Weeks)||11
8266623|NCT01755455|20384132|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8266624|NCT01755455|20384133|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8266625|NCT01755455|20384132|P2|COMPLETED|First Intervention (6 Weeks)||11
8266626|NCT01755455|20384133|P1|COMPLETED|First Intervention (6 Weeks)||11
8266627|NCT01755455|20384132|P2|STARTED|First Intervention (6 Weeks)||11
8266628|NCT01755455|20384133|P1|STARTED|First Intervention (6 Weeks)||11
8266629|NCT01755416|20384145|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
8266630|NCT01755416|20384146|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
8266631|NCT01755416|20384145|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
8266632|NCT01755416|20384146|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
8266633|NCT01755416|20384145|P2|STARTED|Second Intervention (Upto 2 Days)||7
8266634|NCT01755416|20384146|P1|STARTED|Second Intervention (Upto 2 Days)||8
8266635|NCT01755416|20384145|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
8266636|NCT01755416|20384146|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
8266637|NCT01755416|20384145|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
8266638|NCT01755416|20384146|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
8266639|NCT01755416|20384145|P2|STARTED|First Intervention ( Upto 2 Days)||9
8266640|NCT01755416|20384146|P1|STARTED|First Intervention ( Upto 2 Days)||9
8266641|NCT01755234|20384154|P2|NOT COMPLETED|Overall Study||8
8266642|NCT01755234|20384155|P1|NOT COMPLETED|Overall Study||15
8266643|NCT01755234|20384154|P2|COMPLETED|Overall Study||37
8266644|NCT01755234|20384155|P1|COMPLETED|Overall Study||30
8266645|NCT01755234|20384154|P2|STARTED|Overall Study||45
8266646|NCT01755234|20384155|P1|STARTED|Overall Study||45
8266647|NCT01755169|20384171|P4|NOT COMPLETED|Overall Study||0
8266648|NCT01755169|20384172|P3|NOT COMPLETED|Overall Study||0
8266649|NCT01755169|20384173|P2|NOT COMPLETED|Overall Study||0
8266650|NCT01755169|20384174|P1|NOT COMPLETED|Overall Study||0
8266651|NCT01755169|20384171|P4|COMPLETED|Overall Study||1
8266652|NCT01755169|20384172|P3|COMPLETED|Overall Study||0
8266653|NCT01755169|20384173|P2|COMPLETED|Overall Study||1
8266654|NCT01755169|20384174|P1|COMPLETED|Overall Study||2
8266655|NCT01755169|20384171|P4|STARTED|Overall Study||1
8266656|NCT01755169|20384172|P3|STARTED|Overall Study||0
8266657|NCT01755169|20384173|P2|STARTED|Overall Study||1
8266658|NCT01755169|20384174|P1|STARTED|Overall Study||2
8266659|NCT01755156|20384186|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
8266660|NCT01755156|20384187|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
8266661|NCT01755156|20384186|P2|COMPLETED|Phase B (Weeks 24-104)||141
8266662|NCT01755156|20384187|P1|COMPLETED|Phase B (Weeks 24-104)||144
8266663|NCT01755156|20384186|P2|STARTED|Phase B (Weeks 24-104)||177
8266664|NCT01755156|20384187|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
8266665|NCT01755156|20384186|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
8266666|NCT01755156|20384187|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
8266667|NCT01755156|20384186|P2|COMPLETED|Phase A (Weeks 0-24)||177
8266668|NCT01755156|20384187|P1|COMPLETED|Phase A (Weeks 0-24)||184
8266669|NCT01755156|20384186|P2|STARTED|Phase A (Weeks 0-24)||201
8266670|NCT01755156|20384187|P1|STARTED|Phase A (Weeks 0-24)||201
8266671|NCT01755143|20384233|P2|NOT COMPLETED|Overall Study||3
8266672|NCT01755143|20384234|P1|NOT COMPLETED|Overall Study||11
8266673|NCT01755143|20384233|P2|COMPLETED|Overall Study||86
8266674|NCT01755143|20384234|P1|COMPLETED|Overall Study||166
8266675|NCT01755143|20384233|P2|STARTED|Overall Study||89
8266676|NCT01755143|20384234|P1|STARTED|Overall Study||177
8266677|NCT01755091|20384251|P3|NOT COMPLETED|Overall Study||7
8266678|NCT01755091|20384252|P2|NOT COMPLETED|Overall Study||3
8266679|NCT01755091|20384253|P1|NOT COMPLETED|Overall Study||9
8266680|NCT01755091|20384251|P3|COMPLETED|Overall Study||20
8266681|NCT01755091|20384252|P2|COMPLETED|Overall Study||19
8266682|NCT01755091|20384253|P1|COMPLETED|Overall Study||17
8266683|NCT01755091|20384251|P3|STARTED|Overall Study||27
8266684|NCT01755091|20384252|P2|STARTED|Overall Study||22
8266685|NCT01755091|20384253|P1|STARTED|Overall Study||26
8266686|NCT01755026|20384278|P2|NOT COMPLETED|Overall Study||1
8266687|NCT01755026|20384279|P1|NOT COMPLETED|Overall Study||2
8266688|NCT01755026|20384278|P2|COMPLETED|Overall Study||11
8266689|NCT01755026|20384279|P1|COMPLETED|Overall Study||9
8266690|NCT01755026|20384278|P2|STARTED|Overall Study||12
8266691|NCT01755026|20384279|P1|STARTED|Overall Study||11
8266692|NCT01754987|20384287|P2|NOT COMPLETED|Overall Study||0
8266693|NCT01754987|20384288|P1|NOT COMPLETED|Overall Study||0
8266694|NCT01754987|20384287|P2|COMPLETED|Overall Study||0
8266695|NCT01754987|20384288|P1|COMPLETED|Overall Study||5
8266696|NCT01754987|20384287|P2|STARTED|Overall Study||0
8266697|NCT01754987|20384288|P1|STARTED|Overall Study||5
8266698|NCT01754922|20384302|P2|NOT COMPLETED|Overall Study||1
8266699|NCT01754922|20384303|P1|NOT COMPLETED|Overall Study||0
8266700|NCT01754922|20384302|P2|COMPLETED|Overall Study||17
8266701|NCT01754922|20384303|P1|COMPLETED|Overall Study||32
8266702|NCT01754922|20384302|P2|STARTED|Overall Study||18
8266703|NCT01754922|20384303|P1|STARTED|Overall Study||32
8266704|NCT01754909|20384315|P2|NOT COMPLETED|Overall Study||0
8266705|NCT01754909|20384316|P1|NOT COMPLETED|Overall Study||0
8266706|NCT01754909|20384315|P2|COMPLETED|Overall Study||23
8266707|NCT01754909|20384316|P1|COMPLETED|Overall Study||20
8266708|NCT01754909|20384315|P2|STARTED|Overall Study||23
8266709|NCT01754909|20384316|P1|STARTED|Overall Study||20
8266710|NCT01754766|20384329|P3|NOT COMPLETED|Overall Study||0
8266711|NCT01754766|20384330|P2|NOT COMPLETED|Overall Study||1
8266712|NCT01754766|20384331|P1|NOT COMPLETED|Overall Study||1
8266713|NCT01754766|20384329|P3|COMPLETED|Overall Study||30
8266714|NCT01754766|20384330|P2|COMPLETED|Overall Study||28
8266715|NCT01754766|20384331|P1|COMPLETED|Overall Study||30
8266716|NCT01754766|20384329|P3|STARTED|Overall Study||30
8266717|NCT01754766|20384330|P2|STARTED|Overall Study||29
8266718|NCT01754766|20384331|P1|STARTED|Overall Study||31
8266719|NCT01754727|20384345|P1|NOT COMPLETED|Overall Study||2
8266720|NCT01754727|20384345|P1|COMPLETED|Overall Study||450
8266721|NCT01754727|20384345|P1|STARTED|Overall Study||452
8266722|NCT01754714|20384363|P4|NOT COMPLETED|Overall Study||1
8266723|NCT01754714|20384364|P3|NOT COMPLETED|Overall Study||2
8266724|NCT01754714|20384365|P2|NOT COMPLETED|Overall Study||1
8266725|NCT01754714|20384366|P1|NOT COMPLETED|Overall Study||0
8266726|NCT01754714|20384363|P4|COMPLETED|Overall Study||27
8266727|NCT01754714|20384364|P3|COMPLETED|Overall Study||24
8266728|NCT01754714|20384365|P2|COMPLETED|Overall Study||26
8266729|NCT01754714|20384366|P1|COMPLETED|Overall Study||27
8266730|NCT01754714|20384363|P4|STARTED|Overall Study||28
8266731|NCT01754714|20384364|P3|STARTED|Overall Study||26
8266732|NCT01754714|20384365|P2|STARTED|Overall Study||27
8266733|NCT01754714|20384366|P1|STARTED|Overall Study||27
8266734|NCT01754688|20384456|P1|NOT COMPLETED|Overall Study||0
8266735|NCT01754688|20384456|P1|COMPLETED|Overall Study||624
8266736|NCT01754688|20384456|P1|STARTED|Overall Study||624
8266737|NCT01754623|20384461|P1|NOT COMPLETED|Overall Study||0
8266738|NCT01754623|20384461|P1|COMPLETED|Overall Study||9
8266739|NCT01754623|20384461|P1|STARTED|Overall Study||9
8266740|NCT01754519|20384468|P1|NOT COMPLETED|Overall Study||0
8266741|NCT01754519|20384468|P1|COMPLETED|Overall Study||1
8266742|NCT01754519|20384468|P1|STARTED|Overall Study||1
8266743|NCT01754493|20384477|P1|NOT COMPLETED|Overall Study||7
8266744|NCT01754493|20384477|P1|COMPLETED|Overall Study||10
8266745|NCT01754493|20384477|P1|STARTED|Overall Study||17
8266746|NCT01754480|20384487|P2|NOT COMPLETED|Primary Part II||11
8266747|NCT01754480|20384488|P1|NOT COMPLETED|Primary Part II||15
8266748|NCT01754480|20384487|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
8266749|NCT01754480|20384488|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
8266750|NCT01754480|20384487|P2|Completed Study up to Week 6|Primary Part II||108
8266751|NCT01754480|20384488|P1|Completed Study up to Week 6|Primary Part II||100
8266752|NCT01754480|20384487|P2|STARTED|Primary Part II||113
8266753|NCT01754480|20384488|P1|STARTED|Primary Part II||111
8266754|NCT01754480|20384487|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
8266755|NCT01754480|20384488|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
8266756|NCT01754480|20384487|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
8266757|NCT01754480|20384488|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
8266758|NCT01754480|20384487|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
8266759|NCT01754480|20384488|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
8266760|NCT01754480|20384487|P2|STARTED|Part I + Part II (Overall Study)||162
8266761|NCT01754480|20384488|P1|STARTED|Part I + Part II (Overall Study)||163
8266762|NCT01754467|20384502|P1|NOT COMPLETED|Overall Study||1
8266763|NCT01754467|20384502|P1|COMPLETED|Overall Study||8
8266764|NCT01754467|20384502|P1|STARTED|Overall Study||9
8266765|NCT01754402|20384512|P3|NOT COMPLETED|Overall Study||4
8266766|NCT01754402|20384513|P2|NOT COMPLETED|Overall Study||2
8266767|NCT01754402|20384514|P1|NOT COMPLETED|Overall Study||2
8266768|NCT01754402|20384512|P3|COMPLETED|Overall Study||26
8266769|NCT01754402|20384513|P2|COMPLETED|Overall Study||0
8266770|NCT01754402|20384514|P1|COMPLETED|Overall Study||4
8266771|NCT01754402|20384512|P3|STARTED|Overall Study||30
8266772|NCT01754402|20384513|P2|STARTED|Overall Study||2
8266773|NCT01754402|20384514|P1|STARTED|Overall Study||6
8266774|NCT01754389|20384526|P3|NOT COMPLETED|Overall Study||0
8266775|NCT01754389|20384527|P2|NOT COMPLETED|Overall Study||0
8266776|NCT01754389|20384528|P1|NOT COMPLETED|Overall Study||0
8266777|NCT01754389|20384526|P3|COMPLETED|Overall Study||47
8266778|NCT01754389|20384527|P2|COMPLETED|Overall Study||45
8266779|NCT01754389|20384528|P1|COMPLETED|Overall Study||46
8266780|NCT01754389|20384526|P3|STARTED|Overall Study||47
8266781|NCT01754389|20384527|P2|STARTED|Overall Study||45
8266782|NCT01754389|20384528|P1|STARTED|Overall Study||46
8266783|NCT01754376|20384548|P1|NOT COMPLETED|Overall Study||3
8266784|NCT01754376|20384548|P1|COMPLETED|Overall Study||3
8266785|NCT01754376|20384548|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
8266786|NCT01754376|20384548|P1|STARTED|Overall Study||6
8266787|NCT01754259|20384559|P2|NOT COMPLETED|Overall Study||6
8266788|NCT01754259|20384560|P1|NOT COMPLETED|Overall Study||5
8266789|NCT01754259|20384559|P2|COMPLETED|Overall Study||18
8266790|NCT01754259|20384560|P1|COMPLETED|Overall Study||18
8266791|NCT01754259|20384559|P2|STARTED|Overall Study||24
8266792|NCT01754259|20384560|P1|STARTED|Overall Study||23
8266793|NCT01754207|20384568|P1|NOT COMPLETED|Overall Study||3
8266794|NCT01754207|20384568|P1|COMPLETED|Overall Study||17
8266795|NCT01754207|20384568|P1|STARTED|Overall Study||20
8266796|NCT01754194|20384574|P2|NOT COMPLETED|Overall Study||27
8266797|NCT01754194|20384575|P1|NOT COMPLETED|Overall Study||52
8266798|NCT01754194|20384574|P2|COMPLETED|Overall Study||97
8266799|NCT01754194|20384575|P1|COMPLETED|Overall Study||117
8266800|NCT01754194|20384574|P2|STARTED|Overall Study||124
8266801|NCT01754194|20384575|P1|STARTED|Overall Study||169
8266802|NCT01754129|20384595|P1|NOT COMPLETED|Overall Study||33
8266803|NCT01754129|20384595|P1|COMPLETED|Overall Study||115
8266804|NCT01754129|20384595|P1|Visit 3 (Year 2)|Overall Study||115
8266805|NCT01754129|20384595|P1|Visit 2 (Year 1)|Overall Study||129
8266806|NCT01754129|20384595|P1|Visit 1 (Enrollment Day)|Overall Study||145
8266807|NCT01754129|20384595|P1|STARTED|Overall Study||148
8266808|NCT01753999|20384618|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
8266809|NCT01753999|20384619|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
8266810|NCT01753999|20384618|P2|COMPLETED|Period 2 -Cross to Alternate Arm||89
8266811|NCT01753999|20384619|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
8266812|NCT01753999|20384618|P2|Received Intervention|Period 2 -Cross to Alternate Arm||95
8266813|NCT01753999|20384619|P1|Received Intervention|Period 2 -Cross to Alternate Arm||103
8266814|NCT01753999|20384618|P2|STARTED|Period 2 -Cross to Alternate Arm||112
8266815|NCT01753999|20384619|P1|STARTED|Period 2 -Cross to Alternate Arm||116
8266816|NCT01753999|20384618|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
8266817|NCT01753999|20384619|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
8266818|NCT01753999|20384618|P2|COMPLETED|Period 1 - Initial Assignment||112
8266819|NCT01753999|20384619|P1|COMPLETED|Period 1 - Initial Assignment||116
8266820|NCT01753999|20384618|P2|Received Intervention|Period 1 - Initial Assignment||146
8266821|NCT01753999|20384619|P1|Received Intervention|Period 1 - Initial Assignment||144
8266822|NCT01753999|20384618|P2|STARTED|Period 1 - Initial Assignment||162
8266823|NCT01753999|20384619|P1|STARTED|Period 1 - Initial Assignment||155
8266824|NCT01753856|20384637|P2|NOT COMPLETED|Overall Study||2
8266825|NCT01753856|20384638|P1|NOT COMPLETED|Overall Study||3
8266826|NCT01753856|20384637|P2|COMPLETED|Overall Study||34
8266827|NCT01753856|20384638|P1|COMPLETED|Overall Study||30
8266828|NCT01753856|20384637|P2|Completed 3-Month Bone Biopsy|Overall Study||35
8266829|NCT01753856|20384638|P1|Completed 3-Month Bone Biopsy|Overall Study||31
8266830|NCT01753856|20384637|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
8266831|NCT01753856|20384638|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
8266832|NCT01753856|20384637|P2|STARTED|Overall Study||36
8266833|NCT01753856|20384638|P1|STARTED|Overall Study||33
8266834|NCT01753830|20384690|P2|NOT COMPLETED|Overall Study||3
8266835|NCT01753830|20384691|P1|NOT COMPLETED|Overall Study||7
8266836|NCT01753830|20384690|P2|COMPLETED|Overall Study||35
8266837|NCT01753830|20384691|P1|COMPLETED|Overall Study||30
8266838|NCT01753830|20384690|P2|STARTED|Overall Study||38
8266839|NCT01753830|20384691|P1|STARTED|Overall Study||37
8266840|NCT01753739|20384702|P5|NOT COMPLETED|Overall Study||3
8266841|NCT01753739|20384703|P4|NOT COMPLETED|Overall Study||7
8266842|NCT01753739|20384704|P3|NOT COMPLETED|Overall Study||5
8266843|NCT01753739|20384705|P2|NOT COMPLETED|Overall Study||5
8266844|NCT01753739|20384706|P1|NOT COMPLETED|Overall Study||4
8266845|NCT01753739|20384702|P5|COMPLETED|Overall Study||120
8266846|NCT01753739|20384703|P4|COMPLETED|Overall Study||117
8266847|NCT01753739|20384704|P3|COMPLETED|Overall Study||118
8266848|NCT01753739|20384705|P2|COMPLETED|Overall Study||118
8266849|NCT01753739|20384706|P1|COMPLETED|Overall Study||120
8266850|NCT01753739|20384702|P5|STARTED|Overall Study||123
8266851|NCT01753739|20384703|P4|STARTED|Overall Study||124
8266852|NCT01753739|20384704|P3|STARTED|Overall Study||123
8266853|NCT01753739|20384705|P2|STARTED|Overall Study||123
8266854|NCT01753739|20384706|P1|STARTED|Overall Study||124
8266855|NCT01753713|20384730|P2|NOT COMPLETED|Overall Study||0
8266856|NCT01753713|20384731|P1|NOT COMPLETED|Overall Study||0
8266857|NCT01753713|20384730|P2|COMPLETED|Overall Study||19
8266858|NCT01753713|20384731|P1|COMPLETED|Overall Study||14
8266859|NCT01753713|20384730|P2|STARTED|Overall Study||19
8266860|NCT01753713|20384731|P1|STARTED|Overall Study||14
8266861|NCT01753570|20384750|P3|NOT COMPLETED|Overall Study||1
8266862|NCT01753570|20384751|P2|NOT COMPLETED|Overall Study||5
8266863|NCT01753570|20384752|P1|NOT COMPLETED|Overall Study||2
8266864|NCT01753570|20384750|P3|COMPLETED|Overall Study||13
8266865|NCT01753570|20384751|P2|COMPLETED|Overall Study||25
8266866|NCT01753570|20384752|P1|COMPLETED|Overall Study||28
8266867|NCT01753570|20384750|P3|STARTED|Overall Study||14
8266868|NCT01753570|20384751|P2|STARTED|Overall Study||30
8266869|NCT01753570|20384752|P1|STARTED|Overall Study||30
8266870|NCT01753557|20384776|P2|NOT COMPLETED|Overall Study||0
8266871|NCT01753557|20384777|P1|NOT COMPLETED|Overall Study||0
8266872|NCT01753557|20384776|P2|COMPLETED|Overall Study||19
8266873|NCT01753557|20384777|P1|COMPLETED|Overall Study||35
8266874|NCT01753557|20384776|P2|STARTED|Overall Study||19
8266875|NCT01753557|20384777|P1|STARTED|Overall Study||35
8266876|NCT01753518|20384795|P2|NOT COMPLETED|Postpartum Follow-up||15
8266877|NCT01753518|20384796|P1|NOT COMPLETED|Postpartum Follow-up||22
8266878|NCT01753518|20384795|P2|COMPLETED|Postpartum Follow-up||88
8266879|NCT01753518|20384796|P1|COMPLETED|Postpartum Follow-up||81
8266880|NCT01753518|20384795|P2|STARTED|Postpartum Follow-up||103
8266881|NCT01753518|20384796|P1|STARTED|Postpartum Follow-up||103
8266882|NCT01753518|20384795|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
8266883|NCT01753518|20384796|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
8266884|NCT01753518|20384795|P2|COMPLETED|Intention-to-Treat Analysis||103
8266885|NCT01753518|20384796|P1|COMPLETED|Intention-to-Treat Analysis||103
8266886|NCT01753518|20384795|P2|STARTED|Intention-to-Treat Analysis||110
8266887|NCT01753518|20384796|P1|STARTED|Intention-to-Treat Analysis||110
8266888|NCT01753401|20384820|P4|NOT COMPLETED|Open Label Period (44 Weeks)||9
8266889|NCT01753401|20384821|P3|NOT COMPLETED|Open Label Period (44 Weeks)||4
8266890|NCT01753401|20384822|P2|NOT COMPLETED|Open Label Period (44 Weeks)||0
8266891|NCT01753401|20384823|P1|NOT COMPLETED|Open Label Period (44 Weeks)||0
8266892|NCT01753401|20384820|P4|COMPLETED|Open Label Period (44 Weeks)||13
8266893|NCT01753401|20384821|P3|COMPLETED|Open Label Period (44 Weeks)||7
8266894|NCT01753401|20384822|P2|COMPLETED|Open Label Period (44 Weeks)||0
8266895|NCT01753401|20384823|P1|COMPLETED|Open Label Period (44 Weeks)||0
8266896|NCT01753401|20384820|P4|Safety Analysis Set|Open Label Period (44 Weeks)||22
8266897|NCT01753401|20384821|P3|Safety Analysis Set|Open Label Period (44 Weeks)||11
8266898|NCT01753401|20384822|P2|Safety Analysis Set|Open Label Period (44 Weeks)||0
8266899|NCT01753401|20384823|P1|Safety Analysis Set|Open Label Period (44 Weeks)||0
8266900|NCT01753401|20384820|P4|mITT|Open Label Period (44 Weeks)||22
8266901|NCT01753401|20384821|P3|mITT|Open Label Period (44 Weeks)||11
8266902|NCT01753401|20384822|P2|mITT|Open Label Period (44 Weeks)||0
8266903|NCT01753401|20384823|P1|mITT|Open Label Period (44 Weeks)||0
8266904|NCT01753401|20384820|P4|STARTED|Open Label Period (44 Weeks)||22
8266905|NCT01753401|20384821|P3|STARTED|Open Label Period (44 Weeks)||11
8266906|NCT01753401|20384822|P2|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
8266907|NCT01753401|20384823|P1|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
8266908|NCT01753401|20384820|P4|NOT COMPLETED|Double-blind Period (8 Weeks)||0
8266909|NCT01753401|20384821|P3|NOT COMPLETED|Double-blind Period (8 Weeks)||0
8266910|NCT01753401|20384822|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||4
8266911|NCT01753401|20384823|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||1
8266912|NCT01753401|20384820|P4|COMPLETED|Double-blind Period (8 Weeks)||0
8266913|NCT01753401|20384821|P3|COMPLETED|Double-blind Period (8 Weeks)||0
8266914|NCT01753401|20384822|P2|COMPLETED|Double-blind Period (8 Weeks)||22
8266915|NCT01753401|20384823|P1|COMPLETED|Double-blind Period (8 Weeks)||11
8266916|NCT01753401|20384820|P4|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
8266917|NCT01753401|20384821|P3|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
8266918|NCT01753401|20384822|P2|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
8266919|NCT01753401|20384823|P1|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
8266920|NCT01753401|20384820|P4|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
8266921|NCT01753401|20384821|P3|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
8266922|NCT01753401|20384822|P2|STARTED|Double-blind Period (8 Weeks)||26
8266923|NCT01753401|20384823|P1|STARTED|Double-blind Period (8 Weeks)||12
8266924|NCT01753362|20384873|P2|NOT COMPLETED|Overall Study||8
8266925|NCT01753362|20384874|P1|NOT COMPLETED|Overall Study||10
8266926|NCT01753362|20384873|P2|COMPLETED|Overall Study||40
8266927|NCT01753362|20384874|P1|COMPLETED|Overall Study||26
8266928|NCT01753362|20384873|P2|STARTED|Overall Study||48
8266929|NCT01753362|20384874|P1|STARTED|Overall Study||36
8266930|NCT01753336|20384882|P1|NOT COMPLETED|Overall Study||20
8266931|NCT01753336|20384882|P1|COMPLETED|Overall Study||92
8266932|NCT01753336|20384882|P1|Cycle 3|Overall Study||93
8266933|NCT01753336|20384882|P1|Cycle 2|Overall Study||98
8266934|NCT01753336|20384882|P1|Cycle 1|Overall Study||112
8266935|NCT01753336|20384882|P1|STARTED|Overall Study||112
8266936|NCT01753323|20384894|P3|NOT COMPLETED|Overall Study||9
8266937|NCT01753323|20384895|P2|NOT COMPLETED|Overall Study||0
8266938|NCT01753323|20384896|P1|NOT COMPLETED|Overall Study||1
8266939|NCT01753323|20384894|P3|COMPLETED|Overall Study||13
8266940|NCT01753323|20384895|P2|COMPLETED|Overall Study||10
8266941|NCT01753323|20384896|P1|COMPLETED|Overall Study||10
8266942|NCT01753323|20384894|P3|Intent-to-treat Analysis Set|Overall Study||22
8266943|NCT01753323|20384895|P2|Intent-to-treat Analysis Set|Overall Study||10
8266944|NCT01753323|20384896|P1|Intent-to-treat Analysis Set|Overall Study||11
8266945|NCT01753323|20384894|P3|Safety Set|Overall Study||22
8266946|NCT01753323|20384895|P2|Safety Set|Overall Study||10
8266947|NCT01753323|20384896|P1|Safety Set|Overall Study||11
8266948|NCT01753323|20384894|P3|Pharmacokinetic(PK) Set|Overall Study||21
8266949|NCT01753323|20384895|P2|Pharmacokinetic(PK) Set|Overall Study||10
8266950|NCT01753323|20384896|P1|Pharmacokinetic(PK) Set|Overall Study||10
8266951|NCT01753323|20384894|P3|Pharmacodynamic (PD) Set|Overall Study||21
8266952|NCT01753323|20384895|P2|Pharmacodynamic (PD) Set|Overall Study||10
8266953|NCT01753323|20384896|P1|Pharmacodynamic (PD) Set|Overall Study||10
8266954|NCT01753323|20384894|P3|STARTED|Overall Study||22
8266955|NCT01753323|20384895|P2|STARTED|Overall Study||10
8266956|NCT01753323|20384896|P1|STARTED|Overall Study||11
8266957|NCT01753310|20384934|P2|NOT COMPLETED|Overall Study||24
8266958|NCT01753310|20384935|P1|NOT COMPLETED|Overall Study||32
8266959|NCT01753310|20384934|P2|COMPLETED|Overall Study||21
8266960|NCT01753310|20384935|P1|COMPLETED|Overall Study||57
8266961|NCT01753310|20384934|P2|STARTED|Overall Study||45
8266962|NCT01753310|20384935|P1|STARTED|Overall Study||89
8266963|NCT01753297|20384957|P2|NOT COMPLETED|Overall Study||36
8266964|NCT01753297|20384958|P1|NOT COMPLETED|Overall Study||41
8266965|NCT01753297|20384957|P2|COMPLETED|Overall Study||73
8266966|NCT01753297|20384958|P1|COMPLETED|Overall Study||76
8266967|NCT01753297|20384957|P2|Received Triptorelin Treatment|Overall Study||105
8266968|NCT01753297|20384958|P1|Received Triptorelin Treatment|Overall Study||0
8266969|NCT01753297|20384957|P2|STARTED|Overall Study||109
8266970|NCT01753297|20384958|P1|STARTED|Overall Study||117
8266971|NCT01753193|20384990|P1|NOT COMPLETED|Overall Study||46
8266972|NCT01753193|20384990|P1|COMPLETED|Overall Study||172
8266973|NCT01753193|20384990|P1|STARTED|Overall Study||218
8266974|NCT01753115|20385005|P3|NOT COMPLETED|Overall Study||14
8266975|NCT01753115|20385006|P2|NOT COMPLETED|Overall Study||15
8266976|NCT01753115|20385007|P1|NOT COMPLETED|Overall Study||12
8266977|NCT01753115|20385005|P3|COMPLETED|Overall Study||56
8266978|NCT01753115|20385006|P2|COMPLETED|Overall Study||25
8266979|NCT01753115|20385007|P1|COMPLETED|Overall Study||32
8266980|NCT01753115|20385005|P3|Treated|Overall Study||67
8266981|NCT01753115|20385006|P2|Treated|Overall Study||39
8266982|NCT01753115|20385007|P1|Treated|Overall Study||38
8266983|NCT01753115|20385005|P3|STARTED|Overall Study||70
8266984|NCT01753115|20385006|P2|STARTED|Overall Study||40
8266985|NCT01753115|20385007|P1|STARTED|Overall Study||44
8266986|NCT01753076|20385017|P2|NOT COMPLETED|Overall Study||46
8266987|NCT01753076|20385018|P1|NOT COMPLETED|Overall Study||41
8266988|NCT01753076|20385017|P2|COMPLETED|Overall Study||106
8266989|NCT01753076|20385018|P1|COMPLETED|Overall Study||110
8266990|NCT01753076|20385017|P2|STARTED|Overall Study||152
8266991|NCT01753076|20385018|P1|STARTED|Overall Study||151
8266992|NCT01752985|20385045|P3|NOT COMPLETED|Follow-up Period||0
8266993|NCT01752985|20385046|P2|NOT COMPLETED|Follow-up Period||0
8266994|NCT01752985|20385047|P1|NOT COMPLETED|Follow-up Period||0
8266995|NCT01752985|20385045|P3|COMPLETED|Follow-up Period||26
8266996|NCT01752985|20385046|P2|COMPLETED|Follow-up Period||27
8266997|NCT01752985|20385047|P1|COMPLETED|Follow-up Period||28
8266998|NCT01752985|20385045|P3|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
8266999|NCT01752985|20385046|P2|STARTED|Follow-up Period||27
8267000|NCT01752985|20385047|P1|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
8267001|NCT01752985|20385045|P3|NOT COMPLETED|Treatment Period||5
8267002|NCT01752985|20385046|P2|NOT COMPLETED|Treatment Period||3
8267003|NCT01752985|20385047|P1|NOT COMPLETED|Treatment Period||4
8267004|NCT01752985|20385045|P3|COMPLETED|Treatment Period||24
8267005|NCT01752985|20385046|P2|COMPLETED|Treatment Period||27
8267006|NCT01752985|20385047|P1|COMPLETED|Treatment Period||25
8267007|NCT01752985|20385045|P3|STARTED|Treatment Period||29
8267008|NCT01752985|20385046|P2|STARTED|Treatment Period||30
8267009|NCT01752985|20385047|P1|STARTED|Treatment Period||29
8267010|NCT01752933|20385075|P2|NOT COMPLETED|Overall Study and Follow-up||46
8267011|NCT01752933|20385076|P1|NOT COMPLETED|Overall Study and Follow-up||4
8267012|NCT01752933|20385075|P2|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
8267013|NCT01752933|20385076|P1|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
8267014|NCT01752933|20385075|P2|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
8267015|NCT01752933|20385076|P1|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
8267016|NCT01752933|20385075|P2|NOT COMPLETED|Treatment||46
8267017|NCT01752933|20385076|P1|NOT COMPLETED|Treatment||4
8267018|NCT01752933|20385075|P2|COMPLETED|Treatment|Completion not applicable for this survival study|0
8267019|NCT01752933|20385076|P1|COMPLETED|Treatment|Completion not applicable for this survival study|0
8267020|NCT01752933|20385075|P2|STARTED|Treatment|Includes all patients who received any treatment|46
8267021|NCT01752933|20385076|P1|STARTED|Treatment|Includes all patients who received any treatment|4
8267022|NCT01752907|20385094|P2|NOT COMPLETED|Overall Study||20
8267023|NCT01752907|20385095|P1|NOT COMPLETED|Overall Study||12
8267024|NCT01752907|20385094|P2|COMPLETED|Overall Study||133
8267025|NCT01752907|20385095|P1|COMPLETED|Overall Study||139
8267026|NCT01752907|20385094|P2|Received Pegfilgrastim|Overall Study||151
8267027|NCT01752907|20385095|P1|Received Pegfilgrastim|Overall Study||149
8267028|NCT01752907|20385094|P2|STARTED|Overall Study||153
8267029|NCT01752907|20385095|P1|STARTED|Overall Study||151
8267030|NCT01752855|20385115|P2|NOT COMPLETED|Overall Study||4
8267031|NCT01752855|20385116|P1|NOT COMPLETED|Overall Study||1
8267032|NCT01752855|20385115|P2|COMPLETED|Overall Study||40
8267033|NCT01752855|20385116|P1|COMPLETED|Overall Study||43
8267034|NCT01752855|20385115|P2|STARTED|Overall Study||44
8267035|NCT01752855|20385116|P1|STARTED|Overall Study||44
8267036|NCT01752842|20385132|P2|NOT COMPLETED|Overall Study||2
8267037|NCT01752842|20385133|P1|NOT COMPLETED|Overall Study||3
8267038|NCT01752842|20385132|P2|COMPLETED|Overall Study||34
8267039|NCT01752842|20385133|P1|COMPLETED|Overall Study||31
8267040|NCT01752842|20385132|P2|STARTED|Overall Study||36
8267041|NCT01752842|20385133|P1|STARTED|Overall Study||34
8267042|NCT01752712|20385145|P2|NOT COMPLETED|Overall Study||10
8267043|NCT01752712|20385146|P1|NOT COMPLETED|Overall Study||9
8267044|NCT01752712|20385145|P2|COMPLETED|Overall Study||21
8267045|NCT01752712|20385146|P1|COMPLETED|Overall Study||22
8267046|NCT01752712|20385145|P2|STARTED|Overall Study||31
8267047|NCT01752712|20385146|P1|STARTED|Overall Study||31
8267048|NCT01752634|20385168|P6|NOT COMPLETED|Week 24 to Week 260||0
8267049|NCT01752634|20385169|P5|NOT COMPLETED|Week 24 to Week 260||14
8267050|NCT01752634|20385170|P4|NOT COMPLETED|Week 24 to Week 260||14
8267051|NCT01752634|20385171|P3|NOT COMPLETED|Week 24 to Week 260||33
8267052|NCT01752634|20385172|P2|NOT COMPLETED|Week 24 to Week 260||30
8267053|NCT01752634|20385173|P1|NOT COMPLETED|Week 24 to Week 260||34
8267054|NCT01752634|20385168|P6|COMPLETED|Week 24 to Week 260||0
8267055|NCT01752634|20385169|P5|COMPLETED|Week 24 to Week 260||31
8267056|NCT01752634|20385170|P4|COMPLETED|Week 24 to Week 260||29
8267057|NCT01752634|20385171|P3|COMPLETED|Week 24 to Week 260||64
8267058|NCT01752634|20385172|P2|COMPLETED|Week 24 to Week 260||65
8267059|NCT01752634|20385173|P1|COMPLETED|Week 24 to Week 260||59
8267060|NCT01752634|20385168|P6|STARTED|Week 24 to Week 260||0
8267061|NCT01752634|20385169|P5|STARTED|Week 24 to Week 260||45
8267062|NCT01752634|20385170|P4|STARTED|Week 24 to Week 260||43
8267063|NCT01752634|20385171|P3|STARTED|Week 24 to Week 260||97
8267064|NCT01752634|20385172|P2|STARTED|Week 24 to Week 260||95
8267065|NCT01752634|20385173|P1|STARTED|Week 24 to Week 260||93
8267066|NCT01752634|20385168|P6|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
8267067|NCT01752634|20385169|P5|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
8267068|NCT01752634|20385170|P4|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
8267069|NCT01752634|20385171|P3|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
8267070|NCT01752634|20385172|P2|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
8267071|NCT01752634|20385173|P1|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
8267072|NCT01752634|20385168|P6|COMPLETED|Up to Week 24 (Primary Analysis)||0
8267073|NCT01752634|20385169|P5|COMPLETED|Up to Week 24 (Primary Analysis)||45
8267074|NCT01752634|20385170|P4|COMPLETED|Up to Week 24 (Primary Analysis)||43
8267075|NCT01752634|20385171|P3|COMPLETED|Up to Week 24 (Primary Analysis)||97
8267076|NCT01752634|20385172|P2|COMPLETED|Up to Week 24 (Primary Analysis)||95
8267077|NCT01752634|20385173|P1|COMPLETED|Up to Week 24 (Primary Analysis)||93
8267078|NCT01752634|20385168|P6|STARTED|Up to Week 24 (Primary Analysis)||10
8267079|NCT01752634|20385169|P5|STARTED|Up to Week 24 (Primary Analysis)||45
8267080|NCT01752634|20385170|P4|STARTED|Up to Week 24 (Primary Analysis)||43
8267081|NCT01752634|20385171|P3|STARTED|Up to Week 24 (Primary Analysis)||100
8267082|NCT01752634|20385172|P2|STARTED|Up to Week 24 (Primary Analysis)||100
8267083|NCT01752634|20385173|P1|STARTED|Up to Week 24 (Primary Analysis)||99
8267084|NCT01752426|20385215|P1|NOT COMPLETED|Overall Study||0
8267085|NCT01752426|20385215|P1|COMPLETED|Overall Study||30
8267086|NCT01752426|20385215|P1|STARTED|Overall Study||30
8267087|NCT01752400|20385220|P1|NOT COMPLETED|Overall Study||0
8267088|NCT01752400|20385220|P1|COMPLETED|Overall Study||6
8267089|NCT01752400|20385220|P1|STARTED|Overall Study||6
8267090|NCT01752036|20385231|P1|NOT COMPLETED|Overall Study||2
8267091|NCT01752036|20385231|P1|COMPLETED|Overall Study||31
8267092|NCT01752036|20385231|P1|STARTED|Overall Study||33
8267093|NCT01752023|20385244|P2|NOT COMPLETED|Overall Study||1
8267094|NCT01752023|20385245|P1|NOT COMPLETED|Overall Study||2
8267095|NCT01752023|20385244|P2|COMPLETED|Overall Study||0
8267096|NCT01752023|20385245|P1|COMPLETED|Overall Study||0
8267097|NCT01752023|20385244|P2|STARTED|Overall Study||1
8267098|NCT01752023|20385245|P1|STARTED|Overall Study||2
8267099|NCT01751971|20385263|P2|NOT COMPLETED|Overall Study||1
8267100|NCT01751971|20385264|P1|NOT COMPLETED|Overall Study||2
8267101|NCT01751971|20385263|P2|COMPLETED|Overall Study||24
8267102|NCT01751971|20385264|P1|COMPLETED|Overall Study||20
8267103|NCT01751971|20385263|P2|STARTED|Overall Study||25
8267104|NCT01751971|20385264|P1|STARTED|Overall Study||22
8267111|NCT01751867|20385392|P2|NOT COMPLETED|Overall Study||99
8267112|NCT01751867|20385393|P1|NOT COMPLETED|Overall Study||36
8267113|NCT01751867|20385392|P2|COMPLETED|Overall Study||0
8267114|NCT01751867|20385393|P1|COMPLETED|Overall Study||0
8267115|NCT01751867|20385392|P2|Treated|Overall Study||98
8267116|NCT01751867|20385393|P1|Treated|Overall Study||34
8267117|NCT01751867|20385392|P2|STARTED|Overall Study||99
8267118|NCT01751867|20385393|P1|STARTED|Overall Study||36
8267119|NCT01751802|20385413|P2|NOT COMPLETED|Overall Study||2
8267120|NCT01751802|20385414|P1|NOT COMPLETED|Overall Study||4
8267121|NCT01751802|20385413|P2|COMPLETED|Overall Study||2
8267122|NCT01751802|20385414|P1|COMPLETED|Overall Study||1
8267123|NCT01751802|20385413|P2|Completed Period 3|Overall Study||1
8267124|NCT01751802|20385414|P1|Completed Period 3|Overall Study||2
8267125|NCT01751802|20385413|P2|Completed Period 2|Overall Study||1
8267126|NCT01751802|20385414|P1|Completed Period 2|Overall Study||2
8267127|NCT01751802|20385413|P2|Completed Period 1|Overall Study||4
8267128|NCT01751802|20385414|P1|Completed Period 1|Overall Study||2
8267129|NCT01751802|20385413|P2|STARTED|Overall Study||4
8267130|NCT01751802|20385414|P1|STARTED|Overall Study||5
8267131|NCT01751724|20385428|P2|NOT COMPLETED|Overall Study||2
8267132|NCT01751724|20385429|P1|NOT COMPLETED|Overall Study||1
8267133|NCT01751724|20385428|P2|COMPLETED|Overall Study||42
8267134|NCT01751724|20385429|P1|COMPLETED|Overall Study||41
8267135|NCT01751724|20385428|P2|STARTED|Overall Study||44
8267136|NCT01751724|20385429|P1|STARTED|Overall Study||42
8267137|NCT01751646|20385457|P2|NOT COMPLETED|Overall Study||18
8267138|NCT01751646|20385458|P1|NOT COMPLETED|Overall Study||11
8267139|NCT01751646|20385457|P2|COMPLETED|Overall Study||87
8267140|NCT01751646|20385458|P1|COMPLETED|Overall Study||98
8267141|NCT01751646|20385457|P2|STARTED|Overall Study||105
8267142|NCT01751646|20385458|P1|STARTED|Overall Study||109
8267143|NCT01751568|20385609|P3|NOT COMPLETED|Overall Study||0
8267144|NCT01751568|20385610|P2|NOT COMPLETED|Overall Study||0
8267145|NCT01751568|20385611|P1|NOT COMPLETED|Overall Study||1
8267146|NCT01751568|20385609|P3|COMPLETED|Overall Study||13
8267147|NCT01751568|20385610|P2|COMPLETED|Overall Study||14
8267148|NCT01751568|20385611|P1|COMPLETED|Overall Study||12
8267149|NCT01751568|20385609|P3|STARTED|Overall Study||13
8267150|NCT01751568|20385610|P2|STARTED|Overall Study||14
8267151|NCT01751568|20385611|P1|STARTED|Overall Study||13
8267152|NCT01751412|20385640|P1|NOT COMPLETED|Overall Study||1
8267153|NCT01751412|20385640|P1|COMPLETED|Overall Study||11
8267154|NCT01751412|20385640|P1|STARTED|Overall Study||12
8267155|NCT01751399|20385654|P4|NOT COMPLETED|Overall Study||0
8267156|NCT01751399|20385655|P3|NOT COMPLETED|Overall Study||0
8267157|NCT01751399|20385656|P2|NOT COMPLETED|Overall Study||0
8267158|NCT01751399|20385657|P1|NOT COMPLETED|Overall Study||0
8267159|NCT01751399|20385654|P4|COMPLETED|Overall Study||7
8267160|NCT01751399|20385655|P3|COMPLETED|Overall Study||8
8267161|NCT01751399|20385656|P2|COMPLETED|Overall Study||8
8267162|NCT01751399|20385657|P1|COMPLETED|Overall Study||12
8267163|NCT01751399|20385654|P4|Received 1 Dose of Study Drug|Overall Study||7
8267164|NCT01751399|20385655|P3|Received 1 Dose of Study Drug|Overall Study||8
8267165|NCT01751399|20385656|P2|Received 1 Dose of Study Drug|Overall Study||8
8267166|NCT01751399|20385657|P1|Received 1 Dose of Study Drug|Overall Study||12
8267167|NCT01751399|20385654|P4|STARTED|Overall Study||7
8267168|NCT01751399|20385655|P3|STARTED|Overall Study||8
8267169|NCT01751399|20385656|P2|STARTED|Overall Study||8
8267170|NCT01751399|20385657|P1|STARTED|Overall Study||12
8267171|NCT01751386|20385673|P2|NOT COMPLETED|Overall Study||3
8267172|NCT01751386|20385674|P1|NOT COMPLETED|Overall Study||2
8267173|NCT01751386|20385673|P2|COMPLETED|Overall Study||16
8267174|NCT01751386|20385674|P1|COMPLETED|Overall Study||18
8267175|NCT01751386|20385673|P2|STARTED|Overall Study||19
8267176|NCT01751386|20385674|P1|STARTED|Overall Study||20
8267177|NCT01751308|20385685|P5|NOT COMPLETED|Phase 2||0
8267178|NCT01751308|20385686|P4|NOT COMPLETED|Phase 2||0
8267179|NCT01751308|20385687|P3|NOT COMPLETED|Phase 2||0
8267180|NCT01751308|20385688|P2|NOT COMPLETED|Phase 2||0
8267181|NCT01751308|20385689|P1|NOT COMPLETED|Phase 2||0
8267182|NCT01751308|20385685|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
8267183|NCT01751308|20385686|P4|COMPLETED|Phase 2||0
8267184|NCT01751308|20385687|P3|COMPLETED|Phase 2||0
8267185|NCT01751308|20385688|P2|COMPLETED|Phase 2||0
8267186|NCT01751308|20385689|P1|COMPLETED|Phase 2||0
8267187|NCT01751308|20385685|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
8267188|NCT01751308|20385686|P4|STARTED|Phase 2||0
8267189|NCT01751308|20385687|P3|STARTED|Phase 2||0
8267190|NCT01751308|20385688|P2|STARTED|Phase 2||0
8267191|NCT01751308|20385689|P1|STARTED|Phase 2||0
8267192|NCT01751308|20385685|P5|NOT COMPLETED|Phase 1||0
8267193|NCT01751308|20385686|P4|NOT COMPLETED|Phase 1||0
8267194|NCT01751308|20385687|P3|NOT COMPLETED|Phase 1||0
8267195|NCT01751308|20385688|P2|NOT COMPLETED|Phase 1||0
8267196|NCT01751308|20385689|P1|NOT COMPLETED|Phase 1||0
8267197|NCT01751308|20385685|P5|COMPLETED|Phase 1||0
8267198|NCT01751308|20385686|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
8267199|NCT01751308|20385687|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
8267200|NCT01751308|20385688|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
8267201|NCT01751308|20385689|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
8267202|NCT01751308|20385685|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
8267203|NCT01751308|20385686|P4|STARTED|Phase 1||7
8267204|NCT01751308|20385687|P3|STARTED|Phase 1||7
8267205|NCT01751308|20385688|P2|STARTED|Phase 1||3
8267206|NCT01751308|20385689|P1|STARTED|Phase 1||6
8267207|NCT01751230|20385728|P2|NOT COMPLETED|Overall Study||4
8267208|NCT01751230|20385729|P1|NOT COMPLETED|Overall Study||1
8267209|NCT01751230|20385728|P2|COMPLETED|Overall Study||16
8267210|NCT01751230|20385729|P1|COMPLETED|Overall Study||19
8267211|NCT01751230|20385728|P2|STARTED|Overall Study||20
8267212|NCT01751230|20385729|P1|STARTED|Overall Study||20
8267213|NCT01751178|20385750|P3|NOT COMPLETED|Overall Study||2
8267214|NCT01751178|20385751|P2|NOT COMPLETED|Overall Study||0
8267215|NCT01751178|20385752|P1|NOT COMPLETED|Overall Study||3
8267216|NCT01751178|20385750|P3|COMPLETED|Overall Study||105
8267217|NCT01751178|20385751|P2|COMPLETED|Overall Study||109
8267218|NCT01751178|20385752|P1|COMPLETED|Overall Study||105
8267219|NCT01751178|20385750|P3|STARTED|Overall Study||107
8267220|NCT01751178|20385751|P2|STARTED|Overall Study||109
8267221|NCT01751178|20385752|P1|STARTED|Overall Study||108
8267222|NCT01751165|20385772|P3|NOT COMPLETED|Overall Study||3
8267223|NCT01751165|20385773|P2|NOT COMPLETED|Overall Study||3
8267224|NCT01751165|20385774|P1|NOT COMPLETED|Overall Study||2
8267225|NCT01751165|20385772|P3|COMPLETED|Overall Study||113
8267226|NCT01751165|20385773|P2|COMPLETED|Overall Study||116
8267227|NCT01751165|20385774|P1|COMPLETED|Overall Study||117
8267228|NCT01751165|20385772|P3|STARTED|Overall Study||116
8267229|NCT01751165|20385773|P2|STARTED|Overall Study||119
8267230|NCT01751165|20385774|P1|STARTED|Overall Study||119
8267231|NCT01751139|20385814|P1|NOT COMPLETED|Overall Study||2267
8267232|NCT01751139|20385814|P1|COMPLETED|Overall Study||1033
8267233|NCT01751139|20385814|P1|STARTED|Overall Study||3300
8267234|NCT01751113|20385832|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
8267235|NCT01751113|20385833|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267236|NCT01751113|20385834|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267237|NCT01751113|20385835|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267238|NCT01751113|20385836|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267239|NCT01751113|20385837|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267240|NCT01751113|20385832|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
8267241|NCT01751113|20385833|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267242|NCT01751113|20385834|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267243|NCT01751113|20385835|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
8267244|NCT01751113|20385836|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267245|NCT01751113|20385837|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267246|NCT01751113|20385832|P6|STARTED|Treatment Period 3 (4 Weeks)||10
8267247|NCT01751113|20385833|P5|STARTED|Treatment Period 3 (4 Weeks)||8
8267248|NCT01751113|20385834|P4|STARTED|Treatment Period 3 (4 Weeks)||8
8267249|NCT01751113|20385835|P3|STARTED|Treatment Period 3 (4 Weeks)||9
8267250|NCT01751113|20385836|P2|STARTED|Treatment Period 3 (4 Weeks)||8
8267251|NCT01751113|20385837|P1|STARTED|Treatment Period 3 (4 Weeks)||8
8267252|NCT01751113|20385832|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267253|NCT01751113|20385833|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267254|NCT01751113|20385834|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267255|NCT01751113|20385835|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267256|NCT01751113|20385836|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267257|NCT01751113|20385837|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267258|NCT01751113|20385832|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
8267259|NCT01751113|20385833|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
8267260|NCT01751113|20385834|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
8267261|NCT01751113|20385835|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
8267262|NCT01751113|20385836|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
8267263|NCT01751113|20385837|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
8267264|NCT01751113|20385832|P6|STARTED|Washout Period 2 (2 Weeks)||10
8267265|NCT01751113|20385833|P5|STARTED|Washout Period 2 (2 Weeks)||8
8267266|NCT01751113|20385834|P4|STARTED|Washout Period 2 (2 Weeks)||8
8267267|NCT01751113|20385835|P3|STARTED|Washout Period 2 (2 Weeks)||9
8267268|NCT01751113|20385836|P2|STARTED|Washout Period 2 (2 Weeks)||8
8267269|NCT01751113|20385837|P1|STARTED|Washout Period 2 (2 Weeks)||8
8267270|NCT01751113|20385832|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267271|NCT01751113|20385833|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267272|NCT01751113|20385834|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267273|NCT01751113|20385835|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267274|NCT01751113|20385836|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267275|NCT01751113|20385837|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267276|NCT01751113|20385832|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
8267277|NCT01751113|20385833|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267278|NCT01751113|20385834|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267279|NCT01751113|20385835|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
8267280|NCT01751113|20385836|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267281|NCT01751113|20385837|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267282|NCT01751113|20385832|P6|STARTED|Treatment Period 2 (4 Weeks)||10
8267283|NCT01751113|20385833|P5|STARTED|Treatment Period 2 (4 Weeks)||8
8267284|NCT01751113|20385834|P4|STARTED|Treatment Period 2 (4 Weeks)||8
8267285|NCT01751113|20385835|P3|STARTED|Treatment Period 2 (4 Weeks)||9
8267286|NCT01751113|20385836|P2|STARTED|Treatment Period 2 (4 Weeks)||8
8267287|NCT01751113|20385837|P1|STARTED|Treatment Period 2 (4 Weeks)||8
8267288|NCT01751113|20385832|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267289|NCT01751113|20385833|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267290|NCT01751113|20385834|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267291|NCT01751113|20385835|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267292|NCT01751113|20385836|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267293|NCT01751113|20385837|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267294|NCT01751113|20385832|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
8267295|NCT01751113|20385833|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
8267296|NCT01751113|20385834|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
8267297|NCT01751113|20385835|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
8267298|NCT01751113|20385836|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
8267299|NCT01751113|20385837|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
8267300|NCT01751113|20385832|P6|STARTED|Washout Period 1 (2 Weeks)||10
8267301|NCT01751113|20385833|P5|STARTED|Washout Period 1 (2 Weeks)||8
8267302|NCT01751113|20385834|P4|STARTED|Washout Period 1 (2 Weeks)||8
8267303|NCT01751113|20385835|P3|STARTED|Washout Period 1 (2 Weeks)||9
8267304|NCT01751113|20385836|P2|STARTED|Washout Period 1 (2 Weeks)||8
8267305|NCT01751113|20385837|P1|STARTED|Washout Period 1 (2 Weeks)||8
8267306|NCT01751113|20385832|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267307|NCT01751113|20385833|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8267308|NCT01751113|20385834|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8267309|NCT01751113|20385835|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267310|NCT01751113|20385836|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267311|NCT01751113|20385837|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267312|NCT01751113|20385832|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
8267313|NCT01751113|20385833|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267314|NCT01751113|20385834|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267315|NCT01751113|20385835|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
8267316|NCT01751113|20385836|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267317|NCT01751113|20385837|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267318|NCT01751113|20385832|P6|STARTED|Treatment Period 1 (4 Weeks)||10
8267319|NCT01751113|20385833|P5|STARTED|Treatment Period 1 (4 Weeks)||9
8267320|NCT01751113|20385834|P4|STARTED|Treatment Period 1 (4 Weeks)||9
8267321|NCT01751113|20385835|P3|STARTED|Treatment Period 1 (4 Weeks)||9
8267322|NCT01751113|20385836|P2|STARTED|Treatment Period 1 (4 Weeks)||8
8267323|NCT01751113|20385837|P1|STARTED|Treatment Period 1 (4 Weeks)||8
8267324|NCT01751087|20385878|P3|NOT COMPLETED|Overall Study||1
8267325|NCT01751087|20385879|P2|NOT COMPLETED|Overall Study||0
8267326|NCT01751087|20385880|P1|NOT COMPLETED|Overall Study||1
8267327|NCT01751087|20385878|P3|COMPLETED|Overall Study||99
8267328|NCT01751087|20385879|P2|COMPLETED|Overall Study||100
8267329|NCT01751087|20385880|P1|COMPLETED|Overall Study||99
8267330|NCT01751087|20385878|P3|STARTED|Overall Study||100
8267331|NCT01751087|20385879|P2|STARTED|Overall Study||100
8267332|NCT01751087|20385880|P1|STARTED|Overall Study||100
8267333|NCT01751061|20385914|P2|NOT COMPLETED|Overall Study||34
8267334|NCT01751061|20385915|P1|NOT COMPLETED|Overall Study||56
8267335|NCT01751061|20385914|P2|COMPLETED|Overall Study||172
8267336|NCT01751061|20385915|P1|COMPLETED|Overall Study||154
8267337|NCT01751061|20385914|P2|STARTED|Overall Study||206
8267338|NCT01751061|20385915|P1|STARTED|Overall Study||210
8267339|NCT01751022|20385936|P3|NOT COMPLETED|Overall Study||27
8267340|NCT01751022|20385937|P2|NOT COMPLETED|Overall Study||44
8267341|NCT01751022|20385938|P1|NOT COMPLETED|Overall Study||56
8267342|NCT01751022|20385936|P3|COMPLETED|Overall Study|6 month visit|273
8267343|NCT01751022|20385937|P2|COMPLETED|Overall Study|6 month visit|282
8267344|NCT01751022|20385938|P1|COMPLETED|Overall Study|6 month visit|443
8267345|NCT01751022|20385936|P3|STARTED|Overall Study||300
8267346|NCT01751022|20385937|P2|STARTED|Overall Study||326
8267347|NCT01751022|20385938|P1|STARTED|Overall Study||499
8267348|NCT01750931|20385970|P2|NOT COMPLETED|Period 2||0
8267349|NCT01750931|20385971|P1|NOT COMPLETED|Period 2||0
8267350|NCT01750931|20385970|P2|COMPLETED|Period 2||14
8267351|NCT01750931|20385971|P1|COMPLETED|Period 2||14
8267352|NCT01750931|20385970|P2|STARTED|Period 2||14
8267353|NCT01750931|20385971|P1|STARTED|Period 2||14
8267354|NCT01750931|20385970|P2|NOT COMPLETED|Wash Out||0
8267355|NCT01750931|20385971|P1|NOT COMPLETED|Wash Out||0
8267356|NCT01750931|20385970|P2|COMPLETED|Wash Out||14
8267357|NCT01750931|20385971|P1|COMPLETED|Wash Out||14
8267358|NCT01750931|20385970|P2|STARTED|Wash Out||14
8267359|NCT01750931|20385971|P1|STARTED|Wash Out||14
8267360|NCT01750931|20385970|P2|NOT COMPLETED|Period 1||0
8267361|NCT01750931|20385971|P1|NOT COMPLETED|Period 1||0
8267362|NCT01750931|20385970|P2|COMPLETED|Period 1||14
8267363|NCT01750931|20385971|P1|COMPLETED|Period 1||14
8267364|NCT01750931|20385970|P2|STARTED|Period 1||14
8267365|NCT01750931|20385971|P1|STARTED|Period 1||14
8267366|NCT01750840|20385989|P1|NOT COMPLETED|Overall Study||4
8267367|NCT01750840|20385989|P1|COMPLETED|Overall Study||4
8267368|NCT01750840|20385989|P1|STARTED|Overall Study||8
8267369|NCT01750697|20385994|P1|NOT COMPLETED|Overall Study||9
8267370|NCT01750697|20385994|P1|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
8267371|NCT01750697|20385994|P1|Follow-up Phase|Overall Study|Completed required follow-up|24
8267372|NCT01750697|20385994|P1|Completed|Overall Study||25
8267373|NCT01750697|20385994|P1|STARTED|Overall Study||25
8267374|NCT01750684|20386006|P2|NOT COMPLETED|Overall Study||2
8267375|NCT01750684|20386007|P1|NOT COMPLETED|Overall Study||2
8267376|NCT01750684|20386006|P2|COMPLETED|Overall Study||5
8267377|NCT01750684|20386007|P1|COMPLETED|Overall Study||4
8267378|NCT01750684|20386006|P2|STARTED|Overall Study||7
8267379|NCT01750684|20386007|P1|STARTED|Overall Study||6
8267380|NCT01750502|20386017|P2|NOT COMPLETED|Overall Study||0
8267381|NCT01750502|20386018|P1|NOT COMPLETED|Overall Study||0
8267382|NCT01750502|20386017|P2|COMPLETED|Overall Study||186
8267383|NCT01750502|20386018|P1|COMPLETED|Overall Study||70
8267384|NCT01750502|20386017|P2|STARTED|Overall Study||186
8267385|NCT01750502|20386018|P1|STARTED|Overall Study||70
8267386|NCT01750398|20386031|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
8267387|NCT01750398|20386031|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
8267388|NCT01750398|20386031|P1|STARTED|Bipolar Androgen Thearpy Phase||29
8267389|NCT01750398|20386031|P1|NOT COMPLETED|ADT Lead In Phase||4
8267390|NCT01750398|20386031|P1|COMPLETED|ADT Lead In Phase||29
8267391|NCT01750398|20386031|P1|STARTED|ADT Lead In Phase||33
8267392|NCT01750346|20386044|P3|NOT COMPLETED|Overall Study||0
8267393|NCT01750346|20386045|P2|NOT COMPLETED|Overall Study||0
8267394|NCT01750346|20386046|P1|NOT COMPLETED|Overall Study||1
8267395|NCT01750346|20386044|P3|COMPLETED|Overall Study||3
8267396|NCT01750346|20386045|P2|COMPLETED|Overall Study||2
8267397|NCT01750346|20386046|P1|COMPLETED|Overall Study||2
8267398|NCT01750346|20386044|P3|STARTED|Overall Study||3
8267399|NCT01750346|20386045|P2|STARTED|Overall Study||2
8267400|NCT01750346|20386046|P1|STARTED|Overall Study||3
8267401|NCT01750294|20386072|P1|NOT COMPLETED|Overall Study||2
8267402|NCT01750294|20386072|P1|COMPLETED|Overall Study||12
8267403|NCT01750294|20386072|P1|STARTED|Overall Study||14
8267404|NCT01750281|20386079|P3|NOT COMPLETED|Overall Study||84
8267405|NCT01750281|20386080|P2|NOT COMPLETED|Overall Study||85
8267406|NCT01750281|20386081|P1|NOT COMPLETED|Overall Study||43
8267407|NCT01750281|20386079|P3|COMPLETED|Overall Study||0
8267408|NCT01750281|20386080|P2|COMPLETED|Overall Study||0
8267409|NCT01750281|20386081|P1|COMPLETED|Overall Study||0
8267410|NCT01750281|20386079|P3|Did Not Receive Treatment|Overall Study||0
8267411|NCT01750281|20386080|P2|Did Not Receive Treatment|Overall Study||1
8267412|NCT01750281|20386081|P1|Did Not Receive Treatment|Overall Study||0
8267413|NCT01750281|20386079|P3|Received Treatment|Overall Study||84
8267414|NCT01750281|20386080|P2|Received Treatment|Overall Study||84
8267415|NCT01750281|20386081|P1|Received Treatment|Overall Study||43
8267416|NCT01750281|20386079|P3|STARTED|Overall Study||84
8267417|NCT01750281|20386080|P2|STARTED|Overall Study||85
8267418|NCT01750281|20386081|P1|STARTED|Overall Study||43
8267419|NCT01750268|20386094|P2|NOT COMPLETED|Overall Study||5
8267420|NCT01750268|20386095|P1|NOT COMPLETED|Overall Study||2
8267421|NCT01750268|20386094|P2|COMPLETED|Overall Study||12
8267422|NCT01750268|20386095|P1|COMPLETED|Overall Study||13
8267423|NCT01750268|20386094|P2|STARTED|Overall Study||17
8267424|NCT01750268|20386095|P1|STARTED|Overall Study||15
8267425|NCT01750255|20386105|P2|NOT COMPLETED|Overall Study||5
8267426|NCT01750255|20386106|P1|NOT COMPLETED|Overall Study||6
8267427|NCT01750255|20386105|P2|COMPLETED|Overall Study||38
8267428|NCT01750255|20386106|P1|COMPLETED|Overall Study||43
8267429|NCT01750255|20386105|P2|STARTED|Overall Study||43
8267430|NCT01750255|20386106|P1|STARTED|Overall Study||49
8267431|NCT01750242|20386122|P1|NOT COMPLETED|Overall Study||3
8267432|NCT01750242|20386122|P1|COMPLETED|Overall Study||20
8267433|NCT01750242|20386122|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
8267434|NCT01750242|20386122|P1|STARTED|Overall Study||23
8267435|NCT01750229|20386127|P1|NOT COMPLETED|Long-term Follow-up Phase||3
8267436|NCT01750229|20386127|P1|COMPLETED|Long-term Follow-up Phase||25
8267437|NCT01750229|20386127|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
8267438|NCT01750229|20386127|P1|NOT COMPLETED|Randomized Crossover Phase||2
8267439|NCT01750229|20386127|P1|COMPLETED|Randomized Crossover Phase||28
8267440|NCT01750229|20386127|P1|Protocol Violation|Randomized Crossover Phase||4
8267441|NCT01750229|20386127|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
8267442|NCT01750229|20386127|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
8267443|NCT01750229|20386127|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
8267444|NCT01750229|20386127|P1|Subject Received Sham|Randomized Crossover Phase||24
8267445|NCT01750229|20386127|P1|STARTED|Randomized Crossover Phase||30
8267446|NCT01750086|20386139|P2|NOT COMPLETED|Overall Study||1
8267447|NCT01750086|20386140|P1|NOT COMPLETED|Overall Study||1
8267448|NCT01750086|20386139|P2|COMPLETED|Overall Study||13
8267449|NCT01750086|20386140|P1|COMPLETED|Overall Study||12
8267450|NCT01750086|20386139|P2|STARTED|Overall Study||14
8267451|NCT01750086|20386140|P1|STARTED|Overall Study||13
8267452|NCT01749995|20386146|P1|NOT COMPLETED|Overall Study||4
8267453|NCT01749995|20386146|P1|COMPLETED|Overall Study||196
8267454|NCT01749995|20386146|P1|STARTED|Overall Study||200
8267455|NCT01749982|20386154|P4|NOT COMPLETED|Overall Study||3
8267456|NCT01749982|20386155|P3|NOT COMPLETED|Overall Study||0
8267457|NCT01749982|20386156|P2|NOT COMPLETED|Overall Study||0
8267458|NCT01749982|20386157|P1|NOT COMPLETED|Overall Study||0
8267459|NCT01749982|20386154|P4|COMPLETED|Overall Study||12
8267460|NCT01749982|20386155|P3|COMPLETED|Overall Study||15
8267461|NCT01749982|20386156|P2|COMPLETED|Overall Study||15
8267462|NCT01749982|20386157|P1|COMPLETED|Overall Study||15
8267463|NCT01749982|20386154|P4|STARTED|Overall Study||15
8267464|NCT01749982|20386155|P3|STARTED|Overall Study||15
8267465|NCT01749982|20386156|P2|STARTED|Overall Study||15
8267466|NCT01749982|20386157|P1|STARTED|Overall Study||15
8267467|NCT01749956|20386175|P1|NOT COMPLETED|Overall Study||15
8267468|NCT01749956|20386175|P1|COMPLETED|Overall Study||24
8267469|NCT01749956|20386175|P1|STARTED|Overall Study||39
8267470|NCT01749930|20386187|P2|NOT COMPLETED|Overall Study||12
8267471|NCT01749930|20386188|P1|NOT COMPLETED|Overall Study||30
8267472|NCT01749930|20386187|P2|COMPLETED|Overall Study|randomized population|125
8267473|NCT01749930|20386188|P1|COMPLETED|Overall Study|randomized population|253
8267474|NCT01749930|20386187|P2|STARTED|Overall Study|randomized population|137
8267475|NCT01749930|20386188|P1|STARTED|Overall Study|randomized population|283
8267476|NCT01749904|20386204|P2|NOT COMPLETED|Overall Study||11
8267477|NCT01749904|20386205|P1|NOT COMPLETED|Overall Study||22
8267478|NCT01749904|20386204|P2|COMPLETED|Overall Study|randomized population|123
8267479|NCT01749904|20386205|P1|COMPLETED|Overall Study|randomized population|264
8267480|NCT01749904|20386204|P2|STARTED|Overall Study|randomized population|134
8267481|NCT01749904|20386205|P1|STARTED|Overall Study|randomized population|286
8267482|NCT01749826|20386221|P2|NOT COMPLETED|Overall Study||0
8267483|NCT01749826|20386222|P1|NOT COMPLETED|Overall Study||20
8267484|NCT01749826|20386221|P2|COMPLETED|Overall Study||0
8267485|NCT01749826|20386222|P1|COMPLETED|Overall Study||0
8267486|NCT01749826|20386221|P2|STARTED|Overall Study||0
8267487|NCT01749826|20386222|P1|STARTED|Overall Study||20
8267488|NCT01749800|20386237|P3|NOT COMPLETED|Overall Study||0
8267489|NCT01749800|20386238|P2|NOT COMPLETED|Overall Study||1
8267490|NCT01749800|20386239|P1|NOT COMPLETED|Overall Study||3
8267491|NCT01749800|20386237|P3|COMPLETED|Overall Study||0
8267492|NCT01749800|20386238|P2|COMPLETED|Overall Study||0
8267493|NCT01749800|20386239|P1|COMPLETED|Overall Study||3
8267494|NCT01749800|20386237|P3|STARTED|Overall Study||0
8267495|NCT01749800|20386238|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
8267496|NCT01749800|20386239|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
8267497|NCT01749735|20386249|P2|NOT COMPLETED|Overall Study||0
8267498|NCT01749735|20386250|P1|NOT COMPLETED|Overall Study||1
8267499|NCT01749735|20386249|P2|COMPLETED|Overall Study||0
8267500|NCT01749735|20386250|P1|COMPLETED|Overall Study||1
8267501|NCT01749735|20386249|P2|STARTED|Overall Study||0
8267502|NCT01749735|20386250|P1|STARTED|Overall Study||2
8267503|NCT01749631|20386258|P1|NOT COMPLETED|Overall Study||0
8267504|NCT01749631|20386258|P1|COMPLETED|Overall Study||97
8267505|NCT01749631|20386258|P1|STARTED|Overall Study||97
8267506|NCT01749605|20386270|P2|NOT COMPLETED|Overall Study||3
8267507|NCT01749605|20386271|P1|NOT COMPLETED|Overall Study||4
8267508|NCT01749605|20386270|P2|COMPLETED|Overall Study||14
8267509|NCT01749605|20386271|P1|COMPLETED|Overall Study||14
8267510|NCT01749605|20386270|P2|STARTED|Overall Study||17
8267511|NCT01749605|20386271|P1|STARTED|Overall Study||18
8267512|NCT01749501|20386279|P2|NOT COMPLETED|Overall Study||0
8267513|NCT01749501|20386280|P1|NOT COMPLETED|Overall Study||0
8267514|NCT01749501|20386279|P2|COMPLETED|Overall Study||23
8267515|NCT01749501|20386280|P1|COMPLETED|Overall Study||22
8267516|NCT01749501|20386279|P2|STARTED|Overall Study||23
8267517|NCT01749501|20386280|P1|STARTED|Overall Study||22
8267518|NCT01749410|20386288|P1|NOT COMPLETED|Overall Study||0
8267519|NCT01749410|20386288|P1|COMPLETED|Overall Study||33
8267520|NCT01749410|20386288|P1|STARTED|Overall Study||33
8267521|NCT01749293|20386292|P1|NOT COMPLETED|Overall Study||0
8267522|NCT01749293|20386292|P1|COMPLETED|Overall Study||3
8267523|NCT01749293|20386292|P1|STARTED|Overall Study||3
8267524|NCT01749033|20386301|P3|NOT COMPLETED|Overall Study||1
8267525|NCT01749033|20386302|P2|NOT COMPLETED|Overall Study||5
8267526|NCT01749033|20386303|P1|NOT COMPLETED|Overall Study||3
8267527|NCT01749033|20386301|P3|COMPLETED|Overall Study||149
8267528|NCT01749033|20386302|P2|COMPLETED|Overall Study||145
8267529|NCT01749033|20386303|P1|COMPLETED|Overall Study||147
8267530|NCT01749033|20386301|P3|STARTED|Overall Study||150
8267531|NCT01749033|20386302|P2|STARTED|Overall Study||150
8267532|NCT01749033|20386303|P1|STARTED|Overall Study||150
8267533|NCT01748955|20386328|P2|NOT COMPLETED|Overall Study||5
8267534|NCT01748955|20386329|P1|NOT COMPLETED|Overall Study||3
8267535|NCT01748955|20386328|P2|COMPLETED|Overall Study||4
8267536|NCT01748955|20386329|P1|COMPLETED|Overall Study||3
8267537|NCT01748955|20386328|P2|STARTED|Overall Study||9
8267538|NCT01748955|20386329|P1|STARTED|Overall Study||6
8267539|NCT01748942|20386339|P2|NOT COMPLETED|Overall Study||4
8267540|NCT01748942|20386340|P1|NOT COMPLETED|Overall Study||4
8267541|NCT01748942|20386339|P2|COMPLETED|Overall Study||33
8267542|NCT01748942|20386340|P1|COMPLETED|Overall Study||35
8267543|NCT01748942|20386339|P2|STARTED|Overall Study||37
8267544|NCT01748942|20386340|P1|STARTED|Overall Study||39
8267545|NCT01748916|20386360|P6|NOT COMPLETED|Overall Study||0
8267546|NCT01748916|20386361|P5|NOT COMPLETED|Overall Study||0
8267547|NCT01748916|20386362|P4|NOT COMPLETED|Overall Study||0
8267548|NCT01748916|20386363|P3|NOT COMPLETED|Overall Study||0
8267549|NCT01748916|20386364|P2|NOT COMPLETED|Overall Study||0
8267550|NCT01748916|20386365|P1|NOT COMPLETED|Overall Study||0
8267551|NCT01748916|20386360|P6|COMPLETED|Overall Study||3
8267552|NCT01748916|20386361|P5|COMPLETED|Overall Study||3
8267553|NCT01748916|20386362|P4|COMPLETED|Overall Study||3
8267554|NCT01748916|20386363|P3|COMPLETED|Overall Study||2
8267555|NCT01748916|20386364|P2|COMPLETED|Overall Study||3
8267556|NCT01748916|20386365|P1|COMPLETED|Overall Study||2
8267557|NCT01748916|20386360|P6|STARTED|Overall Study||3
8267558|NCT01748916|20386361|P5|STARTED|Overall Study||3
8267559|NCT01748916|20386362|P4|STARTED|Overall Study||3
8267560|NCT01748916|20386363|P3|STARTED|Overall Study||2
8267561|NCT01748916|20386364|P2|STARTED|Overall Study||3
8267562|NCT01748916|20386365|P1|STARTED|Overall Study||2
8267563|NCT01748890|20386373|P1|NOT COMPLETED|Overall Study||4
8267564|NCT01748890|20386373|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
8267565|NCT01748890|20386373|P1|STARTED|Overall Study||4
8267566|NCT01748799|20386385|P8|NOT COMPLETED|Overall Study||0
8267567|NCT01748799|20386386|P7|NOT COMPLETED|Overall Study||1
8267568|NCT01748799|20386387|P6|NOT COMPLETED|Overall Study||1
8267569|NCT01748799|20386388|P5|NOT COMPLETED|Overall Study||0
8267570|NCT01748799|20386389|P4|NOT COMPLETED|Overall Study||0
8267571|NCT01748799|20386390|P3|NOT COMPLETED|Overall Study||0
8267572|NCT01748799|20386391|P2|NOT COMPLETED|Overall Study||0
8267573|NCT01748799|20386392|P1|NOT COMPLETED|Overall Study||5
8267574|NCT01748799|20386385|P8|COMPLETED|Overall Study||1
8267575|NCT01748799|20386386|P7|COMPLETED|Overall Study||1
8267576|NCT01748799|20386387|P6|COMPLETED|Overall Study||1
8267577|NCT01748799|20386388|P5|COMPLETED|Overall Study||1
8267578|NCT01748799|20386389|P4|COMPLETED|Overall Study||2
8267579|NCT01748799|20386390|P3|COMPLETED|Overall Study||1
8267580|NCT01748799|20386391|P2|COMPLETED|Overall Study||1
8267581|NCT01748799|20386392|P1|COMPLETED|Overall Study||1
8267582|NCT01748799|20386385|P8|Completed Self-titrated Sativex|Overall Study||1
8267583|NCT01748799|20386386|P7|Completed Self-titrated Sativex|Overall Study||1
8267584|NCT01748799|20386387|P6|Completed Self-titrated Sativex|Overall Study||1
8267585|NCT01748799|20386388|P5|Completed Self-titrated Sativex|Overall Study||1
8267586|NCT01748799|20386389|P4|Completed Self-titrated Sativex|Overall Study||2
8267587|NCT01748799|20386390|P3|Completed Self-titrated Sativex|Overall Study||1
8267588|NCT01748799|20386391|P2|Completed Self-titrated Sativex|Overall Study||1
8267589|NCT01748799|20386392|P1|Completed Self-titrated Sativex|Overall Study||1
8267590|NCT01748799|20386385|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
8267591|NCT01748799|20386386|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
8267592|NCT01748799|20386387|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
8267593|NCT01748799|20386388|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
8267594|NCT01748799|20386389|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
8267595|NCT01748799|20386390|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
8267596|NCT01748799|20386391|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
8267597|NCT01748799|20386392|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
8267598|NCT01748799|20386385|P8|Completed Self-titrated Placebo|Overall Study||1
8267599|NCT01748799|20386386|P7|Completed Self-titrated Placebo|Overall Study||1
8267600|NCT01748799|20386387|P6|Completed Self-titrated Placebo|Overall Study||2
8267601|NCT01748799|20386388|P5|Completed Self-titrated Placebo|Overall Study||1
8267602|NCT01748799|20386389|P4|Completed Self-titrated Placebo|Overall Study||2
8267603|NCT01748799|20386390|P3|Completed Self-titrated Placebo|Overall Study||1
8267604|NCT01748799|20386391|P2|Completed Self-titrated Placebo|Overall Study||1
8267605|NCT01748799|20386392|P1|Completed Self-titrated Placebo|Overall Study||4
8267606|NCT01748799|20386385|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
8267607|NCT01748799|20386386|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
8267608|NCT01748799|20386387|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
8267609|NCT01748799|20386388|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
8267610|NCT01748799|20386389|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
8267611|NCT01748799|20386390|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
8267612|NCT01748799|20386391|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
8267613|NCT01748799|20386392|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
8267614|NCT01748799|20386385|P8|Completed Fixed Dose Sativex|Overall Study||1
8267615|NCT01748799|20386386|P7|Completed Fixed Dose Sativex|Overall Study||1
8267616|NCT01748799|20386387|P6|Completed Fixed Dose Sativex|Overall Study||1
8267617|NCT01748799|20386388|P5|Completed Fixed Dose Sativex|Overall Study||1
8267618|NCT01748799|20386389|P4|Completed Fixed Dose Sativex|Overall Study||2
8267619|NCT01748799|20386390|P3|Completed Fixed Dose Sativex|Overall Study||1
8267620|NCT01748799|20386391|P2|Completed Fixed Dose Sativex|Overall Study||1
8267621|NCT01748799|20386392|P1|Completed Fixed Dose Sativex|Overall Study||1
8267622|NCT01748799|20386385|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267623|NCT01748799|20386386|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267624|NCT01748799|20386387|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267625|NCT01748799|20386388|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267626|NCT01748799|20386389|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
8267627|NCT01748799|20386390|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267628|NCT01748799|20386391|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267629|NCT01748799|20386392|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267630|NCT01748799|20386385|P8|Completed Fixed Dose Placebo|Overall Study||1
8267631|NCT01748799|20386386|P7|Completed Fixed Dose Placebo|Overall Study||1
8267632|NCT01748799|20386387|P6|Completed Fixed Dose Placebo|Overall Study||1
8267633|NCT01748799|20386388|P5|Completed Fixed Dose Placebo|Overall Study||1
8267634|NCT01748799|20386389|P4|Completed Fixed Dose Placebo|Overall Study||2
8267635|NCT01748799|20386390|P3|Completed Fixed Dose Placebo|Overall Study||1
8267636|NCT01748799|20386391|P2|Completed Fixed Dose Placebo|Overall Study||1
8267637|NCT01748799|20386392|P1|Completed Fixed Dose Placebo|Overall Study||2
8267638|NCT01748799|20386385|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267639|NCT01748799|20386386|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267640|NCT01748799|20386387|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267641|NCT01748799|20386388|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267642|NCT01748799|20386389|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
8267643|NCT01748799|20386390|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267644|NCT01748799|20386391|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267645|NCT01748799|20386392|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
8267646|NCT01748799|20386385|P8|STARTED|Overall Study||1
8267647|NCT01748799|20386386|P7|STARTED|Overall Study||2
8267648|NCT01748799|20386387|P6|STARTED|Overall Study||2
8267649|NCT01748799|20386388|P5|STARTED|Overall Study||1
8267650|NCT01748799|20386389|P4|STARTED|Overall Study||2
8267651|NCT01748799|20386390|P3|STARTED|Overall Study||1
8267652|NCT01748799|20386391|P2|STARTED|Overall Study||1
8267653|NCT01748799|20386392|P1|STARTED|Overall Study||6
8267654|NCT01748760|20386428|P2|NOT COMPLETED|Overall Study||2
8267655|NCT01748760|20386429|P1|NOT COMPLETED|Overall Study||6
8267656|NCT01748760|20386428|P2|COMPLETED|Overall Study||23
8267657|NCT01748760|20386429|P1|COMPLETED|Overall Study||19
8267658|NCT01748760|20386428|P2|STARTED|Overall Study||25
8267659|NCT01748760|20386429|P1|STARTED|Overall Study||25
8267660|NCT01748695|20386435|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8267661|NCT01748695|20386436|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8267662|NCT01748695|20386435|P2|COMPLETED|Second Intervention (4 Weeks)||11
8267663|NCT01748695|20386436|P1|COMPLETED|Second Intervention (4 Weeks)||14
8267664|NCT01748695|20386435|P2|STARTED|Second Intervention (4 Weeks)||11
8267665|NCT01748695|20386436|P1|STARTED|Second Intervention (4 Weeks)||14
8267666|NCT01748695|20386435|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8267667|NCT01748695|20386436|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8267668|NCT01748695|20386435|P2|COMPLETED|First Intervention (4 Weeks)||11
8267669|NCT01748695|20386436|P1|COMPLETED|First Intervention (4 Weeks)||14
8267670|NCT01748695|20386435|P2|STARTED|First Intervention (4 Weeks)||11
8267671|NCT01748695|20386436|P1|STARTED|First Intervention (4 Weeks)||14
8267672|NCT01748643|20386446|P2|NOT COMPLETED|Overall Study||0
8267673|NCT01748643|20386447|P1|NOT COMPLETED|Overall Study||0
8267674|NCT01748643|20386446|P2|COMPLETED|Overall Study||30
8267675|NCT01748643|20386447|P1|COMPLETED|Overall Study||30
8267676|NCT01748643|20386446|P2|STARTED|Overall Study||30
8267677|NCT01748643|20386447|P1|STARTED|Overall Study||30
8267678|NCT01748552|20386475|P12|NOT COMPLETED|Intervention Period 3 and Washout||0
8267679|NCT01748552|20386476|P11|NOT COMPLETED|Intervention Period 3 and Washout||0
8267680|NCT01748552|20386477|P10|NOT COMPLETED|Intervention Period 3 and Washout||0
8267681|NCT01748552|20386478|P9|NOT COMPLETED|Intervention Period 3 and Washout||0
8267682|NCT01748552|20386479|P8|NOT COMPLETED|Intervention Period 3 and Washout||0
8267683|NCT01748552|20386480|P7|NOT COMPLETED|Intervention Period 3 and Washout||0
8267684|NCT01748552|20386481|P6|NOT COMPLETED|Intervention Period 3 and Washout||0
8267685|NCT01748552|20386482|P5|NOT COMPLETED|Intervention Period 3 and Washout||0
8267686|NCT01748552|20386483|P4|NOT COMPLETED|Intervention Period 3 and Washout||0
8267687|NCT01748552|20386484|P3|NOT COMPLETED|Intervention Period 3 and Washout||0
8267688|NCT01748552|20386485|P2|NOT COMPLETED|Intervention Period 3 and Washout||0
8267689|NCT01748552|20386486|P1|NOT COMPLETED|Intervention Period 3 and Washout||0
8267690|NCT01748552|20386475|P12|COMPLETED|Intervention Period 3 and Washout||3
8267691|NCT01748552|20386476|P11|COMPLETED|Intervention Period 3 and Washout||3
8267692|NCT01748552|20386477|P10|COMPLETED|Intervention Period 3 and Washout||3
8267693|NCT01748552|20386478|P9|COMPLETED|Intervention Period 3 and Washout||0
8267694|NCT01748552|20386479|P8|COMPLETED|Intervention Period 3 and Washout||0
8267695|NCT01748552|20386480|P7|COMPLETED|Intervention Period 3 and Washout||0
8267696|NCT01748552|20386481|P6|COMPLETED|Intervention Period 3 and Washout||3
8267697|NCT01748552|20386482|P5|COMPLETED|Intervention Period 3 and Washout||3
8267698|NCT01748552|20386483|P4|COMPLETED|Intervention Period 3 and Washout||3
8267699|NCT01748552|20386484|P3|COMPLETED|Intervention Period 3 and Washout||2
8267700|NCT01748552|20386485|P2|COMPLETED|Intervention Period 3 and Washout||3
8267701|NCT01748552|20386486|P1|COMPLETED|Intervention Period 3 and Washout||3
8267702|NCT01748552|20386475|P12|STARTED|Intervention Period 3 and Washout||3
8267703|NCT01748552|20386476|P11|STARTED|Intervention Period 3 and Washout||3
8267704|NCT01748552|20386477|P10|STARTED|Intervention Period 3 and Washout||3
8267705|NCT01748552|20386478|P9|STARTED|Intervention Period 3 and Washout||0
8267706|NCT01748552|20386479|P8|STARTED|Intervention Period 3 and Washout||0
8267707|NCT01748552|20386480|P7|STARTED|Intervention Period 3 and Washout||0
8267708|NCT01748552|20386481|P6|STARTED|Intervention Period 3 and Washout||3
8267709|NCT01748552|20386482|P5|STARTED|Intervention Period 3 and Washout||3
8267710|NCT01748552|20386483|P4|STARTED|Intervention Period 3 and Washout||3
8267711|NCT01748552|20386484|P3|STARTED|Intervention Period 3 and Washout||2
8267712|NCT01748552|20386485|P2|STARTED|Intervention Period 3 and Washout||3
8267713|NCT01748552|20386486|P1|STARTED|Intervention Period 3 and Washout||3
8267714|NCT01748552|20386475|P12|NOT COMPLETED|Intervention Period 2 and Washout||0
8267715|NCT01748552|20386476|P11|NOT COMPLETED|Intervention Period 2 and Washout||0
8267716|NCT01748552|20386477|P10|NOT COMPLETED|Intervention Period 2 and Washout||0
8267717|NCT01748552|20386478|P9|NOT COMPLETED|Intervention Period 2 and Washout||3
8267718|NCT01748552|20386479|P8|NOT COMPLETED|Intervention Period 2 and Washout||3
8267719|NCT01748552|20386480|P7|NOT COMPLETED|Intervention Period 2 and Washout||3
8267720|NCT01748552|20386481|P6|NOT COMPLETED|Intervention Period 2 and Washout||0
8267721|NCT01748552|20386482|P5|NOT COMPLETED|Intervention Period 2 and Washout||0
8267722|NCT01748552|20386483|P4|NOT COMPLETED|Intervention Period 2 and Washout||0
8267723|NCT01748552|20386484|P3|NOT COMPLETED|Intervention Period 2 and Washout||1
8267724|NCT01748552|20386485|P2|NOT COMPLETED|Intervention Period 2 and Washout||0
8267725|NCT01748552|20386486|P1|NOT COMPLETED|Intervention Period 2 and Washout||0
8267726|NCT01748552|20386475|P12|COMPLETED|Intervention Period 2 and Washout||3
8267727|NCT01748552|20386476|P11|COMPLETED|Intervention Period 2 and Washout||3
8267728|NCT01748552|20386477|P10|COMPLETED|Intervention Period 2 and Washout||3
8267729|NCT01748552|20386478|P9|COMPLETED|Intervention Period 2 and Washout||0
8267730|NCT01748552|20386479|P8|COMPLETED|Intervention Period 2 and Washout||0
8267731|NCT01748552|20386480|P7|COMPLETED|Intervention Period 2 and Washout||0
8267732|NCT01748552|20386481|P6|COMPLETED|Intervention Period 2 and Washout||3
8267733|NCT01748552|20386482|P5|COMPLETED|Intervention Period 2 and Washout||3
8267734|NCT01748552|20386483|P4|COMPLETED|Intervention Period 2 and Washout||3
8267735|NCT01748552|20386484|P3|COMPLETED|Intervention Period 2 and Washout||2
8267736|NCT01748552|20386485|P2|COMPLETED|Intervention Period 2 and Washout||3
8267737|NCT01748552|20386486|P1|COMPLETED|Intervention Period 2 and Washout||3
8267738|NCT01748552|20386475|P12|STARTED|Intervention Period 2 and Washout||3
8267739|NCT01748552|20386476|P11|STARTED|Intervention Period 2 and Washout||3
8267740|NCT01748552|20386477|P10|STARTED|Intervention Period 2 and Washout||3
8267741|NCT01748552|20386478|P9|STARTED|Intervention Period 2 and Washout||3
8267742|NCT01748552|20386479|P8|STARTED|Intervention Period 2 and Washout||3
8267743|NCT01748552|20386480|P7|STARTED|Intervention Period 2 and Washout||3
8267744|NCT01748552|20386481|P6|STARTED|Intervention Period 2 and Washout||3
8267745|NCT01748552|20386482|P5|STARTED|Intervention Period 2 and Washout||3
8267746|NCT01748552|20386483|P4|STARTED|Intervention Period 2 and Washout||3
8267747|NCT01748552|20386484|P3|STARTED|Intervention Period 2 and Washout||3
8267748|NCT01748552|20386485|P2|STARTED|Intervention Period 2 and Washout||3
8267749|NCT01748552|20386486|P1|STARTED|Intervention Period 2 and Washout||3
8267750|NCT01748552|20386475|P12|NOT COMPLETED|Intervention Period 1 and Washout||0
8267751|NCT01748552|20386476|P11|NOT COMPLETED|Intervention Period 1 and Washout||0
8267752|NCT01748552|20386477|P10|NOT COMPLETED|Intervention Period 1 and Washout||0
8267753|NCT01748552|20386478|P9|NOT COMPLETED|Intervention Period 1 and Washout||0
8267754|NCT01748552|20386479|P8|NOT COMPLETED|Intervention Period 1 and Washout||0
8267755|NCT01748552|20386480|P7|NOT COMPLETED|Intervention Period 1 and Washout||0
8267756|NCT01748552|20386481|P6|NOT COMPLETED|Intervention Period 1 and Washout||0
8267757|NCT01748552|20386482|P5|NOT COMPLETED|Intervention Period 1 and Washout||0
8267758|NCT01748552|20386483|P4|NOT COMPLETED|Intervention Period 1 and Washout||0
8267759|NCT01748552|20386484|P3|NOT COMPLETED|Intervention Period 1 and Washout||0
8267760|NCT01748552|20386485|P2|NOT COMPLETED|Intervention Period 1 and Washout||0
8267761|NCT01748552|20386486|P1|NOT COMPLETED|Intervention Period 1 and Washout||0
8267762|NCT01748552|20386475|P12|COMPLETED|Intervention Period 1 and Washout||3
8267763|NCT01748552|20386476|P11|COMPLETED|Intervention Period 1 and Washout||3
8267764|NCT01748552|20386477|P10|COMPLETED|Intervention Period 1 and Washout||3
8267765|NCT01748552|20386478|P9|COMPLETED|Intervention Period 1 and Washout||3
8267766|NCT01748552|20386479|P8|COMPLETED|Intervention Period 1 and Washout||3
8267767|NCT01748552|20386480|P7|COMPLETED|Intervention Period 1 and Washout||3
8267768|NCT01748552|20386481|P6|COMPLETED|Intervention Period 1 and Washout||3
8267769|NCT01748552|20386482|P5|COMPLETED|Intervention Period 1 and Washout||3
8267770|NCT01748552|20386483|P4|COMPLETED|Intervention Period 1 and Washout||3
8267771|NCT01748552|20386484|P3|COMPLETED|Intervention Period 1 and Washout||3
8267772|NCT01748552|20386485|P2|COMPLETED|Intervention Period 1 and Washout||3
8267773|NCT01748552|20386486|P1|COMPLETED|Intervention Period 1 and Washout||3
8267774|NCT01748552|20386475|P12|STARTED|Intervention Period 1 and Washout||3
8267775|NCT01748552|20386476|P11|STARTED|Intervention Period 1 and Washout||3
8267776|NCT01748552|20386477|P10|STARTED|Intervention Period 1 and Washout||3
8267777|NCT01748552|20386478|P9|STARTED|Intervention Period 1 and Washout||3
8267778|NCT01748552|20386479|P8|STARTED|Intervention Period 1 and Washout||3
8267779|NCT01748552|20386480|P7|STARTED|Intervention Period 1 and Washout||3
8267780|NCT01748552|20386481|P6|STARTED|Intervention Period 1 and Washout||3
8267781|NCT01748552|20386482|P5|STARTED|Intervention Period 1 and Washout||3
8267782|NCT01748552|20386483|P4|STARTED|Intervention Period 1 and Washout||3
8267783|NCT01748552|20386484|P3|STARTED|Intervention Period 1 and Washout||3
8267784|NCT01748552|20386485|P2|STARTED|Intervention Period 1 and Washout||3
8267785|NCT01748552|20386486|P1|STARTED|Intervention Period 1 and Washout||3
8267786|NCT01748292|20386556|P2|NOT COMPLETED|Overall Study||12
8267787|NCT01748292|20386557|P1|NOT COMPLETED|Overall Study||2
8267788|NCT01748292|20386556|P2|COMPLETED|Overall Study||28
8267789|NCT01748292|20386557|P1|COMPLETED|Overall Study||18
8267790|NCT01748292|20386556|P2|STARTED|Overall Study||40
8267791|NCT01748292|20386557|P1|STARTED|Overall Study||20
8267792|NCT01748240|20386577|P1|NOT COMPLETED|Overall Study||0
8267793|NCT01748240|20386577|P1|COMPLETED|Overall Study||21
8267794|NCT01748240|20386577|P1|STARTED|Overall Study||21
8267795|NCT01748227|20386581|P1|NOT COMPLETED|Overall Study||3
8267796|NCT01748227|20386581|P1|COMPLETED|Overall Study||17
8267797|NCT01748227|20386581|P1|STARTED|Overall Study||20
8267798|NCT01748162|20386591|P2|NOT COMPLETED|Overall Study||5
8267799|NCT01748162|20386592|P1|NOT COMPLETED|Overall Study||5
8267800|NCT01748162|20386591|P2|COMPLETED|Overall Study||0
8267801|NCT01748162|20386592|P1|COMPLETED|Overall Study||0
8267802|NCT01748162|20386591|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
8267803|NCT01748162|20386592|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
8267804|NCT01748162|20386591|P2|Completed 6 Month Initial Treatment|Overall Study||0
8267805|NCT01748162|20386592|P1|Completed 6 Month Initial Treatment|Overall Study||0
8267806|NCT01748162|20386591|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
8267807|NCT01748162|20386592|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
8267808|NCT01748162|20386591|P2|STARTED|Overall Study||5
8267809|NCT01748162|20386592|P1|STARTED|Overall Study||5
8267810|NCT01748071|20386603|P3|NOT COMPLETED|Overall Study||0
8267811|NCT01748071|20386604|P2|NOT COMPLETED|Overall Study||2
8267812|NCT01748071|20386605|P1|NOT COMPLETED|Overall Study||2
8267813|NCT01748071|20386603|P3|COMPLETED|Overall Study||40
8267814|NCT01748071|20386604|P2|COMPLETED|Overall Study||38
8267815|NCT01748071|20386605|P1|COMPLETED|Overall Study||38
8267816|NCT01748071|20386603|P3|STARTED|Overall Study||40
8267817|NCT01748071|20386604|P2|STARTED|Overall Study||40
8267818|NCT01748071|20386605|P1|STARTED|Overall Study||40
8267819|NCT01748045|20386627|P2|NOT COMPLETED|Overall Study||0
8267820|NCT01748045|20386628|P1|NOT COMPLETED|Overall Study||0
8267821|NCT01748045|20386627|P2|COMPLETED|Overall Study||1
8267822|NCT01748045|20386628|P1|COMPLETED|Overall Study||2
8267823|NCT01748045|20386627|P2|STARTED|Overall Study||1
8267824|NCT01748045|20386628|P1|STARTED|Overall Study||2
8267825|NCT01747928|20386654|P8|NOT COMPLETED|Overall Study||0
8267826|NCT01747928|20386655|P7|NOT COMPLETED|Overall Study||0
8267827|NCT01747928|20386656|P6|NOT COMPLETED|Overall Study||0
8267828|NCT01747928|20386657|P5|NOT COMPLETED|Overall Study||0
8267829|NCT01747928|20386658|P4|NOT COMPLETED|Overall Study||0
8267830|NCT01747928|20386659|P3|NOT COMPLETED|Overall Study||0
8267831|NCT01747928|20386660|P2|NOT COMPLETED|Overall Study||0
8267832|NCT01747928|20386661|P1|NOT COMPLETED|Overall Study||0
8267833|NCT01747928|20386654|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267834|NCT01747928|20386655|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267835|NCT01747928|20386656|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267836|NCT01747928|20386657|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267837|NCT01747928|20386658|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267838|NCT01747928|20386659|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267839|NCT01747928|20386660|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267840|NCT01747928|20386661|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267841|NCT01747928|20386654|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267842|NCT01747928|20386655|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267843|NCT01747928|20386656|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267844|NCT01747928|20386657|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267845|NCT01747928|20386658|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267846|NCT01747928|20386659|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267847|NCT01747928|20386660|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267848|NCT01747928|20386661|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267849|NCT01747915|20386868|P3|NOT COMPLETED|Overall Study||6
8267850|NCT01747915|20386869|P2|NOT COMPLETED|Overall Study||11
8267851|NCT01747915|20386870|P1|NOT COMPLETED|Overall Study||15
8267852|NCT01747915|20386868|P3|COMPLETED|Overall Study||66
8267853|NCT01747915|20386869|P2|COMPLETED|Overall Study||61
8267854|NCT01747915|20386870|P1|COMPLETED|Overall Study||60
8267855|NCT01747915|20386868|P3|STARTED|Overall Study||72
8267856|NCT01747915|20386869|P2|STARTED|Overall Study||72
8267857|NCT01747915|20386870|P1|STARTED|Overall Study||75
8267858|NCT01747876|20386884|P3|NOT COMPLETED|Overall Study||12
8267859|NCT01747876|20386885|P2|NOT COMPLETED|Overall Study||15
8267860|NCT01747876|20386886|P1|NOT COMPLETED|Overall Study||5
8267861|NCT01747876|20386884|P3|COMPLETED|Overall Study||0
8267862|NCT01747876|20386885|P2|COMPLETED|Overall Study||0
8267863|NCT01747876|20386886|P1|COMPLETED|Overall Study||0
8267864|NCT01747876|20386884|P3|STARTED|Overall Study||12
8267865|NCT01747876|20386885|P2|STARTED|Overall Study||15
8267866|NCT01747876|20386886|P1|STARTED|Overall Study||5
8267867|NCT01747850|20386915|P3|NOT COMPLETED|Overall Study||6
8267868|NCT01747850|20386916|P2|NOT COMPLETED|Overall Study||7
8267869|NCT01747850|20386917|P1|NOT COMPLETED|Overall Study||1
8267870|NCT01747850|20386915|P3|COMPLETED|Overall Study||14
8267871|NCT01747850|20386916|P2|COMPLETED|Overall Study||13
8267872|NCT01747850|20386917|P1|COMPLETED|Overall Study||4
8267873|NCT01747850|20386915|P3|STARTED|Overall Study||20
8267874|NCT01747850|20386916|P2|STARTED|Overall Study||20
8267875|NCT01747850|20386917|P1|STARTED|Overall Study||5
8267876|NCT01747837|20386939|P2|NOT COMPLETED|Overall Study||6
8267877|NCT01747837|20386940|P1|NOT COMPLETED|Overall Study||9
8267878|NCT01747837|20386939|P2|COMPLETED|Overall Study||17
8267879|NCT01747837|20386940|P1|COMPLETED|Overall Study||16
8267880|NCT01747837|20386939|P2|STARTED|Overall Study||23
8267881|NCT01747837|20386940|P1|STARTED|Overall Study||25
8267882|NCT01747811|20386970|P2|NOT COMPLETED|Overall Study||4
8267883|NCT01747811|20386971|P1|NOT COMPLETED|Overall Study||2
8267884|NCT01747811|20386970|P2|COMPLETED|Overall Study||12
8267885|NCT01747811|20386971|P1|COMPLETED|Overall Study||14
8267886|NCT01747811|20386970|P2|STARTED|Overall Study||16
8267887|NCT01747811|20386971|P1|STARTED|Overall Study||16
8267888|NCT01747772|20386987|P1|NOT COMPLETED|Overall Study||9
8267889|NCT01747772|20386987|P1|COMPLETED|Overall Study||171
8267890|NCT01747772|20386987|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
8267891|NCT01747772|20386987|P1|STARTED|Overall Study||180
8267892|NCT01747655|20386995|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
8267893|NCT01747655|20386996|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
8267894|NCT01747655|20386995|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
8267895|NCT01747655|20386996|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
8267896|NCT01747655|20386995|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
8267897|NCT01747655|20386996|P1|STARTED|PEG-J Period (Continued Treatment)||41
8267898|NCT01747655|20386995|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
8267899|NCT01747655|20386996|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
8267900|NCT01747655|20386995|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
8267901|NCT01747655|20386996|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
8267902|NCT01747655|20386995|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
8267903|NCT01747655|20386996|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
8267904|NCT01747655|20386995|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
8267905|NCT01747655|20386996|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
8267906|NCT01747655|20386995|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
8267907|NCT01747655|20386996|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
8267908|NCT01747655|20386995|P2|STARTED|Temporary Naso-jejunal Tube Period||0
8267909|NCT01747655|20386996|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
8267910|NCT01747629|20387026|P2|NOT COMPLETED|Overall Study||6
8267911|NCT01747629|20387027|P1|NOT COMPLETED|Overall Study||8
8267912|NCT01747629|20387026|P2|COMPLETED|Overall Study||69
8267913|NCT01747629|20387027|P1|COMPLETED|Overall Study||77
8267914|NCT01747629|20387026|P2|Treated|Overall Study|Safety set and full analysis set|75
8267915|NCT01747629|20387027|P1|Treated|Overall Study|Safety set and full analysis set|84
8267916|NCT01747629|20387026|P2|STARTED|Overall Study||75
8267917|NCT01747629|20387027|P1|STARTED|Overall Study||85
8267918|NCT01747551|20387061|P2|NOT COMPLETED|Overall Study||21
8267919|NCT01747551|20387062|P1|NOT COMPLETED|Overall Study||43
8267920|NCT01747551|20387061|P2|COMPLETED|Overall Study||0
8267921|NCT01747551|20387062|P1|COMPLETED|Overall Study||0
8267922|NCT01747551|20387061|P2|STARTED|Overall Study||21
8267923|NCT01747551|20387062|P1|STARTED|Overall Study||43
8267924|NCT01747499|20387079|P5|NOT COMPLETED|Overall Study||15
8267925|NCT01747499|20387080|P4|NOT COMPLETED|Overall Study||2
8267926|NCT01747499|20387081|P3|NOT COMPLETED|Overall Study||0
8267927|NCT01747499|20387082|P2|NOT COMPLETED|Overall Study||1
8267928|NCT01747499|20387083|P1|NOT COMPLETED|Overall Study||1
8267929|NCT01747499|20387079|P5|COMPLETED|Overall Study||24
8267930|NCT01747499|20387080|P4|COMPLETED|Overall Study||4
8267931|NCT01747499|20387081|P3|COMPLETED|Overall Study||3
8267932|NCT01747499|20387082|P2|COMPLETED|Overall Study||2
8267933|NCT01747499|20387083|P1|COMPLETED|Overall Study||2
8267934|NCT01747499|20387079|P5|STARTED|Overall Study||39
8267935|NCT01747499|20387080|P4|STARTED|Overall Study||6
8267936|NCT01747499|20387081|P3|STARTED|Overall Study||3
8267937|NCT01747499|20387082|P2|STARTED|Overall Study||3
8267938|NCT01747499|20387083|P1|STARTED|Overall Study||3
8267939|NCT01747486|20387119|P2|NOT COMPLETED|Stage 2||0
8267940|NCT01747486|20387120|P1|NOT COMPLETED|Stage 2||9
8267941|NCT01747486|20387119|P2|COMPLETED|Stage 2||0
8267942|NCT01747486|20387120|P1|COMPLETED|Stage 2||3
8267943|NCT01747486|20387119|P2|STARTED|Stage 2||0
8267944|NCT01747486|20387120|P1|STARTED|Stage 2||12
8267945|NCT01747486|20387119|P2|NOT COMPLETED|Stage 1||13
8267946|NCT01747486|20387120|P1|NOT COMPLETED|Stage 1||12
8267947|NCT01747486|20387119|P2|COMPLETED|Stage 1||2
8267948|NCT01747486|20387120|P1|COMPLETED|Stage 1||3
8267949|NCT01747486|20387119|P2|STARTED|Stage 1||15
8267950|NCT01747486|20387120|P1|STARTED|Stage 1||15
8267951|NCT01747343|20387126|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
8267952|NCT01747343|20387126|P1|COMPLETED|Underwear/Differential Reinforcement||4
8267953|NCT01747343|20387126|P1|STARTED|Underwear/Differential Reinforcement||4
8267954|NCT01747343|20387126|P1|NOT COMPLETED|Underwear||0
8267955|NCT01747343|20387126|P1|COMPLETED|Underwear||4
8267956|NCT01747343|20387126|P1|STARTED|Underwear||4
8267957|NCT01747343|20387126|P1|NOT COMPLETED|Baseline||0
8267958|NCT01747343|20387126|P1|COMPLETED|Baseline||4
8267959|NCT01747343|20387126|P1|STARTED|Baseline||4
8267960|NCT01747330|20387132|P1|NOT COMPLETED|Overall Study||0
8267961|NCT01747330|20387132|P1|COMPLETED|Overall Study||40
8267962|NCT01747330|20387132|P1|STARTED|Overall Study||40
8267963|NCT01746979|20387146|P2|NOT COMPLETED|Overall Study||347
8267964|NCT01746979|20387147|P1|NOT COMPLETED|Overall Study||346
8267965|NCT01746979|20387146|P2|COMPLETED|Overall Study||0
8267966|NCT01746979|20387147|P1|COMPLETED|Overall Study||0
8267967|NCT01746979|20387146|P2|STARTED|Overall Study||347
8267968|NCT01746979|20387147|P1|STARTED|Overall Study||346
8267969|NCT01746940|20387159|P4|NOT COMPLETED|Safety Second Phase||0
8267970|NCT01746940|20387160|P3|NOT COMPLETED|Safety Second Phase||0
8267971|NCT01746940|20387161|P2|NOT COMPLETED|Safety Second Phase||0
8267972|NCT01746940|20387162|P1|NOT COMPLETED|Safety Second Phase||0
8267973|NCT01746940|20387159|P4|COMPLETED|Safety Second Phase||0
8267974|NCT01746940|20387160|P3|COMPLETED|Safety Second Phase||0
8267975|NCT01746940|20387161|P2|COMPLETED|Safety Second Phase||18
8267976|NCT01746940|20387162|P1|COMPLETED|Safety Second Phase||18
8267977|NCT01746940|20387159|P4|STARTED|Safety Second Phase||0
8267978|NCT01746940|20387160|P3|STARTED|Safety Second Phase||0
8267979|NCT01746940|20387161|P2|STARTED|Safety Second Phase||18
8267980|NCT01746940|20387162|P1|STARTED|Safety Second Phase||18
8267981|NCT01746940|20387159|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
8267982|NCT01746940|20387160|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
8267983|NCT01746940|20387161|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
8267984|NCT01746940|20387162|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
8267985|NCT01746940|20387159|P4|COMPLETED|Safety and Efficacy First Phase||0
8267986|NCT01746940|20387160|P3|COMPLETED|Safety and Efficacy First Phase||40
8267987|NCT01746940|20387161|P2|COMPLETED|Safety and Efficacy First Phase||41
8267988|NCT01746940|20387162|P1|COMPLETED|Safety and Efficacy First Phase||39
8267989|NCT01746940|20387159|P4|STARTED|Safety and Efficacy First Phase||3
8267990|NCT01746940|20387160|P3|STARTED|Safety and Efficacy First Phase||40
8267991|NCT01746940|20387161|P2|STARTED|Safety and Efficacy First Phase||41
8267992|NCT01746940|20387162|P1|STARTED|Safety and Efficacy First Phase||39
8267993|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267994|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267995|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267996|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267997|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267998|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267999|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8268000|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8268001|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8268002|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
8268003|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
8268004|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
8268005|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
8268006|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
8268007|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
8268008|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
8268009|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
8268010|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
8268011|NCT01746901|20387170|P9|STARTED|Treatment Phase: Sixth Intervention||5
8268012|NCT01746901|20387171|P8|STARTED|Treatment Phase: Sixth Intervention||6
8268013|NCT01746901|20387172|P7|STARTED|Treatment Phase: Sixth Intervention||5
8268014|NCT01746901|20387173|P6|STARTED|Treatment Phase: Sixth Intervention||5
8268015|NCT01746901|20387174|P5|STARTED|Treatment Phase: Sixth Intervention||6
8268016|NCT01746901|20387175|P4|STARTED|Treatment Phase: Sixth Intervention||5
8268017|NCT01746901|20387176|P3|STARTED|Treatment Phase: Sixth Intervention||0
8268018|NCT01746901|20387177|P2|STARTED|Treatment Phase: Sixth Intervention||0
8268019|NCT01746901|20387178|P1|STARTED|Treatment Phase: Sixth Intervention||0
8268020|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268021|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268022|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268023|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268024|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268025|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268026|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268027|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268028|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268029|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 5||5
8268030|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 5||6
8268031|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 5||5
8268032|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 5||5
8268033|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 5||6
8268034|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 5||5
8268035|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 5||0
8268036|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 5||0
8268037|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 5||0
8268038|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 5||5
8268039|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 5||6
8268040|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 5||5
8268041|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 5||5
8268042|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 5||6
8268043|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 5||5
8268044|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 5||0
8268045|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 5||0
8268046|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 5||0
8268047|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268048|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268049|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268050|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268051|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268052|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268053|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268054|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268055|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268056|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
8268057|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
8268058|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
8268059|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
8268060|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
8268061|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
8268062|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
8268063|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
8268064|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
8268065|NCT01746901|20387170|P9|STARTED|Treatment Phase: Fifth Intervention||5
8268066|NCT01746901|20387171|P8|STARTED|Treatment Phase: Fifth Intervention||6
8268067|NCT01746901|20387172|P7|STARTED|Treatment Phase: Fifth Intervention||5
8268068|NCT01746901|20387173|P6|STARTED|Treatment Phase: Fifth Intervention||5
8268069|NCT01746901|20387174|P5|STARTED|Treatment Phase: Fifth Intervention||6
8268070|NCT01746901|20387175|P4|STARTED|Treatment Phase: Fifth Intervention||5
8268071|NCT01746901|20387176|P3|STARTED|Treatment Phase: Fifth Intervention||0
8268072|NCT01746901|20387177|P2|STARTED|Treatment Phase: Fifth Intervention||0
8268073|NCT01746901|20387178|P1|STARTED|Treatment Phase: Fifth Intervention||0
8268074|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268075|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268076|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268077|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268078|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268079|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268080|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268081|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268082|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268083|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 4||5
8268084|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 4||6
8268085|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 4||5
8268086|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 4||5
8268087|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 4||6
8268088|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 4||5
8268089|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 4||0
8268090|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 4||0
8268091|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 4||0
8268092|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 4||5
8268093|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 4||6
8268094|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 4||5
8268095|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 4||5
8268096|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 4||6
8268097|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 4||5
8268098|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 4||0
8268099|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 4||0
8268100|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 4||0
8268101|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
8268102|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268103|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8268104|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8268105|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268106|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8268107|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268108|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268109|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268110|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
8268111|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
8268112|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
8268113|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
8268114|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
8268115|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
8268116|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
8268117|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
8268118|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
8268119|NCT01746901|20387170|P9|STARTED|Treatment Phase: Fourth Intervention||7
8268120|NCT01746901|20387171|P8|STARTED|Treatment Phase: Fourth Intervention||6
8268121|NCT01746901|20387172|P7|STARTED|Treatment Phase: Fourth Intervention||6
8268122|NCT01746901|20387173|P6|STARTED|Treatment Phase: Fourth Intervention||6
8268123|NCT01746901|20387174|P5|STARTED|Treatment Phase: Fourth Intervention||6
8268124|NCT01746901|20387175|P4|STARTED|Treatment Phase: Fourth Intervention||6
8268125|NCT01746901|20387176|P3|STARTED|Treatment Phase: Fourth Intervention||0
8268126|NCT01746901|20387177|P2|STARTED|Treatment Phase: Fourth Intervention||0
8268127|NCT01746901|20387178|P1|STARTED|Treatment Phase: Fourth Intervention||0
8268128|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268129|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268130|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268131|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268132|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268133|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268134|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268135|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268136|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268137|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 3||7
8268138|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 3||6
8268139|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 3||6
8268140|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 3||6
8268141|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 3||6
8268142|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 3||6
8268143|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 3||0
8268144|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 3||0
8268145|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 3||0
8268146|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 3||7
8268147|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 3||6
8268148|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 3||6
8268149|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 3||6
8268150|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 3||6
8268151|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 3||6
8268152|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 3||0
8268153|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 3||0
8268154|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 3||0
8268155|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268156|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268157|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
8268158|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
8268159|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268160|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268161|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268162|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268163|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268164|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Third Intervention||7
8268165|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Third Intervention||6
8268166|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Third Intervention||6
8268167|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Third Intervention||6
8268168|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Third Intervention||6
8268169|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Third Intervention||6
8268170|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Third Intervention||0
8268171|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Third Intervention||0
8268172|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Third Intervention||0
8268173|NCT01746901|20387170|P9|STARTED|Treatment Phase: Third Intervention||7
8268174|NCT01746901|20387171|P8|STARTED|Treatment Phase: Third Intervention||6
8268175|NCT01746901|20387172|P7|STARTED|Treatment Phase: Third Intervention||7
8268176|NCT01746901|20387173|P6|STARTED|Treatment Phase: Third Intervention||7
8268177|NCT01746901|20387174|P5|STARTED|Treatment Phase: Third Intervention||6
8268178|NCT01746901|20387175|P4|STARTED|Treatment Phase: Third Intervention||6
8268179|NCT01746901|20387176|P3|STARTED|Treatment Phase: Third Intervention||0
8268180|NCT01746901|20387177|P2|STARTED|Treatment Phase: Third Intervention||0
8268181|NCT01746901|20387178|P1|STARTED|Treatment Phase: Third Intervention||0
8268182|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268183|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268184|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268185|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268186|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268187|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268188|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268189|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268190|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268191|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 2||7
8268192|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 2||6
8268193|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 2||7
8268194|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 2||7
8268195|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 2||6
8268196|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 2||6
8268197|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 2||0
8268198|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 2||0
8268199|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 2||0
8268200|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 2||7
8268201|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 2||6
8268202|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 2||7
8268203|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 2||7
8268204|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 2||6
8268205|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 2||6
8268206|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 2||0
8268207|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 2||0
8268208|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 2||0
8268209|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268210|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
8268288|NCT01746901|20387177|P2|STARTED|Treatment Phase: First Intervention||0
8268211|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268212|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268213|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268214|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268215|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268216|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268217|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268218|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Second Intervention||7
8268219|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Second Intervention||6
8268220|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Second Intervention||7
8268221|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Second Intervention||7
8268222|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Second Intervention||6
8268223|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Second Intervention||6
8268224|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Second Intervention||0
8268225|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Second Intervention||0
8268226|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Second Intervention||0
8268227|NCT01746901|20387170|P9|STARTED|Treatment Phase: Second Intervention||7
8268228|NCT01746901|20387171|P8|STARTED|Treatment Phase: Second Intervention||7
8268229|NCT01746901|20387172|P7|STARTED|Treatment Phase: Second Intervention||7
8268230|NCT01746901|20387173|P6|STARTED|Treatment Phase: Second Intervention||7
8268231|NCT01746901|20387174|P5|STARTED|Treatment Phase: Second Intervention||6
8268232|NCT01746901|20387175|P4|STARTED|Treatment Phase: Second Intervention||6
8268233|NCT01746901|20387176|P3|STARTED|Treatment Phase: Second Intervention||0
8268234|NCT01746901|20387177|P2|STARTED|Treatment Phase: Second Intervention||0
8268235|NCT01746901|20387178|P1|STARTED|Treatment Phase: Second Intervention||0
8268236|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268237|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268238|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268239|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268240|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268241|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268242|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268243|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268244|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268245|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 1||7
8268246|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 1||7
8268247|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 1||7
8268248|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 1||7
8268249|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 1||6
8268250|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 1||6
8268251|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 1||0
8268252|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 1||0
8268253|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 1||0
8268254|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 1||7
8268255|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 1||7
8268256|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 1||7
8268257|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 1||7
8268258|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 1||6
8268259|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 1||6
8268260|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 1||0
8268261|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 1||0
8268262|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 1||0
8268263|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
8268264|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
8268265|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
8268266|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
8268267|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
8268268|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
8268269|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
8268270|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
8268271|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
8268272|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: First Intervention||7
8268273|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: First Intervention||7
8268274|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: First Intervention||7
8268275|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: First Intervention||7
8268276|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: First Intervention||6
8268277|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: First Intervention||6
8268278|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: First Intervention||0
8268279|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: First Intervention||0
8268280|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: First Intervention||0
8268281|NCT01746901|20387170|P9|STARTED|Treatment Phase: First Intervention||7
8268282|NCT01746901|20387171|P8|STARTED|Treatment Phase: First Intervention||7
8268283|NCT01746901|20387172|P7|STARTED|Treatment Phase: First Intervention||8
8268284|NCT01746901|20387173|P6|STARTED|Treatment Phase: First Intervention||7
8268285|NCT01746901|20387174|P5|STARTED|Treatment Phase: First Intervention||6
8268286|NCT01746901|20387175|P4|STARTED|Treatment Phase: First Intervention||6
8268287|NCT01746901|20387176|P3|STARTED|Treatment Phase: First Intervention||0
8268289|NCT01746901|20387178|P1|STARTED|Treatment Phase: First Intervention||0
8268290|NCT01746901|20387170|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268291|NCT01746901|20387171|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268292|NCT01746901|20387172|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268293|NCT01746901|20387173|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268294|NCT01746901|20387174|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268295|NCT01746901|20387175|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268296|NCT01746901|20387176|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
8268297|NCT01746901|20387177|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
8268298|NCT01746901|20387178|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268299|NCT01746901|20387170|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
8268300|NCT01746901|20387171|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
8268301|NCT01746901|20387172|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
8268302|NCT01746901|20387173|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
8268303|NCT01746901|20387174|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
8268304|NCT01746901|20387175|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
8268305|NCT01746901|20387176|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
8268306|NCT01746901|20387177|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
8268307|NCT01746901|20387178|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
8268308|NCT01746901|20387170|P9|STARTED|Drug Discrimination Phase: Day 2||0
8268309|NCT01746901|20387171|P8|STARTED|Drug Discrimination Phase: Day 2||0
8268310|NCT01746901|20387172|P7|STARTED|Drug Discrimination Phase: Day 2||0
8268311|NCT01746901|20387173|P6|STARTED|Drug Discrimination Phase: Day 2||0
8268312|NCT01746901|20387174|P5|STARTED|Drug Discrimination Phase: Day 2||0
8268313|NCT01746901|20387175|P4|STARTED|Drug Discrimination Phase: Day 2||0
8268314|NCT01746901|20387176|P3|STARTED|Drug Discrimination Phase: Day 2||36
8268315|NCT01746901|20387177|P2|STARTED|Drug Discrimination Phase: Day 2||33
8268316|NCT01746901|20387178|P1|STARTED|Drug Discrimination Phase: Day 2||0
8268317|NCT01746901|20387170|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268318|NCT01746901|20387171|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268319|NCT01746901|20387172|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268320|NCT01746901|20387173|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268321|NCT01746901|20387174|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268322|NCT01746901|20387175|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268323|NCT01746901|20387176|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268324|NCT01746901|20387177|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
8268325|NCT01746901|20387178|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268326|NCT01746901|20387170|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
8268327|NCT01746901|20387171|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
8268328|NCT01746901|20387172|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
8268329|NCT01746901|20387173|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
8268330|NCT01746901|20387174|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
8268331|NCT01746901|20387175|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
8268332|NCT01746901|20387176|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
8268333|NCT01746901|20387177|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
8268334|NCT01746901|20387178|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
8268335|NCT01746901|20387170|P9|STARTED|Drug Discrimination Phase: Day 1||0
8268336|NCT01746901|20387171|P8|STARTED|Drug Discrimination Phase: Day 1||0
8268337|NCT01746901|20387172|P7|STARTED|Drug Discrimination Phase: Day 1||0
8268338|NCT01746901|20387173|P6|STARTED|Drug Discrimination Phase: Day 1||0
8268339|NCT01746901|20387174|P5|STARTED|Drug Discrimination Phase: Day 1||0
8268340|NCT01746901|20387175|P4|STARTED|Drug Discrimination Phase: Day 1||0
8268341|NCT01746901|20387176|P3|STARTED|Drug Discrimination Phase: Day 1||36
8268342|NCT01746901|20387177|P2|STARTED|Drug Discrimination Phase: Day 1||36
8268343|NCT01746901|20387178|P1|STARTED|Drug Discrimination Phase: Day 1||0
8268344|NCT01746901|20387170|P9|NOT COMPLETED|Naloxone Challenge Phase||0
8268345|NCT01746901|20387171|P8|NOT COMPLETED|Naloxone Challenge Phase||0
8268346|NCT01746901|20387172|P7|NOT COMPLETED|Naloxone Challenge Phase||0
8268347|NCT01746901|20387173|P6|NOT COMPLETED|Naloxone Challenge Phase||0
8268348|NCT01746901|20387174|P5|NOT COMPLETED|Naloxone Challenge Phase||0
8268349|NCT01746901|20387175|P4|NOT COMPLETED|Naloxone Challenge Phase||0
8268350|NCT01746901|20387176|P3|NOT COMPLETED|Naloxone Challenge Phase||0
8268351|NCT01746901|20387177|P2|NOT COMPLETED|Naloxone Challenge Phase||0
8268352|NCT01746901|20387178|P1|NOT COMPLETED|Naloxone Challenge Phase||3
8268353|NCT01746901|20387170|P9|COMPLETED|Naloxone Challenge Phase||0
8268354|NCT01746901|20387171|P8|COMPLETED|Naloxone Challenge Phase||0
8268355|NCT01746901|20387172|P7|COMPLETED|Naloxone Challenge Phase||0
8268356|NCT01746901|20387173|P6|COMPLETED|Naloxone Challenge Phase||0
8268357|NCT01746901|20387174|P5|COMPLETED|Naloxone Challenge Phase||0
8268358|NCT01746901|20387175|P4|COMPLETED|Naloxone Challenge Phase||0
8268359|NCT01746901|20387176|P3|COMPLETED|Naloxone Challenge Phase||0
8268360|NCT01746901|20387177|P2|COMPLETED|Naloxone Challenge Phase||0
8268361|NCT01746901|20387178|P1|COMPLETED|Naloxone Challenge Phase||72
8268362|NCT01746901|20387170|P9|STARTED|Naloxone Challenge Phase||0
8268363|NCT01746901|20387171|P8|STARTED|Naloxone Challenge Phase||0
8268364|NCT01746901|20387172|P7|STARTED|Naloxone Challenge Phase||0
8268365|NCT01746901|20387173|P6|STARTED|Naloxone Challenge Phase||0
8268366|NCT01746901|20387174|P5|STARTED|Naloxone Challenge Phase||0
8268367|NCT01746901|20387175|P4|STARTED|Naloxone Challenge Phase||0
8268368|NCT01746901|20387176|P3|STARTED|Naloxone Challenge Phase||0
8268369|NCT01746901|20387177|P2|STARTED|Naloxone Challenge Phase||0
8268370|NCT01746901|20387178|P1|STARTED|Naloxone Challenge Phase||75
8268371|NCT01746862|20387501|P2|NOT COMPLETED|Overall Study||3
8268372|NCT01746862|20387502|P1|NOT COMPLETED|Overall Study||8
8268373|NCT01746862|20387501|P2|COMPLETED|Overall Study||27
8268374|NCT01746862|20387502|P1|COMPLETED|Overall Study||52
8268375|NCT01746862|20387501|P2|Treated|Overall Study||30
8268376|NCT01746862|20387502|P1|Treated|Overall Study||59
8268377|NCT01746862|20387501|P2|STARTED|Overall Study||30
8268378|NCT01746862|20387502|P1|STARTED|Overall Study||60
8268379|NCT01746784|20387527|P5|NOT COMPLETED|Overall Study||0
8268380|NCT01746784|20387528|P4|NOT COMPLETED|Overall Study||0
8268381|NCT01746784|20387529|P3|NOT COMPLETED|Overall Study||0
8268382|NCT01746784|20387530|P2|NOT COMPLETED|Overall Study||0
8268383|NCT01746784|20387531|P1|NOT COMPLETED|Overall Study||0
8268384|NCT01746784|20387527|P5|COMPLETED|Overall Study||19
8268385|NCT01746784|20387528|P4|COMPLETED|Overall Study||9
8268386|NCT01746784|20387529|P3|COMPLETED|Overall Study||9
8268387|NCT01746784|20387530|P2|COMPLETED|Overall Study||10
8268388|NCT01746784|20387531|P1|COMPLETED|Overall Study||19
8268389|NCT01746784|20387527|P5|Enrolled|Overall Study||19
8268390|NCT01746784|20387528|P4|Enrolled|Overall Study||9
8268391|NCT01746784|20387529|P3|Enrolled|Overall Study||9
8268392|NCT01746784|20387530|P2|Enrolled|Overall Study||10
8268393|NCT01746784|20387531|P1|Enrolled|Overall Study||19
8268394|NCT01746784|20387527|P5|STARTED|Overall Study||19
8268395|NCT01746784|20387528|P4|STARTED|Overall Study||9
8268396|NCT01746784|20387529|P3|STARTED|Overall Study||9
8268397|NCT01746784|20387530|P2|STARTED|Overall Study||10
8268398|NCT01746784|20387531|P1|STARTED|Overall Study||19
8268399|NCT01746745|20387553|P1|NOT COMPLETED|Overall Study||0
8268400|NCT01746745|20387553|P1|COMPLETED|Overall Study||6
8268401|NCT01746745|20387553|P1|Received Study Drug|Overall Study||6
8268402|NCT01746745|20387553|P1|STARTED|Overall Study||6
8268403|NCT01746732|20387566|P3|NOT COMPLETED|Period 2||4
8268404|NCT01746732|20387567|P2|NOT COMPLETED|Period 2||0
8268405|NCT01746732|20387568|P1|NOT COMPLETED|Period 2||0
8268406|NCT01746732|20387566|P3|COMPLETED|Period 2||7
8268407|NCT01746732|20387567|P2|COMPLETED|Period 2||10
8268408|NCT01746732|20387568|P1|COMPLETED|Period 2||0
8268409|NCT01746732|20387566|P3|STARTED|Period 2||11
8268410|NCT01746732|20387567|P2|STARTED|Period 2||10
8268411|NCT01746732|20387568|P1|STARTED|Period 2||0
8268412|NCT01746732|20387566|P3|NOT COMPLETED|Period 1||0
8268413|NCT01746732|20387567|P2|NOT COMPLETED|Period 1||1
8268414|NCT01746732|20387568|P1|NOT COMPLETED|Period 1||0
8268415|NCT01746732|20387566|P3|COMPLETED|Period 1||11
8268416|NCT01746732|20387567|P2|COMPLETED|Period 1||10
8268417|NCT01746732|20387568|P1|COMPLETED|Period 1||0
8268418|NCT01746732|20387566|P3|STARTED|Period 1||11
8268419|NCT01746732|20387567|P2|STARTED|Period 1||11
8268420|NCT01746732|20387568|P1|STARTED|Period 1||0
8268421|NCT01746732|20387566|P3|NOT COMPLETED|Lead-In Period||0
8268422|NCT01746732|20387567|P2|NOT COMPLETED|Lead-In Period||0
8268423|NCT01746732|20387568|P1|NOT COMPLETED|Lead-In Period||1
8268424|NCT01746732|20387566|P3|COMPLETED|Lead-In Period||0
8268425|NCT01746732|20387567|P2|COMPLETED|Lead-In Period||0
8268426|NCT01746732|20387568|P1|COMPLETED|Lead-In Period||22
8268427|NCT01746732|20387566|P3|Participants Received at Least 1 Dose|Lead-In Period||0
8268428|NCT01746732|20387567|P2|Participants Received at Least 1 Dose|Lead-In Period||0
8268429|NCT01746732|20387568|P1|Participants Received at Least 1 Dose|Lead-In Period||22
8268430|NCT01746732|20387566|P3|STARTED|Lead-In Period||0
8268431|NCT01746732|20387567|P2|STARTED|Lead-In Period||0
8268432|NCT01746732|20387568|P1|STARTED|Lead-In Period||23
8268433|NCT01746511|20387591|P2|NOT COMPLETED|Overall Study||0
8268434|NCT01746511|20387592|P1|NOT COMPLETED|Overall Study||0
8268435|NCT01746511|20387591|P2|COMPLETED|Overall Study||39
8268436|NCT01746511|20387592|P1|COMPLETED|Overall Study||40
8268437|NCT01746511|20387591|P2|STARTED|Overall Study||39
8268438|NCT01746511|20387592|P1|STARTED|Overall Study||40
8268439|NCT01746420|20387611|P5|NOT COMPLETED|Overall Study||0
8268440|NCT01746420|20387612|P4|NOT COMPLETED|Overall Study||0
8268441|NCT01746420|20387613|P3|NOT COMPLETED|Overall Study||3
8268442|NCT01746420|20387614|P2|NOT COMPLETED|Overall Study||2
8268443|NCT01746420|20387615|P1|NOT COMPLETED|Overall Study||3
8268444|NCT01746420|20387611|P5|COMPLETED|Overall Study||20
8268445|NCT01746420|20387612|P4|COMPLETED|Overall Study||20
8268446|NCT01746420|20387613|P3|COMPLETED|Overall Study||17
8268447|NCT01746420|20387614|P2|COMPLETED|Overall Study||18
8268448|NCT01746420|20387615|P1|COMPLETED|Overall Study||17
8268449|NCT01746420|20387611|P5|STARTED|Overall Study||20
8268450|NCT01746420|20387612|P4|STARTED|Overall Study||20
8268451|NCT01746420|20387613|P3|STARTED|Overall Study||20
8268452|NCT01746420|20387614|P2|STARTED|Overall Study||20
8268453|NCT01746420|20387615|P1|STARTED|Overall Study||20
8268454|NCT01746368|20387649|P2|NOT COMPLETED|Overall Study||1
8268455|NCT01746368|20387650|P1|NOT COMPLETED|Overall Study||2
8268456|NCT01746368|20387649|P2|COMPLETED|Overall Study||16
8268457|NCT01746368|20387650|P1|COMPLETED|Overall Study||31
8268458|NCT01746368|20387649|P2|Analyzed for Satisfaction|Overall Study||16
8268459|NCT01746368|20387650|P1|Analyzed for Satisfaction|Overall Study||30
8268460|NCT01746368|20387649|P2|Analyzed for AD Completion Rate|Overall Study||17
8268461|NCT01746368|20387650|P1|Analyzed for AD Completion Rate|Overall Study||32
8268462|NCT01746368|20387649|P2|Assessment Completed|Overall Study||16
8268463|NCT01746368|20387650|P1|Assessment Completed|Overall Study||31
8268464|NCT01746368|20387649|P2|Recieved Allocated Intervention|Overall Study||8
8268465|NCT01746368|20387650|P1|Recieved Allocated Intervention|Overall Study||31
8268466|NCT01746368|20387649|P2|STARTED|Overall Study||17
8268467|NCT01746368|20387650|P1|STARTED|Overall Study||33
8268468|NCT01746264|20387658|P1|NOT COMPLETED|Overall Study||0
8268469|NCT01746264|20387658|P1|COMPLETED|Overall Study||19
8268470|NCT01746264|20387658|P1|STARTED|Overall Study||19
8268471|NCT01746225|20387680|P3|NOT COMPLETED|Overall Study||43
8268472|NCT01746225|20387681|P2|NOT COMPLETED|Overall Study||46
8268473|NCT01746225|20387682|P1|NOT COMPLETED|Overall Study||40
8268474|NCT01746225|20387680|P3|COMPLETED|Overall Study||43
8268475|NCT01746225|20387681|P2|COMPLETED|Overall Study||40
8268476|NCT01746225|20387682|P1|COMPLETED|Overall Study||43
8268477|NCT01746225|20387680|P3|STARTED|Overall Study||86
8268478|NCT01746225|20387681|P2|STARTED|Overall Study||86
8268479|NCT01746225|20387682|P1|STARTED|Overall Study||83
8268480|NCT01746173|20387705|P1|NOT COMPLETED|Overall Study||2
8268481|NCT01746173|20387705|P1|COMPLETED|Overall Study||3
8268482|NCT01746173|20387705|P1|STARTED|Overall Study||5
8268483|NCT01746108|20387713|P3|NOT COMPLETED|Overall Study||0
8268484|NCT01746108|20387714|P2|NOT COMPLETED|Overall Study||4
8268485|NCT01746108|20387715|P1|NOT COMPLETED|Overall Study||0
8268486|NCT01746108|20387713|P3|COMPLETED|Overall Study||6
8268487|NCT01746108|20387714|P2|COMPLETED|Overall Study||24
8268488|NCT01746108|20387715|P1|COMPLETED|Overall Study||18
8268489|NCT01746108|20387713|P3|STARTED|Overall Study||6
8268490|NCT01746108|20387714|P2|STARTED|Overall Study||28
8268491|NCT01746108|20387715|P1|STARTED|Overall Study||18
8268492|NCT01746095|20387755|P4|NOT COMPLETED|Overall Study||8
8268493|NCT01746095|20387756|P3|NOT COMPLETED|Overall Study||13
8268494|NCT01746095|20387757|P2|NOT COMPLETED|Overall Study||4
8268495|NCT01746095|20387758|P1|NOT COMPLETED|Overall Study||4
8268496|NCT01746095|20387755|P4|COMPLETED|Overall Study||15
8268497|NCT01746095|20387756|P3|COMPLETED|Overall Study||11
8268498|NCT01746095|20387757|P2|COMPLETED|Overall Study||16
8268499|NCT01746095|20387758|P1|COMPLETED|Overall Study||16
8268500|NCT01746095|20387755|P4|STARTED|Overall Study||23
8268501|NCT01746095|20387756|P3|STARTED|Overall Study||24
8268502|NCT01746095|20387757|P2|STARTED|Overall Study||20
8268503|NCT01746095|20387758|P1|STARTED|Overall Study||20
8268504|NCT01746043|20387808|P4|NOT COMPLETED|Overall Study||0
8268505|NCT01746043|20387809|P3|NOT COMPLETED|Overall Study||0
8268506|NCT01746043|20387810|P2|NOT COMPLETED|Overall Study||0
8268507|NCT01746043|20387811|P1|NOT COMPLETED|Overall Study||0
8268508|NCT01746043|20387808|P4|COMPLETED|Overall Study||5
8268509|NCT01746043|20387809|P3|COMPLETED|Overall Study||5
8268510|NCT01746043|20387810|P2|COMPLETED|Overall Study||4
8268511|NCT01746043|20387811|P1|COMPLETED|Overall Study||5
8268512|NCT01746043|20387808|P4|STARTED|Overall Study||5
8268513|NCT01746043|20387809|P3|STARTED|Overall Study||5
8268514|NCT01746043|20387810|P2|STARTED|Overall Study||4
8268515|NCT01746043|20387811|P1|STARTED|Overall Study||5
8268516|NCT01746017|20387832|P11|NOT COMPLETED|Period 4||0
8268517|NCT01746017|20387833|P10|NOT COMPLETED|Period 4||0
8268518|NCT01746017|20387834|P9|NOT COMPLETED|Period 4||0
8268519|NCT01746017|20387835|P8|NOT COMPLETED|Period 4||0
8268520|NCT01746017|20387836|P7|NOT COMPLETED|Period 4||0
8268521|NCT01746017|20387837|P6|NOT COMPLETED|Period 4||0
8268522|NCT01746017|20387838|P5|NOT COMPLETED|Period 4||0
8268523|NCT01746017|20387839|P4|NOT COMPLETED|Period 4||0
8268524|NCT01746017|20387840|P3|NOT COMPLETED|Period 4||0
8268525|NCT01746017|20387841|P2|NOT COMPLETED|Period 4||0
8268526|NCT01746017|20387842|P1|NOT COMPLETED|Period 4||0
8268527|NCT01746017|20387832|P11|COMPLETED|Period 4||0
8268528|NCT01746017|20387833|P10|COMPLETED|Period 4||0
8268529|NCT01746017|20387834|P9|COMPLETED|Period 4||0
8268530|NCT01746017|20387835|P8|COMPLETED|Period 4||2
8268531|NCT01746017|20387836|P7|COMPLETED|Period 4||2
8268532|NCT01746017|20387837|P6|COMPLETED|Period 4||1
8268533|NCT01746017|20387838|P5|COMPLETED|Period 4||2
8268534|NCT01746017|20387839|P4|COMPLETED|Period 4||2
8268535|NCT01746017|20387840|P3|COMPLETED|Period 4||2
8268536|NCT01746017|20387841|P2|COMPLETED|Period 4||2
8268537|NCT01746017|20387842|P1|COMPLETED|Period 4||2
8268538|NCT01746017|20387832|P11|STARTED|Period 4|Part B occurred only for 3 periods.|0
8268539|NCT01746017|20387833|P10|STARTED|Period 4|Part B occurred only for 3 periods.|0
8268540|NCT01746017|20387834|P9|STARTED|Period 4|Part B occurred only for 3 periods.|0
8268541|NCT01746017|20387835|P8|STARTED|Period 4||2
8268542|NCT01746017|20387836|P7|STARTED|Period 4||2
8268543|NCT01746017|20387837|P6|STARTED|Period 4||1
8268544|NCT01746017|20387838|P5|STARTED|Period 4||2
8268545|NCT01746017|20387839|P4|STARTED|Period 4||2
8268546|NCT01746017|20387840|P3|STARTED|Period 4||2
8268547|NCT01746017|20387841|P2|STARTED|Period 4||2
8268548|NCT01746017|20387842|P1|STARTED|Period 4||2
8268549|NCT01746017|20387832|P11|NOT COMPLETED|Period 3||0
8268550|NCT01746017|20387833|P10|NOT COMPLETED|Period 3||0
8268551|NCT01746017|20387834|P9|NOT COMPLETED|Period 3||0
8268552|NCT01746017|20387835|P8|NOT COMPLETED|Period 3||0
8268553|NCT01746017|20387836|P7|NOT COMPLETED|Period 3||0
8268554|NCT01746017|20387837|P6|NOT COMPLETED|Period 3||1
8268555|NCT01746017|20387838|P5|NOT COMPLETED|Period 3||0
8268556|NCT01746017|20387839|P4|NOT COMPLETED|Period 3||0
8268557|NCT01746017|20387840|P3|NOT COMPLETED|Period 3||0
8268558|NCT01746017|20387841|P2|NOT COMPLETED|Period 3||0
8268559|NCT01746017|20387842|P1|NOT COMPLETED|Period 3||0
8268560|NCT01746017|20387832|P11|COMPLETED|Period 3||3
8268561|NCT01746017|20387833|P10|COMPLETED|Period 3||3
8268562|NCT01746017|20387834|P9|COMPLETED|Period 3||3
8268563|NCT01746017|20387835|P8|COMPLETED|Period 3||2
8268564|NCT01746017|20387836|P7|COMPLETED|Period 3||2
8268565|NCT01746017|20387837|P6|COMPLETED|Period 3||1
8268566|NCT01746017|20387838|P5|COMPLETED|Period 3||2
8268567|NCT01746017|20387839|P4|COMPLETED|Period 3||2
8268568|NCT01746017|20387840|P3|COMPLETED|Period 3||2
8268569|NCT01746017|20387841|P2|COMPLETED|Period 3||2
8268570|NCT01746017|20387842|P1|COMPLETED|Period 3||2
8268571|NCT01746017|20387832|P11|STARTED|Period 3||3
8268572|NCT01746017|20387833|P10|STARTED|Period 3||3
8268573|NCT01746017|20387834|P9|STARTED|Period 3||3
8268574|NCT01746017|20387835|P8|STARTED|Period 3||2
8268575|NCT01746017|20387836|P7|STARTED|Period 3||2
8268576|NCT01746017|20387837|P6|STARTED|Period 3||2
8268577|NCT01746017|20387838|P5|STARTED|Period 3||2
8268578|NCT01746017|20387839|P4|STARTED|Period 3||2
8268579|NCT01746017|20387840|P3|STARTED|Period 3||2
8268580|NCT01746017|20387841|P2|STARTED|Period 3||2
8268581|NCT01746017|20387842|P1|STARTED|Period 3||2
8268582|NCT01746017|20387832|P11|NOT COMPLETED|Period 2||0
8268583|NCT01746017|20387833|P10|NOT COMPLETED|Period 2||0
8268584|NCT01746017|20387834|P9|NOT COMPLETED|Period 2||0
8268585|NCT01746017|20387835|P8|NOT COMPLETED|Period 2||0
8268586|NCT01746017|20387836|P7|NOT COMPLETED|Period 2||0
8268587|NCT01746017|20387837|P6|NOT COMPLETED|Period 2||0
8268588|NCT01746017|20387838|P5|NOT COMPLETED|Period 2||0
8268589|NCT01746017|20387839|P4|NOT COMPLETED|Period 2||0
8268590|NCT01746017|20387840|P3|NOT COMPLETED|Period 2||0
8268591|NCT01746017|20387841|P2|NOT COMPLETED|Period 2||0
8268592|NCT01746017|20387842|P1|NOT COMPLETED|Period 2||0
8268593|NCT01746017|20387832|P11|COMPLETED|Period 2||3
8268594|NCT01746017|20387833|P10|COMPLETED|Period 2||3
8268595|NCT01746017|20387834|P9|COMPLETED|Period 2||3
8268596|NCT01746017|20387835|P8|COMPLETED|Period 2||2
8268597|NCT01746017|20387836|P7|COMPLETED|Period 2||2
8268598|NCT01746017|20387837|P6|COMPLETED|Period 2||2
8268599|NCT01746017|20387838|P5|COMPLETED|Period 2||2
8268600|NCT01746017|20387839|P4|COMPLETED|Period 2||2
8268601|NCT01746017|20387840|P3|COMPLETED|Period 2||2
8268602|NCT01746017|20387841|P2|COMPLETED|Period 2||2
8268603|NCT01746017|20387842|P1|COMPLETED|Period 2||2
8268604|NCT01746017|20387832|P11|STARTED|Period 2||3
8268605|NCT01746017|20387833|P10|STARTED|Period 2||3
8268606|NCT01746017|20387834|P9|STARTED|Period 2||3
8268607|NCT01746017|20387835|P8|STARTED|Period 2||2
8268608|NCT01746017|20387836|P7|STARTED|Period 2||2
8268609|NCT01746017|20387837|P6|STARTED|Period 2||2
8268610|NCT01746017|20387838|P5|STARTED|Period 2||2
8268611|NCT01746017|20387839|P4|STARTED|Period 2||2
8268612|NCT01746017|20387840|P3|STARTED|Period 2||2
8268613|NCT01746017|20387841|P2|STARTED|Period 2||2
8268614|NCT01746017|20387842|P1|STARTED|Period 2||2
8268615|NCT01746017|20387832|P11|NOT COMPLETED|Period 1||0
8268616|NCT01746017|20387833|P10|NOT COMPLETED|Period 1||0
8268617|NCT01746017|20387834|P9|NOT COMPLETED|Period 1||0
8268618|NCT01746017|20387835|P8|NOT COMPLETED|Period 1||0
8268619|NCT01746017|20387836|P7|NOT COMPLETED|Period 1||1
8268620|NCT01746017|20387837|P6|NOT COMPLETED|Period 1||0
8268621|NCT01746017|20387838|P5|NOT COMPLETED|Period 1||0
8268622|NCT01746017|20387839|P4|NOT COMPLETED|Period 1||0
8268623|NCT01746017|20387840|P3|NOT COMPLETED|Period 1||0
8268624|NCT01746017|20387841|P2|NOT COMPLETED|Period 1||0
8268625|NCT01746017|20387842|P1|NOT COMPLETED|Period 1||0
8268626|NCT01746017|20387832|P11|COMPLETED|Period 1||3
8268627|NCT01746017|20387833|P10|COMPLETED|Period 1||3
8268628|NCT01746017|20387834|P9|COMPLETED|Period 1||3
8268629|NCT01746017|20387835|P8|COMPLETED|Period 1||2
8268630|NCT01746017|20387836|P7|COMPLETED|Period 1||2
8268631|NCT01746017|20387837|P6|COMPLETED|Period 1||2
8268632|NCT01746017|20387838|P5|COMPLETED|Period 1||2
8268633|NCT01746017|20387839|P4|COMPLETED|Period 1||2
8268634|NCT01746017|20387840|P3|COMPLETED|Period 1||2
8268635|NCT01746017|20387841|P2|COMPLETED|Period 1||2
8268636|NCT01746017|20387842|P1|COMPLETED|Period 1||2
8268637|NCT01746017|20387832|P11|Received at Least 1 Dose of Study Drug|Period 1||3
8268638|NCT01746017|20387833|P10|Received at Least 1 Dose of Study Drug|Period 1||3
8268639|NCT01746017|20387834|P9|Received at Least 1 Dose of Study Drug|Period 1||3
8268640|NCT01746017|20387835|P8|Received at Least 1 Dose of Study Drug|Period 1||2
8268641|NCT01746017|20387836|P7|Received at Least 1 Dose of Study Drug|Period 1||3
8268642|NCT01746017|20387837|P6|Received at Least 1 Dose of Study Drug|Period 1||2
8268643|NCT01746017|20387838|P5|Received at Least 1 Dose of Study Drug|Period 1||2
8268644|NCT01746017|20387839|P4|Received at Least 1 Dose of Study Drug|Period 1||2
8268645|NCT01746017|20387840|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8268646|NCT01746017|20387841|P2|Received at Least 1 Dose of Study Drug|Period 1||2
8268647|NCT01746017|20387842|P1|Received at Least 1 Dose of Study Drug|Period 1||2
8268648|NCT01746017|20387832|P11|STARTED|Period 1||3
8268649|NCT01746017|20387833|P10|STARTED|Period 1||3
8268650|NCT01746017|20387834|P9|STARTED|Period 1||3
8268651|NCT01746017|20387835|P8|STARTED|Period 1||2
8268652|NCT01746017|20387836|P7|STARTED|Period 1||3
8268653|NCT01746017|20387837|P6|STARTED|Period 1||2
8268654|NCT01746017|20387838|P5|STARTED|Period 1||2
8268655|NCT01746017|20387839|P4|STARTED|Period 1||2
8268656|NCT01746017|20387840|P3|STARTED|Period 1||2
8268657|NCT01746017|20387841|P2|STARTED|Period 1||2
8268658|NCT01746017|20387842|P1|STARTED|Period 1||2
8268659|NCT01745952|20387918|P3|NOT COMPLETED|Overall Study||0
8268660|NCT01745952|20387919|P2|NOT COMPLETED|Overall Study||1
8268661|NCT01745952|20387920|P1|NOT COMPLETED|Overall Study||1
8268662|NCT01745952|20387918|P3|COMPLETED|Overall Study||3
8268663|NCT01745952|20387919|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
8268664|NCT01745952|20387920|P1|COMPLETED|Overall Study||3
8268665|NCT01745952|20387918|P3|STARTED|Overall Study||3
8268666|NCT01745952|20387919|P2|STARTED|Overall Study||4
8268667|NCT01745952|20387920|P1|STARTED|Overall Study||4
8268668|NCT01745913|20387946|P2|NOT COMPLETED|Overall Study||1
8268669|NCT01745913|20387947|P1|NOT COMPLETED|Overall Study||1
8268670|NCT01745913|20387946|P2|COMPLETED|Overall Study||0
8268671|NCT01745913|20387947|P1|COMPLETED|Overall Study||0
8268672|NCT01745913|20387946|P2|STARTED|Overall Study||1
8268673|NCT01745913|20387947|P1|STARTED|Overall Study||1
8268674|NCT01745848|20387963|P1|NOT COMPLETED|Overall Study||6
8268675|NCT01745848|20387963|P1|COMPLETED|Overall Study||20
8268676|NCT01745848|20387963|P1|STARTED|Overall Study||26
8268677|NCT01745627|20387968|P1|NOT COMPLETED|Overall Study||22
8268678|NCT01745627|20387968|P1|COMPLETED|Overall Study||20
8268679|NCT01745627|20387968|P1|STARTED|Overall Study||42
8268680|NCT01745393|20387975|P2|NOT COMPLETED|12-month Follow-up||5
8268681|NCT01745393|20387976|P1|NOT COMPLETED|12-month Follow-up||6
8268682|NCT01745393|20387975|P2|COMPLETED|12-month Follow-up||151
8268683|NCT01745393|20387976|P1|COMPLETED|12-month Follow-up||136
8268684|NCT01745393|20387975|P2|STARTED|12-month Follow-up||156
8268685|NCT01745393|20387976|P1|STARTED|12-month Follow-up||142
8268686|NCT01745393|20387975|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
8268687|NCT01745393|20387976|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
8268688|NCT01745393|20387975|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
8268689|NCT01745393|20387976|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
8268690|NCT01745393|20387975|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
8268691|NCT01745393|20387976|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
8268692|NCT01745393|20387975|P2|STARTED|Treatment to End-of-treatment Assessment||164
8268693|NCT01745393|20387976|P1|STARTED|Treatment to End-of-treatment Assessment||163
8268694|NCT01745380|20387988|P2|NOT COMPLETED|Overall Study||1
8268695|NCT01745380|20387989|P1|NOT COMPLETED|Overall Study||1
8268696|NCT01745380|20387988|P2|COMPLETED|Overall Study||49
8268697|NCT01745380|20387989|P1|COMPLETED|Overall Study||99
8268698|NCT01745380|20387988|P2|STARTED|Overall Study||50
8268699|NCT01745380|20387989|P1|STARTED|Overall Study||100
8268700|NCT01745367|20388027|P2|NOT COMPLETED|Overall Study||22
8268701|NCT01745367|20388028|P1|NOT COMPLETED|Overall Study||8
8268702|NCT01745367|20388027|P2|COMPLETED|Overall Study||0
8268703|NCT01745367|20388028|P1|COMPLETED|Overall Study||0
8268704|NCT01745367|20388027|P2|Treated|Overall Study||21
8268705|NCT01745367|20388028|P1|Treated|Overall Study||8
8268706|NCT01745367|20388027|P2|STARTED|Overall Study||22
8268707|NCT01745367|20388028|P1|STARTED|Overall Study||8
8268708|NCT01745146|20388048|P2|NOT COMPLETED|Overall Study||3
8268709|NCT01745146|20388049|P1|NOT COMPLETED|Overall Study||3
8268710|NCT01745146|20388048|P2|COMPLETED|Overall Study||57
8268711|NCT01745146|20388049|P1|COMPLETED|Overall Study||27
8268712|NCT01745146|20388048|P2|Analysis|Overall Study||57
8268713|NCT01745146|20388049|P1|Analysis|Overall Study||27
8268714|NCT01745146|20388048|P2|Primary Outcome Assessment|Overall Study||57
8268715|NCT01745146|20388049|P1|Primary Outcome Assessment|Overall Study||27
8268716|NCT01745146|20388048|P2|Allocation to Intervention|Overall Study||60
8268717|NCT01745146|20388049|P1|Allocation to Intervention|Overall Study||30
8268718|NCT01745146|20388048|P2|STARTED|Overall Study||60
8268719|NCT01745146|20388049|P1|STARTED|Overall Study||30
8268720|NCT01745133|20388059|P3|NOT COMPLETED|Overall Study||4
8268721|NCT01745133|20388060|P2|NOT COMPLETED|Overall Study||4
8268722|NCT01745133|20388061|P1|NOT COMPLETED|Overall Study||6
8268723|NCT01745133|20388059|P3|COMPLETED|Overall Study||15
8268724|NCT01745133|20388060|P2|COMPLETED|Overall Study||16
8268725|NCT01745133|20388061|P1|COMPLETED|Overall Study||13
8268726|NCT01745133|20388059|P3|STARTED|Overall Study||19
8268727|NCT01745133|20388060|P2|STARTED|Overall Study||20
8268728|NCT01745133|20388061|P1|STARTED|Overall Study||19
8268729|NCT01745120|20388071|P2|NOT COMPLETED|Overall Study||0
8268730|NCT01745120|20388072|P1|NOT COMPLETED|Overall Study||1
8268731|NCT01745120|20388071|P2|COMPLETED|Overall Study||8
8268732|NCT01745120|20388072|P1|COMPLETED|Overall Study||10
8268733|NCT01745120|20388071|P2|STARTED|Overall Study||8
8268734|NCT01745120|20388072|P1|STARTED|Overall Study||11
8268735|NCT01745094|20388130|P4|NOT COMPLETED|Overall Study||3
8268736|NCT01745094|20388131|P3|NOT COMPLETED|Overall Study||12
8268737|NCT01745094|20388132|P2|NOT COMPLETED|Overall Study||0
8268738|NCT01745094|20388133|P1|NOT COMPLETED|Overall Study||5
8268739|NCT01745094|20388130|P4|COMPLETED|Overall Study||90
8268740|NCT01745094|20388131|P3|COMPLETED|Overall Study||46
8268741|NCT01745094|20388132|P2|COMPLETED|Overall Study||37
8268742|NCT01745094|20388133|P1|COMPLETED|Overall Study||30
8268743|NCT01745094|20388130|P4|STARTED|Overall Study||93
8268744|NCT01745094|20388131|P3|STARTED|Overall Study||58
8268745|NCT01745094|20388132|P2|STARTED|Overall Study||37
8268746|NCT01745094|20388133|P1|STARTED|Overall Study||35
8268747|NCT01745055|20388199|P1|NOT COMPLETED|Overall Study||0
8268748|NCT01745055|20388199|P1|COMPLETED|Overall Study||12
8268749|NCT01745055|20388199|P1|STARTED|Overall Study||12
8268750|NCT01744977|20388234|P2|NOT COMPLETED|Overall Study||5
8268751|NCT01744977|20388235|P1|NOT COMPLETED|Overall Study||11
8268752|NCT01744977|20388234|P2|COMPLETED|Overall Study||115
8268753|NCT01744977|20388235|P1|COMPLETED|Overall Study||109
8268754|NCT01744977|20388234|P2|6 Month Completed|Overall Study||115
8268755|NCT01744977|20388235|P1|6 Month Completed|Overall Study||113
8268756|NCT01744977|20388234|P2|STARTED|Overall Study||120
8268757|NCT01744977|20388235|P1|STARTED|Overall Study||120
8268758|NCT01744860|20388243|P1|NOT COMPLETED|Overall Study||0
8268759|NCT01744860|20388243|P1|COMPLETED|Overall Study||420
8268760|NCT01744860|20388243|P1|STARTED|Overall Study||420
8268761|NCT01744821|20388281|P4|NOT COMPLETED|Overall Study||0
8268762|NCT01744821|20388282|P3|NOT COMPLETED|Overall Study||0
8268763|NCT01744821|20388283|P2|NOT COMPLETED|Overall Study||0
8268764|NCT01744821|20388284|P1|NOT COMPLETED|Overall Study||0
8268765|NCT01744821|20388281|P4|COMPLETED|Overall Study||1
8268766|NCT01744821|20388282|P3|COMPLETED|Overall Study||2
8268767|NCT01744821|20388283|P2|COMPLETED|Overall Study||3
8268768|NCT01744821|20388284|P1|COMPLETED|Overall Study||1
8268769|NCT01744821|20388281|P4|STARTED|Overall Study||1
8268770|NCT01744821|20388282|P3|STARTED|Overall Study||2
8268771|NCT01744821|20388283|P2|STARTED|Overall Study||3
8268772|NCT01744821|20388284|P1|STARTED|Overall Study||1
8268773|NCT01744782|20388306|P1|NOT COMPLETED|Overall Study||1
8268774|NCT01744782|20388306|P1|COMPLETED|Overall Study||16
8268775|NCT01744782|20388306|P1|STARTED|Overall Study||17
8268776|NCT01744730|20388319|P5|NOT COMPLETED|Overall Study||0
8268777|NCT01744730|20388320|P4|NOT COMPLETED|Overall Study||0
8268778|NCT01744730|20388321|P3|NOT COMPLETED|Overall Study||0
8268779|NCT01744730|20388322|P2|NOT COMPLETED|Overall Study||0
8268780|NCT01744730|20388323|P1|NOT COMPLETED|Overall Study||0
8268781|NCT01744730|20388319|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
8268782|NCT01744730|20388320|P4|COMPLETED|Overall Study||11
8268783|NCT01744730|20388321|P3|COMPLETED|Overall Study||4
8268784|NCT01744730|20388322|P2|COMPLETED|Overall Study||3
8268785|NCT01744730|20388323|P1|COMPLETED|Overall Study||4
8268786|NCT01744730|20388319|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
8268787|NCT01744730|20388320|P4|STARTED|Overall Study||11
8268788|NCT01744730|20388321|P3|STARTED|Overall Study||4
8268789|NCT01744730|20388322|P2|STARTED|Overall Study||3
8268790|NCT01744730|20388323|P1|STARTED|Overall Study||4
8268791|NCT01744704|20388377|P12|NOT COMPLETED|Overall Study||0
8268792|NCT01744704|20388378|P11|NOT COMPLETED|Overall Study||0
8268793|NCT01744704|20388379|P10|NOT COMPLETED|Overall Study||0
8268794|NCT01744704|20388380|P9|NOT COMPLETED|Overall Study||0
8268795|NCT01744704|20388381|P8|NOT COMPLETED|Overall Study||0
8268796|NCT01744704|20388382|P7|NOT COMPLETED|Overall Study||0
8268797|NCT01744704|20388383|P6|NOT COMPLETED|Overall Study||0
8268798|NCT01744704|20388384|P5|NOT COMPLETED|Overall Study||0
8268799|NCT01744704|20388385|P4|NOT COMPLETED|Overall Study||0
8268800|NCT01744704|20388386|P3|NOT COMPLETED|Overall Study||0
8268801|NCT01744704|20388387|P2|NOT COMPLETED|Overall Study||0
8268802|NCT01744704|20388388|P1|NOT COMPLETED|Overall Study||0
8268803|NCT01744704|20388377|P12|COMPLETED|Overall Study||10
8268804|NCT01744704|20388378|P11|COMPLETED|Overall Study||9
8268805|NCT01744704|20388379|P10|COMPLETED|Overall Study||9
8268806|NCT01744704|20388380|P9|COMPLETED|Overall Study||3
8268807|NCT01744704|20388381|P8|COMPLETED|Overall Study||9
8268808|NCT01744704|20388382|P7|COMPLETED|Overall Study||6
8268809|NCT01744704|20388383|P6|COMPLETED|Overall Study||7
8268810|NCT01744704|20388384|P5|COMPLETED|Overall Study||6
8268811|NCT01744704|20388385|P4|COMPLETED|Overall Study||6
8268812|NCT01744704|20388386|P3|COMPLETED|Overall Study||3
8268813|NCT01744704|20388387|P2|COMPLETED|Overall Study||3
8268814|NCT01744704|20388388|P1|COMPLETED|Overall Study||3
8268815|NCT01744704|20388377|P12|STARTED|Overall Study||10
8268816|NCT01744704|20388378|P11|STARTED|Overall Study||9
8268817|NCT01744704|20388379|P10|STARTED|Overall Study||9
8268818|NCT01744704|20388380|P9|STARTED|Overall Study||3
8268819|NCT01744704|20388381|P8|STARTED|Overall Study||9
8268820|NCT01744704|20388382|P7|STARTED|Overall Study||6
8268821|NCT01744704|20388383|P6|STARTED|Overall Study||7
8268822|NCT01744704|20388384|P5|STARTED|Overall Study||6
8268823|NCT01744704|20388385|P4|STARTED|Overall Study||6
8268824|NCT01744704|20388386|P3|STARTED|Overall Study||3
8268825|NCT01744704|20388387|P2|STARTED|Overall Study||3
8268826|NCT01744704|20388388|P1|STARTED|Overall Study||3
8268827|NCT01744691|20388467|P1|NOT COMPLETED|Overall Study||43
8268828|NCT01744691|20388467|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
8268829|NCT01744691|20388467|P1|STARTED|Overall Study|Participants who received study treatment|144
8268830|NCT01744665|20388472|P1|NOT COMPLETED|Re-initiation Phase||13
8268831|NCT01744665|20388472|P1|COMPLETED|Re-initiation Phase||4
8268832|NCT01744665|20388472|P1|STARTED|Re-initiation Phase||17
8268833|NCT01744665|20388472|P1|NOT COMPLETED|Treatment Free Remission Phase||0
8268834|NCT01744665|20388472|P1|COMPLETED|Treatment Free Remission Phase||32
8268835|NCT01744665|20388472|P1|STARTED|Treatment Free Remission Phase||32
8268836|NCT01744665|20388472|P1|NOT COMPLETED|Consolidation Phase||19
8268837|NCT01744665|20388472|P1|COMPLETED|Consolidation Phase||22
8268838|NCT01744665|20388472|P1|STARTED|Consolidation Phase||41
8268839|NCT01744665|20388472|P1|NOT COMPLETED|Monitoring Phase||18
8268840|NCT01744665|20388472|P1|COMPLETED|Monitoring Phase||41
8268841|NCT01744665|20388472|P1|STARTED|Monitoring Phase||59
8268842|NCT01744574|20388503|P4|NOT COMPLETED|Overall Study||11
8268843|NCT01744574|20388504|P3|NOT COMPLETED|Overall Study||20
8268844|NCT01744574|20388505|P2|NOT COMPLETED|Overall Study||25
8268845|NCT01744574|20388506|P1|NOT COMPLETED|Overall Study||24
8268846|NCT01744574|20388503|P4|COMPLETED|Overall Study||40
8268847|NCT01744574|20388504|P3|COMPLETED|Overall Study||32
8268848|NCT01744574|20388505|P2|COMPLETED|Overall Study||31
8268849|NCT01744574|20388506|P1|COMPLETED|Overall Study||33
8268850|NCT01744574|20388503|P4|STARTED|Overall Study||51
8268851|NCT01744574|20388504|P3|STARTED|Overall Study||52
8268852|NCT01744574|20388505|P2|STARTED|Overall Study||56
8268853|NCT01744574|20388506|P1|STARTED|Overall Study||57
8268854|NCT01744496|20388542|P2|NOT COMPLETED|Maintenance Period||4
8268855|NCT01744496|20388543|P1|NOT COMPLETED|Maintenance Period||4
8268856|NCT01744496|20388542|P2|COMPLETED|Maintenance Period||29
8268857|NCT01744496|20388543|P1|COMPLETED|Maintenance Period||27
8268858|NCT01744496|20388542|P2|STARTED|Maintenance Period||33
8268859|NCT01744496|20388543|P1|STARTED|Maintenance Period||31
8268860|NCT01744496|20388542|P2|NOT COMPLETED|Titration Period||2
8268861|NCT01744496|20388543|P1|NOT COMPLETED|Titration Period||2
8268862|NCT01744496|20388542|P2|COMPLETED|Titration Period||33
8268863|NCT01744496|20388543|P1|COMPLETED|Titration Period||31
8268864|NCT01744496|20388542|P2|STARTED|Titration Period||35
8268865|NCT01744496|20388543|P1|STARTED|Titration Period||33
8268866|NCT01744483|20388564|P3|NOT COMPLETED|Overall Study||28
8268867|NCT01744483|20388565|P2|NOT COMPLETED|Overall Study||22
8268868|NCT01744483|20388566|P1|NOT COMPLETED|Overall Study||29
8268869|NCT01744483|20388564|P3|COMPLETED|Overall Study||10
8268870|NCT01744483|20388565|P2|COMPLETED|Overall Study||13
8268871|NCT01744483|20388566|P1|COMPLETED|Overall Study||15
8268872|NCT01744483|20388564|P3|STARTED|Overall Study||38
8268873|NCT01744483|20388565|P2|STARTED|Overall Study||35
8268874|NCT01744483|20388566|P1|STARTED|Overall Study||44
8268875|NCT01744392|20388574|P1|NOT COMPLETED|Overall Study||1
8268876|NCT01744392|20388574|P1|COMPLETED|Overall Study||22
8268877|NCT01744392|20388574|P1|STARTED|Overall Study||23
8268878|NCT01744353|20388590|P3|NOT COMPLETED|Overall Study||0
8268879|NCT01744353|20388591|P2|NOT COMPLETED|Overall Study||0
8268880|NCT01744353|20388592|P1|NOT COMPLETED|Overall Study||0
8268881|NCT01744353|20388590|P3|COMPLETED|Overall Study||3
8268882|NCT01744353|20388591|P2|COMPLETED|Overall Study||26
8268883|NCT01744353|20388592|P1|COMPLETED|Overall Study||6
8268884|NCT01744353|20388590|P3|STARTED|Overall Study||3
8268885|NCT01744353|20388591|P2|STARTED|Overall Study||26
8268886|NCT01744353|20388592|P1|STARTED|Overall Study||6
8268887|NCT01744340|20388603|P2|NOT COMPLETED|Overall Study||0
8268888|NCT01744340|20388604|P1|NOT COMPLETED|Overall Study||0
8268889|NCT01744340|20388603|P2|COMPLETED|Overall Study||15
8268890|NCT01744340|20388604|P1|COMPLETED|Overall Study||8
8268891|NCT01744340|20388603|P2|STARTED|Overall Study||15
8268892|NCT01744340|20388604|P1|STARTED|Overall Study||8
8268893|NCT01744197|20388614|P2|NOT COMPLETED|Overall Study||3
8268894|NCT01744197|20388615|P1|NOT COMPLETED|Overall Study||4
8268895|NCT01744197|20388614|P2|COMPLETED|Overall Study||26
8268896|NCT01744197|20388615|P1|COMPLETED|Overall Study||28
8268897|NCT01744197|20388614|P2|STARTED|Overall Study||29
8268898|NCT01744197|20388615|P1|STARTED|Overall Study||32
8268899|NCT01744093|20388627|P2|NOT COMPLETED|Overall Study||1
8268900|NCT01744093|20388628|P1|NOT COMPLETED|Overall Study||6
8268901|NCT01744093|20388627|P2|COMPLETED|Overall Study||8
8268902|NCT01744093|20388628|P1|COMPLETED|Overall Study||12
8268903|NCT01744093|20388627|P2|STARTED|Overall Study||9
8268904|NCT01744093|20388628|P1|STARTED|Overall Study||18
8268905|NCT01743976|20388638|P2|NOT COMPLETED|Overall Study||0
8268906|NCT01743976|20388639|P1|NOT COMPLETED|Overall Study||0
8268907|NCT01743976|20388638|P2|COMPLETED|Overall Study||3
8268908|NCT01743976|20388639|P1|COMPLETED|Overall Study||2
8268909|NCT01743976|20388638|P2|STARTED|Overall Study||3
8268910|NCT01743976|20388639|P1|STARTED|Overall Study||2
8268911|NCT01743963|20388651|P2|NOT COMPLETED|Overall Study||0
8268912|NCT01743963|20388652|P1|NOT COMPLETED|Overall Study||0
8268913|NCT01743963|20388651|P2|COMPLETED|Overall Study||17
8268914|NCT01743963|20388652|P1|COMPLETED|Overall Study||21
8268915|NCT01743963|20388651|P2|STARTED|Overall Study||17
8268916|NCT01743963|20388652|P1|STARTED|Overall Study||21
8268917|NCT01743859|20388658|P1|NOT COMPLETED|Overall Study||9
8268918|NCT01743859|20388658|P1|COMPLETED|Overall Study||28
8268919|NCT01743859|20388658|P1|STARTED|Overall Study||37
8268920|NCT01743729|20388670|P2|NOT COMPLETED|Overall Study||12
8268921|NCT01743729|20388671|P1|NOT COMPLETED|Overall Study||37
8268922|NCT01743729|20388670|P2|COMPLETED|Overall Study||348
8268923|NCT01743729|20388671|P1|COMPLETED|Overall Study||321
8268924|NCT01743729|20388670|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
8268925|NCT01743729|20388671|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
8268926|NCT01743677|20388679|P6|NOT COMPLETED|Third Intervention Period||0
8268927|NCT01743677|20388680|P5|NOT COMPLETED|Third Intervention Period||0
8268928|NCT01743677|20388681|P4|NOT COMPLETED|Third Intervention Period||0
8268929|NCT01743677|20388682|P3|NOT COMPLETED|Third Intervention Period||0
8268930|NCT01743677|20388683|P2|NOT COMPLETED|Third Intervention Period||0
8268931|NCT01743677|20388684|P1|NOT COMPLETED|Third Intervention Period||0
8268932|NCT01743677|20388679|P6|COMPLETED|Third Intervention Period||10
8268933|NCT01743677|20388680|P5|COMPLETED|Third Intervention Period||10
8268934|NCT01743677|20388681|P4|COMPLETED|Third Intervention Period||10
8268935|NCT01743677|20388682|P3|COMPLETED|Third Intervention Period||10
8268936|NCT01743677|20388683|P2|COMPLETED|Third Intervention Period||10
8268937|NCT01743677|20388684|P1|COMPLETED|Third Intervention Period||10
8268938|NCT01743677|20388679|P6|STARTED|Third Intervention Period||10
8268939|NCT01743677|20388680|P5|STARTED|Third Intervention Period||10
8268940|NCT01743677|20388681|P4|STARTED|Third Intervention Period||10
8268941|NCT01743677|20388682|P3|STARTED|Third Intervention Period||10
8268942|NCT01743677|20388683|P2|STARTED|Third Intervention Period||10
8268943|NCT01743677|20388684|P1|STARTED|Third Intervention Period||10
8268944|NCT01743677|20388679|P6|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268945|NCT01743677|20388680|P5|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268946|NCT01743677|20388681|P4|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268947|NCT01743677|20388682|P3|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268948|NCT01743677|20388683|P2|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268949|NCT01743677|20388684|P1|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268950|NCT01743677|20388679|P6|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268951|NCT01743677|20388680|P5|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268952|NCT01743677|20388681|P4|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268953|NCT01743677|20388682|P3|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268954|NCT01743677|20388683|P2|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268955|NCT01743677|20388684|P1|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268956|NCT01743677|20388679|P6|STARTED|Washout Period 2 (at Least 7 Days)||10
8268957|NCT01743677|20388680|P5|STARTED|Washout Period 2 (at Least 7 Days)||10
8268958|NCT01743677|20388681|P4|STARTED|Washout Period 2 (at Least 7 Days)||10
8268959|NCT01743677|20388682|P3|STARTED|Washout Period 2 (at Least 7 Days)||10
8268960|NCT01743677|20388683|P2|STARTED|Washout Period 2 (at Least 7 Days)||10
8268961|NCT01743677|20388684|P1|STARTED|Washout Period 2 (at Least 7 Days)||10
8268962|NCT01743677|20388679|P6|NOT COMPLETED|Second Intervention Period||0
8268963|NCT01743677|20388680|P5|NOT COMPLETED|Second Intervention Period||0
8268964|NCT01743677|20388681|P4|NOT COMPLETED|Second Intervention Period||0
8268965|NCT01743677|20388682|P3|NOT COMPLETED|Second Intervention Period||0
8268966|NCT01743677|20388683|P2|NOT COMPLETED|Second Intervention Period||0
8268967|NCT01743677|20388684|P1|NOT COMPLETED|Second Intervention Period||0
8268968|NCT01743677|20388679|P6|COMPLETED|Second Intervention Period||10
8268969|NCT01743677|20388680|P5|COMPLETED|Second Intervention Period||10
8268970|NCT01743677|20388681|P4|COMPLETED|Second Intervention Period||10
8268971|NCT01743677|20388682|P3|COMPLETED|Second Intervention Period||10
8268972|NCT01743677|20388683|P2|COMPLETED|Second Intervention Period||10
8268973|NCT01743677|20388684|P1|COMPLETED|Second Intervention Period||10
8268974|NCT01743677|20388679|P6|STARTED|Second Intervention Period||10
8268975|NCT01743677|20388680|P5|STARTED|Second Intervention Period||10
8268976|NCT01743677|20388681|P4|STARTED|Second Intervention Period||10
8268977|NCT01743677|20388682|P3|STARTED|Second Intervention Period||10
8268978|NCT01743677|20388683|P2|STARTED|Second Intervention Period||10
8268979|NCT01743677|20388684|P1|STARTED|Second Intervention Period||10
8268980|NCT01743677|20388679|P6|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268981|NCT01743677|20388680|P5|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268982|NCT01743677|20388681|P4|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268983|NCT01743677|20388682|P3|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268984|NCT01743677|20388683|P2|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268985|NCT01743677|20388684|P1|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268986|NCT01743677|20388679|P6|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268987|NCT01743677|20388680|P5|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268988|NCT01743677|20388681|P4|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268989|NCT01743677|20388682|P3|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268990|NCT01743677|20388683|P2|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268991|NCT01743677|20388684|P1|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268992|NCT01743677|20388679|P6|STARTED|Washout Period 1 (at Least 7 Days)||10
8268993|NCT01743677|20388680|P5|STARTED|Washout Period 1 (at Least 7 Days)||10
8268994|NCT01743677|20388681|P4|STARTED|Washout Period 1 (at Least 7 Days)||10
8268995|NCT01743677|20388682|P3|STARTED|Washout Period 1 (at Least 7 Days)||10
8268996|NCT01743677|20388683|P2|STARTED|Washout Period 1 (at Least 7 Days)||10
8268997|NCT01743677|20388684|P1|STARTED|Washout Period 1 (at Least 7 Days)||10
8268998|NCT01743677|20388679|P6|NOT COMPLETED|First Intervention Period||0
8268999|NCT01743677|20388680|P5|NOT COMPLETED|First Intervention Period||0
8269000|NCT01743677|20388681|P4|NOT COMPLETED|First Intervention Period||0
8269001|NCT01743677|20388682|P3|NOT COMPLETED|First Intervention Period||0
8269002|NCT01743677|20388683|P2|NOT COMPLETED|First Intervention Period||0
8269003|NCT01743677|20388684|P1|NOT COMPLETED|First Intervention Period||0
8269004|NCT01743677|20388679|P6|COMPLETED|First Intervention Period||10
8269005|NCT01743677|20388680|P5|COMPLETED|First Intervention Period||10
8269006|NCT01743677|20388681|P4|COMPLETED|First Intervention Period||10
8269007|NCT01743677|20388682|P3|COMPLETED|First Intervention Period||10
8269008|NCT01743677|20388683|P2|COMPLETED|First Intervention Period||10
8269009|NCT01743677|20388684|P1|COMPLETED|First Intervention Period||10
8269010|NCT01743677|20388679|P6|STARTED|First Intervention Period||10
8269011|NCT01743677|20388680|P5|STARTED|First Intervention Period||10
8269012|NCT01743677|20388681|P4|STARTED|First Intervention Period||10
8269013|NCT01743677|20388682|P3|STARTED|First Intervention Period||10
8269014|NCT01743677|20388683|P2|STARTED|First Intervention Period||10
8269015|NCT01743677|20388684|P1|STARTED|First Intervention Period||10
8269016|NCT01743560|20388721|P1|NOT COMPLETED|Overall Study||43
8269017|NCT01743560|20388721|P1|COMPLETED|Overall Study||9
8269108|NCT01742949|20388947|P1|NOT COMPLETED|Overall Study||0
8269018|NCT01743560|20388721|P1|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
8269019|NCT01743560|20388721|P1|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
8269020|NCT01743560|20388721|P1|STARTED|Overall Study||52
8269021|NCT01743521|20388748|P4|NOT COMPLETED|Overall Study||0
8269022|NCT01743521|20388749|P3|NOT COMPLETED|Overall Study||0
8269023|NCT01743521|20388750|P2|NOT COMPLETED|Overall Study||0
8269024|NCT01743521|20388751|P1|NOT COMPLETED|Overall Study||0
8269025|NCT01743521|20388748|P4|COMPLETED|Overall Study||2
8269026|NCT01743521|20388749|P3|COMPLETED|Overall Study||2
8269027|NCT01743521|20388750|P2|COMPLETED|Overall Study||3
8269028|NCT01743521|20388751|P1|COMPLETED|Overall Study||7
8269029|NCT01743521|20388748|P4|STARTED|Overall Study||2
8269030|NCT01743521|20388749|P3|STARTED|Overall Study||2
8269031|NCT01743521|20388750|P2|STARTED|Overall Study||3
8269032|NCT01743521|20388751|P1|STARTED|Overall Study||7
8269033|NCT01743469|20388805|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
8269034|NCT01743469|20388806|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
8269035|NCT01743469|20388807|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
8269036|NCT01743469|20388808|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
8269037|NCT01743469|20388805|P4|COMPLETED|Follow-up Period - Post-Treatment||5
8269038|NCT01743469|20388806|P3|COMPLETED|Follow-up Period - Post-Treatment||14
8269039|NCT01743469|20388807|P2|COMPLETED|Follow-up Period - Post-Treatment||5
8269040|NCT01743469|20388808|P1|COMPLETED|Follow-up Period - Post-Treatment||6
8269041|NCT01743469|20388805|P4|STARTED|Follow-up Period - Post-Treatment||21
8269042|NCT01743469|20388806|P3|STARTED|Follow-up Period - Post-Treatment||37
8269043|NCT01743469|20388807|P2|STARTED|Follow-up Period - Post-Treatment||53
8269044|NCT01743469|20388808|P1|STARTED|Follow-up Period - Post-Treatment||51
8269045|NCT01743469|20388805|P4|NOT COMPLETED|Active Treatment Phase||21
8269046|NCT01743469|20388806|P3|NOT COMPLETED|Active Treatment Phase||38
8269047|NCT01743469|20388807|P2|NOT COMPLETED|Active Treatment Phase||55
8269048|NCT01743469|20388808|P1|NOT COMPLETED|Active Treatment Phase||53
8269049|NCT01743469|20388805|P4|COMPLETED|Active Treatment Phase||0
8269050|NCT01743469|20388806|P3|COMPLETED|Active Treatment Phase||0
8269051|NCT01743469|20388807|P2|COMPLETED|Active Treatment Phase||0
8269052|NCT01743469|20388808|P1|COMPLETED|Active Treatment Phase||0
8269053|NCT01743469|20388805|P4|STARTED|Active Treatment Phase||21
8269054|NCT01743469|20388806|P3|STARTED|Active Treatment Phase||38
8269055|NCT01743469|20388807|P2|STARTED|Active Treatment Phase||55
8269056|NCT01743469|20388808|P1|STARTED|Active Treatment Phase||53
8269057|NCT01743131|20388850|P5|NOT COMPLETED|Overall Study||0
8269058|NCT01743131|20388851|P4|NOT COMPLETED|Overall Study||0
8269059|NCT01743131|20388852|P3|NOT COMPLETED|Overall Study||0
8269060|NCT01743131|20388853|P2|NOT COMPLETED|Overall Study||0
8269061|NCT01743131|20388854|P1|NOT COMPLETED|Overall Study||0
8269062|NCT01743131|20388850|P5|COMPLETED|Overall Study||127
8269063|NCT01743131|20388851|P4|COMPLETED|Overall Study||1
8269064|NCT01743131|20388852|P3|COMPLETED|Overall Study||43
8269065|NCT01743131|20388853|P2|COMPLETED|Overall Study||69
8269066|NCT01743131|20388854|P1|COMPLETED|Overall Study||73
8269067|NCT01743131|20388850|P5|Not Included in Analysis|Overall Study||0
8269068|NCT01743131|20388851|P4|Not Included in Analysis|Overall Study||1
8269069|NCT01743131|20388852|P3|Not Included in Analysis|Overall Study||0
8269070|NCT01743131|20388853|P2|Not Included in Analysis|Overall Study||0
8269071|NCT01743131|20388854|P1|Not Included in Analysis|Overall Study||0
8269072|NCT01743131|20388850|P5|STARTED|Overall Study||127
8269073|NCT01743131|20388851|P4|STARTED|Overall Study||1
8269074|NCT01743131|20388852|P3|STARTED|Overall Study||43
8269075|NCT01743131|20388853|P2|STARTED|Overall Study||69
8269076|NCT01743131|20388854|P1|STARTED|Overall Study||73
8269077|NCT01743092|20388873|P2|NOT COMPLETED|Overall Study||15
8269078|NCT01743092|20388874|P1|NOT COMPLETED|Overall Study||14
8269079|NCT01743092|20388873|P2|COMPLETED|Overall Study||11
8269080|NCT01743092|20388874|P1|COMPLETED|Overall Study||19
8269081|NCT01743092|20388873|P2|STARTED|Overall Study||26
8269082|NCT01743092|20388874|P1|STARTED|Overall Study||33
8269083|NCT01743040|20388882|P1|NOT COMPLETED|Overall Study||229
8269084|NCT01743040|20388882|P1|COMPLETED|Overall Study||785
8269085|NCT01743040|20388882|P1|CT and/or Standard Angiogram|Overall Study||785
8269086|NCT01743040|20388882|P1|Nuclear Stress Test|Overall Study||992
8269087|NCT01743040|20388882|P1|CADence Testing|Overall Study||1013
8269088|NCT01743040|20388882|P1|STARTED|Overall Study||1014
8269089|NCT01743027|20388890|P4|NOT COMPLETED|Overall Study||1
8269090|NCT01743027|20388891|P3|NOT COMPLETED|Overall Study||9
8269091|NCT01743027|20388892|P2|NOT COMPLETED|Overall Study||5
8269092|NCT01743027|20388893|P1|NOT COMPLETED|Overall Study||5
8269093|NCT01743027|20388890|P4|COMPLETED|Overall Study||48
8269094|NCT01743027|20388891|P3|COMPLETED|Overall Study||90
8269095|NCT01743027|20388892|P2|COMPLETED|Overall Study||94
8269096|NCT01743027|20388893|P1|COMPLETED|Overall Study||93
8269097|NCT01743027|20388890|P4|STARTED|Overall Study||49
8269098|NCT01743027|20388891|P3|STARTED|Overall Study||99
8269099|NCT01743027|20388892|P2|STARTED|Overall Study||99
8269100|NCT01743027|20388893|P1|STARTED|Overall Study||98
8269101|NCT01743001|20388933|P2|NOT COMPLETED|Overall Study||0
8269102|NCT01743001|20388934|P1|NOT COMPLETED|Overall Study||3
8269103|NCT01743001|20388933|P2|COMPLETED|Overall Study||112
8269104|NCT01743001|20388934|P1|COMPLETED|Overall Study||111
8269105|NCT01743001|20388933|P2|STARTED|Overall Study||112
8269106|NCT01743001|20388934|P1|STARTED|Overall Study||114
8269107|NCT01742949|20388946|P2|NOT COMPLETED|Overall Study||0
8269109|NCT01742949|20388946|P2|COMPLETED|Overall Study||20
8269110|NCT01742949|20388947|P1|COMPLETED|Overall Study||20
8269111|NCT01742949|20388946|P2|STARTED|Overall Study||20
8269112|NCT01742949|20388947|P1|STARTED|Overall Study||20
8269113|NCT01742936|20388968|P2|NOT COMPLETED|Overall Study||0
8269114|NCT01742936|20388969|P1|NOT COMPLETED|Overall Study||0
8269115|NCT01742936|20388968|P2|COMPLETED|Overall Study||50
8269116|NCT01742936|20388969|P1|COMPLETED|Overall Study||50
8269117|NCT01742936|20388968|P2|STARTED|Overall Study||50
8269118|NCT01742936|20388969|P1|STARTED|Overall Study||50
8269119|NCT01742897|20388977|P1|NOT COMPLETED|Overall Study||5
8269120|NCT01742897|20388977|P1|COMPLETED|Overall Study||30
8269121|NCT01742897|20388977|P1|Treated|Overall Study||33
8269122|NCT01742897|20388977|P1|STARTED|Overall Study||35
8269123|NCT01742832|20388983|P2|NOT COMPLETED|Overall Study||5
8269124|NCT01742832|20388984|P1|NOT COMPLETED|Overall Study||1
8269125|NCT01742832|20388983|P2|COMPLETED|Overall Study||23
8269126|NCT01742832|20388984|P1|COMPLETED|Overall Study||19
8269127|NCT01742832|20388983|P2|STARTED|Overall Study||28
8269128|NCT01742832|20388984|P1|STARTED|Overall Study||20
8269129|NCT01742364|20388994|P4|NOT COMPLETED|Overall Study||0
8269130|NCT01742364|20388995|P3|NOT COMPLETED|Overall Study||0
8269131|NCT01742364|20388996|P2|NOT COMPLETED|Overall Study||0
8269132|NCT01742364|20388997|P1|NOT COMPLETED|Overall Study||0
8269133|NCT01742364|20388994|P4|COMPLETED|Overall Study||15
8269134|NCT01742364|20388995|P3|COMPLETED|Overall Study||15
8269135|NCT01742364|20388996|P2|COMPLETED|Overall Study||33
8269136|NCT01742364|20388997|P1|COMPLETED|Overall Study||33
8269137|NCT01742364|20388994|P4|STARTED|Overall Study||15
8269138|NCT01742364|20388995|P3|STARTED|Overall Study||15
8269139|NCT01742364|20388996|P2|STARTED|Overall Study||33
8269140|NCT01742364|20388997|P1|STARTED|Overall Study||33
8269141|NCT01742286|20389030|P7|NOT COMPLETED|Expansion Phase||36
8269142|NCT01742286|20389031|P6|NOT COMPLETED|Expansion Phase||0
8269143|NCT01742286|20389032|P5|NOT COMPLETED|Expansion Phase||0
8269144|NCT01742286|20389033|P4|NOT COMPLETED|Expansion Phase||0
8269145|NCT01742286|20389034|P3|NOT COMPLETED|Expansion Phase||7
8269146|NCT01742286|20389035|P2|NOT COMPLETED|Expansion Phase||0
8269147|NCT01742286|20389036|P1|NOT COMPLETED|Expansion Phase||0
8269148|NCT01742286|20389030|P7|COMPLETED|Expansion Phase||0
8269149|NCT01742286|20389031|P6|COMPLETED|Expansion Phase||0
8269150|NCT01742286|20389032|P5|COMPLETED|Expansion Phase||0
8269151|NCT01742286|20389033|P4|COMPLETED|Expansion Phase||0
8269152|NCT01742286|20389034|P3|COMPLETED|Expansion Phase||0
8269153|NCT01742286|20389035|P2|COMPLETED|Expansion Phase||0
8269154|NCT01742286|20389036|P1|COMPLETED|Expansion Phase||0
8269155|NCT01742286|20389030|P7|End of Treatment = Not Ccompleted|Expansion Phase||36
8269156|NCT01742286|20389031|P6|End of Treatment = Not Ccompleted|Expansion Phase||0
8269157|NCT01742286|20389032|P5|End of Treatment = Not Ccompleted|Expansion Phase||0
8269158|NCT01742286|20389033|P4|End of Treatment = Not Ccompleted|Expansion Phase||0
8269159|NCT01742286|20389034|P3|End of Treatment = Not Ccompleted|Expansion Phase||7
8269160|NCT01742286|20389035|P2|End of Treatment = Not Ccompleted|Expansion Phase||0
8269161|NCT01742286|20389036|P1|End of Treatment = Not Ccompleted|Expansion Phase||0
8269162|NCT01742286|20389030|P7|STARTED|Expansion Phase||36
8269163|NCT01742286|20389031|P6|STARTED|Expansion Phase||0
8269164|NCT01742286|20389032|P5|STARTED|Expansion Phase||0
8269165|NCT01742286|20389033|P4|STARTED|Expansion Phase||0
8269166|NCT01742286|20389034|P3|STARTED|Expansion Phase||7
8269167|NCT01742286|20389035|P2|STARTED|Expansion Phase||0
8269168|NCT01742286|20389036|P1|STARTED|Expansion Phase||0
8269169|NCT01742286|20389030|P7|NOT COMPLETED|Escalation Phase||6
8269170|NCT01742286|20389031|P6|NOT COMPLETED|Escalation Phase||5
8269171|NCT01742286|20389032|P5|NOT COMPLETED|Escalation Phase||4
8269172|NCT01742286|20389033|P4|NOT COMPLETED|Escalation Phase||2
8269173|NCT01742286|20389034|P3|NOT COMPLETED|Escalation Phase||6
8269174|NCT01742286|20389035|P2|NOT COMPLETED|Escalation Phase||12
8269175|NCT01742286|20389036|P1|NOT COMPLETED|Escalation Phase||5
8269176|NCT01742286|20389030|P7|COMPLETED|Escalation Phase||0
8269177|NCT01742286|20389031|P6|COMPLETED|Escalation Phase||0
8269178|NCT01742286|20389032|P5|COMPLETED|Escalation Phase||0
8269179|NCT01742286|20389033|P4|COMPLETED|Escalation Phase||0
8269180|NCT01742286|20389034|P3|COMPLETED|Escalation Phase||0
8269181|NCT01742286|20389035|P2|COMPLETED|Escalation Phase||0
8269182|NCT01742286|20389036|P1|COMPLETED|Escalation Phase||0
8269183|NCT01742286|20389030|P7|Ended Treatment = Not Completed)|Escalation Phase||6
8269184|NCT01742286|20389031|P6|Ended Treatment = Not Completed)|Escalation Phase||5
8269185|NCT01742286|20389032|P5|Ended Treatment = Not Completed)|Escalation Phase||4
8269186|NCT01742286|20389033|P4|Ended Treatment = Not Completed)|Escalation Phase||2
8269187|NCT01742286|20389034|P3|Ended Treatment = Not Completed)|Escalation Phase||6
8269188|NCT01742286|20389035|P2|Ended Treatment = Not Completed)|Escalation Phase||12
8269189|NCT01742286|20389036|P1|Ended Treatment = Not Completed)|Escalation Phase||5
8269190|NCT01742286|20389030|P7|STARTED|Escalation Phase||6
8269191|NCT01742286|20389031|P6|STARTED|Escalation Phase||5
8269192|NCT01742286|20389032|P5|STARTED|Escalation Phase||4
8269193|NCT01742286|20389033|P4|STARTED|Escalation Phase||2
8269194|NCT01742286|20389034|P3|STARTED|Escalation Phase||6
8269195|NCT01742286|20389035|P2|STARTED|Escalation Phase||12
8269196|NCT01742286|20389036|P1|STARTED|Escalation Phase||5
8269197|NCT01742208|20389137|P3|NOT COMPLETED|Overall Study||0
8269198|NCT01742208|20389138|P2|NOT COMPLETED|Overall Study||0
8269199|NCT01742208|20389139|P1|NOT COMPLETED|Overall Study||0
8269200|NCT01742208|20389137|P3|COMPLETED|Overall Study||16
8269201|NCT01742208|20389138|P2|COMPLETED|Overall Study||17
8269202|NCT01742208|20389139|P1|COMPLETED|Overall Study||3
8269203|NCT01742208|20389137|P3|STARTED|Overall Study||16
8269204|NCT01742208|20389138|P2|STARTED|Overall Study||17
8269205|NCT01742208|20389139|P1|STARTED|Overall Study||3
8269206|NCT01742091|20389169|P6|NOT COMPLETED|Overall Study||2
8269207|NCT01742091|20389170|P5|NOT COMPLETED|Overall Study||1
8269208|NCT01742091|20389171|P4|NOT COMPLETED|Overall Study||1
8269209|NCT01742091|20389172|P3|NOT COMPLETED|Overall Study||0
8269210|NCT01742091|20389173|P2|NOT COMPLETED|Overall Study||0
8269211|NCT01742091|20389174|P1|NOT COMPLETED|Overall Study||0
8269212|NCT01742091|20389169|P6|COMPLETED|Overall Study||10
8269213|NCT01742091|20389170|P5|COMPLETED|Overall Study||7
8269214|NCT01742091|20389171|P4|COMPLETED|Overall Study||8
8269215|NCT01742091|20389172|P3|COMPLETED|Overall Study||10
8269216|NCT01742091|20389173|P2|COMPLETED|Overall Study||11
8269217|NCT01742091|20389174|P1|COMPLETED|Overall Study||9
8269218|NCT01742091|20389169|P6|RECEIVED STUDY DRUG|Overall Study||12
8269219|NCT01742091|20389170|P5|RECEIVED STUDY DRUG|Overall Study||8
8269220|NCT01742091|20389171|P4|RECEIVED STUDY DRUG|Overall Study||9
8269221|NCT01742091|20389172|P3|RECEIVED STUDY DRUG|Overall Study||10
8269222|NCT01742091|20389173|P2|RECEIVED STUDY DRUG|Overall Study||11
8269223|NCT01742091|20389174|P1|RECEIVED STUDY DRUG|Overall Study||9
8269224|NCT01742091|20389169|P6|STARTED|Overall Study||12
8269225|NCT01742091|20389170|P5|STARTED|Overall Study||8
8269226|NCT01742091|20389171|P4|STARTED|Overall Study||9
8269227|NCT01742091|20389172|P3|STARTED|Overall Study||10
8269228|NCT01742091|20389173|P2|STARTED|Overall Study||11
8269229|NCT01742091|20389174|P1|STARTED|Overall Study||9
8269230|NCT01742078|20389220|P9|NOT COMPLETED|Overall Study||0
8269231|NCT01742078|20389221|P8|NOT COMPLETED|Overall Study||0
8269232|NCT01742078|20389222|P7|NOT COMPLETED|Overall Study||0
8269233|NCT01742078|20389223|P6|NOT COMPLETED|Overall Study||0
8269234|NCT01742078|20389224|P5|NOT COMPLETED|Overall Study||0
8269235|NCT01742078|20389225|P4|NOT COMPLETED|Overall Study||1
8269236|NCT01742078|20389226|P3|NOT COMPLETED|Overall Study||0
8269237|NCT01742078|20389227|P2|NOT COMPLETED|Overall Study||0
8269238|NCT01742078|20389228|P1|NOT COMPLETED|Overall Study||0
8269239|NCT01742078|20389220|P9|COMPLETED|Overall Study||12
8269240|NCT01742078|20389221|P8|COMPLETED|Overall Study||6
8269241|NCT01742078|20389222|P7|COMPLETED|Overall Study||6
8269242|NCT01742078|20389223|P6|COMPLETED|Overall Study||6
8269243|NCT01742078|20389224|P5|COMPLETED|Overall Study||6
8269244|NCT01742078|20389225|P4|COMPLETED|Overall Study||5
8269245|NCT01742078|20389226|P3|COMPLETED|Overall Study||6
8269246|NCT01742078|20389227|P2|COMPLETED|Overall Study||6
8269247|NCT01742078|20389228|P1|COMPLETED|Overall Study||6
8269248|NCT01742078|20389220|P9|RECEIVED STUDY DRUG|Overall Study||12
8269249|NCT01742078|20389221|P8|RECEIVED STUDY DRUG|Overall Study||6
8269250|NCT01742078|20389222|P7|RECEIVED STUDY DRUG|Overall Study||6
8269251|NCT01742078|20389223|P6|RECEIVED STUDY DRUG|Overall Study||6
8269252|NCT01742078|20389224|P5|RECEIVED STUDY DRUG|Overall Study||6
8269253|NCT01742078|20389225|P4|RECEIVED STUDY DRUG|Overall Study||6
8269254|NCT01742078|20389226|P3|RECEIVED STUDY DRUG|Overall Study||6
8269255|NCT01742078|20389227|P2|RECEIVED STUDY DRUG|Overall Study||6
8269256|NCT01742078|20389228|P1|RECEIVED STUDY DRUG|Overall Study||6
8269257|NCT01742078|20389220|P9|STARTED|Overall Study||12
8269258|NCT01742078|20389221|P8|STARTED|Overall Study||6
8269259|NCT01742078|20389222|P7|STARTED|Overall Study||6
8269260|NCT01742078|20389223|P6|STARTED|Overall Study||6
8269261|NCT01742078|20389224|P5|STARTED|Overall Study||6
8269262|NCT01742078|20389225|P4|STARTED|Overall Study||6
8269263|NCT01742078|20389226|P3|STARTED|Overall Study||6
8269264|NCT01742078|20389227|P2|STARTED|Overall Study||6
8269265|NCT01742078|20389228|P1|STARTED|Overall Study||6
8269266|NCT01742065|20389285|P2|NOT COMPLETED|Overall Study||0
8269267|NCT01742065|20389286|P1|NOT COMPLETED|Overall Study||0
8269268|NCT01742065|20389285|P2|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
8269269|NCT01742065|20389286|P1|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
8269270|NCT01742065|20389285|P2|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
8269271|NCT01742065|20389286|P1|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
8269272|NCT01741792|20389297|P3|NOT COMPLETED|Overall Study||12
8269273|NCT01741792|20389298|P2|NOT COMPLETED|Overall Study||1
8269274|NCT01741792|20389299|P1|NOT COMPLETED|Overall Study||6
8269275|NCT01741792|20389297|P3|COMPLETED|Overall Study||2
8269276|NCT01741792|20389298|P2|COMPLETED|Overall Study||1
8269277|NCT01741792|20389299|P1|COMPLETED|Overall Study||3
8269278|NCT01741792|20389297|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
8269279|NCT01741792|20389298|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
8269280|NCT01741792|20389299|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
8269281|NCT01741792|20389297|P3|STARTED|Overall Study||14
8269282|NCT01741792|20389298|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
8269283|NCT01741792|20389299|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
8269284|NCT01741701|20389366|P2|NOT COMPLETED|Overall Study||2
8269285|NCT01741701|20389367|P1|NOT COMPLETED|Overall Study||5
8269286|NCT01741701|20389366|P2|COMPLETED|Overall Study||13
8269287|NCT01741701|20389367|P1|COMPLETED|Overall Study||13
8269288|NCT01741701|20389366|P2|STARTED|Overall Study||15
8269289|NCT01741701|20389367|P1|STARTED|Overall Study||18
8269290|NCT01741688|20389383|P1|NOT COMPLETED|Overall Study||3
8269291|NCT01741688|20389383|P1|COMPLETED|Overall Study||13
8269292|NCT01741688|20389383|P1|STARTED|Overall Study||16
8269293|NCT01741545|20389402|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||2
8269294|NCT01741545|20389403|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
8269295|NCT01741545|20389402|P2|COMPLETED|Follow-up Period (24 Weeks)||37
8269296|NCT01741545|20389403|P1|COMPLETED|Follow-up Period (24 Weeks)||11
8269297|NCT01741545|20389402|P2|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
8269298|NCT01741545|20389403|P1|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
8269299|NCT01741545|20389402|P2|NOT COMPLETED|Treatment Period||4
8269300|NCT01741545|20389403|P1|NOT COMPLETED|Treatment Period||1
8269301|NCT01741545|20389402|P2|COMPLETED|Treatment Period||35
8269302|NCT01741545|20389403|P1|COMPLETED|Treatment Period||11
8269303|NCT01741545|20389402|P2|STARTED|Treatment Period||39
8269304|NCT01741545|20389403|P1|STARTED|Treatment Period||12
8269305|NCT01741532|20389427|P2|NOT COMPLETED|Overall Study||3
8269306|NCT01741532|20389428|P1|NOT COMPLETED|Overall Study||10
8269307|NCT01741532|20389427|P2|COMPLETED|Overall Study||27
8269308|NCT01741532|20389428|P1|COMPLETED|Overall Study||49
8269309|NCT01741532|20389427|P2|Provided Post-baseline Efficacy Data|Overall Study||28
8269310|NCT01741532|20389428|P1|Provided Post-baseline Efficacy Data|Overall Study||58
8269311|NCT01741532|20389427|P2|Exposed|Overall Study||30
8269312|NCT01741532|20389428|P1|Exposed|Overall Study||58
8269313|NCT01741532|20389427|P2|STARTED|Overall Study||30
8269314|NCT01741532|20389428|P1|STARTED|Overall Study||59
8269315|NCT01741480|20389450|P2|NOT COMPLETED|Overall Study||0
8269316|NCT01741480|20389451|P1|NOT COMPLETED|Overall Study||0
8269317|NCT01741480|20389450|P2|COMPLETED|Overall Study||286
8269318|NCT01741480|20389451|P1|COMPLETED|Overall Study||285
8269319|NCT01741480|20389450|P2|STARTED|Overall Study||286
8269320|NCT01741480|20389451|P1|STARTED|Overall Study||285
8269321|NCT01741454|20389461|P4|NOT COMPLETED|Overall Study||22
8269322|NCT01741454|20389462|P3|NOT COMPLETED|Overall Study||17
8269323|NCT01741454|20389463|P2|NOT COMPLETED|Overall Study||6
8269324|NCT01741454|20389464|P1|NOT COMPLETED|Overall Study||13
8269325|NCT01741454|20389461|P4|COMPLETED|Overall Study||21
8269326|NCT01741454|20389462|P3|COMPLETED|Overall Study||22
8269327|NCT01741454|20389463|P2|COMPLETED|Overall Study||44
8269328|NCT01741454|20389464|P1|COMPLETED|Overall Study||36
8269329|NCT01741454|20389461|P4|STARTED|Overall Study||43
8269330|NCT01741454|20389462|P3|STARTED|Overall Study||39
8269331|NCT01741454|20389463|P2|STARTED|Overall Study||50
8269332|NCT01741454|20389464|P1|STARTED|Overall Study||49
8269333|NCT01741350|20389488|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
8269334|NCT01741350|20389489|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
8269335|NCT01741350|20389488|P2|COMPLETED|12-Month Follow-up Assessment||109
8269336|NCT01741350|20389489|P1|COMPLETED|12-Month Follow-up Assessment||111
8269337|NCT01741350|20389488|P2|STARTED|12-Month Follow-up Assessment||111
8269338|NCT01741350|20389489|P1|STARTED|12-Month Follow-up Assessment||114
8269339|NCT01741350|20389488|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
8269340|NCT01741350|20389489|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
8269341|NCT01741350|20389488|P2|COMPLETED|6-Month Follow-up Assessment||111
8269342|NCT01741350|20389489|P1|COMPLETED|6-Month Follow-up Assessment||114
8269343|NCT01741350|20389488|P2|STARTED|6-Month Follow-up Assessment||119
8269344|NCT01741350|20389489|P1|STARTED|6-Month Follow-up Assessment||129
8269345|NCT01741350|20389488|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
8269346|NCT01741350|20389489|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
8269347|NCT01741350|20389488|P2|COMPLETED|3-Month Follow-up Assessment||119
8269348|NCT01741350|20389489|P1|COMPLETED|3-Month Follow-up Assessment||129
8269349|NCT01741350|20389488|P2|STARTED|3-Month Follow-up Assessment||141
8269350|NCT01741350|20389489|P1|STARTED|3-Month Follow-up Assessment||135
8269351|NCT01741350|20389488|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
8269352|NCT01741350|20389489|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
8269353|NCT01741350|20389488|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
8269354|NCT01741350|20389489|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
8269355|NCT01741350|20389488|P2|STARTED|Post Intervention Assessment (at Week 4)||155
8269356|NCT01741350|20389489|P1|STARTED|Post Intervention Assessment (at Week 4)||149
8269357|NCT01741350|20389488|P2|NOT COMPLETED|Study Intervention||0
8269358|NCT01741350|20389489|P1|NOT COMPLETED|Study Intervention||0
8269359|NCT01741350|20389488|P2|COMPLETED|Study Intervention||155
8269360|NCT01741350|20389489|P1|COMPLETED|Study Intervention||149
8269361|NCT01741350|20389488|P2|STARTED|Study Intervention||155
8269362|NCT01741350|20389489|P1|STARTED|Study Intervention||149
8269363|NCT01741272|20389625|P2|NOT COMPLETED|Overall Study||0
8269364|NCT01741272|20389626|P1|NOT COMPLETED|Overall Study||0
8269365|NCT01741272|20389625|P2|COMPLETED|Overall Study||97
8269366|NCT01741272|20389626|P1|COMPLETED|Overall Study||92
8269367|NCT01741272|20389625|P2|STARTED|Overall Study||97
8269368|NCT01741272|20389626|P1|STARTED|Overall Study||92
8269369|NCT01741259|20389642|P2|NOT COMPLETED|Overall Study||6
8269370|NCT01741259|20389643|P1|NOT COMPLETED|Overall Study||6
8269371|NCT01741259|20389642|P2|COMPLETED|Overall Study||129
8269372|NCT01741259|20389643|P1|COMPLETED|Overall Study||127
8269373|NCT01741259|20389642|P2|STARTED|Overall Study||135
8269374|NCT01741259|20389643|P1|STARTED|Overall Study||133
8269375|NCT01741012|20389697|P1|NOT COMPLETED|Overall Study||3
8269376|NCT01741012|20389697|P1|COMPLETED|Overall Study||34
8269377|NCT01741012|20389697|P1|STARTED|Overall Study||37
8269378|NCT01740817|20389704|P2|NOT COMPLETED|Second Intervention (48 h)||0
8269379|NCT01740817|20389705|P1|NOT COMPLETED|Second Intervention (48 h)||0
8269380|NCT01740817|20389704|P2|COMPLETED|Second Intervention (48 h)||4
8269381|NCT01740817|20389705|P1|COMPLETED|Second Intervention (48 h)||8
8269382|NCT01740817|20389704|P2|STARTED|Second Intervention (48 h)||4
8269383|NCT01740817|20389705|P1|STARTED|Second Intervention (48 h)||8
8269384|NCT01740817|20389704|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
8269385|NCT01740817|20389705|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
8269386|NCT01740817|20389704|P2|COMPLETED|Washout (4-6 Weeks)||4
8269387|NCT01740817|20389705|P1|COMPLETED|Washout (4-6 Weeks)||8
8269388|NCT01740817|20389704|P2|STARTED|Washout (4-6 Weeks)||4
8269389|NCT01740817|20389705|P1|STARTED|Washout (4-6 Weeks)||8
8269390|NCT01740817|20389704|P2|NOT COMPLETED|First Intervention (48 h)||0
8269391|NCT01740817|20389705|P1|NOT COMPLETED|First Intervention (48 h)||0
8269392|NCT01740817|20389704|P2|COMPLETED|First Intervention (48 h)||4
8269393|NCT01740817|20389705|P1|COMPLETED|First Intervention (48 h)||8
8269394|NCT01740817|20389704|P2|STARTED|First Intervention (48 h)||4
8269395|NCT01740817|20389705|P1|STARTED|First Intervention (48 h)||8
8269396|NCT01740791|20389721|P6|NOT COMPLETED|Overall Study||11
8269397|NCT01740791|20389722|P5|NOT COMPLETED|Overall Study||3
8269398|NCT01740791|20389723|P4|NOT COMPLETED|Overall Study||7
8269399|NCT01740791|20389724|P3|NOT COMPLETED|Overall Study||6
8269400|NCT01740791|20389725|P2|NOT COMPLETED|Overall Study||3
8269401|NCT01740791|20389726|P1|NOT COMPLETED|Overall Study||12
8269402|NCT01740791|20389721|P6|COMPLETED|Overall Study||23
8269403|NCT01740791|20389722|P5|COMPLETED|Overall Study||6
8269404|NCT01740791|20389723|P4|COMPLETED|Overall Study||7
8269405|NCT01740791|20389724|P3|COMPLETED|Overall Study||11
8269406|NCT01740791|20389725|P2|COMPLETED|Overall Study||4
8269407|NCT01740791|20389726|P1|COMPLETED|Overall Study||10
8269408|NCT01740791|20389721|P6|STARTED|Overall Study||34
8269409|NCT01740791|20389722|P5|STARTED|Overall Study||9
8269410|NCT01740791|20389723|P4|STARTED|Overall Study||14
8269411|NCT01740791|20389724|P3|STARTED|Overall Study||17
8269412|NCT01740791|20389725|P2|STARTED|Overall Study||7
8269413|NCT01740791|20389726|P1|STARTED|Overall Study||22
8269414|NCT01740726|20389857|P2|NOT COMPLETED|Overall Study||0
8269415|NCT01740726|20389858|P1|NOT COMPLETED|Overall Study||0
8269416|NCT01740726|20389857|P2|COMPLETED|Overall Study||1
8269417|NCT01740726|20389858|P1|COMPLETED|Overall Study||0
8269418|NCT01740726|20389857|P2|STARTED|Overall Study||1
8269419|NCT01740726|20389858|P1|STARTED|Overall Study||0
8269420|NCT01740713|20389883|P3|NOT COMPLETED|Overall Study||1
8269421|NCT01740713|20389884|P2|NOT COMPLETED|Overall Study||2
8269422|NCT01740713|20389885|P1|NOT COMPLETED|Overall Study||0
8269423|NCT01740713|20389883|P3|COMPLETED|Overall Study||6
8269424|NCT01740713|20389884|P2|COMPLETED|Overall Study||6
8269425|NCT01740713|20389885|P1|COMPLETED|Overall Study||6
8269426|NCT01740713|20389883|P3|STARTED|Overall Study||7
8269427|NCT01740713|20389884|P2|STARTED|Overall Study||8
8269428|NCT01740713|20389885|P1|STARTED|Overall Study||6
8269429|NCT01740440|20389909|P1|NOT COMPLETED|Overall Study||3
8269430|NCT01740440|20389909|P1|COMPLETED|Overall Study||27
8269431|NCT01740440|20389909|P1|STARTED|Overall Study||30
8269432|NCT01740427|20389917|P2|NOT COMPLETED|Overall Study||222
8269433|NCT01740427|20389918|P1|NOT COMPLETED|Overall Study||444
8269434|NCT01740427|20389917|P2|COMPLETED|Overall Study||0
8269435|NCT01740427|20389918|P1|COMPLETED|Overall Study||0
8269436|NCT01740427|20389917|P2|STARTED|Overall Study||222
8269437|NCT01740427|20389918|P1|STARTED|Overall Study||444
8269438|NCT01740414|20389947|P2|NOT COMPLETED|Overall Study||8
8269439|NCT01740414|20389948|P1|NOT COMPLETED|Overall Study||9
8269440|NCT01740414|20389947|P2|COMPLETED|Overall Study||8
8269441|NCT01740414|20389948|P1|COMPLETED|Overall Study||3
8269442|NCT01740414|20389947|P2|STARTED|Overall Study||16
8269443|NCT01740414|20389948|P1|STARTED|Overall Study||12
8269444|NCT01740401|20389970|P1|NOT COMPLETED|Overall Study||10
8269445|NCT01740401|20389970|P1|COMPLETED|Overall Study||0
8269446|NCT01740401|20389970|P1|STARTED|Overall Study||10
8269447|NCT01740388|20389979|P2|NOT COMPLETED|Overall Study||44
8269448|NCT01740388|20389980|P1|NOT COMPLETED|Overall Study||46
8269449|NCT01740388|20389979|P2|COMPLETED|Overall Study||28
8269450|NCT01740388|20389980|P1|COMPLETED|Overall Study||18
8269451|NCT01740388|20389979|P2|STARTED|Overall Study||72
8269452|NCT01740388|20389980|P1|STARTED|Overall Study||64
8269453|NCT01740362|20390000|P4|NOT COMPLETED|Overall Study||0
8269454|NCT01740362|20390001|P3|NOT COMPLETED|Overall Study||0
8269455|NCT01740362|20390002|P2|NOT COMPLETED|Overall Study||0
8269456|NCT01740362|20390003|P1|NOT COMPLETED|Overall Study||0
8269457|NCT01740362|20390000|P4|COMPLETED|Overall Study||6
8269458|NCT01740362|20390001|P3|COMPLETED|Overall Study||6
8269459|NCT01740362|20390002|P2|COMPLETED|Overall Study||6
8269460|NCT01740362|20390003|P1|COMPLETED|Overall Study||6
8269461|NCT01740362|20390000|P4|STARTED|Overall Study||6
8269462|NCT01740362|20390001|P3|STARTED|Overall Study||6
8269463|NCT01740362|20390002|P2|STARTED|Overall Study||6
8269464|NCT01740362|20390003|P1|STARTED|Overall Study||6
8269465|NCT01740323|20390031|P2|NOT COMPLETED|Overall Study||0
8269466|NCT01740323|20390032|P1|NOT COMPLETED|Overall Study||2
8269467|NCT01740323|20390031|P2|COMPLETED|Overall Study||15
8269468|NCT01740323|20390032|P1|COMPLETED|Overall Study||13
8269469|NCT01740323|20390031|P2|STARTED|Overall Study||15
8269470|NCT01740323|20390032|P1|STARTED|Overall Study||15
8269471|NCT01740297|20390053|P3|NOT COMPLETED|Overall Study||98
8269472|NCT01740297|20390054|P2|NOT COMPLETED|Overall Study||100
8269473|NCT01740297|20390055|P1|NOT COMPLETED|Overall Study||19
8269474|NCT01740297|20390053|P3|COMPLETED|Overall Study||0
8269475|NCT01740297|20390054|P2|COMPLETED|Overall Study||0
8269476|NCT01740297|20390055|P1|COMPLETED|Overall Study||0
8269477|NCT01740297|20390053|P3|Received Ipilimumab|Overall Study||92
8269478|NCT01740297|20390054|P2|Received Ipilimumab|Overall Study||95
8269479|NCT01740297|20390055|P1|Received Ipilimumab|Overall Study||18
8269480|NCT01740297|20390053|P3|Received Talimogene Laherparepvec|Overall Study||95
8269481|NCT01740297|20390054|P2|Received Talimogene Laherparepvec|Overall Study||0
8269482|NCT01740297|20390055|P1|Received Talimogene Laherparepvec|Overall Study||19
8269483|NCT01740297|20390053|P3|STARTED|Overall Study||98
8269484|NCT01740297|20390054|P2|STARTED|Overall Study||100
8269485|NCT01740297|20390055|P1|STARTED|Overall Study||19
8269486|NCT01740258|20390085|P1|NOT COMPLETED|Overall Study||0
8269487|NCT01740258|20390085|P1|COMPLETED|Overall Study||68
8269488|NCT01740258|20390085|P1|Entered Part D|Overall Study||42
8269489|NCT01740258|20390085|P1|Entered Part C|Overall Study||20
8269490|NCT01740258|20390085|P1|Entered Part B|Overall Study||62
8269491|NCT01740258|20390085|P1|Entered Part A|Overall Study||68
8269492|NCT01740258|20390085|P1|STARTED|Overall Study||68
8269493|NCT01740206|20390093|P2|NOT COMPLETED|Overall Study||0
8269494|NCT01740206|20390094|P1|NOT COMPLETED|Overall Study||0
8269495|NCT01740206|20390093|P2|COMPLETED|Overall Study||34
8269496|NCT01740206|20390094|P1|COMPLETED|Overall Study||14
8269497|NCT01740206|20390093|P2|STARTED|Overall Study||34
8269498|NCT01740206|20390094|P1|STARTED|Overall Study||14
8269499|NCT01740154|20390110|P1|NOT COMPLETED|Overall Study||1
8269500|NCT01740154|20390110|P1|COMPLETED|Overall Study||12
8269501|NCT01740154|20390110|P1|STARTED|Overall Study||13
8269502|NCT01740128|20390118|P2|NOT COMPLETED|Overall Study||7
8269503|NCT01740128|20390119|P1|NOT COMPLETED|Overall Study||6
8269504|NCT01740128|20390118|P2|COMPLETED|Overall Study||4
8269505|NCT01740128|20390119|P1|COMPLETED|Overall Study||4
8269506|NCT01740128|20390118|P2|STARTED|Overall Study||11
8269507|NCT01740128|20390119|P1|STARTED|Overall Study||10
8269508|NCT01740089|20390148|P3|NOT COMPLETED|After 12 Weeks||11
8269509|NCT01740089|20390149|P2|NOT COMPLETED|After 12 Weeks||3
8269510|NCT01740089|20390150|P1|NOT COMPLETED|After 12 Weeks||7
8269511|NCT01740089|20390148|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
8269512|NCT01740089|20390149|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:
~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
8269513|NCT01740089|20390150|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
8269514|NCT01740089|20390148|P3|STARTED|After 12 Weeks||48
8269515|NCT01740089|20390149|P2|STARTED|After 12 Weeks||48
8269516|NCT01740089|20390150|P1|STARTED|After 12 Weeks||50
8269517|NCT01740089|20390148|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
8269518|NCT01740089|20390149|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
8269519|NCT01740089|20390150|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
8269520|NCT01740089|20390148|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=2)"|48
8269521|NCT01740089|20390149|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
8269522|NCT01740089|20390150|P1|COMPLETED|First 12 Weeks of Treatment||50
8269523|NCT01740089|20390148|P3|STARTED|First 12 Weeks of Treatment||50
8269524|NCT01740089|20390149|P2|STARTED|First 12 Weeks of Treatment||50
8269525|NCT01740089|20390150|P1|STARTED|First 12 Weeks of Treatment||50
8269526|NCT01739803|20390168|P2|NOT COMPLETED|Overall Study||6
8269527|NCT01739803|20390169|P1|NOT COMPLETED|Overall Study||9
8269528|NCT01739803|20390168|P2|COMPLETED|Overall Study||68
8269529|NCT01739803|20390169|P1|COMPLETED|Overall Study||67
8269530|NCT01739803|20390168|P2|STARTED|Overall Study||74
8269531|NCT01739803|20390169|P1|STARTED|Overall Study||76
8269532|NCT01739790|20390181|P2|NOT COMPLETED|Overall Study||4
8269533|NCT01739790|20390182|P1|NOT COMPLETED|Overall Study||2
8269534|NCT01739790|20390181|P2|COMPLETED|Overall Study||23
8269535|NCT01739790|20390182|P1|COMPLETED|Overall Study||22
8269536|NCT01739790|20390181|P2|STARTED|Overall Study||27
8269537|NCT01739790|20390182|P1|STARTED|Overall Study||24
8269538|NCT01739764|20390191|P3|NOT COMPLETED|Overall Study||126
8269539|NCT01739764|20390192|P2|NOT COMPLETED|Overall Study||36
8269540|NCT01739764|20390193|P1|NOT COMPLETED|Overall Study||26
8269541|NCT01739764|20390191|P3|COMPLETED|Overall Study||20
8269542|NCT01739764|20390192|P2|COMPLETED|Overall Study||4
8269543|NCT01739764|20390193|P1|COMPLETED|Overall Study||3
8269544|NCT01739764|20390191|P3|STARTED|Overall Study||146
8269545|NCT01739764|20390192|P2|STARTED|Overall Study||40
8269546|NCT01739764|20390193|P1|STARTED|Overall Study||29
8269547|NCT01739595|20390207|P3|NOT COMPLETED|Overall Study||2
8269548|NCT01739595|20390208|P2|NOT COMPLETED|Overall Study||1
8269549|NCT01739595|20390209|P1|NOT COMPLETED|Overall Study||13
8269550|NCT01739595|20390207|P3|COMPLETED|Overall Study||45
8269551|NCT01739595|20390208|P2|COMPLETED|Overall Study||21
8269552|NCT01739595|20390209|P1|COMPLETED|Overall Study||99
8269553|NCT01739595|20390207|P3|STARTED|Overall Study||47
8269554|NCT01739595|20390208|P2|STARTED|Overall Study||22
8269555|NCT01739595|20390209|P1|STARTED|Overall Study||112
8269556|NCT01739400|20390219|P2|NOT COMPLETED|Overall Study||9
8269557|NCT01739400|20390220|P1|NOT COMPLETED|Overall Study||17
8269558|NCT01739400|20390219|P2|COMPLETED|Overall Study||99
8269559|NCT01739400|20390220|P1|COMPLETED|Overall Study||92
8269560|NCT01739400|20390219|P2|Treated With 10 mg Macitentan|Overall Study||108
8269561|NCT01739400|20390220|P1|Treated With 10 mg Macitentan|Overall Study||109
8269562|NCT01739400|20390219|P2|STARTED|Overall Study||108
8269563|NCT01739400|20390220|P1|STARTED|Overall Study||109
8269564|NCT01739361|20390233|P2|NOT COMPLETED|Overall Study||1
8269565|NCT01739361|20390234|P1|NOT COMPLETED|Overall Study||3
8269566|NCT01739361|20390233|P2|COMPLETED|Overall Study||22
8269567|NCT01739361|20390234|P1|COMPLETED|Overall Study||18
8269568|NCT01739361|20390233|P2|STARTED|Overall Study||23
8269569|NCT01739361|20390234|P1|STARTED|Overall Study||21
8269570|NCT01739348|20390248|P4|NOT COMPLETED|Part II (Extension Study)||396
8269571|NCT01739348|20390249|P3|NOT COMPLETED|Part II (Extension Study)||61
8269572|NCT01739348|20390250|P2|NOT COMPLETED|Part II (Extension Study)||366
8269573|NCT01739348|20390251|P1|NOT COMPLETED|Part II (Extension Study)||379
8269574|NCT01739348|20390248|P4|COMPLETED|Part II (Extension Study)||0
8269575|NCT01739348|20390249|P3|COMPLETED|Part II (Extension Study)||0
8269576|NCT01739348|20390250|P2|COMPLETED|Part II (Extension Study)||0
8269577|NCT01739348|20390251|P1|COMPLETED|Part II (Extension Study)||0
8269578|NCT01739348|20390248|P4|Treated|Part II (Extension Study)||394
8269579|NCT01739348|20390249|P3|Treated|Part II (Extension Study)||61
8269580|NCT01739348|20390250|P2|Treated|Part II (Extension Study)||365
8269581|NCT01739348|20390251|P1|Treated|Part II (Extension Study)||379
8269582|NCT01739348|20390248|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
8269583|NCT01739348|20390249|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
8269584|NCT01739348|20390250|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
8269585|NCT01739348|20390251|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
8269586|NCT01739348|20390248|P4|NOT COMPLETED|Part I (Base Study)||189
8269587|NCT01739348|20390249|P3|NOT COMPLETED|Part I (Base Study)||26
8269588|NCT01739348|20390250|P2|NOT COMPLETED|Part I (Base Study)||203
8269589|NCT01739348|20390251|P1|NOT COMPLETED|Part I (Base Study)||202
8269590|NCT01739348|20390248|P4|COMPLETED|Part I (Base Study)||516
8269591|NCT01739348|20390249|P3|COMPLETED|Part I (Base Study)||77
8269592|NCT01739348|20390250|P2|COMPLETED|Part I (Base Study)||497
8269593|NCT01739348|20390251|P1|COMPLETED|Part I (Base Study)||501
8269594|NCT01739348|20390248|P4|Treated|Part I (Base Study)||705
8269595|NCT01739348|20390249|P3|Treated|Part I (Base Study)||103
8269596|NCT01739348|20390250|P2|Treated|Part I (Base Study)||700
8269597|NCT01739348|20390251|P1|Treated|Part I (Base Study)||702
8269598|NCT01739348|20390248|P4|STARTED|Part I (Base Study)||705
8269599|NCT01739348|20390249|P3|STARTED|Part I (Base Study)||103
8269600|NCT01739348|20390250|P2|STARTED|Part I (Base Study)||700
8269601|NCT01739348|20390251|P1|STARTED|Part I (Base Study)||703
8269602|NCT01739335|20390323|P2|NOT COMPLETED|Overall Study||5
8269603|NCT01739335|20390324|P1|NOT COMPLETED|Overall Study||7
8269604|NCT01739335|20390323|P2|COMPLETED|Overall Study||35
8269605|NCT01739335|20390324|P1|COMPLETED|Overall Study||34
8269606|NCT01739335|20390323|P2|STARTED|Overall Study||40
8269607|NCT01739335|20390324|P1|STARTED|Overall Study||41
8269608|NCT01739309|20390356|P1|NOT COMPLETED|Overall Study||3
8269609|NCT01739309|20390356|P1|COMPLETED|Overall Study||25
8269610|NCT01739309|20390356|P1|Alive and on Study, Off Treatment|Overall Study||8
8269611|NCT01739309|20390356|P1|Death Due to Any Cause|Overall Study||17
8269612|NCT01739309|20390356|P1|Received at Least One Dose of Study Drug|Overall Study||28
8269613|NCT01739309|20390356|P1|STARTED|Overall Study||28
8269614|NCT01739231|20390379|P4|NOT COMPLETED|Part B||2
8269615|NCT01739231|20390380|P3|NOT COMPLETED|Part B||2
8269616|NCT01739231|20390381|P2|NOT COMPLETED|Part B||5
8269617|NCT01739231|20390382|P1|NOT COMPLETED|Part B||7
8269618|NCT01739231|20390379|P4|COMPLETED|Part B||19
8269619|NCT01739231|20390380|P3|COMPLETED|Part B||10
8269620|NCT01739231|20390381|P2|COMPLETED|Part B||12
8269621|NCT01739231|20390382|P1|COMPLETED|Part B||13
8269622|NCT01739231|20390379|P4|Challenged|Part B||21
8269623|NCT01739231|20390380|P3|Challenged|Part B||10
8269624|NCT01739231|20390381|P2|Challenged|Part B||13
8269625|NCT01739231|20390382|P1|Challenged|Part B||13
8269626|NCT01739231|20390379|P4|STARTED|Part B||21
8269627|NCT01739231|20390380|P3|STARTED|Part B||12
8269628|NCT01739231|20390381|P2|STARTED|Part B||17
8269629|NCT01739231|20390382|P1|STARTED|Part B||20
8269630|NCT01739231|20390379|P4|NOT COMPLETED|Part A||0
8269631|NCT01739231|20390380|P3|NOT COMPLETED|Part A||0
8269632|NCT01739231|20390381|P2|NOT COMPLETED|Part A||7
8269633|NCT01739231|20390382|P1|NOT COMPLETED|Part A||4
8269634|NCT01739231|20390379|P4|COMPLETED|Part A||0
8269635|NCT01739231|20390380|P3|COMPLETED|Part A||12
8269636|NCT01739231|20390381|P2|COMPLETED|Part A||17
8269637|NCT01739231|20390382|P1|COMPLETED|Part A||20
8269638|NCT01739231|20390379|P4|Received All 3 Vaccinations|Part A||0
8269639|NCT01739231|20390380|P3|Received All 3 Vaccinations|Part A||12
8269640|NCT01739231|20390381|P2|Received All 3 Vaccinations|Part A||20
8269641|NCT01739231|20390382|P1|Received All 3 Vaccinations|Part A||21
8269642|NCT01739231|20390379|P4|STARTED|Part A||0
8269643|NCT01739231|20390380|P3|STARTED|Part A||12
8269644|NCT01739231|20390381|P2|STARTED|Part A||24
8269645|NCT01739231|20390382|P1|STARTED|Part A||24
8269646|NCT01738984|20390551|P2|NOT COMPLETED|Overall Study||39
8269647|NCT01738984|20390552|P1|NOT COMPLETED|Overall Study||64
8269648|NCT01738984|20390551|P2|COMPLETED|Overall Study||210
8269649|NCT01738984|20390552|P1|COMPLETED|Overall Study||186
8269650|NCT01738984|20390551|P2|STARTED|Overall Study||249
8269651|NCT01738984|20390552|P1|STARTED|Overall Study||250
8269652|NCT01738971|20390565|P3|NOT COMPLETED|Overall Study||17
8269653|NCT01738971|20390566|P2|NOT COMPLETED|Overall Study||30
8269654|NCT01738971|20390567|P1|NOT COMPLETED|Overall Study||19
8269655|NCT01738971|20390565|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
8269656|NCT01738971|20390566|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
8269657|NCT01738971|20390567|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
8269658|NCT01738971|20390565|P3|STARTED|Overall Study|56 participants recruited to this arm|56
8269659|NCT01738971|20390566|P2|STARTED|Overall Study|58 participants recruited to this arm|58
8269660|NCT01738971|20390567|P1|STARTED|Overall Study|54 participants recruited to this arm|54
8269661|NCT01738919|20390583|P2|NOT COMPLETED|Overall Study||3
8269662|NCT01738919|20390584|P1|NOT COMPLETED|Overall Study||1
8269663|NCT01738919|20390583|P2|COMPLETED|Overall Study||14
8269664|NCT01738919|20390584|P1|COMPLETED|Overall Study||14
8269665|NCT01738919|20390583|P2|STARTED|Overall Study||17
8269666|NCT01738919|20390584|P1|STARTED|Overall Study||15
8269667|NCT01738750|20390602|P2|NOT COMPLETED|Overall Study||0
8269668|NCT01738750|20390603|P1|NOT COMPLETED|Overall Study||0
8269669|NCT01738750|20390602|P2|COMPLETED|Overall Study||51
8269670|NCT01738750|20390603|P1|COMPLETED|Overall Study||49
8269671|NCT01738750|20390602|P2|STARTED|Overall Study||51
8269672|NCT01738750|20390603|P1|STARTED|Overall Study||49
8269673|NCT01738737|20390616|P5|NOT COMPLETED|Overall Study||4
8269674|NCT01738737|20390617|P4|NOT COMPLETED|Overall Study||4
8269675|NCT01738737|20390618|P3|NOT COMPLETED|Overall Study||4
8269676|NCT01738737|20390619|P2|NOT COMPLETED|Overall Study||4
8269677|NCT01738737|20390620|P1|NOT COMPLETED|Overall Study||4
8269678|NCT01738737|20390616|P5|COMPLETED|Overall Study||25
8269679|NCT01738737|20390617|P4|COMPLETED|Overall Study||25
8269680|NCT01738737|20390618|P3|COMPLETED|Overall Study||25
8269681|NCT01738737|20390619|P2|COMPLETED|Overall Study||25
8269682|NCT01738737|20390620|P1|COMPLETED|Overall Study||25
8269683|NCT01738737|20390616|P5|STARTED|Overall Study||29
8269684|NCT01738737|20390617|P4|STARTED|Overall Study||29
8269685|NCT01738737|20390618|P3|STARTED|Overall Study||29
8269686|NCT01738737|20390619|P2|STARTED|Overall Study||29
8269687|NCT01738737|20390620|P1|STARTED|Overall Study||29
8269688|NCT01738698|20390656|P4|NOT COMPLETED|Overall Study||0
8269689|NCT01738698|20390657|P3|NOT COMPLETED|Overall Study||0
8269690|NCT01738698|20390658|P2|NOT COMPLETED|Overall Study||0
8269691|NCT01738698|20390659|P1|NOT COMPLETED|Overall Study||0
8269692|NCT01738698|20390656|P4|COMPLETED|Overall Study||0
8269693|NCT01738698|20390657|P3|COMPLETED|Overall Study||0
8269694|NCT01738698|20390658|P2|COMPLETED|Overall Study||0
8269695|NCT01738698|20390659|P1|COMPLETED|Overall Study||0
8269696|NCT01738698|20390656|P4|STARTED|Overall Study||0
8269697|NCT01738698|20390657|P3|STARTED|Overall Study||0
8269698|NCT01738698|20390658|P2|STARTED|Overall Study||0
8269699|NCT01738698|20390659|P1|STARTED|Overall Study||0
8269700|NCT01738672|20390725|P1|NOT COMPLETED|Overall Study||5
8269701|NCT01738672|20390725|P1|COMPLETED|Overall Study||11
8269702|NCT01738672|20390725|P1|STARTED|Overall Study||16
8269703|NCT01738646|20390734|P1|NOT COMPLETED|Overall Study||2
8269704|NCT01738646|20390734|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
8269705|NCT01738646|20390734|P1|STARTED|Overall Study||40
8269706|NCT01738594|20390745|P8|NOT COMPLETED|Follow up for 1 Year||0
8269707|NCT01738594|20390746|P7|NOT COMPLETED|Follow up for 1 Year||0
8269708|NCT01738594|20390747|P6|NOT COMPLETED|Follow up for 1 Year||3
8269709|NCT01738594|20390748|P5|NOT COMPLETED|Follow up for 1 Year||0
8269710|NCT01738594|20390749|P4|NOT COMPLETED|Follow up for 1 Year||0
8269711|NCT01738594|20390750|P3|NOT COMPLETED|Follow up for 1 Year||0
8269712|NCT01738594|20390751|P2|NOT COMPLETED|Follow up for 1 Year||0
8269713|NCT01738594|20390752|P1|NOT COMPLETED|Follow up for 1 Year||0
8269714|NCT01738594|20390745|P8|COMPLETED|Follow up for 1 Year||0
8269715|NCT01738594|20390746|P7|COMPLETED|Follow up for 1 Year||0
8269716|NCT01738594|20390747|P6|COMPLETED|Follow up for 1 Year||0
8269717|NCT01738594|20390748|P5|COMPLETED|Follow up for 1 Year||1
8269718|NCT01738594|20390749|P4|COMPLETED|Follow up for 1 Year||0
8269719|NCT01738594|20390750|P3|COMPLETED|Follow up for 1 Year||0
8269720|NCT01738594|20390751|P2|COMPLETED|Follow up for 1 Year||2
8269721|NCT01738594|20390752|P1|COMPLETED|Follow up for 1 Year||0
8269722|NCT01738594|20390745|P8|STARTED|Follow up for 1 Year||0
8269723|NCT01738594|20390746|P7|STARTED|Follow up for 1 Year||0
8269724|NCT01738594|20390747|P6|STARTED|Follow up for 1 Year||3
8269725|NCT01738594|20390748|P5|STARTED|Follow up for 1 Year||1
8269726|NCT01738594|20390749|P4|STARTED|Follow up for 1 Year||0
8269727|NCT01738594|20390750|P3|STARTED|Follow up for 1 Year||0
8269728|NCT01738594|20390751|P2|STARTED|Follow up for 1 Year||2
8269729|NCT01738594|20390752|P1|STARTED|Follow up for 1 Year||0
8269730|NCT01738594|20390745|P8|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269731|NCT01738594|20390746|P7|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269732|NCT01738594|20390747|P6|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
8269733|NCT01738594|20390748|P5|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
8269734|NCT01738594|20390749|P4|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269735|NCT01738594|20390750|P3|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269736|NCT01738594|20390751|P2|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269737|NCT01738594|20390752|P1|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269738|NCT01738594|20390745|P8|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269739|NCT01738594|20390746|P7|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269740|NCT01738594|20390747|P6|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269741|NCT01738594|20390748|P5|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269742|NCT01738594|20390749|P4|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269743|NCT01738594|20390750|P3|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269744|NCT01738594|20390751|P2|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269745|NCT01738594|20390752|P1|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269746|NCT01738594|20390745|P8|STARTED|Went on to Continue Treatment Cycle 5||0
8269747|NCT01738594|20390746|P7|STARTED|Went on to Continue Treatment Cycle 5||0
8269748|NCT01738594|20390747|P6|STARTED|Went on to Continue Treatment Cycle 5||1
8269749|NCT01738594|20390748|P5|STARTED|Went on to Continue Treatment Cycle 5||1
8269750|NCT01738594|20390749|P4|STARTED|Went on to Continue Treatment Cycle 5||0
8269751|NCT01738594|20390750|P3|STARTED|Went on to Continue Treatment Cycle 5||0
8269752|NCT01738594|20390751|P2|STARTED|Went on to Continue Treatment Cycle 5||0
8269753|NCT01738594|20390752|P1|STARTED|Went on to Continue Treatment Cycle 5||0
8269754|NCT01738594|20390745|P8|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269755|NCT01738594|20390746|P7|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269756|NCT01738594|20390747|P6|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8269757|NCT01738594|20390748|P5|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269758|NCT01738594|20390749|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269759|NCT01738594|20390750|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269760|NCT01738594|20390751|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||2
8269761|NCT01738594|20390752|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269762|NCT01738594|20390745|P8|COMPLETED|Completed 4 Cycles of Treatment||0
8269763|NCT01738594|20390746|P7|COMPLETED|Completed 4 Cycles of Treatment||0
8269764|NCT01738594|20390747|P6|COMPLETED|Completed 4 Cycles of Treatment||1
8269765|NCT01738594|20390748|P5|COMPLETED|Completed 4 Cycles of Treatment||1
8269766|NCT01738594|20390749|P4|COMPLETED|Completed 4 Cycles of Treatment||0
8269767|NCT01738594|20390750|P3|COMPLETED|Completed 4 Cycles of Treatment||0
8269768|NCT01738594|20390751|P2|COMPLETED|Completed 4 Cycles of Treatment||0
8269769|NCT01738594|20390752|P1|COMPLETED|Completed 4 Cycles of Treatment||0
8269770|NCT01738594|20390745|P8|STARTED|Completed 4 Cycles of Treatment||0
8269771|NCT01738594|20390746|P7|STARTED|Completed 4 Cycles of Treatment||0
8269772|NCT01738594|20390747|P6|STARTED|Completed 4 Cycles of Treatment||2
8269773|NCT01738594|20390748|P5|STARTED|Completed 4 Cycles of Treatment||1
8269774|NCT01738594|20390749|P4|STARTED|Completed 4 Cycles of Treatment||0
8269775|NCT01738594|20390750|P3|STARTED|Completed 4 Cycles of Treatment||0
8269776|NCT01738594|20390751|P2|STARTED|Completed 4 Cycles of Treatment||2
8269777|NCT01738594|20390752|P1|STARTED|Completed 4 Cycles of Treatment||0
8269778|NCT01738594|20390745|P8|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269779|NCT01738594|20390746|P7|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269780|NCT01738594|20390747|P6|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8269781|NCT01738594|20390748|P5|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269782|NCT01738594|20390749|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269783|NCT01738594|20390750|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269784|NCT01738594|20390751|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269785|NCT01738594|20390752|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269786|NCT01738594|20390745|P8|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269787|NCT01738594|20390746|P7|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269788|NCT01738594|20390747|P6|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8269789|NCT01738594|20390748|P5|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8269790|NCT01738594|20390749|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269791|NCT01738594|20390750|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269792|NCT01738594|20390751|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8269793|NCT01738594|20390752|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269794|NCT01738594|20390745|P8|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269795|NCT01738594|20390746|P7|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269796|NCT01738594|20390747|P6|STARTED|Completed 2 Cycles/Reached 1st Response||3
8269797|NCT01738594|20390748|P5|STARTED|Completed 2 Cycles/Reached 1st Response||1
8269798|NCT01738594|20390749|P4|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269799|NCT01738594|20390750|P3|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269800|NCT01738594|20390751|P2|STARTED|Completed 2 Cycles/Reached 1st Response||2
8269801|NCT01738594|20390752|P1|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269802|NCT01738594|20390745|P8|NOT COMPLETED|Registration and Treatment Start||0
8269803|NCT01738594|20390746|P7|NOT COMPLETED|Registration and Treatment Start||0
8269804|NCT01738594|20390747|P6|NOT COMPLETED|Registration and Treatment Start||0
8269805|NCT01738594|20390748|P5|NOT COMPLETED|Registration and Treatment Start||0
8269806|NCT01738594|20390749|P4|NOT COMPLETED|Registration and Treatment Start||0
8269807|NCT01738594|20390750|P3|NOT COMPLETED|Registration and Treatment Start||0
8269808|NCT01738594|20390751|P2|NOT COMPLETED|Registration and Treatment Start||1
8269809|NCT01738594|20390752|P1|NOT COMPLETED|Registration and Treatment Start||0
8269810|NCT01738594|20390745|P8|COMPLETED|Registration and Treatment Start||0
8269811|NCT01738594|20390746|P7|COMPLETED|Registration and Treatment Start||0
8269812|NCT01738594|20390747|P6|COMPLETED|Registration and Treatment Start||3
8269813|NCT01738594|20390748|P5|COMPLETED|Registration and Treatment Start||1
8269814|NCT01738594|20390749|P4|COMPLETED|Registration and Treatment Start||0
8269815|NCT01738594|20390750|P3|COMPLETED|Registration and Treatment Start||0
8269816|NCT01738594|20390751|P2|COMPLETED|Registration and Treatment Start||2
8269817|NCT01738594|20390752|P1|COMPLETED|Registration and Treatment Start||0
8269818|NCT01738594|20390745|P8|Treatment Started|Registration and Treatment Start||0
8269819|NCT01738594|20390746|P7|Treatment Started|Registration and Treatment Start||0
8269820|NCT01738594|20390747|P6|Treatment Started|Registration and Treatment Start||3
8269821|NCT01738594|20390748|P5|Treatment Started|Registration and Treatment Start||1
8269822|NCT01738594|20390749|P4|Treatment Started|Registration and Treatment Start||0
8269823|NCT01738594|20390750|P3|Treatment Started|Registration and Treatment Start||0
8269824|NCT01738594|20390751|P2|Treatment Started|Registration and Treatment Start||2
8269825|NCT01738594|20390752|P1|Treatment Started|Registration and Treatment Start||0
8269826|NCT01738594|20390745|P8|Registered to Study|Registration and Treatment Start||0
8269827|NCT01738594|20390746|P7|Registered to Study|Registration and Treatment Start||0
8269828|NCT01738594|20390747|P6|Registered to Study|Registration and Treatment Start||3
8269829|NCT01738594|20390748|P5|Registered to Study|Registration and Treatment Start||1
8269830|NCT01738594|20390749|P4|Registered to Study|Registration and Treatment Start||0
8269831|NCT01738594|20390750|P3|Registered to Study|Registration and Treatment Start||0
8269832|NCT01738594|20390751|P2|Registered to Study|Registration and Treatment Start||3
8269833|NCT01738594|20390752|P1|Registered to Study|Registration and Treatment Start||0
8269834|NCT01738594|20390745|P8|STARTED|Registration and Treatment Start||0
8269835|NCT01738594|20390746|P7|STARTED|Registration and Treatment Start||0
8269836|NCT01738594|20390747|P6|STARTED|Registration and Treatment Start||3
8269837|NCT01738594|20390748|P5|STARTED|Registration and Treatment Start||1
8269838|NCT01738594|20390749|P4|STARTED|Registration and Treatment Start||0
8269839|NCT01738594|20390750|P3|STARTED|Registration and Treatment Start||0
8269840|NCT01738594|20390751|P2|STARTED|Registration and Treatment Start||3
8269841|NCT01738594|20390752|P1|STARTED|Registration and Treatment Start||0
8269842|NCT01738581|20390770|P2|NOT COMPLETED|Overall Study||0
8269843|NCT01738581|20390771|P1|NOT COMPLETED|Overall Study||1
8269844|NCT01738581|20390770|P2|COMPLETED|Overall Study||4
8269845|NCT01738581|20390771|P1|COMPLETED|Overall Study||4
8269846|NCT01738581|20390770|P2|STARTED|Overall Study||4
8269847|NCT01738581|20390771|P1|STARTED|Overall Study||5
8269848|NCT01738503|20390795|P7|NOT COMPLETED|PET Imaging Sub-study||1
8269849|NCT01738503|20390796|P6|NOT COMPLETED|PET Imaging Sub-study||2
8269850|NCT01738503|20390797|P5|NOT COMPLETED|PET Imaging Sub-study||0
8269851|NCT01738503|20390798|P4|NOT COMPLETED|PET Imaging Sub-study||0
8269852|NCT01738503|20390799|P3|NOT COMPLETED|PET Imaging Sub-study||0
8269853|NCT01738503|20390800|P2|NOT COMPLETED|PET Imaging Sub-study||0
8269854|NCT01738503|20390801|P1|NOT COMPLETED|PET Imaging Sub-study||0
8269855|NCT01738503|20390795|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
8269856|NCT01738503|20390796|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
8269857|NCT01738503|20390797|P5|COMPLETED|PET Imaging Sub-study||0
8269858|NCT01738503|20390798|P4|COMPLETED|PET Imaging Sub-study||0
8269859|NCT01738503|20390799|P3|COMPLETED|PET Imaging Sub-study||0
8269860|NCT01738503|20390800|P2|COMPLETED|PET Imaging Sub-study||0
8269861|NCT01738503|20390801|P1|COMPLETED|PET Imaging Sub-study||0
8269862|NCT01738503|20390795|P7|STARTED|PET Imaging Sub-study||2
8269863|NCT01738503|20390796|P6|STARTED|PET Imaging Sub-study||3
8269864|NCT01738503|20390797|P5|STARTED|PET Imaging Sub-study||0
8269865|NCT01738503|20390798|P4|STARTED|PET Imaging Sub-study||0
8269866|NCT01738503|20390799|P3|STARTED|PET Imaging Sub-study||0
8269867|NCT01738503|20390800|P2|STARTED|PET Imaging Sub-study||0
8269868|NCT01738503|20390801|P1|STARTED|PET Imaging Sub-study||0
8269869|NCT01738503|20390795|P7|NOT COMPLETED|Treatment Period||8
8269870|NCT01738503|20390796|P6|NOT COMPLETED|Treatment Period||6
8269871|NCT01738503|20390797|P5|NOT COMPLETED|Treatment Period||8
8269872|NCT01738503|20390798|P4|NOT COMPLETED|Treatment Period||6
8269873|NCT01738503|20390799|P3|NOT COMPLETED|Treatment Period||5
8269874|NCT01738503|20390800|P2|NOT COMPLETED|Treatment Period||5
8269875|NCT01738503|20390801|P1|NOT COMPLETED|Treatment Period||0
8269876|NCT01738503|20390795|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
8269877|NCT01738503|20390796|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
8269878|NCT01738503|20390797|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
8269879|NCT01738503|20390798|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
8269880|NCT01738503|20390799|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
8269881|NCT01738503|20390800|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
8269882|NCT01738503|20390801|P1|COMPLETED|Treatment Period||0
8269883|NCT01738503|20390795|P7|STARTED|Treatment Period||14
8269884|NCT01738503|20390796|P6|STARTED|Treatment Period||15
8269885|NCT01738503|20390797|P5|STARTED|Treatment Period||15
8269886|NCT01738503|20390798|P4|STARTED|Treatment Period||15
8269887|NCT01738503|20390799|P3|STARTED|Treatment Period||15
8269888|NCT01738503|20390800|P2|STARTED|Treatment Period||15
8269889|NCT01738503|20390801|P1|STARTED|Treatment Period||0
8269890|NCT01738503|20390795|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269891|NCT01738503|20390796|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269892|NCT01738503|20390797|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269893|NCT01738503|20390798|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269894|NCT01738503|20390799|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269895|NCT01738503|20390800|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269896|NCT01738503|20390801|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
8269897|NCT01738503|20390795|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269898|NCT01738503|20390796|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269899|NCT01738503|20390797|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269900|NCT01738503|20390798|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269901|NCT01738503|20390799|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269902|NCT01738503|20390800|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269903|NCT01738503|20390801|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
8269904|NCT01738503|20390795|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269905|NCT01738503|20390796|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269906|NCT01738503|20390797|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269907|NCT01738503|20390798|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269908|NCT01738503|20390799|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269909|NCT01738503|20390800|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269910|NCT01738503|20390801|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
8269911|NCT01738477|20390999|P2|NOT COMPLETED|Overall Study||4
8269912|NCT01738477|20391000|P1|NOT COMPLETED|Overall Study||1
8269913|NCT01738477|20390999|P2|COMPLETED|Overall Study||124
8269914|NCT01738477|20391000|P1|COMPLETED|Overall Study||36
8269915|NCT01738477|20390999|P2|STARTED|Overall Study||128
8269916|NCT01738477|20391000|P1|STARTED|Overall Study||37
8269917|NCT01738438|20391028|P1|NOT COMPLETED|Overall Study||35
8269918|NCT01738438|20391028|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8269919|NCT01738438|20391028|P1|STARTED|Overall Study||35
8269920|NCT01738321|20391036|P2|NOT COMPLETED|Overall Study||0
8269921|NCT01738321|20391037|P1|NOT COMPLETED|Overall Study||0
8269922|NCT01738321|20391036|P2|COMPLETED|Overall Study||30
8269923|NCT01738321|20391037|P1|COMPLETED|Overall Study||33
8269924|NCT01738321|20391036|P2|STARTED|Overall Study||30
8269925|NCT01738321|20391037|P1|STARTED|Overall Study||33
8269926|NCT01738191|20391045|P2|NOT COMPLETED|Overall Study||1
8269927|NCT01738191|20391046|P1|NOT COMPLETED|Overall Study||4
8269928|NCT01738191|20391045|P2|COMPLETED|Overall Study||14
8269929|NCT01738191|20391046|P1|COMPLETED|Overall Study||11
8269930|NCT01738191|20391045|P2|STARTED|Overall Study||15
8269931|NCT01738191|20391046|P1|STARTED|Overall Study||15
8269932|NCT01737996|20391069|P3|NOT COMPLETED|Overall Study||2
8269933|NCT01737996|20391070|P2|NOT COMPLETED|Overall Study||1
8269934|NCT01737996|20391071|P1|NOT COMPLETED|Overall Study||0
8269935|NCT01737996|20391069|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
8269936|NCT01737996|20391070|P2|COMPLETED|Overall Study||7
8269937|NCT01737996|20391071|P1|COMPLETED|Overall Study||8
8269938|NCT01737996|20391069|P3|STARTED|Overall Study||16
8269939|NCT01737996|20391070|P2|STARTED|Overall Study||8
8269940|NCT01737996|20391071|P1|STARTED|Overall Study||8
8269941|NCT01737944|20391112|P4|NOT COMPLETED|Overall Study||0
8269942|NCT01737944|20391113|P3|NOT COMPLETED|Overall Study||0
8269943|NCT01737944|20391114|P2|NOT COMPLETED|Overall Study||0
8269944|NCT01737944|20391115|P1|NOT COMPLETED|Overall Study||0
8269945|NCT01737944|20391112|P4|COMPLETED|Overall Study||9
8269946|NCT01737944|20391113|P3|COMPLETED|Overall Study||9
8269947|NCT01737944|20391114|P2|COMPLETED|Overall Study||9
8269948|NCT01737944|20391115|P1|COMPLETED|Overall Study||9
8269949|NCT01737944|20391112|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
8269950|NCT01737944|20391113|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
8269951|NCT01737944|20391114|P2|STARTED|Overall Study||9
8269952|NCT01737944|20391115|P1|STARTED|Overall Study||9
8269953|NCT01737931|20391133|P3|NOT COMPLETED|Overall Study||1
8269954|NCT01737931|20391134|P2|NOT COMPLETED|Overall Study||2
8269955|NCT01737931|20391135|P1|NOT COMPLETED|Overall Study||0
8269956|NCT01737931|20391133|P3|COMPLETED|Overall Study||38
8269957|NCT01737931|20391134|P2|COMPLETED|Overall Study||38
8269958|NCT01737931|20391135|P1|COMPLETED|Overall Study||38
8269959|NCT01737931|20391133|P3|STARTED|Overall Study||39
8269960|NCT01737931|20391134|P2|STARTED|Overall Study||40
8269961|NCT01737931|20391135|P1|STARTED|Overall Study||38
8269962|NCT01737879|20391150|P1|NOT COMPLETED|Overall Study||41
8269963|NCT01737879|20391150|P1|COMPLETED|Overall Study||0
8269964|NCT01737879|20391150|P1|Transitioned to Epoetin Alfa|Overall Study||0
8269965|NCT01737879|20391150|P1|Received Peginesatide|Overall Study||34
8269966|NCT01737879|20391150|P1|STARTED|Overall Study||41
8269967|NCT01737840|20391159|P2|NOT COMPLETED|Overall Study||2
8269968|NCT01737840|20391160|P1|NOT COMPLETED|Overall Study||2
8269969|NCT01737840|20391159|P2|COMPLETED|Overall Study||33
8269970|NCT01737840|20391160|P1|COMPLETED|Overall Study||33
8269971|NCT01737840|20391159|P2|STARTED|Overall Study||35
8269972|NCT01737840|20391160|P1|STARTED|Overall Study||35
8269973|NCT01737762|20391170|P2|NOT COMPLETED|Overall Study||17
8269974|NCT01737762|20391171|P1|NOT COMPLETED|Overall Study||20
8269975|NCT01737762|20391170|P2|COMPLETED|Overall Study||61
8269976|NCT01737762|20391171|P1|COMPLETED|Overall Study||57
8269977|NCT01737762|20391170|P2|STARTED|Overall Study||78
8269978|NCT01737762|20391171|P1|STARTED|Overall Study||77
8269979|NCT01737710|20391184|P5|NOT COMPLETED|Overall Study||0
8269980|NCT01737710|20391185|P4|NOT COMPLETED|Overall Study||0
8269981|NCT01737710|20391186|P3|NOT COMPLETED|Overall Study||3
8269982|NCT01737710|20391187|P2|NOT COMPLETED|Overall Study||4
8269983|NCT01737710|20391188|P1|NOT COMPLETED|Overall Study||2
8269984|NCT01737710|20391184|P5|COMPLETED|Overall Study||21
8269985|NCT01737710|20391185|P4|COMPLETED|Overall Study||23
8269986|NCT01737710|20391186|P3|COMPLETED|Overall Study||102
8269987|NCT01737710|20391187|P2|COMPLETED|Overall Study||101
8269988|NCT01737710|20391188|P1|COMPLETED|Overall Study||112
8269989|NCT01737710|20391184|P5|STARTED|Overall Study||21
8269990|NCT01737710|20391185|P4|STARTED|Overall Study||23
8269991|NCT01737710|20391186|P3|STARTED|Overall Study||105
8269992|NCT01737710|20391187|P2|STARTED|Overall Study||105
8269993|NCT01737710|20391188|P1|STARTED|Overall Study||114
8269994|NCT01737697|20391230|P15|NOT COMPLETED|Subacute Phase||1
8269995|NCT01737697|20391231|P14|NOT COMPLETED|Subacute Phase||2
8269996|NCT01737697|20391232|P13|NOT COMPLETED|Subacute Phase||2
8269997|NCT01737697|20391233|P12|NOT COMPLETED|Subacute Phase||3
8269998|NCT01737697|20391234|P11|NOT COMPLETED|Subacute Phase||6
8269999|NCT01737697|20391235|P10|NOT COMPLETED|Subacute Phase||2
8270000|NCT01737697|20391236|P9|NOT COMPLETED|Subacute Phase||2
8270001|NCT01737697|20391237|P8|NOT COMPLETED|Subacute Phase||3
8270002|NCT01737697|20391238|P7|NOT COMPLETED|Subacute Phase||1
8270003|NCT01737697|20391239|P6|NOT COMPLETED|Subacute Phase||3
8270004|NCT01737697|20391240|P5|NOT COMPLETED|Subacute Phase||0
8270005|NCT01737697|20391241|P4|NOT COMPLETED|Subacute Phase||0
8270006|NCT01737697|20391242|P3|NOT COMPLETED|Subacute Phase||0
8270007|NCT01737697|20391243|P2|NOT COMPLETED|Subacute Phase||0
8270008|NCT01737697|20391244|P1|NOT COMPLETED|Subacute Phase||0
8270009|NCT01737697|20391230|P15|COMPLETED|Subacute Phase||49
8270010|NCT01737697|20391231|P14|COMPLETED|Subacute Phase||44
8270011|NCT01737697|20391232|P13|COMPLETED|Subacute Phase||61
8270012|NCT01737697|20391233|P12|COMPLETED|Subacute Phase||58
8270013|NCT01737697|20391234|P11|COMPLETED|Subacute Phase||59
8270014|NCT01737697|20391235|P10|COMPLETED|Subacute Phase||66
8270015|NCT01737697|20391236|P9|COMPLETED|Subacute Phase||52
8270016|NCT01737697|20391237|P8|COMPLETED|Subacute Phase||43
8270017|NCT01737697|20391238|P7|COMPLETED|Subacute Phase||48
8270018|NCT01737697|20391239|P6|COMPLETED|Subacute Phase||38
8270019|NCT01737697|20391240|P5|COMPLETED|Subacute Phase||0
8270020|NCT01737697|20391241|P4|COMPLETED|Subacute Phase||0
8270021|NCT01737697|20391242|P3|COMPLETED|Subacute Phase||0
8270022|NCT01737697|20391243|P2|COMPLETED|Subacute Phase||0
8270023|NCT01737697|20391244|P1|COMPLETED|Subacute Phase||0
8270024|NCT01737697|20391230|P15|STARTED|Subacute Phase||50
8270025|NCT01737697|20391231|P14|STARTED|Subacute Phase||46
8270026|NCT01737697|20391232|P13|STARTED|Subacute Phase||63
8270027|NCT01737697|20391233|P12|STARTED|Subacute Phase||61
8270028|NCT01737697|20391234|P11|STARTED|Subacute Phase||65
8270029|NCT01737697|20391235|P10|STARTED|Subacute Phase||68
8270030|NCT01737697|20391236|P9|STARTED|Subacute Phase||54
8270031|NCT01737697|20391237|P8|STARTED|Subacute Phase||46
8270032|NCT01737697|20391238|P7|STARTED|Subacute Phase||49
8270033|NCT01737697|20391239|P6|STARTED|Subacute Phase||41
8270034|NCT01737697|20391240|P5|STARTED|Subacute Phase||0
8270035|NCT01737697|20391241|P4|STARTED|Subacute Phase||0
8270036|NCT01737697|20391242|P3|STARTED|Subacute Phase||0
8270037|NCT01737697|20391243|P2|STARTED|Subacute Phase||0
8270038|NCT01737697|20391244|P1|STARTED|Subacute Phase||0
8270039|NCT01737697|20391230|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270040|NCT01737697|20391231|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270041|NCT01737697|20391232|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270042|NCT01737697|20391233|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270043|NCT01737697|20391234|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270044|NCT01737697|20391235|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270045|NCT01737697|20391236|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270046|NCT01737697|20391237|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270047|NCT01737697|20391238|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270048|NCT01737697|20391239|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270049|NCT01737697|20391240|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
8270050|NCT01737697|20391241|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
8270051|NCT01737697|20391242|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
8270052|NCT01737697|20391243|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
8270053|NCT01737697|20391244|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
8270054|NCT01737697|20391230|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
8270055|NCT01737697|20391231|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
8270056|NCT01737697|20391232|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
8270057|NCT01737697|20391233|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
8270058|NCT01737697|20391234|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
8270059|NCT01737697|20391235|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
8270060|NCT01737697|20391236|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
8270061|NCT01737697|20391237|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
8270062|NCT01737697|20391238|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
8270063|NCT01737697|20391239|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
8270064|NCT01737697|20391240|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
8270065|NCT01737697|20391241|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
8270066|NCT01737697|20391242|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
8270067|NCT01737697|20391243|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
8270068|NCT01737697|20391244|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
8270069|NCT01737697|20391230|P15|STARTED|Acute Phase-Initial 48 Hours||0
8270070|NCT01737697|20391231|P14|STARTED|Acute Phase-Initial 48 Hours||0
8270071|NCT01737697|20391232|P13|STARTED|Acute Phase-Initial 48 Hours||0
8270072|NCT01737697|20391233|P12|STARTED|Acute Phase-Initial 48 Hours||0
8270073|NCT01737697|20391234|P11|STARTED|Acute Phase-Initial 48 Hours||0
8270074|NCT01737697|20391235|P10|STARTED|Acute Phase-Initial 48 Hours||0
8270075|NCT01737697|20391236|P9|STARTED|Acute Phase-Initial 48 Hours||0
8270076|NCT01737697|20391237|P8|STARTED|Acute Phase-Initial 48 Hours||0
8270077|NCT01737697|20391238|P7|STARTED|Acute Phase-Initial 48 Hours||0
8270078|NCT01737697|20391239|P6|STARTED|Acute Phase-Initial 48 Hours||0
8270079|NCT01737697|20391240|P5|STARTED|Acute Phase-Initial 48 Hours||143
8270080|NCT01737697|20391241|P4|STARTED|Acute Phase-Initial 48 Hours||158
8270081|NCT01737697|20391242|P3|STARTED|Acute Phase-Initial 48 Hours||141
8270082|NCT01737697|20391243|P2|STARTED|Acute Phase-Initial 48 Hours||154
8270083|NCT01737697|20391244|P1|STARTED|Acute Phase-Initial 48 Hours||158
8270084|NCT01737684|20391333|P3|NOT COMPLETED|Overall Study||0
8270085|NCT01737684|20391334|P2|NOT COMPLETED|Overall Study||0
8270086|NCT01737684|20391335|P1|NOT COMPLETED|Overall Study||0
8270087|NCT01737684|20391333|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
8270088|NCT01737684|20391334|P2|COMPLETED|Overall Study||8
8270089|NCT01737684|20391335|P1|COMPLETED|Overall Study||8
8270090|NCT01737684|20391333|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
8270091|NCT01737684|20391334|P2|STARTED|Overall Study||8
8270092|NCT01737684|20391335|P1|STARTED|Overall Study||8
8270093|NCT01737593|20391354|P3|NOT COMPLETED|Overall Study||0
8270094|NCT01737593|20391355|P2|NOT COMPLETED|Overall Study||0
8270095|NCT01737593|20391356|P1|NOT COMPLETED|Overall Study||0
8270096|NCT01737593|20391354|P3|COMPLETED|Overall Study||39
8270097|NCT01737593|20391355|P2|COMPLETED|Overall Study||32
8270098|NCT01737593|20391356|P1|COMPLETED|Overall Study||37
8270099|NCT01737593|20391354|P3|STARTED|Overall Study||39
8270100|NCT01737593|20391355|P2|STARTED|Overall Study||32
8270101|NCT01737593|20391356|P1|STARTED|Overall Study||37
8270102|NCT01737398|20391387|P2|NOT COMPLETED|Overall Study||8
8270103|NCT01737398|20391388|P1|NOT COMPLETED|Overall Study||26
8270104|NCT01737398|20391387|P2|COMPLETED|Overall Study||52
8270105|NCT01737398|20391388|P1|COMPLETED|Overall Study||87
8270106|NCT01737398|20391387|P2|Safety Set|Overall Study||60
8270107|NCT01737398|20391388|P1|Safety Set|Overall Study||112
8270108|NCT01737398|20391387|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
8270109|NCT01737398|20391388|P1|Received at Least 1 Dose of Study Drug|Overall Study||112
8270110|NCT01737398|20391387|P2|STARTED|Overall Study||60
8270111|NCT01737398|20391388|P1|STARTED|Overall Study||113
8270112|NCT01737281|20391432|P2|NOT COMPLETED|Overall Study||280
8270113|NCT01737281|20391433|P1|NOT COMPLETED|Overall Study||366
8270114|NCT01737281|20391432|P2|COMPLETED|Overall Study||689
8270115|NCT01737281|20391433|P1|COMPLETED|Overall Study||603
8270116|NCT01737281|20391432|P2|STARTED|Overall Study||969
8270117|NCT01737281|20391433|P1|STARTED|Overall Study||969
8270118|NCT01737268|20391441|P1|NOT COMPLETED|Overall Study||9
8270119|NCT01737268|20391441|P1|COMPLETED|Overall Study||11
8270120|NCT01737268|20391441|P1|Treated|Overall Study||20
8270121|NCT01737268|20391441|P1|STARTED|Overall Study||20
8270122|NCT01737021|20391455|P2|NOT COMPLETED|Overall Study||3
8270123|NCT01737021|20391456|P1|NOT COMPLETED|Overall Study||5
8270124|NCT01737021|20391455|P2|COMPLETED|Overall Study||6
8270125|NCT01737021|20391456|P1|COMPLETED|Overall Study||17
8270126|NCT01737021|20391455|P2|STARTED|Overall Study||9
8270127|NCT01737021|20391456|P1|STARTED|Overall Study||22
8270128|NCT01736930|20391462|P1|NOT COMPLETED|Overall Study||1
8270129|NCT01736930|20391462|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
8270130|NCT01736930|20391462|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
8270131|NCT01736917|20391502|P1|NOT COMPLETED|Overall Study||11
8270132|NCT01736917|20391502|P1|COMPLETED|Overall Study||54
8270133|NCT01736917|20391502|P1|STARTED|Overall Study||65
8270134|NCT01736865|20391511|P2|NOT COMPLETED|Overall Study||0
8270135|NCT01736865|20391512|P1|NOT COMPLETED|Overall Study||0
8270136|NCT01736865|20391511|P2|COMPLETED|Overall Study||66
8270137|NCT01736865|20391512|P1|COMPLETED|Overall Study||61
8270138|NCT01736865|20391511|P2|STARTED|Overall Study||66
8270139|NCT01736865|20391512|P1|STARTED|Overall Study||61
8270140|NCT01736852|20391526|P2|NOT COMPLETED|Overall Study||3
8270141|NCT01736852|20391527|P1|NOT COMPLETED|Overall Study||2
8270142|NCT01736852|20391526|P2|COMPLETED|Overall Study||61
8270143|NCT01736852|20391527|P1|COMPLETED|Overall Study||63
8270144|NCT01736852|20391526|P2|STARTED|Overall Study||64
8270145|NCT01736852|20391527|P1|STARTED|Overall Study||65
8270146|NCT01736696|20391542|P7|NOT COMPLETED|Overall Study||0
8270147|NCT01736696|20391543|P6|NOT COMPLETED|Overall Study||0
8270148|NCT01736696|20391544|P5|NOT COMPLETED|Overall Study||0
8270149|NCT01736696|20391545|P4|NOT COMPLETED|Overall Study||0
8270150|NCT01736696|20391546|P3|NOT COMPLETED|Overall Study||1
8270151|NCT01736696|20391547|P2|NOT COMPLETED|Overall Study||0
8270152|NCT01736696|20391548|P1|NOT COMPLETED|Overall Study||0
8270153|NCT01736696|20391542|P7|COMPLETED|Overall Study||13
8270154|NCT01736696|20391543|P6|COMPLETED|Overall Study||8
8270155|NCT01736696|20391544|P5|COMPLETED|Overall Study||9
8270156|NCT01736696|20391545|P4|COMPLETED|Overall Study||9
8270157|NCT01736696|20391546|P3|COMPLETED|Overall Study||9
8270158|NCT01736696|20391547|P2|COMPLETED|Overall Study||5
8270159|NCT01736696|20391548|P1|COMPLETED|Overall Study||5
8270160|NCT01736696|20391542|P7|STARTED|Overall Study||13
8270161|NCT01736696|20391543|P6|STARTED|Overall Study||8
8270162|NCT01736696|20391544|P5|STARTED|Overall Study||9
8270163|NCT01736696|20391545|P4|STARTED|Overall Study||9
8270164|NCT01736696|20391546|P3|STARTED|Overall Study||10
8270165|NCT01736696|20391547|P2|STARTED|Overall Study||5
8270166|NCT01736696|20391548|P1|STARTED|Overall Study||5
8270167|NCT01736683|20391870|P5|NOT COMPLETED|Overall Study||5
8270168|NCT01736683|20391871|P4|NOT COMPLETED|Overall Study||35
8270169|NCT01736683|20391872|P3|NOT COMPLETED|Overall Study||21
8270170|NCT01736683|20391873|P2|NOT COMPLETED|Overall Study||6
8270171|NCT01736683|20391874|P1|NOT COMPLETED|Overall Study||7
8270172|NCT01736683|20391870|P5|COMPLETED|Overall Study|# who completed treatment|0
8270173|NCT01736683|20391871|P4|COMPLETED|Overall Study|# who completed treatment|0
8270174|NCT01736683|20391872|P3|COMPLETED|Overall Study|# who completed treatment|0
8270175|NCT01736683|20391873|P2|COMPLETED|Overall Study|# who completed treatment|0
8270176|NCT01736683|20391874|P1|COMPLETED|Overall Study|# who completed treatment|0
8270177|NCT01736683|20391870|P5|STARTED|Overall Study||5
8270178|NCT01736683|20391871|P4|STARTED|Overall Study||35
8270179|NCT01736683|20391872|P3|STARTED|Overall Study||21
8270180|NCT01736683|20391873|P2|STARTED|Overall Study||6
8270181|NCT01736683|20391874|P1|STARTED|Overall Study||7
8270182|NCT01736657|20391936|P1|NOT COMPLETED|Overall Study||1
8270183|NCT01736657|20391936|P1|COMPLETED|Overall Study||72
8270184|NCT01736657|20391936|P1|STARTED|Overall Study||73
8270185|NCT01736579|20391945|P2|NOT COMPLETED|Overall Study||2
8270186|NCT01736579|20391946|P1|NOT COMPLETED|Overall Study||2
8270187|NCT01736579|20391945|P2|COMPLETED|Overall Study||0
8270188|NCT01736579|20391946|P1|COMPLETED|Overall Study||0
8270189|NCT01736579|20391945|P2|STARTED|Overall Study||2
8270190|NCT01736579|20391946|P1|STARTED|Overall Study||2
8270191|NCT01736566|20391985|P5|NOT COMPLETED|Long Term Follow-up||1
8270192|NCT01736566|20391986|P4|NOT COMPLETED|Long Term Follow-up||0
8270193|NCT01736566|20391987|P3|NOT COMPLETED|Long Term Follow-up||49
8270194|NCT01736566|20391988|P2|NOT COMPLETED|Long Term Follow-up||0
8270195|NCT01736566|20391989|P1|NOT COMPLETED|Long Term Follow-up||42
8270196|NCT01736566|20391985|P5|COMPLETED|Long Term Follow-up||0
8270197|NCT01736566|20391986|P4|COMPLETED|Long Term Follow-up||0
8270198|NCT01736566|20391987|P3|COMPLETED|Long Term Follow-up||0
8270199|NCT01736566|20391988|P2|COMPLETED|Long Term Follow-up||0
8270200|NCT01736566|20391989|P1|COMPLETED|Long Term Follow-up||0
8270201|NCT01736566|20391985|P5|STARTED|Long Term Follow-up||1
8270202|NCT01736566|20391986|P4|STARTED|Long Term Follow-up||0
8270203|NCT01736566|20391987|P3|STARTED|Long Term Follow-up||49
8270204|NCT01736566|20391988|P2|STARTED|Long Term Follow-up||0
8270205|NCT01736566|20391989|P1|STARTED|Long Term Follow-up||42
8270206|NCT01736566|20391985|P5|NOT COMPLETED|Main Study||4
8270207|NCT01736566|20391986|P4|NOT COMPLETED|Main Study||1
8270208|NCT01736566|20391987|P3|NOT COMPLETED|Main Study||1
8270209|NCT01736566|20391988|P2|NOT COMPLETED|Main Study||0
8270210|NCT01736566|20391989|P1|NOT COMPLETED|Main Study||1
8270211|NCT01736566|20391985|P5|COMPLETED|Main Study||6
8270212|NCT01736566|20391986|P4|COMPLETED|Main Study||51
8270213|NCT01736566|20391987|P3|COMPLETED|Main Study||49
8270214|NCT01736566|20391988|P2|COMPLETED|Main Study||50
8270215|NCT01736566|20391989|P1|COMPLETED|Main Study||50
8270216|NCT01736566|20391985|P5|STARTED|Main Study||10
8270217|NCT01736566|20391986|P4|STARTED|Main Study||52
8270218|NCT01736566|20391987|P3|STARTED|Main Study||50
8270219|NCT01736566|20391988|P2|STARTED|Main Study||50
8270220|NCT01736566|20391989|P1|STARTED|Main Study||51
8270221|NCT01736553|20392074|P2|NOT COMPLETED|Overall Study||4
8270222|NCT01736553|20392075|P1|NOT COMPLETED|Overall Study||19
8270223|NCT01736553|20392074|P2|COMPLETED|Overall Study||23
8270224|NCT01736553|20392075|P1|COMPLETED|Overall Study||7
8270225|NCT01736553|20392074|P2|STARTED|Overall Study||27
8270226|NCT01736553|20392075|P1|STARTED|Overall Study||26
8270227|NCT01736540|20392126|P1|NOT COMPLETED|Overall Study||15
8270228|NCT01736540|20392126|P1|COMPLETED|Overall Study||228
8270229|NCT01736540|20392126|P1|STARTED|Overall Study||243
8270230|NCT01736527|20392183|P1|NOT COMPLETED|Overall Study||0
8270231|NCT01736527|20392183|P1|COMPLETED|Overall Study||12
8270232|NCT01736527|20392183|P1|STARTED|Overall Study||12
8270233|NCT01736475|20392192|P2|NOT COMPLETED|Overall Study||0
8270234|NCT01736475|20392193|P1|NOT COMPLETED|Overall Study||12
8270235|NCT01736475|20392192|P2|COMPLETED|Overall Study||17
8270236|NCT01736475|20392193|P1|COMPLETED|Overall Study||109
8270237|NCT01736475|20392192|P2|STARTED|Overall Study||17
8270238|NCT01736475|20392193|P1|STARTED|Overall Study||121
8270239|NCT01736397|20392248|P2|NOT COMPLETED|Overall Study||24
8270240|NCT01736397|20392249|P1|NOT COMPLETED|Overall Study||14
8270241|NCT01736397|20392248|P2|COMPLETED|Overall Study||50
8270242|NCT01736397|20392249|P1|COMPLETED|Overall Study||61
8270243|NCT01736397|20392248|P2|STARTED|Overall Study||74
8270244|NCT01736397|20392249|P1|STARTED|Overall Study||75
8270245|NCT01736358|20392263|P2|NOT COMPLETED|Overall Study||2
8270246|NCT01736358|20392264|P1|NOT COMPLETED|Overall Study||5
8270247|NCT01736358|20392263|P2|COMPLETED|Overall Study||23
8270248|NCT01736358|20392264|P1|COMPLETED|Overall Study||20
8270249|NCT01736358|20392263|P2|STARTED|Overall Study||25
8270250|NCT01736358|20392264|P1|STARTED|Overall Study||25
8270251|NCT01736267|20392278|P1|NOT COMPLETED|Overall Study||0
8270252|NCT01736267|20392278|P1|COMPLETED|Overall Study||3
8270253|NCT01736267|20392278|P1|STARTED|Overall Study||3
8270254|NCT01736254|20392282|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
8270255|NCT01736254|20392282|P1|COMPLETED|Period 3 (Days 13 to 23)||20
8270256|NCT01736254|20392282|P1|STARTED|Period 3 (Days 13 to 23)||21
8270257|NCT01736254|20392282|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
8270258|NCT01736254|20392282|P1|COMPLETED|Period 2 (Days 2 to 12)||21
8270259|NCT01736254|20392282|P1|STARTED|Period 2 (Days 2 to 12)||24
8270260|NCT01736254|20392282|P1|NOT COMPLETED|Period 1 (Day 1)||0
8270261|NCT01736254|20392282|P1|COMPLETED|Period 1 (Day 1)||24
8270262|NCT01736254|20392282|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
8270263|NCT01736254|20392282|P1|STARTED|Period 1 (Day 1)||24
8270264|NCT01736241|20392306|P7|NOT COMPLETED|Overall Study||0
8270265|NCT01736241|20392307|P6|NOT COMPLETED|Overall Study||0
8270266|NCT01736241|20392308|P5|NOT COMPLETED|Overall Study||0
8270267|NCT01736241|20392309|P4|NOT COMPLETED|Overall Study||0
8270268|NCT01736241|20392310|P3|NOT COMPLETED|Overall Study||0
8270269|NCT01736241|20392311|P2|NOT COMPLETED|Overall Study||0
8270270|NCT01736241|20392312|P1|NOT COMPLETED|Overall Study||0
8270271|NCT01736241|20392306|P7|COMPLETED|Overall Study||6
8270272|NCT01736241|20392307|P6|COMPLETED|Overall Study||6
8270273|NCT01736241|20392308|P5|COMPLETED|Overall Study||6
8270274|NCT01736241|20392309|P4|COMPLETED|Overall Study||5
8270275|NCT01736241|20392310|P3|COMPLETED|Overall Study||6
8270276|NCT01736241|20392311|P2|COMPLETED|Overall Study||6
8270277|NCT01736241|20392312|P1|COMPLETED|Overall Study||6
8270278|NCT01736241|20392306|P7|Received at Least One Dose of Study Drug|Overall Study||6
8270279|NCT01736241|20392307|P6|Received at Least One Dose of Study Drug|Overall Study||6
8270280|NCT01736241|20392308|P5|Received at Least One Dose of Study Drug|Overall Study||6
8270281|NCT01736241|20392309|P4|Received at Least One Dose of Study Drug|Overall Study||5
8270282|NCT01736241|20392310|P3|Received at Least One Dose of Study Drug|Overall Study||6
8270283|NCT01736241|20392311|P2|Received at Least One Dose of Study Drug|Overall Study||6
8270284|NCT01736241|20392312|P1|Received at Least One Dose of Study Drug|Overall Study||6
8270285|NCT01736241|20392306|P7|STARTED|Overall Study||6
8270286|NCT01736241|20392307|P6|STARTED|Overall Study||6
8270287|NCT01736241|20392308|P5|STARTED|Overall Study||6
8270288|NCT01736241|20392309|P4|STARTED|Overall Study||5
8270289|NCT01736241|20392310|P3|STARTED|Overall Study||6
8270290|NCT01736241|20392311|P2|STARTED|Overall Study||6
8270291|NCT01736241|20392312|P1|STARTED|Overall Study||6
8270292|NCT01736215|20392347|P1|NOT COMPLETED|Overall Study||14
8270293|NCT01736215|20392347|P1|COMPLETED|Overall Study||19
8270294|NCT01736215|20392347|P1|Treated|Overall Study||25
8270295|NCT01736215|20392347|P1|STARTED|Overall Study||33
8270296|NCT01736189|20392359|P1|NOT COMPLETED|Overall Study||46
8270297|NCT01736189|20392359|P1|COMPLETED|Overall Study||300
8270298|NCT01736189|20392359|P1|STARTED|Overall Study||346
8270299|NCT01736176|20392368|P1|NOT COMPLETED|Overall Study||11
8270300|NCT01736176|20392368|P1|COMPLETED|Overall Study||28
8270301|NCT01736176|20392368|P1|Received LCIG|Overall Study||38
8270302|NCT01736176|20392368|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
8270303|NCT01736085|20392418|P6|NOT COMPLETED|Overall Study||0
8270304|NCT01736085|20392419|P5|NOT COMPLETED|Overall Study||0
8270305|NCT01736085|20392420|P4|NOT COMPLETED|Overall Study||0
8270306|NCT01736085|20392421|P3|NOT COMPLETED|Overall Study||0
8270307|NCT01736085|20392422|P2|NOT COMPLETED|Overall Study||0
8270308|NCT01736085|20392423|P1|NOT COMPLETED|Overall Study||0
8270309|NCT01736085|20392418|P6|COMPLETED|Overall Study||794
8270310|NCT01736085|20392419|P5|COMPLETED|Overall Study||530
8270311|NCT01736085|20392420|P4|COMPLETED|Overall Study||530
8270312|NCT01736085|20392421|P3|COMPLETED|Overall Study||793
8270313|NCT01736085|20392422|P2|COMPLETED|Overall Study||530
8270314|NCT01736085|20392423|P1|COMPLETED|Overall Study||529
8270315|NCT01736085|20392418|P6|STARTED|Overall Study||794
8270316|NCT01736085|20392419|P5|STARTED|Overall Study||530
8270317|NCT01736085|20392420|P4|STARTED|Overall Study||530
8270318|NCT01736085|20392421|P3|STARTED|Overall Study||793
8270319|NCT01736085|20392422|P2|STARTED|Overall Study||530
8270320|NCT01736085|20392423|P1|STARTED|Overall Study||529
8270321|NCT01735994|20392439|P2|NOT COMPLETED|Overall Study||66
8270322|NCT01735994|20392440|P1|NOT COMPLETED|Overall Study||63
8270323|NCT01735994|20392439|P2|COMPLETED|Overall Study||152
8270324|NCT01735994|20392440|P1|COMPLETED|Overall Study||200
8270325|NCT01735994|20392439|P2|Follow-Up #2 (12 Months)|Overall Study||174
8270326|NCT01735994|20392440|P1|Follow-Up #2 (12 Months)|Overall Study||212
8270327|NCT01735994|20392439|P2|Follow-Up #1 (6 Months)|Overall Study||163
8270328|NCT01735994|20392440|P1|Follow-Up #1 (6 Months)|Overall Study||213
8270329|NCT01735994|20392439|P2|Post Intervention (3 Weeks)|Overall Study||198
8270330|NCT01735994|20392440|P1|Post Intervention (3 Weeks)|Overall Study||239
8270331|NCT01735994|20392439|P2|STARTED|Overall Study||218
8270332|NCT01735994|20392440|P1|STARTED|Overall Study||263
8270333|NCT01735916|20392455|P3|NOT COMPLETED|Overall Study||7
8270334|NCT01735916|20392456|P2|NOT COMPLETED|Overall Study||19
8270335|NCT01735916|20392457|P1|NOT COMPLETED|Overall Study||18
8270336|NCT01735916|20392455|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
8270337|NCT01735916|20392456|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
8270338|NCT01735916|20392457|P1|COMPLETED|Overall Study||0
8270339|NCT01735916|20392455|P3|STARTED|Overall Study||7
8270340|NCT01735916|20392456|P2|STARTED|Overall Study||19
8270341|NCT01735916|20392457|P1|STARTED|Overall Study||18
8270342|NCT01735877|20392478|P2|NOT COMPLETED|Overall Study||0
8270343|NCT01735877|20392479|P1|NOT COMPLETED|Overall Study||1
8270344|NCT01735877|20392478|P2|COMPLETED|Overall Study||21
8270345|NCT01735877|20392479|P1|COMPLETED|Overall Study||26
8270346|NCT01735877|20392478|P2|STARTED|Overall Study||21
8270347|NCT01735877|20392479|P1|STARTED|Overall Study||27
8270348|NCT01735630|20392495|P2|NOT COMPLETED|Overall Study||18
8270349|NCT01735630|20392496|P1|NOT COMPLETED|Overall Study||18
8270350|NCT01735630|20392495|P2|COMPLETED|Overall Study||157
8270351|NCT01735630|20392496|P1|COMPLETED|Overall Study||157
8270352|NCT01735630|20392495|P2|STARTED|Overall Study||175
8270353|NCT01735630|20392496|P1|STARTED|Overall Study||175
8270354|NCT01735617|20392510|P1|NOT COMPLETED|Overall Study||0
8270355|NCT01735617|20392510|P1|COMPLETED|Overall Study||16
8270356|NCT01735617|20392510|P1|STARTED|Overall Study||16
8270357|NCT01735396|20392523|P1|NOT COMPLETED|Overall Study||1
8270358|NCT01735396|20392523|P1|COMPLETED|Overall Study||10
8270359|NCT01735396|20392523|P1|STARTED|Overall Study||11
8270360|NCT01735279|20392534|P2|NOT COMPLETED|Overall Study||8
8270361|NCT01735279|20392535|P1|NOT COMPLETED|Overall Study||11
8270362|NCT01735279|20392534|P2|COMPLETED|Overall Study||21
8270363|NCT01735279|20392535|P1|COMPLETED|Overall Study||18
8270364|NCT01735279|20392534|P2|STARTED|Overall Study||29
8270365|NCT01735279|20392535|P1|STARTED|Overall Study||29
8270366|NCT01735214|20392547|P1|NOT COMPLETED|Overall Study||0
8270367|NCT01735214|20392547|P1|COMPLETED|Overall Study||358
8270368|NCT01735214|20392547|P1|STARTED|Overall Study||358
8270369|NCT01735201|20392567|P8|NOT COMPLETED|Overall Study||2
8270370|NCT01735201|20392568|P7|NOT COMPLETED|Overall Study||3
8270371|NCT01735201|20392569|P6|NOT COMPLETED|Overall Study||5
8270372|NCT01735201|20392570|P5|NOT COMPLETED|Overall Study||1
8270373|NCT01735201|20392571|P4|NOT COMPLETED|Overall Study||2
8270374|NCT01735201|20392572|P3|NOT COMPLETED|Overall Study||0
8270375|NCT01735201|20392573|P2|NOT COMPLETED|Overall Study||1
8270376|NCT01735201|20392574|P1|NOT COMPLETED|Overall Study||3
8270377|NCT01735201|20392567|P8|COMPLETED|Overall Study||42
8270378|NCT01735201|20392568|P7|COMPLETED|Overall Study||42
8270379|NCT01735201|20392569|P6|COMPLETED|Overall Study||40
8270380|NCT01735201|20392570|P5|COMPLETED|Overall Study||44
8270381|NCT01735201|20392571|P4|COMPLETED|Overall Study||42
8270382|NCT01735201|20392572|P3|COMPLETED|Overall Study||44
8270383|NCT01735201|20392573|P2|COMPLETED|Overall Study||43
8270384|NCT01735201|20392574|P1|COMPLETED|Overall Study||42
8270385|NCT01735201|20392567|P8|STARTED|Overall Study||44
8270386|NCT01735201|20392568|P7|STARTED|Overall Study||45
8270387|NCT01735201|20392569|P6|STARTED|Overall Study||45
8270388|NCT01735201|20392570|P5|STARTED|Overall Study||45
8270389|NCT01735201|20392571|P4|STARTED|Overall Study||44
8270390|NCT01735201|20392572|P3|STARTED|Overall Study||44
8270391|NCT01735201|20392573|P2|STARTED|Overall Study||44
8270392|NCT01735201|20392574|P1|STARTED|Overall Study||45
8270393|NCT01735175|20392610|P2|NOT COMPLETED|Overall Study||13
8270394|NCT01735175|20392611|P1|NOT COMPLETED|Overall Study||29
8270395|NCT01735175|20392610|P2|COMPLETED|Overall Study||144
8270396|NCT01735175|20392611|P1|COMPLETED|Overall Study||130
8270397|NCT01735175|20392610|P2|Completed the 6-month SFU Visit|Overall Study||138
8270398|NCT01735175|20392611|P1|Completed the 6-month SFU Visit|Overall Study||120
8270399|NCT01735175|20392610|P2|Completed All Treatments as Planned|Overall Study||150
8270400|NCT01735175|20392611|P1|Completed All Treatments as Planned|Overall Study||140
8270401|NCT01735175|20392610|P2|Completed All Cycles|Overall Study||150
8270402|NCT01735175|20392611|P1|Completed All Cycles|Overall Study||141
8270403|NCT01735175|20392610|P2|STARTED|Overall Study||157
8270404|NCT01735175|20392611|P1|STARTED|Overall Study||159
8270405|NCT01734993|20392631|P1|NOT COMPLETED|Overall Study||2
8270406|NCT01734993|20392631|P1|COMPLETED|Overall Study||9
8270407|NCT01734993|20392631|P1|STARTED|Overall Study||11
8270408|NCT01734902|20392659|P2|NOT COMPLETED|Overall Study||2
8270409|NCT01734902|20392660|P1|NOT COMPLETED|Overall Study||0
8270410|NCT01734902|20392659|P2|COMPLETED|Overall Study||14
8270411|NCT01734902|20392660|P1|COMPLETED|Overall Study||14
8270412|NCT01734902|20392659|P2|STARTED|Overall Study||16
8270413|NCT01734902|20392660|P1|STARTED|Overall Study||14
8270414|NCT01734889|20392670|P1|NOT COMPLETED|Overall Study||0
8270415|NCT01734889|20392670|P1|COMPLETED|Overall Study||18
8270416|NCT01734889|20392670|P1|STARTED|Overall Study||18
8270417|NCT01734850|20392681|P3|NOT COMPLETED|Overall Study||4
8270418|NCT01734850|20392682|P2|NOT COMPLETED|Overall Study||2
8270419|NCT01734850|20392683|P1|NOT COMPLETED|Overall Study||3
8270420|NCT01734850|20392681|P3|COMPLETED|Overall Study||1
8270421|NCT01734850|20392682|P2|COMPLETED|Overall Study||2
8270422|NCT01734850|20392683|P1|COMPLETED|Overall Study||1
8270423|NCT01734850|20392681|P3|STARTED|Overall Study||5
8270424|NCT01734850|20392682|P2|STARTED|Overall Study||4
8270425|NCT01734850|20392683|P1|STARTED|Overall Study||4
8270426|NCT01734811|20392740|P2|NOT COMPLETED|Overall Study||3
8270427|NCT01734811|20392741|P1|NOT COMPLETED|Overall Study||4
8270428|NCT01734811|20392740|P2|COMPLETED|Overall Study||59
8270429|NCT01734811|20392741|P1|COMPLETED|Overall Study||54
8270430|NCT01734811|20392740|P2|STARTED|Overall Study||62
8270431|NCT01734811|20392741|P1|STARTED|Overall Study||58
8270432|NCT01734785|20392768|P4|NOT COMPLETED|Double-Blind Period||0
8270433|NCT01734785|20392769|P3|NOT COMPLETED|Double-Blind Period||5
8270434|NCT01734785|20392770|P2|NOT COMPLETED|Double-Blind Period||9
8270435|NCT01734785|20392771|P1|NOT COMPLETED|Double-Blind Period||5
8270436|NCT01734785|20392768|P4|COMPLETED|Double-Blind Period||0
8270437|NCT01734785|20392769|P3|COMPLETED|Double-Blind Period||105
8270438|NCT01734785|20392770|P2|COMPLETED|Double-Blind Period||103
8270439|NCT01734785|20392771|P1|COMPLETED|Double-Blind Period||106
8270440|NCT01734785|20392768|P4|STARTED|Double-Blind Period||0
8270441|NCT01734785|20392769|P3|STARTED|Double-Blind Period||110
8270442|NCT01734785|20392770|P2|STARTED|Double-Blind Period||112
8270443|NCT01734785|20392771|P1|STARTED|Double-Blind Period||111
8270444|NCT01734785|20392768|P4|NOT COMPLETED|Open-Label Period||273
8270445|NCT01734785|20392769|P3|NOT COMPLETED|Open-Label Period||0
8270446|NCT01734785|20392770|P2|NOT COMPLETED|Open-Label Period||0
8270447|NCT01734785|20392771|P1|NOT COMPLETED|Open-Label Period||0
8270448|NCT01734785|20392768|P4|COMPLETED|Open-Label Period||333
8270449|NCT01734785|20392769|P3|COMPLETED|Open-Label Period||0
8270450|NCT01734785|20392770|P2|COMPLETED|Open-Label Period||0
8270451|NCT01734785|20392771|P1|COMPLETED|Open-Label Period||0
8270452|NCT01734785|20392768|P4|STARTED|Open-Label Period||606
8270453|NCT01734785|20392769|P3|STARTED|Open-Label Period||0
8270454|NCT01734785|20392770|P2|STARTED|Open-Label Period||0
8270455|NCT01734785|20392771|P1|STARTED|Open-Label Period||0
8270456|NCT01734772|20392788|P2|NOT COMPLETED|Overall Study||3
8270457|NCT01734772|20392789|P1|NOT COMPLETED|Overall Study||1
8270458|NCT01734772|20392788|P2|COMPLETED|Overall Study||21
8270459|NCT01734772|20392789|P1|COMPLETED|Overall Study||23
8270460|NCT01734772|20392788|P2|STARTED|Overall Study||24
8270461|NCT01734772|20392789|P1|STARTED|Overall Study||24
8270462|NCT01734746|20392806|P1|NOT COMPLETED|Overall Study||1
8270463|NCT01734746|20392806|P1|COMPLETED|Overall Study||21
8270464|NCT01734746|20392806|P1|STARTED|Overall Study||22
8270465|NCT01734655|20392812|P1|NOT COMPLETED|Overall Study||0
8270466|NCT01734655|20392812|P1|COMPLETED|Overall Study||40
8270467|NCT01734655|20392812|P1|STARTED|Overall Study||40
8270468|NCT01734551|20392823|P2|NOT COMPLETED|Overall Study||0
8270469|NCT01734551|20392824|P1|NOT COMPLETED|Overall Study||0
8270470|NCT01734551|20392823|P2|COMPLETED|Overall Study||16
8270471|NCT01734551|20392824|P1|COMPLETED|Overall Study||15
8270472|NCT01734551|20392823|P2|STARTED|Overall Study||16
8270473|NCT01734551|20392824|P1|STARTED|Overall Study||15
8270474|NCT01734525|20392836|P1|NOT COMPLETED|Overall Study||0
8270475|NCT01734525|20392836|P1|COMPLETED|Overall Study||85
8270476|NCT01734525|20392836|P1|STARTED|Overall Study||85
8270477|NCT01734434|20392844|P4|NOT COMPLETED|Overall Study||23
8270478|NCT01734434|20392845|P3|NOT COMPLETED|Overall Study||129
8270479|NCT01734434|20392846|P2|NOT COMPLETED|Overall Study||12
8270480|NCT01734434|20392847|P1|NOT COMPLETED|Overall Study||10
8270481|NCT01734434|20392844|P4|COMPLETED|Overall Study||228
8270482|NCT01734434|20392845|P3|COMPLETED|Overall Study||1863
8270483|NCT01734434|20392846|P2|COMPLETED|Overall Study||488
8270484|NCT01734434|20392847|P1|COMPLETED|Overall Study||490
8270485|NCT01734434|20392844|P4|STARTED|Overall Study||251
8270486|NCT01734434|20392845|P3|STARTED|Overall Study||1992
8270487|NCT01734434|20392846|P2|STARTED|Overall Study||500
8270488|NCT01734434|20392847|P1|STARTED|Overall Study||500
8270489|NCT01734395|20392869|P1|NOT COMPLETED|Overall Study||410
8270490|NCT01734395|20392869|P1|COMPLETED|Overall Study||1472
8270491|NCT01734395|20392869|P1|STARTED|Overall Study||1882
8270492|NCT01734382|20392878|P3|NOT COMPLETED|Part 2||7
8270493|NCT01734382|20392879|P2|NOT COMPLETED|Part 2||2
8270494|NCT01734382|20392880|P1|NOT COMPLETED|Part 2||0
8270495|NCT01734382|20392878|P3|COMPLETED|Part 2||8
8270496|NCT01734382|20392879|P2|COMPLETED|Part 2||5
8270497|NCT01734382|20392880|P1|COMPLETED|Part 2||0
8270498|NCT01734382|20392878|P3|STARTED|Part 2||15
8270499|NCT01734382|20392879|P2|STARTED|Part 2||7
8270500|NCT01734382|20392880|P1|STARTED|Part 2||0
8270501|NCT01734382|20392878|P3|NOT COMPLETED|Part 1||0
8270502|NCT01734382|20392879|P2|NOT COMPLETED|Part 1||0
8270503|NCT01734382|20392880|P1|NOT COMPLETED|Part 1||2
8270504|NCT01734382|20392878|P3|COMPLETED|Part 1||0
8270505|NCT01734382|20392879|P2|COMPLETED|Part 1||0
8270506|NCT01734382|20392880|P1|COMPLETED|Part 1||17
8270507|NCT01734382|20392878|P3|STARTED|Part 1||0
8270508|NCT01734382|20392879|P2|STARTED|Part 1||0
8270509|NCT01734382|20392880|P1|STARTED|Part 1||19
8270510|NCT01734317|20392940|P1|NOT COMPLETED|Overall Study||0
8270511|NCT01734317|20392940|P1|COMPLETED|Overall Study||10
8270512|NCT01734317|20392940|P1|STARTED|Overall Study||10
8270513|NCT01734239|20392947|P2|NOT COMPLETED|Overall Study||0
8270514|NCT01734239|20392948|P1|NOT COMPLETED|Overall Study||0
8270515|NCT01734239|20392947|P2|COMPLETED|Overall Study||50
8270516|NCT01734239|20392948|P1|COMPLETED|Overall Study||52
8270517|NCT01734239|20392947|P2|STARTED|Overall Study||50
8270518|NCT01734239|20392948|P1|STARTED|Overall Study||52
8270519|NCT01734161|20392963|P2|NOT COMPLETED|Overall Study||8
8270520|NCT01734161|20392964|P1|NOT COMPLETED|Overall Study||6
8270521|NCT01734161|20392963|P2|COMPLETED|Overall Study||53
8270522|NCT01734161|20392964|P1|COMPLETED|Overall Study||55
8270523|NCT01734161|20392963|P2|STARTED|Overall Study||61
8270524|NCT01734161|20392964|P1|STARTED|Overall Study||61
8270525|NCT01733953|20392972|P2|NOT COMPLETED|Overall Study||7
8270526|NCT01733953|20392973|P1|NOT COMPLETED|Overall Study||5
8270527|NCT01733953|20392972|P2|COMPLETED|Overall Study||6
8270528|NCT01733953|20392973|P1|COMPLETED|Overall Study||9
8270529|NCT01733953|20392972|P2|STARTED|Overall Study||13
8270530|NCT01733953|20392973|P1|STARTED|Overall Study||14
8270531|NCT01733758|20392993|P4|NOT COMPLETED|Overall Study||8
8270532|NCT01733758|20392994|P3|NOT COMPLETED|Overall Study||15
8270533|NCT01733758|20392995|P2|NOT COMPLETED|Overall Study||12
8270534|NCT01733758|20392996|P1|NOT COMPLETED|Overall Study||15
8270535|NCT01733758|20392993|P4|COMPLETED|Overall Study||95
8270536|NCT01733758|20392994|P3|COMPLETED|Overall Study||135
8270537|NCT01733758|20392995|P2|COMPLETED|Overall Study||148
8270538|NCT01733758|20392996|P1|COMPLETED|Overall Study||62
8270539|NCT01733758|20392993|P4|STARTED|Overall Study||103
8270540|NCT01733758|20392994|P3|STARTED|Overall Study||150
8270541|NCT01733758|20392995|P2|STARTED|Overall Study||160
8270542|NCT01733758|20392996|P1|STARTED|Overall Study||77
8270543|NCT01733745|20393049|P2|NOT COMPLETED|Overall Study||0
8270544|NCT01733745|20393050|P1|NOT COMPLETED|Overall Study||0
8270545|NCT01733745|20393049|P2|COMPLETED|Overall Study||13
8270546|NCT01733745|20393050|P1|COMPLETED|Overall Study||13
8270547|NCT01733745|20393049|P2|STARTED|Overall Study||13
8270548|NCT01733745|20393050|P1|STARTED|Overall Study||13
8270549|NCT01733732|20393062|P2|NOT COMPLETED|Overall Study||0
8270550|NCT01733732|20393063|P1|NOT COMPLETED|Overall Study||2
8270551|NCT01733732|20393062|P2|COMPLETED|Overall Study||27
8270552|NCT01733732|20393063|P1|COMPLETED|Overall Study||25
8270553|NCT01733732|20393062|P2|STARTED|Overall Study||27
8270554|NCT01733732|20393063|P1|STARTED|Overall Study||27
8270555|NCT01733680|20393099|P2|NOT COMPLETED|Overall Study||1
8270556|NCT01733680|20393100|P1|NOT COMPLETED|Overall Study||0
8270557|NCT01733680|20393099|P2|COMPLETED|Overall Study||0
8270558|NCT01733680|20393100|P1|COMPLETED|Overall Study||2
8270559|NCT01733680|20393099|P2|STARTED|Overall Study||1
8270560|NCT01733680|20393100|P1|STARTED|Overall Study||2
8270561|NCT01733628|20393110|P1|NOT COMPLETED|Overall Study||0
8270562|NCT01733628|20393110|P1|COMPLETED|Overall Study||143
8270563|NCT01733628|20393110|P1|STARTED|Overall Study||143
8270564|NCT01733472|20393119|P2|NOT COMPLETED|Overall Study||0
8270565|NCT01733472|20393120|P1|NOT COMPLETED|Overall Study||0
8270566|NCT01733472|20393119|P2|COMPLETED|Overall Study||60
8270567|NCT01733472|20393120|P1|COMPLETED|Overall Study||60
8270568|NCT01733472|20393119|P2|STARTED|Overall Study||60
8270569|NCT01733472|20393120|P1|STARTED|Overall Study||60
8270570|NCT01733407|20393132|P2|NOT COMPLETED|Overall Study||0
8270571|NCT01733407|20393133|P1|NOT COMPLETED|Overall Study||2
8270572|NCT01733407|20393132|P2|COMPLETED|Overall Study||9
8270573|NCT01733407|20393133|P1|COMPLETED|Overall Study||7
8270574|NCT01733407|20393132|P2|STARTED|Overall Study||9
8270575|NCT01733407|20393133|P1|STARTED|Overall Study||9
8270576|NCT01733368|20393149|P1|NOT COMPLETED|Overall Study||31
8270577|NCT01733368|20393149|P1|COMPLETED|Overall Study||167
8270578|NCT01733368|20393149|P1|STARTED|Overall Study||198
8270579|NCT01733329|20393159|P2|NOT COMPLETED|Overall Study||1
8270580|NCT01733329|20393160|P1|NOT COMPLETED|Overall Study||2
8270581|NCT01733329|20393159|P2|COMPLETED|Overall Study||60
8270582|NCT01733329|20393160|P1|COMPLETED|Overall Study||60
8270583|NCT01733329|20393159|P2|STARTED|Overall Study||61
8270584|NCT01733329|20393160|P1|STARTED|Overall Study||62
8270585|NCT01733316|20393172|P1|NOT COMPLETED|Long Term Extension Phase||5
8270586|NCT01733316|20393172|P1|COMPLETED|Long Term Extension Phase||33
8270587|NCT01733316|20393172|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
8270588|NCT01733316|20393172|P1|NOT COMPLETED|RP103 Phase||1
8270589|NCT01733316|20393172|P1|COMPLETED|RP103 Phase||40
8270590|NCT01733316|20393172|P1|STARTED|RP103 Phase||41
8270591|NCT01733316|20393172|P1|NOT COMPLETED|Cystagon® Phase||0
8270592|NCT01733316|20393172|P1|COMPLETED|Cystagon® Phase||41
8270593|NCT01733316|20393172|P1|STARTED|Cystagon® Phase||41
8270594|NCT01733277|20393188|P2|NOT COMPLETED|Overall Study||0
8270595|NCT01733277|20393189|P1|NOT COMPLETED|Overall Study||0
8270596|NCT01733277|20393188|P2|COMPLETED|Overall Study||25
8270597|NCT01733277|20393189|P1|COMPLETED|Overall Study||25
8270598|NCT01733277|20393188|P2|STARTED|Overall Study||25
8270599|NCT01733277|20393189|P1|STARTED|Overall Study||25
8270600|NCT01733238|20393199|P1|NOT COMPLETED|Overall Study||5
8270601|NCT01733238|20393199|P1|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
8270602|NCT01733238|20393199|P1|STARTED|Overall Study||13
8270603|NCT01733212|20393206|P2|NOT COMPLETED|Overall Study||0
8270604|NCT01733212|20393207|P1|NOT COMPLETED|Overall Study||0
8270605|NCT01733212|20393206|P2|COMPLETED|Overall Study||123
8270606|NCT01733212|20393207|P1|COMPLETED|Overall Study||116
8270607|NCT01733212|20393206|P2|STARTED|Overall Study||123
8270608|NCT01733212|20393207|P1|STARTED|Overall Study||116
8270609|NCT01733121|20393215|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
8270610|NCT01733121|20393216|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
8270611|NCT01733121|20393215|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
8270612|NCT01733121|20393216|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
8270613|NCT01733121|20393215|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
8270614|NCT01733121|20393216|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
8270615|NCT01733121|20393215|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
8270616|NCT01733121|20393216|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
8270617|NCT01733121|20393215|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
8270618|NCT01733121|20393216|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
8270619|NCT01733121|20393215|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
8270620|NCT01733121|20393216|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
8270621|NCT01733069|20393230|P2|NOT COMPLETED|Overall Study||0
8270622|NCT01733069|20393231|P1|NOT COMPLETED|Overall Study||0
8270623|NCT01733069|20393230|P2|COMPLETED|Overall Study||1598
8270624|NCT01733069|20393231|P1|COMPLETED|Overall Study||264
8270625|NCT01733069|20393230|P2|STARTED|Overall Study||1598
8270626|NCT01733069|20393231|P1|STARTED|Overall Study||264
8270627|NCT01733056|20393240|P3|NOT COMPLETED|Overall Study||0
8270628|NCT01733056|20393241|P2|NOT COMPLETED|Overall Study||0
8270629|NCT01733056|20393242|P1|NOT COMPLETED|Overall Study||0
8270630|NCT01733056|20393240|P3|COMPLETED|Overall Study||12
8270631|NCT01733056|20393241|P2|COMPLETED|Overall Study||10
8270632|NCT01733056|20393242|P1|COMPLETED|Overall Study||21
8270633|NCT01733056|20393240|P3|STARTED|Overall Study||12
8270634|NCT01733056|20393241|P2|STARTED|Overall Study||10
8270635|NCT01733056|20393242|P1|STARTED|Overall Study||21
8270636|NCT01732926|20393258|P2|NOT COMPLETED|Overall Study||110
8270637|NCT01732926|20393259|P1|NOT COMPLETED|Overall Study||267
8270638|NCT01732926|20393258|P2|COMPLETED|Overall Study||45
8270639|NCT01732926|20393259|P1|COMPLETED|Overall Study||53
8270640|NCT01732926|20393258|P2|STARTED|Overall Study||155
8270641|NCT01732926|20393259|P1|STARTED|Overall Study||320
8270642|NCT01732913|20393275|P2|NOT COMPLETED|Overall Study||69
8270643|NCT01732913|20393276|P1|NOT COMPLETED|Overall Study||156
8270644|NCT01732913|20393275|P2|COMPLETED|Overall Study||28
8270645|NCT01732913|20393276|P1|COMPLETED|Overall Study||42
8270646|NCT01732913|20393275|P2|STARTED|Overall Study||97
8270647|NCT01732913|20393276|P1|STARTED|Overall Study||198
8270648|NCT01732874|20393292|P2|NOT COMPLETED|Overall Study||3
8270649|NCT01732874|20393293|P1|NOT COMPLETED|Overall Study||8
8270650|NCT01732874|20393292|P2|COMPLETED|Overall Study||8
8270651|NCT01732874|20393293|P1|COMPLETED|Overall Study||8
8270652|NCT01732874|20393292|P2|STARTED|Overall Study||11
8270653|NCT01732874|20393293|P1|STARTED|Overall Study||16
8270654|NCT01732835|20393299|P1|NOT COMPLETED|2-year Extended Follow-up||5
8270655|NCT01732835|20393299|P1|COMPLETED|2-year Extended Follow-up||39
8270656|NCT01732835|20393299|P1|STARTED|2-year Extended Follow-up||44
8270657|NCT01732835|20393299|P1|NOT COMPLETED|6-month Primary Endpoint||24
8270658|NCT01732835|20393299|P1|COMPLETED|6-month Primary Endpoint||44
8270659|NCT01732835|20393299|P1|STARTED|6-month Primary Endpoint||68
8270660|NCT01732822|20393332|P2|NOT COMPLETED|Overall Study||113
8270661|NCT01732822|20393333|P1|NOT COMPLETED|Overall Study||123
8270662|NCT01732822|20393332|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
8270663|NCT01732822|20393333|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
8270664|NCT01732822|20393332|P2|STARTED|Overall Study||6955
8270665|NCT01732822|20393333|P1|STARTED|Overall Study||6930
8270666|NCT01732809|20393405|P2|NOT COMPLETED|Overall Study||1
8270667|NCT01732809|20393406|P1|NOT COMPLETED|Overall Study||0
8270668|NCT01732809|20393405|P2|COMPLETED|Overall Study||9
8270669|NCT01732809|20393406|P1|COMPLETED|Overall Study||9
8270670|NCT01732809|20393405|P2|STARTED|Overall Study||10
8270671|NCT01732809|20393406|P1|STARTED|Overall Study||9
8270672|NCT01732796|20393425|P3|NOT COMPLETED|Overall Study||13
8270673|NCT01732796|20393426|P2|NOT COMPLETED|Overall Study||42
8270674|NCT01732796|20393427|P1|NOT COMPLETED|Overall Study||46
8270675|NCT01732796|20393425|P3|COMPLETED|Overall Study||38
8270676|NCT01732796|20393426|P2|COMPLETED|Overall Study||169
8270677|NCT01732796|20393427|P1|COMPLETED|Overall Study||162
8270678|NCT01732796|20393425|P3|STARTED|Overall Study||51
8270679|NCT01732796|20393426|P2|STARTED|Overall Study||211
8270680|NCT01732796|20393427|P1|STARTED|Overall Study||208
8270681|NCT01732783|20393446|P3|NOT COMPLETED|Overall Study||10
8270682|NCT01732783|20393447|P2|NOT COMPLETED|Overall Study||32
8270683|NCT01732783|20393448|P1|NOT COMPLETED|Overall Study||135
8270684|NCT01732783|20393446|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
8270685|NCT01732783|20393447|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
8270686|NCT01732783|20393448|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
8270687|NCT01732783|20393446|P3|STARTED|Overall Study||12
8270688|NCT01732783|20393447|P2|STARTED|Overall Study||37
8270689|NCT01732783|20393448|P1|STARTED|Overall Study||164
8270690|NCT01732770|20393512|P2|NOT COMPLETED|Overall Study||8
8270691|NCT01732770|20393513|P1|NOT COMPLETED|Overall Study||10
8270692|NCT01732770|20393512|P2|COMPLETED|Overall Study||313
8270693|NCT01732770|20393513|P1|COMPLETED|Overall Study||312
8270694|NCT01732770|20393512|P2|Received Study Treatment|Overall Study||320
8270695|NCT01732770|20393513|P1|Received Study Treatment|Overall Study||320
8270696|NCT01732770|20393512|P2|STARTED|Overall Study||321
8270697|NCT01732770|20393513|P1|STARTED|Overall Study||322
8270698|NCT01732757|20393528|P3|NOT COMPLETED|Overall Study||0
8270699|NCT01732757|20393529|P2|NOT COMPLETED|Overall Study||0
8270700|NCT01732757|20393530|P1|NOT COMPLETED|Overall Study||1
8270701|NCT01732757|20393528|P3|COMPLETED|Overall Study||52
8270702|NCT01732757|20393529|P2|COMPLETED|Overall Study||52
8270703|NCT01732757|20393530|P1|COMPLETED|Overall Study||52
8270704|NCT01732757|20393528|P3|STARTED|Overall Study||52
8270705|NCT01732757|20393529|P2|STARTED|Overall Study||52
8270706|NCT01732757|20393530|P1|STARTED|Overall Study||53
8270707|NCT01732718|20393568|P2|NOT COMPLETED|Second Intervention||0
8270708|NCT01732718|20393569|P1|NOT COMPLETED|Second Intervention||0
8270709|NCT01732718|20393568|P2|COMPLETED|Second Intervention||6
8270710|NCT01732718|20393569|P1|COMPLETED|Second Intervention||7
8270711|NCT01732718|20393568|P2|STARTED|Second Intervention||6
8270712|NCT01732718|20393569|P1|STARTED|Second Intervention||7
8270713|NCT01732718|20393568|P2|NOT COMPLETED|Washout (4 Weeks)||0
8270714|NCT01732718|20393569|P1|NOT COMPLETED|Washout (4 Weeks)||0
8270715|NCT01732718|20393568|P2|COMPLETED|Washout (4 Weeks)||6
8270716|NCT01732718|20393569|P1|COMPLETED|Washout (4 Weeks)||7
8270717|NCT01732718|20393568|P2|STARTED|Washout (4 Weeks)||6
8270718|NCT01732718|20393569|P1|STARTED|Washout (4 Weeks)||7
8270719|NCT01732718|20393568|P2|NOT COMPLETED|First Intervention||0
8270720|NCT01732718|20393569|P1|NOT COMPLETED|First Intervention||0
8270721|NCT01732718|20393568|P2|COMPLETED|First Intervention||6
8270722|NCT01732718|20393569|P1|COMPLETED|First Intervention||7
8270723|NCT01732718|20393568|P2|STARTED|First Intervention||6
8270724|NCT01732718|20393569|P1|STARTED|First Intervention||7
8270725|NCT01732692|20393607|P2|NOT COMPLETED|Overall Study||1
8270726|NCT01732692|20393608|P1|NOT COMPLETED|Overall Study||0
8270727|NCT01732692|20393607|P2|COMPLETED|Overall Study||69
8270728|NCT01732692|20393608|P1|COMPLETED|Overall Study||70
8270729|NCT01732692|20393607|P2|STARTED|Overall Study||70
8270730|NCT01732692|20393608|P1|STARTED|Overall Study||70
8270731|NCT01732640|20393622|P2|NOT COMPLETED|Overall Study||2
8270732|NCT01732640|20393623|P1|NOT COMPLETED|Overall Study||0
8270733|NCT01732640|20393622|P2|COMPLETED|Overall Study||1
8270734|NCT01732640|20393623|P1|COMPLETED|Overall Study||6
8270735|NCT01732640|20393622|P2|STARTED|Overall Study||3
8270736|NCT01732640|20393623|P1|STARTED|Overall Study||6
8270737|NCT01732627|20393640|P2|NOT COMPLETED|Overall Study||0
8270738|NCT01732627|20393641|P1|NOT COMPLETED|Overall Study||1
8270739|NCT01732627|20393640|P2|COMPLETED|Overall Study||100
8270740|NCT01732627|20393641|P1|COMPLETED|Overall Study||200
8270741|NCT01732627|20393640|P2|Safety Analysis Set (SafAS)|Overall Study||100
8270742|NCT01732627|20393641|P1|Safety Analysis Set (SafAS)|Overall Study||199
8270743|NCT01732627|20393640|P2|STARTED|Overall Study||100
8270744|NCT01732627|20393641|P1|STARTED|Overall Study||201
8270745|NCT01732588|20393674|P3|NOT COMPLETED|Third Intervention (7 Days)||0
8270746|NCT01732588|20393675|P2|NOT COMPLETED|Third Intervention (7 Days)||0
8270747|NCT01732588|20393676|P1|NOT COMPLETED|Third Intervention (7 Days)||0
8270748|NCT01732588|20393674|P3|COMPLETED|Third Intervention (7 Days)||4
8270749|NCT01732588|20393675|P2|COMPLETED|Third Intervention (7 Days)||2
8270750|NCT01732588|20393676|P1|COMPLETED|Third Intervention (7 Days)||4
8270751|NCT01732588|20393674|P3|STARTED|Third Intervention (7 Days)||4
8270752|NCT01732588|20393675|P2|STARTED|Third Intervention (7 Days)||2
8270753|NCT01732588|20393676|P1|STARTED|Third Intervention (7 Days)||4
8270754|NCT01732588|20393674|P3|NOT COMPLETED|Second Intervention (7 Days)||0
8270755|NCT01732588|20393675|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8270756|NCT01732588|20393676|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8270757|NCT01732588|20393674|P3|COMPLETED|Second Intervention (7 Days)||4
8270758|NCT01732588|20393675|P2|COMPLETED|Second Intervention (7 Days)||2
8270759|NCT01732588|20393676|P1|COMPLETED|Second Intervention (7 Days)||4
8270760|NCT01732588|20393674|P3|STARTED|Second Intervention (7 Days)||4
8270761|NCT01732588|20393675|P2|STARTED|Second Intervention (7 Days)||2
8270762|NCT01732588|20393676|P1|STARTED|Second Intervention (7 Days)||4
8270763|NCT01732588|20393674|P3|NOT COMPLETED|First Intervention (7 Days)||0
8270764|NCT01732588|20393675|P2|NOT COMPLETED|First Intervention (7 Days)||1
8270765|NCT01732588|20393676|P1|NOT COMPLETED|First Intervention (7 Days)||0
8270766|NCT01732588|20393674|P3|COMPLETED|First Intervention (7 Days)||4
8270767|NCT01732588|20393675|P2|COMPLETED|First Intervention (7 Days)||2
8270768|NCT01732588|20393676|P1|COMPLETED|First Intervention (7 Days)||4
8270769|NCT01732588|20393674|P3|STARTED|First Intervention (7 Days)||4
8270770|NCT01732588|20393675|P2|STARTED|First Intervention (7 Days)||3
8270771|NCT01732588|20393676|P1|STARTED|First Intervention (7 Days)||4
8270772|NCT01732549|20393692|P2|NOT COMPLETED|Overall Study||73
8270773|NCT01732549|20393693|P1|NOT COMPLETED|Overall Study||71
8270774|NCT01732549|20393692|P2|COMPLETED|Overall Study||0
8270775|NCT01732549|20393693|P1|COMPLETED|Overall Study||0
8270776|NCT01732549|20393692|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
8270777|NCT01732549|20393693|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
8270778|NCT01732549|20393692|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
8270779|NCT01732549|20393693|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
8270780|NCT01732549|20393692|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
8270781|NCT01732549|20393693|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
8270782|NCT01732549|20393692|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
8270783|NCT01732549|20393693|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
8270784|NCT01732549|20393692|P2|STARTED|Overall Study||73
8270785|NCT01732549|20393693|P1|STARTED|Overall Study||71
8270786|NCT01732536|20393715|P2|NOT COMPLETED|Overall Study||1
8270787|NCT01732536|20393716|P1|NOT COMPLETED|Overall Study||1
8270788|NCT01732536|20393715|P2|COMPLETED|Overall Study||46
8270789|NCT01732536|20393716|P1|COMPLETED|Overall Study||52
8270790|NCT01732536|20393715|P2|STARTED|Overall Study||47
8270791|NCT01732536|20393716|P1|STARTED|Overall Study||53
8270792|NCT01732510|20393739|P7|NOT COMPLETED|Overall Study||8
8270793|NCT01732510|20393740|P6|NOT COMPLETED|Overall Study||13
8270794|NCT01732510|20393741|P5|NOT COMPLETED|Overall Study||5
8270795|NCT01732510|20393742|P4|NOT COMPLETED|Overall Study||5
8270796|NCT01732510|20393743|P3|NOT COMPLETED|Overall Study||4
8270797|NCT01732510|20393744|P2|NOT COMPLETED|Overall Study||5
8270798|NCT01732510|20393745|P1|NOT COMPLETED|Overall Study||1
8270799|NCT01732510|20393739|P7|COMPLETED|Overall Study||0
8270800|NCT01732510|20393740|P6|COMPLETED|Overall Study||0
8270801|NCT01732510|20393741|P5|COMPLETED|Overall Study||3
8270802|NCT01732510|20393742|P4|COMPLETED|Overall Study||5
8270803|NCT01732510|20393743|P3|COMPLETED|Overall Study||4
8270804|NCT01732510|20393744|P2|COMPLETED|Overall Study||4
8270805|NCT01732510|20393745|P1|COMPLETED|Overall Study||8
8270806|NCT01732510|20393739|P7|STARTED|Overall Study||8
8270807|NCT01732510|20393740|P6|STARTED|Overall Study||13
8270808|NCT01732510|20393741|P5|STARTED|Overall Study||8
8270809|NCT01732510|20393742|P4|STARTED|Overall Study||10
8270810|NCT01732510|20393743|P3|STARTED|Overall Study||8
8270811|NCT01732510|20393744|P2|STARTED|Overall Study||9
8270812|NCT01732510|20393745|P1|STARTED|Overall Study||9
8270813|NCT01732484|20393824|P1|NOT COMPLETED|Overall Study||26
8270814|NCT01732484|20393824|P1|COMPLETED|Overall Study||74
8270815|NCT01732484|20393824|P1|Allocation|Overall Study||100
8270816|NCT01732484|20393824|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
8270817|NCT01732484|20393824|P1|STARTED|Overall Study||100
8270818|NCT01732471|20393832|P1|NOT COMPLETED|Overall Study||1
8270819|NCT01732471|20393832|P1|COMPLETED|Overall Study||89
8270820|NCT01732471|20393832|P1|STARTED|Overall Study||90
8270821|NCT01732458|20393843|P4|NOT COMPLETED|Overall Study||2
8270822|NCT01732458|20393844|P3|NOT COMPLETED|Overall Study||3
8270823|NCT01732458|20393845|P2|NOT COMPLETED|Overall Study||5
8270824|NCT01732458|20393846|P1|NOT COMPLETED|Overall Study||3
8270825|NCT01732458|20393843|P4|COMPLETED|Overall Study||50
8270826|NCT01732458|20393844|P3|COMPLETED|Overall Study||55
8270827|NCT01732458|20393845|P2|COMPLETED|Overall Study||53
8270828|NCT01732458|20393846|P1|COMPLETED|Overall Study||57
8270829|NCT01732458|20393843|P4|Treated|Overall Study||52
8270830|NCT01732458|20393844|P3|Treated|Overall Study||56
8270831|NCT01732458|20393845|P2|Treated|Overall Study||55
8270832|NCT01732458|20393846|P1|Treated|Overall Study||57
8270833|NCT01732458|20393843|P4|STARTED|Overall Study||52
8270834|NCT01732458|20393844|P3|STARTED|Overall Study||58
8270835|NCT01732458|20393845|P2|STARTED|Overall Study||58
8270836|NCT01732458|20393846|P1|STARTED|Overall Study||60
8270837|NCT01732445|20393908|P1|NOT COMPLETED|Overall Study||0
8270838|NCT01732445|20393908|P1|COMPLETED|Overall Study||14
8270839|NCT01732445|20393908|P1|STARTED|Overall Study||14
8270840|NCT01732419|20393917|P2|NOT COMPLETED|Overall Study||4
8270841|NCT01732419|20393918|P1|NOT COMPLETED|Overall Study||8
8270842|NCT01732419|20393917|P2|COMPLETED|Overall Study||41
8270843|NCT01732419|20393918|P1|COMPLETED|Overall Study||37
8270844|NCT01732419|20393917|P2|STARTED|Overall Study||45
8270845|NCT01732419|20393918|P1|STARTED|Overall Study||45
8270846|NCT01732406|20393935|P3|NOT COMPLETED|Overall Study||0
8270847|NCT01732406|20393936|P2|NOT COMPLETED|Overall Study||0
8270848|NCT01732406|20393937|P1|NOT COMPLETED|Overall Study||0
8270849|NCT01732406|20393935|P3|COMPLETED|Overall Study||35
8270850|NCT01732406|20393936|P2|COMPLETED|Overall Study||60
8270851|NCT01732406|20393937|P1|COMPLETED|Overall Study||31
8270852|NCT01732406|20393935|P3|STARTED|Overall Study||35
8270853|NCT01732406|20393936|P2|STARTED|Overall Study||60
8270854|NCT01732406|20393937|P1|STARTED|Overall Study||31
8270855|NCT01732263|20393956|P2|NOT COMPLETED|Overall Study||0
8270856|NCT01732263|20393957|P1|NOT COMPLETED|Overall Study||0
8270857|NCT01732263|20393956|P2|COMPLETED|Overall Study||20
8270858|NCT01732263|20393957|P1|COMPLETED|Overall Study||23
8270859|NCT01732263|20393956|P2|STARTED|Overall Study||20
8270860|NCT01732263|20393957|P1|STARTED|Overall Study||23
8270861|NCT01732211|20393997|P1|NOT COMPLETED|Overall Study||0
8270862|NCT01732211|20393997|P1|COMPLETED|Overall Study||1
8270863|NCT01732211|20393997|P1|STARTED|Overall Study||1
8270864|NCT01732107|20394008|P1|NOT COMPLETED|Overall Study||13
8270865|NCT01732107|20394008|P1|COMPLETED|Overall Study||0
8270866|NCT01732107|20394008|P1|STARTED|Overall Study||13
8270867|NCT01731990|20394025|P2|NOT COMPLETED|Overall Study||8
8270868|NCT01731990|20394026|P1|NOT COMPLETED|Overall Study||4
8270869|NCT01731990|20394025|P2|COMPLETED|Overall Study||12
8270870|NCT01731990|20394026|P1|COMPLETED|Overall Study||14
8270871|NCT01731990|20394025|P2|STARTED|Overall Study||20
8270872|NCT01731990|20394026|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
8270873|NCT01731938|20394042|P2|NOT COMPLETED|Primary Part II||13
8270874|NCT01731938|20394043|P1|NOT COMPLETED|Primary Part II||13
8270875|NCT01731938|20394042|P2|COMPLETED|Primary Part II||95
8270876|NCT01731938|20394043|P1|COMPLETED|Primary Part II||103
8270877|NCT01731938|20394042|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
8270878|NCT01731938|20394043|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
8270879|NCT01731938|20394042|P2|NOT COMPLETED|Preliminary Part I||8
8270880|NCT01731938|20394043|P1|NOT COMPLETED|Preliminary Part I||3
8270881|NCT01731938|20394042|P2|COMPLETED|Preliminary Part I||44
8270882|NCT01731938|20394043|P1|COMPLETED|Preliminary Part I||48
8270883|NCT01731938|20394042|P2|STARTED|Preliminary Part I||52
8270884|NCT01731938|20394043|P1|STARTED|Preliminary Part I||51
8270885|NCT01731912|20394055|P1|NOT COMPLETED|Overall Study||2
8270886|NCT01731912|20394055|P1|COMPLETED|Overall Study||14
8270887|NCT01731912|20394055|P1|STARTED|Overall Study||16
8270888|NCT01731886|20394062|P2|NOT COMPLETED|Overall Study||1
8270889|NCT01731886|20394063|P1|NOT COMPLETED|Overall Study||2
8270890|NCT01731886|20394062|P2|COMPLETED|Overall Study||28
8270891|NCT01731886|20394063|P1|COMPLETED|Overall Study||29
8270892|NCT01731886|20394062|P2|STARTED|Overall Study||29
8270893|NCT01731886|20394063|P1|STARTED|Overall Study||31
8270894|NCT01731691|20394080|P3|NOT COMPLETED|Overall Study||0
8270895|NCT01731691|20394081|P2|NOT COMPLETED|Overall Study||0
8270896|NCT01731691|20394082|P1|NOT COMPLETED|Overall Study||0
8270897|NCT01731691|20394080|P3|COMPLETED|Overall Study||4
8270898|NCT01731691|20394081|P2|COMPLETED|Overall Study||5
8270899|NCT01731691|20394082|P1|COMPLETED|Overall Study||3
8270900|NCT01731691|20394080|P3|STARTED|Overall Study||4
8270901|NCT01731691|20394081|P2|STARTED|Overall Study||5
8270902|NCT01731691|20394082|P1|STARTED|Overall Study||3
8270903|NCT01731678|20394108|P1|NOT COMPLETED|Overall Study||7
8270904|NCT01731678|20394108|P1|COMPLETED|Overall Study||32
8270905|NCT01731678|20394108|P1|STARTED|Overall Study||39
8270906|NCT01731600|20394114|P2|NOT COMPLETED|Overall Study||0
8270907|NCT01731600|20394115|P1|NOT COMPLETED|Overall Study||6
8270908|NCT01731600|20394114|P2|COMPLETED|Overall Study||34
8270909|NCT01731600|20394115|P1|COMPLETED|Overall Study||28
8270910|NCT01731600|20394114|P2|STARTED|Overall Study||34
8270911|NCT01731600|20394115|P1|STARTED|Overall Study||34
8270912|NCT01731470|20394169|P1|NOT COMPLETED|Overall Study||2
8270913|NCT01731470|20394169|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
8270914|NCT01731470|20394169|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
8270915|NCT01731171|20394176|P2|NOT COMPLETED|Overall Study||7
8270916|NCT01731171|20394177|P1|NOT COMPLETED|Overall Study||7
8270917|NCT01731171|20394176|P2|COMPLETED|Overall Study||26
8270918|NCT01731171|20394177|P1|COMPLETED|Overall Study||26
8270919|NCT01731171|20394176|P2|STARTED|Overall Study||33
8270920|NCT01731171|20394177|P1|STARTED|Overall Study||33
8270921|NCT01731119|20394189|P1|NOT COMPLETED|Overall Study||2
8270922|NCT01731119|20394189|P1|COMPLETED|Overall Study||7
8270923|NCT01731119|20394189|P1|STARTED|Overall Study||9
8270924|NCT01731041|20394199|P2|NOT COMPLETED|Overall Study||0
8270925|NCT01731041|20394200|P1|NOT COMPLETED|Overall Study||0
8270926|NCT01731041|20394199|P2|COMPLETED|Overall Study||30
8270927|NCT01731041|20394200|P1|COMPLETED|Overall Study||30
8270928|NCT01731041|20394199|P2|STARTED|Overall Study||30
8270929|NCT01731041|20394200|P1|STARTED|Overall Study||30
8270930|NCT01731002|20394211|P3|NOT COMPLETED|Overall Study||3
8270931|NCT01731002|20394212|P2|NOT COMPLETED|Overall Study||4
8270932|NCT01731002|20394213|P1|NOT COMPLETED|Overall Study||4
8270933|NCT01731002|20394211|P3|COMPLETED|Overall Study||74
8270934|NCT01731002|20394212|P2|COMPLETED|Overall Study||68
8270935|NCT01731002|20394213|P1|COMPLETED|Overall Study||71
8270936|NCT01731002|20394211|P3|STARTED|Overall Study||77
8270937|NCT01731002|20394212|P2|STARTED|Overall Study||72
8270938|NCT01731002|20394213|P1|STARTED|Overall Study||75
8270939|NCT01730950|20394226|P2|NOT COMPLETED|Overall Study||6
8270940|NCT01730950|20394227|P1|NOT COMPLETED|Overall Study||6
8270941|NCT01730950|20394226|P2|COMPLETED|Overall Study||86
8270942|NCT01730950|20394227|P1|COMPLETED|Overall Study||84
8270943|NCT01730950|20394226|P2|Delayed Toxicity Population|Overall Study||83
8270944|NCT01730950|20394227|P1|Delayed Toxicity Population|Overall Study||0
8270945|NCT01730950|20394226|P2|6-month Progression-free Analysis|Overall Study||81
8270946|NCT01730950|20394227|P1|6-month Progression-free Analysis|Overall Study||79
8270947|NCT01730950|20394226|P2|Response Population|Overall Study||77
8270948|NCT01730950|20394227|P1|Response Population|Overall Study||78
8270949|NCT01730950|20394226|P2|Adverse Event Population|Overall Study||83
8270950|NCT01730950|20394227|P1|Adverse Event Population|Overall Study||76
8270951|NCT01730950|20394226|P2|Eligible Population|Overall Study||86
8270952|NCT01730950|20394227|P1|Eligible Population|Overall Study||84
8270953|NCT01730950|20394226|P2|STARTED|Overall Study||92
8270954|NCT01730950|20394227|P1|STARTED|Overall Study||90
8270955|NCT01730872|20394244|P3|NOT COMPLETED|Overall Study||0
8270956|NCT01730872|20394245|P2|NOT COMPLETED|Overall Study||0
8270957|NCT01730872|20394246|P1|NOT COMPLETED|Overall Study||0
8270958|NCT01730872|20394244|P3|COMPLETED|Overall Study||3
8270959|NCT01730872|20394245|P2|COMPLETED|Overall Study||5
8270960|NCT01730872|20394246|P1|COMPLETED|Overall Study||8
8270961|NCT01730872|20394244|P3|Full Analysis Set|Overall Study||0
8270962|NCT01730872|20394245|P2|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
8270963|NCT01730872|20394246|P1|Full Analysis Set|Overall Study||8
8270964|NCT01730872|20394244|P3|STARTED|Overall Study||3
8270965|NCT01730872|20394245|P2|STARTED|Overall Study||5
8270966|NCT01730872|20394246|P1|STARTED|Overall Study||8
8270967|NCT01730846|20394260|P3|NOT COMPLETED|Overall Study||0
8270968|NCT01730846|20394261|P2|NOT COMPLETED|Overall Study||0
8270969|NCT01730846|20394262|P1|NOT COMPLETED|Overall Study||0
8270970|NCT01730846|20394260|P3|COMPLETED|Overall Study||13
8270971|NCT01730846|20394261|P2|COMPLETED|Overall Study||11
8270972|NCT01730846|20394262|P1|COMPLETED|Overall Study||11
8270973|NCT01730846|20394260|P3|STARTED|Overall Study||13
8270974|NCT01730846|20394261|P2|STARTED|Overall Study||11
8270975|NCT01730846|20394262|P1|STARTED|Overall Study||11
8270976|NCT01730729|20394273|P1|NOT COMPLETED|Overall Study||14
8270977|NCT01730729|20394273|P1|COMPLETED|Overall Study||6
8270978|NCT01730729|20394273|P1|Treated Cycle 3 and Beyond|Overall Study||6
8270979|NCT01730729|20394273|P1|Completed 2 Cycles/Reached 1st Response|Overall Study||18
8270980|NCT01730729|20394273|P1|STARTED|Overall Study||20
8270981|NCT01730586|20394287|P1|NOT COMPLETED|Overall Study||13
8270982|NCT01730586|20394287|P1|COMPLETED|Overall Study||21
8270983|NCT01730586|20394287|P1|STARTED|Overall Study||34
8270984|NCT01730534|20394296|P2|NOT COMPLETED|Overall Study||145
8270985|NCT01730534|20394297|P1|NOT COMPLETED|Overall Study||109
8270986|NCT01730534|20394296|P2|COMPLETED|Overall Study||8433
8270987|NCT01730534|20394297|P1|COMPLETED|Overall Study||8473
8270988|NCT01730534|20394296|P2|STARTED|Overall Study||8578
8270989|NCT01730534|20394297|P1|STARTED|Overall Study||8582
8270990|NCT01730378|20394311|P2|NOT COMPLETED|Overall Study||0
8270991|NCT01730378|20394312|P1|NOT COMPLETED|Overall Study||1
8270992|NCT01730378|20394311|P2|COMPLETED|Overall Study||47
8270993|NCT01730378|20394312|P1|COMPLETED|Overall Study||83
8270994|NCT01730378|20394311|P2|STARTED|Overall Study||47
8270995|NCT01730378|20394312|P1|STARTED|Overall Study||84
8270996|NCT01730339|20394343|P2|NOT COMPLETED|Overall Study||3
8270997|NCT01730339|20394344|P1|NOT COMPLETED|Overall Study||5
8270998|NCT01730339|20394343|P2|COMPLETED|Overall Study||52
8270999|NCT01730339|20394344|P1|COMPLETED|Overall Study||40
8271000|NCT01730339|20394343|P2|STARTED|Overall Study||55
8271001|NCT01730339|20394344|P1|STARTED|Overall Study||45
8271002|NCT01730053|20394384|P6|NOT COMPLETED|Overall Study||13
8271003|NCT01730053|20394385|P5|NOT COMPLETED|Overall Study||9
8271004|NCT01730053|20394386|P4|NOT COMPLETED|Overall Study||8
8271005|NCT01730053|20394387|P3|NOT COMPLETED|Overall Study||11
8271006|NCT01730053|20394388|P2|NOT COMPLETED|Overall Study||14
8271007|NCT01730053|20394389|P1|NOT COMPLETED|Overall Study||5
8271008|NCT01730053|20394384|P6|COMPLETED|Overall Study||41
8271009|NCT01730053|20394385|P5|COMPLETED|Overall Study||44
8271010|NCT01730053|20394386|P4|COMPLETED|Overall Study||45
8271011|NCT01730053|20394387|P3|COMPLETED|Overall Study||38
8271012|NCT01730053|20394388|P2|COMPLETED|Overall Study||34
8271013|NCT01730053|20394389|P1|COMPLETED|Overall Study||43
8271014|NCT01730053|20394384|P6|Treated|Overall Study||54
8271015|NCT01730053|20394385|P5|Treated|Overall Study||53
8271016|NCT01730053|20394386|P4|Treated|Overall Study||53
8271017|NCT01730053|20394387|P3|Treated|Overall Study||49
8271018|NCT01730053|20394388|P2|Treated|Overall Study||48
8271019|NCT01730053|20394389|P1|Treated|Overall Study||48
8271020|NCT01730053|20394384|P6|STARTED|Overall Study||54
8271021|NCT01730053|20394385|P5|STARTED|Overall Study||53
8271022|NCT01730053|20394386|P4|STARTED|Overall Study||53
8271023|NCT01730053|20394387|P3|STARTED|Overall Study||49
8271024|NCT01730053|20394388|P2|STARTED|Overall Study||48
8271025|NCT01730053|20394389|P1|STARTED|Overall Study||48
8271026|NCT01730040|20394548|P7|NOT COMPLETED|Overall Study||9
8271027|NCT01730040|20394549|P6|NOT COMPLETED|Overall Study||7
8271028|NCT01730040|20394550|P5|NOT COMPLETED|Overall Study||6
8271029|NCT01730040|20394551|P4|NOT COMPLETED|Overall Study||8
8271030|NCT01730040|20394552|P3|NOT COMPLETED|Overall Study||11
8271031|NCT01730040|20394553|P2|NOT COMPLETED|Overall Study||15
8271032|NCT01730040|20394554|P1|NOT COMPLETED|Overall Study||13
8271033|NCT01730040|20394548|P7|COMPLETED|Overall Study||38
8271034|NCT01730040|20394549|P6|COMPLETED|Overall Study||40
8271035|NCT01730040|20394550|P5|COMPLETED|Overall Study||39
8271036|NCT01730040|20394551|P4|COMPLETED|Overall Study||39
8271037|NCT01730040|20394552|P3|COMPLETED|Overall Study||46
8271038|NCT01730040|20394553|P2|COMPLETED|Overall Study||40
8271039|NCT01730040|20394554|P1|COMPLETED|Overall Study||44
8271040|NCT01730040|20394548|P7|Treated|Overall Study||47
8271041|NCT01730040|20394549|P6|Treated|Overall Study||46
8271042|NCT01730040|20394550|P5|Treated|Overall Study||45
8271043|NCT01730040|20394551|P4|Treated|Overall Study||47
8271044|NCT01730040|20394552|P3|Treated|Overall Study||57
8271045|NCT01730040|20394553|P2|Treated|Overall Study||55
8271046|NCT01730040|20394554|P1|Treated|Overall Study||57
8271047|NCT01730040|20394548|P7|STARTED|Overall Study||47
8271048|NCT01730040|20394549|P6|STARTED|Overall Study||47
8271049|NCT01730040|20394550|P5|STARTED|Overall Study||45
8271050|NCT01730040|20394551|P4|STARTED|Overall Study||47
8271051|NCT01730040|20394552|P3|STARTED|Overall Study||57
8271052|NCT01730040|20394553|P2|STARTED|Overall Study||55
8271053|NCT01730040|20394554|P1|STARTED|Overall Study||57
8271054|NCT01729923|20394731|P1|NOT COMPLETED|Overall Study||27
8271055|NCT01729923|20394731|P1|COMPLETED|Overall Study||0
8271056|NCT01729923|20394731|P1|STARTED|Overall Study||27
8271057|NCT01729871|20394743|P2|NOT COMPLETED|Overall Study||23
8271058|NCT01729871|20394744|P1|NOT COMPLETED|Overall Study||12
8271059|NCT01729871|20394743|P2|COMPLETED|Overall Study||101
8271060|NCT01729871|20394744|P1|COMPLETED|Overall Study||112
8271061|NCT01729871|20394743|P2|STARTED|Overall Study||124
8271062|NCT01729871|20394744|P1|STARTED|Overall Study||124
8271063|NCT01729845|20394763|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
8271064|NCT01729845|20394764|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
8271065|NCT01729845|20394765|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
8271066|NCT01729845|20394763|P3|COMPLETED|Efficacy of Dec/MEC||0
8271067|NCT01729845|20394764|P2|COMPLETED|Efficacy of Dec/MEC||22
8271068|NCT01729845|20394765|P1|COMPLETED|Efficacy of Dec/MEC||0
8271069|NCT01729845|20394763|P3|STARTED|Efficacy of Dec/MEC||0
8271070|NCT01729845|20394764|P2|STARTED|Efficacy of Dec/MEC||22
8271071|NCT01729845|20394765|P1|STARTED|Efficacy of Dec/MEC||0
8271072|NCT01729845|20394763|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8271073|NCT01729845|20394764|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8271074|NCT01729845|20394765|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8271075|NCT01729845|20394763|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
8271076|NCT01729845|20394764|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
8271077|NCT01729845|20394765|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
8271078|NCT01729845|20394763|P3|STARTED|Safety/Tolerability of Dec/MEC||12
8271079|NCT01729845|20394764|P2|STARTED|Safety/Tolerability of Dec/MEC||34
8271080|NCT01729845|20394765|P1|STARTED|Safety/Tolerability of Dec/MEC||6
8271081|NCT01729819|20394778|P2|NOT COMPLETED|Overall Study||7
8271082|NCT01729819|20394779|P1|NOT COMPLETED|Overall Study||6
8271083|NCT01729819|20394778|P2|COMPLETED|Overall Study||50
8271084|NCT01729819|20394779|P1|COMPLETED|Overall Study||43
8271085|NCT01729819|20394778|P2|STARTED|Overall Study||57
8271086|NCT01729819|20394779|P1|STARTED|Overall Study||49
8271087|NCT01729754|20394798|P10|NOT COMPLETED|Part 3||7
8271088|NCT01729754|20394799|P9|NOT COMPLETED|Part 3||1
8271089|NCT01729754|20394800|P8|NOT COMPLETED|Part 3||3
8271090|NCT01729754|20394801|P7|NOT COMPLETED|Part 3||0
8271091|NCT01729754|20394802|P6|NOT COMPLETED|Part 3||13
8271092|NCT01729754|20394803|P5|NOT COMPLETED|Part 3||4
8271093|NCT01729754|20394804|P4|NOT COMPLETED|Part 3||0
8271094|NCT01729754|20394805|P3|NOT COMPLETED|Part 3||5
8271095|NCT01729754|20394806|P2|NOT COMPLETED|Part 3||5
8271096|NCT01729754|20394807|P1|NOT COMPLETED|Part 3||0
8271097|NCT01729754|20394798|P10|COMPLETED|Part 3||114
8271098|NCT01729754|20394799|P9|COMPLETED|Part 3||65
8271099|NCT01729754|20394800|P8|COMPLETED|Part 3||66
8271100|NCT01729754|20394801|P7|COMPLETED|Part 3||0
8271101|NCT01729754|20394802|P6|COMPLETED|Part 3||224
8271102|NCT01729754|20394803|P5|COMPLETED|Part 3||17
8271103|NCT01729754|20394804|P4|COMPLETED|Part 3||0
8271104|NCT01729754|20394805|P3|COMPLETED|Part 3||105
8271105|NCT01729754|20394806|P2|COMPLETED|Part 3||165
8271106|NCT01729754|20394807|P1|COMPLETED|Part 3||0
8271107|NCT01729754|20394798|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
8271108|NCT01729754|20394799|P9|STARTED|Part 3||66
8271109|NCT01729754|20394800|P8|STARTED|Part 3||69
8271110|NCT01729754|20394801|P7|STARTED|Part 3||0
8271111|NCT01729754|20394802|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
8271112|NCT01729754|20394803|P5|STARTED|Part 3||21
8271113|NCT01729754|20394804|P4|STARTED|Part 3||0
8271114|NCT01729754|20394805|P3|STARTED|Part 3||110
8271115|NCT01729754|20394806|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
8271116|NCT01729754|20394807|P1|STARTED|Part 3||0
8271117|NCT01729754|20394798|P10|NOT COMPLETED|Part 2||12
8271118|NCT01729754|20394799|P9|NOT COMPLETED|Part 2||4
8271119|NCT01729754|20394800|P8|NOT COMPLETED|Part 2||3
8271120|NCT01729754|20394801|P7|NOT COMPLETED|Part 2||0
8271121|NCT01729754|20394802|P6|NOT COMPLETED|Part 2||0
8271122|NCT01729754|20394803|P5|NOT COMPLETED|Part 2||0
8271123|NCT01729754|20394804|P4|NOT COMPLETED|Part 2||5
8271124|NCT01729754|20394805|P3|NOT COMPLETED|Part 2||0
8271125|NCT01729754|20394806|P2|NOT COMPLETED|Part 2||0
8271126|NCT01729754|20394807|P1|NOT COMPLETED|Part 2||6
8271127|NCT01729754|20394798|P10|COMPLETED|Part 2||277
8271128|NCT01729754|20394799|P9|COMPLETED|Part 2||66
8271129|NCT01729754|20394800|P8|COMPLETED|Part 2||69
8271130|NCT01729754|20394801|P7|COMPLETED|Part 2||0
8271131|NCT01729754|20394802|P6|COMPLETED|Part 2||268
8271132|NCT01729754|20394803|P5|COMPLETED|Part 2||21
8271133|NCT01729754|20394804|P4|COMPLETED|Part 2||0
8271134|NCT01729754|20394805|P3|COMPLETED|Part 2||110
8271135|NCT01729754|20394806|P2|COMPLETED|Part 2||184
8271136|NCT01729754|20394807|P1|COMPLETED|Part 2||0
8271137|NCT01729754|20394798|P10|STARTED|Part 2||289
8271138|NCT01729754|20394799|P9|STARTED|Part 2||70
8271139|NCT01729754|20394800|P8|STARTED|Part 2||72
8271140|NCT01729754|20394801|P7|STARTED|Part 2||0
8271141|NCT01729754|20394802|P6|STARTED|Part 2||268
8271142|NCT01729754|20394803|P5|STARTED|Part 2||21
8271143|NCT01729754|20394804|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
8271144|NCT01729754|20394805|P3|STARTED|Part 2||110
8271145|NCT01729754|20394806|P2|STARTED|Part 2||184
8271146|NCT01729754|20394807|P1|STARTED|Part 2||6
8271147|NCT01729754|20394798|P10|NOT COMPLETED|Part 1||24
8271148|NCT01729754|20394799|P9|NOT COMPLETED|Part 1||0
8271149|NCT01729754|20394800|P8|NOT COMPLETED|Part 1||0
8271150|NCT01729754|20394801|P7|NOT COMPLETED|Part 1||14
8271151|NCT01729754|20394802|P6|NOT COMPLETED|Part 1||0
8271152|NCT01729754|20394803|P5|NOT COMPLETED|Part 1||0
8271153|NCT01729754|20394804|P4|NOT COMPLETED|Part 1||12
8271154|NCT01729754|20394805|P3|NOT COMPLETED|Part 1||0
8271155|NCT01729754|20394806|P2|NOT COMPLETED|Part 1||0
8271156|NCT01729754|20394807|P1|NOT COMPLETED|Part 1||14
8271157|NCT01729754|20394798|P10|COMPLETED|Part 1||289
8271158|NCT01729754|20394799|P9|COMPLETED|Part 1||70
8271159|NCT01729754|20394800|P8|COMPLETED|Part 1||72
8271160|NCT01729754|20394801|P7|COMPLETED|Part 1||0
8271161|NCT01729754|20394802|P6|COMPLETED|Part 1||268
8271162|NCT01729754|20394803|P5|COMPLETED|Part 1||21
8271163|NCT01729754|20394804|P4|COMPLETED|Part 1||6
8271164|NCT01729754|20394805|P3|COMPLETED|Part 1||110
8271165|NCT01729754|20394806|P2|COMPLETED|Part 1||184
8271166|NCT01729754|20394807|P1|COMPLETED|Part 1||6
8271167|NCT01729754|20394798|P10|STARTED|Part 1||313
8271168|NCT01729754|20394799|P9|STARTED|Part 1||70
8271169|NCT01729754|20394800|P8|STARTED|Part 1||72
8271170|NCT01729754|20394801|P7|STARTED|Part 1||14
8271171|NCT01729754|20394802|P6|STARTED|Part 1||268
8271172|NCT01729754|20394803|P5|STARTED|Part 1||21
8271173|NCT01729754|20394804|P4|STARTED|Part 1||18
8271174|NCT01729754|20394805|P3|STARTED|Part 1||110
8271175|NCT01729754|20394806|P2|STARTED|Part 1||184
8271176|NCT01729754|20394807|P1|STARTED|Part 1||20
8271177|NCT01729728|20395014|P3|NOT COMPLETED|Overall Study||1
8271178|NCT01729728|20395015|P2|NOT COMPLETED|Overall Study||6
8271179|NCT01729728|20395016|P1|NOT COMPLETED|Overall Study||1
8271180|NCT01729728|20395014|P3|COMPLETED|Overall Study||16
8271181|NCT01729728|20395015|P2|COMPLETED|Overall Study||22
8271182|NCT01729728|20395016|P1|COMPLETED|Overall Study||20
8271183|NCT01729728|20395014|P3|STARTED|Overall Study||17
8271184|NCT01729728|20395015|P2|STARTED|Overall Study||28
8271185|NCT01729728|20395016|P1|STARTED|Overall Study||21
8271186|NCT01729598|20395149|P2|NOT COMPLETED|Overall Study||0
8271187|NCT01729598|20395150|P1|NOT COMPLETED|Overall Study||0
8271188|NCT01729598|20395149|P2|COMPLETED|Overall Study||4
8271189|NCT01729598|20395150|P1|COMPLETED|Overall Study||10
8271190|NCT01729598|20395149|P2|STARTED|Overall Study||4
8271191|NCT01729598|20395150|P1|STARTED|Overall Study||10
8271192|NCT01729559|20395166|P2|NOT COMPLETED|Overall Study||28
8271193|NCT01729559|20395167|P1|NOT COMPLETED|Overall Study||31
8271194|NCT01729559|20395166|P2|COMPLETED|Overall Study||216
8271195|NCT01729559|20395167|P1|COMPLETED|Overall Study||220
8271196|NCT01729559|20395166|P2|STARTED|Overall Study||244
8271197|NCT01729559|20395167|P1|STARTED|Overall Study||251
8271198|NCT01729338|20395179|P1|NOT COMPLETED|Overall Study||2
8271199|NCT01729338|20395179|P1|COMPLETED|Overall Study||14
8271200|NCT01729338|20395179|P1|STARTED|Overall Study||16
8271201|NCT01729247|20395194|P1|NOT COMPLETED|Overall Study||0
8271202|NCT01729247|20395194|P1|COMPLETED|Overall Study||50
8271203|NCT01729247|20395194|P1|STARTED|Overall Study||50
8271204|NCT01729208|20395210|P2|NOT COMPLETED|36 Months Follow-up||4
8271205|NCT01729208|20395211|P1|NOT COMPLETED|36 Months Follow-up||3
8271206|NCT01729208|20395210|P2|COMPLETED|36 Months Follow-up||56
8271207|NCT01729208|20395211|P1|COMPLETED|36 Months Follow-up||52
8271208|NCT01729208|20395210|P2|STARTED|36 Months Follow-up||60
8271209|NCT01729208|20395211|P1|STARTED|36 Months Follow-up||55
8271210|NCT01729208|20395210|P2|NOT COMPLETED|24 Months Follow-up||0
8271211|NCT01729208|20395211|P1|NOT COMPLETED|24 Months Follow-up||3
8271212|NCT01729208|20395210|P2|COMPLETED|24 Months Follow-up||60
8271213|NCT01729208|20395211|P1|COMPLETED|24 Months Follow-up||55
8271214|NCT01729208|20395210|P2|STARTED|24 Months Follow-up||60
8271215|NCT01729208|20395211|P1|STARTED|24 Months Follow-up||58
8271216|NCT01729208|20395210|P2|NOT COMPLETED|12 Months Follow-up||10
8271217|NCT01729208|20395211|P1|NOT COMPLETED|12 Months Follow-up||7
8271218|NCT01729208|20395210|P2|COMPLETED|12 Months Follow-up||60
8271219|NCT01729208|20395211|P1|COMPLETED|12 Months Follow-up||58
8271220|NCT01729208|20395210|P2|STARTED|12 Months Follow-up||70
8271221|NCT01729208|20395211|P1|STARTED|12 Months Follow-up||65
8271222|NCT01729208|20395210|P2|NOT COMPLETED|Baseline||4
8271223|NCT01729208|20395211|P1|NOT COMPLETED|Baseline||5
8271224|NCT01729208|20395210|P2|COMPLETED|Baseline||70
8271225|NCT01729208|20395211|P1|COMPLETED|Baseline||65
8271226|NCT01729208|20395210|P2|STARTED|Baseline||74
8271227|NCT01729208|20395211|P1|STARTED|Baseline||70
8271228|NCT01729156|20395244|P3|NOT COMPLETED|Overall Study||0
8271229|NCT01729156|20395245|P2|NOT COMPLETED|Overall Study||0
8271230|NCT01729156|20395246|P1|NOT COMPLETED|Overall Study||1
8271231|NCT01729156|20395244|P3|COMPLETED|Overall Study||12
8271232|NCT01729156|20395245|P2|COMPLETED|Overall Study||12
8271233|NCT01729156|20395246|P1|COMPLETED|Overall Study||11
8271234|NCT01729156|20395244|P3|STARTED|Overall Study||12
8271235|NCT01729156|20395245|P2|STARTED|Overall Study||12
8271236|NCT01729156|20395246|P1|STARTED|Overall Study||12
8271237|NCT01729039|20395274|P2|NOT COMPLETED|Overall Study||12
8271238|NCT01729039|20395275|P1|NOT COMPLETED|Overall Study||10
8271239|NCT01729039|20395274|P2|COMPLETED|Overall Study||14
8271240|NCT01729039|20395275|P1|COMPLETED|Overall Study||13
8271241|NCT01729039|20395274|P2|STARTED|Overall Study||26
8271242|NCT01729039|20395275|P1|STARTED|Overall Study||23
8271243|NCT01729026|20395291|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
8271244|NCT01729026|20395292|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
8271245|NCT01729026|20395291|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
8271246|NCT01729026|20395292|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
8271247|NCT01729026|20395291|P2|STARTED|3-month to 6-month (Final) Follow-up||8
8271248|NCT01729026|20395292|P1|STARTED|3-month to 6-month (Final) Follow-up||7
8271249|NCT01729026|20395291|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
8271250|NCT01729026|20395292|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
8271251|NCT01729026|20395291|P2|COMPLETED|Randomization to 3-month Follow-up||8
8271252|NCT01729026|20395292|P1|COMPLETED|Randomization to 3-month Follow-up||7
8271253|NCT01729026|20395291|P2|STARTED|Randomization to 3-month Follow-up||10
8271254|NCT01729026|20395292|P1|STARTED|Randomization to 3-month Follow-up||9
8271255|NCT01728844|20395324|P4|NOT COMPLETED|Overall Study||2
8271256|NCT01728844|20395325|P3|NOT COMPLETED|Overall Study||0
8271257|NCT01728844|20395326|P2|NOT COMPLETED|Overall Study||0
8271258|NCT01728844|20395327|P1|NOT COMPLETED|Overall Study||1
8271259|NCT01728844|20395324|P4|COMPLETED|Overall Study||21
8271260|NCT01728844|20395325|P3|COMPLETED|Overall Study||22
8271261|NCT01728844|20395326|P2|COMPLETED|Overall Study||21
8271262|NCT01728844|20395327|P1|COMPLETED|Overall Study||21
8271263|NCT01728844|20395324|P4|STARTED|Overall Study||23
8271264|NCT01728844|20395325|P3|STARTED|Overall Study||22
8271265|NCT01728844|20395326|P2|STARTED|Overall Study||21
8271266|NCT01728844|20395327|P1|STARTED|Overall Study||22
8271285|NCT01728792|20395395|P5|NOT COMPLETED|Overall Study||0
8271286|NCT01728792|20395396|P4|NOT COMPLETED|Overall Study||3
8271287|NCT01728792|20395397|P3|NOT COMPLETED|Overall Study||4
8271288|NCT01728792|20395398|P2|NOT COMPLETED|Overall Study||2
8271289|NCT01728792|20395399|P1|NOT COMPLETED|Overall Study||3
8271290|NCT01728792|20395395|P5|COMPLETED|Overall Study||16
8271291|NCT01728792|20395396|P4|COMPLETED|Overall Study||14
8271292|NCT01728792|20395397|P3|COMPLETED|Overall Study||13
8271293|NCT01728792|20395398|P2|COMPLETED|Overall Study||14
8271294|NCT01728792|20395399|P1|COMPLETED|Overall Study||11
8271295|NCT01728792|20395395|P5|STARTED|Overall Study||16
8271296|NCT01728792|20395396|P4|STARTED|Overall Study||17
8271297|NCT01728792|20395397|P3|STARTED|Overall Study||17
8271298|NCT01728792|20395398|P2|STARTED|Overall Study||16
8271299|NCT01728792|20395399|P1|STARTED|Overall Study||14
8271300|NCT01728636|20395448|P2|NOT COMPLETED|Overall Study||0
8271301|NCT01728636|20395449|P1|NOT COMPLETED|Overall Study||0
8271302|NCT01728636|20395448|P2|COMPLETED|Overall Study||30
8271303|NCT01728636|20395449|P1|COMPLETED|Overall Study||31
8271304|NCT01728636|20395448|P2|STARTED|Overall Study||30
8271305|NCT01728636|20395449|P1|STARTED|Overall Study||31
8271306|NCT01728623|20395468|P1|NOT COMPLETED|Overall Study||28
8271307|NCT01728623|20395468|P1|COMPLETED|Overall Study||23
8271308|NCT01728623|20395468|P1|ATC|Overall Study||17
8271309|NCT01728623|20395468|P1|MTC|Overall Study||9
8271310|NCT01728623|20395468|P1|DTC|Overall Study||25
8271311|NCT01728623|20395468|P1|STARTED|Overall Study||51
8271312|NCT01728584|20395494|P4|NOT COMPLETED|Overall Study||1
8271313|NCT01728584|20395495|P3|NOT COMPLETED|Overall Study||1
8271314|NCT01728584|20395496|P2|NOT COMPLETED|Overall Study||0
8271315|NCT01728584|20395497|P1|NOT COMPLETED|Overall Study||8
8271316|NCT01728584|20395494|P4|COMPLETED|Overall Study||29
8271317|NCT01728584|20395495|P3|COMPLETED|Overall Study||30
8271318|NCT01728584|20395496|P2|COMPLETED|Overall Study||30
8271319|NCT01728584|20395497|P1|COMPLETED|Overall Study||28
8271320|NCT01728584|20395494|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
8271321|NCT01728584|20395495|P3|STARTED|Overall Study|Randomized|31
8271322|NCT01728584|20395496|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
8271323|NCT01728584|20395497|P1|STARTED|Overall Study|Randomized|36
8271324|NCT01728454|20395552|P3|NOT COMPLETED|Stage 3||4
8271325|NCT01728454|20395553|P2|NOT COMPLETED|Stage 3||4
8271326|NCT01728454|20395554|P1|NOT COMPLETED|Stage 3||3
8271327|NCT01728454|20395552|P3|COMPLETED|Stage 3||7
8271328|NCT01728454|20395553|P2|COMPLETED|Stage 3||1
8271329|NCT01728454|20395554|P1|COMPLETED|Stage 3||3
8271330|NCT01728454|20395552|P3|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
8271331|NCT01728454|20395553|P2|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
8271332|NCT01728454|20395554|P1|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
8271333|NCT01728454|20395552|P3|NOT COMPLETED|Stage 1 and 2||4
8271334|NCT01728454|20395553|P2|NOT COMPLETED|Stage 1 and 2||4
8271335|NCT01728454|20395554|P1|NOT COMPLETED|Stage 1 and 2||5
8271336|NCT01728454|20395552|P3|COMPLETED|Stage 1 and 2||19
8271337|NCT01728454|20395553|P2|COMPLETED|Stage 1 and 2||16
8271338|NCT01728454|20395554|P1|COMPLETED|Stage 1 and 2||12
8271339|NCT01728454|20395552|P3|STARTED|Stage 1 and 2||23
8271340|NCT01728454|20395553|P2|STARTED|Stage 1 and 2||20
8271341|NCT01728454|20395554|P1|STARTED|Stage 1 and 2||17
8271342|NCT01728376|20395604|P6|NOT COMPLETED|Overall Study||2
8271343|NCT01728376|20395605|P5|NOT COMPLETED|Overall Study||2
8271344|NCT01728376|20395606|P4|NOT COMPLETED|Overall Study||2
8271345|NCT01728376|20395607|P3|NOT COMPLETED|Overall Study||2
8271346|NCT01728376|20395608|P2|NOT COMPLETED|Overall Study||2
8271347|NCT01728376|20395609|P1|NOT COMPLETED|Overall Study||4
8271348|NCT01728376|20395604|P6|COMPLETED|Overall Study||5
8271349|NCT01728376|20395605|P5|COMPLETED|Overall Study||12
8271350|NCT01728376|20395606|P4|COMPLETED|Overall Study||7
8271351|NCT01728376|20395607|P3|COMPLETED|Overall Study||17
8271352|NCT01728376|20395608|P2|COMPLETED|Overall Study||9
8271353|NCT01728376|20395609|P1|COMPLETED|Overall Study||18
8271354|NCT01728376|20395604|P6|Treated|Overall Study||7
8271355|NCT01728376|20395605|P5|Treated|Overall Study||14
8271356|NCT01728376|20395606|P4|Treated|Overall Study||9
8271357|NCT01728376|20395607|P3|Treated|Overall Study||19
8271358|NCT01728376|20395608|P2|Treated|Overall Study||10
8271359|NCT01728376|20395609|P1|Treated|Overall Study||22
8271360|NCT01728376|20395604|P6|STARTED|Overall Study||7
8271361|NCT01728376|20395605|P5|STARTED|Overall Study||14
8271362|NCT01728376|20395606|P4|STARTED|Overall Study||9
8271363|NCT01728376|20395607|P3|STARTED|Overall Study||19
8271364|NCT01728376|20395608|P2|STARTED|Overall Study||11
8271365|NCT01728376|20395609|P1|STARTED|Overall Study||22
8271366|NCT01728337|20395671|P1|NOT COMPLETED|Overall Study||0
8271367|NCT01728337|20395671|P1|COMPLETED|Overall Study||80
8271368|NCT01728337|20395671|P1|STARTED|Overall Study||80
8271369|NCT01728324|20395682|P3|NOT COMPLETED|Termination of RBV||15
8271370|NCT01728324|20395683|P2|NOT COMPLETED|Termination of RBV||37
8271371|NCT01728324|20395684|P1|NOT COMPLETED|Termination of RBV||39
8271372|NCT01728324|20395682|P3|COMPLETED|Termination of RBV||57
8271373|NCT01728324|20395683|P2|COMPLETED|Termination of RBV||176
8271374|NCT01728324|20395684|P1|COMPLETED|Termination of RBV||172
8271375|NCT01728324|20395682|P3|STARTED|Termination of RBV||72
8271376|NCT01728324|20395683|P2|STARTED|Termination of RBV||213
8271377|NCT01728324|20395684|P1|STARTED|Termination of RBV||211
8271378|NCT01728324|20395682|P3|NOT COMPLETED|Termination of FDV||14
8271379|NCT01728324|20395683|P2|NOT COMPLETED|Termination of FDV||36
8271380|NCT01728324|20395684|P1|NOT COMPLETED|Termination of FDV||38
8271381|NCT01728324|20395682|P3|COMPLETED|Termination of FDV||58
8271382|NCT01728324|20395683|P2|COMPLETED|Termination of FDV||177
8271383|NCT01728324|20395684|P1|COMPLETED|Termination of FDV||173
8271384|NCT01728324|20395682|P3|STARTED|Termination of FDV||72
8271385|NCT01728324|20395683|P2|STARTED|Termination of FDV||213
8271386|NCT01728324|20395684|P1|STARTED|Termination of FDV||211
8271387|NCT01728324|20395682|P3|NOT COMPLETED|Termination of DBV||14
8271388|NCT01728324|20395683|P2|NOT COMPLETED|Termination of DBV||36
8271389|NCT01728324|20395684|P1|NOT COMPLETED|Termination of DBV||38
8271390|NCT01728324|20395682|P3|COMPLETED|Termination of DBV||58
8271391|NCT01728324|20395683|P2|COMPLETED|Termination of DBV||177
8271392|NCT01728324|20395684|P1|COMPLETED|Termination of DBV||173
8271393|NCT01728324|20395682|P3|STARTED|Termination of DBV||72
8271394|NCT01728324|20395683|P2|STARTED|Termination of DBV||213
8271395|NCT01728324|20395684|P1|STARTED|Termination of DBV||211
8271396|NCT01728246|20395705|P2|NOT COMPLETED|Overall Study||36
8271397|NCT01728246|20395706|P1|NOT COMPLETED|Overall Study||36
8271398|NCT01728246|20395705|P2|COMPLETED|Overall Study||195
8271399|NCT01728246|20395706|P1|COMPLETED|Overall Study||206
8271400|NCT01728246|20395705|P2|STARTED|Overall Study||231
8271401|NCT01728246|20395706|P1|STARTED|Overall Study||242
8271402|NCT01728194|20395724|P2|NOT COMPLETED|Overall Study||6
8271403|NCT01728194|20395725|P1|NOT COMPLETED|Overall Study||20
8271404|NCT01728194|20395724|P2|COMPLETED|Overall Study||61
8271405|NCT01728194|20395725|P1|COMPLETED|Overall Study||34
8271406|NCT01728194|20395724|P2|STARTED|Overall Study||67
8271407|NCT01728194|20395725|P1|STARTED|Overall Study||54
8271408|NCT01728116|20395735|P2|NOT COMPLETED|Overall Study||47
8271409|NCT01728116|20395736|P1|NOT COMPLETED|Overall Study||161
8271410|NCT01728116|20395735|P2|COMPLETED|Overall Study|Completed to Week 52|60
8271411|NCT01728116|20395736|P1|COMPLETED|Overall Study|Completed to Week 78|52
8271412|NCT01728116|20395735|P2|STARTED|Overall Study|Sham mITT subjects|107
8271413|NCT01728116|20395736|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
8271414|NCT01728077|20395761|P2|NOT COMPLETED|Overall Study||5
8271415|NCT01728077|20395762|P1|NOT COMPLETED|Overall Study||8
8271416|NCT01728077|20395761|P2|COMPLETED|Overall Study||2
8271417|NCT01728077|20395762|P1|COMPLETED|Overall Study||11
8271418|NCT01728077|20395761|P2|STARTED|Overall Study||7
8271419|NCT01728077|20395762|P1|STARTED|Overall Study||19
8271420|NCT01727895|20395777|P2|NOT COMPLETED|Overall Study||0
8271421|NCT01727895|20395778|P1|NOT COMPLETED|Overall Study||0
8271422|NCT01727895|20395777|P2|COMPLETED|Overall Study||5
8271423|NCT01727895|20395778|P1|COMPLETED|Overall Study||10
8271424|NCT01727895|20395777|P2|STARTED|Overall Study||5
8271425|NCT01727895|20395778|P1|STARTED|Overall Study||10
8271426|NCT01727765|20395786|P2|NOT COMPLETED|Overall Study||0
8271427|NCT01727765|20395787|P1|NOT COMPLETED|Overall Study||0
8271428|NCT01727765|20395786|P2|COMPLETED|Overall Study||8
8271429|NCT01727765|20395787|P1|COMPLETED|Overall Study||8
8271430|NCT01727765|20395786|P2|STARTED|Overall Study||8
8271431|NCT01727765|20395787|P1|STARTED|Overall Study||8
8271432|NCT01727726|20395796|P3|NOT COMPLETED|Overall Study||20
8271433|NCT01727726|20395797|P2|NOT COMPLETED|Overall Study||14
8271434|NCT01727726|20395798|P1|NOT COMPLETED|Overall Study||26
8271435|NCT01727726|20395796|P3|COMPLETED|Overall Study||186
8271436|NCT01727726|20395797|P2|COMPLETED|Overall Study||86
8271437|NCT01727726|20395798|P1|COMPLETED|Overall Study||171
8271438|NCT01727726|20395796|P3|STARTED|Overall Study||206
8271439|NCT01727726|20395797|P2|STARTED|Overall Study||100
8271440|NCT01727726|20395798|P1|STARTED|Overall Study||197
8271441|NCT01727713|20395830|P1|NOT COMPLETED|Overall Study||35
8271442|NCT01727713|20395830|P1|COMPLETED|Overall Study||75
8271443|NCT01727713|20395830|P1|STARTED|Overall Study||110
8271444|NCT01727700|20395857|P3|NOT COMPLETED|Overall Study||2
8271445|NCT01727700|20395858|P2|NOT COMPLETED|Overall Study||10
8271446|NCT01727700|20395859|P1|NOT COMPLETED|Overall Study||2
8271447|NCT01727700|20395857|P3|COMPLETED|Overall Study||42
8271448|NCT01727700|20395858|P2|COMPLETED|Overall Study||35
8271449|NCT01727700|20395859|P1|COMPLETED|Overall Study||42
8271450|NCT01727700|20395857|P3|STARTED|Overall Study||44
8271451|NCT01727700|20395858|P2|STARTED|Overall Study||45
8271452|NCT01727700|20395859|P1|STARTED|Overall Study||44
8271453|NCT01727505|20395882|P2|NOT COMPLETED|Second 24 Hours||1
8271454|NCT01727505|20395883|P1|NOT COMPLETED|Second 24 Hours||0
8271455|NCT01727505|20395882|P2|COMPLETED|Second 24 Hours||10
8271456|NCT01727505|20395883|P1|COMPLETED|Second 24 Hours||14
8271457|NCT01727505|20395882|P2|STARTED|Second 24 Hours||11
8271458|NCT01727505|20395883|P1|STARTED|Second 24 Hours||14
8271459|NCT01727505|20395882|P2|NOT COMPLETED|First 24 Hours||1
8271460|NCT01727505|20395883|P1|NOT COMPLETED|First 24 Hours||0
8271461|NCT01727505|20395882|P2|COMPLETED|First 24 Hours||11
8271462|NCT01727505|20395883|P1|COMPLETED|First 24 Hours||14
8271463|NCT01727505|20395882|P2|STARTED|First 24 Hours||12
8271464|NCT01727505|20395883|P1|STARTED|First 24 Hours||14
8271465|NCT01727414|20395901|P2|NOT COMPLETED|Overall Study||0
8271466|NCT01727414|20395902|P1|NOT COMPLETED|Overall Study||3
8271467|NCT01727414|20395901|P2|COMPLETED|Overall Study||45
8271468|NCT01727414|20395902|P1|COMPLETED|Overall Study||123
8271469|NCT01727414|20395901|P2|STARTED|Overall Study||45
8271470|NCT01727414|20395902|P1|STARTED|Overall Study||126
8271471|NCT01727297|20395908|P2|NOT COMPLETED|Overall Study||51
8271472|NCT01727297|20395909|P1|NOT COMPLETED|Overall Study||102
8271473|NCT01727297|20395908|P2|COMPLETED|Overall Study||0
8271474|NCT01727297|20395909|P1|COMPLETED|Overall Study||293
8271475|NCT01727297|20395908|P2|STARTED|Overall Study||51
8271476|NCT01727297|20395909|P1|STARTED|Overall Study||395
8271477|NCT01727258|20395925|P3|NOT COMPLETED|Overall Study||1
8271478|NCT01727258|20395926|P2|NOT COMPLETED|Overall Study||3
8271479|NCT01727258|20395927|P1|NOT COMPLETED|Overall Study||2
8271480|NCT01727258|20395925|P3|COMPLETED|Overall Study||50
8271481|NCT01727258|20395926|P2|COMPLETED|Overall Study||48
8271482|NCT01727258|20395927|P1|COMPLETED|Overall Study||49
8271483|NCT01727258|20395925|P3|STARTED|Overall Study||51
8271484|NCT01727258|20395926|P2|STARTED|Overall Study||51
8271485|NCT01727258|20395927|P1|STARTED|Overall Study||51
8271486|NCT01727180|20395950|P1|NOT COMPLETED|Overall Study||0
8271487|NCT01727180|20395950|P1|COMPLETED|Overall Study||108
8271488|NCT01727180|20395950|P1|STARTED|Overall Study||108
8271489|NCT01727167|20395956|P2|NOT COMPLETED|Overall Study||0
8271490|NCT01727167|20395957|P1|NOT COMPLETED|Overall Study||0
8271491|NCT01727167|20395956|P2|COMPLETED|Overall Study||0
8271492|NCT01727167|20395957|P1|COMPLETED|Overall Study||1
8271493|NCT01727167|20395956|P2|STARTED|Overall Study||0
8271494|NCT01727167|20395957|P1|STARTED|Overall Study||1
8271495|NCT01727154|20395965|P1|NOT COMPLETED|Overall Study||59
8271496|NCT01727154|20395965|P1|COMPLETED|Overall Study||80
8271497|NCT01727154|20395965|P1|STARTED|Overall Study||139
8271498|NCT01727141|20395973|P4|NOT COMPLETED|Overall Study||15
8271499|NCT01727141|20395974|P3|NOT COMPLETED|Overall Study||3
8271500|NCT01727141|20395975|P2|NOT COMPLETED|Overall Study||9
8271501|NCT01727141|20395976|P1|NOT COMPLETED|Overall Study||5
8271502|NCT01727141|20395973|P4|COMPLETED|Overall Study||246
8271503|NCT01727141|20395974|P3|COMPLETED|Overall Study||258
8271504|NCT01727141|20395975|P2|COMPLETED|Overall Study||251
8271505|NCT01727141|20395976|P1|COMPLETED|Overall Study||255
8271506|NCT01727141|20395973|P4|Full Analysis Set|Overall Study||261
8271507|NCT01727141|20395974|P3|Full Analysis Set|Overall Study||261
8271508|NCT01727141|20395975|P2|Full Analysis Set|Overall Study||260
8271509|NCT01727141|20395976|P1|Full Analysis Set|Overall Study||258
8271510|NCT01727141|20395973|P4|Safety Set|Overall Study||260
8271511|NCT01727141|20395974|P3|Safety Set|Overall Study||262
8271512|NCT01727141|20395975|P2|Safety Set|Overall Study||260
8271513|NCT01727141|20395976|P1|Safety Set|Overall Study||258
8271514|NCT01727141|20395973|P4|STARTED|Overall Study||261
8271515|NCT01727141|20395974|P3|STARTED|Overall Study||261
8271516|NCT01727141|20395975|P2|STARTED|Overall Study||260
8271517|NCT01727141|20395976|P1|STARTED|Overall Study||260
8271518|NCT01727089|20396028|P2|NOT COMPLETED|Overall Study||0
8271519|NCT01727089|20396029|P1|NOT COMPLETED|Overall Study||0
8271520|NCT01727089|20396028|P2|COMPLETED|Overall Study||30
8271521|NCT01727089|20396029|P1|COMPLETED|Overall Study||29
8271522|NCT01727089|20396028|P2|STARTED|Overall Study||30
8271523|NCT01727089|20396029|P1|STARTED|Overall Study||29
8271524|NCT01727024|20396041|P2|NOT COMPLETED|Period 2||0
8271525|NCT01727024|20396042|P1|NOT COMPLETED|Period 2||0
8271526|NCT01727024|20396041|P2|COMPLETED|Period 2||64
8271527|NCT01727024|20396042|P1|COMPLETED|Period 2||68
8271528|NCT01727024|20396041|P2|STARTED|Period 2||64
8271529|NCT01727024|20396042|P1|STARTED|Period 2||68
8271530|NCT01727024|20396041|P2|NOT COMPLETED|Period 1||4
8271531|NCT01727024|20396042|P1|NOT COMPLETED|Period 1||3
8271532|NCT01727024|20396041|P2|COMPLETED|Period 1||64
8271533|NCT01727024|20396042|P1|COMPLETED|Period 1||68
8271534|NCT01727024|20396041|P2|STARTED|Period 1||68
8271535|NCT01727024|20396042|P1|STARTED|Period 1||71
8271536|NCT01726803|20396057|P2|NOT COMPLETED|Overall Study||1
8271537|NCT01726803|20396058|P1|NOT COMPLETED|Overall Study||7
8271538|NCT01726803|20396057|P2|COMPLETED|Overall Study||107
8271539|NCT01726803|20396058|P1|COMPLETED|Overall Study||105
8271540|NCT01726803|20396057|P2|STARTED|Overall Study||108
8271541|NCT01726803|20396058|P1|STARTED|Overall Study||112
8271542|NCT01726738|20396078|P1|NOT COMPLETED|Overall Study||0
8271543|NCT01726738|20396078|P1|COMPLETED|Overall Study||17
8271544|NCT01726738|20396078|P1|STARTED|Overall Study||17
8271545|NCT01726673|20396090|P2|NOT COMPLETED|Overall Study||3
8271546|NCT01726673|20396091|P1|NOT COMPLETED|Overall Study||6
8271547|NCT01726673|20396090|P2|COMPLETED|Overall Study||21
8271548|NCT01726673|20396091|P1|COMPLETED|Overall Study||24
8271549|NCT01726673|20396090|P2|STARTED|Overall Study||24
8271550|NCT01726673|20396091|P1|STARTED|Overall Study||30
8271551|NCT01726621|20396101|P1|NOT COMPLETED|Overall Study||4
8271552|NCT01726621|20396101|P1|COMPLETED|Overall Study||51
8271553|NCT01726621|20396101|P1|STARTED|Overall Study||55
8271554|NCT01726517|20396110|P5|NOT COMPLETED|Overall Study||0
8271555|NCT01726517|20396111|P4|NOT COMPLETED|Overall Study||0
8271556|NCT01726517|20396112|P3|NOT COMPLETED|Overall Study||1
8271557|NCT01726517|20396113|P2|NOT COMPLETED|Overall Study||0
8271558|NCT01726517|20396114|P1|NOT COMPLETED|Overall Study||0
8271559|NCT01726517|20396110|P5|COMPLETED|Overall Study||21
8271560|NCT01726517|20396111|P4|COMPLETED|Overall Study||19
8271561|NCT01726517|20396112|P3|COMPLETED|Overall Study||18
8271562|NCT01726517|20396113|P2|COMPLETED|Overall Study||21
8271563|NCT01726517|20396114|P1|COMPLETED|Overall Study||20
8271564|NCT01726517|20396110|P5|STARTED|Overall Study||21
8271565|NCT01726517|20396111|P4|STARTED|Overall Study||19
8271566|NCT01726517|20396112|P3|STARTED|Overall Study||19
8271567|NCT01726517|20396113|P2|STARTED|Overall Study||21
8271568|NCT01726517|20396114|P1|STARTED|Overall Study||20
8271569|NCT01726504|20396143|P2|NOT COMPLETED|Overall Study||28
8271570|NCT01726504|20396144|P1|NOT COMPLETED|Overall Study||12
8271571|NCT01726504|20396143|P2|COMPLETED|Overall Study||511
8271572|NCT01726504|20396144|P1|COMPLETED|Overall Study||524
8271573|NCT01726504|20396143|P2|STARTED|Overall Study||539
8271574|NCT01726504|20396144|P1|STARTED|Overall Study||536
8271575|NCT01726335|20396170|P1|NOT COMPLETED|Overall Study||24
8271576|NCT01726335|20396170|P1|COMPLETED|Overall Study||29
8271577|NCT01726335|20396170|P1|STARTED|Overall Study||53
8271578|NCT01726270|20396186|P1|NOT COMPLETED|Part 2, Actual-Use Phase||39
8271579|NCT01726270|20396186|P1|COMPLETED|Part 2, Actual-Use Phase||330
8271580|NCT01726270|20396186|P1|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
8271581|NCT01726270|20396186|P1|NOT COMPLETED|Eligibility for Part 2||20
8271582|NCT01726270|20396186|P1|COMPLETED|Eligibility for Part 2||369
8271583|NCT01726270|20396186|P1|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
8271584|NCT01726270|20396186|P1|NOT COMPLETED|Part 1, Self-Selection Phase||10
8271585|NCT01726270|20396186|P1|COMPLETED|Part 1, Self-Selection Phase||679
8271586|NCT01726270|20396186|P1|STARTED|Part 1, Self-Selection Phase||689
8271587|NCT01726049|20396199|P2|NOT COMPLETED|Overall Study||4
8271588|NCT01726049|20396200|P1|NOT COMPLETED|Overall Study||5
8271589|NCT01726049|20396199|P2|COMPLETED|Overall Study||22
8271590|NCT01726049|20396200|P1|COMPLETED|Overall Study||21
8271591|NCT01726049|20396199|P2|STARTED|Overall Study||26
8271592|NCT01726049|20396200|P1|STARTED|Overall Study||26
8271593|NCT01726036|20396214|P2|NOT COMPLETED|Overall Study||7
8271594|NCT01726036|20396215|P1|NOT COMPLETED|Overall Study||16
8271595|NCT01726036|20396214|P2|COMPLETED|Overall Study||130
8271596|NCT01726036|20396215|P1|COMPLETED|Overall Study||121
8271597|NCT01726036|20396214|P2|STARTED|Overall Study||137
8271598|NCT01726036|20396215|P1|STARTED|Overall Study||137
8271599|NCT01726023|20396225|P2|NOT COMPLETED|Overall Study||26
8271600|NCT01726023|20396226|P1|NOT COMPLETED|Overall Study||29
8271601|NCT01726023|20396225|P2|COMPLETED|Overall Study||196
8271602|NCT01726023|20396226|P1|COMPLETED|Overall Study||190
8271603|NCT01726023|20396225|P2|STARTED|Overall Study||222
8271604|NCT01726023|20396226|P1|STARTED|Overall Study||219
8271605|NCT01725984|20396318|P2|NOT COMPLETED|Overall Study||0
8271606|NCT01725984|20396319|P1|NOT COMPLETED|Overall Study||0
8271607|NCT01725984|20396318|P2|COMPLETED|Overall Study||41
8271608|NCT01725984|20396319|P1|COMPLETED|Overall Study||39
8271609|NCT01725984|20396318|P2|STARTED|Overall Study||41
8271610|NCT01725984|20396319|P1|STARTED|Overall Study||39
8271611|NCT01725815|20396345|P2|NOT COMPLETED|Overall Study||0
8271612|NCT01725815|20396346|P1|NOT COMPLETED|Overall Study||0
8271613|NCT01725815|20396345|P2|COMPLETED|Overall Study||202
8271614|NCT01725815|20396346|P1|COMPLETED|Overall Study||198
8271615|NCT01725815|20396345|P2|STARTED|Overall Study||202
8271616|NCT01725815|20396346|P1|STARTED|Overall Study||198
8271617|NCT01725750|20396360|P2|NOT COMPLETED|Overall Study||10
8271618|NCT01725750|20396361|P1|NOT COMPLETED|Overall Study||2
8271619|NCT01725750|20396360|P2|COMPLETED|Overall Study||34
8271620|NCT01725750|20396361|P1|COMPLETED|Overall Study||42
8271621|NCT01725750|20396360|P2|STARTED|Overall Study||44
8271622|NCT01725750|20396361|P1|STARTED|Overall Study||44
8271623|NCT01725529|20396394|P3|NOT COMPLETED|Overall Study||10
8271624|NCT01725529|20396395|P2|NOT COMPLETED|Overall Study||16
8271625|NCT01725529|20396396|P1|NOT COMPLETED|Overall Study||15
8271626|NCT01725529|20396394|P3|COMPLETED|Overall Study||142
8271627|NCT01725529|20396395|P2|COMPLETED|Overall Study||137
8271628|NCT01725529|20396396|P1|COMPLETED|Overall Study||137
8271629|NCT01725529|20396394|P3|STARTED|Overall Study||152
8271630|NCT01725529|20396395|P2|STARTED|Overall Study||153
8271631|NCT01725529|20396396|P1|STARTED|Overall Study||152
8271632|NCT01725451|20396422|P4|NOT COMPLETED|Period 6||0
8271633|NCT01725451|20396423|P3|NOT COMPLETED|Period 6||0
8271634|NCT01725451|20396424|P2|NOT COMPLETED|Period 6||0
8271635|NCT01725451|20396425|P1|NOT COMPLETED|Period 6||0
8271636|NCT01725451|20396422|P4|COMPLETED|Period 6||7
8271637|NCT01725451|20396423|P3|COMPLETED|Period 6||6
8271638|NCT01725451|20396424|P2|COMPLETED|Period 6||6
8271639|NCT01725451|20396425|P1|COMPLETED|Period 6||7
8271640|NCT01725451|20396422|P4|STARTED|Period 6||7
8271641|NCT01725451|20396423|P3|STARTED|Period 6||6
8271642|NCT01725451|20396424|P2|STARTED|Period 6||6
8271643|NCT01725451|20396425|P1|STARTED|Period 6||7
8271644|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 5||0
8271645|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 5||0
8271646|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 5||0
8271647|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 5||0
8271648|NCT01725451|20396422|P4|COMPLETED|Washout From Period 5||7
8271649|NCT01725451|20396423|P3|COMPLETED|Washout From Period 5||6
8271650|NCT01725451|20396424|P2|COMPLETED|Washout From Period 5||6
8271651|NCT01725451|20396425|P1|COMPLETED|Washout From Period 5||7
8271652|NCT01725451|20396422|P4|STARTED|Washout From Period 5||7
8271653|NCT01725451|20396423|P3|STARTED|Washout From Period 5||6
8271654|NCT01725451|20396424|P2|STARTED|Washout From Period 5||6
8271655|NCT01725451|20396425|P1|STARTED|Washout From Period 5||7
8271656|NCT01725451|20396422|P4|NOT COMPLETED|Period 5||0
8271657|NCT01725451|20396423|P3|NOT COMPLETED|Period 5||0
8271658|NCT01725451|20396424|P2|NOT COMPLETED|Period 5||0
8271659|NCT01725451|20396425|P1|NOT COMPLETED|Period 5||0
8271660|NCT01725451|20396422|P4|COMPLETED|Period 5||7
8271661|NCT01725451|20396423|P3|COMPLETED|Period 5||6
8271662|NCT01725451|20396424|P2|COMPLETED|Period 5||6
8271663|NCT01725451|20396425|P1|COMPLETED|Period 5||7
8271664|NCT01725451|20396422|P4|STARTED|Period 5||7
8271665|NCT01725451|20396423|P3|STARTED|Period 5||6
8271666|NCT01725451|20396424|P2|STARTED|Period 5||6
8271667|NCT01725451|20396425|P1|STARTED|Period 5||7
8271668|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 4||0
8271669|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 4||0
8271670|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 4||0
8271671|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 4||0
8271672|NCT01725451|20396422|P4|COMPLETED|Washout From Period 4||7
8271673|NCT01725451|20396423|P3|COMPLETED|Washout From Period 4||6
8271674|NCT01725451|20396424|P2|COMPLETED|Washout From Period 4||6
8271675|NCT01725451|20396425|P1|COMPLETED|Washout From Period 4||7
8271676|NCT01725451|20396422|P4|STARTED|Washout From Period 4||7
8271677|NCT01725451|20396423|P3|STARTED|Washout From Period 4||6
8271678|NCT01725451|20396424|P2|STARTED|Washout From Period 4||6
8271679|NCT01725451|20396425|P1|STARTED|Washout From Period 4||7
8271680|NCT01725451|20396422|P4|NOT COMPLETED|Period 4||0
8271681|NCT01725451|20396423|P3|NOT COMPLETED|Period 4||1
8271682|NCT01725451|20396424|P2|NOT COMPLETED|Period 4||0
8271683|NCT01725451|20396425|P1|NOT COMPLETED|Period 4||0
8271684|NCT01725451|20396422|P4|COMPLETED|Period 4||7
8271685|NCT01725451|20396423|P3|COMPLETED|Period 4||6
8271686|NCT01725451|20396424|P2|COMPLETED|Period 4||6
8271687|NCT01725451|20396425|P1|COMPLETED|Period 4||7
8271688|NCT01725451|20396422|P4|STARTED|Period 4||7
8271689|NCT01725451|20396423|P3|STARTED|Period 4||7
8271690|NCT01725451|20396424|P2|STARTED|Period 4||6
8271691|NCT01725451|20396425|P1|STARTED|Period 4||7
8271692|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 3||0
8271693|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 3||1
8271694|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 3||1
8271695|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 3||0
8271696|NCT01725451|20396422|P4|COMPLETED|Washout From Period 3||7
8271697|NCT01725451|20396423|P3|COMPLETED|Washout From Period 3||7
8271698|NCT01725451|20396424|P2|COMPLETED|Washout From Period 3||6
8271699|NCT01725451|20396425|P1|COMPLETED|Washout From Period 3||7
8271700|NCT01725451|20396422|P4|STARTED|Washout From Period 3||7
8271701|NCT01725451|20396423|P3|STARTED|Washout From Period 3||8
8271702|NCT01725451|20396424|P2|STARTED|Washout From Period 3||7
8271703|NCT01725451|20396425|P1|STARTED|Washout From Period 3||7
8271704|NCT01725451|20396422|P4|NOT COMPLETED|Period 3||0
8271705|NCT01725451|20396423|P3|NOT COMPLETED|Period 3||0
8271706|NCT01725451|20396424|P2|NOT COMPLETED|Period 3||0
8271707|NCT01725451|20396425|P1|NOT COMPLETED|Period 3||0
8271708|NCT01725451|20396422|P4|COMPLETED|Period 3||7
8271709|NCT01725451|20396423|P3|COMPLETED|Period 3||8
8271710|NCT01725451|20396424|P2|COMPLETED|Period 3||7
8271711|NCT01725451|20396425|P1|COMPLETED|Period 3||7
8271712|NCT01725451|20396422|P4|STARTED|Period 3||7
8271713|NCT01725451|20396423|P3|STARTED|Period 3||8
8271714|NCT01725451|20396424|P2|STARTED|Period 3||7
8271715|NCT01725451|20396425|P1|STARTED|Period 3||7
8271716|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 2||0
8271717|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 2||0
8271718|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 2||0
8271719|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 2||0
8271720|NCT01725451|20396422|P4|COMPLETED|Washout From Period 2||7
8271721|NCT01725451|20396423|P3|COMPLETED|Washout From Period 2||8
8271722|NCT01725451|20396424|P2|COMPLETED|Washout From Period 2||7
8271723|NCT01725451|20396425|P1|COMPLETED|Washout From Period 2||7
8271724|NCT01725451|20396422|P4|STARTED|Washout From Period 2||7
8271725|NCT01725451|20396423|P3|STARTED|Washout From Period 2||8
8271726|NCT01725451|20396424|P2|STARTED|Washout From Period 2||7
8271727|NCT01725451|20396425|P1|STARTED|Washout From Period 2||7
8271728|NCT01725451|20396422|P4|NOT COMPLETED|Period 2||0
8271729|NCT01725451|20396423|P3|NOT COMPLETED|Period 2||0
8271730|NCT01725451|20396424|P2|NOT COMPLETED|Period 2||0
8271731|NCT01725451|20396425|P1|NOT COMPLETED|Period 2||0
8271732|NCT01725451|20396422|P4|COMPLETED|Period 2||7
8271733|NCT01725451|20396423|P3|COMPLETED|Period 2||8
8271734|NCT01725451|20396424|P2|COMPLETED|Period 2||7
8271735|NCT01725451|20396425|P1|COMPLETED|Period 2||7
8271736|NCT01725451|20396422|P4|STARTED|Period 2||7
8271737|NCT01725451|20396423|P3|STARTED|Period 2||8
8271738|NCT01725451|20396424|P2|STARTED|Period 2||7
8271739|NCT01725451|20396425|P1|STARTED|Period 2||7
8271740|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 1||0
8271741|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 1||0
8271742|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 1||0
8271743|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 1||0
8271744|NCT01725451|20396422|P4|COMPLETED|Washout From Period 1||7
8271745|NCT01725451|20396423|P3|COMPLETED|Washout From Period 1||8
8271746|NCT01725451|20396424|P2|COMPLETED|Washout From Period 1||7
8271747|NCT01725451|20396425|P1|COMPLETED|Washout From Period 1||7
8271748|NCT01725451|20396422|P4|STARTED|Washout From Period 1||7
8271749|NCT01725451|20396423|P3|STARTED|Washout From Period 1||8
8271750|NCT01725451|20396424|P2|STARTED|Washout From Period 1||7
8271751|NCT01725451|20396425|P1|STARTED|Washout From Period 1||7
8271752|NCT01725451|20396422|P4|NOT COMPLETED|Period 1||0
8271753|NCT01725451|20396423|P3|NOT COMPLETED|Period 1||0
8271754|NCT01725451|20396424|P2|NOT COMPLETED|Period 1||0
8271755|NCT01725451|20396425|P1|NOT COMPLETED|Period 1||1
8271756|NCT01725451|20396422|P4|COMPLETED|Period 1||7
8271757|NCT01725451|20396423|P3|COMPLETED|Period 1||8
8271758|NCT01725451|20396424|P2|COMPLETED|Period 1||7
8271759|NCT01725451|20396425|P1|COMPLETED|Period 1||7
8271760|NCT01725451|20396422|P4|STARTED|Period 1||7
8271761|NCT01725451|20396423|P3|STARTED|Period 1||8
8271762|NCT01725451|20396424|P2|STARTED|Period 1||7
8271763|NCT01725451|20396425|P1|STARTED|Period 1||8
8271764|NCT01725386|20396447|P2|NOT COMPLETED|Overall Study||46
8271765|NCT01725386|20396448|P1|NOT COMPLETED|Overall Study||175
8271766|NCT01725386|20396447|P2|COMPLETED|Overall Study||17
8271767|NCT01725386|20396448|P1|COMPLETED|Overall Study||13
8271768|NCT01725386|20396447|P2|STARTED|Overall Study||63
8271769|NCT01725386|20396448|P1|STARTED|Overall Study||188
8271770|NCT01725308|20396467|P3|NOT COMPLETED|Treatment Period II||64
8271771|NCT01725308|20396468|P2|NOT COMPLETED|Treatment Period II||29
8271772|NCT01725308|20396469|P1|NOT COMPLETED|Treatment Period II||55
8271773|NCT01725308|20396467|P3|COMPLETED|Treatment Period II||74
8271774|NCT01725308|20396468|P2|COMPLETED|Treatment Period II||31
8271775|NCT01725308|20396469|P1|COMPLETED|Treatment Period II||79
8271776|NCT01725308|20396467|P3|Treated|Treatment Period II||130
8271777|NCT01725308|20396468|P2|Treated|Treatment Period II||53
8271778|NCT01725308|20396469|P1|Treated|Treatment Period II||120
8271779|NCT01725308|20396467|P3|STARTED|Treatment Period II||138
8271780|NCT01725308|20396468|P2|STARTED|Treatment Period II||60
8271781|NCT01725308|20396469|P1|STARTED|Treatment Period II||134
8271782|NCT01725308|20396467|P3|NOT COMPLETED|Treatment Period I||41
8271783|NCT01725308|20396468|P2|NOT COMPLETED|Treatment Period I||14
8271784|NCT01725308|20396469|P1|NOT COMPLETED|Treatment Period I||44
8271785|NCT01725308|20396467|P3|COMPLETED|Treatment Period I||138
8271786|NCT01725308|20396468|P2|COMPLETED|Treatment Period I||60
8271787|NCT01725308|20396469|P1|COMPLETED|Treatment Period I||134
8271788|NCT01725308|20396467|P3|Treated|Treatment Period I||179
8271789|NCT01725308|20396468|P2|Treated|Treatment Period I||74
8271790|NCT01725308|20396469|P1|Treated|Treatment Period I||177
8271791|NCT01725308|20396467|P3|STARTED|Treatment Period I||179
8271792|NCT01725308|20396468|P2|STARTED|Treatment Period I||74
8271793|NCT01725308|20396469|P1|STARTED|Treatment Period I||178
8271794|NCT01725282|20396616|P4|NOT COMPLETED|Overall Study||7
8271795|NCT01725282|20396617|P3|NOT COMPLETED|Overall Study||8
8271796|NCT01725282|20396618|P2|NOT COMPLETED|Overall Study||5
8271797|NCT01725282|20396619|P1|NOT COMPLETED|Overall Study||2
8271798|NCT01725282|20396616|P4|COMPLETED|Overall Study||36
8271799|NCT01725282|20396617|P3|COMPLETED|Overall Study||33
8271800|NCT01725282|20396618|P2|COMPLETED|Overall Study||39
8271801|NCT01725282|20396619|P1|COMPLETED|Overall Study||42
8271802|NCT01725282|20396616|P4|STARTED|Overall Study||43
8271803|NCT01725282|20396617|P3|STARTED|Overall Study||41
8271804|NCT01725282|20396618|P2|STARTED|Overall Study||44
8271805|NCT01725282|20396619|P1|STARTED|Overall Study||44
8271806|NCT01725217|20396652|P3|NOT COMPLETED|Overall Study||0
8271807|NCT01725217|20396653|P2|NOT COMPLETED|Overall Study||0
8271808|NCT01725217|20396654|P1|NOT COMPLETED|Overall Study||1
8271809|NCT01725217|20396652|P3|COMPLETED|Overall Study||66
8271810|NCT01725217|20396653|P2|COMPLETED|Overall Study||66
8271811|NCT01725217|20396654|P1|COMPLETED|Overall Study||65
8271812|NCT01725217|20396652|P3|STARTED|Overall Study||66
8271813|NCT01725217|20396653|P2|STARTED|Overall Study||66
8271814|NCT01725217|20396654|P1|STARTED|Overall Study||66
8271815|NCT01725126|20396688|P6|NOT COMPLETED|Overall Study||0
8271816|NCT01725126|20396689|P5|NOT COMPLETED|Overall Study||0
8271817|NCT01725126|20396690|P4|NOT COMPLETED|Overall Study||1
8271818|NCT01725126|20396691|P3|NOT COMPLETED|Overall Study||0
8271819|NCT01725126|20396692|P2|NOT COMPLETED|Overall Study||1
8271820|NCT01725126|20396693|P1|NOT COMPLETED|Overall Study||0
8271821|NCT01725126|20396688|P6|COMPLETED|Overall Study||12
8271822|NCT01725126|20396689|P5|COMPLETED|Overall Study||6
8271823|NCT01725126|20396690|P4|COMPLETED|Overall Study||13
8271824|NCT01725126|20396691|P3|COMPLETED|Overall Study||6
8271825|NCT01725126|20396692|P2|COMPLETED|Overall Study||10
8271826|NCT01725126|20396693|P1|COMPLETED|Overall Study||4
8271827|NCT01725126|20396688|P6|STARTED|Overall Study||12
8271828|NCT01725126|20396689|P5|STARTED|Overall Study||6
8271829|NCT01725126|20396690|P4|STARTED|Overall Study||14
8271830|NCT01725126|20396691|P3|STARTED|Overall Study||6
8271831|NCT01725126|20396692|P2|STARTED|Overall Study||11
8271832|NCT01725126|20396693|P1|STARTED|Overall Study||4
8271833|NCT01724528|20396891|P2|NOT COMPLETED|Overall Study||3
8271834|NCT01724528|20396892|P1|NOT COMPLETED|Overall Study||4
8271835|NCT01724528|20396891|P2|COMPLETED|Overall Study||170
8271836|NCT01724528|20396892|P1|COMPLETED|Overall Study||169
8271837|NCT01724528|20396891|P2|STARTED|Overall Study||173
8271838|NCT01724528|20396892|P1|STARTED|Overall Study||173
8271839|NCT01724489|20396908|P2|NOT COMPLETED|Overall Study||12
8271840|NCT01724489|20396909|P1|NOT COMPLETED|Overall Study||16
8271841|NCT01724489|20396908|P2|COMPLETED|Overall Study||26
8271842|NCT01724489|20396909|P1|COMPLETED|Overall Study||23
8271843|NCT01724489|20396908|P2|STARTED|Overall Study||38
8271844|NCT01724489|20396909|P1|STARTED|Overall Study||39
8271845|NCT01724359|20396915|P1|NOT COMPLETED|Overall Study||31
8271846|NCT01724359|20396915|P1|COMPLETED|Overall Study||64
8271847|NCT01724359|20396915|P1|STARTED|Overall Study||95
8271848|NCT01724216|20396928|P1|NOT COMPLETED|Overall Study||1
8271849|NCT01724216|20396928|P1|COMPLETED|Overall Study||10
8271850|NCT01724216|20396928|P1|STARTED|Overall Study||11
8271851|NCT01724177|20396932|P1|NOT COMPLETED|Overall Study||26
8271852|NCT01724177|20396932|P1|COMPLETED|Overall Study||0
8271853|NCT01724177|20396932|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
8271854|NCT01724177|20396932|P1|STARTED|Overall Study||26
8271855|NCT01724060|20396951|P8|NOT COMPLETED|Overall Study||0
8271856|NCT01724060|20396952|P7|NOT COMPLETED|Overall Study||0
8271857|NCT01724060|20396953|P6|NOT COMPLETED|Overall Study||0
8271858|NCT01724060|20396954|P5|NOT COMPLETED|Overall Study||0
8271859|NCT01724060|20396955|P4|NOT COMPLETED|Overall Study||0
8271860|NCT01724060|20396956|P3|NOT COMPLETED|Overall Study||0
8271861|NCT01724060|20396957|P2|NOT COMPLETED|Overall Study||0
8271862|NCT01724060|20396958|P1|NOT COMPLETED|Overall Study||0
8271863|NCT01724060|20396951|P8|COMPLETED|Overall Study||10
8271864|NCT01724060|20396952|P7|COMPLETED|Overall Study||10
8271865|NCT01724060|20396953|P6|COMPLETED|Overall Study||10
8271866|NCT01724060|20396954|P5|COMPLETED|Overall Study||10
8271867|NCT01724060|20396955|P4|COMPLETED|Overall Study||10
8271868|NCT01724060|20396956|P3|COMPLETED|Overall Study||10
8271869|NCT01724060|20396957|P2|COMPLETED|Overall Study||10
8271870|NCT01724060|20396958|P1|COMPLETED|Overall Study||10
8271871|NCT01724060|20396951|P8|STARTED|Overall Study||10
8271872|NCT01724060|20396952|P7|STARTED|Overall Study||10
8271873|NCT01724060|20396953|P6|STARTED|Overall Study||10
8271874|NCT01724060|20396954|P5|STARTED|Overall Study||10
8271875|NCT01724060|20396955|P4|STARTED|Overall Study||10
8271876|NCT01724060|20396956|P3|STARTED|Overall Study||10
8271877|NCT01724060|20396957|P2|STARTED|Overall Study||10
8271878|NCT01724060|20396958|P1|STARTED|Overall Study||10
8271879|NCT01724021|20396978|P2|NOT COMPLETED|Overall Study||133
8271880|NCT01724021|20396979|P1|NOT COMPLETED|Overall Study||127
8271881|NCT01724021|20396978|P2|COMPLETED|Overall Study||236
8271882|NCT01724021|20396979|P1|COMPLETED|Overall Study||244
8271883|NCT01724021|20396978|P2|STARTED|Overall Study||369
8271884|NCT01724021|20396979|P1|STARTED|Overall Study||371
8271885|NCT01723904|20397011|P1|NOT COMPLETED|Overall Study||11
8271886|NCT01723904|20397011|P1|COMPLETED|Overall Study||79
8271887|NCT01723904|20397011|P1|STARTED|Overall Study||90
8271888|NCT01723826|20397025|P4|NOT COMPLETED|Overall Study||90
8271889|NCT01723826|20397026|P3|NOT COMPLETED|Overall Study||57
8271890|NCT01723826|20397027|P2|NOT COMPLETED|Overall Study||36
8271891|NCT01723826|20397028|P1|NOT COMPLETED|Overall Study||27
8271892|NCT01723826|20397025|P4|COMPLETED|Overall Study||59
8271893|NCT01723826|20397026|P3|COMPLETED|Overall Study||44
8271894|NCT01723826|20397027|P2|COMPLETED|Overall Study||27
8271895|NCT01723826|20397028|P1|COMPLETED|Overall Study||20
8271896|NCT01723826|20397025|P4|STARTED|Overall Study||149
8271897|NCT01723826|20397026|P3|STARTED|Overall Study||101
8271898|NCT01723826|20397027|P2|STARTED|Overall Study||63
8271899|NCT01723826|20397028|P1|STARTED|Overall Study||47
8271900|NCT01723722|20397060|P2|NOT COMPLETED|Overall Study||0
8271901|NCT01723722|20397061|P1|NOT COMPLETED|Overall Study||0
8271902|NCT01723722|20397060|P2|COMPLETED|Overall Study||20
8271903|NCT01723722|20397061|P1|COMPLETED|Overall Study||20
8271904|NCT01723722|20397060|P2|STARTED|Overall Study||20
8271905|NCT01723722|20397061|P1|STARTED|Overall Study||20
8271906|NCT01723696|20397069|P2|NOT COMPLETED|Overall Study||13
8271907|NCT01723696|20397070|P1|NOT COMPLETED|Overall Study||17
8271908|NCT01723696|20397069|P2|COMPLETED|Overall Study||113
8271909|NCT01723696|20397070|P1|COMPLETED|Overall Study||109
8271910|NCT01723696|20397069|P2|STARTED|Overall Study||126
8271911|NCT01723696|20397070|P1|STARTED|Overall Study||126
8271912|NCT01723514|20397090|P8|NOT COMPLETED|Overall Study||0
8271913|NCT01723514|20397091|P7|NOT COMPLETED|Overall Study||0
8271914|NCT01723514|20397092|P6|NOT COMPLETED|Overall Study||0
8271915|NCT01723514|20397093|P5|NOT COMPLETED|Overall Study||0
8271916|NCT01723514|20397094|P4|NOT COMPLETED|Overall Study||0
8271917|NCT01723514|20397095|P3|NOT COMPLETED|Overall Study||0
8271918|NCT01723514|20397096|P2|NOT COMPLETED|Overall Study||0
8271919|NCT01723514|20397097|P1|NOT COMPLETED|Overall Study||0
8271920|NCT01723514|20397090|P8|COMPLETED|Overall Study||6
8271921|NCT01723514|20397091|P7|COMPLETED|Overall Study||6
8271922|NCT01723514|20397092|P6|COMPLETED|Overall Study||4
8271923|NCT01723514|20397093|P5|COMPLETED|Overall Study||6
8271924|NCT01723514|20397094|P4|COMPLETED|Overall Study||6
8271925|NCT01723514|20397095|P3|COMPLETED|Overall Study||6
8271926|NCT01723514|20397096|P2|COMPLETED|Overall Study||6
8271927|NCT01723514|20397097|P1|COMPLETED|Overall Study||8
8271928|NCT01723514|20397090|P8|STARTED|Overall Study||6
8271929|NCT01723514|20397091|P7|STARTED|Overall Study||6
8271930|NCT01723514|20397092|P6|STARTED|Overall Study||4
8271931|NCT01723514|20397093|P5|STARTED|Overall Study||6
8271932|NCT01723514|20397094|P4|STARTED|Overall Study||6
8271933|NCT01723514|20397095|P3|STARTED|Overall Study||6
8271934|NCT01723514|20397096|P2|STARTED|Overall Study||6
8271935|NCT01723514|20397097|P1|STARTED|Overall Study||8
8271936|NCT01723397|20397173|P2|NOT COMPLETED|Study Period 2||1
8271937|NCT01723397|20397174|P1|NOT COMPLETED|Study Period 2||0
8271938|NCT01723397|20397173|P2|COMPLETED|Study Period 2||5
8271939|NCT01723397|20397174|P1|COMPLETED|Study Period 2||7
8271940|NCT01723397|20397173|P2|STARTED|Study Period 2||6
8271941|NCT01723397|20397174|P1|STARTED|Study Period 2||7
8271942|NCT01723397|20397173|P2|NOT COMPLETED|Washout||0
8271943|NCT01723397|20397174|P1|NOT COMPLETED|Washout||0
8271944|NCT01723397|20397173|P2|COMPLETED|Washout||6
8271945|NCT01723397|20397174|P1|COMPLETED|Washout||7
8271946|NCT01723397|20397173|P2|STARTED|Washout||6
8271947|NCT01723397|20397174|P1|STARTED|Washout||7
8271948|NCT01723397|20397173|P2|NOT COMPLETED|Study Period 1||1
8271949|NCT01723397|20397174|P1|NOT COMPLETED|Study Period 1||0
8271950|NCT01723397|20397173|P2|COMPLETED|Study Period 1||6
8271951|NCT01723397|20397174|P1|COMPLETED|Study Period 1||7
8271952|NCT01723397|20397173|P2|STARTED|Study Period 1||7
8271953|NCT01723397|20397174|P1|STARTED|Study Period 1||7
8271954|NCT01723384|20397182|P2|NOT COMPLETED|Overall Study||0
8271955|NCT01723384|20397183|P1|NOT COMPLETED|Overall Study||0
8271956|NCT01723384|20397182|P2|COMPLETED|Overall Study||15
8271957|NCT01723384|20397183|P1|COMPLETED|Overall Study||15
8271958|NCT01723384|20397182|P2|STARTED|Overall Study||15
8271959|NCT01723384|20397183|P1|STARTED|Overall Study||15
8271960|NCT01723254|20397201|P8|NOT COMPLETED|Overall Study||3
8271961|NCT01723254|20397202|P7|NOT COMPLETED|Overall Study||1
8271962|NCT01723254|20397203|P6|NOT COMPLETED|Overall Study||2
8271963|NCT01723254|20397204|P5|NOT COMPLETED|Overall Study||2
8271964|NCT01723254|20397205|P4|NOT COMPLETED|Overall Study||2
8271965|NCT01723254|20397206|P3|NOT COMPLETED|Overall Study||3
8271966|NCT01723254|20397207|P2|NOT COMPLETED|Overall Study||3
8271967|NCT01723254|20397208|P1|NOT COMPLETED|Overall Study||1
8271968|NCT01723254|20397201|P8|COMPLETED|Overall Study||60
8271969|NCT01723254|20397202|P7|COMPLETED|Overall Study||19
8271970|NCT01723254|20397203|P6|COMPLETED|Overall Study||18
8271971|NCT01723254|20397204|P5|COMPLETED|Overall Study||18
8271972|NCT01723254|20397205|P4|COMPLETED|Overall Study||18
8271973|NCT01723254|20397206|P3|COMPLETED|Overall Study||17
8271974|NCT01723254|20397207|P2|COMPLETED|Overall Study||18
8271975|NCT01723254|20397208|P1|COMPLETED|Overall Study||5
8271976|NCT01723254|20397201|P8|STARTED|Overall Study||63
8271977|NCT01723254|20397202|P7|STARTED|Overall Study||20
8271978|NCT01723254|20397203|P6|STARTED|Overall Study||20
8271979|NCT01723254|20397204|P5|STARTED|Overall Study||20
8271980|NCT01723254|20397205|P4|STARTED|Overall Study||20
8271981|NCT01723254|20397206|P3|STARTED|Overall Study||20
8271982|NCT01723254|20397207|P2|STARTED|Overall Study||21
8271983|NCT01723254|20397208|P1|STARTED|Overall Study||6
8271984|NCT01723228|20397260|P2|NOT COMPLETED|Overall Study||11
8271985|NCT01723228|20397261|P1|NOT COMPLETED|Overall Study||8
8271986|NCT01723228|20397260|P2|COMPLETED|Overall Study||73
8271987|NCT01723228|20397261|P1|COMPLETED|Overall Study||78
8271988|NCT01723228|20397260|P2|STARTED|Overall Study||84
8271989|NCT01723228|20397261|P1|STARTED|Overall Study||86
8271990|NCT01723163|20397279|P2|NOT COMPLETED|12-Month Follow-up||28
8271991|NCT01723163|20397280|P1|NOT COMPLETED|12-Month Follow-up||24
8271992|NCT01723163|20397279|P2|COMPLETED|12-Month Follow-up||119
8271993|NCT01723163|20397280|P1|COMPLETED|12-Month Follow-up||111
8271994|NCT01723163|20397279|P2|STARTED|12-Month Follow-up||147
8271995|NCT01723163|20397280|P1|STARTED|12-Month Follow-up||135
8271996|NCT01723163|20397279|P2|NOT COMPLETED|6-Month Follow-up||15
8271997|NCT01723163|20397280|P1|NOT COMPLETED|6-Month Follow-up||18
8271998|NCT01723163|20397279|P2|COMPLETED|6-Month Follow-up||132
8271999|NCT01723163|20397280|P1|COMPLETED|6-Month Follow-up||118
8272000|NCT01723163|20397279|P2|STARTED|6-Month Follow-up||147
8272001|NCT01723163|20397280|P1|STARTED|6-Month Follow-up||136
8272002|NCT01723163|20397279|P2|NOT COMPLETED|3-Month Follow-up||19
8272003|NCT01723163|20397280|P1|NOT COMPLETED|3-Month Follow-up||13
8272004|NCT01723163|20397279|P2|COMPLETED|3-Month Follow-up||128
8272005|NCT01723163|20397280|P1|COMPLETED|3-Month Follow-up||124
8272006|NCT01723163|20397279|P2|STARTED|3-Month Follow-up||147
8272007|NCT01723163|20397280|P1|STARTED|3-Month Follow-up||137
8272008|NCT01723163|20397279|P2|NOT COMPLETED|Treatment Phase||7
8272009|NCT01723163|20397280|P1|NOT COMPLETED|Treatment Phase||19
8272010|NCT01723163|20397279|P2|COMPLETED|Treatment Phase||147
8272011|NCT01723163|20397280|P1|COMPLETED|Treatment Phase||137
8272012|NCT01723163|20397279|P2|STARTED|Treatment Phase||154
8272013|NCT01723163|20397280|P1|STARTED|Treatment Phase||156
8272014|NCT01723163|20397279|P2|NOT COMPLETED|Baseline||0
8272015|NCT01723163|20397280|P1|NOT COMPLETED|Baseline||0
8272016|NCT01723163|20397279|P2|COMPLETED|Baseline||154
8272017|NCT01723163|20397280|P1|COMPLETED|Baseline||156
8272018|NCT01723163|20397279|P2|STARTED|Baseline||154
8272019|NCT01723163|20397280|P1|STARTED|Baseline||156
8272020|NCT01723072|20397288|P2|NOT COMPLETED|Overall Study||21
8272021|NCT01723072|20397289|P1|NOT COMPLETED|Overall Study||11
8272022|NCT01723072|20397288|P2|COMPLETED|Overall Study||26
8272023|NCT01723072|20397289|P1|COMPLETED|Overall Study||33
8272024|NCT01723072|20397288|P2|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
8272025|NCT01723072|20397289|P1|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
8272026|NCT01722994|20397327|P2|NOT COMPLETED|Overall Study||17
8272027|NCT01722994|20397328|P1|NOT COMPLETED|Overall Study||25
8272028|NCT01722994|20397327|P2|COMPLETED|Overall Study||31
8272029|NCT01722994|20397328|P1|COMPLETED|Overall Study||24
8272030|NCT01722994|20397327|P2|STARTED|Overall Study||48
8272031|NCT01722994|20397328|P1|STARTED|Overall Study||49
8272032|NCT01722929|20397342|P1|NOT COMPLETED|Overall Study||0
8272033|NCT01722929|20397342|P1|COMPLETED|Overall Study||4
8272034|NCT01722929|20397342|P1|STARTED|Overall Study||4
8272035|NCT01722877|20397347|P1|NOT COMPLETED|Overall Study||2
8272036|NCT01722877|20397347|P1|COMPLETED|Overall Study||27
8272037|NCT01722877|20397347|P1|STARTED|Overall Study||29
8272038|NCT01722734|20397357|P3|NOT COMPLETED|Overall Study||2
8272039|NCT01722734|20397358|P2|NOT COMPLETED|Overall Study||1
8272040|NCT01722734|20397359|P1|NOT COMPLETED|Overall Study||2
8272041|NCT01722734|20397357|P3|COMPLETED|Overall Study||307
8272042|NCT01722734|20397358|P2|COMPLETED|Overall Study||276
8272043|NCT01722734|20397359|P1|COMPLETED|Overall Study||552
8272044|NCT01722734|20397357|P3|STARTED|Overall Study||309
8272045|NCT01722734|20397358|P2|STARTED|Overall Study||277
8272046|NCT01722734|20397359|P1|STARTED|Overall Study||554
8272047|NCT01722669|20397373|P6|NOT COMPLETED|Overall Study||2
8272048|NCT01722669|20397374|P5|NOT COMPLETED|Overall Study||0
8272049|NCT01722669|20397375|P4|NOT COMPLETED|Overall Study||0
8272050|NCT01722669|20397376|P3|NOT COMPLETED|Overall Study||0
8272051|NCT01722669|20397377|P2|NOT COMPLETED|Overall Study||0
8272052|NCT01722669|20397378|P1|NOT COMPLETED|Overall Study||0
8272053|NCT01722669|20397373|P6|COMPLETED|Overall Study||6
8272054|NCT01722669|20397374|P5|COMPLETED|Overall Study||10
8272055|NCT01722669|20397375|P4|COMPLETED|Overall Study||5
8272056|NCT01722669|20397376|P3|COMPLETED|Overall Study||5
8272057|NCT01722669|20397377|P2|COMPLETED|Overall Study||5
8272058|NCT01722669|20397378|P1|COMPLETED|Overall Study||5
8272059|NCT01722669|20397373|P6|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
8272060|NCT01722669|20397374|P5|STARTED|Overall Study||10
8272061|NCT01722669|20397375|P4|STARTED|Overall Study||5
8272062|NCT01722669|20397376|P3|STARTED|Overall Study||5
8272063|NCT01722669|20397377|P2|STARTED|Overall Study||5
8272064|NCT01722669|20397378|P1|STARTED|Overall Study||5
8272065|NCT01722643|20397400|P2|NOT COMPLETED|Overall Study||1
8272066|NCT01722643|20397401|P1|NOT COMPLETED|Overall Study||0
8272067|NCT01722643|20397400|P2|COMPLETED|Overall Study||30
8272068|NCT01722643|20397401|P1|COMPLETED|Overall Study||30
8272069|NCT01722643|20397400|P2|STARTED|Overall Study||31
8272070|NCT01722643|20397401|P1|STARTED|Overall Study||30
8272071|NCT01722552|20397409|P1|NOT COMPLETED|Overall Study||4
8272072|NCT01722552|20397409|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
8272073|NCT01722552|20397409|P1|STARTED|Overall Study|Number of subjects enrolled|120
8272074|NCT01722487|20397419|P2|NOT COMPLETED|Overall Study||7
8272075|NCT01722487|20397420|P1|NOT COMPLETED|Overall Study||2
8272076|NCT01722487|20397419|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
8272077|NCT01722487|20397420|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
8272078|NCT01722487|20397419|P2|STARTED|Overall Study||133
8272079|NCT01722487|20397420|P1|STARTED|Overall Study||136
8272080|NCT01722435|20397438|P1|NOT COMPLETED|Overall Study||0
8272081|NCT01722435|20397438|P1|COMPLETED|Overall Study||78
8272082|NCT01722435|20397438|P1|STARTED|Overall Study||78
8272083|NCT01722331|20397449|P7|NOT COMPLETED|Part 3||2
8272084|NCT01722331|20397450|P6|NOT COMPLETED|Part 3||3
8272085|NCT01722331|20397451|P5|NOT COMPLETED|Part 3||0
8272086|NCT01722331|20397452|P4|NOT COMPLETED|Part 3||1
8272087|NCT01722331|20397453|P3|NOT COMPLETED|Part 3||0
8272088|NCT01722331|20397454|P2|NOT COMPLETED|Part 3||17
8272089|NCT01722331|20397455|P1|NOT COMPLETED|Part 3||15
8272090|NCT01722331|20397449|P7|COMPLETED|Part 3||65
8272091|NCT01722331|20397450|P6|COMPLETED|Part 3||59
8272092|NCT01722331|20397451|P5|COMPLETED|Part 3||0
8272093|NCT01722331|20397452|P4|COMPLETED|Part 3||18
8272094|NCT01722331|20397453|P3|COMPLETED|Part 3||0
8272095|NCT01722331|20397454|P2|COMPLETED|Part 3||232
8272096|NCT01722331|20397455|P1|COMPLETED|Part 3||264
8272097|NCT01722331|20397449|P7|STARTED|Part 3||67
8272098|NCT01722331|20397450|P6|STARTED|Part 3||62
8272099|NCT01722331|20397451|P5|STARTED|Part 3||0
8272100|NCT01722331|20397452|P4|STARTED|Part 3||19
8272101|NCT01722331|20397453|P3|STARTED|Part 3||0
8272102|NCT01722331|20397454|P2|STARTED|Part 3||249
8272103|NCT01722331|20397455|P1|STARTED|Part 3||279
8272104|NCT01722331|20397449|P7|NOT COMPLETED|Part 2||7
8272105|NCT01722331|20397450|P6|NOT COMPLETED|Part 2||10
8272106|NCT01722331|20397451|P5|NOT COMPLETED|Part 2||0
8272107|NCT01722331|20397452|P4|NOT COMPLETED|Part 2||0
8272108|NCT01722331|20397453|P3|NOT COMPLETED|Part 2||31
8272109|NCT01722331|20397454|P2|NOT COMPLETED|Part 2||0
8272110|NCT01722331|20397455|P1|NOT COMPLETED|Part 2||19
8272111|NCT01722331|20397449|P7|COMPLETED|Part 2||67
8272112|NCT01722331|20397450|P6|COMPLETED|Part 2||62
8272113|NCT01722331|20397451|P5|COMPLETED|Part 2||0
8272114|NCT01722331|20397452|P4|COMPLETED|Part 2||19
8272115|NCT01722331|20397453|P3|COMPLETED|Part 2||0
8272116|NCT01722331|20397454|P2|COMPLETED|Part 2||249
8272117|NCT01722331|20397455|P1|COMPLETED|Part 2||279
8272118|NCT01722331|20397449|P7|STARTED|Part 2||74
8272119|NCT01722331|20397450|P6|STARTED|Part 2||72
8272120|NCT01722331|20397451|P5|STARTED|Part 2||0
8272121|NCT01722331|20397452|P4|STARTED|Part 2||19
8272122|NCT01722331|20397453|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
8272123|NCT01722331|20397454|P2|STARTED|Part 2||249
8272124|NCT01722331|20397455|P1|STARTED|Part 2||298
8272125|NCT01722331|20397449|P7|NOT COMPLETED|Part 1||0
8272126|NCT01722331|20397450|P6|NOT COMPLETED|Part 1||0
8272127|NCT01722331|20397451|P5|NOT COMPLETED|Part 1||9
8272128|NCT01722331|20397452|P4|NOT COMPLETED|Part 1||0
8272129|NCT01722331|20397453|P3|NOT COMPLETED|Part 1||9
8272130|NCT01722331|20397454|P2|NOT COMPLETED|Part 1||0
8272131|NCT01722331|20397455|P1|NOT COMPLETED|Part 1||10
8272132|NCT01722331|20397449|P7|COMPLETED|Part 1||74
8272133|NCT01722331|20397450|P6|COMPLETED|Part 1||72
8272134|NCT01722331|20397451|P5|COMPLETED|Part 1||0
8272135|NCT01722331|20397452|P4|COMPLETED|Part 1||19
8272136|NCT01722331|20397453|P3|COMPLETED|Part 1||32
8272137|NCT01722331|20397454|P2|COMPLETED|Part 1||249
8272138|NCT01722331|20397455|P1|COMPLETED|Part 1||298
8272139|NCT01722331|20397449|P7|STARTED|Part 1||74
8272140|NCT01722331|20397450|P6|STARTED|Part 1||72
8272141|NCT01722331|20397451|P5|STARTED|Part 1||9
8272142|NCT01722331|20397452|P4|STARTED|Part 1||19
8272143|NCT01722331|20397453|P3|STARTED|Part 1||41
8272144|NCT01722331|20397454|P2|STARTED|Part 1||249
8272145|NCT01722331|20397455|P1|STARTED|Part 1||308
8272146|NCT01722318|20397499|P5|NOT COMPLETED|Overall Study||18
8272147|NCT01722318|20397500|P4|NOT COMPLETED|Overall Study||20
8272148|NCT01722318|20397501|P3|NOT COMPLETED|Overall Study||20
8272149|NCT01722318|20397502|P2|NOT COMPLETED|Overall Study||20
8272150|NCT01722318|20397503|P1|NOT COMPLETED|Overall Study||14
8272151|NCT01722318|20397499|P5|COMPLETED|Overall Study||68
8272152|NCT01722318|20397500|P4|COMPLETED|Overall Study||65
8272153|NCT01722318|20397501|P3|COMPLETED|Overall Study||66
8272154|NCT01722318|20397502|P2|COMPLETED|Overall Study||65
8272155|NCT01722318|20397503|P1|COMPLETED|Overall Study||72
8272156|NCT01722318|20397499|P5|STARTED|Overall Study||86
8272157|NCT01722318|20397500|P4|STARTED|Overall Study||85
8272158|NCT01722318|20397501|P3|STARTED|Overall Study||86
8272159|NCT01722318|20397502|P2|STARTED|Overall Study||85
8272160|NCT01722318|20397503|P1|STARTED|Overall Study||86
8272161|NCT01722292|20397533|P3|NOT COMPLETED|Overall Study||0
8272162|NCT01722292|20397534|P2|NOT COMPLETED|Overall Study||0
8272163|NCT01722292|20397535|P1|NOT COMPLETED|Overall Study||0
8272164|NCT01722292|20397533|P3|COMPLETED|Overall Study||14
8272165|NCT01722292|20397534|P2|COMPLETED|Overall Study||6
8272166|NCT01722292|20397535|P1|COMPLETED|Overall Study||6
8272167|NCT01722292|20397533|P3|Received at Least One Dose of Study Drug|Overall Study||14
8272168|NCT01722292|20397534|P2|Received at Least One Dose of Study Drug|Overall Study||6
8272169|NCT01722292|20397535|P1|Received at Least One Dose of Study Drug|Overall Study||6
8272170|NCT01722292|20397533|P3|STARTED|Overall Study||14
8272171|NCT01722292|20397534|P2|STARTED|Overall Study||6
8272172|NCT01722292|20397535|P1|STARTED|Overall Study||6
8272173|NCT01722266|20397571|P4|NOT COMPLETED|Overall Study||0
8272174|NCT01722266|20397572|P3|NOT COMPLETED|Overall Study||5
8272175|NCT01722266|20397573|P2|NOT COMPLETED|Overall Study||3
8272176|NCT01722266|20397574|P1|NOT COMPLETED|Overall Study||1
8272177|NCT01722266|20397571|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
8272178|NCT01722266|20397572|P3|COMPLETED|Overall Study||13
8272179|NCT01722266|20397573|P2|COMPLETED|Overall Study||15
8272180|NCT01722266|20397574|P1|COMPLETED|Overall Study||17
8272181|NCT01722266|20397571|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
8272182|NCT01722266|20397572|P3|STARTED|Overall Study||18
8272183|NCT01722266|20397573|P2|STARTED|Overall Study||18
8272184|NCT01722266|20397574|P1|STARTED|Overall Study||18
8272185|NCT01722162|20397602|P2|NOT COMPLETED|Overall Study||6
8272186|NCT01722162|20397603|P1|NOT COMPLETED|Overall Study||5
8272187|NCT01722162|20397602|P2|COMPLETED|Overall Study||18
8272188|NCT01722162|20397603|P1|COMPLETED|Overall Study||18
8272189|NCT01722162|20397602|P2|STARTED|Overall Study||24
8272190|NCT01722162|20397603|P1|STARTED|Overall Study||23
8272191|NCT01722097|20397613|P2|NOT COMPLETED|Overall Study||5
8272192|NCT01722097|20397614|P1|NOT COMPLETED|Overall Study||6
8272193|NCT01722097|20397613|P2|COMPLETED|Overall Study||50
8272194|NCT01722097|20397614|P1|COMPLETED|Overall Study||49
8272195|NCT01722097|20397613|P2|STARTED|Overall Study||55
8272196|NCT01722097|20397614|P1|STARTED|Overall Study||55
8272197|NCT01722071|20397622|P2|NOT COMPLETED|Overall Study||0
8272198|NCT01722071|20397623|P1|NOT COMPLETED|Overall Study||1
8272199|NCT01722071|20397622|P2|COMPLETED|Overall Study||10
8272200|NCT01722071|20397623|P1|COMPLETED|Overall Study||9
8272201|NCT01722071|20397622|P2|STARTED|Overall Study||10
8272202|NCT01722071|20397623|P1|STARTED|Overall Study||10
8272203|NCT01722045|20397629|P1|NOT COMPLETED|Overall Study||28
8272204|NCT01722045|20397629|P1|COMPLETED|Overall Study||126
8272205|NCT01722045|20397629|P1|STARTED|Overall Study||154
8272206|NCT01721967|20397639|P1|NOT COMPLETED|Overall Study||3
8272207|NCT01721967|20397639|P1|COMPLETED|Overall Study||11
8272208|NCT01721967|20397639|P1|STARTED|Overall Study||14
8272209|NCT01721954|20397650|P2|NOT COMPLETED|Overall Study||69
8272210|NCT01721954|20397651|P1|NOT COMPLETED|Overall Study||70
8272211|NCT01721954|20397650|P2|COMPLETED|Overall Study||35
8272212|NCT01721954|20397651|P1|COMPLETED|Overall Study||35
8272213|NCT01721954|20397650|P2|STARTED|Overall Study||104
8272214|NCT01721954|20397651|P1|STARTED|Overall Study||105
8272215|NCT01721837|20397659|P1|NOT COMPLETED|Overall Study||0
8272216|NCT01721837|20397659|P1|COMPLETED|Overall Study||2120
8272217|NCT01721837|20397659|P1|STARTED|Overall Study||2120
8272218|NCT01721772|20397665|P2|NOT COMPLETED|Overall Study||192
8272219|NCT01721772|20397666|P1|NOT COMPLETED|Overall Study||111
8272220|NCT01721772|20397665|P2|COMPLETED|Overall Study|Continuing in treatment period|13
8272221|NCT01721772|20397666|P1|COMPLETED|Overall Study|Continuing in treatment period|95
8272222|NCT01721772|20397665|P2|STARTED|Overall Study||205
8272223|NCT01721772|20397666|P1|STARTED|Overall Study||206
8272224|NCT01721759|20397686|P1|NOT COMPLETED|Overall Study||102
8272225|NCT01721759|20397686|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
8272226|NCT01721759|20397686|P1|STARTED|Overall Study||117
8272227|NCT01721746|20397694|P3|NOT COMPLETED|Follow-Up Period||0
8272228|NCT01721746|20397695|P2|NOT COMPLETED|Follow-Up Period||0
8272229|NCT01721746|20397696|P1|NOT COMPLETED|Follow-Up Period||0
8272230|NCT01721746|20397694|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
8272231|NCT01721746|20397695|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
8272232|NCT01721746|20397696|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
8272233|NCT01721746|20397694|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
8272234|NCT01721746|20397695|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
8272235|NCT01721746|20397696|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
8272236|NCT01721746|20397694|P3|NOT COMPLETED|Treatment Period||57
8272237|NCT01721746|20397695|P2|NOT COMPLETED|Treatment Period||45
8272238|NCT01721746|20397696|P1|NOT COMPLETED|Treatment Period||233
8272239|NCT01721746|20397694|P3|COMPLETED|Treatment Period||0
8272240|NCT01721746|20397695|P2|COMPLETED|Treatment Period||0
8272241|NCT01721746|20397696|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
8272242|NCT01721746|20397694|P3|STARTED|Treatment Period||57
8272243|NCT01721746|20397695|P2|STARTED|Treatment Period||45
8272244|NCT01721746|20397696|P1|STARTED|Treatment Period||268
8272245|NCT01721681|20397712|P1|NOT COMPLETED|Overall Study||0
8272246|NCT01721681|20397712|P1|COMPLETED|Overall Study||9
8272247|NCT01721681|20397712|P1|STARTED|Overall Study||9
8272248|NCT01721603|20397718|P1|NOT COMPLETED|Overall Study||0
8272249|NCT01721603|20397718|P1|COMPLETED|Overall Study||2
8272250|NCT01721603|20397718|P1|STARTED|Overall Study||2
8272251|NCT01721564|20397729|P1|NOT COMPLETED|Overall Study||0
8272252|NCT01721564|20397729|P1|COMPLETED|Overall Study||8
8272253|NCT01721564|20397729|P1|STARTED|Overall Study||8
8272254|NCT01721486|20397736|P2|NOT COMPLETED|Overall Study||1
8272255|NCT01721486|20397737|P1|NOT COMPLETED|Overall Study||1
8272256|NCT01721486|20397736|P2|COMPLETED|Overall Study||19
8272257|NCT01721486|20397737|P1|COMPLETED|Overall Study||20
8272258|NCT01721486|20397736|P2|STARTED|Overall Study||20
8272259|NCT01721486|20397737|P1|STARTED|Overall Study||21
8272260|NCT01721473|20397755|P6|NOT COMPLETED|Overall Study||0
8272261|NCT01721473|20397756|P5|NOT COMPLETED|Overall Study||0
8272262|NCT01721473|20397757|P4|NOT COMPLETED|Overall Study||0
8272263|NCT01721473|20397758|P3|NOT COMPLETED|Overall Study||0
8272264|NCT01721473|20397759|P2|NOT COMPLETED|Overall Study||0
8272265|NCT01721473|20397760|P1|NOT COMPLETED|Overall Study||0
8272266|NCT01721473|20397755|P6|COMPLETED|Overall Study||18
8272267|NCT01721473|20397756|P5|COMPLETED|Overall Study||22
8272268|NCT01721473|20397757|P4|COMPLETED|Overall Study||34
8272269|NCT01721473|20397758|P3|COMPLETED|Overall Study||41
8272270|NCT01721473|20397759|P2|COMPLETED|Overall Study||22
8272271|NCT01721473|20397760|P1|COMPLETED|Overall Study||47
8272272|NCT01721473|20397755|P6|STARTED|Overall Study||18
8272273|NCT01721473|20397756|P5|STARTED|Overall Study||22
8272274|NCT01721473|20397757|P4|STARTED|Overall Study||34
8272275|NCT01721473|20397758|P3|STARTED|Overall Study||41
8272276|NCT01721473|20397759|P2|STARTED|Overall Study||22
8272277|NCT01721473|20397760|P1|STARTED|Overall Study||47
8272278|NCT01721460|20397769|P1|NOT COMPLETED|Overall Study||1
8272279|NCT01721460|20397769|P1|COMPLETED|Overall Study||5
8272280|NCT01721460|20397769|P1|STARTED|Overall Study||6
8272281|NCT01721447|20397776|P1|NOT COMPLETED|Overall Study||0
8272282|NCT01721447|20397776|P1|COMPLETED|Overall Study||100
8272283|NCT01721447|20397776|P1|STARTED|Overall Study||100
8272284|NCT01721408|20397785|P2|NOT COMPLETED|Overall Study||24
8272285|NCT01721408|20397786|P1|NOT COMPLETED|Overall Study||36
8272286|NCT01721408|20397785|P2|COMPLETED|Overall Study||207
8272287|NCT01721408|20397786|P1|COMPLETED|Overall Study||196
8272288|NCT01721408|20397785|P2|STARTED|Overall Study|Number of participants treated.|231
8272289|NCT01721408|20397786|P1|STARTED|Overall Study|Number of participants treated.|232
8272290|NCT01721369|20397800|P1|NOT COMPLETED|Overall Study||12
8272291|NCT01721369|20397800|P1|COMPLETED|Overall Study||569
8272292|NCT01721369|20397800|P1|STARTED|Overall Study||581
8272293|NCT01721330|20397806|P2|NOT COMPLETED|Overall Study||1
8272294|NCT01721330|20397807|P1|NOT COMPLETED|Overall Study||0
8272295|NCT01721330|20397806|P2|COMPLETED|Overall Study||1
8272296|NCT01721330|20397807|P1|COMPLETED|Overall Study||1
8272297|NCT01721330|20397806|P2|STARTED|Overall Study||2
8272298|NCT01721330|20397807|P1|STARTED|Overall Study||1
8272299|NCT01721317|20397815|P2|NOT COMPLETED|Overall Study||4
8272300|NCT01721317|20397816|P1|NOT COMPLETED|Overall Study||2
8272301|NCT01721317|20397815|P2|COMPLETED|Overall Study||0
8272302|NCT01721317|20397816|P1|COMPLETED|Overall Study||0
8272303|NCT01721317|20397815|P2|STARTED|Overall Study||4
8272304|NCT01721317|20397816|P1|STARTED|Overall Study||2
8272305|NCT01721226|20397884|P2|NOT COMPLETED|Overall Study||7
8272306|NCT01721226|20397885|P1|NOT COMPLETED|Overall Study||5
8272307|NCT01721226|20397884|P2|COMPLETED|Overall Study||50
8272308|NCT01721226|20397885|P1|COMPLETED|Overall Study||50
8272309|NCT01721226|20397884|P2|Week 24|Overall Study||50
8272310|NCT01721226|20397885|P1|Week 24|Overall Study||50
8272311|NCT01721226|20397884|P2|Week 12|Overall Study||53
8272312|NCT01721226|20397885|P1|Week 12|Overall Study||48
8272313|NCT01721226|20397884|P2|Baseline|Overall Study||57
8272314|NCT01721226|20397885|P1|Baseline|Overall Study||53
8272315|NCT01721226|20397884|P2|STARTED|Overall Study||57
8272316|NCT01721226|20397885|P1|STARTED|Overall Study||55
8272317|NCT01721200|20397895|P2|NOT COMPLETED|Overall Study||5
8272318|NCT01721200|20397896|P1|NOT COMPLETED|Overall Study||3
8272319|NCT01721200|20397895|P2|COMPLETED|Overall Study||58
8272320|NCT01721200|20397896|P1|COMPLETED|Overall Study||59
8272321|NCT01721200|20397895|P2|Completed 2 Week Follow-up|Overall Study||61
8272322|NCT01721200|20397896|P1|Completed 2 Week Follow-up|Overall Study||60
8272323|NCT01721200|20397895|P2|STARTED|Overall Study||63
8272324|NCT01721200|20397896|P1|STARTED|Overall Study||62
8272325|NCT01721161|20397921|P2|NOT COMPLETED|Overall Study||7
8272326|NCT01721161|20397922|P1|NOT COMPLETED|Overall Study||4
8272327|NCT01721161|20397921|P2|COMPLETED|Overall Study||34
8272328|NCT01721161|20397922|P1|COMPLETED|Overall Study||37
8272329|NCT01721161|20397921|P2|STARTED|Overall Study||41
8272330|NCT01721161|20397922|P1|STARTED|Overall Study||41
8272331|NCT01721109|20397945|P1|NOT COMPLETED|Overall Study||7
8272332|NCT01721109|20397945|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
8272333|NCT01721109|20397945|P1|STARTED|Overall Study||50
8272334|NCT01721096|20397960|P2|NOT COMPLETED|Overall Study||204
8272335|NCT01721096|20397961|P1|NOT COMPLETED|Overall Study||320
8272336|NCT01721096|20397960|P2|COMPLETED|Overall Study||9
8272337|NCT01721096|20397961|P1|COMPLETED|Overall Study||3
8272338|NCT01721096|20397960|P2|STARTED|Overall Study||213
8272339|NCT01721096|20397961|P1|STARTED|Overall Study||323
8272340|NCT01721070|20398140|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
8272341|NCT01721070|20398140|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
8272342|NCT01721070|20398140|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
8272343|NCT01721070|20398140|P1|NOT COMPLETED|SUF NT 15 mcg||0
8272344|NCT01721070|20398140|P1|COMPLETED|SUF NT 15 mcg||19
8272345|NCT01721070|20398140|P1|STARTED|SUF NT 15 mcg||19
8272346|NCT01721057|20398151|P7|NOT COMPLETED|Follow Up||0
8272347|NCT01721057|20398152|P6|NOT COMPLETED|Follow Up||0
8272348|NCT01721057|20398153|P5|NOT COMPLETED|Follow Up||0
8272349|NCT01721057|20398154|P4|NOT COMPLETED|Follow Up||0
8272350|NCT01721057|20398155|P3|NOT COMPLETED|Follow Up||0
8272351|NCT01721057|20398156|P2|NOT COMPLETED|Follow Up||0
8272352|NCT01721057|20398157|P1|NOT COMPLETED|Follow Up||0
8272353|NCT01721057|20398151|P7|COMPLETED|Follow Up||22
8272354|NCT01721057|20398152|P6|COMPLETED|Follow Up||19
8272355|NCT01721057|20398153|P5|COMPLETED|Follow Up||17
8272356|NCT01721057|20398154|P4|COMPLETED|Follow Up||0
8272357|NCT01721057|20398155|P3|COMPLETED|Follow Up||0
8272358|NCT01721057|20398156|P2|COMPLETED|Follow Up||0
8272359|NCT01721057|20398157|P1|COMPLETED|Follow Up||0
8272360|NCT01721057|20398151|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
8272361|NCT01721057|20398152|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
8272362|NCT01721057|20398153|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
8272363|NCT01721057|20398154|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
8272364|NCT01721057|20398155|P3|STARTED|Follow Up||0
8272365|NCT01721057|20398156|P2|STARTED|Follow Up||0
8272366|NCT01721057|20398157|P1|STARTED|Follow Up||0
8272367|NCT01721057|20398151|P7|NOT COMPLETED|Rescue Period||0
8272368|NCT01721057|20398152|P6|NOT COMPLETED|Rescue Period||0
8272369|NCT01721057|20398153|P5|NOT COMPLETED|Rescue Period||0
8272370|NCT01721057|20398154|P4|NOT COMPLETED|Rescue Period||3
8272371|NCT01721057|20398155|P3|NOT COMPLETED|Rescue Period||0
8272372|NCT01721057|20398156|P2|NOT COMPLETED|Rescue Period||0
8272373|NCT01721057|20398157|P1|NOT COMPLETED|Rescue Period||0
8272374|NCT01721057|20398151|P7|COMPLETED|Rescue Period||0
8272375|NCT01721057|20398152|P6|COMPLETED|Rescue Period||0
8272376|NCT01721057|20398153|P5|COMPLETED|Rescue Period||0
8272377|NCT01721057|20398154|P4|COMPLETED|Rescue Period||88
8272378|NCT01721057|20398155|P3|COMPLETED|Rescue Period||0
8272379|NCT01721057|20398156|P2|COMPLETED|Rescue Period||0
8272380|NCT01721057|20398157|P1|COMPLETED|Rescue Period||0
8272381|NCT01721057|20398151|P7|STARTED|Rescue Period||0
8272382|NCT01721057|20398152|P6|STARTED|Rescue Period||0
8272383|NCT01721057|20398153|P5|STARTED|Rescue Period||0
8272384|NCT01721057|20398154|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
8272385|NCT01721057|20398155|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8272386|NCT01721057|20398156|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8272387|NCT01721057|20398157|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8272388|NCT01721057|20398151|P7|NOT COMPLETED|Treatment Period||0
8272389|NCT01721057|20398152|P6|NOT COMPLETED|Treatment Period||0
8272390|NCT01721057|20398153|P5|NOT COMPLETED|Treatment Period||0
8272391|NCT01721057|20398154|P4|NOT COMPLETED|Treatment Period||0
8272392|NCT01721057|20398155|P3|NOT COMPLETED|Treatment Period||23
8272393|NCT01721057|20398156|P2|NOT COMPLETED|Treatment Period||19
8272394|NCT01721057|20398157|P1|NOT COMPLETED|Treatment Period||28
8272395|NCT01721057|20398151|P7|COMPLETED|Treatment Period||0
8272396|NCT01721057|20398152|P6|COMPLETED|Treatment Period||0
8272397|NCT01721057|20398153|P5|COMPLETED|Treatment Period||0
8272398|NCT01721057|20398154|P4|COMPLETED|Treatment Period||0
8272399|NCT01721057|20398155|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
8272400|NCT01721057|20398156|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
8272401|NCT01721057|20398157|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
8272402|NCT01721057|20398151|P7|Rescued|Treatment Period||0
8272403|NCT01721057|20398152|P6|Rescued|Treatment Period||0
8272404|NCT01721057|20398153|P5|Rescued|Treatment Period||0
8272405|NCT01721057|20398154|P4|Rescued|Treatment Period||0
8272406|NCT01721057|20398155|P3|Rescued|Treatment Period||15
8272407|NCT01721057|20398156|P2|Rescued|Treatment Period||21
8272408|NCT01721057|20398157|P1|Rescued|Treatment Period||55
8272409|NCT01721057|20398151|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272410|NCT01721057|20398152|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272411|NCT01721057|20398153|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272412|NCT01721057|20398154|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272413|NCT01721057|20398155|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
8272414|NCT01721057|20398156|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
8272415|NCT01721057|20398157|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
8272416|NCT01721057|20398151|P7|STARTED|Treatment Period||0
8272417|NCT01721057|20398152|P6|STARTED|Treatment Period||0
8272418|NCT01721057|20398153|P5|STARTED|Treatment Period||0
8272419|NCT01721057|20398154|P4|STARTED|Treatment Period||0
8272420|NCT01721057|20398155|P3|STARTED|Treatment Period||227
8272421|NCT01721057|20398156|P2|STARTED|Treatment Period||229
8272422|NCT01721057|20398157|P1|STARTED|Treatment Period||228
8272423|NCT01721044|20398230|P3|NOT COMPLETED|Follow Up||0
8272424|NCT01721044|20398231|P2|NOT COMPLETED|Follow Up||0
8272425|NCT01721044|20398232|P1|NOT COMPLETED|Follow Up||0
8272426|NCT01721044|20398230|P3|COMPLETED|Follow Up||20
8272427|NCT01721044|20398231|P2|COMPLETED|Follow Up||9
8272428|NCT01721044|20398232|P1|COMPLETED|Follow Up||19
8272429|NCT01721044|20398230|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
8272430|NCT01721044|20398231|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
8272431|NCT01721044|20398232|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
8272432|NCT01721044|20398230|P3|NOT COMPLETED|Treatment Period||19
8272433|NCT01721044|20398231|P2|NOT COMPLETED|Treatment Period||17
8272434|NCT01721044|20398232|P1|NOT COMPLETED|Treatment Period||32
8272435|NCT01721044|20398230|P3|COMPLETED|Treatment Period||158
8272436|NCT01721044|20398231|P2|COMPLETED|Treatment Period||157
8272437|NCT01721044|20398232|P1|COMPLETED|Treatment Period||144
8272438|NCT01721044|20398230|P3|Rescue Week 16-24|Treatment Period||33
8272439|NCT01721044|20398231|P2|Rescue Week 16-24|Treatment Period||38
8272440|NCT01721044|20398232|P1|Rescue Week 16-24|Treatment Period||56
8272441|NCT01721044|20398230|P3|STARTED|Treatment Period||177
8272442|NCT01721044|20398231|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
8272443|NCT01721044|20398232|P1|STARTED|Treatment Period||176
8272444|NCT01720797|20398305|P2|NOT COMPLETED|Overall Study||0
8272445|NCT01720797|20398306|P1|NOT COMPLETED|Overall Study||3
8272446|NCT01720797|20398305|P2|COMPLETED|Overall Study||9
8272447|NCT01720797|20398306|P1|COMPLETED|Overall Study||9
8272448|NCT01720797|20398305|P2|STARTED|Overall Study||9
8272449|NCT01720797|20398306|P1|STARTED|Overall Study||12
8272450|NCT01720667|20398314|P2|NOT COMPLETED|Overall Study||1
8272451|NCT01720667|20398315|P1|NOT COMPLETED|Overall Study||4
8272452|NCT01720667|20398314|P2|COMPLETED|Overall Study||41
8272453|NCT01720667|20398315|P1|COMPLETED|Overall Study||60
8272454|NCT01720667|20398314|P2|Modified ITT|Overall Study||30
8272455|NCT01720667|20398315|P1|Modified ITT|Overall Study||53
8272456|NCT01720667|20398314|P2|Received 2nd Infusion of Alternate Drug|Overall Study||6
8272457|NCT01720667|20398315|P1|Received 2nd Infusion of Alternate Drug|Overall Study||27
8272458|NCT01720667|20398314|P2|Recieved Alternate Intervention|Overall Study||10
8272459|NCT01720667|20398315|P1|Recieved Alternate Intervention|Overall Study||45
8272460|NCT01720667|20398314|P2|Recieved Second Infusion of Same Drug|Overall Study||20
8272461|NCT01720667|20398315|P1|Recieved Second Infusion of Same Drug|Overall Study||50
8272462|NCT01720667|20398314|P2|STARTED|Overall Study||42
8272463|NCT01720667|20398315|P1|STARTED|Overall Study||64
8272464|NCT01720602|20398329|P1|NOT COMPLETED|Overall Study||5
8272465|NCT01720602|20398329|P1|COMPLETED|Overall Study||10
8272466|NCT01720602|20398329|P1|STARTED|Overall Study||15
8272467|NCT01720524|20398339|P2|NOT COMPLETED|Part B||14
8272468|NCT01720524|20398340|P1|NOT COMPLETED|Part B||7
8272469|NCT01720524|20398339|P2|COMPLETED|Part B||12
8272470|NCT01720524|20398340|P1|COMPLETED|Part B||20
8272471|NCT01720524|20398339|P2|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
8272472|NCT01720524|20398340|P1|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
8272473|NCT01720524|20398339|P2|NOT COMPLETED|Part A||12
8272474|NCT01720524|20398340|P1|NOT COMPLETED|Part A||7
8272475|NCT01720524|20398339|P2|COMPLETED|Part A||18
8272476|NCT01720524|20398340|P1|COMPLETED|Part A||22
8272477|NCT01720524|20398339|P2|STARTED|Part A||30
8272478|NCT01720524|20398340|P1|STARTED|Part A||29
8272479|NCT01720446|20398373|P4|NOT COMPLETED|Overall Study||20
8272480|NCT01720446|20398374|P3|NOT COMPLETED|Overall Study||20
8272481|NCT01720446|20398375|P2|NOT COMPLETED|Overall Study||11
8272482|NCT01720446|20398376|P1|NOT COMPLETED|Overall Study||14
8272483|NCT01720446|20398373|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
8272484|NCT01720446|20398374|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
8272485|NCT01720446|20398375|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
8272573|NCT01719783|20398607|P1|COMPLETED|Dose 1||30
8272486|NCT01720446|20398376|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
8272487|NCT01720446|20398373|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
8272488|NCT01720446|20398374|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
8272489|NCT01720446|20398375|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
8272490|NCT01720446|20398376|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
8272491|NCT01720446|20398373|P4|STARTED|Overall Study||825
8272492|NCT01720446|20398374|P3|STARTED|Overall Study||824
8272493|NCT01720446|20398375|P2|STARTED|Overall Study||822
8272494|NCT01720446|20398376|P1|STARTED|Overall Study||826
8272495|NCT01720316|20398437|P2|NOT COMPLETED|Open-label Glycine||0
8272496|NCT01720316|20398438|P1|NOT COMPLETED|Open-label Glycine||0
8272497|NCT01720316|20398437|P2|COMPLETED|Open-label Glycine||1
8272498|NCT01720316|20398438|P1|COMPLETED|Open-label Glycine||1
8272499|NCT01720316|20398437|P2|STARTED|Open-label Glycine||1
8272500|NCT01720316|20398438|P1|STARTED|Open-label Glycine||1
8272501|NCT01720316|20398437|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
8272502|NCT01720316|20398438|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
8272503|NCT01720316|20398437|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
8272504|NCT01720316|20398438|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
8272505|NCT01720316|20398437|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
8272506|NCT01720316|20398438|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
8272507|NCT01720277|20398486|P2|NOT COMPLETED|Overall Study||558
8272508|NCT01720277|20398487|P1|NOT COMPLETED|Overall Study||503
8272509|NCT01720277|20398486|P2|COMPLETED|Overall Study|intent-to-treat approach|938
8272510|NCT01720277|20398487|P1|COMPLETED|Overall Study|intent-to-treat approach|958
8272511|NCT01720277|20398486|P2|STARTED|Overall Study||1496
8272512|NCT01720277|20398487|P1|STARTED|Overall Study||1461
8272513|NCT01720264|20398497|P1|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
8272514|NCT01720264|20398497|P1|COMPLETED|Post-transplant (Day 16) to 1 Year||2
8272515|NCT01720264|20398497|P1|STARTED|Post-transplant (Day 16) to 1 Year||14
8272516|NCT01720264|20398497|P1|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
8272517|NCT01720264|20398497|P1|COMPLETED|Transplant With Sitagliptin for 15 Days||14
8272518|NCT01720264|20398497|P1|STARTED|Transplant With Sitagliptin for 15 Days||15
8272519|NCT01720251|20398507|P3|NOT COMPLETED|Overall Study||0
8272520|NCT01720251|20398508|P2|NOT COMPLETED|Overall Study||2
8272521|NCT01720251|20398509|P1|NOT COMPLETED|Overall Study||1
8272522|NCT01720251|20398507|P3|COMPLETED|Overall Study||82
8272523|NCT01720251|20398508|P2|COMPLETED|Overall Study||77
8272524|NCT01720251|20398509|P1|COMPLETED|Overall Study||78
8272525|NCT01720251|20398507|P3|STARTED|Overall Study||82
8272526|NCT01720251|20398508|P2|STARTED|Overall Study||79
8272527|NCT01720251|20398509|P1|STARTED|Overall Study||79
8272528|NCT01720225|20398519|P2|NOT COMPLETED|Overall Study||1
8272529|NCT01720225|20398520|P1|NOT COMPLETED|Overall Study||3
8272530|NCT01720225|20398519|P2|COMPLETED|Overall Study||39
8272531|NCT01720225|20398520|P1|COMPLETED|Overall Study||70
8272532|NCT01720225|20398519|P2|STARTED|Overall Study||40
8272533|NCT01720225|20398520|P1|STARTED|Overall Study||73
8272534|NCT01720173|20398528|P1|NOT COMPLETED|Overall Study||0
8272535|NCT01720173|20398528|P1|COMPLETED|Overall Study||30
8272536|NCT01720173|20398528|P1|STARTED|Overall Study||30
8272537|NCT01720069|20398539|P3|NOT COMPLETED|Overall Study||15
8272538|NCT01720069|20398540|P2|NOT COMPLETED|Overall Study||15
8272539|NCT01720069|20398541|P1|NOT COMPLETED|Overall Study||5
8272540|NCT01720069|20398539|P3|COMPLETED|Overall Study||48
8272541|NCT01720069|20398540|P2|COMPLETED|Overall Study||56
8272542|NCT01720069|20398541|P1|COMPLETED|Overall Study||57
8272543|NCT01720069|20398539|P3|Full Anaylsis Set|Overall Study||63
8272544|NCT01720069|20398540|P2|Full Anaylsis Set|Overall Study||71
8272545|NCT01720069|20398541|P1|Full Anaylsis Set|Overall Study||62
8272546|NCT01720069|20398539|P3|STARTED|Overall Study||63
8272547|NCT01720069|20398540|P2|STARTED|Overall Study||71
8272548|NCT01720069|20398541|P1|STARTED|Overall Study||62
8272549|NCT01720043|20398567|P1|NOT COMPLETED|Overall Study||1
8272550|NCT01720043|20398567|P1|COMPLETED|Overall Study||7
8272551|NCT01720043|20398567|P1|STARTED|Overall Study||8
8272552|NCT01719900|20398573|P2|NOT COMPLETED|Overall Study||2
8272553|NCT01719900|20398574|P1|NOT COMPLETED|Overall Study||7
8272554|NCT01719900|20398573|P2|COMPLETED|Overall Study||22
8272555|NCT01719900|20398574|P1|COMPLETED|Overall Study||22
8272556|NCT01719900|20398573|P2|STARTED|Overall Study||24
8272557|NCT01719900|20398574|P1|STARTED|Overall Study||29
8272558|NCT01719861|20398596|P1|NOT COMPLETED|Cycle 2||1
8272559|NCT01719861|20398596|P1|COMPLETED|Cycle 2||1
8272560|NCT01719861|20398596|P1|STARTED|Cycle 2||2
8272561|NCT01719861|20398596|P1|NOT COMPLETED|Cycle 1||4
8272562|NCT01719861|20398596|P1|COMPLETED|Cycle 1||2
8272563|NCT01719861|20398596|P1|STARTED|Cycle 1||6
8272564|NCT01719783|20398606|P2|NOT COMPLETED|Dose 2||0
8272565|NCT01719783|20398607|P1|NOT COMPLETED|Dose 2||1
8272566|NCT01719783|20398606|P2|COMPLETED|Dose 2||10
8272567|NCT01719783|20398607|P1|COMPLETED|Dose 2||29
8272568|NCT01719783|20398606|P2|STARTED|Dose 2||10
8272569|NCT01719783|20398607|P1|STARTED|Dose 2||30
8272570|NCT01719783|20398606|P2|NOT COMPLETED|Dose 1||0
8272571|NCT01719783|20398607|P1|NOT COMPLETED|Dose 1||0
8272572|NCT01719783|20398606|P2|COMPLETED|Dose 1||10
8272574|NCT01719783|20398606|P2|STARTED|Dose 1||10
8272575|NCT01719783|20398607|P1|STARTED|Dose 1||30
8272576|NCT01719757|20398693|P1|NOT COMPLETED|Overall Study||101
8272577|NCT01719757|20398693|P1|COMPLETED|Overall Study||258
8272578|NCT01719757|20398693|P1|STARTED|Overall Study||359
8272579|NCT01719744|20398701|P1|NOT COMPLETED|Overall Study||0
8272580|NCT01719744|20398701|P1|COMPLETED|Overall Study||25
8272581|NCT01719744|20398701|P1|STARTED|Overall Study||25
8272582|NCT01719653|20398712|P5|NOT COMPLETED|Overall Study||21
8272583|NCT01719653|20398713|P4|NOT COMPLETED|Overall Study||18
8272584|NCT01719653|20398714|P3|NOT COMPLETED|Overall Study||18
8272585|NCT01719653|20398715|P2|NOT COMPLETED|Overall Study||13
8272586|NCT01719653|20398716|P1|NOT COMPLETED|Overall Study||9
8272587|NCT01719653|20398712|P5|COMPLETED|Overall Study||200
8272588|NCT01719653|20398713|P4|COMPLETED|Overall Study||200
8272589|NCT01719653|20398714|P3|COMPLETED|Overall Study||200
8272590|NCT01719653|20398715|P2|COMPLETED|Overall Study||200
8272591|NCT01719653|20398716|P1|COMPLETED|Overall Study||200
8272592|NCT01719653|20398712|P5|STARTED|Overall Study||221
8272593|NCT01719653|20398713|P4|STARTED|Overall Study||218
8272594|NCT01719653|20398714|P3|STARTED|Overall Study||218
8272595|NCT01719653|20398715|P2|STARTED|Overall Study||213
8272596|NCT01719653|20398716|P1|STARTED|Overall Study||209
8272597|NCT01719367|20398738|P2|NOT COMPLETED|Overall Study||0
8272598|NCT01719367|20398739|P1|NOT COMPLETED|Overall Study||0
8272599|NCT01719367|20398738|P2|COMPLETED|Overall Study||19
8272600|NCT01719367|20398739|P1|COMPLETED|Overall Study||19
8272601|NCT01719367|20398738|P2|STARTED|Overall Study||19
8272602|NCT01719367|20398739|P1|STARTED|Overall Study||19
8272603|NCT01719224|20398747|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
8272604|NCT01719224|20398748|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
8272605|NCT01719224|20398747|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
8272606|NCT01719224|20398748|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
8272607|NCT01719224|20398747|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
8272608|NCT01719224|20398748|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
8272609|NCT01719224|20398747|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
8272610|NCT01719224|20398748|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
8272611|NCT01719224|20398747|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
8272612|NCT01719224|20398748|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
8272613|NCT01719224|20398747|P2|STARTED|Intervention 1: Sleeping Position 1||18
8272614|NCT01719224|20398748|P1|STARTED|Intervention 1: Sleeping Position 1||18
8272615|NCT01719172|20398757|P1|NOT COMPLETED|Overall Study||2
8272616|NCT01719172|20398757|P1|COMPLETED|Overall Study||28
8272617|NCT01719172|20398757|P1|STARTED|Overall Study||30
8272618|NCT01719003|20398771|P9|NOT COMPLETED|Overall Study||4
8272619|NCT01719003|20398772|P8|NOT COMPLETED|Overall Study||20
8272620|NCT01719003|20398773|P7|NOT COMPLETED|Overall Study||20
8272621|NCT01719003|20398774|P6|NOT COMPLETED|Overall Study||12
8272622|NCT01719003|20398775|P5|NOT COMPLETED|Overall Study||17
8272623|NCT01719003|20398776|P4|NOT COMPLETED|Overall Study||13
8272624|NCT01719003|20398777|P3|NOT COMPLETED|Overall Study||17
8272625|NCT01719003|20398778|P2|NOT COMPLETED|Overall Study||17
8272626|NCT01719003|20398779|P1|NOT COMPLETED|Overall Study||9
8272627|NCT01719003|20398771|P9|COMPLETED|Overall Study||49
8272628|NCT01719003|20398772|P8|COMPLETED|Overall Study||151
8272629|NCT01719003|20398773|P7|COMPLETED|Overall Study||150
8272630|NCT01719003|20398774|P6|COMPLETED|Overall Study||160
8272631|NCT01719003|20398775|P5|COMPLETED|Overall Study||150
8272632|NCT01719003|20398776|P4|COMPLETED|Overall Study||156
8272633|NCT01719003|20398777|P3|COMPLETED|Overall Study||154
8272634|NCT01719003|20398778|P2|COMPLETED|Overall Study||153
8272635|NCT01719003|20398779|P1|COMPLETED|Overall Study||161
8272636|NCT01719003|20398771|P9|STARTED|Overall Study||53
8272637|NCT01719003|20398772|P8|STARTED|Overall Study||171
8272638|NCT01719003|20398773|P7|STARTED|Overall Study||170
8272639|NCT01719003|20398774|P6|STARTED|Overall Study||172
8272640|NCT01719003|20398775|P5|STARTED|Overall Study||167
8272641|NCT01719003|20398776|P4|STARTED|Overall Study||169
8272642|NCT01719003|20398777|P3|STARTED|Overall Study||171
8272643|NCT01719003|20398778|P2|STARTED|Overall Study||170
8272644|NCT01719003|20398779|P1|STARTED|Overall Study||170
8272645|NCT01718691|20398816|P2|NOT COMPLETED|Overall Study||1
8272646|NCT01718691|20398817|P1|NOT COMPLETED|Overall Study||18
8272647|NCT01718691|20398816|P2|COMPLETED|Overall Study||9
8272648|NCT01718691|20398817|P1|COMPLETED|Overall Study||42
8272649|NCT01718691|20398816|P2|STARTED|Overall Study||10
8272650|NCT01718691|20398817|P1|STARTED|Overall Study||60
8272651|NCT01718535|20398860|P10|NOT COMPLETED|Overall Study||0
8272652|NCT01718535|20398861|P9|NOT COMPLETED|Overall Study||0
8272653|NCT01718535|20398862|P8|NOT COMPLETED|Overall Study||0
8272654|NCT01718535|20398863|P7|NOT COMPLETED|Overall Study||0
8272655|NCT01718535|20398864|P6|NOT COMPLETED|Overall Study||0
8272656|NCT01718535|20398865|P5|NOT COMPLETED|Overall Study||0
8272657|NCT01718535|20398866|P4|NOT COMPLETED|Overall Study||1
8272658|NCT01718535|20398867|P3|NOT COMPLETED|Overall Study||0
8272659|NCT01718535|20398868|P2|NOT COMPLETED|Overall Study||0
8272660|NCT01718535|20398869|P1|NOT COMPLETED|Overall Study||1
8272661|NCT01718535|20398860|P10|COMPLETED|Overall Study||1
8272662|NCT01718535|20398861|P9|COMPLETED|Overall Study||15
8272663|NCT01718535|20398862|P8|COMPLETED|Overall Study||6
8272664|NCT01718535|20398863|P7|COMPLETED|Overall Study||11
8272665|NCT01718535|20398864|P6|COMPLETED|Overall Study||40
8272666|NCT01718535|20398865|P5|COMPLETED|Overall Study||1
8272667|NCT01718535|20398866|P4|COMPLETED|Overall Study||7
8272668|NCT01718535|20398867|P3|COMPLETED|Overall Study||19
8272669|NCT01718535|20398868|P2|COMPLETED|Overall Study||95
8272670|NCT01718535|20398869|P1|COMPLETED|Overall Study||130
8272671|NCT01718535|20398860|P10|First Pass|Overall Study||1
8272672|NCT01718535|20398861|P9|First Pass|Overall Study||15
8272673|NCT01718535|20398862|P8|First Pass|Overall Study||6
8272674|NCT01718535|20398863|P7|First Pass|Overall Study||11
8272675|NCT01718535|20398864|P6|First Pass|Overall Study||39
8272676|NCT01718535|20398865|P5|First Pass|Overall Study||1
8272677|NCT01718535|20398866|P4|First Pass|Overall Study||7
8272678|NCT01718535|20398867|P3|First Pass|Overall Study||19
8272679|NCT01718535|20398868|P2|First Pass|Overall Study||94
8272680|NCT01718535|20398869|P1|First Pass|Overall Study||128
8272681|NCT01718535|20398860|P10|STARTED|Overall Study||1
8272682|NCT01718535|20398861|P9|STARTED|Overall Study||15
8272683|NCT01718535|20398862|P8|STARTED|Overall Study||6
8272684|NCT01718535|20398863|P7|STARTED|Overall Study||11
8272685|NCT01718535|20398864|P6|STARTED|Overall Study||40
8272686|NCT01718535|20398865|P5|STARTED|Overall Study||1
8272687|NCT01718535|20398866|P4|STARTED|Overall Study||8
8272688|NCT01718535|20398867|P3|STARTED|Overall Study||19
8272689|NCT01718535|20398868|P2|STARTED|Overall Study||95
8272690|NCT01718535|20398869|P1|STARTED|Overall Study||131
8272691|NCT01718522|20398891|P1|NOT COMPLETED|Overall Study||8
8272692|NCT01718522|20398891|P1|COMPLETED|Overall Study||67
8272693|NCT01718522|20398891|P1|STARTED|Overall Study||75
8272694|NCT01718509|20398907|P2|NOT COMPLETED|Overall Study||48
8272695|NCT01718509|20398908|P1|NOT COMPLETED|Overall Study||48
8272696|NCT01718509|20398907|P2|COMPLETED|Overall Study||147
8272697|NCT01718509|20398908|P1|COMPLETED|Overall Study||147
8272698|NCT01718509|20398907|P2|STARTED|Overall Study||195
8272699|NCT01718509|20398908|P1|STARTED|Overall Study||195
8272700|NCT01718483|20398954|P2|NOT COMPLETED|Overall Study||34
8272701|NCT01718483|20398955|P1|NOT COMPLETED|Overall Study||34
8272702|NCT01718483|20398954|P2|COMPLETED|Overall Study||158
8272703|NCT01718483|20398955|P1|COMPLETED|Overall Study||157
8272704|NCT01718483|20398954|P2|Treated|Overall Study||192
8272705|NCT01718483|20398955|P1|Treated|Overall Study||187
8272706|NCT01718483|20398954|P2|STARTED|Overall Study||192
8272707|NCT01718483|20398955|P1|STARTED|Overall Study||191
8272708|NCT01718444|20399001|P2|NOT COMPLETED|Overall Study||0
8272709|NCT01718444|20399002|P1|NOT COMPLETED|Overall Study||0
8272710|NCT01718444|20399001|P2|COMPLETED|Overall Study||0
8272711|NCT01718444|20399002|P1|COMPLETED|Overall Study||0
8272712|NCT01718444|20399001|P2|STARTED|Overall Study||0
8272713|NCT01718444|20399002|P1|STARTED|Overall Study||0
8272714|NCT01718353|20399010|P2|NOT COMPLETED|Overall Study||5
8272715|NCT01718353|20399011|P1|NOT COMPLETED|Overall Study||12
8272716|NCT01718353|20399010|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
8272717|NCT01718353|20399011|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
8272718|NCT01718353|20399010|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
8272719|NCT01718353|20399011|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
8272720|NCT01718353|20399010|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
8272721|NCT01718353|20399011|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
8272722|NCT01718353|20399010|P2|Treated|Overall Study||22
8272723|NCT01718353|20399011|P1|Treated|Overall Study||39
8272724|NCT01718353|20399010|P2|STARTED|Overall Study||22
8272725|NCT01718353|20399011|P1|STARTED|Overall Study||41
8272726|NCT01718028|20399029|P2|NOT COMPLETED|Overall Study||0
8272727|NCT01718028|20399030|P1|NOT COMPLETED|Overall Study||0
8272728|NCT01718028|20399029|P2|COMPLETED|Overall Study||24
8272729|NCT01718028|20399030|P1|COMPLETED|Overall Study||25
8272730|NCT01718028|20399029|P2|STARTED|Overall Study||24
8272731|NCT01718028|20399030|P1|STARTED|Overall Study||25
8272732|NCT01717989|20399042|P1|NOT COMPLETED|Overall Study||1066
8272733|NCT01717989|20399042|P1|COMPLETED|Overall Study||1182
8272734|NCT01717989|20399042|P1|STARTED|Overall Study||2248
8272735|NCT01717976|20399110|P2|NOT COMPLETED|Overall Study||1
8272736|NCT01717976|20399111|P1|NOT COMPLETED|Overall Study||0
8272737|NCT01717976|20399110|P2|COMPLETED|Overall Study||256
8272738|NCT01717976|20399111|P1|COMPLETED|Overall Study||257
8272739|NCT01717976|20399110|P2|STARTED|Overall Study||257
8272740|NCT01717976|20399111|P1|STARTED|Overall Study||257
8272741|NCT01717898|20399125|P4|NOT COMPLETED|Overall Study||0
8272742|NCT01717898|20399126|P3|NOT COMPLETED|Overall Study||0
8272743|NCT01717898|20399127|P2|NOT COMPLETED|Overall Study||0
8272744|NCT01717898|20399128|P1|NOT COMPLETED|Overall Study||6
8272745|NCT01717898|20399125|P4|COMPLETED|Overall Study||0
8272746|NCT01717898|20399126|P3|COMPLETED|Overall Study||0
8272747|NCT01717898|20399127|P2|COMPLETED|Overall Study||0
8272748|NCT01717898|20399128|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272749|NCT01717898|20399125|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272750|NCT01717898|20399126|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272751|NCT01717898|20399127|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272752|NCT01717898|20399128|P1|STARTED|Overall Study||6
8272753|NCT01717872|20399155|P2|NOT COMPLETED|Overall Study||0
8272754|NCT01717872|20399156|P1|NOT COMPLETED|Overall Study||0
8272755|NCT01717872|20399155|P2|COMPLETED|Overall Study||25
8272756|NCT01717872|20399156|P1|COMPLETED|Overall Study||25
8272757|NCT01717872|20399155|P2|STARTED|Overall Study||25
8272758|NCT01717872|20399156|P1|STARTED|Overall Study||25
8272759|NCT01717859|20399166|P1|NOT COMPLETED|Overall Study||10
8272760|NCT01717859|20399166|P1|COMPLETED|Overall Study||44
8272761|NCT01717859|20399166|P1|3 Month|Overall Study||50
8272762|NCT01717859|20399166|P1|STARTED|Overall Study||54
8272763|NCT01717768|20399187|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272764|NCT01717768|20399188|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272765|NCT01717768|20399189|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
8272766|NCT01717768|20399190|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272767|NCT01717768|20399191|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
8272768|NCT01717768|20399192|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272769|NCT01717768|20399193|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272770|NCT01717768|20399194|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272771|NCT01717768|20399195|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272772|NCT01717768|20399196|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272773|NCT01717768|20399197|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272774|NCT01717768|20399198|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272775|NCT01717768|20399187|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272776|NCT01717768|20399188|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272777|NCT01717768|20399189|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
8272778|NCT01717768|20399190|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272779|NCT01717768|20399191|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
8272780|NCT01717768|20399192|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272781|NCT01717768|20399193|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272782|NCT01717768|20399194|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272783|NCT01717768|20399195|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272784|NCT01717768|20399196|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272785|NCT01717768|20399197|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272786|NCT01717768|20399198|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272787|NCT01717768|20399187|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272788|NCT01717768|20399188|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272789|NCT01717768|20399189|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
8272790|NCT01717768|20399190|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272791|NCT01717768|20399191|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
8272792|NCT01717768|20399192|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272793|NCT01717768|20399193|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272794|NCT01717768|20399194|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272795|NCT01717768|20399195|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272796|NCT01717768|20399196|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272797|NCT01717768|20399197|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272798|NCT01717768|20399198|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272799|NCT01717768|20399187|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
8272800|NCT01717768|20399188|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272801|NCT01717768|20399189|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272802|NCT01717768|20399190|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272803|NCT01717768|20399191|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272804|NCT01717768|20399192|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272805|NCT01717768|20399193|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272806|NCT01717768|20399194|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272807|NCT01717768|20399195|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272808|NCT01717768|20399196|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272809|NCT01717768|20399197|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272810|NCT01717768|20399198|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272811|NCT01717768|20399187|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
8272812|NCT01717768|20399188|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272813|NCT01717768|20399189|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272814|NCT01717768|20399190|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272815|NCT01717768|20399191|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272816|NCT01717768|20399192|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
8272817|NCT01717768|20399193|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272818|NCT01717768|20399194|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272819|NCT01717768|20399195|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272820|NCT01717768|20399196|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272821|NCT01717768|20399197|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272822|NCT01717768|20399198|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272823|NCT01717768|20399187|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272824|NCT01717768|20399188|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272825|NCT01717768|20399189|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272826|NCT01717768|20399190|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272827|NCT01717768|20399191|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272828|NCT01717768|20399192|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
8272829|NCT01717768|20399193|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272830|NCT01717768|20399194|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272831|NCT01717768|20399195|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272832|NCT01717768|20399196|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272833|NCT01717768|20399197|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272834|NCT01717768|20399198|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272835|NCT01717768|20399187|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272836|NCT01717768|20399188|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272837|NCT01717768|20399189|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272838|NCT01717768|20399190|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272839|NCT01717768|20399191|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272840|NCT01717768|20399192|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272841|NCT01717768|20399193|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272842|NCT01717768|20399194|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272843|NCT01717768|20399195|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272844|NCT01717768|20399196|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272845|NCT01717768|20399197|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272846|NCT01717768|20399198|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272847|NCT01717768|20399187|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272848|NCT01717768|20399188|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272849|NCT01717768|20399189|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272850|NCT01717768|20399190|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272851|NCT01717768|20399191|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272852|NCT01717768|20399192|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272853|NCT01717768|20399193|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272854|NCT01717768|20399194|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272855|NCT01717768|20399195|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
8272856|NCT01717768|20399196|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272857|NCT01717768|20399197|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272858|NCT01717768|20399198|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272859|NCT01717768|20399187|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272860|NCT01717768|20399188|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272861|NCT01717768|20399189|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272862|NCT01717768|20399190|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272863|NCT01717768|20399191|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272864|NCT01717768|20399192|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272865|NCT01717768|20399193|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272866|NCT01717768|20399194|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272867|NCT01717768|20399195|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
8272868|NCT01717768|20399196|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272869|NCT01717768|20399197|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272870|NCT01717768|20399198|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272871|NCT01717768|20399187|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272872|NCT01717768|20399188|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272873|NCT01717768|20399189|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272874|NCT01717768|20399190|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272875|NCT01717768|20399191|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272876|NCT01717768|20399192|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272877|NCT01717768|20399193|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272878|NCT01717768|20399194|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272879|NCT01717768|20399195|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272880|NCT01717768|20399196|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272881|NCT01717768|20399197|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272882|NCT01717768|20399198|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272883|NCT01717768|20399187|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272884|NCT01717768|20399188|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272885|NCT01717768|20399189|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272886|NCT01717768|20399190|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272887|NCT01717768|20399191|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272888|NCT01717768|20399192|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272889|NCT01717768|20399193|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272890|NCT01717768|20399194|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272891|NCT01717768|20399195|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
8272892|NCT01717768|20399196|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272893|NCT01717768|20399197|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272894|NCT01717768|20399198|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272895|NCT01717768|20399187|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272896|NCT01717768|20399188|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272897|NCT01717768|20399189|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272898|NCT01717768|20399190|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272899|NCT01717768|20399191|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272900|NCT01717768|20399192|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272901|NCT01717768|20399193|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272902|NCT01717768|20399194|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272903|NCT01717768|20399195|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
8272904|NCT01717768|20399196|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272905|NCT01717768|20399197|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272906|NCT01717768|20399198|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272907|NCT01717768|20399187|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272908|NCT01717768|20399188|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272909|NCT01717768|20399189|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272910|NCT01717768|20399190|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272911|NCT01717768|20399191|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272912|NCT01717768|20399192|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272913|NCT01717768|20399193|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272914|NCT01717768|20399194|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272915|NCT01717768|20399195|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272916|NCT01717768|20399196|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272917|NCT01717768|20399197|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272918|NCT01717768|20399198|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272919|NCT01717768|20399187|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272920|NCT01717768|20399188|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272921|NCT01717768|20399189|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272922|NCT01717768|20399190|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272923|NCT01717768|20399191|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272924|NCT01717768|20399192|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272925|NCT01717768|20399193|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272926|NCT01717768|20399194|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272927|NCT01717768|20399195|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
8272928|NCT01717768|20399196|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272929|NCT01717768|20399197|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272930|NCT01717768|20399198|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272931|NCT01717768|20399187|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272932|NCT01717768|20399188|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272933|NCT01717768|20399189|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272934|NCT01717768|20399190|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272935|NCT01717768|20399191|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272936|NCT01717768|20399192|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272937|NCT01717768|20399193|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272938|NCT01717768|20399194|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272939|NCT01717768|20399195|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
8272940|NCT01717768|20399196|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272941|NCT01717768|20399197|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272942|NCT01717768|20399198|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272943|NCT01717768|20399187|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272944|NCT01717768|20399188|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272945|NCT01717768|20399189|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272946|NCT01717768|20399190|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272947|NCT01717768|20399191|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272948|NCT01717768|20399192|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272949|NCT01717768|20399193|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272950|NCT01717768|20399194|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272951|NCT01717768|20399195|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272952|NCT01717768|20399196|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272953|NCT01717768|20399197|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272954|NCT01717768|20399198|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272955|NCT01717768|20399187|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
8272956|NCT01717768|20399188|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
8272957|NCT01717768|20399189|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
8272958|NCT01717768|20399190|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
8272959|NCT01717768|20399191|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
8272960|NCT01717768|20399192|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
8272961|NCT01717768|20399193|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
8272962|NCT01717768|20399194|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
8272963|NCT01717768|20399195|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
8272964|NCT01717768|20399196|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
8272965|NCT01717768|20399197|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
8272966|NCT01717768|20399198|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
8272967|NCT01717768|20399187|P12|STARTED|Part 2 (Duration of 15 Days)||0
8272968|NCT01717768|20399188|P11|STARTED|Part 2 (Duration of 15 Days)||0
8272969|NCT01717768|20399189|P10|STARTED|Part 2 (Duration of 15 Days)||0
8272970|NCT01717768|20399190|P9|STARTED|Part 2 (Duration of 15 Days)||0
8272971|NCT01717768|20399191|P8|STARTED|Part 2 (Duration of 15 Days)||0
8272972|NCT01717768|20399192|P7|STARTED|Part 2 (Duration of 15 Days)||0
8272973|NCT01717768|20399193|P6|STARTED|Part 2 (Duration of 15 Days)||0
8272974|NCT01717768|20399194|P5|STARTED|Part 2 (Duration of 15 Days)||0
8272975|NCT01717768|20399195|P4|STARTED|Part 2 (Duration of 15 Days)||0
8272976|NCT01717768|20399196|P3|STARTED|Part 2 (Duration of 15 Days)||17
8272977|NCT01717768|20399197|P2|STARTED|Part 2 (Duration of 15 Days)||0
8272978|NCT01717768|20399198|P1|STARTED|Part 2 (Duration of 15 Days)||0
8272979|NCT01717768|20399187|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272980|NCT01717768|20399188|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272981|NCT01717768|20399189|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272982|NCT01717768|20399190|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272983|NCT01717768|20399191|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272984|NCT01717768|20399192|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272985|NCT01717768|20399193|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272986|NCT01717768|20399194|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272987|NCT01717768|20399195|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272988|NCT01717768|20399196|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272989|NCT01717768|20399197|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
8272990|NCT01717768|20399198|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272991|NCT01717768|20399187|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
8272992|NCT01717768|20399188|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
8272993|NCT01717768|20399189|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
8272994|NCT01717768|20399190|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
8272995|NCT01717768|20399191|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
8272996|NCT01717768|20399192|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
8272997|NCT01717768|20399193|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
8272998|NCT01717768|20399194|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
8272999|NCT01717768|20399195|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
8273000|NCT01717768|20399196|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
8273001|NCT01717768|20399197|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
8273002|NCT01717768|20399198|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
8273003|NCT01717768|20399187|P12|STARTED|Part 1 (Duration of 15 Days)||0
8273004|NCT01717768|20399188|P11|STARTED|Part 1 (Duration of 15 Days)||0
8273005|NCT01717768|20399189|P10|STARTED|Part 1 (Duration of 15 Days)||0
8273006|NCT01717768|20399190|P9|STARTED|Part 1 (Duration of 15 Days)||0
8273007|NCT01717768|20399191|P8|STARTED|Part 1 (Duration of 15 Days)||0
8273008|NCT01717768|20399192|P7|STARTED|Part 1 (Duration of 15 Days)||0
8273009|NCT01717768|20399193|P6|STARTED|Part 1 (Duration of 15 Days)||0
8273010|NCT01717768|20399194|P5|STARTED|Part 1 (Duration of 15 Days)||0
8273011|NCT01717768|20399195|P4|STARTED|Part 1 (Duration of 15 Days)||0
8273012|NCT01717768|20399196|P3|STARTED|Part 1 (Duration of 15 Days)||0
8273013|NCT01717768|20399197|P2|STARTED|Part 1 (Duration of 15 Days)||17
8273014|NCT01717768|20399198|P1|STARTED|Part 1 (Duration of 15 Days)||17
8273015|NCT01717742|20399238|P2|NOT COMPLETED|Overall Study||2
8273016|NCT01717742|20399239|P1|NOT COMPLETED|Overall Study||5
8273017|NCT01717742|20399238|P2|COMPLETED|Overall Study||47
8273018|NCT01717742|20399239|P1|COMPLETED|Overall Study||43
8273019|NCT01717742|20399238|P2|STARTED|Overall Study||49
8273020|NCT01717742|20399239|P1|STARTED|Overall Study||48
8273021|NCT01717638|20399278|P13|NOT COMPLETED|Overall Study||19
8273022|NCT01717638|20399279|P12|NOT COMPLETED|Overall Study||0
8273023|NCT01717638|20399280|P11|NOT COMPLETED|Overall Study||0
8273024|NCT01717638|20399281|P10|NOT COMPLETED|Overall Study||1
8273025|NCT01717638|20399282|P9|NOT COMPLETED|Overall Study||2
8273026|NCT01717638|20399283|P8|NOT COMPLETED|Overall Study||1
8273027|NCT01717638|20399284|P7|NOT COMPLETED|Overall Study||2
8273028|NCT01717638|20399285|P6|NOT COMPLETED|Overall Study||1
8273029|NCT01717638|20399286|P5|NOT COMPLETED|Overall Study||1
8273030|NCT01717638|20399287|P4|NOT COMPLETED|Overall Study||0
8273031|NCT01717638|20399288|P3|NOT COMPLETED|Overall Study||1
8273032|NCT01717638|20399289|P2|NOT COMPLETED|Overall Study||1
8273033|NCT01717638|20399290|P1|NOT COMPLETED|Overall Study||0
8273034|NCT01717638|20399278|P13|COMPLETED|Overall Study||190
8273035|NCT01717638|20399279|P12|COMPLETED|Overall Study||12
8273036|NCT01717638|20399280|P11|COMPLETED|Overall Study||11
8273037|NCT01717638|20399281|P10|COMPLETED|Overall Study||99
8273038|NCT01717638|20399282|P9|COMPLETED|Overall Study||26
8273039|NCT01717638|20399283|P8|COMPLETED|Overall Study||28
8273040|NCT01717638|20399284|P7|COMPLETED|Overall Study||41
8273041|NCT01717638|20399285|P6|COMPLETED|Overall Study||54
8273042|NCT01717638|20399286|P5|COMPLETED|Overall Study||63
8273043|NCT01717638|20399287|P4|COMPLETED|Overall Study||66
8273044|NCT01717638|20399288|P3|COMPLETED|Overall Study||59
8273045|NCT01717638|20399289|P2|COMPLETED|Overall Study||60
8273046|NCT01717638|20399290|P1|COMPLETED|Overall Study||67
8273047|NCT01717638|20399278|P13|STARTED|Overall Study||209
8273048|NCT01717638|20399279|P12|STARTED|Overall Study||12
8273049|NCT01717638|20399280|P11|STARTED|Overall Study||11
8273050|NCT01717638|20399281|P10|STARTED|Overall Study||100
8273051|NCT01717638|20399282|P9|STARTED|Overall Study||28
8273052|NCT01717638|20399283|P8|STARTED|Overall Study||29
8273053|NCT01717638|20399284|P7|STARTED|Overall Study||43
8273054|NCT01717638|20399285|P6|STARTED|Overall Study||55
8273055|NCT01717638|20399286|P5|STARTED|Overall Study||64
8273056|NCT01717638|20399287|P4|STARTED|Overall Study||66
8273057|NCT01717638|20399288|P3|STARTED|Overall Study||60
8273058|NCT01717638|20399289|P2|STARTED|Overall Study||61
8273059|NCT01717638|20399290|P1|STARTED|Overall Study||67
8273060|NCT01717521|20399432|P1|NOT COMPLETED|Overall Study||0
8273061|NCT01717521|20399432|P1|COMPLETED|Overall Study||20
8273062|NCT01717521|20399432|P1|STARTED|Overall Study||20
8273063|NCT01717482|20399451|P2|NOT COMPLETED|Overall Study||0
8273064|NCT01717482|20399452|P1|NOT COMPLETED|Overall Study||4
8273065|NCT01717482|20399451|P2|COMPLETED|Overall Study||2
8273066|NCT01717482|20399452|P1|COMPLETED|Overall Study||0
8273067|NCT01717482|20399451|P2|STARTED|Overall Study||2
8273068|NCT01717482|20399452|P1|STARTED|Overall Study||4
8273069|NCT01717456|20399466|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
8273070|NCT01717456|20399467|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
8273071|NCT01717456|20399466|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
8273072|NCT01717456|20399467|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
8273073|NCT01717456|20399466|P2|STARTED|Follow-Up 6 Months After End of Tx||6
8273074|NCT01717456|20399467|P1|STARTED|Follow-Up 6 Months After End of Tx||11
8273075|NCT01717456|20399466|P2|NOT COMPLETED|End of Treatment||2
8273076|NCT01717456|20399467|P1|NOT COMPLETED|End of Treatment||0
8273077|NCT01717456|20399466|P2|COMPLETED|End of Treatment||6
8273078|NCT01717456|20399467|P1|COMPLETED|End of Treatment||11
8273079|NCT01717456|20399466|P2|STARTED|End of Treatment||8
8273080|NCT01717456|20399467|P1|STARTED|End of Treatment||11
8273081|NCT01717391|20399535|P1|NOT COMPLETED|Overall Study||9
8273082|NCT01717391|20399535|P1|COMPLETED|Overall Study||27
8273083|NCT01717391|20399535|P1|STARTED|Overall Study||36
8273164|NCT01717313|20399847|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
8273165|NCT01717313|20399848|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
8273166|NCT01717313|20399847|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
8273167|NCT01717313|20399848|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
8273168|NCT01717313|20399847|P2|STARTED|Phase B (Weeks 24 to 54)||151
8273169|NCT01717313|20399848|P1|STARTED|Phase B (Weeks 24 to 54)||146
8273170|NCT01717313|20399847|P2|NOT COMPLETED|Interphase||0
8273171|NCT01717313|20399848|P1|NOT COMPLETED|Interphase||1
8273172|NCT01717313|20399847|P2|COMPLETED|Interphase||151
8273173|NCT01717313|20399848|P1|COMPLETED|Interphase||146
8273174|NCT01717313|20399847|P2|STARTED|Interphase||151
8273175|NCT01717313|20399848|P1|STARTED|Interphase||147
8273176|NCT01717313|20399847|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
8273177|NCT01717313|20399848|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
8273178|NCT01717313|20399847|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
8273179|NCT01717313|20399848|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
8273180|NCT01717313|20399847|P2|STARTED|Phase A (Weeks 0 to 24)||164
8273181|NCT01717313|20399848|P1|STARTED|Phase A (Weeks 0 to 24)||165
8273182|NCT01717287|20399886|P2|NOT COMPLETED|Overall Study||3
8273183|NCT01717287|20399887|P1|NOT COMPLETED|Overall Study||0
8273184|NCT01717287|20399886|P2|COMPLETED|Overall Study||25
8273185|NCT01717287|20399887|P1|COMPLETED|Overall Study||4
8273186|NCT01717287|20399886|P2|STARTED|Overall Study||28
8273187|NCT01717287|20399887|P1|STARTED|Overall Study||4
8273188|NCT01717209|20399909|P1|NOT COMPLETED|Overall Study||0
8273189|NCT01717209|20399909|P1|COMPLETED|Overall Study||14
8273190|NCT01717209|20399909|P1|STARTED|Overall Study||14
8273194|NCT01717040|20399927|P2|NOT COMPLETED|Overall Study||5
8273195|NCT01717040|20399928|P1|NOT COMPLETED|Overall Study||5
8273196|NCT01717040|20399927|P2|COMPLETED|Overall Study||15
8273197|NCT01717040|20399928|P1|COMPLETED|Overall Study||12
8273198|NCT01717040|20399927|P2|STARTED|Overall Study||20
8273199|NCT01717040|20399928|P1|STARTED|Overall Study||17
8273200|NCT01717014|20399934|P1|NOT COMPLETED|Overall Study||0
8273201|NCT01717014|20399934|P1|COMPLETED|Overall Study||8
8273202|NCT01717014|20399934|P1|STARTED|Overall Study||8
8273203|NCT01717001|20399944|P2|NOT COMPLETED|Overall Study||4
8273204|NCT01717001|20399945|P1|NOT COMPLETED|Overall Study||6
8273205|NCT01717001|20399944|P2|COMPLETED|Overall Study||24
8273206|NCT01717001|20399945|P1|COMPLETED|Overall Study||32
8273207|NCT01717001|20399944|P2|STARTED|Overall Study||28
8273208|NCT01717001|20399945|P1|STARTED|Overall Study||38
8273209|NCT01716754|20399955|P4|NOT COMPLETED|Overall Study||8
8273210|NCT01716754|20399956|P3|NOT COMPLETED|Overall Study||14
8273211|NCT01716754|20399957|P2|NOT COMPLETED|Overall Study||4
8273212|NCT01716754|20399958|P1|NOT COMPLETED|Overall Study||11
8273213|NCT01716754|20399955|P4|COMPLETED|Overall Study||89
8273214|NCT01716754|20399956|P3|COMPLETED|Overall Study||121
8273215|NCT01716754|20399957|P2|COMPLETED|Overall Study||36
8273216|NCT01716754|20399958|P1|COMPLETED|Overall Study||188
8273217|NCT01716754|20399955|P4|Safety Set|Overall Study||96
8273218|NCT01716754|20399956|P3|Safety Set|Overall Study||131
8273219|NCT01716754|20399957|P2|Safety Set|Overall Study||40
8273220|NCT01716754|20399958|P1|Safety Set|Overall Study||199
8273221|NCT01716754|20399955|P4|FAS|Overall Study||96
8273222|NCT01716754|20399956|P3|FAS|Overall Study||131
8273223|NCT01716754|20399957|P2|FAS|Overall Study||40
8273224|NCT01716754|20399958|P1|FAS|Overall Study||199
8273225|NCT01716754|20399955|P4|STARTED|Overall Study||97
8273226|NCT01716754|20399956|P3|STARTED|Overall Study||135
8273227|NCT01716754|20399957|P2|STARTED|Overall Study||40
8273228|NCT01716754|20399958|P1|STARTED|Overall Study||199
8273229|NCT01716715|20399981|P2|NOT COMPLETED|Overall Study||4
8273230|NCT01716715|20399982|P1|NOT COMPLETED|Overall Study||2
8273231|NCT01716715|20399981|P2|COMPLETED|Overall Study||50
8273232|NCT01716715|20399982|P1|COMPLETED|Overall Study||55
8273233|NCT01716715|20399981|P2|STARTED|Overall Study||54
8273234|NCT01716715|20399982|P1|STARTED|Overall Study||57
8273235|NCT01716663|20399998|P1|NOT COMPLETED|Overall Study||6
8273236|NCT01716663|20399998|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
8273237|NCT01716663|20399998|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
8273238|NCT01716663|20399998|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
8273239|NCT01716585|20400008|P2|NOT COMPLETED|Open-label Treatment||7
8273240|NCT01716585|20400009|P1|NOT COMPLETED|Open-label Treatment||0
8273241|NCT01716585|20400008|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
8273242|NCT01716585|20400009|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
8273243|NCT01716585|20400008|P2|STARTED|Open-label Treatment||157
8273244|NCT01716585|20400009|P1|STARTED|Open-label Treatment|not applicable to this arm|0
8273245|NCT01716585|20400008|P2|NOT COMPLETED|Double-blind Treatment||2
8273246|NCT01716585|20400009|P1|NOT COMPLETED|Double-blind Treatment||13
8273247|NCT01716585|20400008|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
8273248|NCT01716585|20400009|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
8273249|NCT01716585|20400008|P2|Randomized But Not Treated|Double-blind Treatment||1
8273250|NCT01716585|20400009|P1|Randomized But Not Treated|Double-blind Treatment||4
8273251|NCT01716585|20400008|P2|STARTED|Double-blind Treatment||159
8273252|NCT01716585|20400009|P1|STARTED|Double-blind Treatment||477
8273253|NCT01716559|20400021|P1|NOT COMPLETED|Overall Study||111
8273254|NCT01716559|20400021|P1|COMPLETED|Overall Study||49
8273255|NCT01716559|20400021|P1|STARTED|Overall Study||160
8273256|NCT01716533|20400033|P4|NOT COMPLETED|Overall Study||8
8273257|NCT01716533|20400034|P3|NOT COMPLETED|Overall Study||5
8273258|NCT01716533|20400035|P2|NOT COMPLETED|Overall Study||0
8273259|NCT01716533|20400036|P1|NOT COMPLETED|Overall Study||0
8273260|NCT01716533|20400033|P4|COMPLETED|Overall Study||1
8273261|NCT01716533|20400034|P3|COMPLETED|Overall Study||0
8273262|NCT01716533|20400035|P2|COMPLETED|Overall Study||25
8273263|NCT01716533|20400036|P1|COMPLETED|Overall Study||7
8273264|NCT01716533|20400033|P4|STARTED|Overall Study||9
8273265|NCT01716533|20400034|P3|STARTED|Overall Study||5
8273266|NCT01716533|20400035|P2|STARTED|Overall Study||25
8273267|NCT01716533|20400036|P1|STARTED|Overall Study||7
8273268|NCT01716520|20400090|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
8273269|NCT01716520|20400091|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273270|NCT01716520|20400092|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273271|NCT01716520|20400093|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8273272|NCT01716520|20400094|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273273|NCT01716520|20400095|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273274|NCT01716520|20400090|P6|COMPLETED|Treatment Period 3 (14 Days)||23
8273275|NCT01716520|20400091|P5|COMPLETED|Treatment Period 3 (14 Days)||29
8273276|NCT01716520|20400092|P4|COMPLETED|Treatment Period 3 (14 Days)||28
8273277|NCT01716520|20400093|P3|COMPLETED|Treatment Period 3 (14 Days)||25
8273278|NCT01716520|20400094|P2|COMPLETED|Treatment Period 3 (14 Days)||27
8273279|NCT01716520|20400095|P1|COMPLETED|Treatment Period 3 (14 Days)||27
8273280|NCT01716520|20400090|P6|STARTED|Treatment Period 3 (14 Days)||25
8273281|NCT01716520|20400091|P5|STARTED|Treatment Period 3 (14 Days)||29
8273282|NCT01716520|20400092|P4|STARTED|Treatment Period 3 (14 Days)||28
8273283|NCT01716520|20400093|P3|STARTED|Treatment Period 3 (14 Days)||26
8273284|NCT01716520|20400094|P2|STARTED|Treatment Period 3 (14 Days)||27
8273285|NCT01716520|20400095|P1|STARTED|Treatment Period 3 (14 Days)||27
8273286|NCT01716520|20400090|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
8273287|NCT01716520|20400091|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8273288|NCT01716520|20400092|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8273289|NCT01716520|20400093|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
8273290|NCT01716520|20400094|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
8273291|NCT01716520|20400095|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
8273292|NCT01716520|20400090|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
8273293|NCT01716520|20400091|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
8273294|NCT01716520|20400092|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
8273295|NCT01716520|20400093|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
8273296|NCT01716520|20400094|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
8273297|NCT01716520|20400095|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
8273298|NCT01716520|20400090|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
8273299|NCT01716520|20400091|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
8273300|NCT01716520|20400092|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
8273301|NCT01716520|20400093|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
8273302|NCT01716520|20400094|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
8273303|NCT01716520|20400095|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
8273304|NCT01716520|20400090|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273305|NCT01716520|20400091|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8273306|NCT01716520|20400092|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8273307|NCT01716520|20400093|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273308|NCT01716520|20400094|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273309|NCT01716520|20400095|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273310|NCT01716520|20400090|P6|COMPLETED|Treatment Period 2 (14 Days)||27
8273311|NCT01716520|20400091|P5|COMPLETED|Treatment Period 2 (14 Days)||29
8273312|NCT01716520|20400092|P4|COMPLETED|Treatment Period 2 (14 Days)||28
8273313|NCT01716520|20400093|P3|COMPLETED|Treatment Period 2 (14 Days)||27
8273314|NCT01716520|20400094|P2|COMPLETED|Treatment Period 2 (14 Days)||28
8273315|NCT01716520|20400095|P1|COMPLETED|Treatment Period 2 (14 Days)||29
8273316|NCT01716520|20400090|P6|STARTED|Treatment Period 2 (14 Days)||27
8273317|NCT01716520|20400091|P5|STARTED|Treatment Period 2 (14 Days)||31
8273318|NCT01716520|20400092|P4|STARTED|Treatment Period 2 (14 Days)||29
8273319|NCT01716520|20400093|P3|STARTED|Treatment Period 2 (14 Days)||27
8273320|NCT01716520|20400094|P2|STARTED|Treatment Period 2 (14 Days)||28
8273321|NCT01716520|20400095|P1|STARTED|Treatment Period 2 (14 Days)||29
8273322|NCT01716520|20400090|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
8273323|NCT01716520|20400091|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8273324|NCT01716520|20400092|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8273325|NCT01716520|20400093|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8273326|NCT01716520|20400094|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8273327|NCT01716520|20400095|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8273328|NCT01716520|20400090|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
8273329|NCT01716520|20400091|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
8273330|NCT01716520|20400092|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
8273331|NCT01716520|20400093|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
8273332|NCT01716520|20400094|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
8273333|NCT01716520|20400095|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
8273334|NCT01716520|20400090|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
8273335|NCT01716520|20400091|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
8273336|NCT01716520|20400092|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
8273337|NCT01716520|20400093|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
8273338|NCT01716520|20400094|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
8273339|NCT01716520|20400095|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
8273340|NCT01716520|20400090|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8273341|NCT01716520|20400091|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8273342|NCT01716520|20400092|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8273343|NCT01716520|20400093|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8273344|NCT01716520|20400094|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8273345|NCT01716520|20400095|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8273346|NCT01716520|20400090|P6|COMPLETED|Treatment Period 1 (14 Days)||29
8273347|NCT01716520|20400091|P5|COMPLETED|Treatment Period 1 (14 Days)||31
8273348|NCT01716520|20400092|P4|COMPLETED|Treatment Period 1 (14 Days)||29
8273349|NCT01716520|20400093|P3|COMPLETED|Treatment Period 1 (14 Days)||28
8273350|NCT01716520|20400094|P2|COMPLETED|Treatment Period 1 (14 Days)||29
8273351|NCT01716520|20400095|P1|COMPLETED|Treatment Period 1 (14 Days)||29
8273352|NCT01716520|20400090|P6|STARTED|Treatment Period 1 (14 Days)||30
8273353|NCT01716520|20400091|P5|STARTED|Treatment Period 1 (14 Days)||31
8273354|NCT01716520|20400092|P4|STARTED|Treatment Period 1 (14 Days)||30
8273355|NCT01716520|20400093|P3|STARTED|Treatment Period 1 (14 Days)||30
8273356|NCT01716520|20400094|P2|STARTED|Treatment Period 1 (14 Days)||30
8273357|NCT01716520|20400095|P1|STARTED|Treatment Period 1 (14 Days)||31
8273358|NCT01716468|20400111|P1|NOT COMPLETED|Overall Study||6
8273359|NCT01716468|20400111|P1|COMPLETED|Overall Study||11
8273360|NCT01716468|20400111|P1|STARTED|Overall Study||17
8273361|NCT01716455|20400121|P6|NOT COMPLETED|Overall Study||0
8273362|NCT01716455|20400122|P5|NOT COMPLETED|Overall Study||0
8273363|NCT01716455|20400123|P4|NOT COMPLETED|Overall Study||0
8273364|NCT01716455|20400124|P3|NOT COMPLETED|Overall Study||0
8273365|NCT01716455|20400125|P2|NOT COMPLETED|Overall Study||0
8273366|NCT01716455|20400126|P1|NOT COMPLETED|Overall Study||0
8273367|NCT01716455|20400121|P6|COMPLETED|Overall Study||8
8273368|NCT01716455|20400122|P5|COMPLETED|Overall Study||26
8273369|NCT01716455|20400123|P4|COMPLETED|Overall Study||8
8273370|NCT01716455|20400124|P3|COMPLETED|Overall Study||8
8273371|NCT01716455|20400125|P2|COMPLETED|Overall Study||8
8273372|NCT01716455|20400126|P1|COMPLETED|Overall Study||8
8273373|NCT01716455|20400121|P6|STARTED|Overall Study||8
8273374|NCT01716455|20400122|P5|STARTED|Overall Study||26
8273375|NCT01716455|20400123|P4|STARTED|Overall Study||8
8273376|NCT01716455|20400124|P3|STARTED|Overall Study||8
8273377|NCT01716455|20400125|P2|STARTED|Overall Study||8
8273378|NCT01716455|20400126|P1|STARTED|Overall Study||8
8273379|NCT01716234|20400150|P7|NOT COMPLETED|Overall Study||0
8273380|NCT01716234|20400151|P6|NOT COMPLETED|Overall Study||14
8273381|NCT01716234|20400152|P5|NOT COMPLETED|Overall Study||5
8273382|NCT01716234|20400153|P4|NOT COMPLETED|Overall Study||12
8273383|NCT01716234|20400154|P3|NOT COMPLETED|Overall Study||5
8273384|NCT01716234|20400155|P2|NOT COMPLETED|Overall Study||10
8273385|NCT01716234|20400156|P1|NOT COMPLETED|Overall Study||10
8273386|NCT01716234|20400150|P7|COMPLETED|Overall Study||1
8273387|NCT01716234|20400151|P6|COMPLETED|Overall Study||18
8273388|NCT01716234|20400152|P5|COMPLETED|Overall Study||10
8273389|NCT01716234|20400153|P4|COMPLETED|Overall Study||16
8273390|NCT01716234|20400154|P3|COMPLETED|Overall Study||15
8273391|NCT01716234|20400155|P2|COMPLETED|Overall Study||12
8273392|NCT01716234|20400156|P1|COMPLETED|Overall Study||14
8273393|NCT01716234|20400150|P7|Treated|Overall Study||1
8273394|NCT01716234|20400151|P6|Treated|Overall Study||30
8273395|NCT01716234|20400152|P5|Treated|Overall Study||15
8273396|NCT01716234|20400153|P4|Treated|Overall Study||28
8273397|NCT01716234|20400154|P3|Treated|Overall Study||19
8273398|NCT01716234|20400155|P2|Treated|Overall Study||21
8273399|NCT01716234|20400156|P1|Treated|Overall Study||22
8273400|NCT01716234|20400150|P7|STARTED|Overall Study||1
8273401|NCT01716234|20400151|P6|STARTED|Overall Study||32
8273402|NCT01716234|20400152|P5|STARTED|Overall Study||15
8273403|NCT01716234|20400153|P4|STARTED|Overall Study||28
8273404|NCT01716234|20400154|P3|STARTED|Overall Study||20
8273405|NCT01716234|20400155|P2|STARTED|Overall Study||22
8273406|NCT01716234|20400156|P1|STARTED|Overall Study||24
8273407|NCT01716221|20400193|P1|NOT COMPLETED|Overall Study||0
8273408|NCT01716221|20400193|P1|COMPLETED|Overall Study||1
8273409|NCT01716221|20400193|P1|STARTED|Overall Study||1
8273410|NCT01716169|20400219|P1|NOT COMPLETED|Overall Study||4
8273411|NCT01716169|20400219|P1|COMPLETED|Overall Study||6
8273412|NCT01716169|20400219|P1|Standard of Care Dressings Used|Overall Study||7
8273413|NCT01716169|20400219|P1|STARTED|Overall Study||10
8273414|NCT01716156|20400228|P3|NOT COMPLETED|Overall Study||2
8273415|NCT01716156|20400229|P2|NOT COMPLETED|Overall Study||1
8273416|NCT01716156|20400230|P1|NOT COMPLETED|Overall Study||2
8273417|NCT01716156|20400228|P3|COMPLETED|Overall Study||11
8273418|NCT01716156|20400229|P2|COMPLETED|Overall Study||3
8273419|NCT01716156|20400230|P1|COMPLETED|Overall Study||7
8273420|NCT01716156|20400228|P3|STARTED|Overall Study||13
8273421|NCT01716156|20400229|P2|STARTED|Overall Study||4
8273422|NCT01716156|20400230|P1|STARTED|Overall Study||9
8273423|NCT01716117|20400256|P2|NOT COMPLETED|Overall Study||2
8273424|NCT01716117|20400257|P1|NOT COMPLETED|Overall Study||7
8273425|NCT01716117|20400256|P2|COMPLETED|Overall Study||31
8273426|NCT01716117|20400257|P1|COMPLETED|Overall Study||173
8273427|NCT01716117|20400256|P2|6-Month Visit|Overall Study||32
8273428|NCT01716117|20400257|P1|6-Month Visit|Overall Study||174
8273429|NCT01716117|20400256|P2|1-Month Visit|Overall Study||33
8273430|NCT01716117|20400257|P1|1-Month Visit|Overall Study||176
8273431|NCT01716117|20400256|P2|Discharge|Overall Study||33
8273432|NCT01716117|20400257|P1|Discharge|Overall Study||177
8273433|NCT01716117|20400256|P2|STARTED|Overall Study||33
8273434|NCT01716117|20400257|P1|STARTED|Overall Study||180
8273435|NCT01716104|20400276|P2|NOT COMPLETED|Overall Study||7
8273436|NCT01716104|20400277|P1|NOT COMPLETED|Overall Study||6
8273437|NCT01716104|20400276|P2|COMPLETED|Overall Study||117
8273438|NCT01716104|20400277|P1|COMPLETED|Overall Study||119
8273439|NCT01716104|20400276|P2|STARTED|Overall Study||124
8273440|NCT01716104|20400277|P1|STARTED|Overall Study||125
8273441|NCT01716052|20400303|P2|NOT COMPLETED|Overall Study||1
8273442|NCT01716052|20400304|P1|NOT COMPLETED|Overall Study||1
8273443|NCT01716052|20400303|P2|COMPLETED|Overall Study||0
8273444|NCT01716052|20400304|P1|COMPLETED|Overall Study||0
8273445|NCT01716052|20400303|P2|STARTED|Overall Study||1
8273446|NCT01716052|20400304|P1|STARTED|Overall Study||1
8273447|NCT01716013|20400312|P2|NOT COMPLETED|Overall Study||0
8273448|NCT01716013|20400313|P1|NOT COMPLETED|Overall Study||3
8273449|NCT01716013|20400312|P2|COMPLETED|Overall Study||54
8273450|NCT01716013|20400313|P1|COMPLETED|Overall Study||105
8273451|NCT01716013|20400312|P2|STARTED|Overall Study||54
8273452|NCT01716013|20400313|P1|STARTED|Overall Study||108
8273453|NCT01715948|20400325|P1|NOT COMPLETED|Overall Study||1
8273454|NCT01715948|20400325|P1|COMPLETED|Overall Study||8
8273455|NCT01715948|20400325|P1|STARTED|Overall Study||9
8273456|NCT01715896|20400346|P2|NOT COMPLETED|Overall Study||11
8273457|NCT01715896|20400347|P1|NOT COMPLETED|Overall Study||3
8273458|NCT01715896|20400346|P2|COMPLETED|Overall Study||59
8273459|NCT01715896|20400347|P1|COMPLETED|Overall Study||65
8273460|NCT01715896|20400346|P2|STARTED|Overall Study||70
8273461|NCT01715896|20400347|P1|STARTED|Overall Study||68
8273462|NCT01715883|20400410|P1|NOT COMPLETED|Overall Study||1
8273463|NCT01715883|20400410|P1|COMPLETED|Overall Study||2
8273464|NCT01715883|20400410|P1|STARTED|Overall Study||3
8273465|NCT01715857|20400420|P1|NOT COMPLETED|Overall Study||96
8273466|NCT01715857|20400420|P1|COMPLETED|Overall Study||4004
8273467|NCT01715857|20400420|P1|STARTED|Overall Study||4100
8273468|NCT01715831|20400430|P1|NOT COMPLETED|Overall Study||1
8273469|NCT01715831|20400430|P1|COMPLETED|Overall Study||25
8273470|NCT01715831|20400430|P1|STARTED|Overall Study||26
8273471|NCT01715805|20400446|P4|NOT COMPLETED|Double-Blind or Continued Treatment||48
8273472|NCT01715805|20400447|P3|NOT COMPLETED|Double-Blind or Continued Treatment||56
8273473|NCT01715805|20400448|P2|NOT COMPLETED|Double-Blind or Continued Treatment||39
8273474|NCT01715805|20400449|P1|NOT COMPLETED|Double-Blind or Continued Treatment||0
8273475|NCT01715805|20400446|P4|COMPLETED|Double-Blind or Continued Treatment||222
8273476|NCT01715805|20400447|P3|COMPLETED|Double-Blind or Continued Treatment||213
8273477|NCT01715805|20400448|P2|COMPLETED|Double-Blind or Continued Treatment||222
8273478|NCT01715805|20400449|P1|COMPLETED|Double-Blind or Continued Treatment||0
8273479|NCT01715805|20400446|P4|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
8273480|NCT01715805|20400447|P3|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
8273481|NCT01715805|20400448|P2|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
8273482|NCT01715805|20400449|P1|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
8273483|NCT01715805|20400446|P4|STARTED|Double-Blind or Continued Treatment||270
8273484|NCT01715805|20400447|P3|STARTED|Double-Blind or Continued Treatment||269
8273485|NCT01715805|20400448|P2|STARTED|Double-Blind or Continued Treatment||261
8273486|NCT01715805|20400449|P1|STARTED|Double-Blind or Continued Treatment||0
8273487|NCT01715805|20400446|P4|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8273488|NCT01715805|20400447|P3|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8273489|NCT01715805|20400448|P2|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8273490|NCT01715805|20400449|P1|NOT COMPLETED|Placebo + ADT Lead-in Period||215
8273491|NCT01715805|20400446|P4|COMPLETED|Placebo + ADT Lead-in Period||0
8273492|NCT01715805|20400447|P3|COMPLETED|Placebo + ADT Lead-in Period||0
8273493|NCT01715805|20400448|P2|COMPLETED|Placebo + ADT Lead-in Period||0
8273494|NCT01715805|20400449|P1|COMPLETED|Placebo + ADT Lead-in Period||807
8273495|NCT01715805|20400446|P4|STARTED|Placebo + ADT Lead-in Period||0
8273496|NCT01715805|20400447|P3|STARTED|Placebo + ADT Lead-in Period||0
8273497|NCT01715805|20400448|P2|STARTED|Placebo + ADT Lead-in Period||0
8273498|NCT01715805|20400449|P1|STARTED|Placebo + ADT Lead-in Period||1022
8273499|NCT01715415|20400463|P2|NOT COMPLETED|Open-label Treatment||2
8273500|NCT01715415|20400464|P1|NOT COMPLETED|Open-label Treatment||0
8273501|NCT01715415|20400463|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
8273502|NCT01715415|20400464|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
8273503|NCT01715415|20400463|P2|STARTED|Open-label Treatment||96
8273504|NCT01715415|20400464|P1|STARTED|Open-label Treatment|not applicable to this arm|0
8273505|NCT01715415|20400463|P2|NOT COMPLETED|Double-blind Treatment||2
8273506|NCT01715415|20400464|P1|NOT COMPLETED|Double-blind Treatment||5
8273507|NCT01715415|20400463|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
8273508|NCT01715415|20400464|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
8273509|NCT01715415|20400463|P2|Randomized But Not Treated|Double-blind Treatment||1
8273510|NCT01715415|20400464|P1|Randomized But Not Treated|Double-blind Treatment||0
8273511|NCT01715415|20400463|P2|STARTED|Double-blind Treatment||98
8273512|NCT01715415|20400464|P1|STARTED|Double-blind Treatment||297
8273513|NCT01715298|20400478|P2|NOT COMPLETED|Overall Study||11
8273514|NCT01715298|20400479|P1|NOT COMPLETED|Overall Study||7
8273515|NCT01715298|20400478|P2|COMPLETED|Overall Study||205
8273516|NCT01715298|20400479|P1|COMPLETED|Overall Study||209
8273517|NCT01715298|20400478|P2|Full Analysis Set (FAS)|Overall Study||214
8273518|NCT01715298|20400479|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
8273519|NCT01715298|20400478|P2|STARTED|Overall Study||216
8273520|NCT01715298|20400479|P1|STARTED|Overall Study||216
8273521|NCT01715285|20400517|P3|NOT COMPLETED|Open-label (OL) Extension Phase||72
8273522|NCT01715285|20400518|P2|NOT COMPLETED|Open-label (OL) Extension Phase||0
8273523|NCT01715285|20400519|P1|NOT COMPLETED|Open-label (OL) Extension Phase||157
8273524|NCT01715285|20400517|P3|COMPLETED|Open-label (OL) Extension Phase||0
8273525|NCT01715285|20400518|P2|COMPLETED|Open-label (OL) Extension Phase||0
8273526|NCT01715285|20400519|P1|COMPLETED|Open-label (OL) Extension Phase||0
8273527|NCT01715285|20400517|P3|STARTED|Open-label (OL) Extension Phase||72
8273528|NCT01715285|20400518|P2|STARTED|Open-label (OL) Extension Phase||0
8273529|NCT01715285|20400519|P1|STARTED|Open-label (OL) Extension Phase||157
8273530|NCT01715285|20400517|P3|NOT COMPLETED|Treatment Period||0
8273531|NCT01715285|20400518|P2|NOT COMPLETED|Treatment Period||602
8273532|NCT01715285|20400519|P1|NOT COMPLETED|Treatment Period||597
8273533|NCT01715285|20400517|P3|COMPLETED|Treatment Period||0
8273534|NCT01715285|20400518|P2|COMPLETED|Treatment Period||0
8273535|NCT01715285|20400519|P1|COMPLETED|Treatment Period||0
8273536|NCT01715285|20400517|P3|Safety Population|Treatment Period||0
8273537|NCT01715285|20400518|P2|Safety Population|Treatment Period||602
8273538|NCT01715285|20400519|P1|Safety Population|Treatment Period||597
8273539|NCT01715285|20400517|P3|ITT Population|Treatment Period||0
8273540|NCT01715285|20400518|P2|ITT Population|Treatment Period||602
8273541|NCT01715285|20400519|P1|ITT Population|Treatment Period||597
8273542|NCT01715285|20400517|P3|STARTED|Treatment Period||0
8273543|NCT01715285|20400518|P2|STARTED|Treatment Period||602
8273544|NCT01715285|20400519|P1|STARTED|Treatment Period||597
8273545|NCT01715233|20400538|P1|NOT COMPLETED|Overall Study||0
8273546|NCT01715233|20400538|P1|COMPLETED|Overall Study||21
8273547|NCT01715233|20400538|P1|STARTED|Overall Study||21
8273548|NCT01715207|20400546|P2|NOT COMPLETED|Overall Study||1
8273549|NCT01715207|20400547|P1|NOT COMPLETED|Overall Study||1
8273550|NCT01715207|20400546|P2|COMPLETED|Overall Study||14
8273551|NCT01715207|20400547|P1|COMPLETED|Overall Study||14
8273552|NCT01715207|20400546|P2|STARTED|Overall Study||15
8273553|NCT01715207|20400547|P1|STARTED|Overall Study||15
8273554|NCT01715129|20400555|P1|NOT COMPLETED|Overall Study||9
8273555|NCT01715129|20400555|P1|COMPLETED|Overall Study||117
8273556|NCT01715129|20400555|P1|STARTED|Overall Study||126
8273557|NCT01715064|20400574|P2|NOT COMPLETED|Overall Study||0
8273558|NCT01715064|20400575|P1|NOT COMPLETED|Overall Study||0
8273559|NCT01715064|20400574|P2|COMPLETED|Overall Study||18
8273560|NCT01715064|20400575|P1|COMPLETED|Overall Study||18
8273561|NCT01715064|20400574|P2|STARTED|Overall Study||18
8273562|NCT01715064|20400575|P1|STARTED|Overall Study||18
8273563|NCT01714947|20400581|P1|NOT COMPLETED|Part B||3
8273564|NCT01714947|20400581|P1|COMPLETED|Part B||0
8273565|NCT01714947|20400581|P1|STARTED|Part B||3
8273566|NCT01714947|20400581|P1|NOT COMPLETED|Part A||0
8273567|NCT01714947|20400581|P1|COMPLETED|Part A||3
8273568|NCT01714947|20400581|P1|STARTED|Part A||3
8273569|NCT01714921|20400610|P1|NOT COMPLETED|Overall Study||193
8273570|NCT01714921|20400610|P1|COMPLETED|Overall Study||311
8273571|NCT01714921|20400610|P1|STARTED|Overall Study||504
8273592|NCT01714804|20400719|P2|NOT COMPLETED|Overall Study||0
8273593|NCT01714804|20400720|P1|NOT COMPLETED|Overall Study||1
8273594|NCT01714804|20400719|P2|COMPLETED|Overall Study||30
8273595|NCT01714804|20400720|P1|COMPLETED|Overall Study||29
8273596|NCT01714804|20400719|P2|STARTED|Overall Study||30
8273597|NCT01714804|20400720|P1|STARTED|Overall Study||30
8273598|NCT01714726|20400730|P4|NOT COMPLETED|Open-Label Period||28
8273599|NCT01714726|20400731|P3|NOT COMPLETED|Open-Label Period||19
8273600|NCT01714726|20400732|P2|NOT COMPLETED|Open-Label Period||0
8273601|NCT01714726|20400733|P1|NOT COMPLETED|Open-Label Period||0
8273602|NCT01714726|20400730|P4|COMPLETED|Open-Label Period||24
8273603|NCT01714726|20400731|P3|COMPLETED|Open-Label Period||33
8273604|NCT01714726|20400732|P2|COMPLETED|Open-Label Period||0
8273605|NCT01714726|20400733|P1|COMPLETED|Open-Label Period||0
8273606|NCT01714726|20400730|P4|STARTED|Open-Label Period||52
8273607|NCT01714726|20400731|P3|STARTED|Open-Label Period||52
8273608|NCT01714726|20400732|P2|STARTED|Open-Label Period||0
8273609|NCT01714726|20400733|P1|STARTED|Open-Label Period||0
8273610|NCT01714726|20400730|P4|NOT COMPLETED|Double-Blinded Induction Period||0
8273611|NCT01714726|20400731|P3|NOT COMPLETED|Double-Blinded Induction Period||0
8273612|NCT01714726|20400732|P2|NOT COMPLETED|Double-Blinded Induction Period||7
8273613|NCT01714726|20400733|P1|NOT COMPLETED|Double-Blinded Induction Period||8
8273614|NCT01714726|20400730|P4|COMPLETED|Double-Blinded Induction Period||0
8273615|NCT01714726|20400731|P3|COMPLETED|Double-Blinded Induction Period||0
8273616|NCT01714726|20400732|P2|COMPLETED|Double-Blinded Induction Period||52
8273617|NCT01714726|20400733|P1|COMPLETED|Double-Blinded Induction Period||52
8273618|NCT01714726|20400730|P4|STARTED|Double-Blinded Induction Period||0
8273619|NCT01714726|20400731|P3|STARTED|Double-Blinded Induction Period||0
8273620|NCT01714726|20400732|P2|STARTED|Double-Blinded Induction Period||59
8273621|NCT01714726|20400733|P1|STARTED|Double-Blinded Induction Period||60
8273622|NCT01714687|20400813|P2|NOT COMPLETED|Overall Study||4
8273623|NCT01714687|20400814|P1|NOT COMPLETED|Overall Study||3
8273624|NCT01714687|20400813|P2|COMPLETED|Overall Study||26
8273625|NCT01714687|20400814|P1|COMPLETED|Overall Study||26
8273626|NCT01714687|20400813|P2|STARTED|Overall Study||30
8273627|NCT01714687|20400814|P1|STARTED|Overall Study||29
8273628|NCT01714635|20400838|P3|NOT COMPLETED|Overall Study||2
8273629|NCT01714635|20400839|P2|NOT COMPLETED|Overall Study||0
8273630|NCT01714635|20400840|P1|NOT COMPLETED|Overall Study||2
8273631|NCT01714635|20400838|P3|COMPLETED|Overall Study||146
8273632|NCT01714635|20400839|P2|COMPLETED|Overall Study||150
8273633|NCT01714635|20400840|P1|COMPLETED|Overall Study||145
8273634|NCT01714635|20400838|P3|STARTED|Overall Study||148
8273635|NCT01714635|20400839|P2|STARTED|Overall Study||150
8273636|NCT01714635|20400840|P1|STARTED|Overall Study||147
8273637|NCT01714609|20400856|P2|NOT COMPLETED|Overall Study||0
8273638|NCT01714609|20400857|P1|NOT COMPLETED|Overall Study||1
8273639|NCT01714609|20400856|P2|COMPLETED|Overall Study||5
8273640|NCT01714609|20400857|P1|COMPLETED|Overall Study||4
8273641|NCT01714609|20400856|P2|STARTED|Overall Study||5
8273642|NCT01714609|20400857|P1|STARTED|Overall Study||5
8273643|NCT01714544|20400863|P1|NOT COMPLETED|Overall Study||3
8273644|NCT01714544|20400863|P1|COMPLETED|Overall Study||57
8273645|NCT01714544|20400863|P1|STARTED|Overall Study||60
8273646|NCT01714505|20400867|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
8273647|NCT01714505|20400868|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
8273648|NCT01714505|20400867|P2|COMPLETED|Admission 2 (40 Hours)||9
8273649|NCT01714505|20400868|P1|COMPLETED|Admission 2 (40 Hours)||9
8273650|NCT01714505|20400867|P2|STARTED|Admission 2 (40 Hours)||9
8273651|NCT01714505|20400868|P1|STARTED|Admission 2 (40 Hours)||9
8273652|NCT01714505|20400867|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
8273653|NCT01714505|20400868|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
8273654|NCT01714505|20400867|P2|COMPLETED|Admission 1 (40 Hours)||9
8273655|NCT01714505|20400868|P1|COMPLETED|Admission 1 (40 Hours)||9
8273656|NCT01714505|20400867|P2|STARTED|Admission 1 (40 Hours)||10
8273657|NCT01714505|20400868|P1|STARTED|Admission 1 (40 Hours)||10
8273658|NCT01714492|20400878|P1|NOT COMPLETED|Overall Study||0
8273659|NCT01714492|20400878|P1|COMPLETED|Overall Study||8
8273660|NCT01714492|20400878|P1|STARTED|Overall Study||8
8273661|NCT01714336|20400889|P2|NOT COMPLETED|Overall Study||0
8273662|NCT01714336|20400890|P1|NOT COMPLETED|Overall Study||0
8273663|NCT01714336|20400889|P2|COMPLETED|Overall Study||69
8273664|NCT01714336|20400890|P1|COMPLETED|Overall Study||69
8273665|NCT01714336|20400889|P2|STARTED|Overall Study||69
8273666|NCT01714336|20400890|P1|STARTED|Overall Study||69
8273667|NCT01714323|20400912|P2|NOT COMPLETED|Overall Study||172
8273668|NCT01714323|20400913|P1|NOT COMPLETED|Overall Study||164
8273669|NCT01714323|20400912|P2|COMPLETED|Overall Study||508
8273670|NCT01714323|20400913|P1|COMPLETED|Overall Study||513
8273671|NCT01714323|20400912|P2|STARTED|Overall Study||680
8273672|NCT01714323|20400913|P1|STARTED|Overall Study||677
8273673|NCT01714310|20400934|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
8273674|NCT01714310|20400935|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
8273675|NCT01714310|20400936|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
8273676|NCT01714310|20400934|P3|COMPLETED|Double Blind Adjunctive Treatment||0
8273677|NCT01714310|20400935|P2|COMPLETED|Double Blind Adjunctive Treatment||11
8273678|NCT01714310|20400936|P1|COMPLETED|Double Blind Adjunctive Treatment||10
8273679|NCT01714310|20400934|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
8273680|NCT01714310|20400935|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
8273681|NCT01714310|20400936|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
8273682|NCT01714310|20400934|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
8273683|NCT01714310|20400935|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
8273684|NCT01714310|20400936|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
8273685|NCT01714310|20400934|P3|COMPLETED|Open Lisdexamfetamine Titration||30
8273686|NCT01714310|20400935|P2|COMPLETED|Open Lisdexamfetamine Titration||0
8273687|NCT01714310|20400936|P1|COMPLETED|Open Lisdexamfetamine Titration||0
8273688|NCT01714310|20400934|P3|STARTED|Open Lisdexamfetamine Titration||34
8273689|NCT01714310|20400935|P2|STARTED|Open Lisdexamfetamine Titration||0
8273690|NCT01714310|20400936|P1|STARTED|Open Lisdexamfetamine Titration||0
8273691|NCT01714232|20400983|P1|NOT COMPLETED|Overall Study||0
8273692|NCT01714232|20400983|P1|COMPLETED|Overall Study||106
8273693|NCT01714232|20400983|P1|STARTED|Overall Study||106
8273694|NCT01714063|20400989|P1|NOT COMPLETED|Overall Study||2
8273695|NCT01714063|20400989|P1|COMPLETED|Overall Study||32
8273696|NCT01714063|20400989|P1|STARTED|Overall Study||34
8273697|NCT01714024|20401004|P3|NOT COMPLETED|Overall Study||3
8273698|NCT01714024|20401005|P2|NOT COMPLETED|Overall Study||6
8273699|NCT01714024|20401006|P1|NOT COMPLETED|Overall Study||1
8273700|NCT01714024|20401004|P3|COMPLETED|Overall Study||8
8273701|NCT01714024|20401005|P2|COMPLETED|Overall Study||12
8273702|NCT01714024|20401006|P1|COMPLETED|Overall Study||12
8273703|NCT01714024|20401004|P3|STARTED|Overall Study||11
8273704|NCT01714024|20401005|P2|STARTED|Overall Study||18
8273705|NCT01714024|20401006|P1|STARTED|Overall Study||13
8273706|NCT01713998|20401026|P3|NOT COMPLETED|Overall Study||2
8273707|NCT01713998|20401027|P2|NOT COMPLETED|Overall Study||0
8273708|NCT01713998|20401028|P1|NOT COMPLETED|Overall Study||3
8273709|NCT01713998|20401026|P3|COMPLETED|Overall Study||14
8273710|NCT01713998|20401027|P2|COMPLETED|Overall Study||15
8273711|NCT01713998|20401028|P1|COMPLETED|Overall Study||13
8273712|NCT01713998|20401026|P3|STARTED|Overall Study||16
8273713|NCT01713998|20401027|P2|STARTED|Overall Study||15
8273714|NCT01713998|20401028|P1|STARTED|Overall Study||16
8273715|NCT01713946|20401049|P3|NOT COMPLETED|Overall Study||44
8273716|NCT01713946|20401050|P2|NOT COMPLETED|Overall Study||45
8273717|NCT01713946|20401051|P1|NOT COMPLETED|Overall Study||43
8273718|NCT01713946|20401049|P3|COMPLETED|Overall Study||75
8273719|NCT01713946|20401050|P2|COMPLETED|Overall Study||85
8273720|NCT01713946|20401051|P1|COMPLETED|Overall Study||74
8273721|NCT01713946|20401049|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
8273722|NCT01713946|20401050|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
8273723|NCT01713946|20401051|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
8273724|NCT01713946|20401049|P3|Did Not Continue in Ext Phase|Overall Study||0
8273725|NCT01713946|20401050|P2|Did Not Continue in Ext Phase|Overall Study||3
8273726|NCT01713946|20401051|P1|Did Not Continue in Ext Phase|Overall Study||0
8273727|NCT01713946|20401049|P3|Completed Post-Ext Phase|Overall Study||75
8273728|NCT01713946|20401050|P2|Completed Post-Ext Phase|Overall Study||85
8273729|NCT01713946|20401051|P1|Completed Post-Ext Phase|Overall Study||74
8273730|NCT01713946|20401049|P3|Continued in Post-Ext. Phase|Overall Study||81
8273731|NCT01713946|20401050|P2|Continued in Post-Ext. Phase|Overall Study||90
8273732|NCT01713946|20401051|P1|Continued in Post-Ext. Phase|Overall Study||78
8273733|NCT01713946|20401049|P3|Completed Ext. Phase|Overall Study||81
8273734|NCT01713946|20401050|P2|Completed Ext. Phase|Overall Study||92
8273735|NCT01713946|20401051|P1|Completed Ext. Phase|Overall Study||79
8273736|NCT01713946|20401049|P3|Continued in Ext. Phase|Overall Study||114
8273737|NCT01713946|20401050|P2|Continued in Ext. Phase|Overall Study||119
8273738|NCT01713946|20401051|P1|Continued in Ext. Phase|Overall Study||110
8273739|NCT01713946|20401049|P3|Completed Core Phase|Overall Study||114
8273740|NCT01713946|20401050|P2|Completed Core Phase|Overall Study||122
8273741|NCT01713946|20401051|P1|Completed Core Phase|Overall Study||110
8273742|NCT01713946|20401049|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
8273743|NCT01713946|20401050|P2|STARTED|Overall Study||130
8273744|NCT01713946|20401051|P1|STARTED|Overall Study||117
8273745|NCT01713933|20401142|P1|NOT COMPLETED|Overall Study||6
8273746|NCT01713933|20401142|P1|COMPLETED|Overall Study||31
8273747|NCT01713933|20401142|P1|STARTED|Overall Study||37
8273748|NCT01713868|20401158|P4|NOT COMPLETED|Overall Study||95
8273749|NCT01713868|20401159|P3|NOT COMPLETED|Overall Study||80
8273750|NCT01713868|20401160|P2|NOT COMPLETED|Overall Study||65
8273751|NCT01713868|20401161|P1|NOT COMPLETED|Overall Study||97
8273752|NCT01713868|20401158|P4|COMPLETED|Overall Study||305
8273753|NCT01713868|20401159|P3|COMPLETED|Overall Study||320
8273754|NCT01713868|20401160|P2|COMPLETED|Overall Study||335
8273755|NCT01713868|20401161|P1|COMPLETED|Overall Study||303
8273756|NCT01713868|20401158|P4|STARTED|Overall Study||400
8273757|NCT01713868|20401159|P3|STARTED|Overall Study||400
8273758|NCT01713868|20401160|P2|STARTED|Overall Study||400
8273759|NCT01713868|20401161|P1|STARTED|Overall Study||400
8273760|NCT01713686|20401191|P1|NOT COMPLETED|Overall Study||15
8273761|NCT01713686|20401191|P1|COMPLETED|Overall Study||110
8273762|NCT01713686|20401191|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
8273763|NCT01713660|20401200|P1|NOT COMPLETED|Overall Study||0
8273764|NCT01713660|20401200|P1|COMPLETED|Overall Study||37
8273765|NCT01713660|20401200|P1|STARTED|Overall Study||37
8273766|NCT01713621|20401208|P2|NOT COMPLETED|Overall Study||16
8273767|NCT01713621|20401209|P1|NOT COMPLETED|Overall Study||7
8273768|NCT01713621|20401208|P2|COMPLETED|Overall Study||1
8273769|NCT01713621|20401209|P1|COMPLETED|Overall Study||1
8273770|NCT01713621|20401208|P2|STARTED|Overall Study||17
8273771|NCT01713621|20401209|P1|STARTED|Overall Study||8
8273772|NCT01713608|20401219|P4|NOT COMPLETED|Overall Study||0
8273773|NCT01713608|20401220|P3|NOT COMPLETED|Overall Study||0
8273774|NCT01713608|20401221|P2|NOT COMPLETED|Overall Study||0
8273775|NCT01713608|20401222|P1|NOT COMPLETED|Overall Study||0
8273776|NCT01713608|20401219|P4|COMPLETED|Overall Study||12
8273777|NCT01713608|20401220|P3|COMPLETED|Overall Study||8
8273778|NCT01713608|20401221|P2|COMPLETED|Overall Study||6
8273779|NCT01713608|20401222|P1|COMPLETED|Overall Study||8
8273780|NCT01713608|20401219|P4|STARTED|Overall Study||12
8273781|NCT01713608|20401220|P3|STARTED|Overall Study||8
8273782|NCT01713608|20401221|P2|STARTED|Overall Study||6
8273783|NCT01713608|20401222|P1|STARTED|Overall Study||8
8273784|NCT01713582|20401261|P21|NOT COMPLETED|Overall Study||15
8273785|NCT01713582|20401262|P20|NOT COMPLETED|Overall Study||5
8273786|NCT01713582|20401263|P19|NOT COMPLETED|Overall Study||5
8273787|NCT01713582|20401264|P18|NOT COMPLETED|Overall Study||3
8273788|NCT01713582|20401265|P17|NOT COMPLETED|Overall Study||7
8273789|NCT01713582|20401266|P16|NOT COMPLETED|Overall Study||6
8273790|NCT01713582|20401267|P15|NOT COMPLETED|Overall Study||7
8273791|NCT01713582|20401268|P14|NOT COMPLETED|Overall Study||4
8273792|NCT01713582|20401269|P13|NOT COMPLETED|Overall Study||3
8273793|NCT01713582|20401270|P12|NOT COMPLETED|Overall Study||5
8273794|NCT01713582|20401271|P11|NOT COMPLETED|Overall Study||16
8273795|NCT01713582|20401272|P10|NOT COMPLETED|Overall Study||18
8273796|NCT01713582|20401273|P9|NOT COMPLETED|Overall Study||6
8273797|NCT01713582|20401274|P8|NOT COMPLETED|Overall Study||6
8273798|NCT01713582|20401275|P7|NOT COMPLETED|Overall Study||7
8273799|NCT01713582|20401276|P6|NOT COMPLETED|Overall Study||8
8273800|NCT01713582|20401277|P5|NOT COMPLETED|Overall Study||4
8273801|NCT01713582|20401278|P4|NOT COMPLETED|Overall Study||3
8273802|NCT01713582|20401279|P3|NOT COMPLETED|Overall Study||4
8273803|NCT01713582|20401280|P2|NOT COMPLETED|Overall Study||3
8273804|NCT01713582|20401281|P1|NOT COMPLETED|Overall Study||3
8273805|NCT01713582|20401261|P21|COMPLETED|Overall Study||0
8273806|NCT01713582|20401262|P20|COMPLETED|Overall Study||0
8273807|NCT01713582|20401263|P19|COMPLETED|Overall Study||0
8273808|NCT01713582|20401264|P18|COMPLETED|Overall Study||0
8273809|NCT01713582|20401265|P17|COMPLETED|Overall Study||0
8273810|NCT01713582|20401266|P16|COMPLETED|Overall Study||0
8273811|NCT01713582|20401267|P15|COMPLETED|Overall Study||0
8273812|NCT01713582|20401268|P14|COMPLETED|Overall Study||0
8273813|NCT01713582|20401269|P13|COMPLETED|Overall Study||0
8273814|NCT01713582|20401270|P12|COMPLETED|Overall Study||0
8273815|NCT01713582|20401271|P11|COMPLETED|Overall Study||0
8273816|NCT01713582|20401272|P10|COMPLETED|Overall Study||0
8273817|NCT01713582|20401273|P9|COMPLETED|Overall Study||0
8273818|NCT01713582|20401274|P8|COMPLETED|Overall Study||0
8273819|NCT01713582|20401275|P7|COMPLETED|Overall Study||0
8273820|NCT01713582|20401276|P6|COMPLETED|Overall Study||0
8273821|NCT01713582|20401277|P5|COMPLETED|Overall Study||0
8273822|NCT01713582|20401278|P4|COMPLETED|Overall Study||0
8273823|NCT01713582|20401279|P3|COMPLETED|Overall Study||0
8273824|NCT01713582|20401280|P2|COMPLETED|Overall Study||0
8273825|NCT01713582|20401281|P1|COMPLETED|Overall Study||0
8273826|NCT01713582|20401261|P21|STARTED|Overall Study|Number treated|15
8273827|NCT01713582|20401262|P20|STARTED|Overall Study|Number treated|5
8273828|NCT01713582|20401263|P19|STARTED|Overall Study|Number treated|5
8273829|NCT01713582|20401264|P18|STARTED|Overall Study|Number treated|3
8273830|NCT01713582|20401265|P17|STARTED|Overall Study|Number treated|7
8273831|NCT01713582|20401266|P16|STARTED|Overall Study|Number treated|6
8273832|NCT01713582|20401267|P15|STARTED|Overall Study|Number treated|7
8273833|NCT01713582|20401268|P14|STARTED|Overall Study|Number treated|4
8273834|NCT01713582|20401269|P13|STARTED|Overall Study|Number treated|3
8273835|NCT01713582|20401270|P12|STARTED|Overall Study|Number treated|5
8273836|NCT01713582|20401271|P11|STARTED|Overall Study|Number treated|16
8273837|NCT01713582|20401272|P10|STARTED|Overall Study|Number treated|18
8273838|NCT01713582|20401273|P9|STARTED|Overall Study|Number treated|6
8273839|NCT01713582|20401274|P8|STARTED|Overall Study|Number treated|6
8273840|NCT01713582|20401275|P7|STARTED|Overall Study|Number treated|7
8273841|NCT01713582|20401276|P6|STARTED|Overall Study|Number treated|8
8273842|NCT01713582|20401277|P5|STARTED|Overall Study|Number treated|4
8273843|NCT01713582|20401278|P4|STARTED|Overall Study|Number treated|3
8273844|NCT01713582|20401279|P3|STARTED|Overall Study|Number treated|4
8273845|NCT01713582|20401280|P2|STARTED|Overall Study|Number treated|3
8273846|NCT01713582|20401281|P1|STARTED|Overall Study|Number treated|3
8273847|NCT01713530|20401444|P2|NOT COMPLETED|Overall Study||19
8273848|NCT01713530|20401445|P1|NOT COMPLETED|Overall Study||25
8273849|NCT01713530|20401444|P2|COMPLETED|Overall Study||117
8273850|NCT01713530|20401445|P1|COMPLETED|Overall Study||113
8273851|NCT01713530|20401444|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
8273852|NCT01713530|20401445|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
8273853|NCT01713530|20401444|P2|STARTED|Overall Study||136
8273854|NCT01713530|20401445|P1|STARTED|Overall Study||138
8273855|NCT01713400|20401463|P2|NOT COMPLETED|Overall Study||0
8273856|NCT01713400|20401464|P1|NOT COMPLETED|Overall Study||0
8273857|NCT01713400|20401463|P2|COMPLETED|Overall Study||15
8273858|NCT01713400|20401464|P1|COMPLETED|Overall Study||15
8273859|NCT01713400|20401463|P2|STARTED|Overall Study||15
8273860|NCT01713400|20401464|P1|STARTED|Overall Study||15
8273861|NCT01713348|20401476|P4|NOT COMPLETED|Overall Study||0
8273862|NCT01713348|20401477|P3|NOT COMPLETED|Overall Study||2
8273863|NCT01713348|20401478|P2|NOT COMPLETED|Overall Study||2
8273864|NCT01713348|20401479|P1|NOT COMPLETED|Overall Study||4
8273865|NCT01713348|20401476|P4|COMPLETED|Overall Study||15
8273866|NCT01713348|20401477|P3|COMPLETED|Overall Study||28
8273867|NCT01713348|20401478|P2|COMPLETED|Overall Study||11
8273868|NCT01713348|20401479|P1|COMPLETED|Overall Study||25
8273869|NCT01713348|20401476|P4|STARTED|Overall Study||15
8273870|NCT01713348|20401477|P3|STARTED|Overall Study||30
8273871|NCT01713348|20401478|P2|STARTED|Overall Study||13
8273872|NCT01713348|20401479|P1|STARTED|Overall Study||29
8273873|NCT01713283|20401509|P2|NOT COMPLETED|Overall Study||3
8273874|NCT01713283|20401510|P1|NOT COMPLETED|Overall Study||11
8273875|NCT01713283|20401509|P2|COMPLETED|Overall Study||26
8273876|NCT01713283|20401510|P1|COMPLETED|Overall Study||20
8273877|NCT01713283|20401509|P2|STARTED|Overall Study||29
8273878|NCT01713283|20401510|P1|STARTED|Overall Study||31
8273879|NCT01713036|20401532|P1|NOT COMPLETED|Overall Study||1
8273880|NCT01713036|20401532|P1|COMPLETED|Overall Study||5
8273881|NCT01713036|20401532|P1|STARTED|Overall Study||6
8273882|NCT01712984|20401572|P3|NOT COMPLETED|Overall Study||10
8273883|NCT01712984|20401573|P2|NOT COMPLETED|Overall Study||16
8273884|NCT01712984|20401574|P1|NOT COMPLETED|Overall Study||16
8273885|NCT01712984|20401572|P3|COMPLETED|Overall Study||836
8273886|NCT01712984|20401573|P2|COMPLETED|Overall Study||821
8273887|NCT01712984|20401574|P1|COMPLETED|Overall Study||1656
8273888|NCT01712984|20401572|P3|STARTED|Overall Study||846
8273889|NCT01712984|20401573|P2|STARTED|Overall Study||837
8273890|NCT01712984|20401574|P1|STARTED|Overall Study||1672
8273891|NCT01712854|20401594|P1|NOT COMPLETED|Overall Study||1
8273892|NCT01712854|20401594|P1|COMPLETED|Overall Study||8
8273893|NCT01712854|20401594|P1|STARTED|Overall Study||9
8273894|NCT01712776|20401601|P2|NOT COMPLETED|Overall Study||0
8273895|NCT01712776|20401602|P1|NOT COMPLETED|Overall Study||0
8273896|NCT01712776|20401601|P2|COMPLETED|Overall Study||50
8273897|NCT01712776|20401602|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
8273898|NCT01712776|20401601|P2|STARTED|Overall Study||50
8273899|NCT01712776|20401602|P1|STARTED|Overall Study||50
8273900|NCT01712711|20401610|P2|NOT COMPLETED|Overall Study||0
8273901|NCT01712711|20401611|P1|NOT COMPLETED|Overall Study||0
8273902|NCT01712711|20401610|P2|COMPLETED|Overall Study||20
8273903|NCT01712711|20401611|P1|COMPLETED|Overall Study||20
8273904|NCT01712711|20401610|P2|STARTED|Overall Study||20
8273905|NCT01712711|20401611|P1|STARTED|Overall Study||20
8273906|NCT01712685|20401617|P1|NOT COMPLETED|Overall Study||1
8273907|NCT01712685|20401617|P1|COMPLETED|Overall Study||11
8273908|NCT01712685|20401617|P1|STARTED|Overall Study||12
8273909|NCT01712516|20401633|P4|NOT COMPLETED|Overall Study||13
8273910|NCT01712516|20401634|P3|NOT COMPLETED|Overall Study||6
8273911|NCT01712516|20401635|P2|NOT COMPLETED|Overall Study||10
8273912|NCT01712516|20401636|P1|NOT COMPLETED|Overall Study||6
8273913|NCT01712516|20401633|P4|COMPLETED|Overall Study||236
8273914|NCT01712516|20401634|P3|COMPLETED|Overall Study||245
8273915|NCT01712516|20401635|P2|COMPLETED|Overall Study||241
8273916|NCT01712516|20401636|P1|COMPLETED|Overall Study||244
8273917|NCT01712516|20401633|P4|Full Analysis Set|Overall Study||247
8273918|NCT01712516|20401634|P3|Full Analysis Set|Overall Study||250
8273919|NCT01712516|20401635|P2|Full Analysis Set|Overall Study||251
8273920|NCT01712516|20401636|P1|Full Analysis Set|Overall Study||250
8273921|NCT01712516|20401633|P4|Safety Set|Overall Study||248
8273922|NCT01712516|20401634|P3|Safety Set|Overall Study||251
8273923|NCT01712516|20401635|P2|Safety Set|Overall Study||251
8273924|NCT01712516|20401636|P1|Safety Set|Overall Study||250
8273925|NCT01712516|20401633|P4|STARTED|Overall Study||249
8273926|NCT01712516|20401634|P3|STARTED|Overall Study||251
8273927|NCT01712516|20401635|P2|STARTED|Overall Study||251
8273928|NCT01712516|20401636|P1|STARTED|Overall Study||250
8273929|NCT01712490|20401688|P2|NOT COMPLETED|Overall Study||670
8273930|NCT01712490|20401689|P1|NOT COMPLETED|Overall Study||664
8273931|NCT01712490|20401688|P2|COMPLETED|Overall Study||0
8273932|NCT01712490|20401689|P1|COMPLETED|Overall Study||0
8273933|NCT01712490|20401688|P2|Treated|Overall Study||659
8273934|NCT01712490|20401689|P1|Treated|Overall Study||662
8273935|NCT01712490|20401688|P2|STARTED|Overall Study||670
8273936|NCT01712490|20401689|P1|STARTED|Overall Study||664
8273937|NCT01712438|20401726|P1|NOT COMPLETED|Overall Study||37
8273938|NCT01712438|20401726|P1|COMPLETED|Overall Study||73
8273939|NCT01712438|20401726|P1|SURG Population|Overall Study||24
8273940|NCT01712438|20401726|P1|BLEED Population|Overall Study||94
8273941|NCT01712438|20401726|P1|PROPH Population|Overall Study||103
8273942|NCT01712438|20401726|P1|PP Population|Overall Study||95
8273943|NCT01712438|20401726|P1|ITT Population|Overall Study||108
8273944|NCT01712438|20401726|P1|SAF Population|Overall Study||108
8273945|NCT01712438|20401726|P1|STARTED|Overall Study||110
8273946|NCT01712399|20401736|P1|NOT COMPLETED|Overall Study||397
8273947|NCT01712399|20401736|P1|COMPLETED|Overall Study||0
8273948|NCT01712399|20401736|P1|STARTED|Overall Study||397
8273949|NCT01712360|20401753|P4|NOT COMPLETED|Overall Study||2
8273950|NCT01712360|20401754|P3|NOT COMPLETED|Overall Study||0
8273951|NCT01712360|20401755|P2|NOT COMPLETED|Overall Study||1
8273952|NCT01712360|20401756|P1|NOT COMPLETED|Overall Study||0
8273953|NCT01712360|20401753|P4|COMPLETED|Overall Study||4
8273954|NCT01712360|20401754|P3|COMPLETED|Overall Study||6
8273955|NCT01712360|20401755|P2|COMPLETED|Overall Study||21
8273956|NCT01712360|20401756|P1|COMPLETED|Overall Study||22
8273957|NCT01712360|20401753|P4|STARTED|Overall Study||6
8273958|NCT01712360|20401754|P3|STARTED|Overall Study||6
8273959|NCT01712360|20401755|P2|STARTED|Overall Study||22
8273960|NCT01712360|20401756|P1|STARTED|Overall Study||22
8273961|NCT01712334|20401782|P2|NOT COMPLETED|Treatment Period 2||0
8273962|NCT01712334|20401783|P1|NOT COMPLETED|Treatment Period 2||0
8273963|NCT01712334|20401782|P2|COMPLETED|Treatment Period 2||41
8273964|NCT01712334|20401783|P1|COMPLETED|Treatment Period 2||44
8273965|NCT01712334|20401782|P2|STARTED|Treatment Period 2||41
8273966|NCT01712334|20401783|P1|STARTED|Treatment Period 2||44
8273967|NCT01712334|20401782|P2|NOT COMPLETED|Treatment Period 1||2
8273968|NCT01712334|20401783|P1|NOT COMPLETED|Treatment Period 1||0
8273969|NCT01712334|20401782|P2|COMPLETED|Treatment Period 1||41
8273970|NCT01712334|20401783|P1|COMPLETED|Treatment Period 1||44
8273971|NCT01712334|20401782|P2|Received Treatment|Treatment Period 1||41
8273972|NCT01712334|20401783|P1|Received Treatment|Treatment Period 1||44
8273973|NCT01712334|20401782|P2|STARTED|Treatment Period 1||43
8273974|NCT01712334|20401783|P1|STARTED|Treatment Period 1||44
8273975|NCT01712256|20401791|P1|NOT COMPLETED|Overall Study||1
8273976|NCT01712256|20401791|P1|COMPLETED|Overall Study||32
8273977|NCT01712256|20401791|P1|STARTED|Overall Study||33
8273978|NCT01712230|20401803|P3|NOT COMPLETED|Overall Study||7
8273979|NCT01712230|20401804|P2|NOT COMPLETED|Overall Study||4
8273980|NCT01712230|20401805|P1|NOT COMPLETED|Overall Study||2
8273981|NCT01712230|20401803|P3|COMPLETED|Overall Study||11
8273982|NCT01712230|20401804|P2|COMPLETED|Overall Study||14
8273983|NCT01712230|20401805|P1|COMPLETED|Overall Study||9
8273984|NCT01712230|20401803|P3|STARTED|Overall Study||18
8273985|NCT01712230|20401804|P2|STARTED|Overall Study||18
8273986|NCT01712230|20401805|P1|STARTED|Overall Study||11
8273987|NCT01712204|20401821|P2|NOT COMPLETED|Overall Study||5
8273988|NCT01712204|20401822|P1|NOT COMPLETED|Overall Study||8
8273989|NCT01712204|20401821|P2|COMPLETED|Overall Study||36
8273990|NCT01712204|20401822|P1|COMPLETED|Overall Study||33
8273991|NCT01712204|20401821|P2|STARTED|Overall Study||41
8273992|NCT01712204|20401822|P1|STARTED|Overall Study||41
8273993|NCT01712178|20401830|P2|NOT COMPLETED|Overall Study||3
8273994|NCT01712178|20401831|P1|NOT COMPLETED|Overall Study||1
8273995|NCT01712178|20401830|P2|COMPLETED|Overall Study||47
8273996|NCT01712178|20401831|P1|COMPLETED|Overall Study||49
8273997|NCT01712178|20401830|P2|STARTED|Overall Study||50
8273998|NCT01712178|20401831|P1|STARTED|Overall Study||50
8273999|NCT01712074|20401856|P3|NOT COMPLETED|Double Blind Period||8
8274000|NCT01712074|20401857|P2|NOT COMPLETED|Double Blind Period||14
8274001|NCT01712074|20401858|P1|NOT COMPLETED|Double Blind Period||0
8274002|NCT01712074|20401856|P3|COMPLETED|Double Blind Period||86
8274003|NCT01712074|20401857|P2|COMPLETED|Double Blind Period||77
8274004|NCT01712074|20401858|P1|COMPLETED|Double Blind Period||0
8274005|NCT01712074|20401856|P3|STARTED|Double Blind Period||94
8274006|NCT01712074|20401857|P2|STARTED|Double Blind Period||91
8274007|NCT01712074|20401858|P1|STARTED|Double Blind Period||0
8274008|NCT01712074|20401856|P3|NOT COMPLETED|Placebo Run-in Period||0
8274009|NCT01712074|20401857|P2|NOT COMPLETED|Placebo Run-in Period||0
8274010|NCT01712074|20401858|P1|NOT COMPLETED|Placebo Run-in Period||10
8274011|NCT01712074|20401856|P3|COMPLETED|Placebo Run-in Period||0
8274012|NCT01712074|20401857|P2|COMPLETED|Placebo Run-in Period||0
8274013|NCT01712074|20401858|P1|COMPLETED|Placebo Run-in Period||185
8274014|NCT01712074|20401856|P3|STARTED|Placebo Run-in Period||0
8274015|NCT01712074|20401857|P2|STARTED|Placebo Run-in Period||0
8274016|NCT01712074|20401858|P1|STARTED|Placebo Run-in Period||195
8274017|NCT01712061|20401914|P3|NOT COMPLETED|Overall Study||11
8274018|NCT01712061|20401915|P2|NOT COMPLETED|Overall Study||26
8274019|NCT01712061|20401916|P1|NOT COMPLETED|Overall Study||10
8274020|NCT01712061|20401914|P3|COMPLETED|Overall Study||45
8274021|NCT01712061|20401915|P2|COMPLETED|Overall Study||114
8274022|NCT01712061|20401916|P1|COMPLETED|Overall Study||20
8274023|NCT01712061|20401914|P3|STARTED|Overall Study||56
8274024|NCT01712061|20401915|P2|STARTED|Overall Study||140
8274025|NCT01712061|20401916|P1|STARTED|Overall Study||30
8274026|NCT01712009|20401956|P3|NOT COMPLETED|Overall Study||21
8274027|NCT01712009|20401957|P2|NOT COMPLETED|Overall Study||29
8274028|NCT01712009|20401958|P1|NOT COMPLETED|Overall Study||38
8274029|NCT01712009|20401956|P3|COMPLETED|Overall Study||181
8274030|NCT01712009|20401957|P2|COMPLETED|Overall Study||171
8274031|NCT01712009|20401958|P1|COMPLETED|Overall Study||160
8274032|NCT01712009|20401956|P3|Received Naproxen / Loratadine|Overall Study||198
8274033|NCT01712009|20401957|P2|Received Naproxen / Loratadine|Overall Study||193
8274034|NCT01712009|20401958|P1|Received Naproxen / Loratadine|Overall Study||0
8274035|NCT01712009|20401956|P3|Received Pegfilgrastim|Overall Study||200
8274036|NCT01712009|20401957|P2|Received Pegfilgrastim|Overall Study||196
8274037|NCT01712009|20401958|P1|Received Pegfilgrastim|Overall Study||191
8274038|NCT01712009|20401956|P3|STARTED|Overall Study||202
8274039|NCT01712009|20401957|P2|STARTED|Overall Study||200
8274040|NCT01712009|20401958|P1|STARTED|Overall Study||198
8274041|NCT01711983|20401984|P1|NOT COMPLETED|36-Month Closure Evaluation||64
8274042|NCT01711983|20401984|P1|COMPLETED|36-Month Closure Evaluation||278
8274043|NCT01711983|20401984|P1|STARTED|36-Month Closure Evaluation||342
8274044|NCT01711983|20401984|P1|NOT COMPLETED|6-Month Closure Evaluation||26
8274045|NCT01711983|20401984|P1|COMPLETED|6-Month Closure Evaluation||342
8274046|NCT01711983|20401984|P1|STARTED|6-Month Closure Evaluation||368
8274047|NCT01711983|20401984|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||32
8274048|NCT01711983|20401984|P1|COMPLETED|6-Month Clinical Success Evaluation||368
8274049|NCT01711983|20401984|P1|STARTED|6-Month Clinical Success Evaluation||400
8274050|NCT01711918|20401994|P1|NOT COMPLETED|Overall Study||2
8274051|NCT01711918|20401994|P1|COMPLETED|Overall Study||7
8274052|NCT01711918|20401994|P1|STARTED|Overall Study||9
8274053|NCT01711879|20402004|P2|NOT COMPLETED|Overall Study||0
8274054|NCT01711879|20402005|P1|NOT COMPLETED|Overall Study||1
8274055|NCT01711879|20402004|P2|COMPLETED|Overall Study||4
8274056|NCT01711879|20402005|P1|COMPLETED|Overall Study||2
8274057|NCT01711879|20402004|P2|STARTED|Overall Study||4
8274058|NCT01711879|20402005|P1|STARTED|Overall Study||3
8274059|NCT01711866|20402039|P1|NOT COMPLETED|Overall Study||8
8274060|NCT01711866|20402039|P1|COMPLETED|Overall Study||79
8274061|NCT01711866|20402039|P1|STARTED|Overall Study||87
8274062|NCT01711853|20402044|P1|NOT COMPLETED|Overall Study||3
8274063|NCT01711853|20402044|P1|COMPLETED|Overall Study||16
8274064|NCT01711853|20402044|P1|STARTED|Overall Study||19
8274065|NCT01711736|20402051|P2|NOT COMPLETED|Overall Study||8
8274066|NCT01711736|20402052|P1|NOT COMPLETED|Overall Study||12
8274067|NCT01711736|20402051|P2|COMPLETED|Overall Study|Up to Day 180|294
8274068|NCT01711736|20402052|P1|COMPLETED|Overall Study|Up to Day 180|287
8274069|NCT01711736|20402051|P2|STARTED|Overall Study||302
8274070|NCT01711736|20402052|P1|STARTED|Overall Study||299
8274071|NCT01711645|20402080|P1|NOT COMPLETED|Overall Study||19
8274072|NCT01711645|20402080|P1|COMPLETED|Overall Study||36
8274073|NCT01711645|20402080|P1|STARTED|Overall Study||55
8274074|NCT01711619|20402117|P2|NOT COMPLETED|Overall Study||24
8274075|NCT01711619|20402118|P1|NOT COMPLETED|Overall Study||18
8274076|NCT01711619|20402117|P2|COMPLETED|Overall Study||36
8274077|NCT01711619|20402118|P1|COMPLETED|Overall Study||38
8274078|NCT01711619|20402117|P2|STARTED|Overall Study||60
8274079|NCT01711619|20402118|P1|STARTED|Overall Study||56
8274080|NCT01711541|20402135|P5|NOT COMPLETED|Overall Study||0
8274081|NCT01711541|20402136|P4|NOT COMPLETED|Overall Study||1
8274082|NCT01711541|20402137|P3|NOT COMPLETED|Overall Study||0
8274083|NCT01711541|20402138|P2|NOT COMPLETED|Overall Study||1
8274084|NCT01711541|20402139|P1|NOT COMPLETED|Overall Study||0
8274085|NCT01711541|20402135|P5|COMPLETED|Overall Study||7
8274086|NCT01711541|20402136|P4|COMPLETED|Overall Study||5
8274087|NCT01711541|20402137|P3|COMPLETED|Overall Study||3
8274088|NCT01711541|20402138|P2|COMPLETED|Overall Study||3
8274089|NCT01711541|20402139|P1|COMPLETED|Overall Study||4
8274090|NCT01711541|20402135|P5|STARTED|Overall Study||7
8274091|NCT01711541|20402136|P4|STARTED|Overall Study||6
8274092|NCT01711541|20402137|P3|STARTED|Overall Study||3
8274093|NCT01711541|20402138|P2|STARTED|Overall Study||4
8274094|NCT01711541|20402139|P1|STARTED|Overall Study||4
8274095|NCT01711424|20402168|P1|NOT COMPLETED|Overall Study||0
8274096|NCT01711424|20402168|P1|COMPLETED|Overall Study||1209
8274097|NCT01711424|20402168|P1|STARTED|Overall Study||1209
8274098|NCT01711372|20402177|P2|NOT COMPLETED|Overall Study||0
8274099|NCT01711372|20402178|P1|NOT COMPLETED|Overall Study||0
8274100|NCT01711372|20402177|P2|COMPLETED|Overall Study||47
8274101|NCT01711372|20402178|P1|COMPLETED|Overall Study||66
8274102|NCT01711372|20402177|P2|STARTED|Overall Study||47
8274103|NCT01711372|20402178|P1|STARTED|Overall Study||66
8274104|NCT01711359|20402188|P3|NOT COMPLETED|Follow Up||28
8274105|NCT01711359|20402189|P2|NOT COMPLETED|Follow Up||15
8274106|NCT01711359|20402190|P1|NOT COMPLETED|Follow Up||25
8274107|NCT01711359|20402188|P3|COMPLETED|Follow Up||0
8274108|NCT01711359|20402189|P2|COMPLETED|Follow Up||0
8274109|NCT01711359|20402190|P1|COMPLETED|Follow Up||0
8274110|NCT01711359|20402188|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
8274111|NCT01711359|20402189|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
8274112|NCT01711359|20402190|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
8274113|NCT01711359|20402188|P3|NOT COMPLETED|Treatment Period||42
8274114|NCT01711359|20402189|P2|NOT COMPLETED|Treatment Period||24
8274115|NCT01711359|20402190|P1|NOT COMPLETED|Treatment Period||52
8274116|NCT01711359|20402188|P3|COMPLETED|Treatment Period||173
8274117|NCT01711359|20402189|P2|COMPLETED|Treatment Period||136
8274118|NCT01711359|20402190|P1|COMPLETED|Treatment Period||161
8274119|NCT01711359|20402188|P3|Rescued|Treatment Period||6
8274120|NCT01711359|20402189|P2|Rescued|Treatment Period||7
8274121|NCT01711359|20402190|P1|Rescued|Treatment Period||26
8274122|NCT01711359|20402188|P3|Received at Least One Dose of Study Drug|Treatment Period||215
8274123|NCT01711359|20402189|P2|Received at Least One Dose of Study Drug|Treatment Period||159
8274124|NCT01711359|20402190|P1|Received at Least One Dose of Study Drug|Treatment Period||210
8274125|NCT01711359|20402188|P3|STARTED|Treatment Period||215
8274126|NCT01711359|20402189|P2|STARTED|Treatment Period||160
8274127|NCT01711359|20402190|P1|STARTED|Treatment Period||213
8274128|NCT01711294|20402264|P3|NOT COMPLETED|Overall Study||0
8274129|NCT01711294|20402265|P2|NOT COMPLETED|Overall Study||0
8274130|NCT01711294|20402266|P1|NOT COMPLETED|Overall Study||0
8274131|NCT01711294|20402264|P3|COMPLETED|Overall Study||64
8274132|NCT01711294|20402265|P2|COMPLETED|Overall Study||65
8274133|NCT01711294|20402266|P1|COMPLETED|Overall Study||121
8274134|NCT01711294|20402264|P3|STARTED|Overall Study||64
8274135|NCT01711294|20402265|P2|STARTED|Overall Study||65
8274136|NCT01711294|20402266|P1|STARTED|Overall Study||121
8274137|NCT01711216|20402319|P1|NOT COMPLETED|Overall Study||217
8274138|NCT01711216|20402319|P1|COMPLETED|Overall Study||782
8274139|NCT01711216|20402319|P1|STARTED|Overall Study||999
8274140|NCT01711177|20402343|P3|NOT COMPLETED|Overall Study||0
8274141|NCT01711177|20402344|P2|NOT COMPLETED|Overall Study||0
8274142|NCT01711177|20402345|P1|NOT COMPLETED|Overall Study||0
8274143|NCT01711177|20402343|P3|COMPLETED|Overall Study||3
8274144|NCT01711177|20402344|P2|COMPLETED|Overall Study||3
8274145|NCT01711177|20402345|P1|COMPLETED|Overall Study||10
8274146|NCT01711177|20402343|P3|STARTED|Overall Study||3
8274147|NCT01711177|20402344|P2|STARTED|Overall Study||3
8274148|NCT01711177|20402345|P1|STARTED|Overall Study||10
8274149|NCT01710891|20402355|P2|NOT COMPLETED|Overall Study||0
8274150|NCT01710891|20402356|P1|NOT COMPLETED|Overall Study||0
8274151|NCT01710891|20402355|P2|COMPLETED|Overall Study||103
8274152|NCT01710891|20402356|P1|COMPLETED|Overall Study||95
8274153|NCT01710891|20402355|P2|STARTED|Overall Study||103
8274154|NCT01710891|20402356|P1|STARTED|Overall Study||95
8274155|NCT01710839|20402374|P2|NOT COMPLETED|Overall Study||6
8274156|NCT01710839|20402375|P1|NOT COMPLETED|Overall Study||1
8274157|NCT01710839|20402374|P2|COMPLETED|Overall Study||0
8274158|NCT01710839|20402375|P1|COMPLETED|Overall Study||23
8274159|NCT01710839|20402374|P2|STARTED|Overall Study||6
8274160|NCT01710839|20402375|P1|STARTED|Overall Study||24
8274161|NCT01710800|20402397|P1|NOT COMPLETED|Overall Study||22
8274162|NCT01710800|20402397|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
8274163|NCT01710800|20402397|P1|Received Placebo Intervention|Overall Study||45
8274164|NCT01710800|20402397|P1|Received PPI Intervention|Overall Study||44
8274165|NCT01710800|20402397|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
8274166|NCT01710787|20402406|P3|NOT COMPLETED|Overall Study||0
8274167|NCT01710787|20402407|P2|NOT COMPLETED|Overall Study||0
8274168|NCT01710787|20402408|P1|NOT COMPLETED|Overall Study||0
8274169|NCT01710787|20402406|P3|COMPLETED|Overall Study||22
8274170|NCT01710787|20402407|P2|COMPLETED|Overall Study||44
8274171|NCT01710787|20402408|P1|COMPLETED|Overall Study||44
8274172|NCT01710787|20402406|P3|STARTED|Overall Study||22
8274173|NCT01710787|20402407|P2|STARTED|Overall Study||44
8274174|NCT01710787|20402408|P1|STARTED|Overall Study||44
8274175|NCT01710709|20402461|P1|NOT COMPLETED|Overall Study||173
8274176|NCT01710709|20402461|P1|COMPLETED|Overall Study||291
8274177|NCT01710709|20402461|P1|STARTED|Overall Study||464
8274178|NCT01710657|20402476|P3|NOT COMPLETED|Overall Study||32
8274179|NCT01710657|20402477|P2|NOT COMPLETED|Overall Study||12
8274180|NCT01710657|20402478|P1|NOT COMPLETED|Overall Study||18
8274181|NCT01710657|20402476|P3|COMPLETED|Overall Study||148
8274182|NCT01710657|20402477|P2|COMPLETED|Overall Study||171
8274183|NCT01710657|20402478|P1|COMPLETED|Overall Study||166
8274184|NCT01710657|20402476|P3|Maintenance Period (12 Weeks)|Overall Study||168
8274185|NCT01710657|20402477|P2|Maintenance Period (12 Weeks)|Overall Study||175
8274186|NCT01710657|20402478|P1|Maintenance Period (12 Weeks)|Overall Study||176
8274187|NCT01710657|20402476|P3|Titration Period (4 Weeks)|Overall Study||180
8274188|NCT01710657|20402477|P2|Titration Period (4 Weeks)|Overall Study||183
8274189|NCT01710657|20402478|P1|Titration Period (4 Weeks)|Overall Study||184
8274190|NCT01710657|20402476|P3|STARTED|Overall Study||180
8274191|NCT01710657|20402477|P2|STARTED|Overall Study||183
8274192|NCT01710657|20402478|P1|STARTED|Overall Study||184
8274193|NCT01710527|20402495|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
8274194|NCT01710527|20402496|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
8274195|NCT01710527|20402495|P2|COMPLETED|Period 3: Intervention Period 2||15
8274196|NCT01710527|20402496|P1|COMPLETED|Period 3: Intervention Period 2||16
8274197|NCT01710527|20402495|P2|STARTED|Period 3: Intervention Period 2||15
8274198|NCT01710527|20402496|P1|STARTED|Period 3: Intervention Period 2||16
8274199|NCT01710527|20402495|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
8274200|NCT01710527|20402496|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8274201|NCT01710527|20402495|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
8274202|NCT01710527|20402496|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
8274203|NCT01710527|20402495|P2|STARTED|Period 2: Washout Period (7 Days)||16
8274204|NCT01710527|20402496|P1|STARTED|Period 2: Washout Period (7 Days)||16
8274205|NCT01710527|20402495|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
8274206|NCT01710527|20402496|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
8274207|NCT01710527|20402495|P2|COMPLETED|Period 1: Intervention Period 1||16
8274208|NCT01710527|20402496|P1|COMPLETED|Period 1: Intervention Period 1||16
8274209|NCT01710527|20402495|P2|STARTED|Period 1: Intervention Period 1||16
8274210|NCT01710527|20402496|P1|STARTED|Period 1: Intervention Period 1||16
8274211|NCT01710514|20402522|P2|NOT COMPLETED|Overall Study||7
8274212|NCT01710514|20402523|P1|NOT COMPLETED|Overall Study||7
8274213|NCT01710514|20402522|P2|COMPLETED|Overall Study||47
8274214|NCT01710514|20402523|P1|COMPLETED|Overall Study||47
8274215|NCT01710514|20402522|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
8274216|NCT01710514|20402523|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
8274217|NCT01710514|20402522|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
8274218|NCT01710514|20402523|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
8274219|NCT01710514|20402522|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
8274220|NCT01710514|20402523|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
8274221|NCT01710514|20402522|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
8274222|NCT01710514|20402523|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
8274223|NCT01710514|20402522|P2|STARTED|Overall Study||54
8274224|NCT01710514|20402523|P1|STARTED|Overall Study||54
8274234|NCT01710358|20402578|P3|NOT COMPLETED|Follow-up Period||0
8274235|NCT01710358|20402579|P2|NOT COMPLETED|Follow-up Period||0
8274236|NCT01710358|20402580|P1|NOT COMPLETED|Follow-up Period||0
8274237|NCT01710358|20402578|P3|COMPLETED|Follow-up Period||20
8274238|NCT01710358|20402579|P2|COMPLETED|Follow-up Period||76
8274239|NCT01710358|20402580|P1|COMPLETED|Follow-up Period||33
8274240|NCT01710358|20402578|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
8274241|NCT01710358|20402579|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
8274242|NCT01710358|20402580|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
8274243|NCT01710358|20402578|P3|NOT COMPLETED|Rescue Period||0
8274244|NCT01710358|20402579|P2|NOT COMPLETED|Rescue Period||31
8274245|NCT01710358|20402580|P1|NOT COMPLETED|Rescue Period||0
8274246|NCT01710358|20402578|P3|COMPLETED|Rescue Period||0
8274247|NCT01710358|20402579|P2|COMPLETED|Rescue Period||196
8274248|NCT01710358|20402580|P1|COMPLETED|Rescue Period||0
8274249|NCT01710358|20402578|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8274250|NCT01710358|20402579|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
8274251|NCT01710358|20402580|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8274252|NCT01710358|20402578|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
8274253|NCT01710358|20402579|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
8274254|NCT01710358|20402580|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
8274255|NCT01710358|20402578|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
8274256|NCT01710358|20402579|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
8274257|NCT01710358|20402580|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
8274258|NCT01710358|20402578|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
8274259|NCT01710358|20402579|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
8274260|NCT01710358|20402580|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
8274261|NCT01710358|20402578|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
8274262|NCT01710358|20402579|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
8274263|NCT01710358|20402580|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
8274264|NCT01710358|20402578|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
8274265|NCT01710358|20402579|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
8274266|NCT01710358|20402580|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
8274267|NCT01710358|20402578|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
8274268|NCT01710358|20402579|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
8274269|NCT01710358|20402580|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
8274270|NCT01710358|20402578|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
8274271|NCT01710358|20402579|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
8274272|NCT01710358|20402580|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
8274273|NCT01710358|20402578|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
8274274|NCT01710358|20402579|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
8274275|NCT01710358|20402580|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
8274276|NCT01710358|20402578|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
8274277|NCT01710358|20402579|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
8274278|NCT01710358|20402580|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
8274279|NCT01710358|20402578|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
8274280|NCT01710358|20402579|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
8274281|NCT01710358|20402580|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
8274282|NCT01710345|20402651|P3|NOT COMPLETED|Overall Study||1
8274283|NCT01710345|20402652|P2|NOT COMPLETED|Overall Study||5
8274284|NCT01710345|20402653|P1|NOT COMPLETED|Overall Study||3
8274285|NCT01710345|20402651|P3|COMPLETED|Overall Study||19
8274286|NCT01710345|20402652|P2|COMPLETED|Overall Study||35
8274287|NCT01710345|20402653|P1|COMPLETED|Overall Study||37
8274288|NCT01710345|20402651|P3|STARTED|Overall Study||20
8274289|NCT01710345|20402652|P2|STARTED|Overall Study||40
8274290|NCT01710345|20402653|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
8274291|NCT01710332|20402663|P2|NOT COMPLETED|Overall Study||0
8274292|NCT01710332|20402664|P1|NOT COMPLETED|Overall Study||0
8274293|NCT01710332|20402663|P2|COMPLETED|Overall Study||6
8274294|NCT01710332|20402664|P1|COMPLETED|Overall Study||6
8274295|NCT01710332|20402663|P2|STARTED|Overall Study||6
8274296|NCT01710332|20402664|P1|STARTED|Overall Study||6
8274297|NCT01710306|20402674|P2|NOT COMPLETED|Overall Study||30
8274298|NCT01710306|20402675|P1|NOT COMPLETED|Overall Study||18
8274299|NCT01710306|20402674|P2|COMPLETED|Overall Study||55
8274300|NCT01710306|20402675|P1|COMPLETED|Overall Study||68
8274301|NCT01710306|20402674|P2|STARTED|Overall Study||85
8274302|NCT01710306|20402675|P1|STARTED|Overall Study||86
8274303|NCT01710254|20402683|P1|NOT COMPLETED|Overall Study||0
8274304|NCT01710254|20402683|P1|COMPLETED|Overall Study||30
8274305|NCT01710254|20402683|P1|STARTED|Overall Study||30
8274306|NCT01710137|20402691|P2|NOT COMPLETED|Overall Study||14
8274307|NCT01710137|20402692|P1|NOT COMPLETED|Overall Study||24
8274308|NCT01710137|20402691|P2|COMPLETED|Overall Study||76
8274309|NCT01710137|20402692|P1|COMPLETED|Overall Study||65
8274310|NCT01710137|20402691|P2|STARTED|Overall Study||90
8274311|NCT01710137|20402692|P1|STARTED|Overall Study||89
8274312|NCT01710046|20402712|P2|NOT COMPLETED|Overall Study||0
8274313|NCT01710046|20402713|P1|NOT COMPLETED|Overall Study||1
8274314|NCT01710046|20402712|P2|COMPLETED|Overall Study||3
8274315|NCT01710046|20402713|P1|COMPLETED|Overall Study||8
8274316|NCT01710046|20402712|P2|STARTED|Overall Study||3
8274317|NCT01710046|20402713|P1|STARTED|Overall Study||9
8274318|NCT01710033|20402753|P5|NOT COMPLETED|Stage 2||1
8274319|NCT01710033|20402754|P4|NOT COMPLETED|Stage 2||0
8274320|NCT01710033|20402755|P3|NOT COMPLETED|Stage 2||0
8274321|NCT01710033|20402756|P2|NOT COMPLETED|Stage 2||0
8274322|NCT01710033|20402757|P1|NOT COMPLETED|Stage 2||0
8274323|NCT01710033|20402753|P5|COMPLETED|Stage 2||3
8274324|NCT01710033|20402754|P4|COMPLETED|Stage 2||0
8274325|NCT01710033|20402755|P3|COMPLETED|Stage 2||0
8274326|NCT01710033|20402756|P2|COMPLETED|Stage 2||0
8274327|NCT01710033|20402757|P1|COMPLETED|Stage 2||0
8274328|NCT01710033|20402753|P5|STARTED|Stage 2||4
8274329|NCT01710033|20402754|P4|STARTED|Stage 2||0
8274330|NCT01710033|20402755|P3|STARTED|Stage 2||0
8274331|NCT01710033|20402756|P2|STARTED|Stage 2||0
8274332|NCT01710033|20402757|P1|STARTED|Stage 2||0
8274333|NCT01710033|20402753|P5|NOT COMPLETED|Stage 1||0
8274334|NCT01710033|20402754|P4|NOT COMPLETED|Stage 1||0
8274335|NCT01710033|20402755|P3|NOT COMPLETED|Stage 1||0
8274336|NCT01710033|20402756|P2|NOT COMPLETED|Stage 1||0
8274337|NCT01710033|20402757|P1|NOT COMPLETED|Stage 1||0
8274338|NCT01710033|20402753|P5|COMPLETED|Stage 1||0
8274339|NCT01710033|20402754|P4|COMPLETED|Stage 1||6
8274340|NCT01710033|20402755|P3|COMPLETED|Stage 1||6
8274341|NCT01710033|20402756|P2|COMPLETED|Stage 1||6
8274342|NCT01710033|20402757|P1|COMPLETED|Stage 1||6
8274343|NCT01710033|20402753|P5|STARTED|Stage 1||0
8274344|NCT01710033|20402754|P4|STARTED|Stage 1||6
8274345|NCT01710033|20402755|P3|STARTED|Stage 1||6
8274346|NCT01710033|20402756|P2|STARTED|Stage 1||6
8274347|NCT01710033|20402757|P1|STARTED|Stage 1||6
8274348|NCT01710020|20402838|P1|NOT COMPLETED|Period 2||0
8274349|NCT01710020|20402838|P1|COMPLETED|Period 2||11
8274350|NCT01710020|20402838|P1|STARTED|Period 2||11
8274351|NCT01710020|20402838|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8274352|NCT01710020|20402838|P1|COMPLETED|Washout Period (at Least 14 Days)||11
8274353|NCT01710020|20402838|P1|STARTED|Washout Period (at Least 14 Days)||11
8274354|NCT01710020|20402838|P1|NOT COMPLETED|Period 1||1
8274355|NCT01710020|20402838|P1|COMPLETED|Period 1||11
8274356|NCT01710020|20402838|P1|STARTED|Period 1||12
8274357|NCT01709981|20402857|P2|NOT COMPLETED|Overall Study||0
8274358|NCT01709981|20402858|P1|NOT COMPLETED|Overall Study||0
8274359|NCT01709981|20402857|P2|COMPLETED|Overall Study||139
8274360|NCT01709981|20402858|P1|COMPLETED|Overall Study||141
8274361|NCT01709981|20402857|P2|STARTED|Overall Study||139
8274362|NCT01709981|20402858|P1|STARTED|Overall Study||141
8274363|NCT01709903|20402874|P2|NOT COMPLETED|Overall Study||39
8274364|NCT01709903|20402875|P1|NOT COMPLETED|Overall Study||29
8274365|NCT01709903|20402874|P2|COMPLETED|Overall Study||333
8274366|NCT01709903|20402875|P1|COMPLETED|Overall Study||343
8274367|NCT01709903|20402874|P2|STARTED|Overall Study|Randomized set|372
8274368|NCT01709903|20402875|P1|STARTED|Overall Study|Randomized set|372
8274369|NCT01709864|20402899|P2|NOT COMPLETED|Overall Study||11
8274370|NCT01709864|20402900|P1|NOT COMPLETED|Overall Study||7
8274371|NCT01709864|20402899|P2|COMPLETED|Overall Study||208
8274372|NCT01709864|20402900|P1|COMPLETED|Overall Study||215
8274373|NCT01709864|20402899|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
8274374|NCT01709864|20402900|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
8274375|NCT01709864|20402899|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
8274376|NCT01709864|20402900|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
8274377|NCT01709864|20402899|P2|STARTED|Overall Study||219
8274378|NCT01709864|20402900|P1|STARTED|Overall Study||222
8274379|NCT01709838|20402934|P1|NOT COMPLETED|Overall Study||67
8274380|NCT01709838|20402934|P1|COMPLETED|Overall Study||67
8274381|NCT01709838|20402934|P1|STARTED|Overall Study||134
8274382|NCT01709799|20402957|P3|NOT COMPLETED|Overall Study||3
8274383|NCT01709799|20402958|P2|NOT COMPLETED|Overall Study||3
8274384|NCT01709799|20402959|P1|NOT COMPLETED|Overall Study||3
8274385|NCT01709799|20402957|P3|COMPLETED|Overall Study||15
8274386|NCT01709799|20402958|P2|COMPLETED|Overall Study||18
8274387|NCT01709799|20402959|P1|COMPLETED|Overall Study||22
8274388|NCT01709799|20402957|P3|STARTED|Overall Study||18
8274389|NCT01709799|20402958|P2|STARTED|Overall Study||21
8274390|NCT01709799|20402959|P1|STARTED|Overall Study||25
8274391|NCT01709786|20402982|P1|NOT COMPLETED|Overall Study||0
8274392|NCT01709786|20402982|P1|COMPLETED|Overall Study||88
8274393|NCT01709786|20402982|P1|STARTED|Overall Study||88
8274394|NCT01709708|20402991|P2|NOT COMPLETED|Overall Study||2
8274395|NCT01709708|20402992|P1|NOT COMPLETED|Overall Study||1
8274396|NCT01709708|20402991|P2|COMPLETED|Overall Study||12
8274397|NCT01709708|20402992|P1|COMPLETED|Overall Study||26
8274398|NCT01709708|20402991|P2|STARTED|Overall Study||14
8274399|NCT01709708|20402992|P1|STARTED|Overall Study||27
8274400|NCT01709695|20403016|P2|NOT COMPLETED|Overall Study||1
8274401|NCT01709695|20403017|P1|NOT COMPLETED|Overall Study||1
8274402|NCT01709695|20403016|P2|COMPLETED|Overall Study||13
8274403|NCT01709695|20403017|P1|COMPLETED|Overall Study||12
8274404|NCT01709695|20403016|P2|STARTED|Overall Study||14
8274405|NCT01709695|20403017|P1|STARTED|Overall Study||13
8274406|NCT01709578|20403042|P3|NOT COMPLETED|Overall Study||51
8274407|NCT01709578|20403043|P2|NOT COMPLETED|Overall Study||56
8274408|NCT01709578|20403044|P1|NOT COMPLETED|Overall Study||80
8274409|NCT01709578|20403042|P3|COMPLETED|Overall Study||133
8274410|NCT01709578|20403043|P2|COMPLETED|Overall Study||125
8274411|NCT01709578|20403044|P1|COMPLETED|Overall Study||101
8274412|NCT01709578|20403042|P3|STARTED|Overall Study||184
8274413|NCT01709578|20403043|P2|STARTED|Overall Study||181
8274414|NCT01709578|20403044|P1|STARTED|Overall Study||181
8274415|NCT01709513|20403175|P3|NOT COMPLETED|Overall Study||30
8274416|NCT01709513|20403176|P2|NOT COMPLETED|Overall Study||43
8274417|NCT01709513|20403177|P1|NOT COMPLETED|Overall Study||21
8274418|NCT01709513|20403175|P3|COMPLETED|Overall Study||96
8274419|NCT01709513|20403176|P2|COMPLETED|Overall Study||82
8274420|NCT01709513|20403177|P1|COMPLETED|Overall Study||42
8274421|NCT01709513|20403175|P3|Treated|Overall Study||126
8274422|NCT01709513|20403176|P2|Treated|Overall Study||124
8274423|NCT01709513|20403177|P1|Treated|Overall Study||63
8274424|NCT01709513|20403175|P3|STARTED|Overall Study||126
8274425|NCT01709513|20403176|P2|STARTED|Overall Study||125
8274426|NCT01709513|20403177|P1|STARTED|Overall Study||63
8274427|NCT01709500|20403238|P2|NOT COMPLETED|Overall Study||82
8274428|NCT01709500|20403239|P1|NOT COMPLETED|Overall Study||167
8274429|NCT01709500|20403238|P2|COMPLETED|Overall Study||0
8274430|NCT01709500|20403239|P1|COMPLETED|Overall Study||0
8274431|NCT01709500|20403238|P2|Treated|Overall Study||81
8274432|NCT01709500|20403239|P1|Treated|Overall Study||167
8274433|NCT01709500|20403238|P2|STARTED|Overall Study||82
8274434|NCT01709500|20403239|P1|STARTED|Overall Study||167
8274435|NCT01709474|20403295|P2|NOT COMPLETED|Overall Study||0
8274436|NCT01709474|20403296|P1|NOT COMPLETED|Overall Study||0
8274437|NCT01709474|20403295|P2|COMPLETED|Overall Study||4
8274438|NCT01709474|20403296|P1|COMPLETED|Overall Study||3
8274439|NCT01709474|20403295|P2|STARTED|Overall Study||4
8274440|NCT01709474|20403296|P1|STARTED|Overall Study||3
8274441|NCT01709422|20403306|P2|NOT COMPLETED|Overall Study||0
8274442|NCT01709422|20403307|P1|NOT COMPLETED|Overall Study||0
8274443|NCT01709422|20403306|P2|COMPLETED|Overall Study||70
8274444|NCT01709422|20403307|P1|COMPLETED|Overall Study||70
8274445|NCT01709422|20403306|P2|STARTED|Overall Study||70
8274446|NCT01709422|20403307|P1|STARTED|Overall Study||70
8274447|NCT01709409|20403317|P2|NOT COMPLETED|Overall Study||0
8274448|NCT01709409|20403318|P1|NOT COMPLETED|Overall Study||1
8274449|NCT01709409|20403317|P2|COMPLETED|Overall Study||45
8274450|NCT01709409|20403318|P1|COMPLETED|Overall Study||42
8274451|NCT01709409|20403317|P2|STARTED|Overall Study||45
8274452|NCT01709409|20403318|P1|STARTED|Overall Study||43
8274453|NCT01709383|20403326|P2|NOT COMPLETED|Overall Study||0
8274454|NCT01709383|20403327|P1|NOT COMPLETED|Overall Study||1
8274455|NCT01709383|20403326|P2|COMPLETED|Overall Study||14
8274456|NCT01709383|20403327|P1|COMPLETED|Overall Study||23
8274457|NCT01709383|20403326|P2|Included in Analysis|Overall Study||13
8274458|NCT01709383|20403327|P1|Included in Analysis|Overall Study||22
8274459|NCT01709383|20403326|P2|Completed Follow-ups|Overall Study||14
8274460|NCT01709383|20403327|P1|Completed Follow-ups|Overall Study||23
8274461|NCT01709383|20403326|P2|Completed Treatment|Overall Study||14
8274462|NCT01709383|20403327|P1|Completed Treatment|Overall Study||24
8274463|NCT01709383|20403326|P2|STARTED|Overall Study||14
8274464|NCT01709383|20403327|P1|STARTED|Overall Study||24
8274465|NCT01709331|20403345|P1|NOT COMPLETED|Overall Study||1
8274466|NCT01709331|20403345|P1|COMPLETED|Overall Study||17
8274467|NCT01709331|20403345|P1|STARTED|Overall Study||18
8274468|NCT01709318|20403358|P7|NOT COMPLETED|Overall Study||11
8274469|NCT01709318|20403359|P6|NOT COMPLETED|Overall Study||4
8274470|NCT01709318|20403360|P5|NOT COMPLETED|Overall Study||4
8274471|NCT01709318|20403361|P4|NOT COMPLETED|Overall Study||6
8274472|NCT01709318|20403362|P3|NOT COMPLETED|Overall Study||6
8274473|NCT01709318|20403363|P2|NOT COMPLETED|Overall Study||7
8274474|NCT01709318|20403364|P1|NOT COMPLETED|Overall Study||9
8274475|NCT01709318|20403358|P7|COMPLETED|Overall Study||171
8274476|NCT01709318|20403359|P6|COMPLETED|Overall Study||80
8274477|NCT01709318|20403360|P5|COMPLETED|Overall Study||74
8274478|NCT01709318|20403361|P4|COMPLETED|Overall Study||72
8274479|NCT01709318|20403362|P3|COMPLETED|Overall Study||71
8274480|NCT01709318|20403363|P2|COMPLETED|Overall Study||78
8274481|NCT01709318|20403364|P1|COMPLETED|Overall Study||73
8274482|NCT01709318|20403358|P7|Treated|Overall Study||178
8274483|NCT01709318|20403359|P6|Treated|Overall Study||86
8274484|NCT01709318|20403360|P5|Treated|Overall Study||77
8274485|NCT01709318|20403361|P4|Treated|Overall Study||77
8274486|NCT01709318|20403362|P3|Treated|Overall Study||78
8274487|NCT01709318|20403363|P2|Treated|Overall Study||85
8274488|NCT01709318|20403364|P1|Treated|Overall Study||79
8274489|NCT01709318|20403358|P7|STARTED|Overall Study||182
8274490|NCT01709318|20403359|P6|STARTED|Overall Study||84
8274491|NCT01709318|20403360|P5|STARTED|Overall Study||78
8274492|NCT01709318|20403361|P4|STARTED|Overall Study||78
8274493|NCT01709318|20403362|P3|STARTED|Overall Study||77
8274494|NCT01709318|20403363|P2|STARTED|Overall Study||85
8274495|NCT01709318|20403364|P1|STARTED|Overall Study||82
8274496|NCT01709305|20403457|P5|NOT COMPLETED|Phase 2||47
8274497|NCT01709305|20403458|P4|NOT COMPLETED|Phase 2||48
8274498|NCT01709305|20403459|P3|NOT COMPLETED|Phase 2||45
8274499|NCT01709305|20403460|P2|NOT COMPLETED|Phase 2||52
8274500|NCT01709305|20403461|P1|NOT COMPLETED|Phase 2||0
8274501|NCT01709305|20403457|P5|COMPLETED|Phase 2||507
8274502|NCT01709305|20403458|P4|COMPLETED|Phase 2||508
8274503|NCT01709305|20403459|P3|COMPLETED|Phase 2||505
8274504|NCT01709305|20403460|P2|COMPLETED|Phase 2||500
8274505|NCT01709305|20403461|P1|COMPLETED|Phase 2||0
8274506|NCT01709305|20403457|P5|STARTED|Phase 2||554
8274507|NCT01709305|20403458|P4|STARTED|Phase 2||556
8274508|NCT01709305|20403459|P3|STARTED|Phase 2||550
8274509|NCT01709305|20403460|P2|STARTED|Phase 2||552
8274510|NCT01709305|20403461|P1|STARTED|Phase 2||0
8274511|NCT01709305|20403457|P5|NOT COMPLETED|Phase 1||0
8274512|NCT01709305|20403458|P4|NOT COMPLETED|Phase 1||0
8274513|NCT01709305|20403459|P3|NOT COMPLETED|Phase 1||0
8274514|NCT01709305|20403460|P2|NOT COMPLETED|Phase 1||0
8274515|NCT01709305|20403461|P1|NOT COMPLETED|Phase 1||637
8274516|NCT01709305|20403457|P5|COMPLETED|Phase 1||0
8274517|NCT01709305|20403458|P4|COMPLETED|Phase 1||0
8274518|NCT01709305|20403459|P3|COMPLETED|Phase 1||0
8274519|NCT01709305|20403460|P2|COMPLETED|Phase 1||0
8274520|NCT01709305|20403461|P1|COMPLETED|Phase 1||4933
8274521|NCT01709305|20403457|P5|STARTED|Phase 1||0
8274522|NCT01709305|20403458|P4|STARTED|Phase 1||0
8274523|NCT01709305|20403459|P3|STARTED|Phase 1||0
8274524|NCT01709305|20403460|P2|STARTED|Phase 1||0
8274525|NCT01709305|20403461|P1|STARTED|Phase 1||5570
8274526|NCT01709227|20403498|P2|NOT COMPLETED|Overall Study||9
8274527|NCT01709227|20403499|P1|NOT COMPLETED|Overall Study||1
8274528|NCT01709227|20403498|P2|COMPLETED|Overall Study||32
8274529|NCT01709227|20403499|P1|COMPLETED|Overall Study||31
8274530|NCT01709227|20403498|P2|STARTED|Overall Study||41
8274531|NCT01709227|20403499|P1|STARTED|Overall Study||32
8274532|NCT01709162|20403525|P2|NOT COMPLETED|Overall Study||5
8274533|NCT01709162|20403526|P1|NOT COMPLETED|Overall Study||6
8274534|NCT01709162|20403525|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
8274535|NCT01709162|20403526|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
8274536|NCT01709162|20403525|P2|Still Receiving Treatment|Overall Study||0
8274537|NCT01709162|20403526|P1|Still Receiving Treatment|Overall Study||0
8274538|NCT01709162|20403525|P2|Received Treatment|Overall Study||4
8274539|NCT01709162|20403526|P1|Received Treatment|Overall Study||18
8274540|NCT01709162|20403525|P2|STARTED|Overall Study|Randomized|5
8274541|NCT01709162|20403526|P1|STARTED|Overall Study|Randomized|18
8274542|NCT01709149|20403541|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
8274543|NCT01709149|20403542|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
8274544|NCT01709149|20403543|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8274545|NCT01709149|20403541|P3|COMPLETED|Double-blind, Placebo-controlled Phase||204
8274546|NCT01709149|20403542|P2|COMPLETED|Double-blind, Placebo-controlled Phase||269
8274547|NCT01709149|20403543|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
8274548|NCT01709149|20403541|P3|STARTED|Double-blind, Placebo-controlled Phase||301
8274549|NCT01709149|20403542|P2|STARTED|Double-blind, Placebo-controlled Phase||295
8274550|NCT01709149|20403543|P1|STARTED|Double-blind, Placebo-controlled Phase||0
8274551|NCT01709149|20403541|P3|NOT COMPLETED|Open-label Lead-in Phase||0
8274552|NCT01709149|20403542|P2|NOT COMPLETED|Open-label Lead-in Phase||0
8274553|NCT01709149|20403543|P1|NOT COMPLETED|Open-label Lead-in Phase||115
8274554|NCT01709149|20403541|P3|COMPLETED|Open-label Lead-in Phase||0
8274555|NCT01709149|20403542|P2|COMPLETED|Open-label Lead-in Phase||0
8274556|NCT01709149|20403543|P1|COMPLETED|Open-label Lead-in Phase||596
8274557|NCT01709149|20403541|P3|STARTED|Open-label Lead-in Phase||0
8274558|NCT01709149|20403542|P2|STARTED|Open-label Lead-in Phase||0
8274559|NCT01709149|20403543|P1|STARTED|Open-label Lead-in Phase||711
8274560|NCT01709136|20403562|P1|NOT COMPLETED|Overall Study||0
8274561|NCT01709136|20403562|P1|COMPLETED|Overall Study||3
8274562|NCT01709136|20403562|P1|STARTED|Overall Study||3
8274563|NCT01709110|20403571|P2|NOT COMPLETED|Overall Study||168
8274564|NCT01709110|20403572|P1|NOT COMPLETED|Overall Study||185
8274565|NCT01709110|20403571|P2|COMPLETED|Overall Study||515
8274566|NCT01709110|20403572|P1|COMPLETED|Overall Study||498
8274567|NCT01709110|20403571|P2|Received at Least One Dose of Study Drug|Overall Study||680
8274568|NCT01709110|20403572|P1|Received at Least One Dose of Study Drug|Overall Study||680
8274569|NCT01709110|20403571|P2|STARTED|Overall Study||683
8274570|NCT01709110|20403572|P1|STARTED|Overall Study||683
8274579|NCT01709032|20403619|P1|NOT COMPLETED|Overall Study||3
8274580|NCT01709032|20403619|P1|COMPLETED|Overall Study||6
8274581|NCT01709032|20403619|P1|STARTED|Overall Study||9
8274582|NCT01708967|20403626|P2|NOT COMPLETED|Overall Study||7
8274583|NCT01708967|20403627|P1|NOT COMPLETED|Overall Study||0
8274584|NCT01708967|20403626|P2|COMPLETED|Overall Study||43
8274585|NCT01708967|20403627|P1|COMPLETED|Overall Study||50
8274586|NCT01708967|20403626|P2|STARTED|Overall Study||50
8274587|NCT01708967|20403627|P1|STARTED|Overall Study||50
8274631|NCT01708915|20403684|P4|NOT COMPLETED|Overall Study||33
8274632|NCT01708915|20403685|P3|NOT COMPLETED|Overall Study||46
8274633|NCT01708915|20403686|P2|NOT COMPLETED|Overall Study||62
8274634|NCT01708915|20403687|P1|NOT COMPLETED|Overall Study||86
8274635|NCT01708915|20403684|P4|COMPLETED|Overall Study||169
8274636|NCT01708915|20403685|P3|COMPLETED|Overall Study||152
8274637|NCT01708915|20403686|P2|COMPLETED|Overall Study||139
8274638|NCT01708915|20403687|P1|COMPLETED|Overall Study||118
8274639|NCT01708915|20403684|P4|STARTED|Overall Study||202
8274640|NCT01708915|20403685|P3|STARTED|Overall Study||198
8274641|NCT01708915|20403686|P2|STARTED|Overall Study||201
8274642|NCT01708915|20403687|P1|STARTED|Overall Study||204
8274643|NCT01708902|20403716|P7|NOT COMPLETED|Overall Study||7
8274644|NCT01708902|20403717|P6|NOT COMPLETED|Overall Study||7
8274645|NCT01708902|20403718|P5|NOT COMPLETED|Overall Study||16
8274646|NCT01708902|20403719|P4|NOT COMPLETED|Overall Study||10
8274647|NCT01708902|20403720|P3|NOT COMPLETED|Overall Study||17
8274648|NCT01708902|20403721|P2|NOT COMPLETED|Overall Study||8
8274649|NCT01708902|20403722|P1|NOT COMPLETED|Overall Study||17
8274650|NCT01708902|20403716|P7|COMPLETED|Overall Study||65
8274651|NCT01708902|20403717|P6|COMPLETED|Overall Study||64
8274652|NCT01708902|20403718|P5|COMPLETED|Overall Study||131
8274653|NCT01708902|20403719|P4|COMPLETED|Overall Study||137
8274654|NCT01708902|20403720|P3|COMPLETED|Overall Study||127
8274655|NCT01708902|20403721|P2|COMPLETED|Overall Study||137
8274656|NCT01708902|20403722|P1|COMPLETED|Overall Study||130
8274657|NCT01708902|20403716|P7|STARTED|Overall Study||72
8274658|NCT01708902|20403717|P6|STARTED|Overall Study||71
8274659|NCT01708902|20403718|P5|STARTED|Overall Study||147
8274660|NCT01708902|20403719|P4|STARTED|Overall Study||147
8274661|NCT01708902|20403720|P3|STARTED|Overall Study||144
8274662|NCT01708902|20403721|P2|STARTED|Overall Study||145
8274663|NCT01708902|20403722|P1|STARTED|Overall Study||147
8274664|NCT01708629|20403785|P4|NOT COMPLETED|Overall Study||14
8274665|NCT01708629|20403786|P3|NOT COMPLETED|Overall Study||10
8274666|NCT01708629|20403787|P2|NOT COMPLETED|Overall Study||25
8274667|NCT01708629|20403788|P1|NOT COMPLETED|Overall Study||16
8274668|NCT01708629|20403785|P4|COMPLETED|Overall Study||301
8274669|NCT01708629|20403786|P3|COMPLETED|Overall Study||303
8274670|NCT01708629|20403787|P2|COMPLETED|Overall Study||604
8274671|NCT01708629|20403788|P1|COMPLETED|Overall Study||608
8274672|NCT01708629|20403785|P4|STARTED|Overall Study||315
8274673|NCT01708629|20403786|P3|STARTED|Overall Study||313
8274674|NCT01708629|20403787|P2|STARTED|Overall Study||629
8274675|NCT01708629|20403788|P1|STARTED|Overall Study||624
8274676|NCT01708603|20403805|P4|NOT COMPLETED|Overall Study||9
8274677|NCT01708603|20403806|P3|NOT COMPLETED|Overall Study||9
8274678|NCT01708603|20403807|P2|NOT COMPLETED|Overall Study||22
8274679|NCT01708603|20403808|P1|NOT COMPLETED|Overall Study||15
8274680|NCT01708603|20403805|P4|COMPLETED|Overall Study||300
8274681|NCT01708603|20403806|P3|COMPLETED|Overall Study||291
8274682|NCT01708603|20403807|P2|COMPLETED|Overall Study||588
8274683|NCT01708603|20403808|P1|COMPLETED|Overall Study||597
8274684|NCT01708603|20403805|P4|STARTED|Overall Study||309
8274685|NCT01708603|20403806|P3|STARTED|Overall Study||300
8274686|NCT01708603|20403807|P2|STARTED|Overall Study||610
8274687|NCT01708603|20403808|P1|STARTED|Overall Study||612
8274688|NCT01708590|20403829|P7|NOT COMPLETED|Withdrawal Phase||9
8274689|NCT01708590|20403830|P6|NOT COMPLETED|Withdrawal Phase||82
8274690|NCT01708590|20403831|P5|NOT COMPLETED|Withdrawal Phase||12
8274691|NCT01708590|20403832|P4|NOT COMPLETED|Withdrawal Phase||53
8274692|NCT01708590|20403833|P3|NOT COMPLETED|Withdrawal Phase||0
8274693|NCT01708590|20403834|P2|NOT COMPLETED|Withdrawal Phase||0
8274694|NCT01708590|20403835|P1|NOT COMPLETED|Withdrawal Phase||0
8274695|NCT01708590|20403829|P7|COMPLETED|Withdrawal Phase||74
8274696|NCT01708590|20403830|P6|COMPLETED|Withdrawal Phase||2
8274697|NCT01708590|20403831|P5|COMPLETED|Withdrawal Phase||45
8274698|NCT01708590|20403832|P4|COMPLETED|Withdrawal Phase||6
8274699|NCT01708590|20403833|P3|COMPLETED|Withdrawal Phase||0
8274700|NCT01708590|20403834|P2|COMPLETED|Withdrawal Phase||0
8274701|NCT01708590|20403835|P1|COMPLETED|Withdrawal Phase||0
8274702|NCT01708590|20403829|P7|STARTED|Withdrawal Phase||83
8274703|NCT01708590|20403830|P6|STARTED|Withdrawal Phase||84
8274704|NCT01708590|20403831|P5|STARTED|Withdrawal Phase||57
8274705|NCT01708590|20403832|P4|STARTED|Withdrawal Phase||59
8274706|NCT01708590|20403833|P3|STARTED|Withdrawal Phase||0
8274707|NCT01708590|20403834|P2|STARTED|Withdrawal Phase||0
8274708|NCT01708590|20403835|P1|STARTED|Withdrawal Phase||0
8274709|NCT01708590|20403829|P7|NOT COMPLETED|Induction Phase||0
8274710|NCT01708590|20403830|P6|NOT COMPLETED|Induction Phase||0
8274711|NCT01708590|20403831|P5|NOT COMPLETED|Induction Phase||0
8274712|NCT01708590|20403832|P4|NOT COMPLETED|Induction Phase||0
8274713|NCT01708590|20403833|P3|NOT COMPLETED|Induction Phase||11
8274714|NCT01708590|20403834|P2|NOT COMPLETED|Induction Phase||7
8274715|NCT01708590|20403835|P1|NOT COMPLETED|Induction Phase||10
8274716|NCT01708590|20403829|P7|COMPLETED|Induction Phase||0
8274717|NCT01708590|20403830|P6|COMPLETED|Induction Phase||0
8274718|NCT01708590|20403831|P5|COMPLETED|Induction Phase||0
8274719|NCT01708590|20403832|P4|COMPLETED|Induction Phase||0
8274720|NCT01708590|20403833|P3|COMPLETED|Induction Phase||209
8274721|NCT01708590|20403834|P2|COMPLETED|Induction Phase||212
8274722|NCT01708590|20403835|P1|COMPLETED|Induction Phase||212
8274723|NCT01708590|20403829|P7|STARTED|Induction Phase||0
8274724|NCT01708590|20403830|P6|STARTED|Induction Phase||0
8274725|NCT01708590|20403831|P5|STARTED|Induction Phase||0
8274726|NCT01708590|20403832|P4|STARTED|Induction Phase||0
8274727|NCT01708590|20403833|P3|STARTED|Induction Phase||220
8274728|NCT01708590|20403834|P2|STARTED|Induction Phase||219
8274729|NCT01708590|20403835|P1|STARTED|Induction Phase||222
8274730|NCT01708525|20403850|P1|NOT COMPLETED|Overall Study||0
8274731|NCT01708525|20403850|P1|COMPLETED|Overall Study||2
8274732|NCT01708525|20403850|P1|STARTED|Overall Study||2
8274733|NCT01708317|20403855|P1|NOT COMPLETED|Final Education Period||0
8274734|NCT01708317|20403855|P1|COMPLETED|Final Education Period||909
8274735|NCT01708317|20403855|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
8274736|NCT01708317|20403855|P1|NOT COMPLETED|ACASI + Education Period||0
8274737|NCT01708317|20403855|P1|COMPLETED|ACASI + Education Period||2601
8274738|NCT01708317|20403855|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
8274739|NCT01708317|20403855|P1|NOT COMPLETED|Initial Education Period||0
8274740|NCT01708317|20403855|P1|COMPLETED|Initial Education Period||982
8274741|NCT01708317|20403855|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
8274742|NCT01708317|20403855|P1|NOT COMPLETED|2010 Control Period||0
8274743|NCT01708317|20403855|P1|COMPLETED|2010 Control Period||3929
8274744|NCT01708317|20403855|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
8274745|NCT01708291|20403864|P2|NOT COMPLETED|Overall Study||1
8274746|NCT01708291|20403865|P1|NOT COMPLETED|Overall Study||2
8274747|NCT01708291|20403864|P2|COMPLETED|Overall Study||20
8274748|NCT01708291|20403865|P1|COMPLETED|Overall Study||19
8274749|NCT01708291|20403864|P2|STARTED|Overall Study||21
8274750|NCT01708291|20403865|P1|STARTED|Overall Study||21
8274751|NCT01708278|20403877|P6|NOT COMPLETED|Overall Study||0
8274752|NCT01708278|20403878|P5|NOT COMPLETED|Overall Study||0
8274753|NCT01708278|20403879|P4|NOT COMPLETED|Overall Study||0
8274754|NCT01708278|20403880|P3|NOT COMPLETED|Overall Study||0
8274755|NCT01708278|20403881|P2|NOT COMPLETED|Overall Study||0
8274756|NCT01708278|20403882|P1|NOT COMPLETED|Overall Study||0
8274757|NCT01708278|20403877|P6|COMPLETED|Overall Study||1
8274758|NCT01708278|20403878|P5|COMPLETED|Overall Study||1
8274759|NCT01708278|20403879|P4|COMPLETED|Overall Study||2
8274760|NCT01708278|20403880|P3|COMPLETED|Overall Study||2
8274761|NCT01708278|20403881|P2|COMPLETED|Overall Study||2
8274762|NCT01708278|20403882|P1|COMPLETED|Overall Study||1
8274763|NCT01708278|20403877|P6|STARTED|Overall Study||1
8274764|NCT01708278|20403878|P5|STARTED|Overall Study||1
8274765|NCT01708278|20403879|P4|STARTED|Overall Study||2
8274766|NCT01708278|20403880|P3|STARTED|Overall Study||2
8274767|NCT01708278|20403881|P2|STARTED|Overall Study||2
8274768|NCT01708278|20403882|P1|STARTED|Overall Study||1
8274769|NCT01708213|20403896|P1|NOT COMPLETED|Overall Study||1
8274770|NCT01708213|20403896|P1|COMPLETED|Overall Study||71
8274771|NCT01708213|20403896|P1|STARTED|Overall Study||72
8274772|NCT01708187|20403904|P2|NOT COMPLETED|Overall Study||1
8274773|NCT01708187|20403905|P1|NOT COMPLETED|Overall Study||0
8274774|NCT01708187|20403904|P2|COMPLETED|Overall Study||0
8274775|NCT01708187|20403905|P1|COMPLETED|Overall Study||1
8274776|NCT01708187|20403904|P2|STARTED|Overall Study||1
8274777|NCT01708187|20403905|P1|STARTED|Overall Study||1
8274778|NCT01708174|20403914|P3|NOT COMPLETED|Survival Follow-up||0
8274779|NCT01708174|20403915|P2|NOT COMPLETED|Survival Follow-up||0
8274780|NCT01708174|20403916|P1|NOT COMPLETED|Survival Follow-up||0
8274781|NCT01708174|20403914|P3|COMPLETED|Survival Follow-up||0
8274782|NCT01708174|20403915|P2|COMPLETED|Survival Follow-up||10
8274783|NCT01708174|20403916|P1|COMPLETED|Survival Follow-up||1
8274784|NCT01708174|20403914|P3|STARTED|Survival Follow-up||0
8274785|NCT01708174|20403915|P2|STARTED|Survival Follow-up||10
8274786|NCT01708174|20403916|P1|STARTED|Survival Follow-up||1
8274787|NCT01708174|20403914|P3|NOT COMPLETED|Treatment Period||1
8274788|NCT01708174|20403915|P2|NOT COMPLETED|Treatment Period||2
8274789|NCT01708174|20403916|P1|NOT COMPLETED|Treatment Period||1
8274790|NCT01708174|20403914|P3|COMPLETED|Treatment Period||3
8274791|NCT01708174|20403915|P2|COMPLETED|Treatment Period||14
8274792|NCT01708174|20403916|P1|COMPLETED|Treatment Period||1
8274793|NCT01708174|20403914|P3|Pharmacokinetic Analysis Set|Treatment Period||0
8274794|NCT01708174|20403915|P2|Pharmacokinetic Analysis Set|Treatment Period||13
8274795|NCT01708174|20403916|P1|Pharmacokinetic Analysis Set|Treatment Period||2
8274796|NCT01708174|20403914|P3|STARTED|Treatment Period||4
8274797|NCT01708174|20403915|P2|STARTED|Treatment Period||16
8274798|NCT01708174|20403916|P1|STARTED|Treatment Period||2
8274799|NCT01708161|20403948|P6|NOT COMPLETED|Overall Study||1
8274800|NCT01708161|20403949|P5|NOT COMPLETED|Overall Study||6
8274801|NCT01708161|20403950|P4|NOT COMPLETED|Overall Study||16
8274802|NCT01708161|20403951|P3|NOT COMPLETED|Overall Study||10
8274803|NCT01708161|20403952|P2|NOT COMPLETED|Overall Study||10
8274804|NCT01708161|20403953|P1|NOT COMPLETED|Overall Study||4
8274805|NCT01708161|20403948|P6|COMPLETED|Overall Study||0
8274806|NCT01708161|20403949|P5|COMPLETED|Overall Study||0
8274807|NCT01708161|20403950|P4|COMPLETED|Overall Study||0
8274808|NCT01708161|20403951|P3|COMPLETED|Overall Study||0
8274809|NCT01708161|20403952|P2|COMPLETED|Overall Study||0
8274810|NCT01708161|20403953|P1|COMPLETED|Overall Study||0
8274811|NCT01708161|20403948|P6|STARTED|Overall Study||1
8274812|NCT01708161|20403949|P5|STARTED|Overall Study||6
8274813|NCT01708161|20403950|P4|STARTED|Overall Study||16
8274814|NCT01708161|20403951|P3|STARTED|Overall Study||10
8274815|NCT01708161|20403952|P2|STARTED|Overall Study||10
8274816|NCT01708161|20403953|P1|STARTED|Overall Study||4
8274817|NCT01708122|20403995|P2|NOT COMPLETED|Overall Study||0
8274818|NCT01708122|20403996|P1|NOT COMPLETED|Overall Study||0
8274819|NCT01708122|20403995|P2|COMPLETED|Overall Study||26
8274820|NCT01708122|20403996|P1|COMPLETED|Overall Study||27
8274821|NCT01708122|20403995|P2|STARTED|Overall Study||26
8274822|NCT01708122|20403996|P1|STARTED|Overall Study||27
8274823|NCT01708057|20404004|P3|NOT COMPLETED|Overall Study||1
8274824|NCT01708057|20404005|P2|NOT COMPLETED|Overall Study||1
8274825|NCT01708057|20404006|P1|NOT COMPLETED|Overall Study||1
8274826|NCT01708057|20404004|P3|COMPLETED|Overall Study||0
8274827|NCT01708057|20404005|P2|COMPLETED|Overall Study||0
8274828|NCT01708057|20404006|P1|COMPLETED|Overall Study||0
8274829|NCT01708057|20404004|P3|STARTED|Overall Study||1
8274830|NCT01708057|20404005|P2|STARTED|Overall Study||1
8274831|NCT01708057|20404006|P1|STARTED|Overall Study||1
8274832|NCT01707992|20404065|P6|NOT COMPLETED|Active Treatment Phase (24 Months)||215
8274833|NCT01707992|20404066|P5|NOT COMPLETED|Active Treatment Phase (24 Months)||494
8274834|NCT01707992|20404067|P4|NOT COMPLETED|Active Treatment Phase (24 Months)||884
8274835|NCT01707992|20404068|P3|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8274836|NCT01707992|20404069|P2|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8274837|NCT01707992|20404070|P1|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8274838|NCT01707992|20404065|P6|COMPLETED|Active Treatment Phase (24 Months)||0
8274839|NCT01707992|20404066|P5|COMPLETED|Active Treatment Phase (24 Months)||10
8274840|NCT01707992|20404067|P4|COMPLETED|Active Treatment Phase (24 Months)||7
8274841|NCT01707992|20404068|P3|COMPLETED|Active Treatment Phase (24 Months)||0
8274842|NCT01707992|20404069|P2|COMPLETED|Active Treatment Phase (24 Months)||0
8274843|NCT01707992|20404070|P1|COMPLETED|Active Treatment Phase (24 Months)||0
8274844|NCT01707992|20404065|P6|STARTED|Active Treatment Phase (24 Months)||215
8274845|NCT01707992|20404066|P5|STARTED|Active Treatment Phase (24 Months)||504
8274846|NCT01707992|20404067|P4|STARTED|Active Treatment Phase (24 Months)||891
8274847|NCT01707992|20404068|P3|STARTED|Active Treatment Phase (24 Months)||0
8274848|NCT01707992|20404069|P2|STARTED|Active Treatment Phase (24 Months)||0
8274849|NCT01707992|20404070|P1|STARTED|Active Treatment Phase (24 Months)||0
8274850|NCT01707992|20404065|P6|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274851|NCT01707992|20404066|P5|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274852|NCT01707992|20404067|P4|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274853|NCT01707992|20404068|P3|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
8274854|NCT01707992|20404069|P2|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
8274855|NCT01707992|20404070|P1|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
8274856|NCT01707992|20404065|P6|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274857|NCT01707992|20404066|P5|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274858|NCT01707992|20404067|P4|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274859|NCT01707992|20404068|P3|COMPLETED|Placebo-Controlled Phase (24 Months)||532
8274860|NCT01707992|20404069|P2|COMPLETED|Placebo-Controlled Phase (24 Months)||623
8274861|NCT01707992|20404070|P1|COMPLETED|Placebo-Controlled Phase (24 Months)||596
8274862|NCT01707992|20404065|P6|STARTED|Placebo-Controlled Phase (24 Months)||0
8274863|NCT01707992|20404066|P5|STARTED|Placebo-Controlled Phase (24 Months)||0
8274864|NCT01707992|20404067|P4|STARTED|Placebo-Controlled Phase (24 Months)||0
8274865|NCT01707992|20404068|P3|STARTED|Placebo-Controlled Phase (24 Months)||732
8274866|NCT01707992|20404069|P2|STARTED|Placebo-Controlled Phase (24 Months)||727
8274867|NCT01707992|20404070|P1|STARTED|Placebo-Controlled Phase (24 Months)||740
8274868|NCT01707693|20404122|P2|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
8274869|NCT01707693|20404123|P1|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
8274870|NCT01707693|20404122|P2|COMPLETED|Time 3 Measures @ 6 Mth||49
8274871|NCT01707693|20404123|P1|COMPLETED|Time 3 Measures @ 6 Mth||46
8274872|NCT01707693|20404122|P2|STARTED|Time 3 Measures @ 6 Mth||54
8274873|NCT01707693|20404123|P1|STARTED|Time 3 Measures @ 6 Mth||46
8274874|NCT01707693|20404122|P2|NOT COMPLETED|Overall Study Allocation||8
8274875|NCT01707693|20404123|P1|NOT COMPLETED|Overall Study Allocation||13
8274876|NCT01707693|20404122|P2|COMPLETED|Overall Study Allocation||54
8274877|NCT01707693|20404123|P1|COMPLETED|Overall Study Allocation||46
8274878|NCT01707693|20404122|P2|STARTED|Overall Study Allocation||62
8274879|NCT01707693|20404123|P1|STARTED|Overall Study Allocation||59
8274880|NCT01707667|20404137|P2|NOT COMPLETED|Period 2||0
8274881|NCT01707667|20404138|P1|NOT COMPLETED|Period 2||0
8274882|NCT01707667|20404137|P2|COMPLETED|Period 2||6
8274883|NCT01707667|20404138|P1|COMPLETED|Period 2||6
8274884|NCT01707667|20404137|P2|STARTED|Period 2||6
8274885|NCT01707667|20404138|P1|STARTED|Period 2||6
8274886|NCT01707667|20404137|P2|NOT COMPLETED|Period 1||0
8274887|NCT01707667|20404138|P1|NOT COMPLETED|Period 1||1
8274888|NCT01707667|20404137|P2|COMPLETED|Period 1||6
8274889|NCT01707667|20404138|P1|COMPLETED|Period 1||6
8274890|NCT01707667|20404137|P2|STARTED|Period 1||6
8274891|NCT01707667|20404138|P1|STARTED|Period 1||7
8274892|NCT01707654|20404156|P1|NOT COMPLETED|Overall Study||0
8274893|NCT01707654|20404156|P1|COMPLETED|Overall Study||9
8274894|NCT01707654|20404156|P1|STARTED|Overall Study||9
8274895|NCT01707472|20404163|P3|NOT COMPLETED|Overall Study||0
8274896|NCT01707472|20404164|P2|NOT COMPLETED|Overall Study||0
8274897|NCT01707472|20404165|P1|NOT COMPLETED|Overall Study||0
8274898|NCT01707472|20404163|P3|COMPLETED|Overall Study||8
8274899|NCT01707472|20404164|P2|COMPLETED|Overall Study||6
8274900|NCT01707472|20404165|P1|COMPLETED|Overall Study||4
8274901|NCT01707472|20404163|P3|STARTED|Overall Study||8
8274902|NCT01707472|20404164|P2|STARTED|Overall Study||6
8274903|NCT01707472|20404165|P1|STARTED|Overall Study||4
8274904|NCT01707420|20404190|P2|NOT COMPLETED|Overall Study||0
8274905|NCT01707420|20404191|P1|NOT COMPLETED|Overall Study||0
8274906|NCT01707420|20404190|P2|COMPLETED|Overall Study||18
8274907|NCT01707420|20404191|P1|COMPLETED|Overall Study||18
8274908|NCT01707420|20404190|P2|STARTED|Overall Study||18
8274909|NCT01707420|20404191|P1|STARTED|Overall Study||18
8274910|NCT01707381|20404201|P2|NOT COMPLETED|Period 2||0
8274911|NCT01707381|20404202|P1|NOT COMPLETED|Period 2||0
8274912|NCT01707381|20404201|P2|COMPLETED|Period 2||11
8274913|NCT01707381|20404202|P1|COMPLETED|Period 2||10
8274914|NCT01707381|20404201|P2|STARTED|Period 2||11
8274915|NCT01707381|20404202|P1|STARTED|Period 2||10
8274916|NCT01707381|20404201|P2|NOT COMPLETED|Period 1||2
8274917|NCT01707381|20404202|P1|NOT COMPLETED|Period 1||2
8274918|NCT01707381|20404201|P2|COMPLETED|Period 1||11
8274919|NCT01707381|20404202|P1|COMPLETED|Period 1||10
8274920|NCT01707381|20404201|P2|STARTED|Period 1||13
8274921|NCT01707381|20404202|P1|STARTED|Period 1||12
8274922|NCT01707368|20404212|P1|NOT COMPLETED|Overall Study||168
8274923|NCT01707368|20404212|P1|COMPLETED|Overall Study||393
8274924|NCT01707368|20404212|P1|STARTED|Overall Study||561
8274925|NCT01707290|20404221|P2|NOT COMPLETED|Overall Study||1
8274926|NCT01707290|20404222|P1|NOT COMPLETED|Overall Study||86
8274927|NCT01707290|20404221|P2|COMPLETED|Overall Study||3
8274928|NCT01707290|20404222|P1|COMPLETED|Overall Study||35
8274929|NCT01707290|20404221|P2|STARTED|Overall Study||4
8274930|NCT01707290|20404222|P1|STARTED|Overall Study||121
8274931|NCT01707238|20404245|P2|NOT COMPLETED|Overall Study||0
8274932|NCT01707238|20404246|P1|NOT COMPLETED|Overall Study||0
8274933|NCT01707238|20404245|P2|COMPLETED|Overall Study||52
8274934|NCT01707238|20404246|P1|COMPLETED|Overall Study||48
8274935|NCT01707238|20404245|P2|STARTED|Overall Study||52
8274936|NCT01707238|20404246|P1|STARTED|Overall Study||48
8274937|NCT01707225|20404262|P1|NOT COMPLETED|Overall Study||0
8274938|NCT01707225|20404262|P1|COMPLETED|Overall Study||10
8274939|NCT01707225|20404262|P1|STARTED|Overall Study||10
8274940|NCT01707147|20404267|P1|NOT COMPLETED|Overall Study||100
8274941|NCT01707147|20404267|P1|COMPLETED|Overall Study||3119
8274942|NCT01707147|20404267|P1|STARTED|Overall Study||3219
8274943|NCT01707095|20404277|P2|NOT COMPLETED|Overall Study||0
8274944|NCT01707095|20404278|P1|NOT COMPLETED|Overall Study||0
8274945|NCT01707095|20404277|P2|COMPLETED|Overall Study||42
8274946|NCT01707095|20404278|P1|COMPLETED|Overall Study||42
8274947|NCT01707095|20404277|P2|STARTED|Overall Study||42
8274948|NCT01707095|20404278|P1|STARTED|Overall Study||42
8274949|NCT01707043|20404288|P2|NOT COMPLETED|Overall Study||0
8274950|NCT01707043|20404289|P1|NOT COMPLETED|Overall Study||0
8274951|NCT01707043|20404288|P2|COMPLETED|Overall Study||10
8274952|NCT01707043|20404289|P1|COMPLETED|Overall Study||10
8274953|NCT01707043|20404288|P2|STARTED|Overall Study||10
8274954|NCT01707043|20404289|P1|STARTED|Overall Study||10
8274955|NCT01707030|20404299|P2|NOT COMPLETED|Overall Study||17
8274956|NCT01707030|20404300|P1|NOT COMPLETED|Overall Study||11
8274957|NCT01707030|20404299|P2|COMPLETED|Overall Study||54
8274958|NCT01707030|20404300|P1|COMPLETED|Overall Study||56
8274959|NCT01707030|20404299|P2|STARTED|Overall Study||71
8274960|NCT01707030|20404300|P1|STARTED|Overall Study||67
8274961|NCT01707004|20404318|P1|NOT COMPLETED|Overall Study||3
8274962|NCT01707004|20404318|P1|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
8274963|NCT01707004|20404318|P1|STARTED|Overall Study||20
8274964|NCT01706978|20404332|P2|NOT COMPLETED|Overall Study||6
8274965|NCT01706978|20404333|P1|NOT COMPLETED|Overall Study||9
8274966|NCT01706978|20404332|P2|COMPLETED|Overall Study||35
8274967|NCT01706978|20404333|P1|COMPLETED|Overall Study||38
8274968|NCT01706978|20404332|P2|STARTED|Overall Study||41
8274969|NCT01706978|20404333|P1|STARTED|Overall Study||47
8274970|NCT01706965|20404347|P2|NOT COMPLETED|Overall Study||1
8274971|NCT01706965|20404348|P1|NOT COMPLETED|Overall Study||1
8274972|NCT01706965|20404347|P2|COMPLETED|Overall Study||12
8274973|NCT01706965|20404348|P1|COMPLETED|Overall Study||13
8274974|NCT01706965|20404347|P2|STARTED|Overall Study||13
8274975|NCT01706965|20404348|P1|STARTED|Overall Study||14
8274976|NCT01706952|20404356|P1|NOT COMPLETED|Overall Study||8
8274977|NCT01706952|20404356|P1|COMPLETED|Overall Study||37
8274978|NCT01706952|20404356|P1|STARTED|Overall Study||45
8274979|NCT01706926|20404372|P4|NOT COMPLETED|Overall Study||5
8274980|NCT01706926|20404373|P3|NOT COMPLETED|Overall Study||6
8274981|NCT01706926|20404374|P2|NOT COMPLETED|Overall Study||4
8274982|NCT01706926|20404375|P1|NOT COMPLETED|Overall Study||6
8274983|NCT01706926|20404372|P4|COMPLETED|Overall Study||74
8274984|NCT01706926|20404373|P3|COMPLETED|Overall Study||79
8274985|NCT01706926|20404374|P2|COMPLETED|Overall Study||77
8274986|NCT01706926|20404375|P1|COMPLETED|Overall Study||75
8274987|NCT01706926|20404372|P4|STARTED|Overall Study||79
8274988|NCT01706926|20404373|P3|STARTED|Overall Study||85
8274989|NCT01706926|20404374|P2|STARTED|Overall Study||81
8274990|NCT01706926|20404375|P1|STARTED|Overall Study||81
8274991|NCT01706822|20404484|P1|NOT COMPLETED|Overall Study||0
8274992|NCT01706822|20404484|P1|COMPLETED|Overall Study||8
8274993|NCT01706822|20404484|P1|STARTED|Overall Study||8
8274994|NCT01706770|20404494|P2|NOT COMPLETED|Overall Study||0
8274995|NCT01706770|20404495|P1|NOT COMPLETED|Overall Study||2
8274996|NCT01706770|20404494|P2|COMPLETED|Overall Study||17
8274997|NCT01706770|20404495|P1|COMPLETED|Overall Study||31
8274998|NCT01706770|20404494|P2|STARTED|Overall Study||17
8274999|NCT01706770|20404495|P1|STARTED|Overall Study||33
8275000|NCT01706666|20404506|P3|NOT COMPLETED|Overall Study||0
8275001|NCT01706666|20404507|P2|NOT COMPLETED|Overall Study||0
8275002|NCT01706666|20404508|P1|NOT COMPLETED|Overall Study||0
8275003|NCT01706666|20404506|P3|COMPLETED|Overall Study||1
8275004|NCT01706666|20404507|P2|COMPLETED|Overall Study||1
8275005|NCT01706666|20404508|P1|COMPLETED|Overall Study||1
8275006|NCT01706666|20404506|P3|STARTED|Overall Study||1
8275007|NCT01706666|20404507|P2|STARTED|Overall Study||1
8275008|NCT01706666|20404508|P1|STARTED|Overall Study||1
8275009|NCT01706588|20404527|P5|NOT COMPLETED|Overall Study||0
8275010|NCT01706588|20404528|P4|NOT COMPLETED|Overall Study||0
8275011|NCT01706588|20404529|P3|NOT COMPLETED|Overall Study||0
8275012|NCT01706588|20404530|P2|NOT COMPLETED|Overall Study||0
8275013|NCT01706588|20404531|P1|NOT COMPLETED|Overall Study||0
8275014|NCT01706588|20404527|P5|COMPLETED|Overall Study||16
8275015|NCT01706588|20404528|P4|COMPLETED|Overall Study||14
8275016|NCT01706588|20404529|P3|COMPLETED|Overall Study||15
8275017|NCT01706588|20404530|P2|COMPLETED|Overall Study||15
8275018|NCT01706588|20404531|P1|COMPLETED|Overall Study||15
8275019|NCT01706588|20404527|P5|STARTED|Overall Study||16
8275020|NCT01706588|20404528|P4|STARTED|Overall Study||14
8275021|NCT01706588|20404529|P3|STARTED|Overall Study||15
8275022|NCT01706588|20404530|P2|STARTED|Overall Study||15
8275023|NCT01706588|20404531|P1|STARTED|Overall Study||15
8275024|NCT01706575|20404543|P1|NOT COMPLETED|Overall Study||12
8275025|NCT01706575|20404543|P1|COMPLETED|Overall Study||64
8275026|NCT01706575|20404543|P1|Treated|Overall Study||70
8275027|NCT01706575|20404543|P1|STARTED|Overall Study||76
8275028|NCT01706549|20404554|P1|NOT COMPLETED|Overall Study||0
8275029|NCT01706549|20404554|P1|COMPLETED|Overall Study||16
8275030|NCT01706549|20404554|P1|STARTED|Overall Study||16
8275031|NCT01706536|20404564|P5|NOT COMPLETED|Overall Study||2
8275032|NCT01706536|20404565|P4|NOT COMPLETED|Overall Study||4
8275033|NCT01706536|20404566|P3|NOT COMPLETED|Overall Study||5
8275034|NCT01706536|20404567|P2|NOT COMPLETED|Overall Study||4
8275035|NCT01706536|20404568|P1|NOT COMPLETED|Overall Study||4
8275036|NCT01706536|20404564|P5|COMPLETED|Overall Study||57
8275037|NCT01706536|20404565|P4|COMPLETED|Overall Study||53
8275038|NCT01706536|20404566|P3|COMPLETED|Overall Study||49
8275039|NCT01706536|20404567|P2|COMPLETED|Overall Study||51
8275040|NCT01706536|20404568|P1|COMPLETED|Overall Study||53
8275041|NCT01706536|20404564|P5|STARTED|Overall Study||59
8275042|NCT01706536|20404565|P4|STARTED|Overall Study||57
8275043|NCT01706536|20404566|P3|STARTED|Overall Study||54
8275044|NCT01706536|20404567|P2|STARTED|Overall Study||55
8275045|NCT01706536|20404568|P1|STARTED|Overall Study||57
8275046|NCT01706497|20404625|P1|NOT COMPLETED|Overall Study||0
8275047|NCT01706497|20404625|P1|COMPLETED|Overall Study||177
8275048|NCT01706497|20404625|P1|STARTED|Overall Study||177
8275049|NCT01706458|20404635|P2|NOT COMPLETED|Overall Study||4
8275050|NCT01706458|20404636|P1|NOT COMPLETED|Overall Study||3
8275051|NCT01706458|20404635|P2|COMPLETED|Overall Study||5
8275052|NCT01706458|20404636|P1|COMPLETED|Overall Study||6
8275053|NCT01706458|20404635|P2|STARTED|Overall Study||9
8275054|NCT01706458|20404636|P1|STARTED|Overall Study||9
8275055|NCT01706328|20404660|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
8275056|NCT01706328|20404661|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
8275057|NCT01706328|20404662|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
8275058|NCT01706328|20404660|P3|COMPLETED|12-week Double-blind Treatment Period||371
8275059|NCT01706328|20404661|P2|COMPLETED|12-week Double-blind Treatment Period||366
8275060|NCT01706328|20404662|P1|COMPLETED|12-week Double-blind Treatment Period||0
8275061|NCT01706328|20404660|P3|STARTED|12-week Double-blind Treatment Period||416
8275062|NCT01706328|20404661|P2|STARTED|12-week Double-blind Treatment Period||412
8275063|NCT01706328|20404662|P1|STARTED|12-week Double-blind Treatment Period||0
8275064|NCT01706328|20404660|P3|NOT COMPLETED|2-week Run-in Period||0
8275065|NCT01706328|20404661|P2|NOT COMPLETED|2-week Run-in Period||0
8275066|NCT01706328|20404662|P1|NOT COMPLETED|2-week Run-in Period||165
8275067|NCT01706328|20404660|P3|COMPLETED|2-week Run-in Period||0
8275068|NCT01706328|20404661|P2|COMPLETED|2-week Run-in Period||0
8275069|NCT01706328|20404662|P1|COMPLETED|2-week Run-in Period||828
8275070|NCT01706328|20404660|P3|STARTED|2-week Run-in Period||0
8275071|NCT01706328|20404661|P2|STARTED|2-week Run-in Period||0
8275072|NCT01706328|20404662|P1|STARTED|2-week Run-in Period||993
8275073|NCT01706263|20404672|P1|NOT COMPLETED|Overall Study||0
8275074|NCT01706263|20404672|P1|COMPLETED|Overall Study||28
8275075|NCT01706263|20404672|P1|STARTED|Overall Study||28
8275076|NCT01706250|20404681|P1|NOT COMPLETED|Overall Study||2
8275077|NCT01706250|20404681|P1|COMPLETED|Overall Study||18
8275078|NCT01706250|20404681|P1|STARTED|Overall Study||20
8275079|NCT01706198|20404712|P2|NOT COMPLETED|Overall Study||194
8275080|NCT01706198|20404713|P1|NOT COMPLETED|Overall Study||173
8275081|NCT01706198|20404712|P2|COMPLETED|Overall Study||1920
8275082|NCT01706198|20404713|P1|COMPLETED|Overall Study||1946
8275083|NCT01706198|20404712|P2|STARTED|Overall Study||2114
8275084|NCT01706198|20404713|P1|STARTED|Overall Study||2119
8275085|NCT01706159|20404765|P2|NOT COMPLETED|Overall Study||2
8275086|NCT01706159|20404766|P1|NOT COMPLETED|Overall Study||8
8275087|NCT01706159|20404765|P2|COMPLETED|Overall Study||4
8275088|NCT01706159|20404766|P1|COMPLETED|Overall Study||6
8275089|NCT01706159|20404765|P2|Completers (With Baron Score at Week 8)|Overall Study||3
8275090|NCT01706159|20404766|P1|Completers (With Baron Score at Week 8)|Overall Study||6
8275091|NCT01706159|20404765|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
8275092|NCT01706159|20404766|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
8275093|NCT01706159|20404765|P2|STARTED|Overall Study||6
8275094|NCT01706159|20404766|P1|STARTED|Overall Study||14
8275095|NCT01706146|20404780|P1|NOT COMPLETED|Overall Study||6
8275096|NCT01706146|20404780|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
8275097|NCT01706146|20404780|P1|STARTED|Overall Study||59
8275098|NCT01706081|20404787|P2|NOT COMPLETED|Overall Study||0
8275099|NCT01706081|20404788|P1|NOT COMPLETED|Overall Study||0
8275100|NCT01706081|20404787|P2|COMPLETED|Overall Study||42
8275101|NCT01706081|20404788|P1|COMPLETED|Overall Study||40
8275102|NCT01706081|20404787|P2|STARTED|Overall Study||42
8275103|NCT01706081|20404788|P1|STARTED|Overall Study||40
8275104|NCT01706003|20404800|P2|NOT COMPLETED|Overall Study||4
8275105|NCT01706003|20404801|P1|NOT COMPLETED|Overall Study||11
8275106|NCT01706003|20404800|P2|COMPLETED|Overall Study||18
8275107|NCT01706003|20404801|P1|COMPLETED|Overall Study||12
8275108|NCT01706003|20404800|P2|STARTED|Overall Study||22
8275109|NCT01706003|20404801|P1|STARTED|Overall Study||23
8275110|NCT01705977|20404809|P2|NOT COMPLETED|Overall Study||260
8275111|NCT01705977|20404810|P1|NOT COMPLETED|Overall Study||273
8275112|NCT01705977|20404809|P2|COMPLETED|Overall Study||1741
8275113|NCT01705977|20404810|P1|COMPLETED|Overall Study||1729
8275114|NCT01705977|20404809|P2|STARTED|Overall Study||2001
8275115|NCT01705977|20404810|P1|STARTED|Overall Study||2002
8275116|NCT01705730|20404828|P1|NOT COMPLETED|Overall Study||9
8275117|NCT01705730|20404828|P1|COMPLETED|Overall Study||59
8275118|NCT01705730|20404828|P1|STARTED|Overall Study|Participants who received study drug|68
8275119|NCT01705717|20404868|P2|NOT COMPLETED|Overall Study||5
8275120|NCT01705717|20404869|P1|NOT COMPLETED|Overall Study||2
8275121|NCT01705717|20404868|P2|COMPLETED|Overall Study||7
8275122|NCT01705717|20404869|P1|COMPLETED|Overall Study||35
8275123|NCT01705717|20404868|P2|STARTED|Overall Study||12
8275124|NCT01705717|20404869|P1|STARTED|Overall Study||37
8275125|NCT01705691|20404886|P2|NOT COMPLETED|Overall Study||6
8275126|NCT01705691|20404887|P1|NOT COMPLETED|Overall Study||3
8275127|NCT01705691|20404886|P2|COMPLETED|Overall Study||24
8275128|NCT01705691|20404887|P1|COMPLETED|Overall Study||16
8275129|NCT01705691|20404886|P2|STARTED|Overall Study||30
8275130|NCT01705691|20404887|P1|STARTED|Overall Study||19
8275131|NCT01705652|20404907|P2|NOT COMPLETED|Overall Study||3
8275132|NCT01705652|20404908|P1|NOT COMPLETED|Overall Study||3
8275133|NCT01705652|20404907|P2|COMPLETED|Overall Study||9
8275134|NCT01705652|20404908|P1|COMPLETED|Overall Study||6
8275135|NCT01705652|20404907|P2|STARTED|Overall Study||12
8275136|NCT01705652|20404908|P1|STARTED|Overall Study||9
8275137|NCT01705587|20404916|P2|NOT COMPLETED|Overall Study||1
8275138|NCT01705587|20404917|P1|NOT COMPLETED|Overall Study||0
8275139|NCT01705587|20404916|P2|COMPLETED|Overall Study||5
8275140|NCT01705587|20404917|P1|COMPLETED|Overall Study||7
8275141|NCT01705587|20404916|P2|STARTED|Overall Study||6
8275142|NCT01705587|20404917|P1|STARTED|Overall Study||7
8275143|NCT01705574|20404935|P4|NOT COMPLETED|Open-Label Extension Phase||5
8275144|NCT01705574|20404936|P3|NOT COMPLETED|Open-Label Extension Phase||11
8275145|NCT01705574|20404937|P2|NOT COMPLETED|Open-Label Extension Phase||0
8275146|NCT01705574|20404938|P1|NOT COMPLETED|Open-Label Extension Phase||15
8275147|NCT01705574|20404935|P4|COMPLETED|Open-Label Extension Phase||48
8275148|NCT01705574|20404936|P3|COMPLETED|Open-Label Extension Phase||148
8275149|NCT01705574|20404937|P2|COMPLETED|Open-Label Extension Phase||0
8275150|NCT01705574|20404938|P1|COMPLETED|Open-Label Extension Phase||231
8275151|NCT01705574|20404935|P4|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
8275152|NCT01705574|20404936|P3|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
8275153|NCT01705574|20404937|P2|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
8275154|NCT01705574|20404938|P1|STARTED|Open-Label Extension Phase||246
8275155|NCT01705574|20404935|P4|NOT COMPLETED|Double-Blind Phase||0
8275156|NCT01705574|20404936|P3|NOT COMPLETED|Double-Blind Phase||0
8275157|NCT01705574|20404937|P2|NOT COMPLETED|Double-Blind Phase||41
8275158|NCT01705574|20404938|P1|NOT COMPLETED|Double-Blind Phase||33
8275159|NCT01705574|20404935|P4|COMPLETED|Double-Blind Phase||0
8275160|NCT01705574|20404936|P3|COMPLETED|Double-Blind Phase||0
8275161|NCT01705574|20404937|P2|COMPLETED|Double-Blind Phase||249
8275162|NCT01705574|20404938|P1|COMPLETED|Double-Blind Phase||260
8275163|NCT01705574|20404935|P4|STARTED|Double-Blind Phase||0
8275164|NCT01705574|20404936|P3|STARTED|Double-Blind Phase||0
8275165|NCT01705574|20404937|P2|STARTED|Double-Blind Phase||290
8275166|NCT01705574|20404938|P1|STARTED|Double-Blind Phase||293
8275167|NCT01705509|20404955|P1|NOT COMPLETED|CPET w/ Ranexa||2
8275168|NCT01705509|20404955|P1|COMPLETED|CPET w/ Ranexa||5
8275169|NCT01705509|20404955|P1|STARTED|CPET w/ Ranexa||7
8275170|NCT01705509|20404955|P1|NOT COMPLETED|Inclusion CPET||7
8275171|NCT01705509|20404955|P1|COMPLETED|Inclusion CPET||7
8275172|NCT01705509|20404955|P1|STARTED|Inclusion CPET||14
8275173|NCT01705496|20404959|P1|NOT COMPLETED|Overall Study||4
8275174|NCT01705496|20404959|P1|COMPLETED|Overall Study||19
8275175|NCT01705496|20404959|P1|STARTED|Overall Study||23
8275176|NCT01705288|20404971|P2|NOT COMPLETED|Overall Study||0
8275177|NCT01705288|20404972|P1|NOT COMPLETED|Overall Study||0
8275178|NCT01705288|20404971|P2|COMPLETED|Overall Study||51
8275179|NCT01705288|20404972|P1|COMPLETED|Overall Study||52
8275180|NCT01705288|20404971|P2|STARTED|Overall Study||51
8275181|NCT01705288|20404972|P1|STARTED|Overall Study||52
8275182|NCT01705236|20404982|P1|NOT COMPLETED|Overall Study||27
8275183|NCT01705236|20404982|P1|COMPLETED|Overall Study||60
8275184|NCT01705236|20404982|P1|STARTED|Overall Study||87
8275185|NCT01705145|20404991|P1|NOT COMPLETED|Part B||1
8275186|NCT01705145|20404991|P1|COMPLETED|Part B||33
8275187|NCT01705145|20404991|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
8275188|NCT01705145|20404991|P1|NOT COMPLETED|Part A||0
8275189|NCT01705145|20404991|P1|COMPLETED|Part A||9
8275190|NCT01705145|20404991|P1|STARTED|Part A||9
8275191|NCT01705106|20405019|P1|NOT COMPLETED|Overall Study||0
8275192|NCT01705106|20405019|P1|COMPLETED|Overall Study||21
8275193|NCT01705106|20405019|P1|STARTED|Overall Study||21
8275194|NCT01705080|20405031|P4|NOT COMPLETED|Overall Study||42
8275195|NCT01705080|20405032|P3|NOT COMPLETED|Overall Study||5
8275196|NCT01705080|20405033|P2|NOT COMPLETED|Overall Study||16
8275197|NCT01705080|20405034|P1|NOT COMPLETED|Overall Study||15
8275198|NCT01705080|20405031|P4|COMPLETED|Overall Study||9
8275199|NCT01705080|20405032|P3|COMPLETED|Overall Study||27
8275200|NCT01705080|20405033|P2|COMPLETED|Overall Study||98
8275201|NCT01705080|20405034|P1|COMPLETED|Overall Study||142
8275202|NCT01705080|20405031|P4|1 Month|Overall Study||10
8275203|NCT01705080|20405032|P3|1 Month|Overall Study||27
8275204|NCT01705080|20405033|P2|1 Month|Overall Study||97
8275205|NCT01705080|20405034|P1|1 Month|Overall Study||148
8275206|NCT01705080|20405031|P4|Procedure|Overall Study||10
8275207|NCT01705080|20405032|P3|Procedure|Overall Study||29
8275208|NCT01705080|20405033|P2|Procedure|Overall Study||103
8275209|NCT01705080|20405034|P1|Procedure|Overall Study||149
8275210|NCT01705080|20405031|P4|STARTED|Overall Study||51
8275211|NCT01705080|20405032|P3|STARTED|Overall Study||32
8275212|NCT01705080|20405033|P2|STARTED|Overall Study||114
8275213|NCT01705080|20405034|P1|STARTED|Overall Study||157
8275214|NCT01704976|20405146|P2|NOT COMPLETED|Overall Study||2
8275215|NCT01704976|20405147|P1|NOT COMPLETED|Overall Study||1
8275216|NCT01704976|20405146|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
8275217|NCT01704976|20405147|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
8275218|NCT01704976|20405146|P2|STARTED|Overall Study||13
8275219|NCT01704976|20405147|P1|STARTED|Overall Study||14
8275220|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 4||0
8275221|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 4||0
8275222|NCT01704846|20405163|P2|COMPLETED|Treatment Period 4||29
8275223|NCT01704846|20405164|P1|COMPLETED|Treatment Period 4||30
8275224|NCT01704846|20405163|P2|STARTED|Treatment Period 4||29
8275225|NCT01704846|20405164|P1|STARTED|Treatment Period 4||30
8275226|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 3||0
8275227|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 3||0
8275228|NCT01704846|20405163|P2|COMPLETED|Treatment Period 3||29
8275229|NCT01704846|20405164|P1|COMPLETED|Treatment Period 3||30
8275230|NCT01704846|20405163|P2|STARTED|Treatment Period 3||29
8275231|NCT01704846|20405164|P1|STARTED|Treatment Period 3||30
8275232|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 2||1
8275233|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 2||0
8275234|NCT01704846|20405163|P2|COMPLETED|Treatment Period 2||29
8275235|NCT01704846|20405164|P1|COMPLETED|Treatment Period 2||30
8275236|NCT01704846|20405163|P2|STARTED|Treatment Period 2||30
8275237|NCT01704846|20405164|P1|STARTED|Treatment Period 2||30
8275238|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 1||0
8275239|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 1||0
8275240|NCT01704846|20405163|P2|COMPLETED|Treatment Period 1||30
8275241|NCT01704846|20405164|P1|COMPLETED|Treatment Period 1||30
8275242|NCT01704846|20405163|P2|STARTED|Treatment Period 1||30
8275243|NCT01704846|20405164|P1|STARTED|Treatment Period 1||30
8275244|NCT01704781|20405187|P5|NOT COMPLETED|Overall Study||0
8275245|NCT01704781|20405188|P4|NOT COMPLETED|Overall Study||0
8275246|NCT01704781|20405189|P3|NOT COMPLETED|Overall Study||0
8275247|NCT01704781|20405190|P2|NOT COMPLETED|Overall Study||0
8275248|NCT01704781|20405191|P1|NOT COMPLETED|Overall Study||0
8275249|NCT01704781|20405187|P5|COMPLETED|Overall Study||12
8275250|NCT01704781|20405188|P4|COMPLETED|Overall Study||12
8275251|NCT01704781|20405189|P3|COMPLETED|Overall Study||6
8275252|NCT01704781|20405190|P2|COMPLETED|Overall Study||3
8275253|NCT01704781|20405191|P1|COMPLETED|Overall Study||3
8275254|NCT01704781|20405187|P5|STARTED|Overall Study||12
8275255|NCT01704781|20405188|P4|STARTED|Overall Study||12
8275256|NCT01704781|20405189|P3|STARTED|Overall Study||6
8275257|NCT01704781|20405190|P2|STARTED|Overall Study||3
8275258|NCT01704781|20405191|P1|STARTED|Overall Study||3
8275259|NCT01704755|20405219|P2|NOT COMPLETED|Overall Study||7
8275260|NCT01704755|20405220|P1|NOT COMPLETED|Overall Study||12
8275261|NCT01704755|20405219|P2|COMPLETED|Overall Study||165
8275262|NCT01704755|20405220|P1|COMPLETED|Overall Study||196
8275263|NCT01704755|20405219|P2|Completed Study Drug|Overall Study||163
8275264|NCT01704755|20405220|P1|Completed Study Drug|Overall Study||204
8275265|NCT01704755|20405219|P2|STARTED|Overall Study||172
8275266|NCT01704755|20405220|P1|STARTED|Overall Study||208
8275267|NCT01704651|20405234|P2|NOT COMPLETED|Overall Study||7
8275268|NCT01704651|20405235|P1|NOT COMPLETED|Overall Study||5
8275269|NCT01704651|20405234|P2|COMPLETED|Overall Study||68
8275270|NCT01704651|20405235|P1|COMPLETED|Overall Study||66
8275271|NCT01704651|20405234|P2|STARTED|Overall Study||75
8275272|NCT01704651|20405235|P1|STARTED|Overall Study||71
8275273|NCT01704599|20405243|P1|NOT COMPLETED|Overall Study||1
8275274|NCT01704599|20405243|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
8275275|NCT01704599|20405243|P1|STARTED|Overall Study|Study was started January 22, 2010|8
8275276|NCT01704521|20405272|P2|NOT COMPLETED|Overall Study||0
8275277|NCT01704521|20405273|P1|NOT COMPLETED|Overall Study||0
8275278|NCT01704521|20405272|P2|COMPLETED|Overall Study||2
8275279|NCT01704521|20405273|P1|COMPLETED|Overall Study||3
8275280|NCT01704521|20405272|P2|STARTED|Overall Study||2
8275281|NCT01704521|20405273|P1|STARTED|Overall Study||3
8275282|NCT01704495|20405283|P4|NOT COMPLETED|Optional Safety Extension||31
8275283|NCT01704495|20405284|P3|NOT COMPLETED|Optional Safety Extension||31
8275284|NCT01704495|20405285|P2|NOT COMPLETED|Optional Safety Extension||33
8275285|NCT01704495|20405286|P1|NOT COMPLETED|Optional Safety Extension||29
8275286|NCT01704495|20405283|P4|COMPLETED|Optional Safety Extension||85
8275287|NCT01704495|20405284|P3|COMPLETED|Optional Safety Extension||83
8275288|NCT01704495|20405285|P2|COMPLETED|Optional Safety Extension||88
8275289|NCT01704495|20405286|P1|COMPLETED|Optional Safety Extension||87
8275290|NCT01704495|20405283|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
8275291|NCT01704495|20405284|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
8275292|NCT01704495|20405285|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
8275293|NCT01704495|20405286|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
8275294|NCT01704495|20405283|P4|NOT COMPLETED|Subjects Randomized||17
8275295|NCT01704495|20405284|P3|NOT COMPLETED|Subjects Randomized||16
8275296|NCT01704495|20405285|P2|NOT COMPLETED|Subjects Randomized||15
8275297|NCT01704495|20405286|P1|NOT COMPLETED|Subjects Randomized||22
8275298|NCT01704495|20405283|P4|COMPLETED|Subjects Randomized||145
8275299|NCT01704495|20405284|P3|COMPLETED|Subjects Randomized||144
8275300|NCT01704495|20405285|P2|COMPLETED|Subjects Randomized||141
8275301|NCT01704495|20405286|P1|COMPLETED|Subjects Randomized||140
8275302|NCT01704495|20405283|P4|STARTED|Subjects Randomized||162
8275303|NCT01704495|20405284|P3|STARTED|Subjects Randomized||160
8275304|NCT01704495|20405285|P2|STARTED|Subjects Randomized||156
8275305|NCT01704495|20405286|P1|STARTED|Subjects Randomized||162
8275306|NCT01704456|20405462|P2|NOT COMPLETED|Overall Study||14
8275307|NCT01704456|20405463|P1|NOT COMPLETED|Overall Study||8
8275308|NCT01704456|20405462|P2|COMPLETED|Overall Study||49
8275309|NCT01704456|20405463|P1|COMPLETED|Overall Study||59
8275310|NCT01704456|20405462|P2|STARTED|Overall Study||63
8275311|NCT01704456|20405463|P1|STARTED|Overall Study||67
8275312|NCT01704404|20405483|P6|NOT COMPLETED|Overall Study||0
8275313|NCT01704404|20405484|P5|NOT COMPLETED|Overall Study||1
8275314|NCT01704404|20405485|P4|NOT COMPLETED|Overall Study||3
8275315|NCT01704404|20405486|P3|NOT COMPLETED|Overall Study||1
8275316|NCT01704404|20405487|P2|NOT COMPLETED|Overall Study||1
8275317|NCT01704404|20405488|P1|NOT COMPLETED|Overall Study||1
8275318|NCT01704404|20405483|P6|COMPLETED|Overall Study||9
8275319|NCT01704404|20405484|P5|COMPLETED|Overall Study||10
8275320|NCT01704404|20405485|P4|COMPLETED|Overall Study||8
8275321|NCT01704404|20405486|P3|COMPLETED|Overall Study||9
8275322|NCT01704404|20405487|P2|COMPLETED|Overall Study||9
8275323|NCT01704404|20405488|P1|COMPLETED|Overall Study||10
8275324|NCT01704404|20405483|P6|STARTED|Overall Study||9
8275325|NCT01704404|20405484|P5|STARTED|Overall Study||11
8275326|NCT01704404|20405485|P4|STARTED|Overall Study||11
8275327|NCT01704404|20405486|P3|STARTED|Overall Study||10
8275328|NCT01704404|20405487|P2|STARTED|Overall Study||10
8275329|NCT01704404|20405488|P1|STARTED|Overall Study||11
8275330|NCT01704287|20405525|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
8275331|NCT01704287|20405526|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
8275332|NCT01704287|20405527|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275333|NCT01704287|20405528|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275334|NCT01704287|20405529|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275335|NCT01704287|20405525|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||7
8275336|NCT01704287|20405526|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||15
8275337|NCT01704287|20405527|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275338|NCT01704287|20405528|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275339|NCT01704287|20405529|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275340|NCT01704287|20405525|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
8275341|NCT01704287|20405526|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
8275342|NCT01704287|20405527|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
8275343|NCT01704287|20405528|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
8275344|NCT01704287|20405529|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
8275345|NCT01704287|20405525|P5|NOT COMPLETED|Initial Treatment Period||0
8275346|NCT01704287|20405526|P4|NOT COMPLETED|Initial Treatment Period||0
8275347|NCT01704287|20405527|P3|NOT COMPLETED|Initial Treatment Period||173
8275348|NCT01704287|20405528|P2|NOT COMPLETED|Initial Treatment Period||134
8275349|NCT01704287|20405529|P1|NOT COMPLETED|Initial Treatment Period||147
8275350|NCT01704287|20405525|P5|COMPLETED|Initial Treatment Period||0
8275351|NCT01704287|20405526|P4|COMPLETED|Initial Treatment Period||0
8275352|NCT01704287|20405527|P3|COMPLETED|Initial Treatment Period||6
8275353|NCT01704287|20405528|P2|COMPLETED|Initial Treatment Period||47
8275354|NCT01704287|20405529|P1|COMPLETED|Initial Treatment Period||33
8275355|NCT01704287|20405525|P5|Treated|Initial Treatment Period||0
8275356|NCT01704287|20405526|P4|Treated|Initial Treatment Period||0
8275357|NCT01704287|20405527|P3|Treated|Initial Treatment Period||171
8275358|NCT01704287|20405528|P2|Treated|Initial Treatment Period||179
8275359|NCT01704287|20405529|P1|Treated|Initial Treatment Period||178
8275360|NCT01704287|20405525|P5|STARTED|Initial Treatment Period||0
8275361|NCT01704287|20405526|P4|STARTED|Initial Treatment Period||0
8275362|NCT01704287|20405527|P3|STARTED|Initial Treatment Period||179
8275363|NCT01704287|20405528|P2|STARTED|Initial Treatment Period||181
8275364|NCT01704287|20405529|P1|STARTED|Initial Treatment Period||180
8275365|NCT01704261|20405577|P2|NOT COMPLETED|Overall Study||15
8275366|NCT01704261|20405578|P1|NOT COMPLETED|Overall Study||13
8275367|NCT01704261|20405577|P2|COMPLETED|Overall Study||138
8275368|NCT01704261|20405578|P1|COMPLETED|Overall Study||141
8275369|NCT01704261|20405577|P2|STARTED|Overall Study||153
8275370|NCT01704261|20405578|P1|STARTED|Overall Study||154
8275371|NCT01704196|20405594|P2|NOT COMPLETED|Overall Study||24
8275372|NCT01704196|20405595|P1|NOT COMPLETED|Overall Study||19
8275373|NCT01704196|20405594|P2|COMPLETED|Overall Study||65
8275374|NCT01704196|20405595|P1|COMPLETED|Overall Study||71
8275375|NCT01704196|20405594|P2|STARTED|Overall Study||89
8275376|NCT01704196|20405595|P1|STARTED|Overall Study||90
8275377|NCT01704079|20405605|P2|NOT COMPLETED|Overall Study||23
8275378|NCT01704079|20405606|P1|NOT COMPLETED|Overall Study||14
8275379|NCT01704079|20405605|P2|COMPLETED|Overall Study||121
8275380|NCT01704079|20405606|P1|COMPLETED|Overall Study||58
8275381|NCT01704079|20405605|P2|Entered Extension Study|Overall Study||102
8275382|NCT01704079|20405606|P1|Entered Extension Study|Overall Study||53
8275383|NCT01704079|20405605|P2|STARTED|Overall Study||144
8275384|NCT01704079|20405606|P1|STARTED|Overall Study||72
8275385|NCT01703988|20405622|P4|NOT COMPLETED|Overall Study||1
8275386|NCT01703988|20405623|P3|NOT COMPLETED|Overall Study||0
8275387|NCT01703988|20405624|P2|NOT COMPLETED|Overall Study||0
8275388|NCT01703988|20405625|P1|NOT COMPLETED|Overall Study||0
8275389|NCT01703988|20405622|P4|COMPLETED|Overall Study||8
8275390|NCT01703988|20405623|P3|COMPLETED|Overall Study||9
8275391|NCT01703988|20405624|P2|COMPLETED|Overall Study||8
8275392|NCT01703988|20405625|P1|COMPLETED|Overall Study||8
8275393|NCT01703988|20405622|P4|STARTED|Overall Study||9
8275394|NCT01703988|20405623|P3|STARTED|Overall Study||9
8275395|NCT01703988|20405624|P2|STARTED|Overall Study||8
8275396|NCT01703988|20405625|P1|STARTED|Overall Study||8
8275397|NCT01703858|20405655|P3|NOT COMPLETED|Overall Study||0
8275398|NCT01703858|20405656|P2|NOT COMPLETED|Overall Study||1
8275399|NCT01703858|20405657|P1|NOT COMPLETED|Overall Study||0
8275400|NCT01703858|20405655|P3|COMPLETED|Overall Study||5
8275401|NCT01703858|20405656|P2|COMPLETED|Overall Study||4
8275402|NCT01703858|20405657|P1|COMPLETED|Overall Study||5
8275403|NCT01703858|20405655|P3|STARTED|Overall Study||5
8275404|NCT01703858|20405656|P2|STARTED|Overall Study||5
8275405|NCT01703858|20405657|P1|STARTED|Overall Study||5
8275406|NCT01703845|20405682|P2|NOT COMPLETED|Overall Study||0
8275407|NCT01703845|20405683|P1|NOT COMPLETED|Overall Study||3
8275408|NCT01703845|20405682|P2|COMPLETED|Overall Study||16
8275409|NCT01703845|20405683|P1|COMPLETED|Overall Study||13
8275410|NCT01703845|20405682|P2|STARTED|Overall Study|started are actually the randomized|16
8275411|NCT01703845|20405683|P1|STARTED|Overall Study|started are actually the randomized|16
8275412|NCT01703832|20405720|P2|NOT COMPLETED|Overall Study||0
8275413|NCT01703832|20405721|P1|NOT COMPLETED|Overall Study||1
8275414|NCT01703832|20405720|P2|COMPLETED|Overall Study||32
8275415|NCT01703832|20405721|P1|COMPLETED|Overall Study||32
8275416|NCT01703832|20405720|P2|STARTED|Overall Study||32
8275417|NCT01703832|20405721|P1|STARTED|Overall Study||33
8275418|NCT01703819|20405753|P2|NOT COMPLETED|Overall Study||2
8275419|NCT01703819|20405754|P1|NOT COMPLETED|Overall Study||0
8275420|NCT01703819|20405753|P2|COMPLETED|Overall Study||30
8275421|NCT01703819|20405754|P1|COMPLETED|Overall Study||34
8275422|NCT01703819|20405753|P2|STARTED|Overall Study||32
8275423|NCT01703819|20405754|P1|STARTED|Overall Study||34
8275424|NCT01703741|20405784|P1|NOT COMPLETED|Overall Study||18
8275425|NCT01703741|20405784|P1|COMPLETED|Overall Study||127
8275426|NCT01703741|20405784|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
8275427|NCT01703741|20405784|P1|STARTED|Overall Study||145
8275428|NCT01703702|20405802|P2|NOT COMPLETED|Overall Study||22
8275429|NCT01703702|20405803|P1|NOT COMPLETED|Overall Study||36
8275430|NCT01703702|20405802|P2|COMPLETED|Overall Study||288
8275431|NCT01703702|20405803|P1|COMPLETED|Overall Study||272
8275432|NCT01703702|20405802|P2|STARTED|Overall Study||310
8275433|NCT01703702|20405803|P1|STARTED|Overall Study||308
8275434|NCT01703663|20405820|P2|NOT COMPLETED|Second Treatment Period||0
8275435|NCT01703663|20405821|P1|NOT COMPLETED|Second Treatment Period||0
8275436|NCT01703663|20405820|P2|COMPLETED|Second Treatment Period||8
8275437|NCT01703663|20405821|P1|COMPLETED|Second Treatment Period||11
8275438|NCT01703663|20405820|P2|STARTED|Second Treatment Period||8
8275439|NCT01703663|20405821|P1|STARTED|Second Treatment Period||11
8275440|NCT01703663|20405820|P2|NOT COMPLETED|First Treatment Period||0
8275441|NCT01703663|20405821|P1|NOT COMPLETED|First Treatment Period||0
8275442|NCT01703663|20405820|P2|COMPLETED|First Treatment Period||20
8275443|NCT01703663|20405821|P1|COMPLETED|First Treatment Period||20
8275444|NCT01703663|20405820|P2|STARTED|First Treatment Period||20
8275445|NCT01703663|20405821|P1|STARTED|First Treatment Period||20
8275446|NCT01703598|20405827|P1|NOT COMPLETED|Overall Study||0
8275447|NCT01703598|20405827|P1|COMPLETED|Overall Study||69
8275448|NCT01703598|20405827|P1|STARTED|Overall Study||69
8275449|NCT01703507|20405833|P2|NOT COMPLETED|Overall Study||0
8275450|NCT01703507|20405834|P1|NOT COMPLETED|Overall Study||1
8275451|NCT01703507|20405833|P2|COMPLETED|Overall Study||11
8275452|NCT01703507|20405834|P1|COMPLETED|Overall Study||5
8275453|NCT01703507|20405833|P2|STARTED|Overall Study||11
8275454|NCT01703507|20405834|P1|STARTED|Overall Study||6
8275455|NCT01703286|20405850|P6|NOT COMPLETED|Period 3 Including Washout||0
8275456|NCT01703286|20405851|P5|NOT COMPLETED|Period 3 Including Washout||0
8275457|NCT01703286|20405852|P4|NOT COMPLETED|Period 3 Including Washout||0
8275458|NCT01703286|20405853|P3|NOT COMPLETED|Period 3 Including Washout||0
8275459|NCT01703286|20405854|P2|NOT COMPLETED|Period 3 Including Washout||0
8275460|NCT01703286|20405855|P1|NOT COMPLETED|Period 3 Including Washout||0
8275461|NCT01703286|20405850|P6|COMPLETED|Period 3 Including Washout||6
8275462|NCT01703286|20405851|P5|COMPLETED|Period 3 Including Washout||7
8275463|NCT01703286|20405852|P4|COMPLETED|Period 3 Including Washout||5
8275464|NCT01703286|20405853|P3|COMPLETED|Period 3 Including Washout||7
8275465|NCT01703286|20405854|P2|COMPLETED|Period 3 Including Washout||7
8275466|NCT01703286|20405855|P1|COMPLETED|Period 3 Including Washout||7
8275467|NCT01703286|20405850|P6|STARTED|Period 3 Including Washout||6
8275468|NCT01703286|20405851|P5|STARTED|Period 3 Including Washout||7
8275469|NCT01703286|20405852|P4|STARTED|Period 3 Including Washout||5
8275470|NCT01703286|20405853|P3|STARTED|Period 3 Including Washout||7
8275471|NCT01703286|20405854|P2|STARTED|Period 3 Including Washout||7
8275472|NCT01703286|20405855|P1|STARTED|Period 3 Including Washout||7
8275473|NCT01703286|20405850|P6|NOT COMPLETED|Period 2 Including Washout||0
8275474|NCT01703286|20405851|P5|NOT COMPLETED|Period 2 Including Washout||0
8275475|NCT01703286|20405852|P4|NOT COMPLETED|Period 2 Including Washout||1
8275476|NCT01703286|20405853|P3|NOT COMPLETED|Period 2 Including Washout||0
8275477|NCT01703286|20405854|P2|NOT COMPLETED|Period 2 Including Washout||0
8275478|NCT01703286|20405855|P1|NOT COMPLETED|Period 2 Including Washout||0
8275479|NCT01703286|20405850|P6|COMPLETED|Period 2 Including Washout||6
8275480|NCT01703286|20405851|P5|COMPLETED|Period 2 Including Washout||7
8275481|NCT01703286|20405852|P4|COMPLETED|Period 2 Including Washout||5
8275482|NCT01703286|20405853|P3|COMPLETED|Period 2 Including Washout||7
8275483|NCT01703286|20405854|P2|COMPLETED|Period 2 Including Washout||7
8275484|NCT01703286|20405855|P1|COMPLETED|Period 2 Including Washout||7
8275485|NCT01703286|20405850|P6|STARTED|Period 2 Including Washout||6
8275486|NCT01703286|20405851|P5|STARTED|Period 2 Including Washout||7
8275487|NCT01703286|20405852|P4|STARTED|Period 2 Including Washout||6
8275488|NCT01703286|20405853|P3|STARTED|Period 2 Including Washout||7
8275489|NCT01703286|20405854|P2|STARTED|Period 2 Including Washout||7
8275490|NCT01703286|20405855|P1|STARTED|Period 2 Including Washout||7
8275491|NCT01703286|20405850|P6|NOT COMPLETED|Period 1 Including Washout||1
8275492|NCT01703286|20405851|P5|NOT COMPLETED|Period 1 Including Washout||0
8275493|NCT01703286|20405852|P4|NOT COMPLETED|Period 1 Including Washout||1
8275494|NCT01703286|20405853|P3|NOT COMPLETED|Period 1 Including Washout||0
8275495|NCT01703286|20405854|P2|NOT COMPLETED|Period 1 Including Washout||0
8275496|NCT01703286|20405855|P1|NOT COMPLETED|Period 1 Including Washout||0
8275497|NCT01703286|20405850|P6|COMPLETED|Period 1 Including Washout||6
8275498|NCT01703286|20405851|P5|COMPLETED|Period 1 Including Washout||7
8275499|NCT01703286|20405852|P4|COMPLETED|Period 1 Including Washout||6
8275500|NCT01703286|20405853|P3|COMPLETED|Period 1 Including Washout||7
8275501|NCT01703286|20405854|P2|COMPLETED|Period 1 Including Washout||7
8275502|NCT01703286|20405855|P1|COMPLETED|Period 1 Including Washout||7
8275503|NCT01703286|20405850|P6|STARTED|Period 1 Including Washout||7
8275504|NCT01703286|20405851|P5|STARTED|Period 1 Including Washout||7
8275505|NCT01703286|20405852|P4|STARTED|Period 1 Including Washout||7
8275506|NCT01703286|20405853|P3|STARTED|Period 1 Including Washout||7
8275507|NCT01703286|20405854|P2|STARTED|Period 1 Including Washout||7
8275508|NCT01703286|20405855|P1|STARTED|Period 1 Including Washout||7
8275509|NCT01703260|20405878|P3|NOT COMPLETED|Overall Study||3
8275510|NCT01703260|20405879|P2|NOT COMPLETED|Overall Study||4
8275511|NCT01703260|20405880|P1|NOT COMPLETED|Overall Study||3
8275512|NCT01703260|20405878|P3|COMPLETED|Overall Study||3
8275513|NCT01703260|20405879|P2|COMPLETED|Overall Study||3
8275514|NCT01703260|20405880|P1|COMPLETED|Overall Study||4
8275515|NCT01703260|20405878|P3|STARTED|Overall Study||6
8275516|NCT01703260|20405879|P2|STARTED|Overall Study||7
8275517|NCT01703260|20405880|P1|STARTED|Overall Study||7
8275518|NCT01703221|20405906|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
8275519|NCT01703221|20405907|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
8275520|NCT01703221|20405908|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
8275521|NCT01703221|20405906|P3|COMPLETED|Phase B - (Week 25 to 52)||75
8275522|NCT01703221|20405907|P2|COMPLETED|Phase B - (Week 25 to 52)||147
8275523|NCT01703221|20405908|P1|COMPLETED|Phase B - (Week 25 to 52)||143
8275524|NCT01703221|20405906|P3|STARTED|Phase B - (Week 25 to 52)||80
8275525|NCT01703221|20405907|P2|STARTED|Phase B - (Week 25 to 52)||161
8275526|NCT01703221|20405908|P1|STARTED|Phase B - (Week 25 to 52)||159
8275527|NCT01703221|20405906|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8275528|NCT01703221|20405907|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
8275529|NCT01703221|20405908|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
8275530|NCT01703221|20405906|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
8275531|NCT01703221|20405907|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
8275532|NCT01703221|20405908|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
8275533|NCT01703221|20405906|P3|STARTED|Phase A (Up to 24 Weeks)||83
8275534|NCT01703221|20405907|P2|STARTED|Phase A (Up to 24 Weeks)||165
8275535|NCT01703221|20405908|P1|STARTED|Phase A (Up to 24 Weeks)||166
8275536|NCT01703208|20405939|P2|NOT COMPLETED|Overall Study||2102
8275537|NCT01703208|20405940|P1|NOT COMPLETED|Overall Study||2100
8275538|NCT01703208|20405939|P2|COMPLETED|Overall Study||0
8275539|NCT01703208|20405940|P1|COMPLETED|Overall Study||0
8275540|NCT01703208|20405939|P2|Treated|Overall Study||2100
8275541|NCT01703208|20405940|P1|Treated|Overall Study||2092
8275542|NCT01703208|20405939|P2|STARTED|Overall Study||2102
8275543|NCT01703208|20405940|P1|STARTED|Overall Study||2100
8275544|NCT01703169|20405994|P1|NOT COMPLETED|Overall Study||0
8275545|NCT01703169|20405994|P1|COMPLETED|Overall Study||13
8275546|NCT01703169|20405994|P1|STARTED|Overall Study||13
8275547|NCT01703091|20406004|P2|NOT COMPLETED|Overall Study||4
8275548|NCT01703091|20406005|P1|NOT COMPLETED|Overall Study||9
8275549|NCT01703091|20406004|P2|COMPLETED|Overall Study||95
8275550|NCT01703091|20406005|P1|COMPLETED|Overall Study||89
8275551|NCT01703091|20406004|P2|Received at Least One Dose of Study Drug|Overall Study||98
8275552|NCT01703091|20406005|P1|Received at Least One Dose of Study Drug|Overall Study||94
8275553|NCT01703091|20406004|P2|STARTED|Overall Study||99
8275554|NCT01703091|20406005|P1|STARTED|Overall Study||98
8275555|NCT01703065|20406023|P2|NOT COMPLETED|Overall Study||0
8275556|NCT01703065|20406024|P1|NOT COMPLETED|Overall Study||1
8275557|NCT01703065|20406023|P2|COMPLETED|Overall Study||0
8275558|NCT01703065|20406024|P1|COMPLETED|Overall Study||8
8275559|NCT01703065|20406023|P2|STARTED|Overall Study||0
8275560|NCT01703065|20406024|P1|STARTED|Overall Study||9
8275561|NCT01703039|20406039|P2|NOT COMPLETED|Overall Study||5
8275562|NCT01703039|20406040|P1|NOT COMPLETED|Overall Study||3
8275563|NCT01703039|20406039|P2|COMPLETED|Overall Study||7
8275564|NCT01703039|20406040|P1|COMPLETED|Overall Study||6
8275565|NCT01703039|20406039|P2|STARTED|Overall Study||12
8275566|NCT01703039|20406040|P1|STARTED|Overall Study||9
8275567|NCT01703000|20406054|P1|NOT COMPLETED|Overall Study||1
8275568|NCT01703000|20406054|P1|COMPLETED|Overall Study||99
8275569|NCT01703000|20406054|P1|STARTED|Overall Study||100
8275570|NCT01702987|20406087|P2|NOT COMPLETED|Overall Study||0
8275571|NCT01702987|20406088|P1|NOT COMPLETED|Overall Study||1
8275572|NCT01702987|20406087|P2|COMPLETED|Overall Study||12
8275573|NCT01702987|20406088|P1|COMPLETED|Overall Study||9
8275574|NCT01702987|20406087|P2|STARTED|Overall Study||12
8275575|NCT01702987|20406088|P1|STARTED|Overall Study||10
8275576|NCT01702961|20406094|P1|NOT COMPLETED|Overall Study||47
8275577|NCT01702961|20406094|P1|COMPLETED|Overall Study||28
8275578|NCT01702961|20406094|P1|STARTED|Overall Study||75
8275579|NCT01702909|20406100|P1|NOT COMPLETED|Overall Study||0
8275580|NCT01702909|20406100|P1|COMPLETED|Overall Study||7
8275581|NCT01702909|20406100|P1|STARTED|Overall Study||7
8275582|NCT01702896|20406106|P1|NOT COMPLETED|Overall Study||8
8275583|NCT01702896|20406106|P1|COMPLETED|Overall Study||0
8275584|NCT01702896|20406106|P1|STARTED|Overall Study||8
8275585|NCT01702844|20406112|P1|NOT COMPLETED|Overall Study||19
8275586|NCT01702844|20406112|P1|COMPLETED|Overall Study||23
8275587|NCT01702844|20406112|P1|Disease Progression|Overall Study||23
8275588|NCT01702844|20406112|P1|STARTED|Overall Study||42
8275589|NCT01702558|20406124|P5|NOT COMPLETED|Overall Study||42
8275590|NCT01702558|20406125|P4|NOT COMPLETED|Overall Study||47
8275591|NCT01702558|20406126|P3|NOT COMPLETED|Overall Study||5
8275592|NCT01702558|20406127|P2|NOT COMPLETED|Overall Study||4
8275593|NCT01702558|20406128|P1|NOT COMPLETED|Overall Study||4
8275594|NCT01702558|20406124|P5|COMPLETED|Overall Study||38
8275595|NCT01702558|20406125|P4|COMPLETED|Overall Study||34
8275596|NCT01702558|20406126|P3|COMPLETED|Overall Study||1
8275597|NCT01702558|20406127|P2|COMPLETED|Overall Study||1
8275598|NCT01702558|20406128|P1|COMPLETED|Overall Study||3
8275599|NCT01702558|20406124|P5|STARTED|Overall Study||80
8275600|NCT01702558|20406125|P4|STARTED|Overall Study||81
8275601|NCT01702558|20406126|P3|STARTED|Overall Study||6
8275602|NCT01702558|20406127|P2|STARTED|Overall Study||5
8275603|NCT01702558|20406128|P1|STARTED|Overall Study||7
8275604|NCT01702532|20406193|P2|NOT COMPLETED|Overall Study||1
8275605|NCT01702532|20406194|P1|NOT COMPLETED|Overall Study||0
8275606|NCT01702532|20406193|P2|COMPLETED|Overall Study||160
8275607|NCT01702532|20406194|P1|COMPLETED|Overall Study||161
8275608|NCT01702532|20406193|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
8275609|NCT01702532|20406194|P1|Safety Population|Overall Study||161
8275610|NCT01702532|20406193|P2|STARTED|Overall Study||161
8275611|NCT01702532|20406194|P1|STARTED|Overall Study||161
8275612|NCT01702519|20406204|P2|NOT COMPLETED|Period 2||0
8275613|NCT01702519|20406205|P1|NOT COMPLETED|Period 2||0
8275614|NCT01702519|20406204|P2|COMPLETED|Period 2||18
8275615|NCT01702519|20406205|P1|COMPLETED|Period 2||19
8275616|NCT01702519|20406204|P2|STARTED|Period 2||18
8275617|NCT01702519|20406205|P1|STARTED|Period 2||19
8275618|NCT01702519|20406204|P2|NOT COMPLETED|Washout Period||2
8275619|NCT01702519|20406205|P1|NOT COMPLETED|Washout Period||1
8275620|NCT01702519|20406204|P2|COMPLETED|Washout Period||18
8275621|NCT01702519|20406205|P1|COMPLETED|Washout Period||19
8275622|NCT01702519|20406204|P2|STARTED|Washout Period||20
8275623|NCT01702519|20406205|P1|STARTED|Washout Period||20
8275624|NCT01702519|20406204|P2|NOT COMPLETED|Period 1||0
8275625|NCT01702519|20406205|P1|NOT COMPLETED|Period 1||0
8275626|NCT01702519|20406204|P2|COMPLETED|Period 1||20
8275627|NCT01702519|20406205|P1|COMPLETED|Period 1||20
8275628|NCT01702519|20406204|P2|STARTED|Period 1||20
8275629|NCT01702519|20406205|P1|STARTED|Period 1||20
8275630|NCT01702454|20406223|P2|NOT COMPLETED|Overall Study||8
8275631|NCT01702454|20406224|P1|NOT COMPLETED|Overall Study||3
8275632|NCT01702454|20406223|P2|COMPLETED|Overall Study||221
8275633|NCT01702454|20406224|P1|COMPLETED|Overall Study||238
8275634|NCT01702454|20406223|P2|STARTED|Overall Study||229
8275635|NCT01702454|20406224|P1|STARTED|Overall Study||241
8275636|NCT01702428|20406306|P4|NOT COMPLETED|Overall Study||57
8275637|NCT01702428|20406307|P3|NOT COMPLETED|Overall Study||53
8275638|NCT01702428|20406308|P2|NOT COMPLETED|Overall Study||70
8275639|NCT01702428|20406309|P1|NOT COMPLETED|Overall Study||64
8275640|NCT01702428|20406306|P4|COMPLETED|Overall Study||1232
8275641|NCT01702428|20406307|P3|COMPLETED|Overall Study||1190
8275642|NCT01702428|20406308|P2|COMPLETED|Overall Study||1162
8275643|NCT01702428|20406309|P1|COMPLETED|Overall Study||1175
8275644|NCT01702428|20406306|P4|STARTED|Overall Study||1289
8275645|NCT01702428|20406307|P3|STARTED|Overall Study||1243
8275646|NCT01702428|20406308|P2|STARTED|Overall Study||1232
8275647|NCT01702428|20406309|P1|STARTED|Overall Study||1239
8275648|NCT01702363|20406396|P1|NOT COMPLETED|Overall Study||20
8275649|NCT01702363|20406396|P1|COMPLETED|Overall Study||111
8275650|NCT01702363|20406396|P1|STARTED|Overall Study||131
8275651|NCT01702311|20406413|P2|NOT COMPLETED|Overall Study||13
8275652|NCT01702311|20406414|P1|NOT COMPLETED|Overall Study||16
8275653|NCT01702311|20406413|P2|COMPLETED|Overall Study||100
8275654|NCT01702311|20406414|P1|COMPLETED|Overall Study||106
8275655|NCT01702311|20406413|P2|STARTED|Overall Study||113
8275656|NCT01702311|20406414|P1|STARTED|Overall Study||122
8275657|NCT01702298|20406444|P1|NOT COMPLETED|Overall Study||1
8275658|NCT01702298|20406444|P1|COMPLETED|Overall Study||41
8275659|NCT01702298|20406444|P1|STARTED|Overall Study||42
8275660|NCT01702259|20406457|P2|NOT COMPLETED|Overall Study||0
8275661|NCT01702259|20406458|P1|NOT COMPLETED|Overall Study||0
8275662|NCT01702259|20406457|P2|COMPLETED|Overall Study||34
8275663|NCT01702259|20406458|P1|COMPLETED|Overall Study||34
8275664|NCT01702259|20406457|P2|STARTED|Overall Study||34
8275665|NCT01702259|20406458|P1|STARTED|Overall Study||34
8275666|NCT01702246|20406472|P1|NOT COMPLETED|Overall Study||5
8275667|NCT01702246|20406472|P1|COMPLETED|Overall Study||19
8275668|NCT01702246|20406472|P1|STARTED|Overall Study||24
8275669|NCT01702233|20406484|P3|NOT COMPLETED|Overall Study||5
8275670|NCT01702233|20406485|P2|NOT COMPLETED|Overall Study||3
8275671|NCT01702233|20406486|P1|NOT COMPLETED|Overall Study||6
8275672|NCT01702233|20406484|P3|COMPLETED|Overall Study||31
8275673|NCT01702233|20406485|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
8275674|NCT01702233|20406486|P1|COMPLETED|Overall Study||66
8275675|NCT01702233|20406484|P3|Per Protocol Set|Overall Study||27
8275676|NCT01702233|20406485|P2|Per Protocol Set|Overall Study||58
8275677|NCT01702233|20406486|P1|Per Protocol Set|Overall Study||58
8275678|NCT01702233|20406484|P3|Full Analysis Set (ITT)|Overall Study||31
8275679|NCT01702233|20406485|P2|Full Analysis Set (ITT)|Overall Study||63
8275680|NCT01702233|20406486|P1|Full Analysis Set (ITT)|Overall Study||66
8275681|NCT01702233|20406484|P3|STARTED|Overall Study||36
8275682|NCT01702233|20406485|P2|STARTED|Overall Study||67
8275683|NCT01702233|20406486|P1|STARTED|Overall Study||72
8275684|NCT01702025|20406526|P4|NOT COMPLETED|Overall Study||0
8275685|NCT01702025|20406527|P3|NOT COMPLETED|Overall Study||1
8275686|NCT01702025|20406528|P2|NOT COMPLETED|Overall Study||1
8275687|NCT01702025|20406529|P1|NOT COMPLETED|Overall Study||2
8275688|NCT01702025|20406526|P4|COMPLETED|Overall Study||10
8275689|NCT01702025|20406527|P3|COMPLETED|Overall Study||9
8275690|NCT01702025|20406528|P2|COMPLETED|Overall Study||9
8275691|NCT01702025|20406529|P1|COMPLETED|Overall Study||9
8275692|NCT01702025|20406526|P4|STARTED|Overall Study||10
8275693|NCT01702025|20406527|P3|STARTED|Overall Study||10
8275694|NCT01702025|20406528|P2|STARTED|Overall Study||10
8275695|NCT01702025|20406529|P1|STARTED|Overall Study||11
8275696|NCT01701999|20406545|P2|NOT COMPLETED|Overall Study||0
8275697|NCT01701999|20406546|P1|NOT COMPLETED|Overall Study||0
8275698|NCT01701999|20406545|P2|COMPLETED|Overall Study||37
8275699|NCT01701999|20406546|P1|COMPLETED|Overall Study||8
8275700|NCT01701999|20406545|P2|STARTED|Overall Study||37
8275701|NCT01701999|20406546|P1|STARTED|Overall Study||8
8275702|NCT01701973|20406558|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275703|NCT01701973|20406559|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275704|NCT01701973|20406560|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275705|NCT01701973|20406561|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275706|NCT01701973|20406562|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275707|NCT01701973|20406563|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275708|NCT01701973|20406564|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275709|NCT01701973|20406565|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275710|NCT01701973|20406558|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
8275711|NCT01701973|20406559|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
8275712|NCT01701973|20406560|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
8275713|NCT01701973|20406561|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
8275714|NCT01701973|20406562|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
8275715|NCT01701973|20406563|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
8275716|NCT01701973|20406564|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275717|NCT01701973|20406565|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275718|NCT01701973|20406558|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
8275719|NCT01701973|20406559|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
8275720|NCT01701973|20406560|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
8275721|NCT01701973|20406561|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
8275722|NCT01701973|20406562|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
8275723|NCT01701973|20406563|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
8275724|NCT01701973|20406564|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
8275725|NCT01701973|20406565|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
8275726|NCT01701973|20406558|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275727|NCT01701973|20406559|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275728|NCT01701973|20406560|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275729|NCT01701973|20406561|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275730|NCT01701973|20406562|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275731|NCT01701973|20406563|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275732|NCT01701973|20406564|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275733|NCT01701973|20406565|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275734|NCT01701973|20406558|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
8275735|NCT01701973|20406559|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
8275736|NCT01701973|20406560|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
8275737|NCT01701973|20406561|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
8275738|NCT01701973|20406562|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
8275739|NCT01701973|20406563|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
8275740|NCT01701973|20406564|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
8275741|NCT01701973|20406565|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
8275742|NCT01701973|20406558|P8|STARTED|Aim 2: First Intervention (1 Day)||4
8275743|NCT01701973|20406559|P7|STARTED|Aim 2: First Intervention (1 Day)||5
8275744|NCT01701973|20406560|P6|STARTED|Aim 2: First Intervention (1 Day)||3
8275745|NCT01701973|20406561|P5|STARTED|Aim 2: First Intervention (1 Day)||2
8275746|NCT01701973|20406562|P4|STARTED|Aim 2: First Intervention (1 Day)||4
8275747|NCT01701973|20406563|P3|STARTED|Aim 2: First Intervention (1 Day)||5
8275748|NCT01701973|20406564|P2|STARTED|Aim 2: First Intervention (1 Day)||0
8275749|NCT01701973|20406565|P1|STARTED|Aim 2: First Intervention (1 Day)||0
8275750|NCT01701973|20406558|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275751|NCT01701973|20406559|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275752|NCT01701973|20406560|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275753|NCT01701973|20406561|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275754|NCT01701973|20406562|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275755|NCT01701973|20406563|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275756|NCT01701973|20406564|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275757|NCT01701973|20406565|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275758|NCT01701973|20406558|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275759|NCT01701973|20406559|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275760|NCT01701973|20406560|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275761|NCT01701973|20406561|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275762|NCT01701973|20406562|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275763|NCT01701973|20406563|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275764|NCT01701973|20406564|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
8275765|NCT01701973|20406565|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
8275766|NCT01701973|20406558|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
8275767|NCT01701973|20406559|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
8275768|NCT01701973|20406560|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
8275769|NCT01701973|20406561|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
8275770|NCT01701973|20406562|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
8275771|NCT01701973|20406563|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
8275772|NCT01701973|20406564|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
8275773|NCT01701973|20406565|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
8275774|NCT01701973|20406558|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275775|NCT01701973|20406559|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275776|NCT01701973|20406560|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275777|NCT01701973|20406561|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275778|NCT01701973|20406562|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275779|NCT01701973|20406563|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275780|NCT01701973|20406564|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
8275781|NCT01701973|20406565|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275782|NCT01701973|20406558|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275783|NCT01701973|20406559|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275784|NCT01701973|20406560|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275785|NCT01701973|20406561|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275786|NCT01701973|20406562|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275787|NCT01701973|20406563|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275788|NCT01701973|20406564|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
8275789|NCT01701973|20406565|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
8275790|NCT01701973|20406558|P8|STARTED|Aim 1: First Intervention (1 Day)||0
8275791|NCT01701973|20406559|P7|STARTED|Aim 1: First Intervention (1 Day)||0
8275792|NCT01701973|20406560|P6|STARTED|Aim 1: First Intervention (1 Day)||0
8275793|NCT01701973|20406561|P5|STARTED|Aim 1: First Intervention (1 Day)||0
8275794|NCT01701973|20406562|P4|STARTED|Aim 1: First Intervention (1 Day)||0
8275795|NCT01701973|20406563|P3|STARTED|Aim 1: First Intervention (1 Day)||0
8275796|NCT01701973|20406564|P2|STARTED|Aim 1: First Intervention (1 Day)||21
8275797|NCT01701973|20406565|P1|STARTED|Aim 1: First Intervention (1 Day)||23
8275801|NCT01701622|20406619|P1|NOT COMPLETED|Overall Study||0
8275802|NCT01701622|20406619|P1|COMPLETED|Overall Study||1
8275803|NCT01701622|20406619|P1|STARTED|Overall Study||1
8275804|NCT01701583|20406626|P2|NOT COMPLETED|Overall Study||0
8275805|NCT01701583|20406627|P1|NOT COMPLETED|Overall Study||2
8275806|NCT01701583|20406626|P2|COMPLETED|Overall Study||3
8275807|NCT01701583|20406627|P1|COMPLETED|Overall Study||5
8275808|NCT01701583|20406626|P2|STARTED|Overall Study||3
8275809|NCT01701583|20406627|P1|STARTED|Overall Study||7
8275810|NCT01701505|20406642|P6|NOT COMPLETED|Overall Study||0
8275811|NCT01701505|20406643|P5|NOT COMPLETED|Overall Study||0
8275812|NCT01701505|20406644|P4|NOT COMPLETED|Overall Study||0
8275813|NCT01701505|20406645|P3|NOT COMPLETED|Overall Study||0
8275814|NCT01701505|20406646|P2|NOT COMPLETED|Overall Study||0
8275815|NCT01701505|20406647|P1|NOT COMPLETED|Overall Study||0
8275816|NCT01701505|20406642|P6|COMPLETED|Overall Study||8
8275817|NCT01701505|20406643|P5|COMPLETED|Overall Study||8
8275818|NCT01701505|20406644|P4|COMPLETED|Overall Study||8
8275819|NCT01701505|20406645|P3|COMPLETED|Overall Study||8
8275820|NCT01701505|20406646|P2|COMPLETED|Overall Study||8
8275821|NCT01701505|20406647|P1|COMPLETED|Overall Study||8
8275822|NCT01701505|20406642|P6|STARTED|Overall Study||8
8275823|NCT01701505|20406643|P5|STARTED|Overall Study||8
8275824|NCT01701505|20406644|P4|STARTED|Overall Study||8
8275825|NCT01701505|20406645|P3|STARTED|Overall Study||8
8275826|NCT01701505|20406646|P2|STARTED|Overall Study||8
8275827|NCT01701505|20406647|P1|STARTED|Overall Study||8
8275828|NCT01701414|20406699|P2|NOT COMPLETED|Overall Study||1
8275829|NCT01701414|20406700|P1|NOT COMPLETED|Overall Study||1
8275830|NCT01701414|20406699|P2|COMPLETED|Overall Study||18
8275831|NCT01701414|20406700|P1|COMPLETED|Overall Study||18
8275832|NCT01701414|20406699|P2|STARTED|Overall Study||19
8275833|NCT01701414|20406700|P1|STARTED|Overall Study||19
8275834|NCT01701401|20406710|P4|NOT COMPLETED|Overall Study||6
8275835|NCT01701401|20406711|P3|NOT COMPLETED|Overall Study||5
8275836|NCT01701401|20406712|P2|NOT COMPLETED|Overall Study||9
8275837|NCT01701401|20406713|P1|NOT COMPLETED|Overall Study||10
8275838|NCT01701401|20406710|P4|COMPLETED|Overall Study||212
8275839|NCT01701401|20406711|P3|COMPLETED|Overall Study||212
8275840|NCT01701401|20406712|P2|COMPLETED|Overall Study||209
8275841|NCT01701401|20406713|P1|COMPLETED|Overall Study||207
8275842|NCT01701401|20406710|P4|STARTED|Overall Study||218
8275843|NCT01701401|20406711|P3|STARTED|Overall Study||217
8275844|NCT01701401|20406712|P2|STARTED|Overall Study||218
8275845|NCT01701401|20406713|P1|STARTED|Overall Study||217
8275846|NCT01701375|20406759|P1|NOT COMPLETED|Overall Study||0
8275847|NCT01701375|20406759|P1|COMPLETED|Overall Study||2
8275848|NCT01701375|20406759|P1|STARTED|Overall Study||2
8275849|NCT01701271|20406763|P1|NOT COMPLETED|Overall Study||0
8275850|NCT01701271|20406763|P1|COMPLETED|Overall Study||20
8275851|NCT01701271|20406763|P1|STARTED|Overall Study||20
8275852|NCT01701258|20406773|P13|NOT COMPLETED|EEG (Session 4)||0
8275853|NCT01701258|20406774|P12|NOT COMPLETED|EEG (Session 4)||0
8275854|NCT01701258|20406775|P11|NOT COMPLETED|EEG (Session 4)||0
8275855|NCT01701258|20406776|P10|NOT COMPLETED|EEG (Session 4)||0
8275856|NCT01701258|20406777|P9|NOT COMPLETED|EEG (Session 4)||0
8275857|NCT01701258|20406778|P8|NOT COMPLETED|EEG (Session 4)||0
8275858|NCT01701258|20406779|P7|NOT COMPLETED|EEG (Session 4)||0
8275859|NCT01701258|20406780|P6|NOT COMPLETED|EEG (Session 4)||0
8275860|NCT01701258|20406781|P5|NOT COMPLETED|EEG (Session 4)||0
8275861|NCT01701258|20406782|P4|NOT COMPLETED|EEG (Session 4)||0
8275862|NCT01701258|20406783|P3|NOT COMPLETED|EEG (Session 4)||0
8275863|NCT01701258|20406784|P2|NOT COMPLETED|EEG (Session 4)||0
8275864|NCT01701258|20406785|P1|NOT COMPLETED|EEG (Session 4)||0
8275865|NCT01701258|20406773|P13|COMPLETED|EEG (Session 4)||0
8275866|NCT01701258|20406774|P12|COMPLETED|EEG (Session 4)||0
8275867|NCT01701258|20406775|P11|COMPLETED|EEG (Session 4)||17
8275868|NCT01701258|20406776|P10|COMPLETED|EEG (Session 4)||0
8275869|NCT01701258|20406777|P9|COMPLETED|EEG (Session 4)||0
8275870|NCT01701258|20406778|P8|COMPLETED|EEG (Session 4)||16
8275871|NCT01701258|20406779|P7|COMPLETED|EEG (Session 4)||0
8275872|NCT01701258|20406780|P6|COMPLETED|EEG (Session 4)||0
8275873|NCT01701258|20406781|P5|COMPLETED|EEG (Session 4)||14
8275874|NCT01701258|20406782|P4|COMPLETED|EEG (Session 4)||0
8275875|NCT01701258|20406783|P3|COMPLETED|EEG (Session 4)||0
8275876|NCT01701258|20406784|P2|COMPLETED|EEG (Session 4)||19
8275877|NCT01701258|20406785|P1|COMPLETED|EEG (Session 4)||0
8275878|NCT01701258|20406773|P13|STARTED|EEG (Session 4)||0
8275879|NCT01701258|20406774|P12|STARTED|EEG (Session 4)||0
8275880|NCT01701258|20406775|P11|STARTED|EEG (Session 4)||17
8275881|NCT01701258|20406776|P10|STARTED|EEG (Session 4)||0
8275882|NCT01701258|20406777|P9|STARTED|EEG (Session 4)||0
8275883|NCT01701258|20406778|P8|STARTED|EEG (Session 4)||16
8275884|NCT01701258|20406779|P7|STARTED|EEG (Session 4)||0
8275885|NCT01701258|20406780|P6|STARTED|EEG (Session 4)||0
8275886|NCT01701258|20406781|P5|STARTED|EEG (Session 4)||14
8275887|NCT01701258|20406782|P4|STARTED|EEG (Session 4)||0
8275888|NCT01701258|20406783|P3|STARTED|EEG (Session 4)||0
8275889|NCT01701258|20406784|P2|STARTED|EEG (Session 4)||19
8275890|NCT01701258|20406785|P1|STARTED|EEG (Session 4)||0
8275891|NCT01701258|20406773|P13|NOT COMPLETED|PET (Session 3)||0
8275892|NCT01701258|20406774|P12|NOT COMPLETED|PET (Session 3)||0
8275893|NCT01701258|20406775|P11|NOT COMPLETED|PET (Session 3)||0
8275894|NCT01701258|20406776|P10|NOT COMPLETED|PET (Session 3)||0
8275895|NCT01701258|20406777|P9|NOT COMPLETED|PET (Session 3)||0
8275896|NCT01701258|20406778|P8|NOT COMPLETED|PET (Session 3)||0
8275897|NCT01701258|20406779|P7|NOT COMPLETED|PET (Session 3)||0
8275898|NCT01701258|20406780|P6|NOT COMPLETED|PET (Session 3)||0
8275899|NCT01701258|20406781|P5|NOT COMPLETED|PET (Session 3)||0
8275900|NCT01701258|20406782|P4|NOT COMPLETED|PET (Session 3)||0
8275901|NCT01701258|20406783|P3|NOT COMPLETED|PET (Session 3)||0
8275902|NCT01701258|20406784|P2|NOT COMPLETED|PET (Session 3)||0
8275903|NCT01701258|20406785|P1|NOT COMPLETED|PET (Session 3)||0
8275904|NCT01701258|20406773|P13|COMPLETED|PET (Session 3)||0
8275905|NCT01701258|20406774|P12|COMPLETED|PET (Session 3)||0
8275906|NCT01701258|20406775|P11|COMPLETED|PET (Session 3)||18
8275907|NCT01701258|20406776|P10|COMPLETED|PET (Session 3)||0
8275908|NCT01701258|20406777|P9|COMPLETED|PET (Session 3)||0
8275909|NCT01701258|20406778|P8|COMPLETED|PET (Session 3)||19
8275910|NCT01701258|20406779|P7|COMPLETED|PET (Session 3)||0
8275911|NCT01701258|20406780|P6|COMPLETED|PET (Session 3)||0
8275912|NCT01701258|20406781|P5|COMPLETED|PET (Session 3)||16
8275913|NCT01701258|20406782|P4|COMPLETED|PET (Session 3)||0
8275914|NCT01701258|20406783|P3|COMPLETED|PET (Session 3)||0
8275915|NCT01701258|20406784|P2|COMPLETED|PET (Session 3)||20
8275916|NCT01701258|20406785|P1|COMPLETED|PET (Session 3)||0
8275917|NCT01701258|20406773|P13|STARTED|PET (Session 3)||0
8275918|NCT01701258|20406774|P12|STARTED|PET (Session 3)||0
8275919|NCT01701258|20406775|P11|STARTED|PET (Session 3)||18
8275920|NCT01701258|20406776|P10|STARTED|PET (Session 3)||0
8275921|NCT01701258|20406777|P9|STARTED|PET (Session 3)||0
8275922|NCT01701258|20406778|P8|STARTED|PET (Session 3)||19
8275923|NCT01701258|20406779|P7|STARTED|PET (Session 3)||0
8275924|NCT01701258|20406780|P6|STARTED|PET (Session 3)||0
8275925|NCT01701258|20406781|P5|STARTED|PET (Session 3)||16
8275926|NCT01701258|20406782|P4|STARTED|PET (Session 3)||0
8275927|NCT01701258|20406783|P3|STARTED|PET (Session 3)||0
8275928|NCT01701258|20406784|P2|STARTED|PET (Session 3)||20
8275929|NCT01701258|20406785|P1|STARTED|PET (Session 3)||0
8275930|NCT01701258|20406773|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275931|NCT01701258|20406774|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275932|NCT01701258|20406775|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275933|NCT01701258|20406776|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275934|NCT01701258|20406777|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275935|NCT01701258|20406778|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275936|NCT01701258|20406779|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275937|NCT01701258|20406780|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275938|NCT01701258|20406781|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275939|NCT01701258|20406782|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275940|NCT01701258|20406783|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275941|NCT01701258|20406784|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275942|NCT01701258|20406785|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275943|NCT01701258|20406773|P13|COMPLETED|Drug+fMRI (Session 2)||7
8275944|NCT01701258|20406774|P12|COMPLETED|Drug+fMRI (Session 2)||10
8275945|NCT01701258|20406775|P11|COMPLETED|Drug+fMRI (Session 2)||0
8275946|NCT01701258|20406776|P10|COMPLETED|Drug+fMRI (Session 2)||6
8275947|NCT01701258|20406777|P9|COMPLETED|Drug+fMRI (Session 2)||6
8275948|NCT01701258|20406778|P8|COMPLETED|Drug+fMRI (Session 2)||0
8275949|NCT01701258|20406779|P7|COMPLETED|Drug+fMRI (Session 2)||8
8275950|NCT01701258|20406780|P6|COMPLETED|Drug+fMRI (Session 2)||9
8275951|NCT01701258|20406781|P5|COMPLETED|Drug+fMRI (Session 2)||0
8275952|NCT01701258|20406782|P4|COMPLETED|Drug+fMRI (Session 2)||11
8275953|NCT01701258|20406783|P3|COMPLETED|Drug+fMRI (Session 2)||11
8275954|NCT01701258|20406784|P2|COMPLETED|Drug+fMRI (Session 2)||0
8275955|NCT01701258|20406785|P1|COMPLETED|Drug+fMRI (Session 2)||0
8275956|NCT01701258|20406773|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
8275957|NCT01701258|20406774|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
8275958|NCT01701258|20406775|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275959|NCT01701258|20406776|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
8275960|NCT01701258|20406777|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
8275961|NCT01701258|20406778|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275962|NCT01701258|20406779|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
8275963|NCT01701258|20406780|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
8275964|NCT01701258|20406781|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275965|NCT01701258|20406782|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
8275966|NCT01701258|20406783|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
8275967|NCT01701258|20406784|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275968|NCT01701258|20406785|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275969|NCT01701258|20406773|P13|STARTED|Drug+fMRI (Session 2)||7
8275970|NCT01701258|20406774|P12|STARTED|Drug+fMRI (Session 2)||10
8275971|NCT01701258|20406775|P11|STARTED|Drug+fMRI (Session 2)||0
8275972|NCT01701258|20406776|P10|STARTED|Drug+fMRI (Session 2)||6
8275973|NCT01701258|20406777|P9|STARTED|Drug+fMRI (Session 2)||6
8275974|NCT01701258|20406778|P8|STARTED|Drug+fMRI (Session 2)||0
8275975|NCT01701258|20406779|P7|STARTED|Drug+fMRI (Session 2)||8
8275976|NCT01701258|20406780|P6|STARTED|Drug+fMRI (Session 2)||9
8275977|NCT01701258|20406781|P5|STARTED|Drug+fMRI (Session 2)||0
8275978|NCT01701258|20406782|P4|STARTED|Drug+fMRI (Session 2)||11
8275979|NCT01701258|20406783|P3|STARTED|Drug+fMRI (Session 2)||11
8275980|NCT01701258|20406784|P2|STARTED|Drug+fMRI (Session 2)||0
8275981|NCT01701258|20406785|P1|STARTED|Drug+fMRI (Session 2)||0
8275982|NCT01701258|20406773|P13|NOT COMPLETED|Assessment and Scheduling||0
8275983|NCT01701258|20406774|P12|NOT COMPLETED|Assessment and Scheduling||0
8275984|NCT01701258|20406775|P11|NOT COMPLETED|Assessment and Scheduling||0
8275985|NCT01701258|20406776|P10|NOT COMPLETED|Assessment and Scheduling||0
8275986|NCT01701258|20406777|P9|NOT COMPLETED|Assessment and Scheduling||0
8275987|NCT01701258|20406778|P8|NOT COMPLETED|Assessment and Scheduling||0
8275988|NCT01701258|20406779|P7|NOT COMPLETED|Assessment and Scheduling||0
8275989|NCT01701258|20406780|P6|NOT COMPLETED|Assessment and Scheduling||0
8275990|NCT01701258|20406781|P5|NOT COMPLETED|Assessment and Scheduling||0
8275991|NCT01701258|20406782|P4|NOT COMPLETED|Assessment and Scheduling||0
8275992|NCT01701258|20406783|P3|NOT COMPLETED|Assessment and Scheduling||0
8275993|NCT01701258|20406784|P2|NOT COMPLETED|Assessment and Scheduling||0
8275994|NCT01701258|20406785|P1|NOT COMPLETED|Assessment and Scheduling||83
8275995|NCT01701258|20406773|P13|COMPLETED|Assessment and Scheduling||0
8275996|NCT01701258|20406774|P12|COMPLETED|Assessment and Scheduling||0
8275997|NCT01701258|20406775|P11|COMPLETED|Assessment and Scheduling||0
8275998|NCT01701258|20406776|P10|COMPLETED|Assessment and Scheduling||0
8275999|NCT01701258|20406777|P9|COMPLETED|Assessment and Scheduling||0
8276000|NCT01701258|20406778|P8|COMPLETED|Assessment and Scheduling||0
8276001|NCT01701258|20406779|P7|COMPLETED|Assessment and Scheduling||0
8276002|NCT01701258|20406780|P6|COMPLETED|Assessment and Scheduling||0
8276003|NCT01701258|20406781|P5|COMPLETED|Assessment and Scheduling||0
8276004|NCT01701258|20406782|P4|COMPLETED|Assessment and Scheduling||0
8276005|NCT01701258|20406783|P3|COMPLETED|Assessment and Scheduling||0
8276006|NCT01701258|20406784|P2|COMPLETED|Assessment and Scheduling||0
8276007|NCT01701258|20406785|P1|COMPLETED|Assessment and Scheduling||70
8276008|NCT01701258|20406773|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276009|NCT01701258|20406774|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276010|NCT01701258|20406775|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276085|NCT01701115|20406854|P2|COMPLETED|Overall Study||77
8276011|NCT01701258|20406776|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276012|NCT01701258|20406777|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276013|NCT01701258|20406778|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276014|NCT01701258|20406779|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276015|NCT01701258|20406780|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276016|NCT01701258|20406781|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276017|NCT01701258|20406782|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276018|NCT01701258|20406783|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276019|NCT01701258|20406784|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276020|NCT01701258|20406785|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
8276021|NCT01701258|20406773|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
8276022|NCT01701258|20406774|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
8276023|NCT01701258|20406775|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
8276024|NCT01701258|20406776|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
8276025|NCT01701258|20406777|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
8276026|NCT01701258|20406778|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
8276027|NCT01701258|20406779|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
8276028|NCT01701258|20406780|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
8276029|NCT01701258|20406781|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
8276030|NCT01701258|20406782|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
8276031|NCT01701258|20406783|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
8276032|NCT01701258|20406784|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
8276033|NCT01701258|20406785|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
8276034|NCT01701258|20406773|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276035|NCT01701258|20406774|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276036|NCT01701258|20406775|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276037|NCT01701258|20406776|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276038|NCT01701258|20406777|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276039|NCT01701258|20406778|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276040|NCT01701258|20406779|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276041|NCT01701258|20406780|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276042|NCT01701258|20406781|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276043|NCT01701258|20406782|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276044|NCT01701258|20406783|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276045|NCT01701258|20406784|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276046|NCT01701258|20406785|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
8276047|NCT01701258|20406773|P13|Eligible After Screening Visit|Assessment and Scheduling||0
8276048|NCT01701258|20406774|P12|Eligible After Screening Visit|Assessment and Scheduling||0
8276049|NCT01701258|20406775|P11|Eligible After Screening Visit|Assessment and Scheduling||0
8276050|NCT01701258|20406776|P10|Eligible After Screening Visit|Assessment and Scheduling||0
8276051|NCT01701258|20406777|P9|Eligible After Screening Visit|Assessment and Scheduling||0
8276052|NCT01701258|20406778|P8|Eligible After Screening Visit|Assessment and Scheduling||0
8276053|NCT01701258|20406779|P7|Eligible After Screening Visit|Assessment and Scheduling||0
8276054|NCT01701258|20406780|P6|Eligible After Screening Visit|Assessment and Scheduling||0
8276055|NCT01701258|20406781|P5|Eligible After Screening Visit|Assessment and Scheduling||0
8276056|NCT01701258|20406782|P4|Eligible After Screening Visit|Assessment and Scheduling||0
8276057|NCT01701258|20406783|P3|Eligible After Screening Visit|Assessment and Scheduling||0
8276058|NCT01701258|20406784|P2|Eligible After Screening Visit|Assessment and Scheduling||0
8276059|NCT01701258|20406785|P1|Eligible After Screening Visit|Assessment and Scheduling||96
8276060|NCT01701258|20406773|P13|STARTED|Assessment and Scheduling||0
8276061|NCT01701258|20406774|P12|STARTED|Assessment and Scheduling||0
8276062|NCT01701258|20406775|P11|STARTED|Assessment and Scheduling||0
8276063|NCT01701258|20406776|P10|STARTED|Assessment and Scheduling||0
8276064|NCT01701258|20406777|P9|STARTED|Assessment and Scheduling||0
8276065|NCT01701258|20406778|P8|STARTED|Assessment and Scheduling||0
8276066|NCT01701258|20406779|P7|STARTED|Assessment and Scheduling||0
8276067|NCT01701258|20406780|P6|STARTED|Assessment and Scheduling||0
8276068|NCT01701258|20406781|P5|STARTED|Assessment and Scheduling||0
8276069|NCT01701258|20406782|P4|STARTED|Assessment and Scheduling||0
8276070|NCT01701258|20406783|P3|STARTED|Assessment and Scheduling||0
8276071|NCT01701258|20406784|P2|STARTED|Assessment and Scheduling||0
8276072|NCT01701258|20406785|P1|STARTED|Assessment and Scheduling||153
8276073|NCT01701245|20406839|P2|NOT COMPLETED|Overall Study||15
8276074|NCT01701245|20406840|P1|NOT COMPLETED|Overall Study||12
8276075|NCT01701245|20406839|P2|COMPLETED|Overall Study||33
8276076|NCT01701245|20406840|P1|COMPLETED|Overall Study||37
8276077|NCT01701245|20406839|P2|FAS Matched Data|Overall Study||32
8276078|NCT01701245|20406840|P1|FAS Matched Data|Overall Study||42
8276079|NCT01701245|20406839|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
8276080|NCT01701245|20406840|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
8276081|NCT01701245|20406839|P2|STARTED|Overall Study||48
8276082|NCT01701245|20406840|P1|STARTED|Overall Study||49
8276083|NCT01701115|20406854|P2|NOT COMPLETED|Overall Study||0
8276084|NCT01701115|20406855|P1|NOT COMPLETED|Overall Study||2
8276086|NCT01701115|20406855|P1|COMPLETED|Overall Study||75
8276087|NCT01701115|20406854|P2|STARTED|Overall Study||77
8276088|NCT01701115|20406855|P1|STARTED|Overall Study||77
8276089|NCT01701102|20406871|P4|NOT COMPLETED|Overall Study||0
8276090|NCT01701102|20406872|P3|NOT COMPLETED|Overall Study||0
8276091|NCT01701102|20406873|P2|NOT COMPLETED|Overall Study||0
8276092|NCT01701102|20406874|P1|NOT COMPLETED|Overall Study||0
8276093|NCT01701102|20406871|P4|COMPLETED|Overall Study||18
8276094|NCT01701102|20406872|P3|COMPLETED|Overall Study||10
8276095|NCT01701102|20406873|P2|COMPLETED|Overall Study||6
8276096|NCT01701102|20406874|P1|COMPLETED|Overall Study||22
8276097|NCT01701102|20406871|P4|STARTED|Overall Study||18
8276098|NCT01701102|20406872|P3|STARTED|Overall Study||10
8276099|NCT01701102|20406873|P2|STARTED|Overall Study||6
8276100|NCT01701102|20406874|P1|STARTED|Overall Study||22
8276101|NCT01701063|20406887|P3|NOT COMPLETED|Overall Study||2
8276102|NCT01701063|20406888|P2|NOT COMPLETED|Overall Study||1
8276103|NCT01701063|20406889|P1|NOT COMPLETED|Overall Study||0
8276104|NCT01701063|20406887|P3|COMPLETED|Overall Study||8
8276105|NCT01701063|20406888|P2|COMPLETED|Overall Study||18
8276106|NCT01701063|20406889|P1|COMPLETED|Overall Study||13
8276107|NCT01701063|20406887|P3|STARTED|Overall Study||10
8276108|NCT01701063|20406888|P2|STARTED|Overall Study||19
8276109|NCT01701063|20406889|P1|STARTED|Overall Study||13
8276110|NCT01701037|20406931|P1|NOT COMPLETED|Overall Study||0
8276111|NCT01701037|20406931|P1|COMPLETED|Overall Study||13
8276112|NCT01701037|20406931|P1|STARTED|Overall Study||13
8276113|NCT01701024|20406942|P2|NOT COMPLETED|Overall Study||9
8276114|NCT01701024|20406943|P1|NOT COMPLETED|Overall Study||10
8276115|NCT01701024|20406942|P2|COMPLETED|Overall Study||236
8276116|NCT01701024|20406943|P1|COMPLETED|Overall Study||243
8276117|NCT01701024|20406942|P2|STARTED|Overall Study||245
8276118|NCT01701024|20406943|P1|STARTED|Overall Study||253
8276119|NCT01701011|20406958|P3|NOT COMPLETED|Overall Study||34
8276120|NCT01701011|20406959|P2|NOT COMPLETED|Overall Study||24
8276121|NCT01701011|20406960|P1|NOT COMPLETED|Overall Study||35
8276122|NCT01701011|20406958|P3|COMPLETED|Overall Study||90
8276123|NCT01701011|20406959|P2|COMPLETED|Overall Study||102
8276124|NCT01701011|20406960|P1|COMPLETED|Overall Study||92
8276125|NCT01701011|20406958|P3|STARTED|Overall Study||124
8276126|NCT01701011|20406959|P2|STARTED|Overall Study||126
8276127|NCT01701011|20406960|P1|STARTED|Overall Study||127
8276128|NCT01700985|20406973|P2|NOT COMPLETED|Overall Study||1
8276129|NCT01700985|20406974|P1|NOT COMPLETED|Overall Study||0
8276130|NCT01700985|20406973|P2|COMPLETED|Overall Study||20
8276131|NCT01700985|20406974|P1|COMPLETED|Overall Study||23
8276132|NCT01700985|20406973|P2|STARTED|Overall Study||21
8276133|NCT01700985|20406974|P1|STARTED|Overall Study||23
8276134|NCT01700959|20406996|P6|NOT COMPLETED|Overall Study||25
8276135|NCT01700959|20406997|P5|NOT COMPLETED|Overall Study||27
8276136|NCT01700959|20406998|P4|NOT COMPLETED|Overall Study||35
8276137|NCT01700959|20406999|P3|NOT COMPLETED|Overall Study||40
8276138|NCT01700959|20407000|P2|NOT COMPLETED|Overall Study||24
8276139|NCT01700959|20407001|P1|NOT COMPLETED|Overall Study||27
8276140|NCT01700959|20406996|P6|COMPLETED|Overall Study||72
8276141|NCT01700959|20406997|P5|COMPLETED|Overall Study||69
8276142|NCT01700959|20406998|P4|COMPLETED|Overall Study||70
8276143|NCT01700959|20406999|P3|COMPLETED|Overall Study||65
8276144|NCT01700959|20407000|P2|COMPLETED|Overall Study||64
8276145|NCT01700959|20407001|P1|COMPLETED|Overall Study||62
8276146|NCT01700959|20406996|P6|STARTED|Overall Study||97
8276147|NCT01700959|20406997|P5|STARTED|Overall Study||96
8276148|NCT01700959|20406998|P4|STARTED|Overall Study||105
8276149|NCT01700959|20406999|P3|STARTED|Overall Study||105
8276150|NCT01700959|20407000|P2|STARTED|Overall Study||88
8276151|NCT01700959|20407001|P1|STARTED|Overall Study||89
8276152|NCT01700907|20407025|P2|NOT COMPLETED|Overall Study||0
8276153|NCT01700907|20407026|P1|NOT COMPLETED|Overall Study||0
8276154|NCT01700907|20407025|P2|COMPLETED|Overall Study||10
8276155|NCT01700907|20407026|P1|COMPLETED|Overall Study||10
8276156|NCT01700907|20407025|P2|STARTED|Overall Study||10
8276157|NCT01700907|20407026|P1|STARTED|Overall Study||10
8276158|NCT01700829|20407042|P2|NOT COMPLETED|Overall Study||1
8276159|NCT01700829|20407043|P1|NOT COMPLETED|Overall Study||1
8276160|NCT01700829|20407042|P2|COMPLETED|Overall Study||40
8276161|NCT01700829|20407043|P1|COMPLETED|Overall Study||40
8276162|NCT01700829|20407042|P2|STARTED|Overall Study||41
8276163|NCT01700829|20407043|P1|STARTED|Overall Study||41
8276164|NCT01700816|20407055|P2|NOT COMPLETED|Overall Study||0
8276165|NCT01700816|20407056|P1|NOT COMPLETED|Overall Study||0
8276166|NCT01700816|20407055|P2|COMPLETED|Overall Study||19
8276167|NCT01700816|20407056|P1|COMPLETED|Overall Study||21
8276168|NCT01700816|20407055|P2|STARTED|Overall Study||19
8276169|NCT01700816|20407056|P1|STARTED|Overall Study||21
8276170|NCT01700725|20407085|P3|NOT COMPLETED|Overall Study||0
8276171|NCT01700725|20407086|P2|NOT COMPLETED|Overall Study||0
8276172|NCT01700725|20407087|P1|NOT COMPLETED|Overall Study||0
8276173|NCT01700725|20407085|P3|COMPLETED|Overall Study||12
8276174|NCT01700725|20407086|P2|COMPLETED|Overall Study||14
8276175|NCT01700725|20407087|P1|COMPLETED|Overall Study||14
8276176|NCT01700725|20407085|P3|STARTED|Overall Study||12
8276177|NCT01700725|20407086|P2|STARTED|Overall Study||14
8276178|NCT01700725|20407087|P1|STARTED|Overall Study||14
8276179|NCT01700621|20407103|P2|NOT COMPLETED|Analyzed for Immunogenicity||7
8276180|NCT01700621|20407104|P1|NOT COMPLETED|Analyzed for Immunogenicity||13
8276181|NCT01700621|20407103|P2|COMPLETED|Analyzed for Immunogenicity||233
8276182|NCT01700621|20407104|P1|COMPLETED|Analyzed for Immunogenicity||227
8276183|NCT01700621|20407103|P2|STARTED|Analyzed for Immunogenicity||240
8276184|NCT01700621|20407104|P1|STARTED|Analyzed for Immunogenicity||240
8276185|NCT01700621|20407103|P2|NOT COMPLETED|Received Study Vaccines||0
8276186|NCT01700621|20407104|P1|NOT COMPLETED|Received Study Vaccines||0
8276187|NCT01700621|20407103|P2|COMPLETED|Received Study Vaccines||240
8276188|NCT01700621|20407104|P1|COMPLETED|Received Study Vaccines||240
8276189|NCT01700621|20407103|P2|STARTED|Received Study Vaccines||240
8276190|NCT01700621|20407104|P1|STARTED|Received Study Vaccines||240
8276191|NCT01700530|20407142|P3|NOT COMPLETED|Overall Study||1
8276192|NCT01700530|20407143|P2|NOT COMPLETED|Overall Study||3
8276193|NCT01700530|20407144|P1|NOT COMPLETED|Overall Study||0
8276194|NCT01700530|20407142|P3|COMPLETED|Overall Study||19
8276195|NCT01700530|20407143|P2|COMPLETED|Overall Study||18
8276196|NCT01700530|20407144|P1|COMPLETED|Overall Study||9
8276197|NCT01700530|20407142|P3|STARTED|Overall Study||20
8276198|NCT01700530|20407143|P2|STARTED|Overall Study||21
8276199|NCT01700530|20407144|P1|STARTED|Overall Study||9
8276200|NCT01700517|20407158|P3|NOT COMPLETED|Overall Study||0
8276201|NCT01700517|20407159|P2|NOT COMPLETED|Overall Study||0
8276202|NCT01700517|20407160|P1|NOT COMPLETED|Overall Study||0
8276203|NCT01700517|20407158|P3|COMPLETED|Overall Study||40
8276204|NCT01700517|20407159|P2|COMPLETED|Overall Study||40
8276205|NCT01700517|20407160|P1|COMPLETED|Overall Study||40
8276206|NCT01700517|20407158|P3|STARTED|Overall Study||40
8276207|NCT01700517|20407159|P2|STARTED|Overall Study||40
8276208|NCT01700517|20407160|P1|STARTED|Overall Study||40
8276209|NCT01700439|20407168|P1|NOT COMPLETED|Overall Study||889
8276210|NCT01700439|20407168|P1|COMPLETED|Overall Study||0
8276211|NCT01700439|20407168|P1|2 Year|Overall Study||215
8276212|NCT01700439|20407168|P1|1 Year|Overall Study||573
8276213|NCT01700439|20407168|P1|3 Month|Overall Study||778
8276214|NCT01700439|20407168|P1|Discharge|Overall Study||831
8276215|NCT01700439|20407168|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
8276216|NCT01700439|20407168|P1|STARTED|Overall Study||889
8276217|NCT01700387|20407193|P2|NOT COMPLETED|Overall Study||4
8276218|NCT01700387|20407194|P1|NOT COMPLETED|Overall Study||4
8276219|NCT01700387|20407193|P2|COMPLETED|Overall Study||6
8276220|NCT01700387|20407194|P1|COMPLETED|Overall Study||6
8276221|NCT01700387|20407193|P2|STARTED|Overall Study||10
8276222|NCT01700387|20407194|P1|STARTED|Overall Study||10
8276223|NCT01700348|20407224|P1|NOT COMPLETED|Overall Study||23
8276224|NCT01700348|20407224|P1|COMPLETED|Overall Study||93
8276225|NCT01700348|20407224|P1|STARTED|Overall Study||116
8276226|NCT01700335|20407233|P2|NOT COMPLETED|Overall Study||4
8276227|NCT01700335|20407234|P1|NOT COMPLETED|Overall Study||1
8276228|NCT01700335|20407233|P2|COMPLETED|Overall Study||2
8276229|NCT01700335|20407234|P1|COMPLETED|Overall Study||2
8276230|NCT01700335|20407233|P2|STARTED|Overall Study||6
8276231|NCT01700335|20407234|P1|STARTED|Overall Study||3
8276232|NCT01700205|20407247|P2|NOT COMPLETED|Overall Study||15
8276233|NCT01700205|20407248|P1|NOT COMPLETED|Overall Study||15
8276234|NCT01700205|20407247|P2|COMPLETED|Overall Study|Mother-Infant Dyads|39
8276235|NCT01700205|20407248|P1|COMPLETED|Overall Study|Mother-Infant Dyads|44
8276236|NCT01700205|20407247|P2|STARTED|Overall Study|Mother-Infant Dyads|54
8276237|NCT01700205|20407248|P1|STARTED|Overall Study|Mother-Infant Dyads|59
8276238|NCT01700192|20407270|P2|NOT COMPLETED|Overall Study||128
8276239|NCT01700192|20407271|P1|NOT COMPLETED|Overall Study||180
8276240|NCT01700192|20407270|P2|COMPLETED|Overall Study||613
8276241|NCT01700192|20407271|P1|COMPLETED|Overall Study||561
8276242|NCT01700192|20407270|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
8276243|NCT01700192|20407271|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
8276244|NCT01700192|20407270|P2|Treated|Overall Study||741
8276245|NCT01700192|20407271|P1|Treated|Overall Study||740
8276246|NCT01700192|20407270|P2|STARTED|Overall Study||741
8276247|NCT01700192|20407271|P1|STARTED|Overall Study||741
8276248|NCT01700179|20407289|P1|NOT COMPLETED|Overall Study||2
8276249|NCT01700179|20407289|P1|COMPLETED|Overall Study||6
8276250|NCT01700179|20407289|P1|STARTED|Overall Study||8
8276251|NCT01700140|20407296|P3|NOT COMPLETED|Overall Study||1
8276252|NCT01700140|20407297|P2|NOT COMPLETED|Overall Study||9
8276253|NCT01700140|20407298|P1|NOT COMPLETED|Overall Study||6
8276254|NCT01700140|20407296|P3|COMPLETED|Overall Study||61
8276255|NCT01700140|20407297|P2|COMPLETED|Overall Study||57
8276256|NCT01700140|20407298|P1|COMPLETED|Overall Study||55
8276257|NCT01700140|20407296|P3|STARTED|Overall Study||62
8276258|NCT01700140|20407297|P2|STARTED|Overall Study||66
8276259|NCT01700140|20407298|P1|STARTED|Overall Study||61
8276260|NCT01700049|20407330|P1|NOT COMPLETED|Overall Study||1
8276261|NCT01700049|20407330|P1|COMPLETED|Overall Study||27
8276262|NCT01700049|20407330|P1|STARTED|Overall Study||28
8276263|NCT01700036|20407336|P1|NOT COMPLETED|Overall Study||0
8276264|NCT01700036|20407336|P1|COMPLETED|Overall Study||40
8276265|NCT01700036|20407336|P1|STARTED|Overall Study||40
8276266|NCT01699867|20407345|P1|NOT COMPLETED|Overall Study||3
8276267|NCT01699867|20407345|P1|COMPLETED|Overall Study||47
8276268|NCT01699867|20407345|P1|STARTED|Overall Study||50
8276269|NCT01699815|20407352|P2|NOT COMPLETED|Overall Study||8
8276270|NCT01699815|20407353|P1|NOT COMPLETED|Overall Study||5
8276271|NCT01699815|20407352|P2|COMPLETED|Overall Study||56
8276272|NCT01699815|20407353|P1|COMPLETED|Overall Study||57
8276273|NCT01699815|20407352|P2|STARTED|Overall Study||64
8276274|NCT01699815|20407353|P1|STARTED|Overall Study||62
8276275|NCT01699789|20407365|P2|NOT COMPLETED|Overall Study||126
8276276|NCT01699789|20407366|P1|NOT COMPLETED|Overall Study||102
8276277|NCT01699789|20407365|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
8276278|NCT01699789|20407366|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
8276279|NCT01699789|20407365|P2|12-Month Follow-Up|Overall Study||369
8276280|NCT01699789|20407366|P1|12-Month Follow-Up|Overall Study||364
8276281|NCT01699789|20407365|P2|6-Month Follow-Up|Overall Study||379
8276282|NCT01699789|20407366|P1|6-Month Follow-Up|Overall Study||380
8276283|NCT01699789|20407365|P2|Baseline|Overall Study||488
8276284|NCT01699789|20407366|P1|Baseline|Overall Study||492
8276285|NCT01699789|20407365|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
8276286|NCT01699789|20407366|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
8276287|NCT01699763|20407428|P1|NOT COMPLETED|Overall Study||0
8276288|NCT01699763|20407428|P1|COMPLETED|Overall Study||112
8276289|NCT01699763|20407428|P1|STARTED|Overall Study||112
8276290|NCT01699750|20407436|P2|NOT COMPLETED|Overall Study||3
8276291|NCT01699750|20407437|P1|NOT COMPLETED|Overall Study||0
8276292|NCT01699750|20407436|P2|COMPLETED|Overall Study||33
8276293|NCT01699750|20407437|P1|COMPLETED|Overall Study||34
8276294|NCT01699750|20407436|P2|STARTED|Overall Study||36
8276295|NCT01699750|20407437|P1|STARTED|Overall Study||34
8276296|NCT01699698|20407461|P2|NOT COMPLETED|Overall Study||5
8276297|NCT01699698|20407462|P1|NOT COMPLETED|Overall Study||2
8276298|NCT01699698|20407461|P2|COMPLETED|Overall Study||56
8276299|NCT01699698|20407462|P1|COMPLETED|Overall Study||42
8276300|NCT01699698|20407461|P2|STARTED|Overall Study||61
8276301|NCT01699698|20407462|P1|STARTED|Overall Study||44
8276302|NCT01699685|20407472|P2|NOT COMPLETED|Period 2||0
8276303|NCT01699685|20407473|P1|NOT COMPLETED|Period 2||1
8276304|NCT01699685|20407472|P2|COMPLETED|Period 2||36
8276305|NCT01699685|20407473|P1|COMPLETED|Period 2||35
8276306|NCT01699685|20407472|P2|STARTED|Period 2||36
8276307|NCT01699685|20407473|P1|STARTED|Period 2||36
8276308|NCT01699685|20407472|P2|NOT COMPLETED|Period 1||3
8276309|NCT01699685|20407473|P1|NOT COMPLETED|Period 1||3
8276310|NCT01699685|20407472|P2|COMPLETED|Period 1||36
8276311|NCT01699685|20407473|P1|COMPLETED|Period 1||36
8276312|NCT01699685|20407472|P2|Full Analysis Population (FAS)|Period 1||38
8276313|NCT01699685|20407473|P1|Full Analysis Population (FAS)|Period 1||38
8276314|NCT01699685|20407472|P2|Safety Population|Period 1||38
8276315|NCT01699685|20407473|P1|Safety Population|Period 1||39
8276316|NCT01699685|20407472|P2|STARTED|Period 1||39
8276317|NCT01699685|20407473|P1|STARTED|Period 1||39
8276318|NCT01699607|20407491|P2|NOT COMPLETED|Overall Study||0
8276319|NCT01699607|20407492|P1|NOT COMPLETED|Overall Study||0
8276320|NCT01699607|20407491|P2|COMPLETED|Overall Study||4
8276321|NCT01699607|20407492|P1|COMPLETED|Overall Study||6
8276322|NCT01699607|20407491|P2|STARTED|Overall Study||4
8276323|NCT01699607|20407492|P1|STARTED|Overall Study||6
8276324|NCT01699503|20407499|P2|NOT COMPLETED|Overall Study||1005
8276325|NCT01699503|20407500|P1|NOT COMPLETED|Overall Study||1000
8276326|NCT01699503|20407499|P2|COMPLETED|Overall Study||992
8276327|NCT01699503|20407500|P1|COMPLETED|Overall Study||1008
8276328|NCT01699503|20407499|P2|6 Month Follow-up|Overall Study||893
8276329|NCT01699503|20407500|P1|6 Month Follow-up|Overall Study||903
8276330|NCT01699503|20407499|P2|1 Month Follow-up|Overall Study||1022
8276331|NCT01699503|20407500|P1|1 Month Follow-up|Overall Study||998
8276332|NCT01699503|20407499|P2|Baseline|Overall Study||1693
8276333|NCT01699503|20407500|P1|Baseline|Overall Study||1723
8276334|NCT01699503|20407499|P2|STARTED|Overall Study||1997
8276335|NCT01699503|20407500|P1|STARTED|Overall Study||2008
8276336|NCT01699373|20407516|P2|NOT COMPLETED|Overall Study||0
8276337|NCT01699373|20407517|P1|NOT COMPLETED|Overall Study||0
8276338|NCT01699373|20407516|P2|COMPLETED|Overall Study||85
8276339|NCT01699373|20407517|P1|COMPLETED|Overall Study||85
8276340|NCT01699373|20407516|P2|STARTED|Overall Study||85
8276341|NCT01699373|20407517|P1|STARTED|Overall Study||85
8276342|NCT01699178|20407525|P2|NOT COMPLETED|Overall Study||32
8276343|NCT01699178|20407526|P1|NOT COMPLETED|Overall Study||19
8276344|NCT01699178|20407525|P2|COMPLETED|Overall Study||62
8276345|NCT01699178|20407526|P1|COMPLETED|Overall Study||69
8276346|NCT01699178|20407525|P2|STARTED|Overall Study||94
8276347|NCT01699178|20407526|P1|STARTED|Overall Study||88
8276348|NCT01699087|20407542|P1|NOT COMPLETED|Overall Study||24
8276349|NCT01699087|20407542|P1|COMPLETED|Overall Study||152
8276350|NCT01699087|20407542|P1|Treated|Overall Study||161
8276351|NCT01699087|20407542|P1|STARTED|Overall Study||176
8276352|NCT01699022|20407556|P1|NOT COMPLETED|Overall Study||3
8276353|NCT01699022|20407556|P1|COMPLETED|Overall Study||14
8276354|NCT01699022|20407556|P1|STARTED|Overall Study||17
8276359|NCT01698879|20407583|P3|NOT COMPLETED|Overall Study||0
8276360|NCT01698879|20407584|P2|NOT COMPLETED|Overall Study||0
8276361|NCT01698879|20407585|P1|NOT COMPLETED|Overall Study||1
8276362|NCT01698879|20407583|P3|COMPLETED|Overall Study||20
8276363|NCT01698879|20407584|P2|COMPLETED|Overall Study||20
8276364|NCT01698879|20407585|P1|COMPLETED|Overall Study||5
8276365|NCT01698879|20407583|P3|STARTED|Overall Study||20
8276366|NCT01698879|20407584|P2|STARTED|Overall Study||20
8276367|NCT01698879|20407585|P1|STARTED|Overall Study||6
8276368|NCT01698814|20407608|P2|NOT COMPLETED|Overall Study||3
8276369|NCT01698814|20407609|P1|NOT COMPLETED|Overall Study||2
8276370|NCT01698814|20407608|P2|COMPLETED|Overall Study||166
8276371|NCT01698814|20407609|P1|COMPLETED|Overall Study||329
8276372|NCT01698814|20407608|P2|STARTED|Overall Study||169
8276373|NCT01698814|20407609|P1|STARTED|Overall Study||331
8276374|NCT01698801|20407615|P1|NOT COMPLETED|Follow Up Phase||5
8276375|NCT01698801|20407615|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
8276376|NCT01698801|20407615|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
8276377|NCT01698801|20407615|P1|NOT COMPLETED|Treatment Phase||11
8276378|NCT01698801|20407615|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
8276379|NCT01698801|20407615|P1|STARTED|Treatment Phase||26
8276380|NCT01698775|20407626|P2|NOT COMPLETED|Phase B||11
8276381|NCT01698775|20407627|P1|NOT COMPLETED|Phase B||14
8276382|NCT01698775|20407626|P2|COMPLETED|Phase B||86
8276383|NCT01698775|20407627|P1|COMPLETED|Phase B||84
8276384|NCT01698775|20407626|P2|STARTED|Phase B||97
8276385|NCT01698775|20407627|P1|STARTED|Phase B||98
8276386|NCT01698775|20407626|P2|NOT COMPLETED|Phase A||9
8276387|NCT01698775|20407627|P1|NOT COMPLETED|Phase A||9
8276388|NCT01698775|20407626|P2|COMPLETED|Phase A||97
8276389|NCT01698775|20407627|P1|COMPLETED|Phase A||98
8276390|NCT01698775|20407626|P2|STARTED|Phase A||106
8276391|NCT01698775|20407627|P1|STARTED|Phase A||107
8276392|NCT01698710|20407653|P1|NOT COMPLETED|Overall Study||0
8276393|NCT01698710|20407653|P1|COMPLETED|Overall Study||5
8276394|NCT01698710|20407653|P1|STARTED|Overall Study||5
8276395|NCT01698684|20407662|P3|NOT COMPLETED|Overall Study||21
8276396|NCT01698684|20407663|P2|NOT COMPLETED|Overall Study||23
8276397|NCT01698684|20407664|P1|NOT COMPLETED|Overall Study||29
8276398|NCT01698684|20407662|P3|COMPLETED|Overall Study||127
8276399|NCT01698684|20407663|P2|COMPLETED|Overall Study||124
8276400|NCT01698684|20407664|P1|COMPLETED|Overall Study||116
8276401|NCT01698684|20407662|P3|Safety Population|Overall Study||146
8276402|NCT01698684|20407663|P2|Safety Population|Overall Study||146
8276403|NCT01698684|20407664|P1|Safety Population|Overall Study||143
8276404|NCT01698684|20407662|P3|ITT Population|Overall Study||139
8276405|NCT01698684|20407663|P2|ITT Population|Overall Study||139
8276406|NCT01698684|20407664|P1|ITT Population|Overall Study||136
8276407|NCT01698684|20407662|P3|STARTED|Overall Study||148
8276408|NCT01698684|20407663|P2|STARTED|Overall Study||147
8276409|NCT01698684|20407664|P1|STARTED|Overall Study||145
8276410|NCT01698554|20407676|P4|NOT COMPLETED|Overall Study||2
8276411|NCT01698554|20407677|P3|NOT COMPLETED|Overall Study||2
8276412|NCT01698554|20407678|P2|NOT COMPLETED|Overall Study||10
8276413|NCT01698554|20407679|P1|NOT COMPLETED|Overall Study||6
8276414|NCT01698554|20407676|P4|COMPLETED|Overall Study||77
8276415|NCT01698554|20407677|P3|COMPLETED|Overall Study||73
8276416|NCT01698554|20407678|P2|COMPLETED|Overall Study||147
8276417|NCT01698554|20407679|P1|COMPLETED|Overall Study||147
8276418|NCT01698554|20407676|P4|STARTED|Overall Study||79
8276419|NCT01698554|20407677|P3|STARTED|Overall Study||75
8276420|NCT01698554|20407678|P2|STARTED|Overall Study||157
8276421|NCT01698554|20407679|P1|STARTED|Overall Study||153
8276422|NCT01698528|20407707|P2|NOT COMPLETED|Overall Study||4
8276423|NCT01698528|20407708|P1|NOT COMPLETED|Overall Study||1
8276424|NCT01698528|20407707|P2|COMPLETED|Overall Study||16
8276425|NCT01698528|20407708|P1|COMPLETED|Overall Study||19
8276426|NCT01698528|20407707|P2|STARTED|Overall Study||20
8276427|NCT01698528|20407708|P1|STARTED|Overall Study||20
8276428|NCT01698502|20407724|P2|NOT COMPLETED|Overall Study||0
8276429|NCT01698502|20407725|P1|NOT COMPLETED|Overall Study||0
8276430|NCT01698502|20407724|P2|COMPLETED|Overall Study||10
8276431|NCT01698502|20407725|P1|COMPLETED|Overall Study||11
8276432|NCT01698502|20407724|P2|STARTED|Overall Study||10
8276433|NCT01698502|20407725|P1|STARTED|Overall Study||11
8276434|NCT01698463|20407733|P1|NOT COMPLETED|Overall Study||0
8276435|NCT01698463|20407733|P1|COMPLETED|Overall Study||11
8276436|NCT01698463|20407733|P1|STARTED|Overall Study||11
8276437|NCT01698333|20407743|P1|NOT COMPLETED|Overall Study||0
8276438|NCT01698333|20407743|P1|COMPLETED|Overall Study||25
8276439|NCT01698333|20407743|P1|STARTED|Overall Study||25
8276440|NCT01698320|20407749|P3|NOT COMPLETED|40-Week Open-Label Period||10
8276441|NCT01698320|20407750|P2|NOT COMPLETED|40-Week Open-Label Period||19
8276442|NCT01698320|20407751|P1|NOT COMPLETED|40-Week Open-Label Period||0
8276443|NCT01698320|20407749|P3|COMPLETED|40-Week Open-Label Period||146
8276444|NCT01698320|20407750|P2|COMPLETED|40-Week Open-Label Period||146
8276445|NCT01698320|20407751|P1|COMPLETED|40-Week Open-Label Period||0
8276446|NCT01698320|20407749|P3|STARTED|40-Week Open-Label Period||156
8276447|NCT01698320|20407750|P2|STARTED|40-Week Open-Label Period||165
8276448|NCT01698320|20407751|P1|STARTED|40-Week Open-Label Period||0
8276449|NCT01698320|20407749|P3|NOT COMPLETED|12-Week Double-Blind Period||12
8276450|NCT01698320|20407750|P2|NOT COMPLETED|12-Week Double-Blind Period||4
8276451|NCT01698320|20407751|P1|NOT COMPLETED|12-Week Double-Blind Period||0
8276452|NCT01698320|20407749|P3|COMPLETED|12-Week Double-Blind Period||156
8276453|NCT01698320|20407750|P2|COMPLETED|12-Week Double-Blind Period||165
8276454|NCT01698320|20407751|P1|COMPLETED|12-Week Double-Blind Period||0
8276455|NCT01698320|20407749|P3|Safety Population|12-Week Double-Blind Period||168
8276456|NCT01698320|20407750|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
8276457|NCT01698320|20407751|P1|Safety Population|12-Week Double-Blind Period||0
8276458|NCT01698320|20407749|P3|STARTED|12-Week Double-Blind Period||168
8276459|NCT01698320|20407750|P2|STARTED|12-Week Double-Blind Period||169
8276460|NCT01698320|20407751|P1|STARTED|12-Week Double-Blind Period||0
8276461|NCT01698320|20407749|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276462|NCT01698320|20407750|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276463|NCT01698320|20407751|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
8276464|NCT01698320|20407749|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276465|NCT01698320|20407750|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276466|NCT01698320|20407751|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
8276467|NCT01698320|20407749|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
8276468|NCT01698320|20407750|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
8276469|NCT01698320|20407751|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
8276470|NCT01698268|20407771|P2|NOT COMPLETED|Overall Study||1
8276471|NCT01698268|20407772|P1|NOT COMPLETED|Overall Study||2
8276472|NCT01698268|20407771|P2|COMPLETED|Overall Study||24
8276473|NCT01698268|20407772|P1|COMPLETED|Overall Study||23
8276474|NCT01698268|20407771|P2|STARTED|Overall Study||25
8276475|NCT01698268|20407772|P1|STARTED|Overall Study||25
8276476|NCT01698008|20407780|P2|NOT COMPLETED|Overall Study||2
8276477|NCT01698008|20407781|P1|NOT COMPLETED|Overall Study||1
8276478|NCT01698008|20407780|P2|COMPLETED|Overall Study||0
8276479|NCT01698008|20407781|P1|COMPLETED|Overall Study||2
8276480|NCT01698008|20407780|P2|STARTED|Overall Study||2
8276481|NCT01698008|20407781|P1|STARTED|Overall Study||3
8276482|NCT01697969|20407787|P1|NOT COMPLETED|Overall Study||3
8276483|NCT01697969|20407787|P1|COMPLETED|Overall Study||10
8276484|NCT01697969|20407787|P1|STARTED|Overall Study||13
8276485|NCT01697956|20407794|P2|NOT COMPLETED|Overall Study||1
8276486|NCT01697956|20407795|P1|NOT COMPLETED|Overall Study||1
8276487|NCT01697956|20407794|P2|COMPLETED|Overall Study||31
8276488|NCT01697956|20407795|P1|COMPLETED|Overall Study||66
8276489|NCT01697956|20407794|P2|Per Protocol Population|Overall Study||31
8276490|NCT01697956|20407795|P1|Per Protocol Population|Overall Study||66
8276491|NCT01697956|20407794|P2|STARTED|Overall Study|enrolled and randomized|32
8276492|NCT01697956|20407795|P1|STARTED|Overall Study|enrolled and randomized|67
8276493|NCT01697800|20407825|P2|NOT COMPLETED|Overall Study||1
8276494|NCT01697800|20407826|P1|NOT COMPLETED|Overall Study||0
8276495|NCT01697800|20407825|P2|COMPLETED|Overall Study||24
8276496|NCT01697800|20407826|P1|COMPLETED|Overall Study||15
8276497|NCT01697800|20407825|P2|STARTED|Overall Study||25
8276498|NCT01697800|20407826|P1|STARTED|Overall Study||15
8276499|NCT01697748|20407834|P2|NOT COMPLETED|Overall Study||68
8276500|NCT01697748|20407835|P1|NOT COMPLETED|Overall Study||58
8276501|NCT01697748|20407834|P2|COMPLETED|Overall Study||260
8276502|NCT01697748|20407835|P1|COMPLETED|Overall Study||271
8276503|NCT01697748|20407834|P2|STARTED|Overall Study||328
8276504|NCT01697748|20407835|P1|STARTED|Overall Study||329
8276505|NCT01697709|20407853|P2|NOT COMPLETED|Overall Study||28
8276506|NCT01697709|20407854|P1|NOT COMPLETED|Overall Study||30
8276507|NCT01697709|20407853|P2|COMPLETED|Overall Study||38
8276508|NCT01697709|20407854|P1|COMPLETED|Overall Study||34
8276509|NCT01697709|20407853|P2|STARTED|Overall Study||66
8276510|NCT01697709|20407854|P1|STARTED|Overall Study||64
8276511|NCT01697696|20407864|P2|NOT COMPLETED|Overall Study||47
8276512|NCT01697696|20407865|P1|NOT COMPLETED|Overall Study||47
8276513|NCT01697696|20407864|P2|COMPLETED|Overall Study||210
8276514|NCT01697696|20407865|P1|COMPLETED|Overall Study||207
8276515|NCT01697696|20407864|P2|Full Analysis Set (FAS)|Overall Study||255
8276516|NCT01697696|20407865|P1|Full Analysis Set (FAS)|Overall Study||251
8276517|NCT01697696|20407864|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
8276518|NCT01697696|20407865|P1|Safety Set|Overall Study||251
8276519|NCT01697696|20407864|P2|STARTED|Overall Study||257
8276520|NCT01697696|20407865|P1|STARTED|Overall Study||254
8276521|NCT01697592|20407897|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
8276522|NCT01697592|20407898|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
8276523|NCT01697592|20407899|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276524|NCT01697592|20407900|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276525|NCT01697592|20407901|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
8276526|NCT01697592|20407902|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
8276527|NCT01697592|20407903|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
8276528|NCT01697592|20407904|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276529|NCT01697592|20407905|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276530|NCT01697592|20407906|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
8276531|NCT01697592|20407897|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
8276532|NCT01697592|20407898|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
8276533|NCT01697592|20407899|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
8276534|NCT01697592|20407900|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
8276535|NCT01697592|20407901|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
8276536|NCT01697592|20407902|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
8276537|NCT01697592|20407903|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
8276538|NCT01697592|20407904|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
8276539|NCT01697592|20407905|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
8276540|NCT01697592|20407906|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
8276541|NCT01697592|20407897|P10|STARTED|Phase B (Week 25 to Week 52)||30
8276542|NCT01697592|20407898|P9|STARTED|Phase B (Week 25 to Week 52)||34
8276543|NCT01697592|20407899|P8|STARTED|Phase B (Week 25 to Week 52)||33
8276544|NCT01697592|20407900|P7|STARTED|Phase B (Week 25 to Week 52)||32
8276545|NCT01697592|20407901|P6|STARTED|Phase B (Week 25 to Week 52)||62
8276546|NCT01697592|20407902|P5|STARTED|Phase B (Week 25 to Week 52)||67
8276547|NCT01697592|20407903|P4|STARTED|Phase B (Week 25 to Week 52)||63
8276548|NCT01697592|20407904|P3|STARTED|Phase B (Week 25 to Week 52)||65
8276549|NCT01697592|20407905|P2|STARTED|Phase B (Week 25 to Week 52)||62
8276550|NCT01697592|20407906|P1|STARTED|Phase B (Week 25 to Week 52)||123
8276551|NCT01697592|20407897|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8276552|NCT01697592|20407898|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8276553|NCT01697592|20407899|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8276554|NCT01697592|20407900|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8276555|NCT01697592|20407901|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
8276556|NCT01697592|20407902|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8276557|NCT01697592|20407903|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8276558|NCT01697592|20407904|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
8276559|NCT01697592|20407905|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8276560|NCT01697592|20407906|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8276561|NCT01697592|20407897|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
8276562|NCT01697592|20407898|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
8276563|NCT01697592|20407899|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
8276564|NCT01697592|20407900|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
8276565|NCT01697592|20407901|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
8276566|NCT01697592|20407902|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
8276567|NCT01697592|20407903|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
8276568|NCT01697592|20407904|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
8276569|NCT01697592|20407905|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
8276570|NCT01697592|20407906|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
8276571|NCT01697592|20407897|P10|STARTED|Phase A (Up to 24 Weeks)||32
8276572|NCT01697592|20407898|P9|STARTED|Phase A (Up to 24 Weeks)||34
8276573|NCT01697592|20407899|P8|STARTED|Phase A (Up to 24 Weeks)||33
8276574|NCT01697592|20407900|P7|STARTED|Phase A (Up to 24 Weeks)||34
8276575|NCT01697592|20407901|P6|STARTED|Phase A (Up to 24 Weeks)||63
8276576|NCT01697592|20407902|P5|STARTED|Phase A (Up to 24 Weeks)||67
8276577|NCT01697592|20407903|P4|STARTED|Phase A (Up to 24 Weeks)||65
8276578|NCT01697592|20407904|P3|STARTED|Phase A (Up to 24 Weeks)||66
8276579|NCT01697592|20407905|P2|STARTED|Phase A (Up to 24 Weeks)||65
8276580|NCT01697592|20407906|P1|STARTED|Phase A (Up to 24 Weeks)||126
8276581|NCT01697579|20407975|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
8276582|NCT01697579|20407976|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
8276583|NCT01697579|20407977|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276584|NCT01697579|20407978|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276585|NCT01697579|20407979|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276586|NCT01697579|20407980|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276587|NCT01697579|20407981|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276588|NCT01697579|20407975|P7|COMPLETED|Optional Extension-Cycles 2-6||37
8276589|NCT01697579|20407976|P6|COMPLETED|Optional Extension-Cycles 2-6||12
8276590|NCT01697579|20407977|P5|COMPLETED|Optional Extension-Cycles 2-6||0
8276591|NCT01697579|20407978|P4|COMPLETED|Optional Extension-Cycles 2-6||0
8276592|NCT01697579|20407979|P3|COMPLETED|Optional Extension-Cycles 2-6||0
8276593|NCT01697579|20407980|P2|COMPLETED|Optional Extension-Cycles 2-6||0
8276594|NCT01697579|20407981|P1|COMPLETED|Optional Extension-Cycles 2-6||0
8276595|NCT01697579|20407975|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
8276596|NCT01697579|20407976|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
8276597|NCT01697579|20407977|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276598|NCT01697579|20407978|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276599|NCT01697579|20407979|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276600|NCT01697579|20407980|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276601|NCT01697579|20407981|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
8276602|NCT01697579|20407975|P7|NOT COMPLETED|Base Study-Cycle 1||0
8276603|NCT01697579|20407976|P6|NOT COMPLETED|Base Study-Cycle 1||0
8276604|NCT01697579|20407977|P5|NOT COMPLETED|Base Study-Cycle 1||3
8276605|NCT01697579|20407978|P4|NOT COMPLETED|Base Study-Cycle 1||1
8276606|NCT01697579|20407979|P3|NOT COMPLETED|Base Study-Cycle 1||1
8276607|NCT01697579|20407980|P2|NOT COMPLETED|Base Study-Cycle 1||1
8276608|NCT01697579|20407981|P1|NOT COMPLETED|Base Study-Cycle 1||2
8276609|NCT01697579|20407975|P7|COMPLETED|Base Study-Cycle 1||0
8276610|NCT01697579|20407976|P6|COMPLETED|Base Study-Cycle 1||0
8276611|NCT01697579|20407977|P5|COMPLETED|Base Study-Cycle 1||35
8276612|NCT01697579|20407978|P4|COMPLETED|Base Study-Cycle 1||40
8276613|NCT01697579|20407979|P3|COMPLETED|Base Study-Cycle 1||43
8276614|NCT01697579|20407980|P2|COMPLETED|Base Study-Cycle 1||42
8276615|NCT01697579|20407981|P1|COMPLETED|Base Study-Cycle 1||72
8276616|NCT01697579|20407975|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
8276617|NCT01697579|20407976|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
8276618|NCT01697579|20407977|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
8276704|NCT01696773|20408344|P1|COMPLETED|Day 28, Second Intervention||5
8276619|NCT01697579|20407978|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
8276620|NCT01697579|20407979|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
8276621|NCT01697579|20407980|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
8276622|NCT01697579|20407981|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
8276623|NCT01697501|20408093|P1|NOT COMPLETED|Overall Study||2
8276624|NCT01697501|20408093|P1|COMPLETED|Overall Study||86
8276625|NCT01697501|20408093|P1|STARTED|Overall Study||88
8276626|NCT01697462|20408136|P1|NOT COMPLETED|Overall Study||77
8276627|NCT01697462|20408136|P1|COMPLETED|Overall Study||181
8276628|NCT01697462|20408136|P1|STARTED|Overall Study||258
8276629|NCT01697449|20408143|P1|NOT COMPLETED|Overall Study||90
8276630|NCT01697449|20408143|P1|COMPLETED|Overall Study||101
8276631|NCT01697449|20408143|P1|STARTED|Overall Study||191
8276632|NCT01697358|20408154|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
8276633|NCT01697358|20408155|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
8276634|NCT01697358|20408154|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
8276635|NCT01697358|20408155|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
8276636|NCT01697358|20408154|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
8276637|NCT01697358|20408155|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
8276638|NCT01697358|20408154|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
8276639|NCT01697358|20408155|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
8276640|NCT01697358|20408154|P2|COMPLETED|Period I: Randomization to 6 Months||107
8276641|NCT01697358|20408155|P1|COMPLETED|Period I: Randomization to 6 Months||97
8276642|NCT01697358|20408154|P2|STARTED|Period I: Randomization to 6 Months||108
8276643|NCT01697358|20408155|P1|STARTED|Period I: Randomization to 6 Months||110
8276644|NCT01697345|20408171|P1|NOT COMPLETED|Overall Study||1
8276645|NCT01697345|20408171|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
8276646|NCT01697345|20408171|P1|STARTED|Overall Study||13
8276647|NCT01697332|20408190|P1|NOT COMPLETED|Overall Study||0
8276648|NCT01697332|20408190|P1|COMPLETED|Overall Study||1
8276649|NCT01697332|20408190|P1|STARTED|Overall Study||1
8276650|NCT01697319|20408196|P1|NOT COMPLETED|Extension Phase||15
8276651|NCT01697319|20408196|P1|COMPLETED|Extension Phase||0
8276652|NCT01697319|20408196|P1|STARTED|Extension Phase||15
8276653|NCT01697319|20408196|P1|NOT COMPLETED|Primary Phase||1
8276654|NCT01697319|20408196|P1|COMPLETED|Primary Phase||15
8276655|NCT01697319|20408196|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
8276656|NCT01696994|20408205|P2|NOT COMPLETED|Overall Study||8437
8276657|NCT01696994|20408206|P1|NOT COMPLETED|Overall Study||5192
8276658|NCT01696994|20408205|P2|COMPLETED|Overall Study||30668
8276659|NCT01696994|20408206|P1|COMPLETED|Overall Study||33919
8276660|NCT01696994|20408205|P2|STARTED|Overall Study||39105
8276661|NCT01696994|20408206|P1|STARTED|Overall Study||39111
8276662|NCT01696981|20408234|P2|NOT COMPLETED|Overall Study||10374
8276663|NCT01696981|20408235|P1|NOT COMPLETED|Overall Study||1201
8276664|NCT01696981|20408234|P2|COMPLETED|Overall Study||67071
8276665|NCT01696981|20408235|P1|COMPLETED|Overall Study||76254
8276666|NCT01696981|20408234|P2|STARTED|Overall Study||77445
8276667|NCT01696981|20408235|P1|STARTED|Overall Study||77455
8276668|NCT01696968|20408255|P2|NOT COMPLETED|Overall Study||6812
8276669|NCT01696968|20408256|P1|NOT COMPLETED|Overall Study||1201
8276670|NCT01696968|20408255|P2|COMPLETED|Overall Study||70633
8276671|NCT01696968|20408256|P1|COMPLETED|Overall Study||76255
8276672|NCT01696968|20408255|P2|STARTED|Overall Study||77445
8276673|NCT01696968|20408256|P1|STARTED|Overall Study||77456
8276674|NCT01696955|20408278|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8276675|NCT01696955|20408279|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8276676|NCT01696955|20408278|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
8276677|NCT01696955|20408279|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8276678|NCT01696955|20408278|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
8276679|NCT01696955|20408279|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
8276680|NCT01696955|20408278|P2|NOT COMPLETED|Main Study||1
8276681|NCT01696955|20408279|P1|NOT COMPLETED|Main Study||2
8276682|NCT01696955|20408278|P2|COMPLETED|Main Study||38
8276683|NCT01696955|20408279|P1|COMPLETED|Main Study||40
8276684|NCT01696955|20408278|P2|STARTED|Main Study||39
8276685|NCT01696955|20408279|P1|STARTED|Main Study||42
8276686|NCT01696942|20408304|P2|NOT COMPLETED|Overall Study||3
8276687|NCT01696942|20408305|P1|NOT COMPLETED|Overall Study||2
8276688|NCT01696942|20408304|P2|COMPLETED|Overall Study||2
8276689|NCT01696942|20408305|P1|COMPLETED|Overall Study||3
8276690|NCT01696942|20408304|P2|STARTED|Overall Study||5
8276691|NCT01696942|20408305|P1|STARTED|Overall Study||5
8276692|NCT01696929|20408313|P1|NOT COMPLETED|Overall Study||1
8276693|NCT01696929|20408313|P1|COMPLETED|Overall Study||5
8276694|NCT01696929|20408313|P1|STARTED|Overall Study||6
8276695|NCT01696877|20408320|P2|NOT COMPLETED|Overall Study||1
8276696|NCT01696877|20408321|P1|NOT COMPLETED|Overall Study||0
8276697|NCT01696877|20408320|P2|COMPLETED|Overall Study||13
8276698|NCT01696877|20408321|P1|COMPLETED|Overall Study||15
8276699|NCT01696877|20408320|P2|STARTED|Overall Study||14
8276700|NCT01696877|20408321|P1|STARTED|Overall Study||15
8276701|NCT01696773|20408343|P2|NOT COMPLETED|Day 28, Second Intervention||0
8276702|NCT01696773|20408344|P1|NOT COMPLETED|Day 28, Second Intervention||0
8276703|NCT01696773|20408343|P2|COMPLETED|Day 28, Second Intervention||6
8276705|NCT01696773|20408343|P2|STARTED|Day 28, Second Intervention||6
8276706|NCT01696773|20408344|P1|STARTED|Day 28, Second Intervention||5
8276707|NCT01696773|20408343|P2|NOT COMPLETED|Days 15-27, Washout||0
8276708|NCT01696773|20408344|P1|NOT COMPLETED|Days 15-27, Washout||1
8276709|NCT01696773|20408343|P2|COMPLETED|Days 15-27, Washout||6
8276710|NCT01696773|20408344|P1|COMPLETED|Days 15-27, Washout||5
8276711|NCT01696773|20408343|P2|STARTED|Days 15-27, Washout||6
8276712|NCT01696773|20408344|P1|STARTED|Days 15-27, Washout||6
8276713|NCT01696773|20408343|P2|NOT COMPLETED|Day 14, First Intervention||0
8276714|NCT01696773|20408344|P1|NOT COMPLETED|Day 14, First Intervention||0
8276715|NCT01696773|20408343|P2|COMPLETED|Day 14, First Intervention||6
8276716|NCT01696773|20408344|P1|COMPLETED|Day 14, First Intervention||6
8276717|NCT01696773|20408343|P2|STARTED|Day 14, First Intervention||6
8276718|NCT01696773|20408344|P1|STARTED|Day 14, First Intervention||6
8276719|NCT01696773|20408343|P2|NOT COMPLETED|Days 1-13, Washout||0
8276720|NCT01696773|20408344|P1|NOT COMPLETED|Days 1-13, Washout||0
8276721|NCT01696773|20408343|P2|COMPLETED|Days 1-13, Washout||6
8276722|NCT01696773|20408344|P1|COMPLETED|Days 1-13, Washout||6
8276723|NCT01696773|20408343|P2|STARTED|Days 1-13, Washout||6
8276724|NCT01696773|20408344|P1|STARTED|Days 1-13, Washout||6
8276725|NCT01696760|20408352|P2|NOT COMPLETED|Overall Study||0
8276726|NCT01696760|20408353|P1|NOT COMPLETED|Overall Study||0
8276727|NCT01696760|20408352|P2|COMPLETED|Overall Study||3
8276728|NCT01696760|20408353|P1|COMPLETED|Overall Study||9
8276729|NCT01696760|20408352|P2|STARTED|Overall Study||3
8276730|NCT01696760|20408353|P1|STARTED|Overall Study||9
8276731|NCT01696695|20408371|P1|NOT COMPLETED|Overall Study||882
8276732|NCT01696695|20408371|P1|COMPLETED|Overall Study||0
8276733|NCT01696695|20408371|P1|STARTED|Overall Study||882
8276734|NCT01696643|20408383|P2|NOT COMPLETED|Overall Study||535
8276735|NCT01696643|20408384|P1|NOT COMPLETED|Overall Study||529
8276736|NCT01696643|20408383|P2|COMPLETED|Overall Study||169
8276737|NCT01696643|20408384|P1|COMPLETED|Overall Study||174
8276738|NCT01696643|20408383|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
8276739|NCT01696643|20408384|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
8276740|NCT01696643|20408383|P2|STARTED|Overall Study||704
8276741|NCT01696643|20408384|P1|STARTED|Overall Study||703
8276742|NCT01696396|20408403|P4|NOT COMPLETED|Overall Study||14
8276743|NCT01696396|20408404|P3|NOT COMPLETED|Overall Study||26
8276744|NCT01696396|20408405|P2|NOT COMPLETED|Overall Study||7
8276745|NCT01696396|20408406|P1|NOT COMPLETED|Overall Study||31
8276746|NCT01696396|20408403|P4|COMPLETED|Overall Study||28
8276747|NCT01696396|20408404|P3|COMPLETED|Overall Study||59
8276748|NCT01696396|20408405|P2|COMPLETED|Overall Study||20
8276749|NCT01696396|20408406|P1|COMPLETED|Overall Study||69
8276750|NCT01696396|20408403|P4|Entered Open-label Period|Overall Study||37
8276751|NCT01696396|20408404|P3|Entered Open-label Period|Overall Study||75
8276752|NCT01696396|20408405|P2|Entered Open-label Period|Overall Study||21
8276753|NCT01696396|20408406|P1|Entered Open-label Period|Overall Study||84
8276754|NCT01696396|20408403|P4|Received Study Drug|Overall Study||41
8276755|NCT01696396|20408404|P3|Received Study Drug|Overall Study||84
8276756|NCT01696396|20408405|P2|Received Study Drug|Overall Study||26
8276757|NCT01696396|20408406|P1|Received Study Drug|Overall Study||98
8276758|NCT01696396|20408403|P4|STARTED|Overall Study||42
8276759|NCT01696396|20408404|P3|STARTED|Overall Study||85
8276760|NCT01696396|20408405|P2|STARTED|Overall Study||27
8276761|NCT01696396|20408406|P1|STARTED|Overall Study||100
8276762|NCT01696357|20408450|P2|NOT COMPLETED|Overall Study||1
8276763|NCT01696357|20408451|P1|NOT COMPLETED|Overall Study||2
8276764|NCT01696357|20408450|P2|COMPLETED|Overall Study||41
8276765|NCT01696357|20408451|P1|COMPLETED|Overall Study||40
8276766|NCT01696357|20408450|P2|STARTED|Overall Study||42
8276767|NCT01696357|20408451|P1|STARTED|Overall Study||42
8276768|NCT01696279|20408457|P4|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
8276769|NCT01696279|20408458|P3|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8276770|NCT01696279|20408459|P2|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8276771|NCT01696279|20408460|P1|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8276772|NCT01696279|20408457|P4|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
8276773|NCT01696279|20408458|P3|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8276774|NCT01696279|20408459|P2|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8276775|NCT01696279|20408460|P1|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8276776|NCT01696279|20408457|P4|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
8276777|NCT01696279|20408458|P3|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8276778|NCT01696279|20408459|P2|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8276779|NCT01696279|20408460|P1|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8276780|NCT01696279|20408457|P4|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276781|NCT01696279|20408458|P3|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
8276782|NCT01696279|20408459|P2|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276783|NCT01696279|20408460|P1|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276784|NCT01696279|20408457|P4|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276785|NCT01696279|20408458|P3|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
8276786|NCT01696279|20408459|P2|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276787|NCT01696279|20408460|P1|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276788|NCT01696279|20408457|P4|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276789|NCT01696279|20408458|P3|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8276790|NCT01696279|20408459|P2|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276791|NCT01696279|20408460|P1|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276792|NCT01696279|20408457|P4|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276793|NCT01696279|20408458|P3|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276794|NCT01696279|20408459|P2|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276795|NCT01696279|20408460|P1|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276796|NCT01696279|20408457|P4|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276797|NCT01696279|20408458|P3|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8276798|NCT01696279|20408459|P2|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276799|NCT01696279|20408460|P1|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276800|NCT01696279|20408457|P4|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276801|NCT01696279|20408458|P3|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8276802|NCT01696279|20408459|P2|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276803|NCT01696279|20408460|P1|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276804|NCT01696279|20408457|P4|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276805|NCT01696279|20408458|P3|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
8276806|NCT01696279|20408459|P2|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276807|NCT01696279|20408460|P1|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8276808|NCT01696279|20408457|P4|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8276809|NCT01696279|20408458|P3|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8276810|NCT01696279|20408459|P2|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
8276811|NCT01696279|20408460|P1|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8276812|NCT01696279|20408457|P4|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8276813|NCT01696279|20408458|P3|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8276814|NCT01696279|20408459|P2|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
8276815|NCT01696279|20408460|P1|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8276816|NCT01696279|20408457|P4|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8276817|NCT01696279|20408458|P3|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8276818|NCT01696279|20408459|P2|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
8276819|NCT01696279|20408460|P1|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8276820|NCT01696279|20408457|P4|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8276821|NCT01696279|20408458|P3|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8276822|NCT01696279|20408459|P2|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
8276823|NCT01696279|20408460|P1|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8276824|NCT01696279|20408457|P4|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8276825|NCT01696279|20408458|P3|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8276826|NCT01696279|20408459|P2|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
8276827|NCT01696279|20408460|P1|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8276828|NCT01696279|20408457|P4|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8276829|NCT01696279|20408458|P3|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8276830|NCT01696279|20408459|P2|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
8276831|NCT01696279|20408460|P1|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8276832|NCT01696279|20408457|P4|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8276833|NCT01696279|20408458|P3|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8276834|NCT01696279|20408459|P2|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
8276835|NCT01696279|20408460|P1|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8276836|NCT01696279|20408457|P4|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8276837|NCT01696279|20408458|P3|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8276838|NCT01696279|20408459|P2|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
8276839|NCT01696279|20408460|P1|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8276840|NCT01696279|20408457|P4|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8276841|NCT01696279|20408458|P3|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8276842|NCT01696279|20408459|P2|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8276843|NCT01696279|20408460|P1|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
8276844|NCT01696279|20408457|P4|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8276845|NCT01696279|20408458|P3|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8276846|NCT01696279|20408459|P2|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8276847|NCT01696279|20408460|P1|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
8276848|NCT01696279|20408457|P4|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8276849|NCT01696279|20408458|P3|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8276850|NCT01696279|20408459|P2|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8276851|NCT01696279|20408460|P1|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
8276852|NCT01696279|20408457|P4|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8276853|NCT01696279|20408458|P3|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8276854|NCT01696279|20408459|P2|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8276855|NCT01696279|20408460|P1|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
8276856|NCT01696279|20408457|P4|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8276857|NCT01696279|20408458|P3|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8276858|NCT01696279|20408459|P2|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8276859|NCT01696279|20408460|P1|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
8276860|NCT01696214|20408498|P4|NOT COMPLETED|Overall Study||0
8276861|NCT01696214|20408499|P3|NOT COMPLETED|Overall Study||0
8276862|NCT01696214|20408500|P2|NOT COMPLETED|Overall Study||0
8276863|NCT01696214|20408501|P1|NOT COMPLETED|Overall Study||1
8276864|NCT01696214|20408498|P4|COMPLETED|Overall Study||5
8276865|NCT01696214|20408499|P3|COMPLETED|Overall Study||5
8276866|NCT01696214|20408500|P2|COMPLETED|Overall Study||5
8276867|NCT01696214|20408501|P1|COMPLETED|Overall Study||4
8276868|NCT01696214|20408498|P4|STARTED|Overall Study||5
8276869|NCT01696214|20408499|P3|STARTED|Overall Study||5
8276870|NCT01696214|20408500|P2|STARTED|Overall Study||5
8276871|NCT01696214|20408501|P1|STARTED|Overall Study||5
8276872|NCT01696188|20408521|P2|NOT COMPLETED|Overall Study||1
8276873|NCT01696188|20408522|P1|NOT COMPLETED|Overall Study||1
8276874|NCT01696188|20408521|P2|COMPLETED|Overall Study||42
8276875|NCT01696188|20408522|P1|COMPLETED|Overall Study||40
8276876|NCT01696188|20408521|P2|STARTED|Overall Study||43
8276877|NCT01696188|20408522|P1|STARTED|Overall Study||41
8276878|NCT01696084|20408536|P2|NOT COMPLETED|Overall Study||146
8276879|NCT01696084|20408537|P1|NOT COMPLETED|Overall Study||131
8276880|NCT01696084|20408536|P2|COMPLETED|Overall Study||10
8276881|NCT01696084|20408537|P1|COMPLETED|Overall Study||22
8276882|NCT01696084|20408536|P2|STARTED|Overall Study||156
8276883|NCT01696084|20408537|P1|STARTED|Overall Study||153
8276884|NCT01696071|20408553|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
8276885|NCT01696071|20408554|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
8276886|NCT01696071|20408553|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
8276887|NCT01696071|20408554|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
8276888|NCT01696071|20408553|P2|STARTED|Treatment Period 2: 4 Weeks||47
8276889|NCT01696071|20408554|P1|STARTED|Treatment Period 2: 4 Weeks||51
8276890|NCT01696071|20408553|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
8276891|NCT01696071|20408554|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
8276892|NCT01696071|20408553|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
8276893|NCT01696071|20408554|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
8276894|NCT01696071|20408553|P2|STARTED|Treatment Period 1: 4 Weeks||47
8276895|NCT01696071|20408554|P1|STARTED|Treatment Period 1: 4 Weeks||51
8276896|NCT01696058|20408582|P2|NOT COMPLETED|Overall Study||31
8276897|NCT01696058|20408583|P1|NOT COMPLETED|Overall Study||43
8276898|NCT01696058|20408582|P2|COMPLETED|Overall Study||538
8276899|NCT01696058|20408583|P1|COMPLETED|Overall Study||523
8276900|NCT01696058|20408582|P2|STARTED|Overall Study||569
8276901|NCT01696058|20408583|P1|STARTED|Overall Study||566
8276902|NCT01696045|20408611|P2|NOT COMPLETED|Overall Study||7
8276903|NCT01696045|20408612|P1|NOT COMPLETED|Overall Study||3
8276904|NCT01696045|20408611|P2|COMPLETED|Overall Study||1
8276905|NCT01696045|20408612|P1|COMPLETED|Overall Study||1
8276906|NCT01696045|20408611|P2|STARTED|Overall Study||8
8276907|NCT01696045|20408612|P1|STARTED|Overall Study||4
8276908|NCT01695993|20408631|P3|NOT COMPLETED|Overall Study||6
8276909|NCT01695993|20408632|P2|NOT COMPLETED|Overall Study||5
8276910|NCT01695993|20408633|P1|NOT COMPLETED|Overall Study||5
8276911|NCT01695993|20408631|P3|COMPLETED|Overall Study||75
8276912|NCT01695993|20408632|P2|COMPLETED|Overall Study||75
8276913|NCT01695993|20408633|P1|COMPLETED|Overall Study||76
8276914|NCT01695993|20408631|P3|STARTED|Overall Study||81
8276915|NCT01695993|20408632|P2|STARTED|Overall Study||80
8276916|NCT01695993|20408633|P1|STARTED|Overall Study||81
8276917|NCT01695954|20408643|P2|NOT COMPLETED|Overall Study||2
8276918|NCT01695954|20408644|P1|NOT COMPLETED|Overall Study||4
8276919|NCT01695954|20408643|P2|COMPLETED|Overall Study||14
8276920|NCT01695954|20408644|P1|COMPLETED|Overall Study||14
8276921|NCT01695954|20408643|P2|STARTED|Overall Study||16
8276922|NCT01695954|20408644|P1|STARTED|Overall Study||18
8276923|NCT01695772|20408654|P1|NOT COMPLETED|Overall Study||38
8276924|NCT01695772|20408654|P1|COMPLETED|Overall Study||12
8276925|NCT01695772|20408654|P1|STARTED|Overall Study||50
8276926|NCT01695746|20408666|P1|NOT COMPLETED|Overall Study||12
8276927|NCT01695746|20408666|P1|COMPLETED|Overall Study||96
8276928|NCT01695746|20408666|P1|STARTED|Overall Study||108
8276929|NCT01695668|20408682|P2|NOT COMPLETED|Overall Study||17
8276930|NCT01695668|20408683|P1|NOT COMPLETED|Overall Study||15
8276931|NCT01695668|20408682|P2|COMPLETED|Overall Study||20
8276932|NCT01695668|20408683|P1|COMPLETED|Overall Study||23
8276933|NCT01695668|20408682|P2|STARTED|Overall Study||37
8276934|NCT01695668|20408683|P1|STARTED|Overall Study||38
8276935|NCT01695473|20408689|P1|NOT COMPLETED|Overall Study||0
8276936|NCT01695473|20408689|P1|COMPLETED|Overall Study||11
8276937|NCT01695473|20408689|P1|STARTED|Overall Study||11
8276938|NCT01695369|20408696|P1|NOT COMPLETED|Overall Study||0
8276939|NCT01695369|20408696|P1|COMPLETED|Overall Study||61
8276940|NCT01695369|20408696|P1|STARTED|Overall Study||61
8276941|NCT01695330|20408702|P2|NOT COMPLETED|Overall Study||0
8276942|NCT01695330|20408703|P1|NOT COMPLETED|Overall Study||47
8276943|NCT01695330|20408702|P2|COMPLETED|Overall Study||0
8276944|NCT01695330|20408703|P1|COMPLETED|Overall Study||5
8276945|NCT01695330|20408702|P2|STARTED|Overall Study||0
8276946|NCT01695330|20408703|P1|STARTED|Overall Study||52
8276947|NCT01695304|20408709|P2|NOT COMPLETED|Overall Study||0
8276948|NCT01695304|20408710|P1|NOT COMPLETED|Overall Study||0
8276949|NCT01695304|20408709|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
8276950|NCT01695304|20408710|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
8276951|NCT01695304|20408709|P2|STARTED|Overall Study||120
8276952|NCT01695304|20408710|P1|STARTED|Overall Study||120
8276953|NCT01695291|20408720|P2|NOT COMPLETED|Overall Study||7
8276954|NCT01695291|20408721|P1|NOT COMPLETED|Overall Study||2
8276955|NCT01695291|20408720|P2|COMPLETED|Overall Study||14
8276956|NCT01695291|20408721|P1|COMPLETED|Overall Study||8
8276957|NCT01695291|20408720|P2|STARTED|Overall Study||21
8276958|NCT01695291|20408721|P1|STARTED|Overall Study||10
8276959|NCT01695239|20408733|P14|NOT COMPLETED|Post-Treatment Follow-Up Period||5
8276960|NCT01695239|20408734|P13|NOT COMPLETED|Post-Treatment Follow-Up Period||9
8276961|NCT01695239|20408735|P12|NOT COMPLETED|Post-Treatment Follow-Up Period||1
8276962|NCT01695239|20408736|P11|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276963|NCT01695239|20408737|P10|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276964|NCT01695239|20408738|P9|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276965|NCT01695239|20408739|P8|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276966|NCT01695239|20408740|P7|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276967|NCT01695239|20408741|P6|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276968|NCT01695239|20408742|P5|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276969|NCT01695239|20408743|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276970|NCT01695239|20408744|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276971|NCT01695239|20408745|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276972|NCT01695239|20408746|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276973|NCT01695239|20408733|P14|COMPLETED|Post-Treatment Follow-Up Period||166
8276974|NCT01695239|20408734|P13|COMPLETED|Post-Treatment Follow-Up Period||156
8276975|NCT01695239|20408735|P12|COMPLETED|Post-Treatment Follow-Up Period||0
8276976|NCT01695239|20408736|P11|COMPLETED|Post-Treatment Follow-Up Period||20
8276977|NCT01695239|20408737|P10|COMPLETED|Post-Treatment Follow-Up Period||0
8276978|NCT01695239|20408738|P9|COMPLETED|Post-Treatment Follow-Up Period||0
8276979|NCT01695239|20408739|P8|COMPLETED|Post-Treatment Follow-Up Period||0
8276980|NCT01695239|20408740|P7|COMPLETED|Post-Treatment Follow-Up Period||0
8276981|NCT01695239|20408741|P6|COMPLETED|Post-Treatment Follow-Up Period||0
8276982|NCT01695239|20408742|P5|COMPLETED|Post-Treatment Follow-Up Period||0
8276983|NCT01695239|20408743|P4|COMPLETED|Post-Treatment Follow-Up Period||0
8276984|NCT01695239|20408744|P3|COMPLETED|Post-Treatment Follow-Up Period||0
8276985|NCT01695239|20408745|P2|COMPLETED|Post-Treatment Follow-Up Period||0
8276986|NCT01695239|20408746|P1|COMPLETED|Post-Treatment Follow-Up Period||0
8276987|NCT01695239|20408733|P14|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
8276988|NCT01695239|20408734|P13|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
8276989|NCT01695239|20408735|P12|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
8276990|NCT01695239|20408736|P11|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
8276991|NCT01695239|20408737|P10|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
8276992|NCT01695239|20408738|P9|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
8276993|NCT01695239|20408739|P8|STARTED|Post-Treatment Follow-Up Period||0
8276994|NCT01695239|20408740|P7|STARTED|Post-Treatment Follow-Up Period||0
8276995|NCT01695239|20408741|P6|STARTED|Post-Treatment Follow-Up Period||0
8276996|NCT01695239|20408742|P5|STARTED|Post-Treatment Follow-Up Period||0
8276997|NCT01695239|20408743|P4|STARTED|Post-Treatment Follow-Up Period||0
8276998|NCT01695239|20408744|P3|STARTED|Post-Treatment Follow-Up Period||0
8276999|NCT01695239|20408745|P2|STARTED|Post-Treatment Follow-Up Period||0
8277000|NCT01695239|20408746|P1|STARTED|Post-Treatment Follow-Up Period||0
8277001|NCT01695239|20408733|P14|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277002|NCT01695239|20408734|P13|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277003|NCT01695239|20408735|P12|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277004|NCT01695239|20408736|P11|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277005|NCT01695239|20408737|P10|NOT COMPLETED|Extension Long-Term Extension Periods||61
8277006|NCT01695239|20408738|P9|NOT COMPLETED|Extension Long-Term Extension Periods||66
8277007|NCT01695239|20408739|P8|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277008|NCT01695239|20408740|P7|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277009|NCT01695239|20408741|P6|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277010|NCT01695239|20408742|P5|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277011|NCT01695239|20408743|P4|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277012|NCT01695239|20408744|P3|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277013|NCT01695239|20408745|P2|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277014|NCT01695239|20408746|P1|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277015|NCT01695239|20408733|P14|COMPLETED|Extension Long-Term Extension Periods||0
8277016|NCT01695239|20408734|P13|COMPLETED|Extension Long-Term Extension Periods||0
8277017|NCT01695239|20408735|P12|COMPLETED|Extension Long-Term Extension Periods||0
8277018|NCT01695239|20408736|P11|COMPLETED|Extension Long-Term Extension Periods||0
8277019|NCT01695239|20408737|P10|COMPLETED|Extension Long-Term Extension Periods||122
8277020|NCT01695239|20408738|P9|COMPLETED|Extension Long-Term Extension Periods||121
8277021|NCT01695239|20408739|P8|COMPLETED|Extension Long-Term Extension Periods||0
8277022|NCT01695239|20408740|P7|COMPLETED|Extension Long-Term Extension Periods||0
8277023|NCT01695239|20408741|P6|COMPLETED|Extension Long-Term Extension Periods||0
8277024|NCT01695239|20408742|P5|COMPLETED|Extension Long-Term Extension Periods||0
8277025|NCT01695239|20408743|P4|COMPLETED|Extension Long-Term Extension Periods||0
8277026|NCT01695239|20408744|P3|COMPLETED|Extension Long-Term Extension Periods||0
8277027|NCT01695239|20408745|P2|COMPLETED|Extension Long-Term Extension Periods||0
8277028|NCT01695239|20408746|P1|COMPLETED|Extension Long-Term Extension Periods||0
8277029|NCT01695239|20408733|P14|STARTED|Extension Long-Term Extension Periods||0
8277030|NCT01695239|20408734|P13|STARTED|Extension Long-Term Extension Periods||0
8277031|NCT01695239|20408735|P12|STARTED|Extension Long-Term Extension Periods||0
8277032|NCT01695239|20408736|P11|STARTED|Extension Long-Term Extension Periods||0
8277033|NCT01695239|20408737|P10|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
8277034|NCT01695239|20408738|P9|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
8277035|NCT01695239|20408739|P8|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
8277036|NCT01695239|20408740|P7|STARTED|Extension Long-Term Extension Periods||0
8277037|NCT01695239|20408741|P6|STARTED|Extension Long-Term Extension Periods||0
8277038|NCT01695239|20408742|P5|STARTED|Extension Long-Term Extension Periods||0
8277039|NCT01695239|20408743|P4|STARTED|Extension Long-Term Extension Periods||0
8277040|NCT01695239|20408744|P3|STARTED|Extension Long-Term Extension Periods||0
8277041|NCT01695239|20408745|P2|STARTED|Extension Long-Term Extension Periods||0
8277042|NCT01695239|20408746|P1|STARTED|Extension Long-Term Extension Periods||0
8277043|NCT01695239|20408733|P14|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277044|NCT01695239|20408734|P13|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277045|NCT01695239|20408735|P12|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277046|NCT01695239|20408736|P11|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277047|NCT01695239|20408737|P10|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277048|NCT01695239|20408738|P9|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277049|NCT01695239|20408739|P8|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
8277050|NCT01695239|20408740|P7|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277051|NCT01695239|20408741|P6|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277052|NCT01695239|20408742|P5|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277053|NCT01695239|20408743|P4|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277054|NCT01695239|20408744|P3|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277055|NCT01695239|20408745|P2|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277056|NCT01695239|20408746|P1|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277057|NCT01695239|20408733|P14|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277058|NCT01695239|20408734|P13|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277059|NCT01695239|20408735|P12|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277060|NCT01695239|20408736|P11|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277061|NCT01695239|20408737|P10|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277062|NCT01695239|20408738|P9|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277063|NCT01695239|20408739|P8|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
8277064|NCT01695239|20408740|P7|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277065|NCT01695239|20408741|P6|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277066|NCT01695239|20408742|P5|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277067|NCT01695239|20408743|P4|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277068|NCT01695239|20408744|P3|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277069|NCT01695239|20408745|P2|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277070|NCT01695239|20408746|P1|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277071|NCT01695239|20408733|P14|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277072|NCT01695239|20408734|P13|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277073|NCT01695239|20408735|P12|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277074|NCT01695239|20408736|P11|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277075|NCT01695239|20408737|P10|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277076|NCT01695239|20408738|P9|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277077|NCT01695239|20408739|P8|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
8277078|NCT01695239|20408740|P7|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8277079|NCT01695239|20408741|P6|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8277080|NCT01695239|20408742|P5|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8277081|NCT01695239|20408743|P4|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277082|NCT01695239|20408744|P3|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277083|NCT01695239|20408745|P2|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277084|NCT01695239|20408746|P1|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277085|NCT01695239|20408733|P14|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277086|NCT01695239|20408734|P13|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277087|NCT01695239|20408735|P12|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277088|NCT01695239|20408736|P11|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277089|NCT01695239|20408737|P10|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277090|NCT01695239|20408738|P9|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277091|NCT01695239|20408739|P8|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277092|NCT01695239|20408740|P7|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277093|NCT01695239|20408741|P6|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277094|NCT01695239|20408742|P5|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277095|NCT01695239|20408743|P4|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277096|NCT01695239|20408744|P3|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277097|NCT01695239|20408745|P2|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277098|NCT01695239|20408746|P1|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277099|NCT01695239|20408733|P14|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277100|NCT01695239|20408734|P13|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277101|NCT01695239|20408735|P12|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277102|NCT01695239|20408736|P11|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277103|NCT01695239|20408737|P10|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277104|NCT01695239|20408738|P9|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277105|NCT01695239|20408739|P8|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277106|NCT01695239|20408740|P7|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
8277107|NCT01695239|20408741|P6|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
8277108|NCT01695239|20408742|P5|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
8277109|NCT01695239|20408743|P4|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277110|NCT01695239|20408744|P3|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277111|NCT01695239|20408745|P2|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277112|NCT01695239|20408746|P1|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277113|NCT01695239|20408733|P14|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277114|NCT01695239|20408734|P13|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277115|NCT01695239|20408735|P12|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277116|NCT01695239|20408736|P11|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277117|NCT01695239|20408737|P10|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277118|NCT01695239|20408738|P9|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277119|NCT01695239|20408739|P8|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277120|NCT01695239|20408740|P7|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
8277121|NCT01695239|20408741|P6|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
8277122|NCT01695239|20408742|P5|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
8277123|NCT01695239|20408743|P4|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277124|NCT01695239|20408744|P3|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277125|NCT01695239|20408745|P2|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277126|NCT01695239|20408746|P1|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277127|NCT01695239|20408733|P14|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277128|NCT01695239|20408734|P13|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277129|NCT01695239|20408735|P12|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277130|NCT01695239|20408736|P11|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277131|NCT01695239|20408737|P10|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277132|NCT01695239|20408738|P9|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277133|NCT01695239|20408739|P8|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277134|NCT01695239|20408740|P7|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277135|NCT01695239|20408741|P6|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277136|NCT01695239|20408742|P5|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277137|NCT01695239|20408743|P4|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
8277138|NCT01695239|20408744|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
8277139|NCT01695239|20408745|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
8277140|NCT01695239|20408746|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
8277141|NCT01695239|20408733|P14|COMPLETED|Double-Blind (DB) Treatment Period||0
8277142|NCT01695239|20408734|P13|COMPLETED|Double-Blind (DB) Treatment Period||0
8277143|NCT01695239|20408735|P12|COMPLETED|Double-Blind (DB) Treatment Period||0
8277144|NCT01695239|20408736|P11|COMPLETED|Double-Blind (DB) Treatment Period||0
8277145|NCT01695239|20408737|P10|COMPLETED|Double-Blind (DB) Treatment Period||0
8277146|NCT01695239|20408738|P9|COMPLETED|Double-Blind (DB) Treatment Period||0
8277147|NCT01695239|20408739|P8|COMPLETED|Double-Blind (DB) Treatment Period||0
8277148|NCT01695239|20408740|P7|COMPLETED|Double-Blind (DB) Treatment Period||0
8277149|NCT01695239|20408741|P6|COMPLETED|Double-Blind (DB) Treatment Period||0
8277150|NCT01695239|20408742|P5|COMPLETED|Double-Blind (DB) Treatment Period||0
8277151|NCT01695239|20408743|P4|COMPLETED|Double-Blind (DB) Treatment Period||96
8277152|NCT01695239|20408744|P3|COMPLETED|Double-Blind (DB) Treatment Period||97
8277153|NCT01695239|20408745|P2|COMPLETED|Double-Blind (DB) Treatment Period||97
8277154|NCT01695239|20408746|P1|COMPLETED|Double-Blind (DB) Treatment Period||91
8277155|NCT01695239|20408733|P14|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277156|NCT01695239|20408734|P13|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277157|NCT01695239|20408735|P12|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277158|NCT01695239|20408736|P11|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277159|NCT01695239|20408737|P10|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277160|NCT01695239|20408738|P9|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277161|NCT01695239|20408739|P8|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277162|NCT01695239|20408740|P7|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277163|NCT01695239|20408741|P6|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277164|NCT01695239|20408742|P5|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277165|NCT01695239|20408743|P4|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
8277166|NCT01695239|20408744|P3|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
8277167|NCT01695239|20408745|P2|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
8277168|NCT01695239|20408746|P1|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
8277169|NCT01695239|20408733|P14|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277170|NCT01695239|20408734|P13|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277171|NCT01695239|20408735|P12|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277172|NCT01695239|20408736|P11|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277173|NCT01695239|20408737|P10|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277174|NCT01695239|20408738|P9|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277175|NCT01695239|20408739|P8|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277176|NCT01695239|20408740|P7|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277177|NCT01695239|20408741|P6|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277178|NCT01695239|20408742|P5|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277179|NCT01695239|20408743|P4|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
8277180|NCT01695239|20408744|P3|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
8277181|NCT01695239|20408745|P2|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
8277182|NCT01695239|20408746|P1|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
8277183|NCT01695239|20408733|P14|STARTED|Double-Blind (DB) Treatment Period||0
8277184|NCT01695239|20408734|P13|STARTED|Double-Blind (DB) Treatment Period||0
8277185|NCT01695239|20408735|P12|STARTED|Double-Blind (DB) Treatment Period||0
8277186|NCT01695239|20408736|P11|STARTED|Double-Blind (DB) Treatment Period||0
8277187|NCT01695239|20408737|P10|STARTED|Double-Blind (DB) Treatment Period||0
8277188|NCT01695239|20408738|P9|STARTED|Double-Blind (DB) Treatment Period||0
8277189|NCT01695239|20408739|P8|STARTED|Double-Blind (DB) Treatment Period||0
8277190|NCT01695239|20408740|P7|STARTED|Double-Blind (DB) Treatment Period||0
8277191|NCT01695239|20408741|P6|STARTED|Double-Blind (DB) Treatment Period||0
8277192|NCT01695239|20408742|P5|STARTED|Double-Blind (DB) Treatment Period||0
8277193|NCT01695239|20408743|P4|STARTED|Double-Blind (DB) Treatment Period||103
8277194|NCT01695239|20408744|P3|STARTED|Double-Blind (DB) Treatment Period||107
8277195|NCT01695239|20408745|P2|STARTED|Double-Blind (DB) Treatment Period||101
8277196|NCT01695239|20408746|P1|STARTED|Double-Blind (DB) Treatment Period||106
8277197|NCT01695135|20408887|P4|NOT COMPLETED|Open Label Extension Treatment Phase||70
8277198|NCT01695135|20408888|P3|NOT COMPLETED|Open Label Extension Treatment Phase||40
8277199|NCT01695135|20408889|P2|NOT COMPLETED|Open Label Extension Treatment Phase||0
8277200|NCT01695135|20408890|P1|NOT COMPLETED|Open Label Extension Treatment Phase||0
8277201|NCT01695135|20408887|P4|COMPLETED|Open Label Extension Treatment Phase||10
8277202|NCT01695135|20408888|P3|COMPLETED|Open Label Extension Treatment Phase||9
8277203|NCT01695135|20408889|P2|COMPLETED|Open Label Extension Treatment Phase||0
8277204|NCT01695135|20408890|P1|COMPLETED|Open Label Extension Treatment Phase||0
8277205|NCT01695135|20408887|P4|STARTED|Open Label Extension Treatment Phase||80
8277206|NCT01695135|20408888|P3|STARTED|Open Label Extension Treatment Phase||49
8277207|NCT01695135|20408889|P2|STARTED|Open Label Extension Treatment Phase||0
8277208|NCT01695135|20408890|P1|STARTED|Open Label Extension Treatment Phase||0
8277209|NCT01695135|20408887|P4|NOT COMPLETED|Double-blind Treatment Phase||0
8277210|NCT01695135|20408888|P3|NOT COMPLETED|Double-blind Treatment Phase||0
8277211|NCT01695135|20408889|P2|NOT COMPLETED|Double-blind Treatment Phase||139
8277212|NCT01695135|20408890|P1|NOT COMPLETED|Double-blind Treatment Phase||71
8277213|NCT01695135|20408887|P4|COMPLETED|Double-blind Treatment Phase||0
8277214|NCT01695135|20408888|P3|COMPLETED|Double-blind Treatment Phase||0
8277215|NCT01695135|20408889|P2|COMPLETED|Double-blind Treatment Phase||4
8277216|NCT01695135|20408890|P1|COMPLETED|Double-blind Treatment Phase||0
8277217|NCT01695135|20408887|P4|STARTED|Double-blind Treatment Phase||0
8277218|NCT01695135|20408888|P3|STARTED|Double-blind Treatment Phase||0
8277219|NCT01695135|20408889|P2|STARTED|Double-blind Treatment Phase||143
8277220|NCT01695135|20408890|P1|STARTED|Double-blind Treatment Phase||71
8277221|NCT01695044|20408914|P1|NOT COMPLETED|Overall Study||102
8277222|NCT01695044|20408914|P1|COMPLETED|Overall Study||17
8277223|NCT01695044|20408914|P1|STARTED|Overall Study||119
8277224|NCT01694966|20408927|P3|NOT COMPLETED|Overall Study||34
8277225|NCT01694966|20408928|P2|NOT COMPLETED|Overall Study||15
8277226|NCT01694966|20408929|P1|NOT COMPLETED|Overall Study||34
8277227|NCT01694966|20408927|P3|COMPLETED|Overall Study||464
8277228|NCT01694966|20408928|P2|COMPLETED|Overall Study||232
8277229|NCT01694966|20408929|P1|COMPLETED|Overall Study||470
8277230|NCT01694966|20408927|P3|STARTED|Overall Study||498
8277231|NCT01694966|20408928|P2|STARTED|Overall Study||247
8277232|NCT01694966|20408929|P1|STARTED|Overall Study||504
8277233|NCT01694771|20408939|P2|NOT COMPLETED|Overall Study||40
8277234|NCT01694771|20408940|P1|NOT COMPLETED|Overall Study||40
8277235|NCT01694771|20408939|P2|COMPLETED|Overall Study||525
8277236|NCT01694771|20408940|P1|COMPLETED|Overall Study||527
8277237|NCT01694771|20408939|P2|STARTED|Overall Study||565
8277238|NCT01694771|20408940|P1|STARTED|Overall Study||567
8277239|NCT01694706|20408964|P3|NOT COMPLETED|Overall Study||0
8277240|NCT01694706|20408965|P2|NOT COMPLETED|Overall Study||1
8277241|NCT01694706|20408966|P1|NOT COMPLETED|Overall Study||1
8277242|NCT01694706|20408964|P3|COMPLETED|Overall Study||5
8277243|NCT01694706|20408965|P2|COMPLETED|Overall Study||4
8277244|NCT01694706|20408966|P1|COMPLETED|Overall Study||4
8277245|NCT01694706|20408964|P3|Received Faldaprevir Fed|Overall Study||5
8277246|NCT01694706|20408965|P2|Received Faldaprevir Fed|Overall Study||5
8277247|NCT01694706|20408966|P1|Received Faldaprevir Fed|Overall Study||4
8277248|NCT01694706|20408964|P3|Received Faldaprevir +OMP|Overall Study||5
8277249|NCT01694706|20408965|P2|Received Faldaprevir +OMP|Overall Study||5
8277250|NCT01694706|20408966|P1|Received Faldaprevir +OMP|Overall Study||5
8277251|NCT01694706|20408964|P3|Received Faldaprevir|Overall Study||5
8277252|NCT01694706|20408965|P2|Received Faldaprevir|Overall Study||5
8277253|NCT01694706|20408966|P1|Received Faldaprevir|Overall Study||5
8277254|NCT01694706|20408964|P3|STARTED|Overall Study||5
8277255|NCT01694706|20408965|P2|STARTED|Overall Study||5
8277256|NCT01694706|20408966|P1|STARTED|Overall Study||5
8277257|NCT01694667|20408983|P2|NOT COMPLETED|Overall Study||0
8277258|NCT01694667|20408984|P1|NOT COMPLETED|Overall Study||0
8277259|NCT01694667|20408983|P2|COMPLETED|Overall Study||28
8277260|NCT01694667|20408984|P1|COMPLETED|Overall Study||29
8277261|NCT01694667|20408983|P2|STARTED|Overall Study||28
8277262|NCT01694667|20408984|P1|STARTED|Overall Study||29
8277263|NCT01694641|20409004|P2|NOT COMPLETED|Overall Study||10
8277264|NCT01694641|20409005|P1|NOT COMPLETED|Overall Study||12
8277265|NCT01694641|20409004|P2|COMPLETED|Overall Study||71
8277266|NCT01694641|20409005|P1|COMPLETED|Overall Study||68
8277267|NCT01694641|20409004|P2|STARTED|Overall Study||81
8277268|NCT01694641|20409005|P1|STARTED|Overall Study||80
8277269|NCT01694563|20409013|P1|NOT COMPLETED|Overall Study||87
8277270|NCT01694563|20409013|P1|COMPLETED|Overall Study||278
8277271|NCT01694563|20409013|P1|STARTED|Overall Study||365
8277272|NCT01694485|20409025|P5|NOT COMPLETED|Overall Study||25
8277273|NCT01694485|20409026|P4|NOT COMPLETED|Overall Study||38
8277274|NCT01694485|20409027|P3|NOT COMPLETED|Overall Study||13
8277275|NCT01694485|20409028|P2|NOT COMPLETED|Overall Study||7
8277276|NCT01694485|20409029|P1|NOT COMPLETED|Overall Study||33
8277277|NCT01694485|20409025|P5|COMPLETED|Overall Study||55
8277278|NCT01694485|20409026|P4|COMPLETED|Overall Study||62
8277279|NCT01694485|20409027|P3|COMPLETED|Overall Study||27
8277280|NCT01694485|20409028|P2|COMPLETED|Overall Study||15
8277281|NCT01694485|20409029|P1|COMPLETED|Overall Study||84
8277282|NCT01694485|20409025|P5|Entered Open-label Period|Overall Study||68
8277283|NCT01694485|20409026|P4|Entered Open-label Period|Overall Study||88
8277284|NCT01694485|20409027|P3|Entered Open-label Period|Overall Study||36
8277285|NCT01694485|20409028|P2|Entered Open-label Period|Overall Study||19
8277286|NCT01694485|20409029|P1|Entered Open-label Period|Overall Study||100
8277287|NCT01694485|20409025|P5|Completed Week 8 Assessment|Overall Study||76
8277288|NCT01694485|20409026|P4|Completed Week 8 Assessment|Overall Study||94
8277289|NCT01694485|20409027|P3|Completed Week 8 Assessment|Overall Study||38
8277290|NCT01694485|20409028|P2|Completed Week 8 Assessment|Overall Study||18
8277291|NCT01694485|20409029|P1|Completed Week 8 Assessment|Overall Study||106
8277292|NCT01694485|20409025|P5|Received Treatment|Overall Study||79
8277293|NCT01694485|20409026|P4|Received Treatment|Overall Study||98
8277294|NCT01694485|20409027|P3|Received Treatment|Overall Study||40
8277295|NCT01694485|20409028|P2|Received Treatment|Overall Study||21
8277296|NCT01694485|20409029|P1|Received Treatment|Overall Study||116
8277297|NCT01694485|20409025|P5|STARTED|Overall Study||80
8277298|NCT01694485|20409026|P4|STARTED|Overall Study||100
8277299|NCT01694485|20409027|P3|STARTED|Overall Study||40
8277300|NCT01694485|20409028|P2|STARTED|Overall Study||22
8277301|NCT01694485|20409029|P1|STARTED|Overall Study||117
8277302|NCT01694433|20409063|P2|NOT COMPLETED|Overall Study||4
8277303|NCT01694433|20409064|P1|NOT COMPLETED|Overall Study||11
8277304|NCT01694433|20409063|P2|COMPLETED|Overall Study||29
8277305|NCT01694433|20409064|P1|COMPLETED|Overall Study||22
8277306|NCT01694433|20409063|P2|Baseline Visit|Overall Study||32
8277307|NCT01694433|20409064|P1|Baseline Visit|Overall Study||33
8277308|NCT01694433|20409063|P2|STARTED|Overall Study||33
8277309|NCT01694433|20409064|P1|STARTED|Overall Study||33
8277310|NCT01694420|20409072|P1|NOT COMPLETED|Overall Study||3
8277311|NCT01694420|20409072|P1|COMPLETED|Overall Study||30
8277312|NCT01694420|20409072|P1|STARTED|Overall Study||33
8277313|NCT01694199|20409083|P2|NOT COMPLETED|Overall Study||0
8277314|NCT01694199|20409084|P1|NOT COMPLETED|Overall Study||0
8277315|NCT01694199|20409083|P2|COMPLETED|Overall Study||68
8277316|NCT01694199|20409084|P1|COMPLETED|Overall Study||71
8277317|NCT01694199|20409083|P2|STARTED|Overall Study||68
8277318|NCT01694199|20409084|P1|STARTED|Overall Study||71
8277319|NCT01694186|20409100|P2|NOT COMPLETED|Overall Study||7
8277320|NCT01694186|20409101|P1|NOT COMPLETED|Overall Study||6
8277321|NCT01694186|20409100|P2|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
8277322|NCT01694186|20409101|P1|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
8277323|NCT01694186|20409100|P2|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
8277324|NCT01694186|20409101|P1|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
8277325|NCT01694121|20409109|P2|NOT COMPLETED|Overall Study||0
8277326|NCT01694121|20409110|P1|NOT COMPLETED|Overall Study||1
8277327|NCT01694121|20409109|P2|COMPLETED|Overall Study||227
8277328|NCT01694121|20409110|P1|COMPLETED|Overall Study||227
8277329|NCT01694121|20409109|P2|STARTED|Overall Study||227
8277330|NCT01694121|20409110|P1|STARTED|Overall Study||228
8277331|NCT01694108|20409124|P2|NOT COMPLETED|Overall Study||0
8277332|NCT01694108|20409125|P1|NOT COMPLETED|Overall Study||0
8277333|NCT01694108|20409124|P2|COMPLETED|Overall Study|100% follow-up|2133
8277334|NCT01694108|20409125|P1|COMPLETED|Overall Study|100% follow-up|2129
8277335|NCT01694108|20409124|P2|STARTED|Overall Study||2133
8277336|NCT01694108|20409125|P1|STARTED|Overall Study||2129
8277337|NCT01693900|20409181|P2|NOT COMPLETED|Overall Study||0
8277338|NCT01693900|20409182|P1|NOT COMPLETED|Overall Study||0
8277339|NCT01693900|20409181|P2|COMPLETED|Overall Study||25
8277340|NCT01693900|20409182|P1|COMPLETED|Overall Study||25
8277341|NCT01693900|20409181|P2|STARTED|Overall Study||25
8277342|NCT01693900|20409182|P1|STARTED|Overall Study||25
8277343|NCT01693653|20409196|P2|NOT COMPLETED|Overall Study||0
8277344|NCT01693653|20409197|P1|NOT COMPLETED|Overall Study||0
8277345|NCT01693653|20409196|P2|COMPLETED|Overall Study||0
8277346|NCT01693653|20409197|P1|COMPLETED|Overall Study||1
8277347|NCT01693653|20409196|P2|STARTED|Overall Study||0
8277348|NCT01693653|20409197|P1|STARTED|Overall Study||1
8277349|NCT01693614|20409224|P3|NOT COMPLETED|Overall Study||24
8277350|NCT01693614|20409225|P2|NOT COMPLETED|Overall Study||22
8277351|NCT01693614|20409226|P1|NOT COMPLETED|Overall Study||26
8277352|NCT01693614|20409224|P3|COMPLETED|Overall Study||0
8277353|NCT01693614|20409225|P2|COMPLETED|Overall Study||0
8277354|NCT01693614|20409226|P1|COMPLETED|Overall Study||0
8277355|NCT01693614|20409224|P3|STARTED|Overall Study||24
8277356|NCT01693614|20409225|P2|STARTED|Overall Study||22
8277357|NCT01693614|20409226|P1|STARTED|Overall Study||26
8277358|NCT01693523|20409251|P3|NOT COMPLETED|Overall Study||8
8277359|NCT01693523|20409252|P2|NOT COMPLETED|Overall Study||8
8277360|NCT01693523|20409253|P1|NOT COMPLETED|Overall Study||5
8277361|NCT01693523|20409251|P3|COMPLETED|Overall Study||27
8277362|NCT01693523|20409252|P2|COMPLETED|Overall Study||13
8277363|NCT01693523|20409253|P1|COMPLETED|Overall Study||18
8277364|NCT01693523|20409251|P3|STARTED|Overall Study||35
8277365|NCT01693523|20409252|P2|STARTED|Overall Study||21
8277366|NCT01693523|20409253|P1|STARTED|Overall Study||23
8277367|NCT01693484|20409263|P1|NOT COMPLETED|Overall Study||13
8277368|NCT01693484|20409263|P1|COMPLETED|Overall Study|Study closed by PI|0
8277369|NCT01693484|20409263|P1|STARTED|Overall Study||13
8277370|NCT01693367|20409269|P2|NOT COMPLETED|Overall Study||2
8277371|NCT01693367|20409270|P1|NOT COMPLETED|Overall Study||1
8277372|NCT01693367|20409269|P2|COMPLETED|Overall Study||1
8277373|NCT01693367|20409270|P1|COMPLETED|Overall Study||1
8277374|NCT01693367|20409269|P2|STARTED|Overall Study||3
8277375|NCT01693367|20409270|P1|STARTED|Overall Study||2
8277376|NCT01693250|20409288|P2|NOT COMPLETED|Overall Study||2
8277377|NCT01693250|20409289|P1|NOT COMPLETED|Overall Study||2
8277378|NCT01693250|20409288|P2|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
8277379|NCT01693250|20409289|P1|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
8277380|NCT01693250|20409288|P2|STARTED|Overall Study|three month post baseline assessment|17
8277381|NCT01693250|20409289|P1|STARTED|Overall Study|3 months post baseline assessment|23
8277382|NCT01693185|20409299|P2|NOT COMPLETED|Overall Study||6
8277383|NCT01693185|20409300|P1|NOT COMPLETED|Overall Study||0
8277384|NCT01693185|20409299|P2|COMPLETED|Overall Study||27
8277385|NCT01693185|20409300|P1|COMPLETED|Overall Study||27
8277386|NCT01693185|20409299|P2|STARTED|Overall Study||33
8277387|NCT01693185|20409300|P1|STARTED|Overall Study||27
8277388|NCT01693120|20409316|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
8277389|NCT01693120|20409316|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
8277390|NCT01693120|20409316|P1|STARTED|Phased RF Study Procedure and Follow-up||129
8277391|NCT01693120|20409316|P1|NOT COMPLETED|Enrollment||70
8277392|NCT01693120|20409316|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
8277393|NCT01693120|20409316|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
8277394|NCT01693068|20409325|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
8277395|NCT01693068|20409326|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277396|NCT01693068|20409327|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277397|NCT01693068|20409325|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
8277398|NCT01693068|20409326|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277399|NCT01693068|20409327|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277400|NCT01693068|20409325|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
8277401|NCT01693068|20409326|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
8277402|NCT01693068|20409327|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
8277403|NCT01693068|20409325|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
8277404|NCT01693068|20409326|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
8277405|NCT01693068|20409327|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
8277406|NCT01693068|20409325|P3|NOT COMPLETED|Randomization Period||0
8277407|NCT01693068|20409326|P2|NOT COMPLETED|Randomization Period||5
8277408|NCT01693068|20409327|P1|NOT COMPLETED|Randomization Period||2
8277409|NCT01693068|20409325|P3|COMPLETED|Randomization Period||0
8277410|NCT01693068|20409326|P2|COMPLETED|Randomization Period||125
8277411|NCT01693068|20409327|P1|COMPLETED|Randomization Period||62
8277412|NCT01693068|20409325|P3|Treated|Randomization Period||0
8277413|NCT01693068|20409326|P2|Treated|Randomization Period||130
8277414|NCT01693068|20409327|P1|Treated|Randomization Period||61
8277415|NCT01693068|20409325|P3|STARTED|Randomization Period||0
8277416|NCT01693068|20409326|P2|STARTED|Randomization Period||130
8277417|NCT01693068|20409327|P1|STARTED|Randomization Period||64
8277418|NCT01693029|20409359|P2|NOT COMPLETED|Overall Study||57
8277419|NCT01693029|20409360|P1|NOT COMPLETED|Overall Study||44
8277420|NCT01693029|20409359|P2|COMPLETED|Overall Study||161
8277421|NCT01693029|20409360|P1|COMPLETED|Overall Study||173
8277422|NCT01693029|20409359|P2|STARTED|Overall Study||218
8277423|NCT01693029|20409360|P1|STARTED|Overall Study||217
8277424|NCT01692964|20409372|P1|NOT COMPLETED|Overall Study||0
8277425|NCT01692964|20409372|P1|COMPLETED|Overall Study||237
8277426|NCT01692964|20409372|P1|STARTED|Overall Study||237
8277427|NCT01692951|20409381|P4|NOT COMPLETED|Overall Study||0
8277428|NCT01692951|20409382|P3|NOT COMPLETED|Overall Study||0
8277429|NCT01692951|20409383|P2|NOT COMPLETED|Overall Study||0
8277430|NCT01692951|20409384|P1|NOT COMPLETED|Overall Study||0
8277431|NCT01692951|20409381|P4|COMPLETED|Overall Study||54
8277432|NCT01692951|20409382|P3|COMPLETED|Overall Study||18
8277433|NCT01692951|20409383|P2|COMPLETED|Overall Study||111
8277434|NCT01692951|20409384|P1|COMPLETED|Overall Study||37
8277435|NCT01692951|20409381|P4|STARTED|Overall Study||54
8277436|NCT01692951|20409382|P3|STARTED|Overall Study||18
8277437|NCT01692951|20409383|P2|STARTED|Overall Study||111
8277438|NCT01692951|20409384|P1|STARTED|Overall Study||37
8277439|NCT01692938|20409396|P2|NOT COMPLETED|Overall Study||4
8277440|NCT01692938|20409397|P1|NOT COMPLETED|Overall Study||4
8277441|NCT01692938|20409396|P2|COMPLETED|Overall Study||12
8277442|NCT01692938|20409397|P1|COMPLETED|Overall Study||12
8277443|NCT01692938|20409396|P2|STARTED|Overall Study||16
8277444|NCT01692938|20409397|P1|STARTED|Overall Study||16
8277445|NCT01692782|20409408|P3|NOT COMPLETED|Overall Study||10
8277446|NCT01692782|20409409|P2|NOT COMPLETED|Overall Study||56
8277447|NCT01692782|20409410|P1|NOT COMPLETED|Overall Study||20
8277448|NCT01692782|20409408|P3|COMPLETED|Overall Study||100
8277449|NCT01692782|20409409|P2|COMPLETED|Overall Study||59
8277450|NCT01692782|20409410|P1|COMPLETED|Overall Study||96
8277451|NCT01692782|20409408|P3|STARTED|Overall Study||110
8277452|NCT01692782|20409409|P2|STARTED|Overall Study||115
8277453|NCT01692782|20409410|P1|STARTED|Overall Study||116
8277454|NCT01692756|20409437|P4|NOT COMPLETED|Overall Study||0
8277455|NCT01692756|20409438|P3|NOT COMPLETED|Overall Study||2
8277456|NCT01692756|20409439|P2|NOT COMPLETED|Overall Study||1
8277457|NCT01692756|20409440|P1|NOT COMPLETED|Overall Study||1
8277458|NCT01692756|20409437|P4|COMPLETED|Overall Study||12
8277459|NCT01692756|20409438|P3|COMPLETED|Overall Study||11
8277460|NCT01692756|20409439|P2|COMPLETED|Overall Study||11
8277461|NCT01692756|20409440|P1|COMPLETED|Overall Study||11
8277462|NCT01692756|20409437|P4|STARTED|Overall Study||12
8277463|NCT01692756|20409438|P3|STARTED|Overall Study||13
8277464|NCT01692756|20409439|P2|STARTED|Overall Study||12
8277465|NCT01692756|20409440|P1|STARTED|Overall Study||12
8277466|NCT01692743|20409501|P3|NOT COMPLETED|Overall Study||27
8277467|NCT01692743|20409502|P2|NOT COMPLETED|Overall Study||35
8277468|NCT01692743|20409503|P1|NOT COMPLETED|Overall Study||27
8277469|NCT01692743|20409501|P3|COMPLETED|Overall Study||88
8277470|NCT01692743|20409502|P2|COMPLETED|Overall Study||81
8277471|NCT01692743|20409503|P1|COMPLETED|Overall Study||90
8277472|NCT01692743|20409501|P3|STARTED|Overall Study||115
8277473|NCT01692743|20409502|P2|STARTED|Overall Study||116
8277474|NCT01692743|20409503|P1|STARTED|Overall Study||117
8277475|NCT01692730|20409519|P2|NOT COMPLETED|Overall Study||227
8277476|NCT01692730|20409520|P1|NOT COMPLETED|Overall Study||225
8277477|NCT01692730|20409519|P2|COMPLETED|Overall Study||502
8277478|NCT01692730|20409520|P1|COMPLETED|Overall Study||498
8277479|NCT01692730|20409519|P2|STARTED|Overall Study||729
8277480|NCT01692730|20409520|P1|STARTED|Overall Study||723
8277481|NCT01692691|20409528|P1|NOT COMPLETED|Overall Study||0
8277482|NCT01692691|20409528|P1|COMPLETED|Overall Study||1
8277483|NCT01692691|20409528|P1|STARTED|Overall Study||1
8277484|NCT01692626|20409534|P2|NOT COMPLETED|Overall Study||6
8277485|NCT01692626|20409535|P1|NOT COMPLETED|Overall Study||4
8277486|NCT01692626|20409534|P2|COMPLETED|Overall Study||1
8277487|NCT01692626|20409535|P1|COMPLETED|Overall Study||2
8277488|NCT01692626|20409534|P2|STARTED|Overall Study||7
8277489|NCT01692626|20409535|P1|STARTED|Overall Study||6
8277490|NCT01692496|20409540|P1|NOT COMPLETED|Overall Study||0
8277491|NCT01692496|20409540|P1|COMPLETED|Overall Study||52
8277492|NCT01692496|20409540|P1|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
8277493|NCT01692496|20409540|P1|STARTED|Overall Study||52
8277494|NCT01692340|20409553|P3|NOT COMPLETED|Overall Study||0
8277495|NCT01692340|20409554|P2|NOT COMPLETED|Overall Study||0
8277496|NCT01692340|20409555|P1|NOT COMPLETED|Overall Study||0
8277497|NCT01692340|20409553|P3|COMPLETED|Overall Study||0
8277498|NCT01692340|20409554|P2|COMPLETED|Overall Study||4
8277499|NCT01692340|20409555|P1|COMPLETED|Overall Study||8
8277500|NCT01692340|20409553|P3|STARTED|Overall Study||0
8277501|NCT01692340|20409554|P2|STARTED|Overall Study||4
8277502|NCT01692340|20409555|P1|STARTED|Overall Study||8
8277503|NCT01692301|20409570|P2|NOT COMPLETED|Overall Study||42
8277504|NCT01692301|20409571|P1|NOT COMPLETED|Overall Study||45
8277505|NCT01692301|20409570|P2|COMPLETED|Overall Study||183
8277506|NCT01692301|20409571|P1|COMPLETED|Overall Study||184
8277507|NCT01692301|20409570|P2|STARTED|Overall Study||225
8277508|NCT01692301|20409571|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
8277509|NCT01692275|20409603|P2|NOT COMPLETED|Overall Study||59
8277510|NCT01692275|20409604|P1|NOT COMPLETED|Overall Study||66
8277511|NCT01692275|20409603|P2|COMPLETED|Overall Study||316
8277512|NCT01692275|20409604|P1|COMPLETED|Overall Study||309
8277513|NCT01692275|20409603|P2|STARTED|Overall Study||375
8277514|NCT01692275|20409604|P1|STARTED|Overall Study||375
8277515|NCT01692197|20409664|P1|NOT COMPLETED|Overall Study||3
8277516|NCT01692197|20409664|P1|COMPLETED|Overall Study||40
8277517|NCT01692197|20409664|P1|STARTED|Overall Study||43
8277518|NCT01691950|20409673|P2|NOT COMPLETED|Overall Study||0
8277519|NCT01691950|20409674|P1|NOT COMPLETED|Overall Study||10
8277520|NCT01691950|20409673|P2|COMPLETED|Overall Study||10
8277521|NCT01691950|20409674|P1|COMPLETED|Overall Study||10
8277522|NCT01691950|20409673|P2|STARTED|Overall Study||10
8277523|NCT01691950|20409674|P1|STARTED|Overall Study||20
8277524|NCT01691898|20409686|P6|NOT COMPLETED|Overall Study||35
8277525|NCT01691898|20409687|P5|NOT COMPLETED|Overall Study||14
8277526|NCT01691898|20409688|P4|NOT COMPLETED|Overall Study||5
8277527|NCT01691898|20409689|P3|NOT COMPLETED|Overall Study||9
8277528|NCT01691898|20409690|P2|NOT COMPLETED|Overall Study||44
8277529|NCT01691898|20409691|P1|NOT COMPLETED|Overall Study||47
8277530|NCT01691898|20409686|P6|COMPLETED|Overall Study||5
8277531|NCT01691898|20409687|P5|COMPLETED|Overall Study||26
8277532|NCT01691898|20409688|P4|COMPLETED|Overall Study||4
8277533|NCT01691898|20409689|P3|COMPLETED|Overall Study||11
8277534|NCT01691898|20409690|P2|COMPLETED|Overall Study||15
8277535|NCT01691898|20409691|P1|COMPLETED|Overall Study||16
8277536|NCT01691898|20409686|P6|STARTED|Overall Study||40
8277537|NCT01691898|20409687|P5|STARTED|Overall Study||40
8277538|NCT01691898|20409688|P4|STARTED|Overall Study||9
8277539|NCT01691898|20409689|P3|STARTED|Overall Study||20
8277540|NCT01691898|20409690|P2|STARTED|Overall Study||59
8277541|NCT01691898|20409691|P1|STARTED|Overall Study||63
8277542|NCT01691885|20409845|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
8277543|NCT01691885|20409846|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
8277544|NCT01691885|20409845|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
8277545|NCT01691885|20409846|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
8277546|NCT01691885|20409845|P2|STARTED|Treatment Period 2 (7-14 Days)||21
8277547|NCT01691885|20409846|P1|STARTED|Treatment Period 2 (7-14 Days)||21
8277548|NCT01691885|20409845|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
8277549|NCT01691885|20409846|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
8277550|NCT01691885|20409845|P2|COMPLETED|Washout Period (7-9 Days)||21
8277551|NCT01691885|20409846|P1|COMPLETED|Washout Period (7-9 Days)||21
8277552|NCT01691885|20409845|P2|STARTED|Washout Period (7-9 Days)||22
8277553|NCT01691885|20409846|P1|STARTED|Washout Period (7-9 Days)||21
8277554|NCT01691885|20409845|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
8277555|NCT01691885|20409846|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
8277556|NCT01691885|20409845|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
8277557|NCT01691885|20409846|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
8277558|NCT01691885|20409845|P2|STARTED|Treatment Period 1(7-14 Days)||23
8277559|NCT01691885|20409846|P1|STARTED|Treatment Period 1(7-14 Days)||22
8277560|NCT01691859|20409852|P1|NOT COMPLETED|Overall Study||347
8277561|NCT01691859|20409852|P1|COMPLETED|Overall Study||0
8277562|NCT01691859|20409852|P1|STARTED|Overall Study||347
8277563|NCT01691833|20409874|P3|NOT COMPLETED|Overall Study||0
8277564|NCT01691833|20409875|P2|NOT COMPLETED|Overall Study||1
8277565|NCT01691833|20409876|P1|NOT COMPLETED|Overall Study||1
8277566|NCT01691833|20409874|P3|COMPLETED|Overall Study||13
8277567|NCT01691833|20409875|P2|COMPLETED|Overall Study||49
8277568|NCT01691833|20409876|P1|COMPLETED|Overall Study||49
8277569|NCT01691833|20409874|P3|STARTED|Overall Study||13
8277570|NCT01691833|20409875|P2|STARTED|Overall Study||50
8277571|NCT01691833|20409876|P1|STARTED|Overall Study||50
8277572|NCT01691820|20409899|P3|NOT COMPLETED|Overall Study||1
8277573|NCT01691820|20409900|P2|NOT COMPLETED|Overall Study||34
8277574|NCT01691820|20409901|P1|NOT COMPLETED|Overall Study||29
8277575|NCT01691820|20409899|P3|COMPLETED|Overall Study||2
8277576|NCT01691820|20409900|P2|COMPLETED|Overall Study||110
8277577|NCT01691820|20409901|P1|COMPLETED|Overall Study||187
8277578|NCT01691820|20409899|P3|STARTED|Overall Study||3
8277579|NCT01691820|20409900|P2|STARTED|Overall Study||144
8277580|NCT01691820|20409901|P1|STARTED|Overall Study||216
8277581|NCT01691794|20409939|P3|NOT COMPLETED|Overall Study||10
8277582|NCT01691794|20409940|P2|NOT COMPLETED|Overall Study||18
8277583|NCT01691794|20409941|P1|NOT COMPLETED|Overall Study||1
8277584|NCT01691794|20409939|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
8277585|NCT01691794|20409940|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
8277586|NCT01691794|20409941|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
8277587|NCT01691794|20409939|P3|STARTED|Overall Study||23
8277588|NCT01691794|20409940|P2|STARTED|Overall Study||33
8277589|NCT01691794|20409941|P1|STARTED|Overall Study||3
8277590|NCT01691781|20409957|P2|NOT COMPLETED|Overall Study||7
8277591|NCT01691781|20409958|P1|NOT COMPLETED|Overall Study||7
8277592|NCT01691781|20409957|P2|COMPLETED|Overall Study||15
8277593|NCT01691781|20409958|P1|COMPLETED|Overall Study||12
8277594|NCT01691781|20409957|P2|STARTED|Overall Study||22
8277595|NCT01691781|20409958|P1|STARTED|Overall Study||19
8277596|NCT01691768|20409970|P2|NOT COMPLETED|Overall Study||16
8277597|NCT01691768|20409971|P1|NOT COMPLETED|Overall Study||15
8277598|NCT01691768|20409970|P2|COMPLETED|Overall Study||167
8277599|NCT01691768|20409971|P1|COMPLETED|Overall Study||174
8277600|NCT01691768|20409970|P2|STARTED|Overall Study||183
8277601|NCT01691768|20409971|P1|STARTED|Overall Study||189
8277602|NCT01691690|20409995|P2|NOT COMPLETED|Overall Study||4
8277603|NCT01691690|20409996|P1|NOT COMPLETED|Overall Study||7
8277604|NCT01691690|20409995|P2|COMPLETED|Overall Study||121
8277605|NCT01691690|20409996|P1|COMPLETED|Overall Study||118
8277606|NCT01691690|20409995|P2|STARTED|Overall Study||125
8277607|NCT01691690|20409996|P1|STARTED|Overall Study||125
8277608|NCT01691612|20410006|P1|NOT COMPLETED|Overall Study||7
8277609|NCT01691612|20410006|P1|COMPLETED|Overall Study||7
8277610|NCT01691612|20410006|P1|Second Visit (Bronchoscopy)|Overall Study||7
8277611|NCT01691612|20410006|P1|First Visit (Allergen Challenge)|Overall Study||8
8277612|NCT01691612|20410006|P1|STARTED|Overall Study||14
8277613|NCT01691560|20410017|P4|NOT COMPLETED|Overall Study||0
8277614|NCT01691560|20410018|P3|NOT COMPLETED|Overall Study||0
8277615|NCT01691560|20410019|P2|NOT COMPLETED|Overall Study||0
8277616|NCT01691560|20410020|P1|NOT COMPLETED|Overall Study||0
8277617|NCT01691560|20410017|P4|COMPLETED|Overall Study||33
8277618|NCT01691560|20410018|P3|COMPLETED|Overall Study||34
8277619|NCT01691560|20410019|P2|COMPLETED|Overall Study||33
8277620|NCT01691560|20410020|P1|COMPLETED|Overall Study||34
8277621|NCT01691560|20410017|P4|STARTED|Overall Study||33
8277622|NCT01691560|20410018|P3|STARTED|Overall Study||34
8277623|NCT01691560|20410019|P2|STARTED|Overall Study||33
8277624|NCT01691560|20410020|P1|STARTED|Overall Study||34
8277625|NCT01691534|20410057|P7|NOT COMPLETED|Overall Study||1
8277626|NCT01691534|20410058|P6|NOT COMPLETED|Overall Study||1
8277627|NCT01691534|20410059|P5|NOT COMPLETED|Overall Study||0
8277628|NCT01691534|20410060|P4|NOT COMPLETED|Overall Study||1
8277629|NCT01691534|20410061|P3|NOT COMPLETED|Overall Study||1
8277630|NCT01691534|20410062|P2|NOT COMPLETED|Overall Study||1
8277631|NCT01691534|20410063|P1|NOT COMPLETED|Overall Study||0
8277632|NCT01691534|20410057|P7|COMPLETED|Overall Study||14
8277633|NCT01691534|20410058|P6|COMPLETED|Overall Study||14
8277634|NCT01691534|20410059|P5|COMPLETED|Overall Study||15
8277635|NCT01691534|20410060|P4|COMPLETED|Overall Study||14
8277636|NCT01691534|20410061|P3|COMPLETED|Overall Study||14
8277637|NCT01691534|20410062|P2|COMPLETED|Overall Study||14
8277638|NCT01691534|20410063|P1|COMPLETED|Overall Study||15
8277639|NCT01691534|20410057|P7|STARTED|Overall Study||15
8277640|NCT01691534|20410058|P6|STARTED|Overall Study||15
8277641|NCT01691534|20410059|P5|STARTED|Overall Study||15
8277642|NCT01691534|20410060|P4|STARTED|Overall Study||15
8277643|NCT01691534|20410061|P3|STARTED|Overall Study||15
8277644|NCT01691534|20410062|P2|STARTED|Overall Study||15
8277645|NCT01691534|20410063|P1|STARTED|Overall Study||15
8277646|NCT01691521|20410117|P3|NOT COMPLETED|Overall Study||9
8277647|NCT01691521|20410118|P2|NOT COMPLETED|Overall Study||16
8277648|NCT01691521|20410119|P1|NOT COMPLETED|Overall Study||12
8277649|NCT01691521|20410117|P3|COMPLETED|Overall Study||185
8277650|NCT01691521|20410118|P2|COMPLETED|Overall Study||175
8277651|NCT01691521|20410119|P1|COMPLETED|Overall Study||179
8277652|NCT01691521|20410117|P3|STARTED|Overall Study||194
8277653|NCT01691521|20410118|P2|STARTED|Overall Study||191
8277654|NCT01691521|20410119|P1|STARTED|Overall Study||191
8277655|NCT01691508|20410141|P2|NOT COMPLETED|Overall Study||3
8277656|NCT01691508|20410142|P1|NOT COMPLETED|Overall Study||4
8277657|NCT01691508|20410141|P2|COMPLETED|Overall Study||66
8277658|NCT01691508|20410142|P1|COMPLETED|Overall Study||62
8277659|NCT01691508|20410141|P2|STARTED|Overall Study||69
8277660|NCT01691508|20410142|P1|STARTED|Overall Study||66
8277661|NCT01691482|20410156|P2|NOT COMPLETED|Treatment Period 2||2
8277662|NCT01691482|20410157|P1|NOT COMPLETED|Treatment Period 2||1
8277663|NCT01691482|20410156|P2|COMPLETED|Treatment Period 2||26
8277664|NCT01691482|20410157|P1|COMPLETED|Treatment Period 2||27
8277665|NCT01691482|20410156|P2|STARTED|Treatment Period 2||28
8277666|NCT01691482|20410157|P1|STARTED|Treatment Period 2||28
8277667|NCT01691482|20410156|P2|NOT COMPLETED|Treatment Period 1||0
8277668|NCT01691482|20410157|P1|NOT COMPLETED|Treatment Period 1||0
8277669|NCT01691482|20410156|P2|COMPLETED|Treatment Period 1||28
8277670|NCT01691482|20410157|P1|COMPLETED|Treatment Period 1||28
8277671|NCT01691482|20410156|P2|STARTED|Treatment Period 1||28
8277672|NCT01691482|20410157|P1|STARTED|Treatment Period 1||28
8277673|NCT01691430|20410175|P2|NOT COMPLETED|Overall Study||20
8277674|NCT01691430|20410176|P1|NOT COMPLETED|Overall Study||22
8277675|NCT01691430|20410175|P2|COMPLETED|Overall Study||73
8277676|NCT01691430|20410176|P1|COMPLETED|Overall Study||70
8277677|NCT01691430|20410175|P2|Received Medication|Overall Study||93
8277678|NCT01691430|20410176|P1|Received Medication|Overall Study||92
8277679|NCT01691430|20410175|P2|STARTED|Overall Study||93
8277680|NCT01691430|20410176|P1|STARTED|Overall Study||92
8277681|NCT01691378|20410202|P2|NOT COMPLETED|Overall Study||2
8277682|NCT01691378|20410203|P1|NOT COMPLETED|Overall Study||7
8277683|NCT01691378|20410202|P2|COMPLETED|Overall Study||20
8277684|NCT01691378|20410203|P1|COMPLETED|Overall Study||15
8277685|NCT01691378|20410202|P2|STARTED|Overall Study||22
8277686|NCT01691378|20410203|P1|STARTED|Overall Study||22
8277687|NCT01691339|20410217|P4|NOT COMPLETED|Overall Study||0
8277688|NCT01691339|20410218|P3|NOT COMPLETED|Overall Study||0
8277689|NCT01691339|20410219|P2|NOT COMPLETED|Overall Study||0
8277690|NCT01691339|20410220|P1|NOT COMPLETED|Overall Study||0
8277691|NCT01691339|20410217|P4|COMPLETED|Overall Study||49
8277692|NCT01691339|20410218|P3|COMPLETED|Overall Study||51
8277693|NCT01691339|20410219|P2|COMPLETED|Overall Study||50
8277694|NCT01691339|20410220|P1|COMPLETED|Overall Study||50
8277695|NCT01691339|20410217|P4|STARTED|Overall Study||49
8277696|NCT01691339|20410218|P3|STARTED|Overall Study||51
8277697|NCT01691339|20410219|P2|STARTED|Overall Study||50
8277698|NCT01691339|20410220|P1|STARTED|Overall Study||50
8277699|NCT01691326|20410248|P2|NOT COMPLETED|Overall Study||0
8277700|NCT01691326|20410249|P1|NOT COMPLETED|Overall Study||0
8277701|NCT01691326|20410248|P2|COMPLETED|Overall Study||30
8277702|NCT01691326|20410249|P1|COMPLETED|Overall Study||30
8277703|NCT01691326|20410248|P2|STARTED|Overall Study||30
8277704|NCT01691326|20410249|P1|STARTED|Overall Study||30
8277705|NCT01691313|20410267|P4|NOT COMPLETED|Overall Study||0
8277706|NCT01691313|20410268|P3|NOT COMPLETED|Overall Study||0
8277707|NCT01691313|20410269|P2|NOT COMPLETED|Overall Study||0
8277708|NCT01691313|20410270|P1|NOT COMPLETED|Overall Study||0
8277709|NCT01691313|20410267|P4|COMPLETED|Overall Study||25
8277710|NCT01691313|20410268|P3|COMPLETED|Overall Study||25
8277711|NCT01691313|20410269|P2|COMPLETED|Overall Study||32
8277712|NCT01691313|20410270|P1|COMPLETED|Overall Study||22
8277713|NCT01691313|20410267|P4|STARTED|Overall Study||25
8277714|NCT01691313|20410268|P3|STARTED|Overall Study||25
8277715|NCT01691313|20410269|P2|STARTED|Overall Study||32
8277716|NCT01691313|20410270|P1|STARTED|Overall Study||22
8277717|NCT01691248|20410286|P2|NOT COMPLETED|Overall Study||114
8277718|NCT01691248|20410287|P1|NOT COMPLETED|Overall Study||111
8277719|NCT01691248|20410286|P2|COMPLETED|Overall Study||192
8277720|NCT01691248|20410287|P1|COMPLETED|Overall Study||194
8277721|NCT01691248|20410286|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
8277722|NCT01691248|20410287|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
8277723|NCT01691248|20410286|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
8277724|NCT01691248|20410287|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
8277725|NCT01691248|20410286|P2|STARTED|Overall Study|Randomized|306
8277726|NCT01691248|20410287|P1|STARTED|Overall Study|Randomized|305
8277727|NCT01691105|20410299|P2|NOT COMPLETED|12 Month Biochemical Verification||502
8277728|NCT01691105|20410300|P1|NOT COMPLETED|12 Month Biochemical Verification||424
8277729|NCT01691105|20410299|P2|COMPLETED|12 Month Biochemical Verification||65
8277730|NCT01691105|20410300|P1|COMPLETED|12 Month Biochemical Verification||53
8277731|NCT01691105|20410299|P2|STARTED|12 Month Biochemical Verification||567
8277732|NCT01691105|20410300|P1|STARTED|12 Month Biochemical Verification||477
8277733|NCT01691105|20410299|P2|NOT COMPLETED|12 Month Follow-up||101
8277734|NCT01691105|20410300|P1|NOT COMPLETED|12 Month Follow-up||72
8277735|NCT01691105|20410299|P2|COMPLETED|12 Month Follow-up||466
8277736|NCT01691105|20410300|P1|COMPLETED|12 Month Follow-up||405
8277737|NCT01691105|20410299|P2|STARTED|12 Month Follow-up||567
8277738|NCT01691105|20410300|P1|STARTED|12 Month Follow-up||477
8277739|NCT01691105|20410299|P2|NOT COMPLETED|6 Month Follow-up||71
8277740|NCT01691105|20410300|P1|NOT COMPLETED|6 Month Follow-up||52
8277741|NCT01691105|20410299|P2|COMPLETED|6 Month Follow-up||496
8277742|NCT01691105|20410300|P1|COMPLETED|6 Month Follow-up||425
8277743|NCT01691105|20410299|P2|STARTED|6 Month Follow-up||567
8277744|NCT01691105|20410300|P1|STARTED|6 Month Follow-up||477
8277745|NCT01691105|20410299|P2|NOT COMPLETED|1 Month Follow-up||41
8277746|NCT01691105|20410300|P1|NOT COMPLETED|1 Month Follow-up||43
8277747|NCT01691105|20410299|P2|COMPLETED|1 Month Follow-up||526
8277748|NCT01691105|20410300|P1|COMPLETED|1 Month Follow-up||434
8277749|NCT01691105|20410299|P2|STARTED|1 Month Follow-up||567
8277750|NCT01691105|20410300|P1|STARTED|1 Month Follow-up||477
8277751|NCT01691105|20410299|P2|NOT COMPLETED|Baseline||0
8277752|NCT01691105|20410300|P1|NOT COMPLETED|Baseline||0
8277753|NCT01691105|20410299|P2|COMPLETED|Baseline||567
8277754|NCT01691105|20410300|P1|COMPLETED|Baseline||477
8277755|NCT01691105|20410299|P2|STARTED|Baseline||567
8277756|NCT01691105|20410300|P1|STARTED|Baseline||477
8277757|NCT01691092|20410320|P1|NOT COMPLETED|Overall Study||41
8277758|NCT01691092|20410320|P1|COMPLETED|Overall Study||38
8277759|NCT01691092|20410320|P1|STARTED|Overall Study||79
8277760|NCT01691079|20410326|P2|NOT COMPLETED|Overall Study||0
8277761|NCT01691079|20410327|P1|NOT COMPLETED|Overall Study||0
8277762|NCT01691079|20410326|P2|COMPLETED|Overall Study||0
8277763|NCT01691079|20410327|P1|COMPLETED|Overall Study||0
8277764|NCT01691079|20410326|P2|STARTED|Overall Study||0
8277765|NCT01691079|20410327|P1|STARTED|Overall Study||0
8277766|NCT01691027|20410335|P1|NOT COMPLETED|Video Games Training||0
8277767|NCT01691027|20410335|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
8277768|NCT01691027|20410335|P1|STARTED|Video Games Training|Four subjects started video game training module|4
8277769|NCT01691027|20410335|P1|NOT COMPLETED|Line and Circle Tracing Training||0
8277770|NCT01691027|20410335|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
8277771|NCT01691027|20410335|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
8277772|NCT01691027|20410335|P1|NOT COMPLETED|Scotoma Awareness||0
8277773|NCT01691027|20410335|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
8277774|NCT01691027|20410335|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
8277775|NCT01691014|20410344|P4|NOT COMPLETED|Overall Study||5
8277776|NCT01691014|20410345|P3|NOT COMPLETED|Overall Study||11
8277777|NCT01691014|20410346|P2|NOT COMPLETED|Overall Study||15
8277778|NCT01691014|20410347|P1|NOT COMPLETED|Overall Study||3
8277779|NCT01691014|20410344|P4|COMPLETED|Overall Study||4
8277780|NCT01691014|20410345|P3|COMPLETED|Overall Study||25
8277781|NCT01691014|20410346|P2|COMPLETED|Overall Study||11
8277782|NCT01691014|20410347|P1|COMPLETED|Overall Study||5
8277783|NCT01691014|20410344|P4|STARTED|Overall Study||9
8277784|NCT01691014|20410345|P3|STARTED|Overall Study||36
8277785|NCT01691014|20410346|P2|STARTED|Overall Study||26
8277786|NCT01691014|20410347|P1|STARTED|Overall Study||8
8277787|NCT01690988|20410392|P3|NOT COMPLETED|Overall Study||7
8277788|NCT01690988|20410393|P2|NOT COMPLETED|Overall Study||5
8277789|NCT01690988|20410394|P1|NOT COMPLETED|Overall Study||6
8277790|NCT01690988|20410392|P3|COMPLETED|Overall Study||216
8277791|NCT01690988|20410393|P2|COMPLETED|Overall Study||217
8277792|NCT01690988|20410394|P1|COMPLETED|Overall Study||221
8277793|NCT01690988|20410392|P3|STARTED|Overall Study||223
8277794|NCT01690988|20410393|P2|STARTED|Overall Study||222
8277795|NCT01690988|20410394|P1|STARTED|Overall Study||227
8277796|NCT01690923|20410419|P2|NOT COMPLETED|Overall Study||1
8277797|NCT01690923|20410420|P1|NOT COMPLETED|Overall Study||0
8277798|NCT01690923|20410419|P2|COMPLETED|Overall Study||10
8277799|NCT01690923|20410420|P1|COMPLETED|Overall Study||10
8277800|NCT01690923|20410419|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
8277801|NCT01690923|20410420|P1|STARTED|Overall Study||10
8277802|NCT01690663|20410429|P4|NOT COMPLETED|Overall Study||4
8277803|NCT01690663|20410430|P3|NOT COMPLETED|Overall Study||3
8277804|NCT01690663|20410431|P2|NOT COMPLETED|Overall Study||3
8277805|NCT01690663|20410432|P1|NOT COMPLETED|Overall Study||3
8277806|NCT01690663|20410429|P4|COMPLETED|Overall Study||20
8277807|NCT01690663|20410430|P3|COMPLETED|Overall Study||19
8277808|NCT01690663|20410431|P2|COMPLETED|Overall Study||17
8277809|NCT01690663|20410432|P1|COMPLETED|Overall Study||20
8277810|NCT01690663|20410429|P4|STARTED|Overall Study||24
8277811|NCT01690663|20410430|P3|STARTED|Overall Study||22
8277812|NCT01690663|20410431|P2|STARTED|Overall Study||20
8277813|NCT01690663|20410432|P1|STARTED|Overall Study||23
8277814|NCT01690546|20410446|P1|NOT COMPLETED|Overall Study||9
8277815|NCT01690546|20410446|P1|COMPLETED|Overall Study||26
8277816|NCT01690546|20410446|P1|Extended Release Injectable NTX|Overall Study||27
8277817|NCT01690546|20410446|P1|STARTED|Overall Study||35
8277818|NCT01690299|20410462|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
8277819|NCT01690299|20410463|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
8277820|NCT01690299|20410464|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
8277821|NCT01690299|20410465|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277822|NCT01690299|20410466|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277823|NCT01690299|20410467|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277824|NCT01690299|20410462|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
8277825|NCT01690299|20410463|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
8277826|NCT01690299|20410464|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
8277827|NCT01690299|20410465|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277828|NCT01690299|20410466|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277829|NCT01690299|20410467|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277830|NCT01690299|20410462|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
8277831|NCT01690299|20410463|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
8277832|NCT01690299|20410464|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
8277833|NCT01690299|20410465|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8277834|NCT01690299|20410466|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8277835|NCT01690299|20410467|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8277836|NCT01690299|20410462|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
8277837|NCT01690299|20410463|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
8277838|NCT01690299|20410464|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
8277839|NCT01690299|20410465|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8277840|NCT01690299|20410466|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8277841|NCT01690299|20410467|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8277842|NCT01690299|20410462|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277843|NCT01690299|20410463|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277844|NCT01690299|20410464|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277845|NCT01690299|20410465|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
8277846|NCT01690299|20410466|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
8277847|NCT01690299|20410467|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
8277848|NCT01690299|20410462|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277849|NCT01690299|20410463|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277850|NCT01690299|20410464|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277851|NCT01690299|20410465|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
8277852|NCT01690299|20410466|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
8277853|NCT01690299|20410467|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
8277854|NCT01690299|20410462|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8277855|NCT01690299|20410463|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8277856|NCT01690299|20410464|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8277857|NCT01690299|20410465|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
8277858|NCT01690299|20410466|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
8277859|NCT01690299|20410467|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
8277860|NCT01690299|20410462|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8277861|NCT01690299|20410463|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8277862|NCT01690299|20410464|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8277863|NCT01690299|20410465|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
8277864|NCT01690299|20410466|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
8277865|NCT01690299|20410467|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
8277866|NCT01690273|20410512|P3|NOT COMPLETED|Overall Study||0
8277867|NCT01690273|20410513|P2|NOT COMPLETED|Overall Study||0
8277868|NCT01690273|20410514|P1|NOT COMPLETED|Overall Study||0
8277869|NCT01690273|20410512|P3|COMPLETED|Overall Study||20
8277870|NCT01690273|20410513|P2|COMPLETED|Overall Study||17
8277871|NCT01690273|20410514|P1|COMPLETED|Overall Study||18
8277872|NCT01690273|20410512|P3|STARTED|Overall Study||20
8277873|NCT01690273|20410513|P2|STARTED|Overall Study||17
8277874|NCT01690273|20410514|P1|STARTED|Overall Study||18
8277875|NCT01690143|20410564|P1|NOT COMPLETED|Overall Study||1
8277876|NCT01690143|20410564|P1|COMPLETED|Overall Study||44
8277877|NCT01690143|20410564|P1|STARTED|Overall Study||45
8277878|NCT01690130|20410574|P2|NOT COMPLETED|Overall Study||0
8277879|NCT01690130|20410575|P1|NOT COMPLETED|Overall Study||1
8277880|NCT01690130|20410574|P2|COMPLETED|Overall Study||9
8277881|NCT01690130|20410575|P1|COMPLETED|Overall Study||9
8277882|NCT01690130|20410574|P2|STARTED|Overall Study||9
8277883|NCT01690130|20410575|P1|STARTED|Overall Study||10
8277884|NCT01690117|20410585|P2|NOT COMPLETED|Overall Study||14
8277885|NCT01690117|20410586|P1|NOT COMPLETED|Overall Study||16
8277886|NCT01690117|20410585|P2|COMPLETED|Overall Study||31
8277887|NCT01690117|20410586|P1|COMPLETED|Overall Study||31
8277888|NCT01690117|20410585|P2|Post-Measurement|Overall Study||40
8277889|NCT01690117|20410586|P1|Post-Measurement|Overall Study||41
8277890|NCT01690117|20410585|P2|STARTED|Overall Study||45
8277891|NCT01690117|20410586|P1|STARTED|Overall Study||47
8277892|NCT01690052|20410622|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
8277893|NCT01690052|20410623|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
8277894|NCT01690052|20410622|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
8277895|NCT01690052|20410623|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
8277896|NCT01690052|20410622|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
8277897|NCT01690052|20410623|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
8277898|NCT01690052|20410622|P2|NOT COMPLETED|Washout Period of 1 Week||0
8277899|NCT01690052|20410623|P1|NOT COMPLETED|Washout Period of 1 Week||0
8277900|NCT01690052|20410622|P2|COMPLETED|Washout Period of 1 Week||6
8277901|NCT01690052|20410623|P1|COMPLETED|Washout Period of 1 Week||6
8277902|NCT01690052|20410622|P2|STARTED|Washout Period of 1 Week||6
8277903|NCT01690052|20410623|P1|STARTED|Washout Period of 1 Week||6
8277904|NCT01690052|20410622|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
8277905|NCT01690052|20410623|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
8277906|NCT01690052|20410622|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
8277907|NCT01690052|20410623|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
8277908|NCT01690052|20410622|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
8277909|NCT01690052|20410623|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
8277910|NCT01690000|20410631|P2|NOT COMPLETED|Overall Study||6
8277911|NCT01690000|20410632|P1|NOT COMPLETED|Overall Study||3
8277912|NCT01690000|20410631|P2|COMPLETED|Overall Study||35
8277913|NCT01690000|20410632|P1|COMPLETED|Overall Study||37
8277914|NCT01690000|20410631|P2|STARTED|Overall Study||41
8277915|NCT01690000|20410632|P1|STARTED|Overall Study||40
8277916|NCT01689974|20410640|P2|NOT COMPLETED|Overall Study||5
8277917|NCT01689974|20410641|P1|NOT COMPLETED|Overall Study||5
8277918|NCT01689974|20410640|P2|COMPLETED|Overall Study||0
8277919|NCT01689974|20410641|P1|COMPLETED|Overall Study||0
8277920|NCT01689974|20410640|P2|STARTED|Overall Study||5
8277921|NCT01689974|20410641|P1|STARTED|Overall Study||5
8277922|NCT01689909|20410649|P2|NOT COMPLETED|Overall Study||0
8277923|NCT01689909|20410650|P1|NOT COMPLETED|Overall Study||0
8277924|NCT01689909|20410649|P2|COMPLETED|Overall Study||52
8277925|NCT01689909|20410650|P1|COMPLETED|Overall Study||51
8277926|NCT01689909|20410649|P2|STARTED|Overall Study||52
8277927|NCT01689909|20410650|P1|STARTED|Overall Study||51
8277928|NCT01689857|20410672|P2|NOT COMPLETED|Overall Study||2
8277929|NCT01689857|20410673|P1|NOT COMPLETED|Overall Study||5
8277930|NCT01689857|20410672|P2|COMPLETED|Overall Study||18
8277931|NCT01689857|20410673|P1|COMPLETED|Overall Study||15
8277932|NCT01689857|20410672|P2|STARTED|Overall Study||20
8277933|NCT01689857|20410673|P1|STARTED|Overall Study||20
8277934|NCT01689779|20410681|P2|NOT COMPLETED|Overall Study||0
8277935|NCT01689779|20410682|P1|NOT COMPLETED|Overall Study||0
8277936|NCT01689779|20410681|P2|COMPLETED|Overall Study||32
8277937|NCT01689779|20410682|P1|COMPLETED|Overall Study||28
8277938|NCT01689779|20410681|P2|STARTED|Overall Study||32
8277939|NCT01689779|20410682|P1|STARTED|Overall Study||28
8277940|NCT01689740|20410701|P3|NOT COMPLETED|Overall Study||0
8277941|NCT01689740|20410702|P2|NOT COMPLETED|Overall Study||0
8277942|NCT01689740|20410703|P1|NOT COMPLETED|Overall Study||0
8277943|NCT01689740|20410701|P3|COMPLETED|Overall Study||5
8277944|NCT01689740|20410702|P2|COMPLETED|Overall Study||3
8277945|NCT01689740|20410703|P1|COMPLETED|Overall Study||2
8277946|NCT01689740|20410701|P3|STARTED|Overall Study||5
8277947|NCT01689740|20410702|P2|STARTED|Overall Study||3
8277948|NCT01689740|20410703|P1|STARTED|Overall Study||2
8277949|NCT01689701|20410745|P2|NOT COMPLETED|Overall Study||6
8277950|NCT01689701|20410746|P1|NOT COMPLETED|Overall Study||5
8277951|NCT01689701|20410745|P2|COMPLETED|Overall Study||21
8277952|NCT01689701|20410746|P1|COMPLETED|Overall Study||22
8277953|NCT01689701|20410745|P2|STARTED|Overall Study||27
8277954|NCT01689701|20410746|P1|STARTED|Overall Study||27
8277955|NCT01689649|20410766|P1|NOT COMPLETED|Overall Study||22
8277956|NCT01689649|20410766|P1|COMPLETED|Overall Study||117
8277957|NCT01689649|20410766|P1|STARTED|Overall Study||139
8277958|NCT01689532|20410778|P2|NOT COMPLETED|Overall Study||9
8277959|NCT01689532|20410779|P1|NOT COMPLETED|Overall Study||14
8277960|NCT01689532|20410778|P2|COMPLETED|Overall Study||52
8277961|NCT01689532|20410779|P1|COMPLETED|Overall Study||47
8277962|NCT01689532|20410778|P2|STARTED|Overall Study||61
8277963|NCT01689532|20410779|P1|STARTED|Overall Study||61
8277964|NCT01689519|20410843|P2|NOT COMPLETED|Safety Population||245
8277965|NCT01689519|20410844|P1|NOT COMPLETED|Safety Population||248
8277966|NCT01689519|20410843|P2|COMPLETED|Safety Population||0
8277967|NCT01689519|20410844|P1|COMPLETED|Safety Population||0
8277968|NCT01689519|20410843|P2|STARTED|Safety Population||245
8277969|NCT01689519|20410844|P1|STARTED|Safety Population||248
8277970|NCT01689519|20410843|P2|NOT COMPLETED|Intent to Treat||248
8277971|NCT01689519|20410844|P1|NOT COMPLETED|Intent to Treat||247
8277972|NCT01689519|20410843|P2|COMPLETED|Intent to Treat||0
8277973|NCT01689519|20410844|P1|COMPLETED|Intent to Treat||0
8277974|NCT01689519|20410843|P2|STARTED|Intent to Treat||248
8277975|NCT01689519|20410844|P1|STARTED|Intent to Treat||247
8277976|NCT01689441|20410858|P2|NOT COMPLETED|Overall Study||0
8277977|NCT01689441|20410859|P1|NOT COMPLETED|Overall Study||0
8277978|NCT01689441|20410858|P2|COMPLETED|Overall Study||31
8277979|NCT01689441|20410859|P1|COMPLETED|Overall Study||36
8277980|NCT01689441|20410858|P2|STARTED|Overall Study||31
8277981|NCT01689441|20410859|P1|STARTED|Overall Study||36
8277982|NCT01689363|20410869|P8|NOT COMPLETED|Overall Study||0
8277983|NCT01689363|20410870|P7|NOT COMPLETED|Overall Study||0
8277984|NCT01689363|20410871|P6|NOT COMPLETED|Overall Study||0
8277985|NCT01689363|20410872|P5|NOT COMPLETED|Overall Study||0
8277986|NCT01689363|20410873|P4|NOT COMPLETED|Overall Study||0
8277987|NCT01689363|20410874|P3|NOT COMPLETED|Overall Study||0
8277988|NCT01689363|20410875|P2|NOT COMPLETED|Overall Study||1
8277989|NCT01689363|20410876|P1|NOT COMPLETED|Overall Study||0
8277990|NCT01689363|20410869|P8|COMPLETED|Overall Study||32
8277991|NCT01689363|20410870|P7|COMPLETED|Overall Study||32
8277992|NCT01689363|20410871|P6|COMPLETED|Overall Study||31
8277993|NCT01689363|20410872|P5|COMPLETED|Overall Study||31
8277994|NCT01689363|20410873|P4|COMPLETED|Overall Study||31
8277995|NCT01689363|20410874|P3|COMPLETED|Overall Study||32
8277996|NCT01689363|20410875|P2|COMPLETED|Overall Study||31
8277997|NCT01689363|20410876|P1|COMPLETED|Overall Study||32
8277998|NCT01689363|20410869|P8|STARTED|Overall Study||32
8277999|NCT01689363|20410870|P7|STARTED|Overall Study||32
8278000|NCT01689363|20410871|P6|STARTED|Overall Study||31
8278001|NCT01689363|20410872|P5|STARTED|Overall Study||31
8278002|NCT01689363|20410873|P4|STARTED|Overall Study||31
8278003|NCT01689363|20410874|P3|STARTED|Overall Study||32
8278004|NCT01689363|20410875|P2|STARTED|Overall Study||32
8278005|NCT01689363|20410876|P1|STARTED|Overall Study||32
8278006|NCT01689350|20410922|P2|NOT COMPLETED|Overall Study||0
8278007|NCT01689350|20410923|P1|NOT COMPLETED|Overall Study||0
8278008|NCT01689350|20410922|P2|COMPLETED|Overall Study||45
8278009|NCT01689350|20410923|P1|COMPLETED|Overall Study||47
8278010|NCT01689350|20410922|P2|STARTED|Overall Study||45
8278011|NCT01689350|20410923|P1|STARTED|Overall Study||47
8278012|NCT01689337|20410931|P1|NOT COMPLETED|Overall Study||1
8278013|NCT01689337|20410931|P1|COMPLETED|Overall Study||0
8278014|NCT01689337|20410931|P1|STARTED|Overall Study||1
8278015|NCT01689324|20410946|P1|NOT COMPLETED|Overall Study||0
8278016|NCT01689324|20410946|P1|COMPLETED|Overall Study||43
8278017|NCT01689324|20410946|P1|STARTED|Overall Study||43
8278018|NCT01689207|20410970|P11|NOT COMPLETED|Overall Study||0
8278019|NCT01689207|20410971|P10|NOT COMPLETED|Overall Study||0
8278020|NCT01689207|20410972|P9|NOT COMPLETED|Overall Study||1
8278021|NCT01689207|20410973|P8|NOT COMPLETED|Overall Study||0
8278022|NCT01689207|20410974|P7|NOT COMPLETED|Overall Study||0
8278023|NCT01689207|20410975|P6|NOT COMPLETED|Overall Study||1
8278024|NCT01689207|20410976|P5|NOT COMPLETED|Overall Study||2
8278025|NCT01689207|20410977|P4|NOT COMPLETED|Overall Study||0
8278026|NCT01689207|20410978|P3|NOT COMPLETED|Overall Study||0
8278027|NCT01689207|20410979|P2|NOT COMPLETED|Overall Study||1
8278028|NCT01689207|20410980|P1|NOT COMPLETED|Overall Study||0
8278029|NCT01689207|20410970|P11|COMPLETED|Overall Study|Subjects completed study|8
8278030|NCT01689207|20410971|P10|COMPLETED|Overall Study|Subjects completed study|10
8278031|NCT01689207|20410972|P9|COMPLETED|Overall Study|Subjects completed study|5
8278032|NCT01689207|20410973|P8|COMPLETED|Overall Study|Subjects completed study|10
8278033|NCT01689207|20410974|P7|COMPLETED|Overall Study|Subjects completed study|10
8278034|NCT01689207|20410975|P6|COMPLETED|Overall Study|Subjects completed study|7
8278035|NCT01689207|20410976|P5|COMPLETED|Overall Study|Subjects completed study|2
8278036|NCT01689207|20410977|P4|COMPLETED|Overall Study|Subjects completed study|8
8278037|NCT01689207|20410978|P3|COMPLETED|Overall Study|Subjects completed study|16
8278038|NCT01689207|20410979|P2|COMPLETED|Overall Study|Subjects completed study|7
8278039|NCT01689207|20410980|P1|COMPLETED|Overall Study|Subjects completed study|4
8278040|NCT01689207|20410970|P11|STARTED|Overall Study|Subjects randomised|8
8278041|NCT01689207|20410971|P10|STARTED|Overall Study|Subjects randomised|10
8278042|NCT01689207|20410972|P9|STARTED|Overall Study|Subjects randomised|6
8278043|NCT01689207|20410973|P8|STARTED|Overall Study|Subjects randomised|10
8278044|NCT01689207|20410974|P7|STARTED|Overall Study|Subjects randomised|10
8278045|NCT01689207|20410975|P6|STARTED|Overall Study|Subjects randomised|8
8278046|NCT01689207|20410976|P5|STARTED|Overall Study|Subjects randomised|4
8278047|NCT01689207|20410977|P4|STARTED|Overall Study|Subjects randomised|8
8278048|NCT01689207|20410978|P3|STARTED|Overall Study|Subjects randomised|16
8278049|NCT01689207|20410979|P2|STARTED|Overall Study|Subjects randomised|8
8278050|NCT01689207|20410980|P1|STARTED|Overall Study|Subjects randomised|4
8278051|NCT01689155|20411076|P1|NOT COMPLETED|Overall Study||0
8278052|NCT01689155|20411076|P1|COMPLETED|Overall Study||116
8278053|NCT01689155|20411076|P1|STARTED|Overall Study||116
8278054|NCT01688999|20411088|P3|NOT COMPLETED|Overall Study||3
8278055|NCT01688999|20411089|P2|NOT COMPLETED|Overall Study||1
8278056|NCT01688999|20411090|P1|NOT COMPLETED|Overall Study||8
8278057|NCT01688999|20411088|P3|COMPLETED|Overall Study||10
8278058|NCT01688999|20411089|P2|COMPLETED|Overall Study||5
8278059|NCT01688999|20411090|P1|COMPLETED|Overall Study||42
8278060|NCT01688999|20411088|P3|STARTED|Overall Study||13
8278061|NCT01688999|20411089|P2|STARTED|Overall Study||6
8278062|NCT01688999|20411090|P1|STARTED|Overall Study||50
8278063|NCT01688973|20411106|P2|NOT COMPLETED|Overall Study||3
8278064|NCT01688973|20411107|P1|NOT COMPLETED|Overall Study||2
8278065|NCT01688973|20411106|P2|COMPLETED|Overall Study||25
8278066|NCT01688973|20411107|P1|COMPLETED|Overall Study||25
8278067|NCT01688973|20411106|P2|Eligible/Evaluable Patients|Overall Study||25
8278068|NCT01688973|20411107|P1|Eligible/Evaluable Patients|Overall Study||25
8278069|NCT01688973|20411106|P2|STARTED|Overall Study||28
8278070|NCT01688973|20411107|P1|STARTED|Overall Study||27
8278071|NCT01688921|20411121|P2|NOT COMPLETED|Overall Study||15
8278072|NCT01688921|20411122|P1|NOT COMPLETED|Overall Study||16
8278073|NCT01688921|20411121|P2|COMPLETED|Overall Study||608
8278074|NCT01688921|20411122|P1|COMPLETED|Overall Study||611
8278075|NCT01688921|20411121|P2|STARTED|Overall Study||623
8278076|NCT01688921|20411122|P1|STARTED|Overall Study||627
8278077|NCT01688895|20411145|P1|NOT COMPLETED|Overall Study||0
8278078|NCT01688895|20411145|P1|COMPLETED|Overall Study||150
8278079|NCT01688895|20411145|P1|STARTED|Overall Study||150
8278080|NCT01688882|20411154|P2|NOT COMPLETED|Overall Study||1
8278081|NCT01688882|20411155|P1|NOT COMPLETED|Overall Study||3
8278082|NCT01688882|20411154|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
8278083|NCT01688882|20411155|P1|COMPLETED|Overall Study||10
8278084|NCT01688882|20411154|P2|Safety Follow-up|Overall Study||5
8278085|NCT01688882|20411155|P1|Safety Follow-up|Overall Study||11
8278086|NCT01688882|20411154|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
8278087|NCT01688882|20411155|P1|STARTED|Overall Study||13
8278088|NCT01688856|20411172|P3|NOT COMPLETED|Overall Study||3
8278089|NCT01688856|20411173|P2|NOT COMPLETED|Overall Study||4
8278090|NCT01688856|20411174|P1|NOT COMPLETED|Overall Study||7
8278091|NCT01688856|20411172|P3|COMPLETED|Overall Study||8
8278092|NCT01688856|20411173|P2|COMPLETED|Overall Study||24
8278093|NCT01688856|20411174|P1|COMPLETED|Overall Study||21
8278094|NCT01688856|20411172|P3|STARTED|Overall Study||11
8278095|NCT01688856|20411173|P2|STARTED|Overall Study||28
8278096|NCT01688856|20411174|P1|STARTED|Overall Study||28
8278097|NCT01688843|20411194|P1|NOT COMPLETED|Overall Study||0
8278098|NCT01688843|20411194|P1|COMPLETED|Overall Study||1060
8278099|NCT01688843|20411194|P1|STARTED|Overall Study||1060
8278100|NCT01688830|20411226|P21|NOT COMPLETED|Overall Study||0
8278101|NCT01688830|20411227|P20|NOT COMPLETED|Overall Study||0
8278102|NCT01688830|20411228|P19|NOT COMPLETED|Overall Study||0
8278103|NCT01688830|20411229|P18|NOT COMPLETED|Overall Study||0
8278104|NCT01688830|20411230|P17|NOT COMPLETED|Overall Study||0
8278105|NCT01688830|20411231|P16|NOT COMPLETED|Overall Study||0
8278106|NCT01688830|20411232|P15|NOT COMPLETED|Overall Study||0
8278107|NCT01688830|20411233|P14|NOT COMPLETED|Overall Study||0
8278108|NCT01688830|20411234|P13|NOT COMPLETED|Overall Study||0
8278109|NCT01688830|20411235|P12|NOT COMPLETED|Overall Study||0
8278110|NCT01688830|20411236|P11|NOT COMPLETED|Overall Study||1
8278111|NCT01688830|20411237|P10|NOT COMPLETED|Overall Study||0
8278112|NCT01688830|20411238|P9|NOT COMPLETED|Overall Study||0
8278113|NCT01688830|20411239|P8|NOT COMPLETED|Overall Study||0
8278114|NCT01688830|20411240|P7|NOT COMPLETED|Overall Study||0
8278115|NCT01688830|20411241|P6|NOT COMPLETED|Overall Study||0
8278116|NCT01688830|20411242|P5|NOT COMPLETED|Overall Study||0
8278117|NCT01688830|20411243|P4|NOT COMPLETED|Overall Study||0
8278118|NCT01688830|20411244|P3|NOT COMPLETED|Overall Study||0
8278119|NCT01688830|20411245|P2|NOT COMPLETED|Overall Study||0
8278120|NCT01688830|20411246|P1|NOT COMPLETED|Overall Study||0
8278121|NCT01688830|20411226|P21|COMPLETED|Overall Study||9
8278122|NCT01688830|20411227|P20|COMPLETED|Overall Study||3
8278123|NCT01688830|20411228|P19|COMPLETED|Overall Study||8
8278124|NCT01688830|20411229|P18|COMPLETED|Overall Study||9
8278125|NCT01688830|20411230|P17|COMPLETED|Overall Study||9
8278126|NCT01688830|20411231|P16|COMPLETED|Overall Study||9
8278127|NCT01688830|20411232|P15|COMPLETED|Overall Study||6
8278128|NCT01688830|20411233|P14|COMPLETED|Overall Study||6
8278129|NCT01688830|20411234|P13|COMPLETED|Overall Study||6
8278130|NCT01688830|20411235|P12|COMPLETED|Overall Study||6
8278131|NCT01688830|20411236|P11|COMPLETED|Overall Study||5
8278132|NCT01688830|20411237|P10|COMPLETED|Overall Study||6
8278133|NCT01688830|20411238|P9|COMPLETED|Overall Study||6
8278134|NCT01688830|20411239|P8|COMPLETED|Overall Study||6
8278135|NCT01688830|20411240|P7|COMPLETED|Overall Study||12
8278136|NCT01688830|20411241|P6|COMPLETED|Overall Study||6
8278137|NCT01688830|20411242|P5|COMPLETED|Overall Study||5
8278138|NCT01688830|20411243|P4|COMPLETED|Overall Study||6
8278139|NCT01688830|20411244|P3|COMPLETED|Overall Study||6
8278140|NCT01688830|20411245|P2|COMPLETED|Overall Study||6
8278141|NCT01688830|20411246|P1|COMPLETED|Overall Study||21
8278142|NCT01688830|20411226|P21|STARTED|Overall Study||9
8278143|NCT01688830|20411227|P20|STARTED|Overall Study||3
8278144|NCT01688830|20411228|P19|STARTED|Overall Study||8
8278145|NCT01688830|20411229|P18|STARTED|Overall Study||9
8278146|NCT01688830|20411230|P17|STARTED|Overall Study||9
8278147|NCT01688830|20411231|P16|STARTED|Overall Study||9
8278148|NCT01688830|20411232|P15|STARTED|Overall Study||6
8278149|NCT01688830|20411233|P14|STARTED|Overall Study||6
8278150|NCT01688830|20411234|P13|STARTED|Overall Study||6
8278151|NCT01688830|20411235|P12|STARTED|Overall Study||6
8278152|NCT01688830|20411236|P11|STARTED|Overall Study||6
8278153|NCT01688830|20411237|P10|STARTED|Overall Study||6
8278154|NCT01688830|20411238|P9|STARTED|Overall Study||6
8278155|NCT01688830|20411239|P8|STARTED|Overall Study||6
8278156|NCT01688830|20411240|P7|STARTED|Overall Study||12
8278157|NCT01688830|20411241|P6|STARTED|Overall Study||6
8278158|NCT01688830|20411242|P5|STARTED|Overall Study||5
8278159|NCT01688830|20411243|P4|STARTED|Overall Study||6
8278160|NCT01688830|20411244|P3|STARTED|Overall Study||6
8278161|NCT01688830|20411245|P2|STARTED|Overall Study||6
8278162|NCT01688830|20411246|P1|STARTED|Overall Study||21
8278163|NCT01688739|20411400|P10|NOT COMPLETED|Overall Study||0
8278164|NCT01688739|20411401|P9|NOT COMPLETED|Overall Study||0
8278165|NCT01688739|20411402|P8|NOT COMPLETED|Overall Study||0
8278166|NCT01688739|20411403|P7|NOT COMPLETED|Overall Study||0
8278167|NCT01688739|20411404|P6|NOT COMPLETED|Overall Study||0
8278168|NCT01688739|20411405|P5|NOT COMPLETED|Overall Study||0
8278169|NCT01688739|20411406|P4|NOT COMPLETED|Overall Study||0
8278170|NCT01688739|20411407|P3|NOT COMPLETED|Overall Study||0
8278171|NCT01688739|20411408|P2|NOT COMPLETED|Overall Study||0
8278172|NCT01688739|20411409|P1|NOT COMPLETED|Overall Study||1
8278173|NCT01688739|20411400|P10|COMPLETED|Overall Study||6
8278174|NCT01688739|20411401|P9|COMPLETED|Overall Study||6
8278175|NCT01688739|20411402|P8|COMPLETED|Overall Study||6
8278176|NCT01688739|20411403|P7|COMPLETED|Overall Study||6
8278177|NCT01688739|20411404|P6|COMPLETED|Overall Study||6
8278178|NCT01688739|20411405|P5|COMPLETED|Overall Study||6
8278179|NCT01688739|20411406|P4|COMPLETED|Overall Study||6
8278180|NCT01688739|20411407|P3|COMPLETED|Overall Study||3
8278181|NCT01688739|20411408|P2|COMPLETED|Overall Study||3
8278182|NCT01688739|20411409|P1|COMPLETED|Overall Study||12
8278183|NCT01688739|20411400|P10|Received Study Drug|Overall Study||6
8278184|NCT01688739|20411401|P9|Received Study Drug|Overall Study||6
8278185|NCT01688739|20411402|P8|Received Study Drug|Overall Study||6
8278186|NCT01688739|20411403|P7|Received Study Drug|Overall Study||6
8278187|NCT01688739|20411404|P6|Received Study Drug|Overall Study||6
8278188|NCT01688739|20411405|P5|Received Study Drug|Overall Study||6
8278189|NCT01688739|20411406|P4|Received Study Drug|Overall Study||6
8278190|NCT01688739|20411407|P3|Received Study Drug|Overall Study||3
8278191|NCT01688739|20411408|P2|Received Study Drug|Overall Study||3
8278192|NCT01688739|20411409|P1|Received Study Drug|Overall Study||12
8278193|NCT01688739|20411400|P10|STARTED|Overall Study||6
8278194|NCT01688739|20411401|P9|STARTED|Overall Study||6
8278195|NCT01688739|20411402|P8|STARTED|Overall Study||6
8278196|NCT01688739|20411403|P7|STARTED|Overall Study||6
8278197|NCT01688739|20411404|P6|STARTED|Overall Study||6
8278198|NCT01688739|20411405|P5|STARTED|Overall Study||6
8278199|NCT01688739|20411406|P4|STARTED|Overall Study||6
8278200|NCT01688739|20411407|P3|STARTED|Overall Study||3
8278201|NCT01688739|20411408|P2|STARTED|Overall Study||3
8278202|NCT01688739|20411409|P1|STARTED|Overall Study||13
8278203|NCT01688726|20411485|P2|NOT COMPLETED|Overall Study||1
8278204|NCT01688726|20411486|P1|NOT COMPLETED|Overall Study||1
8278205|NCT01688726|20411485|P2|COMPLETED|Overall Study||44
8278206|NCT01688726|20411486|P1|COMPLETED|Overall Study||45
8278207|NCT01688726|20411485|P2|STARTED|Overall Study||45
8278208|NCT01688726|20411486|P1|STARTED|Overall Study||46
8278209|NCT01688635|20411498|P2|NOT COMPLETED|Period 4||0
8278210|NCT01688635|20411499|P1|NOT COMPLETED|Period 4||0
8278211|NCT01688635|20411498|P2|COMPLETED|Period 4||42
8278212|NCT01688635|20411499|P1|COMPLETED|Period 4||40
8278213|NCT01688635|20411498|P2|STARTED|Period 4||42
8278214|NCT01688635|20411499|P1|STARTED|Period 4||40
8278215|NCT01688635|20411498|P2|NOT COMPLETED|Washout 3||0
8278216|NCT01688635|20411499|P1|NOT COMPLETED|Washout 3||1
8278217|NCT01688635|20411498|P2|COMPLETED|Washout 3||42
8278218|NCT01688635|20411499|P1|COMPLETED|Washout 3||40
8278219|NCT01688635|20411498|P2|STARTED|Washout 3||42
8278220|NCT01688635|20411499|P1|STARTED|Washout 3||41
8278221|NCT01688635|20411498|P2|NOT COMPLETED|Period 3||0
8278222|NCT01688635|20411499|P1|NOT COMPLETED|Period 3||0
8278223|NCT01688635|20411498|P2|COMPLETED|Period 3||42
8278224|NCT01688635|20411499|P1|COMPLETED|Period 3||41
8278225|NCT01688635|20411498|P2|STARTED|Period 3||42
8278226|NCT01688635|20411499|P1|STARTED|Period 3||41
8278227|NCT01688635|20411498|P2|NOT COMPLETED|Washout 2||2
8278228|NCT01688635|20411499|P1|NOT COMPLETED|Washout 2||3
8278229|NCT01688635|20411498|P2|COMPLETED|Washout 2||42
8278230|NCT01688635|20411499|P1|COMPLETED|Washout 2||41
8278231|NCT01688635|20411498|P2|STARTED|Washout 2||44
8278232|NCT01688635|20411499|P1|STARTED|Washout 2||44
8278233|NCT01688635|20411498|P2|NOT COMPLETED|Period 2||0
8278234|NCT01688635|20411499|P1|NOT COMPLETED|Period 2||0
8278235|NCT01688635|20411498|P2|COMPLETED|Period 2||44
8278236|NCT01688635|20411499|P1|COMPLETED|Period 2||44
8278237|NCT01688635|20411498|P2|STARTED|Period 2||44
8278238|NCT01688635|20411499|P1|STARTED|Period 2||44
8278239|NCT01688635|20411498|P2|NOT COMPLETED|Washout 1||2
8278240|NCT01688635|20411499|P1|NOT COMPLETED|Washout 1||1
8278241|NCT01688635|20411498|P2|COMPLETED|Washout 1||44
8278242|NCT01688635|20411499|P1|COMPLETED|Washout 1||44
8278243|NCT01688635|20411498|P2|STARTED|Washout 1||46
8278244|NCT01688635|20411499|P1|STARTED|Washout 1||45
8278245|NCT01688635|20411498|P2|NOT COMPLETED|Period 1||0
8278246|NCT01688635|20411499|P1|NOT COMPLETED|Period 1||0
8278247|NCT01688635|20411498|P2|COMPLETED|Period 1||46
8278248|NCT01688635|20411499|P1|COMPLETED|Period 1||45
8278249|NCT01688635|20411498|P2|Received at Least 1 Dose of Study Drug|Period 1||46
8278250|NCT01688635|20411499|P1|Received at Least 1 Dose of Study Drug|Period 1||45
8278251|NCT01688635|20411498|P2|STARTED|Period 1||46
8278252|NCT01688635|20411499|P1|STARTED|Period 1||45
8278253|NCT01688609|20411511|P1|NOT COMPLETED|Overall Study||0
8278254|NCT01688609|20411511|P1|COMPLETED|Overall Study||18
8278255|NCT01688609|20411511|P1|STARTED|Overall Study||18
8278256|NCT01688596|20411521|P2|NOT COMPLETED|Overall Study||9
8278257|NCT01688596|20411522|P1|NOT COMPLETED|Overall Study||8
8278258|NCT01688596|20411521|P2|COMPLETED|Overall Study||59
8278259|NCT01688596|20411522|P1|COMPLETED|Overall Study||59
8278260|NCT01688596|20411521|P2|STARTED|Overall Study||68
8278261|NCT01688596|20411522|P1|STARTED|Overall Study||67
8278262|NCT01688466|20411546|P2|NOT COMPLETED|Overall Study||7
8278263|NCT01688466|20411547|P1|NOT COMPLETED|Overall Study||2
8278264|NCT01688466|20411546|P2|COMPLETED|Overall Study||10
8278265|NCT01688466|20411547|P1|COMPLETED|Overall Study||15
8278266|NCT01688466|20411546|P2|STARTED|Overall Study||17
8278267|NCT01688466|20411547|P1|STARTED|Overall Study||17
8278268|NCT01688336|20411555|P1|NOT COMPLETED|Overall Study||0
8278269|NCT01688336|20411555|P1|COMPLETED|Overall Study||9
8278270|NCT01688336|20411555|P1|STARTED|Overall Study||9
8278271|NCT01688310|20411567|P2|NOT COMPLETED|Overall Study||0
8278272|NCT01688310|20411568|P1|NOT COMPLETED|Overall Study||0
8278273|NCT01688310|20411567|P2|COMPLETED|Overall Study||100
8278274|NCT01688310|20411568|P1|COMPLETED|Overall Study||100
8278275|NCT01688310|20411567|P2|STARTED|Overall Study||100
8278276|NCT01688310|20411568|P1|STARTED|Overall Study||100
8278277|NCT01688141|20411588|P2|NOT COMPLETED|Overall Study||0
8278278|NCT01688141|20411589|P1|NOT COMPLETED|Overall Study||0
8278279|NCT01688141|20411588|P2|COMPLETED|Overall Study||11651
8278280|NCT01688141|20411589|P1|COMPLETED|Overall Study||11706
8278281|NCT01688141|20411588|P2|STARTED|Overall Study||11651
8278282|NCT01688141|20411589|P1|STARTED|Overall Study||11706
8278283|NCT01688102|20411609|P2|NOT COMPLETED|Overall Study||18
8278284|NCT01688102|20411610|P1|NOT COMPLETED|Overall Study||16
8278285|NCT01688102|20411609|P2|COMPLETED|Overall Study||40
8278286|NCT01688102|20411610|P1|COMPLETED|Overall Study||44
8278287|NCT01688102|20411609|P2|STARTED|Overall Study||58
8278288|NCT01688102|20411610|P1|STARTED|Overall Study||60
8278289|NCT01688050|20411638|P1|NOT COMPLETED|Overall Study||31
8278290|NCT01688050|20411638|P1|COMPLETED|Overall Study||19
8278291|NCT01688050|20411638|P1|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
8278292|NCT01688050|20411638|P1|STARTED|Overall Study||50
8278293|NCT01688037|20411647|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
8278294|NCT01688037|20411648|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
8278295|NCT01688037|20411649|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
8278296|NCT01688037|20411647|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
8278297|NCT01688037|20411648|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
8278298|NCT01688037|20411649|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
8278299|NCT01688037|20411647|P3|STARTED|Follow-up Period (Week 12 to 16)||17
8278300|NCT01688037|20411648|P2|STARTED|Follow-up Period (Week 12 to 16)||22
8278301|NCT01688037|20411649|P1|STARTED|Follow-up Period (Week 12 to 16)||42
8278302|NCT01688037|20411647|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
8278303|NCT01688037|20411648|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
8278304|NCT01688037|20411649|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
8278305|NCT01688037|20411647|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
8278306|NCT01688037|20411648|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
8278307|NCT01688037|20411649|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
8278308|NCT01688037|20411647|P3|STARTED|Open-Label Period (Week 6 to 12)||21
8278309|NCT01688037|20411648|P2|STARTED|Open-Label Period (Week 6 to 12)||25
8278310|NCT01688037|20411649|P1|STARTED|Open-Label Period (Week 6 to 12)||47
8278311|NCT01688037|20411647|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
8278312|NCT01688037|20411648|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
8278313|NCT01688037|20411649|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
8278314|NCT01688037|20411647|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
8278315|NCT01688037|20411648|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
8278316|NCT01688037|20411649|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
8278317|NCT01688037|20411647|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
8278318|NCT01688037|20411648|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
8278319|NCT01688037|20411649|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
8278320|NCT01687998|20411665|P2|NOT COMPLETED|Overall Study||120
8278321|NCT01687998|20411666|P1|NOT COMPLETED|Overall Study||112
8278322|NCT01687998|20411665|P2|COMPLETED|Overall Study||5934
8278323|NCT01687998|20411666|P1|COMPLETED|Overall Study||5926
8278420|NCT01687296|20411886|P2|NOT COMPLETED|Overall Study||5
8278324|NCT01687998|20411665|P2|Received at Least One Dose of Study Drug|Overall Study||6052
8278325|NCT01687998|20411666|P1|Received at Least One Dose of Study Drug|Overall Study||6036
8278326|NCT01687998|20411665|P2|STARTED|Overall Study||6054
8278327|NCT01687998|20411666|P1|STARTED|Overall Study||6038
8278328|NCT01687972|20411684|P2|NOT COMPLETED|Overall Study||0
8278329|NCT01687972|20411685|P1|NOT COMPLETED|Overall Study||0
8278330|NCT01687972|20411684|P2|COMPLETED|Overall Study||44
8278331|NCT01687972|20411685|P1|COMPLETED|Overall Study||44
8278332|NCT01687972|20411684|P2|STARTED|Overall Study||44
8278333|NCT01687972|20411685|P1|STARTED|Overall Study||44
8278334|NCT01687790|20411695|P1|NOT COMPLETED|Overall Study||0
8278335|NCT01687790|20411695|P1|COMPLETED|Overall Study||60
8278336|NCT01687790|20411695|P1|STARTED|Overall Study||60
8278337|NCT01687712|20411702|P2|NOT COMPLETED|Cycle 3||24
8278338|NCT01687712|20411703|P1|NOT COMPLETED|Cycle 3||24
8278339|NCT01687712|20411702|P2|COMPLETED|Cycle 3||0
8278340|NCT01687712|20411703|P1|COMPLETED|Cycle 3||4
8278341|NCT01687712|20411702|P2|Clinical Pregnancy|Cycle 3||0
8278342|NCT01687712|20411703|P1|Clinical Pregnancy|Cycle 3||5
8278343|NCT01687712|20411702|P2|Biochemically Pregnant|Cycle 3||2
8278344|NCT01687712|20411703|P1|Biochemically Pregnant|Cycle 3||7
8278345|NCT01687712|20411702|P2|Embryo Transfer|Cycle 3||24
8278346|NCT01687712|20411703|P1|Embryo Transfer|Cycle 3||26
8278347|NCT01687712|20411702|P2|Fertilization Performed|Cycle 3||24
8278348|NCT01687712|20411703|P1|Fertilization Performed|Cycle 3||27
8278349|NCT01687712|20411702|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
8278350|NCT01687712|20411703|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
8278351|NCT01687712|20411702|P2|Received hCG|Cycle 3||24
8278352|NCT01687712|20411703|P1|Received hCG|Cycle 3||27
8278353|NCT01687712|20411702|P2|STARTED|Cycle 3||24
8278354|NCT01687712|20411703|P1|STARTED|Cycle 3||28
8278355|NCT01687712|20411702|P2|NOT COMPLETED|Cycle 2||95
8278356|NCT01687712|20411703|P1|NOT COMPLETED|Cycle 2||93
8278357|NCT01687712|20411702|P2|COMPLETED|Cycle 2||25
8278358|NCT01687712|20411703|P1|COMPLETED|Cycle 2||16
8278359|NCT01687712|20411702|P2|Clinical Pregnancy|Cycle 2||26
8278360|NCT01687712|20411703|P1|Clinical Pregnancy|Cycle 2||17
8278361|NCT01687712|20411702|P2|Biochemical Pregnancy|Cycle 2||43
8278362|NCT01687712|20411703|P1|Biochemical Pregnancy|Cycle 2||35
8278363|NCT01687712|20411702|P2|Embryo Transfer|Cycle 2||117
8278364|NCT01687712|20411703|P1|Embryo Transfer|Cycle 2||101
8278365|NCT01687712|20411702|P2|Fertilization Performed|Cycle 2||119
8278366|NCT01687712|20411703|P1|Fertilization Performed|Cycle 2||106
8278367|NCT01687712|20411702|P2|Oocyte/Ovum Pick Up|Cycle 2||119
8278368|NCT01687712|20411703|P1|Oocyte/Ovum Pick Up|Cycle 2||107
8278369|NCT01687712|20411702|P2|Received hCG|Cycle 2||119
8278370|NCT01687712|20411703|P1|Received hCG|Cycle 2||107
8278371|NCT01687712|20411702|P2|STARTED|Cycle 2||120
8278372|NCT01687712|20411703|P1|STARTED|Cycle 2||109
8278373|NCT01687712|20411702|P2|NOT COMPLETED|Cycle 1||429
8278374|NCT01687712|20411703|P1|NOT COMPLETED|Cycle 1||448
8278375|NCT01687712|20411702|P2|COMPLETED|Cycle 1||122
8278376|NCT01687712|20411703|P1|COMPLETED|Cycle 1||101
8278377|NCT01687712|20411702|P2|Clinical Pregnancy|Cycle 1||138
8278378|NCT01687712|20411703|P1|Clinical Pregnancy|Cycle 1||114
8278379|NCT01687712|20411702|P2|Biochemical Pregnancy|Cycle 1||203
8278380|NCT01687712|20411703|P1|Biochemical Pregnancy|Cycle 1||163
8278381|NCT01687712|20411702|P2|Embryo Transfer|Cycle 1||483
8278382|NCT01687712|20411703|P1|Embryo Transfer|Cycle 1||466
8278383|NCT01687712|20411702|P2|Fertilization Performed|Cycle 1||512
8278384|NCT01687712|20411703|P1|Fertilization Performed|Cycle 1||508
8278385|NCT01687712|20411702|P2|Oocyte/Ovum Pick Up|Cycle 1||517
8278386|NCT01687712|20411703|P1|Oocyte/Ovum Pick Up|Cycle 1||513
8278387|NCT01687712|20411702|P2|Received hCG|Cycle 1||520
8278388|NCT01687712|20411703|P1|Received hCG|Cycle 1||516
8278389|NCT01687712|20411702|P2|STARTED|Cycle 1||551
8278390|NCT01687712|20411703|P1|STARTED|Cycle 1||549
8278391|NCT01687673|20411741|P1|NOT COMPLETED|Overall Study||1
8278392|NCT01687673|20411741|P1|COMPLETED|Overall Study||28
8278393|NCT01687673|20411741|P1|STARTED|Overall Study||29
8278394|NCT01687478|20411755|P2|NOT COMPLETED|Overall Study||39
8278395|NCT01687478|20411756|P1|NOT COMPLETED|Overall Study||32
8278396|NCT01687478|20411755|P2|COMPLETED|Overall Study||49
8278397|NCT01687478|20411756|P1|COMPLETED|Overall Study||56
8278398|NCT01687478|20411755|P2|Safety Analysis Set|Overall Study||87
8278399|NCT01687478|20411756|P1|Safety Analysis Set|Overall Study||88
8278400|NCT01687478|20411755|P2|STARTED|Overall Study||88
8278401|NCT01687478|20411756|P1|STARTED|Overall Study||88
8278402|NCT01687413|20411780|P2|NOT COMPLETED|Overall Study||4
8278403|NCT01687413|20411781|P1|NOT COMPLETED|Overall Study||1
8278404|NCT01687413|20411780|P2|COMPLETED|Overall Study||11
8278405|NCT01687413|20411781|P1|COMPLETED|Overall Study||26
8278406|NCT01687413|20411780|P2|STARTED|Overall Study||15
8278407|NCT01687413|20411781|P1|STARTED|Overall Study||27
8278408|NCT01687400|20411857|P1|NOT COMPLETED|Overall Study||0
8278409|NCT01687400|20411857|P1|COMPLETED|Overall Study||114
8278410|NCT01687400|20411857|P1|STARTED|Overall Study||114
8278411|NCT01687387|20411871|P3|NOT COMPLETED|Overall Study||38
8278412|NCT01687387|20411872|P2|NOT COMPLETED|Overall Study||38
8278413|NCT01687387|20411873|P1|NOT COMPLETED|Overall Study||41
8278414|NCT01687387|20411871|P3|COMPLETED|Overall Study||13
8278415|NCT01687387|20411872|P2|COMPLETED|Overall Study||12
8278416|NCT01687387|20411873|P1|COMPLETED|Overall Study||10
8278417|NCT01687387|20411871|P3|STARTED|Overall Study||51
8278418|NCT01687387|20411872|P2|STARTED|Overall Study||50
8278419|NCT01687387|20411873|P1|STARTED|Overall Study||51
8278421|NCT01687296|20411887|P1|NOT COMPLETED|Overall Study||7
8278422|NCT01687296|20411886|P2|COMPLETED|Overall Study||123
8278423|NCT01687296|20411887|P1|COMPLETED|Overall Study||116
8278424|NCT01687296|20411886|P2|STARTED|Overall Study||128
8278425|NCT01687296|20411887|P1|STARTED|Overall Study||123
8278426|NCT01687283|20411909|P2|NOT COMPLETED|Overall Study||27
8278427|NCT01687283|20411910|P1|NOT COMPLETED|Overall Study||35
8278428|NCT01687283|20411909|P2|COMPLETED|Overall Study||130
8278429|NCT01687283|20411910|P1|COMPLETED|Overall Study||123
8278430|NCT01687283|20411909|P2|STARTED|Overall Study||157
8278431|NCT01687283|20411910|P1|STARTED|Overall Study||158
8278432|NCT01687270|20411933|P1|NOT COMPLETED|Overall Study||12
8278433|NCT01687270|20411933|P1|COMPLETED|Overall Study||28
8278434|NCT01687270|20411933|P1|STARTED|Overall Study||40
8278435|NCT01687257|20411944|P3|NOT COMPLETED|Overall Study||6
8278436|NCT01687257|20411945|P2|NOT COMPLETED|Overall Study||4
8278437|NCT01687257|20411946|P1|NOT COMPLETED|Overall Study||8
8278438|NCT01687257|20411944|P3|COMPLETED|Overall Study||15
8278439|NCT01687257|20411945|P2|COMPLETED|Overall Study||0
8278440|NCT01687257|20411946|P1|COMPLETED|Overall Study||17
8278441|NCT01687257|20411944|P3|STARTED|Overall Study||21
8278442|NCT01687257|20411945|P2|STARTED|Overall Study||4
8278443|NCT01687257|20411946|P1|STARTED|Overall Study||25
8278444|NCT01687244|20411974|P2|NOT COMPLETED|Overall Study||0
8278445|NCT01687244|20411975|P1|NOT COMPLETED|Overall Study||0
8278446|NCT01687244|20411974|P2|COMPLETED|Overall Study||19
8278447|NCT01687244|20411975|P1|COMPLETED|Overall Study||21
8278448|NCT01687244|20411974|P2|STARTED|Overall Study||19
8278449|NCT01687244|20411975|P1|STARTED|Overall Study||21
8278450|NCT01687218|20412011|P6|NOT COMPLETED|Overall Study||0
8278451|NCT01687218|20412012|P5|NOT COMPLETED|Overall Study||1
8278452|NCT01687218|20412013|P4|NOT COMPLETED|Overall Study||2
8278453|NCT01687218|20412014|P3|NOT COMPLETED|Overall Study||1
8278454|NCT01687218|20412015|P2|NOT COMPLETED|Overall Study||3
8278455|NCT01687218|20412016|P1|NOT COMPLETED|Overall Study||3
8278456|NCT01687218|20412011|P6|COMPLETED|Overall Study||32
8278457|NCT01687218|20412012|P5|COMPLETED|Overall Study||32
8278458|NCT01687218|20412013|P4|COMPLETED|Overall Study||32
8278459|NCT01687218|20412014|P3|COMPLETED|Overall Study||30
8278460|NCT01687218|20412015|P2|COMPLETED|Overall Study||29
8278461|NCT01687218|20412016|P1|COMPLETED|Overall Study||30
8278462|NCT01687218|20412011|P6|STARTED|Overall Study||32
8278463|NCT01687218|20412012|P5|STARTED|Overall Study||33
8278464|NCT01687218|20412013|P4|STARTED|Overall Study||34
8278465|NCT01687218|20412014|P3|STARTED|Overall Study||31
8278466|NCT01687218|20412015|P2|STARTED|Overall Study||32
8278467|NCT01687218|20412016|P1|STARTED|Overall Study||33
8278468|NCT01687179|20412057|P2|NOT COMPLETED|Overall Study||4
8278469|NCT01687179|20412058|P1|NOT COMPLETED|Overall Study||1
8278470|NCT01687179|20412057|P2|COMPLETED|Overall Study||6
8278471|NCT01687179|20412058|P1|COMPLETED|Overall Study||2
8278472|NCT01687179|20412057|P2|STARTED|Overall Study||10
8278473|NCT01687179|20412058|P1|STARTED|Overall Study||3
8278474|NCT01687166|20412068|P4|NOT COMPLETED|Overall Study||2
8278475|NCT01687166|20412069|P3|NOT COMPLETED|Overall Study||14
8278476|NCT01687166|20412070|P2|NOT COMPLETED|Overall Study||27
8278477|NCT01687166|20412071|P1|NOT COMPLETED|Overall Study||28
8278478|NCT01687166|20412068|P4|COMPLETED|Overall Study||1
8278479|NCT01687166|20412069|P3|COMPLETED|Overall Study||42
8278480|NCT01687166|20412070|P2|COMPLETED|Overall Study||145
8278481|NCT01687166|20412071|P1|COMPLETED|Overall Study||139
8278482|NCT01687166|20412068|P4|STARTED|Overall Study||3
8278483|NCT01687166|20412069|P3|STARTED|Overall Study||56
8278484|NCT01687166|20412070|P2|STARTED|Overall Study||172
8278485|NCT01687166|20412071|P1|STARTED|Overall Study||167
8278486|NCT01687114|20412083|P1|NOT COMPLETED|Overall Study||0
8278487|NCT01687114|20412083|P1|COMPLETED|Overall Study||5
8278488|NCT01687114|20412083|P1|STARTED|Overall Study||5
8278489|NCT01687101|20412087|P1|NOT COMPLETED|Overall Study||7
8278490|NCT01687101|20412087|P1|COMPLETED|Overall Study||25
8278491|NCT01687101|20412087|P1|STARTED|Overall Study||32
8278492|NCT01687088|20412093|P2|NOT COMPLETED|Overall Study||0
8278493|NCT01687088|20412094|P1|NOT COMPLETED|Overall Study||0
8278494|NCT01687088|20412093|P2|COMPLETED|Overall Study||50
8278495|NCT01687088|20412094|P1|COMPLETED|Overall Study||50
8278496|NCT01687088|20412093|P2|STARTED|Overall Study||50
8278497|NCT01687088|20412094|P1|STARTED|Overall Study||50
8278498|NCT01687036|20412100|P1|NOT COMPLETED|Overall Study||0
8278499|NCT01687036|20412100|P1|COMPLETED|Overall Study||10
8278500|NCT01687036|20412100|P1|STARTED|Overall Study||10
8278501|NCT01686958|20412112|P1|NOT COMPLETED|Overall Study||1
8278502|NCT01686958|20412112|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
8278503|NCT01686958|20412112|P1|STARTED|Overall Study||30
8278504|NCT01686932|20412125|P2|NOT COMPLETED|Period 2||0
8278505|NCT01686932|20412126|P1|NOT COMPLETED|Period 2||0
8278506|NCT01686932|20412125|P2|COMPLETED|Period 2||25
8278507|NCT01686932|20412126|P1|COMPLETED|Period 2||24
8278508|NCT01686932|20412125|P2|STARTED|Period 2||25
8278509|NCT01686932|20412126|P1|STARTED|Period 2||24
8278510|NCT01686932|20412125|P2|NOT COMPLETED|Period 1||1
8278511|NCT01686932|20412126|P1|NOT COMPLETED|Period 1||1
8278512|NCT01686932|20412125|P2|COMPLETED|Period 1||25
8278513|NCT01686932|20412126|P1|COMPLETED|Period 1||24
8278514|NCT01686932|20412125|P2|STARTED|Period 1||26
8278515|NCT01686932|20412126|P1|STARTED|Period 1||25
8278516|NCT01686828|20412156|P4|NOT COMPLETED|Overall Study||0
8278517|NCT01686828|20412157|P3|NOT COMPLETED|Overall Study||1
8278518|NCT01686828|20412158|P2|NOT COMPLETED|Overall Study||1
8278519|NCT01686828|20412159|P1|NOT COMPLETED|Overall Study||1
8278520|NCT01686828|20412156|P4|COMPLETED|Overall Study||13
8278521|NCT01686828|20412157|P3|COMPLETED|Overall Study||12
8278522|NCT01686828|20412158|P2|COMPLETED|Overall Study||13
8278523|NCT01686828|20412159|P1|COMPLETED|Overall Study||12
8278524|NCT01686828|20412156|P4|STARTED|Overall Study||13
8278525|NCT01686828|20412157|P3|STARTED|Overall Study||13
8278526|NCT01686828|20412158|P2|STARTED|Overall Study||14
8278527|NCT01686828|20412159|P1|STARTED|Overall Study||13
8278528|NCT01686750|20412179|P2|NOT COMPLETED|Overall Study||0
8278529|NCT01686750|20412180|P1|NOT COMPLETED|Overall Study||0
8278530|NCT01686750|20412179|P2|COMPLETED|Overall Study||10725
8278531|NCT01686750|20412180|P1|COMPLETED|Overall Study||11001
8278532|NCT01686750|20412179|P2|STARTED|Overall Study||10725
8278533|NCT01686750|20412180|P1|STARTED|Overall Study||11001
8278534|NCT01686646|20412220|P4|NOT COMPLETED|Overall Study||0
8278535|NCT01686646|20412221|P3|NOT COMPLETED|Overall Study||0
8278536|NCT01686646|20412222|P2|NOT COMPLETED|Overall Study||0
8278537|NCT01686646|20412223|P1|NOT COMPLETED|Overall Study||0
8278538|NCT01686646|20412220|P4|COMPLETED|Overall Study||75
8278539|NCT01686646|20412221|P3|COMPLETED|Overall Study||75
8278540|NCT01686646|20412222|P2|COMPLETED|Overall Study||45
8278541|NCT01686646|20412223|P1|COMPLETED|Overall Study||45
8278542|NCT01686646|20412220|P4|Safety Population|Overall Study||75
8278543|NCT01686646|20412221|P3|Safety Population|Overall Study||74
8278544|NCT01686646|20412222|P2|Safety Population|Overall Study||45
8278545|NCT01686646|20412223|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
8278546|NCT01686646|20412220|P4|Intent to Treat Population|Overall Study||75
8278547|NCT01686646|20412221|P3|Intent to Treat Population|Overall Study||75
8278548|NCT01686646|20412222|P2|Intent to Treat Population|Overall Study||45
8278549|NCT01686646|20412223|P1|Intent to Treat Population|Overall Study||45
8278550|NCT01686646|20412220|P4|STARTED|Overall Study||75
8278551|NCT01686646|20412221|P3|STARTED|Overall Study||75
8278552|NCT01686646|20412222|P2|STARTED|Overall Study||45
8278553|NCT01686646|20412223|P1|STARTED|Overall Study||45
8278554|NCT01686633|20412272|P3|NOT COMPLETED|Overall Study||25
8278555|NCT01686633|20412273|P2|NOT COMPLETED|Overall Study||32
8278556|NCT01686633|20412274|P1|NOT COMPLETED|Overall Study||51
8278557|NCT01686633|20412272|P3|COMPLETED|Overall Study||321
8278558|NCT01686633|20412273|P2|COMPLETED|Overall Study||314
8278559|NCT01686633|20412274|P1|COMPLETED|Overall Study||296
8278560|NCT01686633|20412272|P3|STARTED|Overall Study||346
8278561|NCT01686633|20412273|P2|STARTED|Overall Study||346
8278562|NCT01686633|20412274|P1|STARTED|Overall Study||347
8278563|NCT01686581|20412297|P1|NOT COMPLETED|Overall Study||177
8278564|NCT01686581|20412297|P1|COMPLETED|Overall Study||464
8278565|NCT01686581|20412297|P1|Completed 24 Months|Overall Study||128
8278566|NCT01686581|20412297|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
8278567|NCT01686581|20412297|P1|STARTED|Overall Study||641
8278568|NCT01686568|20412310|P2|NOT COMPLETED|Sub-Study||2
8278569|NCT01686568|20412311|P1|NOT COMPLETED|Sub-Study||2
8278570|NCT01686568|20412310|P2|COMPLETED|Sub-Study||9
8278571|NCT01686568|20412311|P1|COMPLETED|Sub-Study||12
8278572|NCT01686568|20412310|P2|STARTED|Sub-Study||11
8278573|NCT01686568|20412311|P1|STARTED|Sub-Study||14
8278574|NCT01686568|20412310|P2|NOT COMPLETED|Main Study||4
8278575|NCT01686568|20412311|P1|NOT COMPLETED|Main Study||2
8278576|NCT01686568|20412310|P2|COMPLETED|Main Study||11
8278577|NCT01686568|20412311|P1|COMPLETED|Main Study||14
8278578|NCT01686568|20412310|P2|STARTED|Main Study||15
8278579|NCT01686568|20412311|P1|STARTED|Main Study||16
8278580|NCT01686503|20412337|P4|NOT COMPLETED|Overall Study||1
8278581|NCT01686503|20412338|P3|NOT COMPLETED|Overall Study||2
8278582|NCT01686503|20412339|P2|NOT COMPLETED|Overall Study||3
8278583|NCT01686503|20412340|P1|NOT COMPLETED|Overall Study||1
8278584|NCT01686503|20412337|P4|COMPLETED|Overall Study||32
8278585|NCT01686503|20412338|P3|COMPLETED|Overall Study||64
8278586|NCT01686503|20412339|P2|COMPLETED|Overall Study||63
8278587|NCT01686503|20412340|P1|COMPLETED|Overall Study||65
8278588|NCT01686503|20412337|P4|STARTED|Overall Study||33
8278589|NCT01686503|20412338|P3|STARTED|Overall Study||66
8278590|NCT01686503|20412339|P2|STARTED|Overall Study||66
8278591|NCT01686503|20412340|P1|STARTED|Overall Study||66
8278592|NCT01686451|20412356|P2|NOT COMPLETED|Overall Study||0
8278593|NCT01686451|20412357|P1|NOT COMPLETED|Overall Study||0
8278594|NCT01686451|20412356|P2|COMPLETED|Overall Study||27
8278595|NCT01686451|20412357|P1|COMPLETED|Overall Study||33
8278596|NCT01686451|20412356|P2|STARTED|Overall Study||27
8278597|NCT01686451|20412357|P1|STARTED|Overall Study||33
8278598|NCT01686438|20412388|P3|NOT COMPLETED|Overall Study||13
8278599|NCT01686438|20412389|P2|NOT COMPLETED|Overall Study||9
8278600|NCT01686438|20412390|P1|NOT COMPLETED|Overall Study||8
8278601|NCT01686438|20412388|P3|COMPLETED|Overall Study||24
8278602|NCT01686438|20412389|P2|COMPLETED|Overall Study||26
8278603|NCT01686438|20412390|P1|COMPLETED|Overall Study||7
8278604|NCT01686438|20412388|P3|6-Month Follow Up|Overall Study||24
8278605|NCT01686438|20412389|P2|6-Month Follow Up|Overall Study||26
8278606|NCT01686438|20412390|P1|6-Month Follow Up|Overall Study||7
8278607|NCT01686438|20412388|P3|3-Month Follow Up|Overall Study||17
8278608|NCT01686438|20412389|P2|3-Month Follow Up|Overall Study||21
8278609|NCT01686438|20412390|P1|3-Month Follow Up|Overall Study||7
8278610|NCT01686438|20412388|P3|2-Week Follow Up|Overall Study||27
8278611|NCT01686438|20412389|P2|2-Week Follow Up|Overall Study||31
8278612|NCT01686438|20412390|P1|2-Week Follow Up|Overall Study||12
8278613|NCT01686438|20412388|P3|STARTED|Overall Study||37
8278614|NCT01686438|20412389|P2|STARTED|Overall Study||35
8278615|NCT01686438|20412390|P1|STARTED|Overall Study||15
8278616|NCT01686373|20412438|P2|NOT COMPLETED|Overall Study||2
8278617|NCT01686373|20412439|P1|NOT COMPLETED|Overall Study||3
8278618|NCT01686373|20412438|P2|COMPLETED|Overall Study||38
8278619|NCT01686373|20412439|P1|COMPLETED|Overall Study||31
8278620|NCT01686373|20412438|P2|Received 15 Treatment Sessions|Overall Study||39
8278621|NCT01686373|20412439|P1|Received 15 Treatment Sessions|Overall Study||33
8278622|NCT01686373|20412438|P2|STARTED|Overall Study||40
8278623|NCT01686373|20412439|P1|STARTED|Overall Study||34
8278624|NCT01686165|20412445|P1|NOT COMPLETED|Overall Study||0
8278625|NCT01686165|20412445|P1|COMPLETED|Overall Study||5
8278626|NCT01686165|20412445|P1|STARTED|Overall Study||5
8278627|NCT01686152|20412455|P3|NOT COMPLETED|Overall Study||9
8278628|NCT01686152|20412456|P2|NOT COMPLETED|Overall Study||35
8278629|NCT01686152|20412457|P1|NOT COMPLETED|Overall Study||41
8278630|NCT01686152|20412455|P3|COMPLETED|Overall Study||75
8278631|NCT01686152|20412456|P2|COMPLETED|Overall Study||218
8278632|NCT01686152|20412457|P1|COMPLETED|Overall Study||211
8278633|NCT01686152|20412455|P3|STARTED|Overall Study||84
8278634|NCT01686152|20412456|P2|STARTED|Overall Study||253
8278635|NCT01686152|20412457|P1|STARTED|Overall Study||252
8278636|NCT01685996|20412467|P2|NOT COMPLETED|Overall Study||13
8278637|NCT01685996|20412468|P1|NOT COMPLETED|Overall Study||16
8278638|NCT01685996|20412467|P2|COMPLETED|Overall Study||27
8278639|NCT01685996|20412468|P1|COMPLETED|Overall Study||18
8278640|NCT01685996|20412467|P2|STARTED|Overall Study||40
8278641|NCT01685996|20412468|P1|STARTED|Overall Study||34
8278642|NCT01685983|20412476|P1|NOT COMPLETED|Overall Study||82
8278643|NCT01685983|20412476|P1|COMPLETED|Overall Study||0
8278644|NCT01685983|20412476|P1|STARTED|Overall Study||82
8278645|NCT01685840|20412488|P2|NOT COMPLETED|Overall Study||332
8278646|NCT01685840|20412489|P1|NOT COMPLETED|Overall Study||329
8278647|NCT01685840|20412488|P2|COMPLETED|Overall Study||114
8278648|NCT01685840|20412489|P1|COMPLETED|Overall Study||119
8278649|NCT01685840|20412488|P2|STARTED|Overall Study||446
8278650|NCT01685840|20412489|P1|STARTED|Overall Study||448
8278651|NCT01685801|20412533|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278652|NCT01685801|20412534|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278653|NCT01685801|20412535|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278654|NCT01685801|20412536|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278655|NCT01685801|20412533|P4|COMPLETED|Open-label Period (8 Weeks)||4
8278656|NCT01685801|20412534|P3|COMPLETED|Open-label Period (8 Weeks)||7
8278657|NCT01685801|20412535|P2|COMPLETED|Open-label Period (8 Weeks)||5
8278658|NCT01685801|20412536|P1|COMPLETED|Open-label Period (8 Weeks)||5
8278659|NCT01685801|20412533|P4|STARTED|Open-label Period (8 Weeks)||4
8278660|NCT01685801|20412534|P3|STARTED|Open-label Period (8 Weeks)||7
8278661|NCT01685801|20412535|P2|STARTED|Open-label Period (8 Weeks)||5
8278662|NCT01685801|20412536|P1|STARTED|Open-label Period (8 Weeks)||5
8278663|NCT01685801|20412533|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278664|NCT01685801|20412534|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278665|NCT01685801|20412535|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278666|NCT01685801|20412536|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278667|NCT01685801|20412533|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
8278668|NCT01685801|20412534|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
8278669|NCT01685801|20412535|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
8278670|NCT01685801|20412536|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
8278671|NCT01685801|20412533|P4|STARTED|Washout Period 2 (4 Weeks)||4
8278672|NCT01685801|20412534|P3|STARTED|Washout Period 2 (4 Weeks)||7
8278673|NCT01685801|20412535|P2|STARTED|Washout Period 2 (4 Weeks)||5
8278674|NCT01685801|20412536|P1|STARTED|Washout Period 2 (4 Weeks)||5
8278675|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
8278676|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
8278677|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
8278678|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
8278679|NCT01685801|20412533|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
8278680|NCT01685801|20412534|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
8278681|NCT01685801|20412535|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
8278682|NCT01685801|20412536|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
8278683|NCT01685801|20412533|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
8278684|NCT01685801|20412534|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
8278685|NCT01685801|20412535|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
8278686|NCT01685801|20412536|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
8278687|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278688|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278689|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278690|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278691|NCT01685801|20412533|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
8278692|NCT01685801|20412534|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
8278693|NCT01685801|20412535|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
8278694|NCT01685801|20412536|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
8278695|NCT01685801|20412533|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
8278696|NCT01685801|20412534|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
8278697|NCT01685801|20412535|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
8278698|NCT01685801|20412536|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
8278699|NCT01685801|20412533|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278700|NCT01685801|20412534|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278701|NCT01685801|20412535|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278702|NCT01685801|20412536|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278703|NCT01685801|20412533|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
8278704|NCT01685801|20412534|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
8278705|NCT01685801|20412535|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
8278706|NCT01685801|20412536|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
8278707|NCT01685801|20412533|P4|STARTED|Washout Period 1 (4 Weeks)||5
8278708|NCT01685801|20412534|P3|STARTED|Washout Period 1 (4 Weeks)||7
8278709|NCT01685801|20412535|P2|STARTED|Washout Period 1 (4 Weeks)||6
8278710|NCT01685801|20412536|P1|STARTED|Washout Period 1 (4 Weeks)||5
8278711|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
8278712|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8278713|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8278714|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8278715|NCT01685801|20412533|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
8278716|NCT01685801|20412534|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
8278717|NCT01685801|20412535|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
8278718|NCT01685801|20412536|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
8278719|NCT01685801|20412533|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
8278720|NCT01685801|20412534|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
8278721|NCT01685801|20412535|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
8278722|NCT01685801|20412536|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
8278723|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278724|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278725|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278726|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278727|NCT01685801|20412533|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
8278728|NCT01685801|20412534|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
8278729|NCT01685801|20412535|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
8278730|NCT01685801|20412536|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
8278731|NCT01685801|20412533|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
8278732|NCT01685801|20412534|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
8278733|NCT01685801|20412535|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
8278734|NCT01685801|20412536|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
8278735|NCT01685697|20412558|P2|NOT COMPLETED|Overall Study||3
8278736|NCT01685697|20412559|P1|NOT COMPLETED|Overall Study||3
8278737|NCT01685697|20412558|P2|COMPLETED|Overall Study||28
8278738|NCT01685697|20412559|P1|COMPLETED|Overall Study||28
8278739|NCT01685697|20412558|P2|STARTED|Overall Study||31
8278740|NCT01685697|20412559|P1|STARTED|Overall Study||31
8278741|NCT01685684|20412567|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
8278742|NCT01685684|20412568|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
8278743|NCT01685684|20412569|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
8278744|NCT01685684|20412567|P3|COMPLETED|Double-blind Maintenance Phase||100
8278745|NCT01685684|20412568|P2|COMPLETED|Double-blind Maintenance Phase||122
8278746|NCT01685684|20412569|P1|COMPLETED|Double-blind Maintenance Phase||0
8278747|NCT01685684|20412567|P3|STARTED|Double-blind Maintenance Phase||196
8278748|NCT01685684|20412568|P2|STARTED|Double-blind Maintenance Phase||193
8278749|NCT01685684|20412569|P1|STARTED|Double-blind Maintenance Phase||0
8278750|NCT01685684|20412567|P3|NOT COMPLETED|Titration Phase||0
8278751|NCT01685684|20412568|P2|NOT COMPLETED|Titration Phase||0
8278752|NCT01685684|20412569|P1|NOT COMPLETED|Titration Phase||351
8278753|NCT01685684|20412567|P3|COMPLETED|Titration Phase||0
8278754|NCT01685684|20412568|P2|COMPLETED|Titration Phase||0
8278755|NCT01685684|20412569|P1|COMPLETED|Titration Phase||389
8278756|NCT01685684|20412567|P3|STARTED|Titration Phase||0
8278757|NCT01685684|20412568|P2|STARTED|Titration Phase||0
8278758|NCT01685684|20412569|P1|STARTED|Titration Phase||740
8278759|NCT01685606|20412593|P1|NOT COMPLETED|Overall Study||1
8278760|NCT01685606|20412593|P1|COMPLETED|Overall Study||5
8278761|NCT01685606|20412593|P1|STARTED|Overall Study||6
8278762|NCT01685567|20412598|P1|NOT COMPLETED|Overall Study||0
8278763|NCT01685567|20412598|P1|COMPLETED|Overall Study||219
8278764|NCT01685567|20412598|P1|STARTED|Overall Study||219
8278765|NCT01685463|20412608|P2|NOT COMPLETED|Overall Study||0
8278766|NCT01685463|20412609|P1|NOT COMPLETED|Overall Study||0
8278767|NCT01685463|20412608|P2|COMPLETED|Overall Study||8
8278768|NCT01685463|20412609|P1|COMPLETED|Overall Study||10
8278769|NCT01685463|20412608|P2|STARTED|Overall Study||8
8278770|NCT01685463|20412609|P1|STARTED|Overall Study||10
8278771|NCT01685437|20412621|P1|NOT COMPLETED|Overall Study||31
8278772|NCT01685437|20412621|P1|COMPLETED|Overall Study||158
8278773|NCT01685437|20412621|P1|STARTED|Overall Study||189
8278774|NCT01685372|20412635|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
8278775|NCT01685372|20412636|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
8278776|NCT01685372|20412635|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
8278777|NCT01685372|20412636|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
8278778|NCT01685372|20412635|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
8278779|NCT01685372|20412636|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
8278780|NCT01685372|20412635|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
8278781|NCT01685372|20412636|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
8278782|NCT01685372|20412635|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
8278783|NCT01685372|20412636|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
8278784|NCT01685372|20412635|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
8278785|NCT01685372|20412636|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
8278786|NCT01685372|20412635|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
8278787|NCT01685372|20412636|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
8278788|NCT01685372|20412635|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
8278789|NCT01685372|20412636|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
8278790|NCT01685372|20412635|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
8278791|NCT01685372|20412636|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
8278798|NCT01685242|20412669|P2|NOT COMPLETED|Overall Study||3
8278799|NCT01685242|20412670|P1|NOT COMPLETED|Overall Study||1
8278800|NCT01685242|20412669|P2|COMPLETED|Overall Study||47
8278801|NCT01685242|20412670|P1|COMPLETED|Overall Study||49
8278802|NCT01685242|20412669|P2|STARTED|Overall Study||50
8278803|NCT01685242|20412670|P1|STARTED|Overall Study||50
8278804|NCT01685229|20412726|P2|NOT COMPLETED|Overall Study||16
8278805|NCT01685229|20412727|P1|NOT COMPLETED|Overall Study||26
8278806|NCT01685229|20412726|P2|COMPLETED|Overall Study||36
8278807|NCT01685229|20412727|P1|COMPLETED|Overall Study||120
8278808|NCT01685229|20412726|P2|STARTED|Overall Study||52
8278809|NCT01685229|20412727|P1|STARTED|Overall Study||146
8278810|NCT01685216|20412753|P1|NOT COMPLETED|Overall Study||1
8278811|NCT01685216|20412753|P1|COMPLETED|Overall Study||6
8278812|NCT01685216|20412753|P1|STARTED|Overall Study||7
8278813|NCT01685203|20412770|P7|NOT COMPLETED|Overall Study||0
8278814|NCT01685203|20412771|P6|NOT COMPLETED|Overall Study||3
8278815|NCT01685203|20412772|P5|NOT COMPLETED|Overall Study||0
8278816|NCT01685203|20412773|P4|NOT COMPLETED|Overall Study||1
8278817|NCT01685203|20412774|P3|NOT COMPLETED|Overall Study||0
8278818|NCT01685203|20412775|P2|NOT COMPLETED|Overall Study||3
8278819|NCT01685203|20412776|P1|NOT COMPLETED|Overall Study||4
8278820|NCT01685203|20412770|P7|COMPLETED|Overall Study||52
8278821|NCT01685203|20412771|P6|COMPLETED|Overall Study||44
8278822|NCT01685203|20412772|P5|COMPLETED|Overall Study||49
8278823|NCT01685203|20412773|P4|COMPLETED|Overall Study||41
8278824|NCT01685203|20412774|P3|COMPLETED|Overall Study||40
8278825|NCT01685203|20412775|P2|COMPLETED|Overall Study||39
8278826|NCT01685203|20412776|P1|COMPLETED|Overall Study||40
8278827|NCT01685203|20412770|P7|Completed Study Drug|Overall Study||52
8278828|NCT01685203|20412771|P6|Completed Study Drug|Overall Study||43
8278829|NCT01685203|20412772|P5|Completed Study Drug|Overall Study||49
8278830|NCT01685203|20412773|P4|Completed Study Drug|Overall Study||42
8278831|NCT01685203|20412774|P3|Completed Study Drug|Overall Study||39
8278832|NCT01685203|20412775|P2|Completed Study Drug|Overall Study||40
8278833|NCT01685203|20412776|P1|Completed Study Drug|Overall Study||42
8278834|NCT01685203|20412770|P7|STARTED|Overall Study||52
8278835|NCT01685203|20412771|P6|STARTED|Overall Study||47
8278836|NCT01685203|20412772|P5|STARTED|Overall Study||49
8278837|NCT01685203|20412773|P4|STARTED|Overall Study||42
8278838|NCT01685203|20412774|P3|STARTED|Overall Study||40
8278839|NCT01685203|20412775|P2|STARTED|Overall Study||42
8278840|NCT01685203|20412776|P1|STARTED|Overall Study||44
8278841|NCT01685138|20412820|P1|NOT COMPLETED|Overall Study||92
8278842|NCT01685138|20412820|P1|COMPLETED|Overall Study||32
8278843|NCT01685138|20412820|P1|Discontinued From Study|Overall Study||51
8278844|NCT01685138|20412820|P1|Entered Survival Follow-up|Overall Study||63
8278845|NCT01685138|20412820|P1|Entered Post-treatment Efficacy f/up|Overall Study||10
8278846|NCT01685138|20412820|P1|Discontinued From Treatment Phase|Overall Study||124
8278847|NCT01685138|20412820|P1|STARTED|Overall Study||124
8278848|NCT01685073|20412836|P2|NOT COMPLETED|Overall Study||32
8278849|NCT01685073|20412837|P1|NOT COMPLETED|Overall Study||30
8278850|NCT01685073|20412836|P2|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
8278851|NCT01685073|20412837|P1|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
8278852|NCT01685073|20412836|P2|STARTED|Overall Study|Randomized|65
8278853|NCT01685073|20412837|P1|STARTED|Overall Study|Randomized|62
8278854|NCT01685060|20412845|P1|NOT COMPLETED|Overall Study||140
8278855|NCT01685060|20412845|P1|COMPLETED|Overall Study||0
8278856|NCT01685060|20412845|P1|Discontinued From Study|Overall Study||35
8278857|NCT01685060|20412845|P1|Entered Survival Follow up|Overall Study||98
8278858|NCT01685060|20412845|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
8278859|NCT01685060|20412845|P1|STARTED|Overall Study||140
8278860|NCT01685047|20412860|P1|NOT COMPLETED|Overall Study||85
8278861|NCT01685047|20412860|P1|COMPLETED|Overall Study||396
8278862|NCT01685047|20412860|P1|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
8278863|NCT01685021|20412864|P1|NOT COMPLETED|Overall Study||16
8278864|NCT01685021|20412864|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
8278865|NCT01685021|20412864|P1|STARTED|Overall Study||22
8278866|NCT01684943|20412876|P3|NOT COMPLETED|Overall Study||1
8278867|NCT01684943|20412877|P2|NOT COMPLETED|Overall Study||1
8278868|NCT01684943|20412878|P1|NOT COMPLETED|Overall Study||9
8278869|NCT01684943|20412876|P3|COMPLETED|Overall Study||0
8278870|NCT01684943|20412877|P2|COMPLETED|Overall Study||2
8278871|NCT01684943|20412878|P1|COMPLETED|Overall Study||20
8278872|NCT01684943|20412876|P3|STARTED|Overall Study||1
8278873|NCT01684943|20412877|P2|STARTED|Overall Study||3
8278874|NCT01684943|20412878|P1|STARTED|Overall Study||29
8278875|NCT01684930|20412897|P2|NOT COMPLETED|Overall Study||1
8278876|NCT01684930|20412898|P1|NOT COMPLETED|Overall Study||3
8278877|NCT01684930|20412897|P2|COMPLETED|Overall Study||13
8278878|NCT01684930|20412898|P1|COMPLETED|Overall Study||9
8278879|NCT01684930|20412897|P2|STARTED|Overall Study||14
8278880|NCT01684930|20412898|P1|STARTED|Overall Study||12
8278881|NCT01684917|20412918|P4|NOT COMPLETED|Overall Study||0
8278882|NCT01684917|20412919|P3|NOT COMPLETED|Overall Study||0
8278883|NCT01684917|20412920|P2|NOT COMPLETED|Overall Study||0
8278884|NCT01684917|20412921|P1|NOT COMPLETED|Overall Study||0
8278885|NCT01684917|20412918|P4|COMPLETED|Overall Study||5
8278886|NCT01684917|20412919|P3|COMPLETED|Overall Study||13
8278887|NCT01684917|20412920|P2|COMPLETED|Overall Study||7
8278888|NCT01684917|20412921|P1|COMPLETED|Overall Study||11
8278889|NCT01684917|20412918|P4|STARTED|Overall Study||5
8278890|NCT01684917|20412919|P3|STARTED|Overall Study||13
8278891|NCT01684917|20412920|P2|STARTED|Overall Study||7
8278892|NCT01684917|20412921|P1|STARTED|Overall Study||11
8278893|NCT01684878|20412955|P4|NOT COMPLETED|Part 2: Randomized Phase||78
8278894|NCT01684878|20412956|P3|NOT COMPLETED|Part 2: Randomized Phase||78
8278895|NCT01684878|20412957|P2|NOT COMPLETED|Part 2: Randomized Phase||0
8278896|NCT01684878|20412958|P1|NOT COMPLETED|Part 2: Randomized Phase||0
8278897|NCT01684878|20412955|P4|COMPLETED|Part 2: Randomized Phase||0
8278898|NCT01684878|20412956|P3|COMPLETED|Part 2: Randomized Phase||0
8278899|NCT01684878|20412957|P2|COMPLETED|Part 2: Randomized Phase||0
8278900|NCT01684878|20412958|P1|COMPLETED|Part 2: Randomized Phase||0
8278901|NCT01684878|20412955|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
8278902|NCT01684878|20412956|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
8278903|NCT01684878|20412957|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
8278904|NCT01684878|20412958|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
8278905|NCT01684878|20412955|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
8278906|NCT01684878|20412956|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
8278907|NCT01684878|20412957|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
8278908|NCT01684878|20412958|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
8278909|NCT01684878|20412955|P4|STARTED|Part 2: Randomized Phase||78
8278910|NCT01684878|20412956|P3|STARTED|Part 2: Randomized Phase||78
8278911|NCT01684878|20412957|P2|STARTED|Part 2: Randomized Phase||0
8278912|NCT01684878|20412958|P1|STARTED|Part 2: Randomized Phase||0
8278913|NCT01684878|20412955|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
8278914|NCT01684878|20412956|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
8278915|NCT01684878|20412957|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
8278916|NCT01684878|20412958|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
8278917|NCT01684878|20412955|P4|COMPLETED|Part 1: Safety Run in Phase||0
8278918|NCT01684878|20412956|P3|COMPLETED|Part 1: Safety Run in Phase||0
8278919|NCT01684878|20412957|P2|COMPLETED|Part 1: Safety Run in Phase||5
8278920|NCT01684878|20412958|P1|COMPLETED|Part 1: Safety Run in Phase||6
8278921|NCT01684878|20412955|P4|STARTED|Part 1: Safety Run in Phase||0
8278922|NCT01684878|20412956|P3|STARTED|Part 1: Safety Run in Phase||0
8278923|NCT01684878|20412957|P2|STARTED|Part 1: Safety Run in Phase||28
8278924|NCT01684878|20412958|P1|STARTED|Part 1: Safety Run in Phase||22
8278925|NCT01684839|20412982|P1|NOT COMPLETED|Overall Study||0
8278926|NCT01684839|20412982|P1|COMPLETED|Overall Study||9
8278927|NCT01684839|20412982|P1|STARTED|Overall Study||9
8278928|NCT01684826|20412986|P1|NOT COMPLETED|Overall Study||10
8278929|NCT01684826|20412986|P1|COMPLETED|Overall Study||39
8278930|NCT01684826|20412986|P1|Collected Dose and Image Information|Overall Study||39
8278931|NCT01684826|20412986|P1|STARTED|Overall Study||49
8278932|NCT01684748|20412994|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
8278933|NCT01684748|20412995|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
8278934|NCT01684748|20412994|P2|COMPLETED|Second Intervention - 8 Weeks||8
8278935|NCT01684748|20412995|P1|COMPLETED|Second Intervention - 8 Weeks||8
8278936|NCT01684748|20412994|P2|STARTED|Second Intervention - 8 Weeks||8
8278937|NCT01684748|20412995|P1|STARTED|Second Intervention - 8 Weeks||8
8278938|NCT01684748|20412994|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
8278939|NCT01684748|20412995|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
8278940|NCT01684748|20412994|P2|COMPLETED|First Intervention - 8 Weeks||8
8278941|NCT01684748|20412995|P1|COMPLETED|First Intervention - 8 Weeks||8
8278942|NCT01684748|20412994|P2|STARTED|First Intervention - 8 Weeks||10
8278943|NCT01684748|20412995|P1|STARTED|First Intervention - 8 Weeks||10
8278944|NCT01684722|20413006|P4|NOT COMPLETED|Overall Study||110
8278945|NCT01684722|20413007|P3|NOT COMPLETED|Overall Study||94
8278946|NCT01684722|20413008|P2|NOT COMPLETED|Overall Study||77
8278947|NCT01684722|20413009|P1|NOT COMPLETED|Overall Study||97
8278948|NCT01684722|20413006|P4|COMPLETED|Overall Study||260
8278949|NCT01684722|20413007|P3|COMPLETED|Overall Study||226
8278950|NCT01684722|20413008|P2|COMPLETED|Overall Study||212
8278951|NCT01684722|20413009|P1|COMPLETED|Overall Study||236
8278952|NCT01684722|20413006|P4|STARTED|Overall Study||370
8278953|NCT01684722|20413007|P3|STARTED|Overall Study||320
8278954|NCT01684722|20413008|P2|STARTED|Overall Study||289
8278955|NCT01684722|20413009|P1|STARTED|Overall Study||333
8278956|NCT01684592|20413025|P2|NOT COMPLETED|Overall Study||24
8278957|NCT01684592|20413026|P1|NOT COMPLETED|Overall Study||26
8278958|NCT01684592|20413025|P2|COMPLETED|Overall Study||40
8278959|NCT01684592|20413026|P1|COMPLETED|Overall Study||38
8278960|NCT01684592|20413025|P2|STARTED|Overall Study||64
8278961|NCT01684592|20413026|P1|STARTED|Overall Study||64
8278962|NCT01684566|20413046|P2|NOT COMPLETED|Overall Study||7
8278963|NCT01684566|20413047|P1|NOT COMPLETED|Overall Study||16
8278964|NCT01684566|20413046|P2|COMPLETED|Overall Study||49
8278965|NCT01684566|20413047|P1|COMPLETED|Overall Study||44
8278966|NCT01684566|20413046|P2|Treated (ITT)|Overall Study||52
8278967|NCT01684566|20413047|P1|Treated (ITT)|Overall Study||57
8278968|NCT01684566|20413046|P2|STARTED|Overall Study||56
8278969|NCT01684566|20413047|P1|STARTED|Overall Study||60
8278970|NCT01684436|20413069|P1|NOT COMPLETED|Overall Study||1
8278971|NCT01684436|20413069|P1|COMPLETED|Overall Study||29
8278972|NCT01684436|20413069|P1|STARTED|Overall Study||30
8278973|NCT01684423|20413083|P5|NOT COMPLETED|Overall Study||0
8278974|NCT01684423|20413084|P4|NOT COMPLETED|Overall Study||0
8278975|NCT01684423|20413085|P3|NOT COMPLETED|Overall Study||1
8278976|NCT01684423|20413086|P2|NOT COMPLETED|Overall Study||0
8278977|NCT01684423|20413087|P1|NOT COMPLETED|Overall Study||0
8278978|NCT01684423|20413083|P5|COMPLETED|Overall Study||7
8278979|NCT01684423|20413084|P4|COMPLETED|Overall Study||19
8278980|NCT01684423|20413085|P3|COMPLETED|Overall Study||12
8278981|NCT01684423|20413086|P2|COMPLETED|Overall Study||13
8278982|NCT01684423|20413087|P1|COMPLETED|Overall Study||11
8278983|NCT01684423|20413083|P5|STARTED|Overall Study||7
8278984|NCT01684423|20413084|P4|STARTED|Overall Study||19
8278985|NCT01684423|20413085|P3|STARTED|Overall Study||13
8278986|NCT01684423|20413086|P2|STARTED|Overall Study||13
8278987|NCT01684423|20413087|P1|STARTED|Overall Study||11
8278988|NCT01684410|20413124|P3|NOT COMPLETED|Overall Study||0
8278989|NCT01684410|20413125|P2|NOT COMPLETED|Overall Study||0
8278990|NCT01684410|20413126|P1|NOT COMPLETED|Overall Study||0
8278991|NCT01684410|20413124|P3|COMPLETED|Overall Study||10
8278992|NCT01684410|20413125|P2|COMPLETED|Overall Study||10
8278993|NCT01684410|20413126|P1|COMPLETED|Overall Study||10
8278994|NCT01684410|20413124|P3|STARTED|Overall Study||10
8278995|NCT01684410|20413125|P2|STARTED|Overall Study||10
8278996|NCT01684410|20413126|P1|STARTED|Overall Study||10
8278997|NCT01684215|20413144|P4|NOT COMPLETED|Phase 2||43
8278998|NCT01684215|20413145|P3|NOT COMPLETED|Phase 2||0
8278999|NCT01684215|20413146|P2|NOT COMPLETED|Phase 2||0
8279000|NCT01684215|20413147|P1|NOT COMPLETED|Phase 2||0
8279001|NCT01684215|20413144|P4|COMPLETED|Phase 2||0
8279002|NCT01684215|20413145|P3|COMPLETED|Phase 2||0
8279003|NCT01684215|20413146|P2|COMPLETED|Phase 2||0
8279004|NCT01684215|20413147|P1|COMPLETED|Phase 2||0
8279005|NCT01684215|20413144|P4|Treated|Phase 2||42
8279006|NCT01684215|20413145|P3|Treated|Phase 2||0
8279007|NCT01684215|20413146|P2|Treated|Phase 2||0
8279008|NCT01684215|20413147|P1|Treated|Phase 2||0
8279009|NCT01684215|20413144|P4|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
8279010|NCT01684215|20413145|P3|STARTED|Phase 2||0
8279011|NCT01684215|20413146|P2|STARTED|Phase 2||0
8279012|NCT01684215|20413147|P1|STARTED|Phase 2||0
8279013|NCT01684215|20413144|P4|NOT COMPLETED|Phase 1, Part 2||0
8279014|NCT01684215|20413145|P3|NOT COMPLETED|Phase 1, Part 2||6
8279015|NCT01684215|20413146|P2|NOT COMPLETED|Phase 1, Part 2||0
8279016|NCT01684215|20413147|P1|NOT COMPLETED|Phase 1, Part 2||0
8279017|NCT01684215|20413144|P4|COMPLETED|Phase 1, Part 2||0
8279018|NCT01684215|20413145|P3|COMPLETED|Phase 1, Part 2||0
8279019|NCT01684215|20413146|P2|COMPLETED|Phase 1, Part 2||0
8279020|NCT01684215|20413147|P1|COMPLETED|Phase 1, Part 2||0
8279021|NCT01684215|20413144|P4|STARTED|Phase 1, Part 2||0
8279022|NCT01684215|20413145|P3|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
8279023|NCT01684215|20413146|P2|STARTED|Phase 1, Part 2||0
8279024|NCT01684215|20413147|P1|STARTED|Phase 1, Part 2||0
8279025|NCT01684215|20413144|P4|NOT COMPLETED|Phase 1, Part 1||0
8279026|NCT01684215|20413145|P3|NOT COMPLETED|Phase 1, Part 1||0
8279027|NCT01684215|20413146|P2|NOT COMPLETED|Phase 1, Part 1||6
8279028|NCT01684215|20413147|P1|NOT COMPLETED|Phase 1, Part 1||6
8279029|NCT01684215|20413144|P4|COMPLETED|Phase 1, Part 1||0
8279030|NCT01684215|20413145|P3|COMPLETED|Phase 1, Part 1||0
8279031|NCT01684215|20413146|P2|COMPLETED|Phase 1, Part 1||0
8279032|NCT01684215|20413147|P1|COMPLETED|Phase 1, Part 1||0
8279033|NCT01684215|20413144|P4|Treated|Phase 1, Part 1||0
8279034|NCT01684215|20413145|P3|Treated|Phase 1, Part 1||0
8279035|NCT01684215|20413146|P2|Treated|Phase 1, Part 1||6
8279036|NCT01684215|20413147|P1|Treated|Phase 1, Part 1||6
8279037|NCT01684215|20413144|P4|STARTED|Phase 1, Part 1||0
8279038|NCT01684215|20413145|P3|STARTED|Phase 1, Part 1||0
8279039|NCT01684215|20413146|P2|STARTED|Phase 1, Part 1||6
8279040|NCT01684215|20413147|P1|STARTED|Phase 1, Part 1||6
8279041|NCT01684046|20413221|P2|NOT COMPLETED|Period 2, Second 30 Days||0
8279042|NCT01684046|20413222|P1|NOT COMPLETED|Period 2, Second 30 Days||0
8279043|NCT01684046|20413221|P2|COMPLETED|Period 2, Second 30 Days||93
8279044|NCT01684046|20413222|P1|COMPLETED|Period 2, Second 30 Days||97
8279045|NCT01684046|20413221|P2|STARTED|Period 2, Second 30 Days||93
8279046|NCT01684046|20413222|P1|STARTED|Period 2, Second 30 Days||97
8279047|NCT01684046|20413221|P2|NOT COMPLETED|Period 1, First 30 Days||2
8279048|NCT01684046|20413222|P1|NOT COMPLETED|Period 1, First 30 Days||0
8279049|NCT01684046|20413221|P2|COMPLETED|Period 1, First 30 Days||93
8279050|NCT01684046|20413222|P1|COMPLETED|Period 1, First 30 Days||97
8279051|NCT01684046|20413221|P2|STARTED|Period 1, First 30 Days||95
8279052|NCT01684046|20413222|P1|STARTED|Period 1, First 30 Days||97
8279053|NCT01684033|20413228|P2|NOT COMPLETED|Period 2, Second 30 Days||0
8279054|NCT01684033|20413229|P1|NOT COMPLETED|Period 2, Second 30 Days||1
8279055|NCT01684033|20413228|P2|COMPLETED|Period 2, Second 30 Days||98
8279056|NCT01684033|20413229|P1|COMPLETED|Period 2, Second 30 Days||94
8279057|NCT01684033|20413228|P2|STARTED|Period 2, Second 30 Days||98
8279058|NCT01684033|20413229|P1|STARTED|Period 2, Second 30 Days||95
8279059|NCT01684033|20413228|P2|NOT COMPLETED|Period 1, First 30 Days||1
8279060|NCT01684033|20413229|P1|NOT COMPLETED|Period 1, First 30 Days||4
8279061|NCT01684033|20413228|P2|COMPLETED|Period 1, First 30 Days||98
8279062|NCT01684033|20413229|P1|COMPLETED|Period 1, First 30 Days||95
8279063|NCT01684033|20413228|P2|STARTED|Period 1, First 30 Days||99
8279064|NCT01684033|20413229|P1|STARTED|Period 1, First 30 Days||99
8279065|NCT01684020|20413239|P2|NOT COMPLETED|Overall Study||0
8279066|NCT01684020|20413240|P1|NOT COMPLETED|Overall Study||1
8279067|NCT01684020|20413239|P2|COMPLETED|Overall Study||5
8279068|NCT01684020|20413240|P1|COMPLETED|Overall Study||4
8279069|NCT01684020|20413239|P2|STARTED|Overall Study||5
8279070|NCT01684020|20413240|P1|STARTED|Overall Study||5
8279071|NCT01684007|20413264|P2|NOT COMPLETED|Overall Study||0
8279072|NCT01684007|20413265|P1|NOT COMPLETED|Overall Study||0
8279073|NCT01684007|20413264|P2|COMPLETED|Overall Study||50
8279074|NCT01684007|20413265|P1|COMPLETED|Overall Study||53
8279075|NCT01684007|20413264|P2|STARTED|Overall Study||50
8279076|NCT01684007|20413265|P1|STARTED|Overall Study||53
8279077|NCT01683994|20413278|P5|NOT COMPLETED|Overall Study||1
8279078|NCT01683994|20413279|P4|NOT COMPLETED|Overall Study||3
8279079|NCT01683994|20413280|P3|NOT COMPLETED|Overall Study||0
8279080|NCT01683994|20413281|P2|NOT COMPLETED|Overall Study||0
8279081|NCT01683994|20413282|P1|NOT COMPLETED|Overall Study||1
8279082|NCT01683994|20413278|P5|COMPLETED|Overall Study||12
8279083|NCT01683994|20413279|P4|COMPLETED|Overall Study||10
8279084|NCT01683994|20413280|P3|COMPLETED|Overall Study||7
8279085|NCT01683994|20413281|P2|COMPLETED|Overall Study||8
8279086|NCT01683994|20413282|P1|COMPLETED|Overall Study||3
8279087|NCT01683994|20413278|P5|# of Patients Who Received Treatment|Overall Study||13
8279088|NCT01683994|20413279|P4|# of Patients Who Received Treatment|Overall Study||12
8279089|NCT01683994|20413280|P3|# of Patients Who Received Treatment|Overall Study||7
8279090|NCT01683994|20413281|P2|# of Patients Who Received Treatment|Overall Study||8
8279091|NCT01683994|20413282|P1|# of Patients Who Received Treatment|Overall Study||4
8279092|NCT01683994|20413278|P5|STARTED|Overall Study||13
8279093|NCT01683994|20413279|P4|STARTED|Overall Study||13
8279094|NCT01683994|20413280|P3|STARTED|Overall Study||7
8279095|NCT01683994|20413281|P2|STARTED|Overall Study||8
8279096|NCT01683994|20413282|P1|STARTED|Overall Study||4
8279097|NCT01683864|20413311|P3|NOT COMPLETED|Overall Study||0
8279098|NCT01683864|20413312|P2|NOT COMPLETED|Overall Study||0
8279099|NCT01683864|20413313|P1|NOT COMPLETED|Overall Study||0
8279100|NCT01683864|20413311|P3|COMPLETED|Overall Study||0
8279101|NCT01683864|20413312|P2|COMPLETED|Overall Study||0
8279102|NCT01683864|20413313|P1|COMPLETED|Overall Study||0
8279103|NCT01683864|20413311|P3|STARTED|Overall Study||0
8279104|NCT01683864|20413312|P2|STARTED|Overall Study||0
8279105|NCT01683864|20413313|P1|STARTED|Overall Study||0
8279106|NCT01683838|20413323|P2|NOT COMPLETED|Overall Study||12
8279107|NCT01683838|20413324|P1|NOT COMPLETED|Overall Study||26
8279108|NCT01683838|20413323|P2|COMPLETED|Overall Study||88
8279109|NCT01683838|20413324|P1|COMPLETED|Overall Study||78
8279110|NCT01683838|20413323|P2|Efficacy Population|Overall Study||93
8279111|NCT01683838|20413324|P1|Efficacy Population|Overall Study||89
8279112|NCT01683838|20413323|P2|Safety Population|Overall Study||100
8279113|NCT01683838|20413324|P1|Safety Population|Overall Study||103
8279114|NCT01683838|20413323|P2|Intent to Treat (ITT) Population|Overall Study||100
8279115|NCT01683838|20413324|P1|Intent to Treat (ITT) Population|Overall Study||103
8279116|NCT01683838|20413323|P2|STARTED|Overall Study||100
8279117|NCT01683838|20413324|P1|STARTED|Overall Study||104
8279118|NCT01683812|20413346|P1|NOT COMPLETED|Overall Study||0
8279119|NCT01683812|20413346|P1|COMPLETED|Overall Study||23
8279120|NCT01683812|20413346|P1|STARTED|Overall Study||23
8279121|NCT01683630|20413353|P2|NOT COMPLETED|Overall Study||0
8279122|NCT01683630|20413354|P1|NOT COMPLETED|Overall Study||0
8279123|NCT01683630|20413353|P2|COMPLETED|Overall Study||445
8279124|NCT01683630|20413354|P1|COMPLETED|Overall Study||1404
8279125|NCT01683630|20413353|P2|STARTED|Overall Study||445
8279126|NCT01683630|20413354|P1|STARTED|Overall Study||1404
8279127|NCT01683604|20413364|P1|NOT COMPLETED|Overall Study||5
8279128|NCT01683604|20413364|P1|COMPLETED|Overall Study||32
8279129|NCT01683604|20413364|P1|STARTED|Overall Study||37
8279130|NCT01683565|20413529|P2|NOT COMPLETED|Overall Study||1
8279131|NCT01683565|20413530|P1|NOT COMPLETED|Overall Study||3
8279132|NCT01683565|20413529|P2|COMPLETED|Overall Study||15
8279133|NCT01683565|20413530|P1|COMPLETED|Overall Study||12
8279134|NCT01683565|20413529|P2|STARTED|Overall Study||16
8279135|NCT01683565|20413530|P1|STARTED|Overall Study||15
8279136|NCT01683526|20413544|P2|NOT COMPLETED|Overall Study||0
8279137|NCT01683526|20413545|P1|NOT COMPLETED|Overall Study||0
8279138|NCT01683526|20413544|P2|COMPLETED|Overall Study||57
8279139|NCT01683526|20413545|P1|COMPLETED|Overall Study||60
8279140|NCT01683526|20413544|P2|STARTED|Overall Study||57
8279141|NCT01683526|20413545|P1|STARTED|Overall Study||60
8279142|NCT01683409|20413564|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
8279143|NCT01683409|20413565|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8279144|NCT01683409|20413566|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
8279145|NCT01683409|20413567|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8279146|NCT01683409|20413568|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8279147|NCT01683409|20413564|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
8279148|NCT01683409|20413565|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8279149|NCT01683409|20413566|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
8279150|NCT01683409|20413567|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8279151|NCT01683409|20413568|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8279152|NCT01683409|20413564|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
8279153|NCT01683409|20413565|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
8279154|NCT01683409|20413566|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
8279155|NCT01683409|20413567|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
8279156|NCT01683409|20413568|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
8279157|NCT01683409|20413564|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
8279158|NCT01683409|20413565|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
8279159|NCT01683409|20413566|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
8279160|NCT01683409|20413567|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
8279161|NCT01683409|20413568|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
8279162|NCT01683409|20413564|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
8279163|NCT01683409|20413565|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
8279164|NCT01683409|20413566|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
8279165|NCT01683409|20413567|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
8279166|NCT01683409|20413568|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
8279167|NCT01683409|20413564|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
8279168|NCT01683409|20413565|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
8279169|NCT01683409|20413566|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
8279170|NCT01683409|20413567|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
8279171|NCT01683409|20413568|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
8279172|NCT01683409|20413564|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
8279173|NCT01683409|20413565|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
8279174|NCT01683409|20413566|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
8279175|NCT01683409|20413567|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
8279176|NCT01683409|20413568|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
8279177|NCT01683409|20413564|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
8279178|NCT01683409|20413565|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
8279179|NCT01683409|20413566|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
8279180|NCT01683409|20413567|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
8279181|NCT01683409|20413568|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
8279182|NCT01683409|20413564|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
8279183|NCT01683409|20413565|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
8279184|NCT01683409|20413566|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
8279185|NCT01683409|20413567|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
8279186|NCT01683409|20413568|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
8279187|NCT01683409|20413564|P5|STARTED|Treatment Period (Weeks 1-24)||25
8279188|NCT01683409|20413565|P4|STARTED|Treatment Period (Weeks 1-24)||26
8279189|NCT01683409|20413566|P3|STARTED|Treatment Period (Weeks 1-24)||27
8279190|NCT01683409|20413567|P2|STARTED|Treatment Period (Weeks 1-24)||25
8279191|NCT01683409|20413568|P1|STARTED|Treatment Period (Weeks 1-24)||27
8279192|NCT01683383|20413611|P2|NOT COMPLETED|Overall Study||0
8279193|NCT01683383|20413612|P1|NOT COMPLETED|Overall Study||1
8279194|NCT01683383|20413611|P2|COMPLETED|Overall Study||51
8279195|NCT01683383|20413612|P1|COMPLETED|Overall Study||49
8279196|NCT01683383|20413611|P2|Transported and Treated|Overall Study||51
8279197|NCT01683383|20413612|P1|Transported and Treated|Overall Study||49
8279198|NCT01683383|20413611|P2|STARTED|Overall Study||51
8279199|NCT01683383|20413612|P1|STARTED|Overall Study||50
8279200|NCT01683331|20413628|P2|NOT COMPLETED|Overall Study||0
8279201|NCT01683331|20413629|P1|NOT COMPLETED|Overall Study||0
8279202|NCT01683331|20413628|P2|COMPLETED|Overall Study||18
8279203|NCT01683331|20413629|P1|COMPLETED|Overall Study||18
8279204|NCT01683331|20413628|P2|24 Months|Overall Study||18
8279205|NCT01683331|20413629|P1|24 Months|Overall Study||18
8279206|NCT01683331|20413628|P2|12 Months|Overall Study||18
8279207|NCT01683331|20413629|P1|12 Months|Overall Study||18
8279208|NCT01683331|20413628|P2|Began Dosage|Overall Study||18
8279209|NCT01683331|20413629|P1|Began Dosage|Overall Study||18
8279210|NCT01683331|20413628|P2|STARTED|Overall Study||18
8279211|NCT01683331|20413629|P1|STARTED|Overall Study||18
8279212|NCT01683266|20413639|P2|NOT COMPLETED|Overall Study||50
8279213|NCT01683266|20413640|P1|NOT COMPLETED|Overall Study||55
8279214|NCT01683266|20413639|P2|COMPLETED|Overall Study||225
8279215|NCT01683266|20413640|P1|COMPLETED|Overall Study||219
8279216|NCT01683266|20413639|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
8279217|NCT01683266|20413640|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
8279218|NCT01683266|20413639|P2|STARTED|Overall Study||275
8279219|NCT01683266|20413640|P1|STARTED|Overall Study||274
8279220|NCT01683071|20413674|P6|NOT COMPLETED|Part 2||15
8279221|NCT01683071|20413675|P5|NOT COMPLETED|Part 2||17
8279222|NCT01683071|20413676|P4|NOT COMPLETED|Part 2||0
8279223|NCT01683071|20413677|P3|NOT COMPLETED|Part 2||0
8279224|NCT01683071|20413678|P2|NOT COMPLETED|Part 2||0
8279225|NCT01683071|20413679|P1|NOT COMPLETED|Part 2||0
8279226|NCT01683071|20413674|P6|COMPLETED|Part 2||82
8279227|NCT01683071|20413675|P5|COMPLETED|Part 2||82
8279228|NCT01683071|20413676|P4|COMPLETED|Part 2||0
8279229|NCT01683071|20413677|P3|COMPLETED|Part 2||0
8279230|NCT01683071|20413678|P2|COMPLETED|Part 2||0
8279231|NCT01683071|20413679|P1|COMPLETED|Part 2||0
8279232|NCT01683071|20413674|P6|STARTED|Part 2||97
8279233|NCT01683071|20413675|P5|STARTED|Part 2||99
8279234|NCT01683071|20413676|P4|STARTED|Part 2||0
8279235|NCT01683071|20413677|P3|STARTED|Part 2||0
8279236|NCT01683071|20413678|P2|STARTED|Part 2||0
8279237|NCT01683071|20413679|P1|STARTED|Part 2||0
8279238|NCT01683071|20413674|P6|NOT COMPLETED|Part 1||0
8279239|NCT01683071|20413675|P5|NOT COMPLETED|Part 1||0
8279240|NCT01683071|20413676|P4|NOT COMPLETED|Part 1||5
8279241|NCT01683071|20413677|P3|NOT COMPLETED|Part 1||3
8279242|NCT01683071|20413678|P2|NOT COMPLETED|Part 1||4
8279243|NCT01683071|20413679|P1|NOT COMPLETED|Part 1||4
8279244|NCT01683071|20413674|P6|COMPLETED|Part 1||0
8279245|NCT01683071|20413675|P5|COMPLETED|Part 1||0
8279246|NCT01683071|20413676|P4|COMPLETED|Part 1||20
8279247|NCT01683071|20413677|P3|COMPLETED|Part 1||22
8279248|NCT01683071|20413678|P2|COMPLETED|Part 1||22
8279249|NCT01683071|20413679|P1|COMPLETED|Part 1||21
8279250|NCT01683071|20413674|P6|STARTED|Part 1||0
8279251|NCT01683071|20413675|P5|STARTED|Part 1||0
8279252|NCT01683071|20413676|P4|STARTED|Part 1||25
8279253|NCT01683071|20413677|P3|STARTED|Part 1||25
8279254|NCT01683071|20413678|P2|STARTED|Part 1||26
8279255|NCT01683071|20413679|P1|STARTED|Part 1||25
8279256|NCT01683058|20413705|P1|NOT COMPLETED|Overall Study||29
8279257|NCT01683058|20413705|P1|COMPLETED|Overall Study||45
8279258|NCT01683058|20413705|P1|STARTED|Overall Study||74
8279259|NCT01683019|20413736|P3|NOT COMPLETED|Overall Study||4
8279260|NCT01683019|20413737|P2|NOT COMPLETED|Overall Study||1
8279261|NCT01683019|20413738|P1|NOT COMPLETED|Overall Study||2
8279262|NCT01683019|20413736|P3|COMPLETED|Overall Study||15
8279263|NCT01683019|20413737|P2|COMPLETED|Overall Study||14
8279264|NCT01683019|20413738|P1|COMPLETED|Overall Study||16
8279265|NCT01683019|20413736|P3|STARTED|Overall Study||19
8279266|NCT01683019|20413737|P2|STARTED|Overall Study||15
8279267|NCT01683019|20413738|P1|STARTED|Overall Study||18
8279268|NCT01682954|20413748|P2|NOT COMPLETED|Overall Study||5
8279269|NCT01682954|20413749|P1|NOT COMPLETED|Overall Study||5
8279270|NCT01682954|20413748|P2|COMPLETED|Overall Study||33
8279271|NCT01682954|20413749|P1|COMPLETED|Overall Study||35
8279272|NCT01682954|20413748|P2|STARTED|Overall Study||38
8279273|NCT01682954|20413749|P1|STARTED|Overall Study||40
8279274|NCT01682928|20413759|P2|NOT COMPLETED|Overall Study||0
8279275|NCT01682928|20413760|P1|NOT COMPLETED|Overall Study||0
8279276|NCT01682928|20413759|P2|COMPLETED|Overall Study||2
8279277|NCT01682928|20413760|P1|COMPLETED|Overall Study||2
8279278|NCT01682928|20413759|P2|STARTED|Overall Study|2 subjects in this Arm|2
8279279|NCT01682928|20413760|P1|STARTED|Overall Study|2 subjects in this Arm|2
8279280|NCT01682876|20413772|P4|NOT COMPLETED|Overall Study||19
8279281|NCT01682876|20413773|P3|NOT COMPLETED|Overall Study||11
8279282|NCT01682876|20413774|P2|NOT COMPLETED|Overall Study||20
8279283|NCT01682876|20413775|P1|NOT COMPLETED|Overall Study||21
8279284|NCT01682876|20413772|P4|COMPLETED|Overall Study||157
8279285|NCT01682876|20413773|P3|COMPLETED|Overall Study||169
8279286|NCT01682876|20413774|P2|COMPLETED|Overall Study||163
8279287|NCT01682876|20413775|P1|COMPLETED|Overall Study||155
8279288|NCT01682876|20413772|P4|STARTED|Overall Study||176
8279289|NCT01682876|20413773|P3|STARTED|Overall Study||180
8279290|NCT01682876|20413774|P2|STARTED|Overall Study||183
8279291|NCT01682876|20413775|P1|STARTED|Overall Study||176
8279292|NCT01682863|20413821|P3|NOT COMPLETED|Overall Study||24
8279293|NCT01682863|20413822|P2|NOT COMPLETED|Overall Study||17
8279294|NCT01682863|20413823|P1|NOT COMPLETED|Overall Study||27
8279295|NCT01682863|20413821|P3|COMPLETED|Overall Study||183
8279296|NCT01682863|20413822|P2|COMPLETED|Overall Study||187
8279297|NCT01682863|20413823|P1|COMPLETED|Overall Study||177
8279298|NCT01682863|20413821|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
8279299|NCT01682863|20413822|P2|Randomized Set|Overall Study||204
8279300|NCT01682863|20413823|P1|Randomized Set|Overall Study||204
8279301|NCT01682863|20413821|P3|Full Analysis Set (FAS)|Overall Study||206
8279302|NCT01682863|20413822|P2|Full Analysis Set (FAS)|Overall Study||204
8279303|NCT01682863|20413823|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
8279304|NCT01682863|20413821|P3|Safety Set|Overall Study||206
8279305|NCT01682863|20413822|P2|Safety Set|Overall Study||204
8279306|NCT01682863|20413823|P1|Safety Set|Overall Study||204
8279307|NCT01682863|20413821|P3|STARTED|Overall Study||207
8279308|NCT01682863|20413822|P2|STARTED|Overall Study||204
8279309|NCT01682863|20413823|P1|STARTED|Overall Study||204
8279310|NCT01682837|20413852|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
8279311|NCT01682837|20413852|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
8279312|NCT01682837|20413852|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
8279313|NCT01682837|20413852|P1|Received KCl|Fourth Intervention (4 Weeks)||8
8279314|NCT01682837|20413852|P1|Received KCit|Fourth Intervention (4 Weeks)||9
8279315|NCT01682837|20413852|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
8279316|NCT01682837|20413852|P1|STARTED|Fourth Intervention (4 Weeks)||30
8279317|NCT01682837|20413852|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
8279318|NCT01682837|20413852|P1|COMPLETED|Third Intervention (4 Weeks)||30
8279319|NCT01682837|20413852|P1|Received Placebo|Third Intervention (4 Weeks)||7
8279320|NCT01682837|20413852|P1|Received KCl|Third Intervention (4 Weeks)||7
8279321|NCT01682837|20413852|P1|Received KCit|Third Intervention (4 Weeks)||7
8279322|NCT01682837|20413852|P1|Received KMgCit|Third Intervention (4 Weeks)||9
8279323|NCT01682837|20413852|P1|STARTED|Third Intervention (4 Weeks)||30
8279324|NCT01682837|20413852|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8279325|NCT01682837|20413852|P1|COMPLETED|Second Intervention (4 Weeks)||30
8279326|NCT01682837|20413852|P1|Received Placebo|Second Intervention (4 Weeks)||9
8279327|NCT01682837|20413852|P1|Received KCl|Second Intervention (4 Weeks)||8
8279328|NCT01682837|20413852|P1|Received KCit|Second Intervention (4 Weeks)||6
8279329|NCT01682837|20413852|P1|Received KMgCit|Second Intervention (4 Weeks)||7
8279330|NCT01682837|20413852|P1|STARTED|Second Intervention (4 Weeks)||30
8279331|NCT01682837|20413852|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8279332|NCT01682837|20413852|P1|COMPLETED|First Intervention (4 Weeks)||30
8279333|NCT01682837|20413852|P1|Received Placebo|First Intervention (4 Weeks)||7
8279334|NCT01682837|20413852|P1|Received KCl|First Intervention (4 Weeks)||7
8279335|NCT01682837|20413852|P1|Received KCit|First Intervention (4 Weeks)||8
8279336|NCT01682837|20413852|P1|Received KMgCit|First Intervention (4 Weeks)||8
8279337|NCT01682837|20413852|P1|STARTED|First Intervention (4 Weeks)||30
8279338|NCT01682837|20413852|P1|NOT COMPLETED|Baseline||5
8279339|NCT01682837|20413852|P1|COMPLETED|Baseline||30
8279340|NCT01682837|20413852|P1|STARTED|Baseline||35
8279341|NCT01682759|20413896|P2|NOT COMPLETED|Overall Study||70
8279342|NCT01682759|20413897|P1|NOT COMPLETED|Overall Study||69
8279343|NCT01682759|20413896|P2|COMPLETED|Overall Study||305
8279344|NCT01682759|20413897|P1|COMPLETED|Overall Study||307
8279345|NCT01682759|20413896|P2|Treated|Overall Study||375
8279346|NCT01682759|20413897|P1|Treated|Overall Study||375
8279347|NCT01682759|20413896|P2|STARTED|Overall Study||375
8279348|NCT01682759|20413897|P1|STARTED|Overall Study||376
8279349|NCT01682720|20413921|P4|NOT COMPLETED|Overall Study||39
8279350|NCT01682720|20413922|P3|NOT COMPLETED|Overall Study||7
8279351|NCT01682720|20413923|P2|NOT COMPLETED|Overall Study||5
8279352|NCT01682720|20413924|P1|NOT COMPLETED|Overall Study||85
8279353|NCT01682720|20413921|P4|COMPLETED|Overall Study||211
8279354|NCT01682720|20413922|P3|COMPLETED|Overall Study||5
8279355|NCT01682720|20413923|P2|COMPLETED|Overall Study||69
8279356|NCT01682720|20413924|P1|COMPLETED|Overall Study||0
8279357|NCT01682720|20413921|P4|Included in Full Analysis Set|Overall Study||250
8279358|NCT01682720|20413922|P3|Included in Full Analysis Set|Overall Study||11
8279359|NCT01682720|20413923|P2|Included in Full Analysis Set|Overall Study||73
8279360|NCT01682720|20413924|P1|Included in Full Analysis Set|Overall Study||0
8279361|NCT01682720|20413921|P4|STARTED|Overall Study||250
8279362|NCT01682720|20413922|P3|STARTED|Overall Study||12
8279363|NCT01682720|20413923|P2|STARTED|Overall Study||74
8279364|NCT01682720|20413924|P1|STARTED|Overall Study||85
8279365|NCT01682681|20413941|P1|NOT COMPLETED|Overall Study||332
8279366|NCT01682681|20413941|P1|COMPLETED|Overall Study||902
8279367|NCT01682681|20413941|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
8279368|NCT01682681|20413941|P1|STARTED|Overall Study||1234
8279369|NCT01682642|20413951|P2|NOT COMPLETED|Overall Study||1
8279370|NCT01682642|20413952|P1|NOT COMPLETED|Overall Study||0
8279371|NCT01682642|20413951|P2|COMPLETED|Overall Study||58
8279372|NCT01682642|20413952|P1|COMPLETED|Overall Study||61
8279373|NCT01682642|20413951|P2|STARTED|Overall Study||59
8279374|NCT01682642|20413952|P1|STARTED|Overall Study||61
8279375|NCT01682603|20413970|P1|NOT COMPLETED|Overall Study||3
8279376|NCT01682603|20413970|P1|COMPLETED|Overall Study||34
8279377|NCT01682603|20413970|P1|STARTED|Overall Study||37
8279378|NCT01682538|20413984|P1|NOT COMPLETED|Overall Study||0
8279379|NCT01682538|20413984|P1|COMPLETED|Overall Study||12
8279380|NCT01682538|20413984|P1|STARTED|Overall Study||12
8279381|NCT01682512|20414015|P3|NOT COMPLETED|Overall Study||18
8279382|NCT01682512|20414016|P2|NOT COMPLETED|Overall Study||71
8279383|NCT01682512|20414017|P1|NOT COMPLETED|Overall Study||72
8279384|NCT01682512|20414015|P3|COMPLETED|Overall Study||48
8279385|NCT01682512|20414016|P2|COMPLETED|Overall Study||40
8279386|NCT01682512|20414017|P1|COMPLETED|Overall Study||44
8279387|NCT01682512|20414015|P3|Randomized in Part-II|Overall Study||0
8279388|NCT01682512|20414016|P2|Randomized in Part-II|Overall Study||46
8279389|NCT01682512|20414017|P1|Randomized in Part-II|Overall Study||50
8279390|NCT01682512|20414015|P3|Randomized in Part-I|Overall Study||66
8279391|NCT01682512|20414016|P2|Randomized in Part-I|Overall Study||65
8279392|NCT01682512|20414017|P1|Randomized in Part-I|Overall Study||66
8279393|NCT01682512|20414015|P3|STARTED|Overall Study||66
8279394|NCT01682512|20414016|P2|STARTED|Overall Study||111
8279395|NCT01682512|20414017|P1|STARTED|Overall Study||116
8279396|NCT01682460|20414042|P1|NOT COMPLETED|Overall Study||4
8279397|NCT01682460|20414042|P1|COMPLETED|Overall Study||11
8279398|NCT01682460|20414042|P1|STARTED|Overall Study||15
8279399|NCT01682213|20414057|P1|NOT COMPLETED|Overall Study||2
8279400|NCT01682213|20414057|P1|COMPLETED|Overall Study||21
8279401|NCT01682213|20414057|P1|STARTED|Overall Study||23
8279402|NCT01682148|20414065|P2|NOT COMPLETED|Overall Study||3
8279403|NCT01682148|20414066|P1|NOT COMPLETED|Overall Study||4
8279404|NCT01682148|20414065|P2|COMPLETED|Overall Study||41
8279405|NCT01682148|20414066|P1|COMPLETED|Overall Study||40
8279406|NCT01682148|20414065|P2|STARTED|Overall Study||44
8279407|NCT01682148|20414066|P1|STARTED|Overall Study||44
8279408|NCT01682135|20414090|P3|NOT COMPLETED|Overall Study||0
8279409|NCT01682135|20414091|P2|NOT COMPLETED|Overall Study||0
8279410|NCT01682135|20414092|P1|NOT COMPLETED|Overall Study||0
8279411|NCT01682135|20414090|P3|COMPLETED|Overall Study||12
8279412|NCT01682135|20414091|P2|COMPLETED|Overall Study||10
8279413|NCT01682135|20414092|P1|COMPLETED|Overall Study||6
8279414|NCT01682135|20414090|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
8279415|NCT01682135|20414091|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8279416|NCT01682135|20414092|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8279417|NCT01682135|20414090|P3|STARTED|Overall Study||12
8279418|NCT01682135|20414091|P2|STARTED|Overall Study||10
8279419|NCT01682135|20414092|P1|STARTED|Overall Study||6
8279420|NCT01682083|20414126|P2|NOT COMPLETED|Overall Study||155
8279421|NCT01682083|20414127|P1|NOT COMPLETED|Overall Study||107
8279422|NCT01682083|20414126|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
8279423|NCT01682083|20414127|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
8279424|NCT01682083|20414126|P2|STARTED|Overall Study||432
8279425|NCT01682083|20414127|P1|STARTED|Overall Study||438
8279426|NCT01682044|20414139|P1|NOT COMPLETED|Overall Study||4
8279427|NCT01682044|20414139|P1|COMPLETED|Overall Study||16
8279428|NCT01682044|20414139|P1|STARTED|Overall Study||20
8279429|NCT01682031|20414151|P2|NOT COMPLETED|Overall Study||5
8279430|NCT01682031|20414152|P1|NOT COMPLETED|Overall Study||1
8279431|NCT01682031|20414151|P2|COMPLETED|Overall Study||5
8279432|NCT01682031|20414152|P1|COMPLETED|Overall Study||7
8279433|NCT01682031|20414151|P2|STARTED|Overall Study||10
8279434|NCT01682031|20414152|P1|STARTED|Overall Study||8
8279435|NCT01681992|20414175|P3|NOT COMPLETED|Overall Study||83
8279436|NCT01681992|20414176|P2|NOT COMPLETED|Overall Study||70
8279437|NCT01681992|20414177|P1|NOT COMPLETED|Overall Study||66
8279438|NCT01681992|20414175|P3|COMPLETED|Overall Study||1443
8279439|NCT01681992|20414176|P2|COMPLETED|Overall Study||1427
8279440|NCT01681992|20414177|P1|COMPLETED|Overall Study||1427
8279441|NCT01681992|20414175|P3|STARTED|Overall Study||1526
8279442|NCT01681992|20414176|P2|STARTED|Overall Study||1497
8279443|NCT01681992|20414177|P1|STARTED|Overall Study||1493
8279444|NCT01681849|20414266|P3|NOT COMPLETED|Overall Study||39
8279445|NCT01681849|20414267|P2|NOT COMPLETED|Overall Study||7
8279446|NCT01681849|20414268|P1|NOT COMPLETED|Overall Study||8
8279447|NCT01681849|20414266|P3|COMPLETED|Overall Study||17
8279448|NCT01681849|20414267|P2|COMPLETED|Overall Study||6
8279449|NCT01681849|20414268|P1|COMPLETED|Overall Study||7
8279450|NCT01681849|20414266|P3|STARTED|Overall Study||56
8279451|NCT01681849|20414267|P2|STARTED|Overall Study||13
8279452|NCT01681849|20414268|P1|STARTED|Overall Study||15
8279453|NCT01681836|20414277|P2|NOT COMPLETED|Second Intervention||1
8279454|NCT01681836|20414278|P1|NOT COMPLETED|Second Intervention||0
8279455|NCT01681836|20414277|P2|COMPLETED|Second Intervention||4
8279456|NCT01681836|20414278|P1|COMPLETED|Second Intervention||6
8279457|NCT01681836|20414277|P2|STARTED|Second Intervention||5
8279458|NCT01681836|20414278|P1|STARTED|Second Intervention||6
8279459|NCT01681836|20414277|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
8279460|NCT01681836|20414278|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
8279461|NCT01681836|20414277|P2|COMPLETED|Washout Period of 3-7 Days||5
8279462|NCT01681836|20414278|P1|COMPLETED|Washout Period of 3-7 Days||6
8279463|NCT01681836|20414277|P2|STARTED|Washout Period of 3-7 Days||5
8279464|NCT01681836|20414278|P1|STARTED|Washout Period of 3-7 Days||6
8279465|NCT01681836|20414277|P2|NOT COMPLETED|First Intervention||0
8279466|NCT01681836|20414278|P1|NOT COMPLETED|First Intervention||0
8279467|NCT01681836|20414277|P2|COMPLETED|First Intervention||5
8279468|NCT01681836|20414278|P1|COMPLETED|First Intervention||6
8279469|NCT01681836|20414277|P2|STARTED|First Intervention||5
8279470|NCT01681836|20414278|P1|STARTED|First Intervention||6
8279471|NCT01681810|20414302|P1|NOT COMPLETED|Overall Study||0
8279472|NCT01681810|20414302|P1|COMPLETED|Overall Study||20
8279473|NCT01681810|20414302|P1|STARTED|Overall Study||20
8279474|NCT01681771|20414312|P2|NOT COMPLETED|Overall Study||2
8279475|NCT01681771|20414313|P1|NOT COMPLETED|Overall Study||4
8279476|NCT01681771|20414312|P2|COMPLETED|Overall Study||23
8279477|NCT01681771|20414313|P1|COMPLETED|Overall Study||21
8279478|NCT01681771|20414312|P2|STARTED|Overall Study||25
8279479|NCT01681771|20414313|P1|STARTED|Overall Study||25
8279480|NCT01681628|20414321|P2|NOT COMPLETED|19 Months Follow-up||43
8279481|NCT01681628|20414322|P1|NOT COMPLETED|19 Months Follow-up||62
8279482|NCT01681628|20414321|P2|COMPLETED|19 Months Follow-up||64
8279483|NCT01681628|20414322|P1|COMPLETED|19 Months Follow-up||52
8279484|NCT01681628|20414321|P2|STARTED|19 Months Follow-up||107
8279485|NCT01681628|20414322|P1|STARTED|19 Months Follow-up||114
8279486|NCT01681628|20414321|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
8279487|NCT01681628|20414322|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
8279488|NCT01681628|20414321|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
8279489|NCT01681628|20414322|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
8279490|NCT01681628|20414321|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
8279491|NCT01681628|20414322|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
8279492|NCT01681628|20414321|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
8279493|NCT01681628|20414322|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
8279494|NCT01681628|20414321|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
8279495|NCT01681628|20414322|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
8279496|NCT01681628|20414321|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
8279497|NCT01681628|20414322|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
8279498|NCT01681589|20414336|P3|NOT COMPLETED|Overall Study||0
8279499|NCT01681589|20414337|P2|NOT COMPLETED|Overall Study||0
8279500|NCT01681589|20414338|P1|NOT COMPLETED|Overall Study||0
8279501|NCT01681589|20414336|P3|COMPLETED|Overall Study||0
8279502|NCT01681589|20414337|P2|COMPLETED|Overall Study||0
8279503|NCT01681589|20414338|P1|COMPLETED|Overall Study||0
8279504|NCT01681589|20414336|P3|STARTED|Overall Study||0
8279505|NCT01681589|20414337|P2|STARTED|Overall Study||0
8279506|NCT01681589|20414338|P1|STARTED|Overall Study||0
8279507|NCT01681576|20414351|P2|NOT COMPLETED|Period 2||1
8279508|NCT01681576|20414352|P1|NOT COMPLETED|Period 2||4
8279509|NCT01681576|20414351|P2|COMPLETED|Period 2||35
8279510|NCT01681576|20414352|P1|COMPLETED|Period 2||30
8279511|NCT01681576|20414351|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
8279512|NCT01681576|20414352|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
8279513|NCT01681576|20414351|P2|NOT COMPLETED|Period 1||0
8279514|NCT01681576|20414352|P1|NOT COMPLETED|Period 1||2
8279515|NCT01681576|20414351|P2|COMPLETED|Period 1||36
8279516|NCT01681576|20414352|P1|COMPLETED|Period 1||34
8279517|NCT01681576|20414351|P2|STARTED|Period 1||36
8279518|NCT01681576|20414352|P1|STARTED|Period 1||36
8279519|NCT01681511|20414368|P2|NOT COMPLETED|Overall Study||14
8279520|NCT01681511|20414369|P1|NOT COMPLETED|Overall Study||18
8279521|NCT01681511|20414368|P2|COMPLETED|Overall Study||35
8279522|NCT01681511|20414369|P1|COMPLETED|Overall Study||28
8279523|NCT01681511|20414368|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
8279524|NCT01681511|20414369|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
8279525|NCT01681511|20414368|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
8279526|NCT01681511|20414369|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
8279527|NCT01681511|20414368|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
8279528|NCT01681511|20414369|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
8279529|NCT01681472|20414387|P4|NOT COMPLETED|Overall Study||0
8279530|NCT01681472|20414388|P3|NOT COMPLETED|Overall Study||0
8279531|NCT01681472|20414389|P2|NOT COMPLETED|Overall Study||1
8279532|NCT01681472|20414390|P1|NOT COMPLETED|Overall Study||0
8279533|NCT01681472|20414387|P4|COMPLETED|Overall Study||8
8279534|NCT01681472|20414388|P3|COMPLETED|Overall Study||8
8279535|NCT01681472|20414389|P2|COMPLETED|Overall Study||7
8279536|NCT01681472|20414390|P1|COMPLETED|Overall Study||8
8279537|NCT01681472|20414387|P4|STARTED|Overall Study||8
8279538|NCT01681472|20414388|P3|STARTED|Overall Study||8
8279539|NCT01681472|20414389|P2|STARTED|Overall Study||8
8279540|NCT01681472|20414390|P1|STARTED|Overall Study||8
8279541|NCT01681433|20414570|P2|NOT COMPLETED|Overall Study||33
8279542|NCT01681433|20414571|P1|NOT COMPLETED|Overall Study||32
8279543|NCT01681433|20414570|P2|COMPLETED|Overall Study||3
8279544|NCT01681433|20414571|P1|COMPLETED|Overall Study||4
8279545|NCT01681433|20414570|P2|STARTED|Overall Study||36
8279546|NCT01681433|20414571|P1|STARTED|Overall Study||36
8279547|NCT01681368|20414589|P1|NOT COMPLETED|Overall Study||2
8279548|NCT01681368|20414589|P1|COMPLETED|Overall Study||9
8279549|NCT01681368|20414589|P1|STARTED|Overall Study||11
8279550|NCT01681277|20414606|P5|NOT COMPLETED|Overall Study||0
8279551|NCT01681277|20414607|P4|NOT COMPLETED|Overall Study||0
8279552|NCT01681277|20414608|P3|NOT COMPLETED|Overall Study||0
8279553|NCT01681277|20414609|P2|NOT COMPLETED|Overall Study||0
8279554|NCT01681277|20414610|P1|NOT COMPLETED|Overall Study||1
8279555|NCT01681277|20414606|P5|COMPLETED|Overall Study||9
8279556|NCT01681277|20414607|P4|COMPLETED|Overall Study||9
8279557|NCT01681277|20414608|P3|COMPLETED|Overall Study||9
8279558|NCT01681277|20414609|P2|COMPLETED|Overall Study||9
8279559|NCT01681277|20414610|P1|COMPLETED|Overall Study||11
8279560|NCT01681277|20414606|P5|STARTED|Overall Study||9
8279561|NCT01681277|20414607|P4|STARTED|Overall Study||9
8279562|NCT01681277|20414608|P3|STARTED|Overall Study||9
8279563|NCT01681277|20414609|P2|STARTED|Overall Study||9
8279564|NCT01681277|20414610|P1|STARTED|Overall Study||12
8279565|NCT01681212|20414651|P1|NOT COMPLETED|Overall Study||6
8279566|NCT01681212|20414651|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
8279567|NCT01681212|20414651|P1|Received Treatment|Overall Study||15
8279568|NCT01681212|20414651|P1|STARTED|Overall Study|Enrolled|21
8279569|NCT01681186|20414665|P8|NOT COMPLETED|Fourth Intervention||1
8279570|NCT01681186|20414666|P7|NOT COMPLETED|Fourth Intervention||0
8279571|NCT01681186|20414667|P6|NOT COMPLETED|Fourth Intervention||0
8279572|NCT01681186|20414668|P5|NOT COMPLETED|Fourth Intervention||0
8279573|NCT01681186|20414669|P4|NOT COMPLETED|Fourth Intervention||0
8279574|NCT01681186|20414670|P3|NOT COMPLETED|Fourth Intervention||0
8279575|NCT01681186|20414671|P2|NOT COMPLETED|Fourth Intervention||0
8279576|NCT01681186|20414672|P1|NOT COMPLETED|Fourth Intervention||0
8279577|NCT01681186|20414665|P8|COMPLETED|Fourth Intervention||5
8279578|NCT01681186|20414666|P7|COMPLETED|Fourth Intervention||5
8279579|NCT01681186|20414667|P6|COMPLETED|Fourth Intervention||0
8279580|NCT01681186|20414668|P5|COMPLETED|Fourth Intervention||0
8279581|NCT01681186|20414669|P4|COMPLETED|Fourth Intervention||0
8279582|NCT01681186|20414670|P3|COMPLETED|Fourth Intervention||0
8279583|NCT01681186|20414671|P2|COMPLETED|Fourth Intervention||0
8279584|NCT01681186|20414672|P1|COMPLETED|Fourth Intervention||0
8279585|NCT01681186|20414665|P8|STARTED|Fourth Intervention||6
8279586|NCT01681186|20414666|P7|STARTED|Fourth Intervention||5
8279587|NCT01681186|20414667|P6|STARTED|Fourth Intervention||0
8279588|NCT01681186|20414668|P5|STARTED|Fourth Intervention||0
8279589|NCT01681186|20414669|P4|STARTED|Fourth Intervention||0
8279590|NCT01681186|20414670|P3|STARTED|Fourth Intervention||0
8279591|NCT01681186|20414671|P2|STARTED|Fourth Intervention||0
8279592|NCT01681186|20414672|P1|STARTED|Fourth Intervention||0
8279593|NCT01681186|20414665|P8|NOT COMPLETED|Washout Period From Third Intervention||0
8279594|NCT01681186|20414666|P7|NOT COMPLETED|Washout Period From Third Intervention||1
8279595|NCT01681186|20414667|P6|NOT COMPLETED|Washout Period From Third Intervention||0
8279596|NCT01681186|20414668|P5|NOT COMPLETED|Washout Period From Third Intervention||0
8279597|NCT01681186|20414669|P4|NOT COMPLETED|Washout Period From Third Intervention||0
8279598|NCT01681186|20414670|P3|NOT COMPLETED|Washout Period From Third Intervention||0
8279599|NCT01681186|20414671|P2|NOT COMPLETED|Washout Period From Third Intervention||0
8279600|NCT01681186|20414672|P1|NOT COMPLETED|Washout Period From Third Intervention||0
8279601|NCT01681186|20414665|P8|COMPLETED|Washout Period From Third Intervention||6
8279602|NCT01681186|20414666|P7|COMPLETED|Washout Period From Third Intervention||5
8279603|NCT01681186|20414667|P6|COMPLETED|Washout Period From Third Intervention||0
8279604|NCT01681186|20414668|P5|COMPLETED|Washout Period From Third Intervention||0
8279605|NCT01681186|20414669|P4|COMPLETED|Washout Period From Third Intervention||0
8279606|NCT01681186|20414670|P3|COMPLETED|Washout Period From Third Intervention||0
8279607|NCT01681186|20414671|P2|COMPLETED|Washout Period From Third Intervention||0
8279608|NCT01681186|20414672|P1|COMPLETED|Washout Period From Third Intervention||0
8279609|NCT01681186|20414665|P8|STARTED|Washout Period From Third Intervention||6
8279610|NCT01681186|20414666|P7|STARTED|Washout Period From Third Intervention||6
8279611|NCT01681186|20414667|P6|STARTED|Washout Period From Third Intervention||0
8279612|NCT01681186|20414668|P5|STARTED|Washout Period From Third Intervention||0
8279613|NCT01681186|20414669|P4|STARTED|Washout Period From Third Intervention||0
8279614|NCT01681186|20414670|P3|STARTED|Washout Period From Third Intervention||0
8279615|NCT01681186|20414671|P2|STARTED|Washout Period From Third Intervention||0
8279616|NCT01681186|20414672|P1|STARTED|Washout Period From Third Intervention||0
8279617|NCT01681186|20414665|P8|NOT COMPLETED|Third Intervention||0
8279618|NCT01681186|20414666|P7|NOT COMPLETED|Third Intervention||0
8279619|NCT01681186|20414667|P6|NOT COMPLETED|Third Intervention||0
8279620|NCT01681186|20414668|P5|NOT COMPLETED|Third Intervention||0
8279621|NCT01681186|20414669|P4|NOT COMPLETED|Third Intervention||0
8279622|NCT01681186|20414670|P3|NOT COMPLETED|Third Intervention||0
8279623|NCT01681186|20414671|P2|NOT COMPLETED|Third Intervention||0
8279624|NCT01681186|20414672|P1|NOT COMPLETED|Third Intervention||0
8279625|NCT01681186|20414665|P8|COMPLETED|Third Intervention||6
8279626|NCT01681186|20414666|P7|COMPLETED|Third Intervention||6
8279627|NCT01681186|20414667|P6|COMPLETED|Third Intervention||0
8279628|NCT01681186|20414668|P5|COMPLETED|Third Intervention||0
8279629|NCT01681186|20414669|P4|COMPLETED|Third Intervention||0
8279630|NCT01681186|20414670|P3|COMPLETED|Third Intervention||0
8279631|NCT01681186|20414671|P2|COMPLETED|Third Intervention||0
8279632|NCT01681186|20414672|P1|COMPLETED|Third Intervention||0
8279633|NCT01681186|20414665|P8|STARTED|Third Intervention||6
8279634|NCT01681186|20414666|P7|STARTED|Third Intervention||6
8279635|NCT01681186|20414667|P6|STARTED|Third Intervention||0
8279636|NCT01681186|20414668|P5|STARTED|Third Intervention||0
8279637|NCT01681186|20414669|P4|STARTED|Third Intervention||0
8279638|NCT01681186|20414670|P3|STARTED|Third Intervention||0
8279639|NCT01681186|20414671|P2|STARTED|Third Intervention||0
8279640|NCT01681186|20414672|P1|STARTED|Third Intervention||0
8279641|NCT01681186|20414665|P8|NOT COMPLETED|Washout Period From Second Intervention||1
8279642|NCT01681186|20414666|P7|NOT COMPLETED|Washout Period From Second Intervention||1
8279643|NCT01681186|20414667|P6|NOT COMPLETED|Washout Period From Second Intervention||0
8279644|NCT01681186|20414668|P5|NOT COMPLETED|Washout Period From Second Intervention||0
8279645|NCT01681186|20414669|P4|NOT COMPLETED|Washout Period From Second Intervention||0
8279646|NCT01681186|20414670|P3|NOT COMPLETED|Washout Period From Second Intervention||0
8279647|NCT01681186|20414671|P2|NOT COMPLETED|Washout Period From Second Intervention||0
8279648|NCT01681186|20414672|P1|NOT COMPLETED|Washout Period From Second Intervention||0
8279649|NCT01681186|20414665|P8|COMPLETED|Washout Period From Second Intervention||6
8279650|NCT01681186|20414666|P7|COMPLETED|Washout Period From Second Intervention||6
8279651|NCT01681186|20414667|P6|COMPLETED|Washout Period From Second Intervention||0
8279652|NCT01681186|20414668|P5|COMPLETED|Washout Period From Second Intervention||0
8279653|NCT01681186|20414669|P4|COMPLETED|Washout Period From Second Intervention||0
8279654|NCT01681186|20414670|P3|COMPLETED|Washout Period From Second Intervention||0
8279655|NCT01681186|20414671|P2|COMPLETED|Washout Period From Second Intervention||0
8279656|NCT01681186|20414672|P1|COMPLETED|Washout Period From Second Intervention||0
8279657|NCT01681186|20414665|P8|STARTED|Washout Period From Second Intervention||7
8279658|NCT01681186|20414666|P7|STARTED|Washout Period From Second Intervention||7
8279659|NCT01681186|20414667|P6|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279660|NCT01681186|20414668|P5|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279661|NCT01681186|20414669|P4|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279662|NCT01681186|20414670|P3|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279663|NCT01681186|20414671|P2|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279664|NCT01681186|20414672|P1|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279665|NCT01681186|20414665|P8|NOT COMPLETED|Second Intervention||0
8279666|NCT01681186|20414666|P7|NOT COMPLETED|Second Intervention||0
8279667|NCT01681186|20414667|P6|NOT COMPLETED|Second Intervention||0
8279668|NCT01681186|20414668|P5|NOT COMPLETED|Second Intervention||0
8279669|NCT01681186|20414669|P4|NOT COMPLETED|Second Intervention||0
8279670|NCT01681186|20414670|P3|NOT COMPLETED|Second Intervention||0
8279671|NCT01681186|20414671|P2|NOT COMPLETED|Second Intervention||0
8279672|NCT01681186|20414672|P1|NOT COMPLETED|Second Intervention||0
8279673|NCT01681186|20414665|P8|COMPLETED|Second Intervention||7
8279674|NCT01681186|20414666|P7|COMPLETED|Second Intervention||7
8279675|NCT01681186|20414667|P6|COMPLETED|Second Intervention||2
8279676|NCT01681186|20414668|P5|COMPLETED|Second Intervention||3
8279677|NCT01681186|20414669|P4|COMPLETED|Second Intervention||3
8279678|NCT01681186|20414670|P3|COMPLETED|Second Intervention||2
8279679|NCT01681186|20414671|P2|COMPLETED|Second Intervention||2
8279680|NCT01681186|20414672|P1|COMPLETED|Second Intervention||4
8279681|NCT01681186|20414665|P8|STARTED|Second Intervention||7
8279682|NCT01681186|20414666|P7|STARTED|Second Intervention||7
8279683|NCT01681186|20414667|P6|STARTED|Second Intervention||2
8279684|NCT01681186|20414668|P5|STARTED|Second Intervention||3
8279685|NCT01681186|20414669|P4|STARTED|Second Intervention||3
8279686|NCT01681186|20414670|P3|STARTED|Second Intervention||2
8279687|NCT01681186|20414671|P2|STARTED|Second Intervention||2
8279688|NCT01681186|20414672|P1|STARTED|Second Intervention||4
8279689|NCT01681186|20414665|P8|NOT COMPLETED|Washout Period From First Intervention||0
8279690|NCT01681186|20414666|P7|NOT COMPLETED|Washout Period From First Intervention||0
8279691|NCT01681186|20414667|P6|NOT COMPLETED|Washout Period From First Intervention||0
8279692|NCT01681186|20414668|P5|NOT COMPLETED|Washout Period From First Intervention||0
8279693|NCT01681186|20414669|P4|NOT COMPLETED|Washout Period From First Intervention||0
8279694|NCT01681186|20414670|P3|NOT COMPLETED|Washout Period From First Intervention||0
8279695|NCT01681186|20414671|P2|NOT COMPLETED|Washout Period From First Intervention||0
8279696|NCT01681186|20414672|P1|NOT COMPLETED|Washout Period From First Intervention||0
8279697|NCT01681186|20414665|P8|COMPLETED|Washout Period From First Intervention||7
8279698|NCT01681186|20414666|P7|COMPLETED|Washout Period From First Intervention||7
8279699|NCT01681186|20414667|P6|COMPLETED|Washout Period From First Intervention||2
8279700|NCT01681186|20414668|P5|COMPLETED|Washout Period From First Intervention||3
8279701|NCT01681186|20414669|P4|COMPLETED|Washout Period From First Intervention||3
8279702|NCT01681186|20414670|P3|COMPLETED|Washout Period From First Intervention||2
8279703|NCT01681186|20414671|P2|COMPLETED|Washout Period From First Intervention||2
8279704|NCT01681186|20414672|P1|COMPLETED|Washout Period From First Intervention||4
8279705|NCT01681186|20414665|P8|STARTED|Washout Period From First Intervention||7
8279706|NCT01681186|20414666|P7|STARTED|Washout Period From First Intervention||7
8279707|NCT01681186|20414667|P6|STARTED|Washout Period From First Intervention||2
8279708|NCT01681186|20414668|P5|STARTED|Washout Period From First Intervention||3
8279709|NCT01681186|20414669|P4|STARTED|Washout Period From First Intervention||3
8279710|NCT01681186|20414670|P3|STARTED|Washout Period From First Intervention||2
8279711|NCT01681186|20414671|P2|STARTED|Washout Period From First Intervention||2
8279712|NCT01681186|20414672|P1|STARTED|Washout Period From First Intervention||4
8279713|NCT01681186|20414665|P8|NOT COMPLETED|First Intervention||0
8279714|NCT01681186|20414666|P7|NOT COMPLETED|First Intervention||0
8279715|NCT01681186|20414667|P6|NOT COMPLETED|First Intervention||0
8279716|NCT01681186|20414668|P5|NOT COMPLETED|First Intervention||0
8279717|NCT01681186|20414669|P4|NOT COMPLETED|First Intervention||0
8279718|NCT01681186|20414670|P3|NOT COMPLETED|First Intervention||0
8279719|NCT01681186|20414671|P2|NOT COMPLETED|First Intervention||0
8279720|NCT01681186|20414672|P1|NOT COMPLETED|First Intervention||0
8279721|NCT01681186|20414665|P8|COMPLETED|First Intervention||7
8279722|NCT01681186|20414666|P7|COMPLETED|First Intervention||7
8279723|NCT01681186|20414667|P6|COMPLETED|First Intervention||2
8279724|NCT01681186|20414668|P5|COMPLETED|First Intervention||3
8279725|NCT01681186|20414669|P4|COMPLETED|First Intervention||3
8279726|NCT01681186|20414670|P3|COMPLETED|First Intervention||2
8279727|NCT01681186|20414671|P2|COMPLETED|First Intervention||2
8279728|NCT01681186|20414672|P1|COMPLETED|First Intervention||4
8279729|NCT01681186|20414665|P8|STARTED|First Intervention||7
8279730|NCT01681186|20414666|P7|STARTED|First Intervention||7
8279731|NCT01681186|20414667|P6|STARTED|First Intervention||2
8279732|NCT01681186|20414668|P5|STARTED|First Intervention||3
8279733|NCT01681186|20414669|P4|STARTED|First Intervention||3
8279734|NCT01681186|20414670|P3|STARTED|First Intervention||2
8279735|NCT01681186|20414671|P2|STARTED|First Intervention||2
8279736|NCT01681186|20414672|P1|STARTED|First Intervention||4
8279737|NCT01681121|20414725|P2|NOT COMPLETED|Overall Study||11
8279738|NCT01681121|20414726|P1|NOT COMPLETED|Overall Study||8
8279739|NCT01681121|20414725|P2|COMPLETED|Overall Study||38
8279740|NCT01681121|20414726|P1|COMPLETED|Overall Study||36
8279741|NCT01681121|20414725|P2|STARTED|Overall Study||49
8279742|NCT01681121|20414726|P1|STARTED|Overall Study||44
8279743|NCT01681095|20414734|P2|NOT COMPLETED|Overall Study||0
8279744|NCT01681095|20414735|P1|NOT COMPLETED|Overall Study||0
8279745|NCT01681095|20414734|P2|COMPLETED|Overall Study||55
8279746|NCT01681095|20414735|P1|COMPLETED|Overall Study||55
8279747|NCT01681095|20414734|P2|STARTED|Overall Study||55
8279748|NCT01681095|20414735|P1|STARTED|Overall Study||55
8279749|NCT01681069|20414775|P2|NOT COMPLETED|Overall Study||7
8279750|NCT01681069|20414776|P1|NOT COMPLETED|Overall Study||5
8279751|NCT01681069|20414775|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
8279752|NCT01681069|20414776|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
8279753|NCT01681069|20414775|P2|Full Analysis Set (FAS)|Overall Study||60
8279754|NCT01681069|20414776|P1|Full Analysis Set (FAS)|Overall Study||57
8279755|NCT01681069|20414775|P2|STARTED|Overall Study||60
8279756|NCT01681069|20414776|P1|STARTED|Overall Study||60
8279757|NCT01681030|20414789|P3|NOT COMPLETED|Overall Study||0
8279758|NCT01681030|20414790|P2|NOT COMPLETED|Overall Study||0
8279759|NCT01681030|20414791|P1|NOT COMPLETED|Overall Study||0
8279760|NCT01681030|20414789|P3|COMPLETED|Overall Study||11
8279761|NCT01681030|20414790|P2|COMPLETED|Overall Study||18
8279762|NCT01681030|20414791|P1|COMPLETED|Overall Study||13
8279763|NCT01681030|20414789|P3|STARTED|Overall Study||11
8279764|NCT01681030|20414790|P2|STARTED|Overall Study||18
8279765|NCT01681030|20414791|P1|STARTED|Overall Study||13
8279766|NCT01681004|20414813|P2|NOT COMPLETED|Study Completion||8
8279767|NCT01681004|20414814|P1|NOT COMPLETED|Study Completion||12
8279768|NCT01681004|20414813|P2|COMPLETED|Study Completion||36
8279769|NCT01681004|20414814|P1|COMPLETED|Study Completion||89
8279770|NCT01681004|20414813|P2|STARTED|Study Completion||44
8279771|NCT01681004|20414814|P1|STARTED|Study Completion||101
8279772|NCT01681004|20414813|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
8279773|NCT01681004|20414814|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
8279774|NCT01681004|20414813|P2|COMPLETED|Primary Endpoint: 6 Months||44
8279775|NCT01681004|20414814|P1|COMPLETED|Primary Endpoint: 6 Months||101
8279776|NCT01681004|20414813|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
8279777|NCT01681004|20414814|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
8279778|NCT01681004|20414813|P2|STARTED|Primary Endpoint: 6 Months||46
8279779|NCT01681004|20414814|P1|STARTED|Primary Endpoint: 6 Months||102
8279780|NCT01680991|20414871|P3|NOT COMPLETED|Overall Study||4
8279781|NCT01680991|20414872|P2|NOT COMPLETED|Overall Study||19
8279782|NCT01680991|20414873|P1|NOT COMPLETED|Overall Study||8
8279783|NCT01680991|20414871|P3|COMPLETED|Overall Study||9
8279784|NCT01680991|20414872|P2|COMPLETED|Overall Study||4
8279785|NCT01680991|20414873|P1|COMPLETED|Overall Study||4
8279786|NCT01680991|20414871|P3|STARTED|Overall Study||13
8279787|NCT01680991|20414872|P2|STARTED|Overall Study||23
8279788|NCT01680991|20414873|P1|STARTED|Overall Study||12
8279789|NCT01680965|20414936|P4|NOT COMPLETED|Overall Study||6
8279790|NCT01680965|20414937|P3|NOT COMPLETED|Overall Study||0
8279791|NCT01680965|20414938|P2|NOT COMPLETED|Overall Study||0
8279792|NCT01680965|20414939|P1|NOT COMPLETED|Overall Study||0
8279793|NCT01680965|20414936|P4|COMPLETED|Overall Study||26
8279794|NCT01680965|20414937|P3|COMPLETED|Overall Study||6
8279795|NCT01680965|20414938|P2|COMPLETED|Overall Study||3
8279796|NCT01680965|20414939|P1|COMPLETED|Overall Study||3
8279797|NCT01680965|20414936|P4|STARTED|Overall Study||32
8279798|NCT01680965|20414937|P3|STARTED|Overall Study||6
8279799|NCT01680965|20414938|P2|STARTED|Overall Study||3
8279800|NCT01680965|20414939|P1|STARTED|Overall Study||3
8279801|NCT01680900|20414950|P2|NOT COMPLETED|Overall Study||1
8279802|NCT01680900|20414951|P1|NOT COMPLETED|Overall Study||4
8279803|NCT01680900|20414950|P2|COMPLETED|Overall Study||11
8279804|NCT01680900|20414951|P1|COMPLETED|Overall Study||20
8279805|NCT01680900|20414950|P2|STARTED|Overall Study||12
8279806|NCT01680900|20414951|P1|STARTED|Overall Study||24
8279807|NCT01680887|20414969|P2|NOT COMPLETED|Overall Study||24
8279808|NCT01680887|20414970|P1|NOT COMPLETED|Overall Study||29
8279809|NCT01680887|20414969|P2|COMPLETED|Overall Study||52
8279810|NCT01680887|20414970|P1|COMPLETED|Overall Study||51
8279811|NCT01680887|20414969|P2|STARTED|Overall Study||76
8279812|NCT01680887|20414970|P1|STARTED|Overall Study||80
8279813|NCT01680861|20414980|P2|NOT COMPLETED|First 12 Months Post-transplant||0
8279814|NCT01680861|20414981|P1|NOT COMPLETED|First 12 Months Post-transplant||0
8279815|NCT01680861|20414980|P2|COMPLETED|First 12 Months Post-transplant||15
8279816|NCT01680861|20414981|P1|COMPLETED|First 12 Months Post-transplant||15
8279817|NCT01680861|20414980|P2|STARTED|First 12 Months Post-transplant||15
8279818|NCT01680861|20414981|P1|STARTED|First 12 Months Post-transplant||15
8279819|NCT01680861|20414980|P2|NOT COMPLETED|Early Post-transplant Period||1
8279820|NCT01680861|20414981|P1|NOT COMPLETED|Early Post-transplant Period||1
8279821|NCT01680861|20414980|P2|COMPLETED|Early Post-transplant Period||15
8279822|NCT01680861|20414981|P1|COMPLETED|Early Post-transplant Period||15
8279823|NCT01680861|20414980|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
8279824|NCT01680861|20414981|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
8279825|NCT01680848|20414999|P1|NOT COMPLETED|Overall Study||93
8279826|NCT01680848|20414999|P1|COMPLETED|Overall Study||189
8279827|NCT01680848|20414999|P1|STARTED|Overall Study||282
8279828|NCT01680835|20415003|P1|NOT COMPLETED|Overall Study||25
8279829|NCT01680835|20415003|P1|COMPLETED|Overall Study||83
8279830|NCT01680835|20415003|P1|STARTED|Overall Study||108
8279831|NCT01680783|20415019|P2|NOT COMPLETED|Overall Study||0
8279832|NCT01680783|20415020|P1|NOT COMPLETED|Overall Study||0
8279833|NCT01680783|20415019|P2|COMPLETED|Overall Study||44
8279834|NCT01680783|20415020|P1|COMPLETED|Overall Study||39
8279835|NCT01680783|20415019|P2|STARTED|Overall Study||44
8279836|NCT01680783|20415020|P1|STARTED|Overall Study||39
8279837|NCT01680666|20415038|P2|NOT COMPLETED|Overall Study||0
8279838|NCT01680666|20415039|P1|NOT COMPLETED|Overall Study||0
8279839|NCT01680666|20415038|P2|COMPLETED|Overall Study||66
8279840|NCT01680666|20415039|P1|COMPLETED|Overall Study||84
8279841|NCT01680666|20415038|P2|STARTED|Overall Study||66
8279842|NCT01680666|20415039|P1|STARTED|Overall Study||84
8279843|NCT01680653|20415053|P1|NOT COMPLETED|Overall Study||0
8279844|NCT01680653|20415053|P1|COMPLETED|Overall Study||57
8279845|NCT01680653|20415053|P1|STARTED|Overall Study||57
8279846|NCT01680549|20415065|P2|NOT COMPLETED|Overall Study||8
8279847|NCT01680549|20415066|P1|NOT COMPLETED|Overall Study||5
8279848|NCT01680549|20415065|P2|COMPLETED|Overall Study||17
8279849|NCT01680549|20415066|P1|COMPLETED|Overall Study||20
8279850|NCT01680549|20415065|P2|STARTED|Overall Study||25
8279851|NCT01680549|20415066|P1|STARTED|Overall Study||25
8279852|NCT01680497|20415078|P1|NOT COMPLETED|Overall Study||2
8279853|NCT01680497|20415078|P1|COMPLETED|Overall Study||68
8279854|NCT01680497|20415078|P1|STARTED|Overall Study||70
8279855|NCT01680341|20415090|P2|NOT COMPLETED|Overall Study||17
8279856|NCT01680341|20415091|P1|NOT COMPLETED|Overall Study||21
8279857|NCT01680341|20415090|P2|COMPLETED|Overall Study||119
8279858|NCT01680341|20415091|P1|COMPLETED|Overall Study||115
8279859|NCT01680341|20415090|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
8279860|NCT01680341|20415091|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
8279861|NCT01680341|20415090|P2|STARTED|Overall Study||136
8279862|NCT01680341|20415091|P1|STARTED|Overall Study||136
8279863|NCT01680328|20415111|P1|NOT COMPLETED|Overall Study||2
8279864|NCT01680328|20415111|P1|COMPLETED|Overall Study||80
8279865|NCT01680328|20415111|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
8279866|NCT01680328|20415111|P1|STARTED|Overall Study||82
8279867|NCT01680172|20415149|P2|NOT COMPLETED|Overall Study||0
8279868|NCT01680172|20415150|P1|NOT COMPLETED|Overall Study||0
8279869|NCT01680172|20415149|P2|COMPLETED|Overall Study||2
8279870|NCT01680172|20415150|P1|COMPLETED|Overall Study||3
8279871|NCT01680172|20415149|P2|STARTED|Overall Study||2
8279872|NCT01680172|20415150|P1|STARTED|Overall Study||3
8279873|NCT01680159|20415162|P1|NOT COMPLETED|Increased Dose Period||8
8279874|NCT01680159|20415162|P1|COMPLETED|Increased Dose Period||43
8279875|NCT01680159|20415162|P1|STARTED|Increased Dose Period||51
8279876|NCT01680159|20415162|P1|NOT COMPLETED|Screening Period||7
8279877|NCT01680159|20415162|P1|COMPLETED|Screening Period||39
8279878|NCT01680159|20415162|P1|STARTED|Screening Period||46
8279879|NCT01680016|20415189|P4|NOT COMPLETED|Overall Study||5
8279880|NCT01680016|20415190|P3|NOT COMPLETED|Overall Study||5
8279881|NCT01680016|20415191|P2|NOT COMPLETED|Overall Study||8
8279882|NCT01680016|20415192|P1|NOT COMPLETED|Overall Study||6
8279883|NCT01680016|20415189|P4|COMPLETED|Overall Study||195
8279884|NCT01680016|20415190|P3|COMPLETED|Overall Study||196
8279885|NCT01680016|20415191|P2|COMPLETED|Overall Study||114
8279886|NCT01680016|20415192|P1|COMPLETED|Overall Study||115
8279887|NCT01680016|20415189|P4|STARTED|Overall Study||200
8279888|NCT01680016|20415190|P3|STARTED|Overall Study||201
8279889|NCT01680016|20415191|P2|STARTED|Overall Study||122
8279890|NCT01680016|20415192|P1|STARTED|Overall Study||121
8279891|NCT01679613|20415254|P4|NOT COMPLETED|Overall Study||2
8279892|NCT01679613|20415255|P3|NOT COMPLETED|Overall Study||2
8279893|NCT01679613|20415256|P2|NOT COMPLETED|Overall Study||1
8279894|NCT01679613|20415257|P1|NOT COMPLETED|Overall Study||0
8279895|NCT01679613|20415254|P4|COMPLETED|Overall Study||11
8279896|NCT01679613|20415255|P3|COMPLETED|Overall Study||11
8279897|NCT01679613|20415256|P2|COMPLETED|Overall Study||3
8279898|NCT01679613|20415257|P1|COMPLETED|Overall Study||4
8279899|NCT01679613|20415254|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
8279900|NCT01679613|20415255|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
8279901|NCT01679613|20415256|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
8279902|NCT01679613|20415257|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
8279903|NCT01679613|20415254|P4|Received Nintedanib (Main)|Overall Study||11
8279904|NCT01679613|20415255|P3|Received Nintedanib (Main)|Overall Study||13
8279905|NCT01679613|20415256|P2|Received Nintedanib (Main)|Overall Study||0
8279906|NCT01679613|20415257|P1|Received Nintedanib (Main)|Overall Study||0
8279907|NCT01679613|20415254|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
8279908|NCT01679613|20415255|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
8279909|NCT01679613|20415256|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
8279910|NCT01679613|20415257|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
8279911|NCT01679613|20415254|P4|Received Nintedanib (Pilot)|Overall Study||0
8279912|NCT01679613|20415255|P3|Received Nintedanib (Pilot)|Overall Study||0
8279913|NCT01679613|20415256|P2|Received Nintedanib (Pilot)|Overall Study||3
8279914|NCT01679613|20415257|P1|Received Nintedanib (Pilot)|Overall Study||4
8279915|NCT01679613|20415254|P4|STARTED|Overall Study||13
8279916|NCT01679613|20415255|P3|STARTED|Overall Study||13
8279917|NCT01679613|20415256|P2|STARTED|Overall Study||4
8279918|NCT01679613|20415257|P1|STARTED|Overall Study||4
8279919|NCT01679600|20415270|P2|NOT COMPLETED|Overall Study||0
8279920|NCT01679600|20415271|P1|NOT COMPLETED|Overall Study||0
8279921|NCT01679600|20415270|P2|COMPLETED|Overall Study||7
8279922|NCT01679600|20415271|P1|COMPLETED|Overall Study||7
8279923|NCT01679600|20415270|P2|STARTED|Overall Study||7
8279924|NCT01679600|20415271|P1|STARTED|Overall Study||7
8279925|NCT01679405|20415279|P2|NOT COMPLETED|Overall Study||5
8279926|NCT01679405|20415280|P1|NOT COMPLETED|Overall Study||2
8279927|NCT01679405|20415279|P2|COMPLETED|Overall Study||1
8279928|NCT01679405|20415280|P1|COMPLETED|Overall Study||1
8279929|NCT01679405|20415279|P2|STARTED|Overall Study||6
8279930|NCT01679405|20415280|P1|STARTED|Overall Study||3
8279931|NCT01679314|20415296|P2|NOT COMPLETED|Overall Study||0
8279932|NCT01679314|20415297|P1|NOT COMPLETED|Overall Study||2
8279933|NCT01679314|20415296|P2|COMPLETED|Overall Study||28
8279934|NCT01679314|20415297|P1|COMPLETED|Overall Study||24
8279935|NCT01679314|20415296|P2|STARTED|Overall Study||28
8279936|NCT01679314|20415297|P1|STARTED|Overall Study||26
8279937|NCT01679301|20415315|P3|NOT COMPLETED|Study Period||0
8279938|NCT01679301|20415316|P2|NOT COMPLETED|Study Period||0
8279939|NCT01679301|20415317|P1|NOT COMPLETED|Study Period||0
8279940|NCT01679301|20415315|P3|COMPLETED|Study Period||4
8279941|NCT01679301|20415316|P2|COMPLETED|Study Period||4
8279942|NCT01679301|20415317|P1|COMPLETED|Study Period||0
8279943|NCT01679301|20415315|P3|STARTED|Study Period||4
8279944|NCT01679301|20415316|P2|STARTED|Study Period||4
8279945|NCT01679301|20415317|P1|STARTED|Study Period||0
8279946|NCT01679301|20415315|P3|NOT COMPLETED|Screening Period||0
8279947|NCT01679301|20415316|P2|NOT COMPLETED|Screening Period||0
8279948|NCT01679301|20415317|P1|NOT COMPLETED|Screening Period||3
8279949|NCT01679301|20415315|P3|COMPLETED|Screening Period||0
8279950|NCT01679301|20415316|P2|COMPLETED|Screening Period||0
8279951|NCT01679301|20415317|P1|COMPLETED|Screening Period||8
8279952|NCT01679301|20415315|P3|STARTED|Screening Period||0
8279953|NCT01679301|20415316|P2|STARTED|Screening Period||0
8279954|NCT01679301|20415317|P1|STARTED|Screening Period||11
8279955|NCT01679236|20415325|P2|NOT COMPLETED|Overall Study||15
8279956|NCT01679236|20415326|P1|NOT COMPLETED|Overall Study||15
8279957|NCT01679236|20415325|P2|COMPLETED|Overall Study||10
8279958|NCT01679236|20415326|P1|COMPLETED|Overall Study||15
8279959|NCT01679236|20415325|P2|STARTED|Overall Study||25
8279960|NCT01679236|20415326|P1|STARTED|Overall Study||30
8279961|NCT01679197|20415332|P1|NOT COMPLETED|Overall Study||4
8279962|NCT01679197|20415332|P1|COMPLETED|Overall Study||19
8279963|NCT01679197|20415332|P1|STARTED|Overall Study||23
8279964|NCT01679028|20415351|P6|NOT COMPLETED|Overall Study||0
8279965|NCT01679028|20415352|P5|NOT COMPLETED|Overall Study||0
8279966|NCT01679028|20415353|P4|NOT COMPLETED|Overall Study||0
8279967|NCT01679028|20415354|P3|NOT COMPLETED|Overall Study||0
8279968|NCT01679028|20415355|P2|NOT COMPLETED|Overall Study||0
8279969|NCT01679028|20415356|P1|NOT COMPLETED|Overall Study||0
8279970|NCT01679028|20415351|P6|COMPLETED|Overall Study||6
8279971|NCT01679028|20415352|P5|COMPLETED|Overall Study||2
8279972|NCT01679028|20415353|P4|COMPLETED|Overall Study||4
8279973|NCT01679028|20415354|P3|COMPLETED|Overall Study||2
8279974|NCT01679028|20415355|P2|COMPLETED|Overall Study||4
8279975|NCT01679028|20415356|P1|COMPLETED|Overall Study||2
8279976|NCT01679028|20415351|P6|STARTED|Overall Study||6
8279977|NCT01679028|20415352|P5|STARTED|Overall Study||2
8279978|NCT01679028|20415353|P4|STARTED|Overall Study||4
8279979|NCT01679028|20415354|P3|STARTED|Overall Study||2
8279980|NCT01679028|20415355|P2|STARTED|Overall Study||4
8279981|NCT01679028|20415356|P1|STARTED|Overall Study||2
8279982|NCT01679002|20415373|P3|NOT COMPLETED|Overall Study||0
8279983|NCT01679002|20415374|P2|NOT COMPLETED|Overall Study||1
8279984|NCT01679002|20415375|P1|NOT COMPLETED|Overall Study||1
8279985|NCT01679002|20415373|P3|COMPLETED|Overall Study||4
8279986|NCT01679002|20415374|P2|COMPLETED|Overall Study||3
8279987|NCT01679002|20415375|P1|COMPLETED|Overall Study||3
8279988|NCT01679002|20415373|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
8279989|NCT01679002|20415374|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
8279990|NCT01679002|20415375|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
8279991|NCT01679002|20415373|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8279992|NCT01679002|20415374|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8279993|NCT01679002|20415375|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8279994|NCT01679002|20415373|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
8279995|NCT01679002|20415374|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
8279996|NCT01679002|20415375|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
8279997|NCT01679002|20415373|P3|STARTED|Overall Study||4
8279998|NCT01679002|20415374|P2|STARTED|Overall Study||4
8279999|NCT01679002|20415375|P1|STARTED|Overall Study||4
8280000|NCT01678976|20415391|P2|NOT COMPLETED|Second Period||0
8280001|NCT01678976|20415392|P1|NOT COMPLETED|Second Period||0
8280002|NCT01678976|20415391|P2|COMPLETED|Second Period||6
8280003|NCT01678976|20415392|P1|COMPLETED|Second Period||6
8280004|NCT01678976|20415391|P2|STARTED|Second Period||6
8280005|NCT01678976|20415392|P1|STARTED|Second Period||6
8280006|NCT01678976|20415391|P2|NOT COMPLETED|First Period||1
8280007|NCT01678976|20415392|P1|NOT COMPLETED|First Period||0
8280008|NCT01678976|20415391|P2|COMPLETED|First Period||6
8280009|NCT01678976|20415392|P1|COMPLETED|First Period||6
8280010|NCT01678976|20415391|P2|STARTED|First Period||7
8280011|NCT01678976|20415392|P1|STARTED|First Period||6
8280012|NCT01678924|20415406|P4|NOT COMPLETED|Overall Study||18
8280013|NCT01678924|20415407|P3|NOT COMPLETED|Overall Study||2
8280014|NCT01678924|20415408|P2|NOT COMPLETED|Overall Study||12
8280015|NCT01678924|20415409|P1|NOT COMPLETED|Overall Study||10
8280016|NCT01678924|20415406|P4|COMPLETED|Overall Study||105
8280017|NCT01678924|20415407|P3|COMPLETED|Overall Study||28
8280018|NCT01678924|20415408|P2|COMPLETED|Overall Study||51
8280019|NCT01678924|20415409|P1|COMPLETED|Overall Study||54
8280020|NCT01678924|20415406|P4|STARTED|Overall Study||123
8280021|NCT01678924|20415407|P3|STARTED|Overall Study||30
8280022|NCT01678924|20415408|P2|STARTED|Overall Study||63
8280023|NCT01678924|20415409|P1|STARTED|Overall Study||64
8280024|NCT01678911|20415540|P2|NOT COMPLETED|Second Intervention||0
8280025|NCT01678911|20415541|P1|NOT COMPLETED|Second Intervention||2
8280026|NCT01678911|20415540|P2|COMPLETED|Second Intervention||1
8280027|NCT01678911|20415541|P1|COMPLETED|Second Intervention||2
8280028|NCT01678911|20415540|P2|STARTED|Second Intervention||1
8280029|NCT01678911|20415541|P1|STARTED|Second Intervention||4
8280030|NCT01678911|20415540|P2|NOT COMPLETED|First Intervention||0
8280031|NCT01678911|20415541|P1|NOT COMPLETED|First Intervention||0
8280032|NCT01678911|20415540|P2|COMPLETED|First Intervention||1
8280033|NCT01678911|20415541|P1|COMPLETED|First Intervention||4
8280034|NCT01678911|20415540|P2|Cross Over|First Intervention||1
8280035|NCT01678911|20415541|P1|Cross Over|First Intervention||4
8280036|NCT01678911|20415540|P2|STARTED|First Intervention||1
8280037|NCT01678911|20415541|P1|STARTED|First Intervention||4
8280038|NCT01678898|20415558|P3|NOT COMPLETED|PB-102-F02||0
8280039|NCT01678898|20415559|P2|NOT COMPLETED|PB-102-F02||0
8280040|NCT01678898|20415560|P1|NOT COMPLETED|PB-102-F02||0
8280041|NCT01678898|20415558|P3|COMPLETED|PB-102-F02||4
8280042|NCT01678898|20415559|P2|COMPLETED|PB-102-F02||6
8280043|NCT01678898|20415560|P1|COMPLETED|PB-102-F02||6
8280044|NCT01678898|20415558|P3|STARTED|PB-102-F02||4
8280045|NCT01678898|20415559|P2|STARTED|PB-102-F02||6
8280046|NCT01678898|20415560|P1|STARTED|PB-102-F02||6
8280047|NCT01678898|20415558|P3|NOT COMPLETED|PB-102-F01||0
8280048|NCT01678898|20415559|P2|NOT COMPLETED|PB-102-F01||2
8280049|NCT01678898|20415560|P1|NOT COMPLETED|PB-102-F01||0
8280050|NCT01678898|20415558|P3|COMPLETED|PB-102-F01||4
8280051|NCT01678898|20415559|P2|COMPLETED|PB-102-F01||6
8280052|NCT01678898|20415560|P1|COMPLETED|PB-102-F01||6
8280053|NCT01678898|20415558|P3|STARTED|PB-102-F01||4
8280054|NCT01678898|20415559|P2|STARTED|PB-102-F01||8
8280055|NCT01678898|20415560|P1|STARTED|PB-102-F01||6
8280056|NCT01678885|20415640|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
8280057|NCT01678885|20415641|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280058|NCT01678885|20415642|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280059|NCT01678885|20415643|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280060|NCT01678885|20415644|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280061|NCT01678885|20415640|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
8280062|NCT01678885|20415641|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280063|NCT01678885|20415642|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280064|NCT01678885|20415643|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280065|NCT01678885|20415644|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280066|NCT01678885|20415640|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
8280067|NCT01678885|20415641|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280068|NCT01678885|20415642|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280069|NCT01678885|20415643|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280070|NCT01678885|20415644|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280071|NCT01678885|20415640|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8280072|NCT01678885|20415641|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
8280073|NCT01678885|20415642|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
8280074|NCT01678885|20415643|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
8280075|NCT01678885|20415644|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8280076|NCT01678885|20415640|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8280077|NCT01678885|20415641|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
8280078|NCT01678885|20415642|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
8280079|NCT01678885|20415643|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
8280080|NCT01678885|20415644|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
8280081|NCT01678885|20415640|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
8280082|NCT01678885|20415641|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
8280083|NCT01678885|20415642|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
8280084|NCT01678885|20415643|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
8280085|NCT01678885|20415644|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
8280086|NCT01678846|20415654|P2|NOT COMPLETED|Overall Study||0
8280087|NCT01678846|20415655|P1|NOT COMPLETED|Overall Study||0
8280088|NCT01678846|20415654|P2|COMPLETED|Overall Study||1899
8280089|NCT01678846|20415655|P1|COMPLETED|Overall Study||1921
8280090|NCT01678846|20415654|P2|STARTED|Overall Study||1899
8280091|NCT01678846|20415655|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
8280092|NCT01678820|20415670|P3|NOT COMPLETED|Overall Study||57
8280093|NCT01678820|20415671|P2|NOT COMPLETED|Overall Study||63
8280094|NCT01678820|20415672|P1|NOT COMPLETED|Overall Study||62
8280095|NCT01678820|20415670|P3|COMPLETED|Overall Study||43
8280096|NCT01678820|20415671|P2|COMPLETED|Overall Study||36
8280097|NCT01678820|20415672|P1|COMPLETED|Overall Study||38
8280098|NCT01678820|20415670|P3|Treated With Double-blind Study Drug|Overall Study||98
8280099|NCT01678820|20415671|P2|Treated With Double-blind Study Drug|Overall Study||97
8280100|NCT01678820|20415672|P1|Treated With Double-blind Study Drug|Overall Study||100
8280101|NCT01678820|20415670|P3|STARTED|Overall Study||100
8280102|NCT01678820|20415671|P2|STARTED|Overall Study||99
8280103|NCT01678820|20415672|P1|STARTED|Overall Study||100
8280104|NCT01678807|20415717|P3|NOT COMPLETED|Overall Study||0
8280105|NCT01678807|20415718|P2|NOT COMPLETED|Overall Study||5
8280106|NCT01678807|20415719|P1|NOT COMPLETED|Overall Study||4
8280107|NCT01678807|20415717|P3|COMPLETED|Overall Study||65
8280108|NCT01678807|20415718|P2|COMPLETED|Overall Study||60
8280109|NCT01678807|20415719|P1|COMPLETED|Overall Study||61
8280110|NCT01678807|20415717|P3|STARTED|Overall Study||65
8280111|NCT01678807|20415718|P2|STARTED|Overall Study||65
8280112|NCT01678807|20415719|P1|STARTED|Overall Study||65
8280113|NCT01678560|20415732|P2|NOT COMPLETED|Overall Study||6
8280114|NCT01678560|20415733|P1|NOT COMPLETED|Overall Study||4
8280115|NCT01678560|20415732|P2|COMPLETED|Overall Study||20
8280116|NCT01678560|20415733|P1|COMPLETED|Overall Study||22
8280117|NCT01678560|20415732|P2|STARTED|Overall Study||26
8280118|NCT01678560|20415733|P1|STARTED|Overall Study||26
8280119|NCT01678443|20415747|P1|NOT COMPLETED|Overall Study||0
8280120|NCT01678443|20415747|P1|COMPLETED|Overall Study||2
8280121|NCT01678443|20415747|P1|STARTED|Overall Study||2
8280122|NCT01678313|20415754|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
8280123|NCT01678313|20415755|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
8280124|NCT01678313|20415754|P2|COMPLETED|Prostate Biopsy at 3 Months||37
8280125|NCT01678313|20415755|P1|COMPLETED|Prostate Biopsy at 3 Months||45
8280126|NCT01678313|20415754|P2|STARTED|Prostate Biopsy at 3 Months||49
8280127|NCT01678313|20415755|P1|STARTED|Prostate Biopsy at 3 Months||56
8280128|NCT01678313|20415754|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
8280129|NCT01678313|20415755|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
8280130|NCT01678313|20415754|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
8280131|NCT01678313|20415755|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
8280132|NCT01678313|20415754|P2|STARTED|PSA >4 ng/dL at 3 Months||58
8280133|NCT01678313|20415755|P1|STARTED|PSA >4 ng/dL at 3 Months||64
8280134|NCT01678313|20415754|P2|NOT COMPLETED|Completed the 3-month Therapy||12
8280135|NCT01678313|20415755|P1|NOT COMPLETED|Completed the 3-month Therapy||6
8280136|NCT01678313|20415754|P2|COMPLETED|Completed the 3-month Therapy||58
8280137|NCT01678313|20415755|P1|COMPLETED|Completed the 3-month Therapy||64
8280138|NCT01678313|20415754|P2|STARTED|Completed the 3-month Therapy||70
8280139|NCT01678313|20415755|P1|STARTED|Completed the 3-month Therapy||70
8280140|NCT01678209|20415774|P3|NOT COMPLETED|Overall Study||18
8280141|NCT01678209|20415775|P2|NOT COMPLETED|Overall Study||18
8280142|NCT01678209|20415776|P1|NOT COMPLETED|Overall Study||17
8280143|NCT01678209|20415774|P3|COMPLETED|Overall Study||22
8280144|NCT01678209|20415775|P2|COMPLETED|Overall Study||22
8280145|NCT01678209|20415776|P1|COMPLETED|Overall Study||30
8280146|NCT01678209|20415774|P3|STARTED|Overall Study||40
8280147|NCT01678209|20415775|P2|STARTED|Overall Study||40
8280148|NCT01678209|20415776|P1|STARTED|Overall Study||47
8280149|NCT01678196|20415804|P2|NOT COMPLETED|Overall Study||0
8280150|NCT01678196|20415805|P1|NOT COMPLETED|Overall Study||0
8280151|NCT01678196|20415804|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
8280152|NCT01678196|20415805|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
8280153|NCT01678196|20415804|P2|STARTED|Overall Study||32
8280154|NCT01678196|20415805|P1|STARTED|Overall Study||34
8280155|NCT01678144|20415817|P1|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
8280156|NCT01678144|20415817|P1|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
8280157|NCT01678144|20415817|P1|STARTED|Stage 2: MAR Regular and MAR Expanded||5
8280158|NCT01678144|20415817|P1|NOT COMPLETED|Stage 1: MAR Classic||1
8280159|NCT01678144|20415817|P1|COMPLETED|Stage 1: MAR Classic||6
8280160|NCT01678144|20415817|P1|STARTED|Stage 1: MAR Classic||7
8280161|NCT01678131|20415836|P3|NOT COMPLETED|Overall Study||2
8280162|NCT01678131|20415837|P2|NOT COMPLETED|Overall Study||1
8280163|NCT01678131|20415838|P1|NOT COMPLETED|Overall Study||0
8280164|NCT01678131|20415836|P3|COMPLETED|Overall Study||9
8280165|NCT01678131|20415837|P2|COMPLETED|Overall Study||9
8280166|NCT01678131|20415838|P1|COMPLETED|Overall Study||10
8280167|NCT01678131|20415836|P3|STARTED|Overall Study||11
8280168|NCT01678131|20415837|P2|STARTED|Overall Study||10
8280169|NCT01678131|20415838|P1|STARTED|Overall Study||10
8280170|NCT01677988|20415846|P1|NOT COMPLETED|Overall Study||2
8280171|NCT01677988|20415846|P1|COMPLETED|Overall Study||1
8280172|NCT01677988|20415846|P1|STARTED|Overall Study||3
8280173|NCT01677936|20415859|P2|NOT COMPLETED|Overall Study||5
8280174|NCT01677936|20415860|P1|NOT COMPLETED|Overall Study||9
8280175|NCT01677936|20415859|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
8280176|NCT01677936|20415860|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
8280177|NCT01677936|20415859|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
8280178|NCT01677936|20415860|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
8280179|NCT01677910|20415871|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
8280180|NCT01677910|20415872|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8280181|NCT01677910|20415873|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8280182|NCT01677910|20415874|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8280183|NCT01677910|20415871|P4|COMPLETED|Open-Label Extension Period (OLE)||79
8280184|NCT01677910|20415872|P3|COMPLETED|Open-Label Extension Period (OLE)||0
8280185|NCT01677910|20415873|P2|COMPLETED|Open-Label Extension Period (OLE)||0
8280186|NCT01677910|20415874|P1|COMPLETED|Open-Label Extension Period (OLE)||0
8280187|NCT01677910|20415871|P4|STARTED|Open-Label Extension Period (OLE)||115
8280188|NCT01677910|20415872|P3|STARTED|Open-Label Extension Period (OLE)||0
8280189|NCT01677910|20415873|P2|STARTED|Open-Label Extension Period (OLE)||0
8280190|NCT01677910|20415874|P1|STARTED|Open-Label Extension Period (OLE)||0
8280191|NCT01677910|20415871|P4|NOT COMPLETED|Double-Blind Treatment Period||0
8280192|NCT01677910|20415872|P3|NOT COMPLETED|Double-Blind Treatment Period||7
8280193|NCT01677910|20415873|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8280194|NCT01677910|20415874|P1|NOT COMPLETED|Double-Blind Treatment Period||7
8280195|NCT01677910|20415871|P4|COMPLETED|Double-Blind Treatment Period||0
8280196|NCT01677910|20415872|P3|COMPLETED|Double-Blind Treatment Period||38
8280197|NCT01677910|20415873|P2|COMPLETED|Double-Blind Treatment Period||42
8280198|NCT01677910|20415874|P1|COMPLETED|Double-Blind Treatment Period||38
8280199|NCT01677910|20415871|P4|STARTED|Double-Blind Treatment Period||0
8280200|NCT01677910|20415872|P3|STARTED|Double-Blind Treatment Period||45
8280201|NCT01677910|20415873|P2|STARTED|Double-Blind Treatment Period||45
8280202|NCT01677910|20415874|P1|STARTED|Double-Blind Treatment Period||45
8280203|NCT01677858|20415901|P5|NOT COMPLETED|Overall Study||85
8280204|NCT01677858|20415902|P4|NOT COMPLETED|Overall Study||6
8280205|NCT01677858|20415903|P3|NOT COMPLETED|Overall Study||14
8280206|NCT01677858|20415904|P2|NOT COMPLETED|Overall Study||2
8280207|NCT01677858|20415905|P1|NOT COMPLETED|Overall Study||3
8280208|NCT01677858|20415901|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
8280209|NCT01677858|20415902|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
8280210|NCT01677858|20415903|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
8280211|NCT01677858|20415904|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
8280212|NCT01677858|20415905|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
8280213|NCT01677858|20415901|P5|STARTED|Overall Study||89
8280214|NCT01677858|20415902|P4|STARTED|Overall Study||6
8280215|NCT01677858|20415903|P3|STARTED|Overall Study||15
8280216|NCT01677858|20415904|P2|STARTED|Overall Study||3
8280217|NCT01677858|20415905|P1|STARTED|Overall Study||3
8280218|NCT01677767|20415978|P1|NOT COMPLETED|Overall Study||22
8280219|NCT01677767|20415978|P1|COMPLETED|Overall Study||102
8280220|NCT01677767|20415978|P1|STARTED|Overall Study||124
8280221|NCT01677624|20415992|P1|NOT COMPLETED|Overall Study||1
8280222|NCT01677624|20415992|P1|COMPLETED|Overall Study||27
8280223|NCT01677624|20415992|P1|STARTED|Overall Study||28
8280224|NCT01677507|20415997|P2|NOT COMPLETED|Second Assigment||5
8280225|NCT01677507|20415998|P1|NOT COMPLETED|Second Assigment||3
8280226|NCT01677507|20415997|P2|COMPLETED|Second Assigment||51
8280227|NCT01677507|20415998|P1|COMPLETED|Second Assigment||60
8280228|NCT01677507|20415997|P2|STARTED|Second Assigment||56
8280229|NCT01677507|20415998|P1|STARTED|Second Assigment||63
8280230|NCT01677507|20415997|P2|NOT COMPLETED|Initial Assignment||2
8280231|NCT01677507|20415998|P1|NOT COMPLETED|Initial Assignment||0
8280232|NCT01677507|20415997|P2|COMPLETED|Initial Assignment||56
8280233|NCT01677507|20415998|P1|COMPLETED|Initial Assignment||63
8280234|NCT01677507|20415997|P2|STARTED|Initial Assignment||58
8280235|NCT01677507|20415998|P1|STARTED|Initial Assignment||63
8280236|NCT01677377|20416011|P3|NOT COMPLETED|Overall Study||6
8280237|NCT01677377|20416012|P2|NOT COMPLETED|Overall Study||1
8280238|NCT01677377|20416013|P1|NOT COMPLETED|Overall Study||1
8280239|NCT01677377|20416011|P3|COMPLETED|Overall Study||9
8280240|NCT01677377|20416012|P2|COMPLETED|Overall Study||14
8280241|NCT01677377|20416013|P1|COMPLETED|Overall Study||14
8280242|NCT01677377|20416011|P3|STARTED|Overall Study||15
8280243|NCT01677377|20416012|P2|STARTED|Overall Study||15
8280244|NCT01677377|20416013|P1|STARTED|Overall Study||15
8280245|NCT01677312|20416212|P2|NOT COMPLETED|Overall Study||0
8280246|NCT01677312|20416213|P1|NOT COMPLETED|Overall Study||0
8280247|NCT01677312|20416212|P2|COMPLETED|Overall Study||36
8280248|NCT01677312|20416213|P1|COMPLETED|Overall Study||36
8280249|NCT01677312|20416212|P2|STARTED|Overall Study||36
8280250|NCT01677312|20416213|P1|STARTED|Overall Study||36
8280251|NCT01677299|20416229|P4|NOT COMPLETED|Overall Study||1
8280252|NCT01677299|20416230|P3|NOT COMPLETED|Overall Study||1
8280253|NCT01677299|20416231|P2|NOT COMPLETED|Overall Study||3
8280254|NCT01677299|20416232|P1|NOT COMPLETED|Overall Study||0
8280255|NCT01677299|20416229|P4|COMPLETED|Overall Study||5
8280256|NCT01677299|20416230|P3|COMPLETED|Overall Study||5
8280257|NCT01677299|20416231|P2|COMPLETED|Overall Study||3
8280258|NCT01677299|20416232|P1|COMPLETED|Overall Study||6
8280259|NCT01677299|20416229|P4|STARTED|Overall Study||6
8280260|NCT01677299|20416230|P3|STARTED|Overall Study||6
8280261|NCT01677299|20416231|P2|STARTED|Overall Study||6
8280262|NCT01677299|20416232|P1|STARTED|Overall Study||6
8280263|NCT01677286|20416254|P1|NOT COMPLETED|Overall Study||11
8280264|NCT01677286|20416254|P1|COMPLETED|Overall Study||14
8280265|NCT01677286|20416254|P1|STARTED|Overall Study||25
8280266|NCT01677195|20416264|P3|NOT COMPLETED|Overall Study||30
8280267|NCT01677195|20416265|P2|NOT COMPLETED|Overall Study||32
8280268|NCT01677195|20416266|P1|NOT COMPLETED|Overall Study||29
8280269|NCT01677195|20416264|P3|COMPLETED|Overall Study||50
8280270|NCT01677195|20416265|P2|COMPLETED|Overall Study||51
8280271|NCT01677195|20416266|P1|COMPLETED|Overall Study||42
8280272|NCT01677195|20416264|P3|STARTED|Overall Study||80
8280273|NCT01677195|20416265|P2|STARTED|Overall Study||83
8280274|NCT01677195|20416266|P1|STARTED|Overall Study||71
8280275|NCT01677182|20416277|P3|NOT COMPLETED|Overall Study||39
8280276|NCT01677182|20416278|P2|NOT COMPLETED|Overall Study||28
8280277|NCT01677182|20416279|P1|NOT COMPLETED|Overall Study||34
8280278|NCT01677182|20416277|P3|COMPLETED|Overall Study||143
8280279|NCT01677182|20416278|P2|COMPLETED|Overall Study||141
8280280|NCT01677182|20416279|P1|COMPLETED|Overall Study||150
8280281|NCT01677182|20416277|P3|STARTED|Overall Study||182
8280282|NCT01677182|20416278|P2|STARTED|Overall Study||169
8280283|NCT01677182|20416279|P1|STARTED|Overall Study||184
8280284|NCT01676961|20416311|P1|NOT COMPLETED|Overall Study||5
8280285|NCT01676961|20416311|P1|COMPLETED|Overall Study||0
8280286|NCT01676961|20416311|P1|STARTED|Overall Study||5
8280287|NCT01676909|20416318|P2|NOT COMPLETED|Overall Study||14
8280288|NCT01676909|20416319|P1|NOT COMPLETED|Overall Study||18
8280289|NCT01676909|20416318|P2|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
8280290|NCT01676909|20416319|P1|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
8280291|NCT01676909|20416318|P2|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
8280292|NCT01676909|20416319|P1|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
8280293|NCT01676909|20416318|P2|STARTED|Overall Study||118
8280294|NCT01676909|20416319|P1|STARTED|Overall Study||124
8280295|NCT01676896|20416384|P3|NOT COMPLETED|Overall Study||19
8280296|NCT01676896|20416385|P2|NOT COMPLETED|Overall Study||7
8280297|NCT01676896|20416386|P1|NOT COMPLETED|Overall Study||12
8280298|NCT01676896|20416384|P3|COMPLETED|Overall Study||81
8280299|NCT01676896|20416385|P2|COMPLETED|Overall Study||89
8280300|NCT01676896|20416386|P1|COMPLETED|Overall Study||84
8280301|NCT01676896|20416384|P3|STARTED|Overall Study||100
8280302|NCT01676896|20416385|P2|STARTED|Overall Study||96
8280303|NCT01676896|20416386|P1|STARTED|Overall Study||96
8280304|NCT01676831|20416483|P2|NOT COMPLETED|Overall Study||1
8280305|NCT01676831|20416484|P1|NOT COMPLETED|Overall Study||0
8280306|NCT01676831|20416483|P2|COMPLETED|Overall Study||4
8280307|NCT01676831|20416484|P1|COMPLETED|Overall Study||8
8280308|NCT01676831|20416483|P2|STARTED|Overall Study||5
8280309|NCT01676831|20416484|P1|STARTED|Overall Study||8
8280310|NCT01676727|20416494|P1|NOT COMPLETED|Overall Study||32
8280311|NCT01676727|20416494|P1|COMPLETED|Overall Study||68
8280312|NCT01676727|20416494|P1|Implanted|Overall Study||92
8280313|NCT01676727|20416494|P1|STARTED|Overall Study||100
8280314|NCT01676714|20416499|P1|NOT COMPLETED|Overall Study||0
8280315|NCT01676714|20416499|P1|COMPLETED|Overall Study||10
8280316|NCT01676714|20416499|P1|STARTED|Overall Study||10
8280317|NCT01676701|20416508|P2|NOT COMPLETED|Overall Study||4
8280318|NCT01676701|20416509|P1|NOT COMPLETED|Overall Study||4
8280319|NCT01676701|20416508|P2|COMPLETED|Overall Study||0
8280320|NCT01676701|20416509|P1|COMPLETED|Overall Study||0
8280321|NCT01676701|20416508|P2|Completed Post-Treatment Follow-Up|Overall Study||4
8280322|NCT01676701|20416509|P1|Completed Post-Treatment Follow-Up|Overall Study||4
8280323|NCT01676701|20416508|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8280324|NCT01676701|20416509|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8280325|NCT01676701|20416508|P2|STARTED|Overall Study||4
8280326|NCT01676701|20416509|P1|STARTED|Overall Study||4
8280327|NCT01676532|20416535|P1|NOT COMPLETED|Overall Study||0
8280328|NCT01676532|20416535|P1|COMPLETED|Overall Study||127
8280329|NCT01676532|20416535|P1|STARTED|Overall Study||127
8280330|NCT01676415|20416546|P2|NOT COMPLETED|Overall Study||0
8280331|NCT01676415|20416547|P1|NOT COMPLETED|Overall Study||0
8280332|NCT01676415|20416546|P2|COMPLETED|Overall Study||5
8280333|NCT01676415|20416547|P1|COMPLETED|Overall Study||4
8280334|NCT01676415|20416546|P2|STARTED|Overall Study||5
8280335|NCT01676415|20416547|P1|STARTED|Overall Study||4
8280336|NCT01676311|20416561|P2|NOT COMPLETED|Overall Study||2
8280337|NCT01676311|20416562|P1|NOT COMPLETED|Overall Study||0
8280338|NCT01676311|20416561|P2|COMPLETED|Overall Study||5
8280339|NCT01676311|20416562|P1|COMPLETED|Overall Study||7
8280340|NCT01676311|20416561|P2|STARTED|Overall Study||7
8280341|NCT01676311|20416562|P1|STARTED|Overall Study||7
8280342|NCT01676298|20416584|P8|NOT COMPLETED|Overall Study||0
8280343|NCT01676298|20416585|P7|NOT COMPLETED|Overall Study||0
8280344|NCT01676298|20416586|P6|NOT COMPLETED|Overall Study||0
8280345|NCT01676298|20416587|P5|NOT COMPLETED|Overall Study||0
8280346|NCT01676298|20416588|P4|NOT COMPLETED|Overall Study||0
8280347|NCT01676298|20416589|P3|NOT COMPLETED|Overall Study||0
8280348|NCT01676298|20416590|P2|NOT COMPLETED|Overall Study||0
8280349|NCT01676298|20416591|P1|NOT COMPLETED|Overall Study||0
8280350|NCT01676298|20416584|P8|COMPLETED|Overall Study||1
8280351|NCT01676298|20416585|P7|COMPLETED|Overall Study||1
8280352|NCT01676298|20416586|P6|COMPLETED|Overall Study||1
8280353|NCT01676298|20416587|P5|COMPLETED|Overall Study||1
8280354|NCT01676298|20416588|P4|COMPLETED|Overall Study||1
8280355|NCT01676298|20416589|P3|COMPLETED|Overall Study||1
8280356|NCT01676298|20416590|P2|COMPLETED|Overall Study||1
8280357|NCT01676298|20416591|P1|COMPLETED|Overall Study||1
8280358|NCT01676298|20416584|P8|Participated in All Tests|Overall Study||1
8280359|NCT01676298|20416585|P7|Participated in All Tests|Overall Study||1
8280360|NCT01676298|20416586|P6|Participated in All Tests|Overall Study||1
8280361|NCT01676298|20416587|P5|Participated in All Tests|Overall Study||1
8280362|NCT01676298|20416588|P4|Participated in All Tests|Overall Study||1
8280363|NCT01676298|20416589|P3|Participated in All Tests|Overall Study||1
8280364|NCT01676298|20416590|P2|Participated in All Tests|Overall Study||1
8280365|NCT01676298|20416591|P1|Participated in All Tests|Overall Study||1
8280366|NCT01676298|20416584|P8|All Genotypes Confirmed With Reference|Overall Study||1
8280367|NCT01676298|20416585|P7|All Genotypes Confirmed With Reference|Overall Study||1
8280368|NCT01676298|20416586|P6|All Genotypes Confirmed With Reference|Overall Study||1
8280369|NCT01676298|20416587|P5|All Genotypes Confirmed With Reference|Overall Study||1
8280370|NCT01676298|20416588|P4|All Genotypes Confirmed With Reference|Overall Study||1
8280371|NCT01676298|20416589|P3|All Genotypes Confirmed With Reference|Overall Study||1
8280372|NCT01676298|20416590|P2|All Genotypes Confirmed With Reference|Overall Study||1
8280373|NCT01676298|20416591|P1|All Genotypes Confirmed With Reference|Overall Study||1
8280374|NCT01676298|20416584|P8|STARTED|Overall Study||1
8280375|NCT01676298|20416585|P7|STARTED|Overall Study||1
8280376|NCT01676298|20416586|P6|STARTED|Overall Study||1
8280377|NCT01676298|20416587|P5|STARTED|Overall Study||1
8280378|NCT01676298|20416588|P4|STARTED|Overall Study||1
8280379|NCT01676298|20416589|P3|STARTED|Overall Study||1
8280380|NCT01676298|20416590|P2|STARTED|Overall Study||1
8280381|NCT01676298|20416591|P1|STARTED|Overall Study||1
8280382|NCT01676220|20416611|P2|NOT COMPLETED|Overall Study||125
8280383|NCT01676220|20416612|P1|NOT COMPLETED|Overall Study||102
8280384|NCT01676220|20416611|P2|COMPLETED|Overall Study||314
8280385|NCT01676220|20416612|P1|COMPLETED|Overall Study||337
8280386|NCT01676220|20416611|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
8280387|NCT01676220|20416612|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
8280388|NCT01676220|20416611|P2|Treated|Overall Study||438
8280389|NCT01676220|20416612|P1|Treated|Overall Study||435
8280390|NCT01676220|20416611|P2|STARTED|Overall Study||439
8280391|NCT01676220|20416612|P1|STARTED|Overall Study||439
8280392|NCT01676116|20416644|P2|NOT COMPLETED|Overall Study||29
8280393|NCT01676116|20416645|P1|NOT COMPLETED|Overall Study||16
8280394|NCT01676116|20416644|P2|COMPLETED|Overall Study||117
8280395|NCT01676116|20416645|P1|COMPLETED|Overall Study||276
8280396|NCT01676116|20416644|P2|STARTED|Overall Study||146
8280397|NCT01676116|20416645|P1|STARTED|Overall Study||292
8280398|NCT01676012|20416667|P1|NOT COMPLETED|Overall Study||3
8280399|NCT01676012|20416667|P1|COMPLETED|Overall Study||29
8280400|NCT01676012|20416667|P1|STARTED|Overall Study||32
8280401|NCT01675960|20416673|P2|NOT COMPLETED|Overall Study||0
8280402|NCT01675960|20416674|P1|NOT COMPLETED|Overall Study||0
8280403|NCT01675960|20416673|P2|COMPLETED|Overall Study||0
8280404|NCT01675960|20416674|P1|COMPLETED|Overall Study||2
8280405|NCT01675960|20416673|P2|STARTED|Overall Study||0
8280406|NCT01675960|20416674|P1|STARTED|Overall Study||2
8280407|NCT01675830|20416682|P1|NOT COMPLETED|Overall Study||0
8280408|NCT01675830|20416682|P1|COMPLETED|Overall Study||10
8280409|NCT01675830|20416682|P1|STARTED|Overall Study||10
8280410|NCT01675778|20416687|P1|NOT COMPLETED|Overall Study||0
8280411|NCT01675778|20416687|P1|COMPLETED|Overall Study||174
8280412|NCT01675778|20416687|P1|STARTED|Overall Study||174
8280413|NCT01675765|20416711|P2|NOT COMPLETED|Overall Study||8
8280414|NCT01675765|20416712|P1|NOT COMPLETED|Overall Study||11
8280415|NCT01675765|20416711|P2|COMPLETED|Overall Study||14
8280416|NCT01675765|20416712|P1|COMPLETED|Overall Study||27
8280417|NCT01675765|20416711|P2|STARTED|Overall Study||22
8280418|NCT01675765|20416712|P1|STARTED|Overall Study||38
8280419|NCT01675661|20416728|P2|NOT COMPLETED|Overall Study||46
8280420|NCT01675661|20416729|P1|NOT COMPLETED|Overall Study||40
8280421|NCT01675661|20416728|P2|COMPLETED|Overall Study||103
8280422|NCT01675661|20416729|P1|COMPLETED|Overall Study||113
8280423|NCT01675661|20416728|P2|STARTED|Overall Study||149
8280424|NCT01675661|20416729|P1|STARTED|Overall Study||153
8280425|NCT01675635|20416737|P2|NOT COMPLETED|Overall Study||0
8280426|NCT01675635|20416738|P1|NOT COMPLETED|Overall Study||0
8280427|NCT01675635|20416737|P2|COMPLETED|Overall Study||117
8280428|NCT01675635|20416738|P1|COMPLETED|Overall Study||117
8280429|NCT01675635|20416737|P2|STARTED|Overall Study||117
8280430|NCT01675635|20416738|P1|STARTED|Overall Study||117
8280431|NCT01675622|20416758|P2|NOT COMPLETED|Overall Study||24
8280432|NCT01675622|20416759|P1|NOT COMPLETED|Overall Study||26
8280433|NCT01675622|20416758|P2|COMPLETED|Overall Study||96
8280434|NCT01675622|20416759|P1|COMPLETED|Overall Study||96
8280435|NCT01675622|20416758|P2|STARTED|Overall Study||120
8280436|NCT01675622|20416759|P1|STARTED|Overall Study||122
8280437|NCT01675596|20416783|P1|NOT COMPLETED|Overall Study||8
8280438|NCT01675596|20416783|P1|COMPLETED|Overall Study||191
8280439|NCT01675596|20416783|P1|STARTED|Overall Study|One patient did not receive the study device.|199
8280440|NCT01675544|20416789|P1|NOT COMPLETED|Overall Study||2
8280441|NCT01675544|20416789|P1|COMPLETED|Overall Study||44
8280442|NCT01675544|20416789|P1|STARTED|Overall Study||46
8280443|NCT01675531|20416794|P1|NOT COMPLETED|Overall Study||25
8280444|NCT01675531|20416794|P1|COMPLETED|Overall Study||41
8280445|NCT01675531|20416794|P1|STARTED|Overall Study||66
8280446|NCT01675492|20416801|P1|NOT COMPLETED|Overall Study||42
8280447|NCT01675492|20416801|P1|COMPLETED|Overall Study||42
8280448|NCT01675492|20416801|P1|STARTED|Overall Study||84
8280449|NCT01675479|20416806|P1|NOT COMPLETED|Overall Study||11
8280450|NCT01675479|20416806|P1|COMPLETED|Overall Study||58
8280451|NCT01675479|20416806|P1|STARTED|Overall Study||69
8280452|NCT01675453|20416813|P2|NOT COMPLETED|Overall Study||0
8280453|NCT01675453|20416814|P1|NOT COMPLETED|Overall Study||0
8280454|NCT01675453|20416813|P2|COMPLETED|Overall Study||20
8280455|NCT01675453|20416814|P1|COMPLETED|Overall Study||20
8280456|NCT01675453|20416813|P2|STARTED|Overall Study||20
8280457|NCT01675453|20416814|P1|STARTED|Overall Study||20
8280458|NCT01675427|20416820|P1|NOT COMPLETED|Overall Study||34
8280459|NCT01675427|20416820|P1|COMPLETED|Overall Study||4732
8280460|NCT01675427|20416820|P1|STARTED|Overall Study||4766
8280461|NCT01675297|20417107|P2|NOT COMPLETED|Overall Study||48
8280462|NCT01675297|20417108|P1|NOT COMPLETED|Overall Study||164
8280463|NCT01675297|20417107|P2|COMPLETED|Overall Study||199
8280464|NCT01675297|20417108|P1|COMPLETED|Overall Study||642
8280465|NCT01675297|20417107|P2|STARTED|Overall Study||247
8280466|NCT01675297|20417108|P1|STARTED|Overall Study||806
8280467|NCT01675167|20417120|P3|NOT COMPLETED|Double-blind Treatment Phase||110
8280468|NCT01675167|20417121|P2|NOT COMPLETED|Double-blind Treatment Phase||48
8280469|NCT01675167|20417122|P1|NOT COMPLETED|Double-blind Treatment Phase||0
8280470|NCT01675167|20417120|P3|COMPLETED|Double-blind Treatment Phase||147
8280471|NCT01675167|20417121|P2|COMPLETED|Double-blind Treatment Phase||206
8280472|NCT01675167|20417122|P1|COMPLETED|Double-blind Treatment Phase||0
8280473|NCT01675167|20417120|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
8280474|NCT01675167|20417121|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
8280475|NCT01675167|20417122|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8280476|NCT01675167|20417120|P3|NOT COMPLETED|Open-label Titration Phase||0
8280477|NCT01675167|20417121|P2|NOT COMPLETED|Open-label Titration Phase||0
8280478|NCT01675167|20417122|P1|NOT COMPLETED|Open-label Titration Phase||304
8280479|NCT01675167|20417120|P3|COMPLETED|Open-label Titration Phase||0
8280480|NCT01675167|20417121|P2|COMPLETED|Open-label Titration Phase||0
8280481|NCT01675167|20417122|P1|COMPLETED|Open-label Titration Phase||511
8280482|NCT01675167|20417120|P3|STARTED|Open-label Titration Phase||0
8280483|NCT01675167|20417121|P2|STARTED|Open-label Titration Phase||0
8280484|NCT01675167|20417122|P1|STARTED|Open-label Titration Phase||815
8280485|NCT01675141|20417144|P1|NOT COMPLETED|Overall Study||11
8280486|NCT01675141|20417144|P1|COMPLETED|Overall Study||0
8280487|NCT01675141|20417144|P1|STARTED|Overall Study||11
8280488|NCT01675128|20417157|P3|NOT COMPLETED|Overall Study||1
8280489|NCT01675128|20417158|P2|NOT COMPLETED|Overall Study||2
8280490|NCT01675128|20417159|P1|NOT COMPLETED|Overall Study||2
8280491|NCT01675128|20417157|P3|COMPLETED|Overall Study||9
8280492|NCT01675128|20417158|P2|COMPLETED|Overall Study||8
8280493|NCT01675128|20417159|P1|COMPLETED|Overall Study||2
8280494|NCT01675128|20417157|P3|STARTED|Overall Study||10
8280495|NCT01675128|20417158|P2|STARTED|Overall Study||10
8280496|NCT01675128|20417159|P1|STARTED|Overall Study||4
8280497|NCT01675063|20417181|P1|NOT COMPLETED|Overall Study||0
8280498|NCT01675063|20417181|P1|COMPLETED|Overall Study||77
8280499|NCT01675063|20417181|P1|STARTED|Overall Study||77
8280500|NCT01675050|20417187|P2|NOT COMPLETED|Second Period Treatment||0
8280501|NCT01675050|20417188|P1|NOT COMPLETED|Second Period Treatment||0
8280502|NCT01675050|20417187|P2|COMPLETED|Second Period Treatment||2
8280503|NCT01675050|20417188|P1|COMPLETED|Second Period Treatment||1
8280504|NCT01675050|20417187|P2|STARTED|Second Period Treatment||2
8280505|NCT01675050|20417188|P1|STARTED|Second Period Treatment||1
8280506|NCT01675050|20417187|P2|NOT COMPLETED|Wash Out Period||0
8280507|NCT01675050|20417188|P1|NOT COMPLETED|Wash Out Period||0
8280508|NCT01675050|20417187|P2|COMPLETED|Wash Out Period||2
8280509|NCT01675050|20417188|P1|COMPLETED|Wash Out Period||1
8280510|NCT01675050|20417187|P2|STARTED|Wash Out Period||2
8280511|NCT01675050|20417188|P1|STARTED|Wash Out Period||1
8280512|NCT01675050|20417187|P2|NOT COMPLETED|Period One Treatment||0
8280513|NCT01675050|20417188|P1|NOT COMPLETED|Period One Treatment||1
8280514|NCT01675050|20417187|P2|COMPLETED|Period One Treatment||2
8280515|NCT01675050|20417188|P1|COMPLETED|Period One Treatment||1
8280516|NCT01675050|20417187|P2|STARTED|Period One Treatment||2
8280517|NCT01675050|20417188|P1|STARTED|Period One Treatment||2
8280518|NCT01675011|20417198|P2|NOT COMPLETED|Overall Study||1
8280519|NCT01675011|20417199|P1|NOT COMPLETED|Overall Study||3
8280520|NCT01675011|20417198|P2|COMPLETED|Overall Study||0
8280521|NCT01675011|20417199|P1|COMPLETED|Overall Study||0
8280522|NCT01675011|20417198|P2|STARTED|Overall Study||1
8280523|NCT01675011|20417199|P1|STARTED|Overall Study||3
8280524|NCT01674725|20417207|P2|NOT COMPLETED|Overall Study||1
8280525|NCT01674725|20417208|P1|NOT COMPLETED|Overall Study||3
8280526|NCT01674725|20417207|P2|COMPLETED|Overall Study||94
8280527|NCT01674725|20417208|P1|COMPLETED|Overall Study||89
8280528|NCT01674725|20417207|P2|STARTED|Overall Study||95
8280529|NCT01674725|20417208|P1|STARTED|Overall Study||92
8280530|NCT01674712|20417227|P5|NOT COMPLETED|Overall Study||11
8280531|NCT01674712|20417228|P4|NOT COMPLETED|Overall Study||8
8280532|NCT01674712|20417229|P3|NOT COMPLETED|Overall Study||9
8280533|NCT01674712|20417230|P2|NOT COMPLETED|Overall Study||9
8280534|NCT01674712|20417231|P1|NOT COMPLETED|Overall Study||10
8280535|NCT01674712|20417227|P5|COMPLETED|Overall Study||102
8280536|NCT01674712|20417228|P4|COMPLETED|Overall Study||108
8280537|NCT01674712|20417229|P3|COMPLETED|Overall Study||106
8280538|NCT01674712|20417230|P2|COMPLETED|Overall Study||108
8280539|NCT01674712|20417231|P1|COMPLETED|Overall Study||104
8280540|NCT01674712|20417227|P5|Safety Subject Sample|Overall Study||112
8280541|NCT01674712|20417228|P4|Safety Subject Sample|Overall Study||115
8280542|NCT01674712|20417229|P3|Safety Subject Sample|Overall Study||113
8280543|NCT01674712|20417230|P2|Safety Subject Sample|Overall Study||117
8280544|NCT01674712|20417231|P1|Safety Subject Sample|Overall Study||111
8280545|NCT01674712|20417227|P5|Full Analysis Subject Sample|Overall Study||111
8280546|NCT01674712|20417228|P4|Full Analysis Subject Sample|Overall Study||112
8280547|NCT01674712|20417229|P3|Full Analysis Subject Sample|Overall Study||110
8280548|NCT01674712|20417230|P2|Full Analysis Subject Sample|Overall Study||114
8280549|NCT01674712|20417231|P1|Full Analysis Subject Sample|Overall Study||109
8280550|NCT01674712|20417227|P5|STARTED|Overall Study||113
8280551|NCT01674712|20417228|P4|STARTED|Overall Study||116
8280552|NCT01674712|20417229|P3|STARTED|Overall Study||115
8280553|NCT01674712|20417230|P2|STARTED|Overall Study||117
8280554|NCT01674712|20417231|P1|STARTED|Overall Study||114
8280555|NCT01674647|20417255|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
8280556|NCT01674647|20417256|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
8280557|NCT01674647|20417255|P2|COMPLETED|30-day Safety Follow-up Period||446
8280558|NCT01674647|20417256|P1|COMPLETED|30-day Safety Follow-up Period||924
8280559|NCT01674647|20417255|P2|STARTED|30-day Safety Follow-up Period||487
8280560|NCT01674647|20417256|P1|STARTED|30-day Safety Follow-up Period||982
8280561|NCT01674647|20417255|P2|NOT COMPLETED|Treatment Period||102
8280562|NCT01674647|20417256|P1|NOT COMPLETED|Treatment Period||156
8280563|NCT01674647|20417255|P2|COMPLETED|Treatment Period||400
8280564|NCT01674647|20417256|P1|COMPLETED|Treatment Period||846
8280565|NCT01674647|20417255|P2|Subjects Received Treatment|Treatment Period||499
8280566|NCT01674647|20417256|P1|Subjects Received Treatment|Treatment Period||988
8280567|NCT01674647|20417255|P2|STARTED|Treatment Period||502
8280568|NCT01674647|20417256|P1|STARTED|Treatment Period||1002
8280569|NCT01674634|20417282|P1|NOT COMPLETED|Overall Study||6
8280570|NCT01674634|20417282|P1|COMPLETED|Overall Study||709
8280571|NCT01674634|20417282|P1|STARTED|Overall Study||715
8280572|NCT01674621|20417302|P5|NOT COMPLETED|Overall Study||6
8280573|NCT01674621|20417303|P4|NOT COMPLETED|Overall Study||6
8280574|NCT01674621|20417304|P3|NOT COMPLETED|Overall Study||7
8280575|NCT01674621|20417305|P2|NOT COMPLETED|Overall Study||8
8280576|NCT01674621|20417306|P1|NOT COMPLETED|Overall Study||5
8280577|NCT01674621|20417302|P5|COMPLETED|Overall Study||44
8280578|NCT01674621|20417303|P4|COMPLETED|Overall Study||45
8280579|NCT01674621|20417304|P3|COMPLETED|Overall Study||41
8280580|NCT01674621|20417305|P2|COMPLETED|Overall Study||43
8280581|NCT01674621|20417306|P1|COMPLETED|Overall Study||45
8280582|NCT01674621|20417302|P5|Safety Population|Overall Study||50
8280583|NCT01674621|20417303|P4|Safety Population|Overall Study||51
8280584|NCT01674621|20417304|P3|Safety Population|Overall Study||47
8280585|NCT01674621|20417305|P2|Safety Population|Overall Study||51
8280586|NCT01674621|20417306|P1|Safety Population|Overall Study||50
8280587|NCT01674621|20417302|P5|Modified Intent-to-Treat Population|Overall Study||46
8280588|NCT01674621|20417303|P4|Modified Intent-to-Treat Population|Overall Study||49
8280589|NCT01674621|20417304|P3|Modified Intent-to-Treat Population|Overall Study||43
8280590|NCT01674621|20417305|P2|Modified Intent-to-Treat Population|Overall Study||46
8280591|NCT01674621|20417306|P1|Modified Intent-to-Treat Population|Overall Study||47
8280592|NCT01674621|20417302|P5|STARTED|Overall Study||50
8280593|NCT01674621|20417303|P4|STARTED|Overall Study||51
8280594|NCT01674621|20417304|P3|STARTED|Overall Study||48
8280595|NCT01674621|20417305|P2|STARTED|Overall Study||51
8280596|NCT01674621|20417306|P1|STARTED|Overall Study||50
8280597|NCT01674569|20417383|P6|NOT COMPLETED|Overall Study||2
8280598|NCT01674569|20417384|P5|NOT COMPLETED|Overall Study||2
8280599|NCT01674569|20417385|P4|NOT COMPLETED|Overall Study||1
8280600|NCT01674569|20417386|P3|NOT COMPLETED|Overall Study||2
8280601|NCT01674569|20417387|P2|NOT COMPLETED|Overall Study||3
8280602|NCT01674569|20417388|P1|NOT COMPLETED|Overall Study||0
8280603|NCT01674569|20417383|P6|COMPLETED|Overall Study||1
8280604|NCT01674569|20417384|P5|COMPLETED|Overall Study||5
8280605|NCT01674569|20417385|P4|COMPLETED|Overall Study||9
8280606|NCT01674569|20417386|P3|COMPLETED|Overall Study||2
8280607|NCT01674569|20417387|P2|COMPLETED|Overall Study||5
8280608|NCT01674569|20417388|P1|COMPLETED|Overall Study||3
8280609|NCT01674569|20417383|P6|STARTED|Overall Study||3
8280610|NCT01674569|20417384|P5|STARTED|Overall Study||7
8280611|NCT01674569|20417385|P4|STARTED|Overall Study||10
8280612|NCT01674569|20417386|P3|STARTED|Overall Study||4
8280613|NCT01674569|20417387|P2|STARTED|Overall Study||8
8280614|NCT01674569|20417388|P1|STARTED|Overall Study||3
8280615|NCT01674478|20417394|P2|NOT COMPLETED|Overall Study||0
8280616|NCT01674478|20417395|P1|NOT COMPLETED|Overall Study||0
8280617|NCT01674478|20417394|P2|COMPLETED|Overall Study||9
8280618|NCT01674478|20417395|P1|COMPLETED|Overall Study||9
8280619|NCT01674478|20417394|P2|STARTED|Overall Study||9
8280620|NCT01674478|20417395|P1|STARTED|Overall Study||9
8280621|NCT01674062|20417409|P2|NOT COMPLETED|Overall Study||29
8280622|NCT01674062|20417410|P1|NOT COMPLETED|Overall Study||66
8280623|NCT01674062|20417409|P2|COMPLETED|Overall Study||0
8280624|NCT01674062|20417410|P1|COMPLETED|Overall Study||0
8280625|NCT01674062|20417409|P2|STARTED|Overall Study||29
8280626|NCT01674062|20417410|P1|STARTED|Overall Study||66
8280627|NCT01674010|20417425|P3|NOT COMPLETED|Randomization Phase 2||61
8280628|NCT01674010|20417426|P2|NOT COMPLETED|Randomization Phase 2||62
8280629|NCT01674010|20417427|P1|NOT COMPLETED|Randomization Phase 2||0
8280630|NCT01674010|20417425|P3|COMPLETED|Randomization Phase 2||3
8280631|NCT01674010|20417426|P2|COMPLETED|Randomization Phase 2||3
8280632|NCT01674010|20417427|P1|COMPLETED|Randomization Phase 2||0
8280633|NCT01674010|20417425|P3|STARTED|Randomization Phase 2||64
8280634|NCT01674010|20417426|P2|STARTED|Randomization Phase 2||65
8280635|NCT01674010|20417427|P1|STARTED|Randomization Phase 2||0
8280636|NCT01674010|20417425|P3|NOT COMPLETED|Open Treatment Phase 1||0
8280637|NCT01674010|20417426|P2|NOT COMPLETED|Open Treatment Phase 1||0
8280638|NCT01674010|20417427|P1|NOT COMPLETED|Open Treatment Phase 1||180
8280639|NCT01674010|20417425|P3|COMPLETED|Open Treatment Phase 1||0
8280640|NCT01674010|20417426|P2|COMPLETED|Open Treatment Phase 1||0
8280641|NCT01674010|20417427|P1|COMPLETED|Open Treatment Phase 1||129
8280642|NCT01674010|20417425|P3|STARTED|Open Treatment Phase 1||0
8280643|NCT01674010|20417426|P2|STARTED|Open Treatment Phase 1||0
8280644|NCT01674010|20417427|P1|STARTED|Open Treatment Phase 1||309
8280645|NCT01673984|20417446|P2|NOT COMPLETED|Overall Study||6
8280646|NCT01673984|20417447|P1|NOT COMPLETED|Overall Study||10
8280647|NCT01673984|20417446|P2|COMPLETED|Overall Study||1
8280648|NCT01673984|20417447|P1|COMPLETED|Overall Study||4
8280649|NCT01673984|20417446|P2|STARTED|Overall Study||7
8280650|NCT01673984|20417447|P1|STARTED|Overall Study||14
8280651|NCT01673919|20417465|P1|NOT COMPLETED|Overall Study||0
8280652|NCT01673919|20417465|P1|COMPLETED|Overall Study||7
8280653|NCT01673919|20417465|P1|STARTED|Overall Study||7
8280654|NCT01673893|20417489|P1|NOT COMPLETED|Overall Study||0
8280655|NCT01673893|20417489|P1|COMPLETED|Overall Study||59
8280656|NCT01673893|20417489|P1|STARTED|Overall Study||59
8280657|NCT01673867|20417497|P2|NOT COMPLETED|Treatment||268
8280658|NCT01673867|20417498|P1|NOT COMPLETED|Treatment||244
8280659|NCT01673867|20417497|P2|COMPLETED|Treatment||0
8280660|NCT01673867|20417498|P1|COMPLETED|Treatment||43
8280661|NCT01673867|20417497|P2|STARTED|Treatment||268
8280662|NCT01673867|20417498|P1|STARTED|Treatment||287
8280663|NCT01673867|20417497|P2|NOT COMPLETED|Randomization||22
8280664|NCT01673867|20417498|P1|NOT COMPLETED|Randomization||5
8280665|NCT01673867|20417497|P2|COMPLETED|Randomization||268
8280666|NCT01673867|20417498|P1|COMPLETED|Randomization||287
8280667|NCT01673867|20417497|P2|STARTED|Randomization||290
8280668|NCT01673867|20417498|P1|STARTED|Randomization||292
8280669|NCT01673854|20417524|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
8280670|NCT01673854|20417524|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
8280671|NCT01673854|20417524|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
8280672|NCT01673854|20417524|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
8280673|NCT01673854|20417524|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
8280674|NCT01673854|20417524|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
8280675|NCT01673854|20417524|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
8280676|NCT01673854|20417524|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
8280677|NCT01673854|20417524|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
8280678|NCT01673828|20417534|P2|NOT COMPLETED|Overall Study||0
8280679|NCT01673828|20417535|P1|NOT COMPLETED|Overall Study||0
8280680|NCT01673828|20417534|P2|COMPLETED|Overall Study||6
8280681|NCT01673828|20417535|P1|COMPLETED|Overall Study||7
8280682|NCT01673828|20417534|P2|STARTED|Overall Study||6
8280683|NCT01673828|20417535|P1|STARTED|Overall Study||7
8280684|NCT01673802|20417541|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
8280685|NCT01673802|20417541|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
8280686|NCT01673802|20417541|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
8280687|NCT01673802|20417541|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
8280688|NCT01673802|20417541|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
8280689|NCT01673802|20417541|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
8280690|NCT01673698|20417547|P2|NOT COMPLETED|Overall Study||13
8280691|NCT01673698|20417548|P1|NOT COMPLETED|Overall Study||51
8280692|NCT01673698|20417547|P2|COMPLETED|Overall Study||126
8280693|NCT01673698|20417548|P1|COMPLETED|Overall Study||136
8280694|NCT01673698|20417547|P2|STARTED|Overall Study||139
8280695|NCT01673698|20417548|P1|STARTED|Overall Study||187
8280696|NCT01673646|20417559|P3|NOT COMPLETED|Overall Study||4
8280697|NCT01673646|20417560|P2|NOT COMPLETED|Overall Study||7
8280698|NCT01673646|20417561|P1|NOT COMPLETED|Overall Study||4
8280699|NCT01673646|20417559|P3|COMPLETED|Overall Study||7
8280700|NCT01673646|20417560|P2|COMPLETED|Overall Study||4
8280701|NCT01673646|20417561|P1|COMPLETED|Overall Study||7
8280702|NCT01673646|20417559|P3|Discontinued Beyond 24 Months|Overall Study||1
8280703|NCT01673646|20417560|P2|Discontinued Beyond 24 Months|Overall Study||4
8280704|NCT01673646|20417561|P1|Discontinued Beyond 24 Months|Overall Study||0
8280705|NCT01673646|20417559|P3|Treated Beyond 24 Months|Overall Study||8
8280706|NCT01673646|20417560|P2|Treated Beyond 24 Months|Overall Study||8
8280707|NCT01673646|20417561|P1|Treated Beyond 24 Months|Overall Study||7
8280708|NCT01673646|20417559|P3|Did Not Enter Ext. Phase|Overall Study||1
8280709|NCT01673646|20417560|P2|Did Not Enter Ext. Phase|Overall Study||1
8280710|NCT01673646|20417561|P1|Did Not Enter Ext. Phase|Overall Study||2
8280711|NCT01673646|20417559|P3|Entered Ext. Phase|Overall Study||9
8280712|NCT01673646|20417560|P2|Entered Ext. Phase|Overall Study||9
8280713|NCT01673646|20417561|P1|Entered Ext. Phase|Overall Study||7
8280714|NCT01673646|20417559|P3|Completed Core Phase|Overall Study||10
8280715|NCT01673646|20417560|P2|Completed Core Phase|Overall Study||10
8280716|NCT01673646|20417561|P1|Completed Core Phase|Overall Study||9
8280717|NCT01673646|20417559|P3|Entered/Treated in Core Phase|Overall Study||11
8280718|NCT01673646|20417560|P2|Entered/Treated in Core Phase|Overall Study||11
8280719|NCT01673646|20417561|P1|Entered/Treated in Core Phase|Overall Study||11
8280720|NCT01673646|20417559|P3|STARTED|Overall Study||11
8280721|NCT01673646|20417560|P2|STARTED|Overall Study||11
8280722|NCT01673646|20417561|P1|STARTED|Overall Study||11
8280723|NCT01673620|20417600|P2|NOT COMPLETED|Overall Study||0
8280724|NCT01673620|20417601|P1|NOT COMPLETED|Overall Study||1
8280725|NCT01673620|20417600|P2|COMPLETED|Overall Study||22
8280726|NCT01673620|20417601|P1|COMPLETED|Overall Study||46
8280727|NCT01673620|20417600|P2|STARTED|Overall Study||22
8280728|NCT01673620|20417601|P1|STARTED|Overall Study||47
8280729|NCT01673594|20417611|P2|NOT COMPLETED|Overall Study||6
8280730|NCT01673594|20417612|P1|NOT COMPLETED|Overall Study||6
8280731|NCT01673594|20417611|P2|COMPLETED|Overall Study||13
8280732|NCT01673594|20417612|P1|COMPLETED|Overall Study||12
8280733|NCT01673594|20417611|P2|STARTED|Overall Study||19
8280734|NCT01673594|20417612|P1|STARTED|Overall Study||18
8280735|NCT01673568|20417622|P2|NOT COMPLETED|Overall Study||0
8280736|NCT01673568|20417623|P1|NOT COMPLETED|Overall Study||0
8280737|NCT01673568|20417622|P2|COMPLETED|Overall Study||28
8280738|NCT01673568|20417623|P1|COMPLETED|Overall Study||28
8280739|NCT01673568|20417622|P2|STARTED|Overall Study||28
8280740|NCT01673568|20417623|P1|STARTED|Overall Study||28
8280741|NCT01673490|20417631|P1|NOT COMPLETED|Overall Study||7
8280742|NCT01673490|20417631|P1|COMPLETED|Overall Study||52
8280743|NCT01673490|20417631|P1|STARTED|Overall Study||59
8280744|NCT01673425|20417644|P1|NOT COMPLETED|Overall Study||1
8280745|NCT01673425|20417644|P1|COMPLETED|Overall Study||4
8280746|NCT01673425|20417644|P1|STARTED|Overall Study||5
8280747|NCT01673386|20417648|P2|NOT COMPLETED|Overall Study||27
8280748|NCT01673386|20417649|P1|NOT COMPLETED|Overall Study||25
8280749|NCT01673386|20417648|P2|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
8280750|NCT01673386|20417649|P1|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
8280751|NCT01673386|20417648|P2|STARTED|Overall Study||31
8280752|NCT01673386|20417649|P1|STARTED|Overall Study||27
8280753|NCT01673373|20417679|P1|NOT COMPLETED|Overall Study||2
8280754|NCT01673373|20417679|P1|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
8280755|NCT01673373|20417679|P1|STARTED|Overall Study||68
8280756|NCT01673347|20417695|P1|NOT COMPLETED|Overall Study||7
8280757|NCT01673347|20417695|P1|COMPLETED|Overall Study||17
8280758|NCT01673347|20417695|P1|STARTED|Overall Study||24
8280759|NCT01673282|20417704|P2|NOT COMPLETED|Overall Study||26
8280760|NCT01673282|20417705|P1|NOT COMPLETED|Overall Study||33
8280761|NCT01673282|20417704|P2|COMPLETED|Overall Study||132
8280762|NCT01673282|20417705|P1|COMPLETED|Overall Study||120
8280763|NCT01673282|20417704|P2|STARTED|Overall Study||158
8280764|NCT01673282|20417705|P1|STARTED|Overall Study||153
8280765|NCT01673256|20417711|P1|NOT COMPLETED|Overall Study||0
8280766|NCT01673256|20417711|P1|COMPLETED|Overall Study||90
8280767|NCT01673256|20417711|P1|STARTED|Overall Study||90
8280768|NCT01673191|20417717|P2|NOT COMPLETED|Overall Study||0
8280769|NCT01673191|20417718|P1|NOT COMPLETED|Overall Study||0
8280770|NCT01673191|20417717|P2|COMPLETED|Overall Study||11
8280771|NCT01673191|20417718|P1|COMPLETED|Overall Study||26
8280772|NCT01673191|20417717|P2|STARTED|Overall Study||11
8280773|NCT01673191|20417718|P1|STARTED|Overall Study||26
8280774|NCT01673178|20417741|P5|NOT COMPLETED|Overall Study||2
8280775|NCT01673178|20417742|P4|NOT COMPLETED|Overall Study||8
8280776|NCT01673178|20417743|P3|NOT COMPLETED|Overall Study||3
8280777|NCT01673178|20417744|P2|NOT COMPLETED|Overall Study||2
8280778|NCT01673178|20417745|P1|NOT COMPLETED|Overall Study||3
8280779|NCT01673178|20417741|P5|COMPLETED|Overall Study||19
8280780|NCT01673178|20417742|P4|COMPLETED|Overall Study||14
8280781|NCT01673178|20417743|P3|COMPLETED|Overall Study||18
8280782|NCT01673178|20417744|P2|COMPLETED|Overall Study||19
8280783|NCT01673178|20417745|P1|COMPLETED|Overall Study||19
8280784|NCT01673178|20417741|P5|STARTED|Overall Study||21
8280785|NCT01673178|20417742|P4|STARTED|Overall Study||22
8280786|NCT01673178|20417743|P3|STARTED|Overall Study||21
8280787|NCT01673178|20417744|P2|STARTED|Overall Study||21
8280788|NCT01673178|20417745|P1|STARTED|Overall Study||22
8280789|NCT01673126|20417984|P2|NOT COMPLETED|Overall Study||3
8280790|NCT01673126|20417985|P1|NOT COMPLETED|Overall Study||4
8280791|NCT01673126|20417984|P2|COMPLETED|Overall Study||23
8280792|NCT01673126|20417985|P1|COMPLETED|Overall Study||32
8280793|NCT01673126|20417984|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
8280794|NCT01673126|20417985|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
8280795|NCT01673113|20417993|P2|NOT COMPLETED|Overall Study||0
8280796|NCT01673113|20417994|P1|NOT COMPLETED|Overall Study||0
8280797|NCT01673113|20417993|P2|COMPLETED|Overall Study||11
8280798|NCT01673113|20417994|P1|COMPLETED|Overall Study||11
8280799|NCT01673113|20417993|P2|STARTED|Overall Study||11
8280800|NCT01673113|20417994|P1|STARTED|Overall Study||11
8280801|NCT01673061|20418003|P2|NOT COMPLETED|Overall Study||0
8280802|NCT01673061|20418004|P1|NOT COMPLETED|Overall Study||0
8280803|NCT01673061|20418003|P2|COMPLETED|Overall Study||0
8280804|NCT01673061|20418004|P1|COMPLETED|Overall Study||0
8280805|NCT01673061|20418003|P2|STARTED|Overall Study||0
8280806|NCT01673061|20418004|P1|STARTED|Overall Study||0
8280807|NCT01673022|20418020|P1|NOT COMPLETED|Overall Study||8
8280808|NCT01673022|20418020|P1|COMPLETED|Overall Study||422
8280809|NCT01673022|20418020|P1|STARTED|Overall Study||430
8280810|NCT01673009|20418024|P1|NOT COMPLETED|Overall Study||13
8280811|NCT01673009|20418024|P1|COMPLETED|Overall Study||23
8280812|NCT01673009|20418024|P1|STARTED|Overall Study||36
8280813|NCT01672996|20418036|P3|NOT COMPLETED|Overall Study||0
8280814|NCT01672996|20418037|P2|NOT COMPLETED|Overall Study||0
8280815|NCT01672996|20418038|P1|NOT COMPLETED|Overall Study||0
8280816|NCT01672996|20418036|P3|COMPLETED|Overall Study||6
8280817|NCT01672996|20418037|P2|COMPLETED|Overall Study||30
8280818|NCT01672996|20418038|P1|COMPLETED|Overall Study||30
8280819|NCT01672996|20418036|P3|STARTED|Overall Study||6
8280820|NCT01672996|20418037|P2|STARTED|Overall Study||30
8280821|NCT01672996|20418038|P1|STARTED|Overall Study||30
8280822|NCT01672983|20418074|P6|NOT COMPLETED|Overall Study||0
8280823|NCT01672983|20418075|P5|NOT COMPLETED|Overall Study||0
8280824|NCT01672983|20418076|P4|NOT COMPLETED|Overall Study||0
8280825|NCT01672983|20418077|P3|NOT COMPLETED|Overall Study||0
8280826|NCT01672983|20418078|P2|NOT COMPLETED|Overall Study||0
8280827|NCT01672983|20418079|P1|NOT COMPLETED|Overall Study||0
8280828|NCT01672983|20418074|P6|COMPLETED|Overall Study||18
8280829|NCT01672983|20418075|P5|COMPLETED|Overall Study||19
8280830|NCT01672983|20418076|P4|COMPLETED|Overall Study||18
8280831|NCT01672983|20418077|P3|COMPLETED|Overall Study||19
8280832|NCT01672983|20418078|P2|COMPLETED|Overall Study||18
8280833|NCT01672983|20418079|P1|COMPLETED|Overall Study||18
8280834|NCT01672983|20418074|P6|Completed Study Drug|Overall Study||17
8280835|NCT01672983|20418075|P5|Completed Study Drug|Overall Study||12
8280836|NCT01672983|20418076|P4|Completed Study Drug|Overall Study||18
8280837|NCT01672983|20418077|P3|Completed Study Drug|Overall Study||18
8280838|NCT01672983|20418078|P2|Completed Study Drug|Overall Study||17
8280839|NCT01672983|20418079|P1|Completed Study Drug|Overall Study||18
8280840|NCT01672983|20418074|P6|STARTED|Overall Study||18
8280841|NCT01672983|20418075|P5|STARTED|Overall Study||19
8280842|NCT01672983|20418076|P4|STARTED|Overall Study||18
8280843|NCT01672983|20418077|P3|STARTED|Overall Study||19
8280844|NCT01672983|20418078|P2|STARTED|Overall Study||18
8280845|NCT01672983|20418079|P1|STARTED|Overall Study||18
8280846|NCT01672970|20418109|P1|NOT COMPLETED|Overall Study||47
8280847|NCT01672970|20418109|P1|COMPLETED|Overall Study||244
8280848|NCT01672970|20418109|P1|Treated|Overall Study||290
8280849|NCT01672970|20418109|P1|STARTED|Overall Study||291
8280850|NCT01672957|20418145|P1|NOT COMPLETED|Overall Study||55
8280851|NCT01672957|20418145|P1|COMPLETED|Overall Study||73
8280852|NCT01672957|20418145|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
8280853|NCT01672957|20418145|P1|STARTED|Overall Study||128
8280854|NCT01672892|20418160|P2|NOT COMPLETED|Overall Study||3
8280855|NCT01672892|20418161|P1|NOT COMPLETED|Overall Study||7
8280856|NCT01672892|20418160|P2|COMPLETED|Overall Study||149
8280857|NCT01672892|20418161|P1|COMPLETED|Overall Study||130
8280858|NCT01672892|20418160|P2|Adverse Event Population|Overall Study||144
8280859|NCT01672892|20418161|P1|Adverse Event Population|Overall Study||125
8280860|NCT01672892|20418160|P2|Eligible Population|Overall Study||149
8280861|NCT01672892|20418161|P1|Eligible Population|Overall Study||130
8280862|NCT01672892|20418160|P2|STARTED|Overall Study||152
8280863|NCT01672892|20418161|P1|STARTED|Overall Study||137
8280864|NCT01672879|20418190|P3|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
8280865|NCT01672879|20418191|P2|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
8280866|NCT01672879|20418192|P1|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
8280867|NCT01672879|20418190|P3|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8280868|NCT01672879|20418191|P2|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8280869|NCT01672879|20418192|P1|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8280870|NCT01672879|20418190|P3|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
8280871|NCT01672879|20418191|P2|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
8280872|NCT01672879|20418192|P1|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
8280873|NCT01672879|20418190|P3|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
8280874|NCT01672879|20418191|P2|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
8280875|NCT01672879|20418192|P1|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
8280876|NCT01672879|20418190|P3|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8280877|NCT01672879|20418191|P2|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8280878|NCT01672879|20418192|P1|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8280879|NCT01672879|20418190|P3|STARTED|Blinded Phase (Up to 240 Weeks)||86
8280880|NCT01672879|20418191|P2|STARTED|Blinded Phase (Up to 240 Weeks)||86
8280881|NCT01672879|20418192|P1|STARTED|Blinded Phase (Up to 240 Weeks)||87
8280882|NCT01672866|20418207|P3|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
8280883|NCT01672866|20418208|P2|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
8280884|NCT01672866|20418209|P1|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
8280885|NCT01672866|20418207|P3|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8280886|NCT01672866|20418208|P2|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8280887|NCT01672866|20418209|P1|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8280888|NCT01672866|20418207|P3|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
8280889|NCT01672866|20418208|P2|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
8280890|NCT01672866|20418209|P1|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
8280891|NCT01672866|20418207|P3|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8280892|NCT01672866|20418208|P2|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8280893|NCT01672866|20418209|P1|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8280894|NCT01672866|20418207|P3|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8280895|NCT01672866|20418208|P2|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8280896|NCT01672866|20418209|P1|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8280897|NCT01672866|20418207|P3|STARTED|Blinded Phase (up to 240 Weeks)||74
8280898|NCT01672866|20418208|P2|STARTED|Blinded Phase (up to 240 Weeks)||74
8280899|NCT01672866|20418209|P1|STARTED|Blinded Phase (up to 240 Weeks)||74
8280900|NCT01672853|20418224|P3|NOT COMPLETED|Overall Study||14
8280901|NCT01672853|20418225|P2|NOT COMPLETED|Overall Study||17
8280902|NCT01672853|20418226|P1|NOT COMPLETED|Overall Study||10
8280903|NCT01672853|20418224|P3|COMPLETED|Overall Study||65
8280904|NCT01672853|20418225|P2|COMPLETED|Overall Study||60
8280905|NCT01672853|20418226|P1|COMPLETED|Overall Study||69
8280906|NCT01672853|20418224|P3|STARTED|Overall Study||79
8280907|NCT01672853|20418225|P2|STARTED|Overall Study||77
8280908|NCT01672853|20418226|P1|STARTED|Overall Study||79
8280909|NCT01672827|20418243|P1|NOT COMPLETED|Overall Study||0
8280910|NCT01672827|20418243|P1|COMPLETED|Overall Study||276
8280911|NCT01672827|20418243|P1|STARTED|Overall Study||276
8280912|NCT01672801|20418251|P2|NOT COMPLETED|Overall Study||1
8280913|NCT01672801|20418252|P1|NOT COMPLETED|Overall Study||0
8280914|NCT01672801|20418251|P2|COMPLETED|Overall Study||8
8280915|NCT01672801|20418252|P1|COMPLETED|Overall Study||9
8280916|NCT01672801|20418251|P2|STARTED|Overall Study||9
8280917|NCT01672801|20418252|P1|STARTED|Overall Study||9
8280918|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280919|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280920|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280921|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280922|NCT01672788|20418260|P4|COMPLETED|Treatment Period 4 (3 Days)||8
8280923|NCT01672788|20418261|P3|COMPLETED|Treatment Period 4 (3 Days)||9
8280924|NCT01672788|20418262|P2|COMPLETED|Treatment Period 4 (3 Days)||9
8280925|NCT01672788|20418263|P1|COMPLETED|Treatment Period 4 (3 Days)||9
8280926|NCT01672788|20418260|P4|STARTED|Treatment Period 4 (3 Days)||8
8280927|NCT01672788|20418261|P3|STARTED|Treatment Period 4 (3 Days)||9
8280928|NCT01672788|20418262|P2|STARTED|Treatment Period 4 (3 Days)||9
8280929|NCT01672788|20418263|P1|STARTED|Treatment Period 4 (3 Days)||9
8280930|NCT01672788|20418260|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280931|NCT01672788|20418261|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280932|NCT01672788|20418262|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280933|NCT01672788|20418263|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280934|NCT01672788|20418260|P4|COMPLETED|Washout Period 3 (7 Days)||8
8280935|NCT01672788|20418261|P3|COMPLETED|Washout Period 3 (7 Days)||9
8280936|NCT01672788|20418262|P2|COMPLETED|Washout Period 3 (7 Days)||9
8280937|NCT01672788|20418263|P1|COMPLETED|Washout Period 3 (7 Days)||9
8280938|NCT01672788|20418260|P4|STARTED|Washout Period 3 (7 Days)||8
8280939|NCT01672788|20418261|P3|STARTED|Washout Period 3 (7 Days)||9
8280940|NCT01672788|20418262|P2|STARTED|Washout Period 3 (7 Days)||9
8280941|NCT01672788|20418263|P1|STARTED|Washout Period 3 (7 Days)||9
8280942|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280943|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280944|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280945|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280946|NCT01672788|20418260|P4|COMPLETED|Treatment Period 3 (3 Days)||8
8280947|NCT01672788|20418261|P3|COMPLETED|Treatment Period 3 (3 Days)||9
8280948|NCT01672788|20418262|P2|COMPLETED|Treatment Period 3 (3 Days)||9
8280949|NCT01672788|20418263|P1|COMPLETED|Treatment Period 3 (3 Days)||9
8280950|NCT01672788|20418260|P4|STARTED|Treatment Period 3 (3 Days)||8
8280951|NCT01672788|20418261|P3|STARTED|Treatment Period 3 (3 Days)||9
8280952|NCT01672788|20418262|P2|STARTED|Treatment Period 3 (3 Days)||9
8280953|NCT01672788|20418263|P1|STARTED|Treatment Period 3 (3 Days)||9
8280954|NCT01672788|20418260|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
8280955|NCT01672788|20418261|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8280956|NCT01672788|20418262|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8280957|NCT01672788|20418263|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8280958|NCT01672788|20418260|P4|COMPLETED|Washout Period 2 (7 Days)||8
8280959|NCT01672788|20418261|P3|COMPLETED|Washout Period 2 (7 Days)||9
8280960|NCT01672788|20418262|P2|COMPLETED|Washout Period 2 (7 Days)||9
8280961|NCT01672788|20418263|P1|COMPLETED|Washout Period 2 (7 Days)||9
8280962|NCT01672788|20418260|P4|STARTED|Washout Period 2 (7 Days)||9
8280963|NCT01672788|20418261|P3|STARTED|Washout Period 2 (7 Days)||9
8280964|NCT01672788|20418262|P2|STARTED|Washout Period 2 (7 Days)||9
8280965|NCT01672788|20418263|P1|STARTED|Washout Period 2 (7 Days)||9
8280966|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280967|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280968|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280969|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280970|NCT01672788|20418260|P4|COMPLETED|Treatment Period 2 (3 Days)||9
8280971|NCT01672788|20418261|P3|COMPLETED|Treatment Period 2 (3 Days)||9
8280972|NCT01672788|20418262|P2|COMPLETED|Treatment Period 2 (3 Days)||9
8280973|NCT01672788|20418263|P1|COMPLETED|Treatment Period 2 (3 Days)||9
8280974|NCT01672788|20418260|P4|STARTED|Treatment Period 2 (3 Days)||9
8280975|NCT01672788|20418261|P3|STARTED|Treatment Period 2 (3 Days)||9
8280976|NCT01672788|20418262|P2|STARTED|Treatment Period 2 (3 Days)||9
8280977|NCT01672788|20418263|P1|STARTED|Treatment Period 2 (3 Days)||9
8280978|NCT01672788|20418260|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280979|NCT01672788|20418261|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280980|NCT01672788|20418262|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280981|NCT01672788|20418263|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280982|NCT01672788|20418260|P4|COMPLETED|Washout Period 1 (7 Days)||9
8280983|NCT01672788|20418261|P3|COMPLETED|Washout Period 1 (7 Days)||9
8280984|NCT01672788|20418262|P2|COMPLETED|Washout Period 1 (7 Days)||9
8280985|NCT01672788|20418263|P1|COMPLETED|Washout Period 1 (7 Days)||9
8280986|NCT01672788|20418260|P4|STARTED|Washout Period 1 (7 Days)||9
8280987|NCT01672788|20418261|P3|STARTED|Washout Period 1 (7 Days)||9
8280988|NCT01672788|20418262|P2|STARTED|Washout Period 1 (7 Days)||9
8280989|NCT01672788|20418263|P1|STARTED|Washout Period 1 (7 Days)||9
8280990|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280991|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280992|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280993|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280994|NCT01672788|20418260|P4|COMPLETED|Treatment Period 1 (3 Days)||9
8280995|NCT01672788|20418261|P3|COMPLETED|Treatment Period 1 (3 Days)||9
8280996|NCT01672788|20418262|P2|COMPLETED|Treatment Period 1 (3 Days)||9
8280997|NCT01672788|20418263|P1|COMPLETED|Treatment Period 1 (3 Days)||9
8280998|NCT01672788|20418260|P4|STARTED|Treatment Period 1 (3 Days)||9
8280999|NCT01672788|20418261|P3|STARTED|Treatment Period 1 (3 Days)||9
8281000|NCT01672788|20418262|P2|STARTED|Treatment Period 1 (3 Days)||9
8281001|NCT01672788|20418263|P1|STARTED|Treatment Period 1 (3 Days)||9
8281002|NCT01672736|20418293|P1|NOT COMPLETED|Overall Study||3
8281003|NCT01672736|20418293|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
8281004|NCT01672736|20418293|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
8281005|NCT01672723|20418297|P2|NOT COMPLETED|Second Intervention||0
8281006|NCT01672723|20418298|P1|NOT COMPLETED|Second Intervention||0
8281007|NCT01672723|20418297|P2|COMPLETED|Second Intervention||15
8281008|NCT01672723|20418298|P1|COMPLETED|Second Intervention||16
8281009|NCT01672723|20418297|P2|STARTED|Second Intervention||15
8281010|NCT01672723|20418298|P1|STARTED|Second Intervention||16
8281011|NCT01672723|20418297|P2|NOT COMPLETED|Washout Period of 10 Days||0
8281012|NCT01672723|20418298|P1|NOT COMPLETED|Washout Period of 10 Days||0
8281013|NCT01672723|20418297|P2|COMPLETED|Washout Period of 10 Days||15
8281014|NCT01672723|20418298|P1|COMPLETED|Washout Period of 10 Days||16
8281015|NCT01672723|20418297|P2|STARTED|Washout Period of 10 Days||15
8281016|NCT01672723|20418298|P1|STARTED|Washout Period of 10 Days||16
8281017|NCT01672723|20418297|P2|NOT COMPLETED|First Intervention||0
8281018|NCT01672723|20418298|P1|NOT COMPLETED|First Intervention||3
8281019|NCT01672723|20418297|P2|COMPLETED|First Intervention||15
8281020|NCT01672723|20418298|P1|COMPLETED|First Intervention||16
8281021|NCT01672723|20418297|P2|STARTED|First Intervention||15
8281022|NCT01672723|20418298|P1|STARTED|First Intervention||19
8281023|NCT01672710|20418310|P2|NOT COMPLETED|3 Month Follow up||4
8281024|NCT01672710|20418311|P1|NOT COMPLETED|3 Month Follow up||6
8281025|NCT01672710|20418310|P2|COMPLETED|3 Month Follow up||5
8281026|NCT01672710|20418311|P1|COMPLETED|3 Month Follow up||16
8281027|NCT01672710|20418310|P2|STARTED|3 Month Follow up||9
8281028|NCT01672710|20418311|P1|STARTED|3 Month Follow up||22
8281029|NCT01672710|20418310|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
8281030|NCT01672710|20418311|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
8281031|NCT01672710|20418310|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
8281032|NCT01672710|20418311|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
8281033|NCT01672710|20418310|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
8281034|NCT01672710|20418311|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
8281035|NCT01672710|20418310|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
8281036|NCT01672710|20418311|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
8281037|NCT01672710|20418310|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
8281038|NCT01672710|20418311|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
8281039|NCT01672710|20418310|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
8281040|NCT01672710|20418311|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
8281041|NCT01672658|20418321|P2|NOT COMPLETED|Overall Study||1
8281042|NCT01672658|20418322|P1|NOT COMPLETED|Overall Study||0
8281043|NCT01672658|20418321|P2|COMPLETED|Overall Study||14
8281044|NCT01672658|20418322|P1|COMPLETED|Overall Study||16
8281045|NCT01672658|20418321|P2|STARTED|Overall Study||15
8281046|NCT01672658|20418322|P1|STARTED|Overall Study||16
8281047|NCT01672294|20418346|P4|NOT COMPLETED|Overall Study||13
8281048|NCT01672294|20418347|P3|NOT COMPLETED|Overall Study||11
8281049|NCT01672294|20418348|P2|NOT COMPLETED|Overall Study||21
8281050|NCT01672294|20418349|P1|NOT COMPLETED|Overall Study||6
8281051|NCT01672294|20418346|P4|COMPLETED|Overall Study||59
8281052|NCT01672294|20418347|P3|COMPLETED|Overall Study||61
8281053|NCT01672294|20418348|P2|COMPLETED|Overall Study||50
8281054|NCT01672294|20418349|P1|COMPLETED|Overall Study||65
8281055|NCT01672294|20418346|P4|STARTED|Overall Study||72
8281056|NCT01672294|20418347|P3|STARTED|Overall Study||72
8281057|NCT01672294|20418348|P2|STARTED|Overall Study||71
8281058|NCT01672294|20418349|P1|STARTED|Overall Study||71
8281059|NCT01672242|20418371|P2|NOT COMPLETED|Period 2||0
8281060|NCT01672242|20418372|P1|NOT COMPLETED|Period 2||0
8281061|NCT01672242|20418371|P2|COMPLETED|Period 2||2
8281062|NCT01672242|20418372|P1|COMPLETED|Period 2||4
8281063|NCT01672242|20418371|P2|STARTED|Period 2||2
8281064|NCT01672242|20418372|P1|STARTED|Period 2||4
8281065|NCT01672242|20418371|P2|NOT COMPLETED|Period 1||0
8281066|NCT01672242|20418372|P1|NOT COMPLETED|Period 1||0
8281067|NCT01672242|20418371|P2|COMPLETED|Period 1||2
8281068|NCT01672242|20418372|P1|COMPLETED|Period 1||4
8281069|NCT01672242|20418371|P2|STARTED|Period 1||2
8281070|NCT01672242|20418372|P1|STARTED|Period 1||4
8281071|NCT01671839|20418378|P1|NOT COMPLETED|Overall Study||18
8281072|NCT01671839|20418378|P1|COMPLETED|Overall Study||37
8281073|NCT01671839|20418378|P1|5-year Follow-up|Overall Study||37
8281074|NCT01671839|20418378|P1|3-year Follow-up|Overall Study||45
8281075|NCT01671839|20418378|P1|STARTED|Overall Study||55
8281076|NCT01671748|20418394|P2|NOT COMPLETED|12 Week Treatment Phase||0
8281077|NCT01671748|20418395|P1|NOT COMPLETED|12 Week Treatment Phase||0
8281078|NCT01671748|20418394|P2|COMPLETED|12 Week Treatment Phase||17
8281079|NCT01671748|20418395|P1|COMPLETED|12 Week Treatment Phase||19
8281080|NCT01671748|20418394|P2|STARTED|12 Week Treatment Phase||17
8281081|NCT01671748|20418395|P1|STARTED|12 Week Treatment Phase||19
8281082|NCT01671748|20418394|P2|NOT COMPLETED|4 Week run-in Phase||0
8281083|NCT01671748|20418395|P1|NOT COMPLETED|4 Week run-in Phase||11
8281084|NCT01671748|20418394|P2|COMPLETED|4 Week run-in Phase||0
8281085|NCT01671748|20418395|P1|COMPLETED|4 Week run-in Phase||36
8281086|NCT01671748|20418394|P2|STARTED|4 Week run-in Phase||0
8281087|NCT01671748|20418395|P1|STARTED|4 Week run-in Phase||47
8281088|NCT01671605|20418415|P2|NOT COMPLETED|Overall Study||0
8281089|NCT01671605|20418416|P1|NOT COMPLETED|Overall Study||0
8281090|NCT01671605|20418415|P2|COMPLETED|Overall Study||31
8281091|NCT01671605|20418416|P1|COMPLETED|Overall Study||72
8281092|NCT01671605|20418415|P2|STARTED|Overall Study||31
8281093|NCT01671605|20418416|P1|STARTED|Overall Study||72
8281094|NCT01671488|20418422|P1|NOT COMPLETED|Overall Study||1
8281095|NCT01671488|20418422|P1|COMPLETED|Overall Study||10
8281096|NCT01671488|20418422|P1|STARTED|Overall Study||11
8281097|NCT01671345|20418430|P2|NOT COMPLETED|Overall Study||9
8281098|NCT01671345|20418431|P1|NOT COMPLETED|Overall Study||13
8281099|NCT01671345|20418430|P2|COMPLETED|Overall Study||83
8281100|NCT01671345|20418431|P1|COMPLETED|Overall Study||64
8281101|NCT01671345|20418430|P2|STARTED|Overall Study||92
8281102|NCT01671345|20418431|P1|STARTED|Overall Study||77
8281103|NCT01671332|20418445|P2|NOT COMPLETED|Overall Study||1
8281104|NCT01671332|20418446|P1|NOT COMPLETED|Overall Study||1
8281105|NCT01671332|20418445|P2|COMPLETED|Overall Study||39
8281106|NCT01671332|20418446|P1|COMPLETED|Overall Study||39
8281107|NCT01671332|20418445|P2|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
8281108|NCT01671332|20418446|P1|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
8281109|NCT01671332|20418445|P2|STARTED|Overall Study||40
8281110|NCT01671332|20418446|P1|STARTED|Overall Study||40
8281111|NCT01671319|20418460|P1|NOT COMPLETED|Overall Study||1
8281112|NCT01671319|20418460|P1|COMPLETED|Overall Study||41
8281113|NCT01671319|20418460|P1|STARTED|Overall Study||42
8281114|NCT01671293|20418468|P2|NOT COMPLETED|Overall Study||2
8281115|NCT01671293|20418469|P1|NOT COMPLETED|Overall Study||3
8281116|NCT01671293|20418468|P2|COMPLETED|Overall Study||32
8281117|NCT01671293|20418469|P1|COMPLETED|Overall Study||33
8281118|NCT01671293|20418468|P2|STARTED|Overall Study||34
8281119|NCT01671293|20418469|P1|STARTED|Overall Study||36
8281120|NCT01671280|20418475|P1|NOT COMPLETED|Overall Study||2
8281121|NCT01671280|20418475|P1|COMPLETED|Overall Study||401
8281122|NCT01671280|20418475|P1|STARTED|Overall Study|The number is enrollment.|403
8281123|NCT01671176|20418481|P1|NOT COMPLETED|Overall Study||0
8281124|NCT01671176|20418481|P1|COMPLETED|Overall Study||30
8281125|NCT01671176|20418481|P1|STARTED|Overall Study||30
8281126|NCT01671111|20418486|P1|NOT COMPLETED|Overall Study||30
8281127|NCT01671111|20418486|P1|COMPLETED|Overall Study||0
8281128|NCT01671111|20418486|P1|STARTED|Overall Study||30
8281129|NCT01671085|20418498|P2|NOT COMPLETED|Overall Study||0
8281130|NCT01671085|20418499|P1|NOT COMPLETED|Overall Study||1
8281131|NCT01671085|20418498|P2|COMPLETED|Overall Study||2
8281132|NCT01671085|20418499|P1|COMPLETED|Overall Study||10
8281133|NCT01671085|20418498|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8281134|NCT01671085|20418499|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
8281135|NCT01671085|20418498|P2|STARTED|Overall Study||2
8281136|NCT01671085|20418499|P1|STARTED|Overall Study|1 participant who dropped out was replaced.|11
8281137|NCT01671059|20418510|P1|NOT COMPLETED|Overall Study||5
8281138|NCT01671059|20418510|P1|COMPLETED|Overall Study||75
8281139|NCT01671059|20418510|P1|STARTED|Overall Study||80
8281140|NCT01671007|20418542|P9|NOT COMPLETED|Overall Study||0
8281141|NCT01671007|20418543|P8|NOT COMPLETED|Overall Study||132
8281142|NCT01671007|20418544|P7|NOT COMPLETED|Overall Study||21
8281143|NCT01671007|20418545|P6|NOT COMPLETED|Overall Study||112
8281144|NCT01671007|20418546|P5|NOT COMPLETED|Overall Study||25
8281145|NCT01671007|20418547|P4|NOT COMPLETED|Overall Study||368
8281146|NCT01671007|20418548|P3|NOT COMPLETED|Overall Study||366
8281147|NCT01671007|20418549|P2|NOT COMPLETED|Overall Study||651
8281148|NCT01671007|20418550|P1|NOT COMPLETED|Overall Study||321
8281149|NCT01671007|20418542|P9|COMPLETED|Overall Study||2
8281150|NCT01671007|20418543|P8|COMPLETED|Overall Study||394
8281151|NCT01671007|20418544|P7|COMPLETED|Overall Study||59
8281152|NCT01671007|20418545|P6|COMPLETED|Overall Study||401
8281153|NCT01671007|20418546|P5|COMPLETED|Overall Study||155
8281154|NCT01671007|20418547|P4|COMPLETED|Overall Study||1846
8281155|NCT01671007|20418548|P3|COMPLETED|Overall Study||1667
8281156|NCT01671007|20418549|P2|COMPLETED|Overall Study||2183
8281157|NCT01671007|20418550|P1|COMPLETED|Overall Study||1768
8281158|NCT01671007|20418542|P9|All Eligible|Overall Study||2
8281159|NCT01671007|20418543|P8|All Eligible|Overall Study||507
8281160|NCT01671007|20418544|P7|All Eligible|Overall Study||79
8281161|NCT01671007|20418545|P6|All Eligible|Overall Study||507
8281162|NCT01671007|20418546|P5|All Eligible|Overall Study||180
8281163|NCT01671007|20418547|P4|All Eligible|Overall Study||2197
8281164|NCT01671007|20418548|P3|All Eligible|Overall Study||2008
8281165|NCT01671007|20418549|P2|All Eligible|Overall Study||2758
8281166|NCT01671007|20418550|P1|All Eligible|Overall Study||2066
8281167|NCT01671007|20418542|P9|STARTED|Overall Study||2
8281168|NCT01671007|20418543|P8|STARTED|Overall Study||526
8281169|NCT01671007|20418544|P7|STARTED|Overall Study||80
8281170|NCT01671007|20418545|P6|STARTED|Overall Study||513
8281171|NCT01671007|20418546|P5|STARTED|Overall Study||180
8281172|NCT01671007|20418547|P4|STARTED|Overall Study||2214
8281173|NCT01671007|20418548|P3|STARTED|Overall Study||2033
8281174|NCT01671007|20418549|P2|STARTED|Overall Study||2834
8281175|NCT01671007|20418550|P1|STARTED|Overall Study||2089
8281176|NCT01670825|20418585|P2|NOT COMPLETED|Overall Study||0
8281177|NCT01670825|20418586|P1|NOT COMPLETED|Overall Study||0
8281178|NCT01670825|20418585|P2|COMPLETED|Overall Study||39
8281179|NCT01670825|20418586|P1|COMPLETED|Overall Study||42
8281180|NCT01670825|20418585|P2|STARTED|Overall Study||39
8281181|NCT01670825|20418586|P1|STARTED|Overall Study||42
8281182|NCT01670760|20418652|P1|NOT COMPLETED|Overall Study||0
8281183|NCT01670760|20418652|P1|COMPLETED|Overall Study||20
8281184|NCT01670760|20418652|P1|STARTED|Overall Study||20
8281185|NCT01670721|20418656|P1|NOT COMPLETED|Overall Study||53
8281186|NCT01670721|20418656|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
8281187|NCT01670721|20418656|P1|STARTED|Overall Study||175
8281188|NCT01670656|20418668|P5|NOT COMPLETED|Overall Study||11
8281189|NCT01670656|20418669|P4|NOT COMPLETED|Overall Study||6
8281190|NCT01670656|20418670|P3|NOT COMPLETED|Overall Study||8
8281191|NCT01670656|20418671|P2|NOT COMPLETED|Overall Study||7
8281192|NCT01670656|20418672|P1|NOT COMPLETED|Overall Study||3
8281193|NCT01670656|20418668|P5|COMPLETED|Overall Study||79
8281194|NCT01670656|20418669|P4|COMPLETED|Overall Study||79
8281195|NCT01670656|20418670|P3|COMPLETED|Overall Study||79
8281196|NCT01670656|20418671|P2|COMPLETED|Overall Study||84
8281197|NCT01670656|20418672|P1|COMPLETED|Overall Study||83
8281198|NCT01670656|20418668|P5|Treated|Overall Study||90
8281199|NCT01670656|20418669|P4|Treated|Overall Study||85
8281200|NCT01670656|20418670|P3|Treated|Overall Study||86
8281201|NCT01670656|20418671|P2|Treated|Overall Study||91
8281202|NCT01670656|20418672|P1|Treated|Overall Study||86
8281203|NCT01670656|20418668|P5|STARTED|Overall Study||90
8281204|NCT01670656|20418669|P4|STARTED|Overall Study||85
8281205|NCT01670656|20418670|P3|STARTED|Overall Study||87
8281206|NCT01670656|20418671|P2|STARTED|Overall Study||91
8281207|NCT01670656|20418672|P1|STARTED|Overall Study||86
8281208|NCT01670526|20418701|P2|NOT COMPLETED|Overall Study||6
8281209|NCT01670526|20418702|P1|NOT COMPLETED|Overall Study||12
8281210|NCT01670526|20418701|P2|COMPLETED|Overall Study||39
8281211|NCT01670526|20418702|P1|COMPLETED|Overall Study||37
8281212|NCT01670526|20418701|P2|STARTED|Overall Study||45
8281213|NCT01670526|20418702|P1|STARTED|Overall Study||49
8281214|NCT01670500|20418716|P2|NOT COMPLETED|Overall Study||0
8281215|NCT01670500|20418717|P1|NOT COMPLETED|Overall Study||1
8281216|NCT01670500|20418716|P2|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
8281217|NCT01670500|20418717|P1|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
8281218|NCT01670500|20418716|P2|STARTED|Overall Study||60
8281219|NCT01670500|20418717|P1|STARTED|Overall Study||58
8281220|NCT01670487|20418733|P2|NOT COMPLETED|Overall Study||0
8281221|NCT01670487|20418734|P1|NOT COMPLETED|Overall Study||0
8281222|NCT01670487|20418733|P2|COMPLETED|Overall Study||150
8281223|NCT01670487|20418734|P1|COMPLETED|Overall Study||150
8281224|NCT01670487|20418733|P2|STARTED|Overall Study||150
8281225|NCT01670487|20418734|P1|STARTED|Overall Study||150
8281226|NCT01670292|20418740|P1|NOT COMPLETED|Overall Study||14
8281227|NCT01670292|20418740|P1|COMPLETED|Overall Study||68
8281228|NCT01670292|20418740|P1|STARTED|Overall Study||82
8281229|NCT01670279|20418781|P4|NOT COMPLETED|Overall Study||1
8281230|NCT01670279|20418782|P3|NOT COMPLETED|Overall Study||0
8281231|NCT01670279|20418783|P2|NOT COMPLETED|Overall Study||2
8281232|NCT01670279|20418784|P1|NOT COMPLETED|Overall Study||0
8281233|NCT01670279|20418781|P4|COMPLETED|Overall Study||4
8281234|NCT01670279|20418782|P3|COMPLETED|Overall Study||0
8281235|NCT01670279|20418783|P2|COMPLETED|Overall Study||5
8281236|NCT01670279|20418784|P1|COMPLETED|Overall Study||6
8281237|NCT01670279|20418781|P4|STARTED|Overall Study||5
8281238|NCT01670279|20418782|P3|STARTED|Overall Study||0
8281239|NCT01670279|20418783|P2|STARTED|Overall Study||7
8281240|NCT01670279|20418784|P1|STARTED|Overall Study||6
8281241|NCT01670201|20418819|P1|NOT COMPLETED|Overall Study||0
8281242|NCT01670201|20418819|P1|COMPLETED|Overall Study||8
8281243|NCT01670201|20418819|P1|STARTED|Overall Study||8
8281244|NCT01670188|20418826|P2|NOT COMPLETED|Overall Study||1
8281245|NCT01670188|20418827|P1|NOT COMPLETED|Overall Study||0
8281246|NCT01670188|20418826|P2|COMPLETED|Overall Study||39
8281247|NCT01670188|20418827|P1|COMPLETED|Overall Study||38
8281248|NCT01670188|20418826|P2|STARTED|Overall Study||40
8281249|NCT01670188|20418827|P1|STARTED|Overall Study||38
8281250|NCT01670110|20418835|P2|NOT COMPLETED|Overall Study||3
8281251|NCT01670110|20418836|P1|NOT COMPLETED|Overall Study||4
8281252|NCT01670110|20418835|P2|COMPLETED|Overall Study||12
8281253|NCT01670110|20418836|P1|COMPLETED|Overall Study||29
8281254|NCT01670110|20418835|P2|STARTED|Overall Study||15
8281255|NCT01670110|20418836|P1|STARTED|Overall Study||33
8281256|NCT01670045|20418856|P1|NOT COMPLETED|Overall Study||16
8281257|NCT01670045|20418856|P1|COMPLETED|Overall Study||27
8281258|NCT01670045|20418856|P1|STARTED|Overall Study||43
8281259|NCT01670019|20418874|P2|NOT COMPLETED|Overall Study||0
8281260|NCT01670019|20418875|P1|NOT COMPLETED|Overall Study||9
8281261|NCT01670019|20418874|P2|COMPLETED|Overall Study||23
8281262|NCT01670019|20418875|P1|COMPLETED|Overall Study||14
8281263|NCT01670019|20418874|P2|STARTED|Overall Study||23
8281264|NCT01670019|20418875|P1|STARTED|Overall Study||23
8281265|NCT01669902|20418889|P1|NOT COMPLETED|Overall Study||29
8281266|NCT01669902|20418889|P1|COMPLETED|Overall Study||78
8281267|NCT01669902|20418889|P1|STARTED|Overall Study||107
8281268|NCT01669863|20418916|P1|NOT COMPLETED|Overall Study||0
8281269|NCT01669863|20418916|P1|COMPLETED|Overall Study||6
8281270|NCT01669863|20418916|P1|STARTED|Overall Study||6
8281271|NCT01669811|20418924|P2|NOT COMPLETED|Overall Study||11
8281272|NCT01669811|20418925|P1|NOT COMPLETED|Overall Study||3
8281273|NCT01669811|20418924|P2|COMPLETED|Overall Study||131
8281274|NCT01669811|20418925|P1|COMPLETED|Overall Study||142
8281275|NCT01669811|20418924|P2|STARTED|Overall Study||142
8281276|NCT01669811|20418925|P1|STARTED|Overall Study||145
8281277|NCT01669798|20418943|P1|NOT COMPLETED|Overall Study||5
8281278|NCT01669798|20418943|P1|COMPLETED|Overall Study||27
8281279|NCT01669798|20418943|P1|STARTED|Overall Study||32
8281280|NCT01669785|20418959|P3|NOT COMPLETED|Overall Study||0
8281281|NCT01669785|20418960|P2|NOT COMPLETED|Overall Study||0
8281282|NCT01669785|20418961|P1|NOT COMPLETED|Overall Study||0
8281283|NCT01669785|20418959|P3|COMPLETED|Overall Study||46
8281284|NCT01669785|20418960|P2|COMPLETED|Overall Study||48
8281285|NCT01669785|20418961|P1|COMPLETED|Overall Study||45
8281286|NCT01669785|20418959|P3|STARTED|Overall Study||46
8281287|NCT01669785|20418960|P2|STARTED|Overall Study||48
8281288|NCT01669785|20418961|P1|STARTED|Overall Study||45
8281289|NCT01669720|20418998|P2|NOT COMPLETED|Overall Study||0
8281290|NCT01669720|20418999|P1|NOT COMPLETED|Overall Study||0
8281291|NCT01669720|20418998|P2|COMPLETED|Overall Study||3
8281292|NCT01669720|20418999|P1|COMPLETED|Overall Study||7
8281293|NCT01669720|20418998|P2|STARTED|Overall Study||3
8281294|NCT01669720|20418999|P1|STARTED|Overall Study||7
8281295|NCT01669642|20419012|P6|NOT COMPLETED|Overall Study||10
8281296|NCT01669642|20419013|P5|NOT COMPLETED|Overall Study||0
8281297|NCT01669642|20419014|P4|NOT COMPLETED|Overall Study||1
8281298|NCT01669642|20419015|P3|NOT COMPLETED|Overall Study||0
8281299|NCT01669642|20419016|P2|NOT COMPLETED|Overall Study||0
8281300|NCT01669642|20419017|P1|NOT COMPLETED|Overall Study||0
8281301|NCT01669642|20419012|P6|COMPLETED|Overall Study||0
8281302|NCT01669642|20419013|P5|COMPLETED|Overall Study||20
8281303|NCT01669642|20419014|P4|COMPLETED|Overall Study||20
8281304|NCT01669642|20419015|P3|COMPLETED|Overall Study||20
8281305|NCT01669642|20419016|P2|COMPLETED|Overall Study||20
8281306|NCT01669642|20419017|P1|COMPLETED|Overall Study||20
8281307|NCT01669642|20419012|P6|STARTED|Overall Study||10
8281308|NCT01669642|20419013|P5|STARTED|Overall Study||20
8281309|NCT01669642|20419014|P4|STARTED|Overall Study||21
8281310|NCT01669642|20419015|P3|STARTED|Overall Study||20
8281311|NCT01669642|20419016|P2|STARTED|Overall Study||20
8281312|NCT01669642|20419017|P1|STARTED|Overall Study||20
8281313|NCT01669629|20419049|P2|NOT COMPLETED|Period 2||0
8281314|NCT01669629|20419050|P1|NOT COMPLETED|Period 2||0
8281315|NCT01669629|20419049|P2|COMPLETED|Period 2||89
8281316|NCT01669629|20419050|P1|COMPLETED|Period 2||91
8281317|NCT01669629|20419049|P2|STARTED|Period 2||89
8281318|NCT01669629|20419050|P1|STARTED|Period 2||91
8281319|NCT01669629|20419049|P2|NOT COMPLETED|Period 1||2
8281320|NCT01669629|20419050|P1|NOT COMPLETED|Period 1||1
8281321|NCT01669629|20419049|P2|COMPLETED|Period 1||89
8281322|NCT01669629|20419050|P1|COMPLETED|Period 1||91
8281323|NCT01669629|20419049|P2|STARTED|Period 1||91
8281324|NCT01669629|20419050|P1|STARTED|Period 1||92
8281325|NCT01669603|20419066|P2|NOT COMPLETED|Overall Study||38
8281326|NCT01669603|20419067|P1|NOT COMPLETED|Overall Study||37
8281327|NCT01669603|20419066|P2|COMPLETED|Overall Study||57
8281328|NCT01669603|20419067|P1|COMPLETED|Overall Study||58
8281329|NCT01669603|20419066|P2|STARTED|Overall Study||95
8281330|NCT01669603|20419067|P1|STARTED|Overall Study||95
8281331|NCT01669577|20419073|P1|NOT COMPLETED|Overall Study||134
8281332|NCT01669577|20419073|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
8281333|NCT01669577|20419073|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
8281334|NCT01669538|20419079|P2|NOT COMPLETED|Overall Study||9
8281335|NCT01669538|20419080|P1|NOT COMPLETED|Overall Study||12
8281336|NCT01669538|20419079|P2|COMPLETED|Overall Study||33
8281337|NCT01669538|20419080|P1|COMPLETED|Overall Study||28
8281338|NCT01669538|20419079|P2|STARTED|Overall Study||42
8281339|NCT01669538|20419080|P1|STARTED|Overall Study||40
8281340|NCT01669434|20419094|P2|NOT COMPLETED|Overall Study||7
8281341|NCT01669434|20419095|P1|NOT COMPLETED|Overall Study||9
8281342|NCT01669434|20419094|P2|COMPLETED|Overall Study||138
8281343|NCT01669434|20419095|P1|COMPLETED|Overall Study||137
8281344|NCT01669434|20419094|P2|STARTED|Overall Study||145
8281345|NCT01669434|20419095|P1|STARTED|Overall Study||146
8281346|NCT01669421|20419111|P1|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
8281347|NCT01669421|20419111|P1|COMPLETED|Phase 3: Standard Dose Therapy||8
8281348|NCT01669421|20419111|P1|STARTED|Phase 3: Standard Dose Therapy||8
8281349|NCT01669421|20419111|P1|NOT COMPLETED|Phase 2: Double Dose Therapy||0
8281350|NCT01669421|20419111|P1|COMPLETED|Phase 2: Double Dose Therapy||8
8281351|NCT01669421|20419111|P1|STARTED|Phase 2: Double Dose Therapy||8
8281352|NCT01669421|20419111|P1|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
8281353|NCT01669421|20419111|P1|COMPLETED|Phase 1: Standard Dose Therapy||8
8281354|NCT01669421|20419111|P1|STARTED|Phase 1: Standard Dose Therapy||10
8281355|NCT01669174|20419130|P2|NOT COMPLETED|Overall Study||6
8281356|NCT01669174|20419131|P1|NOT COMPLETED|Overall Study||6
8281357|NCT01669174|20419130|P2|COMPLETED|Overall Study||28
8281358|NCT01669174|20419131|P1|COMPLETED|Overall Study||27
8281359|NCT01669174|20419130|P2|STARTED|Overall Study||34
8281360|NCT01669174|20419131|P1|STARTED|Overall Study||33
8281361|NCT01669148|20419142|P1|NOT COMPLETED|Overall Study||70
8281362|NCT01669148|20419142|P1|COMPLETED|Overall Study||426
8281363|NCT01669148|20419142|P1|STARTED|Overall Study||496
8281364|NCT01669122|20419147|P1|NOT COMPLETED|Period IV||0
8281365|NCT01669122|20419147|P1|COMPLETED|Period IV||37
8281366|NCT01669122|20419147|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
8281367|NCT01669122|20419147|P1|NOT COMPLETED|Period III||0
8281368|NCT01669122|20419147|P1|COMPLETED|Period III||37
8281369|NCT01669122|20419147|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
8281370|NCT01669122|20419147|P1|NOT COMPLETED|Washout Period III||0
8281371|NCT01669122|20419147|P1|COMPLETED|Washout Period III||37
8281372|NCT01669122|20419147|P1|STARTED|Washout Period III||37
8281373|NCT01669122|20419147|P1|NOT COMPLETED|Washout Period II||2
8281374|NCT01669122|20419147|P1|COMPLETED|Washout Period II||37
8281375|NCT01669122|20419147|P1|STARTED|Washout Period II||39
8281376|NCT01669122|20419147|P1|NOT COMPLETED|Period II||0
8281377|NCT01669122|20419147|P1|COMPLETED|Period II||39
8281378|NCT01669122|20419147|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
8281379|NCT01669122|20419147|P1|NOT COMPLETED|Washout Period I||0
8281380|NCT01669122|20419147|P1|COMPLETED|Washout Period I||39
8281381|NCT01669122|20419147|P1|STARTED|Washout Period I||39
8281382|NCT01669122|20419147|P1|NOT COMPLETED|Period I||1
8281383|NCT01669122|20419147|P1|COMPLETED|Period I||39
8281384|NCT01669122|20419147|P1|Safety Population|Period I||39
8281385|NCT01669122|20419147|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
8281386|NCT01669096|20419177|P1|NOT COMPLETED|Overall Study||0
8281387|NCT01669096|20419177|P1|COMPLETED|Overall Study||20
8281388|NCT01669096|20419177|P1|STARTED|Overall Study||20
8281389|NCT01668966|20419214|P1|NOT COMPLETED|Overall Study||4
8281390|NCT01668966|20419214|P1|COMPLETED|Overall Study||19
8281391|NCT01668966|20419214|P1|Treated|Overall Study||21
8281392|NCT01668966|20419214|P1|STARTED|Overall Study||23
8281393|NCT01668940|20419234|P4|NOT COMPLETED|Overall Study||0
8281394|NCT01668940|20419235|P3|NOT COMPLETED|Overall Study||0
8281395|NCT01668940|20419236|P2|NOT COMPLETED|Overall Study||0
8281396|NCT01668940|20419237|P1|NOT COMPLETED|Overall Study||0
8281397|NCT01668940|20419234|P4|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
8281398|NCT01668940|20419235|P3|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
8281399|NCT01668940|20419236|P2|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
8281400|NCT01668940|20419237|P1|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
8281401|NCT01668940|20419234|P4|STARTED|Overall Study||14
8281402|NCT01668940|20419235|P3|STARTED|Overall Study||9
8281403|NCT01668940|20419236|P2|STARTED|Overall Study||14
8281404|NCT01668940|20419237|P1|STARTED|Overall Study||17
8281405|NCT01668836|20419251|P4|NOT COMPLETED|Overall Study||0
8281406|NCT01668836|20419252|P3|NOT COMPLETED|Overall Study||0
8281407|NCT01668836|20419253|P2|NOT COMPLETED|Overall Study||0
8281408|NCT01668836|20419254|P1|NOT COMPLETED|Overall Study||0
8281409|NCT01668836|20419251|P4|COMPLETED|Overall Study||12
8281410|NCT01668836|20419252|P3|COMPLETED|Overall Study||12
8281411|NCT01668836|20419253|P2|COMPLETED|Overall Study||12
8281412|NCT01668836|20419254|P1|COMPLETED|Overall Study||12
8281413|NCT01668836|20419251|P4|STARTED|Overall Study||12
8281414|NCT01668836|20419252|P3|STARTED|Overall Study||12
8281415|NCT01668836|20419253|P2|STARTED|Overall Study||12
8281416|NCT01668836|20419254|P1|STARTED|Overall Study||12
8281417|NCT01668797|20419310|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
8281418|NCT01668797|20419311|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
8281419|NCT01668797|20419312|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281420|NCT01668797|20419313|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281421|NCT01668797|20419310|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
8281422|NCT01668797|20419311|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
8281423|NCT01668797|20419312|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281424|NCT01668797|20419313|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281425|NCT01668797|20419310|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
8281426|NCT01668797|20419311|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
8281427|NCT01668797|20419312|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
8281428|NCT01668797|20419313|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
8281429|NCT01668797|20419310|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
8281430|NCT01668797|20419311|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
8281431|NCT01668797|20419312|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
8281432|NCT01668797|20419313|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
8281433|NCT01668797|20419310|P4|COMPLETED|Phase B (Stabilization Phase)||0
8281434|NCT01668797|20419311|P3|COMPLETED|Phase B (Stabilization Phase)||0
8281435|NCT01668797|20419312|P2|COMPLETED|Phase B (Stabilization Phase)||202
8281436|NCT01668797|20419313|P1|COMPLETED|Phase B (Stabilization Phase)||0
8281437|NCT01668797|20419310|P4|STARTED|Phase B (Stabilization Phase)||0
8281438|NCT01668797|20419311|P3|STARTED|Phase B (Stabilization Phase)||0
8281439|NCT01668797|20419312|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
8281440|NCT01668797|20419313|P1|STARTED|Phase B (Stabilization Phase)||0
8281441|NCT01668797|20419310|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
8281442|NCT01668797|20419311|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
8281443|NCT01668797|20419312|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
8281444|NCT01668797|20419313|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
8281445|NCT01668797|20419310|P4|COMPLETED|Phase A (Conversion Phase)||0
8281446|NCT01668797|20419311|P3|COMPLETED|Phase A (Conversion Phase)||0
8281447|NCT01668797|20419312|P2|COMPLETED|Phase A (Conversion Phase)||0
8281448|NCT01668797|20419313|P1|COMPLETED|Phase A (Conversion Phase)||346
8281449|NCT01668797|20419310|P4|STARTED|Phase A (Conversion Phase)||0
8281450|NCT01668797|20419311|P3|STARTED|Phase A (Conversion Phase)||0
8281451|NCT01668797|20419312|P2|STARTED|Phase A (Conversion Phase)||0
8281452|NCT01668797|20419313|P1|STARTED|Phase A (Conversion Phase)||406
8281453|NCT01668784|20419378|P2|NOT COMPLETED|Treated (Overall)||369
8281454|NCT01668784|20419379|P1|NOT COMPLETED|Treated (Overall)||339
8281455|NCT01668784|20419378|P2|COMPLETED|Treated (Overall)||28
8281456|NCT01668784|20419379|P1|COMPLETED|Treated (Overall)||67
8281457|NCT01668784|20419378|P2|STARTED|Treated (Overall)||397
8281458|NCT01668784|20419379|P1|STARTED|Treated (Overall)||406
8281459|NCT01668784|20419378|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
8281460|NCT01668784|20419379|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
8281461|NCT01668784|20419378|P2|COMPLETED|Randomized (Pre-treatment)||397
8281462|NCT01668784|20419379|P1|COMPLETED|Randomized (Pre-treatment)||406
8281463|NCT01668784|20419378|P2|STARTED|Randomized (Pre-treatment)||411
8281464|NCT01668784|20419379|P1|STARTED|Randomized (Pre-treatment)||410
8281465|NCT01668667|20419407|P4|NOT COMPLETED|Overall Study||23
8281466|NCT01668667|20419408|P3|NOT COMPLETED|Overall Study||31
8281467|NCT01668667|20419409|P2|NOT COMPLETED|Overall Study||26
8281468|NCT01668667|20419410|P1|NOT COMPLETED|Overall Study||31
8281469|NCT01668667|20419407|P4|COMPLETED|Overall Study||102
8281470|NCT01668667|20419408|P3|COMPLETED|Overall Study||94
8281471|NCT01668667|20419409|P2|COMPLETED|Overall Study||99
8281472|NCT01668667|20419410|P1|COMPLETED|Overall Study||95
8281473|NCT01668667|20419407|P4|STARTED|Overall Study||125
8281474|NCT01668667|20419408|P3|STARTED|Overall Study||125
8281475|NCT01668667|20419409|P2|STARTED|Overall Study||125
8281476|NCT01668667|20419410|P1|STARTED|Overall Study||126
8281477|NCT01668654|20419432|P1|NOT COMPLETED|Overall Study||4
8281478|NCT01668654|20419432|P1|COMPLETED|Overall Study||0
8281479|NCT01668654|20419432|P1|STARTED|Overall Study||4
8281480|NCT01668628|20419475|P3|NOT COMPLETED|Overall Study||0
8281481|NCT01668628|20419476|P2|NOT COMPLETED|Overall Study||0
8281482|NCT01668628|20419477|P1|NOT COMPLETED|Overall Study||2
8281483|NCT01668628|20419475|P3|COMPLETED|Overall Study||367
8281484|NCT01668628|20419476|P2|COMPLETED|Overall Study||359
8281485|NCT01668628|20419477|P1|COMPLETED|Overall Study||347
8281486|NCT01668628|20419475|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
8281487|NCT01668628|20419476|P2|STARTED|Overall Study||359
8281488|NCT01668628|20419477|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
8281489|NCT01668589|20419493|P4|NOT COMPLETED|Overall Study||35
8281490|NCT01668589|20419494|P3|NOT COMPLETED|Overall Study||35
8281491|NCT01668589|20419495|P2|NOT COMPLETED|Overall Study||58
8281492|NCT01668589|20419496|P1|NOT COMPLETED|Overall Study||139
8281493|NCT01668589|20419493|P4|COMPLETED|Overall Study||266
8281494|NCT01668589|20419494|P3|COMPLETED|Overall Study||265
8281495|NCT01668589|20419495|P2|COMPLETED|Overall Study||242
8281496|NCT01668589|20419496|P1|COMPLETED|Overall Study||461
8281497|NCT01668589|20419493|P4|Received Denosumab|Overall Study||301
8281498|NCT01668589|20419494|P3|Received Denosumab|Overall Study||300
8281499|NCT01668589|20419495|P2|Received Denosumab|Overall Study||300
8281500|NCT01668589|20419496|P1|Received Denosumab|Overall Study||599
8281501|NCT01668589|20419493|P4|STARTED|Overall Study||301
8281502|NCT01668589|20419494|P3|STARTED|Overall Study||300
8281503|NCT01668589|20419495|P2|STARTED|Overall Study||300
8281504|NCT01668589|20419496|P1|STARTED|Overall Study||600
8281505|NCT01668537|20419536|P2|NOT COMPLETED|Overall Study||10
8281506|NCT01668537|20419537|P1|NOT COMPLETED|Overall Study||22
8281507|NCT01668537|20419536|P2|COMPLETED|Overall Study||314
8281508|NCT01668537|20419537|P1|COMPLETED|Overall Study||305
8281509|NCT01668537|20419536|P2|STARTED|Overall Study||324
8281510|NCT01668537|20419537|P1|STARTED|Overall Study||327
8281511|NCT01668355|20419579|P2|NOT COMPLETED|Overall Study||2
8281512|NCT01668355|20419580|P1|NOT COMPLETED|Overall Study||9
8281513|NCT01668355|20419579|P2|COMPLETED|Overall Study||165
8281514|NCT01668355|20419580|P1|COMPLETED|Overall Study||155
8281515|NCT01668355|20419579|P2|STARTED|Overall Study||167
8281516|NCT01668355|20419580|P1|STARTED|Overall Study||164
8281517|NCT01668173|20419600|P1|NOT COMPLETED|Overall Study||7
8281518|NCT01668173|20419600|P1|COMPLETED|Overall Study||0
8281519|NCT01668173|20419600|P1|STARTED|Overall Study||7
8281520|NCT01668147|20419604|P1|NOT COMPLETED|Overall Study||6
8281521|NCT01668147|20419604|P1|COMPLETED|Overall Study||7
8281522|NCT01668147|20419604|P1|STARTED|Overall Study||13
8281523|NCT01668030|20419612|P2|NOT COMPLETED|Overall Study||0
8281524|NCT01668030|20419613|P1|NOT COMPLETED|Overall Study||0
8281525|NCT01668030|20419612|P2|COMPLETED|Overall Study||10
8281526|NCT01668030|20419613|P1|COMPLETED|Overall Study||10
8281527|NCT01668030|20419612|P2|STARTED|Overall Study||10
8281528|NCT01668030|20419613|P1|STARTED|Overall Study||10
8281529|NCT01668017|20419623|P5|NOT COMPLETED|Overall Study||0
8281530|NCT01668017|20419624|P4|NOT COMPLETED|Overall Study||0
8281531|NCT01668017|20419625|P3|NOT COMPLETED|Overall Study||0
8281532|NCT01668017|20419626|P2|NOT COMPLETED|Overall Study||0
8281533|NCT01668017|20419627|P1|NOT COMPLETED|Overall Study||0
8281534|NCT01668017|20419623|P5|COMPLETED|Overall Study||2
8281535|NCT01668017|20419624|P4|COMPLETED|Overall Study||5
8281536|NCT01668017|20419625|P3|COMPLETED|Overall Study||6
8281537|NCT01668017|20419626|P2|COMPLETED|Overall Study||9
8281538|NCT01668017|20419627|P1|COMPLETED|Overall Study||4
8281539|NCT01668017|20419623|P5|STARTED|Overall Study||2
8281540|NCT01668017|20419624|P4|STARTED|Overall Study||5
8281541|NCT01668017|20419625|P3|STARTED|Overall Study||6
8281542|NCT01668017|20419626|P2|STARTED|Overall Study||9
8281543|NCT01668017|20419627|P1|STARTED|Overall Study||4
8281544|NCT01668004|20419734|P1|NOT COMPLETED|Overall Study||25
8281545|NCT01668004|20419734|P1|COMPLETED|Overall Study||76
8281546|NCT01668004|20419734|P1|Treated|Overall Study||101
8281547|NCT01668004|20419734|P1|STARTED|Overall Study||101
8281548|NCT01667978|20419747|P2|NOT COMPLETED|Overall Study||0
8281549|NCT01667978|20419748|P1|NOT COMPLETED|Overall Study||2
8281550|NCT01667978|20419747|P2|COMPLETED|Overall Study||17
8281551|NCT01667978|20419748|P1|COMPLETED|Overall Study||16
8281552|NCT01667978|20419747|P2|STARTED|Overall Study||17
8281553|NCT01667978|20419748|P1|STARTED|Overall Study||18
8281554|NCT01667926|20419756|P3|NOT COMPLETED|Overall Study||11
8281555|NCT01667926|20419757|P2|NOT COMPLETED|Overall Study||4
8281556|NCT01667926|20419758|P1|NOT COMPLETED|Overall Study||5
8281557|NCT01667926|20419756|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
8281558|NCT01667926|20419757|P2|COMPLETED|Overall Study||9
8281559|NCT01667926|20419758|P1|COMPLETED|Overall Study||8
8281560|NCT01667926|20419756|P3|STARTED|Overall Study||11
8281561|NCT01667926|20419757|P2|STARTED|Overall Study||13
8281562|NCT01667926|20419758|P1|STARTED|Overall Study||13
8281563|NCT01667900|20419771|P20|NOT COMPLETED|Part B||0
8281564|NCT01667900|20419772|P19|NOT COMPLETED|Part B||0
8281565|NCT01667900|20419773|P18|NOT COMPLETED|Part B||0
8281566|NCT01667900|20419774|P17|NOT COMPLETED|Part B||1
8281567|NCT01667900|20419775|P16|NOT COMPLETED|Part B||0
8281568|NCT01667900|20419776|P15|NOT COMPLETED|Part B||0
8281569|NCT01667900|20419777|P14|NOT COMPLETED|Part B||0
8281570|NCT01667900|20419778|P13|NOT COMPLETED|Part B||0
8281571|NCT01667900|20419779|P12|NOT COMPLETED|Part B||0
8281572|NCT01667900|20419780|P11|NOT COMPLETED|Part B||0
8281573|NCT01667900|20419781|P10|NOT COMPLETED|Part B||0
8281574|NCT01667900|20419782|P9|NOT COMPLETED|Part B||0
8281575|NCT01667900|20419783|P8|NOT COMPLETED|Part B||0
8281576|NCT01667900|20419784|P7|NOT COMPLETED|Part B||0
8281577|NCT01667900|20419785|P6|NOT COMPLETED|Part B||0
8281578|NCT01667900|20419786|P5|NOT COMPLETED|Part B||0
8281579|NCT01667900|20419787|P4|NOT COMPLETED|Part B||0
8281580|NCT01667900|20419788|P3|NOT COMPLETED|Part B||0
8281581|NCT01667900|20419789|P2|NOT COMPLETED|Part B||0
8281582|NCT01667900|20419790|P1|NOT COMPLETED|Part B||0
8281583|NCT01667900|20419771|P20|COMPLETED|Part B||10
8281584|NCT01667900|20419772|P19|COMPLETED|Part B||10
8281585|NCT01667900|20419773|P18|COMPLETED|Part B||11
8281586|NCT01667900|20419774|P17|COMPLETED|Part B||10
8281587|NCT01667900|20419775|P16|COMPLETED|Part B||0
8281588|NCT01667900|20419776|P15|COMPLETED|Part B||0
8281589|NCT01667900|20419777|P14|COMPLETED|Part B||0
8281590|NCT01667900|20419778|P13|COMPLETED|Part B||0
8281591|NCT01667900|20419779|P12|COMPLETED|Part B||0
8281592|NCT01667900|20419780|P11|COMPLETED|Part B||0
8281593|NCT01667900|20419781|P10|COMPLETED|Part B||0
8281594|NCT01667900|20419782|P9|COMPLETED|Part B||0
8281595|NCT01667900|20419783|P8|COMPLETED|Part B||0
8281596|NCT01667900|20419784|P7|COMPLETED|Part B||0
8281597|NCT01667900|20419785|P6|COMPLETED|Part B||0
8281598|NCT01667900|20419786|P5|COMPLETED|Part B||0
8281599|NCT01667900|20419787|P4|COMPLETED|Part B||0
8281600|NCT01667900|20419788|P3|COMPLETED|Part B||0
8281601|NCT01667900|20419789|P2|COMPLETED|Part B||0
8281602|NCT01667900|20419790|P1|COMPLETED|Part B||0
8281603|NCT01667900|20419771|P20|STARTED|Part B||10
8281604|NCT01667900|20419772|P19|STARTED|Part B||10
8281605|NCT01667900|20419773|P18|STARTED|Part B||11
8281606|NCT01667900|20419774|P17|STARTED|Part B||11
8281607|NCT01667900|20419775|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
8281608|NCT01667900|20419776|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
8281609|NCT01667900|20419777|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
8281610|NCT01667900|20419778|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
8281611|NCT01667900|20419779|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
8281612|NCT01667900|20419780|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
8281613|NCT01667900|20419781|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
8281614|NCT01667900|20419782|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
8281615|NCT01667900|20419783|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
8281616|NCT01667900|20419784|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
8281617|NCT01667900|20419785|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
8281618|NCT01667900|20419786|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
8281619|NCT01667900|20419787|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
8281620|NCT01667900|20419788|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
8281621|NCT01667900|20419789|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
8281622|NCT01667900|20419790|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
8281623|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Period 3||0
8281624|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Period 3||0
8281625|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Period 3||0
8281626|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Period 3||0
8281627|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Period 3||0
8281628|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Period 3||0
8281629|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Period 3||0
8281630|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Period 3||0
8281631|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Period 3||0
8281632|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Period 3||0
8281633|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Period 3||0
8281634|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Period 3||0
8281635|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Period 3||0
8281636|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Period 3||0
8281637|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Period 3||0
8281638|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Period 3||0
8281639|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Period 3||0
8281640|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Period 3||0
8281641|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Period 3||0
8281642|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Period 3||0
8281643|NCT01667900|20419771|P20|COMPLETED|Part A, Period 3||0
8281644|NCT01667900|20419772|P19|COMPLETED|Part A, Period 3||0
8281645|NCT01667900|20419773|P18|COMPLETED|Part A, Period 3||0
8281646|NCT01667900|20419774|P17|COMPLETED|Part A, Period 3||0
8281647|NCT01667900|20419775|P16|COMPLETED|Part A, Period 3||1
8281648|NCT01667900|20419776|P15|COMPLETED|Part A, Period 3||1
8281649|NCT01667900|20419777|P14|COMPLETED|Part A, Period 3||1
8281650|NCT01667900|20419778|P13|COMPLETED|Part A, Period 3||1
8281651|NCT01667900|20419779|P12|COMPLETED|Part A, Period 3||1
8281652|NCT01667900|20419780|P11|COMPLETED|Part A, Period 3||1
8281653|NCT01667900|20419781|P10|COMPLETED|Part A, Period 3||1
8281654|NCT01667900|20419782|P9|COMPLETED|Part A, Period 3||1
8281655|NCT01667900|20419783|P8|COMPLETED|Part A, Period 3||1
8281656|NCT01667900|20419784|P7|COMPLETED|Part A, Period 3||1
8281657|NCT01667900|20419785|P6|COMPLETED|Part A, Period 3||1
8281658|NCT01667900|20419786|P5|COMPLETED|Part A, Period 3||1
8281659|NCT01667900|20419787|P4|COMPLETED|Part A, Period 3||1
8281660|NCT01667900|20419788|P3|COMPLETED|Part A, Period 3||1
8281661|NCT01667900|20419789|P2|COMPLETED|Part A, Period 3||1
8281662|NCT01667900|20419790|P1|COMPLETED|Part A, Period 3||1
8281663|NCT01667900|20419771|P20|STARTED|Part A, Period 3||0
8281664|NCT01667900|20419772|P19|STARTED|Part A, Period 3||0
8281665|NCT01667900|20419773|P18|STARTED|Part A, Period 3||0
8281666|NCT01667900|20419774|P17|STARTED|Part A, Period 3||0
8281667|NCT01667900|20419775|P16|STARTED|Part A, Period 3||1
8281668|NCT01667900|20419776|P15|STARTED|Part A, Period 3||1
8281669|NCT01667900|20419777|P14|STARTED|Part A, Period 3||1
8281670|NCT01667900|20419778|P13|STARTED|Part A, Period 3||1
8281671|NCT01667900|20419779|P12|STARTED|Part A, Period 3||1
8281672|NCT01667900|20419780|P11|STARTED|Part A, Period 3||1
8281673|NCT01667900|20419781|P10|STARTED|Part A, Period 3||1
8281674|NCT01667900|20419782|P9|STARTED|Part A, Period 3||1
8281675|NCT01667900|20419783|P8|STARTED|Part A, Period 3||1
8281676|NCT01667900|20419784|P7|STARTED|Part A, Period 3||1
8281677|NCT01667900|20419785|P6|STARTED|Part A, Period 3||1
8281678|NCT01667900|20419786|P5|STARTED|Part A, Period 3||1
8281679|NCT01667900|20419787|P4|STARTED|Part A, Period 3||1
8281680|NCT01667900|20419788|P3|STARTED|Part A, Period 3||1
8281681|NCT01667900|20419789|P2|STARTED|Part A, Period 3||1
8281682|NCT01667900|20419790|P1|STARTED|Part A, Period 3||1
8281683|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Washout 2||0
8281684|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Washout 2||0
8281685|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Washout 2||0
8281686|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Washout 2||0
8281687|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Washout 2||0
8281688|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Washout 2||0
8281689|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Washout 2||0
8281690|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Washout 2||0
8281691|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Washout 2||0
8281692|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Washout 2||0
8281693|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Washout 2||0
8281694|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Washout 2||0
8281695|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Washout 2||0
8281696|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Washout 2||0
8281697|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Washout 2||0
8281698|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Washout 2||0
8281699|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Washout 2||0
8281700|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Washout 2||0
8281701|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Washout 2||0
8281702|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Washout 2||0
8281703|NCT01667900|20419771|P20|COMPLETED|Part A, Washout 2||0
8281704|NCT01667900|20419772|P19|COMPLETED|Part A, Washout 2||0
8281705|NCT01667900|20419773|P18|COMPLETED|Part A, Washout 2||0
8281706|NCT01667900|20419774|P17|COMPLETED|Part A, Washout 2||0
8281707|NCT01667900|20419775|P16|COMPLETED|Part A, Washout 2||1
8281708|NCT01667900|20419776|P15|COMPLETED|Part A, Washout 2||1
8281709|NCT01667900|20419777|P14|COMPLETED|Part A, Washout 2||1
8281710|NCT01667900|20419778|P13|COMPLETED|Part A, Washout 2||1
8281711|NCT01667900|20419779|P12|COMPLETED|Part A, Washout 2||1
8281712|NCT01667900|20419780|P11|COMPLETED|Part A, Washout 2||1
8281713|NCT01667900|20419781|P10|COMPLETED|Part A, Washout 2||1
8281714|NCT01667900|20419782|P9|COMPLETED|Part A, Washout 2||1
8281715|NCT01667900|20419783|P8|COMPLETED|Part A, Washout 2||1
8281716|NCT01667900|20419784|P7|COMPLETED|Part A, Washout 2||1
8281717|NCT01667900|20419785|P6|COMPLETED|Part A, Washout 2||1
8281718|NCT01667900|20419786|P5|COMPLETED|Part A, Washout 2||1
8281719|NCT01667900|20419787|P4|COMPLETED|Part A, Washout 2||1
8281720|NCT01667900|20419788|P3|COMPLETED|Part A, Washout 2||1
8281721|NCT01667900|20419789|P2|COMPLETED|Part A, Washout 2||1
8281722|NCT01667900|20419790|P1|COMPLETED|Part A, Washout 2||1
8281723|NCT01667900|20419771|P20|STARTED|Part A, Washout 2||0
8281724|NCT01667900|20419772|P19|STARTED|Part A, Washout 2||0
8281725|NCT01667900|20419773|P18|STARTED|Part A, Washout 2||0
8281726|NCT01667900|20419774|P17|STARTED|Part A, Washout 2||0
8281727|NCT01667900|20419775|P16|STARTED|Part A, Washout 2||1
8281728|NCT01667900|20419776|P15|STARTED|Part A, Washout 2||1
8281729|NCT01667900|20419777|P14|STARTED|Part A, Washout 2||1
8281730|NCT01667900|20419778|P13|STARTED|Part A, Washout 2||1
8281731|NCT01667900|20419779|P12|STARTED|Part A, Washout 2||1
8281732|NCT01667900|20419780|P11|STARTED|Part A, Washout 2||1
8281733|NCT01667900|20419781|P10|STARTED|Part A, Washout 2||1
8281734|NCT01667900|20419782|P9|STARTED|Part A, Washout 2||1
8281735|NCT01667900|20419783|P8|STARTED|Part A, Washout 2||1
8281736|NCT01667900|20419784|P7|STARTED|Part A, Washout 2||1
8281737|NCT01667900|20419785|P6|STARTED|Part A, Washout 2||1
8281738|NCT01667900|20419786|P5|STARTED|Part A, Washout 2||1
8281739|NCT01667900|20419787|P4|STARTED|Part A, Washout 2||1
8281740|NCT01667900|20419788|P3|STARTED|Part A, Washout 2||1
8281741|NCT01667900|20419789|P2|STARTED|Part A, Washout 2||1
8281742|NCT01667900|20419790|P1|STARTED|Part A, Washout 2||1
8281743|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Period 2||0
8281744|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Period 2||0
8281745|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Period 2||0
8281746|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Period 2||0
8281747|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Period 2||0
8281748|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Period 2||0
8281749|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Period 2||0
8281750|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Period 2||0
8281751|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Period 2||0
8281752|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Period 2||0
8281753|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Period 2||0
8281754|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Period 2||0
8281755|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Period 2||0
8281756|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Period 2||0
8281757|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Period 2||0
8281758|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Period 2||0
8281759|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Period 2||0
8281760|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Period 2||0
8281761|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Period 2||0
8281762|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Period 2||0
8281763|NCT01667900|20419771|P20|COMPLETED|Part A, Period 2||0
8281764|NCT01667900|20419772|P19|COMPLETED|Part A, Period 2||0
8281765|NCT01667900|20419773|P18|COMPLETED|Part A, Period 2||0
8281766|NCT01667900|20419774|P17|COMPLETED|Part A, Period 2||0
8281767|NCT01667900|20419775|P16|COMPLETED|Part A, Period 2||1
8281768|NCT01667900|20419776|P15|COMPLETED|Part A, Period 2||1
8281769|NCT01667900|20419777|P14|COMPLETED|Part A, Period 2||1
8281770|NCT01667900|20419778|P13|COMPLETED|Part A, Period 2||1
8281771|NCT01667900|20419779|P12|COMPLETED|Part A, Period 2||1
8281772|NCT01667900|20419780|P11|COMPLETED|Part A, Period 2||1
8281773|NCT01667900|20419781|P10|COMPLETED|Part A, Period 2||1
8281774|NCT01667900|20419782|P9|COMPLETED|Part A, Period 2||1
8281775|NCT01667900|20419783|P8|COMPLETED|Part A, Period 2||1
8281776|NCT01667900|20419784|P7|COMPLETED|Part A, Period 2||1
8281777|NCT01667900|20419785|P6|COMPLETED|Part A, Period 2||1
8281778|NCT01667900|20419786|P5|COMPLETED|Part A, Period 2||1
8281779|NCT01667900|20419787|P4|COMPLETED|Part A, Period 2||1
8281780|NCT01667900|20419788|P3|COMPLETED|Part A, Period 2||1
8281781|NCT01667900|20419789|P2|COMPLETED|Part A, Period 2||1
8281782|NCT01667900|20419790|P1|COMPLETED|Part A, Period 2||1
8281783|NCT01667900|20419771|P20|STARTED|Part A, Period 2||0
8281784|NCT01667900|20419772|P19|STARTED|Part A, Period 2||0
8281785|NCT01667900|20419773|P18|STARTED|Part A, Period 2||0
8281786|NCT01667900|20419774|P17|STARTED|Part A, Period 2||0
8281787|NCT01667900|20419775|P16|STARTED|Part A, Period 2||1
8281788|NCT01667900|20419776|P15|STARTED|Part A, Period 2||1
8281789|NCT01667900|20419777|P14|STARTED|Part A, Period 2||1
8281790|NCT01667900|20419778|P13|STARTED|Part A, Period 2||1
8281791|NCT01667900|20419779|P12|STARTED|Part A, Period 2||1
8281792|NCT01667900|20419780|P11|STARTED|Part A, Period 2||1
8281793|NCT01667900|20419781|P10|STARTED|Part A, Period 2||1
8281794|NCT01667900|20419782|P9|STARTED|Part A, Period 2||1
8281795|NCT01667900|20419783|P8|STARTED|Part A, Period 2||1
8281796|NCT01667900|20419784|P7|STARTED|Part A, Period 2||1
8281797|NCT01667900|20419785|P6|STARTED|Part A, Period 2||1
8281798|NCT01667900|20419786|P5|STARTED|Part A, Period 2||1
8281799|NCT01667900|20419787|P4|STARTED|Part A, Period 2||1
8281800|NCT01667900|20419788|P3|STARTED|Part A, Period 2||1
8281801|NCT01667900|20419789|P2|STARTED|Part A, Period 2||1
8281802|NCT01667900|20419790|P1|STARTED|Part A, Period 2||1
8281803|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Washout 1||0
8281804|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Washout 1||0
8281805|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Washout 1||0
8281806|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Washout 1||0
8281807|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Washout 1||0
8281808|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Washout 1||0
8281809|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Washout 1||0
8281810|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Washout 1||0
8281811|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Washout 1||0
8281812|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Washout 1||0
8281813|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Washout 1||0
8281814|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Washout 1||0
8281815|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Washout 1||0
8281816|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Washout 1||0
8281817|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Washout 1||0
8281818|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Washout 1||0
8281819|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Washout 1||0
8281820|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Washout 1||0
8281821|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Washout 1||0
8281822|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Washout 1||0
8281823|NCT01667900|20419771|P20|COMPLETED|Part A, Washout 1||0
8281824|NCT01667900|20419772|P19|COMPLETED|Part A, Washout 1||0
8281825|NCT01667900|20419773|P18|COMPLETED|Part A, Washout 1||0
8281826|NCT01667900|20419774|P17|COMPLETED|Part A, Washout 1||0
8281827|NCT01667900|20419775|P16|COMPLETED|Part A, Washout 1||1
8281828|NCT01667900|20419776|P15|COMPLETED|Part A, Washout 1||1
8281829|NCT01667900|20419777|P14|COMPLETED|Part A, Washout 1||1
8281830|NCT01667900|20419778|P13|COMPLETED|Part A, Washout 1||1
8281831|NCT01667900|20419779|P12|COMPLETED|Part A, Washout 1||1
8281832|NCT01667900|20419780|P11|COMPLETED|Part A, Washout 1||1
8281833|NCT01667900|20419781|P10|COMPLETED|Part A, Washout 1||1
8281834|NCT01667900|20419782|P9|COMPLETED|Part A, Washout 1||1
8281835|NCT01667900|20419783|P8|COMPLETED|Part A, Washout 1||1
8281836|NCT01667900|20419784|P7|COMPLETED|Part A, Washout 1||1
8281837|NCT01667900|20419785|P6|COMPLETED|Part A, Washout 1||1
8281838|NCT01667900|20419786|P5|COMPLETED|Part A, Washout 1||1
8281839|NCT01667900|20419787|P4|COMPLETED|Part A, Washout 1||1
8281840|NCT01667900|20419788|P3|COMPLETED|Part A, Washout 1||1
8281841|NCT01667900|20419789|P2|COMPLETED|Part A, Washout 1||1
8281842|NCT01667900|20419790|P1|COMPLETED|Part A, Washout 1||1
8281843|NCT01667900|20419771|P20|STARTED|Part A, Washout 1||0
8281844|NCT01667900|20419772|P19|STARTED|Part A, Washout 1||0
8281845|NCT01667900|20419773|P18|STARTED|Part A, Washout 1||0
8281846|NCT01667900|20419774|P17|STARTED|Part A, Washout 1||0
8281847|NCT01667900|20419775|P16|STARTED|Part A, Washout 1||1
8281848|NCT01667900|20419776|P15|STARTED|Part A, Washout 1||1
8281849|NCT01667900|20419777|P14|STARTED|Part A, Washout 1||1
8281850|NCT01667900|20419778|P13|STARTED|Part A, Washout 1||1
8281851|NCT01667900|20419779|P12|STARTED|Part A, Washout 1||1
8281852|NCT01667900|20419780|P11|STARTED|Part A, Washout 1||1
8281853|NCT01667900|20419781|P10|STARTED|Part A, Washout 1||1
8281854|NCT01667900|20419782|P9|STARTED|Part A, Washout 1||1
8281855|NCT01667900|20419783|P8|STARTED|Part A, Washout 1||1
8281856|NCT01667900|20419784|P7|STARTED|Part A, Washout 1||1
8281857|NCT01667900|20419785|P6|STARTED|Part A, Washout 1||1
8281858|NCT01667900|20419786|P5|STARTED|Part A, Washout 1||1
8281859|NCT01667900|20419787|P4|STARTED|Part A, Washout 1||1
8281860|NCT01667900|20419788|P3|STARTED|Part A, Washout 1||1
8281861|NCT01667900|20419789|P2|STARTED|Part A, Washout 1||1
8281862|NCT01667900|20419790|P1|STARTED|Part A, Washout 1||1
8281863|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Period 1||0
8281864|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Period 1||0
8281865|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Period 1||0
8281866|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Period 1||0
8281867|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Period 1||0
8281868|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Period 1||0
8281869|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Period 1||0
8281870|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Period 1||0
8281871|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Period 1||0
8281872|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Period 1||0
8281873|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Period 1||0
8281874|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Period 1||0
8281875|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Period 1||0
8281876|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Period 1||0
8281877|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Period 1||0
8281878|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Period 1||0
8281879|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Period 1||0
8281880|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Period 1||0
8281881|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Period 1||0
8281882|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Period 1||0
8281883|NCT01667900|20419771|P20|COMPLETED|Part A, Period 1||0
8281884|NCT01667900|20419772|P19|COMPLETED|Part A, Period 1||0
8281885|NCT01667900|20419773|P18|COMPLETED|Part A, Period 1||0
8281886|NCT01667900|20419774|P17|COMPLETED|Part A, Period 1||0
8281887|NCT01667900|20419775|P16|COMPLETED|Part A, Period 1||1
8281888|NCT01667900|20419776|P15|COMPLETED|Part A, Period 1||1
8281889|NCT01667900|20419777|P14|COMPLETED|Part A, Period 1||1
8281890|NCT01667900|20419778|P13|COMPLETED|Part A, Period 1||1
8281891|NCT01667900|20419779|P12|COMPLETED|Part A, Period 1||1
8281892|NCT01667900|20419780|P11|COMPLETED|Part A, Period 1||1
8281893|NCT01667900|20419781|P10|COMPLETED|Part A, Period 1||1
8281894|NCT01667900|20419782|P9|COMPLETED|Part A, Period 1||1
8281895|NCT01667900|20419783|P8|COMPLETED|Part A, Period 1||1
8281896|NCT01667900|20419784|P7|COMPLETED|Part A, Period 1||1
8281897|NCT01667900|20419785|P6|COMPLETED|Part A, Period 1||1
8281898|NCT01667900|20419786|P5|COMPLETED|Part A, Period 1||1
8281899|NCT01667900|20419787|P4|COMPLETED|Part A, Period 1||1
8281900|NCT01667900|20419788|P3|COMPLETED|Part A, Period 1||1
8281901|NCT01667900|20419789|P2|COMPLETED|Part A, Period 1||1
8281902|NCT01667900|20419790|P1|COMPLETED|Part A, Period 1||1
8281903|NCT01667900|20419771|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281904|NCT01667900|20419772|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281905|NCT01667900|20419773|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281906|NCT01667900|20419774|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281907|NCT01667900|20419775|P16|STARTED|Part A, Period 1||1
8281908|NCT01667900|20419776|P15|STARTED|Part A, Period 1||1
8281909|NCT01667900|20419777|P14|STARTED|Part A, Period 1||1
8281910|NCT01667900|20419778|P13|STARTED|Part A, Period 1||1
8281911|NCT01667900|20419779|P12|STARTED|Part A, Period 1||1
8281912|NCT01667900|20419780|P11|STARTED|Part A, Period 1||1
8281913|NCT01667900|20419781|P10|STARTED|Part A, Period 1||1
8281914|NCT01667900|20419782|P9|STARTED|Part A, Period 1||1
8281915|NCT01667900|20419783|P8|STARTED|Part A, Period 1||1
8281916|NCT01667900|20419784|P7|STARTED|Part A, Period 1||1
8281917|NCT01667900|20419785|P6|STARTED|Part A, Period 1||1
8281918|NCT01667900|20419786|P5|STARTED|Part A, Period 1||1
8281919|NCT01667900|20419787|P4|STARTED|Part A, Period 1||1
8281920|NCT01667900|20419788|P3|STARTED|Part A, Period 1||1
8281921|NCT01667900|20419789|P2|STARTED|Part A, Period 1||1
8281922|NCT01667900|20419790|P1|STARTED|Part A, Period 1||1
8281923|NCT01667848|20419830|P2|NOT COMPLETED|Overall Study||0
8281924|NCT01667848|20419831|P1|NOT COMPLETED|Overall Study||0
8281925|NCT01667848|20419830|P2|COMPLETED|Overall Study||81
8281926|NCT01667848|20419831|P1|COMPLETED|Overall Study||67
8281927|NCT01667848|20419830|P2|STARTED|Overall Study||81
8281928|NCT01667848|20419831|P1|STARTED|Overall Study||67
8281929|NCT01667796|20419841|P2|NOT COMPLETED|Overall Study||1
8281930|NCT01667796|20419842|P1|NOT COMPLETED|Overall Study||3
8281931|NCT01667796|20419841|P2|COMPLETED|Overall Study||29
8281932|NCT01667796|20419842|P1|COMPLETED|Overall Study||24
8281933|NCT01667796|20419841|P2|STARTED|Overall Study||30
8281934|NCT01667796|20419842|P1|STARTED|Overall Study||27
8281935|NCT01667731|20419860|P5|NOT COMPLETED|Overall Study||28
8281936|NCT01667731|20419861|P4|NOT COMPLETED|Overall Study||2
8281937|NCT01667731|20419862|P3|NOT COMPLETED|Overall Study||2
8281938|NCT01667731|20419863|P2|NOT COMPLETED|Overall Study||16
8281939|NCT01667731|20419864|P1|NOT COMPLETED|Overall Study||5
8281940|NCT01667731|20419860|P5|COMPLETED|Overall Study||87
8281941|NCT01667731|20419861|P4|COMPLETED|Overall Study||15
8281942|NCT01667731|20419862|P3|COMPLETED|Overall Study||22
8281943|NCT01667731|20419863|P2|COMPLETED|Overall Study||26
8281944|NCT01667731|20419864|P1|COMPLETED|Overall Study||21
8281945|NCT01667731|20419860|P5|STARTED|Overall Study||115
8281946|NCT01667731|20419861|P4|STARTED|Overall Study||17
8281947|NCT01667731|20419862|P3|STARTED|Overall Study||24
8281948|NCT01667731|20419863|P2|STARTED|Overall Study||42
8281949|NCT01667731|20419864|P1|STARTED|Overall Study||26
8281950|NCT01667679|20419919|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
8281951|NCT01667679|20419920|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
8281952|NCT01667679|20419919|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
8281953|NCT01667679|20419920|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
8281954|NCT01667679|20419919|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
8281955|NCT01667679|20419920|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
8281956|NCT01667679|20419919|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
8281957|NCT01667679|20419920|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
8281958|NCT01667679|20419919|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
8281959|NCT01667679|20419920|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
8281960|NCT01667679|20419919|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
8281961|NCT01667679|20419920|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
8281962|NCT01667562|20419978|P2|NOT COMPLETED|Erlotinib Phase||3
8281963|NCT01667562|20419979|P1|NOT COMPLETED|Erlotinib Phase||0
8281964|NCT01667562|20419978|P2|COMPLETED|Erlotinib Phase||27
8281965|NCT01667562|20419979|P1|COMPLETED|Erlotinib Phase||0
8281966|NCT01667562|20419978|P2|STARTED|Erlotinib Phase||30
8281967|NCT01667562|20419979|P1|STARTED|Erlotinib Phase||0
8281968|NCT01667562|20419978|P2|NOT COMPLETED|Diagnostic Phase||0
8281969|NCT01667562|20419979|P1|NOT COMPLETED|Diagnostic Phase||30
8281970|NCT01667562|20419978|P2|COMPLETED|Diagnostic Phase||0
8281971|NCT01667562|20419979|P1|COMPLETED|Diagnostic Phase||345
8281972|NCT01667562|20419978|P2|STARTED|Diagnostic Phase||0
8281973|NCT01667562|20419979|P1|STARTED|Diagnostic Phase||375
8281974|NCT01667549|20419993|P5|NOT COMPLETED|Overall Study||1
8281975|NCT01667549|20419994|P4|NOT COMPLETED|Overall Study||6
8281976|NCT01667549|20419995|P3|NOT COMPLETED|Overall Study||7
8281977|NCT01667549|20419996|P2|NOT COMPLETED|Overall Study||5
8281978|NCT01667549|20419997|P1|NOT COMPLETED|Overall Study||3
8281979|NCT01667549|20419993|P5|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
8281980|NCT01667549|20419994|P4|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
8281981|NCT01667549|20419995|P3|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
8281982|NCT01667549|20419996|P2|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
8281983|NCT01667549|20419997|P1|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
8281984|NCT01667549|20419993|P5|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
8281985|NCT01667549|20419994|P4|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
8281986|NCT01667549|20419995|P3|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
8281987|NCT01667549|20419996|P2|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
8281988|NCT01667549|20419997|P1|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
8281989|NCT01667536|20420029|P1|NOT COMPLETED|Overall Study||0
8281990|NCT01667536|20420029|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
8281991|NCT01667536|20420029|P1|STARTED|Overall Study||105
8281992|NCT01667471|20420040|P1|NOT COMPLETED|Overall Study||0
8281993|NCT01667471|20420040|P1|COMPLETED|Overall Study||7
8281994|NCT01667471|20420040|P1|STARTED|Overall Study||7
8281995|NCT01667432|20420056|P1|NOT COMPLETED|Overall Study||57
8281996|NCT01667432|20420056|P1|COMPLETED|Overall Study||84
8281997|NCT01667432|20420056|P1|STARTED|Overall Study||141
8281998|NCT01667419|20420065|P4|NOT COMPLETED|Overall Study||39
8281999|NCT01667419|20420066|P3|NOT COMPLETED|Overall Study||36
8282000|NCT01667419|20420067|P2|NOT COMPLETED|Overall Study||47
8282001|NCT01667419|20420068|P1|NOT COMPLETED|Overall Study||43
8282002|NCT01667419|20420065|P4|COMPLETED|Overall Study||52
8282003|NCT01667419|20420066|P3|COMPLETED|Overall Study||57
8282004|NCT01667419|20420067|P2|COMPLETED|Overall Study||110
8282005|NCT01667419|20420068|P1|COMPLETED|Overall Study||114
8282006|NCT01667419|20420065|P4|STARTED|Overall Study||91
8282007|NCT01667419|20420066|P3|STARTED|Overall Study||93
8282008|NCT01667419|20420067|P2|STARTED|Overall Study||157
8282009|NCT01667419|20420068|P1|STARTED|Overall Study||157
8282010|NCT01667250|20420098|P3|NOT COMPLETED|Randomised Period||0
8282011|NCT01667250|20420099|P2|NOT COMPLETED|Randomised Period||1
8282012|NCT01667250|20420100|P1|NOT COMPLETED|Randomised Period||1
8282013|NCT01667250|20420098|P3|COMPLETED|Randomised Period||0
8282014|NCT01667250|20420099|P2|COMPLETED|Randomised Period||28
8282015|NCT01667250|20420100|P1|COMPLETED|Randomised Period||29
8282016|NCT01667250|20420098|P3|STARTED|Randomised Period||0
8282017|NCT01667250|20420099|P2|STARTED|Randomised Period||29
8282018|NCT01667250|20420100|P1|STARTED|Randomised Period||30
8282019|NCT01667250|20420098|P3|NOT COMPLETED|Run-in (no Treatment)||14
8282020|NCT01667250|20420099|P2|NOT COMPLETED|Run-in (no Treatment)||0
8282021|NCT01667250|20420100|P1|NOT COMPLETED|Run-in (no Treatment)||0
8282022|NCT01667250|20420098|P3|COMPLETED|Run-in (no Treatment)||59
8282023|NCT01667250|20420099|P2|COMPLETED|Run-in (no Treatment)||0
8282024|NCT01667250|20420100|P1|COMPLETED|Run-in (no Treatment)||0
8282025|NCT01667250|20420098|P3|STARTED|Run-in (no Treatment)||73
8282026|NCT01667250|20420099|P2|STARTED|Run-in (no Treatment)||0
8282027|NCT01667250|20420100|P1|STARTED|Run-in (no Treatment)||0
8282028|NCT01667224|20420116|P2|NOT COMPLETED|Overall Study||2
8282029|NCT01667224|20420117|P1|NOT COMPLETED|Overall Study||4
8282030|NCT01667224|20420116|P2|COMPLETED|Overall Study||38
8282031|NCT01667224|20420117|P1|COMPLETED|Overall Study||36
8282032|NCT01667224|20420116|P2|STARTED|Overall Study||40
8282033|NCT01667224|20420117|P1|STARTED|Overall Study||40
8282034|NCT01667107|20420131|P2|NOT COMPLETED|Overall Study||7
8282035|NCT01667107|20420132|P1|NOT COMPLETED|Overall Study||4
8282036|NCT01667107|20420131|P2|COMPLETED|Overall Study||11
8282037|NCT01667107|20420132|P1|COMPLETED|Overall Study||4
8282038|NCT01667107|20420131|P2|STARTED|Overall Study||18
8282039|NCT01667107|20420132|P1|STARTED|Overall Study||8
8282040|NCT01667029|20420148|P2|NOT COMPLETED|Overall Study||1
8282041|NCT01667029|20420149|P1|NOT COMPLETED|Overall Study||1
8282042|NCT01667029|20420148|P2|COMPLETED|Overall Study||3
8282043|NCT01667029|20420149|P1|COMPLETED|Overall Study||3
8282044|NCT01667029|20420148|P2|STARTED|Overall Study||4
8282045|NCT01667029|20420149|P1|STARTED|Overall Study||4
8282046|NCT01666951|20420191|P2|NOT COMPLETED|Overall Study||1
8282047|NCT01666951|20420192|P1|NOT COMPLETED|Overall Study||1
8282048|NCT01666951|20420191|P2|COMPLETED|Overall Study||17
8282049|NCT01666951|20420192|P1|COMPLETED|Overall Study||17
8282050|NCT01666951|20420191|P2|STARTED|Overall Study||18
8282051|NCT01666951|20420192|P1|STARTED|Overall Study||18
8282052|NCT01666912|20420230|P2|NOT COMPLETED|Overall Study||11
8282053|NCT01666912|20420231|P1|NOT COMPLETED|Overall Study||21
8282054|NCT01666912|20420230|P2|COMPLETED|Overall Study||37
8282055|NCT01666912|20420231|P1|COMPLETED|Overall Study||27
8282056|NCT01666912|20420230|P2|STARTED|Overall Study||48
8282057|NCT01666912|20420231|P1|STARTED|Overall Study||48
8282058|NCT01666782|20420243|P2|NOT COMPLETED|Overall Study||1
8282059|NCT01666782|20420244|P1|NOT COMPLETED|Overall Study||4
8282060|NCT01666782|20420243|P2|COMPLETED|Overall Study||50
8282061|NCT01666782|20420244|P1|COMPLETED|Overall Study||50
8282062|NCT01666782|20420243|P2|STARTED|Overall Study||51
8282063|NCT01666782|20420244|P1|STARTED|Overall Study||54
8282064|NCT01666652|20420265|P5|NOT COMPLETED|Overall Study||1
8282065|NCT01666652|20420266|P4|NOT COMPLETED|Overall Study||4
8282066|NCT01666652|20420267|P3|NOT COMPLETED|Overall Study||1
8282067|NCT01666652|20420268|P2|NOT COMPLETED|Overall Study||1
8282068|NCT01666652|20420269|P1|NOT COMPLETED|Overall Study||2
8282069|NCT01666652|20420265|P5|COMPLETED|Overall Study||19
8282070|NCT01666652|20420266|P4|COMPLETED|Overall Study||16
8282071|NCT01666652|20420267|P3|COMPLETED|Overall Study||19
8282072|NCT01666652|20420268|P2|COMPLETED|Overall Study||19
8282073|NCT01666652|20420269|P1|COMPLETED|Overall Study||18
8282074|NCT01666652|20420265|P5|STARTED|Overall Study||20
8282075|NCT01666652|20420266|P4|STARTED|Overall Study||20
8282076|NCT01666652|20420267|P3|STARTED|Overall Study||20
8282077|NCT01666652|20420268|P2|STARTED|Overall Study||20
8282078|NCT01666652|20420269|P1|STARTED|Overall Study||20
8282079|NCT01666444|20420318|P2|NOT COMPLETED|Overall Study||1
8282080|NCT01666444|20420319|P1|NOT COMPLETED|Overall Study||2
8282081|NCT01666444|20420318|P2|COMPLETED|Overall Study||147
8282082|NCT01666444|20420319|P1|COMPLETED|Overall Study||147
8282083|NCT01666444|20420318|P2|STARTED|Overall Study||148
8282084|NCT01666444|20420319|P1|STARTED|Overall Study||149
8282085|NCT01666314|20420337|P4|NOT COMPLETED|Overall Study||36
8282086|NCT01666314|20420338|P3|NOT COMPLETED|Overall Study||36
8282087|NCT01666314|20420339|P2|NOT COMPLETED|Overall Study||32
8282088|NCT01666314|20420340|P1|NOT COMPLETED|Overall Study||33
8282089|NCT01666314|20420337|P4|COMPLETED|Overall Study||0
8282090|NCT01666314|20420338|P3|COMPLETED|Overall Study||0
8282091|NCT01666314|20420339|P2|COMPLETED|Overall Study||0
8282092|NCT01666314|20420340|P1|COMPLETED|Overall Study||0
8282093|NCT01666314|20420337|P4|STARTED|Overall Study||36
8282094|NCT01666314|20420338|P3|STARTED|Overall Study||36
8282095|NCT01666314|20420339|P2|STARTED|Overall Study||32
8282096|NCT01666314|20420340|P1|STARTED|Overall Study||33
8282097|NCT01666210|20420451|P2|NOT COMPLETED|Overall Study||1
8282098|NCT01666210|20420452|P1|NOT COMPLETED|Overall Study||2
8282099|NCT01666210|20420451|P2|COMPLETED|Overall Study||29
8282100|NCT01666210|20420452|P1|COMPLETED|Overall Study||28
8282101|NCT01666210|20420451|P2|STARTED|Overall Study||30
8282102|NCT01666210|20420452|P1|STARTED|Overall Study||30
8282103|NCT01666197|20420464|P2|NOT COMPLETED|Overall Study||0
8282104|NCT01666197|20420465|P1|NOT COMPLETED|Overall Study||0
8282105|NCT01666197|20420464|P2|COMPLETED|Overall Study||50
8282106|NCT01666197|20420465|P1|COMPLETED|Overall Study||50
8282107|NCT01666197|20420464|P2|STARTED|Overall Study||50
8282108|NCT01666197|20420465|P1|STARTED|Overall Study||50
8282109|NCT01666145|20420471|P1|NOT COMPLETED|Overall Study||0
8282110|NCT01666145|20420471|P1|COMPLETED|Overall Study||14
8282111|NCT01666145|20420471|P1|STARTED|Overall Study||14
8282112|NCT01666119|20420476|P1|NOT COMPLETED|Overall Study||52
8282113|NCT01666119|20420476|P1|COMPLETED|Overall Study||197
8282114|NCT01666119|20420476|P1|STARTED|Overall Study||249
8282115|NCT01666002|20420483|P2|NOT COMPLETED|Overall Study||0
8282116|NCT01666002|20420484|P1|NOT COMPLETED|Overall Study||5
8282117|NCT01666002|20420483|P2|COMPLETED|Overall Study||10
8282118|NCT01666002|20420484|P1|COMPLETED|Overall Study||12
8282119|NCT01666002|20420483|P2|STARTED|Overall Study||10
8282120|NCT01666002|20420484|P1|STARTED|Overall Study||17
8282121|NCT01665950|20420495|P3|NOT COMPLETED|Overall Study||1
8282122|NCT01665950|20420496|P2|NOT COMPLETED|Overall Study||0
8282123|NCT01665950|20420497|P1|NOT COMPLETED|Overall Study||1
8282124|NCT01665950|20420495|P3|COMPLETED|Overall Study||1
8282125|NCT01665950|20420496|P2|COMPLETED|Overall Study||0
8282126|NCT01665950|20420497|P1|COMPLETED|Overall Study||1
8282127|NCT01665950|20420495|P3|STARTED|Overall Study||2
8282128|NCT01665950|20420496|P2|STARTED|Overall Study||0
8282129|NCT01665950|20420497|P1|STARTED|Overall Study||2
8282130|NCT01665911|20420505|P1|NOT COMPLETED|Overall Study||6
8282131|NCT01665911|20420505|P1|COMPLETED|Overall Study||22
8282132|NCT01665911|20420505|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
8282133|NCT01665911|20420505|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
8282134|NCT01665911|20420505|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
8282135|NCT01665911|20420505|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
8282136|NCT01665911|20420505|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
8282137|NCT01665911|20420505|P1|STARTED|Overall Study||28
8282138|NCT01665872|20420513|P2|NOT COMPLETED|12 Month Follow-up||3
8282139|NCT01665872|20420514|P1|NOT COMPLETED|12 Month Follow-up||14
8282140|NCT01665872|20420513|P2|COMPLETED|12 Month Follow-up||47
8282141|NCT01665872|20420514|P1|COMPLETED|12 Month Follow-up||58
8282142|NCT01665872|20420513|P2|STARTED|12 Month Follow-up||50
8282143|NCT01665872|20420514|P1|STARTED|12 Month Follow-up||72
8282144|NCT01665872|20420513|P2|NOT COMPLETED|6 Month Follow-up||1
8282145|NCT01665872|20420514|P1|NOT COMPLETED|6 Month Follow-up||6
8282146|NCT01665872|20420513|P2|COMPLETED|6 Month Follow-up||49
8282147|NCT01665872|20420514|P1|COMPLETED|6 Month Follow-up||66
8282148|NCT01665872|20420513|P2|STARTED|6 Month Follow-up||50
8282149|NCT01665872|20420514|P1|STARTED|6 Month Follow-up||72
8282150|NCT01665872|20420513|P2|NOT COMPLETED|Treatment||17
8282151|NCT01665872|20420514|P1|NOT COMPLETED|Treatment||15
8282152|NCT01665872|20420513|P2|COMPLETED|Treatment||50
8282153|NCT01665872|20420514|P1|COMPLETED|Treatment||72
8282154|NCT01665872|20420513|P2|STARTED|Treatment||67
8282155|NCT01665872|20420514|P1|STARTED|Treatment||87
8282156|NCT01665872|20420513|P2|NOT COMPLETED|Screening||0
8282157|NCT01665872|20420514|P1|NOT COMPLETED|Screening||0
8282158|NCT01665872|20420513|P2|COMPLETED|Screening||172
8282159|NCT01665872|20420514|P1|COMPLETED|Screening||172
8282160|NCT01665872|20420513|P2|STARTED|Screening||172
8282161|NCT01665872|20420514|P1|STARTED|Screening||172
8282162|NCT01665807|20420531|P3|NOT COMPLETED|Overall Study||1
8282163|NCT01665807|20420532|P2|NOT COMPLETED|Overall Study||0
8282164|NCT01665807|20420533|P1|NOT COMPLETED|Overall Study||2
8282165|NCT01665807|20420531|P3|COMPLETED|Overall Study||401
8282166|NCT01665807|20420532|P2|COMPLETED|Overall Study||58
8282167|NCT01665807|20420533|P1|COMPLETED|Overall Study||409
8282168|NCT01665807|20420531|P3|STARTED|Overall Study||402
8282169|NCT01665807|20420532|P2|STARTED|Overall Study||58
8282170|NCT01665807|20420533|P1|STARTED|Overall Study||411
8282171|NCT01665768|20420544|P1|NOT COMPLETED|Overall Study||23
8282172|NCT01665768|20420544|P1|COMPLETED|Overall Study||26
8282173|NCT01665768|20420544|P1|STARTED|Overall Study||49
8282174|NCT01665599|20420549|P1|NOT COMPLETED|Overall Study||8
8282175|NCT01665599|20420549|P1|COMPLETED|Overall Study||172
8282176|NCT01665599|20420549|P1|STARTED|Overall Study||180
8282177|NCT01665508|20420569|P1|NOT COMPLETED|Overall Study||5
8282178|NCT01665508|20420569|P1|COMPLETED|Overall Study||7
8282179|NCT01665508|20420569|P1|STARTED|Overall Study||12
8282180|NCT01665430|20420585|P1|NOT COMPLETED|Overall Study||9
8282181|NCT01665430|20420585|P1|COMPLETED|Overall Study||29
8282182|NCT01665430|20420585|P1|STARTED|Overall Study||38
8282183|NCT01665170|20420601|P2|NOT COMPLETED|Overall Study||0
8282184|NCT01665170|20420602|P1|NOT COMPLETED|Overall Study||0
8282185|NCT01665170|20420601|P2|COMPLETED|Overall Study||30
8282186|NCT01665170|20420602|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
8282187|NCT01665170|20420601|P2|After TSST|Overall Study||30
8282188|NCT01665170|20420602|P1|After TSST|Overall Study||30
8282189|NCT01665170|20420601|P2|During TSST|Overall Study||30
8282190|NCT01665170|20420602|P1|During TSST|Overall Study||30
8282191|NCT01665170|20420601|P2|Bevore TSST|Overall Study||30
8282192|NCT01665170|20420602|P1|Bevore TSST|Overall Study||30
8282193|NCT01665170|20420601|P2|STARTED|Overall Study||30
8282194|NCT01665170|20420602|P1|STARTED|Overall Study|First patient in|30
8282195|NCT01665157|20420653|P3|NOT COMPLETED|Overall Study||0
8282196|NCT01665157|20420654|P2|NOT COMPLETED|Overall Study||0
8282197|NCT01665157|20420655|P1|NOT COMPLETED|Overall Study||0
8282198|NCT01665157|20420653|P3|COMPLETED|Overall Study||60
8282199|NCT01665157|20420654|P2|COMPLETED|Overall Study||60
8282200|NCT01665157|20420655|P1|COMPLETED|Overall Study||60
8282201|NCT01665157|20420653|P3|STARTED|Overall Study||60
8282202|NCT01665157|20420654|P2|STARTED|Overall Study||60
8282203|NCT01665157|20420655|P1|STARTED|Overall Study||60
8282204|NCT01665144|20420683|P2|NOT COMPLETED|Overall Study||122
8282205|NCT01665144|20420684|P1|NOT COMPLETED|Overall Study||202
8282206|NCT01665144|20420683|P2|COMPLETED|Overall Study||424
8282207|NCT01665144|20420684|P1|COMPLETED|Overall Study||903
8282208|NCT01665144|20420683|P2|Full Analysis Set|Overall Study||546
8282209|NCT01665144|20420684|P1|Full Analysis Set|Overall Study||1099
8282210|NCT01665144|20420683|P2|Safety Set|Overall Study||546
8282211|NCT01665144|20420684|P1|Safety Set|Overall Study||1099
8282212|NCT01665144|20420683|P2|STARTED|Overall Study||546
8282213|NCT01665144|20420684|P1|STARTED|Overall Study||1105
8282214|NCT01665092|20420694|P4|NOT COMPLETED|Overall Study||1
8282215|NCT01665092|20420695|P3|NOT COMPLETED|Overall Study||2
8282216|NCT01665092|20420696|P2|NOT COMPLETED|Overall Study||0
8282217|NCT01665092|20420697|P1|NOT COMPLETED|Overall Study||0
8282218|NCT01665092|20420694|P4|COMPLETED|Overall Study||105
8282219|NCT01665092|20420695|P3|COMPLETED|Overall Study||32
8282220|NCT01665092|20420696|P2|COMPLETED|Overall Study||35
8282221|NCT01665092|20420697|P1|COMPLETED|Overall Study||75
8282222|NCT01665092|20420694|P4|STARTED|Overall Study||106
8282223|NCT01665092|20420695|P3|STARTED|Overall Study||34
8282224|NCT01665092|20420696|P2|STARTED|Overall Study||35
8282225|NCT01665092|20420697|P1|STARTED|Overall Study||75
8282226|NCT01665053|20420709|P2|NOT COMPLETED|Overall Study||15
8282227|NCT01665053|20420710|P1|NOT COMPLETED|Overall Study||32
8282228|NCT01665053|20420709|P2|COMPLETED|Overall Study||831
8282229|NCT01665053|20420710|P1|COMPLETED|Overall Study||806
8282230|NCT01665053|20420709|P2|Death With No 12-month Clinical FU|Overall Study||9
8282231|NCT01665053|20420710|P1|Death With No 12-month Clinical FU|Overall Study||9
8282232|NCT01665053|20420709|P2|No 12-Month F/U|Overall Study||15
8282233|NCT01665053|20420710|P1|No 12-Month F/U|Overall Study||32
8282234|NCT01665053|20420709|P2|Completed 12-Month Clinical F/U|Overall Study||822
8282235|NCT01665053|20420710|P1|Completed 12-Month Clinical F/U|Overall Study||797
8282236|NCT01665053|20420709|P2|STARTED|Overall Study||846
8282237|NCT01665053|20420710|P1|STARTED|Overall Study||838
8282238|NCT01665040|20420748|P1|NOT COMPLETED|Overall Study||4
8282239|NCT01665040|20420748|P1|COMPLETED|Overall Study||36
8282240|NCT01665040|20420748|P1|STARTED|Overall Study||40
8282241|NCT01664975|20420755|P2|NOT COMPLETED|Overall Study||3
8282242|NCT01664975|20420756|P1|NOT COMPLETED|Overall Study||5
8282243|NCT01664975|20420755|P2|COMPLETED|Overall Study||51
8282244|NCT01664975|20420756|P1|COMPLETED|Overall Study||52
8282245|NCT01664975|20420755|P2|STARTED|Overall Study||54
8282246|NCT01664975|20420756|P1|STARTED|Overall Study||57
8282247|NCT01664949|20420764|P2|NOT COMPLETED|Overall Study||25
8282248|NCT01664949|20420765|P1|NOT COMPLETED|Overall Study||24
8282249|NCT01664949|20420764|P2|COMPLETED|Overall Study||211
8282250|NCT01664949|20420765|P1|COMPLETED|Overall Study||200
8282251|NCT01664949|20420764|P2|STARTED|Overall Study||236
8282252|NCT01664949|20420765|P1|STARTED|Overall Study||224
8282253|NCT01664923|20420781|P2|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
8282254|NCT01664923|20420782|P1|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
8282255|NCT01664923|20420781|P2|COMPLETED|Period 2: Open-label Phase-36 Months||15
8282256|NCT01664923|20420782|P1|COMPLETED|Period 2: Open-label Phase-36 Months||52
8282257|NCT01664923|20420781|P2|Treated|Period 2: Open-label Phase-36 Months||37
8282258|NCT01664923|20420782|P1|Treated|Period 2: Open-label Phase-36 Months||93
8282259|NCT01664923|20420781|P2|STARTED|Period 2: Open-label Phase-36 Months||38
8282260|NCT01664923|20420782|P1|STARTED|Period 2: Open-label Phase-36 Months||93
8282261|NCT01664923|20420781|P2|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
8282262|NCT01664923|20420782|P1|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
8282263|NCT01664923|20420781|P2|COMPLETED|Period1:Double Blind Phase-29 Months||38
8282264|NCT01664923|20420782|P1|COMPLETED|Period1:Double Blind Phase-29 Months||93
8282265|NCT01664923|20420781|P2|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
8282266|NCT01664923|20420782|P1|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
8282267|NCT01664923|20420781|P2|STARTED|Period1:Double Blind Phase-29 Months||198
8282268|NCT01664923|20420782|P1|STARTED|Period1:Double Blind Phase-29 Months||198
8282269|NCT01664897|20420802|P1|NOT COMPLETED|Overall Study||0
8282270|NCT01664897|20420802|P1|COMPLETED|Overall Study||29
8282271|NCT01664897|20420802|P1|STARTED|Overall Study||29
8282272|NCT01664858|20420813|P3|NOT COMPLETED|Overall Study||6
8282273|NCT01664858|20420814|P2|NOT COMPLETED|Overall Study||13
8282274|NCT01664858|20420815|P1|NOT COMPLETED|Overall Study||14
8282275|NCT01664858|20420813|P3|COMPLETED|Overall Study||234
8282276|NCT01664858|20420814|P2|COMPLETED|Overall Study||468
8282277|NCT01664858|20420815|P1|COMPLETED|Overall Study||467
8282278|NCT01664858|20420813|P3|STARTED|Overall Study||240
8282279|NCT01664858|20420814|P2|STARTED|Overall Study||481
8282280|NCT01664858|20420815|P1|STARTED|Overall Study||481
8282281|NCT01664806|20420831|P2|NOT COMPLETED|Overall Study||0
8282282|NCT01664806|20420832|P1|NOT COMPLETED|Overall Study||0
8282283|NCT01664806|20420831|P2|COMPLETED|Overall Study||20
8282284|NCT01664806|20420832|P1|COMPLETED|Overall Study||20
8282285|NCT01664806|20420831|P2|STARTED|Overall Study||20
8282286|NCT01664806|20420832|P1|STARTED|Overall Study||20
8282287|NCT01664793|20420842|P2|NOT COMPLETED|Overall Study||0
8282288|NCT01664793|20420843|P1|NOT COMPLETED|Overall Study||0
8282289|NCT01664793|20420842|P2|COMPLETED|Overall Study||38626
8282290|NCT01664793|20420843|P1|COMPLETED|Overall Study||49039
8282291|NCT01664793|20420842|P2|STARTED|Overall Study||38626
8282292|NCT01664793|20420843|P1|STARTED|Overall Study||49039
8282293|NCT01664741|20420854|P3|NOT COMPLETED|Overall Study||0
8282294|NCT01664741|20420855|P2|NOT COMPLETED|Overall Study||0
8282295|NCT01664741|20420856|P1|NOT COMPLETED|Overall Study||0
8282296|NCT01664741|20420854|P3|COMPLETED|Overall Study||13
8282297|NCT01664741|20420855|P2|COMPLETED|Overall Study||6
8282298|NCT01664741|20420856|P1|COMPLETED|Overall Study||6
8282299|NCT01664741|20420854|P3|STARTED|Overall Study||13
8282300|NCT01664741|20420855|P2|STARTED|Overall Study||6
8282301|NCT01664741|20420856|P1|STARTED|Overall Study||6
8282302|NCT01664624|20420873|P4|NOT COMPLETED|Overall Study||0
8282303|NCT01664624|20420874|P3|NOT COMPLETED|Overall Study||0
8282304|NCT01664624|20420875|P2|NOT COMPLETED|Overall Study||1
8282305|NCT01664624|20420876|P1|NOT COMPLETED|Overall Study||0
8282306|NCT01664624|20420873|P4|COMPLETED|Overall Study||9
8282307|NCT01664624|20420874|P3|COMPLETED|Overall Study||10
8282308|NCT01664624|20420875|P2|COMPLETED|Overall Study||10
8282309|NCT01664624|20420876|P1|COMPLETED|Overall Study||10
8282310|NCT01664624|20420873|P4|STARTED|Overall Study||9
8282311|NCT01664624|20420874|P3|STARTED|Overall Study||10
8282312|NCT01664624|20420875|P2|STARTED|Overall Study||11
8282313|NCT01664624|20420876|P1|STARTED|Overall Study||10
8282314|NCT01664559|20420908|P2|NOT COMPLETED|Overall Study||0
8282315|NCT01664559|20420909|P1|NOT COMPLETED|Overall Study||0
8282316|NCT01664559|20420908|P2|COMPLETED|Overall Study||33
8282317|NCT01664559|20420909|P1|COMPLETED|Overall Study||34
8282318|NCT01664559|20420908|P2|STARTED|Overall Study||33
8282319|NCT01664559|20420909|P1|STARTED|Overall Study||34
8282320|NCT01664533|20420923|P1|NOT COMPLETED|Overall Study||57
8282321|NCT01664533|20420923|P1|COMPLETED|Overall Study||0
8282322|NCT01664533|20420923|P1|STARTED|Overall Study||57
8282323|NCT01664494|20420931|P1|NOT COMPLETED|Overall Study||193
8282324|NCT01664494|20420931|P1|COMPLETED|Overall Study||370
8282325|NCT01664494|20420931|P1|STARTED|Overall Study||563
8282326|NCT01664247|20420938|P2|NOT COMPLETED|Overall Study||41
8282327|NCT01664247|20420939|P1|NOT COMPLETED|Overall Study||14
8282328|NCT01664247|20420938|P2|COMPLETED|Overall Study||131
8282329|NCT01664247|20420939|P1|COMPLETED|Overall Study||160
8282330|NCT01664247|20420938|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
8282331|NCT01664247|20420939|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
8282332|NCT01664247|20420938|P2|STARTED|Overall Study||172
8282333|NCT01664247|20420939|P1|STARTED|Overall Study||174
8282334|NCT01664130|20420961|P1|NOT COMPLETED|Overall Study||2
8282335|NCT01664130|20420961|P1|COMPLETED|Overall Study||33
8282336|NCT01664130|20420961|P1|STARTED|Overall Study||35
8282337|NCT01664117|20420984|P1|NOT COMPLETED|Overall Study||0
8282338|NCT01664117|20420984|P1|COMPLETED|Overall Study||209
8282339|NCT01664117|20420984|P1|STARTED|Overall Study||209
8282340|NCT01664104|20421039|P1|NOT COMPLETED|Overall Study||16
8282341|NCT01664104|20421039|P1|COMPLETED|Overall Study||120
8282342|NCT01664104|20421039|P1|STARTED|Overall Study||136
8282343|NCT01664091|20421106|P1|NOT COMPLETED|Overall Study||6
8282344|NCT01664091|20421106|P1|COMPLETED|Overall Study||26
8282345|NCT01664091|20421106|P1|STARTED|Overall Study||32
8282346|NCT01664078|20421114|P1|NOT COMPLETED|Overall Study||69
8282347|NCT01664078|20421114|P1|COMPLETED|Overall Study||121
8282348|NCT01664078|20421114|P1|STARTED|Overall Study||190
8282349|NCT01664052|20421167|P2|NOT COMPLETED|Phase 2||4
8282350|NCT01664052|20421168|P1|NOT COMPLETED|Phase 2||0
8282351|NCT01664052|20421167|P2|COMPLETED|Phase 2||31
8282352|NCT01664052|20421168|P1|COMPLETED|Phase 2||0
8282353|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
8282354|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
8282355|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
8282356|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
8282357|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
8282358|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
8282359|NCT01664052|20421167|P2|HSG 1 Hour Post Placement|Phase 2||31
8282360|NCT01664052|20421168|P1|HSG 1 Hour Post Placement|Phase 2||0
8282361|NCT01664052|20421167|P2|Insert Placed|Phase 2||31
8282362|NCT01664052|20421168|P1|Insert Placed|Phase 2||0
8282363|NCT01664052|20421167|P2|STARTED|Phase 2||35
8282364|NCT01664052|20421168|P1|STARTED|Phase 2|Screened and enrolled|0
8282365|NCT01664052|20421167|P2|NOT COMPLETED|Phase 1||0
8282366|NCT01664052|20421168|P1|NOT COMPLETED|Phase 1||7
8282367|NCT01664052|20421167|P2|COMPLETED|Phase 1||0
8282368|NCT01664052|20421168|P1|COMPLETED|Phase 1||24
8282369|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
8282370|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
8282371|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
8282372|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
8282373|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
8282374|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
8282375|NCT01664052|20421167|P2|HSG 1 Hour Post Placement|Phase 1||0
8282376|NCT01664052|20421168|P1|HSG 1 Hour Post Placement|Phase 1||24
8282377|NCT01664052|20421167|P2|Insert Placed in at Least One Tube|Phase 1||0
8282378|NCT01664052|20421168|P1|Insert Placed in at Least One Tube|Phase 1||25
8282379|NCT01664052|20421167|P2|STARTED|Phase 1||0
8282380|NCT01664052|20421168|P1|STARTED|Phase 1|Screening and enrollment|31
8282381|NCT01664039|20421186|P2|NOT COMPLETED|Overall Study||9
8282382|NCT01664039|20421187|P1|NOT COMPLETED|Overall Study||6
8282383|NCT01664039|20421186|P2|COMPLETED|Overall Study||43
8282384|NCT01664039|20421187|P1|COMPLETED|Overall Study||46
8282385|NCT01664039|20421186|P2|STARTED|Overall Study||52
8282386|NCT01664039|20421187|P1|STARTED|Overall Study||52
8282387|NCT01663987|20421209|P2|NOT COMPLETED|Overall Study||6
8282388|NCT01663987|20421210|P1|NOT COMPLETED|Overall Study||13
8282389|NCT01663987|20421209|P2|COMPLETED|Overall Study||34
8282390|NCT01663987|20421210|P1|COMPLETED|Overall Study||26
8282391|NCT01663987|20421209|P2|STARTED|Overall Study||40
8282392|NCT01663987|20421210|P1|STARTED|Overall Study||39
8282393|NCT01663935|20421238|P1|NOT COMPLETED|Overall Study||0
8282394|NCT01663935|20421238|P1|COMPLETED|Overall Study||20
8282395|NCT01663935|20421238|P1|STARTED|Overall Study||20
8282396|NCT01663922|20421243|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
8282397|NCT01663922|20421244|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
8282398|NCT01663922|20421243|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
8282399|NCT01663922|20421244|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
8282400|NCT01663922|20421243|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
8282401|NCT01663922|20421244|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
8282402|NCT01663922|20421243|P2|NOT COMPLETED|Washout (7 Days)||0
8282403|NCT01663922|20421244|P1|NOT COMPLETED|Washout (7 Days)||0
8282404|NCT01663922|20421243|P2|COMPLETED|Washout (7 Days)||9
8282405|NCT01663922|20421244|P1|COMPLETED|Washout (7 Days)||8
8282406|NCT01663922|20421243|P2|STARTED|Washout (7 Days)||9
8282407|NCT01663922|20421244|P1|STARTED|Washout (7 Days)||8
8282408|NCT01663922|20421243|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8282409|NCT01663922|20421244|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8282410|NCT01663922|20421243|P2|COMPLETED|Second Intervention (14 Days)||9
8282411|NCT01663922|20421244|P1|COMPLETED|Second Intervention (14 Days)||8
8282412|NCT01663922|20421243|P2|STARTED|Second Intervention (14 Days)||9
8282413|NCT01663922|20421244|P1|STARTED|Second Intervention (14 Days)||8
8282414|NCT01663922|20421243|P2|NOT COMPLETED|Washout (7 Days)||0
8282415|NCT01663922|20421244|P1|NOT COMPLETED|Washout (7 Days)||0
8282416|NCT01663922|20421243|P2|COMPLETED|Washout (7 Days)||9
8282417|NCT01663922|20421244|P1|COMPLETED|Washout (7 Days)||8
8282418|NCT01663922|20421243|P2|STARTED|Washout (7 Days)||9
8282419|NCT01663922|20421244|P1|STARTED|Washout (7 Days)||8
8282420|NCT01663922|20421243|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
8282421|NCT01663922|20421244|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
8282422|NCT01663922|20421243|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
8282423|NCT01663922|20421244|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
8282424|NCT01663922|20421243|P2|STARTED|First Intervention (14 Days or 5 Days)||9
8282425|NCT01663922|20421244|P1|STARTED|First Intervention (14 Days or 5 Days)||8
8282426|NCT01663896|20421249|P1|NOT COMPLETED|Overall Study||43
8282427|NCT01663896|20421249|P1|COMPLETED|Overall Study||375
8282428|NCT01663896|20421249|P1|STARTED|Overall Study||418
8282429|NCT01663857|20421260|P4|NOT COMPLETED|Overall Study||4
8282430|NCT01663857|20421261|P3|NOT COMPLETED|Overall Study||10
8282431|NCT01663857|20421262|P2|NOT COMPLETED|Overall Study||1
8282432|NCT01663857|20421263|P1|NOT COMPLETED|Overall Study||0
8282433|NCT01663857|20421260|P4|COMPLETED|Overall Study||48
8282434|NCT01663857|20421261|P3|COMPLETED|Overall Study||48
8282435|NCT01663857|20421262|P2|COMPLETED|Overall Study||1
8282436|NCT01663857|20421263|P1|COMPLETED|Overall Study||6
8282437|NCT01663857|20421260|P4|Received at Least One Dose of Study Drug|Overall Study||52
8282438|NCT01663857|20421261|P3|Received at Least One Dose of Study Drug|Overall Study||58
8282439|NCT01663857|20421262|P2|Received at Least One Dose of Study Drug|Overall Study||2
8282440|NCT01663857|20421263|P1|Received at Least One Dose of Study Drug|Overall Study||6
8282441|NCT01663857|20421260|P4|STARTED|Overall Study||52
8282442|NCT01663857|20421261|P3|STARTED|Overall Study||58
8282443|NCT01663857|20421262|P2|STARTED|Overall Study||2
8282444|NCT01663857|20421263|P1|STARTED|Overall Study||6
8282445|NCT01663779|20421282|P2|NOT COMPLETED|Overall Study||0
8282446|NCT01663779|20421283|P1|NOT COMPLETED|Overall Study||0
8282447|NCT01663779|20421282|P2|COMPLETED|Overall Study||23
8282448|NCT01663779|20421283|P1|COMPLETED|Overall Study||27
8282449|NCT01663779|20421282|P2|STARTED|Overall Study||23
8282450|NCT01663779|20421283|P1|STARTED|Overall Study||27
8282451|NCT01663740|20421291|P2|NOT COMPLETED|Overall Study||8
8282452|NCT01663740|20421292|P1|NOT COMPLETED|Overall Study||16
8282453|NCT01663740|20421291|P2|COMPLETED|Overall Study||13
8282454|NCT01663740|20421292|P1|COMPLETED|Overall Study||22
8282455|NCT01663740|20421291|P2|STARTED|Overall Study|Safety Population|21
8282456|NCT01663740|20421292|P1|STARTED|Overall Study|Safety Population|38
8282457|NCT01663727|20421352|P2|NOT COMPLETED|Overall Study||238
8282458|NCT01663727|20421353|P1|NOT COMPLETED|Overall Study||242
8282459|NCT01663727|20421352|P2|COMPLETED|Overall Study||1
8282460|NCT01663727|20421353|P1|COMPLETED|Overall Study||0
8282461|NCT01663727|20421352|P2|STARTED|Overall Study||239
8282462|NCT01663727|20421353|P1|STARTED|Overall Study||242
8282463|NCT01663714|20421385|P1|NOT COMPLETED|Long-Term Follow-Up||6
8282464|NCT01663714|20421385|P1|COMPLETED|Long-Term Follow-Up||16
8282465|NCT01663714|20421385|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
8282466|NCT01663714|20421385|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
8282467|NCT01663714|20421385|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8282468|NCT01663714|20421385|P1|STARTED|Dosimetric and Therapeutic Treatment||30
8282469|NCT01663636|20421414|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
8282470|NCT01663636|20421415|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
8282471|NCT01663636|20421414|P2|COMPLETED|Parent SMS Acceptability Assessment||130
8282472|NCT01663636|20421415|P1|COMPLETED|Parent SMS Acceptability Assessment||135
8282473|NCT01663636|20421414|P2|STARTED|Parent SMS Acceptability Assessment||130
8282474|NCT01663636|20421415|P1|STARTED|Parent SMS Acceptability Assessment||135
8282475|NCT01663636|20421414|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
8282476|NCT01663636|20421415|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
8282477|NCT01663636|20421414|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
8282478|NCT01663636|20421415|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
8282479|NCT01663636|20421414|P2|STARTED|Infant SMS Reminder Feasibility Study||161
8282480|NCT01663636|20421415|P1|STARTED|Infant SMS Reminder Feasibility Study||160
8282481|NCT01663623|20421423|P2|NOT COMPLETED|Overall Study||20
8282482|NCT01663623|20421424|P1|NOT COMPLETED|Overall Study||12
8282483|NCT01663623|20421423|P2|COMPLETED|Overall Study||33
8282484|NCT01663623|20421424|P1|COMPLETED|Overall Study||40
8282485|NCT01663623|20421423|P2|STARTED|Overall Study||53
8282486|NCT01663623|20421424|P1|STARTED|Overall Study||52
8282487|NCT01663532|20421434|P2|NOT COMPLETED|Overall Study||107
8282488|NCT01663532|20421435|P1|NOT COMPLETED|Overall Study||74
8282489|NCT01663532|20421434|P2|COMPLETED|Overall Study||65
8282490|NCT01663532|20421435|P1|COMPLETED|Overall Study||94
8282491|NCT01663532|20421434|P2|STARTED|Overall Study||172
8282492|NCT01663532|20421435|P1|STARTED|Overall Study||168
8282493|NCT01663506|20421453|P1|NOT COMPLETED|Overall Study||8
8282494|NCT01663506|20421453|P1|COMPLETED|Overall Study||15
8282495|NCT01663506|20421453|P1|STARTED|Overall Study||23
8282496|NCT01663402|20421484|P2|NOT COMPLETED|Overall Study||2084
8282497|NCT01663402|20421485|P1|NOT COMPLETED|Overall Study||1515
8282498|NCT01663402|20421484|P2|COMPLETED|Overall Study||7378
8282499|NCT01663402|20421485|P1|COMPLETED|Overall Study||7947
8282500|NCT01663402|20421484|P2|Treated|Overall Study||9451
8282501|NCT01663402|20421485|P1|Treated|Overall Study||9443
8282502|NCT01663402|20421484|P2|STARTED|Overall Study||9462
8282503|NCT01663402|20421485|P1|STARTED|Overall Study||9462
8282504|NCT01663363|20421519|P1|NOT COMPLETED|Overall Study||0
8282505|NCT01663363|20421519|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
8282506|NCT01663363|20421519|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
8282507|NCT01663285|20421524|P1|NOT COMPLETED|Overall Study||0
8282508|NCT01663285|20421524|P1|COMPLETED|Overall Study||1
8282509|NCT01663285|20421524|P1|STARTED|Overall Study||1
8282510|NCT01663272|20421530|P3|NOT COMPLETED|Overall Study||0
8282511|NCT01663272|20421531|P2|NOT COMPLETED|Overall Study||0
8282512|NCT01663272|20421532|P1|NOT COMPLETED|Overall Study||0
8282513|NCT01663272|20421530|P3|COMPLETED|Overall Study||1
8282514|NCT01663272|20421531|P2|COMPLETED|Overall Study||6
8282515|NCT01663272|20421532|P1|COMPLETED|Overall Study||5
8282516|NCT01663272|20421530|P3|STARTED|Overall Study||1
8282517|NCT01663272|20421531|P2|STARTED|Overall Study||6
8282518|NCT01663272|20421532|P1|STARTED|Overall Study||5
8282519|NCT01663259|20421537|P1|NOT COMPLETED|Overall Study||0
8282520|NCT01663259|20421537|P1|COMPLETED|Overall Study||42
8282521|NCT01663259|20421537|P1|STARTED|Overall Study||42
8282522|NCT01663233|20421551|P2|NOT COMPLETED|Overall Study||7
8282523|NCT01663233|20421552|P1|NOT COMPLETED|Overall Study||4
8282524|NCT01663233|20421551|P2|COMPLETED|Overall Study||129
8282525|NCT01663233|20421552|P1|COMPLETED|Overall Study||126
8282526|NCT01663233|20421551|P2|STARTED|Overall Study||136
8282527|NCT01663233|20421552|P1|STARTED|Overall Study||130
8282528|NCT01663103|20421576|P2|NOT COMPLETED|Overall Study||2
8282529|NCT01663103|20421577|P1|NOT COMPLETED|Overall Study||3
8282530|NCT01663103|20421576|P2|COMPLETED|Overall Study||19
8282531|NCT01663103|20421577|P1|COMPLETED|Overall Study||18
8282532|NCT01663103|20421576|P2|STARTED|Overall Study||21
8282533|NCT01663103|20421577|P1|STARTED|Overall Study||21
8282534|NCT01663012|20421593|P1|NOT COMPLETED|Overall Study||0
8282535|NCT01663012|20421593|P1|COMPLETED|Overall Study||20
8282536|NCT01663012|20421593|P1|STARTED|Overall Study||20
8282537|NCT01662999|20421605|P6|NOT COMPLETED|Period 3||0
8282538|NCT01662999|20421606|P5|NOT COMPLETED|Period 3||0
8282539|NCT01662999|20421607|P4|NOT COMPLETED|Period 3||0
8282540|NCT01662999|20421608|P3|NOT COMPLETED|Period 3||0
8282541|NCT01662999|20421609|P2|NOT COMPLETED|Period 3||1
8282542|NCT01662999|20421610|P1|NOT COMPLETED|Period 3||0
8282543|NCT01662999|20421605|P6|COMPLETED|Period 3||7
8282544|NCT01662999|20421606|P5|COMPLETED|Period 3||7
8282545|NCT01662999|20421607|P4|COMPLETED|Period 3||7
8282546|NCT01662999|20421608|P3|COMPLETED|Period 3||7
8282547|NCT01662999|20421609|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
8282548|NCT01662999|20421610|P1|COMPLETED|Period 3||7
8282549|NCT01662999|20421605|P6|STARTED|Period 3||7
8282550|NCT01662999|20421606|P5|STARTED|Period 3||7
8282551|NCT01662999|20421607|P4|STARTED|Period 3||7
8282552|NCT01662999|20421608|P3|STARTED|Period 3||7
8282553|NCT01662999|20421609|P2|STARTED|Period 3||7
8282554|NCT01662999|20421610|P1|STARTED|Period 3||7
8282555|NCT01662999|20421605|P6|NOT COMPLETED|Period 2||0
8282556|NCT01662999|20421606|P5|NOT COMPLETED|Period 2||0
8282557|NCT01662999|20421607|P4|NOT COMPLETED|Period 2||0
8282558|NCT01662999|20421608|P3|NOT COMPLETED|Period 2||0
8282559|NCT01662999|20421609|P2|NOT COMPLETED|Period 2||0
8282560|NCT01662999|20421610|P1|NOT COMPLETED|Period 2||0
8282561|NCT01662999|20421605|P6|COMPLETED|Period 2||7
8282562|NCT01662999|20421606|P5|COMPLETED|Period 2||7
8282563|NCT01662999|20421607|P4|COMPLETED|Period 2||7
8282564|NCT01662999|20421608|P3|COMPLETED|Period 2||7
8282565|NCT01662999|20421609|P2|COMPLETED|Period 2||7
8282566|NCT01662999|20421610|P1|COMPLETED|Period 2||7
8282567|NCT01662999|20421605|P6|STARTED|Period 2||7
8282568|NCT01662999|20421606|P5|STARTED|Period 2||7
8282569|NCT01662999|20421607|P4|STARTED|Period 2||7
8282570|NCT01662999|20421608|P3|STARTED|Period 2||7
8282571|NCT01662999|20421609|P2|STARTED|Period 2||7
8282572|NCT01662999|20421610|P1|STARTED|Period 2||7
8282573|NCT01662999|20421605|P6|NOT COMPLETED|Period 1||0
8282574|NCT01662999|20421606|P5|NOT COMPLETED|Period 1||0
8282575|NCT01662999|20421607|P4|NOT COMPLETED|Period 1||0
8282576|NCT01662999|20421608|P3|NOT COMPLETED|Period 1||0
8282577|NCT01662999|20421609|P2|NOT COMPLETED|Period 1||0
8282578|NCT01662999|20421610|P1|NOT COMPLETED|Period 1||0
8282579|NCT01662999|20421605|P6|COMPLETED|Period 1||7
8282580|NCT01662999|20421606|P5|COMPLETED|Period 1||7
8282581|NCT01662999|20421607|P4|COMPLETED|Period 1||7
8282582|NCT01662999|20421608|P3|COMPLETED|Period 1||7
8282583|NCT01662999|20421609|P2|COMPLETED|Period 1||7
8282584|NCT01662999|20421610|P1|COMPLETED|Period 1||7
8282585|NCT01662999|20421605|P6|STARTED|Period 1||7
8282586|NCT01662999|20421606|P5|STARTED|Period 1||7
8282587|NCT01662999|20421607|P4|STARTED|Period 1||7
8282588|NCT01662999|20421608|P3|STARTED|Period 1||7
8282589|NCT01662999|20421609|P2|STARTED|Period 1||7
8282590|NCT01662999|20421610|P1|STARTED|Period 1||7
8282591|NCT01662986|20421681|P2|NOT COMPLETED|Overall Study||13
8282592|NCT01662986|20421682|P1|NOT COMPLETED|Overall Study||18
8282593|NCT01662986|20421681|P2|COMPLETED|Overall Study||26
8282594|NCT01662986|20421682|P1|COMPLETED|Overall Study||22
8282595|NCT01662986|20421681|P2|STARTED|Overall Study||39
8282596|NCT01662986|20421682|P1|STARTED|Overall Study||40
8282597|NCT01662960|20421718|P4|NOT COMPLETED|3 Month Follow-up||2
8282598|NCT01662960|20421719|P3|NOT COMPLETED|3 Month Follow-up||3
8282599|NCT01662960|20421720|P2|NOT COMPLETED|3 Month Follow-up||3
8282600|NCT01662960|20421721|P1|NOT COMPLETED|3 Month Follow-up||3
8282601|NCT01662960|20421718|P4|COMPLETED|3 Month Follow-up||13
8282602|NCT01662960|20421719|P3|COMPLETED|3 Month Follow-up||5
8282603|NCT01662960|20421720|P2|COMPLETED|3 Month Follow-up||16
8282604|NCT01662960|20421721|P1|COMPLETED|3 Month Follow-up||21
8282605|NCT01662960|20421718|P4|STARTED|3 Month Follow-up||15
8282606|NCT01662960|20421719|P3|STARTED|3 Month Follow-up||8
8282607|NCT01662960|20421720|P2|STARTED|3 Month Follow-up||19
8282608|NCT01662960|20421721|P1|STARTED|3 Month Follow-up||24
8282609|NCT01662960|20421718|P4|NOT COMPLETED|End of 4 Week Treatment Period||0
8282610|NCT01662960|20421719|P3|NOT COMPLETED|End of 4 Week Treatment Period||1
8282611|NCT01662960|20421720|P2|NOT COMPLETED|End of 4 Week Treatment Period||4
8282612|NCT01662960|20421721|P1|NOT COMPLETED|End of 4 Week Treatment Period||1
8282613|NCT01662960|20421718|P4|COMPLETED|End of 4 Week Treatment Period||15
8282614|NCT01662960|20421719|P3|COMPLETED|End of 4 Week Treatment Period||8
8282615|NCT01662960|20421720|P2|COMPLETED|End of 4 Week Treatment Period||19
8282616|NCT01662960|20421721|P1|COMPLETED|End of 4 Week Treatment Period||24
8282617|NCT01662960|20421718|P4|STARTED|End of 4 Week Treatment Period||15
8282618|NCT01662960|20421719|P3|STARTED|End of 4 Week Treatment Period||9
8282619|NCT01662960|20421720|P2|STARTED|End of 4 Week Treatment Period||23
8282620|NCT01662960|20421721|P1|STARTED|End of 4 Week Treatment Period||25
8282621|NCT01662908|20421753|P2|NOT COMPLETED|Overall Study||5
8282622|NCT01662908|20421754|P1|NOT COMPLETED|Overall Study||6
8282623|NCT01662908|20421753|P2|COMPLETED|Overall Study||23
8282624|NCT01662908|20421754|P1|COMPLETED|Overall Study||50
8282625|NCT01662908|20421753|P2|STARTED|Overall Study||28
8282626|NCT01662908|20421754|P1|STARTED|Overall Study||56
8282627|NCT01662895|20421770|P2|NOT COMPLETED|Overall Study||1
8282628|NCT01662895|20421771|P1|NOT COMPLETED|Overall Study||0
8282629|NCT01662895|20421770|P2|COMPLETED|Overall Study||20
8282630|NCT01662895|20421771|P1|COMPLETED|Overall Study||21
8282631|NCT01662895|20421770|P2|Initiated Study Drug|Overall Study||21
8282632|NCT01662895|20421771|P1|Initiated Study Drug|Overall Study||21
8282633|NCT01662895|20421770|P2|STARTED|Overall Study||21
8282634|NCT01662895|20421771|P1|STARTED|Overall Study||21
8282635|NCT01662882|20421794|P3|NOT COMPLETED|Overall Study||0
8282636|NCT01662882|20421795|P2|NOT COMPLETED|Overall Study||0
8282637|NCT01662882|20421796|P1|NOT COMPLETED|Overall Study||0
8282638|NCT01662882|20421794|P3|COMPLETED|Overall Study||15
8282639|NCT01662882|20421795|P2|COMPLETED|Overall Study||18
8282640|NCT01662882|20421796|P1|COMPLETED|Overall Study||15
8282641|NCT01662882|20421794|P3|STARTED|Overall Study||15
8282642|NCT01662882|20421795|P2|STARTED|Overall Study||18
8282643|NCT01662882|20421796|P1|STARTED|Overall Study||15
8282644|NCT01662856|20421809|P2|NOT COMPLETED|Primary Part II||2
8282645|NCT01662856|20421810|P1|NOT COMPLETED|Primary Part II||10
8282646|NCT01662856|20421809|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
8282647|NCT01662856|20421810|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
8282648|NCT01662856|20421809|P2|Completed Study up to Week 6|Primary Part II||56
8282649|NCT01662856|20421810|P1|Completed Study up to Week 6|Primary Part II||106
8282650|NCT01662856|20421809|P2|STARTED|Primary Part II||57
8282651|NCT01662856|20421810|P1|STARTED|Primary Part II||109
8282652|NCT01662856|20421809|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
8282653|NCT01662856|20421810|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
8282654|NCT01662856|20421809|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
8282655|NCT01662856|20421810|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
8282656|NCT01662856|20421809|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
8282657|NCT01662856|20421810|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
8282658|NCT01662856|20421809|P2|STARTED|Part I + Part II (Overall Study)||57
8282659|NCT01662856|20421810|P1|STARTED|Part I + Part II (Overall Study)||168
8282660|NCT01662791|20421824|P2|NOT COMPLETED|Part 2 - Interventional||0
8282661|NCT01662791|20421825|P1|NOT COMPLETED|Part 2 - Interventional||0
8282662|NCT01662791|20421824|P2|COMPLETED|Part 2 - Interventional||0
8282663|NCT01662791|20421825|P1|COMPLETED|Part 2 - Interventional||8
8282664|NCT01662791|20421824|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
8282665|NCT01662791|20421825|P1|STARTED|Part 2 - Interventional||8
8282666|NCT01662791|20421824|P2|NOT COMPLETED|Part 1 - Observational||0
8282667|NCT01662791|20421825|P1|NOT COMPLETED|Part 1 - Observational||0
8282668|NCT01662791|20421824|P2|COMPLETED|Part 1 - Observational||41
8282669|NCT01662791|20421825|P1|COMPLETED|Part 1 - Observational||8
8282670|NCT01662791|20421824|P2|STARTED|Part 1 - Observational||41
8282671|NCT01662791|20421825|P1|STARTED|Part 1 - Observational||8
8282672|NCT01662778|20421847|P4|NOT COMPLETED|Period 4||0
8282673|NCT01662778|20421848|P3|NOT COMPLETED|Period 4||0
8282674|NCT01662778|20421849|P2|NOT COMPLETED|Period 4||0
8282675|NCT01662778|20421850|P1|NOT COMPLETED|Period 4||0
8282676|NCT01662778|20421847|P4|COMPLETED|Period 4||4
8282677|NCT01662778|20421848|P3|COMPLETED|Period 4||6
8282678|NCT01662778|20421849|P2|COMPLETED|Period 4||5
8282679|NCT01662778|20421850|P1|COMPLETED|Period 4||6
8282680|NCT01662778|20421847|P4|STARTED|Period 4||4
8282681|NCT01662778|20421848|P3|STARTED|Period 4||6
8282682|NCT01662778|20421849|P2|STARTED|Period 4||5
8282683|NCT01662778|20421850|P1|STARTED|Period 4||6
8282684|NCT01662778|20421847|P4|NOT COMPLETED|Period 3||0
8282685|NCT01662778|20421848|P3|NOT COMPLETED|Period 3||0
8282686|NCT01662778|20421849|P2|NOT COMPLETED|Period 3||0
8282687|NCT01662778|20421850|P1|NOT COMPLETED|Period 3||0
8282688|NCT01662778|20421847|P4|COMPLETED|Period 3||4
8282689|NCT01662778|20421848|P3|COMPLETED|Period 3||6
8282690|NCT01662778|20421849|P2|COMPLETED|Period 3||5
8282691|NCT01662778|20421850|P1|COMPLETED|Period 3||6
8282692|NCT01662778|20421847|P4|STARTED|Period 3||4
8282693|NCT01662778|20421848|P3|STARTED|Period 3||6
8282694|NCT01662778|20421849|P2|STARTED|Period 3||5
8282695|NCT01662778|20421850|P1|STARTED|Period 3||6
8282696|NCT01662778|20421847|P4|NOT COMPLETED|Period 2||0
8282697|NCT01662778|20421848|P3|NOT COMPLETED|Period 2||0
8282698|NCT01662778|20421849|P2|NOT COMPLETED|Period 2||0
8282699|NCT01662778|20421850|P1|NOT COMPLETED|Period 2||0
8282700|NCT01662778|20421847|P4|COMPLETED|Period 2||4
8282701|NCT01662778|20421848|P3|COMPLETED|Period 2||6
8282702|NCT01662778|20421849|P2|COMPLETED|Period 2||5
8282703|NCT01662778|20421850|P1|COMPLETED|Period 2||6
8282704|NCT01662778|20421847|P4|STARTED|Period 2||4
8282705|NCT01662778|20421848|P3|STARTED|Period 2||6
8282706|NCT01662778|20421849|P2|STARTED|Period 2||5
8282707|NCT01662778|20421850|P1|STARTED|Period 2||6
8282708|NCT01662778|20421847|P4|NOT COMPLETED|Period 1||0
8282709|NCT01662778|20421848|P3|NOT COMPLETED|Period 1||0
8282710|NCT01662778|20421849|P2|NOT COMPLETED|Period 1||0
8282711|NCT01662778|20421850|P1|NOT COMPLETED|Period 1||0
8282712|NCT01662778|20421847|P4|COMPLETED|Period 1||4
8282713|NCT01662778|20421848|P3|COMPLETED|Period 1||6
8282714|NCT01662778|20421849|P2|COMPLETED|Period 1||5
8282715|NCT01662778|20421850|P1|COMPLETED|Period 1||6
8282716|NCT01662778|20421847|P4|STARTED|Period 1||4
8282717|NCT01662778|20421848|P3|STARTED|Period 1||6
8282718|NCT01662778|20421849|P2|STARTED|Period 1||5
8282719|NCT01662778|20421850|P1|STARTED|Period 1||6
8282720|NCT01662765|20421874|P2|NOT COMPLETED|Overall Study||2
8282721|NCT01662765|20421875|P1|NOT COMPLETED|Overall Study||1
8282722|NCT01662765|20421874|P2|COMPLETED|Overall Study||40
8282723|NCT01662765|20421875|P1|COMPLETED|Overall Study||41
8282724|NCT01662765|20421874|P2|STARTED|Overall Study||42
8282725|NCT01662765|20421875|P1|STARTED|Overall Study||42
8282726|NCT01662752|20421887|P1|NOT COMPLETED|Overall Study||0
8282727|NCT01662752|20421887|P1|COMPLETED|Overall Study||30
8282728|NCT01662752|20421887|P1|STARTED|Overall Study||30
8282729|NCT01662648|20421895|P2|NOT COMPLETED|Overall Study||178
8282730|NCT01662648|20421896|P1|NOT COMPLETED|Overall Study||147
8282731|NCT01662648|20421895|P2|COMPLETED|Overall Study||419
8282732|NCT01662648|20421896|P1|COMPLETED|Overall Study||373
8282733|NCT01662648|20421895|P2|STARTED|Overall Study||597
8282734|NCT01662648|20421896|P1|STARTED|Overall Study||520
8282735|NCT01662635|20421918|P1|NOT COMPLETED|Overall Study||30
8282736|NCT01662635|20421918|P1|COMPLETED|Overall Study||200
8282737|NCT01662635|20421918|P1|STARTED|Overall Study||230
8282738|NCT01662583|20421927|P3|NOT COMPLETED|Overall Study||0
8282739|NCT01662583|20421928|P2|NOT COMPLETED|Overall Study||0
8282740|NCT01662583|20421929|P1|NOT COMPLETED|Overall Study||0
8282741|NCT01662583|20421927|P3|COMPLETED|Overall Study||219
8282742|NCT01662583|20421928|P2|COMPLETED|Overall Study||225
8282743|NCT01662583|20421929|P1|COMPLETED|Overall Study||216
8282744|NCT01662583|20421927|P3|STARTED|Overall Study||219
8282745|NCT01662583|20421928|P2|STARTED|Overall Study||225
8282746|NCT01662583|20421929|P1|STARTED|Overall Study||216
8282747|NCT01662531|20421942|P1|NOT COMPLETED|Overall Study||0
8282748|NCT01662531|20421942|P1|COMPLETED|Overall Study||27
8282749|NCT01662531|20421942|P1|STARTED|Overall Study||27
8282750|NCT01662505|20421969|P3|NOT COMPLETED|Overall Study||8
8282751|NCT01662505|20421970|P2|NOT COMPLETED|Overall Study||4
8282752|NCT01662505|20421971|P1|NOT COMPLETED|Overall Study||7
8282753|NCT01662505|20421969|P3|COMPLETED|Overall Study||0
8282754|NCT01662505|20421970|P2|COMPLETED|Overall Study||0
8282755|NCT01662505|20421971|P1|COMPLETED|Overall Study||0
8282756|NCT01662505|20421969|P3|STARTED|Overall Study||8
8282757|NCT01662505|20421970|P2|STARTED|Overall Study||4
8282758|NCT01662505|20421971|P1|STARTED|Overall Study||7
8282759|NCT01662492|20421995|P3|NOT COMPLETED|Overall Study||6
8282760|NCT01662492|20421996|P2|NOT COMPLETED|Overall Study||1
8282761|NCT01662492|20421997|P1|NOT COMPLETED|Overall Study||3
8282762|NCT01662492|20421995|P3|COMPLETED|Overall Study||31
8282763|NCT01662492|20421996|P2|COMPLETED|Overall Study||42
8282764|NCT01662492|20421997|P1|COMPLETED|Overall Study||42
8282765|NCT01662492|20421995|P3|STARTED|Overall Study||37
8282766|NCT01662492|20421996|P2|STARTED|Overall Study||43
8282767|NCT01662492|20421997|P1|STARTED|Overall Study||45
8282768|NCT01662440|20422021|P4|NOT COMPLETED|Overall Study||4
8282769|NCT01662440|20422022|P3|NOT COMPLETED|Overall Study||6
8282770|NCT01662440|20422023|P2|NOT COMPLETED|Overall Study||6
8282771|NCT01662440|20422024|P1|NOT COMPLETED|Overall Study||9
8282772|NCT01662440|20422021|P4|COMPLETED|Overall Study||52
8282773|NCT01662440|20422022|P3|COMPLETED|Overall Study||215
8282774|NCT01662440|20422023|P2|COMPLETED|Overall Study||211
8282775|NCT01662440|20422024|P1|COMPLETED|Overall Study||158
8282776|NCT01662440|20422021|P4|STARTED|Overall Study||56
8282777|NCT01662440|20422022|P3|STARTED|Overall Study||221
8282778|NCT01662440|20422023|P2|STARTED|Overall Study||217
8282779|NCT01662440|20422024|P1|STARTED|Overall Study||167
8282780|NCT01662362|20422072|P1|NOT COMPLETED|Overall Study||38
8282781|NCT01662362|20422072|P1|COMPLETED|Overall Study||25
8282782|NCT01662362|20422072|P1|STARTED|Overall Study||63
8282783|NCT01662336|20422077|P1|NOT COMPLETED|Overall Study||66
8282784|NCT01662336|20422077|P1|COMPLETED|Overall Study||107
8282785|NCT01662336|20422077|P1|Completed Month 12 Visit|Overall Study||109
8282786|NCT01662336|20422077|P1|Completed Month 6 Visit|Overall Study||142
8282787|NCT01662336|20422077|P1|STARTED|Overall Study||173
8282788|NCT01662310|20422103|P5|NOT COMPLETED|Open-Label Extension Phase||10
8282789|NCT01662310|20422104|P4|NOT COMPLETED|Open-Label Extension Phase||11
8282790|NCT01662310|20422105|P3|NOT COMPLETED|Open-Label Extension Phase||0
8282791|NCT01662310|20422106|P2|NOT COMPLETED|Open-Label Extension Phase||0
8282792|NCT01662310|20422107|P1|NOT COMPLETED|Open-Label Extension Phase||0
8282793|NCT01662310|20422103|P5|COMPLETED|Open-Label Extension Phase||49
8282794|NCT01662310|20422104|P4|COMPLETED|Open-Label Extension Phase||36
8282795|NCT01662310|20422105|P3|COMPLETED|Open-Label Extension Phase||0
8282796|NCT01662310|20422106|P2|COMPLETED|Open-Label Extension Phase||0
8282797|NCT01662310|20422107|P1|COMPLETED|Open-Label Extension Phase||0
8282798|NCT01662310|20422103|P5|STARTED|Open-Label Extension Phase||59
8282799|NCT01662310|20422104|P4|STARTED|Open-Label Extension Phase||47
8282800|NCT01662310|20422105|P3|STARTED|Open-Label Extension Phase||0
8282801|NCT01662310|20422106|P2|STARTED|Open-Label Extension Phase||0
8282802|NCT01662310|20422107|P1|STARTED|Open-Label Extension Phase||0
8282803|NCT01662310|20422103|P5|NOT COMPLETED|Double-Blind Phase||0
8282804|NCT01662310|20422104|P4|NOT COMPLETED|Double-Blind Phase||0
8282805|NCT01662310|20422105|P3|NOT COMPLETED|Double-Blind Phase||5
8282806|NCT01662310|20422106|P2|NOT COMPLETED|Double-Blind Phase||15
8282807|NCT01662310|20422107|P1|NOT COMPLETED|Double-Blind Phase||0
8282808|NCT01662310|20422103|P5|COMPLETED|Double-Blind Phase||0
8282809|NCT01662310|20422104|P4|COMPLETED|Double-Blind Phase||0
8282810|NCT01662310|20422105|P3|COMPLETED|Double-Blind Phase||66
8282811|NCT01662310|20422106|P2|COMPLETED|Double-Blind Phase||50
8282812|NCT01662310|20422107|P1|COMPLETED|Double-Blind Phase||0
8282813|NCT01662310|20422103|P5|Treated|Double-Blind Phase||0
8282814|NCT01662310|20422104|P4|Treated|Double-Blind Phase||0
8282815|NCT01662310|20422105|P3|Treated|Double-Blind Phase||71
8282816|NCT01662310|20422106|P2|Treated|Double-Blind Phase||64
8282817|NCT01662310|20422107|P1|Treated|Double-Blind Phase||0
8282818|NCT01662310|20422103|P5|STARTED|Double-Blind Phase||0
8282819|NCT01662310|20422104|P4|STARTED|Double-Blind Phase||0
8282820|NCT01662310|20422105|P3|STARTED|Double-Blind Phase||71
8282821|NCT01662310|20422106|P2|STARTED|Double-Blind Phase||65
8282822|NCT01662310|20422107|P1|STARTED|Double-Blind Phase||0
8282823|NCT01662310|20422103|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
8282824|NCT01662310|20422104|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
8282825|NCT01662310|20422105|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
8282826|NCT01662310|20422106|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
8282827|NCT01662310|20422107|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
8282828|NCT01662310|20422103|P5|COMPLETED|Run-In or Stabilization Phase||0
8282829|NCT01662310|20422104|P4|COMPLETED|Run-In or Stabilization Phase||0
8282830|NCT01662310|20422105|P3|COMPLETED|Run-In or Stabilization Phase||0
8282831|NCT01662310|20422106|P2|COMPLETED|Run-In or Stabilization Phase||0
8282832|NCT01662310|20422107|P1|COMPLETED|Run-In or Stabilization Phase||136
8282833|NCT01662310|20422103|P5|STARTED|Run-In or Stabilization Phase||0
8282834|NCT01662310|20422104|P4|STARTED|Run-In or Stabilization Phase||0
8282835|NCT01662310|20422105|P3|STARTED|Run-In or Stabilization Phase||0
8282836|NCT01662310|20422106|P2|STARTED|Run-In or Stabilization Phase||0
8282837|NCT01662310|20422107|P1|STARTED|Run-In or Stabilization Phase||201
8282838|NCT01662297|20422141|P2|NOT COMPLETED|Overall Study||0
8282839|NCT01662297|20422142|P1|NOT COMPLETED|Overall Study||0
8282840|NCT01662297|20422141|P2|COMPLETED|Overall Study||1
8282841|NCT01662297|20422142|P1|COMPLETED|Overall Study||0
8282842|NCT01662297|20422141|P2|STARTED|Overall Study||1
8282843|NCT01662297|20422142|P1|STARTED|Overall Study||0
8282844|NCT01662115|20422167|P3|NOT COMPLETED|Overall Study||0
8282845|NCT01662115|20422168|P2|NOT COMPLETED|Overall Study||0
8282846|NCT01662115|20422169|P1|NOT COMPLETED|Overall Study||0
8282847|NCT01662115|20422167|P3|COMPLETED|Overall Study||0
8282848|NCT01662115|20422168|P2|COMPLETED|Overall Study||2
8282849|NCT01662115|20422169|P1|COMPLETED|Overall Study||2
8282850|NCT01662115|20422167|P3|STARTED|Overall Study||0
8282851|NCT01662115|20422168|P2|STARTED|Overall Study||2
8282852|NCT01662115|20422169|P1|STARTED|Overall Study||2
8282853|NCT01662102|20422188|P2|NOT COMPLETED|Overall Study||0
8282854|NCT01662102|20422189|P1|NOT COMPLETED|Overall Study||1
8282855|NCT01662102|20422188|P2|COMPLETED|Overall Study||0
8282856|NCT01662102|20422189|P1|COMPLETED|Overall Study||0
8282857|NCT01662102|20422188|P2|STARTED|Overall Study||0
8282858|NCT01662102|20422189|P1|STARTED|Overall Study||1
8282859|NCT01662063|20422197|P3|NOT COMPLETED|Overall Study||1
8282860|NCT01662063|20422198|P2|NOT COMPLETED|Overall Study||29
8282861|NCT01662063|20422199|P1|NOT COMPLETED|Overall Study||5
8282862|NCT01662063|20422197|P3|COMPLETED|Overall Study||0
8282863|NCT01662063|20422198|P2|COMPLETED|Overall Study||144
8282864|NCT01662063|20422199|P1|COMPLETED|Overall Study||39
8282865|NCT01662063|20422197|P3|STARTED|Overall Study||1
8282866|NCT01662063|20422198|P2|STARTED|Overall Study||173
8282867|NCT01662063|20422199|P1|STARTED|Overall Study||44
8282868|NCT01662024|20422278|P1|NOT COMPLETED|Overall Study||5
8282869|NCT01662024|20422278|P1|COMPLETED|Overall Study||15
8282870|NCT01662024|20422278|P1|STARTED|Overall Study||20
8282871|NCT01661972|20422290|P2|NOT COMPLETED|Overall Study||4
8282872|NCT01661972|20422291|P1|NOT COMPLETED|Overall Study||2
8282873|NCT01661972|20422290|P2|COMPLETED|Overall Study||46
8282874|NCT01661972|20422291|P1|COMPLETED|Overall Study||11
8282875|NCT01661972|20422290|P2|STARTED|Overall Study||50
8282876|NCT01661972|20422291|P1|STARTED|Overall Study||13
8282877|NCT01661946|20422303|P2|NOT COMPLETED|Overall Study||0
8282878|NCT01661946|20422304|P1|NOT COMPLETED|Overall Study||0
8282879|NCT01661946|20422303|P2|COMPLETED|Overall Study||5
8282880|NCT01661946|20422304|P1|COMPLETED|Overall Study||5
8282881|NCT01661946|20422303|P2|STARTED|Overall Study||5
8282882|NCT01661946|20422304|P1|STARTED|Overall Study||5
8282883|NCT01661933|20422310|P1|NOT COMPLETED|High-dose Gluten Challenge||2
8282884|NCT01661933|20422310|P1|COMPLETED|High-dose Gluten Challenge||8
8282885|NCT01661933|20422310|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
8282886|NCT01661933|20422310|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
8282887|NCT01661933|20422310|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
8282888|NCT01661933|20422310|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
8282889|NCT01661933|20422310|P1|NOT COMPLETED|Gluten Micro-challenge||0
8282890|NCT01661933|20422310|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
8282891|NCT01661933|20422310|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
8282892|NCT01661881|20422317|P1|NOT COMPLETED|Overall Study||1
8282893|NCT01661881|20422317|P1|COMPLETED|Overall Study||22
8282894|NCT01661881|20422317|P1|STARTED|Overall Study||23
8282895|NCT01661790|20422325|P2|NOT COMPLETED|Overall Study||2
8282896|NCT01661790|20422326|P1|NOT COMPLETED|Overall Study||0
8282897|NCT01661790|20422325|P2|COMPLETED|Overall Study||34
8282898|NCT01661790|20422326|P1|COMPLETED|Overall Study||36
8282899|NCT01661790|20422325|P2|STARTED|Overall Study||36
8282900|NCT01661790|20422326|P1|STARTED|Overall Study||36
8282901|NCT01661764|20422338|P6|NOT COMPLETED|Overall Study||2
8282902|NCT01661764|20422339|P5|NOT COMPLETED|Overall Study||3
8282903|NCT01661764|20422340|P4|NOT COMPLETED|Overall Study||2
8282904|NCT01661764|20422341|P3|NOT COMPLETED|Overall Study||3
8282905|NCT01661764|20422342|P2|NOT COMPLETED|Overall Study||5
8282906|NCT01661764|20422343|P1|NOT COMPLETED|Overall Study||2
8282907|NCT01661764|20422338|P6|COMPLETED|Overall Study||18
8282908|NCT01661764|20422339|P5|COMPLETED|Overall Study||16
8282909|NCT01661764|20422340|P4|COMPLETED|Overall Study||24
8282910|NCT01661764|20422341|P3|COMPLETED|Overall Study||22
8282911|NCT01661764|20422342|P2|COMPLETED|Overall Study||20
8282912|NCT01661764|20422343|P1|COMPLETED|Overall Study||24
8282913|NCT01661764|20422338|P6|STARTED|Overall Study||20
8282914|NCT01661764|20422339|P5|STARTED|Overall Study||19
8282915|NCT01661764|20422340|P4|STARTED|Overall Study||26
8282916|NCT01661764|20422341|P3|STARTED|Overall Study||25
8282917|NCT01661764|20422342|P2|STARTED|Overall Study||25
8282918|NCT01661764|20422343|P1|STARTED|Overall Study||26
8282919|NCT01661712|20422407|P2|NOT COMPLETED|Overall Study||0
8282920|NCT01661712|20422408|P1|NOT COMPLETED|Overall Study||0
8282921|NCT01661712|20422407|P2|COMPLETED|Overall Study|sham stimulation night|18
8282922|NCT01661712|20422408|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
8282923|NCT01661712|20422407|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
8282924|NCT01661712|20422408|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
8282925|NCT01661712|20422407|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
8282926|NCT01661712|20422408|P1|STARTED|Overall Study|initial sham stimulation night|18
8282927|NCT01661686|20422426|P2|NOT COMPLETED|Overall Study||2
8282928|NCT01661686|20422427|P1|NOT COMPLETED|Overall Study||2
8282929|NCT01661686|20422426|P2|COMPLETED|Overall Study||47
8282930|NCT01661686|20422427|P1|COMPLETED|Overall Study||47
8282931|NCT01661686|20422426|P2|STARTED|Overall Study||49
8282932|NCT01661686|20422427|P1|STARTED|Overall Study||49
8282933|NCT01661621|20422443|P2|NOT COMPLETED|Overall Study||0
8282934|NCT01661621|20422444|P1|NOT COMPLETED|Overall Study||0
8282935|NCT01661621|20422443|P2|COMPLETED|Overall Study||279
8282936|NCT01661621|20422444|P1|COMPLETED|Overall Study||116
8282937|NCT01661621|20422443|P2|STARTED|Overall Study||279
8282938|NCT01661621|20422444|P1|STARTED|Overall Study||116
8282939|NCT01661595|20422468|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
8282940|NCT01661595|20422469|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
8282941|NCT01661595|20422470|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
8282942|NCT01661595|20422471|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
8282943|NCT01661595|20422468|P4|COMPLETED|Phase 2: Week 5-8.||4
8282944|NCT01661595|20422469|P3|COMPLETED|Phase 2: Week 5-8.||4
8282945|NCT01661595|20422470|P2|COMPLETED|Phase 2: Week 5-8.||4
8282946|NCT01661595|20422471|P1|COMPLETED|Phase 2: Week 5-8.||4
8282947|NCT01661595|20422468|P4|STARTED|Phase 2: Week 5-8.||4
8282948|NCT01661595|20422469|P3|STARTED|Phase 2: Week 5-8.||5
8282949|NCT01661595|20422470|P2|STARTED|Phase 2: Week 5-8.||4
8282950|NCT01661595|20422471|P1|STARTED|Phase 2: Week 5-8.||4
8282951|NCT01661595|20422468|P4|NOT COMPLETED|Phase 1: Week 0-4||0
8282952|NCT01661595|20422469|P3|NOT COMPLETED|Phase 1: Week 0-4||0
8282953|NCT01661595|20422470|P2|NOT COMPLETED|Phase 1: Week 0-4||0
8282954|NCT01661595|20422471|P1|NOT COMPLETED|Phase 1: Week 0-4||1
8282955|NCT01661595|20422468|P4|COMPLETED|Phase 1: Week 0-4||4
8282956|NCT01661595|20422469|P3|COMPLETED|Phase 1: Week 0-4||5
8282957|NCT01661595|20422470|P2|COMPLETED|Phase 1: Week 0-4||4
8282958|NCT01661595|20422471|P1|COMPLETED|Phase 1: Week 0-4||4
8282959|NCT01661595|20422468|P4|STARTED|Phase 1: Week 0-4||4
8282960|NCT01661595|20422469|P3|STARTED|Phase 1: Week 0-4||5
8282961|NCT01661595|20422470|P2|STARTED|Phase 1: Week 0-4||4
8282962|NCT01661595|20422471|P1|STARTED|Phase 1: Week 0-4||5
8282963|NCT01661283|20422576|P1|NOT COMPLETED|Overall Study||0
8282964|NCT01661283|20422576|P1|COMPLETED|Overall Study||25
8282965|NCT01661283|20422576|P1|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
8282966|NCT01661270|20422587|P2|NOT COMPLETED|Overall Study||0
8282967|NCT01661270|20422588|P1|NOT COMPLETED|Overall Study||0
8282968|NCT01661270|20422587|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
8282969|NCT01661270|20422588|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
8282970|NCT01661270|20422587|P2|Other Reasons|Overall Study||2
8282971|NCT01661270|20422588|P1|Other Reasons|Overall Study||0
8282972|NCT01661270|20422587|P2|Participant's Request|Overall Study|Met EOT criteria|48
8282973|NCT01661270|20422588|P1|Participant's Request|Overall Study|Met EOT criteria|15
8282974|NCT01661270|20422587|P2|Physician Decision|Overall Study|Met EOT criteria|8
8282975|NCT01661270|20422588|P1|Physician Decision|Overall Study|Met EOT criteria|1
8282976|NCT01661270|20422587|P2|Disease Progression|Overall Study|Met EOT criteria|118
8282977|NCT01661270|20422588|P1|Disease Progression|Overall Study|Met EOT criteria|67
8282978|NCT01661270|20422587|P2|Adverse Event|Overall Study|Met EOT criteria|47
8282979|NCT01661270|20422588|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
8282980|NCT01661270|20422587|P2|STARTED|Overall Study||223
8282981|NCT01661270|20422588|P1|STARTED|Overall Study||109
8282982|NCT01661205|20422599|P1|NOT COMPLETED|Overall Study||2
8282983|NCT01661205|20422599|P1|COMPLETED|Overall Study||24
8282984|NCT01661205|20422599|P1|STARTED|Overall Study||26
8282985|NCT01661179|20422610|P1|NOT COMPLETED|Overall Study||6
8282986|NCT01661179|20422610|P1|COMPLETED|Overall Study||8
8282987|NCT01661179|20422610|P1|STARTED|Overall Study||14
8282988|NCT01661140|20422614|P3|NOT COMPLETED|Double-Blind Period||50
8282989|NCT01661140|20422615|P2|NOT COMPLETED|Double-Blind Period||41
8282990|NCT01661140|20422616|P1|NOT COMPLETED|Double-Blind Period||0
8282991|NCT01661140|20422614|P3|COMPLETED|Double-Blind Period||86
8282992|NCT01661140|20422615|P2|COMPLETED|Double-Blind Period||95
8282993|NCT01661140|20422616|P1|COMPLETED|Double-Blind Period||0
8282994|NCT01661140|20422614|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
8282995|NCT01661140|20422615|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
8282996|NCT01661140|20422616|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
8282997|NCT01661140|20422614|P3|NOT COMPLETED|Open-Label Period||0
8282998|NCT01661140|20422615|P2|NOT COMPLETED|Open-Label Period||0
8282999|NCT01661140|20422616|P1|NOT COMPLETED|Open-Label Period||76
8283000|NCT01661140|20422614|P3|COMPLETED|Open-Label Period||0
8283001|NCT01661140|20422615|P2|COMPLETED|Open-Label Period||0
8283002|NCT01661140|20422616|P1|COMPLETED|Open-Label Period||351
8283003|NCT01661140|20422614|P3|STARTED|Open-Label Period||0
8283004|NCT01661140|20422615|P2|STARTED|Open-Label Period||0
8283005|NCT01661140|20422616|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
8283006|NCT01661114|20422657|P1|NOT COMPLETED|Overall Study||0
8283007|NCT01661114|20422657|P1|COMPLETED|Overall Study||39
8283008|NCT01661114|20422657|P1|STARTED|Overall Study||39
8283009|NCT01661088|20422662|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
8283010|NCT01661088|20422662|P1|COMPLETED|IMRT With FDR Gemcitabine||19
8283011|NCT01661088|20422662|P1|STARTED|IMRT With FDR Gemcitabine||21
8283012|NCT01661088|20422662|P1|NOT COMPLETED|FOLFIRINOX||4
8283013|NCT01661088|20422662|P1|COMPLETED|FOLFIRINOX||21
8283014|NCT01661088|20422662|P1|STARTED|FOLFIRINOX||25
8283015|NCT01661062|20422668|P1|NOT COMPLETED|Overall Study||5
8283016|NCT01661062|20422668|P1|COMPLETED|Overall Study||18
8283017|NCT01661062|20422668|P1|STARTED|Overall Study||23
8283018|NCT01660906|20422673|P1|NOT COMPLETED|Overall Study||3
8283019|NCT01660906|20422673|P1|COMPLETED|Overall Study||36
8283020|NCT01660906|20422673|P1|STARTED|Overall Study||39
8283021|NCT01660893|20422685|P3|NOT COMPLETED|Overall Study||0
8283022|NCT01660893|20422686|P2|NOT COMPLETED|Overall Study||0
8283023|NCT01660893|20422687|P1|NOT COMPLETED|Overall Study||0
8283024|NCT01660893|20422685|P3|COMPLETED|Overall Study||6
8283025|NCT01660893|20422686|P2|COMPLETED|Overall Study||10
8283026|NCT01660893|20422687|P1|COMPLETED|Overall Study||10
8283027|NCT01660893|20422685|P3|STARTED|Overall Study||6
8283028|NCT01660893|20422686|P2|STARTED|Overall Study||10
8283029|NCT01660893|20422687|P1|STARTED|Overall Study||10
8283030|NCT01660815|20422734|P1|NOT COMPLETED|Overall Study||0
8283031|NCT01660815|20422734|P1|COMPLETED|Overall Study||7
8283032|NCT01660815|20422734|P1|STARTED|Overall Study||7
8283033|NCT01660802|20422741|P2|NOT COMPLETED|Overall Study||11
8283034|NCT01660802|20422742|P1|NOT COMPLETED|Overall Study||4
8283035|NCT01660802|20422741|P2|COMPLETED|Overall Study||121
8283036|NCT01660802|20422742|P1|COMPLETED|Overall Study||126
8283037|NCT01660802|20422741|P2|STARTED|Overall Study||132
8283038|NCT01660802|20422742|P1|STARTED|Overall Study||130
8283039|NCT01660763|20422756|P2|NOT COMPLETED|Overall Study||61
8283040|NCT01660763|20422757|P1|NOT COMPLETED|Overall Study||100
8283041|NCT01660763|20422756|P2|COMPLETED|Overall Study||43
8283042|NCT01660763|20422757|P1|COMPLETED|Overall Study||215
8283043|NCT01660763|20422756|P2|STARTED|Overall Study||104
8283044|NCT01660763|20422757|P1|STARTED|Overall Study||315
8283045|NCT01660737|20422763|P1|NOT COMPLETED|Overall Study||0
8283046|NCT01660737|20422763|P1|COMPLETED|Overall Study||123
8283047|NCT01660737|20422763|P1|STARTED|Overall Study||123
8283048|NCT01660698|20422780|P2|NOT COMPLETED|Overall Study||0
8283049|NCT01660698|20422781|P1|NOT COMPLETED|Overall Study||0
8283050|NCT01660698|20422780|P2|COMPLETED|Overall Study||10
8283051|NCT01660698|20422781|P1|COMPLETED|Overall Study||10
8283052|NCT01660698|20422780|P2|STARTED|Overall Study||10
8283053|NCT01660698|20422781|P1|STARTED|Overall Study||10
8283054|NCT01660672|20422791|P1|NOT COMPLETED|Overall Study||0
8283055|NCT01660672|20422791|P1|COMPLETED|Overall Study||7
8283056|NCT01660672|20422791|P1|STARTED|Overall Study||7
8283066|NCT01660412|20422835|P2|NOT COMPLETED|Overall Study||3
8283067|NCT01660412|20422836|P1|NOT COMPLETED|Overall Study||0
8283068|NCT01660412|20422835|P2|COMPLETED|Overall Study||28
8283069|NCT01660412|20422836|P1|COMPLETED|Overall Study||29
8283070|NCT01660412|20422835|P2|Injection 4|Overall Study||31
8283071|NCT01660412|20422836|P1|Injection 4|Overall Study||29
8283072|NCT01660412|20422835|P2|Injection 3|Overall Study||31
8283073|NCT01660412|20422836|P1|Injection 3|Overall Study||29
8283074|NCT01660412|20422835|P2|Injection 2|Overall Study||31
8283075|NCT01660412|20422836|P1|Injection 2|Overall Study||29
8283076|NCT01660412|20422835|P2|Injection 1|Overall Study||31
8283077|NCT01660412|20422836|P1|Injection 1|Overall Study||29
8283078|NCT01660412|20422835|P2|Other|Overall Study||4
8283079|NCT01660412|20422836|P1|Other|Overall Study||2
8283080|NCT01660412|20422835|P2|Appendicular Structures|Overall Study||11
8283081|NCT01660412|20422836|P1|Appendicular Structures|Overall Study||17
8283082|NCT01660412|20422835|P2|Thorax|Overall Study||9
8283083|NCT01660412|20422836|P1|Thorax|Overall Study||9
8283084|NCT01660412|20422835|P2|Head|Overall Study||4
8283085|NCT01660412|20422836|P1|Head|Overall Study||1
8283086|NCT01660412|20422835|P2|STARTED|Overall Study||31
8283087|NCT01660412|20422836|P1|STARTED|Overall Study||29
8283088|NCT01660334|20422842|P1|NOT COMPLETED|Overall Study||1
8283089|NCT01660334|20422842|P1|COMPLETED|Overall Study||12
8283090|NCT01660334|20422842|P1|STARTED|Overall Study||13
8283091|NCT01660321|20422847|P1|NOT COMPLETED|Overall Study||0
8283092|NCT01660321|20422847|P1|COMPLETED|Overall Study||26
8283093|NCT01660321|20422847|P1|STARTED|Overall Study||26
8283094|NCT01660230|20422871|P12|NOT COMPLETED|Overall Study||0
8283095|NCT01660230|20422872|P11|NOT COMPLETED|Overall Study||0
8283096|NCT01660230|20422873|P10|NOT COMPLETED|Overall Study||0
8283097|NCT01660230|20422874|P9|NOT COMPLETED|Overall Study||0
8283098|NCT01660230|20422875|P8|NOT COMPLETED|Overall Study||0
8283099|NCT01660230|20422876|P7|NOT COMPLETED|Overall Study||0
8283100|NCT01660230|20422877|P6|NOT COMPLETED|Overall Study||0
8283101|NCT01660230|20422878|P5|NOT COMPLETED|Overall Study||0
8283102|NCT01660230|20422879|P4|NOT COMPLETED|Overall Study||0
8283103|NCT01660230|20422880|P3|NOT COMPLETED|Overall Study||0
8283104|NCT01660230|20422881|P2|NOT COMPLETED|Overall Study||0
8283105|NCT01660230|20422882|P1|NOT COMPLETED|Overall Study||0
8283106|NCT01660230|20422871|P12|COMPLETED|Overall Study||14
8283107|NCT01660230|20422872|P11|COMPLETED|Overall Study||6
8283108|NCT01660230|20422873|P10|COMPLETED|Overall Study||6
8283109|NCT01660230|20422874|P9|COMPLETED|Overall Study||6
8283110|NCT01660230|20422875|P8|COMPLETED|Overall Study||6
8283111|NCT01660230|20422876|P7|COMPLETED|Overall Study||4
8283112|NCT01660230|20422877|P6|COMPLETED|Overall Study||2
8283113|NCT01660230|20422878|P5|COMPLETED|Overall Study||4
8283114|NCT01660230|20422879|P4|COMPLETED|Overall Study||4
8283115|NCT01660230|20422880|P3|COMPLETED|Overall Study||4
8283116|NCT01660230|20422881|P2|COMPLETED|Overall Study||4
8283117|NCT01660230|20422882|P1|COMPLETED|Overall Study||4
8283118|NCT01660230|20422871|P12|STARTED|Overall Study||14
8283119|NCT01660230|20422872|P11|STARTED|Overall Study||6
8283120|NCT01660230|20422873|P10|STARTED|Overall Study||6
8283121|NCT01660230|20422874|P9|STARTED|Overall Study||6
8283122|NCT01660230|20422875|P8|STARTED|Overall Study||6
8283123|NCT01660230|20422876|P7|STARTED|Overall Study||4
8283124|NCT01660230|20422877|P6|STARTED|Overall Study||2
8283125|NCT01660230|20422878|P5|STARTED|Overall Study||4
8283126|NCT01660230|20422879|P4|STARTED|Overall Study||4
8283127|NCT01660230|20422880|P3|STARTED|Overall Study||4
8283128|NCT01660230|20422881|P2|STARTED|Overall Study||4
8283129|NCT01660230|20422882|P1|STARTED|Overall Study||4
8283130|NCT01660191|20423054|P3|NOT COMPLETED|End of Treatment||1
8283131|NCT01660191|20423055|P2|NOT COMPLETED|End of Treatment||6
8283132|NCT01660191|20423056|P1|NOT COMPLETED|End of Treatment||1
8283133|NCT01660191|20423054|P3|COMPLETED|End of Treatment||43
8283134|NCT01660191|20423055|P2|COMPLETED|End of Treatment||39
8283135|NCT01660191|20423056|P1|COMPLETED|End of Treatment||44
8283136|NCT01660191|20423054|P3|STARTED|End of Treatment||44
8283137|NCT01660191|20423055|P2|STARTED|End of Treatment||45
8283138|NCT01660191|20423056|P1|STARTED|End of Treatment||45
8283139|NCT01660191|20423054|P3|NOT COMPLETED|Randomization||0
8283140|NCT01660191|20423055|P2|NOT COMPLETED|Randomization||0
8283141|NCT01660191|20423056|P1|NOT COMPLETED|Randomization||0
8283142|NCT01660191|20423054|P3|COMPLETED|Randomization||44
8283143|NCT01660191|20423055|P2|COMPLETED|Randomization||45
8283144|NCT01660191|20423056|P1|COMPLETED|Randomization||45
8283145|NCT01660191|20423054|P3|STARTED|Randomization||44
8283146|NCT01660191|20423055|P2|STARTED|Randomization||45
8283147|NCT01660191|20423056|P1|STARTED|Randomization||45
8283148|NCT01660191|20423054|P3|NOT COMPLETED|Enrollment and Washout||0
8283149|NCT01660191|20423055|P2|NOT COMPLETED|Enrollment and Washout||0
8283150|NCT01660191|20423056|P1|NOT COMPLETED|Enrollment and Washout||0
8283151|NCT01660191|20423054|P3|COMPLETED|Enrollment and Washout||44
8283152|NCT01660191|20423055|P2|COMPLETED|Enrollment and Washout||45
8283153|NCT01660191|20423056|P1|COMPLETED|Enrollment and Washout||45
8283154|NCT01660191|20423054|P3|STARTED|Enrollment and Washout||44
8283155|NCT01660191|20423055|P2|STARTED|Enrollment and Washout||45
8283156|NCT01660191|20423056|P1|STARTED|Enrollment and Washout||45
8283157|NCT01660022|20423085|P6|NOT COMPLETED|Second Sequence (42 Days)||0
8283158|NCT01660022|20423086|P5|NOT COMPLETED|Second Sequence (42 Days)||0
8283159|NCT01660022|20423087|P4|NOT COMPLETED|Second Sequence (42 Days)||0
8283160|NCT01660022|20423088|P3|NOT COMPLETED|Second Sequence (42 Days)||0
8283161|NCT01660022|20423089|P2|NOT COMPLETED|Second Sequence (42 Days)||0
8283162|NCT01660022|20423090|P1|NOT COMPLETED|Second Sequence (42 Days)||0
8283163|NCT01660022|20423085|P6|COMPLETED|Second Sequence (42 Days)||16
8283164|NCT01660022|20423086|P5|COMPLETED|Second Sequence (42 Days)||6
8283165|NCT01660022|20423087|P4|COMPLETED|Second Sequence (42 Days)||7
8283166|NCT01660022|20423088|P3|COMPLETED|Second Sequence (42 Days)||8
8283167|NCT01660022|20423089|P2|COMPLETED|Second Sequence (42 Days)||7
8283168|NCT01660022|20423090|P1|COMPLETED|Second Sequence (42 Days)||8
8283169|NCT01660022|20423085|P6|STARTED|Second Sequence (42 Days)||16
8283170|NCT01660022|20423086|P5|STARTED|Second Sequence (42 Days)||6
8283171|NCT01660022|20423087|P4|STARTED|Second Sequence (42 Days)||7
8283172|NCT01660022|20423088|P3|STARTED|Second Sequence (42 Days)||8
8283173|NCT01660022|20423089|P2|STARTED|Second Sequence (42 Days)||7
8283174|NCT01660022|20423090|P1|STARTED|Second Sequence (42 Days)||8
8283175|NCT01660022|20423085|P6|NOT COMPLETED|First Sequence (7 Days)||4
8283176|NCT01660022|20423086|P5|NOT COMPLETED|First Sequence (7 Days)||1
8283177|NCT01660022|20423087|P4|NOT COMPLETED|First Sequence (7 Days)||1
8283178|NCT01660022|20423088|P3|NOT COMPLETED|First Sequence (7 Days)||0
8283179|NCT01660022|20423089|P2|NOT COMPLETED|First Sequence (7 Days)||1
8283180|NCT01660022|20423090|P1|NOT COMPLETED|First Sequence (7 Days)||0
8283181|NCT01660022|20423085|P6|COMPLETED|First Sequence (7 Days)||16
8283182|NCT01660022|20423086|P5|COMPLETED|First Sequence (7 Days)||6
8283183|NCT01660022|20423087|P4|COMPLETED|First Sequence (7 Days)||7
8283184|NCT01660022|20423088|P3|COMPLETED|First Sequence (7 Days)||8
8283185|NCT01660022|20423089|P2|COMPLETED|First Sequence (7 Days)||7
8283186|NCT01660022|20423090|P1|COMPLETED|First Sequence (7 Days)||8
8283187|NCT01660022|20423085|P6|STARTED|First Sequence (7 Days)||20
8283188|NCT01660022|20423086|P5|STARTED|First Sequence (7 Days)||7
8283189|NCT01660022|20423087|P4|STARTED|First Sequence (7 Days)||8
8283190|NCT01660022|20423088|P3|STARTED|First Sequence (7 Days)||8
8283191|NCT01660022|20423089|P2|STARTED|First Sequence (7 Days)||8
8283192|NCT01660022|20423090|P1|STARTED|First Sequence (7 Days)||8
8283193|NCT01659996|20423149|P3|NOT COMPLETED|Overall Study||11
8283194|NCT01659996|20423150|P2|NOT COMPLETED|Overall Study||7
8283195|NCT01659996|20423151|P1|NOT COMPLETED|Overall Study||8
8283196|NCT01659996|20423149|P3|COMPLETED|Overall Study||461
8283197|NCT01659996|20423150|P2|COMPLETED|Overall Study||388
8283198|NCT01659996|20423151|P1|COMPLETED|Overall Study||413
8283199|NCT01659996|20423149|P3|STARTED|Overall Study||472
8283200|NCT01659996|20423150|P2|STARTED|Overall Study||395
8283201|NCT01659996|20423151|P1|STARTED|Overall Study||421
8283202|NCT01659866|20423185|P2|NOT COMPLETED|Overall Study||0
8283203|NCT01659866|20423186|P1|NOT COMPLETED|Overall Study||0
8283204|NCT01659866|20423185|P2|COMPLETED|Overall Study||80
8283205|NCT01659866|20423186|P1|COMPLETED|Overall Study||430
8283206|NCT01659866|20423185|P2|STARTED|Overall Study||80
8283207|NCT01659866|20423186|P1|STARTED|Overall Study||430
8283208|NCT01659853|20423192|P2|NOT COMPLETED|Treatment Period 2||0
8283209|NCT01659853|20423193|P1|NOT COMPLETED|Treatment Period 2||0
8283210|NCT01659853|20423192|P2|COMPLETED|Treatment Period 2||35
8283211|NCT01659853|20423193|P1|COMPLETED|Treatment Period 2||33
8283212|NCT01659853|20423192|P2|STARTED|Treatment Period 2||35
8283213|NCT01659853|20423193|P1|STARTED|Treatment Period 2||33
8283214|NCT01659853|20423192|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
8283215|NCT01659853|20423193|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
8283216|NCT01659853|20423192|P2|COMPLETED|Washout , 3 to 7 Days||35
8283217|NCT01659853|20423193|P1|COMPLETED|Washout , 3 to 7 Days||33
8283218|NCT01659853|20423192|P2|STARTED|Washout , 3 to 7 Days||35
8283219|NCT01659853|20423193|P1|STARTED|Washout , 3 to 7 Days||35
8283220|NCT01659853|20423192|P2|NOT COMPLETED|Treatment Period 1||0
8283221|NCT01659853|20423193|P1|NOT COMPLETED|Treatment Period 1||0
8283222|NCT01659853|20423192|P2|COMPLETED|Treatment Period 1||35
8283223|NCT01659853|20423193|P1|COMPLETED|Treatment Period 1||35
8283224|NCT01659853|20423192|P2|STARTED|Treatment Period 1||35
8283225|NCT01659853|20423193|P1|STARTED|Treatment Period 1||35
8283226|NCT01659736|20423203|P2|NOT COMPLETED|3-month Follow-up||1
8283227|NCT01659736|20423204|P1|NOT COMPLETED|3-month Follow-up||0
8283228|NCT01659736|20423203|P2|COMPLETED|3-month Follow-up||9
8283229|NCT01659736|20423204|P1|COMPLETED|3-month Follow-up||9
8283230|NCT01659736|20423203|P2|STARTED|3-month Follow-up||10
8283231|NCT01659736|20423204|P1|STARTED|3-month Follow-up||9
8283232|NCT01659736|20423203|P2|NOT COMPLETED|Treatment Period||2
8283233|NCT01659736|20423204|P1|NOT COMPLETED|Treatment Period||5
8283234|NCT01659736|20423203|P2|COMPLETED|Treatment Period||10
8283235|NCT01659736|20423204|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
8283236|NCT01659736|20423203|P2|STARTED|Treatment Period||12
8283237|NCT01659736|20423204|P1|STARTED|Treatment Period||14
8283238|NCT01659567|20423218|P1|NOT COMPLETED|Overall Study||123
8283239|NCT01659567|20423218|P1|COMPLETED|Overall Study||393
8283240|NCT01659567|20423218|P1|STARTED|Overall Study||516
8283241|NCT01659554|20423235|P1|NOT COMPLETED|Overall Study||4
8283242|NCT01659554|20423235|P1|COMPLETED|Overall Study||0
8283243|NCT01659554|20423235|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
8283244|NCT01659320|20423242|P1|NOT COMPLETED|Overall Study||3
8283245|NCT01659320|20423242|P1|COMPLETED|Overall Study||13
8283246|NCT01659320|20423242|P1|STARTED|Overall Study||16
8283247|NCT01659268|20423248|P2|NOT COMPLETED|Overall Study||0
8283248|NCT01659268|20423249|P1|NOT COMPLETED|Overall Study||0
8283249|NCT01659268|20423248|P2|COMPLETED|Overall Study||8
8283250|NCT01659268|20423249|P1|COMPLETED|Overall Study||9
8283251|NCT01659268|20423248|P2|STARTED|Overall Study||8
8283252|NCT01659268|20423249|P1|STARTED|Overall Study||9
8283253|NCT01659125|20423261|P1|NOT COMPLETED|Overall Study||14
8283254|NCT01659125|20423261|P1|COMPLETED|Overall Study||12
8283255|NCT01659125|20423261|P1|Completed 6-month Follow-up|Overall Study||12
8283256|NCT01659125|20423261|P1|Completed 3-month Follow-up|Overall Study||16
8283257|NCT01659125|20423261|P1|Completed the Posttreatment Assessment|Overall Study||17
8283258|NCT01659125|20423261|P1|Initiated Treatment|Overall Study||24
8283259|NCT01659125|20423261|P1|STARTED|Overall Study||26
8283260|NCT01659021|20423268|P2|NOT COMPLETED|Long-Term Follow Up||4
8283261|NCT01659021|20423269|P1|NOT COMPLETED|Long-Term Follow Up||5
8283262|NCT01659021|20423268|P2|COMPLETED|Long-Term Follow Up||65
8283263|NCT01659021|20423269|P1|COMPLETED|Long-Term Follow Up||133
8283264|NCT01659021|20423268|P2|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
8283265|NCT01659021|20423269|P1|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
8283266|NCT01659021|20423268|P2|NOT COMPLETED|Main Study||37
8283267|NCT01659021|20423269|P1|NOT COMPLETED|Main Study||74
8283268|NCT01659021|20423268|P2|COMPLETED|Main Study||50
8283269|NCT01659021|20423269|P1|COMPLETED|Main Study||100
8283270|NCT01659021|20423268|P2|Randomized and Treated|Main Study||86
8283271|NCT01659021|20423269|P1|Randomized and Treated|Main Study||173
8283272|NCT01659021|20423268|P2|STARTED|Main Study||87
8283273|NCT01659021|20423269|P1|STARTED|Main Study||174
8283274|NCT01658995|20423287|P2|NOT COMPLETED|Overall Study||0
8283275|NCT01658995|20423288|P1|NOT COMPLETED|Overall Study||0
8283276|NCT01658995|20423287|P2|COMPLETED|Overall Study||40
8283277|NCT01658995|20423288|P1|COMPLETED|Overall Study||42
8283278|NCT01658995|20423287|P2|STARTED|Overall Study||40
8283279|NCT01658995|20423288|P1|STARTED|Overall Study||42
8283280|NCT01658943|20423300|P2|NOT COMPLETED|Overall Study||67
8283281|NCT01658943|20423301|P1|NOT COMPLETED|Overall Study||70
8283282|NCT01658943|20423300|P2|COMPLETED|Overall Study||0
8283283|NCT01658943|20423301|P1|COMPLETED|Overall Study||0
8283284|NCT01658943|20423300|P2|Eligible and Began Protocol Therapy|Overall Study||58
8283285|NCT01658943|20423301|P1|Eligible and Began Protocol Therapy|Overall Study||62
8283286|NCT01658943|20423300|P2|Eligible|Overall Study||58
8283287|NCT01658943|20423301|P1|Eligible|Overall Study||63
8283288|NCT01658943|20423300|P2|STARTED|Overall Study||67
8283289|NCT01658943|20423301|P1|STARTED|Overall Study||70
8283290|NCT01658904|20423316|P3|NOT COMPLETED|Overall Study||0
8283291|NCT01658904|20423317|P2|NOT COMPLETED|Overall Study||0
8283292|NCT01658904|20423318|P1|NOT COMPLETED|Overall Study||2
8283293|NCT01658904|20423316|P3|COMPLETED|Overall Study||0
8283294|NCT01658904|20423317|P2|COMPLETED|Overall Study||0
8283295|NCT01658904|20423318|P1|COMPLETED|Overall Study||1
8283296|NCT01658904|20423316|P3|STARTED|Overall Study||0
8283297|NCT01658904|20423317|P2|STARTED|Overall Study||0
8283298|NCT01658904|20423318|P1|STARTED|Overall Study||3
8283299|NCT01658839|20423335|P1|NOT COMPLETED|Overall Study||0
8283300|NCT01658839|20423335|P1|COMPLETED|Overall Study||25
8283301|NCT01658839|20423335|P1|STARTED|Overall Study||25
8283302|NCT01658813|20423344|P1|NOT COMPLETED|Overall Study||3
8283303|NCT01658813|20423344|P1|COMPLETED|Overall Study||15
8283304|NCT01658813|20423344|P1|Treated|Overall Study||18
8283305|NCT01658813|20423344|P1|Eligible|Overall Study||18
8283306|NCT01658813|20423344|P1|STARTED|Overall Study||18
8283307|NCT01658735|20423355|P3|NOT COMPLETED|Overall Study||4
8283308|NCT01658735|20423356|P2|NOT COMPLETED|Overall Study||7
8283309|NCT01658735|20423357|P1|NOT COMPLETED|Overall Study||5
8283310|NCT01658735|20423355|P3|COMPLETED|Overall Study||34
8283311|NCT01658735|20423356|P2|COMPLETED|Overall Study||29
8283312|NCT01658735|20423357|P1|COMPLETED|Overall Study||34
8283313|NCT01658735|20423355|P3|STARTED|Overall Study||38
8283314|NCT01658735|20423356|P2|STARTED|Overall Study||36
8283315|NCT01658735|20423357|P1|STARTED|Overall Study||39
8283316|NCT01658657|20423388|P2|NOT COMPLETED|Overall Study||3
8283317|NCT01658657|20423389|P1|NOT COMPLETED|Overall Study||3
8283318|NCT01658657|20423388|P2|COMPLETED|Overall Study||7
8283319|NCT01658657|20423389|P1|COMPLETED|Overall Study||4
8283320|NCT01658657|20423388|P2|STARTED|Overall Study||10
8283321|NCT01658657|20423389|P1|STARTED|Overall Study||7
8283322|NCT01658579|20423399|P4|NOT COMPLETED|Treatment Period B||1
8283323|NCT01658579|20423400|P3|NOT COMPLETED|Treatment Period B||0
8283324|NCT01658579|20423401|P2|NOT COMPLETED|Treatment Period B||0
8283325|NCT01658579|20423402|P1|NOT COMPLETED|Treatment Period B||0
8283326|NCT01658579|20423399|P4|COMPLETED|Treatment Period B||12
8283327|NCT01658579|20423400|P3|COMPLETED|Treatment Period B||14
8283328|NCT01658579|20423401|P2|COMPLETED|Treatment Period B||15
8283329|NCT01658579|20423402|P1|COMPLETED|Treatment Period B||14
8283330|NCT01658579|20423399|P4|STARTED|Treatment Period B||13
8283331|NCT01658579|20423400|P3|STARTED|Treatment Period B||14
8283332|NCT01658579|20423401|P2|STARTED|Treatment Period B||15
8283333|NCT01658579|20423402|P1|STARTED|Treatment Period B||14
8283334|NCT01658579|20423399|P4|NOT COMPLETED|Treatment Period A||1
8283335|NCT01658579|20423400|P3|NOT COMPLETED|Treatment Period A||1
8283336|NCT01658579|20423401|P2|NOT COMPLETED|Treatment Period A||0
8283337|NCT01658579|20423402|P1|NOT COMPLETED|Treatment Period A||1
8283338|NCT01658579|20423399|P4|COMPLETED|Treatment Period A||13
8283339|NCT01658579|20423400|P3|COMPLETED|Treatment Period A||14
8283340|NCT01658579|20423401|P2|COMPLETED|Treatment Period A||15
8283341|NCT01658579|20423402|P1|COMPLETED|Treatment Period A||14
8283342|NCT01658579|20423399|P4|STARTED|Treatment Period A||14
8283343|NCT01658579|20423400|P3|STARTED|Treatment Period A||15
8283344|NCT01658579|20423401|P2|STARTED|Treatment Period A||15
8283345|NCT01658579|20423402|P1|STARTED|Treatment Period A||15
8283346|NCT01658514|20423430|P3|NOT COMPLETED|Overall Study||2
8283347|NCT01658514|20423431|P2|NOT COMPLETED|Overall Study||0
8283348|NCT01658514|20423432|P1|NOT COMPLETED|Overall Study||1
8283349|NCT01658514|20423430|P3|COMPLETED|Overall Study||12
8283350|NCT01658514|20423431|P2|COMPLETED|Overall Study||11
8283351|NCT01658514|20423432|P1|COMPLETED|Overall Study||13
8283352|NCT01658514|20423430|P3|Completed - Severe RI Cohort Only|Overall Study||3
8283353|NCT01658514|20423431|P2|Completed - Severe RI Cohort Only|Overall Study||2
8283354|NCT01658514|20423432|P1|Completed - Severe RI Cohort Only|Overall Study||3
8283355|NCT01658514|20423430|P3|Started - Severe RI Cohort Only|Overall Study||3
8283356|NCT01658514|20423431|P2|Started - Severe RI Cohort Only|Overall Study||2
8283357|NCT01658514|20423432|P1|Started - Severe RI Cohort Only|Overall Study||3
8283358|NCT01658514|20423430|P3|Completed - Moderate RI Cohort Only|Overall Study||2
8283359|NCT01658514|20423431|P2|Completed - Moderate RI Cohort Only|Overall Study||4
8283360|NCT01658514|20423432|P1|Completed - Moderate RI Cohort Only|Overall Study||3
8283361|NCT01658514|20423430|P3|Started - Moderate RI Cohort Only|Overall Study||4
8283362|NCT01658514|20423431|P2|Started - Moderate RI Cohort Only|Overall Study||4
8283363|NCT01658514|20423432|P1|Started - Moderate RI Cohort Only|Overall Study||4
8283364|NCT01658514|20423430|P3|Completed - Mild RI Cohort Only|Overall Study||4
8283365|NCT01658514|20423431|P2|Completed - Mild RI Cohort Only|Overall Study||3
8283366|NCT01658514|20423432|P1|Completed - Mild RI Cohort Only|Overall Study||4
8283367|NCT01658514|20423430|P3|Started - Mild RI Cohort Only|Overall Study||4
8283368|NCT01658514|20423431|P2|Started - Mild RI Cohort Only|Overall Study||3
8283369|NCT01658514|20423432|P1|Started - Mild RI Cohort Only|Overall Study||4
8283370|NCT01658514|20423430|P3|Completed - Normal RF Cohort Only|Overall Study||3
8283371|NCT01658514|20423431|P2|Completed - Normal RF Cohort Only|Overall Study||2
8283372|NCT01658514|20423432|P1|Completed - Normal RF Cohort Only|Overall Study||3
8283373|NCT01658514|20423430|P3|Started - Normal RF Cohort Only|Overall Study||3
8283374|NCT01658514|20423431|P2|Started - Normal RF Cohort Only|Overall Study||2
8283375|NCT01658514|20423432|P1|Started - Normal RF Cohort Only|Overall Study||3
8283376|NCT01658514|20423430|P3|Completed Treatment C|Overall Study||12
8283377|NCT01658514|20423431|P2|Completed Treatment C|Overall Study||11
8283378|NCT01658514|20423432|P1|Completed Treatment C|Overall Study||13
8283379|NCT01658514|20423430|P3|Completed Treatment B|Overall Study||14
8283380|NCT01658514|20423431|P2|Completed Treatment B|Overall Study||11
8283381|NCT01658514|20423432|P1|Completed Treatment B|Overall Study||13
8283382|NCT01658514|20423430|P3|Completed Treatment A|Overall Study||12
8283383|NCT01658514|20423431|P2|Completed Treatment A|Overall Study||11
8283384|NCT01658514|20423432|P1|Completed Treatment A|Overall Study||14
8283385|NCT01658514|20423430|P3|STARTED|Overall Study||14
8283386|NCT01658514|20423431|P2|STARTED|Overall Study||11
8283387|NCT01658514|20423432|P1|STARTED|Overall Study||14
8283388|NCT01658436|20423443|P2|NOT COMPLETED|Overall Study||11
8283389|NCT01658436|20423444|P1|NOT COMPLETED|Overall Study||20
8283390|NCT01658436|20423443|P2|COMPLETED|Overall Study||0
8283391|NCT01658436|20423444|P1|COMPLETED|Overall Study||0
8283392|NCT01658436|20423443|P2|STARTED|Overall Study||11
8283393|NCT01658436|20423444|P1|STARTED|Overall Study||20
8283394|NCT01658228|20423453|P2|NOT COMPLETED|Overall Study||8
8283395|NCT01658228|20423454|P1|NOT COMPLETED|Overall Study||7
8283396|NCT01658228|20423453|P2|COMPLETED|Overall Study||23
8283397|NCT01658228|20423454|P1|COMPLETED|Overall Study||23
8283398|NCT01658228|20423453|P2|STARTED|Overall Study||31
8283399|NCT01658228|20423454|P1|STARTED|Overall Study||30
8283400|NCT01658150|20423464|P1|NOT COMPLETED|Overall Study||1
8283401|NCT01658150|20423464|P1|COMPLETED|Overall Study||10
8283402|NCT01658150|20423464|P1|STARTED|Overall Study||11
8283403|NCT01658072|20423486|P2|NOT COMPLETED|Overall Study||2
8283404|NCT01658072|20423487|P1|NOT COMPLETED|Overall Study||4
8283405|NCT01658072|20423486|P2|COMPLETED|Overall Study||43
8283406|NCT01658072|20423487|P1|COMPLETED|Overall Study||41
8283407|NCT01658072|20423486|P2|STARTED|Overall Study||45
8283408|NCT01658072|20423487|P1|STARTED|Overall Study||45
8283409|NCT01658059|20423493|P2|NOT COMPLETED|Second Intervention- 2 Days||0
8283410|NCT01658059|20423494|P1|NOT COMPLETED|Second Intervention- 2 Days||0
8283411|NCT01658059|20423493|P2|COMPLETED|Second Intervention- 2 Days||5
8283412|NCT01658059|20423494|P1|COMPLETED|Second Intervention- 2 Days||6
8283413|NCT01658059|20423493|P2|STARTED|Second Intervention- 2 Days||5
8283414|NCT01658059|20423494|P1|STARTED|Second Intervention- 2 Days||6
8283415|NCT01658059|20423493|P2|NOT COMPLETED|Washout Period- 14 Days||0
8283416|NCT01658059|20423494|P1|NOT COMPLETED|Washout Period- 14 Days||0
8283417|NCT01658059|20423493|P2|COMPLETED|Washout Period- 14 Days||5
8283418|NCT01658059|20423494|P1|COMPLETED|Washout Period- 14 Days||6
8283419|NCT01658059|20423493|P2|STARTED|Washout Period- 14 Days||5
8283420|NCT01658059|20423494|P1|STARTED|Washout Period- 14 Days||6
8283421|NCT01658059|20423493|P2|NOT COMPLETED|First Intervention- 2 Days||5
8283422|NCT01658059|20423494|P1|NOT COMPLETED|First Intervention- 2 Days||6
8283423|NCT01658059|20423493|P2|COMPLETED|First Intervention- 2 Days||5
8283424|NCT01658059|20423494|P1|COMPLETED|First Intervention- 2 Days||6
8283425|NCT01658059|20423493|P2|STARTED|First Intervention- 2 Days||10
8283426|NCT01658059|20423494|P1|STARTED|First Intervention- 2 Days||12
8283427|NCT01658020|20423502|P2|NOT COMPLETED|Overall Study||9
8283428|NCT01658020|20423503|P1|NOT COMPLETED|Overall Study||8
8283429|NCT01658020|20423502|P2|COMPLETED|Overall Study||158
8283430|NCT01658020|20423503|P1|COMPLETED|Overall Study||167
8283431|NCT01658020|20423502|P2|STARTED|Overall Study||167
8283432|NCT01658020|20423503|P1|STARTED|Overall Study||175
8283433|NCT01657903|20423519|P1|NOT COMPLETED|Overall Study||2
8283434|NCT01657903|20423519|P1|COMPLETED|Overall Study||54
8283435|NCT01657903|20423519|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
8283436|NCT01657903|20423519|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
8283525|NCT01657292|20423788|P1|STARTED|Overall Study||61
8283437|NCT01657903|20423519|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
8283438|NCT01657903|20423519|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
8283439|NCT01657903|20423519|P1|STARTED|Overall Study||56
8283440|NCT01657877|20423541|P1|NOT COMPLETED|Overall Study||14
8283441|NCT01657877|20423541|P1|COMPLETED|Overall Study||65
8283442|NCT01657877|20423541|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
8283443|NCT01657877|20423541|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
8283444|NCT01657877|20423541|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
8283445|NCT01657877|20423541|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
8283446|NCT01657877|20423541|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
8283447|NCT01657877|20423541|P1|STARTED|Overall Study||79
8283448|NCT01657799|20423561|P3|NOT COMPLETED|Overall Study||102
8283449|NCT01657799|20423562|P2|NOT COMPLETED|Overall Study||103
8283450|NCT01657799|20423563|P1|NOT COMPLETED|Overall Study||102
8283451|NCT01657799|20423561|P3|COMPLETED|Overall Study||0
8283452|NCT01657799|20423562|P2|COMPLETED|Overall Study||0
8283453|NCT01657799|20423563|P1|COMPLETED|Overall Study||0
8283454|NCT01657799|20423561|P3|Received Treatment|Overall Study||102
8283455|NCT01657799|20423562|P2|Received Treatment|Overall Study||103
8283456|NCT01657799|20423563|P1|Received Treatment|Overall Study||101
8283457|NCT01657799|20423561|P3|STARTED|Overall Study||102
8283458|NCT01657799|20423562|P2|STARTED|Overall Study||103
8283459|NCT01657799|20423563|P1|STARTED|Overall Study||102
8283460|NCT01657760|20423582|P4|NOT COMPLETED|Overall Study||3
8283461|NCT01657760|20423583|P3|NOT COMPLETED|Overall Study||1
8283462|NCT01657760|20423584|P2|NOT COMPLETED|Overall Study||1
8283463|NCT01657760|20423585|P1|NOT COMPLETED|Overall Study||1
8283464|NCT01657760|20423582|P4|COMPLETED|Overall Study||4
8283465|NCT01657760|20423583|P3|COMPLETED|Overall Study||6
8283466|NCT01657760|20423584|P2|COMPLETED|Overall Study||6
8283467|NCT01657760|20423585|P1|COMPLETED|Overall Study||4
8283468|NCT01657760|20423582|P4|STARTED|Overall Study||7
8283469|NCT01657760|20423583|P3|STARTED|Overall Study||7
8283470|NCT01657760|20423584|P2|STARTED|Overall Study||7
8283471|NCT01657760|20423585|P1|STARTED|Overall Study||5
8283472|NCT01657617|20423597|P1|NOT COMPLETED|Overall Study||0
8283473|NCT01657617|20423597|P1|COMPLETED|Overall Study||35
8283474|NCT01657617|20423597|P1|STARTED|Overall Study||35
8283475|NCT01657461|20423604|P2|NOT COMPLETED|Overall Study||20
8283476|NCT01657461|20423605|P1|NOT COMPLETED|Overall Study||10
8283477|NCT01657461|20423604|P2|COMPLETED|Overall Study||78
8283478|NCT01657461|20423605|P1|COMPLETED|Overall Study||88
8283479|NCT01657461|20423604|P2|STARTED|Overall Study||98
8283480|NCT01657461|20423605|P1|STARTED|Overall Study||98
8283481|NCT01657370|20423635|P6|NOT COMPLETED|Overall Study||4
8283482|NCT01657370|20423636|P5|NOT COMPLETED|Overall Study||7
8283483|NCT01657370|20423637|P4|NOT COMPLETED|Overall Study||5
8283484|NCT01657370|20423638|P3|NOT COMPLETED|Overall Study||7
8283485|NCT01657370|20423639|P2|NOT COMPLETED|Overall Study||4
8283486|NCT01657370|20423640|P1|NOT COMPLETED|Overall Study||6
8283487|NCT01657370|20423635|P6|COMPLETED|Overall Study||27
8283488|NCT01657370|20423636|P5|COMPLETED|Overall Study||27
8283489|NCT01657370|20423637|P4|COMPLETED|Overall Study||28
8283490|NCT01657370|20423638|P3|COMPLETED|Overall Study||25
8283491|NCT01657370|20423639|P2|COMPLETED|Overall Study||28
8283492|NCT01657370|20423640|P1|COMPLETED|Overall Study||27
8283493|NCT01657370|20423635|P6|STARTED|Overall Study||31
8283494|NCT01657370|20423636|P5|STARTED|Overall Study||34
8283495|NCT01657370|20423637|P4|STARTED|Overall Study||33
8283496|NCT01657370|20423638|P3|STARTED|Overall Study||32
8283497|NCT01657370|20423639|P2|STARTED|Overall Study||32
8283498|NCT01657370|20423640|P1|STARTED|Overall Study||33
8283499|NCT01657344|20423722|P7|NOT COMPLETED|Overall Study||0
8283500|NCT01657344|20423723|P6|NOT COMPLETED|Overall Study||0
8283501|NCT01657344|20423724|P5|NOT COMPLETED|Overall Study||0
8283502|NCT01657344|20423725|P4|NOT COMPLETED|Overall Study||0
8283503|NCT01657344|20423726|P3|NOT COMPLETED|Overall Study||0
8283504|NCT01657344|20423727|P2|NOT COMPLETED|Overall Study||0
8283505|NCT01657344|20423728|P1|NOT COMPLETED|Overall Study||0
8283506|NCT01657344|20423722|P7|COMPLETED|Overall Study||140776
8283507|NCT01657344|20423723|P6|COMPLETED|Overall Study||316477
8283508|NCT01657344|20423724|P5|COMPLETED|Overall Study||157802
8283509|NCT01657344|20423725|P4|COMPLETED|Overall Study||376517
8283510|NCT01657344|20423726|P3|COMPLETED|Overall Study||196300
8283511|NCT01657344|20423727|P2|COMPLETED|Overall Study||409967
8283512|NCT01657344|20423728|P1|COMPLETED|Overall Study||421622
8283513|NCT01657344|20423722|P7|STARTED|Overall Study||140776
8283514|NCT01657344|20423723|P6|STARTED|Overall Study||316477
8283515|NCT01657344|20423724|P5|STARTED|Overall Study||157802
8283516|NCT01657344|20423725|P4|STARTED|Overall Study||376517
8283517|NCT01657344|20423726|P3|STARTED|Overall Study||196300
8283518|NCT01657344|20423727|P2|STARTED|Overall Study||409967
8283519|NCT01657344|20423728|P1|STARTED|Overall Study||421622
8283520|NCT01657305|20423738|P1|NOT COMPLETED|Overall Study||25
8283521|NCT01657305|20423738|P1|COMPLETED|Overall Study||82
8283522|NCT01657305|20423738|P1|STARTED|Overall Study||107
8283523|NCT01657292|20423788|P1|NOT COMPLETED|Overall Study||10
8283524|NCT01657292|20423788|P1|COMPLETED|Overall Study||51
8283526|NCT01657266|20423797|P2|NOT COMPLETED|Overall Study||5
8283527|NCT01657266|20423798|P1|NOT COMPLETED|Overall Study||4
8283528|NCT01657266|20423797|P2|COMPLETED|Overall Study||70
8283529|NCT01657266|20423798|P1|COMPLETED|Overall Study||69
8283530|NCT01657266|20423797|P2|STARTED|Overall Study||75
8283531|NCT01657266|20423798|P1|STARTED|Overall Study||73
8283532|NCT01657253|20423820|P2|NOT COMPLETED|Overall Study||18
8283533|NCT01657253|20423821|P1|NOT COMPLETED|Overall Study||17
8283534|NCT01657253|20423820|P2|COMPLETED|Overall Study||72
8283535|NCT01657253|20423821|P1|COMPLETED|Overall Study||76
8283536|NCT01657253|20423820|P2|STARTED|Overall Study||90
8283537|NCT01657253|20423821|P1|STARTED|Overall Study||93
8283538|NCT01657162|20423833|P2|NOT COMPLETED|Overall Study||75
8283539|NCT01657162|20423834|P1|NOT COMPLETED|Overall Study||59
8283540|NCT01657162|20423833|P2|COMPLETED|Overall Study||506
8283541|NCT01657162|20423834|P1|COMPLETED|Overall Study||499
8283542|NCT01657162|20423833|P2|Study 005 mITT Population|Overall Study||568
8283543|NCT01657162|20423834|P1|Study 005 mITT Population|Overall Study||544
8283544|NCT01657162|20423833|P2|Study 005 Safety Population|Overall Study||580
8283545|NCT01657162|20423834|P1|Study 005 Safety Population|Overall Study||553
8283546|NCT01657162|20423833|P2|Study 005 ITT Population|Overall Study||581
8283547|NCT01657162|20423834|P1|Study 005 ITT Population|Overall Study||558
8283548|NCT01657162|20423833|P2|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
8283549|NCT01657162|20423834|P1|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
8283550|NCT01657162|20423833|P2|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
8283551|NCT01657162|20423834|P1|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
8283552|NCT01657162|20423833|P2|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
8283553|NCT01657162|20423834|P1|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
8283554|NCT01657162|20423833|P2|STARTED|Overall Study||581
8283555|NCT01657162|20423834|P1|STARTED|Overall Study||558
8283556|NCT01657032|20423862|P2|NOT COMPLETED|Overall Study||7
8283557|NCT01657032|20423863|P1|NOT COMPLETED|Overall Study||0
8283558|NCT01657032|20423862|P2|COMPLETED|Overall Study||37
8283559|NCT01657032|20423863|P1|COMPLETED|Overall Study||44
8283560|NCT01657032|20423862|P2|STARTED|Overall Study||44
8283561|NCT01657032|20423863|P1|STARTED|Overall Study||44
8283562|NCT01657019|20423889|P1|NOT COMPLETED|Overall Study||235
8283563|NCT01657019|20423889|P1|COMPLETED|Overall Study||369
8283564|NCT01657019|20423889|P1|STARTED|Overall Study||604
8283565|NCT01656967|20423903|P2|NOT COMPLETED|Overall Study||2
8283566|NCT01656967|20423904|P1|NOT COMPLETED|Overall Study||4
8283567|NCT01656967|20423903|P2|COMPLETED|Overall Study||31
8283568|NCT01656967|20423904|P1|COMPLETED|Overall Study||29
8283569|NCT01656967|20423903|P2|ETT Insertion|Overall Study||31
8283570|NCT01656967|20423904|P1|ETT Insertion|Overall Study||29
8283571|NCT01656967|20423903|P2|SGA Placement|Overall Study||33
8283572|NCT01656967|20423904|P1|SGA Placement|Overall Study||32
8283573|NCT01656967|20423903|P2|STARTED|Overall Study||33
8283574|NCT01656967|20423904|P1|STARTED|Overall Study||33
8283575|NCT01656889|20423930|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
8283576|NCT01656889|20423931|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
8283577|NCT01656889|20423930|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
8283578|NCT01656889|20423931|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
8283579|NCT01656889|20423930|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
8283580|NCT01656889|20423931|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
8283581|NCT01656889|20423930|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
8283582|NCT01656889|20423931|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
8283583|NCT01656889|20423930|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
8283584|NCT01656889|20423931|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
8283585|NCT01656889|20423930|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
8283586|NCT01656889|20423931|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
8283587|NCT01656850|20423951|P2|NOT COMPLETED|Second Intervention (3 Months)||0
8283588|NCT01656850|20423952|P1|NOT COMPLETED|Second Intervention (3 Months)||0
8283589|NCT01656850|20423951|P2|COMPLETED|Second Intervention (3 Months)||16
8283590|NCT01656850|20423952|P1|COMPLETED|Second Intervention (3 Months)||17
8283591|NCT01656850|20423951|P2|STARTED|Second Intervention (3 Months)||16
8283592|NCT01656850|20423952|P1|STARTED|Second Intervention (3 Months)||17
8283593|NCT01656850|20423951|P2|NOT COMPLETED|Washout (2 Weeks)||0
8283594|NCT01656850|20423952|P1|NOT COMPLETED|Washout (2 Weeks)||0
8283595|NCT01656850|20423951|P2|COMPLETED|Washout (2 Weeks)||16
8283596|NCT01656850|20423952|P1|COMPLETED|Washout (2 Weeks)||17
8283597|NCT01656850|20423951|P2|STARTED|Washout (2 Weeks)||16
8283598|NCT01656850|20423952|P1|STARTED|Washout (2 Weeks)||17
8283599|NCT01656850|20423951|P2|NOT COMPLETED|First Intervention (3 Months)||4
8283600|NCT01656850|20423952|P1|NOT COMPLETED|First Intervention (3 Months)||3
8283601|NCT01656850|20423951|P2|COMPLETED|First Intervention (3 Months)||16
8283602|NCT01656850|20423952|P1|COMPLETED|First Intervention (3 Months)||17
8283603|NCT01656850|20423951|P2|STARTED|First Intervention (3 Months)||20
8283604|NCT01656850|20423952|P1|STARTED|First Intervention (3 Months)||20
8283605|NCT01656772|20424032|P2|NOT COMPLETED|Overall Study||0
8283606|NCT01656772|20424033|P1|NOT COMPLETED|Overall Study||0
8283607|NCT01656772|20424032|P2|COMPLETED|Overall Study||77
8283608|NCT01656772|20424033|P1|COMPLETED|Overall Study||43
8283609|NCT01656772|20424032|P2|STARTED|Overall Study||77
8283610|NCT01656772|20424033|P1|STARTED|Overall Study||43
8283611|NCT01656759|20424043|P2|NOT COMPLETED|Overall Study||3
8283612|NCT01656759|20424044|P1|NOT COMPLETED|Overall Study||2
8283613|NCT01656759|20424043|P2|COMPLETED|Overall Study||22
8283614|NCT01656759|20424044|P1|COMPLETED|Overall Study||25
8283615|NCT01656759|20424043|P2|STARTED|Overall Study||25
8283616|NCT01656759|20424044|P1|STARTED|Overall Study||27
8283617|NCT01656733|20424058|P2|NOT COMPLETED|Overall Study||4
8283618|NCT01656733|20424059|P1|NOT COMPLETED|Overall Study||0
8283619|NCT01656733|20424058|P2|COMPLETED|Overall Study||66
8283620|NCT01656733|20424059|P1|COMPLETED|Overall Study||67
8283621|NCT01656733|20424058|P2|Visit 8 (6 Months Postpartum)|Overall Study||28
8283622|NCT01656733|20424059|P1|Visit 8 (6 Months Postpartum)|Overall Study||30
8283623|NCT01656733|20424058|P2|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
8283624|NCT01656733|20424059|P1|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
8283625|NCT01656733|20424058|P2|Participants With Perinatal Outcomes|Overall Study||66
8283626|NCT01656733|20424059|P1|Participants With Perinatal Outcomes|Overall Study||67
8283627|NCT01656733|20424058|P2|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
8283628|NCT01656733|20424059|P1|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
8283629|NCT01656733|20424058|P2|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
8283630|NCT01656733|20424059|P1|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
8283631|NCT01656733|20424058|P2|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
8283632|NCT01656733|20424059|P1|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
8283633|NCT01656733|20424058|P2|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
8283634|NCT01656733|20424059|P1|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
8283635|NCT01656733|20424058|P2|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
8283636|NCT01656733|20424059|P1|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
8283637|NCT01656733|20424058|P2|Visit 1 (1 Week After Quit Date)|Overall Study||42
8283638|NCT01656733|20424059|P1|Visit 1 (1 Week After Quit Date)|Overall Study||45
8283639|NCT01656733|20424058|P2|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
8283640|NCT01656733|20424059|P1|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
8283641|NCT01656629|20424074|P3|NOT COMPLETED|Overall Study||2
8283642|NCT01656629|20424075|P2|NOT COMPLETED|Overall Study||2
8283643|NCT01656629|20424076|P1|NOT COMPLETED|Overall Study||5
8283644|NCT01656629|20424074|P3|COMPLETED|Overall Study||14
8283645|NCT01656629|20424075|P2|COMPLETED|Overall Study||16
8283646|NCT01656629|20424076|P1|COMPLETED|Overall Study||16
8283647|NCT01656629|20424074|P3|STARTED|Overall Study||16
8283648|NCT01656629|20424075|P2|STARTED|Overall Study||18
8283649|NCT01656629|20424076|P1|STARTED|Overall Study||21
8283650|NCT01656486|20424090|P1|NOT COMPLETED|Overall Study||0
8283651|NCT01656486|20424090|P1|COMPLETED|Overall Study||1
8283652|NCT01656486|20424090|P1|STARTED|Overall Study||1
8283653|NCT01656460|20424094|P4|NOT COMPLETED|Overall Study||0
8283654|NCT01656460|20424095|P3|NOT COMPLETED|Overall Study||0
8283655|NCT01656460|20424096|P2|NOT COMPLETED|Overall Study||0
8283656|NCT01656460|20424097|P1|NOT COMPLETED|Overall Study||0
8283657|NCT01656460|20424094|P4|COMPLETED|Overall Study||3
8283658|NCT01656460|20424095|P3|COMPLETED|Overall Study||3
8283659|NCT01656460|20424096|P2|COMPLETED|Overall Study||3
8283660|NCT01656460|20424097|P1|COMPLETED|Overall Study||3
8283661|NCT01656460|20424094|P4|STARTED|Overall Study||3
8283662|NCT01656460|20424095|P3|STARTED|Overall Study||3
8283663|NCT01656460|20424096|P2|STARTED|Overall Study||3
8283664|NCT01656460|20424097|P1|STARTED|Overall Study||3
8283665|NCT01656434|20424109|P2|NOT COMPLETED|Overall Study||580
8283666|NCT01656434|20424110|P1|NOT COMPLETED|Overall Study||2401
8283667|NCT01656434|20424109|P2|COMPLETED|Overall Study||40
8283668|NCT01656434|20424110|P1|COMPLETED|Overall Study||152
8283669|NCT01656434|20424109|P2|Treated|Overall Study||604
8283670|NCT01656434|20424110|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
8283671|NCT01656434|20424109|P2|STARTED|Overall Study||620
8283672|NCT01656434|20424110|P1|STARTED|Overall Study||2553
8283673|NCT01656408|20424136|P10|NOT COMPLETED|Overall Study||3
8283674|NCT01656408|20424137|P9|NOT COMPLETED|Overall Study||2
8283675|NCT01656408|20424138|P8|NOT COMPLETED|Overall Study||1
8283676|NCT01656408|20424139|P7|NOT COMPLETED|Overall Study||1
8283677|NCT01656408|20424140|P6|NOT COMPLETED|Overall Study||2
8283678|NCT01656408|20424141|P5|NOT COMPLETED|Overall Study||1
8283679|NCT01656408|20424142|P4|NOT COMPLETED|Overall Study||0
8283680|NCT01656408|20424143|P3|NOT COMPLETED|Overall Study||2
8283681|NCT01656408|20424144|P2|NOT COMPLETED|Overall Study||0
8283682|NCT01656408|20424145|P1|NOT COMPLETED|Overall Study||1
8283683|NCT01656408|20424136|P10|COMPLETED|Overall Study||15
8283684|NCT01656408|20424137|P9|COMPLETED|Overall Study||16
8283685|NCT01656408|20424138|P8|COMPLETED|Overall Study||7
8283686|NCT01656408|20424139|P7|COMPLETED|Overall Study||9
8283687|NCT01656408|20424140|P6|COMPLETED|Overall Study||7
8283688|NCT01656408|20424141|P5|COMPLETED|Overall Study||8
8283689|NCT01656408|20424142|P4|COMPLETED|Overall Study||7
8283690|NCT01656408|20424143|P3|COMPLETED|Overall Study||6
8283691|NCT01656408|20424144|P2|COMPLETED|Overall Study||8
8283692|NCT01656408|20424145|P1|COMPLETED|Overall Study||7
8283693|NCT01656408|20424136|P10|STARTED|Overall Study||18
8283694|NCT01656408|20424137|P9|STARTED|Overall Study||18
8283695|NCT01656408|20424138|P8|STARTED|Overall Study||8
8283696|NCT01656408|20424139|P7|STARTED|Overall Study||10
8283697|NCT01656408|20424140|P6|STARTED|Overall Study||9
8283698|NCT01656408|20424141|P5|STARTED|Overall Study||9
8283699|NCT01656408|20424142|P4|STARTED|Overall Study||7
8283700|NCT01656408|20424143|P3|STARTED|Overall Study||8
8283701|NCT01656408|20424144|P2|STARTED|Overall Study||8
8283702|NCT01656408|20424145|P1|STARTED|Overall Study||8
8283703|NCT01656395|20424340|P8|NOT COMPLETED|Overall Study||0
8283704|NCT01656395|20424341|P7|NOT COMPLETED|Overall Study||0
8283705|NCT01656395|20424342|P6|NOT COMPLETED|Overall Study||40
8283706|NCT01656395|20424343|P5|NOT COMPLETED|Overall Study||14
8283707|NCT01656395|20424344|P4|NOT COMPLETED|Overall Study||12
8283708|NCT01656395|20424345|P3|NOT COMPLETED|Overall Study||36
8283709|NCT01656395|20424346|P2|NOT COMPLETED|Overall Study||34
8283710|NCT01656395|20424347|P1|NOT COMPLETED|Overall Study||17
8283711|NCT01656395|20424340|P8|COMPLETED|Overall Study||0
8283712|NCT01656395|20424341|P7|COMPLETED|Overall Study||0
8283713|NCT01656395|20424342|P6|COMPLETED|Overall Study||94
8283714|NCT01656395|20424343|P5|COMPLETED|Overall Study||46
8283715|NCT01656395|20424344|P4|COMPLETED|Overall Study||41
8283716|NCT01656395|20424345|P3|COMPLETED|Overall Study||106
8283717|NCT01656395|20424346|P2|COMPLETED|Overall Study||93
8283718|NCT01656395|20424347|P1|COMPLETED|Overall Study||43
8283719|NCT01656395|20424340|P8|Treated Participants|Overall Study||0
8283720|NCT01656395|20424341|P7|Treated Participants|Overall Study||0
8283721|NCT01656395|20424342|P6|Treated Participants|Overall Study||126
8283722|NCT01656395|20424343|P5|Treated Participants|Overall Study||60
8283723|NCT01656395|20424344|P4|Treated Participants|Overall Study||52
8283724|NCT01656395|20424345|P3|Treated Participants|Overall Study||135
8283725|NCT01656395|20424346|P2|Treated Participants|Overall Study||126
8283726|NCT01656395|20424347|P1|Treated Participants|Overall Study||58
8283727|NCT01656395|20424340|P8|STARTED|Overall Study||0
8283728|NCT01656395|20424341|P7|STARTED|Overall Study||0
8283729|NCT01656395|20424342|P6|STARTED|Overall Study||134
8283730|NCT01656395|20424343|P5|STARTED|Overall Study||60
8283731|NCT01656395|20424344|P4|STARTED|Overall Study||53
8283732|NCT01656395|20424345|P3|STARTED|Overall Study||142
8283733|NCT01656395|20424346|P2|STARTED|Overall Study||127
8283734|NCT01656395|20424347|P1|STARTED|Overall Study||60
8283735|NCT01656304|20424433|P1|NOT COMPLETED|Overall Study||1
8283736|NCT01656304|20424433|P1|COMPLETED|Overall Study||15
8283737|NCT01656304|20424433|P1|STARTED|Overall Study||16
8283738|NCT01656252|20424442|P1|NOT COMPLETED|Phase II||0
8283739|NCT01656252|20424442|P1|COMPLETED|Phase II||0
8283740|NCT01656252|20424442|P1|STARTED|Phase II||0
8283741|NCT01656252|20424442|P1|NOT COMPLETED|Phase I||0
8283742|NCT01656252|20424442|P1|COMPLETED|Phase I||14
8283743|NCT01656252|20424442|P1|STARTED|Phase I||14
8283744|NCT01656200|20424474|P1|NOT COMPLETED|Overall Study||1
8283745|NCT01656200|20424474|P1|COMPLETED|Overall Study||16
8283746|NCT01656200|20424474|P1|STARTED|Overall Study||17
8283747|NCT01656187|20424482|P2|NOT COMPLETED|Second Intervention (24 Weeks)||3
8283748|NCT01656187|20424483|P1|NOT COMPLETED|Second Intervention (24 Weeks)||1
8283749|NCT01656187|20424482|P2|COMPLETED|Second Intervention (24 Weeks)||19
8283750|NCT01656187|20424483|P1|COMPLETED|Second Intervention (24 Weeks)||13
8283751|NCT01656187|20424482|P2|STARTED|Second Intervention (24 Weeks)||22
8283752|NCT01656187|20424483|P1|STARTED|Second Intervention (24 Weeks)||14
8283753|NCT01656187|20424482|P2|NOT COMPLETED|Washout (4 Weeks)||1
8283754|NCT01656187|20424483|P1|NOT COMPLETED|Washout (4 Weeks)||0
8283755|NCT01656187|20424482|P2|COMPLETED|Washout (4 Weeks)||22
8283756|NCT01656187|20424483|P1|COMPLETED|Washout (4 Weeks)||14
8283757|NCT01656187|20424482|P2|STARTED|Washout (4 Weeks)||23
8283758|NCT01656187|20424483|P1|STARTED|Washout (4 Weeks)||14
8283759|NCT01656187|20424482|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
8283760|NCT01656187|20424483|P1|NOT COMPLETED|First Intervention (24 Weeks)||6
8283761|NCT01656187|20424482|P2|COMPLETED|First Intervention (24 Weeks)||23
8283762|NCT01656187|20424483|P1|COMPLETED|First Intervention (24 Weeks)||14
8283763|NCT01656187|20424482|P2|STARTED|First Intervention (24 Weeks)||26
8283764|NCT01656187|20424483|P1|STARTED|First Intervention (24 Weeks)||20
8283765|NCT01656161|20424489|P1|NOT COMPLETED|Overall Study||7
8283766|NCT01656161|20424489|P1|COMPLETED|Overall Study|Per protocol analysis set|113
8283767|NCT01656161|20424489|P1|Received Triptorelin at Day 169|Overall Study||115
8283768|NCT01656161|20424489|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
8283769|NCT01656161|20424489|P1|STARTED|Overall Study|Intention to treat analysis set|120
8283770|NCT01656031|20424503|P1|NOT COMPLETED|Overall Study||0
8283771|NCT01656031|20424503|P1|COMPLETED|Overall Study||39
8283772|NCT01656031|20424503|P1|STARTED|Overall Study||39
8283773|NCT01655901|20424507|P6|NOT COMPLETED|Third Intervention (Hour 3)||0
8283774|NCT01655901|20424508|P5|NOT COMPLETED|Third Intervention (Hour 3)||1
8283775|NCT01655901|20424509|P4|NOT COMPLETED|Third Intervention (Hour 3)||0
8283776|NCT01655901|20424510|P3|NOT COMPLETED|Third Intervention (Hour 3)||1
8283777|NCT01655901|20424511|P2|NOT COMPLETED|Third Intervention (Hour 3)||1
8283778|NCT01655901|20424512|P1|NOT COMPLETED|Third Intervention (Hour 3)||1
8283779|NCT01655901|20424507|P6|COMPLETED|Third Intervention (Hour 3)||5
8283780|NCT01655901|20424508|P5|COMPLETED|Third Intervention (Hour 3)||4
8283781|NCT01655901|20424509|P4|COMPLETED|Third Intervention (Hour 3)||5
8283782|NCT01655901|20424510|P3|COMPLETED|Third Intervention (Hour 3)||4
8283783|NCT01655901|20424511|P2|COMPLETED|Third Intervention (Hour 3)||4
8283784|NCT01655901|20424512|P1|COMPLETED|Third Intervention (Hour 3)||4
8283785|NCT01655901|20424507|P6|STARTED|Third Intervention (Hour 3)||5
8283786|NCT01655901|20424508|P5|STARTED|Third Intervention (Hour 3)||5
8283787|NCT01655901|20424509|P4|STARTED|Third Intervention (Hour 3)||5
8283788|NCT01655901|20424510|P3|STARTED|Third Intervention (Hour 3)||5
8283789|NCT01655901|20424511|P2|STARTED|Third Intervention (Hour 3)||5
8283790|NCT01655901|20424512|P1|STARTED|Third Intervention (Hour 3)||5
8283791|NCT01655901|20424507|P6|NOT COMPLETED|Washout (1 Week)||0
8283792|NCT01655901|20424508|P5|NOT COMPLETED|Washout (1 Week)||0
8283793|NCT01655901|20424509|P4|NOT COMPLETED|Washout (1 Week)||0
8283794|NCT01655901|20424510|P3|NOT COMPLETED|Washout (1 Week)||0
8283795|NCT01655901|20424511|P2|NOT COMPLETED|Washout (1 Week)||0
8283796|NCT01655901|20424512|P1|NOT COMPLETED|Washout (1 Week)||0
8283797|NCT01655901|20424507|P6|COMPLETED|Washout (1 Week)||5
8283798|NCT01655901|20424508|P5|COMPLETED|Washout (1 Week)||5
8283799|NCT01655901|20424509|P4|COMPLETED|Washout (1 Week)||5
8283800|NCT01655901|20424510|P3|COMPLETED|Washout (1 Week)||5
8283801|NCT01655901|20424511|P2|COMPLETED|Washout (1 Week)||5
8283802|NCT01655901|20424512|P1|COMPLETED|Washout (1 Week)||5
8283803|NCT01655901|20424507|P6|STARTED|Washout (1 Week)||5
8283804|NCT01655901|20424508|P5|STARTED|Washout (1 Week)||5
8283805|NCT01655901|20424509|P4|STARTED|Washout (1 Week)||5
8283806|NCT01655901|20424510|P3|STARTED|Washout (1 Week)||5
8283807|NCT01655901|20424511|P2|STARTED|Washout (1 Week)||5
8283808|NCT01655901|20424512|P1|STARTED|Washout (1 Week)||5
8283809|NCT01655901|20424507|P6|NOT COMPLETED|Second Intervention (Hour 2)||0
8283810|NCT01655901|20424508|P5|NOT COMPLETED|Second Intervention (Hour 2)||0
8283811|NCT01655901|20424509|P4|NOT COMPLETED|Second Intervention (Hour 2)||0
8283812|NCT01655901|20424510|P3|NOT COMPLETED|Second Intervention (Hour 2)||0
8283813|NCT01655901|20424511|P2|NOT COMPLETED|Second Intervention (Hour 2)||0
8283814|NCT01655901|20424512|P1|NOT COMPLETED|Second Intervention (Hour 2)||0
8283815|NCT01655901|20424507|P6|COMPLETED|Second Intervention (Hour 2)||5
8283816|NCT01655901|20424508|P5|COMPLETED|Second Intervention (Hour 2)||5
8283817|NCT01655901|20424509|P4|COMPLETED|Second Intervention (Hour 2)||5
8283818|NCT01655901|20424510|P3|COMPLETED|Second Intervention (Hour 2)||5
8283819|NCT01655901|20424511|P2|COMPLETED|Second Intervention (Hour 2)||5
8283820|NCT01655901|20424512|P1|COMPLETED|Second Intervention (Hour 2)||5
8283821|NCT01655901|20424507|P6|STARTED|Second Intervention (Hour 2)||5
8283822|NCT01655901|20424508|P5|STARTED|Second Intervention (Hour 2)||5
8283823|NCT01655901|20424509|P4|STARTED|Second Intervention (Hour 2)||5
8283824|NCT01655901|20424510|P3|STARTED|Second Intervention (Hour 2)||5
8283825|NCT01655901|20424511|P2|STARTED|Second Intervention (Hour 2)||5
8283826|NCT01655901|20424512|P1|STARTED|Second Intervention (Hour 2)||5
8283827|NCT01655901|20424507|P6|NOT COMPLETED|Washout (1 Week)||0
8283828|NCT01655901|20424508|P5|NOT COMPLETED|Washout (1 Week)||0
8283829|NCT01655901|20424509|P4|NOT COMPLETED|Washout (1 Week)||0
8283830|NCT01655901|20424510|P3|NOT COMPLETED|Washout (1 Week)||0
8283831|NCT01655901|20424511|P2|NOT COMPLETED|Washout (1 Week)||0
8283832|NCT01655901|20424512|P1|NOT COMPLETED|Washout (1 Week)||0
8283833|NCT01655901|20424507|P6|COMPLETED|Washout (1 Week)||5
8283834|NCT01655901|20424508|P5|COMPLETED|Washout (1 Week)||5
8283835|NCT01655901|20424509|P4|COMPLETED|Washout (1 Week)||5
8283836|NCT01655901|20424510|P3|COMPLETED|Washout (1 Week)||5
8283837|NCT01655901|20424511|P2|COMPLETED|Washout (1 Week)||5
8283838|NCT01655901|20424512|P1|COMPLETED|Washout (1 Week)||5
8283839|NCT01655901|20424507|P6|STARTED|Washout (1 Week)||5
8283840|NCT01655901|20424508|P5|STARTED|Washout (1 Week)||5
8283841|NCT01655901|20424509|P4|STARTED|Washout (1 Week)||5
8283842|NCT01655901|20424510|P3|STARTED|Washout (1 Week)||5
8283843|NCT01655901|20424511|P2|STARTED|Washout (1 Week)||5
8283844|NCT01655901|20424512|P1|STARTED|Washout (1 Week)||5
8283845|NCT01655901|20424507|P6|NOT COMPLETED|First Intervention (Hour 1)||0
8283846|NCT01655901|20424508|P5|NOT COMPLETED|First Intervention (Hour 1)||0
8283847|NCT01655901|20424509|P4|NOT COMPLETED|First Intervention (Hour 1)||0
8283848|NCT01655901|20424510|P3|NOT COMPLETED|First Intervention (Hour 1)||0
8283849|NCT01655901|20424511|P2|NOT COMPLETED|First Intervention (Hour 1)||0
8283850|NCT01655901|20424512|P1|NOT COMPLETED|First Intervention (Hour 1)||0
8283851|NCT01655901|20424507|P6|COMPLETED|First Intervention (Hour 1)||5
8283852|NCT01655901|20424508|P5|COMPLETED|First Intervention (Hour 1)||5
8283853|NCT01655901|20424509|P4|COMPLETED|First Intervention (Hour 1)||5
8283854|NCT01655901|20424510|P3|COMPLETED|First Intervention (Hour 1)||5
8283855|NCT01655901|20424511|P2|COMPLETED|First Intervention (Hour 1)||5
8283856|NCT01655901|20424512|P1|COMPLETED|First Intervention (Hour 1)||5
8283857|NCT01655901|20424507|P6|STARTED|First Intervention (Hour 1)||5
8283858|NCT01655901|20424508|P5|STARTED|First Intervention (Hour 1)||5
8283859|NCT01655901|20424509|P4|STARTED|First Intervention (Hour 1)||5
8283860|NCT01655901|20424510|P3|STARTED|First Intervention (Hour 1)||5
8283861|NCT01655901|20424511|P2|STARTED|First Intervention (Hour 1)||5
8283862|NCT01655901|20424512|P1|STARTED|First Intervention (Hour 1)||5
8283863|NCT01655823|20424526|P5|NOT COMPLETED|Overall Study||1
8283864|NCT01655823|20424527|P4|NOT COMPLETED|Overall Study||1
8283865|NCT01655823|20424528|P3|NOT COMPLETED|Overall Study||0
8283866|NCT01655823|20424529|P2|NOT COMPLETED|Overall Study||2
8283867|NCT01655823|20424530|P1|NOT COMPLETED|Overall Study||0
8283868|NCT01655823|20424526|P5|COMPLETED|Overall Study||25
8283869|NCT01655823|20424527|P4|COMPLETED|Overall Study||24
8283870|NCT01655823|20424528|P3|COMPLETED|Overall Study||24
8283871|NCT01655823|20424529|P2|COMPLETED|Overall Study||23
8283872|NCT01655823|20424530|P1|COMPLETED|Overall Study||25
8283873|NCT01655823|20424526|P5|STARTED|Overall Study||26
8283874|NCT01655823|20424527|P4|STARTED|Overall Study||25
8283875|NCT01655823|20424528|P3|STARTED|Overall Study||24
8283876|NCT01655823|20424529|P2|STARTED|Overall Study||25
8283877|NCT01655823|20424530|P1|STARTED|Overall Study||25
8283878|NCT01655719|20424542|P1|NOT COMPLETED|Overall Study||0
8283879|NCT01655719|20424542|P1|COMPLETED|Overall Study||1
8283880|NCT01655719|20424542|P1|STARTED|Overall Study||1
8283881|NCT01655563|20424550|P2|NOT COMPLETED|Overall Study||0
8283882|NCT01655563|20424551|P1|NOT COMPLETED|Overall Study||0
8283883|NCT01655563|20424550|P2|COMPLETED|Overall Study||35
8283884|NCT01655563|20424551|P1|COMPLETED|Overall Study||18
8283885|NCT01655563|20424550|P2|STARTED|Overall Study||35
8283886|NCT01655563|20424551|P1|STARTED|Overall Study||18
8283887|NCT01655498|20424561|P1|NOT COMPLETED|Overall Study||5
8283888|NCT01655498|20424561|P1|COMPLETED|Overall Study||56
8283889|NCT01655498|20424561|P1|STARTED|Overall Study||61
8283890|NCT01655381|20424568|P1|NOT COMPLETED|Overall Study||3
8283891|NCT01655381|20424568|P1|COMPLETED|Overall Study||12
8283892|NCT01655381|20424568|P1|STARTED|Overall Study||15
8283893|NCT01655329|20424588|P1|NOT COMPLETED|Overall Study||0
8283894|NCT01655329|20424588|P1|COMPLETED|Overall Study||10
8283895|NCT01655329|20424588|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
8283896|NCT01655069|20424608|P4|NOT COMPLETED|Overall Study||4
8283897|NCT01655069|20424609|P3|NOT COMPLETED|Overall Study||2
8283898|NCT01655069|20424610|P2|NOT COMPLETED|Overall Study||12
8283899|NCT01655069|20424611|P1|NOT COMPLETED|Overall Study||8
8283900|NCT01655069|20424608|P4|COMPLETED|Overall Study||11
8283901|NCT01655069|20424609|P3|COMPLETED|Overall Study||12
8283902|NCT01655069|20424610|P2|COMPLETED|Overall Study||46
8283903|NCT01655069|20424611|P1|COMPLETED|Overall Study||53
8283904|NCT01655069|20424608|P4|Full Analysis Set (FAS)|Overall Study||15
8283905|NCT01655069|20424609|P3|Full Analysis Set (FAS)|Overall Study||14
8283906|NCT01655069|20424610|P2|Full Analysis Set (FAS)|Overall Study||57
8283907|NCT01655069|20424611|P1|Full Analysis Set (FAS)|Overall Study||60
8283908|NCT01655069|20424608|P4|Safety Analysis Set (SAF)|Overall Study||15
8283909|NCT01655069|20424609|P3|Safety Analysis Set (SAF)|Overall Study||14
8283910|NCT01655069|20424610|P2|Safety Analysis Set (SAF)|Overall Study||57
8283911|NCT01655069|20424611|P1|Safety Analysis Set (SAF)|Overall Study||61
8283912|NCT01655069|20424608|P4|STARTED|Overall Study||15
8283913|NCT01655069|20424609|P3|STARTED|Overall Study||14
8283914|NCT01655069|20424610|P2|STARTED|Overall Study||58
8283915|NCT01655069|20424611|P1|STARTED|Overall Study||61
8283916|NCT01655043|20424626|P1|NOT COMPLETED|Overall Study||0
8283917|NCT01655043|20424626|P1|COMPLETED|Overall Study||20
8283918|NCT01655043|20424626|P1|STARTED|Overall Study||20
8283919|NCT01654887|20424632|P2|NOT COMPLETED|Overall Study||0
8283920|NCT01654887|20424633|P1|NOT COMPLETED|Overall Study||0
8283921|NCT01654887|20424632|P2|COMPLETED|Overall Study||88
8283922|NCT01654887|20424633|P1|COMPLETED|Overall Study||103
8283923|NCT01654887|20424632|P2|STARTED|Overall Study||88
8283924|NCT01654887|20424633|P1|STARTED|Overall Study||103
8283925|NCT01654861|20424649|P1|NOT COMPLETED|Overall Study||0
8283926|NCT01654861|20424649|P1|COMPLETED|Overall Study||3
8283927|NCT01654861|20424649|P1|STARTED|Overall Study||3
8283928|NCT01654796|20424657|P3|NOT COMPLETED|Overall Study||1
8283929|NCT01654796|20424658|P2|NOT COMPLETED|Overall Study||3
8283930|NCT01654796|20424659|P1|NOT COMPLETED|Overall Study||1
8283931|NCT01654796|20424657|P3|COMPLETED|Overall Study||28
8283932|NCT01654796|20424658|P2|COMPLETED|Overall Study||26
8283933|NCT01654796|20424659|P1|COMPLETED|Overall Study||25
8283934|NCT01654796|20424657|P3|STARTED|Overall Study||29
8283935|NCT01654796|20424658|P2|STARTED|Overall Study||29
8283936|NCT01654796|20424659|P1|STARTED|Overall Study||26
8283937|NCT01654666|20424671|P3|NOT COMPLETED|Overall Study||14
8283938|NCT01654666|20424672|P2|NOT COMPLETED|Overall Study||13
8283939|NCT01654666|20424673|P1|NOT COMPLETED|Overall Study||15
8283940|NCT01654666|20424671|P3|COMPLETED|Overall Study||49
8283941|NCT01654666|20424672|P2|COMPLETED|Overall Study||50
8283942|NCT01654666|20424673|P1|COMPLETED|Overall Study||48
8283943|NCT01654666|20424671|P3|Primary Analysis|Overall Study||54
8283944|NCT01654666|20424672|P2|Primary Analysis|Overall Study||56
8283945|NCT01654666|20424673|P1|Primary Analysis|Overall Study||52
8283946|NCT01654666|20424671|P3|STARTED|Overall Study||63
8283947|NCT01654666|20424672|P2|STARTED|Overall Study||63
8283948|NCT01654666|20424673|P1|STARTED|Overall Study||63
8283949|NCT01654601|20424698|P2|NOT COMPLETED|2nd Administration||1
8283950|NCT01654601|20424699|P1|NOT COMPLETED|2nd Administration||1
8283951|NCT01654601|20424698|P2|COMPLETED|2nd Administration||11
8283952|NCT01654601|20424699|P1|COMPLETED|2nd Administration||11
8283953|NCT01654601|20424698|P2|STARTED|2nd Administration||12
8283954|NCT01654601|20424699|P1|STARTED|2nd Administration||12
8283955|NCT01654601|20424698|P2|NOT COMPLETED|1st Administration||2
8283956|NCT01654601|20424699|P1|NOT COMPLETED|1st Administration||2
8283957|NCT01654601|20424698|P2|COMPLETED|1st Administration||12
8283958|NCT01654601|20424699|P1|COMPLETED|1st Administration||12
8283959|NCT01654601|20424698|P2|STARTED|1st Administration||14
8283960|NCT01654601|20424699|P1|STARTED|1st Administration||14
8283961|NCT01654549|20424713|P2|NOT COMPLETED|Overall Study||1
8283962|NCT01654549|20424714|P1|NOT COMPLETED|Overall Study||0
8283963|NCT01654549|20424713|P2|COMPLETED|Overall Study||19
8283964|NCT01654549|20424714|P1|COMPLETED|Overall Study||20
8283965|NCT01654549|20424713|P2|STARTED|Overall Study||20
8283966|NCT01654549|20424714|P1|STARTED|Overall Study||20
8283967|NCT01654536|20424726|P2|NOT COMPLETED|Overall Study||38
8283968|NCT01654536|20424727|P1|NOT COMPLETED|Overall Study||44
8283969|NCT01654536|20424726|P2|COMPLETED|Overall Study||331
8283970|NCT01654536|20424727|P1|COMPLETED|Overall Study||324
8283971|NCT01654536|20424726|P2|STARTED|Overall Study||369
8283972|NCT01654536|20424727|P1|STARTED|Overall Study||368
8283973|NCT01654523|20424763|P1|NOT COMPLETED|Overall Study||1
8283974|NCT01654523|20424763|P1|COMPLETED|Overall Study||19
8283975|NCT01654523|20424763|P1|STARTED|Overall Study||20
8283976|NCT01654445|20424769|P2|NOT COMPLETED|Overall Study||0
8283977|NCT01654445|20424770|P1|NOT COMPLETED|Overall Study||0
8283978|NCT01654445|20424769|P2|COMPLETED|Overall Study||25
8283979|NCT01654445|20424770|P1|COMPLETED|Overall Study||25
8283980|NCT01654445|20424769|P2|STARTED|Overall Study||25
8283981|NCT01654445|20424770|P1|STARTED|Overall Study||25
8283982|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 4||0
8283983|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 4||0
8283984|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 4||0
8283985|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 4||0
8283986|NCT01654380|20424782|P4|COMPLETED|Part B, Period 4||7
8283987|NCT01654380|20424783|P3|COMPLETED|Part B, Period 4||6
8283988|NCT01654380|20424784|P2|COMPLETED|Part B, Period 4||0
8283989|NCT01654380|20424785|P1|COMPLETED|Part B, Period 4||0
8283990|NCT01654380|20424782|P4|STARTED|Part B, Period 4||7
8283991|NCT01654380|20424783|P3|STARTED|Part B, Period 4||6
8283992|NCT01654380|20424784|P2|STARTED|Part B, Period 4||0
8283993|NCT01654380|20424785|P1|STARTED|Part B, Period 4||0
8283994|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283995|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283996|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283997|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283998|NCT01654380|20424782|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
8283999|NCT01654380|20424783|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
8284000|NCT01654380|20424784|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
8284001|NCT01654380|20424785|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
8284002|NCT01654380|20424782|P4|STARTED|Part B, Washout of at Least 6 Days||7
8284003|NCT01654380|20424783|P3|STARTED|Part B, Washout of at Least 6 Days||6
8284004|NCT01654380|20424784|P2|STARTED|Part B, Washout of at Least 6 Days||0
8284005|NCT01654380|20424785|P1|STARTED|Part B, Washout of at Least 6 Days||0
8284006|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 3||0
8284007|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 3||0
8284008|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 3||0
8284009|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 3||0
8284010|NCT01654380|20424782|P4|COMPLETED|Part B, Period 3||7
8284011|NCT01654380|20424783|P3|COMPLETED|Part B, Period 3||6
8284012|NCT01654380|20424784|P2|COMPLETED|Part B, Period 3||0
8284013|NCT01654380|20424785|P1|COMPLETED|Part B, Period 3||0
8284014|NCT01654380|20424782|P4|STARTED|Part B, Period 3||7
8284015|NCT01654380|20424783|P3|STARTED|Part B, Period 3||6
8284016|NCT01654380|20424784|P2|STARTED|Part B, Period 3||0
8284017|NCT01654380|20424785|P1|STARTED|Part B, Period 3||0
8284018|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284019|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284020|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284021|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284022|NCT01654380|20424782|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
8284023|NCT01654380|20424783|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
8284024|NCT01654380|20424784|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
8284025|NCT01654380|20424785|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
8284026|NCT01654380|20424782|P4|STARTED|Part B, Washout of at Least 6 Days||7
8284027|NCT01654380|20424783|P3|STARTED|Part B, Washout of at Least 6 Days||6
8284028|NCT01654380|20424784|P2|STARTED|Part B, Washout of at Least 6 Days||0
8284029|NCT01654380|20424785|P1|STARTED|Part B, Washout of at Least 6 Days||0
8284030|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 2||0
8284031|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 2||0
8284032|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 2||0
8284033|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 2||0
8284034|NCT01654380|20424782|P4|COMPLETED|Part B, Period 2||7
8284035|NCT01654380|20424783|P3|COMPLETED|Part B, Period 2||6
8284036|NCT01654380|20424784|P2|COMPLETED|Part B, Period 2||0
8284037|NCT01654380|20424785|P1|COMPLETED|Part B, Period 2||0
8284038|NCT01654380|20424782|P4|STARTED|Part B, Period 2||7
8284039|NCT01654380|20424783|P3|STARTED|Part B, Period 2||6
8284040|NCT01654380|20424784|P2|STARTED|Part B, Period 2||0
8284041|NCT01654380|20424785|P1|STARTED|Part B, Period 2||0
8284042|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284043|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284044|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284045|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284046|NCT01654380|20424782|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
8284047|NCT01654380|20424783|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
8284048|NCT01654380|20424784|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
8284049|NCT01654380|20424785|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
8284050|NCT01654380|20424782|P4|STARTED|Part B, Washout of at Least 6 Days||7
8284051|NCT01654380|20424783|P3|STARTED|Part B, Washout of at Least 6 Days||6
8284052|NCT01654380|20424784|P2|STARTED|Part B, Washout of at Least 6 Days||0
8284053|NCT01654380|20424785|P1|STARTED|Part B, Washout of at Least 6 Days||0
8284054|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 1||0
8284055|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 1||1
8284056|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 1||0
8284057|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 1||0
8284058|NCT01654380|20424782|P4|COMPLETED|Part B, Period 1||7
8284059|NCT01654380|20424783|P3|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
8284060|NCT01654380|20424784|P2|COMPLETED|Part B, Period 1||0
8284061|NCT01654380|20424785|P1|COMPLETED|Part B, Period 1||0
8284062|NCT01654380|20424782|P4|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
8284063|NCT01654380|20424783|P3|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
8284064|NCT01654380|20424784|P2|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
8284065|NCT01654380|20424785|P1|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
8284066|NCT01654380|20424782|P4|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
8284067|NCT01654380|20424783|P3|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
8284068|NCT01654380|20424784|P2|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
8284069|NCT01654380|20424785|P1|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
8284070|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 4||0
8284071|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 4||0
8284072|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 4||0
8284073|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 4||0
8284074|NCT01654380|20424782|P4|COMPLETED|Part A, Period 4||0
8284075|NCT01654380|20424783|P3|COMPLETED|Part A, Period 4||0
8284076|NCT01654380|20424784|P2|COMPLETED|Part A, Period 4||4
8284077|NCT01654380|20424785|P1|COMPLETED|Part A, Period 4||4
8284078|NCT01654380|20424782|P4|STARTED|Part A, Period 4||0
8284079|NCT01654380|20424783|P3|STARTED|Part A, Period 4||0
8284080|NCT01654380|20424784|P2|STARTED|Part A, Period 4||4
8284081|NCT01654380|20424785|P1|STARTED|Part A, Period 4||4
8284082|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284083|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284084|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284085|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284086|NCT01654380|20424782|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
8284087|NCT01654380|20424783|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
8284088|NCT01654380|20424784|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
8284089|NCT01654380|20424785|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
8284090|NCT01654380|20424782|P4|STARTED|Part A, Washout of at Least 6 Days||0
8284091|NCT01654380|20424783|P3|STARTED|Part A, Washout of at Least 6 Days||0
8284092|NCT01654380|20424784|P2|STARTED|Part A, Washout of at Least 6 Days||4
8284093|NCT01654380|20424785|P1|STARTED|Part A, Washout of at Least 6 Days||4
8284094|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 3||0
8284095|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 3||0
8284096|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 3||0
8284097|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 3||0
8284098|NCT01654380|20424782|P4|COMPLETED|Part A, Period 3||0
8284099|NCT01654380|20424783|P3|COMPLETED|Part A, Period 3||0
8284100|NCT01654380|20424784|P2|COMPLETED|Part A, Period 3||4
8284101|NCT01654380|20424785|P1|COMPLETED|Part A, Period 3||4
8284102|NCT01654380|20424782|P4|STARTED|Part A, Period 3||0
8284103|NCT01654380|20424783|P3|STARTED|Part A, Period 3||0
8284104|NCT01654380|20424784|P2|STARTED|Part A, Period 3||4
8284105|NCT01654380|20424785|P1|STARTED|Part A, Period 3||4
8284106|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284107|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284108|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284109|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284110|NCT01654380|20424782|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
8284111|NCT01654380|20424783|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
8284112|NCT01654380|20424784|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
8284113|NCT01654380|20424785|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
8284114|NCT01654380|20424782|P4|STARTED|Part A, Washout of at Least 6 Days||0
8284115|NCT01654380|20424783|P3|STARTED|Part A, Washout of at Least 6 Days||0
8284116|NCT01654380|20424784|P2|STARTED|Part A, Washout of at Least 6 Days||4
8284117|NCT01654380|20424785|P1|STARTED|Part A, Washout of at Least 6 Days||4
8284118|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 2||0
8284119|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 2||0
8284120|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 2||0
8284121|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 2||0
8284122|NCT01654380|20424782|P4|COMPLETED|Part A, Period 2||0
8284123|NCT01654380|20424783|P3|COMPLETED|Part A, Period 2||0
8284124|NCT01654380|20424784|P2|COMPLETED|Part A, Period 2||4
8284125|NCT01654380|20424785|P1|COMPLETED|Part A, Period 2||4
8284126|NCT01654380|20424782|P4|STARTED|Part A, Period 2||0
8284127|NCT01654380|20424783|P3|STARTED|Part A, Period 2||0
8284128|NCT01654380|20424784|P2|STARTED|Part A, Period 2||4
8284129|NCT01654380|20424785|P1|STARTED|Part A, Period 2||4
8284130|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284131|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284132|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284133|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284134|NCT01654380|20424782|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
8284135|NCT01654380|20424783|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
8284136|NCT01654380|20424784|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
8284137|NCT01654380|20424785|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
8284138|NCT01654380|20424782|P4|STARTED|Part A, Washout of at Least 6 Days||0
8284139|NCT01654380|20424783|P3|STARTED|Part A, Washout of at Least 6 Days||0
8284140|NCT01654380|20424784|P2|STARTED|Part A, Washout of at Least 6 Days||4
8284141|NCT01654380|20424785|P1|STARTED|Part A, Washout of at Least 6 Days||4
8284142|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 1||0
8284143|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 1||0
8284144|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 1||0
8284145|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 1||0
8284146|NCT01654380|20424782|P4|COMPLETED|Part A, Period 1||0
8284147|NCT01654380|20424783|P3|COMPLETED|Part A, Period 1||0
8284148|NCT01654380|20424784|P2|COMPLETED|Part A, Period 1||4
8284149|NCT01654380|20424785|P1|COMPLETED|Part A, Period 1||4
8284150|NCT01654380|20424782|P4|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8284151|NCT01654380|20424783|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8284152|NCT01654380|20424784|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
8284153|NCT01654380|20424785|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
8284154|NCT01654380|20424782|P4|STARTED|Part A, Period 1||0
8284155|NCT01654380|20424783|P3|STARTED|Part A, Period 1||0
8284156|NCT01654380|20424784|P2|STARTED|Part A, Period 1||4
8284157|NCT01654380|20424785|P1|STARTED|Part A, Period 1||4
8284158|NCT01654315|20424813|P3|NOT COMPLETED|Overall Study||0
8284159|NCT01654315|20424814|P2|NOT COMPLETED|Overall Study||0
8284160|NCT01654315|20424815|P1|NOT COMPLETED|Overall Study||0
8284161|NCT01654315|20424813|P3|COMPLETED|Overall Study||9
8284162|NCT01654315|20424814|P2|COMPLETED|Overall Study||10
8284163|NCT01654315|20424815|P1|COMPLETED|Overall Study||15
8284164|NCT01654315|20424813|P3|STARTED|Overall Study||9
8284165|NCT01654315|20424814|P2|STARTED|Overall Study||10
8284166|NCT01654315|20424815|P1|STARTED|Overall Study||15
8284167|NCT01654302|20424828|P2|NOT COMPLETED|Second Intervention (Day 7)||1
8284168|NCT01654302|20424829|P1|NOT COMPLETED|Second Intervention (Day 7)||1
8284169|NCT01654302|20424828|P2|COMPLETED|Second Intervention (Day 7)||19
8284170|NCT01654302|20424829|P1|COMPLETED|Second Intervention (Day 7)||19
8284171|NCT01654302|20424828|P2|STARTED|Second Intervention (Day 7)||20
8284172|NCT01654302|20424829|P1|STARTED|Second Intervention (Day 7)||20
8284173|NCT01654302|20424828|P2|NOT COMPLETED|First Intervention (Day 1)||0
8284174|NCT01654302|20424829|P1|NOT COMPLETED|First Intervention (Day 1)||0
8284175|NCT01654302|20424828|P2|COMPLETED|First Intervention (Day 1)||20
8284176|NCT01654302|20424829|P1|COMPLETED|First Intervention (Day 1)||20
8284177|NCT01654302|20424828|P2|STARTED|First Intervention (Day 1)||20
8284178|NCT01654302|20424829|P1|STARTED|First Intervention (Day 1)||20
8284179|NCT01654289|20424838|P3|NOT COMPLETED|Overall Study||5
8284180|NCT01654289|20424839|P2|NOT COMPLETED|Overall Study||28
8284181|NCT01654289|20424840|P1|NOT COMPLETED|Overall Study||27
8284182|NCT01654289|20424838|P3|COMPLETED|Overall Study||133
8284183|NCT01654289|20424839|P2|COMPLETED|Overall Study||109
8284184|NCT01654289|20424840|P1|COMPLETED|Overall Study||111
8284185|NCT01654289|20424838|P3|STARTED|Overall Study||138
8284186|NCT01654289|20424839|P2|STARTED|Overall Study||137
8284187|NCT01654289|20424840|P1|STARTED|Overall Study||138
8284188|NCT01654276|20424878|P1|NOT COMPLETED|Overall Study||6
8284189|NCT01654276|20424878|P1|COMPLETED|Overall Study||18
8284190|NCT01654276|20424878|P1|Visit 4 (6months)|Overall Study||18
8284191|NCT01654276|20424878|P1|Visit 3 (4 Months)|Overall Study||18
8284192|NCT01654276|20424878|P1|Visit 2 (2 Months)|Overall Study||19
8284193|NCT01654276|20424878|P1|STARTED|Overall Study||24
8284194|NCT01654263|20424902|P6|NOT COMPLETED|Overall Study||1
8284195|NCT01654263|20424903|P5|NOT COMPLETED|Overall Study||1
8284196|NCT01654263|20424904|P4|NOT COMPLETED|Overall Study||1
8284197|NCT01654263|20424905|P3|NOT COMPLETED|Overall Study||2
8284198|NCT01654263|20424906|P2|NOT COMPLETED|Overall Study||0
8284199|NCT01654263|20424907|P1|NOT COMPLETED|Overall Study||0
8284200|NCT01654263|20424902|P6|COMPLETED|Overall Study||148
8284201|NCT01654263|20424903|P5|COMPLETED|Overall Study||139
8284202|NCT01654263|20424904|P4|COMPLETED|Overall Study||144
8284203|NCT01654263|20424905|P3|COMPLETED|Overall Study||137
8284204|NCT01654263|20424906|P2|COMPLETED|Overall Study||147
8284205|NCT01654263|20424907|P1|COMPLETED|Overall Study||164
8284206|NCT01654263|20424902|P6|STARTED|Overall Study||149
8284207|NCT01654263|20424903|P5|STARTED|Overall Study||140
8284208|NCT01654263|20424904|P4|STARTED|Overall Study||145
8284209|NCT01654263|20424905|P3|STARTED|Overall Study||139
8284210|NCT01654263|20424906|P2|STARTED|Overall Study||147
8284211|NCT01654263|20424907|P1|STARTED|Overall Study||164
8284212|NCT01654250|20424932|P2|NOT COMPLETED|Overall Study||0
8284213|NCT01654250|20424933|P1|NOT COMPLETED|Overall Study||1
8284214|NCT01654250|20424932|P2|COMPLETED|Overall Study||42
8284215|NCT01654250|20424933|P1|COMPLETED|Overall Study||43
8284216|NCT01654250|20424932|P2|STARTED|Overall Study||42
8284217|NCT01654250|20424933|P1|STARTED|Overall Study||44
8284218|NCT01654224|20424950|P2|NOT COMPLETED|Overall Study||12
8284219|NCT01654224|20424951|P1|NOT COMPLETED|Overall Study||6
8284220|NCT01654224|20424950|P2|COMPLETED|Overall Study||98
8284221|NCT01654224|20424951|P1|COMPLETED|Overall Study||89
8284222|NCT01654224|20424950|P2|STARTED|Overall Study||110
8284223|NCT01654224|20424951|P1|STARTED|Overall Study||95
8284224|NCT01654107|20424963|P2|NOT COMPLETED|Overall Study||8
8284225|NCT01654107|20424964|P1|NOT COMPLETED|Overall Study||3
8284226|NCT01654107|20424963|P2|COMPLETED|Overall Study||22
8284227|NCT01654107|20424964|P1|COMPLETED|Overall Study||25
8284228|NCT01654107|20424963|P2|STARTED|Overall Study||30
8284229|NCT01654107|20424964|P1|STARTED|Overall Study||28
8284230|NCT01654068|20424970|P1|NOT COMPLETED|Overall Study||0
8284231|NCT01654068|20424970|P1|COMPLETED|Overall Study||14
8284232|NCT01654068|20424970|P1|STARTED|Overall Study||14
8284233|NCT01653964|20424976|P1|NOT COMPLETED|Overall Study||0
8284234|NCT01653964|20424976|P1|COMPLETED|Overall Study||82
8284235|NCT01653964|20424976|P1|STARTED|Overall Study||82
8284236|NCT01653912|20424982|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
8284237|NCT01653912|20424983|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284238|NCT01653912|20424984|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284239|NCT01653912|20424985|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284240|NCT01653912|20424986|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284241|NCT01653912|20424987|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284242|NCT01653912|20424982|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
8284243|NCT01653912|20424983|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284244|NCT01653912|20424984|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284245|NCT01653912|20424985|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284246|NCT01653912|20424986|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284247|NCT01653912|20424987|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284248|NCT01653912|20424982|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
8284249|NCT01653912|20424983|P5|STARTED|Phase 2: GSK2110183 125 mg||0
8284250|NCT01653912|20424984|P4|STARTED|Phase 2: GSK2110183 125 mg||0
8284251|NCT01653912|20424985|P3|STARTED|Phase 2: GSK2110183 125 mg||0
8284252|NCT01653912|20424986|P2|STARTED|Phase 2: GSK2110183 125 mg||0
8284253|NCT01653912|20424987|P1|STARTED|Phase 2: GSK2110183 125 mg||0
8284254|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284255|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284256|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284257|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284258|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284259|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284260|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284261|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
8284262|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284263|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284264|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284265|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284266|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284267|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
8284268|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284269|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284270|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284271|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284272|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284273|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284274|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
8284275|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284276|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284277|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284278|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284279|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284280|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
8284281|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284282|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284283|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284284|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284285|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284286|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
8284287|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284288|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284289|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284290|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284291|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284292|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284293|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
8284294|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284295|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284296|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284297|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284298|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284299|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
8284300|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284301|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284302|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284303|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284304|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284305|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
8284306|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284307|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284308|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284395|NCT01653262|20425129|P1|NOT COMPLETED|Overall Study||3
8284309|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284310|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284311|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284312|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
8284313|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284314|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284315|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284316|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284317|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284318|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
8284319|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284320|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284321|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284322|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284323|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284324|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
8284325|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284326|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284327|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284328|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284329|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284330|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284331|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284332|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284333|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284334|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284335|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284336|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284337|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
8284338|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284339|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284340|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284341|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284342|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284343|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
8284344|NCT01653782|20425005|P3|NOT COMPLETED|Overall Study||6
8284345|NCT01653782|20425006|P2|NOT COMPLETED|Overall Study||18
8284346|NCT01653782|20425007|P1|NOT COMPLETED|Overall Study||16
8284347|NCT01653782|20425005|P3|COMPLETED|Overall Study||46
8284348|NCT01653782|20425006|P2|COMPLETED|Overall Study||37
8284349|NCT01653782|20425007|P1|COMPLETED|Overall Study||36
8284350|NCT01653782|20425005|P3|STARTED|Overall Study||52
8284351|NCT01653782|20425006|P2|STARTED|Overall Study||55
8284352|NCT01653782|20425007|P1|STARTED|Overall Study||52
8284353|NCT01653743|20425017|P2|NOT COMPLETED|Overall Study||0
8284354|NCT01653743|20425018|P1|NOT COMPLETED|Overall Study||4
8284355|NCT01653743|20425017|P2|COMPLETED|Overall Study||27
8284356|NCT01653743|20425018|P1|COMPLETED|Overall Study||50
8284357|NCT01653743|20425017|P2|STARTED|Overall Study||27
8284358|NCT01653743|20425018|P1|STARTED|Overall Study||54
8284359|NCT01653704|20425034|P2|NOT COMPLETED|Overall Study||1
8284360|NCT01653704|20425035|P1|NOT COMPLETED|Overall Study||2
8284361|NCT01653704|20425034|P2|COMPLETED|Overall Study||20
8284362|NCT01653704|20425035|P1|COMPLETED|Overall Study||19
8284363|NCT01653704|20425034|P2|STARTED|Overall Study||21
8284364|NCT01653704|20425035|P1|STARTED|Overall Study||21
8284365|NCT01653587|20425043|P2|NOT COMPLETED|Overall Study||0
8284366|NCT01653587|20425044|P1|NOT COMPLETED|Overall Study||0
8284367|NCT01653587|20425043|P2|COMPLETED|Overall Study||120
8284368|NCT01653587|20425044|P1|COMPLETED|Overall Study||120
8284369|NCT01653587|20425043|P2|STARTED|Overall Study||120
8284370|NCT01653587|20425044|P1|STARTED|Overall Study||120
8284371|NCT01653509|20425056|P2|NOT COMPLETED|Overall Study||0
8284372|NCT01653509|20425057|P1|NOT COMPLETED|Overall Study||0
8284373|NCT01653509|20425056|P2|COMPLETED|Overall Study||13
8284374|NCT01653509|20425057|P1|COMPLETED|Overall Study||12
8284375|NCT01653509|20425056|P2|STARTED|Overall Study||13
8284376|NCT01653509|20425057|P1|STARTED|Overall Study||12
8284377|NCT01653418|20425075|P1|NOT COMPLETED|Overall Study||0
8284378|NCT01653418|20425075|P1|COMPLETED|Overall Study||10
8284379|NCT01653418|20425075|P1|STARTED|Overall Study||10
8284380|NCT01653405|20425089|P2|NOT COMPLETED|Overall Study||1068803
8284381|NCT01653405|20425090|P1|NOT COMPLETED|Overall Study||3765
8284382|NCT01653405|20425089|P2|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
8284383|NCT01653405|20425090|P1|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
8284384|NCT01653405|20425089|P2|STARTED|Overall Study||1248782
8284385|NCT01653405|20425090|P1|STARTED|Overall Study||11794
8284386|NCT01653327|20425104|P1|NOT COMPLETED|Overall Study||1
8284387|NCT01653327|20425104|P1|COMPLETED|Overall Study||10
8284388|NCT01653327|20425104|P1|STARTED|Overall Study||11
8284389|NCT01653288|20425114|P2|NOT COMPLETED|Overall Study||1
8284390|NCT01653288|20425115|P1|NOT COMPLETED|Overall Study||10
8284391|NCT01653288|20425114|P2|COMPLETED|Overall Study||35
8284392|NCT01653288|20425115|P1|COMPLETED|Overall Study||26
8284393|NCT01653288|20425114|P2|STARTED|Overall Study||36
8284394|NCT01653288|20425115|P1|STARTED|Overall Study||36
8284396|NCT01653262|20425129|P1|COMPLETED|Overall Study||26
8284397|NCT01653262|20425129|P1|STARTED|Overall Study||29
8284398|NCT01653210|20425142|P1|NOT COMPLETED|Overall Study||3
8284399|NCT01653210|20425142|P1|COMPLETED|Overall Study||12
8284400|NCT01653210|20425142|P1|STARTED|Overall Study||15
8284401|NCT01653158|20425147|P8|NOT COMPLETED|Overall Study||15
8284402|NCT01653158|20425148|P7|NOT COMPLETED|Overall Study||2
8284403|NCT01653158|20425149|P6|NOT COMPLETED|Overall Study||1
8284404|NCT01653158|20425150|P5|NOT COMPLETED|Overall Study||1
8284405|NCT01653158|20425151|P4|NOT COMPLETED|Overall Study||2
8284406|NCT01653158|20425152|P3|NOT COMPLETED|Overall Study||0
8284407|NCT01653158|20425153|P2|NOT COMPLETED|Overall Study||0
8284408|NCT01653158|20425154|P1|NOT COMPLETED|Overall Study||1
8284409|NCT01653158|20425147|P8|COMPLETED|Overall Study||4
8284410|NCT01653158|20425148|P7|COMPLETED|Overall Study||7
8284411|NCT01653158|20425149|P6|COMPLETED|Overall Study||2
8284412|NCT01653158|20425150|P5|COMPLETED|Overall Study||2
8284413|NCT01653158|20425151|P4|COMPLETED|Overall Study||1
8284414|NCT01653158|20425152|P3|COMPLETED|Overall Study||3
8284415|NCT01653158|20425153|P2|COMPLETED|Overall Study||3
8284416|NCT01653158|20425154|P1|COMPLETED|Overall Study||2
8284417|NCT01653158|20425147|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
8284418|NCT01653158|20425148|P7|STARTED|Overall Study||9
8284419|NCT01653158|20425149|P6|STARTED|Overall Study||3
8284420|NCT01653158|20425150|P5|STARTED|Overall Study||3
8284421|NCT01653158|20425151|P4|STARTED|Overall Study||3
8284422|NCT01653158|20425152|P3|STARTED|Overall Study||3
8284423|NCT01653158|20425153|P2|STARTED|Overall Study||3
8284424|NCT01653158|20425154|P1|STARTED|Overall Study||3
8284425|NCT01653132|20425426|P2|NOT COMPLETED|Second Intervention||0
8284426|NCT01653132|20425427|P1|NOT COMPLETED|Second Intervention||0
8284427|NCT01653132|20425426|P2|COMPLETED|Second Intervention||5
8284428|NCT01653132|20425427|P1|COMPLETED|Second Intervention||4
8284429|NCT01653132|20425426|P2|STARTED|Second Intervention||5
8284430|NCT01653132|20425427|P1|STARTED|Second Intervention||4
8284431|NCT01653132|20425426|P2|NOT COMPLETED|Washout 1-2 Months||0
8284432|NCT01653132|20425427|P1|NOT COMPLETED|Washout 1-2 Months||0
8284433|NCT01653132|20425426|P2|COMPLETED|Washout 1-2 Months||5
8284434|NCT01653132|20425427|P1|COMPLETED|Washout 1-2 Months||4
8284435|NCT01653132|20425426|P2|STARTED|Washout 1-2 Months||5
8284436|NCT01653132|20425427|P1|STARTED|Washout 1-2 Months||4
8284437|NCT01653132|20425426|P2|NOT COMPLETED|First Intervention||0
8284438|NCT01653132|20425427|P1|NOT COMPLETED|First Intervention||1
8284439|NCT01653132|20425426|P2|COMPLETED|First Intervention||5
8284440|NCT01653132|20425427|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
8284441|NCT01653132|20425426|P2|STARTED|First Intervention||5
8284442|NCT01653132|20425427|P1|STARTED|First Intervention||5
8284443|NCT01653028|20425446|P5|NOT COMPLETED|Overall Study||0
8284444|NCT01653028|20425447|P4|NOT COMPLETED|Overall Study||0
8284445|NCT01653028|20425448|P3|NOT COMPLETED|Overall Study||0
8284446|NCT01653028|20425449|P2|NOT COMPLETED|Overall Study||0
8284447|NCT01653028|20425450|P1|NOT COMPLETED|Overall Study||0
8284448|NCT01653028|20425446|P5|COMPLETED|Overall Study||29
8284449|NCT01653028|20425447|P4|COMPLETED|Overall Study||10
8284450|NCT01653028|20425448|P3|COMPLETED|Overall Study||11
8284451|NCT01653028|20425449|P2|COMPLETED|Overall Study||10
8284452|NCT01653028|20425450|P1|COMPLETED|Overall Study||12
8284453|NCT01653028|20425446|P5|STARTED|Overall Study||29
8284454|NCT01653028|20425447|P4|STARTED|Overall Study||10
8284455|NCT01653028|20425448|P3|STARTED|Overall Study||11
8284456|NCT01653028|20425449|P2|STARTED|Overall Study||10
8284457|NCT01653028|20425450|P1|STARTED|Overall Study||12
8284458|NCT01652976|20425477|P1|NOT COMPLETED|Overall Study||0
8284459|NCT01652976|20425477|P1|COMPLETED|Overall Study||44
8284460|NCT01652976|20425477|P1|STARTED|Overall Study||44
8284461|NCT01652885|20425491|P1|NOT COMPLETED|Overall Study||1
8284462|NCT01652885|20425491|P1|COMPLETED|Overall Study||22
8284463|NCT01652885|20425491|P1|STARTED|Overall Study||23
8284464|NCT01652872|20425518|P2|NOT COMPLETED|Overall Study||153
8284465|NCT01652872|20425519|P1|NOT COMPLETED|Overall Study||145
8284466|NCT01652872|20425518|P2|COMPLETED|Overall Study||226
8284467|NCT01652872|20425519|P1|COMPLETED|Overall Study||232
8284468|NCT01652872|20425518|P2|Received Investigational Product|Overall Study||377
8284469|NCT01652872|20425519|P1|Received Investigational Product|Overall Study||377
8284470|NCT01652872|20425518|P2|STARTED|Overall Study||379
8284471|NCT01652872|20425519|P1|STARTED|Overall Study||377
8284472|NCT01652729|20425536|P3|NOT COMPLETED|Overall Study||14
8284473|NCT01652729|20425537|P2|NOT COMPLETED|Overall Study||13
8284474|NCT01652729|20425538|P1|NOT COMPLETED|Overall Study||27
8284475|NCT01652729|20425536|P3|COMPLETED|Overall Study||47
8284476|NCT01652729|20425537|P2|COMPLETED|Overall Study||109
8284477|NCT01652729|20425538|P1|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
8284478|NCT01652729|20425536|P3|Meal Test Evaluable|Overall Study||15
8284479|NCT01652729|20425537|P2|Meal Test Evaluable|Overall Study||31
8284480|NCT01652729|20425538|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
8284481|NCT01652729|20425536|P3|Meal Test Subjects|Overall Study||20
8284482|NCT01652729|20425537|P2|Meal Test Subjects|Overall Study||41
8284483|NCT01652729|20425538|P1|Meal Test Subjects|Overall Study||60
8284484|NCT01652729|20425536|P3|Evaluable|Overall Study||43
8284485|NCT01652729|20425537|P2|Evaluable|Overall Study||91
8284486|NCT01652729|20425538|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
8284487|NCT01652729|20425536|P3|Treated|Overall Study||61
8284488|NCT01652729|20425537|P2|Treated|Overall Study||122
8284489|NCT01652729|20425538|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
8284490|NCT01652729|20425536|P3|Modified Intent-to-Treat|Overall Study||61
8284491|NCT01652729|20425537|P2|Modified Intent-to-Treat|Overall Study||122
8284492|NCT01652729|20425538|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
8284493|NCT01652729|20425536|P3|STARTED|Overall Study||61
8284494|NCT01652729|20425537|P2|STARTED|Overall Study||122
8284495|NCT01652729|20425538|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
8284496|NCT01652716|20425560|P2|NOT COMPLETED|Overall Study||46
8284497|NCT01652716|20425561|P1|NOT COMPLETED|Overall Study||56
8284498|NCT01652716|20425560|P2|COMPLETED|Overall Study|* completed study|102
8284499|NCT01652716|20425561|P1|COMPLETED|Overall Study|* completed study|173
8284500|NCT01652716|20425560|P2|Completed 28-week|Overall Study||118
8284501|NCT01652716|20425561|P1|Completed 28-week|Overall Study||197
8284502|NCT01652716|20425560|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
8284503|NCT01652716|20425561|P1|STARTED|Overall Study||229
8284504|NCT01652703|20425581|P6|NOT COMPLETED|Overall Study||2
8284505|NCT01652703|20425582|P5|NOT COMPLETED|Overall Study||1
8284506|NCT01652703|20425583|P4|NOT COMPLETED|Overall Study||2
8284507|NCT01652703|20425584|P3|NOT COMPLETED|Overall Study||3
8284508|NCT01652703|20425585|P2|NOT COMPLETED|Overall Study||1
8284509|NCT01652703|20425586|P1|NOT COMPLETED|Overall Study||0
8284510|NCT01652703|20425581|P6|COMPLETED|Overall Study||51
8284511|NCT01652703|20425582|P5|COMPLETED|Overall Study||51
8284512|NCT01652703|20425583|P4|COMPLETED|Overall Study||50
8284513|NCT01652703|20425584|P3|COMPLETED|Overall Study||47
8284514|NCT01652703|20425585|P2|COMPLETED|Overall Study||50
8284515|NCT01652703|20425586|P1|COMPLETED|Overall Study||52
8284516|NCT01652703|20425581|P6|Received Treatment|Overall Study||53
8284517|NCT01652703|20425582|P5|Received Treatment|Overall Study||51
8284518|NCT01652703|20425583|P4|Received Treatment|Overall Study||52
8284519|NCT01652703|20425584|P3|Received Treatment|Overall Study||49
8284520|NCT01652703|20425585|P2|Received Treatment|Overall Study||50
8284521|NCT01652703|20425586|P1|Received Treatment|Overall Study||52
8284522|NCT01652703|20425581|P6|STARTED|Overall Study||53
8284523|NCT01652703|20425582|P5|STARTED|Overall Study||52
8284524|NCT01652703|20425583|P4|STARTED|Overall Study||52
8284525|NCT01652703|20425584|P3|STARTED|Overall Study||50
8284526|NCT01652703|20425585|P2|STARTED|Overall Study||51
8284527|NCT01652703|20425586|P1|STARTED|Overall Study||52
8284528|NCT01652690|20425644|P2|NOT COMPLETED|Overall Study||21
8284529|NCT01652690|20425645|P1|NOT COMPLETED|Overall Study||35
8284530|NCT01652690|20425644|P2|COMPLETED|Overall Study||279
8284531|NCT01652690|20425645|P1|COMPLETED|Overall Study||265
8284532|NCT01652690|20425644|P2|STARTED|Overall Study||300
8284533|NCT01652690|20425645|P1|STARTED|Overall Study||300
8284534|NCT01652664|20425679|P2|NOT COMPLETED|Overall Study||1
8284535|NCT01652664|20425680|P1|NOT COMPLETED|Overall Study||6
8284536|NCT01652664|20425679|P2|COMPLETED|Overall Study||74
8284537|NCT01652664|20425680|P1|COMPLETED|Overall Study||71
8284538|NCT01652664|20425679|P2|STARTED|Overall Study||75
8284539|NCT01652664|20425680|P1|STARTED|Overall Study||77
8284540|NCT01652573|20425689|P2|NOT COMPLETED|Overall Study||1
8284541|NCT01652573|20425690|P1|NOT COMPLETED|Overall Study||0
8284542|NCT01652573|20425689|P2|COMPLETED|Overall Study||10
8284543|NCT01652573|20425690|P1|COMPLETED|Overall Study||10
8284544|NCT01652573|20425689|P2|STARTED|Overall Study||11
8284545|NCT01652573|20425690|P1|STARTED|Overall Study||10
8284546|NCT01652534|20425732|P2|NOT COMPLETED|Overall Study||0
8284547|NCT01652534|20425733|P1|NOT COMPLETED|Overall Study||1
8284548|NCT01652534|20425732|P2|COMPLETED|Overall Study||1
8284549|NCT01652534|20425733|P1|COMPLETED|Overall Study||1
8284550|NCT01652534|20425732|P2|STARTED|Overall Study||1
8284551|NCT01652534|20425733|P1|STARTED|Overall Study||2
8284552|NCT01652495|20425761|P2|NOT COMPLETED|Overall Study||2
8284553|NCT01652495|20425762|P1|NOT COMPLETED|Overall Study||2
8284554|NCT01652495|20425761|P2|COMPLETED|Overall Study||20
8284555|NCT01652495|20425762|P1|COMPLETED|Overall Study||20
8284556|NCT01652495|20425761|P2|STARTED|Overall Study||22
8284557|NCT01652495|20425762|P1|STARTED|Overall Study||22
8284558|NCT01652469|20425774|P2|NOT COMPLETED|Overall Study||6
8284559|NCT01652469|20425775|P1|NOT COMPLETED|Overall Study||1
8284560|NCT01652469|20425774|P2|COMPLETED|Overall Study||36
8284561|NCT01652469|20425775|P1|COMPLETED|Overall Study||37
8284562|NCT01652469|20425774|P2|STARTED|Overall Study||42
8284563|NCT01652469|20425775|P1|STARTED|Overall Study||38
8284564|NCT01652287|20425791|P2|NOT COMPLETED|Overall Study||0
8284565|NCT01652287|20425792|P1|NOT COMPLETED|Overall Study||2
8284566|NCT01652287|20425791|P2|COMPLETED|Overall Study||31
8284567|NCT01652287|20425792|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
8284568|NCT01652287|20425791|P2|STARTED|Overall Study||31
8284569|NCT01652287|20425792|P1|STARTED|Overall Study||31
8284570|NCT01652040|20425800|P2|NOT COMPLETED|Overall Study||2
8284571|NCT01652040|20425801|P1|NOT COMPLETED|Overall Study||2
8284572|NCT01652040|20425800|P2|COMPLETED|Overall Study||11
8284573|NCT01652040|20425801|P1|COMPLETED|Overall Study||11
8284574|NCT01652040|20425800|P2|STARTED|Overall Study||13
8284575|NCT01652040|20425801|P1|STARTED|Overall Study||13
8284576|NCT01652001|20425811|P2|NOT COMPLETED|Overall Study||6
8284577|NCT01652001|20425812|P1|NOT COMPLETED|Overall Study||9
8284578|NCT01652001|20425811|P2|COMPLETED|Overall Study||79
8284579|NCT01652001|20425812|P1|COMPLETED|Overall Study||91
8284580|NCT01652001|20425811|P2|STARTED|Overall Study||85
8284581|NCT01652001|20425812|P1|STARTED|Overall Study||100
8284582|NCT01651949|20425823|P3|NOT COMPLETED|Overall Study||31
8284583|NCT01651949|20425824|P2|NOT COMPLETED|Overall Study||86
8284584|NCT01651949|20425825|P1|NOT COMPLETED|Overall Study||53
8284585|NCT01651949|20425823|P3|COMPLETED|Overall Study||282
8284586|NCT01651949|20425824|P2|COMPLETED|Overall Study||1015
8284587|NCT01651949|20425825|P1|COMPLETED|Overall Study||1053
8284588|NCT01651949|20425823|P3|Vaccination 3|Overall Study||291
8284589|NCT01651949|20425824|P2|Vaccination 3|Overall Study||1037
8284590|NCT01651949|20425825|P1|Vaccination 3|Overall Study||1067
8284591|NCT01651949|20425823|P3|Vaccination 2|Overall Study||298
8284592|NCT01651949|20425824|P2|Vaccination 2|Overall Study||1069
8284593|NCT01651949|20425825|P1|Vaccination 2|Overall Study||1089
8284594|NCT01651949|20425823|P3|Vaccination 1|Overall Study||313
8284595|NCT01651949|20425824|P2|Vaccination 1|Overall Study||1099
8284596|NCT01651949|20425825|P1|Vaccination 1|Overall Study||1103
8284597|NCT01651949|20425823|P3|STARTED|Overall Study||313
8284598|NCT01651949|20425824|P2|STARTED|Overall Study||1101
8284599|NCT01651949|20425825|P1|STARTED|Overall Study||1106
8284600|NCT01651936|20425845|P3|NOT COMPLETED|Extension Study||14
8284601|NCT01651936|20425846|P2|NOT COMPLETED|Extension Study||0
8284602|NCT01651936|20425847|P1|NOT COMPLETED|Extension Study||0
8284603|NCT01651936|20425845|P3|COMPLETED|Extension Study||0
8284604|NCT01651936|20425846|P2|COMPLETED|Extension Study||0
8284605|NCT01651936|20425847|P1|COMPLETED|Extension Study||0
8284606|NCT01651936|20425845|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
8284607|NCT01651936|20425846|P2|STARTED|Extension Study||0
8284608|NCT01651936|20425847|P1|STARTED|Extension Study||0
8284609|NCT01651936|20425845|P3|NOT COMPLETED|Base Study||0
8284610|NCT01651936|20425846|P2|NOT COMPLETED|Base Study||25
8284611|NCT01651936|20425847|P1|NOT COMPLETED|Base Study||27
8284612|NCT01651936|20425845|P3|COMPLETED|Base Study||0
8284613|NCT01651936|20425846|P2|COMPLETED|Base Study||1
8284614|NCT01651936|20425847|P1|COMPLETED|Base Study||3
8284615|NCT01651936|20425845|P3|STARTED|Base Study||0
8284616|NCT01651936|20425846|P2|STARTED|Base Study||26
8284617|NCT01651936|20425847|P1|STARTED|Base Study||30
8284618|NCT01651806|20425873|P5|NOT COMPLETED|Overall Study||0
8284619|NCT01651806|20425874|P4|NOT COMPLETED|Overall Study||0
8284620|NCT01651806|20425875|P3|NOT COMPLETED|Overall Study||0
8284621|NCT01651806|20425876|P2|NOT COMPLETED|Overall Study||0
8284622|NCT01651806|20425877|P1|NOT COMPLETED|Overall Study||0
8284623|NCT01651806|20425873|P5|COMPLETED|Overall Study||8
8284624|NCT01651806|20425874|P4|COMPLETED|Overall Study||7
8284625|NCT01651806|20425875|P3|COMPLETED|Overall Study||25
8284626|NCT01651806|20425876|P2|COMPLETED|Overall Study||12
8284627|NCT01651806|20425877|P1|COMPLETED|Overall Study||13
8284628|NCT01651806|20425873|P5|STARTED|Overall Study||8
8284629|NCT01651806|20425874|P4|STARTED|Overall Study||7
8284630|NCT01651806|20425875|P3|STARTED|Overall Study||25
8284631|NCT01651806|20425876|P2|STARTED|Overall Study||12
8284632|NCT01651806|20425877|P1|STARTED|Overall Study||13
8284633|NCT01651793|20425894|P4|NOT COMPLETED|Overall Study||1
8284634|NCT01651793|20425895|P3|NOT COMPLETED|Overall Study||0
8284635|NCT01651793|20425896|P2|NOT COMPLETED|Overall Study||0
8284636|NCT01651793|20425897|P1|NOT COMPLETED|Overall Study||0
8284637|NCT01651793|20425894|P4|COMPLETED|Overall Study||5
8284638|NCT01651793|20425895|P3|COMPLETED|Overall Study||6
8284639|NCT01651793|20425896|P2|COMPLETED|Overall Study||6
8284640|NCT01651793|20425897|P1|COMPLETED|Overall Study||6
8284641|NCT01651793|20425894|P4|STARTED|Overall Study||6
8284642|NCT01651793|20425895|P3|STARTED|Overall Study||6
8284643|NCT01651793|20425896|P2|STARTED|Overall Study||6
8284644|NCT01651793|20425897|P1|STARTED|Overall Study||6
8284645|NCT01651780|20425917|P2|NOT COMPLETED|Overall Study||10
8284646|NCT01651780|20425918|P1|NOT COMPLETED|Overall Study||11
8284647|NCT01651780|20425917|P2|COMPLETED|Overall Study||388
8284648|NCT01651780|20425918|P1|COMPLETED|Overall Study||394
8284649|NCT01651780|20425917|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
8284650|NCT01651780|20425918|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
8284651|NCT01651780|20425917|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
8284652|NCT01651780|20425918|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
8284653|NCT01651780|20425917|P2|Intent-To-Treat (ITT) Population|Overall Study||398
8284654|NCT01651780|20425918|P1|Intent-To-Treat (ITT) Population|Overall Study||404
8284655|NCT01651780|20425917|P2|STARTED|Overall Study||398
8284656|NCT01651780|20425918|P1|STARTED|Overall Study||405
8284657|NCT01651442|20425950|P6|NOT COMPLETED|Phase II Treatment||10
8284658|NCT01651442|20425951|P5|NOT COMPLETED|Phase II Treatment||6
8284659|NCT01651442|20425952|P4|NOT COMPLETED|Phase II Treatment||12
8284660|NCT01651442|20425953|P3|NOT COMPLETED|Phase II Treatment||2
8284661|NCT01651442|20425954|P2|NOT COMPLETED|Phase II Treatment||0
8284662|NCT01651442|20425955|P1|NOT COMPLETED|Phase II Treatment||0
8284663|NCT01651442|20425950|P6|COMPLETED|Phase II Treatment||17
8284664|NCT01651442|20425951|P5|COMPLETED|Phase II Treatment||21
8284665|NCT01651442|20425952|P4|COMPLETED|Phase II Treatment||15
8284666|NCT01651442|20425953|P3|COMPLETED|Phase II Treatment||25
8284667|NCT01651442|20425954|P2|COMPLETED|Phase II Treatment||0
8284668|NCT01651442|20425955|P1|COMPLETED|Phase II Treatment||0
8284669|NCT01651442|20425950|P6|STARTED|Phase II Treatment||27
8284670|NCT01651442|20425951|P5|STARTED|Phase II Treatment||27
8284671|NCT01651442|20425952|P4|STARTED|Phase II Treatment||27
8284672|NCT01651442|20425953|P3|STARTED|Phase II Treatment||27
8284673|NCT01651442|20425954|P2|STARTED|Phase II Treatment||0
8284674|NCT01651442|20425955|P1|STARTED|Phase II Treatment||0
8284675|NCT01651442|20425950|P6|NOT COMPLETED|Phase I Treatment||0
8284676|NCT01651442|20425951|P5|NOT COMPLETED|Phase I Treatment||0
8284677|NCT01651442|20425952|P4|NOT COMPLETED|Phase I Treatment||0
8284678|NCT01651442|20425953|P3|NOT COMPLETED|Phase I Treatment||0
8284679|NCT01651442|20425954|P2|NOT COMPLETED|Phase I Treatment||27
8284680|NCT01651442|20425955|P1|NOT COMPLETED|Phase I Treatment||16
8284681|NCT01651442|20425950|P6|COMPLETED|Phase I Treatment||0
8284682|NCT01651442|20425951|P5|COMPLETED|Phase I Treatment||0
8284683|NCT01651442|20425952|P4|COMPLETED|Phase I Treatment||0
8284684|NCT01651442|20425953|P3|COMPLETED|Phase I Treatment||0
8284685|NCT01651442|20425954|P2|COMPLETED|Phase I Treatment||80
8284686|NCT01651442|20425955|P1|COMPLETED|Phase I Treatment||88
8284687|NCT01651442|20425950|P6|STARTED|Phase I Treatment||0
8284688|NCT01651442|20425951|P5|STARTED|Phase I Treatment||0
8284689|NCT01651442|20425952|P4|STARTED|Phase I Treatment||0
8284690|NCT01651442|20425953|P3|STARTED|Phase I Treatment||0
8284691|NCT01651442|20425954|P2|STARTED|Phase I Treatment||107
8284692|NCT01651442|20425955|P1|STARTED|Phase I Treatment||104
8284693|NCT01651403|20425969|P2|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||16
8284694|NCT01651403|20425970|P1|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||27
8284695|NCT01651403|20425969|P2|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||9
8284696|NCT01651403|20425970|P1|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||29
8284697|NCT01651403|20425969|P2|STARTED|Open-Label Phase (Weeks 49/73-120/144)|1 participant completed the Double-Blind Period but did not enter the Open-Label Phase.|25
8284698|NCT01651403|20425970|P1|STARTED|Open-Label Phase (Weeks 49/73-120/144)||56
8284699|NCT01651403|20425969|P2|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
8284700|NCT01651403|20425970|P1|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
8284701|NCT01651403|20425969|P2|COMPLETED|Double-Blind Period (Through Week 48/72)||26
8284702|NCT01651403|20425970|P1|COMPLETED|Double-Blind Period (Through Week 48/72)||56
8284703|NCT01651403|20425969|P2|STARTED|Double-Blind Period (Through Week 48/72)||30
8284704|NCT01651403|20425970|P1|STARTED|Double-Blind Period (Through Week 48/72)||60
8284705|NCT01651351|20426002|P2|NOT COMPLETED|Overall Study||0
8284706|NCT01651351|20426003|P1|NOT COMPLETED|Overall Study||0
8284707|NCT01651351|20426002|P2|COMPLETED|Overall Study||15
8284708|NCT01651351|20426003|P1|COMPLETED|Overall Study||15
8284709|NCT01651351|20426002|P2|STARTED|Overall Study||15
8284710|NCT01651351|20426003|P1|STARTED|Overall Study||15
8284711|NCT01651260|20426020|P1|NOT COMPLETED|Overall Study||3
8284712|NCT01651260|20426020|P1|COMPLETED|Overall Study||62
8284713|NCT01651260|20426020|P1|STARTED|Overall Study||65
8284714|NCT01651208|20426027|P2|NOT COMPLETED|Overall Study||16
8284715|NCT01651208|20426028|P1|NOT COMPLETED|Overall Study||14
8284716|NCT01651208|20426027|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
8284717|NCT01651208|20426028|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
8284718|NCT01651208|20426027|P2|STARTED|Overall Study||225
8284719|NCT01651208|20426028|P1|STARTED|Overall Study||227
8284720|NCT01651117|20426040|P4|NOT COMPLETED|Overall Study||2
8284721|NCT01651117|20426041|P3|NOT COMPLETED|Overall Study||2
8284722|NCT01651117|20426042|P2|NOT COMPLETED|Overall Study||3
8284723|NCT01651117|20426043|P1|NOT COMPLETED|Overall Study||2
8284724|NCT01651117|20426040|P4|COMPLETED|Overall Study||68
8284725|NCT01651117|20426041|P3|COMPLETED|Overall Study||47
8284726|NCT01651117|20426042|P2|COMPLETED|Overall Study||202
8284727|NCT01651117|20426043|P1|COMPLETED|Overall Study||154
8284728|NCT01651117|20426040|P4|STARTED|Overall Study||70
8284729|NCT01651117|20426041|P3|STARTED|Overall Study||49
8284730|NCT01651117|20426042|P2|STARTED|Overall Study||205
8284731|NCT01651117|20426043|P1|STARTED|Overall Study||156
8284732|NCT01651104|20426109|P1|NOT COMPLETED|Overall Study||0
8284733|NCT01651104|20426109|P1|COMPLETED|Overall Study||63
8284734|NCT01651104|20426109|P1|STARTED|Overall Study||63
8284735|NCT01651078|20426116|P1|NOT COMPLETED|Overall Study||26
8284736|NCT01651078|20426116|P1|COMPLETED|Overall Study||16
8284737|NCT01651078|20426116|P1|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
8284738|NCT01651052|20426123|P1|NOT COMPLETED|Overall Study||26
8284739|NCT01651052|20426123|P1|COMPLETED|Overall Study||107
8284740|NCT01651052|20426123|P1|Study Valve Group|Overall Study||133
8284741|NCT01651052|20426123|P1|STARTED|Overall Study||133
8284742|NCT01651039|20426143|P1|NOT COMPLETED|Overall Study||30
8284743|NCT01651039|20426143|P1|COMPLETED|Overall Study||2
8284744|NCT01651039|20426143|P1|STARTED|Overall Study||32
8284745|NCT01651000|20426156|P2|NOT COMPLETED|Overall Study||28
8284746|NCT01651000|20426157|P1|NOT COMPLETED|Overall Study||10
8284747|NCT01651000|20426156|P2|COMPLETED|Overall Study||113
8284748|NCT01651000|20426157|P1|COMPLETED|Overall Study||62
8284749|NCT01651000|20426156|P2|Entered Extension Study|Overall Study||93
8284750|NCT01651000|20426157|P1|Entered Extension Study|Overall Study||50
8284751|NCT01651000|20426156|P2|STARTED|Overall Study||141
8284752|NCT01651000|20426157|P1|STARTED|Overall Study||72
8284753|NCT01650844|20426171|P2|NOT COMPLETED|Overall Study||4
8284754|NCT01650844|20426172|P1|NOT COMPLETED|Overall Study||1
8284755|NCT01650844|20426171|P2|COMPLETED|Overall Study||196
8284756|NCT01650844|20426172|P1|COMPLETED|Overall Study||199
8284757|NCT01650844|20426171|P2|STARTED|Overall Study||200
8284758|NCT01650844|20426172|P1|STARTED|Overall Study||200
8284759|NCT01650831|20426178|P1|NOT COMPLETED|Overall Study||1
8284760|NCT01650831|20426178|P1|COMPLETED|Overall Study||112
8284761|NCT01650831|20426178|P1|STARTED|Overall Study||113
8284762|NCT01650805|20426188|P2|NOT COMPLETED|Overall Study||0
8284763|NCT01650805|20426189|P1|NOT COMPLETED|Overall Study||1
8284764|NCT01650805|20426188|P2|COMPLETED|Overall Study||152
8284765|NCT01650805|20426189|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
8284766|NCT01650805|20426188|P2|STARTED|Overall Study||152
8284767|NCT01650805|20426189|P1|STARTED|Overall Study|Started means patient has been randomized.|155
8284768|NCT01650779|20426199|P1|NOT COMPLETED|Overall Study||1
8284769|NCT01650779|20426199|P1|COMPLETED|Overall Study||14
8284770|NCT01650779|20426199|P1|STARTED|Overall Study||15
8284771|NCT01650636|20426208|P2|NOT COMPLETED|9 Month Visit||0
8284772|NCT01650636|20426209|P1|NOT COMPLETED|9 Month Visit||0
8284773|NCT01650636|20426208|P2|COMPLETED|9 Month Visit||129
8284774|NCT01650636|20426209|P1|COMPLETED|9 Month Visit||135
8284775|NCT01650636|20426208|P2|STARTED|9 Month Visit||129
8284776|NCT01650636|20426209|P1|STARTED|9 Month Visit||135
8284777|NCT01650636|20426208|P2|NOT COMPLETED|Washout up to 9 Months||3
8284778|NCT01650636|20426209|P1|NOT COMPLETED|Washout up to 9 Months||6
8284779|NCT01650636|20426208|P2|COMPLETED|Washout up to 9 Months||129
8284780|NCT01650636|20426209|P1|COMPLETED|Washout up to 9 Months||135
8284781|NCT01650636|20426208|P2|STARTED|Washout up to 9 Months||132
8284782|NCT01650636|20426209|P1|STARTED|Washout up to 9 Months||141
8284783|NCT01650636|20426208|P2|NOT COMPLETED|5 Month Visit||0
8284784|NCT01650636|20426209|P1|NOT COMPLETED|5 Month Visit||0
8284785|NCT01650636|20426208|P2|COMPLETED|5 Month Visit||132
8284786|NCT01650636|20426209|P1|COMPLETED|5 Month Visit||141
8284787|NCT01650636|20426208|P2|STARTED|5 Month Visit||132
8284788|NCT01650636|20426209|P1|STARTED|5 Month Visit||141
8284789|NCT01650636|20426208|P2|NOT COMPLETED|Washout up to 5 Months||18
8284790|NCT01650636|20426209|P1|NOT COMPLETED|Washout up to 5 Months||9
8284791|NCT01650636|20426208|P2|COMPLETED|Washout up to 5 Months||132
8284792|NCT01650636|20426209|P1|COMPLETED|Washout up to 5 Months||141
8284793|NCT01650636|20426208|P2|STARTED|Washout up to 5 Months||150
8284794|NCT01650636|20426209|P1|STARTED|Washout up to 5 Months||150
8284795|NCT01650636|20426208|P2|NOT COMPLETED|Intervention Phase||0
8284796|NCT01650636|20426209|P1|NOT COMPLETED|Intervention Phase||0
8284797|NCT01650636|20426208|P2|COMPLETED|Intervention Phase||150
8284798|NCT01650636|20426209|P1|COMPLETED|Intervention Phase||150
8284799|NCT01650636|20426208|P2|STARTED|Intervention Phase||150
8284800|NCT01650636|20426209|P1|STARTED|Intervention Phase||150
8284801|NCT01650584|20426229|P1|NOT COMPLETED|Overall Study||0
8284802|NCT01650584|20426229|P1|COMPLETED|Overall Study||35
8284803|NCT01650584|20426229|P1|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
8284804|NCT01650545|20426236|P2|NOT COMPLETED|Overall Study||0
8284805|NCT01650545|20426237|P1|NOT COMPLETED|Overall Study||0
8284806|NCT01650545|20426236|P2|COMPLETED|Overall Study||10
8284807|NCT01650545|20426237|P1|COMPLETED|Overall Study||11
8284808|NCT01650545|20426236|P2|STARTED|Overall Study||10
8284809|NCT01650545|20426237|P1|STARTED|Overall Study||11
8284810|NCT01650519|20426249|P2|NOT COMPLETED|Overall Study||0
8284811|NCT01650519|20426250|P1|NOT COMPLETED|Overall Study||1
8284812|NCT01650519|20426249|P2|COMPLETED|Overall Study||31
8284813|NCT01650519|20426250|P1|COMPLETED|Overall Study||19
8284814|NCT01650519|20426249|P2|STARTED|Overall Study||31
8284815|NCT01650519|20426250|P1|STARTED|Overall Study||20
8284816|NCT01650402|20426270|P2|NOT COMPLETED|Overall Study||14
8284817|NCT01650402|20426271|P1|NOT COMPLETED|Overall Study||20
8284818|NCT01650402|20426270|P2|COMPLETED|Overall Study||86
8284819|NCT01650402|20426271|P1|COMPLETED|Overall Study||79
8284820|NCT01650402|20426270|P2|STARTED|Overall Study||100
8284821|NCT01650402|20426271|P1|STARTED|Overall Study||99
8284822|NCT01650350|20426279|P1|NOT COMPLETED|Overall Study||0
8284823|NCT01650350|20426279|P1|COMPLETED|Overall Study||7
8284824|NCT01650350|20426279|P1|STARTED|Overall Study||7
8284825|NCT01650324|20426290|P5|NOT COMPLETED|Overall Study||0
8284826|NCT01650324|20426291|P4|NOT COMPLETED|Overall Study||0
8284827|NCT01650324|20426292|P3|NOT COMPLETED|Overall Study||0
8284828|NCT01650324|20426293|P2|NOT COMPLETED|Overall Study||0
8284829|NCT01650324|20426294|P1|NOT COMPLETED|Overall Study||0
8284830|NCT01650324|20426290|P5|COMPLETED|Overall Study||6
8284831|NCT01650324|20426291|P4|COMPLETED|Overall Study||6
8284832|NCT01650324|20426292|P3|COMPLETED|Overall Study||6
8284833|NCT01650324|20426293|P2|COMPLETED|Overall Study||6
8284834|NCT01650324|20426294|P1|COMPLETED|Overall Study||8
8284835|NCT01650324|20426290|P5|STARTED|Overall Study||6
8284836|NCT01650324|20426291|P4|STARTED|Overall Study||6
8284837|NCT01650324|20426292|P3|STARTED|Overall Study||6
8284838|NCT01650324|20426293|P2|STARTED|Overall Study||6
8284839|NCT01650324|20426294|P1|STARTED|Overall Study||8
8284840|NCT01650298|20426325|P2|NOT COMPLETED|Overall Study||6
8284841|NCT01650298|20426326|P1|NOT COMPLETED|Overall Study||5
8284842|NCT01650298|20426325|P2|COMPLETED|Overall Study||42
8284843|NCT01650298|20426326|P1|COMPLETED|Overall Study||11
8284844|NCT01650298|20426325|P2|STARTED|Overall Study||48
8284845|NCT01650298|20426326|P1|STARTED|Overall Study||16
8284846|NCT01650285|20426332|P1|NOT COMPLETED|Overall Study||1
8284847|NCT01650285|20426332|P1|COMPLETED|Overall Study||4
8284848|NCT01650285|20426332|P1|STARTED|Overall Study||5
8284849|NCT01650259|20426339|P2|NOT COMPLETED|Overall Study||235
8284850|NCT01650259|20426340|P1|NOT COMPLETED|Overall Study||1043
8284851|NCT01650259|20426339|P2|COMPLETED|Overall Study||2128
8284852|NCT01650259|20426340|P1|COMPLETED|Overall Study||1470
8284853|NCT01650259|20426339|P2|STARTED|Overall Study|Started are the registered patients|2363
8284854|NCT01650259|20426340|P1|STARTED|Overall Study|Started are the registered patients|2513
8284855|NCT01650246|20426345|P1|NOT COMPLETED|Overall Study||143
8284856|NCT01650246|20426345|P1|COMPLETED|Overall Study||0
8284857|NCT01650246|20426345|P1|STARTED|Overall Study||143
8284858|NCT01650194|20426350|P1|NOT COMPLETED|Overall Study||47
8284859|NCT01650194|20426350|P1|COMPLETED|Overall Study||13
8284860|NCT01650194|20426350|P1|Treated|Overall Study||60
8284861|NCT01650194|20426350|P1|STARTED|Overall Study||60
8284862|NCT01649947|20426375|P2|NOT COMPLETED|Overall Study||18
8284863|NCT01649947|20426376|P1|NOT COMPLETED|Overall Study||12
8284864|NCT01649947|20426375|P2|COMPLETED|Overall Study||2
8284865|NCT01649947|20426376|P1|COMPLETED|Overall Study||0
8284866|NCT01649947|20426375|P2|STARTED|Overall Study||20
8284867|NCT01649947|20426376|P1|STARTED|Overall Study||12
8284868|NCT01649856|20426386|P2|NOT COMPLETED|Overall Study||78
8284869|NCT01649856|20426387|P1|NOT COMPLETED|Overall Study||139
8284870|NCT01649856|20426386|P2|COMPLETED|Overall Study||125
8284871|NCT01649856|20426387|P1|COMPLETED|Overall Study||230
8284872|NCT01649856|20426386|P2|STARTED|Overall Study||203
8284873|NCT01649856|20426387|P1|STARTED|Overall Study||369
8284874|NCT01649804|20426419|P1|NOT COMPLETED|Overall Study||8
8284875|NCT01649804|20426419|P1|COMPLETED|Overall Study||4
8284876|NCT01649804|20426419|P1|STARTED|Overall Study||12
8284877|NCT01649791|20426431|P1|NOT COMPLETED|Overall Study||3
8284878|NCT01649791|20426431|P1|COMPLETED|Overall Study||5
8284879|NCT01649791|20426431|P1|STARTED|Overall Study||8
8284880|NCT01649765|20426440|P2|NOT COMPLETED|Overall Study||8
8284881|NCT01649765|20426441|P1|NOT COMPLETED|Overall Study||9
8284882|NCT01649765|20426440|P2|COMPLETED|Overall Study||45
8284883|NCT01649765|20426441|P1|COMPLETED|Overall Study||31
8284884|NCT01649765|20426440|P2|STARTED|Overall Study||53
8284885|NCT01649765|20426441|P1|STARTED|Overall Study||40
8284886|NCT01649609|20426469|P2|NOT COMPLETED|Overall Study||0
8284887|NCT01649609|20426470|P1|NOT COMPLETED|Overall Study||0
8284888|NCT01649609|20426469|P2|COMPLETED|Overall Study||20
8284889|NCT01649609|20426470|P1|COMPLETED|Overall Study||20
8284890|NCT01649609|20426469|P2|STARTED|Overall Study||20
8284891|NCT01649609|20426470|P1|STARTED|Overall Study||20
8284892|NCT01649596|20426480|P2|NOT COMPLETED|Overall Study||0
8284893|NCT01649596|20426481|P1|NOT COMPLETED|Overall Study||0
8284894|NCT01649596|20426480|P2|COMPLETED|Overall Study||48
8284895|NCT01649596|20426481|P1|COMPLETED|Overall Study||46
8284896|NCT01649596|20426480|P2|STARTED|Overall Study||48
8284897|NCT01649596|20426481|P1|STARTED|Overall Study||46
8284898|NCT01649557|20426492|P3|NOT COMPLETED|Overall Study||9
8284899|NCT01649557|20426493|P2|NOT COMPLETED|Overall Study||14
8284900|NCT01649557|20426494|P1|NOT COMPLETED|Overall Study||44
8284901|NCT01649557|20426492|P3|COMPLETED|Overall Study||15
8284902|NCT01649557|20426493|P2|COMPLETED|Overall Study||27
8284903|NCT01649557|20426494|P1|COMPLETED|Overall Study||135
8284904|NCT01649557|20426492|P3|52-week Enrollers|Overall Study||2
8284905|NCT01649557|20426493|P2|52-week Enrollers|Overall Study||6
8284906|NCT01649557|20426494|P1|52-week Enrollers|Overall Study||20
8284907|NCT01649557|20426492|P3|6-week Enrollers|Overall Study||22
8284908|NCT01649557|20426493|P2|6-week Enrollers|Overall Study||35
8284909|NCT01649557|20426494|P1|6-week Enrollers|Overall Study||159
8284910|NCT01649557|20426492|P3|STARTED|Overall Study||24
8284911|NCT01649557|20426493|P2|STARTED|Overall Study||41
8284912|NCT01649557|20426494|P1|STARTED|Overall Study||179
8284913|NCT01649505|20426531|P2|NOT COMPLETED|Overall Study||1
8284914|NCT01649505|20426532|P1|NOT COMPLETED|Overall Study||1
8284915|NCT01649505|20426531|P2|COMPLETED|Overall Study||0
8284916|NCT01649505|20426532|P1|COMPLETED|Overall Study||0
8284917|NCT01649505|20426531|P2|STARTED|Overall Study||1
8284918|NCT01649505|20426532|P1|STARTED|Overall Study||1
8284919|NCT01649427|20426540|P2|NOT COMPLETED|Overall Study||12
8284920|NCT01649427|20426541|P1|NOT COMPLETED|Overall Study||11
8284921|NCT01649427|20426540|P2|COMPLETED|Overall Study||26
8284922|NCT01649427|20426541|P1|COMPLETED|Overall Study||24
8284923|NCT01649427|20426540|P2|STARTED|Overall Study||38
8284924|NCT01649427|20426541|P1|STARTED|Overall Study||35
8284925|NCT01649375|20426560|P5|NOT COMPLETED|Week 16 up to Week 260||5
8284926|NCT01649375|20426561|P4|NOT COMPLETED|Week 16 up to Week 260||12
8284927|NCT01649375|20426562|P3|NOT COMPLETED|Week 16 up to Week 260||0
8284928|NCT01649375|20426563|P2|NOT COMPLETED|Week 16 up to Week 260||13
8284929|NCT01649375|20426564|P1|NOT COMPLETED|Week 16 up to Week 260||20
8284930|NCT01649375|20426560|P5|COMPLETED|Week 16 up to Week 260||29
8284931|NCT01649375|20426561|P4|COMPLETED|Week 16 up to Week 260||20
8284932|NCT01649375|20426562|P3|COMPLETED|Week 16 up to Week 260||0
8284933|NCT01649375|20426563|P2|COMPLETED|Week 16 up to Week 260||53
8284934|NCT01649375|20426564|P1|COMPLETED|Week 16 up to Week 260||48
8284935|NCT01649375|20426560|P5|STARTED|Week 16 up to Week 260||34
8284936|NCT01649375|20426561|P4|STARTED|Week 16 up to Week 260||32
8284937|NCT01649375|20426562|P3|STARTED|Week 16 up to Week 260||0
8284938|NCT01649375|20426563|P2|STARTED|Week 16 up to Week 260||66
8284939|NCT01649375|20426564|P1|STARTED|Week 16 up to Week 260||68
8284940|NCT01649375|20426560|P5|NOT COMPLETED|Up to Week 16||0
8284941|NCT01649375|20426561|P4|NOT COMPLETED|Up to Week 16||0
8284942|NCT01649375|20426562|P3|NOT COMPLETED|Up to Week 16||8
8284943|NCT01649375|20426563|P2|NOT COMPLETED|Up to Week 16||6
8284944|NCT01649375|20426564|P1|NOT COMPLETED|Up to Week 16||5
8284945|NCT01649375|20426560|P5|COMPLETED|Up to Week 16||0
8284946|NCT01649375|20426561|P4|COMPLETED|Up to Week 16||0
8284947|NCT01649375|20426562|P3|COMPLETED|Up to Week 16||66
8284948|NCT01649375|20426563|P2|COMPLETED|Up to Week 16||66
8284949|NCT01649375|20426564|P1|COMPLETED|Up to Week 16||68
8284950|NCT01649375|20426560|P5|STARTED|Up to Week 16||0
8284951|NCT01649375|20426561|P4|STARTED|Up to Week 16||0
8284952|NCT01649375|20426562|P3|STARTED|Up to Week 16||74
8284953|NCT01649375|20426563|P2|STARTED|Up to Week 16||72
8284954|NCT01649375|20426564|P1|STARTED|Up to Week 16||73
8284955|NCT01649362|20426595|P2|NOT COMPLETED|Overall Study||14
8284956|NCT01649362|20426596|P1|NOT COMPLETED|Overall Study||1
8284957|NCT01649362|20426595|P2|COMPLETED|Overall Study||40
8284958|NCT01649362|20426596|P1|COMPLETED|Overall Study||46
8284959|NCT01649362|20426595|P2|STARTED|Overall Study||54
8284960|NCT01649362|20426596|P1|STARTED|Overall Study||47
8284961|NCT01649297|20426611|P5|NOT COMPLETED|Overall Study||4
8284962|NCT01649297|20426612|P4|NOT COMPLETED|Overall Study||19
8284963|NCT01649297|20426613|P3|NOT COMPLETED|Overall Study||17
8284964|NCT01649297|20426614|P2|NOT COMPLETED|Overall Study||13
8284965|NCT01649297|20426615|P1|NOT COMPLETED|Overall Study||14
8284966|NCT01649297|20426611|P5|COMPLETED|Overall Study||103
8284967|NCT01649297|20426612|P4|COMPLETED|Overall Study||201
8284968|NCT01649297|20426613|P3|COMPLETED|Overall Study||202
8284969|NCT01649297|20426614|P2|COMPLETED|Overall Study||205
8284970|NCT01649297|20426615|P1|COMPLETED|Overall Study||205
8284971|NCT01649297|20426611|P5|STARTED|Overall Study|randomised|107
8284972|NCT01649297|20426612|P4|STARTED|Overall Study|randomised|220
8284973|NCT01649297|20426613|P3|STARTED|Overall Study|randomised|219
8284974|NCT01649297|20426614|P2|STARTED|Overall Study|randomised|218
8284975|NCT01649297|20426615|P1|STARTED|Overall Study|randomised|219
8284976|NCT01649271|20426634|P2|NOT COMPLETED|Overall Study||7
8284977|NCT01649271|20426635|P1|NOT COMPLETED|Overall Study||6
8284978|NCT01649271|20426634|P2|COMPLETED|Overall Study||0
8284979|NCT01649271|20426635|P1|COMPLETED|Overall Study||0
8284980|NCT01649271|20426634|P2|STARTED|Overall Study||7
8284981|NCT01649271|20426635|P1|STARTED|Overall Study||6
8284982|NCT01649232|20426650|P2|NOT COMPLETED|Overall Study||0
8284983|NCT01649232|20426651|P1|NOT COMPLETED|Overall Study||2
8284984|NCT01649232|20426650|P2|COMPLETED|Overall Study||30
8284985|NCT01649232|20426651|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
8284986|NCT01649232|20426650|P2|STARTED|Overall Study||30
8284987|NCT01649232|20426651|P1|STARTED|Overall Study||30
8284988|NCT01649180|20426671|P1|NOT COMPLETED|Overall Study||0
8284989|NCT01649180|20426671|P1|COMPLETED|Overall Study||3
8284990|NCT01649180|20426671|P1|STARTED|Overall Study||3
8284991|NCT01648959|20426679|P1|NOT COMPLETED|Overall Study||0
8284992|NCT01648959|20426679|P1|COMPLETED|Overall Study||5
8284993|NCT01648959|20426679|P1|STARTED|Overall Study||5
8284994|NCT01648920|20426683|P1|NOT COMPLETED|Overall Study||0
8284995|NCT01648920|20426683|P1|COMPLETED|Overall Study||50
8284996|NCT01648920|20426683|P1|STARTED|Overall Study||50
8284997|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 5||0
8284998|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 5||0
8284999|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 5||0
8285000|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 5||0
8285001|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 5||0
8285002|NCT01648790|20426707|P5|COMPLETED|Treatment 5||4
8285003|NCT01648790|20426708|P4|COMPLETED|Treatment 5||3
8285004|NCT01648790|20426709|P3|COMPLETED|Treatment 5||4
8285005|NCT01648790|20426710|P2|COMPLETED|Treatment 5||4
8285006|NCT01648790|20426711|P1|COMPLETED|Treatment 5||4
8285007|NCT01648790|20426707|P5|STARTED|Treatment 5||4
8285008|NCT01648790|20426708|P4|STARTED|Treatment 5||3
8285009|NCT01648790|20426709|P3|STARTED|Treatment 5||4
8285010|NCT01648790|20426710|P2|STARTED|Treatment 5||4
8285011|NCT01648790|20426711|P1|STARTED|Treatment 5||4
8285012|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 4||0
8285013|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 4||0
8285014|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 4||0
8285015|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 4||0
8285016|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 4||0
8285017|NCT01648790|20426707|P5|COMPLETED|Treatment 4||4
8285018|NCT01648790|20426708|P4|COMPLETED|Treatment 4||3
8285019|NCT01648790|20426709|P3|COMPLETED|Treatment 4||4
8285020|NCT01648790|20426710|P2|COMPLETED|Treatment 4||4
8285021|NCT01648790|20426711|P1|COMPLETED|Treatment 4||4
8285022|NCT01648790|20426707|P5|STARTED|Treatment 4||4
8285023|NCT01648790|20426708|P4|STARTED|Treatment 4||3
8285024|NCT01648790|20426709|P3|STARTED|Treatment 4||4
8285025|NCT01648790|20426710|P2|STARTED|Treatment 4||4
8285026|NCT01648790|20426711|P1|STARTED|Treatment 4||4
8285027|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 3||0
8285028|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 3||1
8285029|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 3||0
8285030|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 3||0
8285031|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 3||0
8285032|NCT01648790|20426707|P5|COMPLETED|Treatment 3||4
8285033|NCT01648790|20426708|P4|COMPLETED|Treatment 3||3
8285034|NCT01648790|20426709|P3|COMPLETED|Treatment 3||4
8285035|NCT01648790|20426710|P2|COMPLETED|Treatment 3||4
8285036|NCT01648790|20426711|P1|COMPLETED|Treatment 3||4
8285037|NCT01648790|20426707|P5|STARTED|Treatment 3||4
8285038|NCT01648790|20426708|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
8285039|NCT01648790|20426709|P3|STARTED|Treatment 3||4
8285040|NCT01648790|20426710|P2|STARTED|Treatment 3||4
8285041|NCT01648790|20426711|P1|STARTED|Treatment 3||4
8285042|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 2||0
8285043|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 2||0
8285044|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 2||0
8285045|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 2||0
8285046|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 2||0
8285047|NCT01648790|20426707|P5|COMPLETED|Treatment 2||4
8285048|NCT01648790|20426708|P4|COMPLETED|Treatment 2||4
8285049|NCT01648790|20426709|P3|COMPLETED|Treatment 2||4
8285050|NCT01648790|20426710|P2|COMPLETED|Treatment 2||4
8285051|NCT01648790|20426711|P1|COMPLETED|Treatment 2||4
8285052|NCT01648790|20426707|P5|STARTED|Treatment 2||4
8285053|NCT01648790|20426708|P4|STARTED|Treatment 2||4
8285054|NCT01648790|20426709|P3|STARTED|Treatment 2||4
8285055|NCT01648790|20426710|P2|STARTED|Treatment 2||4
8285056|NCT01648790|20426711|P1|STARTED|Treatment 2||4
8285057|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 1||0
8285058|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 1||0
8285059|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 1||0
8285060|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 1||0
8285061|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 1||0
8285062|NCT01648790|20426707|P5|COMPLETED|Treatment 1||4
8285063|NCT01648790|20426708|P4|COMPLETED|Treatment 1||4
8285064|NCT01648790|20426709|P3|COMPLETED|Treatment 1||4
8285065|NCT01648790|20426710|P2|COMPLETED|Treatment 1||4
8285066|NCT01648790|20426711|P1|COMPLETED|Treatment 1||4
8285067|NCT01648790|20426707|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285068|NCT01648790|20426708|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285069|NCT01648790|20426709|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285070|NCT01648790|20426710|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285071|NCT01648790|20426711|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285072|NCT01648790|20426707|P5|STARTED|Treatment 1||4
8285073|NCT01648790|20426708|P4|STARTED|Treatment 1||4
8285074|NCT01648790|20426709|P3|STARTED|Treatment 1||4
8285075|NCT01648790|20426710|P2|STARTED|Treatment 1||4
8285076|NCT01648790|20426711|P1|STARTED|Treatment 1||4
8285077|NCT01648764|20426746|P14|NOT COMPLETED|Overall Study||3
8285078|NCT01648764|20426747|P13|NOT COMPLETED|Overall Study||4
8285079|NCT01648764|20426748|P12|NOT COMPLETED|Overall Study||5
8285080|NCT01648764|20426749|P11|NOT COMPLETED|Overall Study||0
8285081|NCT01648764|20426750|P10|NOT COMPLETED|Overall Study||3
8285082|NCT01648764|20426751|P9|NOT COMPLETED|Overall Study||0
8285083|NCT01648764|20426752|P8|NOT COMPLETED|Overall Study||0
8285084|NCT01648764|20426753|P7|NOT COMPLETED|Overall Study||5
8285085|NCT01648764|20426754|P6|NOT COMPLETED|Overall Study||2
8285086|NCT01648764|20426755|P5|NOT COMPLETED|Overall Study||0
8285087|NCT01648764|20426756|P4|NOT COMPLETED|Overall Study||0
8285088|NCT01648764|20426757|P3|NOT COMPLETED|Overall Study||0
8285089|NCT01648764|20426758|P2|NOT COMPLETED|Overall Study||1
8285090|NCT01648764|20426759|P1|NOT COMPLETED|Overall Study||0
8285091|NCT01648764|20426746|P14|COMPLETED|Overall Study||9
8285092|NCT01648764|20426747|P13|COMPLETED|Overall Study||3
8285093|NCT01648764|20426748|P12|COMPLETED|Overall Study||4
8285094|NCT01648764|20426749|P11|COMPLETED|Overall Study||3
8285095|NCT01648764|20426750|P10|COMPLETED|Overall Study||4
8285096|NCT01648764|20426751|P9|COMPLETED|Overall Study||3
8285097|NCT01648764|20426752|P8|COMPLETED|Overall Study||3
8285098|NCT01648764|20426753|P7|COMPLETED|Overall Study||4
8285099|NCT01648764|20426754|P6|COMPLETED|Overall Study||3
8285100|NCT01648764|20426755|P5|COMPLETED|Overall Study||3
8285101|NCT01648764|20426756|P4|COMPLETED|Overall Study||3
8285102|NCT01648764|20426757|P3|COMPLETED|Overall Study||3
8285103|NCT01648764|20426758|P2|COMPLETED|Overall Study||2
8285104|NCT01648764|20426759|P1|COMPLETED|Overall Study||3
8285105|NCT01648764|20426746|P14|Received at Least 1 Dose of Study Drug|Overall Study||12
8285106|NCT01648764|20426747|P13|Received at Least 1 Dose of Study Drug|Overall Study||7
8285107|NCT01648764|20426748|P12|Received at Least 1 Dose of Study Drug|Overall Study||9
8285108|NCT01648764|20426749|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
8285109|NCT01648764|20426750|P10|Received at Least 1 Dose of Study Drug|Overall Study||7
8285110|NCT01648764|20426751|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
8285111|NCT01648764|20426752|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8285112|NCT01648764|20426753|P7|Received at Least 1 Dose of Study Drug|Overall Study||9
8285113|NCT01648764|20426754|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
8285114|NCT01648764|20426755|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8285115|NCT01648764|20426756|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8285116|NCT01648764|20426757|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8285117|NCT01648764|20426758|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8285118|NCT01648764|20426759|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8285119|NCT01648764|20426746|P14|STARTED|Overall Study||12
8285120|NCT01648764|20426747|P13|STARTED|Overall Study||7
8285121|NCT01648764|20426748|P12|STARTED|Overall Study||9
8285122|NCT01648764|20426749|P11|STARTED|Overall Study||3
8285123|NCT01648764|20426750|P10|STARTED|Overall Study||7
8285124|NCT01648764|20426751|P9|STARTED|Overall Study||3
8285125|NCT01648764|20426752|P8|STARTED|Overall Study||3
8285126|NCT01648764|20426753|P7|STARTED|Overall Study||9
8285127|NCT01648764|20426754|P6|STARTED|Overall Study||5
8285128|NCT01648764|20426755|P5|STARTED|Overall Study||3
8285129|NCT01648764|20426756|P4|STARTED|Overall Study||3
8285130|NCT01648764|20426757|P3|STARTED|Overall Study||3
8285131|NCT01648764|20426758|P2|STARTED|Overall Study||3
8285132|NCT01648764|20426759|P1|STARTED|Overall Study||3
8285133|NCT01648699|20426911|P1|NOT COMPLETED|Overall Study||5
8285134|NCT01648699|20426911|P1|COMPLETED|Overall Study||15
8285135|NCT01648699|20426911|P1|STARTED|Overall Study||20
8285136|NCT01648582|20426940|P3|NOT COMPLETED|Overall Study||32
8285137|NCT01648582|20426941|P2|NOT COMPLETED|Overall Study||38
8285138|NCT01648582|20426942|P1|NOT COMPLETED|Overall Study||32
8285139|NCT01648582|20426940|P3|COMPLETED|Overall Study||227
8285140|NCT01648582|20426941|P2|COMPLETED|Overall Study||219
8285141|NCT01648582|20426942|P1|COMPLETED|Overall Study||226
8285142|NCT01648582|20426940|P3|Modified Intent-to-Treat Population|Overall Study||250
8285143|NCT01648582|20426941|P2|Modified Intent-to-Treat Population|Overall Study||252
8285144|NCT01648582|20426942|P1|Modified Intent-to-Treat Population|Overall Study||253
8285145|NCT01648582|20426940|P3|Received at Least One Dose of Study Drug|Overall Study||259
8285146|NCT01648582|20426941|P2|Received at Least One Dose of Study Drug|Overall Study||257
8285147|NCT01648582|20426942|P1|Received at Least One Dose of Study Drug|Overall Study||258
8285148|NCT01648582|20426940|P3|STARTED|Overall Study||259
8285149|NCT01648582|20426941|P2|STARTED|Overall Study||257
8285150|NCT01648582|20426942|P1|STARTED|Overall Study||258
8285151|NCT01648530|20427011|P1|NOT COMPLETED|Overall Study||10874
8285152|NCT01648530|20427011|P1|COMPLETED|Overall Study||5915
8285153|NCT01648530|20427011|P1|STARTED|Overall Study||16789
8285154|NCT01648491|20427017|P1|NOT COMPLETED|Overall Study||0
8285155|NCT01648491|20427017|P1|COMPLETED|Overall Study||1
8285156|NCT01648491|20427017|P1|STARTED|Overall Study||1
8285157|NCT01648452|20427024|P1|NOT COMPLETED|Overall Study||0
8285158|NCT01648452|20427024|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
8285159|NCT01648452|20427024|P1|STARTED|Overall Study||5
8285160|NCT01648348|20427045|P6|NOT COMPLETED|Overall Study||6
8285161|NCT01648348|20427046|P5|NOT COMPLETED|Overall Study||3
8285162|NCT01648348|20427047|P4|NOT COMPLETED|Overall Study||0
8285163|NCT01648348|20427048|P3|NOT COMPLETED|Overall Study||1
8285164|NCT01648348|20427049|P2|NOT COMPLETED|Overall Study||0
8285165|NCT01648348|20427050|P1|NOT COMPLETED|Overall Study||2
8285166|NCT01648348|20427045|P6|COMPLETED|Overall Study||43
8285167|NCT01648348|20427046|P5|COMPLETED|Overall Study||49
8285168|NCT01648348|20427047|P4|COMPLETED|Overall Study||3
8285169|NCT01648348|20427048|P3|COMPLETED|Overall Study||3
8285170|NCT01648348|20427049|P2|COMPLETED|Overall Study||3
8285171|NCT01648348|20427050|P1|COMPLETED|Overall Study||3
8285172|NCT01648348|20427045|P6|STARTED|Overall Study||49
8285173|NCT01648348|20427046|P5|STARTED|Overall Study||52
8285174|NCT01648348|20427047|P4|STARTED|Overall Study||3
8285175|NCT01648348|20427048|P3|STARTED|Overall Study||4
8285176|NCT01648348|20427049|P2|STARTED|Overall Study||3
8285177|NCT01648348|20427050|P1|STARTED|Overall Study||5
8285178|NCT01648322|20427079|P4|NOT COMPLETED|Overall Study||4
8285179|NCT01648322|20427080|P3|NOT COMPLETED|Overall Study||5
8285180|NCT01648322|20427081|P2|NOT COMPLETED|Overall Study||5
8285181|NCT01648322|20427082|P1|NOT COMPLETED|Overall Study||2
8285182|NCT01648322|20427079|P4|COMPLETED|Overall Study||61
8285183|NCT01648322|20427080|P3|COMPLETED|Overall Study||60
8285184|NCT01648322|20427081|P2|COMPLETED|Overall Study||62
8285185|NCT01648322|20427082|P1|COMPLETED|Overall Study||33
8285186|NCT01648322|20427079|P4|STARTED|Overall Study||65
8285187|NCT01648322|20427080|P3|STARTED|Overall Study||65
8285188|NCT01648322|20427081|P2|STARTED|Overall Study||67
8285189|NCT01648322|20427082|P1|STARTED|Overall Study||35
8285190|NCT01648296|20427128|P2|NOT COMPLETED|Overall Study||0
8285191|NCT01648296|20427129|P1|NOT COMPLETED|Overall Study||0
8285192|NCT01648296|20427128|P2|COMPLETED|Overall Study||17
8285193|NCT01648296|20427129|P1|COMPLETED|Overall Study||11
8285194|NCT01648296|20427128|P2|STARTED|Overall Study||17
8285195|NCT01648296|20427129|P1|STARTED|Overall Study||11
8285196|NCT01648283|20427137|P1|NOT COMPLETED|Overall Study||14
8285197|NCT01648283|20427137|P1|COMPLETED|Overall Study||64
8285198|NCT01648283|20427137|P1|STARTED|Overall Study||78
8285199|NCT01648270|20427143|P1|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
8285200|NCT01648270|20427143|P1|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
8285201|NCT01648270|20427143|P1|STARTED|Cyclosporine + Sublingual Buprenorphine||13
8285202|NCT01648270|20427143|P1|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
8285203|NCT01648270|20427143|P1|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
8285204|NCT01648270|20427143|P1|STARTED|Cyclosporine Plus IV Buprenorphine||13
8285205|NCT01648270|20427143|P1|NOT COMPLETED|Sublingual Buprenorphine||0
8285206|NCT01648270|20427143|P1|COMPLETED|Sublingual Buprenorphine||13
8285207|NCT01648270|20427143|P1|STARTED|Sublingual Buprenorphine||13
8285208|NCT01648270|20427143|P1|NOT COMPLETED|Intravenous Buprenorphine||12
8285209|NCT01648270|20427143|P1|COMPLETED|Intravenous Buprenorphine||13
8285210|NCT01648270|20427143|P1|STARTED|Intravenous Buprenorphine||25
8285211|NCT01648166|20427155|P2|NOT COMPLETED|Overall Study||100
8285212|NCT01648166|20427156|P1|NOT COMPLETED|Overall Study||53
8285213|NCT01648166|20427155|P2|COMPLETED|Overall Study||267
8285214|NCT01648166|20427156|P1|COMPLETED|Overall Study||100
8285215|NCT01648166|20427155|P2|STARTED|Overall Study||367
8285216|NCT01648166|20427156|P1|STARTED|Overall Study||153
8285217|NCT01648140|20427166|P4|NOT COMPLETED|Overall Study||2
8285218|NCT01648140|20427167|P3|NOT COMPLETED|Overall Study||8
8285219|NCT01648140|20427168|P2|NOT COMPLETED|Overall Study||12
8285220|NCT01648140|20427169|P1|NOT COMPLETED|Overall Study||12
8285221|NCT01648140|20427166|P4|COMPLETED|Overall Study||11
8285222|NCT01648140|20427167|P3|COMPLETED|Overall Study||9
8285223|NCT01648140|20427168|P2|COMPLETED|Overall Study||28
8285224|NCT01648140|20427169|P1|COMPLETED|Overall Study||29
8285225|NCT01648140|20427166|P4|STARTED|Overall Study||13
8285226|NCT01648140|20427167|P3|STARTED|Overall Study||17
8285227|NCT01648140|20427168|P2|STARTED|Overall Study||40
8285228|NCT01648140|20427169|P1|STARTED|Overall Study||41
8285229|NCT01648101|20427334|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
8285230|NCT01648101|20427335|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8285231|NCT01648101|20427336|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
8285232|NCT01648101|20427334|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
8285233|NCT01648101|20427335|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8285234|NCT01648101|20427336|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8285235|NCT01648101|20427334|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
8285236|NCT01648101|20427335|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
8285237|NCT01648101|20427336|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
8285238|NCT01648101|20427334|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
8285239|NCT01648101|20427335|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
8285240|NCT01648101|20427336|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
8285241|NCT01648101|20427334|P3|COMPLETED|Transition Phase (4 Weeks)||5
8285242|NCT01648101|20427335|P2|COMPLETED|Transition Phase (4 Weeks)||13
8285243|NCT01648101|20427336|P1|COMPLETED|Transition Phase (4 Weeks)||12
8285244|NCT01648101|20427334|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
8285245|NCT01648101|20427335|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
8285246|NCT01648101|20427336|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
8285247|NCT01648101|20427334|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
8285248|NCT01648101|20427335|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
8285249|NCT01648101|20427336|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
8285250|NCT01648101|20427334|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
8285251|NCT01648101|20427335|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
8285252|NCT01648101|20427336|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
8285253|NCT01648101|20427334|P3|STARTED|Maintenance Phase (12 Weeks)||18
8285254|NCT01648101|20427335|P2|STARTED|Maintenance Phase (12 Weeks)||23
8285255|NCT01648101|20427336|P1|STARTED|Maintenance Phase (12 Weeks)||23
8285256|NCT01648101|20427334|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
8285257|NCT01648101|20427335|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
8285258|NCT01648101|20427336|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
8285259|NCT01648101|20427334|P3|COMPLETED|Titration Phase (4 Weeks)||18
8285260|NCT01648101|20427335|P2|COMPLETED|Titration Phase (4 Weeks)||23
8285261|NCT01648101|20427336|P1|COMPLETED|Titration Phase (4 Weeks)||23
8285262|NCT01648101|20427334|P3|STARTED|Titration Phase (4 Weeks)||24
8285263|NCT01648101|20427335|P2|STARTED|Titration Phase (4 Weeks)||26
8285264|NCT01648101|20427336|P1|STARTED|Titration Phase (4 Weeks)||25
8285265|NCT01647958|20427386|P2|NOT COMPLETED|Extended Follow-up Phase||0
8285266|NCT01647958|20427387|P1|NOT COMPLETED|Extended Follow-up Phase||8
8285267|NCT01647958|20427386|P2|COMPLETED|Extended Follow-up Phase||0
8285268|NCT01647958|20427387|P1|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
8285269|NCT01647958|20427386|P2|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
8285270|NCT01647958|20427387|P1|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
8285271|NCT01647958|20427386|P2|NOT COMPLETED|Continuation Phase||0
8285272|NCT01647958|20427387|P1|NOT COMPLETED|Continuation Phase||39
8285273|NCT01647958|20427386|P2|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
8285274|NCT01647958|20427387|P1|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
8285275|NCT01647958|20427386|P2|STARTED|Continuation Phase||21
8285276|NCT01647958|20427387|P1|STARTED|Continuation Phase||39
8285277|NCT01647958|20427386|P2|NOT COMPLETED|Initial Study||3
8285278|NCT01647958|20427387|P1|NOT COMPLETED|Initial Study||2
8285279|NCT01647958|20427386|P2|COMPLETED|Initial Study||21
8285280|NCT01647958|20427387|P1|COMPLETED|Initial Study||39
8285281|NCT01647958|20427386|P2|STARTED|Initial Study||24
8285282|NCT01647958|20427387|P1|STARTED|Initial Study||41
8285283|NCT01647945|20427439|P4|NOT COMPLETED|Overall Study||1
8285284|NCT01647945|20427440|P3|NOT COMPLETED|Overall Study||2
8285285|NCT01647945|20427441|P2|NOT COMPLETED|Overall Study||0
8285286|NCT01647945|20427442|P1|NOT COMPLETED|Overall Study||0
8285287|NCT01647945|20427439|P4|COMPLETED|Overall Study||5
8285288|NCT01647945|20427440|P3|COMPLETED|Overall Study||3
8285289|NCT01647945|20427441|P2|COMPLETED|Overall Study||6
8285290|NCT01647945|20427442|P1|COMPLETED|Overall Study||6
8285291|NCT01647945|20427439|P4|STARTED|Overall Study||6
8285292|NCT01647945|20427440|P3|STARTED|Overall Study||5
8285293|NCT01647945|20427441|P2|STARTED|Overall Study||6
8285294|NCT01647945|20427442|P1|STARTED|Overall Study||6
8285295|NCT01647737|20427462|P2|NOT COMPLETED|Overall Study||5
8285296|NCT01647737|20427463|P1|NOT COMPLETED|Overall Study||4
8285297|NCT01647737|20427462|P2|COMPLETED|Overall Study||25
8285298|NCT01647737|20427463|P1|COMPLETED|Overall Study||26
8285299|NCT01647737|20427462|P2|STARTED|Overall Study||30
8285300|NCT01647737|20427463|P1|STARTED|Overall Study||30
8285301|NCT01647711|20427474|P5|NOT COMPLETED|Overall Study||6
8285302|NCT01647711|20427475|P4|NOT COMPLETED|Overall Study||11
8285303|NCT01647711|20427476|P3|NOT COMPLETED|Overall Study||9
8285304|NCT01647711|20427477|P2|NOT COMPLETED|Overall Study||3
8285305|NCT01647711|20427478|P1|NOT COMPLETED|Overall Study||6
8285306|NCT01647711|20427474|P5|COMPLETED|Overall Study||0
8285307|NCT01647711|20427475|P4|COMPLETED|Overall Study||0
8285308|NCT01647711|20427476|P3|COMPLETED|Overall Study||0
8285309|NCT01647711|20427477|P2|COMPLETED|Overall Study||0
8285310|NCT01647711|20427478|P1|COMPLETED|Overall Study||0
8285311|NCT01647711|20427474|P5|STARTED|Overall Study||6
8285312|NCT01647711|20427475|P4|STARTED|Overall Study||11
8285313|NCT01647711|20427476|P3|STARTED|Overall Study||9
8285314|NCT01647711|20427477|P2|STARTED|Overall Study||3
8285315|NCT01647711|20427478|P1|STARTED|Overall Study||6
8285316|NCT01647581|20427505|P2|NOT COMPLETED|Overall Study||31
8285317|NCT01647581|20427506|P1|NOT COMPLETED|Overall Study||17
8285318|NCT01647581|20427505|P2|COMPLETED|Overall Study||520
8285319|NCT01647581|20427506|P1|COMPLETED|Overall Study||530
8285320|NCT01647581|20427505|P2|STARTED|Overall Study||551
8285321|NCT01647581|20427506|P1|STARTED|Overall Study||547
8285322|NCT01647542|20427515|P3|NOT COMPLETED|Overall Study||72
8285323|NCT01647542|20427516|P2|NOT COMPLETED|Overall Study||73
8285324|NCT01647542|20427517|P1|NOT COMPLETED|Overall Study||76
8285325|NCT01647542|20427515|P3|COMPLETED|Overall Study||59
8285326|NCT01647542|20427516|P2|COMPLETED|Overall Study||58
8285327|NCT01647542|20427517|P1|COMPLETED|Overall Study||55
8285328|NCT01647542|20427515|P3|STARTED|Overall Study||131
8285329|NCT01647542|20427516|P2|STARTED|Overall Study||131
8285330|NCT01647542|20427517|P1|STARTED|Overall Study||131
8285331|NCT01647516|20427537|P6|NOT COMPLETED|Open-Label Period||56
8285332|NCT01647516|20427538|P5|NOT COMPLETED|Open-Label Period||51
8285333|NCT01647516|20427539|P4|NOT COMPLETED|Open-Label Period||49
8285334|NCT01647516|20427540|P3|NOT COMPLETED|Open-Label Period||0
8285335|NCT01647516|20427541|P2|NOT COMPLETED|Open-Label Period||0
8285336|NCT01647516|20427542|P1|NOT COMPLETED|Open-Label Period||0
8285337|NCT01647516|20427537|P6|COMPLETED|Open-Label Period||3
8285338|NCT01647516|20427538|P5|COMPLETED|Open-Label Period||5
8285339|NCT01647516|20427539|P4|COMPLETED|Open-Label Period||6
8285340|NCT01647516|20427540|P3|COMPLETED|Open-Label Period||0
8285341|NCT01647516|20427541|P2|COMPLETED|Open-Label Period||0
8285342|NCT01647516|20427542|P1|COMPLETED|Open-Label Period||0
8285343|NCT01647516|20427537|P6|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
8285344|NCT01647516|20427538|P5|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
8285345|NCT01647516|20427539|P4|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
8285346|NCT01647516|20427540|P3|STARTED|Open-Label Period||0
8285347|NCT01647516|20427541|P2|STARTED|Open-Label Period||0
8285348|NCT01647516|20427542|P1|STARTED|Open-Label Period||0
8285349|NCT01647516|20427537|P6|NOT COMPLETED|Maintenance Period (MP)||0
8285350|NCT01647516|20427538|P5|NOT COMPLETED|Maintenance Period (MP)||0
8285351|NCT01647516|20427539|P4|NOT COMPLETED|Maintenance Period (MP)||0
8285352|NCT01647516|20427540|P3|NOT COMPLETED|Maintenance Period (MP)||2
8285353|NCT01647516|20427541|P2|NOT COMPLETED|Maintenance Period (MP)||6
8285354|NCT01647516|20427542|P1|NOT COMPLETED|Maintenance Period (MP)||4
8285355|NCT01647516|20427537|P6|COMPLETED|Maintenance Period (MP)||0
8285356|NCT01647516|20427538|P5|COMPLETED|Maintenance Period (MP)||0
8285357|NCT01647516|20427539|P4|COMPLETED|Maintenance Period (MP)||0
8285358|NCT01647516|20427540|P3|COMPLETED|Maintenance Period (MP)||40
8285359|NCT01647516|20427541|P2|COMPLETED|Maintenance Period (MP)||30
8285360|NCT01647516|20427542|P1|COMPLETED|Maintenance Period (MP)||21
8285361|NCT01647516|20427537|P6|STARTED|Maintenance Period (MP)||0
8285362|NCT01647516|20427538|P5|STARTED|Maintenance Period (MP)||0
8285363|NCT01647516|20427539|P4|STARTED|Maintenance Period (MP)||0
8285364|NCT01647516|20427540|P3|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
8285365|NCT01647516|20427541|P2|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
8285366|NCT01647516|20427542|P1|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
8285367|NCT01647516|20427537|P6|NOT COMPLETED|Induction Period (IP)||0
8285368|NCT01647516|20427538|P5|NOT COMPLETED|Induction Period (IP)||0
8285369|NCT01647516|20427539|P4|NOT COMPLETED|Induction Period (IP)||0
8285370|NCT01647516|20427540|P3|NOT COMPLETED|Induction Period (IP)||4
8285371|NCT01647516|20427541|P2|NOT COMPLETED|Induction Period (IP)||3
8285372|NCT01647516|20427542|P1|NOT COMPLETED|Induction Period (IP)||6
8285373|NCT01647516|20427537|P6|COMPLETED|Induction Period (IP)||0
8285374|NCT01647516|20427538|P5|COMPLETED|Induction Period (IP)||0
8285375|NCT01647516|20427539|P4|COMPLETED|Induction Period (IP)||0
8285376|NCT01647516|20427540|P3|COMPLETED|Induction Period (IP)||63
8285377|NCT01647516|20427541|P2|COMPLETED|Induction Period (IP)||63
8285378|NCT01647516|20427542|P1|COMPLETED|Induction Period (IP)||60
8285379|NCT01647516|20427537|P6|Received Study Drug|Induction Period (IP)||0
8285380|NCT01647516|20427538|P5|Received Study Drug|Induction Period (IP)||0
8285381|NCT01647516|20427539|P4|Received Study Drug|Induction Period (IP)||0
8285382|NCT01647516|20427540|P3|Received Study Drug|Induction Period (IP)||67
8285383|NCT01647516|20427541|P2|Received Study Drug|Induction Period (IP)||65
8285384|NCT01647516|20427542|P1|Received Study Drug|Induction Period (IP)||65
8285385|NCT01647516|20427537|P6|STARTED|Induction Period (IP)||0
8285386|NCT01647516|20427538|P5|STARTED|Induction Period (IP)||0
8285387|NCT01647516|20427539|P4|STARTED|Induction Period (IP)||0
8285388|NCT01647516|20427540|P3|STARTED|Induction Period (IP)||67
8285389|NCT01647516|20427541|P2|STARTED|Induction Period (IP)||66
8285390|NCT01647516|20427542|P1|STARTED|Induction Period (IP)||66
8285391|NCT01647464|20427581|P1|NOT COMPLETED|Overall Study||0
8285392|NCT01647464|20427581|P1|COMPLETED|Overall Study||10
8285393|NCT01647464|20427581|P1|STARTED|Overall Study||10
8285394|NCT01647438|20427587|P2|NOT COMPLETED|Overall Study||0
8285395|NCT01647438|20427588|P1|NOT COMPLETED|Overall Study||0
8285396|NCT01647438|20427587|P2|COMPLETED|Overall Study||31
8285397|NCT01647438|20427588|P1|COMPLETED|Overall Study||32
8285398|NCT01647438|20427587|P2|STARTED|Overall Study||31
8285399|NCT01647438|20427588|P1|STARTED|Overall Study||32
8285400|NCT01647282|20427598|P2|NOT COMPLETED|Overall Study||5
8285401|NCT01647282|20427599|P1|NOT COMPLETED|Overall Study||7
8285402|NCT01647282|20427598|P2|COMPLETED|Overall Study||25
8285403|NCT01647282|20427599|P1|COMPLETED|Overall Study||23
8285404|NCT01647282|20427598|P2|STARTED|Overall Study||30
8285405|NCT01647282|20427599|P1|STARTED|Overall Study||30
8285406|NCT01647217|20427609|P2|NOT COMPLETED|Overall Study||1
8285407|NCT01647217|20427610|P1|NOT COMPLETED|Overall Study||1
8285408|NCT01647217|20427609|P2|COMPLETED|Overall Study||8
8285409|NCT01647217|20427610|P1|COMPLETED|Overall Study||7
8285410|NCT01647217|20427609|P2|STARTED|Overall Study||9
8285411|NCT01647217|20427610|P1|STARTED|Overall Study||8
8285412|NCT01646827|20427620|P2|NOT COMPLETED|Overall Study||5
8285413|NCT01646827|20427621|P1|NOT COMPLETED|Overall Study||2
8285414|NCT01646827|20427620|P2|COMPLETED|Overall Study||14
8285415|NCT01646827|20427621|P1|COMPLETED|Overall Study||16
8285416|NCT01646827|20427620|P2|STARTED|Overall Study||19
8285417|NCT01646827|20427621|P1|STARTED|Overall Study||18
8285418|NCT01646814|20427651|P2|NOT COMPLETED|Overall Study||6
8285419|NCT01646814|20427652|P1|NOT COMPLETED|Overall Study||11
8285420|NCT01646814|20427651|P2|COMPLETED|Overall Study||120
8285421|NCT01646814|20427652|P1|COMPLETED|Overall Study||110
8285422|NCT01646814|20427651|P2|STARTED|Overall Study||126
8285423|NCT01646814|20427652|P1|STARTED|Overall Study||121
8285424|NCT01646762|20427658|P1|NOT COMPLETED|Overall Study||0
8285425|NCT01646762|20427658|P1|COMPLETED|Overall Study||13
8285426|NCT01646762|20427658|P1|STARTED|Overall Study||13
8285427|NCT01646671|20427670|P3|NOT COMPLETED|Overall Study||0
8285428|NCT01646671|20427671|P2|NOT COMPLETED|Overall Study||0
8285429|NCT01646671|20427672|P1|NOT COMPLETED|Overall Study||0
8285430|NCT01646671|20427670|P3|COMPLETED|Overall Study||21
8285431|NCT01646671|20427671|P2|COMPLETED|Overall Study||11
8285432|NCT01646671|20427672|P1|COMPLETED|Overall Study||3
8285433|NCT01646671|20427670|P3|STARTED|Overall Study||21
8285434|NCT01646671|20427671|P2|STARTED|Overall Study||11
8285435|NCT01646671|20427672|P1|STARTED|Overall Study||3
8285436|NCT01646645|20427706|P1|NOT COMPLETED|Overall Study||30
8285437|NCT01646645|20427706|P1|COMPLETED|Overall Study||28
8285438|NCT01646645|20427706|P1|STARTED|Overall Study||58
8285439|NCT01646398|20427713|P2|NOT COMPLETED|Overall Study||0
8285440|NCT01646398|20427714|P1|NOT COMPLETED|Overall Study||1
8285441|NCT01646398|20427713|P2|COMPLETED|Overall Study||382
8285442|NCT01646398|20427714|P1|COMPLETED|Overall Study||381
8285443|NCT01646398|20427713|P2|STARTED|Overall Study||382
8285444|NCT01646398|20427714|P1|STARTED|Overall Study||382
8285445|NCT01646385|20427730|P2|NOT COMPLETED|Overall Study||871
8285446|NCT01646385|20427731|P1|NOT COMPLETED|Overall Study||838
8285447|NCT01646385|20427730|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
8285448|NCT01646385|20427731|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
8285449|NCT01646385|20427730|P2|STARTED|Overall Study||2864
8285450|NCT01646385|20427731|P1|STARTED|Overall Study||3529
8285451|NCT01646346|20427762|P1|NOT COMPLETED|Overall Study||0
8285452|NCT01646346|20427762|P1|COMPLETED|Overall Study||46
8285453|NCT01646346|20427762|P1|STARTED|Overall Study||46
8285454|NCT01646320|20427774|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
8285455|NCT01646320|20427775|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
8285456|NCT01646320|20427774|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
8285457|NCT01646320|20427775|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
8285458|NCT01646320|20427774|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
8285459|NCT01646320|20427775|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
8285460|NCT01646320|20427774|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
8285461|NCT01646320|20427775|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
8285462|NCT01646320|20427774|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
8285463|NCT01646320|20427775|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
8285464|NCT01646320|20427774|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
8285465|NCT01646320|20427775|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
8285466|NCT01646268|20427791|P2|NOT COMPLETED|Overall Study||16
8285467|NCT01646268|20427792|P1|NOT COMPLETED|Overall Study||11
8285468|NCT01646268|20427791|P2|COMPLETED|Overall Study||107
8285469|NCT01646268|20427792|P1|COMPLETED|Overall Study||113
8285470|NCT01646268|20427791|P2|STARTED|Overall Study||123
8285471|NCT01646268|20427792|P1|STARTED|Overall Study||124
8285472|NCT01646255|20427806|P2|NOT COMPLETED|Overall Study||14
8285473|NCT01646255|20427807|P1|NOT COMPLETED|Overall Study||21
8285474|NCT01646255|20427806|P2|COMPLETED|Overall Study||160
8285475|NCT01646255|20427807|P1|COMPLETED|Overall Study||151
8285476|NCT01646255|20427806|P2|STARTED|Overall Study||174
8285477|NCT01646255|20427807|P1|STARTED|Overall Study||172
8285478|NCT01646216|20427839|P2|NOT COMPLETED|Overall Study||13
8285479|NCT01646216|20427840|P1|NOT COMPLETED|Overall Study||11
8285480|NCT01646216|20427839|P2|COMPLETED|Overall Study||4
8285481|NCT01646216|20427840|P1|COMPLETED|Overall Study||6
8285482|NCT01646216|20427839|P2|STARTED|Overall Study||17
8285483|NCT01646216|20427840|P1|STARTED|Overall Study||17
8285484|NCT01646203|20427862|P3|NOT COMPLETED|Overall Study||1
8285485|NCT01646203|20427863|P2|NOT COMPLETED|Overall Study||2
8285486|NCT01646203|20427864|P1|NOT COMPLETED|Overall Study||2
8285487|NCT01646203|20427862|P3|COMPLETED|Overall Study||6
8285488|NCT01646203|20427863|P2|COMPLETED|Overall Study||3
8285489|NCT01646203|20427864|P1|COMPLETED|Overall Study||0
8285490|NCT01646203|20427862|P3|Received at Least One Dose of Study Drug|Overall Study||7
8285491|NCT01646203|20427863|P2|Received at Least One Dose of Study Drug|Overall Study||5
8285492|NCT01646203|20427864|P1|Received at Least One Dose of Study Drug|Overall Study||2
8285493|NCT01646203|20427862|P3|STARTED|Overall Study||7
8285494|NCT01646203|20427863|P2|STARTED|Overall Study||5
8285495|NCT01646203|20427864|P1|STARTED|Overall Study||2
8285496|NCT01646177|20427893|P12|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
8285497|NCT01646177|20427894|P11|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
8285498|NCT01646177|20427895|P10|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
8285499|NCT01646177|20427896|P9|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
8285500|NCT01646177|20427897|P8|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285501|NCT01646177|20427898|P7|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285502|NCT01646177|20427899|P6|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285503|NCT01646177|20427900|P5|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285504|NCT01646177|20427901|P4|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285505|NCT01646177|20427902|P3|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285506|NCT01646177|20427903|P2|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285507|NCT01646177|20427904|P1|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285508|NCT01646177|20427893|P12|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
8285509|NCT01646177|20427894|P11|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
8285510|NCT01646177|20427895|P10|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
8285511|NCT01646177|20427896|P9|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
8285512|NCT01646177|20427897|P8|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285513|NCT01646177|20427898|P7|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285514|NCT01646177|20427899|P6|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285515|NCT01646177|20427900|P5|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285516|NCT01646177|20427901|P4|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285517|NCT01646177|20427902|P3|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285518|NCT01646177|20427903|P2|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285519|NCT01646177|20427904|P1|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285520|NCT01646177|20427893|P12|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
8285521|NCT01646177|20427894|P11|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
8285522|NCT01646177|20427895|P10|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
8285523|NCT01646177|20427896|P9|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
8285524|NCT01646177|20427897|P8|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285525|NCT01646177|20427898|P7|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285526|NCT01646177|20427899|P6|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285527|NCT01646177|20427900|P5|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285528|NCT01646177|20427901|P4|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285529|NCT01646177|20427902|P3|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285530|NCT01646177|20427903|P2|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285531|NCT01646177|20427904|P1|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285532|NCT01646177|20427893|P12|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
8285533|NCT01646177|20427894|P11|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
8285534|NCT01646177|20427895|P10|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
8285535|NCT01646177|20427896|P9|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
8285536|NCT01646177|20427897|P8|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285537|NCT01646177|20427898|P7|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285538|NCT01646177|20427899|P6|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285539|NCT01646177|20427900|P5|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285540|NCT01646177|20427901|P4|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285541|NCT01646177|20427902|P3|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285542|NCT01646177|20427903|P2|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285543|NCT01646177|20427904|P1|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285544|NCT01646177|20427893|P12|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285545|NCT01646177|20427894|P11|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285546|NCT01646177|20427895|P10|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285547|NCT01646177|20427896|P9|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285548|NCT01646177|20427897|P8|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
8285549|NCT01646177|20427898|P7|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
8285550|NCT01646177|20427899|P6|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
8285551|NCT01646177|20427900|P5|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
8285552|NCT01646177|20427901|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285553|NCT01646177|20427902|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285554|NCT01646177|20427903|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285555|NCT01646177|20427904|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285556|NCT01646177|20427893|P12|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285557|NCT01646177|20427894|P11|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285558|NCT01646177|20427895|P10|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285559|NCT01646177|20427896|P9|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285560|NCT01646177|20427897|P8|COMPLETED|Long-Term Extension Period (Week 12-264)||255
8285561|NCT01646177|20427898|P7|COMPLETED|Long-Term Extension Period (Week 12-264)||244
8285562|NCT01646177|20427899|P6|COMPLETED|Long-Term Extension Period (Week 12-264)||256
8285563|NCT01646177|20427900|P5|COMPLETED|Long-Term Extension Period (Week 12-264)||135
8285564|NCT01646177|20427901|P4|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285565|NCT01646177|20427902|P3|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285566|NCT01646177|20427903|P2|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285567|NCT01646177|20427904|P1|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285568|NCT01646177|20427893|P12|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285569|NCT01646177|20427894|P11|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285570|NCT01646177|20427895|P10|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285571|NCT01646177|20427896|P9|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285572|NCT01646177|20427897|P8|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
8285573|NCT01646177|20427898|P7|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
8285574|NCT01646177|20427899|P6|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
8285575|NCT01646177|20427900|P5|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
8285576|NCT01646177|20427901|P4|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285577|NCT01646177|20427902|P3|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285578|NCT01646177|20427903|P2|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285579|NCT01646177|20427904|P1|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285580|NCT01646177|20427893|P12|STARTED|Long-Term Extension Period (Week 12-264)||0
8285581|NCT01646177|20427894|P11|STARTED|Long-Term Extension Period (Week 12-264)||0
8285582|NCT01646177|20427895|P10|STARTED|Long-Term Extension Period (Week 12-264)||0
8285583|NCT01646177|20427896|P9|STARTED|Long-Term Extension Period (Week 12-264)||0
8285584|NCT01646177|20427897|P8|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
8285585|NCT01646177|20427898|P7|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
8285586|NCT01646177|20427899|P6|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
8285587|NCT01646177|20427900|P5|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
8285588|NCT01646177|20427901|P4|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285589|NCT01646177|20427902|P3|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285590|NCT01646177|20427903|P2|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285591|NCT01646177|20427904|P1|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285592|NCT01646177|20427893|P12|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285593|NCT01646177|20427894|P11|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285594|NCT01646177|20427895|P10|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285595|NCT01646177|20427896|P9|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285596|NCT01646177|20427897|P8|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285597|NCT01646177|20427898|P7|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285598|NCT01646177|20427899|P6|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285599|NCT01646177|20427900|P5|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285600|NCT01646177|20427901|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
8285601|NCT01646177|20427902|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
8285602|NCT01646177|20427903|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
8285603|NCT01646177|20427904|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
8285604|NCT01646177|20427893|P12|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285605|NCT01646177|20427894|P11|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285606|NCT01646177|20427895|P10|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285607|NCT01646177|20427896|P9|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285608|NCT01646177|20427897|P8|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285609|NCT01646177|20427898|P7|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285610|NCT01646177|20427899|P6|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285611|NCT01646177|20427900|P5|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285612|NCT01646177|20427901|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
8285613|NCT01646177|20427902|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
8285614|NCT01646177|20427903|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
8285615|NCT01646177|20427904|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
8285616|NCT01646177|20427893|P12|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285617|NCT01646177|20427894|P11|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285618|NCT01646177|20427895|P10|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285619|NCT01646177|20427896|P9|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285620|NCT01646177|20427897|P8|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285621|NCT01646177|20427898|P7|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285622|NCT01646177|20427899|P6|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285623|NCT01646177|20427900|P5|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285624|NCT01646177|20427901|P4|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
8285625|NCT01646177|20427902|P3|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
8285626|NCT01646177|20427903|P2|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
8285627|NCT01646177|20427904|P1|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
8285628|NCT01646177|20427893|P12|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285629|NCT01646177|20427894|P11|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285630|NCT01646177|20427895|P10|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285631|NCT01646177|20427896|P9|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285632|NCT01646177|20427897|P8|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285633|NCT01646177|20427898|P7|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285634|NCT01646177|20427899|P6|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285635|NCT01646177|20427900|P5|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285636|NCT01646177|20427901|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
8285637|NCT01646177|20427902|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
8285638|NCT01646177|20427903|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
8285639|NCT01646177|20427904|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
8285640|NCT01646151|20427990|P1|NOT COMPLETED|Overall Study||170
8285641|NCT01646151|20427990|P1|COMPLETED|Overall Study||2410
8285642|NCT01646151|20427990|P1|STARTED|Overall Study||2580
8285643|NCT01646138|20428006|P5|NOT COMPLETED|Overall Study||2
8285644|NCT01646138|20428007|P4|NOT COMPLETED|Overall Study||0
8285645|NCT01646138|20428008|P3|NOT COMPLETED|Overall Study||0
8285646|NCT01646138|20428009|P2|NOT COMPLETED|Overall Study||0
8285647|NCT01646138|20428010|P1|NOT COMPLETED|Overall Study||0
8285648|NCT01646138|20428006|P5|COMPLETED|Overall Study||13
8285649|NCT01646138|20428007|P4|COMPLETED|Overall Study||19
8285650|NCT01646138|20428008|P3|COMPLETED|Overall Study||5
8285651|NCT01646138|20428009|P2|COMPLETED|Overall Study||4
8285652|NCT01646138|20428010|P1|COMPLETED|Overall Study||5
8285653|NCT01646138|20428006|P5|STARTED|Overall Study||15
8285654|NCT01646138|20428007|P4|STARTED|Overall Study||19
8285655|NCT01646138|20428008|P3|STARTED|Overall Study||5
8285656|NCT01646138|20428009|P2|STARTED|Overall Study||4
8285657|NCT01646138|20428010|P1|STARTED|Overall Study||5
8285658|NCT01646125|20428024|P2|NOT COMPLETED|Overall Study||28
8285659|NCT01646125|20428025|P1|NOT COMPLETED|Overall Study||31
8285660|NCT01646125|20428024|P2|COMPLETED|Overall Study||0
8285661|NCT01646125|20428025|P1|COMPLETED|Overall Study||0
8285662|NCT01646125|20428024|P2|STARTED|Overall Study||28
8285663|NCT01646125|20428025|P1|STARTED|Overall Study||31
8285664|NCT01646073|20428050|P2|NOT COMPLETED|Period B (12 Weeks)||13
8285665|NCT01646073|20428051|P1|NOT COMPLETED|Period B (12 Weeks)||1
8285666|NCT01646073|20428050|P2|COMPLETED|Period B (12 Weeks)||320
8285667|NCT01646073|20428051|P1|COMPLETED|Period B (12 Weeks)||84
8285668|NCT01646073|20428050|P2|STARTED|Period B (12 Weeks)||333
8285669|NCT01646073|20428051|P1|STARTED|Period B (12 Weeks)||85
8285670|NCT01646073|20428050|P2|NOT COMPLETED|Period A (12 Weeks)||5
8285671|NCT01646073|20428051|P1|NOT COMPLETED|Period A (12 Weeks)||2
8285672|NCT01646073|20428050|P2|COMPLETED|Period A (12 Weeks)||333
8285673|NCT01646073|20428051|P1|COMPLETED|Period A (12 Weeks)||85
8285674|NCT01646073|20428050|P2|STARTED|Period A (12 Weeks)||338
8285675|NCT01646073|20428051|P1|STARTED|Period A (12 Weeks)||87
8285676|NCT01646021|20428092|P2|NOT COMPLETED|Overall Study||141
8285677|NCT01646021|20428093|P1|NOT COMPLETED|Overall Study||139
8285678|NCT01646021|20428092|P2|COMPLETED|Overall Study||0
8285679|NCT01646021|20428093|P1|COMPLETED|Overall Study||0
8285680|NCT01646021|20428092|P2|Treated|Overall Study||139
8285681|NCT01646021|20428093|P1|Treated|Overall Study||139
8285682|NCT01646021|20428092|P2|STARTED|Overall Study||141
8285683|NCT01646021|20428093|P1|STARTED|Overall Study||139
8285684|NCT01645930|20428130|P1|NOT COMPLETED|Overall Study||43
8285685|NCT01645930|20428130|P1|COMPLETED|Overall Study||0
8285686|NCT01645930|20428130|P1|STARTED|Overall Study||43
8285687|NCT01645735|20428147|P2|NOT COMPLETED|Overall Study||1
8285688|NCT01645735|20428148|P1|NOT COMPLETED|Overall Study||4
8285689|NCT01645735|20428147|P2|COMPLETED|Overall Study||16
8285690|NCT01645735|20428148|P1|COMPLETED|Overall Study||28
8285691|NCT01645735|20428147|P2|STARTED|Overall Study||17
8285692|NCT01645735|20428148|P1|STARTED|Overall Study||32
8285693|NCT01645709|20428162|P2|NOT COMPLETED|Overall Study||0
8285694|NCT01645709|20428163|P1|NOT COMPLETED|Overall Study||0
8285695|NCT01645709|20428162|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
8285696|NCT01645709|20428163|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
8285697|NCT01645709|20428162|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
8285698|NCT01645709|20428163|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
8285699|NCT01645280|20428190|P5|NOT COMPLETED|Overall Study||8
8285700|NCT01645280|20428191|P4|NOT COMPLETED|Overall Study||6
8285701|NCT01645280|20428192|P3|NOT COMPLETED|Overall Study||6
8285702|NCT01645280|20428193|P2|NOT COMPLETED|Overall Study||3
8285703|NCT01645280|20428194|P1|NOT COMPLETED|Overall Study||6
8285704|NCT01645280|20428190|P5|COMPLETED|Overall Study||47
8285705|NCT01645280|20428191|P4|COMPLETED|Overall Study||48
8285706|NCT01645280|20428192|P3|COMPLETED|Overall Study||49
8285707|NCT01645280|20428193|P2|COMPLETED|Overall Study||51
8285708|NCT01645280|20428194|P1|COMPLETED|Overall Study||49
8285709|NCT01645280|20428190|P5|STARTED|Overall Study||55
8285710|NCT01645280|20428191|P4|STARTED|Overall Study||54
8285711|NCT01645280|20428192|P3|STARTED|Overall Study||55
8285712|NCT01645280|20428193|P2|STARTED|Overall Study||54
8285713|NCT01645280|20428194|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
8285714|NCT01645176|20428222|P1|NOT COMPLETED|Overall Study||5
8285715|NCT01645176|20428222|P1|COMPLETED|Overall Study||16
8285716|NCT01645176|20428222|P1|STARTED|Overall Study||21
8285717|NCT01645111|20428226|P1|NOT COMPLETED|Overall Study||15
8285718|NCT01645111|20428226|P1|COMPLETED|Overall Study||35
8285719|NCT01645111|20428226|P1|STARTED|Overall Study||50
8285720|NCT01645098|20428232|P2|NOT COMPLETED|Overall Study||0
8285721|NCT01645098|20428233|P1|NOT COMPLETED|Overall Study||0
8285722|NCT01645098|20428232|P2|COMPLETED|Overall Study||29
8285723|NCT01645098|20428233|P1|COMPLETED|Overall Study||24
8285724|NCT01645098|20428232|P2|STARTED|Overall Study||29
8285725|NCT01645098|20428233|P1|STARTED|Overall Study||24
8285726|NCT01645059|20428247|P1|NOT COMPLETED|Overall Study||0
8285727|NCT01645059|20428247|P1|COMPLETED|Overall Study||129
8285728|NCT01645059|20428247|P1|STARTED|Overall Study||129
8285729|NCT01644890|20428267|P2|NOT COMPLETED|Overall Study||215
8285730|NCT01644890|20428268|P1|NOT COMPLETED|Overall Study||216
8285731|NCT01644890|20428267|P2|COMPLETED|Overall Study||3
8285732|NCT01644890|20428268|P1|COMPLETED|Overall Study||2
8285733|NCT01644890|20428267|P2|STARTED|Overall Study||218
8285734|NCT01644890|20428268|P1|STARTED|Overall Study||218
8285735|NCT01644734|20428278|P1|NOT COMPLETED|Overall Study||266
8285736|NCT01644734|20428278|P1|COMPLETED|Overall Study||1016
8285737|NCT01644734|20428278|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
8285738|NCT01644695|20428283|P1|NOT COMPLETED|Overall Study||0
8285739|NCT01644695|20428283|P1|COMPLETED|Overall Study||85
8285740|NCT01644695|20428283|P1|STARTED|Overall Study||85
8285741|NCT01644643|20428292|P4|NOT COMPLETED|Overall Study||10
8285742|NCT01644643|20428293|P3|NOT COMPLETED|Overall Study||5
8285743|NCT01644643|20428294|P2|NOT COMPLETED|Overall Study||0
8285744|NCT01644643|20428295|P1|NOT COMPLETED|Overall Study||2
8285745|NCT01644643|20428292|P4|COMPLETED|Overall Study||143
8285746|NCT01644643|20428293|P3|COMPLETED|Overall Study||148
8285747|NCT01644643|20428294|P2|COMPLETED|Overall Study||12
8285748|NCT01644643|20428295|P1|COMPLETED|Overall Study||13
8285749|NCT01644643|20428292|P4|STARTED|Overall Study||153
8285750|NCT01644643|20428293|P3|STARTED|Overall Study||153
8285751|NCT01644643|20428294|P2|STARTED|Overall Study||12
8285752|NCT01644643|20428295|P1|STARTED|Overall Study||15
8285753|NCT01644617|20428460|P3|NOT COMPLETED|Overall Study||7
8285754|NCT01644617|20428461|P2|NOT COMPLETED|Overall Study||5
8285755|NCT01644617|20428462|P1|NOT COMPLETED|Overall Study||6
8285756|NCT01644617|20428460|P3|COMPLETED|Overall Study||34
8285757|NCT01644617|20428461|P2|COMPLETED|Overall Study||36
8285758|NCT01644617|20428462|P1|COMPLETED|Overall Study||36
8285759|NCT01644617|20428460|P3|STARTED|Overall Study||41
8285760|NCT01644617|20428461|P2|STARTED|Overall Study||41
8285761|NCT01644617|20428462|P1|STARTED|Overall Study||42
8285789|NCT01644500|20428561|P3|NOT COMPLETED|Overall Study||15
8285790|NCT01644500|20428562|P2|NOT COMPLETED|Overall Study||24
8285791|NCT01644500|20428563|P1|NOT COMPLETED|Overall Study||22
8285792|NCT01644500|20428561|P3|COMPLETED|Overall Study||230
8285793|NCT01644500|20428562|P2|COMPLETED|Overall Study||224
8285794|NCT01644500|20428563|P1|COMPLETED|Overall Study||222
8285795|NCT01644500|20428561|P3|Modified Intent-to-treat Population|Overall Study||242
8285796|NCT01644500|20428562|P2|Modified Intent-to-treat Population|Overall Study||239
8285797|NCT01644500|20428563|P1|Modified Intent-to-treat Population|Overall Study||239
8285798|NCT01644500|20428561|P3|Received at Least One Dose of Study Drug|Overall Study||243
8285799|NCT01644500|20428562|P2|Received at Least One Dose of Study Drug|Overall Study||248
8285800|NCT01644500|20428563|P1|Received at Least One Dose of Study Drug|Overall Study||244
8285801|NCT01644500|20428561|P3|STARTED|Overall Study||245
8285802|NCT01644500|20428562|P2|STARTED|Overall Study||248
8285803|NCT01644500|20428563|P1|STARTED|Overall Study||244
8285804|NCT01644474|20428633|P2|NOT COMPLETED|Overall Study||8
8285805|NCT01644474|20428634|P1|NOT COMPLETED|Overall Study||7
8285806|NCT01644474|20428633|P2|COMPLETED|Overall Study||44
8285807|NCT01644474|20428634|P1|COMPLETED|Overall Study||44
8285808|NCT01644474|20428633|P2|Treated|Overall Study||52
8285809|NCT01644474|20428634|P1|Treated|Overall Study||51
8285810|NCT01644474|20428633|P2|STARTED|Overall Study|Randomized|52
8285811|NCT01644474|20428634|P1|STARTED|Overall Study|Randomized|51
8285812|NCT01644396|20428674|P1|NOT COMPLETED|Overall Study||0
8285813|NCT01644396|20428674|P1|COMPLETED|Overall Study||50
8285814|NCT01644396|20428674|P1|STARTED|Overall Study||50
8285815|NCT01644331|20428718|P2|NOT COMPLETED|Overall Study||10
8285816|NCT01644331|20428719|P1|NOT COMPLETED|Overall Study||11
8285817|NCT01644331|20428718|P2|COMPLETED|Overall Study||118
8285818|NCT01644331|20428719|P1|COMPLETED|Overall Study||118
8285819|NCT01644331|20428718|P2|STARTED|Overall Study||128
8285820|NCT01644331|20428719|P1|STARTED|Overall Study||129
8285821|NCT01644292|20428751|P1|NOT COMPLETED|Overall Study||0
8285822|NCT01644292|20428751|P1|COMPLETED|Overall Study||2
8285823|NCT01644292|20428751|P1|STARTED|Overall Study||2
8285824|NCT01644240|20428758|P3|NOT COMPLETED|Overall Study||0
8285825|NCT01644240|20428759|P2|NOT COMPLETED|Overall Study||0
8285826|NCT01644240|20428760|P1|NOT COMPLETED|Overall Study||0
8285827|NCT01644240|20428758|P3|COMPLETED|Overall Study||6
8285828|NCT01644240|20428759|P2|COMPLETED|Overall Study||4
8285829|NCT01644240|20428760|P1|COMPLETED|Overall Study||6
8285830|NCT01644240|20428758|P3|STARTED|Overall Study||6
8285831|NCT01644240|20428759|P2|STARTED|Overall Study||4
8285832|NCT01644240|20428760|P1|STARTED|Overall Study||6
8285833|NCT01644188|20428818|P2|NOT COMPLETED|Overall Study||75
8285834|NCT01644188|20428819|P1|NOT COMPLETED|Overall Study||122
8285835|NCT01644188|20428818|P2|COMPLETED|Overall Study||166
8285836|NCT01644188|20428819|P1|COMPLETED|Overall Study||357
8285837|NCT01644188|20428818|P2|Treated|Overall Study||241
8285838|NCT01644188|20428819|P1|Treated|Overall Study||479
8285839|NCT01644188|20428818|P2|STARTED|Overall Study|Randomized|241
8285840|NCT01644188|20428819|P1|STARTED|Overall Study|Randomized|479
8285841|NCT01644175|20428877|P2|NOT COMPLETED|Overall Study||53
8285842|NCT01644175|20428878|P1|NOT COMPLETED|Overall Study||32
8285843|NCT01644175|20428877|P2|COMPLETED|Overall Study||156
8285844|NCT01644175|20428878|P1|COMPLETED|Overall Study||75
8285845|NCT01644175|20428877|P2|Treated|Overall Study||207
8285846|NCT01644175|20428878|P1|Treated|Overall Study||107
8285847|NCT01644175|20428877|P2|STARTED|Overall Study|Randomized|209
8285848|NCT01644175|20428878|P1|STARTED|Overall Study|Randomized|107
8285849|NCT01644149|20428930|P2|NOT COMPLETED|Overall Study||1
8285850|NCT01644149|20428931|P1|NOT COMPLETED|Overall Study||4
8285851|NCT01644149|20428930|P2|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
8285852|NCT01644149|20428931|P1|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
8285853|NCT01644149|20428930|P2|STARTED|Overall Study||40
8285854|NCT01644149|20428931|P1|STARTED|Overall Study||43
8285855|NCT01644058|20428941|P1|NOT COMPLETED|Overall Study||0
8285856|NCT01644058|20428941|P1|COMPLETED|Overall Study||18
8285857|NCT01644058|20428941|P1|STARTED|Overall Study||18
8285858|NCT01643928|20428951|P5|NOT COMPLETED|Overall Study||2
8285859|NCT01643928|20428952|P4|NOT COMPLETED|Overall Study||3
8285860|NCT01643928|20428953|P3|NOT COMPLETED|Overall Study||3
8285861|NCT01643928|20428954|P2|NOT COMPLETED|Overall Study||2
8285862|NCT01643928|20428955|P1|NOT COMPLETED|Overall Study||10
8285863|NCT01643928|20428951|P5|COMPLETED|Overall Study||28
8285864|NCT01643928|20428952|P4|COMPLETED|Overall Study||27
8285865|NCT01643928|20428953|P3|COMPLETED|Overall Study||30
8285866|NCT01643928|20428954|P2|COMPLETED|Overall Study||30
8285867|NCT01643928|20428955|P1|COMPLETED|Overall Study||48
8285868|NCT01643928|20428951|P5|STARTED|Overall Study||30
8285869|NCT01643928|20428952|P4|STARTED|Overall Study||30
8285870|NCT01643928|20428953|P3|STARTED|Overall Study||33
8285871|NCT01643928|20428954|P2|STARTED|Overall Study||32
8285872|NCT01643928|20428955|P1|STARTED|Overall Study||58
8285873|NCT01643902|20429240|P1|NOT COMPLETED|Overall Study||0
8285874|NCT01643902|20429240|P1|COMPLETED|Overall Study||20
8285875|NCT01643902|20429240|P1|STARTED|Overall Study||20
8285876|NCT01643876|20429245|P1|NOT COMPLETED|Overall Study||0
8285877|NCT01643876|20429245|P1|COMPLETED|Overall Study||48
8285878|NCT01643876|20429245|P1|STARTED|Overall Study||48
8285879|NCT01643850|20429259|P9|NOT COMPLETED|Overall Study||1
8285880|NCT01643850|20429260|P8|NOT COMPLETED|Overall Study||0
8285881|NCT01643850|20429261|P7|NOT COMPLETED|Overall Study||1
8285882|NCT01643850|20429262|P6|NOT COMPLETED|Overall Study||0
8285883|NCT01643850|20429263|P5|NOT COMPLETED|Overall Study||3
8285884|NCT01643850|20429264|P4|NOT COMPLETED|Overall Study||0
8285885|NCT01643850|20429265|P3|NOT COMPLETED|Overall Study||1
8285886|NCT01643850|20429266|P2|NOT COMPLETED|Overall Study||0
8285887|NCT01643850|20429267|P1|NOT COMPLETED|Overall Study||0
8285888|NCT01643850|20429259|P9|COMPLETED|Overall Study||3
8285889|NCT01643850|20429260|P8|COMPLETED|Overall Study||4
8285890|NCT01643850|20429261|P7|COMPLETED|Overall Study||3
8285891|NCT01643850|20429262|P6|COMPLETED|Overall Study||3
8285892|NCT01643850|20429263|P5|COMPLETED|Overall Study||0
8285893|NCT01643850|20429264|P4|COMPLETED|Overall Study||3
8285894|NCT01643850|20429265|P3|COMPLETED|Overall Study||7
8285895|NCT01643850|20429266|P2|COMPLETED|Overall Study||2
8285896|NCT01643850|20429267|P1|COMPLETED|Overall Study||5
8285897|NCT01643850|20429259|P9|STARTED|Overall Study||4
8285898|NCT01643850|20429260|P8|STARTED|Overall Study||4
8285899|NCT01643850|20429261|P7|STARTED|Overall Study||4
8285900|NCT01643850|20429262|P6|STARTED|Overall Study||3
8285901|NCT01643850|20429263|P5|STARTED|Overall Study||3
8285902|NCT01643850|20429264|P4|STARTED|Overall Study||3
8285903|NCT01643850|20429265|P3|STARTED|Overall Study||8
8285904|NCT01643850|20429266|P2|STARTED|Overall Study||2
8285905|NCT01643850|20429267|P1|STARTED|Overall Study||5
8285906|NCT01643798|20429406|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
8285907|NCT01643798|20429407|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
8285908|NCT01643798|20429406|P2|COMPLETED|Pretreatment 2 and Stimulation||8
8285909|NCT01643798|20429407|P1|COMPLETED|Pretreatment 2 and Stimulation||6
8285910|NCT01643798|20429406|P2|STARTED|Pretreatment 2 and Stimulation||8
8285911|NCT01643798|20429407|P1|STARTED|Pretreatment 2 and Stimulation||6
8285912|NCT01643798|20429406|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
8285913|NCT01643798|20429407|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
8285914|NCT01643798|20429406|P2|COMPLETED|Pretreatment 1 and Stimulation||8
8285915|NCT01643798|20429407|P1|COMPLETED|Pretreatment 1 and Stimulation||6
8285916|NCT01643798|20429406|P2|STARTED|Pretreatment 1 and Stimulation||8
8285917|NCT01643798|20429407|P1|STARTED|Pretreatment 1 and Stimulation||7
8285918|NCT01643772|20429422|P4|NOT COMPLETED|Overall Study||2
8285919|NCT01643772|20429423|P3|NOT COMPLETED|Overall Study||0
8285920|NCT01643772|20429424|P2|NOT COMPLETED|Overall Study||0
8285921|NCT01643772|20429425|P1|NOT COMPLETED|Overall Study||0
8285922|NCT01643772|20429422|P4|COMPLETED|Overall Study||14
8285923|NCT01643772|20429423|P3|COMPLETED|Overall Study||15
8285924|NCT01643772|20429424|P2|COMPLETED|Overall Study||15
8285925|NCT01643772|20429425|P1|COMPLETED|Overall Study||15
8285926|NCT01643772|20429422|P4|STARTED|Overall Study||16
8285927|NCT01643772|20429423|P3|STARTED|Overall Study||15
8285928|NCT01643772|20429424|P2|STARTED|Overall Study||15
8285929|NCT01643772|20429425|P1|STARTED|Overall Study||15
8285930|NCT01643668|20429465|P1|NOT COMPLETED|Overall Study||1
8285931|NCT01643668|20429465|P1|COMPLETED|Overall Study||33
8285932|NCT01643668|20429465|P1|STARTED|Overall Study||34
8285933|NCT01643616|20429479|P2|NOT COMPLETED|Overall Study||0
8285934|NCT01643616|20429480|P1|NOT COMPLETED|Overall Study||0
8285935|NCT01643616|20429479|P2|COMPLETED|Overall Study||125
8285936|NCT01643616|20429480|P1|COMPLETED|Overall Study||125
8285937|NCT01643616|20429479|P2|STARTED|Overall Study||125
8285938|NCT01643616|20429480|P1|STARTED|Overall Study||125
8285939|NCT01643525|20429490|P1|NOT COMPLETED|Overall Study||0
8285940|NCT01643525|20429490|P1|COMPLETED|Overall Study||29
8285941|NCT01643525|20429490|P1|STARTED|Overall Study||29
8285942|NCT01643473|20429496|P2|NOT COMPLETED|Overall Study||0
8285943|NCT01643473|20429497|P1|NOT COMPLETED|Overall Study||1
8285944|NCT01643473|20429496|P2|COMPLETED|Overall Study||21
8285945|NCT01643473|20429497|P1|COMPLETED|Overall Study||20
8285946|NCT01643473|20429496|P2|STARTED|Overall Study||21
8285947|NCT01643473|20429497|P1|STARTED|Overall Study||21
8285948|NCT01643382|20429511|P2|NOT COMPLETED|Overall Study||0
8285949|NCT01643382|20429512|P1|NOT COMPLETED|Overall Study||0
8285950|NCT01643382|20429511|P2|COMPLETED|Overall Study||30
8285951|NCT01643382|20429512|P1|COMPLETED|Overall Study||30
8285952|NCT01643382|20429511|P2|STARTED|Overall Study||30
8285953|NCT01643382|20429512|P1|STARTED|Overall Study||30
8285954|NCT01643213|20429520|P2|NOT COMPLETED|Overall Study||0
8285955|NCT01643213|20429521|P1|NOT COMPLETED|Overall Study||1
8285956|NCT01643213|20429520|P2|COMPLETED|Overall Study||14
8285957|NCT01643213|20429521|P1|COMPLETED|Overall Study||12
8285958|NCT01643213|20429520|P2|STARTED|Overall Study||14
8285959|NCT01643213|20429521|P1|STARTED|Overall Study||13
8285960|NCT01643044|20429529|P2|NOT COMPLETED|Overall Study||5
8285961|NCT01643044|20429530|P1|NOT COMPLETED|Overall Study||4
8285962|NCT01643044|20429529|P2|COMPLETED|Overall Study||19
8285963|NCT01643044|20429530|P1|COMPLETED|Overall Study||20
8285964|NCT01643044|20429529|P2|STARTED|Overall Study||24
8285965|NCT01643044|20429530|P1|STARTED|Overall Study||24
8285966|NCT01642914|20429539|P3|NOT COMPLETED|Overall Study||40
8285967|NCT01642914|20429540|P2|NOT COMPLETED|Overall Study||32
8285968|NCT01642914|20429541|P1|NOT COMPLETED|Overall Study||46
8285969|NCT01642914|20429539|P3|COMPLETED|Overall Study||120
8285970|NCT01642914|20429540|P2|COMPLETED|Overall Study||122
8285971|NCT01642914|20429541|P1|COMPLETED|Overall Study||127
8285972|NCT01642914|20429539|P3|STARTED|Overall Study||160
8285973|NCT01642914|20429540|P2|STARTED|Overall Study||154
8285974|NCT01642914|20429541|P1|STARTED|Overall Study||173
8285975|NCT01642732|20429616|P1|NOT COMPLETED|Overall Study||1
8285976|NCT01642732|20429616|P1|COMPLETED|Overall Study||0
8285977|NCT01642732|20429616|P1|STARTED|Overall Study||1
8285978|NCT01642615|20429621|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
8285979|NCT01642615|20429622|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
8285980|NCT01642615|20429623|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
8285981|NCT01642615|20429621|P3|COMPLETED|Double Blind Maintenance Phase||20
8285982|NCT01642615|20429622|P2|COMPLETED|Double Blind Maintenance Phase||18
8285983|NCT01642615|20429623|P1|COMPLETED|Double Blind Maintenance Phase||0
8285984|NCT01642615|20429621|P3|STARTED|Double Blind Maintenance Phase||26
8285985|NCT01642615|20429622|P2|STARTED|Double Blind Maintenance Phase||25
8285986|NCT01642615|20429623|P1|STARTED|Double Blind Maintenance Phase||0
8285987|NCT01642615|20429621|P3|NOT COMPLETED|Open Label Maintenance Phase||0
8285988|NCT01642615|20429622|P2|NOT COMPLETED|Open Label Maintenance Phase||0
8285989|NCT01642615|20429623|P1|NOT COMPLETED|Open Label Maintenance Phase||5
8285990|NCT01642615|20429621|P3|COMPLETED|Open Label Maintenance Phase||0
8285991|NCT01642615|20429622|P2|COMPLETED|Open Label Maintenance Phase||0
8285992|NCT01642615|20429623|P1|COMPLETED|Open Label Maintenance Phase||58
8285993|NCT01642615|20429621|P3|Safety Analysis Set|Open Label Maintenance Phase||0
8285994|NCT01642615|20429622|P2|Safety Analysis Set|Open Label Maintenance Phase||0
8285995|NCT01642615|20429623|P1|Safety Analysis Set|Open Label Maintenance Phase||62
8285996|NCT01642615|20429621|P3|STARTED|Open Label Maintenance Phase||0
8285997|NCT01642615|20429622|P2|STARTED|Open Label Maintenance Phase||0
8285998|NCT01642615|20429623|P1|STARTED|Open Label Maintenance Phase||63
8285999|NCT01642602|20429637|P1|NOT COMPLETED|Overall Study||2
8286000|NCT01642602|20429637|P1|COMPLETED|Overall Study||102
8286001|NCT01642602|20429637|P1|STARTED|Overall Study||104
8286002|NCT01642589|20429644|P2|NOT COMPLETED|Overall Study||1
8286003|NCT01642589|20429645|P1|NOT COMPLETED|Overall Study||1
8286004|NCT01642589|20429644|P2|COMPLETED|Overall Study||99
8286005|NCT01642589|20429645|P1|COMPLETED|Overall Study||199
8286006|NCT01642589|20429644|P2|STARTED|Overall Study||100
8286007|NCT01642589|20429645|P1|STARTED|Overall Study||200
8286008|NCT01642485|20429659|P8|NOT COMPLETED|Period 2, Day 3||0
8286009|NCT01642485|20429660|P7|NOT COMPLETED|Period 2, Day 3||0
8286010|NCT01642485|20429661|P6|NOT COMPLETED|Period 2, Day 3||0
8286011|NCT01642485|20429662|P5|NOT COMPLETED|Period 2, Day 3||0
8286012|NCT01642485|20429663|P4|NOT COMPLETED|Period 2, Day 3||0
8286013|NCT01642485|20429664|P3|NOT COMPLETED|Period 2, Day 3||0
8286014|NCT01642485|20429665|P2|NOT COMPLETED|Period 2, Day 3||0
8286015|NCT01642485|20429666|P1|NOT COMPLETED|Period 2, Day 3||0
8286016|NCT01642485|20429659|P8|COMPLETED|Period 2, Day 3||4
8286017|NCT01642485|20429660|P7|COMPLETED|Period 2, Day 3||4
8286018|NCT01642485|20429661|P6|COMPLETED|Period 2, Day 3||4
8286019|NCT01642485|20429662|P5|COMPLETED|Period 2, Day 3||4
8286020|NCT01642485|20429663|P4|COMPLETED|Period 2, Day 3||4
8286021|NCT01642485|20429664|P3|COMPLETED|Period 2, Day 3||4
8286022|NCT01642485|20429665|P2|COMPLETED|Period 2, Day 3||4
8286023|NCT01642485|20429666|P1|COMPLETED|Period 2, Day 3||4
8286024|NCT01642485|20429659|P8|STARTED|Period 2, Day 3||4
8286025|NCT01642485|20429660|P7|STARTED|Period 2, Day 3||4
8286026|NCT01642485|20429661|P6|STARTED|Period 2, Day 3||4
8286027|NCT01642485|20429662|P5|STARTED|Period 2, Day 3||4
8286028|NCT01642485|20429663|P4|STARTED|Period 2, Day 3||4
8286029|NCT01642485|20429664|P3|STARTED|Period 2, Day 3||4
8286030|NCT01642485|20429665|P2|STARTED|Period 2, Day 3||4
8286031|NCT01642485|20429666|P1|STARTED|Period 2, Day 3||4
8286032|NCT01642485|20429659|P8|NOT COMPLETED|Period 2, Day 2||0
8286033|NCT01642485|20429660|P7|NOT COMPLETED|Period 2, Day 2||0
8286034|NCT01642485|20429661|P6|NOT COMPLETED|Period 2, Day 2||0
8286035|NCT01642485|20429662|P5|NOT COMPLETED|Period 2, Day 2||0
8286036|NCT01642485|20429663|P4|NOT COMPLETED|Period 2, Day 2||0
8286037|NCT01642485|20429664|P3|NOT COMPLETED|Period 2, Day 2||0
8286038|NCT01642485|20429665|P2|NOT COMPLETED|Period 2, Day 2||0
8286039|NCT01642485|20429666|P1|NOT COMPLETED|Period 2, Day 2||0
8286040|NCT01642485|20429659|P8|COMPLETED|Period 2, Day 2||4
8286041|NCT01642485|20429660|P7|COMPLETED|Period 2, Day 2||4
8286042|NCT01642485|20429661|P6|COMPLETED|Period 2, Day 2||4
8286043|NCT01642485|20429662|P5|COMPLETED|Period 2, Day 2||4
8286044|NCT01642485|20429663|P4|COMPLETED|Period 2, Day 2||4
8286045|NCT01642485|20429664|P3|COMPLETED|Period 2, Day 2||4
8286046|NCT01642485|20429665|P2|COMPLETED|Period 2, Day 2||4
8286047|NCT01642485|20429666|P1|COMPLETED|Period 2, Day 2||4
8286048|NCT01642485|20429659|P8|STARTED|Period 2, Day 2||4
8286049|NCT01642485|20429660|P7|STARTED|Period 2, Day 2||4
8286050|NCT01642485|20429661|P6|STARTED|Period 2, Day 2||4
8286051|NCT01642485|20429662|P5|STARTED|Period 2, Day 2||4
8286052|NCT01642485|20429663|P4|STARTED|Period 2, Day 2||4
8286053|NCT01642485|20429664|P3|STARTED|Period 2, Day 2||4
8286054|NCT01642485|20429665|P2|STARTED|Period 2, Day 2||4
8286055|NCT01642485|20429666|P1|STARTED|Period 2, Day 2||4
8286056|NCT01642485|20429659|P8|NOT COMPLETED|Period 2, Day 1||0
8286057|NCT01642485|20429660|P7|NOT COMPLETED|Period 2, Day 1||0
8286058|NCT01642485|20429661|P6|NOT COMPLETED|Period 2, Day 1||0
8286059|NCT01642485|20429662|P5|NOT COMPLETED|Period 2, Day 1||0
8286060|NCT01642485|20429663|P4|NOT COMPLETED|Period 2, Day 1||0
8286061|NCT01642485|20429664|P3|NOT COMPLETED|Period 2, Day 1||0
8286062|NCT01642485|20429665|P2|NOT COMPLETED|Period 2, Day 1||0
8286063|NCT01642485|20429666|P1|NOT COMPLETED|Period 2, Day 1||0
8286064|NCT01642485|20429659|P8|COMPLETED|Period 2, Day 1||4
8286065|NCT01642485|20429660|P7|COMPLETED|Period 2, Day 1||4
8286066|NCT01642485|20429661|P6|COMPLETED|Period 2, Day 1||4
8286067|NCT01642485|20429662|P5|COMPLETED|Period 2, Day 1||4
8286068|NCT01642485|20429663|P4|COMPLETED|Period 2, Day 1||4
8286069|NCT01642485|20429664|P3|COMPLETED|Period 2, Day 1||4
8286070|NCT01642485|20429665|P2|COMPLETED|Period 2, Day 1||4
8286071|NCT01642485|20429666|P1|COMPLETED|Period 2, Day 1||4
8286072|NCT01642485|20429659|P8|STARTED|Period 2, Day 1||4
8286073|NCT01642485|20429660|P7|STARTED|Period 2, Day 1||4
8286074|NCT01642485|20429661|P6|STARTED|Period 2, Day 1||4
8286075|NCT01642485|20429662|P5|STARTED|Period 2, Day 1||4
8286076|NCT01642485|20429663|P4|STARTED|Period 2, Day 1||4
8286077|NCT01642485|20429664|P3|STARTED|Period 2, Day 1||4
8286078|NCT01642485|20429665|P2|STARTED|Period 2, Day 1||4
8286079|NCT01642485|20429666|P1|STARTED|Period 2, Day 1||4
8286080|NCT01642485|20429659|P8|NOT COMPLETED|Period 1, Day 3||0
8286081|NCT01642485|20429660|P7|NOT COMPLETED|Period 1, Day 3||0
8286082|NCT01642485|20429661|P6|NOT COMPLETED|Period 1, Day 3||0
8286083|NCT01642485|20429662|P5|NOT COMPLETED|Period 1, Day 3||0
8286084|NCT01642485|20429663|P4|NOT COMPLETED|Period 1, Day 3||0
8286085|NCT01642485|20429664|P3|NOT COMPLETED|Period 1, Day 3||0
8286086|NCT01642485|20429665|P2|NOT COMPLETED|Period 1, Day 3||0
8286087|NCT01642485|20429666|P1|NOT COMPLETED|Period 1, Day 3||0
8286088|NCT01642485|20429659|P8|COMPLETED|Period 1, Day 3||4
8286089|NCT01642485|20429660|P7|COMPLETED|Period 1, Day 3||4
8286090|NCT01642485|20429661|P6|COMPLETED|Period 1, Day 3||4
8286091|NCT01642485|20429662|P5|COMPLETED|Period 1, Day 3||4
8286092|NCT01642485|20429663|P4|COMPLETED|Period 1, Day 3||4
8286093|NCT01642485|20429664|P3|COMPLETED|Period 1, Day 3||4
8286094|NCT01642485|20429665|P2|COMPLETED|Period 1, Day 3||4
8286095|NCT01642485|20429666|P1|COMPLETED|Period 1, Day 3||4
8286096|NCT01642485|20429659|P8|STARTED|Period 1, Day 3||4
8286097|NCT01642485|20429660|P7|STARTED|Period 1, Day 3||4
8286098|NCT01642485|20429661|P6|STARTED|Period 1, Day 3||4
8286099|NCT01642485|20429662|P5|STARTED|Period 1, Day 3||4
8286100|NCT01642485|20429663|P4|STARTED|Period 1, Day 3||4
8286101|NCT01642485|20429664|P3|STARTED|Period 1, Day 3||4
8286102|NCT01642485|20429665|P2|STARTED|Period 1, Day 3||4
8286103|NCT01642485|20429666|P1|STARTED|Period 1, Day 3||4
8286104|NCT01642485|20429659|P8|NOT COMPLETED|Period 1, Day 2||0
8286105|NCT01642485|20429660|P7|NOT COMPLETED|Period 1, Day 2||0
8286106|NCT01642485|20429661|P6|NOT COMPLETED|Period 1, Day 2||0
8286107|NCT01642485|20429662|P5|NOT COMPLETED|Period 1, Day 2||0
8286108|NCT01642485|20429663|P4|NOT COMPLETED|Period 1, Day 2||0
8286109|NCT01642485|20429664|P3|NOT COMPLETED|Period 1, Day 2||0
8286110|NCT01642485|20429665|P2|NOT COMPLETED|Period 1, Day 2||0
8286111|NCT01642485|20429666|P1|NOT COMPLETED|Period 1, Day 2||0
8286112|NCT01642485|20429659|P8|COMPLETED|Period 1, Day 2||4
8286113|NCT01642485|20429660|P7|COMPLETED|Period 1, Day 2||4
8286114|NCT01642485|20429661|P6|COMPLETED|Period 1, Day 2||4
8286115|NCT01642485|20429662|P5|COMPLETED|Period 1, Day 2||4
8286116|NCT01642485|20429663|P4|COMPLETED|Period 1, Day 2||4
8286117|NCT01642485|20429664|P3|COMPLETED|Period 1, Day 2||4
8286118|NCT01642485|20429665|P2|COMPLETED|Period 1, Day 2||4
8286119|NCT01642485|20429666|P1|COMPLETED|Period 1, Day 2||4
8286120|NCT01642485|20429659|P8|STARTED|Period 1, Day 2||4
8286121|NCT01642485|20429660|P7|STARTED|Period 1, Day 2||4
8286122|NCT01642485|20429661|P6|STARTED|Period 1, Day 2||4
8286123|NCT01642485|20429662|P5|STARTED|Period 1, Day 2||4
8286124|NCT01642485|20429663|P4|STARTED|Period 1, Day 2||4
8286125|NCT01642485|20429664|P3|STARTED|Period 1, Day 2||4
8286126|NCT01642485|20429665|P2|STARTED|Period 1, Day 2||4
8286127|NCT01642485|20429666|P1|STARTED|Period 1, Day 2||4
8286128|NCT01642485|20429659|P8|NOT COMPLETED|Period 1, Day 1||0
8286129|NCT01642485|20429660|P7|NOT COMPLETED|Period 1, Day 1||0
8286130|NCT01642485|20429661|P6|NOT COMPLETED|Period 1, Day 1||0
8286131|NCT01642485|20429662|P5|NOT COMPLETED|Period 1, Day 1||0
8286132|NCT01642485|20429663|P4|NOT COMPLETED|Period 1, Day 1||0
8286133|NCT01642485|20429664|P3|NOT COMPLETED|Period 1, Day 1||0
8286134|NCT01642485|20429665|P2|NOT COMPLETED|Period 1, Day 1||0
8286135|NCT01642485|20429666|P1|NOT COMPLETED|Period 1, Day 1||0
8286136|NCT01642485|20429659|P8|COMPLETED|Period 1, Day 1||4
8286137|NCT01642485|20429660|P7|COMPLETED|Period 1, Day 1||4
8286138|NCT01642485|20429661|P6|COMPLETED|Period 1, Day 1||4
8286139|NCT01642485|20429662|P5|COMPLETED|Period 1, Day 1||4
8286140|NCT01642485|20429663|P4|COMPLETED|Period 1, Day 1||4
8286141|NCT01642485|20429664|P3|COMPLETED|Period 1, Day 1||4
8286142|NCT01642485|20429665|P2|COMPLETED|Period 1, Day 1||4
8286143|NCT01642485|20429666|P1|COMPLETED|Period 1, Day 1||4
8286144|NCT01642485|20429659|P8|STARTED|Period 1, Day 1||4
8286145|NCT01642485|20429660|P7|STARTED|Period 1, Day 1||4
8286146|NCT01642485|20429661|P6|STARTED|Period 1, Day 1||4
8286147|NCT01642485|20429662|P5|STARTED|Period 1, Day 1||4
8286148|NCT01642485|20429663|P4|STARTED|Period 1, Day 1||4
8286149|NCT01642485|20429664|P3|STARTED|Period 1, Day 1||4
8286150|NCT01642485|20429665|P2|STARTED|Period 1, Day 1||4
8286151|NCT01642485|20429666|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
8286158|NCT01642277|20429731|P2|NOT COMPLETED|Overall Study||0
8286159|NCT01642277|20429732|P1|NOT COMPLETED|Overall Study||24
8286160|NCT01642277|20429731|P2|COMPLETED|Overall Study||60
8286161|NCT01642277|20429732|P1|COMPLETED|Overall Study||50
8286162|NCT01642277|20429731|P2|STARTED|Overall Study||60
8286163|NCT01642277|20429732|P1|STARTED|Overall Study||74
8286164|NCT01642251|20429744|P4|NOT COMPLETED|Overall Study||23
8286165|NCT01642251|20429745|P3|NOT COMPLETED|Overall Study||22
8286166|NCT01642251|20429746|P2|NOT COMPLETED|Overall Study||0
8286167|NCT01642251|20429747|P1|NOT COMPLETED|Overall Study||0
8286168|NCT01642251|20429744|P4|COMPLETED|Overall Study||49
8286169|NCT01642251|20429745|P3|COMPLETED|Overall Study||53
8286170|NCT01642251|20429746|P2|COMPLETED|Overall Study||6
8286171|NCT01642251|20429747|P1|COMPLETED|Overall Study||3
8286172|NCT01642251|20429744|P4|Eligible and Treated|Overall Study||64
8286173|NCT01642251|20429745|P3|Eligible and Treated|Overall Study||64
8286174|NCT01642251|20429746|P2|Eligible and Treated|Overall Study||6
8286175|NCT01642251|20429747|P1|Eligible and Treated|Overall Study||3
8286176|NCT01642251|20429744|P4|Eligible|Overall Study||69
8286177|NCT01642251|20429745|P3|Eligible|Overall Study||72
8286178|NCT01642251|20429746|P2|Eligible|Overall Study||6
8286179|NCT01642251|20429747|P1|Eligible|Overall Study||3
8286180|NCT01642251|20429744|P4|Started Protocol Therapy|Overall Study||66
8286181|NCT01642251|20429745|P3|Started Protocol Therapy|Overall Study||66
8286182|NCT01642251|20429746|P2|Started Protocol Therapy|Overall Study||6
8286183|NCT01642251|20429747|P1|Started Protocol Therapy|Overall Study||3
8286184|NCT01642251|20429744|P4|STARTED|Overall Study||72
8286185|NCT01642251|20429745|P3|STARTED|Overall Study||75
8286186|NCT01642251|20429746|P2|STARTED|Overall Study||6
8286187|NCT01642251|20429747|P1|STARTED|Overall Study||3
8286188|NCT01642238|20429762|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8286189|NCT01642238|20429763|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8286190|NCT01642238|20429762|P2|COMPLETED|Second Intervention (1 Day)||8
8286191|NCT01642238|20429763|P1|COMPLETED|Second Intervention (1 Day)||7
8286192|NCT01642238|20429762|P2|STARTED|Second Intervention (1 Day)||8
8286193|NCT01642238|20429763|P1|STARTED|Second Intervention (1 Day)||7
8286194|NCT01642238|20429762|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
8286195|NCT01642238|20429763|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
8286196|NCT01642238|20429762|P2|COMPLETED|Washout (1-2 Weeks)||8
8286197|NCT01642238|20429763|P1|COMPLETED|Washout (1-2 Weeks)||7
8286198|NCT01642238|20429762|P2|STARTED|Washout (1-2 Weeks)||8
8286199|NCT01642238|20429763|P1|STARTED|Washout (1-2 Weeks)||7
8286200|NCT01642238|20429762|P2|NOT COMPLETED|First Intervention (1 Day)||0
8286201|NCT01642238|20429763|P1|NOT COMPLETED|First Intervention (1 Day)||0
8286202|NCT01642238|20429762|P2|COMPLETED|First Intervention (1 Day)||8
8286203|NCT01642238|20429763|P1|COMPLETED|First Intervention (1 Day)||7
8286204|NCT01642238|20429762|P2|STARTED|First Intervention (1 Day)||8
8286205|NCT01642238|20429763|P1|STARTED|First Intervention (1 Day)||7
8286206|NCT01642212|20429785|P5|NOT COMPLETED|Open-label Extension||8
8286207|NCT01642212|20429786|P4|NOT COMPLETED|Open-label Extension||10
8286208|NCT01642212|20429787|P3|NOT COMPLETED|Open-label Extension||0
8286209|NCT01642212|20429788|P2|NOT COMPLETED|Open-label Extension||0
8286210|NCT01642212|20429789|P1|NOT COMPLETED|Open-label Extension||0
8286211|NCT01642212|20429785|P5|COMPLETED|Open-label Extension||37
8286212|NCT01642212|20429786|P4|COMPLETED|Open-label Extension||27
8286213|NCT01642212|20429787|P3|COMPLETED|Open-label Extension||0
8286214|NCT01642212|20429788|P2|COMPLETED|Open-label Extension||0
8286215|NCT01642212|20429789|P1|COMPLETED|Open-label Extension||0
8286216|NCT01642212|20429785|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
8286217|NCT01642212|20429786|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
8286218|NCT01642212|20429787|P3|STARTED|Open-label Extension||0
8286219|NCT01642212|20429788|P2|STARTED|Open-label Extension||0
8286220|NCT01642212|20429789|P1|STARTED|Open-label Extension||0
8286221|NCT01642212|20429785|P5|NOT COMPLETED|Double-blind Treatment||0
8286222|NCT01642212|20429786|P4|NOT COMPLETED|Double-blind Treatment||0
8286223|NCT01642212|20429787|P3|NOT COMPLETED|Double-blind Treatment||2
8286224|NCT01642212|20429788|P2|NOT COMPLETED|Double-blind Treatment||3
8286225|NCT01642212|20429789|P1|NOT COMPLETED|Double-blind Treatment||0
8286226|NCT01642212|20429785|P5|COMPLETED|Double-blind Treatment||0
8286227|NCT01642212|20429786|P4|COMPLETED|Double-blind Treatment||0
8286228|NCT01642212|20429787|P3|COMPLETED|Double-blind Treatment||49
8286229|NCT01642212|20429788|P2|COMPLETED|Double-blind Treatment||39
8286230|NCT01642212|20429789|P1|COMPLETED|Double-blind Treatment||0
8286231|NCT01642212|20429785|P5|STARTED|Double-blind Treatment||0
8286232|NCT01642212|20429786|P4|STARTED|Double-blind Treatment||0
8286233|NCT01642212|20429787|P3|STARTED|Double-blind Treatment||51
8286234|NCT01642212|20429788|P2|STARTED|Double-blind Treatment||42
8286235|NCT01642212|20429789|P1|STARTED|Double-blind Treatment||0
8286236|NCT01642212|20429785|P5|NOT COMPLETED|Single-blind Baseline||0
8286237|NCT01642212|20429786|P4|NOT COMPLETED|Single-blind Baseline||0
8286238|NCT01642212|20429787|P3|NOT COMPLETED|Single-blind Baseline||0
8286239|NCT01642212|20429788|P2|NOT COMPLETED|Single-blind Baseline||0
8286240|NCT01642212|20429789|P1|NOT COMPLETED|Single-blind Baseline||26
8286241|NCT01642212|20429785|P5|COMPLETED|Single-blind Baseline||0
8286242|NCT01642212|20429786|P4|COMPLETED|Single-blind Baseline||0
8286243|NCT01642212|20429787|P3|COMPLETED|Single-blind Baseline||0
8286244|NCT01642212|20429788|P2|COMPLETED|Single-blind Baseline||0
8286245|NCT01642212|20429789|P1|COMPLETED|Single-blind Baseline||93
8286246|NCT01642212|20429785|P5|STARTED|Single-blind Baseline||0
8286247|NCT01642212|20429786|P4|STARTED|Single-blind Baseline||0
8286248|NCT01642212|20429787|P3|STARTED|Single-blind Baseline||0
8286249|NCT01642212|20429788|P2|STARTED|Single-blind Baseline||0
8286250|NCT01642212|20429789|P1|STARTED|Single-blind Baseline||119
8286251|NCT01642147|20429839|P2|NOT COMPLETED|Overall Study||0
8286252|NCT01642147|20429840|P1|NOT COMPLETED|Overall Study||0
8286253|NCT01642147|20429839|P2|COMPLETED|Overall Study||30
8286254|NCT01642147|20429840|P1|COMPLETED|Overall Study||30
8286255|NCT01642147|20429839|P2|STARTED|Overall Study||30
8286256|NCT01642147|20429840|P1|STARTED|Overall Study||30
8286257|NCT01642082|20429868|P1|NOT COMPLETED|Overall Study||0
8286258|NCT01642082|20429868|P1|COMPLETED|Overall Study||28
8286259|NCT01642082|20429868|P1|STARTED|Overall Study||28
8286260|NCT01642004|20429884|P2|NOT COMPLETED|Treatment||127
8286261|NCT01642004|20429885|P1|NOT COMPLETED|Treatment||110
8286262|NCT01642004|20429884|P2|COMPLETED|Treatment||2
8286263|NCT01642004|20429885|P1|COMPLETED|Treatment||21
8286264|NCT01642004|20429884|P2|STARTED|Treatment||129
8286265|NCT01642004|20429885|P1|STARTED|Treatment||131
8286266|NCT01642004|20429884|P2|NOT COMPLETED|Randomization||8
8286267|NCT01642004|20429885|P1|NOT COMPLETED|Randomization||4
8286268|NCT01642004|20429884|P2|COMPLETED|Randomization||129
8286269|NCT01642004|20429885|P1|COMPLETED|Randomization||131
8286270|NCT01642004|20429884|P2|STARTED|Randomization||137
8286271|NCT01642004|20429885|P1|STARTED|Randomization||135
8286272|NCT01641991|20429919|P4|NOT COMPLETED|Overall Study||16
8286273|NCT01641991|20429920|P3|NOT COMPLETED|Overall Study||17
8286274|NCT01641991|20429921|P2|NOT COMPLETED|Overall Study||8
8286275|NCT01641991|20429922|P1|NOT COMPLETED|Overall Study||9
8286276|NCT01641991|20429919|P4|COMPLETED|Overall Study||66
8286277|NCT01641991|20429920|P3|COMPLETED|Overall Study||65
8286278|NCT01641991|20429921|P2|COMPLETED|Overall Study||74
8286279|NCT01641991|20429922|P1|COMPLETED|Overall Study||73
8286280|NCT01641991|20429919|P4|STARTED|Overall Study||82
8286281|NCT01641991|20429920|P3|STARTED|Overall Study||82
8286282|NCT01641991|20429921|P2|STARTED|Overall Study||82
8286283|NCT01641991|20429922|P1|STARTED|Overall Study||82
8286284|NCT01641978|20429998|P1|NOT COMPLETED|Overall Study||0
8286285|NCT01641978|20429998|P1|COMPLETED|Overall Study||125
8286286|NCT01641978|20429998|P1|STARTED|Overall Study||125
8286287|NCT01641952|20430006|P1|NOT COMPLETED|Overall Study||34
8286288|NCT01641952|20430006|P1|COMPLETED|Overall Study||471
8286289|NCT01641952|20430006|P1|Treated|Overall Study||504
8286290|NCT01641952|20430006|P1|STARTED|Overall Study||505
8286291|NCT01641939|20430022|P3|NOT COMPLETED|Overall Study||70
8286292|NCT01641939|20430023|P2|NOT COMPLETED|Overall Study||228
8286293|NCT01641939|20430024|P1|NOT COMPLETED|Overall Study||117
8286294|NCT01641939|20430022|P3|COMPLETED|Overall Study||0
8286295|NCT01641939|20430023|P2|COMPLETED|Overall Study||0
8286296|NCT01641939|20430024|P1|COMPLETED|Overall Study||0
8286297|NCT01641939|20430022|P3|Stage 2|Overall Study||0
8286298|NCT01641939|20430023|P2|Stage 2|Overall Study||153
8286299|NCT01641939|20430024|P1|Stage 2|Overall Study||80
8286300|NCT01641939|20430022|P3|Stage 1|Overall Study||70
8286301|NCT01641939|20430023|P2|Stage 1|Overall Study||75
8286302|NCT01641939|20430024|P1|Stage 1|Overall Study||37
8286303|NCT01641939|20430022|P3|STARTED|Overall Study||70
8286304|NCT01641939|20430023|P2|STARTED|Overall Study||228
8286305|NCT01641939|20430024|P1|STARTED|Overall Study||117
8286306|NCT01641926|20430067|P4|NOT COMPLETED|Overall Study||4
8286307|NCT01641926|20430068|P3|NOT COMPLETED|Overall Study||11
8286308|NCT01641926|20430069|P2|NOT COMPLETED|Overall Study||15
8286309|NCT01641926|20430070|P1|NOT COMPLETED|Overall Study||28
8286310|NCT01641926|20430067|P4|COMPLETED|Overall Study||53
8286311|NCT01641926|20430068|P3|COMPLETED|Overall Study||46
8286312|NCT01641926|20430069|P2|COMPLETED|Overall Study||130
8286313|NCT01641926|20430070|P1|COMPLETED|Overall Study||115
8286314|NCT01641926|20430067|P4|Treated (All Participants as Treated)|Overall Study||57
8286315|NCT01641926|20430068|P3|Treated (All Participants as Treated)|Overall Study||56
8286316|NCT01641926|20430069|P2|Treated (All Participants as Treated)|Overall Study||144
8286317|NCT01641926|20430070|P1|Treated (All Participants as Treated)|Overall Study||142
8286318|NCT01641926|20430067|P4|STARTED|Overall Study||57
8286319|NCT01641926|20430068|P3|STARTED|Overall Study||57
8286320|NCT01641926|20430069|P2|STARTED|Overall Study||145
8286321|NCT01641926|20430070|P1|STARTED|Overall Study||143
8286322|NCT01641900|20430098|P2|NOT COMPLETED|Overall Study||2
8286323|NCT01641900|20430099|P1|NOT COMPLETED|Overall Study||2
8286324|NCT01641900|20430098|P2|COMPLETED|Overall Study||29
8286325|NCT01641900|20430099|P1|COMPLETED|Overall Study||26
8286326|NCT01641900|20430098|P2|Completed Drug Intervention|Overall Study||29
8286327|NCT01641900|20430099|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
8286328|NCT01641900|20430098|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
8286329|NCT01641900|20430099|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
8286330|NCT01641900|20430098|P2|STARTED|Overall Study||31
8286331|NCT01641900|20430099|P1|STARTED|Overall Study||28
8286332|NCT01641861|20430111|P2|NOT COMPLETED|Overall Study||25
8286333|NCT01641861|20430112|P1|NOT COMPLETED|Overall Study||35
8286334|NCT01641861|20430111|P2|COMPLETED|Overall Study||217
8286335|NCT01641861|20430112|P1|COMPLETED|Overall Study||211
8286336|NCT01641861|20430111|P2|STARTED|Overall Study||242
8286337|NCT01641861|20430112|P1|STARTED|Overall Study||246
8286338|NCT01641835|20430126|P1|NOT COMPLETED|Overall Study||0
8286339|NCT01641835|20430126|P1|COMPLETED|Overall Study||303
8286340|NCT01641835|20430126|P1|STARTED|Overall Study||303
8286341|NCT01641822|20430133|P3|NOT COMPLETED|Comparative Phase||10
8286342|NCT01641822|20430134|P2|NOT COMPLETED|Comparative Phase||6
8286343|NCT01641822|20430135|P1|NOT COMPLETED|Comparative Phase||0
8286344|NCT01641822|20430133|P3|COMPLETED|Comparative Phase||37
8286345|NCT01641822|20430134|P2|COMPLETED|Comparative Phase||37
8286346|NCT01641822|20430135|P1|COMPLETED|Comparative Phase||0
8286347|NCT01641822|20430133|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
8286348|NCT01641822|20430134|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
8286349|NCT01641822|20430135|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
8286350|NCT01641822|20430133|P3|STARTED|Comparative Phase||47
8286351|NCT01641822|20430134|P2|STARTED|Comparative Phase||43
8286352|NCT01641822|20430135|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
8286353|NCT01641822|20430133|P3|NOT COMPLETED|Run-in Phase||0
8286354|NCT01641822|20430134|P2|NOT COMPLETED|Run-in Phase||0
8286355|NCT01641822|20430135|P1|NOT COMPLETED|Run-in Phase||14
8286356|NCT01641822|20430133|P3|COMPLETED|Run-in Phase||0
8286357|NCT01641822|20430134|P2|COMPLETED|Run-in Phase||0
8286358|NCT01641822|20430135|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
8286359|NCT01641822|20430133|P3|STARTED|Run-in Phase||0
8286360|NCT01641822|20430134|P2|STARTED|Run-in Phase||0
8286361|NCT01641822|20430135|P1|STARTED|Run-in Phase||107
8286362|NCT01641809|20430156|P4|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
8286363|NCT01641809|20430157|P3|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
8286364|NCT01641809|20430158|P2|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
8286365|NCT01641809|20430159|P1|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
8286366|NCT01641809|20430156|P4|COMPLETED|Open-label (Week 96 to Week 324)||0
8286367|NCT01641809|20430157|P3|COMPLETED|Open-label (Week 96 to Week 324)||43
8286368|NCT01641809|20430158|P2|COMPLETED|Open-label (Week 96 to Week 324)||35
8286369|NCT01641809|20430159|P1|COMPLETED|Open-label (Week 96 to Week 324)||30
8286370|NCT01641809|20430156|P4|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
8286371|NCT01641809|20430157|P3|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
8286372|NCT01641809|20430158|P2|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
8286373|NCT01641809|20430159|P1|STARTED|Open-label (Week 96 to Week 324)||46
8286374|NCT01641809|20430156|P4|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
8286375|NCT01641809|20430157|P3|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
8286376|NCT01641809|20430158|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
8286377|NCT01641809|20430159|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
8286378|NCT01641809|20430156|P4|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
8286379|NCT01641809|20430157|P3|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
8286380|NCT01641809|20430158|P2|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
8286381|NCT01641809|20430159|P1|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
8286382|NCT01641809|20430156|P4|STARTED|Maintenance Phase (Week 24 to Week 96)||47
8286383|NCT01641809|20430157|P3|STARTED|Maintenance Phase (Week 24 to Week 96)||55
8286384|NCT01641809|20430158|P2|STARTED|Maintenance Phase (Week 24 to Week 96)||53
8286385|NCT01641809|20430159|P1|STARTED|Maintenance Phase (Week 24 to Week 96)||52
8286386|NCT01641809|20430156|P4|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
8286387|NCT01641809|20430157|P3|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
8286388|NCT01641809|20430158|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
8286389|NCT01641809|20430159|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
8286390|NCT01641809|20430156|P4|COMPLETED|Induction Phase (Day 1 to Week 24)||47
8286391|NCT01641809|20430157|P3|COMPLETED|Induction Phase (Day 1 to Week 24)||55
8286392|NCT01641809|20430158|P2|COMPLETED|Induction Phase (Day 1 to Week 24)||53
8286393|NCT01641809|20430159|P1|COMPLETED|Induction Phase (Day 1 to Week 24)||52
8286394|NCT01641809|20430156|P4|STARTED|Induction Phase (Day 1 to Week 24)||62
8286395|NCT01641809|20430157|P3|STARTED|Induction Phase (Day 1 to Week 24)||61
8286396|NCT01641809|20430158|P2|STARTED|Induction Phase (Day 1 to Week 24)||60
8286397|NCT01641809|20430159|P1|STARTED|Induction Phase (Day 1 to Week 24)||60
8286398|NCT01641692|20430343|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
8286399|NCT01641692|20430344|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286400|NCT01641692|20430345|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
8286401|NCT01641692|20430346|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
8286402|NCT01641692|20430347|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286403|NCT01641692|20430348|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286404|NCT01641692|20430349|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
8286405|NCT01641692|20430350|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286406|NCT01641692|20430343|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
8286407|NCT01641692|20430344|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
8286408|NCT01641692|20430345|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
8286409|NCT01641692|20430346|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
8286410|NCT01641692|20430347|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
8286411|NCT01641692|20430348|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
8286412|NCT01641692|20430349|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
8286413|NCT01641692|20430350|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
8286414|NCT01641692|20430343|P8|STARTED|Washout Period 3 or Follow-up||38
8286415|NCT01641692|20430344|P7|STARTED|Washout Period 3 or Follow-up||33
8286416|NCT01641692|20430345|P6|STARTED|Washout Period 3 or Follow-up||39
8286417|NCT01641692|20430346|P5|STARTED|Washout Period 3 or Follow-up||40
8286418|NCT01641692|20430347|P4|STARTED|Washout Period 3 or Follow-up||42
8286419|NCT01641692|20430348|P3|STARTED|Washout Period 3 or Follow-up||37
8286420|NCT01641692|20430349|P2|STARTED|Washout Period 3 or Follow-up||32
8286421|NCT01641692|20430350|P1|STARTED|Washout Period 3 or Follow-up||43
8286422|NCT01641692|20430343|P8|NOT COMPLETED|Treatment Period 3||0
8286423|NCT01641692|20430344|P7|NOT COMPLETED|Treatment Period 3||2
8286424|NCT01641692|20430345|P6|NOT COMPLETED|Treatment Period 3||0
8286425|NCT01641692|20430346|P5|NOT COMPLETED|Treatment Period 3||0
8286426|NCT01641692|20430347|P4|NOT COMPLETED|Treatment Period 3||0
8286427|NCT01641692|20430348|P3|NOT COMPLETED|Treatment Period 3||1
8286428|NCT01641692|20430349|P2|NOT COMPLETED|Treatment Period 3||1
8286429|NCT01641692|20430350|P1|NOT COMPLETED|Treatment Period 3||0
8286430|NCT01641692|20430343|P8|COMPLETED|Treatment Period 3||38
8286431|NCT01641692|20430344|P7|COMPLETED|Treatment Period 3||33
8286432|NCT01641692|20430345|P6|COMPLETED|Treatment Period 3||39
8286433|NCT01641692|20430346|P5|COMPLETED|Treatment Period 3||40
8286434|NCT01641692|20430347|P4|COMPLETED|Treatment Period 3||42
8286435|NCT01641692|20430348|P3|COMPLETED|Treatment Period 3||37
8286436|NCT01641692|20430349|P2|COMPLETED|Treatment Period 3||32
8286437|NCT01641692|20430350|P1|COMPLETED|Treatment Period 3||43
8286438|NCT01641692|20430343|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
8286439|NCT01641692|20430344|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
8286440|NCT01641692|20430345|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
8286441|NCT01641692|20430346|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
8286442|NCT01641692|20430347|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
8286443|NCT01641692|20430348|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
8286444|NCT01641692|20430349|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
8286445|NCT01641692|20430350|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
8286446|NCT01641692|20430343|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286447|NCT01641692|20430344|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286448|NCT01641692|20430345|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286449|NCT01641692|20430346|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
8286450|NCT01641692|20430347|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8286451|NCT01641692|20430348|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286452|NCT01641692|20430349|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8286453|NCT01641692|20430350|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8286454|NCT01641692|20430343|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
8286455|NCT01641692|20430344|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
8286456|NCT01641692|20430345|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
8286457|NCT01641692|20430346|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
8286458|NCT01641692|20430347|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
8286459|NCT01641692|20430348|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
8286460|NCT01641692|20430349|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
8286461|NCT01641692|20430350|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
8286462|NCT01641692|20430343|P8|STARTED|Washout Period 2 (12-14 Days)||35
8286463|NCT01641692|20430344|P7|STARTED|Washout Period 2 (12-14 Days)||43
8286464|NCT01641692|20430345|P6|STARTED|Washout Period 2 (12-14 Days)||43
8286465|NCT01641692|20430346|P5|STARTED|Washout Period 2 (12-14 Days)||37
8286466|NCT01641692|20430347|P4|STARTED|Washout Period 2 (12-14 Days)||41
8286467|NCT01641692|20430348|P3|STARTED|Washout Period 2 (12-14 Days)||40
8286468|NCT01641692|20430349|P2|STARTED|Washout Period 2 (12-14 Days)||46
8286469|NCT01641692|20430350|P1|STARTED|Washout Period 2 (12-14 Days)||30
8286470|NCT01641692|20430343|P8|NOT COMPLETED|Treatment Period 2||1
8286471|NCT01641692|20430344|P7|NOT COMPLETED|Treatment Period 2||0
8286472|NCT01641692|20430345|P6|NOT COMPLETED|Treatment Period 2||2
8286473|NCT01641692|20430346|P5|NOT COMPLETED|Treatment Period 2||0
8286474|NCT01641692|20430347|P4|NOT COMPLETED|Treatment Period 2||0
8286475|NCT01641692|20430348|P3|NOT COMPLETED|Treatment Period 2||0
8286476|NCT01641692|20430349|P2|NOT COMPLETED|Treatment Period 2||0
8286477|NCT01641692|20430350|P1|NOT COMPLETED|Treatment Period 2||3
8286478|NCT01641692|20430343|P8|COMPLETED|Treatment Period 2||35
8286479|NCT01641692|20430344|P7|COMPLETED|Treatment Period 2||43
8286480|NCT01641692|20430345|P6|COMPLETED|Treatment Period 2||43
8286481|NCT01641692|20430346|P5|COMPLETED|Treatment Period 2||37
8286482|NCT01641692|20430347|P4|COMPLETED|Treatment Period 2||41
8286483|NCT01641692|20430348|P3|COMPLETED|Treatment Period 2||40
8286484|NCT01641692|20430349|P2|COMPLETED|Treatment Period 2||46
8286485|NCT01641692|20430350|P1|COMPLETED|Treatment Period 2||30
8286486|NCT01641692|20430343|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
8286487|NCT01641692|20430344|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
8286488|NCT01641692|20430345|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
8286489|NCT01641692|20430346|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
8286490|NCT01641692|20430347|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
8286491|NCT01641692|20430348|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
8286492|NCT01641692|20430349|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
8286493|NCT01641692|20430350|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
8286494|NCT01641692|20430343|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
8286495|NCT01641692|20430344|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
8286496|NCT01641692|20430345|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
8286497|NCT01641692|20430346|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
8286498|NCT01641692|20430347|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
8286499|NCT01641692|20430348|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
8286500|NCT01641692|20430349|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
8286501|NCT01641692|20430350|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
8286502|NCT01641692|20430343|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
8286503|NCT01641692|20430344|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
8286504|NCT01641692|20430345|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
8286505|NCT01641692|20430346|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
8286506|NCT01641692|20430347|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
8286507|NCT01641692|20430348|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
8286508|NCT01641692|20430349|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
8286509|NCT01641692|20430350|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
8286510|NCT01641692|20430343|P8|STARTED|Washout Period 1 (12-14 Days)||48
8286511|NCT01641692|20430344|P7|STARTED|Washout Period 1 (12-14 Days)||38
8286512|NCT01641692|20430345|P6|STARTED|Washout Period 1 (12-14 Days)||37
8286513|NCT01641692|20430346|P5|STARTED|Washout Period 1 (12-14 Days)||39
8286514|NCT01641692|20430347|P4|STARTED|Washout Period 1 (12-14 Days)||41
8286515|NCT01641692|20430348|P3|STARTED|Washout Period 1 (12-14 Days)||50
8286516|NCT01641692|20430349|P2|STARTED|Washout Period 1 (12-14 Days)||45
8286517|NCT01641692|20430350|P1|STARTED|Washout Period 1 (12-14 Days)||40
8286518|NCT01641692|20430343|P8|NOT COMPLETED|Treatment Period 1||3
8286519|NCT01641692|20430344|P7|NOT COMPLETED|Treatment Period 1||0
8286520|NCT01641692|20430345|P6|NOT COMPLETED|Treatment Period 1||2
8286521|NCT01641692|20430346|P5|NOT COMPLETED|Treatment Period 1||4
8286522|NCT01641692|20430347|P4|NOT COMPLETED|Treatment Period 1||0
8286523|NCT01641692|20430348|P3|NOT COMPLETED|Treatment Period 1||1
8286524|NCT01641692|20430349|P2|NOT COMPLETED|Treatment Period 1||0
8286525|NCT01641692|20430350|P1|NOT COMPLETED|Treatment Period 1||2
8286526|NCT01641692|20430343|P8|COMPLETED|Treatment Period 1||48
8286527|NCT01641692|20430344|P7|COMPLETED|Treatment Period 1||38
8286528|NCT01641692|20430345|P6|COMPLETED|Treatment Period 1||37
8286529|NCT01641692|20430346|P5|COMPLETED|Treatment Period 1||39
8286530|NCT01641692|20430347|P4|COMPLETED|Treatment Period 1||41
8286531|NCT01641692|20430348|P3|COMPLETED|Treatment Period 1||50
8286532|NCT01641692|20430349|P2|COMPLETED|Treatment Period 1||45
8286533|NCT01641692|20430350|P1|COMPLETED|Treatment Period 1||40
8286534|NCT01641692|20430343|P8|STARTED|Treatment Period 1||51
8286535|NCT01641692|20430344|P7|STARTED|Treatment Period 1||38
8286536|NCT01641692|20430345|P6|STARTED|Treatment Period 1||39
8286537|NCT01641692|20430346|P5|STARTED|Treatment Period 1||43
8286538|NCT01641692|20430347|P4|STARTED|Treatment Period 1||41
8286539|NCT01641692|20430348|P3|STARTED|Treatment Period 1||51
8286540|NCT01641692|20430349|P2|STARTED|Treatment Period 1||45
8286541|NCT01641692|20430350|P1|STARTED|Treatment Period 1||42
8286542|NCT01641653|20430539|P2|NOT COMPLETED|Overall Study||0
8286543|NCT01641653|20430540|P1|NOT COMPLETED|Overall Study||0
8286544|NCT01641653|20430539|P2|COMPLETED|Overall Study||30
8286545|NCT01641653|20430540|P1|COMPLETED|Overall Study||30
8286546|NCT01641653|20430539|P2|STARTED|Overall Study||30
8286547|NCT01641653|20430540|P1|STARTED|Overall Study||30
8286548|NCT01641640|20430550|P1|NOT COMPLETED|Overall Study||36
8286549|NCT01641640|20430550|P1|COMPLETED|Overall Study||292
8286550|NCT01641640|20430550|P1|Enrolled and Treated|Overall Study||327
8286551|NCT01641640|20430550|P1|STARTED|Overall Study||328
8286552|NCT01641601|20430561|P2|NOT COMPLETED|Overall Study||5
8286553|NCT01641601|20430562|P1|NOT COMPLETED|Overall Study||3
8286554|NCT01641601|20430561|P2|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
8286555|NCT01641601|20430562|P1|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
8286556|NCT01641601|20430561|P2|STARTED|Overall Study||5
8286557|NCT01641601|20430562|P1|STARTED|Overall Study||3
8286558|NCT01641471|20430572|P2|NOT COMPLETED|Overall Study||27
8286559|NCT01641471|20430573|P1|NOT COMPLETED|Overall Study||23
8286560|NCT01641471|20430572|P2|COMPLETED|Overall Study||31
8286561|NCT01641471|20430573|P1|COMPLETED|Overall Study||35
8286562|NCT01641471|20430572|P2|STARTED|Overall Study||58
8286563|NCT01641471|20430573|P1|STARTED|Overall Study||58
8286564|NCT01641445|20430587|P2|NOT COMPLETED|Overall Study||5
8286565|NCT01641445|20430588|P1|NOT COMPLETED|Overall Study||10
8286566|NCT01641445|20430587|P2|COMPLETED|Overall Study||36
8286567|NCT01641445|20430588|P1|COMPLETED|Overall Study||31
8286568|NCT01641445|20430587|P2|STARTED|Overall Study||41
8286569|NCT01641445|20430588|P1|STARTED|Overall Study||41
8286570|NCT01641380|20430602|P2|NOT COMPLETED|Third Injection Cycle||5
8286571|NCT01641380|20430603|P1|NOT COMPLETED|Third Injection Cycle||3
8286572|NCT01641380|20430602|P2|COMPLETED|Third Injection Cycle||33
8286573|NCT01641380|20430603|P1|COMPLETED|Third Injection Cycle||36
8286574|NCT01641380|20430602|P2|STARTED|Third Injection Cycle||38
8286575|NCT01641380|20430603|P1|STARTED|Third Injection Cycle||39
8286576|NCT01641380|20430602|P2|NOT COMPLETED|Second Injection Cycle||6
8286577|NCT01641380|20430603|P1|NOT COMPLETED|Second Injection Cycle||4
8286578|NCT01641380|20430602|P2|COMPLETED|Second Injection Cycle||38
8286579|NCT01641380|20430603|P1|COMPLETED|Second Injection Cycle||39
8286580|NCT01641380|20430602|P2|STARTED|Second Injection Cycle||44
8286581|NCT01641380|20430603|P1|STARTED|Second Injection Cycle||43
8286582|NCT01641380|20430602|P2|NOT COMPLETED|First Injection Cycle||6
8286583|NCT01641380|20430603|P1|NOT COMPLETED|First Injection Cycle||7
8286584|NCT01641380|20430602|P2|COMPLETED|First Injection Cycle||44
8286585|NCT01641380|20430603|P1|COMPLETED|First Injection Cycle||43
8286586|NCT01641380|20430602|P2|STARTED|First Injection Cycle||50
8286587|NCT01641380|20430603|P1|STARTED|First Injection Cycle||50
8286588|NCT01641367|20430620|P8|NOT COMPLETED|Randomized Adherence Intervention||24
8286589|NCT01641367|20430621|P7|NOT COMPLETED|Randomized Adherence Intervention||19
8286590|NCT01641367|20430622|P6|NOT COMPLETED|Randomized Adherence Intervention||0
8286591|NCT01641367|20430623|P5|NOT COMPLETED|Randomized Adherence Intervention||0
8286592|NCT01641367|20430624|P4|NOT COMPLETED|Randomized Adherence Intervention||0
8286593|NCT01641367|20430625|P3|NOT COMPLETED|Randomized Adherence Intervention||0
8286594|NCT01641367|20430626|P2|NOT COMPLETED|Randomized Adherence Intervention||0
8286595|NCT01641367|20430627|P1|NOT COMPLETED|Randomized Adherence Intervention||0
8286596|NCT01641367|20430620|P8|COMPLETED|Randomized Adherence Intervention||240
8286597|NCT01641367|20430621|P7|COMPLETED|Randomized Adherence Intervention||238
8286598|NCT01641367|20430622|P6|COMPLETED|Randomized Adherence Intervention||0
8286599|NCT01641367|20430623|P5|COMPLETED|Randomized Adherence Intervention||0
8286600|NCT01641367|20430624|P4|COMPLETED|Randomized Adherence Intervention||0
8286601|NCT01641367|20430625|P3|COMPLETED|Randomized Adherence Intervention||0
8286602|NCT01641367|20430626|P2|COMPLETED|Randomized Adherence Intervention||0
8286603|NCT01641367|20430627|P1|COMPLETED|Randomized Adherence Intervention||0
8286604|NCT01641367|20430620|P8|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
8286605|NCT01641367|20430621|P7|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
8286606|NCT01641367|20430622|P6|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286607|NCT01641367|20430623|P5|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286608|NCT01641367|20430624|P4|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286609|NCT01641367|20430625|P3|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286610|NCT01641367|20430626|P2|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286611|NCT01641367|20430627|P1|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286612|NCT01641367|20430620|P8|STARTED|Randomized Adherence Intervention||264
8286613|NCT01641367|20430621|P7|STARTED|Randomized Adherence Intervention||257
8286614|NCT01641367|20430622|P6|STARTED|Randomized Adherence Intervention||0
8286615|NCT01641367|20430623|P5|STARTED|Randomized Adherence Intervention||0
8286616|NCT01641367|20430624|P4|STARTED|Randomized Adherence Intervention||0
8286617|NCT01641367|20430625|P3|STARTED|Randomized Adherence Intervention||0
8286618|NCT01641367|20430626|P2|STARTED|Randomized Adherence Intervention||0
8286619|NCT01641367|20430627|P1|STARTED|Randomized Adherence Intervention||0
8286620|NCT01641367|20430620|P8|NOT COMPLETED|Cohorts||0
8286621|NCT01641367|20430621|P7|NOT COMPLETED|Cohorts||0
8286622|NCT01641367|20430622|P6|NOT COMPLETED|Cohorts||1
8286623|NCT01641367|20430623|P5|NOT COMPLETED|Cohorts||3
8286624|NCT01641367|20430624|P4|NOT COMPLETED|Cohorts||0
8286625|NCT01641367|20430625|P3|NOT COMPLETED|Cohorts||4
8286626|NCT01641367|20430626|P2|NOT COMPLETED|Cohorts||1
8286627|NCT01641367|20430627|P1|NOT COMPLETED|Cohorts||34
8286628|NCT01641367|20430620|P8|COMPLETED|Cohorts||0
8286629|NCT01641367|20430621|P7|COMPLETED|Cohorts||0
8286630|NCT01641367|20430622|P6|COMPLETED|Cohorts||33
8286631|NCT01641367|20430623|P5|COMPLETED|Cohorts||67
8286632|NCT01641367|20430624|P4|COMPLETED|Cohorts||8
8286633|NCT01641367|20430625|P3|COMPLETED|Cohorts||68
8286634|NCT01641367|20430626|P2|COMPLETED|Cohorts||73
8286635|NCT01641367|20430627|P1|COMPLETED|Cohorts||253
8286636|NCT01641367|20430620|P8|Followed 72 Weeks on Step 1/2|Cohorts||0
8286637|NCT01641367|20430621|P7|Followed 72 Weeks on Step 1/2|Cohorts||0
8286638|NCT01641367|20430622|P6|Followed 72 Weeks on Step 1/2|Cohorts||30
8286639|NCT01641367|20430623|P5|Followed 72 Weeks on Step 1/2|Cohorts||52
8286640|NCT01641367|20430624|P4|Followed 72 Weeks on Step 1/2|Cohorts||6
8286641|NCT01641367|20430625|P3|Followed 72 Weeks on Step 1/2|Cohorts||60
8286642|NCT01641367|20430626|P2|Followed 72 Weeks on Step 1/2|Cohorts||60
8286643|NCT01641367|20430627|P1|Followed 72 Weeks on Step 1/2|Cohorts||211
8286644|NCT01641367|20430620|P8|STARTED|Cohorts||0
8286645|NCT01641367|20430621|P7|STARTED|Cohorts||0
8286646|NCT01641367|20430622|P6|STARTED|Cohorts||34
8286647|NCT01641367|20430623|P5|STARTED|Cohorts||70
8286648|NCT01641367|20430624|P4|STARTED|Cohorts||8
8286649|NCT01641367|20430625|P3|STARTED|Cohorts||72
8286650|NCT01641367|20430626|P2|STARTED|Cohorts||74
8286651|NCT01641367|20430627|P1|STARTED|Cohorts||287
8286652|NCT01641237|20430878|P4|NOT COMPLETED|Period IV||0
8286653|NCT01641237|20430879|P3|NOT COMPLETED|Period IV||0
8286654|NCT01641237|20430880|P2|NOT COMPLETED|Period IV||0
8286655|NCT01641237|20430881|P1|NOT COMPLETED|Period IV||0
8286656|NCT01641237|20430878|P4|COMPLETED|Period IV||15
8286657|NCT01641237|20430879|P3|COMPLETED|Period IV||15
8286658|NCT01641237|20430880|P2|COMPLETED|Period IV||15
8286659|NCT01641237|20430881|P1|COMPLETED|Period IV||15
8286660|NCT01641237|20430878|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286661|NCT01641237|20430879|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286662|NCT01641237|20430880|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286663|NCT01641237|20430881|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286664|NCT01641237|20430878|P4|NOT COMPLETED|Period III||0
8286665|NCT01641237|20430879|P3|NOT COMPLETED|Period III||0
8286666|NCT01641237|20430880|P2|NOT COMPLETED|Period III||0
8286667|NCT01641237|20430881|P1|NOT COMPLETED|Period III||1
8286668|NCT01641237|20430878|P4|COMPLETED|Period III||16
8286669|NCT01641237|20430879|P3|COMPLETED|Period III||15
8286670|NCT01641237|20430880|P2|COMPLETED|Period III||14
8286671|NCT01641237|20430881|P1|COMPLETED|Period III||15
8286672|NCT01641237|20430878|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
8286673|NCT01641237|20430879|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
8286674|NCT01641237|20430880|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8286675|NCT01641237|20430881|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
8286676|NCT01641237|20430878|P4|NOT COMPLETED|Period II||0
8286677|NCT01641237|20430879|P3|NOT COMPLETED|Period II||0
8286678|NCT01641237|20430880|P2|NOT COMPLETED|Period II||0
8286679|NCT01641237|20430881|P1|NOT COMPLETED|Period II||1
8286680|NCT01641237|20430878|P4|COMPLETED|Period II||15
8286681|NCT01641237|20430879|P3|COMPLETED|Period II||16
8286682|NCT01641237|20430880|P2|COMPLETED|Period II||16
8286683|NCT01641237|20430881|P1|COMPLETED|Period II||14
8286684|NCT01641237|20430878|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
8286685|NCT01641237|20430879|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
8286686|NCT01641237|20430880|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
8286687|NCT01641237|20430881|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
8286688|NCT01641237|20430878|P4|NOT COMPLETED|Period I||0
8286689|NCT01641237|20430879|P3|NOT COMPLETED|Period I||0
8286690|NCT01641237|20430880|P2|NOT COMPLETED|Period I||0
8286691|NCT01641237|20430881|P1|NOT COMPLETED|Period I||0
8286692|NCT01641237|20430878|P4|COMPLETED|Period I||15
8286693|NCT01641237|20430879|P3|COMPLETED|Period I||15
8286694|NCT01641237|20430880|P2|COMPLETED|Period I||16
8286695|NCT01641237|20430881|P1|COMPLETED|Period I||16
8286696|NCT01641237|20430878|P4|STARTED|Period I||15
8286697|NCT01641237|20430879|P3|STARTED|Period I||15
8286698|NCT01641237|20430880|P2|STARTED|Period I||16
8286699|NCT01641237|20430881|P1|STARTED|Period I||16
8286700|NCT01641198|20430906|P3|NOT COMPLETED|At 15-20 Years of Function||2
8286701|NCT01641198|20430907|P2|NOT COMPLETED|At 15-20 Years of Function||1
8286702|NCT01641198|20430908|P1|NOT COMPLETED|At 15-20 Years of Function||6
8286703|NCT01641198|20430906|P3|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
8286704|NCT01641198|20430907|P2|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
8286705|NCT01641198|20430908|P1|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
8286706|NCT01641198|20430906|P3|STARTED|At 15-20 Years of Function||11
8286707|NCT01641198|20430907|P2|STARTED|At 15-20 Years of Function||7
8286708|NCT01641198|20430908|P1|STARTED|At 15-20 Years of Function||12
8286709|NCT01641198|20430906|P3|NOT COMPLETED|After 24 Months of Function||6
8286710|NCT01641198|20430907|P2|NOT COMPLETED|After 24 Months of Function||9
8286711|NCT01641198|20430908|P1|NOT COMPLETED|After 24 Months of Function||4
8286712|NCT01641198|20430906|P3|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
8286713|NCT01641198|20430907|P2|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
8286714|NCT01641198|20430908|P1|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
8286715|NCT01641198|20430906|P3|STARTED|After 24 Months of Function||17
8286716|NCT01641198|20430907|P2|STARTED|After 24 Months of Function||16
8286717|NCT01641198|20430908|P1|STARTED|After 24 Months of Function||16
8286718|NCT01641198|20430906|P3|NOT COMPLETED|After 12 Months of Function||2
8286719|NCT01641198|20430907|P2|NOT COMPLETED|After 12 Months of Function||3
8286720|NCT01641198|20430908|P1|NOT COMPLETED|After 12 Months of Function||4
8286721|NCT01641198|20430906|P3|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
8286722|NCT01641198|20430907|P2|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
8286723|NCT01641198|20430908|P1|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
8286724|NCT01641198|20430906|P3|STARTED|After 12 Months of Function||19
8286725|NCT01641198|20430907|P2|STARTED|After 12 Months of Function||19
8286726|NCT01641198|20430908|P1|STARTED|After 12 Months of Function||20
8286727|NCT01641159|20430924|P2|NOT COMPLETED|Overall Study||2
8286728|NCT01641159|20430925|P1|NOT COMPLETED|Overall Study||2
8286729|NCT01641159|20430924|P2|COMPLETED|Overall Study||25
8286730|NCT01641159|20430925|P1|COMPLETED|Overall Study||33
8286731|NCT01641159|20430924|P2|STARTED|Overall Study||27
8286732|NCT01641159|20430925|P1|STARTED|Overall Study||35
8286733|NCT01641133|20430936|P3|NOT COMPLETED|Overall Study||8
8286734|NCT01641133|20430937|P2|NOT COMPLETED|Overall Study||9
8286735|NCT01641133|20430938|P1|NOT COMPLETED|Overall Study||10
8286736|NCT01641133|20430936|P3|COMPLETED|Overall Study||90
8286737|NCT01641133|20430937|P2|COMPLETED|Overall Study||90
8286738|NCT01641133|20430938|P1|COMPLETED|Overall Study||87
8286739|NCT01641133|20430936|P3|STARTED|Overall Study||98
8286740|NCT01641133|20430937|P2|STARTED|Overall Study||99
8286741|NCT01641133|20430938|P1|STARTED|Overall Study||97
8286742|NCT01641120|20430979|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
8286743|NCT01641120|20430979|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
8286744|NCT01641120|20430979|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
8286745|NCT01641120|20430979|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
8286746|NCT01641120|20430979|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
8286747|NCT01641120|20430979|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
8286748|NCT01641081|20430991|P10|NOT COMPLETED|Period 5||0
8286749|NCT01641081|20430992|P9|NOT COMPLETED|Period 5||0
8286750|NCT01641081|20430993|P8|NOT COMPLETED|Period 5||0
8286751|NCT01641081|20430994|P7|NOT COMPLETED|Period 5||0
8286752|NCT01641081|20430995|P6|NOT COMPLETED|Period 5||0
8286753|NCT01641081|20430996|P5|NOT COMPLETED|Period 5||0
8286754|NCT01641081|20430997|P4|NOT COMPLETED|Period 5||0
8286755|NCT01641081|20430998|P3|NOT COMPLETED|Period 5||2
8286756|NCT01641081|20430999|P2|NOT COMPLETED|Period 5||0
8286757|NCT01641081|20431000|P1|NOT COMPLETED|Period 5||0
8286758|NCT01641081|20430991|P10|COMPLETED|Period 5||14
8286759|NCT01641081|20430992|P9|COMPLETED|Period 5||14
8286760|NCT01641081|20430993|P8|COMPLETED|Period 5||14
8286761|NCT01641081|20430994|P7|COMPLETED|Period 5||16
8286762|NCT01641081|20430995|P6|COMPLETED|Period 5||18
8286763|NCT01641081|20430996|P5|COMPLETED|Period 5||16
8286764|NCT01641081|20430997|P4|COMPLETED|Period 5||20
8286765|NCT01641081|20430998|P3|COMPLETED|Period 5||12
8286766|NCT01641081|20430999|P2|COMPLETED|Period 5||17
8286767|NCT01641081|20431000|P1|COMPLETED|Period 5||16
8286768|NCT01641081|20430991|P10|STARTED|Period 5||14
8286769|NCT01641081|20430992|P9|STARTED|Period 5||14
8286770|NCT01641081|20430993|P8|STARTED|Period 5||14
8286771|NCT01641081|20430994|P7|STARTED|Period 5||16
8286772|NCT01641081|20430995|P6|STARTED|Period 5||18
8286773|NCT01641081|20430996|P5|STARTED|Period 5||16
8286774|NCT01641081|20430997|P4|STARTED|Period 5||20
8286775|NCT01641081|20430998|P3|STARTED|Period 5||14
8286776|NCT01641081|20430999|P2|STARTED|Period 5||17
8286777|NCT01641081|20431000|P1|STARTED|Period 5||16
8286778|NCT01641081|20430991|P10|NOT COMPLETED|Period 4||0
8286779|NCT01641081|20430992|P9|NOT COMPLETED|Period 4||0
8286780|NCT01641081|20430993|P8|NOT COMPLETED|Period 4||0
8286781|NCT01641081|20430994|P7|NOT COMPLETED|Period 4||0
8286782|NCT01641081|20430995|P6|NOT COMPLETED|Period 4||0
8286783|NCT01641081|20430996|P5|NOT COMPLETED|Period 4||0
8286784|NCT01641081|20430997|P4|NOT COMPLETED|Period 4||1
8286785|NCT01641081|20430998|P3|NOT COMPLETED|Period 4||0
8286786|NCT01641081|20430999|P2|NOT COMPLETED|Period 4||1
8286787|NCT01641081|20431000|P1|NOT COMPLETED|Period 4||0
8286788|NCT01641081|20430991|P10|COMPLETED|Period 4||14
8286789|NCT01641081|20430992|P9|COMPLETED|Period 4||14
8286790|NCT01641081|20430993|P8|COMPLETED|Period 4||14
8286791|NCT01641081|20430994|P7|COMPLETED|Period 4||16
8286792|NCT01641081|20430995|P6|COMPLETED|Period 4||18
8286793|NCT01641081|20430996|P5|COMPLETED|Period 4||16
8286794|NCT01641081|20430997|P4|COMPLETED|Period 4||20
8286795|NCT01641081|20430998|P3|COMPLETED|Period 4||14
8286796|NCT01641081|20430999|P2|COMPLETED|Period 4||17
8286797|NCT01641081|20431000|P1|COMPLETED|Period 4||16
8286798|NCT01641081|20430991|P10|STARTED|Period 4||14
8286799|NCT01641081|20430992|P9|STARTED|Period 4||14
8286800|NCT01641081|20430993|P8|STARTED|Period 4||14
8286801|NCT01641081|20430994|P7|STARTED|Period 4||16
8286802|NCT01641081|20430995|P6|STARTED|Period 4||18
8286803|NCT01641081|20430996|P5|STARTED|Period 4||16
8286804|NCT01641081|20430997|P4|STARTED|Period 4||21
8286805|NCT01641081|20430998|P3|STARTED|Period 4||14
8286806|NCT01641081|20430999|P2|STARTED|Period 4||18
8286807|NCT01641081|20431000|P1|STARTED|Period 4||16
8286808|NCT01641081|20430991|P10|NOT COMPLETED|Period 3||0
8286809|NCT01641081|20430992|P9|NOT COMPLETED|Period 3||1
8286810|NCT01641081|20430993|P8|NOT COMPLETED|Period 3||0
8286811|NCT01641081|20430994|P7|NOT COMPLETED|Period 3||0
8286812|NCT01641081|20430995|P6|NOT COMPLETED|Period 3||0
8286813|NCT01641081|20430996|P5|NOT COMPLETED|Period 3||0
8286814|NCT01641081|20430997|P4|NOT COMPLETED|Period 3||0
8286815|NCT01641081|20430998|P3|NOT COMPLETED|Period 3||1
8286816|NCT01641081|20430999|P2|NOT COMPLETED|Period 3||0
8286817|NCT01641081|20431000|P1|NOT COMPLETED|Period 3||0
8286818|NCT01641081|20430991|P10|COMPLETED|Period 3||14
8286819|NCT01641081|20430992|P9|COMPLETED|Period 3||14
8286820|NCT01641081|20430993|P8|COMPLETED|Period 3||14
8286821|NCT01641081|20430994|P7|COMPLETED|Period 3||16
8286822|NCT01641081|20430995|P6|COMPLETED|Period 3||18
8286823|NCT01641081|20430996|P5|COMPLETED|Period 3||16
8286824|NCT01641081|20430997|P4|COMPLETED|Period 3||21
8286825|NCT01641081|20430998|P3|COMPLETED|Period 3||14
8286826|NCT01641081|20430999|P2|COMPLETED|Period 3||18
8286827|NCT01641081|20431000|P1|COMPLETED|Period 3||16
8286828|NCT01641081|20430991|P10|STARTED|Period 3||14
8286829|NCT01641081|20430992|P9|STARTED|Period 3||15
8286830|NCT01641081|20430993|P8|STARTED|Period 3||14
8286831|NCT01641081|20430994|P7|STARTED|Period 3||16
8286832|NCT01641081|20430995|P6|STARTED|Period 3||18
8286833|NCT01641081|20430996|P5|STARTED|Period 3||16
8286834|NCT01641081|20430997|P4|STARTED|Period 3||21
8286835|NCT01641081|20430998|P3|STARTED|Period 3||15
8286836|NCT01641081|20430999|P2|STARTED|Period 3||18
8286837|NCT01641081|20431000|P1|STARTED|Period 3||16
8286838|NCT01641081|20430991|P10|NOT COMPLETED|Period 2||0
8286839|NCT01641081|20430992|P9|NOT COMPLETED|Period 2||0
8286840|NCT01641081|20430993|P8|NOT COMPLETED|Period 2||0
8286841|NCT01641081|20430994|P7|NOT COMPLETED|Period 2||2
8286842|NCT01641081|20430995|P6|NOT COMPLETED|Period 2||1
8286843|NCT01641081|20430996|P5|NOT COMPLETED|Period 2||0
8286844|NCT01641081|20430997|P4|NOT COMPLETED|Period 2||1
8286845|NCT01641081|20430998|P3|NOT COMPLETED|Period 2||0
8286846|NCT01641081|20430999|P2|NOT COMPLETED|Period 2||0
8286847|NCT01641081|20431000|P1|NOT COMPLETED|Period 2||1
8286848|NCT01641081|20430991|P10|COMPLETED|Period 2||14
8286849|NCT01641081|20430992|P9|COMPLETED|Period 2||15
8286850|NCT01641081|20430993|P8|COMPLETED|Period 2||14
8286851|NCT01641081|20430994|P7|COMPLETED|Period 2||16
8286852|NCT01641081|20430995|P6|COMPLETED|Period 2||18
8286853|NCT01641081|20430996|P5|COMPLETED|Period 2||16
8286854|NCT01641081|20430997|P4|COMPLETED|Period 2||21
8286855|NCT01641081|20430998|P3|COMPLETED|Period 2||15
8286856|NCT01641081|20430999|P2|COMPLETED|Period 2||18
8286857|NCT01641081|20431000|P1|COMPLETED|Period 2||16
8286858|NCT01641081|20430991|P10|STARTED|Period 2||14
8286859|NCT01641081|20430992|P9|STARTED|Period 2||15
8286860|NCT01641081|20430993|P8|STARTED|Period 2||14
8286861|NCT01641081|20430994|P7|STARTED|Period 2||18
8286862|NCT01641081|20430995|P6|STARTED|Period 2||19
8286863|NCT01641081|20430996|P5|STARTED|Period 2||16
8286864|NCT01641081|20430997|P4|STARTED|Period 2||22
8286865|NCT01641081|20430998|P3|STARTED|Period 2||15
8286866|NCT01641081|20430999|P2|STARTED|Period 2||18
8286867|NCT01641081|20431000|P1|STARTED|Period 2||17
8286868|NCT01641081|20430991|P10|NOT COMPLETED|Period 1||0
8286869|NCT01641081|20430992|P9|NOT COMPLETED|Period 1||0
8286870|NCT01641081|20430993|P8|NOT COMPLETED|Period 1||3
8286871|NCT01641081|20430994|P7|NOT COMPLETED|Period 1||1
8286872|NCT01641081|20430995|P6|NOT COMPLETED|Period 1||0
8286873|NCT01641081|20430996|P5|NOT COMPLETED|Period 1||1
8286874|NCT01641081|20430997|P4|NOT COMPLETED|Period 1||0
8286875|NCT01641081|20430998|P3|NOT COMPLETED|Period 1||0
8286876|NCT01641081|20430999|P2|NOT COMPLETED|Period 1||0
8286877|NCT01641081|20431000|P1|NOT COMPLETED|Period 1||1
8286878|NCT01641081|20430991|P10|COMPLETED|Period 1||14
8286879|NCT01641081|20430992|P9|COMPLETED|Period 1||15
8286880|NCT01641081|20430993|P8|COMPLETED|Period 1||14
8286881|NCT01641081|20430994|P7|COMPLETED|Period 1||18
8286882|NCT01641081|20430995|P6|COMPLETED|Period 1||19
8286883|NCT01641081|20430996|P5|COMPLETED|Period 1||16
8286884|NCT01641081|20430997|P4|COMPLETED|Period 1||22
8286885|NCT01641081|20430998|P3|COMPLETED|Period 1||15
8286886|NCT01641081|20430999|P2|COMPLETED|Period 1||18
8286887|NCT01641081|20431000|P1|COMPLETED|Period 1||17
8286888|NCT01641081|20430991|P10|STARTED|Period 1||14
8286889|NCT01641081|20430992|P9|STARTED|Period 1||15
8286890|NCT01641081|20430993|P8|STARTED|Period 1||17
8286891|NCT01641081|20430994|P7|STARTED|Period 1||19
8286892|NCT01641081|20430995|P6|STARTED|Period 1||19
8286893|NCT01641081|20430996|P5|STARTED|Period 1||17
8286894|NCT01641081|20430997|P4|STARTED|Period 1||22
8286895|NCT01641081|20430998|P3|STARTED|Period 1||15
8286896|NCT01641081|20430999|P2|STARTED|Period 1||18
8286897|NCT01641081|20431000|P1|STARTED|Period 1||18
8286898|NCT01641042|20431019|P2|NOT COMPLETED|Overall Study||0
8286899|NCT01641042|20431020|P1|NOT COMPLETED|Overall Study||0
8286900|NCT01641042|20431019|P2|COMPLETED|Overall Study||43
8286901|NCT01641042|20431020|P1|COMPLETED|Overall Study||43
8286902|NCT01641042|20431019|P2|STARTED|Overall Study||43
8286903|NCT01641042|20431020|P1|STARTED|Overall Study||43
8286904|NCT01640964|20431069|P3|NOT COMPLETED|Overall Study||3
8286905|NCT01640964|20431070|P2|NOT COMPLETED|Overall Study||1
8286906|NCT01640964|20431071|P1|NOT COMPLETED|Overall Study||1
8286907|NCT01640964|20431069|P3|COMPLETED|Overall Study||3
8286908|NCT01640964|20431070|P2|COMPLETED|Overall Study||19
8286909|NCT01640964|20431071|P1|COMPLETED|Overall Study||19
8286910|NCT01640964|20431069|P3|STARTED|Overall Study||6
8286911|NCT01640964|20431070|P2|STARTED|Overall Study||20
8286912|NCT01640964|20431071|P1|STARTED|Overall Study||20
8286913|NCT01640951|20431094|P8|NOT COMPLETED|Overall Study||16
8286914|NCT01640951|20431095|P7|NOT COMPLETED|Overall Study||18
8286915|NCT01640951|20431096|P6|NOT COMPLETED|Overall Study||47
8286916|NCT01640951|20431097|P5|NOT COMPLETED|Overall Study||13
8286917|NCT01640951|20431098|P4|NOT COMPLETED|Overall Study||45
8286918|NCT01640951|20431099|P3|NOT COMPLETED|Overall Study||42
8286919|NCT01640951|20431100|P2|NOT COMPLETED|Overall Study||15
8286920|NCT01640951|20431101|P1|NOT COMPLETED|Overall Study||46
8286921|NCT01640951|20431094|P8|COMPLETED|Overall Study||17
8286922|NCT01640951|20431095|P7|COMPLETED|Overall Study||94
8286923|NCT01640951|20431096|P6|COMPLETED|Overall Study||13
8286924|NCT01640951|20431097|P5|COMPLETED|Overall Study||82
8286925|NCT01640951|20431098|P4|COMPLETED|Overall Study||10
8286926|NCT01640951|20431099|P3|COMPLETED|Overall Study||126
8286927|NCT01640951|20431100|P2|COMPLETED|Overall Study||60
8286928|NCT01640951|20431101|P1|COMPLETED|Overall Study||31
8286929|NCT01640951|20431094|P8|STARTED|Overall Study||33
8286930|NCT01640951|20431095|P7|STARTED|Overall Study||112
8286931|NCT01640951|20431096|P6|STARTED|Overall Study||60
8286932|NCT01640951|20431097|P5|STARTED|Overall Study||95
8286933|NCT01640951|20431098|P4|STARTED|Overall Study||55
8286934|NCT01640951|20431099|P3|STARTED|Overall Study||168
8286935|NCT01640951|20431100|P2|STARTED|Overall Study||75
8286936|NCT01640951|20431101|P1|STARTED|Overall Study||77
8286937|NCT01640925|20431203|P2|NOT COMPLETED|Overall Study||11
8286938|NCT01640925|20431204|P1|NOT COMPLETED|Overall Study||14
8286939|NCT01640925|20431203|P2|COMPLETED|Overall Study||164
8286940|NCT01640925|20431204|P1|COMPLETED|Overall Study||161
8286941|NCT01640925|20431203|P2|STARTED|Overall Study||175
8286942|NCT01640925|20431204|P1|STARTED|Overall Study||175
8286943|NCT01640873|20431218|P2|NOT COMPLETED|Overall Study||1
8286944|NCT01640873|20431219|P1|NOT COMPLETED|Overall Study||2
8286945|NCT01640873|20431218|P2|COMPLETED|Overall Study||10
8286946|NCT01640873|20431219|P1|COMPLETED|Overall Study||20
8286947|NCT01640873|20431218|P2|STARTED|Overall Study||11
8286948|NCT01640873|20431219|P1|STARTED|Overall Study||22
8286949|NCT01640834|20431238|P3|NOT COMPLETED|Overall Study||0
8286950|NCT01640834|20431239|P2|NOT COMPLETED|Overall Study||0
8286951|NCT01640834|20431240|P1|NOT COMPLETED|Overall Study||0
8286952|NCT01640834|20431238|P3|COMPLETED|Overall Study||4
8286953|NCT01640834|20431239|P2|COMPLETED|Overall Study||8
8286954|NCT01640834|20431240|P1|COMPLETED|Overall Study||8
8286955|NCT01640834|20431238|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
8286956|NCT01640834|20431239|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8286957|NCT01640834|20431240|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8286958|NCT01640834|20431238|P3|STARTED|Overall Study||4
8286959|NCT01640834|20431239|P2|STARTED|Overall Study||8
8286960|NCT01640834|20431240|P1|STARTED|Overall Study||8
8286961|NCT01640808|20431269|P2|NOT COMPLETED|Overall Study||16
8286962|NCT01640808|20431270|P1|NOT COMPLETED|Overall Study||58
8286963|NCT01640808|20431269|P2|COMPLETED|Overall Study||291
8286964|NCT01640808|20431270|P1|COMPLETED|Overall Study||251
8286965|NCT01640808|20431269|P2|Subjects Received Treatment|Overall Study||305
8286966|NCT01640808|20431270|P1|Subjects Received Treatment|Overall Study||305
8286967|NCT01640808|20431269|P2|STARTED|Overall Study||307
8286968|NCT01640808|20431270|P1|STARTED|Overall Study||309
8286969|NCT01640548|20431280|P1|NOT COMPLETED|Overall Study||0
8286970|NCT01640548|20431280|P1|COMPLETED|Overall Study||309
8286971|NCT01640548|20431280|P1|STARTED|Overall Study||309
8286972|NCT01640379|20431296|P2|NOT COMPLETED|Overall Study||12
8286973|NCT01640379|20431297|P1|NOT COMPLETED|Overall Study||14
8286974|NCT01640379|20431296|P2|COMPLETED|Overall Study||125
8286975|NCT01640379|20431297|P1|COMPLETED|Overall Study||135
8286976|NCT01640379|20431296|P2|STARTED|Overall Study||137
8286977|NCT01640379|20431297|P1|STARTED|Overall Study||149
8286978|NCT01640366|20431305|P1|NOT COMPLETED|Overall Study||22
8286979|NCT01640366|20431305|P1|COMPLETED|Overall Study||178
8286980|NCT01640366|20431305|P1|Day 90 Follow-up|Overall Study||178
8286981|NCT01640366|20431305|P1|Day 42 Follow-up|Overall Study||177
8286982|NCT01640366|20431305|P1|Day 21 Follow-up|Overall Study||185
8286983|NCT01640366|20431305|P1|STARTED|Overall Study||200
8286984|NCT01640353|20431318|P1|NOT COMPLETED|Overall Study||45
8286985|NCT01640353|20431318|P1|COMPLETED|Overall Study||149
8286986|NCT01640353|20431318|P1|Month 18|Overall Study||150
8286987|NCT01640353|20431318|P1|Month 12|Overall Study||160
8286988|NCT01640353|20431318|P1|Month 6|Overall Study||168
8286989|NCT01640353|20431318|P1|Month 3|Overall Study||169
8286990|NCT01640353|20431318|P1|Month 1|Overall Study||171
8286991|NCT01640353|20431318|P1|Treated|Overall Study||172
8286992|NCT01640353|20431318|P1|STARTED|Overall Study||194
8286993|NCT01640340|20431330|P2|NOT COMPLETED|Overall Study||0
8286994|NCT01640340|20431331|P1|NOT COMPLETED|Overall Study||0
8286995|NCT01640340|20431330|P2|COMPLETED|Overall Study||20
8286996|NCT01640340|20431331|P1|COMPLETED|Overall Study||20
8286997|NCT01640340|20431330|P2|Overall Complete Response Rate|Overall Study||20
8286998|NCT01640340|20431331|P1|Overall Complete Response Rate|Overall Study||20
8286999|NCT01640340|20431330|P2|STARTED|Overall Study||20
8287000|NCT01640340|20431331|P1|STARTED|Overall Study||20
8287001|NCT01640327|20431351|P2|NOT COMPLETED|Overall Study||0
8287002|NCT01640327|20431352|P1|NOT COMPLETED|Overall Study||0
8287003|NCT01640327|20431351|P2|COMPLETED|Overall Study||63
8287004|NCT01640327|20431352|P1|COMPLETED|Overall Study||63
8287005|NCT01640327|20431351|P2|STARTED|Overall Study||63
8287006|NCT01640327|20431352|P1|STARTED|Overall Study||63
8287007|NCT01640314|20431366|P2|NOT COMPLETED|Overall Study||1
8287008|NCT01640314|20431367|P1|NOT COMPLETED|Overall Study||0
8287009|NCT01640314|20431366|P2|COMPLETED|Overall Study||62
8287010|NCT01640314|20431367|P1|COMPLETED|Overall Study||63
8287011|NCT01640314|20431366|P2|STARTED|Overall Study||63
8287012|NCT01640314|20431367|P1|STARTED|Overall Study||63
8287013|NCT01640288|20431383|P2|NOT COMPLETED|Overall Study||23
8287014|NCT01640288|20431384|P1|NOT COMPLETED|Overall Study||30
8287015|NCT01640288|20431383|P2|COMPLETED|Overall Study||48
8287016|NCT01640288|20431384|P1|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
8287017|NCT01640288|20431383|P2|Did Not Receive Allocated Intervention|Overall Study||18
8287018|NCT01640288|20431384|P1|Did Not Receive Allocated Intervention|Overall Study||26
8287019|NCT01640288|20431383|P2|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
8287020|NCT01640288|20431384|P1|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
8287021|NCT01640288|20431383|P2|STARTED|Overall Study||71
8287022|NCT01640288|20431384|P1|STARTED|Overall Study||100
8287023|NCT01640249|20431401|P7|NOT COMPLETED|Period 3||0
8287024|NCT01640249|20431402|P6|NOT COMPLETED|Period 3||0
8287025|NCT01640249|20431403|P5|NOT COMPLETED|Period 3||0
8287026|NCT01640249|20431404|P4|NOT COMPLETED|Period 3||1
8287027|NCT01640249|20431405|P3|NOT COMPLETED|Period 3||0
8287028|NCT01640249|20431406|P2|NOT COMPLETED|Period 3||0
8287029|NCT01640249|20431407|P1|NOT COMPLETED|Period 3||0
8287030|NCT01640249|20431401|P7|COMPLETED|Period 3||0
8287031|NCT01640249|20431402|P6|COMPLETED|Period 3||0
8287032|NCT01640249|20431403|P5|COMPLETED|Period 3||0
8287033|NCT01640249|20431404|P4|COMPLETED|Period 3||1
8287034|NCT01640249|20431405|P3|COMPLETED|Period 3||2
8287035|NCT01640249|20431406|P2|COMPLETED|Period 3||2
8287036|NCT01640249|20431407|P1|COMPLETED|Period 3||2
8287037|NCT01640249|20431401|P7|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8287038|NCT01640249|20431402|P6|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8287039|NCT01640249|20431403|P5|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8287040|NCT01640249|20431404|P4|STARTED|Period 3||2
8287041|NCT01640249|20431405|P3|STARTED|Period 3||2
8287042|NCT01640249|20431406|P2|STARTED|Period 3||2
8287043|NCT01640249|20431407|P1|STARTED|Period 3||2
8287044|NCT01640249|20431401|P7|NOT COMPLETED|Period 2||0
8287045|NCT01640249|20431402|P6|NOT COMPLETED|Period 2||0
8287046|NCT01640249|20431403|P5|NOT COMPLETED|Period 2||0
8287047|NCT01640249|20431404|P4|NOT COMPLETED|Period 2||0
8287048|NCT01640249|20431405|P3|NOT COMPLETED|Period 2||0
8287049|NCT01640249|20431406|P2|NOT COMPLETED|Period 2||0
8287050|NCT01640249|20431407|P1|NOT COMPLETED|Period 2||0
8287051|NCT01640249|20431401|P7|COMPLETED|Period 2||2
8287052|NCT01640249|20431402|P6|COMPLETED|Period 2||4
8287053|NCT01640249|20431403|P5|COMPLETED|Period 2||2
8287054|NCT01640249|20431404|P4|COMPLETED|Period 2||2
8287055|NCT01640249|20431405|P3|COMPLETED|Period 2||2
8287056|NCT01640249|20431406|P2|COMPLETED|Period 2||2
8287057|NCT01640249|20431407|P1|COMPLETED|Period 2||2
8287058|NCT01640249|20431401|P7|STARTED|Period 2||2
8287059|NCT01640249|20431402|P6|STARTED|Period 2||4
8287060|NCT01640249|20431403|P5|STARTED|Period 2||2
8287061|NCT01640249|20431404|P4|STARTED|Period 2||2
8287062|NCT01640249|20431405|P3|STARTED|Period 2||2
8287063|NCT01640249|20431406|P2|STARTED|Period 2||2
8287064|NCT01640249|20431407|P1|STARTED|Period 2||2
8287065|NCT01640249|20431401|P7|NOT COMPLETED|Period 1||0
8287066|NCT01640249|20431402|P6|NOT COMPLETED|Period 1||1
8287067|NCT01640249|20431403|P5|NOT COMPLETED|Period 1||0
8287068|NCT01640249|20431404|P4|NOT COMPLETED|Period 1||0
8287069|NCT01640249|20431405|P3|NOT COMPLETED|Period 1||0
8287070|NCT01640249|20431406|P2|NOT COMPLETED|Period 1||0
8287071|NCT01640249|20431407|P1|NOT COMPLETED|Period 1||1
8287072|NCT01640249|20431401|P7|COMPLETED|Period 1||2
8287073|NCT01640249|20431402|P6|COMPLETED|Period 1||4
8287074|NCT01640249|20431403|P5|COMPLETED|Period 1||2
8287075|NCT01640249|20431404|P4|COMPLETED|Period 1||2
8287076|NCT01640249|20431405|P3|COMPLETED|Period 1||2
8287077|NCT01640249|20431406|P2|COMPLETED|Period 1||2
8287078|NCT01640249|20431407|P1|COMPLETED|Period 1||2
8287079|NCT01640249|20431401|P7|Received at Least 1 Dose of Study Drug|Period 1||2
8287080|NCT01640249|20431402|P6|Received at Least 1 Dose of Study Drug|Period 1||5
8287081|NCT01640249|20431403|P5|Received at Least 1 Dose of Study Drug|Period 1||2
8287082|NCT01640249|20431404|P4|Received at Least 1 Dose of Study Drug|Period 1||2
8287083|NCT01640249|20431405|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8287084|NCT01640249|20431406|P2|Received at Least 1 Dose of Study Drug|Period 1||2
8287085|NCT01640249|20431407|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8287086|NCT01640249|20431401|P7|STARTED|Period 1||2
8287087|NCT01640249|20431402|P6|STARTED|Period 1||5
8287088|NCT01640249|20431403|P5|STARTED|Period 1||2
8287089|NCT01640249|20431404|P4|STARTED|Period 1||2
8287090|NCT01640249|20431405|P3|STARTED|Period 1||2
8287091|NCT01640249|20431406|P2|STARTED|Period 1||2
8287092|NCT01640249|20431407|P1|STARTED|Period 1||3
8287093|NCT01640197|20431433|P2|NOT COMPLETED|Overall Study||0
8287094|NCT01640197|20431434|P1|NOT COMPLETED|Overall Study||0
8287095|NCT01640197|20431433|P2|COMPLETED|Overall Study||30
8287096|NCT01640197|20431434|P1|COMPLETED|Overall Study||30
8287097|NCT01640197|20431433|P2|STARTED|Overall Study||30
8287098|NCT01640197|20431434|P1|STARTED|Overall Study||30
8287099|NCT01640184|20431455|P3|NOT COMPLETED|Overall Study||2
8287100|NCT01640184|20431456|P2|NOT COMPLETED|Overall Study||2
8287101|NCT01640184|20431457|P1|NOT COMPLETED|Overall Study||8
8287102|NCT01640184|20431455|P3|COMPLETED|Overall Study||20
8287103|NCT01640184|20431456|P2|COMPLETED|Overall Study||21
8287104|NCT01640184|20431457|P1|COMPLETED|Overall Study||26
8287105|NCT01640184|20431455|P3|STARTED|Overall Study||22
8287106|NCT01640184|20431456|P2|STARTED|Overall Study||23
8287107|NCT01640184|20431457|P1|STARTED|Overall Study||34
8287108|NCT01640171|20431479|P1|NOT COMPLETED|Overall Study||0
8287109|NCT01640171|20431479|P1|COMPLETED|Overall Study||57
8287110|NCT01640171|20431479|P1|STARTED|Overall Study||57
8287111|NCT01640054|20431486|P1|NOT COMPLETED|Overall Study||6
8287112|NCT01640054|20431486|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
8287113|NCT01640054|20431486|P1|Did Not Receive Treatment|Overall Study||0
8287114|NCT01640054|20431486|P1|STARTED|Overall Study|Patients who received treatment|115
8287115|NCT01639872|20431496|P2|NOT COMPLETED|Overall Study||5
8287116|NCT01639872|20431497|P1|NOT COMPLETED|Overall Study||10
8287117|NCT01639872|20431496|P2|COMPLETED|Overall Study||20
8287118|NCT01639872|20431497|P1|COMPLETED|Overall Study||14
8287119|NCT01639872|20431496|P2|STARTED|Overall Study||25
8287120|NCT01639872|20431497|P1|STARTED|Overall Study||24
8287121|NCT01639833|20431507|P2|NOT COMPLETED|Overall Study||4
8287122|NCT01639833|20431508|P1|NOT COMPLETED|Overall Study||6
8287123|NCT01639833|20431507|P2|COMPLETED|Overall Study||41
8287124|NCT01639833|20431508|P1|COMPLETED|Overall Study||39
8287125|NCT01639833|20431507|P2|STARTED|Overall Study||45
8287126|NCT01639833|20431508|P1|STARTED|Overall Study||45
8287127|NCT01639755|20431516|P1|NOT COMPLETED|Overall Study||19
8287128|NCT01639755|20431516|P1|COMPLETED|Overall Study||0
8287129|NCT01639755|20431516|P1|STARTED|Overall Study||19
8287130|NCT01639742|20431524|P1|NOT COMPLETED|Overall Study||18
8287131|NCT01639742|20431524|P1|COMPLETED|Overall Study||0
8287132|NCT01639742|20431524|P1|STARTED|Overall Study||18
8287133|NCT01639729|20431532|P6|NOT COMPLETED|Overall Study||0
8287134|NCT01639729|20431533|P5|NOT COMPLETED|Overall Study||0
8287135|NCT01639729|20431534|P4|NOT COMPLETED|Overall Study||1
8287136|NCT01639729|20431535|P3|NOT COMPLETED|Overall Study||1
8287137|NCT01639729|20431536|P2|NOT COMPLETED|Overall Study||0
8287138|NCT01639729|20431537|P1|NOT COMPLETED|Overall Study||1
8287139|NCT01639729|20431532|P6|COMPLETED|Overall Study||4
8287140|NCT01639729|20431533|P5|COMPLETED|Overall Study||4
8287141|NCT01639729|20431534|P4|COMPLETED|Overall Study||4
8287142|NCT01639729|20431535|P3|COMPLETED|Overall Study||3
8287143|NCT01639729|20431536|P2|COMPLETED|Overall Study||4
8287144|NCT01639729|20431537|P1|COMPLETED|Overall Study||3
8287145|NCT01639729|20431532|P6|STARTED|Overall Study||4
8287146|NCT01639729|20431533|P5|STARTED|Overall Study||4
8287147|NCT01639729|20431534|P4|STARTED|Overall Study||5
8287148|NCT01639729|20431535|P3|STARTED|Overall Study||4
8287149|NCT01639729|20431536|P2|STARTED|Overall Study||4
8287150|NCT01639729|20431537|P1|STARTED|Overall Study||4
8287151|NCT01639703|20431559|P1|NOT COMPLETED|Overall Study||12
8287152|NCT01639703|20431559|P1|COMPLETED|Overall Study||84
8287153|NCT01639703|20431559|P1|STARTED|Overall Study||96
8287154|NCT01639599|20431603|P3|NOT COMPLETED|Overall Study||0
8287155|NCT01639599|20431604|P2|NOT COMPLETED|Overall Study||1
8287156|NCT01639599|20431605|P1|NOT COMPLETED|Overall Study||0
8287157|NCT01639599|20431603|P3|COMPLETED|Overall Study||50
8287158|NCT01639599|20431604|P2|COMPLETED|Overall Study||49
8287159|NCT01639599|20431605|P1|COMPLETED|Overall Study||50
8287160|NCT01639599|20431603|P3|STARTED|Overall Study||50
8287161|NCT01639599|20431604|P2|STARTED|Overall Study||50
8287162|NCT01639599|20431605|P1|STARTED|Overall Study||50
8287163|NCT01639560|20431624|P2|NOT COMPLETED|Overall Study||29
8287164|NCT01639560|20431625|P1|NOT COMPLETED|Overall Study||19
8287165|NCT01639560|20431624|P2|COMPLETED|Overall Study||19
8287166|NCT01639560|20431625|P1|COMPLETED|Overall Study||26
8287167|NCT01639560|20431624|P2|End of Treatment|Overall Study||20
8287168|NCT01639560|20431625|P1|End of Treatment|Overall Study||28
8287169|NCT01639560|20431624|P2|STARTED|Overall Study||48
8287170|NCT01639560|20431625|P1|STARTED|Overall Study||45
8287171|NCT01639495|20431637|P1|NOT COMPLETED|Overall Study||16
8287172|NCT01639495|20431637|P1|COMPLETED|Overall Study||132
8287173|NCT01639495|20431637|P1|Primary Effectiveness Cohort|Overall Study||138
8287174|NCT01639495|20431637|P1|Safety Cohort|Overall Study||144
8287175|NCT01639495|20431637|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
8287176|NCT01639469|20431647|P2|NOT COMPLETED|Overall Study||3
8287177|NCT01639469|20431648|P1|NOT COMPLETED|Overall Study||5
8287178|NCT01639469|20431647|P2|COMPLETED|Overall Study||77
8287179|NCT01639469|20431648|P1|COMPLETED|Overall Study||84
8287180|NCT01639469|20431647|P2|STARTED|Overall Study||80
8287181|NCT01639469|20431648|P1|STARTED|Overall Study||89
8287182|NCT01639443|20431656|P2|NOT COMPLETED|Overall Study||0
8287183|NCT01639443|20431657|P1|NOT COMPLETED|Overall Study||0
8287275|NCT01638013|20431992|P3|COMPLETED|Overall Study||296
8287184|NCT01639443|20431656|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
8287185|NCT01639443|20431657|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
8287186|NCT01639443|20431656|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
8287187|NCT01639443|20431657|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
8287188|NCT01639352|20431673|P1|NOT COMPLETED|Overall Study||0
8287189|NCT01639352|20431673|P1|COMPLETED|Overall Study||20
8287190|NCT01639352|20431673|P1|STARTED|Overall Study||20
8287191|NCT01639339|20431684|P2|NOT COMPLETED|Overall Study||38
8287192|NCT01639339|20431685|P1|NOT COMPLETED|Overall Study||54
8287193|NCT01639339|20431684|P2|COMPLETED|Overall Study||186
8287194|NCT01639339|20431685|P1|COMPLETED|Overall Study||170
8287195|NCT01639339|20431684|P2|STARTED|Overall Study||224
8287196|NCT01639339|20431685|P1|STARTED|Overall Study||224
8287197|NCT01639222|20431703|P1|NOT COMPLETED|Overall Study||0
8287198|NCT01639222|20431703|P1|COMPLETED|Overall Study||55
8287199|NCT01639222|20431703|P1|STARTED|Overall Study||55
8287200|NCT01639157|20431713|P2|NOT COMPLETED|Overall Study||0
8287201|NCT01639157|20431714|P1|NOT COMPLETED|Overall Study||0
8287202|NCT01639157|20431713|P2|COMPLETED|Overall Study||5
8287203|NCT01639157|20431714|P1|COMPLETED|Overall Study||4
8287204|NCT01639157|20431713|P2|STARTED|Overall Study||5
8287205|NCT01639157|20431714|P1|STARTED|Overall Study||4
8287206|NCT01639144|20431774|P2|NOT COMPLETED|Overall Study||5
8287207|NCT01639144|20431775|P1|NOT COMPLETED|Overall Study||10
8287208|NCT01639144|20431774|P2|COMPLETED|Overall Study||250
8287209|NCT01639144|20431775|P1|COMPLETED|Overall Study||250
8287210|NCT01639144|20431774|P2|STARTED|Overall Study||255
8287211|NCT01639144|20431775|P1|STARTED|Overall Study||260
8287212|NCT01639040|20431783|P2|NOT COMPLETED|Overall Study||0
8287213|NCT01639040|20431784|P1|NOT COMPLETED|Overall Study||1
8287214|NCT01639040|20431783|P2|COMPLETED|Overall Study||21
8287215|NCT01639040|20431784|P1|COMPLETED|Overall Study||9
8287216|NCT01639040|20431783|P2|STARTED|Overall Study||21
8287217|NCT01639040|20431784|P1|STARTED|Overall Study||10
8287218|NCT01639001|20431802|P2|NOT COMPLETED|Overall Study||77
8287219|NCT01639001|20431803|P1|NOT COMPLETED|Overall Study||75
8287220|NCT01639001|20431802|P2|COMPLETED|Overall Study||26
8287221|NCT01639001|20431803|P1|COMPLETED|Overall Study||29
8287222|NCT01639001|20431802|P2|Treated|Overall Study||101
8287223|NCT01639001|20431803|P1|Treated|Overall Study||104
8287224|NCT01639001|20431802|P2|STARTED|Overall Study||103
8287225|NCT01639001|20431803|P1|STARTED|Overall Study||104
8287226|NCT01638819|20431849|P2|NOT COMPLETED|Overall Study||0
8287227|NCT01638819|20431850|P1|NOT COMPLETED|Overall Study||1
8287228|NCT01638819|20431849|P2|COMPLETED|Overall Study||15
8287229|NCT01638819|20431850|P1|COMPLETED|Overall Study||14
8287230|NCT01638819|20431849|P2|Second Intervention (24 Weeks)|Overall Study||15
8287231|NCT01638819|20431850|P1|Second Intervention (24 Weeks)|Overall Study||14
8287232|NCT01638819|20431849|P2|First Intervention (8 Weeks)|Overall Study||15
8287233|NCT01638819|20431850|P1|First Intervention (8 Weeks)|Overall Study||15
8287234|NCT01638819|20431849|P2|STARTED|Overall Study||15
8287235|NCT01638819|20431850|P1|STARTED|Overall Study||15
8287236|NCT01638559|20431859|P1|NOT COMPLETED|Overall Study||3
8287237|NCT01638559|20431859|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
8287238|NCT01638559|20431859|P1|STARTED|Overall Study||88
8287239|NCT01638546|20431877|P2|NOT COMPLETED|Overall Study||3
8287240|NCT01638546|20431878|P1|NOT COMPLETED|Overall Study||1
8287241|NCT01638546|20431877|P2|COMPLETED|Overall Study||42
8287242|NCT01638546|20431878|P1|COMPLETED|Overall Study||51
8287243|NCT01638546|20431877|P2|STARTED|Overall Study||45
8287244|NCT01638546|20431878|P1|STARTED|Overall Study||52
8287245|NCT01638507|20431890|P1|NOT COMPLETED|Overall Study||6
8287246|NCT01638507|20431890|P1|COMPLETED|Overall Study||224
8287247|NCT01638507|20431890|P1|STARTED|Overall Study||230
8287248|NCT01638468|20431903|P1|NOT COMPLETED|Overall Study||0
8287249|NCT01638468|20431903|P1|COMPLETED|Overall Study||7
8287250|NCT01638468|20431903|P1|STARTED|Overall Study||7
8287251|NCT01638429|20431917|P1|NOT COMPLETED|Overall Study||1
8287252|NCT01638429|20431917|P1|COMPLETED|Overall Study||11
8287253|NCT01638429|20431917|P1|Post-treatment Testing|Overall Study||11
8287254|NCT01638429|20431917|P1|Antibiotic Treatment|Overall Study||11
8287255|NCT01638429|20431917|P1|Pre-treatment Testing|Overall Study||11
8287256|NCT01638429|20431917|P1|STARTED|Overall Study||12
8287257|NCT01638416|20431947|P2|NOT COMPLETED|Overall Study||42
8287258|NCT01638416|20431948|P1|NOT COMPLETED|Overall Study||33
8287259|NCT01638416|20431947|P2|COMPLETED|Overall Study||2462
8287260|NCT01638416|20431948|P1|COMPLETED|Overall Study||2457
8287261|NCT01638416|20431947|P2|STARTED|Overall Study||2504
8287262|NCT01638416|20431948|P1|STARTED|Overall Study||2490
8287263|NCT01638390|20431968|P1|NOT COMPLETED|Overall Study||21
8287264|NCT01638390|20431968|P1|COMPLETED|Overall Study|treated eyes|336
8287265|NCT01638390|20431968|P1|STARTED|Overall Study|enrolled|357
8287266|NCT01638312|20431982|P2|NOT COMPLETED|Overall Study||0
8287267|NCT01638312|20431983|P1|NOT COMPLETED|Overall Study||0
8287268|NCT01638312|20431982|P2|COMPLETED|Overall Study||30
8287269|NCT01638312|20431983|P1|COMPLETED|Overall Study||20
8287270|NCT01638312|20431982|P2|STARTED|Overall Study||30
8287271|NCT01638312|20431983|P1|STARTED|Overall Study||20
8287272|NCT01638013|20431992|P3|NOT COMPLETED|Overall Study||121
8287273|NCT01638013|20431993|P2|NOT COMPLETED|Overall Study||78
8287274|NCT01638013|20431994|P1|NOT COMPLETED|Overall Study||131
8287276|NCT01638013|20431993|P2|COMPLETED|Overall Study||147
8287277|NCT01638013|20431994|P1|COMPLETED|Overall Study||70
8287278|NCT01638013|20431992|P3|STARTED|Overall Study||417
8287279|NCT01638013|20431993|P2|STARTED|Overall Study||225
8287280|NCT01638013|20431994|P1|STARTED|Overall Study||201
8287281|NCT01638000|20432127|P2|NOT COMPLETED|Overall Study||71
8287282|NCT01638000|20432128|P1|NOT COMPLETED|Overall Study||60
8287283|NCT01638000|20432127|P2|COMPLETED|Overall Study||873
8287284|NCT01638000|20432128|P1|COMPLETED|Overall Study||883
8287285|NCT01638000|20432127|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
8287286|NCT01638000|20432128|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
8287287|NCT01638000|20432127|P2|STARTED|Overall Study||944
8287288|NCT01638000|20432128|P1|STARTED|Overall Study||943
8287289|NCT01637961|20432226|P1|NOT COMPLETED|Overall Study||2
8287290|NCT01637961|20432226|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
8287291|NCT01637961|20432226|P1|STARTED|Overall Study||23
8287292|NCT01637935|20432241|P2|NOT COMPLETED|Overall Study||0
8287293|NCT01637935|20432242|P1|NOT COMPLETED|Overall Study||0
8287294|NCT01637935|20432241|P2|COMPLETED|Overall Study||158918
8287295|NCT01637935|20432242|P1|COMPLETED|Overall Study||34181
8287296|NCT01637935|20432241|P2|STARTED|Overall Study||158918
8287297|NCT01637935|20432242|P1|STARTED|Overall Study||34181
8287298|NCT01637922|20432258|P2|NOT COMPLETED|Overall Study||5
8287299|NCT01637922|20432259|P1|NOT COMPLETED|Overall Study||2
8287300|NCT01637922|20432258|P2|COMPLETED|Overall Study||14
8287301|NCT01637922|20432259|P1|COMPLETED|Overall Study||13
8287302|NCT01637922|20432258|P2|STARTED|Overall Study||19
8287303|NCT01637922|20432259|P1|STARTED|Overall Study||15
8287304|NCT01637870|20432282|P1|NOT COMPLETED|Overall Study||0
8287305|NCT01637870|20432282|P1|COMPLETED|Overall Study||110
8287306|NCT01637870|20432282|P1|STARTED|Overall Study||110
8287307|NCT01637623|20432289|P3|NOT COMPLETED|Overall Study||3
8287308|NCT01637623|20432290|P2|NOT COMPLETED|Overall Study||0
8287309|NCT01637623|20432291|P1|NOT COMPLETED|Overall Study||1
8287310|NCT01637623|20432289|P3|COMPLETED|Overall Study||25
8287311|NCT01637623|20432290|P2|COMPLETED|Overall Study||30
8287312|NCT01637623|20432291|P1|COMPLETED|Overall Study||28
8287313|NCT01637623|20432289|P3|Analyzed|Overall Study||28
8287314|NCT01637623|20432290|P2|Analyzed|Overall Study||30
8287315|NCT01637623|20432291|P1|Analyzed|Overall Study||28
8287316|NCT01637623|20432289|P3|Did Not Receive Intervention|Overall Study||1
8287317|NCT01637623|20432290|P2|Did Not Receive Intervention|Overall Study||0
8287318|NCT01637623|20432291|P1|Did Not Receive Intervention|Overall Study||1
8287319|NCT01637623|20432289|P3|Received Intervention|Overall Study||27
8287320|NCT01637623|20432290|P2|Received Intervention|Overall Study||30
8287321|NCT01637623|20432291|P1|Received Intervention|Overall Study||28
8287322|NCT01637623|20432289|P3|STARTED|Overall Study||28
8287323|NCT01637623|20432290|P2|STARTED|Overall Study||30
8287324|NCT01637623|20432291|P1|STARTED|Overall Study||29
8287325|NCT01637584|20432331|P2|NOT COMPLETED|Overall Study||3
8287326|NCT01637584|20432332|P1|NOT COMPLETED|Overall Study||1
8287327|NCT01637584|20432331|P2|COMPLETED|Overall Study||17
8287328|NCT01637584|20432332|P1|COMPLETED|Overall Study||19
8287329|NCT01637584|20432331|P2|STARTED|Overall Study||20
8287330|NCT01637584|20432332|P1|STARTED|Overall Study||20
8287331|NCT01637402|20432339|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
8287332|NCT01637402|20432340|P1|NOT COMPLETED|Treatment Regiments Post Week 12||9
8287333|NCT01637402|20432339|P2|COMPLETED|Treatment Regiments Post Week 12||14
8287334|NCT01637402|20432340|P1|COMPLETED|Treatment Regiments Post Week 12||5
8287335|NCT01637402|20432339|P2|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
8287336|NCT01637402|20432340|P1|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
8287337|NCT01637402|20432339|P2|NOT COMPLETED|Week 12 Evaluation||0
8287338|NCT01637402|20432340|P1|NOT COMPLETED|Week 12 Evaluation||6
8287339|NCT01637402|20432339|P2|COMPLETED|Week 12 Evaluation||0
8287340|NCT01637402|20432340|P1|COMPLETED|Week 12 Evaluation||32
8287341|NCT01637402|20432339|P2|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
8287342|NCT01637402|20432340|P1|STARTED|Week 12 Evaluation||38
8287343|NCT01637402|20432339|P2|NOT COMPLETED|Standard Dose Regimen||0
8287344|NCT01637402|20432340|P1|NOT COMPLETED|Standard Dose Regimen||3
8287345|NCT01637402|20432339|P2|COMPLETED|Standard Dose Regimen||0
8287346|NCT01637402|20432340|P1|COMPLETED|Standard Dose Regimen||38
8287347|NCT01637402|20432339|P2|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
8287348|NCT01637402|20432340|P1|STARTED|Standard Dose Regimen||41
8287349|NCT01637272|20432371|P1|NOT COMPLETED|Overall Study||20
8287350|NCT01637272|20432371|P1|COMPLETED|Overall Study||23
8287351|NCT01637272|20432371|P1|Completed Core But Did no Enter Ext..|Overall Study||4
8287352|NCT01637272|20432371|P1|Entered Extension Phase|Overall Study||27
8287353|NCT01637272|20432371|P1|Completed Core Phase (sc + LAR)|Overall Study||31
8287354|NCT01637272|20432371|P1|Completed sc Phase|Overall Study||33
8287355|NCT01637272|20432371|P1|STARTED|Overall Study||43
8287356|NCT01637246|20432433|P1|NOT COMPLETED|Overall Study||2139
8287357|NCT01637246|20432433|P1|COMPLETED|Overall Study||2246
8287358|NCT01637246|20432433|P1|STARTED|Overall Study||4385
8287359|NCT01637090|20432441|P1|NOT COMPLETED|Overall Study||3
8287360|NCT01637090|20432441|P1|COMPLETED|Overall Study||0
8287361|NCT01637090|20432441|P1|STARTED|Overall Study||3
8287362|NCT01637077|20432451|P2|NOT COMPLETED|Overall Study||1
8287363|NCT01637077|20432452|P1|NOT COMPLETED|Overall Study||4
8287364|NCT01637077|20432451|P2|COMPLETED|Overall Study||22
8287365|NCT01637077|20432452|P1|COMPLETED|Overall Study||19
8287366|NCT01637077|20432451|P2|STARTED|Overall Study||23
8287367|NCT01637077|20432452|P1|STARTED|Overall Study||23
8287368|NCT01636986|20432480|P2|NOT COMPLETED|Overall Study||2
8287369|NCT01636986|20432481|P1|NOT COMPLETED|Overall Study||0
8287370|NCT01636986|20432480|P2|COMPLETED|Overall Study||30
8287371|NCT01636986|20432481|P1|COMPLETED|Overall Study||30
8287372|NCT01636986|20432480|P2|STARTED|Overall Study||32
8287373|NCT01636986|20432481|P1|STARTED|Overall Study||30
8287374|NCT01636960|20432487|P1|NOT COMPLETED|Maintenance Phase||7
8287375|NCT01636960|20432487|P1|COMPLETED|Maintenance Phase||0
8287376|NCT01636960|20432487|P1|STARTED|Maintenance Phase||7
8287377|NCT01636960|20432487|P1|NOT COMPLETED|Induction Phase||2
8287378|NCT01636960|20432487|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
8287379|NCT01636960|20432487|P1|STARTED|Induction Phase||9
8287380|NCT01636947|20432495|P2|NOT COMPLETED|Overall Study||11
8287381|NCT01636947|20432496|P1|NOT COMPLETED|Overall Study||12
8287382|NCT01636947|20432495|P2|COMPLETED|Overall Study||239
8287383|NCT01636947|20432496|P1|COMPLETED|Overall Study||232
8287384|NCT01636947|20432495|P2|Treated|Overall Study||248
8287385|NCT01636947|20432496|P1|Treated|Overall Study||242
8287386|NCT01636947|20432495|P2|STARTED|Overall Study||250
8287387|NCT01636947|20432496|P1|STARTED|Overall Study||244
8287388|NCT01636934|20432518|P2|NOT COMPLETED|Overall Study||3
8287389|NCT01636934|20432519|P1|NOT COMPLETED|Overall Study||6
8287390|NCT01636934|20432518|P2|COMPLETED|Overall Study||21
8287391|NCT01636934|20432519|P1|COMPLETED|Overall Study||19
8287392|NCT01636934|20432518|P2|STARTED|Overall Study||24
8287393|NCT01636934|20432519|P1|STARTED|Overall Study||25
8287394|NCT01636882|20432527|P1|NOT COMPLETED|Overall Study||0
8287395|NCT01636882|20432527|P1|COMPLETED|Overall Study||16
8287396|NCT01636882|20432527|P1|STARTED|Overall Study||16
8287397|NCT01636778|20432531|P3|NOT COMPLETED|Follow-up Period After Part 2||4
8287398|NCT01636778|20432532|P2|NOT COMPLETED|Follow-up Period After Part 2||0
8287399|NCT01636778|20432533|P1|NOT COMPLETED|Follow-up Period After Part 2||0
8287400|NCT01636778|20432531|P3|COMPLETED|Follow-up Period After Part 2||37
8287401|NCT01636778|20432532|P2|COMPLETED|Follow-up Period After Part 2||0
8287402|NCT01636778|20432533|P1|COMPLETED|Follow-up Period After Part 2||0
8287403|NCT01636778|20432531|P3|STARTED|Follow-up Period After Part 2||41
8287404|NCT01636778|20432532|P2|STARTED|Follow-up Period After Part 2||0
8287405|NCT01636778|20432533|P1|STARTED|Follow-up Period After Part 2||0
8287406|NCT01636778|20432531|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
8287407|NCT01636778|20432532|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
8287408|NCT01636778|20432533|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
8287409|NCT01636778|20432531|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
8287410|NCT01636778|20432532|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
8287411|NCT01636778|20432533|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
8287412|NCT01636778|20432531|P3|STARTED|Antiviral Treatment Period (Part 2)||0
8287413|NCT01636778|20432532|P2|STARTED|Antiviral Treatment Period (Part 2)||41
8287414|NCT01636778|20432533|P1|STARTED|Antiviral Treatment Period (Part 2)||0
8287415|NCT01636778|20432531|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287416|NCT01636778|20432532|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287417|NCT01636778|20432533|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
8287418|NCT01636778|20432531|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287419|NCT01636778|20432532|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287420|NCT01636778|20432533|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
8287421|NCT01636778|20432531|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
8287422|NCT01636778|20432532|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
8287423|NCT01636778|20432533|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
8287424|NCT01636765|20432596|P1|NOT COMPLETED|Overall Study||0
8287425|NCT01636765|20432596|P1|COMPLETED|Overall Study||104
8287426|NCT01636765|20432596|P1|STARTED|Overall Study||104
8287427|NCT01636713|20432604|P3|NOT COMPLETED|Overall Study||23
8287428|NCT01636713|20432605|P2|NOT COMPLETED|Overall Study||28
8287429|NCT01636713|20432606|P1|NOT COMPLETED|Overall Study||32
8287430|NCT01636713|20432604|P3|COMPLETED|Overall Study||170
8287431|NCT01636713|20432605|P2|COMPLETED|Overall Study||166
8287432|NCT01636713|20432606|P1|COMPLETED|Overall Study||161
8287433|NCT01636713|20432604|P3|STARTED|Overall Study||193
8287434|NCT01636713|20432605|P2|STARTED|Overall Study||194
8287435|NCT01636713|20432606|P1|STARTED|Overall Study||193
8287436|NCT01636687|20432623|P5|NOT COMPLETED|Follow-up Period||1
8287437|NCT01636687|20432624|P4|NOT COMPLETED|Follow-up Period||0
8287438|NCT01636687|20432625|P3|NOT COMPLETED|Follow-up Period||0
8287439|NCT01636687|20432626|P2|NOT COMPLETED|Follow-up Period||0
8287440|NCT01636687|20432627|P1|NOT COMPLETED|Follow-up Period||1
8287441|NCT01636687|20432623|P5|COMPLETED|Follow-up Period||1
8287442|NCT01636687|20432624|P4|COMPLETED|Follow-up Period||20
8287443|NCT01636687|20432625|P3|COMPLETED|Follow-up Period||21
8287444|NCT01636687|20432626|P2|COMPLETED|Follow-up Period||45
8287445|NCT01636687|20432627|P1|COMPLETED|Follow-up Period||37
8287446|NCT01636687|20432623|P5|STARTED|Follow-up Period||2
8287447|NCT01636687|20432624|P4|STARTED|Follow-up Period||20
8287448|NCT01636687|20432625|P3|STARTED|Follow-up Period||21
8287449|NCT01636687|20432626|P2|STARTED|Follow-up Period||45
8287450|NCT01636687|20432627|P1|STARTED|Follow-up Period||38
8287451|NCT01636687|20432623|P5|NOT COMPLETED|Extension Period||0
8287452|NCT01636687|20432624|P4|NOT COMPLETED|Extension Period||28
8287453|NCT01636687|20432625|P3|NOT COMPLETED|Extension Period||25
8287454|NCT01636687|20432626|P2|NOT COMPLETED|Extension Period||54
8287455|NCT01636687|20432627|P1|NOT COMPLETED|Extension Period||47
8287456|NCT01636687|20432623|P5|COMPLETED|Extension Period||0
8287457|NCT01636687|20432624|P4|COMPLETED|Extension Period||0
8287458|NCT01636687|20432625|P3|COMPLETED|Extension Period||0
8287459|NCT01636687|20432626|P2|COMPLETED|Extension Period||0
8287460|NCT01636687|20432627|P1|COMPLETED|Extension Period||0
8287461|NCT01636687|20432623|P5|STARTED|Extension Period||0
8287462|NCT01636687|20432624|P4|STARTED|Extension Period||28
8287463|NCT01636687|20432625|P3|STARTED|Extension Period||25
8287464|NCT01636687|20432626|P2|STARTED|Extension Period||54
8287465|NCT01636687|20432627|P1|STARTED|Extension Period||47
8287466|NCT01636687|20432623|P5|NOT COMPLETED|Maintenance Period||2
8287467|NCT01636687|20432624|P4|NOT COMPLETED|Maintenance Period||0
8287468|NCT01636687|20432625|P3|NOT COMPLETED|Maintenance Period||2
8287469|NCT01636687|20432626|P2|NOT COMPLETED|Maintenance Period||2
8287470|NCT01636687|20432627|P1|NOT COMPLETED|Maintenance Period||8
8287471|NCT01636687|20432623|P5|COMPLETED|Maintenance Period||1
8287472|NCT01636687|20432624|P4|COMPLETED|Maintenance Period||28
8287473|NCT01636687|20432625|P3|COMPLETED|Maintenance Period||26
8287474|NCT01636687|20432626|P2|COMPLETED|Maintenance Period||58
8287475|NCT01636687|20432627|P1|COMPLETED|Maintenance Period||50
8287476|NCT01636687|20432623|P5|STARTED|Maintenance Period||3
8287477|NCT01636687|20432624|P4|STARTED|Maintenance Period||28
8287478|NCT01636687|20432625|P3|STARTED|Maintenance Period||28
8287479|NCT01636687|20432626|P2|STARTED|Maintenance Period||60
8287480|NCT01636687|20432627|P1|STARTED|Maintenance Period||58
8287481|NCT01636687|20432623|P5|NOT COMPLETED|Induction Period||2
8287482|NCT01636687|20432624|P4|NOT COMPLETED|Induction Period||0
8287483|NCT01636687|20432625|P3|NOT COMPLETED|Induction Period||0
8287484|NCT01636687|20432626|P2|NOT COMPLETED|Induction Period||0
8287485|NCT01636687|20432627|P1|NOT COMPLETED|Induction Period||3
8287486|NCT01636687|20432623|P5|COMPLETED|Induction Period||59
8287487|NCT01636687|20432624|P4|COMPLETED|Induction Period||0
8287488|NCT01636687|20432625|P3|COMPLETED|Induction Period||0
8287489|NCT01636687|20432626|P2|COMPLETED|Induction Period||60
8287490|NCT01636687|20432627|P1|COMPLETED|Induction Period||58
8287491|NCT01636687|20432623|P5|STARTED|Induction Period||61
8287492|NCT01636687|20432624|P4|STARTED|Induction Period||0
8287493|NCT01636687|20432625|P3|STARTED|Induction Period||0
8287494|NCT01636687|20432626|P2|STARTED|Induction Period||60
8287495|NCT01636687|20432627|P1|STARTED|Induction Period||61
8287496|NCT01636661|20432716|P2|NOT COMPLETED|Overall Study||0
8287497|NCT01636661|20432717|P1|NOT COMPLETED|Overall Study||0
8287498|NCT01636661|20432716|P2|COMPLETED|Overall Study||6
8287499|NCT01636661|20432717|P1|COMPLETED|Overall Study||5
8287500|NCT01636661|20432716|P2|STARTED|Overall Study||6
8287501|NCT01636661|20432717|P1|STARTED|Overall Study||5
8287502|NCT01636466|20432727|P2|NOT COMPLETED|Overall Study||0
8287503|NCT01636466|20432728|P1|NOT COMPLETED|Overall Study||1
8287504|NCT01636466|20432727|P2|COMPLETED|Overall Study||0
8287505|NCT01636466|20432728|P1|COMPLETED|Overall Study||0
8287506|NCT01636466|20432727|P2|STARTED|Overall Study||0
8287507|NCT01636466|20432728|P1|STARTED|Overall Study||1
8287508|NCT01636453|20432736|P1|NOT COMPLETED|Overall Study||8
8287509|NCT01636453|20432736|P1|COMPLETED|Overall Study||112
8287510|NCT01636453|20432736|P1|STARTED|Overall Study||120
8287511|NCT01636414|20432755|P3|NOT COMPLETED|Overall Study||9
8287512|NCT01636414|20432756|P2|NOT COMPLETED|Overall Study||6
8287513|NCT01636414|20432757|P1|NOT COMPLETED|Overall Study||3
8287514|NCT01636414|20432755|P3|COMPLETED|Overall Study||65
8287515|NCT01636414|20432756|P2|COMPLETED|Overall Study||60
8287516|NCT01636414|20432757|P1|COMPLETED|Overall Study||61
8287517|NCT01636414|20432755|P3|STARTED|Overall Study||74
8287518|NCT01636414|20432756|P2|STARTED|Overall Study||66
8287519|NCT01636414|20432757|P1|STARTED|Overall Study||64
8287520|NCT01636362|20432768|P1|NOT COMPLETED|Overall Study||8
8287521|NCT01636362|20432768|P1|COMPLETED|Overall Study||37
8287522|NCT01636362|20432768|P1|STARTED|Overall Study||45
8287523|NCT01636297|20432777|P3|NOT COMPLETED|Overall Study||1
8287524|NCT01636297|20432778|P2|NOT COMPLETED|Overall Study||4
8287525|NCT01636297|20432779|P1|NOT COMPLETED|Overall Study||4
8287526|NCT01636297|20432777|P3|COMPLETED|Overall Study||19
8287527|NCT01636297|20432778|P2|COMPLETED|Overall Study||36
8287528|NCT01636297|20432779|P1|COMPLETED|Overall Study||36
8287529|NCT01636297|20432777|P3|STARTED|Overall Study||20
8287530|NCT01636297|20432778|P2|STARTED|Overall Study||40
8287531|NCT01636297|20432779|P1|STARTED|Overall Study||40
8287532|NCT01636284|20432793|P1|NOT COMPLETED|Overall Study||0
8287533|NCT01636284|20432793|P1|COMPLETED|Overall Study||16
8287534|NCT01636284|20432793|P1|STARTED|Overall Study||16
8287535|NCT01636258|20432801|P2|NOT COMPLETED|Overall Study||0
8287536|NCT01636258|20432802|P1|NOT COMPLETED|Overall Study||1
8287537|NCT01636258|20432801|P2|COMPLETED|Overall Study||14
8287538|NCT01636258|20432802|P1|COMPLETED|Overall Study||12
8287539|NCT01636258|20432801|P2|STARTED|Overall Study||14
8287540|NCT01636258|20432802|P1|STARTED|Overall Study||13
8287541|NCT01636206|20432818|P2|NOT COMPLETED|Overall Study||51
8287542|NCT01636206|20432819|P1|NOT COMPLETED|Overall Study||19
8287543|NCT01636206|20432818|P2|COMPLETED|Overall Study||170
8287544|NCT01636206|20432819|P1|COMPLETED|Overall Study||92
8287545|NCT01636206|20432818|P2|STARTED|Overall Study||221
8287546|NCT01636206|20432819|P1|STARTED|Overall Study||111
8287547|NCT01636102|20432827|P2|NOT COMPLETED|Overall Study||0
8287548|NCT01636102|20432828|P1|NOT COMPLETED|Overall Study||0
8287549|NCT01636102|20432827|P2|COMPLETED|Overall Study||63
8287550|NCT01636102|20432828|P1|COMPLETED|Overall Study||63
8287551|NCT01636102|20432827|P2|STARTED|Overall Study||63
8287552|NCT01636102|20432828|P1|STARTED|Overall Study||63
8287553|NCT01636076|20432842|P2|NOT COMPLETED|Overall Study||25
8287554|NCT01636076|20432843|P1|NOT COMPLETED|Overall Study||17
8287555|NCT01636076|20432842|P2|COMPLETED|Overall Study||288
8287556|NCT01636076|20432843|P1|COMPLETED|Overall Study||299
8287557|NCT01636076|20432842|P2|STARTED|Overall Study||313
8287558|NCT01636076|20432843|P1|STARTED|Overall Study||316
8287559|NCT01636063|20432905|P2|NOT COMPLETED|Overall Study||0
8287560|NCT01636063|20432906|P1|NOT COMPLETED|Overall Study||0
8287561|NCT01636063|20432905|P2|COMPLETED|Overall Study||21
8287562|NCT01636063|20432906|P1|COMPLETED|Overall Study||21
8287563|NCT01636063|20432905|P2|STARTED|Overall Study||21
8287564|NCT01636063|20432906|P1|STARTED|Overall Study||21
8287565|NCT01635998|20432914|P2|NOT COMPLETED|Overall Study||7
8287566|NCT01635998|20432915|P1|NOT COMPLETED|Overall Study||4
8287567|NCT01635998|20432914|P2|COMPLETED|Overall Study||15
8287568|NCT01635998|20432915|P1|COMPLETED|Overall Study||24
8287569|NCT01635998|20432914|P2|STARTED|Overall Study||22
8287570|NCT01635998|20432915|P1|STARTED|Overall Study||28
8287571|NCT01635933|20432943|P2|NOT COMPLETED|Overall Study||8
8287572|NCT01635933|20432944|P1|NOT COMPLETED|Overall Study||2
8287573|NCT01635933|20432943|P2|COMPLETED|Overall Study||177
8287574|NCT01635933|20432944|P1|COMPLETED|Overall Study||176
8287575|NCT01635933|20432943|P2|STARTED|Overall Study||185
8287576|NCT01635933|20432944|P1|STARTED|Overall Study||178
8287577|NCT01635920|20432956|P2|NOT COMPLETED|Overall Study||1
8287578|NCT01635920|20432957|P1|NOT COMPLETED|Overall Study||3
8287579|NCT01635920|20432956|P2|COMPLETED|Overall Study||125
8287580|NCT01635920|20432957|P1|COMPLETED|Overall Study||122
8287581|NCT01635920|20432956|P2|STARTED|Overall Study||126
8287582|NCT01635920|20432957|P1|STARTED|Overall Study||125
8287583|NCT01635881|20432965|P1|NOT COMPLETED|Overall Study||0
8287584|NCT01635881|20432965|P1|COMPLETED|Overall Study||60
8287585|NCT01635881|20432965|P1|STARTED|Overall Study||60
8287586|NCT01635855|20432970|P1|NOT COMPLETED|Overall Study||4
8287587|NCT01635855|20432970|P1|COMPLETED|Overall Study||113
8287588|NCT01635855|20432970|P1|STARTED|Overall Study||117
8287589|NCT01635764|20432979|P1|NOT COMPLETED|Overall Study||273
8287590|NCT01635764|20432979|P1|COMPLETED|Overall Study||235
8287591|NCT01635764|20432979|P1|STARTED|Overall Study||508
8287592|NCT01635504|20433007|P1|NOT COMPLETED|Overall Study||0
8287593|NCT01635504|20433007|P1|COMPLETED|Overall Study||5
8287594|NCT01635504|20433007|P1|STARTED|Overall Study||5
8287595|NCT01635439|20433014|P2|NOT COMPLETED|Overall Study||0
8287596|NCT01635439|20433015|P1|NOT COMPLETED|Overall Study||0
8287597|NCT01635439|20433014|P2|COMPLETED|Overall Study||100
8287598|NCT01635439|20433015|P1|COMPLETED|Overall Study||100
8287599|NCT01635439|20433014|P2|STARTED|Overall Study||100
8287600|NCT01635439|20433015|P1|STARTED|Overall Study||100
8287601|NCT01635283|20433029|P1|NOT COMPLETED|Overall Study||4
8287602|NCT01635283|20433029|P1|COMPLETED|Overall Study||1
8287603|NCT01635283|20433029|P1|STARTED|Overall Study||5
8287604|NCT01635244|20433040|P3|NOT COMPLETED|Overall Study||2
8287605|NCT01635244|20433041|P2|NOT COMPLETED|Overall Study||1
8287606|NCT01635244|20433042|P1|NOT COMPLETED|Overall Study||1
8287607|NCT01635244|20433040|P3|COMPLETED|Overall Study||18
8287608|NCT01635244|20433041|P2|COMPLETED|Overall Study||21
8287609|NCT01635244|20433042|P1|COMPLETED|Overall Study||17
8287610|NCT01635244|20433040|P3|STARTED|Overall Study||20
8287611|NCT01635244|20433041|P2|STARTED|Overall Study||22
8287612|NCT01635244|20433042|P1|STARTED|Overall Study||18
8287613|NCT01635218|20433053|P3|NOT COMPLETED|Overall Study||6
8287614|NCT01635218|20433054|P2|NOT COMPLETED|Overall Study||7
8287615|NCT01635218|20433055|P1|NOT COMPLETED|Overall Study||3
8287616|NCT01635218|20433053|P3|COMPLETED|Overall Study||37
8287617|NCT01635218|20433054|P2|COMPLETED|Overall Study||39
8287618|NCT01635218|20433055|P1|COMPLETED|Overall Study||41
8287619|NCT01635218|20433053|P3|STARTED|Overall Study||43
8287620|NCT01635218|20433054|P2|STARTED|Overall Study||46
8287621|NCT01635218|20433055|P1|STARTED|Overall Study||44
8287622|NCT01635153|20433077|P2|NOT COMPLETED|Overall Study||43
8287623|NCT01635153|20433078|P1|NOT COMPLETED|Overall Study||40
8287624|NCT01635153|20433077|P2|COMPLETED|Overall Study||36
8287625|NCT01635153|20433078|P1|COMPLETED|Overall Study||32
8287626|NCT01635153|20433077|P2|STARTED|Overall Study||79
8287627|NCT01635153|20433078|P1|STARTED|Overall Study||72
8287628|NCT01635101|20433091|P3|NOT COMPLETED|Overall Study||17
8287629|NCT01635101|20433092|P2|NOT COMPLETED|Overall Study||12
8287630|NCT01635101|20433093|P1|NOT COMPLETED|Overall Study||9
8287631|NCT01635101|20433091|P3|COMPLETED|Overall Study||52
8287632|NCT01635101|20433092|P2|COMPLETED|Overall Study||55
8287633|NCT01635101|20433093|P1|COMPLETED|Overall Study||52
8287634|NCT01635101|20433091|P3|Pharmacokinetics Evaluable Population|Overall Study||58
8287635|NCT01635101|20433092|P2|Pharmacokinetics Evaluable Population|Overall Study||59
8287636|NCT01635101|20433093|P1|Pharmacokinetics Evaluable Population|Overall Study||50
8287637|NCT01635101|20433091|P3|Modified Intent to Treat (mITT)|Overall Study||69
8287638|NCT01635101|20433092|P2|Modified Intent to Treat (mITT)|Overall Study||67
8287639|NCT01635101|20433093|P1|Modified Intent to Treat (mITT)|Overall Study||61
8287640|NCT01635101|20433091|P3|Safety Population|Overall Study||69
8287641|NCT01635101|20433092|P2|Safety Population|Overall Study||67
8287642|NCT01635101|20433093|P1|Safety Population|Overall Study||61
8287643|NCT01635101|20433091|P3|STARTED|Overall Study||69
8287644|NCT01635101|20433092|P2|STARTED|Overall Study||67
8287645|NCT01635101|20433093|P1|STARTED|Overall Study||61
8287646|NCT01635062|20433118|P2|NOT COMPLETED|Overall Study||0
8287647|NCT01635062|20433119|P1|NOT COMPLETED|Overall Study||0
8287648|NCT01635062|20433118|P2|COMPLETED|Overall Study||9
8287649|NCT01635062|20433119|P1|COMPLETED|Overall Study||9
8287650|NCT01635062|20433118|P2|Post-Randomization Sodium Loaded|Overall Study||9
8287651|NCT01635062|20433119|P1|Post-Randomization Sodium Loaded|Overall Study||9
8287652|NCT01635062|20433118|P2|Post-randomization Sodium Restriction|Overall Study||9
8287653|NCT01635062|20433119|P1|Post-randomization Sodium Restriction|Overall Study||9
8287654|NCT01635062|20433118|P2|Sodium Loading Baseline Visit|Overall Study||9
8287655|NCT01635062|20433119|P1|Sodium Loading Baseline Visit|Overall Study||9
8287656|NCT01635062|20433118|P2|Sodium Restriction Baseline Visit|Overall Study||9
8287657|NCT01635062|20433119|P1|Sodium Restriction Baseline Visit|Overall Study||9
8287658|NCT01635062|20433118|P2|STARTED|Overall Study||9
8287659|NCT01635062|20433119|P1|STARTED|Overall Study||9
8287660|NCT01634854|20433131|P2|NOT COMPLETED|Overall Study||7
8287661|NCT01634854|20433132|P1|NOT COMPLETED|Overall Study||2
8287662|NCT01634854|20433131|P2|COMPLETED|Overall Study||59
8287663|NCT01634854|20433132|P1|COMPLETED|Overall Study||62
8287664|NCT01634854|20433131|P2|STARTED|Overall Study||66
8287665|NCT01634854|20433132|P1|STARTED|Overall Study||64
8287666|NCT01634659|20433152|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
8287667|NCT01634659|20433153|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
8287668|NCT01634659|20433152|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
8287669|NCT01634659|20433153|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
8287670|NCT01634659|20433152|P2|STARTED|Period 2 - Second 8 Days of Wear||158
8287671|NCT01634659|20433153|P1|STARTED|Period 2 - Second 8 Days of Wear||155
8287672|NCT01634659|20433152|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
8287673|NCT01634659|20433153|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
8287674|NCT01634659|20433152|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
8287675|NCT01634659|20433153|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
8287676|NCT01634659|20433152|P2|STARTED|Period 1 - First 8 Days of Wear||158
8287677|NCT01634659|20433153|P1|STARTED|Period 1 - First 8 Days of Wear||155
8287678|NCT01634620|20433163|P1|NOT COMPLETED|Overall Study||0
8287679|NCT01634620|20433163|P1|COMPLETED|Overall Study||200
8287680|NCT01634620|20433163|P1|STARTED|Overall Study||200
8287681|NCT01634555|20433183|P1|NOT COMPLETED|Overall Study||4
8287682|NCT01634555|20433183|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
8287683|NCT01634555|20433183|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
8287684|NCT01634555|20433183|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
8287685|NCT01634555|20433183|P1|STARTED|Overall Study||29
8287686|NCT01634360|20433194|P2|NOT COMPLETED|Overall Study||136
8287687|NCT01634360|20433195|P1|NOT COMPLETED|Overall Study||49
8287688|NCT01634360|20433194|P2|COMPLETED|Overall Study||0
8287689|NCT01634360|20433195|P1|COMPLETED|Overall Study||0
8287690|NCT01634360|20433194|P2|STARTED|Overall Study||136
8287691|NCT01634360|20433195|P1|STARTED|Overall Study||49
8287692|NCT01634269|20433205|P1|NOT COMPLETED|Overall Study||2
8287693|NCT01634269|20433205|P1|COMPLETED|Overall Study||18
8287694|NCT01634269|20433205|P1|24 Month|Overall Study||18
8287695|NCT01634269|20433205|P1|12 Month|Overall Study||20
8287696|NCT01634269|20433205|P1|6 Month|Overall Study||20
8287697|NCT01634269|20433205|P1|30 Days|Overall Study||20
8287698|NCT01634269|20433205|P1|STARTED|Overall Study||20
8287699|NCT01634256|20433252|P2|NOT COMPLETED|Overall Study||8
8287700|NCT01634256|20433253|P1|NOT COMPLETED|Overall Study||4
8287701|NCT01634256|20433252|P2|COMPLETED|Overall Study||22
8287702|NCT01634256|20433253|P1|COMPLETED|Overall Study||26
8287703|NCT01634256|20433252|P2|STARTED|Overall Study||30
8287704|NCT01634256|20433253|P1|STARTED|Overall Study||30
8287705|NCT01634243|20433269|P2|NOT COMPLETED|Overall Study||5
8287706|NCT01634243|20433270|P1|NOT COMPLETED|Overall Study||6
8287707|NCT01634243|20433269|P2|COMPLETED|Overall Study||38
8287708|NCT01634243|20433270|P1|COMPLETED|Overall Study||15
8287709|NCT01634243|20433269|P2|STARTED|Overall Study||43
8287710|NCT01634243|20433270|P1|STARTED|Overall Study||21
8287711|NCT01634165|20433296|P4|NOT COMPLETED|Period 4||0
8287712|NCT01634165|20433297|P3|NOT COMPLETED|Period 4||0
8287713|NCT01634165|20433298|P2|NOT COMPLETED|Period 4||0
8287714|NCT01634165|20433299|P1|NOT COMPLETED|Period 4||0
8287715|NCT01634165|20433296|P4|COMPLETED|Period 4||6
8287716|NCT01634165|20433297|P3|COMPLETED|Period 4||6
8287717|NCT01634165|20433298|P2|COMPLETED|Period 4||5
8287718|NCT01634165|20433299|P1|COMPLETED|Period 4||6
8287719|NCT01634165|20433296|P4|STARTED|Period 4||6
8287720|NCT01634165|20433297|P3|STARTED|Period 4||6
8287721|NCT01634165|20433298|P2|STARTED|Period 4||5
8287722|NCT01634165|20433299|P1|STARTED|Period 4||6
8287723|NCT01634165|20433296|P4|NOT COMPLETED|Period 3||0
8287724|NCT01634165|20433297|P3|NOT COMPLETED|Period 3||0
8287725|NCT01634165|20433298|P2|NOT COMPLETED|Period 3||0
8287726|NCT01634165|20433299|P1|NOT COMPLETED|Period 3||0
8287727|NCT01634165|20433296|P4|COMPLETED|Period 3||6
8287728|NCT01634165|20433297|P3|COMPLETED|Period 3||6
8287729|NCT01634165|20433298|P2|COMPLETED|Period 3||5
8287730|NCT01634165|20433299|P1|COMPLETED|Period 3||6
8287731|NCT01634165|20433296|P4|STARTED|Period 3||6
8287732|NCT01634165|20433297|P3|STARTED|Period 3||6
8287733|NCT01634165|20433298|P2|STARTED|Period 3||5
8287734|NCT01634165|20433299|P1|STARTED|Period 3||6
8287735|NCT01634165|20433296|P4|NOT COMPLETED|Period 2||0
8287736|NCT01634165|20433297|P3|NOT COMPLETED|Period 2||0
8287737|NCT01634165|20433298|P2|NOT COMPLETED|Period 2||1
8287738|NCT01634165|20433299|P1|NOT COMPLETED|Period 2||0
8287739|NCT01634165|20433296|P4|COMPLETED|Period 2||6
8287740|NCT01634165|20433297|P3|COMPLETED|Period 2||6
8287741|NCT01634165|20433298|P2|COMPLETED|Period 2||5
8287742|NCT01634165|20433299|P1|COMPLETED|Period 2||6
8287743|NCT01634165|20433296|P4|STARTED|Period 2||6
8287744|NCT01634165|20433297|P3|STARTED|Period 2||6
8287745|NCT01634165|20433298|P2|STARTED|Period 2||6
8287746|NCT01634165|20433299|P1|STARTED|Period 2||6
8287747|NCT01634165|20433296|P4|NOT COMPLETED|Period 1||0
8287748|NCT01634165|20433297|P3|NOT COMPLETED|Period 1||0
8287749|NCT01634165|20433298|P2|NOT COMPLETED|Period 1||0
8287750|NCT01634165|20433299|P1|NOT COMPLETED|Period 1||0
8287751|NCT01634165|20433296|P4|COMPLETED|Period 1||6
8287752|NCT01634165|20433297|P3|COMPLETED|Period 1||6
8287753|NCT01634165|20433298|P2|COMPLETED|Period 1||6
8287754|NCT01634165|20433299|P1|COMPLETED|Period 1||6
8287755|NCT01634165|20433296|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8287756|NCT01634165|20433297|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8287757|NCT01634165|20433298|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8287758|NCT01634165|20433299|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8287759|NCT01634165|20433296|P4|STARTED|Period 1||6
8287760|NCT01634165|20433297|P3|STARTED|Period 1||6
8287761|NCT01634165|20433298|P2|STARTED|Period 1||6
8287762|NCT01634165|20433299|P1|STARTED|Period 1||6
8287763|NCT01634152|20433332|P3|NOT COMPLETED|Overall Study||4
8287764|NCT01634152|20433333|P2|NOT COMPLETED|Overall Study||1
8287765|NCT01634152|20433334|P1|NOT COMPLETED|Overall Study||4
8287766|NCT01634152|20433332|P3|COMPLETED|Overall Study||126
8287767|NCT01634152|20433333|P2|COMPLETED|Overall Study||136
8287768|NCT01634152|20433334|P1|COMPLETED|Overall Study||130
8287769|NCT01634152|20433332|P3|STARTED|Overall Study||130
8287770|NCT01634152|20433333|P2|STARTED|Overall Study||137
8287771|NCT01634152|20433334|P1|STARTED|Overall Study||134
8287772|NCT01634139|20433417|P3|NOT COMPLETED|Overall Study||5
8287773|NCT01634139|20433418|P2|NOT COMPLETED|Overall Study||6
8287774|NCT01634139|20433419|P1|NOT COMPLETED|Overall Study||10
8287775|NCT01634139|20433417|P3|COMPLETED|Overall Study||130
8287776|NCT01634139|20433418|P2|COMPLETED|Overall Study||130
8287777|NCT01634139|20433419|P1|COMPLETED|Overall Study||122
8287778|NCT01634139|20433417|P3|STARTED|Overall Study||135
8287779|NCT01634139|20433418|P2|STARTED|Overall Study||136
8287780|NCT01634139|20433419|P1|STARTED|Overall Study||132
8287781|NCT01634113|20433520|P3|NOT COMPLETED|Overall Study||1
8287782|NCT01634113|20433521|P2|NOT COMPLETED|Overall Study||0
8287783|NCT01634113|20433522|P1|NOT COMPLETED|Overall Study||0
8287784|NCT01634113|20433520|P3|COMPLETED|Overall Study||31
8287785|NCT01634113|20433521|P2|COMPLETED|Overall Study||36
8287786|NCT01634113|20433522|P1|COMPLETED|Overall Study||34
8287787|NCT01634113|20433520|P3|STARTED|Overall Study||32
8287788|NCT01634113|20433521|P2|STARTED|Overall Study||36
8287789|NCT01634113|20433522|P1|STARTED|Overall Study||34
8287790|NCT01634100|20433566|P6|NOT COMPLETED|Overall Study||0
8287791|NCT01634100|20433567|P5|NOT COMPLETED|Overall Study||0
8287792|NCT01634100|20433568|P4|NOT COMPLETED|Overall Study||0
8287793|NCT01634100|20433569|P3|NOT COMPLETED|Overall Study||1
8287794|NCT01634100|20433570|P2|NOT COMPLETED|Overall Study||0
8287795|NCT01634100|20433571|P1|NOT COMPLETED|Overall Study||1
8287796|NCT01634100|20433566|P6|COMPLETED|Overall Study||3
8287797|NCT01634100|20433567|P5|COMPLETED|Overall Study||3
8287798|NCT01634100|20433568|P4|COMPLETED|Overall Study||3
8287799|NCT01634100|20433569|P3|COMPLETED|Overall Study||2
8287800|NCT01634100|20433570|P2|COMPLETED|Overall Study||3
8287801|NCT01634100|20433571|P1|COMPLETED|Overall Study||2
8287802|NCT01634100|20433566|P6|Received Empa + Probenecid|Overall Study||3
8287803|NCT01634100|20433567|P5|Received Empa + Probenecid|Overall Study||3
8287804|NCT01634100|20433568|P4|Received Empa + Probenecid|Overall Study||3
8287805|NCT01634100|20433569|P3|Received Empa + Probenecid|Overall Study||2
8287806|NCT01634100|20433570|P2|Received Empa + Probenecid|Overall Study||3
8287807|NCT01634100|20433571|P1|Received Empa + Probenecid|Overall Study||2
8287808|NCT01634100|20433566|P6|Received Empa + Rifampicin|Overall Study||3
8287809|NCT01634100|20433567|P5|Received Empa + Rifampicin|Overall Study||3
8287810|NCT01634100|20433568|P4|Received Empa + Rifampicin|Overall Study||3
8287811|NCT01634100|20433569|P3|Received Empa + Rifampicin|Overall Study||3
8287812|NCT01634100|20433570|P2|Received Empa + Rifampicin|Overall Study||3
8287813|NCT01634100|20433571|P1|Received Empa + Rifampicin|Overall Study||3
8287814|NCT01634100|20433566|P6|Received Empa Alone|Overall Study||3
8287815|NCT01634100|20433567|P5|Received Empa Alone|Overall Study||3
8287816|NCT01634100|20433568|P4|Received Empa Alone|Overall Study||3
8287817|NCT01634100|20433569|P3|Received Empa Alone|Overall Study||3
8287818|NCT01634100|20433570|P2|Received Empa Alone|Overall Study||3
8287819|NCT01634100|20433571|P1|Received Empa Alone|Overall Study||3
8287820|NCT01634100|20433566|P6|STARTED|Overall Study||3
8287821|NCT01634100|20433567|P5|STARTED|Overall Study||3
8287822|NCT01634100|20433568|P4|STARTED|Overall Study||3
8287823|NCT01634100|20433569|P3|STARTED|Overall Study||3
8287824|NCT01634100|20433570|P2|STARTED|Overall Study||3
8287825|NCT01634100|20433571|P1|STARTED|Overall Study||3
8287826|NCT01633944|20433587|P3|NOT COMPLETED|Double-blind Treatment Phase||58
8287827|NCT01633944|20433588|P2|NOT COMPLETED|Double-blind Treatment Phase||54
8287828|NCT01633944|20433589|P1|NOT COMPLETED|Double-blind Treatment Phase||0
8287829|NCT01633944|20433587|P3|COMPLETED|Double-blind Treatment Phase||174
8287830|NCT01633944|20433588|P2|COMPLETED|Double-blind Treatment Phase||176
8287831|NCT01633944|20433589|P1|COMPLETED|Double-blind Treatment Phase||0
8287832|NCT01633944|20433587|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
8287833|NCT01633944|20433588|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
8287834|NCT01633944|20433589|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8287835|NCT01633944|20433587|P3|NOT COMPLETED|Open-label Titration Phase||0
8287836|NCT01633944|20433588|P2|NOT COMPLETED|Open-label Titration Phase||0
8287837|NCT01633944|20433589|P1|NOT COMPLETED|Open-label Titration Phase||290
8287838|NCT01633944|20433587|P3|COMPLETED|Open-label Titration Phase||0
8287839|NCT01633944|20433588|P2|COMPLETED|Open-label Titration Phase||0
8287840|NCT01633944|20433589|P1|COMPLETED|Open-label Titration Phase||462
8287841|NCT01633944|20433587|P3|STARTED|Open-label Titration Phase||0
8287842|NCT01633944|20433588|P2|STARTED|Open-label Titration Phase||0
8287843|NCT01633944|20433589|P1|STARTED|Open-label Titration Phase||752
8287844|NCT01633892|20433609|P1|NOT COMPLETED|Overall Study||0
8287845|NCT01633892|20433609|P1|COMPLETED|Overall Study||5
8287846|NCT01633892|20433609|P1|STARTED|Overall Study||5
8287847|NCT01633853|20433619|P2|NOT COMPLETED|Overall Study||0
8287848|NCT01633853|20433620|P1|NOT COMPLETED|Overall Study||0
8287849|NCT01633853|20433619|P2|COMPLETED|Overall Study||100
8287850|NCT01633853|20433620|P1|COMPLETED|Overall Study||104
8287851|NCT01633853|20433619|P2|STARTED|Overall Study||100
8287852|NCT01633853|20433620|P1|STARTED|Overall Study||104
8287853|NCT01633827|20433634|P2|NOT COMPLETED|Second Intervention||0
8287854|NCT01633827|20433635|P1|NOT COMPLETED|Second Intervention||0
8287855|NCT01633827|20433634|P2|COMPLETED|Second Intervention||11
8287856|NCT01633827|20433635|P1|COMPLETED|Second Intervention||11
8287857|NCT01633827|20433634|P2|STARTED|Second Intervention||11
8287858|NCT01633827|20433635|P1|STARTED|Second Intervention||11
8287859|NCT01633827|20433634|P2|NOT COMPLETED|Washout Period||0
8287860|NCT01633827|20433635|P1|NOT COMPLETED|Washout Period||0
8287861|NCT01633827|20433634|P2|COMPLETED|Washout Period||11
8287862|NCT01633827|20433635|P1|COMPLETED|Washout Period||11
8287863|NCT01633827|20433634|P2|STARTED|Washout Period||11
8287864|NCT01633827|20433635|P1|STARTED|Washout Period||11
8287865|NCT01633827|20433634|P2|NOT COMPLETED|First Intervention||0
8287866|NCT01633827|20433635|P1|NOT COMPLETED|First Intervention||0
8287867|NCT01633827|20433634|P2|COMPLETED|First Intervention||11
8287868|NCT01633827|20433635|P1|COMPLETED|First Intervention||11
8287869|NCT01633827|20433634|P2|STARTED|First Intervention||11
8287870|NCT01633827|20433635|P1|STARTED|First Intervention||11
8287871|NCT01633814|20433648|P1|NOT COMPLETED|Overall Study||0
8287872|NCT01633814|20433648|P1|COMPLETED|Overall Study||4
8287873|NCT01633814|20433648|P1|STARTED|Overall Study||4
8287874|NCT01633788|20433657|P4|NOT COMPLETED|Overall Study||13
8287875|NCT01633788|20433658|P3|NOT COMPLETED|Overall Study||10
8287876|NCT01633788|20433659|P2|NOT COMPLETED|Overall Study||8
8287877|NCT01633788|20433660|P1|NOT COMPLETED|Overall Study||7
8287878|NCT01633788|20433657|P4|COMPLETED|Overall Study||45
8287879|NCT01633788|20433658|P3|COMPLETED|Overall Study||49
8287880|NCT01633788|20433659|P2|COMPLETED|Overall Study||50
8287881|NCT01633788|20433660|P1|COMPLETED|Overall Study||50
8287882|NCT01633788|20433657|P4|STARTED|Overall Study||58
8287883|NCT01633788|20433658|P3|STARTED|Overall Study||59
8287884|NCT01633788|20433659|P2|STARTED|Overall Study||58
8287885|NCT01633788|20433660|P1|STARTED|Overall Study||57
8287886|NCT01633320|20433680|P2|NOT COMPLETED|Overall Study||0
8287887|NCT01633320|20433681|P1|NOT COMPLETED|Overall Study||0
8287888|NCT01633320|20433680|P2|COMPLETED|Overall Study||68
8287889|NCT01633320|20433681|P1|COMPLETED|Overall Study||132
8287890|NCT01633320|20433680|P2|STARTED|Overall Study||68
8287891|NCT01633320|20433681|P1|STARTED|Overall Study||132
8287892|NCT01633112|20433692|P3|NOT COMPLETED|Overall Study||92
8287893|NCT01633112|20433693|P2|NOT COMPLETED|Overall Study||60
8287894|NCT01633112|20433694|P1|NOT COMPLETED|Overall Study||53
8287895|NCT01633112|20433692|P3|COMPLETED|Overall Study||250
8287896|NCT01633112|20433693|P2|COMPLETED|Overall Study||310
8287897|NCT01633112|20433694|P1|COMPLETED|Overall Study||299
8287898|NCT01633112|20433692|P3|STARTED|Overall Study||342
8287899|NCT01633112|20433693|P2|STARTED|Overall Study||370
8287900|NCT01633112|20433694|P1|STARTED|Overall Study||352
8287901|NCT01633060|20433729|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8287902|NCT01633060|20433730|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
8287903|NCT01633060|20433729|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8287904|NCT01633060|20433730|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8287905|NCT01633060|20433729|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8287906|NCT01633060|20433730|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
8287907|NCT01633060|20433729|P2|NOT COMPLETED|Treatment Phase||140
8287908|NCT01633060|20433730|P1|NOT COMPLETED|Treatment Phase||288
8287909|NCT01633060|20433729|P2|COMPLETED|Treatment Phase||0
8287910|NCT01633060|20433730|P1|COMPLETED|Treatment Phase||0
8287911|NCT01633060|20433729|P2|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
8287912|NCT01633060|20433730|P1|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
8287913|NCT01633060|20433729|P2|Safety Set (SS)|Treatment Phase||140
8287914|NCT01633060|20433730|P1|Safety Set (SS)|Treatment Phase||288
8287915|NCT01633060|20433729|P2|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
8287916|NCT01633060|20433730|P1|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
8287917|NCT01633060|20433729|P2|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
8287918|NCT01633060|20433730|P1|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
8287919|NCT01633060|20433729|P2|STARTED|Treatment Phase||140
8287920|NCT01633060|20433730|P1|STARTED|Treatment Phase||288
8287921|NCT01633060|20433729|P2|NOT COMPLETED|Randomization Phase||3
8287922|NCT01633060|20433730|P1|NOT COMPLETED|Randomization Phase||1
8287923|NCT01633060|20433729|P2|COMPLETED|Randomization Phase||140
8287924|NCT01633060|20433730|P1|COMPLETED|Randomization Phase||288
8287925|NCT01633060|20433729|P2|STARTED|Randomization Phase|All randomized patients|143
8287926|NCT01633060|20433730|P1|STARTED|Randomization Phase|All randomized patients|289
8287927|NCT01632995|20433755|P1|NOT COMPLETED|Main Study Follow-up Period||120
8287928|NCT01632995|20433755|P1|COMPLETED|Main Study Follow-up Period||437
8287929|NCT01632995|20433755|P1|STARTED|Main Study Follow-up Period||557
8287930|NCT01632995|20433755|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
8287931|NCT01632995|20433755|P1|COMPLETED|Pre-screening to Enrollment Period||557
8287932|NCT01632995|20433755|P1|STARTED|Pre-screening to Enrollment Period||1069
8287933|NCT01632904|20433770|P2|NOT COMPLETED|Overall Study||6
8287934|NCT01632904|20433771|P1|NOT COMPLETED|Overall Study||7
8287935|NCT01632904|20433770|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
8287936|NCT01632904|20433771|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
8287937|NCT01632904|20433770|P2|STARTED|Overall Study||56
8287938|NCT01632904|20433771|P1|STARTED|Overall Study||54
8287939|NCT01632891|20433782|P2|NOT COMPLETED|Overall Study||1
8287940|NCT01632891|20433783|P1|NOT COMPLETED|Overall Study||1
8287941|NCT01632891|20433782|P2|COMPLETED|Overall Study||25
8287942|NCT01632891|20433783|P1|COMPLETED|Overall Study||25
8287943|NCT01632891|20433782|P2|STARTED|Overall Study||26
8287944|NCT01632891|20433783|P1|STARTED|Overall Study||26
8287945|NCT01632878|20433807|P1|NOT COMPLETED|Treatment||158
8287946|NCT01632878|20433807|P1|COMPLETED|Treatment||1105
8287947|NCT01632878|20433807|P1|STARTED|Treatment||1263
8287948|NCT01632878|20433807|P1|NOT COMPLETED|Screening||268
8287949|NCT01632878|20433807|P1|COMPLETED|Screening||1263
8287950|NCT01632878|20433807|P1|STARTED|Screening||1531
8287951|NCT01632800|20433811|P1|NOT COMPLETED|Overall Study||1
8287952|NCT01632800|20433811|P1|COMPLETED|Overall Study||25
8287953|NCT01632800|20433811|P1|STARTED|Overall Study||26
8287954|NCT01632735|20433817|P2|NOT COMPLETED|Overall Study||3
8287955|NCT01632735|20433818|P1|NOT COMPLETED|Overall Study||4
8287956|NCT01632735|20433817|P2|COMPLETED|Overall Study||37
8287957|NCT01632735|20433818|P1|COMPLETED|Overall Study||36
8287958|NCT01632735|20433817|P2|STARTED|Overall Study||40
8287959|NCT01632735|20433818|P1|STARTED|Overall Study||40
8287960|NCT01632709|20433834|P4|NOT COMPLETED|Overall Study||1
8287961|NCT01632709|20433835|P3|NOT COMPLETED|Overall Study||0
8287962|NCT01632709|20433836|P2|NOT COMPLETED|Overall Study||1
8287963|NCT01632709|20433837|P1|NOT COMPLETED|Overall Study||2
8287964|NCT01632709|20433834|P4|COMPLETED|Overall Study||3
8287965|NCT01632709|20433835|P3|COMPLETED|Overall Study||5
8287966|NCT01632709|20433836|P2|COMPLETED|Overall Study||2
8287967|NCT01632709|20433837|P1|COMPLETED|Overall Study||2
8287968|NCT01632709|20433834|P4|Completed Visit 2 (Received Injection)|Overall Study||3
8287969|NCT01632709|20433835|P3|Completed Visit 2 (Received Injection)|Overall Study||5
8287970|NCT01632709|20433836|P2|Completed Visit 2 (Received Injection)|Overall Study||2
8287971|NCT01632709|20433837|P1|Completed Visit 2 (Received Injection)|Overall Study||4
8287972|NCT01632709|20433834|P4|STARTED|Overall Study||4
8287973|NCT01632709|20433835|P3|STARTED|Overall Study||5
8287974|NCT01632709|20433836|P2|STARTED|Overall Study||3
8287975|NCT01632709|20433837|P1|STARTED|Overall Study||4
8287976|NCT01632683|20433863|P2|NOT COMPLETED|Overall Study||0
8287977|NCT01632683|20433864|P1|NOT COMPLETED|Overall Study||0
8287978|NCT01632683|20433863|P2|COMPLETED|Overall Study||552
8287979|NCT01632683|20433864|P1|COMPLETED|Overall Study||548
8287980|NCT01632683|20433863|P2|STARTED|Overall Study||552
8287981|NCT01632683|20433864|P1|STARTED|Overall Study||548
8287982|NCT01632579|20433878|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
8287983|NCT01632579|20433879|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
8287984|NCT01632579|20433880|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
8287985|NCT01632579|20433881|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
8287986|NCT01632579|20433882|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
8287987|NCT01632579|20433883|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
8287988|NCT01632579|20433884|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
8287989|NCT01632579|20433885|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
8287990|NCT01632579|20433886|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
8287991|NCT01632579|20433878|P9|COMPLETED|Period 3 (Third Intervention)||2
8287992|NCT01632579|20433879|P8|COMPLETED|Period 3 (Third Intervention)||6
8287993|NCT01632579|20433880|P7|COMPLETED|Period 3 (Third Intervention)||2
8287994|NCT01632579|20433881|P6|COMPLETED|Period 3 (Third Intervention)||2
8287995|NCT01632579|20433882|P5|COMPLETED|Period 3 (Third Intervention)||6
8287996|NCT01632579|20433883|P4|COMPLETED|Period 3 (Third Intervention)||2
8287997|NCT01632579|20433884|P3|COMPLETED|Period 3 (Third Intervention)||2
8287998|NCT01632579|20433885|P2|COMPLETED|Period 3 (Third Intervention)||6
8287999|NCT01632579|20433886|P1|COMPLETED|Period 3 (Third Intervention)||0
8288000|NCT01632579|20433878|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288001|NCT01632579|20433879|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8288002|NCT01632579|20433880|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288003|NCT01632579|20433881|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288004|NCT01632579|20433882|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8288005|NCT01632579|20433883|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288006|NCT01632579|20433884|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288007|NCT01632579|20433885|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8288008|NCT01632579|20433886|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
8288009|NCT01632579|20433878|P9|STARTED|Period 3 (Third Intervention)||2
8288010|NCT01632579|20433879|P8|STARTED|Period 3 (Third Intervention)||6
8288011|NCT01632579|20433880|P7|STARTED|Period 3 (Third Intervention)||2
8288012|NCT01632579|20433881|P6|STARTED|Period 3 (Third Intervention)||2
8288013|NCT01632579|20433882|P5|STARTED|Period 3 (Third Intervention)||6
8288014|NCT01632579|20433883|P4|STARTED|Period 3 (Third Intervention)||2
8288015|NCT01632579|20433884|P3|STARTED|Period 3 (Third Intervention)||2
8288016|NCT01632579|20433885|P2|STARTED|Period 3 (Third Intervention)||6
8288017|NCT01632579|20433886|P1|STARTED|Period 3 (Third Intervention)||0
8288018|NCT01632579|20433878|P9|NOT COMPLETED|Washout Period||0
8288019|NCT01632579|20433879|P8|NOT COMPLETED|Washout Period||0
8288020|NCT01632579|20433880|P7|NOT COMPLETED|Washout Period||0
8288021|NCT01632579|20433881|P6|NOT COMPLETED|Washout Period||0
8288022|NCT01632579|20433882|P5|NOT COMPLETED|Washout Period||0
8288023|NCT01632579|20433883|P4|NOT COMPLETED|Washout Period||0
8288024|NCT01632579|20433884|P3|NOT COMPLETED|Washout Period||0
8288025|NCT01632579|20433885|P2|NOT COMPLETED|Washout Period||0
8288026|NCT01632579|20433886|P1|NOT COMPLETED|Washout Period||0
8288027|NCT01632579|20433878|P9|COMPLETED|Washout Period||2
8288028|NCT01632579|20433879|P8|COMPLETED|Washout Period||6
8288029|NCT01632579|20433880|P7|COMPLETED|Washout Period||2
8288030|NCT01632579|20433881|P6|COMPLETED|Washout Period||2
8288031|NCT01632579|20433882|P5|COMPLETED|Washout Period||6
8288032|NCT01632579|20433883|P4|COMPLETED|Washout Period||2
8288033|NCT01632579|20433884|P3|COMPLETED|Washout Period||2
8288034|NCT01632579|20433885|P2|COMPLETED|Washout Period||6
8288035|NCT01632579|20433886|P1|COMPLETED|Washout Period||0
8288036|NCT01632579|20433878|P9|STARTED|Washout Period||2
8288037|NCT01632579|20433879|P8|STARTED|Washout Period||6
8288038|NCT01632579|20433880|P7|STARTED|Washout Period||2
8288039|NCT01632579|20433881|P6|STARTED|Washout Period||2
8288040|NCT01632579|20433882|P5|STARTED|Washout Period||6
8288041|NCT01632579|20433883|P4|STARTED|Washout Period||2
8288042|NCT01632579|20433884|P3|STARTED|Washout Period||2
8288043|NCT01632579|20433885|P2|STARTED|Washout Period||6
8288044|NCT01632579|20433886|P1|STARTED|Washout Period||0
8288045|NCT01632579|20433878|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
8288046|NCT01632579|20433879|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
8288047|NCT01632579|20433880|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
8288048|NCT01632579|20433881|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
8288049|NCT01632579|20433882|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
8288050|NCT01632579|20433883|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
8288051|NCT01632579|20433884|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
8288052|NCT01632579|20433885|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
8288053|NCT01632579|20433886|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
8288054|NCT01632579|20433878|P9|COMPLETED|Period 2 (Second Intervention)||2
8288055|NCT01632579|20433879|P8|COMPLETED|Period 2 (Second Intervention)||6
8288056|NCT01632579|20433880|P7|COMPLETED|Period 2 (Second Intervention)||2
8288057|NCT01632579|20433881|P6|COMPLETED|Period 2 (Second Intervention)||2
8288058|NCT01632579|20433882|P5|COMPLETED|Period 2 (Second Intervention)||6
8288059|NCT01632579|20433883|P4|COMPLETED|Period 2 (Second Intervention)||2
8288060|NCT01632579|20433884|P3|COMPLETED|Period 2 (Second Intervention)||2
8288061|NCT01632579|20433885|P2|COMPLETED|Period 2 (Second Intervention)||6
8288062|NCT01632579|20433886|P1|COMPLETED|Period 2 (Second Intervention)||0
8288063|NCT01632579|20433878|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288064|NCT01632579|20433879|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8288065|NCT01632579|20433880|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288066|NCT01632579|20433881|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288067|NCT01632579|20433882|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8288068|NCT01632579|20433883|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288069|NCT01632579|20433884|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288070|NCT01632579|20433885|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8288071|NCT01632579|20433886|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
8288072|NCT01632579|20433878|P9|STARTED|Period 2 (Second Intervention)||2
8288073|NCT01632579|20433879|P8|STARTED|Period 2 (Second Intervention)||6
8288074|NCT01632579|20433880|P7|STARTED|Period 2 (Second Intervention)||2
8288075|NCT01632579|20433881|P6|STARTED|Period 2 (Second Intervention)||2
8288076|NCT01632579|20433882|P5|STARTED|Period 2 (Second Intervention)||6
8288077|NCT01632579|20433883|P4|STARTED|Period 2 (Second Intervention)||2
8288078|NCT01632579|20433884|P3|STARTED|Period 2 (Second Intervention)||2
8288079|NCT01632579|20433885|P2|STARTED|Period 2 (Second Intervention)||6
8288080|NCT01632579|20433886|P1|STARTED|Period 2 (Second Intervention)||1
8288081|NCT01632579|20433878|P9|NOT COMPLETED|Washout Period||0
8288082|NCT01632579|20433879|P8|NOT COMPLETED|Washout Period||0
8288083|NCT01632579|20433880|P7|NOT COMPLETED|Washout Period||0
8288084|NCT01632579|20433881|P6|NOT COMPLETED|Washout Period||0
8288085|NCT01632579|20433882|P5|NOT COMPLETED|Washout Period||0
8288086|NCT01632579|20433883|P4|NOT COMPLETED|Washout Period||0
8288087|NCT01632579|20433884|P3|NOT COMPLETED|Washout Period||0
8288088|NCT01632579|20433885|P2|NOT COMPLETED|Washout Period||0
8288089|NCT01632579|20433886|P1|NOT COMPLETED|Washout Period||1
8288090|NCT01632579|20433878|P9|COMPLETED|Washout Period||2
8288091|NCT01632579|20433879|P8|COMPLETED|Washout Period||6
8288092|NCT01632579|20433880|P7|COMPLETED|Washout Period||2
8288093|NCT01632579|20433881|P6|COMPLETED|Washout Period||2
8288094|NCT01632579|20433882|P5|COMPLETED|Washout Period||6
8288095|NCT01632579|20433883|P4|COMPLETED|Washout Period||2
8288096|NCT01632579|20433884|P3|COMPLETED|Washout Period||2
8288097|NCT01632579|20433885|P2|COMPLETED|Washout Period||6
8288098|NCT01632579|20433886|P1|COMPLETED|Washout Period||1
8288099|NCT01632579|20433878|P9|STARTED|Washout Period||2
8288100|NCT01632579|20433879|P8|STARTED|Washout Period||6
8288101|NCT01632579|20433880|P7|STARTED|Washout Period||2
8288102|NCT01632579|20433881|P6|STARTED|Washout Period||2
8288103|NCT01632579|20433882|P5|STARTED|Washout Period||6
8288104|NCT01632579|20433883|P4|STARTED|Washout Period||2
8288105|NCT01632579|20433884|P3|STARTED|Washout Period||2
8288106|NCT01632579|20433885|P2|STARTED|Washout Period||6
8288107|NCT01632579|20433886|P1|STARTED|Washout Period||2
8288108|NCT01632579|20433878|P9|NOT COMPLETED|Period 1 (First Intervention)||0
8288109|NCT01632579|20433879|P8|NOT COMPLETED|Period 1 (First Intervention)||0
8288110|NCT01632579|20433880|P7|NOT COMPLETED|Period 1 (First Intervention)||0
8288111|NCT01632579|20433881|P6|NOT COMPLETED|Period 1 (First Intervention)||0
8288112|NCT01632579|20433882|P5|NOT COMPLETED|Period 1 (First Intervention)||0
8288113|NCT01632579|20433883|P4|NOT COMPLETED|Period 1 (First Intervention)||0
8288114|NCT01632579|20433884|P3|NOT COMPLETED|Period 1 (First Intervention)||0
8288115|NCT01632579|20433885|P2|NOT COMPLETED|Period 1 (First Intervention)||0
8288116|NCT01632579|20433886|P1|NOT COMPLETED|Period 1 (First Intervention)||0
8288117|NCT01632579|20433878|P9|COMPLETED|Period 1 (First Intervention)||2
8288118|NCT01632579|20433879|P8|COMPLETED|Period 1 (First Intervention)||6
8288119|NCT01632579|20433880|P7|COMPLETED|Period 1 (First Intervention)||2
8288120|NCT01632579|20433881|P6|COMPLETED|Period 1 (First Intervention)||2
8288121|NCT01632579|20433882|P5|COMPLETED|Period 1 (First Intervention)||6
8288122|NCT01632579|20433883|P4|COMPLETED|Period 1 (First Intervention)||2
8288123|NCT01632579|20433884|P3|COMPLETED|Period 1 (First Intervention)||2
8288124|NCT01632579|20433885|P2|COMPLETED|Period 1 (First Intervention)||6
8288125|NCT01632579|20433886|P1|COMPLETED|Period 1 (First Intervention)||2
8288126|NCT01632579|20433878|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288127|NCT01632579|20433879|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
8288128|NCT01632579|20433880|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288129|NCT01632579|20433881|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288130|NCT01632579|20433882|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
8288131|NCT01632579|20433883|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288132|NCT01632579|20433884|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288133|NCT01632579|20433885|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
8288134|NCT01632579|20433886|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288135|NCT01632579|20433878|P9|STARTED|Period 1 (First Intervention)||2
8288136|NCT01632579|20433879|P8|STARTED|Period 1 (First Intervention)||6
8288137|NCT01632579|20433880|P7|STARTED|Period 1 (First Intervention)||2
8288138|NCT01632579|20433881|P6|STARTED|Period 1 (First Intervention)||2
8288139|NCT01632579|20433882|P5|STARTED|Period 1 (First Intervention)||6
8288140|NCT01632579|20433883|P4|STARTED|Period 1 (First Intervention)||2
8288141|NCT01632579|20433884|P3|STARTED|Period 1 (First Intervention)||2
8288142|NCT01632579|20433885|P2|STARTED|Period 1 (First Intervention)||6
8288143|NCT01632579|20433886|P1|STARTED|Period 1 (First Intervention)||2
8288144|NCT01632566|20433953|P5|NOT COMPLETED|Overall Study||2
8288145|NCT01632566|20433954|P4|NOT COMPLETED|Overall Study||2
8288146|NCT01632566|20433955|P3|NOT COMPLETED|Overall Study||9
8288147|NCT01632566|20433956|P2|NOT COMPLETED|Overall Study||3
8288148|NCT01632566|20433957|P1|NOT COMPLETED|Overall Study||0
8288149|NCT01632566|20433953|P5|COMPLETED|Overall Study||4
8288150|NCT01632566|20433954|P4|COMPLETED|Overall Study||4
8288151|NCT01632566|20433955|P3|COMPLETED|Overall Study||0
8288152|NCT01632566|20433956|P2|COMPLETED|Overall Study||7
8288153|NCT01632566|20433957|P1|COMPLETED|Overall Study||8
8288154|NCT01632566|20433953|P5|Received at Least One Dose Simvastatin|Overall Study||4
8288155|NCT01632566|20433954|P4|Received at Least One Dose Simvastatin|Overall Study||4
8288156|NCT01632566|20433955|P3|Received at Least One Dose Simvastatin|Overall Study||9
8288157|NCT01632566|20433956|P2|Received at Least One Dose Simvastatin|Overall Study||10
8288158|NCT01632566|20433957|P1|Received at Least One Dose Simvastatin|Overall Study||0
8288159|NCT01632566|20433953|P5|Received at Least One Dose LY3031207|Overall Study||0
8288160|NCT01632566|20433954|P4|Received at Least One Dose LY3031207|Overall Study||0
8288161|NCT01632566|20433955|P3|Received at Least One Dose LY3031207|Overall Study||9
8288162|NCT01632566|20433956|P2|Received at Least One Dose LY3031207|Overall Study||10
8288163|NCT01632566|20433957|P1|Received at Least One Dose LY3031207|Overall Study||8
8288164|NCT01632566|20433953|P5|STARTED|Overall Study||6
8288165|NCT01632566|20433954|P4|STARTED|Overall Study||6
8288166|NCT01632566|20433955|P3|STARTED|Overall Study||9
8288167|NCT01632566|20433956|P2|STARTED|Overall Study||10
8288168|NCT01632566|20433957|P1|STARTED|Overall Study||8
8288169|NCT01632423|20433995|P1|NOT COMPLETED|Overall Study||246
8288170|NCT01632423|20433995|P1|COMPLETED|Overall Study||10091
8288171|NCT01632423|20433995|P1|STARTED|Overall Study||10337
8288172|NCT01632345|20434008|P7|NOT COMPLETED|Treatment: Part II||11
8288173|NCT01632345|20434009|P6|NOT COMPLETED|Treatment: Part II||11
8288174|NCT01632345|20434010|P5|NOT COMPLETED|Treatment: Part II||0
8288175|NCT01632345|20434011|P4|NOT COMPLETED|Treatment: Part II||0
8288176|NCT01632345|20434012|P3|NOT COMPLETED|Treatment: Part II||0
8288177|NCT01632345|20434013|P2|NOT COMPLETED|Treatment: Part II||0
8288178|NCT01632345|20434014|P1|NOT COMPLETED|Treatment: Part II||0
8288179|NCT01632345|20434008|P7|COMPLETED|Treatment: Part II||55
8288180|NCT01632345|20434009|P6|COMPLETED|Treatment: Part II||55
8288181|NCT01632345|20434010|P5|COMPLETED|Treatment: Part II||0
8288182|NCT01632345|20434011|P4|COMPLETED|Treatment: Part II||0
8288183|NCT01632345|20434012|P3|COMPLETED|Treatment: Part II||0
8288184|NCT01632345|20434013|P2|COMPLETED|Treatment: Part II||0
8288185|NCT01632345|20434014|P1|COMPLETED|Treatment: Part II||0
8288186|NCT01632345|20434008|P7|Treated|Treatment: Part II||66
8288187|NCT01632345|20434009|P6|Treated|Treatment: Part II||66
8288188|NCT01632345|20434010|P5|Treated|Treatment: Part II||0
8288189|NCT01632345|20434011|P4|Treated|Treatment: Part II||0
8288190|NCT01632345|20434012|P3|Treated|Treatment: Part II||0
8288191|NCT01632345|20434013|P2|Treated|Treatment: Part II||0
8288192|NCT01632345|20434014|P1|Treated|Treatment: Part II||0
8288193|NCT01632345|20434008|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
8288194|NCT01632345|20434009|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
8288195|NCT01632345|20434010|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288196|NCT01632345|20434011|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288197|NCT01632345|20434012|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288198|NCT01632345|20434013|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288199|NCT01632345|20434014|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288200|NCT01632345|20434008|P7|NOT COMPLETED|Treatment: Part I||0
8288201|NCT01632345|20434009|P6|NOT COMPLETED|Treatment: Part I||0
8288202|NCT01632345|20434010|P5|NOT COMPLETED|Treatment: Part I||13
8288203|NCT01632345|20434011|P4|NOT COMPLETED|Treatment: Part I||8
8288204|NCT01632345|20434012|P3|NOT COMPLETED|Treatment: Part I||10
8288205|NCT01632345|20434013|P2|NOT COMPLETED|Treatment: Part I||15
8288206|NCT01632345|20434014|P1|NOT COMPLETED|Treatment: Part I||12
8288207|NCT01632345|20434008|P7|COMPLETED|Treatment: Part I||0
8288208|NCT01632345|20434009|P6|COMPLETED|Treatment: Part I||0
8288209|NCT01632345|20434010|P5|COMPLETED|Treatment: Part I||30
8288210|NCT01632345|20434011|P4|COMPLETED|Treatment: Part I||33
8288211|NCT01632345|20434012|P3|COMPLETED|Treatment: Part I||32
8288212|NCT01632345|20434013|P2|COMPLETED|Treatment: Part I||28
8288213|NCT01632345|20434014|P1|COMPLETED|Treatment: Part I||29
8288214|NCT01632345|20434008|P7|Treated|Treatment: Part I||0
8288215|NCT01632345|20434009|P6|Treated|Treatment: Part I||0
8288216|NCT01632345|20434010|P5|Treated|Treatment: Part I||43
8288217|NCT01632345|20434011|P4|Treated|Treatment: Part I||41
8288218|NCT01632345|20434012|P3|Treated|Treatment: Part I||42
8288219|NCT01632345|20434013|P2|Treated|Treatment: Part I||43
8288220|NCT01632345|20434014|P1|Treated|Treatment: Part I||40
8288221|NCT01632345|20434008|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
8288222|NCT01632345|20434009|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
8288223|NCT01632345|20434010|P5|STARTED|Treatment: Part I||43
8288224|NCT01632345|20434011|P4|STARTED|Treatment: Part I||41
8288225|NCT01632345|20434012|P3|STARTED|Treatment: Part I||42
8288226|NCT01632345|20434013|P2|STARTED|Treatment: Part I||43
8288227|NCT01632345|20434014|P1|STARTED|Treatment: Part I||41
8288228|NCT01632345|20434008|P7|NOT COMPLETED|Randomized Participants||0
8288229|NCT01632345|20434009|P6|NOT COMPLETED|Randomized Participants||0
8288230|NCT01632345|20434010|P5|NOT COMPLETED|Randomized Participants||0
8288231|NCT01632345|20434011|P4|NOT COMPLETED|Randomized Participants||0
8288232|NCT01632345|20434012|P3|NOT COMPLETED|Randomized Participants||0
8288233|NCT01632345|20434013|P2|NOT COMPLETED|Randomized Participants||0
8288234|NCT01632345|20434014|P1|NOT COMPLETED|Randomized Participants||0
8288235|NCT01632345|20434008|P7|COMPLETED|Randomized Participants||66
8288236|NCT01632345|20434009|P6|COMPLETED|Randomized Participants||66
8288237|NCT01632345|20434010|P5|COMPLETED|Randomized Participants||43
8288238|NCT01632345|20434011|P4|COMPLETED|Randomized Participants||41
8288239|NCT01632345|20434012|P3|COMPLETED|Randomized Participants||42
8288240|NCT01632345|20434013|P2|COMPLETED|Randomized Participants||43
8288241|NCT01632345|20434014|P1|COMPLETED|Randomized Participants||41
8288242|NCT01632345|20434008|P7|STARTED|Randomized Participants||66
8288243|NCT01632345|20434009|P6|STARTED|Randomized Participants||66
8288244|NCT01632345|20434010|P5|STARTED|Randomized Participants||43
8288245|NCT01632345|20434011|P4|STARTED|Randomized Participants||41
8288246|NCT01632345|20434012|P3|STARTED|Randomized Participants||42
8288247|NCT01632345|20434013|P2|STARTED|Randomized Participants||43
8288248|NCT01632345|20434014|P1|STARTED|Randomized Participants||41
8288249|NCT01632306|20434076|P3|NOT COMPLETED|Overall Study||0
8288250|NCT01632306|20434077|P2|NOT COMPLETED|Overall Study||0
8288251|NCT01632306|20434078|P1|NOT COMPLETED|Overall Study||1
8288252|NCT01632306|20434076|P3|COMPLETED|Overall Study||0
8288253|NCT01632306|20434077|P2|COMPLETED|Overall Study||10
8288254|NCT01632306|20434078|P1|COMPLETED|Overall Study||2
8288255|NCT01632306|20434076|P3|Received at Least One Dose of Study Drug|Overall Study||0
8288256|NCT01632306|20434077|P2|Received at Least One Dose of Study Drug|Overall Study||10
8288257|NCT01632306|20434078|P1|Received at Least One Dose of Study Drug|Overall Study||3
8288258|NCT01632306|20434076|P3|STARTED|Overall Study||0
8288259|NCT01632306|20434077|P2|STARTED|Overall Study||10
8288260|NCT01632306|20434078|P1|STARTED|Overall Study||3
8288261|NCT01632280|20434094|P2|NOT COMPLETED|Overall Study||0
8288262|NCT01632280|20434095|P1|NOT COMPLETED|Overall Study||1
8288263|NCT01632280|20434094|P2|COMPLETED|Overall Study||6
8288264|NCT01632280|20434095|P1|COMPLETED|Overall Study||5
8288265|NCT01632280|20434094|P2|STARTED|Overall Study||6
8288266|NCT01632280|20434095|P1|STARTED|Overall Study||6
8288267|NCT01632267|20434105|P1|NOT COMPLETED|Overall Study||7
8288268|NCT01632267|20434105|P1|COMPLETED|Overall Study||97
8288269|NCT01632267|20434105|P1|STARTED|Overall Study||104
8288270|NCT01632241|20434111|P2|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
8288271|NCT01632241|20434112|P1|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
8288272|NCT01632241|20434111|P2|COMPLETED|Open-label (Week 52 to Week 76)||220
8288273|NCT01632241|20434112|P1|COMPLETED|Open-label (Week 52 to Week 76)||107
8288274|NCT01632241|20434111|P2|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
8288275|NCT01632241|20434112|P1|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
8288276|NCT01632241|20434111|P2|NOT COMPLETED|Double-blinded (Up to Week 52)||79
8288277|NCT01632241|20434112|P1|NOT COMPLETED|Double-blinded (Up to Week 52)||44
8288278|NCT01632241|20434111|P2|COMPLETED|Double-blinded (Up to Week 52)||252
8288279|NCT01632241|20434112|P1|COMPLETED|Double-blinded (Up to Week 52)||121
8288280|NCT01632241|20434111|P2|STARTED|Double-blinded (Up to Week 52)||331
8288281|NCT01632241|20434112|P1|STARTED|Double-blinded (Up to Week 52)||165
8288282|NCT01632215|20434162|P2|NOT COMPLETED|Overall Study||1
8288283|NCT01632215|20434163|P1|NOT COMPLETED|Overall Study||2
8288284|NCT01632215|20434162|P2|COMPLETED|Overall Study||19
8288285|NCT01632215|20434163|P1|COMPLETED|Overall Study||18
8288286|NCT01632215|20434162|P2|STARTED|Overall Study||20
8288287|NCT01632215|20434163|P1|STARTED|Overall Study||20
8288288|NCT01632202|20434173|P2|NOT COMPLETED|Overall Study||0
8288289|NCT01632202|20434174|P1|NOT COMPLETED|Overall Study||0
8288290|NCT01632202|20434173|P2|COMPLETED|Overall Study||7
8288291|NCT01632202|20434174|P1|COMPLETED|Overall Study||1
8288292|NCT01632202|20434173|P2|STARTED|Overall Study||7
8288293|NCT01632202|20434174|P1|STARTED|Overall Study||1
8288294|NCT01632150|20434182|P1|NOT COMPLETED|Overall Study||40
8288295|NCT01632150|20434182|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
8288296|NCT01632150|20434182|P1|Received Cyclophosphamide|Overall Study||11
8288297|NCT01632150|20434182|P1|STARTED|Overall Study||40
8288298|NCT01632020|20434191|P2|NOT COMPLETED|Overall Study||0
8288299|NCT01632020|20434192|P1|NOT COMPLETED|Overall Study||2
8288300|NCT01632020|20434191|P2|COMPLETED|Overall Study||3
8288301|NCT01632020|20434192|P1|COMPLETED|Overall Study||2
8288302|NCT01632020|20434191|P2|STARTED|Overall Study||3
8288303|NCT01632020|20434192|P1|STARTED|Overall Study||4
8288304|NCT01631929|20434202|P2|NOT COMPLETED|Overall Study||0
8288305|NCT01631929|20434203|P1|NOT COMPLETED|Overall Study||0
8288306|NCT01631929|20434202|P2|COMPLETED|Overall Study||6
8288307|NCT01631929|20434203|P1|COMPLETED|Overall Study||6
8288308|NCT01631929|20434202|P2|STARTED|Overall Study||6
8288309|NCT01631929|20434203|P1|STARTED|Overall Study||6
8288310|NCT01631864|20434211|P2|NOT COMPLETED|Overall Study||4
8288311|NCT01631864|20434212|P1|NOT COMPLETED|Overall Study||2
8288312|NCT01631864|20434211|P2|COMPLETED|Overall Study||44
8288313|NCT01631864|20434212|P1|COMPLETED|Overall Study||48
8288314|NCT01631864|20434211|P2|STARTED|Overall Study||48
8288315|NCT01631864|20434212|P1|STARTED|Overall Study||50
8288316|NCT01631825|20434224|P1|NOT COMPLETED|Overall Study||65
8288317|NCT01631825|20434224|P1|COMPLETED|Overall Study||256
8288318|NCT01631825|20434224|P1|STARTED|Overall Study||321
8288319|NCT01631812|20434244|P1|NOT COMPLETED|Overall Study||37
8288320|NCT01631812|20434244|P1|COMPLETED|Overall Study||93
8288321|NCT01631812|20434244|P1|STARTED|Overall Study||130
8288322|NCT01631747|20434254|P2|NOT COMPLETED|One Year Infant Outcomes||9
8288323|NCT01631747|20434255|P1|NOT COMPLETED|One Year Infant Outcomes||13
8288324|NCT01631747|20434254|P2|COMPLETED|One Year Infant Outcomes||130
8288325|NCT01631747|20434255|P1|COMPLETED|One Year Infant Outcomes||123
8288326|NCT01631747|20434254|P2|STARTED|One Year Infant Outcomes||139
8288327|NCT01631747|20434255|P1|STARTED|One Year Infant Outcomes||136
8288328|NCT01631747|20434254|P2|NOT COMPLETED|Live Birth||1
8288329|NCT01631747|20434255|P1|NOT COMPLETED|Live Birth||4
8288330|NCT01631747|20434254|P2|COMPLETED|Live Birth||139
8288331|NCT01631747|20434255|P1|COMPLETED|Live Birth||136
8288332|NCT01631747|20434254|P2|STARTED|Live Birth||140
8288333|NCT01631747|20434255|P1|STARTED|Live Birth||140
8288334|NCT01631747|20434254|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
8288335|NCT01631747|20434255|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
8288336|NCT01631747|20434254|P2|COMPLETED|Randomization Through End of Pregnancy||140
8288337|NCT01631747|20434255|P1|COMPLETED|Randomization Through End of Pregnancy||140
8288338|NCT01631747|20434254|P2|STARTED|Randomization Through End of Pregnancy||140
8288339|NCT01631747|20434255|P1|STARTED|Randomization Through End of Pregnancy||141
8288340|NCT01631682|20434297|P4|NOT COMPLETED|Overall Study||2
8288341|NCT01631682|20434298|P3|NOT COMPLETED|Overall Study||31
8288342|NCT01631682|20434299|P2|NOT COMPLETED|Overall Study||45
8288343|NCT01631682|20434300|P1|NOT COMPLETED|Overall Study||31
8288344|NCT01631682|20434297|P4|COMPLETED|Overall Study||5
8288345|NCT01631682|20434298|P3|COMPLETED|Overall Study||13
8288346|NCT01631682|20434299|P2|COMPLETED|Overall Study||21
8288347|NCT01631682|20434300|P1|COMPLETED|Overall Study||24
8288348|NCT01631682|20434297|P4|STARTED|Overall Study||7
8288349|NCT01631682|20434298|P3|STARTED|Overall Study||44
8288350|NCT01631682|20434299|P2|STARTED|Overall Study||66
8288351|NCT01631682|20434300|P1|STARTED|Overall Study||55
8288352|NCT01631656|20434312|P2|NOT COMPLETED|Overall Study||0
8288353|NCT01631656|20434313|P1|NOT COMPLETED|Overall Study||0
8288354|NCT01631656|20434312|P2|COMPLETED|Overall Study||5
8288355|NCT01631656|20434313|P1|COMPLETED|Overall Study||5
8288356|NCT01631656|20434312|P2|STARTED|Overall Study||5
8288357|NCT01631656|20434313|P1|STARTED|Overall Study||5
8288358|NCT01631630|20434321|P2|NOT COMPLETED|Overall Study||0
8288359|NCT01631630|20434322|P1|NOT COMPLETED|Overall Study||3
8288360|NCT01631630|20434321|P2|COMPLETED|Overall Study||8
8288361|NCT01631630|20434322|P1|COMPLETED|Overall Study||5
8288362|NCT01631630|20434321|P2|STARTED|Overall Study||8
8288363|NCT01631630|20434322|P1|STARTED|Overall Study||8
8288364|NCT01631474|20434437|P5|NOT COMPLETED|Overall Study||13
8288365|NCT01631474|20434438|P4|NOT COMPLETED|Overall Study||11
8288366|NCT01631474|20434439|P3|NOT COMPLETED|Overall Study||9
8288367|NCT01631474|20434440|P2|NOT COMPLETED|Overall Study||12
8288368|NCT01631474|20434441|P1|NOT COMPLETED|Overall Study||14
8288369|NCT01631474|20434437|P5|COMPLETED|Overall Study||62
8288370|NCT01631474|20434438|P4|COMPLETED|Overall Study||59
8288371|NCT01631474|20434439|P3|COMPLETED|Overall Study||61
8288372|NCT01631474|20434440|P2|COMPLETED|Overall Study||64
8288373|NCT01631474|20434441|P1|COMPLETED|Overall Study||58
8288374|NCT01631474|20434437|P5|STARTED|Overall Study||75
8288375|NCT01631474|20434438|P4|STARTED|Overall Study||70
8288376|NCT01631474|20434439|P3|STARTED|Overall Study||70
8288377|NCT01631474|20434440|P2|STARTED|Overall Study||76
8288378|NCT01631474|20434441|P1|STARTED|Overall Study||72
8288379|NCT01631435|20434478|P1|NOT COMPLETED|Overall Study||9
8288380|NCT01631435|20434478|P1|COMPLETED|Overall Study||66
8288381|NCT01631435|20434478|P1|STARTED|Overall Study||75
8288382|NCT01631331|20434483|P1|NOT COMPLETED|Overall Study||4
8288383|NCT01631331|20434483|P1|COMPLETED|Overall Study||11
8288384|NCT01631331|20434483|P1|STARTED|Overall Study||15
8288385|NCT01631227|20434492|P2|NOT COMPLETED|Overall Study||22
8288386|NCT01631227|20434493|P1|NOT COMPLETED|Overall Study||30
8288387|NCT01631227|20434492|P2|COMPLETED|Overall Study||310
8288388|NCT01631227|20434493|P1|COMPLETED|Overall Study||303
8288389|NCT01631227|20434492|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
8288390|NCT01631227|20434493|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
8288391|NCT01631227|20434492|P2|Safety Subject Sample|Overall Study||332
8288392|NCT01631227|20434493|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
8288393|NCT01631227|20434492|P2|STARTED|Overall Study||332
8288394|NCT01631227|20434493|P1|STARTED|Overall Study||333
8288395|NCT01631214|20434501|P2|NOT COMPLETED|Overall Study||523
8288396|NCT01631214|20434502|P1|NOT COMPLETED|Overall Study||544
8288397|NCT01631214|20434501|P2|COMPLETED|Overall Study||1523
8288398|NCT01631214|20434502|P1|COMPLETED|Overall Study||1503
8288399|NCT01631214|20434501|P2|Completed Primary Analysis Period|Overall Study||1574
8288400|NCT01631214|20434502|P1|Completed Primary Analysis Period|Overall Study||1576
8288401|NCT01631214|20434501|P2|Completed Double-blind Period|Overall Study||1831
8288402|NCT01631214|20434502|P1|Completed Double-blind Period|Overall Study||1823
8288403|NCT01631214|20434501|P2|Received Double-blind Treatment|Overall Study||2038
8288404|NCT01631214|20434502|P1|Received Double-blind Treatment|Overall Study||2040
8288405|NCT01631214|20434501|P2|STARTED|Overall Study||2046
8288406|NCT01631214|20434502|P1|STARTED|Overall Study||2047
8288407|NCT01631149|20434566|P2|NOT COMPLETED|Overall Study||0
8288408|NCT01631149|20434567|P1|NOT COMPLETED|Overall Study||0
8288409|NCT01631149|20434566|P2|COMPLETED|Overall Study||12
8288410|NCT01631149|20434567|P1|COMPLETED|Overall Study||12
8288411|NCT01631149|20434566|P2|STARTED|Overall Study||12
8288412|NCT01631149|20434567|P1|STARTED|Overall Study||12
8288413|NCT01631110|20434583|P2|NOT COMPLETED|Overall Study||0
8288414|NCT01631110|20434584|P1|NOT COMPLETED|Overall Study||0
8288415|NCT01631110|20434583|P2|COMPLETED|Overall Study||55
8288416|NCT01631110|20434584|P1|COMPLETED|Overall Study||55
8288417|NCT01631110|20434583|P2|STARTED|Overall Study||55
8288418|NCT01631110|20434584|P1|STARTED|Overall Study||55
8288419|NCT01631071|20434598|P2|NOT COMPLETED|Overall Study||0
8288420|NCT01631071|20434599|P1|NOT COMPLETED|Overall Study||0
8288421|NCT01631071|20434598|P2|COMPLETED|Overall Study||55
8288422|NCT01631071|20434599|P1|COMPLETED|Overall Study||55
8288423|NCT01631071|20434598|P2|STARTED|Overall Study||55
8288424|NCT01631071|20434599|P1|STARTED|Overall Study||55
8288425|NCT01630811|20434611|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
8288426|NCT01630811|20434612|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
8288427|NCT01630811|20434611|P2|COMPLETED|Second Washout (4 Weeks)||6
8288428|NCT01630811|20434612|P1|COMPLETED|Second Washout (4 Weeks)||6
8288429|NCT01630811|20434611|P2|STARTED|Second Washout (4 Weeks)||6
8288430|NCT01630811|20434612|P1|STARTED|Second Washout (4 Weeks)||6
8288431|NCT01630811|20434611|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8288432|NCT01630811|20434612|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
8288433|NCT01630811|20434611|P2|COMPLETED|Second Intervention (8 Weeks)||6
8288434|NCT01630811|20434612|P1|COMPLETED|Second Intervention (8 Weeks)||6
8288435|NCT01630811|20434611|P2|STARTED|Second Intervention (8 Weeks)||6
8288436|NCT01630811|20434612|P1|STARTED|Second Intervention (8 Weeks)||7
8288437|NCT01630811|20434611|P2|NOT COMPLETED|Washout (4 Weeks)||0
8288438|NCT01630811|20434612|P1|NOT COMPLETED|Washout (4 Weeks)||0
8288439|NCT01630811|20434611|P2|COMPLETED|Washout (4 Weeks)||6
8288440|NCT01630811|20434612|P1|COMPLETED|Washout (4 Weeks)||7
8288441|NCT01630811|20434611|P2|STARTED|Washout (4 Weeks)||6
8288442|NCT01630811|20434612|P1|STARTED|Washout (4 Weeks)||7
8288443|NCT01630811|20434611|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8288444|NCT01630811|20434612|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8288445|NCT01630811|20434611|P2|COMPLETED|First Intervention (8 Weeks)||6
8288446|NCT01630811|20434612|P1|COMPLETED|First Intervention (8 Weeks)||7
8288447|NCT01630811|20434611|P2|STARTED|First Intervention (8 Weeks)||6
8288448|NCT01630811|20434612|P1|STARTED|First Intervention (8 Weeks)||7
8288449|NCT01630694|20434624|P2|NOT COMPLETED|Overall Study||0
8288450|NCT01630694|20434625|P1|NOT COMPLETED|Overall Study||0
8288451|NCT01630694|20434624|P2|COMPLETED|Overall Study||16
8288452|NCT01630694|20434625|P1|COMPLETED|Overall Study||12
8288453|NCT01630694|20434624|P2|STARTED|Overall Study||16
8288454|NCT01630694|20434625|P1|STARTED|Overall Study||12
8288455|NCT01630616|20434639|P6|NOT COMPLETED|Overall Study||0
8288456|NCT01630616|20434640|P5|NOT COMPLETED|Overall Study||0
8288457|NCT01630616|20434641|P4|NOT COMPLETED|Overall Study||3
8288458|NCT01630616|20434642|P3|NOT COMPLETED|Overall Study||0
8288459|NCT01630616|20434643|P2|NOT COMPLETED|Overall Study||0
8288460|NCT01630616|20434644|P1|NOT COMPLETED|Overall Study||0
8288461|NCT01630616|20434639|P6|COMPLETED|Overall Study||2
8288462|NCT01630616|20434640|P5|COMPLETED|Overall Study||6
8288463|NCT01630616|20434641|P4|COMPLETED|Overall Study||9
8288464|NCT01630616|20434642|P3|COMPLETED|Overall Study||3
8288465|NCT01630616|20434643|P2|COMPLETED|Overall Study||3
8288466|NCT01630616|20434644|P1|COMPLETED|Overall Study||5
8288467|NCT01630616|20434639|P6|STARTED|Overall Study||2
8288468|NCT01630616|20434640|P5|STARTED|Overall Study||6
8288469|NCT01630616|20434641|P4|STARTED|Overall Study||12
8288470|NCT01630616|20434642|P3|STARTED|Overall Study||3
8288471|NCT01630616|20434643|P2|STARTED|Overall Study||3
8288472|NCT01630616|20434644|P1|STARTED|Overall Study||5
8288473|NCT01630200|20434719|P2|NOT COMPLETED|Overall Study||6
8288474|NCT01630200|20434720|P1|NOT COMPLETED|Overall Study||7
8288475|NCT01630200|20434719|P2|COMPLETED|Overall Study||34
8288476|NCT01630200|20434720|P1|COMPLETED|Overall Study||33
8288477|NCT01630200|20434719|P2|STARTED|Overall Study||40
8288478|NCT01630200|20434720|P1|STARTED|Overall Study||40
8288479|NCT01630135|20434744|P2|NOT COMPLETED|Overall Study||2
8288480|NCT01630135|20434745|P1|NOT COMPLETED|Overall Study||0
8288481|NCT01630135|20434744|P2|COMPLETED|Overall Study||128
8288482|NCT01630135|20434745|P1|COMPLETED|Overall Study||131
8288483|NCT01630135|20434744|P2|STARTED|Overall Study||130
8288484|NCT01630135|20434745|P1|STARTED|Overall Study||131
8288485|NCT01630109|20434784|P3|NOT COMPLETED|Overall Study||0
8288486|NCT01630109|20434785|P2|NOT COMPLETED|Overall Study||0
8288487|NCT01630109|20434786|P1|NOT COMPLETED|Overall Study||0
8288488|NCT01630109|20434784|P3|COMPLETED|Overall Study||3
8288489|NCT01630109|20434785|P2|COMPLETED|Overall Study||1
8288490|NCT01630109|20434786|P1|COMPLETED|Overall Study||1
8288491|NCT01630109|20434784|P3|STARTED|Overall Study||3
8288492|NCT01630109|20434785|P2|STARTED|Overall Study||1
8288493|NCT01630109|20434786|P1|STARTED|Overall Study||1
8288494|NCT01629966|20434809|P3|NOT COMPLETED|Overall Study||66
8288495|NCT01629966|20434810|P2|NOT COMPLETED|Overall Study||52
8288496|NCT01629966|20434811|P1|NOT COMPLETED|Overall Study||41
8288497|NCT01629966|20434809|P3|COMPLETED|Overall Study||159
8288498|NCT01629966|20434810|P2|COMPLETED|Overall Study||175
8288499|NCT01629966|20434811|P1|COMPLETED|Overall Study||180
8288500|NCT01629966|20434809|P3|STARTED|Overall Study||225
8288501|NCT01629966|20434810|P2|STARTED|Overall Study||227
8288502|NCT01629966|20434811|P1|STARTED|Overall Study||221
8288503|NCT01629953|20434824|P2|NOT COMPLETED|Overall Study||15
8288504|NCT01629953|20434825|P1|NOT COMPLETED|Overall Study||13
8288505|NCT01629953|20434824|P2|COMPLETED|Overall Study||60
8288506|NCT01629953|20434825|P1|COMPLETED|Overall Study||52
8288507|NCT01629953|20434824|P2|STARTED|Overall Study||75
8288508|NCT01629953|20434825|P1|STARTED|Overall Study||65
8288509|NCT01629862|20434835|P2|NOT COMPLETED|Overall Study||2
8288510|NCT01629862|20434836|P1|NOT COMPLETED|Overall Study||2
8288511|NCT01629862|20434835|P2|COMPLETED|Overall Study||23
8288512|NCT01629862|20434836|P1|COMPLETED|Overall Study||26
8288513|NCT01629862|20434835|P2|STARTED|Overall Study||25
8288514|NCT01629862|20434836|P1|STARTED|Overall Study||28
8288515|NCT01629823|20434845|P3|NOT COMPLETED|Washout Period||0
8288516|NCT01629823|20434846|P2|NOT COMPLETED|Washout Period||6
8288517|NCT01629823|20434847|P1|NOT COMPLETED|Washout Period||3
8288518|NCT01629823|20434845|P3|COMPLETED|Washout Period||50
8288519|NCT01629823|20434846|P2|COMPLETED|Washout Period||51
8288520|NCT01629823|20434847|P1|COMPLETED|Washout Period||51
8288521|NCT01629823|20434845|P3|STARTED|Washout Period||50
8288522|NCT01629823|20434846|P2|STARTED|Washout Period||57
8288523|NCT01629823|20434847|P1|STARTED|Washout Period||54
8288524|NCT01629823|20434845|P3|NOT COMPLETED|Trial Period||10
8288525|NCT01629823|20434846|P2|NOT COMPLETED|Trial Period||13
8288526|NCT01629823|20434847|P1|NOT COMPLETED|Trial Period||13
8288527|NCT01629823|20434845|P3|COMPLETED|Trial Period||49
8288528|NCT01629823|20434846|P2|COMPLETED|Trial Period||56
8288529|NCT01629823|20434847|P1|COMPLETED|Trial Period||53
8288530|NCT01629823|20434845|P3|STARTED|Trial Period||59
8288531|NCT01629823|20434846|P2|STARTED|Trial Period||69
8288532|NCT01629823|20434847|P1|STARTED|Trial Period||66
8288533|NCT01629797|20434855|P1|NOT COMPLETED|Overall Study||18
8288534|NCT01629797|20434855|P1|COMPLETED|Overall Study||82
8288535|NCT01629797|20434855|P1|STARTED|Overall Study||100
8288536|NCT01629784|20434862|P1|NOT COMPLETED|Overall Study||6
8288537|NCT01629784|20434862|P1|COMPLETED|Overall Study||25
8288538|NCT01629784|20434862|P1|STARTED|Overall Study||31
8288539|NCT01629771|20434871|P2|NOT COMPLETED|Overall Study||0
8288540|NCT01629771|20434872|P1|NOT COMPLETED|Overall Study||0
8288541|NCT01629771|20434871|P2|COMPLETED|Overall Study||36
8288542|NCT01629771|20434872|P1|COMPLETED|Overall Study||36
8288543|NCT01629771|20434871|P2|STARTED|Overall Study||36
8288544|NCT01629771|20434872|P1|STARTED|Overall Study||36
8288545|NCT01629706|20434882|P1|NOT COMPLETED|Phase 2 Habitual||10
8288546|NCT01629706|20434882|P1|COMPLETED|Phase 2 Habitual||48
8288547|NCT01629706|20434882|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
8288548|NCT01629706|20434882|P1|NOT COMPLETED|Phase 1 PureVision||9
8288549|NCT01629706|20434882|P1|COMPLETED|Phase 1 PureVision||35
8288550|NCT01629706|20434882|P1|STARTED|Phase 1 PureVision||44
8288551|NCT01629693|20434910|P2|NOT COMPLETED|Overall Study||10
8288552|NCT01629693|20434911|P1|NOT COMPLETED|Overall Study||5
8288553|NCT01629693|20434910|P2|COMPLETED|Overall Study||178
8288554|NCT01629693|20434911|P1|COMPLETED|Overall Study||188
8288555|NCT01629693|20434910|P2|STARTED|Overall Study||188
8288556|NCT01629693|20434911|P1|STARTED|Overall Study||193
8288557|NCT01629667|20434920|P3|NOT COMPLETED|Overall Study||45
8288558|NCT01629667|20434921|P2|NOT COMPLETED|Overall Study||41
8288559|NCT01629667|20434922|P1|NOT COMPLETED|Overall Study||47
8288560|NCT01629667|20434920|P3|COMPLETED|Overall Study||14
8288561|NCT01629667|20434921|P2|COMPLETED|Overall Study||17
8288562|NCT01629667|20434922|P1|COMPLETED|Overall Study||12
8288563|NCT01629667|20434920|P3|Randomized and Treated|Overall Study||59
8288564|NCT01629667|20434921|P2|Randomized and Treated|Overall Study||57
8288565|NCT01629667|20434922|P1|Randomized and Treated|Overall Study||57
8288566|NCT01629667|20434920|P3|STARTED|Overall Study||59
8288567|NCT01629667|20434921|P2|STARTED|Overall Study||58
8288568|NCT01629667|20434922|P1|STARTED|Overall Study||59
8288569|NCT01629615|20435004|P1|NOT COMPLETED|Overall Study||0
8288570|NCT01629615|20435004|P1|COMPLETED|Overall Study||50
8288571|NCT01629615|20435004|P1|STARTED|Overall Study||50
8288572|NCT01629589|20435013|P2|NOT COMPLETED|Overall Study||7
8288573|NCT01629589|20435014|P1|NOT COMPLETED|Overall Study||8
8288574|NCT01629589|20435013|P2|COMPLETED|Overall Study||204
8288575|NCT01629589|20435014|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
8288576|NCT01629589|20435013|P2|STARTED|Overall Study||211
8288577|NCT01629589|20435014|P1|STARTED|Overall Study||212
8288578|NCT01629563|20435032|P2|NOT COMPLETED|Overall Study||53
8288579|NCT01629563|20435033|P1|NOT COMPLETED|Overall Study||61
8288580|NCT01629563|20435032|P2|COMPLETED|Overall Study||170
8288581|NCT01629563|20435033|P1|COMPLETED|Overall Study||167
8288582|NCT01629563|20435032|P2|Started Treatment Course 4|Overall Study||176
8288583|NCT01629563|20435033|P1|Started Treatment Course 4|Overall Study||178
8288584|NCT01629563|20435032|P2|Started Treatment Course 3|Overall Study||190
8288585|NCT01629563|20435033|P1|Started Treatment Course 3|Overall Study||191
8288586|NCT01629563|20435032|P2|Started Treatment Course 2|Overall Study||207
8288587|NCT01629563|20435033|P1|Started Treatment Course 2|Overall Study||213
8288588|NCT01629563|20435032|P2|Safety Population|Overall Study||221
8288589|NCT01629563|20435033|P1|Safety Population|Overall Study||230
8288590|NCT01629563|20435032|P2|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
8288591|NCT01629563|20435033|P1|STARTED|Overall Study||228
8288592|NCT01629511|20435055|P4|NOT COMPLETED|Overall Study||0
8288593|NCT01629511|20435056|P3|NOT COMPLETED|Overall Study||0
8288594|NCT01629511|20435057|P2|NOT COMPLETED|Overall Study||0
8288595|NCT01629511|20435058|P1|NOT COMPLETED|Overall Study||0
8288596|NCT01629511|20435055|P4|COMPLETED|Overall Study||3
8288597|NCT01629511|20435056|P3|COMPLETED|Overall Study||8
8288598|NCT01629511|20435057|P2|COMPLETED|Overall Study||0
8288599|NCT01629511|20435058|P1|COMPLETED|Overall Study||4
8288600|NCT01629511|20435055|P4|STARTED|Overall Study||3
8288601|NCT01629511|20435056|P3|STARTED|Overall Study||8
8288602|NCT01629511|20435057|P2|STARTED|Overall Study||0
8288603|NCT01629511|20435058|P1|STARTED|Overall Study||4
8288604|NCT01629329|20435090|P2|NOT COMPLETED|Overall Study||0
8288605|NCT01629329|20435091|P1|NOT COMPLETED|Overall Study||0
8288606|NCT01629329|20435090|P2|COMPLETED|Overall Study||0
8288607|NCT01629329|20435091|P1|COMPLETED|Overall Study||0
8288608|NCT01629329|20435090|P2|STARTED|Overall Study||0
8288609|NCT01629329|20435091|P1|STARTED|Overall Study||0
8288610|NCT01629290|20435099|P1|NOT COMPLETED|Overall Study||0
8288611|NCT01629290|20435099|P1|COMPLETED|Overall Study||15
8288612|NCT01629290|20435099|P1|STARTED|Overall Study||15
8288613|NCT01629134|20435109|P1|NOT COMPLETED|Overall Study||0
8288614|NCT01629134|20435109|P1|COMPLETED|Overall Study||62
8288615|NCT01629134|20435109|P1|STARTED|Overall Study||62
8288616|NCT01628965|20435122|P1|NOT COMPLETED|Overall Study||49
8288617|NCT01628965|20435122|P1|COMPLETED|Overall Study||94
8288618|NCT01628965|20435122|P1|STARTED|Overall Study||143
8288619|NCT01628926|20435131|P3|NOT COMPLETED|Overall Study||17
8288620|NCT01628926|20435132|P2|NOT COMPLETED|Overall Study||23
8288621|NCT01628926|20435133|P1|NOT COMPLETED|Overall Study||26
8288622|NCT01628926|20435131|P3|COMPLETED|Overall Study||68
8288623|NCT01628926|20435132|P2|COMPLETED|Overall Study||144
8288624|NCT01628926|20435133|P1|COMPLETED|Overall Study||142
8288625|NCT01628926|20435131|P3|STARTED|Overall Study||85
8288626|NCT01628926|20435132|P2|STARTED|Overall Study||167
8288627|NCT01628926|20435133|P1|STARTED|Overall Study||168
8288628|NCT01628913|20435182|P2|NOT COMPLETED|Overall Study||31
8288629|NCT01628913|20435183|P1|NOT COMPLETED|Overall Study||31
8288630|NCT01628913|20435182|P2|COMPLETED|Overall Study||0
8288631|NCT01628913|20435183|P1|COMPLETED|Overall Study||0
8288632|NCT01628913|20435182|P2|STARTED|Overall Study||31
8288633|NCT01628913|20435183|P1|STARTED|Overall Study||31
8288634|NCT01628874|20435197|P2|NOT COMPLETED|Overall Study||3
8288635|NCT01628874|20435198|P1|NOT COMPLETED|Overall Study||5
8288636|NCT01628874|20435197|P2|COMPLETED|Overall Study||29
8288637|NCT01628874|20435198|P1|COMPLETED|Overall Study||29
8288638|NCT01628874|20435197|P2|STARTED|Overall Study||32
8288639|NCT01628874|20435198|P1|STARTED|Overall Study||34
8288640|NCT01628848|20435214|P2|NOT COMPLETED|Overall Study||14
8288641|NCT01628848|20435215|P1|NOT COMPLETED|Overall Study||12
8288642|NCT01628848|20435214|P2|COMPLETED|Overall Study||73
8288643|NCT01628848|20435215|P1|COMPLETED|Overall Study||75
8288644|NCT01628848|20435214|P2|STARTED|Overall Study||87
8288645|NCT01628848|20435215|P1|STARTED|Overall Study||87
8288646|NCT01628718|20435245|P2|NOT COMPLETED|Overall Study||25
8288647|NCT01628718|20435246|P1|NOT COMPLETED|Overall Study||27
8288648|NCT01628718|20435245|P2|COMPLETED|Overall Study||37
8288649|NCT01628718|20435246|P1|COMPLETED|Overall Study||33
8288650|NCT01628718|20435245|P2|STARTED|Overall Study||62
8288651|NCT01628718|20435246|P1|STARTED|Overall Study||60
8288652|NCT01628692|20435258|P6|NOT COMPLETED|Overall Study||9
8288653|NCT01628692|20435259|P5|NOT COMPLETED|Overall Study||4
8288654|NCT01628692|20435260|P4|NOT COMPLETED|Overall Study||1
8288655|NCT01628692|20435261|P3|NOT COMPLETED|Overall Study||8
8288656|NCT01628692|20435262|P2|NOT COMPLETED|Overall Study||6
8288657|NCT01628692|20435263|P1|NOT COMPLETED|Overall Study||7
8288658|NCT01628692|20435258|P6|COMPLETED|Overall Study||0
8288659|NCT01628692|20435259|P5|COMPLETED|Overall Study||8
8288660|NCT01628692|20435260|P4|COMPLETED|Overall Study||19
8288661|NCT01628692|20435261|P3|COMPLETED|Overall Study||43
8288662|NCT01628692|20435262|P2|COMPLETED|Overall Study||17
8288663|NCT01628692|20435263|P1|COMPLETED|Overall Study||46
8288664|NCT01628692|20435258|P6|STARTED|Overall Study||9
8288665|NCT01628692|20435259|P5|STARTED|Overall Study||12
8288666|NCT01628692|20435260|P4|STARTED|Overall Study||20
8288667|NCT01628692|20435261|P3|STARTED|Overall Study||51
8288668|NCT01628692|20435262|P2|STARTED|Overall Study||23
8288669|NCT01628692|20435263|P1|STARTED|Overall Study||53
8288670|NCT01628614|20435307|P1|NOT COMPLETED|Overall Study||1775
8288671|NCT01628614|20435307|P1|COMPLETED|Overall Study||3037
8288672|NCT01628614|20435307|P1|STARTED|Overall Study||4812
8288673|NCT01628601|20435313|P1|NOT COMPLETED|Overall Study||41
8288674|NCT01628601|20435313|P1|COMPLETED|Overall Study||351
8288675|NCT01628601|20435313|P1|STARTED|Overall Study||392
8288676|NCT01628588|20435321|P1|NOT COMPLETED|Overall Study||16
8288677|NCT01628588|20435321|P1|COMPLETED|Overall Study||838
8288678|NCT01628588|20435321|P1|STARTED|Overall Study||854
8288679|NCT01628549|20435333|P4|NOT COMPLETED|Overall Study||9
8288680|NCT01628549|20435334|P3|NOT COMPLETED|Overall Study||10
8288681|NCT01628549|20435335|P2|NOT COMPLETED|Overall Study||12
8288682|NCT01628549|20435336|P1|NOT COMPLETED|Overall Study||9
8288683|NCT01628549|20435333|P4|COMPLETED|Overall Study||57
8288684|NCT01628549|20435334|P3|COMPLETED|Overall Study||60
8288685|NCT01628549|20435335|P2|COMPLETED|Overall Study||64
8288686|NCT01628549|20435336|P1|COMPLETED|Overall Study||64
8288687|NCT01628549|20435333|P4|STARTED|Overall Study||66
8288688|NCT01628549|20435334|P3|STARTED|Overall Study||70
8288689|NCT01628549|20435335|P2|STARTED|Overall Study||76
8288690|NCT01628549|20435336|P1|STARTED|Overall Study||73
8288691|NCT01628523|20435370|P1|NOT COMPLETED|Overall Study||0
8288692|NCT01628523|20435370|P1|COMPLETED|Overall Study||219
8288693|NCT01628523|20435370|P1|STARTED|Overall Study||219
8288694|NCT01628510|20435377|P2|NOT COMPLETED|Overall Study||5
8288695|NCT01628510|20435378|P1|NOT COMPLETED|Overall Study||3
8288696|NCT01628510|20435377|P2|COMPLETED|Overall Study||44
8288697|NCT01628510|20435378|P1|COMPLETED|Overall Study||48
8288698|NCT01628510|20435377|P2|STARTED|Overall Study||49
8288699|NCT01628510|20435378|P1|STARTED|Overall Study||51
8288700|NCT01628367|20435388|P2|NOT COMPLETED|Overall Study||0
8288701|NCT01628367|20435389|P1|NOT COMPLETED|Overall Study||1
8288702|NCT01628367|20435388|P2|COMPLETED|Overall Study||16
8288703|NCT01628367|20435389|P1|COMPLETED|Overall Study||15
8288704|NCT01628367|20435388|P2|STARTED|Overall Study||16
8288705|NCT01628367|20435389|P1|STARTED|Overall Study||16
8288706|NCT01628250|20435401|P2|NOT COMPLETED|Overall Study||0
8288707|NCT01628250|20435402|P1|NOT COMPLETED|Overall Study||0
8288708|NCT01628250|20435401|P2|COMPLETED|Overall Study||50
8288709|NCT01628250|20435402|P1|COMPLETED|Overall Study||49
8288710|NCT01628250|20435401|P2|STARTED|Overall Study||50
8288711|NCT01628250|20435402|P1|STARTED|Overall Study||49
8288712|NCT01628198|20435408|P1|NOT COMPLETED|Overall Study||18
8288713|NCT01628198|20435408|P1|COMPLETED|Overall Study||20
8288714|NCT01628198|20435408|P1|STARTED|Overall Study||38
8288715|NCT01628159|20435421|P1|NOT COMPLETED|Overall Study||164
8288716|NCT01628159|20435421|P1|COMPLETED|Overall Study||493
8288717|NCT01628159|20435421|P1|STARTED|Overall Study||657
8288718|NCT01628120|20435435|P1|NOT COMPLETED|Overall Study||44
8288719|NCT01628120|20435435|P1|COMPLETED|Overall Study||129
8288720|NCT01628120|20435435|P1|Treated|Overall Study||170
8288721|NCT01628120|20435435|P1|STARTED|Overall Study||173
8288722|NCT01628107|20435460|P1|NOT COMPLETED|Overall Study||119
8288723|NCT01628107|20435460|P1|COMPLETED|Overall Study||295
8288724|NCT01628107|20435460|P1|Treated|Overall Study||406
8288725|NCT01628107|20435460|P1|STARTED|Overall Study||414
8288726|NCT01628042|20435489|P4|NOT COMPLETED|Overall Study||0
8288727|NCT01628042|20435490|P3|NOT COMPLETED|Overall Study||0
8288728|NCT01628042|20435491|P2|NOT COMPLETED|Overall Study||0
8288729|NCT01628042|20435492|P1|NOT COMPLETED|Overall Study||0
8288730|NCT01628042|20435489|P4|COMPLETED|Overall Study||8
8288731|NCT01628042|20435490|P3|COMPLETED|Overall Study||8
8288732|NCT01628042|20435491|P2|COMPLETED|Overall Study||8
8288733|NCT01628042|20435492|P1|COMPLETED|Overall Study||8
8288734|NCT01628042|20435489|P4|STARTED|Overall Study||8
8288735|NCT01628042|20435490|P3|STARTED|Overall Study||8
8288736|NCT01628042|20435491|P2|STARTED|Overall Study||8
8288737|NCT01628042|20435492|P1|STARTED|Overall Study||8
8288738|NCT01628016|20435513|P3|NOT COMPLETED|Posttraining to 5 Follow-ups||5
8288739|NCT01628016|20435514|P2|NOT COMPLETED|Posttraining to 5 Follow-ups||7
8288740|NCT01628016|20435515|P1|NOT COMPLETED|Posttraining to 5 Follow-ups||4
8288741|NCT01628016|20435513|P3|COMPLETED|Posttraining to 5 Follow-ups||18
8288742|NCT01628016|20435514|P2|COMPLETED|Posttraining to 5 Follow-ups||20
8288743|NCT01628016|20435515|P1|COMPLETED|Posttraining to 5 Follow-ups||23
8288744|NCT01628016|20435513|P3|STARTED|Posttraining to 5 Follow-ups||23
8288745|NCT01628016|20435514|P2|STARTED|Posttraining to 5 Follow-ups||27
8288746|NCT01628016|20435515|P1|STARTED|Posttraining to 5 Follow-ups||27
8288747|NCT01628016|20435513|P3|NOT COMPLETED|Pretraining to Posttraining||0
8288748|NCT01628016|20435514|P2|NOT COMPLETED|Pretraining to Posttraining||0
8288749|NCT01628016|20435515|P1|NOT COMPLETED|Pretraining to Posttraining||0
8288750|NCT01628016|20435513|P3|COMPLETED|Pretraining to Posttraining||23
8288751|NCT01628016|20435514|P2|COMPLETED|Pretraining to Posttraining||27
8288752|NCT01628016|20435515|P1|COMPLETED|Pretraining to Posttraining||27
8288753|NCT01628016|20435513|P3|STARTED|Pretraining to Posttraining||23
8288754|NCT01628016|20435514|P2|STARTED|Pretraining to Posttraining||27
8288755|NCT01628016|20435515|P1|STARTED|Pretraining to Posttraining||27
8288756|NCT01627899|20435526|P1|NOT COMPLETED|Overall Study||5
8288757|NCT01627899|20435526|P1|COMPLETED|Overall Study||0
8288758|NCT01627899|20435526|P1|STARTED|Overall Study||5
8288759|NCT01627860|20435536|P2|NOT COMPLETED|Overall Study||6
8288760|NCT01627860|20435537|P1|NOT COMPLETED|Overall Study||12
8288761|NCT01627860|20435536|P2|COMPLETED|Overall Study||14
8288762|NCT01627860|20435537|P1|COMPLETED|Overall Study||23
8288763|NCT01627860|20435536|P2|STARTED|Overall Study||20
8288764|NCT01627860|20435537|P1|STARTED|Overall Study||35
8288765|NCT01627782|20435551|P4|NOT COMPLETED|Overall Study||6
8288766|NCT01627782|20435552|P3|NOT COMPLETED|Overall Study||15
8288767|NCT01627782|20435553|P2|NOT COMPLETED|Overall Study||6
8288768|NCT01627782|20435554|P1|NOT COMPLETED|Overall Study||16
8288769|NCT01627782|20435551|P4|COMPLETED|Overall Study||11
8288770|NCT01627782|20435552|P3|COMPLETED|Overall Study||1
8288771|NCT01627782|20435553|P2|COMPLETED|Overall Study||12
8288772|NCT01627782|20435554|P1|COMPLETED|Overall Study||1
8288773|NCT01627782|20435551|P4|Treated|Overall Study||17
8288774|NCT01627782|20435552|P3|Treated|Overall Study||16
8288775|NCT01627782|20435553|P2|Treated|Overall Study||18
8288776|NCT01627782|20435554|P1|Treated|Overall Study||16
8288777|NCT01627782|20435551|P4|STARTED|Overall Study||17
8288778|NCT01627782|20435552|P3|STARTED|Overall Study||16
8288779|NCT01627782|20435553|P2|STARTED|Overall Study||18
8288780|NCT01627782|20435554|P1|STARTED|Overall Study||17
8288781|NCT01627691|20435610|P1|NOT COMPLETED|Overall Study||18
8288782|NCT01627691|20435610|P1|COMPLETED|Overall Study||232
8288783|NCT01627691|20435610|P1|Primary Endpoint (30days)|Overall Study||239
8288784|NCT01627691|20435610|P1|STARTED|Overall Study||250
8288785|NCT01627574|20435623|P2|NOT COMPLETED|Overall Study||18
8288786|NCT01627574|20435624|P1|NOT COMPLETED|Overall Study||21
8288787|NCT01627574|20435623|P2|COMPLETED|Overall Study||112
8288788|NCT01627574|20435624|P1|COMPLETED|Overall Study||121
8288789|NCT01627574|20435623|P2|STARTED|Overall Study||130
8288790|NCT01627574|20435624|P1|STARTED|Overall Study||142
8288791|NCT01627561|20435638|P2|NOT COMPLETED|Overall Study||3
8288792|NCT01627561|20435639|P1|NOT COMPLETED|Overall Study||1
8288793|NCT01627561|20435638|P2|COMPLETED|Overall Study||71
8288794|NCT01627561|20435639|P1|COMPLETED|Overall Study||73
8288795|NCT01627561|20435638|P2|STARTED|Overall Study||74
8288796|NCT01627561|20435639|P1|STARTED|Overall Study||74
8288797|NCT01627340|20435705|P2|NOT COMPLETED|Overall Study||4
8288798|NCT01627340|20435706|P1|NOT COMPLETED|Overall Study||12
8288799|NCT01627340|20435705|P2|COMPLETED|Overall Study||254
8288800|NCT01627340|20435706|P1|COMPLETED|Overall Study||404
8288801|NCT01627340|20435705|P2|STARTED|Overall Study||258
8288802|NCT01627340|20435706|P1|STARTED|Overall Study||416
8288803|NCT01627327|20435724|P2|NOT COMPLETED|Overall Study||39
8288804|NCT01627327|20435725|P1|NOT COMPLETED|Overall Study||19
8288805|NCT01627327|20435724|P2|COMPLETED|Overall Study||274
8288806|NCT01627327|20435725|P1|COMPLETED|Overall Study||291
8288807|NCT01627327|20435724|P2|STARTED|Overall Study||313
8288808|NCT01627327|20435725|P1|STARTED|Overall Study||310
8288821|NCT01627249|20435775|P3|NOT COMPLETED|Overall Study||12
8288822|NCT01627249|20435776|P2|NOT COMPLETED|Overall Study||12
8288823|NCT01627249|20435777|P1|NOT COMPLETED|Overall Study||16
8288824|NCT01627249|20435775|P3|COMPLETED|Overall Study||206
8288825|NCT01627249|20435776|P2|COMPLETED|Overall Study||206
8288826|NCT01627249|20435777|P1|COMPLETED|Overall Study||208
8288827|NCT01627249|20435775|P3|STARTED|Overall Study||218
8288828|NCT01627249|20435776|P2|STARTED|Overall Study||218
8288829|NCT01627249|20435777|P1|STARTED|Overall Study||224
8288830|NCT01627067|20435812|P1|NOT COMPLETED|Overall Study||1
8288831|NCT01627067|20435812|P1|COMPLETED|Overall Study||22
8288832|NCT01627067|20435812|P1|STARTED|Overall Study||23
8288833|NCT01627002|20435822|P9|NOT COMPLETED|Overall Study||0
8288834|NCT01627002|20435823|P8|NOT COMPLETED|Overall Study||0
8288835|NCT01627002|20435824|P7|NOT COMPLETED|Overall Study||0
8288836|NCT01627002|20435825|P6|NOT COMPLETED|Overall Study||0
8288837|NCT01627002|20435826|P5|NOT COMPLETED|Overall Study||0
8288838|NCT01627002|20435827|P4|NOT COMPLETED|Overall Study||0
8288839|NCT01627002|20435828|P3|NOT COMPLETED|Overall Study||0
8288840|NCT01627002|20435829|P2|NOT COMPLETED|Overall Study||0
8288841|NCT01627002|20435830|P1|NOT COMPLETED|Overall Study||0
8288842|NCT01627002|20435822|P9|COMPLETED|Overall Study||7
8288843|NCT01627002|20435823|P8|COMPLETED|Overall Study||5
8288844|NCT01627002|20435824|P7|COMPLETED|Overall Study||10
8288845|NCT01627002|20435825|P6|COMPLETED|Overall Study||9
8288846|NCT01627002|20435826|P5|COMPLETED|Overall Study||2
8288847|NCT01627002|20435827|P4|COMPLETED|Overall Study||4
8288848|NCT01627002|20435828|P3|COMPLETED|Overall Study||4
8288849|NCT01627002|20435829|P2|COMPLETED|Overall Study||4
8288850|NCT01627002|20435830|P1|COMPLETED|Overall Study||4
8288851|NCT01627002|20435822|P9|STARTED|Overall Study||7
8288852|NCT01627002|20435823|P8|STARTED|Overall Study||5
8288853|NCT01627002|20435824|P7|STARTED|Overall Study||10
8288854|NCT01627002|20435825|P6|STARTED|Overall Study||9
8288855|NCT01627002|20435826|P5|STARTED|Overall Study||2
8288856|NCT01627002|20435827|P4|STARTED|Overall Study||4
8288857|NCT01627002|20435828|P3|STARTED|Overall Study||4
8288858|NCT01627002|20435829|P2|STARTED|Overall Study||4
8288859|NCT01627002|20435830|P1|STARTED|Overall Study||4
8288860|NCT01626989|20435881|P3|NOT COMPLETED|Second Intervention (Night 2)||0
8288861|NCT01626989|20435882|P2|NOT COMPLETED|Second Intervention (Night 2)||0
8288862|NCT01626989|20435883|P1|NOT COMPLETED|Second Intervention (Night 2)||0
8288863|NCT01626989|20435881|P3|COMPLETED|Second Intervention (Night 2)||12
8288864|NCT01626989|20435882|P2|COMPLETED|Second Intervention (Night 2)||15
8288865|NCT01626989|20435883|P1|COMPLETED|Second Intervention (Night 2)||0
8288866|NCT01626989|20435881|P3|STARTED|Second Intervention (Night 2)||12
8288867|NCT01626989|20435882|P2|STARTED|Second Intervention (Night 2)||15
8288868|NCT01626989|20435883|P1|STARTED|Second Intervention (Night 2)||0
8288869|NCT01626989|20435881|P3|NOT COMPLETED|Fist Intervention (Night 1)||0
8288870|NCT01626989|20435882|P2|NOT COMPLETED|Fist Intervention (Night 1)||0
8288871|NCT01626989|20435883|P1|NOT COMPLETED|Fist Intervention (Night 1)||0
8288872|NCT01626989|20435881|P3|COMPLETED|Fist Intervention (Night 1)||12
8288873|NCT01626989|20435882|P2|COMPLETED|Fist Intervention (Night 1)||15
8288874|NCT01626989|20435883|P1|COMPLETED|Fist Intervention (Night 1)||0
8288875|NCT01626989|20435881|P3|STARTED|Fist Intervention (Night 1)||12
8288876|NCT01626989|20435882|P2|STARTED|Fist Intervention (Night 1)||15
8288877|NCT01626989|20435883|P1|STARTED|Fist Intervention (Night 1)||0
8288878|NCT01626989|20435881|P3|NOT COMPLETED|Screening Period||0
8288879|NCT01626989|20435882|P2|NOT COMPLETED|Screening Period||0
8288880|NCT01626989|20435883|P1|NOT COMPLETED|Screening Period||17
8288881|NCT01626989|20435881|P3|COMPLETED|Screening Period||0
8288882|NCT01626989|20435882|P2|COMPLETED|Screening Period||0
8288883|NCT01626989|20435883|P1|COMPLETED|Screening Period||27
8288884|NCT01626989|20435881|P3|STARTED|Screening Period||0
8288885|NCT01626989|20435882|P2|STARTED|Screening Period||0
8288886|NCT01626989|20435883|P1|STARTED|Screening Period||44
8288887|NCT01626820|20435932|P2|NOT COMPLETED|Overall Study||0
8288888|NCT01626820|20435933|P1|NOT COMPLETED|Overall Study||0
8288889|NCT01626820|20435932|P2|COMPLETED|Overall Study||57
8288890|NCT01626820|20435933|P1|COMPLETED|Overall Study||56
8288891|NCT01626820|20435932|P2|STARTED|Overall Study||57
8288892|NCT01626820|20435933|P1|STARTED|Overall Study||56
8288893|NCT01626690|20435955|P2|NOT COMPLETED|Overall Study||0
8288894|NCT01626690|20435956|P1|NOT COMPLETED|Overall Study||2
8288895|NCT01626690|20435955|P2|COMPLETED|Overall Study||51
8288896|NCT01626690|20435956|P1|COMPLETED|Overall Study||47
8288897|NCT01626690|20435955|P2|STARTED|Overall Study||51
8288898|NCT01626690|20435956|P1|STARTED|Overall Study||49
8288899|NCT01626664|20435978|P3|NOT COMPLETED|Crossover Period||0
8288900|NCT01626664|20435979|P2|NOT COMPLETED|Crossover Period||0
8288901|NCT01626664|20435980|P1|NOT COMPLETED|Crossover Period||0
8288902|NCT01626664|20435978|P3|COMPLETED|Crossover Period||18
8288903|NCT01626664|20435979|P2|COMPLETED|Crossover Period||0
8288904|NCT01626664|20435980|P1|COMPLETED|Crossover Period||0
8288905|NCT01626664|20435978|P3|STARTED|Crossover Period||18
8288906|NCT01626664|20435979|P2|STARTED|Crossover Period||0
8288907|NCT01626664|20435980|P1|STARTED|Crossover Period||0
8288908|NCT01626664|20435978|P3|NOT COMPLETED|Randomization Period||0
8288909|NCT01626664|20435979|P2|NOT COMPLETED|Randomization Period||0
8288910|NCT01626664|20435980|P1|NOT COMPLETED|Randomization Period||0
8288911|NCT01626664|20435978|P3|COMPLETED|Randomization Period||0
8288912|NCT01626664|20435979|P2|COMPLETED|Randomization Period||24
8288913|NCT01626664|20435980|P1|COMPLETED|Randomization Period||47
8288914|NCT01626664|20435978|P3|STARTED|Randomization Period||0
8288915|NCT01626664|20435979|P2|STARTED|Randomization Period||24
8288916|NCT01626664|20435980|P1|STARTED|Randomization Period||47
8288917|NCT01626495|20435993|P1|NOT COMPLETED|Overall Study||52
8288918|NCT01626495|20435993|P1|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
8288919|NCT01626495|20435993|P1|Intervention|Overall Study||62
8288920|NCT01626495|20435993|P1|STARTED|Overall Study|Number of enrolled subjects|73
8288921|NCT01626456|20436002|P2|NOT COMPLETED|Overall Study||117
8288922|NCT01626456|20436003|P1|NOT COMPLETED|Overall Study||35
8288923|NCT01626456|20436002|P2|COMPLETED|Overall Study||251
8288924|NCT01626456|20436003|P1|COMPLETED|Overall Study||75
8288925|NCT01626456|20436002|P2|STARTED|Overall Study||368
8288926|NCT01626456|20436003|P1|STARTED|Overall Study||110
8288927|NCT01626391|20436033|P2|NOT COMPLETED|Overall Study||0
8288928|NCT01626391|20436034|P1|NOT COMPLETED|Overall Study||2
8288929|NCT01626391|20436033|P2|COMPLETED|Overall Study||4
8288930|NCT01626391|20436034|P1|COMPLETED|Overall Study||3
8288931|NCT01626391|20436033|P2|STARTED|Overall Study||4
8288932|NCT01626391|20436034|P1|STARTED|Overall Study||5
8288933|NCT01626352|20436040|P1|NOT COMPLETED|Overall Study||10
8288934|NCT01626352|20436040|P1|COMPLETED|Overall Study||12
8288935|NCT01626352|20436040|P1|STARTED|Overall Study||22
8288936|NCT01626118|20436054|P4|NOT COMPLETED|Overall Study||3
8288937|NCT01626118|20436055|P3|NOT COMPLETED|Overall Study||2
8288938|NCT01626118|20436056|P2|NOT COMPLETED|Overall Study||2
8288939|NCT01626118|20436057|P1|NOT COMPLETED|Overall Study||2
8288940|NCT01626118|20436054|P4|COMPLETED|Overall Study||91
8288941|NCT01626118|20436055|P3|COMPLETED|Overall Study||90
8288942|NCT01626118|20436056|P2|COMPLETED|Overall Study||91
8288943|NCT01626118|20436057|P1|COMPLETED|Overall Study||92
8288944|NCT01626118|20436054|P4|STARTED|Overall Study||94
8288945|NCT01626118|20436055|P3|STARTED|Overall Study||92
8288946|NCT01626118|20436056|P2|STARTED|Overall Study||93
8288947|NCT01626118|20436057|P1|STARTED|Overall Study||94
8288948|NCT01626092|20436095|P1|NOT COMPLETED|Overall Study||0
8288949|NCT01626092|20436095|P1|COMPLETED|Overall Study||3
8288950|NCT01626092|20436095|P1|STARTED|Overall Study||3
8288951|NCT01626079|20436103|P2|NOT COMPLETED|Overall Study||216
8288952|NCT01626079|20436104|P1|NOT COMPLETED|Overall Study||167
8288953|NCT01626079|20436103|P2|COMPLETED|Overall Study||96
8288954|NCT01626079|20436104|P1|COMPLETED|Overall Study||135
8288955|NCT01626079|20436103|P2|STARTED|Overall Study||312
8288956|NCT01626079|20436104|P1|STARTED|Overall Study||302
8288957|NCT01625988|20436477|P2|NOT COMPLETED|Overall Study||13
8288958|NCT01625988|20436478|P1|NOT COMPLETED|Overall Study||14
8288959|NCT01625988|20436477|P2|COMPLETED|Overall Study||97
8288960|NCT01625988|20436478|P1|COMPLETED|Overall Study||94
8288961|NCT01625988|20436477|P2|Received at Least One Dose of Study Drug|Overall Study||110
8288962|NCT01625988|20436478|P1|Received at Least One Dose of Study Drug|Overall Study||107
8288963|NCT01625988|20436477|P2|STARTED|Overall Study||110
8288964|NCT01625988|20436478|P1|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
8288965|NCT01625923|20436492|P1|NOT COMPLETED|Overall Study||0
8288966|NCT01625923|20436492|P1|COMPLETED|Overall Study||3
8288967|NCT01625923|20436492|P1|STARTED|Overall Study||3
8288968|NCT01625910|20436502|P2|NOT COMPLETED|Overall Study||4
8288969|NCT01625910|20436503|P1|NOT COMPLETED|Overall Study||3
8288970|NCT01625910|20436502|P2|COMPLETED|Overall Study||33
8288971|NCT01625910|20436503|P1|COMPLETED|Overall Study||32
8288972|NCT01625910|20436502|P2|STARTED|Overall Study||37
8288973|NCT01625910|20436503|P1|STARTED|Overall Study||35
8288974|NCT01625845|20436513|P2|NOT COMPLETED|Overall Study||3
8288975|NCT01625845|20436514|P1|NOT COMPLETED|Overall Study||5
8288976|NCT01625845|20436513|P2|COMPLETED|Overall Study||3
8288977|NCT01625845|20436514|P1|COMPLETED|Overall Study||5
8288978|NCT01625845|20436513|P2|STARTED|Overall Study||6
8288979|NCT01625845|20436514|P1|STARTED|Overall Study||10
8288980|NCT01625689|20436534|P2|NOT COMPLETED|Overall Study||1
8288981|NCT01625689|20436535|P1|NOT COMPLETED|Overall Study||2
8288982|NCT01625689|20436534|P2|COMPLETED|Overall Study||149
8288983|NCT01625689|20436535|P1|COMPLETED|Overall Study||148
8288984|NCT01625689|20436534|P2|STARTED|Overall Study||150
8288985|NCT01625689|20436535|P1|STARTED|Overall Study||150
8288986|NCT01625507|20436545|P1|NOT COMPLETED|Overall Study||10
8288987|NCT01625507|20436545|P1|COMPLETED|Overall Study||63
8288988|NCT01625507|20436545|P1|STARTED|Overall Study||73
8288989|NCT01625455|20436560|P2|NOT COMPLETED|Overall Study||0
8288990|NCT01625455|20436561|P1|NOT COMPLETED|Overall Study||0
8288991|NCT01625455|20436560|P2|COMPLETED|Overall Study||3
8288992|NCT01625455|20436561|P1|COMPLETED|Overall Study||2
8288993|NCT01625455|20436560|P2|STARTED|Overall Study||3
8288994|NCT01625455|20436561|P1|STARTED|Overall Study||2
8288995|NCT01625416|20436571|P2|NOT COMPLETED|Overall Study||7
8288996|NCT01625416|20436572|P1|NOT COMPLETED|Overall Study||9
8288997|NCT01625416|20436571|P2|COMPLETED|Overall Study||54
8288998|NCT01625416|20436572|P1|COMPLETED|Overall Study||51
8288999|NCT01625416|20436571|P2|STARTED|Overall Study||61
8289000|NCT01625416|20436572|P1|STARTED|Overall Study||60
8289001|NCT01625377|20436590|P2|NOT COMPLETED|Overall Study||22
8289002|NCT01625377|20436591|P1|NOT COMPLETED|Overall Study||7
8289003|NCT01625377|20436590|P2|COMPLETED|Overall Study||71
8289004|NCT01625377|20436591|P1|COMPLETED|Overall Study||88
8289005|NCT01625377|20436590|P2|Intent to Treat Population|Overall Study||90
8289006|NCT01625377|20436591|P1|Intent to Treat Population|Overall Study||93
8289007|NCT01625377|20436590|P2|Safety Set of Population|Overall Study||90
8289008|NCT01625377|20436591|P1|Safety Set of Population|Overall Study||94
8289009|NCT01625377|20436590|P2|STARTED|Overall Study||93
8289010|NCT01625377|20436591|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
8289011|NCT01625338|20436624|P3|NOT COMPLETED|Overall Study||39
8289012|NCT01625338|20436625|P2|NOT COMPLETED|Overall Study||44
8289013|NCT01625338|20436626|P1|NOT COMPLETED|Overall Study||32
8289014|NCT01625338|20436624|P3|COMPLETED|Overall Study||181
8289015|NCT01625338|20436625|P2|COMPLETED|Overall Study||156
8289016|NCT01625338|20436626|P1|COMPLETED|Overall Study||82
8289017|NCT01625338|20436624|P3|STARTED|Overall Study||220
8289018|NCT01625338|20436625|P2|STARTED|Overall Study||200
8289019|NCT01625338|20436626|P1|STARTED|Overall Study||114
8289020|NCT01625286|20436653|P7|NOT COMPLETED|Overall Study||56
8289021|NCT01625286|20436654|P6|NOT COMPLETED|Overall Study||54
8289022|NCT01625286|20436655|P5|NOT COMPLETED|Overall Study||6
8289023|NCT01625286|20436656|P4|NOT COMPLETED|Overall Study||7
8289024|NCT01625286|20436657|P3|NOT COMPLETED|Overall Study||5
8289025|NCT01625286|20436658|P2|NOT COMPLETED|Overall Study||8
8289026|NCT01625286|20436659|P1|NOT COMPLETED|Overall Study||12
8289027|NCT01625286|20436653|P7|COMPLETED|Overall Study||0
8289028|NCT01625286|20436654|P6|COMPLETED|Overall Study||0
8289029|NCT01625286|20436655|P5|COMPLETED|Overall Study||0
8289030|NCT01625286|20436656|P4|COMPLETED|Overall Study||0
8289031|NCT01625286|20436657|P3|COMPLETED|Overall Study||0
8289032|NCT01625286|20436658|P2|COMPLETED|Overall Study||0
8289033|NCT01625286|20436659|P1|COMPLETED|Overall Study||0
8289034|NCT01625286|20436653|P7|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
8289035|NCT01625286|20436654|P6|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8289036|NCT01625286|20436655|P5|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8289037|NCT01625286|20436656|P4|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8289038|NCT01625286|20436657|P3|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8289039|NCT01625286|20436658|P2|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8289040|NCT01625286|20436659|P1|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8289041|NCT01625286|20436653|P7|Received AZD5363/Placebo Treatment|Overall Study||55
8289042|NCT01625286|20436654|P6|Received AZD5363/Placebo Treatment|Overall Study||54
8289043|NCT01625286|20436655|P5|Received AZD5363/Placebo Treatment|Overall Study||6
8289044|NCT01625286|20436656|P4|Received AZD5363/Placebo Treatment|Overall Study||7
8289045|NCT01625286|20436657|P3|Received AZD5363/Placebo Treatment|Overall Study||5
8289046|NCT01625286|20436658|P2|Received AZD5363/Placebo Treatment|Overall Study||8
8289047|NCT01625286|20436659|P1|Received AZD5363/Placebo Treatment|Overall Study||12
8289048|NCT01625286|20436653|P7|STARTED|Overall Study||56
8289049|NCT01625286|20436654|P6|STARTED|Overall Study||54
8289050|NCT01625286|20436655|P5|STARTED|Overall Study||6
8289051|NCT01625286|20436656|P4|STARTED|Overall Study||7
8289052|NCT01625286|20436657|P3|STARTED|Overall Study||5
8289053|NCT01625286|20436658|P2|STARTED|Overall Study||8
8289054|NCT01625286|20436659|P1|STARTED|Overall Study||12
8289055|NCT01625221|20436738|P1|NOT COMPLETED|Overall Study||7
8289056|NCT01625221|20436738|P1|COMPLETED|Overall Study||28
8289057|NCT01625221|20436738|P1|STARTED|Overall Study||35
8289058|NCT01625182|20436745|P2|NOT COMPLETED|Overall Study||11
8289059|NCT01625182|20436746|P1|NOT COMPLETED|Overall Study||20
8289060|NCT01625182|20436745|P2|COMPLETED|Overall Study||41
8289061|NCT01625182|20436746|P1|COMPLETED|Overall Study||34
8289062|NCT01625182|20436745|P2|STARTED|Overall Study||52
8289063|NCT01625182|20436746|P1|STARTED|Overall Study||54
8289064|NCT01625169|20436759|P1|NOT COMPLETED|Overall Study||0
8289065|NCT01625169|20436759|P1|COMPLETED|Overall Study||9
8289066|NCT01625169|20436759|P1|STARTED|Overall Study||9
8289067|NCT01625104|20436774|P2|NOT COMPLETED|Overall Study||0
8289068|NCT01625104|20436775|P1|NOT COMPLETED|Overall Study||0
8289069|NCT01625104|20436774|P2|COMPLETED|Overall Study||434
8289070|NCT01625104|20436775|P1|COMPLETED|Overall Study||448
8289071|NCT01625104|20436774|P2|STARTED|Overall Study||434
8289072|NCT01625104|20436775|P1|STARTED|Overall Study||448
8289073|NCT01625091|20436783|P2|NOT COMPLETED|Post-intervention||2
8289074|NCT01625091|20436784|P1|NOT COMPLETED|Post-intervention||4
8289075|NCT01625091|20436783|P2|COMPLETED|Post-intervention||85
8289076|NCT01625091|20436784|P1|COMPLETED|Post-intervention||81
8289077|NCT01625091|20436783|P2|7 Months|Post-intervention||85
8289078|NCT01625091|20436784|P1|7 Months|Post-intervention||81
8289079|NCT01625091|20436783|P2|STARTED|Post-intervention||87
8289080|NCT01625091|20436784|P1|STARTED|Post-intervention||85
8289081|NCT01625091|20436783|P2|NOT COMPLETED|Intervention||11
8289082|NCT01625091|20436784|P1|NOT COMPLETED|Intervention||11
8289083|NCT01625091|20436783|P2|COMPLETED|Intervention||87
8289084|NCT01625091|20436784|P1|COMPLETED|Intervention||85
8289085|NCT01625091|20436783|P2|4 Months|Intervention||87
8289086|NCT01625091|20436784|P1|4 Months|Intervention||85
8289087|NCT01625091|20436783|P2|2 Months|Intervention||93
8289088|NCT01625091|20436784|P1|2 Months|Intervention||90
8289089|NCT01625091|20436783|P2|STARTED|Intervention||98
8289090|NCT01625091|20436784|P1|STARTED|Intervention||96
8289091|NCT01625013|20436796|P1|NOT COMPLETED|Overall Study||32
8289092|NCT01625013|20436796|P1|COMPLETED|Overall Study||48
8289093|NCT01625013|20436796|P1|STARTED|Overall Study||80
8289094|NCT01624974|20436802|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
8289095|NCT01624974|20436803|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
8289096|NCT01624974|20436802|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
8289097|NCT01624974|20436803|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
8289098|NCT01624974|20436802|P2|STARTED|Period V of Treatment (4 Weeks)||42
8289099|NCT01624974|20436803|P1|STARTED|Period V of Treatment (4 Weeks)||44
8289100|NCT01624974|20436802|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
8289101|NCT01624974|20436803|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
8289102|NCT01624974|20436802|P2|COMPLETED|Period IV Washout (4 Weeks)||42
8289103|NCT01624974|20436803|P1|COMPLETED|Period IV Washout (4 Weeks)||44
8289104|NCT01624974|20436802|P2|STARTED|Period IV Washout (4 Weeks)||45
8289105|NCT01624974|20436803|P1|STARTED|Period IV Washout (4 Weeks)||47
8289106|NCT01624974|20436802|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
8289107|NCT01624974|20436803|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
8289108|NCT01624974|20436802|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
8289109|NCT01624974|20436803|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
8289110|NCT01624974|20436802|P2|STARTED|Period III of Treatment (4 Weeks)||53
8289111|NCT01624974|20436803|P1|STARTED|Period III of Treatment (4 Weeks)||54
8289112|NCT01624948|20436827|P2|NOT COMPLETED|Overall Study||0
8289113|NCT01624948|20436828|P1|NOT COMPLETED|Overall Study||0
8289114|NCT01624948|20436827|P2|COMPLETED|Overall Study||20
8289115|NCT01624948|20436828|P1|COMPLETED|Overall Study||20
8289116|NCT01624948|20436827|P2|STARTED|Overall Study||20
8289117|NCT01624948|20436828|P1|STARTED|Overall Study||20
8289118|NCT01624870|20436844|P1|NOT COMPLETED|Overall Study||27
8289119|NCT01624870|20436844|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
8289120|NCT01624870|20436844|P1|STARTED|Overall Study|provided informed consent|200
8289121|NCT01624740|20436852|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
8289122|NCT01624740|20436853|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
8289123|NCT01624740|20436852|P2|COMPLETED|Second Intervention (3-4 Days)||9
8289124|NCT01624740|20436853|P1|COMPLETED|Second Intervention (3-4 Days)||8
8289125|NCT01624740|20436852|P2|STARTED|Second Intervention (3-4 Days)||9
8289126|NCT01624740|20436853|P1|STARTED|Second Intervention (3-4 Days)||9
8289127|NCT01624740|20436852|P2|NOT COMPLETED|Washout (1 Hour)||0
8289128|NCT01624740|20436853|P1|NOT COMPLETED|Washout (1 Hour)||0
8289129|NCT01624740|20436852|P2|COMPLETED|Washout (1 Hour)||9
8289130|NCT01624740|20436853|P1|COMPLETED|Washout (1 Hour)||9
8289131|NCT01624740|20436852|P2|STARTED|Washout (1 Hour)||9
8289132|NCT01624740|20436853|P1|STARTED|Washout (1 Hour)||9
8289133|NCT01624740|20436852|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
8289134|NCT01624740|20436853|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
8289135|NCT01624740|20436852|P2|COMPLETED|First Intervention (3-4 Days)||9
8289136|NCT01624740|20436853|P1|COMPLETED|First Intervention (3-4 Days)||9
8289137|NCT01624740|20436852|P2|STARTED|First Intervention (3-4 Days)||9
8289138|NCT01624740|20436853|P1|STARTED|First Intervention (3-4 Days)||9
8289139|NCT01624662|20436864|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289140|NCT01624662|20436865|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289141|NCT01624662|20436866|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8289142|NCT01624662|20436867|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289143|NCT01624662|20436864|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
8289144|NCT01624662|20436865|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
8289145|NCT01624662|20436866|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
8289146|NCT01624662|20436867|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
8289147|NCT01624662|20436864|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
8289148|NCT01624662|20436865|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
8289149|NCT01624662|20436866|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
8289150|NCT01624662|20436867|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
8289151|NCT01624662|20436864|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
8289152|NCT01624662|20436865|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
8289153|NCT01624662|20436866|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
8289154|NCT01624662|20436867|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
8289155|NCT01624662|20436864|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
8289156|NCT01624662|20436865|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
8289157|NCT01624662|20436866|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
8289158|NCT01624662|20436867|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
8289159|NCT01624662|20436864|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
8289160|NCT01624662|20436865|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289161|NCT01624662|20436866|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
8289162|NCT01624662|20436867|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289163|NCT01624467|20436938|P1|NOT COMPLETED|Overall Study||31
8289164|NCT01624467|20436938|P1|COMPLETED|Overall Study||44
8289165|NCT01624467|20436938|P1|Received at Least One Dose of Study Drug|Overall Study||75
8289166|NCT01624467|20436938|P1|STARTED|Overall Study||75
8289167|NCT01624363|20436951|P1|NOT COMPLETED|Overall Study||0
8289168|NCT01624363|20436951|P1|COMPLETED|Overall Study||341
8289169|NCT01624363|20436951|P1|STARTED|Overall Study||341
8289170|NCT01624350|20436955|P1|NOT COMPLETED|Overall Study||25
8289171|NCT01624350|20436955|P1|COMPLETED|Overall Study||75
8289172|NCT01624350|20436955|P1|STARTED|Overall Study||100
8289173|NCT01624259|20436977|P2|NOT COMPLETED|Overall Study||31
8289174|NCT01624259|20436978|P1|NOT COMPLETED|Overall Study||30
8289175|NCT01624259|20436977|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
8289176|NCT01624259|20436978|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
8289177|NCT01624259|20436977|P2|Received at Least One Dose of Study Drug|Overall Study||300
8289178|NCT01624259|20436978|P1|Received at Least One Dose of Study Drug|Overall Study||299
8289179|NCT01624259|20436977|P2|STARTED|Overall Study||300
8289180|NCT01624259|20436978|P1|STARTED|Overall Study||299
8289181|NCT01624233|20437027|P1|NOT COMPLETED|Period 6: Follow-up||9
8289182|NCT01624233|20437027|P1|COMPLETED|Period 6: Follow-up||79
8289183|NCT01624233|20437027|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
8289184|NCT01624233|20437027|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
8289185|NCT01624233|20437027|P1|COMPLETED|Period 5 - Retreatment Period||70
8289186|NCT01624233|20437027|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
8289187|NCT01624233|20437027|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
8289188|NCT01624233|20437027|P1|COMPLETED|Period 4 - Drug Free Period||9
8289189|NCT01624233|20437027|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
8289190|NCT01624233|20437027|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
8289191|NCT01624233|20437027|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
8289192|NCT01624233|20437027|P1|NOT COMPLETED|Period 3 - Maintenance||7
8289193|NCT01624233|20437027|P1|COMPLETED|Period 3 - Maintenance||83
8289194|NCT01624233|20437027|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
8289195|NCT01624233|20437027|P1|STARTED|Period 3 - Maintenance||90
8289196|NCT01624233|20437027|P1|NOT COMPLETED|Period 2 - Induction||1
8289197|NCT01624233|20437027|P1|COMPLETED|Period 2 - Induction||90
8289198|NCT01624233|20437027|P1|Plaque Ps|Period 2 - Induction||78
8289199|NCT01624233|20437027|P1|Pustular Ps|Period 2 - Induction||5
8289200|NCT01624233|20437027|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
8289201|NCT01624233|20437027|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
8289202|NCT01624233|20437027|P1|STARTED|Period 2 - Induction||91
8289203|NCT01624194|20437059|P2|NOT COMPLETED|Overall Study||0
8289204|NCT01624194|20437060|P1|NOT COMPLETED|Overall Study||2
8289205|NCT01624194|20437059|P2|COMPLETED|Overall Study||18
8289206|NCT01624194|20437060|P1|COMPLETED|Overall Study||14
8289207|NCT01624194|20437059|P2|STARTED|Overall Study||18
8289208|NCT01624194|20437060|P1|STARTED|Overall Study||16
8289209|NCT01624168|20437101|P3|NOT COMPLETED|Overall Study||6
8289210|NCT01624168|20437102|P2|NOT COMPLETED|Overall Study||12
8289211|NCT01624168|20437103|P1|NOT COMPLETED|Overall Study||4
8289212|NCT01624168|20437101|P3|COMPLETED|Overall Study||22
8289213|NCT01624168|20437102|P2|COMPLETED|Overall Study||16
8289214|NCT01624168|20437103|P1|COMPLETED|Overall Study||15
8289215|NCT01624168|20437101|P3|STARTED|Overall Study||28
8289216|NCT01624168|20437102|P2|STARTED|Overall Study||28
8289217|NCT01624168|20437103|P1|STARTED|Overall Study||19
8289218|NCT01624142|20437128|P2|NOT COMPLETED|Overall Study||16
8289219|NCT01624142|20437129|P1|NOT COMPLETED|Overall Study||32
8289220|NCT01624142|20437128|P2|COMPLETED|Overall Study||178
8289221|NCT01624142|20437129|P1|COMPLETED|Overall Study||74
8289222|NCT01624142|20437128|P2|STARTED|Overall Study||194
8289223|NCT01624142|20437129|P1|STARTED|Overall Study||106
8289224|NCT01624090|20437154|P4|NOT COMPLETED|Overall Study||0
8289225|NCT01624090|20437155|P3|NOT COMPLETED|Overall Study||7
8289226|NCT01624090|20437156|P2|NOT COMPLETED|Overall Study||2
8289227|NCT01624090|20437157|P1|NOT COMPLETED|Overall Study||0
8289228|NCT01624090|20437154|P4|COMPLETED|Overall Study||2
8289229|NCT01624090|20437155|P3|COMPLETED|Overall Study||3
8289230|NCT01624090|20437156|P2|COMPLETED|Overall Study||0
8289231|NCT01624090|20437157|P1|COMPLETED|Overall Study||2
8289232|NCT01624090|20437154|P4|STARTED|Overall Study||2
8289233|NCT01624090|20437155|P3|STARTED|Overall Study||10
8289234|NCT01624090|20437156|P2|STARTED|Overall Study||2
8289235|NCT01624090|20437157|P1|STARTED|Overall Study||2
8289236|NCT01623869|20437171|P1|NOT COMPLETED|Overall Study||0
8289237|NCT01623869|20437171|P1|COMPLETED|Overall Study||16
8289238|NCT01623869|20437171|P1|STARTED|Overall Study||16
8289239|NCT01623830|20437179|P2|NOT COMPLETED|Overall Study||9
8289240|NCT01623830|20437180|P1|NOT COMPLETED|Overall Study||7
8289241|NCT01623830|20437179|P2|COMPLETED|Overall Study||35
8289242|NCT01623830|20437180|P1|COMPLETED|Overall Study||38
8289243|NCT01623830|20437179|P2|STARTED|Overall Study||44
8289244|NCT01623830|20437180|P1|STARTED|Overall Study||45
8289245|NCT01623752|20437197|P3|NOT COMPLETED|Phase 2 (78 Weeks)||0
8289246|NCT01623752|20437198|P2|NOT COMPLETED|Phase 2 (78 Weeks)||18
8289247|NCT01623752|20437199|P1|NOT COMPLETED|Phase 2 (78 Weeks)||66
8289248|NCT01623752|20437197|P3|COMPLETED|Phase 2 (78 Weeks)||0
8289249|NCT01623752|20437198|P2|COMPLETED|Phase 2 (78 Weeks)||98
8289250|NCT01623752|20437199|P1|COMPLETED|Phase 2 (78 Weeks)||225
8289251|NCT01623752|20437197|P3|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
8289252|NCT01623752|20437198|P2|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
8289253|NCT01623752|20437199|P1|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
8289254|NCT01623752|20437197|P3|NOT COMPLETED|Phase 1 (78 Weeks)||2
8289255|NCT01623752|20437198|P2|NOT COMPLETED|Phase 1 (78 Weeks)||207
8289256|NCT01623752|20437199|P1|NOT COMPLETED|Phase 1 (78 Weeks)||631
8289257|NCT01623752|20437197|P3|COMPLETED|Phase 1 (78 Weeks)||1
8289258|NCT01623752|20437198|P2|COMPLETED|Phase 1 (78 Weeks)||233
8289259|NCT01623752|20437199|P1|COMPLETED|Phase 1 (78 Weeks)||747
8289260|NCT01623752|20437197|P3|STARTED|Phase 1 (78 Weeks)||3
8289261|NCT01623752|20437198|P2|STARTED|Phase 1 (78 Weeks)||440
8289262|NCT01623752|20437199|P1|STARTED|Phase 1 (78 Weeks)||1378
8289263|NCT01623739|20437284|P2|NOT COMPLETED|Overall Study||4
8289264|NCT01623739|20437285|P1|NOT COMPLETED|Overall Study||2
8289265|NCT01623739|20437284|P2|COMPLETED|Overall Study||15
8289266|NCT01623739|20437285|P1|COMPLETED|Overall Study||17
8289267|NCT01623739|20437284|P2|STARTED|Overall Study||19
8289268|NCT01623739|20437285|P1|STARTED|Overall Study||19
8289269|NCT01623596|20437302|P2|NOT COMPLETED|Overall Study||100
8289270|NCT01623596|20437303|P1|NOT COMPLETED|Overall Study||62
8289271|NCT01623596|20437302|P2|COMPLETED|Overall Study||339
8289272|NCT01623596|20437303|P1|COMPLETED|Overall Study||374
8289273|NCT01623596|20437302|P2|On Switched Treatment|Overall Study||214
8289274|NCT01623596|20437303|P1|On Switched Treatment|Overall Study||22
8289275|NCT01623596|20437302|P2|On Randomized Treatment|Overall Study||125
8289276|NCT01623596|20437303|P1|On Randomized Treatment|Overall Study||352
8289277|NCT01623596|20437302|P2|STARTED|Overall Study||439
8289278|NCT01623596|20437303|P1|STARTED|Overall Study||436
8289279|NCT01623531|20437321|P2|NOT COMPLETED|Overall Study||2
8289280|NCT01623531|20437322|P1|NOT COMPLETED|Overall Study||4
8289281|NCT01623531|20437321|P2|COMPLETED|Overall Study||29
8289282|NCT01623531|20437322|P1|COMPLETED|Overall Study||27
8289283|NCT01623531|20437321|P2|STARTED|Overall Study||31
8289284|NCT01623531|20437322|P1|STARTED|Overall Study||31
8289285|NCT01623479|20437362|P1|NOT COMPLETED|Overall Study||0
8289286|NCT01623479|20437362|P1|COMPLETED|Overall Study||585
8289287|NCT01623479|20437362|P1|STARTED|Overall Study||585
8289288|NCT01623466|20437370|P2|NOT COMPLETED|Overall Study||0
8289289|NCT01623466|20437371|P1|NOT COMPLETED|Overall Study||1
8289290|NCT01623466|20437370|P2|COMPLETED|Overall Study||18
8289291|NCT01623466|20437371|P1|COMPLETED|Overall Study||17
8289292|NCT01623466|20437370|P2|STARTED|Overall Study||18
8289293|NCT01623466|20437371|P1|STARTED|Overall Study||18
8289294|NCT01623323|20437385|P1|NOT COMPLETED|Overall Study||104
8289295|NCT01623323|20437385|P1|COMPLETED|Overall Study||601
8289296|NCT01623323|20437385|P1|STARTED|Overall Study||705
8289297|NCT01623310|20437389|P1|NOT COMPLETED|Overall Study||79
8289298|NCT01623310|20437389|P1|COMPLETED|Overall Study||144
8289299|NCT01623310|20437389|P1|STARTED|Overall Study||223
8289300|NCT01623271|20437398|P1|NOT COMPLETED|Overall Study||2
8289301|NCT01623271|20437398|P1|COMPLETED|Overall Study||3
8289302|NCT01623271|20437398|P1|STARTED|Overall Study||5
8289303|NCT01623167|20437405|P3|NOT COMPLETED|Overall Study||13
8289304|NCT01623167|20437406|P2|NOT COMPLETED|Overall Study||14
8289305|NCT01623167|20437407|P1|NOT COMPLETED|Overall Study||17
8289306|NCT01623167|20437405|P3|COMPLETED|Overall Study||18
8289307|NCT01623167|20437406|P2|COMPLETED|Overall Study||17
8289308|NCT01623167|20437407|P1|COMPLETED|Overall Study||13
8289309|NCT01623167|20437405|P3|STARTED|Overall Study||31
8289310|NCT01623167|20437406|P2|STARTED|Overall Study||31
8289311|NCT01623167|20437407|P1|STARTED|Overall Study||30
8289312|NCT01623154|20437415|P1|NOT COMPLETED|Overall Study||4
8289313|NCT01623154|20437415|P1|COMPLETED|Overall Study||95
8289314|NCT01623154|20437415|P1|Available for Analysis|Overall Study||95
8289315|NCT01623154|20437415|P1|STARTED|Overall Study||99
8289316|NCT01623115|20437423|P2|NOT COMPLETED|Overall Study||77
8289317|NCT01623115|20437424|P1|NOT COMPLETED|Overall Study||33
8289318|NCT01623115|20437423|P2|COMPLETED|Overall Study||246
8289319|NCT01623115|20437424|P1|COMPLETED|Overall Study||130
8289320|NCT01623115|20437423|P2|Treated|Overall Study||322
8289321|NCT01623115|20437424|P1|Treated|Overall Study||163
8289322|NCT01623115|20437423|P2|STARTED|Overall Study|Randomized|323
8289323|NCT01623115|20437424|P1|STARTED|Overall Study|Randomized|163
8289324|NCT01623050|20437484|P1|NOT COMPLETED|Overall Study||9
8289325|NCT01623050|20437484|P1|COMPLETED|Overall Study||27
8289326|NCT01623050|20437484|P1|Treated|Overall Study||34
8289327|NCT01623050|20437484|P1|STARTED|Overall Study||36
8289328|NCT01623037|20437492|P1|NOT COMPLETED|Overall Study||0
8289329|NCT01623037|20437492|P1|COMPLETED|Overall Study||15
8289330|NCT01623037|20437492|P1|STARTED|Overall Study||15
8289331|NCT01622699|20437503|P2|NOT COMPLETED|Overall Study||0
8289332|NCT01622699|20437504|P1|NOT COMPLETED|Overall Study||0
8289333|NCT01622699|20437503|P2|COMPLETED|Overall Study||217
8289334|NCT01622699|20437504|P1|COMPLETED|Overall Study||213
8289335|NCT01622699|20437503|P2|STARTED|Overall Study||217
8289336|NCT01622699|20437504|P1|STARTED|Overall Study||213
8289337|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 5||0
8289338|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 5||0
8289339|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 5||0
8289340|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 5||0
8289341|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 5||0
8289342|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 5||0
8289343|NCT01622673|20437522|P6|COMPLETED|Treatment Period 5||4
8289344|NCT01622673|20437523|P5|COMPLETED|Treatment Period 5||4
8289345|NCT01622673|20437524|P4|COMPLETED|Treatment Period 5||4
8289346|NCT01622673|20437525|P3|COMPLETED|Treatment Period 5||4
8289347|NCT01622673|20437526|P2|COMPLETED|Treatment Period 5||3
8289348|NCT01622673|20437527|P1|COMPLETED|Treatment Period 5||4
8289349|NCT01622673|20437522|P6|STARTED|Treatment Period 5||4
8289350|NCT01622673|20437523|P5|STARTED|Treatment Period 5||4
8289351|NCT01622673|20437524|P4|STARTED|Treatment Period 5||4
8289352|NCT01622673|20437525|P3|STARTED|Treatment Period 5||4
8289353|NCT01622673|20437526|P2|STARTED|Treatment Period 5||3
8289354|NCT01622673|20437527|P1|STARTED|Treatment Period 5||4
8289355|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 4||0
8289356|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 4||0
8289357|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 4||0
8289358|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 4||0
8289359|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 4||0
8289360|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 4||0
8289361|NCT01622673|20437522|P6|COMPLETED|Treatment Period 4||4
8289362|NCT01622673|20437523|P5|COMPLETED|Treatment Period 4||4
8289363|NCT01622673|20437524|P4|COMPLETED|Treatment Period 4||4
8289364|NCT01622673|20437525|P3|COMPLETED|Treatment Period 4||4
8289365|NCT01622673|20437526|P2|COMPLETED|Treatment Period 4||3
8289366|NCT01622673|20437527|P1|COMPLETED|Treatment Period 4||4
8289367|NCT01622673|20437522|P6|STARTED|Treatment Period 4||4
8289368|NCT01622673|20437523|P5|STARTED|Treatment Period 4||4
8289369|NCT01622673|20437524|P4|STARTED|Treatment Period 4||4
8289370|NCT01622673|20437525|P3|STARTED|Treatment Period 4||4
8289371|NCT01622673|20437526|P2|STARTED|Treatment Period 4||3
8289372|NCT01622673|20437527|P1|STARTED|Treatment Period 4||4
8289373|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 3||0
8289374|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 3||0
8289375|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 3||0
8289376|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 3||0
8289377|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 3||1
8289378|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 3||0
8289379|NCT01622673|20437522|P6|COMPLETED|Treatment Period 3||4
8289380|NCT01622673|20437523|P5|COMPLETED|Treatment Period 3||4
8289381|NCT01622673|20437524|P4|COMPLETED|Treatment Period 3||4
8289382|NCT01622673|20437525|P3|COMPLETED|Treatment Period 3||4
8289383|NCT01622673|20437526|P2|COMPLETED|Treatment Period 3||3
8289384|NCT01622673|20437527|P1|COMPLETED|Treatment Period 3||4
8289385|NCT01622673|20437522|P6|STARTED|Treatment Period 3||4
8289386|NCT01622673|20437523|P5|STARTED|Treatment Period 3||4
8289387|NCT01622673|20437524|P4|STARTED|Treatment Period 3||4
8289388|NCT01622673|20437525|P3|STARTED|Treatment Period 3||4
8289389|NCT01622673|20437526|P2|STARTED|Treatment Period 3||4
8289390|NCT01622673|20437527|P1|STARTED|Treatment Period 3||4
8289391|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 2||0
8289392|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 2||0
8289393|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 2||1
8289394|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 2||0
8289395|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 2||0
8289396|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 2||0
8289397|NCT01622673|20437522|P6|COMPLETED|Treatment Period 2||4
8289398|NCT01622673|20437523|P5|COMPLETED|Treatment Period 2||4
8289399|NCT01622673|20437524|P4|COMPLETED|Treatment Period 2||4
8289400|NCT01622673|20437525|P3|COMPLETED|Treatment Period 2||4
8289401|NCT01622673|20437526|P2|COMPLETED|Treatment Period 2||4
8289402|NCT01622673|20437527|P1|COMPLETED|Treatment Period 2||4
8289403|NCT01622673|20437522|P6|STARTED|Treatment Period 2||4
8289404|NCT01622673|20437523|P5|STARTED|Treatment Period 2||4
8289405|NCT01622673|20437524|P4|STARTED|Treatment Period 2||5
8289406|NCT01622673|20437525|P3|STARTED|Treatment Period 2||4
8289407|NCT01622673|20437526|P2|STARTED|Treatment Period 2||4
8289408|NCT01622673|20437527|P1|STARTED|Treatment Period 2||4
8289409|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 1||0
8289410|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 1||0
8289411|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 1||1
8289412|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 1||0
8289413|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 1||1
8289414|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 1||0
8289415|NCT01622673|20437522|P6|COMPLETED|Treatment Period 1||4
8289416|NCT01622673|20437523|P5|COMPLETED|Treatment Period 1||4
8289417|NCT01622673|20437524|P4|COMPLETED|Treatment Period 1||5
8289418|NCT01622673|20437525|P3|COMPLETED|Treatment Period 1||4
8289419|NCT01622673|20437526|P2|COMPLETED|Treatment Period 1||4
8289420|NCT01622673|20437527|P1|COMPLETED|Treatment Period 1||4
8289421|NCT01622673|20437522|P6|STARTED|Treatment Period 1||4
8289422|NCT01622673|20437523|P5|STARTED|Treatment Period 1||4
8289423|NCT01622673|20437524|P4|STARTED|Treatment Period 1||6
8289424|NCT01622673|20437525|P3|STARTED|Treatment Period 1||4
8289425|NCT01622673|20437526|P2|STARTED|Treatment Period 1||5
8289426|NCT01622673|20437527|P1|STARTED|Treatment Period 1||4
8289427|NCT01622660|20437562|P1|NOT COMPLETED|Overall Study||1
8289428|NCT01622660|20437562|P1|COMPLETED|Overall Study||1
8289429|NCT01622660|20437562|P1|STARTED|Overall Study||2
8289430|NCT01622569|20437570|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8289431|NCT01622569|20437571|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
8289432|NCT01622569|20437572|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8289433|NCT01622569|20437573|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289434|NCT01622569|20437570|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
8289435|NCT01622569|20437571|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
8289436|NCT01622569|20437572|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
8289437|NCT01622569|20437573|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
8289438|NCT01622569|20437570|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
8289439|NCT01622569|20437571|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
8289440|NCT01622569|20437572|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
8289441|NCT01622569|20437573|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
8289442|NCT01622569|20437570|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
8289443|NCT01622569|20437571|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
8289444|NCT01622569|20437572|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
8289445|NCT01622569|20437573|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
8289446|NCT01622569|20437570|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
8289447|NCT01622569|20437571|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
8289448|NCT01622569|20437572|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
8289449|NCT01622569|20437573|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
8289450|NCT01622569|20437570|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289451|NCT01622569|20437571|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289452|NCT01622569|20437572|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
8289453|NCT01622569|20437573|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
8289454|NCT01622543|20437642|P2|NOT COMPLETED|Overall Study||0
8289455|NCT01622543|20437643|P1|NOT COMPLETED|Overall Study||0
8289456|NCT01622543|20437642|P2|COMPLETED|Overall Study||52
8289457|NCT01622543|20437643|P1|COMPLETED|Overall Study||51
8289458|NCT01622543|20437642|P2|STARTED|Overall Study||52
8289459|NCT01622543|20437643|P1|STARTED|Overall Study||51
8289460|NCT01622348|20437658|P3|NOT COMPLETED|Overall Study||1
8289461|NCT01622348|20437659|P2|NOT COMPLETED|Overall Study||0
8289462|NCT01622348|20437660|P1|NOT COMPLETED|Overall Study||1
8289463|NCT01622348|20437658|P3|COMPLETED|Overall Study||14
8289464|NCT01622348|20437659|P2|COMPLETED|Overall Study||14
8289465|NCT01622348|20437660|P1|COMPLETED|Overall Study||14
8289466|NCT01622348|20437658|P3|STARTED|Overall Study||15
8289467|NCT01622348|20437659|P2|STARTED|Overall Study||14
8289468|NCT01622348|20437660|P1|STARTED|Overall Study||15
8289469|NCT01622296|20437668|P2|NOT COMPLETED|Second Intervention||0
8289470|NCT01622296|20437669|P1|NOT COMPLETED|Second Intervention||0
8289471|NCT01622296|20437668|P2|COMPLETED|Second Intervention||10
8289472|NCT01622296|20437669|P1|COMPLETED|Second Intervention||10
8289473|NCT01622296|20437668|P2|STARTED|Second Intervention||10
8289474|NCT01622296|20437669|P1|STARTED|Second Intervention||10
8289475|NCT01622296|20437668|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
8289476|NCT01622296|20437669|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
8289477|NCT01622296|20437668|P2|COMPLETED|Washout Period of at Least 1 Week||10
8289478|NCT01622296|20437669|P1|COMPLETED|Washout Period of at Least 1 Week||10
8289479|NCT01622296|20437668|P2|STARTED|Washout Period of at Least 1 Week||10
8289480|NCT01622296|20437669|P1|STARTED|Washout Period of at Least 1 Week||10
8289481|NCT01622296|20437668|P2|NOT COMPLETED|First Intervention||0
8289482|NCT01622296|20437669|P1|NOT COMPLETED|First Intervention||0
8289483|NCT01622296|20437668|P2|COMPLETED|First Intervention||10
8289484|NCT01622296|20437669|P1|COMPLETED|First Intervention||10
8289485|NCT01622296|20437668|P2|STARTED|First Intervention||10
8289486|NCT01622296|20437669|P1|STARTED|First Intervention||10
8289487|NCT01622257|20437677|P3|NOT COMPLETED|Overall Study||0
8289488|NCT01622257|20437678|P2|NOT COMPLETED|Overall Study||0
8289489|NCT01622257|20437679|P1|NOT COMPLETED|Overall Study||0
8289490|NCT01622257|20437677|P3|COMPLETED|Overall Study||66
8289491|NCT01622257|20437678|P2|COMPLETED|Overall Study||66
8289492|NCT01622257|20437679|P1|COMPLETED|Overall Study||66
8289493|NCT01622257|20437677|P3|STARTED|Overall Study||66
8289494|NCT01622257|20437678|P2|STARTED|Overall Study||66
8289495|NCT01622257|20437679|P1|STARTED|Overall Study||66
8289496|NCT01622231|20437699|P1|NOT COMPLETED|Overall Study||2
8289497|NCT01622231|20437699|P1|COMPLETED|Overall Study||59
8289498|NCT01622231|20437699|P1|STARTED|Overall Study||61
8289499|NCT01621880|20437729|P2|NOT COMPLETED|Overall Study||5
8289500|NCT01621880|20437730|P1|NOT COMPLETED|Overall Study||10
8289501|NCT01621880|20437729|P2|COMPLETED|Overall Study||49
8289502|NCT01621880|20437730|P1|COMPLETED|Overall Study||48
8289503|NCT01621880|20437729|P2|STARTED|Overall Study||54
8289504|NCT01621880|20437730|P1|STARTED|Overall Study||58
8289505|NCT01621802|20437744|P6|NOT COMPLETED|Overall Study||12
8289506|NCT01621802|20437745|P5|NOT COMPLETED|Overall Study||35
8289507|NCT01621802|20437746|P4|NOT COMPLETED|Overall Study||11
8289508|NCT01621802|20437747|P3|NOT COMPLETED|Overall Study||33
8289509|NCT01621802|20437748|P2|NOT COMPLETED|Overall Study||23
8289510|NCT01621802|20437749|P1|NOT COMPLETED|Overall Study||47
8289511|NCT01621802|20437744|P6|COMPLETED|Overall Study||477
8289512|NCT01621802|20437745|P5|COMPLETED|Overall Study||1284
8289513|NCT01621802|20437746|P4|COMPLETED|Overall Study||292
8289514|NCT01621802|20437747|P3|COMPLETED|Overall Study||763
8289515|NCT01621802|20437748|P2|COMPLETED|Overall Study||275
8289516|NCT01621802|20437749|P1|COMPLETED|Overall Study||755
8289517|NCT01621802|20437744|P6|STARTED|Overall Study||489
8289518|NCT01621802|20437745|P5|STARTED|Overall Study||1319
8289519|NCT01621802|20437746|P4|STARTED|Overall Study||303
8289520|NCT01621802|20437747|P3|STARTED|Overall Study||796
8289521|NCT01621802|20437748|P2|STARTED|Overall Study||298
8289522|NCT01621802|20437749|P1|STARTED|Overall Study||802
8289523|NCT01621776|20437856|P3|NOT COMPLETED|Overall Study||0
8289524|NCT01621776|20437857|P2|NOT COMPLETED|Overall Study||0
8289525|NCT01621776|20437858|P1|NOT COMPLETED|Overall Study||0
8289526|NCT01621776|20437856|P3|COMPLETED|Overall Study||18
8289527|NCT01621776|20437857|P2|COMPLETED|Overall Study||40
8289528|NCT01621776|20437858|P1|COMPLETED|Overall Study||41
8289529|NCT01621776|20437856|P3|STARTED|Overall Study||18
8289530|NCT01621776|20437857|P2|STARTED|Overall Study||40
8289531|NCT01621776|20437858|P1|STARTED|Overall Study||41
8289532|NCT01621737|20437872|P1|NOT COMPLETED|Overall Study||0
8289533|NCT01621737|20437872|P1|COMPLETED|Overall Study||0
8289534|NCT01621737|20437872|P1|STARTED|Overall Study||0
8289535|NCT01621672|20437892|P2|NOT COMPLETED|Overall Study||0
8289536|NCT01621672|20437893|P1|NOT COMPLETED|Overall Study||0
8289537|NCT01621672|20437892|P2|COMPLETED|Overall Study||17
8289538|NCT01621672|20437893|P1|COMPLETED|Overall Study||25
8289539|NCT01621672|20437892|P2|STARTED|Overall Study||17
8289540|NCT01621672|20437893|P1|STARTED|Overall Study||25
8289541|NCT01621633|20437903|P4|NOT COMPLETED|Overall Study||0
8289542|NCT01621633|20437904|P3|NOT COMPLETED|Overall Study||0
8289543|NCT01621633|20437905|P2|NOT COMPLETED|Overall Study||0
8289544|NCT01621633|20437906|P1|NOT COMPLETED|Overall Study||0
8289545|NCT01621633|20437903|P4|COMPLETED|Overall Study||8
8289546|NCT01621633|20437904|P3|COMPLETED|Overall Study||8
8289547|NCT01621633|20437905|P2|COMPLETED|Overall Study||8
8289548|NCT01621633|20437906|P1|COMPLETED|Overall Study||8
8289549|NCT01621633|20437903|P4|STARTED|Overall Study||8
8289550|NCT01621633|20437904|P3|STARTED|Overall Study||8
8289551|NCT01621633|20437905|P2|STARTED|Overall Study||8
8289552|NCT01621633|20437906|P1|STARTED|Overall Study||8
8289553|NCT01621542|20437934|P6|NOT COMPLETED|Overall Study||9
8289554|NCT01621542|20437935|P5|NOT COMPLETED|Overall Study||9
8289555|NCT01621542|20437936|P4|NOT COMPLETED|Overall Study||28
8289556|NCT01621542|20437937|P3|NOT COMPLETED|Overall Study||6
8289557|NCT01621542|20437938|P2|NOT COMPLETED|Overall Study||5
8289558|NCT01621542|20437939|P1|NOT COMPLETED|Overall Study||5
8289559|NCT01621542|20437934|P6|COMPLETED|Overall Study||0
8289560|NCT01621542|20437935|P5|COMPLETED|Overall Study||0
8289561|NCT01621542|20437936|P4|COMPLETED|Overall Study||0
8289562|NCT01621542|20437937|P3|COMPLETED|Overall Study||0
8289563|NCT01621542|20437938|P2|COMPLETED|Overall Study||0
8289564|NCT01621542|20437939|P1|COMPLETED|Overall Study||0
8289565|NCT01621542|20437934|P6|STARTED|Overall Study||9
8289566|NCT01621542|20437935|P5|STARTED|Overall Study||9
8289567|NCT01621542|20437936|P4|STARTED|Overall Study||28
8289568|NCT01621542|20437937|P3|STARTED|Overall Study||6
8289569|NCT01621542|20437938|P2|STARTED|Overall Study||5
8289570|NCT01621542|20437939|P1|STARTED|Overall Study||5
8289571|NCT01621490|20437980|P9|NOT COMPLETED|Overall Study||8
8289572|NCT01621490|20437981|P8|NOT COMPLETED|Overall Study||10
8289573|NCT01621490|20437982|P7|NOT COMPLETED|Overall Study||11
8289574|NCT01621490|20437983|P6|NOT COMPLETED|Overall Study||24
8289575|NCT01621490|20437984|P5|NOT COMPLETED|Overall Study||6
8289576|NCT01621490|20437985|P4|NOT COMPLETED|Overall Study||9
8289577|NCT01621490|20437986|P3|NOT COMPLETED|Overall Study||11
8289578|NCT01621490|20437987|P2|NOT COMPLETED|Overall Study||44
8289579|NCT01621490|20437988|P1|NOT COMPLETED|Overall Study||41
8289580|NCT01621490|20437980|P9|COMPLETED|Overall Study||2
8289581|NCT01621490|20437981|P8|COMPLETED|Overall Study||0
8289582|NCT01621490|20437982|P7|COMPLETED|Overall Study||0
8289583|NCT01621490|20437983|P6|COMPLETED|Overall Study||1
8289584|NCT01621490|20437984|P5|COMPLETED|Overall Study||0
8289585|NCT01621490|20437985|P4|COMPLETED|Overall Study||1
8289586|NCT01621490|20437986|P3|COMPLETED|Overall Study||0
8289587|NCT01621490|20437987|P2|COMPLETED|Overall Study||0
8289588|NCT01621490|20437988|P1|COMPLETED|Overall Study||0
8289589|NCT01621490|20437980|P9|STARTED|Overall Study||10
8289590|NCT01621490|20437981|P8|STARTED|Overall Study||10
8289591|NCT01621490|20437982|P7|STARTED|Overall Study||11
8289592|NCT01621490|20437983|P6|STARTED|Overall Study||25
8289593|NCT01621490|20437984|P5|STARTED|Overall Study||6
8289594|NCT01621490|20437985|P4|STARTED|Overall Study||10
8289595|NCT01621490|20437986|P3|STARTED|Overall Study||11
8289596|NCT01621490|20437987|P2|STARTED|Overall Study||44
8289597|NCT01621490|20437988|P1|STARTED|Overall Study||41
8289598|NCT01621477|20438214|P1|NOT COMPLETED|Overall Study||0
8289599|NCT01621477|20438214|P1|COMPLETED|Overall Study||17
8289600|NCT01621477|20438214|P1|STARTED|Overall Study||17
8289601|NCT01621230|20438226|P2|NOT COMPLETED|Overall Study||0
8289602|NCT01621230|20438227|P1|NOT COMPLETED|Overall Study||0
8289603|NCT01621230|20438226|P2|COMPLETED|Overall Study||156
8289604|NCT01621230|20438227|P1|COMPLETED|Overall Study||154
8289605|NCT01621230|20438226|P2|STARTED|Overall Study||156
8289606|NCT01621230|20438227|P1|STARTED|Overall Study||154
8289607|NCT01621191|20438240|P1|NOT COMPLETED|Overall Study||25
8289608|NCT01621191|20438240|P1|COMPLETED|Overall Study||124
8289609|NCT01621191|20438240|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
8289610|NCT01621191|20438240|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
8289611|NCT01621191|20438240|P1|STARTED|Overall Study||149
8289612|NCT01621178|20438254|P3|NOT COMPLETED|Overall Study||36
8289613|NCT01621178|20438255|P2|NOT COMPLETED|Overall Study||30
8289614|NCT01621178|20438256|P1|NOT COMPLETED|Overall Study||31
8289615|NCT01621178|20438254|P3|COMPLETED|Overall Study||157
8289616|NCT01621178|20438255|P2|COMPLETED|Overall Study||160
8289617|NCT01621178|20438256|P1|COMPLETED|Overall Study||163
8289618|NCT01621178|20438254|P3|Modified Intent to Treat Population|Overall Study||183
8289619|NCT01621178|20438255|P2|Modified Intent to Treat Population|Overall Study||180
8289620|NCT01621178|20438256|P1|Modified Intent to Treat Population|Overall Study||186
8289621|NCT01621178|20438254|P3|Received at Least One Dose of Study Drug|Overall Study||192
8289622|NCT01621178|20438255|P2|Received at Least One Dose of Study Drug|Overall Study||190
8289623|NCT01621178|20438256|P1|Received at Least One Dose of Study Drug|Overall Study||194
8289624|NCT01621178|20438254|P3|STARTED|Overall Study||193
8289625|NCT01621178|20438255|P2|STARTED|Overall Study||190
8289626|NCT01621178|20438256|P1|STARTED|Overall Study||194
8289627|NCT01621126|20438348|P1|NOT COMPLETED|Overall Study||6
8289628|NCT01621126|20438348|P1|COMPLETED|Overall Study||34
8289629|NCT01621126|20438348|P1|STARTED|Overall Study||40
8289630|NCT01621009|20438356|P4|NOT COMPLETED|Overall Study||53
8289631|NCT01621009|20438357|P3|NOT COMPLETED|Overall Study||63
8289632|NCT01621009|20438358|P2|NOT COMPLETED|Overall Study||51
8289633|NCT01621009|20438359|P1|NOT COMPLETED|Overall Study||43
8289634|NCT01621009|20438356|P4|COMPLETED|Overall Study||60
8289635|NCT01621009|20438357|P3|COMPLETED|Overall Study||58
8289636|NCT01621009|20438358|P2|COMPLETED|Overall Study||65
8289637|NCT01621009|20438359|P1|COMPLETED|Overall Study||70
8289638|NCT01621009|20438356|P4|STARTED|Overall Study||113
8289639|NCT01621009|20438357|P3|STARTED|Overall Study||121
8289640|NCT01621009|20438358|P2|STARTED|Overall Study||116
8289641|NCT01621009|20438359|P1|STARTED|Overall Study||113
8289642|NCT01620983|20438370|P3|NOT COMPLETED|Overall Study||15
8289643|NCT01620983|20438371|P2|NOT COMPLETED|Overall Study||22
8289644|NCT01620983|20438372|P1|NOT COMPLETED|Overall Study||19
8289645|NCT01620983|20438370|P3|COMPLETED|Overall Study||122
8289646|NCT01620983|20438371|P2|COMPLETED|Overall Study||113
8289647|NCT01620983|20438372|P1|COMPLETED|Overall Study||111
8289648|NCT01620983|20438370|P3|STARTED|Overall Study||137
8289649|NCT01620983|20438371|P2|STARTED|Overall Study||135
8289650|NCT01620983|20438372|P1|STARTED|Overall Study||130
8289651|NCT01620762|20438401|P3|NOT COMPLETED|Overall Study||53
8289652|NCT01620762|20438402|P2|NOT COMPLETED|Overall Study||58
8289653|NCT01620762|20438403|P1|NOT COMPLETED|Overall Study||48
8289654|NCT01620762|20438401|P3|COMPLETED|Overall Study||417
8289655|NCT01620762|20438402|P2|COMPLETED|Overall Study||412
8289656|NCT01620762|20438403|P1|COMPLETED|Overall Study||420
8289657|NCT01620762|20438401|P3|STARTED|Overall Study||470
8289658|NCT01620762|20438402|P2|STARTED|Overall Study||470
8289659|NCT01620762|20438403|P1|STARTED|Overall Study||468
8289660|NCT01620593|20438431|P2|NOT COMPLETED|Overall Study||1
8289661|NCT01620593|20438432|P1|NOT COMPLETED|Overall Study||4
8289662|NCT01620593|20438431|P2|COMPLETED|Overall Study||19
8289663|NCT01620593|20438432|P1|COMPLETED|Overall Study||17
8289664|NCT01620593|20438431|P2|STARTED|Overall Study||20
8289665|NCT01620593|20438432|P1|STARTED|Overall Study||21
8289666|NCT01620567|20438448|P2|NOT COMPLETED|Overall Study||5
8289667|NCT01620567|20438449|P1|NOT COMPLETED|Overall Study||3
8289668|NCT01620567|20438448|P2|COMPLETED|Overall Study||20
8289669|NCT01620567|20438449|P1|COMPLETED|Overall Study||20
8289670|NCT01620567|20438448|P2|STARTED|Overall Study||25
8289671|NCT01620567|20438449|P1|STARTED|Overall Study||23
8289672|NCT01620528|20438464|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
8289673|NCT01620528|20438465|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
8289674|NCT01620528|20438466|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
8289675|NCT01620528|20438464|P3|COMPLETED|Post-Treatment Follow-Up Period||37
8289676|NCT01620528|20438465|P2|COMPLETED|Post-Treatment Follow-Up Period||31
8289677|NCT01620528|20438466|P1|COMPLETED|Post-Treatment Follow-Up Period||48
8289678|NCT01620528|20438464|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
8289679|NCT01620528|20438465|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
8289680|NCT01620528|20438466|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
8289681|NCT01620528|20438464|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
8289682|NCT01620528|20438465|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
8289683|NCT01620528|20438466|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
8289684|NCT01620528|20438464|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
8289685|NCT01620528|20438465|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
8289686|NCT01620528|20438466|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
8289687|NCT01620528|20438464|P3|NOT COMPLETED|Treatment Period||66
8289688|NCT01620528|20438465|P2|NOT COMPLETED|Treatment Period||53
8289689|NCT01620528|20438466|P1|NOT COMPLETED|Treatment Period||100
8289690|NCT01620528|20438464|P3|COMPLETED|Treatment Period||183
8289691|NCT01620528|20438465|P2|COMPLETED|Treatment Period||196
8289692|NCT01620528|20438466|P1|COMPLETED|Treatment Period||274
8289693|NCT01620528|20438464|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
8289694|NCT01620528|20438465|P2|STARTED|Treatment Period||249
8289695|NCT01620528|20438466|P1|STARTED|Treatment Period||374
8289696|NCT01620489|20438806|P2|NOT COMPLETED|Overall Study||34
8289697|NCT01620489|20438807|P1|NOT COMPLETED|Overall Study||35
8289698|NCT01620489|20438806|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
8289699|NCT01620489|20438807|P1|COMPLETED|Overall Study||105
8289700|NCT01620489|20438806|P2|Exposed|Overall Study|2 subjects did not take trial product|137
8289701|NCT01620489|20438807|P1|Exposed|Overall Study||140
8289702|NCT01620489|20438806|P2|STARTED|Overall Study||139
8289703|NCT01620489|20438807|P1|STARTED|Overall Study||140
8289704|NCT01620255|20438828|P5|NOT COMPLETED|Overall Study||6
8289705|NCT01620255|20438829|P4|NOT COMPLETED|Overall Study||3
8289706|NCT01620255|20438830|P3|NOT COMPLETED|Overall Study||2
8289707|NCT01620255|20438831|P2|NOT COMPLETED|Overall Study||6
8289708|NCT01620255|20438832|P1|NOT COMPLETED|Overall Study||4
8289709|NCT01620255|20438828|P5|COMPLETED|Overall Study||64
8289710|NCT01620255|20438829|P4|COMPLETED|Overall Study||70
8289711|NCT01620255|20438830|P3|COMPLETED|Overall Study||68
8289712|NCT01620255|20438831|P2|COMPLETED|Overall Study||65
8289713|NCT01620255|20438832|P1|COMPLETED|Overall Study||69
8289714|NCT01620255|20438828|P5|Treated|Overall Study||70
8289715|NCT01620255|20438829|P4|Treated|Overall Study||73
8289716|NCT01620255|20438830|P3|Treated|Overall Study||70
8289717|NCT01620255|20438831|P2|Treated|Overall Study||71
8289718|NCT01620255|20438832|P1|Treated|Overall Study||73
8289719|NCT01620255|20438828|P5|STARTED|Overall Study||70
8289720|NCT01620255|20438829|P4|STARTED|Overall Study||73
8289721|NCT01620255|20438830|P3|STARTED|Overall Study||70
8289722|NCT01620255|20438831|P2|STARTED|Overall Study||71
8289723|NCT01620255|20438832|P1|STARTED|Overall Study||73
8289724|NCT01620177|20438909|P1|NOT COMPLETED|Overall Study||79
8289725|NCT01620177|20438909|P1|COMPLETED|Overall Study||19
8289726|NCT01620177|20438909|P1|STARTED|Overall Study||98
8289727|NCT01620138|20438934|P2|NOT COMPLETED|Overall Study||0
8289728|NCT01620138|20438935|P1|NOT COMPLETED|Overall Study||6
8289729|NCT01620138|20438934|P2|COMPLETED|Overall Study||9
8289730|NCT01620138|20438935|P1|COMPLETED|Overall Study||6
8289731|NCT01620138|20438934|P2|STARTED|Overall Study||9
8289732|NCT01620138|20438935|P1|STARTED|Overall Study||12
8289733|NCT01620086|20438943|P3|NOT COMPLETED|Overall Study||0
8289734|NCT01620086|20438944|P2|NOT COMPLETED|Overall Study||7
8289735|NCT01620086|20438945|P1|NOT COMPLETED|Overall Study||5
8289736|NCT01620086|20438943|P3|COMPLETED|Overall Study||2
8289737|NCT01620086|20438944|P2|COMPLETED|Overall Study||4
8289738|NCT01620086|20438945|P1|COMPLETED|Overall Study||8
8289739|NCT01620086|20438943|P3|STARTED|Overall Study||2
8289740|NCT01620086|20438944|P2|STARTED|Overall Study||11
8289741|NCT01620086|20438945|P1|STARTED|Overall Study||13
8289742|NCT01620060|20438964|P1|NOT COMPLETED|Overall Study||15
8289743|NCT01620060|20438964|P1|COMPLETED|Overall Study||90
8289744|NCT01620060|20438964|P1|STARTED|Overall Study||105
8289745|NCT01620047|20438973|P3|NOT COMPLETED|Overall Study||0
8289746|NCT01620047|20438974|P2|NOT COMPLETED|Overall Study||0
8289747|NCT01620047|20438975|P1|NOT COMPLETED|Overall Study||0
8289748|NCT01620047|20438973|P3|COMPLETED|Overall Study||20
8289749|NCT01620047|20438974|P2|COMPLETED|Overall Study||20
8289750|NCT01620047|20438975|P1|COMPLETED|Overall Study||20
8289751|NCT01620047|20438973|P3|STARTED|Overall Study||20
8289752|NCT01620047|20438974|P2|STARTED|Overall Study||20
8289753|NCT01620047|20438975|P1|STARTED|Overall Study||20
8289754|NCT01619982|20438985|P2|NOT COMPLETED|Overall Study||0
8289755|NCT01619982|20438986|P1|NOT COMPLETED|Overall Study||0
8289756|NCT01619982|20438985|P2|COMPLETED|Overall Study||12
8289757|NCT01619982|20438986|P1|COMPLETED|Overall Study||20
8289758|NCT01619982|20438985|P2|STARTED|Overall Study||12
8289759|NCT01619982|20438986|P1|STARTED|Overall Study||20
8289760|NCT01619878|20439002|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
8289761|NCT01619878|20439002|P1|COMPLETED|Follow-up at 12 Months of Age||17
8289762|NCT01619878|20439002|P1|STARTED|Follow-up at 12 Months of Age||20
8289763|NCT01619878|20439002|P1|NOT COMPLETED|6 Week Follow-up Phase||1
8289764|NCT01619878|20439002|P1|COMPLETED|6 Week Follow-up Phase||19
8289765|NCT01619878|20439002|P1|STARTED|6 Week Follow-up Phase||20
8289766|NCT01619852|20439016|P2|NOT COMPLETED|3 Month Follow up||34
8289767|NCT01619852|20439017|P1|NOT COMPLETED|3 Month Follow up||31
8289768|NCT01619852|20439016|P2|COMPLETED|3 Month Follow up||40
8289769|NCT01619852|20439017|P1|COMPLETED|3 Month Follow up||43
8289770|NCT01619852|20439016|P2|STARTED|3 Month Follow up||74
8289771|NCT01619852|20439017|P1|STARTED|3 Month Follow up||74
8289772|NCT01619852|20439016|P2|NOT COMPLETED|24 Hour Assessment||1
8289773|NCT01619852|20439017|P1|NOT COMPLETED|24 Hour Assessment||1
8289774|NCT01619852|20439016|P2|COMPLETED|24 Hour Assessment||74
8289775|NCT01619852|20439017|P1|COMPLETED|24 Hour Assessment||74
8289776|NCT01619852|20439016|P2|STARTED|24 Hour Assessment||75
8289777|NCT01619852|20439017|P1|STARTED|24 Hour Assessment||75
8289778|NCT01619800|20439033|P2|NOT COMPLETED|Overall Study||0
8289779|NCT01619800|20439034|P1|NOT COMPLETED|Overall Study||2
8289780|NCT01619800|20439033|P2|COMPLETED|Overall Study||0
8289781|NCT01619800|20439034|P1|COMPLETED|Overall Study||0
8289782|NCT01619800|20439033|P2|STARTED|Overall Study||0
8289783|NCT01619800|20439034|P1|STARTED|Overall Study||2
8289784|NCT01619787|20439042|P1|NOT COMPLETED|Overall Study||5
8289785|NCT01619787|20439042|P1|COMPLETED|Overall Study||212
8289786|NCT01619787|20439042|P1|STARTED|Overall Study||217
8289787|NCT01619774|20439051|P1|NOT COMPLETED|Overall Study||0
8289788|NCT01619774|20439051|P1|COMPLETED|Overall Study||23
8289789|NCT01619774|20439051|P1|STARTED|Overall Study||23
8289790|NCT01619579|20439059|P2|NOT COMPLETED|Overall Study||3
8289791|NCT01619579|20439060|P1|NOT COMPLETED|Overall Study||0
8289792|NCT01619579|20439059|P2|COMPLETED|Overall Study||14
8289793|NCT01619579|20439060|P1|COMPLETED|Overall Study||5
8289794|NCT01619579|20439059|P2|STARTED|Overall Study||17
8289795|NCT01619579|20439060|P1|STARTED|Overall Study||5
8289796|NCT01619423|20439074|P4|NOT COMPLETED|Part 2b||0
8289797|NCT01619423|20439075|P3|NOT COMPLETED|Part 2b||0
8289798|NCT01619423|20439076|P2|NOT COMPLETED|Part 2b||0
8289799|NCT01619423|20439077|P1|NOT COMPLETED|Part 2b||0
8289800|NCT01619423|20439074|P4|COMPLETED|Part 2b||0
8289801|NCT01619423|20439075|P3|COMPLETED|Part 2b||45
8289802|NCT01619423|20439076|P2|COMPLETED|Part 2b||44
8289803|NCT01619423|20439077|P1|COMPLETED|Part 2b||45
8289804|NCT01619423|20439074|P4|STARTED|Part 2b||0
8289805|NCT01619423|20439075|P3|STARTED|Part 2b||45
8289806|NCT01619423|20439076|P2|STARTED|Part 2b||44
8289807|NCT01619423|20439077|P1|STARTED|Part 2b||45
8289808|NCT01619423|20439074|P4|NOT COMPLETED|Part 2a||0
8289809|NCT01619423|20439075|P3|NOT COMPLETED|Part 2a||0
8289810|NCT01619423|20439076|P2|NOT COMPLETED|Part 2a||0
8289811|NCT01619423|20439077|P1|NOT COMPLETED|Part 2a||0
8289812|NCT01619423|20439074|P4|COMPLETED|Part 2a||11
8289813|NCT01619423|20439075|P3|COMPLETED|Part 2a||0
8289814|NCT01619423|20439076|P2|COMPLETED|Part 2a||13
8289815|NCT01619423|20439077|P1|COMPLETED|Part 2a||15
8289816|NCT01619423|20439074|P4|STARTED|Part 2a||11
8289817|NCT01619423|20439075|P3|STARTED|Part 2a||0
8289818|NCT01619423|20439076|P2|STARTED|Part 2a||13
8289819|NCT01619423|20439077|P1|STARTED|Part 2a||15
8289820|NCT01619423|20439074|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
8289821|NCT01619423|20439075|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
8289822|NCT01619423|20439076|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
8289823|NCT01619423|20439077|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
8289824|NCT01619423|20439074|P4|COMPLETED|Part 1 (Dose Escalation)||5
8289825|NCT01619423|20439075|P3|COMPLETED|Part 1 (Dose Escalation)||3
8289826|NCT01619423|20439076|P2|COMPLETED|Part 1 (Dose Escalation)||3
8289827|NCT01619423|20439077|P1|COMPLETED|Part 1 (Dose Escalation)||0
8289828|NCT01619423|20439074|P4|STARTED|Part 1 (Dose Escalation)||5
8289829|NCT01619423|20439075|P3|STARTED|Part 1 (Dose Escalation)||3
8289830|NCT01619423|20439076|P2|STARTED|Part 1 (Dose Escalation)||5
8289831|NCT01619423|20439077|P1|STARTED|Part 1 (Dose Escalation)||0
8289832|NCT01619410|20439090|P2|NOT COMPLETED|Overall Study||4
8289833|NCT01619410|20439091|P1|NOT COMPLETED|Overall Study||7
8289834|NCT01619410|20439090|P2|COMPLETED|Overall Study||7
8289835|NCT01619410|20439091|P1|COMPLETED|Overall Study||7
8289836|NCT01619410|20439090|P2|STARTED|Overall Study||11
8289837|NCT01619410|20439091|P1|STARTED|Overall Study||14
8289841|NCT01619059|20439109|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
8289842|NCT01619059|20439110|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
8289843|NCT01619059|20439109|P2|COMPLETED|Long-Term (LT) Treatment Period||133
8289844|NCT01619059|20439110|P1|COMPLETED|Long-Term (LT) Treatment Period||147
8289845|NCT01619059|20439109|P2|STARTED|Long-Term (LT) Treatment Period||142
8289846|NCT01619059|20439110|P1|STARTED|Long-Term (LT) Treatment Period||155
8289847|NCT01619059|20439109|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
8289848|NCT01619059|20439110|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
8289849|NCT01619059|20439109|P2|COMPLETED|Short-Term (ST) Treatment Period||142
8289850|NCT01619059|20439110|P1|COMPLETED|Short-Term (ST) Treatment Period||156
8289851|NCT01619059|20439109|P2|STARTED|Short-Term (ST) Treatment Period||153
8289852|NCT01619059|20439110|P1|STARTED|Short-Term (ST) Treatment Period||162
8289853|NCT01618968|20439126|P4|NOT COMPLETED|Overall Study||1
8289854|NCT01618968|20439127|P3|NOT COMPLETED|Overall Study||0
8289855|NCT01618968|20439128|P2|NOT COMPLETED|Overall Study||0
8289856|NCT01618968|20439129|P1|NOT COMPLETED|Overall Study||1
8289857|NCT01618968|20439126|P4|COMPLETED|Overall Study||11
8289858|NCT01618968|20439127|P3|COMPLETED|Overall Study||12
8289859|NCT01618968|20439128|P2|COMPLETED|Overall Study||12
8289860|NCT01618968|20439129|P1|COMPLETED|Overall Study||12
8289861|NCT01618968|20439126|P4|Received Treatment C|Overall Study||11
8289862|NCT01618968|20439127|P3|Received Treatment C|Overall Study||12
8289863|NCT01618968|20439128|P2|Received Treatment C|Overall Study||12
8289864|NCT01618968|20439129|P1|Received Treatment C|Overall Study||12
8289865|NCT01618968|20439126|P4|Received Treatment B|Overall Study||12
8289866|NCT01618968|20439127|P3|Received Treatment B|Overall Study||12
8289867|NCT01618968|20439128|P2|Received Treatment B|Overall Study||12
8289868|NCT01618968|20439129|P1|Received Treatment B|Overall Study||13
8289869|NCT01618968|20439126|P4|Received Treatment A|Overall Study||11
8289870|NCT01618968|20439127|P3|Received Treatment A|Overall Study||12
8289871|NCT01618968|20439128|P2|Received Treatment A|Overall Study||12
8289872|NCT01618968|20439129|P1|Received Treatment A|Overall Study||12
8289873|NCT01618968|20439126|P4|STARTED|Overall Study||12
8289874|NCT01618968|20439127|P3|STARTED|Overall Study||12
8289875|NCT01618968|20439128|P2|STARTED|Overall Study||12
8289876|NCT01618968|20439129|P1|STARTED|Overall Study||13
8289877|NCT01618955|20439148|P4|NOT COMPLETED|Overall Study||0
8289878|NCT01618955|20439149|P3|NOT COMPLETED|Overall Study||0
8289879|NCT01618955|20439150|P2|NOT COMPLETED|Overall Study||0
8289880|NCT01618955|20439151|P1|NOT COMPLETED|Overall Study||0
8289881|NCT01618955|20439148|P4|COMPLETED|Overall Study||20
8289882|NCT01618955|20439149|P3|COMPLETED|Overall Study||31
8289883|NCT01618955|20439150|P2|COMPLETED|Overall Study||30
8289884|NCT01618955|20439151|P1|COMPLETED|Overall Study||20
8289885|NCT01618955|20439148|P4|STARTED|Overall Study||20
8289886|NCT01618955|20439149|P3|STARTED|Overall Study||31
8289887|NCT01618955|20439150|P2|STARTED|Overall Study||30
8289888|NCT01618955|20439151|P1|STARTED|Overall Study||20
8289889|NCT01618942|20439175|P2|NOT COMPLETED|Overall Study||0
8289890|NCT01618942|20439176|P1|NOT COMPLETED|Overall Study||0
8289891|NCT01618942|20439175|P2|COMPLETED|Overall Study||50
8289892|NCT01618942|20439176|P1|COMPLETED|Overall Study||50
8289893|NCT01618942|20439175|P2|STARTED|Overall Study||50
8289894|NCT01618942|20439176|P1|STARTED|Overall Study||50
8289895|NCT01618916|20439202|P6|NOT COMPLETED|Overall Study||0
8289896|NCT01618916|20439203|P5|NOT COMPLETED|Overall Study||1
8289897|NCT01618916|20439204|P4|NOT COMPLETED|Overall Study||2
8289898|NCT01618916|20439205|P3|NOT COMPLETED|Overall Study||1
8289899|NCT01618916|20439206|P2|NOT COMPLETED|Overall Study||1
8289900|NCT01618916|20439207|P1|NOT COMPLETED|Overall Study||2
8289901|NCT01618916|20439202|P6|COMPLETED|Overall Study||4
8289902|NCT01618916|20439203|P5|COMPLETED|Overall Study||4
8289903|NCT01618916|20439204|P4|COMPLETED|Overall Study||7
8289904|NCT01618916|20439205|P3|COMPLETED|Overall Study||10
8289905|NCT01618916|20439206|P2|COMPLETED|Overall Study||9
8289906|NCT01618916|20439207|P1|COMPLETED|Overall Study||10
8289907|NCT01618916|20439202|P6|Received At Least 1 Dose of Study Drug|Overall Study||4
8289908|NCT01618916|20439203|P5|Received At Least 1 Dose of Study Drug|Overall Study||5
8289909|NCT01618916|20439204|P4|Received At Least 1 Dose of Study Drug|Overall Study||9
8289910|NCT01618916|20439205|P3|Received At Least 1 Dose of Study Drug|Overall Study||11
8289911|NCT01618916|20439206|P2|Received At Least 1 Dose of Study Drug|Overall Study||10
8289912|NCT01618916|20439207|P1|Received At Least 1 Dose of Study Drug|Overall Study||12
8289913|NCT01618916|20439202|P6|STARTED|Overall Study||4
8289914|NCT01618916|20439203|P5|STARTED|Overall Study||5
8289915|NCT01618916|20439204|P4|STARTED|Overall Study||9
8289916|NCT01618916|20439205|P3|STARTED|Overall Study||11
8289917|NCT01618916|20439206|P2|STARTED|Overall Study||10
8289918|NCT01618916|20439207|P1|STARTED|Overall Study||12
8289919|NCT01618864|20439237|P1|NOT COMPLETED|Overall Study||4
8289920|NCT01618864|20439237|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
8289921|NCT01618864|20439237|P1|Completed 2 Weeks|Overall Study||19
8289922|NCT01618864|20439237|P1|STARTED|Overall Study||23
8289923|NCT01618838|20439246|P1|NOT COMPLETED|Overall Study||4
8289924|NCT01618838|20439246|P1|COMPLETED|Overall Study||0
8289925|NCT01618838|20439246|P1|STARTED|Overall Study||4
8289926|NCT01618708|20439254|P2|NOT COMPLETED|Overall Study||46
8289927|NCT01618708|20439255|P1|NOT COMPLETED|Overall Study||44
8289928|NCT01618708|20439254|P2|COMPLETED|Overall Study||136
8289929|NCT01618708|20439255|P1|COMPLETED|Overall Study||131
8289930|NCT01618708|20439254|P2|Treated|Overall Study||180
8289931|NCT01618708|20439255|P1|Treated|Overall Study||172
8289932|NCT01618708|20439254|P2|STARTED|Overall Study||182
8289933|NCT01618708|20439255|P1|STARTED|Overall Study||175
8289934|NCT01618695|20439271|P4|NOT COMPLETED|Overall Study||36
8289935|NCT01618695|20439272|P3|NOT COMPLETED|Overall Study||30
8289936|NCT01618695|20439273|P2|NOT COMPLETED|Overall Study||20
8289937|NCT01618695|20439274|P1|NOT COMPLETED|Overall Study||25
8289938|NCT01618695|20439271|P4|COMPLETED|Overall Study||144
8289939|NCT01618695|20439272|P3|COMPLETED|Overall Study||147
8289940|NCT01618695|20439273|P2|COMPLETED|Overall Study||156
8289941|NCT01618695|20439274|P1|COMPLETED|Overall Study||152
8289942|NCT01618695|20439271|P4|Treated (Safety Analysis Set)|Overall Study||180
8289943|NCT01618695|20439272|P3|Treated (Safety Analysis Set)|Overall Study||175
8289944|NCT01618695|20439273|P2|Treated (Safety Analysis Set)|Overall Study||176
8289945|NCT01618695|20439274|P1|Treated (Safety Analysis Set)|Overall Study||176
8289946|NCT01618695|20439271|P4|STARTED|Overall Study||180
8289947|NCT01618695|20439272|P3|STARTED|Overall Study||177
8289948|NCT01618695|20439273|P2|STARTED|Overall Study||176
8289949|NCT01618695|20439274|P1|STARTED|Overall Study||177
8289950|NCT01618669|20439298|P2|NOT COMPLETED|Overall Study||23
8289951|NCT01618669|20439299|P1|NOT COMPLETED|Overall Study||34
8289952|NCT01618669|20439298|P2|COMPLETED|Overall Study||546
8289953|NCT01618669|20439299|P1|COMPLETED|Overall Study||544
8289954|NCT01618669|20439298|P2|Received Treatment|Overall Study||567
8289955|NCT01618669|20439299|P1|Received Treatment|Overall Study||575
8289956|NCT01618669|20439298|P2|STARTED|Overall Study||569
8289957|NCT01618669|20439299|P1|STARTED|Overall Study||578
8289958|NCT01618422|20439345|P2|NOT COMPLETED|Overall Study||0
8289959|NCT01618422|20439346|P1|NOT COMPLETED|Overall Study||0
8289960|NCT01618422|20439345|P2|COMPLETED|Overall Study||111
8289961|NCT01618422|20439346|P1|COMPLETED|Overall Study||114
8289962|NCT01618422|20439345|P2|STARTED|Overall Study||111
8289963|NCT01618422|20439346|P1|STARTED|Overall Study||114
8289964|NCT01618344|20439352|P1|NOT COMPLETED|Overall Study||9
8289965|NCT01618344|20439352|P1|COMPLETED|Overall Study||23
8289966|NCT01618344|20439352|P1|STARTED|Overall Study||32
8289967|NCT01618305|20439358|P2|NOT COMPLETED|Overall Study||10
8289968|NCT01618305|20439359|P1|NOT COMPLETED|Overall Study||15
8289969|NCT01618305|20439358|P2|COMPLETED|Overall Study||196
8289970|NCT01618305|20439359|P1|COMPLETED|Overall Study||187
8289971|NCT01618305|20439358|P2|STARTED|Overall Study||206
8289972|NCT01618305|20439359|P1|STARTED|Overall Study||202
8289973|NCT01618266|20439401|P1|NOT COMPLETED|Overall Study||96
8289974|NCT01618266|20439401|P1|COMPLETED|Overall Study||279
8289975|NCT01618266|20439401|P1|STARTED|Overall Study||375
8289976|NCT01618240|20439416|P1|NOT COMPLETED|Overall Study||0
8289977|NCT01618240|20439416|P1|COMPLETED|Overall Study||30
8289978|NCT01618240|20439416|P1|STARTED|Overall Study||30
8289979|NCT01618227|20439423|P2|NOT COMPLETED|Overall Study||2
8289980|NCT01618227|20439424|P1|NOT COMPLETED|Overall Study||0
8289981|NCT01618227|20439423|P2|COMPLETED|Overall Study||0
8289982|NCT01618227|20439424|P1|COMPLETED|Overall Study||2
8289983|NCT01618227|20439423|P2|STARTED|Overall Study||2
8289984|NCT01618227|20439424|P1|STARTED|Overall Study||2
8289985|NCT01618214|20439438|P2|NOT COMPLETED|Overall Study||13
8289986|NCT01618214|20439439|P1|NOT COMPLETED|Overall Study||10
8289987|NCT01618214|20439438|P2|COMPLETED|Overall Study||159
8289988|NCT01618214|20439439|P1|COMPLETED|Overall Study||162
8289989|NCT01618214|20439438|P2|Exposed|Overall Study||172
8289990|NCT01618214|20439439|P1|Exposed|Overall Study||172
8289991|NCT01618214|20439438|P2|STARTED|Overall Study||172
8289992|NCT01618214|20439439|P1|STARTED|Overall Study||172
8289993|NCT01618162|20439455|P2|NOT COMPLETED|Overall Study||35
8289994|NCT01618162|20439456|P1|NOT COMPLETED|Overall Study||38
8289995|NCT01618162|20439455|P2|COMPLETED|Overall Study||111
8289996|NCT01618162|20439456|P1|COMPLETED|Overall Study||251
8289997|NCT01618162|20439455|P2|Exposed|Overall Study||146
8289998|NCT01618162|20439456|P1|Exposed|Overall Study||288
8289999|NCT01618162|20439455|P2|STARTED|Overall Study||146
8290000|NCT01618162|20439456|P1|STARTED|Overall Study||289
8290001|NCT01618019|20439476|P2|NOT COMPLETED|Overall Study||14
8290002|NCT01618019|20439477|P1|NOT COMPLETED|Overall Study||14
8290003|NCT01618019|20439476|P2|COMPLETED|Overall Study||40
8290004|NCT01618019|20439477|P1|COMPLETED|Overall Study||41
8290005|NCT01618019|20439476|P2|STARTED|Overall Study||54
8290006|NCT01618019|20439477|P1|STARTED|Overall Study||55
8290007|NCT01617967|20439503|P6|NOT COMPLETED|Overall Study||1
8290008|NCT01617967|20439504|P5|NOT COMPLETED|Overall Study||0
8290009|NCT01617967|20439505|P4|NOT COMPLETED|Overall Study||1
8290010|NCT01617967|20439506|P3|NOT COMPLETED|Overall Study||0
8290011|NCT01617967|20439507|P2|NOT COMPLETED|Overall Study||0
8290012|NCT01617967|20439508|P1|NOT COMPLETED|Overall Study||1
8290013|NCT01617967|20439503|P6|COMPLETED|Overall Study||8
8290014|NCT01617967|20439504|P5|COMPLETED|Overall Study||3
8290015|NCT01617967|20439505|P4|COMPLETED|Overall Study||6
8290016|NCT01617967|20439506|P3|COMPLETED|Overall Study||3
8290017|NCT01617967|20439507|P2|COMPLETED|Overall Study||3
8290018|NCT01617967|20439508|P1|COMPLETED|Overall Study||3
8290019|NCT01617967|20439503|P6|STARTED|Overall Study||9
8290020|NCT01617967|20439504|P5|STARTED|Overall Study||3
8290021|NCT01617967|20439505|P4|STARTED|Overall Study||7
8290022|NCT01617967|20439506|P3|STARTED|Overall Study||3
8290023|NCT01617967|20439507|P2|STARTED|Overall Study||3
8290024|NCT01617967|20439508|P1|STARTED|Overall Study||4
8290025|NCT01617681|20439562|P5|NOT COMPLETED|Period 2 Open Label||6
8290026|NCT01617681|20439563|P4|NOT COMPLETED|Period 2 Open Label||0
8290027|NCT01617681|20439564|P3|NOT COMPLETED|Period 2 Open Label||0
8290028|NCT01617681|20439565|P2|NOT COMPLETED|Period 2 Open Label||0
8290029|NCT01617681|20439566|P1|NOT COMPLETED|Period 2 Open Label||0
8290030|NCT01617681|20439562|P5|COMPLETED|Period 2 Open Label||114
8290031|NCT01617681|20439563|P4|COMPLETED|Period 2 Open Label||0
8290032|NCT01617681|20439564|P3|COMPLETED|Period 2 Open Label||0
8290033|NCT01617681|20439565|P2|COMPLETED|Period 2 Open Label||0
8290034|NCT01617681|20439566|P1|COMPLETED|Period 2 Open Label||0
8290035|NCT01617681|20439562|P5|STARTED|Period 2 Open Label||120
8290036|NCT01617681|20439563|P4|STARTED|Period 2 Open Label||0
8290037|NCT01617681|20439564|P3|STARTED|Period 2 Open Label||0
8290038|NCT01617681|20439565|P2|STARTED|Period 2 Open Label||0
8290039|NCT01617681|20439566|P1|STARTED|Period 2 Open Label||0
8290040|NCT01617681|20439562|P5|NOT COMPLETED|Period 1 Double Blind||0
8290041|NCT01617681|20439563|P4|NOT COMPLETED|Period 1 Double Blind||2
8290042|NCT01617681|20439564|P3|NOT COMPLETED|Period 1 Double Blind||1
8290043|NCT01617681|20439565|P2|NOT COMPLETED|Period 1 Double Blind||1
8290044|NCT01617681|20439566|P1|NOT COMPLETED|Period 1 Double Blind||3
8290045|NCT01617681|20439562|P5|COMPLETED|Period 1 Double Blind||0
8290046|NCT01617681|20439563|P4|COMPLETED|Period 1 Double Blind||29
8290047|NCT01617681|20439564|P3|COMPLETED|Period 1 Double Blind||32
8290048|NCT01617681|20439565|P2|COMPLETED|Period 1 Double Blind||30
8290049|NCT01617681|20439566|P1|COMPLETED|Period 1 Double Blind||29
8290050|NCT01617681|20439562|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
8290051|NCT01617681|20439563|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
8290052|NCT01617681|20439564|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
8290053|NCT01617681|20439565|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
8290054|NCT01617681|20439566|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
8290055|NCT01617681|20439562|P5|STARTED|Period 1 Double Blind||0
8290056|NCT01617681|20439563|P4|STARTED|Period 1 Double Blind||31
8290057|NCT01617681|20439564|P3|STARTED|Period 1 Double Blind||33
8290058|NCT01617681|20439565|P2|STARTED|Period 1 Double Blind||31
8290059|NCT01617681|20439566|P1|STARTED|Period 1 Double Blind||32
8290060|NCT01617668|20439587|P4|NOT COMPLETED|Overall Study||15
8290061|NCT01617668|20439588|P3|NOT COMPLETED|Overall Study||23
8290062|NCT01617668|20439589|P2|NOT COMPLETED|Overall Study||9
8290063|NCT01617668|20439590|P1|NOT COMPLETED|Overall Study||13
8290064|NCT01617668|20439587|P4|COMPLETED|Overall Study||38
8290065|NCT01617668|20439588|P3|COMPLETED|Overall Study||32
8290066|NCT01617668|20439589|P2|COMPLETED|Overall Study||41
8290067|NCT01617668|20439590|P1|COMPLETED|Overall Study||38
8290068|NCT01617668|20439587|P4|Randomized Patients|Overall Study||55
8290069|NCT01617668|20439588|P3|Randomized Patients|Overall Study||55
8290070|NCT01617668|20439589|P2|Randomized Patients|Overall Study||54
8290071|NCT01617668|20439590|P1|Randomized Patients|Overall Study||51
8290072|NCT01617668|20439587|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
8290073|NCT01617668|20439588|P3|STARTED|Overall Study||55
8290074|NCT01617668|20439589|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
8290075|NCT01617668|20439590|P1|STARTED|Overall Study||51
8290076|NCT01617655|20439631|P2|NOT COMPLETED|Overall Study||29
8290077|NCT01617655|20439632|P1|NOT COMPLETED|Overall Study||9
8290078|NCT01617655|20439631|P2|COMPLETED|Overall Study||43
8290079|NCT01617655|20439632|P1|COMPLETED|Overall Study||26
8290080|NCT01617655|20439631|P2|Treated|Overall Study||72
8290081|NCT01617655|20439632|P1|Treated|Overall Study||35
8290082|NCT01617655|20439631|P2|STARTED|Overall Study|Randomized|72
8290083|NCT01617655|20439632|P1|STARTED|Overall Study|Randomized|35
8290084|NCT01617629|20439692|P1|NOT COMPLETED|Overall Study||6
8290085|NCT01617629|20439692|P1|COMPLETED|Overall Study||3
8290086|NCT01617629|20439692|P1|STARTED|Overall Study||9
8290087|NCT01617603|20439700|P3|NOT COMPLETED|Overall Study||1
8290088|NCT01617603|20439701|P2|NOT COMPLETED|Overall Study||2
8290089|NCT01617603|20439702|P1|NOT COMPLETED|Overall Study||3
8290090|NCT01617603|20439700|P3|COMPLETED|Overall Study||20
8290091|NCT01617603|20439701|P2|COMPLETED|Overall Study||19
8290092|NCT01617603|20439702|P1|COMPLETED|Overall Study||17
8290093|NCT01617603|20439700|P3|STARTED|Overall Study||21
8290094|NCT01617603|20439701|P2|STARTED|Overall Study||21
8290095|NCT01617603|20439702|P1|STARTED|Overall Study||20
8290096|NCT01617577|20439712|P2|NOT COMPLETED|Overall Study||0
8290097|NCT01617577|20439713|P1|NOT COMPLETED|Overall Study||0
8290098|NCT01617577|20439712|P2|COMPLETED|Overall Study||3
8290099|NCT01617577|20439713|P1|COMPLETED|Overall Study||5
8290100|NCT01617577|20439712|P2|STARTED|Overall Study||3
8290101|NCT01617577|20439713|P1|STARTED|Overall Study||5
8290102|NCT01617460|20439720|P1|NOT COMPLETED|Overall Study||40
8290103|NCT01617460|20439720|P1|COMPLETED|Overall Study||46
8290104|NCT01617460|20439720|P1|STARTED|Overall Study||86
8290105|NCT01617447|20439726|P2|NOT COMPLETED|Overall Study||3
8290106|NCT01617447|20439727|P1|NOT COMPLETED|Overall Study||0
8290107|NCT01617447|20439726|P2|COMPLETED|Overall Study||42
8290108|NCT01617447|20439727|P1|COMPLETED|Overall Study||47
8290109|NCT01617447|20439726|P2|STARTED|Overall Study||45
8290110|NCT01617447|20439727|P1|STARTED|Overall Study||47
8290111|NCT01617434|20439735|P2|NOT COMPLETED|Overall Study||51
8290112|NCT01617434|20439736|P1|NOT COMPLETED|Overall Study||35
8290113|NCT01617434|20439735|P2|COMPLETED|Overall Study||174
8290114|NCT01617434|20439736|P1|COMPLETED|Overall Study||191
8290115|NCT01617434|20439735|P2|Exposed|Overall Study||225
8290116|NCT01617434|20439736|P1|Exposed|Overall Study||225
8290117|NCT01617434|20439735|P2|STARTED|Overall Study||225
8290118|NCT01617434|20439736|P1|STARTED|Overall Study||226
8290119|NCT01617421|20439758|P1|NOT COMPLETED|Overall Study||6
8290120|NCT01617421|20439758|P1|COMPLETED|Overall Study||12
8290121|NCT01617421|20439758|P1|STARTED|Overall Study||18
8290122|NCT01617369|20439765|P1|NOT COMPLETED|Overall Study||0
8290123|NCT01617369|20439765|P1|COMPLETED|Overall Study||12
8290124|NCT01617369|20439765|P1|STARTED|Overall Study||12
8290125|NCT01617187|20439775|P4|NOT COMPLETED|Treatment Through Study Completion||10
8290126|NCT01617187|20439776|P3|NOT COMPLETED|Treatment Through Study Completion||5
8290127|NCT01617187|20439777|P2|NOT COMPLETED|Treatment Through Study Completion||11
8290128|NCT01617187|20439778|P1|NOT COMPLETED|Treatment Through Study Completion||11
8290129|NCT01617187|20439775|P4|COMPLETED|Treatment Through Study Completion||91
8290130|NCT01617187|20439776|P3|COMPLETED|Treatment Through Study Completion||41
8290131|NCT01617187|20439777|P2|COMPLETED|Treatment Through Study Completion||102
8290132|NCT01617187|20439778|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
8290133|NCT01617187|20439775|P4|STARTED|Treatment Through Study Completion|Treated|101
8290134|NCT01617187|20439776|P3|STARTED|Treatment Through Study Completion|Treated|46
8290135|NCT01617187|20439777|P2|STARTED|Treatment Through Study Completion|Treated|113
8290136|NCT01617187|20439778|P1|STARTED|Treatment Through Study Completion|Treated|97
8290137|NCT01617187|20439775|P4|NOT COMPLETED|Randomization Through Start Treatment||2
8290138|NCT01617187|20439776|P3|NOT COMPLETED|Randomization Through Start Treatment||0
8290139|NCT01617187|20439777|P2|NOT COMPLETED|Randomization Through Start Treatment||0
8290140|NCT01617187|20439778|P1|NOT COMPLETED|Randomization Through Start Treatment||1
8290141|NCT01617187|20439775|P4|COMPLETED|Randomization Through Start Treatment||101
8290142|NCT01617187|20439776|P3|COMPLETED|Randomization Through Start Treatment||46
8290143|NCT01617187|20439777|P2|COMPLETED|Randomization Through Start Treatment||113
8290144|NCT01617187|20439778|P1|COMPLETED|Randomization Through Start Treatment||97
8290145|NCT01617187|20439775|P4|STARTED|Randomization Through Start Treatment|Randomized|103
8290146|NCT01617187|20439776|P3|STARTED|Randomization Through Start Treatment|Randomized|46
8290147|NCT01617187|20439777|P2|STARTED|Randomization Through Start Treatment|Randomized|113
8290148|NCT01617187|20439778|P1|STARTED|Randomization Through Start Treatment|Randomized|98
8290149|NCT01617148|20439848|P1|NOT COMPLETED|Overall Study||0
8290150|NCT01617148|20439848|P1|COMPLETED|Overall Study||26
8290151|NCT01617148|20439848|P1|STARTED|Overall Study||26
8290152|NCT01617083|20439862|P3|NOT COMPLETED|Overall Study||0
8290153|NCT01617083|20439863|P2|NOT COMPLETED|Overall Study||0
8290154|NCT01617083|20439864|P1|NOT COMPLETED|Overall Study||0
8290155|NCT01617083|20439862|P3|COMPLETED|Overall Study||15
8290156|NCT01617083|20439863|P2|COMPLETED|Overall Study||14
8290157|NCT01617083|20439864|P1|COMPLETED|Overall Study||18
8290158|NCT01617083|20439862|P3|STARTED|Overall Study||15
8290159|NCT01617083|20439863|P2|STARTED|Overall Study||14
8290160|NCT01617083|20439864|P1|STARTED|Overall Study||18
8290161|NCT01617070|20439875|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
8290162|NCT01617070|20439875|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
8290163|NCT01617070|20439875|P1|STARTED|BH4 and LNAA (4 Weeks)||10
8290164|NCT01617070|20439875|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
8290165|NCT01617070|20439875|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
8290166|NCT01617070|20439875|P1|STARTED|BH4 Therapy (4 Weeks)||10
8290167|NCT01617070|20439875|P1|NOT COMPLETED|Washout (4 Weeks)||0
8290168|NCT01617070|20439875|P1|COMPLETED|Washout (4 Weeks)||10
8290169|NCT01617070|20439875|P1|STARTED|Washout (4 Weeks)||10
8290170|NCT01617070|20439875|P1|NOT COMPLETED|LNAA (4 Weeks)||0
8290171|NCT01617070|20439875|P1|COMPLETED|LNAA (4 Weeks)||10
8290172|NCT01617070|20439875|P1|STARTED|LNAA (4 Weeks)||10
8290173|NCT01617005|20439893|P1|NOT COMPLETED|Overall Study||2
8290174|NCT01617005|20439893|P1|COMPLETED|Overall Study||48
8290175|NCT01617005|20439893|P1|STARTED|Overall Study||50
8290176|NCT01616953|20439902|P2|NOT COMPLETED|Overall Study||0
8290177|NCT01616953|20439903|P1|NOT COMPLETED|Overall Study||2
8290178|NCT01616953|20439902|P2|COMPLETED|Overall Study||8
8290179|NCT01616953|20439903|P1|COMPLETED|Overall Study||8
8290180|NCT01616953|20439902|P2|6 Months Post-loading|Overall Study||8
8290181|NCT01616953|20439903|P1|6 Months Post-loading|Overall Study||8
8290182|NCT01616953|20439902|P2|Implant Uncovery|Overall Study||8
8290183|NCT01616953|20439903|P1|Implant Uncovery|Overall Study||8
8290184|NCT01616953|20439902|P2|Implant Placement Surgery|Overall Study||8
8290185|NCT01616953|20439903|P1|Implant Placement Surgery|Overall Study||9
8290186|NCT01616953|20439902|P2|STARTED|Overall Study||8
8290187|NCT01616953|20439903|P1|STARTED|Overall Study||10
8290188|NCT01616771|20439911|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
8290189|NCT01616771|20439911|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
8290190|NCT01616771|20439911|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
8290191|NCT01616771|20439911|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
8290192|NCT01616771|20439911|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
8290193|NCT01616771|20439911|P1|STARTED|GVL Selected by Weight for 5 Sec||23
8290194|NCT01616771|20439911|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
8290195|NCT01616771|20439911|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
8290196|NCT01616771|20439911|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
8290197|NCT01616693|20439924|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
8290198|NCT01616693|20439925|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
8290199|NCT01616693|20439926|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
8290200|NCT01616693|20439927|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
8290201|NCT01616693|20439924|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
8290202|NCT01616693|20439925|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
8290203|NCT01616693|20439926|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
8290204|NCT01616693|20439927|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
8290205|NCT01616693|20439924|P4|STARTED|Blood Analyzed for Immunogenicity||136
8290206|NCT01616693|20439925|P3|STARTED|Blood Analyzed for Immunogenicity||142
8290207|NCT01616693|20439926|P2|STARTED|Blood Analyzed for Immunogenicity||145
8290208|NCT01616693|20439927|P1|STARTED|Blood Analyzed for Immunogenicity||141
8290209|NCT01616693|20439924|P4|NOT COMPLETED|Received Both Vaccines||19
8290210|NCT01616693|20439925|P3|NOT COMPLETED|Received Both Vaccines||12
8290211|NCT01616693|20439926|P2|NOT COMPLETED|Received Both Vaccines||10
8290212|NCT01616693|20439927|P1|NOT COMPLETED|Received Both Vaccines||13
8290213|NCT01616693|20439924|P4|COMPLETED|Received Both Vaccines||136
8290214|NCT01616693|20439925|P3|COMPLETED|Received Both Vaccines||142
8290215|NCT01616693|20439926|P2|COMPLETED|Received Both Vaccines||145
8290216|NCT01616693|20439927|P1|COMPLETED|Received Both Vaccines||141
8290217|NCT01616693|20439924|P4|STARTED|Received Both Vaccines||155
8290218|NCT01616693|20439925|P3|STARTED|Received Both Vaccines||154
8290219|NCT01616693|20439926|P2|STARTED|Received Both Vaccines||155
8290220|NCT01616693|20439927|P1|STARTED|Received Both Vaccines||154
8290221|NCT01616693|20439924|P4|NOT COMPLETED|Evaluated for Safety||0
8290222|NCT01616693|20439925|P3|NOT COMPLETED|Evaluated for Safety||1
8290223|NCT01616693|20439926|P2|NOT COMPLETED|Evaluated for Safety||0
8290224|NCT01616693|20439927|P1|NOT COMPLETED|Evaluated for Safety||1
8290225|NCT01616693|20439924|P4|COMPLETED|Evaluated for Safety||155
8290226|NCT01616693|20439925|P3|COMPLETED|Evaluated for Safety||154
8290227|NCT01616693|20439926|P2|COMPLETED|Evaluated for Safety||155
8290228|NCT01616693|20439927|P1|COMPLETED|Evaluated for Safety||154
8290229|NCT01616693|20439924|P4|STARTED|Evaluated for Safety||155
8290230|NCT01616693|20439925|P3|STARTED|Evaluated for Safety||155
8290231|NCT01616693|20439926|P2|STARTED|Evaluated for Safety||155
8290232|NCT01616693|20439927|P1|STARTED|Evaluated for Safety||155
8290233|NCT01616576|20439979|P2|NOT COMPLETED|Overall Study||0
8290234|NCT01616576|20439980|P1|NOT COMPLETED|Overall Study||0
8290235|NCT01616576|20439979|P2|COMPLETED|Overall Study||18
8290236|NCT01616576|20439980|P1|COMPLETED|Overall Study||18
8290237|NCT01616576|20439979|P2|STARTED|Overall Study||18
8290238|NCT01616576|20439980|P1|STARTED|Overall Study||18
8290239|NCT01616459|20439993|P4|NOT COMPLETED|Overall Study||8
8290240|NCT01616459|20439994|P3|NOT COMPLETED|Overall Study||10
8290241|NCT01616459|20439995|P2|NOT COMPLETED|Overall Study||17
8290242|NCT01616459|20439996|P1|NOT COMPLETED|Overall Study||4
8290243|NCT01616459|20439993|P4|COMPLETED|Overall Study||233
8290244|NCT01616459|20439994|P3|COMPLETED|Overall Study||220
8290245|NCT01616459|20439995|P2|COMPLETED|Overall Study||223
8290246|NCT01616459|20439996|P1|COMPLETED|Overall Study||236
8290247|NCT01616459|20439993|P4|STARTED|Overall Study||241
8290248|NCT01616459|20439994|P3|STARTED|Overall Study||230
8290249|NCT01616459|20439995|P2|STARTED|Overall Study||240
8290250|NCT01616459|20439996|P1|STARTED|Overall Study||240
8290251|NCT01616173|20440097|P3|NOT COMPLETED|Overall Study||0
8290252|NCT01616173|20440098|P2|NOT COMPLETED|Overall Study||2
8290253|NCT01616173|20440099|P1|NOT COMPLETED|Overall Study||0
8290254|NCT01616173|20440097|P3|COMPLETED|Overall Study||27
8290255|NCT01616173|20440098|P2|COMPLETED|Overall Study||24
8290256|NCT01616173|20440099|P1|COMPLETED|Overall Study||27
8290257|NCT01616173|20440097|P3|STARTED|Overall Study||27
8290258|NCT01616173|20440098|P2|STARTED|Overall Study||26
8290259|NCT01616173|20440099|P1|STARTED|Overall Study||27
8290260|NCT01616160|20440113|P1|NOT COMPLETED|Overall Study||2
8290261|NCT01616160|20440113|P1|COMPLETED|Overall Study||9
8290262|NCT01616160|20440113|P1|STARTED|Overall Study||11
8290263|NCT01616082|20440120|P2|NOT COMPLETED|Overall Study||2
8290264|NCT01616082|20440121|P1|NOT COMPLETED|Overall Study||0
8290265|NCT01616082|20440120|P2|COMPLETED|Overall Study||18
8290266|NCT01616082|20440121|P1|COMPLETED|Overall Study||19
8290267|NCT01616082|20440120|P2|STARTED|Overall Study||20
8290268|NCT01616082|20440121|P1|STARTED|Overall Study||19
8290269|NCT01616056|20440131|P1|NOT COMPLETED|Overall Study||1
8290270|NCT01616056|20440131|P1|COMPLETED|Overall Study||19
8290271|NCT01616056|20440131|P1|STARTED|Overall Study||20
8290272|NCT01615939|20440145|P2|NOT COMPLETED|Overall Study||0
8290273|NCT01615939|20440146|P1|NOT COMPLETED|Overall Study||5
8290274|NCT01615939|20440145|P2|COMPLETED|Overall Study||4
8290275|NCT01615939|20440146|P1|COMPLETED|Overall Study||8
8290276|NCT01615939|20440145|P2|STARTED|Overall Study||4
8290277|NCT01615939|20440146|P1|STARTED|Overall Study||13
8290278|NCT01615822|20440159|P3|NOT COMPLETED|Period 2||2
8290279|NCT01615822|20440160|P2|NOT COMPLETED|Period 2||1
8290280|NCT01615822|20440161|P1|NOT COMPLETED|Period 2||0
8290281|NCT01615822|20440159|P3|COMPLETED|Period 2||4
8290282|NCT01615822|20440160|P2|COMPLETED|Period 2||8
8290283|NCT01615822|20440161|P1|COMPLETED|Period 2||7
8290284|NCT01615822|20440159|P3|STARTED|Period 2||6
8290285|NCT01615822|20440160|P2|STARTED|Period 2||9
8290286|NCT01615822|20440161|P1|STARTED|Period 2||7
8290287|NCT01615822|20440159|P3|NOT COMPLETED|Period 1||0
8290288|NCT01615822|20440160|P2|NOT COMPLETED|Period 1||2
8290289|NCT01615822|20440161|P1|NOT COMPLETED|Period 1||1
8290290|NCT01615822|20440159|P3|COMPLETED|Period 1||6
8290291|NCT01615822|20440160|P2|COMPLETED|Period 1||9
8290292|NCT01615822|20440161|P1|COMPLETED|Period 1||7
8290293|NCT01615822|20440159|P3|STARTED|Period 1||6
8290294|NCT01615822|20440160|P2|STARTED|Period 1||11
8290295|NCT01615822|20440161|P1|STARTED|Period 1||8
8290296|NCT01615809|20440178|P1|NOT COMPLETED|Overall Study||10
8290297|NCT01615809|20440178|P1|COMPLETED|Overall Study||22
8290298|NCT01615809|20440178|P1|STARTED|Overall Study|basal visit|32
8290299|NCT01615731|20440186|P2|NOT COMPLETED|Overall Study||2
8290300|NCT01615731|20440187|P1|NOT COMPLETED|Overall Study||3
8290301|NCT01615731|20440186|P2|COMPLETED|Overall Study||24
8290302|NCT01615731|20440187|P1|COMPLETED|Overall Study||21
8290303|NCT01615731|20440186|P2|STARTED|Overall Study||26
8290304|NCT01615731|20440187|P1|STARTED|Overall Study||24
8290305|NCT01615484|20440209|P2|NOT COMPLETED|Overall Study||0
8290306|NCT01615484|20440210|P1|NOT COMPLETED|Overall Study||0
8290307|NCT01615484|20440209|P2|COMPLETED|Overall Study||24
8290308|NCT01615484|20440210|P1|COMPLETED|Overall Study||0
8290309|NCT01615484|20440209|P2|STARTED|Overall Study||24
8290310|NCT01615484|20440210|P1|STARTED|Overall Study||0
8290311|NCT01615367|20440228|P2|NOT COMPLETED|Overall Study||6
8290312|NCT01615367|20440229|P1|NOT COMPLETED|Overall Study||5
8290313|NCT01615367|20440228|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
8290314|NCT01615367|20440229|P1|COMPLETED|Overall Study||14
8290315|NCT01615367|20440228|P2|STARTED|Overall Study||19
8290316|NCT01615367|20440229|P1|STARTED|Overall Study||19
8290317|NCT01615328|20440249|P2|NOT COMPLETED|Overall Study||5
8290318|NCT01615328|20440250|P1|NOT COMPLETED|Overall Study||3
8290319|NCT01615328|20440249|P2|COMPLETED|Overall Study||38
8290320|NCT01615328|20440250|P1|COMPLETED|Overall Study||39
8290321|NCT01615328|20440249|P2|STARTED|Overall Study||43
8290322|NCT01615328|20440250|P1|STARTED|Overall Study||42
8290323|NCT01615263|20440262|P2|NOT COMPLETED|Overall Study||2
8290324|NCT01615263|20440263|P1|NOT COMPLETED|Overall Study||0
8290325|NCT01615263|20440262|P2|COMPLETED|Overall Study||18
8290326|NCT01615263|20440263|P1|COMPLETED|Overall Study||20
8290327|NCT01615263|20440262|P2|STARTED|Overall Study||20
8290328|NCT01615263|20440263|P1|STARTED|Overall Study||20
8290329|NCT01615198|20440277|P2|NOT COMPLETED|Overall Study||19
8290330|NCT01615198|20440278|P1|NOT COMPLETED|Overall Study||24
8290331|NCT01615198|20440277|P2|COMPLETED|Overall Study||273
8290332|NCT01615198|20440278|P1|COMPLETED|Overall Study||272
8290333|NCT01615198|20440277|P2|ABPM Dipper Status Subset|Overall Study||84
8290334|NCT01615198|20440278|P1|ABPM Dipper Status Subset|Overall Study||82
8290335|NCT01615198|20440277|P2|Safety Set|Overall Study||292
8290336|NCT01615198|20440278|P1|Safety Set|Overall Study||296
8290337|NCT01615198|20440277|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
8290338|NCT01615198|20440278|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
8290339|NCT01615198|20440277|P2|Full Analysis Set|Overall Study||292
8290340|NCT01615198|20440278|P1|Full Analysis Set|Overall Study||296
8290341|NCT01615198|20440277|P2|STARTED|Overall Study||292
8290342|NCT01615198|20440278|P1|STARTED|Overall Study||296
8290343|NCT01615029|20440311|P5|NOT COMPLETED|Overall Study||32
8290344|NCT01615029|20440312|P4|NOT COMPLETED|Overall Study||3
8290345|NCT01615029|20440313|P3|NOT COMPLETED|Overall Study||4
8290346|NCT01615029|20440314|P2|NOT COMPLETED|Overall Study||3
8290347|NCT01615029|20440315|P1|NOT COMPLETED|Overall Study||3
8290348|NCT01615029|20440311|P5|COMPLETED|Overall Study||0
8290349|NCT01615029|20440312|P4|COMPLETED|Overall Study||0
8290350|NCT01615029|20440313|P3|COMPLETED|Overall Study||0
8290351|NCT01615029|20440314|P2|COMPLETED|Overall Study||0
8290352|NCT01615029|20440315|P1|COMPLETED|Overall Study||0
8290353|NCT01615029|20440311|P5|STARTED|Overall Study||32
8290354|NCT01615029|20440312|P4|STARTED|Overall Study||3
8290355|NCT01615029|20440313|P3|STARTED|Overall Study||4
8290356|NCT01615029|20440314|P2|STARTED|Overall Study||3
8290357|NCT01615029|20440315|P1|STARTED|Overall Study||3
8290358|NCT01614912|20440336|P1|NOT COMPLETED|Overall Study||125
8290359|NCT01614912|20440336|P1|COMPLETED|Overall Study||159
8290360|NCT01614912|20440336|P1|STARTED|Overall Study||284
8290361|NCT01614899|20440350|P3|NOT COMPLETED|Overall Study||42
8290362|NCT01614899|20440351|P2|NOT COMPLETED|Overall Study||39
8290363|NCT01614899|20440352|P1|NOT COMPLETED|Overall Study||44
8290364|NCT01614899|20440350|P3|COMPLETED|Overall Study||110
8290365|NCT01614899|20440351|P2|COMPLETED|Overall Study||116
8290366|NCT01614899|20440352|P1|COMPLETED|Overall Study||106
8290367|NCT01614899|20440350|P3|STARTED|Overall Study||152
8290368|NCT01614899|20440351|P2|STARTED|Overall Study||155
8290369|NCT01614899|20440352|P1|STARTED|Overall Study||150
8290370|NCT01614886|20440383|P2|NOT COMPLETED|Overall Study||26
8290371|NCT01614886|20440384|P1|NOT COMPLETED|Overall Study||20
8290372|NCT01614886|20440383|P2|COMPLETED|Overall Study||83
8290373|NCT01614886|20440384|P1|COMPLETED|Overall Study||87
8290374|NCT01614886|20440383|P2|Full Analysis Set (FAS)|Overall Study||105
8290375|NCT01614886|20440384|P1|Full Analysis Set (FAS)|Overall Study||104
8290376|NCT01614886|20440383|P2|Safety Population (SAF)|Overall Study||108
8290377|NCT01614886|20440384|P1|Safety Population (SAF)|Overall Study||107
8290378|NCT01614886|20440383|P2|STARTED|Overall Study||109
8290379|NCT01614886|20440384|P1|STARTED|Overall Study||107
8290380|NCT01614847|20440400|P2|NOT COMPLETED|Day 2 (24 Hours Later)||0
8290381|NCT01614847|20440401|P1|NOT COMPLETED|Day 2 (24 Hours Later)||0
8290382|NCT01614847|20440400|P2|COMPLETED|Day 2 (24 Hours Later)||4
8290383|NCT01614847|20440401|P1|COMPLETED|Day 2 (24 Hours Later)||4
8290384|NCT01614847|20440400|P2|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
8290385|NCT01614847|20440401|P1|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
8290386|NCT01614847|20440400|P2|NOT COMPLETED|Day 1||0
8290387|NCT01614847|20440401|P1|NOT COMPLETED|Day 1||0
8290388|NCT01614847|20440400|P2|COMPLETED|Day 1|See Arm 1 comments.|4
8290389|NCT01614847|20440401|P1|COMPLETED|Day 1||4
8290390|NCT01614847|20440400|P2|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
8290391|NCT01614847|20440401|P1|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
8290392|NCT01614821|20440412|P1|NOT COMPLETED|Overall Study||0
8290393|NCT01614821|20440412|P1|COMPLETED|Overall Study||63
8290394|NCT01614821|20440412|P1|STARTED|Overall Study||63
8290395|NCT01614795|20440425|P4|NOT COMPLETED|Overall Study||12
8290396|NCT01614795|20440426|P3|NOT COMPLETED|Overall Study||11
8290397|NCT01614795|20440427|P2|NOT COMPLETED|Overall Study||12
8290398|NCT01614795|20440428|P1|NOT COMPLETED|Overall Study||11
8290399|NCT01614795|20440425|P4|COMPLETED|Overall Study||0
8290400|NCT01614795|20440426|P3|COMPLETED|Overall Study||0
8290401|NCT01614795|20440427|P2|COMPLETED|Overall Study||0
8290402|NCT01614795|20440428|P1|COMPLETED|Overall Study||0
8290403|NCT01614795|20440425|P4|STARTED|Overall Study||12
8290404|NCT01614795|20440426|P3|STARTED|Overall Study||11
8290405|NCT01614795|20440427|P2|STARTED|Overall Study||12
8290406|NCT01614795|20440428|P1|STARTED|Overall Study||11
8290407|NCT01614769|20440448|P6|NOT COMPLETED|Period 3||0
8290408|NCT01614769|20440449|P5|NOT COMPLETED|Period 3||0
8290409|NCT01614769|20440450|P4|NOT COMPLETED|Period 3||0
8290410|NCT01614769|20440451|P3|NOT COMPLETED|Period 3||1
8290411|NCT01614769|20440452|P2|NOT COMPLETED|Period 3||0
8290412|NCT01614769|20440453|P1|NOT COMPLETED|Period 3||0
8290413|NCT01614769|20440448|P6|COMPLETED|Period 3||1
8290414|NCT01614769|20440449|P5|COMPLETED|Period 3||1
8290415|NCT01614769|20440450|P4|COMPLETED|Period 3||0
8290416|NCT01614769|20440451|P3|COMPLETED|Period 3||1
8290417|NCT01614769|20440452|P2|COMPLETED|Period 3||1
8290418|NCT01614769|20440453|P1|COMPLETED|Period 3||1
8290419|NCT01614769|20440448|P6|STARTED|Period 3||1
8290420|NCT01614769|20440449|P5|STARTED|Period 3||1
8290421|NCT01614769|20440450|P4|STARTED|Period 3||0
8290422|NCT01614769|20440451|P3|STARTED|Period 3||2
8290423|NCT01614769|20440452|P2|STARTED|Period 3||1
8290424|NCT01614769|20440453|P1|STARTED|Period 3||1
8290425|NCT01614769|20440448|P6|NOT COMPLETED|7-Day Washout||0
8290426|NCT01614769|20440449|P5|NOT COMPLETED|7-Day Washout||0
8290427|NCT01614769|20440450|P4|NOT COMPLETED|7-Day Washout||0
8290428|NCT01614769|20440451|P3|NOT COMPLETED|7-Day Washout||0
8290429|NCT01614769|20440452|P2|NOT COMPLETED|7-Day Washout||0
8290430|NCT01614769|20440453|P1|NOT COMPLETED|7-Day Washout||0
8290431|NCT01614769|20440448|P6|COMPLETED|7-Day Washout||1
8290432|NCT01614769|20440449|P5|COMPLETED|7-Day Washout||1
8290433|NCT01614769|20440450|P4|COMPLETED|7-Day Washout||0
8290434|NCT01614769|20440451|P3|COMPLETED|7-Day Washout||2
8290435|NCT01614769|20440452|P2|COMPLETED|7-Day Washout||1
8290436|NCT01614769|20440453|P1|COMPLETED|7-Day Washout||1
8290437|NCT01614769|20440448|P6|STARTED|7-Day Washout||1
8290438|NCT01614769|20440449|P5|STARTED|7-Day Washout||1
8290439|NCT01614769|20440450|P4|STARTED|7-Day Washout||0
8290440|NCT01614769|20440451|P3|STARTED|7-Day Washout||2
8290441|NCT01614769|20440452|P2|STARTED|7-Day Washout||1
8290442|NCT01614769|20440453|P1|STARTED|7-Day Washout||1
8290443|NCT01614769|20440448|P6|NOT COMPLETED|Period 2||0
8290444|NCT01614769|20440449|P5|NOT COMPLETED|Period 2||0
8290445|NCT01614769|20440450|P4|NOT COMPLETED|Period 2||0
8290446|NCT01614769|20440451|P3|NOT COMPLETED|Period 2||0
8290447|NCT01614769|20440452|P2|NOT COMPLETED|Period 2||0
8290448|NCT01614769|20440453|P1|NOT COMPLETED|Period 2||0
8290449|NCT01614769|20440448|P6|COMPLETED|Period 2||1
8290450|NCT01614769|20440449|P5|COMPLETED|Period 2||1
8290451|NCT01614769|20440450|P4|COMPLETED|Period 2||0
8290452|NCT01614769|20440451|P3|COMPLETED|Period 2||2
8290453|NCT01614769|20440452|P2|COMPLETED|Period 2||1
8290454|NCT01614769|20440453|P1|COMPLETED|Period 2||1
8290455|NCT01614769|20440448|P6|STARTED|Period 2||1
8290456|NCT01614769|20440449|P5|STARTED|Period 2||1
8290457|NCT01614769|20440450|P4|STARTED|Period 2||0
8290458|NCT01614769|20440451|P3|STARTED|Period 2||2
8290459|NCT01614769|20440452|P2|STARTED|Period 2||1
8290460|NCT01614769|20440453|P1|STARTED|Period 2||1
8290461|NCT01614769|20440448|P6|NOT COMPLETED|7-Day Washout||0
8290462|NCT01614769|20440449|P5|NOT COMPLETED|7-Day Washout||0
8290463|NCT01614769|20440450|P4|NOT COMPLETED|7-Day Washout||0
8290464|NCT01614769|20440451|P3|NOT COMPLETED|7-Day Washout||0
8290465|NCT01614769|20440452|P2|NOT COMPLETED|7-Day Washout||0
8290466|NCT01614769|20440453|P1|NOT COMPLETED|7-Day Washout||0
8290467|NCT01614769|20440448|P6|COMPLETED|7-Day Washout||1
8290468|NCT01614769|20440449|P5|COMPLETED|7-Day Washout||1
8290469|NCT01614769|20440450|P4|COMPLETED|7-Day Washout||0
8290470|NCT01614769|20440451|P3|COMPLETED|7-Day Washout||2
8290471|NCT01614769|20440452|P2|COMPLETED|7-Day Washout||1
8290472|NCT01614769|20440453|P1|COMPLETED|7-Day Washout||1
8290473|NCT01614769|20440448|P6|STARTED|7-Day Washout||1
8290474|NCT01614769|20440449|P5|STARTED|7-Day Washout||1
8290475|NCT01614769|20440450|P4|STARTED|7-Day Washout||0
8290476|NCT01614769|20440451|P3|STARTED|7-Day Washout||2
8290477|NCT01614769|20440452|P2|STARTED|7-Day Washout||1
8290478|NCT01614769|20440453|P1|STARTED|7-Day Washout||1
8290479|NCT01614769|20440448|P6|NOT COMPLETED|Period 1||1
8290480|NCT01614769|20440449|P5|NOT COMPLETED|Period 1||0
8290481|NCT01614769|20440450|P4|NOT COMPLETED|Period 1||2
8290482|NCT01614769|20440451|P3|NOT COMPLETED|Period 1||0
8290483|NCT01614769|20440452|P2|NOT COMPLETED|Period 1||0
8290484|NCT01614769|20440453|P1|NOT COMPLETED|Period 1||1
8290485|NCT01614769|20440448|P6|COMPLETED|Period 1||1
8290486|NCT01614769|20440449|P5|COMPLETED|Period 1||1
8290487|NCT01614769|20440450|P4|COMPLETED|Period 1||0
8290488|NCT01614769|20440451|P3|COMPLETED|Period 1||2
8290489|NCT01614769|20440452|P2|COMPLETED|Period 1||1
8290490|NCT01614769|20440453|P1|COMPLETED|Period 1||1
8290491|NCT01614769|20440448|P6|STARTED|Period 1||2
8290492|NCT01614769|20440449|P5|STARTED|Period 1||1
8290493|NCT01614769|20440450|P4|STARTED|Period 1||2
8290494|NCT01614769|20440451|P3|STARTED|Period 1||2
8290495|NCT01614769|20440452|P2|STARTED|Period 1||1
8290496|NCT01614769|20440453|P1|STARTED|Period 1||2
8290497|NCT01614743|20440469|P2|NOT COMPLETED|Overall Study||0
8290498|NCT01614743|20440470|P1|NOT COMPLETED|Overall Study||1
8290499|NCT01614743|20440469|P2|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
8290500|NCT01614743|20440470|P1|COMPLETED|Overall Study||3
8290501|NCT01614743|20440469|P2|STARTED|Overall Study||5
8290502|NCT01614743|20440470|P1|STARTED|Overall Study||4
8290503|NCT01614613|20440482|P1|NOT COMPLETED|Overall Study||0
8290504|NCT01614613|20440482|P1|COMPLETED|Overall Study||146
8290505|NCT01614613|20440482|P1|STARTED|Overall Study||146
8290506|NCT01614600|20440490|P1|NOT COMPLETED|Overall Study||4
8290507|NCT01614600|20440490|P1|COMPLETED|Overall Study||84
8290508|NCT01614600|20440490|P1|STARTED|Overall Study||88
8290509|NCT01614574|20440494|P1|NOT COMPLETED|Overall Study||0
8290510|NCT01614574|20440494|P1|COMPLETED|Overall Study||6
8290511|NCT01614574|20440494|P1|STARTED|Overall Study||6
8290512|NCT01614509|20440510|P2|NOT COMPLETED|Overall Study||3
8290513|NCT01614509|20440511|P1|NOT COMPLETED|Overall Study||1
8290514|NCT01614509|20440510|P2|COMPLETED|Overall Study||18
8290515|NCT01614509|20440511|P1|COMPLETED|Overall Study||23
8290516|NCT01614509|20440510|P2|STARTED|Overall Study||21
8290517|NCT01614509|20440511|P1|STARTED|Overall Study||24
8290518|NCT01614470|20440521|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290519|NCT01614470|20440522|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290520|NCT01614470|20440523|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290521|NCT01614470|20440521|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
8290522|NCT01614470|20440522|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290523|NCT01614470|20440523|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290524|NCT01614470|20440521|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
8290525|NCT01614470|20440522|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
8290526|NCT01614470|20440523|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
8290527|NCT01614470|20440521|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290528|NCT01614470|20440522|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290529|NCT01614470|20440523|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290530|NCT01614470|20440521|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290531|NCT01614470|20440522|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
8290532|NCT01614470|20440523|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
8290533|NCT01614470|20440521|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
8290534|NCT01614470|20440522|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
8290535|NCT01614470|20440523|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
8290536|NCT01614470|20440521|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290537|NCT01614470|20440522|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290538|NCT01614470|20440523|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290539|NCT01614470|20440521|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290540|NCT01614470|20440522|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
8290541|NCT01614470|20440523|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
8290542|NCT01614470|20440521|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
8290543|NCT01614470|20440522|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
8290544|NCT01614470|20440523|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
8290545|NCT01614470|20440521|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
8290546|NCT01614470|20440522|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
8290547|NCT01614470|20440523|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
8290548|NCT01614470|20440521|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
8290549|NCT01614470|20440522|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
8290550|NCT01614470|20440523|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
8290551|NCT01614470|20440521|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
8290552|NCT01614470|20440522|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
8290553|NCT01614470|20440523|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
8290554|NCT01614457|20440545|P2|NOT COMPLETED|Overall Study||0
8290555|NCT01614457|20440546|P1|NOT COMPLETED|Overall Study||2
8290556|NCT01614457|20440545|P2|COMPLETED|Overall Study||35
8290557|NCT01614457|20440546|P1|COMPLETED|Overall Study||32
8290558|NCT01614457|20440545|P2|STARTED|Overall Study||35
8290559|NCT01614457|20440546|P1|STARTED|Overall Study||34
8290560|NCT01614392|20440564|P2|NOT COMPLETED|Overall Study||3
8290561|NCT01614392|20440565|P1|NOT COMPLETED|Overall Study||1
8290562|NCT01614392|20440564|P2|COMPLETED|Overall Study||24
8290563|NCT01614392|20440565|P1|COMPLETED|Overall Study||24
8290564|NCT01614392|20440564|P2|STARTED|Overall Study||27
8290565|NCT01614392|20440565|P1|STARTED|Overall Study||25
8290566|NCT01614249|20440573|P2|NOT COMPLETED|Overall Study||23
8290567|NCT01614249|20440574|P1|NOT COMPLETED|Overall Study||11
8290568|NCT01614249|20440573|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
8290569|NCT01614249|20440574|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
8290570|NCT01614249|20440573|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
8290571|NCT01614249|20440574|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
8290572|NCT01614249|20440573|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
8290573|NCT01614249|20440574|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
8290574|NCT01614249|20440573|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
8290575|NCT01614249|20440574|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
8290576|NCT01614210|20440580|P1|NOT COMPLETED|Overall Study||0
8290577|NCT01614210|20440580|P1|COMPLETED|Overall Study||52
8290578|NCT01614210|20440580|P1|STARTED|Overall Study||52
8290579|NCT01614093|20440588|P1|NOT COMPLETED|Overall Study||1
8290580|NCT01614093|20440588|P1|COMPLETED|Overall Study||16
8290581|NCT01614093|20440588|P1|STARTED|Overall Study||17
8290582|NCT01613768|20440593|P1|NOT COMPLETED|Overall Study||0
8290583|NCT01613768|20440593|P1|COMPLETED|Overall Study||29
8290584|NCT01613768|20440593|P1|STARTED|Overall Study||29
8290585|NCT01613716|20440601|P1|NOT COMPLETED|Overall Study||7
8290586|NCT01613716|20440601|P1|COMPLETED|Overall Study||23
8290587|NCT01613716|20440601|P1|STARTED|Overall Study||30
8290588|NCT01613599|20440606|P1|NOT COMPLETED|Overall Study||25
8290589|NCT01613599|20440606|P1|COMPLETED|Overall Study||72
8290590|NCT01613599|20440606|P1|STARTED|Overall Study||97
8290591|NCT01613417|20440621|P2|NOT COMPLETED|Second Injection||0
8290592|NCT01613417|20440622|P1|NOT COMPLETED|Second Injection||0
8290593|NCT01613417|20440621|P2|COMPLETED|Second Injection||109
8290594|NCT01613417|20440622|P1|COMPLETED|Second Injection||100
8290595|NCT01613417|20440621|P2|STARTED|Second Injection||109
8290596|NCT01613417|20440622|P1|STARTED|Second Injection||100
8290597|NCT01613417|20440621|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
8290598|NCT01613417|20440622|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
8290599|NCT01613417|20440621|P2|COMPLETED|Washout (no Second Injection/MRI)||109
8290600|NCT01613417|20440622|P1|COMPLETED|Washout (no Second Injection/MRI)||100
8290601|NCT01613417|20440621|P2|STARTED|Washout (no Second Injection/MRI)||116
8290602|NCT01613417|20440622|P1|STARTED|Washout (no Second Injection/MRI)||113
8290603|NCT01613417|20440621|P2|NOT COMPLETED|First Injection||0
8290604|NCT01613417|20440622|P1|NOT COMPLETED|First Injection||0
8290605|NCT01613417|20440621|P2|COMPLETED|First Injection||116
8290606|NCT01613417|20440622|P1|COMPLETED|First Injection||113
8290607|NCT01613417|20440621|P2|STARTED|First Injection||116
8290608|NCT01613417|20440622|P1|STARTED|First Injection||113
8290609|NCT01613378|20440659|P1|NOT COMPLETED|Overall Study||39
8290610|NCT01613378|20440659|P1|COMPLETED|Overall Study||161
8290611|NCT01613378|20440659|P1|STARTED|Overall Study||200
8290612|NCT01613339|20440677|P2|NOT COMPLETED|Overall Study||1
8290613|NCT01613339|20440678|P1|NOT COMPLETED|Overall Study||3
8290614|NCT01613339|20440677|P2|COMPLETED|Overall Study||21
8290615|NCT01613339|20440678|P1|COMPLETED|Overall Study||21
8290616|NCT01613339|20440677|P2|STARTED|Overall Study||22
8290617|NCT01613339|20440678|P1|STARTED|Overall Study||24
8290618|NCT01613326|20440689|P2|NOT COMPLETED|Overall Study||14
8290619|NCT01613326|20440690|P1|NOT COMPLETED|Overall Study||13
8290620|NCT01613326|20440689|P2|COMPLETED|Overall Study||316
8290621|NCT01613326|20440690|P1|COMPLETED|Overall Study||314
8290622|NCT01613326|20440689|P2|STARTED|Overall Study||330
8290623|NCT01613326|20440690|P1|STARTED|Overall Study||327
8290624|NCT01613313|20440724|P4|NOT COMPLETED|Overall Study||0
8290625|NCT01613313|20440725|P3|NOT COMPLETED|Overall Study||0
8290626|NCT01613313|20440726|P2|NOT COMPLETED|Overall Study||0
8290627|NCT01613313|20440727|P1|NOT COMPLETED|Overall Study||0
8290628|NCT01613313|20440724|P4|COMPLETED|Overall Study||4
8290629|NCT01613313|20440725|P3|COMPLETED|Overall Study||4
8290630|NCT01613313|20440726|P2|COMPLETED|Overall Study||4
8290631|NCT01613313|20440727|P1|COMPLETED|Overall Study||2
8290632|NCT01613313|20440724|P4|STARTED|Overall Study||4
8290633|NCT01613313|20440725|P3|STARTED|Overall Study||4
8290634|NCT01613313|20440726|P2|STARTED|Overall Study||4
8290635|NCT01613313|20440727|P1|STARTED|Overall Study||2
8290636|NCT01613248|20440747|P6|NOT COMPLETED|Overall Study||38
8290637|NCT01613248|20440748|P5|NOT COMPLETED|Overall Study||35
8290638|NCT01613248|20440749|P4|NOT COMPLETED|Overall Study||38
8290639|NCT01613248|20440750|P3|NOT COMPLETED|Overall Study||33
8290640|NCT01613248|20440751|P2|NOT COMPLETED|Overall Study||34
8290641|NCT01613248|20440752|P1|NOT COMPLETED|Overall Study||29
8290642|NCT01613248|20440747|P6|COMPLETED|Overall Study||102
8290643|NCT01613248|20440748|P5|COMPLETED|Overall Study||104
8290644|NCT01613248|20440749|P4|COMPLETED|Overall Study||101
8290645|NCT01613248|20440750|P3|COMPLETED|Overall Study||106
8290646|NCT01613248|20440751|P2|COMPLETED|Overall Study||104
8290647|NCT01613248|20440752|P1|COMPLETED|Overall Study||110
8290648|NCT01613248|20440747|P6|STARTED|Overall Study||140
8290649|NCT01613248|20440748|P5|STARTED|Overall Study||139
8290650|NCT01613248|20440749|P4|STARTED|Overall Study||139
8290651|NCT01613248|20440750|P3|STARTED|Overall Study||139
8290652|NCT01613248|20440751|P2|STARTED|Overall Study||138
8290653|NCT01613248|20440752|P1|STARTED|Overall Study||139
8290654|NCT01613222|20440850|P1|NOT COMPLETED|Overall Study||12
8290655|NCT01613222|20440850|P1|COMPLETED|Overall Study||51
8290656|NCT01613222|20440850|P1|STARTED|Overall Study||63
8290657|NCT01613131|20440865|P2|NOT COMPLETED|Overall Study||5
8290658|NCT01613131|20440866|P1|NOT COMPLETED|Overall Study||3
8290659|NCT01613131|20440865|P2|COMPLETED|Overall Study||13
8290660|NCT01613131|20440866|P1|COMPLETED|Overall Study||17
8290661|NCT01613131|20440865|P2|STARTED|Overall Study||18
8290662|NCT01613131|20440866|P1|STARTED|Overall Study||20
8290663|NCT01613027|20440894|P1|NOT COMPLETED|Overall Study||8
8290664|NCT01613027|20440894|P1|COMPLETED|Overall Study||127
8290665|NCT01613027|20440894|P1|STARTED|Overall Study||135
8290666|NCT01613014|20440915|P2|NOT COMPLETED|Overall Study||12
8290667|NCT01613014|20440916|P1|NOT COMPLETED|Overall Study||18
8290668|NCT01613014|20440915|P2|COMPLETED|Overall Study||63
8290669|NCT01613014|20440916|P1|COMPLETED|Overall Study||57
8290670|NCT01613014|20440915|P2|STARTED|Overall Study||75
8290671|NCT01613014|20440916|P1|STARTED|Overall Study||75
8290672|NCT01612884|20440924|P2|NOT COMPLETED|Overall Study||0
8290673|NCT01612884|20440925|P1|NOT COMPLETED|Overall Study||0
8290674|NCT01612884|20440924|P2|COMPLETED|Overall Study||18
8290675|NCT01612884|20440925|P1|COMPLETED|Overall Study||19
8290676|NCT01612884|20440924|P2|STARTED|Overall Study||18
8290677|NCT01612884|20440925|P1|STARTED|Overall Study||19
8290678|NCT01612858|20440937|P2|NOT COMPLETED|Overall Study||1
8290679|NCT01612858|20440938|P1|NOT COMPLETED|Overall Study||5
8290680|NCT01612858|20440937|P2|COMPLETED|Overall Study||3
8290681|NCT01612858|20440938|P1|COMPLETED|Overall Study||11
8290682|NCT01612858|20440937|P2|STARTED|Overall Study||4
8290683|NCT01612858|20440938|P1|STARTED|Overall Study||16
8290684|NCT01612793|20440948|P2|NOT COMPLETED|Overall Study||0
8290685|NCT01612793|20440949|P1|NOT COMPLETED|Overall Study||0
8290686|NCT01612793|20440948|P2|COMPLETED|Overall Study||2
8290687|NCT01612793|20440949|P1|COMPLETED|Overall Study||2
8290688|NCT01612793|20440948|P2|STARTED|Overall Study||2
8290689|NCT01612793|20440949|P1|STARTED|Overall Study||2
8290690|NCT01612780|20440955|P1|NOT COMPLETED|Overall Study||6
8290691|NCT01612780|20440955|P1|COMPLETED|Overall Study||76
8290692|NCT01612780|20440955|P1|STARTED|Overall Study||82
8290693|NCT01612767|20440961|P1|NOT COMPLETED|Overall Study||42
8290694|NCT01612767|20440961|P1|COMPLETED|Overall Study||287
8290695|NCT01612767|20440961|P1|STARTED|Overall Study||329
8290696|NCT01612702|20441017|P2|NOT COMPLETED|Overall Study||11
8290697|NCT01612702|20441018|P1|NOT COMPLETED|Overall Study||11
8290698|NCT01612702|20441017|P2|COMPLETED|Overall Study||134
8290699|NCT01612702|20441018|P1|COMPLETED|Overall Study||135
8290700|NCT01612702|20441017|P2|STARTED|Overall Study||145
8290701|NCT01612702|20441018|P1|STARTED|Overall Study||146
8290702|NCT01612676|20441032|P4|NOT COMPLETED|Overall Study||3
8290703|NCT01612676|20441033|P3|NOT COMPLETED|Overall Study||1
8290704|NCT01612676|20441034|P2|NOT COMPLETED|Overall Study||4
8290705|NCT01612676|20441035|P1|NOT COMPLETED|Overall Study||2
8290706|NCT01612676|20441032|P4|COMPLETED|Overall Study||10
8290707|NCT01612676|20441033|P3|COMPLETED|Overall Study||4
8290708|NCT01612676|20441034|P2|COMPLETED|Overall Study||3
8290709|NCT01612676|20441035|P1|COMPLETED|Overall Study||4
8290710|NCT01612676|20441032|P4|Dosed|Overall Study||13
8290711|NCT01612676|20441033|P3|Dosed|Overall Study||5
8290712|NCT01612676|20441034|P2|Dosed|Overall Study||7
8290713|NCT01612676|20441035|P1|Dosed|Overall Study||5
8290714|NCT01612676|20441032|P4|STARTED|Overall Study||13
8290715|NCT01612676|20441033|P3|STARTED|Overall Study||5
8290716|NCT01612676|20441034|P2|STARTED|Overall Study||7
8290717|NCT01612676|20441035|P1|STARTED|Overall Study||6
8290718|NCT01612546|20441091|P1|NOT COMPLETED|Overall Study||0
8290719|NCT01612546|20441091|P1|COMPLETED|Overall Study||10
8290720|NCT01612546|20441091|P1|STARTED|Overall Study||10
8290721|NCT01612494|20441101|P2|NOT COMPLETED|Overall Study||0
8290722|NCT01612494|20441102|P1|NOT COMPLETED|Overall Study||0
8290723|NCT01612494|20441101|P2|COMPLETED|Overall Study||23
8290724|NCT01612494|20441102|P1|COMPLETED|Overall Study||21
8290725|NCT01612494|20441101|P2|STARTED|Overall Study||23
8290726|NCT01612494|20441102|P1|STARTED|Overall Study||21
8290727|NCT01612351|20441108|P1|NOT COMPLETED|Post-Operative Treatment||0
8290728|NCT01612351|20441108|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
8290729|NCT01612351|20441108|P1|STARTED|Post-Operative Treatment||39
8290730|NCT01612351|20441108|P1|NOT COMPLETED|Transoral Surgery||0
8290731|NCT01612351|20441108|P1|COMPLETED|Transoral Surgery||39
8290732|NCT01612351|20441108|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
8290733|NCT01612351|20441108|P1|NOT COMPLETED|Chemotherapy||0
8290734|NCT01612351|20441108|P1|COMPLETED|Chemotherapy||40
8290735|NCT01612351|20441108|P1|STARTED|Chemotherapy||40
8290736|NCT01612221|20441122|P2|NOT COMPLETED|Overall Study||0
8290737|NCT01612221|20441123|P1|NOT COMPLETED|Overall Study||0
8290738|NCT01612221|20441122|P2|COMPLETED|Overall Study||50
8290739|NCT01612221|20441123|P1|COMPLETED|Overall Study||50
8290740|NCT01612221|20441122|P2|STARTED|Overall Study||50
8290741|NCT01612221|20441123|P1|STARTED|Overall Study||50
8290742|NCT01612156|20441133|P2|NOT COMPLETED|Overall Study||0
8290743|NCT01612156|20441134|P1|NOT COMPLETED|Overall Study||2
8290744|NCT01612156|20441133|P2|COMPLETED|Overall Study||48
8290745|NCT01612156|20441134|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
8290746|NCT01612156|20441133|P2|STARTED|Overall Study||48
8290747|NCT01612156|20441134|P1|STARTED|Overall Study||42
8290748|NCT01612000|20441146|P4|NOT COMPLETED|Overall Study||10
8290749|NCT01612000|20441147|P3|NOT COMPLETED|Overall Study||7
8290750|NCT01612000|20441148|P2|NOT COMPLETED|Overall Study||5
8290751|NCT01612000|20441149|P1|NOT COMPLETED|Overall Study||9
8290752|NCT01612000|20441146|P4|COMPLETED|Overall Study||76
8290753|NCT01612000|20441147|P3|COMPLETED|Overall Study||78
8290754|NCT01612000|20441148|P2|COMPLETED|Overall Study||81
8290755|NCT01612000|20441149|P1|COMPLETED|Overall Study||75
8290756|NCT01612000|20441146|P4|STARTED|Overall Study||86
8290757|NCT01612000|20441147|P3|STARTED|Overall Study||85
8290758|NCT01612000|20441148|P2|STARTED|Overall Study||86
8290759|NCT01612000|20441149|P1|STARTED|Overall Study||84
8290760|NCT01611974|20441174|P3|NOT COMPLETED|Overall Study||16
8290761|NCT01611974|20441175|P2|NOT COMPLETED|Overall Study||15
8290762|NCT01611974|20441176|P1|NOT COMPLETED|Overall Study||15
8290763|NCT01611974|20441174|P3|COMPLETED|Overall Study||24
8290764|NCT01611974|20441175|P2|COMPLETED|Overall Study||25
8290765|NCT01611974|20441176|P1|COMPLETED|Overall Study||25
8290766|NCT01611974|20441174|P3|STARTED|Overall Study||40
8290767|NCT01611974|20441175|P2|STARTED|Overall Study||40
8290768|NCT01611974|20441176|P1|STARTED|Overall Study||40
8290769|NCT01611948|20441213|P2|NOT COMPLETED|Overall Study||12
8290770|NCT01611948|20441214|P1|NOT COMPLETED|Overall Study||14
8290771|NCT01611948|20441213|P2|COMPLETED|Overall Study||26
8290772|NCT01611948|20441214|P1|COMPLETED|Overall Study||18
8290773|NCT01611948|20441213|P2|STARTED|Overall Study||38
8290774|NCT01611948|20441214|P1|STARTED|Overall Study||32
8290775|NCT01611935|20441222|P2|NOT COMPLETED|Overall Study||0
8290776|NCT01611935|20441223|P1|NOT COMPLETED|Overall Study||1
8290777|NCT01611935|20441222|P2|COMPLETED|Overall Study||51
8290778|NCT01611935|20441223|P1|COMPLETED|Overall Study||49
8290779|NCT01611935|20441222|P2|STARTED|Overall Study||51
8290780|NCT01611935|20441223|P1|STARTED|Overall Study||50
8290781|NCT01611883|20441235|P2|NOT COMPLETED|Overall Study||1
8290782|NCT01611883|20441236|P1|NOT COMPLETED|Overall Study||1
8290783|NCT01611883|20441235|P2|COMPLETED|Overall Study||76
8290784|NCT01611883|20441236|P1|COMPLETED|Overall Study||74
8290785|NCT01611883|20441235|P2|STARTED|Overall Study||77
8290786|NCT01611883|20441236|P1|STARTED|Overall Study||75
8290787|NCT01611857|20441262|P2|NOT COMPLETED|Overall Study||2
8290788|NCT01611857|20441263|P1|NOT COMPLETED|Overall Study||0
8290789|NCT01611857|20441262|P2|COMPLETED|Overall Study||32
8290790|NCT01611857|20441263|P1|COMPLETED|Overall Study||15
8290791|NCT01611857|20441262|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
8290792|NCT01611857|20441263|P1|Tivantinib 360 mg|Overall Study||7
8290793|NCT01611857|20441262|P2|Tivantinib 240 mg|Overall Study||0
8290794|NCT01611857|20441263|P1|Tivantinib 240 mg|Overall Study||3
8290795|NCT01611857|20441262|P2|Tivantinib 120 mg|Overall Study||0
8290796|NCT01611857|20441263|P1|Tivantinib 120 mg|Overall Study||5
8290797|NCT01611857|20441262|P2|STARTED|Overall Study||34
8290798|NCT01611857|20441263|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
8290799|NCT01611792|20441275|P2|NOT COMPLETED|Followup: at 6 Months||13
8290800|NCT01611792|20441276|P1|NOT COMPLETED|Followup: at 6 Months||6
8290801|NCT01611792|20441275|P2|COMPLETED|Followup: at 6 Months||7
8290802|NCT01611792|20441276|P1|COMPLETED|Followup: at 6 Months||11
8290803|NCT01611792|20441275|P2|STARTED|Followup: at 6 Months||20
8290804|NCT01611792|20441276|P1|STARTED|Followup: at 6 Months||17
8290805|NCT01611792|20441275|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
8290806|NCT01611792|20441276|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
8290807|NCT01611792|20441275|P2|COMPLETED|Follow-up: at 11 Weeks||20
8290808|NCT01611792|20441276|P1|COMPLETED|Follow-up: at 11 Weeks||17
8290809|NCT01611792|20441275|P2|STARTED|Follow-up: at 11 Weeks||20
8290810|NCT01611792|20441276|P1|STARTED|Follow-up: at 11 Weeks||17
8290811|NCT01611792|20441275|P2|NOT COMPLETED|Initial Period: Time 0||9
8290812|NCT01611792|20441276|P1|NOT COMPLETED|Initial Period: Time 0||12
8290813|NCT01611792|20441275|P2|COMPLETED|Initial Period: Time 0||20
8290814|NCT01611792|20441276|P1|COMPLETED|Initial Period: Time 0||17
8290815|NCT01611792|20441275|P2|STARTED|Initial Period: Time 0||29
8290816|NCT01611792|20441276|P1|STARTED|Initial Period: Time 0||29
8290817|NCT01611779|20441292|P1|NOT COMPLETED|Overall Study||0
8290818|NCT01611779|20441292|P1|COMPLETED|Overall Study||5
8290819|NCT01611779|20441292|P1|STARTED|Overall Study||5
8290820|NCT01611662|20441301|P1|NOT COMPLETED|Overall Study||1
8290821|NCT01611662|20441301|P1|COMPLETED|Overall Study||31
8290822|NCT01611662|20441301|P1|STARTED|Overall Study||32
8290823|NCT01611571|20441308|P3|NOT COMPLETED|Overall Study||1
8290824|NCT01611571|20441309|P2|NOT COMPLETED|Overall Study||0
8290825|NCT01611571|20441310|P1|NOT COMPLETED|Overall Study||1
8290826|NCT01611571|20441308|P3|COMPLETED|Overall Study||9
8290827|NCT01611571|20441309|P2|COMPLETED|Overall Study||10
8290828|NCT01611571|20441310|P1|COMPLETED|Overall Study||10
8290829|NCT01611571|20441308|P3|STARTED|Overall Study||10
8290830|NCT01611571|20441309|P2|STARTED|Overall Study||10
8290831|NCT01611571|20441310|P1|STARTED|Overall Study||11
8290832|NCT01611558|20441330|P1|NOT COMPLETED|Maintenance Phase||2
8290833|NCT01611558|20441330|P1|COMPLETED|Maintenance Phase||0
8290834|NCT01611558|20441330|P1|STARTED|Maintenance Phase||2
8290835|NCT01611558|20441330|P1|NOT COMPLETED|Induction Phase||38
8290836|NCT01611558|20441330|P1|COMPLETED|Induction Phase||2
8290837|NCT01611558|20441330|P1|STARTED|Induction Phase||40
8290838|NCT01611298|20441336|P1|NOT COMPLETED|Overall Study||2
8290839|NCT01611298|20441336|P1|COMPLETED|Overall Study||5
8290840|NCT01611298|20441336|P1|STARTED|Overall Study||7
8290841|NCT01611259|20441341|P1|NOT COMPLETED|Overall Study||14
8290842|NCT01611259|20441341|P1|COMPLETED|Overall Study||34
8290843|NCT01611259|20441341|P1|STARTED|Overall Study||48
8290844|NCT01611194|20441347|P2|NOT COMPLETED|Overall Study||3
8290845|NCT01611194|20441348|P1|NOT COMPLETED|Overall Study||0
8290846|NCT01611194|20441347|P2|COMPLETED|Overall Study||32
8290847|NCT01611194|20441348|P1|COMPLETED|Overall Study||36
8290848|NCT01611194|20441347|P2|STARTED|Overall Study||35
8290849|NCT01611194|20441348|P1|STARTED|Overall Study||36
8290850|NCT01611155|20441386|P2|NOT COMPLETED|Overall Study||7
8290851|NCT01611155|20441387|P1|NOT COMPLETED|Overall Study||9
8290852|NCT01611155|20441386|P2|COMPLETED|Overall Study||18
8290853|NCT01611155|20441387|P1|COMPLETED|Overall Study||16
8290854|NCT01611155|20441386|P2|Received Treatment|Overall Study||25
8290855|NCT01611155|20441387|P1|Received Treatment|Overall Study||25
8290856|NCT01611155|20441386|P2|STARTED|Overall Study||25
8290857|NCT01611155|20441387|P1|STARTED|Overall Study||25
8290858|NCT01611090|20441397|P3|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
8290859|NCT01611090|20441398|P2|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290860|NCT01611090|20441399|P1|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290861|NCT01611090|20441397|P3|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
8290862|NCT01611090|20441398|P2|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290863|NCT01611090|20441399|P1|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290864|NCT01611090|20441397|P3|Treated|Cross Over (Placebo to Ibrutinib)||183
8290865|NCT01611090|20441398|P2|Treated|Cross Over (Placebo to Ibrutinib)||0
8290866|NCT01611090|20441399|P1|Treated|Cross Over (Placebo to Ibrutinib)||0
8290867|NCT01611090|20441397|P3|STARTED|Cross Over (Placebo to Ibrutinib)||183
8290868|NCT01611090|20441398|P2|STARTED|Cross Over (Placebo to Ibrutinib)||0
8290869|NCT01611090|20441399|P1|STARTED|Cross Over (Placebo to Ibrutinib)||0
8290870|NCT01611090|20441397|P3|NOT COMPLETED|Randomized Period||0
8290871|NCT01611090|20441398|P2|NOT COMPLETED|Randomized Period||29
8290872|NCT01611090|20441399|P1|NOT COMPLETED|Randomized Period||30
8290873|NCT01611090|20441397|P3|COMPLETED|Randomized Period||0
8290874|NCT01611090|20441398|P2|COMPLETED|Randomized Period||260
8290875|NCT01611090|20441399|P1|COMPLETED|Randomized Period||259
8290876|NCT01611090|20441397|P3|Treated|Randomized Period||0
8290877|NCT01611090|20441398|P2|Treated|Randomized Period||287
8290878|NCT01611090|20441399|P1|Treated|Randomized Period||287
8290879|NCT01611090|20441397|P3|STARTED|Randomized Period||0
8290880|NCT01611090|20441398|P2|STARTED|Randomized Period||289
8290881|NCT01611090|20441399|P1|STARTED|Randomized Period||289
8290882|NCT01610791|20441432|P1|NOT COMPLETED|Overall Study||21
8290883|NCT01610791|20441432|P1|COMPLETED|Overall Study||100
8290884|NCT01610791|20441432|P1|STARTED|Overall Study||121
8290885|NCT01610752|20441456|P3|NOT COMPLETED|Overall Study||4
8290886|NCT01610752|20441457|P2|NOT COMPLETED|Overall Study||0
8290887|NCT01610752|20441458|P1|NOT COMPLETED|Overall Study||0
8290888|NCT01610752|20441456|P3|COMPLETED|Overall Study||13
8290889|NCT01610752|20441457|P2|COMPLETED|Overall Study||19
8290890|NCT01610752|20441458|P1|COMPLETED|Overall Study||18
8290891|NCT01610752|20441456|P3|STARTED|Overall Study||17
8290892|NCT01610752|20441457|P2|STARTED|Overall Study||19
8290893|NCT01610752|20441458|P1|STARTED|Overall Study||18
8290894|NCT01610713|20441480|P2|NOT COMPLETED|Overall Study||1
8290895|NCT01610713|20441481|P1|NOT COMPLETED|Overall Study||6
8290896|NCT01610713|20441480|P2|COMPLETED|Overall Study||76
8290897|NCT01610713|20441481|P1|COMPLETED|Overall Study||71
8290898|NCT01610713|20441480|P2|STARTED|Overall Study||77
8290899|NCT01610713|20441481|P1|STARTED|Overall Study||77
8290900|NCT01610700|20441539|P2|NOT COMPLETED|Overall Study||3
8290901|NCT01610700|20441540|P1|NOT COMPLETED|Overall Study||3
8290902|NCT01610700|20441539|P2|COMPLETED|Overall Study||77
8290903|NCT01610700|20441540|P1|COMPLETED|Overall Study||77
8290904|NCT01610700|20441539|P2|STARTED|Overall Study||80
8290905|NCT01610700|20441540|P1|STARTED|Overall Study||80
8290906|NCT01610687|20441594|P1|NOT COMPLETED|Overall Study||67
8290907|NCT01610687|20441594|P1|COMPLETED|Overall Study||70
8290908|NCT01610687|20441594|P1|STARTED|Overall Study||137
8290909|NCT01610596|20441607|P2|NOT COMPLETED|Overall Study||1
8290910|NCT01610596|20441608|P1|NOT COMPLETED|Overall Study||0
8290911|NCT01610596|20441607|P2|COMPLETED|Overall Study||35
8290912|NCT01610596|20441608|P1|COMPLETED|Overall Study||36
8290913|NCT01610596|20441607|P2|STARTED|Overall Study||36
8290914|NCT01610596|20441608|P1|STARTED|Overall Study||36
8290915|NCT01610570|20441624|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290916|NCT01610570|20441625|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290917|NCT01610570|20441626|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290918|NCT01610570|20441627|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290919|NCT01610570|20441624|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290920|NCT01610570|20441625|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290921|NCT01610570|20441626|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290922|NCT01610570|20441627|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290923|NCT01610570|20441624|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290924|NCT01610570|20441625|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290925|NCT01610570|20441626|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290926|NCT01610570|20441627|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290927|NCT01610570|20441624|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290928|NCT01610570|20441625|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290929|NCT01610570|20441626|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290930|NCT01610570|20441627|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290931|NCT01610570|20441624|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
8290932|NCT01610570|20441625|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290933|NCT01610570|20441626|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290934|NCT01610570|20441627|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290935|NCT01610570|20441624|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
8290936|NCT01610570|20441625|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8290937|NCT01610570|20441626|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8290938|NCT01610570|20441627|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8290939|NCT01610570|20441624|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290940|NCT01610570|20441625|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290941|NCT01610570|20441626|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290942|NCT01610570|20441627|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290943|NCT01610570|20441624|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290944|NCT01610570|20441625|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290945|NCT01610570|20441626|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
8290946|NCT01610570|20441627|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290947|NCT01610570|20441624|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8290948|NCT01610570|20441625|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8290949|NCT01610570|20441626|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
8290950|NCT01610570|20441627|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8290951|NCT01610557|20441666|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
8290952|NCT01610557|20441667|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
8290953|NCT01610557|20441668|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
8290954|NCT01610557|20441669|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
8290955|NCT01610557|20441670|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
8290956|NCT01610557|20441666|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
8290957|NCT01610557|20441667|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290958|NCT01610557|20441668|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290959|NCT01610557|20441669|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290960|NCT01610557|20441670|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290961|NCT01610557|20441666|P5|STARTED|Post-36-Week Extension Phase||55
8290962|NCT01610557|20441667|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290963|NCT01610557|20441668|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290964|NCT01610557|20441669|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290965|NCT01610557|20441670|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290966|NCT01610557|20441666|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8290967|NCT01610557|20441667|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8290968|NCT01610557|20441668|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8290969|NCT01610557|20441669|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
8290970|NCT01610557|20441670|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8291051|NCT01610154|20441850|P1|COMPLETED|Overall Study||84
8290971|NCT01610557|20441666|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
8290972|NCT01610557|20441667|P4|COMPLETED|36-Week Randomized Crossover Phase||13
8290973|NCT01610557|20441668|P3|COMPLETED|36-Week Randomized Crossover Phase||14
8290974|NCT01610557|20441669|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
8290975|NCT01610557|20441670|P1|COMPLETED|36-Week Randomized Crossover Phase||16
8290976|NCT01610557|20441666|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
8290977|NCT01610557|20441667|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
8290978|NCT01610557|20441668|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
8290979|NCT01610557|20441669|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
8290980|NCT01610557|20441670|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
8290981|NCT01610492|20441683|P1|NOT COMPLETED|Overall Study||6
8290982|NCT01610492|20441683|P1|COMPLETED|Overall Study||8
8290983|NCT01610492|20441683|P1|STARTED|Overall Study||14
8290984|NCT01610453|20441727|P1|NOT COMPLETED|Overall Study||0
8290985|NCT01610453|20441727|P1|COMPLETED|Overall Study||150
8290986|NCT01610453|20441727|P1|STARTED|Overall Study||150
8290987|NCT01610427|20441732|P1|NOT COMPLETED|Overall Study||0
8290988|NCT01610427|20441732|P1|COMPLETED|Overall Study||22
8290989|NCT01610427|20441732|P1|STARTED|Overall Study||22
8290990|NCT01610414|20441749|P2|NOT COMPLETED|After Month 25||53
8290991|NCT01610414|20441750|P1|NOT COMPLETED|After Month 25||48
8290992|NCT01610414|20441749|P2|COMPLETED|After Month 25||871
8290993|NCT01610414|20441750|P1|COMPLETED|After Month 25||874
8290994|NCT01610414|20441749|P2|STARTED|After Month 25||924
8290995|NCT01610414|20441750|P1|STARTED|After Month 25||922
8290996|NCT01610414|20441749|P2|NOT COMPLETED|Month 13 - Month 25||70
8290997|NCT01610414|20441750|P1|NOT COMPLETED|Month 13 - Month 25||65
8290998|NCT01610414|20441749|P2|COMPLETED|Month 13 - Month 25||854
8290999|NCT01610414|20441750|P1|COMPLETED|Month 13 - Month 25||857
8291000|NCT01610414|20441749|P2|STARTED|Month 13 - Month 25||924
8291001|NCT01610414|20441750|P1|STARTED|Month 13 - Month 25||922
8291002|NCT01610414|20441749|P2|NOT COMPLETED|Study Start - Month 13||129
8291003|NCT01610414|20441750|P1|NOT COMPLETED|Study Start - Month 13||115
8291004|NCT01610414|20441749|P2|COMPLETED|Study Start - Month 13||795
8291005|NCT01610414|20441750|P1|COMPLETED|Study Start - Month 13||807
8291006|NCT01610414|20441749|P2|STARTED|Study Start - Month 13||924
8291007|NCT01610414|20441750|P1|STARTED|Study Start - Month 13||922
8291008|NCT01610297|20441779|P1|NOT COMPLETED|Overall Study||1
8291009|NCT01610297|20441779|P1|COMPLETED|Overall Study||26
8291010|NCT01610297|20441779|P1|STARTED|Overall Study||27
8291011|NCT01610284|20441789|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
8291012|NCT01610284|20441790|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
8291013|NCT01610284|20441789|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8291014|NCT01610284|20441790|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8291015|NCT01610284|20441789|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
8291016|NCT01610284|20441790|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
8291017|NCT01610284|20441789|P2|NOT COMPLETED|Treatment Phase||569
8291018|NCT01610284|20441790|P1|NOT COMPLETED|Treatment Phase||574
8291019|NCT01610284|20441789|P2|COMPLETED|Treatment Phase||0
8291020|NCT01610284|20441790|P1|COMPLETED|Treatment Phase||0
8291021|NCT01610284|20441789|P2|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
8291022|NCT01610284|20441790|P1|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
8291023|NCT01610284|20441789|P2|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
8291024|NCT01610284|20441790|P1|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
8291025|NCT01610284|20441789|P2|STARTED|Treatment Phase||569
8291026|NCT01610284|20441790|P1|STARTED|Treatment Phase||574
8291027|NCT01610284|20441789|P2|NOT COMPLETED|Randomization Phase||2
8291028|NCT01610284|20441790|P1|NOT COMPLETED|Randomization Phase||2
8291029|NCT01610284|20441789|P2|COMPLETED|Randomization Phase||569
8291030|NCT01610284|20441790|P1|COMPLETED|Randomization Phase||574
8291031|NCT01610284|20441789|P2|Safety Set (SS)|Randomization Phase||570
8291032|NCT01610284|20441790|P1|Safety Set (SS)|Randomization Phase||573
8291033|NCT01610284|20441789|P2|STARTED|Randomization Phase||571
8291034|NCT01610284|20441790|P1|STARTED|Randomization Phase||576
8291035|NCT01610271|20441812|P2|NOT COMPLETED|Overall Study||4
8291036|NCT01610271|20441813|P1|NOT COMPLETED|Overall Study||2
8291037|NCT01610271|20441812|P2|COMPLETED|Overall Study||146
8291038|NCT01610271|20441813|P1|COMPLETED|Overall Study||148
8291039|NCT01610271|20441812|P2|STARTED|Overall Study||150
8291040|NCT01610271|20441813|P1|STARTED|Overall Study||150
8291041|NCT01610167|20441828|P3|NOT COMPLETED|Overall Study||2
8291042|NCT01610167|20441829|P2|NOT COMPLETED|Overall Study||0
8291043|NCT01610167|20441830|P1|NOT COMPLETED|Overall Study||0
8291044|NCT01610167|20441828|P3|COMPLETED|Overall Study||48
8291045|NCT01610167|20441829|P2|COMPLETED|Overall Study||49
8291046|NCT01610167|20441830|P1|COMPLETED|Overall Study||52
8291047|NCT01610167|20441828|P3|STARTED|Overall Study||50
8291048|NCT01610167|20441829|P2|STARTED|Overall Study||49
8291049|NCT01610167|20441830|P1|STARTED|Overall Study||52
8291050|NCT01610154|20441850|P1|NOT COMPLETED|Overall Study||1
8291052|NCT01610154|20441850|P1|STARTED|Overall Study||85
8291053|NCT01610076|20441867|P2|NOT COMPLETED|Overall Study||5
8291054|NCT01610076|20441868|P1|NOT COMPLETED|Overall Study||3
8291055|NCT01610076|20441867|P2|COMPLETED|Overall Study||100
8291056|NCT01610076|20441868|P1|COMPLETED|Overall Study||100
8291057|NCT01610076|20441867|P2|STARTED|Overall Study||105
8291058|NCT01610076|20441868|P1|STARTED|Overall Study||103
8291059|NCT01610063|20441879|P2|NOT COMPLETED|Overall Study||20
8291060|NCT01610063|20441880|P1|NOT COMPLETED|Overall Study||42
8291061|NCT01610063|20441879|P2|COMPLETED|Overall Study||93
8291062|NCT01610063|20441880|P1|COMPLETED|Overall Study||72
8291063|NCT01610063|20441879|P2|Completed 8-week|Overall Study||93
8291064|NCT01610063|20441880|P1|Completed 8-week|Overall Study||72
8291065|NCT01610063|20441879|P2|Completed 4-week|Overall Study||98
8291066|NCT01610063|20441880|P1|Completed 4-week|Overall Study||86
8291067|NCT01610063|20441879|P2|Completed 2-week|Overall Study||105
8291068|NCT01610063|20441880|P1|Completed 2-week|Overall Study||97
8291069|NCT01610063|20441879|P2|Baseline|Overall Study||113
8291070|NCT01610063|20441880|P1|Baseline|Overall Study||114
8291071|NCT01610063|20441879|P2|STARTED|Overall Study||113
8291072|NCT01610063|20441880|P1|STARTED|Overall Study||114
8291073|NCT01610037|20441903|P3|NOT COMPLETED|Treatment and Follow up Period||26
8291074|NCT01610037|20441904|P2|NOT COMPLETED|Treatment and Follow up Period||28
8291075|NCT01610037|20441905|P1|NOT COMPLETED|Treatment and Follow up Period||25
8291076|NCT01610037|20441903|P3|COMPLETED|Treatment and Follow up Period||378
8291077|NCT01610037|20441904|P2|COMPLETED|Treatment and Follow up Period||377
8291078|NCT01610037|20441905|P1|COMPLETED|Treatment and Follow up Period||382
8291079|NCT01610037|20441903|P3|STARTED|Treatment and Follow up Period||404
8291080|NCT01610037|20441904|P2|STARTED|Treatment and Follow up Period||405
8291081|NCT01610037|20441905|P1|STARTED|Treatment and Follow up Period||407
8291082|NCT01610037|20441903|P3|NOT COMPLETED|All Patients||84
8291083|NCT01610037|20441904|P2|NOT COMPLETED|All Patients||51
8291084|NCT01610037|20441905|P1|NOT COMPLETED|All Patients||59
8291085|NCT01610037|20441903|P3|COMPLETED|All Patients||320
8291086|NCT01610037|20441904|P2|COMPLETED|All Patients||354
8291087|NCT01610037|20441905|P1|COMPLETED|All Patients||348
8291088|NCT01610037|20441903|P3|Full Analysis Set (FAS)|All Patients||403
8291089|NCT01610037|20441904|P2|Full Analysis Set (FAS)|All Patients||405
8291090|NCT01610037|20441905|P1|Full Analysis Set (FAS)|All Patients||407
8291091|NCT01610037|20441903|P3|Randomized Set (RAN)|All Patients||404
8291092|NCT01610037|20441904|P2|Randomized Set (RAN)|All Patients||405
8291093|NCT01610037|20441905|P1|Randomized Set (RAN)|All Patients||407
8291094|NCT01610037|20441903|P3|STARTED|All Patients||404
8291095|NCT01610037|20441904|P2|STARTED|All Patients||405
8291096|NCT01610037|20441905|P1|STARTED|All Patients||407
8291097|NCT01610011|20441948|P2|NOT COMPLETED|Overall Study||0
8291098|NCT01610011|20441949|P1|NOT COMPLETED|Overall Study||10
8291099|NCT01610011|20441948|P2|COMPLETED|Overall Study||2
8291100|NCT01610011|20441949|P1|COMPLETED|Overall Study||9
8291101|NCT01610011|20441948|P2|STARTED|Overall Study||2
8291102|NCT01610011|20441949|P1|STARTED|Overall Study||19
8291103|NCT01609933|20441955|P1|NOT COMPLETED|Overall Study||4
8291104|NCT01609933|20441955|P1|COMPLETED|Overall Study||28
8291105|NCT01609933|20441955|P1|STARTED|Overall Study||32
8291133|NCT01609582|20442015|P2|NOT COMPLETED|Overall Study||1604
8291134|NCT01609582|20442016|P1|NOT COMPLETED|Overall Study||1603
8291135|NCT01609582|20442015|P2|COMPLETED|Overall Study||0
8291136|NCT01609582|20442016|P1|COMPLETED|Overall Study||0
8291137|NCT01609582|20442015|P2|Treated|Overall Study||1601
8291138|NCT01609582|20442016|P1|Treated|Overall Study||1603
8291139|NCT01609582|20442015|P2|STARTED|Overall Study||1604
8291140|NCT01609582|20442016|P1|STARTED|Overall Study||1603
8291141|NCT01609543|20442024|P1|NOT COMPLETED|Overall Study||42
8291142|NCT01609543|20442024|P1|COMPLETED|Overall Study||20
8291143|NCT01609543|20442024|P1|STARTED|Overall Study||62
8291144|NCT01609478|20442033|P3|NOT COMPLETED|Overall Study||9
8291145|NCT01609478|20442034|P2|NOT COMPLETED|Overall Study||2
8291146|NCT01609478|20442035|P1|NOT COMPLETED|Overall Study||7
8291147|NCT01609478|20442033|P3|COMPLETED|Overall Study||107
8291148|NCT01609478|20442034|P2|COMPLETED|Overall Study||106
8291149|NCT01609478|20442035|P1|COMPLETED|Overall Study||104
8291150|NCT01609478|20442033|P3|Full Analysis Set (FAS)|Overall Study||115
8291151|NCT01609478|20442034|P2|Full Analysis Set (FAS)|Overall Study||108
8291152|NCT01609478|20442035|P1|Full Analysis Set (FAS)|Overall Study||110
8291153|NCT01609478|20442033|P3|STARTED|Overall Study||116
8291154|NCT01609478|20442034|P2|STARTED|Overall Study||108
8291155|NCT01609478|20442035|P1|STARTED|Overall Study||111
8291156|NCT01609348|20442101|P2|NOT COMPLETED|Overall Study||0
8291157|NCT01609348|20442102|P1|NOT COMPLETED|Overall Study||0
8291158|NCT01609348|20442101|P2|COMPLETED|Overall Study||2
8291159|NCT01609348|20442102|P1|COMPLETED|Overall Study||3
8291160|NCT01609348|20442101|P2|STARTED|Overall Study||2
8291161|NCT01609348|20442102|P1|STARTED|Overall Study||3
8291165|NCT01609257|20442121|P2|NOT COMPLETED|Overall Study||8
8291166|NCT01609257|20442122|P1|NOT COMPLETED|Overall Study||6
8291167|NCT01609257|20442121|P2|COMPLETED|Overall Study||57
8291168|NCT01609257|20442122|P1|COMPLETED|Overall Study||61
8291169|NCT01609257|20442121|P2|Received Challenge Product|Overall Study||53
8291170|NCT01609257|20442122|P1|Received Challenge Product|Overall Study||56
8291171|NCT01609257|20442121|P2|Received 2 Doses|Overall Study||64
8291172|NCT01609257|20442122|P1|Received 2 Doses|Overall Study||63
8291173|NCT01609257|20442121|P2|STARTED|Overall Study||65
8291174|NCT01609257|20442122|P1|STARTED|Overall Study||67
8291175|NCT01609231|20442194|P2|NOT COMPLETED|Overall Study||3
8291176|NCT01609231|20442195|P1|NOT COMPLETED|Overall Study||3
8291177|NCT01609231|20442194|P2|COMPLETED|Overall Study||2
8291178|NCT01609231|20442195|P1|COMPLETED|Overall Study||3
8291179|NCT01609231|20442194|P2|STARTED|Overall Study||5
8291180|NCT01609231|20442195|P1|STARTED|Overall Study||6
8291181|NCT01609062|20442205|P2|NOT COMPLETED|Extension Phase||10
8291182|NCT01609062|20442206|P1|NOT COMPLETED|Extension Phase||15
8291183|NCT01609062|20442205|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
8291184|NCT01609062|20442206|P1|COMPLETED|Extension Phase||0
8291185|NCT01609062|20442205|P2|STARTED|Extension Phase||10
8291186|NCT01609062|20442206|P1|STARTED|Extension Phase||15
8291187|NCT01609062|20442205|P2|NOT COMPLETED|Primary Phase||0
8291188|NCT01609062|20442206|P1|NOT COMPLETED|Primary Phase||0
8291189|NCT01609062|20442205|P2|COMPLETED|Primary Phase||10
8291190|NCT01609062|20442206|P1|COMPLETED|Primary Phase||15
8291191|NCT01609062|20442205|P2|STARTED|Primary Phase||10
8291192|NCT01609062|20442206|P1|STARTED|Primary Phase||15
8291193|NCT01609023|20442249|P1|NOT COMPLETED|Overall Study||33
8291194|NCT01609023|20442249|P1|COMPLETED|Overall Study||34
8291195|NCT01609023|20442249|P1|STARTED|Overall Study||67
8291196|NCT01609010|20442261|P2|NOT COMPLETED|Overall Study||37
8291197|NCT01609010|20442262|P1|NOT COMPLETED|Overall Study||43
8291198|NCT01609010|20442261|P2|COMPLETED|Overall Study||120
8291199|NCT01609010|20442262|P1|COMPLETED|Overall Study||113
8291200|NCT01609010|20442261|P2|Entering Cycle 2|Overall Study||124
8291201|NCT01609010|20442262|P1|Entering Cycle 2|Overall Study||120
8291202|NCT01609010|20442261|P2|STARTED|Overall Study||157
8291203|NCT01609010|20442262|P1|STARTED|Overall Study||156
8291204|NCT01608971|20442288|P2|NOT COMPLETED|Overall Study||0
8291205|NCT01608971|20442289|P1|NOT COMPLETED|Overall Study||0
8291206|NCT01608971|20442288|P2|COMPLETED|Overall Study||15
8291207|NCT01608971|20442289|P1|COMPLETED|Overall Study||15
8291208|NCT01608971|20442288|P2|STARTED|Overall Study||15
8291209|NCT01608971|20442289|P1|STARTED|Overall Study||15
8291210|NCT01608815|20442304|P3|NOT COMPLETED|Overall Study||0
8291211|NCT01608815|20442305|P2|NOT COMPLETED|Overall Study||0
8291212|NCT01608815|20442306|P1|NOT COMPLETED|Overall Study||0
8291213|NCT01608815|20442304|P3|COMPLETED|Overall Study||5
8291214|NCT01608815|20442305|P2|COMPLETED|Overall Study||7
8291215|NCT01608815|20442306|P1|COMPLETED|Overall Study||188
8291216|NCT01608815|20442304|P3|STARTED|Overall Study||5
8291217|NCT01608815|20442305|P2|STARTED|Overall Study||7
8291218|NCT01608815|20442306|P1|STARTED|Overall Study||188
8291219|NCT01608724|20442323|P1|NOT COMPLETED|Overall Study||243
8291220|NCT01608724|20442323|P1|COMPLETED|Overall Study||1180
8291221|NCT01608724|20442323|P1|Treated|Overall Study||1361
8291222|NCT01608724|20442323|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
8291223|NCT01608672|20442330|P1|NOT COMPLETED|Overall Study||0
8291224|NCT01608672|20442330|P1|COMPLETED|Overall Study||207
8291225|NCT01608672|20442330|P1|STARTED|Overall Study||207
8291226|NCT01608659|20442336|P1|NOT COMPLETED|Overall Study||16
8291227|NCT01608659|20442336|P1|COMPLETED|Overall Study||94
8291228|NCT01608659|20442336|P1|STARTED|Overall Study||110
8291235|NCT01608321|20442365|P2|NOT COMPLETED|Overall Study||0
8291236|NCT01608321|20442366|P1|NOT COMPLETED|Overall Study||1
8291237|NCT01608321|20442365|P2|COMPLETED|Overall Study||4
8291238|NCT01608321|20442366|P1|COMPLETED|Overall Study||12
8291239|NCT01608321|20442365|P2|STARTED|Overall Study||4
8291240|NCT01608321|20442366|P1|STARTED|Overall Study||13
8291241|NCT01608308|20442374|P2|NOT COMPLETED|Overall Study||2
8291242|NCT01608308|20442375|P1|NOT COMPLETED|Overall Study||0
8291243|NCT01608308|20442374|P2|COMPLETED|Overall Study||29
8291244|NCT01608308|20442375|P1|COMPLETED|Overall Study||31
8291245|NCT01608308|20442374|P2|STARTED|Overall Study||31
8291246|NCT01608308|20442375|P1|STARTED|Overall Study||31
8291247|NCT01608295|20442399|P2|NOT COMPLETED|Overall Study||5
8291248|NCT01608295|20442400|P1|NOT COMPLETED|Overall Study||6
8291249|NCT01608295|20442399|P2|COMPLETED|Overall Study||25
8291250|NCT01608295|20442400|P1|COMPLETED|Overall Study||20
8291251|NCT01608295|20442399|P2|STARTED|Overall Study||30
8291252|NCT01608295|20442400|P1|STARTED|Overall Study||26
8291253|NCT01608100|20442411|P1|NOT COMPLETED|Overall Study||0
8291254|NCT01608100|20442411|P1|COMPLETED|Overall Study||1101
8291255|NCT01608100|20442411|P1|STARTED|Overall Study||1101
8291256|NCT01608087|20442438|P3|NOT COMPLETED|Overall Study||0
8291257|NCT01608087|20442439|P2|NOT COMPLETED|Overall Study||2
8291258|NCT01608087|20442440|P1|NOT COMPLETED|Overall Study||0
8291259|NCT01608087|20442438|P3|COMPLETED|Overall Study||31
8291260|NCT01608087|20442439|P2|COMPLETED|Overall Study||28
8291261|NCT01608087|20442440|P1|COMPLETED|Overall Study||30
8291262|NCT01608087|20442438|P3|STARTED|Overall Study||31
8291263|NCT01608087|20442439|P2|STARTED|Overall Study||30
8291264|NCT01608087|20442440|P1|STARTED|Overall Study||30
8291265|NCT01608061|20442456|P2|NOT COMPLETED|Extension Period||2
8291266|NCT01608061|20442457|P1|NOT COMPLETED|Extension Period||0
8291267|NCT01608061|20442456|P2|COMPLETED|Extension Period||14
8291268|NCT01608061|20442457|P1|COMPLETED|Extension Period||14
8291269|NCT01608061|20442456|P2|STARTED|Extension Period||16
8291270|NCT01608061|20442457|P1|STARTED|Extension Period||14
8291271|NCT01608061|20442456|P2|NOT COMPLETED|Long Term Follow-Up||5
8291272|NCT01608061|20442457|P1|NOT COMPLETED|Long Term Follow-Up||7
8291273|NCT01608061|20442456|P2|COMPLETED|Long Term Follow-Up||16
8291274|NCT01608061|20442457|P1|COMPLETED|Long Term Follow-Up||14
8291275|NCT01608061|20442456|P2|STARTED|Long Term Follow-Up||21
8291276|NCT01608061|20442457|P1|STARTED|Long Term Follow-Up||21
8291277|NCT01608061|20442456|P2|NOT COMPLETED|Blinded Period||0
8291278|NCT01608061|20442457|P1|NOT COMPLETED|Blinded Period||0
8291279|NCT01608061|20442456|P2|COMPLETED|Blinded Period||21
8291280|NCT01608061|20442457|P1|COMPLETED|Blinded Period||21
8291281|NCT01608061|20442456|P2|STARTED|Blinded Period||21
8291282|NCT01608061|20442457|P1|STARTED|Blinded Period||21
8291283|NCT01607957|20442470|P2|NOT COMPLETED|Overall Study||215
8291284|NCT01607957|20442471|P1|NOT COMPLETED|Overall Study||372
8291285|NCT01607957|20442470|P2|COMPLETED|Overall Study||51
8291286|NCT01607957|20442471|P1|COMPLETED|Overall Study||162
8291287|NCT01607957|20442470|P2|Treated|Overall Study||265
8291288|NCT01607957|20442471|P1|Treated|Overall Study||533
8291289|NCT01607957|20442470|P2|STARTED|Overall Study||266
8291290|NCT01607957|20442471|P1|STARTED|Overall Study||534
8291291|NCT01607853|20442481|P1|NOT COMPLETED|Overall Study||0
8291292|NCT01607853|20442481|P1|COMPLETED|Overall Study||24
8291293|NCT01607853|20442481|P1|STARTED|Overall Study||24
8291294|NCT01607658|20442592|P4|NOT COMPLETED|Overall Study||11
8291295|NCT01607658|20442593|P3|NOT COMPLETED|Overall Study||11
8291296|NCT01607658|20442594|P2|NOT COMPLETED|Overall Study||11
8291297|NCT01607658|20442595|P1|NOT COMPLETED|Overall Study||9
8291298|NCT01607658|20442592|P4|COMPLETED|Overall Study||52
8291299|NCT01607658|20442593|P3|COMPLETED|Overall Study||47
8291300|NCT01607658|20442594|P2|COMPLETED|Overall Study||56
8291301|NCT01607658|20442595|P1|COMPLETED|Overall Study||56
8291302|NCT01607658|20442592|P4|STARTED|Overall Study||63
8291303|NCT01607658|20442593|P3|STARTED|Overall Study||58
8291304|NCT01607658|20442594|P2|STARTED|Overall Study||67
8291305|NCT01607658|20442595|P1|STARTED|Overall Study||65
8291306|NCT01607645|20442619|P2|NOT COMPLETED|Overall Study||0
8291307|NCT01607645|20442620|P1|NOT COMPLETED|Overall Study||0
8291308|NCT01607645|20442619|P2|COMPLETED|Overall Study||3
8291309|NCT01607645|20442620|P1|COMPLETED|Overall Study||4
8291310|NCT01607645|20442619|P2|STARTED|Overall Study||3
8291311|NCT01607645|20442620|P1|STARTED|Overall Study||4
8291312|NCT01607593|20442650|P1|NOT COMPLETED|Overall Study||93
8291313|NCT01607593|20442650|P1|COMPLETED|Overall Study||29
8291314|NCT01607593|20442650|P1|STARTED|Overall Study||122
8291315|NCT01607554|20442656|P1|NOT COMPLETED|Overall Study||2
8291316|NCT01607554|20442656|P1|COMPLETED|Overall Study||0
8291317|NCT01607554|20442656|P1|STARTED|Overall Study||2
8291318|NCT01607476|20442669|P3|NOT COMPLETED|Overall Study||3
8291319|NCT01607476|20442670|P2|NOT COMPLETED|Overall Study||0
8291320|NCT01607476|20442671|P1|NOT COMPLETED|Overall Study||1
8291321|NCT01607476|20442669|P3|COMPLETED|Overall Study||30
8291322|NCT01607476|20442670|P2|COMPLETED|Overall Study||30
8291323|NCT01607476|20442671|P1|COMPLETED|Overall Study||24
8291324|NCT01607476|20442669|P3|STARTED|Overall Study||33
8291325|NCT01607476|20442670|P2|STARTED|Overall Study||30
8291326|NCT01607476|20442671|P1|STARTED|Overall Study||25
8291327|NCT01607450|20442689|P7|NOT COMPLETED|Overall Study||0
8291328|NCT01607450|20442690|P6|NOT COMPLETED|Overall Study||0
8291329|NCT01607450|20442691|P5|NOT COMPLETED|Overall Study||0
8291330|NCT01607450|20442692|P4|NOT COMPLETED|Overall Study||0
8291331|NCT01607450|20442693|P3|NOT COMPLETED|Overall Study||0
8291332|NCT01607450|20442694|P2|NOT COMPLETED|Overall Study||0
8291333|NCT01607450|20442695|P1|NOT COMPLETED|Overall Study||0
8291334|NCT01607450|20442689|P7|COMPLETED|Overall Study||0
8291335|NCT01607450|20442690|P6|COMPLETED|Overall Study||0
8291336|NCT01607450|20442691|P5|COMPLETED|Overall Study||1
8291337|NCT01607450|20442692|P4|COMPLETED|Overall Study||11
8291338|NCT01607450|20442693|P3|COMPLETED|Overall Study||7
8291339|NCT01607450|20442694|P2|COMPLETED|Overall Study||8
8291340|NCT01607450|20442695|P1|COMPLETED|Overall Study||6
8291341|NCT01607450|20442689|P7|STARTED|Overall Study||0
8291342|NCT01607450|20442690|P6|STARTED|Overall Study||0
8291343|NCT01607450|20442691|P5|STARTED|Overall Study||1
8291344|NCT01607450|20442692|P4|STARTED|Overall Study||11
8291345|NCT01607450|20442693|P3|STARTED|Overall Study||7
8291346|NCT01607450|20442694|P2|STARTED|Overall Study||8
8291347|NCT01607450|20442695|P1|STARTED|Overall Study||6
8291348|NCT01607411|20442739|P4|NOT COMPLETED|Period IV||0
8291349|NCT01607411|20442740|P3|NOT COMPLETED|Period IV||0
8291350|NCT01607411|20442741|P2|NOT COMPLETED|Period IV||0
8291351|NCT01607411|20442742|P1|NOT COMPLETED|Period IV||0
8291352|NCT01607411|20442739|P4|COMPLETED|Period IV||14
8291353|NCT01607411|20442740|P3|COMPLETED|Period IV||14
8291354|NCT01607411|20442741|P2|COMPLETED|Period IV||14
8291355|NCT01607411|20442742|P1|COMPLETED|Period IV||13
8291356|NCT01607411|20442739|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8291357|NCT01607411|20442740|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8291358|NCT01607411|20442741|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8291359|NCT01607411|20442742|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
8291360|NCT01607411|20442739|P4|NOT COMPLETED|Period III||0
8291361|NCT01607411|20442740|P3|NOT COMPLETED|Period III||0
8291362|NCT01607411|20442741|P2|NOT COMPLETED|Period III||0
8291363|NCT01607411|20442742|P1|NOT COMPLETED|Period III||0
8291364|NCT01607411|20442739|P4|COMPLETED|Period III||13
8291365|NCT01607411|20442740|P3|COMPLETED|Period III||14
8291366|NCT01607411|20442741|P2|COMPLETED|Period III||14
8291367|NCT01607411|20442742|P1|COMPLETED|Period III||14
8291368|NCT01607411|20442739|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
8291369|NCT01607411|20442740|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8291370|NCT01607411|20442741|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8291371|NCT01607411|20442742|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8291372|NCT01607411|20442739|P4|NOT COMPLETED|Period II||0
8291373|NCT01607411|20442740|P3|NOT COMPLETED|Period II||0
8291374|NCT01607411|20442741|P2|NOT COMPLETED|Period II||0
8291375|NCT01607411|20442742|P1|NOT COMPLETED|Period II||0
8291376|NCT01607411|20442739|P4|COMPLETED|Period II||14
8291377|NCT01607411|20442740|P3|COMPLETED|Period II||13
8291378|NCT01607411|20442741|P2|COMPLETED|Period II||14
8291379|NCT01607411|20442742|P1|COMPLETED|Period II||14
8291380|NCT01607411|20442739|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8291381|NCT01607411|20442740|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
8291382|NCT01607411|20442741|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8291383|NCT01607411|20442742|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8291384|NCT01607411|20442739|P4|NOT COMPLETED|Period I||0
8291385|NCT01607411|20442740|P3|NOT COMPLETED|Period I||0
8291386|NCT01607411|20442741|P2|NOT COMPLETED|Period I||0
8291387|NCT01607411|20442742|P1|NOT COMPLETED|Period I||0
8291388|NCT01607411|20442739|P4|COMPLETED|Period I||14
8291389|NCT01607411|20442740|P3|COMPLETED|Period I||14
8291390|NCT01607411|20442741|P2|COMPLETED|Period I||13
8291391|NCT01607411|20442742|P1|COMPLETED|Period I||14
8291392|NCT01607411|20442739|P4|STARTED|Period I||14
8291393|NCT01607411|20442740|P3|STARTED|Period I||14
8291394|NCT01607411|20442741|P2|STARTED|Period I||13
8291395|NCT01607411|20442742|P1|STARTED|Period I||14
8291396|NCT01607398|20442765|P2|NOT COMPLETED|Overall Study||2
8291397|NCT01607398|20442766|P1|NOT COMPLETED|Overall Study||2
8291398|NCT01607398|20442765|P2|COMPLETED|Overall Study||26
8291399|NCT01607398|20442766|P1|COMPLETED|Overall Study||26
8291400|NCT01607398|20442765|P2|STARTED|Overall Study||28
8291401|NCT01607398|20442766|P1|STARTED|Overall Study||28
8291402|NCT01607346|20442810|P1|NOT COMPLETED|Overall Study||3
8291403|NCT01607346|20442810|P1|COMPLETED|Overall Study||7
8291404|NCT01607346|20442810|P1|STARTED|Overall Study||10
8291405|NCT01607320|20442826|P2|NOT COMPLETED|Overall Study||0
8291406|NCT01607320|20442827|P1|NOT COMPLETED|Overall Study||0
8291407|NCT01607320|20442826|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
8291408|NCT01607320|20442827|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
8291409|NCT01607320|20442826|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
8291410|NCT01607320|20442827|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
8291411|NCT01607255|20442835|P3|NOT COMPLETED|Overall Study||0
8291412|NCT01607255|20442836|P2|NOT COMPLETED|Overall Study||0
8291413|NCT01607255|20442837|P1|NOT COMPLETED|Overall Study||0
8291414|NCT01607255|20442835|P3|COMPLETED|Overall Study||159
8291415|NCT01607255|20442836|P2|COMPLETED|Overall Study||160
8291416|NCT01607255|20442837|P1|COMPLETED|Overall Study||161
8291417|NCT01607255|20442835|P3|STARTED|Overall Study||159
8291418|NCT01607255|20442836|P2|STARTED|Overall Study||160
8291419|NCT01607255|20442837|P1|STARTED|Overall Study||161
8291420|NCT01607203|20442847|P2|NOT COMPLETED|Overall Study||0
8291421|NCT01607203|20442848|P1|NOT COMPLETED|Overall Study||0
8291422|NCT01607203|20442847|P2|COMPLETED|Overall Study||61
8291423|NCT01607203|20442848|P1|COMPLETED|Overall Study||59
8291424|NCT01607203|20442847|P2|STARTED|Overall Study||61
8291425|NCT01607203|20442848|P1|STARTED|Overall Study||59
8291426|NCT01607112|20442860|P2|NOT COMPLETED|Overall Study||0
8291427|NCT01607112|20442861|P1|NOT COMPLETED|Overall Study||0
8291428|NCT01607112|20442860|P2|COMPLETED|Overall Study||59
8291429|NCT01607112|20442861|P1|COMPLETED|Overall Study||60
8291430|NCT01607112|20442860|P2|STARTED|Overall Study||59
8291431|NCT01607112|20442861|P1|STARTED|Overall Study||60
8291432|NCT01606852|20442897|P2|NOT COMPLETED|Overall Study||0
8291433|NCT01606852|20442898|P1|NOT COMPLETED|Overall Study||0
8291434|NCT01606852|20442897|P2|COMPLETED|Overall Study||8
8291435|NCT01606852|20442898|P1|COMPLETED|Overall Study||7
8291436|NCT01606852|20442897|P2|STARTED|Overall Study||8
8291437|NCT01606852|20442898|P1|STARTED|Overall Study||7
8291438|NCT01606800|20442908|P2|NOT COMPLETED|Overall Study||2
8291439|NCT01606800|20442909|P1|NOT COMPLETED|Overall Study||5
8291440|NCT01606800|20442908|P2|COMPLETED|Overall Study||21
8291441|NCT01606800|20442909|P1|COMPLETED|Overall Study||17
8291442|NCT01606800|20442908|P2|Treated|Overall Study||23
8291443|NCT01606800|20442909|P1|Treated|Overall Study||22
8291444|NCT01606800|20442908|P2|STARTED|Overall Study||23
8291445|NCT01606800|20442909|P1|STARTED|Overall Study||22
8291446|NCT01606787|20442917|P2|NOT COMPLETED|Overall Study||7
8291447|NCT01606787|20442918|P1|NOT COMPLETED|Overall Study||4
8291448|NCT01606787|20442917|P2|COMPLETED|Overall Study||98
8291449|NCT01606787|20442918|P1|COMPLETED|Overall Study||101
8291450|NCT01606787|20442917|P2|STARTED|Overall Study||105
8291451|NCT01606787|20442918|P1|STARTED|Overall Study||105
8291452|NCT01606761|20442929|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
8291453|NCT01606761|20442930|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
8291454|NCT01606761|20442931|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
8291455|NCT01606761|20442932|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
8291456|NCT01606761|20442933|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
8291457|NCT01606761|20442929|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
8291458|NCT01606761|20442930|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
8291459|NCT01606761|20442931|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
8291460|NCT01606761|20442932|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
8291461|NCT01606761|20442933|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
8291462|NCT01606761|20442929|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
8291463|NCT01606761|20442930|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
8291464|NCT01606761|20442931|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
8291465|NCT01606761|20442932|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
8291466|NCT01606761|20442933|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
8291467|NCT01606761|20442929|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
8291468|NCT01606761|20442930|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
8291469|NCT01606761|20442931|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
8291470|NCT01606761|20442932|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
8291471|NCT01606761|20442933|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
8291472|NCT01606761|20442929|P5|NOT COMPLETED|Week 24 to Week 52||20
8291473|NCT01606761|20442930|P4|NOT COMPLETED|Week 24 to Week 52||17
8291474|NCT01606761|20442931|P3|NOT COMPLETED|Week 24 to Week 52||33
8291475|NCT01606761|20442932|P2|NOT COMPLETED|Week 24 to Week 52||33
8291476|NCT01606761|20442933|P1|NOT COMPLETED|Week 24 to Week 52||0
8291477|NCT01606761|20442929|P5|COMPLETED|Week 24 to Week 52||106
8291478|NCT01606761|20442930|P4|COMPLETED|Week 24 to Week 52||109
8291479|NCT01606761|20442931|P3|COMPLETED|Week 24 to Week 52||212
8291480|NCT01606761|20442932|P2|COMPLETED|Week 24 to Week 52||204
8291481|NCT01606761|20442933|P1|COMPLETED|Week 24 to Week 52||0
8291482|NCT01606761|20442929|P5|Treated|Week 24 to Week 52||126
8291483|NCT01606761|20442930|P4|Treated|Week 24 to Week 52||124
8291484|NCT01606761|20442931|P3|Treated|Week 24 to Week 52||245
8291485|NCT01606761|20442932|P2|Treated|Week 24 to Week 52||237
8291486|NCT01606761|20442933|P1|Treated|Week 24 to Week 52||0
8291487|NCT01606761|20442929|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
8291488|NCT01606761|20442930|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
8291489|NCT01606761|20442931|P3|STARTED|Week 24 to Week 52||245
8291490|NCT01606761|20442932|P2|STARTED|Week 24 to Week 52||237
8291491|NCT01606761|20442933|P1|STARTED|Week 24 to Week 52||0
8291492|NCT01606761|20442929|P5|NOT COMPLETED|Prior to Week 24||0
8291493|NCT01606761|20442930|P4|NOT COMPLETED|Prior to Week 24||0
8291494|NCT01606761|20442931|P3|NOT COMPLETED|Prior to Week 24||47
8291495|NCT01606761|20442932|P2|NOT COMPLETED|Prior to Week 24||55
8291496|NCT01606761|20442933|P1|NOT COMPLETED|Prior to Week 24||42
8291497|NCT01606761|20442929|P5|COMPLETED|Prior to Week 24||0
8291498|NCT01606761|20442930|P4|COMPLETED|Prior to Week 24||0
8291499|NCT01606761|20442931|P3|COMPLETED|Prior to Week 24||245
8291500|NCT01606761|20442932|P2|COMPLETED|Prior to Week 24||237
8291501|NCT01606761|20442933|P1|COMPLETED|Prior to Week 24||252
8291502|NCT01606761|20442929|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
8291503|NCT01606761|20442930|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
8291504|NCT01606761|20442931|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
8291505|NCT01606761|20442932|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
8291506|NCT01606761|20442933|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
8291507|NCT01606761|20442929|P5|STARTED|Prior to Week 24||0
8291508|NCT01606761|20442930|P4|STARTED|Prior to Week 24||0
8291509|NCT01606761|20442931|P3|STARTED|Prior to Week 24||292
8291510|NCT01606761|20442932|P2|STARTED|Prior to Week 24||292
8291511|NCT01606761|20442933|P1|STARTED|Prior to Week 24||294
8291512|NCT01606748|20442959|P2|NOT COMPLETED|Overall Study||0
8291513|NCT01606748|20442960|P1|NOT COMPLETED|Overall Study||3
8291514|NCT01606748|20442959|P2|COMPLETED|Overall Study||17
8291515|NCT01606748|20442960|P1|COMPLETED|Overall Study||15
8291516|NCT01606748|20442959|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
8291517|NCT01606748|20442960|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8291518|NCT01606748|20442959|P2|STARTED|Overall Study||17
8291519|NCT01606748|20442960|P1|STARTED|Overall Study||18
8291520|NCT01606735|20442991|P3|NOT COMPLETED|Overall Study||0
8291521|NCT01606735|20442992|P2|NOT COMPLETED|Overall Study||0
8291522|NCT01606735|20442993|P1|NOT COMPLETED|Overall Study||0
8291523|NCT01606735|20442991|P3|COMPLETED|Overall Study||58
8291524|NCT01606735|20442992|P2|COMPLETED|Overall Study||56
8291525|NCT01606735|20442993|P1|COMPLETED|Overall Study||58
8291526|NCT01606735|20442991|P3|STARTED|Overall Study||58
8291527|NCT01606735|20442992|P2|STARTED|Overall Study||56
8291528|NCT01606735|20442993|P1|STARTED|Overall Study||58
8291529|NCT01606709|20443003|P2|NOT COMPLETED|Overall Study||0
8291530|NCT01606709|20443004|P1|NOT COMPLETED|Overall Study||0
8291531|NCT01606709|20443003|P2|COMPLETED|Overall Study||3
8291532|NCT01606709|20443004|P1|COMPLETED|Overall Study||4
8291533|NCT01606709|20443003|P2|STARTED|Overall Study||3
8291534|NCT01606709|20443004|P1|STARTED|Overall Study||4
8291535|NCT01606670|20443012|P1|NOT COMPLETED|Overall Study||16
8291536|NCT01606670|20443012|P1|COMPLETED|Overall Study||77
8291537|NCT01606670|20443012|P1|Full Analysis Set|Overall Study||70
8291538|NCT01606670|20443012|P1|Safety Set|Overall Study||93
8291539|NCT01606670|20443012|P1|STARTED|Overall Study||93
8291540|NCT01606319|20443022|P2|NOT COMPLETED|Overall Study||40
8291541|NCT01606319|20443023|P1|NOT COMPLETED|Overall Study||34
8291542|NCT01606319|20443022|P2|COMPLETED|Overall Study||110
8291543|NCT01606319|20443023|P1|COMPLETED|Overall Study||116
8291544|NCT01606319|20443022|P2|STARTED|Overall Study||150
8291545|NCT01606319|20443023|P1|STARTED|Overall Study||150
8291546|NCT01606306|20443041|P6|NOT COMPLETED|Overall Study||11
8291547|NCT01606306|20443042|P5|NOT COMPLETED|Overall Study||11
8291548|NCT01606306|20443043|P4|NOT COMPLETED|Overall Study||13
8291549|NCT01606306|20443044|P3|NOT COMPLETED|Overall Study||14
8291550|NCT01606306|20443045|P2|NOT COMPLETED|Overall Study||10
8291551|NCT01606306|20443046|P1|NOT COMPLETED|Overall Study||15
8291552|NCT01606306|20443041|P6|COMPLETED|Overall Study||36
8291553|NCT01606306|20443042|P5|COMPLETED|Overall Study||41
8291554|NCT01606306|20443043|P4|COMPLETED|Overall Study||38
8291555|NCT01606306|20443044|P3|COMPLETED|Overall Study||37
8291556|NCT01606306|20443045|P2|COMPLETED|Overall Study||39
8291557|NCT01606306|20443046|P1|COMPLETED|Overall Study||35
8291558|NCT01606306|20443041|P6|Completed Third Treatment Period|Overall Study||36
8291559|NCT01606306|20443042|P5|Completed Third Treatment Period|Overall Study||41
8291560|NCT01606306|20443043|P4|Completed Third Treatment Period|Overall Study||38
8291561|NCT01606306|20443044|P3|Completed Third Treatment Period|Overall Study||37
8291562|NCT01606306|20443045|P2|Completed Third Treatment Period|Overall Study||39
8291563|NCT01606306|20443046|P1|Completed Third Treatment Period|Overall Study||35
8291564|NCT01606306|20443041|P6|Completed Second Treatment Period|Overall Study||41
8291565|NCT01606306|20443042|P5|Completed Second Treatment Period|Overall Study||46
8291566|NCT01606306|20443043|P4|Completed Second Treatment Period|Overall Study||44
8291567|NCT01606306|20443044|P3|Completed Second Treatment Period|Overall Study||43
8291568|NCT01606306|20443045|P2|Completed Second Treatment Period|Overall Study||38
8291569|NCT01606306|20443046|P1|Completed Second Treatment Period|Overall Study||41
8291570|NCT01606306|20443041|P6|Completed First Treatment Period|Overall Study||44
8291571|NCT01606306|20443042|P5|Completed First Treatment Period|Overall Study||47
8291572|NCT01606306|20443043|P4|Completed First Treatment Period|Overall Study||45
8291573|NCT01606306|20443044|P3|Completed First Treatment Period|Overall Study||47
8291574|NCT01606306|20443045|P2|Completed First Treatment Period|Overall Study||47
8291575|NCT01606306|20443046|P1|Completed First Treatment Period|Overall Study||43
8291576|NCT01606306|20443041|P6|STARTED|Overall Study||47
8291577|NCT01606306|20443042|P5|STARTED|Overall Study||52
8291578|NCT01606306|20443043|P4|STARTED|Overall Study||51
8291579|NCT01606306|20443044|P3|STARTED|Overall Study||51
8291580|NCT01606306|20443045|P2|STARTED|Overall Study||49
8291581|NCT01606306|20443046|P1|STARTED|Overall Study||50
8291582|NCT01606254|20443056|P4|NOT COMPLETED|Overall Study||3
8291583|NCT01606254|20443057|P3|NOT COMPLETED|Overall Study||0
8291584|NCT01606254|20443058|P2|NOT COMPLETED|Overall Study||4
8291585|NCT01606254|20443059|P1|NOT COMPLETED|Overall Study||2
8291586|NCT01606254|20443056|P4|COMPLETED|Overall Study||11
8291587|NCT01606254|20443057|P3|COMPLETED|Overall Study||14
8291588|NCT01606254|20443058|P2|COMPLETED|Overall Study||10
8291589|NCT01606254|20443059|P1|COMPLETED|Overall Study||12
8291590|NCT01606254|20443056|P4|STARTED|Overall Study||14
8291591|NCT01606254|20443057|P3|STARTED|Overall Study||14
8291592|NCT01606254|20443058|P2|STARTED|Overall Study||14
8291593|NCT01606254|20443059|P1|STARTED|Overall Study||14
8291594|NCT01606228|20443141|P1|NOT COMPLETED|Overall Study||29
8291595|NCT01606228|20443141|P1|COMPLETED|Overall Study||159
8291596|NCT01606228|20443141|P1|STARTED|Overall Study||188
8291597|NCT01606202|20443158|P2|NOT COMPLETED|Overall Study||3
8291598|NCT01606202|20443159|P1|NOT COMPLETED|Overall Study||7
8291599|NCT01606202|20443158|P2|COMPLETED|Overall Study||57
8291600|NCT01606202|20443159|P1|COMPLETED|Overall Study||49
8291601|NCT01606202|20443158|P2|STARTED|Overall Study||60
8291602|NCT01606202|20443159|P1|STARTED|Overall Study||56
8291603|NCT01606189|20443191|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
8291604|NCT01606189|20443192|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291605|NCT01606189|20443193|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291606|NCT01606189|20443194|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291607|NCT01606189|20443195|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291608|NCT01606189|20443196|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291609|NCT01606189|20443191|P6|COMPLETED|Third Intenvention (14-20 Days)||6
8291610|NCT01606189|20443192|P5|COMPLETED|Third Intenvention (14-20 Days)||8
8291611|NCT01606189|20443193|P4|COMPLETED|Third Intenvention (14-20 Days)||8
8291612|NCT01606189|20443194|P3|COMPLETED|Third Intenvention (14-20 Days)||8
8291613|NCT01606189|20443195|P2|COMPLETED|Third Intenvention (14-20 Days)||8
8291614|NCT01606189|20443196|P1|COMPLETED|Third Intenvention (14-20 Days)||8
8291615|NCT01606189|20443191|P6|STARTED|Third Intenvention (14-20 Days)||7
8291616|NCT01606189|20443192|P5|STARTED|Third Intenvention (14-20 Days)||8
8291617|NCT01606189|20443193|P4|STARTED|Third Intenvention (14-20 Days)||8
8291618|NCT01606189|20443194|P3|STARTED|Third Intenvention (14-20 Days)||8
8291619|NCT01606189|20443195|P2|STARTED|Third Intenvention (14-20 Days)||8
8291620|NCT01606189|20443196|P1|STARTED|Third Intenvention (14-20 Days)||8
8291621|NCT01606189|20443191|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
8291622|NCT01606189|20443192|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291623|NCT01606189|20443193|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291624|NCT01606189|20443194|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291625|NCT01606189|20443195|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291626|NCT01606189|20443196|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291627|NCT01606189|20443191|P6|COMPLETED|Second Intenvention (14-20 Days)||7
8291628|NCT01606189|20443192|P5|COMPLETED|Second Intenvention (14-20 Days)||8
8291629|NCT01606189|20443193|P4|COMPLETED|Second Intenvention (14-20 Days)||8
8291630|NCT01606189|20443194|P3|COMPLETED|Second Intenvention (14-20 Days)||8
8291631|NCT01606189|20443195|P2|COMPLETED|Second Intenvention (14-20 Days)||8
8291632|NCT01606189|20443196|P1|COMPLETED|Second Intenvention (14-20 Days)||8
8291633|NCT01606189|20443191|P6|STARTED|Second Intenvention (14-20 Days)||8
8291634|NCT01606189|20443192|P5|STARTED|Second Intenvention (14-20 Days)||8
8291635|NCT01606189|20443193|P4|STARTED|Second Intenvention (14-20 Days)||8
8291636|NCT01606189|20443194|P3|STARTED|Second Intenvention (14-20 Days)||8
8291637|NCT01606189|20443195|P2|STARTED|Second Intenvention (14-20 Days)||8
8291638|NCT01606189|20443196|P1|STARTED|Second Intenvention (14-20 Days)||8
8291639|NCT01606189|20443191|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291640|NCT01606189|20443192|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291641|NCT01606189|20443193|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291642|NCT01606189|20443194|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291643|NCT01606189|20443195|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291644|NCT01606189|20443196|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291645|NCT01606189|20443191|P6|COMPLETED|First Intenvention (14-20 Days)||8
8291646|NCT01606189|20443192|P5|COMPLETED|First Intenvention (14-20 Days)||8
8291647|NCT01606189|20443193|P4|COMPLETED|First Intenvention (14-20 Days)||8
8291648|NCT01606189|20443194|P3|COMPLETED|First Intenvention (14-20 Days)||8
8291649|NCT01606189|20443195|P2|COMPLETED|First Intenvention (14-20 Days)||8
8291650|NCT01606189|20443196|P1|COMPLETED|First Intenvention (14-20 Days)||8
8291651|NCT01606189|20443191|P6|STARTED|First Intenvention (14-20 Days)||8
8291652|NCT01606189|20443192|P5|STARTED|First Intenvention (14-20 Days)||8
8291653|NCT01606189|20443193|P4|STARTED|First Intenvention (14-20 Days)||8
8291654|NCT01606189|20443194|P3|STARTED|First Intenvention (14-20 Days)||8
8291655|NCT01606189|20443195|P2|STARTED|First Intenvention (14-20 Days)||8
8291656|NCT01606189|20443196|P1|STARTED|First Intenvention (14-20 Days)||8
8291657|NCT01606176|20443230|P2|NOT COMPLETED|Overall Study||3
8291658|NCT01606176|20443231|P1|NOT COMPLETED|Overall Study||4
8291659|NCT01606176|20443230|P2|COMPLETED|Overall Study||31
8291660|NCT01606176|20443231|P1|COMPLETED|Overall Study||32
8291661|NCT01606176|20443230|P2|STARTED|Overall Study||34
8291662|NCT01606176|20443231|P1|STARTED|Overall Study||36
8291663|NCT01606150|20443267|P2|NOT COMPLETED|Overall Study||0
8291664|NCT01606150|20443268|P1|NOT COMPLETED|Overall Study||0
8291665|NCT01606150|20443267|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
8291666|NCT01606150|20443268|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
8291667|NCT01606150|20443267|P2|STARTED|Overall Study||0
8291668|NCT01606150|20443268|P1|STARTED|Overall Study||0
8291669|NCT01606137|20443276|P1|NOT COMPLETED|Overall Study||262
8291670|NCT01606137|20443276|P1|COMPLETED|Overall Study||245
8291671|NCT01606137|20443276|P1|STARTED|Overall Study||507
8291672|NCT01606124|20443298|P2|NOT COMPLETED|Overall Study||0
8291673|NCT01606124|20443299|P1|NOT COMPLETED|Overall Study||0
8291674|NCT01606124|20443298|P2|COMPLETED|Overall Study||20
8291675|NCT01606124|20443299|P1|COMPLETED|Overall Study||19
8291676|NCT01606124|20443298|P2|STARTED|Overall Study||20
8291677|NCT01606124|20443299|P1|STARTED|Overall Study||19
8291678|NCT01606007|20443310|P3|NOT COMPLETED|Overall Study||10
8291679|NCT01606007|20443311|P2|NOT COMPLETED|Overall Study||19
8291680|NCT01606007|20443312|P1|NOT COMPLETED|Overall Study||15
8291681|NCT01606007|20443310|P3|COMPLETED|Overall Study||169
8291682|NCT01606007|20443311|P2|COMPLETED|Overall Study||160
8291683|NCT01606007|20443312|P1|COMPLETED|Overall Study||161
8291684|NCT01606007|20443310|P3|STARTED|Overall Study||179
8291685|NCT01606007|20443311|P2|STARTED|Overall Study||179
8291686|NCT01606007|20443312|P1|STARTED|Overall Study||176
8291687|NCT01605942|20443334|P2|NOT COMPLETED|Overall Study||0
8291688|NCT01605942|20443335|P1|NOT COMPLETED|Overall Study||0
8291689|NCT01605942|20443334|P2|COMPLETED|Overall Study||2
8291690|NCT01605942|20443335|P1|COMPLETED|Overall Study||6
8291691|NCT01605942|20443334|P2|STARTED|Overall Study||2
8291692|NCT01605942|20443335|P1|STARTED|Overall Study||6
8291693|NCT01605916|20443347|P5|NOT COMPLETED|Overall Study||6
8291694|NCT01605916|20443348|P4|NOT COMPLETED|Overall Study||6
8291695|NCT01605916|20443349|P3|NOT COMPLETED|Overall Study||3
8291696|NCT01605916|20443350|P2|NOT COMPLETED|Overall Study||4
8291697|NCT01605916|20443351|P1|NOT COMPLETED|Overall Study||4
8291698|NCT01605916|20443347|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
8291699|NCT01605916|20443348|P4|COMPLETED|Overall Study||0
8291700|NCT01605916|20443349|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
8291701|NCT01605916|20443350|P2|COMPLETED|Overall Study||0
8291702|NCT01605916|20443351|P1|COMPLETED|Overall Study||0
8291703|NCT01605916|20443347|P5|STARTED|Overall Study||7
8291704|NCT01605916|20443348|P4|STARTED|Overall Study||6
8291705|NCT01605916|20443349|P3|STARTED|Overall Study||4
8291706|NCT01605916|20443350|P2|STARTED|Overall Study||4
8291707|NCT01605916|20443351|P1|STARTED|Overall Study||4
8291708|NCT01605903|20443426|P2|NOT COMPLETED|Overall Study||0
8291709|NCT01605903|20443427|P1|NOT COMPLETED|Overall Study||0
8291710|NCT01605903|20443426|P2|COMPLETED|Overall Study||343
8291711|NCT01605903|20443427|P1|COMPLETED|Overall Study||345
8291712|NCT01605903|20443426|P2|STARTED|Overall Study||343
8291713|NCT01605903|20443427|P1|STARTED|Overall Study||345
8291714|NCT01605890|20443433|P1|NOT COMPLETED|Overall Study||2
8291715|NCT01605890|20443433|P1|COMPLETED|Overall Study||28
8291716|NCT01605890|20443433|P1|STARTED|Overall Study||30
8291717|NCT01605877|20443448|P1|NOT COMPLETED|Overall Study||1
8291718|NCT01605877|20443448|P1|COMPLETED|Overall Study||63
8291719|NCT01605877|20443448|P1|STARTED|Overall Study||64
8291720|NCT01605825|20443512|P2|NOT COMPLETED|Overall Study||3
8291721|NCT01605825|20443513|P1|NOT COMPLETED|Overall Study||10
8291722|NCT01605825|20443512|P2|COMPLETED|Overall Study||25
8291723|NCT01605825|20443513|P1|COMPLETED|Overall Study||45
8291724|NCT01605825|20443512|P2|STARTED|Overall Study||28
8291725|NCT01605825|20443513|P1|STARTED|Overall Study||55
8291726|NCT01605799|20443521|P2|NOT COMPLETED|Overall Study||1
8291727|NCT01605799|20443522|P1|NOT COMPLETED|Overall Study||2
8291728|NCT01605799|20443521|P2|COMPLETED|Overall Study||15
8291729|NCT01605799|20443522|P1|COMPLETED|Overall Study||15
8291730|NCT01605799|20443521|P2|STARTED|Overall Study||16
8291731|NCT01605799|20443522|P1|STARTED|Overall Study||17
8291732|NCT01605669|20443530|P1|NOT COMPLETED|Overall Study||0
8291733|NCT01605669|20443530|P1|COMPLETED|Overall Study||50
8291734|NCT01605669|20443530|P1|STARTED|Overall Study||50
8291735|NCT01605617|20443537|P2|NOT COMPLETED|Second Intervention||0
8291736|NCT01605617|20443538|P1|NOT COMPLETED|Second Intervention||0
8291737|NCT01605617|20443537|P2|COMPLETED|Second Intervention||0
8291738|NCT01605617|20443538|P1|COMPLETED|Second Intervention||0
8291739|NCT01605617|20443537|P2|STARTED|Second Intervention||0
8291740|NCT01605617|20443538|P1|STARTED|Second Intervention||0
8291741|NCT01605617|20443537|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
8291742|NCT01605617|20443538|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
8291743|NCT01605617|20443537|P2|COMPLETED|Washout Period of 4 Weeks||0
8291744|NCT01605617|20443538|P1|COMPLETED|Washout Period of 4 Weeks||0
8291745|NCT01605617|20443537|P2|STARTED|Washout Period of 4 Weeks||1
8291746|NCT01605617|20443538|P1|STARTED|Washout Period of 4 Weeks||2
8291747|NCT01605617|20443537|P2|NOT COMPLETED|First Intervention||1
8291748|NCT01605617|20443538|P1|NOT COMPLETED|First Intervention||0
8291749|NCT01605617|20443537|P2|COMPLETED|First Intervention||1
8291750|NCT01605617|20443538|P1|COMPLETED|First Intervention||2
8291751|NCT01605617|20443537|P2|STARTED|First Intervention||2
8291752|NCT01605617|20443538|P1|STARTED|First Intervention||2
8291753|NCT01605552|20443558|P2|NOT COMPLETED|Overall Study||2
8291754|NCT01605552|20443559|P1|NOT COMPLETED|Overall Study||6
8291755|NCT01605552|20443558|P2|COMPLETED|Overall Study||14
8291756|NCT01605552|20443559|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
8291757|NCT01605552|20443558|P2|STARTED|Overall Study||16
8291758|NCT01605552|20443559|P1|STARTED|Overall Study||13
8291759|NCT01605539|20443573|P3|NOT COMPLETED|Overall Study||0
8291760|NCT01605539|20443574|P2|NOT COMPLETED|Overall Study||1
8291761|NCT01605539|20443575|P1|NOT COMPLETED|Overall Study||0
8291762|NCT01605539|20443573|P3|COMPLETED|Overall Study||4
8291763|NCT01605539|20443574|P2|COMPLETED|Overall Study||2
8291764|NCT01605539|20443575|P1|COMPLETED|Overall Study||3
8291765|NCT01605539|20443573|P3|STARTED|Overall Study||4
8291766|NCT01605539|20443574|P2|STARTED|Overall Study||3
8291767|NCT01605539|20443575|P1|STARTED|Overall Study||3
8291768|NCT01605461|20443597|P1|NOT COMPLETED|Overall Study||4
8291769|NCT01605461|20443597|P1|COMPLETED|Overall Study||8
8291770|NCT01605461|20443597|P1|STARTED|Overall Study||12
8291771|NCT01605435|20443606|P2|NOT COMPLETED|Overall Study||0
8291772|NCT01605435|20443607|P1|NOT COMPLETED|Overall Study||0
8291773|NCT01605435|20443606|P2|COMPLETED|Overall Study||3
8291774|NCT01605435|20443607|P1|COMPLETED|Overall Study||2
8291775|NCT01605435|20443606|P2|STARTED|Overall Study||3
8291776|NCT01605435|20443607|P1|STARTED|Overall Study||2
8291777|NCT01605396|20443656|P2|NOT COMPLETED|Overall Study||40
8291778|NCT01605396|20443657|P1|NOT COMPLETED|Overall Study||40
8291779|NCT01605396|20443656|P2|COMPLETED|Overall Study||0
8291780|NCT01605396|20443657|P1|COMPLETED|Overall Study||0
8291781|NCT01605396|20443656|P2|Treated|Overall Study||40
8291782|NCT01605396|20443657|P1|Treated|Overall Study||39
8291783|NCT01605396|20443656|P2|STARTED|Overall Study||40
8291784|NCT01605396|20443657|P1|STARTED|Overall Study||40
8291785|NCT01605370|20443671|P2|NOT COMPLETED|Overall Study||0
8291786|NCT01605370|20443672|P1|NOT COMPLETED|Overall Study||1
8291787|NCT01605370|20443671|P2|COMPLETED|Overall Study||0
8291788|NCT01605370|20443672|P1|COMPLETED|Overall Study||0
8291789|NCT01605370|20443671|P2|STARTED|Overall Study||0
8291790|NCT01605370|20443672|P1|STARTED|Overall Study||1
8291791|NCT01605292|20443680|P2|NOT COMPLETED|Overall Study||0
8291792|NCT01605292|20443681|P1|NOT COMPLETED|Overall Study||0
8291793|NCT01605292|20443680|P2|COMPLETED|Overall Study||347
8291794|NCT01605292|20443681|P1|COMPLETED|Overall Study||351
8291795|NCT01605292|20443680|P2|STARTED|Overall Study||347
8291796|NCT01605292|20443681|P1|STARTED|Overall Study||351
8291797|NCT01605227|20443707|P2|NOT COMPLETED|Overall Study||329
8291798|NCT01605227|20443708|P1|NOT COMPLETED|Overall Study||621
8291799|NCT01605227|20443707|P2|COMPLETED|Overall Study||17
8291800|NCT01605227|20443708|P1|COMPLETED|Overall Study||61
8291801|NCT01605227|20443707|P2|STARTED|Overall Study||346
8291802|NCT01605227|20443708|P1|STARTED|Overall Study||682
8291803|NCT01605136|20443720|P2|NOT COMPLETED|Safety Follow-Up Period||2
8291804|NCT01605136|20443721|P1|NOT COMPLETED|Safety Follow-Up Period||1
8291805|NCT01605136|20443720|P2|COMPLETED|Safety Follow-Up Period||40
8291806|NCT01605136|20443721|P1|COMPLETED|Safety Follow-Up Period||44
8291807|NCT01605136|20443720|P2|STARTED|Safety Follow-Up Period||42
8291808|NCT01605136|20443721|P1|STARTED|Safety Follow-Up Period||45
8291809|NCT01605136|20443720|P2|NOT COMPLETED|Study Period||3
8291810|NCT01605136|20443721|P1|NOT COMPLETED|Study Period||3
8291811|NCT01605136|20443720|P2|COMPLETED|Study Period||42
8291812|NCT01605136|20443721|P1|COMPLETED|Study Period||45
8291813|NCT01605136|20443720|P2|STARTED|Study Period||45
8291814|NCT01605136|20443721|P1|STARTED|Study Period||48
8291815|NCT01605032|20443739|P1|NOT COMPLETED|Overall Study||1
8291816|NCT01605032|20443739|P1|COMPLETED|Overall Study||18
8291817|NCT01605032|20443739|P1|STARTED|Overall Study||19
8291818|NCT01605019|20443750|P2|NOT COMPLETED|Overall Study||0
8291819|NCT01605019|20443751|P1|NOT COMPLETED|Overall Study||3
8291820|NCT01605019|20443750|P2|COMPLETED|Overall Study||0
8291821|NCT01605019|20443751|P1|COMPLETED|Overall Study||1
8291822|NCT01605019|20443750|P2|STARTED|Overall Study||0
8291823|NCT01605019|20443751|P1|STARTED|Overall Study||4
8291824|NCT01604941|20443761|P6|NOT COMPLETED|Overall Study||7
8291825|NCT01604941|20443762|P5|NOT COMPLETED|Overall Study||1
8291826|NCT01604941|20443763|P4|NOT COMPLETED|Overall Study||3
8291827|NCT01604941|20443764|P3|NOT COMPLETED|Overall Study||3
8291828|NCT01604941|20443765|P2|NOT COMPLETED|Overall Study||4
8291829|NCT01604941|20443766|P1|NOT COMPLETED|Overall Study||11
8291830|NCT01604941|20443761|P6|COMPLETED|Overall Study||0
8291831|NCT01604941|20443762|P5|COMPLETED|Overall Study||3
8291832|NCT01604941|20443763|P4|COMPLETED|Overall Study||0
8291833|NCT01604941|20443764|P3|COMPLETED|Overall Study||0
8291834|NCT01604941|20443765|P2|COMPLETED|Overall Study||0
8291835|NCT01604941|20443766|P1|COMPLETED|Overall Study||0
8291836|NCT01604941|20443761|P6|STARTED|Overall Study||7
8291837|NCT01604941|20443762|P5|STARTED|Overall Study||4
8291838|NCT01604941|20443763|P4|STARTED|Overall Study||3
8291839|NCT01604941|20443764|P3|STARTED|Overall Study||3
8291840|NCT01604941|20443765|P2|STARTED|Overall Study||4
8291841|NCT01604941|20443766|P1|STARTED|Overall Study||11
8291842|NCT01604850|20443794|P2|NOT COMPLETED|Overall Study||30
8291843|NCT01604850|20443795|P1|NOT COMPLETED|Overall Study||52
8291844|NCT01604850|20443794|P2|COMPLETED|Overall Study||69
8291845|NCT01604850|20443795|P1|COMPLETED|Overall Study||51
8291846|NCT01604850|20443794|P2|Enrolled and Treated|Overall Study||98
8291847|NCT01604850|20443795|P1|Enrolled and Treated|Overall Study||103
8291848|NCT01604850|20443794|P2|STARTED|Overall Study||99
8291849|NCT01604850|20443795|P1|STARTED|Overall Study||103
8291850|NCT01604824|20443815|P6|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291851|NCT01604824|20443816|P5|NOT COMPLETED|Open-label Extension (OLE) Period||3
8291852|NCT01604824|20443817|P4|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291853|NCT01604824|20443818|P3|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291854|NCT01604824|20443819|P2|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291855|NCT01604824|20443820|P1|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291856|NCT01604824|20443815|P6|COMPLETED|Open-label Extension (OLE) Period||10
8291857|NCT01604824|20443816|P5|COMPLETED|Open-label Extension (OLE) Period||10
8291858|NCT01604824|20443817|P4|COMPLETED|Open-label Extension (OLE) Period||0
8291859|NCT01604824|20443818|P3|COMPLETED|Open-label Extension (OLE) Period||0
8291860|NCT01604824|20443819|P2|COMPLETED|Open-label Extension (OLE) Period||0
8291861|NCT01604824|20443820|P1|COMPLETED|Open-label Extension (OLE) Period||0
8291862|NCT01604824|20443815|P6|Completed Study|Open-label Extension (OLE) Period||10
8291863|NCT01604824|20443816|P5|Completed Study|Open-label Extension (OLE) Period||10
8291864|NCT01604824|20443817|P4|Completed Study|Open-label Extension (OLE) Period||0
8291865|NCT01604824|20443818|P3|Completed Study|Open-label Extension (OLE) Period||0
8291866|NCT01604824|20443819|P2|Completed Study|Open-label Extension (OLE) Period||0
8291867|NCT01604824|20443820|P1|Completed Study|Open-label Extension (OLE) Period||0
8291868|NCT01604824|20443815|P6|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
8291869|NCT01604824|20443816|P5|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
8291870|NCT01604824|20443817|P4|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291871|NCT01604824|20443818|P3|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291872|NCT01604824|20443819|P2|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291873|NCT01604824|20443820|P1|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291874|NCT01604824|20443815|P6|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
8291875|NCT01604824|20443816|P5|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
8291876|NCT01604824|20443817|P4|STARTED|Open-label Extension (OLE) Period||0
8291877|NCT01604824|20443818|P3|STARTED|Open-label Extension (OLE) Period||0
8291878|NCT01604824|20443819|P2|STARTED|Open-label Extension (OLE) Period||0
8291879|NCT01604824|20443820|P1|STARTED|Open-label Extension (OLE) Period||0
8291880|NCT01604824|20443815|P6|NOT COMPLETED|Double-blind (DB) Period||0
8291881|NCT01604824|20443816|P5|NOT COMPLETED|Double-blind (DB) Period||0
8291882|NCT01604824|20443817|P4|NOT COMPLETED|Double-blind (DB) Period||0
8291883|NCT01604824|20443818|P3|NOT COMPLETED|Double-blind (DB) Period||0
8291884|NCT01604824|20443819|P2|NOT COMPLETED|Double-blind (DB) Period||0
8291885|NCT01604824|20443820|P1|NOT COMPLETED|Double-blind (DB) Period||0
8291886|NCT01604824|20443815|P6|COMPLETED|Double-blind (DB) Period||0
8291887|NCT01604824|20443816|P5|COMPLETED|Double-blind (DB) Period||0
8291888|NCT01604824|20443817|P4|COMPLETED|Double-blind (DB) Period||5
8291889|NCT01604824|20443818|P3|COMPLETED|Double-blind (DB) Period||5
8291890|NCT01604824|20443819|P2|COMPLETED|Double-blind (DB) Period||7
8291891|NCT01604824|20443820|P1|COMPLETED|Double-blind (DB) Period||6
8291892|NCT01604824|20443815|P6|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
8291893|NCT01604824|20443816|P5|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
8291894|NCT01604824|20443817|P4|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
8291895|NCT01604824|20443818|P3|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
8291896|NCT01604824|20443819|P2|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
8291897|NCT01604824|20443820|P1|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
8291898|NCT01604824|20443815|P6|Completed DB Period (Day 99)|Double-blind (DB) Period||0
8291899|NCT01604824|20443816|P5|Completed DB Period (Day 99)|Double-blind (DB) Period||0
8291900|NCT01604824|20443817|P4|Completed DB Period (Day 99)|Double-blind (DB) Period||5
8291901|NCT01604824|20443818|P3|Completed DB Period (Day 99)|Double-blind (DB) Period||5
8291902|NCT01604824|20443819|P2|Completed DB Period (Day 99)|Double-blind (DB) Period||7
8291903|NCT01604824|20443820|P1|Completed DB Period (Day 99)|Double-blind (DB) Period||6
8291904|NCT01604824|20443815|P6|STARTED|Double-blind (DB) Period||0
8291905|NCT01604824|20443816|P5|STARTED|Double-blind (DB) Period||0
8291906|NCT01604824|20443817|P4|STARTED|Double-blind (DB) Period||5
8291907|NCT01604824|20443818|P3|STARTED|Double-blind (DB) Period||5
8291908|NCT01604824|20443819|P2|STARTED|Double-blind (DB) Period||7
8291909|NCT01604824|20443820|P1|STARTED|Double-blind (DB) Period||6
8291910|NCT01604785|20443850|P2|NOT COMPLETED|Overall Study||1
8291911|NCT01604785|20443851|P1|NOT COMPLETED|Overall Study||7
8291912|NCT01604785|20443850|P2|COMPLETED|Overall Study||36
8291913|NCT01604785|20443851|P1|COMPLETED|Overall Study||30
8291914|NCT01604785|20443850|P2|STARTED|Overall Study||37
8291915|NCT01604785|20443851|P1|STARTED|Overall Study||37
8291916|NCT01604772|20443861|P1|NOT COMPLETED|Overall Study||0
8291917|NCT01604772|20443861|P1|COMPLETED|Overall Study||16
8291918|NCT01604772|20443861|P1|STARTED|Overall Study||16
8291919|NCT01604408|20443870|P2|NOT COMPLETED|Observation Period||3
8291920|NCT01604408|20443871|P1|NOT COMPLETED|Observation Period||1
8291921|NCT01604408|20443870|P2|COMPLETED|Observation Period||84
8291922|NCT01604408|20443871|P1|COMPLETED|Observation Period||85
8291923|NCT01604408|20443870|P2|STARTED|Observation Period||87
8291924|NCT01604408|20443871|P1|STARTED|Observation Period||86
8291925|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 6||2
8291926|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 6||2
8291927|NCT01604408|20443870|P2|COMPLETED|Treatment Period 6||87
8291928|NCT01604408|20443871|P1|COMPLETED|Treatment Period 6||86
8291929|NCT01604408|20443870|P2|STARTED|Treatment Period 6||89
8291930|NCT01604408|20443871|P1|STARTED|Treatment Period 6||88
8291931|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 5||0
8291932|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 5||4
8291933|NCT01604408|20443870|P2|COMPLETED|Treatment Period 5||89
8291934|NCT01604408|20443871|P1|COMPLETED|Treatment Period 5||88
8291935|NCT01604408|20443870|P2|STARTED|Treatment Period 5||89
8291936|NCT01604408|20443871|P1|STARTED|Treatment Period 5||92
8291937|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 4||2
8291938|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 4||3
8291939|NCT01604408|20443870|P2|COMPLETED|Treatment Period 4||89
8291940|NCT01604408|20443871|P1|COMPLETED|Treatment Period 4||92
8291941|NCT01604408|20443870|P2|STARTED|Treatment Period 4||91
8291942|NCT01604408|20443871|P1|STARTED|Treatment Period 4||95
8291943|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 3||5
8291944|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 3||5
8291945|NCT01604408|20443870|P2|COMPLETED|Treatment Period 3||91
8291946|NCT01604408|20443871|P1|COMPLETED|Treatment Period 3||95
8291947|NCT01604408|20443870|P2|STARTED|Treatment Period 3||96
8291948|NCT01604408|20443871|P1|STARTED|Treatment Period 3||100
8291949|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 2||2
8291950|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 2||2
8291951|NCT01604408|20443870|P2|COMPLETED|Treatment Period 2||96
8291952|NCT01604408|20443871|P1|COMPLETED|Treatment Period 2||100
8291953|NCT01604408|20443870|P2|STARTED|Treatment Period 2||98
8291954|NCT01604408|20443871|P1|STARTED|Treatment Period 2||102
8291955|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 1||1
8291956|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 1||0
8291957|NCT01604408|20443870|P2|COMPLETED|Treatment Period 1||98
8291958|NCT01604408|20443871|P1|COMPLETED|Treatment Period 1||102
8291959|NCT01604408|20443870|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
8291960|NCT01604408|20443871|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
8291961|NCT01604408|20443870|P2|STARTED|Treatment Period 1||99
8291962|NCT01604408|20443871|P1|STARTED|Treatment Period 1||102
8291963|NCT01604343|20443886|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
8291964|NCT01604343|20443887|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
8291965|NCT01604343|20443888|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
8291966|NCT01604343|20443889|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
8291967|NCT01604343|20443890|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
8291968|NCT01604343|20443886|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
8291969|NCT01604343|20443887|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
8291970|NCT01604343|20443888|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
8291971|NCT01604343|20443889|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
8291972|NCT01604343|20443890|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
8291973|NCT01604343|20443886|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
8291974|NCT01604343|20443887|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
8291975|NCT01604343|20443888|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
8291976|NCT01604343|20443889|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
8291977|NCT01604343|20443890|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
8291978|NCT01604343|20443886|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
8291979|NCT01604343|20443887|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
8291980|NCT01604343|20443888|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
8291981|NCT01604343|20443889|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
8291982|NCT01604343|20443890|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
8291983|NCT01604343|20443886|P5|NOT COMPLETED|Week 52 to Week 104||41
8291984|NCT01604343|20443887|P4|NOT COMPLETED|Week 52 to Week 104||46
8291985|NCT01604343|20443888|P3|NOT COMPLETED|Week 52 to Week 104||67
8291986|NCT01604343|20443889|P2|NOT COMPLETED|Week 52 to Week 104||43
8291987|NCT01604343|20443890|P1|NOT COMPLETED|Week 52 to Week 104||0
8291988|NCT01604343|20443886|P5|COMPLETED|Week 52 to Week 104||429
8291989|NCT01604343|20443887|P4|COMPLETED|Week 52 to Week 104||195
8291990|NCT01604343|20443888|P3|COMPLETED|Week 52 to Week 104||414
8291991|NCT01604343|20443889|P2|COMPLETED|Week 52 to Week 104||200
8291992|NCT01604343|20443890|P1|COMPLETED|Week 52 to Week 104||0
8291993|NCT01604343|20443886|P5|Treated|Week 52 to Week 104||470
8291994|NCT01604343|20443887|P4|Treated|Week 52 to Week 104||241
8291995|NCT01604343|20443888|P3|Treated|Week 52 to Week 104||481
8291996|NCT01604343|20443889|P2|Treated|Week 52 to Week 104||242
8291997|NCT01604343|20443890|P1|Treated|Week 52 to Week 104||0
8291998|NCT01604343|20443886|P5|STARTED|Week 52 to Week 104||470
8291999|NCT01604343|20443887|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
8292000|NCT01604343|20443888|P3|STARTED|Week 52 to Week 104||481
8292001|NCT01604343|20443889|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
8292002|NCT01604343|20443890|P1|STARTED|Week 52 to Week 104||0
8292003|NCT01604343|20443886|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
8292004|NCT01604343|20443887|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
8292005|NCT01604343|20443888|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
8292006|NCT01604343|20443889|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
8292007|NCT01604343|20443890|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
8292008|NCT01604343|20443886|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
8292009|NCT01604343|20443887|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
8292010|NCT01604343|20443888|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
8292011|NCT01604343|20443889|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
8292012|NCT01604343|20443890|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
8292013|NCT01604343|20443886|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292014|NCT01604343|20443887|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292015|NCT01604343|20443888|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292016|NCT01604343|20443889|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292017|NCT01604343|20443890|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
8292018|NCT01604343|20443886|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292019|NCT01604343|20443887|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292020|NCT01604343|20443888|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292021|NCT01604343|20443889|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292022|NCT01604343|20443890|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
8292023|NCT01604343|20443886|P5|STARTED|Prior to W52 Administration(Through W52)||557
8292024|NCT01604343|20443887|P4|STARTED|Prior to W52 Administration(Through W52)||0
8292025|NCT01604343|20443888|P3|STARTED|Prior to W52 Administration(Through W52)||557
8292026|NCT01604343|20443889|P2|STARTED|Prior to W52 Administration(Through W52)||0
8292027|NCT01604343|20443890|P1|STARTED|Prior to W52 Administration(Through W52)||556
8292028|NCT01604291|20444003|P4|NOT COMPLETED|Overall Study||0
8292029|NCT01604291|20444004|P3|NOT COMPLETED|Overall Study||0
8292030|NCT01604291|20444005|P2|NOT COMPLETED|Overall Study||0
8292031|NCT01604291|20444006|P1|NOT COMPLETED|Overall Study||0
8292032|NCT01604291|20444003|P4|COMPLETED|Overall Study||44
8292033|NCT01604291|20444004|P3|COMPLETED|Overall Study||193
8292034|NCT01604291|20444005|P2|COMPLETED|Overall Study||443
8292035|NCT01604291|20444006|P1|COMPLETED|Overall Study||311
8292036|NCT01604291|20444003|P4|STARTED|Overall Study||44
8292037|NCT01604291|20444004|P3|STARTED|Overall Study||193
8292038|NCT01604291|20444005|P2|STARTED|Overall Study||443
8292039|NCT01604291|20444006|P1|STARTED|Overall Study||311
8292040|NCT01604278|20444055|P2|NOT COMPLETED|Overall Study||13
8292041|NCT01604278|20444056|P1|NOT COMPLETED|Overall Study||14
8292042|NCT01604278|20444055|P2|COMPLETED|Overall Study||210
8292043|NCT01604278|20444056|P1|COMPLETED|Overall Study||212
8292044|NCT01604278|20444055|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
8292045|NCT01604278|20444056|P1|Full Analysis Set|Overall Study||226
8292046|NCT01604278|20444055|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
8292047|NCT01604278|20444056|P1|Safety Set|Overall Study||226
8292048|NCT01604278|20444055|P2|STARTED|Overall Study||223
8292049|NCT01604278|20444056|P1|STARTED|Overall Study||226
8292050|NCT01604265|20444082|P2|NOT COMPLETED|Overall Study||0
8292051|NCT01604265|20444083|P1|NOT COMPLETED|Overall Study||2
8292052|NCT01604265|20444082|P2|COMPLETED|Overall Study||32
8292053|NCT01604265|20444083|P1|COMPLETED|Overall Study||32
8292054|NCT01604265|20444082|P2|STARTED|Overall Study||32
8292055|NCT01604265|20444083|P1|STARTED|Overall Study||34
8292056|NCT01604122|20444119|P2|NOT COMPLETED|Overall Study||0
8292057|NCT01604122|20444120|P1|NOT COMPLETED|Overall Study||0
8292058|NCT01604122|20444119|P2|COMPLETED|Overall Study||32
8292059|NCT01604122|20444120|P1|COMPLETED|Overall Study||60
8292060|NCT01604122|20444119|P2|STARTED|Overall Study||32
8292061|NCT01604122|20444120|P1|STARTED|Overall Study||60
8292062|NCT01604109|20444167|P2|NOT COMPLETED|Overall Study||34
8292063|NCT01604109|20444168|P1|NOT COMPLETED|Overall Study||33
8292064|NCT01604109|20444167|P2|COMPLETED|Overall Study||112
8292065|NCT01604109|20444168|P1|COMPLETED|Overall Study||117
8292066|NCT01604109|20444167|P2|STARTED|Overall Study||146
8292067|NCT01604109|20444168|P1|STARTED|Overall Study||150
8292068|NCT01603940|20444176|P2|NOT COMPLETED|Overall Study||0
8292069|NCT01603940|20444177|P1|NOT COMPLETED|Overall Study||0
8292070|NCT01603940|20444176|P2|COMPLETED|Overall Study||14
8292071|NCT01603940|20444177|P1|COMPLETED|Overall Study||16
8292072|NCT01603940|20444176|P2|STARTED|Overall Study||14
8292073|NCT01603940|20444177|P1|STARTED|Overall Study||16
8292074|NCT01603875|20444194|P3|NOT COMPLETED|Overall Study||9
8292075|NCT01603875|20444195|P2|NOT COMPLETED|Overall Study||8
8292076|NCT01603875|20444196|P1|NOT COMPLETED|Overall Study||7
8292077|NCT01603875|20444194|P3|COMPLETED|Overall Study||26
8292078|NCT01603875|20444195|P2|COMPLETED|Overall Study||27
8292079|NCT01603875|20444196|P1|COMPLETED|Overall Study||28
8292080|NCT01603875|20444194|P3|STARTED|Overall Study||35
8292081|NCT01603875|20444195|P2|STARTED|Overall Study||35
8292082|NCT01603875|20444196|P1|STARTED|Overall Study||35
8292083|NCT01603641|20444216|P1|NOT COMPLETED|Overall Study||35
8292084|NCT01603641|20444216|P1|COMPLETED|Overall Study||335
8292085|NCT01603641|20444216|P1|Modified Intent-to-treat Population|Overall Study||366
8292086|NCT01603641|20444216|P1|Safety Population (Treated)|Overall Study||367
8292087|NCT01603641|20444216|P1|STARTED|Overall Study||370
8292088|NCT01603628|20444223|P3|NOT COMPLETED|Overall Study||2
8292089|NCT01603628|20444224|P2|NOT COMPLETED|Overall Study||3
8292090|NCT01603628|20444225|P1|NOT COMPLETED|Overall Study||3
8292091|NCT01603628|20444223|P3|COMPLETED|Overall Study||128
8292092|NCT01603628|20444224|P2|COMPLETED|Overall Study||123
8292093|NCT01603628|20444225|P1|COMPLETED|Overall Study||125
8292094|NCT01603628|20444223|P3|Safety Population: Received Treatment|Overall Study||128
8292095|NCT01603628|20444224|P2|Safety Population: Received Treatment|Overall Study||126
8292096|NCT01603628|20444225|P1|Safety Population: Received Treatment|Overall Study||128
8292097|NCT01603628|20444223|P3|STARTED|Overall Study||130
8292098|NCT01603628|20444224|P2|STARTED|Overall Study||126
8292099|NCT01603628|20444225|P1|STARTED|Overall Study||128
8292100|NCT01603615|20444242|P1|NOT COMPLETED|Overall Study||34
8292101|NCT01603615|20444242|P1|COMPLETED|Overall Study||186
8292102|NCT01603615|20444242|P1|Safety Population (Treated)|Overall Study||213
8292103|NCT01603615|20444242|P1|STARTED|Overall Study||220
8292104|NCT01603602|20444249|P3|NOT COMPLETED|Overall Study||1
8292105|NCT01603602|20444250|P2|NOT COMPLETED|Overall Study||0
8292106|NCT01603602|20444251|P1|NOT COMPLETED|Overall Study||2
8292107|NCT01603602|20444249|P3|COMPLETED|Overall Study||79
8292108|NCT01603602|20444250|P2|COMPLETED|Overall Study||78
8292109|NCT01603602|20444251|P1|COMPLETED|Overall Study||75
8292110|NCT01603602|20444249|P3|STARTED|Overall Study||80
8292111|NCT01603602|20444250|P2|STARTED|Overall Study||78
8292112|NCT01603602|20444251|P1|STARTED|Overall Study||77
8292113|NCT01603459|20444271|P1|NOT COMPLETED|Overall Study||18
8292114|NCT01603459|20444271|P1|COMPLETED|Overall Study||137
8292115|NCT01603459|20444271|P1|STARTED|Overall Study||155
8292116|NCT01603420|20444393|P2|NOT COMPLETED|Overall Study||0
8292117|NCT01603420|20444394|P1|NOT COMPLETED|Overall Study||0
8292118|NCT01603420|20444393|P2|COMPLETED|Overall Study||1
8292119|NCT01603420|20444394|P1|COMPLETED|Overall Study||1
8292120|NCT01603420|20444393|P2|STARTED|Overall Study||1
8292121|NCT01603420|20444394|P1|STARTED|Overall Study||1
8292122|NCT01603394|20444422|P1|NOT COMPLETED|Overall Study||1
8292123|NCT01603394|20444422|P1|COMPLETED|Overall Study||8
8292124|NCT01603394|20444422|P1|STARTED|Overall Study||9
8292125|NCT01603368|20444439|P2|NOT COMPLETED|Overall Study||0
8292126|NCT01603368|20444440|P1|NOT COMPLETED|Overall Study||0
8292127|NCT01603368|20444439|P2|COMPLETED|Overall Study||66
8292128|NCT01603368|20444440|P1|COMPLETED|Overall Study||68
8292129|NCT01603368|20444439|P2|STARTED|Overall Study||66
8292130|NCT01603368|20444440|P1|STARTED|Overall Study||68
8292131|NCT01603355|20444476|P1|NOT COMPLETED|Overall Study||2
8292132|NCT01603355|20444476|P1|COMPLETED|Overall Study||1
8292133|NCT01603355|20444476|P1|STARTED|Overall Study||3
8292134|NCT01603277|20444482|P2|NOT COMPLETED|Overall Study||18
8292135|NCT01603277|20444483|P1|NOT COMPLETED|Overall Study||14
8292136|NCT01603277|20444482|P2|COMPLETED|Overall Study||64
8292137|NCT01603277|20444483|P1|COMPLETED|Overall Study||64
8292138|NCT01603277|20444482|P2|STARTED|Overall Study||82
8292139|NCT01603277|20444483|P1|STARTED|Overall Study||78
8292140|NCT01603121|20444489|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
8292141|NCT01603121|20444490|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
8292142|NCT01603121|20444489|P2|COMPLETED|Second Intervention, 10 Hours||0
8292143|NCT01603121|20444490|P1|COMPLETED|Second Intervention, 10 Hours||0
8292144|NCT01603121|20444489|P2|STARTED|Second Intervention, 10 Hours||0
8292145|NCT01603121|20444490|P1|STARTED|Second Intervention, 10 Hours||1
8292146|NCT01603121|20444489|P2|NOT COMPLETED|First Intervention, 10 Hours||0
8292147|NCT01603121|20444490|P1|NOT COMPLETED|First Intervention, 10 Hours||0
8292148|NCT01603121|20444489|P2|COMPLETED|First Intervention, 10 Hours||0
8292149|NCT01603121|20444490|P1|COMPLETED|First Intervention, 10 Hours||1
8292150|NCT01603121|20444489|P2|STARTED|First Intervention, 10 Hours||0
8292151|NCT01603121|20444490|P1|STARTED|First Intervention, 10 Hours||1
8292152|NCT01603082|20444502|P2|NOT COMPLETED|Overall Study||1
8292153|NCT01603082|20444503|P1|NOT COMPLETED|Overall Study||2
8292154|NCT01603082|20444502|P2|COMPLETED|Overall Study|Completed the study|48
8292155|NCT01603082|20444503|P1|COMPLETED|Overall Study|Completed the study.|49
8292156|NCT01603082|20444502|P2|STARTED|Overall Study|Randomized|49
8292157|NCT01603082|20444503|P1|STARTED|Overall Study|Randomized|51
8292158|NCT01603056|20444513|P2|NOT COMPLETED|Overall Study||14
8292159|NCT01603056|20444514|P1|NOT COMPLETED|Overall Study||34
8292160|NCT01603056|20444513|P2|COMPLETED|Overall Study||190
8292161|NCT01603056|20444514|P1|COMPLETED|Overall Study||379
8292162|NCT01603056|20444513|P2|STARTED|Overall Study||204
8292163|NCT01603056|20444514|P1|STARTED|Overall Study||413
8292164|NCT01603043|20444544|P2|NOT COMPLETED|Overall Study||3
8292165|NCT01603043|20444545|P1|NOT COMPLETED|Overall Study||7
8292166|NCT01603043|20444544|P2|COMPLETED|Overall Study||0
8292167|NCT01603043|20444545|P1|COMPLETED|Overall Study||0
8292168|NCT01603043|20444544|P2|STARTED|Overall Study||3
8292169|NCT01603043|20444545|P1|STARTED|Overall Study||7
8292170|NCT01602965|20444557|P2|NOT COMPLETED|Overall Study||2
8292171|NCT01602965|20444558|P1|NOT COMPLETED|Overall Study||4
8292172|NCT01602965|20444557|P2|COMPLETED|Overall Study||18
8292173|NCT01602965|20444558|P1|COMPLETED|Overall Study||16
8292174|NCT01602965|20444557|P2|STARTED|Overall Study||20
8292175|NCT01602965|20444558|P1|STARTED|Overall Study||20
8292176|NCT01602744|20444566|P2|NOT COMPLETED|Overall Study||23
8292177|NCT01602744|20444567|P1|NOT COMPLETED|Overall Study||30
8292178|NCT01602744|20444566|P2|COMPLETED|Overall Study||160
8292179|NCT01602744|20444567|P1|COMPLETED|Overall Study||146
8292180|NCT01602744|20444566|P2|STARTED|Overall Study||183
8292181|NCT01602744|20444567|P1|STARTED|Overall Study||176
8292182|NCT01602731|20444583|P1|NOT COMPLETED|Overall Study||30
8292183|NCT01602731|20444583|P1|COMPLETED|Overall Study||15
8292184|NCT01602731|20444583|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
8292185|NCT01602731|20444583|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
8292186|NCT01602731|20444583|P1|STARTED|Overall Study||45
8292187|NCT01602692|20444591|P2|NOT COMPLETED|Overall Study||0
8292188|NCT01602692|20444592|P1|NOT COMPLETED|Overall Study||0
8292189|NCT01602692|20444591|P2|COMPLETED|Overall Study||20
8292190|NCT01602692|20444592|P1|COMPLETED|Overall Study||20
8292191|NCT01602692|20444591|P2|STARTED|Overall Study||20
8292192|NCT01602692|20444592|P1|STARTED|Overall Study||20
8292193|NCT01602679|20444612|P2|NOT COMPLETED|Overall Study||0
8292194|NCT01602679|20444613|P1|NOT COMPLETED|Overall Study||0
8292195|NCT01602679|20444612|P2|COMPLETED|Overall Study||3
8292196|NCT01602679|20444613|P1|COMPLETED|Overall Study||4
8292197|NCT01602679|20444612|P2|STARTED|Overall Study||3
8292198|NCT01602679|20444613|P1|STARTED|Overall Study||4
8292199|NCT01602666|20444625|P2|NOT COMPLETED|Radiation Therapy on Protocol||31
8292200|NCT01602666|20444626|P1|NOT COMPLETED|Radiation Therapy on Protocol||10
8292201|NCT01602666|20444625|P2|COMPLETED|Radiation Therapy on Protocol||82
8292202|NCT01602666|20444626|P1|COMPLETED|Radiation Therapy on Protocol||60
8292203|NCT01602666|20444625|P2|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
8292204|NCT01602666|20444626|P1|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
8292205|NCT01602666|20444625|P2|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
8292206|NCT01602666|20444626|P1|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
8292207|NCT01602666|20444625|P2|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
8292208|NCT01602666|20444626|P1|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
8292209|NCT01602666|20444625|P2|STARTED|Radiation Therapy on Protocol||113
8292210|NCT01602666|20444626|P1|STARTED|Radiation Therapy on Protocol||70
8292211|NCT01602666|20444625|P2|NOT COMPLETED|Induction Chemotherapy||24
8292212|NCT01602666|20444626|P1|NOT COMPLETED|Induction Chemotherapy||37
8292213|NCT01602666|20444625|P2|COMPLETED|Induction Chemotherapy||113
8292214|NCT01602666|20444626|P1|COMPLETED|Induction Chemotherapy||70
8292215|NCT01602666|20444625|P2|STARTED|Induction Chemotherapy||137
8292216|NCT01602666|20444626|P1|STARTED|Induction Chemotherapy||107
8292217|NCT01602614|20444642|P4|NOT COMPLETED|Overall Study||0
8292218|NCT01602614|20444643|P3|NOT COMPLETED|Overall Study||0
8292219|NCT01602614|20444644|P2|NOT COMPLETED|Overall Study||0
8292220|NCT01602614|20444645|P1|NOT COMPLETED|Overall Study||0
8292221|NCT01602614|20444642|P4|COMPLETED|Overall Study||0
8292222|NCT01602614|20444643|P3|COMPLETED|Overall Study||8
8292223|NCT01602614|20444644|P2|COMPLETED|Overall Study||10
8292224|NCT01602614|20444645|P1|COMPLETED|Overall Study||0
8292225|NCT01602614|20444642|P4|STARTED|Overall Study||0
8292226|NCT01602614|20444643|P3|STARTED|Overall Study||8
8292227|NCT01602614|20444644|P2|STARTED|Overall Study||10
8292228|NCT01602614|20444645|P1|STARTED|Overall Study||0
8292229|NCT01602562|20444713|P2|NOT COMPLETED|Overall Study||3
8292230|NCT01602562|20444714|P1|NOT COMPLETED|Overall Study||5
8292231|NCT01602562|20444713|P2|COMPLETED|Overall Study||16
8292232|NCT01602562|20444714|P1|COMPLETED|Overall Study||16
8292233|NCT01602562|20444713|P2|STARTED|Overall Study||19
8292234|NCT01602562|20444714|P1|STARTED|Overall Study||21
8292235|NCT01602549|20444750|P2|NOT COMPLETED|Overall Study||1
8292236|NCT01602549|20444751|P1|NOT COMPLETED|Overall Study||1
8292237|NCT01602549|20444750|P2|COMPLETED|Overall Study||37
8292238|NCT01602549|20444751|P1|COMPLETED|Overall Study||18
8292239|NCT01602549|20444750|P2|STARTED|Overall Study||38
8292240|NCT01602549|20444751|P1|STARTED|Overall Study||19
8292241|NCT01602510|20444830|P3|NOT COMPLETED|Randomized Phase||73
8292242|NCT01602510|20444831|P2|NOT COMPLETED|Randomized Phase||74
8292243|NCT01602510|20444832|P1|NOT COMPLETED|Randomized Phase||0
8292244|NCT01602510|20444830|P3|COMPLETED|Randomized Phase||58
8292245|NCT01602510|20444831|P2|COMPLETED|Randomized Phase||59
8292246|NCT01602510|20444832|P1|COMPLETED|Randomized Phase||0
8292247|NCT01602510|20444830|P3|STARTED|Randomized Phase||131
8292248|NCT01602510|20444831|P2|STARTED|Randomized Phase||133
8292249|NCT01602510|20444832|P1|STARTED|Randomized Phase||0
8292250|NCT01602510|20444830|P3|NOT COMPLETED|Open Label Phase||0
8292251|NCT01602510|20444831|P2|NOT COMPLETED|Open Label Phase||0
8292252|NCT01602510|20444832|P1|NOT COMPLETED|Open Label Phase||303
8292253|NCT01602510|20444830|P3|COMPLETED|Open Label Phase||0
8292254|NCT01602510|20444831|P2|COMPLETED|Open Label Phase||0
8292255|NCT01602510|20444832|P1|COMPLETED|Open Label Phase||117
8292256|NCT01602510|20444830|P3|STARTED|Open Label Phase||0
8292257|NCT01602510|20444831|P2|STARTED|Open Label Phase||0
8292258|NCT01602510|20444832|P1|STARTED|Open Label Phase||420
8292259|NCT01602484|20444858|P2|NOT COMPLETED|Overall Study||1
8292260|NCT01602484|20444859|P1|NOT COMPLETED|Overall Study||0
8292261|NCT01602484|20444858|P2|COMPLETED|Overall Study||24
8292262|NCT01602484|20444859|P1|COMPLETED|Overall Study||25
8292263|NCT01602484|20444858|P2|STARTED|Overall Study||25
8292264|NCT01602484|20444859|P1|STARTED|Overall Study||25
8292265|NCT01602471|20444871|P1|NOT COMPLETED|Overall Study||0
8292266|NCT01602471|20444871|P1|COMPLETED|Overall Study||4
8292267|NCT01602471|20444871|P1|STARTED|Overall Study||4
8292268|NCT01602419|20444875|P1|NOT COMPLETED|Overall Study||29
8292269|NCT01602419|20444875|P1|COMPLETED|Overall Study||91
8292270|NCT01602419|20444875|P1|EFF Population|Overall Study||91
8292271|NCT01602419|20444875|P1|ITT Population|Overall Study||102
8292272|NCT01602419|20444875|P1|SAF Population|Overall Study||111
8292273|NCT01602419|20444875|P1|STARTED|Overall Study||120
8292280|NCT01602341|20444955|P2|NOT COMPLETED|Overall Study||1
8292281|NCT01602341|20444956|P1|NOT COMPLETED|Overall Study||0
8292282|NCT01602341|20444955|P2|COMPLETED|Overall Study||41
8292283|NCT01602341|20444956|P1|COMPLETED|Overall Study||44
8292284|NCT01602341|20444955|P2|STARTED|Overall Study||42
8292285|NCT01602341|20444956|P1|STARTED|Overall Study||44
8292286|NCT01602315|20444997|P7|NOT COMPLETED|Overall Study||29
8292287|NCT01602315|20444998|P6|NOT COMPLETED|Overall Study||35
8292288|NCT01602315|20444999|P5|NOT COMPLETED|Overall Study||71
8292289|NCT01602315|20445000|P4|NOT COMPLETED|Overall Study||6
8292290|NCT01602315|20445001|P3|NOT COMPLETED|Overall Study||18
8292291|NCT01602315|20445002|P2|NOT COMPLETED|Overall Study||5
8292292|NCT01602315|20445003|P1|NOT COMPLETED|Overall Study||16
8292293|NCT01602315|20444997|P7|COMPLETED|Overall Study||0
8292294|NCT01602315|20444998|P6|COMPLETED|Overall Study||0
8292295|NCT01602315|20444999|P5|COMPLETED|Overall Study||0
8292296|NCT01602315|20445000|P4|COMPLETED|Overall Study||0
8292297|NCT01602315|20445001|P3|COMPLETED|Overall Study||0
8292298|NCT01602315|20445002|P2|COMPLETED|Overall Study||0
8292299|NCT01602315|20445003|P1|COMPLETED|Overall Study||0
8292300|NCT01602315|20444997|P7|STARTED|Overall Study||29
8292301|NCT01602315|20444998|P6|STARTED|Overall Study||35
8292302|NCT01602315|20444999|P5|STARTED|Overall Study||71
8292303|NCT01602315|20445000|P4|STARTED|Overall Study||6
8292304|NCT01602315|20445001|P3|STARTED|Overall Study||18
8292305|NCT01602315|20445002|P2|STARTED|Overall Study||5
8292306|NCT01602315|20445003|P1|STARTED|Overall Study||16
8292307|NCT01602224|20445092|P3|NOT COMPLETED|Overall Study||6
8292308|NCT01602224|20445093|P2|NOT COMPLETED|Overall Study||8
8292309|NCT01602224|20445094|P1|NOT COMPLETED|Overall Study||8
8292310|NCT01602224|20445092|P3|COMPLETED|Overall Study||66
8292311|NCT01602224|20445093|P2|COMPLETED|Overall Study||66
8292312|NCT01602224|20445094|P1|COMPLETED|Overall Study||66
8292313|NCT01602224|20445092|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
8292314|NCT01602224|20445093|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
8292315|NCT01602224|20445094|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
8292316|NCT01602224|20445092|P3|STARTED|Overall Study||72
8292317|NCT01602224|20445093|P2|STARTED|Overall Study||74
8292318|NCT01602224|20445094|P1|STARTED|Overall Study||74
8292319|NCT01602198|20445140|P2|NOT COMPLETED|Overall Study||0
8292320|NCT01602198|20445141|P1|NOT COMPLETED|Overall Study||0
8292321|NCT01602198|20445140|P2|COMPLETED|Overall Study||1
8292322|NCT01602198|20445141|P1|COMPLETED|Overall Study||0
8292323|NCT01602198|20445140|P2|STARTED|Overall Study||1
8292324|NCT01602198|20445141|P1|STARTED|Overall Study||0
8292325|NCT01602172|20445150|P3|NOT COMPLETED|Overall Study||0
8292326|NCT01602172|20445151|P2|NOT COMPLETED|Overall Study||6
8292327|NCT01602172|20445152|P1|NOT COMPLETED|Overall Study||5
8292328|NCT01602172|20445150|P3|COMPLETED|Overall Study||22
8292329|NCT01602172|20445151|P2|COMPLETED|Overall Study||17
8292330|NCT01602172|20445152|P1|COMPLETED|Overall Study||32
8292331|NCT01602172|20445150|P3|STARTED|Overall Study||22
8292332|NCT01602172|20445151|P2|STARTED|Overall Study||23
8292333|NCT01602172|20445152|P1|STARTED|Overall Study||37
8292334|NCT01602120|20445179|P4|NOT COMPLETED|Overall Study||53
8292335|NCT01602120|20445180|P3|NOT COMPLETED|Overall Study||17
8292336|NCT01602120|20445181|P2|NOT COMPLETED|Overall Study||60
8292337|NCT01602120|20445182|P1|NOT COMPLETED|Overall Study||29
8292338|NCT01602120|20445179|P4|COMPLETED|Overall Study||0
8292339|NCT01602120|20445180|P3|COMPLETED|Overall Study||0
8292340|NCT01602120|20445181|P2|COMPLETED|Overall Study||0
8292341|NCT01602120|20445182|P1|COMPLETED|Overall Study||0
8292342|NCT01602120|20445179|P4|STARTED|Overall Study||53
8292343|NCT01602120|20445180|P3|STARTED|Overall Study||17
8292344|NCT01602120|20445181|P2|STARTED|Overall Study||60
8292345|NCT01602120|20445182|P1|STARTED|Overall Study||29
8292346|NCT01602068|20445196|P2|NOT COMPLETED|Overall Study||0
8292347|NCT01602068|20445197|P1|NOT COMPLETED|Overall Study||0
8292348|NCT01602068|20445196|P2|COMPLETED|Overall Study||22
8292349|NCT01602068|20445197|P1|COMPLETED|Overall Study||23
8292350|NCT01602068|20445196|P2|STARTED|Overall Study|Day before surgery|22
8292351|NCT01602068|20445197|P1|STARTED|Overall Study|Day before surgery|23
8292352|NCT01602016|20445203|P1|NOT COMPLETED|Overall Study||0
8292353|NCT01602016|20445203|P1|COMPLETED|Overall Study||0
8292354|NCT01602016|20445203|P1|STARTED|Overall Study||0
8292355|NCT01601977|20445210|P1|NOT COMPLETED|Overall Study||0
8292356|NCT01601977|20445210|P1|COMPLETED|Overall Study||10
8292357|NCT01601977|20445210|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
8292358|NCT01601873|20445230|P2|NOT COMPLETED|Overall Study||3
8292359|NCT01601873|20445231|P1|NOT COMPLETED|Overall Study||2
8292360|NCT01601873|20445230|P2|COMPLETED|Overall Study||44
8292361|NCT01601873|20445231|P1|COMPLETED|Overall Study||48
8292362|NCT01601873|20445230|P2|STARTED|Overall Study||47
8292363|NCT01601873|20445231|P1|STARTED|Overall Study||50
8292364|NCT01601847|20445257|P2|NOT COMPLETED|Overall Study||10
8292365|NCT01601847|20445258|P1|NOT COMPLETED|Overall Study||13
8292366|NCT01601847|20445257|P2|COMPLETED|Overall Study||137
8292367|NCT01601847|20445258|P1|COMPLETED|Overall Study||140
8292368|NCT01601847|20445257|P2|STARTED|Overall Study||147
8292369|NCT01601847|20445258|P1|STARTED|Overall Study||153
8292370|NCT01601821|20445270|P2|NOT COMPLETED|Overall Study||29
8292371|NCT01601821|20445271|P1|NOT COMPLETED|Overall Study||29
8292372|NCT01601821|20445270|P2|COMPLETED|Overall Study||91
8292373|NCT01601821|20445271|P1|COMPLETED|Overall Study||96
8292374|NCT01601821|20445270|P2|STARTED|Overall Study||120
8292375|NCT01601821|20445271|P1|STARTED|Overall Study||125
8292376|NCT01601782|20445301|P1|NOT COMPLETED|Overall Study||0
8292377|NCT01601782|20445301|P1|COMPLETED|Overall Study||16
8292378|NCT01601782|20445301|P1|STARTED|Overall Study||16
8292379|NCT01601704|20445307|P2|NOT COMPLETED|Overall Study||4
8292380|NCT01601704|20445308|P1|NOT COMPLETED|Overall Study||1
8292381|NCT01601704|20445307|P2|COMPLETED|Overall Study||4450
8292382|NCT01601704|20445308|P1|COMPLETED|Overall Study||4455
8292383|NCT01601704|20445307|P2|Treated|Overall Study||4450
8292384|NCT01601704|20445308|P1|Treated|Overall Study||4455
8292385|NCT01601704|20445307|P2|STARTED|Overall Study||4454
8292386|NCT01601704|20445308|P1|STARTED|Overall Study||4456
8292387|NCT01601691|20445322|P1|NOT COMPLETED|Overall Study||0
8292388|NCT01601691|20445322|P1|COMPLETED|Overall Study||10
8292389|NCT01601691|20445322|P1|STARTED|Overall Study||10
8292390|NCT01601652|20445326|P1|NOT COMPLETED|Overall Study||1
8292391|NCT01601652|20445326|P1|COMPLETED|Overall Study||11
8292392|NCT01601652|20445326|P1|STARTED|Overall Study||12
8292393|NCT01601626|20445334|P3|NOT COMPLETED|Overall Study||2
8292394|NCT01601626|20445335|P2|NOT COMPLETED|Overall Study||5
8292395|NCT01601626|20445336|P1|NOT COMPLETED|Overall Study||3
8292396|NCT01601626|20445334|P3|COMPLETED|Overall Study||21
8292397|NCT01601626|20445335|P2|COMPLETED|Overall Study||19
8292398|NCT01601626|20445336|P1|COMPLETED|Overall Study||21
8292399|NCT01601626|20445334|P3|STARTED|Overall Study||23
8292400|NCT01601626|20445335|P2|STARTED|Overall Study||24
8292401|NCT01601626|20445336|P1|STARTED|Overall Study||24
8292402|NCT01601535|20445425|P6|NOT COMPLETED|Phase 2||12
8292403|NCT01601535|20445426|P5|NOT COMPLETED|Phase 2||19
8292404|NCT01601535|20445427|P4|NOT COMPLETED|Phase 2||0
8292405|NCT01601535|20445428|P3|NOT COMPLETED|Phase 2||0
8292406|NCT01601535|20445429|P2|NOT COMPLETED|Phase 2||0
8292407|NCT01601535|20445430|P1|NOT COMPLETED|Phase 2||0
8292408|NCT01601535|20445425|P6|COMPLETED|Phase 2||0
8292409|NCT01601535|20445426|P5|COMPLETED|Phase 2||1
8292410|NCT01601535|20445427|P4|COMPLETED|Phase 2||0
8292411|NCT01601535|20445428|P3|COMPLETED|Phase 2||0
8292412|NCT01601535|20445429|P2|COMPLETED|Phase 2||0
8292413|NCT01601535|20445430|P1|COMPLETED|Phase 2||0
8292414|NCT01601535|20445425|P6|STARTED|Phase 2||12
8292415|NCT01601535|20445426|P5|STARTED|Phase 2||20
8292416|NCT01601535|20445427|P4|STARTED|Phase 2||0
8292417|NCT01601535|20445428|P3|STARTED|Phase 2||0
8292418|NCT01601535|20445429|P2|STARTED|Phase 2||0
8292419|NCT01601535|20445430|P1|STARTED|Phase 2||0
8292420|NCT01601535|20445425|P6|NOT COMPLETED|Phase 1||0
8292421|NCT01601535|20445426|P5|NOT COMPLETED|Phase 1||0
8292422|NCT01601535|20445427|P4|NOT COMPLETED|Phase 1||4
8292423|NCT01601535|20445428|P3|NOT COMPLETED|Phase 1||5
8292424|NCT01601535|20445429|P2|NOT COMPLETED|Phase 1||6
8292425|NCT01601535|20445430|P1|NOT COMPLETED|Phase 1||6
8292426|NCT01601535|20445425|P6|COMPLETED|Phase 1||0
8292427|NCT01601535|20445426|P5|COMPLETED|Phase 1||0
8292428|NCT01601535|20445427|P4|COMPLETED|Phase 1||0
8292429|NCT01601535|20445428|P3|COMPLETED|Phase 1||1
8292430|NCT01601535|20445429|P2|COMPLETED|Phase 1||0
8292431|NCT01601535|20445430|P1|COMPLETED|Phase 1||0
8292432|NCT01601535|20445425|P6|STARTED|Phase 1||0
8292433|NCT01601535|20445426|P5|STARTED|Phase 1||0
8292434|NCT01601535|20445427|P4|STARTED|Phase 1||4
8292435|NCT01601535|20445428|P3|STARTED|Phase 1||6
8292436|NCT01601535|20445429|P2|STARTED|Phase 1||6
8292437|NCT01601535|20445430|P1|STARTED|Phase 1||6
8292438|NCT01601496|20445486|P1|NOT COMPLETED|Overall Study||15
8292439|NCT01601496|20445486|P1|COMPLETED|Overall Study|Completed 12-M F/up|102
8292440|NCT01601496|20445486|P1|STARTED|Overall Study|Enrolled|117
8292441|NCT01601470|20445494|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
8292442|NCT01601470|20445494|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
8292443|NCT01601470|20445494|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
8292444|NCT01601470|20445494|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
8292445|NCT01601470|20445494|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
8292446|NCT01601470|20445494|P1|NOT COMPLETED|Period 2 - LCZ696||1
8292447|NCT01601470|20445494|P1|COMPLETED|Period 2 - LCZ696||27
8292448|NCT01601470|20445494|P1|Safety Set|Period 2 - LCZ696||27
8292449|NCT01601470|20445494|P1|PK Analysis Set|Period 2 - LCZ696||27
8292450|NCT01601470|20445494|P1|STARTED|Period 2 - LCZ696||28
8292451|NCT01601470|20445494|P1|NOT COMPLETED|Period 1 - Sildenafil||0
8292452|NCT01601470|20445494|P1|COMPLETED|Period 1 - Sildenafil||28
8292453|NCT01601470|20445494|P1|Safety Set|Period 1 - Sildenafil||28
8292454|NCT01601470|20445494|P1|PK Analysis Set|Period 1 - Sildenafil||28
8292455|NCT01601470|20445494|P1|STARTED|Period 1 - Sildenafil||28
8292456|NCT01601431|20445511|P2|NOT COMPLETED|Overall Study||3
8292457|NCT01601431|20445512|P1|NOT COMPLETED|Overall Study||12
8292458|NCT01601431|20445511|P2|COMPLETED|Overall Study||214
8292459|NCT01601431|20445512|P1|COMPLETED|Overall Study||211
8292460|NCT01601431|20445511|P2|STARTED|Overall Study||217
8292461|NCT01601431|20445512|P1|STARTED|Overall Study||223
8292462|NCT01601236|20445524|P6|NOT COMPLETED|Overall Study||1
8292463|NCT01601236|20445525|P5|NOT COMPLETED|Overall Study||3
8292464|NCT01601236|20445526|P4|NOT COMPLETED|Overall Study||2
8292465|NCT01601236|20445527|P3|NOT COMPLETED|Overall Study||6
8292466|NCT01601236|20445528|P2|NOT COMPLETED|Overall Study||1
8292467|NCT01601236|20445529|P1|NOT COMPLETED|Overall Study||5
8292468|NCT01601236|20445524|P6|COMPLETED|Overall Study||0
8292469|NCT01601236|20445525|P5|COMPLETED|Overall Study||0
8292470|NCT01601236|20445526|P4|COMPLETED|Overall Study||4
8292471|NCT01601236|20445527|P3|COMPLETED|Overall Study||8
8292472|NCT01601236|20445528|P2|COMPLETED|Overall Study||2
8292473|NCT01601236|20445529|P1|COMPLETED|Overall Study||2
8292474|NCT01601236|20445524|P6|STARTED|Overall Study||1
8292475|NCT01601236|20445525|P5|STARTED|Overall Study||3
8292476|NCT01601236|20445526|P4|STARTED|Overall Study||6
8292477|NCT01601236|20445527|P3|STARTED|Overall Study||14
8292478|NCT01601236|20445528|P2|STARTED|Overall Study||3
8292479|NCT01601236|20445529|P1|STARTED|Overall Study||7
8292480|NCT01601132|20445565|P1|NOT COMPLETED|Overall Study||2
8292481|NCT01601132|20445565|P1|COMPLETED|Overall Study||28
8292482|NCT01601132|20445565|P1|STARTED|Overall Study||30
8292483|NCT01601067|20445584|P2|NOT COMPLETED|Overall Study||22
8292484|NCT01601067|20445585|P1|NOT COMPLETED|Overall Study||33
8292485|NCT01601067|20445584|P2|COMPLETED|Overall Study||34
8292486|NCT01601067|20445585|P1|COMPLETED|Overall Study||30
8292487|NCT01601067|20445584|P2|STARTED|Overall Study||56
8292488|NCT01601067|20445585|P1|STARTED|Overall Study||63
8292489|NCT01600950|20445593|P2|NOT COMPLETED|Period 2||0
8292490|NCT01600950|20445594|P1|NOT COMPLETED|Period 2||0
8292491|NCT01600950|20445593|P2|COMPLETED|Period 2||10
8292492|NCT01600950|20445594|P1|COMPLETED|Period 2||10
8292493|NCT01600950|20445593|P2|STARTED|Period 2||10
8292494|NCT01600950|20445594|P1|STARTED|Period 2||10
8292495|NCT01600950|20445593|P2|NOT COMPLETED|Period 1||0
8292496|NCT01600950|20445594|P1|NOT COMPLETED|Period 1||0
8292497|NCT01600950|20445593|P2|COMPLETED|Period 1||10
8292498|NCT01600950|20445594|P1|COMPLETED|Period 1||10
8292499|NCT01600950|20445593|P2|STARTED|Period 1||10
8292500|NCT01600950|20445594|P1|STARTED|Period 1||10
8292501|NCT01600885|20445610|P2|NOT COMPLETED|Second Period||0
8292502|NCT01600885|20445611|P1|NOT COMPLETED|Second Period||0
8292503|NCT01600885|20445610|P2|COMPLETED|Second Period||8
8292504|NCT01600885|20445611|P1|COMPLETED|Second Period||8
8292505|NCT01600885|20445610|P2|STARTED|Second Period||8
8292506|NCT01600885|20445611|P1|STARTED|Second Period||8
8292507|NCT01600885|20445610|P2|NOT COMPLETED|Wash Out Period||0
8292508|NCT01600885|20445611|P1|NOT COMPLETED|Wash Out Period||0
8292509|NCT01600885|20445610|P2|COMPLETED|Wash Out Period||8
8292510|NCT01600885|20445611|P1|COMPLETED|Wash Out Period||8
8292511|NCT01600885|20445610|P2|STARTED|Wash Out Period||8
8292512|NCT01600885|20445611|P1|STARTED|Wash Out Period||8
8292513|NCT01600885|20445610|P2|NOT COMPLETED|First Period||1
8292514|NCT01600885|20445611|P1|NOT COMPLETED|First Period||2
8292515|NCT01600885|20445610|P2|COMPLETED|First Period||8
8292516|NCT01600885|20445611|P1|COMPLETED|First Period||8
8292517|NCT01600885|20445610|P2|STARTED|First Period||9
8292518|NCT01600885|20445611|P1|STARTED|First Period||10
8292519|NCT01600729|20445621|P1|NOT COMPLETED|Overall Study||1
8292520|NCT01600729|20445621|P1|COMPLETED|Overall Study||65
8292521|NCT01600729|20445621|P1|STARTED|Overall Study||66
8292522|NCT01600716|20445628|P2|NOT COMPLETED|Overall Study||7
8292523|NCT01600716|20445629|P1|NOT COMPLETED|Overall Study||7
8292524|NCT01600716|20445628|P2|COMPLETED|Overall Study||71
8292525|NCT01600716|20445629|P1|COMPLETED|Overall Study||59
8292526|NCT01600716|20445628|P2|STARTED|Overall Study||78
8292527|NCT01600716|20445629|P1|STARTED|Overall Study||66
8292528|NCT01600703|20445645|P2|NOT COMPLETED|Second Intervention||0
8292529|NCT01600703|20445646|P1|NOT COMPLETED|Second Intervention||0
8292530|NCT01600703|20445645|P2|COMPLETED|Second Intervention||8
8292531|NCT01600703|20445646|P1|COMPLETED|Second Intervention||7
8292532|NCT01600703|20445645|P2|STARTED|Second Intervention||8
8292533|NCT01600703|20445646|P1|STARTED|Second Intervention||7
8292534|NCT01600703|20445645|P2|NOT COMPLETED|First Intervention||0
8292535|NCT01600703|20445646|P1|NOT COMPLETED|First Intervention||0
8292536|NCT01600703|20445645|P2|COMPLETED|First Intervention||8
8292537|NCT01600703|20445646|P1|COMPLETED|First Intervention||7
8292538|NCT01600703|20445645|P2|STARTED|First Intervention||8
8292539|NCT01600703|20445646|P1|STARTED|First Intervention||7
8292540|NCT01600677|20445656|P2|NOT COMPLETED|Overall Study||0
8292541|NCT01600677|20445657|P1|NOT COMPLETED|Overall Study||0
8292542|NCT01600677|20445656|P2|COMPLETED|Overall Study||4
8292543|NCT01600677|20445657|P1|COMPLETED|Overall Study||7
8292544|NCT01600677|20445656|P2|STARTED|Overall Study||4
8292545|NCT01600677|20445657|P1|STARTED|Overall Study||7
8292546|NCT01600638|20445667|P1|NOT COMPLETED|Overall Study||0
8292547|NCT01600638|20445667|P1|COMPLETED|Overall Study||25
8292548|NCT01600638|20445667|P1|STARTED|Overall Study||25
8292549|NCT01600586|20445677|P2|NOT COMPLETED|Overall Study||3
8292550|NCT01600586|20445678|P1|NOT COMPLETED|Overall Study||3
8292551|NCT01600586|20445677|P2|COMPLETED|Overall Study||48
8292552|NCT01600586|20445678|P1|COMPLETED|Overall Study||46
8292553|NCT01600586|20445677|P2|STARTED|Overall Study||51
8292554|NCT01600586|20445678|P1|STARTED|Overall Study||49
8292555|NCT01600495|20445694|P2|NOT COMPLETED|Overall Study||0
8292556|NCT01600495|20445695|P1|NOT COMPLETED|Overall Study||0
8292557|NCT01600495|20445694|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
8292558|NCT01600495|20445695|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
8292559|NCT01600495|20445694|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
8292560|NCT01600495|20445695|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
8292561|NCT01600482|20445709|P2|NOT COMPLETED|Overall Study||0
8292562|NCT01600482|20445710|P1|NOT COMPLETED|Overall Study||0
8292563|NCT01600482|20445709|P2|COMPLETED|Overall Study||59
8292564|NCT01600482|20445710|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
8292565|NCT01600482|20445709|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
8292566|NCT01600482|20445710|P1|STARTED|Overall Study||148
8292567|NCT01600326|20445730|P2|NOT COMPLETED|Overall Study||1
8292568|NCT01600326|20445731|P1|NOT COMPLETED|Overall Study||1
8292569|NCT01600326|20445730|P2|COMPLETED|Overall Study||14
8292570|NCT01600326|20445731|P1|COMPLETED|Overall Study||14
8292571|NCT01600326|20445730|P2|Primary Outcome Measure Data Collection|Overall Study||15
8292572|NCT01600326|20445731|P1|Primary Outcome Measure Data Collection|Overall Study||15
8292573|NCT01600326|20445730|P2|STARTED|Overall Study||15
8292574|NCT01600326|20445731|P1|STARTED|Overall Study||15
8292575|NCT01600287|20445741|P2|NOT COMPLETED|Overall Study||0
8292576|NCT01600287|20445742|P1|NOT COMPLETED|Overall Study||0
8292577|NCT01600287|20445741|P2|COMPLETED|Overall Study||20
8292578|NCT01600287|20445742|P1|COMPLETED|Overall Study||20
8292579|NCT01600287|20445741|P2|STARTED|Overall Study||20
8292580|NCT01600287|20445742|P1|STARTED|Overall Study||20
8292581|NCT01600222|20445782|P1|NOT COMPLETED|Overall Study||2
8292582|NCT01600222|20445782|P1|COMPLETED|Overall Study||35
8292583|NCT01600222|20445782|P1|STARTED|Overall Study||37
8292584|NCT01600170|20445807|P2|NOT COMPLETED|Period 2||0
8292585|NCT01600170|20445808|P1|NOT COMPLETED|Period 2||1
8292586|NCT01600170|20445807|P2|COMPLETED|Period 2||5
8292587|NCT01600170|20445808|P1|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
8292588|NCT01600170|20445807|P2|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
8292589|NCT01600170|20445808|P1|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
8292590|NCT01600170|20445807|P2|NOT COMPLETED|Period 1||0
8292591|NCT01600170|20445808|P1|NOT COMPLETED|Period 1||0
8292592|NCT01600170|20445807|P2|COMPLETED|Period 1||5
8292593|NCT01600170|20445808|P1|COMPLETED|Period 1||6
8292594|NCT01600170|20445807|P2|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
8292595|NCT01600170|20445808|P1|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
8292596|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study V||0
8292597|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study V||2
8292598|NCT01600105|20445832|P2|COMPLETED|Sub Study V||0
8292599|NCT01600105|20445833|P1|COMPLETED|Sub Study V||50
8292600|NCT01600105|20445832|P2|STARTED|Sub Study V||0
8292601|NCT01600105|20445833|P1|STARTED|Sub Study V||52
8292602|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study IV||0
8292603|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study IV||0
8292604|NCT01600105|20445832|P2|COMPLETED|Sub Study IV||8
8292605|NCT01600105|20445833|P1|COMPLETED|Sub Study IV||41
8292606|NCT01600105|20445832|P2|STARTED|Sub Study IV||8
8292607|NCT01600105|20445833|P1|STARTED|Sub Study IV||41
8292608|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study III||0
8292609|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study III||5
8292610|NCT01600105|20445832|P2|COMPLETED|Sub Study III||0
8292611|NCT01600105|20445833|P1|COMPLETED|Sub Study III||34
8292612|NCT01600105|20445832|P2|STARTED|Sub Study III||0
8292613|NCT01600105|20445833|P1|STARTED|Sub Study III||39
8292614|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study II||0
8292615|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study II||5
8292616|NCT01600105|20445832|P2|COMPLETED|Sub Study II||0
8292617|NCT01600105|20445833|P1|COMPLETED|Sub Study II||60
8292618|NCT01600105|20445832|P2|STARTED|Sub Study II||0
8292619|NCT01600105|20445833|P1|STARTED|Sub Study II||65
8292620|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study I||10
8292621|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study I||0
8292622|NCT01600105|20445832|P2|COMPLETED|Sub Study I||11
8292623|NCT01600105|20445833|P1|COMPLETED|Sub Study I||19
8292624|NCT01600105|20445832|P2|STARTED|Sub Study I||21
8292625|NCT01600105|20445833|P1|STARTED|Sub Study I||19
8292626|NCT01600105|20445832|P2|NOT COMPLETED|Total Participants||10
8292627|NCT01600105|20445833|P1|NOT COMPLETED|Total Participants||41
8292628|NCT01600105|20445832|P2|COMPLETED|Total Participants||11
8292629|NCT01600105|20445833|P1|COMPLETED|Total Participants||214
8292630|NCT01600105|20445832|P2|STARTED|Total Participants||21
8292631|NCT01600105|20445833|P1|STARTED|Total Participants||255
8292632|NCT01600092|20445861|P2|NOT COMPLETED|Overall Study||16
8292633|NCT01600092|20445862|P1|NOT COMPLETED|Overall Study||18
8292634|NCT01600092|20445861|P2|COMPLETED|Overall Study||491
8292635|NCT01600092|20445862|P1|COMPLETED|Overall Study||495
8292636|NCT01600092|20445861|P2|Received All 3 Vaccinations|Overall Study||494
8292637|NCT01600092|20445862|P1|Received All 3 Vaccinations|Overall Study||500
8292638|NCT01600092|20445861|P2|Received at Least 1 Vaccination|Overall Study||504
8292639|NCT01600092|20445862|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
8292640|NCT01600092|20445861|P2|STARTED|Overall Study||507
8292641|NCT01600092|20445862|P1|STARTED|Overall Study||513
8292642|NCT01600053|20445876|P1|NOT COMPLETED|Overall Study||11
8292643|NCT01600053|20445876|P1|COMPLETED|Overall Study||0
8292644|NCT01600053|20445876|P1|STARTED|Overall Study||11
8292645|NCT01600014|20445881|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
8292646|NCT01600014|20445882|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
8292647|NCT01600014|20445881|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
8292648|NCT01600014|20445882|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
8292649|NCT01600014|20445881|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
8292650|NCT01600014|20445882|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
8292651|NCT01600014|20445881|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
8292652|NCT01600014|20445882|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
8292653|NCT01600014|20445881|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
8292654|NCT01600014|20445882|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
8292655|NCT01600014|20445881|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
8292656|NCT01600014|20445882|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
8292657|NCT01600014|20445881|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
8292658|NCT01600014|20445882|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
8292659|NCT01600014|20445881|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
8292660|NCT01600014|20445882|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
8292661|NCT01600014|20445881|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
8292662|NCT01600014|20445882|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
8292663|NCT01599832|20445900|P1|NOT COMPLETED|Overall Study||0
8292664|NCT01599832|20445900|P1|COMPLETED|Overall Study||20
8292665|NCT01599832|20445900|P1|STARTED|Overall Study||20
8292666|NCT01599806|20445910|P2|NOT COMPLETED|Overall Study||41
8292667|NCT01599806|20445911|P1|NOT COMPLETED|Overall Study||43
8292668|NCT01599806|20445910|P2|COMPLETED|Overall Study||476
8292669|NCT01599806|20445911|P1|COMPLETED|Overall Study||473
8292670|NCT01599806|20445910|P2|STARTED|Overall Study||517
8292671|NCT01599806|20445911|P1|STARTED|Overall Study||516
8292672|NCT01599793|20446035|P1|NOT COMPLETED|Overall Study||2
8292673|NCT01599793|20446035|P1|COMPLETED|Overall Study||17
8292674|NCT01599793|20446035|P1|STARTED|Overall Study||19
8292675|NCT01599754|20446047|P2|NOT COMPLETED|Overall Study||360
8292676|NCT01599754|20446048|P1|NOT COMPLETED|Overall Study||363
8292677|NCT01599754|20446047|P2|COMPLETED|Overall Study||1
8292678|NCT01599754|20446048|P1|COMPLETED|Overall Study||0
8292679|NCT01599754|20446047|P2|Treated|Overall Study||360
8292680|NCT01599754|20446048|P1|Treated|Overall Study||360
8292681|NCT01599754|20446047|P2|STARTED|Overall Study||361
8292682|NCT01599754|20446048|P1|STARTED|Overall Study||363
8292683|NCT01599741|20446070|P1|NOT COMPLETED|Overall Study||3
8292684|NCT01599741|20446070|P1|COMPLETED|Overall Study||48
8292685|NCT01599741|20446070|P1|Collected Dose and Image Information|Overall Study||48
8292686|NCT01599741|20446070|P1|STARTED|Overall Study||51
8292687|NCT01599650|20446079|P3|NOT COMPLETED|Overall Study||27
8292688|NCT01599650|20446080|P2|NOT COMPLETED|Overall Study||26
8292689|NCT01599650|20446081|P1|NOT COMPLETED|Overall Study||22
8292690|NCT01599650|20446079|P3|COMPLETED|Overall Study||65
8292691|NCT01599650|20446080|P2|COMPLETED|Overall Study||154
8292692|NCT01599650|20446081|P1|COMPLETED|Overall Study||161
8292693|NCT01599650|20446079|P3|Completed 6 Mos|Overall Study||80
8292694|NCT01599650|20446080|P2|Completed 6 Mos|Overall Study||170
8292695|NCT01599650|20446081|P1|Completed 6 Mos|Overall Study||174
8292696|NCT01599650|20446079|P3|STARTED|Overall Study||92
8292697|NCT01599650|20446080|P2|STARTED|Overall Study||180
8292698|NCT01599650|20446081|P1|STARTED|Overall Study||183
8292699|NCT01599637|20446120|P3|NOT COMPLETED|Overall Study||0
8292700|NCT01599637|20446121|P2|NOT COMPLETED|Overall Study||2
8292701|NCT01599637|20446122|P1|NOT COMPLETED|Overall Study||1
8292702|NCT01599637|20446120|P3|COMPLETED|Overall Study||10
8292703|NCT01599637|20446121|P2|COMPLETED|Overall Study||8
8292704|NCT01599637|20446122|P1|COMPLETED|Overall Study||19
8292705|NCT01599637|20446120|P3|STARTED|Overall Study||10
8292706|NCT01599637|20446121|P2|STARTED|Overall Study||10
8292707|NCT01599637|20446122|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
8292708|NCT01599585|20446169|P2|NOT COMPLETED|Overall Study||17
8292709|NCT01599585|20446170|P1|NOT COMPLETED|Overall Study||22
8292710|NCT01599585|20446169|P2|COMPLETED|Overall Study||42
8292711|NCT01599585|20446170|P1|COMPLETED|Overall Study||40
8292712|NCT01599585|20446169|P2|STARTED|Overall Study||59
8292713|NCT01599585|20446170|P1|STARTED|Overall Study||62
8292714|NCT01599325|20446208|P1|NOT COMPLETED|Extension Phase||15
8292715|NCT01599325|20446208|P1|COMPLETED|Extension Phase||0
8292716|NCT01599325|20446208|P1|STARTED|Extension Phase||15
8292717|NCT01599325|20446208|P1|NOT COMPLETED|Primary Parent Phase||57
8292718|NCT01599325|20446208|P1|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
8292719|NCT01599325|20446208|P1|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
8292720|NCT01599325|20446208|P1|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
8292721|NCT01599325|20446208|P1|STARTED|Primary Parent Phase||72
8292722|NCT01599234|20446232|P2|NOT COMPLETED|Overall Study||15
8292723|NCT01599234|20446233|P1|NOT COMPLETED|Overall Study||17
8292724|NCT01599234|20446232|P2|COMPLETED|Overall Study||155
8292725|NCT01599234|20446233|P1|COMPLETED|Overall Study||150
8292726|NCT01599234|20446232|P2|STARTED|Overall Study||170
8292727|NCT01599234|20446233|P1|STARTED|Overall Study||167
8292728|NCT01599104|20446258|P3|NOT COMPLETED|Overall Study||26
8292729|NCT01599104|20446259|P2|NOT COMPLETED|Overall Study||14
8292730|NCT01599104|20446260|P1|NOT COMPLETED|Overall Study||16
8292731|NCT01599104|20446258|P3|COMPLETED|Overall Study||363
8292732|NCT01599104|20446259|P2|COMPLETED|Overall Study||371
8292733|NCT01599104|20446260|P1|COMPLETED|Overall Study||371
8292734|NCT01599104|20446258|P3|STARTED|Overall Study||389
8292735|NCT01599104|20446259|P2|STARTED|Overall Study||385
8292736|NCT01599104|20446260|P1|STARTED|Overall Study||387
8292737|NCT01598987|20446298|P1|NOT COMPLETED|Baseline to 24 Month||8
8292738|NCT01598987|20446298|P1|COMPLETED|Baseline to 24 Month||48
8292739|NCT01598987|20446298|P1|STARTED|Baseline to 24 Month||56
8292740|NCT01598987|20446298|P1|NOT COMPLETED|Baseline to Month 12||6
8292741|NCT01598987|20446298|P1|COMPLETED|Baseline to Month 12||50
8292742|NCT01598987|20446298|P1|STARTED|Baseline to Month 12||56
8292743|NCT01598922|20446334|P2|NOT COMPLETED|Overall Study||10
8292744|NCT01598922|20446335|P1|NOT COMPLETED|Overall Study||3
8292745|NCT01598922|20446334|P2|COMPLETED|Overall Study|Sample size (N)|30
8292746|NCT01598922|20446335|P1|COMPLETED|Overall Study|Sample size (N)|34
8292747|NCT01598922|20446334|P2|STARTED|Overall Study|Sample size (N)|40
8292748|NCT01598922|20446335|P1|STARTED|Overall Study|sample size (N)|37
8292749|NCT01598896|20446357|P2|NOT COMPLETED|Overall Study||2
8292750|NCT01598896|20446358|P1|NOT COMPLETED|Overall Study||0
8292751|NCT01598896|20446357|P2|COMPLETED|Overall Study||2
8292752|NCT01598896|20446358|P1|COMPLETED|Overall Study||3
8292753|NCT01598896|20446357|P2|STARTED|Overall Study||4
8292754|NCT01598896|20446358|P1|STARTED|Overall Study||3
8292755|NCT01598831|20446372|P2|NOT COMPLETED|Overall Study||136
8292756|NCT01598831|20446373|P1|NOT COMPLETED|Overall Study||119
8292757|NCT01598831|20446372|P2|COMPLETED|Overall Study||278
8292758|NCT01598831|20446373|P1|COMPLETED|Overall Study||283
8292759|NCT01598831|20446372|P2|Received at Least 1 Dose Study Treatment|Overall Study||405
8292760|NCT01598831|20446373|P1|Received at Least 1 Dose Study Treatment|Overall Study||395
8292761|NCT01598831|20446372|P2|STARTED|Overall Study||414
8292762|NCT01598831|20446373|P1|STARTED|Overall Study||402
8292763|NCT01598779|20446389|P1|NOT COMPLETED|Overall Study||0
8292764|NCT01598779|20446389|P1|COMPLETED|Overall Study||150
8292765|NCT01598779|20446389|P1|STARTED|Overall Study||150
8292766|NCT01598753|20446397|P4|NOT COMPLETED|Overall Study||15
8292767|NCT01598753|20446398|P3|NOT COMPLETED|Overall Study||8
8292768|NCT01598753|20446399|P2|NOT COMPLETED|Overall Study||15
8292769|NCT01598753|20446400|P1|NOT COMPLETED|Overall Study||12
8292770|NCT01598753|20446397|P4|COMPLETED|Overall Study||19
8292771|NCT01598753|20446398|P3|COMPLETED|Overall Study||24
8292772|NCT01598753|20446399|P2|COMPLETED|Overall Study||16
8292773|NCT01598753|20446400|P1|COMPLETED|Overall Study||25
8292774|NCT01598753|20446397|P4|STARTED|Overall Study||34
8292775|NCT01598753|20446398|P3|STARTED|Overall Study||32
8292776|NCT01598753|20446399|P2|STARTED|Overall Study||31
8292777|NCT01598753|20446400|P1|STARTED|Overall Study||37
8292778|NCT01598740|20446412|P2|NOT COMPLETED|Period 2||0
8292779|NCT01598740|20446413|P1|NOT COMPLETED|Period 2||1
8292780|NCT01598740|20446412|P2|COMPLETED|Period 2||9
8292781|NCT01598740|20446413|P1|COMPLETED|Period 2||7
8292782|NCT01598740|20446412|P2|STARTED|Period 2||9
8292783|NCT01598740|20446413|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
8292784|NCT01598740|20446412|P2|NOT COMPLETED|Period 1||0
8292785|NCT01598740|20446413|P1|NOT COMPLETED|Period 1||0
8292786|NCT01598740|20446412|P2|COMPLETED|Period 1||9
8292787|NCT01598740|20446413|P1|COMPLETED|Period 1||9
8292788|NCT01598740|20446412|P2|STARTED|Period 1||9
8292789|NCT01598740|20446413|P1|STARTED|Period 1||9
8292790|NCT01598701|20446423|P2|NOT COMPLETED|Overall Study||9
8292791|NCT01598701|20446424|P1|NOT COMPLETED|Overall Study||5
8292792|NCT01598701|20446423|P2|COMPLETED|Overall Study||41
8292793|NCT01598701|20446424|P1|COMPLETED|Overall Study||45
8292794|NCT01598701|20446423|P2|STARTED|Overall Study||50
8292795|NCT01598701|20446424|P1|STARTED|Overall Study||50
8292796|NCT01598662|20446440|P2|NOT COMPLETED|Overall Study||21
8292797|NCT01598662|20446441|P1|NOT COMPLETED|Overall Study||11
8292798|NCT01598662|20446440|P2|COMPLETED|Overall Study||0
8292799|NCT01598662|20446441|P1|COMPLETED|Overall Study||0
8292800|NCT01598662|20446440|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
8292801|NCT01598662|20446441|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
8292802|NCT01598662|20446440|P2|Patients Who Received IUD|Overall Study||18
8292803|NCT01598662|20446441|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
8292804|NCT01598662|20446440|P2|STARTED|Overall Study||21
8292805|NCT01598662|20446441|P1|STARTED|Overall Study||11
8292806|NCT01598610|20446447|P1|NOT COMPLETED|Overall Study||1
8292807|NCT01598610|20446447|P1|COMPLETED|Overall Study||219
8292808|NCT01598610|20446447|P1|STARTED|Overall Study||220
8292809|NCT01598545|20446456|P1|NOT COMPLETED|Overall Study||0
8292810|NCT01598545|20446456|P1|COMPLETED|Overall Study||20
8292811|NCT01598545|20446456|P1|STARTED|Overall Study||20
8292812|NCT01598532|20446464|P1|NOT COMPLETED|Overall Study||11
8292813|NCT01598532|20446464|P1|COMPLETED|Overall Study||11
8292814|NCT01598532|20446464|P1|STARTED|Overall Study||22
8292815|NCT01598506|20446473|P1|NOT COMPLETED|Overall Study||2
8292816|NCT01598506|20446473|P1|COMPLETED|Overall Study||20
8292817|NCT01598506|20446473|P1|STARTED|Overall Study||22
8292818|NCT01598428|20446478|P1|NOT COMPLETED|Overall Study||0
8292819|NCT01598428|20446478|P1|COMPLETED|Overall Study||20
8292820|NCT01598428|20446478|P1|STARTED|Overall Study||20
8292821|NCT01598350|20446487|P1|NOT COMPLETED|Overall Study||0
8292822|NCT01598350|20446487|P1|COMPLETED|Overall Study||6
8292823|NCT01598350|20446487|P1|STARTED|Overall Study||6
8292824|NCT01598311|20446493|P2|NOT COMPLETED|Overall Study||61
8292825|NCT01598311|20446494|P1|NOT COMPLETED|Overall Study||47
8292826|NCT01598311|20446493|P2|COMPLETED|Overall Study||244
8292827|NCT01598311|20446494|P1|COMPLETED|Overall Study||256
8292828|NCT01598311|20446493|P2|Treated and Confirmed CDAD|Overall Study||292
8292829|NCT01598311|20446494|P1|Treated and Confirmed CDAD|Overall Study||285
8292830|NCT01598311|20446493|P2|Treated|Overall Study||301
8292831|NCT01598311|20446494|P1|Treated|Overall Study||294
8292832|NCT01598311|20446493|P2|STARTED|Overall Study||305
8292833|NCT01598311|20446494|P1|STARTED|Overall Study||303
8292834|NCT01598298|20446510|P2|NOT COMPLETED|Overall Study||41
8292835|NCT01598298|20446511|P1|NOT COMPLETED|Overall Study||40
8292836|NCT01598298|20446510|P2|COMPLETED|Overall Study||108
8292837|NCT01598298|20446511|P1|COMPLETED|Overall Study||110
8292838|NCT01598298|20446510|P2|Patients Evaluable for Adverse Events|Overall Study||141
8292839|NCT01598298|20446511|P1|Patients Evaluable for Adverse Events|Overall Study||138
8292840|NCT01598298|20446510|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
8292841|NCT01598298|20446511|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
8292842|NCT01598298|20446510|P2|STARTED|Overall Study||149
8292843|NCT01598298|20446511|P1|STARTED|Overall Study||150
8292844|NCT01598207|20446523|P2|NOT COMPLETED|Overall Study||0
8292845|NCT01598207|20446524|P1|NOT COMPLETED|Overall Study||1
8292846|NCT01598207|20446523|P2|COMPLETED|Overall Study||6
8292847|NCT01598207|20446524|P1|COMPLETED|Overall Study||6
8292848|NCT01598207|20446523|P2|STARTED|Overall Study||6
8292849|NCT01598207|20446524|P1|STARTED|Overall Study||7
8292850|NCT01598194|20446544|P2|NOT COMPLETED|Overall Study||0
8292851|NCT01598194|20446545|P1|NOT COMPLETED|Overall Study||0
8292852|NCT01598194|20446544|P2|COMPLETED|Overall Study||30
8292853|NCT01598194|20446545|P1|COMPLETED|Overall Study||30
8292854|NCT01598194|20446544|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
8292855|NCT01598194|20446545|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
8292856|NCT01598194|20446544|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
8292857|NCT01598194|20446545|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
8292858|NCT01598194|20446544|P2|2 Passes With 25G for Cytology|Overall Study||30
8292859|NCT01598194|20446545|P1|2 Passes With 25G for Cytology|Overall Study||30
8292860|NCT01598194|20446544|P2|STARTED|Overall Study||30
8292861|NCT01598194|20446545|P1|STARTED|Overall Study||30
8292862|NCT01598129|20446555|P1|NOT COMPLETED|Overall Study||9
8292863|NCT01598129|20446555|P1|COMPLETED|Overall Study||3
8292864|NCT01598129|20446555|P1|STARTED|Overall Study||12
8292865|NCT01598090|20446567|P3|NOT COMPLETED|Follow-up Period||28
8292866|NCT01598090|20446568|P2|NOT COMPLETED|Follow-up Period||35
8292867|NCT01598090|20446569|P1|NOT COMPLETED|Follow-up Period||5
8292868|NCT01598090|20446567|P3|COMPLETED|Follow-up Period||171
8292869|NCT01598090|20446568|P2|COMPLETED|Follow-up Period||364
8292870|NCT01598090|20446569|P1|COMPLETED|Follow-up Period||21
8292871|NCT01598090|20446567|P3|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
8292872|NCT01598090|20446568|P2|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
8292873|NCT01598090|20446569|P1|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
8292874|NCT01598090|20446567|P3|NOT COMPLETED|Treatment Period||35
8292875|NCT01598090|20446568|P2|NOT COMPLETED|Treatment Period||72
8292876|NCT01598090|20446569|P1|NOT COMPLETED|Treatment Period||11
8292877|NCT01598090|20446567|P3|COMPLETED|Treatment Period||171
8292878|NCT01598090|20446568|P2|COMPLETED|Treatment Period||339
8292879|NCT01598090|20446569|P1|COMPLETED|Treatment Period||16
8292880|NCT01598090|20446567|P3|STARTED|Treatment Period||206
8292881|NCT01598090|20446568|P2|STARTED|Treatment Period||411
8292882|NCT01598090|20446569|P1|STARTED|Treatment Period||27
8292883|NCT01598064|20446595|P2|NOT COMPLETED|Overall Study||0
8292884|NCT01598064|20446596|P1|NOT COMPLETED|Overall Study||0
8292885|NCT01598064|20446595|P2|COMPLETED|Overall Study||24
8292886|NCT01598064|20446596|P1|COMPLETED|Overall Study||25
8292887|NCT01598064|20446595|P2|STARTED|Overall Study||24
8292888|NCT01598064|20446596|P1|STARTED|Overall Study||25
8292889|NCT01598025|20446606|P2|NOT COMPLETED|Overall Study||3
8292890|NCT01598025|20446607|P1|NOT COMPLETED|Overall Study||0
8292891|NCT01598025|20446606|P2|COMPLETED|Overall Study||0
8292892|NCT01598025|20446607|P1|COMPLETED|Overall Study||0
8292893|NCT01598025|20446606|P2|STARTED|Overall Study||3
8292894|NCT01598025|20446607|P1|STARTED|Overall Study||0
8292903|NCT01597856|20446632|P3|NOT COMPLETED|Overall Study||54
8292904|NCT01597856|20446633|P2|NOT COMPLETED|Overall Study||26
8292905|NCT01597856|20446634|P1|NOT COMPLETED|Overall Study||22
8292906|NCT01597856|20446632|P3|COMPLETED|Overall Study||120
8292907|NCT01597856|20446633|P2|COMPLETED|Overall Study||61
8292908|NCT01597856|20446634|P1|COMPLETED|Overall Study||63
8292909|NCT01597856|20446632|P3|Week 4 Follow-up|Overall Study||129
8292910|NCT01597856|20446633|P2|Week 4 Follow-up|Overall Study||67
8292911|NCT01597856|20446634|P1|Week 4 Follow-up|Overall Study||62
8292912|NCT01597856|20446632|P3|STARTED|Overall Study||174
8292913|NCT01597856|20446633|P2|STARTED|Overall Study||87
8292914|NCT01597856|20446634|P1|STARTED|Overall Study||85
8292915|NCT01597843|20446651|P3|NOT COMPLETED|Overall Study||0
8292916|NCT01597843|20446652|P2|NOT COMPLETED|Overall Study||0
8292917|NCT01597843|20446653|P1|NOT COMPLETED|Overall Study||0
8292918|NCT01597843|20446651|P3|COMPLETED|Overall Study||81
8292919|NCT01597843|20446652|P2|COMPLETED|Overall Study||122
8292920|NCT01597843|20446653|P1|COMPLETED|Overall Study||79
8292921|NCT01597843|20446651|P3|Survey 3 Responses|Overall Study||76
8292922|NCT01597843|20446652|P2|Survey 3 Responses|Overall Study||56
8292923|NCT01597843|20446653|P1|Survey 3 Responses|Overall Study||65
8292924|NCT01597843|20446651|P3|Survey 2 Responses|Overall Study||58
8292925|NCT01597843|20446652|P2|Survey 2 Responses|Overall Study||42
8292926|NCT01597843|20446653|P1|Survey 2 Responses|Overall Study||52
8292927|NCT01597843|20446651|P3|Survey 1 Responses|Overall Study||59
8292928|NCT01597843|20446652|P2|Survey 1 Responses|Overall Study||71
8292929|NCT01597843|20446653|P1|Survey 1 Responses|Overall Study||45
8292930|NCT01597843|20446651|P3|STARTED|Overall Study||81
8292931|NCT01597843|20446652|P2|STARTED|Overall Study||122
8292932|NCT01597843|20446653|P1|STARTED|Overall Study||79
8292933|NCT01597791|20446663|P2|NOT COMPLETED|Overall Study||10
8292934|NCT01597791|20446664|P1|NOT COMPLETED|Overall Study||8
8292935|NCT01597791|20446663|P2|COMPLETED|Overall Study||18
8292936|NCT01597791|20446664|P1|COMPLETED|Overall Study||20
8292937|NCT01597791|20446663|P2|STARTED|Overall Study||28
8292938|NCT01597791|20446664|P1|STARTED|Overall Study||28
8292939|NCT01597687|20446673|P3|NOT COMPLETED|Overall Study||0
8292940|NCT01597687|20446674|P2|NOT COMPLETED|Overall Study||0
8292941|NCT01597687|20446675|P1|NOT COMPLETED|Overall Study||0
8292942|NCT01597687|20446673|P3|COMPLETED|Overall Study||147
8292943|NCT01597687|20446674|P2|COMPLETED|Overall Study||89
8292944|NCT01597687|20446675|P1|COMPLETED|Overall Study||76
8292945|NCT01597687|20446673|P3|STARTED|Overall Study||147
8292946|NCT01597687|20446674|P2|STARTED|Overall Study||89
8292947|NCT01597687|20446675|P1|STARTED|Overall Study||76
8292948|NCT01597635|20446751|P3|NOT COMPLETED|Part B||4
8292949|NCT01597635|20446752|P2|NOT COMPLETED|Part B||6
8292950|NCT01597635|20446753|P1|NOT COMPLETED|Part B||0
8292951|NCT01597635|20446751|P3|COMPLETED|Part B||15
8292952|NCT01597635|20446752|P2|COMPLETED|Part B||14
8292953|NCT01597635|20446753|P1|COMPLETED|Part B||0
8292954|NCT01597635|20446751|P3|STARTED|Part B||19
8292955|NCT01597635|20446752|P2|STARTED|Part B||20
8292956|NCT01597635|20446753|P1|STARTED|Part B||0
8292957|NCT01597635|20446751|P3|NOT COMPLETED|Part A||0
8292958|NCT01597635|20446752|P2|NOT COMPLETED|Part A||0
8292959|NCT01597635|20446753|P1|NOT COMPLETED|Part A||3
8292960|NCT01597635|20446751|P3|COMPLETED|Part A||0
8292961|NCT01597635|20446752|P2|COMPLETED|Part A||0
8292962|NCT01597635|20446753|P1|COMPLETED|Part A||2
8292963|NCT01597635|20446751|P3|STARTED|Part A||0
8292964|NCT01597635|20446752|P2|STARTED|Part A||0
8292965|NCT01597635|20446753|P1|STARTED|Part A||5
8292966|NCT01597622|20446816|P1|NOT COMPLETED|Overall Study||38
8292967|NCT01597622|20446816|P1|COMPLETED|Overall Study||104
8292968|NCT01597622|20446816|P1|STARTED|Overall Study||142
8292969|NCT01597596|20446823|P2|NOT COMPLETED|Overall Study||1
8292970|NCT01597596|20446824|P1|NOT COMPLETED|Overall Study||1
8292971|NCT01597596|20446823|P2|COMPLETED|Overall Study||2
8292972|NCT01597596|20446824|P1|COMPLETED|Overall Study||0
8292973|NCT01597596|20446823|P2|STARTED|Overall Study||3
8292974|NCT01597596|20446824|P1|STARTED|Overall Study||1
8292975|NCT01597557|20446838|P2|NOT COMPLETED|Overall Study||3
8292976|NCT01597557|20446839|P1|NOT COMPLETED|Overall Study||4
8292977|NCT01597557|20446838|P2|COMPLETED|Overall Study||126
8292978|NCT01597557|20446839|P1|COMPLETED|Overall Study||128
8292979|NCT01597557|20446838|P2|STARTED|Overall Study||129
8292980|NCT01597557|20446839|P1|STARTED|Overall Study||132
8292981|NCT01597505|20446851|P2|NOT COMPLETED|Overall Study||33
8292982|NCT01597505|20446852|P1|NOT COMPLETED|Overall Study||44
8292983|NCT01597505|20446851|P2|COMPLETED|Overall Study||265
8292984|NCT01597505|20446852|P1|COMPLETED|Overall Study||264
8292985|NCT01597505|20446851|P2|Treated|Overall Study||286
8292986|NCT01597505|20446852|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
8292987|NCT01597505|20446851|P2|STARTED|Overall Study|Randomized participants|298
8292988|NCT01597505|20446852|P1|STARTED|Overall Study|Randomized participants|308
8292989|NCT01597492|20446886|P2|NOT COMPLETED|Overall Study||4
8292990|NCT01597492|20446887|P1|NOT COMPLETED|Overall Study||6
8292991|NCT01597492|20446886|P2|COMPLETED|Overall Study||41
8292992|NCT01597492|20446887|P1|COMPLETED|Overall Study||28
8292993|NCT01597492|20446886|P2|STARTED|Overall Study||45
8292994|NCT01597492|20446887|P1|STARTED|Overall Study||34
8292995|NCT01597479|20446895|P2|NOT COMPLETED|Overall Study||0
8292996|NCT01597479|20446896|P1|NOT COMPLETED|Overall Study||2
8292997|NCT01597479|20446895|P2|COMPLETED|Overall Study||26
8292998|NCT01597479|20446896|P1|COMPLETED|Overall Study||24
8292999|NCT01597479|20446895|P2|STARTED|Overall Study||26
8293000|NCT01597479|20446896|P1|STARTED|Overall Study||26
8293001|NCT01597440|20446905|P2|NOT COMPLETED|Overall Study||0
8293002|NCT01597440|20446906|P1|NOT COMPLETED|Overall Study||0
8293003|NCT01597440|20446905|P2|COMPLETED|Overall Study||0
8293004|NCT01597440|20446906|P1|COMPLETED|Overall Study||1
8293005|NCT01597440|20446905|P2|STARTED|Overall Study||0
8293006|NCT01597440|20446906|P1|STARTED|Overall Study||1
8293007|NCT01597388|20446923|P9|NOT COMPLETED|Overall Study||0
8293008|NCT01597388|20446924|P8|NOT COMPLETED|Overall Study||0
8293009|NCT01597388|20446925|P7|NOT COMPLETED|Overall Study||0
8293010|NCT01597388|20446926|P6|NOT COMPLETED|Overall Study||0
8293011|NCT01597388|20446927|P5|NOT COMPLETED|Overall Study||0
8293012|NCT01597388|20446928|P4|NOT COMPLETED|Overall Study||0
8293013|NCT01597388|20446929|P3|NOT COMPLETED|Overall Study||0
8293014|NCT01597388|20446930|P2|NOT COMPLETED|Overall Study||0
8293015|NCT01597388|20446931|P1|NOT COMPLETED|Overall Study||0
8293016|NCT01597388|20446923|P9|COMPLETED|Overall Study||2
8293017|NCT01597388|20446924|P8|COMPLETED|Overall Study||5
8293018|NCT01597388|20446925|P7|COMPLETED|Overall Study||8
8293019|NCT01597388|20446926|P6|COMPLETED|Overall Study||4
8293020|NCT01597388|20446927|P5|COMPLETED|Overall Study||37
8293021|NCT01597388|20446928|P4|COMPLETED|Overall Study||10
8293022|NCT01597388|20446929|P3|COMPLETED|Overall Study||14
8293023|NCT01597388|20446930|P2|COMPLETED|Overall Study||13
8293024|NCT01597388|20446931|P1|COMPLETED|Overall Study||6
8293025|NCT01597388|20446923|P9|STARTED|Overall Study||2
8293026|NCT01597388|20446924|P8|STARTED|Overall Study||5
8293027|NCT01597388|20446925|P7|STARTED|Overall Study||8
8293028|NCT01597388|20446926|P6|STARTED|Overall Study||4
8293029|NCT01597388|20446927|P5|STARTED|Overall Study||37
8293030|NCT01597388|20446928|P4|STARTED|Overall Study||10
8293031|NCT01597388|20446929|P3|STARTED|Overall Study||14
8293032|NCT01597388|20446930|P2|STARTED|Overall Study||13
8293033|NCT01597388|20446931|P1|STARTED|Overall Study||6
8293034|NCT01597375|20447182|P2|NOT COMPLETED|Second Intervention||1
8293035|NCT01597375|20447183|P1|NOT COMPLETED|Second Intervention||1
8293036|NCT01597375|20447182|P2|COMPLETED|Second Intervention||21
8293037|NCT01597375|20447183|P1|COMPLETED|Second Intervention||19
8293038|NCT01597375|20447182|P2|STARTED|Second Intervention||22
8293039|NCT01597375|20447183|P1|STARTED|Second Intervention||20
8293040|NCT01597375|20447182|P2|NOT COMPLETED|Washout (2 Weeks)||0
8293041|NCT01597375|20447183|P1|NOT COMPLETED|Washout (2 Weeks)||1
8293042|NCT01597375|20447182|P2|COMPLETED|Washout (2 Weeks)||22
8293043|NCT01597375|20447183|P1|COMPLETED|Washout (2 Weeks)||20
8293044|NCT01597375|20447182|P2|STARTED|Washout (2 Weeks)||22
8293045|NCT01597375|20447183|P1|STARTED|Washout (2 Weeks)||21
8293046|NCT01597375|20447182|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8293047|NCT01597375|20447183|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8293048|NCT01597375|20447182|P2|COMPLETED|First Intervention (4 Weeks)||22
8293049|NCT01597375|20447183|P1|COMPLETED|First Intervention (4 Weeks)||21
8293050|NCT01597375|20447182|P2|STARTED|First Intervention (4 Weeks)||23
8293051|NCT01597375|20447183|P1|STARTED|First Intervention (4 Weeks)||23
8293052|NCT01597258|20447200|P1|NOT COMPLETED|Overall Study||1
8293053|NCT01597258|20447200|P1|COMPLETED|Overall Study||2028
8293054|NCT01597258|20447200|P1|STARTED|Overall Study||2029
8293055|NCT01597245|20447209|P21|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
8293056|NCT01597245|20447210|P20|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
8293057|NCT01597245|20447211|P19|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
8293058|NCT01597245|20447212|P18|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
8293059|NCT01597245|20447213|P17|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
8293060|NCT01597245|20447214|P16|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293061|NCT01597245|20447215|P15|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293062|NCT01597245|20447216|P14|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293063|NCT01597245|20447217|P13|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293064|NCT01597245|20447218|P12|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293065|NCT01597245|20447219|P11|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293066|NCT01597245|20447220|P10|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293067|NCT01597245|20447221|P9|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293068|NCT01597245|20447222|P8|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293069|NCT01597245|20447223|P7|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293070|NCT01597245|20447224|P6|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293071|NCT01597245|20447225|P5|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293072|NCT01597245|20447226|P4|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293073|NCT01597245|20447227|P3|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293074|NCT01597245|20447228|P2|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293075|NCT01597245|20447229|P1|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293076|NCT01597245|20447209|P21|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
8293077|NCT01597245|20447210|P20|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
8293078|NCT01597245|20447211|P19|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
8293079|NCT01597245|20447212|P18|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293080|NCT01597245|20447213|P17|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293081|NCT01597245|20447214|P16|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293082|NCT01597245|20447215|P15|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293083|NCT01597245|20447216|P14|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293084|NCT01597245|20447217|P13|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293085|NCT01597245|20447218|P12|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293086|NCT01597245|20447219|P11|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293087|NCT01597245|20447220|P10|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293088|NCT01597245|20447221|P9|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293089|NCT01597245|20447222|P8|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293090|NCT01597245|20447223|P7|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293091|NCT01597245|20447224|P6|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293092|NCT01597245|20447225|P5|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293093|NCT01597245|20447226|P4|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293094|NCT01597245|20447227|P3|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293095|NCT01597245|20447228|P2|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293096|NCT01597245|20447229|P1|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293448|NCT01596699|20447522|P1|COMPLETED|Overall Study||10
8293097|NCT01597245|20447209|P21|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
8293098|NCT01597245|20447210|P20|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
8293099|NCT01597245|20447211|P19|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
8293100|NCT01597245|20447212|P18|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
8293101|NCT01597245|20447213|P17|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
8293102|NCT01597245|20447214|P16|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8293103|NCT01597245|20447215|P15|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8293104|NCT01597245|20447216|P14|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293105|NCT01597245|20447217|P13|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293106|NCT01597245|20447218|P12|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293107|NCT01597245|20447219|P11|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293108|NCT01597245|20447220|P10|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293109|NCT01597245|20447221|P9|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293110|NCT01597245|20447222|P8|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293111|NCT01597245|20447223|P7|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293112|NCT01597245|20447224|P6|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293113|NCT01597245|20447225|P5|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293114|NCT01597245|20447226|P4|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293115|NCT01597245|20447227|P3|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293116|NCT01597245|20447228|P2|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293117|NCT01597245|20447229|P1|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293118|NCT01597245|20447209|P21|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293119|NCT01597245|20447210|P20|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293120|NCT01597245|20447211|P19|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293121|NCT01597245|20447212|P18|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293122|NCT01597245|20447213|P17|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293123|NCT01597245|20447214|P16|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
8293124|NCT01597245|20447215|P15|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
8293125|NCT01597245|20447216|P14|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
8293126|NCT01597245|20447217|P13|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293127|NCT01597245|20447218|P12|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293128|NCT01597245|20447219|P11|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293129|NCT01597245|20447220|P10|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293130|NCT01597245|20447221|P9|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293131|NCT01597245|20447222|P8|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293132|NCT01597245|20447223|P7|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293133|NCT01597245|20447224|P6|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293134|NCT01597245|20447225|P5|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293135|NCT01597245|20447226|P4|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293136|NCT01597245|20447227|P3|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293137|NCT01597245|20447228|P2|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293138|NCT01597245|20447229|P1|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293139|NCT01597245|20447209|P21|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293140|NCT01597245|20447210|P20|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293141|NCT01597245|20447211|P19|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293142|NCT01597245|20447212|P18|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293143|NCT01597245|20447213|P17|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293144|NCT01597245|20447214|P16|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
8293145|NCT01597245|20447215|P15|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
8293146|NCT01597245|20447216|P14|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293147|NCT01597245|20447217|P13|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293148|NCT01597245|20447218|P12|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293149|NCT01597245|20447219|P11|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293150|NCT01597245|20447220|P10|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293151|NCT01597245|20447221|P9|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293152|NCT01597245|20447222|P8|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293153|NCT01597245|20447223|P7|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293154|NCT01597245|20447224|P6|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293155|NCT01597245|20447225|P5|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293156|NCT01597245|20447226|P4|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293157|NCT01597245|20447227|P3|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293158|NCT01597245|20447228|P2|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293159|NCT01597245|20447229|P1|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293160|NCT01597245|20447209|P21|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293161|NCT01597245|20447210|P20|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293162|NCT01597245|20447211|P19|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293163|NCT01597245|20447212|P18|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293164|NCT01597245|20447213|P17|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293165|NCT01597245|20447214|P16|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
8293166|NCT01597245|20447215|P15|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
8293167|NCT01597245|20447216|P14|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
8293168|NCT01597245|20447217|P13|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293169|NCT01597245|20447218|P12|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293170|NCT01597245|20447219|P11|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293171|NCT01597245|20447220|P10|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293172|NCT01597245|20447221|P9|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293173|NCT01597245|20447222|P8|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293174|NCT01597245|20447223|P7|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293175|NCT01597245|20447224|P6|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293176|NCT01597245|20447225|P5|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293177|NCT01597245|20447226|P4|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293178|NCT01597245|20447227|P3|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293179|NCT01597245|20447228|P2|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293180|NCT01597245|20447229|P1|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293181|NCT01597245|20447209|P21|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293182|NCT01597245|20447210|P20|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293183|NCT01597245|20447211|P19|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293184|NCT01597245|20447212|P18|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293185|NCT01597245|20447213|P17|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293186|NCT01597245|20447214|P16|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293187|NCT01597245|20447215|P15|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293188|NCT01597245|20447216|P14|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293189|NCT01597245|20447217|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
8293190|NCT01597245|20447218|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
8293191|NCT01597245|20447219|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
8293192|NCT01597245|20447220|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
8293193|NCT01597245|20447221|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
8293194|NCT01597245|20447222|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
8293195|NCT01597245|20447223|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
8293196|NCT01597245|20447224|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
8293197|NCT01597245|20447225|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
8293198|NCT01597245|20447226|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293199|NCT01597245|20447227|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293200|NCT01597245|20447228|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293201|NCT01597245|20447229|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293202|NCT01597245|20447209|P21|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293203|NCT01597245|20447210|P20|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293204|NCT01597245|20447211|P19|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293205|NCT01597245|20447212|P18|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293206|NCT01597245|20447213|P17|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293207|NCT01597245|20447214|P16|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293208|NCT01597245|20447215|P15|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293209|NCT01597245|20447216|P14|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293210|NCT01597245|20447217|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
8293211|NCT01597245|20447218|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
8293212|NCT01597245|20447219|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
8293213|NCT01597245|20447220|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
8293214|NCT01597245|20447221|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
8293215|NCT01597245|20447222|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293216|NCT01597245|20447223|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
8293217|NCT01597245|20447224|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
8293218|NCT01597245|20447225|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
8293219|NCT01597245|20447226|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293220|NCT01597245|20447227|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293221|NCT01597245|20447228|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293222|NCT01597245|20447229|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293223|NCT01597245|20447209|P21|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293224|NCT01597245|20447210|P20|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293225|NCT01597245|20447211|P19|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293226|NCT01597245|20447212|P18|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293227|NCT01597245|20447213|P17|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293228|NCT01597245|20447214|P16|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293229|NCT01597245|20447215|P15|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293230|NCT01597245|20447216|P14|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293231|NCT01597245|20447217|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
8293232|NCT01597245|20447218|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
8293233|NCT01597245|20447219|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
8293234|NCT01597245|20447220|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
8293235|NCT01597245|20447221|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
8293236|NCT01597245|20447222|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
8293237|NCT01597245|20447223|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
8293238|NCT01597245|20447224|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
8293239|NCT01597245|20447225|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
8293240|NCT01597245|20447226|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293241|NCT01597245|20447227|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293242|NCT01597245|20447228|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293243|NCT01597245|20447229|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293244|NCT01597245|20447209|P21|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293245|NCT01597245|20447210|P20|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293246|NCT01597245|20447211|P19|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293247|NCT01597245|20447212|P18|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293248|NCT01597245|20447213|P17|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293249|NCT01597245|20447214|P16|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293250|NCT01597245|20447215|P15|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293251|NCT01597245|20447216|P14|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293252|NCT01597245|20447217|P13|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
8293253|NCT01597245|20447218|P12|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
8293254|NCT01597245|20447219|P11|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
8293255|NCT01597245|20447220|P10|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
8293256|NCT01597245|20447221|P9|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
8293257|NCT01597245|20447222|P8|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
8293258|NCT01597245|20447223|P7|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
8293259|NCT01597245|20447224|P6|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
8293260|NCT01597245|20447225|P5|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
8293261|NCT01597245|20447226|P4|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293262|NCT01597245|20447227|P3|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293263|NCT01597245|20447228|P2|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293264|NCT01597245|20447229|P1|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293265|NCT01597245|20447209|P21|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293266|NCT01597245|20447210|P20|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293267|NCT01597245|20447211|P19|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293268|NCT01597245|20447212|P18|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293269|NCT01597245|20447213|P17|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293270|NCT01597245|20447214|P16|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293271|NCT01597245|20447215|P15|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293272|NCT01597245|20447216|P14|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293273|NCT01597245|20447217|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293274|NCT01597245|20447218|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293275|NCT01597245|20447219|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293276|NCT01597245|20447220|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293277|NCT01597245|20447221|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293278|NCT01597245|20447222|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293279|NCT01597245|20447223|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293280|NCT01597245|20447224|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293281|NCT01597245|20447225|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293282|NCT01597245|20447226|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
8293283|NCT01597245|20447227|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
8293284|NCT01597245|20447228|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
8293285|NCT01597245|20447229|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
8293286|NCT01597245|20447209|P21|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293287|NCT01597245|20447210|P20|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293288|NCT01597245|20447211|P19|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293289|NCT01597245|20447212|P18|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293290|NCT01597245|20447213|P17|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293291|NCT01597245|20447214|P16|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293292|NCT01597245|20447215|P15|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293293|NCT01597245|20447216|P14|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293294|NCT01597245|20447217|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293295|NCT01597245|20447218|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293296|NCT01597245|20447219|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293297|NCT01597245|20447220|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293298|NCT01597245|20447221|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293299|NCT01597245|20447222|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293300|NCT01597245|20447223|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293301|NCT01597245|20447224|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293302|NCT01597245|20447225|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293303|NCT01597245|20447226|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
8293304|NCT01597245|20447227|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
8293305|NCT01597245|20447228|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
8293306|NCT01597245|20447229|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
8293307|NCT01597245|20447209|P21|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293308|NCT01597245|20447210|P20|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293309|NCT01597245|20447211|P19|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293310|NCT01597245|20447212|P18|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293311|NCT01597245|20447213|P17|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293312|NCT01597245|20447214|P16|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293313|NCT01597245|20447215|P15|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293314|NCT01597245|20447216|P14|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293315|NCT01597245|20447217|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293316|NCT01597245|20447218|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293317|NCT01597245|20447219|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293318|NCT01597245|20447220|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293319|NCT01597245|20447221|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293320|NCT01597245|20447222|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293321|NCT01597245|20447223|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293322|NCT01597245|20447224|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293323|NCT01597245|20447225|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293324|NCT01597245|20447226|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
8293325|NCT01597245|20447227|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
8293326|NCT01597245|20447228|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
8293327|NCT01597245|20447229|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
8293328|NCT01597245|20447209|P21|STARTED|Induction Period (Week 0 - Week 12)||0
8293329|NCT01597245|20447210|P20|STARTED|Induction Period (Week 0 - Week 12)||0
8293330|NCT01597245|20447211|P19|STARTED|Induction Period (Week 0 - Week 12)||0
8293331|NCT01597245|20447212|P18|STARTED|Induction Period (Week 0 - Week 12)||0
8293332|NCT01597245|20447213|P17|STARTED|Induction Period (Week 0 - Week 12)||0
8293333|NCT01597245|20447214|P16|STARTED|Induction Period (Week 0 - Week 12)||0
8293334|NCT01597245|20447215|P15|STARTED|Induction Period (Week 0 - Week 12)||0
8293335|NCT01597245|20447216|P14|STARTED|Induction Period (Week 0 - Week 12)||0
8293336|NCT01597245|20447217|P13|STARTED|Induction Period (Week 0 - Week 12)||0
8293337|NCT01597245|20447218|P12|STARTED|Induction Period (Week 0 - Week 12)||0
8293338|NCT01597245|20447219|P11|STARTED|Induction Period (Week 0 - Week 12)||0
8293339|NCT01597245|20447220|P10|STARTED|Induction Period (Week 0 - Week 12)||0
8293340|NCT01597245|20447221|P9|STARTED|Induction Period (Week 0 - Week 12)||0
8293341|NCT01597245|20447222|P8|STARTED|Induction Period (Week 0 - Week 12)||0
8293342|NCT01597245|20447223|P7|STARTED|Induction Period (Week 0 - Week 12)||0
8293343|NCT01597245|20447224|P6|STARTED|Induction Period (Week 0 - Week 12)||0
8293344|NCT01597245|20447225|P5|STARTED|Induction Period (Week 0 - Week 12)||0
8293345|NCT01597245|20447226|P4|STARTED|Induction Period (Week 0 - Week 12)||351
8293346|NCT01597245|20447227|P3|STARTED|Induction Period (Week 0 - Week 12)||347
8293347|NCT01597245|20447228|P2|STARTED|Induction Period (Week 0 - Week 12)||358
8293348|NCT01597245|20447229|P1|STARTED|Induction Period (Week 0 - Week 12)||168
8293349|NCT01597193|20447327|P7|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
8293350|NCT01597193|20447328|P6|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
8293351|NCT01597193|20447329|P5|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
8293352|NCT01597193|20447330|P4|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
8293353|NCT01597193|20447331|P3|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
8293354|NCT01597193|20447332|P2|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293355|NCT01597193|20447333|P1|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293356|NCT01597193|20447327|P7|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293357|NCT01597193|20447328|P6|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293358|NCT01597193|20447329|P5|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293359|NCT01597193|20447330|P4|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293360|NCT01597193|20447331|P3|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293361|NCT01597193|20447332|P2|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293362|NCT01597193|20447333|P1|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293363|NCT01597193|20447327|P7|STARTED|Stage 2: Dose Expansion (1067 Days)||11
8293364|NCT01597193|20447328|P6|STARTED|Stage 2: Dose Expansion (1067 Days)||23
8293365|NCT01597193|20447329|P5|STARTED|Stage 2: Dose Expansion (1067 Days)||16
8293366|NCT01597193|20447330|P4|STARTED|Stage 2: Dose Expansion (1067 Days)||20
8293367|NCT01597193|20447331|P3|STARTED|Stage 2: Dose Expansion (1067 Days)||14
8293368|NCT01597193|20447332|P2|STARTED|Stage 2: Dose Expansion (1067 Days)||0
8293369|NCT01597193|20447333|P1|STARTED|Stage 2: Dose Expansion (1067 Days)||0
8293370|NCT01597193|20447327|P7|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293371|NCT01597193|20447328|P6|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293372|NCT01597193|20447329|P5|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293373|NCT01597193|20447330|P4|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293374|NCT01597193|20447331|P3|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293375|NCT01597193|20447332|P2|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
8293376|NCT01597193|20447333|P1|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
8293377|NCT01597193|20447327|P7|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293378|NCT01597193|20447328|P6|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293379|NCT01597193|20447329|P5|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293380|NCT01597193|20447330|P4|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293381|NCT01597193|20447331|P3|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293382|NCT01597193|20447332|P2|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293383|NCT01597193|20447333|P1|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293384|NCT01597193|20447327|P7|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293385|NCT01597193|20447328|P6|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293386|NCT01597193|20447329|P5|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293387|NCT01597193|20447330|P4|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293388|NCT01597193|20447331|P3|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293389|NCT01597193|20447332|P2|STARTED|Stage 1: Dose Escalation (141 Days)||8
8293390|NCT01597193|20447333|P1|STARTED|Stage 1: Dose Escalation (141 Days)||7
8293391|NCT01597141|20447414|P2|NOT COMPLETED|Overall Study||0
8293392|NCT01597141|20447415|P1|NOT COMPLETED|Overall Study||0
8293393|NCT01597141|20447414|P2|COMPLETED|Overall Study||50
8293394|NCT01597141|20447415|P1|COMPLETED|Overall Study||50
8293395|NCT01597141|20447414|P2|STARTED|Overall Study||50
8293396|NCT01597141|20447415|P1|STARTED|Overall Study||50
8293397|NCT01597128|20447425|P2|NOT COMPLETED|Overall Study||0
8293398|NCT01597128|20447426|P1|NOT COMPLETED|Overall Study||0
8293399|NCT01597128|20447425|P2|COMPLETED|Overall Study||17
8293400|NCT01597128|20447426|P1|COMPLETED|Overall Study||18
8293401|NCT01597128|20447425|P2|STARTED|Overall Study||17
8293402|NCT01597128|20447426|P1|STARTED|Overall Study||18
8293403|NCT01597050|20447452|P2|NOT COMPLETED|Overall Study||0
8293404|NCT01597050|20447453|P1|NOT COMPLETED|Overall Study||1
8293405|NCT01597050|20447452|P2|COMPLETED|Overall Study||18
8293406|NCT01597050|20447453|P1|COMPLETED|Overall Study||35
8293407|NCT01597050|20447452|P2|STARTED|Overall Study||18
8293408|NCT01597050|20447453|P1|STARTED|Overall Study||36
8293409|NCT01596972|20447461|P2|NOT COMPLETED|Overall Study||14
8293410|NCT01596972|20447462|P1|NOT COMPLETED|Overall Study||1
8293411|NCT01596972|20447461|P2|COMPLETED|Overall Study||12
8293412|NCT01596972|20447462|P1|COMPLETED|Overall Study||24
8293413|NCT01596972|20447461|P2|STARTED|Overall Study||26
8293414|NCT01596972|20447462|P1|STARTED|Overall Study||25
8293415|NCT01596842|20447474|P2|NOT COMPLETED|Overall Study||0
8293416|NCT01596842|20447475|P1|NOT COMPLETED|Overall Study||2
8293417|NCT01596842|20447474|P2|COMPLETED|Overall Study||7
8293418|NCT01596842|20447475|P1|COMPLETED|Overall Study||8
8293419|NCT01596842|20447474|P2|STARTED|Overall Study||7
8293420|NCT01596842|20447475|P1|STARTED|Overall Study||10
8293421|NCT01596751|20447491|P8|NOT COMPLETED|Overall Study||0
8293422|NCT01596751|20447492|P7|NOT COMPLETED|Overall Study||0
8293423|NCT01596751|20447493|P6|NOT COMPLETED|Overall Study||0
8293424|NCT01596751|20447494|P5|NOT COMPLETED|Overall Study||0
8293425|NCT01596751|20447495|P4|NOT COMPLETED|Overall Study||0
8293426|NCT01596751|20447496|P3|NOT COMPLETED|Overall Study||0
8293427|NCT01596751|20447497|P2|NOT COMPLETED|Overall Study||0
8293428|NCT01596751|20447498|P1|NOT COMPLETED|Overall Study||0
8293429|NCT01596751|20447491|P8|COMPLETED|Overall Study||22
8293430|NCT01596751|20447492|P7|COMPLETED|Overall Study||17
8293431|NCT01596751|20447493|P6|COMPLETED|Overall Study||6
8293432|NCT01596751|20447494|P5|COMPLETED|Overall Study||4
8293433|NCT01596751|20447495|P4|COMPLETED|Overall Study||6
8293434|NCT01596751|20447496|P3|COMPLETED|Overall Study||3
8293435|NCT01596751|20447497|P2|COMPLETED|Overall Study||4
8293436|NCT01596751|20447498|P1|COMPLETED|Overall Study||5
8293437|NCT01596751|20447491|P8|STARTED|Overall Study||22
8293438|NCT01596751|20447492|P7|STARTED|Overall Study||17
8293439|NCT01596751|20447493|P6|STARTED|Overall Study||6
8293440|NCT01596751|20447494|P5|STARTED|Overall Study||4
8293441|NCT01596751|20447495|P4|STARTED|Overall Study||6
8293442|NCT01596751|20447496|P3|STARTED|Overall Study||3
8293443|NCT01596751|20447497|P2|STARTED|Overall Study||4
8293444|NCT01596751|20447498|P1|STARTED|Overall Study||5
8293445|NCT01596699|20447521|P2|NOT COMPLETED|Overall Study||0
8293446|NCT01596699|20447522|P1|NOT COMPLETED|Overall Study||0
8293447|NCT01596699|20447521|P2|COMPLETED|Overall Study||6
8293449|NCT01596699|20447521|P2|STARTED|Overall Study||6
8293450|NCT01596699|20447522|P1|STARTED|Overall Study||10
8293451|NCT01596582|20447534|P2|NOT COMPLETED|Overall Study||7
8293452|NCT01596582|20447535|P1|NOT COMPLETED|Overall Study||4
8293453|NCT01596582|20447534|P2|COMPLETED|Overall Study||173
8293454|NCT01596582|20447535|P1|COMPLETED|Overall Study||168
8293455|NCT01596582|20447534|P2|STARTED|Overall Study||180
8293456|NCT01596582|20447535|P1|STARTED|Overall Study||172
8293457|NCT01596504|20447562|P3|NOT COMPLETED|Overall Study||1
8293458|NCT01596504|20447563|P2|NOT COMPLETED|Overall Study||3
8293459|NCT01596504|20447564|P1|NOT COMPLETED|Overall Study||2
8293460|NCT01596504|20447562|P3|COMPLETED|Overall Study||46
8293461|NCT01596504|20447563|P2|COMPLETED|Overall Study||44
8293462|NCT01596504|20447564|P1|COMPLETED|Overall Study||46
8293463|NCT01596504|20447562|P3|STARTED|Overall Study||47
8293464|NCT01596504|20447563|P2|STARTED|Overall Study||47
8293465|NCT01596504|20447564|P1|STARTED|Overall Study||48
8293466|NCT01596335|20447622|P2|NOT COMPLETED|Overall Study||9
8293467|NCT01596335|20447623|P1|NOT COMPLETED|Overall Study||5
8293468|NCT01596335|20447622|P2|COMPLETED|Overall Study||6
8293469|NCT01596335|20447623|P1|COMPLETED|Overall Study||11
8293470|NCT01596335|20447622|P2|STARTED|Overall Study||15
8293471|NCT01596335|20447623|P1|STARTED|Overall Study||16
8293472|NCT01596283|20447635|P2|NOT COMPLETED|Overall Study||0
8293473|NCT01596283|20447636|P1|NOT COMPLETED|Overall Study||0
8293474|NCT01596283|20447635|P2|COMPLETED|Overall Study||66
8293475|NCT01596283|20447636|P1|COMPLETED|Overall Study||69
8293476|NCT01596283|20447635|P2|STARTED|Overall Study||66
8293477|NCT01596283|20447636|P1|STARTED|Overall Study||69
8293478|NCT01596231|20447652|P2|NOT COMPLETED|Overall Study||0
8293479|NCT01596231|20447653|P1|NOT COMPLETED|Overall Study||0
8293480|NCT01596231|20447652|P2|COMPLETED|Overall Study||10
8293481|NCT01596231|20447653|P1|COMPLETED|Overall Study||10
8293482|NCT01596231|20447652|P2|STARTED|Overall Study||10
8293483|NCT01596231|20447653|P1|STARTED|Overall Study||10
8293484|NCT01596127|20447659|P1|NOT COMPLETED|Overall Study||1
8293485|NCT01596127|20447659|P1|COMPLETED|Overall Study||3
8293486|NCT01596127|20447659|P1|STARTED|Overall Study||4
8293487|NCT01596088|20447664|P1|NOT COMPLETED|Overall Study||0
8293488|NCT01596088|20447664|P1|COMPLETED|Overall Study||2
8293489|NCT01596088|20447664|P1|STARTED|Overall Study||2
8293490|NCT01596062|20447671|P3|NOT COMPLETED|Overall Study||3
8293491|NCT01596062|20447672|P2|NOT COMPLETED|Overall Study||0
8293492|NCT01596062|20447673|P1|NOT COMPLETED|Overall Study||1
8293493|NCT01596062|20447671|P3|COMPLETED|Overall Study||4
8293494|NCT01596062|20447672|P2|COMPLETED|Overall Study||6
8293495|NCT01596062|20447673|P1|COMPLETED|Overall Study||2
8293496|NCT01596062|20447671|P3|STARTED|Overall Study||7
8293497|NCT01596062|20447672|P2|STARTED|Overall Study||6
8293498|NCT01596062|20447673|P1|STARTED|Overall Study||3
8293499|NCT01595854|20447710|P5|NOT COMPLETED|Overall Study||0
8293500|NCT01595854|20447711|P4|NOT COMPLETED|Overall Study||0
8293501|NCT01595854|20447712|P3|NOT COMPLETED|Overall Study||0
8293502|NCT01595854|20447713|P2|NOT COMPLETED|Overall Study||0
8293503|NCT01595854|20447714|P1|NOT COMPLETED|Overall Study||0
8293504|NCT01595854|20447710|P5|COMPLETED|Overall Study||12
8293505|NCT01595854|20447711|P4|COMPLETED|Overall Study||4
8293506|NCT01595854|20447712|P3|COMPLETED|Overall Study||8
8293507|NCT01595854|20447713|P2|COMPLETED|Overall Study||4
8293508|NCT01595854|20447714|P1|COMPLETED|Overall Study||8
8293509|NCT01595854|20447710|P5|STARTED|Overall Study||12
8293510|NCT01595854|20447711|P4|STARTED|Overall Study||4
8293511|NCT01595854|20447712|P3|STARTED|Overall Study||8
8293512|NCT01595854|20447713|P2|STARTED|Overall Study||4
8293513|NCT01595854|20447714|P1|STARTED|Overall Study||8
8293514|NCT01595646|20447737|P3|NOT COMPLETED|Overall Study||0
8293515|NCT01595646|20447738|P2|NOT COMPLETED|Overall Study||0
8293516|NCT01595646|20447739|P1|NOT COMPLETED|Overall Study||1
8293517|NCT01595646|20447737|P3|COMPLETED|Overall Study||12
8293518|NCT01595646|20447738|P2|COMPLETED|Overall Study||12
8293519|NCT01595646|20447739|P1|COMPLETED|Overall Study||12
8293520|NCT01595646|20447737|P3|STARTED|Overall Study||12
8293521|NCT01595646|20447738|P2|STARTED|Overall Study||12
8293522|NCT01595646|20447739|P1|STARTED|Overall Study||13
8293523|NCT01595529|20447761|P2|NOT COMPLETED|Overall Study||20
8293524|NCT01595529|20447762|P1|NOT COMPLETED|Overall Study||24
8293525|NCT01595529|20447761|P2|COMPLETED|Overall Study||325
8293526|NCT01595529|20447762|P1|COMPLETED|Overall Study||324
8293527|NCT01595529|20447761|P2|Completed All Milestones|Overall Study||318
8293528|NCT01595529|20447762|P1|Completed All Milestones|Overall Study||318
8293529|NCT01595529|20447761|P2|Per-protocol With Stool Sample at TOC|Overall Study||289
8293530|NCT01595529|20447762|P1|Per-protocol With Stool Sample at TOC|Overall Study||280
8293531|NCT01595529|20447761|P2|Per-protocol Without Treatment Failure|Overall Study||305
8293532|NCT01595529|20447762|P1|Per-protocol Without Treatment Failure|Overall Study||306
8293533|NCT01595529|20447761|P2|Per-protocol, Completed 80% of Dose|Overall Study||314
8293534|NCT01595529|20447762|P1|Per-protocol, Completed 80% of Dose|Overall Study||308
8293535|NCT01595529|20447761|P2|ITT With Stool Sample at TOC|Overall Study||310
8293536|NCT01595529|20447762|P1|ITT With Stool Sample at TOC|Overall Study||298
8293537|NCT01595529|20447761|P2|ITT Without Treatment Failure|Overall Study||322
8293538|NCT01595529|20447762|P1|ITT Without Treatment Failure|Overall Study||326
8293539|NCT01595529|20447761|P2|Evaluated for Primary Endpoint, ITT|Overall Study||336
8293540|NCT01595529|20447762|P1|Evaluated for Primary Endpoint, ITT|Overall Study||328
8293541|NCT01595529|20447761|P2|Treated|Overall Study||340
8293542|NCT01595529|20447762|P1|Treated|Overall Study||337
8293543|NCT01595529|20447761|P2|STARTED|Overall Study||345
8293544|NCT01595529|20447762|P1|STARTED|Overall Study||348
8293545|NCT01595516|20447793|P3|NOT COMPLETED|Overall Study||0
8293546|NCT01595516|20447794|P2|NOT COMPLETED|Overall Study||0
8293547|NCT01595516|20447795|P1|NOT COMPLETED|Overall Study||0
8293548|NCT01595516|20447793|P3|COMPLETED|Overall Study||12
8293549|NCT01595516|20447794|P2|COMPLETED|Overall Study||16
8293550|NCT01595516|20447795|P1|COMPLETED|Overall Study||16
8293551|NCT01595516|20447793|P3|STARTED|Overall Study||12
8293552|NCT01595516|20447794|P2|STARTED|Overall Study||16
8293553|NCT01595516|20447795|P1|STARTED|Overall Study||16
8293554|NCT01595438|20447825|P2|NOT COMPLETED|Overall Study||41
8293555|NCT01595438|20447826|P1|NOT COMPLETED|Overall Study||43
8293556|NCT01595438|20447825|P2|COMPLETED|Overall Study||476
8293557|NCT01595438|20447826|P1|COMPLETED|Overall Study||473
8293558|NCT01595438|20447825|P2|STARTED|Overall Study||517
8293559|NCT01595438|20447826|P1|STARTED|Overall Study||516
8293560|NCT01595386|20447952|P2|NOT COMPLETED|Overall Study||0
8293561|NCT01595386|20447953|P1|NOT COMPLETED|Overall Study||0
8293562|NCT01595386|20447952|P2|COMPLETED|Overall Study||19
8293563|NCT01595386|20447953|P1|COMPLETED|Overall Study||21
8293564|NCT01595386|20447952|P2|STARTED|Overall Study||19
8293565|NCT01595386|20447953|P1|STARTED|Overall Study||21
8293566|NCT01595282|20447981|P2|NOT COMPLETED|Overall Study||0
8293567|NCT01595282|20447982|P1|NOT COMPLETED|Overall Study||0
8293568|NCT01595282|20447981|P2|COMPLETED|Overall Study||47
8293569|NCT01595282|20447982|P1|COMPLETED|Overall Study||47
8293570|NCT01595282|20447981|P2|STARTED|Overall Study||47
8293571|NCT01595282|20447982|P1|STARTED|Overall Study||47
8293572|NCT01595009|20447994|P4|NOT COMPLETED|Extension||11
8293573|NCT01595009|20447995|P3|NOT COMPLETED|Extension||4
8293574|NCT01595009|20447996|P2|NOT COMPLETED|Extension||0
8293575|NCT01595009|20447997|P1|NOT COMPLETED|Extension||0
8293576|NCT01595009|20447994|P4|COMPLETED|Extension||0
8293577|NCT01595009|20447995|P3|COMPLETED|Extension||0
8293578|NCT01595009|20447996|P2|COMPLETED|Extension||0
8293579|NCT01595009|20447997|P1|COMPLETED|Extension||0
8293580|NCT01595009|20447994|P4|STARTED|Extension||11
8293581|NCT01595009|20447995|P3|STARTED|Extension||4
8293582|NCT01595009|20447996|P2|STARTED|Extension||0
8293583|NCT01595009|20447997|P1|STARTED|Extension||0
8293584|NCT01595009|20447994|P4|NOT COMPLETED|Core||0
8293585|NCT01595009|20447995|P3|NOT COMPLETED|Core||0
8293586|NCT01595009|20447996|P2|NOT COMPLETED|Core||120
8293587|NCT01595009|20447997|P1|NOT COMPLETED|Core||126
8293588|NCT01595009|20447994|P4|COMPLETED|Core||0
8293589|NCT01595009|20447995|P3|COMPLETED|Core||0
8293590|NCT01595009|20447996|P2|COMPLETED|Core||0
8293591|NCT01595009|20447997|P1|COMPLETED|Core||0
8293592|NCT01595009|20447994|P4|STARTED|Core||0
8293593|NCT01595009|20447995|P3|STARTED|Core||0
8293594|NCT01595009|20447996|P2|STARTED|Core||120
8293595|NCT01595009|20447997|P1|STARTED|Core||126
8293596|NCT01594970|20448032|P3|NOT COMPLETED|Overall Study||66
8293597|NCT01594970|20448033|P2|NOT COMPLETED|Overall Study||82
8293598|NCT01594970|20448034|P1|NOT COMPLETED|Overall Study||75
8293599|NCT01594970|20448032|P3|COMPLETED|Overall Study||191
8293600|NCT01594970|20448033|P2|COMPLETED|Overall Study||166
8293601|NCT01594970|20448034|P1|COMPLETED|Overall Study||220
8293602|NCT01594970|20448032|P3|STARTED|Overall Study||257
8293603|NCT01594970|20448033|P2|STARTED|Overall Study||248
8293604|NCT01594970|20448034|P1|STARTED|Overall Study||295
8293605|NCT01594853|20448053|P2|NOT COMPLETED|Overall Study||3
8293606|NCT01594853|20448054|P1|NOT COMPLETED|Overall Study||2
8293607|NCT01594853|20448053|P2|COMPLETED|Overall Study||12
8293608|NCT01594853|20448054|P1|COMPLETED|Overall Study||14
8293609|NCT01594853|20448053|P2|STARTED|Overall Study||15
8293610|NCT01594853|20448054|P1|STARTED|Overall Study||16
8293611|NCT01594827|20448062|P2|NOT COMPLETED|Overall Study||0
8293612|NCT01594827|20448063|P1|NOT COMPLETED|Overall Study||4
8293613|NCT01594827|20448062|P2|COMPLETED|Overall Study||15
8293614|NCT01594827|20448063|P1|COMPLETED|Overall Study||10
8293615|NCT01594827|20448062|P2|STARTED|Overall Study||15
8293616|NCT01594827|20448063|P1|STARTED|Overall Study||14
8293617|NCT01594762|20448087|P2|NOT COMPLETED|Overall Study||10
8293618|NCT01594762|20448088|P1|NOT COMPLETED|Overall Study||11
8293619|NCT01594762|20448087|P2|COMPLETED|Overall Study||93
8293620|NCT01594762|20448088|P1|COMPLETED|Overall Study||86
8293621|NCT01594762|20448087|P2|STARTED|Overall Study||103
8293622|NCT01594762|20448088|P1|STARTED|Overall Study||97
8293623|NCT01594749|20448100|P2|NOT COMPLETED|Overall Study||18
8293624|NCT01594749|20448101|P1|NOT COMPLETED|Overall Study||22
8293625|NCT01594749|20448100|P2|COMPLETED|Overall Study||490
8293626|NCT01594749|20448101|P1|COMPLETED|Overall Study||485
8293627|NCT01594749|20448100|P2|Treated|Overall Study||498
8293628|NCT01594749|20448101|P1|Treated|Overall Study||503
8293629|NCT01594749|20448100|P2|STARTED|Overall Study||508
8293630|NCT01594749|20448101|P1|STARTED|Overall Study||507
8293631|NCT01594528|20448120|P3|NOT COMPLETED|Overall Study||0
8293632|NCT01594528|20448121|P2|NOT COMPLETED|Overall Study||0
8293633|NCT01594528|20448122|P1|NOT COMPLETED|Overall Study||0
8293634|NCT01594528|20448120|P3|COMPLETED|Overall Study||16
8293635|NCT01594528|20448121|P2|COMPLETED|Overall Study||17
8293636|NCT01594528|20448122|P1|COMPLETED|Overall Study||16
8293637|NCT01594528|20448120|P3|STARTED|Overall Study||16
8293638|NCT01594528|20448121|P2|STARTED|Overall Study||17
8293639|NCT01594528|20448122|P1|STARTED|Overall Study||16
8293640|NCT01594515|20448138|P10|NOT COMPLETED|Overall Study||0
8293641|NCT01594515|20448139|P9|NOT COMPLETED|Overall Study||0
8293642|NCT01594515|20448140|P8|NOT COMPLETED|Overall Study||0
8293643|NCT01594515|20448141|P7|NOT COMPLETED|Overall Study||0
8293644|NCT01594515|20448142|P6|NOT COMPLETED|Overall Study||0
8293645|NCT01594515|20448143|P5|NOT COMPLETED|Overall Study||0
8293646|NCT01594515|20448144|P4|NOT COMPLETED|Overall Study||0
8293647|NCT01594515|20448145|P3|NOT COMPLETED|Overall Study||0
8293648|NCT01594515|20448146|P2|NOT COMPLETED|Overall Study||0
8293649|NCT01594515|20448147|P1|NOT COMPLETED|Overall Study||0
8293650|NCT01594515|20448138|P10|COMPLETED|Overall Study||16
8293651|NCT01594515|20448139|P9|COMPLETED|Overall Study||6
8293652|NCT01594515|20448140|P8|COMPLETED|Overall Study||6
8293653|NCT01594515|20448141|P7|COMPLETED|Overall Study||6
8293654|NCT01594515|20448142|P6|COMPLETED|Overall Study||6
8293655|NCT01594515|20448143|P5|COMPLETED|Overall Study||6
8293656|NCT01594515|20448144|P4|COMPLETED|Overall Study||6
8293657|NCT01594515|20448145|P3|COMPLETED|Overall Study||6
8293658|NCT01594515|20448146|P2|COMPLETED|Overall Study||6
8293659|NCT01594515|20448147|P1|COMPLETED|Overall Study||6
8293660|NCT01594515|20448138|P10|STARTED|Overall Study||16
8293661|NCT01594515|20448139|P9|STARTED|Overall Study||6
8293662|NCT01594515|20448140|P8|STARTED|Overall Study||6
8293663|NCT01594515|20448141|P7|STARTED|Overall Study||6
8293664|NCT01594515|20448142|P6|STARTED|Overall Study||6
8293665|NCT01594515|20448143|P5|STARTED|Overall Study||6
8293666|NCT01594515|20448144|P4|STARTED|Overall Study||6
8293667|NCT01594515|20448145|P3|STARTED|Overall Study||6
8293668|NCT01594515|20448146|P2|STARTED|Overall Study||6
8293669|NCT01594515|20448147|P1|STARTED|Overall Study||6
8293670|NCT01594476|20448239|P2|NOT COMPLETED|Overall Study||3
8293671|NCT01594476|20448240|P1|NOT COMPLETED|Overall Study||1
8293672|NCT01594476|20448239|P2|COMPLETED|Overall Study||97
8293673|NCT01594476|20448240|P1|COMPLETED|Overall Study||100
8293674|NCT01594476|20448239|P2|Pregnant|Overall Study||5
8293675|NCT01594476|20448240|P1|Pregnant|Overall Study||2
8293676|NCT01594476|20448239|P2|IUD Expulsion|Overall Study||0
8293677|NCT01594476|20448240|P1|IUD Expulsion|Overall Study||2
8293678|NCT01594476|20448239|P2|IUD Removal|Overall Study||5
8293679|NCT01594476|20448240|P1|IUD Removal|Overall Study||3
8293680|NCT01594476|20448239|P2|Excluded After Allocation|Overall Study||3
8293681|NCT01594476|20448240|P1|Excluded After Allocation|Overall Study||1
8293682|NCT01594476|20448239|P2|Received Intervention|Overall Study||73
8293683|NCT01594476|20448240|P1|Received Intervention|Overall Study||66
8293684|NCT01594476|20448239|P2|STARTED|Overall Study||100
8293685|NCT01594476|20448240|P1|STARTED|Overall Study||101
8293686|NCT01594424|20448258|P1|NOT COMPLETED|Overall Study||2
8293687|NCT01594424|20448258|P1|COMPLETED|Overall Study||8
8293688|NCT01594424|20448258|P1|STARTED|Overall Study||10
8293689|NCT01594411|20448262|P1|NOT COMPLETED|Overall Study||2
8293690|NCT01594411|20448262|P1|COMPLETED|Overall Study||249
8293691|NCT01594411|20448262|P1|STARTED|Overall Study||251
8293692|NCT01594385|20448271|P2|NOT COMPLETED|Overall Study||0
8293693|NCT01594385|20448272|P1|NOT COMPLETED|Overall Study||0
8293694|NCT01594385|20448271|P2|COMPLETED|Overall Study||13
8293695|NCT01594385|20448272|P1|COMPLETED|Overall Study||17
8293696|NCT01594385|20448271|P2|STARTED|Overall Study||13
8293697|NCT01594385|20448272|P1|STARTED|Overall Study||17
8293698|NCT01594333|20448296|P2|NOT COMPLETED|Overall Study||151
8293699|NCT01594333|20448297|P1|NOT COMPLETED|Overall Study||161
8293700|NCT01594333|20448296|P2|COMPLETED|Overall Study||2244
8293701|NCT01594333|20448297|P1|COMPLETED|Overall Study||2230
8293702|NCT01594333|20448296|P2|STARTED|Overall Study||2395
8293703|NCT01594333|20448297|P1|STARTED|Overall Study||2391
8293704|NCT01594294|20448325|P2|NOT COMPLETED|Overall Study||4
8293705|NCT01594294|20448326|P1|NOT COMPLETED|Overall Study||3
8293706|NCT01594294|20448325|P2|COMPLETED|Overall Study||36
8293707|NCT01594294|20448326|P1|COMPLETED|Overall Study||36
8293708|NCT01594294|20448325|P2|STARTED|Overall Study||40
8293709|NCT01594294|20448326|P1|STARTED|Overall Study||39
8293710|NCT01594281|20448343|P3|NOT COMPLETED|Non-Interventional Follow Up Phase||2
8293711|NCT01594281|20448344|P2|NOT COMPLETED|Non-Interventional Follow Up Phase||2
8293712|NCT01594281|20448345|P1|NOT COMPLETED|Non-Interventional Follow Up Phase||3
8293713|NCT01594281|20448343|P3|COMPLETED|Non-Interventional Follow Up Phase||23
8293714|NCT01594281|20448344|P2|COMPLETED|Non-Interventional Follow Up Phase||19
8293715|NCT01594281|20448345|P1|COMPLETED|Non-Interventional Follow Up Phase||25
8293716|NCT01594281|20448343|P3|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
8293717|NCT01594281|20448344|P2|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
8293718|NCT01594281|20448345|P1|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
8293719|NCT01594281|20448343|P3|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
8293720|NCT01594281|20448344|P2|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
8293721|NCT01594281|20448345|P1|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
8293722|NCT01594281|20448343|P3|NOT COMPLETED|Interventional Core Phase||8
8293723|NCT01594281|20448344|P2|NOT COMPLETED|Interventional Core Phase||10
8293724|NCT01594281|20448345|P1|NOT COMPLETED|Interventional Core Phase||7
8293725|NCT01594281|20448343|P3|COMPLETED|Interventional Core Phase||28
8293726|NCT01594281|20448344|P2|COMPLETED|Interventional Core Phase||26
8293727|NCT01594281|20448345|P1|COMPLETED|Interventional Core Phase||29
8293728|NCT01594281|20448343|P3|Full Analysis Set (FAS)|Interventional Core Phase||36
8293729|NCT01594281|20448344|P2|Full Analysis Set (FAS)|Interventional Core Phase||35
8293730|NCT01594281|20448345|P1|Full Analysis Set (FAS)|Interventional Core Phase||35
8293731|NCT01594281|20448343|P3|STARTED|Interventional Core Phase||36
8293732|NCT01594281|20448344|P2|STARTED|Interventional Core Phase||36
8293733|NCT01594281|20448345|P1|STARTED|Interventional Core Phase||36
8293734|NCT01594125|20448385|P5|NOT COMPLETED|Overall Study||7
8293735|NCT01594125|20448386|P4|NOT COMPLETED|Overall Study||4
8293736|NCT01594125|20448387|P3|NOT COMPLETED|Overall Study||3
8293737|NCT01594125|20448388|P2|NOT COMPLETED|Overall Study||12
8293738|NCT01594125|20448389|P1|NOT COMPLETED|Overall Study||4
8293739|NCT01594125|20448385|P5|COMPLETED|Overall Study||0
8293740|NCT01594125|20448386|P4|COMPLETED|Overall Study||0
8293741|NCT01594125|20448387|P3|COMPLETED|Overall Study||0
8293742|NCT01594125|20448388|P2|COMPLETED|Overall Study||0
8293743|NCT01594125|20448389|P1|COMPLETED|Overall Study||0
8293744|NCT01594125|20448385|P5|STARTED|Overall Study||7
8293745|NCT01594125|20448386|P4|STARTED|Overall Study||4
8293746|NCT01594125|20448387|P3|STARTED|Overall Study||3
8293747|NCT01594125|20448388|P2|STARTED|Overall Study||12
8293748|NCT01594125|20448389|P1|STARTED|Overall Study||4
8293749|NCT01593852|20448423|P2|NOT COMPLETED|Overall Study||0
8293750|NCT01593852|20448424|P1|NOT COMPLETED|Overall Study||0
8293751|NCT01593852|20448423|P2|COMPLETED|Overall Study||68
8293752|NCT01593852|20448424|P1|COMPLETED|Overall Study||68
8293753|NCT01593852|20448423|P2|STARTED|Overall Study||68
8293754|NCT01593852|20448424|P1|STARTED|Overall Study||68
8293755|NCT01593787|20448449|P3|NOT COMPLETED|Overall Study||0
8293756|NCT01593787|20448450|P2|NOT COMPLETED|Overall Study||0
8293757|NCT01593787|20448451|P1|NOT COMPLETED|Overall Study||1
8293758|NCT01593787|20448449|P3|COMPLETED|Overall Study||18
8293759|NCT01593787|20448450|P2|COMPLETED|Overall Study||8
8293760|NCT01593787|20448451|P1|COMPLETED|Overall Study||5
8293761|NCT01593787|20448449|P3|STARTED|Overall Study||18
8293762|NCT01593787|20448450|P2|STARTED|Overall Study||8
8293763|NCT01593787|20448451|P1|STARTED|Overall Study||6
8293764|NCT01593748|20448491|P2|NOT COMPLETED|Overall Study||0
8293765|NCT01593748|20448492|P1|NOT COMPLETED|Overall Study||0
8293766|NCT01593748|20448491|P2|COMPLETED|Overall Study||45
8293767|NCT01593748|20448492|P1|COMPLETED|Overall Study||45
8293768|NCT01593748|20448491|P2|STARTED|Overall Study||45
8293769|NCT01593748|20448492|P1|STARTED|Overall Study||45
8293770|NCT01593722|20448508|P2|NOT COMPLETED|Overall Study||0
8293771|NCT01593722|20448509|P1|NOT COMPLETED|Overall Study||0
8293772|NCT01593722|20448508|P2|COMPLETED|Overall Study||6
8293773|NCT01593722|20448509|P1|COMPLETED|Overall Study||6
8293774|NCT01593722|20448508|P2|STARTED|Overall Study||6
8293775|NCT01593722|20448509|P1|STARTED|Overall Study||6
8293776|NCT01593696|20448527|P4|NOT COMPLETED|Dose Expansion||0
8293777|NCT01593696|20448528|P3|NOT COMPLETED|Dose Expansion||1
8293778|NCT01593696|20448529|P2|NOT COMPLETED|Dose Expansion||0
8293779|NCT01593696|20448530|P1|NOT COMPLETED|Dose Expansion||0
8293780|NCT01593696|20448527|P4|COMPLETED|Dose Expansion||16
8293781|NCT01593696|20448528|P3|COMPLETED|Dose Expansion||15
8293782|NCT01593696|20448529|P2|COMPLETED|Dose Expansion||0
8293783|NCT01593696|20448530|P1|COMPLETED|Dose Expansion||0
8293784|NCT01593696|20448527|P4|STARTED|Dose Expansion||16
8293785|NCT01593696|20448528|P3|STARTED|Dose Expansion||16
8293786|NCT01593696|20448529|P2|STARTED|Dose Expansion||0
8293787|NCT01593696|20448530|P1|STARTED|Dose Expansion||0
8293788|NCT01593696|20448527|P4|NOT COMPLETED|Dose Escalation||0
8293789|NCT01593696|20448528|P3|NOT COMPLETED|Dose Escalation||0
8293790|NCT01593696|20448529|P2|NOT COMPLETED|Dose Escalation||0
8293791|NCT01593696|20448530|P1|NOT COMPLETED|Dose Escalation||2
8293792|NCT01593696|20448527|P4|COMPLETED|Dose Escalation||0
8293793|NCT01593696|20448528|P3|COMPLETED|Dose Escalation||0
8293794|NCT01593696|20448529|P2|COMPLETED|Dose Escalation||5
8293795|NCT01593696|20448530|P1|COMPLETED|Dose Escalation||14
8293796|NCT01593696|20448527|P4|No Prior Transplant|Dose Escalation||0
8293797|NCT01593696|20448528|P3|No Prior Transplant|Dose Escalation||0
8293798|NCT01593696|20448529|P2|No Prior Transplant|Dose Escalation||4
8293799|NCT01593696|20448530|P1|No Prior Transplant|Dose Escalation||9
8293800|NCT01593696|20448527|P4|Prior Transplant|Dose Escalation||0
8293801|NCT01593696|20448528|P3|Prior Transplant|Dose Escalation||0
8293802|NCT01593696|20448529|P2|Prior Transplant|Dose Escalation||1
8293803|NCT01593696|20448530|P1|Prior Transplant|Dose Escalation||7
8293804|NCT01593696|20448527|P4|STARTED|Dose Escalation||0
8293805|NCT01593696|20448528|P3|STARTED|Dose Escalation||0
8293806|NCT01593696|20448529|P2|STARTED|Dose Escalation||5
8293807|NCT01593696|20448530|P1|STARTED|Dose Escalation||16
8293808|NCT01593670|20448564|P1|NOT COMPLETED|Overall Study||0
8293809|NCT01593670|20448564|P1|COMPLETED|Overall Study||9
8293810|NCT01593670|20448564|P1|STARTED|Overall Study||9
8293811|NCT01593592|20448574|P2|NOT COMPLETED|Overall Study||0
8293812|NCT01593592|20448575|P1|NOT COMPLETED|Overall Study||0
8293813|NCT01593592|20448574|P2|COMPLETED|Overall Study||35
8293814|NCT01593592|20448575|P1|COMPLETED|Overall Study||35
8293815|NCT01593592|20448574|P2|STARTED|Overall Study||35
8293816|NCT01593592|20448575|P1|STARTED|Overall Study||35
8293817|NCT01593254|20448587|P2|NOT COMPLETED|Follow-Up Period||11
8293818|NCT01593254|20448588|P1|NOT COMPLETED|Follow-Up Period||3
8293819|NCT01593254|20448587|P2|COMPLETED|Follow-Up Period||17
8293820|NCT01593254|20448588|P1|COMPLETED|Follow-Up Period||11
8293821|NCT01593254|20448587|P2|STARTED|Follow-Up Period||28
8293822|NCT01593254|20448588|P1|STARTED|Follow-Up Period||14
8293823|NCT01593254|20448587|P2|NOT COMPLETED|Treatment Period||31
8293824|NCT01593254|20448588|P1|NOT COMPLETED|Treatment Period||14
8293825|NCT01593254|20448587|P2|COMPLETED|Treatment Period||143
8293826|NCT01593254|20448588|P1|COMPLETED|Treatment Period||72
8293827|NCT01593254|20448587|P2|Crossed Over to Dasatinib|Treatment Period||0
8293828|NCT01593254|20448588|P1|Crossed Over to Dasatinib|Treatment Period||42
8293829|NCT01593254|20448587|P2|STARTED|Treatment Period||174
8293830|NCT01593254|20448588|P1|STARTED|Treatment Period||86
8293831|NCT01593215|20448597|P2|NOT COMPLETED|Overall Study||0
8293832|NCT01593215|20448598|P1|NOT COMPLETED|Overall Study||1
8293833|NCT01593215|20448597|P2|COMPLETED|Overall Study||25
8293834|NCT01593215|20448598|P1|COMPLETED|Overall Study||24
8293835|NCT01593215|20448597|P2|STARTED|Overall Study||25
8293836|NCT01593215|20448598|P1|STARTED|Overall Study||25
8293837|NCT01592864|20448606|P2|NOT COMPLETED|Overall Study||1
8293838|NCT01592864|20448607|P1|NOT COMPLETED|Overall Study||0
8293839|NCT01592864|20448606|P2|COMPLETED|Overall Study||57
8293840|NCT01592864|20448607|P1|COMPLETED|Overall Study||60
8293841|NCT01592864|20448606|P2|STARTED|Overall Study||58
8293842|NCT01592864|20448607|P1|STARTED|Overall Study||60
8293843|NCT01592851|20448621|P2|NOT COMPLETED|Overall Study||0
8293844|NCT01592851|20448622|P1|NOT COMPLETED|Overall Study||0
8293845|NCT01592851|20448621|P2|COMPLETED|Overall Study||57
8293846|NCT01592851|20448622|P1|COMPLETED|Overall Study||56
8293847|NCT01592851|20448621|P2|STARTED|Overall Study||57
8293848|NCT01592851|20448622|P1|STARTED|Overall Study||56
8293849|NCT01592799|20448638|P1|NOT COMPLETED|Overall Study||0
8293850|NCT01592799|20448638|P1|COMPLETED|Overall Study||501
8293851|NCT01592799|20448638|P1|STARTED|Overall Study||501
8293852|NCT01592786|20448668|P1|NOT COMPLETED|Overall Study||138
8293853|NCT01592786|20448668|P1|COMPLETED|Overall Study||765
8293854|NCT01592786|20448668|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
8293855|NCT01592773|20448672|P1|NOT COMPLETED|Overall Study||666
8293856|NCT01592773|20448672|P1|COMPLETED|Overall Study||81
8293857|NCT01592773|20448672|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
8293858|NCT01592760|20448679|P3|NOT COMPLETED|24-hour Follow-Up||2
8293859|NCT01592760|20448680|P2|NOT COMPLETED|24-hour Follow-Up||3
8293860|NCT01592760|20448681|P1|NOT COMPLETED|24-hour Follow-Up||4
8293861|NCT01592760|20448679|P3|COMPLETED|24-hour Follow-Up||43
8293862|NCT01592760|20448680|P2|COMPLETED|24-hour Follow-Up||87
8293863|NCT01592760|20448681|P1|COMPLETED|24-hour Follow-Up||86
8293864|NCT01592760|20448679|P3|STARTED|24-hour Follow-Up||45
8293865|NCT01592760|20448680|P2|STARTED|24-hour Follow-Up||90
8293866|NCT01592760|20448681|P1|STARTED|24-hour Follow-Up||90
8293867|NCT01592760|20448679|P3|NOT COMPLETED|Perioperative to Discharge||0
8293868|NCT01592760|20448680|P2|NOT COMPLETED|Perioperative to Discharge||0
8293869|NCT01592760|20448681|P1|NOT COMPLETED|Perioperative to Discharge||0
8293870|NCT01592760|20448679|P3|COMPLETED|Perioperative to Discharge||45
8293871|NCT01592760|20448680|P2|COMPLETED|Perioperative to Discharge||90
8293872|NCT01592760|20448681|P1|COMPLETED|Perioperative to Discharge||90
8293873|NCT01592760|20448679|P3|STARTED|Perioperative to Discharge||45
8293874|NCT01592760|20448680|P2|STARTED|Perioperative to Discharge||90
8293875|NCT01592760|20448681|P1|STARTED|Perioperative to Discharge||90
8293876|NCT01592747|20448725|P3|NOT COMPLETED|Overall Study||108
8293877|NCT01592747|20448726|P2|NOT COMPLETED|Overall Study||111
8293878|NCT01592747|20448727|P1|NOT COMPLETED|Overall Study||116
8293879|NCT01592747|20448725|P3|COMPLETED|Overall Study||50
8293880|NCT01592747|20448726|P2|COMPLETED|Overall Study||50
8293881|NCT01592747|20448727|P1|COMPLETED|Overall Study||44
8293882|NCT01592747|20448725|P3|STARTED|Overall Study|Based on Randomized Population|158
8293883|NCT01592747|20448726|P2|STARTED|Overall Study|Based on Randomized Population|161
8293884|NCT01592747|20448727|P1|STARTED|Overall Study|Based on Randomized Population|160
8293885|NCT01592708|20448770|P2|NOT COMPLETED|Overall Study||0
8293886|NCT01592708|20448771|P1|NOT COMPLETED|Overall Study||3
8293887|NCT01592708|20448770|P2|COMPLETED|Overall Study||137
8293888|NCT01592708|20448771|P1|COMPLETED|Overall Study||93
8293889|NCT01592708|20448770|P2|STARTED|Overall Study||137
8293890|NCT01592708|20448771|P1|STARTED|Overall Study||96
8293891|NCT01592695|20448787|P2|NOT COMPLETED|Overall Study||4
8293892|NCT01592695|20448788|P1|NOT COMPLETED|Overall Study||8
8293893|NCT01592695|20448787|P2|COMPLETED|Overall Study||28
8293894|NCT01592695|20448788|P1|COMPLETED|Overall Study||23
8293895|NCT01592695|20448787|P2|STARTED|Overall Study||32
8293896|NCT01592695|20448788|P1|STARTED|Overall Study||31
8293897|NCT01592500|20448810|P4|NOT COMPLETED|Overall Study||2
8293898|NCT01592500|20448811|P3|NOT COMPLETED|Overall Study||0
8293899|NCT01592500|20448812|P2|NOT COMPLETED|Overall Study||0
8293900|NCT01592500|20448813|P1|NOT COMPLETED|Overall Study||1
8293901|NCT01592500|20448810|P4|COMPLETED|Overall Study||11
8293902|NCT01592500|20448811|P3|COMPLETED|Overall Study||14
8293903|NCT01592500|20448812|P2|COMPLETED|Overall Study||15
8293904|NCT01592500|20448813|P1|COMPLETED|Overall Study||13
8293905|NCT01592500|20448810|P4|STARTED|Overall Study|Randomized Participants|13
8293906|NCT01592500|20448811|P3|STARTED|Overall Study||14
8293907|NCT01592500|20448812|P2|STARTED|Overall Study||15
8293908|NCT01592500|20448813|P1|STARTED|Overall Study|Randomized Participants|14
8293909|NCT01592435|20448835|P1|NOT COMPLETED|Overall Study||0
8293910|NCT01592435|20448835|P1|COMPLETED|Overall Study||76
8293911|NCT01592435|20448835|P1|STARTED|Overall Study||76
8293912|NCT01592409|20448843|P2|NOT COMPLETED|Overall Study||1
8293913|NCT01592409|20448844|P1|NOT COMPLETED|Overall Study||0
8293914|NCT01592409|20448843|P2|COMPLETED|Overall Study||31
8293915|NCT01592409|20448844|P1|COMPLETED|Overall Study||67
8293916|NCT01592409|20448843|P2|STARTED|Overall Study||32
8293917|NCT01592409|20448844|P1|STARTED|Overall Study||67
8293918|NCT01592396|20448852|P2|NOT COMPLETED|Overall Study||0
8293919|NCT01592396|20448853|P1|NOT COMPLETED|Overall Study||0
8293920|NCT01592396|20448852|P2|COMPLETED|Overall Study||10
8293921|NCT01592396|20448853|P1|COMPLETED|Overall Study||10
8293922|NCT01592396|20448852|P2|STARTED|Overall Study||10
8293923|NCT01592396|20448853|P1|STARTED|Overall Study||10
8293924|NCT01592383|20448868|P1|NOT COMPLETED|Overall Study||1
8293925|NCT01592383|20448868|P1|COMPLETED|Overall Study||1
8293926|NCT01592383|20448868|P1|STARTED|Overall Study||2
8293927|NCT01592344|20448879|P2|NOT COMPLETED|Overall Study||5
8293928|NCT01592344|20448880|P1|NOT COMPLETED|Overall Study||4
8293929|NCT01592344|20448879|P2|COMPLETED|Overall Study||44
8293930|NCT01592344|20448880|P1|COMPLETED|Overall Study||41
8293931|NCT01592344|20448879|P2|STARTED|Overall Study||49
8293932|NCT01592344|20448880|P1|STARTED|Overall Study||45
8293933|NCT01592292|20448894|P4|NOT COMPLETED|Overall Study||1
8293934|NCT01592292|20448895|P3|NOT COMPLETED|Overall Study||3
8293935|NCT01592292|20448896|P2|NOT COMPLETED|Overall Study||5
8293936|NCT01592292|20448897|P1|NOT COMPLETED|Overall Study||6
8293937|NCT01592292|20448894|P4|COMPLETED|Overall Study||10
8293938|NCT01592292|20448895|P3|COMPLETED|Overall Study||10
8293939|NCT01592292|20448896|P2|COMPLETED|Overall Study||15
8293940|NCT01592292|20448897|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
8293941|NCT01592292|20448894|P4|Standard Population Set (SPS)|Overall Study||7
8293942|NCT01592292|20448895|P3|Standard Population Set (SPS)|Overall Study||7
8293943|NCT01592292|20448896|P2|Standard Population Set (SPS)|Overall Study||10
8293944|NCT01592292|20448897|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
8293945|NCT01592292|20448894|P4|Intention to Treat (ITT) Set|Overall Study||8
8293946|NCT01592292|20448895|P3|Intention to Treat (ITT) Set|Overall Study||10
8293947|NCT01592292|20448896|P2|Intention to Treat (ITT) Set|Overall Study||13
8293948|NCT01592292|20448897|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
8293949|NCT01592292|20448894|P4|STARTED|Overall Study||11
8293950|NCT01592292|20448895|P3|STARTED|Overall Study||13
8293951|NCT01592292|20448896|P2|STARTED|Overall Study||20
8293952|NCT01592292|20448897|P1|STARTED|Overall Study||46
8293953|NCT01592240|20448936|P7|NOT COMPLETED|Overall Study||3
8293954|NCT01592240|20448937|P6|NOT COMPLETED|Overall Study||3
8293955|NCT01592240|20448938|P5|NOT COMPLETED|Overall Study||7
8293956|NCT01592240|20448939|P4|NOT COMPLETED|Overall Study||3
8293957|NCT01592240|20448940|P3|NOT COMPLETED|Overall Study||7
8293958|NCT01592240|20448941|P2|NOT COMPLETED|Overall Study||11
8293959|NCT01592240|20448942|P1|NOT COMPLETED|Overall Study||3
8293960|NCT01592240|20448936|P7|COMPLETED|Overall Study||48
8293961|NCT01592240|20448937|P6|COMPLETED|Overall Study||47
8293962|NCT01592240|20448938|P5|COMPLETED|Overall Study||44
8293963|NCT01592240|20448939|P4|COMPLETED|Overall Study||47
8293964|NCT01592240|20448940|P3|COMPLETED|Overall Study||45
8293965|NCT01592240|20448941|P2|COMPLETED|Overall Study||39
8293966|NCT01592240|20448942|P1|COMPLETED|Overall Study||47
8293967|NCT01592240|20448936|P7|STARTED|Overall Study||51
8293968|NCT01592240|20448937|P6|STARTED|Overall Study||50
8293969|NCT01592240|20448938|P5|STARTED|Overall Study||51
8293970|NCT01592240|20448939|P4|STARTED|Overall Study||50
8293971|NCT01592240|20448940|P3|STARTED|Overall Study||52
8293972|NCT01592240|20448941|P2|STARTED|Overall Study||50
8293973|NCT01592240|20448942|P1|STARTED|Overall Study||50
8293974|NCT01592071|20449122|P1|NOT COMPLETED|Overall Study||0
8293975|NCT01592071|20449122|P1|COMPLETED|Overall Study||120
8293976|NCT01592071|20449122|P1|STARTED|Overall Study||120
8293977|NCT01592045|20449135|P2|NOT COMPLETED|Overall Study||2
8293978|NCT01592045|20449136|P1|NOT COMPLETED|Overall Study||5
8293979|NCT01592045|20449135|P2|COMPLETED|Overall Study||12
8293980|NCT01592045|20449136|P1|COMPLETED|Overall Study||9
8293981|NCT01592045|20449135|P2|Completed Course 5|Overall Study||12
8293982|NCT01592045|20449136|P1|Completed Course 5|Overall Study||9
8293983|NCT01592045|20449135|P2|Completed Course 4|Overall Study||12
8293984|NCT01592045|20449136|P1|Completed Course 4|Overall Study||11
8293985|NCT01592045|20449135|P2|Completed Course 3|Overall Study||13
8293986|NCT01592045|20449136|P1|Completed Course 3|Overall Study||11
8293987|NCT01592045|20449135|P2|Completed Course 2|Overall Study||13
8293988|NCT01592045|20449136|P1|Completed Course 2|Overall Study||13
8293989|NCT01592045|20449135|P2|Completed Course 1|Overall Study||14
8293990|NCT01592045|20449136|P1|Completed Course 1|Overall Study||13
8293991|NCT01592045|20449135|P2|STARTED|Overall Study||14
8293992|NCT01592045|20449136|P1|STARTED|Overall Study||14
8293993|NCT01592006|20449144|P1|NOT COMPLETED|Overall Study||0
8293994|NCT01592006|20449144|P1|COMPLETED|Overall Study||3
8293995|NCT01592006|20449144|P1|STARTED|Overall Study||3
8293996|NCT01591954|20449149|P1|NOT COMPLETED|Overall Study||0
8293997|NCT01591954|20449149|P1|COMPLETED|Overall Study||1
8293998|NCT01591954|20449149|P1|STARTED|Overall Study||1
8293999|NCT01591863|20449154|P1|NOT COMPLETED|Overall Study||14
8294000|NCT01591863|20449154|P1|COMPLETED|Overall Study||24
8294001|NCT01591863|20449154|P1|STARTED|Overall Study||38
8294002|NCT01591837|20449166|P2|NOT COMPLETED|Overall Study||0
8294003|NCT01591837|20449167|P1|NOT COMPLETED|Overall Study||0
8294004|NCT01591837|20449166|P2|COMPLETED|Overall Study||60
8294005|NCT01591837|20449167|P1|COMPLETED|Overall Study||60
8294006|NCT01591837|20449166|P2|STARTED|Overall Study||60
8294007|NCT01591837|20449167|P1|STARTED|Overall Study||60
8294008|NCT01591785|20449183|P2|NOT COMPLETED|Overall Study||2
8294009|NCT01591785|20449184|P1|NOT COMPLETED|Overall Study||4
8294010|NCT01591785|20449183|P2|COMPLETED|Overall Study||28
8294011|NCT01591785|20449184|P1|COMPLETED|Overall Study||26
8294012|NCT01591785|20449183|P2|STARTED|Overall Study||30
8294013|NCT01591785|20449184|P1|STARTED|Overall Study||30
8294014|NCT01591746|20449198|P2|NOT COMPLETED|Overall Study||0
8294015|NCT01591746|20449199|P1|NOT COMPLETED|Overall Study||0
8294016|NCT01591746|20449198|P2|COMPLETED|Overall Study||63
8294017|NCT01591746|20449199|P1|COMPLETED|Overall Study||68
8294018|NCT01591746|20449198|P2|STARTED|Overall Study||63
8294019|NCT01591746|20449199|P1|STARTED|Overall Study||68
8294023|NCT01591681|20449226|P1|NOT COMPLETED|Overall Study||4
8294024|NCT01591681|20449226|P1|COMPLETED|Overall Study||45
8294025|NCT01591681|20449226|P1|STARTED|Overall Study||49
8294026|NCT01591655|20449254|P2|NOT COMPLETED|Overall Study||63
8294027|NCT01591655|20449255|P1|NOT COMPLETED|Overall Study||72
8294028|NCT01591655|20449254|P2|COMPLETED|Overall Study||57
8294029|NCT01591655|20449255|P1|COMPLETED|Overall Study||168
8294030|NCT01591655|20449254|P2|STARTED|Overall Study||120
8294031|NCT01591655|20449255|P1|STARTED|Overall Study||240
8294032|NCT01591616|20449273|P1|NOT COMPLETED|Overall Study||1
8294033|NCT01591616|20449273|P1|COMPLETED|Overall Study||15
8294034|NCT01591616|20449273|P1|STARTED|Overall Study||16
8294035|NCT01591499|20449414|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8294036|NCT01591499|20449415|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8294037|NCT01591499|20449416|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8294038|NCT01591499|20449417|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
8294039|NCT01591499|20449414|P4|COMPLETED|Second Intervention (up to 24 Days)||34
8294040|NCT01591499|20449415|P3|COMPLETED|Second Intervention (up to 24 Days)||28
8294041|NCT01591499|20449416|P2|COMPLETED|Second Intervention (up to 24 Days)||34
8294042|NCT01591499|20449417|P1|COMPLETED|Second Intervention (up to 24 Days)||27
8294043|NCT01591499|20449414|P4|STARTED|Second Intervention (up to 24 Days)||37
8294044|NCT01591499|20449415|P3|STARTED|Second Intervention (up to 24 Days)||31
8294045|NCT01591499|20449416|P2|STARTED|Second Intervention (up to 24 Days)||37
8294046|NCT01591499|20449417|P1|STARTED|Second Intervention (up to 24 Days)||33
8294047|NCT01591499|20449414|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294048|NCT01591499|20449415|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294049|NCT01591499|20449416|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294050|NCT01591499|20449417|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294051|NCT01591499|20449414|P4|COMPLETED|First Intervention (up to 24 Days)||37
8294052|NCT01591499|20449415|P3|COMPLETED|First Intervention (up to 24 Days)||31
8294053|NCT01591499|20449416|P2|COMPLETED|First Intervention (up to 24 Days)||37
8294054|NCT01591499|20449417|P1|COMPLETED|First Intervention (up to 24 Days)||33
8294055|NCT01591499|20449414|P4|STARTED|First Intervention (up to 24 Days)||37
8294056|NCT01591499|20449415|P3|STARTED|First Intervention (up to 24 Days)||31
8294057|NCT01591499|20449416|P2|STARTED|First Intervention (up to 24 Days)||37
8294058|NCT01591499|20449417|P1|STARTED|First Intervention (up to 24 Days)||33
8294059|NCT01591499|20449414|P4|NOT COMPLETED|Baseline Visit||2
8294060|NCT01591499|20449415|P3|NOT COMPLETED|Baseline Visit||0
8294061|NCT01591499|20449416|P2|NOT COMPLETED|Baseline Visit||2
8294062|NCT01591499|20449417|P1|NOT COMPLETED|Baseline Visit||0
8294063|NCT01591499|20449414|P4|COMPLETED|Baseline Visit||37
8294064|NCT01591499|20449415|P3|COMPLETED|Baseline Visit||31
8294065|NCT01591499|20449416|P2|COMPLETED|Baseline Visit||37
8294066|NCT01591499|20449417|P1|COMPLETED|Baseline Visit||33
8294067|NCT01591499|20449414|P4|STARTED|Baseline Visit||39
8294068|NCT01591499|20449415|P3|STARTED|Baseline Visit||31
8294069|NCT01591499|20449416|P2|STARTED|Baseline Visit||39
8294070|NCT01591499|20449417|P1|STARTED|Baseline Visit||33
8294071|NCT01591460|20449483|P1|NOT COMPLETED|Overall Study||26
8294072|NCT01591460|20449483|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
8294073|NCT01591460|20449483|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
8294074|NCT01591408|20449565|P2|NOT COMPLETED|Overall Study||8
8294075|NCT01591408|20449566|P1|NOT COMPLETED|Overall Study||12
8294076|NCT01591408|20449565|P2|COMPLETED|Overall Study||24
8294077|NCT01591408|20449566|P1|COMPLETED|Overall Study||24
8294078|NCT01591408|20449565|P2|STARTED|Overall Study||32
8294079|NCT01591408|20449566|P1|STARTED|Overall Study||36
8294080|NCT01591382|20449574|P2|NOT COMPLETED|Overall Study||2
8294081|NCT01591382|20449575|P1|NOT COMPLETED|Overall Study||3
8294082|NCT01591382|20449574|P2|COMPLETED|Overall Study||30
8294083|NCT01591382|20449575|P1|COMPLETED|Overall Study||29
8294084|NCT01591382|20449574|P2|STARTED|Overall Study||32
8294085|NCT01591382|20449575|P1|STARTED|Overall Study||32
8294086|NCT01591317|20449592|P3|NOT COMPLETED|Overall Study||0
8294087|NCT01591317|20449593|P2|NOT COMPLETED|Overall Study||0
8294088|NCT01591317|20449594|P1|NOT COMPLETED|Overall Study||0
8294089|NCT01591317|20449592|P3|COMPLETED|Overall Study||10
8294090|NCT01591317|20449593|P2|COMPLETED|Overall Study||10
8294091|NCT01591317|20449594|P1|COMPLETED|Overall Study||10
8294092|NCT01591317|20449592|P3|STARTED|Overall Study||10
8294093|NCT01591317|20449593|P2|STARTED|Overall Study||10
8294094|NCT01591317|20449594|P1|STARTED|Overall Study||10
8294095|NCT01591161|20449622|P2|NOT COMPLETED|Overall Study||56
8294096|NCT01591161|20449623|P1|NOT COMPLETED|Overall Study||71
8294097|NCT01591161|20449622|P2|COMPLETED|Overall Study||68
8294098|NCT01591161|20449623|P1|COMPLETED|Overall Study||174
8294099|NCT01591161|20449622|P2|STARTED|Overall Study||124
8294100|NCT01591161|20449623|P1|STARTED|Overall Study||245
8294101|NCT01591096|20449643|P1|NOT COMPLETED|Overall Study||1
8294102|NCT01591096|20449643|P1|COMPLETED|Overall Study||0
8294103|NCT01591096|20449643|P1|STARTED|Overall Study||1
8294104|NCT01591044|20449652|P3|NOT COMPLETED|Overall Study||4
8294105|NCT01591044|20449653|P2|NOT COMPLETED|Overall Study||9
8294106|NCT01591044|20449654|P1|NOT COMPLETED|Overall Study||7
8294107|NCT01591044|20449652|P3|COMPLETED|Overall Study||96
8294108|NCT01591044|20449653|P2|COMPLETED|Overall Study||91
8294109|NCT01591044|20449654|P1|COMPLETED|Overall Study||94
8294110|NCT01591044|20449652|P3|STARTED|Overall Study||100
8294111|NCT01591044|20449653|P2|STARTED|Overall Study||100
8294112|NCT01591044|20449654|P1|STARTED|Overall Study||101
8294113|NCT01591018|20449664|P2|NOT COMPLETED|Overall Study||0
8294114|NCT01591018|20449665|P1|NOT COMPLETED|Overall Study||0
8294115|NCT01591018|20449664|P2|COMPLETED|Overall Study||60
8294116|NCT01591018|20449665|P1|COMPLETED|Overall Study||60
8294117|NCT01591018|20449664|P2|STARTED|Overall Study||60
8294118|NCT01591018|20449665|P1|STARTED|Overall Study||60
8294119|NCT01591005|20449679|P4|NOT COMPLETED|Overall Study||0
8294120|NCT01591005|20449680|P3|NOT COMPLETED|Overall Study||0
8294121|NCT01591005|20449681|P2|NOT COMPLETED|Overall Study||0
8294122|NCT01591005|20449682|P1|NOT COMPLETED|Overall Study||0
8294123|NCT01591005|20449679|P4|COMPLETED|Overall Study||68
8294124|NCT01591005|20449680|P3|COMPLETED|Overall Study||68
8294125|NCT01591005|20449681|P2|COMPLETED|Overall Study||53
8294126|NCT01591005|20449682|P1|COMPLETED|Overall Study||53
8294127|NCT01591005|20449679|P4|STARTED|Overall Study||68
8294128|NCT01591005|20449680|P3|STARTED|Overall Study||68
8294129|NCT01591005|20449681|P2|STARTED|Overall Study||53
8294130|NCT01591005|20449682|P1|STARTED|Overall Study||53
8294131|NCT01590979|20449718|P2|NOT COMPLETED|Overall Study||0
8294132|NCT01590979|20449719|P1|NOT COMPLETED|Overall Study||0
8294133|NCT01590979|20449718|P2|COMPLETED|Overall Study||27
8294134|NCT01590979|20449719|P1|COMPLETED|Overall Study||27
8294135|NCT01590979|20449718|P2|STARTED|Overall Study||27
8294136|NCT01590979|20449719|P1|STARTED|Overall Study||27
8294137|NCT01590888|20449728|P3|NOT COMPLETED|Overall Study||1
8294138|NCT01590888|20449729|P2|NOT COMPLETED|Overall Study||0
8294139|NCT01590888|20449730|P1|NOT COMPLETED|Overall Study||4
8294140|NCT01590888|20449728|P3|COMPLETED|Overall Study||34
8294141|NCT01590888|20449729|P2|COMPLETED|Overall Study||38
8294142|NCT01590888|20449730|P1|COMPLETED|Overall Study||32
8294143|NCT01590888|20449728|P3|STARTED|Overall Study||35
8294144|NCT01590888|20449729|P2|STARTED|Overall Study||38
8294145|NCT01590888|20449730|P1|STARTED|Overall Study||36
8294146|NCT01590875|20449776|P2|NOT COMPLETED|Overall Study||0
8294147|NCT01590875|20449777|P1|NOT COMPLETED|Overall Study||0
8294148|NCT01590875|20449776|P2|COMPLETED|Overall Study||10
8294149|NCT01590875|20449777|P1|COMPLETED|Overall Study||10
8294150|NCT01590875|20449776|P2|STARTED|Overall Study||10
8294151|NCT01590875|20449777|P1|STARTED|Overall Study||10
8294152|NCT01590810|20449790|P5|NOT COMPLETED|Overall Study||0
8294153|NCT01590810|20449791|P4|NOT COMPLETED|Overall Study||0
8294154|NCT01590810|20449792|P3|NOT COMPLETED|Overall Study||1
8294155|NCT01590810|20449793|P2|NOT COMPLETED|Overall Study||1
8294156|NCT01590810|20449794|P1|NOT COMPLETED|Overall Study||0
8294157|NCT01590810|20449790|P5|COMPLETED|Overall Study||2
8294158|NCT01590810|20449791|P4|COMPLETED|Overall Study||8
8294159|NCT01590810|20449792|P3|COMPLETED|Overall Study||7
8294160|NCT01590810|20449793|P2|COMPLETED|Overall Study||7
8294161|NCT01590810|20449794|P1|COMPLETED|Overall Study||8
8294162|NCT01590810|20449790|P5|STARTED|Overall Study||2
8294163|NCT01590810|20449791|P4|STARTED|Overall Study||8
8294164|NCT01590810|20449792|P3|STARTED|Overall Study||8
8294165|NCT01590810|20449793|P2|STARTED|Overall Study||8
8294166|NCT01590810|20449794|P1|STARTED|Overall Study||8
8294167|NCT01590797|20449939|P2|NOT COMPLETED|Overall Study||16
8294168|NCT01590797|20449940|P1|NOT COMPLETED|Overall Study||17
8294169|NCT01590797|20449939|P2|COMPLETED|Overall Study||217
8294170|NCT01590797|20449940|P1|COMPLETED|Overall Study||217
8294171|NCT01590797|20449939|P2|STARTED|Overall Study||233
8294172|NCT01590797|20449940|P1|STARTED|Overall Study||234
8294173|NCT01590771|20449956|P2|NOT COMPLETED|Overall Study||39
8294174|NCT01590771|20449957|P1|NOT COMPLETED|Overall Study||19
8294175|NCT01590771|20449956|P2|COMPLETED|Overall Study||210
8294176|NCT01590771|20449957|P1|COMPLETED|Overall Study||230
8294177|NCT01590771|20449956|P2|STARTED|Overall Study||249
8294178|NCT01590771|20449957|P1|STARTED|Overall Study||249
8294179|NCT01590758|20449985|P2|NOT COMPLETED|Overall Study||7
8294180|NCT01590758|20449986|P1|NOT COMPLETED|Overall Study||5
8294181|NCT01590758|20449985|P2|COMPLETED|Overall Study||97
8294182|NCT01590758|20449986|P1|COMPLETED|Overall Study||80
8294183|NCT01590758|20449985|P2|STARTED|Overall Study||104
8294184|NCT01590758|20449986|P1|STARTED|Overall Study||85
8294185|NCT01590563|20449996|P1|NOT COMPLETED|Overall Study||1
8294186|NCT01590563|20449996|P1|COMPLETED|Overall Study||14
8294187|NCT01590563|20449996|P1|STARTED|Overall Study||15
8294188|NCT01590550|20450002|P1|NOT COMPLETED|Overall Study||0
8294189|NCT01590550|20450002|P1|COMPLETED|Overall Study||18
8294190|NCT01590550|20450002|P1|STARTED|Overall Study||18
8294191|NCT01590433|20450010|P2|NOT COMPLETED|Overall Study||22
8294192|NCT01590433|20450011|P1|NOT COMPLETED|Overall Study||52
8294193|NCT01590433|20450010|P2|COMPLETED|Overall Study||33
8294194|NCT01590433|20450011|P1|COMPLETED|Overall Study||75
8294195|NCT01590433|20450010|P2|STARTED|Overall Study||55
8294196|NCT01590433|20450011|P1|STARTED|Overall Study||127
8294197|NCT01590394|20450017|P1|NOT COMPLETED|Overall Study||0
8294198|NCT01590394|20450017|P1|COMPLETED|Overall Study||3
8294199|NCT01590394|20450017|P1|STARTED|Overall Study||3
8294200|NCT01590264|20450021|P1|NOT COMPLETED|Overall Study||0
8294201|NCT01590264|20450021|P1|COMPLETED|Overall Study||5
8294202|NCT01590264|20450021|P1|STARTED|Overall Study||5
8294203|NCT01590238|20450026|P1|NOT COMPLETED|Overall Study||2
8294204|NCT01590238|20450026|P1|COMPLETED|Overall Study||13
8294205|NCT01590238|20450026|P1|STARTED|Overall Study||15
8294206|NCT01590212|20450033|P3|NOT COMPLETED|Overall Study||5
8294207|NCT01590212|20450034|P2|NOT COMPLETED|Overall Study||4
8294208|NCT01590212|20450035|P1|NOT COMPLETED|Overall Study||3
8294209|NCT01590212|20450033|P3|COMPLETED|Overall Study||9
8294210|NCT01590212|20450034|P2|COMPLETED|Overall Study||5
8294211|NCT01590212|20450035|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
8294212|NCT01590212|20450033|P3|Post-intervention|Overall Study|failed contact=1|10
8294213|NCT01590212|20450034|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
8294214|NCT01590212|20450035|P1|Post-intervention|Overall Study|failed contact=3|7
8294215|NCT01590212|20450033|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
8294216|NCT01590212|20450034|P2|Baseline (Pre-intervention)|Overall Study||9
8294217|NCT01590212|20450035|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
8294218|NCT01590212|20450033|P3|STARTED|Overall Study||14
8294219|NCT01590212|20450034|P2|STARTED|Overall Study||9
8294220|NCT01590212|20450035|P1|STARTED|Overall Study||12
8294221|NCT01590082|20450054|P2|NOT COMPLETED|Overall Study||0
8294222|NCT01590082|20450055|P1|NOT COMPLETED|Overall Study||2
8294223|NCT01590082|20450054|P2|COMPLETED|Overall Study||1
8294224|NCT01590082|20450055|P1|COMPLETED|Overall Study||9
8294225|NCT01590082|20450054|P2|STARTED|Overall Study||1
8294226|NCT01590082|20450055|P1|STARTED|Overall Study||11
8294227|NCT01590017|20450061|P1|NOT COMPLETED|Overall Study||4
8294228|NCT01590017|20450061|P1|COMPLETED|Overall Study||37
8294229|NCT01590017|20450061|P1|STARTED|Overall Study||41
8294230|NCT01589978|20450066|P1|NOT COMPLETED|Overall Study||0
8294231|NCT01589978|20450066|P1|COMPLETED|Overall Study||2681
8294232|NCT01589978|20450066|P1|STARTED|Overall Study||2681
8294233|NCT01589926|20450092|P2|NOT COMPLETED|Overall Study||0
8294234|NCT01589926|20450093|P1|NOT COMPLETED|Overall Study||0
8294235|NCT01589926|20450092|P2|COMPLETED|Overall Study||0
8294236|NCT01589926|20450093|P1|COMPLETED|Overall Study||0
8294237|NCT01589926|20450092|P2|STARTED|Overall Study||0
8294238|NCT01589926|20450093|P1|STARTED|Overall Study||0
8294239|NCT01589822|20450114|P3|NOT COMPLETED|Overall Study||1
8294240|NCT01589822|20450115|P2|NOT COMPLETED|Overall Study||3
8294241|NCT01589822|20450116|P1|NOT COMPLETED|Overall Study||4
8294242|NCT01589822|20450114|P3|COMPLETED|Overall Study||40
8294243|NCT01589822|20450115|P2|COMPLETED|Overall Study||86
8294244|NCT01589822|20450116|P1|COMPLETED|Overall Study||80
8294245|NCT01589822|20450114|P3|STARTED|Overall Study||41
8294246|NCT01589822|20450115|P2|STARTED|Overall Study||89
8294247|NCT01589822|20450116|P1|STARTED|Overall Study||84
8294248|NCT01589770|20450135|P2|NOT COMPLETED|Overall Study||5
8294249|NCT01589770|20450136|P1|NOT COMPLETED|Overall Study||8
8294250|NCT01589770|20450135|P2|COMPLETED|Overall Study||56
8294251|NCT01589770|20450136|P1|COMPLETED|Overall Study||59
8294252|NCT01589770|20450135|P2|STARTED|Overall Study||61
8294253|NCT01589770|20450136|P1|STARTED|Overall Study||67
8294254|NCT01589653|20450146|P2|NOT COMPLETED|Overall Study||11
8294255|NCT01589653|20450147|P1|NOT COMPLETED|Overall Study||7
8294256|NCT01589653|20450146|P2|COMPLETED|Overall Study||68
8294257|NCT01589653|20450147|P1|COMPLETED|Overall Study||69
8294258|NCT01589653|20450146|P2|Exposed|Overall Study||78
8294259|NCT01589653|20450147|P1|Exposed|Overall Study||76
8294260|NCT01589653|20450146|P2|STARTED|Overall Study||79
8294261|NCT01589653|20450147|P1|STARTED|Overall Study||76
8294262|NCT01589601|20450163|P2|NOT COMPLETED|Overall Study||49
8294263|NCT01589601|20450164|P1|NOT COMPLETED|Overall Study||47
8294264|NCT01589601|20450163|P2|COMPLETED|Overall Study||26
8294265|NCT01589601|20450164|P1|COMPLETED|Overall Study||28
8294266|NCT01589601|20450163|P2|STARTED|Overall Study||75
8294267|NCT01589601|20450164|P1|STARTED|Overall Study||75
8294268|NCT01589510|20450182|P1|NOT COMPLETED|Overall Study||33
8294269|NCT01589510|20450182|P1|COMPLETED|Overall Study||386
8294270|NCT01589510|20450182|P1|STARTED|Overall Study||419
8294271|NCT01589497|20450197|P4|NOT COMPLETED|Overall Study||1
8294272|NCT01589497|20450198|P3|NOT COMPLETED|Overall Study||1
8294273|NCT01589497|20450199|P2|NOT COMPLETED|Overall Study||1
8294274|NCT01589497|20450200|P1|NOT COMPLETED|Overall Study||1
8294275|NCT01589497|20450197|P4|COMPLETED|Overall Study||17
8294276|NCT01589497|20450198|P3|COMPLETED|Overall Study||15
8294277|NCT01589497|20450199|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
8294278|NCT01589497|20450200|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
8294279|NCT01589497|20450197|P4|STARTED|Overall Study||18
8294280|NCT01589497|20450198|P3|STARTED|Overall Study||16
8294281|NCT01589497|20450199|P2|STARTED|Overall Study||17
8294282|NCT01589497|20450200|P1|STARTED|Overall Study||18
8294283|NCT01589484|20450301|P1|NOT COMPLETED|Overall Study||4
8294284|NCT01589484|20450301|P1|COMPLETED|Overall Study||100
8294285|NCT01589484|20450301|P1|STARTED|Overall Study||104
8294286|NCT01589445|20450306|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
8294287|NCT01589445|20450306|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
8294288|NCT01589445|20450306|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
8294289|NCT01589445|20450306|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
8294290|NCT01589445|20450306|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
8294291|NCT01589445|20450306|P1|STARTED|001 (Pioglitazone) -3 Months||77
8294292|NCT01589315|20450322|P1|NOT COMPLETED|Overall Study||1
8294293|NCT01589315|20450322|P1|COMPLETED|Overall Study||16
8294294|NCT01589315|20450322|P1|STARTED|Overall Study||17
8294295|NCT01589302|20450326|P1|NOT COMPLETED|Overall Study||2
8294296|NCT01589302|20450326|P1|COMPLETED|Overall Study||152
8294297|NCT01589302|20450326|P1|Non-Del17p Patients|Overall Study||76
8294298|NCT01589302|20450326|P1|Del17p Patients|Overall Study||76
8294299|NCT01589302|20450326|P1|STARTED|Overall Study||154
8294300|NCT01589237|20450349|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
8294301|NCT01589237|20450350|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
8294302|NCT01589237|20450351|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
8294303|NCT01589237|20450352|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
8294304|NCT01589237|20450349|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294305|NCT01589237|20450350|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294306|NCT01589237|20450351|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294307|NCT01589237|20450352|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294308|NCT01589237|20450349|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
8294309|NCT01589237|20450350|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
8294310|NCT01589237|20450351|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
8294311|NCT01589237|20450352|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
8294312|NCT01589237|20450349|P4|NOT COMPLETED|Part A (52 Weeks)||0
8294313|NCT01589237|20450350|P3|NOT COMPLETED|Part A (52 Weeks)||2
8294314|NCT01589237|20450351|P2|NOT COMPLETED|Part A (52 Weeks)||3
8294315|NCT01589237|20450352|P1|NOT COMPLETED|Part A (52 Weeks)||2
8294316|NCT01589237|20450349|P4|COMPLETED|Part A (52 Weeks)||5
8294317|NCT01589237|20450350|P3|COMPLETED|Part A (52 Weeks)||8
8294318|NCT01589237|20450351|P2|COMPLETED|Part A (52 Weeks)||9
8294319|NCT01589237|20450352|P1|COMPLETED|Part A (52 Weeks)||9
8294320|NCT01589237|20450349|P4|STARTED|Part A (52 Weeks)||5
8294321|NCT01589237|20450350|P3|STARTED|Part A (52 Weeks)||10
8294322|NCT01589237|20450351|P2|STARTED|Part A (52 Weeks)||12
8294323|NCT01589237|20450352|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
8294324|NCT01589185|20450403|P5|NOT COMPLETED|Overall Study||1
8294325|NCT01589185|20450404|P4|NOT COMPLETED|Overall Study||3
8294326|NCT01589185|20450405|P3|NOT COMPLETED|Overall Study||4
8294327|NCT01589185|20450406|P2|NOT COMPLETED|Overall Study||2
8294328|NCT01589185|20450407|P1|NOT COMPLETED|Overall Study||2
8294329|NCT01589185|20450403|P5|COMPLETED|Overall Study||15
8294330|NCT01589185|20450404|P4|COMPLETED|Overall Study||5
8294331|NCT01589185|20450405|P3|COMPLETED|Overall Study||6
8294332|NCT01589185|20450406|P2|COMPLETED|Overall Study||6
8294333|NCT01589185|20450407|P1|COMPLETED|Overall Study||4
8294334|NCT01589185|20450403|P5|STARTED|Overall Study||16
8294335|NCT01589185|20450404|P4|STARTED|Overall Study||8
8294336|NCT01589185|20450405|P3|STARTED|Overall Study||10
8294337|NCT01589185|20450406|P2|STARTED|Overall Study||8
8294338|NCT01589185|20450407|P1|STARTED|Overall Study||6
8294339|NCT01589094|20450440|P1|NOT COMPLETED|Overall Study||2
8294340|NCT01589094|20450440|P1|COMPLETED|Overall Study||49
8294341|NCT01589094|20450440|P1|STARTED|Overall Study||51
8294342|NCT01588990|20450447|P1|NOT COMPLETED|Phase B||16
8294343|NCT01588990|20450447|P1|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
8294344|NCT01588990|20450447|P1|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
8294345|NCT01588990|20450447|P1|NOT COMPLETED|Phase A||70
8294346|NCT01588990|20450447|P1|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
8294347|NCT01588990|20450447|P1|STARTED|Phase A||128
8294348|NCT01588951|20450475|P3|NOT COMPLETED|Overall Study||1
8294349|NCT01588951|20450476|P2|NOT COMPLETED|Overall Study||0
8294350|NCT01588951|20450477|P1|NOT COMPLETED|Overall Study||0
8294351|NCT01588951|20450475|P3|COMPLETED|Overall Study||5
8294352|NCT01588951|20450476|P2|COMPLETED|Overall Study||2
8294353|NCT01588951|20450477|P1|COMPLETED|Overall Study||2
8294354|NCT01588951|20450475|P3|STARTED|Overall Study||6
8294355|NCT01588951|20450476|P2|STARTED|Overall Study||2
8294356|NCT01588951|20450477|P1|STARTED|Overall Study||2
8294357|NCT01588821|20450485|P1|NOT COMPLETED|Overall Study||0
8294358|NCT01588821|20450485|P1|COMPLETED|Overall Study||37
8294359|NCT01588821|20450485|P1|STARTED|Overall Study||37
8294360|NCT01588561|20450495|P2|NOT COMPLETED|Overall Study||0
8294361|NCT01588561|20450496|P1|NOT COMPLETED|Overall Study||0
8294362|NCT01588561|20450495|P2|COMPLETED|Overall Study||1
8294363|NCT01588561|20450496|P1|COMPLETED|Overall Study||14
8294364|NCT01588561|20450495|P2|Second Injection (Visit 2)|Overall Study||1
8294365|NCT01588561|20450496|P1|Second Injection (Visit 2)|Overall Study||14
8294366|NCT01588561|20450495|P2|Rest Period|Overall Study||1
8294367|NCT01588561|20450496|P1|Rest Period|Overall Study||14
8294368|NCT01588561|20450495|P2|First Injection (Visit 1)|Overall Study||1
8294369|NCT01588561|20450496|P1|First Injection (Visit 1)|Overall Study||14
8294370|NCT01588561|20450495|P2|STARTED|Overall Study||1
8294371|NCT01588561|20450496|P1|STARTED|Overall Study||14
8294372|NCT01588548|20450513|P6|NOT COMPLETED|Overall Study||6
8294373|NCT01588548|20450514|P5|NOT COMPLETED|Overall Study||6
8294374|NCT01588548|20450515|P4|NOT COMPLETED|Overall Study||7
8294375|NCT01588548|20450516|P3|NOT COMPLETED|Overall Study||6
8294376|NCT01588548|20450517|P2|NOT COMPLETED|Overall Study||7
8294377|NCT01588548|20450518|P1|NOT COMPLETED|Overall Study||3
8294378|NCT01588548|20450513|P6|COMPLETED|Overall Study||0
8294379|NCT01588548|20450514|P5|COMPLETED|Overall Study||0
8294380|NCT01588548|20450515|P4|COMPLETED|Overall Study||0
8294381|NCT01588548|20450516|P3|COMPLETED|Overall Study||0
8294382|NCT01588548|20450517|P2|COMPLETED|Overall Study||0
8294383|NCT01588548|20450518|P1|COMPLETED|Overall Study||0
8294384|NCT01588548|20450513|P6|Cycle 1 Day 21|Overall Study||3
8294385|NCT01588548|20450514|P5|Cycle 1 Day 21|Overall Study||3
8294386|NCT01588548|20450515|P4|Cycle 1 Day 21|Overall Study||5
8294387|NCT01588548|20450516|P3|Cycle 1 Day 21|Overall Study||2
8294388|NCT01588548|20450517|P2|Cycle 1 Day 21|Overall Study||5
8294389|NCT01588548|20450518|P1|Cycle 1 Day 21|Overall Study||3
8294390|NCT01588548|20450513|P6|STARTED|Overall Study||6
8294391|NCT01588548|20450514|P5|STARTED|Overall Study||6
8294392|NCT01588548|20450515|P4|STARTED|Overall Study||7
8294393|NCT01588548|20450516|P3|STARTED|Overall Study||6
8294394|NCT01588548|20450517|P2|STARTED|Overall Study||7
8294395|NCT01588548|20450518|P1|STARTED|Overall Study||3
8294396|NCT01588509|20450534|P2|NOT COMPLETED|Overall Study||0
8294397|NCT01588509|20450535|P1|NOT COMPLETED|Overall Study||1
8294398|NCT01588509|20450534|P2|COMPLETED|Overall Study||30
8294399|NCT01588509|20450535|P1|COMPLETED|Overall Study||29
8294400|NCT01588509|20450534|P2|Received Treatment|Overall Study||30
8294401|NCT01588509|20450535|P1|Received Treatment|Overall Study||30
8294402|NCT01588509|20450534|P2|STARTED|Overall Study||30
8294403|NCT01588509|20450535|P1|STARTED|Overall Study||30
8294404|NCT01588496|20450558|P3|NOT COMPLETED|Overall Study||0
8294405|NCT01588496|20450559|P2|NOT COMPLETED|Overall Study||1
8294406|NCT01588496|20450560|P1|NOT COMPLETED|Overall Study||0
8294407|NCT01588496|20450558|P3|COMPLETED|Overall Study||33
8294408|NCT01588496|20450559|P2|COMPLETED|Overall Study||16
8294409|NCT01588496|20450560|P1|COMPLETED|Overall Study||8
8294410|NCT01588496|20450558|P3|Received Treatment|Overall Study||33
8294411|NCT01588496|20450559|P2|Received Treatment|Overall Study||16
8294412|NCT01588496|20450560|P1|Received Treatment|Overall Study||8
8294413|NCT01588496|20450558|P3|STARTED|Overall Study||33
8294414|NCT01588496|20450559|P2|STARTED|Overall Study||17
8294415|NCT01588496|20450560|P1|STARTED|Overall Study||8
8294416|NCT01588470|20450585|P1|NOT COMPLETED|Overall Study||80
8294417|NCT01588470|20450585|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
8294418|NCT01588470|20450585|P1|STARTED|Overall Study|First enrolled April 2007|130
8294419|NCT01588457|20450596|P4|NOT COMPLETED|Randomization 2||5
8294420|NCT01588457|20450597|P3|NOT COMPLETED|Randomization 2||5
8294421|NCT01588457|20450598|P2|NOT COMPLETED|Randomization 2||28
8294422|NCT01588457|20450599|P1|NOT COMPLETED|Randomization 2||20
8294423|NCT01588457|20450596|P4|COMPLETED|Randomization 2||13
8294424|NCT01588457|20450597|P3|COMPLETED|Randomization 2||12
8294425|NCT01588457|20450598|P2|COMPLETED|Randomization 2||3
8294426|NCT01588457|20450599|P1|COMPLETED|Randomization 2||1
8294427|NCT01588457|20450596|P4|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
8294428|NCT01588457|20450597|P3|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
8294429|NCT01588457|20450598|P2|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
8294430|NCT01588457|20450599|P1|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
8294431|NCT01588457|20450596|P4|NOT COMPLETED|Randomization 1||0
8294432|NCT01588457|20450597|P3|NOT COMPLETED|Randomization 1||0
8294433|NCT01588457|20450598|P2|NOT COMPLETED|Randomization 1||16
8294434|NCT01588457|20450599|P1|NOT COMPLETED|Randomization 1||23
8294435|NCT01588457|20450596|P4|COMPLETED|Randomization 1||0
8294436|NCT01588457|20450597|P3|COMPLETED|Randomization 1||0
8294437|NCT01588457|20450598|P2|COMPLETED|Randomization 1||43
8294438|NCT01588457|20450599|P1|COMPLETED|Randomization 1||30
8294439|NCT01588457|20450596|P4|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
8294440|NCT01588457|20450597|P3|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
8294441|NCT01588457|20450598|P2|STARTED|Randomization 1||59
8294442|NCT01588457|20450599|P1|STARTED|Randomization 1||53
8294443|NCT01588444|20450621|P2|NOT COMPLETED|Overall Study||0
8294444|NCT01588444|20450622|P1|NOT COMPLETED|Overall Study||0
8294445|NCT01588444|20450621|P2|COMPLETED|Overall Study||20
8294446|NCT01588444|20450622|P1|COMPLETED|Overall Study||20
8294447|NCT01588444|20450621|P2|STARTED|Overall Study||20
8294448|NCT01588444|20450622|P1|STARTED|Overall Study||20
8294449|NCT01588418|20450628|P2|NOT COMPLETED|Overall Study||0
8294450|NCT01588418|20450629|P1|NOT COMPLETED|Overall Study||0
8294451|NCT01588418|20450628|P2|COMPLETED|Overall Study||4
8294452|NCT01588418|20450629|P1|COMPLETED|Overall Study||11
8294453|NCT01588418|20450628|P2|STARTED|Overall Study||4
8294454|NCT01588418|20450629|P1|STARTED|Overall Study||11
8294455|NCT01588405|20450635|P1|NOT COMPLETED|Overall Study||2
8294456|NCT01588405|20450635|P1|COMPLETED|Overall Study||31
8294457|NCT01588405|20450635|P1|STARTED|Overall Study||33
8294458|NCT01588366|20450664|P6|NOT COMPLETED|Overall Study||2
8294459|NCT01588366|20450665|P5|NOT COMPLETED|Overall Study||0
8294460|NCT01588366|20450666|P4|NOT COMPLETED|Overall Study||1
8294461|NCT01588366|20450667|P3|NOT COMPLETED|Overall Study||0
8294462|NCT01588366|20450668|P2|NOT COMPLETED|Overall Study||1
8294463|NCT01588366|20450669|P1|NOT COMPLETED|Overall Study||0
8294464|NCT01588366|20450664|P6|COMPLETED|Overall Study||7
8294465|NCT01588366|20450665|P5|COMPLETED|Overall Study||3
8294466|NCT01588366|20450666|P4|COMPLETED|Overall Study||6
8294467|NCT01588366|20450667|P3|COMPLETED|Overall Study||2
8294468|NCT01588366|20450668|P2|COMPLETED|Overall Study||6
8294469|NCT01588366|20450669|P1|COMPLETED|Overall Study||2
8294470|NCT01588366|20450664|P6|Received at Least One Dose of Study Drug|Overall Study||9
8294471|NCT01588366|20450665|P5|Received at Least One Dose of Study Drug|Overall Study||3
8294472|NCT01588366|20450666|P4|Received at Least One Dose of Study Drug|Overall Study||7
8294473|NCT01588366|20450667|P3|Received at Least One Dose of Study Drug|Overall Study||2
8294474|NCT01588366|20450668|P2|Received at Least One Dose of Study Drug|Overall Study||7
8294475|NCT01588366|20450669|P1|Received at Least One Dose of Study Drug|Overall Study||2
8294476|NCT01588366|20450664|P6|STARTED|Overall Study||9
8294477|NCT01588366|20450665|P5|STARTED|Overall Study||3
8294478|NCT01588366|20450666|P4|STARTED|Overall Study||7
8294479|NCT01588366|20450667|P3|STARTED|Overall Study||2
8294480|NCT01588366|20450668|P2|STARTED|Overall Study||7
8294481|NCT01588366|20450669|P1|STARTED|Overall Study||2
8294482|NCT01588353|20450697|P3|NOT COMPLETED|Step3||2
8294483|NCT01588353|20450698|P2|NOT COMPLETED|Step3||0
8294484|NCT01588353|20450699|P1|NOT COMPLETED|Step3||0
8294485|NCT01588353|20450697|P3|COMPLETED|Step3||23
8294486|NCT01588353|20450698|P2|COMPLETED|Step3||0
8294487|NCT01588353|20450699|P1|COMPLETED|Step3||0
8294488|NCT01588353|20450697|P3|STARTED|Step3||25
8294489|NCT01588353|20450698|P2|STARTED|Step3||0
8294490|NCT01588353|20450699|P1|STARTED|Step3||0
8294491|NCT01588353|20450697|P3|NOT COMPLETED|Step2||0
8294492|NCT01588353|20450698|P2|NOT COMPLETED|Step2||1
8294493|NCT01588353|20450699|P1|NOT COMPLETED|Step2||0
8294494|NCT01588353|20450697|P3|COMPLETED|Step2||0
8294495|NCT01588353|20450698|P2|COMPLETED|Step2||70
8294496|NCT01588353|20450699|P1|COMPLETED|Step2||0
8294497|NCT01588353|20450697|P3|STARTED|Step2||0
8294498|NCT01588353|20450698|P2|STARTED|Step2||71
8294499|NCT01588353|20450699|P1|STARTED|Step2||0
8294500|NCT01588353|20450697|P3|NOT COMPLETED|Step1||0
8294501|NCT01588353|20450698|P2|NOT COMPLETED|Step1||0
8294502|NCT01588353|20450699|P1|NOT COMPLETED|Step1||0
8294503|NCT01588353|20450697|P3|COMPLETED|Step1||0
8294504|NCT01588353|20450698|P2|COMPLETED|Step1||0
8294505|NCT01588353|20450699|P1|COMPLETED|Step1||6
8294506|NCT01588353|20450697|P3|STARTED|Step1||0
8294507|NCT01588353|20450698|P2|STARTED|Step1||0
8294508|NCT01588353|20450699|P1|STARTED|Step1||6
8294509|NCT01588236|20450718|P3|NOT COMPLETED|Overall Study||25
8294510|NCT01588236|20450719|P2|NOT COMPLETED|Overall Study||28
8294511|NCT01588236|20450720|P1|NOT COMPLETED|Overall Study||16
8294512|NCT01588236|20450718|P3|COMPLETED|Overall Study||69
8294513|NCT01588236|20450719|P2|COMPLETED|Overall Study||66
8294514|NCT01588236|20450720|P1|COMPLETED|Overall Study||76
8294515|NCT01588236|20450718|P3|STARTED|Overall Study||94
8294516|NCT01588236|20450719|P2|STARTED|Overall Study||94
8294517|NCT01588236|20450720|P1|STARTED|Overall Study||92
8294518|NCT01588197|20450748|P2|NOT COMPLETED|Overall Study||1
8294519|NCT01588197|20450749|P1|NOT COMPLETED|Overall Study||1
8294520|NCT01588197|20450748|P2|COMPLETED|Overall Study||9
8294521|NCT01588197|20450749|P1|COMPLETED|Overall Study||9
8294522|NCT01588197|20450748|P2|STARTED|Overall Study||10
8294523|NCT01588197|20450749|P1|STARTED|Overall Study||10
8294524|NCT01588184|20450765|P6|NOT COMPLETED|Overall Study||4
8294525|NCT01588184|20450766|P5|NOT COMPLETED|Overall Study||2
8294526|NCT01588184|20450767|P4|NOT COMPLETED|Overall Study||3
8294527|NCT01588184|20450768|P3|NOT COMPLETED|Overall Study||2
8294528|NCT01588184|20450769|P2|NOT COMPLETED|Overall Study||13
8294529|NCT01588184|20450770|P1|NOT COMPLETED|Overall Study||3
8294530|NCT01588184|20450765|P6|COMPLETED|Overall Study||10
8294531|NCT01588184|20450766|P5|COMPLETED|Overall Study||14
8294532|NCT01588184|20450767|P4|COMPLETED|Overall Study||3
8294533|NCT01588184|20450768|P3|COMPLETED|Overall Study||5
8294534|NCT01588184|20450769|P2|COMPLETED|Overall Study||28
8294535|NCT01588184|20450770|P1|COMPLETED|Overall Study||8
8294536|NCT01588184|20450765|P6|STARTED|Overall Study||14
8294537|NCT01588184|20450766|P5|STARTED|Overall Study||16
8294538|NCT01588184|20450767|P4|STARTED|Overall Study||6
8294539|NCT01588184|20450768|P3|STARTED|Overall Study||7
8294540|NCT01588184|20450769|P2|STARTED|Overall Study||41
8294541|NCT01588184|20450770|P1|STARTED|Overall Study||11
8294542|NCT01588158|20450798|P2|NOT COMPLETED|Overall Study||0
8294543|NCT01588158|20450799|P1|NOT COMPLETED|Overall Study||0
8294544|NCT01588158|20450798|P2|COMPLETED|Overall Study||3
8294545|NCT01588158|20450799|P1|COMPLETED|Overall Study||4
8294546|NCT01588158|20450798|P2|STARTED|Overall Study||3
8294547|NCT01588158|20450799|P1|STARTED|Overall Study||4
8294548|NCT01588106|20450823|P2|NOT COMPLETED|Overall Study||4
8294549|NCT01588106|20450824|P1|NOT COMPLETED|Overall Study||5
8294550|NCT01588106|20450823|P2|COMPLETED|Overall Study||72
8294551|NCT01588106|20450824|P1|COMPLETED|Overall Study||73
8294552|NCT01588106|20450823|P2|STARTED|Overall Study||76
8294553|NCT01588106|20450824|P1|STARTED|Overall Study||78
8294554|NCT01587989|20450832|P3|NOT COMPLETED|Randomized Study Treatment||1
8294555|NCT01587989|20450833|P2|NOT COMPLETED|Randomized Study Treatment||2
8294556|NCT01587989|20450834|P1|NOT COMPLETED|Randomized Study Treatment||0
8294557|NCT01587989|20450832|P3|COMPLETED|Randomized Study Treatment||32
8294558|NCT01587989|20450833|P2|COMPLETED|Randomized Study Treatment||30
8294559|NCT01587989|20450834|P1|COMPLETED|Randomized Study Treatment||0
8294560|NCT01587989|20450832|P3|STARTED|Randomized Study Treatment||33
8294561|NCT01587989|20450833|P2|STARTED|Randomized Study Treatment||32
8294562|NCT01587989|20450834|P1|STARTED|Randomized Study Treatment||0
8294563|NCT01587989|20450832|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
8294564|NCT01587989|20450833|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
8294565|NCT01587989|20450834|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
8294566|NCT01587989|20450832|P3|COMPLETED|12-Week Open-Label Run-In Period||0
8294567|NCT01587989|20450833|P2|COMPLETED|12-Week Open-Label Run-In Period||0
8294568|NCT01587989|20450834|P1|COMPLETED|12-Week Open-Label Run-In Period||65
8294569|NCT01587989|20450832|P3|STARTED|12-Week Open-Label Run-In Period||0
8294570|NCT01587989|20450833|P2|STARTED|12-Week Open-Label Run-In Period||0
8294571|NCT01587989|20450834|P1|STARTED|12-Week Open-Label Run-In Period||77
8294572|NCT01587963|20450858|P2|NOT COMPLETED|Overall Study||0
8294573|NCT01587963|20450859|P1|NOT COMPLETED|Overall Study||1
8294574|NCT01587963|20450858|P2|COMPLETED|Overall Study||4
8294575|NCT01587963|20450859|P1|COMPLETED|Overall Study||6
8294576|NCT01587963|20450858|P2|STARTED|Overall Study||4
8294577|NCT01587963|20450859|P1|STARTED|Overall Study||7
8294578|NCT01587950|20450865|P1|NOT COMPLETED|Period 3||0
8294579|NCT01587950|20450865|P1|COMPLETED|Period 3||12
8294580|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
8294581|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
8294582|NCT01587950|20450865|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
8294583|NCT01587950|20450865|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
8294584|NCT01587950|20450865|P1|Received Sterile Water (5 Minutes)|Period 3||5
8294585|NCT01587950|20450865|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
8294586|NCT01587950|20450865|P1|Received Sterile Water (2 Minutes)|Period 3||2
8294587|NCT01587950|20450865|P1|Received Sterile Water (10 Minutes)|Period 3||5
8294588|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
8294589|NCT01587950|20450865|P1|STARTED|Period 3||12
8294590|NCT01587950|20450865|P1|NOT COMPLETED|Washout 2||0
8294591|NCT01587950|20450865|P1|COMPLETED|Washout 2||12
8294592|NCT01587950|20450865|P1|STARTED|Washout 2||12
8294593|NCT01587950|20450865|P1|NOT COMPLETED|Period 2||0
8294594|NCT01587950|20450865|P1|COMPLETED|Period 2||12
8294595|NCT01587950|20450865|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
8294596|NCT01587950|20450865|P1|Received Sterile Water (10 Minutes)|Period 2||2
8294597|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
8294598|NCT01587950|20450865|P1|Received Sterile Water (5 Minutes)|Period 2||2
8294599|NCT01587950|20450865|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
8294600|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
8294601|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
8294602|NCT01587950|20450865|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
8294603|NCT01587950|20450865|P1|Received Sterile Water (2 Minutes)|Period 2||8
8294604|NCT01587950|20450865|P1|STARTED|Period 2||12
8294605|NCT01587950|20450865|P1|NOT COMPLETED|Washout 1||0
8294606|NCT01587950|20450865|P1|COMPLETED|Washout 1||12
8294607|NCT01587950|20450865|P1|STARTED|Washout 1||12
8294608|NCT01587950|20450865|P1|NOT COMPLETED|Period 1||0
8294609|NCT01587950|20450865|P1|COMPLETED|Period 1||12
8294610|NCT01587950|20450865|P1|Received Sterile Water (5 Minutes)|Period 1||5
8294611|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
8294612|NCT01587950|20450865|P1|Received Sterile Water (10 Minutes)|Period 1||5
8294613|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
8294614|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
8294615|NCT01587950|20450865|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
8294616|NCT01587950|20450865|P1|Received Sterile Water (2 Minutes)|Period 1||2
8294617|NCT01587950|20450865|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
8294618|NCT01587950|20450865|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
8294619|NCT01587950|20450865|P1|STARTED|Period 1||12
8294620|NCT01587924|20450899|P4|NOT COMPLETED|Overall Study||1
8294621|NCT01587924|20450900|P3|NOT COMPLETED|Overall Study||4
8294622|NCT01587924|20450901|P2|NOT COMPLETED|Overall Study||4
8294623|NCT01587924|20450902|P1|NOT COMPLETED|Overall Study||4
8294624|NCT01587924|20450899|P4|COMPLETED|Overall Study||19
8294625|NCT01587924|20450900|P3|COMPLETED|Overall Study||17
8294626|NCT01587924|20450901|P2|COMPLETED|Overall Study||17
8294627|NCT01587924|20450902|P1|COMPLETED|Overall Study||17
8294628|NCT01587924|20450899|P4|STARTED|Overall Study||20
8294629|NCT01587924|20450900|P3|STARTED|Overall Study||21
8294630|NCT01587924|20450901|P2|STARTED|Overall Study||21
8294631|NCT01587924|20450902|P1|STARTED|Overall Study||21
8294632|NCT01587898|20451003|P4|NOT COMPLETED|Overall Study||2
8294633|NCT01587898|20451004|P3|NOT COMPLETED|Overall Study||2
8294634|NCT01587898|20451005|P2|NOT COMPLETED|Overall Study||5
8294635|NCT01587898|20451006|P1|NOT COMPLETED|Overall Study||4
8294636|NCT01587898|20451003|P4|COMPLETED|Overall Study||17
8294637|NCT01587898|20451004|P3|COMPLETED|Overall Study||16
8294638|NCT01587898|20451005|P2|COMPLETED|Overall Study||12
8294639|NCT01587898|20451006|P1|COMPLETED|Overall Study||14
8294640|NCT01587898|20451003|P4|STARTED|Overall Study||19
8294641|NCT01587898|20451004|P3|STARTED|Overall Study||18
8294642|NCT01587898|20451005|P2|STARTED|Overall Study||17
8294643|NCT01587898|20451006|P1|STARTED|Overall Study||18
8294644|NCT01587885|20451182|P2|NOT COMPLETED|Treatment Period 2||0
8294645|NCT01587885|20451183|P1|NOT COMPLETED|Treatment Period 2||0
8294646|NCT01587885|20451182|P2|COMPLETED|Treatment Period 2||19
8294647|NCT01587885|20451183|P1|COMPLETED|Treatment Period 2||26
8294648|NCT01587885|20451182|P2|STARTED|Treatment Period 2||19
8294649|NCT01587885|20451183|P1|STARTED|Treatment Period 2||26
8294650|NCT01587885|20451182|P2|NOT COMPLETED|Treatment Period 1||3
8294651|NCT01587885|20451183|P1|NOT COMPLETED|Treatment Period 1||0
8294652|NCT01587885|20451182|P2|COMPLETED|Treatment Period 1||19
8294653|NCT01587885|20451183|P1|COMPLETED|Treatment Period 1||26
8294654|NCT01587885|20451182|P2|STARTED|Treatment Period 1||22
8294655|NCT01587885|20451183|P1|STARTED|Treatment Period 1||26
8294656|NCT01587703|20451214|P19|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294657|NCT01587703|20451215|P18|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294658|NCT01587703|20451216|P17|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
8294659|NCT01587703|20451217|P16|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
8294660|NCT01587703|20451218|P15|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
8294661|NCT01587703|20451219|P14|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
8294662|NCT01587703|20451220|P13|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
8294663|NCT01587703|20451221|P12|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
8294664|NCT01587703|20451222|P11|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294665|NCT01587703|20451223|P10|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294666|NCT01587703|20451224|P9|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294667|NCT01587703|20451225|P8|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294668|NCT01587703|20451226|P7|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294669|NCT01587703|20451227|P6|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294670|NCT01587703|20451228|P5|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294671|NCT01587703|20451229|P4|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294672|NCT01587703|20451230|P3|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294673|NCT01587703|20451231|P2|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294674|NCT01587703|20451232|P1|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294675|NCT01587703|20451214|P19|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294676|NCT01587703|20451215|P18|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294677|NCT01587703|20451216|P17|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294678|NCT01587703|20451217|P16|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294679|NCT01587703|20451218|P15|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294680|NCT01587703|20451219|P14|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
8294681|NCT01587703|20451220|P13|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294682|NCT01587703|20451221|P12|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294683|NCT01587703|20451222|P11|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294684|NCT01587703|20451223|P10|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294685|NCT01587703|20451224|P9|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294686|NCT01587703|20451225|P8|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294687|NCT01587703|20451226|P7|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294688|NCT01587703|20451227|P6|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294689|NCT01587703|20451228|P5|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294690|NCT01587703|20451229|P4|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294691|NCT01587703|20451230|P3|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294692|NCT01587703|20451231|P2|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294693|NCT01587703|20451232|P1|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294694|NCT01587703|20451214|P19|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294695|NCT01587703|20451215|P18|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294696|NCT01587703|20451216|P17|STARTED|Part2(Median Exposure of 1.41 Months)||13
8294697|NCT01587703|20451217|P16|STARTED|Part2(Median Exposure of 1.41 Months)||21
8294698|NCT01587703|20451218|P15|STARTED|Part2(Median Exposure of 1.41 Months)||19
8294699|NCT01587703|20451219|P14|STARTED|Part2(Median Exposure of 1.41 Months)||23
8294700|NCT01587703|20451220|P13|STARTED|Part2(Median Exposure of 1.41 Months)||14
8294701|NCT01587703|20451221|P12|STARTED|Part2(Median Exposure of 1.41 Months)||12
8294702|NCT01587703|20451222|P11|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294703|NCT01587703|20451223|P10|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294704|NCT01587703|20451224|P9|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294705|NCT01587703|20451225|P8|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294706|NCT01587703|20451226|P7|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294707|NCT01587703|20451227|P6|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294708|NCT01587703|20451228|P5|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294709|NCT01587703|20451229|P4|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294710|NCT01587703|20451230|P3|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294711|NCT01587703|20451231|P2|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294712|NCT01587703|20451232|P1|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294713|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
8294714|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
8294715|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294716|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294717|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8295099|NCT01587027|20451854|P2|COMPLETED|Discharge (1 Day)||8
8294718|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294719|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294720|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294721|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294722|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294723|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294724|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294725|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294726|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294727|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294728|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294729|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294730|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294731|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294732|NCT01587703|20451214|P19|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294733|NCT01587703|20451215|P18|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294734|NCT01587703|20451216|P17|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294735|NCT01587703|20451217|P16|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294736|NCT01587703|20451218|P15|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294737|NCT01587703|20451219|P14|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294738|NCT01587703|20451220|P13|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294739|NCT01587703|20451221|P12|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294740|NCT01587703|20451222|P11|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294741|NCT01587703|20451223|P10|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294742|NCT01587703|20451224|P9|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294743|NCT01587703|20451225|P8|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294744|NCT01587703|20451226|P7|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294745|NCT01587703|20451227|P6|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294746|NCT01587703|20451228|P5|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294747|NCT01587703|20451229|P4|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294748|NCT01587703|20451230|P3|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294749|NCT01587703|20451231|P2|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294750|NCT01587703|20451232|P1|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294751|NCT01587703|20451214|P19|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
8294752|NCT01587703|20451215|P18|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
8294753|NCT01587703|20451216|P17|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294754|NCT01587703|20451217|P16|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294755|NCT01587703|20451218|P15|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294756|NCT01587703|20451219|P14|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294757|NCT01587703|20451220|P13|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294758|NCT01587703|20451221|P12|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294759|NCT01587703|20451222|P11|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294760|NCT01587703|20451223|P10|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294761|NCT01587703|20451224|P9|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294762|NCT01587703|20451225|P8|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294763|NCT01587703|20451226|P7|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294764|NCT01587703|20451227|P6|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294765|NCT01587703|20451228|P5|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294766|NCT01587703|20451229|P4|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294767|NCT01587703|20451230|P3|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294768|NCT01587703|20451231|P2|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294769|NCT01587703|20451232|P1|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294770|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294771|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294772|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294773|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294774|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294775|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294776|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294777|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294778|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294779|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294780|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294781|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294782|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294783|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294784|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294785|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294786|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294787|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294788|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294789|NCT01587703|20451214|P19|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
8294790|NCT01587703|20451215|P18|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
8294791|NCT01587703|20451216|P17|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294792|NCT01587703|20451217|P16|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294793|NCT01587703|20451218|P15|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294794|NCT01587703|20451219|P14|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294795|NCT01587703|20451220|P13|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294796|NCT01587703|20451221|P12|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294797|NCT01587703|20451222|P11|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294798|NCT01587703|20451223|P10|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294799|NCT01587703|20451224|P9|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294800|NCT01587703|20451225|P8|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294801|NCT01587703|20451226|P7|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294802|NCT01587703|20451227|P6|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294803|NCT01587703|20451228|P5|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294804|NCT01587703|20451229|P4|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294805|NCT01587703|20451230|P3|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294806|NCT01587703|20451231|P2|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294807|NCT01587703|20451232|P1|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294808|NCT01587703|20451214|P19|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
8294809|NCT01587703|20451215|P18|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
8294810|NCT01587703|20451216|P17|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294811|NCT01587703|20451217|P16|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294812|NCT01587703|20451218|P15|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294813|NCT01587703|20451219|P14|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294814|NCT01587703|20451220|P13|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294815|NCT01587703|20451221|P12|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294816|NCT01587703|20451222|P11|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294817|NCT01587703|20451223|P10|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294818|NCT01587703|20451224|P9|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294819|NCT01587703|20451225|P8|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294820|NCT01587703|20451226|P7|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294821|NCT01587703|20451227|P6|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294822|NCT01587703|20451228|P5|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294823|NCT01587703|20451229|P4|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294824|NCT01587703|20451230|P3|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294825|NCT01587703|20451231|P2|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294826|NCT01587703|20451232|P1|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294827|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294828|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294829|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294830|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294831|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294832|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294833|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294834|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294835|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294836|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294837|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294838|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294839|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294840|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294841|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294842|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294843|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294844|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294845|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294846|NCT01587703|20451214|P19|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
8294847|NCT01587703|20451215|P18|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
8294848|NCT01587703|20451216|P17|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294849|NCT01587703|20451217|P16|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294850|NCT01587703|20451218|P15|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294851|NCT01587703|20451219|P14|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294852|NCT01587703|20451220|P13|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294853|NCT01587703|20451221|P12|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294854|NCT01587703|20451222|P11|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294855|NCT01587703|20451223|P10|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294856|NCT01587703|20451224|P9|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294857|NCT01587703|20451225|P8|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294858|NCT01587703|20451226|P7|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294859|NCT01587703|20451227|P6|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294860|NCT01587703|20451228|P5|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294861|NCT01587703|20451229|P4|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294862|NCT01587703|20451230|P3|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294863|NCT01587703|20451231|P2|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294864|NCT01587703|20451232|P1|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294865|NCT01587703|20451214|P19|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
8294866|NCT01587703|20451215|P18|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
8294867|NCT01587703|20451216|P17|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294868|NCT01587703|20451217|P16|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294869|NCT01587703|20451218|P15|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294870|NCT01587703|20451219|P14|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294871|NCT01587703|20451220|P13|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294872|NCT01587703|20451221|P12|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294873|NCT01587703|20451222|P11|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294874|NCT01587703|20451223|P10|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294875|NCT01587703|20451224|P9|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294876|NCT01587703|20451225|P8|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294877|NCT01587703|20451226|P7|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294878|NCT01587703|20451227|P6|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294879|NCT01587703|20451228|P5|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294880|NCT01587703|20451229|P4|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294881|NCT01587703|20451230|P3|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294882|NCT01587703|20451231|P2|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294883|NCT01587703|20451232|P1|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294884|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294885|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294886|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294887|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294888|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294889|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294890|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294891|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294892|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294893|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294894|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294895|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294896|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294897|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294898|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294899|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294900|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294901|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294902|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294903|NCT01587703|20451214|P19|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294904|NCT01587703|20451215|P18|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294905|NCT01587703|20451216|P17|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294906|NCT01587703|20451217|P16|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294907|NCT01587703|20451218|P15|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294908|NCT01587703|20451219|P14|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294909|NCT01587703|20451220|P13|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294910|NCT01587703|20451221|P12|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294911|NCT01587703|20451222|P11|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294912|NCT01587703|20451223|P10|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294913|NCT01587703|20451224|P9|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294914|NCT01587703|20451225|P8|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294915|NCT01587703|20451226|P7|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294916|NCT01587703|20451227|P6|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294917|NCT01587703|20451228|P5|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294918|NCT01587703|20451229|P4|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294919|NCT01587703|20451230|P3|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294920|NCT01587703|20451231|P2|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294921|NCT01587703|20451232|P1|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294922|NCT01587703|20451214|P19|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294923|NCT01587703|20451215|P18|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294924|NCT01587703|20451216|P17|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294925|NCT01587703|20451217|P16|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294926|NCT01587703|20451218|P15|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294927|NCT01587703|20451219|P14|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294928|NCT01587703|20451220|P13|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294929|NCT01587703|20451221|P12|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294930|NCT01587703|20451222|P11|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294931|NCT01587703|20451223|P10|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294932|NCT01587703|20451224|P9|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294933|NCT01587703|20451225|P8|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294934|NCT01587703|20451226|P7|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294935|NCT01587703|20451227|P6|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294936|NCT01587703|20451228|P5|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294937|NCT01587703|20451229|P4|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294938|NCT01587703|20451230|P3|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294939|NCT01587703|20451231|P2|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294940|NCT01587703|20451232|P1|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294941|NCT01587703|20451214|P19|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294942|NCT01587703|20451215|P18|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294943|NCT01587703|20451216|P17|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294944|NCT01587703|20451217|P16|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294945|NCT01587703|20451218|P15|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294946|NCT01587703|20451219|P14|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294947|NCT01587703|20451220|P13|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294948|NCT01587703|20451221|P12|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294949|NCT01587703|20451222|P11|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
8294950|NCT01587703|20451223|P10|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
8294951|NCT01587703|20451224|P9|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
8294952|NCT01587703|20451225|P8|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294953|NCT01587703|20451226|P7|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294954|NCT01587703|20451227|P6|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294955|NCT01587703|20451228|P5|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294956|NCT01587703|20451229|P4|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294957|NCT01587703|20451230|P3|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294958|NCT01587703|20451231|P2|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294959|NCT01587703|20451232|P1|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294960|NCT01587703|20451214|P19|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294961|NCT01587703|20451215|P18|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294962|NCT01587703|20451216|P17|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294963|NCT01587703|20451217|P16|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294964|NCT01587703|20451218|P15|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294965|NCT01587703|20451219|P14|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294966|NCT01587703|20451220|P13|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294967|NCT01587703|20451221|P12|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294968|NCT01587703|20451222|P11|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294969|NCT01587703|20451223|P10|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294970|NCT01587703|20451224|P9|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
8294971|NCT01587703|20451225|P8|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294972|NCT01587703|20451226|P7|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294973|NCT01587703|20451227|P6|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294974|NCT01587703|20451228|P5|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294975|NCT01587703|20451229|P4|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294976|NCT01587703|20451230|P3|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294977|NCT01587703|20451231|P2|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294978|NCT01587703|20451232|P1|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294979|NCT01587703|20451214|P19|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294980|NCT01587703|20451215|P18|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294981|NCT01587703|20451216|P17|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294982|NCT01587703|20451217|P16|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294983|NCT01587703|20451218|P15|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294984|NCT01587703|20451219|P14|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294985|NCT01587703|20451220|P13|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294986|NCT01587703|20451221|P12|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294987|NCT01587703|20451222|P11|STARTED|Part1 BID(Median Exposure of 1.41months)||5
8294988|NCT01587703|20451223|P10|STARTED|Part1 BID(Median Exposure of 1.41months)||10
8294989|NCT01587703|20451224|P9|STARTED|Part1 BID(Median Exposure of 1.41months)||4
8294990|NCT01587703|20451225|P8|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294991|NCT01587703|20451226|P7|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294992|NCT01587703|20451227|P6|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294993|NCT01587703|20451228|P5|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294994|NCT01587703|20451229|P4|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294995|NCT01587703|20451230|P3|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294996|NCT01587703|20451231|P2|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294997|NCT01587703|20451232|P1|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294998|NCT01587703|20451214|P19|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8294999|NCT01587703|20451215|P18|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295000|NCT01587703|20451216|P17|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295001|NCT01587703|20451217|P16|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295002|NCT01587703|20451218|P15|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295003|NCT01587703|20451219|P14|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295004|NCT01587703|20451220|P13|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295005|NCT01587703|20451221|P12|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295006|NCT01587703|20451222|P11|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295007|NCT01587703|20451223|P10|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295008|NCT01587703|20451224|P9|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295009|NCT01587703|20451225|P8|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
8295010|NCT01587703|20451226|P7|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
8295011|NCT01587703|20451227|P6|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
8295012|NCT01587703|20451228|P5|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
8295013|NCT01587703|20451229|P4|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
8295014|NCT01587703|20451230|P3|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
8295015|NCT01587703|20451231|P2|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
8295016|NCT01587703|20451232|P1|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
8295017|NCT01587703|20451214|P19|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295018|NCT01587703|20451215|P18|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295019|NCT01587703|20451216|P17|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295020|NCT01587703|20451217|P16|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295021|NCT01587703|20451218|P15|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295022|NCT01587703|20451219|P14|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295023|NCT01587703|20451220|P13|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295024|NCT01587703|20451221|P12|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295025|NCT01587703|20451222|P11|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295026|NCT01587703|20451223|P10|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295027|NCT01587703|20451224|P9|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295028|NCT01587703|20451225|P8|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295029|NCT01587703|20451226|P7|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295030|NCT01587703|20451227|P6|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
8295031|NCT01587703|20451228|P5|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295032|NCT01587703|20451229|P4|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295033|NCT01587703|20451230|P3|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295034|NCT01587703|20451231|P2|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295035|NCT01587703|20451232|P1|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295036|NCT01587703|20451214|P19|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295037|NCT01587703|20451215|P18|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295038|NCT01587703|20451216|P17|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295039|NCT01587703|20451217|P16|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295040|NCT01587703|20451218|P15|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295041|NCT01587703|20451219|P14|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295042|NCT01587703|20451220|P13|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295043|NCT01587703|20451221|P12|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295044|NCT01587703|20451222|P11|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295045|NCT01587703|20451223|P10|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295046|NCT01587703|20451224|P9|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295047|NCT01587703|20451225|P8|STARTED|Part1 QD(Median Exposure of 1.38months)||9
8295048|NCT01587703|20451226|P7|STARTED|Part1 QD(Median Exposure of 1.38months)||32
8295049|NCT01587703|20451227|P6|STARTED|Part1 QD(Median Exposure of 1.38months)||9
8295050|NCT01587703|20451228|P5|STARTED|Part1 QD(Median Exposure of 1.38months)||4
8295051|NCT01587703|20451229|P4|STARTED|Part1 QD(Median Exposure of 1.38months)||3
8295052|NCT01587703|20451230|P3|STARTED|Part1 QD(Median Exposure of 1.38months)||1
8295053|NCT01587703|20451231|P2|STARTED|Part1 QD(Median Exposure of 1.38months)||4
8295054|NCT01587703|20451232|P1|STARTED|Part1 QD(Median Exposure of 1.38months)||3
8295055|NCT01587651|20451639|P3|NOT COMPLETED|Overall Study||1
8295056|NCT01587651|20451640|P2|NOT COMPLETED|Overall Study||3
8295057|NCT01587651|20451641|P1|NOT COMPLETED|Overall Study||0
8295058|NCT01587651|20451639|P3|COMPLETED|Overall Study||34
8295059|NCT01587651|20451640|P2|COMPLETED|Overall Study||38
8295060|NCT01587651|20451641|P1|COMPLETED|Overall Study||34
8295061|NCT01587651|20451639|P3|STARTED|Overall Study||35
8295062|NCT01587651|20451640|P2|STARTED|Overall Study||41
8295063|NCT01587651|20451641|P1|STARTED|Overall Study||34
8295064|NCT01587274|20451671|P3|NOT COMPLETED|Overall Study||3
8295065|NCT01587274|20451672|P2|NOT COMPLETED|Overall Study||5
8295066|NCT01587274|20451673|P1|NOT COMPLETED|Overall Study||4
8295067|NCT01587274|20451671|P3|COMPLETED|Overall Study||104
8295068|NCT01587274|20451672|P2|COMPLETED|Overall Study||103
8295069|NCT01587274|20451673|P1|COMPLETED|Overall Study||104
8295070|NCT01587274|20451671|P3|STARTED|Overall Study||107
8295071|NCT01587274|20451672|P2|STARTED|Overall Study||108
8295072|NCT01587274|20451673|P1|STARTED|Overall Study||108
8295073|NCT01587118|20451681|P1|NOT COMPLETED|Overall Study||7
8295074|NCT01587118|20451681|P1|COMPLETED|Overall Study||11
8295075|NCT01587118|20451681|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
8295076|NCT01587105|20451688|P2|NOT COMPLETED|Overall Study||43
8295077|NCT01587105|20451689|P1|NOT COMPLETED|Overall Study||6
8295078|NCT01587105|20451688|P2|COMPLETED|Overall Study||138
8295079|NCT01587105|20451689|P1|COMPLETED|Overall Study||144
8295080|NCT01587105|20451688|P2|STARTED|Overall Study||181
8295081|NCT01587105|20451689|P1|STARTED|Overall Study||150
8295082|NCT01587079|20451705|P1|NOT COMPLETED|Overall Study||39
8295083|NCT01587079|20451705|P1|COMPLETED|Overall Study||120
8295084|NCT01587079|20451705|P1|STARTED|Overall Study||159
8295085|NCT01587040|20451831|P4|NOT COMPLETED|Overall Study||4
8295086|NCT01587040|20451832|P3|NOT COMPLETED|Overall Study||37
8295087|NCT01587040|20451833|P2|NOT COMPLETED|Overall Study||3
8295088|NCT01587040|20451834|P1|NOT COMPLETED|Overall Study||17
8295089|NCT01587040|20451831|P4|COMPLETED|Overall Study||0
8295090|NCT01587040|20451832|P3|COMPLETED|Overall Study||0
8295091|NCT01587040|20451833|P2|COMPLETED|Overall Study||0
8295092|NCT01587040|20451834|P1|COMPLETED|Overall Study||0
8295093|NCT01587040|20451831|P4|STARTED|Overall Study||4
8295094|NCT01587040|20451832|P3|STARTED|Overall Study||37
8295095|NCT01587040|20451833|P2|STARTED|Overall Study||3
8295096|NCT01587040|20451834|P1|STARTED|Overall Study||17
8295097|NCT01587027|20451854|P2|NOT COMPLETED|Discharge (1 Day)||0
8295098|NCT01587027|20451855|P1|NOT COMPLETED|Discharge (1 Day)||0
8295100|NCT01587027|20451855|P1|COMPLETED|Discharge (1 Day)||8
8295101|NCT01587027|20451854|P2|STARTED|Discharge (1 Day)||8
8295102|NCT01587027|20451855|P1|STARTED|Discharge (1 Day)||8
8295103|NCT01587027|20451854|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8295104|NCT01587027|20451855|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8295105|NCT01587027|20451854|P2|COMPLETED|Third Intervention (1 Day)||8
8295106|NCT01587027|20451855|P1|COMPLETED|Third Intervention (1 Day)||8
8295107|NCT01587027|20451854|P2|STARTED|Third Intervention (1 Day)||8
8295108|NCT01587027|20451855|P1|STARTED|Third Intervention (1 Day)||8
8295109|NCT01587027|20451854|P2|NOT COMPLETED|Washout (1 Day)||0
8295110|NCT01587027|20451855|P1|NOT COMPLETED|Washout (1 Day)||0
8295111|NCT01587027|20451854|P2|COMPLETED|Washout (1 Day)||8
8295112|NCT01587027|20451855|P1|COMPLETED|Washout (1 Day)||8
8295113|NCT01587027|20451854|P2|STARTED|Washout (1 Day)||8
8295114|NCT01587027|20451855|P1|STARTED|Washout (1 Day)||8
8295115|NCT01587027|20451854|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8295116|NCT01587027|20451855|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8295117|NCT01587027|20451854|P2|COMPLETED|Second Intervention (1 Day)||8
8295118|NCT01587027|20451855|P1|COMPLETED|Second Intervention (1 Day)||8
8295119|NCT01587027|20451854|P2|STARTED|Second Intervention (1 Day)||8
8295120|NCT01587027|20451855|P1|STARTED|Second Intervention (1 Day)||8
8295121|NCT01587027|20451854|P2|NOT COMPLETED|Washout (1 Day)||0
8295122|NCT01587027|20451855|P1|NOT COMPLETED|Washout (1 Day)||0
8295123|NCT01587027|20451854|P2|COMPLETED|Washout (1 Day)||8
8295124|NCT01587027|20451855|P1|COMPLETED|Washout (1 Day)||8
8295125|NCT01587027|20451854|P2|STARTED|Washout (1 Day)||8
8295126|NCT01587027|20451855|P1|STARTED|Washout (1 Day)||8
8295127|NCT01587027|20451854|P2|NOT COMPLETED|First Intervention (1 Day)||0
8295128|NCT01587027|20451855|P1|NOT COMPLETED|First Intervention (1 Day)||0
8295129|NCT01587027|20451854|P2|COMPLETED|First Intervention (1 Day)||8
8295130|NCT01587027|20451855|P1|COMPLETED|First Intervention (1 Day)||8
8295131|NCT01587027|20451854|P2|STARTED|First Intervention (1 Day)||8
8295132|NCT01587027|20451855|P1|STARTED|First Intervention (1 Day)||8
8295133|NCT01587014|20451861|P1|NOT COMPLETED|Overall Study||2
8295134|NCT01587014|20451861|P1|COMPLETED|Overall Study||24
8295135|NCT01587014|20451861|P1|STARTED|Overall Study||26
8295136|NCT01587001|20451868|P2|NOT COMPLETED|Overall Study||1
8295137|NCT01587001|20451869|P1|NOT COMPLETED|Overall Study||6
8295138|NCT01587001|20451868|P2|COMPLETED|Overall Study||2
8295139|NCT01587001|20451869|P1|COMPLETED|Overall Study||8
8295140|NCT01587001|20451868|P2|STARTED|Overall Study||3
8295141|NCT01587001|20451869|P1|STARTED|Overall Study||14
8295142|NCT01586975|20451880|P3|NOT COMPLETED|Overall Study||0
8295143|NCT01586975|20451881|P2|NOT COMPLETED|Overall Study||0
8295144|NCT01586975|20451882|P1|NOT COMPLETED|Overall Study||0
8295145|NCT01586975|20451880|P3|COMPLETED|Overall Study||46
8295146|NCT01586975|20451881|P2|COMPLETED|Overall Study||32
8295147|NCT01586975|20451882|P1|COMPLETED|Overall Study||15
8295148|NCT01586975|20451880|P3|STARTED|Overall Study||46
8295149|NCT01586975|20451881|P2|STARTED|Overall Study||32
8295150|NCT01586975|20451882|P1|STARTED|Overall Study||15
8295151|NCT01586962|20451890|P1|NOT COMPLETED|Overall Study||0
8295152|NCT01586962|20451890|P1|COMPLETED|Overall Study||56
8295153|NCT01586962|20451890|P1|STARTED|Overall Study||56
8295154|NCT01586910|20451898|P2|NOT COMPLETED|Overall Study||71
8295155|NCT01586910|20451899|P1|NOT COMPLETED|Overall Study||15
8295156|NCT01586910|20451898|P2|COMPLETED|Overall Study||796
8295157|NCT01586910|20451899|P1|COMPLETED|Overall Study||864
8295158|NCT01586910|20451898|P2|STARTED|Overall Study||867
8295159|NCT01586910|20451899|P1|STARTED|Overall Study||879
8295160|NCT01586897|20451954|P2|NOT COMPLETED|Overall Study||0
8295161|NCT01586897|20451955|P1|NOT COMPLETED|Overall Study||0
8295162|NCT01586897|20451954|P2|COMPLETED|Overall Study||26
8295163|NCT01586897|20451955|P1|COMPLETED|Overall Study||26
8295164|NCT01586897|20451954|P2|STARTED|Overall Study||26
8295165|NCT01586897|20451955|P1|STARTED|Overall Study||26
8295166|NCT01586819|20451973|P2|NOT COMPLETED|Overall Study||0
8295167|NCT01586819|20451974|P1|NOT COMPLETED|Overall Study||1
8295168|NCT01586819|20451973|P2|COMPLETED|Overall Study||14
8295169|NCT01586819|20451974|P1|COMPLETED|Overall Study||11
8295170|NCT01586819|20451973|P2|STARTED|Overall Study||14
8295171|NCT01586819|20451974|P1|STARTED|Overall Study||12
8295172|NCT01586806|20451985|P3|NOT COMPLETED|Overall Study||2
8295173|NCT01586806|20451986|P2|NOT COMPLETED|Overall Study||4
8295174|NCT01586806|20451987|P1|NOT COMPLETED|Overall Study||3
8295175|NCT01586806|20451985|P3|COMPLETED|Overall Study||63
8295176|NCT01586806|20451986|P2|COMPLETED|Overall Study||61
8295177|NCT01586806|20451987|P1|COMPLETED|Overall Study||62
8295178|NCT01586806|20451985|P3|STARTED|Overall Study||65
8295179|NCT01586806|20451986|P2|STARTED|Overall Study||65
8295180|NCT01586806|20451987|P1|STARTED|Overall Study||65
8295181|NCT01586741|20452010|P3|NOT COMPLETED|Overall Study||2
8295182|NCT01586741|20452011|P2|NOT COMPLETED|Overall Study||0
8295183|NCT01586741|20452012|P1|NOT COMPLETED|Overall Study||1
8295184|NCT01586741|20452010|P3|COMPLETED|Overall Study||30
8295185|NCT01586741|20452011|P2|COMPLETED|Overall Study||29
8295186|NCT01586741|20452012|P1|COMPLETED|Overall Study||27
8295187|NCT01586741|20452010|P3|STARTED|Overall Study||32
8295188|NCT01586741|20452011|P2|STARTED|Overall Study||29
8295189|NCT01586741|20452012|P1|STARTED|Overall Study||28
8295190|NCT01586364|20452020|P1|NOT COMPLETED|Overall Study||117
8295191|NCT01586364|20452020|P1|COMPLETED|Overall Study||184
8295192|NCT01586364|20452020|P1|STARTED|Overall Study||301
8295193|NCT01586338|20452073|P1|NOT COMPLETED|Overall Study||8
8295194|NCT01586338|20452073|P1|COMPLETED|Overall Study||229
8295195|NCT01586338|20452073|P1|STARTED|Overall Study||237
8295196|NCT01586312|20452085|P2|NOT COMPLETED|Overall Study||0
8295197|NCT01586312|20452086|P1|NOT COMPLETED|Overall Study||0
8295198|NCT01586312|20452085|P2|COMPLETED|Overall Study||15
8295199|NCT01586312|20452086|P1|COMPLETED|Overall Study||15
8295200|NCT01586312|20452085|P2|STARTED|Overall Study||15
8295201|NCT01586312|20452086|P1|STARTED|Overall Study||15
8295202|NCT01586195|20452096|P1|NOT COMPLETED|Overall Study||26
8295203|NCT01586195|20452096|P1|COMPLETED|Overall Study||5
8295204|NCT01586195|20452096|P1|STARTED|Overall Study||31
8295205|NCT01586156|20452110|P3|NOT COMPLETED|Overall Study||0
8295206|NCT01586156|20452111|P2|NOT COMPLETED|Overall Study||1
8295207|NCT01586156|20452112|P1|NOT COMPLETED|Overall Study||0
8295208|NCT01586156|20452110|P3|COMPLETED|Overall Study||10
8295209|NCT01586156|20452111|P2|COMPLETED|Overall Study||9
8295210|NCT01586156|20452112|P1|COMPLETED|Overall Study||10
8295211|NCT01586156|20452110|P3|STARTED|Overall Study||10
8295212|NCT01586156|20452111|P2|STARTED|Overall Study||10
8295213|NCT01586156|20452112|P1|STARTED|Overall Study||10
8295214|NCT01586091|20452141|P3|NOT COMPLETED|Overall Study||0
8295215|NCT01586091|20452142|P2|NOT COMPLETED|Overall Study||0
8295216|NCT01586091|20452143|P1|NOT COMPLETED|Overall Study||0
8295217|NCT01586091|20452141|P3|COMPLETED|Overall Study||6
8295218|NCT01586091|20452142|P2|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295219|NCT01586091|20452143|P1|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295220|NCT01586091|20452141|P3|STARTED|Overall Study||6
8295221|NCT01586091|20452142|P2|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295222|NCT01586091|20452143|P1|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295223|NCT01586026|20452157|P3|NOT COMPLETED|Overall Study||0
8295224|NCT01586026|20452158|P2|NOT COMPLETED|Overall Study||0
8295225|NCT01586026|20452159|P1|NOT COMPLETED|Overall Study||0
8295226|NCT01586026|20452157|P3|COMPLETED|Overall Study||271
8295227|NCT01586026|20452158|P2|COMPLETED|Overall Study||414
8295228|NCT01586026|20452159|P1|COMPLETED|Overall Study||350
8295229|NCT01586026|20452157|P3|STARTED|Overall Study||271
8295230|NCT01586026|20452158|P2|STARTED|Overall Study||414
8295231|NCT01586026|20452159|P1|STARTED|Overall Study||350
8295232|NCT01585987|20452169|P2|NOT COMPLETED|Treated||49
8295233|NCT01585987|20452170|P1|NOT COMPLETED|Treated||54
8295234|NCT01585987|20452169|P2|COMPLETED|Treated||2
8295235|NCT01585987|20452170|P1|COMPLETED|Treated||3
8295236|NCT01585987|20452169|P2|STARTED|Treated||51
8295237|NCT01585987|20452170|P1|STARTED|Treated||57
8295238|NCT01585987|20452169|P2|NOT COMPLETED|Randomized||6
8295239|NCT01585987|20452170|P1|NOT COMPLETED|Randomized||0
8295240|NCT01585987|20452169|P2|COMPLETED|Randomized||51
8295241|NCT01585987|20452170|P1|COMPLETED|Randomized||57
8295242|NCT01585987|20452169|P2|STARTED|Randomized||57
8295243|NCT01585987|20452170|P1|STARTED|Randomized||57
8295244|NCT01585961|20452185|P1|NOT COMPLETED|Overall Study||33
8295245|NCT01585961|20452185|P1|COMPLETED|Overall Study||478
8295246|NCT01585961|20452185|P1|Safety|Overall Study|Patients ablated with study catheter|508
8295247|NCT01585961|20452185|P1|STARTED|Overall Study||511
8295248|NCT01585779|20452202|P2|NOT COMPLETED|Overall Study||7
8295249|NCT01585779|20452203|P1|NOT COMPLETED|Overall Study||10
8295250|NCT01585779|20452202|P2|COMPLETED|Overall Study||21
8295251|NCT01585779|20452203|P1|COMPLETED|Overall Study||26
8295252|NCT01585779|20452202|P2|STARTED|Overall Study||28
8295253|NCT01585779|20452203|P1|STARTED|Overall Study||36
8295254|NCT01585766|20452263|P6|NOT COMPLETED|Overall Study||0
8295255|NCT01585766|20452264|P5|NOT COMPLETED|Overall Study||0
8295256|NCT01585766|20452265|P4|NOT COMPLETED|Overall Study||0
8295257|NCT01585766|20452266|P3|NOT COMPLETED|Overall Study||2
8295258|NCT01585766|20452267|P2|NOT COMPLETED|Overall Study||2
8295259|NCT01585766|20452268|P1|NOT COMPLETED|Overall Study||0
8295260|NCT01585766|20452263|P6|COMPLETED|Overall Study||6
8295261|NCT01585766|20452264|P5|COMPLETED|Overall Study||3
8295262|NCT01585766|20452265|P4|COMPLETED|Overall Study||4
8295263|NCT01585766|20452266|P3|COMPLETED|Overall Study||1
8295264|NCT01585766|20452267|P2|COMPLETED|Overall Study||3
8295265|NCT01585766|20452268|P1|COMPLETED|Overall Study||7
8295266|NCT01585766|20452263|P6|STARTED|Overall Study||6
8295267|NCT01585766|20452264|P5|STARTED|Overall Study||3
8295268|NCT01585766|20452265|P4|STARTED|Overall Study||4
8295269|NCT01585766|20452266|P3|STARTED|Overall Study||3
8295270|NCT01585766|20452267|P2|STARTED|Overall Study||5
8295271|NCT01585766|20452268|P1|STARTED|Overall Study||7
8295272|NCT01585597|20452367|P1|NOT COMPLETED|Overall Study||0
8295273|NCT01585597|20452367|P1|COMPLETED|Overall Study||20
8295274|NCT01585597|20452367|P1|STARTED|Overall Study||20
8295275|NCT01585584|20452372|P1|NOT COMPLETED|Overall Study||4
8295276|NCT01585584|20452372|P1|COMPLETED|Overall Study||6
8295277|NCT01585584|20452372|P1|STARTED|Overall Study||10
8295278|NCT01585558|20452379|P3|NOT COMPLETED|Overall Study||15
8295279|NCT01585558|20452380|P2|NOT COMPLETED|Overall Study||12
8295280|NCT01585558|20452381|P1|NOT COMPLETED|Overall Study||13
8295281|NCT01585558|20452379|P3|COMPLETED|Overall Study||34
8295282|NCT01585558|20452380|P2|COMPLETED|Overall Study||57
8295283|NCT01585558|20452381|P1|COMPLETED|Overall Study||49
8295284|NCT01585558|20452379|P3|STARTED|Overall Study||49
8295285|NCT01585558|20452380|P2|STARTED|Overall Study||69
8295286|NCT01585558|20452381|P1|STARTED|Overall Study||62
8295287|NCT01585441|20452562|P2|NOT COMPLETED|Overall Study||0
8295288|NCT01585441|20452563|P1|NOT COMPLETED|Overall Study||0
8295289|NCT01585441|20452562|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
8295290|NCT01585441|20452563|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
8295291|NCT01585441|20452562|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
8295292|NCT01585441|20452563|P1|Final Study Safety Visit|Overall Study||3
8295293|NCT01585441|20452562|P2|Received Finasteride at Month 3|Overall Study||2
8295294|NCT01585441|20452563|P1|Received Finasteride at Month 3|Overall Study||2
8295295|NCT01585441|20452562|P2|Month 3|Overall Study||3
8295296|NCT01585441|20452563|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
8295297|NCT01585441|20452562|P2|STARTED|Overall Study||3
8295298|NCT01585441|20452563|P1|STARTED|Overall Study||3
8295299|NCT01585428|20452615|P2|NOT COMPLETED|Overall Study||0
8295300|NCT01585428|20452616|P1|NOT COMPLETED|Overall Study||1
8295301|NCT01585428|20452615|P2|COMPLETED|Overall Study||11
8295302|NCT01585428|20452616|P1|COMPLETED|Overall Study||17
8295303|NCT01585428|20452615|P2|STARTED|Overall Study||11
8295304|NCT01585428|20452616|P1|STARTED|Overall Study||18
8295305|NCT01585324|20452624|P1|NOT COMPLETED|Overall Study||0
8295306|NCT01585324|20452624|P1|COMPLETED|Overall Study||30
8295307|NCT01585324|20452624|P1|STARTED|Overall Study||30
8295308|NCT01585298|20452640|P1|NOT COMPLETED|Overall Study||37
8295309|NCT01585298|20452640|P1|COMPLETED|Overall Study||6961
8295310|NCT01585298|20452640|P1|STARTED|Overall Study||6998
8295311|NCT01585272|20452648|P1|NOT COMPLETED|Overall Study||39
8295312|NCT01585272|20452648|P1|COMPLETED|Overall Study||82
8295313|NCT01585272|20452648|P1|Exelon Patch 10 cm2|Overall Study||96
8295314|NCT01585272|20452648|P1|Exelon Patch 5 cm2|Overall Study||114
8295315|NCT01585272|20452648|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
8295316|NCT01585272|20452648|P1|STARTED|Overall Study||121
8295317|NCT01585246|20452661|P5|NOT COMPLETED|Overall Study||2
8295318|NCT01585246|20452662|P4|NOT COMPLETED|Overall Study||4
8295319|NCT01585246|20452663|P3|NOT COMPLETED|Overall Study||4
8295320|NCT01585246|20452664|P2|NOT COMPLETED|Overall Study||1
8295321|NCT01585246|20452665|P1|NOT COMPLETED|Overall Study||0
8295322|NCT01585246|20452661|P5|COMPLETED|Overall Study||9
8295323|NCT01585246|20452662|P4|COMPLETED|Overall Study||6
8295324|NCT01585246|20452663|P3|COMPLETED|Overall Study||16
8295325|NCT01585246|20452664|P2|COMPLETED|Overall Study||3
8295326|NCT01585246|20452665|P1|COMPLETED|Overall Study||3
8295327|NCT01585246|20452661|P5|STARTED|Overall Study||11
8295328|NCT01585246|20452662|P4|STARTED|Overall Study||10
8295329|NCT01585246|20452663|P3|STARTED|Overall Study||20
8295330|NCT01585246|20452664|P2|STARTED|Overall Study||4
8295331|NCT01585246|20452665|P1|STARTED|Overall Study||3
8295332|NCT01585207|20452680|P1|NOT COMPLETED|Overall Study||0
8295333|NCT01585207|20452680|P1|COMPLETED|Overall Study||4
8295334|NCT01585207|20452680|P1|STARTED|Overall Study||4
8295335|NCT01585194|20452684|P1|NOT COMPLETED|Overall Study||4
8295336|NCT01585194|20452684|P1|COMPLETED|Overall Study||35
8295337|NCT01585194|20452684|P1|STARTED|Overall Study||39
8295338|NCT01585168|20452693|P4|NOT COMPLETED|Overall Study||1
8295339|NCT01585168|20452694|P3|NOT COMPLETED|Overall Study||1
8295340|NCT01585168|20452695|P2|NOT COMPLETED|Overall Study||1
8295341|NCT01585168|20452696|P1|NOT COMPLETED|Overall Study||3
8295342|NCT01585168|20452693|P4|COMPLETED|Overall Study||18
8295343|NCT01585168|20452694|P3|COMPLETED|Overall Study||15
8295344|NCT01585168|20452695|P2|COMPLETED|Overall Study||17
8295345|NCT01585168|20452696|P1|COMPLETED|Overall Study||15
8295346|NCT01585168|20452693|P4|STARTED|Overall Study||19
8295347|NCT01585168|20452694|P3|STARTED|Overall Study||16
8295348|NCT01585168|20452695|P2|STARTED|Overall Study||18
8295349|NCT01585168|20452696|P1|STARTED|Overall Study||18
8295350|NCT01585155|20452716|P1|NOT COMPLETED|Overall Study||5
8295351|NCT01585155|20452716|P1|COMPLETED|Overall Study||16
8295352|NCT01585155|20452716|P1|STARTED|Overall Study||21
8295353|NCT01585129|20452725|P2|NOT COMPLETED|Overall Study||0
8295354|NCT01585129|20452726|P1|NOT COMPLETED|Overall Study||0
8295355|NCT01585129|20452725|P2|COMPLETED|Overall Study||39
8295356|NCT01585129|20452726|P1|COMPLETED|Overall Study||41
8295357|NCT01585129|20452725|P2|STARTED|Overall Study||39
8295358|NCT01585129|20452726|P1|STARTED|Overall Study||41
8295359|NCT01585038|20452738|P2|NOT COMPLETED|Overall Study||2
8295360|NCT01585038|20452739|P1|NOT COMPLETED|Overall Study||2
8295361|NCT01585038|20452738|P2|COMPLETED|Overall Study||18
8295362|NCT01585038|20452739|P1|COMPLETED|Overall Study||18
8295363|NCT01585038|20452738|P2|STARTED|Overall Study||20
8295364|NCT01585038|20452739|P1|STARTED|Overall Study||20
8295365|NCT01585025|20452754|P3|NOT COMPLETED|Overall Study||4
8295366|NCT01585025|20452755|P2|NOT COMPLETED|Overall Study||3
8295367|NCT01585025|20452756|P1|NOT COMPLETED|Overall Study||0
8295368|NCT01585025|20452754|P3|COMPLETED|Overall Study||8
8295369|NCT01585025|20452755|P2|COMPLETED|Overall Study||10
8295370|NCT01585025|20452756|P1|COMPLETED|Overall Study||10
8295371|NCT01585025|20452754|P3|STARTED|Overall Study||12
8295372|NCT01585025|20452755|P2|STARTED|Overall Study||13
8295373|NCT01585025|20452756|P1|STARTED|Overall Study||10
8295374|NCT01584843|20452786|P6|NOT COMPLETED|Second Treatment Period||1
8295375|NCT01584843|20452787|P5|NOT COMPLETED|Second Treatment Period||0
8295376|NCT01584843|20452788|P4|NOT COMPLETED|Second Treatment Period||0
8295377|NCT01584843|20452789|P3|NOT COMPLETED|Second Treatment Period||0
8295378|NCT01584843|20452790|P2|NOT COMPLETED|Second Treatment Period||0
8295379|NCT01584843|20452791|P1|NOT COMPLETED|Second Treatment Period||0
8295380|NCT01584843|20452786|P6|COMPLETED|Second Treatment Period||0
8295381|NCT01584843|20452787|P5|COMPLETED|Second Treatment Period||3
8295382|NCT01584843|20452788|P4|COMPLETED|Second Treatment Period||6
8295383|NCT01584843|20452789|P3|COMPLETED|Second Treatment Period||2
8295384|NCT01584843|20452790|P2|COMPLETED|Second Treatment Period||1
8295385|NCT01584843|20452791|P1|COMPLETED|Second Treatment Period||2
8295386|NCT01584843|20452786|P6|STARTED|Second Treatment Period||1
8295387|NCT01584843|20452787|P5|STARTED|Second Treatment Period||3
8295388|NCT01584843|20452788|P4|STARTED|Second Treatment Period||6
8295389|NCT01584843|20452789|P3|STARTED|Second Treatment Period||2
8295390|NCT01584843|20452790|P2|STARTED|Second Treatment Period||1
8295391|NCT01584843|20452791|P1|STARTED|Second Treatment Period||2
8295392|NCT01584843|20452786|P6|NOT COMPLETED|First Treatment Period||2
8295393|NCT01584843|20452787|P5|NOT COMPLETED|First Treatment Period||0
8295394|NCT01584843|20452788|P4|NOT COMPLETED|First Treatment Period||0
8295395|NCT01584843|20452789|P3|NOT COMPLETED|First Treatment Period||1
8295396|NCT01584843|20452790|P2|NOT COMPLETED|First Treatment Period||0
8295397|NCT01584843|20452791|P1|NOT COMPLETED|First Treatment Period||0
8295398|NCT01584843|20452786|P6|COMPLETED|First Treatment Period||9
8295399|NCT01584843|20452787|P5|COMPLETED|First Treatment Period||10
8295400|NCT01584843|20452788|P4|COMPLETED|First Treatment Period||10
8295401|NCT01584843|20452789|P3|COMPLETED|First Treatment Period||2
8295402|NCT01584843|20452790|P2|COMPLETED|First Treatment Period||4
8295403|NCT01584843|20452791|P1|COMPLETED|First Treatment Period||3
8295404|NCT01584843|20452786|P6|STARTED|First Treatment Period||11
8295405|NCT01584843|20452787|P5|STARTED|First Treatment Period||10
8295406|NCT01584843|20452788|P4|STARTED|First Treatment Period||10
8295407|NCT01584843|20452789|P3|STARTED|First Treatment Period||3
8295408|NCT01584843|20452790|P2|STARTED|First Treatment Period||4
8295409|NCT01584843|20452791|P1|STARTED|First Treatment Period||3
8295418|NCT01584609|20452943|P2|NOT COMPLETED|Overall Study||4
8295419|NCT01584609|20452944|P1|NOT COMPLETED|Overall Study||12
8295420|NCT01584609|20452943|P2|COMPLETED|Overall Study||96
8295421|NCT01584609|20452944|P1|COMPLETED|Overall Study||86
8295422|NCT01584609|20452943|P2|STARTED|Overall Study||100
8295423|NCT01584609|20452944|P1|STARTED|Overall Study||98
8295424|NCT01584544|20452969|P5|NOT COMPLETED|Overall Study||0
8295425|NCT01584544|20452970|P4|NOT COMPLETED|Overall Study||0
8295426|NCT01584544|20452971|P3|NOT COMPLETED|Overall Study||0
8295427|NCT01584544|20452972|P2|NOT COMPLETED|Overall Study||0
8295428|NCT01584544|20452973|P1|NOT COMPLETED|Overall Study||0
8295429|NCT01584544|20452969|P5|COMPLETED|Overall Study||6
8295430|NCT01584544|20452970|P4|COMPLETED|Overall Study||3
8295431|NCT01584544|20452971|P3|COMPLETED|Overall Study||6
8295432|NCT01584544|20452972|P2|COMPLETED|Overall Study||6
8295433|NCT01584544|20452973|P1|COMPLETED|Overall Study||3
8295434|NCT01584544|20452969|P5|STARTED|Overall Study||6
8295435|NCT01584544|20452970|P4|STARTED|Overall Study||3
8295436|NCT01584544|20452971|P3|STARTED|Overall Study||6
8295437|NCT01584544|20452972|P2|STARTED|Overall Study||6
8295438|NCT01584544|20452973|P1|STARTED|Overall Study||3
8295439|NCT01584518|20452987|P2|NOT COMPLETED|Overall Study||0
8295440|NCT01584518|20452988|P1|NOT COMPLETED|Overall Study||0
8295441|NCT01584518|20452987|P2|COMPLETED|Overall Study||25
8295442|NCT01584518|20452988|P1|COMPLETED|Overall Study||25
8295443|NCT01584518|20452987|P2|STARTED|Overall Study||25
8295444|NCT01584518|20452988|P1|STARTED|Overall Study||25
8295445|NCT01584479|20452998|P4|NOT COMPLETED|Overall Study||0
8295446|NCT01584479|20452999|P3|NOT COMPLETED|Overall Study||0
8295447|NCT01584479|20453000|P2|NOT COMPLETED|Overall Study||0
8295448|NCT01584479|20453001|P1|NOT COMPLETED|Overall Study||0
8295449|NCT01584479|20452998|P4|COMPLETED|Overall Study||1847
8295450|NCT01584479|20452999|P3|COMPLETED|Overall Study||852
8295451|NCT01584479|20453000|P2|COMPLETED|Overall Study||1686
8295452|NCT01584479|20453001|P1|COMPLETED|Overall Study||732
8295453|NCT01584479|20452998|P4|STARTED|Overall Study||1847
8295454|NCT01584479|20452999|P3|STARTED|Overall Study||852
8295455|NCT01584479|20453000|P2|STARTED|Overall Study||1686
8295456|NCT01584479|20453001|P1|STARTED|Overall Study||732
8295457|NCT01584388|20453011|P1|NOT COMPLETED|Overall Study||0
8295458|NCT01584388|20453011|P1|COMPLETED|Overall Study||30
8295459|NCT01584388|20453011|P1|STARTED|Overall Study||30
8295460|NCT01584232|20453031|P2|NOT COMPLETED|Overall Study||3
8295461|NCT01584232|20453032|P1|NOT COMPLETED|Overall Study||8
8295462|NCT01584232|20453031|P2|COMPLETED|Overall Study||177
8295463|NCT01584232|20453032|P1|COMPLETED|Overall Study||173
8295464|NCT01584232|20453031|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
8295465|NCT01584232|20453032|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
8295466|NCT01584232|20453031|P2|STARTED|Overall Study||180
8295467|NCT01584232|20453032|P1|STARTED|Overall Study||181
8295468|NCT01584024|20453048|P1|NOT COMPLETED|Overall Study||13
8295469|NCT01584024|20453048|P1|COMPLETED|Overall Study||29
8295470|NCT01584024|20453048|P1|STARTED|Overall Study||42
8295471|NCT01583985|20453057|P2|NOT COMPLETED|Overall Study||3
8295472|NCT01583985|20453058|P1|NOT COMPLETED|Overall Study||3
8295473|NCT01583985|20453057|P2|COMPLETED|Overall Study||117
8295474|NCT01583985|20453058|P1|COMPLETED|Overall Study||117
8295475|NCT01583985|20453057|P2|Included in Primary Analysis|Overall Study||119
8295476|NCT01583985|20453058|P1|Included in Primary Analysis|Overall Study||119
8295477|NCT01583985|20453057|P2|STARTED|Overall Study||120
8295478|NCT01583985|20453058|P1|STARTED|Overall Study||120
8295479|NCT01583894|20453072|P1|NOT COMPLETED|Overall Study||15
8295480|NCT01583894|20453072|P1|COMPLETED|Overall Study||813
8295481|NCT01583894|20453072|P1|STARTED|Overall Study||828
8295482|NCT01583868|20453078|P2|NOT COMPLETED|Overall Study||4
8295483|NCT01583868|20453079|P1|NOT COMPLETED|Overall Study||4
8295484|NCT01583868|20453078|P2|COMPLETED|Overall Study||104
8295485|NCT01583868|20453079|P1|COMPLETED|Overall Study||104
8295486|NCT01583868|20453078|P2|STARTED|Overall Study||108
8295487|NCT01583868|20453079|P1|STARTED|Overall Study||108
8295488|NCT01583686|20453098|P5|NOT COMPLETED|Overall Study||0
8295489|NCT01583686|20453099|P4|NOT COMPLETED|Overall Study||0
8295490|NCT01583686|20453100|P3|NOT COMPLETED|Overall Study||0
8295491|NCT01583686|20453101|P2|NOT COMPLETED|Overall Study||0
8295492|NCT01583686|20453102|P1|NOT COMPLETED|Overall Study||0
8295493|NCT01583686|20453098|P5|COMPLETED|Overall Study||3
8295494|NCT01583686|20453099|P4|COMPLETED|Overall Study||3
8295495|NCT01583686|20453100|P3|COMPLETED|Overall Study||3
8295496|NCT01583686|20453101|P2|COMPLETED|Overall Study||3
8295497|NCT01583686|20453102|P1|COMPLETED|Overall Study||3
8295498|NCT01583686|20453098|P5|STARTED|Overall Study||3
8295499|NCT01583686|20453099|P4|STARTED|Overall Study||3
8295500|NCT01583686|20453100|P3|STARTED|Overall Study||3
8295501|NCT01583686|20453101|P2|STARTED|Overall Study||3
8295502|NCT01583686|20453102|P1|STARTED|Overall Study||3
8295503|NCT01583647|20453119|P2|NOT COMPLETED|Overall Study||0
8295504|NCT01583647|20453120|P1|NOT COMPLETED|Overall Study||0
8295505|NCT01583647|20453119|P2|COMPLETED|Overall Study||0
8295506|NCT01583647|20453120|P1|COMPLETED|Overall Study||10
8295507|NCT01583647|20453119|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
8295508|NCT01583647|20453120|P1|STARTED|Overall Study||10
8295509|NCT01583543|20453132|P1|NOT COMPLETED|Overall Study||0
8295510|NCT01583543|20453132|P1|COMPLETED|Overall Study||12
8295511|NCT01583543|20453132|P1|STARTED|Overall Study||12
8295512|NCT01583530|20453145|P6|NOT COMPLETED|Overall Study||3
8295513|NCT01583530|20453146|P5|NOT COMPLETED|Overall Study||5
8295514|NCT01583530|20453147|P4|NOT COMPLETED|Overall Study||1
8295515|NCT01583530|20453148|P3|NOT COMPLETED|Overall Study||0
8295516|NCT01583530|20453149|P2|NOT COMPLETED|Overall Study||3
8295517|NCT01583530|20453150|P1|NOT COMPLETED|Overall Study||0
8295518|NCT01583530|20453145|P6|COMPLETED|Overall Study||17
8295519|NCT01583530|20453146|P5|COMPLETED|Overall Study||15
8295520|NCT01583530|20453147|P4|COMPLETED|Overall Study||18
8295521|NCT01583530|20453148|P3|COMPLETED|Overall Study||20
8295522|NCT01583530|20453149|P2|COMPLETED|Overall Study||17
8295523|NCT01583530|20453150|P1|COMPLETED|Overall Study||19
8295524|NCT01583530|20453145|P6|STARTED|Overall Study||20
8295525|NCT01583530|20453146|P5|STARTED|Overall Study||20
8295526|NCT01583530|20453147|P4|STARTED|Overall Study||19
8295527|NCT01583530|20453148|P3|STARTED|Overall Study||20
8295528|NCT01583530|20453149|P2|STARTED|Overall Study||20
8295529|NCT01583530|20453150|P1|STARTED|Overall Study||19
8295530|NCT01583452|20453196|P2|NOT COMPLETED|Overall Study||0
8295531|NCT01583452|20453197|P1|NOT COMPLETED|Overall Study||0
8295532|NCT01583452|20453196|P2|COMPLETED|Overall Study||20
8295533|NCT01583452|20453197|P1|COMPLETED|Overall Study||21
8295534|NCT01583452|20453196|P2|STARTED|Overall Study||20
8295535|NCT01583452|20453197|P1|STARTED|Overall Study||21
8295536|NCT01583374|20453212|P9|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
8295537|NCT01583374|20453213|P8|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
8295538|NCT01583374|20453214|P7|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
8295539|NCT01583374|20453215|P6|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
8295540|NCT01583374|20453216|P5|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
8295541|NCT01583374|20453217|P4|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
8295542|NCT01583374|20453218|P3|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
8295543|NCT01583374|20453219|P2|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
8295544|NCT01583374|20453220|P1|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
8295545|NCT01583374|20453212|P9|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
8295546|NCT01583374|20453213|P8|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
8295547|NCT01583374|20453214|P7|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
8295548|NCT01583374|20453215|P6|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
8295549|NCT01583374|20453216|P5|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
8295550|NCT01583374|20453217|P4|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
8295551|NCT01583374|20453218|P3|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
8295552|NCT01583374|20453219|P2|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
8295553|NCT01583374|20453220|P1|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
8295554|NCT01583374|20453212|P9|STARTED|Long-Term Extension Phase Weeks 52-260||20
8295555|NCT01583374|20453213|P8|STARTED|Long-Term Extension Phase Weeks 52-260||21
8295556|NCT01583374|20453214|P7|STARTED|Long-Term Extension Phase Weeks 52-260||38
8295557|NCT01583374|20453215|P6|STARTED|Long-Term Extension Phase Weeks 52-260||39
8295558|NCT01583374|20453216|P5|STARTED|Long-Term Extension Phase Weeks 52-260||81
8295559|NCT01583374|20453217|P4|STARTED|Long-Term Extension Phase Weeks 52-260||35
8295560|NCT01583374|20453218|P3|STARTED|Long-Term Extension Phase Weeks 52-260||61
8295561|NCT01583374|20453219|P2|STARTED|Long-Term Extension Phase Weeks 52-260||66
8295562|NCT01583374|20453220|P1|STARTED|Long-Term Extension Phase Weeks 52-260||0
8295563|NCT01583374|20453212|P9|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
8295564|NCT01583374|20453213|P8|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
8295565|NCT01583374|20453214|P7|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8295566|NCT01583374|20453215|P6|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8295567|NCT01583374|20453216|P5|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
8295568|NCT01583374|20453217|P4|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
8295569|NCT01583374|20453218|P3|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
8295570|NCT01583374|20453219|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8295571|NCT01583374|20453220|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
8295572|NCT01583374|20453212|P9|COMPLETED|Extension Phase (Weeks 24 to 52)||21
8295573|NCT01583374|20453213|P8|COMPLETED|Extension Phase (Weeks 24 to 52)||22
8295574|NCT01583374|20453214|P7|COMPLETED|Extension Phase (Weeks 24 to 52)||43
8295575|NCT01583374|20453215|P6|COMPLETED|Extension Phase (Weeks 24 to 52)||43
8295576|NCT01583374|20453216|P5|COMPLETED|Extension Phase (Weeks 24 to 52)||85
8295577|NCT01583374|20453217|P4|COMPLETED|Extension Phase (Weeks 24 to 52)||41
8295578|NCT01583374|20453218|P3|COMPLETED|Extension Phase (Weeks 24 to 52)||61
8295579|NCT01583374|20453219|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||69
8295580|NCT01583374|20453220|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||0
8295581|NCT01583374|20453212|P9|STARTED|Extension Phase (Weeks 24 to 52)||23
8295582|NCT01583374|20453213|P8|STARTED|Extension Phase (Weeks 24 to 52)||25
8295583|NCT01583374|20453214|P7|STARTED|Extension Phase (Weeks 24 to 52)||48
8295584|NCT01583374|20453215|P6|STARTED|Extension Phase (Weeks 24 to 52)||48
8295585|NCT01583374|20453216|P5|STARTED|Extension Phase (Weeks 24 to 52)||91
8295586|NCT01583374|20453217|P4|STARTED|Extension Phase (Weeks 24 to 52)||47
8295587|NCT01583374|20453218|P3|STARTED|Extension Phase (Weeks 24 to 52)||65
8295588|NCT01583374|20453219|P2|STARTED|Extension Phase (Weeks 24 to 52)||74
8295589|NCT01583374|20453220|P1|STARTED|Extension Phase (Weeks 24 to 52)||0
8295590|NCT01583374|20453212|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295591|NCT01583374|20453213|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295592|NCT01583374|20453214|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295593|NCT01583374|20453215|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295594|NCT01583374|20453216|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295595|NCT01583374|20453217|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295596|NCT01583374|20453218|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
8295597|NCT01583374|20453219|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
8295598|NCT01583374|20453220|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
8295599|NCT01583374|20453212|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295600|NCT01583374|20453213|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295601|NCT01583374|20453214|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295602|NCT01583374|20453215|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295603|NCT01583374|20453216|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295604|NCT01583374|20453217|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295605|NCT01583374|20453218|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
8295606|NCT01583374|20453219|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
8295607|NCT01583374|20453220|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
8295608|NCT01583374|20453212|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295609|NCT01583374|20453213|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295610|NCT01583374|20453214|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295611|NCT01583374|20453215|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295612|NCT01583374|20453216|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295613|NCT01583374|20453217|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295614|NCT01583374|20453218|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
8295615|NCT01583374|20453219|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
8295616|NCT01583374|20453220|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
8295617|NCT01583374|20453212|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295618|NCT01583374|20453213|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295619|NCT01583374|20453214|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295620|NCT01583374|20453215|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295621|NCT01583374|20453216|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295622|NCT01583374|20453217|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295623|NCT01583374|20453218|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
8295624|NCT01583374|20453219|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
8295625|NCT01583374|20453220|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
8295626|NCT01583374|20453212|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295627|NCT01583374|20453213|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295716|NCT01582451|20453441|P2|STARTED|Overall Study||159
8295628|NCT01583374|20453214|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295629|NCT01583374|20453215|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295630|NCT01583374|20453216|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295631|NCT01583374|20453217|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295632|NCT01583374|20453218|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
8295633|NCT01583374|20453219|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
8295634|NCT01583374|20453220|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
8295635|NCT01583374|20453212|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295636|NCT01583374|20453213|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295637|NCT01583374|20453214|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295638|NCT01583374|20453215|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295639|NCT01583374|20453216|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295640|NCT01583374|20453217|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295641|NCT01583374|20453218|P3|STARTED|Placebo-controlled Phase (Week 0-24)||163
8295642|NCT01583374|20453219|P2|STARTED|Placebo-controlled Phase (Week 0-24)||163
8295643|NCT01583374|20453220|P1|STARTED|Placebo-controlled Phase (Week 0-24)||164
8295644|NCT01583218|20453262|P2|NOT COMPLETED|Overall Study||283
8295645|NCT01583218|20453263|P1|NOT COMPLETED|Overall Study||289
8295646|NCT01583218|20453262|P2|COMPLETED|Overall Study||3471
8295647|NCT01583218|20453263|P1|COMPLETED|Overall Study||3470
8295648|NCT01583218|20453262|P2|STARTED|Overall Study||3754
8295649|NCT01583218|20453263|P1|STARTED|Overall Study||3759
8295650|NCT01583179|20453283|P2|NOT COMPLETED|Overall Study||2
8295651|NCT01583179|20453284|P1|NOT COMPLETED|Overall Study||1
8295652|NCT01583179|20453283|P2|COMPLETED|Overall Study||10
8295653|NCT01583179|20453284|P1|COMPLETED|Overall Study||13
8295654|NCT01583179|20453283|P2|STARTED|Overall Study||12
8295655|NCT01583179|20453284|P1|STARTED|Overall Study||14
8295656|NCT01583166|20453294|P2|NOT COMPLETED|Overall Study||6
8295657|NCT01583166|20453295|P1|NOT COMPLETED|Overall Study||4
8295658|NCT01583166|20453294|P2|COMPLETED|Overall Study||39
8295659|NCT01583166|20453295|P1|COMPLETED|Overall Study||41
8295660|NCT01583166|20453294|P2|STARTED|Overall Study||45
8295661|NCT01583166|20453295|P1|STARTED|Overall Study||45
8295662|NCT01583101|20453309|P2|NOT COMPLETED|Overall Study||0
8295663|NCT01583101|20453310|P1|NOT COMPLETED|Overall Study||0
8295664|NCT01583101|20453309|P2|COMPLETED|Overall Study||1161
8295665|NCT01583101|20453310|P1|COMPLETED|Overall Study||1076
8295666|NCT01583101|20453309|P2|STARTED|Overall Study||1161
8295667|NCT01583101|20453310|P1|STARTED|Overall Study||1076
8295668|NCT01582971|20453318|P2|NOT COMPLETED|Overall Study||37
8295669|NCT01582971|20453319|P1|NOT COMPLETED|Overall Study||39
8295670|NCT01582971|20453318|P2|COMPLETED|Overall Study||91
8295671|NCT01582971|20453319|P1|COMPLETED|Overall Study||89
8295672|NCT01582971|20453318|P2|STARTED|Overall Study||128
8295673|NCT01582971|20453319|P1|STARTED|Overall Study||128
8295674|NCT01582945|20453337|P1|NOT COMPLETED|Overall Study||2
8295675|NCT01582945|20453337|P1|COMPLETED|Overall Study||12
8295676|NCT01582945|20453337|P1|STARTED|Overall Study||14
8295677|NCT01582880|20453341|P1|NOT COMPLETED|Overall Study||0
8295678|NCT01582880|20453341|P1|COMPLETED|Overall Study||1
8295679|NCT01582880|20453341|P1|STARTED|Overall Study||1
8295680|NCT01582854|20453351|P2|NOT COMPLETED|Overall Study||34
8295681|NCT01582854|20453352|P1|NOT COMPLETED|Overall Study||36
8295682|NCT01582854|20453351|P2|COMPLETED|Overall Study||221
8295683|NCT01582854|20453352|P1|COMPLETED|Overall Study||212
8295684|NCT01582854|20453351|P2|STARTED|Overall Study||255
8295685|NCT01582854|20453352|P1|STARTED|Overall Study||248
8295686|NCT01582789|20453380|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8295687|NCT01582789|20453381|P1|NOT COMPLETED|Second Intervention (14 Days)||1
8295688|NCT01582789|20453380|P2|COMPLETED|Second Intervention (14 Days)||27
8295689|NCT01582789|20453381|P1|COMPLETED|Second Intervention (14 Days)||33
8295690|NCT01582789|20453380|P2|STARTED|Second Intervention (14 Days)||27
8295691|NCT01582789|20453381|P1|STARTED|Second Intervention (14 Days)||34
8295692|NCT01582789|20453380|P2|NOT COMPLETED|First Intervention (14 Days)||0
8295693|NCT01582789|20453381|P1|NOT COMPLETED|First Intervention (14 Days)||0
8295694|NCT01582789|20453380|P2|COMPLETED|First Intervention (14 Days)||27
8295695|NCT01582789|20453381|P1|COMPLETED|First Intervention (14 Days)||34
8295696|NCT01582789|20453380|P2|STARTED|First Intervention (14 Days)||27
8295697|NCT01582789|20453381|P1|STARTED|First Intervention (14 Days)||34
8295698|NCT01582490|20453399|P2|NOT COMPLETED|Overall Study||1
8295699|NCT01582490|20453400|P1|NOT COMPLETED|Overall Study||1
8295700|NCT01582490|20453399|P2|COMPLETED|Overall Study||9
8295701|NCT01582490|20453400|P1|COMPLETED|Overall Study||8
8295702|NCT01582490|20453399|P2|STARTED|Overall Study||10
8295703|NCT01582490|20453400|P1|STARTED|Overall Study||9
8295704|NCT01582477|20453422|P2|NOT COMPLETED|Overall Study||0
8295705|NCT01582477|20453423|P1|NOT COMPLETED|Overall Study||0
8295706|NCT01582477|20453422|P2|COMPLETED|Overall Study||12
8295707|NCT01582477|20453423|P1|COMPLETED|Overall Study||12
8295708|NCT01582477|20453422|P2|STARTED|Overall Study||12
8295709|NCT01582477|20453423|P1|STARTED|Overall Study||12
8295710|NCT01582451|20453441|P2|NOT COMPLETED|Overall Study||20
8295711|NCT01582451|20453442|P1|NOT COMPLETED|Overall Study||32
8295712|NCT01582451|20453441|P2|COMPLETED|Overall Study||139
8295713|NCT01582451|20453442|P1|COMPLETED|Overall Study||275
8295714|NCT01582451|20453441|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
8295715|NCT01582451|20453442|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
8295717|NCT01582451|20453442|P1|STARTED|Overall Study||307
8295718|NCT01582308|20453484|P10|NOT COMPLETED|Period 5||0
8295719|NCT01582308|20453485|P9|NOT COMPLETED|Period 5||0
8295720|NCT01582308|20453486|P8|NOT COMPLETED|Period 5||0
8295721|NCT01582308|20453487|P7|NOT COMPLETED|Period 5||0
8295722|NCT01582308|20453488|P6|NOT COMPLETED|Period 5||0
8295723|NCT01582308|20453489|P5|NOT COMPLETED|Period 5||0
8295724|NCT01582308|20453490|P4|NOT COMPLETED|Period 5||0
8295725|NCT01582308|20453491|P3|NOT COMPLETED|Period 5||0
8295726|NCT01582308|20453492|P2|NOT COMPLETED|Period 5||0
8295727|NCT01582308|20453493|P1|NOT COMPLETED|Period 5||0
8295728|NCT01582308|20453484|P10|COMPLETED|Period 5||1
8295729|NCT01582308|20453485|P9|COMPLETED|Period 5||2
8295730|NCT01582308|20453486|P8|COMPLETED|Period 5||2
8295731|NCT01582308|20453487|P7|COMPLETED|Period 5||2
8295732|NCT01582308|20453488|P6|COMPLETED|Period 5||1
8295733|NCT01582308|20453489|P5|COMPLETED|Period 5||2
8295734|NCT01582308|20453490|P4|COMPLETED|Period 5||2
8295735|NCT01582308|20453491|P3|COMPLETED|Period 5||2
8295736|NCT01582308|20453492|P2|COMPLETED|Period 5||2
8295737|NCT01582308|20453493|P1|COMPLETED|Period 5||1
8295738|NCT01582308|20453484|P10|STARTED|Period 5||1
8295739|NCT01582308|20453485|P9|STARTED|Period 5||2
8295740|NCT01582308|20453486|P8|STARTED|Period 5||2
8295741|NCT01582308|20453487|P7|STARTED|Period 5||2
8295742|NCT01582308|20453488|P6|STARTED|Period 5||1
8295743|NCT01582308|20453489|P5|STARTED|Period 5||2
8295744|NCT01582308|20453490|P4|STARTED|Period 5||2
8295745|NCT01582308|20453491|P3|STARTED|Period 5||2
8295746|NCT01582308|20453492|P2|STARTED|Period 5||2
8295747|NCT01582308|20453493|P1|STARTED|Period 5||1
8295748|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 4||0
8295749|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 4||0
8295750|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 4||0
8295751|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 4||0
8295752|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 4||0
8295753|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 4||0
8295754|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 4||0
8295755|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 4||0
8295756|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 4||0
8295757|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 4||0
8295758|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 4||1
8295759|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 4||2
8295760|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 4||2
8295761|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 4||2
8295762|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 4||1
8295763|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 4||2
8295764|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 4||2
8295765|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 4||2
8295766|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 4||2
8295767|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 4||1
8295768|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 4||1
8295769|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 4||2
8295770|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 4||2
8295771|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 4||2
8295772|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 4||1
8295773|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 4||2
8295774|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 4||2
8295775|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 4||2
8295776|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 4||2
8295777|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 4||1
8295778|NCT01582308|20453484|P10|NOT COMPLETED|Period 4||1
8295779|NCT01582308|20453485|P9|NOT COMPLETED|Period 4||0
8295780|NCT01582308|20453486|P8|NOT COMPLETED|Period 4||0
8295781|NCT01582308|20453487|P7|NOT COMPLETED|Period 4||0
8295782|NCT01582308|20453488|P6|NOT COMPLETED|Period 4||1
8295783|NCT01582308|20453489|P5|NOT COMPLETED|Period 4||0
8295784|NCT01582308|20453490|P4|NOT COMPLETED|Period 4||0
8295785|NCT01582308|20453491|P3|NOT COMPLETED|Period 4||0
8295786|NCT01582308|20453492|P2|NOT COMPLETED|Period 4||0
8295787|NCT01582308|20453493|P1|NOT COMPLETED|Period 4||1
8295788|NCT01582308|20453484|P10|COMPLETED|Period 4||1
8295789|NCT01582308|20453485|P9|COMPLETED|Period 4||2
8295790|NCT01582308|20453486|P8|COMPLETED|Period 4||2
8295791|NCT01582308|20453487|P7|COMPLETED|Period 4||2
8295792|NCT01582308|20453488|P6|COMPLETED|Period 4||1
8295793|NCT01582308|20453489|P5|COMPLETED|Period 4||2
8295794|NCT01582308|20453490|P4|COMPLETED|Period 4||2
8295795|NCT01582308|20453491|P3|COMPLETED|Period 4||2
8295796|NCT01582308|20453492|P2|COMPLETED|Period 4||2
8295797|NCT01582308|20453493|P1|COMPLETED|Period 4||1
8295798|NCT01582308|20453484|P10|STARTED|Period 4||2
8295799|NCT01582308|20453485|P9|STARTED|Period 4||2
8295800|NCT01582308|20453486|P8|STARTED|Period 4||2
8295801|NCT01582308|20453487|P7|STARTED|Period 4||2
8295802|NCT01582308|20453488|P6|STARTED|Period 4||2
8295803|NCT01582308|20453489|P5|STARTED|Period 4||2
8295804|NCT01582308|20453490|P4|STARTED|Period 4||2
8295805|NCT01582308|20453491|P3|STARTED|Period 4||2
8295806|NCT01582308|20453492|P2|STARTED|Period 4||2
8295807|NCT01582308|20453493|P1|STARTED|Period 4||2
8295808|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 3||0
8295809|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 3||0
8295810|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 3||0
8295811|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 3||0
8295812|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 3||0
8295813|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 3||0
8295814|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 3||0
8295815|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 3||0
8295816|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 3||0
8295817|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 3||0
8295818|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 3||2
8295819|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 3||2
8295820|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 3||2
8295821|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 3||2
8295822|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 3||2
8295823|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 3||2
8295824|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 3||2
8295825|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 3||2
8295826|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 3||2
8295827|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 3||2
8295828|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 3||2
8295829|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 3||2
8295830|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 3||2
8295831|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 3||2
8295832|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 3||2
8295833|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 3||2
8295834|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 3||2
8295835|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 3||2
8295836|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 3||2
8295837|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 3||2
8295838|NCT01582308|20453484|P10|NOT COMPLETED|Period 3||0
8295839|NCT01582308|20453485|P9|NOT COMPLETED|Period 3||0
8295840|NCT01582308|20453486|P8|NOT COMPLETED|Period 3||0
8295841|NCT01582308|20453487|P7|NOT COMPLETED|Period 3||0
8295842|NCT01582308|20453488|P6|NOT COMPLETED|Period 3||0
8295843|NCT01582308|20453489|P5|NOT COMPLETED|Period 3||0
8295844|NCT01582308|20453490|P4|NOT COMPLETED|Period 3||0
8295845|NCT01582308|20453491|P3|NOT COMPLETED|Period 3||0
8295846|NCT01582308|20453492|P2|NOT COMPLETED|Period 3||0
8295847|NCT01582308|20453493|P1|NOT COMPLETED|Period 3||0
8295848|NCT01582308|20453484|P10|COMPLETED|Period 3||2
8295849|NCT01582308|20453485|P9|COMPLETED|Period 3||2
8295850|NCT01582308|20453486|P8|COMPLETED|Period 3||2
8295851|NCT01582308|20453487|P7|COMPLETED|Period 3||2
8295852|NCT01582308|20453488|P6|COMPLETED|Period 3||2
8295853|NCT01582308|20453489|P5|COMPLETED|Period 3||2
8295854|NCT01582308|20453490|P4|COMPLETED|Period 3||2
8295855|NCT01582308|20453491|P3|COMPLETED|Period 3||2
8295856|NCT01582308|20453492|P2|COMPLETED|Period 3||2
8295857|NCT01582308|20453493|P1|COMPLETED|Period 3||2
8295858|NCT01582308|20453484|P10|STARTED|Period 3||2
8295859|NCT01582308|20453485|P9|STARTED|Period 3||2
8295860|NCT01582308|20453486|P8|STARTED|Period 3||2
8295861|NCT01582308|20453487|P7|STARTED|Period 3||2
8295862|NCT01582308|20453488|P6|STARTED|Period 3||2
8295863|NCT01582308|20453489|P5|STARTED|Period 3||2
8295864|NCT01582308|20453490|P4|STARTED|Period 3||2
8295865|NCT01582308|20453491|P3|STARTED|Period 3||2
8295866|NCT01582308|20453492|P2|STARTED|Period 3||2
8295867|NCT01582308|20453493|P1|STARTED|Period 3||2
8295868|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 2||0
8295869|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 2||0
8295870|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 2||0
8295871|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 2||0
8295872|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 2||0
8295873|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 2||0
8295874|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 2||0
8295875|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 2||0
8295876|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 2||0
8295877|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 2||0
8295878|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 2||2
8295879|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 2||2
8295880|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 2||2
8295881|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 2||2
8295882|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 2||2
8295883|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 2||2
8295884|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 2||2
8295885|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 2||2
8295886|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 2||2
8295887|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 2||2
8295888|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 2||2
8295889|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 2||2
8295890|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 2||2
8295891|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 2||2
8295892|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 2||2
8295893|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 2||2
8295894|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 2||2
8295895|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 2||2
8295896|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 2||2
8295897|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 2||2
8295898|NCT01582308|20453484|P10|NOT COMPLETED|Period 2||0
8295899|NCT01582308|20453485|P9|NOT COMPLETED|Period 2||0
8295900|NCT01582308|20453486|P8|NOT COMPLETED|Period 2||0
8295901|NCT01582308|20453487|P7|NOT COMPLETED|Period 2||0
8295902|NCT01582308|20453488|P6|NOT COMPLETED|Period 2||0
8295903|NCT01582308|20453489|P5|NOT COMPLETED|Period 2||0
8295904|NCT01582308|20453490|P4|NOT COMPLETED|Period 2||0
8295905|NCT01582308|20453491|P3|NOT COMPLETED|Period 2||0
8295906|NCT01582308|20453492|P2|NOT COMPLETED|Period 2||0
8295907|NCT01582308|20453493|P1|NOT COMPLETED|Period 2||0
8295908|NCT01582308|20453484|P10|COMPLETED|Period 2||2
8295909|NCT01582308|20453485|P9|COMPLETED|Period 2||2
8295910|NCT01582308|20453486|P8|COMPLETED|Period 2||2
8295911|NCT01582308|20453487|P7|COMPLETED|Period 2||2
8295912|NCT01582308|20453488|P6|COMPLETED|Period 2||2
8295913|NCT01582308|20453489|P5|COMPLETED|Period 2||2
8295914|NCT01582308|20453490|P4|COMPLETED|Period 2||2
8295915|NCT01582308|20453491|P3|COMPLETED|Period 2||2
8295916|NCT01582308|20453492|P2|COMPLETED|Period 2||2
8295917|NCT01582308|20453493|P1|COMPLETED|Period 2||2
8295918|NCT01582308|20453484|P10|STARTED|Period 2||2
8295919|NCT01582308|20453485|P9|STARTED|Period 2||2
8295920|NCT01582308|20453486|P8|STARTED|Period 2||2
8295921|NCT01582308|20453487|P7|STARTED|Period 2||2
8295922|NCT01582308|20453488|P6|STARTED|Period 2||2
8295923|NCT01582308|20453489|P5|STARTED|Period 2||2
8295924|NCT01582308|20453490|P4|STARTED|Period 2||2
8295925|NCT01582308|20453491|P3|STARTED|Period 2||2
8295926|NCT01582308|20453492|P2|STARTED|Period 2||2
8295927|NCT01582308|20453493|P1|STARTED|Period 2||2
8295928|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 1||0
8295929|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 1||0
8295930|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 1||0
8295931|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 1||0
8295932|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 1||0
8295933|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 1||1
8295934|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 1||0
8295935|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 1||0
8295936|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 1||0
8295937|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 1||0
8295938|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 1||2
8295939|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 1||2
8295940|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 1||2
8295941|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 1||2
8295942|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 1||2
8295943|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 1||2
8295944|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 1||2
8295945|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 1||2
8295946|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 1||2
8295947|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 1||2
8295948|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 1||2
8295949|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 1||2
8295950|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 1||2
8295951|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 1||2
8295952|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 1||2
8295953|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 1||3
8295954|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 1||2
8295955|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 1||2
8295956|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 1||2
8295957|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 1||2
8295958|NCT01582308|20453484|P10|NOT COMPLETED|Period 1||0
8295959|NCT01582308|20453485|P9|NOT COMPLETED|Period 1||0
8295960|NCT01582308|20453486|P8|NOT COMPLETED|Period 1||0
8295961|NCT01582308|20453487|P7|NOT COMPLETED|Period 1||1
8295962|NCT01582308|20453488|P6|NOT COMPLETED|Period 1||0
8295963|NCT01582308|20453489|P5|NOT COMPLETED|Period 1||0
8295964|NCT01582308|20453490|P4|NOT COMPLETED|Period 1||0
8295965|NCT01582308|20453491|P3|NOT COMPLETED|Period 1||0
8295966|NCT01582308|20453492|P2|NOT COMPLETED|Period 1||0
8295967|NCT01582308|20453493|P1|NOT COMPLETED|Period 1||0
8295968|NCT01582308|20453484|P10|COMPLETED|Period 1||2
8295969|NCT01582308|20453485|P9|COMPLETED|Period 1||2
8295970|NCT01582308|20453486|P8|COMPLETED|Period 1||2
8295971|NCT01582308|20453487|P7|COMPLETED|Period 1||2
8295972|NCT01582308|20453488|P6|COMPLETED|Period 1||2
8295973|NCT01582308|20453489|P5|COMPLETED|Period 1||3
8295974|NCT01582308|20453490|P4|COMPLETED|Period 1||2
8295975|NCT01582308|20453491|P3|COMPLETED|Period 1||2
8295976|NCT01582308|20453492|P2|COMPLETED|Period 1||2
8295977|NCT01582308|20453493|P1|COMPLETED|Period 1||2
8295978|NCT01582308|20453484|P10|STARTED|Period 1||2
8295979|NCT01582308|20453485|P9|STARTED|Period 1||2
8295980|NCT01582308|20453486|P8|STARTED|Period 1||2
8295981|NCT01582308|20453487|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
8295982|NCT01582308|20453488|P6|STARTED|Period 1||2
8295983|NCT01582308|20453489|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
8295984|NCT01582308|20453490|P4|STARTED|Period 1||2
8295985|NCT01582308|20453491|P3|STARTED|Period 1||2
8295986|NCT01582308|20453492|P2|STARTED|Period 1||2
8295987|NCT01582308|20453493|P1|STARTED|Period 1||2
8295988|NCT01582282|20453521|P3|NOT COMPLETED|Overall Study||0
8295989|NCT01582282|20453522|P2|NOT COMPLETED|Overall Study||2
8295990|NCT01582282|20453523|P1|NOT COMPLETED|Overall Study||2
8295991|NCT01582282|20453521|P3|COMPLETED|Overall Study||8
8295992|NCT01582282|20453522|P2|COMPLETED|Overall Study||12
8295993|NCT01582282|20453523|P1|COMPLETED|Overall Study||13
8295994|NCT01582282|20453521|P3|STARTED|Overall Study||8
8295995|NCT01582282|20453522|P2|STARTED|Overall Study||14
8295996|NCT01582282|20453523|P1|STARTED|Overall Study||15
8295997|NCT01582243|20453546|P1|NOT COMPLETED|Overall Study||3
8295998|NCT01582243|20453546|P1|COMPLETED|Overall Study||37
8295999|NCT01582243|20453546|P1|STARTED|Overall Study||40
8296000|NCT01582178|20453557|P2|NOT COMPLETED|Overall Study||5
8296001|NCT01582178|20453558|P1|NOT COMPLETED|Overall Study||6
8296002|NCT01582178|20453557|P2|COMPLETED|Overall Study||101
8296003|NCT01582178|20453558|P1|COMPLETED|Overall Study||100
8296004|NCT01582178|20453557|P2|STARTED|Overall Study||106
8296005|NCT01582178|20453558|P1|STARTED|Overall Study||106
8296006|NCT01582152|20453566|P2|NOT COMPLETED|Overall Study||6
8296007|NCT01582152|20453567|P1|NOT COMPLETED|Overall Study||6
8296008|NCT01582152|20453566|P2|COMPLETED|Overall Study||0
8296009|NCT01582152|20453567|P1|COMPLETED|Overall Study||0
8296010|NCT01582152|20453566|P2|STARTED|Overall Study||6
8296011|NCT01582152|20453567|P1|STARTED|Overall Study||6
8296012|NCT01582139|20453577|P2|NOT COMPLETED|Overall Study||0
8296013|NCT01582139|20453578|P1|NOT COMPLETED|Overall Study||0
8296014|NCT01582139|20453577|P2|COMPLETED|Overall Study||6
8296015|NCT01582139|20453578|P1|COMPLETED|Overall Study||6
8296016|NCT01582139|20453577|P2|STARTED|Overall Study||6
8296017|NCT01582139|20453578|P1|STARTED|Overall Study||6
8296018|NCT01582100|20453590|P1|NOT COMPLETED|Overall Study||2
8296019|NCT01582100|20453590|P1|COMPLETED|Overall Study||0
8296020|NCT01582100|20453590|P1|STARTED|Overall Study||2
8296021|NCT01582061|20453596|P2|NOT COMPLETED|Overall Study||36
8296022|NCT01582061|20453597|P1|NOT COMPLETED|Overall Study||28
8296023|NCT01582061|20453596|P2|COMPLETED|Overall Study||19
8296024|NCT01582061|20453597|P1|COMPLETED|Overall Study||21
8296025|NCT01582061|20453596|P2|STARTED|Overall Study||55
8296026|NCT01582061|20453597|P1|STARTED|Overall Study||49
8296027|NCT01582009|20453647|P1|NOT COMPLETED|Overall Study||2
8296028|NCT01582009|20453647|P1|COMPLETED|Overall Study||24
8296029|NCT01582009|20453647|P1|STARTED|Overall Study||26
8296030|NCT01581970|20453655|P1|NOT COMPLETED|Overall Study||0
8296031|NCT01581970|20453655|P1|COMPLETED|Overall Study||7
8296032|NCT01581970|20453655|P1|STARTED|Overall Study||7
8296033|NCT01581931|20453664|P2|NOT COMPLETED|Second Period||0
8296034|NCT01581931|20453665|P1|NOT COMPLETED|Second Period||0
8296035|NCT01581931|20453664|P2|COMPLETED|Second Period||15
8296036|NCT01581931|20453665|P1|COMPLETED|Second Period||16
8296037|NCT01581931|20453664|P2|STARTED|Second Period||15
8296038|NCT01581931|20453665|P1|STARTED|Second Period||16
8296039|NCT01581931|20453664|P2|NOT COMPLETED|Washout||1
8296040|NCT01581931|20453665|P1|NOT COMPLETED|Washout||0
8296041|NCT01581931|20453664|P2|COMPLETED|Washout||15
8296042|NCT01581931|20453665|P1|COMPLETED|Washout||16
8296043|NCT01581931|20453664|P2|STARTED|Washout||16
8296044|NCT01581931|20453665|P1|STARTED|Washout||16
8296045|NCT01581931|20453664|P2|NOT COMPLETED|First Period||0
8296046|NCT01581931|20453665|P1|NOT COMPLETED|First Period||0
8296047|NCT01581931|20453664|P2|COMPLETED|First Period||16
8296048|NCT01581931|20453665|P1|COMPLETED|First Period||16
8296049|NCT01581931|20453664|P2|STARTED|First Period||16
8296050|NCT01581931|20453665|P1|STARTED|First Period||16
8296051|NCT01581710|20453679|P2|NOT COMPLETED|Second Intervention (14days)||2
8296052|NCT01581710|20453680|P1|NOT COMPLETED|Second Intervention (14days)||0
8296053|NCT01581710|20453679|P2|COMPLETED|Second Intervention (14days)||12
8296054|NCT01581710|20453680|P1|COMPLETED|Second Intervention (14days)||18
8296055|NCT01581710|20453679|P2|STARTED|Second Intervention (14days)||14
8296056|NCT01581710|20453680|P1|STARTED|Second Intervention (14days)||18
8296057|NCT01581710|20453679|P2|NOT COMPLETED|Washout Period (14days)||0
8296058|NCT01581710|20453680|P1|NOT COMPLETED|Washout Period (14days)||0
8296059|NCT01581710|20453679|P2|COMPLETED|Washout Period (14days)||14
8296060|NCT01581710|20453680|P1|COMPLETED|Washout Period (14days)||18
8296061|NCT01581710|20453679|P2|STARTED|Washout Period (14days)||14
8296062|NCT01581710|20453680|P1|STARTED|Washout Period (14days)||18
8296063|NCT01581710|20453679|P2|NOT COMPLETED|First Intervention (14days)||0
8296064|NCT01581710|20453680|P1|NOT COMPLETED|First Intervention (14days)||0
8296065|NCT01581710|20453679|P2|COMPLETED|First Intervention (14days)||14
8296066|NCT01581710|20453680|P1|COMPLETED|First Intervention (14days)||18
8296067|NCT01581710|20453679|P2|STARTED|First Intervention (14days)||14
8296068|NCT01581710|20453680|P1|STARTED|First Intervention (14days)||18
8296069|NCT01581684|20453718|P10|NOT COMPLETED|Overall Study||0
8296070|NCT01581684|20453719|P9|NOT COMPLETED|Overall Study||1
8296071|NCT01581684|20453720|P8|NOT COMPLETED|Overall Study||0
8296072|NCT01581684|20453721|P7|NOT COMPLETED|Overall Study||0
8296073|NCT01581684|20453722|P6|NOT COMPLETED|Overall Study||0
8296074|NCT01581684|20453723|P5|NOT COMPLETED|Overall Study||0
8296075|NCT01581684|20453724|P4|NOT COMPLETED|Overall Study||0
8296076|NCT01581684|20453725|P3|NOT COMPLETED|Overall Study||0
8296077|NCT01581684|20453726|P2|NOT COMPLETED|Overall Study||0
8296078|NCT01581684|20453727|P1|NOT COMPLETED|Overall Study||0
8296079|NCT01581684|20453718|P10|COMPLETED|Overall Study||5
8296080|NCT01581684|20453719|P9|COMPLETED|Overall Study||0
8296081|NCT01581684|20453720|P8|COMPLETED|Overall Study||6
8296082|NCT01581684|20453721|P7|COMPLETED|Overall Study||6
8296083|NCT01581684|20453722|P6|COMPLETED|Overall Study||6
8296084|NCT01581684|20453723|P5|COMPLETED|Overall Study||6
8296085|NCT01581684|20453724|P4|COMPLETED|Overall Study||6
8296086|NCT01581684|20453725|P3|COMPLETED|Overall Study||6
8296087|NCT01581684|20453726|P2|COMPLETED|Overall Study||6
8296088|NCT01581684|20453727|P1|COMPLETED|Overall Study||14
8296089|NCT01581684|20453718|P10|STARTED|Overall Study||5
8296090|NCT01581684|20453719|P9|STARTED|Overall Study||1
8296091|NCT01581684|20453720|P8|STARTED|Overall Study||6
8296092|NCT01581684|20453721|P7|STARTED|Overall Study||6
8296093|NCT01581684|20453722|P6|STARTED|Overall Study||6
8296094|NCT01581684|20453723|P5|STARTED|Overall Study||6
8296095|NCT01581684|20453724|P4|STARTED|Overall Study||6
8296096|NCT01581684|20453725|P3|STARTED|Overall Study||6
8296097|NCT01581684|20453726|P2|STARTED|Overall Study||6
8296098|NCT01581684|20453727|P1|STARTED|Overall Study||14
8296099|NCT01581658|20453802|P4|NOT COMPLETED|Overall Study||0
8296100|NCT01581658|20453803|P3|NOT COMPLETED|Overall Study||0
8296101|NCT01581658|20453804|P2|NOT COMPLETED|Overall Study||0
8296102|NCT01581658|20453805|P1|NOT COMPLETED|Overall Study||0
8296103|NCT01581658|20453802|P4|COMPLETED|Overall Study||8
8296104|NCT01581658|20453803|P3|COMPLETED|Overall Study||8
8296105|NCT01581658|20453804|P2|COMPLETED|Overall Study||8
8296106|NCT01581658|20453805|P1|COMPLETED|Overall Study||8
8296107|NCT01581658|20453802|P4|STARTED|Overall Study||8
8296108|NCT01581658|20453803|P3|STARTED|Overall Study||8
8296109|NCT01581658|20453804|P2|STARTED|Overall Study||8
8296110|NCT01581658|20453805|P1|STARTED|Overall Study||8
8296111|NCT01581619|20453823|P1|NOT COMPLETED|Overall Study||2
8296112|NCT01581619|20453823|P1|COMPLETED|Overall Study||52
8296113|NCT01581619|20453823|P1|STARTED|Overall Study||54
8296114|NCT01581541|20453831|P11|NOT COMPLETED|Overall Study||0
8296115|NCT01581541|20453832|P10|NOT COMPLETED|Overall Study||0
8296116|NCT01581541|20453833|P9|NOT COMPLETED|Overall Study||0
8296117|NCT01581541|20453834|P8|NOT COMPLETED|Overall Study||0
8296118|NCT01581541|20453835|P7|NOT COMPLETED|Overall Study||0
8296119|NCT01581541|20453836|P6|NOT COMPLETED|Overall Study||0
8296120|NCT01581541|20453837|P5|NOT COMPLETED|Overall Study||0
8296121|NCT01581541|20453838|P4|NOT COMPLETED|Overall Study||0
8296122|NCT01581541|20453839|P3|NOT COMPLETED|Overall Study||0
8296123|NCT01581541|20453840|P2|NOT COMPLETED|Overall Study||0
8296124|NCT01581541|20453841|P1|NOT COMPLETED|Overall Study||0
8296125|NCT01581541|20453831|P11|COMPLETED|Overall Study||1
8296126|NCT01581541|20453832|P10|COMPLETED|Overall Study||3
8296127|NCT01581541|20453833|P9|COMPLETED|Overall Study||1
8296128|NCT01581541|20453834|P8|COMPLETED|Overall Study||2
8296129|NCT01581541|20453835|P7|COMPLETED|Overall Study||1
8296130|NCT01581541|20453836|P6|COMPLETED|Overall Study||3
8296131|NCT01581541|20453837|P5|COMPLETED|Overall Study||2
8296132|NCT01581541|20453838|P4|COMPLETED|Overall Study||1
8296133|NCT01581541|20453839|P3|COMPLETED|Overall Study||1
8296134|NCT01581541|20453840|P2|COMPLETED|Overall Study||1
8296135|NCT01581541|20453841|P1|COMPLETED|Overall Study||1
8296136|NCT01581541|20453831|P11|STARTED|Overall Study||1
8296137|NCT01581541|20453832|P10|STARTED|Overall Study||3
8296138|NCT01581541|20453833|P9|STARTED|Overall Study||1
8296139|NCT01581541|20453834|P8|STARTED|Overall Study||2
8296140|NCT01581541|20453835|P7|STARTED|Overall Study||1
8296141|NCT01581541|20453836|P6|STARTED|Overall Study||3
8296142|NCT01581541|20453837|P5|STARTED|Overall Study||2
8296143|NCT01581541|20453838|P4|STARTED|Overall Study||1
8296144|NCT01581541|20453839|P3|STARTED|Overall Study||1
8296145|NCT01581541|20453840|P2|STARTED|Overall Study||1
8296146|NCT01581541|20453841|P1|STARTED|Overall Study||1
8296147|NCT01581437|20453965|P1|NOT COMPLETED|Overall Study||0
8296148|NCT01581437|20453965|P1|COMPLETED|Overall Study||78
8296149|NCT01581437|20453965|P1|STARTED|Overall Study||78
8296150|NCT01581307|20453976|P1|NOT COMPLETED|Overall Study||1
8296151|NCT01581307|20453976|P1|COMPLETED|Overall Study||8
8296152|NCT01581307|20453976|P1|STARTED|Overall Study||9
8296153|NCT01581281|20453985|P3|NOT COMPLETED|Overall Study||12
8296154|NCT01581281|20453986|P2|NOT COMPLETED|Overall Study||6
8296155|NCT01581281|20453987|P1|NOT COMPLETED|Overall Study||15
8296156|NCT01581281|20453985|P3|COMPLETED|Overall Study||132
8296157|NCT01581281|20453986|P2|COMPLETED|Overall Study||66
8296158|NCT01581281|20453987|P1|COMPLETED|Overall Study||130
8296159|NCT01581281|20453985|P3|STARTED|Overall Study||144
8296160|NCT01581281|20453986|P2|STARTED|Overall Study||72
8296161|NCT01581281|20453987|P1|STARTED|Overall Study||145
8296162|NCT01581021|20454009|P2|NOT COMPLETED|Overall Study||11
8296163|NCT01581021|20454010|P1|NOT COMPLETED|Overall Study||10
8296164|NCT01581021|20454009|P2|COMPLETED|Overall Study||18
8296165|NCT01581021|20454010|P1|COMPLETED|Overall Study||19
8296166|NCT01581021|20454009|P2|STARTED|Overall Study||29
8296167|NCT01581021|20454010|P1|STARTED|Overall Study||29
8296168|NCT01581008|20454024|P2|NOT COMPLETED|Overall Study||6
8296169|NCT01581008|20454025|P1|NOT COMPLETED|Overall Study||1
8296170|NCT01581008|20454024|P2|COMPLETED|Overall Study||7
8296171|NCT01581008|20454025|P1|COMPLETED|Overall Study||16
8296172|NCT01581008|20454024|P2|STARTED|Overall Study||13
8296173|NCT01581008|20454025|P1|STARTED|Overall Study||17
8296174|NCT01580995|20454037|P2|NOT COMPLETED|Overall Study||2
8296175|NCT01580995|20454038|P1|NOT COMPLETED|Overall Study||2
8296176|NCT01580995|20454037|P2|COMPLETED|Overall Study||7
8296177|NCT01580995|20454038|P1|COMPLETED|Overall Study||8
8296178|NCT01580995|20454037|P2|STARTED|Overall Study||9
8296179|NCT01580995|20454038|P1|STARTED|Overall Study||10
8296180|NCT01580969|20454047|P3|NOT COMPLETED|Overall Study||0
8296181|NCT01580969|20454048|P2|NOT COMPLETED|Overall Study||0
8296182|NCT01580969|20454049|P1|NOT COMPLETED|Overall Study||3
8296183|NCT01580969|20454047|P3|COMPLETED|Overall Study||13
8296184|NCT01580969|20454048|P2|COMPLETED|Overall Study||3
8296185|NCT01580969|20454049|P1|COMPLETED|Overall Study||3
8296186|NCT01580969|20454047|P3|STARTED|Overall Study||13
8296187|NCT01580969|20454048|P2|STARTED|Overall Study||3
8296188|NCT01580969|20454049|P1|STARTED|Overall Study||6
8296189|NCT01580904|20454083|P2|NOT COMPLETED|Overall Study||7
8296190|NCT01580904|20454084|P1|NOT COMPLETED|Overall Study||4
8296191|NCT01580904|20454083|P2|COMPLETED|Overall Study||42
8296192|NCT01580904|20454084|P1|COMPLETED|Overall Study||47
8296193|NCT01580904|20454083|P2|STARTED|Overall Study||49
8296194|NCT01580904|20454084|P1|STARTED|Overall Study||51
8296195|NCT01580670|20454096|P1|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
8296196|NCT01580670|20454096|P1|COMPLETED|Maintenance Period (Week 14 to 54)||12
8296197|NCT01580670|20454096|P1|STARTED|Maintenance Period (Week 14 to 54)||14
8296198|NCT01580670|20454096|P1|NOT COMPLETED|Induction Period (Week 0 to 14)||0
8296199|NCT01580670|20454096|P1|COMPLETED|Induction Period (Week 0 to 14)||14
8296200|NCT01580670|20454096|P1|STARTED|Induction Period (Week 0 to 14)||14
8296201|NCT01580618|20454107|P2|NOT COMPLETED|Overall Study||0
8296202|NCT01580618|20454108|P1|NOT COMPLETED|Overall Study||1
8296203|NCT01580618|20454107|P2|COMPLETED|Overall Study||12
8296204|NCT01580618|20454108|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
8296205|NCT01580618|20454107|P2|STARTED|Overall Study||12
8296206|NCT01580618|20454108|P1|STARTED|Overall Study||8
8296207|NCT01580592|20454124|P3|NOT COMPLETED|Overall Study||0
8296208|NCT01580592|20454125|P2|NOT COMPLETED|Overall Study||0
8296209|NCT01580592|20454126|P1|NOT COMPLETED|Overall Study||0
8296210|NCT01580592|20454124|P3|COMPLETED|Overall Study||12
8296211|NCT01580592|20454125|P2|COMPLETED|Overall Study||9
8296212|NCT01580592|20454126|P1|COMPLETED|Overall Study||10
8296213|NCT01580592|20454124|P3|STARTED|Overall Study||12
8296214|NCT01580592|20454125|P2|STARTED|Overall Study||9
8296215|NCT01580592|20454126|P1|STARTED|Overall Study||10
8296216|NCT01580488|20454137|P1|NOT COMPLETED|Overall Study||1
8296217|NCT01580488|20454137|P1|COMPLETED|Overall Study||23
8296218|NCT01580488|20454137|P1|STARTED|Overall Study||24
8296219|NCT01580423|20454181|P2|NOT COMPLETED|Second Intervention||0
8296220|NCT01580423|20454182|P1|NOT COMPLETED|Second Intervention||0
8296221|NCT01580423|20454181|P2|COMPLETED|Second Intervention||8
8296222|NCT01580423|20454182|P1|COMPLETED|Second Intervention||8
8296223|NCT01580423|20454181|P2|STARTED|Second Intervention||8
8296224|NCT01580423|20454182|P1|STARTED|Second Intervention||8
8296225|NCT01580423|20454181|P2|NOT COMPLETED|First Intervention||0
8296226|NCT01580423|20454182|P1|NOT COMPLETED|First Intervention||0
8296227|NCT01580423|20454181|P2|COMPLETED|First Intervention||8
8296228|NCT01580423|20454182|P1|COMPLETED|First Intervention||8
8296229|NCT01580423|20454181|P2|STARTED|First Intervention||8
8296230|NCT01580423|20454182|P1|STARTED|First Intervention||8
8296231|NCT01580410|20454194|P2|NOT COMPLETED|Overall Study||8
8296232|NCT01580410|20454195|P1|NOT COMPLETED|Overall Study||11
8296233|NCT01580410|20454194|P2|COMPLETED|Overall Study||60
8296234|NCT01580410|20454195|P1|COMPLETED|Overall Study||57
8296235|NCT01580410|20454194|P2|STARTED|Overall Study||68
8296236|NCT01580410|20454195|P1|STARTED|Overall Study||68
8296237|NCT01580306|20454211|P4|NOT COMPLETED|Overall Study||0
8296238|NCT01580306|20454212|P3|NOT COMPLETED|Overall Study||0
8296239|NCT01580306|20454213|P2|NOT COMPLETED|Overall Study||0
8296240|NCT01580306|20454214|P1|NOT COMPLETED|Overall Study||0
8296241|NCT01580306|20454211|P4|COMPLETED|Overall Study||8
8296242|NCT01580306|20454212|P3|COMPLETED|Overall Study||8
8296243|NCT01580306|20454213|P2|COMPLETED|Overall Study||8
8296244|NCT01580306|20454214|P1|COMPLETED|Overall Study||8
8296245|NCT01580306|20454211|P4|STARTED|Overall Study||8
8296246|NCT01580306|20454212|P3|STARTED|Overall Study||8
8296247|NCT01580306|20454213|P2|STARTED|Overall Study||8
8296248|NCT01580306|20454214|P1|STARTED|Overall Study||8
8296249|NCT01580293|20454243|P3|NOT COMPLETED|Part B||2
8296250|NCT01580293|20454244|P2|NOT COMPLETED|Part B||0
8296251|NCT01580293|20454245|P1|NOT COMPLETED|Part B||0
8296252|NCT01580293|20454243|P3|COMPLETED|Part B||17
8296253|NCT01580293|20454244|P2|COMPLETED|Part B||0
8296254|NCT01580293|20454245|P1|COMPLETED|Part B||0
8296255|NCT01580293|20454243|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
8296256|NCT01580293|20454244|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
8296257|NCT01580293|20454245|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
8296258|NCT01580293|20454243|P3|NOT COMPLETED|Part A_Extension||0
8296259|NCT01580293|20454244|P2|NOT COMPLETED|Part A_Extension||12
8296260|NCT01580293|20454245|P1|NOT COMPLETED|Part A_Extension||0
8296261|NCT01580293|20454243|P3|COMPLETED|Part A_Extension||0
8296262|NCT01580293|20454244|P2|COMPLETED|Part A_Extension||95
8296263|NCT01580293|20454245|P1|COMPLETED|Part A_Extension||14
8296264|NCT01580293|20454243|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
8296265|NCT01580293|20454244|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
8296266|NCT01580293|20454245|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
8296267|NCT01580293|20454243|P3|NOT COMPLETED|Part A_Main Trial||0
8296268|NCT01580293|20454244|P2|NOT COMPLETED|Part A_Main Trial||6
8296269|NCT01580293|20454245|P1|NOT COMPLETED|Part A_Main Trial||2
8296270|NCT01580293|20454243|P3|COMPLETED|Part A_Main Trial||0
8296271|NCT01580293|20454244|P2|COMPLETED|Part A_Main Trial||108
8296272|NCT01580293|20454245|P1|COMPLETED|Part A_Main Trial||18
8296273|NCT01580293|20454243|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
8296274|NCT01580293|20454244|P2|STARTED|Part A_Main Trial||114
8296275|NCT01580293|20454245|P1|STARTED|Part A_Main Trial||20
8296276|NCT01580098|20454330|P3|NOT COMPLETED|Overall Study||3
8296277|NCT01580098|20454331|P2|NOT COMPLETED|Overall Study||13
8296278|NCT01580098|20454332|P1|NOT COMPLETED|Overall Study||15
8296279|NCT01580098|20454330|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
8296280|NCT01580098|20454331|P2|COMPLETED|Overall Study||101
8296281|NCT01580098|20454332|P1|COMPLETED|Overall Study||61
8296282|NCT01580098|20454330|P3|STARTED|Overall Study||3
8296283|NCT01580098|20454331|P2|STARTED|Overall Study||114
8296284|NCT01580098|20454332|P1|STARTED|Overall Study||76
8296285|NCT01580072|20454355|P3|NOT COMPLETED|Overall Study||0
8296286|NCT01580072|20454356|P2|NOT COMPLETED|Overall Study||9
8296287|NCT01580072|20454357|P1|NOT COMPLETED|Overall Study||12
8296288|NCT01580072|20454355|P3|COMPLETED|Overall Study||0
8296289|NCT01580072|20454356|P2|COMPLETED|Overall Study||28
8296290|NCT01580072|20454357|P1|COMPLETED|Overall Study||16
8296291|NCT01580072|20454355|P3|STARTED|Overall Study||0
8296292|NCT01580072|20454356|P2|STARTED|Overall Study||37
8296293|NCT01580072|20454357|P1|STARTED|Overall Study||28
8296294|NCT01580020|20454385|P4|NOT COMPLETED|Overall Study||2
8296295|NCT01580020|20454386|P3|NOT COMPLETED|Overall Study||4
8296296|NCT01580020|20454387|P2|NOT COMPLETED|Overall Study||7
8296297|NCT01580020|20454388|P1|NOT COMPLETED|Overall Study||1
8296298|NCT01580020|20454385|P4|COMPLETED|Overall Study||20
8296299|NCT01580020|20454386|P3|COMPLETED|Overall Study||57
8296300|NCT01580020|20454387|P2|COMPLETED|Overall Study||33
8296301|NCT01580020|20454388|P1|COMPLETED|Overall Study||51
8296302|NCT01580020|20454385|P4|STARTED|Overall Study||22
8296303|NCT01580020|20454386|P3|STARTED|Overall Study||61
8296304|NCT01580020|20454387|P2|STARTED|Overall Study||40
8296305|NCT01580020|20454388|P1|STARTED|Overall Study||52
8296306|NCT01579916|20454432|P2|NOT COMPLETED|Overall Study||2
8296307|NCT01579916|20454433|P1|NOT COMPLETED|Overall Study||8
8296308|NCT01579916|20454432|P2|COMPLETED|Overall Study||59
8296309|NCT01579916|20454433|P1|COMPLETED|Overall Study||234
8296310|NCT01579916|20454432|P2|STARTED|Overall Study||61
8296311|NCT01579916|20454433|P1|STARTED|Overall Study||242
8296312|NCT01579812|20454459|P1|NOT COMPLETED|Overall Study||52
8296313|NCT01579812|20454459|P1|COMPLETED|Overall Study||38
8296314|NCT01579812|20454459|P1|STARTED|Overall Study||90
8296315|NCT01579747|20454469|P2|NOT COMPLETED|Overall Study||0
8296316|NCT01579747|20454470|P1|NOT COMPLETED|Overall Study||0
8296317|NCT01579747|20454469|P2|COMPLETED|Overall Study||12
8296318|NCT01579747|20454470|P1|COMPLETED|Overall Study||12
8296319|NCT01579747|20454469|P2|STARTED|Overall Study||12
8296320|NCT01579747|20454470|P1|STARTED|Overall Study||12
8296321|NCT01579669|20454480|P2|NOT COMPLETED|Overall Study||0
8296322|NCT01579669|20454481|P1|NOT COMPLETED|Overall Study||36
8296323|NCT01579669|20454480|P2|COMPLETED|Overall Study||41
8296324|NCT01579669|20454481|P1|COMPLETED|Overall Study||134
8296325|NCT01579669|20454480|P2|STARTED|Overall Study||41
8296326|NCT01579669|20454481|P1|STARTED|Overall Study||170
8296327|NCT01579578|20454493|P2|NOT COMPLETED|Overall Study||12
8296328|NCT01579578|20454494|P1|NOT COMPLETED|Overall Study||13
8296329|NCT01579578|20454493|P2|COMPLETED|Overall Study||0
8296330|NCT01579578|20454494|P1|COMPLETED|Overall Study||0
8296331|NCT01579578|20454493|P2|Ongoing|Overall Study||0
8296332|NCT01579578|20454494|P1|Ongoing|Overall Study||3
8296333|NCT01579578|20454493|P2|STARTED|Overall Study||12
8296334|NCT01579578|20454494|P1|STARTED|Overall Study||13
8296335|NCT01579565|20454506|P2|NOT COMPLETED|Treated||3
8296336|NCT01579565|20454507|P1|NOT COMPLETED|Treated||2
8296337|NCT01579565|20454506|P2|COMPLETED|Treated||201
8296338|NCT01579565|20454507|P1|COMPLETED|Treated||200
8296339|NCT01579565|20454506|P2|STARTED|Treated||204
8296340|NCT01579565|20454507|P1|STARTED|Treated||202
8296341|NCT01579565|20454506|P2|NOT COMPLETED|Randomized||5
8296342|NCT01579565|20454507|P1|NOT COMPLETED|Randomized||5
8296343|NCT01579565|20454506|P2|COMPLETED|Randomized||204
8296344|NCT01579565|20454507|P1|COMPLETED|Randomized||202
8296345|NCT01579565|20454506|P2|STARTED|Randomized||209
8296346|NCT01579565|20454507|P1|STARTED|Randomized||207
8296347|NCT01579513|20454537|P2|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
8296348|NCT01579513|20454538|P1|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
8296349|NCT01579513|20454537|P2|COMPLETED|1 Year Neurodevelopmental Follow up||68
8296350|NCT01579513|20454538|P1|COMPLETED|1 Year Neurodevelopmental Follow up||61
8296351|NCT01579513|20454537|P2|STARTED|1 Year Neurodevelopmental Follow up||95
8296352|NCT01579513|20454538|P1|STARTED|1 Year Neurodevelopmental Follow up||81
8296353|NCT01579513|20454537|P2|NOT COMPLETED|Primary Hospitalization||4
8296354|NCT01579513|20454538|P1|NOT COMPLETED|Primary Hospitalization||10
8296355|NCT01579513|20454537|P2|COMPLETED|Primary Hospitalization||95
8296356|NCT01579513|20454538|P1|COMPLETED|Primary Hospitalization||81
8296357|NCT01579513|20454537|P2|STARTED|Primary Hospitalization||99
8296358|NCT01579513|20454538|P1|STARTED|Primary Hospitalization||91
8296359|NCT01579474|20454558|P6|NOT COMPLETED|Overall Study||1
8296360|NCT01579474|20454559|P5|NOT COMPLETED|Overall Study||1
8296361|NCT01579474|20454560|P4|NOT COMPLETED|Overall Study||0
8296362|NCT01579474|20454561|P3|NOT COMPLETED|Overall Study||2
8296363|NCT01579474|20454562|P2|NOT COMPLETED|Overall Study||13
8296364|NCT01579474|20454563|P1|NOT COMPLETED|Overall Study||3
8296365|NCT01579474|20454558|P6|COMPLETED|Overall Study||1
8296366|NCT01579474|20454559|P5|COMPLETED|Overall Study||9
8296367|NCT01579474|20454560|P4|COMPLETED|Overall Study||3
8296368|NCT01579474|20454561|P3|COMPLETED|Overall Study||27
8296369|NCT01579474|20454562|P2|COMPLETED|Overall Study||30
8296370|NCT01579474|20454563|P1|COMPLETED|Overall Study||41
8296371|NCT01579474|20454558|P6|STARTED|Overall Study||2
8296372|NCT01579474|20454559|P5|STARTED|Overall Study||10
8296373|NCT01579474|20454560|P4|STARTED|Overall Study||3
8296374|NCT01579474|20454561|P3|STARTED|Overall Study||29
8296375|NCT01579474|20454562|P2|STARTED|Overall Study||43
8296376|NCT01579474|20454563|P1|STARTED|Overall Study||44
8296377|NCT01579318|20454637|P1|NOT COMPLETED|Overall Study||1
8296378|NCT01579318|20454637|P1|COMPLETED|Overall Study||1
8296379|NCT01579318|20454637|P1|STARTED|Overall Study||2
8296380|NCT01579305|20454650|P2|NOT COMPLETED|Overall Study||27
8296381|NCT01579305|20454651|P1|NOT COMPLETED|Overall Study||21
8296382|NCT01579305|20454650|P2|COMPLETED|Overall Study||115
8296383|NCT01579305|20454651|P1|COMPLETED|Overall Study||118
8296384|NCT01579305|20454650|P2|Continued After Treatment|Overall Study||141
8296385|NCT01579305|20454651|P1|Continued After Treatment|Overall Study||139
8296386|NCT01579305|20454650|P2|Discontinued Before Treatment|Overall Study||1
8296387|NCT01579305|20454651|P1|Discontinued Before Treatment|Overall Study||0
8296388|NCT01579305|20454650|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
8296389|NCT01579305|20454651|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
8296390|NCT01579214|20454659|P2|NOT COMPLETED|Overall Study||0
8296391|NCT01579214|20454660|P1|NOT COMPLETED|Overall Study||0
8296392|NCT01579214|20454659|P2|COMPLETED|Overall Study||138
8296393|NCT01579214|20454660|P1|COMPLETED|Overall Study||45
8296394|NCT01579214|20454659|P2|STARTED|Overall Study||138
8296395|NCT01579214|20454660|P1|STARTED|Overall Study||45
8296396|NCT01579084|20454678|P10|NOT COMPLETED|Overall Study||0
8296397|NCT01579084|20454679|P9|NOT COMPLETED|Overall Study||0
8296398|NCT01579084|20454680|P8|NOT COMPLETED|Overall Study||0
8296399|NCT01579084|20454681|P7|NOT COMPLETED|Overall Study||0
8296400|NCT01579084|20454682|P6|NOT COMPLETED|Overall Study||0
8296401|NCT01579084|20454683|P5|NOT COMPLETED|Overall Study||0
8296402|NCT01579084|20454684|P4|NOT COMPLETED|Overall Study||0
8296403|NCT01579084|20454685|P3|NOT COMPLETED|Overall Study||0
8296404|NCT01579084|20454686|P2|NOT COMPLETED|Overall Study||0
8296405|NCT01579084|20454687|P1|NOT COMPLETED|Overall Study||0
8296406|NCT01579084|20454678|P10|COMPLETED|Overall Study||4
8296407|NCT01579084|20454679|P9|COMPLETED|Overall Study||4
8296408|NCT01579084|20454680|P8|COMPLETED|Overall Study||4
8296409|NCT01579084|20454681|P7|COMPLETED|Overall Study||4
8296410|NCT01579084|20454682|P6|COMPLETED|Overall Study||8
8296411|NCT01579084|20454683|P5|COMPLETED|Overall Study||8
8296412|NCT01579084|20454684|P4|COMPLETED|Overall Study||8
8296413|NCT01579084|20454685|P3|COMPLETED|Overall Study||8
8296414|NCT01579084|20454686|P2|COMPLETED|Overall Study||8
8296415|NCT01579084|20454687|P1|COMPLETED|Overall Study||8
8296416|NCT01579084|20454678|P10|STARTED|Overall Study||4
8296417|NCT01579084|20454679|P9|STARTED|Overall Study||4
8296418|NCT01579084|20454680|P8|STARTED|Overall Study||4
8296419|NCT01579084|20454681|P7|STARTED|Overall Study||4
8296420|NCT01579084|20454682|P6|STARTED|Overall Study||8
8296421|NCT01579084|20454683|P5|STARTED|Overall Study||8
8296422|NCT01579084|20454684|P4|STARTED|Overall Study||8
8296423|NCT01579084|20454685|P3|STARTED|Overall Study||8
8296424|NCT01579084|20454686|P2|STARTED|Overall Study||8
8296425|NCT01579084|20454687|P1|STARTED|Overall Study||8
8296426|NCT01579045|20454715|P1|NOT COMPLETED|Overall Study||0
8296427|NCT01579045|20454715|P1|COMPLETED|Overall Study||24
8296428|NCT01579045|20454715|P1|STARTED|Overall Study||24
8296429|NCT01579006|20454732|P1|NOT COMPLETED|Overall Study||33
8296430|NCT01579006|20454732|P1|COMPLETED|Overall Study||151
8296431|NCT01579006|20454732|P1|STARTED|Overall Study||184
8296432|NCT01578993|20454771|P1|NOT COMPLETED|Overall Study||0
8296433|NCT01578993|20454771|P1|COMPLETED|Overall Study||101
8296434|NCT01578993|20454771|P1|STARTED|Overall Study||101
8296435|NCT01578980|20454775|P1|NOT COMPLETED|Overall Study||0
8296436|NCT01578980|20454775|P1|COMPLETED|Overall Study||20
8296437|NCT01578980|20454775|P1|STARTED|Overall Study||20
8296438|NCT01578967|20454780|P1|NOT COMPLETED|Overall Study||0
8296439|NCT01578967|20454780|P1|COMPLETED|Overall Study||41
8296440|NCT01578967|20454780|P1|STARTED|Overall Study||41
8296441|NCT01578902|20454789|P1|NOT COMPLETED|Overall Study||0
8296442|NCT01578902|20454789|P1|COMPLETED|Overall Study||84
8296443|NCT01578902|20454789|P1|STARTED|Overall Study||84
8296444|NCT01578850|20454800|P3|NOT COMPLETED|Period 2||14
8296445|NCT01578850|20454801|P2|NOT COMPLETED|Period 2||13
8296446|NCT01578850|20454802|P1|NOT COMPLETED|Period 2||0
8296447|NCT01578850|20454800|P3|COMPLETED|Period 2||162
8296448|NCT01578850|20454801|P2|COMPLETED|Period 2||154
8296449|NCT01578850|20454802|P1|COMPLETED|Period 2||0
8296450|NCT01578850|20454800|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
8296451|NCT01578850|20454801|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
8296452|NCT01578850|20454802|P1|STARTED|Period 2||0
8296453|NCT01578850|20454800|P3|NOT COMPLETED|Period 1||0
8296454|NCT01578850|20454801|P2|NOT COMPLETED|Period 1||0
8296455|NCT01578850|20454802|P1|NOT COMPLETED|Period 1||37
8296456|NCT01578850|20454800|P3|COMPLETED|Period 1||0
8296457|NCT01578850|20454801|P2|COMPLETED|Period 1||0
8296458|NCT01578850|20454802|P1|COMPLETED|Period 1||452
8296459|NCT01578850|20454800|P3|STARTED|Period 1||0
8296460|NCT01578850|20454801|P2|STARTED|Period 1||0
8296461|NCT01578850|20454802|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
8296462|NCT01578785|20454854|P2|NOT COMPLETED|Overall Study||119
8296463|NCT01578785|20454855|P1|NOT COMPLETED|Overall Study||59
8296464|NCT01578785|20454854|P2|COMPLETED|Overall Study||0
8296465|NCT01578785|20454855|P1|COMPLETED|Overall Study||0
8296466|NCT01578785|20454854|P2|STARTED|Overall Study||119
8296467|NCT01578785|20454855|P1|STARTED|Overall Study||59
8296468|NCT01578772|20454867|P1|NOT COMPLETED|Overall Study||0
8296469|NCT01578772|20454867|P1|COMPLETED|Overall Study||17
8296470|NCT01578772|20454867|P1|STARTED|Overall Study||17
8296471|NCT01578707|20454876|P2|NOT COMPLETED|Overall Study||0
8296472|NCT01578707|20454877|P1|NOT COMPLETED|Overall Study||0
8296473|NCT01578707|20454876|P2|COMPLETED|Overall Study||195
8296474|NCT01578707|20454877|P1|COMPLETED|Overall Study||196
8296475|NCT01578707|20454876|P2|STARTED|Overall Study||195
8296476|NCT01578707|20454877|P1|STARTED|Overall Study||196
8296477|NCT01578577|20454896|P3|NOT COMPLETED|Overall Study||35
8296478|NCT01578577|20454897|P2|NOT COMPLETED|Overall Study||40
8296479|NCT01578577|20454898|P1|NOT COMPLETED|Overall Study||51
8296480|NCT01578577|20454896|P3|COMPLETED|Overall Study||278
8296481|NCT01578577|20454897|P2|COMPLETED|Overall Study||262
8296482|NCT01578577|20454898|P1|COMPLETED|Overall Study||254
8296483|NCT01578577|20454896|P3|STARTED|Overall Study||313
8296484|NCT01578577|20454897|P2|STARTED|Overall Study||302
8296485|NCT01578577|20454898|P1|STARTED|Overall Study||305
8296486|NCT01578551|20454920|P2|NOT COMPLETED|Overall Study||0
8296487|NCT01578551|20454921|P1|NOT COMPLETED|Overall Study||1
8296488|NCT01578551|20454920|P2|COMPLETED|Overall Study||6
8296489|NCT01578551|20454921|P1|COMPLETED|Overall Study||18
8296490|NCT01578551|20454920|P2|STARTED|Overall Study||6
8296491|NCT01578551|20454921|P1|STARTED|Overall Study||19
8296492|NCT01578499|20454933|P2|NOT COMPLETED|Overall Study||43
8296493|NCT01578499|20454934|P1|NOT COMPLETED|Overall Study||34
8296494|NCT01578499|20454933|P2|COMPLETED|Overall Study||22
8296495|NCT01578499|20454934|P1|COMPLETED|Overall Study||32
8296496|NCT01578499|20454933|P2|Intent to Treat Population: CD30+|Overall Study||64
8296497|NCT01578499|20454934|P1|Intent to Treat Population: CD30+|Overall Study||64
8296498|NCT01578499|20454933|P2|Safety Population: Treated|Overall Study||62
8296499|NCT01578499|20454934|P1|Safety Population: Treated|Overall Study||66
8296500|NCT01578499|20454933|P2|STARTED|Overall Study||65
8296501|NCT01578499|20454934|P1|STARTED|Overall Study||66
8296502|NCT01578486|20454968|P1|NOT COMPLETED|Overall Study||5
8296503|NCT01578486|20454968|P1|COMPLETED|Overall Study||8
8296504|NCT01578486|20454968|P1|STARTED|Overall Study||13
8296505|NCT01578330|20454979|P1|NOT COMPLETED|Overall Study||7
8296506|NCT01578330|20454979|P1|COMPLETED|Overall Study||35
8296507|NCT01578330|20454979|P1|Per Protocol Population|Overall Study||35
8296508|NCT01578330|20454979|P1|STARTED|Overall Study||42
8296509|NCT01578317|20454988|P2|NOT COMPLETED|Overall Study||1
8296510|NCT01578317|20454989|P1|NOT COMPLETED|Overall Study||0
8296511|NCT01578317|20454988|P2|COMPLETED|Overall Study||20
8296512|NCT01578317|20454989|P1|COMPLETED|Overall Study||22
8296513|NCT01578317|20454988|P2|Analysis Population|Overall Study||20
8296514|NCT01578317|20454989|P1|Analysis Population|Overall Study||22
8296515|NCT01578317|20454988|P2|STARTED|Overall Study||21
8296516|NCT01578317|20454989|P1|STARTED|Overall Study||22
8296517|NCT01578278|20454999|P4|NOT COMPLETED|Overall Study||9
8296518|NCT01578278|20455000|P3|NOT COMPLETED|Overall Study||4
8296519|NCT01578278|20455001|P2|NOT COMPLETED|Overall Study||2
8296520|NCT01578278|20455002|P1|NOT COMPLETED|Overall Study||4
8296521|NCT01578278|20454999|P4|COMPLETED|Overall Study||139
8296522|NCT01578278|20455000|P3|COMPLETED|Overall Study||150
8296523|NCT01578278|20455001|P2|COMPLETED|Overall Study||150
8296524|NCT01578278|20455002|P1|COMPLETED|Overall Study||148
8296525|NCT01578278|20454999|P4|STARTED|Overall Study||148
8296526|NCT01578278|20455000|P3|STARTED|Overall Study||154
8296527|NCT01578278|20455001|P2|STARTED|Overall Study||152
8296528|NCT01578278|20455002|P1|STARTED|Overall Study||152
8296529|NCT01578239|20455014|P2|NOT COMPLETED|Overall Study||25
8296530|NCT01578239|20455015|P1|NOT COMPLETED|Overall Study||22
8296531|NCT01578239|20455014|P2|COMPLETED|Overall Study||88
8296532|NCT01578239|20455015|P1|COMPLETED|Overall Study||94
8296533|NCT01578239|20455014|P2|STARTED|Overall Study||113
8296534|NCT01578239|20455015|P1|STARTED|Overall Study||116
8296535|NCT01578187|20455021|P1|NOT COMPLETED|Usability Phase||1
8296536|NCT01578187|20455021|P1|COMPLETED|Usability Phase||47
8296537|NCT01578187|20455021|P1|STARTED|Usability Phase||48
8296538|NCT01578187|20455021|P1|NOT COMPLETED|Label Comprehension Phase||0
8296539|NCT01578187|20455021|P1|COMPLETED|Label Comprehension Phase||63
8296540|NCT01578187|20455021|P1|STARTED|Label Comprehension Phase||63
8296541|NCT01578044|20455029|P2|NOT COMPLETED|Overall Study||0
8296542|NCT01578044|20455030|P1|NOT COMPLETED|Overall Study||0
8296543|NCT01578044|20455029|P2|COMPLETED|Overall Study||6
8296544|NCT01578044|20455030|P1|COMPLETED|Overall Study||6
8296545|NCT01578044|20455029|P2|STARTED|Overall Study||6
8296546|NCT01578044|20455030|P1|STARTED|Overall Study||6
8296547|NCT01578031|20455040|P4|NOT COMPLETED|Overall Study||0
8296548|NCT01578031|20455041|P3|NOT COMPLETED|Overall Study||0
8296549|NCT01578031|20455042|P2|NOT COMPLETED|Overall Study||34
8296550|NCT01578031|20455043|P1|NOT COMPLETED|Overall Study||62
8296551|NCT01578031|20455040|P4|COMPLETED|Overall Study|Only baseline data collected|30
8296552|NCT01578031|20455041|P3|COMPLETED|Overall Study|Only baseline data collected|12
8296553|NCT01578031|20455042|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
8296554|NCT01578031|20455043|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
8296555|NCT01578031|20455040|P4|STARTED|Overall Study||30
8296556|NCT01578031|20455041|P3|STARTED|Overall Study||12
8296557|NCT01578031|20455042|P2|STARTED|Overall Study||69
8296558|NCT01578031|20455043|P1|STARTED|Overall Study||129
8296559|NCT01577966|20455059|P1|NOT COMPLETED|Overall Study||0
8296560|NCT01577966|20455059|P1|COMPLETED|Overall Study||9
8296561|NCT01577966|20455059|P1|STARTED|Overall Study||9
8296562|NCT01577758|20455063|P8|NOT COMPLETED|mCRC Expansion Phase||25
8296563|NCT01577758|20455064|P7|NOT COMPLETED|mCRC Expansion Phase||0
8296564|NCT01577758|20455065|P6|NOT COMPLETED|mCRC Expansion Phase||0
8296565|NCT01577758|20455066|P5|NOT COMPLETED|mCRC Expansion Phase||0
8296566|NCT01577758|20455067|P4|NOT COMPLETED|mCRC Expansion Phase||0
8296567|NCT01577758|20455068|P3|NOT COMPLETED|mCRC Expansion Phase||0
8296568|NCT01577758|20455069|P2|NOT COMPLETED|mCRC Expansion Phase||0
8296569|NCT01577758|20455070|P1|NOT COMPLETED|mCRC Expansion Phase||0
8296570|NCT01577758|20455063|P8|COMPLETED|mCRC Expansion Phase||0
8296571|NCT01577758|20455064|P7|COMPLETED|mCRC Expansion Phase||0
8296572|NCT01577758|20455065|P6|COMPLETED|mCRC Expansion Phase||0
8296573|NCT01577758|20455066|P5|COMPLETED|mCRC Expansion Phase||0
8296574|NCT01577758|20455067|P4|COMPLETED|mCRC Expansion Phase||0
8296575|NCT01577758|20455068|P3|COMPLETED|mCRC Expansion Phase||0
8296576|NCT01577758|20455069|P2|COMPLETED|mCRC Expansion Phase||0
8296577|NCT01577758|20455070|P1|COMPLETED|mCRC Expansion Phase||0
8296578|NCT01577758|20455063|P8|STARTED|mCRC Expansion Phase||25
8296579|NCT01577758|20455064|P7|STARTED|mCRC Expansion Phase||0
8296580|NCT01577758|20455065|P6|STARTED|mCRC Expansion Phase||0
8296581|NCT01577758|20455066|P5|STARTED|mCRC Expansion Phase||0
8296582|NCT01577758|20455067|P4|STARTED|mCRC Expansion Phase||0
8296583|NCT01577758|20455068|P3|STARTED|mCRC Expansion Phase||0
8296584|NCT01577758|20455069|P2|STARTED|mCRC Expansion Phase||0
8296585|NCT01577758|20455070|P1|STARTED|mCRC Expansion Phase||0
8296586|NCT01577758|20455063|P8|NOT COMPLETED|Dose Escalation Phase||0
8296587|NCT01577758|20455064|P7|NOT COMPLETED|Dose Escalation Phase||1
8296588|NCT01577758|20455065|P6|NOT COMPLETED|Dose Escalation Phase||4
8296589|NCT01577758|20455066|P5|NOT COMPLETED|Dose Escalation Phase||6
8296590|NCT01577758|20455067|P4|NOT COMPLETED|Dose Escalation Phase||2
8296591|NCT01577758|20455068|P3|NOT COMPLETED|Dose Escalation Phase||2
8296592|NCT01577758|20455069|P2|NOT COMPLETED|Dose Escalation Phase||2
8296593|NCT01577758|20455070|P1|NOT COMPLETED|Dose Escalation Phase||2
8296594|NCT01577758|20455063|P8|COMPLETED|Dose Escalation Phase||0
8296595|NCT01577758|20455064|P7|COMPLETED|Dose Escalation Phase||0
8296596|NCT01577758|20455065|P6|COMPLETED|Dose Escalation Phase||0
8296597|NCT01577758|20455066|P5|COMPLETED|Dose Escalation Phase||0
8296598|NCT01577758|20455067|P4|COMPLETED|Dose Escalation Phase||0
8296599|NCT01577758|20455068|P3|COMPLETED|Dose Escalation Phase||0
8296600|NCT01577758|20455069|P2|COMPLETED|Dose Escalation Phase||0
8296601|NCT01577758|20455070|P1|COMPLETED|Dose Escalation Phase||0
8296602|NCT01577758|20455063|P8|STARTED|Dose Escalation Phase||0
8296603|NCT01577758|20455064|P7|STARTED|Dose Escalation Phase||1
8296604|NCT01577758|20455065|P6|STARTED|Dose Escalation Phase||4
8296605|NCT01577758|20455066|P5|STARTED|Dose Escalation Phase||6
8296606|NCT01577758|20455067|P4|STARTED|Dose Escalation Phase||2
8296607|NCT01577758|20455068|P3|STARTED|Dose Escalation Phase||2
8296608|NCT01577758|20455069|P2|STARTED|Dose Escalation Phase||2
8296609|NCT01577758|20455070|P1|STARTED|Dose Escalation Phase||2
8296610|NCT01577745|20455109|P6|NOT COMPLETED|Overall Study||4
8296611|NCT01577745|20455110|P5|NOT COMPLETED|Overall Study||5
8296612|NCT01577745|20455111|P4|NOT COMPLETED|Overall Study||6
8296613|NCT01577745|20455112|P3|NOT COMPLETED|Overall Study||2
8296614|NCT01577745|20455113|P2|NOT COMPLETED|Overall Study||3
8296615|NCT01577745|20455114|P1|NOT COMPLETED|Overall Study||3
8296616|NCT01577745|20455109|P6|COMPLETED|Overall Study||1
8296617|NCT01577745|20455110|P5|COMPLETED|Overall Study||0
8296618|NCT01577745|20455111|P4|COMPLETED|Overall Study||0
8296619|NCT01577745|20455112|P3|COMPLETED|Overall Study||1
8296620|NCT01577745|20455113|P2|COMPLETED|Overall Study||0
8296621|NCT01577745|20455114|P1|COMPLETED|Overall Study||0
8296622|NCT01577745|20455109|P6|STARTED|Overall Study||5
8296623|NCT01577745|20455110|P5|STARTED|Overall Study||5
8296624|NCT01577745|20455111|P4|STARTED|Overall Study||6
8296625|NCT01577745|20455112|P3|STARTED|Overall Study||3
8296626|NCT01577745|20455113|P2|STARTED|Overall Study||3
8296627|NCT01577745|20455114|P1|STARTED|Overall Study||3
8296628|NCT01577732|20455231|P1|NOT COMPLETED|Overall Study||0
8296629|NCT01577732|20455231|P1|COMPLETED|Overall Study||300
8296630|NCT01577732|20455231|P1|STARTED|Overall Study||300
8296631|NCT01577706|20455238|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8296632|NCT01577706|20455239|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8296633|NCT01577706|20455240|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8296634|NCT01577706|20455238|P3|COMPLETED|Third Intervention (1 Day)||3
8296635|NCT01577706|20455239|P2|COMPLETED|Third Intervention (1 Day)||1
8296636|NCT01577706|20455240|P1|COMPLETED|Third Intervention (1 Day)||3
8296637|NCT01577706|20455238|P3|STARTED|Third Intervention (1 Day)||3
8296638|NCT01577706|20455239|P2|STARTED|Third Intervention (1 Day)||1
8296639|NCT01577706|20455240|P1|STARTED|Third Intervention (1 Day)||3
8296640|NCT01577706|20455238|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
8296641|NCT01577706|20455239|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
8296642|NCT01577706|20455240|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
8296643|NCT01577706|20455238|P3|COMPLETED|Washout (at Least 1 Week)||3
8296644|NCT01577706|20455239|P2|COMPLETED|Washout (at Least 1 Week)||1
8296645|NCT01577706|20455240|P1|COMPLETED|Washout (at Least 1 Week)||3
8296646|NCT01577706|20455238|P3|STARTED|Washout (at Least 1 Week)||3
8296647|NCT01577706|20455239|P2|STARTED|Washout (at Least 1 Week)||1
8296648|NCT01577706|20455240|P1|STARTED|Washout (at Least 1 Week)||3
8296649|NCT01577706|20455238|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8296650|NCT01577706|20455239|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8296651|NCT01577706|20455240|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8296652|NCT01577706|20455238|P3|COMPLETED|Second Intervention (1 Day)||3
8296653|NCT01577706|20455239|P2|COMPLETED|Second Intervention (1 Day)||1
8296654|NCT01577706|20455240|P1|COMPLETED|Second Intervention (1 Day)||3
8296655|NCT01577706|20455238|P3|STARTED|Second Intervention (1 Day)||3
8296656|NCT01577706|20455239|P2|STARTED|Second Intervention (1 Day)||1
8296657|NCT01577706|20455240|P1|STARTED|Second Intervention (1 Day)||3
8296658|NCT01577706|20455238|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
8296659|NCT01577706|20455239|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
8296660|NCT01577706|20455240|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
8296661|NCT01577706|20455238|P3|COMPLETED|Washout (at Least 1 Week)||3
8296662|NCT01577706|20455239|P2|COMPLETED|Washout (at Least 1 Week)||1
8296663|NCT01577706|20455240|P1|COMPLETED|Washout (at Least 1 Week)||3
8296664|NCT01577706|20455238|P3|STARTED|Washout (at Least 1 Week)||3
8296665|NCT01577706|20455239|P2|STARTED|Washout (at Least 1 Week)||1
8296666|NCT01577706|20455240|P1|STARTED|Washout (at Least 1 Week)||3
8296667|NCT01577706|20455238|P3|NOT COMPLETED|First Intervention (1 Day)||0
8296668|NCT01577706|20455239|P2|NOT COMPLETED|First Intervention (1 Day)||0
8296669|NCT01577706|20455240|P1|NOT COMPLETED|First Intervention (1 Day)||0
8296670|NCT01577706|20455238|P3|COMPLETED|First Intervention (1 Day)||3
8296671|NCT01577706|20455239|P2|COMPLETED|First Intervention (1 Day)||1
8296672|NCT01577706|20455240|P1|COMPLETED|First Intervention (1 Day)||3
8296673|NCT01577706|20455238|P3|STARTED|First Intervention (1 Day)||3
8296674|NCT01577706|20455239|P2|STARTED|First Intervention (1 Day)||1
8296675|NCT01577706|20455240|P1|STARTED|First Intervention (1 Day)||3
8296676|NCT01577628|20455268|P3|NOT COMPLETED|Overall Study||2
8296677|NCT01577628|20455269|P2|NOT COMPLETED|Overall Study||0
8296678|NCT01577628|20455270|P1|NOT COMPLETED|Overall Study||0
8296679|NCT01577628|20455268|P3|COMPLETED|Overall Study||0
8296680|NCT01577628|20455269|P2|COMPLETED|Overall Study||0
8296681|NCT01577628|20455270|P1|COMPLETED|Overall Study||0
8296682|NCT01577628|20455268|P3|STARTED|Overall Study||2
8296683|NCT01577628|20455269|P2|STARTED|Overall Study||0
8296684|NCT01577628|20455270|P1|STARTED|Overall Study||0
8296685|NCT01577537|20455296|P2|NOT COMPLETED|Overall Study||7
8296686|NCT01577537|20455297|P1|NOT COMPLETED|Overall Study||8
8296687|NCT01577537|20455296|P2|COMPLETED|Overall Study||116
8296688|NCT01577537|20455297|P1|COMPLETED|Overall Study||120
8296689|NCT01577537|20455296|P2|STARTED|Overall Study||123
8296690|NCT01577537|20455297|P1|STARTED|Overall Study||128
8296691|NCT01577381|20455315|P4|NOT COMPLETED|Overall Study||2
8296692|NCT01577381|20455316|P3|NOT COMPLETED|Overall Study||3
8296693|NCT01577381|20455317|P2|NOT COMPLETED|Overall Study||3
8296694|NCT01577381|20455318|P1|NOT COMPLETED|Overall Study||2
8296695|NCT01577381|20455315|P4|COMPLETED|Overall Study||0
8296696|NCT01577381|20455316|P3|COMPLETED|Overall Study||0
8296697|NCT01577381|20455317|P2|COMPLETED|Overall Study||0
8296698|NCT01577381|20455318|P1|COMPLETED|Overall Study||0
8296699|NCT01577381|20455315|P4|STARTED|Overall Study||2
8296700|NCT01577381|20455316|P3|STARTED|Overall Study||3
8296701|NCT01577381|20455317|P2|STARTED|Overall Study||3
8296702|NCT01577381|20455318|P1|STARTED|Overall Study||2
8296703|NCT01577329|20455449|P2|NOT COMPLETED|Overall Study||0
8296704|NCT01577329|20455450|P1|NOT COMPLETED|Overall Study||3
8296705|NCT01577329|20455449|P2|COMPLETED|Overall Study||22
8296706|NCT01577329|20455450|P1|COMPLETED|Overall Study||16
8296707|NCT01577329|20455449|P2|STARTED|Overall Study||22
8296708|NCT01577329|20455450|P1|STARTED|Overall Study||19
8296709|NCT01577238|20455458|P2|NOT COMPLETED|Overall Study||12
8296710|NCT01577238|20455459|P1|NOT COMPLETED|Overall Study||10
8296711|NCT01577238|20455458|P2|COMPLETED|Overall Study||111
8296712|NCT01577238|20455459|P1|COMPLETED|Overall Study||117
8296713|NCT01577238|20455458|P2|STARTED|Overall Study||123
8296714|NCT01577238|20455459|P1|STARTED|Overall Study||127
8296715|NCT01577186|20455473|P1|NOT COMPLETED|Overall Study||130
8296716|NCT01577186|20455473|P1|COMPLETED|Overall Study||350
8296717|NCT01577186|20455473|P1|STARTED|Overall Study||480
8296718|NCT01577160|20455481|P1|NOT COMPLETED|Overall Study||98
8296719|NCT01577160|20455481|P1|COMPLETED|Overall Study||255
8296720|NCT01577160|20455481|P1|STARTED|Overall Study||353
8296721|NCT01577108|20455491|P2|NOT COMPLETED|Overall Study||6
8296722|NCT01577108|20455492|P1|NOT COMPLETED|Overall Study||5
8296723|NCT01577108|20455491|P2|COMPLETED|Overall Study||50
8296724|NCT01577108|20455492|P1|COMPLETED|Overall Study||49
8296725|NCT01577108|20455491|P2|STARTED|Overall Study||56
8296726|NCT01577108|20455492|P1|STARTED|Overall Study||54
8296727|NCT01576952|20455500|P2|NOT COMPLETED|Overall Study||55
8296728|NCT01576952|20455501|P1|NOT COMPLETED|Overall Study||41
8296729|NCT01576952|20455500|P2|COMPLETED|Overall Study||33
8296730|NCT01576952|20455501|P1|COMPLETED|Overall Study||139
8296731|NCT01576952|20455500|P2|mITT Population|Overall Study||85
8296732|NCT01576952|20455501|P1|mITT Population|Overall Study||168
8296733|NCT01576952|20455500|P2|Safety Population|Overall Study||85
8296734|NCT01576952|20455501|P1|Safety Population|Overall Study||169
8296735|NCT01576952|20455500|P2|STARTED|Overall Study||88
8296736|NCT01576952|20455501|P1|STARTED|Overall Study||180
8296737|NCT01576939|20455507|P1|NOT COMPLETED|Overall Study||0
8296738|NCT01576939|20455507|P1|COMPLETED|Overall Study||30
8296739|NCT01576939|20455507|P1|STARTED|Overall Study||30
8296740|NCT01576874|20455517|P2|NOT COMPLETED|Overall Study||0
8296741|NCT01576874|20455518|P1|NOT COMPLETED|Overall Study||0
8296742|NCT01576874|20455517|P2|COMPLETED|Overall Study||72
8296743|NCT01576874|20455518|P1|COMPLETED|Overall Study||72
8296744|NCT01576874|20455517|P2|STARTED|Overall Study||72
8296745|NCT01576874|20455518|P1|STARTED|Overall Study||72
8296746|NCT01576809|20455528|P1|NOT COMPLETED|Overall Study||0
8296747|NCT01576809|20455528|P1|COMPLETED|Overall Study||51
8296748|NCT01576809|20455528|P1|STARTED|Overall Study||51
8296755|NCT01576718|20455563|P7|NOT COMPLETED|Treatment Period||30
8296756|NCT01576718|20455564|P6|NOT COMPLETED|Treatment Period||48
8296757|NCT01576718|20455565|P5|NOT COMPLETED|Treatment Period||27
8296758|NCT01576718|20455566|P4|NOT COMPLETED|Treatment Period||31
8296759|NCT01576718|20455567|P3|NOT COMPLETED|Treatment Period||20
8296760|NCT01576718|20455568|P2|NOT COMPLETED|Treatment Period||25
8296761|NCT01576718|20455569|P1|NOT COMPLETED|Treatment Period||0
8296762|NCT01576718|20455563|P7|COMPLETED|Treatment Period||77
8296763|NCT01576718|20455564|P6|COMPLETED|Treatment Period||58
8296764|NCT01576718|20455565|P5|COMPLETED|Treatment Period||80
8296765|NCT01576718|20455566|P4|COMPLETED|Treatment Period||75
8296766|NCT01576718|20455567|P3|COMPLETED|Treatment Period||87
8296767|NCT01576718|20455568|P2|COMPLETED|Treatment Period||82
8296768|NCT01576718|20455569|P1|COMPLETED|Treatment Period||0
8296769|NCT01576718|20455563|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
8296770|NCT01576718|20455564|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
8296771|NCT01576718|20455565|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
8296772|NCT01576718|20455566|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
8296773|NCT01576718|20455567|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
8296774|NCT01576718|20455568|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
8296775|NCT01576718|20455569|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
8296776|NCT01576718|20455563|P7|Safety Population|Treatment Period||106
8296777|NCT01576718|20455564|P6|Safety Population|Treatment Period||106
8296778|NCT01576718|20455565|P5|Safety Population|Treatment Period||107
8296779|NCT01576718|20455566|P4|Safety Population|Treatment Period||106
8296780|NCT01576718|20455567|P3|Safety Population|Treatment Period||107
8296781|NCT01576718|20455568|P2|Safety Population|Treatment Period||107
8296782|NCT01576718|20455569|P1|Safety Population|Treatment Period||0
8296783|NCT01576718|20455563|P7|STARTED|Treatment Period||107
8296784|NCT01576718|20455564|P6|STARTED|Treatment Period||106
8296785|NCT01576718|20455565|P5|STARTED|Treatment Period||107
8296786|NCT01576718|20455566|P4|STARTED|Treatment Period||106
8296787|NCT01576718|20455567|P3|STARTED|Treatment Period||107
8296788|NCT01576718|20455568|P2|STARTED|Treatment Period||107
8296789|NCT01576718|20455569|P1|STARTED|Treatment Period||0
8296790|NCT01576718|20455563|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296791|NCT01576718|20455564|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296792|NCT01576718|20455565|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296793|NCT01576718|20455566|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296794|NCT01576718|20455567|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296795|NCT01576718|20455568|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296796|NCT01576718|20455569|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
8296797|NCT01576718|20455563|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296798|NCT01576718|20455564|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296799|NCT01576718|20455565|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296800|NCT01576718|20455566|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296801|NCT01576718|20455567|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296802|NCT01576718|20455568|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296803|NCT01576718|20455569|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
8296804|NCT01576718|20455563|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296805|NCT01576718|20455564|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296806|NCT01576718|20455565|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296807|NCT01576718|20455566|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296808|NCT01576718|20455567|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296809|NCT01576718|20455568|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296810|NCT01576718|20455569|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
8296811|NCT01576705|20455665|P4|NOT COMPLETED|Overall Study||3
8296812|NCT01576705|20455666|P3|NOT COMPLETED|Overall Study||5
8296813|NCT01576705|20455667|P2|NOT COMPLETED|Overall Study||8
8296814|NCT01576705|20455668|P1|NOT COMPLETED|Overall Study||3
8296815|NCT01576705|20455665|P4|COMPLETED|Overall Study||41
8296816|NCT01576705|20455666|P3|COMPLETED|Overall Study||38
8296817|NCT01576705|20455667|P2|COMPLETED|Overall Study||37
8296818|NCT01576705|20455668|P1|COMPLETED|Overall Study||40
8296819|NCT01576705|20455665|P4|STARTED|Overall Study||44
8296820|NCT01576705|20455666|P3|STARTED|Overall Study||43
8296821|NCT01576705|20455667|P2|STARTED|Overall Study||45
8296822|NCT01576705|20455668|P1|STARTED|Overall Study||43
8296823|NCT01576588|20455682|P1|NOT COMPLETED|Overall Study||2
8296824|NCT01576588|20455682|P1|COMPLETED|Overall Study||23
8296825|NCT01576588|20455682|P1|STARTED|Overall Study||25
8296826|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine + Ketoconazole||0
8296827|NCT01576575|20455689|P1|COMPLETED|Buprenorphine + Ketoconazole||14
8296828|NCT01576575|20455689|P1|STARTED|Buprenorphine + Ketoconazole||14
8296829|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine + Grapefruit||1
8296830|NCT01576575|20455689|P1|COMPLETED|Buprenorphine + Grapefruit||14
8296831|NCT01576575|20455689|P1|STARTED|Buprenorphine + Grapefruit||15
8296832|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine + Rifampin||3
8296833|NCT01576575|20455689|P1|COMPLETED|Buprenorphine + Rifampin||15
8296834|NCT01576575|20455689|P1|STARTED|Buprenorphine + Rifampin||18
8296835|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine Control||3
8296836|NCT01576575|20455689|P1|COMPLETED|Buprenorphine Control||18
8296837|NCT01576575|20455689|P1|STARTED|Buprenorphine Control||21
8296838|NCT01576549|20455699|P1|NOT COMPLETED|Overall Study||2
8296839|NCT01576549|20455699|P1|COMPLETED|Overall Study||0
8296840|NCT01576549|20455699|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
8296841|NCT01576549|20455699|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8296842|NCT01576549|20455699|P1|STARTED|Overall Study||2
8296843|NCT01576536|20455707|P1|NOT COMPLETED|Overall Study||0
8296844|NCT01576536|20455707|P1|COMPLETED|Overall Study||117
8296845|NCT01576536|20455707|P1|STARTED|Overall Study||117
8296846|NCT01576484|20455715|P2|NOT COMPLETED|Overall Study||19
8296847|NCT01576484|20455716|P1|NOT COMPLETED|Overall Study||5
8296848|NCT01576484|20455715|P2|COMPLETED|Overall Study||27
8296849|NCT01576484|20455716|P1|COMPLETED|Overall Study||7
8296850|NCT01576484|20455715|P2|STARTED|Overall Study||46
8296851|NCT01576484|20455716|P1|STARTED|Overall Study||12
8296852|NCT01576471|20455782|P2|NOT COMPLETED|Overall Study||9
8296853|NCT01576471|20455783|P1|NOT COMPLETED|Overall Study||8
8296854|NCT01576471|20455782|P2|COMPLETED|Overall Study||116
8296855|NCT01576471|20455783|P1|COMPLETED|Overall Study||117
8296856|NCT01576471|20455782|P2|STARTED|Overall Study||125
8296857|NCT01576471|20455783|P1|STARTED|Overall Study||125
8296858|NCT01576406|20455795|P6|NOT COMPLETED|Overall Study||12
8296859|NCT01576406|20455796|P5|NOT COMPLETED|Overall Study||8
8296860|NCT01576406|20455797|P4|NOT COMPLETED|Overall Study||9
8296861|NCT01576406|20455798|P3|NOT COMPLETED|Overall Study||16
8296862|NCT01576406|20455799|P2|NOT COMPLETED|Overall Study||8
8296863|NCT01576406|20455800|P1|NOT COMPLETED|Overall Study||6
8296864|NCT01576406|20455795|P6|COMPLETED|Overall Study||4
8296865|NCT01576406|20455796|P5|COMPLETED|Overall Study||8
8296866|NCT01576406|20455797|P4|COMPLETED|Overall Study||1
8296867|NCT01576406|20455798|P3|COMPLETED|Overall Study||4
8296868|NCT01576406|20455799|P2|COMPLETED|Overall Study||7
8296869|NCT01576406|20455800|P1|COMPLETED|Overall Study||5
8296870|NCT01576406|20455795|P6|STARTED|Overall Study||16
8296871|NCT01576406|20455796|P5|STARTED|Overall Study||16
8296872|NCT01576406|20455797|P4|STARTED|Overall Study||10
8296873|NCT01576406|20455798|P3|STARTED|Overall Study||20
8296874|NCT01576406|20455799|P2|STARTED|Overall Study||15
8296875|NCT01576406|20455800|P1|STARTED|Overall Study||11
8296876|NCT01576367|20456048|P1|NOT COMPLETED|Overall Study||3
8296877|NCT01576367|20456048|P1|COMPLETED|Overall Study||14
8296878|NCT01576367|20456048|P1|STARTED|Overall Study||17
8296879|NCT01576341|20456056|P1|NOT COMPLETED|Overall Study||93
8296880|NCT01576341|20456056|P1|COMPLETED|Overall Study||324
8296881|NCT01576341|20456056|P1|STARTED|Overall Study||417
8296882|NCT01576276|20456065|P2|NOT COMPLETED|Overall Study||11
8296883|NCT01576276|20456066|P1|NOT COMPLETED|Overall Study||8
8296884|NCT01576276|20456065|P2|COMPLETED|Overall Study||18
8296885|NCT01576276|20456066|P1|COMPLETED|Overall Study||14
8296886|NCT01576276|20456065|P2|STARTED|Overall Study||29
8296887|NCT01576276|20456066|P1|STARTED|Overall Study||22
8296888|NCT01576172|20456075|P2|NOT COMPLETED|Overall Study||1
8296889|NCT01576172|20456076|P1|NOT COMPLETED|Overall Study||5
8296890|NCT01576172|20456075|P2|COMPLETED|Overall Study||79
8296891|NCT01576172|20456076|P1|COMPLETED|Overall Study||74
8296892|NCT01576172|20456075|P2|STARTED|Overall Study||80
8296893|NCT01576172|20456076|P1|STARTED|Overall Study||79
8296894|NCT01576159|20456094|P4|NOT COMPLETED|Overall Study||1
8296895|NCT01576159|20456095|P3|NOT COMPLETED|Overall Study||1
8296896|NCT01576159|20456096|P2|NOT COMPLETED|Overall Study||1
8296897|NCT01576159|20456097|P1|NOT COMPLETED|Overall Study||1
8296898|NCT01576159|20456094|P4|COMPLETED|Overall Study||11
8296899|NCT01576159|20456095|P3|COMPLETED|Overall Study||11
8296900|NCT01576159|20456096|P2|COMPLETED|Overall Study||11
8296901|NCT01576159|20456097|P1|COMPLETED|Overall Study||11
8296902|NCT01576159|20456094|P4|STARTED|Overall Study||12
8296903|NCT01576159|20456095|P3|STARTED|Overall Study||12
8296904|NCT01576159|20456096|P2|STARTED|Overall Study||12
8296905|NCT01576159|20456097|P1|STARTED|Overall Study||12
8296906|NCT01576146|20456115|P1|NOT COMPLETED|Extension Period 2||17
8296907|NCT01576146|20456115|P1|COMPLETED|Extension Period 2||0
8296908|NCT01576146|20456115|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
8296909|NCT01576146|20456115|P1|NOT COMPLETED|Extension Period 1||10
8296910|NCT01576146|20456115|P1|COMPLETED|Extension Period 1||20
8296911|NCT01576146|20456115|P1|STARTED|Extension Period 1||30
8296912|NCT01576120|20456124|P2|NOT COMPLETED|Overall Study||0
8296913|NCT01576120|20456125|P1|NOT COMPLETED|Overall Study||0
8296914|NCT01576120|20456124|P2|COMPLETED|Overall Study||19
8296915|NCT01576120|20456125|P1|COMPLETED|Overall Study||21
8296916|NCT01576120|20456124|P2|STARTED|Overall Study||19
8296917|NCT01576120|20456125|P1|STARTED|Overall Study||21
8296918|NCT01576055|20456133|P2|NOT COMPLETED|Overall Study||6
8296919|NCT01576055|20456134|P1|NOT COMPLETED|Overall Study||19
8296920|NCT01576055|20456133|P2|COMPLETED|Overall Study||64
8296921|NCT01576055|20456134|P1|COMPLETED|Overall Study||178
8296922|NCT01576055|20456133|P2|STARTED|Overall Study||70
8296923|NCT01576055|20456134|P1|STARTED|Overall Study||197
8296924|NCT01576042|20456148|P2|NOT COMPLETED|Overall Study||0
8296925|NCT01576042|20456149|P1|NOT COMPLETED|Overall Study||2
8296926|NCT01576042|20456148|P2|COMPLETED|Overall Study||14
8296927|NCT01576042|20456149|P1|COMPLETED|Overall Study||11
8296928|NCT01576042|20456148|P2|Switched to the Other Arm|Overall Study||1
8296929|NCT01576042|20456149|P1|Switched to the Other Arm|Overall Study||5
8296930|NCT01576042|20456148|P2|STARTED|Overall Study||14
8296931|NCT01576042|20456149|P1|STARTED|Overall Study||13
8296932|NCT01576016|20456171|P2|NOT COMPLETED|MRI Safety||74
8296933|NCT01576016|20456172|P1|NOT COMPLETED|MRI Safety||0
8296934|NCT01576016|20456171|P2|COMPLETED|MRI Safety||181
8296935|NCT01576016|20456172|P1|COMPLETED|MRI Safety||0
8296936|NCT01576016|20456171|P2|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
8296937|NCT01576016|20456172|P1|STARTED|MRI Safety||0
8296938|NCT01576016|20456171|P2|NOT COMPLETED|Lead Safety||0
8296939|NCT01576016|20456172|P1|NOT COMPLETED|Lead Safety||273
8296940|NCT01576016|20456171|P2|COMPLETED|Lead Safety||0
8296941|NCT01576016|20456172|P1|COMPLETED|Lead Safety||647
8296942|NCT01576016|20456171|P2|STARTED|Lead Safety||0
8296943|NCT01576016|20456172|P1|STARTED|Lead Safety||920
8296944|NCT01576003|20456191|P3|NOT COMPLETED|Overall Study||0
8296945|NCT01576003|20456192|P2|NOT COMPLETED|Overall Study||2
8296946|NCT01576003|20456193|P1|NOT COMPLETED|Overall Study||1
8296947|NCT01576003|20456191|P3|COMPLETED|Overall Study||4
8296948|NCT01576003|20456192|P2|COMPLETED|Overall Study||1
8296949|NCT01576003|20456193|P1|COMPLETED|Overall Study||1
8296950|NCT01576003|20456191|P3|STARTED|Overall Study||4
8296951|NCT01576003|20456192|P2|STARTED|Overall Study||3
8296952|NCT01576003|20456193|P1|STARTED|Overall Study||2
8296953|NCT01575912|20456211|P3|NOT COMPLETED|Overall Study||0
8296954|NCT01575912|20456212|P2|NOT COMPLETED|Overall Study||0
8296955|NCT01575912|20456213|P1|NOT COMPLETED|Overall Study||0
8296956|NCT01575912|20456211|P3|COMPLETED|Overall Study||30
8296957|NCT01575912|20456212|P2|COMPLETED|Overall Study||32
8296958|NCT01575912|20456213|P1|COMPLETED|Overall Study||30
8296959|NCT01575912|20456211|P3|STARTED|Overall Study||30
8296960|NCT01575912|20456212|P2|STARTED|Overall Study||32
8296961|NCT01575912|20456213|P1|STARTED|Overall Study||30
8296962|NCT01575899|20456224|P3|NOT COMPLETED|Overall Study||2
8296963|NCT01575899|20456225|P2|NOT COMPLETED|Overall Study||5
8296964|NCT01575899|20456226|P1|NOT COMPLETED|Overall Study||5
8296965|NCT01575899|20456224|P3|COMPLETED|Overall Study||60
8296966|NCT01575899|20456225|P2|COMPLETED|Overall Study||68
8296967|NCT01575899|20456226|P1|COMPLETED|Overall Study||68
8296968|NCT01575899|20456224|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
8296969|NCT01575899|20456225|P2|STARTED|Overall Study||73
8296970|NCT01575899|20456226|P1|STARTED|Overall Study||73
8296971|NCT01575873|20456240|P4|NOT COMPLETED|Overall Study||67
8296972|NCT01575873|20456241|P3|NOT COMPLETED|Overall Study||74
8296973|NCT01575873|20456242|P2|NOT COMPLETED|Overall Study||36
8296974|NCT01575873|20456243|P1|NOT COMPLETED|Overall Study||28
8296975|NCT01575873|20456240|P4|COMPLETED|Overall Study||186
8296976|NCT01575873|20456241|P3|COMPLETED|Overall Study||178
8296977|NCT01575873|20456242|P2|COMPLETED|Overall Study||109
8296978|NCT01575873|20456243|P1|COMPLETED|Overall Study||117
8296979|NCT01575873|20456240|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
8296980|NCT01575873|20456241|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
8296981|NCT01575873|20456242|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
8296982|NCT01575873|20456243|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
8296983|NCT01575873|20456240|P4|STARTED|Overall Study||253
8296984|NCT01575873|20456241|P3|STARTED|Overall Study||252
8296985|NCT01575873|20456242|P2|STARTED|Overall Study||145
8296986|NCT01575873|20456243|P1|STARTED|Overall Study||145
8296987|NCT01575860|20456267|P1|NOT COMPLETED|Overall Study||2
8296988|NCT01575860|20456267|P1|COMPLETED|Overall Study||6
8296989|NCT01575860|20456267|P1|STARTED|Overall Study||8
8296990|NCT01575834|20456275|P2|NOT COMPLETED|Overall Study||738
8296991|NCT01575834|20456276|P1|NOT COMPLETED|Overall Study||699
8296992|NCT01575834|20456275|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
8296993|NCT01575834|20456276|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
8296994|NCT01575834|20456275|P2|Completed 24-month Study Period|Overall Study||2994
8296995|NCT01575834|20456276|P1|Completed 24-month Study Period|Overall Study||3032
8296996|NCT01575834|20456275|P2|Completed Double-blind Period|Overall Study||3185
8296997|NCT01575834|20456276|P1|Completed Double-blind Period|Overall Study||3205
8296998|NCT01575834|20456275|P2|Received Double-blind Treatment|Overall Study||3575
8296999|NCT01575834|20456276|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
8297000|NCT01575834|20456275|P2|STARTED|Overall Study||3589
8297001|NCT01575834|20456276|P1|STARTED|Overall Study||3591
8297002|NCT01575808|20456328|P2|NOT COMPLETED|Overall Study||0
8297003|NCT01575808|20456329|P1|NOT COMPLETED|Overall Study||3
8297004|NCT01575808|20456328|P2|COMPLETED|Overall Study||68
8297005|NCT01575808|20456329|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
8297006|NCT01575808|20456328|P2|STARTED|Overall Study||68
8297007|NCT01575808|20456329|P1|STARTED|Overall Study||103
8297008|NCT01575769|20456376|P1|NOT COMPLETED|Overall Study||41
8297009|NCT01575769|20456376|P1|COMPLETED|Overall Study||0
8297010|NCT01575769|20456376|P1|STARTED|Overall Study||41
8297011|NCT01575756|20456402|P2|NOT COMPLETED|Treatment Period 2||0
8297012|NCT01575756|20456403|P1|NOT COMPLETED|Treatment Period 2||0
8297013|NCT01575756|20456402|P2|COMPLETED|Treatment Period 2||11
8297014|NCT01575756|20456403|P1|COMPLETED|Treatment Period 2||11
8297015|NCT01575756|20456402|P2|STARTED|Treatment Period 2||11
8297016|NCT01575756|20456403|P1|STARTED|Treatment Period 2||11
8297017|NCT01575756|20456402|P2|NOT COMPLETED|Treatment Period 1||0
8297018|NCT01575756|20456403|P1|NOT COMPLETED|Treatment Period 1||0
8297019|NCT01575756|20456402|P2|COMPLETED|Treatment Period 1||11
8297020|NCT01575756|20456403|P1|COMPLETED|Treatment Period 1||11
8297021|NCT01575756|20456402|P2|STARTED|Treatment Period 1||11
8297022|NCT01575756|20456403|P1|STARTED|Treatment Period 1||11
8297023|NCT01575561|20456434|P1|NOT COMPLETED|Overall Study||39
8297024|NCT01575561|20456434|P1|COMPLETED|Overall Study||338
8297025|NCT01575561|20456434|P1|STARTED|Overall Study||377
8297026|NCT01575522|20456446|P1|NOT COMPLETED|Overall Study||0
8297027|NCT01575522|20456446|P1|COMPLETED|Overall Study||22
8297028|NCT01575522|20456446|P1|STARTED|Overall Study||22
8297029|NCT01575275|20456454|P1|NOT COMPLETED|Overall Study||0
8297030|NCT01575275|20456454|P1|COMPLETED|Overall Study||8
8297031|NCT01575275|20456454|P1|STARTED|Overall Study||8
8297032|NCT01575197|20456464|P3|NOT COMPLETED|Overall Study||6
8297033|NCT01575197|20456465|P2|NOT COMPLETED|Overall Study||9
8297034|NCT01575197|20456466|P1|NOT COMPLETED|Overall Study||3
8297035|NCT01575197|20456464|P3|COMPLETED|Overall Study||146
8297036|NCT01575197|20456465|P2|COMPLETED|Overall Study||143
8297037|NCT01575197|20456466|P1|COMPLETED|Overall Study||149
8297038|NCT01575197|20456464|P3|STARTED|Overall Study||152
8297039|NCT01575197|20456465|P2|STARTED|Overall Study||152
8297040|NCT01575197|20456466|P1|STARTED|Overall Study||152
8297041|NCT01575106|20456479|P1|NOT COMPLETED|Overall Study||14
8297042|NCT01575106|20456479|P1|COMPLETED|Overall Study||24
8297043|NCT01575106|20456479|P1|STARTED|Overall Study||38
8297044|NCT01575080|20456485|P1|NOT COMPLETED|Overall Study||0
8297045|NCT01575080|20456485|P1|COMPLETED|Overall Study||102
8297046|NCT01575080|20456485|P1|STARTED|Overall Study||102
8297047|NCT01575054|20456494|P2|NOT COMPLETED|Overall Study||26
8297048|NCT01575054|20456495|P1|NOT COMPLETED|Overall Study||29
8297049|NCT01575054|20456494|P2|COMPLETED|Overall Study||209
8297050|NCT01575054|20456495|P1|COMPLETED|Overall Study||204
8297051|NCT01575054|20456494|P2|STARTED|Overall Study||235
8297052|NCT01575054|20456495|P1|STARTED|Overall Study||233
8297053|NCT01575028|20456511|P2|NOT COMPLETED|Overall Study||1
8297054|NCT01575028|20456512|P1|NOT COMPLETED|Overall Study||0
8297055|NCT01575028|20456511|P2|COMPLETED|Overall Study||0
8297056|NCT01575028|20456512|P1|COMPLETED|Overall Study||2
8297057|NCT01575028|20456511|P2|STARTED|Overall Study||1
8297058|NCT01575028|20456512|P1|STARTED|Overall Study||2
8297059|NCT01574807|20456518|P2|NOT COMPLETED|Second Appointment||0
8297060|NCT01574807|20456519|P1|NOT COMPLETED|Second Appointment||0
8297061|NCT01574807|20456518|P2|COMPLETED|Second Appointment||50
8297062|NCT01574807|20456519|P1|COMPLETED|Second Appointment||50
8297063|NCT01574807|20456518|P2|STARTED|Second Appointment||50
8297064|NCT01574807|20456519|P1|STARTED|Second Appointment||50
8297065|NCT01574807|20456518|P2|NOT COMPLETED|Wash Out Period 2 Weeks||0
8297066|NCT01574807|20456519|P1|NOT COMPLETED|Wash Out Period 2 Weeks||0
8297067|NCT01574807|20456518|P2|COMPLETED|Wash Out Period 2 Weeks||50
8297068|NCT01574807|20456519|P1|COMPLETED|Wash Out Period 2 Weeks||50
8297069|NCT01574807|20456518|P2|STARTED|Wash Out Period 2 Weeks||50
8297070|NCT01574807|20456519|P1|STARTED|Wash Out Period 2 Weeks||50
8297071|NCT01574807|20456518|P2|NOT COMPLETED|First Appointment||0
8297072|NCT01574807|20456519|P1|NOT COMPLETED|First Appointment||0
8297073|NCT01574807|20456518|P2|COMPLETED|First Appointment||50
8297074|NCT01574807|20456519|P1|COMPLETED|First Appointment||50
8297075|NCT01574807|20456518|P2|STARTED|First Appointment||50
8297076|NCT01574807|20456519|P1|STARTED|First Appointment||50
8297077|NCT01574716|20456529|P5|NOT COMPLETED|Part 2||70
8297078|NCT01574716|20456530|P4|NOT COMPLETED|Part 2||137
8297079|NCT01574716|20456531|P3|NOT COMPLETED|Part 2||0
8297080|NCT01574716|20456532|P2|NOT COMPLETED|Part 2||0
8297081|NCT01574716|20456533|P1|NOT COMPLETED|Part 2||0
8297082|NCT01574716|20456529|P5|COMPLETED|Part 2||0
8297083|NCT01574716|20456530|P4|COMPLETED|Part 2||2
8297084|NCT01574716|20456531|P3|COMPLETED|Part 2||0
8297085|NCT01574716|20456532|P2|COMPLETED|Part 2||0
8297086|NCT01574716|20456533|P1|COMPLETED|Part 2||0
8297087|NCT01574716|20456529|P5|Treated Participants|Part 2||67
8297088|NCT01574716|20456530|P4|Treated Participants|Part 2||140
8297089|NCT01574716|20456531|P3|Treated Participants|Part 2||0
8297090|NCT01574716|20456532|P2|Treated Participants|Part 2||0
8297091|NCT01574716|20456533|P1|Treated Participants|Part 2||0
8297092|NCT01574716|20456529|P5|STARTED|Part 2||70
8297093|NCT01574716|20456530|P4|STARTED|Part 2||139
8297094|NCT01574716|20456531|P3|STARTED|Part 2||0
8297095|NCT01574716|20456532|P2|STARTED|Part 2||0
8297096|NCT01574716|20456533|P1|STARTED|Part 2||0
8297097|NCT01574716|20456529|P5|NOT COMPLETED|Part 1||0
8297098|NCT01574716|20456530|P4|NOT COMPLETED|Part 1||0
8297099|NCT01574716|20456531|P3|NOT COMPLETED|Part 1||9
8297100|NCT01574716|20456532|P2|NOT COMPLETED|Part 1||4
8297101|NCT01574716|20456533|P1|NOT COMPLETED|Part 1||3
8297102|NCT01574716|20456529|P5|COMPLETED|Part 1||0
8297103|NCT01574716|20456530|P4|COMPLETED|Part 1||0
8297104|NCT01574716|20456531|P3|COMPLETED|Part 1||0
8297105|NCT01574716|20456532|P2|COMPLETED|Part 1||0
8297106|NCT01574716|20456533|P1|COMPLETED|Part 1||0
8297107|NCT01574716|20456529|P5|STARTED|Part 1||0
8297108|NCT01574716|20456530|P4|STARTED|Part 1||0
8297109|NCT01574716|20456531|P3|STARTED|Part 1||9
8297110|NCT01574716|20456532|P2|STARTED|Part 1||4
8297111|NCT01574716|20456533|P1|STARTED|Part 1||3
8297112|NCT01574703|20456556|P4|NOT COMPLETED|Overall Study||114
8297113|NCT01574703|20456557|P3|NOT COMPLETED|Overall Study||105
8297114|NCT01574703|20456558|P2|NOT COMPLETED|Overall Study||112
8297115|NCT01574703|20456559|P1|NOT COMPLETED|Overall Study||125
8297116|NCT01574703|20456556|P4|COMPLETED|Overall Study||1007
8297117|NCT01574703|20456557|P3|COMPLETED|Overall Study||1011
8297118|NCT01574703|20456558|P2|COMPLETED|Overall Study||1054
8297119|NCT01574703|20456559|P1|COMPLETED|Overall Study||1067
8297120|NCT01574703|20456556|P4|STARTED|Overall Study||1121
8297121|NCT01574703|20456557|P3|STARTED|Overall Study||1116
8297122|NCT01574703|20456558|P2|STARTED|Overall Study||1166
8297123|NCT01574703|20456559|P1|STARTED|Overall Study||1192
8297124|NCT01574651|20456603|P2|NOT COMPLETED|Overall Study||52
8297125|NCT01574651|20456604|P1|NOT COMPLETED|Overall Study||61
8297126|NCT01574651|20456603|P2|COMPLETED|Overall Study||406
8297127|NCT01574651|20456604|P1|COMPLETED|Overall Study||415
8297128|NCT01574651|20456603|P2|Per Protocol Set (PPS)|Overall Study||374
8297129|NCT01574651|20456604|P1|Per Protocol Set (PPS)|Overall Study||373
8297130|NCT01574651|20456603|P2|Full Analysis Set (FAS)|Overall Study||458
8297131|NCT01574651|20456604|P1|Full Analysis Set (FAS)|Overall Study||476
8297132|NCT01574651|20456603|P2|STARTED|Overall Study||458
8297133|NCT01574651|20456604|P1|STARTED|Overall Study||476
8297134|NCT01574612|20456626|P1|NOT COMPLETED|Overall Study||8
8297135|NCT01574612|20456626|P1|COMPLETED|Overall Study||46
8297136|NCT01574612|20456626|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
8297137|NCT01574352|20456632|P2|NOT COMPLETED|Overall Study||13
8297138|NCT01574352|20456633|P1|NOT COMPLETED|Overall Study||7
8297139|NCT01574352|20456632|P2|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
8297140|NCT01574352|20456633|P1|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
8297141|NCT01574352|20456632|P2|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
8297142|NCT01574352|20456633|P1|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
8297143|NCT01574326|20456645|P2|NOT COMPLETED|Overall Study||19
8297144|NCT01574326|20456646|P1|NOT COMPLETED|Overall Study||16
8297145|NCT01574326|20456645|P2|COMPLETED|Overall Study||31
8297146|NCT01574326|20456646|P1|COMPLETED|Overall Study||35
8297147|NCT01574326|20456645|P2|Treated|Overall Study||49
8297148|NCT01574326|20456646|P1|Treated|Overall Study||51
8297149|NCT01574326|20456645|P2|STARTED|Overall Study||50
8297150|NCT01574326|20456646|P1|STARTED|Overall Study||51
8297151|NCT01574287|20456657|P1|NOT COMPLETED|Overall Study||0
8297152|NCT01574287|20456657|P1|COMPLETED|Overall Study||4
8297153|NCT01574287|20456657|P1|STARTED|Overall Study||4
8297154|NCT01574248|20456664|P2|NOT COMPLETED|Overall Study||0
8297155|NCT01574248|20456665|P1|NOT COMPLETED|Overall Study||3
8297156|NCT01574248|20456664|P2|COMPLETED|Overall Study||18
8297157|NCT01574248|20456665|P1|COMPLETED|Overall Study||12
8297158|NCT01574248|20456664|P2|STARTED|Overall Study||18
8297159|NCT01574248|20456665|P1|STARTED|Overall Study||15
8297160|NCT01574183|20456685|P2|NOT COMPLETED|Overall Study||18
8297161|NCT01574183|20456686|P1|NOT COMPLETED|Overall Study||27
8297162|NCT01574183|20456685|P2|COMPLETED|Overall Study||17
8297163|NCT01574183|20456686|P1|COMPLETED|Overall Study||14
8297164|NCT01574183|20456685|P2|STARTED|Overall Study||35
8297165|NCT01574183|20456686|P1|STARTED|Overall Study||41
8297166|NCT01574157|20456698|P2|NOT COMPLETED|Overall Study||8
8297167|NCT01574157|20456699|P1|NOT COMPLETED|Overall Study||4
8297168|NCT01574157|20456698|P2|COMPLETED|Overall Study||31
8297169|NCT01574157|20456699|P1|COMPLETED|Overall Study||31
8297170|NCT01574157|20456698|P2|Month 3|Overall Study||33
8297171|NCT01574157|20456699|P1|Month 3|Overall Study||31
8297172|NCT01574157|20456698|P2|STARTED|Overall Study||39
8297173|NCT01574157|20456699|P1|STARTED|Overall Study||35
8297174|NCT01574144|20456715|P1|NOT COMPLETED|Overall Study||0
8297175|NCT01574144|20456715|P1|COMPLETED|Overall Study||70
8297176|NCT01574144|20456715|P1|STARTED|Overall Study||70
8297177|NCT01574105|20456722|P2|NOT COMPLETED|Overall Study||0
8297178|NCT01574105|20456723|P1|NOT COMPLETED|Overall Study||0
8297179|NCT01574105|20456722|P2|COMPLETED|Overall Study||37
8297180|NCT01574105|20456723|P1|COMPLETED|Overall Study||29
8297181|NCT01574105|20456722|P2|STARTED|Overall Study||37
8297182|NCT01574105|20456723|P1|STARTED|Overall Study||29
8297183|NCT01574079|20456733|P2|NOT COMPLETED|Overall Study||2
8297184|NCT01574079|20456734|P1|NOT COMPLETED|Overall Study||1
8297185|NCT01574079|20456733|P2|COMPLETED|Overall Study||13
8297186|NCT01574079|20456734|P1|COMPLETED|Overall Study||17
8297187|NCT01574079|20456733|P2|STARTED|Overall Study||15
8297188|NCT01574079|20456734|P1|STARTED|Overall Study||18
8297189|NCT01573949|20456744|P1|NOT COMPLETED|Overall Study||0
8297190|NCT01573949|20456744|P1|COMPLETED|Overall Study||7
8297191|NCT01573949|20456744|P1|STARTED|Overall Study||7
8297192|NCT01573910|20456753|P2|NOT COMPLETED|Overall Study||17
8297193|NCT01573910|20456754|P1|NOT COMPLETED|Overall Study||20
8297194|NCT01573910|20456753|P2|COMPLETED|Overall Study||476
8297195|NCT01573910|20456754|P1|COMPLETED|Overall Study||469
8297196|NCT01573910|20456753|P2|STARTED|Overall Study||493
8297197|NCT01573910|20456754|P1|STARTED|Overall Study||489
8297198|NCT01573767|20456766|P4|NOT COMPLETED|Overall Study||24
8297199|NCT01573767|20456767|P3|NOT COMPLETED|Overall Study||14
8297200|NCT01573767|20456768|P2|NOT COMPLETED|Overall Study||21
8297201|NCT01573767|20456769|P1|NOT COMPLETED|Overall Study||22
8297202|NCT01573767|20456766|P4|COMPLETED|Overall Study||90
8297203|NCT01573767|20456767|P3|COMPLETED|Overall Study||99
8297204|NCT01573767|20456768|P2|COMPLETED|Overall Study||93
8297205|NCT01573767|20456769|P1|COMPLETED|Overall Study||93
8297206|NCT01573767|20456766|P4|STARTED|Overall Study||114
8297207|NCT01573767|20456767|P3|STARTED|Overall Study||113
8297208|NCT01573767|20456768|P2|STARTED|Overall Study||114
8297209|NCT01573767|20456769|P1|STARTED|Overall Study||115
8297210|NCT01573702|20456803|P1|NOT COMPLETED|Overall Study||0
8297211|NCT01573702|20456803|P1|COMPLETED|Overall Study||25
8297212|NCT01573702|20456803|P1|STARTED|Overall Study||25
8297213|NCT01573624|20456811|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297214|NCT01573624|20456812|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
8297215|NCT01573624|20456813|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
8297216|NCT01573624|20456814|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297217|NCT01573624|20456815|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297218|NCT01573624|20456816|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297219|NCT01573624|20456817|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
8297220|NCT01573624|20456811|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
8297221|NCT01573624|20456812|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
8297222|NCT01573624|20456813|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
8297223|NCT01573624|20456814|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
8297224|NCT01573624|20456815|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
8297225|NCT01573624|20456816|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
8297226|NCT01573624|20456817|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
8297227|NCT01573624|20456811|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
8297228|NCT01573624|20456812|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
8297229|NCT01573624|20456813|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
8297230|NCT01573624|20456814|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
8297231|NCT01573624|20456815|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
8297232|NCT01573624|20456816|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
8297233|NCT01573624|20456817|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
8297234|NCT01573624|20456811|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
8297235|NCT01573624|20456812|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
8297236|NCT01573624|20456813|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
8297237|NCT01573624|20456814|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
8297238|NCT01573624|20456815|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
8297239|NCT01573624|20456816|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
8297240|NCT01573624|20456817|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
8297241|NCT01573624|20456811|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
8297242|NCT01573624|20456812|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
8297243|NCT01573624|20456813|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
8297244|NCT01573624|20456814|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
8297245|NCT01573624|20456815|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
8297246|NCT01573624|20456816|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
8297247|NCT01573624|20456817|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
8297248|NCT01573624|20456811|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
8297249|NCT01573624|20456812|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
8297250|NCT01573624|20456813|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
8297251|NCT01573624|20456814|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
8297252|NCT01573624|20456815|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
8297253|NCT01573624|20456816|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
8297254|NCT01573624|20456817|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
8297255|NCT01573624|20456811|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
8297256|NCT01573624|20456812|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8297257|NCT01573624|20456813|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
8297258|NCT01573624|20456814|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8297259|NCT01573624|20456815|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8297260|NCT01573624|20456816|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
8297516|NCT01572792|20457215|P2|NOT COMPLETED|Extension Study||29
8297261|NCT01573624|20456817|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
8297262|NCT01573624|20456811|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
8297263|NCT01573624|20456812|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
8297264|NCT01573624|20456813|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
8297265|NCT01573624|20456814|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
8297266|NCT01573624|20456815|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
8297267|NCT01573624|20456816|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
8297268|NCT01573624|20456817|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
8297269|NCT01573624|20456811|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
8297270|NCT01573624|20456812|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
8297271|NCT01573624|20456813|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
8297272|NCT01573624|20456814|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
8297273|NCT01573624|20456815|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
8297274|NCT01573624|20456816|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
8297275|NCT01573624|20456817|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
8297276|NCT01573624|20456811|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
8297277|NCT01573624|20456812|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
8297278|NCT01573624|20456813|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
8297279|NCT01573624|20456814|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
8297280|NCT01573624|20456815|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
8297281|NCT01573624|20456816|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
8297282|NCT01573624|20456817|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
8297283|NCT01573624|20456811|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
8297284|NCT01573624|20456812|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
8297285|NCT01573624|20456813|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
8297286|NCT01573624|20456814|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
8297287|NCT01573624|20456815|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
8297288|NCT01573624|20456816|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
8297289|NCT01573624|20456817|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
8297290|NCT01573624|20456811|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
8297291|NCT01573624|20456812|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
8297292|NCT01573624|20456813|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
8297293|NCT01573624|20456814|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
8297294|NCT01573624|20456815|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
8297295|NCT01573624|20456816|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
8297296|NCT01573624|20456817|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
8297297|NCT01573624|20456811|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
8297298|NCT01573624|20456812|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
8297299|NCT01573624|20456813|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
8297300|NCT01573624|20456814|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
8297301|NCT01573624|20456815|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
8297302|NCT01573624|20456816|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
8297303|NCT01573624|20456817|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
8297304|NCT01573624|20456811|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
8297305|NCT01573624|20456812|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
8297306|NCT01573624|20456813|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
8297307|NCT01573624|20456814|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
8297308|NCT01573624|20456815|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
8297309|NCT01573624|20456816|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
8297310|NCT01573624|20456817|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
8297311|NCT01573624|20456811|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
8297312|NCT01573624|20456812|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
8297313|NCT01573624|20456813|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
8297314|NCT01573624|20456814|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
8297315|NCT01573624|20456815|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
8297316|NCT01573624|20456816|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
8297317|NCT01573624|20456817|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
8297318|NCT01573624|20456811|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8297319|NCT01573624|20456812|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
8297320|NCT01573624|20456813|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8297321|NCT01573624|20456814|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8297322|NCT01573624|20456815|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
8297323|NCT01573624|20456816|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
8297324|NCT01573624|20456817|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
8297325|NCT01573624|20456811|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
8297326|NCT01573624|20456812|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
8297327|NCT01573624|20456813|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
8297328|NCT01573624|20456814|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
8297329|NCT01573624|20456815|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
8297330|NCT01573624|20456816|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
8297331|NCT01573624|20456817|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
8297332|NCT01573624|20456811|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
8297333|NCT01573624|20456812|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
8297334|NCT01573624|20456813|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
8297335|NCT01573624|20456814|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
8297336|NCT01573624|20456815|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
8297337|NCT01573624|20456816|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
8297338|NCT01573624|20456817|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
8297339|NCT01573572|20456864|P1|NOT COMPLETED|Overall Study||28
8297340|NCT01573572|20456864|P1|COMPLETED|Overall Study||103
8297341|NCT01573572|20456864|P1|STARTED|Overall Study||131
8297342|NCT01573533|20456868|P1|NOT COMPLETED|Overall Study||0
8297343|NCT01573533|20456868|P1|COMPLETED|Overall Study||9
8297344|NCT01573533|20456868|P1|STARTED|Overall Study||9
8297345|NCT01573442|20456877|P2|NOT COMPLETED|Overall Study||10
8297346|NCT01573442|20456878|P1|NOT COMPLETED|Overall Study||9
8297347|NCT01573442|20456877|P2|COMPLETED|Overall Study||104
8297348|NCT01573442|20456878|P1|COMPLETED|Overall Study||104
8297349|NCT01573442|20456877|P2|STARTED|Overall Study||114
8297350|NCT01573442|20456878|P1|STARTED|Overall Study||113
8297351|NCT01573325|20456914|P1|NOT COMPLETED|Overall Study||0
8297352|NCT01573325|20456914|P1|COMPLETED|Overall Study||50
8297353|NCT01573325|20456914|P1|STARTED|Overall Study||50
8297354|NCT01573273|20456923|P12|NOT COMPLETED|MRI 2||0
8297355|NCT01573273|20456924|P11|NOT COMPLETED|MRI 2||0
8297356|NCT01573273|20456925|P10|NOT COMPLETED|MRI 2||0
8297357|NCT01573273|20456926|P9|NOT COMPLETED|MRI 2||0
8297358|NCT01573273|20456927|P8|NOT COMPLETED|MRI 2||0
8297359|NCT01573273|20456928|P7|NOT COMPLETED|MRI 2||0
8297360|NCT01573273|20456929|P6|NOT COMPLETED|MRI 2||0
8297361|NCT01573273|20456930|P5|NOT COMPLETED|MRI 2||0
8297362|NCT01573273|20456931|P4|NOT COMPLETED|MRI 2||0
8297363|NCT01573273|20456932|P3|NOT COMPLETED|MRI 2||0
8297364|NCT01573273|20456933|P2|NOT COMPLETED|MRI 2||0
8297365|NCT01573273|20456934|P1|NOT COMPLETED|MRI 2||0
8297366|NCT01573273|20456923|P12|COMPLETED|MRI 2||28
8297367|NCT01573273|20456924|P11|COMPLETED|MRI 2||27
8297368|NCT01573273|20456925|P10|COMPLETED|MRI 2||0
8297369|NCT01573273|20456926|P9|COMPLETED|MRI 2||0
8297370|NCT01573273|20456927|P8|COMPLETED|MRI 2||0
8297371|NCT01573273|20456928|P7|COMPLETED|MRI 2||0
8297372|NCT01573273|20456929|P6|COMPLETED|MRI 2||18
8297373|NCT01573273|20456930|P5|COMPLETED|MRI 2||23
8297374|NCT01573273|20456931|P4|COMPLETED|MRI 2||0
8297375|NCT01573273|20456932|P3|COMPLETED|MRI 2||0
8297376|NCT01573273|20456933|P2|COMPLETED|MRI 2||0
8297377|NCT01573273|20456934|P1|COMPLETED|MRI 2||0
8297378|NCT01573273|20456923|P12|STARTED|MRI 2||28
8297379|NCT01573273|20456924|P11|STARTED|MRI 2||27
8297380|NCT01573273|20456925|P10|STARTED|MRI 2||0
8297381|NCT01573273|20456926|P9|STARTED|MRI 2||0
8297382|NCT01573273|20456927|P8|STARTED|MRI 2||0
8297383|NCT01573273|20456928|P7|STARTED|MRI 2||0
8297384|NCT01573273|20456929|P6|STARTED|MRI 2||18
8297385|NCT01573273|20456930|P5|STARTED|MRI 2||23
8297386|NCT01573273|20456931|P4|STARTED|MRI 2||0
8297387|NCT01573273|20456932|P3|STARTED|MRI 2||0
8297388|NCT01573273|20456933|P2|STARTED|MRI 2||0
8297389|NCT01573273|20456934|P1|STARTED|MRI 2||0
8297390|NCT01573273|20456923|P12|NOT COMPLETED|MRI 1||0
8297391|NCT01573273|20456924|P11|NOT COMPLETED|MRI 1||0
8297392|NCT01573273|20456925|P10|NOT COMPLETED|MRI 1||0
8297393|NCT01573273|20456926|P9|NOT COMPLETED|MRI 1||0
8297394|NCT01573273|20456927|P8|NOT COMPLETED|MRI 1||0
8297395|NCT01573273|20456928|P7|NOT COMPLETED|MRI 1||0
8297396|NCT01573273|20456929|P6|NOT COMPLETED|MRI 1||0
8297397|NCT01573273|20456930|P5|NOT COMPLETED|MRI 1||0
8297398|NCT01573273|20456931|P4|NOT COMPLETED|MRI 1||0
8297399|NCT01573273|20456932|P3|NOT COMPLETED|MRI 1||0
8297400|NCT01573273|20456933|P2|NOT COMPLETED|MRI 1||0
8297401|NCT01573273|20456934|P1|NOT COMPLETED|MRI 1||0
8297402|NCT01573273|20456923|P12|COMPLETED|MRI 1||0
8297403|NCT01573273|20456924|P11|COMPLETED|MRI 1||0
8297404|NCT01573273|20456925|P10|COMPLETED|MRI 1||29
8297405|NCT01573273|20456926|P9|COMPLETED|MRI 1||28
8297406|NCT01573273|20456927|P8|COMPLETED|MRI 1||0
8297407|NCT01573273|20456928|P7|COMPLETED|MRI 1||0
8297408|NCT01573273|20456929|P6|COMPLETED|MRI 1||0
8297409|NCT01573273|20456930|P5|COMPLETED|MRI 1||0
8297410|NCT01573273|20456931|P4|COMPLETED|MRI 1||23
8297411|NCT01573273|20456932|P3|COMPLETED|MRI 1||19
8297412|NCT01573273|20456933|P2|COMPLETED|MRI 1||0
8297413|NCT01573273|20456934|P1|COMPLETED|MRI 1||0
8297414|NCT01573273|20456923|P12|STARTED|MRI 1||0
8297415|NCT01573273|20456924|P11|STARTED|MRI 1||0
8297416|NCT01573273|20456925|P10|STARTED|MRI 1||29
8297417|NCT01573273|20456926|P9|STARTED|MRI 1||28
8297418|NCT01573273|20456927|P8|STARTED|MRI 1||0
8297419|NCT01573273|20456928|P7|STARTED|MRI 1||0
8297420|NCT01573273|20456929|P6|STARTED|MRI 1||0
8297421|NCT01573273|20456930|P5|STARTED|MRI 1||0
8297422|NCT01573273|20456931|P4|STARTED|MRI 1||23
8297423|NCT01573273|20456932|P3|STARTED|MRI 1||19
8297424|NCT01573273|20456933|P2|STARTED|MRI 1||0
8297425|NCT01573273|20456934|P1|STARTED|MRI 1||0
8297426|NCT01573273|20456923|P12|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297427|NCT01573273|20456924|P11|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297428|NCT01573273|20456925|P10|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297429|NCT01573273|20456926|P9|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297430|NCT01573273|20456927|P8|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297431|NCT01573273|20456928|P7|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297432|NCT01573273|20456929|P6|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297433|NCT01573273|20456930|P5|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297434|NCT01573273|20456931|P4|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297435|NCT01573273|20456932|P3|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297436|NCT01573273|20456933|P2|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297437|NCT01573273|20456934|P1|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297438|NCT01573273|20456923|P12|COMPLETED|TSST : Trier Social Stress Task||0
8297439|NCT01573273|20456924|P11|COMPLETED|TSST : Trier Social Stress Task||0
8297440|NCT01573273|20456925|P10|COMPLETED|TSST : Trier Social Stress Task||0
8297441|NCT01573273|20456926|P9|COMPLETED|TSST : Trier Social Stress Task||0
8297442|NCT01573273|20456927|P8|COMPLETED|TSST : Trier Social Stress Task||31
8297443|NCT01573273|20456928|P7|COMPLETED|TSST : Trier Social Stress Task||32
8297444|NCT01573273|20456929|P6|COMPLETED|TSST : Trier Social Stress Task||0
8297445|NCT01573273|20456930|P5|COMPLETED|TSST : Trier Social Stress Task||0
8297446|NCT01573273|20456931|P4|COMPLETED|TSST : Trier Social Stress Task||0
8297447|NCT01573273|20456932|P3|COMPLETED|TSST : Trier Social Stress Task||0
8297448|NCT01573273|20456933|P2|COMPLETED|TSST : Trier Social Stress Task||25
8297449|NCT01573273|20456934|P1|COMPLETED|TSST : Trier Social Stress Task||24
8297450|NCT01573273|20456923|P12|STARTED|TSST : Trier Social Stress Task||0
8297451|NCT01573273|20456924|P11|STARTED|TSST : Trier Social Stress Task||0
8297452|NCT01573273|20456925|P10|STARTED|TSST : Trier Social Stress Task||0
8297453|NCT01573273|20456926|P9|STARTED|TSST : Trier Social Stress Task||0
8297454|NCT01573273|20456927|P8|STARTED|TSST : Trier Social Stress Task||31
8297455|NCT01573273|20456928|P7|STARTED|TSST : Trier Social Stress Task||32
8297456|NCT01573273|20456929|P6|STARTED|TSST : Trier Social Stress Task||0
8297457|NCT01573273|20456930|P5|STARTED|TSST : Trier Social Stress Task||0
8297458|NCT01573273|20456931|P4|STARTED|TSST : Trier Social Stress Task||0
8297459|NCT01573273|20456932|P3|STARTED|TSST : Trier Social Stress Task||0
8297460|NCT01573273|20456933|P2|STARTED|TSST : Trier Social Stress Task||25
8297461|NCT01573273|20456934|P1|STARTED|TSST : Trier Social Stress Task||24
8297462|NCT01573260|20456974|P2|NOT COMPLETED|Overall Study||0
8297463|NCT01573260|20456975|P1|NOT COMPLETED|Overall Study||0
8297464|NCT01573260|20456974|P2|COMPLETED|Overall Study||15
8297465|NCT01573260|20456975|P1|COMPLETED|Overall Study||18
8297466|NCT01573260|20456974|P2|STARTED|Overall Study||15
8297467|NCT01573260|20456975|P1|STARTED|Overall Study||18
8297468|NCT01573052|20457009|P2|NOT COMPLETED|Overall Study||6
8297469|NCT01573052|20457010|P1|NOT COMPLETED|Overall Study||3
8297470|NCT01573052|20457009|P2|COMPLETED|Overall Study||11
8297471|NCT01573052|20457010|P1|COMPLETED|Overall Study||6
8297472|NCT01573052|20457009|P2|STARTED|Overall Study||17
8297473|NCT01573052|20457010|P1|STARTED|Overall Study||9
8297474|NCT01573000|20457022|P2|NOT COMPLETED|Long-Term Follow-Up||1
8297475|NCT01573000|20457023|P1|NOT COMPLETED|Long-Term Follow-Up||3
8297476|NCT01573000|20457022|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
8297477|NCT01573000|20457023|P1|COMPLETED|Long-Term Follow-Up||11
8297478|NCT01573000|20457022|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
8297479|NCT01573000|20457023|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
8297480|NCT01573000|20457022|P2|NOT COMPLETED|Crossover Phase||18
8297481|NCT01573000|20457023|P1|NOT COMPLETED|Crossover Phase||0
8297482|NCT01573000|20457022|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
8297483|NCT01573000|20457023|P1|COMPLETED|Crossover Phase||0
8297484|NCT01573000|20457022|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
8297485|NCT01573000|20457023|P1|STARTED|Crossover Phase||0
8297486|NCT01573000|20457022|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
8297487|NCT01573000|20457023|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
8297488|NCT01573000|20457022|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
8297489|NCT01573000|20457023|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
8297490|NCT01573000|20457022|P2|STARTED|Dosimetric and Therapeutic Treatment||36
8297491|NCT01573000|20457023|P1|STARTED|Dosimetric and Therapeutic Treatment||42
8297492|NCT01572948|20457119|P2|NOT COMPLETED|Overall Study||1
8297493|NCT01572948|20457120|P1|NOT COMPLETED|Overall Study||1
8297494|NCT01572948|20457119|P2|COMPLETED|Overall Study||15
8297495|NCT01572948|20457120|P1|COMPLETED|Overall Study||10
8297496|NCT01572948|20457119|P2|STARTED|Overall Study||16
8297497|NCT01572948|20457120|P1|STARTED|Overall Study||11
8297498|NCT01572922|20457136|P1|NOT COMPLETED|Overall Study||3
8297499|NCT01572922|20457136|P1|COMPLETED|Overall Study||139
8297500|NCT01572922|20457136|P1|STARTED|Overall Study||142
8297501|NCT01572909|20457148|P2|NOT COMPLETED|Overall Study||25
8297502|NCT01572909|20457149|P1|NOT COMPLETED|Overall Study||32
8297503|NCT01572909|20457148|P2|COMPLETED|Overall Study||123
8297504|NCT01572909|20457149|P1|COMPLETED|Overall Study||120
8297505|NCT01572909|20457148|P2|STARTED|Overall Study||148
8297506|NCT01572909|20457149|P1|STARTED|Overall Study||152
8297507|NCT01572844|20457193|P2|NOT COMPLETED|Overall Study||1
8297508|NCT01572844|20457194|P1|NOT COMPLETED|Overall Study||1
8297509|NCT01572844|20457193|P2|COMPLETED|Overall Study||2
8297510|NCT01572844|20457194|P1|COMPLETED|Overall Study||2
8297511|NCT01572844|20457193|P2|STARTED|Overall Study||3
8297512|NCT01572844|20457194|P1|STARTED|Overall Study||3
8297513|NCT01572792|20457212|P5|NOT COMPLETED|Extension Study||32
8297514|NCT01572792|20457213|P4|NOT COMPLETED|Extension Study||29
8297515|NCT01572792|20457214|P3|NOT COMPLETED|Extension Study||26
8297517|NCT01572792|20457216|P1|NOT COMPLETED|Extension Study||25
8297518|NCT01572792|20457212|P5|COMPLETED|Extension Study||160
8297519|NCT01572792|20457213|P4|COMPLETED|Extension Study||165
8297520|NCT01572792|20457214|P3|COMPLETED|Extension Study||179
8297521|NCT01572792|20457215|P2|COMPLETED|Extension Study||155
8297522|NCT01572792|20457216|P1|COMPLETED|Extension Study||121
8297523|NCT01572792|20457212|P5|STARTED|Extension Study||192
8297524|NCT01572792|20457213|P4|STARTED|Extension Study||194
8297525|NCT01572792|20457214|P3|STARTED|Extension Study||205
8297526|NCT01572792|20457215|P2|STARTED|Extension Study||184
8297527|NCT01572792|20457216|P1|STARTED|Extension Study||146
8297528|NCT01572792|20457212|P5|NOT COMPLETED|Lead-in Study||69
8297529|NCT01572792|20457213|P4|NOT COMPLETED|Lead-in Study||72
8297530|NCT01572792|20457214|P3|NOT COMPLETED|Lead-in Study||62
8297531|NCT01572792|20457215|P2|NOT COMPLETED|Lead-in Study||66
8297532|NCT01572792|20457216|P1|NOT COMPLETED|Lead-in Study||101
8297533|NCT01572792|20457212|P5|COMPLETED|Lead-in Study||270
8297534|NCT01572792|20457213|P4|COMPLETED|Lead-in Study||268
8297535|NCT01572792|20457214|P3|COMPLETED|Lead-in Study||276
8297536|NCT01572792|20457215|P2|COMPLETED|Lead-in Study||272
8297537|NCT01572792|20457216|P1|COMPLETED|Lead-in Study||236
8297538|NCT01572792|20457212|P5|STARTED|Lead-in Study||339
8297539|NCT01572792|20457213|P4|STARTED|Lead-in Study||340
8297540|NCT01572792|20457214|P3|STARTED|Lead-in Study||338
8297541|NCT01572792|20457215|P2|STARTED|Lead-in Study||338
8297542|NCT01572792|20457216|P1|STARTED|Lead-in Study||337
8297543|NCT01572740|20457265|P2|NOT COMPLETED|Overall Study||5
8297544|NCT01572740|20457266|P1|NOT COMPLETED|Overall Study||6
8297545|NCT01572740|20457265|P2|COMPLETED|Overall Study||125
8297546|NCT01572740|20457266|P1|COMPLETED|Overall Study||121
8297547|NCT01572740|20457265|P2|STARTED|Overall Study||130
8297548|NCT01572740|20457266|P1|STARTED|Overall Study||127
8297549|NCT01572727|20457296|P2|NOT COMPLETED|Overall Study||209
8297550|NCT01572727|20457297|P1|NOT COMPLETED|Overall Study||207
8297551|NCT01572727|20457296|P2|COMPLETED|Overall Study||0
8297552|NCT01572727|20457297|P1|COMPLETED|Overall Study||0
8297553|NCT01572727|20457296|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
8297554|NCT01572727|20457297|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
8297555|NCT01572727|20457296|P2|STARTED|Overall Study||209
8297556|NCT01572727|20457297|P1|STARTED|Overall Study||207
8297557|NCT01572675|20457319|P2|NOT COMPLETED|Overall Study||223
8297558|NCT01572675|20457320|P1|NOT COMPLETED|Overall Study||237
8297559|NCT01572675|20457319|P2|COMPLETED|Overall Study||56
8297560|NCT01572675|20457320|P1|COMPLETED|Overall Study||31
8297561|NCT01572675|20457319|P2|STARTED|Overall Study||279
8297562|NCT01572675|20457320|P1|STARTED|Overall Study||268
8297563|NCT01572428|20457419|P2|NOT COMPLETED|Overall Study||1
8297564|NCT01572428|20457420|P1|NOT COMPLETED|Overall Study||3
8297565|NCT01572428|20457419|P2|COMPLETED|Overall Study||401
8297566|NCT01572428|20457420|P1|COMPLETED|Overall Study||399
8297567|NCT01572428|20457419|P2|STARTED|Overall Study||402
8297568|NCT01572428|20457420|P1|STARTED|Overall Study||402
8297569|NCT01572389|20457438|P2|NOT COMPLETED|Overall Study||21
8297570|NCT01572389|20457439|P1|NOT COMPLETED|Overall Study||46
8297571|NCT01572389|20457438|P2|COMPLETED|Overall Study||68
8297572|NCT01572389|20457439|P1|COMPLETED|Overall Study||90
8297573|NCT01572389|20457438|P2|STARTED|Overall Study||89
8297574|NCT01572389|20457439|P1|STARTED|Overall Study||136
8297575|NCT01572298|20457449|P2|NOT COMPLETED|Overall Study||1
8297576|NCT01572298|20457450|P1|NOT COMPLETED|Overall Study||2
8297577|NCT01572298|20457449|P2|COMPLETED|Overall Study||12
8297578|NCT01572298|20457450|P1|COMPLETED|Overall Study||12
8297579|NCT01572298|20457449|P2|STARTED|Overall Study||13
8297580|NCT01572298|20457450|P1|STARTED|Overall Study||14
8297581|NCT01572207|20457460|P2|NOT COMPLETED|Overall Study||3
8297582|NCT01572207|20457461|P1|NOT COMPLETED|Overall Study||2
8297583|NCT01572207|20457460|P2|COMPLETED|Overall Study||13
8297584|NCT01572207|20457461|P1|COMPLETED|Overall Study||12
8297585|NCT01572207|20457460|P2|STARTED|Overall Study||16
8297586|NCT01572207|20457461|P1|STARTED|Overall Study||14
8297587|NCT01572038|20457471|P1|NOT COMPLETED|Overall Study||991
8297588|NCT01572038|20457471|P1|COMPLETED|Overall Study||445
8297589|NCT01572038|20457471|P1|Received at Least One Dose of Study Drug|Overall Study||1436
8297590|NCT01572038|20457471|P1|STARTED|Overall Study|All participants who were enrolled in the study.|1436
8297591|NCT01571557|20457577|P1|NOT COMPLETED|Overall Study||0
8297592|NCT01571557|20457577|P1|COMPLETED|Overall Study||573
8297593|NCT01571557|20457577|P1|STARTED|Overall Study||573
8297594|NCT01571453|20457586|P2|NOT COMPLETED|Overall Study||62
8297595|NCT01571453|20457587|P1|NOT COMPLETED|Overall Study||38
8297596|NCT01571453|20457586|P2|COMPLETED|Overall Study||164
8297597|NCT01571453|20457587|P1|COMPLETED|Overall Study||173
8297598|NCT01571453|20457586|P2|STARTED|Overall Study||226
8297599|NCT01571453|20457587|P1|STARTED|Overall Study||211
8297600|NCT01571427|20457605|P2|NOT COMPLETED|Overall Study||0
8297601|NCT01571427|20457606|P1|NOT COMPLETED|Overall Study||0
8297602|NCT01571427|20457605|P2|COMPLETED|Overall Study||42
8297603|NCT01571427|20457606|P1|COMPLETED|Overall Study||41
8297604|NCT01571427|20457605|P2|STARTED|Overall Study||42
8297605|NCT01571427|20457606|P1|STARTED|Overall Study||41
8297606|NCT01571362|20457634|P3|NOT COMPLETED|Double-Blind Treatment Period||39
8297607|NCT01571362|20457635|P2|NOT COMPLETED|Double-Blind Treatment Period||53
8297608|NCT01571362|20457636|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8297609|NCT01571362|20457634|P3|COMPLETED|Double-Blind Treatment Period||107
8297610|NCT01571362|20457635|P2|COMPLETED|Double-Blind Treatment Period||81
8297611|NCT01571362|20457636|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
8297612|NCT01571362|20457634|P3|STARTED|Double-Blind Treatment Period||146
8297613|NCT01571362|20457635|P2|STARTED|Double-Blind Treatment Period||134
8297614|NCT01571362|20457636|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
8297615|NCT01571362|20457634|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
8297616|NCT01571362|20457635|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
8297617|NCT01571362|20457636|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
8297618|NCT01571362|20457634|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297619|NCT01571362|20457635|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297620|NCT01571362|20457636|P1|COMPLETED|Open-Label Conversion + Titration Period||281
8297621|NCT01571362|20457634|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297622|NCT01571362|20457635|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297623|NCT01571362|20457636|P1|STARTED|Open-Label Conversion + Titration Period||410
8297624|NCT01571284|20457806|P1|NOT COMPLETED|Overall Study||169
8297625|NCT01571284|20457806|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
8297626|NCT01571284|20457806|P1|Safety Population|Overall Study||779
8297627|NCT01571284|20457806|P1|STARTED|Overall Study||781
8297628|NCT01571232|20457829|P2|NOT COMPLETED|Overall Study||1
8297629|NCT01571232|20457830|P1|NOT COMPLETED|Overall Study||1
8297630|NCT01571232|20457829|P2|COMPLETED|Overall Study||9
8297631|NCT01571232|20457830|P1|COMPLETED|Overall Study||9
8297632|NCT01571232|20457829|P2|STARTED|Overall Study||10
8297633|NCT01571232|20457830|P1|STARTED|Overall Study||10
8297634|NCT01570868|20457842|P2|NOT COMPLETED|Overall Study||8
8297635|NCT01570868|20457843|P1|NOT COMPLETED|Overall Study||43
8297636|NCT01570868|20457842|P2|COMPLETED|Overall Study||0
8297637|NCT01570868|20457843|P1|COMPLETED|Overall Study||0
8297638|NCT01570868|20457842|P2|STARTED|Overall Study||8
8297639|NCT01570868|20457843|P1|STARTED|Overall Study||43
8297640|NCT01570751|20457855|P2|NOT COMPLETED|Period B (16 Weeks)||1
8297641|NCT01570751|20457856|P1|NOT COMPLETED|Period B (16 Weeks)||1
8297642|NCT01570751|20457855|P2|COMPLETED|Period B (16 Weeks)||66
8297643|NCT01570751|20457856|P1|COMPLETED|Period B (16 Weeks)||69
8297644|NCT01570751|20457855|P2|Exposed|Period B (16 Weeks)||67
8297645|NCT01570751|20457856|P1|Exposed|Period B (16 Weeks)||70
8297646|NCT01570751|20457855|P2|STARTED|Period B (16 Weeks)||67
8297647|NCT01570751|20457856|P1|STARTED|Period B (16 Weeks)||70
8297648|NCT01570751|20457855|P2|NOT COMPLETED|Period A (16 Weeks)||5
8297649|NCT01570751|20457856|P1|NOT COMPLETED|Period A (16 Weeks)||3
8297650|NCT01570751|20457855|P2|COMPLETED|Period A (16 Weeks)||67
8297651|NCT01570751|20457856|P1|COMPLETED|Period A (16 Weeks)||70
8297652|NCT01570751|20457855|P2|Exposed|Period A (16 Weeks)||72
8297653|NCT01570751|20457856|P1|Exposed|Period A (16 Weeks)||73
8297654|NCT01570751|20457855|P2|STARTED|Period A (16 Weeks)||72
8297655|NCT01570751|20457856|P1|STARTED|Period A (16 Weeks)||73
8297656|NCT01570686|20457874|P2|NOT COMPLETED|Overall Study||16
8297657|NCT01570686|20457875|P1|NOT COMPLETED|Overall Study||22
8297658|NCT01570686|20457874|P2|COMPLETED|Overall Study||278
8297659|NCT01570686|20457875|P1|COMPLETED|Overall Study||274
8297660|NCT01570686|20457874|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
8297661|NCT01570686|20457875|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
8297662|NCT01570686|20457874|P2|STARTED|Overall Study||294
8297663|NCT01570686|20457875|P1|STARTED|Overall Study||296
8297664|NCT01570634|20457901|P1|NOT COMPLETED|Overall Study||0
8297665|NCT01570634|20457901|P1|COMPLETED|Overall Study||2
8297666|NCT01570634|20457901|P1|STARTED|Overall Study||2
8297667|NCT01570491|20457911|P2|NOT COMPLETED|Overall Study||1
8297668|NCT01570491|20457912|P1|NOT COMPLETED|Overall Study||5
8297669|NCT01570491|20457911|P2|COMPLETED|Overall Study||18
8297670|NCT01570491|20457912|P1|COMPLETED|Overall Study||14
8297671|NCT01570491|20457911|P2|STARTED|Overall Study||19
8297672|NCT01570491|20457912|P1|STARTED|Overall Study||19
8297673|NCT01570387|20457928|P4|NOT COMPLETED|Overall Study||2
8297674|NCT01570387|20457929|P3|NOT COMPLETED|Overall Study||0
8297675|NCT01570387|20457930|P2|NOT COMPLETED|Overall Study||0
8297676|NCT01570387|20457931|P1|NOT COMPLETED|Overall Study||1
8297677|NCT01570387|20457928|P4|COMPLETED|Overall Study||10
8297678|NCT01570387|20457929|P3|COMPLETED|Overall Study||6
8297679|NCT01570387|20457930|P2|COMPLETED|Overall Study||3
8297680|NCT01570387|20457931|P1|COMPLETED|Overall Study||5
8297681|NCT01570387|20457928|P4|Response to Maximal Tolerated Dose|Overall Study||6
8297682|NCT01570387|20457929|P3|Response to Maximal Tolerated Dose|Overall Study||3
8297683|NCT01570387|20457930|P2|Response to Maximal Tolerated Dose|Overall Study||0
8297684|NCT01570387|20457931|P1|Response to Maximal Tolerated Dose|Overall Study||0
8297685|NCT01570387|20457928|P4|Dose Limiting Toxicity|Overall Study||12
8297686|NCT01570387|20457929|P3|Dose Limiting Toxicity|Overall Study||6
8297687|NCT01570387|20457930|P2|Dose Limiting Toxicity|Overall Study||0
8297688|NCT01570387|20457931|P1|Dose Limiting Toxicity|Overall Study||0
8297689|NCT01570387|20457928|P4|STARTED|Overall Study||12
8297690|NCT01570387|20457929|P3|STARTED|Overall Study||6
8297691|NCT01570387|20457930|P2|STARTED|Overall Study||3
8297692|NCT01570387|20457931|P1|STARTED|Overall Study||6
8297693|NCT01570361|20457943|P2|NOT COMPLETED|Overall Study||75
8297694|NCT01570361|20457944|P1|NOT COMPLETED|Overall Study||82
8297695|NCT01570361|20457943|P2|COMPLETED|Overall Study||52
8297696|NCT01570361|20457944|P1|COMPLETED|Overall Study||46
8297697|NCT01570361|20457943|P2|AAD Therapy Only|Overall Study||108
8297698|NCT01570361|20457944|P1|AAD Therapy Only|Overall Study||0
8297699|NCT01570361|20457943|P2|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
8297700|NCT01570361|20457944|P1|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
8297701|NCT01570361|20457943|P2|Received Study Treatment|Overall Study||123
8297702|NCT01570361|20457944|P1|Received Study Treatment|Overall Study||102
8297703|NCT01570361|20457943|P2|STARTED|Overall Study||127
8297704|NCT01570361|20457944|P1|STARTED|Overall Study||128
8297705|NCT01570348|20457971|P1|NOT COMPLETED|Overall Study||0
8297706|NCT01570348|20457971|P1|COMPLETED|Overall Study||2
8297707|NCT01570348|20457971|P1|STARTED|Overall Study||2
8297708|NCT01570309|20457987|P2|NOT COMPLETED|Overall Study||3
8297709|NCT01570309|20457988|P1|NOT COMPLETED|Overall Study||3
8297710|NCT01570309|20457987|P2|COMPLETED|Overall Study||45
8297711|NCT01570309|20457988|P1|COMPLETED|Overall Study||45
8297712|NCT01570309|20457987|P2|STARTED|Overall Study||48
8297713|NCT01570309|20457988|P1|STARTED|Overall Study||48
8297714|NCT01570283|20458005|P6|NOT COMPLETED|Cohort 3: Dose Level 3||2
8297715|NCT01570283|20458006|P5|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297716|NCT01570283|20458007|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297717|NCT01570283|20458008|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297718|NCT01570283|20458009|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297719|NCT01570283|20458010|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297720|NCT01570283|20458005|P6|COMPLETED|Cohort 3: Dose Level 3||10
8297721|NCT01570283|20458006|P5|COMPLETED|Cohort 3: Dose Level 3||1
8297722|NCT01570283|20458007|P4|COMPLETED|Cohort 3: Dose Level 3||0
8297723|NCT01570283|20458008|P3|COMPLETED|Cohort 3: Dose Level 3||0
8297724|NCT01570283|20458009|P2|COMPLETED|Cohort 3: Dose Level 3||0
8297725|NCT01570283|20458010|P1|COMPLETED|Cohort 3: Dose Level 3||0
8297726|NCT01570283|20458005|P6|STARTED|Cohort 3: Dose Level 3||12
8297727|NCT01570283|20458006|P5|STARTED|Cohort 3: Dose Level 3||1
8297728|NCT01570283|20458007|P4|STARTED|Cohort 3: Dose Level 3||0
8297729|NCT01570283|20458008|P3|STARTED|Cohort 3: Dose Level 3||0
8297730|NCT01570283|20458009|P2|STARTED|Cohort 3: Dose Level 3||0
8297731|NCT01570283|20458010|P1|STARTED|Cohort 3: Dose Level 3||0
8297732|NCT01570283|20458005|P6|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297733|NCT01570283|20458006|P5|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297734|NCT01570283|20458007|P4|NOT COMPLETED|Cohort 2: Dose Level 2||1
8297735|NCT01570283|20458008|P3|NOT COMPLETED|Cohort 2: Dose Level 2||1
8297736|NCT01570283|20458009|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297737|NCT01570283|20458010|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297738|NCT01570283|20458005|P6|COMPLETED|Cohort 2: Dose Level 2||0
8297739|NCT01570283|20458006|P5|COMPLETED|Cohort 2: Dose Level 2||0
8297740|NCT01570283|20458007|P4|COMPLETED|Cohort 2: Dose Level 2||1
8297741|NCT01570283|20458008|P3|COMPLETED|Cohort 2: Dose Level 2||1
8297742|NCT01570283|20458009|P2|COMPLETED|Cohort 2: Dose Level 2||0
8297743|NCT01570283|20458010|P1|COMPLETED|Cohort 2: Dose Level 2||0
8297744|NCT01570283|20458005|P6|STARTED|Cohort 2: Dose Level 2||0
8297745|NCT01570283|20458006|P5|STARTED|Cohort 2: Dose Level 2||0
8297746|NCT01570283|20458007|P4|STARTED|Cohort 2: Dose Level 2||2
8297747|NCT01570283|20458008|P3|STARTED|Cohort 2: Dose Level 2||2
8297748|NCT01570283|20458009|P2|STARTED|Cohort 2: Dose Level 2||0
8297749|NCT01570283|20458010|P1|STARTED|Cohort 2: Dose Level 2||0
8297750|NCT01570283|20458005|P6|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297751|NCT01570283|20458006|P5|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297752|NCT01570283|20458007|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297753|NCT01570283|20458008|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297754|NCT01570283|20458009|P2|NOT COMPLETED|Cohort 1: Dose Level 1||2
8297755|NCT01570283|20458010|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297756|NCT01570283|20458005|P6|COMPLETED|Cohort 1: Dose Level 1||0
8297757|NCT01570283|20458006|P5|COMPLETED|Cohort 1: Dose Level 1||0
8297758|NCT01570283|20458007|P4|COMPLETED|Cohort 1: Dose Level 1||0
8297759|NCT01570283|20458008|P3|COMPLETED|Cohort 1: Dose Level 1||0
8297760|NCT01570283|20458009|P2|COMPLETED|Cohort 1: Dose Level 1||1
8297761|NCT01570283|20458010|P1|COMPLETED|Cohort 1: Dose Level 1||1
8297762|NCT01570283|20458005|P6|STARTED|Cohort 1: Dose Level 1||0
8297763|NCT01570283|20458006|P5|STARTED|Cohort 1: Dose Level 1||0
8297764|NCT01570283|20458007|P4|STARTED|Cohort 1: Dose Level 1||0
8297765|NCT01570283|20458008|P3|STARTED|Cohort 1: Dose Level 1||0
8297766|NCT01570283|20458009|P2|STARTED|Cohort 1: Dose Level 1||3
8297767|NCT01570283|20458010|P1|STARTED|Cohort 1: Dose Level 1||1
8297768|NCT01570244|20458027|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
8297769|NCT01570244|20458027|P1|COMPLETED|Microgynon+Faldaprevir||15
8297770|NCT01570244|20458027|P1|STARTED|Microgynon+Faldaprevir||16
8297771|NCT01570244|20458027|P1|NOT COMPLETED|Microgynon||0
8297772|NCT01570244|20458027|P1|COMPLETED|Microgynon||16
8297773|NCT01570244|20458027|P1|STARTED|Microgynon||16
8297774|NCT01570192|20458049|P2|NOT COMPLETED|Overall Study||13
8297775|NCT01570192|20458050|P1|NOT COMPLETED|Overall Study||7
8297776|NCT01570192|20458049|P2|COMPLETED|Overall Study||17
8297777|NCT01570192|20458050|P1|COMPLETED|Overall Study||6
8297778|NCT01570192|20458049|P2|STARTED|Overall Study||30
8297779|NCT01570192|20458050|P1|STARTED|Overall Study||13
8297780|NCT01570036|20458090|P2|NOT COMPLETED|Overall Study||122
8297781|NCT01570036|20458091|P1|NOT COMPLETED|Overall Study||118
8297782|NCT01570036|20458090|P2|COMPLETED|Overall Study||17
8297783|NCT01570036|20458091|P1|COMPLETED|Overall Study||18
8297784|NCT01570036|20458090|P2|Booster Series Completed|Overall Study||30
8297785|NCT01570036|20458091|P1|Booster Series Completed|Overall Study||40
8297786|NCT01570036|20458090|P2|Primary Vaccine Series Completed|Overall Study||132
8297787|NCT01570036|20458091|P1|Primary Vaccine Series Completed|Overall Study||121
8297788|NCT01570036|20458090|P2|STARTED|Overall Study||139
8297789|NCT01570036|20458091|P1|STARTED|Overall Study||136
8297790|NCT01569841|20458103|P2|NOT COMPLETED|Period B (6 Weeks)||0
8297791|NCT01569841|20458104|P1|NOT COMPLETED|Period B (6 Weeks)||0
8297792|NCT01569841|20458103|P2|COMPLETED|Period B (6 Weeks)||11
8297793|NCT01569841|20458104|P1|COMPLETED|Period B (6 Weeks)||12
8297794|NCT01569841|20458103|P2|Exposed|Period B (6 Weeks)||11
8297795|NCT01569841|20458104|P1|Exposed|Period B (6 Weeks)||12
8297796|NCT01569841|20458103|P2|STARTED|Period B (6 Weeks)||11
8297797|NCT01569841|20458104|P1|STARTED|Period B (6 Weeks)||12
8297798|NCT01569841|20458103|P2|NOT COMPLETED|Period A (6 Weeks)||1
8297799|NCT01569841|20458104|P1|NOT COMPLETED|Period A (6 Weeks)||0
8297800|NCT01569841|20458103|P2|COMPLETED|Period A (6 Weeks)||11
8297801|NCT01569841|20458104|P1|COMPLETED|Period A (6 Weeks)||12
8297802|NCT01569841|20458103|P2|Exposed|Period A (6 Weeks)||12
8297803|NCT01569841|20458104|P1|Exposed|Period A (6 Weeks)||12
8297804|NCT01569841|20458103|P2|STARTED|Period A (6 Weeks)||12
8297805|NCT01569841|20458104|P1|STARTED|Period A (6 Weeks)||12
8297806|NCT01569828|20458122|P2|NOT COMPLETED|Overall Study||0
8297807|NCT01569828|20458123|P1|NOT COMPLETED|Overall Study||0
8297808|NCT01569828|20458122|P2|COMPLETED|Overall Study||6
8297809|NCT01569828|20458123|P1|COMPLETED|Overall Study||6
8297810|NCT01569828|20458122|P2|STARTED|Overall Study||6
8297811|NCT01569828|20458123|P1|STARTED|Overall Study||6
8297812|NCT01569815|20458145|P4|NOT COMPLETED|Overall Study||0
8297813|NCT01569815|20458146|P3|NOT COMPLETED|Overall Study||0
8297814|NCT01569815|20458147|P2|NOT COMPLETED|Overall Study||0
8297815|NCT01569815|20458148|P1|NOT COMPLETED|Overall Study||0
8297816|NCT01569815|20458145|P4|COMPLETED|Overall Study||8
8297817|NCT01569815|20458146|P3|COMPLETED|Overall Study||8
8297818|NCT01569815|20458147|P2|COMPLETED|Overall Study||8
8297819|NCT01569815|20458148|P1|COMPLETED|Overall Study||8
8297820|NCT01569815|20458145|P4|STARTED|Overall Study||8
8297821|NCT01569815|20458146|P3|STARTED|Overall Study||8
8297822|NCT01569815|20458147|P2|STARTED|Overall Study||8
8297823|NCT01569815|20458148|P1|STARTED|Overall Study||8
8297824|NCT01569763|20458193|P2|NOT COMPLETED|Overall Study||7
8297825|NCT01569763|20458194|P1|NOT COMPLETED|Overall Study||3
8297826|NCT01569763|20458193|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
8297827|NCT01569763|20458194|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
8297828|NCT01569763|20458193|P2|Treated|Overall Study||51
8297829|NCT01569763|20458194|P1|Treated|Overall Study||102
8297830|NCT01569763|20458193|P2|STARTED|Overall Study||51
8297831|NCT01569763|20458194|P1|STARTED|Overall Study||102
8297832|NCT01569737|20458204|P1|NOT COMPLETED|Overall Study||3
8297833|NCT01569737|20458204|P1|COMPLETED|Overall Study||95
8297834|NCT01569737|20458204|P1|STARTED|Overall Study||98
8297835|NCT01569607|20458210|P2|NOT COMPLETED|Overall Study||1
8297836|NCT01569607|20458211|P1|NOT COMPLETED|Overall Study||1
8297837|NCT01569607|20458210|P2|COMPLETED|Overall Study||10
8297838|NCT01569607|20458211|P1|COMPLETED|Overall Study||10
8297839|NCT01569607|20458210|P2|STARTED|Overall Study||11
8297840|NCT01569607|20458211|P1|STARTED|Overall Study||11
8297841|NCT01569594|20458233|P1|NOT COMPLETED|Overall Study||67
8297842|NCT01569594|20458233|P1|COMPLETED|Overall Study||163
8297843|NCT01569594|20458233|P1|STARTED|Overall Study||230
8297844|NCT01569568|20458239|P2|NOT COMPLETED|Overall Study||2
8297845|NCT01569568|20458240|P1|NOT COMPLETED|Overall Study||0
8297846|NCT01569568|20458239|P2|COMPLETED|Overall Study||27
8297847|NCT01569568|20458240|P1|COMPLETED|Overall Study||20
8297848|NCT01569568|20458239|P2|STARTED|Overall Study||29
8297849|NCT01569568|20458240|P1|STARTED|Overall Study||20
8297850|NCT01569529|20458254|P2|NOT COMPLETED|Overall Study||0
8297851|NCT01569529|20458255|P1|NOT COMPLETED|Overall Study||0
8297852|NCT01569529|20458254|P2|COMPLETED|Overall Study||394
8297853|NCT01569529|20458255|P1|COMPLETED|Overall Study||2676
8297854|NCT01569529|20458254|P2|STARTED|Overall Study||394
8297855|NCT01569529|20458255|P1|STARTED|Overall Study||2676
8297856|NCT01569464|20458263|P2|NOT COMPLETED|Overall Study||5
8297857|NCT01569464|20458264|P1|NOT COMPLETED|Overall Study||10
8297858|NCT01569464|20458263|P2|COMPLETED|Overall Study||44
8297859|NCT01569464|20458264|P1|COMPLETED|Overall Study||91
8297860|NCT01569464|20458263|P2|STARTED|Overall Study||49
8297861|NCT01569464|20458264|P1|STARTED|Overall Study||101
8297862|NCT01569451|20458302|P2|NOT COMPLETED|Overall Study||13
8297863|NCT01569451|20458303|P1|NOT COMPLETED|Overall Study||14
8297864|NCT01569451|20458302|P2|COMPLETED|Overall Study||14
8297865|NCT01569451|20458303|P1|COMPLETED|Overall Study||12
8297866|NCT01569451|20458302|P2|STARTED|Overall Study||27
8297867|NCT01569451|20458303|P1|STARTED|Overall Study||26
8297868|NCT01569438|20458331|P2|NOT COMPLETED|Overall Study||22
8297869|NCT01569438|20458332|P1|NOT COMPLETED|Overall Study||7
8297870|NCT01569438|20458331|P2|COMPLETED|Overall Study||33
8297871|NCT01569438|20458332|P1|COMPLETED|Overall Study||45
8297872|NCT01569438|20458331|P2|Titration Set|Overall Study||36
8297873|NCT01569438|20458332|P1|Titration Set|Overall Study||38
8297874|NCT01569438|20458331|P2|Treated|Overall Study||54
8297875|NCT01569438|20458332|P1|Treated|Overall Study||51
8297876|NCT01569438|20458331|P2|STARTED|Overall Study||55
8297877|NCT01569438|20458332|P1|STARTED|Overall Study||52
8297878|NCT01569295|20458346|P2|NOT COMPLETED|Overall Study||209
8297879|NCT01569295|20458347|P1|NOT COMPLETED|Overall Study||207
8297880|NCT01569295|20458346|P2|COMPLETED|Overall Study||0
8297881|NCT01569295|20458347|P1|COMPLETED|Overall Study||0
8297882|NCT01569295|20458346|P2|Long-Term Follow-up|Overall Study||161
8297883|NCT01569295|20458347|P1|Long-Term Follow-up|Overall Study||109
8297884|NCT01569295|20458346|P2|STARTED|Overall Study||209
8297885|NCT01569295|20458347|P1|STARTED|Overall Study||207
8297886|NCT01569191|20458363|P2|NOT COMPLETED|Overall Study||0
8297887|NCT01569191|20458364|P1|NOT COMPLETED|Overall Study||0
8297888|NCT01569191|20458363|P2|COMPLETED|Overall Study||7
8297889|NCT01569191|20458364|P1|COMPLETED|Overall Study||11
8297890|NCT01569191|20458363|P2|STARTED|Overall Study||7
8297891|NCT01569191|20458364|P1|STARTED|Overall Study||11
8297892|NCT01569152|20458384|P3|NOT COMPLETED|Safety Extension, Period 3||55
8297893|NCT01569152|20458385|P2|NOT COMPLETED|Safety Extension, Period 3||0
8297894|NCT01569152|20458386|P1|NOT COMPLETED|Safety Extension, Period 3||0
8297895|NCT01569152|20458384|P3|COMPLETED|Safety Extension, Period 3||0
8297896|NCT01569152|20458385|P2|COMPLETED|Safety Extension, Period 3||0
8297897|NCT01569152|20458386|P1|COMPLETED|Safety Extension, Period 3||0
8297898|NCT01569152|20458384|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
8297899|NCT01569152|20458385|P2|STARTED|Safety Extension, Period 3||0
8297900|NCT01569152|20458386|P1|STARTED|Safety Extension, Period 3||0
8297901|NCT01569152|20458384|P3|NOT COMPLETED|Phase IIa, Period 1||0
8297902|NCT01569152|20458385|P2|NOT COMPLETED|Phase IIa, Period 1||32
8297903|NCT01569152|20458386|P1|NOT COMPLETED|Phase IIa, Period 1||21
8297904|NCT01569152|20458384|P3|COMPLETED|Phase IIa, Period 1||0
8297905|NCT01569152|20458385|P2|COMPLETED|Phase IIa, Period 1||9
8297906|NCT01569152|20458386|P1|COMPLETED|Phase IIa, Period 1||20
8297907|NCT01569152|20458384|P3|STARTED|Phase IIa, Period 1||0
8297908|NCT01569152|20458385|P2|STARTED|Phase IIa, Period 1||41
8297909|NCT01569152|20458386|P1|STARTED|Phase IIa, Period 1||41
8297910|NCT01569126|20458449|P6|NOT COMPLETED|Overall Study||0
8297911|NCT01569126|20458450|P5|NOT COMPLETED|Overall Study||0
8297912|NCT01569126|20458451|P4|NOT COMPLETED|Overall Study||0
8297913|NCT01569126|20458452|P3|NOT COMPLETED|Overall Study||0
8297914|NCT01569126|20458453|P2|NOT COMPLETED|Overall Study||0
8297915|NCT01569126|20458454|P1|NOT COMPLETED|Overall Study||0
8297916|NCT01569126|20458449|P6|COMPLETED|Overall Study||12
8297917|NCT01569126|20458450|P5|COMPLETED|Overall Study||12
8297918|NCT01569126|20458451|P4|COMPLETED|Overall Study||8
8297919|NCT01569126|20458452|P3|COMPLETED|Overall Study||8
8297920|NCT01569126|20458453|P2|COMPLETED|Overall Study||8
8297921|NCT01569126|20458454|P1|COMPLETED|Overall Study||8
8297922|NCT01569126|20458449|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
8297923|NCT01569126|20458450|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
8297924|NCT01569126|20458451|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
8297925|NCT01569126|20458452|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8297926|NCT01569126|20458453|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8297927|NCT01569126|20458454|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8297928|NCT01569126|20458449|P6|STARTED|Overall Study||12
8297929|NCT01569126|20458450|P5|STARTED|Overall Study||12
8297930|NCT01569126|20458451|P4|STARTED|Overall Study||8
8297931|NCT01569126|20458452|P3|STARTED|Overall Study||8
8297932|NCT01569126|20458453|P2|STARTED|Overall Study||8
8297933|NCT01569126|20458454|P1|STARTED|Overall Study||8
8297934|NCT01569087|20458492|P3|NOT COMPLETED|Overall Study||1
8297935|NCT01569087|20458493|P2|NOT COMPLETED|Overall Study||0
8297936|NCT01569087|20458494|P1|NOT COMPLETED|Overall Study||1
8297937|NCT01569087|20458492|P3|COMPLETED|Overall Study||18
8297938|NCT01569087|20458493|P2|COMPLETED|Overall Study||20
8297939|NCT01569087|20458494|P1|COMPLETED|Overall Study||20
8297940|NCT01569087|20458492|P3|STARTED|Overall Study||19
8297941|NCT01569087|20458493|P2|STARTED|Overall Study||20
8297942|NCT01569087|20458494|P1|STARTED|Overall Study||21
8297943|NCT01569074|20458522|P5|NOT COMPLETED|Overall Study||8
8297944|NCT01569074|20458523|P4|NOT COMPLETED|Overall Study||8
8297945|NCT01569074|20458524|P3|NOT COMPLETED|Overall Study||12
8297946|NCT01569074|20458525|P2|NOT COMPLETED|Overall Study||9
8297947|NCT01569074|20458526|P1|NOT COMPLETED|Overall Study||7
8297948|NCT01569074|20458522|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
8297949|NCT01569074|20458523|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
8297950|NCT01569074|20458524|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
8297951|NCT01569074|20458525|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
8297952|NCT01569074|20458526|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
8297953|NCT01569074|20458522|P5|Randomised But Did Not Receive Treatment|Overall Study||0
8297954|NCT01569074|20458523|P4|Randomised But Did Not Receive Treatment|Overall Study||0
8297955|NCT01569074|20458524|P3|Randomised But Did Not Receive Treatment|Overall Study||0
8297956|NCT01569074|20458525|P2|Randomised But Did Not Receive Treatment|Overall Study||0
8297957|NCT01569074|20458526|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8297958|NCT01569074|20458522|P5|STARTED|Overall Study|Patients who received treatment|33
8297959|NCT01569074|20458523|P4|STARTED|Overall Study|Patients who received treatment|33
8297960|NCT01569074|20458524|P3|STARTED|Overall Study|Patients who received treatment|33
8297961|NCT01569074|20458525|P2|STARTED|Overall Study|Patients who received treatment|33
8297962|NCT01569074|20458526|P1|STARTED|Overall Study|Patients who received treatment|31
8297963|NCT01569022|20458582|P2|NOT COMPLETED|Second Intervention||2
8297964|NCT01569022|20458583|P1|NOT COMPLETED|Second Intervention||2
8297965|NCT01569022|20458582|P2|COMPLETED|Second Intervention||18
8297966|NCT01569022|20458583|P1|COMPLETED|Second Intervention||17
8297967|NCT01569022|20458582|P2|STARTED|Second Intervention||20
8297968|NCT01569022|20458583|P1|STARTED|Second Intervention||19
8297969|NCT01569022|20458582|P2|NOT COMPLETED|First Intervention||1
8297970|NCT01569022|20458583|P1|NOT COMPLETED|First Intervention||2
8297971|NCT01569022|20458582|P2|COMPLETED|First Intervention||20
8297972|NCT01569022|20458583|P1|COMPLETED|First Intervention||19
8297973|NCT01569022|20458582|P2|STARTED|First Intervention||21
8297974|NCT01569022|20458583|P1|STARTED|First Intervention||21
8297975|NCT01568944|20458597|P2|NOT COMPLETED|Overall Study||0
8297976|NCT01568944|20458598|P1|NOT COMPLETED|Overall Study||0
8297977|NCT01568944|20458597|P2|COMPLETED|Overall Study||10
8297978|NCT01568944|20458598|P1|COMPLETED|Overall Study||8
8297979|NCT01568944|20458597|P2|STARTED|Overall Study||10
8297980|NCT01568944|20458598|P1|STARTED|Overall Study||8
8297981|NCT01568905|20458617|P3|NOT COMPLETED|Overall Study||0
8297982|NCT01568905|20458618|P2|NOT COMPLETED|Overall Study||0
8297983|NCT01568905|20458619|P1|NOT COMPLETED|Overall Study||1
8297984|NCT01568905|20458617|P3|COMPLETED|Overall Study||12
8297985|NCT01568905|20458618|P2|COMPLETED|Overall Study||11
8297986|NCT01568905|20458619|P1|COMPLETED|Overall Study||12
8297987|NCT01568905|20458617|P3|STARTED|Overall Study||12
8297988|NCT01568905|20458618|P2|STARTED|Overall Study||11
8297989|NCT01568905|20458619|P1|STARTED|Overall Study||13
8297990|NCT01568892|20458638|P2|NOT COMPLETED|Open-label Phase||3
8297991|NCT01568892|20458639|P1|NOT COMPLETED|Open-label Phase||6
8297992|NCT01568892|20458638|P2|COMPLETED|Open-label Phase||13
8297993|NCT01568892|20458639|P1|COMPLETED|Open-label Phase||7
8297994|NCT01568892|20458638|P2|STARTED|Open-label Phase||16
8297995|NCT01568892|20458639|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
8297996|NCT01568892|20458638|P2|NOT COMPLETED|Double-blind Phase||0
8297997|NCT01568892|20458639|P1|NOT COMPLETED|Double-blind Phase||0
8297998|NCT01568892|20458638|P2|COMPLETED|Double-blind Phase||16
8297999|NCT01568892|20458639|P1|COMPLETED|Double-blind Phase||14
8298000|NCT01568892|20458638|P2|STARTED|Double-blind Phase||16
8298001|NCT01568892|20458639|P1|STARTED|Double-blind Phase||14
8298002|NCT01568866|20458709|P2|NOT COMPLETED|Overall Study||416
8298003|NCT01568866|20458710|P1|NOT COMPLETED|Overall Study||438
8298004|NCT01568866|20458709|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
8298005|NCT01568866|20458710|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
8298006|NCT01568866|20458709|P2|Received Treatment|Overall Study||463
8298007|NCT01568866|20458710|P1|Received Treatment|Overall Study||456
8298008|NCT01568866|20458709|P2|STARTED|Overall Study||464
8298009|NCT01568866|20458710|P1|STARTED|Overall Study||465
8298010|NCT01568827|20458732|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
8298011|NCT01568827|20458733|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
8298012|NCT01568827|20458732|P2|COMPLETED|Intervention 2 (5 Days)||5
8298013|NCT01568827|20458733|P1|COMPLETED|Intervention 2 (5 Days)||5
8298014|NCT01568827|20458732|P2|STARTED|Intervention 2 (5 Days)||5
8298015|NCT01568827|20458733|P1|STARTED|Intervention 2 (5 Days)||5
8298016|NCT01568827|20458732|P2|NOT COMPLETED|Washout (2 Days)||0
8298017|NCT01568827|20458733|P1|NOT COMPLETED|Washout (2 Days)||0
8298018|NCT01568827|20458732|P2|COMPLETED|Washout (2 Days)||5
8298019|NCT01568827|20458733|P1|COMPLETED|Washout (2 Days)||5
8298020|NCT01568827|20458732|P2|STARTED|Washout (2 Days)||5
8298021|NCT01568827|20458733|P1|STARTED|Washout (2 Days)||5
8298022|NCT01568827|20458732|P2|NOT COMPLETED|First Intervention (6 Days)||0
8298023|NCT01568827|20458733|P1|NOT COMPLETED|First Intervention (6 Days)||0
8298024|NCT01568827|20458732|P2|COMPLETED|First Intervention (6 Days)||5
8298025|NCT01568827|20458733|P1|COMPLETED|First Intervention (6 Days)||5
8298026|NCT01568827|20458732|P2|STARTED|First Intervention (6 Days)||5
8298027|NCT01568827|20458733|P1|STARTED|First Intervention (6 Days)||5
8298028|NCT01568606|20458739|P1|NOT COMPLETED|Overall Study||0
8298029|NCT01568606|20458739|P1|COMPLETED|Overall Study||20
8298030|NCT01568606|20458739|P1|STARTED|Overall Study||20
8298031|NCT01568593|20458745|P2|NOT COMPLETED|Overall Study||3
8298032|NCT01568593|20458746|P1|NOT COMPLETED|Overall Study||7
8298033|NCT01568593|20458745|P2|COMPLETED|Overall Study||42
8298034|NCT01568593|20458746|P1|COMPLETED|Overall Study||41
8298035|NCT01568593|20458745|P2|STARTED|Overall Study||45
8298036|NCT01568593|20458746|P1|STARTED|Overall Study||48
8298037|NCT01568528|20458755|P3|NOT COMPLETED|Overall Study||0
8298038|NCT01568528|20458756|P2|NOT COMPLETED|Overall Study||0
8298039|NCT01568528|20458757|P1|NOT COMPLETED|Overall Study||0
8298040|NCT01568528|20458755|P3|COMPLETED|Overall Study||9
8298041|NCT01568528|20458756|P2|COMPLETED|Overall Study||11
8298042|NCT01568528|20458757|P1|COMPLETED|Overall Study||19
8298043|NCT01568528|20458755|P3|STARTED|Overall Study||9
8298044|NCT01568528|20458756|P2|STARTED|Overall Study||11
8298045|NCT01568528|20458757|P1|STARTED|Overall Study||19
8298046|NCT01568424|20458777|P1|NOT COMPLETED|Overall Study||0
8298047|NCT01568424|20458777|P1|COMPLETED|Overall Study||25
8298048|NCT01568424|20458777|P1|STARTED|Overall Study||25
8298049|NCT01568112|20458791|P4|NOT COMPLETED|Overall Study||12
8298050|NCT01568112|20458792|P3|NOT COMPLETED|Overall Study||7
8298051|NCT01568112|20458793|P2|NOT COMPLETED|Overall Study||8
8298052|NCT01568112|20458794|P1|NOT COMPLETED|Overall Study||5
8298053|NCT01568112|20458791|P4|COMPLETED|Overall Study||30
8298054|NCT01568112|20458792|P3|COMPLETED|Overall Study||36
8298055|NCT01568112|20458793|P2|COMPLETED|Overall Study||36
8298056|NCT01568112|20458794|P1|COMPLETED|Overall Study||39
8298057|NCT01568112|20458791|P4|STARTED|Overall Study||42
8298058|NCT01568112|20458792|P3|STARTED|Overall Study||43
8298059|NCT01568112|20458793|P2|STARTED|Overall Study||44
8298060|NCT01568112|20458794|P1|STARTED|Overall Study||44
8298061|NCT01568073|20458917|P5|NOT COMPLETED|Overall Study||9
8298062|NCT01568073|20458918|P4|NOT COMPLETED|Overall Study||11
8298063|NCT01568073|20458919|P3|NOT COMPLETED|Overall Study||12
8298064|NCT01568073|20458920|P2|NOT COMPLETED|Overall Study||15
8298065|NCT01568073|20458921|P1|NOT COMPLETED|Overall Study||11
8298066|NCT01568073|20458917|P5|COMPLETED|Overall Study||107
8298067|NCT01568073|20458918|P4|COMPLETED|Overall Study||108
8298068|NCT01568073|20458919|P3|COMPLETED|Overall Study||110
8298069|NCT01568073|20458920|P2|COMPLETED|Overall Study||107
8298070|NCT01568073|20458921|P1|COMPLETED|Overall Study||110
8298071|NCT01568073|20458917|P5|STARTED|Overall Study||116
8298072|NCT01568073|20458918|P4|STARTED|Overall Study||119
8298073|NCT01568073|20458919|P3|STARTED|Overall Study||122
8298074|NCT01568073|20458920|P2|STARTED|Overall Study||122
8298075|NCT01568073|20458921|P1|STARTED|Overall Study||121
8298076|NCT01568047|20458952|P4|NOT COMPLETED|Overall Study||1
8298077|NCT01568047|20458953|P3|NOT COMPLETED|Overall Study||1
8298078|NCT01568047|20458954|P2|NOT COMPLETED|Overall Study||1
8298079|NCT01568047|20458955|P1|NOT COMPLETED|Overall Study||1
8298080|NCT01568047|20458952|P4|COMPLETED|Overall Study||9
8298081|NCT01568047|20458953|P3|COMPLETED|Overall Study||9
8298082|NCT01568047|20458954|P2|COMPLETED|Overall Study||9
8298083|NCT01568047|20458955|P1|COMPLETED|Overall Study||9
8298084|NCT01568047|20458952|P4|STARTED|Overall Study||10
8298085|NCT01568047|20458953|P3|STARTED|Overall Study||10
8298086|NCT01568047|20458954|P2|STARTED|Overall Study||10
8298087|NCT01568047|20458955|P1|STARTED|Overall Study||10
8298088|NCT01568034|20458973|P4|NOT COMPLETED|Overall Study||0
8298089|NCT01568034|20458974|P3|NOT COMPLETED|Overall Study||0
8298090|NCT01568034|20458975|P2|NOT COMPLETED|Overall Study||0
8298091|NCT01568034|20458976|P1|NOT COMPLETED|Overall Study||1
8298092|NCT01568034|20458973|P4|COMPLETED|Overall Study||3
8298093|NCT01568034|20458974|P3|COMPLETED|Overall Study||3
8298094|NCT01568034|20458975|P2|COMPLETED|Overall Study||2
8298095|NCT01568034|20458976|P1|COMPLETED|Overall Study||1
8298096|NCT01568034|20458973|P4|Placebo|Overall Study||3
8298097|NCT01568034|20458974|P3|Placebo|Overall Study||3
8298098|NCT01568034|20458975|P2|Placebo|Overall Study||2
8298099|NCT01568034|20458976|P1|Placebo|Overall Study||1
8298100|NCT01568034|20458973|P4|100 mg BIA 9-1067|Overall Study||3
8298101|NCT01568034|20458974|P3|100 mg BIA 9-1067|Overall Study||3
8298102|NCT01568034|20458975|P2|100 mg BIA 9-1067|Overall Study||2
8298103|NCT01568034|20458976|P1|100 mg BIA 9-1067|Overall Study||2
8298104|NCT01568034|20458973|P4|50 mg BIA 9-1067|Overall Study||3
8298105|NCT01568034|20458974|P3|50 mg BIA 9-1067|Overall Study||3
8298106|NCT01568034|20458975|P2|50 mg BIA 9-1067|Overall Study||2
8298107|NCT01568034|20458976|P1|50 mg BIA 9-1067|Overall Study||2
8298108|NCT01568034|20458973|P4|25 mg BIA 9-1067|Overall Study||3
8298109|NCT01568034|20458974|P3|25 mg BIA 9-1067|Overall Study||3
8298110|NCT01568034|20458975|P2|25 mg BIA 9-1067|Overall Study||2
8298111|NCT01568034|20458976|P1|25 mg BIA 9-1067|Overall Study||2
8298112|NCT01568034|20458973|P4|STARTED|Overall Study||3
8298113|NCT01568034|20458974|P3|STARTED|Overall Study||3
8298114|NCT01568034|20458975|P2|STARTED|Overall Study||2
8298115|NCT01568034|20458976|P1|STARTED|Overall Study||2
8298116|NCT01568021|20458994|P1|NOT COMPLETED|Overall Study||16
8298117|NCT01568021|20458994|P1|COMPLETED|Overall Study||83
8298118|NCT01568021|20458994|P1|STARTED|Overall Study||99
8298119|NCT01568008|20459000|P1|NOT COMPLETED|Overall Study||234
8298120|NCT01568008|20459000|P1|COMPLETED|Overall Study||699
8298121|NCT01568008|20459000|P1|STARTED|Overall Study||933
8298122|NCT01567943|20459011|P3|NOT COMPLETED|Overall Study||0
8298123|NCT01567943|20459012|P2|NOT COMPLETED|Overall Study||10
8298124|NCT01567943|20459013|P1|NOT COMPLETED|Overall Study||14
8298125|NCT01567943|20459011|P3|COMPLETED|Overall Study||44
8298126|NCT01567943|20459012|P2|COMPLETED|Overall Study||29
8298127|NCT01567943|20459013|P1|COMPLETED|Overall Study||26
8298128|NCT01567943|20459011|P3|STARTED|Overall Study||44
8298129|NCT01567943|20459012|P2|STARTED|Overall Study||39
8298130|NCT01567943|20459013|P1|STARTED|Overall Study||40
8298131|NCT01567891|20459021|P1|NOT COMPLETED|Overall Study||3
8298132|NCT01567891|20459021|P1|COMPLETED|Overall Study||6
8298133|NCT01567891|20459021|P1|Received T-cell|Overall Study||6
8298134|NCT01567891|20459021|P1|STARTED|Overall Study||9
8298135|NCT01567865|20459039|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
8298136|NCT01567865|20459040|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
8298137|NCT01567865|20459041|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
8298138|NCT01567865|20459042|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
8298139|NCT01567865|20459039|P4|COMPLETED|Evaluated for Immunogenicity||194
8298140|NCT01567865|20459040|P3|COMPLETED|Evaluated for Immunogenicity||192
8298141|NCT01567865|20459041|P2|COMPLETED|Evaluated for Immunogenicity||195
8298142|NCT01567865|20459042|P1|COMPLETED|Evaluated for Immunogenicity||146
8298143|NCT01567865|20459039|P4|STARTED|Evaluated for Immunogenicity||224
8298144|NCT01567865|20459040|P3|STARTED|Evaluated for Immunogenicity||211
8298145|NCT01567865|20459041|P2|STARTED|Evaluated for Immunogenicity||220
8298146|NCT01567865|20459042|P1|STARTED|Evaluated for Immunogenicity||163
8298147|NCT01567865|20459039|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298148|NCT01567865|20459040|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298149|NCT01567865|20459041|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298150|NCT01567865|20459042|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298151|NCT01567865|20459039|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
8298152|NCT01567865|20459040|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
8298153|NCT01567865|20459041|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
8298154|NCT01567865|20459042|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
8298155|NCT01567865|20459039|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
8298156|NCT01567865|20459040|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
8298157|NCT01567865|20459041|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
8298158|NCT01567865|20459042|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
8298159|NCT01567852|20459072|P2|NOT COMPLETED|Overall Study||7
8298160|NCT01567852|20459073|P1|NOT COMPLETED|Overall Study||4
8298161|NCT01567852|20459072|P2|COMPLETED|Overall Study||5
8298162|NCT01567852|20459073|P1|COMPLETED|Overall Study||4
8298163|NCT01567852|20459072|P2|STARTED|Overall Study||12
8298164|NCT01567852|20459073|P1|STARTED|Overall Study||8
8298165|NCT01567839|20459081|P1|NOT COMPLETED|Overall Study||0
8298166|NCT01567839|20459081|P1|COMPLETED|Overall Study||60
8298167|NCT01567839|20459081|P1|STARTED|Overall Study||60
8298168|NCT01567826|20459091|P2|NOT COMPLETED|Overall Study||2
8298169|NCT01567826|20459092|P1|NOT COMPLETED|Overall Study||3
8298170|NCT01567826|20459091|P2|COMPLETED|Overall Study||42
8298171|NCT01567826|20459092|P1|COMPLETED|Overall Study||40
8298172|NCT01567826|20459091|P2|STARTED|Overall Study||44
8298173|NCT01567826|20459092|P1|STARTED|Overall Study||43
8298174|NCT01567527|20459118|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
8298175|NCT01567527|20459119|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
8298176|NCT01567527|20459120|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8298177|NCT01567527|20459121|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8298178|NCT01567527|20459122|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8298179|NCT01567527|20459118|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
8298180|NCT01567527|20459119|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
8298181|NCT01567527|20459120|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
8298182|NCT01567527|20459121|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
8298183|NCT01567527|20459122|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
8298184|NCT01567527|20459118|P5|STARTED|Double-blind, Placebo-controlled Phase||133
8298185|NCT01567527|20459119|P4|STARTED|Double-blind, Placebo-controlled Phase||133
8298186|NCT01567527|20459120|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
8298187|NCT01567527|20459121|P2|STARTED|Double-blind, Placebo-controlled Phase||0
8298188|NCT01567527|20459122|P1|STARTED|Double-blind, Placebo-controlled Phase||0
8298189|NCT01567527|20459118|P5|NOT COMPLETED|IM Depot Stabilization.||0
8298190|NCT01567527|20459119|P4|NOT COMPLETED|IM Depot Stabilization.||0
8298191|NCT01567527|20459120|P3|NOT COMPLETED|IM Depot Stabilization.||159
8298192|NCT01567527|20459121|P2|NOT COMPLETED|IM Depot Stabilization.||0
8298193|NCT01567527|20459122|P1|NOT COMPLETED|IM Depot Stabilization.||0
8298194|NCT01567527|20459118|P5|COMPLETED|IM Depot Stabilization.||0
8298195|NCT01567527|20459119|P4|COMPLETED|IM Depot Stabilization.||0
8298196|NCT01567527|20459120|P3|COMPLETED|IM Depot Stabilization.||266
8298197|NCT01567527|20459121|P2|COMPLETED|IM Depot Stabilization.||0
8298198|NCT01567527|20459122|P1|COMPLETED|IM Depot Stabilization.||0
8298199|NCT01567527|20459118|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298200|NCT01567527|20459119|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298201|NCT01567527|20459120|P3|STARTED|IM Depot Stabilization.||425
8298202|NCT01567527|20459121|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298203|NCT01567527|20459122|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298204|NCT01567527|20459118|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298205|NCT01567527|20459119|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298206|NCT01567527|20459120|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298207|NCT01567527|20459121|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
8298208|NCT01567527|20459122|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298209|NCT01567527|20459118|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298210|NCT01567527|20459119|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298211|NCT01567527|20459120|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298212|NCT01567527|20459121|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
8298213|NCT01567527|20459122|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298214|NCT01567527|20459118|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298215|NCT01567527|20459119|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298216|NCT01567527|20459120|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298305|NCT01566773|20459270|P1|GP MDI 1.2 µg BID|Overall Study||57
8298217|NCT01567527|20459121|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
8298218|NCT01567527|20459122|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298219|NCT01567527|20459118|P5|NOT COMPLETED|Conversion Phase.||0
8298220|NCT01567527|20459119|P4|NOT COMPLETED|Conversion Phase.||0
8298221|NCT01567527|20459120|P3|NOT COMPLETED|Conversion Phase.||0
8298222|NCT01567527|20459121|P2|NOT COMPLETED|Conversion Phase.||0
8298223|NCT01567527|20459122|P1|NOT COMPLETED|Conversion Phase.||99
8298224|NCT01567527|20459118|P5|COMPLETED|Conversion Phase.||0
8298225|NCT01567527|20459119|P4|COMPLETED|Conversion Phase.||0
8298226|NCT01567527|20459120|P3|COMPLETED|Conversion Phase.||0
8298227|NCT01567527|20459121|P2|COMPLETED|Conversion Phase.||0
8298228|NCT01567527|20459122|P1|COMPLETED|Conversion Phase.||367
8298229|NCT01567527|20459118|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298230|NCT01567527|20459119|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298231|NCT01567527|20459120|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298232|NCT01567527|20459121|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298233|NCT01567527|20459122|P1|STARTED|Conversion Phase.||466
8298234|NCT01567462|20459139|P2|NOT COMPLETED|Overall Study||7
8298235|NCT01567462|20459140|P1|NOT COMPLETED|Overall Study||4
8298236|NCT01567462|20459139|P2|COMPLETED|Overall Study||38
8298237|NCT01567462|20459140|P1|COMPLETED|Overall Study||41
8298238|NCT01567462|20459139|P2|STARTED|Overall Study||45
8298239|NCT01567462|20459140|P1|STARTED|Overall Study||45
8298240|NCT01567371|20459152|P1|NOT COMPLETED|Overall Study||0
8298241|NCT01567371|20459152|P1|COMPLETED|Overall Study||30
8298242|NCT01567371|20459152|P1|STARTED|Overall Study||30
8298243|NCT01567306|20459163|P6|NOT COMPLETED|Overall Study||3
8298244|NCT01567306|20459164|P5|NOT COMPLETED|Overall Study||7
8298245|NCT01567306|20459165|P4|NOT COMPLETED|Overall Study||5
8298246|NCT01567306|20459166|P3|NOT COMPLETED|Overall Study||0
8298247|NCT01567306|20459167|P2|NOT COMPLETED|Overall Study||2
8298248|NCT01567306|20459168|P1|NOT COMPLETED|Overall Study||3
8298249|NCT01567306|20459163|P6|COMPLETED|Overall Study||23
8298250|NCT01567306|20459164|P5|COMPLETED|Overall Study||18
8298251|NCT01567306|20459165|P4|COMPLETED|Overall Study||19
8298252|NCT01567306|20459166|P3|COMPLETED|Overall Study||24
8298253|NCT01567306|20459167|P2|COMPLETED|Overall Study||23
8298254|NCT01567306|20459168|P1|COMPLETED|Overall Study||24
8298255|NCT01567306|20459163|P6|STARTED|Overall Study||26
8298256|NCT01567306|20459164|P5|STARTED|Overall Study||25
8298257|NCT01567306|20459165|P4|STARTED|Overall Study||24
8298258|NCT01567306|20459166|P3|STARTED|Overall Study||24
8298259|NCT01567306|20459167|P2|STARTED|Overall Study||25
8298260|NCT01567306|20459168|P1|STARTED|Overall Study||27
8298261|NCT01567163|20459182|P1|NOT COMPLETED|Overall Study||4
8298262|NCT01567163|20459182|P1|COMPLETED|Overall Study||18
8298263|NCT01567163|20459182|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
8298264|NCT01567163|20459182|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
8298265|NCT01567163|20459182|P1|STARTED|Overall Study||22
8298266|NCT01567150|20459194|P2|NOT COMPLETED|Overall Study||2
8298267|NCT01567150|20459195|P1|NOT COMPLETED|Overall Study||2
8298268|NCT01567150|20459194|P2|COMPLETED|Overall Study||16
8298269|NCT01567150|20459195|P1|COMPLETED|Overall Study||19
8298270|NCT01567150|20459194|P2|STARTED|Overall Study||18
8298271|NCT01567150|20459195|P1|STARTED|Overall Study||21
8298272|NCT01567085|20459203|P1|NOT COMPLETED|Overall Study||20
8298273|NCT01567085|20459203|P1|COMPLETED|Overall Study||60
8298274|NCT01567085|20459203|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
8298275|NCT01567085|20459203|P1|STARTED|Overall Study||80
8298276|NCT01567020|20459213|P4|NOT COMPLETED|Overall Study||1
8298277|NCT01567020|20459214|P3|NOT COMPLETED|Overall Study||2
8298278|NCT01567020|20459215|P2|NOT COMPLETED|Overall Study||5
8298279|NCT01567020|20459216|P1|NOT COMPLETED|Overall Study||7
8298280|NCT01567020|20459213|P4|COMPLETED|Overall Study||10
8298281|NCT01567020|20459214|P3|COMPLETED|Overall Study||18
8298282|NCT01567020|20459215|P2|COMPLETED|Overall Study||41
8298283|NCT01567020|20459216|P1|COMPLETED|Overall Study||21
8298284|NCT01567020|20459213|P4|STARTED|Overall Study||11
8298285|NCT01567020|20459214|P3|STARTED|Overall Study||20
8298286|NCT01567020|20459215|P2|STARTED|Overall Study||46
8298287|NCT01567020|20459216|P1|STARTED|Overall Study||28
8298288|NCT01566981|20459240|P2|NOT COMPLETED|Overall Study||8
8298289|NCT01566981|20459241|P1|NOT COMPLETED|Overall Study||5
8298290|NCT01566981|20459240|P2|COMPLETED|Overall Study||54
8298291|NCT01566981|20459241|P1|COMPLETED|Overall Study||53
8298292|NCT01566981|20459240|P2|STARTED|Overall Study||62
8298293|NCT01566981|20459241|P1|STARTED|Overall Study||58
8298294|NCT01566838|20459253|P2|NOT COMPLETED|Overall Study||0
8298295|NCT01566838|20459254|P1|NOT COMPLETED|Overall Study||3
8298296|NCT01566838|20459253|P2|COMPLETED|Overall Study||42
8298297|NCT01566838|20459254|P1|COMPLETED|Overall Study||38
8298298|NCT01566838|20459253|P2|STARTED|Overall Study||42
8298299|NCT01566838|20459254|P1|STARTED|Overall Study||41
8298300|NCT01566773|20459270|P1|NOT COMPLETED|Overall Study||30
8298301|NCT01566773|20459270|P1|COMPLETED|Overall Study||110
8298302|NCT01566773|20459270|P1|Spiriva® Handihaler®|Overall Study||62
8298303|NCT01566773|20459270|P1|Placebo MDI|Overall Study||62
8298304|NCT01566773|20459270|P1|GP MDI 0.6 µg BID|Overall Study||59
8298306|NCT01566773|20459270|P1|GP MDI 2.4 µg BID|Overall Study||64
8298307|NCT01566773|20459270|P1|GP MDI 4.6 µg BID|Overall Study||62
8298308|NCT01566773|20459270|P1|GP MDI 9 µg BID|Overall Study||64
8298309|NCT01566773|20459270|P1|GP MDI 18 µg BID|Overall Study||64
8298310|NCT01566773|20459270|P1|STARTED|Overall Study||140
8298311|NCT01566721|20459479|P2|NOT COMPLETED|Overall Study||710
8298312|NCT01566721|20459480|P1|NOT COMPLETED|Overall Study||1867
8298313|NCT01566721|20459479|P2|COMPLETED|Overall Study||0
8298314|NCT01566721|20459480|P1|COMPLETED|Overall Study||0
8298315|NCT01566721|20459479|P2|Received Treatment|Overall Study||709
8298316|NCT01566721|20459480|P1|Received Treatment|Overall Study||1864
8298317|NCT01566721|20459479|P2|STARTED|Overall Study||710
8298318|NCT01566721|20459480|P1|STARTED|Overall Study||1867
8298319|NCT01566695|20459505|P2|NOT COMPLETED|Overall Study||99
8298320|NCT01566695|20459506|P1|NOT COMPLETED|Overall Study||95
8298321|NCT01566695|20459505|P2|COMPLETED|Overall Study||10
8298322|NCT01566695|20459506|P1|COMPLETED|Overall Study||12
8298323|NCT01566695|20459505|P2|STARTED|Overall Study||109
8298324|NCT01566695|20459506|P1|STARTED|Overall Study||107
8298325|NCT01566682|20459608|P1|NOT COMPLETED|Overall Study||46
8298326|NCT01566682|20459608|P1|COMPLETED|Overall Study||374
8298327|NCT01566682|20459608|P1|STARTED|Overall Study||420
8298328|NCT01566630|20459614|P2|NOT COMPLETED|Overall Study||0
8298329|NCT01566630|20459615|P1|NOT COMPLETED|Overall Study||0
8298330|NCT01566630|20459614|P2|COMPLETED|Overall Study||1
8298331|NCT01566630|20459615|P1|COMPLETED|Overall Study||2
8298332|NCT01566630|20459614|P2|STARTED|Overall Study||1
8298333|NCT01566630|20459615|P1|STARTED|Overall Study||2
8298334|NCT01566604|20459671|P2|NOT COMPLETED|Overall Study||11
8298335|NCT01566604|20459672|P1|NOT COMPLETED|Overall Study||24
8298336|NCT01566604|20459671|P2|COMPLETED|Overall Study||143
8298337|NCT01566604|20459672|P1|COMPLETED|Overall Study||282
8298338|NCT01566604|20459671|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
8298339|NCT01566604|20459672|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
8298340|NCT01566604|20459671|P2|Full Analysis Set (FAS)|Overall Study||154
8298341|NCT01566604|20459672|P1|Full Analysis Set (FAS)|Overall Study||305
8298342|NCT01566604|20459671|P2|Safety Set|Overall Study||154
8298343|NCT01566604|20459672|P1|Safety Set|Overall Study||305
8298344|NCT01566604|20459671|P2|STARTED|Overall Study||154
8298345|NCT01566604|20459672|P1|STARTED|Overall Study||306
8298346|NCT01566539|20459706|P9|NOT COMPLETED|Within Subject Group||0
8298347|NCT01566539|20459707|P8|NOT COMPLETED|Within Subject Group||0
8298348|NCT01566539|20459708|P7|NOT COMPLETED|Within Subject Group||0
8298349|NCT01566539|20459709|P6|NOT COMPLETED|Within Subject Group||0
8298350|NCT01566539|20459710|P5|NOT COMPLETED|Within Subject Group||0
8298351|NCT01566539|20459711|P4|NOT COMPLETED|Within Subject Group||3
8298352|NCT01566539|20459712|P3|NOT COMPLETED|Within Subject Group||0
8298353|NCT01566539|20459713|P2|NOT COMPLETED|Within Subject Group||0
8298354|NCT01566539|20459714|P1|NOT COMPLETED|Within Subject Group||0
8298355|NCT01566539|20459706|P9|COMPLETED|Within Subject Group||0
8298356|NCT01566539|20459707|P8|COMPLETED|Within Subject Group||0
8298357|NCT01566539|20459708|P7|COMPLETED|Within Subject Group||0
8298358|NCT01566539|20459709|P6|COMPLETED|Within Subject Group||0
8298359|NCT01566539|20459710|P5|COMPLETED|Within Subject Group||0
8298360|NCT01566539|20459711|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
8298361|NCT01566539|20459712|P3|COMPLETED|Within Subject Group||0
8298362|NCT01566539|20459713|P2|COMPLETED|Within Subject Group||0
8298363|NCT01566539|20459714|P1|COMPLETED|Within Subject Group||0
8298364|NCT01566539|20459706|P9|STARTED|Within Subject Group||0
8298365|NCT01566539|20459707|P8|STARTED|Within Subject Group||0
8298366|NCT01566539|20459708|P7|STARTED|Within Subject Group||0
8298367|NCT01566539|20459709|P6|STARTED|Within Subject Group||0
8298368|NCT01566539|20459710|P5|STARTED|Within Subject Group||0
8298369|NCT01566539|20459711|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
8298370|NCT01566539|20459712|P3|STARTED|Within Subject Group||0
8298371|NCT01566539|20459713|P2|STARTED|Within Subject Group||0
8298372|NCT01566539|20459714|P1|STARTED|Within Subject Group||0
8298373|NCT01566539|20459706|P9|NOT COMPLETED|Main Study Period||0
8298374|NCT01566539|20459707|P8|NOT COMPLETED|Main Study Period||0
8298375|NCT01566539|20459708|P7|NOT COMPLETED|Main Study Period||0
8298376|NCT01566539|20459709|P6|NOT COMPLETED|Main Study Period||3
8298377|NCT01566539|20459710|P5|NOT COMPLETED|Main Study Period||0
8298378|NCT01566539|20459711|P4|NOT COMPLETED|Main Study Period||0
8298379|NCT01566539|20459712|P3|NOT COMPLETED|Main Study Period||0
8298380|NCT01566539|20459713|P2|NOT COMPLETED|Main Study Period||0
8298381|NCT01566539|20459714|P1|NOT COMPLETED|Main Study Period||1
8298382|NCT01566539|20459706|P9|COMPLETED|Main Study Period||1
8298383|NCT01566539|20459707|P8|COMPLETED|Main Study Period||30
8298384|NCT01566539|20459708|P7|COMPLETED|Main Study Period||30
8298385|NCT01566539|20459709|P6|COMPLETED|Main Study Period||40
8298386|NCT01566539|20459710|P5|COMPLETED|Main Study Period||40
8298387|NCT01566539|20459711|P4|COMPLETED|Main Study Period||0
8298388|NCT01566539|20459712|P3|COMPLETED|Main Study Period||104
8298389|NCT01566539|20459713|P2|COMPLETED|Main Study Period||100
8298390|NCT01566539|20459714|P1|COMPLETED|Main Study Period||100
8298391|NCT01566539|20459706|P9|STARTED|Main Study Period||1
8298392|NCT01566539|20459707|P8|STARTED|Main Study Period||30
8298393|NCT01566539|20459708|P7|STARTED|Main Study Period||30
8298394|NCT01566539|20459709|P6|STARTED|Main Study Period||43
8298395|NCT01566539|20459710|P5|STARTED|Main Study Period||40
8298396|NCT01566539|20459711|P4|STARTED|Main Study Period||0
8298397|NCT01566539|20459712|P3|STARTED|Main Study Period||104
8298398|NCT01566539|20459713|P2|STARTED|Main Study Period||100
8298399|NCT01566539|20459714|P1|STARTED|Main Study Period||101
8298400|NCT01566526|20459767|P1|NOT COMPLETED|Overall Study||0
8298401|NCT01566526|20459767|P1|COMPLETED|Overall Study||26
8298402|NCT01566526|20459767|P1|STARTED|Overall Study||26
8298403|NCT01566500|20459777|P1|NOT COMPLETED|Overall Study||0
8298404|NCT01566500|20459777|P1|COMPLETED|Overall Study||140
8298405|NCT01566500|20459777|P1|STARTED|Overall Study||140
8298406|NCT01566461|20459783|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
8298407|NCT01566461|20459784|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
8298408|NCT01566461|20459783|P2|COMPLETED|IN.PACT SFA II Phase||55
8298409|NCT01566461|20459784|P1|COMPLETED|IN.PACT SFA II Phase||109
8298410|NCT01566461|20459783|P2|STARTED|IN.PACT SFA II Phase||60
8298411|NCT01566461|20459784|P1|STARTED|IN.PACT SFA II Phase||121
8298412|NCT01566461|20459783|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
8298413|NCT01566461|20459784|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
8298414|NCT01566461|20459783|P2|COMPLETED|IN.PACT SFA I Phase||49
8298415|NCT01566461|20459784|P1|COMPLETED|IN.PACT SFA I Phase||88
8298416|NCT01566461|20459783|P2|STARTED|IN.PACT SFA I Phase||51
8298417|NCT01566461|20459784|P1|STARTED|IN.PACT SFA I Phase||99
8298418|NCT01566448|20459828|P1|NOT COMPLETED|Overall Study||0
8298419|NCT01566448|20459828|P1|COMPLETED|Overall Study||30
8298420|NCT01566448|20459828|P1|STARTED|Overall Study||30
8298421|NCT01566435|20459837|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
8298422|NCT01566435|20459837|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
8298423|NCT01566435|20459837|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
8298424|NCT01566435|20459837|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
8298425|NCT01566435|20459837|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
8298426|NCT01566435|20459837|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
8298427|NCT01566435|20459837|P1|NOT COMPLETED|ACF Induction Therapy||0
8298428|NCT01566435|20459837|P1|COMPLETED|ACF Induction Therapy||30
8298429|NCT01566435|20459837|P1|STARTED|ACF Induction Therapy||30
8298430|NCT01566409|20459858|P2|NOT COMPLETED|Overall Study||5
8298431|NCT01566409|20459859|P1|NOT COMPLETED|Overall Study||2
8298432|NCT01566409|20459858|P2|COMPLETED|Overall Study||48
8298433|NCT01566409|20459859|P1|COMPLETED|Overall Study||47
8298434|NCT01566409|20459858|P2|STARTED|Overall Study||53
8298435|NCT01566409|20459859|P1|STARTED|Overall Study||49
8298436|NCT01566370|20459867|P2|NOT COMPLETED|Overall Study||1
8298437|NCT01566370|20459868|P1|NOT COMPLETED|Overall Study||2
8298438|NCT01566370|20459867|P2|COMPLETED|Overall Study||0
8298439|NCT01566370|20459868|P1|COMPLETED|Overall Study||0
8298440|NCT01566370|20459867|P2|STARTED|Overall Study||1
8298441|NCT01566370|20459868|P1|STARTED|Overall Study||2
8298442|NCT01566331|20459894|P2|NOT COMPLETED|Overall Study||0
8298443|NCT01566331|20459895|P1|NOT COMPLETED|Overall Study||0
8298444|NCT01566331|20459894|P2|COMPLETED|Overall Study||40
8298445|NCT01566331|20459895|P1|COMPLETED|Overall Study||40
8298446|NCT01566331|20459894|P2|STARTED|Overall Study||40
8298447|NCT01566331|20459895|P1|STARTED|Overall Study||40
8298448|NCT01566214|20459903|P2|NOT COMPLETED|Overall Study||0
8298449|NCT01566214|20459904|P1|NOT COMPLETED|Overall Study||3
8298450|NCT01566214|20459903|P2|COMPLETED|Overall Study||6
8298451|NCT01566214|20459904|P1|COMPLETED|Overall Study||3
8298452|NCT01566214|20459903|P2|STARTED|Overall Study||6
8298453|NCT01566214|20459904|P1|STARTED|Overall Study||6
8298454|NCT01566162|20459934|P1|NOT COMPLETED|Overall Study||36
8298455|NCT01566162|20459934|P1|COMPLETED|Overall Study||155
8298456|NCT01566162|20459934|P1|STARTED|Overall Study||191
8298457|NCT01566149|20459948|P2|NOT COMPLETED|Overall Study||2
8298458|NCT01566149|20459949|P1|NOT COMPLETED|Overall Study||3
8298459|NCT01566149|20459948|P2|COMPLETED|Overall Study||23
8298460|NCT01566149|20459949|P1|COMPLETED|Overall Study||21
8298461|NCT01566149|20459948|P2|STARTED|Overall Study||25
8298462|NCT01566149|20459949|P1|STARTED|Overall Study||24
8298463|NCT01566084|20459965|P2|NOT COMPLETED|Overall Study||0
8298464|NCT01566084|20459966|P1|NOT COMPLETED|Overall Study||0
8298465|NCT01566084|20459965|P2|COMPLETED|Overall Study||10
8298466|NCT01566084|20459966|P1|COMPLETED|Overall Study||7
8298467|NCT01566084|20459965|P2|STARTED|Overall Study||10
8298468|NCT01566084|20459966|P1|STARTED|Overall Study||7
8298469|NCT01565993|20459982|P2|NOT COMPLETED|Overall Study||3
8298470|NCT01565993|20459983|P1|NOT COMPLETED|Overall Study||0
8298471|NCT01565993|20459982|P2|COMPLETED|Overall Study||39
8298472|NCT01565993|20459983|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
8298473|NCT01565993|20459982|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
8298474|NCT01565993|20459983|P1|STARTED|Overall Study||66
8298475|NCT01565980|20459991|P2|NOT COMPLETED|Overall Study||4
8298476|NCT01565980|20459992|P1|NOT COMPLETED|Overall Study||4
8298477|NCT01565980|20459991|P2|COMPLETED|Overall Study||16
8298478|NCT01565980|20459992|P1|COMPLETED|Overall Study||16
8298479|NCT01565980|20459991|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
8298480|NCT01565980|20459992|P1|STARTED|Overall Study||20
8298487|NCT01565928|20460055|P1|NOT COMPLETED|Overall Study||22
8298488|NCT01565928|20460055|P1|COMPLETED|Overall Study||0
8298489|NCT01565928|20460055|P1|STARTED|Overall Study||22
8298490|NCT01565902|20460072|P4|NOT COMPLETED|Overall Study||0
8298491|NCT01565902|20460073|P3|NOT COMPLETED|Overall Study||0
8298492|NCT01565902|20460074|P2|NOT COMPLETED|Overall Study||0
8298493|NCT01565902|20460075|P1|NOT COMPLETED|Overall Study||0
8298494|NCT01565902|20460072|P4|COMPLETED|Overall Study||16
8298495|NCT01565902|20460073|P3|COMPLETED|Overall Study||8
8298496|NCT01565902|20460074|P2|COMPLETED|Overall Study||8
8298497|NCT01565902|20460075|P1|COMPLETED|Overall Study||8
8298498|NCT01565902|20460072|P4|STARTED|Overall Study||16
8298499|NCT01565902|20460073|P3|STARTED|Overall Study||8
8298500|NCT01565902|20460074|P2|STARTED|Overall Study||8
8298501|NCT01565902|20460075|P1|STARTED|Overall Study||8
8298502|NCT01565889|20460109|P6|NOT COMPLETED|Part B||4
8298503|NCT01565889|20460110|P5|NOT COMPLETED|Part B||0
8298504|NCT01565889|20460111|P4|NOT COMPLETED|Part B||0
8298505|NCT01565889|20460112|P3|NOT COMPLETED|Part B||0
8298506|NCT01565889|20460113|P2|NOT COMPLETED|Part B||0
8298507|NCT01565889|20460114|P1|NOT COMPLETED|Part B||0
8298508|NCT01565889|20460109|P6|COMPLETED|Part B||19
8298509|NCT01565889|20460110|P5|COMPLETED|Part B||0
8298510|NCT01565889|20460111|P4|COMPLETED|Part B||0
8298511|NCT01565889|20460112|P3|COMPLETED|Part B||0
8298512|NCT01565889|20460113|P2|COMPLETED|Part B||0
8298513|NCT01565889|20460114|P1|COMPLETED|Part B||0
8298514|NCT01565889|20460109|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
8298515|NCT01565889|20460110|P5|STARTED|Part B||0
8298516|NCT01565889|20460111|P4|STARTED|Part B||0
8298517|NCT01565889|20460112|P3|STARTED|Part B||0
8298518|NCT01565889|20460113|P2|STARTED|Part B||0
8298519|NCT01565889|20460114|P1|STARTED|Part B||0
8298520|NCT01565889|20460109|P6|NOT COMPLETED|Part A||0
8298521|NCT01565889|20460110|P5|NOT COMPLETED|Part A||0
8298522|NCT01565889|20460111|P4|NOT COMPLETED|Part A||0
8298523|NCT01565889|20460112|P3|NOT COMPLETED|Part A||0
8298524|NCT01565889|20460113|P2|NOT COMPLETED|Part A||0
8298525|NCT01565889|20460114|P1|NOT COMPLETED|Part A||1
8298526|NCT01565889|20460109|P6|COMPLETED|Part A||0
8298527|NCT01565889|20460110|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
8298528|NCT01565889|20460111|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
8298529|NCT01565889|20460112|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
8298530|NCT01565889|20460113|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
8298531|NCT01565889|20460114|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
8298532|NCT01565889|20460109|P6|STARTED|Part A||0
8298533|NCT01565889|20460110|P5|STARTED|Part A||7
8298534|NCT01565889|20460111|P4|STARTED|Part A||7
8298535|NCT01565889|20460112|P3|STARTED|Part A||8
8298536|NCT01565889|20460113|P2|STARTED|Part A||4
8298537|NCT01565889|20460114|P1|STARTED|Part A||12
8298538|NCT01565850|20460145|P2|NOT COMPLETED|Overall Study||8
8298539|NCT01565850|20460146|P1|NOT COMPLETED|Overall Study||20
8298540|NCT01565850|20460145|P2|COMPLETED|Overall Study||42
8298541|NCT01565850|20460146|P1|COMPLETED|Overall Study||83
8298542|NCT01565850|20460145|P2|STARTED|Overall Study||50
8298543|NCT01565850|20460146|P1|STARTED|Overall Study||103
8298544|NCT01565707|20460166|P4|NOT COMPLETED|Overall Study||5
8298545|NCT01565707|20460167|P3|NOT COMPLETED|Overall Study||3
8298546|NCT01565707|20460168|P2|NOT COMPLETED|Overall Study||8
8298547|NCT01565707|20460169|P1|NOT COMPLETED|Overall Study||9
8298548|NCT01565707|20460166|P4|COMPLETED|Overall Study||17
8298549|NCT01565707|20460167|P3|COMPLETED|Overall Study||16
8298550|NCT01565707|20460168|P2|COMPLETED|Overall Study||65
8298551|NCT01565707|20460169|P1|COMPLETED|Overall Study||66
8298552|NCT01565707|20460166|P4|Treated|Overall Study||22
8298553|NCT01565707|20460167|P3|Treated|Overall Study||19
8298554|NCT01565707|20460168|P2|Treated|Overall Study||73
8298555|NCT01565707|20460169|P1|Treated|Overall Study||73
8298556|NCT01565707|20460166|P4|STARTED|Overall Study||22
8298557|NCT01565707|20460167|P3|STARTED|Overall Study||19
8298558|NCT01565707|20460168|P2|STARTED|Overall Study||73
8298559|NCT01565707|20460169|P1|STARTED|Overall Study||75
8298560|NCT01565694|20460260|P1|NOT COMPLETED|Fixed-Dose Assessment Period||4
8298561|NCT01565694|20460260|P1|COMPLETED|Fixed-Dose Assessment Period||58
8298562|NCT01565694|20460260|P1|STARTED|Fixed-Dose Assessment Period||62
8298563|NCT01565694|20460260|P1|NOT COMPLETED|Dose-Titration Period||14
8298564|NCT01565694|20460260|P1|COMPLETED|Dose-Titration Period||62
8298565|NCT01565694|20460260|P1|STARTED|Dose-Titration Period||76
8298566|NCT01565668|20460281|P2|NOT COMPLETED|Overall Study||38
8298567|NCT01565668|20460282|P1|NOT COMPLETED|Overall Study||38
8298568|NCT01565668|20460281|P2|COMPLETED|Overall Study||0
8298569|NCT01565668|20460282|P1|COMPLETED|Overall Study||0
8298570|NCT01565668|20460281|P2|Completed Long-term Follow-up|Overall Study||0
8298571|NCT01565668|20460282|P1|Completed Long-term Follow-up|Overall Study||0
8298572|NCT01565668|20460281|P2|Started Long-term Follow-up|Overall Study||33
8298573|NCT01565668|20460282|P1|Started Long-term Follow-up|Overall Study||36
8298574|NCT01565668|20460281|P2|Completed 30-day Follow-up|Overall Study||5
8298575|NCT01565668|20460282|P1|Completed 30-day Follow-up|Overall Study||11
8298576|NCT01565668|20460281|P2|Started 30-day Follow-up|Overall Study||37
8298577|NCT01565668|20460282|P1|Started 30-day Follow-up|Overall Study||37
8298578|NCT01565668|20460281|P2|Completed Treatment Per Protocol|Overall Study||0
8298579|NCT01565668|20460282|P1|Completed Treatment Per Protocol|Overall Study||0
8298580|NCT01565668|20460281|P2|STARTED|Overall Study||38
8298581|NCT01565668|20460282|P1|STARTED|Overall Study||38
8298582|NCT01565642|20460306|P2|NOT COMPLETED|Overall Study||1
8298583|NCT01565642|20460307|P1|NOT COMPLETED|Overall Study||2
8298584|NCT01565642|20460306|P2|COMPLETED|Overall Study||150
8298585|NCT01565642|20460307|P1|COMPLETED|Overall Study||149
8298586|NCT01565642|20460306|P2|STARTED|Overall Study||151
8298587|NCT01565642|20460307|P1|STARTED|Overall Study||151
8298588|NCT01565616|20460329|P1|NOT COMPLETED|Overall Study||0
8298589|NCT01565616|20460329|P1|COMPLETED|Overall Study||22
8298590|NCT01565616|20460329|P1|Second Component: Related or Unrelated|Overall Study||17
8298591|NCT01565616|20460329|P1|First Component: 5 Related Donors|Overall Study||5
8298592|NCT01565616|20460329|P1|STARTED|Overall Study||22
8298593|NCT01565564|20460342|P2|NOT COMPLETED|Overall Study||1
8298594|NCT01565564|20460343|P1|NOT COMPLETED|Overall Study||5
8298595|NCT01565564|20460342|P2|COMPLETED|Overall Study||361
8298596|NCT01565564|20460343|P1|COMPLETED|Overall Study||339
8298597|NCT01565564|20460342|P2|STARTED|Overall Study||362
8298598|NCT01565564|20460343|P1|STARTED|Overall Study||344
8298599|NCT01565551|20460353|P2|NOT COMPLETED|Overall Study||0
8298600|NCT01565551|20460354|P1|NOT COMPLETED|Overall Study||0
8298601|NCT01565551|20460353|P2|COMPLETED|Overall Study||51
8298602|NCT01565551|20460354|P1|COMPLETED|Overall Study||586
8298603|NCT01565551|20460353|P2|6-Month Outcomes|Overall Study||30
8298604|NCT01565551|20460354|P1|6-Month Outcomes|Overall Study||412
8298605|NCT01565551|20460353|P2|Neuroimaging|Overall Study||25
8298606|NCT01565551|20460354|P1|Neuroimaging|Overall Study||233
8298607|NCT01565551|20460353|P2|Biospecimens/Biomarkers|Overall Study||22
8298608|NCT01565551|20460354|P1|Biospecimens/Biomarkers|Overall Study||479
8298609|NCT01565551|20460353|P2|Clinical/Demographics|Overall Study||51
8298610|NCT01565551|20460354|P1|Clinical/Demographics|Overall Study||586
8298611|NCT01565551|20460353|P2|STARTED|Overall Study||51
8298612|NCT01565551|20460354|P1|STARTED|Overall Study||586
8298613|NCT01565538|20460362|P2|NOT COMPLETED|Overall Study||0
8298614|NCT01565538|20460363|P1|NOT COMPLETED|Overall Study||0
8298615|NCT01565538|20460362|P2|COMPLETED|Overall Study||62
8298616|NCT01565538|20460363|P1|COMPLETED|Overall Study||61
8298617|NCT01565538|20460362|P2|STARTED|Overall Study||62
8298618|NCT01565538|20460363|P1|STARTED|Overall Study||61
8298619|NCT01565499|20460373|P1|NOT COMPLETED|Overall Study||8
8298620|NCT01565499|20460373|P1|COMPLETED|Overall Study||75
8298621|NCT01565499|20460373|P1|STARTED|Overall Study||83
8298622|NCT01565382|20460387|P2|NOT COMPLETED|Overall Study||0
8298623|NCT01565382|20460388|P1|NOT COMPLETED|Overall Study||0
8298624|NCT01565382|20460387|P2|COMPLETED|Overall Study||7
8298625|NCT01565382|20460388|P1|COMPLETED|Overall Study||40
8298626|NCT01565382|20460387|P2|STARTED|Overall Study||7
8298627|NCT01565382|20460388|P1|STARTED|Overall Study||40
8298628|NCT01565369|20460393|P1|NOT COMPLETED|Overall Study||0
8298629|NCT01565369|20460393|P1|COMPLETED|Overall Study||35
8298630|NCT01565369|20460393|P1|STARTED|Overall Study||35
8298631|NCT01565356|20460399|P1|NOT COMPLETED|Overall Study||0
8298632|NCT01565356|20460399|P1|COMPLETED|Overall Study||41
8298633|NCT01565356|20460399|P1|STARTED|Overall Study||41
8298634|NCT01565343|20460407|P3|NOT COMPLETED|Overall Study||0
8298635|NCT01565343|20460408|P2|NOT COMPLETED|Overall Study||0
8298636|NCT01565343|20460409|P1|NOT COMPLETED|Overall Study||1
8298637|NCT01565343|20460407|P3|COMPLETED|Overall Study||10
8298638|NCT01565343|20460408|P2|COMPLETED|Overall Study||4
8298639|NCT01565343|20460409|P1|COMPLETED|Overall Study||10
8298640|NCT01565343|20460407|P3|STARTED|Overall Study||10
8298641|NCT01565343|20460408|P2|STARTED|Overall Study||4
8298642|NCT01565343|20460409|P1|STARTED|Overall Study||11
8298643|NCT01565330|20460420|P4|NOT COMPLETED|Overall Study||0
8298644|NCT01565330|20460421|P3|NOT COMPLETED|Overall Study||0
8298645|NCT01565330|20460422|P2|NOT COMPLETED|Overall Study||0
8298646|NCT01565330|20460423|P1|NOT COMPLETED|Overall Study||0
8298647|NCT01565330|20460420|P4|COMPLETED|Overall Study||7
8298648|NCT01565330|20460421|P3|COMPLETED|Overall Study||4
8298649|NCT01565330|20460422|P2|COMPLETED|Overall Study||4
8298650|NCT01565330|20460423|P1|COMPLETED|Overall Study||5
8298651|NCT01565330|20460420|P4|STARTED|Overall Study||7
8298652|NCT01565330|20460421|P3|STARTED|Overall Study||4
8298653|NCT01565330|20460422|P2|STARTED|Overall Study||4
8298654|NCT01565330|20460423|P1|STARTED|Overall Study||5
8298655|NCT01565291|20460439|P2|NOT COMPLETED|Overall Study||0
8298656|NCT01565291|20460440|P1|NOT COMPLETED|Overall Study||1
8298657|NCT01565291|20460439|P2|COMPLETED|Overall Study||16
8298658|NCT01565291|20460440|P1|COMPLETED|Overall Study||15
8298659|NCT01565291|20460439|P2|STARTED|Overall Study||16
8298660|NCT01565291|20460440|P1|STARTED|Overall Study||16
8298661|NCT01565148|20460452|P4|NOT COMPLETED|Overall Study||13
8298662|NCT01565148|20460453|P3|NOT COMPLETED|Overall Study||7
8298663|NCT01565148|20460454|P2|NOT COMPLETED|Overall Study||15
8298664|NCT01565148|20460455|P1|NOT COMPLETED|Overall Study||15
8298665|NCT01565148|20460452|P4|COMPLETED|Overall Study||32
8298666|NCT01565148|20460453|P3|COMPLETED|Overall Study||40
8298667|NCT01565148|20460454|P2|COMPLETED|Overall Study||31
8298668|NCT01565148|20460455|P1|COMPLETED|Overall Study||32
8298669|NCT01565148|20460452|P4|STARTED|Overall Study||45
8298670|NCT01565148|20460453|P3|STARTED|Overall Study||47
8298671|NCT01565148|20460454|P2|STARTED|Overall Study||46
8298672|NCT01565148|20460455|P1|STARTED|Overall Study||47
8298673|NCT01565083|20460491|P2|NOT COMPLETED|Overall Study||39
8298674|NCT01565083|20460492|P1|NOT COMPLETED|Overall Study||33
8298675|NCT01565083|20460491|P2|COMPLETED|Overall Study||68
8298676|NCT01565083|20460492|P1|COMPLETED|Overall Study||73
8298677|NCT01565083|20460491|P2|STARTED|Overall Study||107
8298678|NCT01565083|20460492|P1|STARTED|Overall Study||106
8298679|NCT01564953|20460518|P1|NOT COMPLETED|Overall Study||0
8298680|NCT01564953|20460518|P1|COMPLETED|Overall Study||143
8298681|NCT01564953|20460518|P1|STARTED|Overall Study||143
8298682|NCT01564914|20460528|P2|NOT COMPLETED|Overall Study||0
8298683|NCT01564914|20460529|P1|NOT COMPLETED|Overall Study||0
8298684|NCT01564914|20460528|P2|COMPLETED|Overall Study||6
8298685|NCT01564914|20460529|P1|COMPLETED|Overall Study||16
8298686|NCT01564914|20460528|P2|STARTED|Overall Study||6
8298687|NCT01564914|20460529|P1|STARTED|Overall Study||16
8298688|NCT01564862|20460543|P3|NOT COMPLETED|Overall Study||30
8298689|NCT01564862|20460544|P2|NOT COMPLETED|Overall Study||34
8298690|NCT01564862|20460545|P1|NOT COMPLETED|Overall Study||30
8298691|NCT01564862|20460543|P3|COMPLETED|Overall Study||164
8298692|NCT01564862|20460544|P2|COMPLETED|Overall Study||176
8298693|NCT01564862|20460545|P1|COMPLETED|Overall Study||168
8298694|NCT01564862|20460543|P3|Received Treatment|Overall Study||191
8298695|NCT01564862|20460544|P2|Received Treatment|Overall Study||207
8298696|NCT01564862|20460545|P1|Received Treatment|Overall Study||196
8298697|NCT01564862|20460543|P3|STARTED|Overall Study||194
8298698|NCT01564862|20460544|P2|STARTED|Overall Study||210
8298699|NCT01564862|20460545|P1|STARTED|Overall Study||198
8298700|NCT01564784|20460596|P2|NOT COMPLETED|Overall Study||133
8298701|NCT01564784|20460597|P1|NOT COMPLETED|Overall Study||134
8298702|NCT01564784|20460596|P2|COMPLETED|Overall Study||10
8298703|NCT01564784|20460597|P1|COMPLETED|Overall Study||30
8298704|NCT01564784|20460596|P2|STARTED|Overall Study|Treated (162 randomized)|143
8298705|NCT01564784|20460597|P1|STARTED|Overall Study|Treated (164 randomized)|164
8298706|NCT01564758|20460624|P1|NOT COMPLETED|Overall Study||14
8298707|NCT01564758|20460624|P1|COMPLETED|Overall Study||85
8298708|NCT01564758|20460624|P1|STARTED|Overall Study||99
8298709|NCT01564732|20460631|P2|NOT COMPLETED|Overall Study||5
8298710|NCT01564732|20460632|P1|NOT COMPLETED|Overall Study||6
8298711|NCT01564732|20460631|P2|COMPLETED|Overall Study||0
8298712|NCT01564732|20460632|P1|COMPLETED|Overall Study||0
8298713|NCT01564732|20460631|P2|STARTED|Overall Study||5
8298714|NCT01564732|20460632|P1|STARTED|Overall Study||6
8298715|NCT01564706|20460648|P1|NOT COMPLETED|Overall Study||0
8298716|NCT01564706|20460648|P1|COMPLETED|Overall Study||9
8298717|NCT01564706|20460648|P1|STARTED|Overall Study||9
8298718|NCT01564693|20460655|P3|NOT COMPLETED|Overall Study||0
8298719|NCT01564693|20460656|P2|NOT COMPLETED|Overall Study||0
8298720|NCT01564693|20460657|P1|NOT COMPLETED|Overall Study||0
8298721|NCT01564693|20460655|P3|COMPLETED|Overall Study||2
8298722|NCT01564693|20460656|P2|COMPLETED|Overall Study||4
8298723|NCT01564693|20460657|P1|COMPLETED|Overall Study||9
8298724|NCT01564693|20460655|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
8298725|NCT01564693|20460656|P2|STARTED|Overall Study||4
8298726|NCT01564693|20460657|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
8298727|NCT01564654|20460665|P1|NOT COMPLETED|Overall Study||0
8298728|NCT01564654|20460665|P1|COMPLETED|Overall Study|106 knees (bilateral)|89
8298729|NCT01564654|20460665|P1|STARTED|Overall Study|106 knees (bilateral)|89
8298730|NCT01564628|20460672|P3|NOT COMPLETED|Overall Study||2
8298731|NCT01564628|20460673|P2|NOT COMPLETED|Overall Study||2
8298732|NCT01564628|20460674|P1|NOT COMPLETED|Overall Study||4
8298733|NCT01564628|20460672|P3|COMPLETED|Overall Study||61
8298734|NCT01564628|20460673|P2|COMPLETED|Overall Study||56
8298735|NCT01564628|20460674|P1|COMPLETED|Overall Study||181
8298736|NCT01564628|20460672|P3|STARTED|Overall Study||63
8298737|NCT01564628|20460673|P2|STARTED|Overall Study||58
8298738|NCT01564628|20460674|P1|STARTED|Overall Study||185
8298739|NCT01564537|20460680|P2|NOT COMPLETED|Overall Study||6
8298740|NCT01564537|20460681|P1|NOT COMPLETED|Overall Study||6
8298741|NCT01564537|20460680|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
8298742|NCT01564537|20460681|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
8298743|NCT01564537|20460680|P2|Safety Population: Received Study Drug|Overall Study||360
8298744|NCT01564537|20460681|P1|Safety Population: Received Study Drug|Overall Study||360
8298745|NCT01564537|20460680|P2|STARTED|Overall Study||362
8298746|NCT01564537|20460681|P1|STARTED|Overall Study||360
8298747|NCT01564459|20460704|P3|NOT COMPLETED|Double-blind Treatment||1
8298748|NCT01564459|20460705|P2|NOT COMPLETED|Double-blind Treatment||0
8298749|NCT01564459|20460706|P1|NOT COMPLETED|Double-blind Treatment||0
8298750|NCT01564459|20460704|P3|COMPLETED|Double-blind Treatment||82
8298751|NCT01564459|20460705|P2|COMPLETED|Double-blind Treatment||87
8298752|NCT01564459|20460706|P1|COMPLETED|Double-blind Treatment||0
8298753|NCT01564459|20460704|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
8298754|NCT01564459|20460705|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
8298755|NCT01564459|20460706|P1|STARTED|Double-blind Treatment||0
8298756|NCT01564459|20460704|P3|NOT COMPLETED|Run-In||0
8298757|NCT01564459|20460705|P2|NOT COMPLETED|Run-In||0
8298758|NCT01564459|20460706|P1|NOT COMPLETED|Run-In||12
8298759|NCT01564459|20460704|P3|COMPLETED|Run-In||83
8298760|NCT01564459|20460705|P2|COMPLETED|Run-In||87
8298761|NCT01564459|20460706|P1|COMPLETED|Run-In||0
8298762|NCT01564459|20460704|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
8298763|NCT01564459|20460705|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
8298764|NCT01564459|20460706|P1|STARTED|Run-In||12
8298765|NCT01564407|20460730|P5|NOT COMPLETED|Overall Study||0
8298766|NCT01564407|20460731|P4|NOT COMPLETED|Overall Study||1
8298767|NCT01564407|20460732|P3|NOT COMPLETED|Overall Study||0
8298768|NCT01564407|20460733|P2|NOT COMPLETED|Overall Study||2
8298769|NCT01564407|20460734|P1|NOT COMPLETED|Overall Study||0
8298770|NCT01564407|20460730|P5|COMPLETED|Overall Study||0
8298771|NCT01564407|20460731|P4|COMPLETED|Overall Study||1
8298772|NCT01564407|20460732|P3|COMPLETED|Overall Study||4
8298773|NCT01564407|20460733|P2|COMPLETED|Overall Study||3
8298774|NCT01564407|20460734|P1|COMPLETED|Overall Study||4
8298775|NCT01564407|20460730|P5|STARTED|Overall Study||0
8298776|NCT01564407|20460731|P4|STARTED|Overall Study||2
8298777|NCT01564407|20460732|P3|STARTED|Overall Study||4
8298778|NCT01564407|20460733|P2|STARTED|Overall Study||5
8298779|NCT01564407|20460734|P1|STARTED|Overall Study||4
8298780|NCT01564394|20460775|P2|NOT COMPLETED|Overall Study||10
8298781|NCT01564394|20460776|P1|NOT COMPLETED|Overall Study||6
8298782|NCT01564394|20460775|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
8298783|NCT01564394|20460776|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
8298784|NCT01564394|20460775|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
8298785|NCT01564394|20460776|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
8298786|NCT01564277|20460790|P2|NOT COMPLETED|Overall Study||1
8298787|NCT01564277|20460791|P1|NOT COMPLETED|Overall Study||1
8298788|NCT01564277|20460790|P2|COMPLETED|Overall Study||11
8298789|NCT01564277|20460791|P1|COMPLETED|Overall Study||11
8298790|NCT01564277|20460790|P2|STARTED|Overall Study||12
8298791|NCT01564277|20460791|P1|STARTED|Overall Study||12
8298792|NCT01563978|20460809|P2|NOT COMPLETED|Overall Study||2
8298793|NCT01563978|20460810|P1|NOT COMPLETED|Overall Study||4
8298794|NCT01563978|20460809|P2|COMPLETED|Overall Study||65
8298795|NCT01563978|20460810|P1|COMPLETED|Overall Study||64
8298796|NCT01563978|20460809|P2|Randomised But Did Not Receive Treatment|Overall Study||0
8298797|NCT01563978|20460810|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8298798|NCT01563978|20460809|P2|STARTED|Overall Study|Patients who received treatment.|67
8298799|NCT01563978|20460810|P1|STARTED|Overall Study|Patients who received treatment.|68
8298800|NCT01563913|20460836|P2|NOT COMPLETED|Overall Study||0
8298801|NCT01563913|20460837|P1|NOT COMPLETED|Overall Study||2
8298802|NCT01563913|20460836|P2|COMPLETED|Overall Study||15
8298803|NCT01563913|20460837|P1|COMPLETED|Overall Study||13
8298804|NCT01563913|20460836|P2|STARTED|Overall Study||15
8298805|NCT01563913|20460837|P1|STARTED|Overall Study||15
8298806|NCT01563536|20460849|P2|NOT COMPLETED|Overall Study||2
8298807|NCT01563536|20460850|P1|NOT COMPLETED|Overall Study||1
8298808|NCT01563536|20460849|P2|COMPLETED|Overall Study||4
8298809|NCT01563536|20460850|P1|COMPLETED|Overall Study||5
8298810|NCT01563536|20460849|P2|STARTED|Overall Study||6
8298811|NCT01563536|20460850|P1|STARTED|Overall Study||6
8298812|NCT01563406|20460882|P4|NOT COMPLETED|Overall Study||0
8298813|NCT01563406|20460883|P3|NOT COMPLETED|Overall Study||0
8298814|NCT01563406|20460884|P2|NOT COMPLETED|Overall Study||0
8298815|NCT01563406|20460885|P1|NOT COMPLETED|Overall Study||0
8298816|NCT01563406|20460882|P4|COMPLETED|Overall Study|112 hubs|29
8298817|NCT01563406|20460883|P3|COMPLETED|Overall Study|101 hubs|30
8298818|NCT01563406|20460884|P2|COMPLETED|Overall Study|102 hubs|30
8298819|NCT01563406|20460885|P1|COMPLETED|Overall Study|194 hubs|60
8298820|NCT01563406|20460882|P4|STARTED|Overall Study|112 hubs|29
8298821|NCT01563406|20460883|P3|STARTED|Overall Study|101 hubs|30
8298822|NCT01563406|20460884|P2|STARTED|Overall Study|102 hubs|30
8298823|NCT01563406|20460885|P1|STARTED|Overall Study|194 hubs|60
8298824|NCT01563198|20460903|P1|NOT COMPLETED|After Training||0
8298825|NCT01563198|20460903|P1|COMPLETED|After Training||47979
8298826|NCT01563198|20460903|P1|STARTED|After Training||47979
8298827|NCT01563198|20460903|P1|NOT COMPLETED|Baseline||0
8298828|NCT01563198|20460903|P1|COMPLETED|Baseline||49733
8298829|NCT01563198|20460903|P1|STARTED|Baseline||49733
8298830|NCT01563185|20460909|P1|NOT COMPLETED|Overall Study||2
8298831|NCT01563185|20460909|P1|COMPLETED|Overall Study||10
8298832|NCT01563185|20460909|P1|STARTED|Overall Study||12
8298833|NCT01563172|20460923|P1|NOT COMPLETED|Overall Study||13
8298834|NCT01563172|20460923|P1|COMPLETED|Overall Study||52
8298835|NCT01563172|20460923|P1|Control Dentifrice|Overall Study||60
8298836|NCT01563172|20460923|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
8298837|NCT01563172|20460923|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
8298838|NCT01563172|20460923|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
8298839|NCT01563172|20460923|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
8298840|NCT01563172|20460923|P1|STARTED|Overall Study||65
8298841|NCT01563081|20460952|P2|NOT COMPLETED|Overall Study||0
8298842|NCT01563081|20460953|P1|NOT COMPLETED|Overall Study||0
8298843|NCT01563081|20460952|P2|COMPLETED|Overall Study||30
8298844|NCT01563081|20460953|P1|COMPLETED|Overall Study||30
8298845|NCT01563081|20460952|P2|STARTED|Overall Study||30
8298846|NCT01563081|20460953|P1|STARTED|Overall Study||30
8298847|NCT01563055|20460966|P1|NOT COMPLETED|Overall Study||0
8298848|NCT01563055|20460966|P1|COMPLETED|Overall Study||10
8298849|NCT01563055|20460966|P1|STARTED|Overall Study||10
8298850|NCT01563029|20461029|P5|NOT COMPLETED|Overall Study||29
8298851|NCT01563029|20461030|P4|NOT COMPLETED|Overall Study||33
8298852|NCT01563029|20461031|P3|NOT COMPLETED|Overall Study||33
8298853|NCT01563029|20461032|P2|NOT COMPLETED|Overall Study||24
8298854|NCT01563029|20461033|P1|NOT COMPLETED|Overall Study||53
8298855|NCT01563029|20461029|P5|COMPLETED|Overall Study||89
8298856|NCT01563029|20461030|P4|COMPLETED|Overall Study||85
8298857|NCT01563029|20461031|P3|COMPLETED|Overall Study||87
8298858|NCT01563029|20461032|P2|COMPLETED|Overall Study||94
8298859|NCT01563029|20461033|P1|COMPLETED|Overall Study||66
8298860|NCT01563029|20461029|P5|STARTED|Overall Study||118
8298861|NCT01563029|20461030|P4|STARTED|Overall Study||118
8298862|NCT01563029|20461031|P3|STARTED|Overall Study||120
8298863|NCT01563029|20461032|P2|STARTED|Overall Study||118
8298864|NCT01563029|20461033|P1|STARTED|Overall Study||119
8298865|NCT01563003|20461083|P2|NOT COMPLETED|Overall Study||0
8298866|NCT01563003|20461084|P1|NOT COMPLETED|Overall Study||0
8298867|NCT01563003|20461083|P2|COMPLETED|Overall Study||15
8298868|NCT01563003|20461084|P1|COMPLETED|Overall Study||16
8298869|NCT01563003|20461083|P2|STARTED|Overall Study||15
8298870|NCT01563003|20461084|P1|STARTED|Overall Study||16
8298871|NCT01562886|20461094|P1|NOT COMPLETED|Overall Study||1
8298872|NCT01562886|20461094|P1|COMPLETED|Overall Study||13
8298873|NCT01562886|20461094|P1|STARTED|Overall Study||14
8298874|NCT01562873|20461099|P2|NOT COMPLETED|Overall Study||0
8298875|NCT01562873|20461100|P1|NOT COMPLETED|Overall Study||21
8298876|NCT01562873|20461099|P2|COMPLETED|Overall Study||0
8298877|NCT01562873|20461100|P1|COMPLETED|Overall Study||0
8298878|NCT01562873|20461099|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
8298879|NCT01562873|20461100|P1|STARTED|Overall Study||21
8298880|NCT01562782|20461109|P2|NOT COMPLETED|Overall Study||5
8298881|NCT01562782|20461110|P1|NOT COMPLETED|Overall Study||4
8298882|NCT01562782|20461109|P2|COMPLETED|Overall Study||15
8298883|NCT01562782|20461110|P1|COMPLETED|Overall Study||15
8298884|NCT01562782|20461109|P2|STARTED|Overall Study||20
8298885|NCT01562782|20461110|P1|STARTED|Overall Study||19
8298886|NCT01562756|20461134|P1|NOT COMPLETED|Overall Study||0
8298887|NCT01562756|20461134|P1|COMPLETED|Overall Study||6
8298888|NCT01562756|20461134|P1|STARTED|Overall Study||6
8298889|NCT01562743|20461139|P1|NOT COMPLETED|Overall Study||52
8298890|NCT01562743|20461139|P1|COMPLETED|Overall Study||133
8298891|NCT01562743|20461139|P1|STARTED|Overall Study||185
8298892|NCT01562678|20461151|P2|NOT COMPLETED|Overall Study||2
8298893|NCT01562678|20461152|P1|NOT COMPLETED|Overall Study||6
8298894|NCT01562678|20461151|P2|COMPLETED|Overall Study||12
8298895|NCT01562678|20461152|P1|COMPLETED|Overall Study||8
8298896|NCT01562678|20461151|P2|STARTED|Overall Study||14
8298897|NCT01562678|20461152|P1|STARTED|Overall Study||14
8298898|NCT01562613|20461158|P1|NOT COMPLETED|Overall Study||4
8298899|NCT01562613|20461158|P1|COMPLETED|Overall Study||529
8298900|NCT01562613|20461158|P1|STARTED|Overall Study||533
8298901|NCT01562548|20461168|P4|NOT COMPLETED|Overall Study||0
8298902|NCT01562548|20461169|P3|NOT COMPLETED|Overall Study||1
8298903|NCT01562548|20461170|P2|NOT COMPLETED|Overall Study||0
8298904|NCT01562548|20461171|P1|NOT COMPLETED|Overall Study||0
8298905|NCT01562548|20461168|P4|COMPLETED|Overall Study||14
8298906|NCT01562548|20461169|P3|COMPLETED|Overall Study||24
8298907|NCT01562548|20461170|P2|COMPLETED|Overall Study||15
8298908|NCT01562548|20461171|P1|COMPLETED|Overall Study||25
8298909|NCT01562548|20461168|P4|STARTED|Overall Study||14
8298910|NCT01562548|20461169|P3|STARTED|Overall Study||25
8298911|NCT01562548|20461170|P2|STARTED|Overall Study||15
8298912|NCT01562548|20461171|P1|STARTED|Overall Study||25
8298913|NCT01562444|20461224|P3|NOT COMPLETED|Overall Study||7
8298914|NCT01562444|20461225|P2|NOT COMPLETED|Overall Study||2
8298915|NCT01562444|20461226|P1|NOT COMPLETED|Overall Study||5
8298916|NCT01562444|20461224|P3|COMPLETED|Overall Study||99
8298917|NCT01562444|20461225|P2|COMPLETED|Overall Study||49
8298918|NCT01562444|20461226|P1|COMPLETED|Overall Study||43
8298919|NCT01562444|20461224|P3|STARTED|Overall Study||106
8298920|NCT01562444|20461225|P2|STARTED|Overall Study||51
8298921|NCT01562444|20461226|P1|STARTED|Overall Study||48
8298922|NCT01562379|20461476|P5|NOT COMPLETED|Overall Study||40
8298923|NCT01562379|20461477|P4|NOT COMPLETED|Overall Study||57
8298924|NCT01562379|20461478|P3|NOT COMPLETED|Overall Study||62
8298925|NCT01562379|20461479|P2|NOT COMPLETED|Overall Study||97
8298926|NCT01562379|20461480|P1|NOT COMPLETED|Overall Study||126
8298927|NCT01562379|20461476|P5|COMPLETED|Overall Study||785
8298928|NCT01562379|20461477|P4|COMPLETED|Overall Study||786
8298929|NCT01562379|20461478|P3|COMPLETED|Overall Study||789
8298930|NCT01562379|20461479|P2|COMPLETED|Overall Study||1395
8298931|NCT01562379|20461480|P1|COMPLETED|Overall Study||1312
8298932|NCT01562379|20461476|P5|STARTED|Overall Study||825
8298933|NCT01562379|20461477|P4|STARTED|Overall Study||843
8298934|NCT01562379|20461478|P3|STARTED|Overall Study||851
8298935|NCT01562379|20461479|P2|STARTED|Overall Study||1492
8298936|NCT01562379|20461480|P1|STARTED|Overall Study||1438
8298937|NCT01562327|20461492|P1|NOT COMPLETED|Overall Study||8
8298938|NCT01562327|20461492|P1|COMPLETED|Overall Study||42
8298939|NCT01562327|20461492|P1|STARTED|Overall Study||50
8298940|NCT01562314|20461522|P2|NOT COMPLETED|Overall Study||8
8298941|NCT01562314|20461523|P1|NOT COMPLETED|Overall Study||13
8298942|NCT01562314|20461522|P2|COMPLETED|Overall Study||23
8298943|NCT01562314|20461523|P1|COMPLETED|Overall Study||16
8298944|NCT01562314|20461522|P2|Per Protocol (PP) Analysis Set|Overall Study||27
8298945|NCT01562314|20461523|P1|Per Protocol (PP) Analysis Set|Overall Study||17
8298946|NCT01562314|20461522|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
8298947|NCT01562314|20461523|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
8298948|NCT01562314|20461522|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
8298949|NCT01562314|20461523|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
8298950|NCT01562314|20461522|P2|STARTED|Overall Study||31
8298951|NCT01562314|20461523|P1|STARTED|Overall Study||29
8298952|NCT01562275|20461580|P13|NOT COMPLETED|Stage 2||5
8298953|NCT01562275|20461581|P12|NOT COMPLETED|Stage 2||14
8298954|NCT01562275|20461582|P11|NOT COMPLETED|Stage 2||0
8298955|NCT01562275|20461583|P10|NOT COMPLETED|Stage 2||0
8298956|NCT01562275|20461584|P9|NOT COMPLETED|Stage 2||0
8298957|NCT01562275|20461585|P8|NOT COMPLETED|Stage 2||0
8298958|NCT01562275|20461586|P7|NOT COMPLETED|Stage 2||0
8298959|NCT01562275|20461587|P6|NOT COMPLETED|Stage 2||0
8298960|NCT01562275|20461588|P5|NOT COMPLETED|Stage 2||0
8298961|NCT01562275|20461589|P4|NOT COMPLETED|Stage 2||0
8298962|NCT01562275|20461590|P3|NOT COMPLETED|Stage 2||0
8298963|NCT01562275|20461591|P2|NOT COMPLETED|Stage 2||0
8298964|NCT01562275|20461592|P1|NOT COMPLETED|Stage 2||0
8298965|NCT01562275|20461580|P13|COMPLETED|Stage 2||0
8298966|NCT01562275|20461581|P12|COMPLETED|Stage 2||0
8298967|NCT01562275|20461582|P11|COMPLETED|Stage 2||0
8298968|NCT01562275|20461583|P10|COMPLETED|Stage 2||0
8298969|NCT01562275|20461584|P9|COMPLETED|Stage 2||0
8298970|NCT01562275|20461585|P8|COMPLETED|Stage 2||0
8298971|NCT01562275|20461586|P7|COMPLETED|Stage 2||0
8298972|NCT01562275|20461587|P6|COMPLETED|Stage 2||0
8298973|NCT01562275|20461588|P5|COMPLETED|Stage 2||0
8298974|NCT01562275|20461589|P4|COMPLETED|Stage 2||0
8298975|NCT01562275|20461590|P3|COMPLETED|Stage 2||0
8298976|NCT01562275|20461591|P2|COMPLETED|Stage 2||0
8298977|NCT01562275|20461592|P1|COMPLETED|Stage 2||0
8298978|NCT01562275|20461580|P13|STARTED|Stage 2||5
8298979|NCT01562275|20461581|P12|STARTED|Stage 2||14
8298980|NCT01562275|20461582|P11|STARTED|Stage 2||0
8298981|NCT01562275|20461583|P10|STARTED|Stage 2||0
8298982|NCT01562275|20461584|P9|STARTED|Stage 2||0
8298983|NCT01562275|20461585|P8|STARTED|Stage 2||0
8298984|NCT01562275|20461586|P7|STARTED|Stage 2||0
8298985|NCT01562275|20461587|P6|STARTED|Stage 2||0
8298986|NCT01562275|20461588|P5|STARTED|Stage 2||0
8298987|NCT01562275|20461589|P4|STARTED|Stage 2||0
8298988|NCT01562275|20461590|P3|STARTED|Stage 2||0
8298989|NCT01562275|20461591|P2|STARTED|Stage 2||0
8298990|NCT01562275|20461592|P1|STARTED|Stage 2||0
8298991|NCT01562275|20461580|P13|NOT COMPLETED|Stage 1||0
8298992|NCT01562275|20461581|P12|NOT COMPLETED|Stage 1||0
8298993|NCT01562275|20461582|P11|NOT COMPLETED|Stage 1||3
8298994|NCT01562275|20461583|P10|NOT COMPLETED|Stage 1||7
8298995|NCT01562275|20461584|P9|NOT COMPLETED|Stage 1||3
8298996|NCT01562275|20461585|P8|NOT COMPLETED|Stage 1||7
8298997|NCT01562275|20461586|P7|NOT COMPLETED|Stage 1||3
8298998|NCT01562275|20461587|P6|NOT COMPLETED|Stage 1||4
8298999|NCT01562275|20461588|P5|NOT COMPLETED|Stage 1||4
8299000|NCT01562275|20461589|P4|NOT COMPLETED|Stage 1||4
8299001|NCT01562275|20461590|P3|NOT COMPLETED|Stage 1||3
8299002|NCT01562275|20461591|P2|NOT COMPLETED|Stage 1||7
8299003|NCT01562275|20461592|P1|NOT COMPLETED|Stage 1||3
8299004|NCT01562275|20461580|P13|COMPLETED|Stage 1||0
8299005|NCT01562275|20461581|P12|COMPLETED|Stage 1||0
8299006|NCT01562275|20461582|P11|COMPLETED|Stage 1||0
8299007|NCT01562275|20461583|P10|COMPLETED|Stage 1||0
8299008|NCT01562275|20461584|P9|COMPLETED|Stage 1||0
8299009|NCT01562275|20461585|P8|COMPLETED|Stage 1||0
8299010|NCT01562275|20461586|P7|COMPLETED|Stage 1||0
8299011|NCT01562275|20461587|P6|COMPLETED|Stage 1||0
8299012|NCT01562275|20461588|P5|COMPLETED|Stage 1||0
8299013|NCT01562275|20461589|P4|COMPLETED|Stage 1||0
8299014|NCT01562275|20461590|P3|COMPLETED|Stage 1||0
8299015|NCT01562275|20461591|P2|COMPLETED|Stage 1||0
8299016|NCT01562275|20461592|P1|COMPLETED|Stage 1||0
8299017|NCT01562275|20461580|P13|STARTED|Stage 1||0
8299018|NCT01562275|20461581|P12|STARTED|Stage 1||0
8299019|NCT01562275|20461582|P11|STARTED|Stage 1||3
8299020|NCT01562275|20461583|P10|STARTED|Stage 1||7
8299021|NCT01562275|20461584|P9|STARTED|Stage 1||3
8299022|NCT01562275|20461585|P8|STARTED|Stage 1||7
8299023|NCT01562275|20461586|P7|STARTED|Stage 1||3
8299024|NCT01562275|20461587|P6|STARTED|Stage 1||4
8299025|NCT01562275|20461588|P5|STARTED|Stage 1||4
8299026|NCT01562275|20461589|P4|STARTED|Stage 1||4
8299027|NCT01562275|20461590|P3|STARTED|Stage 1||3
8299028|NCT01562275|20461591|P2|STARTED|Stage 1||7
8299029|NCT01562275|20461592|P1|STARTED|Stage 1||3
8299030|NCT01562132|20461724|P2|NOT COMPLETED|Overall Study||0
8299031|NCT01562132|20461725|P1|NOT COMPLETED|Overall Study||0
8299032|NCT01562132|20461724|P2|COMPLETED|Overall Study||3
8299033|NCT01562132|20461725|P1|COMPLETED|Overall Study||3
8299034|NCT01562132|20461724|P2|STARTED|Overall Study||3
8299035|NCT01562132|20461725|P1|STARTED|Overall Study||3
8299036|NCT01562028|20461733|P2|NOT COMPLETED|Overall Study||2
8299037|NCT01562028|20461734|P1|NOT COMPLETED|Overall Study||3
8299038|NCT01562028|20461733|P2|COMPLETED|Overall Study||70
8299039|NCT01562028|20461734|P1|COMPLETED|Overall Study||34
8299040|NCT01562028|20461733|P2|STARTED|Overall Study||72
8299041|NCT01562028|20461734|P1|STARTED|Overall Study||37
8299042|NCT01561989|20461754|P2|NOT COMPLETED|Overall Study||6
8299043|NCT01561989|20461755|P1|NOT COMPLETED|Overall Study||5
8299044|NCT01561989|20461754|P2|COMPLETED|Overall Study||0
8299045|NCT01561989|20461755|P1|COMPLETED|Overall Study||0
8299046|NCT01561989|20461754|P2|STARTED|Overall Study||6
8299047|NCT01561989|20461755|P1|STARTED|Overall Study||5
8299048|NCT01561976|20461777|P6|NOT COMPLETED|Period 3||0
8299049|NCT01561976|20461778|P5|NOT COMPLETED|Period 3||0
8299050|NCT01561976|20461779|P4|NOT COMPLETED|Period 3||0
8299051|NCT01561976|20461780|P3|NOT COMPLETED|Period 3||0
8299052|NCT01561976|20461781|P2|NOT COMPLETED|Period 3||0
8299053|NCT01561976|20461782|P1|NOT COMPLETED|Period 3||0
8299054|NCT01561976|20461777|P6|COMPLETED|Period 3||4
8299055|NCT01561976|20461778|P5|COMPLETED|Period 3||5
8299056|NCT01561976|20461779|P4|COMPLETED|Period 3||4
8299057|NCT01561976|20461780|P3|COMPLETED|Period 3||3
8299058|NCT01561976|20461781|P2|COMPLETED|Period 3||5
8299059|NCT01561976|20461782|P1|COMPLETED|Period 3||4
8299060|NCT01561976|20461777|P6|STARTED|Period 3||4
8299061|NCT01561976|20461778|P5|STARTED|Period 3||5
8299062|NCT01561976|20461779|P4|STARTED|Period 3||4
8299063|NCT01561976|20461780|P3|STARTED|Period 3||3
8299064|NCT01561976|20461781|P2|STARTED|Period 3||5
8299065|NCT01561976|20461782|P1|STARTED|Period 3||4
8299066|NCT01561976|20461777|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299067|NCT01561976|20461778|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299068|NCT01561976|20461779|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299069|NCT01561976|20461780|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
8299070|NCT01561976|20461781|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299071|NCT01561976|20461782|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
8299072|NCT01561976|20461777|P6|COMPLETED|Washout Period 2 (7 Days)||4
8299073|NCT01561976|20461778|P5|COMPLETED|Washout Period 2 (7 Days)||5
8299074|NCT01561976|20461779|P4|COMPLETED|Washout Period 2 (7 Days)||4
8299075|NCT01561976|20461780|P3|COMPLETED|Washout Period 2 (7 Days)||3
8299076|NCT01561976|20461781|P2|COMPLETED|Washout Period 2 (7 Days)||5
8299077|NCT01561976|20461782|P1|COMPLETED|Washout Period 2 (7 Days)||4
8299078|NCT01561976|20461777|P6|STARTED|Washout Period 2 (7 Days)||4
8299079|NCT01561976|20461778|P5|STARTED|Washout Period 2 (7 Days)||5
8299080|NCT01561976|20461779|P4|STARTED|Washout Period 2 (7 Days)||4
8299081|NCT01561976|20461780|P3|STARTED|Washout Period 2 (7 Days)||4
8299082|NCT01561976|20461781|P2|STARTED|Washout Period 2 (7 Days)||5
8299083|NCT01561976|20461782|P1|STARTED|Washout Period 2 (7 Days)||5
8299084|NCT01561976|20461777|P6|NOT COMPLETED|Period 2||0
8299085|NCT01561976|20461778|P5|NOT COMPLETED|Period 2||0
8299086|NCT01561976|20461779|P4|NOT COMPLETED|Period 2||0
8299087|NCT01561976|20461780|P3|NOT COMPLETED|Period 2||0
8299088|NCT01561976|20461781|P2|NOT COMPLETED|Period 2||0
8299089|NCT01561976|20461782|P1|NOT COMPLETED|Period 2||0
8299090|NCT01561976|20461777|P6|COMPLETED|Period 2||4
8299091|NCT01561976|20461778|P5|COMPLETED|Period 2||5
8299092|NCT01561976|20461779|P4|COMPLETED|Period 2||4
8299093|NCT01561976|20461780|P3|COMPLETED|Period 2||4
8299094|NCT01561976|20461781|P2|COMPLETED|Period 2||5
8299095|NCT01561976|20461782|P1|COMPLETED|Period 2||5
8299096|NCT01561976|20461777|P6|STARTED|Period 2||4
8299097|NCT01561976|20461778|P5|STARTED|Period 2||5
8299098|NCT01561976|20461779|P4|STARTED|Period 2||4
8299099|NCT01561976|20461780|P3|STARTED|Period 2||4
8299100|NCT01561976|20461781|P2|STARTED|Period 2||5
8299101|NCT01561976|20461782|P1|STARTED|Period 2||5
8299102|NCT01561976|20461777|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
8299103|NCT01561976|20461778|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299104|NCT01561976|20461779|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8299105|NCT01561976|20461780|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299106|NCT01561976|20461781|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299107|NCT01561976|20461782|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299108|NCT01561976|20461777|P6|COMPLETED|Washout Period 1 (7 Days)||4
8299109|NCT01561976|20461778|P5|COMPLETED|Washout Period 1 (7 Days)||5
8299110|NCT01561976|20461779|P4|COMPLETED|Washout Period 1 (7 Days)||4
8299111|NCT01561976|20461780|P3|COMPLETED|Washout Period 1 (7 Days)||4
8299112|NCT01561976|20461781|P2|COMPLETED|Washout Period 1 (7 Days)||5
8299113|NCT01561976|20461782|P1|COMPLETED|Washout Period 1 (7 Days)||5
8299114|NCT01561976|20461777|P6|STARTED|Washout Period 1 (7 Days)||5
8299115|NCT01561976|20461778|P5|STARTED|Washout Period 1 (7 Days)||5
8299116|NCT01561976|20461779|P4|STARTED|Washout Period 1 (7 Days)||5
8299117|NCT01561976|20461780|P3|STARTED|Washout Period 1 (7 Days)||4
8299118|NCT01561976|20461781|P2|STARTED|Washout Period 1 (7 Days)||5
8299119|NCT01561976|20461782|P1|STARTED|Washout Period 1 (7 Days)||5
8299120|NCT01561976|20461777|P6|NOT COMPLETED|Period 1||0
8299121|NCT01561976|20461778|P5|NOT COMPLETED|Period 1||0
8299122|NCT01561976|20461779|P4|NOT COMPLETED|Period 1||0
8299123|NCT01561976|20461780|P3|NOT COMPLETED|Period 1||1
8299124|NCT01561976|20461781|P2|NOT COMPLETED|Period 1||0
8299125|NCT01561976|20461782|P1|NOT COMPLETED|Period 1||0
8299126|NCT01561976|20461777|P6|COMPLETED|Period 1||5
8299127|NCT01561976|20461778|P5|COMPLETED|Period 1||5
8299128|NCT01561976|20461779|P4|COMPLETED|Period 1||5
8299129|NCT01561976|20461780|P3|COMPLETED|Period 1||4
8299130|NCT01561976|20461781|P2|COMPLETED|Period 1||5
8299131|NCT01561976|20461782|P1|COMPLETED|Period 1||5
8299132|NCT01561976|20461777|P6|STARTED|Period 1||5
8299133|NCT01561976|20461778|P5|STARTED|Period 1||5
8299134|NCT01561976|20461779|P4|STARTED|Period 1||5
8299135|NCT01561976|20461780|P3|STARTED|Period 1||5
8299136|NCT01561976|20461781|P2|STARTED|Period 1||5
8299137|NCT01561976|20461782|P1|STARTED|Period 1||5
8299138|NCT01561898|20461815|P4|NOT COMPLETED|Overall Study||20
8299139|NCT01561898|20461816|P3|NOT COMPLETED|Overall Study||44
8299140|NCT01561898|20461817|P2|NOT COMPLETED|Overall Study||41
8299141|NCT01561898|20461818|P1|NOT COMPLETED|Overall Study||2
8299142|NCT01561898|20461815|P4|COMPLETED|Overall Study||12
8299143|NCT01561898|20461816|P3|COMPLETED|Overall Study||53
8299144|NCT01561898|20461817|P2|COMPLETED|Overall Study||51
8299145|NCT01561898|20461818|P1|COMPLETED|Overall Study||5
8299146|NCT01561898|20461815|P4|STARTED|Overall Study||32
8299147|NCT01561898|20461816|P3|STARTED|Overall Study||97
8299148|NCT01561898|20461817|P2|STARTED|Overall Study||92
8299149|NCT01561898|20461818|P1|STARTED|Overall Study||7
8299150|NCT01561833|20461830|P1|NOT COMPLETED|Overall Study||0
8299151|NCT01561833|20461830|P1|COMPLETED|Overall Study||12
8299152|NCT01561833|20461830|P1|STARTED|Overall Study||12
8299153|NCT01561755|20461836|P2|NOT COMPLETED|Overall Study||1
8299154|NCT01561755|20461837|P1|NOT COMPLETED|Overall Study||0
8299155|NCT01561755|20461836|P2|COMPLETED|Overall Study||5
8299156|NCT01561755|20461837|P1|COMPLETED|Overall Study||6
8299157|NCT01561755|20461836|P2|STARTED|Overall Study||6
8299158|NCT01561755|20461837|P1|STARTED|Overall Study||6
8299159|NCT01561716|20461861|P6|NOT COMPLETED|Overall Study||0
8299160|NCT01561716|20461862|P5|NOT COMPLETED|Overall Study||0
8299161|NCT01561716|20461863|P4|NOT COMPLETED|Overall Study||0
8299162|NCT01561716|20461864|P3|NOT COMPLETED|Overall Study||0
8299163|NCT01561716|20461865|P2|NOT COMPLETED|Overall Study||0
8299164|NCT01561716|20461866|P1|NOT COMPLETED|Overall Study||0
8299165|NCT01561716|20461861|P6|COMPLETED|Overall Study||5
8299166|NCT01561716|20461862|P5|COMPLETED|Overall Study||5
8299167|NCT01561716|20461863|P4|COMPLETED|Overall Study||5
8299168|NCT01561716|20461864|P3|COMPLETED|Overall Study||5
8299169|NCT01561716|20461865|P2|COMPLETED|Overall Study||5
8299170|NCT01561716|20461866|P1|COMPLETED|Overall Study||5
8299171|NCT01561716|20461861|P6|STARTED|Overall Study||5
8299172|NCT01561716|20461862|P5|STARTED|Overall Study||5
8299173|NCT01561716|20461863|P4|STARTED|Overall Study||5
8299174|NCT01561716|20461864|P3|STARTED|Overall Study||5
8299175|NCT01561716|20461865|P2|STARTED|Overall Study||5
8299176|NCT01561716|20461866|P1|STARTED|Overall Study||5
8299177|NCT01561703|20461882|P2|NOT COMPLETED|Overall Study||6
8299178|NCT01561703|20461883|P1|NOT COMPLETED|Overall Study||8
8299179|NCT01561703|20461882|P2|COMPLETED|Overall Study||24
8299180|NCT01561703|20461883|P1|COMPLETED|Overall Study||20
8299181|NCT01561703|20461882|P2|STARTED|Overall Study||30
8299182|NCT01561703|20461883|P1|STARTED|Overall Study||28
8299183|NCT01561560|20461889|P2|NOT COMPLETED|Second Two Weeks of Wear||1
8299184|NCT01561560|20461890|P1|NOT COMPLETED|Second Two Weeks of Wear||0
8299185|NCT01561560|20461889|P2|COMPLETED|Second Two Weeks of Wear||58
8299186|NCT01561560|20461890|P1|COMPLETED|Second Two Weeks of Wear||60
8299187|NCT01561560|20461889|P2|STARTED|Second Two Weeks of Wear||59
8299188|NCT01561560|20461890|P1|STARTED|Second Two Weeks of Wear||60
8299189|NCT01561560|20461889|P2|NOT COMPLETED|First Two Weeks of Wear||2
8299190|NCT01561560|20461890|P1|NOT COMPLETED|First Two Weeks of Wear||0
8299191|NCT01561560|20461889|P2|COMPLETED|First Two Weeks of Wear||59
8299192|NCT01561560|20461890|P1|COMPLETED|First Two Weeks of Wear||60
8299193|NCT01561560|20461889|P2|STARTED|First Two Weeks of Wear||61
8299194|NCT01561560|20461890|P1|STARTED|First Two Weeks of Wear||60
8299195|NCT01561495|20461896|P1|NOT COMPLETED|Overall Study||0
8299196|NCT01561495|20461896|P1|COMPLETED|Overall Study||1
8299197|NCT01561495|20461896|P1|STARTED|Overall Study||1
8299198|NCT01561469|20461902|P2|NOT COMPLETED|Overall Study||0
8299199|NCT01561469|20461903|P1|NOT COMPLETED|Overall Study||0
8299200|NCT01561469|20461902|P2|COMPLETED|Overall Study||87
8299201|NCT01561469|20461903|P1|COMPLETED|Overall Study||101
8299202|NCT01561469|20461902|P2|STARTED|Overall Study||87
8299203|NCT01561469|20461903|P1|STARTED|Overall Study||101
8299204|NCT01561430|20461925|P4|NOT COMPLETED|Overall Study||13
8299205|NCT01561430|20461926|P3|NOT COMPLETED|Overall Study||17
8299206|NCT01561430|20461927|P2|NOT COMPLETED|Overall Study||15
8299207|NCT01561430|20461928|P1|NOT COMPLETED|Overall Study||1
8299208|NCT01561430|20461925|P4|COMPLETED|Overall Study||7
8299209|NCT01561430|20461926|P3|COMPLETED|Overall Study||1
8299210|NCT01561430|20461927|P2|COMPLETED|Overall Study||8
8299211|NCT01561430|20461928|P1|COMPLETED|Overall Study||8
8299212|NCT01561430|20461925|P4|Received at Least One Dose of Study Drug|Overall Study||20
8299213|NCT01561430|20461926|P3|Received at Least One Dose of Study Drug|Overall Study||18
8299214|NCT01561430|20461927|P2|Received at Least One Dose of Study Drug|Overall Study||23
8299215|NCT01561430|20461928|P1|Received at Least One Dose of Study Drug|Overall Study||9
8299216|NCT01561430|20461925|P4|STARTED|Overall Study||20
8299217|NCT01561430|20461926|P3|STARTED|Overall Study||18
8299218|NCT01561430|20461927|P2|STARTED|Overall Study||23
8299219|NCT01561430|20461928|P1|STARTED|Overall Study||9
8299220|NCT01561378|20461968|P2|NOT COMPLETED|Overall Study||0
8299221|NCT01561378|20461969|P1|NOT COMPLETED|Overall Study||0
8299222|NCT01561378|20461968|P2|COMPLETED|Overall Study||11
8299223|NCT01561378|20461969|P1|COMPLETED|Overall Study||11
8299224|NCT01561378|20461968|P2|STARTED|Overall Study||11
8299225|NCT01561378|20461969|P1|STARTED|Overall Study||11
8299226|NCT01561313|20461991|P2|NOT COMPLETED|Overall Study||0
8299227|NCT01561313|20461992|P1|NOT COMPLETED|Overall Study||2
8299228|NCT01561313|20461991|P2|COMPLETED|Overall Study||31
8299229|NCT01561313|20461992|P1|COMPLETED|Overall Study||31
8299230|NCT01561313|20461991|P2|STARTED|Overall Study||31
8299231|NCT01561313|20461992|P1|STARTED|Overall Study||33
8299232|NCT01561300|20462010|P2|NOT COMPLETED|Second Intervention||0
8299233|NCT01561300|20462011|P1|NOT COMPLETED|Second Intervention||0
8299234|NCT01561300|20462010|P2|COMPLETED|Second Intervention||15
8299235|NCT01561300|20462011|P1|COMPLETED|Second Intervention||14
8299236|NCT01561300|20462010|P2|STARTED|Second Intervention||15
8299237|NCT01561300|20462011|P1|STARTED|Second Intervention||14
8299238|NCT01561300|20462010|P2|NOT COMPLETED|Washout on Placebo||0
8299239|NCT01561300|20462011|P1|NOT COMPLETED|Washout on Placebo||0
8299240|NCT01561300|20462010|P2|COMPLETED|Washout on Placebo||15
8299241|NCT01561300|20462011|P1|COMPLETED|Washout on Placebo||14
8299242|NCT01561300|20462010|P2|STARTED|Washout on Placebo||15
8299243|NCT01561300|20462011|P1|STARTED|Washout on Placebo||14
8299244|NCT01561300|20462010|P2|NOT COMPLETED|First Intervention||0
8299245|NCT01561300|20462011|P1|NOT COMPLETED|First Intervention||0
8299246|NCT01561300|20462010|P2|COMPLETED|First Intervention||15
8299247|NCT01561300|20462011|P1|COMPLETED|First Intervention||14
8299248|NCT01561300|20462010|P2|STARTED|First Intervention||15
8299249|NCT01561300|20462011|P1|STARTED|First Intervention||14
8299250|NCT01561300|20462010|P2|NOT COMPLETED|Run in on Placebo||0
8299251|NCT01561300|20462011|P1|NOT COMPLETED|Run in on Placebo||1
8299252|NCT01561300|20462010|P2|COMPLETED|Run in on Placebo||15
8299253|NCT01561300|20462011|P1|COMPLETED|Run in on Placebo||14
8299254|NCT01561300|20462010|P2|STARTED|Run in on Placebo||15
8299255|NCT01561300|20462011|P1|STARTED|Run in on Placebo||15
8299256|NCT01561079|20462022|P1|NOT COMPLETED|Overall Study||78
8299257|NCT01561079|20462022|P1|COMPLETED|Overall Study||49
8299258|NCT01561079|20462022|P1|STARTED|Overall Study||127
8299259|NCT01561053|20462069|P4|NOT COMPLETED|Overall Study||23
8299260|NCT01561053|20462070|P3|NOT COMPLETED|Overall Study||21
8299261|NCT01561053|20462071|P2|NOT COMPLETED|Overall Study||36
8299262|NCT01561053|20462072|P1|NOT COMPLETED|Overall Study||35
8299263|NCT01561053|20462069|P4|COMPLETED|Overall Study||64
8299264|NCT01561053|20462070|P3|COMPLETED|Overall Study||61
8299265|NCT01561053|20462071|P2|COMPLETED|Overall Study||56
8299266|NCT01561053|20462072|P1|COMPLETED|Overall Study||51
8299267|NCT01561053|20462069|P4|Evaluable Subjects|Overall Study||80
8299268|NCT01561053|20462070|P3|Evaluable Subjects|Overall Study||78
8299269|NCT01561053|20462071|P2|Evaluable Subjects|Overall Study||86
8299270|NCT01561053|20462072|P1|Evaluable Subjects|Overall Study||78
8299271|NCT01561053|20462069|P4|Randomized Not Treated|Overall Study||7
8299272|NCT01561053|20462070|P3|Randomized Not Treated|Overall Study||4
8299273|NCT01561053|20462071|P2|Randomized Not Treated|Overall Study||6
8299274|NCT01561053|20462072|P1|Randomized Not Treated|Overall Study||8
8299275|NCT01561053|20462069|P4|Patients With Baseline MMSE:22-26|Overall Study||45
8299276|NCT01561053|20462070|P3|Patients With Baseline MMSE:22-26|Overall Study||35
8299277|NCT01561053|20462071|P2|Patients With Baseline MMSE:22-26|Overall Study||52
8299278|NCT01561053|20462072|P1|Patients With Baseline MMSE:22-26|Overall Study||39
8299279|NCT01561053|20462069|P4|Patients With Baseline MMSE:18-21|Overall Study||42
8299280|NCT01561053|20462070|P3|Patients With Baseline MMSE:18-21|Overall Study||47
8299281|NCT01561053|20462071|P2|Patients With Baseline MMSE:18-21|Overall Study||40
8299282|NCT01561053|20462072|P1|Patients With Baseline MMSE:18-21|Overall Study||47
8299283|NCT01561053|20462069|P4|STARTED|Overall Study||87
8299284|NCT01561053|20462070|P3|STARTED|Overall Study||82
8299285|NCT01561053|20462071|P2|STARTED|Overall Study||92
8299286|NCT01561053|20462072|P1|STARTED|Overall Study||86
8299287|NCT01560988|20462108|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
8299288|NCT01560988|20462109|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
8299289|NCT01560988|20462108|P2|COMPLETED|Second Intervention (Six Weeks)||22
8299290|NCT01560988|20462109|P1|COMPLETED|Second Intervention (Six Weeks)||18
8299291|NCT01560988|20462108|P2|STARTED|Second Intervention (Six Weeks)||24
8299292|NCT01560988|20462109|P1|STARTED|Second Intervention (Six Weeks)||20
8299293|NCT01560988|20462108|P2|NOT COMPLETED|Washout (Six Weeks)||2
8299294|NCT01560988|20462109|P1|NOT COMPLETED|Washout (Six Weeks)||2
8299295|NCT01560988|20462108|P2|COMPLETED|Washout (Six Weeks)||24
8299296|NCT01560988|20462109|P1|COMPLETED|Washout (Six Weeks)||20
8299297|NCT01560988|20462108|P2|STARTED|Washout (Six Weeks)||26
8299298|NCT01560988|20462109|P1|STARTED|Washout (Six Weeks)||22
8299299|NCT01560988|20462108|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
8299300|NCT01560988|20462109|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
8299301|NCT01560988|20462108|P2|COMPLETED|First Intervention (Six Weeks)||26
8299302|NCT01560988|20462109|P1|COMPLETED|First Intervention (Six Weeks)||22
8299303|NCT01560988|20462108|P2|STARTED|First Intervention (Six Weeks)||30
8299304|NCT01560988|20462109|P1|STARTED|First Intervention (Six Weeks)||32
8299305|NCT01560975|20462132|P1|NOT COMPLETED|Overall Study||0
8299306|NCT01560975|20462132|P1|COMPLETED|Overall Study||10
8299307|NCT01560975|20462132|P1|STARTED|Overall Study||10
8299308|NCT01560949|20462145|P1|NOT COMPLETED|Surgery Phase||3
8299309|NCT01560949|20462145|P1|COMPLETED|Surgery Phase||15
8299310|NCT01560949|20462145|P1|STARTED|Surgery Phase||18
8299311|NCT01560949|20462145|P1|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
8299312|NCT01560949|20462145|P1|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
8299313|NCT01560949|20462145|P1|STARTED|Chemoradiation Phase: With Gemcitabine||23
8299314|NCT01560949|20462145|P1|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
8299315|NCT01560949|20462145|P1|COMPLETED|Systemic Phase: mFOLFIRINOX||27
8299316|NCT01560949|20462145|P1|STARTED|Systemic Phase: mFOLFIRINOX||33
8299317|NCT01560923|20462160|P2|NOT COMPLETED|Overall Study||0
8299318|NCT01560923|20462161|P1|NOT COMPLETED|Overall Study||0
8299319|NCT01560923|20462160|P2|COMPLETED|Overall Study||22
8299320|NCT01560923|20462161|P1|COMPLETED|Overall Study||24
8299321|NCT01560923|20462160|P2|STARTED|Overall Study||22
8299322|NCT01560923|20462161|P1|STARTED|Overall Study||24
8299323|NCT01560871|20462179|P2|NOT COMPLETED|Overall Study||2
8299324|NCT01560871|20462180|P1|NOT COMPLETED|Overall Study||6
8299325|NCT01560871|20462179|P2|COMPLETED|Overall Study||5
8299326|NCT01560871|20462180|P1|COMPLETED|Overall Study||3
8299327|NCT01560871|20462179|P2|STARTED|Overall Study||7
8299328|NCT01560871|20462180|P1|STARTED|Overall Study||9
8299329|NCT01560819|20462196|P2|NOT COMPLETED|Overall Study||0
8299330|NCT01560819|20462197|P1|NOT COMPLETED|Overall Study||1
8299331|NCT01560819|20462196|P2|COMPLETED|Overall Study||10
8299332|NCT01560819|20462197|P1|COMPLETED|Overall Study||9
8299333|NCT01560819|20462196|P2|STARTED|Overall Study||10
8299334|NCT01560819|20462197|P1|STARTED|Overall Study||10
8299335|NCT01560780|20462203|P2|NOT COMPLETED|Overall Study||12
8299336|NCT01560780|20462204|P1|NOT COMPLETED|Overall Study||13
8299337|NCT01560780|20462203|P2|COMPLETED|Overall Study||30
8299338|NCT01560780|20462204|P1|COMPLETED|Overall Study||29
8299339|NCT01560780|20462203|P2|Completed Study Drug for 12 Months|Overall Study||27
8299340|NCT01560780|20462204|P1|Completed Study Drug for 12 Months|Overall Study||27
8299341|NCT01560780|20462203|P2|Clinical Follow-Up at 12 Months|Overall Study||42
8299342|NCT01560780|20462204|P1|Clinical Follow-Up at 12 Months|Overall Study||42
8299343|NCT01560780|20462203|P2|STARTED|Overall Study||42
8299344|NCT01560780|20462204|P1|STARTED|Overall Study||42
8299345|NCT01560624|20462224|P2|NOT COMPLETED|Overall Study||189
8299346|NCT01560624|20462225|P1|NOT COMPLETED|Overall Study||198
8299347|NCT01560624|20462224|P2|COMPLETED|Overall Study||155
8299348|NCT01560624|20462225|P1|COMPLETED|Overall Study||148
8299349|NCT01560624|20462224|P2|Early Discontinuation From Treatment|Overall Study||56
8299350|NCT01560624|20462225|P1|Early Discontinuation From Treatment|Overall Study||107
8299351|NCT01560624|20462224|P2|Clinical Worsening Event|Overall Study||133
8299352|NCT01560624|20462225|P1|Clinical Worsening Event|Overall Study||91
8299353|NCT01560624|20462224|P2|STARTED|Overall Study||344
8299354|NCT01560624|20462225|P1|STARTED|Overall Study||346
8299355|NCT01560507|20462240|P3|NOT COMPLETED|Overall Study||2
8299356|NCT01560507|20462241|P2|NOT COMPLETED|Overall Study||2
8299357|NCT01560507|20462242|P1|NOT COMPLETED|Overall Study||4
8299358|NCT01560507|20462240|P3|COMPLETED|Overall Study||0
8299359|NCT01560507|20462241|P2|COMPLETED|Overall Study||0
8299360|NCT01560507|20462242|P1|COMPLETED|Overall Study||1
8299361|NCT01560507|20462240|P3|STARTED|Overall Study||2
8299362|NCT01560507|20462241|P2|STARTED|Overall Study||2
8299363|NCT01560507|20462242|P1|STARTED|Overall Study||5
8299364|NCT01560429|20462255|P2|NOT COMPLETED|Overall Study||6
8299365|NCT01560429|20462256|P1|NOT COMPLETED|Overall Study||3
8299366|NCT01560429|20462255|P2|COMPLETED|Overall Study||20
8299367|NCT01560429|20462256|P1|COMPLETED|Overall Study||23
8299368|NCT01560429|20462255|P2|STARTED|Overall Study||26
8299369|NCT01560429|20462256|P1|STARTED|Overall Study||26
8299370|NCT01560416|20462266|P2|NOT COMPLETED|Crossover Phase||0
8299371|NCT01560416|20462267|P1|NOT COMPLETED|Crossover Phase||0
8299372|NCT01560416|20462266|P2|COMPLETED|Crossover Phase||0
8299373|NCT01560416|20462267|P1|COMPLETED|Crossover Phase||7
8299374|NCT01560416|20462266|P2|STARTED|Crossover Phase||0
8299375|NCT01560416|20462267|P1|STARTED|Crossover Phase||7
8299376|NCT01560416|20462266|P2|NOT COMPLETED|Randomized Phase||0
8299377|NCT01560416|20462267|P1|NOT COMPLETED|Randomized Phase||7
8299378|NCT01560416|20462266|P2|COMPLETED|Randomized Phase||35
8299379|NCT01560416|20462267|P1|COMPLETED|Randomized Phase||8
8299380|NCT01560416|20462266|P2|STARTED|Randomized Phase||35
8299381|NCT01560416|20462267|P1|STARTED|Randomized Phase||15
8299382|NCT01560403|20462285|P2|NOT COMPLETED|Overall Study||1
8299383|NCT01560403|20462286|P1|NOT COMPLETED|Overall Study||0
8299384|NCT01560403|20462285|P2|COMPLETED|Overall Study||8
8299385|NCT01560403|20462286|P1|COMPLETED|Overall Study||5
8299386|NCT01560403|20462285|P2|STARTED|Overall Study||9
8299387|NCT01560403|20462286|P1|STARTED|Overall Study||5
8299388|NCT01560377|20462292|P1|NOT COMPLETED|Overall Study||0
8299389|NCT01560377|20462292|P1|COMPLETED|Overall Study||147
8299390|NCT01560377|20462292|P1|Eligible for Analysis|Overall Study||139
8299391|NCT01560377|20462292|P1|STARTED|Overall Study||147
8299392|NCT01560286|20462297|P1|NOT COMPLETED|Overall Study||0
8299393|NCT01560286|20462297|P1|COMPLETED|Overall Study||24
8299394|NCT01560286|20462297|P1|STARTED|Overall Study||24
8299395|NCT01560260|20462310|P1|NOT COMPLETED|Overall Study||0
8299396|NCT01560260|20462310|P1|COMPLETED|Overall Study||20
8299397|NCT01560260|20462310|P1|STARTED|Overall Study||20
8299398|NCT01560234|20462334|P8|NOT COMPLETED|Overall Study||2
8299399|NCT01560234|20462335|P7|NOT COMPLETED|Overall Study||0
8299400|NCT01560234|20462336|P6|NOT COMPLETED|Overall Study||2
8299401|NCT01560234|20462337|P5|NOT COMPLETED|Overall Study||0
8299402|NCT01560234|20462338|P4|NOT COMPLETED|Overall Study||0
8299403|NCT01560234|20462339|P3|NOT COMPLETED|Overall Study||1
8299404|NCT01560234|20462340|P2|NOT COMPLETED|Overall Study||0
8299405|NCT01560234|20462341|P1|NOT COMPLETED|Overall Study||3
8299406|NCT01560234|20462334|P8|COMPLETED|Overall Study||6
8299407|NCT01560234|20462335|P7|COMPLETED|Overall Study||4
8299408|NCT01560234|20462336|P6|COMPLETED|Overall Study||2
8299409|NCT01560234|20462337|P5|COMPLETED|Overall Study||4
8299410|NCT01560234|20462338|P4|COMPLETED|Overall Study||3
8299411|NCT01560234|20462339|P3|COMPLETED|Overall Study||3
8299412|NCT01560234|20462340|P2|COMPLETED|Overall Study||4
8299413|NCT01560234|20462341|P1|COMPLETED|Overall Study||13
8299414|NCT01560234|20462334|P8|STARTED|Overall Study||8
8299415|NCT01560234|20462335|P7|STARTED|Overall Study||4
8299416|NCT01560234|20462336|P6|STARTED|Overall Study||4
8299417|NCT01560234|20462337|P5|STARTED|Overall Study||4
8299418|NCT01560234|20462338|P4|STARTED|Overall Study||3
8299419|NCT01560234|20462339|P3|STARTED|Overall Study||4
8299420|NCT01560234|20462340|P2|STARTED|Overall Study||4
8299421|NCT01560234|20462341|P1|STARTED|Overall Study||16
8299422|NCT01560143|20462415|P1|NOT COMPLETED|Overall Study||0
8299423|NCT01560143|20462415|P1|COMPLETED|Overall Study||12
8299424|NCT01560143|20462415|P1|STARTED|Overall Study||12
8299425|NCT01559948|20462421|P2|NOT COMPLETED|Overall Study||0
8299426|NCT01559948|20462422|P1|NOT COMPLETED|Overall Study||0
8299427|NCT01559948|20462421|P2|COMPLETED|Overall Study||15
8299428|NCT01559948|20462422|P1|COMPLETED|Overall Study||15
8299429|NCT01559948|20462421|P2|STARTED|Overall Study||15
8299430|NCT01559948|20462422|P1|STARTED|Overall Study||15
8299431|NCT01559935|20462436|P1|NOT COMPLETED|Maintenance Phase||54
8299432|NCT01559935|20462436|P1|COMPLETED|Maintenance Phase||0
8299433|NCT01559935|20462436|P1|STARTED|Maintenance Phase||54
8299434|NCT01559935|20462436|P1|NOT COMPLETED|BiRD Phase||4
8299435|NCT01559935|20462436|P1|COMPLETED|BiRD Phase||54
8299436|NCT01559935|20462436|P1|STARTED|BiRD Phase||58
8299437|NCT01559935|20462436|P1|NOT COMPLETED|Car Phase||14
8299438|NCT01559935|20462436|P1|COMPLETED|Car Phase||58
8299439|NCT01559935|20462436|P1|STARTED|Car Phase||72
8299440|NCT01559922|20462446|P2|NOT COMPLETED|Overall Study||10
8299441|NCT01559922|20462447|P1|NOT COMPLETED|Overall Study||4
8299442|NCT01559922|20462446|P2|COMPLETED|Overall Study||87
8299443|NCT01559922|20462447|P1|COMPLETED|Overall Study||46
8299444|NCT01559922|20462446|P2|STARTED|Overall Study||97
8299445|NCT01559922|20462447|P1|STARTED|Overall Study||50
8299446|NCT01559857|20462455|P2|NOT COMPLETED|Overall Study||0
8299447|NCT01559857|20462456|P1|NOT COMPLETED|Overall Study||0
8299448|NCT01559857|20462455|P2|COMPLETED|Overall Study||18
8299449|NCT01559857|20462456|P1|COMPLETED|Overall Study||19
8299450|NCT01559857|20462455|P2|STARTED|Overall Study||18
8299451|NCT01559857|20462456|P1|STARTED|Overall Study||19
8299452|NCT01559844|20462472|P1|NOT COMPLETED|Overall Study||25
8299453|NCT01559844|20462472|P1|COMPLETED|Overall Study||36
8299454|NCT01559844|20462472|P1|STARTED|Overall Study||61
8299455|NCT01559675|20462485|P2|NOT COMPLETED|Overall Study||14
8299456|NCT01559675|20462486|P1|NOT COMPLETED|Overall Study||15
8299457|NCT01559675|20462485|P2|COMPLETED|Overall Study||49
8299458|NCT01559675|20462486|P1|COMPLETED|Overall Study||43
8299459|NCT01559675|20462485|P2|STARTED|Overall Study||63
8299460|NCT01559675|20462486|P1|STARTED|Overall Study||58
8299461|NCT01559649|20462494|P2|NOT COMPLETED|Overall Study||6
8299462|NCT01559649|20462495|P1|NOT COMPLETED|Overall Study||19
8299463|NCT01559649|20462494|P2|COMPLETED|Overall Study||9
8299464|NCT01559649|20462495|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
8299465|NCT01559649|20462494|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
8299466|NCT01559649|20462495|P1|STARTED|Overall Study||269
8299467|NCT01559506|20462508|P2|NOT COMPLETED|Overall Study||3
8299468|NCT01559506|20462509|P1|NOT COMPLETED|Overall Study||0
8299469|NCT01559506|20462508|P2|COMPLETED|Overall Study||18
8299470|NCT01559506|20462509|P1|COMPLETED|Overall Study||20
8299471|NCT01559506|20462508|P2|STARTED|Overall Study||21
8299472|NCT01559506|20462509|P1|STARTED|Overall Study||20
8299473|NCT01559454|20462517|P2|NOT COMPLETED|Overall Study||6
8299474|NCT01559454|20462518|P1|NOT COMPLETED|Overall Study||3
8299475|NCT01559454|20462517|P2|COMPLETED|Overall Study||4
8299476|NCT01559454|20462518|P1|COMPLETED|Overall Study||6
8299477|NCT01559454|20462517|P2|STARTED|Overall Study||10
8299478|NCT01559454|20462518|P1|STARTED|Overall Study||9
8299479|NCT01559389|20462536|P2|NOT COMPLETED|Overall Study||20
8299480|NCT01559389|20462537|P1|NOT COMPLETED|Overall Study||20
8299481|NCT01559389|20462536|P2|COMPLETED|Overall Study||49
8299482|NCT01559389|20462537|P1|COMPLETED|Overall Study||49
8299483|NCT01559389|20462536|P2|STARTED|Overall Study||69
8299484|NCT01559389|20462537|P1|STARTED|Overall Study||69
8299485|NCT01559311|20462550|P3|NOT COMPLETED|Overall Study||8
8299486|NCT01559311|20462551|P2|NOT COMPLETED|Overall Study||6
8299487|NCT01559311|20462552|P1|NOT COMPLETED|Overall Study||3
8299488|NCT01559311|20462550|P3|COMPLETED|Overall Study|12-Month|26
8299489|NCT01559311|20462551|P2|COMPLETED|Overall Study|12-Month|28
8299490|NCT01559311|20462552|P1|COMPLETED|Overall Study|12-Month|27
8299491|NCT01559311|20462550|P3|6-Month|Overall Study||28
8299492|NCT01559311|20462551|P2|6-Month|Overall Study||33
8299493|NCT01559311|20462552|P1|6-Month|Overall Study||27
8299494|NCT01559311|20462550|P3|3-Month|Overall Study||29
8299495|NCT01559311|20462551|P2|3-Month|Overall Study||34
8299496|NCT01559311|20462552|P1|3-Month|Overall Study||27
8299497|NCT01559311|20462550|P3|1-Month|Overall Study||29
8299498|NCT01559311|20462551|P2|1-Month|Overall Study||34
8299499|NCT01559311|20462552|P1|1-Month|Overall Study||27
8299500|NCT01559311|20462550|P3|Implant|Overall Study||32
8299501|NCT01559311|20462551|P2|Implant|Overall Study||34
8299502|NCT01559311|20462552|P1|Implant|Overall Study||28
8299503|NCT01559311|20462550|P3|STARTED|Overall Study|Enrollment & Baseline|34
8299504|NCT01559311|20462551|P2|STARTED|Overall Study|Enrollment & Baseline|34
8299505|NCT01559311|20462552|P1|STARTED|Overall Study|Enrollment & Baseline|30
8299506|NCT01559259|20462568|P5|NOT COMPLETED|Overall Study||0
8299507|NCT01559259|20462569|P4|NOT COMPLETED|Overall Study||1
8299508|NCT01559259|20462570|P3|NOT COMPLETED|Overall Study||1
8299509|NCT01559259|20462571|P2|NOT COMPLETED|Overall Study||1
8299510|NCT01559259|20462572|P1|NOT COMPLETED|Overall Study||0
8299511|NCT01559259|20462568|P5|COMPLETED|Overall Study||92
8299512|NCT01559259|20462569|P4|COMPLETED|Overall Study||88
8299513|NCT01559259|20462570|P3|COMPLETED|Overall Study||92
8299514|NCT01559259|20462571|P2|COMPLETED|Overall Study||89
8299515|NCT01559259|20462572|P1|COMPLETED|Overall Study||30
8299516|NCT01559259|20462568|P5|STARTED|Overall Study||92
8299517|NCT01559259|20462569|P4|STARTED|Overall Study||89
8299518|NCT01559259|20462570|P3|STARTED|Overall Study||93
8299519|NCT01559259|20462571|P2|STARTED|Overall Study||90
8299520|NCT01559259|20462572|P1|STARTED|Overall Study||30
8299521|NCT01559129|20462661|P2|NOT COMPLETED|Open-label Extension Period||2
8299522|NCT01559129|20462662|P1|NOT COMPLETED|Open-label Extension Period||6
8299523|NCT01559129|20462661|P2|COMPLETED|Open-label Extension Period||0
8299524|NCT01559129|20462662|P1|COMPLETED|Open-label Extension Period||0
8299525|NCT01559129|20462661|P2|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
8299526|NCT01559129|20462662|P1|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
8299527|NCT01559129|20462661|P2|NOT COMPLETED|Treatment Phase||7
8299528|NCT01559129|20462662|P1|NOT COMPLETED|Treatment Phase||5
8299529|NCT01559129|20462661|P2|COMPLETED|Treatment Phase||4
8299530|NCT01559129|20462662|P1|COMPLETED|Treatment Phase||7
8299531|NCT01559129|20462661|P2|Received Treatment|Treatment Phase||10
8299532|NCT01559129|20462662|P1|Received Treatment|Treatment Phase||12
8299533|NCT01559129|20462661|P2|STARTED|Treatment Phase||11
8299534|NCT01559129|20462662|P1|STARTED|Treatment Phase||12
8299535|NCT01559116|20462738|P1|NOT COMPLETED|Overall Study||26
8299536|NCT01559116|20462738|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
8299537|NCT01559116|20462738|P1|STARTED|Overall Study|Randomised|219
8299538|NCT01559090|20462809|P3|NOT COMPLETED|Stage II||0
8299539|NCT01559090|20462810|P2|NOT COMPLETED|Stage II||0
8299540|NCT01559090|20462811|P1|NOT COMPLETED|Stage II||1
8299541|NCT01559090|20462809|P3|COMPLETED|Stage II||2
8299542|NCT01559090|20462810|P2|COMPLETED|Stage II||3
8299543|NCT01559090|20462811|P1|COMPLETED|Stage II||3
8299544|NCT01559090|20462809|P3|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
8299545|NCT01559090|20462810|P2|STARTED|Stage II||3
8299546|NCT01559090|20462811|P1|STARTED|Stage II||4
8299547|NCT01559090|20462809|P3|NOT COMPLETED|Stage I||3
8299548|NCT01559090|20462810|P2|NOT COMPLETED|Stage I||2
8299549|NCT01559090|20462811|P1|NOT COMPLETED|Stage I||2
8299550|NCT01559090|20462809|P3|COMPLETED|Stage I||3
8299551|NCT01559090|20462810|P2|COMPLETED|Stage I||3
8299552|NCT01559090|20462811|P1|COMPLETED|Stage I||4
8299553|NCT01559090|20462809|P3|STARTED|Stage I||6
8299554|NCT01559090|20462810|P2|STARTED|Stage I||5
8299555|NCT01559090|20462811|P1|STARTED|Stage I||6
8299556|NCT01559064|20462831|P3|NOT COMPLETED|Overall Study||2
8299557|NCT01559064|20462832|P2|NOT COMPLETED|Overall Study||1
8299558|NCT01559064|20462833|P1|NOT COMPLETED|Overall Study||1
8299559|NCT01559064|20462831|P3|COMPLETED|Overall Study||57
8299560|NCT01559064|20462832|P2|COMPLETED|Overall Study||39
8299561|NCT01559064|20462833|P1|COMPLETED|Overall Study||15
8299562|NCT01559064|20462831|P3|STARTED|Overall Study||59
8299563|NCT01559064|20462832|P2|STARTED|Overall Study||40
8299564|NCT01559064|20462833|P1|STARTED|Overall Study||16
8299565|NCT01559012|20462843|P2|NOT COMPLETED|Overall Study||1
8299566|NCT01559012|20462844|P1|NOT COMPLETED|Overall Study||0
8299567|NCT01559012|20462843|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
8299568|NCT01559012|20462844|P1|COMPLETED|Overall Study||6
8299569|NCT01559012|20462843|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
8299570|NCT01559012|20462844|P1|STARTED|Overall Study||6
8299571|NCT01558791|20462869|P2|NOT COMPLETED|Overall Study||0
8299572|NCT01558791|20462870|P1|NOT COMPLETED|Overall Study||0
8299573|NCT01558791|20462869|P2|COMPLETED|Overall Study||629
8299574|NCT01558791|20462870|P1|COMPLETED|Overall Study||607
8299575|NCT01558791|20462869|P2|STARTED|Overall Study||629
8299576|NCT01558791|20462870|P1|STARTED|Overall Study||607
8299577|NCT01558752|20462884|P2|NOT COMPLETED|Overall Study||0
8299578|NCT01558752|20462885|P1|NOT COMPLETED|Overall Study||2
8299579|NCT01558752|20462884|P2|COMPLETED|Overall Study||46
8299580|NCT01558752|20462885|P1|COMPLETED|Overall Study||40
8299581|NCT01558752|20462884|P2|STARTED|Overall Study||46
8299582|NCT01558752|20462885|P1|STARTED|Overall Study||42
8299583|NCT01558739|20462891|P1|NOT COMPLETED|Overall Study||17
8299584|NCT01558739|20462891|P1|COMPLETED|Overall Study||31
8299585|NCT01558739|20462891|P1|STARTED|Overall Study||48
8299586|NCT01558700|20462905|P2|NOT COMPLETED|Overall Study||0
8299587|NCT01558700|20462906|P1|NOT COMPLETED|Overall Study||0
8299588|NCT01558700|20462905|P2|COMPLETED|Overall Study||21
8299589|NCT01558700|20462906|P1|COMPLETED|Overall Study||19
8299590|NCT01558700|20462905|P2|STARTED|Overall Study||21
8299591|NCT01558700|20462906|P1|STARTED|Overall Study||19
8299592|NCT01558674|20462916|P2|NOT COMPLETED|Part 2||0
8299593|NCT01558674|20462917|P1|NOT COMPLETED|Part 2||0
8299594|NCT01558674|20462916|P2|COMPLETED|Part 2||0
8299595|NCT01558674|20462917|P1|COMPLETED|Part 2||0
8299596|NCT01558674|20462916|P2|STARTED|Part 2||0
8299597|NCT01558674|20462917|P1|STARTED|Part 2||0
8299598|NCT01558674|20462916|P2|NOT COMPLETED|Part 1||0
8299599|NCT01558674|20462917|P1|NOT COMPLETED|Part 1||11
8299600|NCT01558674|20462916|P2|COMPLETED|Part 1||0
8299601|NCT01558674|20462917|P1|COMPLETED|Part 1||0
8299602|NCT01558674|20462916|P2|STARTED|Part 1||0
8299603|NCT01558674|20462917|P1|STARTED|Part 1||11
8299604|NCT01558661|20462961|P1|NOT COMPLETED|Overall Study||0
8299605|NCT01558661|20462961|P1|COMPLETED|Overall Study||33
8299606|NCT01558661|20462961|P1|Second Stage|Overall Study||15
8299607|NCT01558661|20462961|P1|First Stage|Overall Study||18
8299608|NCT01558661|20462961|P1|STARTED|Overall Study||33
8299609|NCT01558635|20462968|P1|NOT COMPLETED|Overall Study||6
8299610|NCT01558635|20462968|P1|COMPLETED|Overall Study||11
8299611|NCT01558635|20462968|P1|6 Months Post-procedure|Overall Study||14
8299612|NCT01558635|20462968|P1|3 Months Post-procedure|Overall Study||14
8299613|NCT01558635|20462968|P1|Discharge /1 Month Post-procedure|Overall Study||15
8299614|NCT01558635|20462968|P1|Treated|Overall Study||17
8299615|NCT01558635|20462968|P1|STARTED|Overall Study||17
8299616|NCT01558596|20462985|P2|NOT COMPLETED|Overall Study||1
8299617|NCT01558596|20462986|P1|NOT COMPLETED|Overall Study||3
8299618|NCT01558596|20462985|P2|COMPLETED|Overall Study||100
8299619|NCT01558596|20462986|P1|COMPLETED|Overall Study||101
8299620|NCT01558596|20462985|P2|STARTED|Overall Study||101
8299621|NCT01558596|20462986|P1|STARTED|Overall Study||104
8299622|NCT01558492|20462992|P1|NOT COMPLETED|Overall Study||0
8299623|NCT01558492|20462992|P1|COMPLETED|Overall Study||3
8299624|NCT01558492|20462992|P1|STARTED|Overall Study||3
8299625|NCT01558297|20463001|P3|NOT COMPLETED|Overall Study||1
8299626|NCT01558297|20463002|P2|NOT COMPLETED|Overall Study||2
8299627|NCT01558297|20463003|P1|NOT COMPLETED|Overall Study||2
8299628|NCT01558297|20463001|P3|COMPLETED|Overall Study||29
8299629|NCT01558297|20463002|P2|COMPLETED|Overall Study||27
8299630|NCT01558297|20463003|P1|COMPLETED|Overall Study||28
8299631|NCT01558297|20463001|P3|STARTED|Overall Study||30
8299632|NCT01558297|20463002|P2|STARTED|Overall Study||29
8299633|NCT01558297|20463003|P1|STARTED|Overall Study||30
8299634|NCT01558271|20463020|P3|NOT COMPLETED|Overall Study||17
8299635|NCT01558271|20463021|P2|NOT COMPLETED|Overall Study||11
8299636|NCT01558271|20463022|P1|NOT COMPLETED|Overall Study||18
8299637|NCT01558271|20463020|P3|COMPLETED|Overall Study||124
8299638|NCT01558271|20463021|P2|COMPLETED|Overall Study||59
8299639|NCT01558271|20463022|P1|COMPLETED|Overall Study||263
8299640|NCT01558271|20463020|P3|Completed 26 Weeks|Overall Study||128
8299641|NCT01558271|20463021|P2|Completed 26 Weeks|Overall Study||63
8299642|NCT01558271|20463022|P1|Completed 26 Weeks|Overall Study||271
8299643|NCT01558271|20463020|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
8299644|NCT01558271|20463021|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
8299645|NCT01558271|20463022|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
8299646|NCT01558271|20463020|P3|STARTED|Overall Study||141
8299647|NCT01558271|20463021|P2|STARTED|Overall Study||70
8299648|NCT01558271|20463022|P1|STARTED|Overall Study||281
8299649|NCT01558128|20463084|P1|NOT COMPLETED|Overall Study||0
8299650|NCT01558128|20463084|P1|COMPLETED|Overall Study||1
8299651|NCT01558128|20463084|P1|STARTED|Overall Study||1
8299652|NCT01558089|20463088|P1|NOT COMPLETED|Overall Study||13
8299653|NCT01558089|20463088|P1|COMPLETED|Overall Study||63
8299654|NCT01558089|20463088|P1|STARTED|Overall Study||76
8299655|NCT01558063|20463105|P6|NOT COMPLETED|Overall Study||0
8299656|NCT01558063|20463106|P5|NOT COMPLETED|Overall Study||0
8299657|NCT01558063|20463107|P4|NOT COMPLETED|Overall Study||0
8299658|NCT01558063|20463108|P3|NOT COMPLETED|Overall Study||0
8299659|NCT01558063|20463109|P2|NOT COMPLETED|Overall Study||0
8299660|NCT01558063|20463110|P1|NOT COMPLETED|Overall Study||0
8299661|NCT01558063|20463105|P6|COMPLETED|Overall Study||5
8299662|NCT01558063|20463106|P5|COMPLETED|Overall Study||9
8299663|NCT01558063|20463107|P4|COMPLETED|Overall Study||5
8299664|NCT01558063|20463108|P3|COMPLETED|Overall Study||8
8299665|NCT01558063|20463109|P2|COMPLETED|Overall Study||6
8299666|NCT01558063|20463110|P1|COMPLETED|Overall Study||5
8299667|NCT01558063|20463105|P6|STARTED|Overall Study||5
8299668|NCT01558063|20463106|P5|STARTED|Overall Study||9
8299669|NCT01558063|20463107|P4|STARTED|Overall Study||5
8299670|NCT01558063|20463108|P3|STARTED|Overall Study||8
8299671|NCT01558063|20463109|P2|STARTED|Overall Study||6
8299672|NCT01558063|20463110|P1|STARTED|Overall Study||5
8299673|NCT01557959|20463131|P1|NOT COMPLETED|Overall Study||0
8299674|NCT01557959|20463131|P1|COMPLETED|Overall Study||45
8299675|NCT01557959|20463131|P1|STARTED|Overall Study||45
8299676|NCT01557946|20463141|P2|NOT COMPLETED|Overall Study||0
8299677|NCT01557946|20463142|P1|NOT COMPLETED|Overall Study||3
8299678|NCT01557946|20463141|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
8299679|NCT01557946|20463142|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
8299680|NCT01557946|20463141|P2|STARTED|Overall Study||12
8299681|NCT01557946|20463142|P1|STARTED|Overall Study||20
8299682|NCT01557920|20463148|P2|NOT COMPLETED|Overall Study||3
8299683|NCT01557920|20463149|P1|NOT COMPLETED|Overall Study||3
8299684|NCT01557920|20463148|P2|COMPLETED|Overall Study||6
8299685|NCT01557920|20463149|P1|COMPLETED|Overall Study||6
8299686|NCT01557920|20463148|P2|STARTED|Overall Study||9
8299687|NCT01557920|20463149|P1|STARTED|Overall Study||9
8299688|NCT01557894|20463184|P2|NOT COMPLETED|Overall Study||5
8299689|NCT01557894|20463185|P1|NOT COMPLETED|Overall Study||3
8299690|NCT01557894|20463184|P2|COMPLETED|Overall Study||33
8299691|NCT01557894|20463185|P1|COMPLETED|Overall Study||35
8299692|NCT01557894|20463184|P2|STARTED|Overall Study||38
8299693|NCT01557894|20463185|P1|STARTED|Overall Study||38
8299694|NCT01557881|20463199|P1|NOT COMPLETED|Overall Study||0
8299695|NCT01557881|20463199|P1|COMPLETED|Overall Study||98
8299696|NCT01557881|20463199|P1|STARTED|Overall Study||98
8299697|NCT01557868|20463207|P2|NOT COMPLETED|Overall Study||30
8299698|NCT01557868|20463208|P1|NOT COMPLETED|Overall Study||27
8299699|NCT01557868|20463207|P2|COMPLETED|Overall Study||65
8299700|NCT01557868|20463208|P1|COMPLETED|Overall Study||76
8299701|NCT01557868|20463207|P2|STARTED|Overall Study||95
8299702|NCT01557868|20463208|P1|STARTED|Overall Study||103
8299703|NCT01557842|20463218|P2|NOT COMPLETED|Overall Study||6
8299704|NCT01557842|20463219|P1|NOT COMPLETED|Overall Study||9
8299705|NCT01557842|20463218|P2|COMPLETED|Overall Study||0
8299706|NCT01557842|20463219|P1|COMPLETED|Overall Study||0
8299707|NCT01557842|20463218|P2|STARTED|Overall Study||6
8299708|NCT01557842|20463219|P1|STARTED|Overall Study||9
8299709|NCT01557790|20463227|P1|NOT COMPLETED|Overall Study||1
8299710|NCT01557790|20463227|P1|COMPLETED|Overall Study||4
8299711|NCT01557790|20463227|P1|STARTED|Overall Study||5
8299715|NCT01557699|20463238|P3|NOT COMPLETED|Overall Study||0
8299716|NCT01557699|20463239|P2|NOT COMPLETED|Overall Study||0
8299717|NCT01557699|20463240|P1|NOT COMPLETED|Overall Study||0
8299718|NCT01557699|20463238|P3|COMPLETED|Overall Study||20
8299719|NCT01557699|20463239|P2|COMPLETED|Overall Study||20
8299720|NCT01557699|20463240|P1|COMPLETED|Overall Study||20
8299721|NCT01557699|20463238|P3|STARTED|Overall Study||20
8299722|NCT01557699|20463239|P2|STARTED|Overall Study||20
8299723|NCT01557699|20463240|P1|STARTED|Overall Study||20
8299724|NCT01557595|20463272|P1|NOT COMPLETED|Overall Study||8
8299725|NCT01557595|20463272|P1|COMPLETED|Overall Study||14
8299726|NCT01557595|20463272|P1|STARTED|Overall Study||22
8299727|NCT01557582|20463276|P1|NOT COMPLETED|Overall Study||6
8299728|NCT01557582|20463276|P1|COMPLETED|Overall Study||97
8299729|NCT01557582|20463276|P1|STARTED|Overall Study||103
8299730|NCT01557569|20463284|P2|NOT COMPLETED|Overall Study||7
8299731|NCT01557569|20463285|P1|NOT COMPLETED|Overall Study||5
8299732|NCT01557569|20463284|P2|COMPLETED|Overall Study||0
8299733|NCT01557569|20463285|P1|COMPLETED|Overall Study||1
8299734|NCT01557569|20463284|P2|Completed 2-wk Residential Stay|Overall Study||1
8299735|NCT01557569|20463285|P1|Completed 2-wk Residential Stay|Overall Study||3
8299736|NCT01557569|20463284|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
8299737|NCT01557569|20463285|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
8299738|NCT01557517|20463293|P2|NOT COMPLETED|Overall Study||4
8299739|NCT01557517|20463294|P1|NOT COMPLETED|Overall Study||2
8299740|NCT01557517|20463293|P2|COMPLETED|Overall Study||17
8299741|NCT01557517|20463294|P1|COMPLETED|Overall Study||17
8299742|NCT01557517|20463293|P2|STARTED|Overall Study||21
8299743|NCT01557517|20463294|P1|STARTED|Overall Study||19
8299744|NCT01557504|20463320|P2|NOT COMPLETED|Overall Study||0
8299745|NCT01557504|20463321|P1|NOT COMPLETED|Overall Study||1
8299746|NCT01557504|20463320|P2|COMPLETED|Overall Study||12
8299747|NCT01557504|20463321|P1|COMPLETED|Overall Study||12
8299748|NCT01557504|20463320|P2|STARTED|Overall Study||12
8299749|NCT01557504|20463321|P1|STARTED|Overall Study||13
8299750|NCT01557400|20463344|P1|NOT COMPLETED|Overall Study||57
8299751|NCT01557400|20463344|P1|COMPLETED|Overall Study||37
8299752|NCT01557400|20463344|P1|Received at Least 1 Dose of Study Drug|Overall Study||94
8299753|NCT01557400|20463344|P1|STARTED|Overall Study||94
8299754|NCT01557348|20463356|P2|NOT COMPLETED|Overall Study||90
8299755|NCT01557348|20463357|P1|NOT COMPLETED|Overall Study||80
8299756|NCT01557348|20463356|P2|COMPLETED|Overall Study||417
8299757|NCT01557348|20463357|P1|COMPLETED|Overall Study||524
8299758|NCT01557348|20463356|P2|Safety Population|Overall Study||507
8299759|NCT01557348|20463357|P1|Safety Population|Overall Study||604
8299760|NCT01557348|20463356|P2|STARTED|Overall Study||507
8299761|NCT01557348|20463357|P1|STARTED|Overall Study||604
8299762|NCT01557322|20463399|P2|NOT COMPLETED|Overall Study||0
8299763|NCT01557322|20463400|P1|NOT COMPLETED|Overall Study||0
8299764|NCT01557322|20463399|P2|COMPLETED|Overall Study||1543
8299765|NCT01557322|20463400|P1|COMPLETED|Overall Study||211
8299766|NCT01557322|20463399|P2|STARTED|Overall Study||1543
8299767|NCT01557322|20463400|P1|STARTED|Overall Study||211
8299768|NCT01557283|20463474|P1|NOT COMPLETED|Overall Study||44
8299769|NCT01557283|20463474|P1|COMPLETED|Overall Study||96
8299770|NCT01557283|20463474|P1|STARTED|Overall Study||140
8299771|NCT01557166|20463486|P2|NOT COMPLETED|Overall Study||37
8299772|NCT01557166|20463487|P1|NOT COMPLETED|Overall Study||46
8299773|NCT01557166|20463486|P2|COMPLETED|Overall Study||142
8299774|NCT01557166|20463487|P1|COMPLETED|Overall Study||134
8299775|NCT01557166|20463486|P2|Exposed|Overall Study||179
8299776|NCT01557166|20463487|P1|Exposed|Overall Study||176
8299777|NCT01557166|20463486|P2|STARTED|Overall Study||179
8299778|NCT01557166|20463487|P1|STARTED|Overall Study||180
8299779|NCT01556997|20463502|P3|NOT COMPLETED|Overall Study||32
8299780|NCT01556997|20463503|P2|NOT COMPLETED|Overall Study||28
8299781|NCT01556997|20463504|P1|NOT COMPLETED|Overall Study||26
8299782|NCT01556997|20463502|P3|COMPLETED|Overall Study||246
8299783|NCT01556997|20463503|P2|COMPLETED|Overall Study||252
8299784|NCT01556997|20463504|P1|COMPLETED|Overall Study||253
8299785|NCT01556997|20463502|P3|STARTED|Overall Study||278
8299786|NCT01556997|20463503|P2|STARTED|Overall Study||280
8299787|NCT01556997|20463504|P1|STARTED|Overall Study||279
8299788|NCT01556932|20463515|P2|NOT COMPLETED|Second Treament||0
8299789|NCT01556932|20463516|P1|NOT COMPLETED|Second Treament||0
8299790|NCT01556932|20463515|P2|COMPLETED|Second Treament||8
8299791|NCT01556932|20463516|P1|COMPLETED|Second Treament||12
8299792|NCT01556932|20463515|P2|Recieved|Second Treament||8
8299793|NCT01556932|20463516|P1|Recieved|Second Treament||12
8299794|NCT01556932|20463515|P2|STARTED|Second Treament||8
8299795|NCT01556932|20463516|P1|STARTED|Second Treament||12
8299796|NCT01556932|20463515|P2|NOT COMPLETED|Time Point 60 Minutes||1
8299797|NCT01556932|20463516|P1|NOT COMPLETED|Time Point 60 Minutes||1
8299798|NCT01556932|20463515|P2|COMPLETED|Time Point 60 Minutes||8
8299799|NCT01556932|20463516|P1|COMPLETED|Time Point 60 Minutes||12
8299800|NCT01556932|20463515|P2|Recieved|Time Point 60 Minutes||8
8299801|NCT01556932|20463516|P1|Recieved|Time Point 60 Minutes||12
8299802|NCT01556932|20463515|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
8299803|NCT01556932|20463516|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
8299804|NCT01556932|20463515|P2|NOT COMPLETED|Baseline First Treatment||0
8299805|NCT01556932|20463516|P1|NOT COMPLETED|Baseline First Treatment||0
8299806|NCT01556932|20463515|P2|COMPLETED|Baseline First Treatment||9
8299807|NCT01556932|20463516|P1|COMPLETED|Baseline First Treatment||13
8299808|NCT01556932|20463515|P2|Recieved|Baseline First Treatment||9
8299809|NCT01556932|20463516|P1|Recieved|Baseline First Treatment||13
8299810|NCT01556932|20463515|P2|STARTED|Baseline First Treatment||9
8299811|NCT01556932|20463516|P1|STARTED|Baseline First Treatment||13
8299812|NCT01556906|20463521|P1|NOT COMPLETED|Overall Study||0
8299813|NCT01556906|20463521|P1|COMPLETED|Overall Study||6
8299814|NCT01556906|20463521|P1|STARTED|Overall Study||6
8299815|NCT01556763|20463542|P3|NOT COMPLETED|Overall Study||0
8299816|NCT01556763|20463543|P2|NOT COMPLETED|Overall Study||1
8299817|NCT01556763|20463544|P1|NOT COMPLETED|Overall Study||0
8299818|NCT01556763|20463542|P3|COMPLETED|Overall Study||8
8299819|NCT01556763|20463543|P2|COMPLETED|Overall Study||8
8299820|NCT01556763|20463544|P1|COMPLETED|Overall Study||4
8299821|NCT01556763|20463542|P3|STARTED|Overall Study||8
8299822|NCT01556763|20463543|P2|STARTED|Overall Study||9
8299823|NCT01556763|20463544|P1|STARTED|Overall Study||4
8299824|NCT01556724|20463582|P2|NOT COMPLETED|Overall Study||0
8299825|NCT01556724|20463583|P1|NOT COMPLETED|Overall Study||0
8299826|NCT01556724|20463582|P2|COMPLETED|Overall Study||14
8299827|NCT01556724|20463583|P1|COMPLETED|Overall Study||16
8299828|NCT01556724|20463582|P2|STARTED|Overall Study||14
8299829|NCT01556724|20463583|P1|STARTED|Overall Study||16
8299830|NCT01556633|20463599|P2|NOT COMPLETED|Overall Study||0
8299831|NCT01556633|20463600|P1|NOT COMPLETED|Overall Study||0
8299832|NCT01556633|20463599|P2|COMPLETED|Overall Study||6
8299833|NCT01556633|20463600|P1|COMPLETED|Overall Study||10
8299834|NCT01556633|20463599|P2|STARTED|Overall Study||6
8299835|NCT01556633|20463600|P1|STARTED|Overall Study||10
8299836|NCT01556594|20463625|P3|NOT COMPLETED|Overall Study||0
8299837|NCT01556594|20463626|P2|NOT COMPLETED|Overall Study||0
8299838|NCT01556594|20463627|P1|NOT COMPLETED|Overall Study||0
8299839|NCT01556594|20463625|P3|COMPLETED|Overall Study||6
8299840|NCT01556594|20463626|P2|COMPLETED|Overall Study||2
8299841|NCT01556594|20463627|P1|COMPLETED|Overall Study||10
8299842|NCT01556594|20463625|P3|STARTED|Overall Study||6
8299843|NCT01556594|20463626|P2|STARTED|Overall Study||2
8299844|NCT01556594|20463627|P1|STARTED|Overall Study||10
8299845|NCT01556581|20463663|P2|NOT COMPLETED|Overall Study||0
8299846|NCT01556581|20463664|P1|NOT COMPLETED|Overall Study||0
8299847|NCT01556581|20463663|P2|COMPLETED|Overall Study||58
8299848|NCT01556581|20463664|P1|COMPLETED|Overall Study||61
8299849|NCT01556581|20463663|P2|STARTED|Overall Study||58
8299850|NCT01556581|20463664|P1|STARTED|Overall Study||61
8299851|NCT01556451|20463674|P1|NOT COMPLETED|Overall Study||0
8299852|NCT01556451|20463674|P1|COMPLETED|Overall Study||180
8299853|NCT01556451|20463674|P1|STARTED|Overall Study||180
8299854|NCT01556438|20463683|P2|NOT COMPLETED|Overall Study||11
8299855|NCT01556438|20463684|P1|NOT COMPLETED|Overall Study||4
8299856|NCT01556438|20463683|P2|COMPLETED|Overall Study||1
8299857|NCT01556438|20463684|P1|COMPLETED|Overall Study||0
8299858|NCT01556438|20463683|P2|Received BTZ SC|Overall Study||8
8299859|NCT01556438|20463684|P1|Received BTZ SC|Overall Study||0
8299860|NCT01556438|20463683|P2|Received BTZ IV|Overall Study||4
8299861|NCT01556438|20463684|P1|Received BTZ IV|Overall Study||4
8299862|NCT01556438|20463683|P2|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
8299863|NCT01556438|20463684|P1|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
8299864|NCT01556438|20463683|P2|STARTED|Overall Study||12
8299865|NCT01556438|20463684|P1|STARTED|Overall Study||4
8299866|NCT01556425|20463713|P4|NOT COMPLETED|Overall Study||0
8299867|NCT01556425|20463714|P3|NOT COMPLETED|Overall Study||0
8299868|NCT01556425|20463715|P2|NOT COMPLETED|Overall Study||0
8299869|NCT01556425|20463716|P1|NOT COMPLETED|Overall Study||0
8299870|NCT01556425|20463713|P4|COMPLETED|Overall Study||18
8299871|NCT01556425|20463714|P3|COMPLETED|Overall Study||18
8299872|NCT01556425|20463715|P2|COMPLETED|Overall Study||23
8299873|NCT01556425|20463716|P1|COMPLETED|Overall Study||25
8299874|NCT01556425|20463713|P4|STARTED|Overall Study||18
8299875|NCT01556425|20463714|P3|STARTED|Overall Study||18
8299876|NCT01556425|20463715|P2|STARTED|Overall Study||23
8299877|NCT01556425|20463716|P1|STARTED|Overall Study||25
8299878|NCT01556347|20463730|P1|NOT COMPLETED|Recovery Phase||0
8299879|NCT01556347|20463730|P1|COMPLETED|Recovery Phase||2
8299880|NCT01556347|20463730|P1|STARTED|Recovery Phase||2
8299881|NCT01556347|20463730|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
8299882|NCT01556347|20463730|P1|COMPLETED|Bortezomib Treatment Phase||2
8299883|NCT01556347|20463730|P1|STARTED|Bortezomib Treatment Phase||2
8299884|NCT01556347|20463730|P1|NOT COMPLETED|Induction Immunotherapy||0
8299885|NCT01556347|20463730|P1|COMPLETED|Induction Immunotherapy||2
8299886|NCT01556347|20463730|P1|STARTED|Induction Immunotherapy||2
8299887|NCT01556204|20463760|P2|NOT COMPLETED|Overall Study||0
8299888|NCT01556204|20463761|P1|NOT COMPLETED|Overall Study||0
8299889|NCT01556204|20463760|P2|COMPLETED|Overall Study||38
8299890|NCT01556204|20463761|P1|COMPLETED|Overall Study||35
8299891|NCT01556204|20463760|P2|STARTED|Overall Study||38
8299892|NCT01556204|20463761|P1|STARTED|Overall Study||35
8299893|NCT01556165|20463771|P2|NOT COMPLETED|Overall Study||7
8299894|NCT01556165|20463772|P1|NOT COMPLETED|Overall Study||12
8299895|NCT01556165|20463771|P2|COMPLETED|Overall Study||58
8299896|NCT01556165|20463772|P1|COMPLETED|Overall Study||53
8299897|NCT01556165|20463771|P2|STARTED|Overall Study||65
8299898|NCT01556165|20463772|P1|STARTED|Overall Study||65
8299899|NCT01556100|20463784|P1|NOT COMPLETED|Overall Study||6
8299900|NCT01556100|20463784|P1|COMPLETED|Overall Study||34
8299901|NCT01556100|20463784|P1|STARTED|Overall Study||40
8299902|NCT01556061|20463791|P2|NOT COMPLETED|Overall Study||0
8299903|NCT01556061|20463792|P1|NOT COMPLETED|Overall Study||0
8299904|NCT01556061|20463791|P2|COMPLETED|Overall Study||25
8299905|NCT01556061|20463792|P1|COMPLETED|Overall Study||25
8299906|NCT01556061|20463791|P2|STARTED|Overall Study||25
8299907|NCT01556061|20463792|P1|STARTED|Overall Study||25
8299908|NCT01556009|20463804|P2|NOT COMPLETED|Overall Study||0
8299909|NCT01556009|20463805|P1|NOT COMPLETED|Overall Study||0
8299910|NCT01556009|20463804|P2|COMPLETED|Overall Study||0
8299911|NCT01556009|20463805|P1|COMPLETED|Overall Study||0
8299912|NCT01556009|20463804|P2|STARTED|Overall Study||0
8299913|NCT01556009|20463805|P1|STARTED|Overall Study||0
8299914|NCT01555983|20463813|P6|NOT COMPLETED|Overall Study||1
8299915|NCT01555983|20463814|P5|NOT COMPLETED|Overall Study||1
8299916|NCT01555983|20463815|P4|NOT COMPLETED|Overall Study||0
8299917|NCT01555983|20463816|P3|NOT COMPLETED|Overall Study||0
8299918|NCT01555983|20463817|P2|NOT COMPLETED|Overall Study||0
8299919|NCT01555983|20463818|P1|NOT COMPLETED|Overall Study||1
8299920|NCT01555983|20463813|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
8299921|NCT01555983|20463814|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
8299922|NCT01555983|20463815|P4|COMPLETED|Overall Study||7
8299923|NCT01555983|20463816|P3|COMPLETED|Overall Study||7
8299924|NCT01555983|20463817|P2|COMPLETED|Overall Study||7
8299925|NCT01555983|20463818|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
8299926|NCT01555983|20463813|P6|STARTED|Overall Study||7
8299927|NCT01555983|20463814|P5|STARTED|Overall Study||5
8299928|NCT01555983|20463815|P4|STARTED|Overall Study||7
8299929|NCT01555983|20463816|P3|STARTED|Overall Study||7
8299930|NCT01555983|20463817|P2|STARTED|Overall Study||7
8299931|NCT01555983|20463818|P1|STARTED|Overall Study||9
8299932|NCT01555957|20463828|P2|NOT COMPLETED|Overall Study||0
8299933|NCT01555957|20463829|P1|NOT COMPLETED|Overall Study||0
8299934|NCT01555957|20463828|P2|COMPLETED|Overall Study||20
8299935|NCT01555957|20463829|P1|COMPLETED|Overall Study||20
8299936|NCT01555957|20463828|P2|STARTED|Overall Study||20
8299937|NCT01555957|20463829|P1|STARTED|Overall Study||20
8299938|NCT01555931|20463839|P2|NOT COMPLETED|Overall Study||5
8299939|NCT01555931|20463840|P1|NOT COMPLETED|Overall Study||2
8299940|NCT01555931|20463839|P2|COMPLETED|Overall Study||13
8299941|NCT01555931|20463840|P1|COMPLETED|Overall Study||15
8299942|NCT01555931|20463839|P2|STARTED|Overall Study||18
8299943|NCT01555931|20463840|P1|STARTED|Overall Study||17
8299944|NCT01555762|20463848|P1|NOT COMPLETED|Overall Study||274
8299945|NCT01555762|20463848|P1|COMPLETED|Overall Study||128
8299946|NCT01555762|20463848|P1|Efficacy Population|Overall Study||358
8299947|NCT01555762|20463848|P1|Safety Population|Overall Study||383
8299948|NCT01555762|20463848|P1|STARTED|Overall Study||402
8299949|NCT01555697|20463866|P8|NOT COMPLETED|Overall Study||0
8299950|NCT01555697|20463867|P7|NOT COMPLETED|Overall Study||0
8299951|NCT01555697|20463868|P6|NOT COMPLETED|Overall Study||0
8299952|NCT01555697|20463869|P5|NOT COMPLETED|Overall Study||0
8299953|NCT01555697|20463870|P4|NOT COMPLETED|Overall Study||0
8299954|NCT01555697|20463871|P3|NOT COMPLETED|Overall Study||0
8299955|NCT01555697|20463872|P2|NOT COMPLETED|Overall Study||0
8299956|NCT01555697|20463873|P1|NOT COMPLETED|Overall Study||0
8299957|NCT01555697|20463866|P8|COMPLETED|Overall Study||10
8299958|NCT01555697|20463867|P7|COMPLETED|Overall Study||10
8299959|NCT01555697|20463868|P6|COMPLETED|Overall Study||10
8299960|NCT01555697|20463869|P5|COMPLETED|Overall Study||10
8299961|NCT01555697|20463870|P4|COMPLETED|Overall Study||10
8299962|NCT01555697|20463871|P3|COMPLETED|Overall Study||10
8299963|NCT01555697|20463872|P2|COMPLETED|Overall Study||10
8299964|NCT01555697|20463873|P1|COMPLETED|Overall Study||10
8299965|NCT01555697|20463866|P8|6 Hours Lab Testing Day 2|Overall Study||10
8299966|NCT01555697|20463867|P7|6 Hours Lab Testing Day 2|Overall Study||10
8299967|NCT01555697|20463868|P6|6 Hours Lab Testing Day 2|Overall Study||10
8299968|NCT01555697|20463869|P5|6 Hours Lab Testing Day 2|Overall Study||10
8299969|NCT01555697|20463870|P4|6 Hours Lab Testing Day 2|Overall Study||10
8299970|NCT01555697|20463871|P3|6 Hours Lab Testing Day 2|Overall Study||10
8299971|NCT01555697|20463872|P2|6 Hours Lab Testing Day 2|Overall Study||10
8299972|NCT01555697|20463873|P1|6 Hours Lab Testing Day 2|Overall Study||10
8299973|NCT01555697|20463866|P8|Approx 7 Day Washout|Overall Study||10
8299974|NCT01555697|20463867|P7|Approx 7 Day Washout|Overall Study||10
8299975|NCT01555697|20463868|P6|Approx 7 Day Washout|Overall Study||10
8299976|NCT01555697|20463869|P5|Approx 7 Day Washout|Overall Study||10
8299977|NCT01555697|20463870|P4|Approx 7 Day Washout|Overall Study||10
8299978|NCT01555697|20463871|P3|Approx 7 Day Washout|Overall Study||10
8299979|NCT01555697|20463872|P2|Approx 7 Day Washout|Overall Study||10
8299980|NCT01555697|20463873|P1|Approx 7 Day Washout|Overall Study||10
8299981|NCT01555697|20463866|P8|6 Hours Lab Testing Day 1|Overall Study||10
8299982|NCT01555697|20463867|P7|6 Hours Lab Testing Day 1|Overall Study||10
8299983|NCT01555697|20463868|P6|6 Hours Lab Testing Day 1|Overall Study||10
8299984|NCT01555697|20463869|P5|6 Hours Lab Testing Day 1|Overall Study||10
8299985|NCT01555697|20463870|P4|6 Hours Lab Testing Day 1|Overall Study||10
8299986|NCT01555697|20463871|P3|6 Hours Lab Testing Day 1|Overall Study||10
8299987|NCT01555697|20463872|P2|6 Hours Lab Testing Day 1|Overall Study||10
8299988|NCT01555697|20463873|P1|6 Hours Lab Testing Day 1|Overall Study||10
8299989|NCT01555697|20463866|P8|STARTED|Overall Study||10
8299990|NCT01555697|20463867|P7|STARTED|Overall Study||10
8299991|NCT01555697|20463868|P6|STARTED|Overall Study||10
8299992|NCT01555697|20463869|P5|STARTED|Overall Study||10
8299993|NCT01555697|20463870|P4|STARTED|Overall Study||10
8299994|NCT01555697|20463871|P3|STARTED|Overall Study||10
8299995|NCT01555697|20463872|P2|STARTED|Overall Study||10
8299996|NCT01555697|20463873|P1|STARTED|Overall Study||10
8299997|NCT01555567|20463897|P4|NOT COMPLETED|Return to Activity||1
8299998|NCT01555567|20463898|P3|NOT COMPLETED|Return to Activity||0
8299999|NCT01555567|20463899|P2|NOT COMPLETED|Return to Activity||2
8300000|NCT01555567|20463900|P1|NOT COMPLETED|Return to Activity||1
8300001|NCT01555567|20463897|P4|COMPLETED|Return to Activity||8
8300002|NCT01555567|20463898|P3|COMPLETED|Return to Activity||8
8300003|NCT01555567|20463899|P2|COMPLETED|Return to Activity||10
8300004|NCT01555567|20463900|P1|COMPLETED|Return to Activity||10
8300005|NCT01555567|20463897|P4|STARTED|Return to Activity||9
8300006|NCT01555567|20463898|P3|STARTED|Return to Activity||8
8300007|NCT01555567|20463899|P2|STARTED|Return to Activity||12
8300008|NCT01555567|20463900|P1|STARTED|Return to Activity||11
8300009|NCT01555567|20463897|P4|NOT COMPLETED|12 Week||0
8300010|NCT01555567|20463898|P3|NOT COMPLETED|12 Week||1
8300011|NCT01555567|20463899|P2|NOT COMPLETED|12 Week||1
8300012|NCT01555567|20463900|P1|NOT COMPLETED|12 Week||1
8300013|NCT01555567|20463897|P4|COMPLETED|12 Week||9
8300014|NCT01555567|20463898|P3|COMPLETED|12 Week||8
8300015|NCT01555567|20463899|P2|COMPLETED|12 Week||12
8300016|NCT01555567|20463900|P1|COMPLETED|12 Week||11
8300017|NCT01555567|20463897|P4|STARTED|12 Week||9
8300018|NCT01555567|20463898|P3|STARTED|12 Week||9
8300019|NCT01555567|20463899|P2|STARTED|12 Week||13
8300020|NCT01555567|20463900|P1|STARTED|12 Week||12
8300021|NCT01555541|20463914|P1|NOT COMPLETED|Autologous Stem Cell Transplantation||0
8300022|NCT01555541|20463914|P1|COMPLETED|Autologous Stem Cell Transplantation||12
8300023|NCT01555541|20463914|P1|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
8300024|NCT01555541|20463914|P1|NOT COMPLETED|OVA Treatment||0
8300025|NCT01555541|20463914|P1|COMPLETED|OVA Treatment||19
8300026|NCT01555541|20463914|P1|STARTED|OVA Treatment||19
8300027|NCT01555541|20463914|P1|NOT COMPLETED|Salvage Response Assessment||0
8300028|NCT01555541|20463914|P1|COMPLETED|Salvage Response Assessment||19
8300029|NCT01555541|20463914|P1|STARTED|Salvage Response Assessment||19
8300030|NCT01555489|20463921|P1|NOT COMPLETED|Overall Study||0
8300031|NCT01555489|20463921|P1|COMPLETED|Overall Study||11
8300032|NCT01555489|20463921|P1|STARTED|Overall Study||11
8300033|NCT01555463|20463928|P2|NOT COMPLETED|Follow up||45
8300034|NCT01555463|20463929|P1|NOT COMPLETED|Follow up||38
8300035|NCT01555463|20463928|P2|COMPLETED|Follow up||394
8300036|NCT01555463|20463929|P1|COMPLETED|Follow up||409
8300037|NCT01555463|20463928|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
8300038|NCT01555463|20463929|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
8300039|NCT01555463|20463928|P2|NOT COMPLETED|Treatment||79
8300040|NCT01555463|20463929|P1|NOT COMPLETED|Treatment||64
8300041|NCT01555463|20463928|P2|COMPLETED|Treatment||399
8300042|NCT01555463|20463929|P1|COMPLETED|Treatment||419
8300043|NCT01555463|20463928|P2|STARTED|Treatment||478
8300044|NCT01555463|20463929|P1|STARTED|Treatment||483
8300045|NCT01555164|20463971|P2|NOT COMPLETED|Overall Study||35
8300046|NCT01555164|20463972|P1|NOT COMPLETED|Overall Study||40
8300047|NCT01555164|20463971|P2|COMPLETED|Overall Study||185
8300048|NCT01555164|20463972|P1|COMPLETED|Overall Study||182
8300049|NCT01555164|20463971|P2|STARTED|Overall Study||220
8300050|NCT01555164|20463972|P1|STARTED|Overall Study||222
8300051|NCT01555151|20463986|P4|NOT COMPLETED|Overall Study||10
8300052|NCT01555151|20463987|P3|NOT COMPLETED|Overall Study||6
8300053|NCT01555151|20463988|P2|NOT COMPLETED|Overall Study||8
8300054|NCT01555151|20463989|P1|NOT COMPLETED|Overall Study||13
8300055|NCT01555151|20463986|P4|COMPLETED|Overall Study||176
8300056|NCT01555151|20463987|P3|COMPLETED|Overall Study||178
8300057|NCT01555151|20463988|P2|COMPLETED|Overall Study||173
8300058|NCT01555151|20463989|P1|COMPLETED|Overall Study||175
8300059|NCT01555151|20463986|P4|Safety Set (SAF)|Overall Study||186
8300060|NCT01555151|20463987|P3|Safety Set (SAF)|Overall Study||183
8300061|NCT01555151|20463988|P2|Safety Set (SAF)|Overall Study||180
8300062|NCT01555151|20463989|P1|Safety Set (SAF)|Overall Study||186
8300063|NCT01555151|20463986|P4|STARTED|Overall Study||186
8300064|NCT01555151|20463987|P3|STARTED|Overall Study||184
8300065|NCT01555151|20463988|P2|STARTED|Overall Study||181
8300066|NCT01555151|20463989|P1|STARTED|Overall Study||188
8300067|NCT01555138|20464042|P2|NOT COMPLETED|Overall Study||38
8300068|NCT01555138|20464043|P1|NOT COMPLETED|Overall Study||47
8300069|NCT01555138|20464042|P2|COMPLETED|Overall Study||250
8300070|NCT01555138|20464043|P1|COMPLETED|Overall Study||246
8300071|NCT01555138|20464042|P2|STARTED|Overall Study||288
8300072|NCT01555138|20464043|P1|STARTED|Overall Study||293
8300073|NCT01555125|20464072|P5|NOT COMPLETED|Follow-Up Period||0
8300074|NCT01555125|20464073|P4|NOT COMPLETED|Follow-Up Period||1
8300075|NCT01555125|20464074|P3|NOT COMPLETED|Follow-Up Period||1
8300076|NCT01555125|20464075|P2|NOT COMPLETED|Follow-Up Period||1
8300077|NCT01555125|20464076|P1|NOT COMPLETED|Follow-Up Period||4
8300078|NCT01555125|20464072|P5|COMPLETED|Follow-Up Period||0
8300079|NCT01555125|20464073|P4|COMPLETED|Follow-Up Period||17
8300080|NCT01555125|20464074|P3|COMPLETED|Follow-Up Period||18
8300081|NCT01555125|20464075|P2|COMPLETED|Follow-Up Period||30
8300082|NCT01555125|20464076|P1|COMPLETED|Follow-Up Period||32
8300083|NCT01555125|20464072|P5|STARTED|Follow-Up Period||0
8300084|NCT01555125|20464073|P4|STARTED|Follow-Up Period||18
8300085|NCT01555125|20464074|P3|STARTED|Follow-Up Period||19
8300086|NCT01555125|20464075|P2|STARTED|Follow-Up Period||31
8300087|NCT01555125|20464076|P1|STARTED|Follow-Up Period||36
8300088|NCT01555125|20464072|P5|NOT COMPLETED|Extension||0
8300089|NCT01555125|20464073|P4|NOT COMPLETED|Extension||22
8300090|NCT01555125|20464074|P3|NOT COMPLETED|Extension||23
8300091|NCT01555125|20464075|P2|NOT COMPLETED|Extension||51
8300092|NCT01555125|20464076|P1|NOT COMPLETED|Extension||45
8300093|NCT01555125|20464072|P5|COMPLETED|Extension||0
8300094|NCT01555125|20464073|P4|COMPLETED|Extension||1
8300095|NCT01555125|20464074|P3|COMPLETED|Extension||0
8300096|NCT01555125|20464075|P2|COMPLETED|Extension||0
8300097|NCT01555125|20464076|P1|COMPLETED|Extension||1
8300098|NCT01555125|20464072|P5|STARTED|Extension||0
8300099|NCT01555125|20464073|P4|STARTED|Extension||23
8300100|NCT01555125|20464074|P3|STARTED|Extension||23
8300101|NCT01555125|20464075|P2|STARTED|Extension||51
8300102|NCT01555125|20464076|P1|STARTED|Extension||46
8300103|NCT01555125|20464072|P5|NOT COMPLETED|Maintenance Period||0
8300104|NCT01555125|20464073|P4|NOT COMPLETED|Maintenance Period||2
8300105|NCT01555125|20464074|P3|NOT COMPLETED|Maintenance Period||4
8300106|NCT01555125|20464075|P2|NOT COMPLETED|Maintenance Period||4
8300107|NCT01555125|20464076|P1|NOT COMPLETED|Maintenance Period||10
8300108|NCT01555125|20464072|P5|COMPLETED|Maintenance Period||0
8300109|NCT01555125|20464073|P4|COMPLETED|Maintenance Period||25
8300110|NCT01555125|20464074|P3|COMPLETED|Maintenance Period||25
8300111|NCT01555125|20464075|P2|COMPLETED|Maintenance Period||52
8300112|NCT01555125|20464076|P1|COMPLETED|Maintenance Period||48
8300113|NCT01555125|20464072|P5|STARTED|Maintenance Period||0
8300114|NCT01555125|20464073|P4|STARTED|Maintenance Period||27
8300115|NCT01555125|20464074|P3|STARTED|Maintenance Period||29
8300116|NCT01555125|20464075|P2|STARTED|Maintenance Period||56
8300117|NCT01555125|20464076|P1|STARTED|Maintenance Period||58
8300118|NCT01555125|20464072|P5|NOT COMPLETED|Induction Period||3
8300119|NCT01555125|20464073|P4|NOT COMPLETED|Induction Period||0
8300120|NCT01555125|20464074|P3|NOT COMPLETED|Induction Period||0
8300121|NCT01555125|20464075|P2|NOT COMPLETED|Induction Period||3
8300122|NCT01555125|20464076|P1|NOT COMPLETED|Induction Period||1
8300123|NCT01555125|20464072|P5|COMPLETED|Induction Period||56
8300124|NCT01555125|20464073|P4|COMPLETED|Induction Period||0
8300125|NCT01555125|20464074|P3|COMPLETED|Induction Period||0
8300126|NCT01555125|20464075|P2|COMPLETED|Induction Period||56
8300127|NCT01555125|20464076|P1|COMPLETED|Induction Period||58
8300128|NCT01555125|20464072|P5|STARTED|Induction Period||59
8300129|NCT01555125|20464073|P4|STARTED|Induction Period||0
8300130|NCT01555125|20464074|P3|STARTED|Induction Period||0
8300131|NCT01555125|20464075|P2|STARTED|Induction Period||59
8300132|NCT01555125|20464076|P1|STARTED|Induction Period||59
8300133|NCT01555073|20464169|P4|NOT COMPLETED|Overall Study||5
8300134|NCT01555073|20464170|P3|NOT COMPLETED|Overall Study||0
8300135|NCT01555073|20464171|P2|NOT COMPLETED|Overall Study||2
8300136|NCT01555073|20464172|P1|NOT COMPLETED|Overall Study||1
8300137|NCT01555073|20464169|P4|COMPLETED|Overall Study||1
8300138|NCT01555073|20464170|P3|COMPLETED|Overall Study||7
8300139|NCT01555073|20464171|P2|COMPLETED|Overall Study||1
8300140|NCT01555073|20464172|P1|COMPLETED|Overall Study||6
8300141|NCT01555073|20464169|P4|STARTED|Overall Study||6
8300142|NCT01555073|20464170|P3|STARTED|Overall Study||7
8300143|NCT01555073|20464171|P2|STARTED|Overall Study||3
8300144|NCT01555073|20464172|P1|STARTED|Overall Study||7
8300145|NCT01555021|20464188|P2|NOT COMPLETED|Overall Study||2
8300146|NCT01555021|20464189|P1|NOT COMPLETED|Overall Study||1
8300147|NCT01555021|20464188|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
8300148|NCT01555021|20464189|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
8300149|NCT01555021|20464188|P2|STARTED|Overall Study||2
8300150|NCT01555021|20464189|P1|STARTED|Overall Study||2
8300151|NCT01554982|20464201|P1|NOT COMPLETED|Overall Study||43
8300152|NCT01554982|20464201|P1|COMPLETED|Overall Study||125
8300153|NCT01554982|20464201|P1|Received Drug|Overall Study||166
8300154|NCT01554982|20464201|P1|STARTED|Overall Study||168
8300155|NCT01554904|20464214|P1|NOT COMPLETED|Overall Study||4
8300156|NCT01554904|20464214|P1|COMPLETED|Overall Study||14
8300157|NCT01554904|20464214|P1|Home Sleep Study 2|Overall Study||14
8300158|NCT01554904|20464214|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
8300159|NCT01554904|20464214|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
8300160|NCT01554904|20464214|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
8300161|NCT01554904|20464214|P1|STARTED|Overall Study||18
8300162|NCT01554891|20464222|P3|NOT COMPLETED|Overall Study||2
8300163|NCT01554891|20464223|P2|NOT COMPLETED|Overall Study||5
8300164|NCT01554891|20464224|P1|NOT COMPLETED|Overall Study||7
8300165|NCT01554891|20464222|P3|COMPLETED|Overall Study||55
8300166|NCT01554891|20464223|P2|COMPLETED|Overall Study||115
8300167|NCT01554891|20464224|P1|COMPLETED|Overall Study||98
8300168|NCT01554891|20464222|P3|STARTED|Overall Study||57
8300169|NCT01554891|20464223|P2|STARTED|Overall Study||120
8300170|NCT01554891|20464224|P1|STARTED|Overall Study||105
8300171|NCT01554683|20464232|P6|NOT COMPLETED|Overall Study||0
8300172|NCT01554683|20464233|P5|NOT COMPLETED|Overall Study||0
8300173|NCT01554683|20464234|P4|NOT COMPLETED|Overall Study||0
8300174|NCT01554683|20464235|P3|NOT COMPLETED|Overall Study||0
8300175|NCT01554683|20464236|P2|NOT COMPLETED|Overall Study||0
8300176|NCT01554683|20464237|P1|NOT COMPLETED|Overall Study||0
8300177|NCT01554683|20464232|P6|COMPLETED|Overall Study||0
8300178|NCT01554683|20464233|P5|COMPLETED|Overall Study||1
8300179|NCT01554683|20464234|P4|COMPLETED|Overall Study||2
8300180|NCT01554683|20464235|P3|COMPLETED|Overall Study||3
8300181|NCT01554683|20464236|P2|COMPLETED|Overall Study||1
8300182|NCT01554683|20464237|P1|COMPLETED|Overall Study||2
8300183|NCT01554683|20464232|P6|STARTED|Overall Study||0
8300184|NCT01554683|20464233|P5|STARTED|Overall Study||1
8300185|NCT01554683|20464234|P4|STARTED|Overall Study||2
8300186|NCT01554683|20464235|P3|STARTED|Overall Study||3
8300187|NCT01554683|20464236|P2|STARTED|Overall Study||1
8300188|NCT01554683|20464237|P1|STARTED|Overall Study||2
8300189|NCT01554618|20464259|P2|NOT COMPLETED|Open-Label Extension Period||5
8300190|NCT01554618|20464260|P1|NOT COMPLETED|Open-Label Extension Period||3
8300191|NCT01554618|20464259|P2|COMPLETED|Open-Label Extension Period||18
8300192|NCT01554618|20464260|P1|COMPLETED|Open-Label Extension Period||46
8300193|NCT01554618|20464259|P2|STARTED|Open-Label Extension Period||23
8300194|NCT01554618|20464260|P1|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
8300195|NCT01554618|20464259|P2|NOT COMPLETED|Controlled Assessment Period||1
8300196|NCT01554618|20464260|P1|NOT COMPLETED|Controlled Assessment Period||8
8300197|NCT01554618|20464259|P2|COMPLETED|Controlled Assessment Period||23
8300198|NCT01554618|20464260|P1|COMPLETED|Controlled Assessment Period||50
8300199|NCT01554618|20464259|P2|STARTED|Controlled Assessment Period||24
8300200|NCT01554618|20464260|P1|STARTED|Controlled Assessment Period||58
8300201|NCT01554618|20464259|P2|NOT COMPLETED|Randomized Through Start of Treatment||0
8300202|NCT01554618|20464260|P1|NOT COMPLETED|Randomized Through Start of Treatment||1
8300203|NCT01554618|20464259|P2|COMPLETED|Randomized Through Start of Treatment||24
8300204|NCT01554618|20464260|P1|COMPLETED|Randomized Through Start of Treatment||58
8300205|NCT01554618|20464259|P2|STARTED|Randomized Through Start of Treatment||24
8300206|NCT01554618|20464260|P1|STARTED|Randomized Through Start of Treatment||59
8300207|NCT01554579|20464312|P2|NOT COMPLETED|Overall Study||27
8300208|NCT01554579|20464313|P1|NOT COMPLETED|Overall Study||10
8300209|NCT01554579|20464312|P2|COMPLETED|Overall Study||58
8300210|NCT01554579|20464313|P1|COMPLETED|Overall Study||76
8300211|NCT01554579|20464312|P2|STARTED|Overall Study||85
8300212|NCT01554579|20464313|P1|STARTED|Overall Study||86
8300213|NCT01554527|20464326|P3|NOT COMPLETED|Overall Study||8
8300214|NCT01554527|20464327|P2|NOT COMPLETED|Overall Study||0
8300215|NCT01554527|20464328|P1|NOT COMPLETED|Overall Study||1
8300216|NCT01554527|20464326|P3|COMPLETED|Overall Study||25
8300217|NCT01554527|20464327|P2|COMPLETED|Overall Study||38
8300218|NCT01554527|20464328|P1|COMPLETED|Overall Study||33
8300219|NCT01554527|20464326|P3|Completed as a Control|Overall Study||1
8300220|NCT01554527|20464327|P2|Completed as a Control|Overall Study||0
8300221|NCT01554527|20464328|P1|Completed as a Control|Overall Study||33
8300222|NCT01554527|20464326|P3|Initiated CPAP Treatment at Home|Overall Study||28
8300223|NCT01554527|20464327|P2|Initiated CPAP Treatment at Home|Overall Study||38
8300224|NCT01554527|20464328|P1|Initiated CPAP Treatment at Home|Overall Study||0
8300225|NCT01554527|20464326|P3|Had CPAP Titration|Overall Study||30
8300226|NCT01554527|20464327|P2|Had CPAP Titration|Overall Study||38
8300227|NCT01554527|20464328|P1|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
8300228|NCT01554527|20464326|P3|Crossed Over to Control|Overall Study||2
8300229|NCT01554527|20464327|P2|Crossed Over to Control|Overall Study||0
8300230|NCT01554527|20464328|P1|Crossed Over to Control|Overall Study||0
8300231|NCT01554527|20464326|P3|STARTED|Overall Study||33
8300232|NCT01554527|20464327|P2|STARTED|Overall Study||38
8300233|NCT01554527|20464328|P1|STARTED|Overall Study||34
8300234|NCT01554488|20464357|P2|NOT COMPLETED|Overall Study||3
8300235|NCT01554488|20464358|P1|NOT COMPLETED|Overall Study||1
8300236|NCT01554488|20464357|P2|COMPLETED|Overall Study||9
8300237|NCT01554488|20464358|P1|COMPLETED|Overall Study||12
8300238|NCT01554488|20464357|P2|STARTED|Overall Study||12
8300239|NCT01554488|20464358|P1|STARTED|Overall Study||13
8300240|NCT01554241|20464384|P4|NOT COMPLETED|Overall Study||1
8300241|NCT01554241|20464385|P3|NOT COMPLETED|Overall Study||4
8300242|NCT01554241|20464386|P2|NOT COMPLETED|Overall Study||1
8300243|NCT01554241|20464387|P1|NOT COMPLETED|Overall Study||3
8300244|NCT01554241|20464384|P4|COMPLETED|Overall Study||13
8300245|NCT01554241|20464385|P3|COMPLETED|Overall Study||20
8300246|NCT01554241|20464386|P2|COMPLETED|Overall Study||19
8300247|NCT01554241|20464387|P1|COMPLETED|Overall Study||20
8300248|NCT01554241|20464384|P4|STARTED|Overall Study||14
8300249|NCT01554241|20464385|P3|STARTED|Overall Study||24
8300250|NCT01554241|20464386|P2|STARTED|Overall Study||20
8300251|NCT01554241|20464387|P1|STARTED|Overall Study||23
8300252|NCT01554176|20464403|P5|NOT COMPLETED|Run-out Phase||0
8300253|NCT01554176|20464404|P4|NOT COMPLETED|Run-out Phase||1
8300254|NCT01554176|20464405|P3|NOT COMPLETED|Run-out Phase||0
8300255|NCT01554176|20464406|P2|NOT COMPLETED|Run-out Phase||0
8300256|NCT01554176|20464407|P1|NOT COMPLETED|Run-out Phase||0
8300257|NCT01554176|20464403|P5|COMPLETED|Run-out Phase||59
8300258|NCT01554176|20464404|P4|COMPLETED|Run-out Phase||27
8300259|NCT01554176|20464405|P3|COMPLETED|Run-out Phase||29
8300260|NCT01554176|20464406|P2|COMPLETED|Run-out Phase||0
8300261|NCT01554176|20464407|P1|COMPLETED|Run-out Phase||0
8300262|NCT01554176|20464403|P5|Treated|Run-out Phase||59
8300263|NCT01554176|20464404|P4|Treated|Run-out Phase||28
8300264|NCT01554176|20464405|P3|Treated|Run-out Phase||29
8300265|NCT01554176|20464406|P2|Treated|Run-out Phase||0
8300266|NCT01554176|20464407|P1|Treated|Run-out Phase||0
8300267|NCT01554176|20464403|P5|STARTED|Run-out Phase||59
8300268|NCT01554176|20464404|P4|STARTED|Run-out Phase||28
8300269|NCT01554176|20464405|P3|STARTED|Run-out Phase||29
8300270|NCT01554176|20464406|P2|STARTED|Run-out Phase||0
8300271|NCT01554176|20464407|P1|STARTED|Run-out Phase||0
8300272|NCT01554176|20464403|P5|NOT COMPLETED|Treatment Phase||0
8300273|NCT01554176|20464404|P4|NOT COMPLETED|Treatment Phase||0
8300274|NCT01554176|20464405|P3|NOT COMPLETED|Treatment Phase||0
8300275|NCT01554176|20464406|P2|NOT COMPLETED|Treatment Phase||5
8300276|NCT01554176|20464407|P1|NOT COMPLETED|Treatment Phase||8
8300277|NCT01554176|20464403|P5|COMPLETED|Treatment Phase||0
8300278|NCT01554176|20464404|P4|COMPLETED|Treatment Phase||0
8300279|NCT01554176|20464405|P3|COMPLETED|Treatment Phase||0
8300280|NCT01554176|20464406|P2|COMPLETED|Treatment Phase||59
8300281|NCT01554176|20464407|P1|COMPLETED|Treatment Phase||57
8300282|NCT01554176|20464403|P5|Treated|Treatment Phase||0
8300283|NCT01554176|20464404|P4|Treated|Treatment Phase||0
8300284|NCT01554176|20464405|P3|Treated|Treatment Phase||0
8300285|NCT01554176|20464406|P2|Treated|Treatment Phase||64
8300286|NCT01554176|20464407|P1|Treated|Treatment Phase||64
8300287|NCT01554176|20464403|P5|STARTED|Treatment Phase||0
8300288|NCT01554176|20464404|P4|STARTED|Treatment Phase||0
8300289|NCT01554176|20464405|P3|STARTED|Treatment Phase||0
8300290|NCT01554176|20464406|P2|STARTED|Treatment Phase||64
8300291|NCT01554176|20464407|P1|STARTED|Treatment Phase||65
8300292|NCT01554163|20464434|P2|NOT COMPLETED|Overall Study||10
8300293|NCT01554163|20464435|P1|NOT COMPLETED|Overall Study||8
8300294|NCT01554163|20464434|P2|COMPLETED|Overall Study||109
8300295|NCT01554163|20464435|P1|COMPLETED|Overall Study||112
8300296|NCT01554163|20464434|P2|Number Treated|Overall Study||119
8300297|NCT01554163|20464435|P1|Number Treated|Overall Study||119
8300298|NCT01554163|20464434|P2|STARTED|Overall Study||119
8300299|NCT01554163|20464435|P1|STARTED|Overall Study||120
8300300|NCT01553916|20464453|P1|NOT COMPLETED|Overall Study||3
8300301|NCT01553916|20464453|P1|COMPLETED|Overall Study||16
8300302|NCT01553916|20464453|P1|STARTED|Overall Study||19
8300303|NCT01553851|20464470|P1|NOT COMPLETED|Overall Study||3
8300304|NCT01553851|20464470|P1|COMPLETED|Overall Study||17
8300305|NCT01553851|20464470|P1|STARTED|Overall Study||20
8300306|NCT01553747|20464485|P3|NOT COMPLETED|Overall Study||109
8300307|NCT01553747|20464486|P2|NOT COMPLETED|Overall Study||119
8300308|NCT01553747|20464487|P1|NOT COMPLETED|Overall Study||131
8300309|NCT01553747|20464485|P3|COMPLETED|Overall Study||273
8300310|NCT01553747|20464486|P2|COMPLETED|Overall Study||264
8300311|NCT01553747|20464487|P1|COMPLETED|Overall Study||250
8300312|NCT01553747|20464485|P3|Participated in Blinded-Placebo Period|Overall Study||272
8300313|NCT01553747|20464486|P2|Participated in Blinded-Placebo Period|Overall Study||253
8300314|NCT01553747|20464487|P1|Participated in Blinded-Placebo Period|Overall Study||246
8300315|NCT01553747|20464485|P3|Attended Week 26 Visit|Overall Study||278
8300316|NCT01553747|20464486|P2|Attended Week 26 Visit|Overall Study||271
8300317|NCT01553747|20464487|P1|Attended Week 26 Visit|Overall Study||259
8300318|NCT01553747|20464485|P3|Attended Week 12 Visit|Overall Study||312
8300319|NCT01553747|20464486|P2|Attended Week 12 Visit|Overall Study||301
8300320|NCT01553747|20464487|P1|Attended Week 12 Visit|Overall Study||296
8300321|NCT01553747|20464485|P3|STARTED|Overall Study||382
8300322|NCT01553747|20464486|P2|STARTED|Overall Study||383
8300323|NCT01553747|20464487|P1|STARTED|Overall Study||381
8300324|NCT01553708|20464539|P2|NOT COMPLETED|Overall Study||0
8300325|NCT01553708|20464540|P1|NOT COMPLETED|Overall Study||0
8300326|NCT01553708|20464539|P2|COMPLETED|Overall Study||17
8300327|NCT01553708|20464540|P1|COMPLETED|Overall Study||17
8300328|NCT01553708|20464539|P2|STARTED|Overall Study||17
8300329|NCT01553708|20464540|P1|STARTED|Overall Study||17
8300330|NCT01553591|20464549|P3|NOT COMPLETED|Overall Study||158
8300331|NCT01553591|20464550|P2|NOT COMPLETED|Overall Study||169
8300332|NCT01553591|20464551|P1|NOT COMPLETED|Overall Study||172
8300333|NCT01553591|20464549|P3|COMPLETED|Overall Study||269
8300334|NCT01553591|20464550|P2|COMPLETED|Overall Study||257
8300335|NCT01553591|20464551|P1|COMPLETED|Overall Study||257
8300336|NCT01553591|20464549|P3|Attended Week 26 Visit|Overall Study||290
8300337|NCT01553591|20464550|P2|Attended Week 26 Visit|Overall Study||291
8300338|NCT01553591|20464551|P1|Attended Week 26 Visit|Overall Study||289
8300339|NCT01553591|20464549|P3|Attended Week 12 Visit|Overall Study||342
8300340|NCT01553591|20464550|P2|Attended Week 12 Visit|Overall Study||330
8300341|NCT01553591|20464551|P1|Attended Week 12 Visit|Overall Study||341
8300342|NCT01553591|20464549|P3|STARTED|Overall Study||427
8300343|NCT01553591|20464550|P2|STARTED|Overall Study||426
8300344|NCT01553591|20464551|P1|STARTED|Overall Study||429
8300345|NCT01553539|20464601|P1|NOT COMPLETED|Overall Study||0
8300346|NCT01553539|20464601|P1|COMPLETED|Overall Study||20
8300347|NCT01553539|20464601|P1|STARTED|Overall Study||20
8300348|NCT01553318|20464611|P2|NOT COMPLETED|Overall Study||2
8300349|NCT01553318|20464612|P1|NOT COMPLETED|Overall Study||3
8300350|NCT01553318|20464611|P2|COMPLETED|Overall Study||25
8300351|NCT01553318|20464612|P1|COMPLETED|Overall Study||21
8300352|NCT01553318|20464611|P2|STARTED|Overall Study||27
8300353|NCT01553318|20464612|P1|STARTED|Overall Study||24
8300354|NCT01553292|20464624|P1|NOT COMPLETED|Overall Study||0
8300355|NCT01553292|20464624|P1|COMPLETED|Overall Study||21
8300356|NCT01553292|20464624|P1|STARTED|Overall Study||21
8300357|NCT01553279|20464642|P2|NOT COMPLETED|Period 2: Toddler Vaccinations||7
8300358|NCT01553279|20464643|P1|NOT COMPLETED|Period 2: Toddler Vaccinations||3
8300359|NCT01553279|20464642|P2|COMPLETED|Period 2: Toddler Vaccinations||132
8300360|NCT01553279|20464643|P1|COMPLETED|Period 2: Toddler Vaccinations||134
8300361|NCT01553279|20464642|P2|STARTED|Period 2: Toddler Vaccinations||139
8300362|NCT01553279|20464643|P1|STARTED|Period 2: Toddler Vaccinations||137
8300363|NCT01553279|20464642|P2|NOT COMPLETED|Interim Period||2
8300364|NCT01553279|20464643|P1|NOT COMPLETED|Interim Period||3
8300365|NCT01553279|20464642|P2|COMPLETED|Interim Period||139
8300366|NCT01553279|20464643|P1|COMPLETED|Interim Period||137
8300367|NCT01553279|20464642|P2|STARTED|Interim Period||141
8300368|NCT01553279|20464643|P1|STARTED|Interim Period||140
8300369|NCT01553279|20464642|P2|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
8300370|NCT01553279|20464643|P1|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
8300371|NCT01553279|20464642|P2|COMPLETED|Part 1 (Infant Vaccinations)||141
8300372|NCT01553279|20464643|P1|COMPLETED|Part 1 (Infant Vaccinations)||140
8300373|NCT01553279|20464642|P2|STARTED|Part 1 (Infant Vaccinations)||142
8300374|NCT01553279|20464643|P1|STARTED|Part 1 (Infant Vaccinations)||142
8300375|NCT01553240|20464700|P1|NOT COMPLETED|Overall Study||0
8300376|NCT01553240|20464700|P1|COMPLETED|Overall Study||0
8300377|NCT01553240|20464700|P1|STARTED|Overall Study||0
8300378|NCT01553201|20464707|P2|NOT COMPLETED|Overall Study||0
8300379|NCT01553201|20464708|P1|NOT COMPLETED|Overall Study||0
8300380|NCT01553201|20464707|P2|COMPLETED|Overall Study||15
8300381|NCT01553201|20464708|P1|COMPLETED|Overall Study||15
8300382|NCT01553201|20464707|P2|STARTED|Overall Study||15
8300383|NCT01553201|20464708|P1|STARTED|Overall Study||15
8300384|NCT01553188|20464718|P4|NOT COMPLETED|Overall Study||0
8300385|NCT01553188|20464719|P3|NOT COMPLETED|Overall Study||2
8300386|NCT01553188|20464720|P2|NOT COMPLETED|Overall Study||1
8300387|NCT01553188|20464721|P1|NOT COMPLETED|Overall Study||1
8300388|NCT01553188|20464718|P4|COMPLETED|Overall Study||11
8300389|NCT01553188|20464719|P3|COMPLETED|Overall Study||14
8300390|NCT01553188|20464720|P2|COMPLETED|Overall Study||5
8300391|NCT01553188|20464721|P1|COMPLETED|Overall Study||2
8300392|NCT01553188|20464718|P4|STARTED|Overall Study||11
8300393|NCT01553188|20464719|P3|STARTED|Overall Study||16
8300394|NCT01553188|20464720|P2|STARTED|Overall Study||6
8300395|NCT01553188|20464721|P1|STARTED|Overall Study||3
8300396|NCT01553136|20464748|P2|NOT COMPLETED|Overall Study||22
8300397|NCT01553136|20464749|P1|NOT COMPLETED|Overall Study||16
8300398|NCT01553136|20464748|P2|COMPLETED|Overall Study||45
8300399|NCT01553136|20464749|P1|COMPLETED|Overall Study||48
8300400|NCT01553136|20464748|P2|Completed Treatment|Overall Study||52
8300401|NCT01553136|20464749|P1|Completed Treatment|Overall Study||55
8300402|NCT01553136|20464748|P2|STARTED|Overall Study||67
8300403|NCT01553136|20464749|P1|STARTED|Overall Study||64
8300404|NCT01553084|20464766|P3|NOT COMPLETED|Overall Study||35
8300405|NCT01553084|20464767|P2|NOT COMPLETED|Overall Study||13
8300406|NCT01553084|20464768|P1|NOT COMPLETED|Overall Study||15
8300407|NCT01553084|20464766|P3|COMPLETED|Overall Study||389
8300408|NCT01553084|20464767|P2|COMPLETED|Overall Study||408
8300409|NCT01553084|20464768|P1|COMPLETED|Overall Study||226
8300410|NCT01553084|20464766|P3|STARTED|Overall Study||424
8300411|NCT01553084|20464767|P2|STARTED|Overall Study||421
8300412|NCT01553084|20464768|P1|STARTED|Overall Study||241
8300413|NCT01553058|20464787|P3|NOT COMPLETED|Overall Study||3
8300414|NCT01553058|20464788|P2|NOT COMPLETED|Overall Study||1
8300415|NCT01553058|20464789|P1|NOT COMPLETED|Overall Study||1
8300416|NCT01553058|20464787|P3|COMPLETED|Overall Study||30
8300417|NCT01553058|20464788|P2|COMPLETED|Overall Study||30
8300418|NCT01553058|20464789|P1|COMPLETED|Overall Study||32
8300419|NCT01553058|20464787|P3|STARTED|Overall Study||33
8300420|NCT01553058|20464788|P2|STARTED|Overall Study||31
8300421|NCT01553058|20464789|P1|STARTED|Overall Study||33
8300422|NCT01552954|20464850|P2|NOT COMPLETED|Overall Study||6
8300423|NCT01552954|20464851|P1|NOT COMPLETED|Overall Study||5
8300424|NCT01552954|20464850|P2|COMPLETED|Overall Study||119
8300425|NCT01552954|20464851|P1|COMPLETED|Overall Study||126
8300426|NCT01552954|20464850|P2|STARTED|Overall Study||125
8300427|NCT01552954|20464851|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
8300428|NCT01552928|20464867|P4|NOT COMPLETED|Period 4||0
8300429|NCT01552928|20464868|P3|NOT COMPLETED|Period 4||0
8300430|NCT01552928|20464869|P2|NOT COMPLETED|Period 4||0
8300431|NCT01552928|20464870|P1|NOT COMPLETED|Period 4||0
8300432|NCT01552928|20464867|P4|COMPLETED|Period 4||16
8300433|NCT01552928|20464868|P3|COMPLETED|Period 4||14
8300434|NCT01552928|20464869|P2|COMPLETED|Period 4||15
8300435|NCT01552928|20464870|P1|COMPLETED|Period 4||14
8300436|NCT01552928|20464867|P4|STARTED|Period 4||16
8300437|NCT01552928|20464868|P3|STARTED|Period 4||14
8300438|NCT01552928|20464869|P2|STARTED|Period 4||15
8300439|NCT01552928|20464870|P1|STARTED|Period 4||14
8300440|NCT01552928|20464867|P4|NOT COMPLETED|Period 3||0
8300441|NCT01552928|20464868|P3|NOT COMPLETED|Period 3||1
8300442|NCT01552928|20464869|P2|NOT COMPLETED|Period 3||0
8300443|NCT01552928|20464870|P1|NOT COMPLETED|Period 3||0
8300444|NCT01552928|20464867|P4|COMPLETED|Period 3||16
8300445|NCT01552928|20464868|P3|COMPLETED|Period 3||14
8300446|NCT01552928|20464869|P2|COMPLETED|Period 3||15
8300447|NCT01552928|20464870|P1|COMPLETED|Period 3||14
8300448|NCT01552928|20464867|P4|STARTED|Period 3||16
8300449|NCT01552928|20464868|P3|STARTED|Period 3||15
8300450|NCT01552928|20464869|P2|STARTED|Period 3||15
8300451|NCT01552928|20464870|P1|STARTED|Period 3||14
8300452|NCT01552928|20464867|P4|NOT COMPLETED|Period 2||0
8300453|NCT01552928|20464868|P3|NOT COMPLETED|Period 2||0
8300454|NCT01552928|20464869|P2|NOT COMPLETED|Period 2||0
8300455|NCT01552928|20464870|P1|NOT COMPLETED|Period 2||0
8300456|NCT01552928|20464867|P4|COMPLETED|Period 2||16
8300457|NCT01552928|20464868|P3|COMPLETED|Period 2||15
8300458|NCT01552928|20464869|P2|COMPLETED|Period 2||15
8300459|NCT01552928|20464870|P1|COMPLETED|Period 2||14
8300460|NCT01552928|20464867|P4|STARTED|Period 2||16
8300461|NCT01552928|20464868|P3|STARTED|Period 2||15
8300462|NCT01552928|20464869|P2|STARTED|Period 2||15
8300463|NCT01552928|20464870|P1|STARTED|Period 2||14
8300464|NCT01552928|20464867|P4|NOT COMPLETED|Period 1||0
8300465|NCT01552928|20464868|P3|NOT COMPLETED|Period 1||0
8300466|NCT01552928|20464869|P2|NOT COMPLETED|Period 1||0
8300467|NCT01552928|20464870|P1|NOT COMPLETED|Period 1||0
8300468|NCT01552928|20464867|P4|COMPLETED|Period 1||16
8300469|NCT01552928|20464868|P3|COMPLETED|Period 1||15
8300470|NCT01552928|20464869|P2|COMPLETED|Period 1||15
8300471|NCT01552928|20464870|P1|COMPLETED|Period 1||14
8300472|NCT01552928|20464867|P4|STARTED|Period 1||16
8300473|NCT01552928|20464868|P3|STARTED|Period 1||15
8300474|NCT01552928|20464869|P2|STARTED|Period 1||15
8300475|NCT01552928|20464870|P1|STARTED|Period 1||14
8300476|NCT01552915|20464917|P3|NOT COMPLETED|Overall Study||27
8300477|NCT01552915|20464918|P2|NOT COMPLETED|Overall Study||29
8300478|NCT01552915|20464919|P1|NOT COMPLETED|Overall Study||23
8300479|NCT01552915|20464917|P3|COMPLETED|Overall Study||157
8300480|NCT01552915|20464918|P2|COMPLETED|Overall Study||155
8300481|NCT01552915|20464919|P1|COMPLETED|Overall Study||68
8300482|NCT01552915|20464917|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
8300483|NCT01552915|20464918|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
8300484|NCT01552915|20464919|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
8300485|NCT01552902|20464942|P3|NOT COMPLETED|Overall Study||33
8300486|NCT01552902|20464943|P2|NOT COMPLETED|Overall Study||37
8300487|NCT01552902|20464944|P1|NOT COMPLETED|Overall Study||13
8300488|NCT01552902|20464942|P3|COMPLETED|Overall Study||186
8300489|NCT01552902|20464943|P2|COMPLETED|Overall Study||181
8300490|NCT01552902|20464944|P1|COMPLETED|Overall Study||97
8300491|NCT01552902|20464942|P3|STARTED|Overall Study||219
8300492|NCT01552902|20464943|P2|STARTED|Overall Study||218
8300493|NCT01552902|20464944|P1|STARTED|Overall Study||110
8300494|NCT01552889|20464966|P2|NOT COMPLETED|Overall Study||5
8300495|NCT01552889|20464967|P1|NOT COMPLETED|Overall Study||11
8300496|NCT01552889|20464966|P2|COMPLETED|Overall Study||95
8300497|NCT01552889|20464967|P1|COMPLETED|Overall Study||90
8300498|NCT01552889|20464966|P2|STARTED|Overall Study||100
8300499|NCT01552889|20464967|P1|STARTED|Overall Study||101
8300500|NCT01552876|20464977|P2|NOT COMPLETED|Overall Study||0
8300501|NCT01552876|20464978|P1|NOT COMPLETED|Overall Study||0
8300502|NCT01552876|20464977|P2|COMPLETED|Overall Study||20
8300503|NCT01552876|20464978|P1|COMPLETED|Overall Study||20
8300504|NCT01552876|20464977|P2|STARTED|Overall Study||20
8300505|NCT01552876|20464978|P1|STARTED|Overall Study||20
8300506|NCT01552772|20464994|P1|NOT COMPLETED|Overall Study||4
8300507|NCT01552772|20464994|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
8300508|NCT01552772|20464994|P1|STARTED|Overall Study||60
8300509|NCT01552694|20465010|P2|NOT COMPLETED|Overall Study||2
8300510|NCT01552694|20465011|P1|NOT COMPLETED|Overall Study||0
8300511|NCT01552694|20465010|P2|COMPLETED|Overall Study||18
8300512|NCT01552694|20465011|P1|COMPLETED|Overall Study||18
8300513|NCT01552694|20465010|P2|STARTED|Overall Study||20
8300514|NCT01552694|20465011|P1|STARTED|Overall Study||18
8300515|NCT01552681|20465027|P2|NOT COMPLETED|Overall Study||1
8300516|NCT01552681|20465028|P1|NOT COMPLETED|Overall Study||5
8300517|NCT01552681|20465027|P2|COMPLETED|Overall Study||18
8300518|NCT01552681|20465028|P1|COMPLETED|Overall Study||28
8300519|NCT01552681|20465027|P2|STARTED|Overall Study||19
8300520|NCT01552681|20465028|P1|STARTED|Overall Study||33
8300521|NCT01552603|20465076|P1|NOT COMPLETED|Overall Study||1
8300522|NCT01552603|20465076|P1|COMPLETED|Overall Study||13
8300523|NCT01552603|20465076|P1|STARTED|Overall Study||14
8300524|NCT01552408|20465083|P2|NOT COMPLETED|Overall Study||2
8300525|NCT01552408|20465084|P1|NOT COMPLETED|Overall Study||4
8300526|NCT01552408|20465083|P2|COMPLETED|Overall Study||18
8300527|NCT01552408|20465084|P1|COMPLETED|Overall Study||16
8300528|NCT01552408|20465083|P2|STARTED|Overall Study||20
8300529|NCT01552408|20465084|P1|STARTED|Overall Study||20
8300530|NCT01552369|20465106|P2|NOT COMPLETED|Overall Study||9
8300531|NCT01552369|20465107|P1|NOT COMPLETED|Overall Study||8
8300532|NCT01552369|20465106|P2|COMPLETED|Overall Study||96
8300533|NCT01552369|20465107|P1|COMPLETED|Overall Study||92
8300534|NCT01552369|20465106|P2|Final Follow up|Overall Study||96
8300535|NCT01552369|20465107|P1|Final Follow up|Overall Study||92
8300536|NCT01552369|20465106|P2|One Year|Overall Study||105
8300537|NCT01552369|20465107|P1|One Year|Overall Study||100
8300538|NCT01552369|20465106|P2|STARTED|Overall Study||105
8300539|NCT01552369|20465107|P1|STARTED|Overall Study||100
8300540|NCT01552343|20465135|P2|NOT COMPLETED|Overall Study||0
8300541|NCT01552343|20465136|P1|NOT COMPLETED|Overall Study||0
8300542|NCT01552343|20465135|P2|COMPLETED|Overall Study||27
8300543|NCT01552343|20465136|P1|COMPLETED|Overall Study||29
8300544|NCT01552343|20465135|P2|STARTED|Overall Study||27
8300545|NCT01552343|20465136|P1|STARTED|Overall Study||29
8300546|NCT01552213|20465159|P2|NOT COMPLETED|Overall Study||8
8300547|NCT01552213|20465160|P1|NOT COMPLETED|Overall Study||13
8300548|NCT01552213|20465159|P2|COMPLETED|Overall Study||37
8300549|NCT01552213|20465160|P1|COMPLETED|Overall Study||37
8300550|NCT01552213|20465159|P2|Analyzed|Overall Study||41
8300551|NCT01552213|20465160|P1|Analyzed|Overall Study||42
8300552|NCT01552213|20465159|P2|STARTED|Overall Study||45
8300553|NCT01552213|20465160|P1|STARTED|Overall Study||50
8300554|NCT01552057|20465196|P2|NOT COMPLETED|Overall Study||48
8300555|NCT01552057|20465197|P1|NOT COMPLETED|Overall Study||30
8300556|NCT01552057|20465196|P2|COMPLETED|Overall Study||149
8300557|NCT01552057|20465197|P1|COMPLETED|Overall Study||166
8300558|NCT01552057|20465196|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
8300559|NCT01552057|20465197|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
8300560|NCT01552057|20465196|P2|STARTED|Overall Study||197
8300561|NCT01552057|20465197|P1|STARTED|Overall Study||196
8300562|NCT01551979|20465231|P2|NOT COMPLETED|Overall Study||2
8300563|NCT01551979|20465232|P1|NOT COMPLETED|Overall Study||2
8300564|NCT01551979|20465231|P2|COMPLETED|Overall Study||5
8300565|NCT01551979|20465232|P1|COMPLETED|Overall Study||8
8300566|NCT01551979|20465231|P2|1 Week Post Treatment|Overall Study||6
8300567|NCT01551979|20465232|P1|1 Week Post Treatment|Overall Study||10
8300568|NCT01551979|20465231|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
8300569|NCT01551979|20465232|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
8300570|NCT01551979|20465231|P2|STARTED|Overall Study||7
8300571|NCT01551979|20465232|P1|STARTED|Overall Study||10
8300572|NCT01551888|20465248|P2|NOT COMPLETED|Period 2||0
8300573|NCT01551888|20465249|P1|NOT COMPLETED|Period 2||0
8300574|NCT01551888|20465248|P2|COMPLETED|Period 2||12
8300575|NCT01551888|20465249|P1|COMPLETED|Period 2||12
8300576|NCT01551888|20465248|P2|STARTED|Period 2||12
8300577|NCT01551888|20465249|P1|STARTED|Period 2||12
8300578|NCT01551888|20465248|P2|NOT COMPLETED|Period 1||0
8300579|NCT01551888|20465249|P1|NOT COMPLETED|Period 1||0
8300580|NCT01551888|20465248|P2|COMPLETED|Period 1||12
8300581|NCT01551888|20465249|P1|COMPLETED|Period 1||12
8300582|NCT01551888|20465248|P2|STARTED|Period 1||12
8300583|NCT01551888|20465249|P1|STARTED|Period 1||12
8300584|NCT01551758|20465263|P2|NOT COMPLETED|Overall Study||105
8300585|NCT01551758|20465264|P1|NOT COMPLETED|Overall Study||94
8300586|NCT01551758|20465263|P2|COMPLETED|Overall Study||1291
8300587|NCT01551758|20465264|P1|COMPLETED|Overall Study||1309
8300588|NCT01551758|20465263|P2|STARTED|Overall Study||1396
8300589|NCT01551758|20465264|P1|STARTED|Overall Study||1403
8300593|NCT01551693|20465311|P2|NOT COMPLETED|Overall Study||2
8300594|NCT01551693|20465312|P1|NOT COMPLETED|Overall Study||1
8300595|NCT01551693|20465311|P2|COMPLETED|Overall Study||0
8300596|NCT01551693|20465312|P1|COMPLETED|Overall Study||0
8300597|NCT01551693|20465311|P2|STARTED|Overall Study||2
8300598|NCT01551693|20465312|P1|STARTED|Overall Study||1
8300599|NCT01551550|20465324|P2|NOT COMPLETED|Overall Study||1
8300600|NCT01551550|20465325|P1|NOT COMPLETED|Overall Study||0
8300601|NCT01551550|20465324|P2|COMPLETED|Overall Study||40
8300602|NCT01551550|20465325|P1|COMPLETED|Overall Study||41
8300603|NCT01551550|20465324|P2|STARTED|Overall Study||41
8300604|NCT01551550|20465325|P1|STARTED|Overall Study||41
8300605|NCT01551420|20465333|P2|NOT COMPLETED|Home Use (Part B)||1
8300606|NCT01551420|20465334|P1|NOT COMPLETED|Home Use (Part B)||6
8300607|NCT01551420|20465333|P2|COMPLETED|Home Use (Part B)||7
8300608|NCT01551420|20465334|P1|COMPLETED|Home Use (Part B)||18
8300609|NCT01551420|20465333|P2|STARTED|Home Use (Part B)||8
8300610|NCT01551420|20465334|P1|STARTED|Home Use (Part B)||24
8300611|NCT01551420|20465333|P2|NOT COMPLETED|Screened for Part B Eligibility||3
8300612|NCT01551420|20465334|P1|NOT COMPLETED|Screened for Part B Eligibility||9
8300613|NCT01551420|20465333|P2|COMPLETED|Screened for Part B Eligibility||8
8300614|NCT01551420|20465334|P1|COMPLETED|Screened for Part B Eligibility||24
8300615|NCT01551420|20465333|P2|STARTED|Screened for Part B Eligibility||11
8300616|NCT01551420|20465334|P1|STARTED|Screened for Part B Eligibility||33
8300617|NCT01551420|20465333|P2|NOT COMPLETED|In-laboratory (Part A)||2
8300618|NCT01551420|20465334|P1|NOT COMPLETED|In-laboratory (Part A)||6
8300619|NCT01551420|20465333|P2|COMPLETED|In-laboratory (Part A)||11
8300620|NCT01551420|20465334|P1|COMPLETED|In-laboratory (Part A)||33
8300621|NCT01551420|20465333|P2|STARTED|In-laboratory (Part A)||13
8300622|NCT01551420|20465334|P1|STARTED|In-laboratory (Part A)||39
8300623|NCT01551355|20465364|P6|NOT COMPLETED|Overall Study||6
8300624|NCT01551355|20465365|P5|NOT COMPLETED|Overall Study||9
8300625|NCT01551355|20465366|P4|NOT COMPLETED|Overall Study||24
8300626|NCT01551355|20465367|P3|NOT COMPLETED|Overall Study||34
8300627|NCT01551355|20465368|P2|NOT COMPLETED|Overall Study||49
8300628|NCT01551355|20465369|P1|NOT COMPLETED|Overall Study||51
8300629|NCT01551355|20465364|P6|COMPLETED|Overall Study||65
8300630|NCT01551355|20465365|P5|COMPLETED|Overall Study||55
8300631|NCT01551355|20465366|P4|COMPLETED|Overall Study||411
8300632|NCT01551355|20465367|P3|COMPLETED|Overall Study||459
8300633|NCT01551355|20465368|P2|COMPLETED|Overall Study||545
8300634|NCT01551355|20465369|P1|COMPLETED|Overall Study||571
8300635|NCT01551355|20465364|P6|STARTED|Overall Study||71
8300636|NCT01551355|20465365|P5|STARTED|Overall Study||64
8300637|NCT01551355|20465366|P4|STARTED|Overall Study||435
8300638|NCT01551355|20465367|P3|STARTED|Overall Study||493
8300639|NCT01551355|20465368|P2|STARTED|Overall Study||594
8300640|NCT01551355|20465369|P1|STARTED|Overall Study||622
8300641|NCT01551303|20465383|P2|NOT COMPLETED|Overall Study||7
8300642|NCT01551303|20465384|P1|NOT COMPLETED|Overall Study||4
8300643|NCT01551303|20465383|P2|COMPLETED|Overall Study||15
8300644|NCT01551303|20465384|P1|COMPLETED|Overall Study||21
8300645|NCT01551303|20465383|P2|STARTED|Overall Study||22
8300646|NCT01551303|20465384|P1|STARTED|Overall Study||25
8300647|NCT01551212|20465392|P2|NOT COMPLETED|Overall Study||20
8300648|NCT01551212|20465393|P1|NOT COMPLETED|Overall Study||5
8300649|NCT01551212|20465392|P2|COMPLETED|Overall Study||148
8300650|NCT01551212|20465393|P1|COMPLETED|Overall Study||166
8300651|NCT01551212|20465392|P2|Per Protocol Set (PP)|Overall Study||101
8300652|NCT01551212|20465393|P1|Per Protocol Set (PP)|Overall Study||110
8300653|NCT01551212|20465392|P2|Safety Set|Overall Study||164
8300654|NCT01551212|20465393|P1|Safety Set|Overall Study||169
8300655|NCT01551212|20465392|P2|Full Anylsis Set (FAS)|Overall Study||164
8300656|NCT01551212|20465393|P1|Full Anylsis Set (FAS)|Overall Study||169
8300657|NCT01551212|20465392|P2|STARTED|Overall Study||168
8300658|NCT01551212|20465393|P1|STARTED|Overall Study||171
8300659|NCT01551199|20465411|P1|NOT COMPLETED|Overall Study||5
8300660|NCT01551199|20465411|P1|COMPLETED|Overall Study||2
8300661|NCT01551199|20465411|P1|STARTED|Overall Study||7
8300662|NCT01551186|20465419|P2|NOT COMPLETED|Overall Study||13
8300663|NCT01551186|20465420|P1|NOT COMPLETED|Overall Study||20
8300664|NCT01551186|20465419|P2|COMPLETED|Overall Study||40
8300665|NCT01551186|20465420|P1|COMPLETED|Overall Study||30
8300666|NCT01551186|20465419|P2|STARTED|Overall Study||53
8300667|NCT01551186|20465420|P1|STARTED|Overall Study||50
8300668|NCT01551173|20465428|P2|NOT COMPLETED|Overall Study||32
8300669|NCT01551173|20465429|P1|NOT COMPLETED|Overall Study||28
8300670|NCT01551173|20465428|P2|COMPLETED|Overall Study||186
8300671|NCT01551173|20465429|P1|COMPLETED|Overall Study||190
8300672|NCT01551173|20465428|P2|Full Analysis Set (FAS)|Overall Study||214
8300673|NCT01551173|20465429|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
8300674|NCT01551173|20465428|P2|STARTED|Overall Study||218
8300675|NCT01551173|20465429|P1|STARTED|Overall Study|"Started indicates randomized"|218
8300676|NCT01551095|20465440|P1|NOT COMPLETED|Overall Study||0
8300677|NCT01551095|20465440|P1|COMPLETED|Overall Study||7
8300678|NCT01551095|20465440|P1|STARTED|Overall Study||7
8300679|NCT01551082|20465445|P1|NOT COMPLETED|Overall Study||0
8300680|NCT01551082|20465445|P1|COMPLETED|Overall Study||12
8300681|NCT01551082|20465445|P1|STARTED|Overall Study||12
8300682|NCT01551056|20465451|P2|NOT COMPLETED|Overall Study||0
8300683|NCT01551056|20465452|P1|NOT COMPLETED|Overall Study||2
8300684|NCT01551056|20465451|P2|COMPLETED|Overall Study||45
8300685|NCT01551056|20465452|P1|COMPLETED|Overall Study||44
8300686|NCT01551056|20465451|P2|STARTED|Overall Study||45
8300687|NCT01551056|20465452|P1|STARTED|Overall Study||46
8300688|NCT01550965|20465506|P1|NOT COMPLETED|Overall Study||110
8300689|NCT01550965|20465506|P1|COMPLETED|Overall Study||353
8300690|NCT01550965|20465506|P1|STARTED|Overall Study||463
8300691|NCT01550952|20465525|P1|NOT COMPLETED|Overall Study||0
8300692|NCT01550952|20465525|P1|COMPLETED|Overall Study||10
8300693|NCT01550952|20465525|P1|STARTED|Overall Study||10
8300694|NCT01550809|20465535|P2|NOT COMPLETED|Overall Study||0
8300695|NCT01550809|20465536|P1|NOT COMPLETED|Overall Study||0
8300696|NCT01550809|20465535|P2|COMPLETED|Overall Study||6
8300697|NCT01550809|20465536|P1|COMPLETED|Overall Study||6
8300698|NCT01550809|20465535|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
8300699|NCT01550809|20465536|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
8300700|NCT01550757|20465550|P4|NOT COMPLETED|Overall Study||54
8300701|NCT01550757|20465551|P3|NOT COMPLETED|Overall Study||45
8300702|NCT01550757|20465552|P2|NOT COMPLETED|Overall Study||14
8300703|NCT01550757|20465553|P1|NOT COMPLETED|Overall Study||23
8300704|NCT01550757|20465550|P4|COMPLETED|Overall Study||90
8300705|NCT01550757|20465551|P3|COMPLETED|Overall Study||85
8300706|NCT01550757|20465552|P2|COMPLETED|Overall Study||38
8300707|NCT01550757|20465553|P1|COMPLETED|Overall Study||33
8300708|NCT01550757|20465550|P4|STARTED|Overall Study||144
8300709|NCT01550757|20465551|P3|STARTED|Overall Study||130
8300710|NCT01550757|20465552|P2|STARTED|Overall Study||52
8300711|NCT01550757|20465553|P1|STARTED|Overall Study||56
8300712|NCT01550744|20465563|P3|NOT COMPLETED|Double-Blind||67
8300713|NCT01550744|20465564|P2|NOT COMPLETED|Double-Blind||17
8300714|NCT01550744|20465565|P1|NOT COMPLETED|Double-Blind||0
8300715|NCT01550744|20465563|P3|COMPLETED|Double-Blind||235
8300716|NCT01550744|20465564|P2|COMPLETED|Double-Blind||59
8300717|NCT01550744|20465565|P1|COMPLETED|Double-Blind||0
8300718|NCT01550744|20465563|P3|STARTED|Double-Blind||302
8300719|NCT01550744|20465564|P2|STARTED|Double-Blind||76
8300720|NCT01550744|20465565|P1|STARTED|Double-Blind||0
8300721|NCT01550744|20465563|P3|NOT COMPLETED|Open-Label||0
8300722|NCT01550744|20465564|P2|NOT COMPLETED|Open-Label||0
8300723|NCT01550744|20465565|P1|NOT COMPLETED|Open-Label||100
8300724|NCT01550744|20465563|P3|COMPLETED|Open-Label||0
8300725|NCT01550744|20465564|P2|COMPLETED|Open-Label||0
8300726|NCT01550744|20465565|P1|COMPLETED|Open-Label||378
8300727|NCT01550744|20465563|P3|STARTED|Open-Label||0
8300728|NCT01550744|20465564|P2|STARTED|Open-Label||0
8300729|NCT01550744|20465565|P1|STARTED|Open-Label||478
8300730|NCT01550731|20465580|P2|NOT COMPLETED|Overall Study||0
8300731|NCT01550731|20465581|P1|NOT COMPLETED|Overall Study||0
8300732|NCT01550731|20465580|P2|COMPLETED|Overall Study||209
8300733|NCT01550731|20465581|P1|COMPLETED|Overall Study||205
8300734|NCT01550731|20465580|P2|STARTED|Overall Study||209
8300735|NCT01550731|20465581|P1|STARTED|Overall Study||205
8300736|NCT01550705|20465589|P1|NOT COMPLETED|Overall Study||1
8300737|NCT01550705|20465589|P1|COMPLETED|Overall Study||10
8300738|NCT01550705|20465589|P1|STARTED|Overall Study||11
8300739|NCT01550549|20465594|P1|NOT COMPLETED|Overall Study||0
8300740|NCT01550549|20465594|P1|COMPLETED|Overall Study||151
8300741|NCT01550549|20465594|P1|STARTED|Overall Study||151
8300742|NCT01550510|20465608|P2|NOT COMPLETED|Overall Study||0
8300743|NCT01550510|20465609|P1|NOT COMPLETED|Overall Study||0
8300744|NCT01550510|20465608|P2|COMPLETED|Overall Study||0
8300745|NCT01550510|20465609|P1|COMPLETED|Overall Study||4
8300746|NCT01550510|20465608|P2|STARTED|Overall Study||0
8300747|NCT01550510|20465609|P1|STARTED|Overall Study||4
8300748|NCT01550471|20465617|P6|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300749|NCT01550471|20465618|P5|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300750|NCT01550471|20465619|P4|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300751|NCT01550471|20465620|P3|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300752|NCT01550471|20465621|P2|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300753|NCT01550471|20465622|P1|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300754|NCT01550471|20465617|P6|COMPLETED|Third Wash Out Period (3 Weeks)||3
8300755|NCT01550471|20465618|P5|COMPLETED|Third Wash Out Period (3 Weeks)||4
8300756|NCT01550471|20465619|P4|COMPLETED|Third Wash Out Period (3 Weeks)||4
8300757|NCT01550471|20465620|P3|COMPLETED|Third Wash Out Period (3 Weeks)||3
8300758|NCT01550471|20465621|P2|COMPLETED|Third Wash Out Period (3 Weeks)||4
8300759|NCT01550471|20465622|P1|COMPLETED|Third Wash Out Period (3 Weeks)||3
8300760|NCT01550471|20465617|P6|STARTED|Third Wash Out Period (3 Weeks)||3
8300761|NCT01550471|20465618|P5|STARTED|Third Wash Out Period (3 Weeks)||4
8300762|NCT01550471|20465619|P4|STARTED|Third Wash Out Period (3 Weeks)||4
8300763|NCT01550471|20465620|P3|STARTED|Third Wash Out Period (3 Weeks)||3
8300764|NCT01550471|20465621|P2|STARTED|Third Wash Out Period (3 Weeks)||4
8300765|NCT01550471|20465622|P1|STARTED|Third Wash Out Period (3 Weeks)||3
8300766|NCT01550471|20465617|P6|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300767|NCT01550471|20465618|P5|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300768|NCT01550471|20465619|P4|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300769|NCT01550471|20465620|P3|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300770|NCT01550471|20465621|P2|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300771|NCT01550471|20465622|P1|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300772|NCT01550471|20465617|P6|COMPLETED|Third Treatment Period (3 Weeks)||3
8300773|NCT01550471|20465618|P5|COMPLETED|Third Treatment Period (3 Weeks)||4
8300774|NCT01550471|20465619|P4|COMPLETED|Third Treatment Period (3 Weeks)||4
8300775|NCT01550471|20465620|P3|COMPLETED|Third Treatment Period (3 Weeks)||3
8300776|NCT01550471|20465621|P2|COMPLETED|Third Treatment Period (3 Weeks)||4
8300777|NCT01550471|20465622|P1|COMPLETED|Third Treatment Period (3 Weeks)||3
8300778|NCT01550471|20465617|P6|STARTED|Third Treatment Period (3 Weeks)||3
8300779|NCT01550471|20465618|P5|STARTED|Third Treatment Period (3 Weeks)||4
8300780|NCT01550471|20465619|P4|STARTED|Third Treatment Period (3 Weeks)||4
8300781|NCT01550471|20465620|P3|STARTED|Third Treatment Period (3 Weeks)||3
8300782|NCT01550471|20465621|P2|STARTED|Third Treatment Period (3 Weeks)||4
8300783|NCT01550471|20465622|P1|STARTED|Third Treatment Period (3 Weeks)||3
8300784|NCT01550471|20465617|P6|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
8300785|NCT01550471|20465618|P5|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300786|NCT01550471|20465619|P4|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300787|NCT01550471|20465620|P3|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300788|NCT01550471|20465621|P2|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300789|NCT01550471|20465622|P1|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300790|NCT01550471|20465617|P6|COMPLETED|Second Wash Out Period (3 Weeks)||3
8300791|NCT01550471|20465618|P5|COMPLETED|Second Wash Out Period (3 Weeks)||4
8300792|NCT01550471|20465619|P4|COMPLETED|Second Wash Out Period (3 Weeks)||4
8300793|NCT01550471|20465620|P3|COMPLETED|Second Wash Out Period (3 Weeks)||3
8300794|NCT01550471|20465621|P2|COMPLETED|Second Wash Out Period (3 Weeks)||4
8300795|NCT01550471|20465622|P1|COMPLETED|Second Wash Out Period (3 Weeks)||3
8300796|NCT01550471|20465617|P6|STARTED|Second Wash Out Period (3 Weeks)||4
8300797|NCT01550471|20465618|P5|STARTED|Second Wash Out Period (3 Weeks)||4
8300798|NCT01550471|20465619|P4|STARTED|Second Wash Out Period (3 Weeks)||4
8300799|NCT01550471|20465620|P3|STARTED|Second Wash Out Period (3 Weeks)||3
8300800|NCT01550471|20465621|P2|STARTED|Second Wash Out Period (3 Weeks)||4
8300801|NCT01550471|20465622|P1|STARTED|Second Wash Out Period (3 Weeks)||3
8300802|NCT01550471|20465617|P6|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300803|NCT01550471|20465618|P5|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300804|NCT01550471|20465619|P4|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300805|NCT01550471|20465620|P3|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300806|NCT01550471|20465621|P2|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300807|NCT01550471|20465622|P1|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300808|NCT01550471|20465617|P6|COMPLETED|Second Treatment Period (3 Weeks)||4
8300809|NCT01550471|20465618|P5|COMPLETED|Second Treatment Period (3 Weeks)||4
8300810|NCT01550471|20465619|P4|COMPLETED|Second Treatment Period (3 Weeks)||4
8300811|NCT01550471|20465620|P3|COMPLETED|Second Treatment Period (3 Weeks)||3
8300812|NCT01550471|20465621|P2|COMPLETED|Second Treatment Period (3 Weeks)||4
8300813|NCT01550471|20465622|P1|COMPLETED|Second Treatment Period (3 Weeks)||3
8300814|NCT01550471|20465617|P6|STARTED|Second Treatment Period (3 Weeks)||4
8300815|NCT01550471|20465618|P5|STARTED|Second Treatment Period (3 Weeks)||4
8300816|NCT01550471|20465619|P4|STARTED|Second Treatment Period (3 Weeks)||4
8300817|NCT01550471|20465620|P3|STARTED|Second Treatment Period (3 Weeks)||3
8300818|NCT01550471|20465621|P2|STARTED|Second Treatment Period (3 Weeks)||4
8300819|NCT01550471|20465622|P1|STARTED|Second Treatment Period (3 Weeks)||3
8300820|NCT01550471|20465617|P6|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300821|NCT01550471|20465618|P5|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300822|NCT01550471|20465619|P4|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300823|NCT01550471|20465620|P3|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300824|NCT01550471|20465621|P2|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300825|NCT01550471|20465622|P1|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300826|NCT01550471|20465617|P6|COMPLETED|First Wash Out Period (3 Weeks)||4
8300827|NCT01550471|20465618|P5|COMPLETED|First Wash Out Period (3 Weeks)||4
8300828|NCT01550471|20465619|P4|COMPLETED|First Wash Out Period (3 Weeks)||4
8300829|NCT01550471|20465620|P3|COMPLETED|First Wash Out Period (3 Weeks)||3
8300830|NCT01550471|20465621|P2|COMPLETED|First Wash Out Period (3 Weeks)||4
8300831|NCT01550471|20465622|P1|COMPLETED|First Wash Out Period (3 Weeks)||3
8300832|NCT01550471|20465617|P6|STARTED|First Wash Out Period (3 Weeks)||4
8300833|NCT01550471|20465618|P5|STARTED|First Wash Out Period (3 Weeks)||4
8300834|NCT01550471|20465619|P4|STARTED|First Wash Out Period (3 Weeks)||4
8300835|NCT01550471|20465620|P3|STARTED|First Wash Out Period (3 Weeks)||3
8300836|NCT01550471|20465621|P2|STARTED|First Wash Out Period (3 Weeks)||4
8300837|NCT01550471|20465622|P1|STARTED|First Wash Out Period (3 Weeks)||3
8300838|NCT01550471|20465617|P6|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300839|NCT01550471|20465618|P5|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300840|NCT01550471|20465619|P4|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300841|NCT01550471|20465620|P3|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300842|NCT01550471|20465621|P2|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300843|NCT01550471|20465622|P1|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300844|NCT01550471|20465617|P6|COMPLETED|First Treatment Period (3 Weeks)||4
8300845|NCT01550471|20465618|P5|COMPLETED|First Treatment Period (3 Weeks)||4
8300846|NCT01550471|20465619|P4|COMPLETED|First Treatment Period (3 Weeks)||4
8300847|NCT01550471|20465620|P3|COMPLETED|First Treatment Period (3 Weeks)||3
8300848|NCT01550471|20465621|P2|COMPLETED|First Treatment Period (3 Weeks)||4
8300849|NCT01550471|20465622|P1|COMPLETED|First Treatment Period (3 Weeks)||3
8300850|NCT01550471|20465617|P6|STARTED|First Treatment Period (3 Weeks)||4
8300851|NCT01550471|20465618|P5|STARTED|First Treatment Period (3 Weeks)||4
8300852|NCT01550471|20465619|P4|STARTED|First Treatment Period (3 Weeks)||4
8300853|NCT01550471|20465620|P3|STARTED|First Treatment Period (3 Weeks)||3
8300854|NCT01550471|20465621|P2|STARTED|First Treatment Period (3 Weeks)||4
8300855|NCT01550471|20465622|P1|STARTED|First Treatment Period (3 Weeks)||3
8300856|NCT01550471|20465617|P6|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300857|NCT01550471|20465618|P5|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300858|NCT01550471|20465619|P4|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300859|NCT01550471|20465620|P3|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300860|NCT01550471|20465621|P2|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300861|NCT01550471|20465622|P1|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300862|NCT01550471|20465617|P6|COMPLETED|Run-In Period (3 Weeks)||4
8300863|NCT01550471|20465618|P5|COMPLETED|Run-In Period (3 Weeks)||4
8300864|NCT01550471|20465619|P4|COMPLETED|Run-In Period (3 Weeks)||4
8300865|NCT01550471|20465620|P3|COMPLETED|Run-In Period (3 Weeks)||3
8300866|NCT01550471|20465621|P2|COMPLETED|Run-In Period (3 Weeks)||4
8300867|NCT01550471|20465622|P1|COMPLETED|Run-In Period (3 Weeks)||3
8300868|NCT01550471|20465617|P6|STARTED|Run-In Period (3 Weeks)||4
8300869|NCT01550471|20465618|P5|STARTED|Run-In Period (3 Weeks)||4
8300870|NCT01550471|20465619|P4|STARTED|Run-In Period (3 Weeks)||4
8300871|NCT01550471|20465620|P3|STARTED|Run-In Period (3 Weeks)||3
8300872|NCT01550471|20465621|P2|STARTED|Run-In Period (3 Weeks)||4
8300873|NCT01550471|20465622|P1|STARTED|Run-In Period (3 Weeks)||3
8300874|NCT01550367|20465631|P1|NOT COMPLETED|Overall Study||0
8300875|NCT01550367|20465631|P1|COMPLETED|Overall Study||30
8300876|NCT01550367|20465631|P1|600 mg/d HCQ|Overall Study||17
8300877|NCT01550367|20465631|P1|1200 mg/d HCQ|Overall Study||13
8300878|NCT01550367|20465631|P1|STARTED|Overall Study||30
8300879|NCT01550341|20465658|P2|NOT COMPLETED|Overall Study||0
8300880|NCT01550341|20465659|P1|NOT COMPLETED|Overall Study||0
8300881|NCT01550341|20465658|P2|COMPLETED|Overall Study||18
8300882|NCT01550341|20465659|P1|COMPLETED|Overall Study||32
8300883|NCT01550341|20465658|P2|STARTED|Overall Study||18
8300884|NCT01550341|20465659|P1|STARTED|Overall Study||32
8300885|NCT01550302|20465693|P2|NOT COMPLETED|Overall Study||0
8300886|NCT01550302|20465694|P1|NOT COMPLETED|Overall Study||0
8300887|NCT01550302|20465693|P2|COMPLETED|Overall Study||5
8300888|NCT01550302|20465694|P1|COMPLETED|Overall Study||5
8300889|NCT01550302|20465693|P2|STARTED|Overall Study||5
8300890|NCT01550302|20465694|P1|STARTED|Overall Study||5
8300891|NCT01550289|20465714|P2|NOT COMPLETED|Overall Study||4
8300892|NCT01550289|20465715|P1|NOT COMPLETED|Overall Study||13
8300893|NCT01550289|20465714|P2|COMPLETED|Overall Study||57
8300894|NCT01550289|20465715|P1|COMPLETED|Overall Study||115
8300895|NCT01550289|20465714|P2|STARTED|Overall Study||61
8300896|NCT01550289|20465715|P1|STARTED|Overall Study||128
8300897|NCT01550224|20465747|P2|NOT COMPLETED|Overall Study||0
8300898|NCT01550224|20465748|P1|NOT COMPLETED|Overall Study||0
8300899|NCT01550224|20465747|P2|COMPLETED|Overall Study||20
8300900|NCT01550224|20465748|P1|COMPLETED|Overall Study||3
8300901|NCT01550224|20465747|P2|STARTED|Overall Study||20
8300902|NCT01550224|20465748|P1|STARTED|Overall Study||3
8300903|NCT01549977|20465772|P2|NOT COMPLETED|Overall Study||0
8300904|NCT01549977|20465773|P1|NOT COMPLETED|Overall Study||0
8300905|NCT01549977|20465772|P2|COMPLETED|Overall Study||0
8300906|NCT01549977|20465773|P1|COMPLETED|Overall Study||1
8300907|NCT01549977|20465772|P2|STARTED|Overall Study||0
8300908|NCT01549977|20465773|P1|STARTED|Overall Study||1
8300909|NCT01549964|20465791|P4|NOT COMPLETED|80-Week Extension Period||137
8300910|NCT01549964|20465792|P3|NOT COMPLETED|80-Week Extension Period||140
8300911|NCT01549964|20465793|P2|NOT COMPLETED|80-Week Extension Period||138
8300912|NCT01549964|20465794|P1|NOT COMPLETED|80-Week Extension Period||66
8300913|NCT01549964|20465791|P4|COMPLETED|80-Week Extension Period||0
8300914|NCT01549964|20465792|P3|COMPLETED|80-Week Extension Period||0
8300915|NCT01549964|20465793|P2|COMPLETED|80-Week Extension Period||0
8300916|NCT01549964|20465794|P1|COMPLETED|80-Week Extension Period||0
8300917|NCT01549964|20465791|P4|STARTED|80-Week Extension Period||137
8300918|NCT01549964|20465792|P3|STARTED|80-Week Extension Period||140
8300919|NCT01549964|20465793|P2|STARTED|80-Week Extension Period||138
8300920|NCT01549964|20465794|P1|STARTED|80-Week Extension Period||66
8300921|NCT01549964|20465791|P4|NOT COMPLETED|24-Week Treatment Period||121
8300922|NCT01549964|20465792|P3|NOT COMPLETED|24-Week Treatment Period||116
8300923|NCT01549964|20465793|P2|NOT COMPLETED|24-Week Treatment Period||111
8300924|NCT01549964|20465794|P1|NOT COMPLETED|24-Week Treatment Period||61
8300925|NCT01549964|20465791|P4|COMPLETED|24-Week Treatment Period||140
8300926|NCT01549964|20465792|P3|COMPLETED|24-Week Treatment Period||147
8300927|NCT01549964|20465793|P2|COMPLETED|24-Week Treatment Period||149
8300928|NCT01549964|20465794|P1|COMPLETED|24-Week Treatment Period||71
8300929|NCT01549964|20465791|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
8300930|NCT01549964|20465792|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
8300931|NCT01549964|20465793|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
8300932|NCT01549964|20465794|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
8300933|NCT01549964|20465791|P4|STARTED|24-Week Treatment Period||261
8300934|NCT01549964|20465792|P3|STARTED|24-Week Treatment Period||263
8300935|NCT01549964|20465793|P2|STARTED|24-Week Treatment Period||260
8300936|NCT01549964|20465794|P1|STARTED|24-Week Treatment Period||132
8300937|NCT01549951|20465812|P1|NOT COMPLETED|Overall Study||50
8300938|NCT01549951|20465812|P1|COMPLETED|Overall Study||0
8300939|NCT01549951|20465812|P1|Primary Reason Off Study Treatment|Overall Study||50
8300940|NCT01549951|20465812|P1|STARTED|Overall Study||50
8300941|NCT01549925|20465830|P2|NOT COMPLETED|Overall Study||0
8300942|NCT01549925|20465831|P1|NOT COMPLETED|Overall Study||0
8300943|NCT01549925|20465830|P2|COMPLETED|Overall Study||25
8300944|NCT01549925|20465831|P1|COMPLETED|Overall Study||25
8300945|NCT01549925|20465830|P2|STARTED|Overall Study||25
8300946|NCT01549925|20465831|P1|STARTED|Overall Study||25
8300947|NCT01549873|20465839|P2|NOT COMPLETED|Overall Study||1
8300948|NCT01549873|20465840|P1|NOT COMPLETED|Overall Study||0
8300949|NCT01549873|20465839|P2|COMPLETED|Overall Study||14
8300950|NCT01549873|20465840|P1|COMPLETED|Overall Study||15
8300951|NCT01549873|20465839|P2|STARTED|Overall Study||15
8300952|NCT01549873|20465840|P1|STARTED|Overall Study||15
8300953|NCT01549860|20465852|P2|NOT COMPLETED|Overall Study||1
8300954|NCT01549860|20465853|P1|NOT COMPLETED|Overall Study||2
8300955|NCT01549860|20465852|P2|COMPLETED|Overall Study||40
8300956|NCT01549860|20465853|P1|COMPLETED|Overall Study||38
8300957|NCT01549860|20465852|P2|STARTED|Overall Study||41
8300958|NCT01549860|20465853|P1|STARTED|Overall Study||40
8300959|NCT01549652|20465866|P4|NOT COMPLETED|Overall Study||11
8300960|NCT01549652|20465867|P3|NOT COMPLETED|Overall Study||17
8300961|NCT01549652|20465868|P2|NOT COMPLETED|Overall Study||12
8300962|NCT01549652|20465869|P1|NOT COMPLETED|Overall Study||12
8300963|NCT01549652|20465866|P4|COMPLETED|Overall Study||25
8300964|NCT01549652|20465867|P3|COMPLETED|Overall Study||23
8300965|NCT01549652|20465868|P2|COMPLETED|Overall Study||18
8300966|NCT01549652|20465869|P1|COMPLETED|Overall Study||15
8300967|NCT01549652|20465866|P4|STARTED|Overall Study||36
8300968|NCT01549652|20465867|P3|STARTED|Overall Study||40
8300969|NCT01549652|20465868|P2|STARTED|Overall Study||30
8300970|NCT01549652|20465869|P1|STARTED|Overall Study||27
8300971|NCT01549613|20465887|P2|NOT COMPLETED|Overall Study||11
8300972|NCT01549613|20465888|P1|NOT COMPLETED|Overall Study||11
8300973|NCT01549613|20465887|P2|COMPLETED|Overall Study||39
8300974|NCT01549613|20465888|P1|COMPLETED|Overall Study||39
8300975|NCT01549613|20465887|P2|STARTED|Overall Study||50
8300976|NCT01549613|20465888|P1|STARTED|Overall Study||50
8300977|NCT01549587|20465896|P2|NOT COMPLETED|Overall Study||37
8300978|NCT01549587|20465897|P1|NOT COMPLETED|Overall Study||39
8300979|NCT01549587|20465896|P2|COMPLETED|Overall Study||336
8300980|NCT01549587|20465897|P1|COMPLETED|Overall Study||334
8300981|NCT01549587|20465896|P2|STARTED|Overall Study||373
8300982|NCT01549587|20465897|P1|STARTED|Overall Study||373
8300983|NCT01549405|20465915|P2|NOT COMPLETED|Overall Study||0
8300984|NCT01549405|20465916|P1|NOT COMPLETED|Overall Study||0
8300985|NCT01549405|20465915|P2|COMPLETED|Overall Study||20
8300986|NCT01549405|20465916|P1|COMPLETED|Overall Study||20
8300987|NCT01549405|20465915|P2|STARTED|Overall Study||20
8300988|NCT01549405|20465916|P1|STARTED|Overall Study||20
8300989|NCT01549392|20465926|P2|NOT COMPLETED|Overall Study||0
8300990|NCT01549392|20465927|P1|NOT COMPLETED|Overall Study||1
8300991|NCT01549392|20465926|P2|COMPLETED|Overall Study||0
8300992|NCT01549392|20465927|P1|COMPLETED|Overall Study||2
8300993|NCT01549392|20465926|P2|STARTED|Overall Study||0
8300994|NCT01549392|20465927|P1|STARTED|Overall Study||3
8300995|NCT01549340|20465933|P1|NOT COMPLETED|Overall Study||8405
8300996|NCT01549340|20465933|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
8300997|NCT01549340|20465933|P1|Started AIT|Overall Study||3182
8300998|NCT01549340|20465933|P1|STARTED|Overall Study|Advised to receive AIT|8790
8300999|NCT01549314|20465947|P3|NOT COMPLETED|Overall Study||2
8301000|NCT01549314|20465948|P2|NOT COMPLETED|Overall Study||5
8301001|NCT01549314|20465949|P1|NOT COMPLETED|Overall Study||4
8301002|NCT01549314|20465947|P3|COMPLETED|Overall Study||24
8301003|NCT01549314|20465948|P2|COMPLETED|Overall Study||21
8301004|NCT01549314|20465949|P1|COMPLETED|Overall Study||23
8301005|NCT01549314|20465947|P3|STARTED|Overall Study||26
8301006|NCT01549314|20465948|P2|STARTED|Overall Study||26
8301007|NCT01549314|20465949|P1|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
8301008|NCT01549275|20465965|P2|NOT COMPLETED|Overall Study||0
8301009|NCT01549275|20465966|P1|NOT COMPLETED|Overall Study||1
8301010|NCT01549275|20465965|P2|COMPLETED|Overall Study||29
8301011|NCT01549275|20465966|P1|COMPLETED|Overall Study||75
8301012|NCT01549275|20465965|P2|STARTED|Overall Study||29
8301013|NCT01549275|20465966|P1|STARTED|Overall Study||76
8301014|NCT01549223|20465978|P2|NOT COMPLETED|Overall Study||0
8301015|NCT01549223|20465979|P1|NOT COMPLETED|Overall Study||0
8301016|NCT01549223|20465978|P2|COMPLETED|Overall Study||30
8301017|NCT01549223|20465979|P1|COMPLETED|Overall Study||30
8301018|NCT01549223|20465978|P2|STARTED|Overall Study||30
8301019|NCT01549223|20465979|P1|STARTED|Overall Study||30
8301020|NCT01549041|20465989|P2|NOT COMPLETED|Overall Study||8
8301021|NCT01549041|20465990|P1|NOT COMPLETED|Overall Study||2
8301022|NCT01549041|20465989|P2|COMPLETED|Overall Study||10
8301023|NCT01549041|20465990|P1|COMPLETED|Overall Study||10
8301024|NCT01549041|20465989|P2|STARTED|Overall Study||18
8301025|NCT01549041|20465990|P1|STARTED|Overall Study||12
8301026|NCT01549002|20466000|P2|NOT COMPLETED|Overall Study||4
8301027|NCT01549002|20466001|P1|NOT COMPLETED|Overall Study||0
8301028|NCT01549002|20466000|P2|COMPLETED|Overall Study||6
8301029|NCT01549002|20466001|P1|COMPLETED|Overall Study||10
8301030|NCT01549002|20466000|P2|STARTED|Overall Study||10
8301031|NCT01549002|20466001|P1|STARTED|Overall Study||10
8301032|NCT01548885|20466011|P1|NOT COMPLETED|Overall Study||0
8301033|NCT01548885|20466011|P1|COMPLETED|Overall Study||146
8301034|NCT01548885|20466011|P1|STARTED|Overall Study||146
8301035|NCT01548833|20466016|P1|NOT COMPLETED|Overall Study||0
8301036|NCT01548833|20466016|P1|COMPLETED|Overall Study||39
8301037|NCT01548833|20466016|P1|STARTED|Overall Study||39
8301038|NCT01548768|20466028|P4|NOT COMPLETED|Overall Study||4
8301039|NCT01548768|20466029|P3|NOT COMPLETED|Overall Study||1
8301040|NCT01548768|20466030|P2|NOT COMPLETED|Overall Study||2
8301041|NCT01548768|20466031|P1|NOT COMPLETED|Overall Study||1
8301042|NCT01548768|20466028|P4|COMPLETED|Overall Study||117
8301043|NCT01548768|20466029|P3|COMPLETED|Overall Study||15
8301044|NCT01548768|20466030|P2|COMPLETED|Overall Study||2
8301045|NCT01548768|20466031|P1|COMPLETED|Overall Study||7
8301046|NCT01548768|20466028|P4|STARTED|Overall Study||121
8301047|NCT01548768|20466029|P3|STARTED|Overall Study||16
8301048|NCT01548768|20466030|P2|STARTED|Overall Study||4
8301049|NCT01548768|20466031|P1|STARTED|Overall Study||8
8301050|NCT01548742|20466048|P2|NOT COMPLETED|Overall Study||4
8301051|NCT01548742|20466049|P1|NOT COMPLETED|Overall Study||13
8301052|NCT01548742|20466048|P2|COMPLETED|Overall Study||54
8301053|NCT01548742|20466049|P1|COMPLETED|Overall Study||45
8301054|NCT01548742|20466048|P2|STARTED|Overall Study||58
8301055|NCT01548742|20466049|P1|STARTED|Overall Study||58
8301056|NCT01548690|20466067|P4|NOT COMPLETED|Overall Study||5
8301057|NCT01548690|20466068|P3|NOT COMPLETED|Overall Study||5
8301058|NCT01548690|20466069|P2|NOT COMPLETED|Overall Study||3
8301059|NCT01548690|20466070|P1|NOT COMPLETED|Overall Study||0
8301060|NCT01548690|20466067|P4|COMPLETED|Overall Study||10
8301061|NCT01548690|20466068|P3|COMPLETED|Overall Study||8
8301062|NCT01548690|20466069|P2|COMPLETED|Overall Study||7
8301063|NCT01548690|20466070|P1|COMPLETED|Overall Study||9
8301064|NCT01548690|20466067|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
8301065|NCT01548690|20466068|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
8301066|NCT01548690|20466069|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
8301067|NCT01548690|20466070|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
8301068|NCT01548690|20466067|P4|STARTED|Overall Study||15
8301069|NCT01548690|20466068|P3|STARTED|Overall Study||13
8301070|NCT01548690|20466069|P2|STARTED|Overall Study||10
8301071|NCT01548690|20466070|P1|STARTED|Overall Study||9
8301072|NCT01548651|20466098|P2|NOT COMPLETED|Overall Study||0
8301073|NCT01548651|20466099|P1|NOT COMPLETED|Overall Study||1
8301074|NCT01548651|20466098|P2|COMPLETED|Overall Study||4
8301075|NCT01548651|20466099|P1|COMPLETED|Overall Study||3
8301076|NCT01548651|20466098|P2|STARTED|Overall Study||4
8301077|NCT01548651|20466099|P1|STARTED|Overall Study||4
8301078|NCT01548638|20466109|P1|NOT COMPLETED|Overall Study||4
8301079|NCT01548638|20466109|P1|COMPLETED|Overall Study||9
8301080|NCT01548638|20466109|P1|STARTED|Overall Study||13
8301081|NCT01548599|20466121|P2|NOT COMPLETED|Overall Study||2
8301082|NCT01548599|20466122|P1|NOT COMPLETED|Overall Study||6
8301083|NCT01548599|20466121|P2|COMPLETED|Overall Study||66
8301084|NCT01548599|20466122|P1|COMPLETED|Overall Study||66
8301085|NCT01548599|20466121|P2|STARTED|Overall Study||68
8301086|NCT01548599|20466122|P1|STARTED|Overall Study||72
8301087|NCT01548573|20466138|P1|NOT COMPLETED|Overall Study||5
8301088|NCT01548573|20466138|P1|COMPLETED|Overall Study||14
8301089|NCT01548573|20466138|P1|STARTED|Overall Study||19
8301090|NCT01548417|20466147|P2|NOT COMPLETED|Overall Study||2
8301091|NCT01548417|20466148|P1|NOT COMPLETED|Overall Study||0
8301092|NCT01548417|20466147|P2|COMPLETED|Overall Study||26
8301093|NCT01548417|20466148|P1|COMPLETED|Overall Study||28
8301094|NCT01548417|20466147|P2|STARTED|Overall Study||28
8301095|NCT01548417|20466148|P1|STARTED|Overall Study||28
8301096|NCT01548404|20466158|P2|NOT COMPLETED|Overall Study||14
8301097|NCT01548404|20466159|P1|NOT COMPLETED|Overall Study||30
8301098|NCT01548404|20466158|P2|COMPLETED|Overall Study||41
8301099|NCT01548404|20466159|P1|COMPLETED|Overall Study||24
8301100|NCT01548404|20466158|P2|STARTED|Overall Study||55
8301101|NCT01548404|20466159|P1|STARTED|Overall Study||54
8301102|NCT01548339|20466183|P2|NOT COMPLETED|Overall Study||1
8301103|NCT01548339|20466184|P1|NOT COMPLETED|Overall Study||6
8301104|NCT01548339|20466183|P2|COMPLETED|Overall Study||41
8301105|NCT01548339|20466184|P1|COMPLETED|Overall Study||38
8301106|NCT01548339|20466183|P2|STARTED|Overall Study||42
8301107|NCT01548339|20466184|P1|STARTED|Overall Study||44
8301108|NCT01548287|20466198|P5|NOT COMPLETED|Randomized Period||0
8301109|NCT01548287|20466199|P4|NOT COMPLETED|Randomized Period||0
8301110|NCT01548287|20466200|P3|NOT COMPLETED|Randomized Period||7
8301111|NCT01548287|20466201|P2|NOT COMPLETED|Randomized Period||2
8301112|NCT01548287|20466202|P1|NOT COMPLETED|Randomized Period||0
8301113|NCT01548287|20466198|P5|COMPLETED|Randomized Period||0
8301114|NCT01548287|20466199|P4|COMPLETED|Randomized Period||20
8301115|NCT01548287|20466200|P3|COMPLETED|Randomized Period||13
8301116|NCT01548287|20466201|P2|COMPLETED|Randomized Period||20
8301117|NCT01548287|20466202|P1|COMPLETED|Randomized Period||19
8301118|NCT01548287|20466198|P5|STARTED|Randomized Period||0
8301119|NCT01548287|20466199|P4|STARTED|Randomized Period||20
8301120|NCT01548287|20466200|P3|STARTED|Randomized Period||20
8301121|NCT01548287|20466201|P2|STARTED|Randomized Period||22
8301122|NCT01548287|20466202|P1|STARTED|Randomized Period||19
8301123|NCT01548287|20466198|P5|NOT COMPLETED|Screening||83
8301124|NCT01548287|20466199|P4|NOT COMPLETED|Screening||0
8301125|NCT01548287|20466200|P3|NOT COMPLETED|Screening||0
8301126|NCT01548287|20466201|P2|NOT COMPLETED|Screening||0
8301127|NCT01548287|20466202|P1|NOT COMPLETED|Screening||0
8301128|NCT01548287|20466198|P5|COMPLETED|Screening||0
8301129|NCT01548287|20466199|P4|COMPLETED|Screening||20
8301130|NCT01548287|20466200|P3|COMPLETED|Screening||20
8301131|NCT01548287|20466201|P2|COMPLETED|Screening||22
8301132|NCT01548287|20466202|P1|COMPLETED|Screening||19
8301133|NCT01548287|20466198|P5|STARTED|Screening||83
8301134|NCT01548287|20466199|P4|STARTED|Screening||20
8301135|NCT01548287|20466200|P3|STARTED|Screening||20
8301136|NCT01548287|20466201|P2|STARTED|Screening||22
8301137|NCT01548287|20466202|P1|STARTED|Screening||19
8301138|NCT01548040|20466234|P2|NOT COMPLETED|Overall Study||10
8301139|NCT01548040|20466235|P1|NOT COMPLETED|Overall Study||13
8301140|NCT01548040|20466234|P2|COMPLETED|Overall Study||45
8301141|NCT01548040|20466235|P1|COMPLETED|Overall Study||43
8301142|NCT01548040|20466234|P2|STARTED|Overall Study||55
8301143|NCT01548040|20466235|P1|STARTED|Overall Study||56
8301144|NCT01547806|20466243|P1|NOT COMPLETED|Overall Study||0
8301145|NCT01547806|20466243|P1|COMPLETED|Overall Study||49
8301146|NCT01547806|20466243|P1|STARTED|Overall Study||49
8301147|NCT01547728|20466259|P1|NOT COMPLETED|Overall Study||41
8301148|NCT01547728|20466259|P1|COMPLETED|Overall Study||1
8301149|NCT01547728|20466259|P1|STARTED|Overall Study||42
8301150|NCT01547715|20466266|P3|NOT COMPLETED|Overall Study||0
8301151|NCT01547715|20466267|P2|NOT COMPLETED|Overall Study||0
8301152|NCT01547715|20466268|P1|NOT COMPLETED|Overall Study||0
8301153|NCT01547715|20466266|P3|COMPLETED|Overall Study||60
8301154|NCT01547715|20466267|P2|COMPLETED|Overall Study||60
8301155|NCT01547715|20466268|P1|COMPLETED|Overall Study||60
8301156|NCT01547715|20466266|P3|STARTED|Overall Study||60
8301157|NCT01547715|20466267|P2|STARTED|Overall Study||60
8301158|NCT01547715|20466268|P1|STARTED|Overall Study||60
8301159|NCT01547598|20466368|P2|NOT COMPLETED|Overall Study||5
8301160|NCT01547598|20466369|P1|NOT COMPLETED|Overall Study||6
8301161|NCT01547598|20466368|P2|COMPLETED|Overall Study||63
8301162|NCT01547598|20466369|P1|COMPLETED|Overall Study||61
8301163|NCT01547598|20466368|P2|STARTED|Overall Study||68
8301164|NCT01547598|20466369|P1|STARTED|Overall Study||67
8301165|NCT01547390|20466386|P2|NOT COMPLETED|Overall Study||10
8301166|NCT01547390|20466387|P1|NOT COMPLETED|Overall Study||13
8301167|NCT01547390|20466386|P2|COMPLETED|Overall Study||16
8301168|NCT01547390|20466387|P1|COMPLETED|Overall Study||14
8301169|NCT01547390|20466386|P2|STARTED|Overall Study||26
8301170|NCT01547390|20466387|P1|STARTED|Overall Study||27
8301171|NCT01547299|20466397|P2|NOT COMPLETED|Overall Study||2
8301172|NCT01547299|20466398|P1|NOT COMPLETED|Overall Study||2
8301173|NCT01547299|20466397|P2|COMPLETED|Overall Study||25
8301174|NCT01547299|20466398|P1|COMPLETED|Overall Study||23
8301175|NCT01547299|20466397|P2|STARTED|Overall Study||27
8301176|NCT01547299|20466398|P1|STARTED|Overall Study||25
8301177|NCT01547286|20466464|P1|NOT COMPLETED|Overall Study||2
8301178|NCT01547286|20466464|P1|COMPLETED|Overall Study||5
8301179|NCT01547286|20466464|P1|STARTED|Overall Study||7
8301180|NCT01547247|20466473|P2|NOT COMPLETED|Overall Study||6
8301181|NCT01547247|20466474|P1|NOT COMPLETED|Overall Study||6
8301182|NCT01547247|20466473|P2|COMPLETED|Overall Study||98
8301183|NCT01547247|20466474|P1|COMPLETED|Overall Study||98
8301184|NCT01547247|20466473|P2|STARTED|Overall Study||104
8301185|NCT01547247|20466474|P1|STARTED|Overall Study||104
8301186|NCT01547130|20466484|P2|NOT COMPLETED|Overall Study||5
8301187|NCT01547130|20466485|P1|NOT COMPLETED|Overall Study||9
8301188|NCT01547130|20466484|P2|COMPLETED|Overall Study||68
8301189|NCT01547130|20466485|P1|COMPLETED|Overall Study||65
8301190|NCT01547130|20466484|P2|STARTED|Overall Study||73
8301191|NCT01547130|20466485|P1|STARTED|Overall Study||74
8301192|NCT01547000|20466501|P2|NOT COMPLETED|Overall Study||0
8301193|NCT01547000|20466502|P1|NOT COMPLETED|Overall Study||0
8301194|NCT01547000|20466501|P2|COMPLETED|Overall Study||16
8301195|NCT01547000|20466502|P1|COMPLETED|Overall Study||18
8301196|NCT01547000|20466501|P2|STARTED|Overall Study||16
8301197|NCT01547000|20466502|P1|STARTED|Overall Study||18
8301198|NCT01546922|20466508|P2|NOT COMPLETED|Second Period of 10 Weeks||3
8301199|NCT01546922|20466509|P1|NOT COMPLETED|Second Period of 10 Weeks||3
8301200|NCT01546922|20466508|P2|COMPLETED|Second Period of 10 Weeks||25
8301201|NCT01546922|20466509|P1|COMPLETED|Second Period of 10 Weeks||22
8301202|NCT01546922|20466508|P2|STARTED|Second Period of 10 Weeks||28
8301203|NCT01546922|20466509|P1|STARTED|Second Period of 10 Weeks||25
8301204|NCT01546922|20466508|P2|NOT COMPLETED|First Period of 10 Weeks||2
8301205|NCT01546922|20466509|P1|NOT COMPLETED|First Period of 10 Weeks||5
8301206|NCT01546922|20466508|P2|COMPLETED|First Period of 10 Weeks||28
8301207|NCT01546922|20466509|P1|COMPLETED|First Period of 10 Weeks||25
8301208|NCT01546922|20466508|P2|STARTED|First Period of 10 Weeks||30
8301209|NCT01546922|20466509|P1|STARTED|First Period of 10 Weeks||30
8301210|NCT01546883|20466515|P1|NOT COMPLETED|Overall Study||12
8301211|NCT01546883|20466515|P1|COMPLETED|Overall Study||2
8301212|NCT01546883|20466515|P1|STARTED|Overall Study||14
8301213|NCT01546857|20466521|P2|NOT COMPLETED|Overall Study||3
8301214|NCT01546857|20466522|P1|NOT COMPLETED|Overall Study||2
8301215|NCT01546857|20466521|P2|COMPLETED|Overall Study||17
8301216|NCT01546857|20466522|P1|COMPLETED|Overall Study||12
8301217|NCT01546857|20466521|P2|STARTED|Overall Study||20
8301218|NCT01546857|20466522|P1|STARTED|Overall Study||14
8301219|NCT01546688|20466536|P2|NOT COMPLETED|Overall Study||5
8301220|NCT01546688|20466537|P1|NOT COMPLETED|Overall Study||3
8301221|NCT01546688|20466536|P2|COMPLETED|Overall Study||28
8301222|NCT01546688|20466537|P1|COMPLETED|Overall Study||15
8301223|NCT01546688|20466536|P2|STARTED|Overall Study||33
8301224|NCT01546688|20466537|P1|STARTED|Overall Study||18
8301225|NCT01546675|20466551|P2|NOT COMPLETED|Overall Study||0
8301226|NCT01546675|20466552|P1|NOT COMPLETED|Overall Study||0
8301227|NCT01546675|20466551|P2|COMPLETED|Overall Study||1
8301228|NCT01546675|20466552|P1|COMPLETED|Overall Study||1
8301229|NCT01546675|20466551|P2|STARTED|Overall Study||1
8301230|NCT01546675|20466552|P1|STARTED|Overall Study||1
8301231|NCT01546649|20466569|P2|NOT COMPLETED|Overall Study||9
8301232|NCT01546649|20466570|P1|NOT COMPLETED|Overall Study||8
8301233|NCT01546649|20466569|P2|COMPLETED|Overall Study||75
8301234|NCT01546649|20466570|P1|COMPLETED|Overall Study||75
8301235|NCT01546649|20466569|P2|STARTED|Overall Study||84
8301236|NCT01546649|20466570|P1|STARTED|Overall Study||83
8301237|NCT01546636|20466592|P2|NOT COMPLETED|Overall Study||0
8301238|NCT01546636|20466593|P1|NOT COMPLETED|Overall Study||0
8301239|NCT01546636|20466592|P2|COMPLETED|Overall Study||34
8301240|NCT01546636|20466593|P1|COMPLETED|Overall Study||36
8301241|NCT01546636|20466592|P2|STARTED|Overall Study||34
8301242|NCT01546636|20466593|P1|STARTED|Overall Study||36
8301243|NCT01546623|20466605|P2|NOT COMPLETED|Overall Study||6
8301244|NCT01546623|20466606|P1|NOT COMPLETED|Overall Study||6
8301245|NCT01546623|20466605|P2|COMPLETED|Overall Study||74
8301246|NCT01546623|20466606|P1|COMPLETED|Overall Study||76
8301247|NCT01546623|20466605|P2|Received Study Drug|Overall Study||79
8301248|NCT01546623|20466606|P1|Received Study Drug|Overall Study||81
8301249|NCT01546623|20466605|P2|STARTED|Overall Study||80
8301250|NCT01546623|20466606|P1|STARTED|Overall Study||82
8301251|NCT01546519|20466636|P4|NOT COMPLETED|Overall Study||6
8301252|NCT01546519|20466637|P3|NOT COMPLETED|Overall Study||8
8301253|NCT01546519|20466638|P2|NOT COMPLETED|Overall Study||8
8301254|NCT01546519|20466639|P1|NOT COMPLETED|Overall Study||9
8301255|NCT01546519|20466636|P4|COMPLETED|Overall Study||0
8301256|NCT01546519|20466637|P3|COMPLETED|Overall Study||0
8301257|NCT01546519|20466638|P2|COMPLETED|Overall Study||0
8301258|NCT01546519|20466639|P1|COMPLETED|Overall Study||0
8301259|NCT01546519|20466636|P4|Safety-Evaluable Participants|Overall Study||6
8301260|NCT01546519|20466637|P3|Safety-Evaluable Participants|Overall Study||8
8301261|NCT01546519|20466638|P2|Safety-Evaluable Participants|Overall Study||8
8301262|NCT01546519|20466639|P1|Safety-Evaluable Participants|Overall Study||9
8301263|NCT01546519|20466636|P4|STARTED|Overall Study||6
8301264|NCT01546519|20466637|P3|STARTED|Overall Study||8
8301265|NCT01546519|20466638|P2|STARTED|Overall Study||8
8301266|NCT01546519|20466639|P1|STARTED|Overall Study||9
8301267|NCT01546454|20466681|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
8301268|NCT01546454|20466681|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
8301269|NCT01546454|20466681|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
8301270|NCT01546454|20466681|P1|NOT COMPLETED|Eligard Treatment||0
8301271|NCT01546454|20466681|P1|COMPLETED|Eligard Treatment||4
8301272|NCT01546454|20466681|P1|STARTED|Eligard Treatment||4
8301273|NCT01546454|20466681|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
8301274|NCT01546454|20466681|P1|COMPLETED|Oral Contraceptive Cycle||4
8301275|NCT01546454|20466681|P1|STARTED|Oral Contraceptive Cycle||4
8301276|NCT01546454|20466681|P1|NOT COMPLETED|Natural Menstrual Cycle||0
8301277|NCT01546454|20466681|P1|COMPLETED|Natural Menstrual Cycle||4
8301278|NCT01546454|20466681|P1|STARTED|Natural Menstrual Cycle||4
8301279|NCT01546402|20466689|P2|NOT COMPLETED|Overall Study||0
8301280|NCT01546402|20466690|P1|NOT COMPLETED|Overall Study||0
8301281|NCT01546402|20466689|P2|COMPLETED|Overall Study||10
8301282|NCT01546402|20466690|P1|COMPLETED|Overall Study||10
8301283|NCT01546402|20466689|P2|STARTED|Overall Study||10
8301284|NCT01546402|20466690|P1|STARTED|Overall Study||10
8301285|NCT01546285|20466698|P1|NOT COMPLETED|Overall Study||0
8301286|NCT01546285|20466698|P1|COMPLETED|Overall Study||66
8301287|NCT01546285|20466698|P1|STARTED|Overall Study||66
8301288|NCT01546207|20466704|P1|NOT COMPLETED|Overall Study||1
8301289|NCT01546207|20466704|P1|COMPLETED|Overall Study||3
8301290|NCT01546207|20466704|P1|STARTED|Overall Study||4
8301291|NCT01546194|20466710|P2|NOT COMPLETED|Overall Study||35
8301292|NCT01546194|20466711|P1|NOT COMPLETED|Overall Study||36
8301293|NCT01546194|20466710|P2|COMPLETED|Overall Study||65
8301294|NCT01546194|20466711|P1|COMPLETED|Overall Study||64
8301295|NCT01546194|20466710|P2|STARTED|Overall Study||100
8301296|NCT01546194|20466711|P1|STARTED|Overall Study||100
8301297|NCT01546168|20466719|P2|NOT COMPLETED|Overall Study||0
8301298|NCT01546168|20466720|P1|NOT COMPLETED|Overall Study||4
8301299|NCT01546168|20466719|P2|COMPLETED|Overall Study||33
8301300|NCT01546168|20466720|P1|COMPLETED|Overall Study||51
8301301|NCT01546168|20466719|P2|STARTED|Overall Study||33
8301302|NCT01546168|20466720|P1|STARTED|Overall Study||55
8301303|NCT01546155|20466732|P1|NOT COMPLETED|Overall Study||3
8301304|NCT01546155|20466732|P1|COMPLETED|Overall Study||8
8301305|NCT01546155|20466732|P1|STARTED|Overall Study||11
8301306|NCT01546142|20466738|P2|NOT COMPLETED|Overall Study||34
8301307|NCT01546142|20466739|P1|NOT COMPLETED|Overall Study||44
8301308|NCT01546142|20466738|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
8301309|NCT01546142|20466739|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
8301310|NCT01546142|20466738|P2|Received Treatment|Overall Study||257
8301311|NCT01546142|20466739|P1|Received Treatment|Overall Study||257
8301312|NCT01546142|20466738|P2|STARTED|Overall Study||258
8301313|NCT01546142|20466739|P1|STARTED|Overall Study||258
8301314|NCT01546038|20466757|P9|NOT COMPLETED|Overall Study||43
8301315|NCT01546038|20466758|P8|NOT COMPLETED|Overall Study||84
8301316|NCT01546038|20466759|P7|NOT COMPLETED|Overall Study||53
8301317|NCT01546038|20466760|P6|NOT COMPLETED|Overall Study||4
8301318|NCT01546038|20466761|P5|NOT COMPLETED|Overall Study||10
8301319|NCT01546038|20466762|P4|NOT COMPLETED|Overall Study||3
8301320|NCT01546038|20466763|P3|NOT COMPLETED|Overall Study||4
8301321|NCT01546038|20466764|P2|NOT COMPLETED|Overall Study||6
8301322|NCT01546038|20466765|P1|NOT COMPLETED|Overall Study||16
8301323|NCT01546038|20466757|P9|COMPLETED|Overall Study||1
8301324|NCT01546038|20466758|P8|COMPLETED|Overall Study||4
8301325|NCT01546038|20466759|P7|COMPLETED|Overall Study||18
8301326|NCT01546038|20466760|P6|COMPLETED|Overall Study||2
8301327|NCT01546038|20466761|P5|COMPLETED|Overall Study||6
8301328|NCT01546038|20466762|P4|COMPLETED|Overall Study||0
8301329|NCT01546038|20466763|P3|COMPLETED|Overall Study||0
8301330|NCT01546038|20466764|P2|COMPLETED|Overall Study||0
8301331|NCT01546038|20466765|P1|COMPLETED|Overall Study||1
8301332|NCT01546038|20466757|P9|Received Treatment|Overall Study||41
8301333|NCT01546038|20466758|P8|Received Treatment|Overall Study||84
8301334|NCT01546038|20466759|P7|Received Treatment|Overall Study||69
8301335|NCT01546038|20466760|P6|Received Treatment|Overall Study||6
8301336|NCT01546038|20466761|P5|Received Treatment|Overall Study||16
8301337|NCT01546038|20466762|P4|Received Treatment|Overall Study||3
8301338|NCT01546038|20466763|P3|Received Treatment|Overall Study||4
8301339|NCT01546038|20466764|P2|Received Treatment|Overall Study||6
8301340|NCT01546038|20466765|P1|Received Treatment|Overall Study||17
8301341|NCT01546038|20466757|P9|STARTED|Overall Study||44
8301342|NCT01546038|20466758|P8|STARTED|Overall Study||88
8301343|NCT01546038|20466759|P7|STARTED|Overall Study||71
8301344|NCT01546038|20466760|P6|STARTED|Overall Study||6
8301345|NCT01546038|20466761|P5|STARTED|Overall Study||16
8301346|NCT01546038|20466762|P4|STARTED|Overall Study||3
8301347|NCT01546038|20466763|P3|STARTED|Overall Study||4
8301348|NCT01546038|20466764|P2|STARTED|Overall Study||6
8301349|NCT01546038|20466765|P1|STARTED|Overall Study||17
8301350|NCT01545843|20466928|P3|NOT COMPLETED|Overall Study||4
8301351|NCT01545843|20466929|P2|NOT COMPLETED|Overall Study||7
8301352|NCT01545843|20466930|P1|NOT COMPLETED|Overall Study||3
8301353|NCT01545843|20466928|P3|COMPLETED|Overall Study||21
8301354|NCT01545843|20466929|P2|COMPLETED|Overall Study||17
8301355|NCT01545843|20466930|P1|COMPLETED|Overall Study||16
8301356|NCT01545843|20466928|P3|STARTED|Overall Study||25
8301357|NCT01545843|20466929|P2|STARTED|Overall Study||24
8301358|NCT01545843|20466930|P1|STARTED|Overall Study||19
8301359|NCT01545817|20466959|P2|NOT COMPLETED|Everolimus||38
8301360|NCT01545817|20466960|P1|NOT COMPLETED|Everolimus||0
8301361|NCT01545817|20466959|P2|COMPLETED|Everolimus||0
8301362|NCT01545817|20466960|P1|COMPLETED|Everolimus||0
8301363|NCT01545817|20466959|P2|STARTED|Everolimus||38
8301364|NCT01545817|20466960|P1|STARTED|Everolimus||0
8301365|NCT01545817|20466959|P2|NOT COMPLETED|Pazopanib||0
8301366|NCT01545817|20466960|P1|NOT COMPLETED|Pazopanib||74
8301367|NCT01545817|20466959|P2|COMPLETED|Pazopanib||0
8301368|NCT01545817|20466960|P1|COMPLETED|Pazopanib||0
8301369|NCT01545817|20466959|P2|STARTED|Pazopanib||0
8301370|NCT01545817|20466960|P1|STARTED|Pazopanib||74
8301374|NCT01545700|20466988|P6|NOT COMPLETED|Overall Study||0
8301375|NCT01545700|20466989|P5|NOT COMPLETED|Overall Study||1
8301376|NCT01545700|20466990|P4|NOT COMPLETED|Overall Study||0
8301377|NCT01545700|20466991|P3|NOT COMPLETED|Overall Study||2
8301378|NCT01545700|20466992|P2|NOT COMPLETED|Overall Study||1
8301379|NCT01545700|20466993|P1|NOT COMPLETED|Overall Study||1
8301380|NCT01545700|20466988|P6|COMPLETED|Overall Study||33
8301381|NCT01545700|20466989|P5|COMPLETED|Overall Study||32
8301382|NCT01545700|20466990|P4|COMPLETED|Overall Study||34
8301383|NCT01545700|20466991|P3|COMPLETED|Overall Study||31
8301384|NCT01545700|20466992|P2|COMPLETED|Overall Study||32
8301385|NCT01545700|20466993|P1|COMPLETED|Overall Study||33
8301386|NCT01545700|20466988|P6|STARTED|Overall Study||33
8301387|NCT01545700|20466989|P5|STARTED|Overall Study||33
8301388|NCT01545700|20466990|P4|STARTED|Overall Study||34
8301389|NCT01545700|20466991|P3|STARTED|Overall Study||33
8301390|NCT01545700|20466992|P2|STARTED|Overall Study||33
8301391|NCT01545700|20466993|P1|STARTED|Overall Study||34
8301392|NCT01545648|20467027|P1|NOT COMPLETED|Overall Study||0
8301393|NCT01545648|20467027|P1|COMPLETED|Overall Study||4
8301394|NCT01545648|20467027|P1|6 Months of Treatment|Overall Study||4
8301395|NCT01545648|20467027|P1|STARTED|Overall Study||4
8301396|NCT01545583|20467042|P9|NOT COMPLETED|Overall Study||0
8301397|NCT01545583|20467043|P8|NOT COMPLETED|Overall Study||0
8301398|NCT01545583|20467044|P7|NOT COMPLETED|Overall Study||0
8301399|NCT01545583|20467045|P6|NOT COMPLETED|Overall Study||0
8301400|NCT01545583|20467046|P5|NOT COMPLETED|Overall Study||0
8301401|NCT01545583|20467047|P4|NOT COMPLETED|Overall Study||0
8301402|NCT01545583|20467048|P3|NOT COMPLETED|Overall Study||0
8301403|NCT01545583|20467049|P2|NOT COMPLETED|Overall Study||0
8301404|NCT01545583|20467050|P1|NOT COMPLETED|Overall Study||0
8301405|NCT01545583|20467042|P9|COMPLETED|Overall Study||6
8301406|NCT01545583|20467043|P8|COMPLETED|Overall Study||6
8301407|NCT01545583|20467044|P7|COMPLETED|Overall Study||6
8301408|NCT01545583|20467045|P6|COMPLETED|Overall Study||6
8301409|NCT01545583|20467046|P5|COMPLETED|Overall Study||6
8301410|NCT01545583|20467047|P4|COMPLETED|Overall Study||6
8301411|NCT01545583|20467048|P3|COMPLETED|Overall Study||6
8301412|NCT01545583|20467049|P2|COMPLETED|Overall Study||2
8301413|NCT01545583|20467050|P1|COMPLETED|Overall Study||12
8301414|NCT01545583|20467042|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
8301415|NCT01545583|20467043|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
8301416|NCT01545583|20467044|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8301417|NCT01545583|20467045|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
8301418|NCT01545583|20467046|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8301419|NCT01545583|20467047|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8301420|NCT01545583|20467048|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8301421|NCT01545583|20467049|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8301422|NCT01545583|20467050|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8301423|NCT01545583|20467042|P9|STARTED|Overall Study||6
8301424|NCT01545583|20467043|P8|STARTED|Overall Study||6
8301425|NCT01545583|20467044|P7|STARTED|Overall Study||6
8301426|NCT01545583|20467045|P6|STARTED|Overall Study||6
8301427|NCT01545583|20467046|P5|STARTED|Overall Study||6
8301428|NCT01545583|20467047|P4|STARTED|Overall Study||6
8301429|NCT01545583|20467048|P3|STARTED|Overall Study||6
8301430|NCT01545583|20467049|P2|STARTED|Overall Study||2
8301431|NCT01545583|20467050|P1|STARTED|Overall Study||12
8301432|NCT01545518|20467102|P1|NOT COMPLETED|Overall Study||0
8301433|NCT01545518|20467102|P1|COMPLETED|Overall Study||20
8301434|NCT01545518|20467102|P1|STARTED|Overall Study||20
8301435|NCT01545388|20467109|P3|NOT COMPLETED|Overall Study||8
8301436|NCT01545388|20467110|P2|NOT COMPLETED|Overall Study||11
8301437|NCT01545388|20467111|P1|NOT COMPLETED|Overall Study||8
8301438|NCT01545388|20467109|P3|COMPLETED|Overall Study||58
8301439|NCT01545388|20467110|P2|COMPLETED|Overall Study||122
8301440|NCT01545388|20467111|P1|COMPLETED|Overall Study||130
8301441|NCT01545388|20467109|P3|STARTED|Overall Study||66
8301442|NCT01545388|20467110|P2|STARTED|Overall Study||133
8301443|NCT01545388|20467111|P1|STARTED|Overall Study||138
8301444|NCT01545375|20467130|P2|NOT COMPLETED|Overall Study||90
8301445|NCT01545375|20467131|P1|NOT COMPLETED|Overall Study||97
8301446|NCT01545375|20467130|P2|COMPLETED|Overall Study||813
8301447|NCT01545375|20467131|P1|COMPLETED|Overall Study||803
8301448|NCT01545375|20467130|P2|STARTED|Overall Study||903
8301449|NCT01545375|20467131|P1|STARTED|Overall Study||900
8301450|NCT01545336|20467187|P2|NOT COMPLETED|Overall Study||0
8301451|NCT01545336|20467188|P1|NOT COMPLETED|Overall Study||0
8301452|NCT01545336|20467187|P2|COMPLETED|Overall Study||6
8301453|NCT01545336|20467188|P1|COMPLETED|Overall Study||12
8301454|NCT01545336|20467187|P2|STARTED|Overall Study||6
8301455|NCT01545336|20467188|P1|STARTED|Overall Study||12
8301456|NCT01545232|20467200|P2|NOT COMPLETED|Overall Study||0
8301457|NCT01545232|20467201|P1|NOT COMPLETED|Overall Study||0
8301458|NCT01545232|20467200|P2|COMPLETED|Overall Study||342
8301459|NCT01545232|20467201|P1|COMPLETED|Overall Study||338
8301460|NCT01545232|20467200|P2|STARTED|Overall Study||342
8301461|NCT01545232|20467201|P1|STARTED|Overall Study||338
8301462|NCT01545193|20467233|P2|NOT COMPLETED|Overall Study||1
8301463|NCT01545193|20467234|P1|NOT COMPLETED|Overall Study||0
8301464|NCT01545193|20467233|P2|COMPLETED|Overall Study||149
8301465|NCT01545193|20467234|P1|COMPLETED|Overall Study||150
8301466|NCT01545193|20467233|P2|STARTED|Overall Study||150
8301467|NCT01545193|20467234|P1|STARTED|Overall Study||150
8301468|NCT01545141|20467250|P4|NOT COMPLETED|Overall Study||0
8301469|NCT01545141|20467251|P3|NOT COMPLETED|Overall Study||0
8301470|NCT01545141|20467252|P2|NOT COMPLETED|Overall Study||0
8301471|NCT01545141|20467253|P1|NOT COMPLETED|Overall Study||0
8301472|NCT01545141|20467250|P4|COMPLETED|Overall Study||7
8301473|NCT01545141|20467251|P3|COMPLETED|Overall Study||3
8301474|NCT01545141|20467252|P2|COMPLETED|Overall Study||3
8301475|NCT01545141|20467253|P1|COMPLETED|Overall Study||2
8301476|NCT01545141|20467250|P4|STARTED|Overall Study||7
8301477|NCT01545141|20467251|P3|STARTED|Overall Study||3
8301478|NCT01545141|20467252|P2|STARTED|Overall Study||3
8301479|NCT01545141|20467253|P1|STARTED|Overall Study||2
8301480|NCT01545076|20467263|P5|NOT COMPLETED|IgPro10 Rescue Period||0
8301481|NCT01545076|20467264|P4|NOT COMPLETED|IgPro10 Rescue Period||0
8301482|NCT01545076|20467265|P3|NOT COMPLETED|IgPro10 Rescue Period||0
8301483|NCT01545076|20467266|P2|NOT COMPLETED|IgPro10 Rescue Period||0
8301484|NCT01545076|20467267|P1|NOT COMPLETED|IgPro10 Rescue Period||0
8301485|NCT01545076|20467263|P5|COMPLETED|IgPro10 Rescue Period||60
8301486|NCT01545076|20467264|P4|COMPLETED|IgPro10 Rescue Period||0
8301487|NCT01545076|20467265|P3|COMPLETED|IgPro10 Rescue Period||0
8301488|NCT01545076|20467266|P2|COMPLETED|IgPro10 Rescue Period||0
8301489|NCT01545076|20467267|P1|COMPLETED|IgPro10 Rescue Period||0
8301490|NCT01545076|20467263|P5|STARTED|IgPro10 Rescue Period||60
8301491|NCT01545076|20467264|P4|STARTED|IgPro10 Rescue Period||0
8301492|NCT01545076|20467265|P3|STARTED|IgPro10 Rescue Period||0
8301493|NCT01545076|20467266|P2|STARTED|IgPro10 Rescue Period||0
8301494|NCT01545076|20467267|P1|STARTED|IgPro10 Rescue Period||0
8301495|NCT01545076|20467263|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301496|NCT01545076|20467264|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
8301497|NCT01545076|20467265|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
8301498|NCT01545076|20467266|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
8301499|NCT01545076|20467267|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301500|NCT01545076|20467263|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301501|NCT01545076|20467264|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
8301502|NCT01545076|20467265|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
8301503|NCT01545076|20467266|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
8301504|NCT01545076|20467267|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301505|NCT01545076|20467263|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
8301506|NCT01545076|20467264|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
8301507|NCT01545076|20467265|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
8301508|NCT01545076|20467266|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
8301509|NCT01545076|20467267|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
8301510|NCT01545076|20467263|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
8301511|NCT01545076|20467264|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
8301512|NCT01545076|20467265|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
8301513|NCT01545076|20467266|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
8301514|NCT01545076|20467267|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
8301515|NCT01545076|20467263|P5|COMPLETED|IgPro10 Restabilization Period||0
8301516|NCT01545076|20467264|P4|COMPLETED|IgPro10 Restabilization Period||0
8301517|NCT01545076|20467265|P3|COMPLETED|IgPro10 Restabilization Period||0
8301518|NCT01545076|20467266|P2|COMPLETED|IgPro10 Restabilization Period||0
8301519|NCT01545076|20467267|P1|COMPLETED|IgPro10 Restabilization Period||172
8301520|NCT01545076|20467263|P5|STARTED|IgPro10 Restabilization Period||0
8301521|NCT01545076|20467264|P4|STARTED|IgPro10 Restabilization Period||0
8301522|NCT01545076|20467265|P3|STARTED|IgPro10 Restabilization Period||0
8301523|NCT01545076|20467266|P2|STARTED|IgPro10 Restabilization Period||0
8301524|NCT01545076|20467267|P1|STARTED|IgPro10 Restabilization Period||208
8301525|NCT01544998|20467317|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
8301526|NCT01544998|20467318|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
8301527|NCT01544998|20467317|P2|COMPLETED|Second Intervention (3 Hours)||15
8301528|NCT01544998|20467318|P1|COMPLETED|Second Intervention (3 Hours)||26
8301529|NCT01544998|20467317|P2|STARTED|Second Intervention (3 Hours)||15
8301530|NCT01544998|20467318|P1|STARTED|Second Intervention (3 Hours)||26
8301531|NCT01544998|20467317|P2|NOT COMPLETED|Washout (1 Week)||0
8301532|NCT01544998|20467318|P1|NOT COMPLETED|Washout (1 Week)||0
8301533|NCT01544998|20467317|P2|COMPLETED|Washout (1 Week)||15
8301534|NCT01544998|20467318|P1|COMPLETED|Washout (1 Week)||26
8301535|NCT01544998|20467317|P2|STARTED|Washout (1 Week)||15
8301536|NCT01544998|20467318|P1|STARTED|Washout (1 Week)||26
8301537|NCT01544998|20467317|P2|NOT COMPLETED|First Intervention (3 Hours)||0
8301538|NCT01544998|20467318|P1|NOT COMPLETED|First Intervention (3 Hours)||0
8301539|NCT01544998|20467317|P2|COMPLETED|First Intervention (3 Hours)||15
8301540|NCT01544998|20467318|P1|COMPLETED|First Intervention (3 Hours)||26
8301541|NCT01544998|20467317|P2|STARTED|First Intervention (3 Hours)||15
8301542|NCT01544998|20467318|P1|STARTED|First Intervention (3 Hours)||26
8301543|NCT01544920|20467338|P2|NOT COMPLETED|Overall Study||23
8301544|NCT01544920|20467339|P1|NOT COMPLETED|Overall Study||19
8301545|NCT01544920|20467338|P2|COMPLETED|Overall Study||346
8301546|NCT01544920|20467339|P1|COMPLETED|Overall Study||349
8301547|NCT01544920|20467338|P2|STARTED|Overall Study||369
8301548|NCT01544920|20467339|P1|STARTED|Overall Study||368
8301549|NCT01544595|20467353|P6|NOT COMPLETED|Status at Week 156||15
8301550|NCT01544595|20467354|P5|NOT COMPLETED|Status at Week 156||38
8301551|NCT01544595|20467355|P4|NOT COMPLETED|Status at Week 156||166
8301552|NCT01544595|20467356|P3|NOT COMPLETED|Status at Week 156||140
8301553|NCT01544595|20467357|P2|NOT COMPLETED|Status at Week 156||78
8301554|NCT01544595|20467358|P1|NOT COMPLETED|Status at Week 156||117
8301555|NCT01544595|20467353|P6|COMPLETED|Status at Week 156||38
8301556|NCT01544595|20467354|P5|COMPLETED|Status at Week 156||60
8301557|NCT01544595|20467355|P4|COMPLETED|Status at Week 156||15
8301558|NCT01544595|20467356|P3|COMPLETED|Status at Week 156||10
8301559|NCT01544595|20467357|P2|COMPLETED|Status at Week 156||285
8301560|NCT01544595|20467358|P1|COMPLETED|Status at Week 156||184
8301561|NCT01544595|20467353|P6|STARTED|Status at Week 156||53
8301562|NCT01544595|20467354|P5|STARTED|Status at Week 156||98
8301563|NCT01544595|20467355|P4|STARTED|Status at Week 156||181
8301564|NCT01544595|20467356|P3|STARTED|Status at Week 156||150
8301565|NCT01544595|20467357|P2|STARTED|Status at Week 156||363
8301566|NCT01544595|20467358|P1|STARTED|Status at Week 156||301
8301567|NCT01544595|20467353|P6|NOT COMPLETED|Status at Week 68||0
8301568|NCT01544595|20467354|P5|NOT COMPLETED|Status at Week 68||0
8301569|NCT01544595|20467355|P4|NOT COMPLETED|Status at Week 68||51
8301570|NCT01544595|20467356|P3|NOT COMPLETED|Status at Week 68||63
8301571|NCT01544595|20467357|P2|NOT COMPLETED|Status at Week 68||17
8301572|NCT01544595|20467358|P1|NOT COMPLETED|Status at Week 68||39
8301573|NCT01544595|20467353|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301574|NCT01544595|20467354|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301575|NCT01544595|20467355|P4|COMPLETED|Status at Week 68||130
8301576|NCT01544595|20467356|P3|COMPLETED|Status at Week 68||87
8301577|NCT01544595|20467357|P2|COMPLETED|Status at Week 68||346
8301578|NCT01544595|20467358|P1|COMPLETED|Status at Week 68||262
8301579|NCT01544595|20467353|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301580|NCT01544595|20467354|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301581|NCT01544595|20467355|P4|STARTED|Status at Week 68||181
8301582|NCT01544595|20467356|P3|STARTED|Status at Week 68||150
8301583|NCT01544595|20467357|P2|STARTED|Status at Week 68||363
8301584|NCT01544595|20467358|P1|STARTED|Status at Week 68||301
8301585|NCT01544582|20467434|P4|NOT COMPLETED|Analysis Population||39
8301586|NCT01544582|20467435|P3|NOT COMPLETED|Analysis Population||102
8301587|NCT01544582|20467436|P2|NOT COMPLETED|Analysis Population||118
8301588|NCT01544582|20467437|P1|NOT COMPLETED|Analysis Population||0
8301589|NCT01544582|20467434|P4|COMPLETED|Analysis Population||35
8301590|NCT01544582|20467435|P3|COMPLETED|Analysis Population||205
8301591|NCT01544582|20467436|P2|COMPLETED|Analysis Population||180
8301592|NCT01544582|20467437|P1|COMPLETED|Analysis Population||0
8301593|NCT01544582|20467434|P4|STARTED|Analysis Population||74
8301594|NCT01544582|20467435|P3|STARTED|Analysis Population||307
8301595|NCT01544582|20467436|P2|STARTED|Analysis Population||298
8301596|NCT01544582|20467437|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
8301597|NCT01544582|20467434|P4|NOT COMPLETED|Screening/Eligibility||0
8301598|NCT01544582|20467435|P3|NOT COMPLETED|Screening/Eligibility||0
8301599|NCT01544582|20467436|P2|NOT COMPLETED|Screening/Eligibility||0
8301600|NCT01544582|20467437|P1|NOT COMPLETED|Screening/Eligibility||34
8301601|NCT01544582|20467434|P4|COMPLETED|Screening/Eligibility||0
8301602|NCT01544582|20467435|P3|COMPLETED|Screening/Eligibility||0
8301603|NCT01544582|20467436|P2|COMPLETED|Screening/Eligibility||0
8301604|NCT01544582|20467437|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
8301605|NCT01544582|20467434|P4|Analysis Population|Screening/Eligibility||0
8301606|NCT01544582|20467435|P3|Analysis Population|Screening/Eligibility||0
8301607|NCT01544582|20467436|P2|Analysis Population|Screening/Eligibility||0
8301608|NCT01544582|20467437|P1|Analysis Population|Screening/Eligibility||679
8301609|NCT01544582|20467434|P4|STARTED|Screening/Eligibility||0
8301610|NCT01544582|20467435|P3|STARTED|Screening/Eligibility||0
8301611|NCT01544582|20467436|P2|STARTED|Screening/Eligibility||0
8301612|NCT01544582|20467437|P1|STARTED|Screening/Eligibility||713
8301613|NCT01544491|20467497|P2|NOT COMPLETED|Overall Study||3
8301614|NCT01544491|20467498|P1|NOT COMPLETED|Overall Study||5
8301615|NCT01544491|20467497|P2|COMPLETED|Overall Study||51
8301616|NCT01544491|20467498|P1|COMPLETED|Overall Study||47
8301617|NCT01544491|20467497|P2|STARTED|Overall Study||54
8301618|NCT01544491|20467498|P1|STARTED|Overall Study||52
8301619|NCT01544478|20467524|P1|NOT COMPLETED|Overall Study||118
8301620|NCT01544478|20467524|P1|COMPLETED|Overall Study||912
8301621|NCT01544478|20467524|P1|Vaccination 3|Overall Study||1019
8301622|NCT01544478|20467524|P1|Vaccination 2|Overall Study||1026
8301623|NCT01544478|20467524|P1|Vaccination 1|Overall Study||1030
8301624|NCT01544478|20467524|P1|STARTED|Overall Study||1030
8301625|NCT01544361|20467533|P5|NOT COMPLETED|Overall Study||0
8301626|NCT01544361|20467534|P4|NOT COMPLETED|Overall Study||0
8301627|NCT01544361|20467535|P3|NOT COMPLETED|Overall Study||0
8301628|NCT01544361|20467536|P2|NOT COMPLETED|Overall Study||0
8301629|NCT01544361|20467537|P1|NOT COMPLETED|Overall Study||0
8301630|NCT01544361|20467533|P5|COMPLETED|Overall Study||6
8301631|NCT01544361|20467534|P4|COMPLETED|Overall Study||6
8301632|NCT01544361|20467535|P3|COMPLETED|Overall Study||6
8301633|NCT01544361|20467536|P2|COMPLETED|Overall Study||6
8301634|NCT01544361|20467537|P1|COMPLETED|Overall Study||8
8301635|NCT01544361|20467533|P5|STARTED|Overall Study||6
8301636|NCT01544361|20467534|P4|STARTED|Overall Study||6
8301637|NCT01544361|20467535|P3|STARTED|Overall Study||6
8301638|NCT01544361|20467536|P2|STARTED|Overall Study||6
8301639|NCT01544361|20467537|P1|STARTED|Overall Study||8
8301640|NCT01544348|20467567|P8|NOT COMPLETED|Overall Study||0
8301641|NCT01544348|20467568|P7|NOT COMPLETED|Overall Study||2
8301642|NCT01544348|20467569|P6|NOT COMPLETED|Overall Study||3
8301643|NCT01544348|20467570|P5|NOT COMPLETED|Overall Study||1
8301644|NCT01544348|20467571|P4|NOT COMPLETED|Overall Study||0
8301645|NCT01544348|20467572|P3|NOT COMPLETED|Overall Study||0
8301646|NCT01544348|20467573|P2|NOT COMPLETED|Overall Study||0
8301647|NCT01544348|20467574|P1|NOT COMPLETED|Overall Study||2
8301648|NCT01544348|20467567|P8|COMPLETED|Overall Study||8
8301649|NCT01544348|20467568|P7|COMPLETED|Overall Study||12
8301650|NCT01544348|20467569|P6|COMPLETED|Overall Study||16
8301651|NCT01544348|20467570|P5|COMPLETED|Overall Study||15
8301652|NCT01544348|20467571|P4|COMPLETED|Overall Study||3
8301653|NCT01544348|20467572|P3|COMPLETED|Overall Study||3
8301654|NCT01544348|20467573|P2|COMPLETED|Overall Study||6
8301655|NCT01544348|20467574|P1|COMPLETED|Overall Study||15
8301656|NCT01544348|20467567|P8|Treated|Overall Study||8
8301657|NCT01544348|20467568|P7|Treated|Overall Study||14
8301658|NCT01544348|20467569|P6|Treated|Overall Study||18
8301659|NCT01544348|20467570|P5|Treated|Overall Study||15
8301660|NCT01544348|20467571|P4|Treated|Overall Study||3
8301661|NCT01544348|20467572|P3|Treated|Overall Study||3
8301662|NCT01544348|20467573|P2|Treated|Overall Study||6
8301663|NCT01544348|20467574|P1|Treated|Overall Study||17
8301664|NCT01544348|20467567|P8|STARTED|Overall Study||8
8301665|NCT01544348|20467568|P7|STARTED|Overall Study||14
8301666|NCT01544348|20467569|P6|STARTED|Overall Study||19
8301667|NCT01544348|20467570|P5|STARTED|Overall Study||16
8301668|NCT01544348|20467571|P4|STARTED|Overall Study||3
8301669|NCT01544348|20467572|P3|STARTED|Overall Study||3
8301670|NCT01544348|20467573|P2|STARTED|Overall Study||6
8301671|NCT01544348|20467574|P1|STARTED|Overall Study||17
8301672|NCT01544309|20467616|P2|NOT COMPLETED|Overall Study||11
8301673|NCT01544309|20467617|P1|NOT COMPLETED|Overall Study||20
8301674|NCT01544309|20467616|P2|COMPLETED|Overall Study||514
8301675|NCT01544309|20467617|P1|COMPLETED|Overall Study||504
8301676|NCT01544309|20467616|P2|STARTED|Overall Study||525
8301677|NCT01544309|20467617|P1|STARTED|Overall Study||524
8301678|NCT01544179|20467655|P2|NOT COMPLETED|Overall Study||46
8301679|NCT01544179|20467656|P1|NOT COMPLETED|Overall Study||63
8301680|NCT01544179|20467655|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
8301681|NCT01544179|20467656|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
8301682|NCT01544179|20467655|P2|Did Not Receive Treatment|Overall Study||0
8301683|NCT01544179|20467656|P1|Did Not Receive Treatment|Overall Study||1
8301684|NCT01544179|20467655|P2|Received Treatment|Overall Study||132
8301685|NCT01544179|20467656|P1|Received Treatment|Overall Study||132
8301686|NCT01544179|20467655|P2|STARTED|Overall Study||132
8301687|NCT01544179|20467656|P1|STARTED|Overall Study||133
8301688|NCT01544166|20467684|P1|NOT COMPLETED|Overall Study||0
8301689|NCT01544166|20467684|P1|COMPLETED|Overall Study||44
8301690|NCT01544166|20467684|P1|STARTED|Overall Study||44
8301691|NCT01544153|20467749|P4|NOT COMPLETED|Overall Study||0
8301692|NCT01544153|20467750|P3|NOT COMPLETED|Overall Study||1
8301693|NCT01544153|20467751|P2|NOT COMPLETED|Overall Study||1
8301694|NCT01544153|20467752|P1|NOT COMPLETED|Overall Study||0
8301695|NCT01544153|20467749|P4|COMPLETED|Overall Study||1317
8301696|NCT01544153|20467750|P3|COMPLETED|Overall Study||1313
8301697|NCT01544153|20467751|P2|COMPLETED|Overall Study||1323
8301698|NCT01544153|20467752|P1|COMPLETED|Overall Study||1337
8301699|NCT01544153|20467749|P4|STARTED|Overall Study||1317
8301700|NCT01544153|20467750|P3|STARTED|Overall Study||1314
8301701|NCT01544153|20467751|P2|STARTED|Overall Study||1324
8301702|NCT01544153|20467752|P1|STARTED|Overall Study||1337
8301703|NCT01544127|20467769|P3|NOT COMPLETED|Overall Study||14
8301704|NCT01544127|20467770|P2|NOT COMPLETED|Overall Study||6
8301705|NCT01544127|20467771|P1|NOT COMPLETED|Overall Study||11
8301706|NCT01544127|20467769|P3|COMPLETED|Overall Study||52
8301707|NCT01544127|20467770|P2|COMPLETED|Overall Study||27
8301708|NCT01544127|20467771|P1|COMPLETED|Overall Study||22
8301709|NCT01544127|20467769|P3|STARTED|Overall Study||66
8301710|NCT01544127|20467770|P2|STARTED|Overall Study||33
8301711|NCT01544127|20467771|P1|STARTED|Overall Study||33
8301712|NCT01544114|20467791|P3|NOT COMPLETED|Overall Study||5
8301713|NCT01544114|20467792|P2|NOT COMPLETED|Overall Study||4
8301714|NCT01544114|20467793|P1|NOT COMPLETED|Overall Study||1
8301715|NCT01544114|20467791|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
8301716|NCT01544114|20467792|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
8301717|NCT01544114|20467793|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
8301718|NCT01544114|20467791|P3|STARTED|Overall Study||22
8301719|NCT01544114|20467792|P2|STARTED|Overall Study||20
8301720|NCT01544114|20467793|P1|STARTED|Overall Study||4
8301721|NCT01544088|20467824|P2|NOT COMPLETED|Overall Study||21
8301722|NCT01544088|20467825|P1|NOT COMPLETED|Overall Study||37
8301723|NCT01544088|20467824|P2|COMPLETED|Overall Study||79
8301724|NCT01544088|20467825|P1|COMPLETED|Overall Study||61
8301725|NCT01544088|20467824|P2|STARTED|Overall Study||100
8301726|NCT01544088|20467825|P1|STARTED|Overall Study||98
8301727|NCT01544062|20467839|P2|NOT COMPLETED|Overall Study||0
8301728|NCT01544062|20467840|P1|NOT COMPLETED|Overall Study||0
8301729|NCT01544062|20467839|P2|COMPLETED|Overall Study||35
8301730|NCT01544062|20467840|P1|COMPLETED|Overall Study||33
8301731|NCT01544062|20467839|P2|STARTED|Overall Study||35
8301732|NCT01544062|20467840|P1|STARTED|Overall Study||33
8301733|NCT01544023|20467886|P1|NOT COMPLETED|Overall Study||0
8301734|NCT01544023|20467886|P1|COMPLETED|Overall Study||207
8301735|NCT01544023|20467886|P1|STARTED|Overall Study|retrospective|207
8301736|NCT01543958|20467891|P1|NOT COMPLETED|Overall Study||4
8301737|NCT01543958|20467891|P1|COMPLETED|Overall Study||36
8301738|NCT01543958|20467891|P1|STARTED|Overall Study||40
8301739|NCT01543828|20467946|P2|NOT COMPLETED|Treatment 2||0
8301740|NCT01543828|20467947|P1|NOT COMPLETED|Treatment 2||1
8301741|NCT01543828|20467946|P2|COMPLETED|Treatment 2||19
8301742|NCT01543828|20467947|P1|COMPLETED|Treatment 2||19
8301743|NCT01543828|20467946|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
8301744|NCT01543828|20467947|P1|STARTED|Treatment 2||20
8301745|NCT01543828|20467946|P2|NOT COMPLETED|Treatment 1||0
8301746|NCT01543828|20467947|P1|NOT COMPLETED|Treatment 1||0
8301747|NCT01543828|20467946|P2|COMPLETED|Treatment 1||20
8301748|NCT01543828|20467947|P1|COMPLETED|Treatment 1||20
8301749|NCT01543828|20467946|P2|STARTED|Treatment 1||20
8301750|NCT01543828|20467947|P1|STARTED|Treatment 1||20
8301751|NCT01543776|20467957|P2|NOT COMPLETED|Overall Study||2
8301752|NCT01543776|20467958|P1|NOT COMPLETED|Overall Study||2
8301753|NCT01543776|20467957|P2|COMPLETED|Overall Study||34
8301754|NCT01543776|20467958|P1|COMPLETED|Overall Study||34
8301755|NCT01543776|20467957|P2|STARTED|Overall Study||36
8301756|NCT01543776|20467958|P1|STARTED|Overall Study||36
8301757|NCT01543685|20467977|P5|NOT COMPLETED|Overall Study||4
8301758|NCT01543685|20467978|P4|NOT COMPLETED|Overall Study||0
8301759|NCT01543685|20467979|P3|NOT COMPLETED|Overall Study||2
8301760|NCT01543685|20467980|P2|NOT COMPLETED|Overall Study||3
8301761|NCT01543685|20467981|P1|NOT COMPLETED|Overall Study||3
8301762|NCT01543685|20467977|P5|COMPLETED|Overall Study||90
8301763|NCT01543685|20467978|P4|COMPLETED|Overall Study||93
8301764|NCT01543685|20467979|P3|COMPLETED|Overall Study||89
8301765|NCT01543685|20467980|P2|COMPLETED|Overall Study||88
8301766|NCT01543685|20467981|P1|COMPLETED|Overall Study||90
8301767|NCT01543685|20467977|P5|STARTED|Overall Study||94
8301768|NCT01543685|20467978|P4|STARTED|Overall Study||93
8301769|NCT01543685|20467979|P3|STARTED|Overall Study||91
8301770|NCT01543685|20467980|P2|STARTED|Overall Study||91
8301771|NCT01543685|20467981|P1|STARTED|Overall Study||93
8301772|NCT01543607|20468028|P1|NOT COMPLETED|Overall Study||0
8301773|NCT01543607|20468028|P1|COMPLETED|Overall Study||1
8301774|NCT01543607|20468028|P1|STARTED|Overall Study||1
8301775|NCT01543581|20468034|P2|NOT COMPLETED|Overall Study||0
8301776|NCT01543581|20468035|P1|NOT COMPLETED|Overall Study||0
8301777|NCT01543581|20468034|P2|COMPLETED|Overall Study||0
8301778|NCT01543581|20468035|P1|COMPLETED|Overall Study||1
8301779|NCT01543581|20468034|P2|STARTED|Overall Study||0
8301780|NCT01543581|20468035|P1|STARTED|Overall Study||1
8301781|NCT01543568|20468041|P1|NOT COMPLETED|Overall Study||1
8301782|NCT01543568|20468041|P1|COMPLETED|Overall Study||45
8301783|NCT01543568|20468041|P1|STARTED|Overall Study||46
8301784|NCT01543503|20468053|P2|NOT COMPLETED|Overall Study||87
8301785|NCT01543503|20468054|P1|NOT COMPLETED|Overall Study||76
8301786|NCT01543503|20468053|P2|COMPLETED|Overall Study||711
8301787|NCT01543503|20468054|P1|COMPLETED|Overall Study||350
8301788|NCT01543503|20468053|P2|STARTED|Overall Study||798
8301789|NCT01543503|20468054|P1|STARTED|Overall Study||426
8301790|NCT01543204|20468098|P1|NOT COMPLETED|Overall Study||8
8301791|NCT01543204|20468098|P1|COMPLETED|Overall Study||56
8301792|NCT01543204|20468098|P1|STARTED|Overall Study||64
8301793|NCT01543178|20468145|P3|NOT COMPLETED|Double-blind Period||37
8301794|NCT01543178|20468146|P2|NOT COMPLETED|Double-blind Period||44
8301795|NCT01543178|20468147|P1|NOT COMPLETED|Double-blind Period||0
8301796|NCT01543178|20468145|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
8301797|NCT01543178|20468146|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
8301798|NCT01543178|20468147|P1|COMPLETED|Double-blind Period||0
8301799|NCT01543178|20468145|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
8301800|NCT01543178|20468146|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
8301801|NCT01543178|20468147|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
8301802|NCT01543178|20468145|P3|NOT COMPLETED|Open-label Period||0
8301803|NCT01543178|20468146|P2|NOT COMPLETED|Open-label Period||0
8301804|NCT01543178|20468147|P1|NOT COMPLETED|Open-label Period||1947
8301805|NCT01543178|20468145|P3|COMPLETED|Open-label Period||0
8301806|NCT01543178|20468146|P2|COMPLETED|Open-label Period||0
8301807|NCT01543178|20468147|P1|COMPLETED|Open-label Period||636
8301808|NCT01543178|20468145|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
8301809|NCT01543178|20468146|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
8301810|NCT01543178|20468147|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
8301811|NCT01543087|20468160|P6|NOT COMPLETED|Booster Stage (26 Months)||0
8301812|NCT01543087|20468161|P5|NOT COMPLETED|Booster Stage (26 Months)||2
8301813|NCT01543087|20468162|P4|NOT COMPLETED|Booster Stage (26 Months)||0
8301814|NCT01543087|20468163|P3|NOT COMPLETED|Booster Stage (26 Months)||1
8301815|NCT01543087|20468164|P2|NOT COMPLETED|Booster Stage (26 Months)||1
8301816|NCT01543087|20468165|P1|NOT COMPLETED|Booster Stage (26 Months)||0
8301817|NCT01543087|20468160|P6|COMPLETED|Booster Stage (26 Months)||32
8301818|NCT01543087|20468161|P5|COMPLETED|Booster Stage (26 Months)||54
8301819|NCT01543087|20468162|P4|COMPLETED|Booster Stage (26 Months)||64
8301820|NCT01543087|20468163|P3|COMPLETED|Booster Stage (26 Months)||91
8301821|NCT01543087|20468164|P2|COMPLETED|Booster Stage (26 Months)||59
8301822|NCT01543087|20468165|P1|COMPLETED|Booster Stage (26 Months)||0
8301823|NCT01543087|20468160|P6|Vaccinated|Booster Stage (26 Months)||32
8301824|NCT01543087|20468161|P5|Vaccinated|Booster Stage (26 Months)||54
8301825|NCT01543087|20468162|P4|Vaccinated|Booster Stage (26 Months)||64
8301826|NCT01543087|20468163|P3|Vaccinated|Booster Stage (26 Months)||92
8301827|NCT01543087|20468164|P2|Vaccinated|Booster Stage (26 Months)||59
8301828|NCT01543087|20468165|P1|Vaccinated|Booster Stage (26 Months)||0
8301829|NCT01543087|20468160|P6|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
8301830|NCT01543087|20468161|P5|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
8301831|NCT01543087|20468162|P4|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
8301832|NCT01543087|20468163|P3|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
8301833|NCT01543087|20468164|P2|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
8301834|NCT01543087|20468165|P1|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
8301835|NCT01543087|20468160|P6|NOT COMPLETED|Stage 1 (48 Months)||0
8301836|NCT01543087|20468161|P5|NOT COMPLETED|Stage 1 (48 Months)||3
8301837|NCT01543087|20468162|P4|NOT COMPLETED|Stage 1 (48 Months)||8
8301838|NCT01543087|20468163|P3|NOT COMPLETED|Stage 1 (48 Months)||40
8301839|NCT01543087|20468164|P2|NOT COMPLETED|Stage 1 (48 Months)||10
8301840|NCT01543087|20468165|P1|NOT COMPLETED|Stage 1 (48 Months)||14
8301841|NCT01543087|20468160|P6|COMPLETED|Stage 1 (48 Months)||46
8301842|NCT01543087|20468161|P5|COMPLETED|Stage 1 (48 Months)||83
8301843|NCT01543087|20468162|P4|COMPLETED|Stage 1 (48 Months)||108
8301844|NCT01543087|20468163|P3|COMPLETED|Stage 1 (48 Months)||237
8301845|NCT01543087|20468164|P2|COMPLETED|Stage 1 (48 Months)||93
8301846|NCT01543087|20468165|P1|COMPLETED|Stage 1 (48 Months)||56
8301847|NCT01543087|20468160|P6|Safety Population|Stage 1 (48 Months)||46
8301848|NCT01543087|20468161|P5|Safety Population|Stage 1 (48 Months)||86
8301849|NCT01543087|20468162|P4|Safety Population|Stage 1 (48 Months)||116
8301850|NCT01543087|20468163|P3|Safety Population|Stage 1 (48 Months)||277
8301851|NCT01543087|20468164|P2|Safety Population|Stage 1 (48 Months)||101
8301852|NCT01543087|20468165|P1|Safety Population|Stage 1 (48 Months)||70
8301853|NCT01543087|20468160|P6|STARTED|Stage 1 (48 Months)||46
8301854|NCT01543087|20468161|P5|STARTED|Stage 1 (48 Months)||86
8301855|NCT01543087|20468162|P4|STARTED|Stage 1 (48 Months)||116
8301856|NCT01543087|20468163|P3|STARTED|Stage 1 (48 Months)||277
8301857|NCT01543087|20468164|P2|STARTED|Stage 1 (48 Months)||103
8301858|NCT01543087|20468165|P1|STARTED|Stage 1 (48 Months)||70
8301859|NCT01543074|20468306|P4|NOT COMPLETED|Overall Study||0
8301860|NCT01543074|20468307|P3|NOT COMPLETED|Overall Study||0
8301861|NCT01543074|20468308|P2|NOT COMPLETED|Overall Study||0
8301862|NCT01543074|20468309|P1|NOT COMPLETED|Overall Study||0
8301863|NCT01543074|20468306|P4|COMPLETED|Overall Study||6
8301864|NCT01543074|20468307|P3|COMPLETED|Overall Study||5
8301865|NCT01543074|20468308|P2|COMPLETED|Overall Study||7
8301866|NCT01543074|20468309|P1|COMPLETED|Overall Study||5
8301867|NCT01543074|20468306|P4|STARTED|Overall Study||6
8301868|NCT01543074|20468307|P3|STARTED|Overall Study||5
8301869|NCT01543074|20468308|P2|STARTED|Overall Study||7
8301870|NCT01543074|20468309|P1|STARTED|Overall Study||5
8301871|NCT01542957|20468329|P2|NOT COMPLETED|12-month Follow-up||13
8301872|NCT01542957|20468330|P1|NOT COMPLETED|12-month Follow-up||16
8301873|NCT01542957|20468329|P2|COMPLETED|12-month Follow-up||40
8301874|NCT01542957|20468330|P1|COMPLETED|12-month Follow-up||37
8301875|NCT01542957|20468329|P2|STARTED|12-month Follow-up||53
8301876|NCT01542957|20468330|P1|STARTED|12-month Follow-up||53
8301877|NCT01542957|20468329|P2|NOT COMPLETED|3-month Follow-up||8
8301878|NCT01542957|20468330|P1|NOT COMPLETED|3-month Follow-up||3
8301879|NCT01542957|20468329|P2|COMPLETED|3-month Follow-up||45
8301880|NCT01542957|20468330|P1|COMPLETED|3-month Follow-up||50
8301881|NCT01542957|20468329|P2|STARTED|3-month Follow-up||53
8301882|NCT01542957|20468330|P1|STARTED|3-month Follow-up||53
8301883|NCT01542957|20468329|P2|NOT COMPLETED|End of Therapy||10
8301884|NCT01542957|20468330|P1|NOT COMPLETED|End of Therapy||12
8301885|NCT01542957|20468329|P2|COMPLETED|End of Therapy||53
8301886|NCT01542957|20468330|P1|COMPLETED|End of Therapy||53
8301887|NCT01542957|20468329|P2|STARTED|End of Therapy||63
8301888|NCT01542957|20468330|P1|STARTED|End of Therapy||65
8301889|NCT01542788|20468342|P2|NOT COMPLETED|Overall Study||71
8301890|NCT01542788|20468343|P1|NOT COMPLETED|Overall Study||55
8301891|NCT01542788|20468342|P2|COMPLETED|Overall Study||0
8301892|NCT01542788|20468343|P1|COMPLETED|Overall Study||154
8301893|NCT01542788|20468342|P2|Randomized and Treated|Overall Study||71
8301894|NCT01542788|20468343|P1|Randomized and Treated|Overall Study||207
8301895|NCT01542788|20468342|P2|STARTED|Overall Study||71
8301896|NCT01542788|20468343|P1|STARTED|Overall Study||209
8301897|NCT01542684|20468359|P1|NOT COMPLETED|Overall Study||0
8301898|NCT01542684|20468359|P1|COMPLETED|Overall Study||8
8301899|NCT01542684|20468359|P1|STARTED|Overall Study||8
8301900|NCT01542645|20468365|P2|NOT COMPLETED|Overall Study||3
8301901|NCT01542645|20468366|P1|NOT COMPLETED|Overall Study||5
8301902|NCT01542645|20468365|P2|COMPLETED|Overall Study||79
8301903|NCT01542645|20468366|P1|COMPLETED|Overall Study||77
8301904|NCT01542645|20468365|P2|STARTED|Overall Study||82
8301905|NCT01542645|20468366|P1|STARTED|Overall Study||82
8301906|NCT01542632|20468390|P6|NOT COMPLETED|Overall Study||0
8301907|NCT01542632|20468391|P5|NOT COMPLETED|Overall Study||4
8301908|NCT01542632|20468392|P4|NOT COMPLETED|Overall Study||2
8301909|NCT01542632|20468393|P3|NOT COMPLETED|Overall Study||1
8301910|NCT01542632|20468394|P2|NOT COMPLETED|Overall Study||1
8301911|NCT01542632|20468395|P1|NOT COMPLETED|Overall Study||0
8301912|NCT01542632|20468390|P6|COMPLETED|Overall Study||24
8301913|NCT01542632|20468391|P5|COMPLETED|Overall Study||17
8301914|NCT01542632|20468392|P4|COMPLETED|Overall Study||19
8301915|NCT01542632|20468393|P3|COMPLETED|Overall Study||23
8301916|NCT01542632|20468394|P2|COMPLETED|Overall Study||24
8301917|NCT01542632|20468395|P1|COMPLETED|Overall Study||25
8301918|NCT01542632|20468390|P6|STARTED|Overall Study||24
8301919|NCT01542632|20468391|P5|STARTED|Overall Study||21
8301920|NCT01542632|20468392|P4|STARTED|Overall Study||21
8301921|NCT01542632|20468393|P3|STARTED|Overall Study||24
8301922|NCT01542632|20468394|P2|STARTED|Overall Study||25
8301923|NCT01542632|20468395|P1|STARTED|Overall Study||25
8301924|NCT01542541|20468441|P2|NOT COMPLETED|Overall Study||0
8301925|NCT01542541|20468442|P1|NOT COMPLETED|Overall Study||8
8301926|NCT01542541|20468441|P2|COMPLETED|Overall Study||30
8301927|NCT01542541|20468442|P1|COMPLETED|Overall Study||30
8301928|NCT01542541|20468441|P2|STARTED|Overall Study||30
8301929|NCT01542541|20468442|P1|STARTED|Overall Study||38
8301930|NCT01542528|20468452|P2|NOT COMPLETED|Overall Study||7
8301931|NCT01542528|20468453|P1|NOT COMPLETED|Overall Study||12
8301932|NCT01542528|20468452|P2|COMPLETED|Overall Study||49
8301933|NCT01542528|20468453|P1|COMPLETED|Overall Study||49
8301934|NCT01542528|20468452|P2|STARTED|Overall Study||56
8301935|NCT01542528|20468453|P1|STARTED|Overall Study||61
8301936|NCT01542502|20468461|P2|NOT COMPLETED|Overall Study||0
8301937|NCT01542502|20468462|P1|NOT COMPLETED|Overall Study||0
8301938|NCT01542502|20468461|P2|COMPLETED|Overall Study||6
8301939|NCT01542502|20468462|P1|COMPLETED|Overall Study||6
8301940|NCT01542502|20468461|P2|STARTED|Overall Study||6
8301941|NCT01542502|20468462|P1|STARTED|Overall Study||6
8301942|NCT01542398|20468472|P2|NOT COMPLETED|Overall Study||13
8301943|NCT01542398|20468473|P1|NOT COMPLETED|Overall Study||8
8301944|NCT01542398|20468472|P2|COMPLETED|Overall Study||67
8301945|NCT01542398|20468473|P1|COMPLETED|Overall Study||71
8301946|NCT01542398|20468472|P2|Post-Intervention Assessment|Overall Study||80
8301947|NCT01542398|20468473|P1|Post-Intervention Assessment|Overall Study||78
8301948|NCT01542398|20468472|P2|STARTED|Overall Study||80
8301949|NCT01542398|20468473|P1|STARTED|Overall Study||79
8301950|NCT01542372|20468481|P2|NOT COMPLETED|Overall Study||0
8301951|NCT01542372|20468482|P1|NOT COMPLETED|Overall Study||0
8301952|NCT01542372|20468481|P2|COMPLETED|Overall Study||11
8301953|NCT01542372|20468482|P1|COMPLETED|Overall Study||11
8301954|NCT01542372|20468481|P2|STARTED|Overall Study||11
8301955|NCT01542372|20468482|P1|STARTED|Overall Study||11
8301956|NCT01542307|20468497|P2|NOT COMPLETED|Overall Study||0
8301957|NCT01542307|20468498|P1|NOT COMPLETED|Overall Study||0
8301958|NCT01542307|20468497|P2|COMPLETED|Overall Study||22
8301959|NCT01542307|20468498|P1|COMPLETED|Overall Study||22
8301960|NCT01542307|20468497|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
8301961|NCT01542307|20468498|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
8301962|NCT01542255|20468518|P1|NOT COMPLETED|Overall Study||0
8301963|NCT01542255|20468518|P1|COMPLETED|Overall Study||7
8301964|NCT01542255|20468518|P1|Analyzed for Time to Progression|Overall Study||7
8301965|NCT01542255|20468518|P1|STARTED|Overall Study||7
8301966|NCT01542229|20468525|P2|NOT COMPLETED|Overall Study||36
8301967|NCT01542229|20468526|P1|NOT COMPLETED|Overall Study||23
8301968|NCT01542229|20468525|P2|COMPLETED|Overall Study||30
8301969|NCT01542229|20468526|P1|COMPLETED|Overall Study||45
8301970|NCT01542229|20468525|P2|STARTED|Overall Study||66
8301971|NCT01542229|20468526|P1|STARTED|Overall Study||68
8301972|NCT01542125|20468552|P2|NOT COMPLETED|Overall Study||0
8301973|NCT01542125|20468553|P1|NOT COMPLETED|Overall Study||0
8301974|NCT01542125|20468552|P2|COMPLETED|Overall Study||141
8301975|NCT01542125|20468553|P1|COMPLETED|Overall Study||140
8301976|NCT01542125|20468552|P2|STARTED|Overall Study||141
8301977|NCT01542125|20468553|P1|STARTED|Overall Study||140
8301978|NCT01542034|20468561|P2|NOT COMPLETED|Overall Study||23
8301979|NCT01542034|20468562|P1|NOT COMPLETED|Overall Study||30
8301980|NCT01542034|20468561|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
8301981|NCT01542034|20468562|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
8301982|NCT01542034|20468561|P2|Received Treatment|Overall Study||249
8301983|NCT01542034|20468562|P1|Received Treatment|Overall Study||256
8301984|NCT01542034|20468561|P2|STARTED|Overall Study||250
8301985|NCT01542034|20468562|P1|STARTED|Overall Study||256
8301986|NCT01541969|20468576|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
8301987|NCT01541969|20468577|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
8301988|NCT01541969|20468576|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
8301989|NCT01541969|20468577|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
8301990|NCT01541969|20468576|P2|STARTED|Open Label Extension (12-36 Weeks)||48
8301991|NCT01541969|20468577|P1|STARTED|Open Label Extension (12-36 Weeks)||44
8301992|NCT01541969|20468576|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
8301993|NCT01541969|20468577|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
8301994|NCT01541969|20468576|P2|COMPLETED|Double-blind (0-12 Weeks)||48
8301995|NCT01541969|20468577|P1|COMPLETED|Double-blind (0-12 Weeks)||44
8301996|NCT01541969|20468576|P2|STARTED|Double-blind (0-12 Weeks)||50
8301997|NCT01541969|20468577|P1|STARTED|Double-blind (0-12 Weeks)||50
8301998|NCT01541930|20468593|P1|NOT COMPLETED|Overall Study||1
8301999|NCT01541930|20468593|P1|COMPLETED|Overall Study||20
8302000|NCT01541930|20468593|P1|STARTED|Overall Study||21
8302001|NCT01541917|20468615|P2|NOT COMPLETED|Overall Study||9
8302002|NCT01541917|20468616|P1|NOT COMPLETED|Overall Study||15
8302003|NCT01541917|20468615|P2|COMPLETED|Overall Study||136
8302004|NCT01541917|20468616|P1|COMPLETED|Overall Study||129
8302005|NCT01541917|20468615|P2|STARTED|Overall Study||145
8302006|NCT01541917|20468616|P1|STARTED|Overall Study||144
8302007|NCT01541891|20468634|P2|NOT COMPLETED|Overall Study||1
8302008|NCT01541891|20468635|P1|NOT COMPLETED|Overall Study||1
8302009|NCT01541891|20468634|P2|COMPLETED|Overall Study||14
8302010|NCT01541891|20468635|P1|COMPLETED|Overall Study||14
8302011|NCT01541891|20468634|P2|STARTED|Overall Study||15
8302012|NCT01541891|20468635|P1|STARTED|Overall Study||15
8302013|NCT01541865|20468645|P1|NOT COMPLETED|Overall Study||22
8302014|NCT01541865|20468645|P1|COMPLETED|Overall Study||124
8302015|NCT01541865|20468645|P1|STARTED|Overall Study||146
8302016|NCT01541826|20468663|P3|NOT COMPLETED|Overall Study||0
8302017|NCT01541826|20468664|P2|NOT COMPLETED|Overall Study||3
8302018|NCT01541826|20468665|P1|NOT COMPLETED|Overall Study||4
8302019|NCT01541826|20468663|P3|COMPLETED|Overall Study||6
8302020|NCT01541826|20468664|P2|COMPLETED|Overall Study||25
8302021|NCT01541826|20468665|P1|COMPLETED|Overall Study||24
8302022|NCT01541826|20468663|P3|STARTED|Overall Study||6
8302023|NCT01541826|20468664|P2|STARTED|Overall Study||28
8302024|NCT01541826|20468665|P1|STARTED|Overall Study||28
8302025|NCT01541748|20468732|P1|NOT COMPLETED|Overall Study||31
8302026|NCT01541748|20468732|P1|COMPLETED|Overall Study||43
8302027|NCT01541748|20468732|P1|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
8302028|NCT01541735|20468755|P2|NOT COMPLETED|Overall Study||0
8302029|NCT01541735|20468756|P1|NOT COMPLETED|Overall Study||0
8302030|NCT01541735|20468755|P2|COMPLETED|Overall Study||7
8302031|NCT01541735|20468756|P1|COMPLETED|Overall Study||7
8302032|NCT01541735|20468755|P2|STARTED|Overall Study||7
8302033|NCT01541735|20468756|P1|STARTED|Overall Study||7
8302034|NCT01541644|20468768|P1|NOT COMPLETED|Overall Study||3
8302035|NCT01541644|20468768|P1|COMPLETED|Overall Study||24
8302036|NCT01541644|20468768|P1|STARTED|Overall Study||27
8302037|NCT01541553|20468774|P2|NOT COMPLETED|Overall Study||14
8302038|NCT01541553|20468775|P1|NOT COMPLETED|Overall Study||12
8302039|NCT01541553|20468774|P2|COMPLETED|Overall Study||148
8302040|NCT01541553|20468775|P1|COMPLETED|Overall Study||155
8302041|NCT01541553|20468774|P2|STARTED|Overall Study||162
8302042|NCT01541553|20468775|P1|STARTED|Overall Study||167
8302043|NCT01541397|20468787|P2|NOT COMPLETED|Overall Study||2
8302044|NCT01541397|20468788|P1|NOT COMPLETED|Overall Study||4
8302045|NCT01541397|20468787|P2|COMPLETED|Overall Study||0
8302046|NCT01541397|20468788|P1|COMPLETED|Overall Study||0
8302047|NCT01541397|20468787|P2|STARTED|Overall Study||2
8302048|NCT01541397|20468788|P1|STARTED|Overall Study||4
8302049|NCT01541384|20468803|P3|NOT COMPLETED|Overall Study||2
8302050|NCT01541384|20468804|P2|NOT COMPLETED|Overall Study||1
8302051|NCT01541384|20468805|P1|NOT COMPLETED|Overall Study||0
8302052|NCT01541384|20468803|P3|COMPLETED|Overall Study||38
8302053|NCT01541384|20468804|P2|COMPLETED|Overall Study||39
8302054|NCT01541384|20468805|P1|COMPLETED|Overall Study||40
8302055|NCT01541384|20468803|P3|STARTED|Overall Study||40
8302056|NCT01541384|20468804|P2|STARTED|Overall Study||40
8302057|NCT01541384|20468805|P1|STARTED|Overall Study||40
8302058|NCT01541371|20468813|P1|NOT COMPLETED|Overall Study||77
8302059|NCT01541371|20468813|P1|COMPLETED|Overall Study||326
8302060|NCT01541371|20468813|P1|Full Analysis Set|Overall Study||394
8302061|NCT01541371|20468813|P1|STARTED|Overall Study||403
8302062|NCT01541358|20468836|P1|NOT COMPLETED|Overall Study||0
8302063|NCT01541358|20468836|P1|COMPLETED|Overall Study||2
8302064|NCT01541358|20468836|P1|STARTED|Overall Study||2
8302065|NCT01541254|20468842|P1|NOT COMPLETED|Overall Study||6
8302066|NCT01541254|20468842|P1|COMPLETED|Overall Study||30
8302067|NCT01541254|20468842|P1|STARTED|Overall Study||36
8302068|NCT01541215|20468849|P2|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
8302069|NCT01541215|20468850|P1|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
8302070|NCT01541215|20468849|P2|COMPLETED|Follow up 1 (Weeks 53-104)||0
8302071|NCT01541215|20468850|P1|COMPLETED|Follow up 1 (Weeks 53-104)||50
8302072|NCT01541215|20468849|P2|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
8302073|NCT01541215|20468850|P1|STARTED|Follow up 1 (Weeks 53-104)|Subjects who provided safety follow up data were included.|52
8302074|NCT01541215|20468849|P2|NOT COMPLETED|Treatment Period (52 Weeks)||16
8302075|NCT01541215|20468850|P1|NOT COMPLETED|Treatment Period (52 Weeks)||10
8302076|NCT01541215|20468849|P2|COMPLETED|Treatment Period (52 Weeks)||53
8302077|NCT01541215|20468850|P1|COMPLETED|Treatment Period (52 Weeks)||56
8302078|NCT01541215|20468849|P2|Exposed|Treatment Period (52 Weeks)||68
8302079|NCT01541215|20468850|P1|Exposed|Treatment Period (52 Weeks)||66
8302080|NCT01541215|20468849|P2|STARTED|Treatment Period (52 Weeks)||69
8302081|NCT01541215|20468850|P1|STARTED|Treatment Period (52 Weeks)||66
8302082|NCT01540981|20468996|P2|NOT COMPLETED|Overall Study||0
8302083|NCT01540981|20468997|P1|NOT COMPLETED|Overall Study||1
8302084|NCT01540981|20468996|P2|COMPLETED|Overall Study||6
8302085|NCT01540981|20468997|P1|COMPLETED|Overall Study||5
8302086|NCT01540981|20468996|P2|STARTED|Overall Study||6
8302087|NCT01540981|20468997|P1|STARTED|Overall Study||6
8302088|NCT01540851|20469007|P2|NOT COMPLETED|Overall Study||18
8302089|NCT01540851|20469008|P1|NOT COMPLETED|Overall Study||21
8302090|NCT01540851|20469007|P2|COMPLETED|Overall Study||136
8302091|NCT01540851|20469008|P1|COMPLETED|Overall Study||133
8302092|NCT01540851|20469007|P2|STARTED|Overall Study||154
8302093|NCT01540851|20469008|P1|STARTED|Overall Study||154
8302094|NCT01540838|20469020|P2|NOT COMPLETED|Overall Study||23
8302095|NCT01540838|20469021|P1|NOT COMPLETED|Overall Study||22
8302096|NCT01540838|20469020|P2|COMPLETED|Overall Study||164
8302097|NCT01540838|20469021|P1|COMPLETED|Overall Study||166
8302098|NCT01540838|20469020|P2|STARTED|Overall Study||187
8302099|NCT01540838|20469021|P1|STARTED|Overall Study||188
8302100|NCT01540825|20469054|P11|NOT COMPLETED|Overall Study||0
8302101|NCT01540825|20469055|P10|NOT COMPLETED|Overall Study||0
8302102|NCT01540825|20469056|P9|NOT COMPLETED|Overall Study||0
8302103|NCT01540825|20469057|P8|NOT COMPLETED|Overall Study||0
8302104|NCT01540825|20469058|P7|NOT COMPLETED|Overall Study||0
8302105|NCT01540825|20469059|P6|NOT COMPLETED|Overall Study||0
8302106|NCT01540825|20469060|P5|NOT COMPLETED|Overall Study||0
8302107|NCT01540825|20469061|P4|NOT COMPLETED|Overall Study||0
8302108|NCT01540825|20469062|P3|NOT COMPLETED|Overall Study||0
8302109|NCT01540825|20469063|P2|NOT COMPLETED|Overall Study||0
8302110|NCT01540825|20469064|P1|NOT COMPLETED|Overall Study||0
8302111|NCT01540825|20469054|P11|COMPLETED|Overall Study||6
8302112|NCT01540825|20469055|P10|COMPLETED|Overall Study||6
8302113|NCT01540825|20469056|P9|COMPLETED|Overall Study||6
8302114|NCT01540825|20469057|P8|COMPLETED|Overall Study||6
8302115|NCT01540825|20469058|P7|COMPLETED|Overall Study||6
8302116|NCT01540825|20469059|P6|COMPLETED|Overall Study||6
8302117|NCT01540825|20469060|P5|COMPLETED|Overall Study||6
8302118|NCT01540825|20469061|P4|COMPLETED|Overall Study||6
8302119|NCT01540825|20469062|P3|COMPLETED|Overall Study||6
8302120|NCT01540825|20469063|P2|COMPLETED|Overall Study||6
8302121|NCT01540825|20469064|P1|COMPLETED|Overall Study||20
8302122|NCT01540825|20469054|P11|STARTED|Overall Study||6
8302123|NCT01540825|20469055|P10|STARTED|Overall Study||6
8302124|NCT01540825|20469056|P9|STARTED|Overall Study||6
8302125|NCT01540825|20469057|P8|STARTED|Overall Study||6
8302126|NCT01540825|20469058|P7|STARTED|Overall Study||6
8302127|NCT01540825|20469059|P6|STARTED|Overall Study||6
8302128|NCT01540825|20469060|P5|STARTED|Overall Study||6
8302129|NCT01540825|20469061|P4|STARTED|Overall Study||6
8302130|NCT01540825|20469062|P3|STARTED|Overall Study||6
8302131|NCT01540825|20469063|P2|STARTED|Overall Study||6
8302132|NCT01540825|20469064|P1|STARTED|Overall Study||20
8302133|NCT01540773|20469160|P2|NOT COMPLETED|Second Intervention||0
8302134|NCT01540773|20469161|P1|NOT COMPLETED|Second Intervention||0
8302135|NCT01540773|20469160|P2|COMPLETED|Second Intervention||8
8302136|NCT01540773|20469161|P1|COMPLETED|Second Intervention||8
8302137|NCT01540773|20469160|P2|STARTED|Second Intervention||8
8302138|NCT01540773|20469161|P1|STARTED|Second Intervention||8
8302139|NCT01540773|20469160|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
8302140|NCT01540773|20469161|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
8302141|NCT01540773|20469160|P2|COMPLETED|Wash Out Period of 1 Week||8
8302142|NCT01540773|20469161|P1|COMPLETED|Wash Out Period of 1 Week||8
8302143|NCT01540773|20469160|P2|STARTED|Wash Out Period of 1 Week||8
8302144|NCT01540773|20469161|P1|STARTED|Wash Out Period of 1 Week||8
8302145|NCT01540773|20469160|P2|NOT COMPLETED|First Intervention||0
8302146|NCT01540773|20469161|P1|NOT COMPLETED|First Intervention||0
8302147|NCT01540773|20469160|P2|COMPLETED|First Intervention||8
8302148|NCT01540773|20469161|P1|COMPLETED|First Intervention||8
8302149|NCT01540773|20469160|P2|STARTED|First Intervention||8
8302150|NCT01540773|20469161|P1|STARTED|First Intervention||8
8302151|NCT01540565|20469171|P1|NOT COMPLETED|Overall Study||2
8302152|NCT01540565|20469171|P1|COMPLETED|Overall Study||50
8302153|NCT01540565|20469171|P1|STARTED|Overall Study||52
8302154|NCT01540513|20469181|P1|NOT COMPLETED|Overall Study||0
8302155|NCT01540513|20469181|P1|COMPLETED|Overall Study||12
8302156|NCT01540513|20469181|P1|STARTED|Overall Study||12
8302157|NCT01540487|20469190|P2|NOT COMPLETED|Overall Study||0
8302158|NCT01540487|20469191|P1|NOT COMPLETED|Overall Study||1
8302159|NCT01540487|20469190|P2|COMPLETED|Overall Study||24
8302160|NCT01540487|20469191|P1|COMPLETED|Overall Study||23
8302161|NCT01540487|20469190|P2|STARTED|Overall Study||24
8302162|NCT01540487|20469191|P1|STARTED|Overall Study||24
8302163|NCT01540409|20469227|P2|NOT COMPLETED|Overall Study||0
8302164|NCT01540409|20469228|P1|NOT COMPLETED|Overall Study||0
8302165|NCT01540409|20469227|P2|COMPLETED|Overall Study||6
8302166|NCT01540409|20469228|P1|COMPLETED|Overall Study||6
8302167|NCT01540409|20469227|P2|STARTED|Overall Study||6
8302168|NCT01540409|20469228|P1|STARTED|Overall Study||6
8302169|NCT01540370|20469237|P1|NOT COMPLETED|Overall Study||2
8302170|NCT01540370|20469237|P1|COMPLETED|Overall Study||100
8302171|NCT01540370|20469237|P1|STARTED|Overall Study||102
8302172|NCT01540266|20469248|P6|NOT COMPLETED|Overall Study||0
8302173|NCT01540266|20469249|P5|NOT COMPLETED|Overall Study||0
8302174|NCT01540266|20469250|P4|NOT COMPLETED|Overall Study||0
8302175|NCT01540266|20469251|P3|NOT COMPLETED|Overall Study||1
8302176|NCT01540266|20469252|P2|NOT COMPLETED|Overall Study||1
8302177|NCT01540266|20469253|P1|NOT COMPLETED|Overall Study||6
8302178|NCT01540266|20469248|P6|COMPLETED|Overall Study||19
8302179|NCT01540266|20469249|P5|COMPLETED|Overall Study||20
8302180|NCT01540266|20469250|P4|COMPLETED|Overall Study||38
8302181|NCT01540266|20469251|P3|COMPLETED|Overall Study||59
8302182|NCT01540266|20469252|P2|COMPLETED|Overall Study||41
8302183|NCT01540266|20469253|P1|COMPLETED|Overall Study||57
8302184|NCT01540266|20469248|P6|STARTED|Overall Study||19
8302185|NCT01540266|20469249|P5|STARTED|Overall Study||20
8302186|NCT01540266|20469250|P4|STARTED|Overall Study||38
8302187|NCT01540266|20469251|P3|STARTED|Overall Study||60
8302188|NCT01540266|20469252|P2|STARTED|Overall Study||42
8302189|NCT01540266|20469253|P1|STARTED|Overall Study||63
8302190|NCT01540162|20469269|P2|NOT COMPLETED|Overall Study||0
8302191|NCT01540162|20469270|P1|NOT COMPLETED|Overall Study||0
8302192|NCT01540162|20469269|P2|COMPLETED|Overall Study||32
8302193|NCT01540162|20469270|P1|COMPLETED|Overall Study||30
8302194|NCT01540162|20469269|P2|STARTED|Overall Study||32
8302195|NCT01540162|20469270|P1|STARTED|Overall Study||30
8302196|NCT01540045|20469280|P1|NOT COMPLETED|Overall Study||0
8302197|NCT01540045|20469280|P1|COMPLETED|Overall Study||40
8302198|NCT01540045|20469280|P1|STARTED|Overall Study||40
8302199|NCT01539980|20469319|P1|NOT COMPLETED|Overall Study||0
8302200|NCT01539980|20469319|P1|COMPLETED|Overall Study||30
8302201|NCT01539980|20469319|P1|STARTED|Overall Study||30
8302202|NCT01539837|20469330|P3|NOT COMPLETED|Overall Study||2
8302203|NCT01539837|20469331|P2|NOT COMPLETED|Overall Study||1
8302204|NCT01539837|20469332|P1|NOT COMPLETED|Overall Study||0
8302205|NCT01539837|20469330|P3|COMPLETED|Overall Study||5
8302206|NCT01539837|20469331|P2|COMPLETED|Overall Study||6
8302207|NCT01539837|20469332|P1|COMPLETED|Overall Study||8
8302208|NCT01539837|20469330|P3|STARTED|Overall Study||7
8302209|NCT01539837|20469331|P2|STARTED|Overall Study||7
8302210|NCT01539837|20469332|P1|STARTED|Overall Study||8
8302211|NCT01539811|20469345|P2|NOT COMPLETED|Overall Study||0
8302212|NCT01539811|20469346|P1|NOT COMPLETED|Overall Study||0
8302213|NCT01539811|20469345|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302214|NCT01539811|20469346|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302215|NCT01539811|20469345|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302216|NCT01539811|20469346|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302217|NCT01539759|20469354|P2|NOT COMPLETED|Overall Study||8
8302218|NCT01539759|20469355|P1|NOT COMPLETED|Overall Study||6
8302219|NCT01539759|20469354|P2|COMPLETED|Overall Study||48
8302220|NCT01539759|20469355|P1|COMPLETED|Overall Study||50
8302221|NCT01539759|20469354|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
8302222|NCT01539759|20469355|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
8302223|NCT01539759|20469354|P2|IUD Removal|Overall Study||7
8302224|NCT01539759|20469355|P1|IUD Removal|Overall Study||2
8302225|NCT01539759|20469354|P2|IUD Expulsion|Overall Study||4
8302226|NCT01539759|20469355|P1|IUD Expulsion|Overall Study||1
8302227|NCT01539759|20469354|P2|Had Successful IUD Placement|Overall Study||53
8302228|NCT01539759|20469355|P1|Had Successful IUD Placement|Overall Study||34
8302229|NCT01539759|20469354|P2|STARTED|Overall Study||56
8302230|NCT01539759|20469355|P1|STARTED|Overall Study||56
8302231|NCT01539694|20469365|P2|NOT COMPLETED|Overall Study||1
8302232|NCT01539694|20469366|P1|NOT COMPLETED|Overall Study||1
8302233|NCT01539694|20469365|P2|COMPLETED|Overall Study||62
8302234|NCT01539694|20469366|P1|COMPLETED|Overall Study||62
8302235|NCT01539694|20469365|P2|STARTED|Overall Study||63
8302236|NCT01539694|20469366|P1|STARTED|Overall Study||63
8302237|NCT01539642|20469376|P2|NOT COMPLETED|Overall Study||31
8302238|NCT01539642|20469377|P1|NOT COMPLETED|Overall Study||36
8302239|NCT01539642|20469376|P2|COMPLETED|Overall Study||27
8302240|NCT01539642|20469377|P1|COMPLETED|Overall Study||78
8302241|NCT01539642|20469376|P2|STARTED|Overall Study||58
8302242|NCT01539642|20469377|P1|STARTED|Overall Study||114
8302243|NCT01539590|20469385|P2|NOT COMPLETED|Overall Study||0
8302244|NCT01539590|20469386|P1|NOT COMPLETED|Overall Study||3
8302245|NCT01539590|20469385|P2|COMPLETED|Overall Study||2
8302246|NCT01539590|20469386|P1|COMPLETED|Overall Study||0
8302247|NCT01539590|20469385|P2|Complete Study Treatment|Overall Study||2
8302248|NCT01539590|20469386|P1|Complete Study Treatment|Overall Study||1
8302249|NCT01539590|20469385|P2|STARTED|Overall Study||2
8302250|NCT01539590|20469386|P1|STARTED|Overall Study||3
8302251|NCT01539538|20469394|P2|NOT COMPLETED|Overall Study||44
8302252|NCT01539538|20469395|P1|NOT COMPLETED|Overall Study||31
8302253|NCT01539538|20469394|P2|COMPLETED|Overall Study||136
8302254|NCT01539538|20469395|P1|COMPLETED|Overall Study||146
8302255|NCT01539538|20469394|P2|STARTED|Overall Study||180
8302256|NCT01539538|20469395|P1|STARTED|Overall Study||177
8302257|NCT01539525|20469404|P3|NOT COMPLETED|Overall Study||17
8302258|NCT01539525|20469405|P2|NOT COMPLETED|Overall Study||16
8302259|NCT01539525|20469406|P1|NOT COMPLETED|Overall Study||20
8302260|NCT01539525|20469404|P3|COMPLETED|Overall Study||134
8302261|NCT01539525|20469405|P2|COMPLETED|Overall Study||127
8302262|NCT01539525|20469406|P1|COMPLETED|Overall Study||125
8302263|NCT01539525|20469404|P3|STARTED|Overall Study||151
8302264|NCT01539525|20469405|P2|STARTED|Overall Study||143
8302265|NCT01539525|20469406|P1|STARTED|Overall Study||145
8302266|NCT01539512|20469425|P2|NOT COMPLETED|Overall Study||13
8302267|NCT01539512|20469426|P1|NOT COMPLETED|Overall Study||23
8302268|NCT01539512|20469425|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
8302269|NCT01539512|20469426|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
8302270|NCT01539512|20469425|P2|STARTED|Overall Study||110
8302271|NCT01539512|20469426|P1|STARTED|Overall Study||110
8302272|NCT01539317|20469442|P2|NOT COMPLETED|Overall Study||0
8302273|NCT01539317|20469443|P1|NOT COMPLETED|Overall Study||1
8302274|NCT01539317|20469442|P2|COMPLETED|Overall Study||25
8302275|NCT01539317|20469443|P1|COMPLETED|Overall Study||24
8302276|NCT01539317|20469442|P2|STARTED|Overall Study||25
8302277|NCT01539317|20469443|P1|STARTED|Overall Study||25
8302278|NCT01539291|20469461|P4|NOT COMPLETED|Study GS-US-312-0117||26
8302279|NCT01539291|20469462|P3|NOT COMPLETED|Study GS-US-312-0117||22
8302280|NCT01539291|20469463|P2|NOT COMPLETED|Study GS-US-312-0117||2
8302281|NCT01539291|20469464|P1|NOT COMPLETED|Study GS-US-312-0117||41
8302282|NCT01539291|20469461|P4|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
8302283|NCT01539291|20469462|P3|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
8302284|NCT01539291|20469463|P2|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
8302285|NCT01539291|20469464|P1|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
8302286|NCT01539291|20469461|P4|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
8302287|NCT01539291|20469462|P3|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
8302288|NCT01539291|20469463|P2|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
8302289|NCT01539291|20469464|P1|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
8302290|NCT01539291|20469461|P4|NOT COMPLETED|Study GS-US-312-0116||0
8302291|NCT01539291|20469462|P3|NOT COMPLETED|Study GS-US-312-0116||0
8302292|NCT01539291|20469463|P2|NOT COMPLETED|Study GS-US-312-0116||0
8302293|NCT01539291|20469464|P1|NOT COMPLETED|Study GS-US-312-0116||25
8302294|NCT01539291|20469461|P4|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
8302295|NCT01539291|20469462|P3|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
8302296|NCT01539291|20469463|P2|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
8302297|NCT01539291|20469464|P1|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
8302298|NCT01539291|20469461|P4|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
8302299|NCT01539291|20469462|P3|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
8302300|NCT01539291|20469463|P2|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
8302301|NCT01539291|20469464|P1|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
8302302|NCT01539239|20469536|P2|NOT COMPLETED|Overall Study||17
8302303|NCT01539239|20469537|P1|NOT COMPLETED|Overall Study||12
8302304|NCT01539239|20469536|P2|COMPLETED|Overall Study||170
8302305|NCT01539239|20469537|P1|COMPLETED|Overall Study||357
8302306|NCT01539239|20469536|P2|STARTED|Overall Study||187
8302307|NCT01539239|20469537|P1|STARTED|Overall Study||369
8302308|NCT01539135|20469547|P2|NOT COMPLETED|Overall Study||0
8302309|NCT01539135|20469548|P1|NOT COMPLETED|Overall Study||0
8302310|NCT01539135|20469547|P2|COMPLETED|Overall Study||37
8302311|NCT01539135|20469548|P1|COMPLETED|Overall Study||43
8302312|NCT01539135|20469547|P2|STARTED|Overall Study||37
8302313|NCT01539135|20469548|P1|STARTED|Overall Study||43
8302314|NCT01539083|20469560|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
8302315|NCT01539083|20469561|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
8302316|NCT01539083|20469562|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
8302317|NCT01539083|20469560|P3|COMPLETED|After Randomization (TP and VTP)||80
8302318|NCT01539083|20469561|P2|COMPLETED|After Randomization (TP and VTP)||79
8302319|NCT01539083|20469562|P1|COMPLETED|After Randomization (TP and VTP)||0
8302320|NCT01539083|20469560|P3|Safety Population|After Randomization (TP and VTP)||103
8302321|NCT01539083|20469561|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
8302322|NCT01539083|20469562|P1|Safety Population|After Randomization (TP and VTP)||0
8302323|NCT01539083|20469560|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
8302324|NCT01539083|20469561|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
8302325|NCT01539083|20469562|P1|STARTED|After Randomization (TP and VTP)||0
8302326|NCT01539083|20469560|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
8302327|NCT01539083|20469561|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
8302328|NCT01539083|20469562|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
8302329|NCT01539083|20469560|P3|COMPLETED|Before Randomization (VCD Induction)||0
8302330|NCT01539083|20469561|P2|COMPLETED|Before Randomization (VCD Induction)||0
8302331|NCT01539083|20469562|P1|COMPLETED|Before Randomization (VCD Induction)||203
8302332|NCT01539083|20469560|P3|Treated|Before Randomization (VCD Induction)||0
8302333|NCT01539083|20469561|P2|Treated|Before Randomization (VCD Induction)||0
8302334|NCT01539083|20469562|P1|Treated|Before Randomization (VCD Induction)||254
8302335|NCT01539083|20469560|P3|STARTED|Before Randomization (VCD Induction)||0
8302336|NCT01539083|20469561|P2|STARTED|Before Randomization (VCD Induction)||0
8302337|NCT01539083|20469562|P1|STARTED|Before Randomization (VCD Induction)||256
8302338|NCT01539070|20469585|P2|NOT COMPLETED|Overall Study||39
8302339|NCT01539070|20469586|P1|NOT COMPLETED|Overall Study||59
8302340|NCT01539070|20469585|P2|COMPLETED|Overall Study||99
8302341|NCT01539070|20469586|P1|COMPLETED|Overall Study||109
8302342|NCT01539070|20469585|P2|STARTED|Overall Study||138
8302343|NCT01539070|20469586|P1|STARTED|Overall Study||168
8302344|NCT01538862|20469598|P1|NOT COMPLETED|Overall Study||0
8302345|NCT01538862|20469598|P1|COMPLETED|Overall Study||7
8302346|NCT01538862|20469598|P1|STARTED|Overall Study||7
8302347|NCT01538719|20469606|P2|NOT COMPLETED|Overall Study||0
8302348|NCT01538719|20469607|P1|NOT COMPLETED|Overall Study||2
8302349|NCT01538719|20469606|P2|COMPLETED|Overall Study||12
8302350|NCT01538719|20469607|P1|COMPLETED|Overall Study||5
8302351|NCT01538719|20469606|P2|STARTED|Overall Study||12
8302352|NCT01538719|20469607|P1|STARTED|Overall Study||7
8302353|NCT01538615|20469617|P2|NOT COMPLETED|Overall Study||12
8302354|NCT01538615|20469618|P1|NOT COMPLETED|Overall Study||22
8302355|NCT01538615|20469617|P2|COMPLETED|Overall Study||146
8302356|NCT01538615|20469618|P1|COMPLETED|Overall Study||140
8302357|NCT01538615|20469617|P2|STARTED|Overall Study||158
8302358|NCT01538615|20469618|P1|STARTED|Overall Study||162
8302359|NCT01538472|20469630|P1|NOT COMPLETED|Overall Study||4
8302360|NCT01538472|20469630|P1|COMPLETED|Overall Study||36
8302361|NCT01538472|20469630|P1|STARTED|Overall Study||40
8302362|NCT01538199|20469641|P4|NOT COMPLETED|Overall Study||2
8302363|NCT01538199|20469642|P3|NOT COMPLETED|Overall Study||1
8302364|NCT01538199|20469643|P2|NOT COMPLETED|Overall Study||3
8302365|NCT01538199|20469644|P1|NOT COMPLETED|Overall Study||2
8302366|NCT01538199|20469641|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
8302367|NCT01538199|20469642|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
8302368|NCT01538199|20469643|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
8302369|NCT01538199|20469644|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
8302370|NCT01538199|20469641|P4|STARTED|Overall Study||3
8302371|NCT01538199|20469642|P3|STARTED|Overall Study||4
8302372|NCT01538199|20469643|P2|STARTED|Overall Study||11
8302373|NCT01538199|20469644|P1|STARTED|Overall Study||10
8302374|NCT01537900|20469667|P1|NOT COMPLETED|Overall Study||0
8302375|NCT01537900|20469667|P1|COMPLETED|Overall Study||4
8302376|NCT01537900|20469667|P1|STARTED|Overall Study||4
8302377|NCT01537887|20469678|P6|NOT COMPLETED|Period 3||0
8302378|NCT01537887|20469679|P5|NOT COMPLETED|Period 3||0
8302379|NCT01537887|20469680|P4|NOT COMPLETED|Period 3||0
8302380|NCT01537887|20469681|P3|NOT COMPLETED|Period 3||1
8302381|NCT01537887|20469682|P2|NOT COMPLETED|Period 3||1
8302382|NCT01537887|20469683|P1|NOT COMPLETED|Period 3||0
8302383|NCT01537887|20469678|P6|COMPLETED|Period 3||11
8302384|NCT01537887|20469679|P5|COMPLETED|Period 3||11
8302385|NCT01537887|20469680|P4|COMPLETED|Period 3||12
8302386|NCT01537887|20469681|P3|COMPLETED|Period 3||10
8302387|NCT01537887|20469682|P2|COMPLETED|Period 3||10
8302388|NCT01537887|20469683|P1|COMPLETED|Period 3||12
8302389|NCT01537887|20469678|P6|STARTED|Period 3||11
8302390|NCT01537887|20469679|P5|STARTED|Period 3||11
8302391|NCT01537887|20469680|P4|STARTED|Period 3||12
8302392|NCT01537887|20469681|P3|STARTED|Period 3||11
8302393|NCT01537887|20469682|P2|STARTED|Period 3||11
8302394|NCT01537887|20469683|P1|STARTED|Period 3||12
8302395|NCT01537887|20469678|P6|NOT COMPLETED|Period 2||0
8302396|NCT01537887|20469679|P5|NOT COMPLETED|Period 2||0
8302397|NCT01537887|20469680|P4|NOT COMPLETED|Period 2||0
8302398|NCT01537887|20469681|P3|NOT COMPLETED|Period 2||0
8302399|NCT01537887|20469682|P2|NOT COMPLETED|Period 2||1
8302400|NCT01537887|20469683|P1|NOT COMPLETED|Period 2||0
8302401|NCT01537887|20469678|P6|COMPLETED|Period 2||11
8302402|NCT01537887|20469679|P5|COMPLETED|Period 2||11
8302403|NCT01537887|20469680|P4|COMPLETED|Period 2||12
8302404|NCT01537887|20469681|P3|COMPLETED|Period 2||11
8302405|NCT01537887|20469682|P2|COMPLETED|Period 2||11
8302406|NCT01537887|20469683|P1|COMPLETED|Period 2||12
8302407|NCT01537887|20469678|P6|STARTED|Period 2||11
8302408|NCT01537887|20469679|P5|STARTED|Period 2||11
8302409|NCT01537887|20469680|P4|STARTED|Period 2||12
8302410|NCT01537887|20469681|P3|STARTED|Period 2||11
8302411|NCT01537887|20469682|P2|STARTED|Period 2||12
8302412|NCT01537887|20469683|P1|STARTED|Period 2||12
8302413|NCT01537887|20469678|P6|NOT COMPLETED|Period 1||1
8302414|NCT01537887|20469679|P5|NOT COMPLETED|Period 1||1
8302415|NCT01537887|20469680|P4|NOT COMPLETED|Period 1||0
8302416|NCT01537887|20469681|P3|NOT COMPLETED|Period 1||1
8302417|NCT01537887|20469682|P2|NOT COMPLETED|Period 1||0
8302418|NCT01537887|20469683|P1|NOT COMPLETED|Period 1||0
8302419|NCT01537887|20469678|P6|COMPLETED|Period 1||11
8302420|NCT01537887|20469679|P5|COMPLETED|Period 1||11
8302421|NCT01537887|20469680|P4|COMPLETED|Period 1||12
8302422|NCT01537887|20469681|P3|COMPLETED|Period 1||11
8302423|NCT01537887|20469682|P2|COMPLETED|Period 1||12
8302424|NCT01537887|20469683|P1|COMPLETED|Period 1||12
8302425|NCT01537887|20469678|P6|Received at Least 1 Dose of Study Drug|Period 1||12
8302426|NCT01537887|20469679|P5|Received at Least 1 Dose of Study Drug|Period 1||12
8302427|NCT01537887|20469680|P4|Received at Least 1 Dose of Study Drug|Period 1||12
8302428|NCT01537887|20469681|P3|Received at Least 1 Dose of Study Drug|Period 1||11
8302429|NCT01537887|20469682|P2|Received at Least 1 Dose of Study Drug|Period 1||12
8302430|NCT01537887|20469683|P1|Received at Least 1 Dose of Study Drug|Period 1||12
8302431|NCT01537887|20469678|P6|STARTED|Period 1||12
8302432|NCT01537887|20469679|P5|STARTED|Period 1||12
8302433|NCT01537887|20469680|P4|STARTED|Period 1||12
8302434|NCT01537887|20469681|P3|STARTED|Period 1||12
8302435|NCT01537887|20469682|P2|STARTED|Period 1||12
8302436|NCT01537887|20469683|P1|STARTED|Period 1||12
8302437|NCT01537835|20469697|P3|NOT COMPLETED|Overall Study||0
8302438|NCT01537835|20469698|P2|NOT COMPLETED|Overall Study||0
8302439|NCT01537835|20469699|P1|NOT COMPLETED|Overall Study||0
8302440|NCT01537835|20469697|P3|COMPLETED|Overall Study||35
8302441|NCT01537835|20469698|P2|COMPLETED|Overall Study||37
8302442|NCT01537835|20469699|P1|COMPLETED|Overall Study||37
8302443|NCT01537835|20469697|P3|STARTED|Overall Study||35
8302444|NCT01537835|20469698|P2|STARTED|Overall Study||37
8302445|NCT01537835|20469699|P1|STARTED|Overall Study||37
8302446|NCT01537783|20469712|P2|NOT COMPLETED|Overall Study||2
8302447|NCT01537783|20469713|P1|NOT COMPLETED|Overall Study||11
8302448|NCT01537783|20469712|P2|COMPLETED|Overall Study||23
8302449|NCT01537783|20469713|P1|COMPLETED|Overall Study||14
8302450|NCT01537783|20469712|P2|STARTED|Overall Study||25
8302451|NCT01537783|20469713|P1|STARTED|Overall Study||25
8302452|NCT01537666|20469723|P4|NOT COMPLETED|Overall Study||0
8302453|NCT01537666|20469724|P3|NOT COMPLETED|Overall Study||0
8302454|NCT01537666|20469725|P2|NOT COMPLETED|Overall Study||0
8302455|NCT01537666|20469726|P1|NOT COMPLETED|Overall Study||0
8302456|NCT01537666|20469723|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
8302457|NCT01537666|20469724|P3|COMPLETED|Overall Study||6
8302458|NCT01537666|20469725|P2|COMPLETED|Overall Study||6
8302459|NCT01537666|20469726|P1|COMPLETED|Overall Study||6
8302460|NCT01537666|20469723|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
8302461|NCT01537666|20469724|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8302462|NCT01537666|20469725|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8302463|NCT01537666|20469726|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8302464|NCT01537549|20469764|P1|NOT COMPLETED|Overall Study||3
8302465|NCT01537549|20469764|P1|COMPLETED|Overall Study||8
8302466|NCT01537549|20469764|P1|STARTED|Overall Study||11
8302467|NCT01537432|20469772|P2|NOT COMPLETED|Overall Study||2
8302468|NCT01537432|20469773|P1|NOT COMPLETED|Overall Study||6
8302469|NCT01537432|20469772|P2|COMPLETED|Overall Study||10
8302470|NCT01537432|20469773|P1|COMPLETED|Overall Study||18
8302471|NCT01537432|20469772|P2|STARTED|Overall Study||12
8302472|NCT01537432|20469773|P1|STARTED|Overall Study||24
8302473|NCT01537419|20469783|P2|NOT COMPLETED|Overall Study||12
8302474|NCT01537419|20469784|P1|NOT COMPLETED|Overall Study||11
8302475|NCT01537419|20469783|P2|COMPLETED|Overall Study||54
8302476|NCT01537419|20469784|P1|COMPLETED|Overall Study||52
8302477|NCT01537419|20469783|P2|STARTED|Overall Study||66
8302478|NCT01537419|20469784|P1|STARTED|Overall Study||63
8302479|NCT01537393|20469796|P2|NOT COMPLETED|Overall Study||191
8302480|NCT01537393|20469797|P1|NOT COMPLETED|Overall Study||154
8302481|NCT01537393|20469796|P2|COMPLETED|Overall Study||507
8302482|NCT01537393|20469797|P1|COMPLETED|Overall Study||553
8302483|NCT01537393|20469796|P2|STARTED|Overall Study||698
8302484|NCT01537393|20469797|P1|STARTED|Overall Study||707
8302485|NCT01537367|20469808|P3|NOT COMPLETED|Overall Study||0
8302486|NCT01537367|20469809|P2|NOT COMPLETED|Overall Study||0
8302487|NCT01537367|20469810|P1|NOT COMPLETED|Overall Study||0
8302488|NCT01537367|20469808|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
8302489|NCT01537367|20469809|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
8302490|NCT01537367|20469810|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
8302491|NCT01537367|20469808|P3|STARTED|Overall Study||613
8302492|NCT01537367|20469809|P2|STARTED|Overall Study||610
8302493|NCT01537367|20469810|P1|STARTED|Overall Study||615
8302494|NCT01537315|20469826|P2|NOT COMPLETED|Overall Study||0
8302495|NCT01537315|20469827|P1|NOT COMPLETED|Overall Study||0
8302496|NCT01537315|20469826|P2|COMPLETED|Overall Study||7
8302497|NCT01537315|20469827|P1|COMPLETED|Overall Study||1
8302498|NCT01537315|20469826|P2|STARTED|Overall Study||7
8302499|NCT01537315|20469827|P1|STARTED|Overall Study||1
8302500|NCT01537302|20469833|P1|NOT COMPLETED|Overall Study||2
8302501|NCT01537302|20469833|P1|COMPLETED|Overall Study||199
8302502|NCT01537302|20469833|P1|STARTED|Overall Study||201
8302503|NCT01537211|20469842|P2|NOT COMPLETED|Overall Study||1
8302504|NCT01537211|20469843|P1|NOT COMPLETED|Overall Study||0
8302505|NCT01537211|20469842|P2|COMPLETED|Overall Study||5
8302506|NCT01537211|20469843|P1|COMPLETED|Overall Study||4
8302507|NCT01537211|20469842|P2|STARTED|Overall Study||6
8302508|NCT01537211|20469843|P1|STARTED|Overall Study||4
8302509|NCT01537198|20469877|P1|NOT COMPLETED|Overall Study||154
8302510|NCT01537198|20469877|P1|COMPLETED|Overall Study||463
8302511|NCT01537198|20469877|P1|STARTED|Overall Study||617
8302512|NCT01537185|20469885|P4|NOT COMPLETED|Overall Study||2
8302513|NCT01537185|20469886|P3|NOT COMPLETED|Overall Study||6
8302514|NCT01537185|20469887|P2|NOT COMPLETED|Overall Study||6
8302515|NCT01537185|20469888|P1|NOT COMPLETED|Overall Study||3
8302516|NCT01537185|20469885|P4|COMPLETED|Overall Study||8
8302517|NCT01537185|20469886|P3|COMPLETED|Overall Study||4
8302518|NCT01537185|20469887|P2|COMPLETED|Overall Study||6
8302519|NCT01537185|20469888|P1|COMPLETED|Overall Study||7
8302520|NCT01537185|20469885|P4|STARTED|Overall Study||10
8302521|NCT01537185|20469886|P3|STARTED|Overall Study||10
8302522|NCT01537185|20469887|P2|STARTED|Overall Study||12
8302523|NCT01537185|20469888|P1|STARTED|Overall Study||10
8302524|NCT01537133|20469906|P4|NOT COMPLETED|Overall Study||0
8302525|NCT01537133|20469907|P3|NOT COMPLETED|Overall Study||0
8302526|NCT01537133|20469908|P2|NOT COMPLETED|Overall Study||0
8302527|NCT01537133|20469909|P1|NOT COMPLETED|Overall Study||3
8302528|NCT01537133|20469906|P4|COMPLETED|Overall Study||21
8302529|NCT01537133|20469907|P3|COMPLETED|Overall Study||21
8302530|NCT01537133|20469908|P2|COMPLETED|Overall Study||14
8302531|NCT01537133|20469909|P1|COMPLETED|Overall Study||25
8302532|NCT01537133|20469906|P4|STARTED|Overall Study||21
8302533|NCT01537133|20469907|P3|STARTED|Overall Study||21
8302534|NCT01537133|20469908|P2|STARTED|Overall Study||14
8302535|NCT01537133|20469909|P1|STARTED|Overall Study||28
8302536|NCT01537120|20469925|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
8302537|NCT01537120|20469925|P1|COMPLETED|12 Weeks Vildagliptin||23
8302538|NCT01537120|20469925|P1|STARTED|12 Weeks Vildagliptin||23
8302539|NCT01537120|20469925|P1|NOT COMPLETED|3 Weeks Placebo||1
8302540|NCT01537120|20469925|P1|COMPLETED|3 Weeks Placebo||23
8302541|NCT01537120|20469925|P1|STARTED|3 Weeks Placebo||24
8302542|NCT01537120|20469925|P1|NOT COMPLETED|8 Weeks Washout||1
8302543|NCT01537120|20469925|P1|COMPLETED|8 Weeks Washout||24
8302544|NCT01537120|20469925|P1|STARTED|8 Weeks Washout||25
8302545|NCT01537120|20469925|P1|NOT COMPLETED|Enrolled||0
8302546|NCT01537120|20469925|P1|COMPLETED|Enrolled||25
8302547|NCT01537120|20469925|P1|STARTED|Enrolled||25
8302548|NCT01537081|20469938|P3|NOT COMPLETED|Overall Study||16
8302549|NCT01537081|20469939|P2|NOT COMPLETED|Overall Study||38
8302550|NCT01537081|20469940|P1|NOT COMPLETED|Overall Study||39
8302551|NCT01537081|20469938|P3|COMPLETED|Overall Study||547
8302552|NCT01537081|20469939|P2|COMPLETED|Overall Study||1086
8302553|NCT01537081|20469940|P1|COMPLETED|Overall Study||1084
8302554|NCT01537081|20469938|P3|Modified Intent to Treat Population|Overall Study||556
8302555|NCT01537081|20469939|P2|Modified Intent to Treat Population|Overall Study||1109
8302556|NCT01537081|20469940|P1|Modified Intent to Treat Population|Overall Study||1106
8302557|NCT01537081|20469938|P3|Safety Population|Overall Study||561
8302558|NCT01537081|20469939|P2|Safety Population|Overall Study||1122
8302559|NCT01537081|20469940|P1|Safety Population|Overall Study||1122
8302560|NCT01537081|20469938|P3|STARTED|Overall Study||563
8302561|NCT01537081|20469939|P2|STARTED|Overall Study||1124
8302562|NCT01537081|20469940|P1|STARTED|Overall Study||1123
8302563|NCT01537068|20469953|P2|NOT COMPLETED|Overall Study||3
8302564|NCT01537068|20469954|P1|NOT COMPLETED|Overall Study||4
8302565|NCT01537068|20469953|P2|COMPLETED|Overall Study||26
8302566|NCT01537068|20469954|P1|COMPLETED|Overall Study||26
8302567|NCT01537068|20469953|P2|STARTED|Overall Study||29
8302568|NCT01537068|20469954|P1|STARTED|Overall Study||30
8302569|NCT01537042|20469966|P2|NOT COMPLETED|Overall Study||5
8302570|NCT01537042|20469967|P1|NOT COMPLETED|Overall Study||0
8302571|NCT01537042|20469966|P2|COMPLETED|Overall Study||15
8302572|NCT01537042|20469967|P1|COMPLETED|Overall Study||10
8302573|NCT01537042|20469966|P2|STARTED|Overall Study||20
8302574|NCT01537042|20469967|P1|STARTED|Overall Study||10
8302575|NCT01537029|20470003|P1|NOT COMPLETED|Overall Study||0
8302576|NCT01537029|20470003|P1|COMPLETED|Overall Study||15
8302577|NCT01537029|20470003|P1|STARTED|Overall Study||15
8302578|NCT01536951|20470009|P9|NOT COMPLETED|Third Intervention||0
8302579|NCT01536951|20470010|P8|NOT COMPLETED|Third Intervention||0
8302580|NCT01536951|20470011|P7|NOT COMPLETED|Third Intervention||0
8302581|NCT01536951|20470012|P6|NOT COMPLETED|Third Intervention||0
8302582|NCT01536951|20470013|P5|NOT COMPLETED|Third Intervention||0
8302583|NCT01536951|20470014|P4|NOT COMPLETED|Third Intervention||0
8302584|NCT01536951|20470015|P3|NOT COMPLETED|Third Intervention||0
8302585|NCT01536951|20470016|P2|NOT COMPLETED|Third Intervention||0
8302586|NCT01536951|20470017|P1|NOT COMPLETED|Third Intervention||0
8302587|NCT01536951|20470009|P9|COMPLETED|Third Intervention||9
8302588|NCT01536951|20470010|P8|COMPLETED|Third Intervention||8
8302589|NCT01536951|20470011|P7|COMPLETED|Third Intervention||9
8302590|NCT01536951|20470012|P6|COMPLETED|Third Intervention||9
8302591|NCT01536951|20470013|P5|COMPLETED|Third Intervention||9
8302592|NCT01536951|20470014|P4|COMPLETED|Third Intervention||8
8302593|NCT01536951|20470015|P3|COMPLETED|Third Intervention||2
8302594|NCT01536951|20470016|P2|COMPLETED|Third Intervention||3
8302595|NCT01536951|20470017|P1|COMPLETED|Third Intervention||3
8302596|NCT01536951|20470009|P9|STARTED|Third Intervention||9
8302597|NCT01536951|20470010|P8|STARTED|Third Intervention||8
8302598|NCT01536951|20470011|P7|STARTED|Third Intervention||9
8302599|NCT01536951|20470012|P6|STARTED|Third Intervention||9
8302600|NCT01536951|20470013|P5|STARTED|Third Intervention||9
8302601|NCT01536951|20470014|P4|STARTED|Third Intervention||8
8302602|NCT01536951|20470015|P3|STARTED|Third Intervention||2
8302603|NCT01536951|20470016|P2|STARTED|Third Intervention||3
8302604|NCT01536951|20470017|P1|STARTED|Third Intervention||3
8302605|NCT01536951|20470009|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302606|NCT01536951|20470010|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
8302607|NCT01536951|20470011|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302608|NCT01536951|20470012|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302609|NCT01536951|20470013|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302610|NCT01536951|20470014|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302611|NCT01536951|20470015|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302612|NCT01536951|20470016|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302613|NCT01536951|20470017|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302614|NCT01536951|20470009|P9|COMPLETED|Second Intervention and Washout Period 2||9
8302615|NCT01536951|20470010|P8|COMPLETED|Second Intervention and Washout Period 2||8
8302616|NCT01536951|20470011|P7|COMPLETED|Second Intervention and Washout Period 2||9
8302617|NCT01536951|20470012|P6|COMPLETED|Second Intervention and Washout Period 2||9
8302618|NCT01536951|20470013|P5|COMPLETED|Second Intervention and Washout Period 2||9
8302619|NCT01536951|20470014|P4|COMPLETED|Second Intervention and Washout Period 2||8
8302620|NCT01536951|20470015|P3|COMPLETED|Second Intervention and Washout Period 2||2
8302621|NCT01536951|20470016|P2|COMPLETED|Second Intervention and Washout Period 2||3
8302622|NCT01536951|20470017|P1|COMPLETED|Second Intervention and Washout Period 2||3
8302623|NCT01536951|20470009|P9|STARTED|Second Intervention and Washout Period 2||9
8302624|NCT01536951|20470010|P8|STARTED|Second Intervention and Washout Period 2||9
8302625|NCT01536951|20470011|P7|STARTED|Second Intervention and Washout Period 2||9
8302626|NCT01536951|20470012|P6|STARTED|Second Intervention and Washout Period 2||9
8302627|NCT01536951|20470013|P5|STARTED|Second Intervention and Washout Period 2||9
8302628|NCT01536951|20470014|P4|STARTED|Second Intervention and Washout Period 2||8
8302629|NCT01536951|20470015|P3|STARTED|Second Intervention and Washout Period 2||2
8302630|NCT01536951|20470016|P2|STARTED|Second Intervention and Washout Period 2||3
8302631|NCT01536951|20470017|P1|STARTED|Second Intervention and Washout Period 2||3
8302632|NCT01536951|20470009|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
8302633|NCT01536951|20470010|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
8302634|NCT01536951|20470011|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
8302635|NCT01536951|20470012|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
8302636|NCT01536951|20470013|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
8302637|NCT01536951|20470014|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
8302638|NCT01536951|20470015|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
8302639|NCT01536951|20470016|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
8302640|NCT01536951|20470017|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
8302641|NCT01536951|20470009|P9|COMPLETED|First Intervention and Washout Period 1||9
8302642|NCT01536951|20470010|P8|COMPLETED|First Intervention and Washout Period 1||9
8302643|NCT01536951|20470011|P7|COMPLETED|First Intervention and Washout Period 1||9
8302644|NCT01536951|20470012|P6|COMPLETED|First Intervention and Washout Period 1||9
8302645|NCT01536951|20470013|P5|COMPLETED|First Intervention and Washout Period 1||9
8302646|NCT01536951|20470014|P4|COMPLETED|First Intervention and Washout Period 1||8
8302647|NCT01536951|20470015|P3|COMPLETED|First Intervention and Washout Period 1||2
8302648|NCT01536951|20470016|P2|COMPLETED|First Intervention and Washout Period 1||3
8302649|NCT01536951|20470017|P1|COMPLETED|First Intervention and Washout Period 1||3
8302650|NCT01536951|20470009|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302651|NCT01536951|20470010|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302652|NCT01536951|20470011|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302653|NCT01536951|20470012|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302654|NCT01536951|20470013|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302655|NCT01536951|20470014|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
8302656|NCT01536951|20470015|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
8302657|NCT01536951|20470016|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
8302658|NCT01536951|20470017|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
8302659|NCT01536951|20470009|P9|STARTED|First Intervention and Washout Period 1||9
8302660|NCT01536951|20470010|P8|STARTED|First Intervention and Washout Period 1||9
8302661|NCT01536951|20470011|P7|STARTED|First Intervention and Washout Period 1||9
8302662|NCT01536951|20470012|P6|STARTED|First Intervention and Washout Period 1||9
8302663|NCT01536951|20470013|P5|STARTED|First Intervention and Washout Period 1||9
8302664|NCT01536951|20470014|P4|STARTED|First Intervention and Washout Period 1||8
8302665|NCT01536951|20470015|P3|STARTED|First Intervention and Washout Period 1||3
8302666|NCT01536951|20470016|P2|STARTED|First Intervention and Washout Period 1||3
8302667|NCT01536951|20470017|P1|STARTED|First Intervention and Washout Period 1||3
8302668|NCT01536938|20470047|P3|NOT COMPLETED|Overall Study||8
8302669|NCT01536938|20470048|P2|NOT COMPLETED|Overall Study||7
8302670|NCT01536938|20470049|P1|NOT COMPLETED|Overall Study||6
8302671|NCT01536938|20470047|P3|COMPLETED|Overall Study||93
8302672|NCT01536938|20470048|P2|COMPLETED|Overall Study||94
8302673|NCT01536938|20470049|P1|COMPLETED|Overall Study||94
8302674|NCT01536938|20470047|P3|STARTED|Overall Study||101
8302675|NCT01536938|20470048|P2|STARTED|Overall Study||101
8302676|NCT01536938|20470049|P1|STARTED|Overall Study||100
8302677|NCT01536886|20470061|P4|NOT COMPLETED|Overall Study||3
8302678|NCT01536886|20470062|P3|NOT COMPLETED|Overall Study||2
8302679|NCT01536886|20470063|P2|NOT COMPLETED|Overall Study||8
8302680|NCT01536886|20470064|P1|NOT COMPLETED|Overall Study||5
8302681|NCT01536886|20470061|P4|COMPLETED|Overall Study||48
8302682|NCT01536886|20470062|P3|COMPLETED|Overall Study||47
8302683|NCT01536886|20470063|P2|COMPLETED|Overall Study||127
8302684|NCT01536886|20470064|P1|COMPLETED|Overall Study||136
8302685|NCT01536886|20470061|P4|STARTED|Overall Study||51
8302686|NCT01536886|20470062|P3|STARTED|Overall Study||49
8302687|NCT01536886|20470063|P2|STARTED|Overall Study||135
8302688|NCT01536886|20470064|P1|STARTED|Overall Study||141
8302689|NCT01536860|20470074|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8302690|NCT01536860|20470075|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8302691|NCT01536860|20470076|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8302692|NCT01536860|20470074|P3|COMPLETED|Third Intervention (1 Day)||4
8302693|NCT01536860|20470075|P2|COMPLETED|Third Intervention (1 Day)||4
8302694|NCT01536860|20470076|P1|COMPLETED|Third Intervention (1 Day)||3
8302695|NCT01536860|20470074|P3|STARTED|Third Intervention (1 Day)||4
8302696|NCT01536860|20470075|P2|STARTED|Third Intervention (1 Day)||4
8302697|NCT01536860|20470076|P1|STARTED|Third Intervention (1 Day)||3
8302698|NCT01536860|20470074|P3|NOT COMPLETED|Washout Period (3 Days)||0
8302699|NCT01536860|20470075|P2|NOT COMPLETED|Washout Period (3 Days)||0
8302700|NCT01536860|20470076|P1|NOT COMPLETED|Washout Period (3 Days)||1
8302701|NCT01536860|20470074|P3|COMPLETED|Washout Period (3 Days)||4
8302702|NCT01536860|20470075|P2|COMPLETED|Washout Period (3 Days)||4
8302703|NCT01536860|20470076|P1|COMPLETED|Washout Period (3 Days)||3
8302704|NCT01536860|20470074|P3|STARTED|Washout Period (3 Days)||4
8302705|NCT01536860|20470075|P2|STARTED|Washout Period (3 Days)||4
8302706|NCT01536860|20470076|P1|STARTED|Washout Period (3 Days)||4
8302707|NCT01536860|20470074|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8302708|NCT01536860|20470075|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8302709|NCT01536860|20470076|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8302710|NCT01536860|20470074|P3|COMPLETED|Second Intervention (1 Day)||4
8302711|NCT01536860|20470075|P2|COMPLETED|Second Intervention (1 Day)||4
8302712|NCT01536860|20470076|P1|COMPLETED|Second Intervention (1 Day)||4
8302713|NCT01536860|20470074|P3|STARTED|Second Intervention (1 Day)||4
8302714|NCT01536860|20470075|P2|STARTED|Second Intervention (1 Day)||4
8302715|NCT01536860|20470076|P1|STARTED|Second Intervention (1 Day)||4
8302716|NCT01536860|20470074|P3|NOT COMPLETED|Washout Period (3 Days)||0
8302717|NCT01536860|20470075|P2|NOT COMPLETED|Washout Period (3 Days)||0
8302718|NCT01536860|20470076|P1|NOT COMPLETED|Washout Period (3 Days)||0
8302719|NCT01536860|20470074|P3|COMPLETED|Washout Period (3 Days)||4
8302720|NCT01536860|20470075|P2|COMPLETED|Washout Period (3 Days)||4
8302721|NCT01536860|20470076|P1|COMPLETED|Washout Period (3 Days)||4
8302722|NCT01536860|20470074|P3|STARTED|Washout Period (3 Days)||4
8302723|NCT01536860|20470075|P2|STARTED|Washout Period (3 Days)||4
8302724|NCT01536860|20470076|P1|STARTED|Washout Period (3 Days)||4
8302725|NCT01536860|20470074|P3|NOT COMPLETED|First Intervention (1 Day)||0
8302726|NCT01536860|20470075|P2|NOT COMPLETED|First Intervention (1 Day)||0
8302727|NCT01536860|20470076|P1|NOT COMPLETED|First Intervention (1 Day)||0
8302728|NCT01536860|20470074|P3|COMPLETED|First Intervention (1 Day)||4
8302729|NCT01536860|20470075|P2|COMPLETED|First Intervention (1 Day)||4
8302730|NCT01536860|20470076|P1|COMPLETED|First Intervention (1 Day)||4
8302731|NCT01536860|20470074|P3|STARTED|First Intervention (1 Day)||4
8302732|NCT01536860|20470075|P2|STARTED|First Intervention (1 Day)||4
8302733|NCT01536860|20470076|P1|STARTED|First Intervention (1 Day)||4
8302740|NCT01536704|20470101|P4|NOT COMPLETED|Period 4||0
8302741|NCT01536704|20470102|P3|NOT COMPLETED|Period 4||0
8302742|NCT01536704|20470103|P2|NOT COMPLETED|Period 4||0
8302743|NCT01536704|20470104|P1|NOT COMPLETED|Period 4||0
8302744|NCT01536704|20470101|P4|COMPLETED|Period 4||10
8302745|NCT01536704|20470102|P3|COMPLETED|Period 4||10
8302746|NCT01536704|20470103|P2|COMPLETED|Period 4||11
8302747|NCT01536704|20470104|P1|COMPLETED|Period 4||12
8302748|NCT01536704|20470101|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8302834|NCT01536561|20470192|P1|COMPLETED|Long-Term Follow-Up||13
8302749|NCT01536704|20470102|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8302750|NCT01536704|20470103|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8302751|NCT01536704|20470104|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
8302752|NCT01536704|20470101|P4|NOT COMPLETED|Washout Period 3||0
8302753|NCT01536704|20470102|P3|NOT COMPLETED|Washout Period 3||1
8302754|NCT01536704|20470103|P2|NOT COMPLETED|Washout Period 3||0
8302755|NCT01536704|20470104|P1|NOT COMPLETED|Washout Period 3||0
8302756|NCT01536704|20470101|P4|COMPLETED|Washout Period 3||10
8302757|NCT01536704|20470102|P3|COMPLETED|Washout Period 3||11
8302758|NCT01536704|20470103|P2|COMPLETED|Washout Period 3||12
8302759|NCT01536704|20470104|P1|COMPLETED|Washout Period 3||10
8302760|NCT01536704|20470101|P4|STARTED|Washout Period 3||10
8302761|NCT01536704|20470102|P3|STARTED|Washout Period 3||12
8302762|NCT01536704|20470103|P2|STARTED|Washout Period 3||12
8302763|NCT01536704|20470104|P1|STARTED|Washout Period 3||10
8302764|NCT01536704|20470101|P4|NOT COMPLETED|Period 3||1
8302765|NCT01536704|20470102|P3|NOT COMPLETED|Period 3||0
8302766|NCT01536704|20470103|P2|NOT COMPLETED|Period 3||0
8302767|NCT01536704|20470104|P1|NOT COMPLETED|Period 3||0
8302768|NCT01536704|20470101|P4|COMPLETED|Period 3||10
8302769|NCT01536704|20470102|P3|COMPLETED|Period 3||12
8302770|NCT01536704|20470103|P2|COMPLETED|Period 3||12
8302771|NCT01536704|20470104|P1|COMPLETED|Period 3||10
8302772|NCT01536704|20470101|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
8302773|NCT01536704|20470102|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8302774|NCT01536704|20470103|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8302775|NCT01536704|20470104|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
8302776|NCT01536704|20470101|P4|NOT COMPLETED|Washout Period 2||1
8302777|NCT01536704|20470102|P3|NOT COMPLETED|Washout Period 2||0
8302778|NCT01536704|20470103|P2|NOT COMPLETED|Washout Period 2||0
8302779|NCT01536704|20470104|P1|NOT COMPLETED|Washout Period 2||1
8302780|NCT01536704|20470101|P4|COMPLETED|Washout Period 2||12
8302781|NCT01536704|20470102|P3|COMPLETED|Washout Period 2||10
8302782|NCT01536704|20470103|P2|COMPLETED|Washout Period 2||11
8302783|NCT01536704|20470104|P1|COMPLETED|Washout Period 2||12
8302784|NCT01536704|20470101|P4|STARTED|Washout Period 2||13
8302785|NCT01536704|20470102|P3|STARTED|Washout Period 2||10
8302786|NCT01536704|20470103|P2|STARTED|Washout Period 2||11
8302787|NCT01536704|20470104|P1|STARTED|Washout Period 2||13
8302788|NCT01536704|20470101|P4|NOT COMPLETED|Period 2||0
8302789|NCT01536704|20470102|P3|NOT COMPLETED|Period 2||0
8302790|NCT01536704|20470103|P2|NOT COMPLETED|Period 2||0
8302791|NCT01536704|20470104|P1|NOT COMPLETED|Period 2||0
8302792|NCT01536704|20470101|P4|COMPLETED|Period 2||13
8302793|NCT01536704|20470102|P3|COMPLETED|Period 2||10
8302794|NCT01536704|20470103|P2|COMPLETED|Period 2||11
8302795|NCT01536704|20470104|P1|COMPLETED|Period 2||13
8302796|NCT01536704|20470101|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8302797|NCT01536704|20470102|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
8302798|NCT01536704|20470103|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
8302799|NCT01536704|20470104|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8302800|NCT01536704|20470101|P4|NOT COMPLETED|Washout Period 1||0
8302801|NCT01536704|20470102|P3|NOT COMPLETED|Washout Period 1||0
8302802|NCT01536704|20470103|P2|NOT COMPLETED|Washout Period 1||2
8302803|NCT01536704|20470104|P1|NOT COMPLETED|Washout Period 1||1
8302804|NCT01536704|20470101|P4|COMPLETED|Washout Period 1||13
8302805|NCT01536704|20470102|P3|COMPLETED|Washout Period 1||13
8302806|NCT01536704|20470103|P2|COMPLETED|Washout Period 1||10
8302807|NCT01536704|20470104|P1|COMPLETED|Washout Period 1||11
8302808|NCT01536704|20470101|P4|STARTED|Washout Period 1||13
8302809|NCT01536704|20470102|P3|STARTED|Washout Period 1||13
8302810|NCT01536704|20470103|P2|STARTED|Washout Period 1||12
8302811|NCT01536704|20470104|P1|STARTED|Washout Period 1||12
8302812|NCT01536704|20470101|P4|NOT COMPLETED|Period 1||0
8302813|NCT01536704|20470102|P3|NOT COMPLETED|Period 1||0
8302814|NCT01536704|20470103|P2|NOT COMPLETED|Period 1||0
8302815|NCT01536704|20470104|P1|NOT COMPLETED|Period 1||0
8302816|NCT01536704|20470101|P4|COMPLETED|Period 1||13
8302817|NCT01536704|20470102|P3|COMPLETED|Period 1||13
8302818|NCT01536704|20470103|P2|COMPLETED|Period 1||12
8302819|NCT01536704|20470104|P1|COMPLETED|Period 1||12
8302820|NCT01536704|20470101|P4|STARTED|Period 1||13
8302821|NCT01536704|20470102|P3|STARTED|Period 1||13
8302822|NCT01536704|20470103|P2|STARTED|Period 1||12
8302823|NCT01536704|20470104|P1|STARTED|Period 1||12
8302824|NCT01536587|20470134|P1|NOT COMPLETED|Overall Study||2
8302825|NCT01536587|20470134|P1|COMPLETED|Overall Study||30
8302826|NCT01536587|20470134|P1|STARTED|Overall Study||32
8302827|NCT01536574|20470173|P2|NOT COMPLETED|Overall Study||7
8302828|NCT01536574|20470174|P1|NOT COMPLETED|Overall Study||6
8302829|NCT01536574|20470173|P2|COMPLETED|Overall Study||126
8302830|NCT01536574|20470174|P1|COMPLETED|Overall Study||156
8302831|NCT01536574|20470173|P2|STARTED|Overall Study||133
8302832|NCT01536574|20470174|P1|STARTED|Overall Study||162
8302833|NCT01536561|20470192|P1|NOT COMPLETED|Long-Term Follow-Up||0
8302835|NCT01536561|20470192|P1|STARTED|Long-Term Follow-Up||13
8302836|NCT01536561|20470192|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
8302837|NCT01536561|20470192|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8302838|NCT01536561|20470192|P1|STARTED|Dosimetric and Therapeutic Treatment||59
8302839|NCT01536535|20470232|P2|NOT COMPLETED|Overall Study||13
8302840|NCT01536535|20470233|P1|NOT COMPLETED|Overall Study||15
8302841|NCT01536535|20470232|P2|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
8302842|NCT01536535|20470233|P1|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
8302843|NCT01536535|20470232|P2|STARTED|Overall Study||250
8302844|NCT01536535|20470233|P1|STARTED|Overall Study||178
8302845|NCT01536496|20470245|P2|NOT COMPLETED|Overall Study||1
8302846|NCT01536496|20470246|P1|NOT COMPLETED|Overall Study||2
8302847|NCT01536496|20470245|P2|COMPLETED|Overall Study||56
8302848|NCT01536496|20470246|P1|COMPLETED|Overall Study||55
8302849|NCT01536496|20470245|P2|STARTED|Overall Study||57
8302850|NCT01536496|20470246|P1|STARTED|Overall Study||57
8302851|NCT01536418|20470282|P2|NOT COMPLETED|Overall Study||66
8302852|NCT01536418|20470283|P1|NOT COMPLETED|Overall Study||69
8302853|NCT01536418|20470282|P2|COMPLETED|Overall Study||60
8302854|NCT01536418|20470283|P1|COMPLETED|Overall Study||58
8302855|NCT01536418|20470282|P2|STARTED|Overall Study||126
8302856|NCT01536418|20470283|P1|STARTED|Overall Study||127
8302857|NCT01536405|20470303|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
8302858|NCT01536405|20470304|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
8302859|NCT01536405|20470303|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
8302860|NCT01536405|20470304|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
8302861|NCT01536405|20470303|P2|STARTED|Visit 4 to Extended Study Follow-up||618
8302862|NCT01536405|20470304|P1|STARTED|Visit 4 to Extended Study Follow-up||615
8302863|NCT01536405|20470303|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
8302864|NCT01536405|20470304|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
8302865|NCT01536405|20470303|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
8302866|NCT01536405|20470304|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
8302867|NCT01536405|20470303|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
8302868|NCT01536405|20470304|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
8302869|NCT01536405|20470303|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
8302870|NCT01536405|20470304|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
8302871|NCT01536405|20470303|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
8302872|NCT01536405|20470304|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
8302873|NCT01536405|20470303|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
8302874|NCT01536405|20470304|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
8302875|NCT01536405|20470303|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
8302876|NCT01536405|20470304|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
8302877|NCT01536405|20470303|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
8302878|NCT01536405|20470304|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
8302879|NCT01536405|20470303|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
8302880|NCT01536405|20470304|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
8302881|NCT01536405|20470303|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
8302882|NCT01536405|20470304|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
8302883|NCT01536405|20470303|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
8302884|NCT01536405|20470304|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
8302885|NCT01536405|20470303|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
8302886|NCT01536405|20470304|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
8302887|NCT01536405|20470303|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
8302888|NCT01536405|20470304|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
8302889|NCT01536405|20470303|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
8302890|NCT01536405|20470304|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
8302891|NCT01536379|20470342|P2|NOT COMPLETED|Overall Study||3
8302892|NCT01536379|20470343|P1|NOT COMPLETED|Overall Study||2
8302893|NCT01536379|20470342|P2|COMPLETED|Overall Study||9
8302894|NCT01536379|20470343|P1|COMPLETED|Overall Study||11
8302895|NCT01536379|20470342|P2|STARTED|Overall Study||12
8302896|NCT01536379|20470343|P1|STARTED|Overall Study||13
8302897|NCT01536366|20470419|P2|NOT COMPLETED|Overall Study||4
8302898|NCT01536366|20470420|P1|NOT COMPLETED|Overall Study||13
8302899|NCT01536366|20470419|P2|COMPLETED|Overall Study||9
8302900|NCT01536366|20470420|P1|COMPLETED|Overall Study||1
8302901|NCT01536366|20470419|P2|Follow-up|Overall Study||9
8302902|NCT01536366|20470420|P1|Follow-up|Overall Study||13
8302903|NCT01536366|20470419|P2|Repaglinide|Overall Study||13
8302904|NCT01536366|20470420|P1|Repaglinide|Overall Study||14
8302905|NCT01536366|20470419|P2|BIA 9-1067 + Repaglinide|Overall Study||10
8302906|NCT01536366|20470420|P1|BIA 9-1067 + Repaglinide|Overall Study||14
8302907|NCT01536366|20470419|P2|STARTED|Overall Study||13
8302908|NCT01536366|20470420|P1|STARTED|Overall Study||14
8302909|NCT01536262|20470435|P3|NOT COMPLETED|Overall Study||2
8302910|NCT01536262|20470436|P2|NOT COMPLETED|Overall Study||2
8302911|NCT01536262|20470437|P1|NOT COMPLETED|Overall Study||8
8302912|NCT01536262|20470435|P3|COMPLETED|Overall Study||39
8302913|NCT01536262|20470436|P2|COMPLETED|Overall Study||38
8302914|NCT01536262|20470437|P1|COMPLETED|Overall Study||33
8302915|NCT01536262|20470435|P3|STARTED|Overall Study||41
8302916|NCT01536262|20470436|P2|STARTED|Overall Study||40
8302917|NCT01536262|20470437|P1|STARTED|Overall Study||41
8302918|NCT01536197|20470453|P2|NOT COMPLETED|Overall Study||0
8302919|NCT01536197|20470454|P1|NOT COMPLETED|Overall Study||0
8302920|NCT01536197|20470453|P2|COMPLETED|Overall Study||10
8302921|NCT01536197|20470454|P1|COMPLETED|Overall Study||23
8302922|NCT01536197|20470453|P2|STARTED|Overall Study||10
8302923|NCT01536197|20470454|P1|STARTED|Overall Study||23
8302924|NCT01536184|20470464|P2|NOT COMPLETED|Overall Study||0
8302925|NCT01536184|20470465|P1|NOT COMPLETED|Overall Study||0
8302926|NCT01536184|20470464|P2|COMPLETED|Overall Study||4
8302927|NCT01536184|20470465|P1|COMPLETED|Overall Study||8
8302928|NCT01536184|20470464|P2|STARTED|Overall Study||4
8302929|NCT01536184|20470465|P1|STARTED|Overall Study||8
8302930|NCT01536171|20470479|P1|NOT COMPLETED|Overall Study||1
8302931|NCT01536171|20470479|P1|COMPLETED|Overall Study||21
8302932|NCT01536171|20470479|P1|STARTED|Overall Study||22
8302933|NCT01536145|20470484|P11|NOT COMPLETED|Overall Study||10
8302934|NCT01536145|20470485|P10|NOT COMPLETED|Overall Study||6
8302935|NCT01536145|20470486|P9|NOT COMPLETED|Overall Study||3
8302936|NCT01536145|20470487|P8|NOT COMPLETED|Overall Study||4
8302937|NCT01536145|20470488|P7|NOT COMPLETED|Overall Study||2
8302938|NCT01536145|20470489|P6|NOT COMPLETED|Overall Study||3
8302939|NCT01536145|20470490|P5|NOT COMPLETED|Overall Study||2
8302940|NCT01536145|20470491|P4|NOT COMPLETED|Overall Study||2
8302941|NCT01536145|20470492|P3|NOT COMPLETED|Overall Study||2
8302942|NCT01536145|20470493|P2|NOT COMPLETED|Overall Study||4
8302943|NCT01536145|20470494|P1|NOT COMPLETED|Overall Study||3
8302944|NCT01536145|20470484|P11|COMPLETED|Overall Study||0
8302945|NCT01536145|20470485|P10|COMPLETED|Overall Study||1
8302946|NCT01536145|20470486|P9|COMPLETED|Overall Study||0
8302947|NCT01536145|20470487|P8|COMPLETED|Overall Study||0
8302948|NCT01536145|20470488|P7|COMPLETED|Overall Study||1
8302949|NCT01536145|20470489|P6|COMPLETED|Overall Study||0
8302950|NCT01536145|20470490|P5|COMPLETED|Overall Study||2
8302951|NCT01536145|20470491|P4|COMPLETED|Overall Study||1
8302952|NCT01536145|20470492|P3|COMPLETED|Overall Study||1
8302953|NCT01536145|20470493|P2|COMPLETED|Overall Study||0
8302954|NCT01536145|20470494|P1|COMPLETED|Overall Study||0
8302955|NCT01536145|20470484|P11|STARTED|Overall Study||10
8302956|NCT01536145|20470485|P10|STARTED|Overall Study||7
8302957|NCT01536145|20470486|P9|STARTED|Overall Study||3
8302958|NCT01536145|20470487|P8|STARTED|Overall Study||4
8302959|NCT01536145|20470488|P7|STARTED|Overall Study||3
8302960|NCT01536145|20470489|P6|STARTED|Overall Study||3
8302961|NCT01536145|20470490|P5|STARTED|Overall Study||4
8302962|NCT01536145|20470491|P4|STARTED|Overall Study||3
8302963|NCT01536145|20470492|P3|STARTED|Overall Study||3
8302964|NCT01536145|20470493|P2|STARTED|Overall Study||4
8302965|NCT01536145|20470494|P1|STARTED|Overall Study||3
8302966|NCT01536119|20470601|P2|NOT COMPLETED|Overall Study||14
8302967|NCT01536119|20470602|P1|NOT COMPLETED|Overall Study||17
8302968|NCT01536119|20470601|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
8302969|NCT01536119|20470602|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
8302970|NCT01536119|20470601|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
8302971|NCT01536119|20470602|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
8302972|NCT01536093|20470628|P2|NOT COMPLETED|Overall Study||3
8302973|NCT01536093|20470629|P1|NOT COMPLETED|Overall Study||3
8302974|NCT01536093|20470628|P2|COMPLETED|Overall Study||21
8302975|NCT01536093|20470629|P1|COMPLETED|Overall Study||21
8302976|NCT01536093|20470628|P2|STARTED|Overall Study||24
8302977|NCT01536093|20470629|P1|STARTED|Overall Study||24
8302978|NCT01536067|20470645|P1|NOT COMPLETED|Overall Study||1
8302979|NCT01536067|20470645|P1|COMPLETED|Overall Study||2
8302980|NCT01536067|20470645|P1|STARTED|Overall Study||3
8302981|NCT01536015|20470658|P2|NOT COMPLETED|Overall Study||10
8302982|NCT01536015|20470659|P1|NOT COMPLETED|Overall Study||8
8302983|NCT01536015|20470658|P2|COMPLETED|Overall Study||3
8302984|NCT01536015|20470659|P1|COMPLETED|Overall Study||4
8302985|NCT01536015|20470658|P2|STARTED|Overall Study||13
8302986|NCT01536015|20470659|P1|STARTED|Overall Study||12
8302987|NCT01535976|20470677|P2|NOT COMPLETED|Overall Study||1
8302988|NCT01535976|20470678|P1|NOT COMPLETED|Overall Study||1
8302989|NCT01535976|20470677|P2|COMPLETED|Overall Study||26
8302990|NCT01535976|20470678|P1|COMPLETED|Overall Study||26
8302991|NCT01535976|20470677|P2|STARTED|Overall Study||27
8302992|NCT01535976|20470678|P1|STARTED|Overall Study||27
8302993|NCT01535937|20470686|P2|NOT COMPLETED|Overall Study||0
8302994|NCT01535937|20470687|P1|NOT COMPLETED|Overall Study||0
8302995|NCT01535937|20470686|P2|COMPLETED|Overall Study||28
8302996|NCT01535937|20470687|P1|COMPLETED|Overall Study||27
8302997|NCT01535937|20470686|P2|STARTED|Overall Study||28
8302998|NCT01535937|20470687|P1|STARTED|Overall Study||27
8302999|NCT01535807|20470697|P2|NOT COMPLETED|Overall Study||2
8303000|NCT01535807|20470698|P1|NOT COMPLETED|Overall Study||2
8303001|NCT01535807|20470697|P2|COMPLETED|Overall Study||20
8303002|NCT01535807|20470698|P1|COMPLETED|Overall Study||20
8303003|NCT01535807|20470697|P2|STARTED|Overall Study||22
8303004|NCT01535807|20470698|P1|STARTED|Overall Study||22
8303005|NCT01535729|20470704|P1|NOT COMPLETED|Overall Study||416
8303006|NCT01535729|20470704|P1|COMPLETED|Overall Study||49
8303007|NCT01535729|20470704|P1|Treated|Overall Study||385
8303008|NCT01535729|20470704|P1|STARTED|Overall Study||465
8303009|NCT01535664|20470731|P1|NOT COMPLETED|Overall Study||0
8303010|NCT01535664|20470731|P1|COMPLETED|Overall Study||20
8303011|NCT01535664|20470731|P1|STARTED|Overall Study||20
8303012|NCT01535638|20470745|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303013|NCT01535638|20470746|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303014|NCT01535638|20470747|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
8303015|NCT01535638|20470748|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303016|NCT01535638|20470749|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303017|NCT01535638|20470750|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303018|NCT01535638|20470745|P6|COMPLETED|Treatment 3 (Single Dose)||2
8303019|NCT01535638|20470746|P5|COMPLETED|Treatment 3 (Single Dose)||3
8303020|NCT01535638|20470747|P4|COMPLETED|Treatment 3 (Single Dose)||2
8303021|NCT01535638|20470748|P3|COMPLETED|Treatment 3 (Single Dose)||3
8303022|NCT01535638|20470749|P2|COMPLETED|Treatment 3 (Single Dose)||3
8303023|NCT01535638|20470750|P1|COMPLETED|Treatment 3 (Single Dose)||3
8303024|NCT01535638|20470745|P6|STARTED|Treatment 3 (Single Dose)||2
8303025|NCT01535638|20470746|P5|STARTED|Treatment 3 (Single Dose)||3
8303026|NCT01535638|20470747|P4|STARTED|Treatment 3 (Single Dose)||3
8303027|NCT01535638|20470748|P3|STARTED|Treatment 3 (Single Dose)||3
8303028|NCT01535638|20470749|P2|STARTED|Treatment 3 (Single Dose)||3
8303029|NCT01535638|20470750|P1|STARTED|Treatment 3 (Single Dose)||3
8303030|NCT01535638|20470745|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303031|NCT01535638|20470746|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303032|NCT01535638|20470747|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303033|NCT01535638|20470748|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303034|NCT01535638|20470749|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303035|NCT01535638|20470750|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303036|NCT01535638|20470745|P6|COMPLETED|Treatment 2 (Single Dose)||2
8303037|NCT01535638|20470746|P5|COMPLETED|Treatment 2 (Single Dose)||3
8303038|NCT01535638|20470747|P4|COMPLETED|Treatment 2 (Single Dose)||3
8303039|NCT01535638|20470748|P3|COMPLETED|Treatment 2 (Single Dose)||3
8303040|NCT01535638|20470749|P2|COMPLETED|Treatment 2 (Single Dose)||3
8303041|NCT01535638|20470750|P1|COMPLETED|Treatment 2 (Single Dose)||3
8303042|NCT01535638|20470745|P6|STARTED|Treatment 2 (Single Dose)||2
8303043|NCT01535638|20470746|P5|STARTED|Treatment 2 (Single Dose)||3
8303044|NCT01535638|20470747|P4|STARTED|Treatment 2 (Single Dose)||3
8303045|NCT01535638|20470748|P3|STARTED|Treatment 2 (Single Dose)||3
8303046|NCT01535638|20470749|P2|STARTED|Treatment 2 (Single Dose)||3
8303047|NCT01535638|20470750|P1|STARTED|Treatment 2 (Single Dose)||3
8303048|NCT01535638|20470745|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
8303049|NCT01535638|20470746|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303050|NCT01535638|20470747|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303051|NCT01535638|20470748|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303052|NCT01535638|20470749|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303053|NCT01535638|20470750|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303054|NCT01535638|20470745|P6|COMPLETED|Treatment 1 (Single Dose)||2
8303055|NCT01535638|20470746|P5|COMPLETED|Treatment 1 (Single Dose)||3
8303056|NCT01535638|20470747|P4|COMPLETED|Treatment 1 (Single Dose)||3
8303057|NCT01535638|20470748|P3|COMPLETED|Treatment 1 (Single Dose)||3
8303058|NCT01535638|20470749|P2|COMPLETED|Treatment 1 (Single Dose)||3
8303059|NCT01535638|20470750|P1|COMPLETED|Treatment 1 (Single Dose)||3
8303060|NCT01535638|20470745|P6|STARTED|Treatment 1 (Single Dose)||3
8303061|NCT01535638|20470746|P5|STARTED|Treatment 1 (Single Dose)||3
8303062|NCT01535638|20470747|P4|STARTED|Treatment 1 (Single Dose)||3
8303063|NCT01535638|20470748|P3|STARTED|Treatment 1 (Single Dose)||3
8303064|NCT01535638|20470749|P2|STARTED|Treatment 1 (Single Dose)||3
8303065|NCT01535638|20470750|P1|STARTED|Treatment 1 (Single Dose)||3
8303066|NCT01535599|20470764|P2|NOT COMPLETED|Overall Study||96
8303067|NCT01535599|20470765|P1|NOT COMPLETED|Overall Study||50
8303068|NCT01535599|20470764|P2|COMPLETED|Overall Study||250
8303069|NCT01535599|20470765|P1|COMPLETED|Overall Study||297
8303070|NCT01535599|20470764|P2|STARTED|Overall Study||346
8303071|NCT01535599|20470765|P1|STARTED|Overall Study||347
8303072|NCT01535573|20470778|P3|NOT COMPLETED|Overall Study||19
8303073|NCT01535573|20470779|P2|NOT COMPLETED|Overall Study||21
8303074|NCT01535573|20470780|P1|NOT COMPLETED|Overall Study||8
8303075|NCT01535573|20470778|P3|COMPLETED|Overall Study||24
8303076|NCT01535573|20470779|P2|COMPLETED|Overall Study||23
8303077|NCT01535573|20470780|P1|COMPLETED|Overall Study||13
8303078|NCT01535573|20470778|P3|STARTED|Overall Study||43
8303079|NCT01535573|20470779|P2|STARTED|Overall Study||44
8303080|NCT01535573|20470780|P1|STARTED|Overall Study||21
8303081|NCT01535560|20470799|P2|NOT COMPLETED|Overall Study||96
8303082|NCT01535560|20470800|P1|NOT COMPLETED|Overall Study||37
8303083|NCT01535560|20470799|P2|COMPLETED|Overall Study||179
8303084|NCT01535560|20470800|P1|COMPLETED|Overall Study||237
8303085|NCT01535560|20470799|P2|STARTED|Overall Study||275
8303086|NCT01535560|20470800|P1|STARTED|Overall Study||274
8303087|NCT01535443|20470810|P1|NOT COMPLETED|Overall Study||3
8303088|NCT01535443|20470810|P1|COMPLETED|Overall Study||32
8303089|NCT01535443|20470810|P1|STARTED|Overall Study||35
8303090|NCT01535365|20470827|P2|NOT COMPLETED|Overall Study||0
8303091|NCT01535365|20470828|P1|NOT COMPLETED|Overall Study||0
8303092|NCT01535365|20470827|P2|COMPLETED|Overall Study||29
8303093|NCT01535365|20470828|P1|COMPLETED|Overall Study||31
8303094|NCT01535365|20470827|P2|STARTED|Overall Study||29
8303095|NCT01535365|20470828|P1|STARTED|Overall Study||31
8303096|NCT01535326|20470839|P3|NOT COMPLETED|Overall Study||0
8303097|NCT01535326|20470840|P2|NOT COMPLETED|Overall Study||0
8303098|NCT01535326|20470841|P1|NOT COMPLETED|Overall Study||0
8303099|NCT01535326|20470839|P3|COMPLETED|Overall Study||90
8303100|NCT01535326|20470840|P2|COMPLETED|Overall Study||90
8303101|NCT01535326|20470841|P1|COMPLETED|Overall Study||90
8303102|NCT01535326|20470839|P3|STARTED|Overall Study||90
8303103|NCT01535326|20470840|P2|STARTED|Overall Study||90
8303104|NCT01535326|20470841|P1|STARTED|Overall Study||90
8303105|NCT01535287|20470860|P2|NOT COMPLETED|Overall Study||6
8303106|NCT01535287|20470861|P1|NOT COMPLETED|Overall Study||5
8303107|NCT01535287|20470860|P2|COMPLETED|Overall Study||64
8303108|NCT01535287|20470861|P1|COMPLETED|Overall Study||65
8303109|NCT01535287|20470860|P2|STARTED|Overall Study||70
8303110|NCT01535287|20470861|P1|STARTED|Overall Study||70
8303111|NCT01535261|20470877|P1|NOT COMPLETED|Overall Study||50
8303112|NCT01535261|20470877|P1|COMPLETED|Overall Study||307
8303113|NCT01535261|20470877|P1|STARTED|Overall Study||357
8303114|NCT01535235|20470890|P2|NOT COMPLETED|Overall Study||0
8303115|NCT01535235|20470891|P1|NOT COMPLETED|Overall Study||1
8303116|NCT01535235|20470890|P2|COMPLETED|Overall Study||15
8303117|NCT01535235|20470891|P1|COMPLETED|Overall Study||15
8303118|NCT01535235|20470890|P2|STARTED|Overall Study||15
8303119|NCT01535235|20470891|P1|STARTED|Overall Study||16
8303120|NCT01535222|20470905|P6|NOT COMPLETED|Overall Study||0
8303121|NCT01535222|20470906|P5|NOT COMPLETED|Overall Study||0
8303122|NCT01535222|20470907|P4|NOT COMPLETED|Overall Study||0
8303123|NCT01535222|20470908|P3|NOT COMPLETED|Overall Study||1
8303124|NCT01535222|20470909|P2|NOT COMPLETED|Overall Study||0
8303125|NCT01535222|20470910|P1|NOT COMPLETED|Overall Study||0
8303126|NCT01535222|20470905|P6|COMPLETED|Overall Study||8
8303127|NCT01535222|20470906|P5|COMPLETED|Overall Study||6
8303128|NCT01535222|20470907|P4|COMPLETED|Overall Study||6
8303129|NCT01535222|20470908|P3|COMPLETED|Overall Study||6
8303130|NCT01535222|20470909|P2|COMPLETED|Overall Study||3
8303131|NCT01535222|20470910|P1|COMPLETED|Overall Study||3
8303132|NCT01535222|20470905|P6|STARTED|Overall Study||8
8303133|NCT01535222|20470906|P5|STARTED|Overall Study||6
8303134|NCT01535222|20470907|P4|STARTED|Overall Study||6
8303135|NCT01535222|20470908|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
8303136|NCT01535222|20470909|P2|STARTED|Overall Study||3
8303137|NCT01535222|20470910|P1|STARTED|Overall Study||3
8303138|NCT01535118|20470930|P1|NOT COMPLETED|Overall Study||0
8303139|NCT01535118|20470930|P1|COMPLETED|Overall Study||2765
8303140|NCT01535118|20470930|P1|STARTED|Overall Study||2765
8303141|NCT01535053|20470941|P2|NOT COMPLETED|Overall Study||2
8303142|NCT01535053|20470942|P1|NOT COMPLETED|Overall Study||1
8303143|NCT01535053|20470941|P2|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
8303144|NCT01535053|20470942|P1|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
8303145|NCT01535053|20470941|P2|STARTED|Overall Study||28
8303146|NCT01535053|20470942|P1|STARTED|Overall Study||29
8303147|NCT01535040|20470960|P2|NOT COMPLETED|Overall Study||21
8303148|NCT01535040|20470961|P1|NOT COMPLETED|Overall Study||30
8303149|NCT01535040|20470960|P2|COMPLETED|Overall Study||44
8303150|NCT01535040|20470961|P1|COMPLETED|Overall Study||35
8303151|NCT01535040|20470960|P2|STARTED|Overall Study||65
8303152|NCT01535040|20470961|P1|STARTED|Overall Study||65
8303153|NCT01535014|20470977|P4|NOT COMPLETED|Overall Study||0
8303154|NCT01535014|20470978|P3|NOT COMPLETED|Overall Study||1
8303155|NCT01535014|20470979|P2|NOT COMPLETED|Overall Study||6
8303156|NCT01535014|20470980|P1|NOT COMPLETED|Overall Study||2
8303157|NCT01535014|20470977|P4|COMPLETED|Overall Study||33
8303158|NCT01535014|20470978|P3|COMPLETED|Overall Study||49
8303159|NCT01535014|20470979|P2|COMPLETED|Overall Study||194
8303160|NCT01535014|20470980|P1|COMPLETED|Overall Study||208
8303161|NCT01535014|20470977|P4|STARTED|Overall Study||33
8303162|NCT01535014|20470978|P3|STARTED|Overall Study||50
8303163|NCT01535014|20470979|P2|STARTED|Overall Study||200
8303164|NCT01535014|20470980|P1|STARTED|Overall Study||210
8303165|NCT01535001|20471014|P2|NOT COMPLETED|Overall Study||6
8303166|NCT01535001|20471015|P1|NOT COMPLETED|Overall Study||3
8303167|NCT01535001|20471014|P2|COMPLETED|Overall Study||44
8303168|NCT01535001|20471015|P1|COMPLETED|Overall Study||47
8303169|NCT01535001|20471014|P2|STARTED|Overall Study||50
8303170|NCT01535001|20471015|P1|STARTED|Overall Study||50
8303171|NCT01534975|20471041|P4|NOT COMPLETED|Overall Study||0
8303172|NCT01534975|20471042|P3|NOT COMPLETED|Overall Study||0
8303173|NCT01534975|20471043|P2|NOT COMPLETED|Overall Study||0
8303174|NCT01534975|20471044|P1|NOT COMPLETED|Overall Study||0
8303175|NCT01534975|20471041|P4|COMPLETED|Overall Study||84
8303176|NCT01534975|20471042|P3|COMPLETED|Overall Study||160
8303177|NCT01534975|20471043|P2|COMPLETED|Overall Study||133
8303178|NCT01534975|20471044|P1|COMPLETED|Overall Study||136
8303179|NCT01534975|20471041|P4|STARTED|Overall Study||84
8303180|NCT01534975|20471042|P3|STARTED|Overall Study||160
8303181|NCT01534975|20471043|P2|STARTED|Overall Study||133
8303182|NCT01534975|20471044|P1|STARTED|Overall Study||136
8303183|NCT01534962|20471058|P4|NOT COMPLETED|Overall Study||32
8303184|NCT01534962|20471059|P3|NOT COMPLETED|Overall Study||24
8303185|NCT01534962|20471060|P2|NOT COMPLETED|Overall Study||26
8303186|NCT01534962|20471061|P1|NOT COMPLETED|Overall Study||37
8303187|NCT01534962|20471058|P4|COMPLETED|Overall Study||24
8303188|NCT01534962|20471059|P3|COMPLETED|Overall Study||34
8303189|NCT01534962|20471060|P2|COMPLETED|Overall Study||34
8303190|NCT01534962|20471061|P1|COMPLETED|Overall Study||30
8303191|NCT01534962|20471058|P4|STARTED|Overall Study||56
8303192|NCT01534962|20471059|P3|STARTED|Overall Study||58
8303193|NCT01534962|20471060|P2|STARTED|Overall Study||60
8303194|NCT01534962|20471061|P1|STARTED|Overall Study||67
8303195|NCT01534910|20471093|P2|NOT COMPLETED|Overall Study||4
8303196|NCT01534910|20471094|P1|NOT COMPLETED|Overall Study||4
8303197|NCT01534910|20471093|P2|COMPLETED|Overall Study||28
8303198|NCT01534910|20471094|P1|COMPLETED|Overall Study||29
8303199|NCT01534910|20471093|P2|STARTED|Overall Study||32
8303200|NCT01534910|20471094|P1|STARTED|Overall Study||33
8303201|NCT01534897|20471102|P1|NOT COMPLETED|Overall Study||0
8303202|NCT01534897|20471102|P1|COMPLETED|Overall Study||10
8303203|NCT01534897|20471102|P1|Day 37 Iodine-131 Treatment|Overall Study||6
8303204|NCT01534897|20471102|P1|Day 25 Iodine-131 Scan|Overall Study||10
8303205|NCT01534897|20471102|P1|STARTED|Overall Study||10
8303206|NCT01534689|20471110|P1|NOT COMPLETED|Overall Study||0
8303207|NCT01534689|20471110|P1|COMPLETED|Overall Study||105
8303208|NCT01534689|20471110|P1|STARTED|Overall Study||105
8303209|NCT01534676|20471118|P2|NOT COMPLETED|Overall Study||1
8303210|NCT01534676|20471119|P1|NOT COMPLETED|Overall Study||2
8303211|NCT01534676|20471118|P2|COMPLETED|Overall Study||0
8303212|NCT01534676|20471119|P1|COMPLETED|Overall Study||0
8303213|NCT01534676|20471118|P2|STARTED|Overall Study||1
8303214|NCT01534676|20471119|P1|STARTED|Overall Study||2
8303215|NCT01534663|20471127|P2|NOT COMPLETED|Overall Study||3
8303216|NCT01534663|20471128|P1|NOT COMPLETED|Overall Study||2
8303217|NCT01534663|20471127|P2|COMPLETED|Overall Study||14
8303218|NCT01534663|20471128|P1|COMPLETED|Overall Study||12
8303219|NCT01534663|20471127|P2|STARTED|Overall Study||17
8303220|NCT01534663|20471128|P1|STARTED|Overall Study||14
8303221|NCT01534637|20471162|P1|NOT COMPLETED|Overall Study||9
8303222|NCT01534637|20471162|P1|COMPLETED|Overall Study||13
8303223|NCT01534637|20471162|P1|STARTED|Overall Study||22
8303224|NCT01534533|20471172|P4|NOT COMPLETED|Overall Study||4
8303225|NCT01534533|20471173|P3|NOT COMPLETED|Overall Study||8
8303226|NCT01534533|20471174|P2|NOT COMPLETED|Overall Study||3
8303227|NCT01534533|20471175|P1|NOT COMPLETED|Overall Study||8
8303228|NCT01534533|20471172|P4|COMPLETED|Overall Study||44
8303229|NCT01534533|20471173|P3|COMPLETED|Overall Study||40
8303230|NCT01534533|20471174|P2|COMPLETED|Overall Study||45
8303231|NCT01534533|20471175|P1|COMPLETED|Overall Study||40
8303232|NCT01534533|20471172|P4|STARTED|Overall Study||48
8303233|NCT01534533|20471173|P3|STARTED|Overall Study||48
8303234|NCT01534533|20471174|P2|STARTED|Overall Study||48
8303235|NCT01534533|20471175|P1|STARTED|Overall Study||48
8303236|NCT01534520|20471203|P2|NOT COMPLETED|Overall Study||1
8303237|NCT01534520|20471204|P1|NOT COMPLETED|Overall Study||0
8303238|NCT01534520|20471203|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
8303239|NCT01534520|20471204|P1|COMPLETED|Overall Study||30
8303240|NCT01534520|20471203|P2|STARTED|Overall Study||29
8303241|NCT01534520|20471204|P1|STARTED|Overall Study||30
8303242|NCT01534416|20471218|P2|NOT COMPLETED|Overall Study||0
8303243|NCT01534416|20471219|P1|NOT COMPLETED|Overall Study||0
8303244|NCT01534416|20471218|P2|COMPLETED|Overall Study||64
8303245|NCT01534416|20471219|P1|COMPLETED|Overall Study||68
8303246|NCT01534416|20471218|P2|STARTED|Overall Study||64
8303247|NCT01534416|20471219|P1|STARTED|Overall Study||68
8303248|NCT01534351|20471238|P3|NOT COMPLETED|Overall Study||0
8303249|NCT01534351|20471239|P2|NOT COMPLETED|Overall Study||0
8303250|NCT01534351|20471240|P1|NOT COMPLETED|Overall Study||1
8303251|NCT01534351|20471238|P3|COMPLETED|Overall Study||0
8303252|NCT01534351|20471239|P2|COMPLETED|Overall Study||0
8303253|NCT01534351|20471240|P1|COMPLETED|Overall Study||0
8303254|NCT01534351|20471238|P3|STARTED|Overall Study||0
8303255|NCT01534351|20471239|P2|STARTED|Overall Study||0
8303256|NCT01534351|20471240|P1|STARTED|Overall Study||1
8303257|NCT01534273|20471261|P7|NOT COMPLETED|Period 2||0
8303258|NCT01534273|20471262|P6|NOT COMPLETED|Period 2||0
8303259|NCT01534273|20471263|P5|NOT COMPLETED|Period 2||0
8303260|NCT01534273|20471264|P4|NOT COMPLETED|Period 2||0
8303261|NCT01534273|20471265|P3|NOT COMPLETED|Period 2||0
8303262|NCT01534273|20471266|P2|NOT COMPLETED|Period 2||0
8303263|NCT01534273|20471267|P1|NOT COMPLETED|Period 2||0
8303264|NCT01534273|20471261|P7|COMPLETED|Period 2||0
8303265|NCT01534273|20471262|P6|COMPLETED|Period 2||0
8303266|NCT01534273|20471263|P5|COMPLETED|Period 2||0
8303267|NCT01534273|20471264|P4|COMPLETED|Period 2||6
8303268|NCT01534273|20471265|P3|COMPLETED|Period 2||2
8303269|NCT01534273|20471266|P2|COMPLETED|Period 2||0
8303270|NCT01534273|20471267|P1|COMPLETED|Period 2||0
8303271|NCT01534273|20471261|P7|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8303272|NCT01534273|20471262|P6|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8303273|NCT01534273|20471263|P5|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8303274|NCT01534273|20471264|P4|STARTED|Period 2||6
8303275|NCT01534273|20471265|P3|STARTED|Period 2||2
8303276|NCT01534273|20471266|P2|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
8303277|NCT01534273|20471267|P1|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
8303278|NCT01534273|20471261|P7|NOT COMPLETED|Period 1||0
8303279|NCT01534273|20471262|P6|NOT COMPLETED|Period 1||0
8303280|NCT01534273|20471263|P5|NOT COMPLETED|Period 1||0
8303281|NCT01534273|20471264|P4|NOT COMPLETED|Period 1||1
8303282|NCT01534273|20471265|P3|NOT COMPLETED|Period 1||0
8303283|NCT01534273|20471266|P2|NOT COMPLETED|Period 1||0
8303284|NCT01534273|20471267|P1|NOT COMPLETED|Period 1||0
8303285|NCT01534273|20471261|P7|COMPLETED|Period 1||6
8303286|NCT01534273|20471262|P6|COMPLETED|Period 1||3
8303287|NCT01534273|20471263|P5|COMPLETED|Period 1||3
8303288|NCT01534273|20471264|P4|COMPLETED|Period 1||6
8303289|NCT01534273|20471265|P3|COMPLETED|Period 1||2
8303290|NCT01534273|20471266|P2|COMPLETED|Period 1||6
8303291|NCT01534273|20471267|P1|COMPLETED|Period 1||3
8303292|NCT01534273|20471261|P7|Received at Least 1 Dose of Study Drug|Period 1||6
8303293|NCT01534273|20471262|P6|Received at Least 1 Dose of Study Drug|Period 1||3
8303294|NCT01534273|20471263|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8303295|NCT01534273|20471264|P4|Received at Least 1 Dose of Study Drug|Period 1||7
8303296|NCT01534273|20471265|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8303297|NCT01534273|20471266|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8303298|NCT01534273|20471267|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8303299|NCT01534273|20471261|P7|STARTED|Period 1||6
8303300|NCT01534273|20471262|P6|STARTED|Period 1||3
8303301|NCT01534273|20471263|P5|STARTED|Period 1||3
8303302|NCT01534273|20471264|P4|STARTED|Period 1||7
8303303|NCT01534273|20471265|P3|STARTED|Period 1||2
8303304|NCT01534273|20471266|P2|STARTED|Period 1||6
8303305|NCT01534273|20471267|P1|STARTED|Period 1||3
8303306|NCT01534260|20471294|P2|NOT COMPLETED|Overall Study||20
8303307|NCT01534260|20471295|P1|NOT COMPLETED|Overall Study||16
8303308|NCT01534260|20471294|P2|COMPLETED|Overall Study||0
8303309|NCT01534260|20471295|P1|COMPLETED|Overall Study||1
8303310|NCT01534260|20471294|P2|STARTED|Overall Study||20
8303311|NCT01534260|20471295|P1|STARTED|Overall Study||17
8303312|NCT01534208|20471305|P2|NOT COMPLETED|Overall Study||49
8303313|NCT01534208|20471306|P1|NOT COMPLETED|Overall Study||57
8303314|NCT01534208|20471305|P2|COMPLETED|Overall Study||234
8303315|NCT01534208|20471306|P1|COMPLETED|Overall Study||159
8303316|NCT01534208|20471305|P2|STARTED|Overall Study||283
8303317|NCT01534208|20471306|P1|STARTED|Overall Study||216
8303318|NCT01534195|20471324|P2|NOT COMPLETED|Overall Study||1
8303319|NCT01534195|20471325|P1|NOT COMPLETED|Overall Study||1
8303320|NCT01534195|20471324|P2|COMPLETED|Overall Study||5
8303321|NCT01534195|20471325|P1|COMPLETED|Overall Study||4
8303322|NCT01534195|20471324|P2|STARTED|Overall Study||6
8303323|NCT01534195|20471325|P1|STARTED|Overall Study||5
8303324|NCT01534182|20471339|P2|NOT COMPLETED|Overall Study||10
8303325|NCT01534182|20471340|P1|NOT COMPLETED|Overall Study||12
8303326|NCT01534182|20471339|P2|COMPLETED|Overall Study||58
8303327|NCT01534182|20471340|P1|COMPLETED|Overall Study||218
8303328|NCT01534182|20471339|P2|Full Analysis Set|Overall Study||62
8303329|NCT01534182|20471340|P1|Full Analysis Set|Overall Study||229
8303330|NCT01534182|20471339|P2|Safety Set|Overall Study||64
8303331|NCT01534182|20471340|P1|Safety Set|Overall Study||230
8303332|NCT01534182|20471339|P2|STARTED|Overall Study||68
8303333|NCT01534182|20471340|P1|STARTED|Overall Study||230
8303334|NCT01534143|20471355|P1|NOT COMPLETED|Overall Study||0
8303335|NCT01534143|20471355|P1|COMPLETED|Overall Study||1
8303336|NCT01534143|20471355|P1|STARTED|Overall Study||1
8303337|NCT01534078|20471371|P1|NOT COMPLETED|Overall Study||2
8303338|NCT01534078|20471371|P1|COMPLETED|Overall Study||32
8303339|NCT01534078|20471371|P1|STARTED|Overall Study||34
8303340|NCT01534052|20471378|P1|NOT COMPLETED|Overall Study||0
8303341|NCT01534052|20471378|P1|COMPLETED|Overall Study||52
8303342|NCT01534052|20471378|P1|Treatment Received|Overall Study||52
8303343|NCT01534052|20471378|P1|STARTED|Overall Study||52
8303344|NCT01534013|20471384|P2|NOT COMPLETED|Overall Study||0
8303345|NCT01534013|20471385|P1|NOT COMPLETED|Overall Study||2
8303346|NCT01534013|20471384|P2|COMPLETED|Overall Study||6
8303347|NCT01534013|20471385|P1|COMPLETED|Overall Study||6
8303348|NCT01534013|20471384|P2|STARTED|Overall Study||6
8303349|NCT01534013|20471385|P1|STARTED|Overall Study||8
8303350|NCT01533974|20471393|P2|NOT COMPLETED|Overall Study||50
8303351|NCT01533974|20471394|P1|NOT COMPLETED|Overall Study||51
8303352|NCT01533974|20471393|P2|COMPLETED|Overall Study||176
8303353|NCT01533974|20471394|P1|COMPLETED|Overall Study||173
8303354|NCT01533974|20471393|P2|STARTED|Overall Study||226
8303355|NCT01533974|20471394|P1|STARTED|Overall Study||224
8303356|NCT01533948|20471400|P1|NOT COMPLETED|Overall Study||0
8303357|NCT01533948|20471400|P1|COMPLETED|Overall Study||25
8303358|NCT01533948|20471400|P1|STARTED|Overall Study||25
8303359|NCT01533935|20471408|P5|NOT COMPLETED|Overall Study||8
8303360|NCT01533935|20471409|P4|NOT COMPLETED|Overall Study||7
8303361|NCT01533935|20471410|P3|NOT COMPLETED|Overall Study||8
8303362|NCT01533935|20471411|P2|NOT COMPLETED|Overall Study||13
8303363|NCT01533935|20471412|P1|NOT COMPLETED|Overall Study||6
8303364|NCT01533935|20471408|P5|COMPLETED|Overall Study|All treatment periods|50
8303365|NCT01533935|20471409|P4|COMPLETED|Overall Study|All treatment periods|52
8303366|NCT01533935|20471410|P3|COMPLETED|Overall Study|All treatment periods|50
8303367|NCT01533935|20471411|P2|COMPLETED|Overall Study|All treatment periods|45
8303368|NCT01533935|20471412|P1|COMPLETED|Overall Study|All treatment periods|52
8303369|NCT01533935|20471408|P5|Received Tio+Olo 5/5|Overall Study||55
8303370|NCT01533935|20471409|P4|Received Tio+Olo 5/5|Overall Study||54
8303371|NCT01533935|20471410|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
8303372|NCT01533935|20471411|P2|Received Tio+Olo 5/5|Overall Study||58
8303373|NCT01533935|20471412|P1|Received Tio+Olo 5/5|Overall Study||56
8303374|NCT01533935|20471408|P5|Received Tio+Olo 2.5/5|Overall Study||56
8303375|NCT01533935|20471409|P4|Received Tio+Olo 2.5/5|Overall Study||56
8303376|NCT01533935|20471410|P3|Received Tio+Olo 2.5/5|Overall Study||49
8303377|NCT01533935|20471411|P2|Received Tio+Olo 2.5/5|Overall Study||0
8303378|NCT01533935|20471412|P1|Received Tio+Olo 2.5/5|Overall Study||58
8303379|NCT01533935|20471408|P5|Received Tio 5|Overall Study||52
8303380|NCT01533935|20471409|P4|Received Tio 5|Overall Study||0
8303381|NCT01533935|20471410|P3|Received Tio 5|Overall Study||58
8303382|NCT01533935|20471411|P2|Received Tio 5|Overall Study||54
8303383|NCT01533935|20471412|P1|Received Tio 5|Overall Study||54
8303384|NCT01533935|20471408|P5|Received Olo 5|Overall Study||0
8303385|NCT01533935|20471409|P4|Received Olo 5|Overall Study||59
8303386|NCT01533935|20471410|P3|Received Olo 5|Overall Study||55
8303387|NCT01533935|20471411|P2|Received Olo 5|Overall Study||52
8303388|NCT01533935|20471412|P1|Received Olo 5|Overall Study||52
8303389|NCT01533935|20471408|P5|Received Placebo|Overall Study||58
8303390|NCT01533935|20471409|P4|Received Placebo|Overall Study||57
8303391|NCT01533935|20471410|P3|Received Placebo|Overall Study||52
8303392|NCT01533935|20471411|P2|Received Placebo|Overall Study||47
8303393|NCT01533935|20471412|P1|Received Placebo|Overall Study||0
8303394|NCT01533935|20471408|P5|STARTED|Overall Study||58
8303395|NCT01533935|20471409|P4|STARTED|Overall Study||59
8303396|NCT01533935|20471410|P3|STARTED|Overall Study||58
8303397|NCT01533935|20471411|P2|STARTED|Overall Study||58
8303398|NCT01533935|20471412|P1|STARTED|Overall Study||58
8303399|NCT01533922|20471439|P5|NOT COMPLETED|Overall Study||6
8303400|NCT01533922|20471440|P4|NOT COMPLETED|Overall Study||5
8303401|NCT01533922|20471441|P3|NOT COMPLETED|Overall Study||10
8303402|NCT01533922|20471442|P2|NOT COMPLETED|Overall Study||12
8303403|NCT01533922|20471443|P1|NOT COMPLETED|Overall Study||10
8303404|NCT01533922|20471439|P5|COMPLETED|Overall Study|Completed all treatment arms|53
8303405|NCT01533922|20471440|P4|COMPLETED|Overall Study|Completed all treatment arms|53
8303406|NCT01533922|20471441|P3|COMPLETED|Overall Study|Completed all treatment arms|50
8303407|NCT01533922|20471442|P2|COMPLETED|Overall Study|Completed all treatment arms|47
8303408|NCT01533922|20471443|P1|COMPLETED|Overall Study|Completed all treatment arms|49
8303409|NCT01533922|20471439|P5|Received Tio+Olo 5/5|Overall Study||56
8303410|NCT01533922|20471440|P4|Received Tio+Olo 5/5|Overall Study||53
8303411|NCT01533922|20471441|P3|Received Tio+Olo 5/5|Overall Study||0
8303412|NCT01533922|20471442|P2|Received Tio+Olo 5/5|Overall Study||59
8303413|NCT01533922|20471443|P1|Received Tio+Olo 5/5|Overall Study||58
8303414|NCT01533922|20471439|P5|Received Tio+Olo 2.5/5|Overall Study||56
8303415|NCT01533922|20471440|P4|Received Tio+Olo 2.5/5|Overall Study||55
8303416|NCT01533922|20471441|P3|Received Tio+Olo 2.5/5|Overall Study||52
8303417|NCT01533922|20471442|P2|Received Tio+Olo 2.5/5|Overall Study||0
8303418|NCT01533922|20471443|P1|Received Tio+Olo 2.5/5|Overall Study||59
8303419|NCT01533922|20471439|P5|Received Tio 5|Overall Study||54
8303420|NCT01533922|20471440|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
8303421|NCT01533922|20471441|P3|Received Tio 5|Overall Study||59
8303422|NCT01533922|20471442|P2|Received Tio 5|Overall Study||58
8303423|NCT01533922|20471443|P1|Received Tio 5|Overall Study||54
8303424|NCT01533922|20471439|P5|Received Olo 5|Overall Study||0
8303425|NCT01533922|20471440|P4|Received Olo 5|Overall Study||57
8303426|NCT01533922|20471441|P3|Received Olo 5|Overall Study||57
8303427|NCT01533922|20471442|P2|Received Olo 5|Overall Study||52
8303428|NCT01533922|20471443|P1|Received Olo 5|Overall Study||51
8303429|NCT01533922|20471439|P5|Received Placebo|Overall Study||59
8303430|NCT01533922|20471440|P4|Received Placebo|Overall Study||57
8303431|NCT01533922|20471441|P3|Received Placebo|Overall Study||57
8303432|NCT01533922|20471442|P2|Received Placebo|Overall Study||49
8303433|NCT01533922|20471443|P1|Received Placebo|Overall Study||0
8303434|NCT01533922|20471439|P5|STARTED|Overall Study||59
8303435|NCT01533922|20471440|P4|STARTED|Overall Study||58
8303436|NCT01533922|20471441|P3|STARTED|Overall Study||60
8303437|NCT01533922|20471442|P2|STARTED|Overall Study||59
8303438|NCT01533922|20471443|P1|STARTED|Overall Study||59
8303439|NCT01533753|20471472|P2|NOT COMPLETED|Overall Study||0
8303440|NCT01533753|20471473|P1|NOT COMPLETED|Overall Study||0
8303441|NCT01533753|20471472|P2|COMPLETED|Overall Study||3
8303442|NCT01533753|20471473|P1|COMPLETED|Overall Study||2
8303443|NCT01533753|20471472|P2|STARTED|Overall Study||3
8303444|NCT01533753|20471473|P1|STARTED|Overall Study||2
8303445|NCT01533688|20471488|P3|NOT COMPLETED|Overall Study||8
8303446|NCT01533688|20471489|P2|NOT COMPLETED|Overall Study||10
8303447|NCT01533688|20471490|P1|NOT COMPLETED|Overall Study||8
8303448|NCT01533688|20471488|P3|COMPLETED|Overall Study||63
8303449|NCT01533688|20471489|P2|COMPLETED|Overall Study||60
8303450|NCT01533688|20471490|P1|COMPLETED|Overall Study||63
8303451|NCT01533688|20471488|P3|STARTED|Overall Study||71
8303452|NCT01533688|20471489|P2|STARTED|Overall Study||70
8303453|NCT01533688|20471490|P1|STARTED|Overall Study||71
8303454|NCT01533597|20471503|P2|NOT COMPLETED|Overall Study||10
8303455|NCT01533597|20471504|P1|NOT COMPLETED|Overall Study||6
8303456|NCT01533597|20471503|P2|COMPLETED|Overall Study||25
8303457|NCT01533597|20471504|P1|COMPLETED|Overall Study||29
8303458|NCT01533597|20471503|P2|STARTED|Overall Study||35
8303459|NCT01533597|20471504|P1|STARTED|Overall Study||35
8303460|NCT01533493|20471522|P2|NOT COMPLETED|Overall Study||3
8303461|NCT01533493|20471523|P1|NOT COMPLETED|Overall Study||5
8303462|NCT01533493|20471522|P2|COMPLETED|Overall Study||11
8303463|NCT01533493|20471523|P1|COMPLETED|Overall Study||7
8303464|NCT01533493|20471522|P2|STARTED|Overall Study||14
8303465|NCT01533493|20471523|P1|STARTED|Overall Study||12
8303466|NCT01533428|20471531|P2|NOT COMPLETED|Overall Study||8
8303467|NCT01533428|20471532|P1|NOT COMPLETED|Overall Study||9
8303468|NCT01533428|20471531|P2|COMPLETED|Overall Study||175
8303469|NCT01533428|20471532|P1|COMPLETED|Overall Study||177
8303470|NCT01533428|20471531|P2|STARTED|Overall Study||183
8303471|NCT01533428|20471532|P1|STARTED|Overall Study||186
8303472|NCT01533259|20471572|P1|NOT COMPLETED|Overall Study||0
8303473|NCT01533259|20471572|P1|COMPLETED|Overall Study||48
8303474|NCT01533259|20471572|P1|STARTED|Overall Study||48
8303475|NCT01533246|20471578|P1|NOT COMPLETED|Overall Study||2
8303476|NCT01533246|20471578|P1|COMPLETED|Overall Study||15
8303477|NCT01533246|20471578|P1|STARTED|Overall Study||17
8303478|NCT01533207|20471589|P2|NOT COMPLETED|Overall Study||0
8303479|NCT01533207|20471590|P1|NOT COMPLETED|Overall Study||0
8303480|NCT01533207|20471589|P2|COMPLETED|Overall Study||18
8303481|NCT01533207|20471590|P1|COMPLETED|Overall Study||20
8303482|NCT01533207|20471589|P2|STARTED|Overall Study||18
8303483|NCT01533207|20471590|P1|STARTED|Overall Study||20
8303484|NCT01533181|20471602|P2|NOT COMPLETED|Overall Study||1
8303485|NCT01533181|20471603|P1|NOT COMPLETED|Overall Study||1
8303486|NCT01533181|20471602|P2|COMPLETED|Overall Study||28
8303487|NCT01533181|20471603|P1|COMPLETED|Overall Study||14
8303488|NCT01533181|20471602|P2|STARTED|Overall Study||29
8303489|NCT01533181|20471603|P1|STARTED|Overall Study||15
8303490|NCT01533116|20471619|P4|NOT COMPLETED|Overall Study||0
8303491|NCT01533116|20471620|P3|NOT COMPLETED|Overall Study||1
8303492|NCT01533116|20471621|P2|NOT COMPLETED|Overall Study||1
8303493|NCT01533116|20471622|P1|NOT COMPLETED|Overall Study||2
8303494|NCT01533116|20471619|P4|COMPLETED|Overall Study||12
8303495|NCT01533116|20471620|P3|COMPLETED|Overall Study||12
8303496|NCT01533116|20471621|P2|COMPLETED|Overall Study||12
8303497|NCT01533116|20471622|P1|COMPLETED|Overall Study||12
8303498|NCT01533116|20471619|P4|STARTED|Overall Study||12
8303499|NCT01533116|20471620|P3|STARTED|Overall Study||13
8303500|NCT01533116|20471621|P2|STARTED|Overall Study||13
8303501|NCT01533116|20471622|P1|STARTED|Overall Study||14
8303502|NCT01533077|20471652|P4|NOT COMPLETED|Overall Study||0
8303503|NCT01533077|20471653|P3|NOT COMPLETED|Overall Study||0
8303504|NCT01533077|20471654|P2|NOT COMPLETED|Overall Study||1
8303505|NCT01533077|20471655|P1|NOT COMPLETED|Overall Study||1
8303506|NCT01533077|20471652|P4|COMPLETED|Overall Study||4
8303507|NCT01533077|20471653|P3|COMPLETED|Overall Study||4
8303508|NCT01533077|20471654|P2|COMPLETED|Overall Study||4
8303509|NCT01533077|20471655|P1|COMPLETED|Overall Study||4
8303510|NCT01533077|20471652|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
8303511|NCT01533077|20471653|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
8303512|NCT01533077|20471654|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
8303513|NCT01533077|20471655|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
8303514|NCT01533077|20471652|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303515|NCT01533077|20471653|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303516|NCT01533077|20471654|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303517|NCT01533077|20471655|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303518|NCT01533077|20471652|P4|Sinemet® 100/25|Overall Study||4
8303519|NCT01533077|20471653|P3|Sinemet® 100/25|Overall Study||4
8303520|NCT01533077|20471654|P2|Sinemet® 100/25|Overall Study||5
8303521|NCT01533077|20471655|P1|Sinemet® 100/25|Overall Study||4
8303522|NCT01533077|20471652|P4|BIA 9-1067 50 mg|Overall Study||4
8303523|NCT01533077|20471653|P3|BIA 9-1067 50 mg|Overall Study||4
8303524|NCT01533077|20471654|P2|BIA 9-1067 50 mg|Overall Study||5
8303525|NCT01533077|20471655|P1|BIA 9-1067 50 mg|Overall Study||5
8303526|NCT01533077|20471652|P4|STARTED|Overall Study||4
8303527|NCT01533077|20471653|P3|STARTED|Overall Study||4
8303528|NCT01533077|20471654|P2|STARTED|Overall Study||5
8303529|NCT01533077|20471655|P1|STARTED|Overall Study||5
8303530|NCT01533038|20471711|P2|NOT COMPLETED|Overall Study||1
8303531|NCT01533038|20471712|P1|NOT COMPLETED|Overall Study||0
8303532|NCT01533038|20471711|P2|COMPLETED|Overall Study||34
8303533|NCT01533038|20471712|P1|COMPLETED|Overall Study||45
8303534|NCT01533038|20471711|P2|STARTED|Overall Study||35
8303535|NCT01533038|20471712|P1|STARTED|Overall Study||45
8303536|NCT01532999|20471720|P2|NOT COMPLETED|Overall Study||18
8303537|NCT01532999|20471721|P1|NOT COMPLETED|Overall Study||31
8303538|NCT01532999|20471720|P2|COMPLETED|Overall Study||77
8303539|NCT01532999|20471721|P1|COMPLETED|Overall Study||65
8303540|NCT01532999|20471720|P2|STARTED|Overall Study||95
8303541|NCT01532999|20471721|P1|STARTED|Overall Study||96
8303542|NCT01532986|20471745|P2|NOT COMPLETED|Overall Study||24
8303543|NCT01532986|20471746|P1|NOT COMPLETED|Overall Study||23
8303544|NCT01532986|20471745|P2|COMPLETED|Overall Study||138
8303545|NCT01532986|20471746|P1|COMPLETED|Overall Study||143
8303546|NCT01532986|20471745|P2|STARTED|Overall Study||162
8303547|NCT01532986|20471746|P1|STARTED|Overall Study||166
8303548|NCT01532973|20471779|P10|NOT COMPLETED|Part 3||0
8303549|NCT01532973|20471780|P9|NOT COMPLETED|Part 3||0
8303550|NCT01532973|20471781|P8|NOT COMPLETED|Part 3||0
8303551|NCT01532973|20471782|P7|NOT COMPLETED|Part 3||0
8303552|NCT01532973|20471783|P6|NOT COMPLETED|Part 3||0
8303553|NCT01532973|20471784|P5|NOT COMPLETED|Part 3||0
8303554|NCT01532973|20471785|P4|NOT COMPLETED|Part 3||0
8303555|NCT01532973|20471786|P3|NOT COMPLETED|Part 3||0
8303556|NCT01532973|20471787|P2|NOT COMPLETED|Part 3||0
8303557|NCT01532973|20471788|P1|NOT COMPLETED|Part 3||0
8303558|NCT01532973|20471779|P10|COMPLETED|Part 3||6
8303559|NCT01532973|20471780|P9|COMPLETED|Part 3||6
8303560|NCT01532973|20471781|P8|COMPLETED|Part 3||0
8303561|NCT01532973|20471782|P7|COMPLETED|Part 3||0
8303562|NCT01532973|20471783|P6|COMPLETED|Part 3||0
8303563|NCT01532973|20471784|P5|COMPLETED|Part 3||0
8303564|NCT01532973|20471785|P4|COMPLETED|Part 3||0
8303565|NCT01532973|20471786|P3|COMPLETED|Part 3||0
8303566|NCT01532973|20471787|P2|COMPLETED|Part 3||0
8303567|NCT01532973|20471788|P1|COMPLETED|Part 3||0
8303568|NCT01532973|20471779|P10|STARTED|Part 3||6
8303569|NCT01532973|20471780|P9|STARTED|Part 3||6
8303570|NCT01532973|20471781|P8|STARTED|Part 3||0
8303571|NCT01532973|20471782|P7|STARTED|Part 3||0
8303572|NCT01532973|20471783|P6|STARTED|Part 3||0
8303573|NCT01532973|20471784|P5|STARTED|Part 3||0
8303574|NCT01532973|20471785|P4|STARTED|Part 3||0
8303575|NCT01532973|20471786|P3|STARTED|Part 3||0
8303576|NCT01532973|20471787|P2|STARTED|Part 3||0
8303577|NCT01532973|20471788|P1|STARTED|Part 3||0
8303578|NCT01532973|20471779|P10|NOT COMPLETED|Part 2||0
8303579|NCT01532973|20471780|P9|NOT COMPLETED|Part 2||0
8303580|NCT01532973|20471781|P8|NOT COMPLETED|Part 2||0
8303581|NCT01532973|20471782|P7|NOT COMPLETED|Part 2||0
8303582|NCT01532973|20471783|P6|NOT COMPLETED|Part 2||0
8303583|NCT01532973|20471784|P5|NOT COMPLETED|Part 2||0
8303584|NCT01532973|20471785|P4|NOT COMPLETED|Part 2||0
8303585|NCT01532973|20471786|P3|NOT COMPLETED|Part 2||0
8303586|NCT01532973|20471787|P2|NOT COMPLETED|Part 2||0
8303587|NCT01532973|20471788|P1|NOT COMPLETED|Part 2||0
8303588|NCT01532973|20471779|P10|COMPLETED|Part 2||0
8303589|NCT01532973|20471780|P9|COMPLETED|Part 2||0
8303590|NCT01532973|20471781|P8|COMPLETED|Part 2||0
8303591|NCT01532973|20471782|P7|COMPLETED|Part 2||6
8303592|NCT01532973|20471783|P6|COMPLETED|Part 2||6
8303593|NCT01532973|20471784|P5|COMPLETED|Part 2||6
8303594|NCT01532973|20471785|P4|COMPLETED|Part 2||0
8303595|NCT01532973|20471786|P3|COMPLETED|Part 2||0
8303596|NCT01532973|20471787|P2|COMPLETED|Part 2||0
8303597|NCT01532973|20471788|P1|COMPLETED|Part 2||0
8303598|NCT01532973|20471779|P10|STARTED|Part 2||0
8303599|NCT01532973|20471780|P9|STARTED|Part 2||0
8303600|NCT01532973|20471781|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
8303601|NCT01532973|20471782|P7|STARTED|Part 2||6
8303602|NCT01532973|20471783|P6|STARTED|Part 2||6
8303603|NCT01532973|20471784|P5|STARTED|Part 2||6
8303604|NCT01532973|20471785|P4|STARTED|Part 2||0
8303605|NCT01532973|20471786|P3|STARTED|Part 2||0
8303606|NCT01532973|20471787|P2|STARTED|Part 2||0
8303607|NCT01532973|20471788|P1|STARTED|Part 2||0
8303608|NCT01532973|20471779|P10|NOT COMPLETED|Part 1||0
8303609|NCT01532973|20471780|P9|NOT COMPLETED|Part 1||0
8303610|NCT01532973|20471781|P8|NOT COMPLETED|Part 1||0
8303611|NCT01532973|20471782|P7|NOT COMPLETED|Part 1||0
8303612|NCT01532973|20471783|P6|NOT COMPLETED|Part 1||0
8303613|NCT01532973|20471784|P5|NOT COMPLETED|Part 1||0
8303614|NCT01532973|20471785|P4|NOT COMPLETED|Part 1||0
8303615|NCT01532973|20471786|P3|NOT COMPLETED|Part 1||0
8303616|NCT01532973|20471787|P2|NOT COMPLETED|Part 1||0
8303617|NCT01532973|20471788|P1|NOT COMPLETED|Part 1||0
8303618|NCT01532973|20471779|P10|COMPLETED|Part 1||0
8303619|NCT01532973|20471780|P9|COMPLETED|Part 1||0
8303620|NCT01532973|20471781|P8|COMPLETED|Part 1||0
8303621|NCT01532973|20471782|P7|COMPLETED|Part 1||0
8303622|NCT01532973|20471783|P6|COMPLETED|Part 1||0
8303623|NCT01532973|20471784|P5|COMPLETED|Part 1||0
8303624|NCT01532973|20471785|P4|COMPLETED|Part 1||0
8303625|NCT01532973|20471786|P3|COMPLETED|Part 1||6
8303626|NCT01532973|20471787|P2|COMPLETED|Part 1||6
8303627|NCT01532973|20471788|P1|COMPLETED|Part 1||6
8303628|NCT01532973|20471779|P10|STARTED|Part 1||0
8303629|NCT01532973|20471780|P9|STARTED|Part 1||0
8303630|NCT01532973|20471781|P8|STARTED|Part 1||0
8303631|NCT01532973|20471782|P7|STARTED|Part 1||0
8303632|NCT01532973|20471783|P6|STARTED|Part 1||0
8303633|NCT01532973|20471784|P5|STARTED|Part 1||0
8303634|NCT01532973|20471785|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
8303635|NCT01532973|20471786|P3|STARTED|Part 1||6
8303636|NCT01532973|20471787|P2|STARTED|Part 1||6
8303637|NCT01532973|20471788|P1|STARTED|Part 1||6
8303638|NCT01532934|20471830|P2|NOT COMPLETED|Overall Study||13
8303639|NCT01532934|20471831|P1|NOT COMPLETED|Overall Study||14
8303640|NCT01532934|20471830|P2|COMPLETED|Overall Study||39
8303641|NCT01532934|20471831|P1|COMPLETED|Overall Study||39
8303642|NCT01532934|20471830|P2|STARTED|Overall Study||52
8303643|NCT01532934|20471831|P1|STARTED|Overall Study||53
8303644|NCT01532921|20471841|P1|NOT COMPLETED|Overall Study||16
8303645|NCT01532921|20471841|P1|COMPLETED|Overall Study||69
8303646|NCT01532921|20471841|P1|6 Months Follow Up|Overall Study||68
8303647|NCT01532921|20471841|P1|Discharge|Overall Study||75
8303648|NCT01532921|20471841|P1|Implantation Procedure|Overall Study||76
8303649|NCT01532921|20471841|P1|STARTED|Overall Study||85
8303650|NCT01532869|20471863|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
8303651|NCT01532869|20471864|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
8303652|NCT01532869|20471863|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
8303653|NCT01532869|20471864|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
8303654|NCT01532869|20471863|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
8303655|NCT01532869|20471864|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
8303656|NCT01532869|20471863|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
8303657|NCT01532869|20471864|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
8303658|NCT01532869|20471863|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
8303659|NCT01532869|20471864|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
8303660|NCT01532869|20471863|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
8303661|NCT01532869|20471864|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
8303662|NCT01532869|20471863|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
8303663|NCT01532869|20471864|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
8303664|NCT01532869|20471863|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
8303665|NCT01532869|20471864|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
8303666|NCT01532869|20471863|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
8303667|NCT01532869|20471864|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
8303668|NCT01532830|20471901|P1|NOT COMPLETED|Overall Study||4
8303669|NCT01532830|20471901|P1|COMPLETED|Overall Study||26
8303670|NCT01532830|20471901|P1|STARTED|Overall Study||30
8303671|NCT01532817|20471910|P1|NOT COMPLETED|Overall Study||0
8303672|NCT01532817|20471910|P1|COMPLETED|Overall Study||30
8303673|NCT01532817|20471910|P1|STARTED|Overall Study||30
8303674|NCT01532700|20471914|P1|NOT COMPLETED|Overall Study||0
8303675|NCT01532700|20471914|P1|COMPLETED|Overall Study||28
8303676|NCT01532700|20471914|P1|STARTED|Overall Study||28
8303677|NCT01532648|20471923|P2|NOT COMPLETED|Overall Study||17
8303678|NCT01532648|20471924|P1|NOT COMPLETED|Overall Study||36
8303679|NCT01532648|20471923|P2|COMPLETED|Overall Study||238
8303680|NCT01532648|20471924|P1|COMPLETED|Overall Study||219
8303681|NCT01532648|20471923|P2|Intent-To-Treat Population|Overall Study||228
8303682|NCT01532648|20471924|P1|Intent-To-Treat Population|Overall Study||230
8303683|NCT01532648|20471923|P2|Safety Population|Overall Study||255
8303684|NCT01532648|20471924|P1|Safety Population|Overall Study||255
8303685|NCT01532648|20471923|P2|STARTED|Overall Study||255
8303686|NCT01532648|20471924|P1|STARTED|Overall Study||255
8303687|NCT01532635|20471942|P1|NOT COMPLETED|Overall Study||0
8303688|NCT01532635|20471942|P1|COMPLETED|Overall Study||4
8303689|NCT01532635|20471942|P1|STARTED|Overall Study||4
8303690|NCT01532570|20471958|P4|NOT COMPLETED|Overall Study||0
8303691|NCT01532570|20471959|P3|NOT COMPLETED|Overall Study||0
8303692|NCT01532570|20471960|P2|NOT COMPLETED|Overall Study||1
8303693|NCT01532570|20471961|P1|NOT COMPLETED|Overall Study||1
8303694|NCT01532570|20471958|P4|COMPLETED|Overall Study||4
8303695|NCT01532570|20471959|P3|COMPLETED|Overall Study||1
8303696|NCT01532570|20471960|P2|COMPLETED|Overall Study||1
8303697|NCT01532570|20471961|P1|COMPLETED|Overall Study||10
8303698|NCT01532570|20471958|P4|STARTED|Overall Study||4
8303699|NCT01532570|20471959|P3|STARTED|Overall Study||1
8303700|NCT01532570|20471960|P2|STARTED|Overall Study||2
8303701|NCT01532570|20471961|P1|STARTED|Overall Study||11
8303702|NCT01532453|20471994|P2|NOT COMPLETED|Overall Study||70
8303703|NCT01532453|20471995|P1|NOT COMPLETED|Overall Study||27
8303704|NCT01532453|20471994|P2|COMPLETED|Overall Study||90
8303705|NCT01532453|20471995|P1|COMPLETED|Overall Study||54
8303706|NCT01532453|20471994|P2|STARTED|Overall Study||160
8303707|NCT01532453|20471995|P1|STARTED|Overall Study||81
8303708|NCT01532414|20472006|P3|NOT COMPLETED|Overall Study||3
8303709|NCT01532414|20472007|P2|NOT COMPLETED|Overall Study||2
8303710|NCT01532414|20472008|P1|NOT COMPLETED|Overall Study||7
8303711|NCT01532414|20472006|P3|COMPLETED|Overall Study||35
8303712|NCT01532414|20472007|P2|COMPLETED|Overall Study||19
8303713|NCT01532414|20472008|P1|COMPLETED|Overall Study||85
8303714|NCT01532414|20472006|P3|STARTED|Overall Study||38
8303715|NCT01532414|20472007|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
8303716|NCT01532414|20472008|P1|STARTED|Overall Study||92
8303717|NCT01532388|20472018|P2|NOT COMPLETED|12-month Follow-up||67
8303718|NCT01532388|20472019|P1|NOT COMPLETED|12-month Follow-up||69
8303719|NCT01532388|20472018|P2|COMPLETED|12-month Follow-up||34
8303720|NCT01532388|20472019|P1|COMPLETED|12-month Follow-up||32
8303721|NCT01532388|20472018|P2|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303722|NCT01532388|20472019|P1|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303723|NCT01532388|20472018|P2|NOT COMPLETED|6-month Follow-up||66
8303724|NCT01532388|20472019|P1|NOT COMPLETED|6-month Follow-up||74
8303725|NCT01532388|20472018|P2|COMPLETED|6-month Follow-up||35
8303726|NCT01532388|20472019|P1|COMPLETED|6-month Follow-up||27
8303727|NCT01532388|20472018|P2|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303728|NCT01532388|20472019|P1|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303729|NCT01532388|20472018|P2|NOT COMPLETED|3-month Follow-up||68
8303730|NCT01532388|20472019|P1|NOT COMPLETED|3-month Follow-up||68
8303731|NCT01532388|20472018|P2|COMPLETED|3-month Follow-up||33
8303732|NCT01532388|20472019|P1|COMPLETED|3-month Follow-up||33
8303733|NCT01532388|20472018|P2|STARTED|3-month Follow-up||101
8303734|NCT01532388|20472019|P1|STARTED|3-month Follow-up||101
8303735|NCT01532362|20472049|P2|NOT COMPLETED|Overall Study||0
8303736|NCT01532362|20472050|P1|NOT COMPLETED|Overall Study||0
8303737|NCT01532362|20472049|P2|COMPLETED|Overall Study||0
8303738|NCT01532362|20472050|P1|COMPLETED|Overall Study||1
8303739|NCT01532362|20472049|P2|STARTED|Overall Study||0
8303740|NCT01532362|20472050|P1|STARTED|Overall Study||1
8303741|NCT01532349|20472060|P2|NOT COMPLETED|Overall Study||5
8303742|NCT01532349|20472061|P1|NOT COMPLETED|Overall Study||2
8303743|NCT01532349|20472060|P2|COMPLETED|Overall Study||12
8303744|NCT01532349|20472061|P1|COMPLETED|Overall Study||15
8303745|NCT01532349|20472060|P2|STARTED|Overall Study||17
8303746|NCT01532349|20472061|P1|STARTED|Overall Study||17
8303747|NCT01532141|20472070|P3|NOT COMPLETED|Overall Study||0
8303748|NCT01532141|20472071|P2|NOT COMPLETED|Overall Study||0
8303749|NCT01532141|20472072|P1|NOT COMPLETED|Overall Study||1
8303750|NCT01532141|20472070|P3|COMPLETED|Overall Study||8
8303751|NCT01532141|20472071|P2|COMPLETED|Overall Study||8
8303752|NCT01532141|20472072|P1|COMPLETED|Overall Study||8
8303753|NCT01532141|20472070|P3|Period 3|Overall Study||8
8303754|NCT01532141|20472071|P2|Period 3|Overall Study||8
8303755|NCT01532141|20472072|P1|Period 3|Overall Study||8
8303756|NCT01532141|20472070|P3|Period 2|Overall Study||8
8303757|NCT01532141|20472071|P2|Period 2|Overall Study||8
8303758|NCT01532141|20472072|P1|Period 2|Overall Study||8
8303759|NCT01532141|20472070|P3|Period 1|Overall Study||8
8303760|NCT01532141|20472071|P2|Period 1|Overall Study||8
8303761|NCT01532141|20472072|P1|Period 1|Overall Study||9
8303762|NCT01532141|20472070|P3|STARTED|Overall Study||8
8303763|NCT01532141|20472071|P2|STARTED|Overall Study||8
8303764|NCT01532141|20472072|P1|STARTED|Overall Study||9
8303765|NCT01532128|20472090|P3|NOT COMPLETED|Overall Study||0
8303766|NCT01532128|20472091|P2|NOT COMPLETED|Overall Study||0
8303767|NCT01532128|20472092|P1|NOT COMPLETED|Overall Study||0
8303768|NCT01532128|20472090|P3|COMPLETED|Overall Study||8
8303769|NCT01532128|20472091|P2|COMPLETED|Overall Study||8
8303770|NCT01532128|20472092|P1|COMPLETED|Overall Study||8
8303771|NCT01532128|20472090|P3|STARTED|Overall Study||8
8303772|NCT01532128|20472091|P2|STARTED|Overall Study||8
8303773|NCT01532128|20472092|P1|STARTED|Overall Study||8
8303774|NCT01532089|20472109|P2|NOT COMPLETED|Overall Study||0
8303775|NCT01532089|20472110|P1|NOT COMPLETED|Overall Study||0
8303776|NCT01532089|20472109|P2|COMPLETED|Overall Study||43
8303777|NCT01532089|20472110|P1|COMPLETED|Overall Study||45
8303778|NCT01532089|20472109|P2|STARTED|Overall Study||43
8303779|NCT01532089|20472110|P1|STARTED|Overall Study||45
8303780|NCT01531998|20472124|P1|NOT COMPLETED|Overall Study||3
8303781|NCT01531998|20472124|P1|COMPLETED|Overall Study||8
8303782|NCT01531998|20472124|P1|STARTED|Overall Study||11
8303783|NCT01531959|20472131|P2|NOT COMPLETED|Overall Study||2
8303784|NCT01531959|20472132|P1|NOT COMPLETED|Overall Study||2
8303785|NCT01531959|20472131|P2|COMPLETED|Overall Study||66
8303786|NCT01531959|20472132|P1|COMPLETED|Overall Study||66
8303787|NCT01531959|20472131|P2|STARTED|Overall Study||68
8303788|NCT01531959|20472132|P1|STARTED|Overall Study||68
8303789|NCT01531894|20472146|P1|NOT COMPLETED|Overall Study||9
8303790|NCT01531894|20472146|P1|COMPLETED|Overall Study||2
8303791|NCT01531894|20472146|P1|STARTED|Overall Study||11
8303792|NCT01531738|20472152|P2|NOT COMPLETED|Overall Study||0
8303793|NCT01531738|20472153|P1|NOT COMPLETED|Overall Study||0
8303794|NCT01531738|20472152|P2|COMPLETED|Overall Study||11
8303795|NCT01531738|20472153|P1|COMPLETED|Overall Study||11
8303796|NCT01531738|20472152|P2|STARTED|Overall Study||11
8303797|NCT01531738|20472153|P1|STARTED|Overall Study||11
8303798|NCT01531725|20472163|P1|NOT COMPLETED|Overall Study||5
8303799|NCT01531725|20472163|P1|COMPLETED|Overall Study||197
8303800|NCT01531725|20472163|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
8303801|NCT01531673|20472181|P13|NOT COMPLETED|Overall Study||0
8303802|NCT01531673|20472182|P12|NOT COMPLETED|Overall Study||0
8303803|NCT01531673|20472183|P11|NOT COMPLETED|Overall Study||0
8303804|NCT01531673|20472184|P10|NOT COMPLETED|Overall Study||1
8303805|NCT01531673|20472185|P9|NOT COMPLETED|Overall Study||0
8303806|NCT01531673|20472186|P8|NOT COMPLETED|Overall Study||0
8303807|NCT01531673|20472187|P7|NOT COMPLETED|Overall Study||0
8303808|NCT01531673|20472188|P6|NOT COMPLETED|Overall Study||1
8303809|NCT01531673|20472189|P5|NOT COMPLETED|Overall Study||1
8303810|NCT01531673|20472190|P4|NOT COMPLETED|Overall Study||1
8303811|NCT01531673|20472191|P3|NOT COMPLETED|Overall Study||0
8303812|NCT01531673|20472192|P2|NOT COMPLETED|Overall Study||1
8303813|NCT01531673|20472193|P1|NOT COMPLETED|Overall Study||0
8303814|NCT01531673|20472181|P13|COMPLETED|Overall Study||14
8303815|NCT01531673|20472182|P12|COMPLETED|Overall Study||4
8303816|NCT01531673|20472183|P11|COMPLETED|Overall Study||16
8303817|NCT01531673|20472184|P10|COMPLETED|Overall Study||18
8303818|NCT01531673|20472185|P9|COMPLETED|Overall Study||17
8303819|NCT01531673|20472186|P8|COMPLETED|Overall Study||9
8303820|NCT01531673|20472187|P7|COMPLETED|Overall Study||17
8303821|NCT01531673|20472188|P6|COMPLETED|Overall Study||18
8303822|NCT01531673|20472189|P5|COMPLETED|Overall Study||7
8303823|NCT01531673|20472190|P4|COMPLETED|Overall Study||17
8303824|NCT01531673|20472191|P3|COMPLETED|Overall Study||8
8303825|NCT01531673|20472192|P2|COMPLETED|Overall Study||7
8303826|NCT01531673|20472193|P1|COMPLETED|Overall Study||33
8303827|NCT01531673|20472181|P13|STARTED|Overall Study||14
8303828|NCT01531673|20472182|P12|STARTED|Overall Study||4
8303829|NCT01531673|20472183|P11|STARTED|Overall Study||16
8303830|NCT01531673|20472184|P10|STARTED|Overall Study||19
8303831|NCT01531673|20472185|P9|STARTED|Overall Study||17
8303832|NCT01531673|20472186|P8|STARTED|Overall Study||9
8303833|NCT01531673|20472187|P7|STARTED|Overall Study||17
8303834|NCT01531673|20472188|P6|STARTED|Overall Study||19
8303835|NCT01531673|20472189|P5|STARTED|Overall Study||8
8303836|NCT01531673|20472190|P4|STARTED|Overall Study||18
8303837|NCT01531673|20472191|P3|STARTED|Overall Study||8
8303838|NCT01531673|20472192|P2|STARTED|Overall Study||8
8303839|NCT01531673|20472193|P1|STARTED|Overall Study||33
8303840|NCT01531439|20472304|P2|NOT COMPLETED|Overall Study||1
8303841|NCT01531439|20472305|P1|NOT COMPLETED|Overall Study||4
8303842|NCT01531439|20472304|P2|COMPLETED|Overall Study||42
8303843|NCT01531439|20472305|P1|COMPLETED|Overall Study||37
8303844|NCT01531439|20472304|P2|STARTED|Overall Study||43
8303845|NCT01531439|20472305|P1|STARTED|Overall Study||41
8303846|NCT01531387|20472319|P2|NOT COMPLETED|Overall Study||11
8303847|NCT01531387|20472320|P1|NOT COMPLETED|Overall Study||11
8303848|NCT01531387|20472319|P2|COMPLETED|Overall Study||0
8303849|NCT01531387|20472320|P1|COMPLETED|Overall Study||0
8303850|NCT01531387|20472319|P2|STARTED|Overall Study||11
8303851|NCT01531387|20472320|P1|STARTED|Overall Study||11
8303852|NCT01531374|20472337|P3|NOT COMPLETED|Overall Study||283
8303853|NCT01531374|20472338|P2|NOT COMPLETED|Overall Study||142
8303854|NCT01531374|20472339|P1|NOT COMPLETED|Overall Study||364
8303855|NCT01531374|20472337|P3|COMPLETED|Overall Study||836
8303856|NCT01531374|20472338|P2|COMPLETED|Overall Study||231
8303857|NCT01531374|20472339|P1|COMPLETED|Overall Study||921
8303858|NCT01531374|20472337|P3|STARTED|Overall Study||1119
8303859|NCT01531374|20472338|P2|STARTED|Overall Study||373
8303860|NCT01531374|20472339|P1|STARTED|Overall Study||1285
8303861|NCT01531335|20472403|P2|NOT COMPLETED|Overall Study||0
8303862|NCT01531335|20472404|P1|NOT COMPLETED|Overall Study||0
8303863|NCT01531335|20472403|P2|COMPLETED|Overall Study||40
8303864|NCT01531335|20472404|P1|COMPLETED|Overall Study||40
8303865|NCT01531335|20472403|P2|STARTED|Overall Study||40
8303866|NCT01531335|20472404|P1|STARTED|Overall Study||40
8303867|NCT01531205|20472412|P1|NOT COMPLETED|Overall Study||1
8303868|NCT01531205|20472412|P1|COMPLETED|Overall Study||1
8303869|NCT01531205|20472412|P1|STARTED|Overall Study||2
8303870|NCT01531153|20472424|P3|NOT COMPLETED|Overall Study||15
8303871|NCT01531153|20472425|P2|NOT COMPLETED|Overall Study||9
8303872|NCT01531153|20472426|P1|NOT COMPLETED|Overall Study||10
8303873|NCT01531153|20472424|P3|COMPLETED|Overall Study||15
8303874|NCT01531153|20472425|P2|COMPLETED|Overall Study||22
8303875|NCT01531153|20472426|P1|COMPLETED|Overall Study||22
8303876|NCT01531153|20472424|P3|STARTED|Overall Study||30
8303877|NCT01531153|20472425|P2|STARTED|Overall Study||31
8303878|NCT01531153|20472426|P1|STARTED|Overall Study||32
8303879|NCT01530997|20472482|P1|NOT COMPLETED|Overall Study||2
8303880|NCT01530997|20472482|P1|COMPLETED|Overall Study||43
8303881|NCT01530997|20472482|P1|STARTED|Overall Study||45
8303882|NCT01530880|20472502|P1|NOT COMPLETED|Overall Study||0
8303883|NCT01530880|20472502|P1|COMPLETED|Overall Study||35
8303884|NCT01530880|20472502|P1|STARTED|Overall Study||35
8303885|NCT01530477|20472516|P3|NOT COMPLETED|Overall Study||0
8303886|NCT01530477|20472517|P2|NOT COMPLETED|Overall Study||0
8303887|NCT01530477|20472518|P1|NOT COMPLETED|Overall Study||0
8303888|NCT01530477|20472516|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
8303889|NCT01530477|20472517|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
8303890|NCT01530477|20472518|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
8303891|NCT01530477|20472516|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
8303892|NCT01530477|20472517|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
8303893|NCT01530477|20472518|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
8303894|NCT01530464|20472526|P2|NOT COMPLETED|Washout (24h)||1
8303895|NCT01530464|20472527|P1|NOT COMPLETED|Washout (24h)||0
8303896|NCT01530464|20472526|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
8303897|NCT01530464|20472527|P1|COMPLETED|Washout (24h)||9
8303898|NCT01530464|20472526|P2|STARTED|Washout (24h)||8
8303899|NCT01530464|20472527|P1|STARTED|Washout (24h)||9
8303900|NCT01530464|20472526|P2|NOT COMPLETED|Third Intervention (24h)||0
8303901|NCT01530464|20472527|P1|NOT COMPLETED|Third Intervention (24h)||0
8303902|NCT01530464|20472526|P2|COMPLETED|Third Intervention (24h)||8
8303903|NCT01530464|20472527|P1|COMPLETED|Third Intervention (24h)||9
8303904|NCT01530464|20472526|P2|STARTED|Third Intervention (24h)||8
8303905|NCT01530464|20472527|P1|STARTED|Third Intervention (24h)||9
8303906|NCT01530464|20472526|P2|NOT COMPLETED|Washout (24h)||0
8303907|NCT01530464|20472527|P1|NOT COMPLETED|Washout (24h)||1
8303908|NCT01530464|20472526|P2|COMPLETED|Washout (24h)||8
8303909|NCT01530464|20472527|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
8303910|NCT01530464|20472526|P2|STARTED|Washout (24h)||8
8303911|NCT01530464|20472527|P1|STARTED|Washout (24h)||10
8303912|NCT01530464|20472526|P2|NOT COMPLETED|Second Intervention (24h)||0
8303913|NCT01530464|20472527|P1|NOT COMPLETED|Second Intervention (24h)||0
8303914|NCT01530464|20472526|P2|COMPLETED|Second Intervention (24h)||8
8303915|NCT01530464|20472527|P1|COMPLETED|Second Intervention (24h)||10
8303916|NCT01530464|20472526|P2|STARTED|Second Intervention (24h)||8
8303917|NCT01530464|20472527|P1|STARTED|Second Intervention (24h)||10
8303918|NCT01530464|20472526|P2|NOT COMPLETED|Washout (24h)||0
8303919|NCT01530464|20472527|P1|NOT COMPLETED|Washout (24h)||0
8303920|NCT01530464|20472526|P2|COMPLETED|Washout (24h)||8
8303921|NCT01530464|20472527|P1|COMPLETED|Washout (24h)||10
8303922|NCT01530464|20472526|P2|STARTED|Washout (24h)||8
8303923|NCT01530464|20472527|P1|STARTED|Washout (24h)||10
8303924|NCT01530464|20472526|P2|NOT COMPLETED|First Intervention (24h)||0
8303925|NCT01530464|20472527|P1|NOT COMPLETED|First Intervention (24h)||0
8303926|NCT01530464|20472526|P2|COMPLETED|First Intervention (24h)||8
8303927|NCT01530464|20472527|P1|COMPLETED|First Intervention (24h)||10
8303928|NCT01530464|20472526|P2|STARTED|First Intervention (24h)||8
8303929|NCT01530464|20472527|P1|STARTED|First Intervention (24h)||10
8303930|NCT01530399|20472560|P6|NOT COMPLETED|Overall Study||1
8303931|NCT01530399|20472561|P5|NOT COMPLETED|Overall Study||0
8303932|NCT01530399|20472562|P4|NOT COMPLETED|Overall Study||0
8303933|NCT01530399|20472563|P3|NOT COMPLETED|Overall Study||1
8303934|NCT01530399|20472564|P2|NOT COMPLETED|Overall Study||2
8303935|NCT01530399|20472565|P1|NOT COMPLETED|Overall Study||1
8303936|NCT01530399|20472560|P6|COMPLETED|Overall Study||6
8303937|NCT01530399|20472561|P5|COMPLETED|Overall Study||6
8303938|NCT01530399|20472562|P4|COMPLETED|Overall Study||10
8303939|NCT01530399|20472563|P3|COMPLETED|Overall Study||7
8303940|NCT01530399|20472564|P2|COMPLETED|Overall Study||8
8303941|NCT01530399|20472565|P1|COMPLETED|Overall Study||7
8303942|NCT01530399|20472560|P6|STARTED|Overall Study||7
8303943|NCT01530399|20472561|P5|STARTED|Overall Study||6
8303944|NCT01530399|20472562|P4|STARTED|Overall Study||10
8303945|NCT01530399|20472563|P3|STARTED|Overall Study||8
8303946|NCT01530399|20472564|P2|STARTED|Overall Study||10
8303947|NCT01530399|20472565|P1|STARTED|Overall Study||8
8303948|NCT01530334|20472579|P1|NOT COMPLETED|Overall Study||51
8303949|NCT01530334|20472579|P1|COMPLETED|Overall Study||10
8303950|NCT01530334|20472579|P1|STARTED|Overall Study||61
8303951|NCT01530243|20472592|P4|NOT COMPLETED|Overall Study||2
8303952|NCT01530243|20472593|P3|NOT COMPLETED|Overall Study||3
8303953|NCT01530243|20472594|P2|NOT COMPLETED|Overall Study||3
8303954|NCT01530243|20472595|P1|NOT COMPLETED|Overall Study||2
8303955|NCT01530243|20472592|P4|COMPLETED|Overall Study||24
8303956|NCT01530243|20472593|P3|COMPLETED|Overall Study||23
8303957|NCT01530243|20472594|P2|COMPLETED|Overall Study||23
8303958|NCT01530243|20472595|P1|COMPLETED|Overall Study||24
8303959|NCT01530243|20472592|P4|STARTED|Overall Study||26
8303960|NCT01530243|20472593|P3|STARTED|Overall Study||26
8303961|NCT01530243|20472594|P2|STARTED|Overall Study||26
8303962|NCT01530243|20472595|P1|STARTED|Overall Study||26
8303963|NCT01530178|20472615|P2|NOT COMPLETED|Overall Study||0
8303964|NCT01530178|20472616|P1|NOT COMPLETED|Overall Study||0
8303965|NCT01530178|20472615|P2|COMPLETED|Overall Study||6
8303966|NCT01530178|20472616|P1|COMPLETED|Overall Study||2
8303967|NCT01530178|20472615|P2|STARTED|Overall Study||6
8303968|NCT01530178|20472616|P1|STARTED|Overall Study||2
8303969|NCT01530087|20472626|P1|NOT COMPLETED|Overall Study||2
8303970|NCT01530087|20472626|P1|COMPLETED|Overall Study||1
8303971|NCT01530087|20472626|P1|STARTED|Overall Study||3
8303972|NCT01529827|20472631|P1|NOT COMPLETED|Overall Study||0
8303973|NCT01529827|20472631|P1|COMPLETED|Overall Study||94
8303974|NCT01529827|20472631|P1|STARTED|Overall Study||94
8303975|NCT01529749|20472642|P4|NOT COMPLETED|Overall Study||2
8303976|NCT01529749|20472643|P3|NOT COMPLETED|Overall Study||2
8303977|NCT01529749|20472644|P2|NOT COMPLETED|Overall Study||2
8303978|NCT01529749|20472645|P1|NOT COMPLETED|Overall Study||0
8303979|NCT01529749|20472642|P4|COMPLETED|Overall Study||10
8303980|NCT01529749|20472643|P3|COMPLETED|Overall Study||10
8303981|NCT01529749|20472644|P2|COMPLETED|Overall Study||10
8303982|NCT01529749|20472645|P1|COMPLETED|Overall Study||12
8303983|NCT01529749|20472642|P4|STARTED|Overall Study||12
8303984|NCT01529749|20472643|P3|STARTED|Overall Study||12
8303985|NCT01529749|20472644|P2|STARTED|Overall Study||12
8303986|NCT01529749|20472645|P1|STARTED|Overall Study||12
8303987|NCT01529645|20472729|P10|NOT COMPLETED|Overall Study||0
8303988|NCT01529645|20472730|P9|NOT COMPLETED|Overall Study||1
8303989|NCT01529645|20472731|P8|NOT COMPLETED|Overall Study||0
8303990|NCT01529645|20472732|P7|NOT COMPLETED|Overall Study||2
8303991|NCT01529645|20472733|P6|NOT COMPLETED|Overall Study||1
8303992|NCT01529645|20472734|P5|NOT COMPLETED|Overall Study||2
8303993|NCT01529645|20472735|P4|NOT COMPLETED|Overall Study||2
8303994|NCT01529645|20472736|P3|NOT COMPLETED|Overall Study||2
8303995|NCT01529645|20472737|P2|NOT COMPLETED|Overall Study||1
8303996|NCT01529645|20472738|P1|NOT COMPLETED|Overall Study||2
8303997|NCT01529645|20472729|P10|COMPLETED|Overall Study||42
8303998|NCT01529645|20472730|P9|COMPLETED|Overall Study||41
8303999|NCT01529645|20472731|P8|COMPLETED|Overall Study||42
8304000|NCT01529645|20472732|P7|COMPLETED|Overall Study||40
8304001|NCT01529645|20472733|P6|COMPLETED|Overall Study||41
8304002|NCT01529645|20472734|P5|COMPLETED|Overall Study||40
8304003|NCT01529645|20472735|P4|COMPLETED|Overall Study||40
8304004|NCT01529645|20472736|P3|COMPLETED|Overall Study||40
8304005|NCT01529645|20472737|P2|COMPLETED|Overall Study||41
8304006|NCT01529645|20472738|P1|COMPLETED|Overall Study||40
8304007|NCT01529645|20472729|P10|STARTED|Overall Study||42
8304008|NCT01529645|20472730|P9|STARTED|Overall Study||42
8304009|NCT01529645|20472731|P8|STARTED|Overall Study||42
8304010|NCT01529645|20472732|P7|STARTED|Overall Study||42
8304011|NCT01529645|20472733|P6|STARTED|Overall Study||42
8304012|NCT01529645|20472734|P5|STARTED|Overall Study||42
8304013|NCT01529645|20472735|P4|STARTED|Overall Study||42
8304014|NCT01529645|20472736|P3|STARTED|Overall Study||42
8304015|NCT01529645|20472737|P2|STARTED|Overall Study||42
8304016|NCT01529645|20472738|P1|STARTED|Overall Study||42
8304017|NCT01529632|20472836|P2|NOT COMPLETED|Overall Study||3
8304018|NCT01529632|20472837|P1|NOT COMPLETED|Overall Study||3
8304019|NCT01529632|20472836|P2|COMPLETED|Overall Study||100
8304020|NCT01529632|20472837|P1|COMPLETED|Overall Study||87
8304021|NCT01529632|20472836|P2|STARTED|Overall Study||103
8304022|NCT01529632|20472837|P1|STARTED|Overall Study||90
8304023|NCT01529606|20472857|P2|NOT COMPLETED|Overall Study||18
8304024|NCT01529606|20472858|P1|NOT COMPLETED|Overall Study||21
8304025|NCT01529606|20472857|P2|COMPLETED|Overall Study||29
8304026|NCT01529606|20472858|P1|COMPLETED|Overall Study||34
8304027|NCT01529606|20472857|P2|STARTED|Overall Study||47
8304028|NCT01529606|20472858|P1|STARTED|Overall Study||55
8304029|NCT01529515|20472870|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
8304030|NCT01529515|20472871|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
8304031|NCT01529515|20472872|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
8304032|NCT01529515|20472873|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
8304033|NCT01529515|20472870|P4|COMPLETED|DOUBLE BLIND PHASE||148
8304034|NCT01529515|20472871|P3|COMPLETED|DOUBLE BLIND PHASE||122
8304035|NCT01529515|20472872|P2|COMPLETED|DOUBLE BLIND PHASE||0
8304036|NCT01529515|20472873|P1|COMPLETED|DOUBLE BLIND PHASE||0
8304037|NCT01529515|20472870|P4|STARTED|DOUBLE BLIND PHASE||160
8304038|NCT01529515|20472871|P3|STARTED|DOUBLE BLIND PHASE||145
8304039|NCT01529515|20472872|P2|STARTED|DOUBLE BLIND PHASE||0
8304040|NCT01529515|20472873|P1|STARTED|DOUBLE BLIND PHASE||0
8304041|NCT01529515|20472870|P4|NOT COMPLETED|MAINTENANCE PHASE||0
8304042|NCT01529515|20472871|P3|NOT COMPLETED|MAINTENANCE PHASE||0
8304043|NCT01529515|20472872|P2|NOT COMPLETED|MAINTENANCE PHASE||74
8304044|NCT01529515|20472873|P1|NOT COMPLETED|MAINTENANCE PHASE||0
8304045|NCT01529515|20472870|P4|COMPLETED|MAINTENANCE PHASE||0
8304046|NCT01529515|20472871|P3|COMPLETED|MAINTENANCE PHASE||0
8304047|NCT01529515|20472872|P2|COMPLETED|MAINTENANCE PHASE||305
8304048|NCT01529515|20472873|P1|COMPLETED|MAINTENANCE PHASE||0
8304049|NCT01529515|20472870|P4|STARTED|MAINTENANCE PHASE||0
8304050|NCT01529515|20472871|P3|STARTED|MAINTENANCE PHASE||0
8304051|NCT01529515|20472872|P2|STARTED|MAINTENANCE PHASE||379
8304052|NCT01529515|20472873|P1|STARTED|MAINTENANCE PHASE||0
8304053|NCT01529515|20472870|P4|NOT COMPLETED|TRANSITION PHASE||0
8304054|NCT01529515|20472871|P3|NOT COMPLETED|TRANSITION PHASE||0
8304055|NCT01529515|20472872|P2|NOT COMPLETED|TRANSITION PHASE||0
8304056|NCT01529515|20472873|P1|NOT COMPLETED|TRANSITION PHASE||127
8304057|NCT01529515|20472870|P4|COMPLETED|TRANSITION PHASE||0
8304058|NCT01529515|20472871|P3|COMPLETED|TRANSITION PHASE||0
8304059|NCT01529515|20472872|P2|COMPLETED|TRANSITION PHASE||0
8304060|NCT01529515|20472873|P1|COMPLETED|TRANSITION PHASE||379
8304061|NCT01529515|20472870|P4|STARTED|TRANSITION PHASE||0
8304062|NCT01529515|20472871|P3|STARTED|TRANSITION PHASE||0
8304063|NCT01529515|20472872|P2|STARTED|TRANSITION PHASE||0
8304064|NCT01529515|20472873|P1|STARTED|TRANSITION PHASE||506
8304065|NCT01529502|20472892|P6|NOT COMPLETED|Overall Study||0
8304066|NCT01529502|20472893|P5|NOT COMPLETED|Overall Study||0
8304067|NCT01529502|20472894|P4|NOT COMPLETED|Overall Study||2
8304068|NCT01529502|20472895|P3|NOT COMPLETED|Overall Study||0
8304069|NCT01529502|20472896|P2|NOT COMPLETED|Overall Study||0
8304070|NCT01529502|20472897|P1|NOT COMPLETED|Overall Study||0
8304071|NCT01529502|20472892|P6|COMPLETED|Overall Study||2
8304072|NCT01529502|20472893|P5|COMPLETED|Overall Study||2
8304073|NCT01529502|20472894|P4|COMPLETED|Overall Study||1
8304074|NCT01529502|20472895|P3|COMPLETED|Overall Study||2
8304075|NCT01529502|20472896|P2|COMPLETED|Overall Study||3
8304076|NCT01529502|20472897|P1|COMPLETED|Overall Study||2
8304077|NCT01529502|20472892|P6|STARTED|Overall Study||2
8304078|NCT01529502|20472893|P5|STARTED|Overall Study||2
8304079|NCT01529502|20472894|P4|STARTED|Overall Study||3
8304080|NCT01529502|20472895|P3|STARTED|Overall Study||2
8304081|NCT01529502|20472896|P2|STARTED|Overall Study||3
8304082|NCT01529502|20472897|P1|STARTED|Overall Study||2
8304083|NCT01529450|20472910|P2|NOT COMPLETED|Overall Study||2
8304084|NCT01529450|20472911|P1|NOT COMPLETED|Overall Study||0
8304085|NCT01529450|20472910|P2|COMPLETED|Overall Study||6
8304086|NCT01529450|20472911|P1|COMPLETED|Overall Study||3
8304087|NCT01529450|20472910|P2|STARTED|Overall Study||8
8304088|NCT01529450|20472911|P1|STARTED|Overall Study||3
8304089|NCT01529385|20472920|P2|NOT COMPLETED|Overall Study||1
8304090|NCT01529385|20472921|P1|NOT COMPLETED|Overall Study||2
8304091|NCT01529385|20472920|P2|COMPLETED|Overall Study||39
8304092|NCT01529385|20472921|P1|COMPLETED|Overall Study||38
8304093|NCT01529385|20472920|P2|Received Intervention|Overall Study||40
8304094|NCT01529385|20472921|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
8304095|NCT01529385|20472920|P2|STARTED|Overall Study||40
8304096|NCT01529385|20472921|P1|STARTED|Overall Study||40
8304097|NCT01529346|20472950|P5|NOT COMPLETED|Overall Study||0
8304098|NCT01529346|20472951|P4|NOT COMPLETED|Overall Study||0
8304099|NCT01529346|20472952|P3|NOT COMPLETED|Overall Study||2
8304100|NCT01529346|20472953|P2|NOT COMPLETED|Overall Study||1
8304101|NCT01529346|20472954|P1|NOT COMPLETED|Overall Study||2
8304102|NCT01529346|20472950|P5|COMPLETED|Overall Study||36
8304103|NCT01529346|20472951|P4|COMPLETED|Overall Study||36
8304104|NCT01529346|20472952|P3|COMPLETED|Overall Study||52
8304105|NCT01529346|20472953|P2|COMPLETED|Overall Study||53
8304106|NCT01529346|20472954|P1|COMPLETED|Overall Study||53
8304107|NCT01529346|20472950|P5|STARTED|Overall Study||36
8304108|NCT01529346|20472951|P4|STARTED|Overall Study||36
8304109|NCT01529346|20472952|P3|STARTED|Overall Study||54
8304110|NCT01529346|20472953|P2|STARTED|Overall Study||54
8304111|NCT01529346|20472954|P1|STARTED|Overall Study||55
8304112|NCT01529268|20473042|P2|NOT COMPLETED|Overall Study||3
8304113|NCT01529268|20473043|P1|NOT COMPLETED|Overall Study||12
8304114|NCT01529268|20473042|P2|COMPLETED|Overall Study||78
8304115|NCT01529268|20473043|P1|COMPLETED|Overall Study||76
8304116|NCT01529268|20473042|P2|Completed 52-week Biopsy|Overall Study||75
8304117|NCT01529268|20473043|P1|Completed 52-week Biopsy|Overall Study||71
8304118|NCT01529268|20473042|P2|STARTED|Overall Study||81
8304119|NCT01529268|20473043|P1|STARTED|Overall Study||88
8304123|NCT01529112|20473105|P2|NOT COMPLETED|Overall Study||41
8304124|NCT01529112|20473106|P1|NOT COMPLETED|Overall Study||69
8304125|NCT01529112|20473105|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
8304126|NCT01529112|20473106|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
8304127|NCT01529112|20473105|P2|STARTED|Overall Study||46
8304128|NCT01529112|20473106|P1|STARTED|Overall Study||89
8304129|NCT01529060|20473133|P2|NOT COMPLETED|Overall Study||0
8304130|NCT01529060|20473134|P1|NOT COMPLETED|Overall Study||0
8304131|NCT01529060|20473133|P2|COMPLETED|Overall Study||10
8304132|NCT01529060|20473134|P1|COMPLETED|Overall Study||10
8304133|NCT01529060|20473133|P2|STARTED|Overall Study||10
8304134|NCT01529060|20473134|P1|STARTED|Overall Study||10
8304135|NCT01529034|20473142|P1|NOT COMPLETED|Overall Study||174
8304136|NCT01529034|20473142|P1|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
8304137|NCT01529034|20473142|P1|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
8304138|NCT01529034|20473142|P1|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
8304139|NCT01528969|20473157|P2|NOT COMPLETED|Overall Study||0
8304140|NCT01528969|20473158|P1|NOT COMPLETED|Overall Study||2
8304141|NCT01528969|20473157|P2|COMPLETED|Overall Study||38
8304142|NCT01528969|20473158|P1|COMPLETED|Overall Study||35
8304143|NCT01528969|20473157|P2|STARTED|Overall Study||38
8304144|NCT01528969|20473158|P1|STARTED|Overall Study||37
8304145|NCT01528891|20473166|P2|NOT COMPLETED|Overall Study||0
8304146|NCT01528891|20473167|P1|NOT COMPLETED|Overall Study||0
8304147|NCT01528891|20473166|P2|COMPLETED|Overall Study||200
8304148|NCT01528891|20473167|P1|COMPLETED|Overall Study||200
8304149|NCT01528891|20473166|P2|STARTED|Overall Study||200
8304150|NCT01528891|20473167|P1|STARTED|Overall Study||200
8304151|NCT01528878|20473179|P1|NOT COMPLETED|Overall Study||0
8304152|NCT01528878|20473179|P1|COMPLETED|Overall Study||30
8304153|NCT01528878|20473179|P1|STARTED|Overall Study||30
8304154|NCT01528787|20473191|P4|NOT COMPLETED|Overall Study||1
8304155|NCT01528787|20473192|P3|NOT COMPLETED|Overall Study||1
8304156|NCT01528787|20473193|P2|NOT COMPLETED|Overall Study||0
8304157|NCT01528787|20473194|P1|NOT COMPLETED|Overall Study||0
8304158|NCT01528787|20473191|P4|COMPLETED|Overall Study||22
8304159|NCT01528787|20473192|P3|COMPLETED|Overall Study||18
8304160|NCT01528787|20473193|P2|COMPLETED|Overall Study||21
8304161|NCT01528787|20473194|P1|COMPLETED|Overall Study||22
8304162|NCT01528787|20473191|P4|STARTED|Overall Study||23
8304163|NCT01528787|20473192|P3|STARTED|Overall Study||19
8304164|NCT01528787|20473193|P2|STARTED|Overall Study||21
8304165|NCT01528787|20473194|P1|STARTED|Overall Study||22
8304166|NCT01528735|20473206|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
8304167|NCT01528735|20473207|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
8304168|NCT01528735|20473206|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
8304169|NCT01528735|20473207|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
8304170|NCT01528735|20473206|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
8304171|NCT01528735|20473207|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
8304172|NCT01528735|20473206|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
8304173|NCT01528735|20473207|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
8304174|NCT01528735|20473206|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
8304175|NCT01528735|20473207|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
8304176|NCT01528735|20473206|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
8304177|NCT01528735|20473207|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
8304178|NCT01528709|20473309|P2|NOT COMPLETED|Overall Study||15
8304179|NCT01528709|20473310|P1|NOT COMPLETED|Overall Study||13
8304180|NCT01528709|20473309|P2|COMPLETED|Overall Study||72
8304181|NCT01528709|20473310|P1|COMPLETED|Overall Study||73
8304182|NCT01528709|20473309|P2|STARTED|Overall Study||87
8304183|NCT01528709|20473310|P1|STARTED|Overall Study||86
8304184|NCT01528696|20473320|P2|NOT COMPLETED|Overall Study||19
8304185|NCT01528696|20473321|P1|NOT COMPLETED|Overall Study||18
8304186|NCT01528696|20473320|P2|COMPLETED|Overall Study||0
8304187|NCT01528696|20473321|P1|COMPLETED|Overall Study||0
8304188|NCT01528696|20473320|P2|Hospital Stay (2-5 Days)|Overall Study||19
8304189|NCT01528696|20473321|P1|Hospital Stay (2-5 Days)|Overall Study||18
8304190|NCT01528696|20473320|P2|STARTED|Overall Study||19
8304191|NCT01528696|20473321|P1|STARTED|Overall Study||18
8304192|NCT01528605|20473337|P6|NOT COMPLETED|Overall Study||0
8304193|NCT01528605|20473338|P5|NOT COMPLETED|Overall Study||0
8304194|NCT01528605|20473339|P4|NOT COMPLETED|Overall Study||1
8304195|NCT01528605|20473340|P3|NOT COMPLETED|Overall Study||1
8304196|NCT01528605|20473341|P2|NOT COMPLETED|Overall Study||0
8304197|NCT01528605|20473342|P1|NOT COMPLETED|Overall Study||2
8304198|NCT01528605|20473337|P6|COMPLETED|Overall Study||28
8304199|NCT01528605|20473338|P5|COMPLETED|Overall Study||28
8304200|NCT01528605|20473339|P4|COMPLETED|Overall Study||27
8304201|NCT01528605|20473340|P3|COMPLETED|Overall Study||27
8304202|NCT01528605|20473341|P2|COMPLETED|Overall Study||28
8304203|NCT01528605|20473342|P1|COMPLETED|Overall Study||26
8304204|NCT01528605|20473337|P6|STARTED|Overall Study||28
8304205|NCT01528605|20473338|P5|STARTED|Overall Study||28
8304206|NCT01528605|20473339|P4|STARTED|Overall Study||28
8304207|NCT01528605|20473340|P3|STARTED|Overall Study||28
8304208|NCT01528605|20473341|P2|STARTED|Overall Study||28
8304209|NCT01528605|20473342|P1|STARTED|Overall Study||28
8304210|NCT01528592|20473366|P1|NOT COMPLETED|Overall Study||0
8304211|NCT01528592|20473366|P1|COMPLETED|Overall Study||18
8304212|NCT01528592|20473366|P1|STARTED|Overall Study||18
8304213|NCT01528345|20473372|P2|NOT COMPLETED|Overall Study||50
8304214|NCT01528345|20473373|P1|NOT COMPLETED|Overall Study||47
8304215|NCT01528345|20473372|P2|COMPLETED|Overall Study||0
8304216|NCT01528345|20473373|P1|COMPLETED|Overall Study||0
8304217|NCT01528345|20473372|P2|STARTED|Overall Study||50
8304218|NCT01528345|20473373|P1|STARTED|Overall Study||47
8304219|NCT01528332|20473391|P2|NOT COMPLETED|Overall Study||2
8304220|NCT01528332|20473392|P1|NOT COMPLETED|Overall Study||4
8304221|NCT01528332|20473391|P2|COMPLETED|Overall Study||84
8304222|NCT01528332|20473392|P1|COMPLETED|Overall Study||81
8304223|NCT01528332|20473391|P2|STARTED|Overall Study||86
8304224|NCT01528332|20473392|P1|STARTED|Overall Study||85
8304225|NCT01528319|20473398|P1|NOT COMPLETED|Overall Study||1
8304226|NCT01528319|20473398|P1|COMPLETED|Overall Study||23
8304227|NCT01528319|20473398|P1|12 Weeks After Surgery|Overall Study||24
8304228|NCT01528319|20473398|P1|STARTED|Overall Study||24
8304229|NCT01528293|20473409|P2|NOT COMPLETED|Overall Study||0
8304230|NCT01528293|20473410|P1|NOT COMPLETED|Overall Study||1
8304231|NCT01528293|20473409|P2|COMPLETED|Overall Study||1
8304232|NCT01528293|20473410|P1|COMPLETED|Overall Study||0
8304233|NCT01528293|20473409|P2|STARTED|Overall Study||1
8304234|NCT01528293|20473410|P1|STARTED|Overall Study||1
8304235|NCT01528254|20473424|P2|NOT COMPLETED|Overall Study||216
8304236|NCT01528254|20473425|P1|NOT COMPLETED|Overall Study||187
8304237|NCT01528254|20473424|P2|COMPLETED|Overall Study||787
8304238|NCT01528254|20473425|P1|COMPLETED|Overall Study||811
8304239|NCT01528254|20473424|P2|Completed Treatment Period 3|Overall Study||115
8304240|NCT01528254|20473425|P1|Completed Treatment Period 3|Overall Study||109
8304241|NCT01528254|20473424|P2|Completed Treatment Period 2|Overall Study||399
8304242|NCT01528254|20473425|P1|Completed Treatment Period 2|Overall Study||244
8304243|NCT01528254|20473424|P2|Completed Treatment Period 1|Overall Study||273
8304244|NCT01528254|20473425|P1|Completed Treatment Period 1|Overall Study||458
8304245|NCT01528254|20473424|P2|Full Analysis Set (FAS)|Overall Study||989
8304246|NCT01528254|20473425|P1|Full Analysis Set (FAS)|Overall Study||983
8304247|NCT01528254|20473424|P2|Safety Set|Overall Study||1001
8304248|NCT01528254|20473425|P1|Safety Set|Overall Study||998
8304249|NCT01528254|20473424|P2|STARTED|Overall Study||1003
8304250|NCT01528254|20473425|P1|STARTED|Overall Study||998
8304251|NCT01528228|20473448|P2|NOT COMPLETED|Overall Study||1
8304252|NCT01528228|20473449|P1|NOT COMPLETED|Overall Study||1
8304253|NCT01528228|20473448|P2|COMPLETED|Overall Study||9
8304254|NCT01528228|20473449|P1|COMPLETED|Overall Study||9
8304255|NCT01528228|20473448|P2|STARTED|Overall Study||10
8304256|NCT01528228|20473449|P1|STARTED|Overall Study||10
8304257|NCT01528215|20473457|P2|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
8304258|NCT01528215|20473458|P1|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
8304259|NCT01528215|20473457|P2|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
8304260|NCT01528215|20473458|P1|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
8304261|NCT01528215|20473457|P2|STARTED|1 Year Follow-up to 5 Year Follow-up||60
8304262|NCT01528215|20473458|P1|STARTED|1 Year Follow-up to 5 Year Follow-up||55
8304263|NCT01528215|20473457|P2|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
8304264|NCT01528215|20473458|P1|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
8304265|NCT01528215|20473457|P2|COMPLETED|Enrollment to 1 Year Follow-up||60
8304266|NCT01528215|20473458|P1|COMPLETED|Enrollment to 1 Year Follow-up||55
8304267|NCT01528215|20473457|P2|STARTED|Enrollment to 1 Year Follow-up||61
8304268|NCT01528215|20473458|P1|STARTED|Enrollment to 1 Year Follow-up||59
8304269|NCT01528150|20473466|P1|NOT COMPLETED|Overall Study||44
8304270|NCT01528150|20473466|P1|COMPLETED|Overall Study||422
8304271|NCT01528150|20473466|P1|STARTED|Overall Study||466
8304272|NCT01528124|20473477|P7|NOT COMPLETED|Overall Study||0
8304273|NCT01528124|20473478|P6|NOT COMPLETED|Overall Study||0
8304274|NCT01528124|20473479|P5|NOT COMPLETED|Overall Study||0
8304275|NCT01528124|20473480|P4|NOT COMPLETED|Overall Study||0
8304276|NCT01528124|20473481|P3|NOT COMPLETED|Overall Study||0
8304277|NCT01528124|20473482|P2|NOT COMPLETED|Overall Study||0
8304278|NCT01528124|20473483|P1|NOT COMPLETED|Overall Study||0
8304279|NCT01528124|20473477|P7|COMPLETED|Overall Study||6
8304280|NCT01528124|20473478|P6|COMPLETED|Overall Study||6
8304281|NCT01528124|20473479|P5|COMPLETED|Overall Study||5
8304282|NCT01528124|20473480|P4|COMPLETED|Overall Study||6
8304283|NCT01528124|20473481|P3|COMPLETED|Overall Study||6
8304284|NCT01528124|20473482|P2|COMPLETED|Overall Study||6
8304285|NCT01528124|20473483|P1|COMPLETED|Overall Study||6
8304286|NCT01528124|20473477|P7|Received Study Drug|Overall Study||6
8304287|NCT01528124|20473478|P6|Received Study Drug|Overall Study||6
8304288|NCT01528124|20473479|P5|Received Study Drug|Overall Study||5
8304289|NCT01528124|20473480|P4|Received Study Drug|Overall Study||6
8304290|NCT01528124|20473481|P3|Received Study Drug|Overall Study||6
8304291|NCT01528124|20473482|P2|Received Study Drug|Overall Study||6
8304292|NCT01528124|20473483|P1|Received Study Drug|Overall Study||6
8304293|NCT01528124|20473477|P7|STARTED|Overall Study||6
8304294|NCT01528124|20473478|P6|STARTED|Overall Study||6
8304295|NCT01528124|20473479|P5|STARTED|Overall Study||5
8304296|NCT01528124|20473480|P4|STARTED|Overall Study||6
8304297|NCT01528124|20473481|P3|STARTED|Overall Study||6
8304298|NCT01528124|20473482|P2|STARTED|Overall Study||6
8304299|NCT01528124|20473483|P1|STARTED|Overall Study||6
8304300|NCT01528072|20473517|P1|NOT COMPLETED|Overall Study||74
8304301|NCT01528072|20473517|P1|COMPLETED|Overall Study||66
8304302|NCT01528072|20473517|P1|STARTED|Overall Study||140
8304303|NCT01528033|20473523|P2|NOT COMPLETED|Follow Up||44
8304304|NCT01528033|20473524|P1|NOT COMPLETED|Follow Up||46
8304305|NCT01528033|20473523|P2|COMPLETED|Follow Up||207
8304306|NCT01528033|20473524|P1|COMPLETED|Follow Up||210
8304307|NCT01528033|20473523|P2|STARTED|Follow Up||251
8304308|NCT01528033|20473524|P1|STARTED|Follow Up||256
8304309|NCT01528033|20473523|P2|NOT COMPLETED|Primary Endpoint Assessment ITT||15
8304310|NCT01528033|20473524|P1|NOT COMPLETED|Primary Endpoint Assessment ITT||17
8304311|NCT01528033|20473523|P2|COMPLETED|Primary Endpoint Assessment ITT||251
8304312|NCT01528033|20473524|P1|COMPLETED|Primary Endpoint Assessment ITT||256
8304313|NCT01528033|20473523|P2|STARTED|Primary Endpoint Assessment ITT||266
8304314|NCT01528033|20473524|P1|STARTED|Primary Endpoint Assessment ITT||273
8304315|NCT01527942|20473536|P2|NOT COMPLETED|Overall Study||0
8304316|NCT01527942|20473537|P1|NOT COMPLETED|Overall Study||0
8304317|NCT01527942|20473536|P2|COMPLETED|Overall Study||18
8304318|NCT01527942|20473537|P1|COMPLETED|Overall Study||16
8304319|NCT01527942|20473536|P2|STARTED|Overall Study||18
8304320|NCT01527942|20473537|P1|STARTED|Overall Study||16
8304321|NCT01527682|20473547|P1|NOT COMPLETED|Overall Study||8
8304322|NCT01527682|20473547|P1|COMPLETED|Overall Study||29
8304323|NCT01527682|20473547|P1|STARTED|Overall Study||37
8304324|NCT01527513|20473555|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
8304325|NCT01527513|20473556|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
8304326|NCT01527513|20473555|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
8304327|NCT01527513|20473556|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
8304328|NCT01527513|20473555|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
8304329|NCT01527513|20473556|P1|STARTED|Eligible for 1-Year Open Label Period||0
8304330|NCT01527513|20473555|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
8304331|NCT01527513|20473556|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
8304332|NCT01527513|20473555|P2|COMPLETED|Double Blind Period (DB) - Part I||75
8304333|NCT01527513|20473556|P1|COMPLETED|Double Blind Period (DB) - Part I||37
8304334|NCT01527513|20473555|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
8304335|NCT01527513|20473556|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
8304336|NCT01527513|20473555|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
8304337|NCT01527513|20473556|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
8304338|NCT01527513|20473555|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
8304339|NCT01527513|20473556|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
8304340|NCT01527513|20473555|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
8304341|NCT01527513|20473556|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
8304342|NCT01527513|20473555|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
8304343|NCT01527513|20473556|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
8304344|NCT01527513|20473555|P2|Safety Population|Double Blind Period (DB) - Part I||83
8304345|NCT01527513|20473556|P1|Safety Population|Double Blind Period (DB) - Part I||40
8304346|NCT01527513|20473555|P2|Randomized|Double Blind Period (DB) - Part I||83
8304347|NCT01527513|20473556|P1|Randomized|Double Blind Period (DB) - Part I||40
8304348|NCT01527513|20473555|P2|STARTED|Double Blind Period (DB) - Part I||83
8304349|NCT01527513|20473556|P1|STARTED|Double Blind Period (DB) - Part I||40
8304350|NCT01527500|20473570|P2|NOT COMPLETED|Part B||0
8304351|NCT01527500|20473571|P1|NOT COMPLETED|Part B||1
8304352|NCT01527500|20473570|P2|COMPLETED|Part B||1
8304353|NCT01527500|20473571|P1|COMPLETED|Part B||6
8304354|NCT01527500|20473570|P2|STARTED|Part B||1
8304355|NCT01527500|20473571|P1|STARTED|Part B||7
8304356|NCT01527500|20473570|P2|NOT COMPLETED|Part A||13
8304357|NCT01527500|20473571|P1|NOT COMPLETED|Part A||30
8304358|NCT01527500|20473570|P2|COMPLETED|Part A||38
8304359|NCT01527500|20473571|P1|COMPLETED|Part A||69
8304360|NCT01527500|20473570|P2|STARTED|Part A||51
8304361|NCT01527500|20473571|P1|STARTED|Part A||99
8304362|NCT01527487|20473601|P2|NOT COMPLETED|Overall Study||7
8304363|NCT01527487|20473602|P1|NOT COMPLETED|Overall Study||8
8304364|NCT01527487|20473601|P2|COMPLETED|Overall Study||15
8304365|NCT01527487|20473602|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
8304366|NCT01527487|20473601|P2|STARTED|Overall Study||22
8304367|NCT01527487|20473602|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
8304368|NCT01527383|20473616|P2|NOT COMPLETED|Overall Study||4
8304369|NCT01527383|20473617|P1|NOT COMPLETED|Overall Study||15
8304370|NCT01527383|20473616|P2|COMPLETED|Overall Study||58
8304371|NCT01527383|20473617|P1|COMPLETED|Overall Study||277
8304372|NCT01527383|20473616|P2|Vaccination 4 (~Day 90)|Overall Study||58
8304373|NCT01527383|20473617|P1|Vaccination 4 (~Day 90)|Overall Study||277
8304374|NCT01527383|20473616|P2|Vaccination 3 (~Day 60)|Overall Study||58
8304375|NCT01527383|20473617|P1|Vaccination 3 (~Day 60)|Overall Study||278
8304376|NCT01527383|20473616|P2|Vaccination 2 (~Day 30)|Overall Study||61
8304377|NCT01527383|20473617|P1|Vaccination 2 (~Day 30)|Overall Study||283
8304378|NCT01527383|20473616|P2|Vaccination 1 (Day 1)|Overall Study||62
8304379|NCT01527383|20473617|P1|Vaccination 1 (Day 1)|Overall Study||291
8304380|NCT01527383|20473616|P2|STARTED|Overall Study||62
8304381|NCT01527383|20473617|P1|STARTED|Overall Study||292
8304382|NCT01527370|20473631|P1|NOT COMPLETED|Overall Study||6
8304383|NCT01527370|20473631|P1|COMPLETED|Overall Study||244
8304384|NCT01527370|20473631|P1|STARTED|Overall Study||250
8304385|NCT01527357|20473639|P2|NOT COMPLETED|Overall Study||9
8304386|NCT01527357|20473640|P1|NOT COMPLETED|Overall Study||17
8304387|NCT01527357|20473639|P2|COMPLETED|Overall Study||230
8304388|NCT01527357|20473640|P1|COMPLETED|Overall Study||465
8304389|NCT01527357|20473639|P2|Efficacy Population|Overall Study||239
8304390|NCT01527357|20473640|P1|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
8304391|NCT01527357|20473639|P2|STARTED|Overall Study||239
8304392|NCT01527357|20473640|P1|STARTED|Overall Study||482
8304393|NCT01527292|20473662|P2|NOT COMPLETED|Overall Study||3
8304394|NCT01527292|20473663|P1|NOT COMPLETED|Overall Study||0
8304395|NCT01527292|20473662|P2|COMPLETED|Overall Study||0
8304396|NCT01527292|20473663|P1|COMPLETED|Overall Study||0
8304397|NCT01527292|20473662|P2|STARTED|Overall Study||3
8304398|NCT01527292|20473663|P1|STARTED|Overall Study||0
8304399|NCT01527162|20473679|P2|NOT COMPLETED|Overall Study||0
8304400|NCT01527162|20473680|P1|NOT COMPLETED|Overall Study||0
8304401|NCT01527162|20473679|P2|COMPLETED|Overall Study||5
8304402|NCT01527162|20473680|P1|COMPLETED|Overall Study||6
8304403|NCT01527162|20473679|P2|STARTED|Overall Study||5
8304404|NCT01527162|20473680|P1|STARTED|Overall Study||6
8304405|NCT01527149|20473690|P1|NOT COMPLETED|Overall Study||2
8304406|NCT01527149|20473690|P1|COMPLETED|Overall Study||35
8304407|NCT01527149|20473690|P1|STARTED|Overall Study||37
8304408|NCT01527110|20473705|P1|NOT COMPLETED|Overall Study||1
8304409|NCT01527110|20473705|P1|COMPLETED|Overall Study||20
8304410|NCT01527110|20473705|P1|STARTED|Overall Study||21
8304411|NCT01527045|20473753|P3|NOT COMPLETED|Overall Study||0
8304412|NCT01527045|20473754|P2|NOT COMPLETED|Overall Study||0
8304413|NCT01527045|20473755|P1|NOT COMPLETED|Overall Study||1
8304414|NCT01527045|20473753|P3|COMPLETED|Overall Study||12
8304415|NCT01527045|20473754|P2|COMPLETED|Overall Study||5
8304416|NCT01527045|20473755|P1|COMPLETED|Overall Study||29
8304417|NCT01527045|20473753|P3|STARTED|Overall Study||12
8304418|NCT01527045|20473754|P2|STARTED|Overall Study||5
8304419|NCT01527045|20473755|P1|STARTED|Overall Study||30
8304420|NCT01527006|20473786|P2|NOT COMPLETED|Extension Phase||8
8304421|NCT01527006|20473787|P1|NOT COMPLETED|Extension Phase||6
8304422|NCT01527006|20473786|P2|COMPLETED|Extension Phase||14
8304423|NCT01527006|20473787|P1|COMPLETED|Extension Phase||13
8304424|NCT01527006|20473786|P2|STARTED|Extension Phase||22
8304425|NCT01527006|20473787|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
8304426|NCT01527006|20473786|P2|NOT COMPLETED|Core Study||6
8304427|NCT01527006|20473787|P1|NOT COMPLETED|Core Study||2
8304428|NCT01527006|20473786|P2|COMPLETED|Core Study||22
8304429|NCT01527006|20473787|P1|COMPLETED|Core Study||20
8304430|NCT01527006|20473786|P2|STARTED|Core Study||28
8304431|NCT01527006|20473787|P1|STARTED|Core Study||22
8304432|NCT01526928|20473843|P6|NOT COMPLETED|Overall Study||6
8304433|NCT01526928|20473844|P5|NOT COMPLETED|Overall Study||95
8304434|NCT01526928|20473845|P4|NOT COMPLETED|Overall Study||245
8304435|NCT01526928|20473846|P3|NOT COMPLETED|Overall Study||209
8304436|NCT01526928|20473847|P2|NOT COMPLETED|Overall Study||19
8304437|NCT01526928|20473848|P1|NOT COMPLETED|Overall Study||38
8304438|NCT01526928|20473843|P6|COMPLETED|Overall Study||0
8304439|NCT01526928|20473844|P5|COMPLETED|Overall Study||0
8304440|NCT01526928|20473845|P4|COMPLETED|Overall Study||0
8304441|NCT01526928|20473846|P3|COMPLETED|Overall Study||0
8304442|NCT01526928|20473847|P2|COMPLETED|Overall Study||0
8304443|NCT01526928|20473848|P1|COMPLETED|Overall Study||0
8304444|NCT01526928|20473843|P6|Started Phase 2|Overall Study||0
8304445|NCT01526928|20473844|P5|Started Phase 2|Overall Study||82
8304446|NCT01526928|20473845|P4|Started Phase 2|Overall Study||228
8304447|NCT01526928|20473846|P3|Started Phase 2|Overall Study||191
8304448|NCT01526928|20473847|P2|Started Phase 2|Overall Study||0
8304449|NCT01526928|20473848|P1|Started Phase 2|Overall Study||0
8304450|NCT01526928|20473843|P6|Started Phase 1|Overall Study||6
8304451|NCT01526928|20473844|P5|Started Phase 1|Overall Study||13
8304452|NCT01526928|20473845|P4|Started Phase 1|Overall Study||17
8304453|NCT01526928|20473846|P3|Started Phase 1|Overall Study||18
8304454|NCT01526928|20473847|P2|Started Phase 1|Overall Study||19
8304455|NCT01526928|20473848|P1|Started Phase 1|Overall Study||38
8304456|NCT01526928|20473843|P6|STARTED|Overall Study||6
8304457|NCT01526928|20473844|P5|STARTED|Overall Study||95
8304458|NCT01526928|20473845|P4|STARTED|Overall Study||245
8304459|NCT01526928|20473846|P3|STARTED|Overall Study||209
8304460|NCT01526928|20473847|P2|STARTED|Overall Study||19
8304461|NCT01526928|20473848|P1|STARTED|Overall Study||38
8304462|NCT01526902|20473967|P2|NOT COMPLETED|Overall Study||0
8304463|NCT01526902|20473968|P1|NOT COMPLETED|Overall Study||0
8304464|NCT01526902|20473967|P2|COMPLETED|Overall Study||24
8304465|NCT01526902|20473968|P1|COMPLETED|Overall Study||25
8304466|NCT01526902|20473967|P2|STARTED|Overall Study||24
8304467|NCT01526902|20473968|P1|STARTED|Overall Study||25
8304468|NCT01526889|20473986|P2|NOT COMPLETED|Treatment Extension Period||0
8304469|NCT01526889|20473987|P1|NOT COMPLETED|Treatment Extension Period||1
8304470|NCT01526889|20473986|P2|COMPLETED|Treatment Extension Period||0
8304471|NCT01526889|20473987|P1|COMPLETED|Treatment Extension Period||4
8304472|NCT01526889|20473986|P2|STARTED|Treatment Extension Period||0
8304473|NCT01526889|20473987|P1|STARTED|Treatment Extension Period||5
8304474|NCT01526889|20473986|P2|NOT COMPLETED|Treatment Period||0
8304475|NCT01526889|20473987|P1|NOT COMPLETED|Treatment Period||2
8304476|NCT01526889|20473986|P2|COMPLETED|Treatment Period||7
8304477|NCT01526889|20473987|P1|COMPLETED|Treatment Period||16
8304478|NCT01526889|20473986|P2|STARTED|Treatment Period||7
8304479|NCT01526889|20473987|P1|STARTED|Treatment Period||18
8304480|NCT01526785|20474008|P1|NOT COMPLETED|Overall Study||13
8304481|NCT01526785|20474008|P1|COMPLETED|Overall Study||100
8304482|NCT01526785|20474008|P1|STARTED|Overall Study||113
8304483|NCT01526733|20474018|P2|NOT COMPLETED|Phase 2||0
8304484|NCT01526733|20474019|P1|NOT COMPLETED|Phase 2||0
8304485|NCT01526733|20474018|P2|COMPLETED|Phase 2||12
8304486|NCT01526733|20474019|P1|COMPLETED|Phase 2||10
8304487|NCT01526733|20474018|P2|STARTED|Phase 2||12
8304488|NCT01526733|20474019|P1|STARTED|Phase 2||10
8304489|NCT01526733|20474018|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
8304490|NCT01526733|20474019|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
8304491|NCT01526733|20474018|P2|COMPLETED|Washout Period of 5 to 21 Days||12
8304492|NCT01526733|20474019|P1|COMPLETED|Washout Period of 5 to 21 Days||10
8304493|NCT01526733|20474018|P2|STARTED|Washout Period of 5 to 21 Days||12
8304494|NCT01526733|20474019|P1|STARTED|Washout Period of 5 to 21 Days||10
8304495|NCT01526733|20474018|P2|NOT COMPLETED|Phase 1||1
8304496|NCT01526733|20474019|P1|NOT COMPLETED|Phase 1||2
8304497|NCT01526733|20474018|P2|COMPLETED|Phase 1||12
8304498|NCT01526733|20474019|P1|COMPLETED|Phase 1||10
8304499|NCT01526733|20474018|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
8304500|NCT01526733|20474019|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
8304501|NCT01526733|20474018|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
8304502|NCT01526733|20474019|P1|STARTED|Phase 1||12
8304503|NCT01526629|20474037|P1|NOT COMPLETED|Overall Study||46
8304504|NCT01526629|20474037|P1|COMPLETED|Overall Study||308
8304505|NCT01526629|20474037|P1|STARTED|Overall Study||354
8304506|NCT01526577|20474046|P5|NOT COMPLETED|Overall Study||2
8304507|NCT01526577|20474047|P4|NOT COMPLETED|Overall Study||1
8304508|NCT01526577|20474048|P3|NOT COMPLETED|Overall Study||1
8304509|NCT01526577|20474049|P2|NOT COMPLETED|Overall Study||0
8304510|NCT01526577|20474050|P1|NOT COMPLETED|Overall Study||1
8304511|NCT01526577|20474046|P5|COMPLETED|Overall Study||8
8304512|NCT01526577|20474047|P4|COMPLETED|Overall Study||8
8304513|NCT01526577|20474048|P3|COMPLETED|Overall Study||32
8304514|NCT01526577|20474049|P2|COMPLETED|Overall Study||12
8304515|NCT01526577|20474050|P1|COMPLETED|Overall Study||48
8304516|NCT01526577|20474046|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
8304517|NCT01526577|20474047|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
8304518|NCT01526577|20474048|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
8304519|NCT01526577|20474049|P2|STARTED|Overall Study||12
8304520|NCT01526577|20474050|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
8304521|NCT01526551|20474058|P1|NOT COMPLETED|Overall Study||424
8304522|NCT01526551|20474058|P1|COMPLETED|Overall Study||511
8304523|NCT01526551|20474058|P1|STARTED|Overall Study||935
8304524|NCT01526538|20474065|P2|NOT COMPLETED|Overall Study||4
8304525|NCT01526538|20474066|P1|NOT COMPLETED|Overall Study||9
8304526|NCT01526538|20474065|P2|COMPLETED|Overall Study||18
8304527|NCT01526538|20474066|P1|COMPLETED|Overall Study||21
8304528|NCT01526538|20474065|P2|STARTED|Overall Study||22
8304529|NCT01526538|20474066|P1|STARTED|Overall Study||30
8304530|NCT01526356|20474079|P3|NOT COMPLETED|Overall Study||12
8304531|NCT01526356|20474080|P2|NOT COMPLETED|Overall Study||10
8304532|NCT01526356|20474081|P1|NOT COMPLETED|Overall Study||8
8304533|NCT01526356|20474079|P3|COMPLETED|Overall Study||45
8304534|NCT01526356|20474080|P2|COMPLETED|Overall Study||53
8304535|NCT01526356|20474081|P1|COMPLETED|Overall Study||51
8304536|NCT01526356|20474079|P3|STARTED|Overall Study||57
8304537|NCT01526356|20474080|P2|STARTED|Overall Study||63
8304538|NCT01526356|20474081|P1|STARTED|Overall Study||59
8304539|NCT01526343|20474107|P1|NOT COMPLETED|Overall Study||0
8304540|NCT01526343|20474107|P1|COMPLETED|Overall Study||47
8304541|NCT01526343|20474107|P1|STARTED|Overall Study||47
8304542|NCT01526213|20474118|P6|NOT COMPLETED|Period 3 (5 Days)||0
8304543|NCT01526213|20474119|P5|NOT COMPLETED|Period 3 (5 Days)||0
8304544|NCT01526213|20474120|P4|NOT COMPLETED|Period 3 (5 Days)||0
8304545|NCT01526213|20474121|P3|NOT COMPLETED|Period 3 (5 Days)||0
8304546|NCT01526213|20474122|P2|NOT COMPLETED|Period 3 (5 Days)||0
8304547|NCT01526213|20474123|P1|NOT COMPLETED|Period 3 (5 Days)||0
8304548|NCT01526213|20474118|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304549|NCT01526213|20474119|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304550|NCT01526213|20474120|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304551|NCT01526213|20474121|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304552|NCT01526213|20474122|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304553|NCT01526213|20474123|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304554|NCT01526213|20474118|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304714|NCT01525615|20474415|P3|STARTED|Overall Study||139
8304555|NCT01526213|20474119|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304556|NCT01526213|20474120|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304557|NCT01526213|20474121|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304558|NCT01526213|20474122|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304559|NCT01526213|20474123|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304560|NCT01526213|20474118|P6|NOT COMPLETED|Washout 2 (10 Days)||0
8304561|NCT01526213|20474119|P5|NOT COMPLETED|Washout 2 (10 Days)||0
8304562|NCT01526213|20474120|P4|NOT COMPLETED|Washout 2 (10 Days)||0
8304563|NCT01526213|20474121|P3|NOT COMPLETED|Washout 2 (10 Days)||0
8304564|NCT01526213|20474122|P2|NOT COMPLETED|Washout 2 (10 Days)||0
8304565|NCT01526213|20474123|P1|NOT COMPLETED|Washout 2 (10 Days)||0
8304566|NCT01526213|20474118|P6|COMPLETED|Washout 2 (10 Days)||3
8304567|NCT01526213|20474119|P5|COMPLETED|Washout 2 (10 Days)||3
8304568|NCT01526213|20474120|P4|COMPLETED|Washout 2 (10 Days)||3
8304569|NCT01526213|20474121|P3|COMPLETED|Washout 2 (10 Days)||3
8304570|NCT01526213|20474122|P2|COMPLETED|Washout 2 (10 Days)||3
8304571|NCT01526213|20474123|P1|COMPLETED|Washout 2 (10 Days)||3
8304572|NCT01526213|20474118|P6|STARTED|Washout 2 (10 Days)||3
8304573|NCT01526213|20474119|P5|STARTED|Washout 2 (10 Days)||3
8304574|NCT01526213|20474120|P4|STARTED|Washout 2 (10 Days)||3
8304575|NCT01526213|20474121|P3|STARTED|Washout 2 (10 Days)||3
8304576|NCT01526213|20474122|P2|STARTED|Washout 2 (10 Days)||3
8304577|NCT01526213|20474123|P1|STARTED|Washout 2 (10 Days)||3
8304578|NCT01526213|20474118|P6|NOT COMPLETED|Period 2 (5 Days)||0
8304579|NCT01526213|20474119|P5|NOT COMPLETED|Period 2 (5 Days)||0
8304580|NCT01526213|20474120|P4|NOT COMPLETED|Period 2 (5 Days)||0
8304581|NCT01526213|20474121|P3|NOT COMPLETED|Period 2 (5 Days)||0
8304582|NCT01526213|20474122|P2|NOT COMPLETED|Period 2 (5 Days)||0
8304583|NCT01526213|20474123|P1|NOT COMPLETED|Period 2 (5 Days)||0
8304584|NCT01526213|20474118|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304585|NCT01526213|20474119|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304586|NCT01526213|20474120|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304587|NCT01526213|20474121|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304588|NCT01526213|20474122|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304589|NCT01526213|20474123|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304590|NCT01526213|20474118|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304591|NCT01526213|20474119|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304592|NCT01526213|20474120|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304593|NCT01526213|20474121|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304594|NCT01526213|20474122|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304595|NCT01526213|20474123|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304596|NCT01526213|20474118|P6|NOT COMPLETED|Washout 1 (10 Days)||0
8304597|NCT01526213|20474119|P5|NOT COMPLETED|Washout 1 (10 Days)||0
8304598|NCT01526213|20474120|P4|NOT COMPLETED|Washout 1 (10 Days)||0
8304599|NCT01526213|20474121|P3|NOT COMPLETED|Washout 1 (10 Days)||0
8304600|NCT01526213|20474122|P2|NOT COMPLETED|Washout 1 (10 Days)||0
8304601|NCT01526213|20474123|P1|NOT COMPLETED|Washout 1 (10 Days)||0
8304602|NCT01526213|20474118|P6|COMPLETED|Washout 1 (10 Days)||3
8304603|NCT01526213|20474119|P5|COMPLETED|Washout 1 (10 Days)||3
8304604|NCT01526213|20474120|P4|COMPLETED|Washout 1 (10 Days)||3
8304605|NCT01526213|20474121|P3|COMPLETED|Washout 1 (10 Days)||3
8304606|NCT01526213|20474122|P2|COMPLETED|Washout 1 (10 Days)||3
8304607|NCT01526213|20474123|P1|COMPLETED|Washout 1 (10 Days)||3
8304608|NCT01526213|20474118|P6|STARTED|Washout 1 (10 Days)||3
8304609|NCT01526213|20474119|P5|STARTED|Washout 1 (10 Days)||3
8304610|NCT01526213|20474120|P4|STARTED|Washout 1 (10 Days)||3
8304611|NCT01526213|20474121|P3|STARTED|Washout 1 (10 Days)||3
8304612|NCT01526213|20474122|P2|STARTED|Washout 1 (10 Days)||3
8304613|NCT01526213|20474123|P1|STARTED|Washout 1 (10 Days)||3
8304614|NCT01526213|20474118|P6|NOT COMPLETED|Period 1 (5 Days)||0
8304615|NCT01526213|20474119|P5|NOT COMPLETED|Period 1 (5 Days)||0
8304616|NCT01526213|20474120|P4|NOT COMPLETED|Period 1 (5 Days)||0
8304617|NCT01526213|20474121|P3|NOT COMPLETED|Period 1 (5 Days)||0
8304618|NCT01526213|20474122|P2|NOT COMPLETED|Period 1 (5 Days)||0
8304619|NCT01526213|20474123|P1|NOT COMPLETED|Period 1 (5 Days)||0
8304620|NCT01526213|20474118|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304621|NCT01526213|20474119|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304622|NCT01526213|20474120|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304623|NCT01526213|20474121|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304624|NCT01526213|20474122|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304625|NCT01526213|20474123|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304715|NCT01525615|20474416|P2|STARTED|Overall Study||133
8304626|NCT01526213|20474118|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
8304627|NCT01526213|20474119|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304628|NCT01526213|20474120|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304629|NCT01526213|20474121|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304630|NCT01526213|20474122|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304631|NCT01526213|20474123|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304632|NCT01526148|20474136|P2|NOT COMPLETED|Overall Study||13
8304633|NCT01526148|20474137|P1|NOT COMPLETED|Overall Study||14
8304634|NCT01526148|20474136|P2|COMPLETED|Overall Study||11
8304635|NCT01526148|20474137|P1|COMPLETED|Overall Study||4
8304636|NCT01526148|20474136|P2|STARTED|Overall Study||24
8304637|NCT01526148|20474137|P1|STARTED|Overall Study||18
8304638|NCT01526057|20474148|P3|NOT COMPLETED|Overall Study||6
8304639|NCT01526057|20474149|P2|NOT COMPLETED|Overall Study||3
8304640|NCT01526057|20474150|P1|NOT COMPLETED|Overall Study||9
8304641|NCT01526057|20474148|P3|COMPLETED|Overall Study||67
8304642|NCT01526057|20474149|P2|COMPLETED|Overall Study||71
8304643|NCT01526057|20474150|P1|COMPLETED|Overall Study||64
8304644|NCT01526057|20474148|P3|STARTED|Overall Study||73
8304645|NCT01526057|20474149|P2|STARTED|Overall Study||74
8304646|NCT01526057|20474150|P1|STARTED|Overall Study||73
8304647|NCT01525927|20474235|P1|NOT COMPLETED|Overall Study||0
8304648|NCT01525927|20474235|P1|COMPLETED|Overall Study||0
8304649|NCT01525927|20474235|P1|STARTED|Overall Study||0
8304650|NCT01525875|20474249|P2|NOT COMPLETED|Open-label Period||2
8304651|NCT01525875|20474250|P1|NOT COMPLETED|Open-label Period||0
8304652|NCT01525875|20474249|P2|COMPLETED|Open-label Period||18
8304653|NCT01525875|20474250|P1|COMPLETED|Open-label Period||21
8304654|NCT01525875|20474249|P2|STARTED|Open-label Period||20
8304655|NCT01525875|20474250|P1|STARTED|Open-label Period||21
8304656|NCT01525875|20474249|P2|NOT COMPLETED|Placebo-controlled Period||2
8304657|NCT01525875|20474250|P1|NOT COMPLETED|Placebo-controlled Period||1
8304658|NCT01525875|20474249|P2|COMPLETED|Placebo-controlled Period||20
8304659|NCT01525875|20474250|P1|COMPLETED|Placebo-controlled Period||21
8304660|NCT01525875|20474249|P2|STARTED|Placebo-controlled Period||22
8304661|NCT01525875|20474250|P1|STARTED|Placebo-controlled Period||22
8304662|NCT01525862|20474264|P1|NOT COMPLETED|Overall Study||0
8304663|NCT01525862|20474264|P1|COMPLETED|Overall Study||21
8304664|NCT01525862|20474264|P1|STARTED|Overall Study||21
8304665|NCT01525849|20474273|P2|NOT COMPLETED|Overall Study||16
8304666|NCT01525849|20474274|P1|NOT COMPLETED|Overall Study||5
8304667|NCT01525849|20474273|P2|COMPLETED|Overall Study||59
8304668|NCT01525849|20474274|P1|COMPLETED|Overall Study||71
8304669|NCT01525849|20474273|P2|6-Months|Overall Study||60
8304670|NCT01525849|20474274|P1|6-Months|Overall Study||73
8304671|NCT01525849|20474273|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
8304672|NCT01525849|20474274|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
8304673|NCT01525849|20474273|P2|STARTED|Overall Study||75
8304674|NCT01525849|20474274|P1|STARTED|Overall Study||76
8304675|NCT01525745|20474290|P2|NOT COMPLETED|Overall Study||1
8304676|NCT01525745|20474291|P1|NOT COMPLETED|Overall Study||1
8304677|NCT01525745|20474290|P2|COMPLETED|Overall Study||1
8304678|NCT01525745|20474291|P1|COMPLETED|Overall Study||3
8304679|NCT01525745|20474290|P2|STARTED|Overall Study||2
8304680|NCT01525745|20474291|P1|STARTED|Overall Study||4
8304681|NCT01525667|20474308|P3|NOT COMPLETED|Overall Study||0
8304682|NCT01525667|20474309|P2|NOT COMPLETED|Overall Study||0
8304683|NCT01525667|20474310|P1|NOT COMPLETED|Overall Study||0
8304684|NCT01525667|20474308|P3|COMPLETED|Overall Study||7
8304685|NCT01525667|20474309|P2|COMPLETED|Overall Study||6
8304686|NCT01525667|20474310|P1|COMPLETED|Overall Study||7
8304687|NCT01525667|20474308|P3|STARTED|Overall Study||7
8304688|NCT01525667|20474309|P2|STARTED|Overall Study||6
8304689|NCT01525667|20474310|P1|STARTED|Overall Study||7
8304690|NCT01525641|20474330|P1|NOT COMPLETED|Overall Study||180
8304691|NCT01525641|20474330|P1|COMPLETED|Overall Study||435
8304692|NCT01525641|20474330|P1|STARTED|Overall Study||615
8304693|NCT01525628|20474344|P5|NOT COMPLETED|Overall Study||3
8304694|NCT01525628|20474345|P4|NOT COMPLETED|Overall Study||4
8304695|NCT01525628|20474346|P3|NOT COMPLETED|Overall Study||5
8304696|NCT01525628|20474347|P2|NOT COMPLETED|Overall Study||5
8304697|NCT01525628|20474348|P1|NOT COMPLETED|Overall Study||2
8304698|NCT01525628|20474344|P5|COMPLETED|Overall Study||4
8304699|NCT01525628|20474345|P4|COMPLETED|Overall Study||10
8304700|NCT01525628|20474346|P3|COMPLETED|Overall Study||11
8304701|NCT01525628|20474347|P2|COMPLETED|Overall Study||14
8304702|NCT01525628|20474348|P1|COMPLETED|Overall Study||14
8304703|NCT01525628|20474344|P5|STARTED|Overall Study||7
8304704|NCT01525628|20474345|P4|STARTED|Overall Study||14
8304705|NCT01525628|20474346|P3|STARTED|Overall Study||16
8304706|NCT01525628|20474347|P2|STARTED|Overall Study||19
8304707|NCT01525628|20474348|P1|STARTED|Overall Study||16
8304708|NCT01525615|20474415|P3|NOT COMPLETED|Overall Study||6
8304709|NCT01525615|20474416|P2|NOT COMPLETED|Overall Study||7
8304710|NCT01525615|20474417|P1|NOT COMPLETED|Overall Study||14
8304711|NCT01525615|20474415|P3|COMPLETED|Overall Study||133
8304712|NCT01525615|20474416|P2|COMPLETED|Overall Study||126
8304713|NCT01525615|20474417|P1|COMPLETED|Overall Study||118
8304716|NCT01525615|20474417|P1|STARTED|Overall Study||132
8304717|NCT01525602|20474469|P8|NOT COMPLETED|Overall Study||7
8304718|NCT01525602|20474470|P7|NOT COMPLETED|Overall Study||6
8304719|NCT01525602|20474471|P6|NOT COMPLETED|Overall Study||7
8304720|NCT01525602|20474472|P5|NOT COMPLETED|Overall Study||33
8304721|NCT01525602|20474473|P4|NOT COMPLETED|Overall Study||6
8304722|NCT01525602|20474474|P3|NOT COMPLETED|Overall Study||3
8304723|NCT01525602|20474475|P2|NOT COMPLETED|Overall Study||3
8304724|NCT01525602|20474476|P1|NOT COMPLETED|Overall Study||9
8304725|NCT01525602|20474469|P8|COMPLETED|Overall Study||0
8304726|NCT01525602|20474470|P7|COMPLETED|Overall Study||0
8304727|NCT01525602|20474471|P6|COMPLETED|Overall Study||0
8304728|NCT01525602|20474472|P5|COMPLETED|Overall Study||0
8304729|NCT01525602|20474473|P4|COMPLETED|Overall Study||0
8304730|NCT01525602|20474474|P3|COMPLETED|Overall Study||0
8304731|NCT01525602|20474475|P2|COMPLETED|Overall Study||0
8304732|NCT01525602|20474476|P1|COMPLETED|Overall Study||0
8304733|NCT01525602|20474469|P8|STARTED|Overall Study||7
8304734|NCT01525602|20474470|P7|STARTED|Overall Study||6
8304735|NCT01525602|20474471|P6|STARTED|Overall Study||7
8304736|NCT01525602|20474472|P5|STARTED|Overall Study||33
8304737|NCT01525602|20474473|P4|STARTED|Overall Study||6
8304738|NCT01525602|20474474|P3|STARTED|Overall Study||3
8304739|NCT01525602|20474475|P2|STARTED|Overall Study||3
8304740|NCT01525602|20474476|P1|STARTED|Overall Study||9
8304741|NCT01525589|20474547|P3|NOT COMPLETED|Overall Study||35
8304742|NCT01525589|20474548|P2|NOT COMPLETED|Overall Study||20
8304743|NCT01525589|20474549|P1|NOT COMPLETED|Overall Study||56
8304744|NCT01525589|20474547|P3|COMPLETED|Overall Study||0
8304745|NCT01525589|20474548|P2|COMPLETED|Overall Study||0
8304746|NCT01525589|20474549|P1|COMPLETED|Overall Study||0
8304747|NCT01525589|20474547|P3|STARTED|Overall Study||35
8304748|NCT01525589|20474548|P2|STARTED|Overall Study||20
8304749|NCT01525589|20474549|P1|STARTED|Overall Study||56
8304750|NCT01525563|20474593|P1|NOT COMPLETED|Overall Study||212
8304751|NCT01525563|20474593|P1|COMPLETED|Overall Study|6 Months Follow-up|788
8304752|NCT01525563|20474593|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
8304753|NCT01525563|20474593|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
8304754|NCT01525563|20474593|P1|STARTED|Overall Study||1000
8304755|NCT01525550|20474605|P2|NOT COMPLETED|Overall Study||45
8304756|NCT01525550|20474606|P1|NOT COMPLETED|Overall Study||61
8304757|NCT01525550|20474605|P2|COMPLETED|Overall Study||0
8304758|NCT01525550|20474606|P1|COMPLETED|Overall Study||0
8304759|NCT01525550|20474605|P2|STARTED|Overall Study||45
8304760|NCT01525550|20474606|P1|STARTED|Overall Study||61
8304761|NCT01525420|20474668|P2|NOT COMPLETED|Overall Study||24
8304762|NCT01525420|20474669|P1|NOT COMPLETED|Overall Study||16
8304763|NCT01525420|20474668|P2|COMPLETED|Overall Study||38
8304764|NCT01525420|20474669|P1|COMPLETED|Overall Study||43
8304765|NCT01525420|20474668|P2|STARTED|Overall Study||62
8304766|NCT01525420|20474669|P1|STARTED|Overall Study||59
8304767|NCT01525407|20474677|P2|NOT COMPLETED|Overall Study||4
8304768|NCT01525407|20474678|P1|NOT COMPLETED|Overall Study||3
8304769|NCT01525407|20474677|P2|COMPLETED|Overall Study||38
8304770|NCT01525407|20474678|P1|COMPLETED|Overall Study||38
8304771|NCT01525407|20474677|P2|STARTED|Overall Study||42
8304772|NCT01525407|20474678|P1|STARTED|Overall Study||41
8304773|NCT01525329|20474694|P2|NOT COMPLETED|Overall Study||0
8304774|NCT01525329|20474695|P1|NOT COMPLETED|Overall Study||0
8304775|NCT01525329|20474694|P2|COMPLETED|Overall Study||14
8304776|NCT01525329|20474695|P1|COMPLETED|Overall Study||4
8304777|NCT01525329|20474694|P2|STARTED|Overall Study||14
8304778|NCT01525329|20474695|P1|STARTED|Overall Study||4
8304779|NCT01525238|20474712|P3|NOT COMPLETED|Overall Study||0
8304780|NCT01525238|20474713|P2|NOT COMPLETED|Overall Study||0
8304781|NCT01525238|20474714|P1|NOT COMPLETED|Overall Study||1
8304782|NCT01525238|20474712|P3|COMPLETED|Overall Study||8
8304783|NCT01525238|20474713|P2|COMPLETED|Overall Study||8
8304784|NCT01525238|20474714|P1|COMPLETED|Overall Study||7
8304785|NCT01525238|20474712|P3|STARTED|Overall Study||8
8304786|NCT01525238|20474713|P2|STARTED|Overall Study||8
8304787|NCT01525238|20474714|P1|STARTED|Overall Study||8
8304788|NCT01525225|20474779|P1|NOT COMPLETED|Treated||0
8304789|NCT01525225|20474779|P1|COMPLETED|Treated||2
8304790|NCT01525225|20474779|P1|STARTED|Treated||2
8304791|NCT01525225|20474779|P1|NOT COMPLETED|Enrollment||2
8304792|NCT01525225|20474779|P1|COMPLETED|Enrollment||2
8304793|NCT01525225|20474779|P1|STARTED|Enrollment||4
8304794|NCT01525173|20474786|P2|NOT COMPLETED|Overall Study||5
8304795|NCT01525173|20474787|P1|NOT COMPLETED|Overall Study||7
8304796|NCT01525173|20474786|P2|COMPLETED|Overall Study||62
8304797|NCT01525173|20474787|P1|COMPLETED|Overall Study||63
8304798|NCT01525173|20474786|P2|STARTED|Overall Study||67
8304799|NCT01525173|20474787|P1|STARTED|Overall Study||70
8304800|NCT01525082|20474793|P1|NOT COMPLETED|Overall Study||1
8304801|NCT01525082|20474793|P1|COMPLETED|Overall Study||19
8304802|NCT01525082|20474793|P1|STARTED|Overall Study||20
8304803|NCT01524991|20474804|P1|NOT COMPLETED|Overall Study||34
8304804|NCT01524991|20474804|P1|COMPLETED|Overall Study||2
8304805|NCT01524991|20474804|P1|STARTED|Overall Study||36
8304806|NCT01524978|20474822|P11|NOT COMPLETED|Overall Study||28
8304807|NCT01524978|20474823|P10|NOT COMPLETED|Overall Study||9
8304808|NCT01524978|20474824|P9|NOT COMPLETED|Overall Study||12
8304809|NCT01524978|20474825|P8|NOT COMPLETED|Overall Study||12
8304810|NCT01524978|20474826|P7|NOT COMPLETED|Overall Study||26
8304811|NCT01524978|20474827|P6|NOT COMPLETED|Overall Study||9
8304812|NCT01524978|20474828|P5|NOT COMPLETED|Overall Study||9
8304813|NCT01524978|20474829|P4|NOT COMPLETED|Overall Study||27
8304814|NCT01524978|20474830|P3|NOT COMPLETED|Overall Study||10
8304815|NCT01524978|20474831|P2|NOT COMPLETED|Overall Study||4
8304816|NCT01524978|20474832|P1|NOT COMPLETED|Overall Study||62
8304817|NCT01524978|20474822|P11|COMPLETED|Overall Study||0
8304818|NCT01524978|20474823|P10|COMPLETED|Overall Study||0
8304819|NCT01524978|20474824|P9|COMPLETED|Overall Study||0
8304820|NCT01524978|20474825|P8|COMPLETED|Overall Study||0
8304821|NCT01524978|20474826|P7|COMPLETED|Overall Study||0
8304822|NCT01524978|20474827|P6|COMPLETED|Overall Study||0
8304823|NCT01524978|20474828|P5|COMPLETED|Overall Study||0
8304824|NCT01524978|20474829|P4|COMPLETED|Overall Study||0
8304825|NCT01524978|20474830|P3|COMPLETED|Overall Study||0
8304826|NCT01524978|20474831|P2|COMPLETED|Overall Study||0
8304827|NCT01524978|20474832|P1|COMPLETED|Overall Study||0
8304828|NCT01524978|20474822|P11|STARTED|Overall Study||28
8304829|NCT01524978|20474823|P10|STARTED|Overall Study||9
8304830|NCT01524978|20474824|P9|STARTED|Overall Study||12
8304831|NCT01524978|20474825|P8|STARTED|Overall Study||12
8304832|NCT01524978|20474826|P7|STARTED|Overall Study||26
8304833|NCT01524978|20474827|P6|STARTED|Overall Study||9
8304834|NCT01524978|20474828|P5|STARTED|Overall Study||9
8304835|NCT01524978|20474829|P4|STARTED|Overall Study||27
8304836|NCT01524978|20474830|P3|STARTED|Overall Study||10
8304837|NCT01524978|20474831|P2|STARTED|Overall Study||4
8304838|NCT01524978|20474832|P1|STARTED|Overall Study||62
8304839|NCT01524913|20474960|P3|NOT COMPLETED|Overall Study||0
8304840|NCT01524913|20474961|P2|NOT COMPLETED|Overall Study||0
8304841|NCT01524913|20474962|P1|NOT COMPLETED|Overall Study||4
8304842|NCT01524913|20474960|P3|COMPLETED|Overall Study||31
8304843|NCT01524913|20474961|P2|COMPLETED|Overall Study||36
8304844|NCT01524913|20474962|P1|COMPLETED|Overall Study||31
8304845|NCT01524913|20474960|P3|STARTED|Overall Study||31
8304846|NCT01524913|20474961|P2|STARTED|Overall Study||36
8304847|NCT01524913|20474962|P1|STARTED|Overall Study||35
8304848|NCT01524900|20474984|P5|NOT COMPLETED|Overall Study||0
8304849|NCT01524900|20474985|P4|NOT COMPLETED|Overall Study||1
8304850|NCT01524900|20474986|P3|NOT COMPLETED|Overall Study||1
8304851|NCT01524900|20474987|P2|NOT COMPLETED|Overall Study||14
8304852|NCT01524900|20474988|P1|NOT COMPLETED|Overall Study||6
8304853|NCT01524900|20474984|P5|COMPLETED|Overall Study||40
8304854|NCT01524900|20474985|P4|COMPLETED|Overall Study||21
8304855|NCT01524900|20474986|P3|COMPLETED|Overall Study||29
8304856|NCT01524900|20474987|P2|COMPLETED|Overall Study||232
8304857|NCT01524900|20474988|P1|COMPLETED|Overall Study||43
8304858|NCT01524900|20474984|P5|STARTED|Overall Study||40
8304859|NCT01524900|20474985|P4|STARTED|Overall Study||22
8304860|NCT01524900|20474986|P3|STARTED|Overall Study||30
8304861|NCT01524900|20474987|P2|STARTED|Overall Study||246
8304862|NCT01524900|20474988|P1|STARTED|Overall Study||49
8304863|NCT01524887|20475033|P3|NOT COMPLETED|Overall Study||86
8304864|NCT01524887|20475034|P2|NOT COMPLETED|Overall Study||90
8304865|NCT01524887|20475035|P1|NOT COMPLETED|Overall Study||85
8304866|NCT01524887|20475033|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8304867|NCT01524887|20475034|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8304868|NCT01524887|20475035|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8304869|NCT01524887|20475033|P3|Received Treatment|Overall Study||83
8304870|NCT01524887|20475034|P2|Received Treatment|Overall Study||85
8304871|NCT01524887|20475035|P1|Received Treatment|Overall Study||83
8304872|NCT01524887|20475033|P3|STARTED|Overall Study||86
8304873|NCT01524887|20475034|P2|STARTED|Overall Study||90
8304874|NCT01524887|20475035|P1|STARTED|Overall Study||85
8304875|NCT01524783|20475081|P2|NOT COMPLETED|Randomized and Treated||84
8304876|NCT01524783|20475082|P1|NOT COMPLETED|Randomized and Treated||155
8304877|NCT01524783|20475081|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
8304878|NCT01524783|20475082|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
8304879|NCT01524783|20475081|P2|STARTED|Randomized and Treated||97
8304880|NCT01524783|20475082|P1|STARTED|Randomized and Treated||203
8304881|NCT01524783|20475081|P2|NOT COMPLETED|Randomized But Not Treated||0
8304882|NCT01524783|20475082|P1|NOT COMPLETED|Randomized But Not Treated||2
8304883|NCT01524783|20475081|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
8304884|NCT01524783|20475082|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
8304885|NCT01524783|20475081|P2|STARTED|Randomized But Not Treated||97
8304886|NCT01524783|20475082|P1|STARTED|Randomized But Not Treated||205
8304887|NCT01524770|20475090|P2|NOT COMPLETED|Second Intervention||0
8304888|NCT01524770|20475091|P1|NOT COMPLETED|Second Intervention||0
8304889|NCT01524770|20475090|P2|COMPLETED|Second Intervention||23
8304890|NCT01524770|20475091|P1|COMPLETED|Second Intervention||23
8304891|NCT01524770|20475090|P2|STARTED|Second Intervention||23
8304892|NCT01524770|20475091|P1|STARTED|Second Intervention||23
8304893|NCT01524770|20475090|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
8304894|NCT01524770|20475091|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
8304895|NCT01524770|20475090|P2|COMPLETED|Washout Period of at Least 28 Days||23
8304896|NCT01524770|20475091|P1|COMPLETED|Washout Period of at Least 28 Days||23
8304897|NCT01524770|20475090|P2|STARTED|Washout Period of at Least 28 Days||23
8304898|NCT01524770|20475091|P1|STARTED|Washout Period of at Least 28 Days||23
8304899|NCT01524770|20475090|P2|NOT COMPLETED|First Intervention||1
8304900|NCT01524770|20475091|P1|NOT COMPLETED|First Intervention||3
8304901|NCT01524770|20475090|P2|COMPLETED|First Intervention||23
8304902|NCT01524770|20475091|P1|COMPLETED|First Intervention||23
8304903|NCT01524770|20475090|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
8304904|NCT01524770|20475091|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
8304905|NCT01524770|20475090|P2|STARTED|First Intervention||24
8304906|NCT01524770|20475091|P1|STARTED|First Intervention||26
8304907|NCT01524692|20475101|P1|NOT COMPLETED|Overall Study||3
8304908|NCT01524692|20475101|P1|COMPLETED|Overall Study||32
8304909|NCT01524692|20475101|P1|STARTED|Overall Study||35
8304910|NCT01524679|20475111|P2|NOT COMPLETED|Overall Study||9
8304911|NCT01524679|20475112|P1|NOT COMPLETED|Overall Study||23
8304912|NCT01524679|20475111|P2|COMPLETED|Overall Study||49
8304913|NCT01524679|20475112|P1|COMPLETED|Overall Study||89
8304914|NCT01524679|20475111|P2|STARTED|Overall Study||58
8304915|NCT01524679|20475112|P1|STARTED|Overall Study||112
8304916|NCT01524627|20475124|P2|NOT COMPLETED|Overall Study||2
8304917|NCT01524627|20475125|P1|NOT COMPLETED|Overall Study||1
8304918|NCT01524627|20475124|P2|COMPLETED|Overall Study||19
8304919|NCT01524627|20475125|P1|COMPLETED|Overall Study||21
8304920|NCT01524627|20475124|P2|STARTED|Overall Study||21
8304921|NCT01524627|20475125|P1|STARTED|Overall Study||22
8304922|NCT01524302|20475133|P2|NOT COMPLETED|Overall Study||0
8304923|NCT01524302|20475134|P1|NOT COMPLETED|Overall Study||0
8304924|NCT01524302|20475133|P2|COMPLETED|Overall Study||6
8304925|NCT01524302|20475134|P1|COMPLETED|Overall Study||6
8304926|NCT01524302|20475133|P2|STARTED|Overall Study||6
8304927|NCT01524302|20475134|P1|STARTED|Overall Study||6
8304928|NCT01524289|20475152|P2|NOT COMPLETED|Overall Study||14
8304929|NCT01524289|20475153|P1|NOT COMPLETED|Overall Study||30
8304930|NCT01524289|20475152|P2|COMPLETED|Overall Study||88
8304931|NCT01524289|20475153|P1|COMPLETED|Overall Study||174
8304932|NCT01524289|20475152|P2|Treated|Overall Study||102
8304933|NCT01524289|20475153|P1|Treated|Overall Study||203
8304934|NCT01524289|20475152|P2|STARTED|Overall Study||102
8304935|NCT01524289|20475153|P1|STARTED|Overall Study||204
8304936|NCT01524224|20475211|P8|NOT COMPLETED|Overall Study||6
8304937|NCT01524224|20475212|P7|NOT COMPLETED|Overall Study||3
8304938|NCT01524224|20475213|P6|NOT COMPLETED|Overall Study||2
8304939|NCT01524224|20475214|P5|NOT COMPLETED|Overall Study||4
8304940|NCT01524224|20475215|P4|NOT COMPLETED|Overall Study||2
8304941|NCT01524224|20475216|P3|NOT COMPLETED|Overall Study||2
8304942|NCT01524224|20475217|P2|NOT COMPLETED|Overall Study||1
8304943|NCT01524224|20475218|P1|NOT COMPLETED|Overall Study||3
8304944|NCT01524224|20475211|P8|COMPLETED|Overall Study||0
8304945|NCT01524224|20475212|P7|COMPLETED|Overall Study||0
8304946|NCT01524224|20475213|P6|COMPLETED|Overall Study||1
8304947|NCT01524224|20475214|P5|COMPLETED|Overall Study||0
8304948|NCT01524224|20475215|P4|COMPLETED|Overall Study||1
8304949|NCT01524224|20475216|P3|COMPLETED|Overall Study||1
8304950|NCT01524224|20475217|P2|COMPLETED|Overall Study||2
8304951|NCT01524224|20475218|P1|COMPLETED|Overall Study||1
8304952|NCT01524224|20475211|P8|Received at Least One Dose of Study Drug|Overall Study||6
8304953|NCT01524224|20475212|P7|Received at Least One Dose of Study Drug|Overall Study||3
8304954|NCT01524224|20475213|P6|Received at Least One Dose of Study Drug|Overall Study||3
8304955|NCT01524224|20475214|P5|Received at Least One Dose of Study Drug|Overall Study||4
8304956|NCT01524224|20475215|P4|Received at Least One Dose of Study Drug|Overall Study||3
8304957|NCT01524224|20475216|P3|Received at Least One Dose of Study Drug|Overall Study||3
8304958|NCT01524224|20475217|P2|Received at Least One Dose of Study Drug|Overall Study||3
8304959|NCT01524224|20475218|P1|Received at Least One Dose of Study Drug|Overall Study||4
8304960|NCT01524224|20475211|P8|STARTED|Overall Study||6
8304961|NCT01524224|20475212|P7|STARTED|Overall Study||3
8304962|NCT01524224|20475213|P6|STARTED|Overall Study||3
8304963|NCT01524224|20475214|P5|STARTED|Overall Study||4
8304964|NCT01524224|20475215|P4|STARTED|Overall Study||3
8304965|NCT01524224|20475216|P3|STARTED|Overall Study||3
8304966|NCT01524224|20475217|P2|STARTED|Overall Study||3
8304967|NCT01524224|20475218|P1|STARTED|Overall Study||4
8304968|NCT01524198|20475254|P2|NOT COMPLETED|Overall Study||16
8304969|NCT01524198|20475255|P1|NOT COMPLETED|Overall Study||23
8304970|NCT01524198|20475254|P2|COMPLETED|Overall Study||458
8304971|NCT01524198|20475255|P1|COMPLETED|Overall Study||448
8304972|NCT01524198|20475254|P2|STARTED|Overall Study||474
8304973|NCT01524198|20475255|P1|STARTED|Overall Study||471
8304974|NCT01524133|20475266|P3|NOT COMPLETED|Overall Study 52 Weeks||27
8304975|NCT01524133|20475267|P2|NOT COMPLETED|Overall Study 52 Weeks||20
8304976|NCT01524133|20475268|P1|NOT COMPLETED|Overall Study 52 Weeks||21
8304977|NCT01524133|20475266|P3|COMPLETED|Overall Study 52 Weeks||40
8304978|NCT01524133|20475267|P2|COMPLETED|Overall Study 52 Weeks||49
8304979|NCT01524133|20475268|P1|COMPLETED|Overall Study 52 Weeks||50
8304980|NCT01524133|20475266|P3|STARTED|Overall Study 52 Weeks||67
8304981|NCT01524133|20475267|P2|STARTED|Overall Study 52 Weeks||69
8304982|NCT01524133|20475268|P1|STARTED|Overall Study 52 Weeks||71
8304983|NCT01524133|20475266|P3|NOT COMPLETED|Treatment Phase||36
8304984|NCT01524133|20475267|P2|NOT COMPLETED|Treatment Phase||32
8304985|NCT01524133|20475268|P1|NOT COMPLETED|Treatment Phase||19
8304986|NCT01524133|20475266|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
8304987|NCT01524133|20475267|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
8304988|NCT01524133|20475268|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
8304989|NCT01524133|20475266|P3|STARTED|Treatment Phase||67
8304990|NCT01524133|20475267|P2|STARTED|Treatment Phase||69
8304991|NCT01524133|20475268|P1|STARTED|Treatment Phase||71
8304992|NCT01523964|20475283|P4|NOT COMPLETED|Overall Study||0
8304993|NCT01523964|20475284|P3|NOT COMPLETED|Overall Study||0
8304994|NCT01523964|20475285|P2|NOT COMPLETED|Overall Study||0
8304995|NCT01523964|20475286|P1|NOT COMPLETED|Overall Study||0
8304996|NCT01523964|20475283|P4|COMPLETED|Overall Study||15
8304997|NCT01523964|20475284|P3|COMPLETED|Overall Study||16
8304998|NCT01523964|20475285|P2|COMPLETED|Overall Study||30
8304999|NCT01523964|20475286|P1|COMPLETED|Overall Study||31
8305000|NCT01523964|20475283|P4|STARTED|Overall Study||15
8305001|NCT01523964|20475284|P3|STARTED|Overall Study||16
8305002|NCT01523964|20475285|P2|STARTED|Overall Study||30
8305003|NCT01523964|20475286|P1|STARTED|Overall Study||31
8305004|NCT01523899|20475298|P2|NOT COMPLETED|Overall Study||0
8305005|NCT01523899|20475299|P1|NOT COMPLETED|Overall Study||0
8305006|NCT01523899|20475298|P2|COMPLETED|Overall Study||126
8305007|NCT01523899|20475299|P1|COMPLETED|Overall Study||126
8305008|NCT01523899|20475298|P2|STARTED|Overall Study||126
8305009|NCT01523899|20475299|P1|STARTED|Overall Study||126
8305010|NCT01523886|20475311|P2|NOT COMPLETED|Overall Study||1
8305011|NCT01523886|20475312|P1|NOT COMPLETED|Overall Study||0
8305012|NCT01523886|20475311|P2|COMPLETED|Overall Study||23
8305013|NCT01523886|20475312|P1|COMPLETED|Overall Study||25
8305014|NCT01523886|20475311|P2|STARTED|Overall Study||24
8305015|NCT01523886|20475312|P1|STARTED|Overall Study||25
8305016|NCT01523873|20475318|P1|NOT COMPLETED|Overall Study||422
8305017|NCT01523873|20475318|P1|COMPLETED|Overall Study||35499
8305018|NCT01523873|20475318|P1|Administered With Dotarem|Overall Study||35474
8305019|NCT01523873|20475318|P1|STARTED|Overall Study||35921
8305020|NCT01523834|20475325|P1|NOT COMPLETED|Overall Study||31
8305021|NCT01523834|20475325|P1|COMPLETED|Overall Study||4
8305022|NCT01523834|20475325|P1|Maintenance Phase|Overall Study|Started Maintenance Phase|6
8305023|NCT01523834|20475325|P1|Consolidation Phase|Overall Study|Started Consolidation Phase|7
8305024|NCT01523834|20475325|P1|STARTED|Overall Study|Started Induction Phase|35
8305025|NCT01523821|20475336|P3|NOT COMPLETED|Overall Study||0
8305026|NCT01523821|20475337|P2|NOT COMPLETED|Overall Study||0
8305027|NCT01523821|20475338|P1|NOT COMPLETED|Overall Study||0
8305028|NCT01523821|20475336|P3|COMPLETED|Overall Study||6
8305029|NCT01523821|20475337|P2|COMPLETED|Overall Study||6
8305030|NCT01523821|20475338|P1|COMPLETED|Overall Study||8
8305031|NCT01523821|20475336|P3|STARTED|Overall Study||6
8305032|NCT01523821|20475337|P2|STARTED|Overall Study||6
8305033|NCT01523821|20475338|P1|STARTED|Overall Study||8
8305034|NCT01523782|20475364|P3|NOT COMPLETED|Overall Study||5
8305035|NCT01523782|20475365|P2|NOT COMPLETED|Overall Study||0
8305036|NCT01523782|20475366|P1|NOT COMPLETED|Overall Study||1
8305037|NCT01523782|20475364|P3|COMPLETED|Overall Study||9
8305038|NCT01523782|20475365|P2|COMPLETED|Overall Study||13
8305039|NCT01523782|20475366|P1|COMPLETED|Overall Study||2
8305040|NCT01523782|20475364|P3|STARTED|Overall Study||14
8305041|NCT01523782|20475365|P2|STARTED|Overall Study||13
8305042|NCT01523782|20475366|P1|STARTED|Overall Study||3
8305043|NCT01523756|20475413|P2|NOT COMPLETED|Test Period 2||1
8305044|NCT01523756|20475414|P1|NOT COMPLETED|Test Period 2||0
8305045|NCT01523756|20475413|P2|COMPLETED|Test Period 2||7
8305046|NCT01523756|20475414|P1|COMPLETED|Test Period 2||10
8305047|NCT01523756|20475413|P2|STARTED|Test Period 2||8
8305048|NCT01523756|20475414|P1|STARTED|Test Period 2||10
8305049|NCT01523756|20475413|P2|NOT COMPLETED|Test Period 1||0
8305050|NCT01523756|20475414|P1|NOT COMPLETED|Test Period 1||1
8305051|NCT01523756|20475413|P2|COMPLETED|Test Period 1||8
8305052|NCT01523756|20475414|P1|COMPLETED|Test Period 1||10
8305053|NCT01523756|20475413|P2|STARTED|Test Period 1||8
8305054|NCT01523756|20475414|P1|STARTED|Test Period 1||11
8305055|NCT01523756|20475413|P2|NOT COMPLETED|Baseline Period||1
8305056|NCT01523756|20475414|P1|NOT COMPLETED|Baseline Period||0
8305057|NCT01523756|20475413|P2|COMPLETED|Baseline Period||8
8305058|NCT01523756|20475414|P1|COMPLETED|Baseline Period||11
8305059|NCT01523756|20475413|P2|STARTED|Baseline Period||9
8305060|NCT01523756|20475414|P1|STARTED|Baseline Period||11
8305061|NCT01523743|20475422|P2|NOT COMPLETED|Period 2||2
8305062|NCT01523743|20475423|P1|NOT COMPLETED|Period 2||1
8305063|NCT01523743|20475422|P2|COMPLETED|Period 2||58
8305064|NCT01523743|20475423|P1|COMPLETED|Period 2||52
8305065|NCT01523743|20475422|P2|STARTED|Period 2||60
8305066|NCT01523743|20475423|P1|STARTED|Period 2||53
8305067|NCT01523743|20475422|P2|NOT COMPLETED|Period 1||2
8305068|NCT01523743|20475423|P1|NOT COMPLETED|Period 1||10
8305069|NCT01523743|20475422|P2|COMPLETED|Period 1||60
8305070|NCT01523743|20475423|P1|COMPLETED|Period 1||53
8305071|NCT01523743|20475422|P2|STARTED|Period 1||62
8305072|NCT01523743|20475423|P1|STARTED|Period 1||63
8305073|NCT01523704|20475431|P2|NOT COMPLETED|Overall Study||88
8305074|NCT01523704|20475432|P1|NOT COMPLETED|Overall Study||78
8305075|NCT01523704|20475431|P2|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
8305076|NCT01523704|20475432|P1|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
8305077|NCT01523704|20475431|P2|STARTED|Overall Study|January 2012|638
8305078|NCT01523704|20475432|P1|STARTED|Overall Study|January 2012|636
8305079|NCT01523613|20475445|P3|NOT COMPLETED|Overall Study||12
8305080|NCT01523613|20475446|P2|NOT COMPLETED|Overall Study||5
8305081|NCT01523613|20475447|P1|NOT COMPLETED|Overall Study||7
8305082|NCT01523613|20475445|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
8305083|NCT01523613|20475446|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
8305084|NCT01523613|20475447|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
8305085|NCT01523613|20475445|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
8305086|NCT01523613|20475446|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
8305087|NCT01523613|20475447|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
8305088|NCT01523587|20475459|P2|NOT COMPLETED|Overall Study||397
8305089|NCT01523587|20475460|P1|NOT COMPLETED|Overall Study||398
8305090|NCT01523587|20475459|P2|COMPLETED|Overall Study||0
8305091|NCT01523587|20475460|P1|COMPLETED|Overall Study||0
8305092|NCT01523587|20475459|P2|Treated|Overall Study||395
8305093|NCT01523587|20475460|P1|Treated|Overall Study||392
8305094|NCT01523587|20475459|P2|STARTED|Overall Study||397
8305095|NCT01523587|20475460|P1|STARTED|Overall Study||398
8305096|NCT01523496|20475484|P4|NOT COMPLETED|Overall Study||3
8305097|NCT01523496|20475485|P3|NOT COMPLETED|Overall Study||12
8305098|NCT01523496|20475486|P2|NOT COMPLETED|Overall Study||4
8305099|NCT01523496|20475487|P1|NOT COMPLETED|Overall Study||10
8305100|NCT01523496|20475484|P4|COMPLETED|Overall Study||27
8305101|NCT01523496|20475485|P3|COMPLETED|Overall Study||46
8305102|NCT01523496|20475486|P2|COMPLETED|Overall Study||32
8305103|NCT01523496|20475487|P1|COMPLETED|Overall Study||56
8305104|NCT01523496|20475484|P4|STARTED|Overall Study||30
8305105|NCT01523496|20475485|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
8305106|NCT01523496|20475486|P2|STARTED|Overall Study||36
8305107|NCT01523496|20475487|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
8305108|NCT01523457|20475503|P2|NOT COMPLETED|Overall Study||2
8305109|NCT01523457|20475504|P1|NOT COMPLETED|Overall Study||7
8305110|NCT01523457|20475503|P2|COMPLETED|Overall Study||29
8305111|NCT01523457|20475504|P1|COMPLETED|Overall Study||37
8305112|NCT01523457|20475503|P2|STARTED|Overall Study||31
8305113|NCT01523457|20475504|P1|STARTED|Overall Study||44
8305114|NCT01523392|20475522|P2|NOT COMPLETED|Treatment Period 2||0
8305115|NCT01523392|20475523|P1|NOT COMPLETED|Treatment Period 2||0
8305116|NCT01523392|20475522|P2|COMPLETED|Treatment Period 2||14
8305117|NCT01523392|20475523|P1|COMPLETED|Treatment Period 2||17
8305118|NCT01523392|20475522|P2|STARTED|Treatment Period 2||14
8305119|NCT01523392|20475523|P1|STARTED|Treatment Period 2||17
8305120|NCT01523392|20475522|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
8305121|NCT01523392|20475523|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
8305122|NCT01523392|20475522|P2|COMPLETED|Washout Period - 10 to 14 Days||14
8305123|NCT01523392|20475523|P1|COMPLETED|Washout Period - 10 to 14 Days||17
8305124|NCT01523392|20475522|P2|STARTED|Washout Period - 10 to 14 Days||14
8305125|NCT01523392|20475523|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
8305126|NCT01523392|20475522|P2|NOT COMPLETED|Treatment Period 1||0
8305127|NCT01523392|20475523|P1|NOT COMPLETED|Treatment Period 1||3
8305128|NCT01523392|20475522|P2|COMPLETED|Treatment Period 1||14
8305129|NCT01523392|20475523|P1|COMPLETED|Treatment Period 1||17
8305130|NCT01523392|20475522|P2|STARTED|Treatment Period 1||14
8305131|NCT01523392|20475523|P1|STARTED|Treatment Period 1||20
8305132|NCT01523366|20475539|P2|NOT COMPLETED|Treatment Period 2||0
8305133|NCT01523366|20475540|P1|NOT COMPLETED|Treatment Period 2||1
8305134|NCT01523366|20475539|P2|COMPLETED|Treatment Period 2||20
8305135|NCT01523366|20475540|P1|COMPLETED|Treatment Period 2||18
8305136|NCT01523366|20475539|P2|STARTED|Treatment Period 2||20
8305137|NCT01523366|20475540|P1|STARTED|Treatment Period 2||19
8305138|NCT01523366|20475539|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
8305139|NCT01523366|20475540|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
8305140|NCT01523366|20475539|P2|COMPLETED|Washout Period - 10-14 Days||20
8305141|NCT01523366|20475540|P1|COMPLETED|Washout Period - 10-14 Days||19
8305142|NCT01523366|20475539|P2|STARTED|Washout Period - 10-14 Days||20
8305143|NCT01523366|20475540|P1|STARTED|Washout Period - 10-14 Days||19
8305144|NCT01523366|20475539|P2|NOT COMPLETED|Treatment Period 1||0
8305145|NCT01523366|20475540|P1|NOT COMPLETED|Treatment Period 1||1
8305146|NCT01523366|20475539|P2|COMPLETED|Treatment Period 1||20
8305147|NCT01523366|20475540|P1|COMPLETED|Treatment Period 1||19
8305148|NCT01523366|20475539|P2|STARTED|Treatment Period 1||20
8305149|NCT01523366|20475540|P1|STARTED|Treatment Period 1||20
8305150|NCT01523301|20475556|P2|NOT COMPLETED|Overall Study||32
8305151|NCT01523301|20475557|P1|NOT COMPLETED|Overall Study||35
8305152|NCT01523301|20475556|P2|COMPLETED|Overall Study||164
8305153|NCT01523301|20475557|P1|COMPLETED|Overall Study||149
8305154|NCT01523301|20475556|P2|STARTED|Overall Study||196
8305155|NCT01523301|20475557|P1|STARTED|Overall Study||184
8305156|NCT01523275|20475577|P2|NOT COMPLETED|Overall Study||2
8305157|NCT01523275|20475578|P1|NOT COMPLETED|Overall Study||2
8305158|NCT01523275|20475577|P2|COMPLETED|Overall Study||7
8305159|NCT01523275|20475578|P1|COMPLETED|Overall Study||4
8305160|NCT01523275|20475577|P2|STARTED|Overall Study||9
8305161|NCT01523275|20475578|P1|STARTED|Overall Study||6
8305162|NCT01522976|20475591|P3|NOT COMPLETED|Overall Study||93
8305163|NCT01522976|20475592|P2|NOT COMPLETED|Overall Study||92
8305164|NCT01522976|20475593|P1|NOT COMPLETED|Overall Study||97
8305165|NCT01522976|20475591|P3|COMPLETED|Overall Study||0
8305166|NCT01522976|20475592|P2|COMPLETED|Overall Study||0
8305167|NCT01522976|20475593|P1|COMPLETED|Overall Study||0
8305168|NCT01522976|20475591|P3|STARTED|Overall Study||93
8305169|NCT01522976|20475592|P2|STARTED|Overall Study||92
8305170|NCT01522976|20475593|P1|STARTED|Overall Study||97
8305171|NCT01522963|20475620|P4|NOT COMPLETED|Overall Study||6
8305172|NCT01522963|20475621|P3|NOT COMPLETED|Overall Study||3
8305173|NCT01522963|20475622|P2|NOT COMPLETED|Overall Study||3
8305174|NCT01522963|20475623|P1|NOT COMPLETED|Overall Study||2
8305175|NCT01522963|20475620|P4|COMPLETED|Overall Study||18
8305176|NCT01522963|20475621|P3|COMPLETED|Overall Study||22
8305177|NCT01522963|20475622|P2|COMPLETED|Overall Study||22
8305178|NCT01522963|20475623|P1|COMPLETED|Overall Study||22
8305179|NCT01522963|20475620|P4|STARTED|Overall Study||24
8305180|NCT01522963|20475621|P3|STARTED|Overall Study||25
8305181|NCT01522963|20475622|P2|STARTED|Overall Study||25
8305182|NCT01522963|20475623|P1|STARTED|Overall Study||24
8305183|NCT01522950|20475638|P3|NOT COMPLETED|Overall Study||5
8305184|NCT01522950|20475639|P2|NOT COMPLETED|Overall Study||5
8305185|NCT01522950|20475640|P1|NOT COMPLETED|Overall Study||6
8305186|NCT01522950|20475638|P3|COMPLETED|Overall Study||22
8305187|NCT01522950|20475639|P2|COMPLETED|Overall Study||18
8305188|NCT01522950|20475640|P1|COMPLETED|Overall Study||20
8305189|NCT01522950|20475638|P3|STARTED|Overall Study||27
8305190|NCT01522950|20475639|P2|STARTED|Overall Study||23
8305191|NCT01522950|20475640|P1|STARTED|Overall Study||26
8305192|NCT01522937|20475657|P1|NOT COMPLETED|Overall Study||0
8305193|NCT01522937|20475657|P1|COMPLETED|Overall Study||146
8305194|NCT01522937|20475657|P1|STARTED|Overall Study||146
8305195|NCT01522924|20475667|P2|NOT COMPLETED|Overall Study||0
8305196|NCT01522924|20475668|P1|NOT COMPLETED|Overall Study||0
8305197|NCT01522924|20475667|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
8305198|NCT01522924|20475668|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
8305199|NCT01522924|20475667|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
8305200|NCT01522924|20475668|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
8305201|NCT01522755|20475686|P1|NOT COMPLETED|Overall Study||0
8305202|NCT01522755|20475686|P1|COMPLETED|Overall Study||409
8305203|NCT01522755|20475686|P1|STARTED|Overall Study||409
8305204|NCT01522703|20475696|P2|NOT COMPLETED|Overall Study||6
8305205|NCT01522703|20475697|P1|NOT COMPLETED|Overall Study||5
8305206|NCT01522703|20475696|P2|COMPLETED|Overall Study||20
8305207|NCT01522703|20475697|P1|COMPLETED|Overall Study||20
8305208|NCT01522703|20475696|P2|STARTED|Overall Study||26
8305209|NCT01522703|20475697|P1|STARTED|Overall Study||25
8305210|NCT01522651|20475708|P5|NOT COMPLETED|Overall Study||6
8305211|NCT01522651|20475709|P4|NOT COMPLETED|Overall Study||8
8305212|NCT01522651|20475710|P3|NOT COMPLETED|Overall Study||4
8305213|NCT01522651|20475711|P2|NOT COMPLETED|Overall Study||8
8305214|NCT01522651|20475712|P1|NOT COMPLETED|Overall Study||9
8305215|NCT01522651|20475708|P5|COMPLETED|Overall Study||21
8305216|NCT01522651|20475709|P4|COMPLETED|Overall Study||20
8305217|NCT01522651|20475710|P3|COMPLETED|Overall Study||22
8305218|NCT01522651|20475711|P2|COMPLETED|Overall Study||19
8305219|NCT01522651|20475712|P1|COMPLETED|Overall Study||17
8305220|NCT01522651|20475708|P5|STARTED|Overall Study||27
8305221|NCT01522651|20475709|P4|STARTED|Overall Study||28
8305222|NCT01522651|20475710|P3|STARTED|Overall Study||26
8305223|NCT01522651|20475711|P2|STARTED|Overall Study||27
8305224|NCT01522651|20475712|P1|STARTED|Overall Study||26
8305225|NCT01522456|20475739|P1|NOT COMPLETED|Overall Study||8
8305226|NCT01522456|20475739|P1|COMPLETED|Overall Study||65
8305227|NCT01522456|20475739|P1|STARTED|Overall Study||73
8305228|NCT01522443|20475802|P2|NOT COMPLETED|Overall Study||55
8305229|NCT01522443|20475803|P1|NOT COMPLETED|Overall Study||53
8305230|NCT01522443|20475802|P2|COMPLETED|Overall Study||3
8305231|NCT01522443|20475803|P1|COMPLETED|Overall Study||8
8305232|NCT01522443|20475802|P2|STARTED|Overall Study||58
8305233|NCT01522443|20475803|P1|STARTED|Overall Study||61
8305234|NCT01522404|20475815|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
8305235|NCT01522404|20475816|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
8305236|NCT01522404|20475815|P2|COMPLETED|Second Intervention (up to Week 58)||19
8305237|NCT01522404|20475816|P1|COMPLETED|Second Intervention (up to Week 58)||17
8305238|NCT01522404|20475815|P2|STARTED|Second Intervention (up to Week 58)||19
8305239|NCT01522404|20475816|P1|STARTED|Second Intervention (up to Week 58)||18
8305240|NCT01522404|20475815|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
8305241|NCT01522404|20475816|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
8305242|NCT01522404|20475815|P2|COMPLETED|First Intervention (up to Week 29)||19
8305243|NCT01522404|20475816|P1|COMPLETED|First Intervention (up to Week 29)||18
8305244|NCT01522404|20475815|P2|STARTED|First Intervention (up to Week 29)||19
8305245|NCT01522404|20475816|P1|STARTED|First Intervention (up to Week 29)||20
8305246|NCT01522391|20475834|P2|NOT COMPLETED|Overall Study||1
8305247|NCT01522391|20475835|P1|NOT COMPLETED|Overall Study||1
8305248|NCT01522391|20475834|P2|COMPLETED|Overall Study||20
8305249|NCT01522391|20475835|P1|COMPLETED|Overall Study||19
8305250|NCT01522391|20475834|P2|STARTED|Overall Study||21
8305251|NCT01522391|20475835|P1|STARTED|Overall Study||20
8305252|NCT01522339|20475895|P1|NOT COMPLETED|Overall Study||0
8305253|NCT01522339|20475895|P1|COMPLETED|Overall Study||15
8305254|NCT01522339|20475895|P1|STARTED|Overall Study||15
8305255|NCT01522248|20475902|P2|NOT COMPLETED|Overall Study||0
8305256|NCT01522248|20475903|P1|NOT COMPLETED|Overall Study||1
8305257|NCT01522248|20475902|P2|COMPLETED|Overall Study||10
8305258|NCT01522248|20475903|P1|COMPLETED|Overall Study||9
8305259|NCT01522248|20475902|P2|STARTED|Overall Study||10
8305260|NCT01522248|20475903|P1|STARTED|Overall Study||10
8305261|NCT01522235|20475918|P2|NOT COMPLETED|Overall Study||1
8305262|NCT01522235|20475919|P1|NOT COMPLETED|Overall Study||1
8305263|NCT01522235|20475918|P2|COMPLETED|Overall Study||2
8305264|NCT01522235|20475919|P1|COMPLETED|Overall Study||2
8305265|NCT01522235|20475918|P2|Randomized|Overall Study||3
8305266|NCT01522235|20475919|P1|Randomized|Overall Study||2
8305267|NCT01522235|20475918|P2|STARTED|Overall Study||3
8305268|NCT01522235|20475919|P1|STARTED|Overall Study||3
8305269|NCT01522131|20475937|P2|NOT COMPLETED|Overall Study||0
8305270|NCT01522131|20475938|P1|NOT COMPLETED|Overall Study||2
8305271|NCT01522131|20475937|P2|COMPLETED|Overall Study||17
8305272|NCT01522131|20475938|P1|COMPLETED|Overall Study||14
8305273|NCT01522131|20475937|P2|STARTED|Overall Study||17
8305274|NCT01522131|20475938|P1|STARTED|Overall Study||16
8305275|NCT01521949|20475946|P1|NOT COMPLETED|Overall Study||0
8305276|NCT01521949|20475946|P1|COMPLETED|Overall Study||21
8305277|NCT01521949|20475946|P1|STARTED|Overall Study||21
8305278|NCT01521923|20475955|P4|NOT COMPLETED|Overall Study||13
8305279|NCT01521923|20475956|P3|NOT COMPLETED|Overall Study||15
8305280|NCT01521923|20475957|P2|NOT COMPLETED|Overall Study||9
8305281|NCT01521923|20475958|P1|NOT COMPLETED|Overall Study||7
8305282|NCT01521923|20475955|P4|COMPLETED|Overall Study||70
8305283|NCT01521923|20475956|P3|COMPLETED|Overall Study||112
8305284|NCT01521923|20475957|P2|COMPLETED|Overall Study||72
8305285|NCT01521923|20475958|P1|COMPLETED|Overall Study||59
8305286|NCT01521923|20475955|P4|STARTED|Overall Study||83
8305287|NCT01521923|20475956|P3|STARTED|Overall Study||127
8305288|NCT01521923|20475957|P2|STARTED|Overall Study||81
8305289|NCT01521923|20475958|P1|STARTED|Overall Study||66
8305290|NCT01521897|20476078|P1|NOT COMPLETED|Overall Study||23
8305291|NCT01521897|20476078|P1|COMPLETED|Overall Study||1120
8305292|NCT01521897|20476078|P1|STARTED|Overall Study||1143
8305293|NCT01521884|20476090|P1|NOT COMPLETED|Overall Study||27
8305294|NCT01521884|20476090|P1|COMPLETED|Overall Study||35
8305295|NCT01521884|20476090|P1|STARTED|Overall Study||62
8305296|NCT01521871|20476109|P2|NOT COMPLETED|Overall Study||0
8305297|NCT01521871|20476110|P1|NOT COMPLETED|Overall Study||0
8305298|NCT01521871|20476109|P2|COMPLETED|Overall Study||32
8305299|NCT01521871|20476110|P1|COMPLETED|Overall Study||32
8305300|NCT01521871|20476109|P2|STARTED|Overall Study||32
8305301|NCT01521871|20476110|P1|STARTED|Overall Study||32
8305302|NCT01521845|20476150|P2|NOT COMPLETED|Overall Study||5
8305303|NCT01521845|20476151|P1|NOT COMPLETED|Overall Study||9
8305304|NCT01521845|20476150|P2|COMPLETED|Overall Study||47
8305305|NCT01521845|20476151|P1|COMPLETED|Overall Study||43
8305306|NCT01521845|20476150|P2|STARTED|Overall Study||52
8305307|NCT01521845|20476151|P1|STARTED|Overall Study||52
8305308|NCT01521780|20476161|P3|NOT COMPLETED|Overall Study||0
8305309|NCT01521780|20476162|P2|NOT COMPLETED|Overall Study||0
8305310|NCT01521780|20476163|P1|NOT COMPLETED|Overall Study||0
8305311|NCT01521780|20476161|P3|COMPLETED|Overall Study||2
8305312|NCT01521780|20476162|P2|COMPLETED|Overall Study||1
8305313|NCT01521780|20476163|P1|COMPLETED|Overall Study||9
8305314|NCT01521780|20476161|P3|STARTED|Overall Study||2
8305315|NCT01521780|20476162|P2|STARTED|Overall Study||1
8305316|NCT01521780|20476163|P1|STARTED|Overall Study||9
8305317|NCT01521559|20476187|P2|NOT COMPLETED|Overall Study||18
8305318|NCT01521559|20476188|P1|NOT COMPLETED|Overall Study||15
8305319|NCT01521559|20476187|P2|COMPLETED|Overall Study||73
8305320|NCT01521559|20476188|P1|COMPLETED|Overall Study||77
8305321|NCT01521559|20476187|P2|Completed Week 52|Overall Study||73
8305322|NCT01521559|20476188|P1|Completed Week 52|Overall Study||77
8305323|NCT01521559|20476187|P2|Completed Week 24|Overall Study||85
8305324|NCT01521559|20476188|P1|Completed Week 24|Overall Study||83
8305325|NCT01521559|20476187|P2|STARTED|Overall Study||91
8305326|NCT01521559|20476188|P1|STARTED|Overall Study||92
8305327|NCT01521546|20476202|P2|NOT COMPLETED|Overall Study||0
8305328|NCT01521546|20476203|P1|NOT COMPLETED|Overall Study||2
8305329|NCT01521546|20476202|P2|COMPLETED|Overall Study||20
8305330|NCT01521546|20476203|P1|COMPLETED|Overall Study||20
8305331|NCT01521546|20476202|P2|STARTED|Overall Study||20
8305332|NCT01521546|20476203|P1|STARTED|Overall Study||22
8305333|NCT01521507|20476211|P2|NOT COMPLETED|Stage 2: Observational Design||2
8305334|NCT01521507|20476212|P1|NOT COMPLETED|Stage 2: Observational Design||4
8305335|NCT01521507|20476211|P2|COMPLETED|Stage 2: Observational Design||92
8305336|NCT01521507|20476212|P1|COMPLETED|Stage 2: Observational Design||94
8305337|NCT01521507|20476211|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
8305338|NCT01521507|20476212|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
8305339|NCT01521507|20476211|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
8305340|NCT01521507|20476212|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
8305341|NCT01521507|20476211|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
8305342|NCT01521507|20476212|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
8305343|NCT01521507|20476211|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
8305344|NCT01521507|20476212|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
8305345|NCT01521507|20476211|P2|STARTED|Stage 2: Observational Design||94
8305346|NCT01521507|20476212|P1|STARTED|Stage 2: Observational Design||98
8305347|NCT01521507|20476211|P2|NOT COMPLETED|Stage 1: Randomized Design||5
8305348|NCT01521507|20476212|P1|NOT COMPLETED|Stage 1: Randomized Design||3
8305349|NCT01521507|20476211|P2|COMPLETED|Stage 1: Randomized Design||94
8305350|NCT01521507|20476212|P1|COMPLETED|Stage 1: Randomized Design||98
8305351|NCT01521507|20476211|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
8305352|NCT01521507|20476212|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
8305353|NCT01521507|20476211|P2|STARTED|Stage 1: Randomized Design||99
8305354|NCT01521507|20476212|P1|STARTED|Stage 1: Randomized Design||101
8305355|NCT01521494|20476234|P5|NOT COMPLETED|Overall Study||7
8305356|NCT01521494|20476235|P4|NOT COMPLETED|Overall Study||21
8305357|NCT01521494|20476236|P3|NOT COMPLETED|Overall Study||12
8305358|NCT01521494|20476237|P2|NOT COMPLETED|Overall Study||5
8305359|NCT01521494|20476238|P1|NOT COMPLETED|Overall Study||2
8305360|NCT01521494|20476234|P5|COMPLETED|Overall Study||30
8305361|NCT01521494|20476235|P4|COMPLETED|Overall Study||15
8305362|NCT01521494|20476236|P3|COMPLETED|Overall Study||23
8305363|NCT01521494|20476237|P2|COMPLETED|Overall Study||31
8305364|NCT01521494|20476238|P1|COMPLETED|Overall Study||37
8305365|NCT01521494|20476234|P5|STARTED|Overall Study||37
8305366|NCT01521494|20476235|P4|STARTED|Overall Study||36
8305367|NCT01521494|20476236|P3|STARTED|Overall Study||35
8305368|NCT01521494|20476237|P2|STARTED|Overall Study||36
8305369|NCT01521494|20476238|P1|STARTED|Overall Study||39
8305370|NCT01521364|20476260|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
8305371|NCT01521364|20476260|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
8305372|NCT01521364|20476260|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
8305373|NCT01521364|20476260|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
8305374|NCT01521364|20476260|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
8305375|NCT01521364|20476260|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
8305376|NCT01521364|20476260|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
8305377|NCT01521364|20476260|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
8305378|NCT01521364|20476260|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
8305379|NCT01521260|20476273|P2|NOT COMPLETED|Overall Study||0
8305380|NCT01521260|20476274|P1|NOT COMPLETED|Overall Study||0
8305381|NCT01521260|20476273|P2|COMPLETED|Overall Study||15
8305382|NCT01521260|20476274|P1|COMPLETED|Overall Study||15
8305383|NCT01521260|20476273|P2|STARTED|Overall Study||15
8305384|NCT01521260|20476274|P1|STARTED|Overall Study||15
8305385|NCT01521143|20476284|P4|NOT COMPLETED|Overall Study||7
8305386|NCT01521143|20476285|P3|NOT COMPLETED|Overall Study||8
8305387|NCT01521143|20476286|P2|NOT COMPLETED|Overall Study||26
8305388|NCT01521143|20476287|P1|NOT COMPLETED|Overall Study||29
8305389|NCT01521143|20476284|P4|COMPLETED|Overall Study||0
8305390|NCT01521143|20476285|P3|COMPLETED|Overall Study||0
8305391|NCT01521143|20476286|P2|COMPLETED|Overall Study||10
8305392|NCT01521143|20476287|P1|COMPLETED|Overall Study||11
8305393|NCT01521143|20476284|P4|Received Treatment|Overall Study||4
8305394|NCT01521143|20476285|P3|Received Treatment|Overall Study||3
8305395|NCT01521143|20476286|P2|Received Treatment|Overall Study||20
8305396|NCT01521143|20476287|P1|Received Treatment|Overall Study||20
8305397|NCT01521143|20476284|P4|STARTED|Overall Study||7
8305398|NCT01521143|20476285|P3|STARTED|Overall Study||8
8305399|NCT01521143|20476286|P2|STARTED|Overall Study||36
8305400|NCT01521143|20476287|P1|STARTED|Overall Study||40
8305401|NCT01521026|20476319|P2|NOT COMPLETED|Overall Study||3
8305402|NCT01521026|20476320|P1|NOT COMPLETED|Overall Study||15
8305403|NCT01521026|20476319|P2|COMPLETED|Overall Study||28
8305404|NCT01521026|20476320|P1|COMPLETED|Overall Study||23
8305405|NCT01521026|20476319|P2|STARTED|Overall Study||31
8305406|NCT01521026|20476320|P1|STARTED|Overall Study||38
8305407|NCT01520987|20476336|P8|NOT COMPLETED|Overall Study||0
8305408|NCT01520987|20476337|P7|NOT COMPLETED|Overall Study||0
8305409|NCT01520987|20476338|P6|NOT COMPLETED|Overall Study||1
8305410|NCT01520987|20476339|P5|NOT COMPLETED|Overall Study||0
8305411|NCT01520987|20476340|P4|NOT COMPLETED|Overall Study||0
8305412|NCT01520987|20476341|P3|NOT COMPLETED|Overall Study||0
8305413|NCT01520987|20476342|P2|NOT COMPLETED|Overall Study||0
8305414|NCT01520987|20476343|P1|NOT COMPLETED|Overall Study||1
8305415|NCT01520987|20476336|P8|COMPLETED|Overall Study||14
8305416|NCT01520987|20476337|P7|COMPLETED|Overall Study||12
8305417|NCT01520987|20476338|P6|COMPLETED|Overall Study||13
8305418|NCT01520987|20476339|P5|COMPLETED|Overall Study||14
8305419|NCT01520987|20476340|P4|COMPLETED|Overall Study||15
8305420|NCT01520987|20476341|P3|COMPLETED|Overall Study||11
8305421|NCT01520987|20476342|P2|COMPLETED|Overall Study||12
8305422|NCT01520987|20476343|P1|COMPLETED|Overall Study||12
8305423|NCT01520987|20476336|P8|Dosed|Overall Study||14
8305424|NCT01520987|20476337|P7|Dosed|Overall Study||12
8305425|NCT01520987|20476338|P6|Dosed|Overall Study||14
8305426|NCT01520987|20476339|P5|Dosed|Overall Study||14
8305427|NCT01520987|20476340|P4|Dosed|Overall Study||15
8305428|NCT01520987|20476341|P3|Dosed|Overall Study||11
8305429|NCT01520987|20476342|P2|Dosed|Overall Study||12
8305430|NCT01520987|20476343|P1|Dosed|Overall Study||13
8305431|NCT01520987|20476336|P8|STARTED|Overall Study||14
8305432|NCT01520987|20476337|P7|STARTED|Overall Study||12
8305433|NCT01520987|20476338|P6|STARTED|Overall Study||14
8305434|NCT01520987|20476339|P5|STARTED|Overall Study||14
8305435|NCT01520987|20476340|P4|STARTED|Overall Study||15
8305436|NCT01520987|20476341|P3|STARTED|Overall Study||11
8305437|NCT01520987|20476342|P2|STARTED|Overall Study||12
8305438|NCT01520987|20476343|P1|STARTED|Overall Study||13
8305439|NCT01520922|20476403|P2|NOT COMPLETED|Survival Follow-up||0
8305440|NCT01520922|20476404|P1|NOT COMPLETED|Survival Follow-up||1
8305441|NCT01520922|20476403|P2|COMPLETED|Survival Follow-up||40
8305442|NCT01520922|20476404|P1|COMPLETED|Survival Follow-up||20
8305443|NCT01520922|20476403|P2|STARTED|Survival Follow-up||40
8305444|NCT01520922|20476404|P1|STARTED|Survival Follow-up||21
8305445|NCT01520922|20476403|P2|NOT COMPLETED|Follow up||1
8305446|NCT01520922|20476404|P1|NOT COMPLETED|Follow up||0
8305447|NCT01520922|20476403|P2|COMPLETED|Follow up||44
8305448|NCT01520922|20476404|P1|COMPLETED|Follow up||44
8305449|NCT01520922|20476403|P2|STARTED|Follow up||45
8305450|NCT01520922|20476404|P1|STARTED|Follow up||44
8305451|NCT01520922|20476403|P2|NOT COMPLETED|Treatment Phase||8
8305452|NCT01520922|20476404|P1|NOT COMPLETED|Treatment Phase||5
8305453|NCT01520922|20476403|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
8305454|NCT01520922|20476404|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
8305455|NCT01520922|20476403|P2|STARTED|Treatment Phase||53
8305456|NCT01520922|20476404|P1|STARTED|Treatment Phase||44
8305457|NCT01520909|20476466|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
8305458|NCT01520909|20476467|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305459|NCT01520909|20476468|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305460|NCT01520909|20476466|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
8305461|NCT01520909|20476467|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305462|NCT01520909|20476468|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305463|NCT01520909|20476466|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
8305464|NCT01520909|20476467|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
8305465|NCT01520909|20476468|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
8305466|NCT01520909|20476466|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
8305467|NCT01520909|20476467|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
8305468|NCT01520909|20476468|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
8305469|NCT01520909|20476466|P3|COMPLETED|Part 1 (Randomized Period)||0
8305470|NCT01520909|20476467|P2|COMPLETED|Part 1 (Randomized Period)||61
8305471|NCT01520909|20476468|P1|COMPLETED|Part 1 (Randomized Period)||28
8305472|NCT01520909|20476466|P3|STARTED|Part 1 (Randomized Period)||0
8305473|NCT01520909|20476467|P2|STARTED|Part 1 (Randomized Period)||63
8305474|NCT01520909|20476468|P1|STARTED|Part 1 (Randomized Period)||29
8305475|NCT01520727|20476539|P9|NOT COMPLETED|Overall Study||0
8305476|NCT01520727|20476540|P8|NOT COMPLETED|Overall Study||0
8305477|NCT01520727|20476541|P7|NOT COMPLETED|Overall Study||0
8305478|NCT01520727|20476542|P6|NOT COMPLETED|Overall Study||0
8305479|NCT01520727|20476543|P5|NOT COMPLETED|Overall Study||0
8305480|NCT01520727|20476544|P4|NOT COMPLETED|Overall Study||0
8305481|NCT01520727|20476545|P3|NOT COMPLETED|Overall Study||0
8305482|NCT01520727|20476546|P2|NOT COMPLETED|Overall Study||0
8305483|NCT01520727|20476547|P1|NOT COMPLETED|Overall Study||0
8305484|NCT01520727|20476539|P9|COMPLETED|Overall Study||16
8305485|NCT01520727|20476540|P8|COMPLETED|Overall Study||6
8305486|NCT01520727|20476541|P7|COMPLETED|Overall Study||6
8305487|NCT01520727|20476542|P6|COMPLETED|Overall Study||6
8305488|NCT01520727|20476543|P5|COMPLETED|Overall Study||6
8305489|NCT01520727|20476544|P4|COMPLETED|Overall Study||6
8305490|NCT01520727|20476545|P3|COMPLETED|Overall Study||6
8305491|NCT01520727|20476546|P2|COMPLETED|Overall Study||6
8305492|NCT01520727|20476547|P1|COMPLETED|Overall Study||6
8305493|NCT01520727|20476539|P9|STARTED|Overall Study||16
8305494|NCT01520727|20476540|P8|STARTED|Overall Study||6
8305495|NCT01520727|20476541|P7|STARTED|Overall Study||6
8305496|NCT01520727|20476542|P6|STARTED|Overall Study||6
8305497|NCT01520727|20476543|P5|STARTED|Overall Study||6
8305498|NCT01520727|20476544|P4|STARTED|Overall Study||6
8305499|NCT01520727|20476545|P3|STARTED|Overall Study||6
8305500|NCT01520727|20476546|P2|STARTED|Overall Study||6
8305501|NCT01520727|20476547|P1|STARTED|Overall Study||6
8305502|NCT01520714|20476585|P2|NOT COMPLETED|Overall Study||6
8305503|NCT01520714|20476586|P1|NOT COMPLETED|Overall Study||0
8305504|NCT01520714|20476585|P2|COMPLETED|Overall Study||5
8305505|NCT01520714|20476586|P1|COMPLETED|Overall Study||0
8305506|NCT01520714|20476585|P2|STARTED|Overall Study||11
8305507|NCT01520714|20476586|P1|STARTED|Overall Study||0
8305508|NCT01520688|20476592|P7|NOT COMPLETED|Overall Study||5
8305509|NCT01520688|20476593|P6|NOT COMPLETED|Overall Study||0
8305510|NCT01520688|20476594|P5|NOT COMPLETED|Overall Study||1
8305511|NCT01520688|20476595|P4|NOT COMPLETED|Overall Study||1
8305512|NCT01520688|20476596|P3|NOT COMPLETED|Overall Study||0
8305513|NCT01520688|20476597|P2|NOT COMPLETED|Overall Study||2
8305514|NCT01520688|20476598|P1|NOT COMPLETED|Overall Study||0
8305515|NCT01520688|20476592|P7|COMPLETED|Overall Study||0
8305516|NCT01520688|20476593|P6|COMPLETED|Overall Study||5
8305517|NCT01520688|20476594|P5|COMPLETED|Overall Study||4
8305518|NCT01520688|20476595|P4|COMPLETED|Overall Study||4
8305519|NCT01520688|20476596|P3|COMPLETED|Overall Study||4
8305520|NCT01520688|20476597|P2|COMPLETED|Overall Study||2
8305521|NCT01520688|20476598|P1|COMPLETED|Overall Study||4
8305522|NCT01520688|20476592|P7|STARTED|Overall Study||5
8305523|NCT01520688|20476593|P6|STARTED|Overall Study||5
8305524|NCT01520688|20476594|P5|STARTED|Overall Study||5
8305525|NCT01520688|20476595|P4|STARTED|Overall Study||5
8305526|NCT01520688|20476596|P3|STARTED|Overall Study||4
8305527|NCT01520688|20476597|P2|STARTED|Overall Study||4
8305528|NCT01520688|20476598|P1|STARTED|Overall Study||4
8305529|NCT01520558|20476610|P3|NOT COMPLETED|Overall Study||3
8305530|NCT01520558|20476611|P2|NOT COMPLETED|Overall Study||2
8305531|NCT01520558|20476612|P1|NOT COMPLETED|Overall Study||2
8305532|NCT01520558|20476610|P3|COMPLETED|Overall Study||3
8305533|NCT01520558|20476611|P2|COMPLETED|Overall Study||1
8305534|NCT01520558|20476612|P1|COMPLETED|Overall Study||1
8305535|NCT01520558|20476610|P3|STARTED|Overall Study||6
8305536|NCT01520558|20476611|P2|STARTED|Overall Study||3
8305537|NCT01520558|20476612|P1|STARTED|Overall Study||3
8305538|NCT01520532|20476620|P1|NOT COMPLETED|Overall Study||0
8305539|NCT01520532|20476620|P1|COMPLETED|Overall Study||60
8305540|NCT01520532|20476620|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
8305541|NCT01520519|20476626|P1|NOT COMPLETED|Overall Study||0
8305542|NCT01520519|20476626|P1|COMPLETED|Overall Study||40
8305543|NCT01520519|20476626|P1|STARTED|Overall Study||40
8305544|NCT01520506|20476631|P1|NOT COMPLETED|Overall Study||6
8305545|NCT01520506|20476631|P1|COMPLETED|Overall Study||44
8305546|NCT01520506|20476631|P1|STARTED|Overall Study||50
8305547|NCT01520454|20476641|P4|NOT COMPLETED|Overall Study||0
8305548|NCT01520454|20476642|P3|NOT COMPLETED|Overall Study||0
8305549|NCT01520454|20476643|P2|NOT COMPLETED|Overall Study||0
8305550|NCT01520454|20476644|P1|NOT COMPLETED|Overall Study||0
8305551|NCT01520454|20476641|P4|COMPLETED|Overall Study||6
8305552|NCT01520454|20476642|P3|COMPLETED|Overall Study||5
8305553|NCT01520454|20476643|P2|COMPLETED|Overall Study||6
8305554|NCT01520454|20476644|P1|COMPLETED|Overall Study||9
8305555|NCT01520454|20476641|P4|STARTED|Overall Study||6
8305556|NCT01520454|20476642|P3|STARTED|Overall Study||5
8305557|NCT01520454|20476643|P2|STARTED|Overall Study||6
8305558|NCT01520454|20476644|P1|STARTED|Overall Study||9
8305559|NCT01520402|20476686|P1|NOT COMPLETED|Overall Study||5
8305560|NCT01520402|20476686|P1|COMPLETED|Overall Study||30
8305561|NCT01520402|20476686|P1|STARTED|Overall Study||35
8305562|NCT01520363|20476699|P2|NOT COMPLETED|Overall Study||0
8305563|NCT01520363|20476700|P1|NOT COMPLETED|Overall Study||2
8305564|NCT01520363|20476699|P2|COMPLETED|Overall Study||26
8305565|NCT01520363|20476700|P1|COMPLETED|Overall Study||24
8305566|NCT01520363|20476699|P2|STARTED|Overall Study||26
8305567|NCT01520363|20476700|P1|STARTED|Overall Study||26
8305568|NCT01520324|20476774|P1|NOT COMPLETED|Overall Study||1
8305569|NCT01520324|20476774|P1|COMPLETED|Overall Study||52
8305570|NCT01520324|20476774|P1|STARTED|Overall Study||53
8305571|NCT01520207|20476787|P2|NOT COMPLETED|Overall Study||0
8305572|NCT01520207|20476788|P1|NOT COMPLETED|Overall Study||2
8305573|NCT01520207|20476787|P2|COMPLETED|Overall Study||25
8305574|NCT01520207|20476788|P1|COMPLETED|Overall Study||25
8305575|NCT01520207|20476787|P2|STARTED|Overall Study||25
8305576|NCT01520207|20476788|P1|STARTED|Overall Study||27
8305577|NCT01520038|20476794|P1|NOT COMPLETED|Overall Study||1
8305578|NCT01520038|20476794|P1|COMPLETED|Overall Study||1
8305579|NCT01520038|20476794|P1|STARTED|Overall Study||2
8305580|NCT01519960|20476803|P3|NOT COMPLETED|Overall Study||10
8305581|NCT01519960|20476804|P2|NOT COMPLETED|Overall Study||50
8305582|NCT01519960|20476805|P1|NOT COMPLETED|Overall Study||101
8305583|NCT01519960|20476803|P3|COMPLETED|Overall Study||0
8305584|NCT01519960|20476804|P2|COMPLETED|Overall Study||0
8305585|NCT01519960|20476805|P1|COMPLETED|Overall Study||0
8305586|NCT01519960|20476803|P3|Completed FU Week 24|Overall Study||10
8305587|NCT01519960|20476804|P2|Completed FU Week 24|Overall Study||15
8305588|NCT01519960|20476805|P1|Completed FU Week 24|Overall Study||101
8305589|NCT01519960|20476803|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
8305590|NCT01519960|20476804|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
8305591|NCT01519960|20476805|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
8305592|NCT01519960|20476803|P3|Completed Week 48|Overall Study||10
8305593|NCT01519960|20476804|P2|Completed Week 48|Overall Study||47
8305594|NCT01519960|20476805|P1|Completed Week 48|Overall Study||99
8305595|NCT01519960|20476803|P3|STARTED|Overall Study||10
8305596|NCT01519960|20476804|P2|STARTED|Overall Study||50
8305597|NCT01519960|20476805|P1|STARTED|Overall Study||101
8305598|NCT01519947|20476915|P4|NOT COMPLETED|Overall Study||8
8305599|NCT01519947|20476916|P3|NOT COMPLETED|Overall Study||7
8305600|NCT01519947|20476917|P2|NOT COMPLETED|Overall Study||4
8305601|NCT01519947|20476918|P1|NOT COMPLETED|Overall Study||2
8305602|NCT01519947|20476915|P4|COMPLETED|Overall Study||34
8305603|NCT01519947|20476916|P3|COMPLETED|Overall Study||8
8305604|NCT01519947|20476917|P2|COMPLETED|Overall Study||7
8305605|NCT01519947|20476918|P1|COMPLETED|Overall Study||17
8305606|NCT01519947|20476915|P4|STARTED|Overall Study||42
8305607|NCT01519947|20476916|P3|STARTED|Overall Study||15
8305608|NCT01519947|20476917|P2|STARTED|Overall Study||11
8305609|NCT01519947|20476918|P1|STARTED|Overall Study||19
8305610|NCT01519934|20476948|P1|NOT COMPLETED|Overall Study||3
8305611|NCT01519934|20476948|P1|COMPLETED|Overall Study||45
8305612|NCT01519934|20476948|P1|STARTED|Overall Study||48
8305613|NCT01519921|20476957|P2|NOT COMPLETED|Overall Study||15
8305614|NCT01519921|20476958|P1|NOT COMPLETED|Overall Study||21
8305615|NCT01519921|20476957|P2|COMPLETED|Overall Study||49
8305616|NCT01519921|20476958|P1|COMPLETED|Overall Study||65
8305617|NCT01519921|20476957|P2|STARTED|Overall Study||64
8305618|NCT01519921|20476958|P1|STARTED|Overall Study||86
8305619|NCT01519882|20476982|P2|NOT COMPLETED|Overall Study||0
8305620|NCT01519882|20476983|P1|NOT COMPLETED|Overall Study||0
8305621|NCT01519882|20476982|P2|COMPLETED|Overall Study||0
8305622|NCT01519882|20476983|P1|COMPLETED|Overall Study||1
8305623|NCT01519882|20476982|P2|STARTED|Overall Study||0
8305624|NCT01519882|20476983|P1|STARTED|Overall Study||1
8305625|NCT01519869|20477007|P1|NOT COMPLETED|Overall Study||1
8305626|NCT01519869|20477007|P1|COMPLETED|Overall Study||27
8305627|NCT01519869|20477007|P1|STARTED|Overall Study||28
8305628|NCT01519817|20477011|P4|NOT COMPLETED|Overall Study||1
8305629|NCT01519817|20477012|P3|NOT COMPLETED|Overall Study||0
8305630|NCT01519817|20477013|P2|NOT COMPLETED|Overall Study||0
8305631|NCT01519817|20477014|P1|NOT COMPLETED|Overall Study||1
8305632|NCT01519817|20477011|P4|COMPLETED|Overall Study||10
8305633|NCT01519817|20477012|P3|COMPLETED|Overall Study||16
8305634|NCT01519817|20477013|P2|COMPLETED|Overall Study||3
8305635|NCT01519817|20477014|P1|COMPLETED|Overall Study||3
8305636|NCT01519817|20477011|P4|STARTED|Overall Study||11
8305637|NCT01519817|20477012|P3|STARTED|Overall Study||16
8305638|NCT01519817|20477013|P2|STARTED|Overall Study||3
8305639|NCT01519817|20477014|P1|STARTED|Overall Study||4
8305640|NCT01519791|20477054|P2|NOT COMPLETED|Overall Study||368
8305641|NCT01519791|20477055|P1|NOT COMPLETED|Overall Study||152
8305642|NCT01519791|20477054|P2|COMPLETED|Overall Study||292
8305643|NCT01519791|20477055|P1|COMPLETED|Overall Study||67
8305644|NCT01519791|20477054|P2|Completed Week 52|Overall Study||500
8305645|NCT01519791|20477055|P1|Completed Week 52|Overall Study||143
8305646|NCT01519791|20477054|P2|STARTED|Overall Study||660
8305647|NCT01519791|20477055|P1|STARTED|Overall Study||219
8305648|NCT01519778|20477119|P1|NOT COMPLETED|Overall Study||14
8305649|NCT01519778|20477119|P1|COMPLETED|Overall Study||186
8305650|NCT01519778|20477119|P1|STARTED|Overall Study||200
8305651|NCT01519765|20477125|P2|NOT COMPLETED|Overall Study||2
8305652|NCT01519765|20477126|P1|NOT COMPLETED|Overall Study||3
8305653|NCT01519765|20477125|P2|COMPLETED|Overall Study||34
8305654|NCT01519765|20477126|P1|COMPLETED|Overall Study||34
8305655|NCT01519765|20477125|P2|STARTED|Overall Study||36
8305656|NCT01519765|20477126|P1|STARTED|Overall Study||37
8305657|NCT01519713|20477175|P3|NOT COMPLETED|Overall Study||0
8305658|NCT01519713|20477176|P2|NOT COMPLETED|Overall Study||0
8305659|NCT01519713|20477177|P1|NOT COMPLETED|Overall Study||0
8305660|NCT01519713|20477175|P3|COMPLETED|Overall Study||4
8305661|NCT01519713|20477176|P2|COMPLETED|Overall Study||2
8305662|NCT01519713|20477177|P1|COMPLETED|Overall Study||194
8305663|NCT01519713|20477175|P3|STARTED|Overall Study||4
8305664|NCT01519713|20477176|P2|STARTED|Overall Study||2
8305665|NCT01519713|20477177|P1|STARTED|Overall Study||194
8305666|NCT01519700|20477204|P4|NOT COMPLETED|Overall Study||7
8305667|NCT01519700|20477205|P3|NOT COMPLETED|Overall Study||7
8305668|NCT01519700|20477206|P2|NOT COMPLETED|Overall Study||6
8305669|NCT01519700|20477207|P1|NOT COMPLETED|Overall Study||9
8305670|NCT01519700|20477204|P4|COMPLETED|Overall Study||47
8305671|NCT01519700|20477205|P3|COMPLETED|Overall Study||48
8305672|NCT01519700|20477206|P2|COMPLETED|Overall Study||49
8305673|NCT01519700|20477207|P1|COMPLETED|Overall Study||45
8305674|NCT01519700|20477204|P4|Treated Cycle 6 Neupogen|Overall Study||49
8305675|NCT01519700|20477205|P3|Treated Cycle 6 Neupogen|Overall Study||0
8305676|NCT01519700|20477206|P2|Treated Cycle 6 Neupogen|Overall Study||49
8305677|NCT01519700|20477207|P1|Treated Cycle 6 Neupogen|Overall Study||0
8305678|NCT01519700|20477204|P4|Treated Cycle 6 EP2006|Overall Study||0
8305679|NCT01519700|20477205|P3|Treated Cycle 6 EP2006|Overall Study||48
8305680|NCT01519700|20477206|P2|Treated Cycle 6 EP2006|Overall Study||0
8305681|NCT01519700|20477207|P1|Treated Cycle 6 EP2006|Overall Study||45
8305682|NCT01519700|20477204|P4|Treated Cycle 5 Neupogen|Overall Study||50
8305683|NCT01519700|20477205|P3|Treated Cycle 5 Neupogen|Overall Study||48
8305684|NCT01519700|20477206|P2|Treated Cycle 5 Neupogen|Overall Study||0
8305685|NCT01519700|20477207|P1|Treated Cycle 5 Neupogen|Overall Study||0
8305686|NCT01519700|20477204|P4|Treated Cycle 5 EP2006|Overall Study||0
8305687|NCT01519700|20477205|P3|Treated Cycle 5 EP2006|Overall Study||0
8305688|NCT01519700|20477206|P2|Treated Cycle 5 EP2006|Overall Study||49
8305689|NCT01519700|20477207|P1|Treated Cycle 5 EP2006|Overall Study||46
8305690|NCT01519700|20477204|P4|Treated Cycle 4 Neupogen|Overall Study||50
8305691|NCT01519700|20477205|P3|Treated Cycle 4 Neupogen|Overall Study||0
8305692|NCT01519700|20477206|P2|Treated Cycle 4 Neupogen|Overall Study||51
8305693|NCT01519700|20477207|P1|Treated Cycle 4 Neupogen|Overall Study||0
8305694|NCT01519700|20477204|P4|Treated Cycle 4 EP2006|Overall Study||0
8305695|NCT01519700|20477205|P3|Treated Cycle 4 EP2006|Overall Study||50
8305696|NCT01519700|20477206|P2|Treated Cycle 4 EP2006|Overall Study||0
8305697|NCT01519700|20477207|P1|Treated Cycle 4 EP2006|Overall Study||51
8305698|NCT01519700|20477204|P4|Treated Cycle 3 Neupogen|Overall Study||51
8305699|NCT01519700|20477205|P3|Treated Cycle 3 Neupogen|Overall Study||54
8305700|NCT01519700|20477206|P2|Treated Cycle 3 Neupogen|Overall Study||0
8305701|NCT01519700|20477207|P1|Treated Cycle 3 Neupogen|Overall Study||0
8305702|NCT01519700|20477204|P4|Treated Cycle 3 EP2006|Overall Study||0
8305703|NCT01519700|20477205|P3|Treated Cycle 3 EP2006|Overall Study||0
8305704|NCT01519700|20477206|P2|Treated Cycle 3 EP2006|Overall Study||51
8305705|NCT01519700|20477207|P1|Treated Cycle 3 EP2006|Overall Study||51
8305706|NCT01519700|20477204|P4|Treated Cycle 2 Neupogen|Overall Study||51
8305707|NCT01519700|20477205|P3|Treated Cycle 2 Neupogen|Overall Study||0
8305708|NCT01519700|20477206|P2|Treated Cycle 2 Neupogen|Overall Study||52
8305709|NCT01519700|20477207|P1|Treated Cycle 2 Neupogen|Overall Study||0
8305710|NCT01519700|20477204|P4|Treated Cycle 2 EP2006|Overall Study||0
8305711|NCT01519700|20477205|P3|Treated Cycle 2 EP2006|Overall Study||55
8305712|NCT01519700|20477206|P2|Treated Cycle 2 EP2006|Overall Study||0
8305713|NCT01519700|20477207|P1|Treated Cycle 2 EP2006|Overall Study||52
8305714|NCT01519700|20477204|P4|Treated Cycle 1 Neupogen|Overall Study||52
8305715|NCT01519700|20477205|P3|Treated Cycle 1 Neupogen|Overall Study||55
8305716|NCT01519700|20477206|P2|Treated Cycle 1 Neupogen|Overall Study||0
8305717|NCT01519700|20477207|P1|Treated Cycle 1 Neupogen|Overall Study||0
8305718|NCT01519700|20477204|P4|Treated Cycle 1 EP2006|Overall Study||0
8305719|NCT01519700|20477205|P3|Treated Cycle 1 EP2006|Overall Study||0
8305720|NCT01519700|20477206|P2|Treated Cycle 1 EP2006|Overall Study||54
8305721|NCT01519700|20477207|P1|Treated Cycle 1 EP2006|Overall Study||53
8305722|NCT01519700|20477204|P4|STARTED|Overall Study||54
8305723|NCT01519700|20477205|P3|STARTED|Overall Study||55
8305724|NCT01519700|20477206|P2|STARTED|Overall Study||55
8305725|NCT01519700|20477207|P1|STARTED|Overall Study||54
8305726|NCT01519674|20477242|P3|NOT COMPLETED|Overall Study||12
8305727|NCT01519674|20477243|P2|NOT COMPLETED|Overall Study||13
8305728|NCT01519674|20477244|P1|NOT COMPLETED|Overall Study||21
8305729|NCT01519674|20477242|P3|COMPLETED|Overall Study||181
8305730|NCT01519674|20477243|P2|COMPLETED|Overall Study||182
8305731|NCT01519674|20477244|P1|COMPLETED|Overall Study||173
8305732|NCT01519674|20477242|P3|Exposed|Overall Study||190
8305733|NCT01519674|20477243|P2|Exposed|Overall Study||193
8305734|NCT01519674|20477244|P1|Exposed|Overall Study||192
8305735|NCT01519674|20477242|P3|STARTED|Overall Study||193
8305736|NCT01519674|20477243|P2|STARTED|Overall Study||195
8305737|NCT01519674|20477244|P1|STARTED|Overall Study||194
8305738|NCT01519661|20477282|P1|NOT COMPLETED|Overall Study||61
8305739|NCT01519661|20477282|P1|COMPLETED|Overall Study||96
8305740|NCT01519661|20477282|P1|STARTED|Overall Study||157
8305741|NCT01519648|20477299|P2|NOT COMPLETED|Overall Study||0
8305742|NCT01519648|20477300|P1|NOT COMPLETED|Overall Study||0
8305743|NCT01519648|20477299|P2|COMPLETED|Overall Study||306
8305744|NCT01519648|20477300|P1|COMPLETED|Overall Study||502
8305745|NCT01519648|20477299|P2|STARTED|Overall Study||306
8305746|NCT01519648|20477300|P1|STARTED|Overall Study||502
8305747|NCT01519635|20477308|P2|NOT COMPLETED|Overall Study||3
8305748|NCT01519635|20477309|P1|NOT COMPLETED|Overall Study||1
8305749|NCT01519635|20477308|P2|COMPLETED|Overall Study||9
8305750|NCT01519635|20477309|P1|COMPLETED|Overall Study||11
8305751|NCT01519635|20477308|P2|STARTED|Overall Study||12
8305752|NCT01519635|20477309|P1|STARTED|Overall Study||12
8305753|NCT01519570|20477317|P2|NOT COMPLETED|Overall Study||0
8305754|NCT01519570|20477318|P1|NOT COMPLETED|Overall Study||0
8305755|NCT01519570|20477317|P2|COMPLETED|Overall Study||2089
8305756|NCT01519570|20477318|P1|COMPLETED|Overall Study||500
8305757|NCT01519570|20477317|P2|STARTED|Overall Study||2089
8305758|NCT01519570|20477318|P1|STARTED|Overall Study||500
8305759|NCT01519518|20477326|P2|NOT COMPLETED|Overall Study||10
8305760|NCT01519518|20477327|P1|NOT COMPLETED|Overall Study||7
8305761|NCT01519518|20477326|P2|COMPLETED|Overall Study||905
8305762|NCT01519518|20477327|P1|COMPLETED|Overall Study||907
8305763|NCT01519518|20477326|P2|STARTED|Overall Study||915
8305764|NCT01519518|20477327|P1|STARTED|Overall Study||914
8305765|NCT01519466|20477341|P2|NOT COMPLETED|Overall Study||0
8305766|NCT01519466|20477342|P1|NOT COMPLETED|Overall Study||0
8305767|NCT01519466|20477341|P2|COMPLETED|Overall Study||16
8305768|NCT01519466|20477342|P1|COMPLETED|Overall Study||33
8305769|NCT01519466|20477341|P2|STARTED|Overall Study||16
8305770|NCT01519466|20477342|P1|STARTED|Overall Study||33
8305771|NCT01519427|20477352|P1|NOT COMPLETED|Overall Study||2
8305772|NCT01519427|20477352|P1|COMPLETED|Overall Study||0
8305773|NCT01519427|20477352|P1|STARTED|Overall Study||2
8305774|NCT01519414|20477361|P3|NOT COMPLETED|Post Cross-over||0
8305775|NCT01519414|20477362|P2|NOT COMPLETED|Post Cross-over||0
8305776|NCT01519414|20477363|P1|NOT COMPLETED|Post Cross-over||0
8305777|NCT01519414|20477361|P3|COMPLETED|Post Cross-over||12
8305778|NCT01519414|20477362|P2|COMPLETED|Post Cross-over||14
8305779|NCT01519414|20477363|P1|COMPLETED|Post Cross-over||52
8305780|NCT01519414|20477361|P3|STARTED|Post Cross-over||12
8305781|NCT01519414|20477362|P2|STARTED|Post Cross-over||14
8305782|NCT01519414|20477363|P1|STARTED|Post Cross-over||52
8305783|NCT01519414|20477361|P3|NOT COMPLETED|Pre Cross-over||0
8305784|NCT01519414|20477362|P2|NOT COMPLETED|Pre Cross-over||0
8305785|NCT01519414|20477363|P1|NOT COMPLETED|Pre Cross-over||0
8305786|NCT01519414|20477361|P3|COMPLETED|Pre Cross-over||0
8305787|NCT01519414|20477362|P2|COMPLETED|Pre Cross-over||26
8305788|NCT01519414|20477363|P1|COMPLETED|Pre Cross-over||52
8305789|NCT01519414|20477361|P3|STARTED|Pre Cross-over||0
8305790|NCT01519414|20477362|P2|STARTED|Pre Cross-over||26
8305791|NCT01519414|20477363|P1|STARTED|Pre Cross-over||52
8305792|NCT01519323|20477384|P2|NOT COMPLETED|Overall Study||3
8305793|NCT01519323|20477385|P1|NOT COMPLETED|Overall Study||3
8305794|NCT01519323|20477384|P2|COMPLETED|Overall Study||0
8305795|NCT01519323|20477385|P1|COMPLETED|Overall Study||0
8305796|NCT01519323|20477384|P2|STARTED|Overall Study||3
8305797|NCT01519323|20477385|P1|STARTED|Overall Study||3
8305798|NCT01519284|20477401|P5|NOT COMPLETED|Overall Study||0
8305799|NCT01519284|20477402|P4|NOT COMPLETED|Overall Study||0
8305800|NCT01519284|20477403|P3|NOT COMPLETED|Overall Study||2
8305801|NCT01519284|20477404|P2|NOT COMPLETED|Overall Study||0
8305802|NCT01519284|20477405|P1|NOT COMPLETED|Overall Study||0
8305803|NCT01519284|20477401|P5|COMPLETED|Overall Study||16
8305804|NCT01519284|20477402|P4|COMPLETED|Overall Study||16
8305805|NCT01519284|20477403|P3|COMPLETED|Overall Study||16
8305806|NCT01519284|20477404|P2|COMPLETED|Overall Study||16
8305807|NCT01519284|20477405|P1|COMPLETED|Overall Study||16
8305808|NCT01519284|20477401|P5|STARTED|Overall Study||16
8305809|NCT01519284|20477402|P4|STARTED|Overall Study||16
8305810|NCT01519284|20477403|P3|STARTED|Overall Study||18
8305811|NCT01519284|20477404|P2|STARTED|Overall Study||16
8305812|NCT01519284|20477405|P1|STARTED|Overall Study||16
8305813|NCT01519271|20477434|P2|NOT COMPLETED|Phase 2||0
8305814|NCT01519271|20477435|P1|NOT COMPLETED|Phase 2||0
8305815|NCT01519271|20477434|P2|COMPLETED|Phase 2||14
8305816|NCT01519271|20477435|P1|COMPLETED|Phase 2||12
8305817|NCT01519271|20477434|P2|STARTED|Phase 2||14
8305818|NCT01519271|20477435|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
8305819|NCT01519271|20477434|P2|NOT COMPLETED|Phase 1||1
8305820|NCT01519271|20477435|P1|NOT COMPLETED|Phase 1||0
8305821|NCT01519271|20477434|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
8305822|NCT01519271|20477435|P1|COMPLETED|Phase 1||14
8305823|NCT01519271|20477434|P2|STARTED|Phase 1||14
8305824|NCT01519271|20477435|P1|STARTED|Phase 1||14
8305825|NCT01519245|20477445|P2|NOT COMPLETED|Overall Study||2
8305826|NCT01519245|20477446|P1|NOT COMPLETED|Overall Study||1
8305827|NCT01519245|20477445|P2|COMPLETED|Overall Study||18
8305828|NCT01519245|20477446|P1|COMPLETED|Overall Study||23
8305829|NCT01519245|20477445|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
8305830|NCT01519245|20477446|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
8305831|NCT01519245|20477445|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
8305832|NCT01519245|20477446|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
8305833|NCT01519245|20477445|P2|STARTED|Overall Study||20
8305834|NCT01519245|20477446|P1|STARTED|Overall Study||24
8305835|NCT01519206|20477458|P1|NOT COMPLETED|Overall Study||5
8305836|NCT01519206|20477458|P1|COMPLETED|Overall Study||27
8305837|NCT01519206|20477458|P1|STARTED|Overall Study||32
8305838|NCT01519167|20477472|P2|NOT COMPLETED|Overall Study||8
8305839|NCT01519167|20477473|P1|NOT COMPLETED|Overall Study||0
8305840|NCT01519167|20477472|P2|COMPLETED|Overall Study||81
8305841|NCT01519167|20477473|P1|COMPLETED|Overall Study||1
8305842|NCT01519167|20477472|P2|STARTED|Overall Study||89
8305843|NCT01519167|20477473|P1|STARTED|Overall Study||1
8305844|NCT01519089|20477499|P2|NOT COMPLETED|Overall Study||15
8305845|NCT01519089|20477500|P1|NOT COMPLETED|Overall Study||7
8305846|NCT01519089|20477499|P2|COMPLETED|Overall Study||33
8305847|NCT01519089|20477500|P1|COMPLETED|Overall Study||40
8305848|NCT01519089|20477499|P2|Received Treatment|Overall Study||47
8305849|NCT01519089|20477500|P1|Received Treatment|Overall Study||47
8305850|NCT01519089|20477499|P2|STARTED|Overall Study||48
8305851|NCT01519089|20477500|P1|STARTED|Overall Study||47
8305852|NCT01519063|20477621|P2|NOT COMPLETED|Overall Study||5
8305853|NCT01519063|20477622|P1|NOT COMPLETED|Overall Study||7
8305854|NCT01519063|20477621|P2|COMPLETED|Overall Study||25
8305855|NCT01519063|20477622|P1|COMPLETED|Overall Study||19
8305856|NCT01519063|20477621|P2|STARTED|Overall Study||30
8305857|NCT01519063|20477622|P1|STARTED|Overall Study||26
8305858|NCT01518972|20477642|P2|NOT COMPLETED|Overall Study||4
8305859|NCT01518972|20477643|P1|NOT COMPLETED|Overall Study||6
8305860|NCT01518972|20477642|P2|COMPLETED|Overall Study||11
8305861|NCT01518972|20477643|P1|COMPLETED|Overall Study||9
8305862|NCT01518972|20477642|P2|STARTED|Overall Study||15
8305863|NCT01518972|20477643|P1|STARTED|Overall Study||15
8305864|NCT01518946|20477657|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8305865|NCT01518946|20477658|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8305866|NCT01518946|20477659|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8305867|NCT01518946|20477657|P3|COMPLETED|Randomized Phase (Second Intervention)||10
8305868|NCT01518946|20477658|P2|COMPLETED|Randomized Phase (Second Intervention)||9
8305869|NCT01518946|20477659|P1|COMPLETED|Randomized Phase (Second Intervention)||0
8305870|NCT01518946|20477657|P3|STARTED|Randomized Phase (Second Intervention)||10
8305871|NCT01518946|20477658|P2|STARTED|Randomized Phase (Second Intervention)||9
8305872|NCT01518946|20477659|P1|STARTED|Randomized Phase (Second Intervention)||0
8305873|NCT01518946|20477657|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
8305874|NCT01518946|20477658|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
8305875|NCT01518946|20477659|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
8305876|NCT01518946|20477657|P3|COMPLETED|Randomized Phase (First Intervention)||10
8305877|NCT01518946|20477658|P2|COMPLETED|Randomized Phase (First Intervention)||9
8305878|NCT01518946|20477659|P1|COMPLETED|Randomized Phase (First Intervention)||0
8305879|NCT01518946|20477657|P3|STARTED|Randomized Phase (First Intervention)||10
8305880|NCT01518946|20477658|P2|STARTED|Randomized Phase (First Intervention)||10
8305881|NCT01518946|20477659|P1|STARTED|Randomized Phase (First Intervention)||0
8305882|NCT01518946|20477657|P3|NOT COMPLETED|Open-label Phase||0
8305883|NCT01518946|20477658|P2|NOT COMPLETED|Open-label Phase||0
8305884|NCT01518946|20477659|P1|NOT COMPLETED|Open-label Phase||4
8305885|NCT01518946|20477657|P3|COMPLETED|Open-label Phase||0
8305886|NCT01518946|20477658|P2|COMPLETED|Open-label Phase||0
8305887|NCT01518946|20477659|P1|COMPLETED|Open-label Phase||20
8305888|NCT01518946|20477657|P3|STARTED|Open-label Phase||0
8305889|NCT01518946|20477658|P2|STARTED|Open-label Phase||0
8305890|NCT01518946|20477659|P1|STARTED|Open-label Phase||24
8305891|NCT01518868|20477666|P2|NOT COMPLETED|Overall Study||4
8305892|NCT01518868|20477667|P1|NOT COMPLETED|Overall Study||4
8305893|NCT01518868|20477666|P2|COMPLETED|Overall Study||59
8305894|NCT01518868|20477667|P1|COMPLETED|Overall Study||59
8305895|NCT01518868|20477666|P2|STARTED|Overall Study||63
8305896|NCT01518868|20477667|P1|STARTED|Overall Study||63
8305897|NCT01518530|20477675|P1|NOT COMPLETED|Post-Treatment Follow-up||0
8305898|NCT01518530|20477675|P1|COMPLETED|Post-Treatment Follow-up||9
8305899|NCT01518530|20477675|P1|STARTED|Post-Treatment Follow-up||9
8305900|NCT01518530|20477675|P1|NOT COMPLETED|Active Treatment Period||1
8305901|NCT01518530|20477675|P1|COMPLETED|Active Treatment Period||9
8305902|NCT01518530|20477675|P1|STARTED|Active Treatment Period||10
8305903|NCT01518374|20477679|P1|NOT COMPLETED|Overall Study||7
8305904|NCT01518374|20477679|P1|COMPLETED|Overall Study||1761
8305905|NCT01518374|20477679|P1|STARTED|Overall Study||1768
8305906|NCT01518322|20477683|P1|NOT COMPLETED|Overall Study||13
8305907|NCT01518322|20477683|P1|COMPLETED|Overall Study||222
8305908|NCT01518322|20477683|P1|STARTED|Overall Study||235
8305909|NCT01518309|20477696|P1|NOT COMPLETED|Overall Study||39
8305910|NCT01518309|20477696|P1|COMPLETED|Overall Study||0
8305911|NCT01518309|20477696|P1|STARTED|Overall Study||39
8305912|NCT01518270|20477700|P1|NOT COMPLETED|Overall Study||0
8305913|NCT01518270|20477700|P1|COMPLETED|Overall Study||179
8305914|NCT01518270|20477700|P1|STARTED|Overall Study||179
8305915|NCT01518257|20477708|P2|NOT COMPLETED|Overall Study||0
8305916|NCT01518257|20477709|P1|NOT COMPLETED|Overall Study||2
8305917|NCT01518257|20477708|P2|COMPLETED|Overall Study||60
8305918|NCT01518257|20477709|P1|COMPLETED|Overall Study||59
8305919|NCT01518257|20477708|P2|STARTED|Overall Study||60
8305920|NCT01518257|20477709|P1|STARTED|Overall Study||61
8305921|NCT01518244|20477731|P1|NOT COMPLETED|Overall Study||3
8305922|NCT01518244|20477731|P1|COMPLETED|Overall Study||47
8305923|NCT01518244|20477731|P1|STARTED|Overall Study||50
8305924|NCT01518192|20477739|P3|NOT COMPLETED|Overall Study||35
8305925|NCT01518192|20477740|P2|NOT COMPLETED|Overall Study||26
8305926|NCT01518192|20477741|P1|NOT COMPLETED|Overall Study||29
8305927|NCT01518192|20477739|P3|COMPLETED|Overall Study||224
8305928|NCT01518192|20477740|P2|COMPLETED|Overall Study||114
8305929|NCT01518192|20477741|P1|COMPLETED|Overall Study||116
8305930|NCT01518192|20477739|P3|STARTED|Overall Study||259
8305931|NCT01518192|20477740|P2|STARTED|Overall Study||140
8305932|NCT01518192|20477741|P1|STARTED|Overall Study||145
8305933|NCT01518153|20477762|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
8305934|NCT01518153|20477763|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
8305935|NCT01518153|20477764|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
8305936|NCT01518153|20477762|P3|COMPLETED|Donor Lymphocyte Infusion||3
8305937|NCT01518153|20477763|P2|COMPLETED|Donor Lymphocyte Infusion||1
8305938|NCT01518153|20477764|P1|COMPLETED|Donor Lymphocyte Infusion||0
8305939|NCT01518153|20477762|P3|STARTED|Donor Lymphocyte Infusion||4
8305940|NCT01518153|20477763|P2|STARTED|Donor Lymphocyte Infusion||3
8305941|NCT01518153|20477764|P1|STARTED|Donor Lymphocyte Infusion||0
8305942|NCT01518153|20477762|P3|NOT COMPLETED|Stem Cell Transplant||0
8305943|NCT01518153|20477763|P2|NOT COMPLETED|Stem Cell Transplant||0
8305944|NCT01518153|20477764|P1|NOT COMPLETED|Stem Cell Transplant||9
8305945|NCT01518153|20477762|P3|COMPLETED|Stem Cell Transplant||0
8305946|NCT01518153|20477763|P2|COMPLETED|Stem Cell Transplant||0
8305947|NCT01518153|20477764|P1|COMPLETED|Stem Cell Transplant||7
8305948|NCT01518153|20477762|P3|STARTED|Stem Cell Transplant||0
8305949|NCT01518153|20477763|P2|STARTED|Stem Cell Transplant||0
8305950|NCT01518153|20477764|P1|STARTED|Stem Cell Transplant||16
8305951|NCT01517984|20477775|P4|NOT COMPLETED|Overall Study||1
8305952|NCT01517984|20477776|P3|NOT COMPLETED|Overall Study||4
8305953|NCT01517984|20477777|P2|NOT COMPLETED|Overall Study||23
8305954|NCT01517984|20477778|P1|NOT COMPLETED|Overall Study||5
8305955|NCT01517984|20477775|P4|COMPLETED|Overall Study||6
8305956|NCT01517984|20477776|P3|COMPLETED|Overall Study||10
8305957|NCT01517984|20477777|P2|COMPLETED|Overall Study||3
8305958|NCT01517984|20477778|P1|COMPLETED|Overall Study||0
8305959|NCT01517984|20477775|P4|STARTED|Overall Study||7
8305960|NCT01517984|20477776|P3|STARTED|Overall Study||14
8305961|NCT01517984|20477777|P2|STARTED|Overall Study||26
8305962|NCT01517984|20477778|P1|STARTED|Overall Study||5
8305963|NCT01517893|20477804|P2|NOT COMPLETED|Overall Study||0
8305964|NCT01517893|20477805|P1|NOT COMPLETED|Overall Study||3
8305965|NCT01517893|20477804|P2|COMPLETED|Overall Study||7
8305966|NCT01517893|20477805|P1|COMPLETED|Overall Study||5
8305967|NCT01517893|20477804|P2|STARTED|Overall Study||7
8305968|NCT01517893|20477805|P1|STARTED|Overall Study||8
8305969|NCT01517867|20477827|P2|NOT COMPLETED|Overall Study||65
8305970|NCT01517867|20477828|P1|NOT COMPLETED|Overall Study||63
8305971|NCT01517867|20477827|P2|COMPLETED|Overall Study||15
8305972|NCT01517867|20477828|P1|COMPLETED|Overall Study||18
8305973|NCT01517867|20477827|P2|STARTED|Overall Study||80
8305974|NCT01517867|20477828|P1|STARTED|Overall Study||81
8305975|NCT01517763|20477839|P3|NOT COMPLETED|Overall Study||0
8305976|NCT01517763|20477840|P2|NOT COMPLETED|Overall Study||0
8305977|NCT01517763|20477841|P1|NOT COMPLETED|Overall Study||0
8305978|NCT01517763|20477839|P3|COMPLETED|Overall Study||0
8305979|NCT01517763|20477840|P2|COMPLETED|Overall Study||0
8305980|NCT01517763|20477841|P1|COMPLETED|Overall Study||0
8305981|NCT01517763|20477839|P3|STARTED|Overall Study||0
8305982|NCT01517763|20477840|P2|STARTED|Overall Study||0
8305983|NCT01517763|20477841|P1|STARTED|Overall Study||0
8305984|NCT01517750|20477856|P4|NOT COMPLETED|Overall Study||1
8305985|NCT01517750|20477857|P3|NOT COMPLETED|Overall Study||4
8305986|NCT01517750|20477858|P2|NOT COMPLETED|Overall Study||2
8305987|NCT01517750|20477859|P1|NOT COMPLETED|Overall Study||1
8305988|NCT01517750|20477856|P4|COMPLETED|Overall Study||18
8305989|NCT01517750|20477857|P3|COMPLETED|Overall Study||17
8305990|NCT01517750|20477858|P2|COMPLETED|Overall Study||17
8305991|NCT01517750|20477859|P1|COMPLETED|Overall Study||20
8305992|NCT01517750|20477856|P4|STARTED|Overall Study||19
8305993|NCT01517750|20477857|P3|STARTED|Overall Study||21
8305994|NCT01517750|20477858|P2|STARTED|Overall Study||19
8305995|NCT01517750|20477859|P1|STARTED|Overall Study||21
8305996|NCT01517659|20477889|P1|NOT COMPLETED|Overall Study||0
8305997|NCT01517659|20477889|P1|COMPLETED|Overall Study||45
8305998|NCT01517659|20477889|P1|STARTED|Overall Study||45
8305999|NCT01517529|20477896|P1|NOT COMPLETED|Overall Study||0
8306000|NCT01517529|20477896|P1|COMPLETED|Overall Study||10
8306001|NCT01517529|20477896|P1|STARTED|Overall Study||10
8306002|NCT01517412|20477903|P2|NOT COMPLETED|Overall Study||24
8306003|NCT01517412|20477904|P1|NOT COMPLETED|Overall Study||36
8306004|NCT01517412|20477903|P2|COMPLETED|Overall Study||202
8306005|NCT01517412|20477904|P1|COMPLETED|Overall Study||189
8306006|NCT01517412|20477903|P2|STARTED|Overall Study||226
8306007|NCT01517412|20477904|P1|STARTED|Overall Study||225
8306008|NCT01517373|20477933|P6|NOT COMPLETED|Treatment Period||7
8306009|NCT01517373|20477934|P5|NOT COMPLETED|Treatment Period||6
8306010|NCT01517373|20477935|P4|NOT COMPLETED|Treatment Period||7
8306011|NCT01517373|20477936|P3|NOT COMPLETED|Treatment Period||6
8306012|NCT01517373|20477937|P2|NOT COMPLETED|Treatment Period||4
8306013|NCT01517373|20477938|P1|NOT COMPLETED|Treatment Period||0
8306014|NCT01517373|20477933|P6|COMPLETED|Treatment Period||54
8306015|NCT01517373|20477934|P5|COMPLETED|Treatment Period||55
8306016|NCT01517373|20477935|P4|COMPLETED|Treatment Period||54
8306017|NCT01517373|20477936|P3|COMPLETED|Treatment Period||54
8306018|NCT01517373|20477937|P2|COMPLETED|Treatment Period||57
8306019|NCT01517373|20477938|P1|COMPLETED|Treatment Period||0
8306020|NCT01517373|20477933|P6|STARTED|Treatment Period||61
8306021|NCT01517373|20477934|P5|STARTED|Treatment Period||61
8306022|NCT01517373|20477935|P4|STARTED|Treatment Period||61
8306023|NCT01517373|20477936|P3|STARTED|Treatment Period||60
8306024|NCT01517373|20477937|P2|STARTED|Treatment Period||61
8306025|NCT01517373|20477938|P1|STARTED|Treatment Period||0
8306026|NCT01517373|20477933|P6|NOT COMPLETED|Run-in Period||0
8306027|NCT01517373|20477934|P5|NOT COMPLETED|Run-in Period||0
8306028|NCT01517373|20477935|P4|NOT COMPLETED|Run-in Period||0
8306029|NCT01517373|20477936|P3|NOT COMPLETED|Run-in Period||0
8306030|NCT01517373|20477937|P2|NOT COMPLETED|Run-in Period||0
8306031|NCT01517373|20477938|P1|NOT COMPLETED|Run-in Period||57
8306032|NCT01517373|20477933|P6|COMPLETED|Run-in Period||0
8306033|NCT01517373|20477934|P5|COMPLETED|Run-in Period||0
8306034|NCT01517373|20477935|P4|COMPLETED|Run-in Period||0
8306035|NCT01517373|20477936|P3|COMPLETED|Run-in Period||0
8306036|NCT01517373|20477937|P2|COMPLETED|Run-in Period||0
8306037|NCT01517373|20477938|P1|COMPLETED|Run-in Period||304
8306038|NCT01517373|20477933|P6|STARTED|Run-in Period||0
8306039|NCT01517373|20477934|P5|STARTED|Run-in Period||0
8306040|NCT01517373|20477935|P4|STARTED|Run-in Period||0
8306041|NCT01517373|20477936|P3|STARTED|Run-in Period||0
8306042|NCT01517373|20477937|P2|STARTED|Run-in Period||0
8306043|NCT01517373|20477938|P1|STARTED|Run-in Period||361
8306044|NCT01517295|20478008|P2|NOT COMPLETED|Overall Study||0
8306045|NCT01517295|20478009|P1|NOT COMPLETED|Overall Study||1
8306046|NCT01517295|20478008|P2|COMPLETED|Overall Study||14
8306047|NCT01517295|20478009|P1|COMPLETED|Overall Study||15
8306048|NCT01517295|20478008|P2|STARTED|Overall Study||14
8306049|NCT01517295|20478009|P1|STARTED|Overall Study||16
8306050|NCT01517282|20478023|P4|NOT COMPLETED|Overall Study||1
8306051|NCT01517282|20478024|P3|NOT COMPLETED|Overall Study||1
8306052|NCT01517282|20478025|P2|NOT COMPLETED|Overall Study||1
8306053|NCT01517282|20478026|P1|NOT COMPLETED|Overall Study||1
8306054|NCT01517282|20478023|P4|COMPLETED|Overall Study||5
8306055|NCT01517282|20478024|P3|COMPLETED|Overall Study||8
8306056|NCT01517282|20478025|P2|COMPLETED|Overall Study||7
8306057|NCT01517282|20478026|P1|COMPLETED|Overall Study||8
8306058|NCT01517282|20478023|P4|STARTED|Overall Study||6
8306059|NCT01517282|20478024|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
8306060|NCT01517282|20478025|P2|STARTED|Overall Study||8
8306061|NCT01517282|20478026|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
8306062|NCT01517178|20478060|P2|NOT COMPLETED|Period 2||2
8306063|NCT01517178|20478061|P1|NOT COMPLETED|Period 2||6
8306064|NCT01517178|20478060|P2|COMPLETED|Period 2||4
8306065|NCT01517178|20478061|P1|COMPLETED|Period 2||5
8306066|NCT01517178|20478060|P2|STARTED|Period 2||6
8306067|NCT01517178|20478061|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
8306068|NCT01517178|20478060|P2|NOT COMPLETED|Period 1||5
8306069|NCT01517178|20478061|P1|NOT COMPLETED|Period 1||4
8306070|NCT01517178|20478060|P2|COMPLETED|Period 1||6
8306071|NCT01517178|20478061|P1|COMPLETED|Period 1||12
8306072|NCT01517178|20478060|P2|STARTED|Period 1||11
8306073|NCT01517178|20478061|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
8306074|NCT01517074|20478067|P1|NOT COMPLETED|Overall Study||0
8306075|NCT01517074|20478067|P1|COMPLETED|Overall Study||5
8306076|NCT01517074|20478067|P1|STARTED|Overall Study||5
8306077|NCT01516970|20478089|P2|NOT COMPLETED|Overall Study||21
8306078|NCT01516970|20478090|P1|NOT COMPLETED|Overall Study||18
8306079|NCT01516970|20478089|P2|COMPLETED|Overall Study||132
8306080|NCT01516970|20478090|P1|COMPLETED|Overall Study||141
8306081|NCT01516970|20478089|P2|STARTED|Overall Study||153
8306082|NCT01516970|20478090|P1|STARTED|Overall Study||159
8306083|NCT01516957|20478105|P4|NOT COMPLETED|Open-label Phase||156
8306084|NCT01516957|20478106|P3|NOT COMPLETED|Open-label Phase||0
8306085|NCT01516957|20478107|P2|NOT COMPLETED|Open-label Phase||0
8306086|NCT01516957|20478108|P1|NOT COMPLETED|Open-label Phase||0
8306087|NCT01516957|20478105|P4|COMPLETED|Open-label Phase||0
8306088|NCT01516957|20478106|P3|COMPLETED|Open-label Phase||0
8306089|NCT01516957|20478107|P2|COMPLETED|Open-label Phase||0
8306090|NCT01516957|20478108|P1|COMPLETED|Open-label Phase||0
8306091|NCT01516957|20478105|P4|STARTED|Open-label Phase||156
8306092|NCT01516957|20478106|P3|STARTED|Open-label Phase||0
8306093|NCT01516957|20478107|P2|STARTED|Open-label Phase||0
8306094|NCT01516957|20478108|P1|STARTED|Open-label Phase||0
8306095|NCT01516957|20478105|P4|NOT COMPLETED|Placebo-controlled Phase||0
8306096|NCT01516957|20478106|P3|NOT COMPLETED|Placebo-controlled Phase||5
8306097|NCT01516957|20478107|P2|NOT COMPLETED|Placebo-controlled Phase||4
8306098|NCT01516957|20478108|P1|NOT COMPLETED|Placebo-controlled Phase||3
8306099|NCT01516957|20478105|P4|COMPLETED|Placebo-controlled Phase||0
8306100|NCT01516957|20478106|P3|COMPLETED|Placebo-controlled Phase||51
8306101|NCT01516957|20478107|P2|COMPLETED|Placebo-controlled Phase||53
8306102|NCT01516957|20478108|P1|COMPLETED|Placebo-controlled Phase||52
8306103|NCT01516957|20478105|P4|STARTED|Placebo-controlled Phase||0
8306104|NCT01516957|20478106|P3|STARTED|Placebo-controlled Phase||56
8306105|NCT01516957|20478107|P2|STARTED|Placebo-controlled Phase||57
8306106|NCT01516957|20478108|P1|STARTED|Placebo-controlled Phase||55
8306107|NCT01516892|20478129|P1|NOT COMPLETED|Overall Study||343
8306108|NCT01516892|20478129|P1|COMPLETED|Overall Study||373
8306109|NCT01516892|20478129|P1|STARTED|Overall Study||716
8306110|NCT01516879|20478137|P2|NOT COMPLETED|Overall Study||34
8306111|NCT01516879|20478138|P1|NOT COMPLETED|Overall Study||16
8306112|NCT01516879|20478137|P2|COMPLETED|Overall Study||568
8306113|NCT01516879|20478138|P1|COMPLETED|Overall Study||287
8306114|NCT01516879|20478137|P2|Received Treatment|Overall Study||599
8306115|NCT01516879|20478138|P1|Received Treatment|Overall Study||302
8306116|NCT01516879|20478137|P2|STARTED|Overall Study||602
8306117|NCT01516879|20478138|P1|STARTED|Overall Study||303
8306118|NCT01516749|20478172|P1|NOT COMPLETED|Follow-up Off Therapy||1
8306119|NCT01516749|20478172|P1|COMPLETED|Follow-up Off Therapy||4
8306120|NCT01516749|20478172|P1|STARTED|Follow-up Off Therapy||5
8306121|NCT01516749|20478172|P1|NOT COMPLETED|Active Therapy||1
8306122|NCT01516749|20478172|P1|COMPLETED|Active Therapy||5
8306123|NCT01516749|20478172|P1|STARTED|Active Therapy||6
8306124|NCT01516736|20478181|P2|NOT COMPLETED|Overall Study||13
8306125|NCT01516736|20478182|P1|NOT COMPLETED|Overall Study||20
8306126|NCT01516736|20478181|P2|COMPLETED|Overall Study||140
8306127|NCT01516736|20478182|P1|COMPLETED|Overall Study||135
8306128|NCT01516736|20478181|P2|STARTED|Overall Study||153
8306129|NCT01516736|20478182|P1|STARTED|Overall Study||155
8306130|NCT01516684|20478204|P2|NOT COMPLETED|Overall Study||0
8306131|NCT01516684|20478205|P1|NOT COMPLETED|Overall Study||0
8306132|NCT01516684|20478204|P2|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152
~Trials were randomized for each arm, not participants"|0
8306133|NCT01516684|20478205|P1|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|0
8306134|NCT01516684|20478204|P2|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
8306135|NCT01516684|20478205|P1|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
8306136|NCT01516632|20478221|P2|NOT COMPLETED|Overall Study||15
8306137|NCT01516632|20478222|P1|NOT COMPLETED|Overall Study||24
8306138|NCT01516632|20478221|P2|COMPLETED|Overall Study||48
8306139|NCT01516632|20478222|P1|COMPLETED|Overall Study||77
8306140|NCT01516632|20478221|P2|STARTED|Overall Study||63
8306141|NCT01516632|20478222|P1|STARTED|Overall Study||101
8306142|NCT01516437|20478236|P4|NOT COMPLETED|Overall Study||1
8306143|NCT01516437|20478237|P3|NOT COMPLETED|Overall Study||1
8306144|NCT01516437|20478238|P2|NOT COMPLETED|Overall Study||0
8306145|NCT01516437|20478239|P1|NOT COMPLETED|Overall Study||0
8306146|NCT01516437|20478236|P4|COMPLETED|Overall Study||6
8306147|NCT01516437|20478237|P3|COMPLETED|Overall Study||14
8306148|NCT01516437|20478238|P2|COMPLETED|Overall Study||24
8306149|NCT01516437|20478239|P1|COMPLETED|Overall Study||24
8306150|NCT01516437|20478236|P4|STARTED|Overall Study||7
8306151|NCT01516437|20478237|P3|STARTED|Overall Study||15
8306152|NCT01516437|20478238|P2|STARTED|Overall Study||24
8306153|NCT01516437|20478239|P1|STARTED|Overall Study||24
8306154|NCT01516424|20478295|P2|NOT COMPLETED|Overall Study||22
8306155|NCT01516424|20478296|P1|NOT COMPLETED|Overall Study||35
8306156|NCT01516424|20478295|P2|COMPLETED|Overall Study||114
8306157|NCT01516424|20478296|P1|COMPLETED|Overall Study||96
8306158|NCT01516424|20478295|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
8306159|NCT01516424|20478296|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
8306160|NCT01516268|20478304|P2|NOT COMPLETED|Overall Study||0
8306161|NCT01516268|20478305|P1|NOT COMPLETED|Overall Study||0
8306162|NCT01516268|20478304|P2|COMPLETED|Overall Study||25
8306163|NCT01516268|20478305|P1|COMPLETED|Overall Study||25
8306164|NCT01516268|20478304|P2|STARTED|Overall Study||25
8306165|NCT01516268|20478305|P1|STARTED|Overall Study||25
8306166|NCT01516034|20478311|P1|NOT COMPLETED|Overall Study||8
8306167|NCT01516034|20478311|P1|COMPLETED|Overall Study||0
8306168|NCT01516034|20478311|P1|STARTED|Overall Study||8
8306169|NCT01516008|20478318|P3|NOT COMPLETED|Overall Study||18
8306170|NCT01516008|20478319|P2|NOT COMPLETED|Overall Study||16
8306171|NCT01516008|20478320|P1|NOT COMPLETED|Overall Study||45
8306172|NCT01516008|20478318|P3|COMPLETED|Overall Study||99
8306173|NCT01516008|20478319|P2|COMPLETED|Overall Study||105
8306174|NCT01516008|20478320|P1|COMPLETED|Overall Study||69
8306175|NCT01516008|20478318|P3|STARTED|Overall Study||117
8306176|NCT01516008|20478319|P2|STARTED|Overall Study||121
8306177|NCT01516008|20478320|P1|STARTED|Overall Study||114
8306178|NCT01515995|20478354|P2|NOT COMPLETED|Overall Study||4
8306179|NCT01515995|20478355|P1|NOT COMPLETED|Overall Study||3
8306180|NCT01515995|20478354|P2|COMPLETED|Overall Study||21
8306181|NCT01515995|20478355|P1|COMPLETED|Overall Study||22
8306182|NCT01515995|20478354|P2|STARTED|Overall Study||25
8306183|NCT01515995|20478355|P1|STARTED|Overall Study||25
8306184|NCT01515956|20478361|P1|NOT COMPLETED|Overall Study||0
8306185|NCT01515956|20478361|P1|COMPLETED|Overall Study||15
8306186|NCT01515956|20478361|P1|STARTED|Overall Study||15
8306187|NCT01515943|20478370|P3|NOT COMPLETED|Overall Study||13
8306188|NCT01515943|20478371|P2|NOT COMPLETED|Overall Study||16
8306189|NCT01515943|20478372|P1|NOT COMPLETED|Overall Study||6
8306190|NCT01515943|20478370|P3|COMPLETED|Overall Study||31
8306191|NCT01515943|20478371|P2|COMPLETED|Overall Study||69
8306192|NCT01515943|20478372|P1|COMPLETED|Overall Study||69
8306193|NCT01515943|20478370|P3|STARTED|Overall Study||44
8306194|NCT01515943|20478371|P2|STARTED|Overall Study||85
8306195|NCT01515943|20478372|P1|STARTED|Overall Study||75
8306196|NCT01515891|20478418|P1|NOT COMPLETED|Overall Study||0
8306197|NCT01515891|20478418|P1|COMPLETED|Overall Study||4
8306198|NCT01515891|20478418|P1|STARTED|Overall Study||4
8306199|NCT01515865|20478425|P3|NOT COMPLETED|Part C (Randomized)||0
8306200|NCT01515865|20478426|P2|NOT COMPLETED|Part C (Randomized)||0
8306201|NCT01515865|20478427|P1|NOT COMPLETED|Part C (Randomized)||0
8306202|NCT01515865|20478425|P3|COMPLETED|Part C (Randomized)||34
8306203|NCT01515865|20478426|P2|COMPLETED|Part C (Randomized)||33
8306204|NCT01515865|20478427|P1|COMPLETED|Part C (Randomized)||0
8306205|NCT01515865|20478425|P3|STARTED|Part C (Randomized)||34
8306206|NCT01515865|20478426|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
8306207|NCT01515865|20478427|P1|STARTED|Part C (Randomized)||0
8306208|NCT01515865|20478425|P3|NOT COMPLETED|Part B (Open-label)||0
8306209|NCT01515865|20478426|P2|NOT COMPLETED|Part B (Open-label)||0
8306210|NCT01515865|20478427|P1|NOT COMPLETED|Part B (Open-label)||2
8306211|NCT01515865|20478425|P3|COMPLETED|Part B (Open-label)||0
8306212|NCT01515865|20478426|P2|COMPLETED|Part B (Open-label)||0
8306213|NCT01515865|20478427|P1|COMPLETED|Part B (Open-label)||69
8306214|NCT01515865|20478425|P3|STARTED|Part B (Open-label)||0
8306215|NCT01515865|20478426|P2|STARTED|Part B (Open-label)||0
8306216|NCT01515865|20478427|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
8306217|NCT01515865|20478425|P3|NOT COMPLETED|Part A (Open-label)||0
8306218|NCT01515865|20478426|P2|NOT COMPLETED|Part A (Open-label)||0
8306219|NCT01515865|20478427|P1|NOT COMPLETED|Part A (Open-label)||3
8306220|NCT01515865|20478425|P3|COMPLETED|Part A (Open-label)||0
8306221|NCT01515865|20478426|P2|COMPLETED|Part A (Open-label)||0
8306222|NCT01515865|20478427|P1|COMPLETED|Part A (Open-label)||95
8306223|NCT01515865|20478425|P3|STARTED|Part A (Open-label)||0
8306224|NCT01515865|20478426|P2|STARTED|Part A (Open-label)||0
8306225|NCT01515865|20478427|P1|STARTED|Part A (Open-label)||98
8306226|NCT01515748|20478437|P2|NOT COMPLETED|Overall Study||135
8306227|NCT01515748|20478438|P1|NOT COMPLETED|Overall Study||120
8306228|NCT01515748|20478437|P2|COMPLETED|Overall Study||131
8306229|NCT01515748|20478438|P1|COMPLETED|Overall Study||144
8306230|NCT01515748|20478437|P2|Treated|Overall Study||241
8306231|NCT01515748|20478438|P1|Treated|Overall Study||195
8306232|NCT01515748|20478437|P2|STARTED|Overall Study||266
8306233|NCT01515748|20478438|P1|STARTED|Overall Study||264
8306234|NCT01515696|20478461|P2|NOT COMPLETED|Overall Study||10
8306235|NCT01515696|20478462|P1|NOT COMPLETED|Overall Study||8
8306236|NCT01515696|20478461|P2|COMPLETED|Overall Study||39
8306237|NCT01515696|20478462|P1|COMPLETED|Overall Study||39
8306238|NCT01515696|20478461|P2|STARTED|Overall Study||49
8306239|NCT01515696|20478462|P1|STARTED|Overall Study||47
8306240|NCT01515657|20478472|P3|NOT COMPLETED|Third Intervention||0
8306241|NCT01515657|20478473|P2|NOT COMPLETED|Third Intervention||0
8306242|NCT01515657|20478474|P1|NOT COMPLETED|Third Intervention||1
8306243|NCT01515657|20478472|P3|COMPLETED|Third Intervention||13
8306244|NCT01515657|20478473|P2|COMPLETED|Third Intervention||11
8306245|NCT01515657|20478474|P1|COMPLETED|Third Intervention||13
8306246|NCT01515657|20478472|P3|STARTED|Third Intervention||13
8306247|NCT01515657|20478473|P2|STARTED|Third Intervention||11
8306248|NCT01515657|20478474|P1|STARTED|Third Intervention||14
8306249|NCT01515657|20478472|P3|NOT COMPLETED|Second Intervention||0
8306250|NCT01515657|20478473|P2|NOT COMPLETED|Second Intervention||1
8306251|NCT01515657|20478474|P1|NOT COMPLETED|Second Intervention||0
8306252|NCT01515657|20478472|P3|COMPLETED|Second Intervention||13
8306253|NCT01515657|20478473|P2|COMPLETED|Second Intervention||11
8306254|NCT01515657|20478474|P1|COMPLETED|Second Intervention||14
8306255|NCT01515657|20478472|P3|STARTED|Second Intervention||13
8306256|NCT01515657|20478473|P2|STARTED|Second Intervention||12
8306257|NCT01515657|20478474|P1|STARTED|Second Intervention||14
8306258|NCT01515657|20478472|P3|NOT COMPLETED|First Intervention||0
8306259|NCT01515657|20478473|P2|NOT COMPLETED|First Intervention||1
8306260|NCT01515657|20478474|P1|NOT COMPLETED|First Intervention||0
8306261|NCT01515657|20478472|P3|COMPLETED|First Intervention||13
8306262|NCT01515657|20478473|P2|COMPLETED|First Intervention||12
8306263|NCT01515657|20478474|P1|COMPLETED|First Intervention||14
8306264|NCT01515657|20478472|P3|STARTED|First Intervention||13
8306265|NCT01515657|20478473|P2|STARTED|First Intervention||13
8306266|NCT01515657|20478474|P1|STARTED|First Intervention||14
8306267|NCT01515566|20478484|P2|NOT COMPLETED|Overall Study||0
8306268|NCT01515566|20478485|P1|NOT COMPLETED|Overall Study||0
8306269|NCT01515566|20478484|P2|COMPLETED|Overall Study||10
8306270|NCT01515566|20478485|P1|COMPLETED|Overall Study||10
8306271|NCT01515566|20478484|P2|STARTED|Overall Study||10
8306272|NCT01515566|20478485|P1|STARTED|Overall Study||10
8306273|NCT01515540|20478497|P2|NOT COMPLETED|Overall Study||3
8306274|NCT01515540|20478498|P1|NOT COMPLETED|Overall Study||5
8306275|NCT01515540|20478497|P2|COMPLETED|Overall Study||15
8306276|NCT01515540|20478498|P1|COMPLETED|Overall Study||15
8306277|NCT01515540|20478497|P2|STARTED|Overall Study||18
8306278|NCT01515540|20478498|P1|STARTED|Overall Study||20
8306279|NCT01515488|20478506|P2|NOT COMPLETED|Overall Study||0
8306280|NCT01515488|20478507|P1|NOT COMPLETED|Overall Study||0
8306281|NCT01515488|20478506|P2|COMPLETED|Overall Study||200
8306282|NCT01515488|20478507|P1|COMPLETED|Overall Study||200
8306283|NCT01515488|20478506|P2|STARTED|Overall Study||200
8306284|NCT01515488|20478507|P1|STARTED|Overall Study||200
8306285|NCT01515475|20478521|P4|NOT COMPLETED|Overall Study||12
8306286|NCT01515475|20478522|P3|NOT COMPLETED|Overall Study||12
8306287|NCT01515475|20478523|P2|NOT COMPLETED|Overall Study||15
8306288|NCT01515475|20478524|P1|NOT COMPLETED|Overall Study||20
8306289|NCT01515475|20478521|P4|COMPLETED|Overall Study||53
8306290|NCT01515475|20478522|P3|COMPLETED|Overall Study||53
8306291|NCT01515475|20478523|P2|COMPLETED|Overall Study||43
8306292|NCT01515475|20478524|P1|COMPLETED|Overall Study||41
8306293|NCT01515475|20478521|P4|STARTED|Overall Study||65
8306294|NCT01515475|20478522|P3|STARTED|Overall Study||65
8306295|NCT01515475|20478523|P2|STARTED|Overall Study||58
8306296|NCT01515475|20478524|P1|STARTED|Overall Study||61
8306297|NCT01515423|20478598|P3|NOT COMPLETED|DOUBLE BLIND||92
8306298|NCT01515423|20478599|P2|NOT COMPLETED|DOUBLE BLIND||82
8306299|NCT01515423|20478600|P1|NOT COMPLETED|DOUBLE BLIND||0
8306300|NCT01515423|20478598|P3|COMPLETED|DOUBLE BLIND||420
8306301|NCT01515423|20478599|P2|COMPLETED|DOUBLE BLIND||422
8306302|NCT01515423|20478600|P1|COMPLETED|DOUBLE BLIND||0
8306303|NCT01515423|20478598|P3|STARTED|DOUBLE BLIND||512
8306304|NCT01515423|20478599|P2|STARTED|DOUBLE BLIND||504
8306305|NCT01515423|20478600|P1|STARTED|DOUBLE BLIND||0
8306306|NCT01515423|20478598|P3|NOT COMPLETED|Open Label Phase||0
8306307|NCT01515423|20478599|P2|NOT COMPLETED|Open Label Phase||0
8306308|NCT01515423|20478600|P1|NOT COMPLETED|Open Label Phase||413
8306309|NCT01515423|20478598|P3|COMPLETED|Open Label Phase||0
8306310|NCT01515423|20478599|P2|COMPLETED|Open Label Phase||0
8306311|NCT01515423|20478600|P1|COMPLETED|Open Label Phase||1016
8306312|NCT01515423|20478598|P3|STARTED|Open Label Phase||0
8306313|NCT01515423|20478599|P2|STARTED|Open Label Phase||0
8306314|NCT01515423|20478600|P1|STARTED|Open Label Phase||1429
8306315|NCT01515410|20478619|P2|NOT COMPLETED|Overall Study||0
8306316|NCT01515410|20478620|P1|NOT COMPLETED|Overall Study||0
8306317|NCT01515410|20478619|P2|COMPLETED|Overall Study||15
8306318|NCT01515410|20478620|P1|COMPLETED|Overall Study||19
8306319|NCT01515410|20478619|P2|STARTED|Overall Study||15
8306320|NCT01515410|20478620|P1|STARTED|Overall Study||19
8306321|NCT01515345|20478628|P2|NOT COMPLETED|Overall Study||0
8306322|NCT01515345|20478629|P1|NOT COMPLETED|Overall Study||1
8306323|NCT01515345|20478628|P2|COMPLETED|Overall Study||343
8306324|NCT01515345|20478629|P1|COMPLETED|Overall Study||664
8306325|NCT01515345|20478628|P2|STARTED|Overall Study||343
8306326|NCT01515345|20478629|P1|STARTED|Overall Study||665
8306327|NCT01515306|20478641|P2|NOT COMPLETED|Overall Study||14
8306328|NCT01515306|20478642|P1|NOT COMPLETED|Overall Study||12
8306329|NCT01515306|20478641|P2|COMPLETED|Overall Study||2
8306330|NCT01515306|20478642|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
8306331|NCT01515306|20478641|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
8306332|NCT01515306|20478642|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
8306333|NCT01515306|20478641|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8306334|NCT01515306|20478642|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
8306335|NCT01515306|20478641|P2|STARTED|Overall Study||16
8306336|NCT01515306|20478642|P1|STARTED|Overall Study||24
8306337|NCT01515189|20478655|P2|NOT COMPLETED|First Re-Induction Phase||15
8306338|NCT01515189|20478656|P1|NOT COMPLETED|First Re-Induction Phase||14
8306339|NCT01515189|20478655|P2|COMPLETED|First Re-Induction Phase||17
8306340|NCT01515189|20478656|P1|COMPLETED|First Re-Induction Phase||9
8306341|NCT01515189|20478655|P2|STARTED|First Re-Induction Phase||32
8306342|NCT01515189|20478656|P1|STARTED|First Re-Induction Phase||23
8306343|NCT01515189|20478655|P2|NOT COMPLETED|Induction||232
8306344|NCT01515189|20478656|P1|NOT COMPLETED|Induction||237
8306345|NCT01515189|20478655|P2|COMPLETED|Induction||130
8306346|NCT01515189|20478656|P1|COMPLETED|Induction||128
8306347|NCT01515189|20478655|P2|STARTED|Induction||362
8306348|NCT01515189|20478656|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
8306349|NCT01515176|20478678|P2|NOT COMPLETED|Overall Study||0
8306350|NCT01515176|20478679|P1|NOT COMPLETED|Overall Study||0
8306351|NCT01515176|20478678|P2|COMPLETED|Overall Study||32
8306352|NCT01515176|20478679|P1|COMPLETED|Overall Study||4
8306353|NCT01515176|20478678|P2|STARTED|Overall Study||32
8306354|NCT01515176|20478679|P1|STARTED|Overall Study||4
8306355|NCT01515072|20478693|P2|NOT COMPLETED|Overall Study||0
8306356|NCT01515072|20478694|P1|NOT COMPLETED|Overall Study||0
8306357|NCT01515072|20478693|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
8306358|NCT01515072|20478694|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
8306359|NCT01515072|20478693|P2|STARTED|Overall Study||155
8306360|NCT01515072|20478694|P1|STARTED|Overall Study||166
8306361|NCT01515046|20478734|P1|NOT COMPLETED|Overall Study||0
8306362|NCT01515046|20478734|P1|COMPLETED|Overall Study||1
8306363|NCT01515046|20478734|P1|STARTED|Overall Study||1
8306364|NCT01514864|20478744|P2|NOT COMPLETED|Overall Study||5
8306365|NCT01514864|20478745|P1|NOT COMPLETED|Overall Study||9
8306366|NCT01514864|20478744|P2|COMPLETED|Overall Study||0
8306367|NCT01514864|20478745|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
8306368|NCT01514864|20478744|P2|STARTED|Overall Study||5
8306369|NCT01514864|20478745|P1|STARTED|Overall Study||9
8306370|NCT01514786|20478763|P2|NOT COMPLETED|Overall Study||0
8306371|NCT01514786|20478764|P1|NOT COMPLETED|Overall Study||0
8306372|NCT01514786|20478763|P2|COMPLETED|Overall Study||284
8306373|NCT01514786|20478764|P1|COMPLETED|Overall Study||286
8306374|NCT01514786|20478763|P2|STARTED|Overall Study||284
8306375|NCT01514786|20478764|P1|STARTED|Overall Study||286
8306376|NCT01514760|20478770|P1|NOT COMPLETED|Overall Study||2
8306377|NCT01514760|20478770|P1|COMPLETED|Overall Study||20
8306378|NCT01514760|20478770|P1|STARTED|Overall Study||22
8306379|NCT01514734|20478777|P1|NOT COMPLETED|Overall Study||0
8306380|NCT01514734|20478777|P1|COMPLETED|Overall Study||9
8306381|NCT01514734|20478777|P1|STARTED|Overall Study||9
8306382|NCT01514682|20478783|P2|NOT COMPLETED|Overall Study||6
8306383|NCT01514682|20478784|P1|NOT COMPLETED|Overall Study||6
8306384|NCT01514682|20478783|P2|COMPLETED|Overall Study||14
8306385|NCT01514682|20478784|P1|COMPLETED|Overall Study||13
8306386|NCT01514682|20478783|P2|STARTED|Overall Study||20
8306387|NCT01514682|20478784|P1|STARTED|Overall Study||19
8306388|NCT01514630|20478800|P1|NOT COMPLETED|Overall Study||3
8306389|NCT01514630|20478800|P1|COMPLETED|Overall Study||11
8306390|NCT01514630|20478800|P1|STARTED|Overall Study||14
8306391|NCT01514513|20478806|P2|NOT COMPLETED|Overall Study||1
8306392|NCT01514513|20478807|P1|NOT COMPLETED|Overall Study||1
8306393|NCT01514513|20478806|P2|COMPLETED|Overall Study||20
8306394|NCT01514513|20478807|P1|COMPLETED|Overall Study||20
8306395|NCT01514513|20478806|P2|STARTED|Overall Study||21
8306396|NCT01514513|20478807|P1|STARTED|Overall Study||21
8306397|NCT01514461|20478818|P3|NOT COMPLETED|Overall Study||4
8306398|NCT01514461|20478819|P2|NOT COMPLETED|Overall Study||3
8306399|NCT01514461|20478820|P1|NOT COMPLETED|Overall Study||5
8306400|NCT01514461|20478818|P3|COMPLETED|Overall Study||11
8306401|NCT01514461|20478819|P2|COMPLETED|Overall Study||12
8306402|NCT01514461|20478820|P1|COMPLETED|Overall Study||10
8306403|NCT01514461|20478818|P3|STARTED|Overall Study||15
8306404|NCT01514461|20478819|P2|STARTED|Overall Study||15
8306405|NCT01514461|20478820|P1|STARTED|Overall Study||15
8306406|NCT01514448|20478859|P2|NOT COMPLETED|Overall Study||8
8306407|NCT01514448|20478860|P1|NOT COMPLETED|Overall Study||12
8306408|NCT01514448|20478859|P2|COMPLETED|Overall Study||5
8306409|NCT01514448|20478860|P1|COMPLETED|Overall Study||4
8306410|NCT01514448|20478859|P2|Full Analysis Set (FAS)|Overall Study||13
8306411|NCT01514448|20478860|P1|Full Analysis Set (FAS)|Overall Study||12
8306412|NCT01514448|20478859|P2|STARTED|Overall Study||13
8306413|NCT01514448|20478860|P1|STARTED|Overall Study||16
8306414|NCT01514422|20478875|P1|NOT COMPLETED|Overall Study||1
8306415|NCT01514422|20478875|P1|COMPLETED|Overall Study||19
8306416|NCT01514422|20478875|P1|STARTED|Overall Study||20
8306417|NCT01514396|20478881|P1|NOT COMPLETED|Overall Study||0
8306418|NCT01514396|20478881|P1|COMPLETED|Overall Study||8
8306419|NCT01514396|20478881|P1|STARTED|Overall Study||8
8306420|NCT01514383|20478886|P1|NOT COMPLETED|Overall Study||0
8306421|NCT01514383|20478886|P1|COMPLETED|Overall Study||34
8306422|NCT01514383|20478886|P1|STARTED|Overall Study||34
8306423|NCT01514370|20478893|P2|NOT COMPLETED|Overall Study||16
8306424|NCT01514370|20478894|P1|NOT COMPLETED|Overall Study||11
8306425|NCT01514370|20478893|P2|COMPLETED|Overall Study||24
8306426|NCT01514370|20478894|P1|COMPLETED|Overall Study||29
8306427|NCT01514370|20478893|P2|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
8306428|NCT01514370|20478894|P1|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
8306429|NCT01514370|20478893|P2|STARTED|Overall Study||40
8306430|NCT01514370|20478894|P1|STARTED|Overall Study||40
8306431|NCT01514357|20478940|P2|NOT COMPLETED|Overall Study||0
8306432|NCT01514357|20478941|P1|NOT COMPLETED|Overall Study||4
8306433|NCT01514357|20478940|P2|COMPLETED|Overall Study||0
8306434|NCT01514357|20478941|P1|COMPLETED|Overall Study||8
8306435|NCT01514357|20478940|P2|STARTED|Overall Study||0
8306436|NCT01514357|20478941|P1|STARTED|Overall Study||12
8306437|NCT01514318|20478947|P1|NOT COMPLETED|Overall Study||0
8306438|NCT01514318|20478947|P1|COMPLETED|Overall Study||8
8306439|NCT01514318|20478947|P1|STARTED|Overall Study||8
8306440|NCT01514292|20478953|P1|NOT COMPLETED|Overall Study||0
8306441|NCT01514292|20478953|P1|COMPLETED|Overall Study||72
8306442|NCT01514292|20478953|P1|STARTED|Overall Study||72
8306443|NCT01514279|20478960|P3|NOT COMPLETED|Overall Study||5
8306444|NCT01514279|20478961|P2|NOT COMPLETED|Overall Study||13
8306445|NCT01514279|20478962|P1|NOT COMPLETED|Overall Study||11
8306446|NCT01514279|20478960|P3|COMPLETED|Overall Study||114
8306447|NCT01514279|20478961|P2|COMPLETED|Overall Study||110
8306448|NCT01514279|20478962|P1|COMPLETED|Overall Study||107
8306449|NCT01514279|20478960|P3|STARTED|Overall Study||119
8306450|NCT01514279|20478961|P2|STARTED|Overall Study||123
8306451|NCT01514279|20478962|P1|STARTED|Overall Study||118
8306452|NCT01514240|20479026|P2|NOT COMPLETED|Overall Study||11
8306453|NCT01514240|20479027|P1|NOT COMPLETED|Overall Study||6
8306454|NCT01514240|20479026|P2|COMPLETED|Overall Study||45
8306455|NCT01514240|20479027|P1|COMPLETED|Overall Study||50
8306456|NCT01514240|20479026|P2|STARTED|Overall Study||56
8306457|NCT01514240|20479027|P1|STARTED|Overall Study||56
8306458|NCT01514201|20479105|P4|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
8306459|NCT01514201|20479106|P3|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306460|NCT01514201|20479107|P2|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306461|NCT01514201|20479108|P1|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306462|NCT01514201|20479105|P4|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
8306463|NCT01514201|20479106|P3|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306464|NCT01514201|20479107|P2|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306465|NCT01514201|20479108|P1|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306466|NCT01514201|20479105|P4|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
8306467|NCT01514201|20479106|P3|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8306468|NCT01514201|20479107|P2|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8306469|NCT01514201|20479108|P1|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8306470|NCT01514201|20479105|P4|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
8306471|NCT01514201|20479106|P3|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306472|NCT01514201|20479107|P2|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306473|NCT01514201|20479108|P1|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306474|NCT01514201|20479105|P4|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
8306475|NCT01514201|20479106|P3|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306476|NCT01514201|20479107|P2|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306477|NCT01514201|20479108|P1|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306478|NCT01514201|20479105|P4|STARTED|PHASE II: Veliparib + Radiation Therapy||47
8306479|NCT01514201|20479106|P3|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8306480|NCT01514201|20479107|P2|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8306481|NCT01514201|20479108|P1|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8306482|NCT01514201|20479105|P4|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306483|NCT01514201|20479106|P3|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
8306484|NCT01514201|20479107|P2|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
8306485|NCT01514201|20479108|P1|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
8306486|NCT01514201|20479105|P4|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306487|NCT01514201|20479106|P3|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306488|NCT01514201|20479107|P2|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306489|NCT01514201|20479108|P1|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306490|NCT01514201|20479105|P4|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
8306491|NCT01514201|20479106|P3|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
8306492|NCT01514201|20479107|P2|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
8306493|NCT01514201|20479108|P1|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
8306494|NCT01514201|20479105|P4|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306495|NCT01514201|20479106|P3|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306496|NCT01514201|20479107|P2|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306497|NCT01514201|20479108|P1|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
8306498|NCT01514201|20479105|P4|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306499|NCT01514201|20479106|P3|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
8306500|NCT01514201|20479107|P2|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
8306501|NCT01514201|20479108|P1|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
8306502|NCT01514201|20479105|P4|STARTED|PHASE I: Veliparib + Radiation Therapy||0
8306503|NCT01514201|20479106|P3|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8306504|NCT01514201|20479107|P2|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8306505|NCT01514201|20479108|P1|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8306506|NCT01514162|20479167|P1|NOT COMPLETED|Overall Study||85
8306507|NCT01514162|20479167|P1|COMPLETED|Overall Study||160
8306508|NCT01514162|20479167|P1|STARTED|Overall Study||245
8306509|NCT01514149|20479178|P5|NOT COMPLETED|Overall Study||1
8306510|NCT01514149|20479179|P4|NOT COMPLETED|Overall Study||1
8306511|NCT01514149|20479180|P3|NOT COMPLETED|Overall Study||3
8306512|NCT01514149|20479181|P2|NOT COMPLETED|Overall Study||1
8306513|NCT01514149|20479182|P1|NOT COMPLETED|Overall Study||3
8306514|NCT01514149|20479178|P5|COMPLETED|Overall Study||14
8306515|NCT01514149|20479179|P4|COMPLETED|Overall Study||13
8306516|NCT01514149|20479180|P3|COMPLETED|Overall Study||11
8306517|NCT01514149|20479181|P2|COMPLETED|Overall Study||14
8306518|NCT01514149|20479182|P1|COMPLETED|Overall Study||12
8306519|NCT01514149|20479178|P5|STARTED|Overall Study||15
8306520|NCT01514149|20479179|P4|STARTED|Overall Study||14
8306521|NCT01514149|20479180|P3|STARTED|Overall Study||14
8306522|NCT01514149|20479181|P2|STARTED|Overall Study||15
8306523|NCT01514149|20479182|P1|STARTED|Overall Study||15
8306524|NCT01514136|20479206|P8|NOT COMPLETED|Test Period; Test D*||0
8306525|NCT01514136|20479207|P7|NOT COMPLETED|Test Period; Test D*||0
8306526|NCT01514136|20479208|P6|NOT COMPLETED|Test Period; Test D*||0
8306527|NCT01514136|20479209|P5|NOT COMPLETED|Test Period; Test D*||0
8306528|NCT01514136|20479210|P4|NOT COMPLETED|Test Period; Test D*||0
8306529|NCT01514136|20479211|P3|NOT COMPLETED|Test Period; Test D*||0
8306530|NCT01514136|20479212|P2|NOT COMPLETED|Test Period; Test D*||0
8306531|NCT01514136|20479213|P1|NOT COMPLETED|Test Period; Test D*||0
8306532|NCT01514136|20479206|P8|COMPLETED|Test Period; Test D*||23
8306533|NCT01514136|20479207|P7|COMPLETED|Test Period; Test D*||0
8306534|NCT01514136|20479208|P6|COMPLETED|Test Period; Test D*||0
8306535|NCT01514136|20479209|P5|COMPLETED|Test Period; Test D*||0
8306536|NCT01514136|20479210|P4|COMPLETED|Test Period; Test D*||0
8306537|NCT01514136|20479211|P3|COMPLETED|Test Period; Test D*||0
8306538|NCT01514136|20479212|P2|COMPLETED|Test Period; Test D*||0
8306539|NCT01514136|20479213|P1|COMPLETED|Test Period; Test D*||0
8306540|NCT01514136|20479206|P8|STARTED|Test Period; Test D*||23
8306541|NCT01514136|20479207|P7|STARTED|Test Period; Test D*||0
8306542|NCT01514136|20479208|P6|STARTED|Test Period; Test D*||0
8306543|NCT01514136|20479209|P5|STARTED|Test Period; Test D*||0
8306544|NCT01514136|20479210|P4|STARTED|Test Period; Test D*||0
8306545|NCT01514136|20479211|P3|STARTED|Test Period; Test D*||0
8306546|NCT01514136|20479212|P2|STARTED|Test Period; Test D*||0
8306547|NCT01514136|20479213|P1|STARTED|Test Period; Test D*||0
8306548|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 2; Test C*||0
8306549|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 2; Test C*||3
8306550|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 2; Test C*||0
8306551|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 2; Test C*||0
8306552|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 2; Test C*||0
8306553|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 2; Test C*||0
8306554|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 2; Test C*||0
8306555|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 2; Test C*||0
8306556|NCT01514136|20479206|P8|COMPLETED|Test Period 2; Test C*||0
8306557|NCT01514136|20479207|P7|COMPLETED|Test Period 2; Test C*||23
8306558|NCT01514136|20479208|P6|COMPLETED|Test Period 2; Test C*||0
8306559|NCT01514136|20479209|P5|COMPLETED|Test Period 2; Test C*||0
8306560|NCT01514136|20479210|P4|COMPLETED|Test Period 2; Test C*||0
8306561|NCT01514136|20479211|P3|COMPLETED|Test Period 2; Test C*||0
8306562|NCT01514136|20479212|P2|COMPLETED|Test Period 2; Test C*||0
8306563|NCT01514136|20479213|P1|COMPLETED|Test Period 2; Test C*||0
8306564|NCT01514136|20479206|P8|STARTED|Test Period 2; Test C*||0
8306565|NCT01514136|20479207|P7|STARTED|Test Period 2; Test C*||26
8306566|NCT01514136|20479208|P6|STARTED|Test Period 2; Test C*||0
8306567|NCT01514136|20479209|P5|STARTED|Test Period 2; Test C*||0
8306568|NCT01514136|20479210|P4|STARTED|Test Period 2; Test C*||0
8306569|NCT01514136|20479211|P3|STARTED|Test Period 2; Test C*||0
8306570|NCT01514136|20479212|P2|STARTED|Test Period 2; Test C*||0
8306571|NCT01514136|20479213|P1|STARTED|Test Period 2; Test C*||0
8306572|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 2; Test B*||0
8306573|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 2; Test B*||0
8306574|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 2; Test B*||2
8306575|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 2; Test B*||0
8306576|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 2; Test B*||0
8306577|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 2; Test B*||0
8306578|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 2; Test B*||0
8306579|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 2; Test B*||0
8306580|NCT01514136|20479206|P8|COMPLETED|Test Period 2; Test B*||0
8306581|NCT01514136|20479207|P7|COMPLETED|Test Period 2; Test B*||0
8306582|NCT01514136|20479208|P6|COMPLETED|Test Period 2; Test B*||26
8306583|NCT01514136|20479209|P5|COMPLETED|Test Period 2; Test B*||0
8306584|NCT01514136|20479210|P4|COMPLETED|Test Period 2; Test B*||0
8306585|NCT01514136|20479211|P3|COMPLETED|Test Period 2; Test B*||0
8306586|NCT01514136|20479212|P2|COMPLETED|Test Period 2; Test B*||0
8306587|NCT01514136|20479213|P1|COMPLETED|Test Period 2; Test B*||0
8306588|NCT01514136|20479206|P8|STARTED|Test Period 2; Test B*||0
8306589|NCT01514136|20479207|P7|STARTED|Test Period 2; Test B*||0
8306590|NCT01514136|20479208|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
8306591|NCT01514136|20479209|P5|STARTED|Test Period 2; Test B*||0
8306592|NCT01514136|20479210|P4|STARTED|Test Period 2; Test B*||0
8306593|NCT01514136|20479211|P3|STARTED|Test Period 2; Test B*||0
8306594|NCT01514136|20479212|P2|STARTED|Test Period 2; Test B*||0
8306595|NCT01514136|20479213|P1|STARTED|Test Period 2; Test B*||0
8306596|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 2; Test A*||0
8306597|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 2; Test A*||0
8306598|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 2; Test A*||0
8306599|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 2; Test A*||2
8306600|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 2; Test A*||0
8306601|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 2; Test A*||0
8306602|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 2; Test A*||0
8306603|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 2; Test A*||0
8306604|NCT01514136|20479206|P8|COMPLETED|Test Period 2; Test A*||0
8306605|NCT01514136|20479207|P7|COMPLETED|Test Period 2; Test A*||0
8306606|NCT01514136|20479208|P6|COMPLETED|Test Period 2; Test A*||0
8306607|NCT01514136|20479209|P5|COMPLETED|Test Period 2; Test A*||26
8306608|NCT01514136|20479210|P4|COMPLETED|Test Period 2; Test A*||0
8306609|NCT01514136|20479211|P3|COMPLETED|Test Period 2; Test A*||0
8306610|NCT01514136|20479212|P2|COMPLETED|Test Period 2; Test A*||0
8306611|NCT01514136|20479213|P1|COMPLETED|Test Period 2; Test A*||0
8306612|NCT01514136|20479206|P8|STARTED|Test Period 2; Test A*||0
8306613|NCT01514136|20479207|P7|STARTED|Test Period 2; Test A*||0
8306614|NCT01514136|20479208|P6|STARTED|Test Period 2; Test A*||0
8306615|NCT01514136|20479209|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
8306616|NCT01514136|20479210|P4|STARTED|Test Period 2; Test A*||0
8306617|NCT01514136|20479211|P3|STARTED|Test Period 2; Test A*||0
8306618|NCT01514136|20479212|P2|STARTED|Test Period 2; Test A*||0
8306619|NCT01514136|20479213|P1|STARTED|Test Period 2; Test A*||0
8306620|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test D||0
8306621|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test D||0
8306622|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test D||0
8306623|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test D||0
8306624|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test D||2
8306625|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test D||0
8306626|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test D||0
8306627|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test D||0
8306628|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test D||0
8306629|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test D||0
8306630|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test D||0
8306631|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test D||0
8306632|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test D||24
8306633|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test D||0
8306634|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test D||0
8306635|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test D||0
8306636|NCT01514136|20479206|P8|STARTED|Test Period 1; Test D||0
8306637|NCT01514136|20479207|P7|STARTED|Test Period 1; Test D||0
8306638|NCT01514136|20479208|P6|STARTED|Test Period 1; Test D||0
8306639|NCT01514136|20479209|P5|STARTED|Test Period 1; Test D||0
8306640|NCT01514136|20479210|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
8306641|NCT01514136|20479211|P3|STARTED|Test Period 1; Test D||0
8306642|NCT01514136|20479212|P2|STARTED|Test Period 1; Test D||0
8306643|NCT01514136|20479213|P1|STARTED|Test Period 1; Test D||0
8306644|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test C||0
8306645|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test C||0
8306646|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test C||0
8306647|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test C||0
8306648|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test C||0
8306649|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test C||0
8306650|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test C||0
8306651|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test C||0
8306652|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test C||0
8306653|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test C||0
8306654|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test C||0
8306655|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test C||0
8306656|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test C||0
8306657|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test C||24
8306658|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test C||0
8306659|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test C||0
8306660|NCT01514136|20479206|P8|STARTED|Test Period 1; Test C||0
8306661|NCT01514136|20479207|P7|STARTED|Test Period 1; Test C||0
8306662|NCT01514136|20479208|P6|STARTED|Test Period 1; Test C||0
8306663|NCT01514136|20479209|P5|STARTED|Test Period 1; Test C||0
8306664|NCT01514136|20479210|P4|STARTED|Test Period 1; Test C||0
8306665|NCT01514136|20479211|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
8306666|NCT01514136|20479212|P2|STARTED|Test Period 1; Test C||0
8306667|NCT01514136|20479213|P1|STARTED|Test Period 1; Test C||0
8306668|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test B||0
8306669|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test B||0
8306670|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test B||0
8306671|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test B||0
8306672|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test B||0
8306673|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test B||0
8306674|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test B||1
8306675|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test B||0
8306676|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test B||0
8306677|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test B||0
8306678|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test B||0
8306679|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test B||0
8306680|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test B||0
8306681|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test B||0
8306682|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test B||23
8306683|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test B||0
8306684|NCT01514136|20479206|P8|STARTED|Test Period 1; Test B||0
8306685|NCT01514136|20479207|P7|STARTED|Test Period 1; Test B||0
8306686|NCT01514136|20479208|P6|STARTED|Test Period 1; Test B||0
8306687|NCT01514136|20479209|P5|STARTED|Test Period 1; Test B||0
8306688|NCT01514136|20479210|P4|STARTED|Test Period 1; Test B||0
8306689|NCT01514136|20479211|P3|STARTED|Test Period 1; Test B||0
8306690|NCT01514136|20479212|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
8306691|NCT01514136|20479213|P1|STARTED|Test Period 1; Test B||0
8306692|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test A||0
8306693|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test A||0
8306694|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test A||0
8306695|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test A||0
8306696|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test A||0
8306697|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test A||0
8306698|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test A||0
8306699|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test A||3
8306700|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test A||0
8306701|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test A||0
8306702|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test A||0
8306703|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test A||0
8306704|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test A||0
8306705|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test A||0
8306706|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test A||0
8306707|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test A||22
8306708|NCT01514136|20479206|P8|STARTED|Test Period 1; Test A||0
8306709|NCT01514136|20479207|P7|STARTED|Test Period 1; Test A||0
8306710|NCT01514136|20479208|P6|STARTED|Test Period 1; Test A||0
8306711|NCT01514136|20479209|P5|STARTED|Test Period 1; Test A||0
8306712|NCT01514136|20479210|P4|STARTED|Test Period 1; Test A||0
8306713|NCT01514136|20479211|P3|STARTED|Test Period 1; Test A||0
8306714|NCT01514136|20479212|P2|STARTED|Test Period 1; Test A||0
8306715|NCT01514136|20479213|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
8306716|NCT01513967|20479247|P8|NOT COMPLETED|Overall Study||2
8306717|NCT01513967|20479248|P7|NOT COMPLETED|Overall Study||2
8306718|NCT01513967|20479249|P6|NOT COMPLETED|Overall Study||1
8306719|NCT01513967|20479250|P5|NOT COMPLETED|Overall Study||0
8306720|NCT01513967|20479251|P4|NOT COMPLETED|Overall Study||0
8306721|NCT01513967|20479252|P3|NOT COMPLETED|Overall Study||0
8306722|NCT01513967|20479253|P2|NOT COMPLETED|Overall Study||0
8306723|NCT01513967|20479254|P1|NOT COMPLETED|Overall Study||0
8306724|NCT01513967|20479247|P8|COMPLETED|Overall Study||6
8306725|NCT01513967|20479248|P7|COMPLETED|Overall Study||3
8306726|NCT01513967|20479249|P6|COMPLETED|Overall Study||3
8306727|NCT01513967|20479250|P5|COMPLETED|Overall Study||4
8306728|NCT01513967|20479251|P4|COMPLETED|Overall Study||6
8306729|NCT01513967|20479252|P3|COMPLETED|Overall Study||4
8306730|NCT01513967|20479253|P2|COMPLETED|Overall Study||4
8306731|NCT01513967|20479254|P1|COMPLETED|Overall Study||4
8306732|NCT01513967|20479247|P8|STARTED|Overall Study||8
8306733|NCT01513967|20479248|P7|STARTED|Overall Study||5
8306734|NCT01513967|20479249|P6|STARTED|Overall Study||4
8306735|NCT01513967|20479250|P5|STARTED|Overall Study||4
8306736|NCT01513967|20479251|P4|STARTED|Overall Study||6
8306737|NCT01513967|20479252|P3|STARTED|Overall Study||4
8306738|NCT01513967|20479253|P2|STARTED|Overall Study||4
8306739|NCT01513967|20479254|P1|STARTED|Overall Study||4
8306740|NCT01513902|20479275|P3|NOT COMPLETED|Overall Study||0
8306741|NCT01513902|20479276|P2|NOT COMPLETED|Overall Study||0
8306742|NCT01513902|20479277|P1|NOT COMPLETED|Overall Study||0
8306743|NCT01513902|20479275|P3|COMPLETED|Overall Study||9
8306744|NCT01513902|20479276|P2|COMPLETED|Overall Study||9
8306745|NCT01513902|20479277|P1|COMPLETED|Overall Study||8
8306746|NCT01513902|20479275|P3|STARTED|Overall Study||9
8306747|NCT01513902|20479276|P2|STARTED|Overall Study||9
8306748|NCT01513902|20479277|P1|STARTED|Overall Study||8
8306749|NCT01513759|20479312|P1|NOT COMPLETED|Overall Study||5
8306750|NCT01513759|20479312|P1|COMPLETED|Overall Study||145
8306751|NCT01513759|20479312|P1|At Least One Device Successfully Placed|Overall Study||149
8306752|NCT01513759|20479312|P1|STARTED|Overall Study||150
8306753|NCT01513590|20479323|P2|NOT COMPLETED|Overall Study||13
8306754|NCT01513590|20479324|P1|NOT COMPLETED|Overall Study||10
8306755|NCT01513590|20479323|P2|COMPLETED|Overall Study||184
8306756|NCT01513590|20479324|P1|COMPLETED|Overall Study||187
8306757|NCT01513590|20479323|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
8306758|NCT01513590|20479324|P1|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
8306759|NCT01513590|20479323|P2|STARTED|Overall Study||197
8306760|NCT01513590|20479324|P1|STARTED|Overall Study||197
8306761|NCT01513551|20479345|P3|NOT COMPLETED|Overall Study||5
8306762|NCT01513551|20479346|P2|NOT COMPLETED|Overall Study||6
8306763|NCT01513551|20479347|P1|NOT COMPLETED|Overall Study||4
8306764|NCT01513551|20479345|P3|COMPLETED|Overall Study||226
8306765|NCT01513551|20479346|P2|COMPLETED|Overall Study||225
8306766|NCT01513551|20479347|P1|COMPLETED|Overall Study||226
8306767|NCT01513551|20479345|P3|Vaccinated|Overall Study||230
8306768|NCT01513551|20479346|P2|Vaccinated|Overall Study||231
8306769|NCT01513551|20479347|P1|Vaccinated|Overall Study||230
8306770|NCT01513551|20479345|P3|STARTED|Overall Study||231
8306771|NCT01513551|20479346|P2|STARTED|Overall Study||231
8306772|NCT01513551|20479347|P1|STARTED|Overall Study||230
8306773|NCT01513538|20479373|P1|NOT COMPLETED|Overall Study||5
8306774|NCT01513538|20479373|P1|COMPLETED|Overall Study||573
8306775|NCT01513538|20479373|P1|STARTED|Overall Study||578
8306776|NCT01513473|20479379|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
8306777|NCT01513473|20479380|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
8306778|NCT01513473|20479379|P2|COMPLETED|Extension Trial (26 Weeks)||122
8306779|NCT01513473|20479380|P1|COMPLETED|Extension Trial (26 Weeks)||151
8306780|NCT01513473|20479379|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
8306781|NCT01513473|20479380|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
8306782|NCT01513473|20479379|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
8306783|NCT01513473|20479380|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
8306784|NCT01513473|20479379|P2|COMPLETED|Main Trial (26 Weeks)||165
8306785|NCT01513473|20479380|P1|COMPLETED|Main Trial (26 Weeks)||170
8306786|NCT01513473|20479379|P2|Exposed|Main Trial (26 Weeks)||175
8306787|NCT01513473|20479380|P1|Exposed|Main Trial (26 Weeks)||174
8306788|NCT01513473|20479379|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
8306789|NCT01513473|20479380|P1|STARTED|Main Trial (26 Weeks)||174
8306790|NCT01513460|20479407|P3|NOT COMPLETED|Overall Study||56
8306791|NCT01513460|20479408|P2|NOT COMPLETED|Overall Study||32
8306792|NCT01513460|20479409|P1|NOT COMPLETED|Overall Study||29
8306793|NCT01513460|20479407|P3|COMPLETED|Overall Study||201
8306794|NCT01513460|20479408|P2|COMPLETED|Overall Study||226
8306795|NCT01513460|20479409|P1|COMPLETED|Overall Study||229
8306796|NCT01513460|20479407|P3|Per-protocol Set|Overall Study||166
8306797|NCT01513460|20479408|P2|Per-protocol Set|Overall Study||186
8306798|NCT01513460|20479409|P1|Per-protocol Set|Overall Study||196
8306799|NCT01513460|20479407|P3|Full Analysis Set|Overall Study||257
8306800|NCT01513460|20479408|P2|Full Analysis Set|Overall Study||258
8306801|NCT01513460|20479409|P1|Full Analysis Set|Overall Study||257
8306802|NCT01513460|20479407|P3|STARTED|Overall Study||257
8306803|NCT01513460|20479408|P2|STARTED|Overall Study||258
8306804|NCT01513460|20479409|P1|STARTED|Overall Study||258
8306805|NCT01513447|20479435|P2|NOT COMPLETED|Overall Study||0
8306806|NCT01513447|20479436|P1|NOT COMPLETED|Overall Study||0
8306807|NCT01513447|20479435|P2|COMPLETED|Overall Study||5
8306808|NCT01513447|20479436|P1|COMPLETED|Overall Study||3
8306809|NCT01513447|20479435|P2|STARTED|Overall Study||5
8306810|NCT01513447|20479436|P1|STARTED|Overall Study||3
8306811|NCT01513330|20479444|P2|NOT COMPLETED|Standard Care First,||4
8306812|NCT01513330|20479445|P1|NOT COMPLETED|Standard Care First,||4
8306813|NCT01513330|20479444|P2|COMPLETED|Standard Care First,||52
8306814|NCT01513330|20479445|P1|COMPLETED|Standard Care First,||56
8306815|NCT01513330|20479444|P2|STARTED|Standard Care First,||56
8306816|NCT01513330|20479445|P1|STARTED|Standard Care First,||60
8306817|NCT01513330|20479444|P2|NOT COMPLETED|SenSura Mio First,||2
8306818|NCT01513330|20479445|P1|NOT COMPLETED|SenSura Mio First,||4
8306819|NCT01513330|20479444|P2|COMPLETED|SenSura Mio First,||56
8306820|NCT01513330|20479445|P1|COMPLETED|SenSura Mio First,||60
8306821|NCT01513330|20479444|P2|STARTED|SenSura Mio First,||58
8306822|NCT01513330|20479445|P1|STARTED|SenSura Mio First,||64
8306823|NCT01513317|20479453|P2|NOT COMPLETED|Overall Study||24
8306824|NCT01513317|20479454|P1|NOT COMPLETED|Overall Study||34
8306825|NCT01513317|20479453|P2|COMPLETED|Overall Study||2
8306826|NCT01513317|20479454|P1|COMPLETED|Overall Study||16
8306827|NCT01513317|20479453|P2|STARTED|Overall Study||26
8306828|NCT01513317|20479454|P1|STARTED|Overall Study||50
8306829|NCT01513291|20479472|P5|NOT COMPLETED|Run-out Period||0
8306830|NCT01513291|20479473|P4|NOT COMPLETED|Run-out Period||2
8306831|NCT01513291|20479474|P3|NOT COMPLETED|Run-out Period||0
8306832|NCT01513291|20479475|P2|NOT COMPLETED|Run-out Period||0
8306833|NCT01513291|20479476|P1|NOT COMPLETED|Run-out Period||0
8306834|NCT01513291|20479472|P5|COMPLETED|Run-out Period||101
8306835|NCT01513291|20479473|P4|COMPLETED|Run-out Period||45
8306836|NCT01513291|20479474|P3|COMPLETED|Run-out Period||50
8306837|NCT01513291|20479475|P2|COMPLETED|Run-out Period||0
8306838|NCT01513291|20479476|P1|COMPLETED|Run-out Period||0
8306839|NCT01513291|20479472|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
8306840|NCT01513291|20479473|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
8306841|NCT01513291|20479474|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
8306842|NCT01513291|20479475|P2|STARTED|Run-out Period||0
8306843|NCT01513291|20479476|P1|STARTED|Run-out Period||0
8306844|NCT01513291|20479472|P5|NOT COMPLETED|Treatment Period||0
8306845|NCT01513291|20479473|P4|NOT COMPLETED|Treatment Period||0
8306846|NCT01513291|20479474|P3|NOT COMPLETED|Treatment Period||0
8306847|NCT01513291|20479475|P2|NOT COMPLETED|Treatment Period||16
8306848|NCT01513291|20479476|P1|NOT COMPLETED|Treatment Period||23
8306849|NCT01513291|20479472|P5|COMPLETED|Treatment Period||0
8306850|NCT01513291|20479473|P4|COMPLETED|Treatment Period||0
8306851|NCT01513291|20479474|P3|COMPLETED|Treatment Period||0
8306852|NCT01513291|20479475|P2|COMPLETED|Treatment Period||101
8306853|NCT01513291|20479476|P1|COMPLETED|Treatment Period||97
8306854|NCT01513291|20479472|P5|Treated|Treatment Period||0
8306855|NCT01513291|20479473|P4|Treated|Treatment Period||0
8306856|NCT01513291|20479474|P3|Treated|Treatment Period||0
8306857|NCT01513291|20479475|P2|Treated|Treatment Period||115
8306858|NCT01513291|20479476|P1|Treated|Treatment Period||120
8306859|NCT01513291|20479472|P5|STARTED|Treatment Period||0
8306860|NCT01513291|20479473|P4|STARTED|Treatment Period||0
8306861|NCT01513291|20479474|P3|STARTED|Treatment Period||0
8306862|NCT01513291|20479475|P2|STARTED|Treatment Period||117
8306863|NCT01513291|20479476|P1|STARTED|Treatment Period||120
8306864|NCT01513239|20479504|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
8306865|NCT01513239|20479505|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
8306866|NCT01513239|20479506|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
8306867|NCT01513239|20479507|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8306868|NCT01513239|20479508|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8306869|NCT01513239|20479509|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8306870|NCT01513239|20479504|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
8306871|NCT01513239|20479505|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
8306872|NCT01513239|20479506|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
8306873|NCT01513239|20479507|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
8306874|NCT01513239|20479508|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
8306875|NCT01513239|20479509|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
8306876|NCT01513239|20479504|P6|STARTED|Period 2: 9 Month Extension Phase||83
8306877|NCT01513239|20479505|P5|STARTED|Period 2: 9 Month Extension Phase||100
8306878|NCT01513239|20479506|P4|STARTED|Period 2: 9 Month Extension Phase||112
8306879|NCT01513239|20479507|P3|STARTED|Period 2: 9 Month Extension Phase||0
8306880|NCT01513239|20479508|P2|STARTED|Period 2: 9 Month Extension Phase||0
8306881|NCT01513239|20479509|P1|STARTED|Period 2: 9 Month Extension Phase||0
8306882|NCT01513239|20479504|P6|NOT COMPLETED|Period 1: Main Phase||0
8306883|NCT01513239|20479505|P5|NOT COMPLETED|Period 1: Main Phase||0
8306884|NCT01513239|20479506|P4|NOT COMPLETED|Period 1: Main Phase||0
8306885|NCT01513239|20479507|P3|NOT COMPLETED|Period 1: Main Phase||88
8306886|NCT01513239|20479508|P2|NOT COMPLETED|Period 1: Main Phase||70
8306887|NCT01513239|20479509|P1|NOT COMPLETED|Period 1: Main Phase||75
8306888|NCT01513239|20479504|P6|COMPLETED|Period 1: Main Phase||0
8306889|NCT01513239|20479505|P5|COMPLETED|Period 1: Main Phase||0
8306890|NCT01513239|20479506|P4|COMPLETED|Period 1: Main Phase||0
8306891|NCT01513239|20479507|P3|COMPLETED|Period 1: Main Phase||311
8306892|NCT01513239|20479508|P2|COMPLETED|Period 1: Main Phase||337
8306893|NCT01513239|20479509|P1|COMPLETED|Period 1: Main Phase||322
8306894|NCT01513239|20479504|P6|All Participants as Treated|Period 1: Main Phase||0
8306895|NCT01513239|20479505|P5|All Participants as Treated|Period 1: Main Phase||0
8306896|NCT01513239|20479506|P4|All Participants as Treated|Period 1: Main Phase||0
8306897|NCT01513239|20479507|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
8306898|NCT01513239|20479508|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
8306899|NCT01513239|20479509|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
8306900|NCT01513239|20479504|P6|Treated|Period 1: Main Phase||0
8306901|NCT01513239|20479505|P5|Treated|Period 1: Main Phase||0
8306902|NCT01513239|20479506|P4|Treated|Period 1: Main Phase||0
8306903|NCT01513239|20479507|P3|Treated|Period 1: Main Phase|Treated participants|381
8306904|NCT01513239|20479508|P2|Treated|Period 1: Main Phase|Treated participants|396
8306905|NCT01513239|20479509|P1|Treated|Period 1: Main Phase|Treated participants|391
8306906|NCT01513239|20479504|P6|STARTED|Period 1: Main Phase||0
8306907|NCT01513239|20479505|P5|STARTED|Period 1: Main Phase||0
8306908|NCT01513239|20479506|P4|STARTED|Period 1: Main Phase||0
8306909|NCT01513239|20479507|P3|STARTED|Period 1: Main Phase|Randomized participants|399
8306910|NCT01513239|20479508|P2|STARTED|Period 1: Main Phase|Randomized participants|407
8306911|NCT01513239|20479509|P1|STARTED|Period 1: Main Phase|Randomized participants|397
8306912|NCT01513148|20479562|P2|NOT COMPLETED|Overall Study||2
8306913|NCT01513148|20479563|P1|NOT COMPLETED|Overall Study||2
8306914|NCT01513148|20479562|P2|COMPLETED|Overall Study||14
8306915|NCT01513148|20479563|P1|COMPLETED|Overall Study||14
8306916|NCT01513148|20479562|P2|STARTED|Overall Study||16
8306917|NCT01513148|20479563|P1|STARTED|Overall Study||16
8306918|NCT01513122|20479611|P2|NOT COMPLETED|Overall Study||3
8306919|NCT01513122|20479612|P1|NOT COMPLETED|Overall Study||11
8306920|NCT01513122|20479611|P2|COMPLETED|Overall Study||105
8306921|NCT01513122|20479612|P1|COMPLETED|Overall Study||91
8306922|NCT01513122|20479611|P2|STARTED|Overall Study||108
8306923|NCT01513122|20479612|P1|STARTED|Overall Study||102
8306924|NCT01512979|20479630|P2|NOT COMPLETED|Overall Study||22
8306925|NCT01512979|20479631|P1|NOT COMPLETED|Overall Study||19
8306926|NCT01512979|20479630|P2|COMPLETED|Overall Study||135
8306927|NCT01512979|20479631|P1|COMPLETED|Overall Study||140
8306928|NCT01512979|20479630|P2|STARTED|Overall Study|Randomised and treated|157
8306929|NCT01512979|20479631|P1|STARTED|Overall Study|Randomised and treated|159
8306930|NCT01512849|20479651|P4|NOT COMPLETED|Crossover Period 2||0
8306931|NCT01512849|20479652|P3|NOT COMPLETED|Crossover Period 2||0
8306932|NCT01512849|20479653|P2|NOT COMPLETED|Crossover Period 2||0
8306933|NCT01512849|20479654|P1|NOT COMPLETED|Crossover Period 2||0
8306934|NCT01512849|20479651|P4|COMPLETED|Crossover Period 2||6
8306935|NCT01512849|20479652|P3|COMPLETED|Crossover Period 2||6
8306936|NCT01512849|20479653|P2|COMPLETED|Crossover Period 2||6
8306937|NCT01512849|20479654|P1|COMPLETED|Crossover Period 2||6
8306938|NCT01512849|20479651|P4|STARTED|Crossover Period 2||6
8306939|NCT01512849|20479652|P3|STARTED|Crossover Period 2||6
8306940|NCT01512849|20479653|P2|STARTED|Crossover Period 2||6
8306941|NCT01512849|20479654|P1|STARTED|Crossover Period 2||6
8306942|NCT01512849|20479651|P4|NOT COMPLETED|Crossover Period 1||0
8306943|NCT01512849|20479652|P3|NOT COMPLETED|Crossover Period 1||0
8306944|NCT01512849|20479653|P2|NOT COMPLETED|Crossover Period 1||0
8306945|NCT01512849|20479654|P1|NOT COMPLETED|Crossover Period 1||0
8306946|NCT01512849|20479651|P4|COMPLETED|Crossover Period 1||6
8306947|NCT01512849|20479652|P3|COMPLETED|Crossover Period 1||6
8306948|NCT01512849|20479653|P2|COMPLETED|Crossover Period 1||6
8306949|NCT01512849|20479654|P1|COMPLETED|Crossover Period 1||6
8306950|NCT01512849|20479651|P4|STARTED|Crossover Period 1||6
8306951|NCT01512849|20479652|P3|STARTED|Crossover Period 1||6
8306952|NCT01512849|20479653|P2|STARTED|Crossover Period 1||6
8306953|NCT01512849|20479654|P1|STARTED|Crossover Period 1||6
8306954|NCT01512797|20479678|P2|NOT COMPLETED|Overall Study||0
8306955|NCT01512797|20479679|P1|NOT COMPLETED|Overall Study||0
8306956|NCT01512797|20479678|P2|COMPLETED|Overall Study||16
8306957|NCT01512797|20479679|P1|COMPLETED|Overall Study||16
8306958|NCT01512797|20479678|P2|STARTED|Overall Study||16
8306959|NCT01512797|20479679|P1|STARTED|Overall Study||16
8306960|NCT01512758|20479695|P2|NOT COMPLETED|Overall Study||0
8306961|NCT01512758|20479696|P1|NOT COMPLETED|Overall Study||0
8306962|NCT01512758|20479695|P2|COMPLETED|Overall Study||6
8306963|NCT01512758|20479696|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
8306964|NCT01512758|20479695|P2|STARTED|Overall Study||6
8306965|NCT01512758|20479696|P1|STARTED|Overall Study||30
8306966|NCT01512745|20479731|P2|NOT COMPLETED|Overall Study||20
8306967|NCT01512745|20479732|P1|NOT COMPLETED|Overall Study||40
8306968|NCT01512745|20479731|P2|COMPLETED|Overall Study||71
8306969|NCT01512745|20479732|P1|COMPLETED|Overall Study||136
8306970|NCT01512745|20479731|P2|STARTED|Overall Study||91
8306971|NCT01512745|20479732|P1|STARTED|Overall Study||176
8306972|NCT01512693|20479748|P2|NOT COMPLETED|Overall Study||1
8306973|NCT01512693|20479749|P1|NOT COMPLETED|Overall Study||0
8306974|NCT01512693|20479748|P2|COMPLETED|Overall Study||8
8306975|NCT01512693|20479749|P1|COMPLETED|Overall Study||8
8306976|NCT01512693|20479748|P2|STARTED|Overall Study||9
8306977|NCT01512693|20479749|P1|STARTED|Overall Study||8
8306978|NCT01512667|20479763|P2|NOT COMPLETED|Overall Study||0
8306979|NCT01512667|20479764|P1|NOT COMPLETED|Overall Study||0
8306980|NCT01512667|20479763|P2|COMPLETED|Overall Study||12
8306981|NCT01512667|20479764|P1|COMPLETED|Overall Study||13
8306982|NCT01512667|20479763|P2|Unmatched Participants|Overall Study||0
8306983|NCT01512667|20479764|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
8306984|NCT01512667|20479763|P2|Matched Participants|Overall Study||12
8306985|NCT01512667|20479764|P1|Matched Participants|Overall Study||12
8306986|NCT01512667|20479763|P2|STARTED|Overall Study||12
8306987|NCT01512667|20479764|P1|STARTED|Overall Study||13
8306988|NCT01512446|20479778|P2|NOT COMPLETED|Overall Study||215
8306989|NCT01512446|20479779|P1|NOT COMPLETED|Overall Study||221
8306990|NCT01512446|20479778|P2|COMPLETED|Overall Study||0
8306991|NCT01512446|20479779|P1|COMPLETED|Overall Study||0
8306992|NCT01512446|20479778|P2|Safety Analysis Set|Overall Study||188
8306993|NCT01512446|20479779|P1|Safety Analysis Set|Overall Study||197
8306994|NCT01512446|20479778|P2|STARTED|Overall Study||215
8306995|NCT01512446|20479779|P1|STARTED|Overall Study||221
8306996|NCT01512368|20479789|P1|NOT COMPLETED|Overall Study||3
8306997|NCT01512368|20479789|P1|COMPLETED|Overall Study||60
8306998|NCT01512368|20479789|P1|STARTED|Overall Study||63
8306999|NCT01512264|20479802|P4|NOT COMPLETED|Overall Study||1
8307000|NCT01512264|20479803|P3|NOT COMPLETED|Overall Study||0
8307001|NCT01512264|20479804|P2|NOT COMPLETED|Overall Study||0
8307002|NCT01512264|20479805|P1|NOT COMPLETED|Overall Study||0
8307003|NCT01512264|20479802|P4|COMPLETED|Overall Study||6
8307004|NCT01512264|20479803|P3|COMPLETED|Overall Study||7
8307005|NCT01512264|20479804|P2|COMPLETED|Overall Study||7
8307006|NCT01512264|20479805|P1|COMPLETED|Overall Study||7
8307007|NCT01512264|20479802|P4|STARTED|Overall Study||7
8307008|NCT01512264|20479803|P3|STARTED|Overall Study||7
8307009|NCT01512264|20479804|P2|STARTED|Overall Study||7
8307010|NCT01512264|20479805|P1|STARTED|Overall Study||7
8307011|NCT01512251|20479897|P2|NOT COMPLETED|Phase II||0
8307012|NCT01512251|20479898|P1|NOT COMPLETED|Phase II||0
8307013|NCT01512251|20479897|P2|COMPLETED|Phase II||0
8307014|NCT01512251|20479898|P1|COMPLETED|Phase II||0
8307015|NCT01512251|20479897|P2|STARTED|Phase II||0
8307016|NCT01512251|20479898|P1|STARTED|Phase II||0
8307017|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 4||0
8307018|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 4||0
8307019|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 4||0
8307020|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 4||0
8307021|NCT01512251|20479897|P2|STARTED|Phase I, Dose 4||0
8307022|NCT01512251|20479898|P1|STARTED|Phase I, Dose 4||0
8307023|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 3||0
8307024|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 3||0
8307025|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 3||0
8307026|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 3||0
8307027|NCT01512251|20479897|P2|STARTED|Phase I, Dose 3||0
8307028|NCT01512251|20479898|P1|STARTED|Phase I, Dose 3||0
8307029|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 2||0
8307030|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 2||0
8307031|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 2||0
8307032|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 2||0
8307033|NCT01512251|20479897|P2|STARTED|Phase I, Dose 2||0
8307034|NCT01512251|20479898|P1|STARTED|Phase I, Dose 2||0
8307035|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 1||5
8307036|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 1||3
8307037|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 1||0
8307038|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 1||0
8307039|NCT01512251|20479897|P2|STARTED|Phase I, Dose 1||5
8307040|NCT01512251|20479898|P1|STARTED|Phase I, Dose 1||3
8307041|NCT01512251|20479897|P2|NOT COMPLETED|Dose Level -1||0
8307042|NCT01512251|20479898|P1|NOT COMPLETED|Dose Level -1||0
8307043|NCT01512251|20479897|P2|COMPLETED|Dose Level -1||5
8307044|NCT01512251|20479898|P1|COMPLETED|Dose Level -1||3
8307045|NCT01512251|20479897|P2|STARTED|Dose Level -1||5
8307046|NCT01512251|20479898|P1|STARTED|Dose Level -1||3
8307047|NCT01512225|20479919|P2|NOT COMPLETED|Overall Study||0
8307048|NCT01512225|20479920|P1|NOT COMPLETED|Overall Study||0
8307049|NCT01512225|20479919|P2|COMPLETED|Overall Study||45
8307050|NCT01512225|20479920|P1|COMPLETED|Overall Study||45
8307051|NCT01512225|20479919|P2|Provided Day 14 Volume|Overall Study||40
8307052|NCT01512225|20479920|P1|Provided Day 14 Volume|Overall Study||45
8307053|NCT01512225|20479919|P2|STARTED|Overall Study||45
8307054|NCT01512225|20479920|P1|STARTED|Overall Study||45
8307055|NCT01512160|20479944|P4|NOT COMPLETED|Overall Study||1
8307056|NCT01512160|20479945|P3|NOT COMPLETED|Overall Study||0
8307057|NCT01512160|20479946|P2|NOT COMPLETED|Overall Study||0
8307058|NCT01512160|20479947|P1|NOT COMPLETED|Overall Study||2
8307059|NCT01512160|20479944|P4|COMPLETED|Overall Study||22
8307060|NCT01512160|20479945|P3|COMPLETED|Overall Study||22
8307061|NCT01512160|20479946|P2|COMPLETED|Overall Study||23
8307062|NCT01512160|20479947|P1|COMPLETED|Overall Study||20
8307063|NCT01512160|20479944|P4|STARTED|Overall Study||23
8307064|NCT01512160|20479945|P3|STARTED|Overall Study||22
8307065|NCT01512160|20479946|P2|STARTED|Overall Study||23
8307066|NCT01512160|20479947|P1|STARTED|Overall Study||22
8307067|NCT01512108|20480039|P2|NOT COMPLETED|Overall Study||9
8307068|NCT01512108|20480040|P1|NOT COMPLETED|Overall Study||22
8307069|NCT01512108|20480039|P2|COMPLETED|Overall Study||111
8307070|NCT01512108|20480040|P1|COMPLETED|Overall Study||221
8307071|NCT01512108|20480039|P2|Exposed|Overall Study||120
8307072|NCT01512108|20480040|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
8307073|NCT01512108|20480039|P2|STARTED|Overall Study||120
8307074|NCT01512108|20480040|P1|STARTED|Overall Study||243
8307075|NCT01511978|20480054|P2|NOT COMPLETED|Overall Study||0
8307076|NCT01511978|20480055|P1|NOT COMPLETED|Overall Study||0
8307077|NCT01511978|20480054|P2|COMPLETED|Overall Study||18
8307078|NCT01511978|20480055|P1|COMPLETED|Overall Study||14
8307079|NCT01511978|20480054|P2|STARTED|Overall Study||18
8307080|NCT01511978|20480055|P1|STARTED|Overall Study||14
8307081|NCT01511939|20480066|P3|NOT COMPLETED|Overall Study||0
8307082|NCT01511939|20480067|P2|NOT COMPLETED|Overall Study||1
8307083|NCT01511939|20480068|P1|NOT COMPLETED|Overall Study||2
8307084|NCT01511939|20480066|P3|COMPLETED|Overall Study||8
8307085|NCT01511939|20480067|P2|COMPLETED|Overall Study||4
8307086|NCT01511939|20480068|P1|COMPLETED|Overall Study||7
8307087|NCT01511939|20480066|P3|STARTED|Overall Study||8
8307088|NCT01511939|20480067|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
8307089|NCT01511939|20480068|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
8307090|NCT01511809|20480087|P2|NOT COMPLETED|Overall Study||7
8307091|NCT01511809|20480088|P1|NOT COMPLETED|Overall Study||7
8307092|NCT01511809|20480087|P2|COMPLETED|Overall Study||52
8307093|NCT01511809|20480088|P1|COMPLETED|Overall Study||51
8307094|NCT01511809|20480087|P2|STARTED|Overall Study||59
8307095|NCT01511809|20480088|P1|STARTED|Overall Study||58
8307096|NCT01511536|20480097|P3|NOT COMPLETED|Phase 2||9
8307097|NCT01511536|20480098|P2|NOT COMPLETED|Phase 2||0
8307098|NCT01511536|20480099|P1|NOT COMPLETED|Phase 2||0
8307099|NCT01511536|20480097|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
8307100|NCT01511536|20480098|P2|COMPLETED|Phase 2||0
8307101|NCT01511536|20480099|P1|COMPLETED|Phase 2||0
8307102|NCT01511536|20480097|P3|STARTED|Phase 2||27
8307103|NCT01511536|20480098|P2|STARTED|Phase 2||0
8307104|NCT01511536|20480099|P1|STARTED|Phase 2||0
8307105|NCT01511536|20480097|P3|NOT COMPLETED|Phase 1||0
8307106|NCT01511536|20480098|P2|NOT COMPLETED|Phase 1||1
8307107|NCT01511536|20480099|P1|NOT COMPLETED|Phase 1||0
8307108|NCT01511536|20480097|P3|COMPLETED|Phase 1||0
8307109|NCT01511536|20480098|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
8307110|NCT01511536|20480099|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
8307111|NCT01511536|20480097|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
8307112|NCT01511536|20480098|P2|STARTED|Phase 1||7
8307113|NCT01511536|20480099|P1|STARTED|Phase 1||3
8307114|NCT01511445|20480121|P2|NOT COMPLETED|Overall Study||4
8307115|NCT01511445|20480122|P1|NOT COMPLETED|Overall Study||5
8307116|NCT01511445|20480121|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
8307117|NCT01511445|20480122|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
8307118|NCT01511445|20480121|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
8307119|NCT01511445|20480122|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
8307120|NCT01511445|20480121|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
8307121|NCT01511445|20480122|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
8307122|NCT01511445|20480121|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
8307123|NCT01511445|20480122|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
8307124|NCT01511445|20480121|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
8307125|NCT01511445|20480122|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
8307126|NCT01511419|20480132|P2|NOT COMPLETED|Dose 2||0
8307127|NCT01511419|20480133|P1|NOT COMPLETED|Dose 2||1
8307128|NCT01511419|20480132|P2|COMPLETED|Dose 2||10
8307129|NCT01511419|20480133|P1|COMPLETED|Dose 2||29
8307130|NCT01511419|20480132|P2|STARTED|Dose 2||10
8307131|NCT01511419|20480133|P1|STARTED|Dose 2||30
8307132|NCT01511419|20480132|P2|NOT COMPLETED|Dose 1||0
8307133|NCT01511419|20480133|P1|NOT COMPLETED|Dose 1||0
8307134|NCT01511419|20480132|P2|COMPLETED|Dose 1||10
8307135|NCT01511419|20480133|P1|COMPLETED|Dose 1||30
8307136|NCT01511419|20480132|P2|STARTED|Dose 1||10
8307137|NCT01511419|20480133|P1|STARTED|Dose 1||30
8307138|NCT01511315|20480225|P1|NOT COMPLETED|Overall Study||4
8307139|NCT01511315|20480225|P1|COMPLETED|Overall Study||32
8307140|NCT01511315|20480225|P1|STARTED|Overall Study||36
8307141|NCT01511250|20480245|P10|NOT COMPLETED|Overall Study||5
8307142|NCT01511250|20480246|P9|NOT COMPLETED|Overall Study||14
8307143|NCT01511250|20480247|P8|NOT COMPLETED|Overall Study||4
8307144|NCT01511250|20480248|P7|NOT COMPLETED|Overall Study||2
8307145|NCT01511250|20480249|P6|NOT COMPLETED|Overall Study||0
8307146|NCT01511250|20480250|P5|NOT COMPLETED|Overall Study||0
8307147|NCT01511250|20480251|P4|NOT COMPLETED|Overall Study||3
8307148|NCT01511250|20480252|P3|NOT COMPLETED|Overall Study||4
8307149|NCT01511250|20480253|P2|NOT COMPLETED|Overall Study||5
8307150|NCT01511250|20480254|P1|NOT COMPLETED|Overall Study||9
8307151|NCT01511250|20480245|P10|COMPLETED|Overall Study||48
8307152|NCT01511250|20480246|P9|COMPLETED|Overall Study||145
8307153|NCT01511250|20480247|P8|COMPLETED|Overall Study||9
8307154|NCT01511250|20480248|P7|COMPLETED|Overall Study||21
8307155|NCT01511250|20480249|P6|COMPLETED|Overall Study||17
8307156|NCT01511250|20480250|P5|COMPLETED|Overall Study||21
8307157|NCT01511250|20480251|P4|COMPLETED|Overall Study||11
8307158|NCT01511250|20480252|P3|COMPLETED|Overall Study||18
8307159|NCT01511250|20480253|P2|COMPLETED|Overall Study||9
8307160|NCT01511250|20480254|P1|COMPLETED|Overall Study||15
8307161|NCT01511250|20480245|P10|STARTED|Overall Study||53
8307162|NCT01511250|20480246|P9|STARTED|Overall Study||159
8307163|NCT01511250|20480247|P8|STARTED|Overall Study||13
8307164|NCT01511250|20480248|P7|STARTED|Overall Study||23
8307165|NCT01511250|20480249|P6|STARTED|Overall Study||17
8307166|NCT01511250|20480250|P5|STARTED|Overall Study||21
8307167|NCT01511250|20480251|P4|STARTED|Overall Study||14
8307168|NCT01511250|20480252|P3|STARTED|Overall Study||22
8307169|NCT01511250|20480253|P2|STARTED|Overall Study||14
8307170|NCT01511250|20480254|P1|STARTED|Overall Study||24
8307171|NCT01511107|20480402|P2|NOT COMPLETED|Overall Study||41
8307172|NCT01511107|20480403|P1|NOT COMPLETED|Overall Study||22
8307173|NCT01511107|20480402|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
8307174|NCT01511107|20480403|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
8307175|NCT01511107|20480402|P2|STARTED|Overall Study|Randomized to the treatment group.|260
8307176|NCT01511107|20480403|P1|STARTED|Overall Study|Randomized to the treatment group.|260
8307177|NCT01511081|20480453|P2|NOT COMPLETED|Overall Study||0
8307178|NCT01511081|20480454|P1|NOT COMPLETED|Overall Study||0
8307179|NCT01511081|20480453|P2|COMPLETED|Overall Study||9
8307180|NCT01511081|20480454|P1|COMPLETED|Overall Study||8
8307181|NCT01511081|20480453|P2|STARTED|Overall Study||9
8307182|NCT01511081|20480454|P1|STARTED|Overall Study||8
8307183|NCT01511068|20480462|P1|NOT COMPLETED|Overall Study||0
8307184|NCT01511068|20480462|P1|COMPLETED|Overall Study||2
8307185|NCT01511068|20480462|P1|STARTED|Overall Study||2
8307186|NCT01511055|20480475|P1|NOT COMPLETED|Overall Study||6
8307187|NCT01511055|20480475|P1|COMPLETED|Overall Study||21
8307188|NCT01511055|20480475|P1|STARTED|Overall Study||27
8307189|NCT01511016|20480482|P2|NOT COMPLETED|Overall Study||2
8307190|NCT01511016|20480483|P1|NOT COMPLETED|Overall Study||2
8307191|NCT01511016|20480482|P2|COMPLETED|Overall Study||7
8307192|NCT01511016|20480483|P1|COMPLETED|Overall Study||6
8307193|NCT01511016|20480482|P2|STARTED|Overall Study||9
8307194|NCT01511016|20480483|P1|STARTED|Overall Study||8
8307195|NCT01510912|20480499|P1|NOT COMPLETED|Overall Study||242
8307196|NCT01510912|20480499|P1|COMPLETED|Overall Study||360
8307197|NCT01510912|20480499|P1|STARTED|Overall Study||602
8307198|NCT01510834|20480505|P1|NOT COMPLETED|Overall Study||33
8307199|NCT01510834|20480505|P1|COMPLETED|Overall Study||57
8307200|NCT01510834|20480505|P1|STARTED|Overall Study||90
8307201|NCT01510769|20480515|P3|NOT COMPLETED|Overall Study||22
8307202|NCT01510769|20480516|P2|NOT COMPLETED|Overall Study||25
8307203|NCT01510769|20480517|P1|NOT COMPLETED|Overall Study||27
8307204|NCT01510769|20480515|P3|COMPLETED|Overall Study||87
8307205|NCT01510769|20480516|P2|COMPLETED|Overall Study||84
8307206|NCT01510769|20480517|P1|COMPLETED|Overall Study||79
8307207|NCT01510769|20480515|P3|STARTED|Overall Study||109
8307208|NCT01510769|20480516|P2|STARTED|Overall Study||109
8307209|NCT01510769|20480517|P1|STARTED|Overall Study||106
8307210|NCT01510756|20480534|P1|NOT COMPLETED|Overall Study||4
8307211|NCT01510756|20480534|P1|COMPLETED|Overall Study||0
8307212|NCT01510756|20480534|P1|STARTED|Overall Study||4
8307213|NCT01510717|20480542|P2|NOT COMPLETED|Overall Study||5
8307214|NCT01510717|20480543|P1|NOT COMPLETED|Overall Study||2
8307215|NCT01510717|20480542|P2|COMPLETED|Overall Study||160
8307216|NCT01510717|20480543|P1|COMPLETED|Overall Study||153
8307217|NCT01510717|20480542|P2|STARTED|Overall Study||165
8307218|NCT01510717|20480543|P1|STARTED|Overall Study||155
8307219|NCT01510704|20480571|P4|NOT COMPLETED|Overall Study||0
8307220|NCT01510704|20480572|P3|NOT COMPLETED|Overall Study||0
8307221|NCT01510704|20480573|P2|NOT COMPLETED|Overall Study||0
8307222|NCT01510704|20480574|P1|NOT COMPLETED|Overall Study||0
8307223|NCT01510704|20480571|P4|COMPLETED|Overall Study||53
8307224|NCT01510704|20480572|P3|COMPLETED|Overall Study||50
8307225|NCT01510704|20480573|P2|COMPLETED|Overall Study||58
8307226|NCT01510704|20480574|P1|COMPLETED|Overall Study||54
8307227|NCT01510704|20480571|P4|STARTED|Overall Study||53
8307228|NCT01510704|20480572|P3|STARTED|Overall Study||50
8307229|NCT01510704|20480573|P2|STARTED|Overall Study||58
8307230|NCT01510704|20480574|P1|STARTED|Overall Study||54
8307231|NCT01510652|20480586|P2|NOT COMPLETED|Overall Study||67
8307232|NCT01510652|20480587|P1|NOT COMPLETED|Overall Study||92
8307233|NCT01510652|20480586|P2|COMPLETED|Overall Study||288
8307234|NCT01510652|20480587|P1|COMPLETED|Overall Study||627
8307235|NCT01510652|20480586|P2|Baseline|Overall Study||348
8307236|NCT01510652|20480587|P1|Baseline|Overall Study||718
8307237|NCT01510652|20480586|P2|STARTED|Overall Study||355
8307238|NCT01510652|20480587|P1|STARTED|Overall Study||719
8307239|NCT01510457|20480599|P2|NOT COMPLETED|Overall Study||3
8307240|NCT01510457|20480600|P1|NOT COMPLETED|Overall Study||5
8307241|NCT01510457|20480599|P2|COMPLETED|Overall Study||26
8307242|NCT01510457|20480600|P1|COMPLETED|Overall Study||12
8307243|NCT01510457|20480599|P2|STARTED|Overall Study||29
8307244|NCT01510457|20480600|P1|STARTED|Overall Study||17
8307245|NCT01510379|20480620|P2|NOT COMPLETED|Overall Study||0
8307246|NCT01510379|20480621|P1|NOT COMPLETED|Overall Study||0
8307247|NCT01510379|20480620|P2|COMPLETED|Overall Study||51
8307248|NCT01510379|20480621|P1|COMPLETED|Overall Study||49
8307249|NCT01510379|20480620|P2|STARTED|Overall Study||51
8307250|NCT01510379|20480621|P1|STARTED|Overall Study||49
8307251|NCT01510327|20480629|P1|NOT COMPLETED|Overall Study||0
8307252|NCT01510327|20480629|P1|COMPLETED|Overall Study||22
8307253|NCT01510327|20480629|P1|STARTED|Overall Study||22
8307254|NCT01510158|20480663|P3|NOT COMPLETED|Overall Study||50
8307255|NCT01510158|20480664|P2|NOT COMPLETED|Overall Study||53
8307256|NCT01510158|20480665|P1|NOT COMPLETED|Overall Study||51
8307257|NCT01510158|20480663|P3|COMPLETED|Overall Study||152
8307258|NCT01510158|20480664|P2|COMPLETED|Overall Study||150
8307259|NCT01510158|20480665|P1|COMPLETED|Overall Study||151
8307260|NCT01510158|20480663|P3|STARTED|Overall Study||202
8307261|NCT01510158|20480664|P2|STARTED|Overall Study||203
8307262|NCT01510158|20480665|P1|STARTED|Overall Study||202
8307263|NCT01510145|20480679|P1|NOT COMPLETED|Overall Study||18
8307264|NCT01510145|20480679|P1|COMPLETED|Overall Study||173
8307265|NCT01510145|20480679|P1|STARTED|Overall Study||191
8307266|NCT01510028|20480688|P4|NOT COMPLETED|Overall Study||0
8307267|NCT01510028|20480689|P3|NOT COMPLETED|Overall Study||0
8307268|NCT01510028|20480690|P2|NOT COMPLETED|Overall Study||0
8307269|NCT01510028|20480691|P1|NOT COMPLETED|Overall Study||1
8307270|NCT01510028|20480688|P4|COMPLETED|Overall Study||6
8307271|NCT01510028|20480689|P3|COMPLETED|Overall Study||6
8307272|NCT01510028|20480690|P2|COMPLETED|Overall Study||6
8307273|NCT01510028|20480691|P1|COMPLETED|Overall Study||5
8307274|NCT01510028|20480688|P4|STARTED|Overall Study||6
8307275|NCT01510028|20480689|P3|STARTED|Overall Study||6
8307276|NCT01510028|20480690|P2|STARTED|Overall Study||6
8307277|NCT01510028|20480691|P1|STARTED|Overall Study||6
8307278|NCT01509950|20480807|P3|NOT COMPLETED|Overall Study||0
8307279|NCT01509950|20480808|P2|NOT COMPLETED|Overall Study||0
8307280|NCT01509950|20480809|P1|NOT COMPLETED|Overall Study||0
8307281|NCT01509950|20480807|P3|COMPLETED|Overall Study||0
8307282|NCT01509950|20480808|P2|COMPLETED|Overall Study||8
8307283|NCT01509950|20480809|P1|COMPLETED|Overall Study||7
8307284|NCT01509950|20480807|P3|STARTED|Overall Study||0
8307285|NCT01509950|20480808|P2|STARTED|Overall Study||8
8307286|NCT01509950|20480809|P1|STARTED|Overall Study||7
8307287|NCT01509872|20480837|P2|NOT COMPLETED|Overall Study||0
8307288|NCT01509872|20480838|P1|NOT COMPLETED|Overall Study||1
8307289|NCT01509872|20480837|P2|COMPLETED|Overall Study||24
8307290|NCT01509872|20480838|P1|COMPLETED|Overall Study||25
8307291|NCT01509872|20480837|P2|Post-Intervention Assessment|Overall Study||24
8307292|NCT01509872|20480838|P1|Post-Intervention Assessment|Overall Study||26
8307293|NCT01509872|20480837|P2|STARTED|Overall Study||24
8307294|NCT01509872|20480838|P1|STARTED|Overall Study||26
8307295|NCT01509807|20480852|P2|NOT COMPLETED|Overall Study||1
8307296|NCT01509807|20480853|P1|NOT COMPLETED|Overall Study||1
8307297|NCT01509807|20480852|P2|COMPLETED|Overall Study||16
8307298|NCT01509807|20480853|P1|COMPLETED|Overall Study||15
8307299|NCT01509807|20480852|P2|STARTED|Overall Study||17
8307300|NCT01509807|20480853|P1|STARTED|Overall Study||16
8307301|NCT01509677|20480879|P2|NOT COMPLETED|Overall Study||6
8307302|NCT01509677|20480880|P1|NOT COMPLETED|Overall Study||3
8307303|NCT01509677|20480879|P2|COMPLETED|Overall Study||73
8307304|NCT01509677|20480880|P1|COMPLETED|Overall Study||76
8307305|NCT01509677|20480879|P2|STARTED|Overall Study||79
8307306|NCT01509677|20480880|P1|STARTED|Overall Study||79
8307307|NCT01509664|20480952|P2|NOT COMPLETED|Overall Study||21
8307308|NCT01509664|20480953|P1|NOT COMPLETED|Overall Study||15
8307309|NCT01509664|20480952|P2|COMPLETED|Overall Study||28
8307310|NCT01509664|20480953|P1|COMPLETED|Overall Study||34
8307311|NCT01509664|20480952|P2|T3 Follow-up|Overall Study||33
8307312|NCT01509664|20480953|P1|T3 Follow-up|Overall Study||40
8307313|NCT01509664|20480952|P2|T2 Follow-up|Overall Study||38
8307314|NCT01509664|20480953|P1|T2 Follow-up|Overall Study||45
8307315|NCT01509664|20480952|P2|STARTED|Overall Study||49
8307316|NCT01509664|20480953|P1|STARTED|Overall Study||49
8307317|NCT01509638|20480961|P2|NOT COMPLETED|Overall Study||2
8307318|NCT01509638|20480962|P1|NOT COMPLETED|Overall Study||3
8307319|NCT01509638|20480961|P2|COMPLETED|Overall Study||24
8307320|NCT01509638|20480962|P1|COMPLETED|Overall Study||20
8307321|NCT01509638|20480961|P2|STARTED|Overall Study||26
8307322|NCT01509638|20480962|P1|STARTED|Overall Study||23
8307323|NCT01509625|20480986|P1|NOT COMPLETED|Overall Study||9
8307324|NCT01509625|20480986|P1|COMPLETED|Overall Study||263
8307325|NCT01509625|20480986|P1|STARTED|Overall Study||272
8307326|NCT01509612|20481005|P3|NOT COMPLETED|Overall Study||0
8307327|NCT01509612|20481006|P2|NOT COMPLETED|Overall Study||0
8307328|NCT01509612|20481007|P1|NOT COMPLETED|Overall Study||0
8307329|NCT01509612|20481005|P3|COMPLETED|Overall Study||52
8307330|NCT01509612|20481006|P2|COMPLETED|Overall Study||51
8307331|NCT01509612|20481007|P1|COMPLETED|Overall Study||47
8307332|NCT01509612|20481005|P3|STARTED|Overall Study||52
8307333|NCT01509612|20481006|P2|STARTED|Overall Study||51
8307334|NCT01509612|20481007|P1|STARTED|Overall Study||47
8307335|NCT01509586|20481020|P2|NOT COMPLETED|Overall Study||0
8307336|NCT01509586|20481021|P1|NOT COMPLETED|Overall Study||0
8307337|NCT01509586|20481020|P2|COMPLETED|Overall Study|final intent to treat sample|610
8307338|NCT01509586|20481021|P1|COMPLETED|Overall Study|final intent to treat sample|626
8307339|NCT01509586|20481020|P2|Week 58 (Month 12)|Overall Study||499
8307340|NCT01509586|20481021|P1|Week 58 (Month 12)|Overall Study||492
8307341|NCT01509586|20481020|P2|Week 46|Overall Study||494
8307342|NCT01509586|20481021|P1|Week 46|Overall Study||483
8307343|NCT01509586|20481020|P2|Week 32 (Month 6)|Overall Study||523
8307344|NCT01509586|20481021|P1|Week 32 (Month 6)|Overall Study||504
8307345|NCT01509586|20481020|P2|Week18|Overall Study||555
8307346|NCT01509586|20481021|P1|Week18|Overall Study||529
8307347|NCT01509586|20481020|P2|Week 14|Overall Study||566
8307348|NCT01509586|20481021|P1|Week 14|Overall Study||528
8307349|NCT01509586|20481020|P2|Week 10|Overall Study||574
8307350|NCT01509586|20481021|P1|Week 10|Overall Study||537
8307351|NCT01509586|20481020|P2|Week 6|Overall Study||585
8307352|NCT01509586|20481021|P1|Week 6|Overall Study||551
8307353|NCT01509586|20481020|P2|Week 3|Overall Study||585
8307354|NCT01509586|20481021|P1|Week 3|Overall Study||574
8307355|NCT01509586|20481020|P2|STARTED|Overall Study|Week 0|610
8307356|NCT01509586|20481021|P1|STARTED|Overall Study|Week 0|626
8307357|NCT01509547|20481029|P2|NOT COMPLETED|Overall Study||39
8307358|NCT01509547|20481030|P1|NOT COMPLETED|Overall Study||35
8307359|NCT01509547|20481029|P2|COMPLETED|Overall Study||41
8307360|NCT01509547|20481030|P1|COMPLETED|Overall Study||42
8307361|NCT01509547|20481029|P2|STARTED|Overall Study||80
8307362|NCT01509547|20481030|P1|STARTED|Overall Study||77
8307363|NCT01509404|20481048|P2|NOT COMPLETED|Overall Study||0
8307364|NCT01509404|20481049|P1|NOT COMPLETED|Overall Study||0
8307365|NCT01509404|20481048|P2|COMPLETED|Overall Study||20
8307366|NCT01509404|20481049|P1|COMPLETED|Overall Study||20
8307367|NCT01509404|20481048|P2|STARTED|Overall Study||20
8307368|NCT01509404|20481049|P1|STARTED|Overall Study||20
8307369|NCT01509183|20481071|P2|NOT COMPLETED|Overall Study||111
8307370|NCT01509183|20481072|P1|NOT COMPLETED|Overall Study||109
8307371|NCT01509183|20481071|P2|COMPLETED|Overall Study||134
8307372|NCT01509183|20481072|P1|COMPLETED|Overall Study||141
8307373|NCT01509183|20481071|P2|STARTED|Overall Study||245
8307374|NCT01509183|20481072|P1|STARTED|Overall Study||250
8307375|NCT01509105|20481080|P1|NOT COMPLETED|Overall Study||0
8307376|NCT01509105|20481080|P1|COMPLETED|Overall Study||649
8307377|NCT01509105|20481080|P1|STARTED|Overall Study||649
8307378|NCT01509079|20481097|P2|NOT COMPLETED|Overall Study||3
8307379|NCT01509079|20481098|P1|NOT COMPLETED|Overall Study||0
8307380|NCT01509079|20481097|P2|COMPLETED|Overall Study||56
8307381|NCT01509079|20481098|P1|COMPLETED|Overall Study||57
8307382|NCT01509079|20481097|P2|STARTED|Overall Study||59
8307383|NCT01509079|20481098|P1|STARTED|Overall Study||57
8307384|NCT01509053|20481118|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
8307385|NCT01509053|20481118|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
8307386|NCT01509053|20481118|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
8307387|NCT01509053|20481118|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
8307388|NCT01509053|20481118|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
8307389|NCT01509053|20481118|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
8307390|NCT01509053|20481118|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
8307391|NCT01509053|20481118|P1|COMPLETED|Oral Aripirazole (Phase A)||8
8307392|NCT01509053|20481118|P1|STARTED|Oral Aripirazole (Phase A)||19
8307393|NCT01509040|20481132|P3|NOT COMPLETED|Overall Study||0
8307394|NCT01509040|20481133|P2|NOT COMPLETED|Overall Study||1
8307395|NCT01509040|20481134|P1|NOT COMPLETED|Overall Study||0
8307396|NCT01509040|20481132|P3|COMPLETED|Overall Study||0
8307397|NCT01509040|20481133|P2|COMPLETED|Overall Study||1
8307398|NCT01509040|20481134|P1|COMPLETED|Overall Study||0
8307399|NCT01509040|20481132|P3|STARTED|Overall Study||0
8307400|NCT01509040|20481133|P2|STARTED|Overall Study||2
8307401|NCT01509040|20481134|P1|STARTED|Overall Study||0
8307402|NCT01508936|20481180|P2|NOT COMPLETED|Overall Study||79
8307403|NCT01508936|20481181|P1|NOT COMPLETED|Overall Study||23
8307404|NCT01508936|20481180|P2|COMPLETED|Overall Study||330
8307405|NCT01508936|20481181|P1|COMPLETED|Overall Study||79
8307406|NCT01508936|20481180|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
8307407|NCT01508936|20481181|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
8307408|NCT01508936|20481180|P2|Full Analysis Set|Overall Study||395
8307409|NCT01508936|20481181|P1|Full Analysis Set|Overall Study||97
8307410|NCT01508936|20481180|P2|Safety Analysis Set|Overall Study||395
8307411|NCT01508936|20481181|P1|Safety Analysis Set|Overall Study||97
8307412|NCT01508936|20481180|P2|Randomized, Not Treated|Overall Study||3
8307413|NCT01508936|20481181|P1|Randomized, Not Treated|Overall Study||1
8307414|NCT01508936|20481180|P2|Randomized|Overall Study||398
8307415|NCT01508936|20481181|P1|Randomized|Overall Study||98
8307416|NCT01508936|20481180|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
8307417|NCT01508936|20481181|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
8307418|NCT01508936|20481180|P2|STARTED|Overall Study||409
8307419|NCT01508936|20481181|P1|STARTED|Overall Study||102
8307420|NCT01508910|20481220|P4|NOT COMPLETED|Treatment||3
8307421|NCT01508910|20481221|P3|NOT COMPLETED|Treatment||10
8307422|NCT01508910|20481222|P2|NOT COMPLETED|Treatment||4
8307423|NCT01508910|20481223|P1|NOT COMPLETED|Treatment||2
8307424|NCT01508910|20481220|P4|COMPLETED|Treatment||3
8307425|NCT01508910|20481221|P3|COMPLETED|Treatment||18
8307426|NCT01508910|20481222|P2|COMPLETED|Treatment||24
8307427|NCT01508910|20481223|P1|COMPLETED|Treatment||48
8307428|NCT01508910|20481220|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
8307429|NCT01508910|20481221|P3|STARTED|Treatment||28
8307430|NCT01508910|20481222|P2|STARTED|Treatment||28
8307431|NCT01508910|20481223|P1|STARTED|Treatment||50
8307432|NCT01508910|20481220|P4|NOT COMPLETED|Randomization||0
8307433|NCT01508910|20481221|P3|NOT COMPLETED|Randomization||0
8307434|NCT01508910|20481222|P2|NOT COMPLETED|Randomization||0
8307435|NCT01508910|20481223|P1|NOT COMPLETED|Randomization||0
8307436|NCT01508910|20481220|P4|COMPLETED|Randomization||0
8307437|NCT01508910|20481221|P3|COMPLETED|Randomization||28
8307438|NCT01508910|20481222|P2|COMPLETED|Randomization||27
8307439|NCT01508910|20481223|P1|COMPLETED|Randomization||57
8307440|NCT01508910|20481220|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
8307441|NCT01508910|20481221|P3|STARTED|Randomization||28
8307442|NCT01508910|20481222|P2|STARTED|Randomization||27
8307443|NCT01508910|20481223|P1|STARTED|Randomization||57
8307444|NCT01508832|20481247|P2|NOT COMPLETED|Overall Study||0
8307445|NCT01508832|20481248|P1|NOT COMPLETED|Overall Study||0
8307446|NCT01508832|20481247|P2|COMPLETED|Overall Study||6
8307447|NCT01508832|20481248|P1|COMPLETED|Overall Study||6
8307448|NCT01508832|20481247|P2|STARTED|Overall Study||6
8307449|NCT01508832|20481248|P1|STARTED|Overall Study||6
8307450|NCT01508702|20481256|P2|NOT COMPLETED|Overall Study||13
8307451|NCT01508702|20481257|P1|NOT COMPLETED|Overall Study||23
8307452|NCT01508702|20481256|P2|COMPLETED|Overall Study||94
8307453|NCT01508702|20481257|P1|COMPLETED|Overall Study||84
8307454|NCT01508702|20481256|P2|STARTED|Overall Study||107
8307455|NCT01508702|20481257|P1|STARTED|Overall Study||107
8307456|NCT01508676|20481265|P2|NOT COMPLETED|Phase II (2 Weeks)||1
8307457|NCT01508676|20481266|P1|NOT COMPLETED|Phase II (2 Weeks)||1
8307458|NCT01508676|20481265|P2|COMPLETED|Phase II (2 Weeks)||13
8307459|NCT01508676|20481266|P1|COMPLETED|Phase II (2 Weeks)||15
8307460|NCT01508676|20481265|P2|STARTED|Phase II (2 Weeks)||14
8307461|NCT01508676|20481266|P1|STARTED|Phase II (2 Weeks)||16
8307462|NCT01508676|20481265|P2|NOT COMPLETED|Washout Period (1 Week)||0
8307463|NCT01508676|20481266|P1|NOT COMPLETED|Washout Period (1 Week)||0
8307464|NCT01508676|20481265|P2|COMPLETED|Washout Period (1 Week)||14
8307465|NCT01508676|20481266|P1|COMPLETED|Washout Period (1 Week)||16
8307466|NCT01508676|20481265|P2|STARTED|Washout Period (1 Week)||14
8307467|NCT01508676|20481266|P1|STARTED|Washout Period (1 Week)||16
8307468|NCT01508676|20481265|P2|NOT COMPLETED|Phase I (2 Weeks)||3
8307469|NCT01508676|20481266|P1|NOT COMPLETED|Phase I (2 Weeks)||2
8307470|NCT01508676|20481265|P2|COMPLETED|Phase I (2 Weeks)||14
8307471|NCT01508676|20481266|P1|COMPLETED|Phase I (2 Weeks)||16
8307472|NCT01508676|20481265|P2|STARTED|Phase I (2 Weeks)||17
8307473|NCT01508676|20481266|P1|STARTED|Phase I (2 Weeks)||18
8307474|NCT01508650|20481278|P2|NOT COMPLETED|Overall Study||3
8307475|NCT01508650|20481279|P1|NOT COMPLETED|Overall Study||0
8307476|NCT01508650|20481278|P2|COMPLETED|Overall Study||12
8307477|NCT01508650|20481279|P1|COMPLETED|Overall Study||12
8307478|NCT01508650|20481278|P2|STARTED|Overall Study||15
8307479|NCT01508650|20481279|P1|STARTED|Overall Study||12
8307480|NCT01508455|20481287|P1|NOT COMPLETED|Overall Study||0
8307481|NCT01508455|20481287|P1|COMPLETED|Overall Study||6
8307482|NCT01508455|20481287|P1|STARTED|Overall Study||6
8307483|NCT01508325|20481298|P2|NOT COMPLETED|Overall Study||21
8307484|NCT01508325|20481299|P1|NOT COMPLETED|Overall Study||18
8307485|NCT01508325|20481298|P2|COMPLETED|Overall Study||72
8307486|NCT01508325|20481299|P1|COMPLETED|Overall Study||75
8307487|NCT01508325|20481298|P2|STARTED|Overall Study||93
8307488|NCT01508325|20481299|P1|STARTED|Overall Study||93
8307489|NCT01508169|20481329|P2|NOT COMPLETED|Overall Study||2
8307490|NCT01508169|20481330|P1|NOT COMPLETED|Overall Study||3
8307491|NCT01508169|20481329|P2|COMPLETED|Overall Study||45
8307492|NCT01508169|20481330|P1|COMPLETED|Overall Study||44
8307493|NCT01508169|20481329|P2|STARTED|Overall Study||47
8307494|NCT01508169|20481330|P1|STARTED|Overall Study||47
8307495|NCT01508130|20481344|P2|NOT COMPLETED|Overall Study||69
8307496|NCT01508130|20481345|P1|NOT COMPLETED|Overall Study||227
8307497|NCT01508130|20481344|P2|COMPLETED|Overall Study||73
8307498|NCT01508130|20481345|P1|COMPLETED|Overall Study||266
8307499|NCT01508130|20481344|P2|mTRT|Overall Study||142
8307500|NCT01508130|20481345|P1|mTRT|Overall Study||493
8307501|NCT01508130|20481344|P2|STARTED|Overall Study||142
8307502|NCT01508130|20481345|P1|STARTED|Overall Study||493
8307503|NCT01508117|20481387|P1|NOT COMPLETED|Overall Study||0
8307504|NCT01508117|20481387|P1|COMPLETED|Overall Study||1
8307505|NCT01508117|20481387|P1|STARTED|Overall Study||1
8307506|NCT01508052|20481393|P2|NOT COMPLETED|Overall Study||0
8307507|NCT01508052|20481394|P1|NOT COMPLETED|Overall Study||0
8307508|NCT01508052|20481393|P2|COMPLETED|Overall Study||20
8307509|NCT01508052|20481394|P1|COMPLETED|Overall Study||20
8307510|NCT01508052|20481393|P2|STARTED|Overall Study||20
8307511|NCT01508052|20481394|P1|STARTED|Overall Study||20
8307512|NCT01508013|20481402|P2|NOT COMPLETED|Overall Study||23
8307513|NCT01508013|20481403|P1|NOT COMPLETED|Overall Study||32
8307514|NCT01508013|20481402|P2|COMPLETED|Overall Study||206
8307515|NCT01508013|20481403|P1|COMPLETED|Overall Study||182
8307516|NCT01508013|20481402|P2|STARTED|Overall Study||229
8307517|NCT01508013|20481403|P1|STARTED|Overall Study||214
8307518|NCT01507896|20481413|P1|NOT COMPLETED|Overall Study||2
8307519|NCT01507896|20481413|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
8307520|NCT01507896|20481413|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
8307521|NCT01507831|20481456|P2|NOT COMPLETED|Overall Study||440
8307522|NCT01507831|20481457|P1|NOT COMPLETED|Overall Study||193
8307523|NCT01507831|20481456|P2|COMPLETED|Overall Study||1113
8307524|NCT01507831|20481457|P1|COMPLETED|Overall Study||595
8307525|NCT01507831|20481456|P2|Treated|Overall Study||1550
8307526|NCT01507831|20481457|P1|Treated|Overall Study||788
8307527|NCT01507831|20481456|P2|STARTED|Overall Study|Randomized|1553
8307528|NCT01507831|20481457|P1|STARTED|Overall Study|Randomized|788
8307529|NCT01507779|20481527|P2|NOT COMPLETED|Overall Study||0
8307530|NCT01507779|20481528|P1|NOT COMPLETED|Overall Study||0
8307531|NCT01507779|20481527|P2|COMPLETED|Overall Study||25
8307532|NCT01507779|20481528|P1|COMPLETED|Overall Study||23
8307533|NCT01507779|20481527|P2|STARTED|Overall Study||25
8307534|NCT01507779|20481528|P1|STARTED|Overall Study||23
8307535|NCT01507688|20481568|P2|NOT COMPLETED|6 Month to 12 Month Assessment||3
8307536|NCT01507688|20481569|P1|NOT COMPLETED|6 Month to 12 Month Assessment||5
8307537|NCT01507688|20481568|P2|COMPLETED|6 Month to 12 Month Assessment||116
8307538|NCT01507688|20481569|P1|COMPLETED|6 Month to 12 Month Assessment||108
8307539|NCT01507688|20481568|P2|STARTED|6 Month to 12 Month Assessment||119
8307540|NCT01507688|20481569|P1|STARTED|6 Month to 12 Month Assessment||113
8307541|NCT01507688|20481568|P2|NOT COMPLETED|Baseline to 6 Month Assessment||10
8307542|NCT01507688|20481569|P1|NOT COMPLETED|Baseline to 6 Month Assessment||16
8307543|NCT01507688|20481568|P2|COMPLETED|Baseline to 6 Month Assessment||119
8307544|NCT01507688|20481569|P1|COMPLETED|Baseline to 6 Month Assessment||113
8307545|NCT01507688|20481568|P2|STARTED|Baseline to 6 Month Assessment||129
8307546|NCT01507688|20481569|P1|STARTED|Baseline to 6 Month Assessment||129
8307547|NCT01507662|20481577|P2|NOT COMPLETED|Overall Study||831
8307548|NCT01507662|20481578|P1|NOT COMPLETED|Overall Study||816
8307549|NCT01507662|20481577|P2|COMPLETED|Overall Study||3020
8307550|NCT01507662|20481578|P1|COMPLETED|Overall Study||3082
8307551|NCT01507662|20481577|P2|STARTED|Overall Study||3851
8307552|NCT01507662|20481578|P1|STARTED|Overall Study||3898
8307553|NCT01507584|20481584|P1|NOT COMPLETED|Overall Study||0
8307554|NCT01507584|20481584|P1|COMPLETED|Overall Study||0
8307555|NCT01507584|20481584|P1|STARTED|Overall Study||0
8307556|NCT01507493|20481592|P2|NOT COMPLETED|Overall Study||0
8307557|NCT01507493|20481593|P1|NOT COMPLETED|Overall Study||0
8307558|NCT01507493|20481592|P2|COMPLETED|Overall Study||178
8307559|NCT01507493|20481593|P1|COMPLETED|Overall Study||22
8307560|NCT01507493|20481592|P2|STARTED|Overall Study||178
8307561|NCT01507493|20481593|P1|STARTED|Overall Study||22
8307562|NCT01507350|20481607|P1|NOT COMPLETED|Overall Study||0
8307563|NCT01507350|20481607|P1|COMPLETED|Overall Study||9
8307564|NCT01507350|20481607|P1|STARTED|Overall Study||9
8307565|NCT01507298|20481613|P2|NOT COMPLETED|Overall Study||6
8307566|NCT01507298|20481614|P1|NOT COMPLETED|Overall Study||0
8307567|NCT01507298|20481613|P2|COMPLETED|Overall Study||14
8307568|NCT01507298|20481614|P1|COMPLETED|Overall Study||1
8307569|NCT01507298|20481613|P2|STARTED|Overall Study||20
8307570|NCT01507298|20481614|P1|STARTED|Overall Study||1
8307571|NCT01507246|20481624|P2|NOT COMPLETED|Overall Study||1
8307572|NCT01507246|20481625|P1|NOT COMPLETED|Overall Study||2
8307573|NCT01507246|20481624|P2|COMPLETED|Overall Study||21
8307574|NCT01507246|20481625|P1|COMPLETED|Overall Study||18
8307575|NCT01507246|20481624|P2|STARTED|Overall Study||22
8307576|NCT01507246|20481625|P1|STARTED|Overall Study||20
8307577|NCT01507233|20481639|P2|NOT COMPLETED|Overall Study||0
8307578|NCT01507233|20481640|P1|NOT COMPLETED|Overall Study||0
8307579|NCT01507233|20481639|P2|COMPLETED|Overall Study||0
8307580|NCT01507233|20481640|P1|COMPLETED|Overall Study||5
8307581|NCT01507233|20481639|P2|STARTED|Overall Study||0
8307582|NCT01507233|20481640|P1|STARTED|Overall Study||5
8307583|NCT01507220|20481652|P2|NOT COMPLETED|Overall Study||0
8307584|NCT01507220|20481653|P1|NOT COMPLETED|Overall Study||0
8307585|NCT01507220|20481652|P2|COMPLETED|Overall Study||0
8307586|NCT01507220|20481653|P1|COMPLETED|Overall Study||2
8307587|NCT01507220|20481652|P2|STARTED|Overall Study||0
8307588|NCT01507220|20481653|P1|STARTED|Overall Study||2
8307589|NCT01507181|20481667|P2|NOT COMPLETED|Overall Study||0
8307590|NCT01507181|20481668|P1|NOT COMPLETED|Overall Study||0
8307591|NCT01507181|20481667|P2|COMPLETED|Overall Study||12
8307592|NCT01507181|20481668|P1|COMPLETED|Overall Study||12
8307593|NCT01507181|20481667|P2|STARTED|Overall Study||12
8307594|NCT01507181|20481668|P1|STARTED|Overall Study||12
8307595|NCT01507155|20481688|P2|NOT COMPLETED|Overall Study||0
8307596|NCT01507155|20481689|P1|NOT COMPLETED|Overall Study||0
8307597|NCT01507155|20481688|P2|COMPLETED|Overall Study||60
8307598|NCT01507155|20481689|P1|COMPLETED|Overall Study||625
8307599|NCT01507155|20481688|P2|STARTED|Overall Study||60
8307600|NCT01507155|20481689|P1|STARTED|Overall Study||625
8307601|NCT01507103|20481698|P3|NOT COMPLETED|Overall Study||0
8307602|NCT01507103|20481699|P2|NOT COMPLETED|Overall Study||0
8307603|NCT01507103|20481700|P1|NOT COMPLETED|Overall Study||0
8307604|NCT01507103|20481698|P3|COMPLETED|Overall Study||42
8307605|NCT01507103|20481699|P2|COMPLETED|Overall Study||41
8307606|NCT01507103|20481700|P1|COMPLETED|Overall Study||41
8307607|NCT01507103|20481698|P3|STARTED|Overall Study||42
8307608|NCT01507103|20481699|P2|STARTED|Overall Study||41
8307609|NCT01507103|20481700|P1|STARTED|Overall Study||41
8307610|NCT01507090|20481723|P1|NOT COMPLETED|Overall Study||18
8307611|NCT01507090|20481723|P1|COMPLETED|Overall Study||624
8307612|NCT01507090|20481723|P1|STARTED|Overall Study||642
8307613|NCT01507051|20481762|P4|NOT COMPLETED|Overall Study||7
8307614|NCT01507051|20481763|P3|NOT COMPLETED|Overall Study||1
8307615|NCT01507051|20481764|P2|NOT COMPLETED|Overall Study||3
8307616|NCT01507051|20481765|P1|NOT COMPLETED|Overall Study||2
8307617|NCT01507051|20481762|P4|COMPLETED|Overall Study||0
8307618|NCT01507051|20481763|P3|COMPLETED|Overall Study||28
8307619|NCT01507051|20481764|P2|COMPLETED|Overall Study||28
8307620|NCT01507051|20481765|P1|COMPLETED|Overall Study||27
8307621|NCT01507051|20481762|P4|Received Placebo or Rivaroxaban|Overall Study||0
8307622|NCT01507051|20481763|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
8307623|NCT01507051|20481764|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
8307624|NCT01507051|20481765|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
8307625|NCT01507051|20481762|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
8307626|NCT01507051|20481763|P3|Warfarin run-in Phase|Overall Study||0
8307627|NCT01507051|20481764|P2|Warfarin run-in Phase|Overall Study||28
8307628|NCT01507051|20481765|P1|Warfarin run-in Phase|Overall Study||28
8307629|NCT01507051|20481762|P4|STARTED|Overall Study||7
8307630|NCT01507051|20481763|P3|STARTED|Overall Study||29
8307631|NCT01507051|20481764|P2|STARTED|Overall Study||31
8307632|NCT01507051|20481765|P1|STARTED|Overall Study||29
8307633|NCT01506960|20481883|P1|NOT COMPLETED|Overall Study||47
8307634|NCT01506960|20481883|P1|COMPLETED|Overall Study||17
8307635|NCT01506960|20481883|P1|STARTED|Overall Study||64
8307636|NCT01506947|20481889|P1|NOT COMPLETED|Overall Study||16
8307637|NCT01506947|20481889|P1|COMPLETED|Overall Study||49
8307638|NCT01506947|20481889|P1|STARTED|Overall Study||65
8307639|NCT01506908|20481907|P2|NOT COMPLETED|Overall Study||0
8307640|NCT01506908|20481908|P1|NOT COMPLETED|Overall Study||1
8307641|NCT01506908|20481907|P2|COMPLETED|Overall Study||161
8307642|NCT01506908|20481908|P1|COMPLETED|Overall Study||161
8307643|NCT01506908|20481907|P2|STARTED|Overall Study||161
8307644|NCT01506908|20481908|P1|STARTED|Overall Study||162
8307645|NCT01506882|20481926|P2|NOT COMPLETED|Overall Study||7
8307646|NCT01506882|20481927|P1|NOT COMPLETED|Overall Study||22
8307647|NCT01506882|20481926|P2|COMPLETED|Overall Study||3
8307648|NCT01506882|20481927|P1|COMPLETED|Overall Study||39
8307649|NCT01506882|20481926|P2|STARTED|Overall Study||10
8307650|NCT01506882|20481927|P1|STARTED|Overall Study||61
8307651|NCT01506726|20481941|P2|NOT COMPLETED|Overall Study||2
8307652|NCT01506726|20481942|P1|NOT COMPLETED|Overall Study||1
8307653|NCT01506726|20481941|P2|COMPLETED|Overall Study||3
8307654|NCT01506726|20481942|P1|COMPLETED|Overall Study||5
8307655|NCT01506726|20481941|P2|STARTED|Overall Study||5
8307656|NCT01506726|20481942|P1|STARTED|Overall Study||6
8307657|NCT01506596|20481982|P1|NOT COMPLETED|Overall Study||1
8307658|NCT01506596|20481982|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
8307659|NCT01506596|20481982|P1|STARTED|Overall Study||42
8307660|NCT01506479|20481993|P3|NOT COMPLETED|Overall Study||3
8307661|NCT01506479|20481994|P2|NOT COMPLETED|Overall Study||5
8307662|NCT01506479|20481995|P1|NOT COMPLETED|Overall Study||3
8307663|NCT01506479|20481993|P3|COMPLETED|Overall Study||42
8307664|NCT01506479|20481994|P2|COMPLETED|Overall Study||38
8307665|NCT01506479|20481995|P1|COMPLETED|Overall Study||37
8307666|NCT01506479|20481993|P3|STARTED|Overall Study||45
8307667|NCT01506479|20481994|P2|STARTED|Overall Study||43
8307668|NCT01506479|20481995|P1|STARTED|Overall Study||40
8307669|NCT01506453|20482009|P2|NOT COMPLETED|Overall Study||2
8307670|NCT01506453|20482010|P1|NOT COMPLETED|Overall Study||0
8307671|NCT01506453|20482009|P2|COMPLETED|Overall Study||24
8307672|NCT01506453|20482010|P1|COMPLETED|Overall Study||25
8307673|NCT01506453|20482009|P2|STARTED|Overall Study||26
8307674|NCT01506453|20482010|P1|STARTED|Overall Study||25
8307675|NCT01506362|20482020|P1|NOT COMPLETED|Overall Study||6
8307676|NCT01506362|20482020|P1|COMPLETED|Overall Study||16
8307677|NCT01506362|20482020|P1|STARTED|Overall Study||22
8307678|NCT01506323|20482026|P2|NOT COMPLETED|Overall Study||13
8307679|NCT01506323|20482027|P1|NOT COMPLETED|Overall Study||24
8307680|NCT01506323|20482026|P2|COMPLETED|Overall Study||71
8307681|NCT01506323|20482027|P1|COMPLETED|Overall Study||65
8307682|NCT01506323|20482026|P2|Post-treatment Completed CAPS|Overall Study||72
8307683|NCT01506323|20482027|P1|Post-treatment Completed CAPS|Overall Study||68
8307684|NCT01506323|20482026|P2|Post-treatment Completers|Overall Study||72
8307685|NCT01506323|20482027|P1|Post-treatment Completers|Overall Study||69
8307686|NCT01506323|20482026|P2|STARTED|Overall Study||84
8307687|NCT01506323|20482027|P1|STARTED|Overall Study||89
8307688|NCT01506271|20482056|P3|NOT COMPLETED|Overall Study||3
8307689|NCT01506271|20482057|P2|NOT COMPLETED|Overall Study||7
8307690|NCT01506271|20482058|P1|NOT COMPLETED|Overall Study||4
8307691|NCT01506271|20482056|P3|COMPLETED|Overall Study||114
8307692|NCT01506271|20482057|P2|COMPLETED|Overall Study||109
8307693|NCT01506271|20482058|P1|COMPLETED|Overall Study||114
8307694|NCT01506271|20482056|P3|Treated|Overall Study||114
8307695|NCT01506271|20482057|P2|Treated|Overall Study||116
8307696|NCT01506271|20482058|P1|Treated|Overall Study||117
8307697|NCT01506271|20482056|P3|STARTED|Overall Study||117
8307698|NCT01506271|20482057|P2|STARTED|Overall Study||116
8307699|NCT01506271|20482058|P1|STARTED|Overall Study||118
8307700|NCT01506193|20482120|P3|NOT COMPLETED|Overall Study||14
8307701|NCT01506193|20482121|P2|NOT COMPLETED|Overall Study||4
8307702|NCT01506193|20482122|P1|NOT COMPLETED|Overall Study||14
8307703|NCT01506193|20482120|P3|COMPLETED|Overall Study||168
8307704|NCT01506193|20482121|P2|COMPLETED|Overall Study||179
8307705|NCT01506193|20482122|P1|COMPLETED|Overall Study||337
8307706|NCT01506193|20482120|P3|STARTED|Overall Study||182
8307707|NCT01506193|20482121|P2|STARTED|Overall Study||183
8307708|NCT01506193|20482122|P1|STARTED|Overall Study||351
8307709|NCT01505933|20482155|P2|NOT COMPLETED|Overall Study||0
8307710|NCT01505933|20482156|P1|NOT COMPLETED|Overall Study||0
8307711|NCT01505933|20482155|P2|COMPLETED|Overall Study||14
8307712|NCT01505933|20482156|P1|COMPLETED|Overall Study||10
8307713|NCT01505933|20482155|P2|STARTED|Overall Study||14
8307714|NCT01505933|20482156|P1|STARTED|Overall Study||10
8307715|NCT01505881|20482168|P2|NOT COMPLETED|Overall Study||1
8307716|NCT01505881|20482169|P1|NOT COMPLETED|Overall Study||4
8307717|NCT01505881|20482168|P2|COMPLETED|Overall Study||58
8307718|NCT01505881|20482169|P1|COMPLETED|Overall Study||95
8307719|NCT01505881|20482168|P2|STARTED|Overall Study||59
8307720|NCT01505881|20482169|P1|STARTED|Overall Study||99
8307721|NCT01505764|20482183|P2|NOT COMPLETED|Overall Study||1
8307722|NCT01505764|20482184|P1|NOT COMPLETED|Overall Study||3
8307723|NCT01505764|20482183|P2|COMPLETED|Overall Study||2
8307724|NCT01505764|20482184|P1|COMPLETED|Overall Study||3
8307725|NCT01505764|20482183|P2|STARTED|Overall Study||3
8307726|NCT01505764|20482184|P1|STARTED|Overall Study||6
8307727|NCT01505673|20482214|P2|NOT COMPLETED|Overall Study||2
8307728|NCT01505673|20482215|P1|NOT COMPLETED|Overall Study||3
8307729|NCT01505673|20482214|P2|COMPLETED|Overall Study||34
8307730|NCT01505673|20482215|P1|COMPLETED|Overall Study||32
8307731|NCT01505673|20482214|P2|STARTED|Overall Study||36
8307732|NCT01505673|20482215|P1|STARTED|Overall Study||35
8307733|NCT01505647|20482275|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
8307734|NCT01505647|20482276|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
8307735|NCT01505647|20482275|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
8307736|NCT01505647|20482276|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
8307737|NCT01505647|20482275|P2|STARTED|Day 43 Through Day 182 Follow-up||166
8307738|NCT01505647|20482276|P1|STARTED|Day 43 Through Day 182 Follow-up||329
8307739|NCT01505647|20482275|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
8307740|NCT01505647|20482276|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
8307741|NCT01505647|20482275|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
8307742|NCT01505647|20482276|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
8307743|NCT01505647|20482275|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
8307744|NCT01505647|20482276|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
8307745|NCT01505647|20482275|P2|STARTED|Day 1 Through Day 42 Follow-up||166
8307746|NCT01505647|20482276|P1|STARTED|Day 1 Through Day 42 Follow-up||332
8307747|NCT01505634|20482293|P3|NOT COMPLETED|Overall Study||6
8307748|NCT01505634|20482294|P2|NOT COMPLETED|Overall Study||10
8307749|NCT01505634|20482295|P1|NOT COMPLETED|Overall Study||9
8307750|NCT01505634|20482293|P3|COMPLETED|Overall Study||94
8307751|NCT01505634|20482294|P2|COMPLETED|Overall Study||91
8307752|NCT01505634|20482295|P1|COMPLETED|Overall Study||92
8307753|NCT01505634|20482293|P3|Treated|Overall Study||100
8307754|NCT01505634|20482294|P2|Treated|Overall Study||99
8307755|NCT01505634|20482295|P1|Treated|Overall Study||99
8307756|NCT01505634|20482293|P3|STARTED|Overall Study||100
8307757|NCT01505634|20482294|P2|STARTED|Overall Study||101
8307758|NCT01505634|20482295|P1|STARTED|Overall Study||101
8307759|NCT01505608|20482350|P2|NOT COMPLETED|Phase II||2
8307760|NCT01505608|20482351|P1|NOT COMPLETED|Phase II||2
8307761|NCT01505608|20482350|P2|COMPLETED|Phase II||2
8307762|NCT01505608|20482351|P1|COMPLETED|Phase II||0
8307763|NCT01505608|20482350|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
8307764|NCT01505608|20482351|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
8307765|NCT01505608|20482350|P2|NOT COMPLETED|Phase I||6
8307766|NCT01505608|20482351|P1|NOT COMPLETED|Phase I||0
8307767|NCT01505608|20482350|P2|COMPLETED|Phase I||2
8307768|NCT01505608|20482351|P1|COMPLETED|Phase I||0
8307769|NCT01505608|20482350|P2|STARTED|Phase I||8
8307770|NCT01505608|20482351|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
8307771|NCT01505530|20482370|P3|NOT COMPLETED|Overall Study||41
8307772|NCT01505530|20482371|P2|NOT COMPLETED|Overall Study||43
8307773|NCT01505530|20482372|P1|NOT COMPLETED|Overall Study||41
8307774|NCT01505530|20482370|P3|COMPLETED|Overall Study||0
8307775|NCT01505530|20482371|P2|COMPLETED|Overall Study||0
8307776|NCT01505530|20482372|P1|COMPLETED|Overall Study||0
8307777|NCT01505530|20482370|P3|Completed One Cycle of Study Drug|Overall Study||31
8307778|NCT01505530|20482371|P2|Completed One Cycle of Study Drug|Overall Study||27
8307779|NCT01505530|20482372|P1|Completed One Cycle of Study Drug|Overall Study||29
8307780|NCT01505530|20482370|P3|Received At Least One Dose of Study Drug|Overall Study||41
8307781|NCT01505530|20482371|P2|Received At Least One Dose of Study Drug|Overall Study||42
8307782|NCT01505530|20482372|P1|Received At Least One Dose of Study Drug|Overall Study||41
8307783|NCT01505530|20482370|P3|STARTED|Overall Study||41
8307784|NCT01505530|20482371|P2|STARTED|Overall Study||43
8307785|NCT01505530|20482372|P1|STARTED|Overall Study||41
8307786|NCT01505491|20482416|P3|NOT COMPLETED|Overall Study||5
8307787|NCT01505491|20482417|P2|NOT COMPLETED|Overall Study||1
8307788|NCT01505491|20482418|P1|NOT COMPLETED|Overall Study||2
8307789|NCT01505491|20482416|P3|COMPLETED|Overall Study||59
8307790|NCT01505491|20482417|P2|COMPLETED|Overall Study||61
8307791|NCT01505491|20482418|P1|COMPLETED|Overall Study||65
8307792|NCT01505491|20482416|P3|STARTED|Overall Study||64
8307793|NCT01505491|20482417|P2|STARTED|Overall Study||62
8307794|NCT01505491|20482418|P1|STARTED|Overall Study||67
8307795|NCT01505465|20482440|P2|NOT COMPLETED|Overall Study||7
8307796|NCT01505465|20482441|P1|NOT COMPLETED|Overall Study||6
8307797|NCT01505465|20482440|P2|COMPLETED|Overall Study||18
8307798|NCT01505465|20482441|P1|COMPLETED|Overall Study||19
8307799|NCT01505465|20482440|P2|STARTED|Overall Study||25
8307800|NCT01505465|20482441|P1|STARTED|Overall Study||25
8307801|NCT01505387|20482457|P2|NOT COMPLETED|Overall Study||1
8307802|NCT01505387|20482458|P1|NOT COMPLETED|Overall Study||2
8307803|NCT01505387|20482457|P2|COMPLETED|Overall Study||24
8307804|NCT01505387|20482458|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
8307805|NCT01505387|20482457|P2|Treated|Overall Study||24
8307806|NCT01505387|20482458|P1|Treated|Overall Study||24
8307807|NCT01505387|20482457|P2|STARTED|Overall Study||25
8307808|NCT01505387|20482458|P1|STARTED|Overall Study||25
8307809|NCT01505374|20482464|P2|NOT COMPLETED|Overall Study||0
8307810|NCT01505374|20482465|P1|NOT COMPLETED|Overall Study||1
8307811|NCT01505374|20482464|P2|COMPLETED|Overall Study||30
8307812|NCT01505374|20482465|P1|COMPLETED|Overall Study||29
8307813|NCT01505374|20482464|P2|STARTED|Overall Study||30
8307814|NCT01505374|20482465|P1|STARTED|Overall Study||30
8307815|NCT01505179|20482481|P2|NOT COMPLETED|Overall Study||0
8307816|NCT01505179|20482482|P1|NOT COMPLETED|Overall Study||0
8307817|NCT01505179|20482481|P2|COMPLETED|Overall Study||4
8307818|NCT01505179|20482482|P1|COMPLETED|Overall Study||6
8307819|NCT01505179|20482481|P2|STARTED|Overall Study||4
8307820|NCT01505179|20482482|P1|STARTED|Overall Study||6
8307830|NCT01505114|20482515|P4|NOT COMPLETED|Overall Study||23
8307831|NCT01505114|20482516|P3|NOT COMPLETED|Overall Study||18
8307832|NCT01505114|20482517|P2|NOT COMPLETED|Overall Study||13
8307833|NCT01505114|20482518|P1|NOT COMPLETED|Overall Study||25
8307834|NCT01505114|20482515|P4|COMPLETED|Overall Study||128
8307835|NCT01505114|20482516|P3|COMPLETED|Overall Study||129
8307836|NCT01505114|20482517|P2|COMPLETED|Overall Study||135
8307837|NCT01505114|20482518|P1|COMPLETED|Overall Study||123
8307838|NCT01505114|20482515|P4|STARTED|Overall Study||151
8307839|NCT01505114|20482516|P3|STARTED|Overall Study||147
8307840|NCT01505114|20482517|P2|STARTED|Overall Study||148
8307841|NCT01505114|20482518|P1|STARTED|Overall Study||148
8307842|NCT01505062|20482531|P3|NOT COMPLETED|Overall Study||0
8307843|NCT01505062|20482532|P2|NOT COMPLETED|Overall Study||0
8307844|NCT01505062|20482533|P1|NOT COMPLETED|Overall Study||0
8307845|NCT01505062|20482531|P3|COMPLETED|Overall Study||3
8307846|NCT01505062|20482532|P2|COMPLETED|Overall Study||3
8307847|NCT01505062|20482533|P1|COMPLETED|Overall Study||3
8307848|NCT01505062|20482531|P3|STARTED|Overall Study||3
8307849|NCT01505062|20482532|P2|STARTED|Overall Study||3
8307850|NCT01505062|20482533|P1|STARTED|Overall Study||3
8307851|NCT01505010|20482546|P2|NOT COMPLETED|Overall Study||2
8307852|NCT01505010|20482547|P1|NOT COMPLETED|Overall Study||0
8307853|NCT01505010|20482546|P2|COMPLETED|Overall Study||6
8307854|NCT01505010|20482547|P1|COMPLETED|Overall Study||9
8307855|NCT01505010|20482546|P2|STARTED|Overall Study||8
8307856|NCT01505010|20482547|P1|STARTED|Overall Study||9
8307857|NCT01504997|20482557|P1|NOT COMPLETED|Overall Study||0
8307858|NCT01504997|20482557|P1|COMPLETED|Overall Study||18
8307859|NCT01504997|20482557|P1|STARTED|Overall Study||18
8307860|NCT01504971|20482561|P1|NOT COMPLETED|Overall Study||13
8307861|NCT01504971|20482561|P1|COMPLETED|Overall Study||82
8307862|NCT01504971|20482561|P1|STARTED|Overall Study||95
8307863|NCT01504958|20482572|P3|NOT COMPLETED|Overall Study||0
8307864|NCT01504958|20482573|P2|NOT COMPLETED|Overall Study||0
8307865|NCT01504958|20482574|P1|NOT COMPLETED|Overall Study||0
8307866|NCT01504958|20482572|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
8307867|NCT01504958|20482573|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
8307868|NCT01504958|20482574|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
8307869|NCT01504958|20482572|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
8307870|NCT01504958|20482573|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
8307871|NCT01504958|20482574|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
8307872|NCT01504867|20482590|P2|NOT COMPLETED|Overall Study||3
8307873|NCT01504867|20482591|P1|NOT COMPLETED|Overall Study||7
8307874|NCT01504867|20482590|P2|COMPLETED|Overall Study||195
8307875|NCT01504867|20482591|P1|COMPLETED|Overall Study||195
8307876|NCT01504867|20482590|P2|STARTED|Overall Study||198
8307877|NCT01504867|20482591|P1|STARTED|Overall Study||202
8307878|NCT01504854|20482611|P2|NOT COMPLETED|Overall Study||7
8307879|NCT01504854|20482612|P1|NOT COMPLETED|Overall Study||8
8307880|NCT01504854|20482611|P2|COMPLETED|Overall Study||48
8307881|NCT01504854|20482612|P1|COMPLETED|Overall Study||56
8307882|NCT01504854|20482611|P2|STARTED|Overall Study||55
8307883|NCT01504854|20482612|P1|STARTED|Overall Study||64
8307884|NCT01504841|20482629|P3|NOT COMPLETED|Overall Study||0
8307885|NCT01504841|20482630|P2|NOT COMPLETED|Overall Study||4
8307886|NCT01504841|20482631|P1|NOT COMPLETED|Overall Study||16
8307887|NCT01504841|20482629|P3|COMPLETED|Overall Study||0
8307888|NCT01504841|20482630|P2|COMPLETED|Overall Study||2
8307889|NCT01504841|20482631|P1|COMPLETED|Overall Study||4
8307890|NCT01504841|20482629|P3|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
8307891|NCT01504841|20482630|P2|STARTED|Overall Study||6
8307892|NCT01504841|20482631|P1|STARTED|Overall Study||20
8307893|NCT01504711|20482664|P1|NOT COMPLETED|Overall Study||3
8307894|NCT01504711|20482664|P1|COMPLETED|Overall Study||27
8307895|NCT01504711|20482664|P1|STARTED|Overall Study||30
8307896|NCT01504477|20482671|P1|NOT COMPLETED|Overall Study||0
8307897|NCT01504477|20482671|P1|COMPLETED|Overall Study||6
8307898|NCT01504477|20482671|P1|STARTED|Overall Study||6
8307899|NCT01504412|20482684|P5|NOT COMPLETED|Overall Study||13
8307900|NCT01504412|20482685|P4|NOT COMPLETED|Overall Study||19
8307901|NCT01504412|20482686|P3|NOT COMPLETED|Overall Study||4
8307902|NCT01504412|20482687|P2|NOT COMPLETED|Overall Study||12
8307903|NCT01504412|20482688|P1|NOT COMPLETED|Overall Study||5
8307904|NCT01504412|20482684|P5|COMPLETED|Overall Study||77
8307905|NCT01504412|20482685|P4|COMPLETED|Overall Study||75
8307906|NCT01504412|20482686|P3|COMPLETED|Overall Study||86
8307907|NCT01504412|20482687|P2|COMPLETED|Overall Study||75
8307908|NCT01504412|20482688|P1|COMPLETED|Overall Study||84
8307909|NCT01504412|20482684|P5|STARTED|Overall Study||90
8307910|NCT01504412|20482685|P4|STARTED|Overall Study||94
8307911|NCT01504412|20482686|P3|STARTED|Overall Study||90
8307912|NCT01504412|20482687|P2|STARTED|Overall Study||87
8307913|NCT01504412|20482688|P1|STARTED|Overall Study||89
8307914|NCT01504204|20482707|P2|NOT COMPLETED|Overall Study||1
8307915|NCT01504204|20482708|P1|NOT COMPLETED|Overall Study||1
8307916|NCT01504204|20482707|P2|COMPLETED|Overall Study||9
8307917|NCT01504204|20482708|P1|COMPLETED|Overall Study||9
8307918|NCT01504204|20482707|P2|STARTED|Overall Study||10
8307919|NCT01504204|20482708|P1|STARTED|Overall Study||10
8307920|NCT01503749|20482721|P3|NOT COMPLETED|Overall Study||0
8307921|NCT01503749|20482722|P2|NOT COMPLETED|Overall Study||0
8307922|NCT01503749|20482723|P1|NOT COMPLETED|Overall Study||0
8307923|NCT01503749|20482721|P3|COMPLETED|Overall Study||3
8307924|NCT01503749|20482722|P2|COMPLETED|Overall Study||3
8307925|NCT01503749|20482723|P1|COMPLETED|Overall Study||3
8307926|NCT01503749|20482721|P3|STARTED|Overall Study||3
8307927|NCT01503749|20482722|P2|STARTED|Overall Study||3
8307928|NCT01503749|20482723|P1|STARTED|Overall Study||3
8307929|NCT01503515|20482736|P2|NOT COMPLETED|Overall Study||35
8307930|NCT01503515|20482737|P1|NOT COMPLETED|Overall Study||21
8307931|NCT01503515|20482736|P2|COMPLETED|Overall Study||112
8307932|NCT01503515|20482737|P1|COMPLETED|Overall Study||124
8307933|NCT01503515|20482736|P2|STARTED|Overall Study||147
8307934|NCT01503515|20482737|P1|STARTED|Overall Study||145
8307935|NCT01503333|20482745|P2|NOT COMPLETED|Overall Study||305
8307936|NCT01503333|20482746|P1|NOT COMPLETED|Overall Study||340
8307937|NCT01503333|20482745|P2|COMPLETED|Overall Study||461
8307938|NCT01503333|20482746|P1|COMPLETED|Overall Study||437
8307939|NCT01503333|20482745|P2|Completed Post-intervention|Overall Study||706
8307940|NCT01503333|20482746|P1|Completed Post-intervention|Overall Study||680
8307941|NCT01503333|20482745|P2|Completed Baseline|Overall Study||753
8307942|NCT01503333|20482746|P1|Completed Baseline|Overall Study||766
8307943|NCT01503333|20482745|P2|STARTED|Overall Study||766
8307944|NCT01503333|20482746|P1|STARTED|Overall Study||777
8307945|NCT01503164|20482774|P2|NOT COMPLETED|Overall Study||1
8307946|NCT01503164|20482775|P1|NOT COMPLETED|Overall Study||2
8307947|NCT01503164|20482774|P2|COMPLETED|Overall Study||55
8307948|NCT01503164|20482775|P1|COMPLETED|Overall Study||53
8307949|NCT01503164|20482774|P2|STARTED|Overall Study||56
8307950|NCT01503164|20482775|P1|STARTED|Overall Study||55
8307951|NCT01503021|20482805|P2|NOT COMPLETED|Overall Study||26
8307952|NCT01503021|20482806|P1|NOT COMPLETED|Overall Study||27
8307953|NCT01503021|20482805|P2|COMPLETED|Overall Study||332
8307954|NCT01503021|20482806|P1|COMPLETED|Overall Study||333
8307955|NCT01503021|20482805|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
8307956|NCT01503021|20482806|P1|Completed Treatment|Overall Study||333
8307957|NCT01503021|20482805|P2|Dosed|Overall Study||352
8307958|NCT01503021|20482806|P1|Dosed|Overall Study||351
8307959|NCT01503021|20482805|P2|STARTED|Overall Study||358
8307960|NCT01503021|20482806|P1|STARTED|Overall Study||360
8307961|NCT01502956|20482855|P2|NOT COMPLETED|Overall Study||26
8307962|NCT01502956|20482856|P1|NOT COMPLETED|Overall Study||24
8307963|NCT01502956|20482855|P2|COMPLETED|Overall Study||168
8307964|NCT01502956|20482856|P1|COMPLETED|Overall Study||168
8307965|NCT01502956|20482855|P2|STARTED|Overall Study||194
8307966|NCT01502956|20482856|P1|STARTED|Overall Study||192
8307967|NCT01502787|20482880|P2|NOT COMPLETED|Overall Study||0
8307968|NCT01502787|20482881|P1|NOT COMPLETED|Overall Study||0
8307969|NCT01502787|20482880|P2|COMPLETED|Overall Study||10
8307970|NCT01502787|20482881|P1|COMPLETED|Overall Study||11
8307971|NCT01502787|20482880|P2|STARTED|Overall Study||10
8307972|NCT01502787|20482881|P1|STARTED|Overall Study||11
8307973|NCT01502761|20482895|P4|NOT COMPLETED|Overall Study||0
8307974|NCT01502761|20482896|P3|NOT COMPLETED|Overall Study||0
8307975|NCT01502761|20482897|P2|NOT COMPLETED|Overall Study||0
8307976|NCT01502761|20482898|P1|NOT COMPLETED|Overall Study||0
8307977|NCT01502761|20482895|P4|COMPLETED|Overall Study||0
8307978|NCT01502761|20482896|P3|COMPLETED|Overall Study||0
8307979|NCT01502761|20482897|P2|COMPLETED|Overall Study||0
8307980|NCT01502761|20482898|P1|COMPLETED|Overall Study||4
8307981|NCT01502761|20482895|P4|STARTED|Overall Study||0
8307982|NCT01502761|20482896|P3|STARTED|Overall Study||0
8307983|NCT01502761|20482897|P2|STARTED|Overall Study||0
8307984|NCT01502761|20482898|P1|STARTED|Overall Study||4
8307985|NCT01502709|20482914|P2|NOT COMPLETED|Overall Study||0
8307986|NCT01502709|20482915|P1|NOT COMPLETED|Overall Study||4
8307987|NCT01502709|20482914|P2|COMPLETED|Overall Study||0
8307988|NCT01502709|20482915|P1|COMPLETED|Overall Study||1
8307989|NCT01502709|20482914|P2|STARTED|Overall Study||0
8307990|NCT01502709|20482915|P1|STARTED|Overall Study||5
8307991|NCT01502644|20482928|P4|NOT COMPLETED|Assigned to NA Groups||8
8307992|NCT01502644|20482929|P3|NOT COMPLETED|Assigned to NA Groups||3
8307993|NCT01502644|20482930|P2|NOT COMPLETED|Assigned to NA Groups||6
8307994|NCT01502644|20482931|P1|NOT COMPLETED|Assigned to NA Groups||0
8307995|NCT01502644|20482928|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
8307996|NCT01502644|20482929|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
8307997|NCT01502644|20482930|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
8307998|NCT01502644|20482931|P1|COMPLETED|Assigned to NA Groups||0
8307999|NCT01502644|20482928|P4|STARTED|Assigned to NA Groups||32
8308000|NCT01502644|20482929|P3|STARTED|Assigned to NA Groups||10
8308001|NCT01502644|20482930|P2|STARTED|Assigned to NA Groups||30
8308002|NCT01502644|20482931|P1|STARTED|Assigned to NA Groups||0
8308003|NCT01502644|20482928|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308004|NCT01502644|20482929|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308005|NCT01502644|20482930|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308006|NCT01502644|20482931|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
8308007|NCT01502644|20482928|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308008|NCT01502644|20482929|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308009|NCT01502644|20482930|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308010|NCT01502644|20482931|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
8308011|NCT01502644|20482928|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
8308012|NCT01502644|20482929|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
8308013|NCT01502644|20482930|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
8308014|NCT01502644|20482931|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
8308015|NCT01502631|20482941|P2|NOT COMPLETED|Overall Study||20
8308016|NCT01502631|20482942|P1|NOT COMPLETED|Overall Study||20
8308017|NCT01502631|20482941|P2|COMPLETED|Overall Study||11
8308018|NCT01502631|20482942|P1|COMPLETED|Overall Study||10
8308019|NCT01502631|20482941|P2|STARTED|Overall Study||31
8308020|NCT01502631|20482942|P1|STARTED|Overall Study||30
8308021|NCT01502423|20482962|P2|NOT COMPLETED|Overall Study||1
8308022|NCT01502423|20482963|P1|NOT COMPLETED|Overall Study||0
8308023|NCT01502423|20482962|P2|COMPLETED|Overall Study||29
8308024|NCT01502423|20482963|P1|COMPLETED|Overall Study||31
8308025|NCT01502423|20482962|P2|STARTED|Overall Study||30
8308026|NCT01502423|20482963|P1|STARTED|Overall Study||31
8308027|NCT01502410|20482985|P4|NOT COMPLETED|Overall Study||0
8308028|NCT01502410|20482986|P3|NOT COMPLETED|Overall Study||0
8308029|NCT01502410|20482987|P2|NOT COMPLETED|Overall Study||10
8308030|NCT01502410|20482988|P1|NOT COMPLETED|Overall Study||10
8308031|NCT01502410|20482985|P4|COMPLETED|Overall Study||0
8308032|NCT01502410|20482986|P3|COMPLETED|Overall Study||0
8308033|NCT01502410|20482987|P2|COMPLETED|Overall Study||0
8308034|NCT01502410|20482988|P1|COMPLETED|Overall Study||0
8308035|NCT01502410|20482985|P4|STARTED|Overall Study||0
8308036|NCT01502410|20482986|P3|STARTED|Overall Study||0
8308037|NCT01502410|20482987|P2|STARTED|Overall Study||10
8308038|NCT01502410|20482988|P1|STARTED|Overall Study||10
8308039|NCT01502371|20483006|P5|NOT COMPLETED|Overall Study||52
8308040|NCT01502371|20483007|P4|NOT COMPLETED|Overall Study||37
8308041|NCT01502371|20483008|P3|NOT COMPLETED|Overall Study||25
8308042|NCT01502371|20483009|P2|NOT COMPLETED|Overall Study||32
8308043|NCT01502371|20483010|P1|NOT COMPLETED|Overall Study||41
8308044|NCT01502371|20483006|P5|COMPLETED|Overall Study||60
8308045|NCT01502371|20483007|P4|COMPLETED|Overall Study||88
8308046|NCT01502371|20483008|P3|COMPLETED|Overall Study||83
8308047|NCT01502371|20483009|P2|COMPLETED|Overall Study||81
8308048|NCT01502371|20483010|P1|COMPLETED|Overall Study||79
8308049|NCT01502371|20483006|P5|STARTED|Overall Study||112
8308050|NCT01502371|20483007|P4|STARTED|Overall Study||125
8308051|NCT01502371|20483008|P3|STARTED|Overall Study||108
8308052|NCT01502371|20483009|P2|STARTED|Overall Study||113
8308053|NCT01502371|20483010|P1|STARTED|Overall Study||120
8308054|NCT01502332|20483035|P2|NOT COMPLETED|Overall Study||0
8308055|NCT01502332|20483036|P1|NOT COMPLETED|Overall Study||0
8308056|NCT01502332|20483035|P2|COMPLETED|Overall Study||163
8308057|NCT01502332|20483036|P1|COMPLETED|Overall Study||157
8308058|NCT01502332|20483035|P2|STARTED|Overall Study||163
8308059|NCT01502332|20483036|P1|STARTED|Overall Study||157
8308060|NCT01502306|20483053|P3|NOT COMPLETED|Overall Study||0
8308061|NCT01502306|20483054|P2|NOT COMPLETED|Overall Study||0
8308062|NCT01502306|20483055|P1|NOT COMPLETED|Overall Study||0
8308063|NCT01502306|20483053|P3|COMPLETED|Overall Study||1407
8308064|NCT01502306|20483054|P2|COMPLETED|Overall Study||1405
8308065|NCT01502306|20483055|P1|COMPLETED|Overall Study||1004
8308066|NCT01502306|20483053|P3|STARTED|Overall Study||1407
8308067|NCT01502306|20483054|P2|STARTED|Overall Study||1405
8308068|NCT01502306|20483055|P1|STARTED|Overall Study||1004
8308069|NCT01502293|20483075|P3|NOT COMPLETED|Overall Study||4
8308070|NCT01502293|20483076|P2|NOT COMPLETED|Overall Study||17
8308071|NCT01502293|20483077|P1|NOT COMPLETED|Overall Study||25
8308072|NCT01502293|20483075|P3|COMPLETED|Overall Study||0
8308073|NCT01502293|20483076|P2|COMPLETED|Overall Study||0
8308074|NCT01502293|20483077|P1|COMPLETED|Overall Study||5
8308075|NCT01502293|20483075|P3|STARTED|Overall Study||4
8308076|NCT01502293|20483076|P2|STARTED|Overall Study||17
8308077|NCT01502293|20483077|P1|STARTED|Overall Study||30
8308078|NCT01502228|20483106|P1|NOT COMPLETED|Overall Study||1
8308079|NCT01502228|20483106|P1|COMPLETED|Overall Study||13
8308080|NCT01502228|20483106|P1|STARTED|Overall Study||14
8308081|NCT01502033|20483111|P1|NOT COMPLETED|Overall Study||3
8308082|NCT01502033|20483111|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
8308083|NCT01502033|20483111|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
8308098|NCT01501929|20483162|P2|NOT COMPLETED|Second Intervention||0
8308099|NCT01501929|20483163|P1|NOT COMPLETED|Second Intervention||0
8308100|NCT01501929|20483162|P2|COMPLETED|Second Intervention||17
8308101|NCT01501929|20483163|P1|COMPLETED|Second Intervention||8
8308102|NCT01501929|20483162|P2|STARTED|Second Intervention||17
8308103|NCT01501929|20483163|P1|STARTED|Second Intervention||8
8308104|NCT01501929|20483162|P2|NOT COMPLETED|First Intervention||0
8308105|NCT01501929|20483163|P1|NOT COMPLETED|First Intervention||0
8308106|NCT01501929|20483162|P2|COMPLETED|First Intervention||17
8308107|NCT01501929|20483163|P1|COMPLETED|First Intervention||8
8308108|NCT01501929|20483162|P2|STARTED|First Intervention||17
8308109|NCT01501929|20483163|P1|STARTED|First Intervention||8
8308110|NCT01501162|20483173|P2|NOT COMPLETED|Overall Study||5
8308111|NCT01501162|20483174|P1|NOT COMPLETED|Overall Study||8
8308112|NCT01501162|20483173|P2|COMPLETED|Overall Study||60
8308113|NCT01501162|20483174|P1|COMPLETED|Overall Study||57
8308114|NCT01501162|20483173|P2|STARTED|Overall Study||65
8308115|NCT01501162|20483174|P1|STARTED|Overall Study||65
8308116|NCT01501110|20483184|P2|NOT COMPLETED|Overall Study||1
8308117|NCT01501110|20483185|P1|NOT COMPLETED|Overall Study||0
8308118|NCT01501110|20483184|P2|COMPLETED|Overall Study||33
8308119|NCT01501110|20483185|P1|COMPLETED|Overall Study||34
8308120|NCT01501110|20483184|P2|STARTED|Overall Study||34
8308121|NCT01501110|20483185|P1|STARTED|Overall Study||34
8308122|NCT01500772|20483191|P1|NOT COMPLETED|Overall Study||6
8308123|NCT01500772|20483191|P1|COMPLETED|Overall Study||0
8308124|NCT01500772|20483191|P1|STARTED|Overall Study||6
8308125|NCT01500759|20483200|P2|NOT COMPLETED|Overall Study||0
8308126|NCT01500759|20483201|P1|NOT COMPLETED|Overall Study||0
8308127|NCT01500759|20483200|P2|COMPLETED|Overall Study||3190
8308128|NCT01500759|20483201|P1|COMPLETED|Overall Study||3686
8308129|NCT01500759|20483200|P2|STARTED|Overall Study||3190
8308130|NCT01500759|20483201|P1|STARTED|Overall Study||3686
8308131|NCT01500746|20483252|P2|NOT COMPLETED|Overall Study||0
8308132|NCT01500746|20483253|P1|NOT COMPLETED|Overall Study||0
8308133|NCT01500746|20483252|P2|COMPLETED|Overall Study||4
8308134|NCT01500746|20483253|P1|COMPLETED|Overall Study||4
8308135|NCT01500746|20483252|P2|STARTED|Overall Study||4
8308136|NCT01500746|20483253|P1|STARTED|Overall Study||4
8308137|NCT01500733|20483261|P2|NOT COMPLETED|Overall Study||3
8308138|NCT01500733|20483262|P1|NOT COMPLETED|Overall Study||2
8308139|NCT01500733|20483261|P2|COMPLETED|Overall Study||48
8308140|NCT01500733|20483262|P1|COMPLETED|Overall Study||33
8308141|NCT01500733|20483261|P2|STARTED|Overall Study||51
8308142|NCT01500733|20483262|P1|STARTED|Overall Study||35
8308143|NCT01500720|20483270|P2|NOT COMPLETED|Overall Study||9
8308144|NCT01500720|20483271|P1|NOT COMPLETED|Overall Study||5
8308145|NCT01500720|20483270|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
8308146|NCT01500720|20483271|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
8308147|NCT01500720|20483270|P2|Treated|Overall Study||88
8308148|NCT01500720|20483271|P1|Treated|Overall Study||89
8308149|NCT01500720|20483270|P2|STARTED|Overall Study|Randomized|89
8308150|NCT01500720|20483271|P1|STARTED|Overall Study|Randomized|90
8308151|NCT01500694|20483285|P2|NOT COMPLETED|Overall Study||29
8308152|NCT01500694|20483286|P1|NOT COMPLETED|Overall Study||52
8308153|NCT01500694|20483285|P2|COMPLETED|Overall Study||54
8308154|NCT01500694|20483286|P1|COMPLETED|Overall Study||79
8308155|NCT01500694|20483285|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
8308156|NCT01500694|20483286|P1|STARTED|Overall Study||131
8308157|NCT01500629|20483312|P2|NOT COMPLETED|Period 2 (Single Dose)||0
8308158|NCT01500629|20483313|P1|NOT COMPLETED|Period 2 (Single Dose)||0
8308159|NCT01500629|20483312|P2|COMPLETED|Period 2 (Single Dose)||10
8308160|NCT01500629|20483313|P1|COMPLETED|Period 2 (Single Dose)||10
8308161|NCT01500629|20483312|P2|STARTED|Period 2 (Single Dose)||10
8308162|NCT01500629|20483313|P1|STARTED|Period 2 (Single Dose)||10
8308163|NCT01500629|20483312|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
8308164|NCT01500629|20483313|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
8308165|NCT01500629|20483312|P2|COMPLETED|Washout Period of 14 to 30 Days||10
8308166|NCT01500629|20483313|P1|COMPLETED|Washout Period of 14 to 30 Days||10
8308167|NCT01500629|20483312|P2|STARTED|Washout Period of 14 to 30 Days||10
8308168|NCT01500629|20483313|P1|STARTED|Washout Period of 14 to 30 Days||11
8308169|NCT01500629|20483312|P2|NOT COMPLETED|Period 1 (Single Dose)||0
8308170|NCT01500629|20483313|P1|NOT COMPLETED|Period 1 (Single Dose)||0
8308171|NCT01500629|20483312|P2|COMPLETED|Period 1 (Single Dose)||10
8308172|NCT01500629|20483313|P1|COMPLETED|Period 1 (Single Dose)||11
8308173|NCT01500629|20483312|P2|STARTED|Period 1 (Single Dose)||10
8308174|NCT01500629|20483313|P1|STARTED|Period 1 (Single Dose)||11
8308175|NCT01500434|20483397|P1|NOT COMPLETED|Overall Study||7
8308176|NCT01500434|20483397|P1|COMPLETED|Overall Study||95
8308177|NCT01500434|20483397|P1|STARTED|Overall Study||102
8308178|NCT01500382|20483430|P4|NOT COMPLETED|Treatment Period 2||0
8308179|NCT01500382|20483431|P3|NOT COMPLETED|Treatment Period 2||0
8308180|NCT01500382|20483432|P2|NOT COMPLETED|Treatment Period 2||0
8308181|NCT01500382|20483433|P1|NOT COMPLETED|Treatment Period 2||0
8308182|NCT01500382|20483430|P4|COMPLETED|Treatment Period 2||1
8308183|NCT01500382|20483431|P3|COMPLETED|Treatment Period 2||0
8308184|NCT01500382|20483432|P2|COMPLETED|Treatment Period 2||1
8308185|NCT01500382|20483433|P1|COMPLETED|Treatment Period 2||1
8308186|NCT01500382|20483430|P4|STARTED|Treatment Period 2||1
8308187|NCT01500382|20483431|P3|STARTED|Treatment Period 2||0
8308188|NCT01500382|20483432|P2|STARTED|Treatment Period 2||1
8308189|NCT01500382|20483433|P1|STARTED|Treatment Period 2||1
8308190|NCT01500382|20483430|P4|NOT COMPLETED|Washout Period||0
8308191|NCT01500382|20483431|P3|NOT COMPLETED|Washout Period||1
8308192|NCT01500382|20483432|P2|NOT COMPLETED|Washout Period||0
8308193|NCT01500382|20483433|P1|NOT COMPLETED|Washout Period||0
8308194|NCT01500382|20483430|P4|COMPLETED|Washout Period||1
8308195|NCT01500382|20483431|P3|COMPLETED|Washout Period||0
8308196|NCT01500382|20483432|P2|COMPLETED|Washout Period||1
8308197|NCT01500382|20483433|P1|COMPLETED|Washout Period||1
8308198|NCT01500382|20483430|P4|STARTED|Washout Period||1
8308199|NCT01500382|20483431|P3|STARTED|Washout Period||1
8308200|NCT01500382|20483432|P2|STARTED|Washout Period||1
8308201|NCT01500382|20483433|P1|STARTED|Washout Period||1
8308202|NCT01500382|20483430|P4|NOT COMPLETED|Treatment Period 1||0
8308203|NCT01500382|20483431|P3|NOT COMPLETED|Treatment Period 1||0
8308204|NCT01500382|20483432|P2|NOT COMPLETED|Treatment Period 1||0
8308205|NCT01500382|20483433|P1|NOT COMPLETED|Treatment Period 1||0
8308206|NCT01500382|20483430|P4|COMPLETED|Treatment Period 1||1
8308207|NCT01500382|20483431|P3|COMPLETED|Treatment Period 1||1
8308208|NCT01500382|20483432|P2|COMPLETED|Treatment Period 1||1
8308209|NCT01500382|20483433|P1|COMPLETED|Treatment Period 1||1
8308210|NCT01500382|20483430|P4|STARTED|Treatment Period 1||1
8308211|NCT01500382|20483431|P3|STARTED|Treatment Period 1||1
8308212|NCT01500382|20483432|P2|STARTED|Treatment Period 1||1
8308213|NCT01500382|20483433|P1|STARTED|Treatment Period 1||1
8308214|NCT01500317|20483458|P3|NOT COMPLETED|Overall Study||0
8308215|NCT01500317|20483459|P2|NOT COMPLETED|Overall Study||2
8308216|NCT01500317|20483460|P1|NOT COMPLETED|Overall Study||3
8308217|NCT01500317|20483458|P3|COMPLETED|Overall Study||13
8308218|NCT01500317|20483459|P2|COMPLETED|Overall Study||10
8308219|NCT01500317|20483460|P1|COMPLETED|Overall Study||10
8308220|NCT01500317|20483458|P3|STARTED|Overall Study||13
8308221|NCT01500317|20483459|P2|STARTED|Overall Study||12
8308222|NCT01500317|20483460|P1|STARTED|Overall Study||13
8308223|NCT01500278|20483482|P2|NOT COMPLETED|Week 13 - Week 104||126
8308224|NCT01500278|20483483|P1|NOT COMPLETED|Week 13 - Week 104||139
8308225|NCT01500278|20483482|P2|COMPLETED|Week 13 - Week 104||302
8308226|NCT01500278|20483483|P1|COMPLETED|Week 13 - Week 104||287
8308227|NCT01500278|20483482|P2|STARTED|Week 13 - Week 104||428
8308228|NCT01500278|20483483|P1|STARTED|Week 13 - Week 104||426
8308229|NCT01500278|20483482|P2|NOT COMPLETED|Week 0 - Week 12||30
8308230|NCT01500278|20483483|P1|NOT COMPLETED|Week 0 - Week 12||31
8308231|NCT01500278|20483482|P2|COMPLETED|Week 0 - Week 12||428
8308232|NCT01500278|20483483|P1|COMPLETED|Week 0 - Week 12||426
8308233|NCT01500278|20483482|P2|STARTED|Week 0 - Week 12||458
8308234|NCT01500278|20483483|P1|STARTED|Week 0 - Week 12||457
8308235|NCT01500252|20483507|P2|NOT COMPLETED|Overall Study||6
8308236|NCT01500252|20483508|P1|NOT COMPLETED|Overall Study||9
8308237|NCT01500252|20483507|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
8308238|NCT01500252|20483508|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
8308239|NCT01500252|20483507|P2|Ten Years|Overall Study||11
8308240|NCT01500252|20483508|P1|Ten Years|Overall Study||12
8308241|NCT01500252|20483507|P2|Five Years|Overall Study||13
8308242|NCT01500252|20483508|P1|Five Years|Overall Study||17
8308243|NCT01500252|20483507|P2|One Years|Overall Study||16
8308244|NCT01500252|20483508|P1|One Years|Overall Study||20
8308245|NCT01500252|20483507|P2|STARTED|Overall Study||17
8308246|NCT01500252|20483508|P1|STARTED|Overall Study||21
8308247|NCT01500226|20483534|P2|NOT COMPLETED|Overall Study||494
8308248|NCT01500226|20483535|P1|NOT COMPLETED|Overall Study||499
8308249|NCT01500226|20483534|P2|COMPLETED|Overall Study||191
8308250|NCT01500226|20483535|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
8308251|NCT01500226|20483534|P2|STARTED|Overall Study||685
8308252|NCT01500226|20483535|P1|STARTED|Overall Study|Number of randomized patients|684
8308253|NCT01500213|20483547|P2|NOT COMPLETED|Overall Study||224
8308254|NCT01500213|20483548|P1|NOT COMPLETED|Overall Study||217
8308255|NCT01500213|20483547|P2|COMPLETED|Overall Study||53
8308256|NCT01500213|20483548|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
8308257|NCT01500213|20483547|P2|STARTED|Overall Study||277
8308258|NCT01500213|20483548|P1|STARTED|Overall Study|Number of randomized patients|278
8308259|NCT01500200|20483561|P6|NOT COMPLETED|Stage 2||4
8308260|NCT01500200|20483562|P5|NOT COMPLETED|Stage 2||5
8308261|NCT01500200|20483563|P4|NOT COMPLETED|Stage 2||0
8308262|NCT01500200|20483564|P3|NOT COMPLETED|Stage 2||0
8308263|NCT01500200|20483565|P2|NOT COMPLETED|Stage 2||0
8308264|NCT01500200|20483566|P1|NOT COMPLETED|Stage 2||0
8308265|NCT01500200|20483561|P6|COMPLETED|Stage 2||18
8308266|NCT01500200|20483562|P5|COMPLETED|Stage 2||18
8308267|NCT01500200|20483563|P4|COMPLETED|Stage 2||20
8308268|NCT01500200|20483564|P3|COMPLETED|Stage 2||0
8308269|NCT01500200|20483565|P2|COMPLETED|Stage 2||0
8308270|NCT01500200|20483566|P1|COMPLETED|Stage 2||0
8308271|NCT01500200|20483561|P6|STARTED|Stage 2||22
8308272|NCT01500200|20483562|P5|STARTED|Stage 2||23
8308273|NCT01500200|20483563|P4|STARTED|Stage 2||20
8308274|NCT01500200|20483564|P3|STARTED|Stage 2||0
8308275|NCT01500200|20483565|P2|STARTED|Stage 2||0
8308276|NCT01500200|20483566|P1|STARTED|Stage 2||0
8308277|NCT01500200|20483561|P6|NOT COMPLETED|Stage 1||0
8308278|NCT01500200|20483562|P5|NOT COMPLETED|Stage 1||0
8308279|NCT01500200|20483563|P4|NOT COMPLETED|Stage 1||0
8308280|NCT01500200|20483564|P3|NOT COMPLETED|Stage 1||6
8308281|NCT01500200|20483565|P2|NOT COMPLETED|Stage 1||6
8308282|NCT01500200|20483566|P1|NOT COMPLETED|Stage 1||8
8308283|NCT01500200|20483561|P6|COMPLETED|Stage 1||0
8308284|NCT01500200|20483562|P5|COMPLETED|Stage 1||0
8308285|NCT01500200|20483563|P4|COMPLETED|Stage 1||0
8308286|NCT01500200|20483564|P3|COMPLETED|Stage 1||13
8308287|NCT01500200|20483565|P2|COMPLETED|Stage 1||18
8308288|NCT01500200|20483566|P1|COMPLETED|Stage 1||90
8308289|NCT01500200|20483561|P6|STARTED|Stage 1||0
8308290|NCT01500200|20483562|P5|STARTED|Stage 1||0
8308291|NCT01500200|20483563|P4|STARTED|Stage 1||0
8308292|NCT01500200|20483564|P3|STARTED|Stage 1||19
8308293|NCT01500200|20483565|P2|STARTED|Stage 1||24
8308294|NCT01500200|20483566|P1|STARTED|Stage 1||98
8308295|NCT01500187|20483600|P2|NOT COMPLETED|Overall Study||0
8308296|NCT01500187|20483601|P1|NOT COMPLETED|Overall Study||6
8308297|NCT01500187|20483600|P2|COMPLETED|Overall Study||15
8308298|NCT01500187|20483601|P1|COMPLETED|Overall Study||17
8308299|NCT01500187|20483600|P2|STARTED|Overall Study||15
8308300|NCT01500187|20483601|P1|STARTED|Overall Study||23
8308301|NCT01500135|20483609|P2|NOT COMPLETED|Overall Study||11
8308302|NCT01500135|20483610|P1|NOT COMPLETED|Overall Study||17
8308303|NCT01500135|20483609|P2|COMPLETED|Overall Study||39
8308304|NCT01500135|20483610|P1|COMPLETED|Overall Study||83
8308305|NCT01500135|20483609|P2|STARTED|Overall Study||50
8308306|NCT01500135|20483610|P1|STARTED|Overall Study||100
8308307|NCT01500109|20483623|P3|NOT COMPLETED|Overall Study||0
8308308|NCT01500109|20483624|P2|NOT COMPLETED|Overall Study||0
8308309|NCT01500109|20483625|P1|NOT COMPLETED|Overall Study||0
8308310|NCT01500109|20483623|P3|COMPLETED|Overall Study||16
8308311|NCT01500109|20483624|P2|COMPLETED|Overall Study||14
8308312|NCT01500109|20483625|P1|COMPLETED|Overall Study||15
8308313|NCT01500109|20483623|P3|STARTED|Overall Study||16
8308314|NCT01500109|20483624|P2|STARTED|Overall Study||14
8308315|NCT01500109|20483625|P1|STARTED|Overall Study||15
8308316|NCT01500096|20483637|P4|NOT COMPLETED|Overall Study||2
8308317|NCT01500096|20483638|P3|NOT COMPLETED|Overall Study||0
8308318|NCT01500096|20483639|P2|NOT COMPLETED|Overall Study||0
8308319|NCT01500096|20483640|P1|NOT COMPLETED|Overall Study||1
8308320|NCT01500096|20483637|P4|COMPLETED|Overall Study||14
8308321|NCT01500096|20483638|P3|COMPLETED|Overall Study||31
8308322|NCT01500096|20483639|P2|COMPLETED|Overall Study||17
8308323|NCT01500096|20483640|P1|COMPLETED|Overall Study||31
8308324|NCT01500096|20483637|P4|STARTED|Overall Study||16
8308325|NCT01500096|20483638|P3|STARTED|Overall Study||31
8308326|NCT01500096|20483639|P2|STARTED|Overall Study||17
8308327|NCT01500096|20483640|P1|STARTED|Overall Study||32
8308328|NCT01500083|20483696|P2|NOT COMPLETED|Overall Study||43
8308329|NCT01500083|20483697|P1|NOT COMPLETED|Overall Study||12
8308330|NCT01500083|20483696|P2|COMPLETED|Overall Study||31
8308331|NCT01500083|20483697|P1|COMPLETED|Overall Study||4
8308332|NCT01500083|20483696|P2|STARTED|Overall Study||74
8308333|NCT01500083|20483697|P1|STARTED|Overall Study||16
8308334|NCT01500057|20483705|P2|NOT COMPLETED|Overall Study||4
8308335|NCT01500057|20483706|P1|NOT COMPLETED|Overall Study||6
8308336|NCT01500057|20483705|P2|COMPLETED|Overall Study||31
8308337|NCT01500057|20483706|P1|COMPLETED|Overall Study||25
8308338|NCT01500057|20483705|P2|STARTED|Overall Study||35
8308339|NCT01500057|20483706|P1|STARTED|Overall Study||31
8308340|NCT01500031|20483716|P1|NOT COMPLETED|Overall Study||5
8308341|NCT01500031|20483716|P1|COMPLETED|Overall Study||87
8308342|NCT01500031|20483716|P1|STARTED|Overall Study||92
8308343|NCT01499862|20483731|P1|NOT COMPLETED|Overall Study||0
8308344|NCT01499862|20483731|P1|COMPLETED|Overall Study||3
8308345|NCT01499862|20483731|P1|STARTED|Overall Study||3
8308346|NCT01499849|20483751|P2|NOT COMPLETED|Overall Study||226
8308347|NCT01499849|20483752|P1|NOT COMPLETED|Overall Study||224
8308348|NCT01499849|20483751|P2|COMPLETED|Overall Study||40
8308349|NCT01499849|20483752|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
8308350|NCT01499849|20483751|P2|STARTED|Overall Study||266
8308351|NCT01499849|20483752|P1|STARTED|Overall Study|Number of randomized patients|266
8308352|NCT01499810|20483762|P1|NOT COMPLETED|Overall Study||12
8308353|NCT01499810|20483762|P1|COMPLETED|Overall Study||41
8308354|NCT01499810|20483762|P1|STARTED|Overall Study||53
8308355|NCT01499667|20483812|P3|NOT COMPLETED|Overall Study||10
8308356|NCT01499667|20483813|P2|NOT COMPLETED|Overall Study||11
8308357|NCT01499667|20483814|P1|NOT COMPLETED|Overall Study||9
8308358|NCT01499667|20483812|P3|COMPLETED|Overall Study||40
8308359|NCT01499667|20483813|P2|COMPLETED|Overall Study||31
8308360|NCT01499667|20483814|P1|COMPLETED|Overall Study||41
8308361|NCT01499667|20483812|P3|Modified Full Analysis Set|Overall Study||39
8308362|NCT01499667|20483813|P2|Modified Full Analysis Set|Overall Study||29
8308363|NCT01499667|20483814|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
8308364|NCT01499667|20483812|P3|Full Analysis Set (FAS)|Overall Study||50
8308365|NCT01499667|20483813|P2|Full Analysis Set (FAS)|Overall Study||42
8308366|NCT01499667|20483814|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
8308367|NCT01499667|20483812|P3|STARTED|Overall Study||50
8308368|NCT01499667|20483813|P2|STARTED|Overall Study||42
8308369|NCT01499667|20483814|P1|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
8308370|NCT01499654|20483843|P1|NOT COMPLETED|Overall Study||0
8308371|NCT01499654|20483843|P1|COMPLETED|Overall Study||64
8308372|NCT01499654|20483843|P1|STARTED|Overall Study||64
8308373|NCT01499576|20483862|P1|NOT COMPLETED|Overall Study||21
8308374|NCT01499576|20483862|P1|COMPLETED|Overall Study||105
8308375|NCT01499576|20483862|P1|STARTED|Overall Study||126
8308376|NCT01499511|20483870|P2|NOT COMPLETED|Overall Study||0
8308377|NCT01499511|20483871|P1|NOT COMPLETED|Overall Study||1
8308378|NCT01499511|20483870|P2|COMPLETED|Overall Study||833
8308379|NCT01499511|20483871|P1|COMPLETED|Overall Study||884
8308380|NCT01499511|20483870|P2|STARTED|Overall Study||833
8308381|NCT01499511|20483871|P1|STARTED|Overall Study||885
8308382|NCT01499498|20483888|P1|NOT COMPLETED|Overall Study||0
8308383|NCT01499498|20483888|P1|COMPLETED|Overall Study||13
8308384|NCT01499498|20483888|P1|STARTED|Overall Study||13
8308385|NCT01499368|20483899|P3|NOT COMPLETED|Overall Study||21
8308386|NCT01499368|20483900|P2|NOT COMPLETED|Overall Study||18
8308387|NCT01499368|20483901|P1|NOT COMPLETED|Overall Study||27
8308388|NCT01499368|20483899|P3|COMPLETED|Overall Study||146
8308389|NCT01499368|20483900|P2|COMPLETED|Overall Study||145
8308390|NCT01499368|20483901|P1|COMPLETED|Overall Study||138
8308391|NCT01499368|20483899|P3|STARTED|Overall Study||167
8308392|NCT01499368|20483900|P2|STARTED|Overall Study||163
8308393|NCT01499368|20483901|P1|STARTED|Overall Study||165
8308394|NCT01499355|20483918|P4|NOT COMPLETED|Double-Blind Period||23
8308395|NCT01499355|20483919|P3|NOT COMPLETED|Double-Blind Period||25
8308396|NCT01499355|20483920|P2|NOT COMPLETED|Double-Blind Period||23
8308397|NCT01499355|20483921|P1|NOT COMPLETED|Double-Blind Period||0
8308398|NCT01499355|20483918|P4|COMPLETED|Double-Blind Period||39
8308399|NCT01499355|20483919|P3|COMPLETED|Double-Blind Period||38
8308400|NCT01499355|20483920|P2|COMPLETED|Double-Blind Period||40
8308401|NCT01499355|20483921|P1|COMPLETED|Double-Blind Period||0
8308402|NCT01499355|20483918|P4|STARTED|Double-Blind Period||62
8308403|NCT01499355|20483919|P3|STARTED|Double-Blind Period||63
8308404|NCT01499355|20483920|P2|STARTED|Double-Blind Period||63
8308405|NCT01499355|20483921|P1|STARTED|Double-Blind Period||0
8308406|NCT01499355|20483918|P4|NOT COMPLETED|Run-In Period||0
8308407|NCT01499355|20483919|P3|NOT COMPLETED|Run-In Period||0
8308408|NCT01499355|20483920|P2|NOT COMPLETED|Run-In Period||0
8308409|NCT01499355|20483921|P1|NOT COMPLETED|Run-In Period||31
8308410|NCT01499355|20483918|P4|COMPLETED|Run-In Period||0
8308411|NCT01499355|20483919|P3|COMPLETED|Run-In Period||0
8308412|NCT01499355|20483920|P2|COMPLETED|Run-In Period||0
8308413|NCT01499355|20483921|P1|COMPLETED|Run-In Period||245
8308414|NCT01499355|20483918|P4|STARTED|Run-In Period||0
8308415|NCT01499355|20483919|P3|STARTED|Run-In Period||0
8308416|NCT01499355|20483920|P2|STARTED|Run-In Period||0
8308417|NCT01499355|20483921|P1|STARTED|Run-In Period||276
8308418|NCT01499303|20483954|P2|NOT COMPLETED|Overall Study||7
8308419|NCT01499303|20483955|P1|NOT COMPLETED|Overall Study||3
8308420|NCT01499303|20483954|P2|COMPLETED|Overall Study||40
8308421|NCT01499303|20483955|P1|COMPLETED|Overall Study||18
8308422|NCT01499303|20483954|P2|STARTED|Overall Study||47
8308423|NCT01499303|20483955|P1|STARTED|Overall Study||21
8308424|NCT01499290|20483963|P2|NOT COMPLETED|Overall Study||35
8308425|NCT01499290|20483964|P1|NOT COMPLETED|Overall Study||55
8308426|NCT01499290|20483963|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
8308427|NCT01499290|20483964|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
8308428|NCT01499290|20483963|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
8308429|NCT01499290|20483964|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
8308430|NCT01499277|20484014|P2|NOT COMPLETED|Overall Study||32
8308431|NCT01499277|20484015|P1|NOT COMPLETED|Overall Study||47
8308432|NCT01499277|20484014|P2|COMPLETED|Overall Study||223
8308433|NCT01499277|20484015|P1|COMPLETED|Overall Study||459
8308434|NCT01499277|20484014|P2|STARTED|Overall Study||255
8308435|NCT01499277|20484015|P1|STARTED|Overall Study||506
8308436|NCT01499199|20484037|P1|NOT COMPLETED|Overall Study||2
8308437|NCT01499199|20484037|P1|COMPLETED|Overall Study||11
8308438|NCT01499199|20484037|P1|STARTED|Overall Study||13
8308439|NCT01499173|20484056|P1|NOT COMPLETED|Overall Study||37
8308440|NCT01499173|20484056|P1|COMPLETED|Overall Study||64
8308441|NCT01499173|20484056|P1|STARTED|Overall Study||101
8308442|NCT01499160|20484066|P1|NOT COMPLETED|Overall Study||2
8308443|NCT01499160|20484066|P1|COMPLETED|Overall Study|"1 pt-withdrew consent
~1pt-had cardiac toxicity"|5
8308444|NCT01499160|20484066|P1|STARTED|Overall Study||7
8308445|NCT01499147|20484073|P2|NOT COMPLETED|Overall Study||5
8308446|NCT01499147|20484074|P1|NOT COMPLETED|Overall Study||15
8308447|NCT01499147|20484073|P2|COMPLETED|Overall Study||12
8308448|NCT01499147|20484074|P1|COMPLETED|Overall Study||18
8308449|NCT01499147|20484073|P2|STARTED|Overall Study||17
8308450|NCT01499147|20484074|P1|STARTED|Overall Study||33
8308451|NCT01499134|20484089|P2|NOT COMPLETED|Overall Study||1
8308452|NCT01499134|20484090|P1|NOT COMPLETED|Overall Study||0
8308453|NCT01499134|20484089|P2|COMPLETED|Overall Study||7
8308454|NCT01499134|20484090|P1|COMPLETED|Overall Study||9
8308455|NCT01499134|20484089|P2|STARTED|Overall Study||8
8308456|NCT01499134|20484090|P1|STARTED|Overall Study||9
8308457|NCT01499095|20484112|P2|NOT COMPLETED|Overall Study||93
8308458|NCT01499095|20484113|P1|NOT COMPLETED|Overall Study||89
8308459|NCT01499095|20484112|P2|COMPLETED|Overall Study||314
8308460|NCT01499095|20484113|P1|COMPLETED|Overall Study||315
8308461|NCT01499095|20484112|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
8308462|NCT01499095|20484113|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
8308463|NCT01499095|20484112|P2|Participated in Substudy|Overall Study||0
8308464|NCT01499095|20484113|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
8308465|NCT01499095|20484112|P2|Treated|Overall Study||406
8308466|NCT01499095|20484113|P1|Treated|Overall Study||403
8308467|NCT01499095|20484112|P2|STARTED|Overall Study||407
8308468|NCT01499095|20484113|P1|STARTED|Overall Study||404
8308469|NCT01499082|20484143|P2|NOT COMPLETED|Overall Study||48
8308470|NCT01499082|20484144|P1|NOT COMPLETED|Overall Study||45
8308471|NCT01499082|20484143|P2|COMPLETED|Overall Study||355
8308472|NCT01499082|20484144|P1|COMPLETED|Overall Study||359
8308473|NCT01499082|20484143|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
8308474|NCT01499082|20484144|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
8308475|NCT01499082|20484143|P2|Participated in Substudy|Overall Study||0
8308476|NCT01499082|20484144|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
8308477|NCT01499082|20484143|P2|Treated|Overall Study||402
8308478|NCT01499082|20484144|P1|Treated|Overall Study||404
8308479|NCT01499082|20484143|P2|STARTED|Overall Study||403
8308480|NCT01499082|20484144|P1|STARTED|Overall Study||404
8308481|NCT01499043|20484172|P1|NOT COMPLETED|Overall Study||6
8308482|NCT01499043|20484172|P1|COMPLETED|Overall Study||0
8308483|NCT01499043|20484172|P1|STARTED|Overall Study||6
8308484|NCT01498991|20484182|P1|NOT COMPLETED|Overall Study||0
8308485|NCT01498991|20484182|P1|COMPLETED|Overall Study||2
8308486|NCT01498991|20484182|P1|STARTED|Overall Study||2
8308487|NCT01498978|20484193|P1|NOT COMPLETED|Overall Study||2
8308488|NCT01498978|20484193|P1|COMPLETED|Overall Study||8
8308489|NCT01498978|20484193|P1|STARTED|Overall Study||10
8308490|NCT01498952|20484215|P5|NOT COMPLETED|Overall Study||0
8308491|NCT01498952|20484216|P4|NOT COMPLETED|Overall Study||0
8308492|NCT01498952|20484217|P3|NOT COMPLETED|Overall Study||0
8308493|NCT01498952|20484218|P2|NOT COMPLETED|Overall Study||2
8308494|NCT01498952|20484219|P1|NOT COMPLETED|Overall Study||2
8308495|NCT01498952|20484215|P5|COMPLETED|Overall Study||0
8308496|NCT01498952|20484216|P4|COMPLETED|Overall Study||0
8308497|NCT01498952|20484217|P3|COMPLETED|Overall Study||0
8308498|NCT01498952|20484218|P2|COMPLETED|Overall Study||1
8308499|NCT01498952|20484219|P1|COMPLETED|Overall Study||1
8308500|NCT01498952|20484215|P5|STARTED|Overall Study||0
8308501|NCT01498952|20484216|P4|STARTED|Overall Study||0
8308502|NCT01498952|20484217|P3|STARTED|Overall Study||0
8308503|NCT01498952|20484218|P2|STARTED|Overall Study||3
8308504|NCT01498952|20484219|P1|STARTED|Overall Study||3
8308505|NCT01498887|20484261|P2|NOT COMPLETED|Overall Study||11
8308506|NCT01498887|20484262|P1|NOT COMPLETED|Overall Study||16
8308507|NCT01498887|20484261|P2|COMPLETED|Overall Study||136
8308508|NCT01498887|20484262|P1|COMPLETED|Overall Study||184
8308509|NCT01498887|20484261|P2|Intent-to-treat|Overall Study||135
8308510|NCT01498887|20484262|P1|Intent-to-treat|Overall Study||185
8308511|NCT01498887|20484261|P2|Safety Set|Overall Study||147
8308512|NCT01498887|20484262|P1|Safety Set|Overall Study||200
8308513|NCT01498887|20484261|P2|STARTED|Overall Study||147
8308514|NCT01498887|20484262|P1|STARTED|Overall Study||200
8308515|NCT01498822|20484283|P2|NOT COMPLETED|Overall Study||56
8308516|NCT01498822|20484284|P1|NOT COMPLETED|Overall Study||54
8308517|NCT01498822|20484283|P2|COMPLETED|Overall Study||122
8308518|NCT01498822|20484284|P1|COMPLETED|Overall Study||121
8308519|NCT01498822|20484283|P2|STARTED|Overall Study||178
8308520|NCT01498822|20484284|P1|STARTED|Overall Study||175
8308521|NCT01498744|20484298|P2|NOT COMPLETED|Overall Study||0
8308522|NCT01498744|20484299|P1|NOT COMPLETED|Overall Study||0
8308523|NCT01498744|20484298|P2|COMPLETED|Overall Study||31
8308524|NCT01498744|20484299|P1|COMPLETED|Overall Study||22
8308525|NCT01498744|20484298|P2|STARTED|Overall Study||31
8308526|NCT01498744|20484299|P1|STARTED|Overall Study||22
8308527|NCT01498692|20484311|P1|NOT COMPLETED|Overall Study||8
8308528|NCT01498692|20484311|P1|COMPLETED|Overall Study||86
8308529|NCT01498692|20484311|P1|STARTED|Overall Study||94
8308530|NCT01498679|20484342|P2|NOT COMPLETED|Overall Study||22
8308531|NCT01498679|20484343|P1|NOT COMPLETED|Overall Study||89
8308532|NCT01498679|20484342|P2|COMPLETED|Overall Study||131
8308533|NCT01498679|20484343|P1|COMPLETED|Overall Study||65
8308534|NCT01498679|20484342|P2|STARTED|Overall Study||153
8308535|NCT01498679|20484343|P1|STARTED|Overall Study||154
8308536|NCT01498653|20484359|P2|NOT COMPLETED|Overall Study||35
8308537|NCT01498653|20484360|P1|NOT COMPLETED|Overall Study||19
8308538|NCT01498653|20484359|P2|COMPLETED|Overall Study||119
8308539|NCT01498653|20484360|P1|COMPLETED|Overall Study||136
8308540|NCT01498653|20484359|P2|STARTED|Overall Study||154
8308541|NCT01498653|20484360|P1|STARTED|Overall Study||155
8308542|NCT01498640|20484374|P1|NOT COMPLETED|Overall Study||5
8308543|NCT01498640|20484374|P1|COMPLETED|Overall Study||47
8308544|NCT01498640|20484374|P1|STARTED|Overall Study||52
8308545|NCT01498601|20484390|P2|NOT COMPLETED|Overall Study||0
8308546|NCT01498601|20484391|P1|NOT COMPLETED|Overall Study||0
8308547|NCT01498601|20484390|P2|COMPLETED|Overall Study||32
8308548|NCT01498601|20484391|P1|COMPLETED|Overall Study||51
8308549|NCT01498601|20484390|P2|STARTED|Overall Study||32
8308550|NCT01498601|20484391|P1|STARTED|Overall Study||51
8308551|NCT01498588|20484397|P1|NOT COMPLETED|Overall Study||0
8308552|NCT01498588|20484397|P1|COMPLETED|Overall Study||7
8308553|NCT01498588|20484397|P1|STARTED|Overall Study||7
8308554|NCT01498575|20484404|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
8308555|NCT01498575|20484405|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
8308556|NCT01498575|20484404|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
8308557|NCT01498575|20484405|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
8308558|NCT01498575|20484404|P2|STARTED|On the Road Driving Assessment (ODA)||89
8308559|NCT01498575|20484405|P1|STARTED|On the Road Driving Assessment (ODA)||128
8308560|NCT01498575|20484404|P2|NOT COMPLETED|Overall Sample||14
8308561|NCT01498575|20484405|P1|NOT COMPLETED|Overall Sample||60
8308562|NCT01498575|20484404|P2|COMPLETED|Overall Sample||400
8308563|NCT01498575|20484405|P1|COMPLETED|Overall Sample||550
8308564|NCT01498575|20484404|P2|STARTED|Overall Sample||414
8308565|NCT01498575|20484405|P1|STARTED|Overall Sample||610
8308566|NCT01498549|20484411|P1|NOT COMPLETED|Overall Study||4
8308567|NCT01498549|20484411|P1|COMPLETED|Overall Study||35
8308568|NCT01498549|20484411|P1|Sugar Pill 0 mg|Overall Study||36
8308569|NCT01498549|20484411|P1|Atomoxetine 80 mg|Overall Study||37
8308570|NCT01498549|20484411|P1|Atomoxetine 40 mg|Overall Study||39
8308571|NCT01498549|20484411|P1|STARTED|Overall Study||39
8308572|NCT01498458|20484422|P1|NOT COMPLETED|Overall Study||7
8308573|NCT01498458|20484422|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
8308574|NCT01498458|20484422|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
8308575|NCT01498445|20484437|P6|NOT COMPLETED|Overall Study||1
8308576|NCT01498445|20484438|P5|NOT COMPLETED|Overall Study||1
8308577|NCT01498445|20484439|P4|NOT COMPLETED|Overall Study||2
8308578|NCT01498445|20484440|P3|NOT COMPLETED|Overall Study||1
8308579|NCT01498445|20484441|P2|NOT COMPLETED|Overall Study||0
8308580|NCT01498445|20484442|P1|NOT COMPLETED|Overall Study||0
8308581|NCT01498445|20484437|P6|COMPLETED|Overall Study||4
8308582|NCT01498445|20484438|P5|COMPLETED|Overall Study||3
8308583|NCT01498445|20484439|P4|COMPLETED|Overall Study||6
8308584|NCT01498445|20484440|P3|COMPLETED|Overall Study||7
8308585|NCT01498445|20484441|P2|COMPLETED|Overall Study||3
8308586|NCT01498445|20484442|P1|COMPLETED|Overall Study||4
8308587|NCT01498445|20484437|P6|STARTED|Overall Study||5
8308588|NCT01498445|20484438|P5|STARTED|Overall Study||4
8308589|NCT01498445|20484439|P4|STARTED|Overall Study||8
8308590|NCT01498445|20484440|P3|STARTED|Overall Study||8
8308591|NCT01498445|20484441|P2|STARTED|Overall Study||3
8308592|NCT01498445|20484442|P1|STARTED|Overall Study||4
8308593|NCT01498419|20484478|P4|NOT COMPLETED|Overall Study||19
8308594|NCT01498419|20484479|P3|NOT COMPLETED|Overall Study||18
8308595|NCT01498419|20484480|P2|NOT COMPLETED|Overall Study||23
8308596|NCT01498419|20484481|P1|NOT COMPLETED|Overall Study||18
8308597|NCT01498419|20484478|P4|COMPLETED|Overall Study||7
8308598|NCT01498419|20484479|P3|COMPLETED|Overall Study||41
8308599|NCT01498419|20484480|P2|COMPLETED|Overall Study||39
8308600|NCT01498419|20484481|P1|COMPLETED|Overall Study||42
8308601|NCT01498419|20484478|P4|STARTED|Overall Study||26
8308602|NCT01498419|20484479|P3|STARTED|Overall Study||59
8308603|NCT01498419|20484480|P2|STARTED|Overall Study||62
8308604|NCT01498419|20484481|P1|STARTED|Overall Study||60
8308605|NCT01498289|20484517|P2|NOT COMPLETED|Overall Study||104
8308606|NCT01498289|20484518|P1|NOT COMPLETED|Overall Study||98
8308607|NCT01498289|20484517|P2|COMPLETED|Overall Study||0
8308608|NCT01498289|20484518|P1|COMPLETED|Overall Study||0
8308609|NCT01498289|20484517|P2|Participants Assessed for AEs|Overall Study||98
8308610|NCT01498289|20484518|P1|Participants Assessed for AEs|Overall Study||91
8308611|NCT01498289|20484517|P2|STARTED|Overall Study||104
8308612|NCT01498289|20484518|P1|STARTED|Overall Study||98
8308613|NCT01498185|20484539|P5|NOT COMPLETED|Overall Study||3
8308614|NCT01498185|20484540|P4|NOT COMPLETED|Overall Study||3
8308615|NCT01498185|20484541|P3|NOT COMPLETED|Overall Study||0
8308616|NCT01498185|20484542|P2|NOT COMPLETED|Overall Study||1
8308617|NCT01498185|20484543|P1|NOT COMPLETED|Overall Study||1
8308618|NCT01498185|20484539|P5|COMPLETED|Overall Study||12
8308619|NCT01498185|20484540|P4|COMPLETED|Overall Study||11
8308620|NCT01498185|20484541|P3|COMPLETED|Overall Study||15
8308621|NCT01498185|20484542|P2|COMPLETED|Overall Study||12
8308622|NCT01498185|20484543|P1|COMPLETED|Overall Study||12
8308623|NCT01498185|20484539|P5|STARTED|Overall Study||15
8308624|NCT01498185|20484540|P4|STARTED|Overall Study||14
8308625|NCT01498185|20484541|P3|STARTED|Overall Study||15
8308626|NCT01498185|20484542|P2|STARTED|Overall Study||13
8308627|NCT01498185|20484543|P1|STARTED|Overall Study||13
8308628|NCT01498120|20484583|P1|NOT COMPLETED|Overall Study||13
8308629|NCT01498120|20484583|P1|COMPLETED|Overall Study||1
8308630|NCT01498120|20484583|P1|STARTED|Overall Study||14
8308631|NCT01498068|20484590|P2|NOT COMPLETED|Overall Study||1
8308632|NCT01498068|20484591|P1|NOT COMPLETED|Overall Study||1
8308633|NCT01498068|20484590|P2|COMPLETED|Overall Study||19
8308634|NCT01498068|20484591|P1|COMPLETED|Overall Study||15
8308635|NCT01498068|20484590|P2|STARTED|Overall Study||20
8308636|NCT01498068|20484591|P1|STARTED|Overall Study||16
8308637|NCT01497938|20484609|P2|NOT COMPLETED|Overall Study||2
8308638|NCT01497938|20484610|P1|NOT COMPLETED|Overall Study||5
8308639|NCT01497938|20484609|P2|COMPLETED|Overall Study||124
8308640|NCT01497938|20484610|P1|COMPLETED|Overall Study||116
8308641|NCT01497938|20484609|P2|STARTED|Overall Study||126
8308642|NCT01497938|20484610|P1|STARTED|Overall Study||121
8308643|NCT01497899|20484622|P4|NOT COMPLETED|Open-Label Extension Phase||5
8308644|NCT01497899|20484623|P3|NOT COMPLETED|Open-Label Extension Phase||9
8308645|NCT01497899|20484624|P2|NOT COMPLETED|Open-Label Extension Phase||7
8308646|NCT01497899|20484625|P1|NOT COMPLETED|Open-Label Extension Phase||19
8308647|NCT01497899|20484622|P4|COMPLETED|Open-Label Extension Phase||33
8308648|NCT01497899|20484623|P3|COMPLETED|Open-Label Extension Phase||61
8308649|NCT01497899|20484624|P2|COMPLETED|Open-Label Extension Phase||46
8308650|NCT01497899|20484625|P1|COMPLETED|Open-Label Extension Phase||86
8308651|NCT01497899|20484622|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
8308652|NCT01497899|20484623|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
8308653|NCT01497899|20484624|P2|STARTED|Open-Label Extension Phase||53
8308654|NCT01497899|20484625|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
8308655|NCT01497899|20484622|P4|NOT COMPLETED|Double-Blind Phase||0
8308656|NCT01497899|20484623|P3|NOT COMPLETED|Double-Blind Phase||0
8308657|NCT01497899|20484624|P2|NOT COMPLETED|Double-Blind Phase||5
8308658|NCT01497899|20484625|P1|NOT COMPLETED|Double-Blind Phase||6
8308659|NCT01497899|20484622|P4|COMPLETED|Double-Blind Phase||0
8308660|NCT01497899|20484623|P3|COMPLETED|Double-Blind Phase||0
8308661|NCT01497899|20484624|P2|COMPLETED|Double-Blind Phase||53
8308662|NCT01497899|20484625|P1|COMPLETED|Double-Blind Phase||107
8308663|NCT01497899|20484622|P4|STARTED|Double-Blind Phase||0
8308664|NCT01497899|20484623|P3|STARTED|Double-Blind Phase||0
8308665|NCT01497899|20484624|P2|STARTED|Double-Blind Phase||58
8308666|NCT01497899|20484625|P1|STARTED|Double-Blind Phase||113
8308667|NCT01497860|20484638|P1|NOT COMPLETED|Overall Study||0
8308668|NCT01497860|20484638|P1|COMPLETED|Overall Study||12
8308669|NCT01497860|20484638|P1|STARTED|Overall Study||12
8308670|NCT01497756|20484642|P1|NOT COMPLETED|Overall Study||0
8308671|NCT01497756|20484642|P1|COMPLETED|Overall Study||10
8308672|NCT01497756|20484642|P1|STARTED|Overall Study||10
8308673|NCT01497665|20484647|P1|NOT COMPLETED|Overall Study||0
8308674|NCT01497665|20484647|P1|COMPLETED|Overall Study||16
8308675|NCT01497665|20484647|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
8308676|NCT01497665|20484647|P1|STARTED|Overall Study||16
8308677|NCT01497613|20484657|P2|NOT COMPLETED|Overall Study||19
8308678|NCT01497613|20484658|P1|NOT COMPLETED|Overall Study||37
8308679|NCT01497613|20484657|P2|COMPLETED|Overall Study||131
8308680|NCT01497613|20484658|P1|COMPLETED|Overall Study||113
8308681|NCT01497613|20484657|P2|STARTED|Overall Study||150
8308682|NCT01497613|20484658|P1|STARTED|Overall Study||150
8308683|NCT01497496|20484694|P1|NOT COMPLETED|Overall Study||0
8308684|NCT01497496|20484694|P1|COMPLETED|Overall Study||29
8308685|NCT01497496|20484694|P1|STARTED|Overall Study||29
8308686|NCT01497366|20484702|P2|NOT COMPLETED|Overall Study||88
8308687|NCT01497366|20484703|P1|NOT COMPLETED|Overall Study||39
8308688|NCT01497366|20484702|P2|COMPLETED|Overall Study||176
8308689|NCT01497366|20484703|P1|COMPLETED|Overall Study||224
8308690|NCT01497366|20484702|P2|Randomized But Not Treated|Overall Study||21
8308691|NCT01497366|20484703|P1|Randomized But Not Treated|Overall Study||7
8308692|NCT01497366|20484702|P2|STARTED|Overall Study||264
8308693|NCT01497366|20484703|P1|STARTED|Overall Study||263
8308694|NCT01497275|20484721|P1|NOT COMPLETED|Overall Study||2
8308695|NCT01497275|20484721|P1|COMPLETED|Overall Study||3
8308696|NCT01497275|20484721|P1|STARTED|Overall Study||5
8308697|NCT01497262|20484728|P1|NOT COMPLETED|Overall Study||11
8308698|NCT01497262|20484728|P1|COMPLETED|Overall Study||151
8308699|NCT01497262|20484728|P1|STARTED|Overall Study||162
8308700|NCT01497197|20484735|P2|NOT COMPLETED|Overall Study||15
8308701|NCT01497197|20484736|P1|NOT COMPLETED|Overall Study||17
8308702|NCT01497197|20484735|P2|COMPLETED|Overall Study||70
8308703|NCT01497197|20484736|P1|COMPLETED|Overall Study||72
8308704|NCT01497197|20484735|P2|STARTED|Overall Study||85
8308705|NCT01497197|20484736|P1|STARTED|Overall Study||89
8308706|NCT01497171|20484764|P2|NOT COMPLETED|Overall Study||0
8308707|NCT01497171|20484765|P1|NOT COMPLETED|Overall Study||0
8308708|NCT01497171|20484764|P2|COMPLETED|Overall Study||3
8308709|NCT01497171|20484765|P1|COMPLETED|Overall Study||2
8308710|NCT01497171|20484764|P2|STARTED|Overall Study||3
8308711|NCT01497171|20484765|P1|STARTED|Overall Study||2
8308712|NCT01497067|20484771|P1|NOT COMPLETED|Overall Study||82
8308713|NCT01497067|20484771|P1|COMPLETED|Overall Study||575
8308714|NCT01497067|20484771|P1|STARTED|Overall Study||657
8308715|NCT01496846|20484782|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308716|NCT01496846|20484783|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308717|NCT01496846|20484784|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308718|NCT01496846|20484785|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308719|NCT01496846|20484786|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308720|NCT01496846|20484787|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308721|NCT01496846|20484782|P6|COMPLETED|Supplemental Buccal Infiltration||38
8308722|NCT01496846|20484783|P5|COMPLETED|Supplemental Buccal Infiltration||35
8308723|NCT01496846|20484784|P4|COMPLETED|Supplemental Buccal Infiltration||40
8308724|NCT01496846|20484785|P3|COMPLETED|Supplemental Buccal Infiltration||36
8308725|NCT01496846|20484786|P2|COMPLETED|Supplemental Buccal Infiltration||0
8308726|NCT01496846|20484787|P1|COMPLETED|Supplemental Buccal Infiltration||0
8308727|NCT01496846|20484782|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
8308728|NCT01496846|20484783|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
8308729|NCT01496846|20484784|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
8308730|NCT01496846|20484785|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
8308731|NCT01496846|20484786|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
8308732|NCT01496846|20484787|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
8308733|NCT01496846|20484782|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
8308734|NCT01496846|20484783|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
8308735|NCT01496846|20484784|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
8308736|NCT01496846|20484785|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
8308737|NCT01496846|20484786|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
8308738|NCT01496846|20484787|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
8308739|NCT01496846|20484782|P6|COMPLETED|IANB Articaine (All Participants)||38
8308740|NCT01496846|20484783|P5|COMPLETED|IANB Articaine (All Participants)||35
8308741|NCT01496846|20484784|P4|COMPLETED|IANB Articaine (All Participants)||40
8308742|NCT01496846|20484785|P3|COMPLETED|IANB Articaine (All Participants)||36
8308743|NCT01496846|20484786|P2|COMPLETED|IANB Articaine (All Participants)||23
8308744|NCT01496846|20484787|P1|COMPLETED|IANB Articaine (All Participants)||27
8308745|NCT01496846|20484782|P6|STARTED|IANB Articaine (All Participants)||38
8308746|NCT01496846|20484783|P5|STARTED|IANB Articaine (All Participants)||35
8308747|NCT01496846|20484784|P4|STARTED|IANB Articaine (All Participants)||40
8308748|NCT01496846|20484785|P3|STARTED|IANB Articaine (All Participants)||36
8308749|NCT01496846|20484786|P2|STARTED|IANB Articaine (All Participants)||24
8308750|NCT01496846|20484787|P1|STARTED|IANB Articaine (All Participants)||28
8308751|NCT01496807|20484798|P1|NOT COMPLETED|Overall Study||30
8308752|NCT01496807|20484798|P1|COMPLETED|Overall Study||1
8308753|NCT01496807|20484798|P1|STARTED|Overall Study||31
8308754|NCT01496469|20484810|P2|NOT COMPLETED|Overall Study||8
8308755|NCT01496469|20484811|P1|NOT COMPLETED|Overall Study||10
8308756|NCT01496469|20484810|P2|COMPLETED|Overall Study||53
8308757|NCT01496469|20484811|P1|COMPLETED|Overall Study||50
8308758|NCT01496469|20484810|P2|STARTED|Overall Study||61
8308759|NCT01496469|20484811|P1|STARTED|Overall Study||60
8308760|NCT01496456|20484821|P1|NOT COMPLETED|Overall Study||8
8308761|NCT01496456|20484821|P1|COMPLETED|Overall Study||9
8308762|NCT01496456|20484821|P1|3-yr Final Recall|Overall Study||9
8308763|NCT01496456|20484821|P1|2-yr Recall|Overall Study||10
8308764|NCT01496456|20484821|P1|1-yr Recall|Overall Study||12
8308765|NCT01496456|20484821|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
8308766|NCT01496456|20484821|P1|STARTED|Overall Study||17
8308767|NCT01496430|20484834|P3|NOT COMPLETED|Overall Study||10
8308768|NCT01496430|20484835|P2|NOT COMPLETED|Overall Study||5
8308769|NCT01496430|20484836|P1|NOT COMPLETED|Overall Study||6
8308770|NCT01496430|20484834|P3|COMPLETED|Overall Study||25
8308771|NCT01496430|20484835|P2|COMPLETED|Overall Study||30
8308772|NCT01496430|20484836|P1|COMPLETED|Overall Study||29
8308773|NCT01496430|20484834|P3|STARTED|Overall Study||35
8308774|NCT01496430|20484835|P2|STARTED|Overall Study||35
8308775|NCT01496430|20484836|P1|STARTED|Overall Study||35
8308776|NCT01496365|20484917|P7|NOT COMPLETED|Overall Study||6
8308777|NCT01496365|20484918|P6|NOT COMPLETED|Overall Study||10
8308778|NCT01496365|20484919|P5|NOT COMPLETED|Overall Study||13
8308779|NCT01496365|20484920|P4|NOT COMPLETED|Overall Study||4
8308780|NCT01496365|20484921|P3|NOT COMPLETED|Overall Study||6
8308781|NCT01496365|20484922|P2|NOT COMPLETED|Overall Study||15
8308782|NCT01496365|20484923|P1|NOT COMPLETED|Overall Study||15
8308783|NCT01496365|20484917|P7|COMPLETED|Overall Study||51
8308784|NCT01496365|20484918|P6|COMPLETED|Overall Study||46
8308785|NCT01496365|20484919|P5|COMPLETED|Overall Study||44
8308786|NCT01496365|20484920|P4|COMPLETED|Overall Study||53
8308787|NCT01496365|20484921|P3|COMPLETED|Overall Study||51
8308788|NCT01496365|20484922|P2|COMPLETED|Overall Study||41
8308789|NCT01496365|20484923|P1|COMPLETED|Overall Study||97
8308790|NCT01496365|20484917|P7|STARTED|Overall Study||57
8308791|NCT01496365|20484918|P6|STARTED|Overall Study||56
8308792|NCT01496365|20484919|P5|STARTED|Overall Study||57
8308793|NCT01496365|20484920|P4|STARTED|Overall Study||57
8308794|NCT01496365|20484921|P3|STARTED|Overall Study||57
8308795|NCT01496365|20484922|P2|STARTED|Overall Study||56
8308796|NCT01496365|20484923|P1|STARTED|Overall Study||112
8308797|NCT01496352|20485025|P2|NOT COMPLETED|Overall Study||0
8308798|NCT01496352|20485026|P1|NOT COMPLETED|Overall Study||0
8308799|NCT01496352|20485025|P2|COMPLETED|Overall Study||6
8308800|NCT01496352|20485026|P1|COMPLETED|Overall Study||24
8308801|NCT01496352|20485025|P2|STARTED|Overall Study||6
8308802|NCT01496352|20485026|P1|STARTED|Overall Study||24
8308803|NCT01496313|20485044|P2|NOT COMPLETED|Overall Study||15
8308804|NCT01496313|20485045|P1|NOT COMPLETED|Overall Study||5
8308805|NCT01496313|20485044|P2|COMPLETED|Overall Study||26
8308806|NCT01496313|20485045|P1|COMPLETED|Overall Study||35
8308807|NCT01496313|20485044|P2|STARTED|Overall Study||41
8308808|NCT01496313|20485045|P1|STARTED|Overall Study||40
8308809|NCT01496287|20485061|P1|NOT COMPLETED|Overall Study||6
8308810|NCT01496287|20485061|P1|COMPLETED|Overall Study||64
8308811|NCT01496287|20485061|P1|STARTED|Overall Study||70
8308812|NCT01496274|20485071|P2|NOT COMPLETED|Overall Study||5
8308813|NCT01496274|20485072|P1|NOT COMPLETED|Overall Study||3
8308814|NCT01496274|20485071|P2|COMPLETED|Overall Study||18
8308815|NCT01496274|20485072|P1|COMPLETED|Overall Study||37
8308816|NCT01496274|20485071|P2|STARTED|Overall Study||23
8308817|NCT01496274|20485072|P1|STARTED|Overall Study||40
8308818|NCT01496248|20485104|P1|NOT COMPLETED|Overall Study||10
8308819|NCT01496248|20485104|P1|COMPLETED|Overall Study||25
8308820|NCT01496248|20485104|P1|STARTED|Overall Study||35
8308821|NCT01496183|20485117|P2|NOT COMPLETED|Overall Study||2
8308822|NCT01496183|20485118|P1|NOT COMPLETED|Overall Study||3
8308823|NCT01496183|20485117|P2|COMPLETED|Overall Study||13
8308824|NCT01496183|20485118|P1|COMPLETED|Overall Study||6
8308825|NCT01496183|20485117|P2|STARTED|Overall Study||15
8308826|NCT01496183|20485118|P1|STARTED|Overall Study||9
8308827|NCT01496157|20485148|P1|NOT COMPLETED|Overall Study||0
8308828|NCT01496157|20485148|P1|COMPLETED|Overall Study||13
8308829|NCT01496157|20485148|P1|STARTED|Overall Study||13
8308830|NCT01496131|20485155|P2|NOT COMPLETED|Overall Study||0
8308831|NCT01496131|20485156|P1|NOT COMPLETED|Overall Study||0
8308832|NCT01496131|20485155|P2|COMPLETED|Overall Study||14
8308833|NCT01496131|20485156|P1|COMPLETED|Overall Study||14
8308834|NCT01496131|20485155|P2|STARTED|Overall Study||14
8308835|NCT01496131|20485156|P1|STARTED|Overall Study||14
8308836|NCT01496066|20485170|P2|NOT COMPLETED|Overall Study||9
8308837|NCT01496066|20485171|P1|NOT COMPLETED|Overall Study||12
8308838|NCT01496066|20485170|P2|COMPLETED|Overall Study||188
8308839|NCT01496066|20485171|P1|COMPLETED|Overall Study||391
8308840|NCT01496066|20485170|P2|STARTED|Overall Study||197
8308841|NCT01496066|20485171|P1|STARTED|Overall Study||403
8308842|NCT01495988|20485194|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308843|NCT01495988|20485195|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308844|NCT01495988|20485196|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308845|NCT01495988|20485197|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308846|NCT01495988|20485194|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308847|NCT01495988|20485195|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308848|NCT01495988|20485196|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
8308849|NCT01495988|20485197|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308850|NCT01495988|20485194|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308851|NCT01495988|20485195|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308852|NCT01495988|20485196|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
8308853|NCT01495988|20485197|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308854|NCT01495988|20485194|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308855|NCT01495988|20485195|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308856|NCT01495988|20485196|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308857|NCT01495988|20485197|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308858|NCT01495988|20485194|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
8308859|NCT01495988|20485195|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
8308860|NCT01495988|20485196|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308861|NCT01495988|20485197|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308862|NCT01495988|20485194|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
8308863|NCT01495988|20485195|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
8308864|NCT01495988|20485196|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
8308865|NCT01495988|20485197|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
8308866|NCT01495975|20485233|P2|NOT COMPLETED|Overall Study||0
8308867|NCT01495975|20485234|P1|NOT COMPLETED|Overall Study||1
8308868|NCT01495975|20485233|P2|COMPLETED|Overall Study||14
8308869|NCT01495975|20485234|P1|COMPLETED|Overall Study||14
8308870|NCT01495975|20485233|P2|STARTED|Overall Study||14
8308871|NCT01495975|20485234|P1|STARTED|Overall Study||15
8308872|NCT01495923|20485242|P2|NOT COMPLETED|Overall Study||0
8308873|NCT01495923|20485243|P1|NOT COMPLETED|Overall Study||0
8308874|NCT01495923|20485242|P2|COMPLETED|Overall Study||72
8308875|NCT01495923|20485243|P1|COMPLETED|Overall Study||73
8308876|NCT01495923|20485242|P2|STARTED|Overall Study||72
8308877|NCT01495923|20485243|P1|STARTED|Overall Study||73
8308878|NCT01495858|20485276|P3|NOT COMPLETED|Overall Study||0
8308879|NCT01495858|20485277|P2|NOT COMPLETED|Overall Study||0
8308880|NCT01495858|20485278|P1|NOT COMPLETED|Overall Study||0
8308881|NCT01495858|20485276|P3|COMPLETED|Overall Study||54
8308882|NCT01495858|20485277|P2|COMPLETED|Overall Study||106
8308883|NCT01495858|20485278|P1|COMPLETED|Overall Study||107
8308884|NCT01495858|20485276|P3|STARTED|Overall Study||54
8308885|NCT01495858|20485277|P2|STARTED|Overall Study||106
8308886|NCT01495858|20485278|P1|STARTED|Overall Study||107
8308887|NCT01495793|20485358|P1|NOT COMPLETED|Overall Study||2
8308888|NCT01495793|20485358|P1|COMPLETED|Overall Study||22
8308889|NCT01495793|20485358|P1|STARTED|Overall Study||24
8308890|NCT01495702|20485371|P2|NOT COMPLETED|Extension Phase||0
8308891|NCT01495702|20485372|P1|NOT COMPLETED|Extension Phase||0
8308892|NCT01495702|20485371|P2|COMPLETED|Extension Phase||2
8308893|NCT01495702|20485372|P1|COMPLETED|Extension Phase||26
8308894|NCT01495702|20485371|P2|STARTED|Extension Phase||2
8308895|NCT01495702|20485372|P1|STARTED|Extension Phase||26
8308896|NCT01495702|20485371|P2|NOT COMPLETED|Randomized Phase||28
8308897|NCT01495702|20485372|P1|NOT COMPLETED|Randomized Phase||26
8308898|NCT01495702|20485371|P2|COMPLETED|Randomized Phase||119
8308899|NCT01495702|20485372|P1|COMPLETED|Randomized Phase||266
8308900|NCT01495702|20485371|P2|STARTED|Randomized Phase||147
8308901|NCT01495702|20485372|P1|STARTED|Randomized Phase||292
8308902|NCT01495689|20485387|P2|NOT COMPLETED|Overall Study||7
8308903|NCT01495689|20485388|P1|NOT COMPLETED|Overall Study||10
8308904|NCT01495689|20485387|P2|COMPLETED|Overall Study||16
8308905|NCT01495689|20485388|P1|COMPLETED|Overall Study||16
8308906|NCT01495689|20485387|P2|STARTED|Overall Study||23
8308907|NCT01495689|20485388|P1|STARTED|Overall Study||26
8308908|NCT01495585|20485397|P3|NOT COMPLETED|Overall Study||0
8308909|NCT01495585|20485398|P2|NOT COMPLETED|Overall Study||0
8308910|NCT01495585|20485399|P1|NOT COMPLETED|Overall Study||0
8308911|NCT01495585|20485397|P3|COMPLETED|Overall Study||4
8308912|NCT01495585|20485398|P2|COMPLETED|Overall Study||6
8308913|NCT01495585|20485399|P1|COMPLETED|Overall Study||4
8308914|NCT01495585|20485397|P3|Open Label Lonafarnib 200 mg|Overall Study||0
8308915|NCT01495585|20485398|P2|Open Label Lonafarnib 200 mg|Overall Study||0
8308916|NCT01495585|20485399|P1|Open Label Lonafarnib 200 mg|Overall Study||2
8308917|NCT01495585|20485397|P3|STARTED|Overall Study||4
8308918|NCT01495585|20485398|P2|STARTED|Overall Study||6
8308919|NCT01495585|20485399|P1|STARTED|Overall Study||4
8308920|NCT01495572|20485412|P2|NOT COMPLETED|Overall Study||0
8308921|NCT01495572|20485413|P1|NOT COMPLETED|Overall Study||0
8308922|NCT01495572|20485412|P2|COMPLETED|Overall Study||5
8308923|NCT01495572|20485413|P1|COMPLETED|Overall Study||0
8308924|NCT01495572|20485412|P2|STARTED|Overall Study||5
8308925|NCT01495572|20485413|P1|STARTED|Overall Study||0
8308926|NCT01495481|20485421|P1|NOT COMPLETED|Dexmedetomidine||0
8308927|NCT01495481|20485421|P1|COMPLETED|Dexmedetomidine||22
8308928|NCT01495481|20485421|P1|STARTED|Dexmedetomidine||22
8308929|NCT01495481|20485421|P1|NOT COMPLETED|Washout||0
8308930|NCT01495481|20485421|P1|COMPLETED|Washout||22
8308931|NCT01495481|20485421|P1|STARTED|Washout||22
8308932|NCT01495481|20485421|P1|NOT COMPLETED|Adenosine||0
8308933|NCT01495481|20485421|P1|COMPLETED|Adenosine||22
8308934|NCT01495481|20485421|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
8308935|NCT01495286|20485433|P1|NOT COMPLETED|Overall Study||0
8308936|NCT01495286|20485433|P1|COMPLETED|Overall Study||30
8308937|NCT01495286|20485433|P1|STARTED|Overall Study||30
8308938|NCT01495221|20485441|P1|NOT COMPLETED|Overall Study||0
8308939|NCT01495221|20485441|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
8308940|NCT01495221|20485441|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
8308941|NCT01495000|20485450|P2|NOT COMPLETED|Overall Study||12
8308942|NCT01495000|20485451|P1|NOT COMPLETED|Overall Study||13
8308943|NCT01495000|20485450|P2|COMPLETED|Overall Study||114
8308944|NCT01495000|20485451|P1|COMPLETED|Overall Study||111
8308945|NCT01495000|20485450|P2|STARTED|Overall Study||126
8308946|NCT01495000|20485451|P1|STARTED|Overall Study||124
8308947|NCT01494987|20485493|P2|NOT COMPLETED|Overall Study||28
8308948|NCT01494987|20485494|P1|NOT COMPLETED|Overall Study||28
8308949|NCT01494987|20485493|P2|COMPLETED|Overall Study||187
8308950|NCT01494987|20485494|P1|COMPLETED|Overall Study||188
8308951|NCT01494987|20485493|P2|STARTED|Overall Study||215
8308952|NCT01494987|20485494|P1|STARTED|Overall Study||216
8308953|NCT01494818|20485508|P2|NOT COMPLETED|Overall Study||2
8308954|NCT01494818|20485509|P1|NOT COMPLETED|Overall Study||2
8308955|NCT01494818|20485508|P2|COMPLETED|Overall Study||37
8308956|NCT01494818|20485509|P1|COMPLETED|Overall Study||37
8308957|NCT01494818|20485508|P2|STARTED|Overall Study||39
8308958|NCT01494818|20485509|P1|STARTED|Overall Study||39
8308959|NCT01494753|20485531|P2|NOT COMPLETED|Day42-Day84||0
8308960|NCT01494753|20485532|P1|NOT COMPLETED|Day42-Day84||0
8308961|NCT01494753|20485531|P2|COMPLETED|Day42-Day84||15
8308962|NCT01494753|20485532|P1|COMPLETED|Day42-Day84||15
8308963|NCT01494753|20485531|P2|STARTED|Day42-Day84||15
8308964|NCT01494753|20485532|P1|STARTED|Day42-Day84||15
8308965|NCT01494753|20485531|P2|NOT COMPLETED|Day0-Day42||0
8308966|NCT01494753|20485532|P1|NOT COMPLETED|Day0-Day42||0
8308967|NCT01494753|20485531|P2|COMPLETED|Day0-Day42||15
8308968|NCT01494753|20485532|P1|COMPLETED|Day0-Day42||15
8308969|NCT01494753|20485531|P2|STARTED|Day0-Day42||15
8308970|NCT01494753|20485532|P1|STARTED|Day0-Day42||15
8308971|NCT01494649|20485540|P2|NOT COMPLETED|Overall Study||1
8308972|NCT01494649|20485541|P1|NOT COMPLETED|Overall Study||0
8308973|NCT01494649|20485540|P2|COMPLETED|Overall Study||58
8308974|NCT01494649|20485541|P1|COMPLETED|Overall Study||59
8308975|NCT01494649|20485540|P2|STARTED|Overall Study||59
8308976|NCT01494649|20485541|P1|STARTED|Overall Study||59
8308977|NCT01494610|20485557|P2|NOT COMPLETED|Period 4||0
8308978|NCT01494610|20485558|P1|NOT COMPLETED|Period 4||1
8308979|NCT01494610|20485557|P2|COMPLETED|Period 4||28
8308980|NCT01494610|20485558|P1|COMPLETED|Period 4||27
8308981|NCT01494610|20485557|P2|STARTED|Period 4||28
8308982|NCT01494610|20485558|P1|STARTED|Period 4||28
8308983|NCT01494610|20485557|P2|NOT COMPLETED|Period 3||0
8308984|NCT01494610|20485558|P1|NOT COMPLETED|Period 3||2
8308985|NCT01494610|20485557|P2|COMPLETED|Period 3||28
8308986|NCT01494610|20485558|P1|COMPLETED|Period 3||28
8308987|NCT01494610|20485557|P2|STARTED|Period 3||28
8308988|NCT01494610|20485558|P1|STARTED|Period 3||30
8308989|NCT01494610|20485557|P2|NOT COMPLETED|Period 2||0
8308990|NCT01494610|20485558|P1|NOT COMPLETED|Period 2||0
8308991|NCT01494610|20485557|P2|COMPLETED|Period 2||28
8308992|NCT01494610|20485558|P1|COMPLETED|Period 2||30
8308993|NCT01494610|20485557|P2|STARTED|Period 2||28
8308994|NCT01494610|20485558|P1|STARTED|Period 2||30
8308995|NCT01494610|20485557|P2|NOT COMPLETED|Period 1||1
8308996|NCT01494610|20485558|P1|NOT COMPLETED|Period 1||1
8308997|NCT01494610|20485557|P2|COMPLETED|Period 1||28
8308998|NCT01494610|20485558|P1|COMPLETED|Period 1||30
8308999|NCT01494610|20485557|P2|STARTED|Period 1||29
8309000|NCT01494610|20485558|P1|STARTED|Period 1||31
8309001|NCT01494584|20485626|P1|NOT COMPLETED|Overall Study||1
8309002|NCT01494584|20485626|P1|COMPLETED|Overall Study||4
8309003|NCT01494584|20485626|P1|STARTED|Overall Study||5
8309004|NCT01494545|20485715|P1|NOT COMPLETED|Overall Study||10
8309005|NCT01494545|20485715|P1|COMPLETED|Overall Study||92
8309006|NCT01494545|20485715|P1|STARTED|Overall Study||102
8309007|NCT01494532|20485758|P6|NOT COMPLETED|Overall Study||0
8309008|NCT01494532|20485759|P5|NOT COMPLETED|Overall Study||12
8309009|NCT01494532|20485760|P4|NOT COMPLETED|Overall Study||15
8309010|NCT01494532|20485761|P3|NOT COMPLETED|Overall Study||17
8309011|NCT01494532|20485762|P2|NOT COMPLETED|Overall Study||4
8309012|NCT01494532|20485763|P1|NOT COMPLETED|Overall Study||10
8309013|NCT01494532|20485758|P6|COMPLETED|Overall Study||25
8309014|NCT01494532|20485759|P5|COMPLETED|Overall Study||64
8309015|NCT01494532|20485760|P4|COMPLETED|Overall Study||60
8309016|NCT01494532|20485761|P3|COMPLETED|Overall Study||59
8309017|NCT01494532|20485762|P2|COMPLETED|Overall Study||21
8309018|NCT01494532|20485763|P1|COMPLETED|Overall Study||65
8309019|NCT01494532|20485758|P6|STARTED|Overall Study||25
8309020|NCT01494532|20485759|P5|STARTED|Overall Study||76
8309021|NCT01494532|20485760|P4|STARTED|Overall Study||75
8309022|NCT01494532|20485761|P3|STARTED|Overall Study||76
8309023|NCT01494532|20485762|P2|STARTED|Overall Study||25
8309024|NCT01494532|20485763|P1|STARTED|Overall Study||75
8309025|NCT01494506|20485918|P3|NOT COMPLETED|Overall Study||103
8309026|NCT01494506|20485919|P2|NOT COMPLETED|Overall Study||143
8309027|NCT01494506|20485920|P1|NOT COMPLETED|Overall Study||148
8309028|NCT01494506|20485918|P3|COMPLETED|Overall Study||14
8309029|NCT01494506|20485919|P2|COMPLETED|Overall Study||6
8309030|NCT01494506|20485920|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
8309031|NCT01494506|20485918|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
8309032|NCT01494506|20485919|P2|Treated Population|Overall Study||134
8309033|NCT01494506|20485920|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
8309034|NCT01494506|20485918|P3|STARTED|Overall Study||117
8309035|NCT01494506|20485919|P2|STARTED|Overall Study||149
8309036|NCT01494506|20485920|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
8309055|NCT01494350|20485974|P1|NOT COMPLETED|Overall Study||1
8309056|NCT01494350|20485974|P1|COMPLETED|Overall Study||49
8309057|NCT01494350|20485974|P1|STARTED|Overall Study||50
8309058|NCT01494298|20485984|P2|NOT COMPLETED|Overall Study||8
8309059|NCT01494298|20485985|P1|NOT COMPLETED|Overall Study||2
8309060|NCT01494298|20485984|P2|COMPLETED|Overall Study||47
8309061|NCT01494298|20485985|P1|COMPLETED|Overall Study||54
8309062|NCT01494298|20485984|P2|STARTED|Overall Study||55
8309063|NCT01494298|20485985|P1|STARTED|Overall Study||56
8309064|NCT01494051|20485997|P2|NOT COMPLETED|Overall Study||0
8309065|NCT01494051|20485998|P1|NOT COMPLETED|Overall Study||0
8309066|NCT01494051|20485997|P2|COMPLETED|Overall Study||7
8309067|NCT01494051|20485998|P1|COMPLETED|Overall Study||6
8309068|NCT01494051|20485997|P2|STARTED|Overall Study||7
8309069|NCT01494051|20485998|P1|STARTED|Overall Study||6
8309070|NCT01494038|20486008|P2|NOT COMPLETED|Overall Study||83
8309071|NCT01494038|20486009|P1|NOT COMPLETED|Overall Study||88
8309072|NCT01494038|20486008|P2|COMPLETED|Overall Study||396
8309073|NCT01494038|20486009|P1|COMPLETED|Overall Study||389
8309074|NCT01494038|20486008|P2|STARTED|Overall Study||479
8309075|NCT01494038|20486009|P1|STARTED|Overall Study||477
8309076|NCT01493960|20486097|P2|NOT COMPLETED|Overall Study||18
8309077|NCT01493960|20486098|P1|NOT COMPLETED|Overall Study||32
8309078|NCT01493960|20486097|P2|COMPLETED|Overall Study||26
8309079|NCT01493960|20486098|P1|COMPLETED|Overall Study||55
8309080|NCT01493960|20486097|P2|Received Study Drug|Overall Study||43
8309081|NCT01493960|20486098|P1|Received Study Drug|Overall Study||87
8309082|NCT01493960|20486097|P2|STARTED|Overall Study||44
8309083|NCT01493960|20486098|P1|STARTED|Overall Study||87
8309084|NCT01493947|20486118|P2|NOT COMPLETED|Period B Extension Period||32
8309085|NCT01493947|20486119|P1|NOT COMPLETED|Period B Extension Period||33
8309086|NCT01493947|20486118|P2|COMPLETED|Period B Extension Period||326
8309087|NCT01493947|20486119|P1|COMPLETED|Period B Extension Period||366
8309088|NCT01493947|20486118|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
8309089|NCT01493947|20486119|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
8309090|NCT01493947|20486118|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
8309091|NCT01493947|20486119|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
8309092|NCT01493947|20486118|P2|COMPLETED|Period A Efficacy and Safety Data||456
8309093|NCT01493947|20486119|P1|COMPLETED|Period A Efficacy and Safety Data||446
8309094|NCT01493947|20486118|P2|STARTED|Period A Efficacy and Safety Data||484
8309095|NCT01493947|20486119|P1|STARTED|Period A Efficacy and Safety Data||478
8309096|NCT01493778|20486129|P1|NOT COMPLETED|Overall Study||8
8309097|NCT01493778|20486129|P1|COMPLETED|Overall Study||52
8309098|NCT01493778|20486129|P1|STARTED|Overall Study||60
8309117|NCT01493557|20486211|P3|NOT COMPLETED|Adding the Second Strategy||0
8309118|NCT01493557|20486212|P2|NOT COMPLETED|Adding the Second Strategy||4
8309119|NCT01493557|20486213|P1|NOT COMPLETED|Adding the Second Strategy||2
8309120|NCT01493557|20486211|P3|COMPLETED|Adding the Second Strategy||0
8309121|NCT01493557|20486212|P2|COMPLETED|Adding the Second Strategy||11
8309122|NCT01493557|20486213|P1|COMPLETED|Adding the Second Strategy||12
8309123|NCT01493557|20486211|P3|STARTED|Adding the Second Strategy||0
8309124|NCT01493557|20486212|P2|STARTED|Adding the Second Strategy||15
8309125|NCT01493557|20486213|P1|STARTED|Adding the Second Strategy||14
8309126|NCT01493557|20486211|P3|NOT COMPLETED|Randomized to Management Strategies||0
8309127|NCT01493557|20486212|P2|NOT COMPLETED|Randomized to Management Strategies||11
8309128|NCT01493557|20486213|P1|NOT COMPLETED|Randomized to Management Strategies||15
8309129|NCT01493557|20486211|P3|COMPLETED|Randomized to Management Strategies||0
8309130|NCT01493557|20486212|P2|COMPLETED|Randomized to Management Strategies||47
8309131|NCT01493557|20486213|P1|COMPLETED|Randomized to Management Strategies||44
8309132|NCT01493557|20486211|P3|STARTED|Randomized to Management Strategies||0
8309133|NCT01493557|20486212|P2|STARTED|Randomized to Management Strategies||58
8309134|NCT01493557|20486213|P1|STARTED|Randomized to Management Strategies||59
8309135|NCT01493557|20486211|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
8309136|NCT01493557|20486212|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
8309137|NCT01493557|20486213|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
8309138|NCT01493557|20486211|P3|COMPLETED|Not Randomized to Management Strategies||816
8309139|NCT01493557|20486212|P2|COMPLETED|Not Randomized to Management Strategies||0
8309140|NCT01493557|20486213|P1|COMPLETED|Not Randomized to Management Strategies||0
8309141|NCT01493557|20486211|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
8309142|NCT01493557|20486212|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
8309143|NCT01493557|20486213|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
8309144|NCT01493557|20486211|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
8309145|NCT01493557|20486212|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
8309146|NCT01493557|20486213|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
8309147|NCT01493557|20486211|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
8309148|NCT01493557|20486212|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
8309149|NCT01493557|20486213|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
8309150|NCT01493557|20486211|P3|STARTED|Not Randomized to Management Strategies||950
8309151|NCT01493557|20486212|P2|STARTED|Not Randomized to Management Strategies||0
8309152|NCT01493557|20486213|P1|STARTED|Not Randomized to Management Strategies||0
8309153|NCT01493531|20486241|P3|NOT COMPLETED|Overall Study||48
8309154|NCT01493531|20486242|P2|NOT COMPLETED|Overall Study||50
8309155|NCT01493531|20486243|P1|NOT COMPLETED|Overall Study||41
8309156|NCT01493531|20486241|P3|COMPLETED|Overall Study||158
8309157|NCT01493531|20486242|P2|COMPLETED|Overall Study||150
8309158|NCT01493531|20486243|P1|COMPLETED|Overall Study||163
8309159|NCT01493531|20486241|P3|STARTED|Overall Study||206
8309160|NCT01493531|20486242|P2|STARTED|Overall Study||200
8309161|NCT01493531|20486243|P1|STARTED|Overall Study||204
8309162|NCT01493427|20486257|P1|NOT COMPLETED|Overall Study||20
8309163|NCT01493427|20486257|P1|COMPLETED|Overall Study||179
8309164|NCT01493427|20486257|P1|STARTED|Overall Study||199
8309165|NCT01493414|20486262|P1|NOT COMPLETED|Overall Study||950
8309166|NCT01493414|20486262|P1|COMPLETED|Overall Study||1283
8309167|NCT01493414|20486262|P1|STARTED|Overall Study||2233
8309168|NCT01493284|20486275|P1|NOT COMPLETED|Overall Study||61
8309169|NCT01493284|20486275|P1|COMPLETED|Overall Study||161
8309170|NCT01493284|20486275|P1|STARTED|Overall Study||222
8309171|NCT01493180|20486284|P2|NOT COMPLETED|Overall Study||2
8309172|NCT01493180|20486285|P1|NOT COMPLETED|Overall Study||3
8309173|NCT01493180|20486284|P2|COMPLETED|Overall Study||49
8309174|NCT01493180|20486285|P1|COMPLETED|Overall Study||48
8309175|NCT01493180|20486284|P2|STARTED|Overall Study||51
8309176|NCT01493180|20486285|P1|STARTED|Overall Study||51
8309177|NCT01493167|20486291|P1|NOT COMPLETED|Overall Study||0
8309178|NCT01493167|20486291|P1|COMPLETED|Overall Study||97
8309179|NCT01493167|20486291|P1|STARTED|Overall Study||97
8309180|NCT01493089|20486297|P2|NOT COMPLETED|Overall Study||3
8309181|NCT01493089|20486298|P1|NOT COMPLETED|Overall Study||3
8309182|NCT01493089|20486297|P2|COMPLETED|Overall Study||114
8309183|NCT01493089|20486298|P1|COMPLETED|Overall Study||119
8309184|NCT01493089|20486297|P2|STARTED|Overall Study||117
8309185|NCT01493089|20486298|P1|STARTED|Overall Study||122
8309186|NCT01493024|20486318|P4|NOT COMPLETED|Overall Study||0
8309187|NCT01493024|20486319|P3|NOT COMPLETED|Overall Study||0
8309188|NCT01493024|20486320|P2|NOT COMPLETED|Overall Study||0
8309189|NCT01493024|20486321|P1|NOT COMPLETED|Overall Study||0
8309190|NCT01493024|20486318|P4|COMPLETED|Overall Study||24
8309191|NCT01493024|20486319|P3|COMPLETED|Overall Study||24
8309192|NCT01493024|20486320|P2|COMPLETED|Overall Study||12
8309193|NCT01493024|20486321|P1|COMPLETED|Overall Study||30
8309194|NCT01493024|20486318|P4|STARTED|Overall Study||24
8309195|NCT01493024|20486319|P3|STARTED|Overall Study||24
8309196|NCT01493024|20486320|P2|STARTED|Overall Study||12
8309197|NCT01493024|20486321|P1|STARTED|Overall Study||30
8309198|NCT01492686|20486397|P2|NOT COMPLETED|Open-label Phase||18
8309199|NCT01492686|20486398|P1|NOT COMPLETED|Open-label Phase||12
8309200|NCT01492686|20486397|P2|COMPLETED|Open-label Phase||40
8309201|NCT01492686|20486398|P1|COMPLETED|Open-label Phase||53
8309202|NCT01492686|20486397|P2|STARTED|Open-label Phase||58
8309203|NCT01492686|20486398|P1|STARTED|Open-label Phase||65
8309204|NCT01492686|20486397|P2|NOT COMPLETED|Double-blind Phase||8
8309205|NCT01492686|20486398|P1|NOT COMPLETED|Double-blind Phase||2
8309206|NCT01492686|20486397|P2|COMPLETED|Double-blind Phase||60
8309207|NCT01492686|20486398|P1|COMPLETED|Double-blind Phase||67
8309208|NCT01492686|20486397|P2|STARTED|Double-blind Phase||68
8309209|NCT01492686|20486398|P1|STARTED|Double-blind Phase||69
8309210|NCT01492673|20486422|P1|NOT COMPLETED|Overall Study||0
8309211|NCT01492673|20486422|P1|COMPLETED|Overall Study||9
8309212|NCT01492673|20486422|P1|STARTED|Overall Study||9
8309213|NCT01492582|20486429|P2|NOT COMPLETED|Overall Study||64
8309214|NCT01492582|20486430|P1|NOT COMPLETED|Overall Study||69
8309215|NCT01492582|20486429|P2|COMPLETED|Overall Study|Returned evaluable survey|982
8309216|NCT01492582|20486430|P1|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
8309217|NCT01492582|20486429|P2|Received First Nonavalent Vaccine Dose|Overall Study||0
8309218|NCT01492582|20486430|P1|Received First Nonavalent Vaccine Dose|Overall Study||182
8309219|NCT01492582|20486429|P2|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
8309220|NCT01492582|20486430|P1|Received First Quadrivalent Vaccine Dose|Overall Study||254
8309221|NCT01492582|20486429|P2|STARTED|Overall Study|Consented to the survey arm of the study|1046
8309222|NCT01492582|20486430|P1|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
8309223|NCT01492439|20486455|P2|NOT COMPLETED|Overall Study||9
8309224|NCT01492439|20486456|P1|NOT COMPLETED|Overall Study||4
8309225|NCT01492439|20486455|P2|COMPLETED|Overall Study||9
8309226|NCT01492439|20486456|P1|COMPLETED|Overall Study||15
8309227|NCT01492439|20486455|P2|Post-intervention|Overall Study||13
8309228|NCT01492439|20486456|P1|Post-intervention|Overall Study||18
8309229|NCT01492439|20486455|P2|STARTED|Overall Study||18
8309230|NCT01492439|20486456|P1|STARTED|Overall Study||19
8309231|NCT01492426|20486504|P2|NOT COMPLETED|Follow-Up||10
8309232|NCT01492426|20486505|P1|NOT COMPLETED|Follow-Up||25
8309233|NCT01492426|20486504|P2|COMPLETED|Follow-Up||181
8309234|NCT01492426|20486505|P1|COMPLETED|Follow-Up||359
8309235|NCT01492426|20486504|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
8309236|NCT01492426|20486505|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
8309237|NCT01492426|20486504|P2|NOT COMPLETED|Treatment||40
8309238|NCT01492426|20486505|P1|NOT COMPLETED|Treatment||83
8309239|NCT01492426|20486504|P2|COMPLETED|Treatment||160
8309240|NCT01492426|20486505|P1|COMPLETED|Treatment||319
8309241|NCT01492426|20486504|P2|STARTED|Treatment||200
8309242|NCT01492426|20486505|P1|STARTED|Treatment||402
8309243|NCT01492400|20486523|P2|NOT COMPLETED|Overall Study||16
8309244|NCT01492400|20486524|P1|NOT COMPLETED|Overall Study||16
8309245|NCT01492400|20486523|P2|COMPLETED|Overall Study||166
8309246|NCT01492400|20486524|P1|COMPLETED|Overall Study||165
8309247|NCT01492400|20486523|P2|STARTED|Overall Study||182
8309248|NCT01492400|20486524|P1|STARTED|Overall Study||181
8309249|NCT01492309|20486536|P2|NOT COMPLETED|Overall Study||0
8309250|NCT01492309|20486537|P1|NOT COMPLETED|Overall Study||0
8309251|NCT01492309|20486536|P2|COMPLETED|Overall Study||11
8309252|NCT01492309|20486537|P1|COMPLETED|Overall Study||11
8309253|NCT01492309|20486536|P2|STARTED|Overall Study||11
8309254|NCT01492309|20486537|P1|STARTED|Overall Study||11
8309255|NCT01492088|20486548|P3|NOT COMPLETED|Overall Study||14
8309256|NCT01492088|20486549|P2|NOT COMPLETED|Overall Study||14
8309257|NCT01492088|20486550|P1|NOT COMPLETED|Overall Study||3
8309258|NCT01492088|20486548|P3|COMPLETED|Overall Study||3
8309259|NCT01492088|20486549|P2|COMPLETED|Overall Study||2
8309260|NCT01492088|20486550|P1|COMPLETED|Overall Study||0
8309261|NCT01492088|20486548|P3|STARTED|Overall Study||17
8309262|NCT01492088|20486549|P2|STARTED|Overall Study||16
8309263|NCT01492088|20486550|P1|STARTED|Overall Study||3
8309264|NCT01491984|20486610|P2|NOT COMPLETED|Overall Study||1
8309265|NCT01491984|20486611|P1|NOT COMPLETED|Overall Study||2
8309266|NCT01491984|20486610|P2|COMPLETED|Overall Study||44
8309267|NCT01491984|20486611|P1|COMPLETED|Overall Study||47
8309268|NCT01491984|20486610|P2|STARTED|Overall Study||45
8309269|NCT01491984|20486611|P1|STARTED|Overall Study||49
8309270|NCT01491958|20486619|P2|NOT COMPLETED|Overall Study||0
8309271|NCT01491958|20486620|P1|NOT COMPLETED|Overall Study||0
8309272|NCT01491958|20486619|P2|COMPLETED|Overall Study||40
8309273|NCT01491958|20486620|P1|COMPLETED|Overall Study||40
8309274|NCT01491958|20486619|P2|STARTED|Overall Study||40
8309275|NCT01491958|20486620|P1|STARTED|Overall Study||40
8309276|NCT01491919|20486631|P3|NOT COMPLETED|Overall Study||1
8309277|NCT01491919|20486632|P2|NOT COMPLETED|Overall Study||2
8309278|NCT01491919|20486633|P1|NOT COMPLETED|Overall Study||1
8309279|NCT01491919|20486631|P3|COMPLETED|Overall Study||2
8309280|NCT01491919|20486632|P2|COMPLETED|Overall Study||8
8309281|NCT01491919|20486633|P1|COMPLETED|Overall Study||12
8309282|NCT01491919|20486631|P3|STARTED|Overall Study||3
8309283|NCT01491919|20486632|P2|STARTED|Overall Study||10
8309284|NCT01491919|20486633|P1|STARTED|Overall Study||13
8309285|NCT01491893|20486679|P10|NOT COMPLETED|Overall Study||0
8309286|NCT01491893|20486680|P9|NOT COMPLETED|Overall Study||0
8309287|NCT01491893|20486681|P8|NOT COMPLETED|Overall Study||0
8309288|NCT01491893|20486682|P7|NOT COMPLETED|Overall Study||0
8309289|NCT01491893|20486683|P6|NOT COMPLETED|Overall Study||0
8309290|NCT01491893|20486684|P5|NOT COMPLETED|Overall Study||0
8309291|NCT01491893|20486685|P4|NOT COMPLETED|Overall Study||0
8309292|NCT01491893|20486686|P3|NOT COMPLETED|Overall Study||0
8309293|NCT01491893|20486687|P2|NOT COMPLETED|Overall Study||0
8309294|NCT01491893|20486688|P1|NOT COMPLETED|Overall Study||0
8309295|NCT01491893|20486679|P10|COMPLETED|Overall Study||7
8309296|NCT01491893|20486680|P9|COMPLETED|Overall Study||15
8309297|NCT01491893|20486681|P8|COMPLETED|Overall Study||24
8309298|NCT01491893|20486682|P7|COMPLETED|Overall Study||6
8309299|NCT01491893|20486683|P6|COMPLETED|Overall Study||1
8309300|NCT01491893|20486684|P5|COMPLETED|Overall Study||4
8309301|NCT01491893|20486685|P4|COMPLETED|Overall Study||1
8309302|NCT01491893|20486686|P3|COMPLETED|Overall Study||1
8309303|NCT01491893|20486687|P2|COMPLETED|Overall Study||1
8309304|NCT01491893|20486688|P1|COMPLETED|Overall Study||1
8309305|NCT01491893|20486679|P10|STARTED|Overall Study||7
8309306|NCT01491893|20486680|P9|STARTED|Overall Study||15
8309307|NCT01491893|20486681|P8|STARTED|Overall Study||24
8309308|NCT01491893|20486682|P7|STARTED|Overall Study||6
8309309|NCT01491893|20486683|P6|STARTED|Overall Study||1
8309310|NCT01491893|20486684|P5|STARTED|Overall Study||4
8309311|NCT01491893|20486685|P4|STARTED|Overall Study||1
8309312|NCT01491893|20486686|P3|STARTED|Overall Study||1
8309313|NCT01491893|20486687|P2|STARTED|Overall Study||1
8309314|NCT01491893|20486688|P1|STARTED|Overall Study||1
8309315|NCT01491854|20486704|P1|NOT COMPLETED|Overall Study||130
8309316|NCT01491854|20486704|P1|COMPLETED|Overall Study||0
8309317|NCT01491854|20486704|P1|STARTED|Overall Study||130
8309318|NCT01491841|20486715|P1|NOT COMPLETED|Overall Study||11
8309319|NCT01491841|20486715|P1|COMPLETED|Overall Study||22
8309320|NCT01491841|20486715|P1|STARTED|Overall Study||33
8309321|NCT01491802|20486729|P2|NOT COMPLETED|Overall Study||2
8309322|NCT01491802|20486730|P1|NOT COMPLETED|Overall Study||1
8309323|NCT01491802|20486729|P2|COMPLETED|Overall Study||6
8309324|NCT01491802|20486730|P1|COMPLETED|Overall Study||8
8309325|NCT01491802|20486729|P2|STARTED|Overall Study||8
8309326|NCT01491802|20486730|P1|STARTED|Overall Study||9
8309327|NCT01491737|20486757|P2|NOT COMPLETED|Overall Study||129
8309328|NCT01491737|20486758|P1|NOT COMPLETED|Overall Study||129
8309329|NCT01491737|20486757|P2|COMPLETED|Overall Study||0
8309330|NCT01491737|20486758|P1|COMPLETED|Overall Study||0
8309331|NCT01491737|20486757|P2|Entered Follow-Up (Post-Treatment)|Overall Study||116
8309332|NCT01491737|20486758|P1|Entered Follow-Up (Post-Treatment)|Overall Study||120
8309333|NCT01491737|20486757|P2|Received at Least One Dose of Study Drug|Overall Study||124
8309334|NCT01491737|20486758|P1|Received at Least One Dose of Study Drug|Overall Study||127
8309335|NCT01491737|20486757|P2|STARTED|Overall Study||129
8309336|NCT01491737|20486758|P1|STARTED|Overall Study||129
8309337|NCT01491672|20486785|P3|NOT COMPLETED|Overall Study||11
8309338|NCT01491672|20486786|P2|NOT COMPLETED|Overall Study||60
8309339|NCT01491672|20486787|P1|NOT COMPLETED|Overall Study||56
8309340|NCT01491672|20486785|P3|COMPLETED|Overall Study||3
8309341|NCT01491672|20486786|P2|COMPLETED|Overall Study||2
8309342|NCT01491672|20486787|P1|COMPLETED|Overall Study||2
8309343|NCT01491672|20486785|P3|Safety Set|Overall Study||14
8309344|NCT01491672|20486786|P2|Safety Set|Overall Study||61
8309345|NCT01491672|20486787|P1|Safety Set|Overall Study||58
8309346|NCT01491672|20486785|P3|STARTED|Overall Study||14
8309347|NCT01491672|20486786|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
8309348|NCT01491672|20486787|P1|STARTED|Overall Study||58
8309349|NCT01491633|20486812|P1|NOT COMPLETED|Overall Study||5
8309350|NCT01491633|20486812|P1|COMPLETED|Overall Study||0
8309351|NCT01491633|20486812|P1|STARTED|Overall Study||5
8309352|NCT01491607|20486824|P1|NOT COMPLETED|Overall Study||10
8309353|NCT01491607|20486824|P1|COMPLETED|Overall Study||190
8309354|NCT01491607|20486824|P1|STARTED|Overall Study||200
8309355|NCT01491490|20486922|P2|NOT COMPLETED|Overall Study||0
8309356|NCT01491490|20486923|P1|NOT COMPLETED|Overall Study||0
8309357|NCT01491490|20486922|P2|COMPLETED|Overall Study||1
8309358|NCT01491490|20486923|P1|COMPLETED|Overall Study||1
8309359|NCT01491490|20486922|P2|STARTED|Overall Study||1
8309360|NCT01491490|20486923|P1|STARTED|Overall Study||1
8309361|NCT01491178|20486929|P1|NOT COMPLETED|Overall Study||2794
8309362|NCT01491178|20486929|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
8309363|NCT01491178|20486929|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
8309364|NCT01491113|20486939|P5|NOT COMPLETED|Overall Study||0
8309365|NCT01491113|20486940|P4|NOT COMPLETED|Overall Study||0
8309366|NCT01491113|20486941|P3|NOT COMPLETED|Overall Study||0
8309367|NCT01491113|20486942|P2|NOT COMPLETED|Overall Study||0
8309368|NCT01491113|20486943|P1|NOT COMPLETED|Overall Study||0
8309369|NCT01491113|20486939|P5|COMPLETED|Overall Study||6
8309370|NCT01491113|20486940|P4|COMPLETED|Overall Study||6
8309371|NCT01491113|20486941|P3|COMPLETED|Overall Study||6
8309372|NCT01491113|20486942|P2|COMPLETED|Overall Study||6
8309373|NCT01491113|20486943|P1|COMPLETED|Overall Study||6
8309374|NCT01491113|20486939|P5|STARTED|Overall Study||6
8309375|NCT01491113|20486940|P4|STARTED|Overall Study||6
8309376|NCT01491113|20486941|P3|STARTED|Overall Study||6
8309377|NCT01491113|20486942|P2|STARTED|Overall Study||6
8309378|NCT01491113|20486943|P1|STARTED|Overall Study||6
8309379|NCT01491035|20487038|P8|NOT COMPLETED|Overall Study||0
8309380|NCT01491035|20487039|P7|NOT COMPLETED|Overall Study||0
8309381|NCT01491035|20487040|P6|NOT COMPLETED|Overall Study||0
8309382|NCT01491035|20487041|P5|NOT COMPLETED|Overall Study||1
8309383|NCT01491035|20487042|P4|NOT COMPLETED|Overall Study||0
8309384|NCT01491035|20487043|P3|NOT COMPLETED|Overall Study||0
8309385|NCT01491035|20487044|P2|NOT COMPLETED|Overall Study||0
8309386|NCT01491035|20487045|P1|NOT COMPLETED|Overall Study||0
8309387|NCT01491035|20487038|P8|COMPLETED|Overall Study||6
8309388|NCT01491035|20487039|P7|COMPLETED|Overall Study||6
8309389|NCT01491035|20487040|P6|COMPLETED|Overall Study||6
8309390|NCT01491035|20487041|P5|COMPLETED|Overall Study||5
8309391|NCT01491035|20487042|P4|COMPLETED|Overall Study||6
8309392|NCT01491035|20487043|P3|COMPLETED|Overall Study||6
8309393|NCT01491035|20487044|P2|COMPLETED|Overall Study||6
8309394|NCT01491035|20487045|P1|COMPLETED|Overall Study||6
8309395|NCT01491035|20487038|P8|STARTED|Overall Study||6
8309396|NCT01491035|20487039|P7|STARTED|Overall Study||6
8309397|NCT01491035|20487040|P6|STARTED|Overall Study||6
8309398|NCT01491035|20487041|P5|STARTED|Overall Study||6
8309399|NCT01491035|20487042|P4|STARTED|Overall Study||6
8309400|NCT01491035|20487043|P3|STARTED|Overall Study||6
8309401|NCT01491035|20487044|P2|STARTED|Overall Study||6
8309402|NCT01491035|20487045|P1|STARTED|Overall Study||6
8309403|NCT01491022|20487113|P2|NOT COMPLETED|Intervention 2||0
8309404|NCT01491022|20487114|P1|NOT COMPLETED|Intervention 2||1
8309405|NCT01491022|20487113|P2|COMPLETED|Intervention 2||11
8309406|NCT01491022|20487114|P1|COMPLETED|Intervention 2||8
8309407|NCT01491022|20487113|P2|STARTED|Intervention 2||11
8309408|NCT01491022|20487114|P1|STARTED|Intervention 2||9
8309409|NCT01491022|20487113|P2|NOT COMPLETED|2 Week Washout||0
8309410|NCT01491022|20487114|P1|NOT COMPLETED|2 Week Washout||0
8309411|NCT01491022|20487113|P2|COMPLETED|2 Week Washout||11
8309412|NCT01491022|20487114|P1|COMPLETED|2 Week Washout||9
8309413|NCT01491022|20487113|P2|STARTED|2 Week Washout||11
8309414|NCT01491022|20487114|P1|STARTED|2 Week Washout||9
8309415|NCT01491022|20487113|P2|NOT COMPLETED|Intervention 1||1
8309416|NCT01491022|20487114|P1|NOT COMPLETED|Intervention 1||1
8309417|NCT01491022|20487113|P2|COMPLETED|Intervention 1||11
8309418|NCT01491022|20487114|P1|COMPLETED|Intervention 1||9
8309419|NCT01491022|20487113|P2|STARTED|Intervention 1||12
8309420|NCT01491022|20487114|P1|STARTED|Intervention 1||10
8309421|NCT01490931|20487130|P1|NOT COMPLETED|Overall Study||0
8309422|NCT01490931|20487130|P1|COMPLETED|Overall Study||25
8309423|NCT01490931|20487130|P1|STARTED|Overall Study||25
8309424|NCT01490918|20487149|P3|NOT COMPLETED|Overall Study||12
8309425|NCT01490918|20487150|P2|NOT COMPLETED|Overall Study||14
8309426|NCT01490918|20487151|P1|NOT COMPLETED|Overall Study||13
8309427|NCT01490918|20487149|P3|COMPLETED|Overall Study||22
8309428|NCT01490918|20487150|P2|COMPLETED|Overall Study||52
8309429|NCT01490918|20487151|P1|COMPLETED|Overall Study||52
8309430|NCT01490918|20487149|P3|STARTED|Overall Study||34
8309431|NCT01490918|20487150|P2|STARTED|Overall Study||66
8309432|NCT01490918|20487151|P1|STARTED|Overall Study||65
8309433|NCT01490892|20487184|P1|NOT COMPLETED|Overall Study||0
8309434|NCT01490892|20487184|P1|COMPLETED|Overall Study||219
8309435|NCT01490892|20487184|P1|STARTED|Overall Study||219
8309436|NCT01490866|20487189|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
8309437|NCT01490866|20487189|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
8309438|NCT01490866|20487189|P1|STARTED|Axitinib Maintenance Therapy||49
8309439|NCT01490866|20487189|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
8309440|NCT01490866|20487189|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
8309441|NCT01490866|20487189|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
8309442|NCT01490840|20487200|P2|NOT COMPLETED|Phase 2||6
8309443|NCT01490840|20487201|P1|NOT COMPLETED|Phase 2||6
8309444|NCT01490840|20487200|P2|COMPLETED|Phase 2||68
8309445|NCT01490840|20487201|P1|COMPLETED|Phase 2||75
8309446|NCT01490840|20487200|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
8309447|NCT01490840|20487201|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
8309448|NCT01490840|20487200|P2|NOT COMPLETED|Phase 1||6
8309449|NCT01490840|20487201|P1|NOT COMPLETED|Phase 1||10
8309450|NCT01490840|20487200|P2|COMPLETED|Phase 1||78
8309451|NCT01490840|20487201|P1|COMPLETED|Phase 1||84
8309452|NCT01490840|20487200|P2|Modified Full Analysis Set|Phase 1||83
8309453|NCT01490840|20487201|P1|Modified Full Analysis Set|Phase 1||56
8309454|NCT01490840|20487200|P2|STARTED|Phase 1||84
8309455|NCT01490840|20487201|P1|STARTED|Phase 1||94
8309456|NCT01490814|20487225|P2|NOT COMPLETED|Overall Study||8
8309457|NCT01490814|20487226|P1|NOT COMPLETED|Overall Study||4
8309458|NCT01490814|20487225|P2|COMPLETED|Overall Study|376 received ablation|376
8309459|NCT01490814|20487226|P1|COMPLETED|Overall Study|374 received ablation|374
8309460|NCT01490814|20487225|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
8309461|NCT01490814|20487226|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
8309462|NCT01490788|20487246|P6|NOT COMPLETED|Overall Study||0
8309463|NCT01490788|20487247|P5|NOT COMPLETED|Overall Study||0
8309464|NCT01490788|20487248|P4|NOT COMPLETED|Overall Study||0
8309465|NCT01490788|20487249|P3|NOT COMPLETED|Overall Study||0
8309466|NCT01490788|20487250|P2|NOT COMPLETED|Overall Study||0
8309467|NCT01490788|20487251|P1|NOT COMPLETED|Overall Study||1
8309468|NCT01490788|20487246|P6|COMPLETED|Overall Study||5
8309469|NCT01490788|20487247|P5|COMPLETED|Overall Study||5
8309470|NCT01490788|20487248|P4|COMPLETED|Overall Study||5
8309471|NCT01490788|20487249|P3|COMPLETED|Overall Study||5
8309472|NCT01490788|20487250|P2|COMPLETED|Overall Study||5
8309473|NCT01490788|20487251|P1|COMPLETED|Overall Study||4
8309474|NCT01490788|20487246|P6|STARTED|Overall Study||5
8309475|NCT01490788|20487247|P5|STARTED|Overall Study||5
8309476|NCT01490788|20487248|P4|STARTED|Overall Study||5
8309477|NCT01490788|20487249|P3|STARTED|Overall Study||5
8309478|NCT01490788|20487250|P2|STARTED|Overall Study||5
8309479|NCT01490788|20487251|P1|STARTED|Overall Study||5
8309480|NCT01490723|20487262|P1|NOT COMPLETED|Overall Study||0
8309481|NCT01490723|20487262|P1|COMPLETED|Overall Study||20
8309482|NCT01490723|20487262|P1|STARTED|Overall Study||20
8309483|NCT01490697|20487269|P2|NOT COMPLETED|Overall Study||2
8309484|NCT01490697|20487270|P1|NOT COMPLETED|Overall Study||1
8309485|NCT01490697|20487269|P2|COMPLETED|Overall Study||16
8309486|NCT01490697|20487270|P1|COMPLETED|Overall Study||15
8309487|NCT01490697|20487269|P2|STARTED|Overall Study||18
8309488|NCT01490697|20487270|P1|STARTED|Overall Study||16
8309489|NCT01490684|20487278|P1|NOT COMPLETED|Overall Study||0
8309490|NCT01490684|20487278|P1|COMPLETED|Overall Study||162
8309491|NCT01490684|20487278|P1|STARTED|Overall Study||162
8309492|NCT01490632|20487290|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
8309493|NCT01490632|20487291|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
8309494|NCT01490632|20487292|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
8309495|NCT01490632|20487293|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
8309496|NCT01490632|20487294|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
8309497|NCT01490632|20487295|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
8309498|NCT01490632|20487296|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
8309499|NCT01490632|20487297|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
8309500|NCT01490632|20487298|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
8309501|NCT01490632|20487299|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
8309502|NCT01490632|20487300|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
8309503|NCT01490632|20487301|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
8309504|NCT01490632|20487302|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
8309505|NCT01490632|20487303|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
8309506|NCT01490632|20487304|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
8309507|NCT01490632|20487305|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
8309508|NCT01490632|20487306|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
8309509|NCT01490632|20487307|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
8309510|NCT01490632|20487308|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
8309511|NCT01490632|20487309|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
8309512|NCT01490632|20487290|P20|COMPLETED|Part D: Re-Treatment Period||30
8309513|NCT01490632|20487291|P19|COMPLETED|Part D: Re-Treatment Period||12
8309514|NCT01490632|20487292|P18|COMPLETED|Part D: Re-Treatment Period||8
8309515|NCT01490632|20487293|P17|COMPLETED|Part D: Re-Treatment Period||3
8309516|NCT01490632|20487294|P16|COMPLETED|Part D: Re-Treatment Period||0
8309517|NCT01490632|20487295|P15|COMPLETED|Part D: Re-Treatment Period||0
8309518|NCT01490632|20487296|P14|COMPLETED|Part D: Re-Treatment Period||0
8309519|NCT01490632|20487297|P13|COMPLETED|Part D: Re-Treatment Period||0
8309520|NCT01490632|20487298|P12|COMPLETED|Part D: Re-Treatment Period||0
8309521|NCT01490632|20487299|P11|COMPLETED|Part D: Re-Treatment Period||0
8309522|NCT01490632|20487300|P10|COMPLETED|Part D: Re-Treatment Period||0
8309523|NCT01490632|20487301|P9|COMPLETED|Part D: Re-Treatment Period||0
8309524|NCT01490632|20487302|P8|COMPLETED|Part D: Re-Treatment Period||0
8309525|NCT01490632|20487303|P7|COMPLETED|Part D: Re-Treatment Period||0
8309526|NCT01490632|20487304|P6|COMPLETED|Part D: Re-Treatment Period||0
8309527|NCT01490632|20487305|P5|COMPLETED|Part D: Re-Treatment Period||0
8309528|NCT01490632|20487306|P4|COMPLETED|Part D: Re-Treatment Period||0
8309529|NCT01490632|20487307|P3|COMPLETED|Part D: Re-Treatment Period||0
8309530|NCT01490632|20487308|P2|COMPLETED|Part D: Re-Treatment Period||0
8309531|NCT01490632|20487309|P1|COMPLETED|Part D: Re-Treatment Period||0
8309532|NCT01490632|20487290|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
8309533|NCT01490632|20487291|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
8309534|NCT01490632|20487292|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
8309535|NCT01490632|20487293|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
8309536|NCT01490632|20487294|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
8309537|NCT01490632|20487295|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
8309538|NCT01490632|20487296|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
8309539|NCT01490632|20487297|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
8309540|NCT01490632|20487298|P12|STARTED|Part D: Re-Treatment Period||0
8309541|NCT01490632|20487299|P11|STARTED|Part D: Re-Treatment Period||0
8309542|NCT01490632|20487300|P10|STARTED|Part D: Re-Treatment Period||0
8309543|NCT01490632|20487301|P9|STARTED|Part D: Re-Treatment Period||0
8309544|NCT01490632|20487302|P8|STARTED|Part D: Re-Treatment Period||0
8309545|NCT01490632|20487303|P7|STARTED|Part D: Re-Treatment Period||0
8309546|NCT01490632|20487304|P6|STARTED|Part D: Re-Treatment Period||0
8309547|NCT01490632|20487305|P5|STARTED|Part D: Re-Treatment Period||0
8309548|NCT01490632|20487306|P4|STARTED|Part D: Re-Treatment Period||0
8309549|NCT01490632|20487307|P3|STARTED|Part D: Re-Treatment Period||0
8309550|NCT01490632|20487308|P2|STARTED|Part D: Re-Treatment Period||0
8309551|NCT01490632|20487309|P1|STARTED|Part D: Re-Treatment Period||0
8309552|NCT01490632|20487290|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309553|NCT01490632|20487291|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309554|NCT01490632|20487292|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309555|NCT01490632|20487293|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309556|NCT01490632|20487294|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
8309557|NCT01490632|20487295|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
8309558|NCT01490632|20487296|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
8309559|NCT01490632|20487297|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
8309560|NCT01490632|20487298|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309561|NCT01490632|20487299|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309562|NCT01490632|20487300|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309563|NCT01490632|20487301|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309564|NCT01490632|20487302|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309565|NCT01490632|20487303|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309566|NCT01490632|20487304|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309567|NCT01490632|20487305|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309568|NCT01490632|20487306|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309569|NCT01490632|20487307|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309570|NCT01490632|20487308|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309571|NCT01490632|20487309|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309572|NCT01490632|20487290|P20|COMPLETED|Part C: Washout or Step-Down Period||0
8309573|NCT01490632|20487291|P19|COMPLETED|Part C: Washout or Step-Down Period||0
8309574|NCT01490632|20487292|P18|COMPLETED|Part C: Washout or Step-Down Period||0
8309575|NCT01490632|20487293|P17|COMPLETED|Part C: Washout or Step-Down Period||0
8309576|NCT01490632|20487294|P16|COMPLETED|Part C: Washout or Step-Down Period||18
8309577|NCT01490632|20487295|P15|COMPLETED|Part C: Washout or Step-Down Period||37
8309578|NCT01490632|20487296|P14|COMPLETED|Part C: Washout or Step-Down Period||6
8309579|NCT01490632|20487297|P13|COMPLETED|Part C: Washout or Step-Down Period||10
8309580|NCT01490632|20487298|P12|COMPLETED|Part C: Washout or Step-Down Period||0
8309581|NCT01490632|20487299|P11|COMPLETED|Part C: Washout or Step-Down Period||0
8309582|NCT01490632|20487300|P10|COMPLETED|Part C: Washout or Step-Down Period||0
8309583|NCT01490632|20487301|P9|COMPLETED|Part C: Washout or Step-Down Period||0
8309584|NCT01490632|20487302|P8|COMPLETED|Part C: Washout or Step-Down Period||0
8309585|NCT01490632|20487303|P7|COMPLETED|Part C: Washout or Step-Down Period||0
8309586|NCT01490632|20487304|P6|COMPLETED|Part C: Washout or Step-Down Period||0
8309587|NCT01490632|20487305|P5|COMPLETED|Part C: Washout or Step-Down Period||0
8309588|NCT01490632|20487306|P4|COMPLETED|Part C: Washout or Step-Down Period||0
8309589|NCT01490632|20487307|P3|COMPLETED|Part C: Washout or Step-Down Period||0
8309590|NCT01490632|20487308|P2|COMPLETED|Part C: Washout or Step-Down Period||0
8309591|NCT01490632|20487309|P1|COMPLETED|Part C: Washout or Step-Down Period||0
8309592|NCT01490632|20487290|P20|STARTED|Part C: Washout or Step-Down Period||0
8309593|NCT01490632|20487291|P19|STARTED|Part C: Washout or Step-Down Period||0
8309594|NCT01490632|20487292|P18|STARTED|Part C: Washout or Step-Down Period||0
8309595|NCT01490632|20487293|P17|STARTED|Part C: Washout or Step-Down Period||0
8309596|NCT01490632|20487294|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
8309597|NCT01490632|20487295|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
8309598|NCT01490632|20487296|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
8309599|NCT01490632|20487297|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
8309600|NCT01490632|20487298|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
8309601|NCT01490632|20487299|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
8309602|NCT01490632|20487300|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
8309603|NCT01490632|20487301|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
8309604|NCT01490632|20487302|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
8309605|NCT01490632|20487303|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
8309606|NCT01490632|20487304|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
8309607|NCT01490632|20487305|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
8309608|NCT01490632|20487306|P4|STARTED|Part C: Washout or Step-Down Period||0
8309609|NCT01490632|20487307|P3|STARTED|Part C: Washout or Step-Down Period||0
8309610|NCT01490632|20487308|P2|STARTED|Part C: Washout or Step-Down Period||0
8309611|NCT01490632|20487309|P1|STARTED|Part C: Washout or Step-Down Period||0
8309612|NCT01490632|20487290|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309613|NCT01490632|20487291|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309614|NCT01490632|20487292|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309615|NCT01490632|20487293|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309616|NCT01490632|20487294|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309617|NCT01490632|20487295|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309618|NCT01490632|20487296|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309619|NCT01490632|20487297|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309620|NCT01490632|20487298|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
8309621|NCT01490632|20487299|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
8309622|NCT01490632|20487300|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
8309623|NCT01490632|20487301|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
8309624|NCT01490632|20487302|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
8309625|NCT01490632|20487303|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
8309626|NCT01490632|20487304|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
8309627|NCT01490632|20487305|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309628|NCT01490632|20487306|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309629|NCT01490632|20487307|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309630|NCT01490632|20487308|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309631|NCT01490632|20487309|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309632|NCT01490632|20487290|P20|COMPLETED|Part B: Extension or Step-Up Period||0
8309633|NCT01490632|20487291|P19|COMPLETED|Part B: Extension or Step-Up Period||0
8309634|NCT01490632|20487292|P18|COMPLETED|Part B: Extension or Step-Up Period||0
8309635|NCT01490632|20487293|P17|COMPLETED|Part B: Extension or Step-Up Period||0
8309636|NCT01490632|20487294|P16|COMPLETED|Part B: Extension or Step-Up Period||0
8309637|NCT01490632|20487295|P15|COMPLETED|Part B: Extension or Step-Up Period||0
8309638|NCT01490632|20487296|P14|COMPLETED|Part B: Extension or Step-Up Period||0
8309639|NCT01490632|20487297|P13|COMPLETED|Part B: Extension or Step-Up Period||0
8309640|NCT01490632|20487298|P12|COMPLETED|Part B: Extension or Step-Up Period||0
8309641|NCT01490632|20487299|P11|COMPLETED|Part B: Extension or Step-Up Period||22
8309642|NCT01490632|20487300|P10|COMPLETED|Part B: Extension or Step-Up Period||25
8309643|NCT01490632|20487301|P9|COMPLETED|Part B: Extension or Step-Up Period||6
8309644|NCT01490632|20487302|P8|COMPLETED|Part B: Extension or Step-Up Period||13
8309645|NCT01490632|20487303|P7|COMPLETED|Part B: Extension or Step-Up Period||51
8309646|NCT01490632|20487304|P6|COMPLETED|Part B: Extension or Step-Up Period||25
8309647|NCT01490632|20487305|P5|COMPLETED|Part B: Extension or Step-Up Period||0
8309648|NCT01490632|20487306|P4|COMPLETED|Part B: Extension or Step-Up Period||0
8309649|NCT01490632|20487307|P3|COMPLETED|Part B: Extension or Step-Up Period||0
8309650|NCT01490632|20487308|P2|COMPLETED|Part B: Extension or Step-Up Period||0
8309651|NCT01490632|20487309|P1|COMPLETED|Part B: Extension or Step-Up Period||0
8309652|NCT01490632|20487290|P20|STARTED|Part B: Extension or Step-Up Period||0
8309653|NCT01490632|20487291|P19|STARTED|Part B: Extension or Step-Up Period||0
8309654|NCT01490632|20487292|P18|STARTED|Part B: Extension or Step-Up Period||0
8309655|NCT01490632|20487293|P17|STARTED|Part B: Extension or Step-Up Period||0
8309656|NCT01490632|20487294|P16|STARTED|Part B: Extension or Step-Up Period||0
8309657|NCT01490632|20487295|P15|STARTED|Part B: Extension or Step-Up Period||0
8309658|NCT01490632|20487296|P14|STARTED|Part B: Extension or Step-Up Period||0
8309659|NCT01490632|20487297|P13|STARTED|Part B: Extension or Step-Up Period||0
8309660|NCT01490632|20487298|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
8309661|NCT01490632|20487299|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
8309662|NCT01490632|20487300|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
8309663|NCT01490632|20487301|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
8309664|NCT01490632|20487302|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
8309665|NCT01490632|20487303|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
8309666|NCT01490632|20487304|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
8309667|NCT01490632|20487305|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309668|NCT01490632|20487306|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309669|NCT01490632|20487307|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309670|NCT01490632|20487308|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309671|NCT01490632|20487309|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309672|NCT01490632|20487290|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
8309673|NCT01490632|20487291|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
8309674|NCT01490632|20487292|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
8309675|NCT01490632|20487293|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
8309676|NCT01490632|20487294|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
8309677|NCT01490632|20487295|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
8309678|NCT01490632|20487296|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
8309679|NCT01490632|20487297|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
8309680|NCT01490632|20487298|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
8309681|NCT01490632|20487299|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
8309682|NCT01490632|20487300|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
8309683|NCT01490632|20487301|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
8309684|NCT01490632|20487302|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
8309685|NCT01490632|20487303|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
8309686|NCT01490632|20487304|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
8309687|NCT01490632|20487305|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
8309688|NCT01490632|20487306|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
8309689|NCT01490632|20487307|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
8309690|NCT01490632|20487308|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
8309691|NCT01490632|20487309|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
8309692|NCT01490632|20487290|P20|COMPLETED|Part A: Initial Treatment Period||0
8309693|NCT01490632|20487291|P19|COMPLETED|Part A: Initial Treatment Period||0
8309694|NCT01490632|20487292|P18|COMPLETED|Part A: Initial Treatment Period||0
8309695|NCT01490632|20487293|P17|COMPLETED|Part A: Initial Treatment Period||0
8309696|NCT01490632|20487294|P16|COMPLETED|Part A: Initial Treatment Period||0
8309697|NCT01490632|20487295|P15|COMPLETED|Part A: Initial Treatment Period||0
8309698|NCT01490632|20487296|P14|COMPLETED|Part A: Initial Treatment Period||0
8309699|NCT01490632|20487297|P13|COMPLETED|Part A: Initial Treatment Period||0
8309700|NCT01490632|20487298|P12|COMPLETED|Part A: Initial Treatment Period||0
8309701|NCT01490632|20487299|P11|COMPLETED|Part A: Initial Treatment Period||0
8309702|NCT01490632|20487300|P10|COMPLETED|Part A: Initial Treatment Period||0
8309703|NCT01490632|20487301|P9|COMPLETED|Part A: Initial Treatment Period||0
8309704|NCT01490632|20487302|P8|COMPLETED|Part A: Initial Treatment Period||0
8309705|NCT01490632|20487303|P7|COMPLETED|Part A: Initial Treatment Period||0
8309706|NCT01490632|20487304|P6|COMPLETED|Part A: Initial Treatment Period||0
8309707|NCT01490632|20487305|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
8309708|NCT01490632|20487306|P4|COMPLETED|Part A: Initial Treatment Period||55
8309709|NCT01490632|20487307|P3|COMPLETED|Part A: Initial Treatment Period||67
8309710|NCT01490632|20487308|P2|COMPLETED|Part A: Initial Treatment Period||28
8309711|NCT01490632|20487309|P1|COMPLETED|Part A: Initial Treatment Period||27
8309712|NCT01490632|20487290|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309713|NCT01490632|20487291|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309714|NCT01490632|20487292|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309715|NCT01490632|20487293|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309716|NCT01490632|20487294|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309717|NCT01490632|20487295|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309718|NCT01490632|20487296|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309719|NCT01490632|20487297|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309720|NCT01490632|20487298|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309721|NCT01490632|20487299|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309722|NCT01490632|20487300|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309723|NCT01490632|20487301|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309724|NCT01490632|20487302|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309725|NCT01490632|20487303|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309726|NCT01490632|20487304|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309727|NCT01490632|20487305|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
8309728|NCT01490632|20487306|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
8309729|NCT01490632|20487307|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
8309730|NCT01490632|20487308|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
8309731|NCT01490632|20487309|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
8309732|NCT01490632|20487290|P20|STARTED|Part A: Initial Treatment Period||0
8309733|NCT01490632|20487291|P19|STARTED|Part A: Initial Treatment Period||0
8309734|NCT01490632|20487292|P18|STARTED|Part A: Initial Treatment Period||0
8309735|NCT01490632|20487293|P17|STARTED|Part A: Initial Treatment Period||0
8309736|NCT01490632|20487294|P16|STARTED|Part A: Initial Treatment Period||0
8309737|NCT01490632|20487295|P15|STARTED|Part A: Initial Treatment Period||0
8309738|NCT01490632|20487296|P14|STARTED|Part A: Initial Treatment Period||0
8309739|NCT01490632|20487297|P13|STARTED|Part A: Initial Treatment Period||0
8309740|NCT01490632|20487298|P12|STARTED|Part A: Initial Treatment Period||0
8309741|NCT01490632|20487299|P11|STARTED|Part A: Initial Treatment Period||0
8309742|NCT01490632|20487300|P10|STARTED|Part A: Initial Treatment Period||0
8309743|NCT01490632|20487301|P9|STARTED|Part A: Initial Treatment Period||0
8309744|NCT01490632|20487302|P8|STARTED|Part A: Initial Treatment Period||0
8309745|NCT01490632|20487303|P7|STARTED|Part A: Initial Treatment Period||0
8309746|NCT01490632|20487304|P6|STARTED|Part A: Initial Treatment Period||0
8309747|NCT01490632|20487305|P5|STARTED|Part A: Initial Treatment Period||69
8309748|NCT01490632|20487306|P4|STARTED|Part A: Initial Treatment Period||64
8309749|NCT01490632|20487307|P3|STARTED|Part A: Initial Treatment Period||72
8309750|NCT01490632|20487308|P2|STARTED|Part A: Initial Treatment Period||32
8309751|NCT01490632|20487309|P1|STARTED|Part A: Initial Treatment Period||34
8309752|NCT01490580|20487439|P2|NOT COMPLETED|Overall Study||2
8309753|NCT01490580|20487440|P1|NOT COMPLETED|Overall Study||0
8309754|NCT01490580|20487439|P2|COMPLETED|Overall Study||89
8309755|NCT01490580|20487440|P1|COMPLETED|Overall Study||82
8309756|NCT01490580|20487439|P2|STARTED|Overall Study||91
8309757|NCT01490580|20487440|P1|STARTED|Overall Study||82
8309758|NCT01490359|20487462|P2|NOT COMPLETED|Overall Study||17
8309759|NCT01490359|20487463|P1|NOT COMPLETED|Overall Study||24
8309760|NCT01490359|20487462|P2|COMPLETED|Overall Study||555
8309761|NCT01490359|20487463|P1|COMPLETED|Overall Study||585
8309762|NCT01490359|20487462|P2|Followed-up at 12 mo|Overall Study||537
8309763|NCT01490359|20487463|P1|Followed-up at 12 mo|Overall Study||569
8309764|NCT01490359|20487462|P2|Followed-up at 6 mo|Overall Study||535
8309765|NCT01490359|20487463|P1|Followed-up at 6 mo|Overall Study||558
8309766|NCT01490359|20487462|P2|STARTED|Overall Study||572
8309767|NCT01490359|20487463|P1|STARTED|Overall Study||609
8309768|NCT01490294|20487487|P4|NOT COMPLETED|Overall Study||1
8309769|NCT01490294|20487488|P3|NOT COMPLETED|Overall Study||1
8309770|NCT01490294|20487489|P2|NOT COMPLETED|Overall Study||0
8309771|NCT01490294|20487490|P1|NOT COMPLETED|Overall Study||5
8309772|NCT01490294|20487487|P4|COMPLETED|Overall Study||54
8309773|NCT01490294|20487488|P3|COMPLETED|Overall Study||58
8309774|NCT01490294|20487489|P2|COMPLETED|Overall Study||60
8309775|NCT01490294|20487490|P1|COMPLETED|Overall Study||53
8309776|NCT01490294|20487487|P4|Participant Received Treatment|Overall Study||54
8309777|NCT01490294|20487488|P3|Participant Received Treatment|Overall Study||58
8309778|NCT01490294|20487489|P2|Participant Received Treatment|Overall Study||60
8309779|NCT01490294|20487490|P1|Participant Received Treatment|Overall Study||54
8309780|NCT01490294|20487487|P4|STARTED|Overall Study||55
8309781|NCT01490294|20487488|P3|STARTED|Overall Study||59
8309782|NCT01490294|20487489|P2|STARTED|Overall Study||60
8309783|NCT01490294|20487490|P1|STARTED|Overall Study||58
8309784|NCT01490190|20487724|P1|NOT COMPLETED|Overall Study||48
8309785|NCT01490190|20487724|P1|COMPLETED|Overall Study||204
8309786|NCT01490190|20487724|P1|STARTED|Overall Study||252
8309787|NCT01490151|20487745|P1|NOT COMPLETED|Overall Study||0
8309788|NCT01490151|20487745|P1|COMPLETED|Overall Study||22
8309789|NCT01490151|20487745|P1|STARTED|Overall Study||22
8309790|NCT01490125|20487751|P6|NOT COMPLETED|Period III||0
8309791|NCT01490125|20487752|P5|NOT COMPLETED|Period III||1
8309792|NCT01490125|20487753|P4|NOT COMPLETED|Period III||2
8309793|NCT01490125|20487754|P3|NOT COMPLETED|Period III||0
8309794|NCT01490125|20487755|P2|NOT COMPLETED|Period III||1
8309795|NCT01490125|20487756|P1|NOT COMPLETED|Period III||3
8309796|NCT01490125|20487751|P6|COMPLETED|Period III||35
8309797|NCT01490125|20487752|P5|COMPLETED|Period III||31
8309798|NCT01490125|20487753|P4|COMPLETED|Period III||28
8309799|NCT01490125|20487754|P3|COMPLETED|Period III||34
8309800|NCT01490125|20487755|P2|COMPLETED|Period III||32
8309801|NCT01490125|20487756|P1|COMPLETED|Period III||31
8309802|NCT01490125|20487751|P6|STARTED|Period III||35
8309803|NCT01490125|20487752|P5|STARTED|Period III||32
8309804|NCT01490125|20487753|P4|STARTED|Period III||30
8309805|NCT01490125|20487754|P3|STARTED|Period III||34
8309806|NCT01490125|20487755|P2|STARTED|Period III||33
8309807|NCT01490125|20487756|P1|STARTED|Period III||34
8309808|NCT01490125|20487751|P6|NOT COMPLETED|Period II||2
8309809|NCT01490125|20487752|P5|NOT COMPLETED|Period II||4
8309810|NCT01490125|20487753|P4|NOT COMPLETED|Period II||3
8309811|NCT01490125|20487754|P3|NOT COMPLETED|Period II||3
8309812|NCT01490125|20487755|P2|NOT COMPLETED|Period II||4
8309813|NCT01490125|20487756|P1|NOT COMPLETED|Period II||3
8309814|NCT01490125|20487751|P6|COMPLETED|Period II||35
8309815|NCT01490125|20487752|P5|COMPLETED|Period II||32
8309816|NCT01490125|20487753|P4|COMPLETED|Period II||30
8309817|NCT01490125|20487754|P3|COMPLETED|Period II||34
8309818|NCT01490125|20487755|P2|COMPLETED|Period II||33
8309819|NCT01490125|20487756|P1|COMPLETED|Period II||34
8309820|NCT01490125|20487751|P6|STARTED|Period II||37
8309821|NCT01490125|20487752|P5|STARTED|Period II||36
8309822|NCT01490125|20487753|P4|STARTED|Period II||33
8309823|NCT01490125|20487754|P3|STARTED|Period II||37
8309824|NCT01490125|20487755|P2|STARTED|Period II||37
8309825|NCT01490125|20487756|P1|STARTED|Period II||37
8309826|NCT01490125|20487751|P6|NOT COMPLETED|Period I||5
8309827|NCT01490125|20487752|P5|NOT COMPLETED|Period I||4
8309828|NCT01490125|20487753|P4|NOT COMPLETED|Period I||5
8309829|NCT01490125|20487754|P3|NOT COMPLETED|Period I||4
8309830|NCT01490125|20487755|P2|NOT COMPLETED|Period I||5
8309831|NCT01490125|20487756|P1|NOT COMPLETED|Period I||6
8309832|NCT01490125|20487751|P6|COMPLETED|Period I||37
8309833|NCT01490125|20487752|P5|COMPLETED|Period I||36
8309834|NCT01490125|20487753|P4|COMPLETED|Period I||33
8309835|NCT01490125|20487754|P3|COMPLETED|Period I||37
8309836|NCT01490125|20487755|P2|COMPLETED|Period I||37
8309837|NCT01490125|20487756|P1|COMPLETED|Period I||37
8309838|NCT01490125|20487751|P6|STARTED|Period I||42
8309839|NCT01490125|20487752|P5|STARTED|Period I||40
8309840|NCT01490125|20487753|P4|STARTED|Period I||38
8309841|NCT01490125|20487754|P3|STARTED|Period I||41
8309842|NCT01490125|20487755|P2|STARTED|Period I||42
8309843|NCT01490125|20487756|P1|STARTED|Period I||43
8309844|NCT01490086|20487784|P5|NOT COMPLETED|Overall Study||11
8309845|NCT01490086|20487785|P4|NOT COMPLETED|Overall Study||7
8309846|NCT01490086|20487786|P3|NOT COMPLETED|Overall Study||7
8309847|NCT01490086|20487787|P2|NOT COMPLETED|Overall Study||15
8309848|NCT01490086|20487788|P1|NOT COMPLETED|Overall Study||8
8309849|NCT01490086|20487784|P5|COMPLETED|Overall Study||28
8309850|NCT01490086|20487785|P4|COMPLETED|Overall Study||13
8309851|NCT01490086|20487786|P3|COMPLETED|Overall Study||51
8309852|NCT01490086|20487787|P2|COMPLETED|Overall Study||44
8309853|NCT01490086|20487788|P1|COMPLETED|Overall Study||50
8309854|NCT01490086|20487784|P5|STARTED|Overall Study||39
8309855|NCT01490086|20487785|P4|STARTED|Overall Study||20
8309856|NCT01490086|20487786|P3|STARTED|Overall Study||58
8309857|NCT01490086|20487787|P2|STARTED|Overall Study||59
8309858|NCT01490086|20487788|P1|STARTED|Overall Study||58
8309859|NCT01490073|20487822|P2|NOT COMPLETED|Overall Study||0
8309860|NCT01490073|20487823|P1|NOT COMPLETED|Overall Study||0
8309861|NCT01490073|20487822|P2|COMPLETED|Overall Study||12
8309862|NCT01490073|20487823|P1|COMPLETED|Overall Study||12
8309863|NCT01490073|20487822|P2|STARTED|Overall Study||12
8309864|NCT01490073|20487823|P1|STARTED|Overall Study||12
8309865|NCT01490060|20487833|P4|NOT COMPLETED|Cycle 2||0
8309866|NCT01490060|20487834|P3|NOT COMPLETED|Cycle 2||1
8309867|NCT01490060|20487835|P2|NOT COMPLETED|Cycle 2||1
8309868|NCT01490060|20487836|P1|NOT COMPLETED|Cycle 2||2
8309869|NCT01490060|20487833|P4|COMPLETED|Cycle 2||8
8309870|NCT01490060|20487834|P3|COMPLETED|Cycle 2||8
8309871|NCT01490060|20487835|P2|COMPLETED|Cycle 2||11
8309872|NCT01490060|20487836|P1|COMPLETED|Cycle 2||9
8309873|NCT01490060|20487833|P4|STARTED|Cycle 2||8
8309874|NCT01490060|20487834|P3|STARTED|Cycle 2||9
8309875|NCT01490060|20487835|P2|STARTED|Cycle 2||12
8309876|NCT01490060|20487836|P1|STARTED|Cycle 2||11
8309877|NCT01490060|20487833|P4|NOT COMPLETED|Cycle 1||3
8309878|NCT01490060|20487834|P3|NOT COMPLETED|Cycle 1||3
8309879|NCT01490060|20487835|P2|NOT COMPLETED|Cycle 1||1
8309880|NCT01490060|20487836|P1|NOT COMPLETED|Cycle 1||0
8309881|NCT01490060|20487833|P4|COMPLETED|Cycle 1||8
8309882|NCT01490060|20487834|P3|COMPLETED|Cycle 1||9
8309883|NCT01490060|20487835|P2|COMPLETED|Cycle 1||12
8309884|NCT01490060|20487836|P1|COMPLETED|Cycle 1||11
8309885|NCT01490060|20487833|P4|STARTED|Cycle 1||11
8309886|NCT01490060|20487834|P3|STARTED|Cycle 1||12
8309887|NCT01490060|20487835|P2|STARTED|Cycle 1||13
8309888|NCT01490060|20487836|P1|STARTED|Cycle 1||11
8309889|NCT01489969|20487847|P3|NOT COMPLETED|Overall Study||1
8309890|NCT01489969|20487848|P2|NOT COMPLETED|Overall Study||4
8309891|NCT01489969|20487849|P1|NOT COMPLETED|Overall Study||5
8309892|NCT01489969|20487847|P3|COMPLETED|Overall Study||44
8309893|NCT01489969|20487848|P2|COMPLETED|Overall Study||43
8309894|NCT01489969|20487849|P1|COMPLETED|Overall Study||40
8309895|NCT01489969|20487847|P3|STARTED|Overall Study||45
8309896|NCT01489969|20487848|P2|STARTED|Overall Study||47
8309897|NCT01489969|20487849|P1|STARTED|Overall Study||45
8309898|NCT01489956|20487865|P3|NOT COMPLETED|Overall Study||1
8309899|NCT01489956|20487866|P2|NOT COMPLETED|Overall Study||0
8309900|NCT01489956|20487867|P1|NOT COMPLETED|Overall Study||1
8309901|NCT01489956|20487865|P3|COMPLETED|Overall Study||5
8309902|NCT01489956|20487866|P2|COMPLETED|Overall Study||0
8309903|NCT01489956|20487867|P1|COMPLETED|Overall Study||12
8309904|NCT01489956|20487865|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
8309905|NCT01489956|20487866|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
8309906|NCT01489956|20487867|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
8309907|NCT01489891|20487904|P2|NOT COMPLETED|Overall Study||0
8309908|NCT01489891|20487905|P1|NOT COMPLETED|Overall Study||1
8309909|NCT01489891|20487904|P2|COMPLETED|Overall Study||60
8309910|NCT01489891|20487905|P1|COMPLETED|Overall Study||59
8309911|NCT01489891|20487904|P2|STARTED|Overall Study||60
8309912|NCT01489891|20487905|P1|STARTED|Overall Study||60
8309913|NCT01489826|20487926|P9|NOT COMPLETED|Overall Study||0
8309914|NCT01489826|20487927|P8|NOT COMPLETED|Overall Study||0
8309915|NCT01489826|20487928|P7|NOT COMPLETED|Overall Study||0
8309916|NCT01489826|20487929|P6|NOT COMPLETED|Overall Study||0
8309917|NCT01489826|20487930|P5|NOT COMPLETED|Overall Study||0
8309918|NCT01489826|20487931|P4|NOT COMPLETED|Overall Study||0
8309919|NCT01489826|20487932|P3|NOT COMPLETED|Overall Study||0
8309920|NCT01489826|20487933|P2|NOT COMPLETED|Overall Study||0
8309921|NCT01489826|20487934|P1|NOT COMPLETED|Overall Study||0
8309922|NCT01489826|20487926|P9|COMPLETED|Overall Study||6
8309923|NCT01489826|20487927|P8|COMPLETED|Overall Study||3
8309924|NCT01489826|20487928|P7|COMPLETED|Overall Study||9
8309925|NCT01489826|20487929|P6|COMPLETED|Overall Study||3
8309926|NCT01489826|20487930|P5|COMPLETED|Overall Study||3
8309927|NCT01489826|20487931|P4|COMPLETED|Overall Study||7
8309928|NCT01489826|20487932|P3|COMPLETED|Overall Study||3
8309929|NCT01489826|20487933|P2|COMPLETED|Overall Study||3
8309930|NCT01489826|20487934|P1|COMPLETED|Overall Study||3
8309931|NCT01489826|20487926|P9|STARTED|Overall Study||6
8309932|NCT01489826|20487927|P8|STARTED|Overall Study||3
8309933|NCT01489826|20487928|P7|STARTED|Overall Study||9
8309934|NCT01489826|20487929|P6|STARTED|Overall Study||3
8309935|NCT01489826|20487930|P5|STARTED|Overall Study||3
8309936|NCT01489826|20487931|P4|STARTED|Overall Study||7
8309937|NCT01489826|20487932|P3|STARTED|Overall Study||3
8309938|NCT01489826|20487933|P2|STARTED|Overall Study||3
8309939|NCT01489826|20487934|P1|STARTED|Overall Study||3
8309940|NCT01489670|20488031|P1|NOT COMPLETED|Overall Study||53
8309941|NCT01489670|20488031|P1|COMPLETED|Overall Study||334
8309942|NCT01489670|20488031|P1|STARTED|Overall Study||387
8309943|NCT01489579|20488043|P2|NOT COMPLETED|Overall Study||7
8309944|NCT01489579|20488044|P1|NOT COMPLETED|Overall Study||9
8309945|NCT01489579|20488043|P2|COMPLETED|Overall Study||57
8309946|NCT01489579|20488044|P1|COMPLETED|Overall Study||47
8309947|NCT01489579|20488043|P2|STARTED|Overall Study||64
8309948|NCT01489579|20488044|P1|STARTED|Overall Study||56
8309949|NCT01489527|20488060|P2|NOT COMPLETED|Overall Study||26
8309950|NCT01489527|20488061|P1|NOT COMPLETED|Overall Study||22
8309951|NCT01489527|20488060|P2|COMPLETED|Overall Study||175
8309952|NCT01489527|20488061|P1|COMPLETED|Overall Study||183
8309953|NCT01489527|20488060|P2|STARTED|Overall Study||201
8309954|NCT01489527|20488061|P1|STARTED|Overall Study||205
8309955|NCT01489358|20488078|P3|NOT COMPLETED|Overall Study||2
8309956|NCT01489358|20488079|P2|NOT COMPLETED|Overall Study||0
8309957|NCT01489358|20488080|P1|NOT COMPLETED|Overall Study||0
8309958|NCT01489358|20488078|P3|COMPLETED|Overall Study||8
8309959|NCT01489358|20488079|P2|COMPLETED|Overall Study||10
8309960|NCT01489358|20488080|P1|COMPLETED|Overall Study||5
8309961|NCT01489358|20488078|P3|STARTED|Overall Study||10
8309962|NCT01489358|20488079|P2|STARTED|Overall Study||10
8309963|NCT01489358|20488080|P1|STARTED|Overall Study||5
8309964|NCT01489254|20488130|P4|NOT COMPLETED|Open-label Extension Part||58
8309965|NCT01489254|20488131|P3|NOT COMPLETED|Open-label Extension Part||0
8309966|NCT01489254|20488132|P2|NOT COMPLETED|Open-label Extension Part||0
8309967|NCT01489254|20488133|P1|NOT COMPLETED|Open-label Extension Part||0
8309968|NCT01489254|20488130|P4|COMPLETED|Open-label Extension Part||670
8309969|NCT01489254|20488131|P3|COMPLETED|Open-label Extension Part||0
8309970|NCT01489254|20488132|P2|COMPLETED|Open-label Extension Part||0
8309971|NCT01489254|20488133|P1|COMPLETED|Open-label Extension Part||0
8309972|NCT01489254|20488130|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
8309973|NCT01489254|20488131|P3|STARTED|Open-label Extension Part||0
8309974|NCT01489254|20488132|P2|STARTED|Open-label Extension Part||0
8309975|NCT01489254|20488133|P1|STARTED|Open-label Extension Part||0
8309976|NCT01489254|20488130|P4|NOT COMPLETED|Double-blind Part||0
8309977|NCT01489254|20488131|P3|NOT COMPLETED|Double-blind Part||3
8309978|NCT01489254|20488132|P2|NOT COMPLETED|Double-blind Part||33
8309979|NCT01489254|20488133|P1|NOT COMPLETED|Double-blind Part||25
8309980|NCT01489254|20488130|P4|COMPLETED|Double-blind Part||0
8309981|NCT01489254|20488131|P3|COMPLETED|Double-blind Part||81
8309982|NCT01489254|20488132|P2|COMPLETED|Double-blind Part||324
8309983|NCT01489254|20488133|P1|COMPLETED|Double-blind Part||330
8309984|NCT01489254|20488130|P4|STARTED|Double-blind Part||0
8309985|NCT01489254|20488131|P3|STARTED|Double-blind Part||84
8309986|NCT01489254|20488132|P2|STARTED|Double-blind Part||357
8309987|NCT01489254|20488133|P1|STARTED|Double-blind Part||355
8309988|NCT01489189|20488144|P2|NOT COMPLETED|Overall Study||35
8309989|NCT01489189|20488145|P1|NOT COMPLETED|Overall Study||31
8309990|NCT01489189|20488144|P2|COMPLETED|Overall Study|Number of Eyes|168
8309991|NCT01489189|20488145|P1|COMPLETED|Overall Study|Number of Eyes|160
8309992|NCT01489189|20488144|P2|STARTED|Overall Study|Number of Eyes|203
8309993|NCT01489189|20488145|P1|STARTED|Overall Study|Number of Eyes|191
8309994|NCT01489111|20488170|P1|NOT COMPLETED|Overall Study||1
8309995|NCT01489111|20488170|P1|COMPLETED|Overall Study||35
8309996|NCT01489111|20488170|P1|STARTED|Overall Study||36
8309997|NCT01489020|20488191|P6|NOT COMPLETED|Overall Study||0
8309998|NCT01489020|20488192|P5|NOT COMPLETED|Overall Study||6
8309999|NCT01489020|20488193|P4|NOT COMPLETED|Overall Study||0
8310000|NCT01489020|20488194|P3|NOT COMPLETED|Overall Study||3
8310001|NCT01489020|20488195|P2|NOT COMPLETED|Overall Study||0
8310002|NCT01489020|20488196|P1|NOT COMPLETED|Overall Study||1
8310003|NCT01489020|20488191|P6|COMPLETED|Overall Study||4
8310004|NCT01489020|20488192|P5|COMPLETED|Overall Study||6
8310005|NCT01489020|20488193|P4|COMPLETED|Overall Study||4
8310006|NCT01489020|20488194|P3|COMPLETED|Overall Study||9
8310007|NCT01489020|20488195|P2|COMPLETED|Overall Study||4
8310008|NCT01489020|20488196|P1|COMPLETED|Overall Study||11
8310009|NCT01489020|20488191|P6|STARTED|Overall Study||4
8310010|NCT01489020|20488192|P5|STARTED|Overall Study||12
8310011|NCT01489020|20488193|P4|STARTED|Overall Study||4
8310012|NCT01489020|20488194|P3|STARTED|Overall Study||12
8310013|NCT01489020|20488195|P2|STARTED|Overall Study||4
8310014|NCT01489020|20488196|P1|STARTED|Overall Study||12
8310015|NCT01488994|20488230|P2|NOT COMPLETED|Overall Study||1
8310016|NCT01488994|20488231|P1|NOT COMPLETED|Overall Study||0
8310017|NCT01488994|20488230|P2|COMPLETED|Overall Study||11
8310018|NCT01488994|20488231|P1|COMPLETED|Overall Study||11
8310019|NCT01488994|20488230|P2|STARTED|Overall Study||12
8310020|NCT01488994|20488231|P1|STARTED|Overall Study||11
8310021|NCT01488890|20488322|P4|NOT COMPLETED|Overall Study||5
8310022|NCT01488890|20488323|P3|NOT COMPLETED|Overall Study||35
8310023|NCT01488890|20488324|P2|NOT COMPLETED|Overall Study||20
8310024|NCT01488890|20488325|P1|NOT COMPLETED|Overall Study||32
8310025|NCT01488890|20488322|P4|COMPLETED|Overall Study||25
8310026|NCT01488890|20488323|P3|COMPLETED|Overall Study||85
8310027|NCT01488890|20488324|P2|COMPLETED|Overall Study||100
8310028|NCT01488890|20488325|P1|COMPLETED|Overall Study||88
8310029|NCT01488890|20488322|P4|Treated|Overall Study||30
8310030|NCT01488890|20488323|P3|Treated|Overall Study||119
8310031|NCT01488890|20488324|P2|Treated|Overall Study||120
8310032|NCT01488890|20488325|P1|Treated|Overall Study||120
8310033|NCT01488890|20488322|P4|STARTED|Overall Study||30
8310034|NCT01488890|20488323|P3|STARTED|Overall Study||120
8310035|NCT01488890|20488324|P2|STARTED|Overall Study||120
8310036|NCT01488890|20488325|P1|STARTED|Overall Study||120
8310037|NCT01488877|20488363|P3|NOT COMPLETED|Re-randomization||0
8310038|NCT01488877|20488364|P2|NOT COMPLETED|Re-randomization||0
8310039|NCT01488877|20488365|P1|NOT COMPLETED|Re-randomization||0
8310040|NCT01488877|20488363|P3|COMPLETED|Re-randomization||3
8310041|NCT01488877|20488364|P2|COMPLETED|Re-randomization||0
8310042|NCT01488877|20488365|P1|COMPLETED|Re-randomization||0
8310043|NCT01488877|20488363|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
8310044|NCT01488877|20488364|P2|STARTED|Re-randomization||0
8310045|NCT01488877|20488365|P1|STARTED|Re-randomization||0
8310046|NCT01488877|20488363|P3|NOT COMPLETED|Initial Randomization||0
8310047|NCT01488877|20488364|P2|NOT COMPLETED|Initial Randomization||0
8310048|NCT01488877|20488365|P1|NOT COMPLETED|Initial Randomization||0
8310049|NCT01488877|20488363|P3|COMPLETED|Initial Randomization||0
8310050|NCT01488877|20488364|P2|COMPLETED|Initial Randomization||5
8310051|NCT01488877|20488365|P1|COMPLETED|Initial Randomization||1
8310052|NCT01488877|20488363|P3|STARTED|Initial Randomization||0
8310053|NCT01488877|20488364|P2|STARTED|Initial Randomization||5
8310054|NCT01488877|20488365|P1|STARTED|Initial Randomization||1
8310055|NCT01488708|20488382|P2|NOT COMPLETED|Overall Study||578
8310056|NCT01488708|20488383|P1|NOT COMPLETED|Overall Study||940
8310057|NCT01488708|20488382|P2|COMPLETED|Overall Study||0
8310058|NCT01488708|20488383|P1|COMPLETED|Overall Study||0
8310059|NCT01488708|20488382|P2|Participated in Follow Up|Overall Study||526
8310060|NCT01488708|20488383|P1|Participated in Follow Up|Overall Study||810
8310061|NCT01488708|20488382|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
8310062|NCT01488708|20488383|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
8310063|NCT01488708|20488382|P2|STARTED|Overall Study||578
8310064|NCT01488708|20488383|P1|STARTED|Overall Study||940
8310065|NCT01488487|20488403|P1|NOT COMPLETED|Overall Study||9
8310066|NCT01488487|20488403|P1|COMPLETED|Overall Study||15
8310067|NCT01488487|20488403|P1|Received Treatment|Overall Study||24
8310068|NCT01488487|20488403|P1|STARTED|Overall Study||24
8310069|NCT01488448|20488412|P2|NOT COMPLETED|Overall Study||17
8310070|NCT01488448|20488413|P1|NOT COMPLETED|Overall Study||20
8310071|NCT01488448|20488412|P2|COMPLETED|Overall Study||97
8310072|NCT01488448|20488413|P1|COMPLETED|Overall Study||93
8310073|NCT01488448|20488412|P2|STARTED|Overall Study||114
8310074|NCT01488448|20488413|P1|STARTED|Overall Study||113
8310075|NCT01488409|20488437|P2|NOT COMPLETED|Overall Study||4
8310076|NCT01488409|20488438|P1|NOT COMPLETED|Overall Study||4
8310077|NCT01488409|20488437|P2|COMPLETED|Overall Study||15
8310078|NCT01488409|20488438|P1|COMPLETED|Overall Study||16
8310079|NCT01488409|20488437|P2|STARTED|Overall Study||19
8310080|NCT01488409|20488438|P1|STARTED|Overall Study||20
8310081|NCT01488370|20488455|P3|NOT COMPLETED|Overall Study||1
8310082|NCT01488370|20488456|P2|NOT COMPLETED|Overall Study||1
8310083|NCT01488370|20488457|P1|NOT COMPLETED|Overall Study||0
8310084|NCT01488370|20488455|P3|COMPLETED|Overall Study||19
8310085|NCT01488370|20488456|P2|COMPLETED|Overall Study||22
8310086|NCT01488370|20488457|P1|COMPLETED|Overall Study||22
8310087|NCT01488370|20488455|P3|STARTED|Overall Study||20
8310088|NCT01488370|20488456|P2|STARTED|Overall Study||23
8310089|NCT01488370|20488457|P1|STARTED|Overall Study||22
8310090|NCT01488318|20488477|P1|NOT COMPLETED|Overall Study||0
8310091|NCT01488318|20488477|P1|COMPLETED|Overall Study||14
8310092|NCT01488318|20488477|P1|STARTED|Overall Study||14
8310093|NCT01488279|20488486|P2|NOT COMPLETED|Overall Study||0
8310094|NCT01488279|20488487|P1|NOT COMPLETED|Overall Study||0
8310095|NCT01488279|20488486|P2|COMPLETED|Overall Study||5
8310096|NCT01488279|20488487|P1|COMPLETED|Overall Study||5
8310097|NCT01488279|20488486|P2|STARTED|Overall Study||5
8310098|NCT01488279|20488487|P1|STARTED|Overall Study||5
8310099|NCT01488188|20488503|P2|NOT COMPLETED|Overall Study||0
8310100|NCT01488188|20488504|P1|NOT COMPLETED|Overall Study||0
8310101|NCT01488188|20488503|P2|COMPLETED|Overall Study||20
8310102|NCT01488188|20488504|P1|COMPLETED|Overall Study||20
8310103|NCT01488188|20488503|P2|STARTED|Overall Study||20
8310104|NCT01488188|20488504|P1|STARTED|Overall Study||20
8310105|NCT01488097|20488516|P1|NOT COMPLETED|Overall Study||1
8310106|NCT01488097|20488516|P1|COMPLETED|Overall Study||7
8310107|NCT01488097|20488516|P1|Received Study Drug in Extension Study|Overall Study||8
8310108|NCT01488097|20488516|P1|STARTED|Overall Study||8
8310109|NCT01488071|20488529|P2|NOT COMPLETED|Overall Study||63
8310110|NCT01488071|20488530|P1|NOT COMPLETED|Overall Study||53
8310111|NCT01488071|20488529|P2|COMPLETED|Overall Study||179
8310112|NCT01488071|20488530|P1|COMPLETED|Overall Study||200
8310113|NCT01488071|20488529|P2|STARTED|Overall Study|APTS|242
8310114|NCT01488071|20488530|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
8310115|NCT01488019|20488564|P2|NOT COMPLETED|Overall Study||304
8310116|NCT01488019|20488565|P1|NOT COMPLETED|Overall Study||247
8310117|NCT01488019|20488564|P2|COMPLETED|Overall Study||226
8310118|NCT01488019|20488565|P1|COMPLETED|Overall Study||294
8310119|NCT01488019|20488564|P2|STARTED|Overall Study||530
8310120|NCT01488019|20488565|P1|STARTED|Overall Study||541
8310121|NCT01487954|20488599|P2|NOT COMPLETED|Overall Study||0
8310122|NCT01487954|20488600|P1|NOT COMPLETED|Overall Study||0
8310123|NCT01487954|20488599|P2|COMPLETED|Overall Study||16
8310124|NCT01487954|20488600|P1|COMPLETED|Overall Study||29
8310125|NCT01487954|20488599|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
8310126|NCT01487954|20488600|P1|Safety lead-in|Overall Study||10
8310127|NCT01487954|20488599|P2|STARTED|Overall Study||16
8310128|NCT01487954|20488600|P1|STARTED|Overall Study||29
8310129|NCT01487863|20488610|P2|NOT COMPLETED|Overall Study||19
8310130|NCT01487863|20488611|P1|NOT COMPLETED|Overall Study||19
8310131|NCT01487863|20488610|P2|COMPLETED|Overall Study||15
8310132|NCT01487863|20488611|P1|COMPLETED|Overall Study||16
8310133|NCT01487863|20488610|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
8310134|NCT01487863|20488611|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
8310135|NCT01487863|20488610|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
8310136|NCT01487863|20488611|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
8310137|NCT01487863|20488610|P2|STARTED|Overall Study||34
8310138|NCT01487863|20488611|P1|STARTED|Overall Study||35
8310139|NCT01487668|20488619|P2|NOT COMPLETED|Overall Study||17
8310140|NCT01487668|20488620|P1|NOT COMPLETED|Overall Study||25
8310141|NCT01487668|20488619|P2|COMPLETED|Overall Study||124
8310142|NCT01487668|20488620|P1|COMPLETED|Overall Study||121
8310143|NCT01487668|20488619|P2|STARTED|Overall Study||141
8310144|NCT01487668|20488620|P1|STARTED|Overall Study||146
8310145|NCT01487577|20488628|P1|NOT COMPLETED|Overall Study||1
8310146|NCT01487577|20488628|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
8310147|NCT01487577|20488628|P1|STARTED|Overall Study||19
8310148|NCT01487525|20488642|P2|NOT COMPLETED|Overall Study||1
8310149|NCT01487525|20488643|P1|NOT COMPLETED|Overall Study||0
8310150|NCT01487525|20488642|P2|COMPLETED|Overall Study||19
8310151|NCT01487525|20488643|P1|COMPLETED|Overall Study||22
8310152|NCT01487525|20488642|P2|STARTED|Overall Study||20
8310153|NCT01487525|20488643|P1|STARTED|Overall Study||22
8310154|NCT01487499|20488653|P1|NOT COMPLETED|Overall Study||0
8310155|NCT01487499|20488653|P1|COMPLETED|Overall Study||4
8310156|NCT01487499|20488653|P1|STARTED|Overall Study||4
8310157|NCT01487265|20488659|P1|NOT COMPLETED|Overall Study||37
8310158|NCT01487265|20488659|P1|COMPLETED|Overall Study||0
8310159|NCT01487265|20488659|P1|STARTED|Overall Study||37
8310160|NCT01487200|20488671|P4|NOT COMPLETED|Overall Study||0
8310161|NCT01487200|20488672|P3|NOT COMPLETED|Overall Study||0
8310162|NCT01487200|20488673|P2|NOT COMPLETED|Overall Study||1
8310163|NCT01487200|20488674|P1|NOT COMPLETED|Overall Study||0
8310164|NCT01487200|20488671|P4|COMPLETED|Overall Study||5
8310165|NCT01487200|20488672|P3|COMPLETED|Overall Study||7
8310166|NCT01487200|20488673|P2|COMPLETED|Overall Study||6
8310167|NCT01487200|20488674|P1|COMPLETED|Overall Study||5
8310168|NCT01487200|20488671|P4|STARTED|Overall Study||5
8310169|NCT01487200|20488672|P3|STARTED|Overall Study||7
8310170|NCT01487200|20488673|P2|STARTED|Overall Study||7
8310171|NCT01487200|20488674|P1|STARTED|Overall Study||5
8310172|NCT01487161|20488704|P4|NOT COMPLETED|Overall Study||2
8310173|NCT01487161|20488705|P3|NOT COMPLETED|Overall Study||1
8310174|NCT01487161|20488706|P2|NOT COMPLETED|Overall Study||2
8310175|NCT01487161|20488707|P1|NOT COMPLETED|Overall Study||2
8310176|NCT01487161|20488704|P4|COMPLETED|Overall Study||50
8310177|NCT01487161|20488705|P3|COMPLETED|Overall Study||59
8310178|NCT01487161|20488706|P2|COMPLETED|Overall Study||57
8310179|NCT01487161|20488707|P1|COMPLETED|Overall Study||56
8310180|NCT01487161|20488704|P4|STARTED|Overall Study||52
8310181|NCT01487161|20488705|P3|STARTED|Overall Study||60
8310182|NCT01487161|20488706|P2|STARTED|Overall Study||59
8310183|NCT01487161|20488707|P1|STARTED|Overall Study||58
8310184|NCT01486966|20488772|P2|NOT COMPLETED|Overall Study||2
8310185|NCT01486966|20488773|P1|NOT COMPLETED|Overall Study||0
8310186|NCT01486966|20488772|P2|COMPLETED|Overall Study||27
8310187|NCT01486966|20488773|P1|COMPLETED|Overall Study||29
8310188|NCT01486966|20488772|P2|STARTED|Overall Study||29
8310189|NCT01486966|20488773|P1|STARTED|Overall Study||29
8310190|NCT01486927|20488797|P1|NOT COMPLETED|Overall Study||13
8310191|NCT01486927|20488797|P1|COMPLETED|Overall Study||161
8310192|NCT01486927|20488797|P1|STARTED|Overall Study||174
8310193|NCT01486810|20488828|P1|NOT COMPLETED|Overall Study||8
8310194|NCT01486810|20488828|P1|COMPLETED|Overall Study||9
8310195|NCT01486810|20488828|P1|STARTED|Overall Study||17
8310196|NCT01486758|20488835|P2|NOT COMPLETED|Overall Study||1
8310197|NCT01486758|20488836|P1|NOT COMPLETED|Overall Study||0
8310198|NCT01486758|20488835|P2|COMPLETED|Overall Study||19
8310199|NCT01486758|20488836|P1|COMPLETED|Overall Study||20
8310200|NCT01486758|20488835|P2|STARTED|Overall Study||20
8310201|NCT01486758|20488836|P1|STARTED|Overall Study||20
8310202|NCT01486615|20488860|P4|NOT COMPLETED|Overall Study||2
8310203|NCT01486615|20488861|P3|NOT COMPLETED|Overall Study||2
8310204|NCT01486615|20488862|P2|NOT COMPLETED|Overall Study||1
8310205|NCT01486615|20488863|P1|NOT COMPLETED|Overall Study||0
8310206|NCT01486615|20488860|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
8310207|NCT01486615|20488861|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
8310208|NCT01486615|20488862|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
8310209|NCT01486615|20488863|P1|COMPLETED|Overall Study||20
8310210|NCT01486615|20488860|P4|STARTED|Overall Study||20
8310211|NCT01486615|20488861|P3|STARTED|Overall Study||20
8310212|NCT01486615|20488862|P2|STARTED|Overall Study||20
8310213|NCT01486615|20488863|P1|STARTED|Overall Study||20
8310214|NCT01486446|20488903|P2|NOT COMPLETED|Overall Study||0
8310215|NCT01486446|20488904|P1|NOT COMPLETED|Overall Study||1
8310216|NCT01486446|20488903|P2|COMPLETED|Overall Study||1
8310217|NCT01486446|20488904|P1|COMPLETED|Overall Study||6
8310218|NCT01486446|20488903|P2|STARTED|Overall Study||1
8310219|NCT01486446|20488904|P1|STARTED|Overall Study||7
8310220|NCT01486316|20488927|P4|NOT COMPLETED|Overall Study||2
8310221|NCT01486316|20488928|P3|NOT COMPLETED|Overall Study||5
8310222|NCT01486316|20488929|P2|NOT COMPLETED|Overall Study||3
8310223|NCT01486316|20488930|P1|NOT COMPLETED|Overall Study||4
8310224|NCT01486316|20488927|P4|COMPLETED|Overall Study||0
8310225|NCT01486316|20488928|P3|COMPLETED|Overall Study||0
8310226|NCT01486316|20488929|P2|COMPLETED|Overall Study||7
8310227|NCT01486316|20488930|P1|COMPLETED|Overall Study||3
8310228|NCT01486316|20488927|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
8310229|NCT01486316|20488928|P3|STARTED|Overall Study|Exited prior to implant|5
8310230|NCT01486316|20488929|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
8310231|NCT01486316|20488930|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
8310232|NCT01486264|20488942|P2|NOT COMPLETED|Overall Study||47
8310233|NCT01486264|20488943|P1|NOT COMPLETED|Overall Study||29
8310234|NCT01486264|20488942|P2|COMPLETED|Overall Study||94
8310235|NCT01486264|20488943|P1|COMPLETED|Overall Study||113
8310236|NCT01486264|20488942|P2|Treated|Overall Study||140
8310237|NCT01486264|20488943|P1|Treated|Overall Study||142
8310238|NCT01486264|20488942|P2|STARTED|Overall Study||141
8310239|NCT01486264|20488943|P1|STARTED|Overall Study||142
8310240|NCT01486238|20488975|P2|NOT COMPLETED|Overall Study||6
8310241|NCT01486238|20488976|P1|NOT COMPLETED|Overall Study||2
8310242|NCT01486238|20488975|P2|COMPLETED|Overall Study||43
8310243|NCT01486238|20488976|P1|COMPLETED|Overall Study||21
8310244|NCT01486238|20488975|P2|STARTED|Overall Study||49
8310245|NCT01486238|20488976|P1|STARTED|Overall Study||23
8310246|NCT01486199|20488984|P2|NOT COMPLETED|Study Day at t= 2 Years||0
8310247|NCT01486199|20488985|P1|NOT COMPLETED|Study Day at t= 2 Years||0
8310248|NCT01486199|20488984|P2|COMPLETED|Study Day at t= 2 Years||0
8310249|NCT01486199|20488985|P1|COMPLETED|Study Day at t= 2 Years||9
8310250|NCT01486199|20488984|P2|STARTED|Study Day at t= 2 Years||0
8310251|NCT01486199|20488985|P1|STARTED|Study Day at t= 2 Years||9
8310252|NCT01486199|20488984|P2|NOT COMPLETED|Two Year Period Between Study Days||0
8310253|NCT01486199|20488985|P1|NOT COMPLETED|Two Year Period Between Study Days||1
8310254|NCT01486199|20488984|P2|COMPLETED|Two Year Period Between Study Days||0
8310255|NCT01486199|20488985|P1|COMPLETED|Two Year Period Between Study Days||9
8310256|NCT01486199|20488984|P2|STARTED|Two Year Period Between Study Days||0
8310257|NCT01486199|20488985|P1|STARTED|Two Year Period Between Study Days||10
8310258|NCT01486199|20488984|P2|NOT COMPLETED|Baseline Study Day||1
8310259|NCT01486199|20488985|P1|NOT COMPLETED|Baseline Study Day||0
8310260|NCT01486199|20488984|P2|COMPLETED|Baseline Study Day||9
8310261|NCT01486199|20488985|P1|COMPLETED|Baseline Study Day||10
8310262|NCT01486199|20488984|P2|STARTED|Baseline Study Day||10
8310263|NCT01486199|20488985|P1|STARTED|Baseline Study Day||10
8310264|NCT01486043|20488997|P1|NOT COMPLETED|Overall Study||2
8310265|NCT01486043|20488997|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
8310266|NCT01486043|20488997|P1|STARTED|Overall Study||4
8310267|NCT01485991|20489005|P2|NOT COMPLETED|Overall Study||36
8310268|NCT01485991|20489006|P1|NOT COMPLETED|Overall Study||32
8310269|NCT01485991|20489005|P2|COMPLETED|Overall Study||350
8310270|NCT01485991|20489006|P1|COMPLETED|Overall Study||353
8310271|NCT01485991|20489005|P2|Treated|Overall Study||384
8310272|NCT01485991|20489006|P1|Treated|Overall Study||379
8310273|NCT01485991|20489005|P2|STARTED|Overall Study||386
8310274|NCT01485991|20489006|P1|STARTED|Overall Study||385
8310275|NCT01485796|20489016|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
8310276|NCT01485796|20489016|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
8310277|NCT01485796|20489016|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
8310278|NCT01485796|20489016|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
8310279|NCT01485796|20489016|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
8310280|NCT01485796|20489016|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
8310281|NCT01485796|20489016|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
8310282|NCT01485796|20489016|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
8310283|NCT01485796|20489016|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
8310284|NCT01485796|20489016|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
8310285|NCT01485796|20489016|P1|NOT COMPLETED|Period 2: Epoch 2||35
8310286|NCT01485796|20489016|P1|COMPLETED|Period 2: Epoch 2||1
8310287|NCT01485796|20489016|P1|Treated in Epoch 2|Period 2: Epoch 2||36
8310288|NCT01485796|20489016|P1|STARTED|Period 2: Epoch 2||36
8310289|NCT01485796|20489016|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
8310290|NCT01485796|20489016|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
8310291|NCT01485796|20489016|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
8310292|NCT01485796|20489016|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
8310293|NCT01485640|20489038|P1|NOT COMPLETED|Overall Study||122
8310294|NCT01485640|20489038|P1|COMPLETED|Overall Study||40
8310295|NCT01485640|20489038|P1|STARTED|Overall Study||162
8310296|NCT01485627|20489045|P2|NOT COMPLETED|Overall Study||57
8310297|NCT01485627|20489046|P1|NOT COMPLETED|Overall Study||66
8310298|NCT01485627|20489045|P2|COMPLETED|Overall Study|135 patients and 49 caregivers|184
8310299|NCT01485627|20489046|P1|COMPLETED|Overall Study|130 patients and 48 caregivers|178
8310300|NCT01485627|20489045|P2|Bereaved Caregivers: 7 Month Completed|Overall Study||49
8310301|NCT01485627|20489046|P1|Bereaved Caregivers: 7 Month Completed|Overall Study||48
8310302|NCT01485627|20489045|P2|Bereaved Caregivers: 2 Month Completed|Overall Study||52
8310303|NCT01485627|20489046|P1|Bereaved Caregivers: 2 Month Completed|Overall Study||49
8310304|NCT01485627|20489045|P2|Bereaved Caregivers: 1 Month|Overall Study||51
8310305|NCT01485627|20489046|P1|Bereaved Caregivers: 1 Month|Overall Study||51
8310306|NCT01485627|20489045|P2|Bereaved Caregivers: Total|Overall Study||64
8310307|NCT01485627|20489046|P1|Bereaved Caregivers: Total|Overall Study||63
8310308|NCT01485627|20489045|P2|Allocated Caregivers: Total|Overall Study||99
8310309|NCT01485627|20489046|P1|Allocated Caregivers: Total|Overall Study||105
8310310|NCT01485627|20489045|P2|STARTED|Overall Study|142 patients and 99 caregivers|241
8310311|NCT01485627|20489046|P1|STARTED|Overall Study|139 patients and 105 caregivers|244
8310312|NCT01485614|20489068|P4|NOT COMPLETED|Weeks 20-54||0
8310313|NCT01485614|20489069|P3|NOT COMPLETED|Weeks 20-54||2
8310314|NCT01485614|20489070|P2|NOT COMPLETED|Weeks 20-54||8
8310315|NCT01485614|20489071|P1|NOT COMPLETED|Weeks 20-54||11
8310316|NCT01485614|20489068|P4|COMPLETED|Weeks 20-54||5
8310317|NCT01485614|20489069|P3|COMPLETED|Weeks 20-54||6
8310318|NCT01485614|20489070|P2|COMPLETED|Weeks 20-54||78
8310319|NCT01485614|20489071|P1|COMPLETED|Weeks 20-54||74
8310320|NCT01485614|20489068|P4|STARTED|Weeks 20-54||5
8310321|NCT01485614|20489069|P3|STARTED|Weeks 20-54||8
8310322|NCT01485614|20489070|P2|STARTED|Weeks 20-54||86
8310323|NCT01485614|20489071|P1|STARTED|Weeks 20-54||85
8310324|NCT01485614|20489068|P4|NOT COMPLETED|Weeks 0-20||0
8310325|NCT01485614|20489069|P3|NOT COMPLETED|Weeks 0-20||1
8310326|NCT01485614|20489070|P2|NOT COMPLETED|Weeks 0-20||4
8310327|NCT01485614|20489071|P1|NOT COMPLETED|Weeks 0-20||10
8310328|NCT01485614|20489068|P4|COMPLETED|Weeks 0-20||5
8310329|NCT01485614|20489069|P3|COMPLETED|Weeks 0-20||8
8310330|NCT01485614|20489070|P2|COMPLETED|Weeks 0-20||86
8310331|NCT01485614|20489071|P1|COMPLETED|Weeks 0-20||85
8310332|NCT01485614|20489068|P4|Treated|Weeks 0-20||5
8310333|NCT01485614|20489069|P3|Treated|Weeks 0-20||9
8310334|NCT01485614|20489070|P2|Treated|Weeks 0-20||90
8310335|NCT01485614|20489071|P1|Treated|Weeks 0-20||95
8310336|NCT01485614|20489068|P4|STARTED|Weeks 0-20||5
8310337|NCT01485614|20489069|P3|STARTED|Weeks 0-20||9
8310338|NCT01485614|20489070|P2|STARTED|Weeks 0-20||90
8310339|NCT01485614|20489071|P1|STARTED|Weeks 0-20||95
8310340|NCT01485614|20489068|P4|NOT COMPLETED|Randomization||0
8310341|NCT01485614|20489069|P3|NOT COMPLETED|Randomization||0
8310342|NCT01485614|20489070|P2|NOT COMPLETED|Randomization||0
8310343|NCT01485614|20489071|P1|NOT COMPLETED|Randomization||1
8310344|NCT01485614|20489068|P4|COMPLETED|Randomization||5
8310345|NCT01485614|20489069|P3|COMPLETED|Randomization||9
8310346|NCT01485614|20489070|P2|COMPLETED|Randomization||90
8310347|NCT01485614|20489071|P1|COMPLETED|Randomization||95
8310348|NCT01485614|20489068|P4|STARTED|Randomization||5
8310349|NCT01485614|20489069|P3|STARTED|Randomization||9
8310350|NCT01485614|20489070|P2|STARTED|Randomization||90
8310351|NCT01485614|20489071|P1|STARTED|Randomization||96
8310352|NCT01485588|20489430|P3|NOT COMPLETED|Overall Study||0
8310353|NCT01485588|20489431|P2|NOT COMPLETED|Overall Study||0
8310354|NCT01485588|20489432|P1|NOT COMPLETED|Overall Study||0
8310355|NCT01485588|20489430|P3|COMPLETED|Overall Study||6
8310356|NCT01485588|20489431|P2|COMPLETED|Overall Study||6
8310357|NCT01485588|20489432|P1|COMPLETED|Overall Study||6
8310358|NCT01485588|20489430|P3|STARTED|Overall Study||6
8310359|NCT01485588|20489431|P2|STARTED|Overall Study||6
8310360|NCT01485588|20489432|P1|STARTED|Overall Study||6
8310361|NCT01485536|20489443|P1|NOT COMPLETED|Overall Study||4
8310362|NCT01485536|20489443|P1|COMPLETED|Overall Study||17
8310363|NCT01485536|20489443|P1|STARTED|Overall Study||21
8310364|NCT01485393|20489448|P2|NOT COMPLETED|Overall Study||0
8310365|NCT01485393|20489449|P1|NOT COMPLETED|Overall Study||0
8310366|NCT01485393|20489448|P2|COMPLETED|Overall Study||5
8310367|NCT01485393|20489449|P1|COMPLETED|Overall Study||5
8310368|NCT01485393|20489448|P2|STARTED|Overall Study||5
8310369|NCT01485393|20489449|P1|STARTED|Overall Study||5
8310370|NCT01485380|20489457|P1|NOT COMPLETED|Overall Study||3
8310371|NCT01485380|20489457|P1|COMPLETED|Overall Study||17
8310372|NCT01485380|20489457|P1|STARTED|Overall Study||20
8310373|NCT01485354|20489461|P1|NOT COMPLETED|Overall Study||5
8310374|NCT01485354|20489461|P1|COMPLETED|Overall Study||12
8310375|NCT01485354|20489461|P1|STARTED|Overall Study||17
8310376|NCT01485172|20489475|P6|NOT COMPLETED|Overall Study||4
8310377|NCT01485172|20489476|P5|NOT COMPLETED|Overall Study||5
8310378|NCT01485172|20489477|P4|NOT COMPLETED|Overall Study||8
8310379|NCT01485172|20489478|P3|NOT COMPLETED|Overall Study||7
8310380|NCT01485172|20489479|P2|NOT COMPLETED|Overall Study||1
8310381|NCT01485172|20489480|P1|NOT COMPLETED|Overall Study||7
8310382|NCT01485172|20489475|P6|COMPLETED|Overall Study||9
8310383|NCT01485172|20489476|P5|COMPLETED|Overall Study||34
8310384|NCT01485172|20489477|P4|COMPLETED|Overall Study||32
8310385|NCT01485172|20489478|P3|COMPLETED|Overall Study||34
8310386|NCT01485172|20489479|P2|COMPLETED|Overall Study||12
8310387|NCT01485172|20489480|P1|COMPLETED|Overall Study||33
8310388|NCT01485172|20489475|P6|STARTED|Overall Study||13
8310389|NCT01485172|20489476|P5|STARTED|Overall Study||39
8310390|NCT01485172|20489477|P4|STARTED|Overall Study||40
8310391|NCT01485172|20489478|P3|STARTED|Overall Study||41
8310392|NCT01485172|20489479|P2|STARTED|Overall Study||13
8310393|NCT01485172|20489480|P1|STARTED|Overall Study||40
8310394|NCT01485120|20489554|P1|NOT COMPLETED|Overall Study||2
8310395|NCT01485120|20489554|P1|COMPLETED|Overall Study||32
8310396|NCT01485120|20489554|P1|STARTED|Overall Study||34
8310397|NCT01485094|20489562|P3|NOT COMPLETED|Overall Study||1
8310398|NCT01485094|20489563|P2|NOT COMPLETED|Overall Study||2
8310399|NCT01485094|20489564|P1|NOT COMPLETED|Overall Study||3
8310400|NCT01485094|20489562|P3|COMPLETED|Overall Study||18
8310401|NCT01485094|20489563|P2|COMPLETED|Overall Study||18
8310402|NCT01485094|20489564|P1|COMPLETED|Overall Study||17
8310403|NCT01485094|20489562|P3|STARTED|Overall Study||19
8310404|NCT01485094|20489563|P2|STARTED|Overall Study||20
8310405|NCT01485094|20489564|P1|STARTED|Overall Study||20
8310406|NCT01485055|20489605|P1|NOT COMPLETED|Overall Study||0
8310407|NCT01485055|20489605|P1|COMPLETED|Overall Study||11
8310408|NCT01485055|20489605|P1|STARTED|Overall Study||11
8310409|NCT01484977|20489609|P1|NOT COMPLETED|Overall Study||27
8310410|NCT01484977|20489609|P1|COMPLETED|Overall Study||93
8310411|NCT01484977|20489609|P1|STARTED|Overall Study||120
8310412|NCT01484951|20489613|P1|NOT COMPLETED|Overall Study||5
8310413|NCT01484951|20489613|P1|COMPLETED|Overall Study||69
8310414|NCT01484951|20489613|P1|STARTED|Overall Study||74
8310415|NCT01484938|20489618|P1|NOT COMPLETED|Overall Study||4
8310416|NCT01484938|20489618|P1|COMPLETED|Overall Study||171
8310417|NCT01484938|20489618|P1|STARTED|Overall Study||175
8310418|NCT01484912|20489625|P2|NOT COMPLETED|Overall Study||1
8310419|NCT01484912|20489626|P1|NOT COMPLETED|Overall Study||1
8310420|NCT01484912|20489625|P2|COMPLETED|Overall Study||39
8310421|NCT01484912|20489626|P1|COMPLETED|Overall Study||38
8310422|NCT01484912|20489625|P2|STARTED|Overall Study||40
8310423|NCT01484912|20489626|P1|STARTED|Overall Study||39
8310424|NCT01484873|20489636|P1|NOT COMPLETED|Overall Study||2
8310425|NCT01484873|20489636|P1|COMPLETED|Overall Study||8
8310426|NCT01484873|20489636|P1|STARTED|Overall Study||10
8310427|NCT01484834|20489648|P4|NOT COMPLETED|Overall Study||4
8310428|NCT01484834|20489649|P3|NOT COMPLETED|Overall Study||1
8310429|NCT01484834|20489650|P2|NOT COMPLETED|Overall Study||8
8310430|NCT01484834|20489651|P1|NOT COMPLETED|Overall Study||5
8310431|NCT01484834|20489648|P4|COMPLETED|Overall Study||20
8310432|NCT01484834|20489649|P3|COMPLETED|Overall Study||38
8310433|NCT01484834|20489650|P2|COMPLETED|Overall Study||54
8310434|NCT01484834|20489651|P1|COMPLETED|Overall Study||60
8310435|NCT01484834|20489648|P4|STARTED|Overall Study||24
8310436|NCT01484834|20489649|P3|STARTED|Overall Study||39
8310437|NCT01484834|20489650|P2|STARTED|Overall Study||62
8310438|NCT01484834|20489651|P1|STARTED|Overall Study||65
8310439|NCT01484652|20489679|P2|NOT COMPLETED|Overall Study||21
8310440|NCT01484652|20489680|P1|NOT COMPLETED|Overall Study||15
8310441|NCT01484652|20489679|P2|COMPLETED|Overall Study||142
8310442|NCT01484652|20489680|P1|COMPLETED|Overall Study||151
8310443|NCT01484652|20489679|P2|STARTED|Overall Study||163
8310444|NCT01484652|20489680|P1|STARTED|Overall Study||166
8310445|NCT01484626|20489686|P1|NOT COMPLETED|Overall Study||0
8310446|NCT01484626|20489686|P1|COMPLETED|Overall Study||3
8310447|NCT01484626|20489686|P1|STARTED|Overall Study||3
8310448|NCT01484561|20489692|P2|NOT COMPLETED|Overall Study||6
8310449|NCT01484561|20489693|P1|NOT COMPLETED|Overall Study||9
8310450|NCT01484561|20489692|P2|COMPLETED|Overall Study||45
8310451|NCT01484561|20489693|P1|COMPLETED|Overall Study||88
8310452|NCT01484561|20489692|P2|STARTED|Overall Study||51
8310453|NCT01484561|20489693|P1|STARTED|Overall Study||97
8310454|NCT01484496|20489783|P4|NOT COMPLETED|Period 2||22
8310455|NCT01484496|20489784|P3|NOT COMPLETED|Period 2||15
8310456|NCT01484496|20489785|P2|NOT COMPLETED|Period 2||0
8310457|NCT01484496|20489786|P1|NOT COMPLETED|Period 2||0
8310458|NCT01484496|20489783|P4|COMPLETED|Period 2||434
8310459|NCT01484496|20489784|P3|COMPLETED|Period 2||191
8310460|NCT01484496|20489785|P2|COMPLETED|Period 2||0
8310461|NCT01484496|20489786|P1|COMPLETED|Period 2||0
8310462|NCT01484496|20489783|P4|STARTED|Period 2||456
8310463|NCT01484496|20489784|P3|STARTED|Period 2||206
8310464|NCT01484496|20489785|P2|STARTED|Period 2||0
8310465|NCT01484496|20489786|P1|STARTED|Period 2||0
8310466|NCT01484496|20489783|P4|NOT COMPLETED|Period 1||0
8310467|NCT01484496|20489784|P3|NOT COMPLETED|Period 1||0
8310468|NCT01484496|20489785|P2|NOT COMPLETED|Period 1||93
8310469|NCT01484496|20489786|P1|NOT COMPLETED|Period 1||66
8310470|NCT01484496|20489783|P4|COMPLETED|Period 1||0
8310471|NCT01484496|20489784|P3|COMPLETED|Period 1||0
8310472|NCT01484496|20489785|P2|COMPLETED|Period 1||463
8310473|NCT01484496|20489786|P1|COMPLETED|Period 1||214
8310474|NCT01484496|20489783|P4|STARTED|Period 1||0
8310475|NCT01484496|20489784|P3|STARTED|Period 1||0
8310476|NCT01484496|20489785|P2|STARTED|Period 1||556
8310477|NCT01484496|20489786|P1|STARTED|Period 1||280
8310478|NCT01484431|20489801|P3|NOT COMPLETED|Period 2||2
8310479|NCT01484431|20489802|P2|NOT COMPLETED|Period 2||1
8310480|NCT01484431|20489803|P1|NOT COMPLETED|Period 2||1
8310481|NCT01484431|20489801|P3|COMPLETED|Period 2||4
8310482|NCT01484431|20489802|P2|COMPLETED|Period 2||5
8310483|NCT01484431|20489803|P1|COMPLETED|Period 2||5
8310484|NCT01484431|20489801|P3|Received 40 mg|Period 2||1
8310485|NCT01484431|20489802|P2|Received 40 mg|Period 2||0
8310486|NCT01484431|20489803|P1|Received 40 mg|Period 2||0
8310487|NCT01484431|20489801|P3|Received 20 mg|Period 2||4
8310488|NCT01484431|20489802|P2|Received 20 mg|Period 2||1
8310489|NCT01484431|20489803|P1|Received 20 mg|Period 2||3
8310490|NCT01484431|20489801|P3|Received 15 mg|Period 2||1
8310491|NCT01484431|20489802|P2|Received 15 mg|Period 2||2
8310492|NCT01484431|20489803|P1|Received 15 mg|Period 2||1
8310493|NCT01484431|20489801|P3|Received 10 mg|Period 2||0
8310494|NCT01484431|20489802|P2|Received 10 mg|Period 2||1
8310495|NCT01484431|20489803|P1|Received 10 mg|Period 2||0
8310496|NCT01484431|20489801|P3|Received 8 mg|Period 2||0
8310497|NCT01484431|20489802|P2|Received 8 mg|Period 2||0
8310498|NCT01484431|20489803|P1|Received 8 mg|Period 2||1
8310499|NCT01484431|20489801|P3|Received 7.5 mg|Period 2||0
8310500|NCT01484431|20489802|P2|Received 7.5 mg|Period 2||2
8310501|NCT01484431|20489803|P1|Received 7.5 mg|Period 2||0
8310502|NCT01484431|20489801|P3|Received 7 mg|Period 2||0
8310503|NCT01484431|20489802|P2|Received 7 mg|Period 2||0
8310504|NCT01484431|20489803|P1|Received 7 mg|Period 2||1
8310505|NCT01484431|20489801|P3|STARTED|Period 2||6
8310506|NCT01484431|20489802|P2|STARTED|Period 2||6
8310507|NCT01484431|20489803|P1|STARTED|Period 2||6
8310508|NCT01484431|20489801|P3|NOT COMPLETED|Period 1: High Dose||0
8310509|NCT01484431|20489802|P2|NOT COMPLETED|Period 1: High Dose||1
8310510|NCT01484431|20489803|P1|NOT COMPLETED|Period 1: High Dose||0
8310511|NCT01484431|20489801|P3|COMPLETED|Period 1: High Dose||6
8310512|NCT01484431|20489802|P2|COMPLETED|Period 1: High Dose||6
8310513|NCT01484431|20489803|P1|COMPLETED|Period 1: High Dose||6
8310514|NCT01484431|20489801|P3|Received 40 mg|Period 1: High Dose||5
8310515|NCT01484431|20489802|P2|Received 40 mg|Period 1: High Dose||0
8310516|NCT01484431|20489803|P1|Received 40 mg|Period 1: High Dose||0
8310517|NCT01484431|20489801|P3|Received 20 mg|Period 1: High Dose||1
8310518|NCT01484431|20489802|P2|Received 20 mg|Period 1: High Dose||5
8310519|NCT01484431|20489803|P1|Received 20 mg|Period 1: High Dose||3
8310520|NCT01484431|20489801|P3|Received 15 mg|Period 1: High Dose||0
8310521|NCT01484431|20489802|P2|Received 15 mg|Period 1: High Dose||1
8310522|NCT01484431|20489803|P1|Received 15 mg|Period 1: High Dose||1
8310523|NCT01484431|20489801|P3|Received 10 mg|Period 1: High Dose||0
8310524|NCT01484431|20489802|P2|Received 10 mg|Period 1: High Dose||1
8310525|NCT01484431|20489803|P1|Received 10 mg|Period 1: High Dose||1
8310526|NCT01484431|20489801|P3|Received 8 mg|Period 1: High Dose||0
8310527|NCT01484431|20489802|P2|Received 8 mg|Period 1: High Dose||0
8310528|NCT01484431|20489803|P1|Received 8 mg|Period 1: High Dose||1
8310529|NCT01484431|20489801|P3|STARTED|Period 1: High Dose||6
8310530|NCT01484431|20489802|P2|STARTED|Period 1: High Dose||7
8310531|NCT01484431|20489803|P1|STARTED|Period 1: High Dose||6
8310532|NCT01484431|20489801|P3|NOT COMPLETED|Period 1: Low Dose||0
8310533|NCT01484431|20489802|P2|NOT COMPLETED|Period 1: Low Dose||0
8310534|NCT01484431|20489803|P1|NOT COMPLETED|Period 1: Low Dose||0
8310535|NCT01484431|20489801|P3|COMPLETED|Period 1: Low Dose||6
8310536|NCT01484431|20489802|P2|COMPLETED|Period 1: Low Dose||7
8310537|NCT01484431|20489803|P1|COMPLETED|Period 1: Low Dose||6
8310538|NCT01484431|20489801|P3|Received 10 mg|Period 1: Low Dose||6
8310539|NCT01484431|20489802|P2|Received 10 mg|Period 1: Low Dose||0
8310540|NCT01484431|20489803|P1|Received 10 mg|Period 1: Low Dose||0
8310541|NCT01484431|20489801|P3|Received 5 mg|Period 1: Low Dose||0
8310542|NCT01484431|20489802|P2|Received 5 mg|Period 1: Low Dose||7
8310543|NCT01484431|20489803|P1|Received 5 mg|Period 1: Low Dose||0
8310544|NCT01484431|20489801|P3|Received 4 mg|Period 1: Low Dose||0
8310545|NCT01484431|20489802|P2|Received 4 mg|Period 1: Low Dose||0
8310546|NCT01484431|20489803|P1|Received 4 mg|Period 1: Low Dose||5
8310547|NCT01484431|20489801|P3|Received 2 mg|Period 1: Low Dose||0
8310548|NCT01484431|20489802|P2|Received 2 mg|Period 1: Low Dose||0
8310549|NCT01484431|20489803|P1|Received 2 mg|Period 1: Low Dose||1
8310550|NCT01484431|20489801|P3|STARTED|Period 1: Low Dose||6
8310551|NCT01484431|20489802|P2|STARTED|Period 1: Low Dose||7
8310552|NCT01484431|20489803|P1|STARTED|Period 1: Low Dose||6
8310553|NCT01484340|20489820|P2|NOT COMPLETED|Overall Study||0
8310554|NCT01484340|20489821|P1|NOT COMPLETED|Overall Study||0
8310555|NCT01484340|20489820|P2|COMPLETED|Overall Study||279
8310556|NCT01484340|20489821|P1|COMPLETED|Overall Study||281
8310557|NCT01484340|20489820|P2|STARTED|Overall Study||279
8310558|NCT01484340|20489821|P1|STARTED|Overall Study||281
8310559|NCT01484314|20489833|P1|NOT COMPLETED|Overall Study||0
8310560|NCT01484314|20489833|P1|COMPLETED|Overall Study||1
8310561|NCT01484314|20489833|P1|STARTED|Overall Study||1
8310562|NCT01484275|20489841|P2|NOT COMPLETED|Overall Study||42
8310563|NCT01484275|20489842|P1|NOT COMPLETED|Overall Study||43
8310564|NCT01484275|20489841|P2|COMPLETED|Overall Study||0
8310565|NCT01484275|20489842|P1|COMPLETED|Overall Study||0
8310566|NCT01484275|20489841|P2|STARTED|Overall Study||42
8310567|NCT01484275|20489842|P1|STARTED|Overall Study||43
8310568|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 4||0
8310569|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 4||0
8310570|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 4||0
8310571|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 4||0
8310572|NCT01484197|20489864|P4|COMPLETED|Treatment Period 4||6
8310573|NCT01484197|20489865|P3|COMPLETED|Treatment Period 4||9
8310574|NCT01484197|20489866|P2|COMPLETED|Treatment Period 4||8
8310575|NCT01484197|20489867|P1|COMPLETED|Treatment Period 4||7
8310576|NCT01484197|20489864|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
8310577|NCT01484197|20489865|P3|STARTED|Treatment Period 4||9
8310578|NCT01484197|20489866|P2|STARTED|Treatment Period 4||8
8310579|NCT01484197|20489867|P1|STARTED|Treatment Period 4||7
8310580|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 3||0
8310581|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 3||0
8310582|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 3||0
8310583|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 3||0
8310584|NCT01484197|20489864|P4|COMPLETED|Treatment Period 3||8
8310585|NCT01484197|20489865|P3|COMPLETED|Treatment Period 3||9
8310586|NCT01484197|20489866|P2|COMPLETED|Treatment Period 3||8
8310587|NCT01484197|20489867|P1|COMPLETED|Treatment Period 3||7
8310588|NCT01484197|20489864|P4|STARTED|Treatment Period 3||8
8310589|NCT01484197|20489865|P3|STARTED|Treatment Period 3||9
8310590|NCT01484197|20489866|P2|STARTED|Treatment Period 3||8
8310591|NCT01484197|20489867|P1|STARTED|Treatment Period 3||7
8310592|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 2||1
8310593|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 2||0
8310594|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 2||0
8310595|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 2||0
8310596|NCT01484197|20489864|P4|COMPLETED|Treatment Period 2||8
8310597|NCT01484197|20489865|P3|COMPLETED|Treatment Period 2||9
8310598|NCT01484197|20489866|P2|COMPLETED|Treatment Period 2||8
8310599|NCT01484197|20489867|P1|COMPLETED|Treatment Period 2||7
8310600|NCT01484197|20489864|P4|STARTED|Treatment Period 2||9
8310601|NCT01484197|20489865|P3|STARTED|Treatment Period 2||9
8310602|NCT01484197|20489866|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
8310603|NCT01484197|20489867|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
8310604|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 1||0
8310605|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 1||0
8310606|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 1||0
8310607|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 1||1
8310608|NCT01484197|20489864|P4|COMPLETED|Treatment Period 1||9
8310609|NCT01484197|20489865|P3|COMPLETED|Treatment Period 1||9
8310610|NCT01484197|20489866|P2|COMPLETED|Treatment Period 1||9
8310611|NCT01484197|20489867|P1|COMPLETED|Treatment Period 1||8
8310612|NCT01484197|20489864|P4|STARTED|Treatment Period 1||9
8310613|NCT01484197|20489865|P3|STARTED|Treatment Period 1||9
8310614|NCT01484197|20489866|P2|STARTED|Treatment Period 1||9
8310615|NCT01484197|20489867|P1|STARTED|Treatment Period 1||9
8310616|NCT01484132|20489950|P1|NOT COMPLETED|Overall Study||22
8310617|NCT01484132|20489950|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
8310618|NCT01484132|20489950|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
8310619|NCT01484132|20489950|P1|STARTED|Overall Study||113
8310620|NCT01484054|20489958|P2|NOT COMPLETED|Period 2||0
8310621|NCT01484054|20489959|P1|NOT COMPLETED|Period 2||0
8310622|NCT01484054|20489958|P2|COMPLETED|Period 2||49
8310623|NCT01484054|20489959|P1|COMPLETED|Period 2||50
8310624|NCT01484054|20489958|P2|STARTED|Period 2||49
8310625|NCT01484054|20489959|P1|STARTED|Period 2||50
8310626|NCT01484054|20489958|P2|NOT COMPLETED|Period 1||1
8310627|NCT01484054|20489959|P1|NOT COMPLETED|Period 1||0
8310628|NCT01484054|20489958|P2|COMPLETED|Period 1||49
8310629|NCT01484054|20489959|P1|COMPLETED|Period 1||50
8310630|NCT01484054|20489958|P2|STARTED|Period 1||50
8310631|NCT01484054|20489959|P1|STARTED|Period 1||50
8310632|NCT01484041|20489969|P1|NOT COMPLETED|Overall Study||0
8310633|NCT01484041|20489969|P1|COMPLETED|Overall Study||12
8310634|NCT01484041|20489969|P1|STARTED|Overall Study||12
8310635|NCT01484028|20489977|P4|NOT COMPLETED|Period 2||0
8310636|NCT01484028|20489978|P3|NOT COMPLETED|Period 2||0
8310637|NCT01484028|20489979|P2|NOT COMPLETED|Period 2||0
8310638|NCT01484028|20489980|P1|NOT COMPLETED|Period 2||0
8310639|NCT01484028|20489977|P4|COMPLETED|Period 2||66
8310640|NCT01484028|20489978|P3|COMPLETED|Period 2||64
8310641|NCT01484028|20489979|P2|COMPLETED|Period 2||67
8310642|NCT01484028|20489980|P1|COMPLETED|Period 2||66
8310643|NCT01484028|20489977|P4|STARTED|Period 2||66
8310644|NCT01484028|20489978|P3|STARTED|Period 2||64
8310645|NCT01484028|20489979|P2|STARTED|Period 2||67
8310646|NCT01484028|20489980|P1|STARTED|Period 2||66
8310647|NCT01484028|20489977|P4|NOT COMPLETED|Period 1||1
8310648|NCT01484028|20489978|P3|NOT COMPLETED|Period 1||0
8310649|NCT01484028|20489979|P2|NOT COMPLETED|Period 1||3
8310650|NCT01484028|20489980|P1|NOT COMPLETED|Period 1||0
8310651|NCT01484028|20489977|P4|COMPLETED|Period 1||66
8310652|NCT01484028|20489978|P3|COMPLETED|Period 1||64
8310653|NCT01484028|20489979|P2|COMPLETED|Period 1||67
8310654|NCT01484028|20489980|P1|COMPLETED|Period 1||66
8310655|NCT01484028|20489977|P4|STARTED|Period 1||67
8310656|NCT01484028|20489978|P3|STARTED|Period 1||64
8310657|NCT01484028|20489979|P2|STARTED|Period 1||70
8310658|NCT01484028|20489980|P1|STARTED|Period 1||66
8310659|NCT01483963|20489995|P5|NOT COMPLETED|Overall Study||0
8310660|NCT01483963|20489996|P4|NOT COMPLETED|Overall Study||0
8310661|NCT01483963|20489997|P3|NOT COMPLETED|Overall Study||0
8310662|NCT01483963|20489998|P2|NOT COMPLETED|Overall Study||0
8310663|NCT01483963|20489999|P1|NOT COMPLETED|Overall Study||0
8310664|NCT01483963|20489995|P5|COMPLETED|Overall Study||10
8310665|NCT01483963|20489996|P4|COMPLETED|Overall Study||10
8310666|NCT01483963|20489997|P3|COMPLETED|Overall Study||10
8310667|NCT01483963|20489998|P2|COMPLETED|Overall Study||10
8310668|NCT01483963|20489999|P1|COMPLETED|Overall Study||10
8310669|NCT01483963|20489995|P5|STARTED|Overall Study||10
8310670|NCT01483963|20489996|P4|STARTED|Overall Study||10
8310671|NCT01483963|20489997|P3|STARTED|Overall Study||10
8310672|NCT01483963|20489998|P2|STARTED|Overall Study||10
8310673|NCT01483963|20489999|P1|STARTED|Overall Study||10
8310674|NCT01483937|20490073|P2|NOT COMPLETED|Overall Study||3
8310675|NCT01483937|20490074|P1|NOT COMPLETED|Overall Study||4
8310676|NCT01483937|20490073|P2|COMPLETED|Overall Study||14
8310677|NCT01483937|20490074|P1|COMPLETED|Overall Study||11
8310678|NCT01483937|20490073|P2|STARTED|Overall Study||17
8310679|NCT01483937|20490074|P1|STARTED|Overall Study||15
8310680|NCT01483924|20490101|P5|NOT COMPLETED|Overall Study||2
8310681|NCT01483924|20490102|P4|NOT COMPLETED|Overall Study||4
8310682|NCT01483924|20490103|P3|NOT COMPLETED|Overall Study||1
8310683|NCT01483924|20490104|P2|NOT COMPLETED|Overall Study||0
8310684|NCT01483924|20490105|P1|NOT COMPLETED|Overall Study||2
8310685|NCT01483924|20490101|P5|COMPLETED|Overall Study||10
8310686|NCT01483924|20490102|P4|COMPLETED|Overall Study||8
8310687|NCT01483924|20490103|P3|COMPLETED|Overall Study||11
8310688|NCT01483924|20490104|P2|COMPLETED|Overall Study||12
8310689|NCT01483924|20490105|P1|COMPLETED|Overall Study||10
8310690|NCT01483924|20490101|P5|STARTED|Overall Study||12
8310691|NCT01483924|20490102|P4|STARTED|Overall Study||12
8310692|NCT01483924|20490103|P3|STARTED|Overall Study||12
8310693|NCT01483924|20490104|P2|STARTED|Overall Study||12
8310694|NCT01483924|20490105|P1|STARTED|Overall Study||12
8310695|NCT01483872|20490153|P2|NOT COMPLETED|Overall Study||0
8310696|NCT01483872|20490154|P1|NOT COMPLETED|Overall Study||0
8310697|NCT01483872|20490153|P2|COMPLETED|Overall Study||1
8310698|NCT01483872|20490154|P1|COMPLETED|Overall Study||0
8310699|NCT01483872|20490153|P2|STARTED|Overall Study||1
8310700|NCT01483872|20490154|P1|STARTED|Overall Study||0
8310701|NCT01483820|20490158|P1|NOT COMPLETED|Overall Study||8
8310702|NCT01483820|20490158|P1|COMPLETED|Overall Study||0
8310703|NCT01483820|20490158|P1|STARTED|Overall Study||8
8310704|NCT01483807|20490167|P2|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8310705|NCT01483807|20490168|P1|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8310706|NCT01483807|20490167|P2|COMPLETED|Second Treatment Phase (7 Weeks)||10
8310707|NCT01483807|20490168|P1|COMPLETED|Second Treatment Phase (7 Weeks)||10
8310708|NCT01483807|20490167|P2|STARTED|Second Treatment Phase (7 Weeks)||10
8310709|NCT01483807|20490168|P1|STARTED|Second Treatment Phase (7 Weeks)||10
8310710|NCT01483807|20490167|P2|NOT COMPLETED|Washout (2 Weeks)||0
8310711|NCT01483807|20490168|P1|NOT COMPLETED|Washout (2 Weeks)||0
8310712|NCT01483807|20490167|P2|COMPLETED|Washout (2 Weeks)||10
8310713|NCT01483807|20490168|P1|COMPLETED|Washout (2 Weeks)||10
8310714|NCT01483807|20490167|P2|STARTED|Washout (2 Weeks)||10
8310715|NCT01483807|20490168|P1|STARTED|Washout (2 Weeks)||10
8310716|NCT01483807|20490167|P2|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
8310717|NCT01483807|20490168|P1|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
8310718|NCT01483807|20490167|P2|COMPLETED|First Treatment Phase (7 Weeks)||10
8310719|NCT01483807|20490168|P1|COMPLETED|First Treatment Phase (7 Weeks)||10
8310720|NCT01483807|20490167|P2|STARTED|First Treatment Phase (7 Weeks)||10
8310721|NCT01483807|20490168|P1|STARTED|First Treatment Phase (7 Weeks)||10
8310722|NCT01483690|20490181|P2|NOT COMPLETED|Overall Study||5
8310723|NCT01483690|20490182|P1|NOT COMPLETED|Overall Study||2
8310724|NCT01483690|20490181|P2|COMPLETED|Overall Study||13
8310725|NCT01483690|20490182|P1|COMPLETED|Overall Study||3
8310726|NCT01483690|20490181|P2|STARTED|Overall Study||18
8310727|NCT01483690|20490182|P1|STARTED|Overall Study||5
8310728|NCT01483651|20490190|P6|NOT COMPLETED|Overall Study||1
8310729|NCT01483651|20490191|P5|NOT COMPLETED|Overall Study||0
8310730|NCT01483651|20490192|P4|NOT COMPLETED|Overall Study||0
8310731|NCT01483651|20490193|P3|NOT COMPLETED|Overall Study||1
8310732|NCT01483651|20490194|P2|NOT COMPLETED|Overall Study||1
8310733|NCT01483651|20490195|P1|NOT COMPLETED|Overall Study||0
8310734|NCT01483651|20490190|P6|COMPLETED|Overall Study||1
8310735|NCT01483651|20490191|P5|COMPLETED|Overall Study||2
8310736|NCT01483651|20490192|P4|COMPLETED|Overall Study||1
8310737|NCT01483651|20490193|P3|COMPLETED|Overall Study||1
8310738|NCT01483651|20490194|P2|COMPLETED|Overall Study||2
8310739|NCT01483651|20490195|P1|COMPLETED|Overall Study||1
8310740|NCT01483651|20490190|P6|STARTED|Overall Study||2
8310741|NCT01483651|20490191|P5|STARTED|Overall Study||2
8310742|NCT01483651|20490192|P4|STARTED|Overall Study||1
8310743|NCT01483651|20490193|P3|STARTED|Overall Study||2
8310744|NCT01483651|20490194|P2|STARTED|Overall Study||3
8310745|NCT01483651|20490195|P1|STARTED|Overall Study||1
8310746|NCT01483625|20490205|P2|NOT COMPLETED|Overall Study||2
8310747|NCT01483625|20490206|P1|NOT COMPLETED|Overall Study||4
8310748|NCT01483625|20490205|P2|COMPLETED|Overall Study||66
8310749|NCT01483625|20490206|P1|COMPLETED|Overall Study||68
8310750|NCT01483625|20490205|P2|STARTED|Overall Study||68
8310751|NCT01483625|20490206|P1|STARTED|Overall Study||72
8310752|NCT01483599|20490229|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
8310753|NCT01483599|20490230|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
8310754|NCT01483599|20490231|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
8310755|NCT01483599|20490232|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
8310756|NCT01483599|20490233|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
8310757|NCT01483599|20490234|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
8310758|NCT01483599|20490235|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
8310759|NCT01483599|20490236|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310760|NCT01483599|20490237|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310761|NCT01483599|20490238|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310762|NCT01483599|20490239|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310763|NCT01483599|20490240|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310764|NCT01483599|20490241|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310765|NCT01483599|20490242|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310766|NCT01483599|20490229|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
8310767|NCT01483599|20490230|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
8310768|NCT01483599|20490231|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
8310769|NCT01483599|20490232|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8310770|NCT01483599|20490233|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8310771|NCT01483599|20490234|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
8310772|NCT01483599|20490235|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8310773|NCT01483599|20490236|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310774|NCT01483599|20490237|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310775|NCT01483599|20490238|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310776|NCT01483599|20490239|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310777|NCT01483599|20490240|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310778|NCT01483599|20490241|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310779|NCT01483599|20490242|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310780|NCT01483599|20490229|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
8310781|NCT01483599|20490230|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
8310782|NCT01483599|20490231|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
8310783|NCT01483599|20490232|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
8310784|NCT01483599|20490233|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
8310785|NCT01483599|20490234|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
8310786|NCT01483599|20490235|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
8310787|NCT01483599|20490236|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
8310788|NCT01483599|20490237|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
8310789|NCT01483599|20490238|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
8310790|NCT01483599|20490239|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
8310791|NCT01483599|20490240|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
8310792|NCT01483599|20490241|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
8310793|NCT01483599|20490242|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
8310794|NCT01483599|20490229|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310795|NCT01483599|20490230|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310796|NCT01483599|20490231|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310797|NCT01483599|20490232|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310798|NCT01483599|20490233|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310799|NCT01483599|20490234|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310800|NCT01483599|20490235|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310801|NCT01483599|20490236|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
8310802|NCT01483599|20490237|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
8310803|NCT01483599|20490238|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
8310804|NCT01483599|20490239|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8310805|NCT01483599|20490240|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310806|NCT01483599|20490241|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8310807|NCT01483599|20490242|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8310808|NCT01483599|20490229|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310809|NCT01483599|20490230|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310810|NCT01483599|20490231|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310811|NCT01483599|20490232|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310812|NCT01483599|20490233|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310813|NCT01483599|20490234|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310814|NCT01483599|20490235|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310815|NCT01483599|20490236|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8310816|NCT01483599|20490237|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
8310817|NCT01483599|20490238|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
8310818|NCT01483599|20490239|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8310819|NCT01483599|20490240|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
8310820|NCT01483599|20490241|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
8310821|NCT01483599|20490242|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8310822|NCT01483599|20490229|P14|Treated|Controlled Period (CP) (up to Week 16)||0
8310823|NCT01483599|20490230|P13|Treated|Controlled Period (CP) (up to Week 16)||0
8310824|NCT01483599|20490231|P12|Treated|Controlled Period (CP) (up to Week 16)||0
8310825|NCT01483599|20490232|P11|Treated|Controlled Period (CP) (up to Week 16)||0
8310826|NCT01483599|20490233|P10|Treated|Controlled Period (CP) (up to Week 16)||0
8310827|NCT01483599|20490234|P9|Treated|Controlled Period (CP) (up to Week 16)||0
8310828|NCT01483599|20490235|P8|Treated|Controlled Period (CP) (up to Week 16)||0
8310829|NCT01483599|20490236|P7|Treated|Controlled Period (CP) (up to Week 16)||43
8310830|NCT01483599|20490237|P6|Treated|Controlled Period (CP) (up to Week 16)||41
8310831|NCT01483599|20490238|P5|Treated|Controlled Period (CP) (up to Week 16)||42
8310832|NCT01483599|20490239|P4|Treated|Controlled Period (CP) (up to Week 16)||42
8310833|NCT01483599|20490240|P3|Treated|Controlled Period (CP) (up to Week 16)||41
8310834|NCT01483599|20490241|P2|Treated|Controlled Period (CP) (up to Week 16)||41
8310835|NCT01483599|20490242|P1|Treated|Controlled Period (CP) (up to Week 16)||42
8310836|NCT01483599|20490229|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
8310837|NCT01483599|20490230|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
8310838|NCT01483599|20490231|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
8310839|NCT01483599|20490232|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
8310840|NCT01483599|20490233|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
8310841|NCT01483599|20490234|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
8310842|NCT01483599|20490235|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
8310843|NCT01483599|20490236|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
8310844|NCT01483599|20490237|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
8310845|NCT01483599|20490238|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
8310846|NCT01483599|20490239|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
8310847|NCT01483599|20490240|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
8310848|NCT01483599|20490241|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
8310849|NCT01483599|20490242|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
8310850|NCT01483560|20490293|P2|NOT COMPLETED|Overall Study||15
8310851|NCT01483560|20490294|P1|NOT COMPLETED|Overall Study||26
8310852|NCT01483560|20490293|P2|COMPLETED|Overall Study||194
8310853|NCT01483560|20490294|P1|COMPLETED|Overall Study||193
8310854|NCT01483560|20490293|P2|STARTED|Overall Study||209
8310855|NCT01483560|20490294|P1|STARTED|Overall Study||219
8310856|NCT01483378|20490314|P2|NOT COMPLETED|Overall Study||0
8310857|NCT01483378|20490315|P1|NOT COMPLETED|Overall Study||0
8310858|NCT01483378|20490314|P2|COMPLETED|Overall Study||66
8310859|NCT01483378|20490315|P1|COMPLETED|Overall Study||100
8310860|NCT01483378|20490314|P2|STARTED|Overall Study||66
8310861|NCT01483378|20490315|P1|STARTED|Overall Study||100
8310862|NCT01483352|20490321|P1|NOT COMPLETED|Overall Study||0
8310863|NCT01483352|20490321|P1|COMPLETED|Overall Study||12
8310864|NCT01483352|20490321|P1|STARTED|Overall Study||12
8310865|NCT01483209|20490340|P1|NOT COMPLETED|Overall Study||1
8310866|NCT01483209|20490340|P1|COMPLETED|Overall Study||1
8310867|NCT01483209|20490340|P1|STARTED|Overall Study||2
8310868|NCT01483183|20490355|P10|NOT COMPLETED|Overall Study||1
8310869|NCT01483183|20490356|P9|NOT COMPLETED|Overall Study||0
8310870|NCT01483183|20490357|P8|NOT COMPLETED|Overall Study||0
8310871|NCT01483183|20490358|P7|NOT COMPLETED|Overall Study||2
8310872|NCT01483183|20490359|P6|NOT COMPLETED|Overall Study||0
8310873|NCT01483183|20490360|P5|NOT COMPLETED|Overall Study||0
8310874|NCT01483183|20490361|P4|NOT COMPLETED|Overall Study||0
8310875|NCT01483183|20490362|P3|NOT COMPLETED|Overall Study||0
8310876|NCT01483183|20490363|P2|NOT COMPLETED|Overall Study||0
8310877|NCT01483183|20490364|P1|NOT COMPLETED|Overall Study||0
8310878|NCT01483183|20490355|P10|COMPLETED|Overall Study||4
8310879|NCT01483183|20490356|P9|COMPLETED|Overall Study||4
8310880|NCT01483183|20490357|P8|COMPLETED|Overall Study||4
8310881|NCT01483183|20490358|P7|COMPLETED|Overall Study||4
8310882|NCT01483183|20490359|P6|COMPLETED|Overall Study||4
8310883|NCT01483183|20490360|P5|COMPLETED|Overall Study||4
8310884|NCT01483183|20490361|P4|COMPLETED|Overall Study||3
8310885|NCT01483183|20490362|P3|COMPLETED|Overall Study||5
8310886|NCT01483183|20490363|P2|COMPLETED|Overall Study||1
8310887|NCT01483183|20490364|P1|COMPLETED|Overall Study||4
8310888|NCT01483183|20490355|P10|STARTED|Overall Study||5
8310889|NCT01483183|20490356|P9|STARTED|Overall Study||4
8310890|NCT01483183|20490357|P8|STARTED|Overall Study||4
8310891|NCT01483183|20490358|P7|STARTED|Overall Study||6
8310892|NCT01483183|20490359|P6|STARTED|Overall Study||4
8310893|NCT01483183|20490360|P5|STARTED|Overall Study||4
8310894|NCT01483183|20490361|P4|STARTED|Overall Study||3
8310895|NCT01483183|20490362|P3|STARTED|Overall Study||5
8310896|NCT01483183|20490363|P2|STARTED|Overall Study||1
8310897|NCT01483183|20490364|P1|STARTED|Overall Study||4
8310898|NCT01483118|20490434|P2|NOT COMPLETED|Overall Study||16
8310899|NCT01483118|20490435|P1|NOT COMPLETED|Overall Study||12
8310900|NCT01483118|20490434|P2|COMPLETED|Overall Study||6
8310901|NCT01483118|20490435|P1|COMPLETED|Overall Study||11
8310902|NCT01483118|20490434|P2|Completed 3 Months|Overall Study||11
8310903|NCT01483118|20490435|P1|Completed 3 Months|Overall Study||15
8310904|NCT01483118|20490434|P2|STARTED|Overall Study||22
8310905|NCT01483118|20490435|P1|STARTED|Overall Study||23
8310906|NCT01482962|20490447|P2|NOT COMPLETED|Overall Study||133
8310907|NCT01482962|20490448|P1|NOT COMPLETED|Overall Study||138
8310908|NCT01482962|20490447|P2|COMPLETED|Overall Study||0
8310909|NCT01482962|20490448|P1|COMPLETED|Overall Study||0
8310910|NCT01482962|20490447|P2|Safety Population: Received Study Drug|Overall Study||127
8310911|NCT01482962|20490448|P1|Safety Population: Received Study Drug|Overall Study||137
8310912|NCT01482962|20490447|P2|STARTED|Overall Study||133
8310913|NCT01482962|20490448|P1|STARTED|Overall Study||138
8310914|NCT01482910|20490481|P2|NOT COMPLETED|Overall Study||9
8310915|NCT01482910|20490482|P1|NOT COMPLETED|Overall Study||15
8310916|NCT01482910|20490481|P2|COMPLETED|Overall Study||67
8310917|NCT01482910|20490482|P1|COMPLETED|Overall Study||213
8310918|NCT01482910|20490481|P2|Completed Week 28|Overall Study||71
8310919|NCT01482910|20490482|P1|Completed Week 28|Overall Study||216
8310920|NCT01482910|20490481|P2|STARTED|Overall Study||76
8310921|NCT01482910|20490482|P1|STARTED|Overall Study||228
8310922|NCT01482884|20490494|P2|NOT COMPLETED|Overall Study||18
8310923|NCT01482884|20490495|P1|NOT COMPLETED|Overall Study||13
8310924|NCT01482884|20490494|P2|COMPLETED|Overall Study||37
8310925|NCT01482884|20490495|P1|COMPLETED|Overall Study||43
8310926|NCT01482884|20490494|P2|STARTED|Overall Study||55
8310927|NCT01482884|20490495|P1|STARTED|Overall Study|One participant did not receive study treatment|56
8310928|NCT01482819|20490521|P1|NOT COMPLETED|Overall Study||2
8310929|NCT01482819|20490521|P1|COMPLETED|Overall Study||19
8310930|NCT01482819|20490521|P1|STARTED|Overall Study||21
8310931|NCT01482767|20490541|P2|NOT COMPLETED|Overall Study||49
8310932|NCT01482767|20490542|P1|NOT COMPLETED|Overall Study||54
8310933|NCT01482767|20490541|P2|COMPLETED|Overall Study||78
8310934|NCT01482767|20490542|P1|COMPLETED|Overall Study||81
8310935|NCT01482767|20490541|P2|STARTED|Overall Study||127
8310936|NCT01482767|20490542|P1|STARTED|Overall Study||135
8310937|NCT01482715|20490575|P13|NOT COMPLETED|Overall Study||0
8310938|NCT01482715|20490576|P12|NOT COMPLETED|Overall Study||0
8310939|NCT01482715|20490577|P11|NOT COMPLETED|Overall Study||0
8310940|NCT01482715|20490578|P10|NOT COMPLETED|Overall Study||0
8310941|NCT01482715|20490579|P9|NOT COMPLETED|Overall Study||0
8310942|NCT01482715|20490580|P8|NOT COMPLETED|Overall Study||0
8310943|NCT01482715|20490581|P7|NOT COMPLETED|Overall Study||0
8310944|NCT01482715|20490582|P6|NOT COMPLETED|Overall Study||0
8310945|NCT01482715|20490583|P5|NOT COMPLETED|Overall Study||0
8310946|NCT01482715|20490584|P4|NOT COMPLETED|Overall Study||0
8310947|NCT01482715|20490585|P3|NOT COMPLETED|Overall Study||0
8310948|NCT01482715|20490586|P2|NOT COMPLETED|Overall Study||0
8310949|NCT01482715|20490587|P1|NOT COMPLETED|Overall Study||0
8310950|NCT01482715|20490575|P13|COMPLETED|Overall Study||26
8310951|NCT01482715|20490576|P12|COMPLETED|Overall Study||12
8310952|NCT01482715|20490577|P11|COMPLETED|Overall Study||42
8310953|NCT01482715|20490578|P10|COMPLETED|Overall Study||3
8310954|NCT01482715|20490579|P9|COMPLETED|Overall Study||7
8310955|NCT01482715|20490580|P8|COMPLETED|Overall Study||9
8310956|NCT01482715|20490581|P7|COMPLETED|Overall Study||8
8310957|NCT01482715|20490582|P6|COMPLETED|Overall Study||3
8310958|NCT01482715|20490583|P5|COMPLETED|Overall Study||4
8310959|NCT01482715|20490584|P4|COMPLETED|Overall Study||9
8310960|NCT01482715|20490585|P3|COMPLETED|Overall Study||4
8310961|NCT01482715|20490586|P2|COMPLETED|Overall Study||3
8310962|NCT01482715|20490587|P1|COMPLETED|Overall Study||6
8310963|NCT01482715|20490575|P13|STARTED|Overall Study||26
8310964|NCT01482715|20490576|P12|STARTED|Overall Study||12
8310965|NCT01482715|20490577|P11|STARTED|Overall Study||42
8310966|NCT01482715|20490578|P10|STARTED|Overall Study||3
8310967|NCT01482715|20490579|P9|STARTED|Overall Study||7
8310968|NCT01482715|20490580|P8|STARTED|Overall Study||9
8310969|NCT01482715|20490581|P7|STARTED|Overall Study||8
8310970|NCT01482715|20490582|P6|STARTED|Overall Study||3
8310971|NCT01482715|20490583|P5|STARTED|Overall Study||4
8310972|NCT01482715|20490584|P4|STARTED|Overall Study||9
8310973|NCT01482715|20490585|P3|STARTED|Overall Study||4
8310974|NCT01482715|20490586|P2|STARTED|Overall Study||3
8310975|NCT01482715|20490587|P1|STARTED|Overall Study||6
8310976|NCT01482598|20490670|P2|NOT COMPLETED|Overall Study||22
8310977|NCT01482598|20490671|P1|NOT COMPLETED|Overall Study||16
8310978|NCT01482598|20490670|P2|COMPLETED|Overall Study||51
8310979|NCT01482598|20490671|P1|COMPLETED|Overall Study||50
8310980|NCT01482598|20490670|P2|STARTED|Overall Study||73
8310981|NCT01482598|20490671|P1|STARTED|Overall Study||66
8310982|NCT01482429|20490679|P2|NOT COMPLETED|Protocol||0
8310983|NCT01482429|20490680|P1|NOT COMPLETED|Protocol||275
8310984|NCT01482429|20490679|P2|COMPLETED|Protocol||0
8310985|NCT01482429|20490680|P1|COMPLETED|Protocol||139
8310986|NCT01482429|20490679|P2|STARTED|Protocol||0
8310987|NCT01482429|20490680|P1|STARTED|Protocol||414
8310988|NCT01482429|20490679|P2|NOT COMPLETED|Care Usual||173
8310989|NCT01482429|20490680|P1|NOT COMPLETED|Care Usual||0
8310990|NCT01482429|20490679|P2|COMPLETED|Care Usual||96
8310991|NCT01482429|20490680|P1|COMPLETED|Care Usual||0
8310992|NCT01482429|20490679|P2|STARTED|Care Usual||269
8310993|NCT01482429|20490680|P1|STARTED|Care Usual||0
8310994|NCT01482351|20490690|P1|NOT COMPLETED|Overall Study||14
8310995|NCT01482351|20490690|P1|COMPLETED|Overall Study||54
8310996|NCT01482351|20490690|P1|12 Months|Overall Study||54
8310997|NCT01482351|20490690|P1|6 Months|Overall Study|14 dropped out|54
8310998|NCT01482351|20490690|P1|STARTED|Overall Study||68
8310999|NCT01482325|20490712|P1|NOT COMPLETED|Overall Study||0
8311000|NCT01482325|20490712|P1|COMPLETED|Overall Study||31
8311001|NCT01482325|20490712|P1|STARTED|Overall Study||31
8311002|NCT01482312|20490716|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8311003|NCT01482312|20490717|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8311004|NCT01482312|20490718|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8311005|NCT01482312|20490716|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
8311006|NCT01482312|20490717|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
8311007|NCT01482312|20490718|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
8311008|NCT01482312|20490716|P3|STARTED|Period 3, 90 Minutes of Wear||9
8311009|NCT01482312|20490717|P2|STARTED|Period 3, 90 Minutes of Wear||9
8311010|NCT01482312|20490718|P1|STARTED|Period 3, 90 Minutes of Wear||8
8311011|NCT01482312|20490716|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
8311012|NCT01482312|20490717|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
8311013|NCT01482312|20490718|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
8311014|NCT01482312|20490716|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
8311015|NCT01482312|20490717|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
8311016|NCT01482312|20490718|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
8311017|NCT01482312|20490716|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
8311018|NCT01482312|20490717|P2|STARTED|Period 2, 90 Minutes of Wear||9
8311019|NCT01482312|20490718|P1|STARTED|Period 2, 90 Minutes of Wear||9
8311020|NCT01482312|20490716|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
8311021|NCT01482312|20490717|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
8311022|NCT01482312|20490718|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
8311023|NCT01482312|20490716|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
8311024|NCT01482312|20490717|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
8311025|NCT01482312|20490718|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
8311026|NCT01482312|20490716|P3|STARTED|Period 1, 90 Minutes of Wear||10
8311027|NCT01482312|20490717|P2|STARTED|Period 1, 90 Minutes of Wear||9
8311028|NCT01482312|20490718|P1|STARTED|Period 1, 90 Minutes of Wear||10
8311029|NCT01482221|20490732|P3|NOT COMPLETED|Overall Study||23
8311030|NCT01482221|20490733|P2|NOT COMPLETED|Overall Study||20
8311031|NCT01482221|20490734|P1|NOT COMPLETED|Overall Study||21
8311032|NCT01482221|20490732|P3|COMPLETED|Overall Study||77
8311033|NCT01482221|20490733|P2|COMPLETED|Overall Study||81
8311034|NCT01482221|20490734|P1|COMPLETED|Overall Study||80
8311035|NCT01482221|20490732|P3|STARTED|Overall Study||100
8311036|NCT01482221|20490733|P2|STARTED|Overall Study||101
8311037|NCT01482221|20490734|P1|STARTED|Overall Study||101
8311038|NCT01482169|20490775|P1|NOT COMPLETED|Overall Study||2
8311039|NCT01482169|20490775|P1|COMPLETED|Overall Study||46
8311040|NCT01482169|20490775|P1|STARTED|Overall Study||48
8311041|NCT01482091|20490784|P2|NOT COMPLETED|Overall Study||0
8311042|NCT01482091|20490785|P1|NOT COMPLETED|Overall Study||0
8311043|NCT01482091|20490784|P2|COMPLETED|Overall Study||24
8311044|NCT01482091|20490785|P1|COMPLETED|Overall Study||25
8311045|NCT01482091|20490784|P2|STARTED|Overall Study||24
8311046|NCT01482091|20490785|P1|STARTED|Overall Study||25
8311047|NCT01482065|20490817|P2|NOT COMPLETED|Overall Study||1
8311048|NCT01482065|20490818|P1|NOT COMPLETED|Overall Study||0
8311049|NCT01482065|20490817|P2|COMPLETED|Overall Study||4
8311050|NCT01482065|20490818|P1|COMPLETED|Overall Study||4
8311051|NCT01482065|20490817|P2|STARTED|Overall Study||5
8311052|NCT01482065|20490818|P1|STARTED|Overall Study||4
8311053|NCT01481935|20490832|P2|NOT COMPLETED|Overall Study||0
8311054|NCT01481935|20490833|P1|NOT COMPLETED|Overall Study||0
8311055|NCT01481935|20490832|P2|COMPLETED|Overall Study||93
8311056|NCT01481935|20490833|P1|COMPLETED|Overall Study||97
8311057|NCT01481935|20490832|P2|STARTED|Overall Study||93
8311058|NCT01481935|20490833|P1|STARTED|Overall Study||97
8311059|NCT01481896|20490839|P1|NOT COMPLETED|Overall Study||12
8311060|NCT01481896|20490839|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
8311061|NCT01481896|20490839|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
8311062|NCT01481896|20490839|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
8311063|NCT01481779|20490855|P2|NOT COMPLETED|Overall Study||28
8311064|NCT01481779|20490856|P1|NOT COMPLETED|Overall Study||70
8311065|NCT01481779|20490855|P2|COMPLETED|Overall Study||132
8311066|NCT01481779|20490856|P1|COMPLETED|Overall Study||225
8311067|NCT01481779|20490855|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
8311068|NCT01481779|20490856|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
8311069|NCT01481779|20490855|P2|STARTED|Overall Study||160
8311070|NCT01481779|20490856|P1|STARTED|Overall Study||295
8311071|NCT01481740|20490904|P2|NOT COMPLETED|Overall Study||7
8311072|NCT01481740|20490905|P1|NOT COMPLETED|Overall Study||11
8311073|NCT01481740|20490904|P2|COMPLETED|Overall Study||81
8311074|NCT01481740|20490905|P1|COMPLETED|Overall Study||79
8311075|NCT01481740|20490904|P2|STARTED|Overall Study||88
8311076|NCT01481740|20490905|P1|STARTED|Overall Study||90
8311077|NCT01481558|20490923|P2|NOT COMPLETED|Overall Study||0
8311078|NCT01481558|20490924|P1|NOT COMPLETED|Overall Study||0
8311079|NCT01481558|20490923|P2|COMPLETED|Overall Study||20
8311080|NCT01481558|20490924|P1|COMPLETED|Overall Study||20
8311081|NCT01481558|20490923|P2|STARTED|Overall Study||20
8311082|NCT01481558|20490924|P1|STARTED|Overall Study||20
8311083|NCT01481376|20490930|P1|NOT COMPLETED|Overall Study||31
8311084|NCT01481376|20490930|P1|COMPLETED|Overall Study||169
8311085|NCT01481376|20490930|P1|STARTED|Overall Study||200
8311086|NCT01481324|20490941|P3|NOT COMPLETED|Overall Study||2
8311087|NCT01481324|20490942|P2|NOT COMPLETED|Overall Study||2
8311088|NCT01481324|20490943|P1|NOT COMPLETED|Overall Study||0
8311089|NCT01481324|20490941|P3|COMPLETED|Overall Study||20
8311090|NCT01481324|20490942|P2|COMPLETED|Overall Study||22
8311091|NCT01481324|20490943|P1|COMPLETED|Overall Study||21
8311092|NCT01481324|20490941|P3|Month 3-Wear Rate Data|Overall Study||6
8311093|NCT01481324|20490942|P2|Month 3-Wear Rate Data|Overall Study||11
8311094|NCT01481324|20490943|P1|Month 3-Wear Rate Data|Overall Study||7
8311095|NCT01481324|20490941|P3|Month 2-Wear Rate Data|Overall Study||7
8311096|NCT01481324|20490942|P2|Month 2-Wear Rate Data|Overall Study||13
8311097|NCT01481324|20490943|P1|Month 2-Wear Rate Data|Overall Study||9
8311098|NCT01481324|20490941|P3|Month 1-Wear Rate Data|Overall Study||8
8311099|NCT01481324|20490942|P2|Month 1-Wear Rate Data|Overall Study||16
8311100|NCT01481324|20490943|P1|Month 1-Wear Rate Data|Overall Study||15
8311101|NCT01481324|20490941|P3|STARTED|Overall Study||22
8311102|NCT01481324|20490942|P2|STARTED|Overall Study||24
8311103|NCT01481324|20490943|P1|STARTED|Overall Study||21
8311104|NCT01481129|20490951|P1|NOT COMPLETED|Overall Study||0
8311105|NCT01481129|20490951|P1|COMPLETED|Overall Study||22
8311106|NCT01481129|20490951|P1|STARTED|Overall Study||22
8311107|NCT01481116|20490962|P3|NOT COMPLETED|Overall Study||813
8311108|NCT01481116|20490963|P2|NOT COMPLETED|Overall Study||817
8311109|NCT01481116|20490964|P1|NOT COMPLETED|Overall Study||824
8311110|NCT01481116|20490962|P3|COMPLETED|Overall Study||0
8311111|NCT01481116|20490963|P2|COMPLETED|Overall Study||0
8311112|NCT01481116|20490964|P1|COMPLETED|Overall Study||0
8311113|NCT01481116|20490962|P3|Treated|Overall Study||813
8311114|NCT01481116|20490963|P2|Treated|Overall Study||816
8311115|NCT01481116|20490964|P1|Treated|Overall Study||822
8311116|NCT01481116|20490962|P3|STARTED|Overall Study||813
8311117|NCT01481116|20490963|P2|STARTED|Overall Study||817
8311118|NCT01481116|20490964|P1|STARTED|Overall Study||824
8311119|NCT01480843|20490990|P1|NOT COMPLETED|Overall Study||5
8311120|NCT01480843|20490990|P1|COMPLETED|Overall Study||60
8311121|NCT01480843|20490990|P1|STARTED|Overall Study||65
8311122|NCT01480674|20490995|P1|NOT COMPLETED|Overall Study||35
8311123|NCT01480674|20490995|P1|COMPLETED|Overall Study||125
8311124|NCT01480674|20490995|P1|Analysed Set|Overall Study||128
8311125|NCT01480674|20490995|P1|Safety Set|Overall Study||154
8311126|NCT01480674|20490995|P1|STARTED|Overall Study||160
8311127|NCT01480596|20491009|P2|NOT COMPLETED|Overall Study||2
8311128|NCT01480596|20491010|P1|NOT COMPLETED|Overall Study||5
8311129|NCT01480596|20491009|P2|COMPLETED|Overall Study||16
8311130|NCT01480596|20491010|P1|COMPLETED|Overall Study||17
8311131|NCT01480596|20491009|P2|STARTED|Overall Study||18
8311132|NCT01480596|20491010|P1|STARTED|Overall Study||22
8311133|NCT01480297|20491052|P1|NOT COMPLETED|Overall Study||0
8311134|NCT01480297|20491052|P1|COMPLETED|Overall Study||8
8311135|NCT01480297|20491052|P1|STARTED|Overall Study||8
8311136|NCT01480284|20491058|P2|NOT COMPLETED|Overall Study||0
8311137|NCT01480284|20491059|P1|NOT COMPLETED|Overall Study||8
8311138|NCT01480284|20491058|P2|COMPLETED|Overall Study||56
8311139|NCT01480284|20491059|P1|COMPLETED|Overall Study||102
8311140|NCT01480284|20491058|P2|STARTED|Overall Study||56
8311141|NCT01480284|20491059|P1|STARTED|Overall Study||110
8311142|NCT01480258|20491089|P2|NOT COMPLETED|Toddler Dose||0
8311143|NCT01480258|20491090|P1|NOT COMPLETED|Toddler Dose||0
8311144|NCT01480258|20491089|P2|COMPLETED|Toddler Dose||642
8311145|NCT01480258|20491090|P1|COMPLETED|Toddler Dose||639
8311146|NCT01480258|20491089|P2|STARTED|Toddler Dose||642
8311147|NCT01480258|20491090|P1|STARTED|Toddler Dose||639
8311148|NCT01480258|20491089|P2|NOT COMPLETED|Interim Period||9
8311149|NCT01480258|20491090|P1|NOT COMPLETED|Interim Period||10
8311150|NCT01480258|20491089|P2|COMPLETED|Interim Period||642
8311151|NCT01480258|20491090|P1|COMPLETED|Interim Period||639
8311152|NCT01480258|20491089|P2|STARTED|Interim Period||651
8311153|NCT01480258|20491090|P1|STARTED|Interim Period||649
8311154|NCT01480258|20491089|P2|NOT COMPLETED|Infant Series||8
8311155|NCT01480258|20491090|P1|NOT COMPLETED|Infant Series||7
8311156|NCT01480258|20491089|P2|COMPLETED|Infant Series||651
8311157|NCT01480258|20491090|P1|COMPLETED|Infant Series||649
8311158|NCT01480258|20491089|P2|Vaccinated|Infant Series||659
8311159|NCT01480258|20491090|P1|Vaccinated|Infant Series||653
8311160|NCT01480258|20491089|P2|STARTED|Infant Series||659
8311161|NCT01480258|20491090|P1|STARTED|Infant Series||656
8311162|NCT01480232|20491116|P4|NOT COMPLETED|Overall Study||19
8311163|NCT01480232|20491117|P3|NOT COMPLETED|Overall Study||17
8311164|NCT01480232|20491118|P2|NOT COMPLETED|Overall Study||22
8311165|NCT01480232|20491119|P1|NOT COMPLETED|Overall Study||18
8311166|NCT01480232|20491116|P4|COMPLETED|Overall Study||22
8311167|NCT01480232|20491117|P3|COMPLETED|Overall Study||21
8311168|NCT01480232|20491118|P2|COMPLETED|Overall Study||19
8311169|NCT01480232|20491119|P1|COMPLETED|Overall Study||22
8311170|NCT01480232|20491116|P4|STARTED|Overall Study||41
8311171|NCT01480232|20491117|P3|STARTED|Overall Study||38
8311172|NCT01480232|20491118|P2|STARTED|Overall Study||41
8311173|NCT01480232|20491119|P1|STARTED|Overall Study||40
8311174|NCT01480219|20491147|P2|NOT COMPLETED|Overall Study||0
8311175|NCT01480219|20491148|P1|NOT COMPLETED|Overall Study||0
8311176|NCT01480219|20491147|P2|COMPLETED|Overall Study||142
8311177|NCT01480219|20491148|P1|COMPLETED|Overall Study||325
8311178|NCT01480219|20491147|P2|STARTED|Overall Study||142
8311179|NCT01480219|20491148|P1|STARTED|Overall Study||325
8311180|NCT01480180|20491156|P6|NOT COMPLETED|Extension Phase, Part 2||0
8311181|NCT01480180|20491157|P5|NOT COMPLETED|Extension Phase, Part 2||2
8311182|NCT01480180|20491158|P4|NOT COMPLETED|Extension Phase, Part 2||7
8311183|NCT01480180|20491159|P3|NOT COMPLETED|Extension Phase, Part 2||17
8311184|NCT01480180|20491160|P2|NOT COMPLETED|Extension Phase, Part 2||0
8311185|NCT01480180|20491161|P1|NOT COMPLETED|Extension Phase, Part 2||0
8311186|NCT01480180|20491156|P6|COMPLETED|Extension Phase, Part 2||0
8311187|NCT01480180|20491157|P5|COMPLETED|Extension Phase, Part 2||3
8311188|NCT01480180|20491158|P4|COMPLETED|Extension Phase, Part 2||33
8311189|NCT01480180|20491159|P3|COMPLETED|Extension Phase, Part 2||77
8311190|NCT01480180|20491160|P2|COMPLETED|Extension Phase, Part 2||0
8311191|NCT01480180|20491161|P1|COMPLETED|Extension Phase, Part 2||0
8311192|NCT01480180|20491156|P6|STARTED|Extension Phase, Part 2||0
8311193|NCT01480180|20491157|P5|STARTED|Extension Phase, Part 2||5
8311194|NCT01480180|20491158|P4|STARTED|Extension Phase, Part 2||40
8311195|NCT01480180|20491159|P3|STARTED|Extension Phase, Part 2||94
8311196|NCT01480180|20491160|P2|STARTED|Extension Phase, Part 2||0
8311197|NCT01480180|20491161|P1|STARTED|Extension Phase, Part 2||0
8311198|NCT01480180|20491156|P6|NOT COMPLETED|Extension Phase, Part 1||0
8311199|NCT01480180|20491157|P5|NOT COMPLETED|Extension Phase, Part 1||0
8311200|NCT01480180|20491158|P4|NOT COMPLETED|Extension Phase, Part 1||10
8311201|NCT01480180|20491159|P3|NOT COMPLETED|Extension Phase, Part 1||10
8311202|NCT01480180|20491160|P2|NOT COMPLETED|Extension Phase, Part 1||0
8311203|NCT01480180|20491161|P1|NOT COMPLETED|Extension Phase, Part 1||0
8311204|NCT01480180|20491156|P6|COMPLETED|Extension Phase, Part 1||0
8311205|NCT01480180|20491157|P5|COMPLETED|Extension Phase, Part 1||7
8311206|NCT01480180|20491158|P4|COMPLETED|Extension Phase, Part 1||28
8311207|NCT01480180|20491159|P3|COMPLETED|Extension Phase, Part 1||95
8311208|NCT01480180|20491160|P2|COMPLETED|Extension Phase, Part 1||0
8311209|NCT01480180|20491161|P1|COMPLETED|Extension Phase, Part 1||0
8311210|NCT01480180|20491156|P6|STARTED|Extension Phase, Part 1||0
8311211|NCT01480180|20491157|P5|STARTED|Extension Phase, Part 1||7
8311212|NCT01480180|20491158|P4|STARTED|Extension Phase, Part 1||38
8311213|NCT01480180|20491159|P3|STARTED|Extension Phase, Part 1||105
8311214|NCT01480180|20491160|P2|STARTED|Extension Phase, Part 1||0
8311215|NCT01480180|20491161|P1|STARTED|Extension Phase, Part 1||0
8311216|NCT01480180|20491156|P6|NOT COMPLETED|Main Phase||0
8311217|NCT01480180|20491157|P5|NOT COMPLETED|Main Phase||0
8311218|NCT01480180|20491158|P4|NOT COMPLETED|Main Phase||0
8311219|NCT01480180|20491159|P3|NOT COMPLETED|Main Phase||0
8311220|NCT01480180|20491160|P2|NOT COMPLETED|Main Phase||1
8311221|NCT01480180|20491161|P1|NOT COMPLETED|Main Phase||19
8311222|NCT01480180|20491156|P6|COMPLETED|Main Phase|Not applicable for this phase|0
8311223|NCT01480180|20491157|P5|COMPLETED|Main Phase|Not applicable for this phase|0
8311224|NCT01480180|20491158|P4|COMPLETED|Main Phase|Not applicable for this phase|0
8311225|NCT01480180|20491159|P3|COMPLETED|Main Phase|Not applicable for this phase|0
8311226|NCT01480180|20491160|P2|COMPLETED|Main Phase||11
8311227|NCT01480180|20491161|P1|COMPLETED|Main Phase||155
8311228|NCT01480180|20491156|P6|Max. Participants After Switching|Main Phase||0
8311229|NCT01480180|20491157|P5|Max. Participants After Switching|Main Phase||0
8311230|NCT01480180|20491158|P4|Max. Participants After Switching|Main Phase||0
8311231|NCT01480180|20491159|P3|Max. Participants After Switching|Main Phase||0
8311232|NCT01480180|20491160|P2|Max. Participants After Switching|Main Phase||11
8311233|NCT01480180|20491161|P1|Max. Participants After Switching|Main Phase||175
8311234|NCT01480180|20491156|P6|STARTED|Main Phase|Not applicable for this phase|0
8311235|NCT01480180|20491157|P5|STARTED|Main Phase|Not applicable for this phase|0
8311236|NCT01480180|20491158|P4|STARTED|Main Phase|Not applicable for this phase|0
8311237|NCT01480180|20491159|P3|STARTED|Main Phase|Not applicable for this phase|0
8311238|NCT01480180|20491160|P2|STARTED|Main Phase||12
8311239|NCT01480180|20491161|P1|STARTED|Main Phase||174
8311240|NCT01480089|20491318|P2|NOT COMPLETED|Overall Study||0
8311241|NCT01480089|20491319|P1|NOT COMPLETED|Overall Study||0
8311242|NCT01480089|20491318|P2|COMPLETED|Overall Study||30
8311243|NCT01480089|20491319|P1|COMPLETED|Overall Study||25
8311244|NCT01480089|20491318|P2|STARTED|Overall Study||30
8311245|NCT01480089|20491319|P1|STARTED|Overall Study||25
8311246|NCT01480076|20491329|P1|NOT COMPLETED|Overall Study||290
8311247|NCT01480076|20491329|P1|COMPLETED|Overall Study||611
8311248|NCT01480076|20491329|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
8311249|NCT01480076|20491329|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
8311250|NCT01479985|20491450|P2|NOT COMPLETED|Overall Study||6
8311251|NCT01479985|20491451|P1|NOT COMPLETED|Overall Study||6
8311252|NCT01479985|20491450|P2|COMPLETED|Overall Study||80
8311253|NCT01479985|20491451|P1|COMPLETED|Overall Study||161
8311254|NCT01479985|20491450|P2|Baseline Survey|Overall Study||85
8311255|NCT01479985|20491451|P1|Baseline Survey|Overall Study||166
8311256|NCT01479985|20491450|P2|STARTED|Overall Study||86
8311257|NCT01479985|20491451|P1|STARTED|Overall Study||167
8311258|NCT01479868|20491459|P1|NOT COMPLETED|Overall Study||9
8311259|NCT01479868|20491459|P1|COMPLETED|Overall Study||97
8311260|NCT01479868|20491459|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
8311261|NCT01479777|20491474|P1|NOT COMPLETED|Overall Study||2
8311262|NCT01479777|20491474|P1|COMPLETED|Overall Study||10
8311263|NCT01479777|20491474|P1|STARTED|Overall Study||12
8311264|NCT01479764|20491486|P2|NOT COMPLETED|Treated||2
8311265|NCT01479764|20491487|P1|NOT COMPLETED|Treated||0
8311266|NCT01479764|20491486|P2|COMPLETED|Treated||75
8311267|NCT01479764|20491487|P1|COMPLETED|Treated||74
8311268|NCT01479764|20491486|P2|STARTED|Treated||77
8311269|NCT01479764|20491487|P1|STARTED|Treated||74
8311270|NCT01479764|20491486|P2|NOT COMPLETED|Randomized||1
8311271|NCT01479764|20491487|P1|NOT COMPLETED|Randomized||2
8311272|NCT01479764|20491486|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
8311273|NCT01479764|20491487|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
8311274|NCT01479764|20491486|P2|STARTED|Randomized||78
8311275|NCT01479764|20491487|P1|STARTED|Randomized||76
8311276|NCT01479725|20491497|P2|NOT COMPLETED|Overall Study||1
8311277|NCT01479725|20491498|P1|NOT COMPLETED|Overall Study||2
8311278|NCT01479725|20491497|P2|COMPLETED|Overall Study||1
8311279|NCT01479725|20491498|P1|COMPLETED|Overall Study||4
8311280|NCT01479725|20491497|P2|STARTED|Overall Study||2
8311281|NCT01479725|20491498|P1|STARTED|Overall Study||6
8311282|NCT01479621|20491510|P7|NOT COMPLETED|Treatment Period||20
8311283|NCT01479621|20491511|P6|NOT COMPLETED|Treatment Period||41
8311284|NCT01479621|20491512|P5|NOT COMPLETED|Treatment Period||21
8311285|NCT01479621|20491513|P4|NOT COMPLETED|Treatment Period||12
8311286|NCT01479621|20491514|P3|NOT COMPLETED|Treatment Period||21
8311287|NCT01479621|20491515|P2|NOT COMPLETED|Treatment Period||24
8311288|NCT01479621|20491516|P1|NOT COMPLETED|Treatment Period||0
8311289|NCT01479621|20491510|P7|COMPLETED|Treatment Period||84
8311290|NCT01479621|20491511|P6|COMPLETED|Treatment Period||63
8311291|NCT01479621|20491512|P5|COMPLETED|Treatment Period||82
8311292|NCT01479621|20491513|P4|COMPLETED|Treatment Period||92
8311293|NCT01479621|20491514|P3|COMPLETED|Treatment Period||83
8311294|NCT01479621|20491515|P2|COMPLETED|Treatment Period||79
8311295|NCT01479621|20491516|P1|COMPLETED|Treatment Period||0
8311296|NCT01479621|20491510|P7|Full Analysis Set|Treatment Period||102
8311297|NCT01479621|20491511|P6|Full Analysis Set|Treatment Period||102
8311298|NCT01479621|20491512|P5|Full Analysis Set|Treatment Period||102
8311299|NCT01479621|20491513|P4|Full Analysis Set|Treatment Period||102
8311300|NCT01479621|20491514|P3|Full Analysis Set|Treatment Period||101
8311301|NCT01479621|20491515|P2|Full Analysis Set|Treatment Period||102
8311302|NCT01479621|20491516|P1|Full Analysis Set|Treatment Period||0
8311303|NCT01479621|20491510|P7|Safety Population|Treatment Period||104
8311304|NCT01479621|20491511|P6|Safety Population|Treatment Period||104
8311305|NCT01479621|20491512|P5|Safety Population|Treatment Period||103
8311306|NCT01479621|20491513|P4|Safety Population|Treatment Period||104
8311307|NCT01479621|20491514|P3|Safety Population|Treatment Period||104
8311308|NCT01479621|20491515|P2|Safety Population|Treatment Period||103
8311309|NCT01479621|20491516|P1|Safety Population|Treatment Period||0
8311310|NCT01479621|20491510|P7|STARTED|Treatment Period||104
8311311|NCT01479621|20491511|P6|STARTED|Treatment Period||104
8311312|NCT01479621|20491512|P5|STARTED|Treatment Period||103
8311313|NCT01479621|20491513|P4|STARTED|Treatment Period||104
8311314|NCT01479621|20491514|P3|STARTED|Treatment Period||104
8311315|NCT01479621|20491515|P2|STARTED|Treatment Period||103
8311316|NCT01479621|20491516|P1|STARTED|Treatment Period||0
8311317|NCT01479621|20491510|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311318|NCT01479621|20491511|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311319|NCT01479621|20491512|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311320|NCT01479621|20491513|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311321|NCT01479621|20491514|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311322|NCT01479621|20491515|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311323|NCT01479621|20491516|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
8311324|NCT01479621|20491510|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311325|NCT01479621|20491511|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311326|NCT01479621|20491512|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311327|NCT01479621|20491513|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311328|NCT01479621|20491514|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311329|NCT01479621|20491515|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311330|NCT01479621|20491516|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
8311331|NCT01479621|20491510|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311332|NCT01479621|20491511|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311333|NCT01479621|20491512|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311334|NCT01479621|20491513|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311335|NCT01479621|20491514|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311336|NCT01479621|20491515|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311337|NCT01479621|20491516|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
8311338|NCT01479595|20491604|P2|NOT COMPLETED|Overall Study||2
8311339|NCT01479595|20491605|P1|NOT COMPLETED|Overall Study||2
8311340|NCT01479595|20491604|P2|COMPLETED|Overall Study||19
8311341|NCT01479595|20491605|P1|COMPLETED|Overall Study||42
8311342|NCT01479595|20491604|P2|Per Protocol Analysis Set|Overall Study||20
8311343|NCT01479595|20491605|P1|Per Protocol Analysis Set|Overall Study||41
8311344|NCT01479595|20491604|P2|PK Analysis Set|Overall Study||0
8311345|NCT01479595|20491605|P1|PK Analysis Set|Overall Study||42
8311346|NCT01479595|20491604|P2|STARTED|Overall Study||21
8311347|NCT01479595|20491605|P1|STARTED|Overall Study||44
8311348|NCT01479543|20491632|P5|NOT COMPLETED|Overall Study||1
8311349|NCT01479543|20491633|P4|NOT COMPLETED|Overall Study||0
8311350|NCT01479543|20491634|P3|NOT COMPLETED|Overall Study||1
8311351|NCT01479543|20491635|P2|NOT COMPLETED|Overall Study||0
8311352|NCT01479543|20491636|P1|NOT COMPLETED|Overall Study||1
8311353|NCT01479543|20491632|P5|COMPLETED|Overall Study||20
8311354|NCT01479543|20491633|P4|COMPLETED|Overall Study||20
8311355|NCT01479543|20491634|P3|COMPLETED|Overall Study||20
8311356|NCT01479543|20491635|P2|COMPLETED|Overall Study||20
8311357|NCT01479543|20491636|P1|COMPLETED|Overall Study||20
8311358|NCT01479543|20491632|P5|STARTED|Overall Study||21
8311359|NCT01479543|20491633|P4|STARTED|Overall Study||20
8311360|NCT01479543|20491634|P3|STARTED|Overall Study||21
8311361|NCT01479543|20491635|P2|STARTED|Overall Study||20
8311362|NCT01479543|20491636|P1|STARTED|Overall Study||21
8311363|NCT01479530|20491650|P2|NOT COMPLETED|Overall Study||12
8311364|NCT01479530|20491651|P1|NOT COMPLETED|Overall Study||10
8311365|NCT01479530|20491650|P2|COMPLETED|Overall Study||151
8311366|NCT01479530|20491651|P1|COMPLETED|Overall Study||148
8311367|NCT01479530|20491650|P2|STARTED|Overall Study||163
8311368|NCT01479530|20491651|P1|STARTED|Overall Study||158
8311369|NCT01479517|20491666|P3|NOT COMPLETED|Overall Study||0
8311370|NCT01479517|20491667|P2|NOT COMPLETED|Overall Study||0
8311371|NCT01479517|20491668|P1|NOT COMPLETED|Overall Study||0
8311372|NCT01479517|20491666|P3|COMPLETED|Overall Study||10
8311373|NCT01479517|20491667|P2|COMPLETED|Overall Study||10
8311374|NCT01479517|20491668|P1|COMPLETED|Overall Study||10
8311375|NCT01479517|20491666|P3|STARTED|Overall Study||10
8311376|NCT01479517|20491667|P2|STARTED|Overall Study||10
8311377|NCT01479517|20491668|P1|STARTED|Overall Study||10
8311378|NCT01479478|20491687|P2|NOT COMPLETED|Overall Study||0
8311379|NCT01479478|20491688|P1|NOT COMPLETED|Overall Study||0
8311380|NCT01479478|20491687|P2|COMPLETED|Overall Study||126
8311381|NCT01479478|20491688|P1|COMPLETED|Overall Study||125
8311382|NCT01479478|20491687|P2|STARTED|Overall Study||126
8311383|NCT01479478|20491688|P1|STARTED|Overall Study||125
8311384|NCT01479465|20491732|P4|NOT COMPLETED|Overall Study||85
8311385|NCT01479465|20491733|P3|NOT COMPLETED|Overall Study||86
8311386|NCT01479465|20491734|P2|NOT COMPLETED|Overall Study||84
8311387|NCT01479465|20491735|P1|NOT COMPLETED|Overall Study||11
8311388|NCT01479465|20491732|P4|COMPLETED|Overall Study||0
8311389|NCT01479465|20491733|P3|COMPLETED|Overall Study||0
8311390|NCT01479465|20491734|P2|COMPLETED|Overall Study||0
8311391|NCT01479465|20491735|P1|COMPLETED|Overall Study||0
8311392|NCT01479465|20491732|P4|STARTED|Overall Study||85
8311393|NCT01479465|20491733|P3|STARTED|Overall Study||86
8311394|NCT01479465|20491734|P2|STARTED|Overall Study||84
8311395|NCT01479465|20491735|P1|STARTED|Overall Study||11
8311396|NCT01479439|20491756|P3|NOT COMPLETED|Overall Study||2
8311397|NCT01479439|20491757|P2|NOT COMPLETED|Overall Study||1
8311398|NCT01479439|20491758|P1|NOT COMPLETED|Overall Study||1
8311399|NCT01479439|20491756|P3|COMPLETED|Overall Study||6
8311400|NCT01479439|20491757|P2|COMPLETED|Overall Study||12
8311401|NCT01479439|20491758|P1|COMPLETED|Overall Study||14
8311402|NCT01479439|20491756|P3|STARTED|Overall Study||8
8311403|NCT01479439|20491757|P2|STARTED|Overall Study||13
8311404|NCT01479439|20491758|P1|STARTED|Overall Study||15
8311405|NCT01479426|20491774|P2|NOT COMPLETED|Overall Study||3
8311406|NCT01479426|20491775|P1|NOT COMPLETED|Overall Study||4
8311407|NCT01479426|20491774|P2|COMPLETED|Overall Study||37
8311408|NCT01479426|20491775|P1|COMPLETED|Overall Study||36
8311409|NCT01479426|20491774|P2|STARTED|Overall Study||40
8311410|NCT01479426|20491775|P1|STARTED|Overall Study||40
8311411|NCT01479374|20491790|P3|NOT COMPLETED|Overall Study||5
8311412|NCT01479374|20491791|P2|NOT COMPLETED|Overall Study||8
8311413|NCT01479374|20491792|P1|NOT COMPLETED|Overall Study||3
8311414|NCT01479374|20491790|P3|COMPLETED|Overall Study||63
8311415|NCT01479374|20491791|P2|COMPLETED|Overall Study||60
8311416|NCT01479374|20491792|P1|COMPLETED|Overall Study||63
8311417|NCT01479374|20491790|P3|STARTED|Overall Study||68
8311418|NCT01479374|20491791|P2|STARTED|Overall Study||68
8311419|NCT01479374|20491792|P1|STARTED|Overall Study||66
8311420|NCT01479348|20491818|P2|NOT COMPLETED|Overall Study||0
8311421|NCT01479348|20491819|P1|NOT COMPLETED|Overall Study||0
8311422|NCT01479348|20491818|P2|COMPLETED|Overall Study||0
8311423|NCT01479348|20491819|P1|COMPLETED|Overall Study||5
8311424|NCT01479348|20491818|P2|STARTED|Overall Study||0
8311425|NCT01479348|20491819|P1|STARTED|Overall Study||5
8311426|NCT01479270|20491828|P2|NOT COMPLETED|Overall Study||0
8311427|NCT01479270|20491829|P1|NOT COMPLETED|Overall Study||0
8311428|NCT01479270|20491828|P2|COMPLETED|Overall Study||28
8311429|NCT01479270|20491829|P1|COMPLETED|Overall Study||28
8311430|NCT01479270|20491828|P2|STARTED|Overall Study||28
8311431|NCT01479270|20491829|P1|STARTED|Overall Study||28
8311432|NCT01479127|20491841|P1|NOT COMPLETED|Overall Study||3
8311433|NCT01479127|20491841|P1|COMPLETED|Overall Study||5
8311434|NCT01479127|20491841|P1|Started LCIG|Overall Study||6
8311435|NCT01479127|20491841|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
8311436|NCT01479010|20491875|P1|NOT COMPLETED|Overall Study||1
8311437|NCT01479010|20491875|P1|COMPLETED|Overall Study||1
8311438|NCT01479010|20491875|P1|STARTED|Overall Study||2
8311439|NCT01478971|20491886|P1|NOT COMPLETED|Peginesatide Treatment Period||14
8311440|NCT01478971|20491886|P1|COMPLETED|Peginesatide Treatment Period||143
8311441|NCT01478971|20491886|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
8311442|NCT01478971|20491886|P1|NOT COMPLETED|Standard of Care Period||25
8311443|NCT01478971|20491886|P1|COMPLETED|Standard of Care Period||159
8311444|NCT01478971|20491886|P1|Received Treatment|Standard of Care Period||178
8311445|NCT01478971|20491886|P1|STARTED|Standard of Care Period||184
8311446|NCT01478958|20491903|P3|NOT COMPLETED|Overall Study||3
8311447|NCT01478958|20491904|P2|NOT COMPLETED|Overall Study||2
8311448|NCT01478958|20491905|P1|NOT COMPLETED|Overall Study||2
8311449|NCT01478958|20491903|P3|COMPLETED|Overall Study||66
8311450|NCT01478958|20491904|P2|COMPLETED|Overall Study||64
8311451|NCT01478958|20491905|P1|COMPLETED|Overall Study||65
8311452|NCT01478958|20491903|P3|STARTED|Overall Study||69
8311453|NCT01478958|20491904|P2|STARTED|Overall Study||66
8311454|NCT01478958|20491905|P1|STARTED|Overall Study||67
8311455|NCT01478854|20491913|P1|NOT COMPLETED|Overall Study||0
8311456|NCT01478854|20491913|P1|COMPLETED|Overall Study||30
8311457|NCT01478854|20491913|P1|STARTED|Overall Study||30
8311458|NCT01478828|20491925|P1|NOT COMPLETED|Overall Study||1
8311459|NCT01478828|20491925|P1|COMPLETED|Overall Study||1
8311460|NCT01478828|20491925|P1|STARTED|Overall Study||2
8311461|NCT01478620|20491936|P1|NOT COMPLETED|Overall Study||6
8311462|NCT01478620|20491936|P1|COMPLETED|Overall Study||119
8311463|NCT01478620|20491936|P1|STARTED|Overall Study||125
8311464|NCT01478594|20491942|P2|NOT COMPLETED|Overall Study||28
8311465|NCT01478594|20491943|P1|NOT COMPLETED|Overall Study||65
8311466|NCT01478594|20491942|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
8311467|NCT01478594|20491943|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
8311468|NCT01478594|20491942|P2|Treated|Overall Study||87
8311469|NCT01478594|20491943|P1|Treated|Overall Study||177
8311470|NCT01478594|20491942|P2|STARTED|Overall Study||88
8311471|NCT01478594|20491943|P1|STARTED|Overall Study||177
8311472|NCT01478581|20492019|P4|NOT COMPLETED|Overall Study||0
8311473|NCT01478581|20492020|P3|NOT COMPLETED|Overall Study||0
8311474|NCT01478581|20492021|P2|NOT COMPLETED|Overall Study||0
8311475|NCT01478581|20492022|P1|NOT COMPLETED|Overall Study||0
8311476|NCT01478581|20492019|P4|COMPLETED|Overall Study||43
8311477|NCT01478581|20492020|P3|COMPLETED|Overall Study||18
8311478|NCT01478581|20492021|P2|COMPLETED|Overall Study||18
8311479|NCT01478581|20492022|P1|COMPLETED|Overall Study||13
8311480|NCT01478581|20492019|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
8311481|NCT01478581|20492020|P3|STARTED|Overall Study||18
8311482|NCT01478581|20492021|P2|STARTED|Overall Study||18
8311483|NCT01478581|20492022|P1|STARTED|Overall Study||13
8311484|NCT01478373|20492072|P1|NOT COMPLETED|Survival Phase||38
8311485|NCT01478373|20492072|P1|COMPLETED|Survival Phase||0
8311486|NCT01478373|20492072|P1|STARTED|Survival Phase||38
8311487|NCT01478373|20492072|P1|NOT COMPLETED|Treatment Phase||1
8311488|NCT01478373|20492072|P1|COMPLETED|Treatment Phase||38
8311489|NCT01478373|20492072|P1|STARTED|Treatment Phase||39
8311490|NCT01478360|20492085|P2|NOT COMPLETED|Overall Study||3
8311491|NCT01478360|20492086|P1|NOT COMPLETED|Overall Study||2
8311492|NCT01478360|20492085|P2|COMPLETED|Overall Study||12
8311493|NCT01478360|20492086|P1|COMPLETED|Overall Study||29
8311494|NCT01478360|20492085|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
8311495|NCT01478360|20492086|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
8311496|NCT01478360|20492085|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
8311497|NCT01478360|20492086|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
8311498|NCT01478360|20492085|P2|STARTED|Overall Study||15
8311499|NCT01478360|20492086|P1|STARTED|Overall Study||31
8311500|NCT01478347|20492092|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
8311501|NCT01478347|20492092|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
8311502|NCT01478347|20492092|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
8311503|NCT01478347|20492092|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
8311504|NCT01478347|20492092|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
8311505|NCT01478347|20492092|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
8311506|NCT01478321|20492097|P1|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
8311507|NCT01478321|20492097|P1|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
8311508|NCT01478321|20492097|P1|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
8311509|NCT01478321|20492097|P1|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
8311510|NCT01478321|20492097|P1|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
8311511|NCT01478321|20492097|P1|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
8311512|NCT01478321|20492097|P1|STARTED|Adjuvant Therapy Until PD or Toxicity||37
8311513|NCT01478321|20492097|P1|NOT COMPLETED|Started Adjuvant Therapy||1
8311514|NCT01478321|20492097|P1|COMPLETED|Started Adjuvant Therapy||37
8311515|NCT01478321|20492097|P1|Completed First Cycle|Started Adjuvant Therapy||37
8311516|NCT01478321|20492097|P1|STARTED|Started Adjuvant Therapy||38
8311517|NCT01478321|20492097|P1|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
8311518|NCT01478321|20492097|P1|COMPLETED|Concurrent Therapy (5 Weeks)||38
8311519|NCT01478321|20492097|P1|STARTED|Concurrent Therapy (5 Weeks)||54
8311520|NCT01478256|20492109|P2|NOT COMPLETED|Overall Study||0
8311521|NCT01478256|20492110|P1|NOT COMPLETED|Overall Study||0
8311522|NCT01478256|20492109|P2|COMPLETED|Overall Study||15
8311523|NCT01478256|20492110|P1|COMPLETED|Overall Study||15
8311524|NCT01478256|20492109|P2|STARTED|Overall Study||15
8311525|NCT01478256|20492110|P1|STARTED|Overall Study||15
8311526|NCT01478113|20492120|P2|NOT COMPLETED|Overall Study||1
8311527|NCT01478113|20492121|P1|NOT COMPLETED|Overall Study||1
8311528|NCT01478113|20492120|P2|COMPLETED|Overall Study||1
8311529|NCT01478113|20492121|P1|COMPLETED|Overall Study||1
8311530|NCT01478113|20492120|P2|STARTED|Overall Study||2
8311531|NCT01478113|20492121|P1|STARTED|Overall Study||2
8311532|NCT01478087|20492139|P1|NOT COMPLETED|Overall Study||1
8311533|NCT01478087|20492139|P1|COMPLETED|Overall Study||2
8311534|NCT01478087|20492139|P1|STARTED|Overall Study||3
8311535|NCT01478048|20492146|P2|NOT COMPLETED|Overall Study||75
8311536|NCT01478048|20492147|P1|NOT COMPLETED|Overall Study||77
8311537|NCT01478048|20492146|P2|COMPLETED|Overall Study||0
8311538|NCT01478048|20492147|P1|COMPLETED|Overall Study||0
8311539|NCT01478048|20492146|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
8311540|NCT01478048|20492147|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
8311541|NCT01478048|20492146|P2|STARTED|Overall Study||75
8311542|NCT01478048|20492147|P1|STARTED|Overall Study||77
8311543|NCT01478009|20492165|P2|NOT COMPLETED|Overall Study||1
8311544|NCT01478009|20492166|P1|NOT COMPLETED|Overall Study||1
8311545|NCT01478009|20492165|P2|COMPLETED|Overall Study||49
8311546|NCT01478009|20492166|P1|COMPLETED|Overall Study||49
8311547|NCT01478009|20492165|P2|STARTED|Overall Study||50
8311548|NCT01478009|20492166|P1|STARTED|Overall Study||50
8311549|NCT01477892|20492176|P2|NOT COMPLETED|Overall Study||2
8311550|NCT01477892|20492177|P1|NOT COMPLETED|Overall Study||0
8311551|NCT01477892|20492176|P2|COMPLETED|Overall Study||5
8311552|NCT01477892|20492177|P1|COMPLETED|Overall Study||7
8311553|NCT01477892|20492176|P2|STARTED|Overall Study||7
8311554|NCT01477892|20492177|P1|STARTED|Overall Study||7
8311555|NCT01477853|20492188|P3|NOT COMPLETED|Phase B||11
8311556|NCT01477853|20492189|P2|NOT COMPLETED|Phase B||11
8311557|NCT01477853|20492190|P1|NOT COMPLETED|Phase B||12
8311558|NCT01477853|20492188|P3|COMPLETED|Phase B||0
8311559|NCT01477853|20492189|P2|COMPLETED|Phase B||0
8311560|NCT01477853|20492190|P1|COMPLETED|Phase B||0
8311561|NCT01477853|20492188|P3|STARTED|Phase B||11
8311562|NCT01477853|20492189|P2|STARTED|Phase B||11
8311563|NCT01477853|20492190|P1|STARTED|Phase B||12
8311564|NCT01477853|20492188|P3|NOT COMPLETED|Phase A||44
8311565|NCT01477853|20492189|P2|NOT COMPLETED|Phase A||45
8311566|NCT01477853|20492190|P1|NOT COMPLETED|Phase A||43
8311567|NCT01477853|20492188|P3|COMPLETED|Phase A||11
8311568|NCT01477853|20492189|P2|COMPLETED|Phase A||11
8311569|NCT01477853|20492190|P1|COMPLETED|Phase A||12
8311570|NCT01477853|20492188|P3|STARTED|Phase A||55
8311571|NCT01477853|20492189|P2|STARTED|Phase A||56
8311572|NCT01477853|20492190|P1|STARTED|Phase A||55
8311573|NCT01477762|20492232|P4|NOT COMPLETED|Overall Study||2
8311574|NCT01477762|20492233|P3|NOT COMPLETED|Overall Study||4
8311575|NCT01477762|20492234|P2|NOT COMPLETED|Overall Study||13
8311576|NCT01477762|20492235|P1|NOT COMPLETED|Overall Study||9
8311577|NCT01477762|20492232|P4|COMPLETED|Overall Study||11
8311578|NCT01477762|20492233|P3|COMPLETED|Overall Study||16
8311579|NCT01477762|20492234|P2|COMPLETED|Overall Study||20
8311580|NCT01477762|20492235|P1|COMPLETED|Overall Study||16
8311581|NCT01477762|20492232|P4|STARTED|Overall Study||13
8311582|NCT01477762|20492233|P3|STARTED|Overall Study||20
8311583|NCT01477762|20492234|P2|STARTED|Overall Study||33
8311584|NCT01477762|20492235|P1|STARTED|Overall Study||25
8311585|NCT01477749|20492257|P1|NOT COMPLETED|Overall Study||4
8311586|NCT01477749|20492257|P1|COMPLETED|Overall Study||43
8311587|NCT01477749|20492257|P1|STARTED|Overall Study||47
8311588|NCT01477710|20492264|P1|NOT COMPLETED|Overall Study||0
8311589|NCT01477710|20492264|P1|COMPLETED|Overall Study||30
8311590|NCT01477710|20492264|P1|STARTED|Overall Study||30
8311591|NCT01477567|20492279|P7|NOT COMPLETED|Overall Study||0
8311592|NCT01477567|20492280|P6|NOT COMPLETED|Overall Study||0
8311593|NCT01477567|20492281|P5|NOT COMPLETED|Overall Study||0
8311594|NCT01477567|20492282|P4|NOT COMPLETED|Overall Study||0
8311595|NCT01477567|20492283|P3|NOT COMPLETED|Overall Study||0
8311596|NCT01477567|20492284|P2|NOT COMPLETED|Overall Study||0
8311597|NCT01477567|20492285|P1|NOT COMPLETED|Overall Study||0
8311598|NCT01477567|20492279|P7|COMPLETED|Overall Study||6
8311599|NCT01477567|20492280|P6|COMPLETED|Overall Study||5
8311600|NCT01477567|20492281|P5|COMPLETED|Overall Study||6
8311601|NCT01477567|20492282|P4|COMPLETED|Overall Study||6
8311602|NCT01477567|20492283|P3|COMPLETED|Overall Study||6
8311603|NCT01477567|20492284|P2|COMPLETED|Overall Study||6
8311604|NCT01477567|20492285|P1|COMPLETED|Overall Study||5
8311605|NCT01477567|20492279|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8311606|NCT01477567|20492280|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
8311607|NCT01477567|20492281|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8311608|NCT01477567|20492282|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8311609|NCT01477567|20492283|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8311610|NCT01477567|20492284|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8311611|NCT01477567|20492285|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
8311612|NCT01477567|20492279|P7|STARTED|Overall Study||6
8311613|NCT01477567|20492280|P6|STARTED|Overall Study||5
8311614|NCT01477567|20492281|P5|STARTED|Overall Study||6
8311615|NCT01477567|20492282|P4|STARTED|Overall Study||6
8311616|NCT01477567|20492283|P3|STARTED|Overall Study||6
8311617|NCT01477567|20492284|P2|STARTED|Overall Study||6
8311618|NCT01477567|20492285|P1|STARTED|Overall Study||5
8311619|NCT01477463|20492341|P2|NOT COMPLETED|Overall Study||0
8311620|NCT01477463|20492342|P1|NOT COMPLETED|Overall Study||0
8311621|NCT01477463|20492341|P2|COMPLETED|Overall Study||6
8311622|NCT01477463|20492342|P1|COMPLETED|Overall Study||18
8311623|NCT01477463|20492341|P2|STARTED|Overall Study||6
8311624|NCT01477463|20492342|P1|STARTED|Overall Study||18
8311625|NCT01477450|20492355|P3|NOT COMPLETED|Overall Study||0
8311626|NCT01477450|20492356|P2|NOT COMPLETED|Overall Study||0
8311627|NCT01477450|20492357|P1|NOT COMPLETED|Overall Study||0
8311628|NCT01477450|20492355|P3|COMPLETED|Overall Study||10
8311629|NCT01477450|20492356|P2|COMPLETED|Overall Study||10
8311630|NCT01477450|20492357|P1|COMPLETED|Overall Study||10
8311631|NCT01477450|20492355|P3|STARTED|Overall Study||10
8311632|NCT01477450|20492356|P2|STARTED|Overall Study||10
8311633|NCT01477450|20492357|P1|STARTED|Overall Study||10
8311634|NCT01477333|20492365|P1|NOT COMPLETED|Overall Study||3
8311635|NCT01477333|20492365|P1|COMPLETED|Overall Study||15
8311636|NCT01477333|20492365|P1|STARTED|Overall Study||18
8311637|NCT01477320|20492383|P2|NOT COMPLETED|Overall Study||15
8311638|NCT01477320|20492384|P1|NOT COMPLETED|Overall Study||7
8311639|NCT01477320|20492383|P2|COMPLETED|Overall Study||47
8311640|NCT01477320|20492384|P1|COMPLETED|Overall Study||55
8311641|NCT01477320|20492383|P2|STARTED|Overall Study||62
8311642|NCT01477320|20492384|P1|STARTED|Overall Study||62
8311643|NCT01477177|20492392|P1|NOT COMPLETED|Overall Study||0
8311644|NCT01477177|20492392|P1|COMPLETED|Overall Study||4
8311645|NCT01477177|20492392|P1|STARTED|Overall Study||4
8311646|NCT01476748|20492403|P3|NOT COMPLETED|Overall Study||0
8311647|NCT01476748|20492404|P2|NOT COMPLETED|Overall Study||0
8311648|NCT01476748|20492405|P1|NOT COMPLETED|Overall Study||0
8311649|NCT01476748|20492403|P3|COMPLETED|Overall Study||5
8311650|NCT01476748|20492404|P2|COMPLETED|Overall Study||5
8311651|NCT01476748|20492405|P1|COMPLETED|Overall Study||5
8311652|NCT01476748|20492403|P3|STARTED|Overall Study||5
8311653|NCT01476748|20492404|P2|STARTED|Overall Study||5
8311654|NCT01476748|20492405|P1|STARTED|Overall Study||5
8311655|NCT01476722|20492416|P1|NOT COMPLETED|Overall Study||1
8311656|NCT01476722|20492416|P1|COMPLETED|Overall Study||124
8311657|NCT01476722|20492416|P1|STARTED|Overall Study||125
8311658|NCT01476696|20492423|P3|NOT COMPLETED|Overall Study||0
8311659|NCT01476696|20492424|P2|NOT COMPLETED|Overall Study||1
8311660|NCT01476696|20492425|P1|NOT COMPLETED|Overall Study||3
8311661|NCT01476696|20492423|P3|COMPLETED|Overall Study||9
8311662|NCT01476696|20492424|P2|COMPLETED|Overall Study||8
8311663|NCT01476696|20492425|P1|COMPLETED|Overall Study||12
8311664|NCT01476696|20492423|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8311665|NCT01476696|20492424|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
8311666|NCT01476696|20492425|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8311667|NCT01476696|20492423|P3|STARTED|Overall Study||9
8311668|NCT01476696|20492424|P2|STARTED|Overall Study||9
8311669|NCT01476696|20492425|P1|STARTED|Overall Study||15
8311670|NCT01476644|20492439|P1|NOT COMPLETED|Overall Study||39
8311671|NCT01476644|20492439|P1|COMPLETED|Overall Study||122
8311672|NCT01476644|20492439|P1|STARTED|Overall Study||161
8311673|NCT01476475|20492446|P2|NOT COMPLETED|Overall Study||3
8311674|NCT01476475|20492447|P1|NOT COMPLETED|Overall Study||11
8311675|NCT01476475|20492446|P2|COMPLETED|Overall Study||159
8311676|NCT01476475|20492447|P1|COMPLETED|Overall Study||150
8311677|NCT01476475|20492446|P2|STARTED|Overall Study||162
8311678|NCT01476475|20492447|P1|STARTED|Overall Study||161
8311679|NCT01476449|20492481|P2|NOT COMPLETED|Overall Study||2
8311680|NCT01476449|20492482|P1|NOT COMPLETED|Overall Study||2
8311681|NCT01476449|20492481|P2|COMPLETED|Overall Study||8
8311682|NCT01476449|20492482|P1|COMPLETED|Overall Study||8
8311683|NCT01476449|20492481|P2|STARTED|Overall Study||10
8311684|NCT01476449|20492482|P1|STARTED|Overall Study||10
8311685|NCT01476345|20492496|P2|NOT COMPLETED|Period 4||0
8311686|NCT01476345|20492497|P1|NOT COMPLETED|Period 4||0
8311687|NCT01476345|20492496|P2|COMPLETED|Period 4||39
8311688|NCT01476345|20492497|P1|COMPLETED|Period 4||39
8311689|NCT01476345|20492496|P2|STARTED|Period 4||39
8311690|NCT01476345|20492497|P1|STARTED|Period 4||39
8311691|NCT01476345|20492496|P2|NOT COMPLETED|Period 3||0
8311692|NCT01476345|20492497|P1|NOT COMPLETED|Period 3||0
8311693|NCT01476345|20492496|P2|COMPLETED|Period 3||39
8311694|NCT01476345|20492497|P1|COMPLETED|Period 3||39
8311695|NCT01476345|20492496|P2|STARTED|Period 3||39
8311696|NCT01476345|20492497|P1|STARTED|Period 3||39
8311697|NCT01476345|20492496|P2|NOT COMPLETED|Period 2||0
8311698|NCT01476345|20492497|P1|NOT COMPLETED|Period 2||0
8311699|NCT01476345|20492496|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
8311700|NCT01476345|20492497|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
8311701|NCT01476345|20492496|P2|STARTED|Period 2||40
8311702|NCT01476345|20492497|P1|STARTED|Period 2||40
8311703|NCT01476345|20492496|P2|NOT COMPLETED|Period 1||0
8311704|NCT01476345|20492497|P1|NOT COMPLETED|Period 1||0
8311705|NCT01476345|20492496|P2|COMPLETED|Period 1||40
8311706|NCT01476345|20492497|P1|COMPLETED|Period 1||40
8311707|NCT01476345|20492496|P2|Received at Least 1 Dose of Study Drug|Period 1||40
8311708|NCT01476345|20492497|P1|Received at Least 1 Dose of Study Drug|Period 1||40
8311709|NCT01476345|20492496|P2|STARTED|Period 1||40
8311710|NCT01476345|20492497|P1|STARTED|Period 1||40
8311711|NCT01476267|20492509|P1|NOT COMPLETED|Overall Study||0
8311712|NCT01476267|20492509|P1|COMPLETED|Overall Study||6
8311713|NCT01476267|20492509|P1|STARTED|Overall Study||6
8311714|NCT01476202|20492517|P3|NOT COMPLETED|Overall Study||0
8311715|NCT01476202|20492518|P2|NOT COMPLETED|Overall Study||0
8311716|NCT01476202|20492519|P1|NOT COMPLETED|Overall Study||0
8311717|NCT01476202|20492517|P3|COMPLETED|Overall Study||40
8311718|NCT01476202|20492518|P2|COMPLETED|Overall Study||40
8311719|NCT01476202|20492519|P1|COMPLETED|Overall Study||40
8311720|NCT01476202|20492517|P3|STARTED|Overall Study||40
8311721|NCT01476202|20492518|P2|STARTED|Overall Study||40
8311722|NCT01476202|20492519|P1|STARTED|Overall Study||40
8311723|NCT01475955|20492535|P5|NOT COMPLETED|Overall Study||0
8311724|NCT01475955|20492536|P4|NOT COMPLETED|Overall Study||0
8311725|NCT01475955|20492537|P3|NOT COMPLETED|Overall Study||3
8311726|NCT01475955|20492538|P2|NOT COMPLETED|Overall Study||0
8311727|NCT01475955|20492539|P1|NOT COMPLETED|Overall Study||1
8311728|NCT01475955|20492535|P5|COMPLETED|Overall Study||46
8311729|NCT01475955|20492536|P4|COMPLETED|Overall Study||46
8311730|NCT01475955|20492537|P3|COMPLETED|Overall Study||44
8311731|NCT01475955|20492538|P2|COMPLETED|Overall Study||48
8311732|NCT01475955|20492539|P1|COMPLETED|Overall Study||47
8311733|NCT01475955|20492535|P5|STARTED|Overall Study||46
8311734|NCT01475955|20492536|P4|STARTED|Overall Study||46
8311735|NCT01475955|20492537|P3|STARTED|Overall Study||47
8311736|NCT01475955|20492538|P2|STARTED|Overall Study||48
8311737|NCT01475955|20492539|P1|STARTED|Overall Study||48
8311738|NCT01475851|20492898|P2|NOT COMPLETED|Overall Study||0
8311739|NCT01475851|20492899|P1|NOT COMPLETED|Overall Study||1
8311740|NCT01475851|20492898|P2|COMPLETED|Overall Study||21
8311741|NCT01475851|20492899|P1|COMPLETED|Overall Study||12
8311742|NCT01475851|20492898|P2|STARTED|Overall Study||21
8311743|NCT01475851|20492899|P1|STARTED|Overall Study||13
8311744|NCT01475838|20492927|P2|NOT COMPLETED|Extension Phase||0
8311745|NCT01475838|20492928|P1|NOT COMPLETED|Extension Phase||1
8311746|NCT01475838|20492927|P2|COMPLETED|Extension Phase||20
8311747|NCT01475838|20492928|P1|COMPLETED|Extension Phase||41
8311748|NCT01475838|20492927|P2|STARTED|Extension Phase||20
8311749|NCT01475838|20492928|P1|STARTED|Extension Phase||42
8311750|NCT01475838|20492927|P2|NOT COMPLETED|Randomized Phase||36
8311751|NCT01475838|20492928|P1|NOT COMPLETED|Randomized Phase||30
8311752|NCT01475838|20492927|P2|COMPLETED|Randomized Phase||109
8311753|NCT01475838|20492928|P1|COMPLETED|Randomized Phase||263
8311754|NCT01475838|20492927|P2|STARTED|Randomized Phase||145
8311755|NCT01475838|20492928|P1|STARTED|Randomized Phase||293
8311756|NCT01475825|20492945|P4|NOT COMPLETED|Overall Study||30
8311757|NCT01475825|20492946|P3|NOT COMPLETED|Overall Study||64
8311758|NCT01475825|20492947|P2|NOT COMPLETED|Overall Study||32
8311759|NCT01475825|20492948|P1|NOT COMPLETED|Overall Study||67
8311760|NCT01475825|20492945|P4|COMPLETED|Overall Study||22
8311761|NCT01475825|20492946|P3|COMPLETED|Overall Study||38
8311762|NCT01475825|20492947|P2|COMPLETED|Overall Study||19
8311763|NCT01475825|20492948|P1|COMPLETED|Overall Study||37
8311764|NCT01475825|20492945|P4|Completed Open-Label Continuation|Overall Study||22
8311765|NCT01475825|20492946|P3|Completed Open-Label Continuation|Overall Study||38
8311766|NCT01475825|20492947|P2|Completed Open-Label Continuation|Overall Study||19
8311767|NCT01475825|20492948|P1|Completed Open-Label Continuation|Overall Study||37
8311768|NCT01475825|20492945|P4|Entered Open-Label Continuation|Overall Study||29
8311769|NCT01475825|20492946|P3|Entered Open-Label Continuation|Overall Study||44
8311770|NCT01475825|20492947|P2|Entered Open-Label Continuation|Overall Study||31
8311771|NCT01475825|20492948|P1|Entered Open-Label Continuation|Overall Study||45
8311772|NCT01475825|20492945|P4|Completed Blinded Treatment Period|Overall Study||40
8311773|NCT01475825|20492946|P3|Completed Blinded Treatment Period|Overall Study||59
8311774|NCT01475825|20492947|P2|Completed Blinded Treatment Period|Overall Study||42
8311775|NCT01475825|20492948|P1|Completed Blinded Treatment Period|Overall Study||60
8311776|NCT01475825|20492945|P4|Randomized and Treated|Overall Study||52
8311777|NCT01475825|20492946|P3|Randomized and Treated|Overall Study||102
8311778|NCT01475825|20492947|P2|Randomized and Treated|Overall Study||51
8311779|NCT01475825|20492948|P1|Randomized and Treated|Overall Study||104
8311780|NCT01475825|20492945|P4|STARTED|Overall Study||52
8311781|NCT01475825|20492946|P3|STARTED|Overall Study||102
8311782|NCT01475825|20492947|P2|STARTED|Overall Study||51
8311783|NCT01475825|20492948|P1|STARTED|Overall Study||104
8311784|NCT01475734|20492980|P2|NOT COMPLETED|Overall Study||1
8311785|NCT01475734|20492981|P1|NOT COMPLETED|Overall Study||2
8311786|NCT01475734|20492980|P2|COMPLETED|Overall Study||21
8311787|NCT01475734|20492981|P1|COMPLETED|Overall Study||20
8311788|NCT01475734|20492980|P2|STARTED|Overall Study||22
8311789|NCT01475734|20492981|P1|STARTED|Overall Study||22
8311790|NCT01475721|20493009|P2|NOT COMPLETED|Overall Study||14
8311791|NCT01475721|20493010|P1|NOT COMPLETED|Overall Study||11
8311792|NCT01475721|20493009|P2|COMPLETED|Overall Study||5831
8311793|NCT01475721|20493010|P1|COMPLETED|Overall Study||5823
8311794|NCT01475721|20493009|P2|STARTED|Overall Study||5845
8311795|NCT01475721|20493010|P1|STARTED|Overall Study||5834
8311796|NCT01475643|20493026|P2|NOT COMPLETED|Overall Study||10
8311797|NCT01475643|20493027|P1|NOT COMPLETED|Overall Study||14
8311798|NCT01475643|20493026|P2|COMPLETED|Overall Study||43
8311799|NCT01475643|20493027|P1|COMPLETED|Overall Study||40
8311800|NCT01475643|20493026|P2|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
8311801|NCT01475643|20493027|P1|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
8311802|NCT01475513|20493037|P2|NOT COMPLETED|Overall Study||10
8311803|NCT01475513|20493038|P1|NOT COMPLETED|Overall Study||3
8311804|NCT01475513|20493037|P2|COMPLETED|Overall Study||16
8311805|NCT01475513|20493038|P1|COMPLETED|Overall Study||17
8311806|NCT01475513|20493037|P2|STARTED|Overall Study||26
8311807|NCT01475513|20493038|P1|STARTED|Overall Study||20
8311808|NCT01475487|20493076|P2|NOT COMPLETED|Overall Study||1
8311809|NCT01475487|20493077|P1|NOT COMPLETED|Overall Study||2
8311810|NCT01475487|20493076|P2|COMPLETED|Overall Study||24
8311811|NCT01475487|20493077|P1|COMPLETED|Overall Study||23
8311812|NCT01475487|20493076|P2|STARTED|Overall Study||25
8311813|NCT01475487|20493077|P1|STARTED|Overall Study||25
8311814|NCT01475474|20493089|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
8311815|NCT01475474|20493089|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
8311816|NCT01475474|20493089|P1|STARTED|Return to Baseline Period - 4 Weeks||73
8311817|NCT01475474|20493089|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
8311818|NCT01475474|20493089|P1|COMPLETED|Treatment Period - 12 Weeks||73
8311819|NCT01475474|20493089|P1|STARTED|Treatment Period - 12 Weeks||91
8311820|NCT01475474|20493089|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
8311821|NCT01475474|20493089|P1|COMPLETED|Baseline Period - 4 Weeks||91
8311822|NCT01475474|20493089|P1|STARTED|Baseline Period - 4 Weeks||97
8311823|NCT01475461|20493100|P7|NOT COMPLETED|Treatment Period||2
8311824|NCT01475461|20493101|P6|NOT COMPLETED|Treatment Period||5
8311825|NCT01475461|20493102|P5|NOT COMPLETED|Treatment Period||4
8311826|NCT01475461|20493103|P4|NOT COMPLETED|Treatment Period||8
8311827|NCT01475461|20493104|P3|NOT COMPLETED|Treatment Period||4
8311828|NCT01475461|20493105|P2|NOT COMPLETED|Treatment Period||9
8311829|NCT01475461|20493106|P1|NOT COMPLETED|Treatment Period||0
8311830|NCT01475461|20493100|P7|COMPLETED|Treatment Period||53
8311831|NCT01475461|20493101|P6|COMPLETED|Treatment Period||51
8311832|NCT01475461|20493102|P5|COMPLETED|Treatment Period||52
8311833|NCT01475461|20493103|P4|COMPLETED|Treatment Period||46
8311834|NCT01475461|20493104|P3|COMPLETED|Treatment Period||53
8311835|NCT01475461|20493105|P2|COMPLETED|Treatment Period||48
8311836|NCT01475461|20493106|P1|COMPLETED|Treatment Period||0
8311837|NCT01475461|20493100|P7|STARTED|Treatment Period||55
8311838|NCT01475461|20493101|P6|STARTED|Treatment Period||56
8311839|NCT01475461|20493102|P5|STARTED|Treatment Period||56
8311840|NCT01475461|20493103|P4|STARTED|Treatment Period||54
8311841|NCT01475461|20493104|P3|STARTED|Treatment Period||57
8311842|NCT01475461|20493105|P2|STARTED|Treatment Period||57
8311843|NCT01475461|20493106|P1|STARTED|Treatment Period||0
8311844|NCT01475461|20493100|P7|NOT COMPLETED|Run-in Period||0
8311845|NCT01475461|20493101|P6|NOT COMPLETED|Run-in Period||0
8311846|NCT01475461|20493102|P5|NOT COMPLETED|Run-in Period||0
8311847|NCT01475461|20493103|P4|NOT COMPLETED|Run-in Period||0
8311848|NCT01475461|20493104|P3|NOT COMPLETED|Run-in Period||0
8311849|NCT01475461|20493105|P2|NOT COMPLETED|Run-in Period||0
8311850|NCT01475461|20493106|P1|NOT COMPLETED|Run-in Period||41
8311851|NCT01475461|20493100|P7|COMPLETED|Run-in Period||0
8311852|NCT01475461|20493101|P6|COMPLETED|Run-in Period||0
8311853|NCT01475461|20493102|P5|COMPLETED|Run-in Period||0
8311854|NCT01475461|20493103|P4|COMPLETED|Run-in Period||0
8311855|NCT01475461|20493104|P3|COMPLETED|Run-in Period||0
8311856|NCT01475461|20493105|P2|COMPLETED|Run-in Period||0
8311857|NCT01475461|20493106|P1|COMPLETED|Run-in Period||335
8311858|NCT01475461|20493100|P7|STARTED|Run-in Period||0
8311859|NCT01475461|20493101|P6|STARTED|Run-in Period||0
8311860|NCT01475461|20493102|P5|STARTED|Run-in Period||0
8311861|NCT01475461|20493103|P4|STARTED|Run-in Period||0
8311862|NCT01475461|20493104|P3|STARTED|Run-in Period||0
8311863|NCT01475461|20493105|P2|STARTED|Run-in Period||0
8311864|NCT01475461|20493106|P1|STARTED|Run-in Period||376
8311865|NCT01475331|20493186|P2|NOT COMPLETED|Overall Study||2
8311866|NCT01475331|20493187|P1|NOT COMPLETED|Overall Study||5
8311867|NCT01475331|20493186|P2|COMPLETED|Overall Study||21
8311868|NCT01475331|20493187|P1|COMPLETED|Overall Study||18
8311869|NCT01475331|20493186|P2|STARTED|Overall Study||23
8311870|NCT01475331|20493187|P1|STARTED|Overall Study||23
8311871|NCT01475305|20493195|P2|NOT COMPLETED|Overall Study||0
8311872|NCT01475305|20493196|P1|NOT COMPLETED|Overall Study||0
8311873|NCT01475305|20493195|P2|COMPLETED|Overall Study||3
8311874|NCT01475305|20493196|P1|COMPLETED|Overall Study||4
8311875|NCT01475305|20493195|P2|End of Quarantine, Day 15|Overall Study||3
8311876|NCT01475305|20493196|P1|End of Quarantine, Day 15|Overall Study||4
8311877|NCT01475305|20493195|P2|STARTED|Overall Study||3
8311878|NCT01475305|20493196|P1|STARTED|Overall Study||4
8311879|NCT01475253|20493239|P4|NOT COMPLETED|Open Label Extension||0
8311880|NCT01475253|20493240|P3|NOT COMPLETED|Open Label Extension||0
8311881|NCT01475253|20493241|P2|NOT COMPLETED|Open Label Extension||0
8311882|NCT01475253|20493242|P1|NOT COMPLETED|Open Label Extension||0
8311883|NCT01475253|20493239|P4|COMPLETED|Open Label Extension||56
8311884|NCT01475253|20493240|P3|COMPLETED|Open Label Extension||0
8311885|NCT01475253|20493241|P2|COMPLETED|Open Label Extension||0
8311886|NCT01475253|20493242|P1|COMPLETED|Open Label Extension||0
8311887|NCT01475253|20493239|P4|STARTED|Open Label Extension||56
8311888|NCT01475253|20493240|P3|STARTED|Open Label Extension||0
8311889|NCT01475253|20493241|P2|STARTED|Open Label Extension||0
8311890|NCT01475253|20493242|P1|STARTED|Open Label Extension||0
8311891|NCT01475253|20493239|P4|NOT COMPLETED|Randomized, Blinded Study||0
8311892|NCT01475253|20493240|P3|NOT COMPLETED|Randomized, Blinded Study||0
8311893|NCT01475253|20493241|P2|NOT COMPLETED|Randomized, Blinded Study||1
8311894|NCT01475253|20493242|P1|NOT COMPLETED|Randomized, Blinded Study||2
8311895|NCT01475253|20493239|P4|COMPLETED|Randomized, Blinded Study||0
8311896|NCT01475253|20493240|P3|COMPLETED|Randomized, Blinded Study||11
8311897|NCT01475253|20493241|P2|COMPLETED|Randomized, Blinded Study||45
8311898|NCT01475253|20493242|P1|COMPLETED|Randomized, Blinded Study||45
8311899|NCT01475253|20493239|P4|STARTED|Randomized, Blinded Study||0
8311900|NCT01475253|20493240|P3|STARTED|Randomized, Blinded Study||11
8311901|NCT01475253|20493241|P2|STARTED|Randomized, Blinded Study||46
8311902|NCT01475253|20493242|P1|STARTED|Randomized, Blinded Study||47
8311903|NCT01475214|20493271|P3|NOT COMPLETED|Overall Study||2
8311904|NCT01475214|20493272|P2|NOT COMPLETED|Overall Study||4
8311905|NCT01475214|20493273|P1|NOT COMPLETED|Overall Study||5
8311906|NCT01475214|20493271|P3|COMPLETED|Overall Study||79
8311907|NCT01475214|20493272|P2|COMPLETED|Overall Study||75
8311908|NCT01475214|20493273|P1|COMPLETED|Overall Study||79
8311909|NCT01475214|20493271|P3|STARTED|Overall Study||81
8311910|NCT01475214|20493272|P2|STARTED|Overall Study||79
8311911|NCT01475214|20493273|P1|STARTED|Overall Study||84
8311912|NCT01475175|20493284|P1|NOT COMPLETED|Overall Study||0
8311913|NCT01475175|20493284|P1|COMPLETED|Overall Study||12
8311914|NCT01475175|20493284|P1|STARTED|Overall Study||12
8311915|NCT01475162|20493296|P1|NOT COMPLETED|Overall Study||14
8311916|NCT01475162|20493296|P1|COMPLETED|Overall Study||0
8311917|NCT01475162|20493296|P1|STARTED|Overall Study||14
8311918|NCT01475097|20493309|P2|NOT COMPLETED|Overall Study||1
8311919|NCT01475097|20493310|P1|NOT COMPLETED|Overall Study||1
8311920|NCT01475097|20493309|P2|COMPLETED|Overall Study||126
8311921|NCT01475097|20493310|P1|COMPLETED|Overall Study||127
8311922|NCT01475097|20493309|P2|STARTED|Overall Study||127
8311923|NCT01475097|20493310|P1|STARTED|Overall Study||128
8311927|NCT01474993|20493328|P2|NOT COMPLETED|Overall Study||3
8311928|NCT01474993|20493329|P1|NOT COMPLETED|Overall Study||1
8311929|NCT01474993|20493328|P2|COMPLETED|Overall Study||26
8311930|NCT01474993|20493329|P1|COMPLETED|Overall Study||14
8311931|NCT01474993|20493328|P2|STARTED|Overall Study||29
8311932|NCT01474993|20493329|P1|STARTED|Overall Study||15
8311933|NCT01474915|20493359|P2|NOT COMPLETED|Overall Study||10
8311934|NCT01474915|20493360|P1|NOT COMPLETED|Overall Study||10
8311935|NCT01474915|20493359|P2|COMPLETED|Overall Study||51
8311936|NCT01474915|20493360|P1|COMPLETED|Overall Study||50
8311937|NCT01474915|20493359|P2|STARTED|Overall Study||61
8311938|NCT01474915|20493360|P1|STARTED|Overall Study||60
8311939|NCT01474876|20493371|P3|NOT COMPLETED|Overall Study||0
8311940|NCT01474876|20493372|P2|NOT COMPLETED|Overall Study||23
8311941|NCT01474876|20493373|P1|NOT COMPLETED|Overall Study||66
8311942|NCT01474876|20493371|P3|COMPLETED|Overall Study||1
8311943|NCT01474876|20493372|P2|COMPLETED|Overall Study||128
8311944|NCT01474876|20493373|P1|COMPLETED|Overall Study||337
8311945|NCT01474876|20493371|P3|STARTED|Overall Study||1
8311946|NCT01474876|20493372|P2|STARTED|Overall Study||151
8311947|NCT01474876|20493373|P1|STARTED|Overall Study||403
8311948|NCT01474863|20493407|P3|NOT COMPLETED|Overall Study||0
8311949|NCT01474863|20493408|P2|NOT COMPLETED|Overall Study||0
8311950|NCT01474863|20493409|P1|NOT COMPLETED|Overall Study||0
8311951|NCT01474863|20493407|P3|COMPLETED|Overall Study||24
8311952|NCT01474863|20493408|P2|COMPLETED|Overall Study||22
8311953|NCT01474863|20493409|P1|COMPLETED|Overall Study||26
8311954|NCT01474863|20493407|P3|STARTED|Overall Study||24
8311955|NCT01474863|20493408|P2|STARTED|Overall Study||22
8311956|NCT01474863|20493409|P1|STARTED|Overall Study||26
8311957|NCT01474746|20493419|P2|NOT COMPLETED|Overall Study||2
8311958|NCT01474746|20493420|P1|NOT COMPLETED|Overall Study||3
8311959|NCT01474746|20493419|P2|COMPLETED|Overall Study||25
8311960|NCT01474746|20493420|P1|COMPLETED|Overall Study||27
8311961|NCT01474746|20493419|P2|STARTED|Overall Study||27
8311962|NCT01474746|20493420|P1|STARTED|Overall Study||30
8311963|NCT01474681|20493484|P4|NOT COMPLETED|Overall Study||6
8311964|NCT01474681|20493485|P3|NOT COMPLETED|Overall Study||2
8311965|NCT01474681|20493486|P2|NOT COMPLETED|Overall Study||3
8311966|NCT01474681|20493487|P1|NOT COMPLETED|Overall Study||0
8311967|NCT01474681|20493484|P4|COMPLETED|Overall Study||9
8311968|NCT01474681|20493485|P3|COMPLETED|Overall Study||1
8311969|NCT01474681|20493486|P2|COMPLETED|Overall Study||5
8311970|NCT01474681|20493487|P1|COMPLETED|Overall Study||1
8311971|NCT01474681|20493484|P4|STARTED|Overall Study||15
8311972|NCT01474681|20493485|P3|STARTED|Overall Study||3
8311973|NCT01474681|20493486|P2|STARTED|Overall Study||8
8311974|NCT01474681|20493487|P1|STARTED|Overall Study||1
8311981|NCT01474551|20493538|P1|NOT COMPLETED|Overall Study||1
8311982|NCT01474551|20493538|P1|COMPLETED|Overall Study||1
8311983|NCT01474551|20493538|P1|STARTED|Overall Study||2
8311984|NCT01474538|20493544|P2|NOT COMPLETED|Treatment Period 2||2
8311985|NCT01474538|20493545|P1|NOT COMPLETED|Treatment Period 2||6
8311986|NCT01474538|20493544|P2|COMPLETED|Treatment Period 2||56
8311987|NCT01474538|20493545|P1|COMPLETED|Treatment Period 2||51
8311988|NCT01474538|20493544|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
8311989|NCT01474538|20493545|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
8311990|NCT01474538|20493544|P2|STARTED|Treatment Period 2||58
8311991|NCT01474538|20493545|P1|STARTED|Treatment Period 2||57
8311992|NCT01474538|20493544|P2|NOT COMPLETED|Treatment Period 1||4
8311993|NCT01474538|20493545|P1|NOT COMPLETED|Treatment Period 1||3
8311994|NCT01474538|20493544|P2|COMPLETED|Treatment Period 1||58
8311995|NCT01474538|20493545|P1|COMPLETED|Treatment Period 1||57
8311996|NCT01474538|20493544|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
8311997|NCT01474538|20493545|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
8311998|NCT01474538|20493544|P2|STARTED|Treatment Period 1||62
8311999|NCT01474538|20493545|P1|STARTED|Treatment Period 1||60
8312000|NCT01474512|20493562|P18|NOT COMPLETED|Post-Treatment Follow-Up||46
8312001|NCT01474512|20493563|P17|NOT COMPLETED|Post-Treatment Follow-Up||156
8312002|NCT01474512|20493564|P16|NOT COMPLETED|Post-Treatment Follow-Up||8
8312003|NCT01474512|20493565|P15|NOT COMPLETED|Post-Treatment Follow-Up||18
8312004|NCT01474512|20493566|P14|NOT COMPLETED|Post-Treatment Follow-Up||0
8312005|NCT01474512|20493567|P13|NOT COMPLETED|Post-Treatment Follow-Up||0
8312006|NCT01474512|20493568|P12|NOT COMPLETED|Post-Treatment Follow-Up||0
8312007|NCT01474512|20493569|P11|NOT COMPLETED|Post-Treatment Follow-Up||0
8312008|NCT01474512|20493570|P10|NOT COMPLETED|Post-Treatment Follow-Up||0
8312009|NCT01474512|20493571|P9|NOT COMPLETED|Post-Treatment Follow-Up||0
8312010|NCT01474512|20493572|P8|NOT COMPLETED|Post-Treatment Follow-Up||0
8312011|NCT01474512|20493573|P7|NOT COMPLETED|Post-Treatment Follow-Up||0
8312012|NCT01474512|20493574|P6|NOT COMPLETED|Post-Treatment Follow-Up||0
8312013|NCT01474512|20493575|P5|NOT COMPLETED|Post-Treatment Follow-Up||0
8312014|NCT01474512|20493576|P4|NOT COMPLETED|Post-Treatment Follow-Up||0
8312015|NCT01474512|20493577|P3|NOT COMPLETED|Post-Treatment Follow-Up||0
8312016|NCT01474512|20493578|P2|NOT COMPLETED|Post-Treatment Follow-Up||0
8312017|NCT01474512|20493579|P1|NOT COMPLETED|Post-Treatment Follow-Up||0
8312018|NCT01474512|20493562|P18|COMPLETED|Post-Treatment Follow-Up||239
8312019|NCT01474512|20493563|P17|COMPLETED|Post-Treatment Follow-Up||544
8312020|NCT01474512|20493564|P16|COMPLETED|Post-Treatment Follow-Up||17
8312021|NCT01474512|20493565|P15|COMPLETED|Post-Treatment Follow-Up||0
8312022|NCT01474512|20493566|P14|COMPLETED|Post-Treatment Follow-Up||0
8312023|NCT01474512|20493567|P13|COMPLETED|Post-Treatment Follow-Up||0
8312024|NCT01474512|20493568|P12|COMPLETED|Post-Treatment Follow-Up||0
8312025|NCT01474512|20493569|P11|COMPLETED|Post-Treatment Follow-Up||0
8312026|NCT01474512|20493570|P10|COMPLETED|Post-Treatment Follow-Up||0
8312027|NCT01474512|20493571|P9|COMPLETED|Post-Treatment Follow-Up||0
8312028|NCT01474512|20493572|P8|COMPLETED|Post-Treatment Follow-Up||0
8312029|NCT01474512|20493573|P7|COMPLETED|Post-Treatment Follow-Up||0
8312030|NCT01474512|20493574|P6|COMPLETED|Post-Treatment Follow-Up||0
8312031|NCT01474512|20493575|P5|COMPLETED|Post-Treatment Follow-Up||0
8312032|NCT01474512|20493576|P4|COMPLETED|Post-Treatment Follow-Up||0
8312033|NCT01474512|20493577|P3|COMPLETED|Post-Treatment Follow-Up||0
8312034|NCT01474512|20493578|P2|COMPLETED|Post-Treatment Follow-Up||0
8312035|NCT01474512|20493579|P1|COMPLETED|Post-Treatment Follow-Up||0
8312036|NCT01474512|20493562|P18|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
8312037|NCT01474512|20493563|P17|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
8312038|NCT01474512|20493564|P16|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
8312039|NCT01474512|20493565|P15|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
8312040|NCT01474512|20493566|P14|STARTED|Post-Treatment Follow-Up||0
8312041|NCT01474512|20493567|P13|STARTED|Post-Treatment Follow-Up||0
8312042|NCT01474512|20493568|P12|STARTED|Post-Treatment Follow-Up||0
8312043|NCT01474512|20493569|P11|STARTED|Post-Treatment Follow-Up||0
8312044|NCT01474512|20493570|P10|STARTED|Post-Treatment Follow-Up||0
8312045|NCT01474512|20493571|P9|STARTED|Post-Treatment Follow-Up||0
8312046|NCT01474512|20493572|P8|STARTED|Post-Treatment Follow-Up||0
8312047|NCT01474512|20493573|P7|STARTED|Post-Treatment Follow-Up||0
8312048|NCT01474512|20493574|P6|STARTED|Post-Treatment Follow-Up||0
8312049|NCT01474512|20493575|P5|STARTED|Post-Treatment Follow-Up||0
8312050|NCT01474512|20493576|P4|STARTED|Post-Treatment Follow-Up||0
8312051|NCT01474512|20493577|P3|STARTED|Post-Treatment Follow-Up||0
8312052|NCT01474512|20493578|P2|STARTED|Post-Treatment Follow-Up||0
8312053|NCT01474512|20493579|P1|STARTED|Post-Treatment Follow-Up||0
8312054|NCT01474512|20493562|P18|NOT COMPLETED|Long-Term Extension Period||0
8312055|NCT01474512|20493563|P17|NOT COMPLETED|Long-Term Extension Period||0
8312056|NCT01474512|20493564|P16|NOT COMPLETED|Long-Term Extension Period||0
8312057|NCT01474512|20493565|P15|NOT COMPLETED|Long-Term Extension Period||0
8312058|NCT01474512|20493566|P14|NOT COMPLETED|Long-Term Extension Period||220
8312059|NCT01474512|20493567|P13|NOT COMPLETED|Long-Term Extension Period||218
8312060|NCT01474512|20493568|P12|NOT COMPLETED|Long-Term Extension Period||26
8312061|NCT01474512|20493569|P11|NOT COMPLETED|Long-Term Extension Period||0
8312062|NCT01474512|20493570|P10|NOT COMPLETED|Long-Term Extension Period||0
8312063|NCT01474512|20493571|P9|NOT COMPLETED|Long-Term Extension Period||0
8312064|NCT01474512|20493572|P8|NOT COMPLETED|Long-Term Extension Period||0
8312065|NCT01474512|20493573|P7|NOT COMPLETED|Long-Term Extension Period||0
8312066|NCT01474512|20493574|P6|NOT COMPLETED|Long-Term Extension Period||0
8312067|NCT01474512|20493575|P5|NOT COMPLETED|Long-Term Extension Period||0
8312068|NCT01474512|20493576|P4|NOT COMPLETED|Long-Term Extension Period||0
8312069|NCT01474512|20493577|P3|NOT COMPLETED|Long-Term Extension Period||0
8312070|NCT01474512|20493578|P2|NOT COMPLETED|Long-Term Extension Period||0
8312071|NCT01474512|20493579|P1|NOT COMPLETED|Long-Term Extension Period||0
8312072|NCT01474512|20493562|P18|COMPLETED|Long-Term Extension Period||0
8312073|NCT01474512|20493563|P17|COMPLETED|Long-Term Extension Period||0
8312074|NCT01474512|20493564|P16|COMPLETED|Long-Term Extension Period||0
8312075|NCT01474512|20493565|P15|COMPLETED|Long-Term Extension Period||0
8312076|NCT01474512|20493566|P14|COMPLETED|Long-Term Extension Period||855
8312077|NCT01474512|20493567|P13|COMPLETED|Long-Term Extension Period||836
8312078|NCT01474512|20493568|P12|COMPLETED|Long-Term Extension Period||0
8312079|NCT01474512|20493569|P11|COMPLETED|Long-Term Extension Period||0
8312080|NCT01474512|20493570|P10|COMPLETED|Long-Term Extension Period||0
8312081|NCT01474512|20493571|P9|COMPLETED|Long-Term Extension Period||0
8312082|NCT01474512|20493572|P8|COMPLETED|Long-Term Extension Period||0
8312083|NCT01474512|20493573|P7|COMPLETED|Long-Term Extension Period||0
8312084|NCT01474512|20493574|P6|COMPLETED|Long-Term Extension Period||0
8312085|NCT01474512|20493575|P5|COMPLETED|Long-Term Extension Period||0
8312086|NCT01474512|20493576|P4|COMPLETED|Long-Term Extension Period||0
8312087|NCT01474512|20493577|P3|COMPLETED|Long-Term Extension Period||0
8312088|NCT01474512|20493578|P2|COMPLETED|Long-Term Extension Period||0
8312089|NCT01474512|20493579|P1|COMPLETED|Long-Term Extension Period||0
8312090|NCT01474512|20493562|P18|STARTED|Long-Term Extension Period||0
8312091|NCT01474512|20493563|P17|STARTED|Long-Term Extension Period||0
8312092|NCT01474512|20493564|P16|STARTED|Long-Term Extension Period||0
8312093|NCT01474512|20493565|P15|STARTED|Long-Term Extension Period||0
8312094|NCT01474512|20493566|P14|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
8312095|NCT01474512|20493567|P13|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
8312096|NCT01474512|20493568|P12|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
8312097|NCT01474512|20493569|P11|STARTED|Long-Term Extension Period||0
8312098|NCT01474512|20493570|P10|STARTED|Long-Term Extension Period||0
8312099|NCT01474512|20493571|P9|STARTED|Long-Term Extension Period||0
8312100|NCT01474512|20493572|P8|STARTED|Long-Term Extension Period||0
8312101|NCT01474512|20493573|P7|STARTED|Long-Term Extension Period||0
8312102|NCT01474512|20493574|P6|STARTED|Long-Term Extension Period||0
8312103|NCT01474512|20493575|P5|STARTED|Long-Term Extension Period||0
8312104|NCT01474512|20493576|P4|STARTED|Long-Term Extension Period||0
8312105|NCT01474512|20493577|P3|STARTED|Long-Term Extension Period||0
8312106|NCT01474512|20493578|P2|STARTED|Long-Term Extension Period||0
8312107|NCT01474512|20493579|P1|STARTED|Long-Term Extension Period||0
8312108|NCT01474512|20493562|P18|NOT COMPLETED|Maintenance Period||0
8312109|NCT01474512|20493563|P17|NOT COMPLETED|Maintenance Period||0
8312110|NCT01474512|20493564|P16|NOT COMPLETED|Maintenance Period||0
8312111|NCT01474512|20493565|P15|NOT COMPLETED|Maintenance Period||0
8312112|NCT01474512|20493566|P14|NOT COMPLETED|Maintenance Period||0
8312113|NCT01474512|20493567|P13|NOT COMPLETED|Maintenance Period||0
8312114|NCT01474512|20493568|P12|NOT COMPLETED|Maintenance Period||0
8312115|NCT01474512|20493569|P11|NOT COMPLETED|Maintenance Period||0
8312116|NCT01474512|20493570|P10|NOT COMPLETED|Maintenance Period||18
8312117|NCT01474512|20493571|P9|NOT COMPLETED|Maintenance Period||16
8312118|NCT01474512|20493572|P8|NOT COMPLETED|Maintenance Period||41
8312119|NCT01474512|20493573|P7|NOT COMPLETED|Maintenance Period||10
8312120|NCT01474512|20493574|P6|NOT COMPLETED|Maintenance Period||52
8312121|NCT01474512|20493575|P5|NOT COMPLETED|Maintenance Period||119
8312122|NCT01474512|20493576|P4|NOT COMPLETED|Maintenance Period||202
8312123|NCT01474512|20493577|P3|NOT COMPLETED|Maintenance Period||0
8312124|NCT01474512|20493578|P2|NOT COMPLETED|Maintenance Period||0
8312125|NCT01474512|20493579|P1|NOT COMPLETED|Maintenance Period||0
8312126|NCT01474512|20493562|P18|COMPLETED|Maintenance Period||0
8312127|NCT01474512|20493563|P17|COMPLETED|Maintenance Period||0
8312128|NCT01474512|20493564|P16|COMPLETED|Maintenance Period||0
8312129|NCT01474512|20493565|P15|COMPLETED|Maintenance Period||0
8312130|NCT01474512|20493566|P14|COMPLETED|Maintenance Period||0
8312131|NCT01474512|20493567|P13|COMPLETED|Maintenance Period||0
8312132|NCT01474512|20493568|P12|COMPLETED|Maintenance Period||0
8312133|NCT01474512|20493569|P11|COMPLETED|Maintenance Period||0
8312134|NCT01474512|20493570|P10|COMPLETED|Maintenance Period||44
8312135|NCT01474512|20493571|P9|COMPLETED|Maintenance Period||62
8312136|NCT01474512|20493572|P8|COMPLETED|Maintenance Period||350
8312137|NCT01474512|20493573|P7|COMPLETED|Maintenance Period||6
8312138|NCT01474512|20493574|P6|COMPLETED|Maintenance Period||177
8312139|NCT01474512|20493575|P5|COMPLETED|Maintenance Period||108
8312140|NCT01474512|20493576|P4|COMPLETED|Maintenance Period||24
8312141|NCT01474512|20493577|P3|COMPLETED|Maintenance Period||0
8312142|NCT01474512|20493578|P2|COMPLETED|Maintenance Period||0
8312143|NCT01474512|20493579|P1|COMPLETED|Maintenance Period||0
8312144|NCT01474512|20493562|P18|Relapsed Population Completers|Maintenance Period||0
8312145|NCT01474512|20493563|P17|Relapsed Population Completers|Maintenance Period||0
8312146|NCT01474512|20493564|P16|Relapsed Population Completers|Maintenance Period||0
8312147|NCT01474512|20493565|P15|Relapsed Population Completers|Maintenance Period||0
8312148|NCT01474512|20493566|P14|Relapsed Population Completers|Maintenance Period||0
8312149|NCT01474512|20493567|P13|Relapsed Population Completers|Maintenance Period||0
8312150|NCT01474512|20493568|P12|Relapsed Population Completers|Maintenance Period||0
8312151|NCT01474512|20493569|P11|Relapsed Population Completers|Maintenance Period||321
8312152|NCT01474512|20493570|P10|Relapsed Population Completers|Maintenance Period||0
8312153|NCT01474512|20493571|P9|Relapsed Population Completers|Maintenance Period||0
8312154|NCT01474512|20493572|P8|Relapsed Population Completers|Maintenance Period||0
8312155|NCT01474512|20493573|P7|Relapsed Population Completers|Maintenance Period||0
8312156|NCT01474512|20493574|P6|Relapsed Population Completers|Maintenance Period||0
8312157|NCT01474512|20493575|P5|Relapsed Population Completers|Maintenance Period||0
8312158|NCT01474512|20493576|P4|Relapsed Population Completers|Maintenance Period||0
8312159|NCT01474512|20493577|P3|Relapsed Population Completers|Maintenance Period||0
8312160|NCT01474512|20493578|P2|Relapsed Population Completers|Maintenance Period||0
8312161|NCT01474512|20493579|P1|Relapsed Population Completers|Maintenance Period||0
8312162|NCT01474512|20493562|P18|Relapsed Population Received Drug|Maintenance Period||0
8312163|NCT01474512|20493563|P17|Relapsed Population Received Drug|Maintenance Period||0
8312164|NCT01474512|20493564|P16|Relapsed Population Received Drug|Maintenance Period||0
8312165|NCT01474512|20493565|P15|Relapsed Population Received Drug|Maintenance Period||0
8312166|NCT01474512|20493566|P14|Relapsed Population Received Drug|Maintenance Period||0
8312167|NCT01474512|20493567|P13|Relapsed Population Received Drug|Maintenance Period||0
8312168|NCT01474512|20493568|P12|Relapsed Population Received Drug|Maintenance Period||0
8312169|NCT01474512|20493569|P11|Relapsed Population Received Drug|Maintenance Period||348
8312170|NCT01474512|20493570|P10|Relapsed Population Received Drug|Maintenance Period||0
8312171|NCT01474512|20493571|P9|Relapsed Population Received Drug|Maintenance Period||0
8312172|NCT01474512|20493572|P8|Relapsed Population Received Drug|Maintenance Period||0
8312173|NCT01474512|20493573|P7|Relapsed Population Received Drug|Maintenance Period||0
8312174|NCT01474512|20493574|P6|Relapsed Population Received Drug|Maintenance Period||0
8312175|NCT01474512|20493575|P5|Relapsed Population Received Drug|Maintenance Period||0
8312176|NCT01474512|20493576|P4|Relapsed Population Received Drug|Maintenance Period||0
8312177|NCT01474512|20493577|P3|Relapsed Population Received Drug|Maintenance Period||0
8312178|NCT01474512|20493578|P2|Relapsed Population Received Drug|Maintenance Period||0
8312179|NCT01474512|20493579|P1|Relapsed Population Received Drug|Maintenance Period||0
8312180|NCT01474512|20493562|P18|Received Study Drug|Maintenance Period||0
8312181|NCT01474512|20493563|P17|Received Study Drug|Maintenance Period||0
8312182|NCT01474512|20493564|P16|Received Study Drug|Maintenance Period||0
8312183|NCT01474512|20493565|P15|Received Study Drug|Maintenance Period||0
8312184|NCT01474512|20493566|P14|Received Study Drug|Maintenance Period||0
8312185|NCT01474512|20493567|P13|Received Study Drug|Maintenance Period||0
8312186|NCT01474512|20493568|P12|Received Study Drug|Maintenance Period||0
8312187|NCT01474512|20493569|P11|Received Study Drug|Maintenance Period||0
8312188|NCT01474512|20493570|P10|Received Study Drug|Maintenance Period||62
8312189|NCT01474512|20493571|P9|Received Study Drug|Maintenance Period||78
8312190|NCT01474512|20493572|P8|Received Study Drug|Maintenance Period||391
8312191|NCT01474512|20493573|P7|Received Study Drug|Maintenance Period||16
8312192|NCT01474512|20493574|P6|Received Study Drug|Maintenance Period||229
8312193|NCT01474512|20493575|P5|Received Study Drug|Maintenance Period||227
8312194|NCT01474512|20493576|P4|Received Study Drug|Maintenance Period||226
8312195|NCT01474512|20493577|P3|Received Study Drug|Maintenance Period||0
8312196|NCT01474512|20493578|P2|Received Study Drug|Maintenance Period||0
8312197|NCT01474512|20493579|P1|Received Study Drug|Maintenance Period||0
8312198|NCT01474512|20493562|P18|STARTED|Maintenance Period||0
8312199|NCT01474512|20493563|P17|STARTED|Maintenance Period||0
8312200|NCT01474512|20493564|P16|STARTED|Maintenance Period||0
8312201|NCT01474512|20493565|P15|STARTED|Maintenance Period||0
8312202|NCT01474512|20493566|P14|STARTED|Maintenance Period||0
8312203|NCT01474512|20493567|P13|STARTED|Maintenance Period||0
8312204|NCT01474512|20493568|P12|STARTED|Maintenance Period||0
8312205|NCT01474512|20493569|P11|STARTED|Maintenance Period||0
8312206|NCT01474512|20493570|P10|STARTED|Maintenance Period||62
8312207|NCT01474512|20493571|P9|STARTED|Maintenance Period||78
8312208|NCT01474512|20493572|P8|STARTED|Maintenance Period||391
8312209|NCT01474512|20493573|P7|STARTED|Maintenance Period||16
8312210|NCT01474512|20493574|P6|STARTED|Maintenance Period||229
8312298|NCT01474434|20493657|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
8312211|NCT01474512|20493575|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
8312212|NCT01474512|20493576|P4|STARTED|Maintenance Period||226
8312213|NCT01474512|20493577|P3|STARTED|Maintenance Period||0
8312214|NCT01474512|20493578|P2|STARTED|Maintenance Period||0
8312215|NCT01474512|20493579|P1|STARTED|Maintenance Period||0
8312216|NCT01474512|20493562|P18|NOT COMPLETED|Induction Period||0
8312217|NCT01474512|20493563|P17|NOT COMPLETED|Induction Period||0
8312218|NCT01474512|20493564|P16|NOT COMPLETED|Induction Period||0
8312219|NCT01474512|20493565|P15|NOT COMPLETED|Induction Period||0
8312220|NCT01474512|20493566|P14|NOT COMPLETED|Induction Period||0
8312221|NCT01474512|20493567|P13|NOT COMPLETED|Induction Period||0
8312222|NCT01474512|20493568|P12|NOT COMPLETED|Induction Period||0
8312223|NCT01474512|20493569|P11|NOT COMPLETED|Induction Period||0
8312224|NCT01474512|20493570|P10|NOT COMPLETED|Induction Period||0
8312225|NCT01474512|20493571|P9|NOT COMPLETED|Induction Period||0
8312226|NCT01474512|20493572|P8|NOT COMPLETED|Induction Period||0
8312227|NCT01474512|20493573|P7|NOT COMPLETED|Induction Period||0
8312228|NCT01474512|20493574|P6|NOT COMPLETED|Induction Period||0
8312229|NCT01474512|20493575|P5|NOT COMPLETED|Induction Period||0
8312230|NCT01474512|20493576|P4|NOT COMPLETED|Induction Period||0
8312231|NCT01474512|20493577|P3|NOT COMPLETED|Induction Period||18
8312232|NCT01474512|20493578|P2|NOT COMPLETED|Induction Period||24
8312233|NCT01474512|20493579|P1|NOT COMPLETED|Induction Period||24
8312234|NCT01474512|20493562|P18|COMPLETED|Induction Period||0
8312235|NCT01474512|20493563|P17|COMPLETED|Induction Period||0
8312236|NCT01474512|20493564|P16|COMPLETED|Induction Period||0
8312237|NCT01474512|20493565|P15|COMPLETED|Induction Period||0
8312238|NCT01474512|20493566|P14|COMPLETED|Induction Period||0
8312239|NCT01474512|20493567|P13|COMPLETED|Induction Period||0
8312240|NCT01474512|20493568|P12|COMPLETED|Induction Period||0
8312241|NCT01474512|20493569|P11|COMPLETED|Induction Period||0
8312242|NCT01474512|20493570|P10|COMPLETED|Induction Period||0
8312243|NCT01474512|20493571|P9|COMPLETED|Induction Period||0
8312244|NCT01474512|20493572|P8|COMPLETED|Induction Period||0
8312245|NCT01474512|20493573|P7|COMPLETED|Induction Period||0
8312246|NCT01474512|20493574|P6|COMPLETED|Induction Period||0
8312247|NCT01474512|20493575|P5|COMPLETED|Induction Period||0
8312248|NCT01474512|20493576|P4|COMPLETED|Induction Period||0
8312249|NCT01474512|20493577|P3|COMPLETED|Induction Period||415
8312250|NCT01474512|20493578|P2|COMPLETED|Induction Period||408
8312251|NCT01474512|20493579|P1|COMPLETED|Induction Period||407
8312252|NCT01474512|20493562|P18|Received Study Drug|Induction Period||0
8312253|NCT01474512|20493563|P17|Received Study Drug|Induction Period||0
8312254|NCT01474512|20493564|P16|Received Study Drug|Induction Period||0
8312255|NCT01474512|20493565|P15|Received Study Drug|Induction Period||0
8312256|NCT01474512|20493566|P14|Received Study Drug|Induction Period||0
8312257|NCT01474512|20493567|P13|Received Study Drug|Induction Period||0
8312258|NCT01474512|20493568|P12|Received Study Drug|Induction Period||0
8312259|NCT01474512|20493569|P11|Received Study Drug|Induction Period||0
8312260|NCT01474512|20493570|P10|Received Study Drug|Induction Period||0
8312261|NCT01474512|20493571|P9|Received Study Drug|Induction Period||0
8312262|NCT01474512|20493572|P8|Received Study Drug|Induction Period||0
8312263|NCT01474512|20493573|P7|Received Study Drug|Induction Period||0
8312264|NCT01474512|20493574|P6|Received Study Drug|Induction Period||0
8312265|NCT01474512|20493575|P5|Received Study Drug|Induction Period||0
8312266|NCT01474512|20493576|P4|Received Study Drug|Induction Period||0
8312267|NCT01474512|20493577|P3|Received Study Drug|Induction Period||433
8312268|NCT01474512|20493578|P2|Received Study Drug|Induction Period||432
8312269|NCT01474512|20493579|P1|Received Study Drug|Induction Period||431
8312270|NCT01474512|20493562|P18|STARTED|Induction Period||0
8312271|NCT01474512|20493563|P17|STARTED|Induction Period||0
8312272|NCT01474512|20493564|P16|STARTED|Induction Period||0
8312273|NCT01474512|20493565|P15|STARTED|Induction Period||0
8312274|NCT01474512|20493566|P14|STARTED|Induction Period||0
8312275|NCT01474512|20493567|P13|STARTED|Induction Period||0
8312276|NCT01474512|20493568|P12|STARTED|Induction Period||0
8312277|NCT01474512|20493569|P11|STARTED|Induction Period||0
8312278|NCT01474512|20493570|P10|STARTED|Induction Period||0
8312279|NCT01474512|20493571|P9|STARTED|Induction Period||0
8312280|NCT01474512|20493572|P8|STARTED|Induction Period||0
8312281|NCT01474512|20493573|P7|STARTED|Induction Period||0
8312282|NCT01474512|20493574|P6|STARTED|Induction Period||0
8312283|NCT01474512|20493575|P5|STARTED|Induction Period||0
8312284|NCT01474512|20493576|P4|STARTED|Induction Period||0
8312285|NCT01474512|20493577|P3|STARTED|Induction Period||433
8312286|NCT01474512|20493578|P2|STARTED|Induction Period||432
8312287|NCT01474512|20493579|P1|STARTED|Induction Period||431
8312288|NCT01474434|20493655|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312289|NCT01474434|20493656|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312290|NCT01474434|20493657|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312291|NCT01474434|20493658|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312292|NCT01474434|20493655|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
8312293|NCT01474434|20493656|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
8312294|NCT01474434|20493657|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
8312295|NCT01474434|20493658|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
8312296|NCT01474434|20493655|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
8312297|NCT01474434|20493656|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
8312299|NCT01474434|20493658|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
8312300|NCT01474434|20493655|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
8312301|NCT01474434|20493656|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
8312302|NCT01474434|20493657|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
8312303|NCT01474434|20493658|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
8312304|NCT01474434|20493655|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
8312305|NCT01474434|20493656|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
8312306|NCT01474434|20493657|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
8312307|NCT01474434|20493658|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
8312308|NCT01474434|20493655|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
8312309|NCT01474434|20493656|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
8312310|NCT01474434|20493657|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
8312311|NCT01474434|20493658|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
8312312|NCT01474317|20493700|P1|NOT COMPLETED|Overall Study||2
8312313|NCT01474317|20493700|P1|COMPLETED|Overall Study||224
8312314|NCT01474317|20493700|P1|STARTED|Overall Study||226
8312315|NCT01474291|20493709|P1|NOT COMPLETED|Overall Study||220
8312316|NCT01474291|20493709|P1|COMPLETED|Overall Study||383
8312317|NCT01474291|20493709|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
8312318|NCT01474291|20493709|P1|STARTED|Overall Study||603
8312319|NCT01474239|20493753|P2|NOT COMPLETED|Overall Study||32
8312320|NCT01474239|20493754|P1|NOT COMPLETED|Overall Study||59
8312321|NCT01474239|20493753|P2|COMPLETED|Overall Study||0
8312322|NCT01474239|20493754|P1|COMPLETED|Overall Study||0
8312323|NCT01474239|20493753|P2|STARTED|Overall Study||32
8312324|NCT01474239|20493754|P1|STARTED|Overall Study||59
8312325|NCT01474213|20493792|P2|NOT COMPLETED|Overall Study||0
8312326|NCT01474213|20493793|P1|NOT COMPLETED|Overall Study||0
8312327|NCT01474213|20493792|P2|COMPLETED|Overall Study||20
8312328|NCT01474213|20493793|P1|COMPLETED|Overall Study||20
8312329|NCT01474213|20493792|P2|STARTED|Overall Study||20
8312330|NCT01474213|20493793|P1|STARTED|Overall Study||20
8312331|NCT01474200|20493817|P2|NOT COMPLETED|Overall Study||30
8312332|NCT01474200|20493818|P1|NOT COMPLETED|Overall Study||29
8312333|NCT01474200|20493817|P2|COMPLETED|Overall Study||84
8312334|NCT01474200|20493818|P1|COMPLETED|Overall Study||81
8312335|NCT01474200|20493817|P2|STARTED|Overall Study||114
8312336|NCT01474200|20493818|P1|STARTED|Overall Study||110
8312337|NCT01474122|20493871|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
8312338|NCT01474122|20493872|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
8312339|NCT01474122|20493873|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
8312340|NCT01474122|20493871|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
8312341|NCT01474122|20493872|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
8312342|NCT01474122|20493873|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
8312343|NCT01474122|20493871|P3|STARTED|Period 2: Week 16 to End of Study||88
8312344|NCT01474122|20493872|P2|STARTED|Period 2: Week 16 to End of Study||86
8312345|NCT01474122|20493873|P1|STARTED|Period 2: Week 16 to End of Study||87
8312346|NCT01474122|20493871|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
8312347|NCT01474122|20493872|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
8312348|NCT01474122|20493873|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
8312349|NCT01474122|20493871|P3|COMPLETED|Period 1: Baseline to Week 16||88
8312350|NCT01474122|20493872|P2|COMPLETED|Period 1: Baseline to Week 16||86
8312351|NCT01474122|20493873|P1|COMPLETED|Period 1: Baseline to Week 16||87
8312352|NCT01474122|20493871|P3|STARTED|Period 1: Baseline to Week 16||89
8312353|NCT01474122|20493872|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
8312354|NCT01474122|20493873|P1|STARTED|Period 1: Baseline to Week 16||88
8312355|NCT01474109|20493899|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
8312356|NCT01474109|20493900|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
8312357|NCT01474109|20493901|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
8312358|NCT01474109|20493899|P3|COMPLETED|Period 2: Week 16 to End of Study||83
8312359|NCT01474109|20493900|P2|COMPLETED|Period 2: Week 16 to End of Study||73
8312360|NCT01474109|20493901|P1|COMPLETED|Period 2: Week 16 to End of Study||70
8312361|NCT01474109|20493899|P3|STARTED|Period 2: Week 16 to End of Study||95
8312362|NCT01474109|20493900|P2|STARTED|Period 2: Week 16 to End of Study||91
8312363|NCT01474109|20493901|P1|STARTED|Period 2: Week 16 to End of Study||88
8312364|NCT01474109|20493899|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
8312365|NCT01474109|20493900|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
8312366|NCT01474109|20493901|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
8312367|NCT01474109|20493899|P3|COMPLETED|Period 1: Baseline to Week 16||95
8312368|NCT01474109|20493900|P2|COMPLETED|Period 1: Baseline to Week 16||91
8312369|NCT01474109|20493901|P1|COMPLETED|Period 1: Baseline to Week 16||88
8312370|NCT01474109|20493899|P3|STARTED|Period 1: Baseline to Week 16||97
8312371|NCT01474109|20493900|P2|STARTED|Period 1: Baseline to Week 16||97
8312372|NCT01474109|20493901|P1|STARTED|Period 1: Baseline to Week 16||95
8312373|NCT01474018|20493926|P2|NOT COMPLETED|Overall Study||3
8312374|NCT01474018|20493927|P1|NOT COMPLETED|Overall Study||0
8312375|NCT01474018|20493926|P2|COMPLETED|Overall Study||7
8312376|NCT01474018|20493927|P1|COMPLETED|Overall Study|Writing paper|5
8312377|NCT01474018|20493926|P2|STARTED|Overall Study||10
8312378|NCT01474018|20493927|P1|STARTED|Overall Study||5
8312379|NCT01473992|20493937|P3|NOT COMPLETED|Overall Study||0
8312380|NCT01473992|20493938|P2|NOT COMPLETED|Overall Study||0
8312381|NCT01473992|20493939|P1|NOT COMPLETED|Overall Study||0
8312382|NCT01473992|20493937|P3|COMPLETED|Overall Study||5
8312383|NCT01473992|20493938|P2|COMPLETED|Overall Study||10
8312384|NCT01473992|20493939|P1|COMPLETED|Overall Study||10
8312385|NCT01473992|20493937|P3|STARTED|Overall Study||5
8312386|NCT01473992|20493938|P2|STARTED|Overall Study||10
8312387|NCT01473992|20493939|P1|STARTED|Overall Study||10
8312388|NCT01473953|20493959|P5|NOT COMPLETED|Overall Study||0
8312389|NCT01473953|20493960|P4|NOT COMPLETED|Overall Study||0
8312390|NCT01473953|20493961|P3|NOT COMPLETED|Overall Study||0
8312391|NCT01473953|20493962|P2|NOT COMPLETED|Overall Study||0
8312392|NCT01473953|20493963|P1|NOT COMPLETED|Overall Study||1
8312393|NCT01473953|20493959|P5|COMPLETED|Overall Study||8
8312394|NCT01473953|20493960|P4|COMPLETED|Overall Study||5
8312395|NCT01473953|20493961|P3|COMPLETED|Overall Study||6
8312396|NCT01473953|20493962|P2|COMPLETED|Overall Study||6
8312397|NCT01473953|20493963|P1|COMPLETED|Overall Study||5
8312398|NCT01473953|20493959|P5|STARTED|Overall Study||8
8312399|NCT01473953|20493960|P4|STARTED|Overall Study||5
8312400|NCT01473953|20493961|P3|STARTED|Overall Study||6
8312401|NCT01473953|20493962|P2|STARTED|Overall Study||6
8312402|NCT01473953|20493963|P1|STARTED|Overall Study||6
8312403|NCT01473940|20494009|P4|NOT COMPLETED|Follow-up Until Death||0
8312404|NCT01473940|20494010|P3|NOT COMPLETED|Follow-up Until Death||0
8312405|NCT01473940|20494011|P2|NOT COMPLETED|Follow-up Until Death||0
8312406|NCT01473940|20494012|P1|NOT COMPLETED|Follow-up Until Death||0
8312407|NCT01473940|20494009|P4|COMPLETED|Follow-up Until Death||7
8312408|NCT01473940|20494010|P3|COMPLETED|Follow-up Until Death||5
8312409|NCT01473940|20494011|P2|COMPLETED|Follow-up Until Death||4
8312410|NCT01473940|20494012|P1|COMPLETED|Follow-up Until Death||3
8312411|NCT01473940|20494009|P4|STARTED|Follow-up Until Death||7
8312412|NCT01473940|20494010|P3|STARTED|Follow-up Until Death||5
8312413|NCT01473940|20494011|P2|STARTED|Follow-up Until Death||4
8312414|NCT01473940|20494012|P1|STARTED|Follow-up Until Death||3
8312415|NCT01473940|20494009|P4|NOT COMPLETED|Maintenance Therapy||4
8312416|NCT01473940|20494010|P3|NOT COMPLETED|Maintenance Therapy||1
8312417|NCT01473940|20494011|P2|NOT COMPLETED|Maintenance Therapy||2
8312418|NCT01473940|20494012|P1|NOT COMPLETED|Maintenance Therapy||1
8312419|NCT01473940|20494009|P4|COMPLETED|Maintenance Therapy||3
8312420|NCT01473940|20494010|P3|COMPLETED|Maintenance Therapy||3
8312421|NCT01473940|20494011|P2|COMPLETED|Maintenance Therapy||1
8312422|NCT01473940|20494012|P1|COMPLETED|Maintenance Therapy||2
8312423|NCT01473940|20494009|P4|Went on to Start Maintenance Therapy|Maintenance Therapy||3
8312424|NCT01473940|20494010|P3|Went on to Start Maintenance Therapy|Maintenance Therapy||3
8312425|NCT01473940|20494011|P2|Went on to Start Maintenance Therapy|Maintenance Therapy||1
8312426|NCT01473940|20494012|P1|Went on to Start Maintenance Therapy|Maintenance Therapy||2
8312427|NCT01473940|20494009|P4|Evaluated for Response|Maintenance Therapy||7
8312428|NCT01473940|20494010|P3|Evaluated for Response|Maintenance Therapy||4
8312429|NCT01473940|20494011|P2|Evaluated for Response|Maintenance Therapy||3
8312430|NCT01473940|20494012|P1|Evaluated for Response|Maintenance Therapy||3
8312431|NCT01473940|20494009|P4|STARTED|Maintenance Therapy||7
8312432|NCT01473940|20494010|P3|STARTED|Maintenance Therapy||4
8312433|NCT01473940|20494011|P2|STARTED|Maintenance Therapy||3
8312434|NCT01473940|20494012|P1|STARTED|Maintenance Therapy||3
8312435|NCT01473940|20494009|P4|NOT COMPLETED|Induction Therapy||1
8312436|NCT01473940|20494010|P3|NOT COMPLETED|Induction Therapy||2
8312437|NCT01473940|20494011|P2|NOT COMPLETED|Induction Therapy||1
8312438|NCT01473940|20494012|P1|NOT COMPLETED|Induction Therapy||0
8312439|NCT01473940|20494009|P4|COMPLETED|Induction Therapy||7
8312440|NCT01473940|20494010|P3|COMPLETED|Induction Therapy||4
8312441|NCT01473940|20494011|P2|COMPLETED|Induction Therapy||3
8312442|NCT01473940|20494012|P1|COMPLETED|Induction Therapy||3
8312443|NCT01473940|20494009|P4|Completed Induction- 12 Weeks|Induction Therapy||7
8312444|NCT01473940|20494010|P3|Completed Induction- 12 Weeks|Induction Therapy||4
8312445|NCT01473940|20494011|P2|Completed Induction- 12 Weeks|Induction Therapy||3
8312446|NCT01473940|20494012|P1|Completed Induction- 12 Weeks|Induction Therapy||3
8312447|NCT01473940|20494009|P4|Started Treatment|Induction Therapy||8
8312448|NCT01473940|20494010|P3|Started Treatment|Induction Therapy||6
8312449|NCT01473940|20494011|P2|Started Treatment|Induction Therapy||4
8312450|NCT01473940|20494012|P1|Started Treatment|Induction Therapy||3
8312451|NCT01473940|20494009|P4|STARTED|Induction Therapy||8
8312452|NCT01473940|20494010|P3|STARTED|Induction Therapy||6
8312453|NCT01473940|20494011|P2|STARTED|Induction Therapy||4
8312454|NCT01473940|20494012|P1|STARTED|Induction Therapy||3
8312455|NCT01473836|20494042|P1|NOT COMPLETED|Overall Study||6
8312456|NCT01473836|20494042|P1|COMPLETED|Overall Study||32
8312457|NCT01473836|20494042|P1|STARTED|Overall Study||38
8312458|NCT01473758|20494053|P4|NOT COMPLETED|Cycle 2||0
8312459|NCT01473758|20494054|P3|NOT COMPLETED|Cycle 2||5
8312460|NCT01473758|20494055|P2|NOT COMPLETED|Cycle 2||0
8312461|NCT01473758|20494056|P1|NOT COMPLETED|Cycle 2||0
8312462|NCT01473758|20494053|P4|COMPLETED|Cycle 2||4
8312463|NCT01473758|20494054|P3|COMPLETED|Cycle 2||5
8312464|NCT01473758|20494055|P2|COMPLETED|Cycle 2||0
8312465|NCT01473758|20494056|P1|COMPLETED|Cycle 2||0
8312466|NCT01473758|20494053|P4|STARTED|Cycle 2||4
8312467|NCT01473758|20494054|P3|STARTED|Cycle 2||10
8312468|NCT01473758|20494055|P2|STARTED|Cycle 2||0
8312469|NCT01473758|20494056|P1|STARTED|Cycle 2||0
8312470|NCT01473758|20494053|P4|NOT COMPLETED|Cycle 1||0
8312471|NCT01473758|20494054|P3|NOT COMPLETED|Cycle 1||0
8312472|NCT01473758|20494055|P2|NOT COMPLETED|Cycle 1||3
8312473|NCT01473758|20494056|P1|NOT COMPLETED|Cycle 1||11
8312474|NCT01473758|20494053|P4|COMPLETED|Cycle 1||0
8312475|NCT01473758|20494054|P3|COMPLETED|Cycle 1||0
8312476|NCT01473758|20494055|P2|COMPLETED|Cycle 1||40
8312477|NCT01473758|20494056|P1|COMPLETED|Cycle 1||27
8312478|NCT01473758|20494053|P4|STARTED|Cycle 1||0
8312479|NCT01473758|20494054|P3|STARTED|Cycle 1||0
8312480|NCT01473758|20494055|P2|STARTED|Cycle 1||43
8312481|NCT01473758|20494056|P1|STARTED|Cycle 1||38
8312482|NCT01473745|20494180|P2|NOT COMPLETED|Overall Study||0
8312483|NCT01473745|20494181|P1|NOT COMPLETED|Overall Study||0
8312484|NCT01473745|20494180|P2|COMPLETED|Overall Study||24
8312485|NCT01473745|20494181|P1|COMPLETED|Overall Study||24
8312486|NCT01473745|20494180|P2|STARTED|Overall Study||24
8312487|NCT01473745|20494181|P1|STARTED|Overall Study||24
8312488|NCT01473732|20494193|P2|NOT COMPLETED|Overall Study||0
8312489|NCT01473732|20494194|P1|NOT COMPLETED|Overall Study||2
8312490|NCT01473732|20494193|P2|COMPLETED|Overall Study||0
8312491|NCT01473732|20494194|P1|COMPLETED|Overall Study||0
8312492|NCT01473732|20494193|P2|STARTED|Overall Study||0
8312493|NCT01473732|20494194|P1|STARTED|Overall Study||2
8312494|NCT01473602|20494202|P2|NOT COMPLETED|Overall Study||8
8312495|NCT01473602|20494203|P1|NOT COMPLETED|Overall Study||8
8312496|NCT01473602|20494202|P2|COMPLETED|Overall Study||13
8312497|NCT01473602|20494203|P1|COMPLETED|Overall Study||10
8312498|NCT01473602|20494202|P2|Completed 12 Months|Overall Study||13
8312499|NCT01473602|20494203|P1|Completed 12 Months|Overall Study||10
8312500|NCT01473602|20494202|P2|Completed 6 Months|Overall Study||15
8312501|NCT01473602|20494203|P1|Completed 6 Months|Overall Study||12
8312502|NCT01473602|20494202|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
8312503|NCT01473602|20494203|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8312504|NCT01473602|20494202|P2|STARTED|Overall Study||21
8312505|NCT01473602|20494203|P1|STARTED|Overall Study||18
8312506|NCT01473589|20494239|P2|NOT COMPLETED|Overall Study||16
8312507|NCT01473589|20494240|P1|NOT COMPLETED|Overall Study||11
8312508|NCT01473589|20494239|P2|COMPLETED|Overall Study||46
8312509|NCT01473589|20494240|P1|COMPLETED|Overall Study||49
8312510|NCT01473589|20494239|P2|Completed 12 Months|Overall Study||48
8312511|NCT01473589|20494240|P1|Completed 12 Months|Overall Study||49
8312512|NCT01473589|20494239|P2|Completed 6 Months|Overall Study||54
8312513|NCT01473589|20494240|P1|Completed 6 Months|Overall Study||51
8312514|NCT01473589|20494239|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
8312515|NCT01473589|20494240|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
8312516|NCT01473589|20494239|P2|STARTED|Overall Study||62
8312517|NCT01473589|20494240|P1|STARTED|Overall Study||60
8312518|NCT01473563|20494274|P1|NOT COMPLETED|Overall Study||1
8312519|NCT01473563|20494274|P1|COMPLETED|Overall Study||51
8312520|NCT01473563|20494274|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
8312521|NCT01473563|20494274|P1|STARTED|Overall Study||52
8312522|NCT01473524|20494296|P6|NOT COMPLETED|LTSE Phase||21
8312523|NCT01473524|20494297|P5|NOT COMPLETED|LTSE Phase||17
8312524|NCT01473524|20494298|P4|NOT COMPLETED|LTSE Phase||9
8312525|NCT01473524|20494299|P3|NOT COMPLETED|LTSE Phase||0
8312526|NCT01473524|20494300|P2|NOT COMPLETED|LTSE Phase||0
8312527|NCT01473524|20494301|P1|NOT COMPLETED|LTSE Phase||0
8312528|NCT01473524|20494296|P6|COMPLETED|LTSE Phase||45
8312529|NCT01473524|20494297|P5|COMPLETED|LTSE Phase||47
8312530|NCT01473524|20494298|P4|COMPLETED|LTSE Phase||54
8312531|NCT01473524|20494299|P3|COMPLETED|LTSE Phase||0
8312532|NCT01473524|20494300|P2|COMPLETED|LTSE Phase||0
8312533|NCT01473524|20494301|P1|COMPLETED|LTSE Phase||0
8312534|NCT01473524|20494296|P6|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
8312535|NCT01473524|20494297|P5|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
8312536|NCT01473524|20494298|P4|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
8312537|NCT01473524|20494299|P3|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8312538|NCT01473524|20494300|P2|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8312539|NCT01473524|20494301|P1|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8312540|NCT01473524|20494296|P6|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
8312541|NCT01473524|20494297|P5|STARTED|LTSE Phase||64
8312542|NCT01473524|20494298|P4|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
8312543|NCT01473524|20494299|P3|STARTED|LTSE Phase||0
8312544|NCT01473524|20494300|P2|STARTED|LTSE Phase||0
8312545|NCT01473524|20494301|P1|STARTED|LTSE Phase||0
8312546|NCT01473524|20494296|P6|NOT COMPLETED|DB Phase||0
8312547|NCT01473524|20494297|P5|NOT COMPLETED|DB Phase||0
8312548|NCT01473524|20494298|P4|NOT COMPLETED|DB Phase||0
8312549|NCT01473524|20494299|P3|NOT COMPLETED|DB Phase||3
8312550|NCT01473524|20494300|P2|NOT COMPLETED|DB Phase||9
8312551|NCT01473524|20494301|P1|NOT COMPLETED|DB Phase||7
8312552|NCT01473524|20494296|P6|COMPLETED|DB Phase||0
8312553|NCT01473524|20494297|P5|COMPLETED|DB Phase||0
8312554|NCT01473524|20494298|P4|COMPLETED|DB Phase||0
8312555|NCT01473524|20494299|P3|COMPLETED|DB Phase||70
8312556|NCT01473524|20494300|P2|COMPLETED|DB Phase||64
8312557|NCT01473524|20494301|P1|COMPLETED|DB Phase||64
8312558|NCT01473524|20494296|P6|Received at Least 1 Dose of Study Drug|DB Phase||0
8312559|NCT01473524|20494297|P5|Received at Least 1 Dose of Study Drug|DB Phase||0
8312560|NCT01473524|20494298|P4|Received at Least 1 Dose of Study Drug|DB Phase||0
8312561|NCT01473524|20494299|P3|Received at Least 1 Dose of Study Drug|DB Phase||73
8312562|NCT01473524|20494300|P2|Received at Least 1 Dose of Study Drug|DB Phase||73
8312563|NCT01473524|20494301|P1|Received at Least 1 Dose of Study Drug|DB Phase||70
8312564|NCT01473524|20494296|P6|STARTED|DB Phase||0
8312565|NCT01473524|20494297|P5|STARTED|DB Phase||0
8312566|NCT01473524|20494298|P4|STARTED|DB Phase||0
8312567|NCT01473524|20494299|P3|STARTED|DB Phase||73
8312568|NCT01473524|20494300|P2|STARTED|DB Phase||73
8312569|NCT01473524|20494301|P1|STARTED|DB Phase||71
8312570|NCT01473420|20494350|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
8312571|NCT01473420|20494351|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
8312572|NCT01473420|20494350|P2|COMPLETED|Maintenance Period (16 Weeks)||105
8312573|NCT01473420|20494351|P1|COMPLETED|Maintenance Period (16 Weeks)||106
8312574|NCT01473420|20494350|P2|STARTED|Maintenance Period (16 Weeks)||122
8312575|NCT01473420|20494351|P1|STARTED|Maintenance Period (16 Weeks)||124
8312576|NCT01473420|20494350|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
8312577|NCT01473420|20494351|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
8312578|NCT01473420|20494350|P2|COMPLETED|Titration Period (18 Weeks)||122
8312579|NCT01473420|20494351|P1|COMPLETED|Titration Period (18 Weeks)||124
8312580|NCT01473420|20494350|P2|Treated|Titration Period (18 Weeks)||86
8312581|NCT01473420|20494351|P1|Treated|Titration Period (18 Weeks)||80
8312582|NCT01473420|20494350|P2|STARTED|Titration Period (18 Weeks)||160
8312583|NCT01473420|20494351|P1|STARTED|Titration Period (18 Weeks)||160
8312584|NCT01473407|20494435|P2|NOT COMPLETED|Overall Study||47
8312585|NCT01473407|20494436|P1|NOT COMPLETED|Overall Study||54
8312586|NCT01473407|20494435|P2|COMPLETED|Overall Study||259
8312587|NCT01473407|20494436|P1|COMPLETED|Overall Study||252
8312588|NCT01473407|20494435|P2|STARTED|Overall Study||306
8312589|NCT01473407|20494436|P1|STARTED|Overall Study||306
8312590|NCT01473394|20494490|P2|NOT COMPLETED|Overall Study||43
8312591|NCT01473394|20494491|P1|NOT COMPLETED|Overall Study||45
8312592|NCT01473394|20494490|P2|COMPLETED|Overall Study||212
8312593|NCT01473394|20494491|P1|COMPLETED|Overall Study||208
8312594|NCT01473394|20494490|P2|STARTED|Overall Study||255
8312595|NCT01473394|20494491|P1|STARTED|Overall Study||253
8312596|NCT01473381|20494505|P4|NOT COMPLETED|Overall Study||89
8312597|NCT01473381|20494506|P3|NOT COMPLETED|Overall Study||102
8312598|NCT01473381|20494507|P2|NOT COMPLETED|Overall Study||93
8312599|NCT01473381|20494508|P1|NOT COMPLETED|Overall Study||80
8312600|NCT01473381|20494505|P4|COMPLETED|Overall Study||200
8312601|NCT01473381|20494506|P3|COMPLETED|Overall Study||189
8312602|NCT01473381|20494507|P2|COMPLETED|Overall Study||199
8312603|NCT01473381|20494508|P1|COMPLETED|Overall Study||210
8312604|NCT01473381|20494505|P4|Safety Population|Overall Study||282
8312605|NCT01473381|20494506|P3|Safety Population|Overall Study||287
8312606|NCT01473381|20494507|P2|Safety Population|Overall Study||288
8312607|NCT01473381|20494508|P1|Safety Population|Overall Study||281
8312608|NCT01473381|20494505|P4|STARTED|Overall Study||289
8312609|NCT01473381|20494506|P3|STARTED|Overall Study||291
8312610|NCT01473381|20494507|P2|STARTED|Overall Study||292
8312611|NCT01473381|20494508|P1|STARTED|Overall Study||290
8312612|NCT01473368|20494530|P4|NOT COMPLETED|Overall Study||0
8312613|NCT01473368|20494531|P3|NOT COMPLETED|Overall Study||3
8312614|NCT01473368|20494532|P2|NOT COMPLETED|Overall Study||0
8312615|NCT01473368|20494533|P1|NOT COMPLETED|Overall Study||1
8312616|NCT01473368|20494530|P4|COMPLETED|Overall Study||12
8312617|NCT01473368|20494531|P3|COMPLETED|Overall Study||12
8312618|NCT01473368|20494532|P2|COMPLETED|Overall Study||12
8312619|NCT01473368|20494533|P1|COMPLETED|Overall Study||13
8312620|NCT01473368|20494530|P4|STARTED|Overall Study||12
8312621|NCT01473368|20494531|P3|STARTED|Overall Study||15
8312622|NCT01473368|20494532|P2|STARTED|Overall Study||12
8312623|NCT01473368|20494533|P1|STARTED|Overall Study||14
8312624|NCT01473355|20494570|P1|NOT COMPLETED|Overall Study||6
8312625|NCT01473355|20494570|P1|COMPLETED|Overall Study||39
8312626|NCT01473355|20494570|P1|STARTED|Overall Study||45
8312627|NCT01473160|20494579|P1|NOT COMPLETED|Overall Study||0
8312628|NCT01473160|20494579|P1|COMPLETED|Overall Study||9
8312629|NCT01473160|20494579|P1|STARTED|Overall Study||9
8312630|NCT01472965|20494599|P2|NOT COMPLETED|Overall Study||0
8312631|NCT01472965|20494600|P1|NOT COMPLETED|Overall Study||1
8312632|NCT01472965|20494599|P2|COMPLETED|Overall Study||46
8312633|NCT01472965|20494600|P1|COMPLETED|Overall Study||48
8312634|NCT01472965|20494599|P2|STARTED|Overall Study||46
8312635|NCT01472965|20494600|P1|STARTED|Overall Study||49
8312636|NCT01472939|20494620|P4|NOT COMPLETED|Overall Study||20
8312637|NCT01472939|20494621|P3|NOT COMPLETED|Overall Study||11
8312638|NCT01472939|20494622|P2|NOT COMPLETED|Overall Study||14
8312639|NCT01472939|20494623|P1|NOT COMPLETED|Overall Study||20
8312640|NCT01472939|20494620|P4|COMPLETED|Overall Study||99
8312641|NCT01472939|20494621|P3|COMPLETED|Overall Study||108
8312642|NCT01472939|20494622|P2|COMPLETED|Overall Study||105
8312643|NCT01472939|20494623|P1|COMPLETED|Overall Study||103
8312644|NCT01472939|20494620|P4|STARTED|Overall Study||119
8312645|NCT01472939|20494621|P3|STARTED|Overall Study||119
8312646|NCT01472939|20494622|P2|STARTED|Overall Study||119
8312647|NCT01472939|20494623|P1|STARTED|Overall Study||123
8312648|NCT01472874|20494650|P1|NOT COMPLETED|Overall Study||0
8312649|NCT01472874|20494650|P1|COMPLETED|Overall Study||8
8312650|NCT01472874|20494650|P1|STARTED|Overall Study||8
8312651|NCT01472835|20494667|P2|NOT COMPLETED|Overall Study||0
8312652|NCT01472835|20494668|P1|NOT COMPLETED|Overall Study||2
8312653|NCT01472835|20494667|P2|COMPLETED|Overall Study||36
8312654|NCT01472835|20494668|P1|COMPLETED|Overall Study||35
8312655|NCT01472835|20494667|P2|STARTED|Overall Study||36
8312656|NCT01472835|20494668|P1|STARTED|Overall Study||37
8312657|NCT01472822|20494684|P2|NOT COMPLETED|Overall Study||2
8312658|NCT01472822|20494685|P1|NOT COMPLETED|Overall Study||2
8312659|NCT01472822|20494684|P2|COMPLETED|Overall Study||28
8312660|NCT01472822|20494685|P1|COMPLETED|Overall Study||28
8312661|NCT01472822|20494684|P2|STARTED|Overall Study||30
8312662|NCT01472822|20494685|P1|STARTED|Overall Study||30
8312663|NCT01472757|20494703|P4|NOT COMPLETED|Overall Study||19
8312664|NCT01472757|20494704|P3|NOT COMPLETED|Overall Study||19
8312665|NCT01472757|20494705|P2|NOT COMPLETED|Overall Study||13
8312666|NCT01472757|20494706|P1|NOT COMPLETED|Overall Study||30
8312667|NCT01472757|20494703|P4|COMPLETED|Overall Study||75
8312668|NCT01472757|20494704|P3|COMPLETED|Overall Study||76
8312669|NCT01472757|20494705|P2|COMPLETED|Overall Study||80
8312670|NCT01472757|20494706|P1|COMPLETED|Overall Study||61
8312671|NCT01472757|20494703|P4|Full Analysis Set|Overall Study||92
8312672|NCT01472757|20494704|P3|Full Analysis Set|Overall Study||92
8312673|NCT01472757|20494705|P2|Full Analysis Set|Overall Study||93
8312674|NCT01472757|20494706|P1|Full Analysis Set|Overall Study||91
8312675|NCT01472757|20494703|P4|STARTED|Overall Study||94
8312676|NCT01472757|20494704|P3|STARTED|Overall Study||95
8312677|NCT01472757|20494705|P2|STARTED|Overall Study||93
8312678|NCT01472757|20494706|P1|STARTED|Overall Study||91
8312679|NCT01472718|20494730|P2|NOT COMPLETED|Overall Study||7
8312680|NCT01472718|20494731|P1|NOT COMPLETED|Overall Study||6
8312681|NCT01472718|20494730|P2|COMPLETED|Overall Study||97
8312682|NCT01472718|20494731|P1|COMPLETED|Overall Study||98
8312683|NCT01472718|20494730|P2|STARTED|Overall Study||104
8312684|NCT01472718|20494731|P1|STARTED|Overall Study||104
8312685|NCT01472692|20494741|P2|NOT COMPLETED|Overall Study||0
8312686|NCT01472692|20494742|P1|NOT COMPLETED|Overall Study||0
8312687|NCT01472692|20494741|P2|COMPLETED|Overall Study||0
8312688|NCT01472692|20494742|P1|COMPLETED|Overall Study||0
8312689|NCT01472692|20494741|P2|STARTED|Overall Study||0
8312690|NCT01472692|20494742|P1|STARTED|Overall Study||0
8312691|NCT01472562|20494750|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
8312692|NCT01472562|20494750|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
8312693|NCT01472562|20494750|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
8312694|NCT01472562|20494750|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
8312695|NCT01472562|20494750|P1|COMPLETED|Induction Phase (Week 1- 48)||27
8312696|NCT01472562|20494750|P1|STARTED|Induction Phase (Week 1- 48)||38
8312697|NCT01472549|20494756|P2|NOT COMPLETED|Overall Study||0
8312698|NCT01472549|20494757|P1|NOT COMPLETED|Overall Study||0
8312699|NCT01472549|20494756|P2|COMPLETED|Overall Study||575
8312700|NCT01472549|20494757|P1|COMPLETED|Overall Study||572
8312701|NCT01472549|20494756|P2|STARTED|Overall Study||575
8312702|NCT01472549|20494757|P1|STARTED|Overall Study||572
8312703|NCT01472445|20494779|P2|NOT COMPLETED|Overall Study||0
8312704|NCT01472445|20494780|P1|NOT COMPLETED|Overall Study||0
8312705|NCT01472445|20494779|P2|COMPLETED|Overall Study||16
8312706|NCT01472445|20494780|P1|COMPLETED|Overall Study||25
8312707|NCT01472445|20494779|P2|STARTED|Overall Study||16
8312708|NCT01472445|20494780|P1|STARTED|Overall Study||25
8312709|NCT01472432|20494804|P2|NOT COMPLETED|Overall Study||0
8312710|NCT01472432|20494805|P1|NOT COMPLETED|Overall Study||0
8312711|NCT01472432|20494804|P2|COMPLETED|Overall Study||53
8312712|NCT01472432|20494805|P1|COMPLETED|Overall Study||53
8312713|NCT01472432|20494804|P2|Ulcer Reduction|Overall Study||33
8312714|NCT01472432|20494805|P1|Ulcer Reduction|Overall Study||13
8312715|NCT01472432|20494804|P2|STARTED|Overall Study||53
8312716|NCT01472432|20494805|P1|STARTED|Overall Study||53
8312717|NCT01472380|20494821|P1|NOT COMPLETED|Efavirenz and FFA||0
8312718|NCT01472380|20494821|P1|COMPLETED|Efavirenz and FFA||28
8312719|NCT01472380|20494821|P1|STARTED|Efavirenz and FFA||28
8312720|NCT01472380|20494821|P1|NOT COMPLETED|1 Day Period Between Dosing||1
8312721|NCT01472380|20494821|P1|COMPLETED|1 Day Period Between Dosing||28
8312722|NCT01472380|20494821|P1|STARTED|1 Day Period Between Dosing||29
8312723|NCT01472380|20494821|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
8312724|NCT01472380|20494821|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
8312725|NCT01472380|20494821|P1|STARTED|Fenofibric Acid (FFA) Alone||29
8312726|NCT01472380|20494821|P1|NOT COMPLETED|Efavirenz Alone||1
8312727|NCT01472380|20494821|P1|COMPLETED|Efavirenz Alone||29
8312728|NCT01472380|20494821|P1|STARTED|Efavirenz Alone||30
8312729|NCT01472341|20494832|P1|NOT COMPLETED|Overall Study||272
8312730|NCT01472341|20494832|P1|COMPLETED|Overall Study||235
8312731|NCT01472341|20494832|P1|STARTED|Overall Study||507
8312732|NCT01472289|20494838|P1|NOT COMPLETED|Overall Study||2
8312733|NCT01472289|20494838|P1|COMPLETED|Overall Study||15
8312734|NCT01472289|20494838|P1|STARTED|Overall Study||17
8312735|NCT01472185|20494850|P2|NOT COMPLETED|Overall Study||34
8312736|NCT01472185|20494851|P1|NOT COMPLETED|Overall Study||34
8312737|NCT01472185|20494850|P2|COMPLETED|Overall Study||199
8312738|NCT01472185|20494851|P1|COMPLETED|Overall Study||198
8312739|NCT01472185|20494850|P2|STARTED|Overall Study||233
8312740|NCT01472185|20494851|P1|STARTED|Overall Study||232
8312741|NCT01472081|20494871|P6|NOT COMPLETED|Overall Study||6
8312742|NCT01472081|20494872|P5|NOT COMPLETED|Overall Study||47
8312743|NCT01472081|20494873|P4|NOT COMPLETED|Overall Study||46
8312744|NCT01472081|20494874|P3|NOT COMPLETED|Overall Study||20
8312745|NCT01472081|20494875|P2|NOT COMPLETED|Overall Study||26
8312746|NCT01472081|20494876|P1|NOT COMPLETED|Overall Study||7
8312747|NCT01472081|20494871|P6|COMPLETED|Overall Study||0
8312748|NCT01472081|20494872|P5|COMPLETED|Overall Study||0
8312749|NCT01472081|20494873|P4|COMPLETED|Overall Study||1
8312750|NCT01472081|20494874|P3|COMPLETED|Overall Study||0
8312751|NCT01472081|20494875|P2|COMPLETED|Overall Study||0
8312752|NCT01472081|20494876|P1|COMPLETED|Overall Study||0
8312753|NCT01472081|20494871|P6|STARTED|Overall Study||6
8312754|NCT01472081|20494872|P5|STARTED|Overall Study||47
8312755|NCT01472081|20494873|P4|STARTED|Overall Study||47
8312756|NCT01472081|20494874|P3|STARTED|Overall Study||20
8312757|NCT01472081|20494875|P2|STARTED|Overall Study||26
8312758|NCT01472081|20494876|P1|STARTED|Overall Study||7
8312759|NCT01471782|20494925|P6|NOT COMPLETED|Overall Study||41
8312760|NCT01471782|20494926|P5|NOT COMPLETED|Overall Study||26
8312761|NCT01471782|20494927|P4|NOT COMPLETED|Overall Study||5
8312762|NCT01471782|20494928|P3|NOT COMPLETED|Overall Study||5
8312763|NCT01471782|20494929|P2|NOT COMPLETED|Overall Study||6
8312764|NCT01471782|20494930|P1|NOT COMPLETED|Overall Study||5
8312765|NCT01471782|20494925|P6|COMPLETED|Overall Study|Completed 5 cycles|3
8312766|NCT01471782|20494926|P5|COMPLETED|Overall Study|Completed 5 cycles|0
8312767|NCT01471782|20494927|P4|COMPLETED|Overall Study|Completed 5 cycles|1
8312768|NCT01471782|20494928|P3|COMPLETED|Overall Study|Completed 5 cycles|0
8312769|NCT01471782|20494929|P2|COMPLETED|Overall Study|Completed 5 cycles|1
8312770|NCT01471782|20494930|P1|COMPLETED|Overall Study|Completed 5 cycles|0
8312771|NCT01471782|20494925|P6|STARTED|Overall Study||44
8312772|NCT01471782|20494926|P5|STARTED|Overall Study||26
8312773|NCT01471782|20494927|P4|STARTED|Overall Study||6
8312774|NCT01471782|20494928|P3|STARTED|Overall Study||5
8312775|NCT01471782|20494929|P2|STARTED|Overall Study||7
8312776|NCT01471782|20494930|P1|STARTED|Overall Study||5
8312777|NCT01471691|20494984|P2|NOT COMPLETED|Overall Study||1
8312778|NCT01471691|20494985|P1|NOT COMPLETED|Overall Study||0
8312779|NCT01471691|20494984|P2|COMPLETED|Overall Study||5
8312780|NCT01471691|20494985|P1|COMPLETED|Overall Study||8
8312781|NCT01471691|20494984|P2|STARTED|Overall Study||6
8312782|NCT01471691|20494985|P1|STARTED|Overall Study||8
8312783|NCT01471379|20494994|P3|NOT COMPLETED|Overall Study||0
8312784|NCT01471379|20494995|P2|NOT COMPLETED|Overall Study||1
8312785|NCT01471379|20494996|P1|NOT COMPLETED|Overall Study||1
8312786|NCT01471379|20494994|P3|COMPLETED|Overall Study||0
8312787|NCT01471379|20494995|P2|COMPLETED|Overall Study||0
8312788|NCT01471379|20494996|P1|COMPLETED|Overall Study||0
8312789|NCT01471379|20494994|P3|STARTED|Overall Study||0
8312790|NCT01471379|20494995|P2|STARTED|Overall Study||1
8312791|NCT01471379|20494996|P1|STARTED|Overall Study||1
8312792|NCT01471353|20495016|P1|NOT COMPLETED|Overall Study||3
8312793|NCT01471353|20495016|P1|COMPLETED|Overall Study||39
8312794|NCT01471353|20495016|P1|STARTED|Overall Study||42
8312795|NCT01471340|20495027|P2|NOT COMPLETED|Overall Study||6
8312796|NCT01471340|20495028|P1|NOT COMPLETED|Overall Study||6
8312797|NCT01471340|20495027|P2|COMPLETED|Overall Study||5855
8312798|NCT01471340|20495028|P1|COMPLETED|Overall Study||5862
8312799|NCT01471340|20495027|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
8312800|NCT01471340|20495028|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
8312801|NCT01471639|20495038|P1|NOT COMPLETED|Overall Study||0
8312802|NCT01471639|20495038|P1|COMPLETED|Overall Study||37
8312803|NCT01471639|20495038|P1|STARTED|Overall Study||37
8312804|NCT01471626|20495043|P1|NOT COMPLETED|Overall Study||0
8312805|NCT01471626|20495043|P1|COMPLETED|Overall Study||21
8312806|NCT01471626|20495043|P1|STARTED|Overall Study||21
8312807|NCT01471574|20495051|P4|NOT COMPLETED|Follow-up Period||3
8312808|NCT01471574|20495052|P3|NOT COMPLETED|Follow-up Period||7
8312809|NCT01471574|20495053|P2|NOT COMPLETED|Follow-up Period||2
8312810|NCT01471574|20495054|P1|NOT COMPLETED|Follow-up Period||7
8312811|NCT01471574|20495051|P4|COMPLETED|Follow-up Period||21
8312812|NCT01471574|20495052|P3|COMPLETED|Follow-up Period||95
8312813|NCT01471574|20495053|P2|COMPLETED|Follow-up Period||32
8312814|NCT01471574|20495054|P1|COMPLETED|Follow-up Period||114
8312815|NCT01471574|20495051|P4|STARTED|Follow-up Period||24
8312816|NCT01471574|20495052|P3|STARTED|Follow-up Period||102
8312817|NCT01471574|20495053|P2|STARTED|Follow-up Period||34
8312818|NCT01471574|20495054|P1|STARTED|Follow-up Period||121
8312819|NCT01471574|20495051|P4|NOT COMPLETED|Treatment Period||3
8312820|NCT01471574|20495052|P3|NOT COMPLETED|Treatment Period||24
8312821|NCT01471574|20495053|P2|NOT COMPLETED|Treatment Period||10
8312822|NCT01471574|20495054|P1|NOT COMPLETED|Treatment Period||31
8312823|NCT01471574|20495051|P4|COMPLETED|Treatment Period||21
8312824|NCT01471574|20495052|P3|COMPLETED|Treatment Period||82
8312825|NCT01471574|20495053|P2|COMPLETED|Treatment Period||29
8312826|NCT01471574|20495054|P1|COMPLETED|Treatment Period||101
8312827|NCT01471574|20495051|P4|STARTED|Treatment Period||24
8312828|NCT01471574|20495052|P3|STARTED|Treatment Period||106
8312829|NCT01471574|20495053|P2|STARTED|Treatment Period||39
8312830|NCT01471574|20495054|P1|STARTED|Treatment Period||132
8312831|NCT01471522|20495085|P2|NOT COMPLETED|Overall Study||48
8312832|NCT01471522|20495086|P1|NOT COMPLETED|Overall Study||64
8312833|NCT01471522|20495085|P2|COMPLETED|Overall Study||2543
8312834|NCT01471522|20495086|P1|COMPLETED|Overall Study||2524
8312835|NCT01471522|20495085|P2|STARTED|Overall Study||2591
8312836|NCT01471522|20495086|P1|STARTED|Overall Study||2588
8312837|NCT01471457|20495112|P2|NOT COMPLETED|Overall Study||18
8312838|NCT01471457|20495113|P1|NOT COMPLETED|Overall Study||19
8312839|NCT01471457|20495112|P2|COMPLETED|Overall Study||74
8312840|NCT01471457|20495113|P1|COMPLETED|Overall Study||73
8312841|NCT01471457|20495112|P2|STARTED|Overall Study||92
8312842|NCT01471457|20495113|P1|STARTED|Overall Study||92
8312843|NCT01471197|20495123|P2|NOT COMPLETED|Overall Study||2
8312844|NCT01471197|20495124|P1|NOT COMPLETED|Overall Study||6
8312845|NCT01471197|20495123|P2|COMPLETED|Overall Study||0
8312846|NCT01471197|20495124|P1|COMPLETED|Overall Study||0
8312847|NCT01471197|20495123|P2|STARTED|Overall Study||2
8312848|NCT01471197|20495124|P1|STARTED|Overall Study||6
8312849|NCT01471171|20495134|P2|NOT COMPLETED|Treatment Period 2||0
8312850|NCT01471171|20495135|P1|NOT COMPLETED|Treatment Period 2||1
8312851|NCT01471171|20495134|P2|COMPLETED|Treatment Period 2||54
8312852|NCT01471171|20495135|P1|COMPLETED|Treatment Period 2||52
8312853|NCT01471171|20495134|P2|STARTED|Treatment Period 2||54
8312854|NCT01471171|20495135|P1|STARTED|Treatment Period 2||53
8312855|NCT01471171|20495134|P2|NOT COMPLETED|Treatment Period 1||1
8312856|NCT01471171|20495135|P1|NOT COMPLETED|Treatment Period 1||4
8312857|NCT01471171|20495134|P2|COMPLETED|Treatment Period 1||54
8312858|NCT01471171|20495135|P1|COMPLETED|Treatment Period 1||53
8312859|NCT01471171|20495134|P2|STARTED|Treatment Period 1||55
8312860|NCT01471171|20495135|P1|STARTED|Treatment Period 1||57
8312861|NCT01471054|20495147|P2|NOT COMPLETED|Overall Study||0
8312862|NCT01471054|20495148|P1|NOT COMPLETED|Overall Study||4
8312863|NCT01471054|20495147|P2|COMPLETED|Overall Study||1
8312864|NCT01471054|20495148|P1|COMPLETED|Overall Study||1
8312865|NCT01471054|20495147|P2|STARTED|Overall Study||1
8312866|NCT01471054|20495148|P1|STARTED|Overall Study||5
8312867|NCT01471041|20495164|P1|NOT COMPLETED|Overall Study||7
8312868|NCT01471041|20495164|P1|COMPLETED|Overall Study||47
8312869|NCT01471041|20495164|P1|STARTED|Overall Study||54
8312870|NCT01471028|20495171|P2|NOT COMPLETED|VTI-208E||12
8312871|NCT01471028|20495172|P1|NOT COMPLETED|VTI-208E||8
8312872|NCT01471028|20495171|P2|COMPLETED|VTI-208E||51
8312873|NCT01471028|20495172|P1|COMPLETED|VTI-208E||48
8312874|NCT01471028|20495171|P2|Database Lock, 31 July 2015|VTI-208E||63
8312875|NCT01471028|20495172|P1|Database Lock, 31 July 2015|VTI-208E||56
8312876|NCT01471028|20495171|P2|STARTED|VTI-208E||63
8312877|NCT01471028|20495172|P1|STARTED|VTI-208E||56
8312878|NCT01471028|20495171|P2|NOT COMPLETED|VTI-208||44
8312879|NCT01471028|20495172|P1|NOT COMPLETED|VTI-208||40
8312880|NCT01471028|20495171|P2|COMPLETED|VTI-208||63
8312881|NCT01471028|20495172|P1|COMPLETED|VTI-208||56
8312882|NCT01471028|20495171|P2|STARTED|VTI-208||107
8312883|NCT01471028|20495172|P1|STARTED|VTI-208||96
8312884|NCT01471015|20495187|P3|NOT COMPLETED|Overall Study||1
8312885|NCT01471015|20495188|P2|NOT COMPLETED|Overall Study||1
8312886|NCT01471015|20495189|P1|NOT COMPLETED|Overall Study||0
8312887|NCT01471015|20495187|P3|COMPLETED|Overall Study||9
8312888|NCT01471015|20495188|P2|COMPLETED|Overall Study||9
8312889|NCT01471015|20495189|P1|COMPLETED|Overall Study||10
8312890|NCT01471015|20495187|P3|STARTED|Overall Study||10
8312891|NCT01471015|20495188|P2|STARTED|Overall Study||10
8312892|NCT01471015|20495189|P1|STARTED|Overall Study||10
8312893|NCT01470859|20495203|P2|NOT COMPLETED|Overall Study||0
8312894|NCT01470859|20495204|P1|NOT COMPLETED|Overall Study||1
8312895|NCT01470859|20495203|P2|COMPLETED|Overall Study||15
8312896|NCT01470859|20495204|P1|COMPLETED|Overall Study||14
8312897|NCT01470859|20495203|P2|STARTED|Overall Study||15
8312898|NCT01470859|20495204|P1|STARTED|Overall Study||15
8312899|NCT01470781|20495220|P2|NOT COMPLETED|Overall Study||12
8312900|NCT01470781|20495221|P1|NOT COMPLETED|Overall Study||18
8312901|NCT01470781|20495220|P2|COMPLETED|Overall Study||21
8312902|NCT01470781|20495221|P1|COMPLETED|Overall Study||21
8312903|NCT01470781|20495220|P2|Post-Treatment Assessment|Overall Study||23
8312904|NCT01470781|20495221|P1|Post-Treatment Assessment|Overall Study||22
8312905|NCT01470781|20495220|P2|Midpoint Assessment|Overall Study||30
8312906|NCT01470781|20495221|P1|Midpoint Assessment|Overall Study||30
8312907|NCT01470781|20495220|P2|STARTED|Overall Study||33
8312908|NCT01470781|20495221|P1|STARTED|Overall Study||39
8312909|NCT01470651|20495239|P2|NOT COMPLETED|Overall Study||3
8312910|NCT01470651|20495240|P1|NOT COMPLETED|Overall Study||7
8312911|NCT01470651|20495239|P2|COMPLETED|Overall Study||10
8312912|NCT01470651|20495240|P1|COMPLETED|Overall Study||6
8312913|NCT01470651|20495239|P2|STARTED|Overall Study||13
8312914|NCT01470651|20495240|P1|STARTED|Overall Study||13
8312915|NCT01470599|20495250|P2|NOT COMPLETED|Overall Study||43
8312916|NCT01470599|20495251|P1|NOT COMPLETED|Overall Study||19
8312917|NCT01470599|20495250|P2|COMPLETED|Overall Study||45
8312918|NCT01470599|20495251|P1|COMPLETED|Overall Study||43
8312919|NCT01470599|20495250|P2|STARTED|Overall Study||88
8312920|NCT01470599|20495251|P1|STARTED|Overall Study||62
8312921|NCT01470469|20495315|P2|NOT COMPLETED|Overall Study||24
8312922|NCT01470469|20495316|P1|NOT COMPLETED|Overall Study||10
8312923|NCT01470469|20495315|P2|COMPLETED|Overall Study||38
8312924|NCT01470469|20495316|P1|COMPLETED|Overall Study||11
8312925|NCT01470469|20495315|P2|STARTED|Overall Study||62
8312926|NCT01470469|20495316|P1|STARTED|Overall Study||21
8312927|NCT01470417|20495336|P2|NOT COMPLETED|Overall Study||2
8312928|NCT01470417|20495337|P1|NOT COMPLETED|Overall Study||0
8312929|NCT01470417|20495336|P2|COMPLETED|Overall Study||5
8312930|NCT01470417|20495337|P1|COMPLETED|Overall Study||3
8312931|NCT01470417|20495336|P2|STARTED|Overall Study||7
8312932|NCT01470417|20495337|P1|STARTED|Overall Study||3
8312933|NCT01470326|20495349|P1|NOT COMPLETED|Overall Study||153
8312934|NCT01470326|20495349|P1|COMPLETED|Overall Study||3034
8312935|NCT01470326|20495349|P1|STARTED|Overall Study||3187
8312939|NCT01470196|20495367|P1|NOT COMPLETED|Overall Study||0
8312940|NCT01470196|20495367|P1|COMPLETED|Overall Study||31
8312941|NCT01470196|20495367|P1|STARTED|Overall Study||31
8312942|NCT01470170|20495380|P5|NOT COMPLETED|Overall Study||0
8312943|NCT01470170|20495381|P4|NOT COMPLETED|Overall Study||0
8312944|NCT01470170|20495382|P3|NOT COMPLETED|Overall Study||0
8312945|NCT01470170|20495383|P2|NOT COMPLETED|Overall Study||0
8312946|NCT01470170|20495384|P1|NOT COMPLETED|Overall Study||0
8312947|NCT01470170|20495380|P5|COMPLETED|Overall Study||34
8312948|NCT01470170|20495381|P4|COMPLETED|Overall Study||36
8312949|NCT01470170|20495382|P3|COMPLETED|Overall Study||34
8312950|NCT01470170|20495383|P2|COMPLETED|Overall Study||35
8312951|NCT01470170|20495384|P1|COMPLETED|Overall Study||34
8312952|NCT01470170|20495380|P5|STARTED|Overall Study||34
8312953|NCT01470170|20495381|P4|STARTED|Overall Study||36
8312954|NCT01470170|20495382|P3|STARTED|Overall Study||34
8312955|NCT01470170|20495383|P2|STARTED|Overall Study||35
8312956|NCT01470170|20495384|P1|STARTED|Overall Study||34
8312957|NCT01470144|20495416|P1|NOT COMPLETED|Overall Study||10
8312958|NCT01470144|20495416|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
8312959|NCT01470144|20495416|P1|STARTED|Overall Study||41
8312960|NCT01470118|20495424|P3|NOT COMPLETED|Overall Study||2
8312961|NCT01470118|20495425|P2|NOT COMPLETED|Overall Study||5
8312962|NCT01470118|20495426|P1|NOT COMPLETED|Overall Study||5
8312963|NCT01470118|20495424|P3|COMPLETED|Overall Study||39
8312964|NCT01470118|20495425|P2|COMPLETED|Overall Study||38
8312965|NCT01470118|20495426|P1|COMPLETED|Overall Study||38
8312966|NCT01470118|20495424|P3|STARTED|Overall Study||41
8312967|NCT01470118|20495425|P2|STARTED|Overall Study||43
8312968|NCT01470118|20495426|P1|STARTED|Overall Study||43
8312969|NCT01470027|20495461|P3|NOT COMPLETED|Overall Study||1
8312970|NCT01470027|20495462|P2|NOT COMPLETED|Overall Study||1
8312971|NCT01470027|20495463|P1|NOT COMPLETED|Overall Study||1
8312972|NCT01470027|20495461|P3|COMPLETED|Overall Study||15
8312973|NCT01470027|20495462|P2|COMPLETED|Overall Study||14
8312974|NCT01470027|20495463|P1|COMPLETED|Overall Study||15
8312975|NCT01470027|20495461|P3|STARTED|Overall Study||16
8312976|NCT01470027|20495462|P2|STARTED|Overall Study||15
8312977|NCT01470027|20495463|P1|STARTED|Overall Study||16
8312978|NCT01470001|20495521|P2|NOT COMPLETED|Overall Study||2
8312979|NCT01470001|20495522|P1|NOT COMPLETED|Overall Study||5
8312980|NCT01470001|20495521|P2|COMPLETED|Overall Study||58
8312981|NCT01470001|20495522|P1|COMPLETED|Overall Study||53
8312982|NCT01470001|20495521|P2|STARTED|Overall Study||60
8312983|NCT01470001|20495522|P1|STARTED|Overall Study||58
8312984|NCT01469819|20495532|P1|NOT COMPLETED|Overall Study||8
8312985|NCT01469819|20495532|P1|COMPLETED|Overall Study||29
8312986|NCT01469819|20495532|P1|STARTED|Overall Study||37
8312987|NCT01469767|20495542|P1|NOT COMPLETED|Overall Study||0
8312988|NCT01469767|20495542|P1|COMPLETED|Overall Study||10
8312989|NCT01469767|20495542|P1|STARTED|Overall Study||10
8312990|NCT01469715|20495550|P1|NOT COMPLETED|Overall Study||0
8312991|NCT01469715|20495550|P1|COMPLETED|Overall Study||16
8312992|NCT01469715|20495550|P1|STARTED|Overall Study||16
8312993|NCT01469637|20495556|P2|NOT COMPLETED|Second Intervention||0
8312994|NCT01469637|20495557|P1|NOT COMPLETED|Second Intervention||1
8312995|NCT01469637|20495556|P2|COMPLETED|Second Intervention||21
8312996|NCT01469637|20495557|P1|COMPLETED|Second Intervention||21
8312997|NCT01469637|20495556|P2|STARTED|Second Intervention||21
8312998|NCT01469637|20495557|P1|STARTED|Second Intervention||22
8312999|NCT01469637|20495556|P2|NOT COMPLETED|First Intervention||1
8313000|NCT01469637|20495557|P1|NOT COMPLETED|First Intervention||0
8313001|NCT01469637|20495556|P2|COMPLETED|First Intervention||21
8313002|NCT01469637|20495557|P1|COMPLETED|First Intervention||22
8313003|NCT01469637|20495556|P2|STARTED|First Intervention||22
8313004|NCT01469637|20495557|P1|STARTED|First Intervention||22
8313005|NCT01469585|20495567|P2|NOT COMPLETED|Overall Study||3
8313006|NCT01469585|20495568|P1|NOT COMPLETED|Overall Study||7
8313007|NCT01469585|20495567|P2|COMPLETED|Overall Study||6
8313008|NCT01469585|20495568|P1|COMPLETED|Overall Study||4
8313009|NCT01469585|20495567|P2|STARTED|Overall Study||9
8313010|NCT01469585|20495568|P1|STARTED|Overall Study||11
8313011|NCT01469546|20495576|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
8313012|NCT01469546|20495576|P1|COMPLETED|Dose Escalation to 10 mg||19
8313013|NCT01469546|20495576|P1|STARTED|Dose Escalation to 10 mg||19
8313014|NCT01469546|20495576|P1|NOT COMPLETED|Received 5 mg Dose||23
8313015|NCT01469546|20495576|P1|COMPLETED|Received 5 mg Dose||19
8313016|NCT01469546|20495576|P1|Completed First Cycle|Received 5 mg Dose||30
8313017|NCT01469546|20495576|P1|STARTED|Received 5 mg Dose||42
8313018|NCT01469377|20495586|P3|NOT COMPLETED|Overall Study||66
8313019|NCT01469377|20495587|P2|NOT COMPLETED|Overall Study||48
8313020|NCT01469377|20495588|P1|NOT COMPLETED|Overall Study||35
8313021|NCT01469377|20495586|P3|COMPLETED|Overall Study||210
8313022|NCT01469377|20495587|P2|COMPLETED|Overall Study||226
8313023|NCT01469377|20495588|P1|COMPLETED|Overall Study||234
8313024|NCT01469377|20495586|P3|STARTED|Overall Study||276
8313025|NCT01469377|20495587|P2|STARTED|Overall Study||274
8313026|NCT01469377|20495588|P1|STARTED|Overall Study||269
8313027|NCT01469364|20495599|P1|NOT COMPLETED|Overall Study||2
8313028|NCT01469364|20495599|P1|COMPLETED|Overall Study||28
8313029|NCT01469364|20495599|P1|STARTED|Overall Study||30
8313030|NCT01469234|20495617|P3|NOT COMPLETED|Overall Study||0
8313031|NCT01469234|20495618|P2|NOT COMPLETED|Overall Study||0
8313032|NCT01469234|20495619|P1|NOT COMPLETED|Overall Study||0
8313033|NCT01469234|20495617|P3|COMPLETED|Overall Study||85
8313034|NCT01469234|20495618|P2|COMPLETED|Overall Study||85
8313035|NCT01469234|20495619|P1|COMPLETED|Overall Study||85
8313036|NCT01469234|20495617|P3|STARTED|Overall Study||85
8313037|NCT01469234|20495618|P2|STARTED|Overall Study||85
8313038|NCT01469234|20495619|P1|STARTED|Overall Study||85
8313039|NCT01469221|20495650|P3|NOT COMPLETED|Double Blind Phase||0
8313040|NCT01469221|20495651|P2|NOT COMPLETED|Double Blind Phase||17
8313041|NCT01469221|20495652|P1|NOT COMPLETED|Double Blind Phase||14
8313042|NCT01469221|20495650|P3|COMPLETED|Double Blind Phase||0
8313043|NCT01469221|20495651|P2|COMPLETED|Double Blind Phase||0
8313044|NCT01469221|20495652|P1|COMPLETED|Double Blind Phase||0
8313045|NCT01469221|20495650|P3|STARTED|Double Blind Phase||0
8313046|NCT01469221|20495651|P2|STARTED|Double Blind Phase||17
8313047|NCT01469221|20495652|P1|STARTED|Double Blind Phase||14
8313048|NCT01469221|20495650|P3|NOT COMPLETED|Open Label Phase||3
8313049|NCT01469221|20495651|P2|NOT COMPLETED|Open Label Phase||0
8313050|NCT01469221|20495652|P1|NOT COMPLETED|Open Label Phase||0
8313051|NCT01469221|20495650|P3|COMPLETED|Open Label Phase||44
8313052|NCT01469221|20495651|P2|COMPLETED|Open Label Phase||0
8313053|NCT01469221|20495652|P1|COMPLETED|Open Label Phase||0
8313054|NCT01469221|20495650|P3|STARTED|Open Label Phase||47
8313055|NCT01469221|20495651|P2|STARTED|Open Label Phase||0
8313056|NCT01469221|20495652|P1|STARTED|Open Label Phase||0
8313057|NCT01469182|20495663|P2|NOT COMPLETED|Overall Study||6
8313058|NCT01469182|20495664|P1|NOT COMPLETED|Overall Study||35
8313059|NCT01469182|20495663|P2|COMPLETED|Overall Study||298
8313060|NCT01469182|20495664|P1|COMPLETED|Overall Study||575
8313061|NCT01469182|20495663|P2|Treated|Overall Study||304
8313062|NCT01469182|20495664|P1|Treated|Overall Study||609
8313063|NCT01469182|20495663|P2|STARTED|Overall Study||304
8313064|NCT01469182|20495664|P1|STARTED|Overall Study||610
8313065|NCT01469065|20495691|P5|NOT COMPLETED|Overall Study||1
8313066|NCT01469065|20495692|P4|NOT COMPLETED|Overall Study||0
8313067|NCT01469065|20495693|P3|NOT COMPLETED|Overall Study||0
8313068|NCT01469065|20495694|P2|NOT COMPLETED|Overall Study||1
8313069|NCT01469065|20495695|P1|NOT COMPLETED|Overall Study||0
8313070|NCT01469065|20495691|P5|COMPLETED|Overall Study||16
8313071|NCT01469065|20495692|P4|COMPLETED|Overall Study||16
8313072|NCT01469065|20495693|P3|COMPLETED|Overall Study||16
8313073|NCT01469065|20495694|P2|COMPLETED|Overall Study||16
8313074|NCT01469065|20495695|P1|COMPLETED|Overall Study||16
8313075|NCT01469065|20495691|P5|STARTED|Overall Study||17
8313076|NCT01469065|20495692|P4|STARTED|Overall Study||16
8313077|NCT01469065|20495693|P3|STARTED|Overall Study||16
8313078|NCT01469065|20495694|P2|STARTED|Overall Study||17
8313079|NCT01469065|20495695|P1|STARTED|Overall Study||16
8313080|NCT01469052|20495791|P6|NOT COMPLETED|Overall Study||6
8313081|NCT01469052|20495792|P5|NOT COMPLETED|Overall Study||8
8313082|NCT01469052|20495793|P4|NOT COMPLETED|Overall Study||5
8313083|NCT01469052|20495794|P3|NOT COMPLETED|Overall Study||6
8313084|NCT01469052|20495795|P2|NOT COMPLETED|Overall Study||4
8313085|NCT01469052|20495796|P1|NOT COMPLETED|Overall Study||6
8313086|NCT01469052|20495791|P6|COMPLETED|Overall Study||0
8313087|NCT01469052|20495792|P5|COMPLETED|Overall Study||0
8313088|NCT01469052|20495793|P4|COMPLETED|Overall Study||1
8313089|NCT01469052|20495794|P3|COMPLETED|Overall Study||0
8313090|NCT01469052|20495795|P2|COMPLETED|Overall Study||0
8313091|NCT01469052|20495796|P1|COMPLETED|Overall Study||0
8313092|NCT01469052|20495791|P6|STARTED|Overall Study||6
8313093|NCT01469052|20495792|P5|STARTED|Overall Study||8
8313094|NCT01469052|20495793|P4|STARTED|Overall Study||6
8313095|NCT01469052|20495794|P3|STARTED|Overall Study||6
8313096|NCT01469052|20495795|P2|STARTED|Overall Study||4
8313097|NCT01469052|20495796|P1|STARTED|Overall Study||6
8313098|NCT01469039|20495843|P3|NOT COMPLETED|Overall Study||113
8313099|NCT01469039|20495844|P2|NOT COMPLETED|Overall Study||73
8313100|NCT01469039|20495845|P1|NOT COMPLETED|Overall Study||77
8313101|NCT01469039|20495843|P3|COMPLETED|Overall Study||95
8313102|NCT01469039|20495844|P2|COMPLETED|Overall Study||135
8313103|NCT01469039|20495845|P1|COMPLETED|Overall Study||130
8313104|NCT01469039|20495843|P3|STARTED|Overall Study||208
8313105|NCT01469039|20495844|P2|STARTED|Overall Study||208
8313106|NCT01469039|20495845|P1|STARTED|Overall Study||207
8313107|NCT01469013|20495861|P13|NOT COMPLETED|Part B (Extension Period)||6
8313108|NCT01469013|20495862|P12|NOT COMPLETED|Part B (Extension Period)||6
8313109|NCT01469013|20495863|P11|NOT COMPLETED|Part B (Extension Period)||2
8313110|NCT01469013|20495864|P10|NOT COMPLETED|Part B (Extension Period)||3
8313111|NCT01469013|20495865|P9|NOT COMPLETED|Part B (Extension Period)||4
8313112|NCT01469013|20495866|P8|NOT COMPLETED|Part B (Extension Period)||5
8313113|NCT01469013|20495867|P7|NOT COMPLETED|Part B (Extension Period)||5
8313114|NCT01469013|20495868|P6|NOT COMPLETED|Part B (Extension Period)||2
8313115|NCT01469013|20495869|P5|NOT COMPLETED|Part B (Extension Period)||0
8313116|NCT01469013|20495870|P4|NOT COMPLETED|Part B (Extension Period)||0
8313117|NCT01469013|20495871|P3|NOT COMPLETED|Part B (Extension Period)||0
8313118|NCT01469013|20495872|P2|NOT COMPLETED|Part B (Extension Period)||0
8313119|NCT01469013|20495873|P1|NOT COMPLETED|Part B (Extension Period)||0
8313120|NCT01469013|20495861|P13|COMPLETED|Part B (Extension Period)||18
8313121|NCT01469013|20495862|P12|COMPLETED|Part B (Extension Period)||18
8313122|NCT01469013|20495863|P11|COMPLETED|Part B (Extension Period)||10
8313123|NCT01469013|20495864|P10|COMPLETED|Part B (Extension Period)||8
8313124|NCT01469013|20495865|P9|COMPLETED|Part B (Extension Period)||20
8313125|NCT01469013|20495866|P8|COMPLETED|Part B (Extension Period)||18
8313126|NCT01469013|20495867|P7|COMPLETED|Part B (Extension Period)||7
8313127|NCT01469013|20495868|P6|COMPLETED|Part B (Extension Period)||10
8313128|NCT01469013|20495869|P5|COMPLETED|Part B (Extension Period)||0
8313129|NCT01469013|20495870|P4|COMPLETED|Part B (Extension Period)||0
8313130|NCT01469013|20495871|P3|COMPLETED|Part B (Extension Period)||0
8313131|NCT01469013|20495872|P2|COMPLETED|Part B (Extension Period)||0
8313132|NCT01469013|20495873|P1|COMPLETED|Part B (Extension Period)||0
8313133|NCT01469013|20495861|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
8313134|NCT01469013|20495862|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
8313135|NCT01469013|20495863|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8313136|NCT01469013|20495864|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
8313137|NCT01469013|20495865|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
8313138|NCT01469013|20495866|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
8313139|NCT01469013|20495867|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8313140|NCT01469013|20495868|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8313141|NCT01469013|20495869|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313142|NCT01469013|20495870|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313143|NCT01469013|20495871|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313144|NCT01469013|20495872|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313145|NCT01469013|20495873|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313146|NCT01469013|20495861|P13|STARTED|Part B (Extension Period)||24
8313147|NCT01469013|20495862|P12|STARTED|Part B (Extension Period)||24
8313148|NCT01469013|20495863|P11|STARTED|Part B (Extension Period)||12
8313149|NCT01469013|20495864|P10|STARTED|Part B (Extension Period)||11
8313150|NCT01469013|20495865|P9|STARTED|Part B (Extension Period)||24
8313151|NCT01469013|20495866|P8|STARTED|Part B (Extension Period)||23
8313152|NCT01469013|20495867|P7|STARTED|Part B (Extension Period)||12
8313153|NCT01469013|20495868|P6|STARTED|Part B (Extension Period)||12
8313154|NCT01469013|20495869|P5|STARTED|Part B (Extension Period)||0
8313155|NCT01469013|20495870|P4|STARTED|Part B (Extension Period)||0
8313156|NCT01469013|20495871|P3|STARTED|Part B (Extension Period)||0
8313157|NCT01469013|20495872|P2|STARTED|Part B (Extension Period)||0
8313158|NCT01469013|20495873|P1|STARTED|Part B (Extension Period)||0
8313159|NCT01469013|20495861|P13|NOT COMPLETED|Part A (Treatment Period)||0
8313160|NCT01469013|20495862|P12|NOT COMPLETED|Part A (Treatment Period)||0
8313161|NCT01469013|20495863|P11|NOT COMPLETED|Part A (Treatment Period)||0
8313162|NCT01469013|20495864|P10|NOT COMPLETED|Part A (Treatment Period)||0
8313163|NCT01469013|20495865|P9|NOT COMPLETED|Part A (Treatment Period)||0
8313164|NCT01469013|20495866|P8|NOT COMPLETED|Part A (Treatment Period)||0
8313165|NCT01469013|20495867|P7|NOT COMPLETED|Part A (Treatment Period)||0
8313166|NCT01469013|20495868|P6|NOT COMPLETED|Part A (Treatment Period)||0
8313167|NCT01469013|20495869|P5|NOT COMPLETED|Part A (Treatment Period)||1
8313168|NCT01469013|20495870|P4|NOT COMPLETED|Part A (Treatment Period)||0
8313169|NCT01469013|20495871|P3|NOT COMPLETED|Part A (Treatment Period)||1
8313170|NCT01469013|20495872|P2|NOT COMPLETED|Part A (Treatment Period)||0
8313171|NCT01469013|20495873|P1|NOT COMPLETED|Part A (Treatment Period)||1
8313172|NCT01469013|20495861|P13|COMPLETED|Part A (Treatment Period)||0
8313173|NCT01469013|20495862|P12|COMPLETED|Part A (Treatment Period)||0
8313174|NCT01469013|20495863|P11|COMPLETED|Part A (Treatment Period)||0
8313175|NCT01469013|20495864|P10|COMPLETED|Part A (Treatment Period)||0
8313176|NCT01469013|20495865|P9|COMPLETED|Part A (Treatment Period)||0
8313177|NCT01469013|20495866|P8|COMPLETED|Part A (Treatment Period)||0
8313178|NCT01469013|20495867|P7|COMPLETED|Part A (Treatment Period)||0
8313179|NCT01469013|20495868|P6|COMPLETED|Part A (Treatment Period)||0
8313180|NCT01469013|20495869|P5|COMPLETED|Part A (Treatment Period)||48
8313181|NCT01469013|20495870|P4|COMPLETED|Part A (Treatment Period)||24
8313182|NCT01469013|20495871|P3|COMPLETED|Part A (Treatment Period)||23
8313183|NCT01469013|20495872|P2|COMPLETED|Part A (Treatment Period)||24
8313184|NCT01469013|20495873|P1|COMPLETED|Part A (Treatment Period)||23
8313185|NCT01469013|20495861|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313186|NCT01469013|20495862|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313187|NCT01469013|20495863|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313188|NCT01469013|20495864|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313189|NCT01469013|20495865|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313190|NCT01469013|20495866|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313191|NCT01469013|20495867|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313192|NCT01469013|20495868|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313193|NCT01469013|20495869|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
8313194|NCT01469013|20495870|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313195|NCT01469013|20495871|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313196|NCT01469013|20495872|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313197|NCT01469013|20495873|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313198|NCT01469013|20495861|P13|STARTED|Part A (Treatment Period)||0
8313199|NCT01469013|20495862|P12|STARTED|Part A (Treatment Period)||0
8313200|NCT01469013|20495863|P11|STARTED|Part A (Treatment Period)||0
8313201|NCT01469013|20495864|P10|STARTED|Part A (Treatment Period)||0
8313202|NCT01469013|20495865|P9|STARTED|Part A (Treatment Period)||0
8313203|NCT01469013|20495866|P8|STARTED|Part A (Treatment Period)||0
8313204|NCT01469013|20495867|P7|STARTED|Part A (Treatment Period)||0
8313205|NCT01469013|20495868|P6|STARTED|Part A (Treatment Period)||0
8313206|NCT01469013|20495869|P5|STARTED|Part A (Treatment Period)||49
8313207|NCT01469013|20495870|P4|STARTED|Part A (Treatment Period)||24
8313208|NCT01469013|20495871|P3|STARTED|Part A (Treatment Period)||24
8313209|NCT01469013|20495872|P2|STARTED|Part A (Treatment Period)||24
8313210|NCT01469013|20495873|P1|STARTED|Part A (Treatment Period)||24
8313211|NCT01469000|20495958|P2|NOT COMPLETED|Overall Study||4
8313212|NCT01469000|20495959|P1|NOT COMPLETED|Overall Study||20
8313213|NCT01469000|20495958|P2|COMPLETED|Overall Study||62
8313214|NCT01469000|20495959|P1|COMPLETED|Overall Study||109
8313215|NCT01469000|20495958|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
8313216|NCT01469000|20495959|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
8313217|NCT01469000|20495958|P2|STARTED|Overall Study||66
8313218|NCT01469000|20495959|P1|STARTED|Overall Study||129
8313219|NCT01468987|20495979|P2|NOT COMPLETED|Overall Study||60
8313220|NCT01468987|20495980|P1|NOT COMPLETED|Overall Study||71
8313221|NCT01468987|20495979|P2|COMPLETED|Overall Study||618
8313222|NCT01468987|20495980|P1|COMPLETED|Overall Study||620
8313223|NCT01468987|20495979|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
8313224|NCT01468987|20495980|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
8313225|NCT01468987|20495979|P2|STARTED|Overall Study||678
8313226|NCT01468987|20495980|P1|STARTED|Overall Study||691
8313227|NCT01468974|20496024|P1|NOT COMPLETED|3 Years Follow-up||6
8313228|NCT01468974|20496024|P1|COMPLETED|3 Years Follow-up||26
8313229|NCT01468974|20496024|P1|STARTED|3 Years Follow-up||32
8313230|NCT01468974|20496024|P1|NOT COMPLETED|2 Years Follow-up||2
8313231|NCT01468974|20496024|P1|COMPLETED|2 Years Follow-up||32
8313232|NCT01468974|20496024|P1|STARTED|2 Years Follow-up||34
8313233|NCT01468974|20496024|P1|NOT COMPLETED|1 Year Follow-up||0
8313234|NCT01468974|20496024|P1|COMPLETED|1 Year Follow-up||34
8313235|NCT01468974|20496024|P1|STARTED|1 Year Follow-up||34
8313236|NCT01468974|20496024|P1|NOT COMPLETED|6 Months Follow-up||0
8313237|NCT01468974|20496024|P1|COMPLETED|6 Months Follow-up||34
8313238|NCT01468974|20496024|P1|STARTED|6 Months Follow-up||34
8313239|NCT01468974|20496024|P1|NOT COMPLETED|1 Month Follow-up||1
8313240|NCT01468974|20496024|P1|COMPLETED|1 Month Follow-up||34
8313241|NCT01468974|20496024|P1|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
8313242|NCT01468909|20496157|P2|NOT COMPLETED|Overall Study||2
8313243|NCT01468909|20496158|P1|NOT COMPLETED|Overall Study||2
8313244|NCT01468909|20496157|P2|COMPLETED|Overall Study||52
8313245|NCT01468909|20496158|P1|COMPLETED|Overall Study||50
8313246|NCT01468909|20496157|P2|STARTED|Overall Study||54
8313247|NCT01468909|20496158|P1|STARTED|Overall Study||52
8313248|NCT01468896|20496174|P2|NOT COMPLETED|Overall Study||0
8313249|NCT01468896|20496175|P1|NOT COMPLETED|Overall Study||0
8313250|NCT01468896|20496174|P2|COMPLETED|Overall Study||17
8313251|NCT01468896|20496175|P1|COMPLETED|Overall Study||6
8313252|NCT01468896|20496174|P2|STARTED|Overall Study||17
8313253|NCT01468896|20496175|P1|STARTED|Overall Study||6
8313254|NCT01468818|20496191|P1|NOT COMPLETED|Overall Study||2
8313255|NCT01468818|20496191|P1|COMPLETED|Overall Study||16
8313256|NCT01468818|20496191|P1|STARTED|Overall Study||18
8313257|NCT01468675|20496198|P2|NOT COMPLETED|Overall Study||1372
8313258|NCT01468675|20496199|P1|NOT COMPLETED|Overall Study||1000
8313259|NCT01468675|20496198|P2|COMPLETED|Overall Study||2004
8313260|NCT01468675|20496199|P1|COMPLETED|Overall Study||1699
8313261|NCT01468675|20496198|P2|STARTED|Overall Study||3376
8313262|NCT01468675|20496199|P1|STARTED|Overall Study||2699
8313263|NCT01468597|20496205|P1|NOT COMPLETED|Overall Study||35
8313264|NCT01468597|20496205|P1|COMPLETED|Overall Study||149
8313265|NCT01468597|20496205|P1|STARTED|Overall Study||184
8313266|NCT01468584|20496210|P1|NOT COMPLETED|Overall Study||0
8313267|NCT01468584|20496210|P1|COMPLETED|Overall Study||10
8313268|NCT01468584|20496210|P1|STARTED|Overall Study||10
8313269|NCT01468558|20496214|P1|NOT COMPLETED|Overall Study||2
8313270|NCT01468558|20496214|P1|COMPLETED|Overall Study||22
8313271|NCT01468558|20496214|P1|STARTED|Overall Study||24
8313272|NCT01468350|20496229|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313273|NCT01468350|20496230|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313274|NCT01468350|20496231|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313275|NCT01468350|20496232|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313276|NCT01468350|20496229|P4|COMPLETED|(PART B) Day 1, Day 15||12
8313277|NCT01468350|20496230|P3|COMPLETED|(PART B) Day 1, Day 15||12
8313278|NCT01468350|20496231|P2|COMPLETED|(PART B) Day 1, Day 15||0
8313279|NCT01468350|20496232|P1|COMPLETED|(PART B) Day 1, Day 15||0
8313280|NCT01468350|20496229|P4|STARTED|(PART B) Day 1, Day 15||12
8313281|NCT01468350|20496230|P3|STARTED|(PART B) Day 1, Day 15||12
8313282|NCT01468350|20496231|P2|STARTED|(PART B) Day 1, Day 15||0
8313283|NCT01468350|20496232|P1|STARTED|(PART B) Day 1, Day 15||0
8313284|NCT01468350|20496229|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313285|NCT01468350|20496230|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313286|NCT01468350|20496231|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313287|NCT01468350|20496232|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313288|NCT01468350|20496229|P4|COMPLETED|(PART A) Day 1, Day 3||0
8313289|NCT01468350|20496230|P3|COMPLETED|(PART A) Day 1, Day 3||0
8313290|NCT01468350|20496231|P2|COMPLETED|(PART A) Day 1, Day 3||5
8313291|NCT01468350|20496232|P1|COMPLETED|(PART A) Day 1, Day 3||6
8313292|NCT01468350|20496229|P4|STARTED|(PART A) Day 1, Day 3||0
8313293|NCT01468350|20496230|P3|STARTED|(PART A) Day 1, Day 3||0
8313294|NCT01468350|20496231|P2|STARTED|(PART A) Day 1, Day 3||5
8313295|NCT01468350|20496232|P1|STARTED|(PART A) Day 1, Day 3||6
8313296|NCT01468337|20496242|P1|NOT COMPLETED|Overall Study||0
8313297|NCT01468337|20496242|P1|COMPLETED|Overall Study||5
8313298|NCT01468337|20496242|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
8313299|NCT01468337|20496242|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
8313300|NCT01468337|20496242|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
8313301|NCT01468337|20496242|P1|Week 2|Overall Study||5
8313302|NCT01468337|20496242|P1|STARTED|Overall Study||5
8313303|NCT01468311|20496254|P1|NOT COMPLETED|Overall Study||2
8313304|NCT01468311|20496254|P1|COMPLETED|Overall Study||4
8313305|NCT01468311|20496254|P1|STARTED|Overall Study||6
8313306|NCT01468233|20496266|P6|NOT COMPLETED|Treatment Period 2||23
8313307|NCT01468233|20496267|P5|NOT COMPLETED|Treatment Period 2||28
8313308|NCT01468233|20496268|P4|NOT COMPLETED|Treatment Period 2||28
8313309|NCT01468233|20496269|P3|NOT COMPLETED|Treatment Period 2||111
8313310|NCT01468233|20496270|P2|NOT COMPLETED|Treatment Period 2||0
8313311|NCT01468233|20496271|P1|NOT COMPLETED|Treatment Period 2||0
8313312|NCT01468233|20496266|P6|COMPLETED|Treatment Period 2||28
8313313|NCT01468233|20496267|P5|COMPLETED|Treatment Period 2||25
8313314|NCT01468233|20496268|P4|COMPLETED|Treatment Period 2||23
8313315|NCT01468233|20496269|P3|COMPLETED|Treatment Period 2||40
8313316|NCT01468233|20496270|P2|COMPLETED|Treatment Period 2||0
8313317|NCT01468233|20496271|P1|COMPLETED|Treatment Period 2||0
8313318|NCT01468233|20496266|P6|STARTED|Treatment Period 2||51
8313319|NCT01468233|20496267|P5|STARTED|Treatment Period 2||53
8313320|NCT01468233|20496268|P4|STARTED|Treatment Period 2||51
8313321|NCT01468233|20496269|P3|STARTED|Treatment Period 2||151
8313322|NCT01468233|20496270|P2|STARTED|Treatment Period 2||0
8313323|NCT01468233|20496271|P1|STARTED|Treatment Period 2||0
8313324|NCT01468233|20496266|P6|NOT COMPLETED|Treatment Period 1||0
8313325|NCT01468233|20496267|P5|NOT COMPLETED|Treatment Period 1||0
8313326|NCT01468233|20496268|P4|NOT COMPLETED|Treatment Period 1||0
8313327|NCT01468233|20496269|P3|NOT COMPLETED|Treatment Period 1||0
8313328|NCT01468233|20496270|P2|NOT COMPLETED|Treatment Period 1||8
8313329|NCT01468233|20496271|P1|NOT COMPLETED|Treatment Period 1||12
8313330|NCT01468233|20496266|P6|COMPLETED|Treatment Period 1||0
8313331|NCT01468233|20496267|P5|COMPLETED|Treatment Period 1||0
8313332|NCT01468233|20496268|P4|COMPLETED|Treatment Period 1||0
8313333|NCT01468233|20496269|P3|COMPLETED|Treatment Period 1||0
8313334|NCT01468233|20496270|P2|COMPLETED|Treatment Period 1||155
8313335|NCT01468233|20496271|P1|COMPLETED|Treatment Period 1||151
8313336|NCT01468233|20496266|P6|STARTED|Treatment Period 1||0
8313337|NCT01468233|20496267|P5|STARTED|Treatment Period 1||0
8313338|NCT01468233|20496268|P4|STARTED|Treatment Period 1||0
8313339|NCT01468233|20496269|P3|STARTED|Treatment Period 1||0
8313340|NCT01468233|20496270|P2|STARTED|Treatment Period 1||163
8313341|NCT01468233|20496271|P1|STARTED|Treatment Period 1||163
8313342|NCT01468207|20496293|P6|NOT COMPLETED|Treatment Period 2||20
8313343|NCT01468207|20496294|P5|NOT COMPLETED|Treatment Period 2||21
8313344|NCT01468207|20496295|P4|NOT COMPLETED|Treatment Period 2||27
8313345|NCT01468207|20496296|P3|NOT COMPLETED|Treatment Period 2||52
8313346|NCT01468207|20496297|P2|NOT COMPLETED|Treatment Period 2||0
8313347|NCT01468207|20496298|P1|NOT COMPLETED|Treatment Period 2||0
8313348|NCT01468207|20496293|P6|COMPLETED|Treatment Period 2||28
8313349|NCT01468207|20496294|P5|COMPLETED|Treatment Period 2||27
8313350|NCT01468207|20496295|P4|COMPLETED|Treatment Period 2||22
8313351|NCT01468207|20496296|P3|COMPLETED|Treatment Period 2||93
8313352|NCT01468207|20496297|P2|COMPLETED|Treatment Period 2||0
8313353|NCT01468207|20496298|P1|COMPLETED|Treatment Period 2||0
8313354|NCT01468207|20496293|P6|STARTED|Treatment Period 2||48
8313355|NCT01468207|20496294|P5|STARTED|Treatment Period 2||48
8313356|NCT01468207|20496295|P4|STARTED|Treatment Period 2||49
8313357|NCT01468207|20496296|P3|STARTED|Treatment Period 2||145
8313358|NCT01468207|20496297|P2|STARTED|Treatment Period 2||0
8313359|NCT01468207|20496298|P1|STARTED|Treatment Period 2||0
8313360|NCT01468207|20496293|P6|NOT COMPLETED|Treatment Period 1||0
8313361|NCT01468207|20496294|P5|NOT COMPLETED|Treatment Period 1||0
8313362|NCT01468207|20496295|P4|NOT COMPLETED|Treatment Period 1||0
8313363|NCT01468207|20496296|P3|NOT COMPLETED|Treatment Period 1||0
8313364|NCT01468207|20496297|P2|NOT COMPLETED|Treatment Period 1||8
8313365|NCT01468207|20496298|P1|NOT COMPLETED|Treatment Period 1||9
8313366|NCT01468207|20496293|P6|COMPLETED|Treatment Period 1||0
8313367|NCT01468207|20496294|P5|COMPLETED|Treatment Period 1||0
8313368|NCT01468207|20496295|P4|COMPLETED|Treatment Period 1||0
8313369|NCT01468207|20496296|P3|COMPLETED|Treatment Period 1||0
8313370|NCT01468207|20496297|P2|COMPLETED|Treatment Period 1||145
8313371|NCT01468207|20496298|P1|COMPLETED|Treatment Period 1||145
8313372|NCT01468207|20496293|P6|Received Study Drug|Treatment Period 1||0
8313373|NCT01468207|20496294|P5|Received Study Drug|Treatment Period 1||0
8313374|NCT01468207|20496295|P4|Received Study Drug|Treatment Period 1||0
8313375|NCT01468207|20496296|P3|Received Study Drug|Treatment Period 1||0
8313376|NCT01468207|20496297|P2|Received Study Drug|Treatment Period 1||153
8313377|NCT01468207|20496298|P1|Received Study Drug|Treatment Period 1||152
8313378|NCT01468207|20496293|P6|STARTED|Treatment Period 1||0
8313379|NCT01468207|20496294|P5|STARTED|Treatment Period 1||0
8313380|NCT01468207|20496295|P4|STARTED|Treatment Period 1||0
8313381|NCT01468207|20496296|P3|STARTED|Treatment Period 1||0
8313382|NCT01468207|20496297|P2|STARTED|Treatment Period 1||153
8313383|NCT01468207|20496298|P1|STARTED|Treatment Period 1||154
8313384|NCT01468181|20496323|P5|NOT COMPLETED|Overall Study||5
8313385|NCT01468181|20496324|P4|NOT COMPLETED|Overall Study||3
8313386|NCT01468181|20496325|P3|NOT COMPLETED|Overall Study||8
8313387|NCT01468181|20496326|P2|NOT COMPLETED|Overall Study||2
8313388|NCT01468181|20496327|P1|NOT COMPLETED|Overall Study||10
8313389|NCT01468181|20496323|P5|COMPLETED|Overall Study||66
8313390|NCT01468181|20496324|P4|COMPLETED|Overall Study||63
8313391|NCT01468181|20496325|P3|COMPLETED|Overall Study||57
8313392|NCT01468181|20496326|P2|COMPLETED|Overall Study||59
8313393|NCT01468181|20496327|P1|COMPLETED|Overall Study||121
8313394|NCT01468181|20496323|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
8313395|NCT01468181|20496324|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
8313396|NCT01468181|20496325|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
8313397|NCT01468181|20496326|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
8313398|NCT01468181|20496327|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
8313399|NCT01468181|20496323|P5|STARTED|Overall Study||71
8313400|NCT01468181|20496324|P4|STARTED|Overall Study||66
8313401|NCT01468181|20496325|P3|STARTED|Overall Study||65
8313402|NCT01468181|20496326|P2|STARTED|Overall Study||61
8313403|NCT01468181|20496327|P1|STARTED|Overall Study||131
8313404|NCT01468077|20496376|P2|NOT COMPLETED|Overall Study||3
8313405|NCT01468077|20496377|P1|NOT COMPLETED|Overall Study||4
8313406|NCT01468077|20496376|P2|COMPLETED|Overall Study||22
8313407|NCT01468077|20496377|P1|COMPLETED|Overall Study||18
8313408|NCT01468077|20496376|P2|STARTED|Overall Study||25
8313409|NCT01468077|20496377|P1|STARTED|Overall Study||22
8313410|NCT01468012|20496416|P3|NOT COMPLETED|Overall Study||4
8313411|NCT01468012|20496417|P2|NOT COMPLETED|Overall Study||1
8313412|NCT01468012|20496418|P1|NOT COMPLETED|Overall Study||2
8313413|NCT01468012|20496416|P3|COMPLETED|Overall Study||0
8313414|NCT01468012|20496417|P2|COMPLETED|Overall Study||9
8313415|NCT01468012|20496418|P1|COMPLETED|Overall Study||7
8313416|NCT01468012|20496416|P3|STARTED|Overall Study||4
8313417|NCT01468012|20496417|P2|STARTED|Overall Study||10
8313418|NCT01468012|20496418|P1|STARTED|Overall Study||9
8313419|NCT01467999|20496429|P1|NOT COMPLETED|Overall Study||13
8313420|NCT01467999|20496429|P1|COMPLETED|Overall Study||9
8313421|NCT01467999|20496429|P1|STARTED|Overall Study||22
8313422|NCT01467960|20496439|P6|NOT COMPLETED|Overall Study||30
8313423|NCT01467960|20496440|P5|NOT COMPLETED|Overall Study||30
8313424|NCT01467960|20496441|P4|NOT COMPLETED|Overall Study||30
8313425|NCT01467960|20496442|P3|NOT COMPLETED|Overall Study||0
8313426|NCT01467960|20496443|P2|NOT COMPLETED|Overall Study||0
8313427|NCT01467960|20496444|P1|NOT COMPLETED|Overall Study||0
8313428|NCT01467960|20496439|P6|COMPLETED|Overall Study||0
8313429|NCT01467960|20496440|P5|COMPLETED|Overall Study||0
8313430|NCT01467960|20496441|P4|COMPLETED|Overall Study||0
8313431|NCT01467960|20496442|P3|COMPLETED|Overall Study||30
8313432|NCT01467960|20496443|P2|COMPLETED|Overall Study||30
8313433|NCT01467960|20496444|P1|COMPLETED|Overall Study||30
8313434|NCT01467960|20496439|P6|STARTED|Overall Study||30
8313435|NCT01467960|20496440|P5|STARTED|Overall Study||30
8313436|NCT01467960|20496441|P4|STARTED|Overall Study||30
8313437|NCT01467960|20496442|P3|STARTED|Overall Study||30
8313438|NCT01467960|20496443|P2|STARTED|Overall Study||30
8313439|NCT01467960|20496444|P1|STARTED|Overall Study||30
8313440|NCT01467947|20496458|P1|NOT COMPLETED|Overall Study||0
8313441|NCT01467947|20496458|P1|COMPLETED|Overall Study||46
8313442|NCT01467947|20496458|P1|STARTED|Overall Study||46
8313443|NCT01467934|20496466|P3|NOT COMPLETED|Overall Study||0
8313444|NCT01467934|20496467|P2|NOT COMPLETED|Overall Study||0
8313445|NCT01467934|20496468|P1|NOT COMPLETED|Overall Study||0
8313446|NCT01467934|20496466|P3|COMPLETED|Overall Study||110
8313447|NCT01467934|20496467|P2|COMPLETED|Overall Study||212
8313448|NCT01467934|20496468|P1|COMPLETED|Overall Study||208
8313449|NCT01467934|20496466|P3|STARTED|Overall Study||110
8313450|NCT01467934|20496467|P2|STARTED|Overall Study||212
8313451|NCT01467934|20496468|P1|STARTED|Overall Study||208
8313452|NCT01467882|20496476|P1|NOT COMPLETED|Overall Study||0
8313453|NCT01467882|20496476|P1|COMPLETED|Overall Study||44
8313454|NCT01467882|20496476|P1|STARTED|Overall Study||44
8313455|NCT01467713|20496503|P4|NOT COMPLETED|Overall Study||109
8313456|NCT01467713|20496504|P3|NOT COMPLETED|Overall Study||102
8313457|NCT01467713|20496505|P2|NOT COMPLETED|Overall Study||104
8313458|NCT01467713|20496506|P1|NOT COMPLETED|Overall Study||102
8313459|NCT01467713|20496503|P4|COMPLETED|Overall Study||45
8313460|NCT01467713|20496504|P3|COMPLETED|Overall Study||58
8313461|NCT01467713|20496505|P2|COMPLETED|Overall Study||60
8313462|NCT01467713|20496506|P1|COMPLETED|Overall Study||62
8313463|NCT01467713|20496503|P4|Safety Analysis Set: Received Treatment|Overall Study||154
8313464|NCT01467713|20496504|P3|Safety Analysis Set: Received Treatment|Overall Study||159
8313465|NCT01467713|20496505|P2|Safety Analysis Set: Received Treatment|Overall Study||164
8313466|NCT01467713|20496506|P1|Safety Analysis Set: Received Treatment|Overall Study||163
8313467|NCT01467713|20496503|P4|STARTED|Overall Study||154
8313468|NCT01467713|20496504|P3|STARTED|Overall Study||160
8313469|NCT01467713|20496505|P2|STARTED|Overall Study||164
8313470|NCT01467713|20496506|P1|STARTED|Overall Study||164
8313471|NCT01467700|20496560|P4|NOT COMPLETED|Overall Study||27
8313472|NCT01467700|20496561|P3|NOT COMPLETED|Overall Study||27
8313473|NCT01467700|20496562|P2|NOT COMPLETED|Overall Study||28
8313474|NCT01467700|20496563|P1|NOT COMPLETED|Overall Study||29
8313475|NCT01467700|20496560|P4|COMPLETED|Overall Study||96
8313476|NCT01467700|20496561|P3|COMPLETED|Overall Study||97
8313477|NCT01467700|20496562|P2|COMPLETED|Overall Study||100
8313478|NCT01467700|20496563|P1|COMPLETED|Overall Study||86
8313479|NCT01467700|20496560|P4|Safety Set - Received Treatment|Overall Study||123
8313480|NCT01467700|20496561|P3|Safety Set - Received Treatment|Overall Study||124
8313481|NCT01467700|20496562|P2|Safety Set - Received Treatment|Overall Study||127
8313482|NCT01467700|20496563|P1|Safety Set - Received Treatment|Overall Study||115
8313483|NCT01467700|20496560|P4|STARTED|Overall Study||123
8313484|NCT01467700|20496561|P3|STARTED|Overall Study||124
8313485|NCT01467700|20496562|P2|STARTED|Overall Study||128
8313486|NCT01467700|20496563|P1|STARTED|Overall Study||115
8313487|NCT01467661|20496605|P1|NOT COMPLETED|Overall Study||21
8313488|NCT01467661|20496605|P1|COMPLETED|Overall Study||32
8313489|NCT01467661|20496605|P1|Started Post Marketing Trial|Overall Study||33
8313490|NCT01467661|20496605|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
8313491|NCT01467661|20496605|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
8313492|NCT01467661|20496605|P1|STARTED|Overall Study||53
8313493|NCT01467583|20496625|P3|NOT COMPLETED|Overall Study||2
8313494|NCT01467583|20496626|P2|NOT COMPLETED|Overall Study||1
8313495|NCT01467583|20496627|P1|NOT COMPLETED|Overall Study||2
8313496|NCT01467583|20496625|P3|COMPLETED|Overall Study||10
8313497|NCT01467583|20496626|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
8313498|NCT01467583|20496627|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
8313499|NCT01467583|20496625|P3|STARTED|Overall Study||12
8313500|NCT01467583|20496626|P2|STARTED|Overall Study||4
8313501|NCT01467583|20496627|P1|STARTED|Overall Study||16
8313502|NCT01467570|20496640|P2|NOT COMPLETED|Overall Study||9
8313503|NCT01467570|20496641|P1|NOT COMPLETED|Overall Study||8
8313504|NCT01467570|20496640|P2|COMPLETED|Overall Study||63
8313505|NCT01467570|20496641|P1|COMPLETED|Overall Study||67
8313506|NCT01467570|20496640|P2|STARTED|Overall Study||72
8313507|NCT01467570|20496641|P1|STARTED|Overall Study||75
8313508|NCT01467557|20496667|P2|NOT COMPLETED|Overall Study||107
8313509|NCT01467557|20496668|P1|NOT COMPLETED|Overall Study||99
8313510|NCT01467557|20496667|P2|COMPLETED|Overall Study||463
8313511|NCT01467557|20496668|P1|COMPLETED|Overall Study||502
8313512|NCT01467557|20496667|P2|12 Month Survey Completed|Overall Study||463
8313513|NCT01467557|20496668|P1|12 Month Survey Completed|Overall Study||502
8313514|NCT01467557|20496667|P2|4 Month Survey Completed|Overall Study||493
8313515|NCT01467557|20496668|P1|4 Month Survey Completed|Overall Study||533
8313516|NCT01467557|20496667|P2|2 Week Survey Completed|Overall Study||522
8313517|NCT01467557|20496668|P1|2 Week Survey Completed|Overall Study||551
8313518|NCT01467557|20496667|P2|STARTED|Overall Study||570
8313519|NCT01467557|20496668|P1|STARTED|Overall Study||601
8313520|NCT01467505|20496678|P2|NOT COMPLETED|Overall Study||3
8313521|NCT01467505|20496679|P1|NOT COMPLETED|Overall Study||33
8313522|NCT01467505|20496678|P2|COMPLETED|Overall Study||7
8313523|NCT01467505|20496679|P1|COMPLETED|Overall Study||18
8313524|NCT01467505|20496678|P2|STARTED|Overall Study||10
8313525|NCT01467505|20496679|P1|STARTED|Overall Study||51
8313526|NCT01467492|20496711|P2|NOT COMPLETED|Overall Study||13
8313527|NCT01467492|20496712|P1|NOT COMPLETED|Overall Study||22
8313528|NCT01467492|20496711|P2|COMPLETED|Overall Study||25
8313529|NCT01467492|20496712|P1|COMPLETED|Overall Study||61
8313530|NCT01467492|20496711|P2|STARTED|Overall Study||38
8313531|NCT01467492|20496712|P1|STARTED|Overall Study||83
8313532|NCT01467479|20496736|P3|NOT COMPLETED|Overall Study||16
8313533|NCT01467479|20496737|P2|NOT COMPLETED|Overall Study||17
8313534|NCT01467479|20496738|P1|NOT COMPLETED|Overall Study||9
8313535|NCT01467479|20496736|P3|COMPLETED|Overall Study||45
8313536|NCT01467479|20496737|P2|COMPLETED|Overall Study||52
8313537|NCT01467479|20496738|P1|COMPLETED|Overall Study||46
8313538|NCT01467479|20496736|P3|Treated|Overall Study||59
8313539|NCT01467479|20496737|P2|Treated|Overall Study||69
8313540|NCT01467479|20496738|P1|Treated|Overall Study||54
8313541|NCT01467479|20496736|P3|STARTED|Overall Study||61
8313542|NCT01467479|20496737|P2|STARTED|Overall Study||69
8313543|NCT01467479|20496738|P1|STARTED|Overall Study||55
8313544|NCT01467466|20496769|P4|NOT COMPLETED|Overall Study||88
8313545|NCT01467466|20496770|P3|NOT COMPLETED|Overall Study||104
8313546|NCT01467466|20496771|P2|NOT COMPLETED|Overall Study||104
8313547|NCT01467466|20496772|P1|NOT COMPLETED|Overall Study||109
8313548|NCT01467466|20496769|P4|COMPLETED|Overall Study||1203
8313549|NCT01467466|20496770|P3|COMPLETED|Overall Study||1190
8313550|NCT01467466|20496771|P2|COMPLETED|Overall Study||1188
8313551|NCT01467466|20496772|P1|COMPLETED|Overall Study||1191
8313552|NCT01467466|20496769|P4|STARTED|Overall Study||1291
8313553|NCT01467466|20496770|P3|STARTED|Overall Study||1294
8313554|NCT01467466|20496771|P2|STARTED|Overall Study||1292
8313555|NCT01467466|20496772|P1|STARTED|Overall Study||1300
8313556|NCT01467427|20496784|P2|NOT COMPLETED|Overall Study||13
8313557|NCT01467427|20496785|P1|NOT COMPLETED|Overall Study||12
8313558|NCT01467427|20496784|P2|COMPLETED|Overall Study||0
8313559|NCT01467427|20496785|P1|COMPLETED|Overall Study||0
8313560|NCT01467427|20496784|P2|Completed Main Phase|Overall Study||13
8313561|NCT01467427|20496785|P1|Completed Main Phase|Overall Study||11
8313562|NCT01467427|20496784|P2|STARTED|Overall Study||13
8313563|NCT01467427|20496785|P1|STARTED|Overall Study||12
8313564|NCT01467271|20496803|P1|NOT COMPLETED|Overall Study||202
8313565|NCT01467271|20496803|P1|COMPLETED|Overall Study||338
8313566|NCT01467271|20496803|P1|STARTED|Overall Study||540
8313567|NCT01467076|20496810|P3|NOT COMPLETED|Overall Study||0
8313568|NCT01467076|20496811|P2|NOT COMPLETED|Overall Study||0
8313569|NCT01467076|20496812|P1|NOT COMPLETED|Overall Study||1
8313570|NCT01467076|20496810|P3|COMPLETED|Overall Study||2
8313571|NCT01467076|20496811|P2|COMPLETED|Overall Study||2
8313572|NCT01467076|20496812|P1|COMPLETED|Overall Study||2
8313573|NCT01467076|20496810|P3|STARTED|Overall Study||2
8313574|NCT01467076|20496811|P2|STARTED|Overall Study||2
8313575|NCT01467076|20496812|P1|STARTED|Overall Study||3
8313576|NCT01467037|20496849|P1|NOT COMPLETED|Overall Study||0
8313577|NCT01467037|20496849|P1|COMPLETED|Overall Study||374
8313578|NCT01467037|20496849|P1|STARTED|Overall Study||374
8313579|NCT01466985|20496859|P3|NOT COMPLETED|Overall Study||0
8313580|NCT01466985|20496860|P2|NOT COMPLETED|Overall Study||0
8313581|NCT01466985|20496861|P1|NOT COMPLETED|Overall Study||0
8313582|NCT01466985|20496859|P3|COMPLETED|Overall Study||6
8313583|NCT01466985|20496860|P2|COMPLETED|Overall Study||6
8313584|NCT01466985|20496861|P1|COMPLETED|Overall Study||6
8313585|NCT01466985|20496859|P3|STARTED|Overall Study||6
8313586|NCT01466985|20496860|P2|STARTED|Overall Study||6
8313587|NCT01466985|20496861|P1|STARTED|Overall Study||6
8313588|NCT01466972|20496878|P1|NOT COMPLETED|Overall Study||0
8313589|NCT01466972|20496878|P1|COMPLETED|Overall Study||30
8313590|NCT01466972|20496878|P1|STARTED|Overall Study||30
8313591|NCT01466881|20496884|P1|NOT COMPLETED|Overall Study||40
8313592|NCT01466881|20496884|P1|COMPLETED|Overall Study||2
8313593|NCT01466881|20496884|P1|Eligible and Treated|Overall Study||37
8313594|NCT01466881|20496884|P1|STARTED|Overall Study||42
8313595|NCT01466790|20496901|P8|NOT COMPLETED|Overall Study||1
8313596|NCT01466790|20496902|P7|NOT COMPLETED|Overall Study||1
8313597|NCT01466790|20496903|P6|NOT COMPLETED|Overall Study||0
8313598|NCT01466790|20496904|P5|NOT COMPLETED|Overall Study||3
8313599|NCT01466790|20496905|P4|NOT COMPLETED|Overall Study||0
8313600|NCT01466790|20496906|P3|NOT COMPLETED|Overall Study||0
8313601|NCT01466790|20496907|P2|NOT COMPLETED|Overall Study||1
8313602|NCT01466790|20496908|P1|NOT COMPLETED|Overall Study||4
8313603|NCT01466790|20496901|P8|COMPLETED|Overall Study||13
8313604|NCT01466790|20496902|P7|COMPLETED|Overall Study||26
8313605|NCT01466790|20496903|P6|COMPLETED|Overall Study||16
8313606|NCT01466790|20496904|P5|COMPLETED|Overall Study||27
8313607|NCT01466790|20496905|P4|COMPLETED|Overall Study||14
8313608|NCT01466790|20496906|P3|COMPLETED|Overall Study||27
8313609|NCT01466790|20496907|P2|COMPLETED|Overall Study||14
8313610|NCT01466790|20496908|P1|COMPLETED|Overall Study||20
8313611|NCT01466790|20496901|P8|STARTED|Overall Study||14
8313612|NCT01466790|20496902|P7|STARTED|Overall Study||27
8313613|NCT01466790|20496903|P6|STARTED|Overall Study||16
8313614|NCT01466790|20496904|P5|STARTED|Overall Study||30
8313615|NCT01466790|20496905|P4|STARTED|Overall Study||14
8313616|NCT01466790|20496906|P3|STARTED|Overall Study||27
8313617|NCT01466790|20496907|P2|STARTED|Overall Study||15
8313618|NCT01466790|20496908|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
8313619|NCT01466764|20496972|P2|NOT COMPLETED|Overall Study||0
8313620|NCT01466764|20496973|P1|NOT COMPLETED|Overall Study||0
8313621|NCT01466764|20496972|P2|COMPLETED|Overall Study||5
8313622|NCT01466764|20496973|P1|COMPLETED|Overall Study||5
8313623|NCT01466764|20496972|P2|STARTED|Overall Study||5
8313624|NCT01466764|20496973|P1|STARTED|Overall Study||5
8313625|NCT01466751|20496993|P2|NOT COMPLETED|Overall Study||0
8313626|NCT01466751|20496994|P1|NOT COMPLETED|Overall Study||1
8313627|NCT01466751|20496993|P2|COMPLETED|Overall Study||14
8313628|NCT01466751|20496994|P1|COMPLETED|Overall Study||13
8313629|NCT01466751|20496993|P2|STARTED|Overall Study||14
8313630|NCT01466751|20496994|P1|STARTED|Overall Study||14
8313631|NCT01466673|20497004|P2|NOT COMPLETED|Overall Study||6
8313632|NCT01466673|20497005|P1|NOT COMPLETED|Overall Study||7
8313633|NCT01466673|20497004|P2|COMPLETED|Overall Study||95
8313634|NCT01466673|20497005|P1|COMPLETED|Overall Study||93
8313635|NCT01466673|20497004|P2|STARTED|Overall Study||101
8313636|NCT01466673|20497005|P1|STARTED|Overall Study||100
8313637|NCT01466660|20497031|P2|NOT COMPLETED|Overall Study||159
8313638|NCT01466660|20497032|P1|NOT COMPLETED|Overall Study||160
8313639|NCT01466660|20497031|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
8313640|NCT01466660|20497032|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
8313641|NCT01466660|20497031|P2|STARTED|Overall Study||159
8313642|NCT01466660|20497032|P1|STARTED|Overall Study||160
8313643|NCT01466595|20497058|P2|NOT COMPLETED|Overall Study||1
8313644|NCT01466595|20497059|P1|NOT COMPLETED|Overall Study||0
8313645|NCT01466595|20497058|P2|COMPLETED|Overall Study||23
8313646|NCT01466595|20497059|P1|COMPLETED|Overall Study||49
8313647|NCT01466595|20497058|P2|STARTED|Overall Study||24
8313648|NCT01466595|20497059|P1|STARTED|Overall Study||49
8313649|NCT01466491|20497153|P4|NOT COMPLETED|Overall Study||0
8313650|NCT01466491|20497154|P3|NOT COMPLETED|Overall Study||3
8313651|NCT01466491|20497155|P2|NOT COMPLETED|Overall Study||3
8313652|NCT01466491|20497156|P1|NOT COMPLETED|Overall Study||0
8313653|NCT01466491|20497153|P4|COMPLETED|Overall Study||83
8313654|NCT01466491|20497154|P3|COMPLETED|Overall Study||80
8313655|NCT01466491|20497155|P2|COMPLETED|Overall Study||80
8313656|NCT01466491|20497156|P1|COMPLETED|Overall Study||83
8313657|NCT01466491|20497153|P4|STARTED|Overall Study||83
8313658|NCT01466491|20497154|P3|STARTED|Overall Study||83
8313659|NCT01466491|20497155|P2|STARTED|Overall Study||83
8313660|NCT01466491|20497156|P1|STARTED|Overall Study||83
8313661|NCT01466387|20497176|P6|NOT COMPLETED|Overall Study||1
8313662|NCT01466387|20497177|P5|NOT COMPLETED|Overall Study||0
8313663|NCT01466387|20497178|P4|NOT COMPLETED|Overall Study||2
8313664|NCT01466387|20497179|P3|NOT COMPLETED|Overall Study||1
8313665|NCT01466387|20497180|P2|NOT COMPLETED|Overall Study||0
8313666|NCT01466387|20497181|P1|NOT COMPLETED|Overall Study||1
8313667|NCT01466387|20497176|P6|COMPLETED|Overall Study||99
8313668|NCT01466387|20497177|P5|COMPLETED|Overall Study||51
8313669|NCT01466387|20497178|P4|COMPLETED|Overall Study||99
8313670|NCT01466387|20497179|P3|COMPLETED|Overall Study||98
8313671|NCT01466387|20497180|P2|COMPLETED|Overall Study||100
8313672|NCT01466387|20497181|P1|COMPLETED|Overall Study||100
8313673|NCT01466387|20497176|P6|STARTED|Overall Study||100
8313674|NCT01466387|20497177|P5|STARTED|Overall Study||51
8313675|NCT01466387|20497178|P4|STARTED|Overall Study||101
8313676|NCT01466387|20497179|P3|STARTED|Overall Study||99
8313677|NCT01466387|20497180|P2|STARTED|Overall Study||100
8313678|NCT01466387|20497181|P1|STARTED|Overall Study||101
8313679|NCT01466361|20497223|P4|NOT COMPLETED|Overall Study||0
8313680|NCT01466361|20497224|P3|NOT COMPLETED|Overall Study||0
8313681|NCT01466361|20497225|P2|NOT COMPLETED|Overall Study||0
8313682|NCT01466361|20497226|P1|NOT COMPLETED|Overall Study||0
8313683|NCT01466361|20497223|P4|COMPLETED|Overall Study||41
8313684|NCT01466361|20497224|P3|COMPLETED|Overall Study||60
8313685|NCT01466361|20497225|P2|COMPLETED|Overall Study||34
8313686|NCT01466361|20497226|P1|COMPLETED|Overall Study||52
8313687|NCT01466361|20497223|P4|STARTED|Overall Study||41
8313688|NCT01466361|20497224|P3|STARTED|Overall Study||60
8313689|NCT01466361|20497225|P2|STARTED|Overall Study||34
8313690|NCT01466361|20497226|P1|STARTED|Overall Study||52
8313691|NCT01466348|20497242|P2|NOT COMPLETED|Period II - Second Intervention||0
8313692|NCT01466348|20497243|P1|NOT COMPLETED|Period II - Second Intervention||0
8313693|NCT01466348|20497242|P2|COMPLETED|Period II - Second Intervention||36
8313694|NCT01466348|20497243|P1|COMPLETED|Period II - Second Intervention||35
8313695|NCT01466348|20497242|P2|STARTED|Period II - Second Intervention||36
8313696|NCT01466348|20497243|P1|STARTED|Period II - Second Intervention||35
8313697|NCT01466348|20497242|P2|NOT COMPLETED|Period I - First Intervention||1
8313698|NCT01466348|20497243|P1|NOT COMPLETED|Period I - First Intervention||0
8313699|NCT01466348|20497242|P2|COMPLETED|Period I - First Intervention||35
8313700|NCT01466348|20497243|P1|COMPLETED|Period I - First Intervention||36
8313701|NCT01466348|20497242|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
8313702|NCT01466348|20497243|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
8313703|NCT01466348|20497242|P2|STARTED|Period I - First Intervention||36
8313704|NCT01466348|20497243|P1|STARTED|Period I - First Intervention||36
8313705|NCT01466270|20497271|P2|NOT COMPLETED|Overall Study||6
8313706|NCT01466270|20497272|P1|NOT COMPLETED|Overall Study||12
8313707|NCT01466270|20497271|P2|COMPLETED|Overall Study||25
8313708|NCT01466270|20497272|P1|COMPLETED|Overall Study||19
8313709|NCT01466270|20497271|P2|STARTED|Overall Study||31
8313710|NCT01466270|20497272|P1|STARTED|Overall Study||31
8313711|NCT01466192|20497284|P1|NOT COMPLETED|Overall Study||4
8313712|NCT01466192|20497284|P1|COMPLETED|Overall Study||104
8313713|NCT01466192|20497284|P1|STARTED|Overall Study||108
8313714|NCT01466179|20497288|P1|NOT COMPLETED|Overall Study||179
8313715|NCT01466179|20497288|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
8313716|NCT01466179|20497288|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
8313717|NCT01466166|20497308|P1|NOT COMPLETED|Overall Study||163
8313718|NCT01466166|20497308|P1|COMPLETED|Overall Study||25
8313719|NCT01466166|20497308|P1|Completed 24 Weeks of Treatment|Overall Study||55
8313720|NCT01466166|20497308|P1|Received Treatment|Overall Study||188
8313721|NCT01466166|20497308|P1|STARTED|Overall Study||188
8313722|NCT01466153|20497322|P3|NOT COMPLETED|Overall Study||25
8313723|NCT01466153|20497323|P2|NOT COMPLETED|Overall Study||24
8313724|NCT01466153|20497324|P1|NOT COMPLETED|Overall Study||29
8313725|NCT01466153|20497322|P3|COMPLETED|Overall Study||36
8313726|NCT01466153|20497323|P2|COMPLETED|Overall Study||12
8313727|NCT01466153|20497324|P1|COMPLETED|Overall Study||33
8313728|NCT01466153|20497322|P3|STARTED|Overall Study||61
8313729|NCT01466153|20497323|P2|STARTED|Overall Study||36
8313730|NCT01466153|20497324|P1|STARTED|Overall Study||62
8313731|NCT01466127|20497365|P2|NOT COMPLETED|Overall Study||16
8313732|NCT01466127|20497366|P1|NOT COMPLETED|Overall Study||14
8313733|NCT01466127|20497365|P2|COMPLETED|Overall Study||14
8313734|NCT01466127|20497366|P1|COMPLETED|Overall Study||16
8313735|NCT01466127|20497365|P2|STARTED|Overall Study||30
8313736|NCT01466127|20497366|P1|STARTED|Overall Study||30
8313737|NCT01466075|20497372|P1|NOT COMPLETED|Overall Study||0
8313738|NCT01466075|20497372|P1|COMPLETED|Overall Study||207
8313739|NCT01466075|20497372|P1|STARTED|Overall Study||207
8313740|NCT01466062|20497379|P1|NOT COMPLETED|Overall Study||2
8313741|NCT01466062|20497379|P1|COMPLETED|Overall Study||26
8313742|NCT01466062|20497379|P1|STARTED|Overall Study||28
8313743|NCT01465997|20497402|P2|NOT COMPLETED|Overall Study||89
8313744|NCT01465997|20497403|P1|NOT COMPLETED|Overall Study||68
8313745|NCT01465997|20497402|P2|COMPLETED|Overall Study||180
8313746|NCT01465997|20497403|P1|COMPLETED|Overall Study||211
8313747|NCT01465997|20497402|P2|STARTED|Overall Study||269
8313748|NCT01465997|20497403|P1|STARTED|Overall Study||279
8313749|NCT01465958|20497413|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
8313750|NCT01465958|20497414|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
8313751|NCT01465958|20497413|P2|COMPLETED|Subcutaneous (SC) Phase||10
8313752|NCT01465958|20497414|P1|COMPLETED|Subcutaneous (SC) Phase||0
8313753|NCT01465958|20497413|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
8313754|NCT01465958|20497414|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
8313755|NCT01465958|20497413|P2|NOT COMPLETED|Intravenous (IV) Phase||0
8313756|NCT01465958|20497414|P1|NOT COMPLETED|Intravenous (IV) Phase||0
8313757|NCT01465958|20497413|P2|COMPLETED|Intravenous (IV) Phase||0
8313758|NCT01465958|20497414|P1|COMPLETED|Intravenous (IV) Phase||11
8313759|NCT01465958|20497413|P2|STARTED|Intravenous (IV) Phase||0
8313760|NCT01465958|20497414|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
8313761|NCT01465958|20497413|P2|NOT COMPLETED|Run-in Phase||0
8313762|NCT01465958|20497414|P1|NOT COMPLETED|Run-in Phase||1
8313763|NCT01465958|20497413|P2|COMPLETED|Run-in Phase||0
8313764|NCT01465958|20497414|P1|COMPLETED|Run-in Phase||10
8313765|NCT01465958|20497413|P2|STARTED|Run-in Phase||0
8313766|NCT01465958|20497414|P1|STARTED|Run-in Phase||11
8313767|NCT01465841|20497422|P1|NOT COMPLETED|Overall Study||68
8313768|NCT01465841|20497422|P1|COMPLETED|Overall Study||449
8313769|NCT01465841|20497422|P1|STARTED|Overall Study||517
8313770|NCT01465802|20497435|P5|NOT COMPLETED|Overall Study||12
8313771|NCT01465802|20497436|P4|NOT COMPLETED|Overall Study||29
8313772|NCT01465802|20497437|P3|NOT COMPLETED|Overall Study||0
8313773|NCT01465802|20497438|P2|NOT COMPLETED|Overall Study||24
8313774|NCT01465802|20497439|P1|NOT COMPLETED|Overall Study||33
8313775|NCT01465802|20497435|P5|COMPLETED|Overall Study||13
8313776|NCT01465802|20497436|P4|COMPLETED|Overall Study||38
8313777|NCT01465802|20497437|P3|COMPLETED|Overall Study||7
8313778|NCT01465802|20497438|P2|COMPLETED|Overall Study||42
8313779|NCT01465802|20497439|P1|COMPLETED|Overall Study||33
8313780|NCT01465802|20497435|P5|STARTED|Overall Study||25
8313781|NCT01465802|20497436|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
8313782|NCT01465802|20497437|P3|STARTED|Overall Study||7
8313783|NCT01465802|20497438|P2|STARTED|Overall Study||66
8313784|NCT01465802|20497439|P1|STARTED|Overall Study||66
8313785|NCT01465763|20497491|P3|NOT COMPLETED|Overall Study||4
8313786|NCT01465763|20497492|P2|NOT COMPLETED|Overall Study||1
8313787|NCT01465763|20497493|P1|NOT COMPLETED|Overall Study||31
8313788|NCT01465763|20497491|P3|COMPLETED|Overall Study||118
8313789|NCT01465763|20497492|P2|COMPLETED|Overall Study||15
8313790|NCT01465763|20497493|P1|COMPLETED|Overall Study||445
8313791|NCT01465763|20497491|P3|STARTED|Overall Study||122
8313792|NCT01465763|20497492|P2|STARTED|Overall Study||16
8313793|NCT01465763|20497493|P1|STARTED|Overall Study||476
8313794|NCT01465659|20497522|P4|NOT COMPLETED|Completed Follow for 1 Year||6
8313795|NCT01465659|20497523|P3|NOT COMPLETED|Completed Follow for 1 Year||2
8313796|NCT01465659|20497524|P2|NOT COMPLETED|Completed Follow for 1 Year||3
8313797|NCT01465659|20497525|P1|NOT COMPLETED|Completed Follow for 1 Year||6
8313798|NCT01465659|20497522|P4|COMPLETED|Completed Follow for 1 Year||5
8313799|NCT01465659|20497523|P3|COMPLETED|Completed Follow for 1 Year||4
8313800|NCT01465659|20497524|P2|COMPLETED|Completed Follow for 1 Year||1
8313801|NCT01465659|20497525|P1|COMPLETED|Completed Follow for 1 Year||1
8313802|NCT01465659|20497522|P4|STARTED|Completed Follow for 1 Year||11
8313803|NCT01465659|20497523|P3|STARTED|Completed Follow for 1 Year||6
8313804|NCT01465659|20497524|P2|STARTED|Completed Follow for 1 Year||4
8313805|NCT01465659|20497525|P1|STARTED|Completed Follow for 1 Year||7
8313806|NCT01465659|20497522|P4|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8313807|NCT01465659|20497523|P3|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8313808|NCT01465659|20497524|P2|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8313809|NCT01465659|20497525|P1|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8313810|NCT01465659|20497522|P4|COMPLETED|Went on to Cycle 3 and Beyond||9
8313811|NCT01465659|20497523|P3|COMPLETED|Went on to Cycle 3 and Beyond||4
8313812|NCT01465659|20497524|P2|COMPLETED|Went on to Cycle 3 and Beyond||4
8313813|NCT01465659|20497525|P1|COMPLETED|Went on to Cycle 3 and Beyond||5
8313814|NCT01465659|20497522|P4|STARTED|Went on to Cycle 3 and Beyond||9
8313815|NCT01465659|20497523|P3|STARTED|Went on to Cycle 3 and Beyond||4
8313816|NCT01465659|20497524|P2|STARTED|Went on to Cycle 3 and Beyond||4
8313817|NCT01465659|20497525|P1|STARTED|Went on to Cycle 3 and Beyond||5
8313818|NCT01465659|20497522|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8313819|NCT01465659|20497523|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8313820|NCT01465659|20497524|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8313821|NCT01465659|20497525|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8313822|NCT01465659|20497522|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
8313823|NCT01465659|20497523|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
8313824|NCT01465659|20497524|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
8313825|NCT01465659|20497525|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
8313826|NCT01465659|20497522|P4|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
8313827|NCT01465659|20497523|P3|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
8313828|NCT01465659|20497524|P2|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
8313829|NCT01465659|20497525|P1|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
8313830|NCT01465659|20497522|P4|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
8313831|NCT01465659|20497523|P3|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
8313832|NCT01465659|20497524|P2|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
8313833|NCT01465659|20497525|P1|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
8313834|NCT01465659|20497522|P4|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
8313835|NCT01465659|20497523|P3|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
8313836|NCT01465659|20497524|P2|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
8313837|NCT01465659|20497525|P1|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
8313838|NCT01465659|20497522|P4|STARTED|Completed 2 Cycles/Reached 1st Response||10
8313839|NCT01465659|20497523|P3|STARTED|Completed 2 Cycles/Reached 1st Response||6
8313840|NCT01465659|20497524|P2|STARTED|Completed 2 Cycles/Reached 1st Response||4
8313841|NCT01465659|20497525|P1|STARTED|Completed 2 Cycles/Reached 1st Response||7
8313842|NCT01465659|20497522|P4|NOT COMPLETED|Completed 1 Cycle of Treatment||1
8313843|NCT01465659|20497523|P3|NOT COMPLETED|Completed 1 Cycle of Treatment||0
8313844|NCT01465659|20497524|P2|NOT COMPLETED|Completed 1 Cycle of Treatment||1
8313845|NCT01465659|20497525|P1|NOT COMPLETED|Completed 1 Cycle of Treatment||0
8313846|NCT01465659|20497522|P4|COMPLETED|Completed 1 Cycle of Treatment||10
8313847|NCT01465659|20497523|P3|COMPLETED|Completed 1 Cycle of Treatment||6
8313848|NCT01465659|20497524|P2|COMPLETED|Completed 1 Cycle of Treatment||4
8313849|NCT01465659|20497525|P1|COMPLETED|Completed 1 Cycle of Treatment||7
8313850|NCT01465659|20497522|P4|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
8313851|NCT01465659|20497523|P3|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
8313852|NCT01465659|20497524|P2|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
8313853|NCT01465659|20497525|P1|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
8313854|NCT01465659|20497522|P4|STARTED|Completed 1 Cycle of Treatment||11
8313855|NCT01465659|20497523|P3|STARTED|Completed 1 Cycle of Treatment||6
8313856|NCT01465659|20497524|P2|STARTED|Completed 1 Cycle of Treatment||5
8313857|NCT01465659|20497525|P1|STARTED|Completed 1 Cycle of Treatment||7
8313858|NCT01465464|20497535|P2|NOT COMPLETED|Overall Study||444
8313859|NCT01465464|20497536|P1|NOT COMPLETED|Overall Study||444
8313860|NCT01465464|20497535|P2|COMPLETED|Overall Study||0
8313861|NCT01465464|20497536|P1|COMPLETED|Overall Study||0
8313862|NCT01465464|20497535|P2|STARTED|Overall Study||444
8313863|NCT01465464|20497536|P1|STARTED|Overall Study||444
8313864|NCT01465412|20497548|P4|NOT COMPLETED|Overall Study||0
8313865|NCT01465412|20497549|P3|NOT COMPLETED|Overall Study||0
8313866|NCT01465412|20497550|P2|NOT COMPLETED|Overall Study||0
8313867|NCT01465412|20497551|P1|NOT COMPLETED|Overall Study||0
8313868|NCT01465412|20497548|P4|COMPLETED|Overall Study||9
8313869|NCT01465412|20497549|P3|COMPLETED|Overall Study||9
8313870|NCT01465412|20497550|P2|COMPLETED|Overall Study||12
8313871|NCT01465412|20497551|P1|COMPLETED|Overall Study||12
8313872|NCT01465412|20497548|P4|STARTED|Overall Study||9
8313873|NCT01465412|20497549|P3|STARTED|Overall Study||9
8313874|NCT01465412|20497550|P2|STARTED|Overall Study||12
8313875|NCT01465412|20497551|P1|STARTED|Overall Study||12
8313876|NCT01465386|20497589|P1|NOT COMPLETED|Overall Study||4
8313877|NCT01465386|20497589|P1|COMPLETED|Overall Study||2
8313878|NCT01465386|20497589|P1|STARTED|Overall Study||6
8313879|NCT01465347|20497593|P2|NOT COMPLETED|Overall Study||3
8313880|NCT01465347|20497594|P1|NOT COMPLETED|Overall Study||1
8313881|NCT01465347|20497593|P2|COMPLETED|Overall Study||53
8313882|NCT01465347|20497594|P1|COMPLETED|Overall Study||2
8313883|NCT01465347|20497593|P2|STARTED|Overall Study||56
8313884|NCT01465347|20497594|P1|STARTED|Overall Study||3
8313885|NCT01465334|20497606|P2|NOT COMPLETED|Overall Study||6
8313886|NCT01465334|20497607|P1|NOT COMPLETED|Overall Study||2
8313887|NCT01465334|20497606|P2|COMPLETED|Overall Study||9
8313888|NCT01465334|20497607|P1|COMPLETED|Overall Study||13
8313889|NCT01465334|20497606|P2|Eligible for Allogeneic Transplant|Overall Study||9
8313890|NCT01465334|20497607|P1|Eligible for Allogeneic Transplant|Overall Study||9
8313891|NCT01465334|20497606|P2|Complete Part B Induction|Overall Study||15
8313892|NCT01465334|20497607|P1|Complete Part B Induction|Overall Study||7
8313893|NCT01465334|20497606|P2|Complete Part A Induction|Overall Study||15
8313894|NCT01465334|20497607|P1|Complete Part A Induction|Overall Study||12
8313895|NCT01465334|20497606|P2|STARTED|Overall Study||15
8313896|NCT01465334|20497607|P1|STARTED|Overall Study||15
8313897|NCT01465230|20497633|P1|NOT COMPLETED|Overall Study||2
8313898|NCT01465230|20497633|P1|COMPLETED|Overall Study||0
8313899|NCT01465230|20497633|P1|STARTED|Overall Study||2
8313900|NCT01465191|20497640|P3|NOT COMPLETED|Overall Study||7
8313901|NCT01465191|20497641|P2|NOT COMPLETED|Overall Study||9
8313902|NCT01465191|20497642|P1|NOT COMPLETED|Overall Study||9
8313903|NCT01465191|20497640|P3|COMPLETED|Overall Study||43
8313904|NCT01465191|20497641|P2|COMPLETED|Overall Study||54
8313905|NCT01465191|20497642|P1|COMPLETED|Overall Study||47
8313906|NCT01465191|20497640|P3|STARTED|Overall Study||50
8313907|NCT01465191|20497641|P2|STARTED|Overall Study||63
8313908|NCT01465191|20497642|P1|STARTED|Overall Study||56
8313909|NCT01465178|20497691|P2|NOT COMPLETED|Overall Study||0
8313910|NCT01465178|20497692|P1|NOT COMPLETED|Overall Study||1
8313911|NCT01465178|20497691|P2|COMPLETED|Overall Study||31
8313912|NCT01465178|20497692|P1|COMPLETED|Overall Study||30
8313913|NCT01465178|20497691|P2|STARTED|Overall Study||31
8313914|NCT01465178|20497692|P1|STARTED|Overall Study||31
8313915|NCT01465048|20497703|P3|NOT COMPLETED|Overall Study||0
8313916|NCT01465048|20497704|P2|NOT COMPLETED|Overall Study||0
8313917|NCT01465048|20497705|P1|NOT COMPLETED|Overall Study||0
8313918|NCT01465048|20497703|P3|COMPLETED|Overall Study||6
8313919|NCT01465048|20497704|P2|COMPLETED|Overall Study||6
8313920|NCT01465048|20497705|P1|COMPLETED|Overall Study||6
8313921|NCT01465048|20497703|P3|STARTED|Overall Study||6
8313922|NCT01465048|20497704|P2|STARTED|Overall Study||6
8313923|NCT01465048|20497705|P1|STARTED|Overall Study||6
8313924|NCT01465022|20497716|P3|NOT COMPLETED|Overall Study||70
8313925|NCT01465022|20497717|P2|NOT COMPLETED|Overall Study||23
8313926|NCT01465022|20497718|P1|NOT COMPLETED|Overall Study||23
8313927|NCT01465022|20497716|P3|COMPLETED|Overall Study||0
8313928|NCT01465022|20497717|P2|COMPLETED|Overall Study||40
8313929|NCT01465022|20497718|P1|COMPLETED|Overall Study||41
8313930|NCT01465022|20497716|P3|STARTED|Overall Study||70
8313931|NCT01465022|20497717|P2|STARTED|Overall Study||63
8313932|NCT01465022|20497718|P1|STARTED|Overall Study||64
8313933|NCT01464996|20497732|P1|NOT COMPLETED|Overall Study||0
8313934|NCT01464996|20497732|P1|COMPLETED|Overall Study||24
8313935|NCT01464996|20497732|P1|OptiBond FL|Overall Study||24
8313936|NCT01464996|20497732|P1|OptiBond XTR|Overall Study||23
8313937|NCT01464996|20497732|P1|STARTED|Overall Study||24
8313938|NCT01464931|20497752|P2|NOT COMPLETED|Overall Study||0
8313939|NCT01464931|20497753|P1|NOT COMPLETED|Overall Study||1
8313940|NCT01464931|20497752|P2|COMPLETED|Overall Study||16
8313941|NCT01464931|20497753|P1|COMPLETED|Overall Study||15
8313942|NCT01464931|20497752|P2|STARTED|Overall Study||16
8313943|NCT01464931|20497753|P1|STARTED|Overall Study||16
8313944|NCT01464879|20497790|P1|NOT COMPLETED|Overall Study||2
8313945|NCT01464879|20497790|P1|COMPLETED|Overall Study||18
8313946|NCT01464879|20497790|P1|Applicator Application (3.75 mL)|Overall Study||18
8313947|NCT01464879|20497790|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
8313948|NCT01464879|20497790|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
8313949|NCT01464879|20497790|P1|Washout Period|Overall Study||20
8313950|NCT01464879|20497790|P1|Hand Application (2.50 mL)|Overall Study||20
8313951|NCT01464879|20497790|P1|STARTED|Overall Study||20
8313952|NCT01464840|20497827|P3|NOT COMPLETED|Overall Study||0
8313953|NCT01464840|20497828|P2|NOT COMPLETED|Overall Study||0
8313954|NCT01464840|20497829|P1|NOT COMPLETED|Overall Study||0
8313955|NCT01464840|20497827|P3|COMPLETED|Overall Study||10
8313956|NCT01464840|20497828|P2|COMPLETED|Overall Study||10
8313957|NCT01464840|20497829|P1|COMPLETED|Overall Study||10
8313958|NCT01464840|20497827|P3|STARTED|Overall Study||10
8313959|NCT01464840|20497828|P2|STARTED|Overall Study||10
8313960|NCT01464840|20497829|P1|STARTED|Overall Study||10
8313961|NCT01464827|20497851|P14|NOT COMPLETED|Overall Study||3
8313962|NCT01464827|20497852|P13|NOT COMPLETED|Overall Study||2
8313963|NCT01464827|20497853|P12|NOT COMPLETED|Overall Study||2
8313964|NCT01464827|20497854|P11|NOT COMPLETED|Overall Study||2
8313965|NCT01464827|20497855|P10|NOT COMPLETED|Overall Study||3
8313966|NCT01464827|20497856|P9|NOT COMPLETED|Overall Study||3
8313967|NCT01464827|20497857|P8|NOT COMPLETED|Overall Study||3
8313968|NCT01464827|20497858|P7|NOT COMPLETED|Overall Study||4
8313969|NCT01464827|20497859|P6|NOT COMPLETED|Overall Study||1
8313970|NCT01464827|20497860|P5|NOT COMPLETED|Overall Study||8
8313971|NCT01464827|20497861|P4|NOT COMPLETED|Overall Study||4
8313972|NCT01464827|20497862|P3|NOT COMPLETED|Overall Study||0
8313973|NCT01464827|20497863|P2|NOT COMPLETED|Overall Study||7
8313974|NCT01464827|20497864|P1|NOT COMPLETED|Overall Study||3
8313975|NCT01464827|20497851|P14|COMPLETED|Overall Study||19
8313976|NCT01464827|20497852|P13|COMPLETED|Overall Study||21
8313977|NCT01464827|20497853|P12|COMPLETED|Overall Study||21
8313978|NCT01464827|20497854|P11|COMPLETED|Overall Study||21
8313979|NCT01464827|20497855|P10|COMPLETED|Overall Study||44
8313980|NCT01464827|20497856|P9|COMPLETED|Overall Study||37
8313981|NCT01464827|20497857|P8|COMPLETED|Overall Study||37
8313982|NCT01464827|20497858|P7|COMPLETED|Overall Study||37
8313983|NCT01464827|20497859|P6|COMPLETED|Overall Study||38
8313984|NCT01464827|20497860|P5|COMPLETED|Overall Study||72
8313985|NCT01464827|20497861|P4|COMPLETED|Overall Study||36
8313986|NCT01464827|20497862|P3|COMPLETED|Overall Study||39
8313987|NCT01464827|20497863|P2|COMPLETED|Overall Study||36
8313988|NCT01464827|20497864|P1|COMPLETED|Overall Study||77
8313989|NCT01464827|20497851|P14|Treated|Overall Study||20
8313990|NCT01464827|20497852|P13|Treated|Overall Study||23
8313991|NCT01464827|20497853|P12|Treated|Overall Study||22
8313992|NCT01464827|20497854|P11|Treated|Overall Study||23
8313993|NCT01464827|20497855|P10|Treated|Overall Study||45
8313994|NCT01464827|20497856|P9|Treated|Overall Study||40
8313995|NCT01464827|20497857|P8|Treated|Overall Study||40
8313996|NCT01464827|20497858|P7|Treated|Overall Study||40
8313997|NCT01464827|20497859|P6|Treated|Overall Study||39
8313998|NCT01464827|20497860|P5|Treated|Overall Study||79
8313999|NCT01464827|20497861|P4|Treated|Overall Study||40
8314000|NCT01464827|20497862|P3|Treated|Overall Study||39
8314001|NCT01464827|20497863|P2|Treated|Overall Study||41
8314002|NCT01464827|20497864|P1|Treated|Overall Study||80
8314003|NCT01464827|20497851|P14|STARTED|Overall Study||22
8314004|NCT01464827|20497852|P13|STARTED|Overall Study||23
8314005|NCT01464827|20497853|P12|STARTED|Overall Study||23
8314006|NCT01464827|20497854|P11|STARTED|Overall Study||23
8314007|NCT01464827|20497855|P10|STARTED|Overall Study||47
8314008|NCT01464827|20497856|P9|STARTED|Overall Study||40
8314009|NCT01464827|20497857|P8|STARTED|Overall Study||40
8314010|NCT01464827|20497858|P7|STARTED|Overall Study||41
8314011|NCT01464827|20497859|P6|STARTED|Overall Study||39
8314012|NCT01464827|20497860|P5|STARTED|Overall Study||80
8314013|NCT01464827|20497861|P4|STARTED|Overall Study||40
8314014|NCT01464827|20497862|P3|STARTED|Overall Study||39
8314015|NCT01464827|20497863|P2|STARTED|Overall Study||43
8314016|NCT01464827|20497864|P1|STARTED|Overall Study||80
8314017|NCT01464788|20497911|P3|NOT COMPLETED|Overall Study||0
8314018|NCT01464788|20497912|P2|NOT COMPLETED|Overall Study||2
8314019|NCT01464788|20497913|P1|NOT COMPLETED|Overall Study||0
8314020|NCT01464788|20497911|P3|COMPLETED|Overall Study||29
8314021|NCT01464788|20497912|P2|COMPLETED|Overall Study||29
8314022|NCT01464788|20497913|P1|COMPLETED|Overall Study||30
8314023|NCT01464788|20497911|P3|STARTED|Overall Study||29
8314024|NCT01464788|20497912|P2|STARTED|Overall Study||31
8314025|NCT01464788|20497913|P1|STARTED|Overall Study||30
8314026|NCT01464775|20497926|P2|NOT COMPLETED|Overall Study||6
8314027|NCT01464775|20497927|P1|NOT COMPLETED|Overall Study||11
8314028|NCT01464775|20497926|P2|COMPLETED|Overall Study||38
8314029|NCT01464775|20497927|P1|COMPLETED|Overall Study||112
8314030|NCT01464775|20497926|P2|STARTED|Overall Study||44
8314031|NCT01464775|20497927|P1|STARTED|Overall Study||123
8314032|NCT01464723|20497935|P1|NOT COMPLETED|Overall Study||0
8314033|NCT01464723|20497935|P1|COMPLETED|Overall Study||0
8314034|NCT01464723|20497935|P1|STARTED|Overall Study||0
8314035|NCT01464697|20497944|P2|NOT COMPLETED|Overall Study||10
8314036|NCT01464697|20497945|P1|NOT COMPLETED|Overall Study||3
8314037|NCT01464697|20497944|P2|COMPLETED|Overall Study||86
8314038|NCT01464697|20497945|P1|COMPLETED|Overall Study||90
8314039|NCT01464697|20497944|P2|STARTED|Overall Study||96
8314040|NCT01464697|20497945|P1|STARTED|Overall Study||93
8314041|NCT01464619|20497999|P2|NOT COMPLETED|Overall Study||4
8314042|NCT01464619|20498000|P1|NOT COMPLETED|Overall Study||3
8314043|NCT01464619|20497999|P2|COMPLETED|Overall Study||25
8314044|NCT01464619|20498000|P1|COMPLETED|Overall Study||29
8314045|NCT01464619|20497999|P2|STARTED|Overall Study||29
8314046|NCT01464619|20498000|P1|STARTED|Overall Study||32
8314047|NCT01464424|20498020|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
8314048|NCT01464424|20498021|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
8314049|NCT01464424|20498020|P2|COMPLETED|Period 2, Second 6 Weeks||41
8314050|NCT01464424|20498021|P1|COMPLETED|Period 2, Second 6 Weeks||42
8314051|NCT01464424|20498020|P2|STARTED|Period 2, Second 6 Weeks||41
8314052|NCT01464424|20498021|P1|STARTED|Period 2, Second 6 Weeks||42
8314053|NCT01464424|20498020|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
8314054|NCT01464424|20498021|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
8314055|NCT01464424|20498020|P2|COMPLETED|Period 1, First 6 Weeks||41
8314056|NCT01464424|20498021|P1|COMPLETED|Period 1, First 6 Weeks||42
8314057|NCT01464424|20498020|P2|STARTED|Period 1, First 6 Weeks||42
8314058|NCT01464424|20498021|P1|STARTED|Period 1, First 6 Weeks||42
8314059|NCT01464359|20498029|P1|NOT COMPLETED|Overall Study||0
8314060|NCT01464359|20498029|P1|COMPLETED|Overall Study||3
8314061|NCT01464359|20498029|P1|STARTED|Overall Study||3
8314062|NCT01464346|20498041|P3|NOT COMPLETED|Overall Study||1
8314063|NCT01464346|20498042|P2|NOT COMPLETED|Overall Study||0
8314064|NCT01464346|20498043|P1|NOT COMPLETED|Overall Study||0
8314065|NCT01464346|20498041|P3|COMPLETED|Overall Study||28
8314066|NCT01464346|20498042|P2|COMPLETED|Overall Study||32
8314067|NCT01464346|20498043|P1|COMPLETED|Overall Study||29
8314068|NCT01464346|20498041|P3|STARTED|Overall Study||29
8314069|NCT01464346|20498042|P2|STARTED|Overall Study||32
8314070|NCT01464346|20498043|P1|STARTED|Overall Study||29
8314071|NCT01464333|20498052|P1|NOT COMPLETED|Overall Study||163
8314072|NCT01464333|20498052|P1|COMPLETED|Overall Study||226
8314073|NCT01464333|20498052|P1|STARTED|Overall Study||389
8314074|NCT01464307|20498065|P2|NOT COMPLETED|Open-Label Extension Period||0
8314075|NCT01464307|20498066|P1|NOT COMPLETED|Open-Label Extension Period||51
8314076|NCT01464307|20498065|P2|COMPLETED|Open-Label Extension Period||0
8314077|NCT01464307|20498066|P1|COMPLETED|Open-Label Extension Period||218
8314078|NCT01464307|20498065|P2|Treated|Open-Label Extension Period||0
8314079|NCT01464307|20498066|P1|Treated|Open-Label Extension Period||269
8314080|NCT01464307|20498065|P2|STARTED|Open-Label Extension Period||0
8314081|NCT01464307|20498066|P1|STARTED|Open-Label Extension Period||269
8314082|NCT01464307|20498065|P2|NOT COMPLETED|Main Period||5
8314083|NCT01464307|20498066|P1|NOT COMPLETED|Main Period||15
8314084|NCT01464307|20498065|P2|COMPLETED|Main Period||140
8314085|NCT01464307|20498066|P1|COMPLETED|Main Period||129
8314086|NCT01464307|20498065|P2|Treated|Main Period||145
8314087|NCT01464307|20498066|P1|Treated|Main Period||144
8314088|NCT01464307|20498065|P2|STARTED|Main Period||145
8314089|NCT01464307|20498066|P1|STARTED|Main Period||144
8314090|NCT01464255|20498081|P2|NOT COMPLETED|Overall Study||1
8314091|NCT01464255|20498082|P1|NOT COMPLETED|Overall Study||0
8314092|NCT01464255|20498081|P2|COMPLETED|Overall Study||24
8314093|NCT01464255|20498082|P1|COMPLETED|Overall Study||25
8314094|NCT01464255|20498081|P2|STARTED|Overall Study||25
8314095|NCT01464255|20498082|P1|STARTED|Overall Study||25
8314096|NCT01464229|20498107|P2|NOT COMPLETED|Overall Study||2
8314097|NCT01464229|20498108|P1|NOT COMPLETED|Overall Study||5
8314098|NCT01464229|20498107|P2|COMPLETED|Overall Study||8
8314099|NCT01464229|20498108|P1|COMPLETED|Overall Study||5
8314100|NCT01464229|20498107|P2|STARTED|Overall Study||10
8314101|NCT01464229|20498108|P1|STARTED|Overall Study||10
8314102|NCT01464190|20498116|P2|NOT COMPLETED|Overall Study||41
8314103|NCT01464190|20498117|P1|NOT COMPLETED|Overall Study||69
8314104|NCT01464190|20498116|P2|COMPLETED|Overall Study||227
8314105|NCT01464190|20498117|P1|COMPLETED|Overall Study||322
8314106|NCT01464190|20498116|P2|STARTED|Overall Study||268
8314107|NCT01464190|20498117|P1|STARTED|Overall Study||391
8314108|NCT01464021|20498127|P1|NOT COMPLETED|Overall Study||26
8314109|NCT01464021|20498127|P1|COMPLETED|Overall Study||0
8314110|NCT01464021|20498127|P1|STARTED|Overall Study||26
8314111|NCT01463982|20498143|P4|NOT COMPLETED|Overall Study||0
8314112|NCT01463982|20498144|P3|NOT COMPLETED|Overall Study||2
8314113|NCT01463982|20498145|P2|NOT COMPLETED|Overall Study||1
8314114|NCT01463982|20498146|P1|NOT COMPLETED|Overall Study||0
8314115|NCT01463982|20498143|P4|COMPLETED|Overall Study||6
8314116|NCT01463982|20498144|P3|COMPLETED|Overall Study||2
8314117|NCT01463982|20498145|P2|COMPLETED|Overall Study||7
8314118|NCT01463982|20498146|P1|COMPLETED|Overall Study||3
8314119|NCT01463982|20498143|P4|STARTED|Overall Study||6
8314120|NCT01463982|20498144|P3|STARTED|Overall Study||4
8314121|NCT01463982|20498145|P2|STARTED|Overall Study||8
8314122|NCT01463982|20498146|P1|STARTED|Overall Study||3
8314123|NCT01463878|20498162|P2|NOT COMPLETED|Overall Study||2
8314124|NCT01463878|20498163|P1|NOT COMPLETED|Overall Study||2
8314125|NCT01463878|20498162|P2|COMPLETED|Overall Study||7
8314126|NCT01463878|20498163|P1|COMPLETED|Overall Study||7
8314127|NCT01463878|20498162|P2|STARTED|Overall Study||9
8314128|NCT01463878|20498163|P1|STARTED|Overall Study||9
8314129|NCT01463696|20498177|P8|NOT COMPLETED|Overall Study||4
8314130|NCT01463696|20498178|P7|NOT COMPLETED|Overall Study||10
8314131|NCT01463696|20498179|P6|NOT COMPLETED|Overall Study||3
8314132|NCT01463696|20498180|P5|NOT COMPLETED|Overall Study||1
8314133|NCT01463696|20498181|P4|NOT COMPLETED|Overall Study||4
8314134|NCT01463696|20498182|P3|NOT COMPLETED|Overall Study||1
8314135|NCT01463696|20498183|P2|NOT COMPLETED|Overall Study||2
8314136|NCT01463696|20498184|P1|NOT COMPLETED|Overall Study||0
8314137|NCT01463696|20498177|P8|COMPLETED|Overall Study||2
8314138|NCT01463696|20498178|P7|COMPLETED|Overall Study||6
8314139|NCT01463696|20498179|P6|COMPLETED|Overall Study||3
8314140|NCT01463696|20498180|P5|COMPLETED|Overall Study||2
8314141|NCT01463696|20498181|P4|COMPLETED|Overall Study||3
8314142|NCT01463696|20498182|P3|COMPLETED|Overall Study||2
8314143|NCT01463696|20498183|P2|COMPLETED|Overall Study||4
8314144|NCT01463696|20498184|P1|COMPLETED|Overall Study||1
8314145|NCT01463696|20498177|P8|Treated|Overall Study||6
8314146|NCT01463696|20498178|P7|Treated|Overall Study||15
8314147|NCT01463696|20498179|P6|Treated|Overall Study||6
8314148|NCT01463696|20498180|P5|Treated|Overall Study||3
8314149|NCT01463696|20498181|P4|Treated|Overall Study||7
8314150|NCT01463696|20498182|P3|Treated|Overall Study||3
8314151|NCT01463696|20498183|P2|Treated|Overall Study||6
8314152|NCT01463696|20498184|P1|Treated|Overall Study||1
8314153|NCT01463696|20498177|P8|STARTED|Overall Study||6
8314154|NCT01463696|20498178|P7|STARTED|Overall Study||16
8314155|NCT01463696|20498179|P6|STARTED|Overall Study||6
8314156|NCT01463696|20498180|P5|STARTED|Overall Study||3
8314157|NCT01463696|20498181|P4|STARTED|Overall Study||7
8314158|NCT01463696|20498182|P3|STARTED|Overall Study||3
8314159|NCT01463696|20498183|P2|STARTED|Overall Study||6
8314160|NCT01463696|20498184|P1|STARTED|Overall Study||1
8314161|NCT01463683|20498237|P3|NOT COMPLETED|Overall Study||11
8314162|NCT01463683|20498238|P2|NOT COMPLETED|Overall Study||31
8314163|NCT01463683|20498239|P1|NOT COMPLETED|Overall Study||19
8314164|NCT01463683|20498237|P3|COMPLETED|Overall Study||93
8314165|NCT01463683|20498238|P2|COMPLETED|Overall Study||278
8314166|NCT01463683|20498239|P1|COMPLETED|Overall Study||290
8314167|NCT01463683|20498237|P3|Received Vaccination 3 (Month 6)|Overall Study||93
8314168|NCT01463683|20498238|P2|Received Vaccination 3 (Month 6)|Overall Study||281
8314169|NCT01463683|20498239|P1|Received Vaccination 3 (Month 6)|Overall Study||290
8314170|NCT01463683|20498237|P3|Received Vaccination 2 (Month 1)|Overall Study||103
8314171|NCT01463683|20498238|P2|Received Vaccination 2 (Month 1)|Overall Study||300
8314172|NCT01463683|20498239|P1|Received Vaccination 2 (Month 1)|Overall Study||302
8314173|NCT01463683|20498237|P3|Received Vaccination 1 (Day 1)|Overall Study||104
8314174|NCT01463683|20498238|P2|Received Vaccination 1 (Day 1)|Overall Study||308
8314175|NCT01463683|20498239|P1|Received Vaccination 1 (Day 1)|Overall Study||309
8314176|NCT01463683|20498237|P3|STARTED|Overall Study||104
8314177|NCT01463683|20498238|P2|STARTED|Overall Study||309
8314178|NCT01463683|20498239|P1|STARTED|Overall Study||309
8314179|NCT01463631|20498256|P4|NOT COMPLETED|Overall Study||6
8314180|NCT01463631|20498257|P3|NOT COMPLETED|Overall Study||1
8314181|NCT01463631|20498258|P2|NOT COMPLETED|Overall Study||0
8314182|NCT01463631|20498259|P1|NOT COMPLETED|Overall Study||0
8314183|NCT01463631|20498256|P4|COMPLETED|Overall Study||9
8314184|NCT01463631|20498257|P3|COMPLETED|Overall Study||4
8314185|NCT01463631|20498258|P2|COMPLETED|Overall Study||4
8314186|NCT01463631|20498259|P1|COMPLETED|Overall Study||3
8314187|NCT01463631|20498256|P4|Received at Least One Dose of Study Drug|Overall Study||15
8314188|NCT01463631|20498257|P3|Received at Least One Dose of Study Drug|Overall Study||5
8314189|NCT01463631|20498258|P2|Received at Least One Dose of Study Drug|Overall Study||4
8314190|NCT01463631|20498259|P1|Received at Least One Dose of Study Drug|Overall Study||3
8314191|NCT01463631|20498256|P4|STARTED|Overall Study||15
8314192|NCT01463631|20498257|P3|STARTED|Overall Study||5
8314193|NCT01463631|20498258|P2|STARTED|Overall Study||4
8314194|NCT01463631|20498259|P1|STARTED|Overall Study||3
8314195|NCT01463527|20498281|P2|NOT COMPLETED|Overall Study||7
8314196|NCT01463527|20498282|P1|NOT COMPLETED|Overall Study||6
8314197|NCT01463527|20498281|P2|COMPLETED|Overall Study||77
8314198|NCT01463527|20498282|P1|COMPLETED|Overall Study||77
8314199|NCT01463527|20498281|P2|STARTED|Overall Study||84
8314200|NCT01463527|20498282|P1|STARTED|Overall Study||83
8314201|NCT01463384|20498290|P1|NOT COMPLETED|Overall Study||0
8314202|NCT01463384|20498290|P1|COMPLETED|Overall Study||13
8314203|NCT01463384|20498290|P1|STARTED|Overall Study||13
8314204|NCT01463306|20498305|P3|NOT COMPLETED|Overall Study||5
8314205|NCT01463306|20498306|P2|NOT COMPLETED|Overall Study||52
8314206|NCT01463306|20498307|P1|NOT COMPLETED|Overall Study||86
8314207|NCT01463306|20498305|P3|COMPLETED|Overall Study||6
8314208|NCT01463306|20498306|P2|COMPLETED|Overall Study||158
8314209|NCT01463306|20498307|P1|COMPLETED|Overall Study||298
8314210|NCT01463306|20498305|P3|STARTED|Overall Study||11
8314211|NCT01463306|20498306|P2|STARTED|Overall Study||210
8314212|NCT01463306|20498307|P1|STARTED|Overall Study||384
8314213|NCT01463293|20498378|P3|NOT COMPLETED|Overall Study||12
8314214|NCT01463293|20498379|P2|NOT COMPLETED|Overall Study||16
8314215|NCT01463293|20498380|P1|NOT COMPLETED|Overall Study||6
8314216|NCT01463293|20498378|P3|COMPLETED|Overall Study||59
8314217|NCT01463293|20498379|P2|COMPLETED|Overall Study||63
8314218|NCT01463293|20498380|P1|COMPLETED|Overall Study||68
8314219|NCT01463293|20498378|P3|STARTED|Overall Study||71
8314220|NCT01463293|20498379|P2|STARTED|Overall Study||79
8314221|NCT01463293|20498380|P1|STARTED|Overall Study||74
8314222|NCT01463267|20498392|P4|NOT COMPLETED|Overall Study||2
8314223|NCT01463267|20498393|P3|NOT COMPLETED|Overall Study||2
8314224|NCT01463267|20498394|P2|NOT COMPLETED|Overall Study||0
8314225|NCT01463267|20498395|P1|NOT COMPLETED|Overall Study||1
8314226|NCT01463267|20498392|P4|COMPLETED|Overall Study||13
8314227|NCT01463267|20498393|P3|COMPLETED|Overall Study||13
8314228|NCT01463267|20498394|P2|COMPLETED|Overall Study||15
8314229|NCT01463267|20498395|P1|COMPLETED|Overall Study||14
8314230|NCT01463267|20498392|P4|STARTED|Overall Study||15
8314231|NCT01463267|20498393|P3|STARTED|Overall Study||15
8314232|NCT01463267|20498394|P2|STARTED|Overall Study||15
8314233|NCT01463267|20498395|P1|STARTED|Overall Study||15
8314234|NCT01463202|20498411|P2|NOT COMPLETED|Overall Study||0
8314235|NCT01463202|20498412|P1|NOT COMPLETED|Overall Study||0
8314236|NCT01463202|20498411|P2|COMPLETED|Overall Study||78
8314237|NCT01463202|20498412|P1|COMPLETED|Overall Study||79
8314238|NCT01463202|20498411|P2|STARTED|Overall Study||78
8314239|NCT01463202|20498412|P1|STARTED|Overall Study||79
8314240|NCT01463111|20498424|P1|NOT COMPLETED|Overall Study||9
8314241|NCT01463111|20498424|P1|COMPLETED|Overall Study||17
8314242|NCT01463111|20498424|P1|STARTED|Overall Study||26
8314243|NCT01463098|20498446|P14|NOT COMPLETED|Part B (11 Days)||0
8314244|NCT01463098|20498447|P13|NOT COMPLETED|Part B (11 Days)||0
8314245|NCT01463098|20498448|P12|NOT COMPLETED|Part B (11 Days)||1
8314246|NCT01463098|20498449|P11|NOT COMPLETED|Part B (11 Days)||0
8314247|NCT01463098|20498450|P10|NOT COMPLETED|Part B (11 Days)||0
8314248|NCT01463098|20498451|P9|NOT COMPLETED|Part B (11 Days)||0
8314249|NCT01463098|20498452|P8|NOT COMPLETED|Part B (11 Days)||0
8314250|NCT01463098|20498453|P7|NOT COMPLETED|Part B (11 Days)||0
8314251|NCT01463098|20498454|P6|NOT COMPLETED|Part B (11 Days)||0
8314252|NCT01463098|20498455|P5|NOT COMPLETED|Part B (11 Days)||0
8314253|NCT01463098|20498456|P4|NOT COMPLETED|Part B (11 Days)||0
8314254|NCT01463098|20498457|P3|NOT COMPLETED|Part B (11 Days)||0
8314255|NCT01463098|20498458|P2|NOT COMPLETED|Part B (11 Days)||0
8314256|NCT01463098|20498459|P1|NOT COMPLETED|Part B (11 Days)||0
8314257|NCT01463098|20498446|P14|COMPLETED|Part B (11 Days)||12
8314258|NCT01463098|20498447|P13|COMPLETED|Part B (11 Days)||10
8314259|NCT01463098|20498448|P12|COMPLETED|Part B (11 Days)||12
8314260|NCT01463098|20498449|P11|COMPLETED|Part B (11 Days)||11
8314261|NCT01463098|20498450|P10|COMPLETED|Part B (11 Days)||12
8314262|NCT01463098|20498451|P9|COMPLETED|Part B (11 Days)||0
8314263|NCT01463098|20498452|P8|COMPLETED|Part B (11 Days)||0
8314264|NCT01463098|20498453|P7|COMPLETED|Part B (11 Days)||0
8314265|NCT01463098|20498454|P6|COMPLETED|Part B (11 Days)||0
8314266|NCT01463098|20498455|P5|COMPLETED|Part B (11 Days)||0
8314267|NCT01463098|20498456|P4|COMPLETED|Part B (11 Days)||0
8314268|NCT01463098|20498457|P3|COMPLETED|Part B (11 Days)||0
8314269|NCT01463098|20498458|P2|COMPLETED|Part B (11 Days)||0
8314270|NCT01463098|20498459|P1|COMPLETED|Part B (11 Days)||0
8314271|NCT01463098|20498446|P14|STARTED|Part B (11 Days)||12
8314272|NCT01463098|20498447|P13|STARTED|Part B (11 Days)||10
8314273|NCT01463098|20498448|P12|STARTED|Part B (11 Days)||13
8314274|NCT01463098|20498449|P11|STARTED|Part B (11 Days)||11
8314275|NCT01463098|20498450|P10|STARTED|Part B (11 Days)||12
8314276|NCT01463098|20498451|P9|STARTED|Part B (11 Days)||0
8314277|NCT01463098|20498452|P8|STARTED|Part B (11 Days)||0
8314278|NCT01463098|20498453|P7|STARTED|Part B (11 Days)||0
8314279|NCT01463098|20498454|P6|STARTED|Part B (11 Days)||0
8314280|NCT01463098|20498455|P5|STARTED|Part B (11 Days)||0
8314281|NCT01463098|20498456|P4|STARTED|Part B (11 Days)||0
8314282|NCT01463098|20498457|P3|STARTED|Part B (11 Days)||0
8314283|NCT01463098|20498458|P2|STARTED|Part B (11 Days)||0
8314284|NCT01463098|20498459|P1|STARTED|Part B (11 Days)||0
8314285|NCT01463098|20498446|P14|NOT COMPLETED|Part A (11 Days)||0
8314286|NCT01463098|20498447|P13|NOT COMPLETED|Part A (11 Days)||0
8314287|NCT01463098|20498448|P12|NOT COMPLETED|Part A (11 Days)||0
8314288|NCT01463098|20498449|P11|NOT COMPLETED|Part A (11 Days)||0
8314289|NCT01463098|20498450|P10|NOT COMPLETED|Part A (11 Days)||0
8314290|NCT01463098|20498451|P9|NOT COMPLETED|Part A (11 Days)||1
8314291|NCT01463098|20498452|P8|NOT COMPLETED|Part A (11 Days)||0
8314292|NCT01463098|20498453|P7|NOT COMPLETED|Part A (11 Days)||0
8314293|NCT01463098|20498454|P6|NOT COMPLETED|Part A (11 Days)||0
8314294|NCT01463098|20498455|P5|NOT COMPLETED|Part A (11 Days)||1
8314295|NCT01463098|20498456|P4|NOT COMPLETED|Part A (11 Days)||0
8314296|NCT01463098|20498457|P3|NOT COMPLETED|Part A (11 Days)||0
8314297|NCT01463098|20498458|P2|NOT COMPLETED|Part A (11 Days)||0
8314298|NCT01463098|20498459|P1|NOT COMPLETED|Part A (11 Days)||2
8314299|NCT01463098|20498446|P14|COMPLETED|Part A (11 Days)||0
8314300|NCT01463098|20498447|P13|COMPLETED|Part A (11 Days)||0
8314301|NCT01463098|20498448|P12|COMPLETED|Part A (11 Days)||0
8314302|NCT01463098|20498449|P11|COMPLETED|Part A (11 Days)||0
8314303|NCT01463098|20498450|P10|COMPLETED|Part A (11 Days)||0
8314304|NCT01463098|20498451|P9|COMPLETED|Part A (11 Days)||5
8314305|NCT01463098|20498452|P8|COMPLETED|Part A (11 Days)||6
8314306|NCT01463098|20498453|P7|COMPLETED|Part A (11 Days)||6
8314307|NCT01463098|20498454|P6|COMPLETED|Part A (11 Days)||6
8314308|NCT01463098|20498455|P5|COMPLETED|Part A (11 Days)||5
8314309|NCT01463098|20498456|P4|COMPLETED|Part A (11 Days)||6
8314310|NCT01463098|20498457|P3|COMPLETED|Part A (11 Days)||6
8314311|NCT01463098|20498458|P2|COMPLETED|Part A (11 Days)||6
8314312|NCT01463098|20498459|P1|COMPLETED|Part A (11 Days)||14
8314313|NCT01463098|20498446|P14|STARTED|Part A (11 Days)||0
8314314|NCT01463098|20498447|P13|STARTED|Part A (11 Days)||0
8314315|NCT01463098|20498448|P12|STARTED|Part A (11 Days)||0
8314316|NCT01463098|20498449|P11|STARTED|Part A (11 Days)||0
8314317|NCT01463098|20498450|P10|STARTED|Part A (11 Days)||0
8314318|NCT01463098|20498451|P9|STARTED|Part A (11 Days)||6
8314319|NCT01463098|20498452|P8|STARTED|Part A (11 Days)||6
8314320|NCT01463098|20498453|P7|STARTED|Part A (11 Days)||6
8314321|NCT01463098|20498454|P6|STARTED|Part A (11 Days)||6
8314322|NCT01463098|20498455|P5|STARTED|Part A (11 Days)||6
8314323|NCT01463098|20498456|P4|STARTED|Part A (11 Days)||6
8314324|NCT01463098|20498457|P3|STARTED|Part A (11 Days)||6
8314325|NCT01463098|20498458|P2|STARTED|Part A (11 Days)||6
8314326|NCT01463098|20498459|P1|STARTED|Part A (11 Days)||16
8314327|NCT01463033|20498782|P2|NOT COMPLETED|Overall Study||6
8314328|NCT01463033|20498783|P1|NOT COMPLETED|Overall Study||7
8314329|NCT01463033|20498782|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
8314330|NCT01463033|20498783|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
8314331|NCT01463033|20498782|P2|STARTED|Overall Study||60
8314332|NCT01463033|20498783|P1|STARTED|Overall Study||66
8314333|NCT01463007|20498790|P1|NOT COMPLETED|Overall Study||1
8314334|NCT01463007|20498790|P1|COMPLETED|Overall Study||40
8314335|NCT01463007|20498790|P1|STARTED|Overall Study||41
8314336|NCT01462942|20498801|P5|NOT COMPLETED|Overall Study||45
8314337|NCT01462942|20498802|P4|NOT COMPLETED|Overall Study||50
8314338|NCT01462942|20498803|P3|NOT COMPLETED|Overall Study||40
8314339|NCT01462942|20498804|P2|NOT COMPLETED|Overall Study||34
8314340|NCT01462942|20498805|P1|NOT COMPLETED|Overall Study||34
8314341|NCT01462942|20498801|P5|COMPLETED|Overall Study||339
8314342|NCT01462942|20498802|P4|COMPLETED|Overall Study||335
8314343|NCT01462942|20498803|P3|COMPLETED|Overall Study||341
8314344|NCT01462942|20498804|P2|COMPLETED|Overall Study||351
8314345|NCT01462942|20498805|P1|COMPLETED|Overall Study||160
8314346|NCT01462942|20498801|P5|STARTED|Overall Study||384
8314347|NCT01462942|20498802|P4|STARTED|Overall Study||385
8314348|NCT01462942|20498803|P3|STARTED|Overall Study||381
8314349|NCT01462942|20498804|P2|STARTED|Overall Study||385
8314350|NCT01462942|20498805|P1|STARTED|Overall Study||194
8314351|NCT01462929|20498835|P3|NOT COMPLETED|Overall Study||5
8314352|NCT01462929|20498836|P2|NOT COMPLETED|Overall Study||4
8314353|NCT01462929|20498837|P1|NOT COMPLETED|Overall Study||5
8314354|NCT01462929|20498835|P3|COMPLETED|Overall Study||80
8314355|NCT01462929|20498836|P2|COMPLETED|Overall Study||154
8314356|NCT01462929|20498837|P1|COMPLETED|Overall Study||166
8314357|NCT01462929|20498835|P3|STARTED|Overall Study||85
8314358|NCT01462929|20498836|P2|STARTED|Overall Study||158
8314359|NCT01462929|20498837|P1|STARTED|Overall Study||171
8314360|NCT01462877|20498848|P1|NOT COMPLETED|Overall Study||71
8314361|NCT01462877|20498848|P1|COMPLETED|Overall Study||435
8314362|NCT01462877|20498848|P1|Per-protocol Set|Overall Study||364
8314363|NCT01462877|20498848|P1|Full Analysis Set|Overall Study||468
8314364|NCT01462877|20498848|P1|Safety Set|Overall Study||492
8314365|NCT01462877|20498848|P1|STARTED|Overall Study||506
8314366|NCT01462812|20498864|P2|NOT COMPLETED|Overall Study||1
8314367|NCT01462812|20498865|P1|NOT COMPLETED|Overall Study||0
8314368|NCT01462812|20498864|P2|COMPLETED|Overall Study||111
8314369|NCT01462812|20498865|P1|COMPLETED|Overall Study||111
8314370|NCT01462812|20498864|P2|STARTED|Overall Study||112
8314371|NCT01462812|20498865|P1|STARTED|Overall Study||111
8314372|NCT01462773|20498871|P1|NOT COMPLETED|Overall Study||0
8314373|NCT01462773|20498871|P1|COMPLETED|Overall Study||16
8314374|NCT01462773|20498871|P1|STARTED|Overall Study||16
8314375|NCT01462695|20498878|P2|NOT COMPLETED|Overall Study||13
8314376|NCT01462695|20498879|P1|NOT COMPLETED|Overall Study||17
8314377|NCT01462695|20498878|P2|COMPLETED|Overall Study||0
8314378|NCT01462695|20498879|P1|COMPLETED|Overall Study||0
8314379|NCT01462695|20498878|P2|STARTED|Overall Study||13
8314380|NCT01462695|20498879|P1|STARTED|Overall Study||17
8314381|NCT01462565|20498885|P1|NOT COMPLETED|Overall Study||0
8314382|NCT01462565|20498885|P1|COMPLETED|Overall Study||16
8314383|NCT01462565|20498885|P1|STARTED|Overall Study||16
8314384|NCT01462435|20498907|P4|NOT COMPLETED|Overall Study||5
8314385|NCT01462435|20498908|P3|NOT COMPLETED|Overall Study||1
8314386|NCT01462435|20498909|P2|NOT COMPLETED|Overall Study||0
8314387|NCT01462435|20498910|P1|NOT COMPLETED|Overall Study||1
8314388|NCT01462435|20498907|P4|COMPLETED|Overall Study||101
8314389|NCT01462435|20498908|P3|COMPLETED|Overall Study||106
8314390|NCT01462435|20498909|P2|COMPLETED|Overall Study||109
8314391|NCT01462435|20498910|P1|COMPLETED|Overall Study||105
8314392|NCT01462435|20498907|P4|STARTED|Overall Study||106
8314393|NCT01462435|20498908|P3|STARTED|Overall Study||107
8314394|NCT01462435|20498909|P2|STARTED|Overall Study||109
8314395|NCT01462435|20498910|P1|STARTED|Overall Study||106
8314396|NCT01462370|20498948|P2|NOT COMPLETED|Overall Study||5
8314397|NCT01462370|20498949|P1|NOT COMPLETED|Overall Study||1
8314398|NCT01462370|20498948|P2|COMPLETED|Overall Study||65
8314399|NCT01462370|20498949|P1|COMPLETED|Overall Study||68
8314400|NCT01462370|20498948|P2|STARTED|Overall Study||70
8314401|NCT01462370|20498949|P1|STARTED|Overall Study||69
8314402|NCT01462357|20498984|P3|NOT COMPLETED|Overall Study||12
8314403|NCT01462357|20498985|P2|NOT COMPLETED|Overall Study||19
8314404|NCT01462357|20498986|P1|NOT COMPLETED|Overall Study||8
8314405|NCT01462357|20498984|P3|COMPLETED|Overall Study||346
8314406|NCT01462357|20498985|P2|COMPLETED|Overall Study||339
8314407|NCT01462357|20498986|P1|COMPLETED|Overall Study||351
8314408|NCT01462357|20498984|P3|STARTED|Overall Study||358
8314409|NCT01462357|20498985|P2|STARTED|Overall Study||358
8314410|NCT01462357|20498986|P1|STARTED|Overall Study||359
8314411|NCT01462344|20499059|P2|NOT COMPLETED|Overall Study||350
8314412|NCT01462344|20499060|P1|NOT COMPLETED|Overall Study||383
8314413|NCT01462344|20499059|P2|COMPLETED|Overall Study||2751
8314414|NCT01462344|20499060|P1|COMPLETED|Overall Study||2724
8314415|NCT01462344|20499059|P2|STARTED|Overall Study||3101
8314416|NCT01462344|20499060|P1|STARTED|Overall Study||3107
8314417|NCT01462318|20499082|P3|NOT COMPLETED|Extension Phase||45
8314418|NCT01462318|20499083|P2|NOT COMPLETED|Extension Phase||0
8314419|NCT01462318|20499084|P1|NOT COMPLETED|Extension Phase||0
8314420|NCT01462318|20499082|P3|COMPLETED|Extension Phase||70
8314421|NCT01462318|20499083|P2|COMPLETED|Extension Phase||0
8314422|NCT01462318|20499084|P1|COMPLETED|Extension Phase||0
8314423|NCT01462318|20499082|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
8314424|NCT01462318|20499083|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
8314425|NCT01462318|20499084|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
8314426|NCT01462318|20499082|P3|NOT COMPLETED|Main Study / TP-DI Study||0
8314427|NCT01462318|20499083|P2|NOT COMPLETED|Main Study / TP-DI Study||0
8314428|NCT01462318|20499084|P1|NOT COMPLETED|Main Study / TP-DI Study||8
8314429|NCT01462318|20499082|P3|COMPLETED|Main Study / TP-DI Study||0
8314430|NCT01462318|20499083|P2|COMPLETED|Main Study / TP-DI Study||20
8314431|NCT01462318|20499084|P1|COMPLETED|Main Study / TP-DI Study||105
8314432|NCT01462318|20499082|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
8314433|NCT01462318|20499083|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
8314434|NCT01462318|20499084|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
8314435|NCT01462318|20499082|P3|STARTED|Main Study / TP-DI Study||0
8314436|NCT01462318|20499083|P2|STARTED|Main Study / TP-DI Study||20
8314437|NCT01462318|20499084|P1|STARTED|Main Study / TP-DI Study||113
8314438|NCT01462305|20499103|P2|NOT COMPLETED|Overall Study||4
8314439|NCT01462305|20499104|P1|NOT COMPLETED|Overall Study||2
8314440|NCT01462305|20499103|P2|COMPLETED|Overall Study||13
8314441|NCT01462305|20499104|P1|COMPLETED|Overall Study||16
8314442|NCT01462305|20499103|P2|STARTED|Overall Study||17
8314443|NCT01462305|20499104|P1|STARTED|Overall Study||18
8314444|NCT01462292|20499117|P3|NOT COMPLETED|Overall Study||0
8314445|NCT01462292|20499118|P2|NOT COMPLETED|Overall Study||0
8314446|NCT01462292|20499119|P1|NOT COMPLETED|Overall Study||0
8314447|NCT01462292|20499117|P3|COMPLETED|Overall Study||18
8314448|NCT01462292|20499118|P2|COMPLETED|Overall Study||17
8314449|NCT01462292|20499119|P1|COMPLETED|Overall Study||16
8314450|NCT01462292|20499117|P3|STARTED|Overall Study||18
8314451|NCT01462292|20499118|P2|STARTED|Overall Study||17
8314452|NCT01462292|20499119|P1|STARTED|Overall Study||16
8314453|NCT01462279|20499178|P1|NOT COMPLETED|Overall Study||3
8314454|NCT01462279|20499178|P1|COMPLETED|Overall Study||17
8314455|NCT01462279|20499178|P1|STARTED|Overall Study||20
8314456|NCT01462266|20499185|P2|NOT COMPLETED|Overall Study||27
8314457|NCT01462266|20499186|P1|NOT COMPLETED|Overall Study||35
8314458|NCT01462266|20499185|P2|COMPLETED|Overall Study||303
8314459|NCT01462266|20499186|P1|COMPLETED|Overall Study||295
8314460|NCT01462266|20499185|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
8314461|NCT01462266|20499186|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
8314462|NCT01462266|20499185|P2|STARTED|Overall Study||330
8314463|NCT01462266|20499186|P1|STARTED|Overall Study||330
8314464|NCT01462253|20499200|P1|NOT COMPLETED|Overall Study||8
8314465|NCT01462253|20499200|P1|COMPLETED|Overall Study||27
8314466|NCT01462253|20499200|P1|STARTED|Overall Study||35
8314467|NCT01462227|20499211|P4|NOT COMPLETED|Second Assignment||0
8314468|NCT01462227|20499212|P3|NOT COMPLETED|Second Assignment||1
8314469|NCT01462227|20499213|P2|NOT COMPLETED|Second Assignment||1
8314470|NCT01462227|20499214|P1|NOT COMPLETED|Second Assignment||1
8314471|NCT01462227|20499211|P4|COMPLETED|Second Assignment||5
8314472|NCT01462227|20499212|P3|COMPLETED|Second Assignment||5
8314473|NCT01462227|20499213|P2|COMPLETED|Second Assignment||1
8314474|NCT01462227|20499214|P1|COMPLETED|Second Assignment||3
8314475|NCT01462227|20499211|P4|STARTED|Second Assignment||5
8314476|NCT01462227|20499212|P3|STARTED|Second Assignment||6
8314477|NCT01462227|20499213|P2|STARTED|Second Assignment||2
8314478|NCT01462227|20499214|P1|STARTED|Second Assignment||4
8314479|NCT01462227|20499211|P4|NOT COMPLETED|First Assignment||0
8314480|NCT01462227|20499212|P3|NOT COMPLETED|First Assignment||0
8314481|NCT01462227|20499213|P2|NOT COMPLETED|First Assignment||0
8314482|NCT01462227|20499214|P1|NOT COMPLETED|First Assignment||0
8314483|NCT01462227|20499211|P4|COMPLETED|First Assignment||5
8314484|NCT01462227|20499212|P3|COMPLETED|First Assignment||6
8314485|NCT01462227|20499213|P2|COMPLETED|First Assignment||2
8314486|NCT01462227|20499214|P1|COMPLETED|First Assignment||4
8314487|NCT01462227|20499211|P4|STARTED|First Assignment||5
8314488|NCT01462227|20499212|P3|STARTED|First Assignment||6
8314489|NCT01462227|20499213|P2|STARTED|First Assignment||2
8314490|NCT01462227|20499214|P1|STARTED|First Assignment||4
8314491|NCT01462162|20499232|P1|NOT COMPLETED|Overall Study||12
8314492|NCT01462162|20499232|P1|COMPLETED|Overall Study||108
8314493|NCT01462162|20499232|P1|STARTED|Overall Study||120
8314494|NCT01462110|20499259|P2|NOT COMPLETED|Overall Study||0
8314495|NCT01462110|20499260|P1|NOT COMPLETED|Overall Study||1
8314496|NCT01462110|20499259|P2|COMPLETED|Overall Study||43
8314497|NCT01462110|20499260|P1|COMPLETED|Overall Study||43
8314498|NCT01462110|20499259|P2|STARTED|Overall Study||43
8314499|NCT01462110|20499260|P1|STARTED|Overall Study||44
8314500|NCT01462084|20499280|P2|NOT COMPLETED|Overall Study||1
8314501|NCT01462084|20499281|P1|NOT COMPLETED|Overall Study||2
8314502|NCT01462084|20499280|P2|COMPLETED|Overall Study||9
8314503|NCT01462084|20499281|P1|COMPLETED|Overall Study||9
8314504|NCT01462084|20499280|P2|Included for Analysis|Overall Study||9
8314505|NCT01462084|20499281|P1|Included for Analysis|Overall Study||9
8314506|NCT01462084|20499280|P2|STARTED|Overall Study||10
8314507|NCT01462084|20499281|P1|STARTED|Overall Study||11
8314508|NCT01462045|20499292|P3|NOT COMPLETED|Overall Study||0
8314509|NCT01462045|20499293|P2|NOT COMPLETED|Overall Study||1
8314510|NCT01462045|20499294|P1|NOT COMPLETED|Overall Study||0
8314511|NCT01462045|20499292|P3|COMPLETED|Overall Study||7
8314512|NCT01462045|20499293|P2|COMPLETED|Overall Study||10
8314513|NCT01462045|20499294|P1|COMPLETED|Overall Study||11
8314514|NCT01462045|20499292|P3|STARTED|Overall Study||7
8314515|NCT01462045|20499293|P2|STARTED|Overall Study||11
8314516|NCT01462045|20499294|P1|STARTED|Overall Study||11
8314517|NCT01461993|20499308|P3|NOT COMPLETED|Overall Study||64
8314518|NCT01461993|20499309|P2|NOT COMPLETED|Overall Study||157
8314519|NCT01461993|20499310|P1|NOT COMPLETED|Overall Study||151
8314520|NCT01461993|20499308|P3|COMPLETED|Overall Study||438
8314521|NCT01461993|20499309|P2|COMPLETED|Overall Study||841
8314522|NCT01461993|20499310|P1|COMPLETED|Overall Study||848
8314523|NCT01461993|20499308|P3|STARTED|Overall Study||502
8314524|NCT01461993|20499309|P2|STARTED|Overall Study||998
8314525|NCT01461993|20499310|P1|STARTED|Overall Study||999
8314526|NCT01461980|20499335|P3|NOT COMPLETED|Overall Study||165
8314527|NCT01461980|20499336|P2|NOT COMPLETED|Overall Study||145
8314528|NCT01461980|20499337|P1|NOT COMPLETED|Overall Study||166
8314529|NCT01461980|20499335|P3|COMPLETED|Overall Study||717
8314530|NCT01461980|20499336|P2|COMPLETED|Overall Study||733
8314531|NCT01461980|20499337|P1|COMPLETED|Overall Study||722
8314532|NCT01461980|20499335|P3|Vaccination 3|Overall Study||748
8314533|NCT01461980|20499336|P2|Vaccination 3|Overall Study||777
8314534|NCT01461980|20499337|P1|Vaccination 3|Overall Study||757
8314535|NCT01461980|20499335|P3|Vaccination 2|Overall Study||799
8314536|NCT01461980|20499336|P2|Vaccination 2|Overall Study||819
8314537|NCT01461980|20499337|P1|Vaccination 2|Overall Study||802
8314538|NCT01461980|20499335|P3|Vaccination 1|Overall Study||875
8314539|NCT01461980|20499336|P2|Vaccination 1|Overall Study||870
8314540|NCT01461980|20499337|P1|Vaccination 1|Overall Study||884
8314541|NCT01461980|20499335|P3|STARTED|Overall Study||882
8314542|NCT01461980|20499336|P2|STARTED|Overall Study||878
8314543|NCT01461980|20499337|P1|STARTED|Overall Study||888
8314544|NCT01461928|20499367|P3|NOT COMPLETED|Maintenance II (15 Months)||27
8314545|NCT01461928|20499368|P2|NOT COMPLETED|Maintenance II (15 Months)||23
8314546|NCT01461928|20499369|P1|NOT COMPLETED|Maintenance II (15 Months)||0
8314547|NCT01461928|20499367|P3|COMPLETED|Maintenance II (15 Months)||111
8314548|NCT01461928|20499368|P2|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
8314549|NCT01461928|20499369|P1|COMPLETED|Maintenance II (15 Months)||0
8314550|NCT01461928|20499367|P3|STARTED|Maintenance II (15 Months)||138
8314551|NCT01461928|20499368|P2|STARTED|Maintenance II (15 Months)||138
8314552|NCT01461928|20499369|P1|STARTED|Maintenance II (15 Months)||0
8314553|NCT01461928|20499367|P3|NOT COMPLETED|Maintenance I (24 Months)||0
8314554|NCT01461928|20499368|P2|NOT COMPLETED|Maintenance I (24 Months)||0
8314555|NCT01461928|20499369|P1|NOT COMPLETED|Maintenance I (24 Months)||218
8314556|NCT01461928|20499367|P3|COMPLETED|Maintenance I (24 Months)||0
8314557|NCT01461928|20499368|P2|COMPLETED|Maintenance I (24 Months)||0
8314558|NCT01461928|20499369|P1|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
8314559|NCT01461928|20499367|P3|STARTED|Maintenance I (24 Months)||0
8314560|NCT01461928|20499368|P2|STARTED|Maintenance I (24 Months)||0
8314561|NCT01461928|20499369|P1|STARTED|Maintenance I (24 Months)||494
8314562|NCT01461928|20499367|P3|NOT COMPLETED|Induction (up to 8 Months)||0
8314563|NCT01461928|20499368|P2|NOT COMPLETED|Induction (up to 8 Months)||0
8314564|NCT01461928|20499369|P1|NOT COMPLETED|Induction (up to 8 Months)||198
8314565|NCT01461928|20499367|P3|COMPLETED|Induction (up to 8 Months)||0
8314566|NCT01461928|20499368|P2|COMPLETED|Induction (up to 8 Months)||0
8314567|NCT01461928|20499369|P1|COMPLETED|Induction (up to 8 Months)||494
8314568|NCT01461928|20499367|P3|STARTED|Induction (up to 8 Months)||0
8314569|NCT01461928|20499368|P2|STARTED|Induction (up to 8 Months)||0
8314570|NCT01461928|20499369|P1|STARTED|Induction (up to 8 Months)||692
8314571|NCT01461863|20499390|P2|NOT COMPLETED|Overall Study||0
8314572|NCT01461863|20499391|P1|NOT COMPLETED|Overall Study||0
8314573|NCT01461863|20499390|P2|COMPLETED|Overall Study||48
8314574|NCT01461863|20499391|P1|COMPLETED|Overall Study||48
8314575|NCT01461863|20499390|P2|STARTED|Overall Study||48
8314576|NCT01461863|20499391|P1|STARTED|Overall Study||48
8314577|NCT01461824|20499402|P3|NOT COMPLETED|Overall Study||3
8314578|NCT01461824|20499403|P2|NOT COMPLETED|Overall Study||4
8314579|NCT01461824|20499404|P1|NOT COMPLETED|Overall Study||2
8314580|NCT01461824|20499402|P3|COMPLETED|Overall Study||8
8314581|NCT01461824|20499403|P2|COMPLETED|Overall Study||7
8314582|NCT01461824|20499404|P1|COMPLETED|Overall Study||10
8314583|NCT01461824|20499402|P3|STARTED|Overall Study||11
8314584|NCT01461824|20499403|P2|STARTED|Overall Study||11
8314585|NCT01461824|20499404|P1|STARTED|Overall Study||12
8314586|NCT01461811|20499420|P2|NOT COMPLETED|Overall Study||3
8314587|NCT01461811|20499421|P1|NOT COMPLETED|Overall Study||4
8314588|NCT01461811|20499420|P2|COMPLETED|Overall Study||46
8314589|NCT01461811|20499421|P1|COMPLETED|Overall Study||91
8314590|NCT01461811|20499420|P2|STARTED|Overall Study||49
8314591|NCT01461811|20499421|P1|STARTED|Overall Study||95
8314592|NCT01461733|20499451|P2|NOT COMPLETED|Overall Study||4
8314593|NCT01461733|20499452|P1|NOT COMPLETED|Overall Study||4
8314594|NCT01461733|20499451|P2|COMPLETED|Overall Study||8
8314595|NCT01461733|20499452|P1|COMPLETED|Overall Study||8
8314596|NCT01461733|20499451|P2|STARTED|Overall Study||12
8314597|NCT01461733|20499452|P1|STARTED|Overall Study||12
8314598|NCT01461707|20499460|P2|NOT COMPLETED|Overall Study||0
8314599|NCT01461707|20499461|P1|NOT COMPLETED|Overall Study||1
8314600|NCT01461707|20499460|P2|COMPLETED|Overall Study||15
8314601|NCT01461707|20499461|P1|COMPLETED|Overall Study||14
8314602|NCT01461707|20499460|P2|STARTED|Overall Study||15
8314603|NCT01461707|20499461|P1|STARTED|Overall Study||15
8314604|NCT01461668|20499471|P2|NOT COMPLETED|Overall Study||1
8314605|NCT01461668|20499472|P1|NOT COMPLETED|Overall Study||2
8314606|NCT01461668|20499471|P2|COMPLETED|Overall Study||25
8314607|NCT01461668|20499472|P1|COMPLETED|Overall Study||25
8314608|NCT01461668|20499471|P2|STARTED|Overall Study||26
8314609|NCT01461668|20499472|P1|STARTED|Overall Study||27
8314610|NCT01461655|20499478|P1|NOT COMPLETED|Overall Study||0
8314611|NCT01461655|20499478|P1|COMPLETED|Overall Study||40
8314612|NCT01461655|20499478|P1|STARTED|Overall Study||40
8314613|NCT01461551|20499498|P3|NOT COMPLETED|Overall Study||2
8314614|NCT01461551|20499499|P2|NOT COMPLETED|Overall Study||1
8314615|NCT01461551|20499500|P1|NOT COMPLETED|Overall Study||2
8314616|NCT01461551|20499498|P3|COMPLETED|Overall Study||33
8314617|NCT01461551|20499499|P2|COMPLETED|Overall Study||34
8314618|NCT01461551|20499500|P1|COMPLETED|Overall Study||33
8314619|NCT01461551|20499498|P3|STARTED|Overall Study||35
8314620|NCT01461551|20499499|P2|STARTED|Overall Study||35
8314621|NCT01461551|20499500|P1|STARTED|Overall Study||35
8314622|NCT01461538|20499511|P3|NOT COMPLETED|Overall Study||2
8314623|NCT01461538|20499512|P2|NOT COMPLETED|Overall Study||8
8314624|NCT01461538|20499513|P1|NOT COMPLETED|Overall Study||18
8314625|NCT01461538|20499511|P3|COMPLETED|Overall Study||7
8314626|NCT01461538|20499512|P2|COMPLETED|Overall Study||20
8314627|NCT01461538|20499513|P1|COMPLETED|Overall Study||28
8314628|NCT01461538|20499511|P3|STARTED|Overall Study||9
8314629|NCT01461538|20499512|P2|STARTED|Overall Study||28
8314630|NCT01461538|20499513|P1|STARTED|Overall Study||46
8314631|NCT01461499|20499551|P2|NOT COMPLETED|Overall Study||4
8314632|NCT01461499|20499552|P1|NOT COMPLETED|Overall Study||8
8314633|NCT01461499|20499551|P2|COMPLETED|Overall Study||114
8314634|NCT01461499|20499552|P1|COMPLETED|Overall Study||111
8314635|NCT01461499|20499551|P2|STARTED|Overall Study||118
8314636|NCT01461499|20499552|P1|STARTED|Overall Study||119
8314637|NCT01461473|20499562|P2|NOT COMPLETED|Overall Study||4
8314638|NCT01461473|20499563|P1|NOT COMPLETED|Overall Study||5
8314639|NCT01461473|20499562|P2|COMPLETED|Overall Study||55
8314640|NCT01461473|20499563|P1|COMPLETED|Overall Study||67
8314641|NCT01461473|20499562|P2|STARTED|Overall Study||59
8314642|NCT01461473|20499563|P1|STARTED|Overall Study||72
8314643|NCT01461369|20499582|P3|NOT COMPLETED|Overall Study||17
8314644|NCT01461369|20499583|P2|NOT COMPLETED|Overall Study||17
8314645|NCT01461369|20499584|P1|NOT COMPLETED|Overall Study||13
8314646|NCT01461369|20499582|P3|COMPLETED|Overall Study||86
8314647|NCT01461369|20499583|P2|COMPLETED|Overall Study||81
8314648|NCT01461369|20499584|P1|COMPLETED|Overall Study||91
8314649|NCT01461369|20499582|P3|STARTED|Overall Study||103
8314650|NCT01461369|20499583|P2|STARTED|Overall Study||98
8314651|NCT01461369|20499584|P1|STARTED|Overall Study||104
8314652|NCT01461096|20499609|P2|NOT COMPLETED|Overall Study||61
8314653|NCT01461096|20499610|P1|NOT COMPLETED|Overall Study||62
8314654|NCT01461096|20499609|P2|COMPLETED|Overall Study||226
8314655|NCT01461096|20499610|P1|COMPLETED|Overall Study||226
8314656|NCT01461096|20499609|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
8314657|NCT01461096|20499610|P1|Did Not Start Treatment|Overall Study||0
8314658|NCT01461096|20499609|P2|STARTED|Overall Study||287
8314659|NCT01461096|20499610|P1|STARTED|Overall Study||288
8314660|NCT01461057|20499626|P2|NOT COMPLETED|Overall Study||15
8314661|NCT01461057|20499627|P1|NOT COMPLETED|Overall Study||15
8314662|NCT01461057|20499626|P2|COMPLETED|Overall Study||0
8314663|NCT01461057|20499627|P1|COMPLETED|Overall Study||0
8314664|NCT01461057|20499626|P2|STARTED|Overall Study||15
8314665|NCT01461057|20499627|P1|STARTED|Overall Study||15
8314666|NCT01461044|20499637|P2|NOT COMPLETED|Overall Study||40
8314667|NCT01461044|20499638|P1|NOT COMPLETED|Overall Study||70
8314668|NCT01461044|20499637|P2|COMPLETED|Overall Study||37
8314669|NCT01461044|20499638|P1|COMPLETED|Overall Study||80
8314670|NCT01461044|20499637|P2|Participants Alive at Inclusion|Overall Study||58
8314671|NCT01461044|20499638|P1|Participants Alive at Inclusion|Overall Study||127
8314672|NCT01461044|20499637|P2|STARTED|Overall Study||77
8314673|NCT01461044|20499638|P1|STARTED|Overall Study||150
8314674|NCT01461005|20499711|P1|NOT COMPLETED|Overall Study||1
8314675|NCT01461005|20499711|P1|COMPLETED|Overall Study||0
8314676|NCT01461005|20499711|P1|STARTED|Overall Study||1
8314677|NCT01460940|20499720|P1|NOT COMPLETED|Overall Study||0
8314678|NCT01460940|20499720|P1|COMPLETED|Overall Study||24
8314679|NCT01460940|20499720|P1|STARTED|Overall Study||24
8314680|NCT01460927|20499726|P1|NOT COMPLETED|Overall Study||0
8314681|NCT01460927|20499726|P1|COMPLETED|Overall Study||25
8314682|NCT01460927|20499726|P1|STARTED|Overall Study||25
8314683|NCT01460901|20499734|P1|NOT COMPLETED|Overall Study||2
8314684|NCT01460901|20499734|P1|COMPLETED|Overall Study|Follow-up completed|3
8314685|NCT01460901|20499734|P1|tV-CTL Infusion|Overall Study||3
8314686|NCT01460901|20499734|P1|STARTED|Overall Study|First enrollment|5
8314687|NCT01460875|20499742|P1|NOT COMPLETED|Overall Study||0
8314688|NCT01460875|20499742|P1|COMPLETED|Overall Study||34
8314689|NCT01460875|20499742|P1|STARTED|Overall Study||34
8314690|NCT01460732|20499753|P1|NOT COMPLETED|Overall Study||0
8314691|NCT01460732|20499753|P1|COMPLETED|Overall Study||81
8314692|NCT01460732|20499753|P1|STARTED|Overall Study||81
8314693|NCT01460719|20499766|P1|NOT COMPLETED|Overall Study||2
8314694|NCT01460719|20499766|P1|COMPLETED|Overall Study||78
8314695|NCT01460719|20499766|P1|Vaccination 4 (~Day 90)|Overall Study||78
8314696|NCT01460719|20499766|P1|Vaccination 3 (~Day 60)|Overall Study||78
8314697|NCT01460719|20499766|P1|Vaccination 2 (~Day 30)|Overall Study||78
8314698|NCT01460719|20499766|P1|Vaccination 1 (Day 1)|Overall Study||80
8314699|NCT01460719|20499766|P1|STARTED|Overall Study||80
8314700|NCT01460628|20499776|P1|NOT COMPLETED|Overall Study||5
8314701|NCT01460628|20499776|P1|COMPLETED|Overall Study||20
8314702|NCT01460628|20499776|P1|STARTED|Overall Study||25
8314703|NCT01460446|20499788|P2|NOT COMPLETED|Overall Study||20
8314704|NCT01460446|20499789|P1|NOT COMPLETED|Overall Study||5
8314705|NCT01460446|20499788|P2|COMPLETED|Overall Study||93
8314706|NCT01460446|20499789|P1|COMPLETED|Overall Study||100
8314707|NCT01460446|20499788|P2|STARTED|Overall Study||113
8314708|NCT01460446|20499789|P1|STARTED|Overall Study||105
8314709|NCT01460407|20499816|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
8314710|NCT01460407|20499817|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
8314711|NCT01460407|20499816|P2|COMPLETED|Period 2: Day 6 to Day 14||13
8314712|NCT01460407|20499817|P1|COMPLETED|Period 2: Day 6 to Day 14||0
8314713|NCT01460407|20499816|P2|STARTED|Period 2: Day 6 to Day 14||14
8314714|NCT01460407|20499817|P1|STARTED|Period 2: Day 6 to Day 14||0
8314715|NCT01460407|20499816|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
8314716|NCT01460407|20499817|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
8314717|NCT01460407|20499816|P2|COMPLETED|Period 1: Day 1 to Day 5||0
8314718|NCT01460407|20499817|P1|COMPLETED|Period 1: Day 1 to Day 5||14
8314719|NCT01460407|20499816|P2|STARTED|Period 1: Day 1 to Day 5||0
8314720|NCT01460407|20499817|P1|STARTED|Period 1: Day 1 to Day 5||14
8314721|NCT01460381|20499830|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
8314722|NCT01460381|20499831|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
8314723|NCT01460381|20499830|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
8314724|NCT01460381|20499831|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
8314725|NCT01460381|20499830|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
8314726|NCT01460381|20499831|P1|STARTED|Period 2 (Days 8-15)||7
8314727|NCT01460381|20499830|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
8314728|NCT01460381|20499831|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
8314729|NCT01460381|20499830|P2|COMPLETED|Period 1 (Days 1-7)||11
8314730|NCT01460381|20499831|P1|COMPLETED|Period 1 (Days 1-7)||7
8314731|NCT01460381|20499830|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
8314732|NCT01460381|20499831|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
8314733|NCT01460381|20499830|P2|STARTED|Period 1 (Days 1-7)||11
8314734|NCT01460381|20499831|P1|STARTED|Period 1 (Days 1-7)||7
8314735|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314736|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8314737|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314738|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8314739|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8314740|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314741|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314742|NCT01460368|20499847|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
8314743|NCT01460368|20499848|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
8314744|NCT01460368|20499849|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
8314745|NCT01460368|20499850|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
8314746|NCT01460368|20499851|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
8314747|NCT01460368|20499852|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
8314748|NCT01460368|20499853|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
8314749|NCT01460368|20499847|P7|STARTED|Part B: Third Interventions (Period 3)||9
8314750|NCT01460368|20499848|P6|STARTED|Part B: Third Interventions (Period 3)||10
8314751|NCT01460368|20499849|P5|STARTED|Part B: Third Interventions (Period 3)||9
8314752|NCT01460368|20499850|P4|STARTED|Part B: Third Interventions (Period 3)||10
8314753|NCT01460368|20499851|P3|STARTED|Part B: Third Interventions (Period 3)||9
8314754|NCT01460368|20499852|P2|STARTED|Part B: Third Interventions (Period 3)||8
8314755|NCT01460368|20499853|P1|STARTED|Part B: Third Interventions (Period 3)||0
8314756|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314757|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314758|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314759|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314760|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
8314761|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314762|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314763|NCT01460368|20499847|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
8314764|NCT01460368|20499848|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
8314765|NCT01460368|20499849|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
8314766|NCT01460368|20499850|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
8314767|NCT01460368|20499851|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
8314768|NCT01460368|20499852|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
8314769|NCT01460368|20499853|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
8314770|NCT01460368|20499847|P7|STARTED|Part B: Washout (up to 15 Days)||9
8314771|NCT01460368|20499848|P6|STARTED|Part B: Washout (up to 15 Days)||10
8314772|NCT01460368|20499849|P5|STARTED|Part B: Washout (up to 15 Days)||9
8314773|NCT01460368|20499850|P4|STARTED|Part B: Washout (up to 15 Days)||10
8314774|NCT01460368|20499851|P3|STARTED|Part B: Washout (up to 15 Days)||10
8314775|NCT01460368|20499852|P2|STARTED|Part B: Washout (up to 15 Days)||8
8314776|NCT01460368|20499853|P1|STARTED|Part B: Washout (up to 15 Days)||0
8314777|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
8314778|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314779|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314780|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314781|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314782|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
8314783|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314784|NCT01460368|20499847|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
8314785|NCT01460368|20499848|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
8314786|NCT01460368|20499849|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
8314787|NCT01460368|20499850|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
8314788|NCT01460368|20499851|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
8314789|NCT01460368|20499852|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
8314790|NCT01460368|20499853|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
8314791|NCT01460368|20499847|P7|STARTED|Part B: Second Intervention (Period 2)||10
8314792|NCT01460368|20499848|P6|STARTED|Part B: Second Intervention (Period 2)||10
8314793|NCT01460368|20499849|P5|STARTED|Part B: Second Intervention (Period 2)||9
8314794|NCT01460368|20499850|P4|STARTED|Part B: Second Intervention (Period 2)||10
8314795|NCT01460368|20499851|P3|STARTED|Part B: Second Intervention (Period 2)||10
8314796|NCT01460368|20499852|P2|STARTED|Part B: Second Intervention (Period 2)||10
8314797|NCT01460368|20499853|P1|STARTED|Part B: Second Intervention (Period 2)||0
8314798|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314799|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314800|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314801|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314802|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314803|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314804|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314805|NCT01460368|20499847|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
8314806|NCT01460368|20499848|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
8314807|NCT01460368|20499849|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
8314808|NCT01460368|20499850|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
8314809|NCT01460368|20499851|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
8314810|NCT01460368|20499852|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
8314811|NCT01460368|20499853|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
8314812|NCT01460368|20499847|P7|STARTED|Part B: Washout (up to 15 Days)||10
8314813|NCT01460368|20499848|P6|STARTED|Part B: Washout (up to 15 Days)||10
8314814|NCT01460368|20499849|P5|STARTED|Part B: Washout (up to 15 Days)||9
8314815|NCT01460368|20499850|P4|STARTED|Part B: Washout (up to 15 Days)||10
8314816|NCT01460368|20499851|P3|STARTED|Part B: Washout (up to 15 Days)||10
8314817|NCT01460368|20499852|P2|STARTED|Part B: Washout (up to 15 Days)||10
8314818|NCT01460368|20499853|P1|STARTED|Part B: Washout (up to 15 Days)||0
8314819|NCT01460368|20499847|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314820|NCT01460368|20499848|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314821|NCT01460368|20499849|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
8314822|NCT01460368|20499850|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314823|NCT01460368|20499851|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314824|NCT01460368|20499852|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314825|NCT01460368|20499853|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314826|NCT01460368|20499847|P7|COMPLETED|Part B: First Intervention (Period 1)||10
8314827|NCT01460368|20499848|P6|COMPLETED|Part B: First Intervention (Period 1)||10
8314828|NCT01460368|20499849|P5|COMPLETED|Part B: First Intervention (Period 1)||9
8314829|NCT01460368|20499850|P4|COMPLETED|Part B: First Intervention (Period 1)||10
8314830|NCT01460368|20499851|P3|COMPLETED|Part B: First Intervention (Period 1)||10
8314831|NCT01460368|20499852|P2|COMPLETED|Part B: First Intervention (Period 1)||10
8314832|NCT01460368|20499853|P1|COMPLETED|Part B: First Intervention (Period 1)||0
8314833|NCT01460368|20499847|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314834|NCT01460368|20499848|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314835|NCT01460368|20499849|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314836|NCT01460368|20499850|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314837|NCT01460368|20499851|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314838|NCT01460368|20499852|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314839|NCT01460368|20499853|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
8314840|NCT01460368|20499847|P7|STARTED|Part B: First Intervention (Period 1)||10
8314841|NCT01460368|20499848|P6|STARTED|Part B: First Intervention (Period 1)||10
8314842|NCT01460368|20499849|P5|STARTED|Part B: First Intervention (Period 1)||10
8314843|NCT01460368|20499850|P4|STARTED|Part B: First Intervention (Period 1)||10
8314844|NCT01460368|20499851|P3|STARTED|Part B: First Intervention (Period 1)||10
8314845|NCT01460368|20499852|P2|STARTED|Part B: First Intervention (Period 1)||10
8314846|NCT01460368|20499853|P1|STARTED|Part B: First Intervention (Period 1)||0
8314847|NCT01460368|20499847|P7|NOT COMPLETED|Part A||0
8314848|NCT01460368|20499848|P6|NOT COMPLETED|Part A||0
8314849|NCT01460368|20499849|P5|NOT COMPLETED|Part A||0
8314850|NCT01460368|20499850|P4|NOT COMPLETED|Part A||0
8314851|NCT01460368|20499851|P3|NOT COMPLETED|Part A||0
8314852|NCT01460368|20499852|P2|NOT COMPLETED|Part A||0
8314853|NCT01460368|20499853|P1|NOT COMPLETED|Part A||0
8314854|NCT01460368|20499847|P7|COMPLETED|Part A||0
8314855|NCT01460368|20499848|P6|COMPLETED|Part A||0
8314856|NCT01460368|20499849|P5|COMPLETED|Part A||0
8314857|NCT01460368|20499850|P4|COMPLETED|Part A||0
8314858|NCT01460368|20499851|P3|COMPLETED|Part A||0
8314859|NCT01460368|20499852|P2|COMPLETED|Part A||0
8314860|NCT01460368|20499853|P1|COMPLETED|Part A||7
8314861|NCT01460368|20499847|P7|Received at Least One Dose of Study Drug|Part A||0
8314862|NCT01460368|20499848|P6|Received at Least One Dose of Study Drug|Part A||0
8314863|NCT01460368|20499849|P5|Received at Least One Dose of Study Drug|Part A||0
8314864|NCT01460368|20499850|P4|Received at Least One Dose of Study Drug|Part A||0
8314865|NCT01460368|20499851|P3|Received at Least One Dose of Study Drug|Part A||0
8314866|NCT01460368|20499852|P2|Received at Least One Dose of Study Drug|Part A||0
8314867|NCT01460368|20499853|P1|Received at Least One Dose of Study Drug|Part A||7
8314868|NCT01460368|20499847|P7|STARTED|Part A||0
8314869|NCT01460368|20499848|P6|STARTED|Part A||0
8314870|NCT01460368|20499849|P5|STARTED|Part A||0
8314871|NCT01460368|20499850|P4|STARTED|Part A||0
8314872|NCT01460368|20499851|P3|STARTED|Part A||0
8314873|NCT01460368|20499852|P2|STARTED|Part A||0
8314874|NCT01460368|20499853|P1|STARTED|Part A||7
8314875|NCT01460342|20499865|P2|NOT COMPLETED|Overall Study||14
8314876|NCT01460342|20499866|P1|NOT COMPLETED|Overall Study||11
8314877|NCT01460342|20499865|P2|COMPLETED|Overall Study||292
8314878|NCT01460342|20499866|P1|COMPLETED|Overall Study||293
8314879|NCT01460342|20499865|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
8314880|NCT01460342|20499866|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
8314881|NCT01460342|20499865|P2|STARTED|Overall Study||306
8314882|NCT01460342|20499866|P1|STARTED|Overall Study||304
8314883|NCT01460303|20499888|P2|NOT COMPLETED|Overall Study||0
8314884|NCT01460303|20499889|P1|NOT COMPLETED|Overall Study||0
8314885|NCT01460303|20499888|P2|COMPLETED|Overall Study||24
8314886|NCT01460303|20499889|P1|COMPLETED|Overall Study||25
8314887|NCT01460303|20499888|P2|STARTED|Overall Study||24
8314888|NCT01460303|20499889|P1|STARTED|Overall Study||25
8314889|NCT01460290|20499897|P1|NOT COMPLETED|Overall Study||4
8314890|NCT01460290|20499897|P1|COMPLETED|Overall Study||11
8314891|NCT01460290|20499897|P1|STARTED|Overall Study||15
8314892|NCT01460225|20499917|P1|NOT COMPLETED|Overall Study||0
8314893|NCT01460225|20499917|P1|COMPLETED|Overall Study|November 2010|19
8314894|NCT01460225|20499917|P1|STARTED|Overall Study|January 2009.|19
8314895|NCT01460160|20499924|P2|NOT COMPLETED|Follow-up||2
8314896|NCT01460160|20499925|P1|NOT COMPLETED|Follow-up||11
8314897|NCT01460160|20499924|P2|COMPLETED|Follow-up||20
8314898|NCT01460160|20499925|P1|COMPLETED|Follow-up||67
8314899|NCT01460160|20499924|P2|STARTED|Follow-up||22
8314900|NCT01460160|20499925|P1|STARTED|Follow-up||78
8314901|NCT01460160|20499924|P2|NOT COMPLETED|Treatment||5
8314902|NCT01460160|20499925|P1|NOT COMPLETED|Treatment||23
8314903|NCT01460160|20499924|P2|COMPLETED|Treatment||19
8314904|NCT01460160|20499925|P1|COMPLETED|Treatment||59
8314905|NCT01460160|20499924|P2|STARTED|Treatment||24
8314906|NCT01460160|20499925|P1|STARTED|Treatment||82
8314907|NCT01459913|20499966|P4|NOT COMPLETED|Overall Study||33
8314908|NCT01459913|20499967|P3|NOT COMPLETED|Overall Study||13
8314909|NCT01459913|20499968|P2|NOT COMPLETED|Overall Study||20
8314910|NCT01459913|20499969|P1|NOT COMPLETED|Overall Study||41
8314911|NCT01459913|20499966|P4|COMPLETED|Overall Study||29
8314912|NCT01459913|20499967|P3|COMPLETED|Overall Study||6
8314913|NCT01459913|20499968|P2|COMPLETED|Overall Study||32
8314914|NCT01459913|20499969|P1|COMPLETED|Overall Study||65
8314915|NCT01459913|20499966|P4|STARTED|Overall Study||62
8314916|NCT01459913|20499967|P3|STARTED|Overall Study||19
8314917|NCT01459913|20499968|P2|STARTED|Overall Study||52
8314918|NCT01459913|20499969|P1|STARTED|Overall Study||106
8314919|NCT01459796|20500000|P2|NOT COMPLETED|Overall Study||126
8314920|NCT01459796|20500001|P1|NOT COMPLETED|Overall Study||94
8314921|NCT01459796|20500000|P2|COMPLETED|Overall Study||0
8314922|NCT01459796|20500001|P1|COMPLETED|Overall Study||0
8314923|NCT01459796|20500000|P2|STARTED|Overall Study||126
8314924|NCT01459796|20500001|P1|STARTED|Overall Study||94
8314925|NCT01459783|20500019|P2|NOT COMPLETED|6 Months to 12 Months||30
8314926|NCT01459783|20500020|P1|NOT COMPLETED|6 Months to 12 Months||19
8314927|NCT01459783|20500019|P2|COMPLETED|6 Months to 12 Months||23
8314928|NCT01459783|20500020|P1|COMPLETED|6 Months to 12 Months||20
8314929|NCT01459783|20500019|P2|STARTED|6 Months to 12 Months||53
8314930|NCT01459783|20500020|P1|STARTED|6 Months to 12 Months||39
8314931|NCT01459783|20500019|P2|NOT COMPLETED|Baseline to 6 Months||20
8314932|NCT01459783|20500020|P1|NOT COMPLETED|Baseline to 6 Months||32
8314933|NCT01459783|20500019|P2|COMPLETED|Baseline to 6 Months||53
8314934|NCT01459783|20500020|P1|COMPLETED|Baseline to 6 Months||39
8314935|NCT01459783|20500019|P2|STARTED|Baseline to 6 Months||73
8314936|NCT01459783|20500020|P1|STARTED|Baseline to 6 Months||71
8314937|NCT01459718|20500028|P1|NOT COMPLETED|Overall Study||3
8314938|NCT01459718|20500028|P1|COMPLETED|Overall Study||10
8314939|NCT01459718|20500028|P1|Safety Analysis Set|Overall Study||13
8314940|NCT01459718|20500028|P1|STARTED|Overall Study||13
8314941|NCT01459705|20500042|P3|NOT COMPLETED|Overall Study||7
8314942|NCT01459705|20500043|P2|NOT COMPLETED|Overall Study||24
8314943|NCT01459705|20500044|P1|NOT COMPLETED|Overall Study||22
8314944|NCT01459705|20500042|P3|COMPLETED|Overall Study||47
8314945|NCT01459705|20500043|P2|COMPLETED|Overall Study||30
8314946|NCT01459705|20500044|P1|COMPLETED|Overall Study||32
8314947|NCT01459705|20500042|P3|STARTED|Overall Study||54
8314948|NCT01459705|20500043|P2|STARTED|Overall Study||54
8314949|NCT01459705|20500044|P1|STARTED|Overall Study||54
8314950|NCT01459653|20500062|P1|NOT COMPLETED|Overall Study||668
8314951|NCT01459653|20500062|P1|COMPLETED|Overall Study||828
8314952|NCT01459653|20500062|P1|STARTED|Overall Study||1496
8314953|NCT01459614|20500210|P2|NOT COMPLETED|Overall Study||0
8314954|NCT01459614|20500211|P1|NOT COMPLETED|Overall Study||1
8314955|NCT01459614|20500210|P2|COMPLETED|Overall Study||10
8314956|NCT01459614|20500211|P1|COMPLETED|Overall Study||28
8314957|NCT01459614|20500210|P2|STARTED|Overall Study||10
8314958|NCT01459614|20500211|P1|STARTED|Overall Study||29
8314959|NCT01459588|20500227|P4|NOT COMPLETED|Overall Study||1
8314960|NCT01459588|20500228|P3|NOT COMPLETED|Overall Study||1
8314961|NCT01459588|20500229|P2|NOT COMPLETED|Overall Study||2
8314962|NCT01459588|20500230|P1|NOT COMPLETED|Overall Study||1
8314963|NCT01459588|20500227|P4|COMPLETED|Overall Study||55
8314964|NCT01459588|20500228|P3|COMPLETED|Overall Study||102
8314965|NCT01459588|20500229|P2|COMPLETED|Overall Study||49
8314966|NCT01459588|20500230|P1|COMPLETED|Overall Study||104
8314967|NCT01459588|20500227|P4|STARTED|Overall Study||56
8314968|NCT01459588|20500228|P3|STARTED|Overall Study||103
8314969|NCT01459588|20500229|P2|STARTED|Overall Study||51
8314970|NCT01459588|20500230|P1|STARTED|Overall Study||105
8314971|NCT01459068|20500258|P2|NOT COMPLETED|Overall Study||34
8314972|NCT01459068|20500259|P1|NOT COMPLETED|Overall Study||39
8314973|NCT01459068|20500258|P2|COMPLETED|Overall Study||148
8314974|NCT01459068|20500259|P1|COMPLETED|Overall Study||126
8314975|NCT01459068|20500258|P2|STARTED|Overall Study||182
8314976|NCT01459068|20500259|P1|STARTED|Overall Study||165
8314977|NCT01459016|20500275|P1|NOT COMPLETED|Overall Study||15
8314978|NCT01459016|20500275|P1|COMPLETED|Overall Study||41
8314979|NCT01459016|20500275|P1|STARTED|Overall Study||56
8314980|NCT01458990|20500291|P2|NOT COMPLETED|Overall Study||0
8314981|NCT01458990|20500292|P1|NOT COMPLETED|Overall Study||0
8314982|NCT01458990|20500291|P2|COMPLETED|Overall Study||15
8314983|NCT01458990|20500292|P1|COMPLETED|Overall Study||45
8314984|NCT01458990|20500291|P2|STARTED|Overall Study||15
8314985|NCT01458990|20500292|P1|STARTED|Overall Study||45
8314986|NCT01458951|20500303|P3|NOT COMPLETED|Overall Study||15
8314987|NCT01458951|20500304|P2|NOT COMPLETED|Overall Study||1
8314988|NCT01458951|20500305|P1|NOT COMPLETED|Overall Study||32
8314989|NCT01458951|20500303|P3|COMPLETED|Overall Study||97
8314990|NCT01458951|20500304|P2|COMPLETED|Overall Study||5
8314991|NCT01458951|20500305|P1|COMPLETED|Overall Study||397
8314992|NCT01458951|20500303|P3|STARTED|Overall Study||112
8314993|NCT01458951|20500304|P2|STARTED|Overall Study||6
8314994|NCT01458951|20500305|P1|STARTED|Overall Study||429
8314995|NCT01458639|20500330|P1|NOT COMPLETED|Overall Study||6
8314996|NCT01458639|20500330|P1|COMPLETED|Overall Study||12
8314997|NCT01458639|20500330|P1|STARTED|Overall Study||18
8314998|NCT01458587|20500342|P2|NOT COMPLETED|Overall Study||0
8314999|NCT01458587|20500343|P1|NOT COMPLETED|Overall Study||1
8315000|NCT01458587|20500342|P2|COMPLETED|Overall Study||35
8315001|NCT01458587|20500343|P1|COMPLETED|Overall Study||34
8315002|NCT01458587|20500342|P2|STARTED|Overall Study||35
8315003|NCT01458587|20500343|P1|STARTED|Overall Study||35
8315004|NCT01458574|20500506|P3|NOT COMPLETED|Overall Study||145
8315005|NCT01458574|20500507|P2|NOT COMPLETED|Overall Study||71
8315006|NCT01458574|20500508|P1|NOT COMPLETED|Overall Study||87
8315007|NCT01458574|20500506|P3|COMPLETED|Overall Study||53
8315008|NCT01458574|20500507|P2|COMPLETED|Overall Study||126
8315009|NCT01458574|20500508|P1|COMPLETED|Overall Study||111
8315010|NCT01458574|20500506|P3|Treated|Overall Study||198
8315011|NCT01458574|20500507|P2|Treated|Overall Study||196
8315012|NCT01458574|20500508|P1|Treated|Overall Study||198
8315013|NCT01458574|20500506|P3|STARTED|Overall Study||198
8315014|NCT01458574|20500507|P2|STARTED|Overall Study||197
8315015|NCT01458574|20500508|P1|STARTED|Overall Study||198
8315016|NCT01458561|20500593|P2|NOT COMPLETED|Overall Study||0
8315017|NCT01458561|20500594|P1|NOT COMPLETED|Overall Study||0
8315018|NCT01458561|20500593|P2|COMPLETED|Overall Study||1
8315019|NCT01458561|20500594|P1|COMPLETED|Overall Study||0
8315020|NCT01458561|20500593|P2|STARTED|Overall Study||1
8315021|NCT01458561|20500594|P1|STARTED|Overall Study||0
8315022|NCT01458535|20500638|P6|NOT COMPLETED|Overall Study||4
8315023|NCT01458535|20500639|P5|NOT COMPLETED|Overall Study||4
8315024|NCT01458535|20500640|P4|NOT COMPLETED|Overall Study||4
8315025|NCT01458535|20500641|P3|NOT COMPLETED|Overall Study||2
8315026|NCT01458535|20500642|P2|NOT COMPLETED|Overall Study||2
8315027|NCT01458535|20500643|P1|NOT COMPLETED|Overall Study||0
8315028|NCT01458535|20500638|P6|COMPLETED|Overall Study||7
8315029|NCT01458535|20500639|P5|COMPLETED|Overall Study||6
8315030|NCT01458535|20500640|P4|COMPLETED|Overall Study||6
8315031|NCT01458535|20500641|P3|COMPLETED|Overall Study||8
8315032|NCT01458535|20500642|P2|COMPLETED|Overall Study||8
8315033|NCT01458535|20500643|P1|COMPLETED|Overall Study||10
8315034|NCT01458535|20500638|P6|STARTED|Overall Study||11
8315035|NCT01458535|20500639|P5|STARTED|Overall Study||10
8315036|NCT01458535|20500640|P4|STARTED|Overall Study||10
8315037|NCT01458535|20500641|P3|STARTED|Overall Study||10
8315038|NCT01458535|20500642|P2|STARTED|Overall Study||10
8315039|NCT01458535|20500643|P1|STARTED|Overall Study||10
8315040|NCT01458522|20500695|P2|NOT COMPLETED|Overall Study||11
8315041|NCT01458522|20500696|P1|NOT COMPLETED|Overall Study||3
8315042|NCT01458522|20500695|P2|COMPLETED|Overall Study||26
8315043|NCT01458522|20500696|P1|COMPLETED|Overall Study||34
8315044|NCT01458522|20500695|P2|Crossover to Second Drug|Overall Study||10
8315045|NCT01458522|20500696|P1|Crossover to Second Drug|Overall Study||15
8315046|NCT01458522|20500695|P2|Received First Drug|Overall Study||35
8315047|NCT01458522|20500696|P1|Received First Drug|Overall Study||35
8315048|NCT01458522|20500695|P2|STARTED|Overall Study||37
8315049|NCT01458522|20500696|P1|STARTED|Overall Study||37
8315050|NCT01458418|20500726|P4|NOT COMPLETED|Overall Study||0
8315051|NCT01458418|20500727|P3|NOT COMPLETED|Overall Study||0
8315052|NCT01458418|20500728|P2|NOT COMPLETED|Overall Study||0
8315053|NCT01458418|20500729|P1|NOT COMPLETED|Overall Study||0
8315054|NCT01458418|20500726|P4|COMPLETED|Overall Study||4
8315055|NCT01458418|20500727|P3|COMPLETED|Overall Study||0
8315056|NCT01458418|20500728|P2|COMPLETED|Overall Study||0
8315057|NCT01458418|20500729|P1|COMPLETED|Overall Study||0
8315058|NCT01458418|20500726|P4|STARTED|Overall Study||4
8315059|NCT01458418|20500727|P3|STARTED|Overall Study||0
8315060|NCT01458418|20500728|P2|STARTED|Overall Study||0
8315061|NCT01458418|20500729|P1|STARTED|Overall Study||0
8315062|NCT01458392|20500742|P3|NOT COMPLETED|Overall Study||31
8315063|NCT01458392|20500743|P2|NOT COMPLETED|Overall Study||13
8315064|NCT01458392|20500744|P1|NOT COMPLETED|Overall Study||2
8315065|NCT01458392|20500742|P3|COMPLETED|Overall Study||0
8315066|NCT01458392|20500743|P2|COMPLETED|Overall Study||0
8315067|NCT01458392|20500744|P1|COMPLETED|Overall Study||0
8315068|NCT01458392|20500742|P3|STARTED|Overall Study||31
8315069|NCT01458392|20500743|P2|STARTED|Overall Study||13
8315070|NCT01458392|20500744|P1|STARTED|Overall Study||2
8315071|NCT01458366|20500769|P5|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
8315072|NCT01458366|20500770|P4|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315073|NCT01458366|20500771|P3|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315074|NCT01458366|20500772|P2|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315075|NCT01458366|20500773|P1|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315076|NCT01458366|20500769|P5|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
8315077|NCT01458366|20500770|P4|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315078|NCT01458366|20500771|P3|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315079|NCT01458366|20500772|P2|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315080|NCT01458366|20500773|P1|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8315081|NCT01458366|20500769|P5|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
8315082|NCT01458366|20500770|P4|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8315083|NCT01458366|20500771|P3|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8315084|NCT01458366|20500772|P2|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8315085|NCT01458366|20500773|P1|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8315086|NCT01458366|20500769|P5|NOT COMPLETED|Period 4: 120mg/m^2||0
8315087|NCT01458366|20500770|P4|NOT COMPLETED|Period 4: 120mg/m^2||0
8315088|NCT01458366|20500771|P3|NOT COMPLETED|Period 4: 120mg/m^2||0
8315089|NCT01458366|20500772|P2|NOT COMPLETED|Period 4: 120mg/m^2||0
8315090|NCT01458366|20500773|P1|NOT COMPLETED|Period 4: 120mg/m^2||0
8315091|NCT01458366|20500769|P5|COMPLETED|Period 4: 120mg/m^2||0
8315092|NCT01458366|20500770|P4|COMPLETED|Period 4: 120mg/m^2||3
8315093|NCT01458366|20500771|P3|COMPLETED|Period 4: 120mg/m^2||0
8315094|NCT01458366|20500772|P2|COMPLETED|Period 4: 120mg/m^2||0
8315095|NCT01458366|20500773|P1|COMPLETED|Period 4: 120mg/m^2||0
8315096|NCT01458366|20500769|P5|STARTED|Period 4: 120mg/m^2||0
8315097|NCT01458366|20500770|P4|STARTED|Period 4: 120mg/m^2||3
8315098|NCT01458366|20500771|P3|STARTED|Period 4: 120mg/m^2||0
8315099|NCT01458366|20500772|P2|STARTED|Period 4: 120mg/m^2||0
8315100|NCT01458366|20500773|P1|STARTED|Period 4: 120mg/m^2||0
8315101|NCT01458366|20500769|P5|NOT COMPLETED|Period 3: 90mg/m^2||0
8315102|NCT01458366|20500770|P4|NOT COMPLETED|Period 3: 90mg/m^2||0
8315103|NCT01458366|20500771|P3|NOT COMPLETED|Period 3: 90mg/m^2||0
8315104|NCT01458366|20500772|P2|NOT COMPLETED|Period 3: 90mg/m^2||0
8315105|NCT01458366|20500773|P1|NOT COMPLETED|Period 3: 90mg/m^2||0
8315106|NCT01458366|20500769|P5|COMPLETED|Period 3: 90mg/m^2||0
8315107|NCT01458366|20500770|P4|COMPLETED|Period 3: 90mg/m^2||0
8315108|NCT01458366|20500771|P3|COMPLETED|Period 3: 90mg/m^2||3
8315109|NCT01458366|20500772|P2|COMPLETED|Period 3: 90mg/m^2||0
8315110|NCT01458366|20500773|P1|COMPLETED|Period 3: 90mg/m^2||0
8315111|NCT01458366|20500769|P5|STARTED|Period 3: 90mg/m^2||0
8315112|NCT01458366|20500770|P4|STARTED|Period 3: 90mg/m^2||0
8315113|NCT01458366|20500771|P3|STARTED|Period 3: 90mg/m^2||3
8315114|NCT01458366|20500772|P2|STARTED|Period 3: 90mg/m^2||0
8315115|NCT01458366|20500773|P1|STARTED|Period 3: 90mg/m^2||0
8315116|NCT01458366|20500769|P5|NOT COMPLETED|Period 2: 50mg/m^2||0
8315117|NCT01458366|20500770|P4|NOT COMPLETED|Period 2: 50mg/m^2||0
8315118|NCT01458366|20500771|P3|NOT COMPLETED|Period 2: 50mg/m^2||0
8315119|NCT01458366|20500772|P2|NOT COMPLETED|Period 2: 50mg/m^2||0
8315120|NCT01458366|20500773|P1|NOT COMPLETED|Period 2: 50mg/m^2||0
8315121|NCT01458366|20500769|P5|COMPLETED|Period 2: 50mg/m^2||0
8315122|NCT01458366|20500770|P4|COMPLETED|Period 2: 50mg/m^2||0
8315123|NCT01458366|20500771|P3|COMPLETED|Period 2: 50mg/m^2||0
8315124|NCT01458366|20500772|P2|COMPLETED|Period 2: 50mg/m^2||0
8315125|NCT01458366|20500773|P1|COMPLETED|Period 2: 50mg/m^2||0
8315126|NCT01458366|20500769|P5|STARTED|Period 2: 50mg/m^2||0
8315127|NCT01458366|20500770|P4|STARTED|Period 2: 50mg/m^2||0
8315128|NCT01458366|20500771|P3|STARTED|Period 2: 50mg/m^2||0
8315129|NCT01458366|20500772|P2|STARTED|Period 2: 50mg/m^2||0
8315130|NCT01458366|20500773|P1|STARTED|Period 2: 50mg/m^2||0
8315131|NCT01458366|20500769|P5|NOT COMPLETED|Period 1: 70mg/m^2||0
8315132|NCT01458366|20500770|P4|NOT COMPLETED|Period 1: 70mg/m^2||0
8315133|NCT01458366|20500771|P3|NOT COMPLETED|Period 1: 70mg/m^2||0
8315134|NCT01458366|20500772|P2|NOT COMPLETED|Period 1: 70mg/m^2||0
8315135|NCT01458366|20500773|P1|NOT COMPLETED|Period 1: 70mg/m^2||2
8315136|NCT01458366|20500769|P5|COMPLETED|Period 1: 70mg/m^2||0
8315137|NCT01458366|20500770|P4|COMPLETED|Period 1: 70mg/m^2||0
8315138|NCT01458366|20500771|P3|COMPLETED|Period 1: 70mg/m^2||0
8315139|NCT01458366|20500772|P2|COMPLETED|Period 1: 70mg/m^2||0
8315140|NCT01458366|20500773|P1|COMPLETED|Period 1: 70mg/m^2||3
8315141|NCT01458366|20500769|P5|STARTED|Period 1: 70mg/m^2||0
8315142|NCT01458366|20500770|P4|STARTED|Period 1: 70mg/m^2||0
8315143|NCT01458366|20500771|P3|STARTED|Period 1: 70mg/m^2||0
8315144|NCT01458366|20500772|P2|STARTED|Period 1: 70mg/m^2||0
8315145|NCT01458366|20500773|P1|STARTED|Period 1: 70mg/m^2||5
8315146|NCT01458288|20500788|P1|NOT COMPLETED|Overall Study||0
8315147|NCT01458288|20500788|P1|COMPLETED|Overall Study||12
8315148|NCT01458288|20500788|P1|STARTED|Overall Study||12
8315149|NCT01458275|20500800|P3|NOT COMPLETED|Overall Study||9
8315150|NCT01458275|20500801|P2|NOT COMPLETED|Overall Study||13
8315151|NCT01458275|20500802|P1|NOT COMPLETED|Overall Study||14
8315152|NCT01458275|20500800|P3|COMPLETED|Overall Study||273
8315153|NCT01458275|20500801|P2|COMPLETED|Overall Study||269
8315154|NCT01458275|20500802|P1|COMPLETED|Overall Study||269
8315155|NCT01458275|20500800|P3|STARTED|Overall Study||282
8315156|NCT01458275|20500801|P2|STARTED|Overall Study||282
8315157|NCT01458275|20500802|P1|STARTED|Overall Study||283
8315158|NCT01458249|20500844|P1|NOT COMPLETED|Overall Study||8
8315159|NCT01458249|20500844|P1|COMPLETED|Overall Study||44
8315160|NCT01458249|20500844|P1|Participants Treated|Overall Study||51
8315161|NCT01458249|20500844|P1|STARTED|Overall Study||52
8315162|NCT01458210|20500863|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
8315163|NCT01458210|20500863|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
8315164|NCT01458210|20500863|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
8315165|NCT01458210|20500863|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
8315166|NCT01458210|20500863|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
8315167|NCT01458210|20500863|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
8315168|NCT01458210|20500863|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
8315169|NCT01458210|20500863|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
8315170|NCT01458210|20500863|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
8315171|NCT01458210|20500863|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
8315172|NCT01458171|20500880|P1|NOT COMPLETED|Overall Study||1
8315173|NCT01458171|20500880|P1|COMPLETED|Overall Study||22
8315174|NCT01458171|20500880|P1|STARTED|Overall Study||23
8315175|NCT01458132|20500903|P2|NOT COMPLETED|Overall Study||3
8315176|NCT01458132|20500904|P1|NOT COMPLETED|Overall Study||15
8315177|NCT01458132|20500903|P2|COMPLETED|Overall Study||1
8315178|NCT01458132|20500904|P1|COMPLETED|Overall Study||0
8315179|NCT01458132|20500903|P2|STARTED|Overall Study||4
8315180|NCT01458132|20500904|P1|STARTED|Overall Study||15
8315181|NCT01458119|20500912|P1|NOT COMPLETED|Overall Study||20
8315182|NCT01458119|20500912|P1|COMPLETED|Overall Study||65
8315183|NCT01458119|20500912|P1|ITT-Amenable Population|Overall Study||68
8315184|NCT01458119|20500912|P1|Intent to Treat (ITT) Population|Overall Study||85
8315185|NCT01458119|20500912|P1|Safety Population|Overall Study||85
8315186|NCT01458119|20500912|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
8315187|NCT01458119|20500912|P1|STARTED|Overall Study||85
8315188|NCT01458106|20500919|P2|NOT COMPLETED|Overall Study||1
8315189|NCT01458106|20500920|P1|NOT COMPLETED|Overall Study||3
8315190|NCT01458106|20500919|P2|COMPLETED|Overall Study||34
8315191|NCT01458106|20500920|P1|COMPLETED|Overall Study||33
8315192|NCT01458106|20500919|P2|Non-PK Subgroup|Overall Study||0
8315193|NCT01458106|20500920|P1|Non-PK Subgroup|Overall Study||11
8315194|NCT01458106|20500919|P2|PK Subgroup|Overall Study||35
8315195|NCT01458106|20500920|P1|PK Subgroup|Overall Study||25
8315196|NCT01458106|20500919|P2|STARTED|Overall Study||35
8315197|NCT01458106|20500920|P1|STARTED|Overall Study||36
8315198|NCT01457950|20500997|P4|NOT COMPLETED|Open-Label Phase||2
8315199|NCT01457950|20500998|P3|NOT COMPLETED|Open-Label Phase||2
8315200|NCT01457950|20500999|P2|NOT COMPLETED|Open-Label Phase||0
8315201|NCT01457950|20501000|P1|NOT COMPLETED|Open-Label Phase||0
8315202|NCT01457950|20500997|P4|COMPLETED|Open-Label Phase||61
8315203|NCT01457950|20500998|P3|COMPLETED|Open-Label Phase||58
8315204|NCT01457950|20500999|P2|COMPLETED|Open-Label Phase||0
8315205|NCT01457950|20501000|P1|COMPLETED|Open-Label Phase||0
8315206|NCT01457950|20500997|P4|STARTED|Open-Label Phase||63
8315207|NCT01457950|20500998|P3|STARTED|Open-Label Phase||60
8315208|NCT01457950|20500999|P2|STARTED|Open-Label Phase||0
8315209|NCT01457950|20501000|P1|STARTED|Open-Label Phase||0
8315210|NCT01457950|20500997|P4|NOT COMPLETED|Double-Blind Phase||0
8315211|NCT01457950|20500998|P3|NOT COMPLETED|Double-Blind Phase||0
8315212|NCT01457950|20500999|P2|NOT COMPLETED|Double-Blind Phase||3
8315213|NCT01457950|20501000|P1|NOT COMPLETED|Double-Blind Phase||9
8315214|NCT01457950|20500997|P4|COMPLETED|Double-Blind Phase||0
8315215|NCT01457950|20500998|P3|COMPLETED|Double-Blind Phase||0
8315216|NCT01457950|20500999|P2|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
8315217|NCT01457950|20501000|P1|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
8315218|NCT01457950|20500997|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
8315219|NCT01457950|20500998|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
8315220|NCT01457950|20500999|P2|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
8315221|NCT01457950|20501000|P1|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
8315222|NCT01457950|20500997|P4|STARTED|Double-Blind Phase||0
8315223|NCT01457950|20500998|P3|STARTED|Double-Blind Phase||0
8315224|NCT01457950|20500999|P2|STARTED|Double-Blind Phase||66
8315225|NCT01457950|20501000|P1|STARTED|Double-Blind Phase||69
8315226|NCT01457924|20501079|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
8315227|NCT01457924|20501080|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
8315228|NCT01457924|20501081|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
8315229|NCT01457924|20501082|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
8315230|NCT01457924|20501083|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
8315231|NCT01457924|20501079|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
8315232|NCT01457924|20501080|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
8315233|NCT01457924|20501081|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
8315234|NCT01457924|20501082|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
8315235|NCT01457924|20501083|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
8315236|NCT01457924|20501079|P5|STARTED|Individualized FUP (Weeks 48+)||42
8315237|NCT01457924|20501080|P4|STARTED|Individualized FUP (Weeks 48+)||20
8315238|NCT01457924|20501081|P3|STARTED|Individualized FUP (Weeks 48+)||16
8315239|NCT01457924|20501082|P2|STARTED|Individualized FUP (Weeks 48+)||18
8315240|NCT01457924|20501083|P1|STARTED|Individualized FUP (Weeks 48+)||16
8315241|NCT01457924|20501079|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
8315242|NCT01457924|20501080|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
8315243|NCT01457924|20501081|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
8315244|NCT01457924|20501082|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
8315245|NCT01457924|20501083|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
8315246|NCT01457924|20501079|P5|COMPLETED|FUP (Weeks 24-48)||57
8315247|NCT01457924|20501080|P4|COMPLETED|FUP (Weeks 24-48)||32
8315248|NCT01457924|20501081|P3|COMPLETED|FUP (Weeks 24-48)||30
8315249|NCT01457924|20501082|P2|COMPLETED|FUP (Weeks 24-48)||30
8315250|NCT01457924|20501083|P1|COMPLETED|FUP (Weeks 24-48)||63
8315251|NCT01457924|20501079|P5|STARTED|FUP (Weeks 24-48)||59
8315252|NCT01457924|20501080|P4|STARTED|FUP (Weeks 24-48)||33
8315253|NCT01457924|20501081|P3|STARTED|FUP (Weeks 24-48)||32
8315254|NCT01457924|20501082|P2|STARTED|FUP (Weeks 24-48)||31
8315255|NCT01457924|20501083|P1|STARTED|FUP (Weeks 24-48)||66
8315256|NCT01457924|20501079|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
8315257|NCT01457924|20501080|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
8315258|NCT01457924|20501081|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
8315259|NCT01457924|20501082|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
8315260|NCT01457924|20501083|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
8315261|NCT01457924|20501079|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
8315262|NCT01457924|20501080|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
8315263|NCT01457924|20501081|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
8315264|NCT01457924|20501082|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
8315265|NCT01457924|20501083|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
8315266|NCT01457924|20501079|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
8315267|NCT01457924|20501080|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
8315268|NCT01457924|20501081|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
8315269|NCT01457924|20501082|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
8315270|NCT01457924|20501083|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
8315271|NCT01457924|20501079|P5|STARTED|Treatment Phase (Weeks 0-24)||64
8315272|NCT01457924|20501080|P4|STARTED|Treatment Phase (Weeks 0-24)||34
8315273|NCT01457924|20501081|P3|STARTED|Treatment Phase (Weeks 0-24)||32
8315274|NCT01457924|20501082|P2|STARTED|Treatment Phase (Weeks 0-24)||34
8315275|NCT01457924|20501083|P1|STARTED|Treatment Phase (Weeks 0-24)||67
8315276|NCT01457885|20501145|P1|NOT COMPLETED|Overall Study||0
8315277|NCT01457885|20501145|P1|COMPLETED|Overall Study||74
8315278|NCT01457885|20501145|P1|STARTED|Overall Study||74
8315279|NCT01457846|20501153|P2|NOT COMPLETED|Overall Study||30
8315280|NCT01457846|20501154|P1|NOT COMPLETED|Overall Study||41
8315281|NCT01457846|20501153|P2|COMPLETED|Overall Study||0
8315282|NCT01457846|20501154|P1|COMPLETED|Overall Study||0
8315283|NCT01457846|20501153|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
8315284|NCT01457846|20501154|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
8315285|NCT01457846|20501153|P2|Did Not Receive Treatment|Overall Study||3
8315286|NCT01457846|20501154|P1|Did Not Receive Treatment|Overall Study||1
8315287|NCT01457846|20501153|P2|Received Treatment|Overall Study||27
8315288|NCT01457846|20501154|P1|Received Treatment|Overall Study||40
8315289|NCT01457846|20501153|P2|STARTED|Overall Study||30
8315290|NCT01457846|20501154|P1|STARTED|Overall Study||41
8315291|NCT01457703|20501170|P2|NOT COMPLETED|Overall Study||11
8315292|NCT01457703|20501171|P1|NOT COMPLETED|Overall Study||6
8315293|NCT01457703|20501170|P2|COMPLETED|Overall Study||22
8315294|NCT01457703|20501171|P1|COMPLETED|Overall Study||23
8315295|NCT01457703|20501170|P2|STARTED|Overall Study||33
8315296|NCT01457703|20501171|P1|STARTED|Overall Study||29
8315297|NCT01457573|20501185|P1|NOT COMPLETED|Overall Study||0
8315298|NCT01457573|20501185|P1|COMPLETED|Overall Study||10
8315299|NCT01457573|20501185|P1|STARTED|Overall Study||10
8315300|NCT01457521|20501201|P2|NOT COMPLETED|Overall Study||10
8315301|NCT01457521|20501202|P1|NOT COMPLETED|Overall Study||12
8315302|NCT01457521|20501201|P2|COMPLETED|Overall Study||117
8315303|NCT01457521|20501202|P1|COMPLETED|Overall Study||111
8315304|NCT01457521|20501201|P2|STARTED|Overall Study||127
8315305|NCT01457521|20501202|P1|STARTED|Overall Study||123
8315306|NCT01457430|20501208|P1|NOT COMPLETED|Overall Study||0
8315307|NCT01457430|20501208|P1|COMPLETED|Overall Study||19
8315308|NCT01457430|20501208|P1|STARTED|Overall Study||19
8315309|NCT01457417|20501220|P5|NOT COMPLETED|Overall Study||0
8315310|NCT01457417|20501221|P4|NOT COMPLETED|Overall Study||0
8315311|NCT01457417|20501222|P3|NOT COMPLETED|Overall Study||0
8315312|NCT01457417|20501223|P2|NOT COMPLETED|Overall Study||0
8315313|NCT01457417|20501224|P1|NOT COMPLETED|Overall Study||0
8315314|NCT01457417|20501220|P5|COMPLETED|Overall Study||19
8315315|NCT01457417|20501221|P4|COMPLETED|Overall Study||3
8315316|NCT01457417|20501222|P3|COMPLETED|Overall Study||4
8315317|NCT01457417|20501223|P2|COMPLETED|Overall Study||3
8315318|NCT01457417|20501224|P1|COMPLETED|Overall Study||3
8315319|NCT01457417|20501220|P5|STARTED|Overall Study||19
8315320|NCT01457417|20501221|P4|STARTED|Overall Study||3
8315321|NCT01457417|20501222|P3|STARTED|Overall Study||4
8315322|NCT01457417|20501223|P2|STARTED|Overall Study||3
8315323|NCT01457417|20501224|P1|STARTED|Overall Study||3
8315324|NCT01457352|20501282|P2|NOT COMPLETED|Period 3||5
8315325|NCT01457352|20501283|P1|NOT COMPLETED|Period 3||1
8315326|NCT01457352|20501282|P2|COMPLETED|Period 3||144
8315327|NCT01457352|20501283|P1|COMPLETED|Period 3||146
8315328|NCT01457352|20501282|P2|Randomization|Period 3||149
8315329|NCT01457352|20501283|P1|Randomization|Period 3||147
8315330|NCT01457352|20501282|P2|STARTED|Period 3||149
8315331|NCT01457352|20501283|P1|STARTED|Period 3||147
8315332|NCT01457352|20501282|P2|NOT COMPLETED|Period 2||0
8315333|NCT01457352|20501283|P1|NOT COMPLETED|Period 2||80
8315334|NCT01457352|20501282|P2|COMPLETED|Period 2||0
8315335|NCT01457352|20501283|P1|COMPLETED|Period 2||296
8315336|NCT01457352|20501282|P2|STARTED|Period 2||0
8315337|NCT01457352|20501283|P1|STARTED|Period 2||376
8315338|NCT01457352|20501282|P2|NOT COMPLETED|Period 1||0
8315339|NCT01457352|20501283|P1|NOT COMPLETED|Period 1||16
8315340|NCT01457352|20501282|P2|COMPLETED|Period 1||0
8315341|NCT01457352|20501283|P1|COMPLETED|Period 1||376
8315342|NCT01457352|20501282|P2|STARTED|Period 1||0
8315343|NCT01457352|20501283|P1|STARTED|Period 1||392
8315344|NCT01457339|20501295|P2|NOT COMPLETED|Period 6 (250 mg)||1
8315345|NCT01457339|20501296|P1|NOT COMPLETED|Period 6 (250 mg)||1
8315346|NCT01457339|20501295|P2|COMPLETED|Period 6 (250 mg)||21
8315347|NCT01457339|20501296|P1|COMPLETED|Period 6 (250 mg)||6
8315348|NCT01457339|20501295|P2|STARTED|Period 6 (250 mg)||22
8315349|NCT01457339|20501296|P1|STARTED|Period 6 (250 mg)||7
8315350|NCT01457339|20501295|P2|NOT COMPLETED|Period 5 (200 mg)||1
8315351|NCT01457339|20501296|P1|NOT COMPLETED|Period 5 (200 mg)||0
8315352|NCT01457339|20501295|P2|COMPLETED|Period 5 (200 mg)||22
8315353|NCT01457339|20501296|P1|COMPLETED|Period 5 (200 mg)||7
8315354|NCT01457339|20501295|P2|STARTED|Period 5 (200 mg)||23
8315355|NCT01457339|20501296|P1|STARTED|Period 5 (200 mg)||7
8315356|NCT01457339|20501295|P2|NOT COMPLETED|Period 4 (150 mg)||0
8315357|NCT01457339|20501296|P1|NOT COMPLETED|Period 4 (150 mg)||0
8315358|NCT01457339|20501295|P2|COMPLETED|Period 4 (150 mg)||23
8315359|NCT01457339|20501296|P1|COMPLETED|Period 4 (150 mg)||7
8315360|NCT01457339|20501295|P2|STARTED|Period 4 (150 mg)||23
8315361|NCT01457339|20501296|P1|STARTED|Period 4 (150 mg)||7
8315362|NCT01457339|20501295|P2|NOT COMPLETED|Period 3 (100 mg)||1
8315363|NCT01457339|20501296|P1|NOT COMPLETED|Period 3 (100 mg)||0
8315364|NCT01457339|20501295|P2|COMPLETED|Period 3 (100 mg)||23
8315365|NCT01457339|20501296|P1|COMPLETED|Period 3 (100 mg)||7
8315366|NCT01457339|20501295|P2|STARTED|Period 3 (100 mg)||24
8315367|NCT01457339|20501296|P1|STARTED|Period 3 (100 mg)||7
8315368|NCT01457339|20501295|P2|NOT COMPLETED|Period 2 (70 mg)||0
8315369|NCT01457339|20501296|P1|NOT COMPLETED|Period 2 (70 mg)||0
8315370|NCT01457339|20501295|P2|COMPLETED|Period 2 (70 mg)||24
8315371|NCT01457339|20501296|P1|COMPLETED|Period 2 (70 mg)||7
8315372|NCT01457339|20501295|P2|STARTED|Period 2 (70 mg)||24
8315373|NCT01457339|20501296|P1|STARTED|Period 2 (70 mg)||7
8315374|NCT01457339|20501295|P2|NOT COMPLETED|Period 1 (50 mg)||0
8315375|NCT01457339|20501296|P1|NOT COMPLETED|Period 1 (50 mg)||0
8315376|NCT01457339|20501295|P2|COMPLETED|Period 1 (50 mg)||24
8315377|NCT01457339|20501296|P1|COMPLETED|Period 1 (50 mg)||7
8315378|NCT01457339|20501295|P2|STARTED|Period 1 (50 mg)||24
8315379|NCT01457339|20501296|P1|STARTED|Period 1 (50 mg)||7
8315380|NCT01457196|20501462|P1|NOT COMPLETED|Overall Study||0
8315381|NCT01457196|20501462|P1|COMPLETED|Overall Study||2074
8315382|NCT01457196|20501462|P1|STARTED|Overall Study||2074
8315383|NCT01457053|20501468|P2|NOT COMPLETED|Overall Study||1
8315384|NCT01457053|20501469|P1|NOT COMPLETED|Overall Study||1
8315385|NCT01457053|20501468|P2|COMPLETED|Overall Study||1
8315386|NCT01457053|20501469|P1|COMPLETED|Overall Study||1
8315387|NCT01457053|20501468|P2|STARTED|Overall Study||2
8315388|NCT01457053|20501469|P1|STARTED|Overall Study||2
8315389|NCT01457014|20501475|P4|NOT COMPLETED|Fourth Night||0
8315390|NCT01457014|20501476|P3|NOT COMPLETED|Fourth Night||0
8315391|NCT01457014|20501477|P2|NOT COMPLETED|Fourth Night||0
8315392|NCT01457014|20501478|P1|NOT COMPLETED|Fourth Night||0
8315393|NCT01457014|20501475|P4|COMPLETED|Fourth Night||11
8315394|NCT01457014|20501476|P3|COMPLETED|Fourth Night||12
8315395|NCT01457014|20501477|P2|COMPLETED|Fourth Night||11
8315396|NCT01457014|20501478|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
8315397|NCT01457014|20501475|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315398|NCT01457014|20501476|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8315399|NCT01457014|20501477|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315400|NCT01457014|20501478|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
8315401|NCT01457014|20501475|P4|NOT COMPLETED|Third Night||0
8315402|NCT01457014|20501476|P3|NOT COMPLETED|Third Night||0
8315403|NCT01457014|20501477|P2|NOT COMPLETED|Third Night||0
8315404|NCT01457014|20501478|P1|NOT COMPLETED|Third Night||0
8315405|NCT01457014|20501475|P4|COMPLETED|Third Night||12
8315406|NCT01457014|20501476|P3|COMPLETED|Third Night||11
8315407|NCT01457014|20501477|P2|COMPLETED|Third Night||11
8315408|NCT01457014|20501478|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
8315409|NCT01457014|20501475|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8315410|NCT01457014|20501476|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315411|NCT01457014|20501477|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315412|NCT01457014|20501478|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
8315413|NCT01457014|20501475|P4|NOT COMPLETED|Second Night||0
8315414|NCT01457014|20501476|P3|NOT COMPLETED|Second Night||0
8315415|NCT01457014|20501477|P2|NOT COMPLETED|Second Night||0
8315416|NCT01457014|20501478|P1|NOT COMPLETED|Second Night||0
8315417|NCT01457014|20501475|P4|COMPLETED|Second Night||11
8315418|NCT01457014|20501476|P3|COMPLETED|Second Night||11
8315419|NCT01457014|20501477|P2|COMPLETED|Second Night||12
8315420|NCT01457014|20501478|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
8315421|NCT01457014|20501475|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315422|NCT01457014|20501476|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315423|NCT01457014|20501477|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8315424|NCT01457014|20501478|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
8315425|NCT01457014|20501475|P4|NOT COMPLETED|First Night||0
8315426|NCT01457014|20501476|P3|NOT COMPLETED|First Night||0
8315427|NCT01457014|20501477|P2|NOT COMPLETED|First Night||0
8315428|NCT01457014|20501478|P1|NOT COMPLETED|First Night||40
8315429|NCT01457014|20501475|P4|COMPLETED|First Night||0
8315430|NCT01457014|20501476|P3|COMPLETED|First Night||0
8315431|NCT01457014|20501477|P2|COMPLETED|First Night||0
8315432|NCT01457014|20501478|P1|COMPLETED|First Night||34
8315433|NCT01457014|20501475|P4|STARTED|First Night||0
8315434|NCT01457014|20501476|P3|STARTED|First Night||0
8315435|NCT01457014|20501477|P2|STARTED|First Night||0
8315436|NCT01457014|20501478|P1|STARTED|First Night||74
8315437|NCT01456962|20501495|P2|NOT COMPLETED|Overall Study||1
8315438|NCT01456962|20501496|P1|NOT COMPLETED|Overall Study||2
8315439|NCT01456962|20501495|P2|COMPLETED|Overall Study||19
8315440|NCT01456962|20501496|P1|COMPLETED|Overall Study||14
8315441|NCT01456962|20501495|P2|STARTED|Overall Study||20
8315442|NCT01456962|20501496|P1|STARTED|Overall Study||16
8315443|NCT01456949|20501502|P1|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
8315444|NCT01456949|20501502|P1|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
8315445|NCT01456949|20501502|P1|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
8315446|NCT01456949|20501502|P1|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
8315447|NCT01456949|20501502|P1|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
8315448|NCT01456949|20501502|P1|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
8315449|NCT01456949|20501502|P1|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
8315450|NCT01456949|20501502|P1|STARTED|Study Cryoablation Procedure & Follow-up||365
8315451|NCT01456949|20501502|P1|NOT COMPLETED|Enrollment||37
8315452|NCT01456949|20501502|P1|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
8315453|NCT01456949|20501502|P1|Modified Intent to Treat Group (mITT)|Enrollment||354
8315454|NCT01456949|20501502|P1|Treated|Enrollment||359
8315455|NCT01456949|20501502|P1|STARTED|Enrollment||402
8315456|NCT01456936|20501513|P4|NOT COMPLETED|Overall Study||483
8315457|NCT01456936|20501514|P3|NOT COMPLETED|Overall Study||481
8315458|NCT01456936|20501515|P2|NOT COMPLETED|Overall Study||448
8315459|NCT01456936|20501516|P1|NOT COMPLETED|Overall Study||439
8315460|NCT01456936|20501513|P4|COMPLETED|Overall Study||1552
8315461|NCT01456936|20501514|P3|COMPLETED|Overall Study||1557
8315462|NCT01456936|20501515|P2|COMPLETED|Overall Study||1586
8315463|NCT01456936|20501516|P1|COMPLETED|Overall Study||1598
8315464|NCT01456936|20501513|P4|Randomized and Treated|Overall Study||2014
8315465|NCT01456936|20501514|P3|Randomized and Treated|Overall Study||2022
8315466|NCT01456936|20501515|P2|Randomized and Treated|Overall Study||2006
8315467|NCT01456936|20501516|P1|Randomized and Treated|Overall Study||2016
8315468|NCT01456936|20501513|P4|STARTED|Overall Study||2035
8315469|NCT01456936|20501514|P3|STARTED|Overall Study||2038
8315470|NCT01456936|20501515|P2|STARTED|Overall Study||2034
8315471|NCT01456936|20501516|P1|STARTED|Overall Study||2037
8315472|NCT01456897|20501624|P2|NOT COMPLETED|Overall Study||57
8315473|NCT01456897|20501625|P1|NOT COMPLETED|Overall Study||75
8315474|NCT01456897|20501624|P2|COMPLETED|Overall Study||41
8315475|NCT01456897|20501625|P1|COMPLETED|Overall Study||109
8315476|NCT01456897|20501624|P2|STARTED|Overall Study||98
8315477|NCT01456897|20501625|P1|STARTED|Overall Study||184
8315478|NCT01456780|20501644|P3|NOT COMPLETED|Overall Study||0
8315479|NCT01456780|20501645|P2|NOT COMPLETED|Overall Study||3
8315480|NCT01456780|20501646|P1|NOT COMPLETED|Overall Study||3
8315481|NCT01456780|20501644|P3|COMPLETED|Overall Study||20
8315482|NCT01456780|20501645|P2|COMPLETED|Overall Study||17
8315483|NCT01456780|20501646|P1|COMPLETED|Overall Study||17
8315484|NCT01456780|20501644|P3|STARTED|Overall Study||20
8315485|NCT01456780|20501645|P2|STARTED|Overall Study||20
8315486|NCT01456780|20501646|P1|STARTED|Overall Study||20
8315487|NCT01456494|20501665|P2|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
8315488|NCT01456494|20501666|P1|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
8315489|NCT01456494|20501665|P2|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
8315490|NCT01456494|20501666|P1|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
8315491|NCT01456494|20501665|P2|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
8315492|NCT01456494|20501666|P1|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
8315493|NCT01456494|20501665|P2|NOT COMPLETED|Initial Inpatient Visit||0
8315494|NCT01456494|20501666|P1|NOT COMPLETED|Initial Inpatient Visit||0
8315495|NCT01456494|20501665|P2|COMPLETED|Initial Inpatient Visit||26
8315496|NCT01456494|20501666|P1|COMPLETED|Initial Inpatient Visit||24
8315497|NCT01456494|20501665|P2|STARTED|Initial Inpatient Visit||26
8315498|NCT01456494|20501666|P1|STARTED|Initial Inpatient Visit||24
8315499|NCT01456299|20501683|P3|NOT COMPLETED|Overall Study||1
8315500|NCT01456299|20501684|P2|NOT COMPLETED|Overall Study||1
8315501|NCT01456299|20501685|P1|NOT COMPLETED|Overall Study||0
8315502|NCT01456299|20501683|P3|COMPLETED|Overall Study||33
8315503|NCT01456299|20501684|P2|COMPLETED|Overall Study||33
8315504|NCT01456299|20501685|P1|COMPLETED|Overall Study||34
8315505|NCT01456299|20501683|P3|STARTED|Overall Study||34
8315506|NCT01456299|20501684|P2|STARTED|Overall Study||34
8315507|NCT01456299|20501685|P1|STARTED|Overall Study||34
8315508|NCT01456221|20501695|P2|NOT COMPLETED|Overall Study||57
8315509|NCT01456221|20501696|P1|NOT COMPLETED|Overall Study||64
8315510|NCT01456221|20501695|P2|COMPLETED|Overall Study||126
8315511|NCT01456221|20501696|P1|COMPLETED|Overall Study||119
8315512|NCT01456221|20501695|P2|STARTED|Overall Study||183
8315513|NCT01456221|20501696|P1|STARTED|Overall Study||183
8315514|NCT01456195|20501711|P3|NOT COMPLETED|Overall Study||14
8315515|NCT01456195|20501712|P2|NOT COMPLETED|Overall Study||10
8315516|NCT01456195|20501713|P1|NOT COMPLETED|Overall Study||11
8315517|NCT01456195|20501711|P3|COMPLETED|Overall Study||127
8315518|NCT01456195|20501712|P2|COMPLETED|Overall Study||127
8315519|NCT01456195|20501713|P1|COMPLETED|Overall Study||132
8315520|NCT01456195|20501711|P3|STARTED|Overall Study||141
8315521|NCT01456195|20501712|P2|STARTED|Overall Study||137
8315522|NCT01456195|20501713|P1|STARTED|Overall Study||143
8315523|NCT01456169|20501733|P3|NOT COMPLETED|Overall Study||12
8315524|NCT01456169|20501734|P2|NOT COMPLETED|Overall Study||5
8315525|NCT01456169|20501735|P1|NOT COMPLETED|Overall Study||10
8315526|NCT01456169|20501733|P3|COMPLETED|Overall Study||123
8315527|NCT01456169|20501734|P2|COMPLETED|Overall Study||122
8315528|NCT01456169|20501735|P1|COMPLETED|Overall Study||123
8315529|NCT01456169|20501733|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
8315530|NCT01456169|20501734|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
8315623|NCT01454947|20502092|P3|COMPLETED|Overall Study||32
8315531|NCT01456169|20501735|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
8315532|NCT01456143|20501786|P1|NOT COMPLETED|Overall Study||0
8315533|NCT01456143|20501786|P1|COMPLETED|Overall Study||33
8315534|NCT01456143|20501786|P1|STARTED|Overall Study||33
8315535|NCT01456130|20501795|P1|NOT COMPLETED|Overall Study||10
8315536|NCT01456130|20501795|P1|COMPLETED|Overall Study||57
8315537|NCT01456130|20501795|P1|STARTED|Overall Study||67
8315538|NCT01456052|20501805|P3|NOT COMPLETED|Overall Study||5
8315539|NCT01456052|20501806|P2|NOT COMPLETED|Overall Study||5
8315540|NCT01456052|20501807|P1|NOT COMPLETED|Overall Study||2
8315541|NCT01456052|20501805|P3|COMPLETED|Overall Study||19
8315542|NCT01456052|20501806|P2|COMPLETED|Overall Study||20
8315543|NCT01456052|20501807|P1|COMPLETED|Overall Study||8
8315544|NCT01456052|20501805|P3|STARTED|Overall Study||24
8315545|NCT01456052|20501806|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
8315546|NCT01456052|20501807|P1|STARTED|Overall Study||10
8315547|NCT01456039|20501827|P3|NOT COMPLETED|Phase 2 (Second Step)||33
8315548|NCT01456039|20501828|P2|NOT COMPLETED|Phase 2 (Second Step)||0
8315549|NCT01456039|20501829|P1|NOT COMPLETED|Phase 2 (Second Step)||0
8315550|NCT01456039|20501827|P3|COMPLETED|Phase 2 (Second Step)||7
8315551|NCT01456039|20501828|P2|COMPLETED|Phase 2 (Second Step)||0
8315552|NCT01456039|20501829|P1|COMPLETED|Phase 2 (Second Step)||0
8315553|NCT01456039|20501827|P3|STARTED|Phase 2 (Second Step)||40
8315554|NCT01456039|20501828|P2|STARTED|Phase 2 (Second Step)||0
8315555|NCT01456039|20501829|P1|STARTED|Phase 2 (Second Step)||0
8315556|NCT01456039|20501827|P3|NOT COMPLETED|Phase 1 (First Step)||0
8315557|NCT01456039|20501828|P2|NOT COMPLETED|Phase 1 (First Step)||7
8315558|NCT01456039|20501829|P1|NOT COMPLETED|Phase 1 (First Step)||2
8315559|NCT01456039|20501827|P3|COMPLETED|Phase 1 (First Step)||0
8315560|NCT01456039|20501828|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
8315561|NCT01456039|20501829|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
8315562|NCT01456039|20501827|P3|STARTED|Phase 1 (First Step)||0
8315563|NCT01456039|20501828|P2|STARTED|Phase 1 (First Step)||8
8315564|NCT01456039|20501829|P1|STARTED|Phase 1 (First Step)||3
8315565|NCT01456000|20501901|P2|NOT COMPLETED|Overall Study||3
8315566|NCT01456000|20501902|P1|NOT COMPLETED|Overall Study||8
8315567|NCT01456000|20501901|P2|COMPLETED|Overall Study||172
8315568|NCT01456000|20501902|P1|COMPLETED|Overall Study||170
8315569|NCT01456000|20501901|P2|STARTED|Overall Study||175
8315570|NCT01456000|20501902|P1|STARTED|Overall Study||178
8315571|NCT01455545|20501908|P2|NOT COMPLETED|Overall Study||0
8315572|NCT01455545|20501909|P1|NOT COMPLETED|Overall Study||0
8315573|NCT01455545|20501908|P2|COMPLETED|Overall Study||45
8315574|NCT01455545|20501909|P1|COMPLETED|Overall Study||55
8315575|NCT01455545|20501908|P2|STARTED|Overall Study||45
8315576|NCT01455545|20501909|P1|STARTED|Overall Study||55
8315577|NCT01455519|20501939|P2|NOT COMPLETED|Overall Study||5
8315578|NCT01455519|20501940|P1|NOT COMPLETED|Overall Study||4
8315579|NCT01455519|20501939|P2|COMPLETED|Overall Study||18
8315580|NCT01455519|20501940|P1|COMPLETED|Overall Study||8
8315581|NCT01455519|20501939|P2|STARTED|Overall Study||23
8315582|NCT01455519|20501940|P1|STARTED|Overall Study||12
8315583|NCT01455220|20501970|P1|NOT COMPLETED|Overall Study||30
8315584|NCT01455220|20501970|P1|COMPLETED|Overall Study||15
8315585|NCT01455220|20501970|P1|STARTED|Overall Study||45
8315586|NCT01455194|20501980|P4|NOT COMPLETED|Overall Study||28
8315587|NCT01455194|20501981|P3|NOT COMPLETED|Overall Study||30
8315588|NCT01455194|20501982|P2|NOT COMPLETED|Overall Study||31
8315589|NCT01455194|20501983|P1|NOT COMPLETED|Overall Study||153
8315590|NCT01455194|20501980|P4|COMPLETED|Overall Study||97
8315591|NCT01455194|20501981|P3|COMPLETED|Overall Study||92
8315592|NCT01455194|20501982|P2|COMPLETED|Overall Study||89
8315593|NCT01455194|20501983|P1|COMPLETED|Overall Study||0
8315594|NCT01455194|20501980|P4|STARTED|Overall Study||125
8315595|NCT01455194|20501981|P3|STARTED|Overall Study||122
8315596|NCT01455194|20501982|P2|STARTED|Overall Study||120
8315597|NCT01455194|20501983|P1|STARTED|Overall Study||153
8315598|NCT01455181|20502032|P1|NOT COMPLETED|Overall Study||0
8315599|NCT01455181|20502032|P1|COMPLETED|Overall Study||24
8315600|NCT01455181|20502032|P1|STARTED|Overall Study||24
8315601|NCT01455064|20502040|P1|NOT COMPLETED|Overall Study||1
8315602|NCT01455064|20502040|P1|COMPLETED|Overall Study||30
8315603|NCT01455064|20502040|P1|STARTED|Overall Study||31
8315604|NCT01455012|20502046|P2|NOT COMPLETED|Overall Study||4
8315605|NCT01455012|20502047|P1|NOT COMPLETED|Overall Study||11
8315606|NCT01455012|20502046|P2|COMPLETED|Overall Study||36
8315607|NCT01455012|20502047|P1|COMPLETED|Overall Study||30
8315608|NCT01455012|20502046|P2|STARTED|Overall Study||40
8315609|NCT01455012|20502047|P1|STARTED|Overall Study||41
8315610|NCT01454947|20502087|P8|NOT COMPLETED|Overall Study||5
8315611|NCT01454947|20502088|P7|NOT COMPLETED|Overall Study||1
8315612|NCT01454947|20502089|P6|NOT COMPLETED|Overall Study||3
8315613|NCT01454947|20502090|P5|NOT COMPLETED|Overall Study||1
8315614|NCT01454947|20502091|P4|NOT COMPLETED|Overall Study||1
8315615|NCT01454947|20502092|P3|NOT COMPLETED|Overall Study||3
8315616|NCT01454947|20502093|P2|NOT COMPLETED|Overall Study||4
8315617|NCT01454947|20502094|P1|NOT COMPLETED|Overall Study||3
8315618|NCT01454947|20502087|P8|COMPLETED|Overall Study||23
8315619|NCT01454947|20502088|P7|COMPLETED|Overall Study||26
8315620|NCT01454947|20502089|P6|COMPLETED|Overall Study||32
8315621|NCT01454947|20502090|P5|COMPLETED|Overall Study||33
8315622|NCT01454947|20502091|P4|COMPLETED|Overall Study||19
8315624|NCT01454947|20502093|P2|COMPLETED|Overall Study||38
8315625|NCT01454947|20502094|P1|COMPLETED|Overall Study||24
8315626|NCT01454947|20502087|P8|STARTED|Overall Study||28
8315627|NCT01454947|20502088|P7|STARTED|Overall Study||27
8315628|NCT01454947|20502089|P6|STARTED|Overall Study||35
8315629|NCT01454947|20502090|P5|STARTED|Overall Study||34
8315630|NCT01454947|20502091|P4|STARTED|Overall Study||20
8315631|NCT01454947|20502092|P3|STARTED|Overall Study||35
8315632|NCT01454947|20502093|P2|STARTED|Overall Study||42
8315633|NCT01454947|20502094|P1|STARTED|Overall Study||27
8315634|NCT01454934|20502114|P2|NOT COMPLETED|Overall Study||270
8315635|NCT01454934|20502115|P1|NOT COMPLETED|Overall Study||270
8315636|NCT01454934|20502114|P2|COMPLETED|Overall Study||0
8315637|NCT01454934|20502115|P1|COMPLETED|Overall Study||0
8315638|NCT01454934|20502114|P2|STARTED|Overall Study||270
8315639|NCT01454934|20502115|P1|STARTED|Overall Study||270
8315640|NCT01454830|20502127|P2|NOT COMPLETED|Overall Study||27
8315641|NCT01454830|20502128|P1|NOT COMPLETED|Overall Study||31
8315642|NCT01454830|20502127|P2|COMPLETED|Overall Study||30
8315643|NCT01454830|20502128|P1|COMPLETED|Overall Study||30
8315644|NCT01454830|20502127|P2|STARTED|Overall Study||57
8315645|NCT01454830|20502128|P1|STARTED|Overall Study||61
8315646|NCT01454791|20502148|P2|NOT COMPLETED|Overall Study||0
8315647|NCT01454791|20502149|P1|NOT COMPLETED|Overall Study||0
8315648|NCT01454791|20502148|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
8315649|NCT01454791|20502149|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
8315650|NCT01454791|20502148|P2|STARTED|Overall Study||20
8315651|NCT01454791|20502149|P1|STARTED|Overall Study||20
8315652|NCT01454778|20502159|P1|NOT COMPLETED|Overall Study||3
8315653|NCT01454778|20502159|P1|COMPLETED|Overall Study||47
8315654|NCT01454778|20502159|P1|STARTED|Overall Study||50
8315655|NCT01454739|20502170|P2|NOT COMPLETED|Overall Study||21
8315656|NCT01454739|20502171|P1|NOT COMPLETED|Overall Study||7
8315657|NCT01454739|20502170|P2|COMPLETED|Overall Study||158
8315658|NCT01454739|20502171|P1|COMPLETED|Overall Study||54
8315659|NCT01454739|20502170|P2|Surgery Subgroup|Overall Study||26
8315660|NCT01454739|20502171|P1|Surgery Subgroup|Overall Study||2
8315661|NCT01454739|20502170|P2|Episodic|Overall Study||13
8315662|NCT01454739|20502171|P1|Episodic|Overall Study||0
8315663|NCT01454739|20502170|P2|Personalized Prophylaxis|Overall Study||23
8315664|NCT01454739|20502171|P1|Personalized Prophylaxis|Overall Study||3
8315665|NCT01454739|20502170|P2|Weekly Prophylaxis|Overall Study||34
8315666|NCT01454739|20502171|P1|Weekly Prophylaxis|Overall Study||0
8315667|NCT01454739|20502170|P2|Tailored Prophylaxis|Overall Study||131
8315668|NCT01454739|20502171|P1|Tailored Prophylaxis|Overall Study||59
8315669|NCT01454739|20502170|P2|STARTED|Overall Study||179
8315670|NCT01454739|20502171|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
8315671|NCT01454726|20502200|P2|NOT COMPLETED|Overall Study||1
8315672|NCT01454726|20502201|P1|NOT COMPLETED|Overall Study||0
8315673|NCT01454726|20502200|P2|COMPLETED|Overall Study||10
8315674|NCT01454726|20502201|P1|COMPLETED|Overall Study||16
8315675|NCT01454726|20502200|P2|STARTED|Overall Study||11
8315676|NCT01454726|20502201|P1|STARTED|Overall Study||16
8315677|NCT01454596|20502219|P12|NOT COMPLETED|Overall Study||0
8315678|NCT01454596|20502220|P11|NOT COMPLETED|Overall Study||1
8315679|NCT01454596|20502221|P10|NOT COMPLETED|Overall Study||1
8315680|NCT01454596|20502222|P9|NOT COMPLETED|Overall Study||0
8315681|NCT01454596|20502223|P8|NOT COMPLETED|Overall Study||0
8315682|NCT01454596|20502224|P7|NOT COMPLETED|Overall Study||0
8315683|NCT01454596|20502225|P6|NOT COMPLETED|Overall Study||0
8315684|NCT01454596|20502226|P5|NOT COMPLETED|Overall Study||0
8315685|NCT01454596|20502227|P4|NOT COMPLETED|Overall Study||0
8315686|NCT01454596|20502228|P3|NOT COMPLETED|Overall Study||0
8315687|NCT01454596|20502229|P2|NOT COMPLETED|Overall Study||0
8315688|NCT01454596|20502230|P1|NOT COMPLETED|Overall Study||0
8315689|NCT01454596|20502219|P12|COMPLETED|Overall Study||1
8315690|NCT01454596|20502220|P11|COMPLETED|Overall Study||0
8315691|NCT01454596|20502221|P10|COMPLETED|Overall Study||2
8315692|NCT01454596|20502222|P9|COMPLETED|Overall Study||3
8315693|NCT01454596|20502223|P8|COMPLETED|Overall Study||3
8315694|NCT01454596|20502224|P7|COMPLETED|Overall Study||1
8315695|NCT01454596|20502225|P6|COMPLETED|Overall Study||1
8315696|NCT01454596|20502226|P5|COMPLETED|Overall Study||1
8315697|NCT01454596|20502227|P4|COMPLETED|Overall Study||1
8315698|NCT01454596|20502228|P3|COMPLETED|Overall Study||1
8315699|NCT01454596|20502229|P2|COMPLETED|Overall Study||1
8315700|NCT01454596|20502230|P1|COMPLETED|Overall Study||1
8315701|NCT01454596|20502219|P12|STARTED|Overall Study||1
8315702|NCT01454596|20502220|P11|STARTED|Overall Study||1
8315703|NCT01454596|20502221|P10|STARTED|Overall Study||3
8315704|NCT01454596|20502222|P9|STARTED|Overall Study||3
8315705|NCT01454596|20502223|P8|STARTED|Overall Study||3
8315706|NCT01454596|20502224|P7|STARTED|Overall Study||1
8315707|NCT01454596|20502225|P6|STARTED|Overall Study||1
8315708|NCT01454596|20502226|P5|STARTED|Overall Study||1
8315709|NCT01454596|20502227|P4|STARTED|Overall Study||1
8315710|NCT01454596|20502228|P3|STARTED|Overall Study||1
8315711|NCT01454596|20502229|P2|STARTED|Overall Study||1
8315712|NCT01454596|20502230|P1|STARTED|Overall Study||1
8315713|NCT01454583|20502307|P3|NOT COMPLETED|3rd Year||297
8315714|NCT01454583|20502308|P2|NOT COMPLETED|3rd Year||512
8315715|NCT01454583|20502309|P1|NOT COMPLETED|3rd Year||1959
8315716|NCT01454583|20502307|P3|COMPLETED|3rd Year||285
8315717|NCT01454583|20502308|P2|COMPLETED|3rd Year||470
8315718|NCT01454583|20502309|P1|COMPLETED|3rd Year||1832
8315719|NCT01454583|20502307|P3|STARTED|3rd Year||582
8315720|NCT01454583|20502308|P2|STARTED|3rd Year||982
8315721|NCT01454583|20502309|P1|STARTED|3rd Year||3791
8315722|NCT01454583|20502307|P3|NOT COMPLETED|2nd Year||737
8315723|NCT01454583|20502308|P2|NOT COMPLETED|2nd Year||1049
8315724|NCT01454583|20502309|P1|NOT COMPLETED|2nd Year||3965
8315725|NCT01454583|20502307|P3|COMPLETED|2nd Year||1376
8315726|NCT01454583|20502308|P2|COMPLETED|2nd Year||1647
8315727|NCT01454583|20502309|P1|COMPLETED|2nd Year||6212
8315728|NCT01454583|20502307|P3|STARTED|2nd Year||2113
8315729|NCT01454583|20502308|P2|STARTED|2nd Year||2696
8315730|NCT01454583|20502309|P1|STARTED|2nd Year||10177
8315731|NCT01454583|20502307|P3|NOT COMPLETED|1st Year||180
8315732|NCT01454583|20502308|P2|NOT COMPLETED|1st Year||318
8315733|NCT01454583|20502309|P1|NOT COMPLETED|1st Year||1057
8315734|NCT01454583|20502307|P3|COMPLETED|1st Year||1933
8315735|NCT01454583|20502308|P2|COMPLETED|1st Year||2378
8315736|NCT01454583|20502309|P1|COMPLETED|1st Year||9120
8315737|NCT01454583|20502307|P3|STARTED|1st Year||2113
8315738|NCT01454583|20502308|P2|STARTED|1st Year||2696
8315739|NCT01454583|20502309|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
8315740|NCT01454570|20502377|P1|NOT COMPLETED|Overall Study||9
8315741|NCT01454570|20502377|P1|COMPLETED|Overall Study||10
8315742|NCT01454570|20502377|P1|STARTED|Overall Study||19
8315743|NCT01454531|20502381|P1|NOT COMPLETED|Overall Study||23
8315744|NCT01454531|20502381|P1|COMPLETED|Overall Study||173
8315745|NCT01454531|20502381|P1|Subjects Treated|Overall Study||192
8315746|NCT01454531|20502381|P1|STARTED|Overall Study||196
8315747|NCT01454505|20502393|P4|NOT COMPLETED|Overall Study||0
8315748|NCT01454505|20502394|P3|NOT COMPLETED|Overall Study||0
8315749|NCT01454505|20502395|P2|NOT COMPLETED|Overall Study||0
8315750|NCT01454505|20502396|P1|NOT COMPLETED|Overall Study||0
8315751|NCT01454505|20502393|P4|COMPLETED|Overall Study||20
8315752|NCT01454505|20502394|P3|COMPLETED|Overall Study||40
8315753|NCT01454505|20502395|P2|COMPLETED|Overall Study||15
8315754|NCT01454505|20502396|P1|COMPLETED|Overall Study||35
8315755|NCT01454505|20502393|P4|STARTED|Overall Study||20
8315756|NCT01454505|20502394|P3|STARTED|Overall Study||40
8315757|NCT01454505|20502395|P2|STARTED|Overall Study||15
8315758|NCT01454505|20502396|P1|STARTED|Overall Study||35
8315759|NCT01454414|20502410|P2|NOT COMPLETED|Overall Study||16
8315760|NCT01454414|20502411|P1|NOT COMPLETED|Overall Study||13
8315761|NCT01454414|20502410|P2|COMPLETED|Overall Study||64
8315762|NCT01454414|20502411|P1|COMPLETED|Overall Study||66
8315763|NCT01454414|20502410|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
8315764|NCT01454414|20502411|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
8315765|NCT01454414|20502410|P2|STARTED|Overall Study||80
8315766|NCT01454414|20502411|P1|STARTED|Overall Study||79
8315767|NCT01454401|20502417|P1|NOT COMPLETED|Overall Study||5
8315768|NCT01454401|20502417|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
8315769|NCT01454401|20502417|P1|STARTED|Overall Study|ITT|44
8315770|NCT01454362|20502424|P2|NOT COMPLETED|Overall Study||0
8315771|NCT01454362|20502425|P1|NOT COMPLETED|Overall Study||0
8315772|NCT01454362|20502424|P2|COMPLETED|Overall Study||23
8315773|NCT01454362|20502425|P1|COMPLETED|Overall Study||28
8315774|NCT01454362|20502424|P2|STARTED|Overall Study||23
8315775|NCT01454362|20502425|P1|STARTED|Overall Study||28
8315776|NCT01454284|20502441|P2|NOT COMPLETED|Overall Study||73
8315777|NCT01454284|20502442|P1|NOT COMPLETED|Overall Study||116
8315778|NCT01454284|20502441|P2|COMPLETED|Overall Study||377
8315779|NCT01454284|20502442|P1|COMPLETED|Overall Study||548
8315780|NCT01454284|20502441|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
8315781|NCT01454284|20502442|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
8315782|NCT01454284|20502441|P2|STARTED|Overall Study||450
8315783|NCT01454284|20502442|P1|STARTED|Overall Study||664
8315784|NCT01454258|20502490|P1|NOT COMPLETED|Overall Study||997
8315785|NCT01454258|20502490|P1|COMPLETED|Overall Study||9103
8315786|NCT01454258|20502490|P1|STARTED|Overall Study||10100
8315787|NCT01454102|20502512|P16|NOT COMPLETED|Overall Study||1
8315788|NCT01454102|20502513|P15|NOT COMPLETED|Overall Study||3
8315789|NCT01454102|20502514|P14|NOT COMPLETED|Overall Study||4
8315790|NCT01454102|20502515|P13|NOT COMPLETED|Overall Study||7
8315791|NCT01454102|20502516|P12|NOT COMPLETED|Overall Study||4
8315792|NCT01454102|20502517|P11|NOT COMPLETED|Overall Study||0
8315793|NCT01454102|20502518|P10|NOT COMPLETED|Overall Study||0
8315794|NCT01454102|20502519|P9|NOT COMPLETED|Overall Study||1
8315795|NCT01454102|20502520|P8|NOT COMPLETED|Overall Study||0
8315796|NCT01454102|20502521|P7|NOT COMPLETED|Overall Study||2
8315797|NCT01454102|20502522|P6|NOT COMPLETED|Overall Study||3
8315798|NCT01454102|20502523|P5|NOT COMPLETED|Overall Study||3
8315799|NCT01454102|20502524|P4|NOT COMPLETED|Overall Study||0
8315800|NCT01454102|20502525|P3|NOT COMPLETED|Overall Study||0
8315801|NCT01454102|20502526|P2|NOT COMPLETED|Overall Study||0
8315802|NCT01454102|20502527|P1|NOT COMPLETED|Overall Study||0
8315803|NCT01454102|20502512|P16|COMPLETED|Overall Study||13
8315804|NCT01454102|20502513|P15|COMPLETED|Overall Study||36
8315805|NCT01454102|20502514|P14|COMPLETED|Overall Study||34
8315806|NCT01454102|20502515|P13|COMPLETED|Overall Study||33
8315807|NCT01454102|20502516|P12|COMPLETED|Overall Study||27
8315808|NCT01454102|20502517|P11|COMPLETED|Overall Study||12
8315809|NCT01454102|20502518|P10|COMPLETED|Overall Study||13
8315810|NCT01454102|20502519|P9|COMPLETED|Overall Study||12
8315811|NCT01454102|20502520|P8|COMPLETED|Overall Study||25
8315812|NCT01454102|20502521|P7|COMPLETED|Overall Study||22
8315813|NCT01454102|20502522|P6|COMPLETED|Overall Study||49
8315814|NCT01454102|20502523|P5|COMPLETED|Overall Study||18
8315815|NCT01454102|20502524|P4|COMPLETED|Overall Study||12
8315816|NCT01454102|20502525|P3|COMPLETED|Overall Study||15
8315817|NCT01454102|20502526|P2|COMPLETED|Overall Study||15
8315818|NCT01454102|20502527|P1|COMPLETED|Overall Study||12
8315819|NCT01454102|20502512|P16|STARTED|Overall Study||14
8315820|NCT01454102|20502513|P15|STARTED|Overall Study||39
8315821|NCT01454102|20502514|P14|STARTED|Overall Study||38
8315822|NCT01454102|20502515|P13|STARTED|Overall Study||40
8315823|NCT01454102|20502516|P12|STARTED|Overall Study||31
8315824|NCT01454102|20502517|P11|STARTED|Overall Study||12
8315825|NCT01454102|20502518|P10|STARTED|Overall Study||13
8315826|NCT01454102|20502519|P9|STARTED|Overall Study||13
8315827|NCT01454102|20502520|P8|STARTED|Overall Study||25
8315828|NCT01454102|20502521|P7|STARTED|Overall Study||24
8315829|NCT01454102|20502522|P6|STARTED|Overall Study||52
8315830|NCT01454102|20502523|P5|STARTED|Overall Study||21
8315831|NCT01454102|20502524|P4|STARTED|Overall Study||12
8315832|NCT01454102|20502525|P3|STARTED|Overall Study||15
8315833|NCT01454102|20502526|P2|STARTED|Overall Study||15
8315834|NCT01454102|20502527|P1|STARTED|Overall Study||12
8315835|NCT01454076|20502647|P5|NOT COMPLETED|Overall Study||6
8315836|NCT01454076|20502648|P4|NOT COMPLETED|Overall Study||2
8315837|NCT01454076|20502649|P3|NOT COMPLETED|Overall Study||9
8315838|NCT01454076|20502650|P2|NOT COMPLETED|Overall Study||6
8315839|NCT01454076|20502651|P1|NOT COMPLETED|Overall Study||13
8315840|NCT01454076|20502647|P5|COMPLETED|Overall Study||15
8315841|NCT01454076|20502648|P4|COMPLETED|Overall Study||16
8315842|NCT01454076|20502649|P3|COMPLETED|Overall Study||15
8315843|NCT01454076|20502650|P2|COMPLETED|Overall Study||14
8315844|NCT01454076|20502651|P1|COMPLETED|Overall Study||16
8315845|NCT01454076|20502647|P5|STARTED|Overall Study||21
8315846|NCT01454076|20502648|P4|STARTED|Overall Study||18
8315847|NCT01454076|20502649|P3|STARTED|Overall Study||24
8315848|NCT01454076|20502650|P2|STARTED|Overall Study||20
8315849|NCT01454076|20502651|P1|STARTED|Overall Study||29
8315850|NCT01454063|20502704|P2|NOT COMPLETED|Treated||0
8315851|NCT01454063|20502705|P1|NOT COMPLETED|Treated||2
8315852|NCT01454063|20502704|P2|COMPLETED|Treated||201
8315853|NCT01454063|20502705|P1|COMPLETED|Treated||199
8315854|NCT01454063|20502704|P2|STARTED|Treated||201
8315855|NCT01454063|20502705|P1|STARTED|Treated||201
8315856|NCT01454063|20502704|P2|NOT COMPLETED|Randomized||2
8315857|NCT01454063|20502705|P1|NOT COMPLETED|Randomized||1
8315858|NCT01454063|20502704|P2|COMPLETED|Randomized||201
8315859|NCT01454063|20502705|P1|COMPLETED|Randomized||201
8315860|NCT01454063|20502704|P2|STARTED|Randomized||203
8315861|NCT01454063|20502705|P1|STARTED|Randomized||202
8315862|NCT01453998|20502726|P3|NOT COMPLETED|After Protocol Amendment 2.||0
8315863|NCT01453998|20502727|P2|NOT COMPLETED|After Protocol Amendment 2.||0
8315864|NCT01453998|20502728|P1|NOT COMPLETED|After Protocol Amendment 2.||1
8315865|NCT01453998|20502726|P3|COMPLETED|After Protocol Amendment 2.||124
8315866|NCT01453998|20502727|P2|COMPLETED|After Protocol Amendment 2.||130
8315867|NCT01453998|20502728|P1|COMPLETED|After Protocol Amendment 2.||130
8315868|NCT01453998|20502726|P3|STARTED|After Protocol Amendment 2.||124
8315869|NCT01453998|20502727|P2|STARTED|After Protocol Amendment 2.||130
8315870|NCT01453998|20502728|P1|STARTED|After Protocol Amendment 2.||131
8315871|NCT01453998|20502726|P3|NOT COMPLETED|Before Protocol Amendment 2||0
8315872|NCT01453998|20502727|P2|NOT COMPLETED|Before Protocol Amendment 2||0
8315873|NCT01453998|20502728|P1|NOT COMPLETED|Before Protocol Amendment 2||0
8315874|NCT01453998|20502726|P3|COMPLETED|Before Protocol Amendment 2||99
8315875|NCT01453998|20502727|P2|COMPLETED|Before Protocol Amendment 2||88
8315876|NCT01453998|20502728|P1|COMPLETED|Before Protocol Amendment 2||85
8315877|NCT01453998|20502726|P3|STARTED|Before Protocol Amendment 2||99
8315878|NCT01453998|20502727|P2|STARTED|Before Protocol Amendment 2||88
8315879|NCT01453998|20502728|P1|STARTED|Before Protocol Amendment 2||85
8315880|NCT01453946|20502892|P1|NOT COMPLETED|Overall Study||9
8315881|NCT01453946|20502892|P1|COMPLETED|Overall Study||41
8315882|NCT01453946|20502892|P1|STARTED|Overall Study||50
8315883|NCT01453894|20502900|P2|NOT COMPLETED|Overall Study||0
8315884|NCT01453894|20502901|P1|NOT COMPLETED|Overall Study||0
8315885|NCT01453894|20502900|P2|COMPLETED|Overall Study||225
8315886|NCT01453894|20502901|P1|COMPLETED|Overall Study||225
8315887|NCT01453894|20502900|P2|STARTED|Overall Study||225
8315888|NCT01453894|20502901|P1|STARTED|Overall Study||225
8315889|NCT01453855|20502909|P2|NOT COMPLETED|Overall Study||14
8315890|NCT01453855|20502910|P1|NOT COMPLETED|Overall Study||10
8315891|NCT01453855|20502909|P2|COMPLETED|Overall Study||408
8315892|NCT01453855|20502910|P1|COMPLETED|Overall Study||432
8315893|NCT01453855|20502909|P2|STARTED|Overall Study||422
8315894|NCT01453855|20502910|P1|STARTED|Overall Study||442
8315895|NCT01453725|20502918|P2|NOT COMPLETED|Overall Study||11
8315896|NCT01453725|20502919|P1|NOT COMPLETED|Overall Study||13
8315897|NCT01453725|20502918|P2|COMPLETED|Overall Study||89
8315898|NCT01453725|20502919|P1|COMPLETED|Overall Study||85
8315899|NCT01453725|20502918|P2|STARTED|Overall Study||100
8315900|NCT01453725|20502919|P1|STARTED|Overall Study||98
8315901|NCT01453595|20502942|P3|NOT COMPLETED|Overall Study||2
8315902|NCT01453595|20502943|P2|NOT COMPLETED|Overall Study||1
8315903|NCT01453595|20502944|P1|NOT COMPLETED|Overall Study||2
8315904|NCT01453595|20502942|P3|COMPLETED|Overall Study||0
8315905|NCT01453595|20502943|P2|COMPLETED|Overall Study||5
8315906|NCT01453595|20502944|P1|COMPLETED|Overall Study||0
8315907|NCT01453595|20502942|P3|STARTED|Overall Study||2
8315908|NCT01453595|20502943|P2|STARTED|Overall Study||6
8315909|NCT01453595|20502944|P1|STARTED|Overall Study||2
8315910|NCT01453569|20502953|P3|NOT COMPLETED|Overall Study||7
8315911|NCT01453569|20502954|P2|NOT COMPLETED|Overall Study||14
8315912|NCT01453569|20502955|P1|NOT COMPLETED|Overall Study||11
8315913|NCT01453569|20502953|P3|COMPLETED|Overall Study||78
8315914|NCT01453569|20502954|P2|COMPLETED|Overall Study||70
8315915|NCT01453569|20502955|P1|COMPLETED|Overall Study||75
8315916|NCT01453569|20502953|P3|STARTED|Overall Study||85
8315917|NCT01453569|20502954|P2|STARTED|Overall Study||84
8315918|NCT01453569|20502955|P1|STARTED|Overall Study||86
8315919|NCT01453439|20502974|P2|NOT COMPLETED|Follow-up||11
8315920|NCT01453439|20502975|P1|NOT COMPLETED|Follow-up||5
8315921|NCT01453439|20502974|P2|COMPLETED|Follow-up||37
8315922|NCT01453439|20502975|P1|COMPLETED|Follow-up||39
8315923|NCT01453439|20502974|P2|STARTED|Follow-up||48
8315924|NCT01453439|20502975|P1|STARTED|Follow-up||44
8315925|NCT01453439|20502974|P2|NOT COMPLETED|Treatment Phase||11
8315926|NCT01453439|20502975|P1|NOT COMPLETED|Treatment Phase||17
8315927|NCT01453439|20502974|P2|COMPLETED|Treatment Phase||48
8315928|NCT01453439|20502975|P1|COMPLETED|Treatment Phase||44
8315929|NCT01453439|20502974|P2|STARTED|Treatment Phase||59
8315930|NCT01453439|20502975|P1|STARTED|Treatment Phase||61
8315931|NCT01453413|20502995|P1|NOT COMPLETED|Overall Study||0
8315932|NCT01453413|20502995|P1|COMPLETED|Overall Study||297
8315933|NCT01453413|20502995|P1|STARTED|Overall Study||297
8315934|NCT01453387|20503002|P2|NOT COMPLETED|Overall Study||0
8315935|NCT01453387|20503003|P1|NOT COMPLETED|Overall Study||0
8315936|NCT01453387|20503002|P2|COMPLETED|Overall Study||7
8315937|NCT01453387|20503003|P1|COMPLETED|Overall Study||21
8315938|NCT01453387|20503002|P2|STARTED|Overall Study||7
8315939|NCT01453387|20503003|P1|STARTED|Overall Study||21
8315940|NCT01453374|20503086|P1|NOT COMPLETED|Overall Study||18
8315941|NCT01453374|20503086|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
8315942|NCT01453374|20503086|P1|STARTED|Overall Study||27
8315943|NCT01453361|20503102|P1|NOT COMPLETED|Overall Study||16
8315944|NCT01453361|20503102|P1|COMPLETED|Overall Study||2
8315945|NCT01453361|20503102|P1|STARTED|Overall Study||18
8315946|NCT01453348|20503110|P3|NOT COMPLETED|Overall Study||1
8315947|NCT01453348|20503111|P2|NOT COMPLETED|Overall Study||1
8315948|NCT01453348|20503112|P1|NOT COMPLETED|Overall Study||1
8315949|NCT01453348|20503110|P3|COMPLETED|Overall Study||83
8315950|NCT01453348|20503111|P2|COMPLETED|Overall Study||83
8315951|NCT01453348|20503112|P1|COMPLETED|Overall Study||83
8315952|NCT01453348|20503110|P3|STARTED|Overall Study||84
8315953|NCT01453348|20503111|P2|STARTED|Overall Study||84
8315954|NCT01453348|20503112|P1|STARTED|Overall Study||84
8315955|NCT01453296|20503128|P2|NOT COMPLETED|Treatment Period 2||0
8315956|NCT01453296|20503129|P1|NOT COMPLETED|Treatment Period 2||2
8315957|NCT01453296|20503128|P2|COMPLETED|Treatment Period 2||13
8315958|NCT01453296|20503129|P1|COMPLETED|Treatment Period 2||11
8315959|NCT01453296|20503128|P2|STARTED|Treatment Period 2||13
8315960|NCT01453296|20503129|P1|STARTED|Treatment Period 2||13
8315961|NCT01453296|20503128|P2|NOT COMPLETED|Washout Period||0
8315962|NCT01453296|20503129|P1|NOT COMPLETED|Washout Period||0
8315963|NCT01453296|20503128|P2|COMPLETED|Washout Period||13
8315964|NCT01453296|20503129|P1|COMPLETED|Washout Period||13
8315965|NCT01453296|20503128|P2|STARTED|Washout Period||13
8315966|NCT01453296|20503129|P1|STARTED|Washout Period||13
8315967|NCT01453296|20503128|P2|NOT COMPLETED|Treatment Period 1||1
8315968|NCT01453296|20503129|P1|NOT COMPLETED|Treatment Period 1||1
8315969|NCT01453296|20503128|P2|COMPLETED|Treatment Period 1||13
8315970|NCT01453296|20503129|P1|COMPLETED|Treatment Period 1||13
8315971|NCT01453296|20503128|P2|STARTED|Treatment Period 1||14
8315972|NCT01453296|20503129|P1|STARTED|Treatment Period 1||14
8315973|NCT01453205|20503196|P3|NOT COMPLETED|Overall Study||54
8315974|NCT01453205|20503197|P2|NOT COMPLETED|Overall Study||52
8315975|NCT01453205|20503198|P1|NOT COMPLETED|Overall Study||80
8315976|NCT01453205|20503196|P3|COMPLETED|Overall Study||1
8315977|NCT01453205|20503197|P2|COMPLETED|Overall Study||0
8315978|NCT01453205|20503198|P1|COMPLETED|Overall Study||0
8315979|NCT01453205|20503196|P3|STARTED|Overall Study||55
8315980|NCT01453205|20503197|P2|STARTED|Overall Study||52
8315981|NCT01453205|20503198|P1|STARTED|Overall Study||80
8315982|NCT01453166|20503249|P3|NOT COMPLETED|Overall Study||1
8315983|NCT01453166|20503250|P2|NOT COMPLETED|Overall Study||2
8315984|NCT01453166|20503251|P1|NOT COMPLETED|Overall Study||2
8315985|NCT01453166|20503249|P3|COMPLETED|Overall Study||38
8315986|NCT01453166|20503250|P2|COMPLETED|Overall Study||39
8315987|NCT01453166|20503251|P1|COMPLETED|Overall Study||40
8315988|NCT01453166|20503249|P3|STARTED|Overall Study||39
8315989|NCT01453166|20503250|P2|STARTED|Overall Study||41
8315990|NCT01453166|20503251|P1|STARTED|Overall Study||42
8315991|NCT01453153|20503274|P3|NOT COMPLETED|Overall Study||20
8315992|NCT01453153|20503275|P2|NOT COMPLETED|Overall Study||4
8315993|NCT01453153|20503276|P1|NOT COMPLETED|Overall Study||4
8315994|NCT01453153|20503274|P3|COMPLETED|Overall Study||0
8315995|NCT01453153|20503275|P2|COMPLETED|Overall Study||0
8315996|NCT01453153|20503276|P1|COMPLETED|Overall Study||0
8315997|NCT01453153|20503274|P3|STARTED|Overall Study||20
8315998|NCT01453153|20503275|P2|STARTED|Overall Study||4
8315999|NCT01453153|20503276|P1|STARTED|Overall Study||4
8316000|NCT01453075|20503349|P2|NOT COMPLETED|Overall Study||1
8316001|NCT01453075|20503350|P1|NOT COMPLETED|Overall Study||5
8316002|NCT01453075|20503349|P2|COMPLETED|Overall Study||14
8316003|NCT01453075|20503350|P1|COMPLETED|Overall Study||11
8316004|NCT01453075|20503349|P2|STARTED|Overall Study||15
8316005|NCT01453075|20503350|P1|STARTED|Overall Study||16
8316006|NCT01453049|20503358|P2|NOT COMPLETED|Overall Study||42
8316007|NCT01453049|20503359|P1|NOT COMPLETED|Overall Study||41
8316008|NCT01453049|20503358|P2|COMPLETED|Overall Study||2
8316009|NCT01453049|20503359|P1|COMPLETED|Overall Study||1
8316010|NCT01453049|20503358|P2|STARTED|Overall Study||44
8316011|NCT01453049|20503359|P1|STARTED|Overall Study||42
8316012|NCT01453036|20503432|P3|NOT COMPLETED|Overall Study||31
8316013|NCT01453036|20503433|P2|NOT COMPLETED|Overall Study||115
8316014|NCT01453036|20503434|P1|NOT COMPLETED|Overall Study||26
8316015|NCT01453036|20503432|P3|COMPLETED|Overall Study||277
8316016|NCT01453036|20503433|P2|COMPLETED|Overall Study||193
8316017|NCT01453036|20503434|P1|COMPLETED|Overall Study||282
8316018|NCT01453036|20503432|P3|STARTED|Overall Study||308
8316019|NCT01453036|20503433|P2|STARTED|Overall Study||308
8316020|NCT01453036|20503434|P1|STARTED|Overall Study||308
8316021|NCT01453023|20503442|P2|NOT COMPLETED|Treatment Period 2||1
8316022|NCT01453023|20503443|P1|NOT COMPLETED|Treatment Period 2||0
8316023|NCT01453023|20503442|P2|COMPLETED|Treatment Period 2||11
8316024|NCT01453023|20503443|P1|COMPLETED|Treatment Period 2||12
8316025|NCT01453023|20503442|P2|STARTED|Treatment Period 2||12
8316026|NCT01453023|20503443|P1|STARTED|Treatment Period 2||12
8316027|NCT01453023|20503442|P2|NOT COMPLETED|Washout Period||0
8316028|NCT01453023|20503443|P1|NOT COMPLETED|Washout Period||0
8316029|NCT01453023|20503442|P2|COMPLETED|Washout Period||12
8316030|NCT01453023|20503443|P1|COMPLETED|Washout Period||12
8316031|NCT01453023|20503442|P2|STARTED|Washout Period||12
8316032|NCT01453023|20503443|P1|STARTED|Washout Period||12
8316033|NCT01453023|20503442|P2|NOT COMPLETED|Treatment Period (TP) 1||1
8316034|NCT01453023|20503443|P1|NOT COMPLETED|Treatment Period (TP) 1||1
8316035|NCT01453023|20503442|P2|COMPLETED|Treatment Period (TP) 1||12
8316036|NCT01453023|20503443|P1|COMPLETED|Treatment Period (TP) 1||12
8316037|NCT01453023|20503442|P2|STARTED|Treatment Period (TP) 1||13
8316038|NCT01453023|20503443|P1|STARTED|Treatment Period (TP) 1||13
8316039|NCT01452854|20503511|P1|NOT COMPLETED|Overall Study||0
8316040|NCT01452854|20503511|P1|COMPLETED|Overall Study||2
8316041|NCT01452854|20503511|P1|STARTED|Overall Study||2
8316042|NCT01452789|20503517|P2|NOT COMPLETED|Overall Study||2
8316043|NCT01452789|20503518|P1|NOT COMPLETED|Overall Study||3
8316044|NCT01452789|20503517|P2|COMPLETED|Overall Study||28
8316045|NCT01452789|20503518|P1|COMPLETED|Overall Study||30
8316046|NCT01452789|20503517|P2|STARTED|Overall Study||30
8316047|NCT01452789|20503518|P1|STARTED|Overall Study||33
8316048|NCT01452529|20503532|P3|NOT COMPLETED|Double-blind (DB) Period||82
8316049|NCT01452529|20503533|P2|NOT COMPLETED|Double-blind (DB) Period||67
8316050|NCT01452529|20503534|P1|NOT COMPLETED|Double-blind (DB) Period||0
8316051|NCT01452529|20503532|P3|COMPLETED|Double-blind (DB) Period||210
8316052|NCT01452529|20503533|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
8316053|NCT01452529|20503534|P1|COMPLETED|Double-blind (DB) Period||0
8316054|NCT01452529|20503532|P3|STARTED|Double-blind (DB) Period||292
8316055|NCT01452529|20503533|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
8316056|NCT01452529|20503534|P1|STARTED|Double-blind (DB) Period||0
8316057|NCT01452529|20503532|P3|NOT COMPLETED|Run-in Period||0
8316058|NCT01452529|20503533|P2|NOT COMPLETED|Run-in Period||0
8316059|NCT01452529|20503534|P1|NOT COMPLETED|Run-in Period||313
8316060|NCT01452529|20503532|P3|COMPLETED|Run-in Period||0
8316061|NCT01452529|20503533|P2|COMPLETED|Run-in Period||0
8316062|NCT01452529|20503534|P1|COMPLETED|Run-in Period||592
8316063|NCT01452529|20503532|P3|STARTED|Run-in Period||0
8316064|NCT01452529|20503533|P2|STARTED|Run-in Period||0
8316065|NCT01452529|20503534|P1|STARTED|Run-in Period||905
8316066|NCT01452425|20503549|P1|NOT COMPLETED|Overall Study||0
8316067|NCT01452425|20503549|P1|COMPLETED|Overall Study||10
8316068|NCT01452425|20503549|P1|STARTED|Overall Study||10
8316069|NCT01452412|20503556|P2|NOT COMPLETED|Overall Study||17
8316070|NCT01452412|20503557|P1|NOT COMPLETED|Overall Study||28
8316071|NCT01452412|20503556|P2|COMPLETED|Overall Study||58
8316072|NCT01452412|20503557|P1|COMPLETED|Overall Study||46
8316073|NCT01452412|20503556|P2|STARTED|Overall Study||75
8316074|NCT01452412|20503557|P1|STARTED|Overall Study||74
8316075|NCT01452347|20503573|P2|NOT COMPLETED|Overall Study||7
8316076|NCT01452347|20503574|P1|NOT COMPLETED|Overall Study||17
8316077|NCT01452347|20503573|P2|COMPLETED|Overall Study||77
8316078|NCT01452347|20503574|P1|COMPLETED|Overall Study||151
8316079|NCT01452347|20503573|P2|STARTED|Overall Study||84
8316080|NCT01452347|20503574|P1|STARTED|Overall Study||168
8316081|NCT01452269|20503592|P2|NOT COMPLETED|Overall Study||5
8316082|NCT01452269|20503593|P1|NOT COMPLETED|Overall Study||1
8316083|NCT01452269|20503592|P2|COMPLETED|Overall Study||51
8316084|NCT01452269|20503593|P1|COMPLETED|Overall Study||47
8316085|NCT01452269|20503592|P2|STARTED|Overall Study||56
8316086|NCT01452269|20503593|P1|STARTED|Overall Study||48
8316087|NCT01452191|20503606|P3|NOT COMPLETED|Overall Study||112
8316088|NCT01452191|20503607|P2|NOT COMPLETED|Overall Study||117
8316089|NCT01452191|20503608|P1|NOT COMPLETED|Overall Study||132
8316090|NCT01452191|20503606|P3|COMPLETED|Overall Study||258
8316091|NCT01452191|20503607|P2|COMPLETED|Overall Study||252
8316092|NCT01452191|20503608|P1|COMPLETED|Overall Study||241
8316093|NCT01452191|20503606|P3|STARTED|Overall Study||370
8316094|NCT01452191|20503607|P2|STARTED|Overall Study||369
8316095|NCT01452191|20503608|P1|STARTED|Overall Study||373
8316096|NCT01452152|20503634|P3|NOT COMPLETED|Overall Study||4
8316097|NCT01452152|20503635|P2|NOT COMPLETED|Overall Study||0
8316098|NCT01452152|20503636|P1|NOT COMPLETED|Overall Study||5
8316099|NCT01452152|20503634|P3|COMPLETED|Overall Study||0
8316100|NCT01452152|20503635|P2|COMPLETED|Overall Study||0
8316101|NCT01452152|20503636|P1|COMPLETED|Overall Study||0
8316102|NCT01452152|20503634|P3|STARTED|Overall Study||4
8316103|NCT01452152|20503635|P2|STARTED|Overall Study||0
8316104|NCT01452152|20503636|P1|STARTED|Overall Study||5
8316105|NCT01452126|20503659|P1|NOT COMPLETED|Overall Study||0
8316106|NCT01452126|20503659|P1|COMPLETED|Overall Study||49
8316107|NCT01452126|20503659|P1|STARTED|Overall Study||49
8316108|NCT01451996|20503671|P4|NOT COMPLETED|Overall Study||0
8316109|NCT01451996|20503672|P3|NOT COMPLETED|Overall Study||0
8316110|NCT01451996|20503673|P2|NOT COMPLETED|Overall Study||0
8316111|NCT01451996|20503674|P1|NOT COMPLETED|Overall Study||0
8316112|NCT01451996|20503671|P4|COMPLETED|Overall Study||85
8316113|NCT01451996|20503672|P3|COMPLETED|Overall Study||85
8316114|NCT01451996|20503673|P2|COMPLETED|Overall Study||87
8316115|NCT01451996|20503674|P1|COMPLETED|Overall Study||83
8316116|NCT01451996|20503671|P4|STARTED|Overall Study||85
8316117|NCT01451996|20503672|P3|STARTED|Overall Study||85
8316118|NCT01451996|20503673|P2|STARTED|Overall Study||87
8316119|NCT01451996|20503674|P1|STARTED|Overall Study||83
8316120|NCT01451983|20503692|P4|NOT COMPLETED|Overall Study||0
8316121|NCT01451983|20503693|P3|NOT COMPLETED|Overall Study||0
8316122|NCT01451983|20503694|P2|NOT COMPLETED|Overall Study||0
8316123|NCT01451983|20503695|P1|NOT COMPLETED|Overall Study||0
8316124|NCT01451983|20503692|P4|COMPLETED|Overall Study||24
8316125|NCT01451983|20503693|P3|COMPLETED|Overall Study||61
8316126|NCT01451983|20503694|P2|COMPLETED|Overall Study||27
8316127|NCT01451983|20503695|P1|COMPLETED|Overall Study||26
8316128|NCT01451983|20503692|P4|STARTED|Overall Study||24
8316129|NCT01451983|20503693|P3|STARTED|Overall Study||61
8316130|NCT01451983|20503694|P2|STARTED|Overall Study||27
8316131|NCT01451983|20503695|P1|STARTED|Overall Study||26
8316132|NCT01451931|20503708|P3|NOT COMPLETED|Overall Study||43
8316133|NCT01451931|20503709|P2|NOT COMPLETED|Overall Study||58
8316134|NCT01451931|20503710|P1|NOT COMPLETED|Overall Study||33
8316135|NCT01451931|20503708|P3|COMPLETED|Overall Study||923
8316136|NCT01451931|20503709|P2|COMPLETED|Overall Study||843
8316137|NCT01451931|20503710|P1|COMPLETED|Overall Study||876
8316138|NCT01451931|20503708|P3|6-month Follow up|Overall Study||923
8316139|NCT01451931|20503709|P2|6-month Follow up|Overall Study||843
8316140|NCT01451931|20503710|P1|6-month Follow up|Overall Study||876
8316141|NCT01451931|20503708|P3|Baseline Data Collection|Overall Study||958
8316142|NCT01451931|20503709|P2|Baseline Data Collection|Overall Study||893
8316143|NCT01451931|20503710|P1|Baseline Data Collection|Overall Study||908
8316144|NCT01451931|20503708|P3|STARTED|Overall Study||966
8316145|NCT01451931|20503709|P2|STARTED|Overall Study||901
8316146|NCT01451931|20503710|P1|STARTED|Overall Study||909
8316147|NCT01451827|20503734|P4|NOT COMPLETED|Overall Study||4
8316148|NCT01451827|20503735|P3|NOT COMPLETED|Overall Study||2
8316149|NCT01451827|20503736|P2|NOT COMPLETED|Overall Study||5
8316150|NCT01451827|20503737|P1|NOT COMPLETED|Overall Study||3
8316151|NCT01451827|20503734|P4|COMPLETED|Overall Study||39
8316152|NCT01451827|20503735|P3|COMPLETED|Overall Study||42
8316153|NCT01451827|20503736|P2|COMPLETED|Overall Study||40
8316154|NCT01451827|20503737|P1|COMPLETED|Overall Study||42
8316155|NCT01451827|20503734|P4|STARTED|Overall Study||43
8316156|NCT01451827|20503735|P3|STARTED|Overall Study||44
8316157|NCT01451827|20503736|P2|STARTED|Overall Study||45
8316158|NCT01451827|20503737|P1|STARTED|Overall Study||45
8316159|NCT01451814|20503757|P2|NOT COMPLETED|Overall Study||5
8316160|NCT01451814|20503758|P1|NOT COMPLETED|Overall Study||6
8316161|NCT01451814|20503757|P2|COMPLETED|Overall Study||26
8316162|NCT01451814|20503758|P1|COMPLETED|Overall Study||29
8316163|NCT01451814|20503757|P2|Attended a Session|Overall Study||31
8316164|NCT01451814|20503758|P1|Attended a Session|Overall Study||35
8316165|NCT01451814|20503757|P2|STARTED|Overall Study||31
8316166|NCT01451814|20503758|P1|STARTED|Overall Study||35
8316167|NCT01451775|20503768|P6|NOT COMPLETED|Overall Study||0
8316168|NCT01451775|20503769|P5|NOT COMPLETED|Overall Study||0
8316169|NCT01451775|20503770|P4|NOT COMPLETED|Overall Study||0
8316170|NCT01451775|20503771|P3|NOT COMPLETED|Overall Study||0
8316171|NCT01451775|20503772|P2|NOT COMPLETED|Overall Study||0
8316172|NCT01451775|20503773|P1|NOT COMPLETED|Overall Study||0
8316173|NCT01451775|20503768|P6|COMPLETED|Overall Study||3
8316174|NCT01451775|20503769|P5|COMPLETED|Overall Study||3
8316175|NCT01451775|20503770|P4|COMPLETED|Overall Study||3
8316176|NCT01451775|20503771|P3|COMPLETED|Overall Study||3
8316177|NCT01451775|20503772|P2|COMPLETED|Overall Study||3
8316178|NCT01451775|20503773|P1|COMPLETED|Overall Study||3
8316179|NCT01451775|20503768|P6|STARTED|Overall Study||3
8316180|NCT01451775|20503769|P5|STARTED|Overall Study||3
8316181|NCT01451775|20503770|P4|STARTED|Overall Study||3
8316182|NCT01451775|20503771|P3|STARTED|Overall Study||3
8316183|NCT01451775|20503772|P2|STARTED|Overall Study||3
8316184|NCT01451775|20503773|P1|STARTED|Overall Study||3
8316185|NCT01451762|20503790|P3|NOT COMPLETED|Overall Study||6
8316186|NCT01451762|20503791|P2|NOT COMPLETED|Overall Study||6
8316187|NCT01451762|20503792|P1|NOT COMPLETED|Overall Study||3
8316188|NCT01451762|20503790|P3|COMPLETED|Overall Study||24
8316189|NCT01451762|20503791|P2|COMPLETED|Overall Study||24
8316190|NCT01451762|20503792|P1|COMPLETED|Overall Study||27
8316191|NCT01451762|20503790|P3|STARTED|Overall Study||30
8316192|NCT01451762|20503791|P2|STARTED|Overall Study||30
8316193|NCT01451762|20503792|P1|STARTED|Overall Study||30
8316194|NCT01451749|20503802|P2|NOT COMPLETED|Overall Study||14
8316195|NCT01451749|20503803|P1|NOT COMPLETED|Overall Study||32
8316196|NCT01451749|20503802|P2|COMPLETED|Overall Study||94
8316197|NCT01451749|20503803|P1|COMPLETED|Overall Study||184
8316198|NCT01451749|20503802|P2|STARTED|Overall Study||108
8316199|NCT01451749|20503803|P1|STARTED|Overall Study||216
8316200|NCT01451723|20503815|P2|NOT COMPLETED|Overall Study||5
8316201|NCT01451723|20503816|P1|NOT COMPLETED|Overall Study||6
8316202|NCT01451723|20503815|P2|COMPLETED|Overall Study||0
8316203|NCT01451723|20503816|P1|COMPLETED|Overall Study||0
8316204|NCT01451723|20503815|P2|STARTED|Overall Study||5
8316205|NCT01451723|20503816|P1|STARTED|Overall Study||6
8316206|NCT01451645|20503826|P2|NOT COMPLETED|Overall Study||8
8316207|NCT01451645|20503827|P1|NOT COMPLETED|Overall Study||9
8316208|NCT01451645|20503826|P2|COMPLETED|Overall Study||33
8316209|NCT01451645|20503827|P1|COMPLETED|Overall Study||32
8316210|NCT01451645|20503826|P2|STARTED|Overall Study||41
8316211|NCT01451645|20503827|P1|STARTED|Overall Study||41
8316212|NCT01451632|20503841|P10|NOT COMPLETED|Overall Study||0
8316213|NCT01451632|20503842|P9|NOT COMPLETED|Overall Study||0
8316214|NCT01451632|20503843|P8|NOT COMPLETED|Overall Study||0
8316215|NCT01451632|20503844|P7|NOT COMPLETED|Overall Study||0
8316216|NCT01451632|20503845|P6|NOT COMPLETED|Overall Study||0
8316217|NCT01451632|20503846|P5|NOT COMPLETED|Overall Study||0
8316218|NCT01451632|20503847|P4|NOT COMPLETED|Overall Study||0
8316219|NCT01451632|20503848|P3|NOT COMPLETED|Overall Study||0
8316220|NCT01451632|20503849|P2|NOT COMPLETED|Overall Study||0
8316221|NCT01451632|20503850|P1|NOT COMPLETED|Overall Study||0
8316222|NCT01451632|20503841|P10|COMPLETED|Overall Study||4
8316223|NCT01451632|20503842|P9|COMPLETED|Overall Study||4
8316224|NCT01451632|20503843|P8|COMPLETED|Overall Study||6
8316225|NCT01451632|20503844|P7|COMPLETED|Overall Study||8
8316226|NCT01451632|20503845|P6|COMPLETED|Overall Study||4
8316227|NCT01451632|20503846|P5|COMPLETED|Overall Study||4
8316228|NCT01451632|20503847|P4|COMPLETED|Overall Study||3
8316229|NCT01451632|20503848|P3|COMPLETED|Overall Study||3
8316230|NCT01451632|20503849|P2|COMPLETED|Overall Study||4
8316231|NCT01451632|20503850|P1|COMPLETED|Overall Study||8
8316232|NCT01451632|20503841|P10|STARTED|Overall Study||4
8316233|NCT01451632|20503842|P9|STARTED|Overall Study||4
8316234|NCT01451632|20503843|P8|STARTED|Overall Study||6
8316235|NCT01451632|20503844|P7|STARTED|Overall Study||8
8316236|NCT01451632|20503845|P6|STARTED|Overall Study||4
8316237|NCT01451632|20503846|P5|STARTED|Overall Study||4
8316238|NCT01451632|20503847|P4|STARTED|Overall Study||3
8316239|NCT01451632|20503848|P3|STARTED|Overall Study||3
8316240|NCT01451632|20503849|P2|STARTED|Overall Study||4
8316241|NCT01451632|20503850|P1|STARTED|Overall Study||8
8316242|NCT01451606|20503898|P2|NOT COMPLETED|Overall Study||3
8316243|NCT01451606|20503899|P1|NOT COMPLETED|Overall Study||4
8316244|NCT01451606|20503898|P2|COMPLETED|Overall Study||15
8316245|NCT01451606|20503899|P1|COMPLETED|Overall Study||12
8316246|NCT01451606|20503898|P2|STARTED|Overall Study||18
8316247|NCT01451606|20503899|P1|STARTED|Overall Study||16
8316248|NCT01451554|20503909|P2|NOT COMPLETED|Overall Study||9
8316249|NCT01451554|20503910|P1|NOT COMPLETED|Overall Study||14
8316250|NCT01451554|20503909|P2|COMPLETED|Overall Study||23
8316251|NCT01451554|20503910|P1|COMPLETED|Overall Study||19
8316252|NCT01451554|20503909|P2|STARTED|Overall Study||32
8316253|NCT01451554|20503910|P1|STARTED|Overall Study||33
8316254|NCT01451541|20503921|P3|NOT COMPLETED|Overall Study||27
8316255|NCT01451541|20503922|P2|NOT COMPLETED|Overall Study||25
8316256|NCT01451541|20503923|P1|NOT COMPLETED|Overall Study||36
8316257|NCT01451541|20503921|P3|COMPLETED|Overall Study||254
8316258|NCT01451541|20503922|P2|COMPLETED|Overall Study||257
8316259|NCT01451541|20503923|P1|COMPLETED|Overall Study||247
8316260|NCT01451541|20503921|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
8316261|NCT01451541|20503922|P2|STARTED|Overall Study||282
8316262|NCT01451541|20503923|P1|STARTED|Overall Study||283
8316263|NCT01451463|20503963|P1|NOT COMPLETED|Overall Study||0
8316264|NCT01451463|20503963|P1|COMPLETED|Overall Study||11
8316265|NCT01451463|20503963|P1|STARTED|Overall Study||11
8316266|NCT01451437|20503981|P9|NOT COMPLETED|Overall Study||4
8316267|NCT01451437|20503982|P8|NOT COMPLETED|Overall Study||3
8316268|NCT01451437|20503983|P7|NOT COMPLETED|Overall Study||6
8316269|NCT01451437|20503984|P6|NOT COMPLETED|Overall Study||3
8316270|NCT01451437|20503985|P5|NOT COMPLETED|Overall Study||4
8316271|NCT01451437|20503986|P4|NOT COMPLETED|Overall Study||1
8316272|NCT01451437|20503987|P3|NOT COMPLETED|Overall Study||3
8316273|NCT01451437|20503988|P2|NOT COMPLETED|Overall Study||1
8316274|NCT01451437|20503989|P1|NOT COMPLETED|Overall Study||1
8316275|NCT01451437|20503981|P9|COMPLETED|Overall Study||0
8316276|NCT01451437|20503982|P8|COMPLETED|Overall Study||0
8316277|NCT01451437|20503983|P7|COMPLETED|Overall Study||0
8316278|NCT01451437|20503984|P6|COMPLETED|Overall Study||0
8316279|NCT01451437|20503985|P5|COMPLETED|Overall Study||0
8316280|NCT01451437|20503986|P4|COMPLETED|Overall Study||0
8316281|NCT01451437|20503987|P3|COMPLETED|Overall Study||0
8316282|NCT01451437|20503988|P2|COMPLETED|Overall Study||0
8316283|NCT01451437|20503989|P1|COMPLETED|Overall Study||0
8316284|NCT01451437|20503981|P9|STARTED|Overall Study||4
8316285|NCT01451437|20503982|P8|STARTED|Overall Study||3
8316286|NCT01451437|20503983|P7|STARTED|Overall Study||6
8316287|NCT01451437|20503984|P6|STARTED|Overall Study||3
8316288|NCT01451437|20503985|P5|STARTED|Overall Study||4
8316289|NCT01451437|20503986|P4|STARTED|Overall Study||1
8316290|NCT01451437|20503987|P3|STARTED|Overall Study||3
8316291|NCT01451437|20503988|P2|STARTED|Overall Study||1
8316292|NCT01451437|20503989|P1|STARTED|Overall Study||1
8316293|NCT01451424|20504121|P4|NOT COMPLETED|Overall Study||5
8316294|NCT01451424|20504122|P3|NOT COMPLETED|Overall Study||1
8316295|NCT01451424|20504123|P2|NOT COMPLETED|Overall Study||2
8316296|NCT01451424|20504124|P1|NOT COMPLETED|Overall Study||1
8316297|NCT01451424|20504121|P4|COMPLETED|Overall Study||5
8316298|NCT01451424|20504122|P3|COMPLETED|Overall Study||11
8316299|NCT01451424|20504123|P2|COMPLETED|Overall Study||7
8316300|NCT01451424|20504124|P1|COMPLETED|Overall Study||8
8316301|NCT01451424|20504121|P4|STARTED|Overall Study||10
8316302|NCT01451424|20504122|P3|STARTED|Overall Study||12
8316303|NCT01451424|20504123|P2|STARTED|Overall Study||9
8316304|NCT01451424|20504124|P1|STARTED|Overall Study||9
8316305|NCT01451411|20504157|P2|NOT COMPLETED|Overall Study||0
8316306|NCT01451411|20504158|P1|NOT COMPLETED|Overall Study||0
8316307|NCT01451411|20504157|P2|COMPLETED|Overall Study||1
8316308|NCT01451411|20504158|P1|COMPLETED|Overall Study||3
8316309|NCT01451411|20504157|P2|STARTED|Overall Study||1
8316310|NCT01451411|20504158|P1|STARTED|Overall Study||3
8316311|NCT01451398|20504182|P2|NOT COMPLETED|Overall Study||37
8316312|NCT01451398|20504183|P1|NOT COMPLETED|Overall Study||27
8316313|NCT01451398|20504182|P2|COMPLETED|Overall Study||139
8316314|NCT01451398|20504183|P1|COMPLETED|Overall Study||150
8316315|NCT01451398|20504182|P2|STARTED|Overall Study||176
8316316|NCT01451398|20504183|P1|STARTED|Overall Study||177
8316317|NCT01451385|20504215|P1|NOT COMPLETED|Overall Study||91
8316318|NCT01451385|20504215|P1|COMPLETED|Overall Study||285
8316319|NCT01451385|20504215|P1|STARTED|Overall Study||376
8316320|NCT01451372|20504227|P1|NOT COMPLETED|Overall Study||0
8316321|NCT01451372|20504227|P1|COMPLETED|Overall Study||69
8316322|NCT01451372|20504227|P1|STARTED|Overall Study||69
8316323|NCT01451203|20504234|P2|NOT COMPLETED|Post-treatment Period||34
8316324|NCT01451203|20504235|P1|NOT COMPLETED|Post-treatment Period||14
8316325|NCT01451203|20504234|P2|COMPLETED|Post-treatment Period||74
8316326|NCT01451203|20504235|P1|COMPLETED|Post-treatment Period||57
8316327|NCT01451203|20504234|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
8316328|NCT01451203|20504235|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
8316329|NCT01451203|20504234|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
8316330|NCT01451203|20504235|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
8316331|NCT01451203|20504234|P2|NOT COMPLETED|Double-blind Treatment Period||50
8316332|NCT01451203|20504235|P1|NOT COMPLETED|Double-blind Treatment Period||85
8316333|NCT01451203|20504234|P2|COMPLETED|Double-blind Treatment Period||111
8316334|NCT01451203|20504235|P1|COMPLETED|Double-blind Treatment Period||73
8316335|NCT01451203|20504234|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
8316336|NCT01451203|20504235|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
8316337|NCT01451203|20504234|P2|Received Treatment|Double-blind Treatment Period||159
8316338|NCT01451203|20504235|P1|Received Treatment|Double-blind Treatment Period||157
8316339|NCT01451203|20504234|P2|STARTED|Double-blind Treatment Period||161
8316340|NCT01451203|20504235|P1|STARTED|Double-blind Treatment Period||158
8316341|NCT01451164|20504253|P4|NOT COMPLETED|Overall Study||46
8316342|NCT01451164|20504254|P3|NOT COMPLETED|Overall Study||45
8316343|NCT01451164|20504255|P2|NOT COMPLETED|Overall Study||34
8316344|NCT01451164|20504256|P1|NOT COMPLETED|Overall Study||43
8316345|NCT01451164|20504253|P4|COMPLETED|Overall Study||70
8316346|NCT01451164|20504254|P3|COMPLETED|Overall Study||68
8316347|NCT01451164|20504255|P2|COMPLETED|Overall Study||81
8316348|NCT01451164|20504256|P1|COMPLETED|Overall Study||72
8316349|NCT01451164|20504253|P4|STARTED|Overall Study||116
8316350|NCT01451164|20504254|P3|STARTED|Overall Study||113
8316351|NCT01451164|20504255|P2|STARTED|Overall Study||115
8316352|NCT01451164|20504256|P1|STARTED|Overall Study||115
8316353|NCT01450943|20504285|P3|NOT COMPLETED|Overall Study||6
8316354|NCT01450943|20504286|P2|NOT COMPLETED|Overall Study||7
8316355|NCT01450943|20504287|P1|NOT COMPLETED|Overall Study||2
8316356|NCT01450943|20504285|P3|COMPLETED|Overall Study||42
8316357|NCT01450943|20504286|P2|COMPLETED|Overall Study||35
8316358|NCT01450943|20504287|P1|COMPLETED|Overall Study||26
8316359|NCT01450943|20504285|P3|STARTED|Overall Study||48
8316360|NCT01450943|20504286|P2|STARTED|Overall Study||42
8316361|NCT01450943|20504287|P1|STARTED|Overall Study||28
8316362|NCT01450826|20504303|P2|NOT COMPLETED|Overall Study||0
8316363|NCT01450826|20504304|P1|NOT COMPLETED|Overall Study||0
8316364|NCT01450826|20504303|P2|COMPLETED|Overall Study||66
8316365|NCT01450826|20504304|P1|COMPLETED|Overall Study||70
8316366|NCT01450826|20504303|P2|STARTED|Overall Study||66
8316367|NCT01450826|20504304|P1|STARTED|Overall Study||70
8316368|NCT01450813|20504320|P4|NOT COMPLETED|Overall Study||3
8316369|NCT01450813|20504321|P3|NOT COMPLETED|Overall Study||0
8316370|NCT01450813|20504322|P2|NOT COMPLETED|Overall Study||1
8316371|NCT01450813|20504323|P1|NOT COMPLETED|Overall Study||1
8316372|NCT01450813|20504320|P4|COMPLETED|Overall Study||17
8316373|NCT01450813|20504321|P3|COMPLETED|Overall Study||20
8316374|NCT01450813|20504322|P2|COMPLETED|Overall Study||19
8316375|NCT01450813|20504323|P1|COMPLETED|Overall Study||19
8316376|NCT01450813|20504320|P4|STARTED|Overall Study||20
8316377|NCT01450813|20504321|P3|STARTED|Overall Study||20
8316378|NCT01450813|20504322|P2|STARTED|Overall Study||20
8316379|NCT01450813|20504323|P1|STARTED|Overall Study||20
8316380|NCT01450800|20504337|P2|NOT COMPLETED|Overall Study||3
8316381|NCT01450800|20504338|P1|NOT COMPLETED|Overall Study||1
8316382|NCT01450800|20504337|P2|COMPLETED|Overall Study||78
8316383|NCT01450800|20504338|P1|COMPLETED|Overall Study||81
8316384|NCT01450800|20504337|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
8316385|NCT01450800|20504338|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
8316386|NCT01450787|20504354|P2|NOT COMPLETED|Overall Study||0
8316387|NCT01450787|20504355|P1|NOT COMPLETED|Overall Study||0
8316388|NCT01450787|20504354|P2|COMPLETED|Overall Study||25
8316389|NCT01450787|20504355|P1|COMPLETED|Overall Study||38
8316390|NCT01450787|20504354|P2|STARTED|Overall Study||25
8316391|NCT01450787|20504355|P1|STARTED|Overall Study||38
8316392|NCT01450761|20504373|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
8316393|NCT01450761|20504374|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
8316394|NCT01450761|20504373|P2|COMPLETED|Treatment With Blinded Study Therapy||0
8316395|NCT01450761|20504374|P1|COMPLETED|Treatment With Blinded Study Therapy||0
8316396|NCT01450761|20504373|P2|STARTED|Treatment With Blinded Study Therapy||476
8316397|NCT01450761|20504374|P1|STARTED|Treatment With Blinded Study Therapy||478
8316398|NCT01450761|20504373|P2|NOT COMPLETED|Lead-in Chemotherapy||85
8316399|NCT01450761|20504374|P1|NOT COMPLETED|Lead-in Chemotherapy||84
8316400|NCT01450761|20504373|P2|COMPLETED|Lead-in Chemotherapy||476
8316401|NCT01450761|20504374|P1|COMPLETED|Lead-in Chemotherapy||478
8316402|NCT01450761|20504373|P2|STARTED|Lead-in Chemotherapy||561
8316403|NCT01450761|20504374|P1|STARTED|Lead-in Chemotherapy||562
8316404|NCT01450761|20504373|P2|NOT COMPLETED|Randomization||5
8316405|NCT01450761|20504374|P1|NOT COMPLETED|Randomization||4
8316406|NCT01450761|20504373|P2|COMPLETED|Randomization||561
8316407|NCT01450761|20504374|P1|COMPLETED|Randomization||562
8316408|NCT01450761|20504373|P2|STARTED|Randomization||566
8316409|NCT01450761|20504374|P1|STARTED|Randomization||566
8316410|NCT01450696|20504386|P2|NOT COMPLETED|Overall Study||148
8316411|NCT01450696|20504387|P1|NOT COMPLETED|Overall Study||148
8316412|NCT01450696|20504386|P2|COMPLETED|Overall Study||0
8316413|NCT01450696|20504387|P1|COMPLETED|Overall Study||0
8316414|NCT01450696|20504386|P2|Treated (Safety Population)|Overall Study||147
8316415|NCT01450696|20504387|P1|Treated (Safety Population)|Overall Study||147
8316416|NCT01450696|20504386|P2|STARTED|Overall Study||148
8316417|NCT01450696|20504387|P1|STARTED|Overall Study||148
8316418|NCT01450683|20504409|P1|NOT COMPLETED|Overall Study||2
8316419|NCT01450683|20504409|P1|COMPLETED|Overall Study||2
8316420|NCT01450683|20504409|P1|STARTED|Overall Study||4
8316421|NCT01450631|20504415|P2|NOT COMPLETED|Overall Study||4
8316422|NCT01450631|20504416|P1|NOT COMPLETED|Overall Study||3
8316423|NCT01450631|20504415|P2|COMPLETED|Overall Study||42
8316424|NCT01450631|20504416|P1|COMPLETED|Overall Study||43
8316425|NCT01450631|20504415|P2|STARTED|Overall Study||46
8316426|NCT01450631|20504416|P1|STARTED|Overall Study||46
8316427|NCT01450397|20504424|P1|NOT COMPLETED|Overall Study||0
8316428|NCT01450397|20504424|P1|COMPLETED|Overall Study||5
8316429|NCT01450397|20504424|P1|STARTED|Overall Study||5
8316430|NCT01450319|20504428|P1|NOT COMPLETED|Overall Study||0
8316431|NCT01450319|20504428|P1|COMPLETED|Overall Study||70
8316432|NCT01450319|20504428|P1|STARTED|Overall Study||70
8316433|NCT01450306|20504441|P2|NOT COMPLETED|Overall Study||0
8316434|NCT01450306|20504442|P1|NOT COMPLETED|Overall Study||0
8316435|NCT01450306|20504441|P2|COMPLETED|Overall Study||10
8316436|NCT01450306|20504442|P1|COMPLETED|Overall Study||10
8316437|NCT01450306|20504441|P2|STARTED|Overall Study||10
8316438|NCT01450306|20504442|P1|STARTED|Overall Study||10
8316439|NCT01450189|20504455|P3|NOT COMPLETED|Overall Study||0
8316440|NCT01450189|20504456|P2|NOT COMPLETED|Overall Study||0
8316441|NCT01450189|20504457|P1|NOT COMPLETED|Overall Study||0
8316442|NCT01450189|20504455|P3|COMPLETED|Overall Study||19
8316443|NCT01450189|20504456|P2|COMPLETED|Overall Study||18
8316444|NCT01450189|20504457|P1|COMPLETED|Overall Study||9
8316445|NCT01450189|20504455|P3|STARTED|Overall Study||19
8316446|NCT01450189|20504456|P2|STARTED|Overall Study||18
8316447|NCT01450189|20504457|P1|STARTED|Overall Study||9
8316448|NCT01450137|20504546|P2|NOT COMPLETED|Week 12 to Study End||2
8316449|NCT01450137|20504547|P1|NOT COMPLETED|Week 12 to Study End||0
8316450|NCT01450137|20504546|P2|COMPLETED|Week 12 to Study End||5
8316451|NCT01450137|20504547|P1|COMPLETED|Week 12 to Study End||18
8316452|NCT01450137|20504546|P2|STARTED|Week 12 to Study End||7
8316453|NCT01450137|20504547|P1|STARTED|Week 12 to Study End||18
8316454|NCT01450137|20504546|P2|NOT COMPLETED|Up to Week 12||3
8316455|NCT01450137|20504547|P1|NOT COMPLETED|Up to Week 12||2
8316456|NCT01450137|20504546|P2|COMPLETED|Up to Week 12||7
8316457|NCT01450137|20504547|P1|COMPLETED|Up to Week 12||18
8316458|NCT01450137|20504546|P2|STARTED|Up to Week 12||10
8316459|NCT01450137|20504547|P1|STARTED|Up to Week 12||20
8316460|NCT01450098|20504561|P2|NOT COMPLETED|Period 3||3
8316461|NCT01450098|20504562|P1|NOT COMPLETED|Period 3||0
8316462|NCT01450098|20504561|P2|COMPLETED|Period 3||28
8316463|NCT01450098|20504562|P1|COMPLETED|Period 3||8
8316464|NCT01450098|20504561|P2|Received at Least 1 Dose of Study Drug|Period 3||30
8316465|NCT01450098|20504562|P1|Received at Least 1 Dose of Study Drug|Period 3||8
8316466|NCT01450098|20504561|P2|STARTED|Period 3||31
8316467|NCT01450098|20504562|P1|STARTED|Period 3||8
8316468|NCT01450098|20504561|P2|NOT COMPLETED|Washout of at Least 14 Days||0
8316469|NCT01450098|20504562|P1|NOT COMPLETED|Washout of at Least 14 Days||0
8316470|NCT01450098|20504561|P2|COMPLETED|Washout of at Least 14 Days||31
8316471|NCT01450098|20504562|P1|COMPLETED|Washout of at Least 14 Days||8
8316472|NCT01450098|20504561|P2|STARTED|Washout of at Least 14 Days||31
8316473|NCT01450098|20504562|P1|STARTED|Washout of at Least 14 Days||8
8316474|NCT01450098|20504561|P2|NOT COMPLETED|Period 2||0
8316475|NCT01450098|20504562|P1|NOT COMPLETED|Period 2||0
8316476|NCT01450098|20504561|P2|COMPLETED|Period 2||31
8316477|NCT01450098|20504562|P1|COMPLETED|Period 2||8
8316478|NCT01450098|20504561|P2|Received at Least 1 Dose of Study Drug|Period 2||31
8316479|NCT01450098|20504562|P1|Received at Least 1 Dose of Study Drug|Period 2||8
8316480|NCT01450098|20504561|P2|STARTED|Period 2||31
8316481|NCT01450098|20504562|P1|STARTED|Period 2||8
8316482|NCT01450098|20504561|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
8316483|NCT01450098|20504562|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
8316484|NCT01450098|20504561|P2|COMPLETED|Washout Period of at Least 14 Days||31
8316485|NCT01450098|20504562|P1|COMPLETED|Washout Period of at Least 14 Days||8
8316486|NCT01450098|20504561|P2|STARTED|Washout Period of at Least 14 Days||31
8316487|NCT01450098|20504562|P1|STARTED|Washout Period of at Least 14 Days||8
8316488|NCT01450098|20504561|P2|NOT COMPLETED|Period 1||0
8316489|NCT01450098|20504562|P1|NOT COMPLETED|Period 1||0
8316490|NCT01450098|20504561|P2|COMPLETED|Period 1||31
8316491|NCT01450098|20504562|P1|COMPLETED|Period 1||8
8316492|NCT01450098|20504561|P2|Received at Least 1 Dose of Study Drug|Period 1||31
8316493|NCT01450098|20504562|P1|Received at Least 1 Dose of Study Drug|Period 1||8
8316494|NCT01450098|20504561|P2|STARTED|Period 1||31
8316495|NCT01450098|20504562|P1|STARTED|Period 1||8
8316496|NCT01450007|20504581|P3|NOT COMPLETED|Overall Study||3
8316497|NCT01450007|20504582|P2|NOT COMPLETED|Overall Study||5
8316498|NCT01450007|20504583|P1|NOT COMPLETED|Overall Study||2
8316499|NCT01450007|20504581|P3|COMPLETED|Overall Study||41
8316500|NCT01450007|20504582|P2|COMPLETED|Overall Study||37
8316501|NCT01450007|20504583|P1|COMPLETED|Overall Study||42
8316502|NCT01450007|20504581|P3|STARTED|Overall Study||44
8316503|NCT01450007|20504582|P2|STARTED|Overall Study||42
8316504|NCT01450007|20504583|P1|STARTED|Overall Study||44
8316505|NCT01449955|20504602|P2|NOT COMPLETED|Overall Study||2
8316506|NCT01449955|20504603|P1|NOT COMPLETED|Overall Study||1
8316507|NCT01449955|20504602|P2|COMPLETED|Overall Study||24
8316508|NCT01449955|20504603|P1|COMPLETED|Overall Study||27
8316509|NCT01449955|20504602|P2|STARTED|Overall Study||26
8316510|NCT01449955|20504603|P1|STARTED|Overall Study||28
8316511|NCT01449929|20504631|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
8316512|NCT01449929|20504632|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
8316513|NCT01449929|20504633|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
8316514|NCT01449929|20504631|P3|COMPLETED|Extension Phase Approximately 3 Years||115
8316515|NCT01449929|20504632|P2|COMPLETED|Extension Phase Approximately 3 Years||0
8316516|NCT01449929|20504633|P1|COMPLETED|Extension Phase Approximately 3 Years||0
8316517|NCT01449929|20504631|P3|STARTED|Extension Phase Approximately 3 Years||123
8316518|NCT01449929|20504632|P2|STARTED|Extension Phase Approximately 3 Years||0
8316519|NCT01449929|20504633|P1|STARTED|Extension Phase Approximately 3 Years||0
8316520|NCT01449929|20504631|P3|NOT COMPLETED|Randomization Phase 96 Week||0
8316521|NCT01449929|20504632|P2|NOT COMPLETED|Randomization Phase 96 Week||53
8316522|NCT01449929|20504633|P1|NOT COMPLETED|Randomization Phase 96 Week||33
8316523|NCT01449929|20504631|P3|COMPLETED|Randomization Phase 96 Week||0
8316524|NCT01449929|20504632|P2|COMPLETED|Randomization Phase 96 Week||189
8316525|NCT01449929|20504633|P1|COMPLETED|Randomization Phase 96 Week||209
8316526|NCT01449929|20504631|P3|STARTED|Randomization Phase 96 Week||0
8316527|NCT01449929|20504632|P2|STARTED|Randomization Phase 96 Week||242
8316528|NCT01449929|20504633|P1|STARTED|Randomization Phase 96 Week||242
8316529|NCT01449864|20504670|P1|NOT COMPLETED|Overall Study||5
8316530|NCT01449864|20504670|P1|COMPLETED|Overall Study||17
8316531|NCT01449864|20504670|P1|STARTED|Overall Study||22
8316532|NCT01449812|20504678|P3|NOT COMPLETED|Overall Study||1
8316533|NCT01449812|20504679|P2|NOT COMPLETED|Overall Study||0
8316534|NCT01449812|20504680|P1|NOT COMPLETED|Overall Study||2
8316535|NCT01449812|20504678|P3|COMPLETED|Overall Study||279
8316536|NCT01449812|20504679|P2|COMPLETED|Overall Study||273
8316537|NCT01449812|20504680|P1|COMPLETED|Overall Study||270
8316538|NCT01449812|20504678|P3|STARTED|Overall Study||280
8316539|NCT01449812|20504679|P2|STARTED|Overall Study||273
8316540|NCT01449812|20504680|P1|STARTED|Overall Study||272
8316541|NCT01449747|20504774|P2|NOT COMPLETED|Overall Study||0
8316542|NCT01449747|20504775|P1|NOT COMPLETED|Overall Study||0
8316543|NCT01449747|20504774|P2|COMPLETED|Overall Study||12
8316544|NCT01449747|20504775|P1|COMPLETED|Overall Study||12
8316545|NCT01449747|20504774|P2|STARTED|Overall Study||12
8316546|NCT01449747|20504775|P1|STARTED|Overall Study||12
8316547|NCT01449734|20504789|P1|NOT COMPLETED|Overall Study||0
8316548|NCT01449734|20504789|P1|COMPLETED|Overall Study||215
8316549|NCT01449734|20504789|P1|STARTED|Overall Study||215
8316550|NCT01449721|20504795|P2|NOT COMPLETED|Overall Study||2
8316551|NCT01449721|20504796|P1|NOT COMPLETED|Overall Study||0
8316552|NCT01449721|20504795|P2|COMPLETED|Overall Study||28
8316553|NCT01449721|20504796|P1|COMPLETED|Overall Study||112
8316554|NCT01449721|20504795|P2|STARTED|Overall Study||30
8316555|NCT01449721|20504796|P1|STARTED|Overall Study||112
8316556|NCT01449708|20504808|P2|NOT COMPLETED|Overall Study||3
8316557|NCT01449708|20504809|P1|NOT COMPLETED|Overall Study||2
8316558|NCT01449708|20504808|P2|COMPLETED|Overall Study||60
8316559|NCT01449708|20504809|P1|COMPLETED|Overall Study||59
8316560|NCT01449708|20504808|P2|STARTED|Overall Study||63
8316561|NCT01449708|20504809|P1|STARTED|Overall Study||61
8316562|NCT01449682|20504820|P2|NOT COMPLETED|Overall Study||1
8316563|NCT01449682|20504821|P1|NOT COMPLETED|Overall Study||1
8316564|NCT01449682|20504820|P2|COMPLETED|Overall Study||4
8316565|NCT01449682|20504821|P1|COMPLETED|Overall Study||4
8316566|NCT01449682|20504820|P2|STARTED|Overall Study||5
8316567|NCT01449682|20504821|P1|STARTED|Overall Study||5
8316568|NCT01449630|20504842|P9|NOT COMPLETED|Period 3||0
8316569|NCT01449630|20504843|P8|NOT COMPLETED|Period 3||0
8316570|NCT01449630|20504844|P7|NOT COMPLETED|Period 3||0
8316571|NCT01449630|20504845|P6|NOT COMPLETED|Period 3||0
8316572|NCT01449630|20504846|P5|NOT COMPLETED|Period 3||0
8316573|NCT01449630|20504847|P4|NOT COMPLETED|Period 3||0
8316574|NCT01449630|20504848|P3|NOT COMPLETED|Period 3||0
8316575|NCT01449630|20504849|P2|NOT COMPLETED|Period 3||0
8316576|NCT01449630|20504850|P1|NOT COMPLETED|Period 3||0
8316577|NCT01449630|20504842|P9|COMPLETED|Period 3||2
8316578|NCT01449630|20504843|P8|COMPLETED|Period 3||6
8316579|NCT01449630|20504844|P7|COMPLETED|Period 3||1
8316580|NCT01449630|20504845|P6|COMPLETED|Period 3||1
8316581|NCT01449630|20504846|P5|COMPLETED|Period 3||5
8316582|NCT01449630|20504847|P4|COMPLETED|Period 3||1
8316583|NCT01449630|20504848|P3|COMPLETED|Period 3||2
8316584|NCT01449630|20504849|P2|COMPLETED|Period 3||6
8316585|NCT01449630|20504850|P1|COMPLETED|Period 3||1
8316586|NCT01449630|20504842|P9|STARTED|Period 3||2
8316587|NCT01449630|20504843|P8|STARTED|Period 3||6
8316588|NCT01449630|20504844|P7|STARTED|Period 3||1
8316589|NCT01449630|20504845|P6|STARTED|Period 3||1
8316590|NCT01449630|20504846|P5|STARTED|Period 3||5
8316591|NCT01449630|20504847|P4|STARTED|Period 3||1
8316592|NCT01449630|20504848|P3|STARTED|Period 3||2
8316593|NCT01449630|20504849|P2|STARTED|Period 3||6
8316594|NCT01449630|20504850|P1|STARTED|Period 3||1
8316595|NCT01449630|20504842|P9|NOT COMPLETED|Period 2||0
8316596|NCT01449630|20504843|P8|NOT COMPLETED|Period 2||0
8316597|NCT01449630|20504844|P7|NOT COMPLETED|Period 2||1
8316598|NCT01449630|20504845|P6|NOT COMPLETED|Period 2||0
8316599|NCT01449630|20504846|P5|NOT COMPLETED|Period 2||0
8316600|NCT01449630|20504847|P4|NOT COMPLETED|Period 2||0
8316601|NCT01449630|20504848|P3|NOT COMPLETED|Period 2||0
8316602|NCT01449630|20504849|P2|NOT COMPLETED|Period 2||0
8316603|NCT01449630|20504850|P1|NOT COMPLETED|Period 2||0
8316604|NCT01449630|20504842|P9|COMPLETED|Period 2||2
8316605|NCT01449630|20504843|P8|COMPLETED|Period 2||6
8316606|NCT01449630|20504844|P7|COMPLETED|Period 2||1
8316607|NCT01449630|20504845|P6|COMPLETED|Period 2||1
8316608|NCT01449630|20504846|P5|COMPLETED|Period 2||5
8316609|NCT01449630|20504847|P4|COMPLETED|Period 2||1
8316610|NCT01449630|20504848|P3|COMPLETED|Period 2||2
8316611|NCT01449630|20504849|P2|COMPLETED|Period 2||6
8316612|NCT01449630|20504850|P1|COMPLETED|Period 2||1
8316613|NCT01449630|20504842|P9|STARTED|Period 2||2
8316614|NCT01449630|20504843|P8|STARTED|Period 2||6
8316615|NCT01449630|20504844|P7|STARTED|Period 2||2
8316616|NCT01449630|20504845|P6|STARTED|Period 2||1
8316617|NCT01449630|20504846|P5|STARTED|Period 2||5
8316618|NCT01449630|20504847|P4|STARTED|Period 2||1
8316619|NCT01449630|20504848|P3|STARTED|Period 2||2
8316620|NCT01449630|20504849|P2|STARTED|Period 2||6
8316621|NCT01449630|20504850|P1|STARTED|Period 2||1
8316622|NCT01449630|20504842|P9|NOT COMPLETED|Period 1||0
8316623|NCT01449630|20504843|P8|NOT COMPLETED|Period 1||0
8316624|NCT01449630|20504844|P7|NOT COMPLETED|Period 1||0
8316625|NCT01449630|20504845|P6|NOT COMPLETED|Period 1||1
8316626|NCT01449630|20504846|P5|NOT COMPLETED|Period 1||0
8316627|NCT01449630|20504847|P4|NOT COMPLETED|Period 1||1
8316628|NCT01449630|20504848|P3|NOT COMPLETED|Period 1||0
8316629|NCT01449630|20504849|P2|NOT COMPLETED|Period 1||0
8316630|NCT01449630|20504850|P1|NOT COMPLETED|Period 1||1
8316631|NCT01449630|20504842|P9|COMPLETED|Period 1||2
8316632|NCT01449630|20504843|P8|COMPLETED|Period 1||6
8316633|NCT01449630|20504844|P7|COMPLETED|Period 1||2
8316634|NCT01449630|20504845|P6|COMPLETED|Period 1||1
8316635|NCT01449630|20504846|P5|COMPLETED|Period 1||5
8316636|NCT01449630|20504847|P4|COMPLETED|Period 1||1
8316637|NCT01449630|20504848|P3|COMPLETED|Period 1||2
8316638|NCT01449630|20504849|P2|COMPLETED|Period 1||6
8316639|NCT01449630|20504850|P1|COMPLETED|Period 1||1
8316640|NCT01449630|20504842|P9|Received at Least 1 Dose|Period 1||2
8316641|NCT01449630|20504843|P8|Received at Least 1 Dose|Period 1||6
8316642|NCT01449630|20504844|P7|Received at Least 1 Dose|Period 1||2
8316643|NCT01449630|20504845|P6|Received at Least 1 Dose|Period 1||1
8316644|NCT01449630|20504846|P5|Received at Least 1 Dose|Period 1||5
8316645|NCT01449630|20504847|P4|Received at Least 1 Dose|Period 1||2
8316646|NCT01449630|20504848|P3|Received at Least 1 Dose|Period 1||2
8316647|NCT01449630|20504849|P2|Received at Least 1 Dose|Period 1||6
8316648|NCT01449630|20504850|P1|Received at Least 1 Dose|Period 1||2
8316649|NCT01449630|20504842|P9|STARTED|Period 1||2
8316650|NCT01449630|20504843|P8|STARTED|Period 1||6
8316651|NCT01449630|20504844|P7|STARTED|Period 1||2
8316652|NCT01449630|20504845|P6|STARTED|Period 1||2
8316653|NCT01449630|20504846|P5|STARTED|Period 1||5
8316654|NCT01449630|20504847|P4|STARTED|Period 1||2
8316655|NCT01449630|20504848|P3|STARTED|Period 1||2
8316656|NCT01449630|20504849|P2|STARTED|Period 1||6
8316657|NCT01449630|20504850|P1|STARTED|Period 1||2
8316658|NCT01449539|20504920|P1|NOT COMPLETED|Overall Study||4
8316659|NCT01449539|20504920|P1|COMPLETED|Overall Study||4
8316660|NCT01449539|20504920|P1|STARTED|Overall Study||8
8316661|NCT01449526|20504926|P2|NOT COMPLETED|Overall Study||6
8316662|NCT01449526|20504927|P1|NOT COMPLETED|Overall Study||2
8316663|NCT01449526|20504926|P2|COMPLETED|Overall Study||77
8316664|NCT01449526|20504927|P1|COMPLETED|Overall Study||81
8316665|NCT01449526|20504926|P2|STARTED|Overall Study||83
8316666|NCT01449526|20504927|P1|STARTED|Overall Study||83
8316667|NCT01449513|20504937|P2|NOT COMPLETED|Overall Study||0
8316668|NCT01449513|20504938|P1|NOT COMPLETED|Overall Study||0
8316669|NCT01449513|20504937|P2|COMPLETED|Overall Study||8
8316670|NCT01449513|20504938|P1|COMPLETED|Overall Study||16
8316671|NCT01449513|20504937|P2|STARTED|Overall Study||8
8316672|NCT01449513|20504938|P1|STARTED|Overall Study||16
8316673|NCT01449461|20504996|P6|NOT COMPLETED|Overall Study||15
8316674|NCT01449461|20504997|P5|NOT COMPLETED|Overall Study||48
8316675|NCT01449461|20504998|P4|NOT COMPLETED|Overall Study||32
8316676|NCT01449461|20504999|P3|NOT COMPLETED|Overall Study||18
8316677|NCT01449461|20505000|P2|NOT COMPLETED|Overall Study||18
8316678|NCT01449461|20505001|P1|NOT COMPLETED|Overall Study||6
8316679|NCT01449461|20504996|P6|COMPLETED|Overall Study||0
8316680|NCT01449461|20504997|P5|COMPLETED|Overall Study||0
8316681|NCT01449461|20504998|P4|COMPLETED|Overall Study||0
8316682|NCT01449461|20504999|P3|COMPLETED|Overall Study||0
8316683|NCT01449461|20505000|P2|COMPLETED|Overall Study||0
8316684|NCT01449461|20505001|P1|COMPLETED|Overall Study||0
8316685|NCT01449461|20504996|P6|STARTED|Overall Study||15
8316686|NCT01449461|20504997|P5|STARTED|Overall Study||48
8316687|NCT01449461|20504998|P4|STARTED|Overall Study||32
8316688|NCT01449461|20504999|P3|STARTED|Overall Study||18
8316689|NCT01449461|20505000|P2|STARTED|Overall Study||18
8316690|NCT01449461|20505001|P1|STARTED|Overall Study||6
8316691|NCT01449370|20505138|P25|NOT COMPLETED|Overall Study||8
8316692|NCT01449370|20505139|P24|NOT COMPLETED|Overall Study||10
8316693|NCT01449370|20505140|P23|NOT COMPLETED|Overall Study||4
8316694|NCT01449370|20505141|P22|NOT COMPLETED|Overall Study||4
8316695|NCT01449370|20505142|P21|NOT COMPLETED|Overall Study||6
8316696|NCT01449370|20505143|P20|NOT COMPLETED|Overall Study||3
8316697|NCT01449370|20505144|P19|NOT COMPLETED|Overall Study||3
8316698|NCT01449370|20505145|P18|NOT COMPLETED|Overall Study||3
8316699|NCT01449370|20505146|P17|NOT COMPLETED|Overall Study||7
8316700|NCT01449370|20505147|P16|NOT COMPLETED|Overall Study||3
8316701|NCT01449370|20505148|P15|NOT COMPLETED|Overall Study||3
8316702|NCT01449370|20505149|P14|NOT COMPLETED|Overall Study||11
8316703|NCT01449370|20505150|P13|NOT COMPLETED|Overall Study||3
8316704|NCT01449370|20505151|P12|NOT COMPLETED|Overall Study||3
8316705|NCT01449370|20505152|P11|NOT COMPLETED|Overall Study||3
8316706|NCT01449370|20505153|P10|NOT COMPLETED|Overall Study||3
8316707|NCT01449370|20505154|P9|NOT COMPLETED|Overall Study||12
8316708|NCT01449370|20505155|P8|NOT COMPLETED|Overall Study||3
8316709|NCT01449370|20505156|P7|NOT COMPLETED|Overall Study||3
8316710|NCT01449370|20505157|P6|NOT COMPLETED|Overall Study||3
8316711|NCT01449370|20505158|P5|NOT COMPLETED|Overall Study||3
8316712|NCT01449370|20505159|P4|NOT COMPLETED|Overall Study||4
8316713|NCT01449370|20505160|P3|NOT COMPLETED|Overall Study||8
8316714|NCT01449370|20505161|P2|NOT COMPLETED|Overall Study||6
8316715|NCT01449370|20505162|P1|NOT COMPLETED|Overall Study||6
8316716|NCT01449370|20505138|P25|COMPLETED|Overall Study||0
8316717|NCT01449370|20505139|P24|COMPLETED|Overall Study||0
8316718|NCT01449370|20505140|P23|COMPLETED|Overall Study||0
8316719|NCT01449370|20505141|P22|COMPLETED|Overall Study||0
8316720|NCT01449370|20505142|P21|COMPLETED|Overall Study||0
8316721|NCT01449370|20505143|P20|COMPLETED|Overall Study||0
8316722|NCT01449370|20505144|P19|COMPLETED|Overall Study||0
8316723|NCT01449370|20505145|P18|COMPLETED|Overall Study||0
8316724|NCT01449370|20505146|P17|COMPLETED|Overall Study||0
8316725|NCT01449370|20505147|P16|COMPLETED|Overall Study||0
8316726|NCT01449370|20505148|P15|COMPLETED|Overall Study||0
8316727|NCT01449370|20505149|P14|COMPLETED|Overall Study||0
8316728|NCT01449370|20505150|P13|COMPLETED|Overall Study||0
8316729|NCT01449370|20505151|P12|COMPLETED|Overall Study||0
8316730|NCT01449370|20505152|P11|COMPLETED|Overall Study||0
8316731|NCT01449370|20505153|P10|COMPLETED|Overall Study||0
8316732|NCT01449370|20505154|P9|COMPLETED|Overall Study||0
8316733|NCT01449370|20505155|P8|COMPLETED|Overall Study||0
8316734|NCT01449370|20505156|P7|COMPLETED|Overall Study||0
8316735|NCT01449370|20505157|P6|COMPLETED|Overall Study||0
8316736|NCT01449370|20505158|P5|COMPLETED|Overall Study||0
8316737|NCT01449370|20505159|P4|COMPLETED|Overall Study||0
8316738|NCT01449370|20505160|P3|COMPLETED|Overall Study||0
8316739|NCT01449370|20505161|P2|COMPLETED|Overall Study||0
8316740|NCT01449370|20505162|P1|COMPLETED|Overall Study||0
8316741|NCT01449370|20505138|P25|STARTED|Overall Study||8
8316742|NCT01449370|20505139|P24|STARTED|Overall Study||10
8316743|NCT01449370|20505140|P23|STARTED|Overall Study||4
8316744|NCT01449370|20505141|P22|STARTED|Overall Study||4
8316745|NCT01449370|20505142|P21|STARTED|Overall Study||6
8316746|NCT01449370|20505143|P20|STARTED|Overall Study||3
8316747|NCT01449370|20505144|P19|STARTED|Overall Study||3
8316748|NCT01449370|20505145|P18|STARTED|Overall Study||3
8316749|NCT01449370|20505146|P17|STARTED|Overall Study||7
8316750|NCT01449370|20505147|P16|STARTED|Overall Study||3
8316751|NCT01449370|20505148|P15|STARTED|Overall Study||3
8316752|NCT01449370|20505149|P14|STARTED|Overall Study||11
8316753|NCT01449370|20505150|P13|STARTED|Overall Study||3
8316754|NCT01449370|20505151|P12|STARTED|Overall Study||3
8316755|NCT01449370|20505152|P11|STARTED|Overall Study||3
8316756|NCT01449370|20505153|P10|STARTED|Overall Study||3
8316757|NCT01449370|20505154|P9|STARTED|Overall Study||12
8316758|NCT01449370|20505155|P8|STARTED|Overall Study||3
8316759|NCT01449370|20505156|P7|STARTED|Overall Study||3
8316760|NCT01449370|20505157|P6|STARTED|Overall Study||3
8316761|NCT01449370|20505158|P5|STARTED|Overall Study||3
8316762|NCT01449370|20505159|P4|STARTED|Overall Study||4
8316763|NCT01449370|20505160|P3|STARTED|Overall Study||8
8316764|NCT01449370|20505161|P2|STARTED|Overall Study||6
8316765|NCT01449370|20505162|P1|STARTED|Overall Study||6
8316766|NCT01449305|20505535|P1|NOT COMPLETED|Overall Study||2
8316767|NCT01449305|20505535|P1|COMPLETED|Overall Study||42
8316768|NCT01449305|20505535|P1|STARTED|Overall Study||44
8316769|NCT01449279|20505540|P1|NOT COMPLETED|Overall Study||7
8316770|NCT01449279|20505540|P1|COMPLETED|Overall Study||15
8316771|NCT01449279|20505540|P1|STARTED|Overall Study||22
8316772|NCT01449266|20505551|P1|NOT COMPLETED|Overall Study||0
8316773|NCT01449266|20505551|P1|COMPLETED|Overall Study||10
8316774|NCT01449266|20505551|P1|STARTED|Overall Study||10
8316775|NCT01449240|20505558|P1|NOT COMPLETED|Overall Study||0
8316776|NCT01449240|20505558|P1|COMPLETED|Overall Study||10
8316777|NCT01449240|20505558|P1|STARTED|Overall Study||10
8316778|NCT01449006|20505565|P2|NOT COMPLETED|Overall Study||0
8316779|NCT01449006|20505566|P1|NOT COMPLETED|Overall Study||3
8316780|NCT01449006|20505565|P2|COMPLETED|Overall Study||9
8316781|NCT01449006|20505566|P1|COMPLETED|Overall Study||5
8316782|NCT01449006|20505565|P2|STARTED|Overall Study||9
8316783|NCT01449006|20505566|P1|STARTED|Overall Study||8
8316784|NCT01448850|20505580|P2|NOT COMPLETED|Overall Study||40
8316785|NCT01448850|20505581|P1|NOT COMPLETED|Overall Study||34
8316786|NCT01448850|20505580|P2|COMPLETED|Overall Study||120
8316787|NCT01448850|20505581|P1|COMPLETED|Overall Study||130
8316788|NCT01448850|20505580|P2|STARTED|Overall Study||160
8316789|NCT01448850|20505581|P1|STARTED|Overall Study||164
8316790|NCT01448824|20505612|P8|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
8316791|NCT01448824|20505613|P7|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316792|NCT01448824|20505614|P6|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316793|NCT01448824|20505615|P5|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316794|NCT01448824|20505616|P4|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316795|NCT01448824|20505617|P3|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316796|NCT01448824|20505618|P2|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316797|NCT01448824|20505619|P1|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316798|NCT01448824|20505612|P8|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
8316799|NCT01448824|20505613|P7|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316800|NCT01448824|20505614|P6|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316801|NCT01448824|20505615|P5|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316802|NCT01448824|20505616|P4|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316803|NCT01448824|20505617|P3|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316804|NCT01448824|20505618|P2|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316805|NCT01448824|20505619|P1|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316806|NCT01448824|20505612|P8|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
8316807|NCT01448824|20505613|P7|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316808|NCT01448824|20505614|P6|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316809|NCT01448824|20505615|P5|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316810|NCT01448824|20505616|P4|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316811|NCT01448824|20505617|P3|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316812|NCT01448824|20505618|P2|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316813|NCT01448824|20505619|P1|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316814|NCT01448824|20505612|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
8316815|NCT01448824|20505613|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316816|NCT01448824|20505614|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316817|NCT01448824|20505615|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316818|NCT01448824|20505616|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316819|NCT01448824|20505617|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316820|NCT01448824|20505618|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316821|NCT01448824|20505619|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316822|NCT01448824|20505612|P8|STARTED|Part 2 Period 2: Drug-drug Interaction||11
8316823|NCT01448824|20505613|P7|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316824|NCT01448824|20505614|P6|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316825|NCT01448824|20505615|P5|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316826|NCT01448824|20505616|P4|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316827|NCT01448824|20505617|P3|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316828|NCT01448824|20505618|P2|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316829|NCT01448824|20505619|P1|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316830|NCT01448824|20505612|P8|NOT COMPLETED|Part 2: Washout Period||0
8316831|NCT01448824|20505613|P7|NOT COMPLETED|Part 2: Washout Period||0
8316832|NCT01448824|20505614|P6|NOT COMPLETED|Part 2: Washout Period||0
8316833|NCT01448824|20505615|P5|NOT COMPLETED|Part 2: Washout Period||0
8316834|NCT01448824|20505616|P4|NOT COMPLETED|Part 2: Washout Period||0
8316835|NCT01448824|20505617|P3|NOT COMPLETED|Part 2: Washout Period||0
8316836|NCT01448824|20505618|P2|NOT COMPLETED|Part 2: Washout Period||0
8316837|NCT01448824|20505619|P1|NOT COMPLETED|Part 2: Washout Period||0
8316838|NCT01448824|20505612|P8|COMPLETED|Part 2: Washout Period||11
8316839|NCT01448824|20505613|P7|COMPLETED|Part 2: Washout Period||0
8316840|NCT01448824|20505614|P6|COMPLETED|Part 2: Washout Period||0
8316841|NCT01448824|20505615|P5|COMPLETED|Part 2: Washout Period||0
8316842|NCT01448824|20505616|P4|COMPLETED|Part 2: Washout Period||0
8316843|NCT01448824|20505617|P3|COMPLETED|Part 2: Washout Period||0
8316844|NCT01448824|20505618|P2|COMPLETED|Part 2: Washout Period||0
8316845|NCT01448824|20505619|P1|COMPLETED|Part 2: Washout Period||0
8316846|NCT01448824|20505612|P8|STARTED|Part 2: Washout Period||11
8316847|NCT01448824|20505613|P7|STARTED|Part 2: Washout Period||0
8316848|NCT01448824|20505614|P6|STARTED|Part 2: Washout Period||0
8316849|NCT01448824|20505615|P5|STARTED|Part 2: Washout Period||0
8316850|NCT01448824|20505616|P4|STARTED|Part 2: Washout Period||0
8316851|NCT01448824|20505617|P3|STARTED|Part 2: Washout Period||0
8316852|NCT01448824|20505618|P2|STARTED|Part 2: Washout Period||0
8316853|NCT01448824|20505619|P1|STARTED|Part 2: Washout Period||0
8316854|NCT01448824|20505612|P8|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
8316855|NCT01448824|20505613|P7|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316856|NCT01448824|20505614|P6|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316857|NCT01448824|20505615|P5|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316858|NCT01448824|20505616|P4|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316859|NCT01448824|20505617|P3|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316860|NCT01448824|20505618|P2|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316861|NCT01448824|20505619|P1|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316862|NCT01448824|20505612|P8|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
8316863|NCT01448824|20505613|P7|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316864|NCT01448824|20505614|P6|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316865|NCT01448824|20505615|P5|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316866|NCT01448824|20505616|P4|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316867|NCT01448824|20505617|P3|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316868|NCT01448824|20505618|P2|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316869|NCT01448824|20505619|P1|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316870|NCT01448824|20505612|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
8316871|NCT01448824|20505613|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316872|NCT01448824|20505614|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316873|NCT01448824|20505615|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316874|NCT01448824|20505616|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316875|NCT01448824|20505617|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316876|NCT01448824|20505618|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316877|NCT01448824|20505619|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316878|NCT01448824|20505612|P8|STARTED|Part 2 Period 1: Drug-drug Interaction||12
8316879|NCT01448824|20505613|P7|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316880|NCT01448824|20505614|P6|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316881|NCT01448824|20505615|P5|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316882|NCT01448824|20505616|P4|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316883|NCT01448824|20505617|P3|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316884|NCT01448824|20505618|P2|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316885|NCT01448824|20505619|P1|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316886|NCT01448824|20505612|P8|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316887|NCT01448824|20505613|P7|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316888|NCT01448824|20505614|P6|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316889|NCT01448824|20505615|P5|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316890|NCT01448824|20505616|P4|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316891|NCT01448824|20505617|P3|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316892|NCT01448824|20505618|P2|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316893|NCT01448824|20505619|P1|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316894|NCT01448824|20505612|P8|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316895|NCT01448824|20505613|P7|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316896|NCT01448824|20505614|P6|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316897|NCT01448824|20505615|P5|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316898|NCT01448824|20505616|P4|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316899|NCT01448824|20505617|P3|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
8316900|NCT01448824|20505618|P2|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
8316901|NCT01448824|20505619|P1|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
8316902|NCT01448824|20505612|P8|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316903|NCT01448824|20505613|P7|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316904|NCT01448824|20505614|P6|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316905|NCT01448824|20505615|P5|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316906|NCT01448824|20505616|P4|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316907|NCT01448824|20505617|P3|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
8316908|NCT01448824|20505618|P2|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
8316909|NCT01448824|20505619|P1|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
8316910|NCT01448824|20505612|P8|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
8316911|NCT01448824|20505613|P7|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
8316912|NCT01448824|20505614|P6|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
8316913|NCT01448824|20505615|P5|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
8316914|NCT01448824|20505616|P4|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
8316915|NCT01448824|20505617|P3|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
8316916|NCT01448824|20505618|P2|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
8316917|NCT01448824|20505619|P1|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
8316918|NCT01448824|20505612|P8|NOT COMPLETED|Part 1: Washout Period||0
8316919|NCT01448824|20505613|P7|NOT COMPLETED|Part 1: Washout Period||0
8316920|NCT01448824|20505614|P6|NOT COMPLETED|Part 1: Washout Period||0
8316921|NCT01448824|20505615|P5|NOT COMPLETED|Part 1: Washout Period||0
8316922|NCT01448824|20505616|P4|NOT COMPLETED|Part 1: Washout Period||0
8316923|NCT01448824|20505617|P3|NOT COMPLETED|Part 1: Washout Period||0
8316924|NCT01448824|20505618|P2|NOT COMPLETED|Part 1: Washout Period||0
8316925|NCT01448824|20505619|P1|NOT COMPLETED|Part 1: Washout Period||1
8316926|NCT01448824|20505612|P8|COMPLETED|Part 1: Washout Period||0
8316927|NCT01448824|20505613|P7|COMPLETED|Part 1: Washout Period||0
8316928|NCT01448824|20505614|P6|COMPLETED|Part 1: Washout Period||0
8316929|NCT01448824|20505615|P5|COMPLETED|Part 1: Washout Period||0
8316930|NCT01448824|20505616|P4|COMPLETED|Part 1: Washout Period||0
8316931|NCT01448824|20505617|P3|COMPLETED|Part 1: Washout Period||4
8316932|NCT01448824|20505618|P2|COMPLETED|Part 1: Washout Period||4
8316933|NCT01448824|20505619|P1|COMPLETED|Part 1: Washout Period||11
8316934|NCT01448824|20505612|P8|STARTED|Part 1: Washout Period||0
8316935|NCT01448824|20505613|P7|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
8316936|NCT01448824|20505614|P6|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
8316937|NCT01448824|20505615|P5|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
8316938|NCT01448824|20505616|P4|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
8316939|NCT01448824|20505617|P3|STARTED|Part 1: Washout Period||4
8316940|NCT01448824|20505618|P2|STARTED|Part 1: Washout Period||4
8316941|NCT01448824|20505619|P1|STARTED|Part 1: Washout Period||12
8316942|NCT01448824|20505612|P8|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316943|NCT01448824|20505613|P7|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
8316944|NCT01448824|20505614|P6|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
8316945|NCT01448824|20505615|P5|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
8316946|NCT01448824|20505616|P4|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
8316947|NCT01448824|20505617|P3|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316948|NCT01448824|20505618|P2|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316949|NCT01448824|20505619|P1|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316950|NCT01448824|20505612|P8|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316951|NCT01448824|20505613|P7|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
8316952|NCT01448824|20505614|P6|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
8316953|NCT01448824|20505615|P5|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
8316954|NCT01448824|20505616|P4|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
8316955|NCT01448824|20505617|P3|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
8316956|NCT01448824|20505618|P2|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
8316957|NCT01448824|20505619|P1|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
8316958|NCT01448824|20505612|P8|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
8316959|NCT01448824|20505613|P7|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8316960|NCT01448824|20505614|P6|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8316961|NCT01448824|20505615|P5|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
8316962|NCT01448824|20505616|P4|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
8316963|NCT01448824|20505617|P3|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
8316964|NCT01448824|20505618|P2|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
8316965|NCT01448824|20505619|P1|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8316966|NCT01448824|20505612|P8|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
8316967|NCT01448824|20505613|P7|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8316968|NCT01448824|20505614|P6|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8316969|NCT01448824|20505615|P5|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
8316970|NCT01448824|20505616|P4|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
8316971|NCT01448824|20505617|P3|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
8316972|NCT01448824|20505618|P2|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
8316973|NCT01448824|20505619|P1|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8316974|NCT01448707|20505670|P2|NOT COMPLETED|Overall Study||18
8316975|NCT01448707|20505671|P1|NOT COMPLETED|Overall Study||18
8316976|NCT01448707|20505670|P2|COMPLETED|Overall Study||118
8316977|NCT01448707|20505671|P1|COMPLETED|Overall Study||119
8316978|NCT01448707|20505670|P2|STARTED|Overall Study||136
8316979|NCT01448707|20505671|P1|STARTED|Overall Study||137
8316980|NCT01448616|20505692|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
8316981|NCT01448616|20505693|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
8316982|NCT01448616|20505694|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
8316983|NCT01448616|20505695|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
8316984|NCT01448616|20505692|P4|COMPLETED|Study Drug (Treatment Phase)||9
8316985|NCT01448616|20505693|P3|COMPLETED|Study Drug (Treatment Phase)||23
8316986|NCT01448616|20505694|P2|COMPLETED|Study Drug (Treatment Phase)||22
8316987|NCT01448616|20505695|P1|COMPLETED|Study Drug (Treatment Phase)||0
8316988|NCT01448616|20505692|P4|STARTED|Study Drug (Treatment Phase)||13
8316989|NCT01448616|20505693|P3|STARTED|Study Drug (Treatment Phase)||27
8316990|NCT01448616|20505694|P2|STARTED|Study Drug (Treatment Phase)||24
8316991|NCT01448616|20505695|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
8316992|NCT01448616|20505692|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
8316993|NCT01448616|20505693|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
8316994|NCT01448616|20505694|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
8316995|NCT01448616|20505695|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
8316996|NCT01448616|20505692|P4|COMPLETED|Lead-In (Observational Phase)||0
8316997|NCT01448616|20505693|P3|COMPLETED|Lead-In (Observational Phase)||0
8316998|NCT01448616|20505694|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
8316999|NCT01448616|20505695|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
8317000|NCT01448616|20505692|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8317001|NCT01448616|20505693|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8317002|NCT01448616|20505694|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8317003|NCT01448616|20505695|P1|STARTED|Lead-In (Observational Phase)||73
8317004|NCT01448525|20505715|P2|NOT COMPLETED|Overall Study||2
8317005|NCT01448525|20505716|P1|NOT COMPLETED|Overall Study||1
8317006|NCT01448525|20505715|P2|COMPLETED|Overall Study||42
8317007|NCT01448525|20505716|P1|COMPLETED|Overall Study||43
8317008|NCT01448525|20505715|P2|STARTED|Overall Study||44
8317009|NCT01448525|20505716|P1|STARTED|Overall Study||44
8317010|NCT01448486|20505726|P2|NOT COMPLETED|Overall Study||0
8317011|NCT01448486|20505727|P1|NOT COMPLETED|Overall Study||0
8317012|NCT01448486|20505726|P2|COMPLETED|Overall Study||3
8317013|NCT01448486|20505727|P1|COMPLETED|Overall Study||3
8317014|NCT01448486|20505726|P2|STARTED|Overall Study||3
8317015|NCT01448486|20505727|P1|STARTED|Overall Study||3
8317016|NCT01448421|20505735|P1|NOT COMPLETED|Overall Study||0
8317017|NCT01448421|20505735|P1|COMPLETED|Overall Study||37
8317018|NCT01448421|20505735|P1|STARTED|Overall Study||37
8317019|NCT01448356|20505740|P1|NOT COMPLETED|Overall Study||0
8317020|NCT01448356|20505740|P1|COMPLETED|Overall Study|cross-over|10
8317021|NCT01448356|20505740|P1|STARTED|Overall Study||10
8317022|NCT01448213|20505747|P2|NOT COMPLETED|Overall Study||22
8317023|NCT01448213|20505748|P1|NOT COMPLETED|Overall Study||17
8317024|NCT01448213|20505747|P2|COMPLETED|Overall Study||112
8317025|NCT01448213|20505748|P1|COMPLETED|Overall Study||113
8317026|NCT01448213|20505747|P2|STARTED|Overall Study||134
8317027|NCT01448213|20505748|P1|STARTED|Overall Study||130
8317028|NCT01448057|20505758|P2|NOT COMPLETED|Overall Study||4
8317029|NCT01448057|20505759|P1|NOT COMPLETED|Overall Study||8
8317030|NCT01448057|20505758|P2|COMPLETED|Overall Study||167
8317031|NCT01448057|20505759|P1|COMPLETED|Overall Study||162
8317032|NCT01448057|20505758|P2|STARTED|Overall Study||171
8317033|NCT01448057|20505759|P1|STARTED|Overall Study||170
8317034|NCT01448044|20505769|P2|NOT COMPLETED|Follow Up Period||14
8317035|NCT01448044|20505770|P1|NOT COMPLETED|Follow Up Period||12
8317036|NCT01448044|20505769|P2|COMPLETED|Follow Up Period||26
8317037|NCT01448044|20505770|P1|COMPLETED|Follow Up Period||65
8317038|NCT01448044|20505769|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
8317039|NCT01448044|20505770|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
8317040|NCT01448044|20505769|P2|NOT COMPLETED|Treatment Period||16
8317041|NCT01448044|20505770|P1|NOT COMPLETED|Treatment Period||23
8317042|NCT01448044|20505769|P2|COMPLETED|Treatment Period||26
8317043|NCT01448044|20505770|P1|COMPLETED|Treatment Period||59
8317044|NCT01448044|20505769|P2|STARTED|Treatment Period||42
8317045|NCT01448044|20505770|P1|STARTED|Treatment Period||82
8317046|NCT01447927|20505786|P2|NOT COMPLETED|Overall Study||3
8317047|NCT01447927|20505787|P1|NOT COMPLETED|Overall Study||5
8317048|NCT01447927|20505786|P2|COMPLETED|Overall Study||33
8317049|NCT01447927|20505787|P1|COMPLETED|Overall Study||33
8317050|NCT01447927|20505786|P2|STARTED|Overall Study||36
8317051|NCT01447927|20505787|P1|STARTED|Overall Study||38
8317052|NCT01447914|20505795|P1|NOT COMPLETED|Overall Study||0
8317053|NCT01447914|20505795|P1|COMPLETED|Overall Study||16
8317054|NCT01447914|20505795|P1|STARTED|Overall Study||16
8317055|NCT01447888|20505806|P2|NOT COMPLETED|Overall Study||0
8317056|NCT01447888|20505807|P1|NOT COMPLETED|Overall Study||0
8317057|NCT01447888|20505806|P2|COMPLETED|Overall Study||55
8317058|NCT01447888|20505807|P1|COMPLETED|Overall Study||45
8317059|NCT01447888|20505806|P2|STARTED|Overall Study||55
8317060|NCT01447888|20505807|P1|STARTED|Overall Study||45
8317061|NCT01447849|20505819|P4|NOT COMPLETED|Second Intervention||0
8317062|NCT01447849|20505820|P3|NOT COMPLETED|Second Intervention||0
8317063|NCT01447849|20505821|P2|NOT COMPLETED|Second Intervention||0
8317064|NCT01447849|20505822|P1|NOT COMPLETED|Second Intervention||0
8317065|NCT01447849|20505819|P4|COMPLETED|Second Intervention||10
8317066|NCT01447849|20505820|P3|COMPLETED|Second Intervention||10
8317067|NCT01447849|20505821|P2|COMPLETED|Second Intervention||10
8317068|NCT01447849|20505822|P1|COMPLETED|Second Intervention||10
8317069|NCT01447849|20505819|P4|STARTED|Second Intervention||10
8317070|NCT01447849|20505820|P3|STARTED|Second Intervention||10
8317071|NCT01447849|20505821|P2|STARTED|Second Intervention||10
8317072|NCT01447849|20505822|P1|STARTED|Second Intervention||10
8317073|NCT01447849|20505819|P4|NOT COMPLETED|Washout Period for 1 Week||0
8317074|NCT01447849|20505820|P3|NOT COMPLETED|Washout Period for 1 Week||0
8317075|NCT01447849|20505821|P2|NOT COMPLETED|Washout Period for 1 Week||0
8317076|NCT01447849|20505822|P1|NOT COMPLETED|Washout Period for 1 Week||0
8317077|NCT01447849|20505819|P4|COMPLETED|Washout Period for 1 Week||10
8317078|NCT01447849|20505820|P3|COMPLETED|Washout Period for 1 Week||10
8317079|NCT01447849|20505821|P2|COMPLETED|Washout Period for 1 Week||10
8317080|NCT01447849|20505822|P1|COMPLETED|Washout Period for 1 Week||10
8317081|NCT01447849|20505819|P4|STARTED|Washout Period for 1 Week||10
8317082|NCT01447849|20505820|P3|STARTED|Washout Period for 1 Week||10
8317083|NCT01447849|20505821|P2|STARTED|Washout Period for 1 Week||10
8317084|NCT01447849|20505822|P1|STARTED|Washout Period for 1 Week||10
8317085|NCT01447849|20505819|P4|NOT COMPLETED|First Intervention||0
8317086|NCT01447849|20505820|P3|NOT COMPLETED|First Intervention||0
8317087|NCT01447849|20505821|P2|NOT COMPLETED|First Intervention||0
8317088|NCT01447849|20505822|P1|NOT COMPLETED|First Intervention||0
8317089|NCT01447849|20505819|P4|COMPLETED|First Intervention||10
8317090|NCT01447849|20505820|P3|COMPLETED|First Intervention||10
8317091|NCT01447849|20505821|P2|COMPLETED|First Intervention||10
8317092|NCT01447849|20505822|P1|COMPLETED|First Intervention||10
8317093|NCT01447849|20505819|P4|STARTED|First Intervention||10
8317094|NCT01447849|20505820|P3|STARTED|First Intervention||10
8317095|NCT01447849|20505821|P2|STARTED|First Intervention||10
8317096|NCT01447849|20505822|P1|STARTED|First Intervention||10
8317097|NCT01447719|20505832|P1|NOT COMPLETED|Overall Study||93
8317098|NCT01447719|20505832|P1|COMPLETED|Overall Study||59
8317099|NCT01447719|20505832|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
8317100|NCT01447719|20505832|P1|Valid AV-45 Scan Acquired|Overall Study||147
8317101|NCT01447719|20505832|P1|STARTED|Overall Study||152
8317102|NCT01447706|20505845|P2|NOT COMPLETED|Overall Study||3
8317103|NCT01447706|20505846|P1|NOT COMPLETED|Overall Study||0
8317104|NCT01447706|20505845|P2|COMPLETED|Overall Study||80
8317105|NCT01447706|20505846|P1|COMPLETED|Overall Study||140
8317106|NCT01447706|20505845|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
8317107|NCT01447706|20505846|P1|STARTED|Overall Study||140
8317108|NCT01447576|20505858|P1|NOT COMPLETED|Overall Study||476
8317109|NCT01447576|20505858|P1|COMPLETED|Overall Study||560
8317110|NCT01447576|20505858|P1|STARTED|Overall Study||1036
8317111|NCT01447511|20505869|P5|NOT COMPLETED|Rifampin Period||0
8317112|NCT01447511|20505870|P4|NOT COMPLETED|Rifampin Period||1
8317113|NCT01447511|20505871|P3|NOT COMPLETED|Rifampin Period||0
8317114|NCT01447511|20505872|P2|NOT COMPLETED|Rifampin Period||0
8317115|NCT01447511|20505873|P1|NOT COMPLETED|Rifampin Period||0
8317116|NCT01447511|20505869|P5|COMPLETED|Rifampin Period||4
8317117|NCT01447511|20505870|P4|COMPLETED|Rifampin Period||2
8317118|NCT01447511|20505871|P3|COMPLETED|Rifampin Period||8
8317119|NCT01447511|20505872|P2|COMPLETED|Rifampin Period||5
8317120|NCT01447511|20505873|P1|COMPLETED|Rifampin Period||8
8317121|NCT01447511|20505869|P5|STARTED|Rifampin Period||4
8317122|NCT01447511|20505870|P4|STARTED|Rifampin Period||3
8317123|NCT01447511|20505871|P3|STARTED|Rifampin Period||8
8317124|NCT01447511|20505872|P2|STARTED|Rifampin Period||5
8317125|NCT01447511|20505873|P1|STARTED|Rifampin Period||8
8317126|NCT01447511|20505869|P5|NOT COMPLETED|Fluconazole Period||0
8317127|NCT01447511|20505870|P4|NOT COMPLETED|Fluconazole Period||0
8317128|NCT01447511|20505871|P3|NOT COMPLETED|Fluconazole Period||1
8317129|NCT01447511|20505872|P2|NOT COMPLETED|Fluconazole Period||0
8317130|NCT01447511|20505873|P1|NOT COMPLETED|Fluconazole Period||0
8317131|NCT01447511|20505869|P5|COMPLETED|Fluconazole Period||4
8317132|NCT01447511|20505870|P4|COMPLETED|Fluconazole Period||3
8317133|NCT01447511|20505871|P3|COMPLETED|Fluconazole Period||8
8317134|NCT01447511|20505872|P2|COMPLETED|Fluconazole Period||0
8317135|NCT01447511|20505873|P1|COMPLETED|Fluconazole Period||8
8317136|NCT01447511|20505869|P5|STARTED|Fluconazole Period||4
8317137|NCT01447511|20505870|P4|STARTED|Fluconazole Period||3
8317138|NCT01447511|20505871|P3|STARTED|Fluconazole Period||9
8317139|NCT01447511|20505872|P2|STARTED|Fluconazole Period||0
8317140|NCT01447511|20505873|P1|STARTED|Fluconazole Period||8
8317141|NCT01447511|20505869|P5|NOT COMPLETED|Control Period||0
8317142|NCT01447511|20505870|P4|NOT COMPLETED|Control Period||0
8317143|NCT01447511|20505871|P3|NOT COMPLETED|Control Period||0
8317144|NCT01447511|20505872|P2|NOT COMPLETED|Control Period||0
8317145|NCT01447511|20505873|P1|NOT COMPLETED|Control Period||0
8317146|NCT01447511|20505869|P5|COMPLETED|Control Period||4
8317147|NCT01447511|20505870|P4|COMPLETED|Control Period||3
8317148|NCT01447511|20505871|P3|COMPLETED|Control Period||9
8317149|NCT01447511|20505872|P2|COMPLETED|Control Period||5
8317150|NCT01447511|20505873|P1|COMPLETED|Control Period||8
8317151|NCT01447511|20505869|P5|STARTED|Control Period||4
8317152|NCT01447511|20505870|P4|STARTED|Control Period||3
8317153|NCT01447511|20505871|P3|STARTED|Control Period||9
8317154|NCT01447511|20505872|P2|STARTED|Control Period||5
8317155|NCT01447511|20505873|P1|STARTED|Control Period||8
8317156|NCT01447446|20505891|P6|NOT COMPLETED|Overall Study||32
8317157|NCT01447446|20505892|P5|NOT COMPLETED|Overall Study||211
8317158|NCT01447446|20505893|P4|NOT COMPLETED|Overall Study||33
8317159|NCT01447446|20505894|P3|NOT COMPLETED|Overall Study||100
8317160|NCT01447446|20505895|P2|NOT COMPLETED|Overall Study||165
8317161|NCT01447446|20505896|P1|NOT COMPLETED|Overall Study||722
8317162|NCT01447446|20505891|P6|COMPLETED|Overall Study||54
8317163|NCT01447446|20505892|P5|COMPLETED|Overall Study||610
8317164|NCT01447446|20505893|P4|COMPLETED|Overall Study||60
8317165|NCT01447446|20505894|P3|COMPLETED|Overall Study||192
8317166|NCT01447446|20505895|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
8317167|NCT01447446|20505896|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
8317168|NCT01447446|20505891|P6|STARTED|Overall Study||86
8317169|NCT01447446|20505892|P5|STARTED|Overall Study||821
8317170|NCT01447446|20505893|P4|STARTED|Overall Study||93
8317171|NCT01447446|20505894|P3|STARTED|Overall Study||292
8317172|NCT01447446|20505895|P2|STARTED|Overall Study||496
8317173|NCT01447446|20505896|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
8317174|NCT01447433|20505986|P2|NOT COMPLETED|Overall Study||6
8317175|NCT01447433|20505987|P1|NOT COMPLETED|Overall Study||4
8317176|NCT01447433|20505986|P2|COMPLETED|Overall Study||21
8317177|NCT01447433|20505987|P1|COMPLETED|Overall Study||22
8317178|NCT01447433|20505986|P2|STARTED|Overall Study||27
8317179|NCT01447433|20505987|P1|STARTED|Overall Study||26
8317180|NCT01447420|20506014|P3|NOT COMPLETED|Overall Study||10
8317181|NCT01447420|20506015|P2|NOT COMPLETED|Overall Study||27
8317182|NCT01447420|20506016|P1|NOT COMPLETED|Overall Study||10
8317183|NCT01447420|20506014|P3|COMPLETED|Overall Study||8
8317184|NCT01447420|20506015|P2|COMPLETED|Overall Study||45
8317185|NCT01447420|20506016|P1|COMPLETED|Overall Study||29
8317186|NCT01447420|20506014|P3|STARTED|Overall Study||18
8317187|NCT01447420|20506015|P2|STARTED|Overall Study||72
8317188|NCT01447420|20506016|P1|STARTED|Overall Study||39
8317189|NCT01447407|20506036|P4|NOT COMPLETED|Overall Study||2
8317190|NCT01447407|20506037|P3|NOT COMPLETED|Overall Study||1
8317191|NCT01447407|20506038|P2|NOT COMPLETED|Overall Study||0
8317192|NCT01447407|20506039|P1|NOT COMPLETED|Overall Study||2
8317193|NCT01447407|20506036|P4|COMPLETED|Overall Study||40
8317194|NCT01447407|20506037|P3|COMPLETED|Overall Study||40
8317195|NCT01447407|20506038|P2|COMPLETED|Overall Study||40
8317196|NCT01447407|20506039|P1|COMPLETED|Overall Study||39
8317197|NCT01447407|20506036|P4|STARTED|Overall Study||42
8317198|NCT01447407|20506037|P3|STARTED|Overall Study||41
8317199|NCT01447407|20506038|P2|STARTED|Overall Study||40
8317200|NCT01447407|20506039|P1|STARTED|Overall Study||41
8317201|NCT01447225|20506077|P10|NOT COMPLETED|Overall Study||0
8317202|NCT01447225|20506078|P9|NOT COMPLETED|Overall Study||0
8317203|NCT01447225|20506079|P8|NOT COMPLETED|Overall Study||0
8317204|NCT01447225|20506080|P7|NOT COMPLETED|Overall Study||0
8317205|NCT01447225|20506081|P6|NOT COMPLETED|Overall Study||0
8317206|NCT01447225|20506082|P5|NOT COMPLETED|Overall Study||0
8317207|NCT01447225|20506083|P4|NOT COMPLETED|Overall Study||0
8317208|NCT01447225|20506084|P3|NOT COMPLETED|Overall Study||0
8317209|NCT01447225|20506085|P2|NOT COMPLETED|Overall Study||0
8317210|NCT01447225|20506086|P1|NOT COMPLETED|Overall Study||0
8317211|NCT01447225|20506077|P10|COMPLETED|Overall Study||4
8317212|NCT01447225|20506078|P9|COMPLETED|Overall Study||3
8317213|NCT01447225|20506079|P8|COMPLETED|Overall Study||4
8317214|NCT01447225|20506080|P7|COMPLETED|Overall Study||7
8317215|NCT01447225|20506081|P6|COMPLETED|Overall Study||3
8317216|NCT01447225|20506082|P5|COMPLETED|Overall Study||3
8317217|NCT01447225|20506083|P4|COMPLETED|Overall Study||3
8317218|NCT01447225|20506084|P3|COMPLETED|Overall Study||5
8317219|NCT01447225|20506085|P2|COMPLETED|Overall Study||8
8317220|NCT01447225|20506086|P1|COMPLETED|Overall Study||3
8317221|NCT01447225|20506077|P10|STARTED|Overall Study||4
8317222|NCT01447225|20506078|P9|STARTED|Overall Study||3
8317223|NCT01447225|20506079|P8|STARTED|Overall Study||4
8317224|NCT01447225|20506080|P7|STARTED|Overall Study||7
8317225|NCT01447225|20506081|P6|STARTED|Overall Study||3
8317226|NCT01447225|20506082|P5|STARTED|Overall Study||3
8317227|NCT01447225|20506083|P4|STARTED|Overall Study||3
8317228|NCT01447225|20506084|P3|STARTED|Overall Study||5
8317229|NCT01447225|20506085|P2|STARTED|Overall Study||8
8317230|NCT01447225|20506086|P1|STARTED|Overall Study||3
8317231|NCT01447121|20506156|P1|NOT COMPLETED|Overall Study||0
8317232|NCT01447121|20506156|P1|COMPLETED|Overall Study||118
8317233|NCT01447121|20506156|P1|STARTED|Overall Study||118
8317234|NCT01447017|20506163|P2|NOT COMPLETED|Overall Study||10
8317235|NCT01447017|20506164|P1|NOT COMPLETED|Overall Study||10
8317236|NCT01447017|20506163|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
8317237|NCT01447017|20506164|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
8317238|NCT01447017|20506163|P2|Performed Visit 2|Overall Study||24
8317239|NCT01447017|20506164|P1|Performed Visit 2|Overall Study||43
8317240|NCT01447017|20506163|P2|STARTED|Overall Study||24
8317241|NCT01447017|20506164|P1|STARTED|Overall Study||45
8317242|NCT01446965|20506172|P2|NOT COMPLETED|Participants Followed and Analyzed||12
8317243|NCT01446965|20506173|P1|NOT COMPLETED|Participants Followed and Analyzed||10
8317244|NCT01446965|20506172|P2|COMPLETED|Participants Followed and Analyzed||766
8317245|NCT01446965|20506173|P1|COMPLETED|Participants Followed and Analyzed||1514
8317246|NCT01446965|20506172|P2|Given WCD Out of Protocol|Participants Followed and Analyzed||20
8317247|NCT01446965|20506173|P1|Given WCD Out of Protocol|Participants Followed and Analyzed||0
8317248|NCT01446965|20506172|P2|Never Given WCD|Participants Followed and Analyzed||758
8317249|NCT01446965|20506173|P1|Never Given WCD|Participants Followed and Analyzed||0
8317250|NCT01446965|20506172|P2|Never Wore WCD|Participants Followed and Analyzed||0
8317251|NCT01446965|20506173|P1|Never Wore WCD|Participants Followed and Analyzed||43
8317252|NCT01446965|20506172|P2|Received WCD|Participants Followed and Analyzed||0
8317253|NCT01446965|20506173|P1|Received WCD|Participants Followed and Analyzed||1481
8317254|NCT01446965|20506172|P2|STARTED|Participants Followed and Analyzed||778
8317255|NCT01446965|20506173|P1|STARTED|Participants Followed and Analyzed||1524
8317256|NCT01446965|20506172|P2|NOT COMPLETED|Randominization||16
8317257|NCT01446965|20506173|P1|NOT COMPLETED|Randominization||30
8317258|NCT01446965|20506172|P2|COMPLETED|Randominization||778
8317259|NCT01446965|20506173|P1|COMPLETED|Randominization||1524
8317260|NCT01446965|20506172|P2|STARTED|Randominization||794
8317261|NCT01446965|20506173|P1|STARTED|Randominization||1554
8317262|NCT01446913|20506186|P3|NOT COMPLETED|Overall Study||11
8317263|NCT01446913|20506187|P2|NOT COMPLETED|Overall Study||9
8317264|NCT01446913|20506188|P1|NOT COMPLETED|Overall Study||9
8317265|NCT01446913|20506186|P3|COMPLETED|Overall Study||73
8317266|NCT01446913|20506187|P2|COMPLETED|Overall Study||73
8317267|NCT01446913|20506188|P1|COMPLETED|Overall Study||77
8317268|NCT01446913|20506186|P3|Patients With Sleep Apnea|Overall Study||21
8317269|NCT01446913|20506187|P2|Patients With Sleep Apnea|Overall Study||45
8317270|NCT01446913|20506188|P1|Patients With Sleep Apnea|Overall Study||39
8317271|NCT01446913|20506186|P3|Patients With Sleep Study|Overall Study||29
8317272|NCT01446913|20506187|P2|Patients With Sleep Study|Overall Study||56
8317273|NCT01446913|20506188|P1|Patients With Sleep Study|Overall Study||53
8317274|NCT01446913|20506186|P3|STARTED|Overall Study||84
8317275|NCT01446913|20506187|P2|STARTED|Overall Study||82
8317276|NCT01446913|20506188|P1|STARTED|Overall Study||86
8317277|NCT01446874|20506249|P3|NOT COMPLETED|Overall Study||18
8317278|NCT01446874|20506250|P2|NOT COMPLETED|Overall Study||4
8317279|NCT01446874|20506251|P1|NOT COMPLETED|Overall Study||2
8317280|NCT01446874|20506249|P3|COMPLETED|Overall Study||62
8317281|NCT01446874|20506250|P2|COMPLETED|Overall Study||46
8317282|NCT01446874|20506251|P1|COMPLETED|Overall Study||18
8317283|NCT01446874|20506249|P3|STARTED|Overall Study||80
8317284|NCT01446874|20506250|P2|STARTED|Overall Study||50
8317285|NCT01446874|20506251|P1|STARTED|Overall Study||20
8317286|NCT01446809|20506279|P3|NOT COMPLETED|Overall Study||2
8317287|NCT01446809|20506280|P2|NOT COMPLETED|Overall Study||0
8317288|NCT01446809|20506281|P1|NOT COMPLETED|Overall Study||0
8317289|NCT01446809|20506279|P3|COMPLETED|Overall Study||0
8317290|NCT01446809|20506280|P2|COMPLETED|Overall Study||7
8317291|NCT01446809|20506281|P1|COMPLETED|Overall Study||14
8317292|NCT01446809|20506279|P3|STARTED|Overall Study||2
8317293|NCT01446809|20506280|P2|STARTED|Overall Study||7
8317294|NCT01446809|20506281|P1|STARTED|Overall Study||14
8317295|NCT01446796|20506304|P2|NOT COMPLETED|Overall Study||0
8317296|NCT01446796|20506305|P1|NOT COMPLETED|Overall Study||1
8317297|NCT01446796|20506304|P2|COMPLETED|Overall Study|Study terminated early|0
8317298|NCT01446796|20506305|P1|COMPLETED|Overall Study|"Study terminated early
~One subject of three withdrew prior to randomization and did not start"|2
8317299|NCT01446796|20506304|P2|STARTED|Overall Study||0
8317300|NCT01446796|20506305|P1|STARTED|Overall Study||3
8317301|NCT01446705|20506319|P2|NOT COMPLETED|Overall Study||0
8317302|NCT01446705|20506320|P1|NOT COMPLETED|Overall Study||0
8317303|NCT01446705|20506319|P2|COMPLETED|Overall Study||6627
8317304|NCT01446705|20506320|P1|COMPLETED|Overall Study||50446
8317305|NCT01446705|20506319|P2|STARTED|Overall Study||6627
8317306|NCT01446705|20506320|P1|STARTED|Overall Study||50446
8317307|NCT01446666|20506336|P1|NOT COMPLETED|Overall Study||81
8317308|NCT01446666|20506336|P1|COMPLETED|Overall Study||326
8317309|NCT01446666|20506336|P1|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
8317310|NCT01446419|20506351|P2|NOT COMPLETED|Overall Study||1
8317311|NCT01446419|20506352|P1|NOT COMPLETED|Overall Study||5
8317312|NCT01446419|20506351|P2|COMPLETED|Overall Study||77
8317313|NCT01446419|20506352|P1|COMPLETED|Overall Study||142
8317314|NCT01446419|20506351|P2|12 Month Follow-up|Overall Study||77
8317315|NCT01446419|20506352|P1|12 Month Follow-up|Overall Study||142
8317316|NCT01446419|20506351|P2|6 Month Follow-up|Overall Study||77
8317317|NCT01446419|20506352|P1|6 Month Follow-up|Overall Study||144
8317318|NCT01446419|20506351|P2|3 Month Follow-up|Overall Study||77
8317319|NCT01446419|20506352|P1|3 Month Follow-up|Overall Study||146
8317320|NCT01446419|20506351|P2|STARTED|Overall Study||78
8317321|NCT01446419|20506352|P1|STARTED|Overall Study||147
8317322|NCT01446289|20506366|P4|NOT COMPLETED|Overall Study||0
8317323|NCT01446289|20506367|P3|NOT COMPLETED|Overall Study||1
8317324|NCT01446289|20506368|P2|NOT COMPLETED|Overall Study||0
8317325|NCT01446289|20506369|P1|NOT COMPLETED|Overall Study||1
8317326|NCT01446289|20506366|P4|COMPLETED|Overall Study||35
8317327|NCT01446289|20506367|P3|COMPLETED|Overall Study||50
8317328|NCT01446289|20506368|P2|COMPLETED|Overall Study||35
8317329|NCT01446289|20506369|P1|COMPLETED|Overall Study||50
8317330|NCT01446289|20506366|P4|STARTED|Overall Study||35
8317331|NCT01446289|20506367|P3|STARTED|Overall Study||51
8317332|NCT01446289|20506368|P2|STARTED|Overall Study||35
8317333|NCT01446289|20506369|P1|STARTED|Overall Study||51
8317334|NCT01446250|20506397|P4|NOT COMPLETED|Follow-up||6
8317335|NCT01446250|20506398|P3|NOT COMPLETED|Follow-up||0
8317336|NCT01446250|20506399|P2|NOT COMPLETED|Follow-up||0
8317337|NCT01446250|20506400|P1|NOT COMPLETED|Follow-up||0
8317338|NCT01446250|20506397|P4|COMPLETED|Follow-up||0
8317339|NCT01446250|20506398|P3|COMPLETED|Follow-up||0
8317340|NCT01446250|20506399|P2|COMPLETED|Follow-up||0
8317341|NCT01446250|20506400|P1|COMPLETED|Follow-up||0
8317342|NCT01446250|20506397|P4|STARTED|Follow-up||6
8317343|NCT01446250|20506398|P3|STARTED|Follow-up||0
8317344|NCT01446250|20506399|P2|STARTED|Follow-up||0
8317345|NCT01446250|20506400|P1|STARTED|Follow-up||0
8317346|NCT01446250|20506397|P4|NOT COMPLETED|Treatment Period 2||0
8317347|NCT01446250|20506398|P3|NOT COMPLETED|Treatment Period 2||0
8317348|NCT01446250|20506399|P2|NOT COMPLETED|Treatment Period 2||1
8317349|NCT01446250|20506400|P1|NOT COMPLETED|Treatment Period 2||0
8317350|NCT01446250|20506397|P4|COMPLETED|Treatment Period 2||0
8317351|NCT01446250|20506398|P3|COMPLETED|Treatment Period 2||0
8317352|NCT01446250|20506399|P2|COMPLETED|Treatment Period 2||6
8317353|NCT01446250|20506400|P1|COMPLETED|Treatment Period 2||0
8317354|NCT01446250|20506397|P4|STARTED|Treatment Period 2||0
8317355|NCT01446250|20506398|P3|STARTED|Treatment Period 2||0
8317356|NCT01446250|20506399|P2|STARTED|Treatment Period 2||7
8317357|NCT01446250|20506400|P1|STARTED|Treatment Period 2||0
8317358|NCT01446250|20506397|P4|NOT COMPLETED|Clinical Hold||0
8317359|NCT01446250|20506398|P3|NOT COMPLETED|Clinical Hold||0
8317360|NCT01446250|20506399|P2|NOT COMPLETED|Clinical Hold||0
8317361|NCT01446250|20506400|P1|NOT COMPLETED|Clinical Hold||0
8317362|NCT01446250|20506397|P4|COMPLETED|Clinical Hold||0
8317363|NCT01446250|20506398|P3|COMPLETED|Clinical Hold||5
8317364|NCT01446250|20506399|P2|COMPLETED|Clinical Hold||2
8317365|NCT01446250|20506400|P1|COMPLETED|Clinical Hold||0
8317366|NCT01446250|20506397|P4|STARTED|Clinical Hold||0
8317367|NCT01446250|20506398|P3|STARTED|Clinical Hold||5
8317368|NCT01446250|20506399|P2|STARTED|Clinical Hold||2
8317369|NCT01446250|20506400|P1|STARTED|Clinical Hold||0
8317370|NCT01446250|20506397|P4|NOT COMPLETED|Treatment Period 1||0
8317371|NCT01446250|20506398|P3|NOT COMPLETED|Treatment Period 1||0
8317372|NCT01446250|20506399|P2|NOT COMPLETED|Treatment Period 1||1
8317373|NCT01446250|20506400|P1|NOT COMPLETED|Treatment Period 1||0
8317374|NCT01446250|20506397|P4|COMPLETED|Treatment Period 1||0
8317375|NCT01446250|20506398|P3|COMPLETED|Treatment Period 1||0
8317376|NCT01446250|20506399|P2|COMPLETED|Treatment Period 1||2
8317377|NCT01446250|20506400|P1|COMPLETED|Treatment Period 1||5
8317378|NCT01446250|20506397|P4|STARTED|Treatment Period 1||0
8317379|NCT01446250|20506398|P3|STARTED|Treatment Period 1||0
8317380|NCT01446250|20506399|P2|STARTED|Treatment Period 1||3
8317381|NCT01446250|20506400|P1|STARTED|Treatment Period 1||5
8317382|NCT01446237|20506412|P1|NOT COMPLETED|Overall Study||10
8317383|NCT01446237|20506412|P1|COMPLETED|Overall Study||115
8317384|NCT01446237|20506412|P1|STARTED|Overall Study||125
8317385|NCT01446159|20506424|P4|NOT COMPLETED|Overall Study||62
8317386|NCT01446159|20506425|P3|NOT COMPLETED|Overall Study||71
8317387|NCT01446159|20506426|P2|NOT COMPLETED|Overall Study||3
8317388|NCT01446159|20506427|P1|NOT COMPLETED|Overall Study||3
8317389|NCT01446159|20506424|P4|COMPLETED|Overall Study||23
8317390|NCT01446159|20506425|P3|COMPLETED|Overall Study||21
8317391|NCT01446159|20506426|P2|COMPLETED|Overall Study||0
8317392|NCT01446159|20506427|P1|COMPLETED|Overall Study||0
8317393|NCT01446159|20506424|P4|STARTED|Overall Study||85
8317394|NCT01446159|20506425|P3|STARTED|Overall Study||92
8317395|NCT01446159|20506426|P2|STARTED|Overall Study||3
8317396|NCT01446159|20506427|P1|STARTED|Overall Study||3
8317397|NCT01446042|20506502|P3|NOT COMPLETED|Overall Study||9
8317398|NCT01446042|20506503|P2|NOT COMPLETED|Overall Study||3
8317399|NCT01446042|20506504|P1|NOT COMPLETED|Overall Study||20
8317400|NCT01446042|20506502|P3|COMPLETED|Overall Study||69
8317401|NCT01446042|20506503|P2|COMPLETED|Overall Study||83
8317402|NCT01446042|20506504|P1|COMPLETED|Overall Study||122
8317403|NCT01446042|20506502|P3|STARTED|Overall Study||78
8317404|NCT01446042|20506503|P2|STARTED|Overall Study||86
8317405|NCT01446042|20506504|P1|STARTED|Overall Study||142
8317406|NCT01446003|20506515|P2|NOT COMPLETED|Period 2||0
8317407|NCT01446003|20506516|P1|NOT COMPLETED|Period 2||1
8317408|NCT01446003|20506515|P2|COMPLETED|Period 2||15
8317409|NCT01446003|20506516|P1|COMPLETED|Period 2||13
8317410|NCT01446003|20506515|P2|STARTED|Period 2||15
8317411|NCT01446003|20506516|P1|STARTED|Period 2||14
8317412|NCT01446003|20506515|P2|NOT COMPLETED|Period 1||0
8317413|NCT01446003|20506516|P1|NOT COMPLETED|Period 1||2
8317414|NCT01446003|20506515|P2|COMPLETED|Period 1||15
8317415|NCT01446003|20506516|P1|COMPLETED|Period 1||14
8317416|NCT01446003|20506515|P2|STARTED|Period 1||15
8317417|NCT01446003|20506516|P1|STARTED|Period 1||16
8317418|NCT01445951|20506537|P3|NOT COMPLETED|Overall Study||19
8317419|NCT01445951|20506538|P2|NOT COMPLETED|Overall Study||36
8317420|NCT01445951|20506539|P1|NOT COMPLETED|Overall Study||44
8317421|NCT01445951|20506537|P3|COMPLETED|Overall Study||151
8317422|NCT01445951|20506538|P2|COMPLETED|Overall Study||138
8317423|NCT01445951|20506539|P1|COMPLETED|Overall Study||130
8317424|NCT01445951|20506537|P3|STARTED|Overall Study||170
8317425|NCT01445951|20506538|P2|STARTED|Overall Study||174
8317426|NCT01445951|20506539|P1|STARTED|Overall Study||174
8317427|NCT01445886|20506577|P1|NOT COMPLETED|Overall Study||5
8317428|NCT01445886|20506577|P1|COMPLETED|Overall Study||28
8317429|NCT01445886|20506577|P1|STARTED|Overall Study||33
8317430|NCT01445873|20506587|P1|NOT COMPLETED|Overall Study||0
8317431|NCT01445873|20506587|P1|COMPLETED|Overall Study||36
8317432|NCT01445873|20506587|P1|STARTED|Overall Study||36
8317433|NCT01445847|20506617|P2|NOT COMPLETED|Overall Study||14
8317434|NCT01445847|20506618|P1|NOT COMPLETED|Overall Study||14
8317435|NCT01445847|20506617|P2|COMPLETED|Overall Study||36
8317436|NCT01445847|20506618|P1|COMPLETED|Overall Study||36
8317437|NCT01445847|20506617|P2|STARTED|Overall Study||50
8317438|NCT01445847|20506618|P1|STARTED|Overall Study||50
8317439|NCT01445821|20506626|P2|NOT COMPLETED|Overall Study||0
8317440|NCT01445821|20506627|P1|NOT COMPLETED|Overall Study||0
8317441|NCT01445821|20506626|P2|COMPLETED|Overall Study||22
8317442|NCT01445821|20506627|P1|COMPLETED|Overall Study||22
8317443|NCT01445821|20506626|P2|STARTED|Overall Study||22
8317444|NCT01445821|20506627|P1|STARTED|Overall Study||22
8317445|NCT01445769|20506635|P1|NOT COMPLETED|Overall Study||8
8317446|NCT01445769|20506635|P1|COMPLETED|Overall Study||37
8317447|NCT01445769|20506635|P1|STARTED|Overall Study||45
8317448|NCT01445678|20506655|P2|NOT COMPLETED|Overall Study||21
8317449|NCT01445678|20506656|P1|NOT COMPLETED|Overall Study||30
8317450|NCT01445678|20506655|P2|COMPLETED|Overall Study||476
8317451|NCT01445678|20506656|P1|COMPLETED|Overall Study||452
8317452|NCT01445678|20506655|P2|STARTED|Overall Study||497
8317453|NCT01445678|20506656|P1|STARTED|Overall Study||482
8317454|NCT01445652|20506674|P2|NOT COMPLETED|Overall Study||3
8317455|NCT01445652|20506675|P1|NOT COMPLETED|Overall Study||10
8317456|NCT01445652|20506674|P2|COMPLETED|Overall Study||50
8317457|NCT01445652|20506675|P1|COMPLETED|Overall Study||47
8317458|NCT01445652|20506674|P2|STARTED|Overall Study||53
8317459|NCT01445652|20506675|P1|STARTED|Overall Study||57
8317460|NCT01445626|20506683|P1|NOT COMPLETED|Overall Study||0
8317461|NCT01445626|20506683|P1|COMPLETED|Overall Study||87
8317462|NCT01445626|20506683|P1|STARTED|Overall Study||87
8317463|NCT01445613|20506693|P1|NOT COMPLETED|1-year Follow-up||77
8317464|NCT01445613|20506693|P1|COMPLETED|1-year Follow-up||1088
8317465|NCT01445613|20506693|P1|STARTED|1-year Follow-up||1165
8317466|NCT01445613|20506693|P1|NOT COMPLETED|30-day Follow-up||35
8317467|NCT01445613|20506693|P1|COMPLETED|30-day Follow-up||1165
8317468|NCT01445613|20506693|P1|STARTED|30-day Follow-up||1200
8317469|NCT01445548|20506711|P1|NOT COMPLETED|Overall Study||1
8317470|NCT01445548|20506711|P1|COMPLETED|Overall Study||5
8317471|NCT01445548|20506711|P1|STARTED|Overall Study||6
8317472|NCT01445535|20506737|P4|NOT COMPLETED|Overall Study||2
8317473|NCT01445535|20506738|P3|NOT COMPLETED|Overall Study||1
8317474|NCT01445535|20506739|P2|NOT COMPLETED|Overall Study||0
8317475|NCT01445535|20506740|P1|NOT COMPLETED|Overall Study||1
8317476|NCT01445535|20506737|P4|COMPLETED|Overall Study||4
8317477|NCT01445535|20506738|P3|COMPLETED|Overall Study||2
8317478|NCT01445535|20506739|P2|COMPLETED|Overall Study||3
8317479|NCT01445535|20506740|P1|COMPLETED|Overall Study||2
8317480|NCT01445535|20506737|P4|STARTED|Overall Study||6
8317481|NCT01445535|20506738|P3|STARTED|Overall Study||3
8317482|NCT01445535|20506739|P2|STARTED|Overall Study||3
8317483|NCT01445535|20506740|P1|STARTED|Overall Study||3
8317484|NCT01445301|20506764|P3|NOT COMPLETED|Overall Study||9
8317485|NCT01445301|20506765|P2|NOT COMPLETED|Overall Study||35
8317486|NCT01445301|20506766|P1|NOT COMPLETED|Overall Study||21
8317487|NCT01445301|20506764|P3|COMPLETED|Overall Study||290
8317488|NCT01445301|20506765|P2|COMPLETED|Overall Study||262
8317489|NCT01445301|20506766|P1|COMPLETED|Overall Study||183
8317490|NCT01445301|20506764|P3|STARTED|Overall Study||299
8317491|NCT01445301|20506765|P2|STARTED|Overall Study||297
8317492|NCT01445301|20506766|P1|STARTED|Overall Study||204
8317493|NCT01445171|20506801|P1|NOT COMPLETED|Overall Study||95
8317494|NCT01445171|20506801|P1|COMPLETED|Overall Study||200
8317495|NCT01445171|20506801|P1|Implanted With Study Device|Overall Study||287
8317496|NCT01445171|20506801|P1|STARTED|Overall Study||295
8317497|NCT01445028|20506824|P2|NOT COMPLETED|Overall Study||3
8317498|NCT01445028|20506825|P1|NOT COMPLETED|Overall Study||0
8317499|NCT01445028|20506824|P2|COMPLETED|Overall Study||51
8317500|NCT01445028|20506825|P1|COMPLETED|Overall Study||58
8317501|NCT01445028|20506824|P2|STARTED|Overall Study||54
8317502|NCT01445028|20506825|P1|STARTED|Overall Study||58
8317503|NCT01444924|20506833|P2|NOT COMPLETED|Overall Study||0
8317504|NCT01444924|20506834|P1|NOT COMPLETED|Overall Study||0
8317505|NCT01444924|20506833|P2|COMPLETED|Overall Study||33
8317506|NCT01444924|20506834|P1|COMPLETED|Overall Study||31
8317507|NCT01444924|20506833|P2|STARTED|Overall Study||33
8317508|NCT01444924|20506834|P1|STARTED|Overall Study||31
8317509|NCT01444911|20506844|P2|NOT COMPLETED|Overall Study||0
8317510|NCT01444911|20506845|P1|NOT COMPLETED|Overall Study||8
8317511|NCT01444911|20506844|P2|COMPLETED|Overall Study||13
8317512|NCT01444911|20506845|P1|COMPLETED|Overall Study||8
8317513|NCT01444911|20506844|P2|STARTED|Overall Study||13
8317514|NCT01444911|20506845|P1|STARTED|Overall Study||16
8317515|NCT01444898|20506857|P1|NOT COMPLETED|Overall Study||1
8317516|NCT01444898|20506857|P1|COMPLETED|Overall Study||9
8317517|NCT01444898|20506857|P1|STARTED|Overall Study||10
8317518|NCT01444781|20506872|P3|NOT COMPLETED|Overall Study||3
8317519|NCT01444781|20506873|P2|NOT COMPLETED|Overall Study||4
8317520|NCT01444781|20506874|P1|NOT COMPLETED|Overall Study||3
8317521|NCT01444781|20506872|P3|COMPLETED|Overall Study||272
8317522|NCT01444781|20506873|P2|COMPLETED|Overall Study||411
8317523|NCT01444781|20506874|P1|COMPLETED|Overall Study||413
8317524|NCT01444781|20506872|P3|STARTED|Overall Study||275
8317525|NCT01444781|20506873|P2|STARTED|Overall Study||415
8317526|NCT01444781|20506874|P1|STARTED|Overall Study||416
8317527|NCT01444742|20506912|P1|NOT COMPLETED|Overall Study||1
8317528|NCT01444742|20506912|P1|COMPLETED|Overall Study||80
8317529|NCT01444742|20506912|P1|STARTED|Overall Study||81
8317530|NCT01444651|20506919|P2|NOT COMPLETED|Overall Study||9
8317531|NCT01444651|20506920|P1|NOT COMPLETED|Overall Study||11
8317532|NCT01444651|20506919|P2|COMPLETED|Overall Study||28
8317533|NCT01444651|20506920|P1|COMPLETED|Overall Study||25
8317534|NCT01444651|20506919|P2|STARTED|Overall Study||37
8317535|NCT01444651|20506920|P1|STARTED|Overall Study||36
8317536|NCT01444456|20506936|P1|NOT COMPLETED|Overall Study||285
8317537|NCT01444456|20506936|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
8317538|NCT01444456|20506936|P1|Received Darbepoetin Alfa|Overall Study||1134
8317539|NCT01444456|20506936|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
8317540|NCT01444456|20506936|P1|STARTED|Overall Study||1262
8317541|NCT01444430|20506947|P2|NOT COMPLETED|Overall Study||81
8317542|NCT01444430|20506948|P1|NOT COMPLETED|Overall Study||61
8317543|NCT01444430|20506947|P2|COMPLETED|Overall Study||5766
8317544|NCT01444430|20506948|P1|COMPLETED|Overall Study||5785
8317545|NCT01444430|20506947|P2|STARTED|Overall Study||5847
8317546|NCT01444430|20506948|P1|STARTED|Overall Study||5846
8317547|NCT01444417|20506970|P2|NOT COMPLETED|Overall Study||1
8317548|NCT01444417|20506971|P1|NOT COMPLETED|Overall Study||2
8317549|NCT01444417|20506970|P2|COMPLETED|Overall Study||41
8317550|NCT01444417|20506971|P1|COMPLETED|Overall Study||18
8317551|NCT01444417|20506970|P2|Received Treatment|Overall Study||42
8317552|NCT01444417|20506971|P1|Received Treatment|Overall Study||19
8317553|NCT01444417|20506970|P2|STARTED|Overall Study||42
8317554|NCT01444417|20506971|P1|STARTED|Overall Study||20
8317555|NCT01444391|20506987|P1|NOT COMPLETED|Overall Study||1
8317556|NCT01444391|20506987|P1|COMPLETED|Overall Study||41
8317557|NCT01444391|20506987|P1|STARTED|Overall Study||42
8317558|NCT01444378|20506995|P1|NOT COMPLETED|Overall Study||17
8317559|NCT01444378|20506995|P1|COMPLETED|Overall Study||124
8317560|NCT01444378|20506995|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
8317561|NCT01444300|20507107|P2|NOT COMPLETED|Overall Study||0
8317562|NCT01444300|20507108|P1|NOT COMPLETED|Overall Study||4
8317563|NCT01444300|20507107|P2|COMPLETED|Overall Study||12
8317564|NCT01444300|20507108|P1|COMPLETED|Overall Study||8
8317565|NCT01444300|20507107|P2|STARTED|Overall Study||12
8317566|NCT01444300|20507108|P1|STARTED|Overall Study||12
8317567|NCT01444287|20507118|P1|NOT COMPLETED|Period 4||0
8317568|NCT01444287|20507118|P1|COMPLETED|Period 4||22
8317569|NCT01444287|20507118|P1|STARTED|Period 4||22
8317570|NCT01444287|20507118|P1|NOT COMPLETED|Period 3||0
8317571|NCT01444287|20507118|P1|COMPLETED|Period 3||22
8317572|NCT01444287|20507118|P1|STARTED|Period 3||22
8317573|NCT01444287|20507118|P1|NOT COMPLETED|Period 2||0
8317574|NCT01444287|20507118|P1|COMPLETED|Period 2||22
8317575|NCT01444287|20507118|P1|STARTED|Period 2||22
8317576|NCT01444287|20507118|P1|NOT COMPLETED|Period 1||0
8317577|NCT01444287|20507118|P1|COMPLETED|Period 1||22
8317578|NCT01444287|20507118|P1|STARTED|Period 1||22
8317579|NCT01444092|20507140|P1|NOT COMPLETED|Overall Study||17
8317580|NCT01444092|20507140|P1|COMPLETED|Overall Study||91
8317581|NCT01444092|20507140|P1|INFORMED CONSENT OBTAINED|Overall Study||108
8317582|NCT01444092|20507140|P1|STARTED|Overall Study||108
8317583|NCT01444027|20507149|P3|NOT COMPLETED|Overall Study||38
8317584|NCT01444027|20507150|P2|NOT COMPLETED|Overall Study||30
8317585|NCT01444027|20507151|P1|NOT COMPLETED|Overall Study||30
8317586|NCT01444027|20507149|P3|COMPLETED|Overall Study||133
8317587|NCT01444027|20507150|P2|COMPLETED|Overall Study||141
8317588|NCT01444027|20507151|P1|COMPLETED|Overall Study||142
8317589|NCT01444027|20507149|P3|3 Month Follow-up|Overall Study||133
8317590|NCT01444027|20507150|P2|3 Month Follow-up|Overall Study||141
8317591|NCT01444027|20507151|P1|3 Month Follow-up|Overall Study||142
8317592|NCT01444027|20507149|P3|1 Month Follow-up|Overall Study||141
8317593|NCT01444027|20507150|P2|1 Month Follow-up|Overall Study||159
8317594|NCT01444027|20507151|P1|1 Month Follow-up|Overall Study||160
8317595|NCT01444027|20507149|P3|Received Intervention as Assigned|Overall Study||147
8317596|NCT01444027|20507150|P2|Received Intervention as Assigned|Overall Study||161
8317597|NCT01444027|20507151|P1|Received Intervention as Assigned|Overall Study||168
8317598|NCT01444027|20507149|P3|STARTED|Overall Study||171
8317599|NCT01444027|20507150|P2|STARTED|Overall Study||171
8317600|NCT01444027|20507151|P1|STARTED|Overall Study||172
8317601|NCT01443923|20507173|P2|NOT COMPLETED|Overall Study||0
8317602|NCT01443923|20507174|P1|NOT COMPLETED|Overall Study||1
8317603|NCT01443923|20507173|P2|COMPLETED|Overall Study||1
8317604|NCT01443923|20507174|P1|COMPLETED|Overall Study||2
8317605|NCT01443923|20507173|P2|STARTED|Overall Study||1
8317606|NCT01443923|20507174|P1|STARTED|Overall Study||3
8317607|NCT01443858|20507191|P3|NOT COMPLETED|Overall Study||7
8317608|NCT01443858|20507192|P2|NOT COMPLETED|Overall Study||13
8317609|NCT01443858|20507193|P1|NOT COMPLETED|Overall Study||15
8317610|NCT01443858|20507191|P3|COMPLETED|Overall Study||18
8317611|NCT01443858|20507192|P2|COMPLETED|Overall Study||12
8317612|NCT01443858|20507193|P1|COMPLETED|Overall Study||10
8317613|NCT01443858|20507191|P3|STARTED|Overall Study||25
8317614|NCT01443858|20507192|P2|STARTED|Overall Study||25
8317615|NCT01443858|20507193|P1|STARTED|Overall Study||25
8317616|NCT01443845|20507215|P2|NOT COMPLETED|Overall Study||337
8317617|NCT01443845|20507216|P1|NOT COMPLETED|Overall Study||254
8317618|NCT01443845|20507215|P2|COMPLETED|Overall Study||841
8317619|NCT01443845|20507216|P1|COMPLETED|Overall Study||922
8317620|NCT01443845|20507215|P2|STARTED|Overall Study||1178
8317621|NCT01443845|20507216|P1|STARTED|Overall Study||1176
8317622|NCT01443546|20507231|P3|NOT COMPLETED|Overall Study||0
8317623|NCT01443546|20507232|P2|NOT COMPLETED|Overall Study||0
8317624|NCT01443546|20507233|P1|NOT COMPLETED|Overall Study||0
8317625|NCT01443546|20507231|P3|COMPLETED|Overall Study||8
8317626|NCT01443546|20507232|P2|COMPLETED|Overall Study||9
8317627|NCT01443546|20507233|P1|COMPLETED|Overall Study||9
8317628|NCT01443546|20507231|P3|STARTED|Overall Study||8
8317629|NCT01443546|20507232|P2|STARTED|Overall Study||9
8317630|NCT01443546|20507233|P1|STARTED|Overall Study||9
8317631|NCT01443494|20507253|P1|NOT COMPLETED|Overall Study||0
8317632|NCT01443494|20507253|P1|COMPLETED|Overall Study||19
8317633|NCT01443494|20507253|P1|STARTED|Overall Study||19
8317634|NCT01443442|20507260|P2|NOT COMPLETED|Overall Study||0
8317635|NCT01443442|20507261|P1|NOT COMPLETED|Overall Study||0
8317636|NCT01443442|20507260|P2|COMPLETED|Overall Study||11
8317637|NCT01443442|20507261|P1|COMPLETED|Overall Study||12
8317638|NCT01443442|20507260|P2|STARTED|Overall Study||11
8317639|NCT01443442|20507261|P1|STARTED|Overall Study||12
8317640|NCT01443403|20507271|P4|NOT COMPLETED|Overall Study||9
8317641|NCT01443403|20507272|P3|NOT COMPLETED|Overall Study||7
8317642|NCT01443403|20507273|P2|NOT COMPLETED|Overall Study||6
8317643|NCT01443403|20507274|P1|NOT COMPLETED|Overall Study||6
8317644|NCT01443403|20507271|P4|COMPLETED|Overall Study||52
8317645|NCT01443403|20507272|P3|COMPLETED|Overall Study||54
8317646|NCT01443403|20507273|P2|COMPLETED|Overall Study||55
8317647|NCT01443403|20507274|P1|COMPLETED|Overall Study||55
8317648|NCT01443403|20507271|P4|Received Treatment|Overall Study||61
8317649|NCT01443403|20507272|P3|Received Treatment|Overall Study||60
8317650|NCT01443403|20507273|P2|Received Treatment|Overall Study||61
8317651|NCT01443403|20507274|P1|Received Treatment|Overall Study||61
8317652|NCT01443403|20507271|P4|STARTED|Overall Study||61
8317653|NCT01443403|20507272|P3|STARTED|Overall Study||61
8317654|NCT01443403|20507273|P2|STARTED|Overall Study||61
8317655|NCT01443403|20507274|P1|STARTED|Overall Study||61
8317656|NCT01443364|20507421|P1|NOT COMPLETED|Overall Study||41
8317657|NCT01443364|20507421|P1|COMPLETED|Overall Study||91
8317658|NCT01443364|20507421|P1|STARTED|Overall Study||132
8317659|NCT01443130|20507550|P6|NOT COMPLETED|Overall Study||34
8317660|NCT01443130|20507551|P5|NOT COMPLETED|Overall Study||44
8317661|NCT01443130|20507552|P4|NOT COMPLETED|Overall Study||39
8317662|NCT01443130|20507553|P3|NOT COMPLETED|Overall Study||77
8317663|NCT01443130|20507554|P2|NOT COMPLETED|Overall Study||69
8317664|NCT01443130|20507555|P1|NOT COMPLETED|Overall Study||68
8317665|NCT01443130|20507550|P6|COMPLETED|Overall Study||225
8317666|NCT01443130|20507551|P5|COMPLETED|Overall Study||230
8317667|NCT01443130|20507552|P4|COMPLETED|Overall Study||231
8317668|NCT01443130|20507553|P3|COMPLETED|Overall Study||223
8317669|NCT01443130|20507554|P2|COMPLETED|Overall Study||231
8317670|NCT01443130|20507555|P1|COMPLETED|Overall Study||232
8317671|NCT01443130|20507550|P6|STARTED|Overall Study||259
8317672|NCT01443130|20507551|P5|STARTED|Overall Study||274
8317673|NCT01443130|20507552|P4|STARTED|Overall Study||270
8317674|NCT01443130|20507553|P3|STARTED|Overall Study||300
8317675|NCT01443130|20507554|P2|STARTED|Overall Study||300
8317676|NCT01443130|20507555|P1|STARTED|Overall Study||300
8317677|NCT01443078|20507605|P1|NOT COMPLETED|Overall Study||29
8317678|NCT01443078|20507605|P1|COMPLETED|Overall Study||13
8317679|NCT01443078|20507605|P1|STARTED|Overall Study||42
8317680|NCT01443026|20507612|P2|NOT COMPLETED|Overall Study||5
8317681|NCT01443026|20507613|P1|NOT COMPLETED|Overall Study||3
8317682|NCT01443026|20507612|P2|COMPLETED|Overall Study||32
8317683|NCT01443026|20507613|P1|COMPLETED|Overall Study||26
8317684|NCT01443026|20507612|P2|STARTED|Overall Study||37
8317685|NCT01443026|20507613|P1|STARTED|Overall Study||29
8317686|NCT01442844|20507621|P2|NOT COMPLETED|Overall Study||0
8317687|NCT01442844|20507622|P1|NOT COMPLETED|Overall Study||0
8317688|NCT01442844|20507621|P2|COMPLETED|Overall Study||2
8317689|NCT01442844|20507622|P1|COMPLETED|Overall Study||1
8317690|NCT01442844|20507621|P2|STARTED|Overall Study||2
8317691|NCT01442844|20507622|P1|STARTED|Overall Study||1
8317692|NCT01442779|20507628|P1|NOT COMPLETED|Overall Study||7
8317693|NCT01442779|20507628|P1|COMPLETED|Overall Study||11
8317694|NCT01442779|20507628|P1|STARTED|Overall Study||18
8317695|NCT01442714|20507634|P1|NOT COMPLETED|Overall Study||12
8317696|NCT01442714|20507634|P1|COMPLETED|Overall Study||21
8317697|NCT01442714|20507634|P1|STARTED|Overall Study||33
8317698|NCT01442688|20507642|P2|NOT COMPLETED|Second Intervention||0
8317699|NCT01442688|20507643|P1|NOT COMPLETED|Second Intervention||1
8317700|NCT01442688|20507642|P2|COMPLETED|Second Intervention||31
8317701|NCT01442688|20507643|P1|COMPLETED|Second Intervention||28
8317702|NCT01442688|20507642|P2|STARTED|Second Intervention||31
8317703|NCT01442688|20507643|P1|STARTED|Second Intervention||29
8317704|NCT01442688|20507642|P2|NOT COMPLETED|First Intervention||0
8317705|NCT01442688|20507643|P1|NOT COMPLETED|First Intervention||2
8317706|NCT01442688|20507642|P2|COMPLETED|First Intervention||31
8317707|NCT01442688|20507643|P1|COMPLETED|First Intervention||29
8317708|NCT01442688|20507642|P2|STARTED|First Intervention||31
8317709|NCT01442688|20507643|P1|STARTED|First Intervention||31
8317710|NCT01442675|20507651|P1|NOT COMPLETED|Overall Study||12
8317711|NCT01442675|20507651|P1|COMPLETED|Overall Study||822
8317712|NCT01442675|20507651|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
8317713|NCT01442675|20507651|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
8317714|NCT01442675|20507651|P1|STARTED|Overall Study||834
8317715|NCT01442493|20507663|P2|NOT COMPLETED|Overall Study||2
8317716|NCT01442493|20507664|P1|NOT COMPLETED|Overall Study||3
8317717|NCT01442493|20507663|P2|COMPLETED|Overall Study||149
8317718|NCT01442493|20507664|P1|COMPLETED|Overall Study||146
8317719|NCT01442493|20507663|P2|STARTED|Overall Study||151
8317720|NCT01442493|20507664|P1|STARTED|Overall Study||149
8317721|NCT01442376|20507685|P3|NOT COMPLETED|Overall Study||5
8317722|NCT01442376|20507686|P2|NOT COMPLETED|Overall Study||9
8317723|NCT01442376|20507687|P1|NOT COMPLETED|Overall Study||3
8317724|NCT01442376|20507685|P3|COMPLETED|Overall Study||159
8317725|NCT01442376|20507686|P2|COMPLETED|Overall Study||160
8317726|NCT01442376|20507687|P1|COMPLETED|Overall Study||166
8317727|NCT01442376|20507685|P3|STARTED|Overall Study|Randomized patients|164
8317728|NCT01442376|20507686|P2|STARTED|Overall Study|Randomized patients|169
8317729|NCT01442376|20507687|P1|STARTED|Overall Study|Randomized patients|169
8317730|NCT01442181|20507700|P2|NOT COMPLETED|Overall Study||3
8317731|NCT01442181|20507701|P1|NOT COMPLETED|Overall Study||4
8317732|NCT01442181|20507700|P2|COMPLETED|Overall Study||8
8317733|NCT01442181|20507701|P1|COMPLETED|Overall Study||10
8317734|NCT01442181|20507700|P2|STARTED|Overall Study||11
8317735|NCT01442181|20507701|P1|STARTED|Overall Study||14
8317736|NCT01442155|20507725|P1|NOT COMPLETED|Overall Study||65
8317737|NCT01442155|20507725|P1|COMPLETED|Overall Study||9
8317738|NCT01442155|20507725|P1|STARTED|Overall Study||74
8317739|NCT01442129|20507732|P2|NOT COMPLETED|Overall Study||0
8317740|NCT01442129|20507733|P1|NOT COMPLETED|Overall Study||0
8317741|NCT01442129|20507732|P2|COMPLETED|Overall Study||10
8317742|NCT01442129|20507733|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
8317743|NCT01442129|20507732|P2|STARTED|Overall Study||10
8317744|NCT01442129|20507733|P1|STARTED|Overall Study||20
8317745|NCT01442103|20507741|P1|NOT COMPLETED|Overall Study||2
8317746|NCT01442103|20507741|P1|COMPLETED|Overall Study||8
8317747|NCT01442103|20507741|P1|STARTED|Overall Study||10
8317748|NCT01442064|20507751|P6|NOT COMPLETED|Overall Study||99
8317749|NCT01442064|20507752|P5|NOT COMPLETED|Overall Study||106
8317750|NCT01442064|20507753|P4|NOT COMPLETED|Overall Study||98
8317751|NCT01442064|20507754|P3|NOT COMPLETED|Overall Study||104
8317752|NCT01442064|20507755|P2|NOT COMPLETED|Overall Study||101
8317753|NCT01442064|20507756|P1|NOT COMPLETED|Overall Study||97
8317754|NCT01442064|20507751|P6|COMPLETED|Overall Study||0
8317755|NCT01442064|20507752|P5|COMPLETED|Overall Study||1
8317756|NCT01442064|20507753|P4|COMPLETED|Overall Study||0
8317757|NCT01442064|20507754|P3|COMPLETED|Overall Study||0
8317758|NCT01442064|20507755|P2|COMPLETED|Overall Study||2
8317759|NCT01442064|20507756|P1|COMPLETED|Overall Study||0
8317760|NCT01442064|20507751|P6|Received Study Drug in Extension Study|Overall Study||81
8317761|NCT01442064|20507752|P5|Received Study Drug in Extension Study|Overall Study||89
8317762|NCT01442064|20507753|P4|Received Study Drug in Extension Study|Overall Study||70
8317763|NCT01442064|20507754|P3|Received Study Drug in Extension Study|Overall Study||60
8317764|NCT01442064|20507755|P2|Received Study Drug in Extension Study|Overall Study||70
8317765|NCT01442064|20507756|P1|Received Study Drug in Extension Study|Overall Study||61
8317766|NCT01442064|20507751|P6|Ranibizumab-Treated Subjects|Overall Study||99
8317767|NCT01442064|20507752|P5|Ranibizumab-Treated Subjects|Overall Study||107
8317768|NCT01442064|20507753|P4|Ranibizumab-Treated Subjects|Overall Study||96
8317769|NCT01442064|20507754|P3|Ranibizumab-Treated Subjects|Overall Study||104
8317770|NCT01442064|20507755|P2|Ranibizumab-Treated Subjects|Overall Study||103
8317771|NCT01442064|20507756|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
8317772|NCT01442064|20507751|P6|STARTED|Overall Study||99
8317773|NCT01442064|20507752|P5|STARTED|Overall Study||107
8317774|NCT01442064|20507753|P4|STARTED|Overall Study||98
8317775|NCT01442064|20507754|P3|STARTED|Overall Study||104
8317776|NCT01442064|20507755|P2|STARTED|Overall Study||103
8317777|NCT01442064|20507756|P1|STARTED|Overall Study||97
8317778|NCT01442038|20507793|P2|NOT COMPLETED|Overall Study||279
8317779|NCT01442038|20507794|P1|NOT COMPLETED|Overall Study||303
8317780|NCT01442038|20507793|P2|COMPLETED|Overall Study||1040
8317781|NCT01442038|20507794|P1|COMPLETED|Overall Study||1029
8317782|NCT01442038|20507793|P2|STARTED|Overall Study||1319
8317783|NCT01442038|20507794|P1|STARTED|Overall Study||1332
8317784|NCT01441973|20507808|P2|NOT COMPLETED|Overall Study||16
8317785|NCT01441973|20507809|P1|NOT COMPLETED|Overall Study||15
8317786|NCT01441973|20507808|P2|COMPLETED|Overall Study|Still receiving treatment|0
8317787|NCT01441973|20507809|P1|COMPLETED|Overall Study|Still receiving treatment|0
8317788|NCT01441973|20507808|P2|STARTED|Overall Study||16
8317789|NCT01441973|20507809|P1|STARTED|Overall Study||15
8317790|NCT01441960|20507831|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
8317791|NCT01441960|20507832|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
8317792|NCT01441960|20507831|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
8317793|NCT01441960|20507832|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
8317794|NCT01441960|20507831|P2|STARTED|Second Neuromuscular Blocking Agent||13
8317795|NCT01441960|20507832|P1|STARTED|Second Neuromuscular Blocking Agent||18
8317796|NCT01441960|20507831|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
8317891|NCT01441180|20508260|P1|COMPLETED|Overall Study||9
8317797|NCT01441960|20507832|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
8317798|NCT01441960|20507831|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
8317799|NCT01441960|20507832|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
8317800|NCT01441960|20507831|P2|STARTED|First Neuromuscular Blocking Agent:||19
8317801|NCT01441960|20507832|P1|STARTED|First Neuromuscular Blocking Agent:||26
8317802|NCT01441882|20507842|P1|NOT COMPLETED|Overall Study||6
8317803|NCT01441882|20507842|P1|COMPLETED|Overall Study||13
8317804|NCT01441882|20507842|P1|STARTED|Overall Study||19
8317805|NCT01441843|20507848|P2|NOT COMPLETED|Overall Study||5
8317806|NCT01441843|20507849|P1|NOT COMPLETED|Overall Study||12
8317807|NCT01441843|20507848|P2|COMPLETED|Overall Study||195
8317808|NCT01441843|20507849|P1|COMPLETED|Overall Study||188
8317809|NCT01441843|20507848|P2|STARTED|Overall Study||200
8317810|NCT01441843|20507849|P1|STARTED|Overall Study||200
8317811|NCT01441765|20507857|P2|NOT COMPLETED|Overall Study||0
8317812|NCT01441765|20507858|P1|NOT COMPLETED|Overall Study||1
8317813|NCT01441765|20507857|P2|COMPLETED|Overall Study|not opened|0
8317814|NCT01441765|20507858|P1|COMPLETED|Overall Study||10
8317815|NCT01441765|20507857|P2|STARTED|Overall Study|not opened|0
8317816|NCT01441765|20507858|P1|STARTED|Overall Study||11
8317817|NCT01441635|20507882|P10|NOT COMPLETED|Overall Study||2
8317818|NCT01441635|20507883|P9|NOT COMPLETED|Overall Study||2
8317819|NCT01441635|20507884|P8|NOT COMPLETED|Overall Study||4
8317820|NCT01441635|20507885|P7|NOT COMPLETED|Overall Study||6
8317821|NCT01441635|20507886|P6|NOT COMPLETED|Overall Study||5
8317822|NCT01441635|20507887|P5|NOT COMPLETED|Overall Study||2
8317823|NCT01441635|20507888|P4|NOT COMPLETED|Overall Study||7
8317824|NCT01441635|20507889|P3|NOT COMPLETED|Overall Study||3
8317825|NCT01441635|20507890|P2|NOT COMPLETED|Overall Study||6
8317826|NCT01441635|20507891|P1|NOT COMPLETED|Overall Study||6
8317827|NCT01441635|20507882|P10|COMPLETED|Overall Study||25
8317828|NCT01441635|20507883|P9|COMPLETED|Overall Study||14
8317829|NCT01441635|20507884|P8|COMPLETED|Overall Study||26
8317830|NCT01441635|20507885|P7|COMPLETED|Overall Study||24
8317831|NCT01441635|20507886|P6|COMPLETED|Overall Study||29
8317832|NCT01441635|20507887|P5|COMPLETED|Overall Study||16
8317833|NCT01441635|20507888|P4|COMPLETED|Overall Study||28
8317834|NCT01441635|20507889|P3|COMPLETED|Overall Study||13
8317835|NCT01441635|20507890|P2|COMPLETED|Overall Study||27
8317836|NCT01441635|20507891|P1|COMPLETED|Overall Study||26
8317837|NCT01441635|20507882|P10|STARTED|Overall Study||27
8317838|NCT01441635|20507883|P9|STARTED|Overall Study||16
8317839|NCT01441635|20507884|P8|STARTED|Overall Study||30
8317840|NCT01441635|20507885|P7|STARTED|Overall Study||30
8317841|NCT01441635|20507886|P6|STARTED|Overall Study||34
8317842|NCT01441635|20507887|P5|STARTED|Overall Study||18
8317843|NCT01441635|20507888|P4|STARTED|Overall Study||35
8317844|NCT01441635|20507889|P3|STARTED|Overall Study||16
8317845|NCT01441635|20507890|P2|STARTED|Overall Study||33
8317846|NCT01441635|20507891|P1|STARTED|Overall Study||32
8317847|NCT01441596|20508106|P3|NOT COMPLETED|Overall Study||4
8317848|NCT01441596|20508107|P2|NOT COMPLETED|Overall Study||3
8317849|NCT01441596|20508108|P1|NOT COMPLETED|Overall Study||4
8317850|NCT01441596|20508106|P3|COMPLETED|Overall Study||39
8317851|NCT01441596|20508107|P2|COMPLETED|Overall Study||35
8317852|NCT01441596|20508108|P1|COMPLETED|Overall Study||36
8317853|NCT01441596|20508106|P3|STARTED|Overall Study||43
8317854|NCT01441596|20508107|P2|STARTED|Overall Study||38
8317855|NCT01441596|20508108|P1|STARTED|Overall Study||40
8317856|NCT01441570|20508124|P2|NOT COMPLETED|Overall Study||0
8317857|NCT01441570|20508125|P1|NOT COMPLETED|Overall Study||0
8317858|NCT01441570|20508124|P2|COMPLETED|Overall Study||5
8317859|NCT01441570|20508125|P1|COMPLETED|Overall Study||6
8317860|NCT01441570|20508124|P2|STARTED|Overall Study||5
8317861|NCT01441570|20508125|P1|STARTED|Overall Study||6
8317862|NCT01441492|20508135|P2|NOT COMPLETED|Overall Study||28
8317863|NCT01441492|20508136|P1|NOT COMPLETED|Overall Study||27
8317864|NCT01441492|20508135|P2|COMPLETED|Overall Study||174
8317865|NCT01441492|20508136|P1|COMPLETED|Overall Study||170
8317866|NCT01441492|20508135|P2|STARTED|Overall Study||202
8317867|NCT01441492|20508136|P1|STARTED|Overall Study||197
8317868|NCT01441466|20508162|P2|NOT COMPLETED|Overall Study||0
8317869|NCT01441466|20508163|P1|NOT COMPLETED|Overall Study||0
8317870|NCT01441466|20508162|P2|COMPLETED|Overall Study||11
8317871|NCT01441466|20508163|P1|COMPLETED|Overall Study||37
8317872|NCT01441466|20508162|P2|STARTED|Overall Study||11
8317873|NCT01441466|20508163|P1|STARTED|Overall Study||37
8317874|NCT01441414|20508179|P1|NOT COMPLETED|Overall Study||15
8317875|NCT01441414|20508179|P1|COMPLETED|Overall Study||3
8317876|NCT01441414|20508179|P1|STARTED|Overall Study||18
8317880|NCT01441245|20508232|P2|NOT COMPLETED|Overall Study||0
8317881|NCT01441245|20508233|P1|NOT COMPLETED|Overall Study||0
8317882|NCT01441245|20508232|P2|COMPLETED|Overall Study||27
8317883|NCT01441245|20508233|P1|COMPLETED|Overall Study||30
8317884|NCT01441245|20508232|P2|STARTED|Overall Study||27
8317885|NCT01441245|20508233|P1|STARTED|Overall Study||30
8317886|NCT01441180|20508258|P3|NOT COMPLETED|Overall Study||3
8317887|NCT01441180|20508259|P2|NOT COMPLETED|Overall Study||1
8317888|NCT01441180|20508260|P1|NOT COMPLETED|Overall Study||1
8317889|NCT01441180|20508258|P3|COMPLETED|Overall Study||22
8317890|NCT01441180|20508259|P2|COMPLETED|Overall Study||24
8317892|NCT01441180|20508258|P3|STARTED|Overall Study||25
8317893|NCT01441180|20508259|P2|STARTED|Overall Study||25
8317894|NCT01441180|20508260|P1|STARTED|Overall Study||10
8317895|NCT01441102|20508271|P1|NOT COMPLETED|Overall Study||3
8317896|NCT01441102|20508271|P1|COMPLETED|Overall Study||4
8317897|NCT01441102|20508271|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
8317898|NCT01441076|20508291|P1|NOT COMPLETED|Overall Study||2
8317899|NCT01441076|20508291|P1|COMPLETED|Overall Study||4
8317900|NCT01441076|20508291|P1|STARTED|Overall Study||6
8317901|NCT01441063|20508309|P1|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
8317902|NCT01441063|20508309|P1|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
8317903|NCT01441063|20508309|P1|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
8317904|NCT01441063|20508309|P1|NOT COMPLETED|Tocilizumab Alone||3
8317905|NCT01441063|20508309|P1|COMPLETED|Tocilizumab Alone||5
8317906|NCT01441063|20508309|P1|STARTED|Tocilizumab Alone||8
8317907|NCT01441037|20508338|P1|NOT COMPLETED|Overall Study||0
8317908|NCT01441037|20508338|P1|COMPLETED|Overall Study||27
8317909|NCT01441037|20508338|P1|STARTED|Overall Study||27
8317910|NCT01440972|20508344|P2|NOT COMPLETED|Overall Study||2
8317911|NCT01440972|20508345|P1|NOT COMPLETED|Overall Study||3
8317912|NCT01440972|20508344|P2|COMPLETED|Overall Study||19
8317913|NCT01440972|20508345|P1|COMPLETED|Overall Study||21
8317914|NCT01440972|20508344|P2|STARTED|Overall Study||21
8317915|NCT01440972|20508345|P1|STARTED|Overall Study||24
8317916|NCT01440959|20508359|P1|NOT COMPLETED|Overall Study||0
8317917|NCT01440959|20508359|P1|COMPLETED|Overall Study||30
8317918|NCT01440959|20508359|P1|STARTED|Overall Study||30
8317919|NCT01440946|20508369|P2|NOT COMPLETED|Overall Study||1
8317920|NCT01440946|20508370|P1|NOT COMPLETED|Overall Study||2
8317921|NCT01440946|20508369|P2|COMPLETED|Overall Study||14
8317922|NCT01440946|20508370|P1|COMPLETED|Overall Study||13
8317923|NCT01440946|20508369|P2|STARTED|Overall Study||15
8317924|NCT01440946|20508370|P1|STARTED|Overall Study||15
8317925|NCT01440881|20508409|P2|NOT COMPLETED|Overall Study||1
8317926|NCT01440881|20508410|P1|NOT COMPLETED|Overall Study||0
8317927|NCT01440881|20508409|P2|COMPLETED|Overall Study||14
8317928|NCT01440881|20508410|P1|COMPLETED|Overall Study||14
8317929|NCT01440881|20508409|P2|STARTED|Overall Study||15
8317930|NCT01440881|20508410|P1|STARTED|Overall Study||14
8317931|NCT01440816|20508424|P2|NOT COMPLETED|Overall Study||11
8317932|NCT01440816|20508425|P1|NOT COMPLETED|Overall Study||1
8317933|NCT01440816|20508424|P2|COMPLETED|Overall Study||1
8317934|NCT01440816|20508425|P1|COMPLETED|Overall Study||2
8317935|NCT01440816|20508424|P2|STARTED|Overall Study||12
8317936|NCT01440816|20508425|P1|STARTED|Overall Study||3
8317937|NCT01440803|20508441|P2|NOT COMPLETED|Overall Study||4
8317938|NCT01440803|20508442|P1|NOT COMPLETED|Overall Study||2
8317939|NCT01440803|20508441|P2|COMPLETED|Overall Study||24
8317940|NCT01440803|20508442|P1|COMPLETED|Overall Study||11
8317941|NCT01440803|20508441|P2|Period 3 - Forteo Open Label|Overall Study||27
8317942|NCT01440803|20508442|P1|Period 3 - Forteo Open Label|Overall Study||13
8317943|NCT01440803|20508441|P2|Period 2 - Forteo/Forteo|Overall Study||28
8317944|NCT01440803|20508442|P1|Period 2 - Forteo/Forteo|Overall Study||13
8317945|NCT01440803|20508441|P2|Period 1 - Forteo/Placebo|Overall Study||28
8317946|NCT01440803|20508442|P1|Period 1 - Forteo/Placebo|Overall Study||13
8317947|NCT01440803|20508441|P2|STARTED|Overall Study||28
8317948|NCT01440803|20508442|P1|STARTED|Overall Study||13
8317949|NCT01440764|20508451|P7|NOT COMPLETED|Test Day 3||0
8317950|NCT01440764|20508452|P6|NOT COMPLETED|Test Day 3||0
8317951|NCT01440764|20508453|P5|NOT COMPLETED|Test Day 3||0
8317952|NCT01440764|20508454|P4|NOT COMPLETED|Test Day 3||0
8317953|NCT01440764|20508455|P3|NOT COMPLETED|Test Day 3||0
8317954|NCT01440764|20508456|P2|NOT COMPLETED|Test Day 3||0
8317955|NCT01440764|20508457|P1|NOT COMPLETED|Test Day 3||0
8317956|NCT01440764|20508451|P7|COMPLETED|Test Day 3||3
8317957|NCT01440764|20508452|P6|COMPLETED|Test Day 3||5
8317958|NCT01440764|20508453|P5|COMPLETED|Test Day 3||3
8317959|NCT01440764|20508454|P4|COMPLETED|Test Day 3||1
8317960|NCT01440764|20508455|P3|COMPLETED|Test Day 3||6
8317961|NCT01440764|20508456|P2|COMPLETED|Test Day 3||2
8317962|NCT01440764|20508457|P1|COMPLETED|Test Day 3||3
8317963|NCT01440764|20508451|P7|STARTED|Test Day 3||3
8317964|NCT01440764|20508452|P6|STARTED|Test Day 3||5
8317965|NCT01440764|20508453|P5|STARTED|Test Day 3||3
8317966|NCT01440764|20508454|P4|STARTED|Test Day 3||1
8317967|NCT01440764|20508455|P3|STARTED|Test Day 3||6
8317968|NCT01440764|20508456|P2|STARTED|Test Day 3||2
8317969|NCT01440764|20508457|P1|STARTED|Test Day 3||3
8317970|NCT01440764|20508451|P7|NOT COMPLETED|Test Day 2||0
8317971|NCT01440764|20508452|P6|NOT COMPLETED|Test Day 2||0
8317972|NCT01440764|20508453|P5|NOT COMPLETED|Test Day 2||0
8317973|NCT01440764|20508454|P4|NOT COMPLETED|Test Day 2||0
8317974|NCT01440764|20508455|P3|NOT COMPLETED|Test Day 2||0
8317975|NCT01440764|20508456|P2|NOT COMPLETED|Test Day 2||0
8317976|NCT01440764|20508457|P1|NOT COMPLETED|Test Day 2||0
8317977|NCT01440764|20508451|P7|COMPLETED|Test Day 2||3
8317978|NCT01440764|20508452|P6|COMPLETED|Test Day 2||5
8317979|NCT01440764|20508453|P5|COMPLETED|Test Day 2||3
8317980|NCT01440764|20508454|P4|COMPLETED|Test Day 2||1
8317981|NCT01440764|20508455|P3|COMPLETED|Test Day 2||6
8317982|NCT01440764|20508456|P2|COMPLETED|Test Day 2||2
8317983|NCT01440764|20508457|P1|COMPLETED|Test Day 2||3
8317984|NCT01440764|20508451|P7|STARTED|Test Day 2||3
8317985|NCT01440764|20508452|P6|STARTED|Test Day 2||5
8317986|NCT01440764|20508453|P5|STARTED|Test Day 2||3
8317987|NCT01440764|20508454|P4|STARTED|Test Day 2||1
8317988|NCT01440764|20508455|P3|STARTED|Test Day 2||6
8317989|NCT01440764|20508456|P2|STARTED|Test Day 2||2
8317990|NCT01440764|20508457|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
8317991|NCT01440764|20508451|P7|NOT COMPLETED|Test Day 1||0
8317992|NCT01440764|20508452|P6|NOT COMPLETED|Test Day 1||0
8317993|NCT01440764|20508453|P5|NOT COMPLETED|Test Day 1||0
8317994|NCT01440764|20508454|P4|NOT COMPLETED|Test Day 1||0
8317995|NCT01440764|20508455|P3|NOT COMPLETED|Test Day 1||0
8317996|NCT01440764|20508456|P2|NOT COMPLETED|Test Day 1||0
8317997|NCT01440764|20508457|P1|NOT COMPLETED|Test Day 1||0
8317998|NCT01440764|20508451|P7|COMPLETED|Test Day 1||3
8317999|NCT01440764|20508452|P6|COMPLETED|Test Day 1||5
8318000|NCT01440764|20508453|P5|COMPLETED|Test Day 1||3
8318001|NCT01440764|20508454|P4|COMPLETED|Test Day 1||1
8318002|NCT01440764|20508455|P3|COMPLETED|Test Day 1||6
8318003|NCT01440764|20508456|P2|COMPLETED|Test Day 1||2
8318004|NCT01440764|20508457|P1|COMPLETED|Test Day 1||4
8318005|NCT01440764|20508451|P7|STARTED|Test Day 1||3
8318006|NCT01440764|20508452|P6|STARTED|Test Day 1||5
8318007|NCT01440764|20508453|P5|STARTED|Test Day 1||3
8318008|NCT01440764|20508454|P4|STARTED|Test Day 1||1
8318009|NCT01440764|20508455|P3|STARTED|Test Day 1||6
8318010|NCT01440764|20508456|P2|STARTED|Test Day 1||2
8318011|NCT01440764|20508457|P1|STARTED|Test Day 1||4
8318012|NCT01440647|20508478|P2|NOT COMPLETED|Overall Study||3
8318013|NCT01440647|20508479|P1|NOT COMPLETED|Overall Study||2
8318014|NCT01440647|20508478|P2|COMPLETED|Overall Study||15
8318015|NCT01440647|20508479|P1|COMPLETED|Overall Study||14
8318016|NCT01440647|20508478|P2|STARTED|Overall Study||18
8318017|NCT01440647|20508479|P1|STARTED|Overall Study||16
8318018|NCT01440634|20508489|P2|NOT COMPLETED|Randomization Phase||10
8318019|NCT01440634|20508490|P1|NOT COMPLETED|Randomization Phase||6
8318020|NCT01440634|20508489|P2|COMPLETED|Randomization Phase||14
8318021|NCT01440634|20508490|P1|COMPLETED|Randomization Phase||24
8318022|NCT01440634|20508489|P2|STARTED|Randomization Phase||24
8318023|NCT01440634|20508490|P1|STARTED|Randomization Phase||30
8318024|NCT01440634|20508489|P2|NOT COMPLETED|Cross Sectional Phase||0
8318025|NCT01440634|20508490|P1|NOT COMPLETED|Cross Sectional Phase||0
8318026|NCT01440634|20508489|P2|COMPLETED|Cross Sectional Phase||347
8318027|NCT01440634|20508490|P1|COMPLETED|Cross Sectional Phase||0
8318028|NCT01440634|20508489|P2|STARTED|Cross Sectional Phase||347
8318029|NCT01440634|20508490|P1|STARTED|Cross Sectional Phase||0
8318030|NCT01440595|20508498|P3|NOT COMPLETED|Overall Study||1
8318031|NCT01440595|20508499|P2|NOT COMPLETED|Overall Study||3
8318032|NCT01440595|20508500|P1|NOT COMPLETED|Overall Study||1
8318033|NCT01440595|20508498|P3|COMPLETED|Overall Study||0
8318034|NCT01440595|20508499|P2|COMPLETED|Overall Study||0
8318035|NCT01440595|20508500|P1|COMPLETED|Overall Study||0
8318036|NCT01440595|20508498|P3|STARTED|Overall Study||1
8318037|NCT01440595|20508499|P2|STARTED|Overall Study||3
8318038|NCT01440595|20508500|P1|STARTED|Overall Study||1
8318039|NCT01440569|20508520|P2|NOT COMPLETED|Open-Label Rollover Phase||6
8318040|NCT01440569|20508521|P1|NOT COMPLETED|Open-Label Rollover Phase||47
8318041|NCT01440569|20508520|P2|COMPLETED|Open-Label Rollover Phase||7
8318042|NCT01440569|20508521|P1|COMPLETED|Open-Label Rollover Phase||204
8318043|NCT01440569|20508520|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
8318044|NCT01440569|20508521|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
8318045|NCT01440569|20508520|P2|NOT COMPLETED|Main Study||4
8318046|NCT01440569|20508521|P1|NOT COMPLETED|Main Study||36
8318047|NCT01440569|20508520|P2|COMPLETED|Main Study||14
8318048|NCT01440569|20508521|P1|COMPLETED|Main Study||260
8318049|NCT01440569|20508520|P2|Enrolled and Treated|Main Study||18
8318050|NCT01440569|20508521|P1|Enrolled and Treated|Main Study||295
8318051|NCT01440569|20508520|P2|STARTED|Main Study||18
8318052|NCT01440569|20508521|P1|STARTED|Main Study||296
8318053|NCT01440543|20508543|P4|NOT COMPLETED|Overall Study||6
8318054|NCT01440543|20508544|P3|NOT COMPLETED|Overall Study||2
8318055|NCT01440543|20508545|P2|NOT COMPLETED|Overall Study||4
8318056|NCT01440543|20508546|P1|NOT COMPLETED|Overall Study||4
8318057|NCT01440543|20508543|P4|COMPLETED|Overall Study||101
8318058|NCT01440543|20508544|P3|COMPLETED|Overall Study||100
8318059|NCT01440543|20508545|P2|COMPLETED|Overall Study||101
8318060|NCT01440543|20508546|P1|COMPLETED|Overall Study||102
8318061|NCT01440543|20508543|P4|STARTED|Overall Study||107
8318062|NCT01440543|20508544|P3|STARTED|Overall Study||102
8318063|NCT01440543|20508545|P2|STARTED|Overall Study||105
8318064|NCT01440543|20508546|P1|STARTED|Overall Study||106
8318065|NCT01440517|20508556|P1|NOT COMPLETED|Overall Study||1
8318066|NCT01440517|20508556|P1|COMPLETED|Overall Study||4
8318067|NCT01440517|20508556|P1|STARTED|Overall Study||5
8318068|NCT01440452|20508565|P4|NOT COMPLETED|Overall Study||0
8318069|NCT01440452|20508566|P3|NOT COMPLETED|Overall Study||0
8318070|NCT01440452|20508567|P2|NOT COMPLETED|Overall Study||0
8318071|NCT01440452|20508568|P1|NOT COMPLETED|Overall Study||0
8318072|NCT01440452|20508565|P4|COMPLETED|Overall Study||4
8318073|NCT01440452|20508566|P3|COMPLETED|Overall Study||8
8318074|NCT01440452|20508567|P2|COMPLETED|Overall Study||7
8318075|NCT01440452|20508568|P1|COMPLETED|Overall Study||6
8318076|NCT01440452|20508565|P4|STARTED|Overall Study||4
8318077|NCT01440452|20508566|P3|STARTED|Overall Study||8
8318078|NCT01440452|20508567|P2|STARTED|Overall Study||7
8318079|NCT01440452|20508568|P1|STARTED|Overall Study||6
8318080|NCT01440387|20508608|P2|NOT COMPLETED|Overall Study||0
8318081|NCT01440387|20508609|P1|NOT COMPLETED|Overall Study||0
8318082|NCT01440387|20508608|P2|COMPLETED|Overall Study||56
8318083|NCT01440387|20508609|P1|COMPLETED|Overall Study||56
8318084|NCT01440387|20508608|P2|STARTED|Overall Study||56
8318085|NCT01440387|20508609|P1|STARTED|Overall Study||56
8318086|NCT01440374|20508632|P4|NOT COMPLETED|Part 3: Extension||32
8318087|NCT01440374|20508633|P3|NOT COMPLETED|Part 3: Extension||0
8318088|NCT01440374|20508634|P2|NOT COMPLETED|Part 3: Extension||0
8318089|NCT01440374|20508635|P1|NOT COMPLETED|Part 3: Extension||0
8318090|NCT01440374|20508632|P4|COMPLETED|Part 3: Extension||27
8318091|NCT01440374|20508633|P3|COMPLETED|Part 3: Extension||0
8318092|NCT01440374|20508634|P2|COMPLETED|Part 3: Extension||0
8318093|NCT01440374|20508635|P1|COMPLETED|Part 3: Extension||0
8318094|NCT01440374|20508632|P4|STARTED|Part 3: Extension||59
8318095|NCT01440374|20508633|P3|STARTED|Part 3: Extension||0
8318096|NCT01440374|20508634|P2|STARTED|Part 3: Extension||0
8318097|NCT01440374|20508635|P1|STARTED|Part 3: Extension||0
8318098|NCT01440374|20508632|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
8318099|NCT01440374|20508633|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
8318100|NCT01440374|20508634|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
8318101|NCT01440374|20508635|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
8318102|NCT01440374|20508632|P4|COMPLETED|Part 2; Double-blind Phase||0
8318103|NCT01440374|20508633|P3|COMPLETED|Part 2; Double-blind Phase||43
8318104|NCT01440374|20508634|P2|COMPLETED|Part 2; Double-blind Phase||27
8318105|NCT01440374|20508635|P1|COMPLETED|Part 2; Double-blind Phase||0
8318106|NCT01440374|20508632|P4|STARTED|Part 2; Double-blind Phase||0
8318107|NCT01440374|20508633|P3|STARTED|Part 2; Double-blind Phase||98
8318108|NCT01440374|20508634|P2|STARTED|Part 2; Double-blind Phase||47
8318109|NCT01440374|20508635|P1|STARTED|Part 2; Double-blind Phase||0
8318110|NCT01440374|20508632|P4|NOT COMPLETED|Part 1: Open-label Phase||0
8318111|NCT01440374|20508633|P3|NOT COMPLETED|Part 1: Open-label Phase||0
8318112|NCT01440374|20508634|P2|NOT COMPLETED|Part 1: Open-label Phase||0
8318113|NCT01440374|20508635|P1|NOT COMPLETED|Part 1: Open-label Phase||6
8318114|NCT01440374|20508632|P4|COMPLETED|Part 1: Open-label Phase||0
8318115|NCT01440374|20508633|P3|COMPLETED|Part 1: Open-label Phase||0
8318116|NCT01440374|20508634|P2|COMPLETED|Part 1: Open-label Phase||0
8318117|NCT01440374|20508635|P1|COMPLETED|Part 1: Open-label Phase||11
8318118|NCT01440374|20508632|P4|STARTED|Part 1: Open-label Phase||0
8318119|NCT01440374|20508633|P3|STARTED|Part 1: Open-label Phase||0
8318120|NCT01440374|20508634|P2|STARTED|Part 1: Open-label Phase||0
8318121|NCT01440374|20508635|P1|STARTED|Part 1: Open-label Phase||17
8318122|NCT01440322|20508670|P2|NOT COMPLETED|Overall Study||1
8318123|NCT01440322|20508671|P1|NOT COMPLETED|Overall Study||7
8318124|NCT01440322|20508670|P2|COMPLETED|Overall Study||49
8318125|NCT01440322|20508671|P1|COMPLETED|Overall Study||90
8318126|NCT01440322|20508670|P2|STARTED|Overall Study||50
8318127|NCT01440322|20508671|P1|STARTED|Overall Study||97
8318128|NCT01440283|20508693|P1|NOT COMPLETED|Overall Study||10
8318129|NCT01440283|20508693|P1|COMPLETED|Overall Study||4
8318130|NCT01440283|20508693|P1|STARTED|Overall Study||14
8318131|NCT01440101|20508708|P3|NOT COMPLETED|Overall Study||1
8318132|NCT01440101|20508709|P2|NOT COMPLETED|Overall Study||4
8318133|NCT01440101|20508710|P1|NOT COMPLETED|Overall Study||2
8318134|NCT01440101|20508708|P3|COMPLETED|Overall Study||46
8318135|NCT01440101|20508709|P2|COMPLETED|Overall Study||43
8318136|NCT01440101|20508710|P1|COMPLETED|Overall Study||10
8318137|NCT01440101|20508708|P3|STARTED|Overall Study||47
8318138|NCT01440101|20508709|P2|STARTED|Overall Study||47
8318139|NCT01440101|20508710|P1|STARTED|Overall Study||12
8318140|NCT01440049|20508743|P1|NOT COMPLETED|Overall Study||5
8318141|NCT01440049|20508743|P1|COMPLETED|Overall Study||155
8318142|NCT01440049|20508743|P1|STARTED|Overall Study||160
8318143|NCT01439971|20508775|P5|NOT COMPLETED|Overall Study||1
8318144|NCT01439971|20508776|P4|NOT COMPLETED|Overall Study||0
8318145|NCT01439971|20508777|P3|NOT COMPLETED|Overall Study||2
8318146|NCT01439971|20508778|P2|NOT COMPLETED|Overall Study||1
8318147|NCT01439971|20508779|P1|NOT COMPLETED|Overall Study||0
8318148|NCT01439971|20508775|P5|COMPLETED|Overall Study||6
8318149|NCT01439971|20508776|P4|COMPLETED|Overall Study||6
8318150|NCT01439971|20508777|P3|COMPLETED|Overall Study||6
8318151|NCT01439971|20508778|P2|COMPLETED|Overall Study||6
8318152|NCT01439971|20508779|P1|COMPLETED|Overall Study||1
8318153|NCT01439971|20508775|P5|Received Treatment|Overall Study||6
8318154|NCT01439971|20508776|P4|Received Treatment|Overall Study||6
8318155|NCT01439971|20508777|P3|Received Treatment|Overall Study||6
8318156|NCT01439971|20508778|P2|Received Treatment|Overall Study||6
8318157|NCT01439971|20508779|P1|Received Treatment|Overall Study||1
8318158|NCT01439971|20508775|P5|STARTED|Overall Study||7
8318159|NCT01439971|20508776|P4|STARTED|Overall Study||6
8318160|NCT01439971|20508777|P3|STARTED|Overall Study||8
8318161|NCT01439971|20508778|P2|STARTED|Overall Study||7
8318162|NCT01439971|20508779|P1|STARTED|Overall Study||1
8318163|NCT01439945|20508959|P4|NOT COMPLETED|Optional Continuation Phase||0
8318164|NCT01439945|20508960|P3|NOT COMPLETED|Optional Continuation Phase||0
8318165|NCT01439945|20508961|P2|NOT COMPLETED|Optional Continuation Phase||0
8318166|NCT01439945|20508962|P1|NOT COMPLETED|Optional Continuation Phase||0
8318167|NCT01439945|20508959|P4|COMPLETED|Optional Continuation Phase||0
8318168|NCT01439945|20508960|P3|COMPLETED|Optional Continuation Phase||0
8318169|NCT01439945|20508961|P2|COMPLETED|Optional Continuation Phase||44
8318170|NCT01439945|20508962|P1|COMPLETED|Optional Continuation Phase||72
8318171|NCT01439945|20508959|P4|STARTED|Optional Continuation Phase||0
8318172|NCT01439945|20508960|P3|STARTED|Optional Continuation Phase||0
8318173|NCT01439945|20508961|P2|STARTED|Optional Continuation Phase||44
8318174|NCT01439945|20508962|P1|STARTED|Optional Continuation Phase||72
8318175|NCT01439945|20508959|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
8318176|NCT01439945|20508960|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
8318177|NCT01439945|20508961|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
8318178|NCT01439945|20508962|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
8318179|NCT01439945|20508959|P4|COMPLETED|Double-Blind Treatment Phase||46
8318180|NCT01439945|20508960|P3|COMPLETED|Double-Blind Treatment Phase||45
8318181|NCT01439945|20508961|P2|COMPLETED|Double-Blind Treatment Phase||91
8318182|NCT01439945|20508962|P1|COMPLETED|Double-Blind Treatment Phase||93
8318183|NCT01439945|20508959|P4|STARTED|Double-Blind Treatment Phase||48
8318184|NCT01439945|20508960|P3|STARTED|Double-Blind Treatment Phase||48
8318185|NCT01439945|20508961|P2|STARTED|Double-Blind Treatment Phase||96
8318186|NCT01439945|20508962|P1|STARTED|Double-Blind Treatment Phase||97
8318187|NCT01439880|20508987|P2|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
8318188|NCT01439880|20508988|P1|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
8318189|NCT01439880|20508987|P2|COMPLETED|All-IP Period (Years 2 to 5)||682
8318190|NCT01439880|20508988|P1|COMPLETED|All-IP Period (Years 2 to 5)||328
8318191|NCT01439880|20508987|P2|Received Evolocumab|All-IP Period (Years 2 to 5)||777
8318192|NCT01439880|20508988|P1|Received Evolocumab|All-IP Period (Years 2 to 5)||374
8318193|NCT01439880|20508987|P2|STARTED|All-IP Period (Years 2 to 5)||822
8318194|NCT01439880|20508988|P1|STARTED|All-IP Period (Years 2 to 5)||398
8318195|NCT01439880|20508987|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||60
8318196|NCT01439880|20508988|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||44
8318197|NCT01439880|20508987|P2|COMPLETED|SOC-controlled Period (Year 1)||822
8318198|NCT01439880|20508988|P1|COMPLETED|SOC-controlled Period (Year 1)||398
8318199|NCT01439880|20508987|P2|Received Evolocumab|SOC-controlled Period (Year 1)||881
8318200|NCT01439880|20508988|P1|Received Evolocumab|SOC-controlled Period (Year 1)||0
8318201|NCT01439880|20508987|P2|STARTED|SOC-controlled Period (Year 1)||882
8318202|NCT01439880|20508988|P1|STARTED|SOC-controlled Period (Year 1)||442
8318203|NCT01439867|20509031|P2|NOT COMPLETED|Overall Study||8
8318204|NCT01439867|20509032|P1|NOT COMPLETED|Overall Study||6
8318205|NCT01439867|20509031|P2|COMPLETED|Overall Study||2
8318206|NCT01439867|20509032|P1|COMPLETED|Overall Study||2
8318207|NCT01439867|20509031|P2|Received Treatment|Overall Study||10
8318208|NCT01439867|20509032|P1|Received Treatment|Overall Study||7
8318209|NCT01439867|20509031|P2|STARTED|Overall Study||10
8318210|NCT01439867|20509032|P1|STARTED|Overall Study||8
8318211|NCT01439854|20509073|P2|NOT COMPLETED|Overall Study||0
8318212|NCT01439854|20509074|P1|NOT COMPLETED|Overall Study||0
8318213|NCT01439854|20509073|P2|COMPLETED|Overall Study||10
8318214|NCT01439854|20509074|P1|COMPLETED|Overall Study||8
8318215|NCT01439854|20509073|P2|STARTED|Overall Study||10
8318216|NCT01439854|20509074|P1|STARTED|Overall Study||8
8318217|NCT01439724|20509084|P2|NOT COMPLETED|Overall Study||8
8318218|NCT01439724|20509085|P1|NOT COMPLETED|Overall Study||9
8318219|NCT01439724|20509084|P2|COMPLETED|Overall Study||39
8318220|NCT01439724|20509085|P1|COMPLETED|Overall Study||38
8318221|NCT01439724|20509084|P2|STARTED|Overall Study||47
8318222|NCT01439724|20509085|P1|STARTED|Overall Study||47
8318223|NCT01439711|20509091|P1|NOT COMPLETED|Overall Study||40
8318224|NCT01439711|20509091|P1|COMPLETED|Overall Study||68
8318225|NCT01439711|20509091|P1|STARTED|Overall Study||108
8318226|NCT01439672|20509102|P1|NOT COMPLETED|Overall Study||24
8318227|NCT01439672|20509102|P1|COMPLETED|Overall Study||11
8318228|NCT01439672|20509102|P1|STARTED|Overall Study||35
8318229|NCT01439633|20509106|P1|NOT COMPLETED|Overall Study||0
8318230|NCT01439633|20509106|P1|COMPLETED|Overall Study||22
8318231|NCT01439633|20509106|P1|STARTED|Overall Study||22
8318232|NCT01439620|20509110|P1|NOT COMPLETED|Overall Study||0
8318233|NCT01439620|20509110|P1|COMPLETED|Overall Study||7
8318234|NCT01439620|20509110|P1|STARTED|Overall Study||7
8318235|NCT01439594|20509114|P1|NOT COMPLETED|Overall Study||0
8318236|NCT01439594|20509114|P1|COMPLETED|Overall Study||17
8318237|NCT01439594|20509114|P1|STARTED|Overall Study||17
8318238|NCT01439581|20509120|P2|NOT COMPLETED|Overall Study||0
8318239|NCT01439581|20509121|P1|NOT COMPLETED|Overall Study||0
8318240|NCT01439581|20509120|P2|COMPLETED|Overall Study||212
8318241|NCT01439581|20509121|P1|COMPLETED|Overall Study||216
8318242|NCT01439581|20509120|P2|STARTED|Overall Study||212
8318243|NCT01439581|20509121|P1|STARTED|Overall Study||216
8318244|NCT01439568|20509129|P2|NOT COMPLETED|Overall Study||2
8318245|NCT01439568|20509130|P1|NOT COMPLETED|Overall Study||3
8318246|NCT01439568|20509129|P2|COMPLETED|Overall Study||41
8318247|NCT01439568|20509130|P1|COMPLETED|Overall Study||44
8318248|NCT01439568|20509129|P2|Received at Least One Dose of Study Drug|Overall Study||43
8318249|NCT01439568|20509130|P1|Received at Least One Dose of Study Drug|Overall Study||47
8318250|NCT01439568|20509129|P2|STARTED|Overall Study||43
8318251|NCT01439568|20509130|P1|STARTED|Overall Study||47
8318252|NCT01439555|20509142|P1|NOT COMPLETED|Overall Study||1
8318253|NCT01439555|20509142|P1|COMPLETED|Overall Study||10
8318254|NCT01439555|20509142|P1|STARTED|Overall Study||11
8318255|NCT01439373|20509154|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
8318256|NCT01439373|20509155|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
8318257|NCT01439373|20509154|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
8318258|NCT01439373|20509155|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
8318259|NCT01439373|20509154|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
8318260|NCT01439373|20509155|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
8318261|NCT01439373|20509154|P2|NOT COMPLETED|Monotherapy (Day 1)||1
8318262|NCT01439373|20509155|P1|NOT COMPLETED|Monotherapy (Day 1)||0
8318263|NCT01439373|20509154|P2|COMPLETED|Monotherapy (Day 1)||4
8318264|NCT01439373|20509155|P1|COMPLETED|Monotherapy (Day 1)||11
8318265|NCT01439373|20509154|P2|STARTED|Monotherapy (Day 1)||5
8318266|NCT01439373|20509155|P1|STARTED|Monotherapy (Day 1)||11
8318267|NCT01439360|20509198|P2|NOT COMPLETED|Overall Study||208
8318268|NCT01439360|20509199|P1|NOT COMPLETED|Overall Study||198
8318269|NCT01439360|20509198|P2|COMPLETED|Overall Study||5804
8318270|NCT01439360|20509199|P1|COMPLETED|Overall Study||5808
8318271|NCT01439360|20509198|P2|STARTED|Overall Study||6012
8318272|NCT01439360|20509199|P1|STARTED|Overall Study||6006
8318273|NCT01439282|20509249|P2|NOT COMPLETED|Overall Study||1
8318274|NCT01439282|20509250|P1|NOT COMPLETED|Overall Study||8
8318275|NCT01439282|20509249|P2|COMPLETED|Overall Study||9
8318276|NCT01439282|20509250|P1|COMPLETED|Overall Study||59
8318277|NCT01439282|20509249|P2|STARTED|Overall Study||10
8318278|NCT01439282|20509250|P1|STARTED|Overall Study||67
8318279|NCT01439204|20509262|P2|NOT COMPLETED|Overall Study||3
8318280|NCT01439204|20509263|P1|NOT COMPLETED|Overall Study||4
8318281|NCT01439204|20509262|P2|COMPLETED|Overall Study||33
8318282|NCT01439204|20509263|P1|COMPLETED|Overall Study||32
8318283|NCT01439204|20509262|P2|STARTED|Overall Study||36
8318284|NCT01439204|20509263|P1|STARTED|Overall Study||36
8318285|NCT01439165|20509297|P2|NOT COMPLETED|Overall Study||2
8318286|NCT01439165|20509298|P1|NOT COMPLETED|Overall Study||21
8318287|NCT01439165|20509297|P2|COMPLETED|Overall Study||326
8318288|NCT01439165|20509298|P1|COMPLETED|Overall Study||981
8318289|NCT01439165|20509297|P2|STARTED|Overall Study||328
8318290|NCT01439165|20509298|P1|STARTED|Overall Study||1002
8318291|NCT01439126|20509312|P2|NOT COMPLETED|Overall Study||42
8318292|NCT01439126|20509313|P1|NOT COMPLETED|Overall Study||31
8318293|NCT01439126|20509312|P2|COMPLETED|Overall Study||25
8318294|NCT01439126|20509313|P1|COMPLETED|Overall Study||37
8318295|NCT01439126|20509312|P2|STARTED|Overall Study||67
8318296|NCT01439126|20509313|P1|STARTED|Overall Study||68
8318297|NCT01439087|20509333|P1|NOT COMPLETED|Overall Study||0
8318298|NCT01439087|20509333|P1|COMPLETED|Overall Study||2
8318299|NCT01439087|20509333|P1|STARTED|Overall Study||2
8318300|NCT01439074|20509339|P2|NOT COMPLETED|Overall Study||13
8318301|NCT01439074|20509340|P1|NOT COMPLETED|Overall Study||9
8318302|NCT01439074|20509339|P2|COMPLETED|Overall Study||74
8318303|NCT01439074|20509340|P1|COMPLETED|Overall Study||66
8318304|NCT01439074|20509339|P2|STARTED|Overall Study||87
8318305|NCT01439074|20509340|P1|STARTED|Overall Study||75
8318306|NCT01439035|20509352|P1|NOT COMPLETED|Overall Study||0
8318307|NCT01439035|20509352|P1|COMPLETED|Overall Study||6
8318308|NCT01439035|20509352|P1|STARTED|Overall Study||6
8318309|NCT01439009|20509358|P2|NOT COMPLETED|Overall Study||3
8318310|NCT01439009|20509359|P1|NOT COMPLETED|Overall Study||8
8318311|NCT01439009|20509358|P2|COMPLETED|Overall Study||47
8318312|NCT01439009|20509359|P1|COMPLETED|Overall Study||42
8318313|NCT01439009|20509358|P2|STARTED|Overall Study||50
8318314|NCT01439009|20509359|P1|STARTED|Overall Study||50
8318315|NCT01438996|20509392|P3|NOT COMPLETED|Overall Study||0
8318316|NCT01438996|20509393|P2|NOT COMPLETED|Overall Study||1
8318317|NCT01438996|20509394|P1|NOT COMPLETED|Overall Study||4
8318318|NCT01438996|20509392|P3|COMPLETED|Overall Study||20
8318319|NCT01438996|20509393|P2|COMPLETED|Overall Study||12
8318320|NCT01438996|20509394|P1|COMPLETED|Overall Study||14
8318321|NCT01438996|20509392|P3|STARTED|Overall Study||20
8318322|NCT01438996|20509393|P2|STARTED|Overall Study||13
8318323|NCT01438996|20509394|P1|STARTED|Overall Study||18
8318324|NCT01438840|20509428|P3|NOT COMPLETED|Extension Phase||10
8318325|NCT01438840|20509429|P2|NOT COMPLETED|Extension Phase||0
8318326|NCT01438840|20509430|P1|NOT COMPLETED|Extension Phase||0
8318327|NCT01438840|20509428|P3|COMPLETED|Extension Phase||29
8318328|NCT01438840|20509429|P2|COMPLETED|Extension Phase||0
8318329|NCT01438840|20509430|P1|COMPLETED|Extension Phase||0
8318330|NCT01438840|20509428|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
8318331|NCT01438840|20509429|P2|STARTED|Extension Phase||0
8318332|NCT01438840|20509430|P1|STARTED|Extension Phase||0
8318333|NCT01438840|20509428|P3|NOT COMPLETED|Core Study||0
8318334|NCT01438840|20509429|P2|NOT COMPLETED|Core Study||10
8318335|NCT01438840|20509430|P1|NOT COMPLETED|Core Study||16
8318336|NCT01438840|20509428|P3|COMPLETED|Core Study||0
8318337|NCT01438840|20509429|P2|COMPLETED|Core Study||22
8318338|NCT01438840|20509430|P1|COMPLETED|Core Study||1
8318339|NCT01438840|20509428|P3|STARTED|Core Study||0
8318340|NCT01438840|20509429|P2|STARTED|Core Study||32
8318341|NCT01438840|20509430|P1|STARTED|Core Study||17
8318342|NCT01438814|20509443|P2|NOT COMPLETED|Overall Study||14
8318343|NCT01438814|20509444|P1|NOT COMPLETED|Overall Study||14
8318344|NCT01438814|20509443|P2|COMPLETED|Overall Study||331
8318345|NCT01438814|20509444|P1|COMPLETED|Overall Study||330
8318346|NCT01438814|20509443|P2|STARTED|Overall Study||345
8318347|NCT01438814|20509444|P1|STARTED|Overall Study||344
8318348|NCT01438710|20509474|P2|NOT COMPLETED|Second Week of Treatment||0
8318349|NCT01438710|20509475|P1|NOT COMPLETED|Second Week of Treatment||1
8318350|NCT01438710|20509474|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
8318351|NCT01438710|20509475|P1|COMPLETED|Second Week of Treatment||40
8318352|NCT01438710|20509474|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
8318353|NCT01438710|20509475|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
8318354|NCT01438710|20509474|P2|NOT COMPLETED|First Week of Treatment||3
8318355|NCT01438710|20509475|P1|NOT COMPLETED|First Week of Treatment||0
8318356|NCT01438710|20509474|P2|COMPLETED|First Week of Treatment||41
8318357|NCT01438710|20509475|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
8318358|NCT01438710|20509474|P2|STARTED|First Week of Treatment||44
8318359|NCT01438710|20509475|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
8318360|NCT01438541|20509480|P1|NOT COMPLETED|Overall Study||7
8318361|NCT01438541|20509480|P1|COMPLETED|Overall Study||22
8318362|NCT01438541|20509480|P1|STARTED|Overall Study||29
8318363|NCT01438489|20509489|P3|NOT COMPLETED|Overall Study||19
8318364|NCT01438489|20509490|P2|NOT COMPLETED|Overall Study||16
8318365|NCT01438489|20509491|P1|NOT COMPLETED|Overall Study||26
8318366|NCT01438489|20509489|P3|COMPLETED|Overall Study||85
8318367|NCT01438489|20509490|P2|COMPLETED|Overall Study||84
8318368|NCT01438489|20509491|P1|COMPLETED|Overall Study||77
8318369|NCT01438489|20509489|P3|STARTED|Overall Study||104
8318370|NCT01438489|20509490|P2|STARTED|Overall Study||100
8318371|NCT01438489|20509491|P1|STARTED|Overall Study||103
8318372|NCT01438476|20509536|P2|NOT COMPLETED|Overall Study||11
8318373|NCT01438476|20509537|P1|NOT COMPLETED|Overall Study||10
8318374|NCT01438476|20509536|P2|COMPLETED|Overall Study||34
8318375|NCT01438476|20509537|P1|COMPLETED|Overall Study||106
8318376|NCT01438476|20509536|P2|STARTED|Overall Study||45
8318377|NCT01438476|20509537|P1|STARTED|Overall Study||116
8318378|NCT01438424|20509543|P1|NOT COMPLETED|Overall Study||417
8318379|NCT01438424|20509543|P1|COMPLETED|Overall Study|Completed treatment|634
8318380|NCT01438424|20509543|P1|STARTED|Overall Study|Received treatment|1051
8318381|NCT01438411|20509579|P1|NOT COMPLETED|Overall Study||13
8318382|NCT01438411|20509579|P1|COMPLETED|Overall Study||40
8318383|NCT01438411|20509579|P1|STARTED|Overall Study||53
8318384|NCT01438307|20509594|P2|NOT COMPLETED|Overall Study||1
8318385|NCT01438307|20509595|P1|NOT COMPLETED|Overall Study||1
8318386|NCT01438307|20509594|P2|COMPLETED|Overall Study||13
8318387|NCT01438307|20509595|P1|COMPLETED|Overall Study||13
8318388|NCT01438307|20509594|P2|STARTED|Overall Study||14
8318389|NCT01438307|20509595|P1|STARTED|Overall Study||14
8318390|NCT01438294|20509609|P2|NOT COMPLETED|Overall Study||7
8318391|NCT01438294|20509610|P1|NOT COMPLETED|Overall Study||3
8318392|NCT01438294|20509609|P2|COMPLETED|Overall Study||13
8318393|NCT01438294|20509610|P1|COMPLETED|Overall Study||13
8318394|NCT01438294|20509609|P2|STARTED|Overall Study||20
8318395|NCT01438294|20509610|P1|STARTED|Overall Study||16
8318396|NCT01438229|20509620|P1|NOT COMPLETED|Overall Study||3
8318397|NCT01438229|20509620|P1|COMPLETED|Overall Study||44
8318398|NCT01438229|20509620|P1|Underwent Procedure|Overall Study||46
8318399|NCT01438229|20509620|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
8318400|NCT01438229|20509620|P1|STARTED|Overall Study||47
8318401|NCT01438177|20509653|P1|NOT COMPLETED|Overall Study||2
8318402|NCT01438177|20509653|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
8318403|NCT01438177|20509653|P1|STARTED|Overall Study||11
8318404|NCT01438151|20509660|P1|NOT COMPLETED|Overall Study||8
8318405|NCT01438151|20509660|P1|COMPLETED|Overall Study||3
8318406|NCT01438151|20509660|P1|STARTED|Overall Study||11
8318407|NCT01438060|20509666|P2|NOT COMPLETED|On Study Beyond Week 140||8
8318408|NCT01438060|20509667|P1|NOT COMPLETED|On Study Beyond Week 140||0
8318409|NCT01438060|20509666|P2|COMPLETED|On Study Beyond Week 140||1
8318410|NCT01438060|20509667|P1|COMPLETED|On Study Beyond Week 140||0
8318411|NCT01438060|20509666|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
8318412|NCT01438060|20509667|P1|STARTED|On Study Beyond Week 140||0
8318413|NCT01438060|20509666|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
8318414|NCT01438060|20509667|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
8318415|NCT01438060|20509666|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
8318416|NCT01438060|20509667|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
8318417|NCT01438060|20509666|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
8318418|NCT01438060|20509667|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
8318419|NCT01438060|20509666|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
8318420|NCT01438060|20509667|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
8318421|NCT01438060|20509666|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
8318422|NCT01438060|20509667|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
8318423|NCT01438060|20509666|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
8318424|NCT01438060|20509667|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
8318425|NCT01438008|20509747|P2|NOT COMPLETED|Overall Study||0
8318426|NCT01438008|20509748|P1|NOT COMPLETED|Overall Study||0
8318427|NCT01438008|20509747|P2|COMPLETED|Overall Study||5
8318428|NCT01438008|20509748|P1|COMPLETED|Overall Study||4
8318429|NCT01438008|20509747|P2|STARTED|Overall Study||5
8318430|NCT01438008|20509748|P1|STARTED|Overall Study||4
8318431|NCT01437995|20509759|P3|NOT COMPLETED|Overall Study||20
8318432|NCT01437995|20509760|P2|NOT COMPLETED|Overall Study||18
8318433|NCT01437995|20509761|P1|NOT COMPLETED|Overall Study||11
8318434|NCT01437995|20509759|P3|COMPLETED|Overall Study||135
8318435|NCT01437995|20509760|P2|COMPLETED|Overall Study||131
8318436|NCT01437995|20509761|P1|COMPLETED|Overall Study||140
8318437|NCT01437995|20509759|P3|Included in Treatment Failure Analysis|Overall Study||151
8318438|NCT01437995|20509760|P2|Included in Treatment Failure Analysis|Overall Study||146
8318439|NCT01437995|20509761|P1|Included in Treatment Failure Analysis|Overall Study||150
8318440|NCT01437995|20509759|P3|STARTED|Overall Study||155
8318441|NCT01437995|20509760|P2|STARTED|Overall Study||149
8318442|NCT01437995|20509761|P1|STARTED|Overall Study||151
8318443|NCT01437943|20509783|P2|NOT COMPLETED|Overall Study||2
8318444|NCT01437943|20509784|P1|NOT COMPLETED|Overall Study||7
8318445|NCT01437943|20509783|P2|COMPLETED|Overall Study||1
8318446|NCT01437943|20509784|P1|COMPLETED|Overall Study||0
8318447|NCT01437943|20509783|P2|STARTED|Overall Study||3
8318448|NCT01437943|20509784|P1|STARTED|Overall Study||7
8318449|NCT01437878|20509792|P2|NOT COMPLETED|Overall Study||0
8318450|NCT01437878|20509793|P1|NOT COMPLETED|Overall Study||1
8318451|NCT01437878|20509792|P2|COMPLETED|Overall Study||1
8318452|NCT01437878|20509793|P1|COMPLETED|Overall Study||0
8318453|NCT01437878|20509792|P2|STARTED|Overall Study||1
8318454|NCT01437878|20509793|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
8318455|NCT01437852|20509833|P1|NOT COMPLETED|Overall Study||0
8318456|NCT01437852|20509833|P1|COMPLETED|Overall Study||30
8318457|NCT01437852|20509833|P1|Received Autograft|Overall Study||30
8318458|NCT01437852|20509833|P1|Received StrataGraft Skin Tissue|Overall Study||30
8318459|NCT01437852|20509833|P1|STARTED|Overall Study||30
8318460|NCT01437605|20509841|P2|NOT COMPLETED|Overall Study||0
8318461|NCT01437605|20509842|P1|NOT COMPLETED|Overall Study||0
8318462|NCT01437605|20509841|P2|COMPLETED|Overall Study||5
8318463|NCT01437605|20509842|P1|COMPLETED|Overall Study||9
8318464|NCT01437605|20509841|P2|STARTED|Overall Study||5
8318465|NCT01437605|20509842|P1|STARTED|Overall Study||9
8318466|NCT01437540|20509860|P2|NOT COMPLETED|Overall Study||65
8318467|NCT01437540|20509861|P1|NOT COMPLETED|Overall Study||127
8318468|NCT01437540|20509860|P2|COMPLETED|Overall Study||133
8318469|NCT01437540|20509861|P1|COMPLETED|Overall Study||265
8318470|NCT01437540|20509860|P2|STARTED|Overall Study||198
8318471|NCT01437540|20509861|P1|STARTED|Overall Study||392
8318472|NCT01437501|20509875|P2|NOT COMPLETED|Overall Study||11
8318473|NCT01437501|20509876|P1|NOT COMPLETED|Overall Study||13
8318474|NCT01437501|20509875|P2|COMPLETED|Overall Study||132
8318475|NCT01437501|20509876|P1|COMPLETED|Overall Study||135
8318476|NCT01437501|20509875|P2|STARTED|Overall Study||143
8318477|NCT01437501|20509876|P1|STARTED|Overall Study||148
8318478|NCT01437488|20509884|P1|NOT COMPLETED|Overall Study||0
8318479|NCT01437488|20509884|P1|COMPLETED|Overall Study||14
8318480|NCT01437488|20509884|P1|STARTED|Overall Study||14
8318481|NCT01437449|20509891|P1|NOT COMPLETED|Overall Study||0
8318482|NCT01437449|20509891|P1|COMPLETED|Overall Study||27
8318483|NCT01437449|20509891|P1|STARTED|Overall Study||27
8318484|NCT01437423|20509898|P1|NOT COMPLETED|Overall Study||15
8318485|NCT01437423|20509898|P1|COMPLETED|Overall Study||647
8318486|NCT01437423|20509898|P1|STARTED|Overall Study||662
8318487|NCT01437397|20509910|P5|NOT COMPLETED|Overall Study||101
8318488|NCT01437397|20509911|P4|NOT COMPLETED|Overall Study||69
8318489|NCT01437397|20509912|P3|NOT COMPLETED|Overall Study||72
8318490|NCT01437397|20509913|P2|NOT COMPLETED|Overall Study||62
8318491|NCT01437397|20509914|P1|NOT COMPLETED|Overall Study||66
8318492|NCT01437397|20509910|P5|COMPLETED|Overall Study||236
8318493|NCT01437397|20509911|P4|COMPLETED|Overall Study||270
8318494|NCT01437397|20509912|P3|COMPLETED|Overall Study||268
8318495|NCT01437397|20509913|P2|COMPLETED|Overall Study||276
8318496|NCT01437397|20509914|P1|COMPLETED|Overall Study||272
8318497|NCT01437397|20509910|P5|STARTED|Overall Study||337
8318498|NCT01437397|20509911|P4|STARTED|Overall Study||339
8318499|NCT01437397|20509912|P3|STARTED|Overall Study||340
8318500|NCT01437397|20509913|P2|STARTED|Overall Study||338
8318501|NCT01437397|20509914|P1|STARTED|Overall Study||338
8318502|NCT01437319|20509941|P3|NOT COMPLETED|Phase II||37
8318503|NCT01437319|20509942|P2|NOT COMPLETED|Phase II||44
8318504|NCT01437319|20509943|P1|NOT COMPLETED|Phase II||0
8318505|NCT01437319|20509941|P3|COMPLETED|Phase II||75
8318506|NCT01437319|20509942|P2|COMPLETED|Phase II||71
8318507|NCT01437319|20509943|P1|COMPLETED|Phase II||0
8318508|NCT01437319|20509941|P3|STARTED|Phase II||112
8318509|NCT01437319|20509942|P2|STARTED|Phase II||115
8318510|NCT01437319|20509943|P1|STARTED|Phase II||0
8318511|NCT01437319|20509941|P3|NOT COMPLETED|Phase I||0
8318512|NCT01437319|20509942|P2|NOT COMPLETED|Phase I||0
8318513|NCT01437319|20509943|P1|NOT COMPLETED|Phase I||55
8318514|NCT01437319|20509941|P3|COMPLETED|Phase I||0
8318515|NCT01437319|20509942|P2|COMPLETED|Phase I||0
8318516|NCT01437319|20509943|P1|COMPLETED|Phase I||227
8318517|NCT01437319|20509941|P3|STARTED|Phase I||0
8318518|NCT01437319|20509942|P2|STARTED|Phase I||0
8318519|NCT01437319|20509943|P1|STARTED|Phase I||282
8318520|NCT01437267|20509958|P6|NOT COMPLETED|Overall Study||0
8318521|NCT01437267|20509959|P5|NOT COMPLETED|Overall Study||0
8318522|NCT01437267|20509960|P4|NOT COMPLETED|Overall Study||1
8318523|NCT01437267|20509961|P3|NOT COMPLETED|Overall Study||0
8318524|NCT01437267|20509962|P2|NOT COMPLETED|Overall Study||1
8318525|NCT01437267|20509963|P1|NOT COMPLETED|Overall Study||0
8318526|NCT01437267|20509958|P6|COMPLETED|Overall Study||20
8318527|NCT01437267|20509959|P5|COMPLETED|Overall Study||20
8318528|NCT01437267|20509960|P4|COMPLETED|Overall Study||19
8318529|NCT01437267|20509961|P3|COMPLETED|Overall Study||20
8318530|NCT01437267|20509962|P2|COMPLETED|Overall Study||19
8318531|NCT01437267|20509963|P1|COMPLETED|Overall Study||20
8318532|NCT01437267|20509958|P6|STARTED|Overall Study||20
8318533|NCT01437267|20509959|P5|STARTED|Overall Study||20
8318534|NCT01437267|20509960|P4|STARTED|Overall Study||20
8318535|NCT01437267|20509961|P3|STARTED|Overall Study||20
8318536|NCT01437267|20509962|P2|STARTED|Overall Study||20
8318537|NCT01437267|20509963|P1|STARTED|Overall Study||20
8318538|NCT01437124|20510001|P1|NOT COMPLETED|Overall Study||0
8318539|NCT01437124|20510001|P1|COMPLETED|Overall Study||83
8318540|NCT01437124|20510001|P1|STARTED|Overall Study||83
8318541|NCT01437111|20510006|P1|NOT COMPLETED|Overall Study||18
8318542|NCT01437111|20510006|P1|COMPLETED|Overall Study||182
8318543|NCT01437111|20510006|P1|Treated Participants|Overall Study||198
8318544|NCT01437111|20510006|P1|STARTED|Overall Study||200
8318545|NCT01437098|20510017|P1|NOT COMPLETED|Overall Study||13
8318546|NCT01437098|20510017|P1|COMPLETED|Overall Study||42
8318547|NCT01437098|20510017|P1|36 Months|Overall Study||36
8318548|NCT01437098|20510017|P1|24 Months|Overall Study||42
8318549|NCT01437098|20510017|P1|12 Months|Overall Study||45
8318550|NCT01437098|20510017|P1|6 Months|Overall Study||47
8318551|NCT01437098|20510017|P1|30 Days|Overall Study||51
8318552|NCT01437098|20510017|P1|STARTED|Overall Study||55
8318553|NCT01436799|20510074|P2|NOT COMPLETED|Overall Study||0
8318554|NCT01436799|20510075|P1|NOT COMPLETED|Overall Study||0
8318555|NCT01436799|20510074|P2|COMPLETED|Overall Study||20
8318556|NCT01436799|20510075|P1|COMPLETED|Overall Study||20
8318557|NCT01436799|20510074|P2|STARTED|Overall Study||20
8318558|NCT01436799|20510075|P1|STARTED|Overall Study||20
8318559|NCT01436643|20510084|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
8318560|NCT01436643|20510085|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
8318561|NCT01436643|20510086|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
8318562|NCT01436643|20510087|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
8318563|NCT01436643|20510084|P4|COMPLETED|Core Phase (16 Weeks)||0
8318564|NCT01436643|20510085|P3|COMPLETED|Core Phase (16 Weeks)||17
8318565|NCT01436643|20510086|P2|COMPLETED|Core Phase (16 Weeks)||11
8318566|NCT01436643|20510087|P1|COMPLETED|Core Phase (16 Weeks)||16
8318567|NCT01436643|20510084|P4|STARTED|Core Phase (16 Weeks)||0
8318568|NCT01436643|20510085|P3|STARTED|Core Phase (16 Weeks)||20
8318569|NCT01436643|20510086|P2|STARTED|Core Phase (16 Weeks)||15
8318570|NCT01436643|20510087|P1|STARTED|Core Phase (16 Weeks)||17
8318571|NCT01436643|20510084|P4|NOT COMPLETED|2-week Pre-treatment||10
8318572|NCT01436643|20510085|P3|NOT COMPLETED|2-week Pre-treatment||0
8318573|NCT01436643|20510086|P2|NOT COMPLETED|2-week Pre-treatment||0
8318574|NCT01436643|20510087|P1|NOT COMPLETED|2-week Pre-treatment||0
8318575|NCT01436643|20510084|P4|COMPLETED|2-week Pre-treatment||44
8318576|NCT01436643|20510085|P3|COMPLETED|2-week Pre-treatment||0
8318577|NCT01436643|20510086|P2|COMPLETED|2-week Pre-treatment||0
8318578|NCT01436643|20510087|P1|COMPLETED|2-week Pre-treatment||0
8318579|NCT01436643|20510084|P4|STARTED|2-week Pre-treatment||54
8318580|NCT01436643|20510085|P3|STARTED|2-week Pre-treatment||0
8318581|NCT01436643|20510086|P2|STARTED|2-week Pre-treatment||0
8318582|NCT01436643|20510087|P1|STARTED|2-week Pre-treatment||0
8318583|NCT01436526|20510099|P2|NOT COMPLETED|Period 2||0
8318584|NCT01436526|20510100|P1|NOT COMPLETED|Period 2||0
8318585|NCT01436526|20510099|P2|COMPLETED|Period 2||13
8318586|NCT01436526|20510100|P1|COMPLETED|Period 2||13
8318587|NCT01436526|20510099|P2|Participants Received Treatment|Period 2||13
8318588|NCT01436526|20510100|P1|Participants Received Treatment|Period 2||13
8318589|NCT01436526|20510099|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
8318590|NCT01436526|20510100|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
8318591|NCT01436526|20510099|P2|NOT COMPLETED|Period 1||0
8318592|NCT01436526|20510100|P1|NOT COMPLETED|Period 1||0
8318593|NCT01436526|20510099|P2|COMPLETED|Period 1||14
8318594|NCT01436526|20510100|P1|COMPLETED|Period 1||14
8318595|NCT01436526|20510099|P2|Participants Received Treatment|Period 1||14
8318596|NCT01436526|20510100|P1|Participants Received Treatment|Period 1||14
8318597|NCT01436526|20510099|P2|STARTED|Period 1||14
8318598|NCT01436526|20510100|P1|STARTED|Period 1||14
8318599|NCT01436500|20510122|P5|NOT COMPLETED|Overall Study||4
8318600|NCT01436500|20510123|P4|NOT COMPLETED|Overall Study||1
8318601|NCT01436500|20510124|P3|NOT COMPLETED|Overall Study||5
8318602|NCT01436500|20510125|P2|NOT COMPLETED|Overall Study||3
8318603|NCT01436500|20510126|P1|NOT COMPLETED|Overall Study||3
8318604|NCT01436500|20510122|P5|COMPLETED|Overall Study||9
8318605|NCT01436500|20510123|P4|COMPLETED|Overall Study||5
8318606|NCT01436500|20510124|P3|COMPLETED|Overall Study||7
8318607|NCT01436500|20510125|P2|COMPLETED|Overall Study||9
8318608|NCT01436500|20510126|P1|COMPLETED|Overall Study||9
8318609|NCT01436500|20510122|P5|STARTED|Overall Study||13
8318610|NCT01436500|20510123|P4|STARTED|Overall Study||6
8318611|NCT01436500|20510124|P3|STARTED|Overall Study||12
8318612|NCT01436500|20510125|P2|STARTED|Overall Study||12
8318613|NCT01436500|20510126|P1|STARTED|Overall Study||12
8318614|NCT01436435|20510159|P1|NOT COMPLETED|Overall Study||64
8318615|NCT01436435|20510159|P1|COMPLETED|Overall Study||177
8318616|NCT01436435|20510159|P1|STARTED|Overall Study||241
8318617|NCT01436396|20510170|P2|NOT COMPLETED|Overall Study||42
8318618|NCT01436396|20510171|P1|NOT COMPLETED|Overall Study||32
8318619|NCT01436396|20510170|P2|COMPLETED|Overall Study||354
8318620|NCT01436396|20510171|P1|COMPLETED|Overall Study||364
8318621|NCT01436396|20510170|P2|Vaccinated|Overall Study||393
8318622|NCT01436396|20510171|P1|Vaccinated|Overall Study||394
8318623|NCT01436396|20510170|P2|STARTED|Overall Study||396
8318624|NCT01436396|20510171|P1|STARTED|Overall Study||396
8318625|NCT01436370|20510211|P8|NOT COMPLETED|Overall Study||0
8318626|NCT01436370|20510212|P7|NOT COMPLETED|Overall Study||0
8318627|NCT01436370|20510213|P6|NOT COMPLETED|Overall Study||0
8318628|NCT01436370|20510214|P5|NOT COMPLETED|Overall Study||1
8318629|NCT01436370|20510215|P4|NOT COMPLETED|Overall Study||0
8318630|NCT01436370|20510216|P3|NOT COMPLETED|Overall Study||0
8318631|NCT01436370|20510217|P2|NOT COMPLETED|Overall Study||0
8318632|NCT01436370|20510218|P1|NOT COMPLETED|Overall Study||0
8318633|NCT01436370|20510211|P8|COMPLETED|Overall Study||16
8318634|NCT01436370|20510212|P7|COMPLETED|Overall Study||16
8318635|NCT01436370|20510213|P6|COMPLETED|Overall Study||19
8318636|NCT01436370|20510214|P5|COMPLETED|Overall Study||18
8318637|NCT01436370|20510215|P4|COMPLETED|Overall Study||10
8318638|NCT01436370|20510216|P3|COMPLETED|Overall Study||10
8318639|NCT01436370|20510217|P2|COMPLETED|Overall Study||6
8318640|NCT01436370|20510218|P1|COMPLETED|Overall Study||6
8318641|NCT01436370|20510211|P8|STARTED|Overall Study||16
8318642|NCT01436370|20510212|P7|STARTED|Overall Study||16
8318643|NCT01436370|20510213|P6|STARTED|Overall Study||19
8318644|NCT01436370|20510214|P5|STARTED|Overall Study||19
8318645|NCT01436370|20510215|P4|STARTED|Overall Study||10
8318646|NCT01436370|20510216|P3|STARTED|Overall Study||10
8318647|NCT01436370|20510217|P2|STARTED|Overall Study||6
8318648|NCT01436370|20510218|P1|STARTED|Overall Study||6
8318649|NCT01436357|20510298|P2|NOT COMPLETED|Overall Study||128
8318650|NCT01436357|20510299|P1|NOT COMPLETED|Overall Study||122
8318651|NCT01436357|20510298|P2|COMPLETED|Overall Study||146
8318652|NCT01436357|20510299|P1|COMPLETED|Overall Study||152
8318653|NCT01436357|20510298|P2|Stage 2|Overall Study||226
8318654|NCT01436357|20510299|P1|Stage 2|Overall Study||225
8318655|NCT01436357|20510298|P2|Stage 1|Overall Study||48
8318656|NCT01436357|20510299|P1|Stage 1|Overall Study||49
8318657|NCT01436357|20510298|P2|STARTED|Overall Study||274
8318658|NCT01436357|20510299|P1|STARTED|Overall Study||274
8318659|NCT01436305|20510320|P3|NOT COMPLETED|Overall Study||0
8318660|NCT01436305|20510321|P2|NOT COMPLETED|Overall Study||4
8318661|NCT01436305|20510322|P1|NOT COMPLETED|Overall Study||2
8318662|NCT01436305|20510320|P3|COMPLETED|Overall Study||7
8318663|NCT01436305|20510321|P2|COMPLETED|Overall Study||2
8318664|NCT01436305|20510322|P1|COMPLETED|Overall Study||4
8318665|NCT01436305|20510320|P3|STARTED|Overall Study||7
8318666|NCT01436305|20510321|P2|STARTED|Overall Study||6
8318667|NCT01436305|20510322|P1|STARTED|Overall Study||6
8318668|NCT01436279|20510419|P2|NOT COMPLETED|Overall Study||0
8318669|NCT01436279|20510420|P1|NOT COMPLETED|Overall Study||0
8318670|NCT01436279|20510419|P2|COMPLETED|Overall Study||20
8318671|NCT01436279|20510420|P1|COMPLETED|Overall Study||30
8318672|NCT01436279|20510419|P2|STARTED|Overall Study||20
8318673|NCT01436279|20510420|P1|STARTED|Overall Study||30
8318674|NCT01436266|20510442|P2|NOT COMPLETED|Overall Study||0
8318675|NCT01436266|20510443|P1|NOT COMPLETED|Overall Study||0
8318676|NCT01436266|20510442|P2|COMPLETED|Overall Study||1
8318677|NCT01436266|20510443|P1|COMPLETED|Overall Study||1
8318678|NCT01436266|20510442|P2|STARTED|Overall Study||1
8318679|NCT01436266|20510443|P1|STARTED|Overall Study||1
8318680|NCT01436253|20510449|P1|NOT COMPLETED|Overall Study||299
8318681|NCT01436253|20510449|P1|COMPLETED|Overall Study||1897
8318682|NCT01436253|20510449|P1|STARTED|Overall Study||2196
8318683|NCT01436201|20510454|P1|NOT COMPLETED|Overall Study||4
8318684|NCT01436201|20510454|P1|COMPLETED|Overall Study||20
8318685|NCT01436201|20510454|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
8318686|NCT01436201|20510454|P1|STARTED|Overall Study||24
8318687|NCT01436175|20510464|P1|NOT COMPLETED|Overall Study||1270
8318688|NCT01436175|20510464|P1|COMPLETED|Overall Study||300
8318689|NCT01436175|20510464|P1|STARTED|Overall Study||1570
8318690|NCT01436162|20510491|P3|NOT COMPLETED|Randomized Phase||25
8318691|NCT01436162|20510492|P2|NOT COMPLETED|Randomized Phase||31
8318692|NCT01436162|20510493|P1|NOT COMPLETED|Randomized Phase||44
8318693|NCT01436162|20510491|P3|COMPLETED|Randomized Phase||189
8318694|NCT01436162|20510492|P2|COMPLETED|Randomized Phase||181
8318695|NCT01436162|20510493|P1|COMPLETED|Randomized Phase||353
8318696|NCT01436162|20510491|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
8318697|NCT01436162|20510492|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
8318698|NCT01436162|20510493|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
8318699|NCT01436162|20510491|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
8318700|NCT01436162|20510492|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
8318701|NCT01436162|20510493|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
8318702|NCT01436162|20510491|P3|COMPLETED|Single-blind Lead-in Phase||0
8318703|NCT01436162|20510492|P2|COMPLETED|Single-blind Lead-in Phase||0
8318704|NCT01436162|20510493|P1|COMPLETED|Single-blind Lead-in Phase||823
8318705|NCT01436162|20510491|P3|STARTED|Single-blind Lead-in Phase||0
8318706|NCT01436162|20510492|P2|STARTED|Single-blind Lead-in Phase||0
8318707|NCT01436162|20510493|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
8318708|NCT01436149|20510527|P3|NOT COMPLETED|Randomized Phase||42
8318709|NCT01436149|20510528|P2|NOT COMPLETED|Randomized Phase||38
8318710|NCT01436149|20510529|P1|NOT COMPLETED|Randomized Phase||77
8318711|NCT01436149|20510527|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
8318712|NCT01436149|20510528|P2|COMPLETED|Randomized Phase||164
8318713|NCT01436149|20510529|P1|COMPLETED|Randomized Phase||415
8318714|NCT01436149|20510527|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
8318715|NCT01436149|20510528|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
8318716|NCT01436149|20510529|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
8318717|NCT01436149|20510527|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
8318718|NCT01436149|20510528|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
8318719|NCT01436149|20510529|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
8318720|NCT01436149|20510527|P3|COMPLETED|Antidepressant Lead-in Phase||0
8318721|NCT01436149|20510528|P2|COMPLETED|Antidepressant Lead-in Phase||0
8318722|NCT01436149|20510529|P1|COMPLETED|Antidepressant Lead-in Phase||896
8318723|NCT01436149|20510527|P3|STARTED|Antidepressant Lead-in Phase||0
8318724|NCT01436149|20510528|P2|STARTED|Antidepressant Lead-in Phase||0
8318725|NCT01436149|20510529|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
8318726|NCT01436110|20510560|P3|NOT COMPLETED|Overall Study||23
8318727|NCT01436110|20510561|P2|NOT COMPLETED|Overall Study||26
8318728|NCT01436110|20510562|P1|NOT COMPLETED|Overall Study||39
8318729|NCT01436110|20510560|P3|COMPLETED|Overall Study||95
8318730|NCT01436110|20510561|P2|COMPLETED|Overall Study||91
8318731|NCT01436110|20510562|P1|COMPLETED|Overall Study||77
8318732|NCT01436110|20510560|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
8318733|NCT01436110|20510561|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
8318734|NCT01436110|20510562|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
8318735|NCT01436110|20510560|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
8318736|NCT01436110|20510561|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
8318737|NCT01436110|20510562|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
8318738|NCT01436084|20510585|P1|NOT COMPLETED|Overall Study||4
8318739|NCT01436084|20510585|P1|COMPLETED|Overall Study||0
8318740|NCT01436084|20510585|P1|STARTED|Overall Study||4
8318741|NCT01436071|20510591|P2|NOT COMPLETED|Overall Study||14
8318742|NCT01436071|20510592|P1|NOT COMPLETED|Overall Study||26
8318743|NCT01436071|20510591|P2|COMPLETED|Overall Study||110
8318744|NCT01436071|20510592|P1|COMPLETED|Overall Study||98
8318745|NCT01436071|20510591|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
8318746|NCT01436071|20510592|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
8318747|NCT01436071|20510591|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
8318748|NCT01436071|20510592|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
8318749|NCT01436045|20510608|P2|NOT COMPLETED|Overall Study||0
8318750|NCT01436045|20510609|P1|NOT COMPLETED|Overall Study||0
8318751|NCT01436045|20510608|P2|COMPLETED|Overall Study||6
8318752|NCT01436045|20510609|P1|COMPLETED|Overall Study||6
8318753|NCT01436045|20510608|P2|STARTED|Overall Study||6
8318754|NCT01436045|20510609|P1|STARTED|Overall Study||6
8318755|NCT01436006|20510620|P1|NOT COMPLETED|Overall Study||37
8318756|NCT01436006|20510620|P1|COMPLETED|Overall Study||6663
8318757|NCT01436006|20510620|P1|STARTED|Overall Study||6700
8318758|NCT01435928|20510634|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
8318759|NCT01435928|20510635|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
8318760|NCT01435928|20510636|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
8318761|NCT01435928|20510634|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
8318762|NCT01435928|20510635|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
8318763|NCT01435928|20510636|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
8318764|NCT01435928|20510634|P3|STARTED|Double Blind Phase - 28 Weeks||141
8318765|NCT01435928|20510635|P2|STARTED|Double Blind Phase - 28 Weeks||144
8318766|NCT01435928|20510636|P1|STARTED|Double Blind Phase - 28 Weeks||0
8318767|NCT01435928|20510634|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
8318768|NCT01435928|20510635|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
8318769|NCT01435928|20510636|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
8318770|NCT01435928|20510634|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
8318771|NCT01435928|20510635|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
8318772|NCT01435928|20510636|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
8318773|NCT01435928|20510634|P3|STARTED|Open Label Phase - up to 24 Weeks||0
8318774|NCT01435928|20510635|P2|STARTED|Open Label Phase - up to 24 Weeks||0
8318775|NCT01435928|20510636|P1|STARTED|Open Label Phase - up to 24 Weeks||676
8318776|NCT01435824|20510663|P2|NOT COMPLETED|Second Intervention||0
8318777|NCT01435824|20510664|P1|NOT COMPLETED|Second Intervention||0
8318778|NCT01435824|20510663|P2|COMPLETED|Second Intervention||8
8318779|NCT01435824|20510664|P1|COMPLETED|Second Intervention||8
8318780|NCT01435824|20510663|P2|STARTED|Second Intervention||8
8318781|NCT01435824|20510664|P1|STARTED|Second Intervention||8
8318782|NCT01435824|20510663|P2|NOT COMPLETED|Washout of 1-2 Weeks||0
8318783|NCT01435824|20510664|P1|NOT COMPLETED|Washout of 1-2 Weeks||0
8318784|NCT01435824|20510663|P2|COMPLETED|Washout of 1-2 Weeks||8
8318785|NCT01435824|20510664|P1|COMPLETED|Washout of 1-2 Weeks||8
8318786|NCT01435824|20510663|P2|STARTED|Washout of 1-2 Weeks||8
8318787|NCT01435824|20510664|P1|STARTED|Washout of 1-2 Weeks||8
8318788|NCT01435824|20510663|P2|NOT COMPLETED|First Intervention||0
8318789|NCT01435824|20510664|P1|NOT COMPLETED|First Intervention||0
8318790|NCT01435824|20510663|P2|COMPLETED|First Intervention||8
8318791|NCT01435824|20510664|P1|COMPLETED|First Intervention||8
8318792|NCT01435824|20510663|P2|STARTED|First Intervention||8
8318793|NCT01435824|20510664|P1|STARTED|First Intervention||8
8318794|NCT01435798|20510682|P1|NOT COMPLETED|Overall Study||1
8318795|NCT01435798|20510682|P1|COMPLETED|Overall Study|Crossover design|25
8318796|NCT01435798|20510682|P1|100% MTD|Overall Study||25
8318797|NCT01435798|20510682|P1|50% MTD|Overall Study||25
8318798|NCT01435798|20510682|P1|25% MTD|Overall Study||26
8318799|NCT01435798|20510682|P1|0% MTD|Overall Study||25
8318800|NCT01435798|20510682|P1|STARTED|Overall Study|Crossover design|26
8318801|NCT01435772|20510699|P3|NOT COMPLETED|Overall Study||15
8318802|NCT01435772|20510700|P2|NOT COMPLETED|Overall Study||3
8318803|NCT01435772|20510701|P1|NOT COMPLETED|Overall Study||3
8318804|NCT01435772|20510699|P3|COMPLETED|Overall Study||0
8318805|NCT01435772|20510700|P2|COMPLETED|Overall Study||0
8318806|NCT01435772|20510701|P1|COMPLETED|Overall Study||0
8318807|NCT01435772|20510699|P3|STARTED|Overall Study||15
8318808|NCT01435772|20510700|P2|STARTED|Overall Study||3
8318809|NCT01435772|20510701|P1|STARTED|Overall Study||3
8318810|NCT01435759|20510751|P6|NOT COMPLETED|Double-blind Phase||9
8318811|NCT01435759|20510752|P5|NOT COMPLETED|Double-blind Phase||9
8318812|NCT01435759|20510753|P4|NOT COMPLETED|Double-blind Phase||9
8318813|NCT01435759|20510754|P3|NOT COMPLETED|Double-blind Phase||7
8318814|NCT01435759|20510755|P2|NOT COMPLETED|Double-blind Phase||7
8318815|NCT01435759|20510756|P1|NOT COMPLETED|Double-blind Phase||66
8318816|NCT01435759|20510751|P6|COMPLETED|Double-blind Phase||71
8318817|NCT01435759|20510752|P5|COMPLETED|Double-blind Phase||69
8318818|NCT01435759|20510753|P4|COMPLETED|Double-blind Phase||69
8318819|NCT01435759|20510754|P3|COMPLETED|Double-blind Phase||71
8318820|NCT01435759|20510755|P2|COMPLETED|Double-blind Phase||71
8318821|NCT01435759|20510756|P1|COMPLETED|Double-blind Phase||397
8318822|NCT01435759|20510751|P6|STARTED|Double-blind Phase||80
8318823|NCT01435759|20510752|P5|STARTED|Double-blind Phase||78
8318824|NCT01435759|20510753|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
8318825|NCT01435759|20510754|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
8318826|NCT01435759|20510755|P2|STARTED|Double-blind Phase||78
8318827|NCT01435759|20510756|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
8318828|NCT01435759|20510751|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
8318829|NCT01435759|20510752|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
8318830|NCT01435759|20510753|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
8318831|NCT01435759|20510754|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
8318832|NCT01435759|20510755|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
8318833|NCT01435759|20510756|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
8318834|NCT01435759|20510751|P6|COMPLETED|Antidepressant Lead-in Phase||0
8318835|NCT01435759|20510752|P5|COMPLETED|Antidepressant Lead-in Phase||0
8318836|NCT01435759|20510753|P4|COMPLETED|Antidepressant Lead-in Phase||0
8318837|NCT01435759|20510754|P3|COMPLETED|Antidepressant Lead-in Phase||0
8318838|NCT01435759|20510755|P2|COMPLETED|Antidepressant Lead-in Phase||0
8318839|NCT01435759|20510756|P1|COMPLETED|Antidepressant Lead-in Phase||855
8318840|NCT01435759|20510751|P6|STARTED|Antidepressant Lead-in Phase||0
8318841|NCT01435759|20510752|P5|STARTED|Antidepressant Lead-in Phase||0
8318842|NCT01435759|20510753|P4|STARTED|Antidepressant Lead-in Phase||0
8318843|NCT01435759|20510754|P3|STARTED|Antidepressant Lead-in Phase||0
8318844|NCT01435759|20510755|P2|STARTED|Antidepressant Lead-in Phase||0
8318845|NCT01435759|20510756|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
8318846|NCT01435655|20510783|P1|NOT COMPLETED|Overall Study||3
8318847|NCT01435655|20510783|P1|COMPLETED|Overall Study||7
8318848|NCT01435655|20510783|P1|STARTED|Overall Study||10
8318849|NCT01435616|20510797|P2|NOT COMPLETED|Overall Study||80
8318850|NCT01435616|20510798|P1|NOT COMPLETED|Overall Study||171
8318851|NCT01435616|20510797|P2|COMPLETED|Overall Study||455
8318852|NCT01435616|20510798|P1|COMPLETED|Overall Study||832
8318853|NCT01435616|20510797|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
8318854|NCT01435616|20510798|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
8318855|NCT01435616|20510797|P2|STARTED|Overall Study||535
8318856|NCT01435616|20510798|P1|STARTED|Overall Study||1003
8318857|NCT01435603|20510844|P2|NOT COMPLETED|Overall Study||35
8318858|NCT01435603|20510845|P1|NOT COMPLETED|Overall Study||39
8318859|NCT01435603|20510844|P2|COMPLETED|Overall Study||129
8318860|NCT01435603|20510845|P1|COMPLETED|Overall Study||128
8318861|NCT01435603|20510844|P2|STARTED|Overall Study||164
8318862|NCT01435603|20510845|P1|STARTED|Overall Study||167
8318863|NCT01435577|20510853|P2|NOT COMPLETED|Overall Study||52
8318864|NCT01435577|20510854|P1|NOT COMPLETED|Overall Study||17
8318865|NCT01435577|20510853|P2|COMPLETED|Overall Study||13
8318866|NCT01435577|20510854|P1|COMPLETED|Overall Study||47
8318867|NCT01435577|20510853|P2|STARTED|Overall Study||65
8318868|NCT01435577|20510854|P1|STARTED|Overall Study||64
8318869|NCT01435512|20510904|P2|NOT COMPLETED|Overall Study||0
8318870|NCT01435512|20510905|P1|NOT COMPLETED|Overall Study||0
8318871|NCT01435512|20510904|P2|COMPLETED|Overall Study||68
8318872|NCT01435512|20510905|P1|COMPLETED|Overall Study||67
8318873|NCT01435512|20510904|P2|STARTED|Overall Study||68
8318874|NCT01435512|20510905|P1|STARTED|Overall Study||67
8318875|NCT01435460|20510915|P2|NOT COMPLETED|Overall Study||6
8318876|NCT01435460|20510916|P1|NOT COMPLETED|Overall Study||11
8318877|NCT01435460|20510915|P2|COMPLETED|Overall Study||143
8318878|NCT01435460|20510916|P1|COMPLETED|Overall Study||140
8318879|NCT01435460|20510915|P2|STARTED|Overall Study||149
8318880|NCT01435460|20510916|P1|STARTED|Overall Study||151
8318881|NCT01435382|20510932|P4|NOT COMPLETED|Overall Study||1
8318882|NCT01435382|20510933|P3|NOT COMPLETED|Overall Study||1
8318883|NCT01435382|20510934|P2|NOT COMPLETED|Overall Study||2
8318884|NCT01435382|20510935|P1|NOT COMPLETED|Overall Study||1
8318885|NCT01435382|20510932|P4|COMPLETED|Overall Study||10
8318886|NCT01435382|20510933|P3|COMPLETED|Overall Study||12
8318887|NCT01435382|20510934|P2|COMPLETED|Overall Study||11
8318888|NCT01435382|20510935|P1|COMPLETED|Overall Study||11
8318889|NCT01435382|20510932|P4|STARTED|Overall Study||11
8318890|NCT01435382|20510933|P3|STARTED|Overall Study||13
8318891|NCT01435382|20510934|P2|STARTED|Overall Study||13
8318892|NCT01435382|20510935|P1|STARTED|Overall Study||12
8318893|NCT01435356|20511024|P2|NOT COMPLETED|Overall Study||24
8318894|NCT01435356|20511025|P1|NOT COMPLETED|Overall Study||32
8318895|NCT01435356|20511024|P2|COMPLETED|Overall Study||5
8318896|NCT01435356|20511025|P1|COMPLETED|Overall Study||16
8318897|NCT01435356|20511024|P2|STARTED|Overall Study||29
8318898|NCT01435356|20511025|P1|STARTED|Overall Study||48
8318899|NCT01435304|20511039|P2|NOT COMPLETED|Overall Study||0
8318900|NCT01435304|20511040|P1|NOT COMPLETED|Overall Study||0
8318901|NCT01435304|20511039|P2|COMPLETED|Overall Study||50
8318902|NCT01435304|20511040|P1|COMPLETED|Overall Study||50
8318903|NCT01435304|20511039|P2|STARTED|Overall Study||50
8318904|NCT01435304|20511040|P1|STARTED|Overall Study||50
8318905|NCT01435265|20511058|P2|NOT COMPLETED|Overall Study||1
8318906|NCT01435265|20511059|P1|NOT COMPLETED|Overall Study||0
8318907|NCT01435265|20511058|P2|COMPLETED|Overall Study||3
8318908|NCT01435265|20511059|P1|COMPLETED|Overall Study||3
8318909|NCT01435265|20511058|P2|STARTED|Overall Study||4
8318910|NCT01435265|20511059|P1|STARTED|Overall Study||3
8318911|NCT01435174|20511069|P1|NOT COMPLETED|Overall Study||9
8318912|NCT01435174|20511069|P1|COMPLETED|Overall Study||8
8318913|NCT01435174|20511069|P1|STARTED|Overall Study||17
8318914|NCT01435122|20511073|P1|NOT COMPLETED|Overall Study||8
8318915|NCT01435122|20511073|P1|COMPLETED|Overall Study||22
8318916|NCT01435122|20511073|P1|STARTED|Overall Study||30
8318917|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 4 Years||7
8318918|NCT01435031|20511082|P1|COMPLETED|ITT at 4 Years||171
8318919|NCT01435031|20511082|P1|STARTED|ITT at 4 Years||178
8318920|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 3 Years||11
8318921|NCT01435031|20511082|P1|COMPLETED|ITT at 3 Years||178
8318922|NCT01435031|20511082|P1|STARTED|ITT at 3 Years||189
8318923|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 2 Years||13
8318924|NCT01435031|20511082|P1|COMPLETED|ITT at 2 Years||189
8318925|NCT01435031|20511082|P1|STARTED|ITT at 2 Years||202
8318926|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 1 Year||9
8318927|NCT01435031|20511082|P1|COMPLETED|ITT at 1 Year||202
8318928|NCT01435031|20511082|P1|STARTED|ITT at 1 Year||211
8318929|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 6 Months||5
8318930|NCT01435031|20511082|P1|COMPLETED|ITT at 6 Months||211
8318931|NCT01435031|20511082|P1|STARTED|ITT at 6 Months||216
8318932|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 1 Month||6
8318933|NCT01435031|20511082|P1|COMPLETED|ITT at 1 Month||216
8318934|NCT01435031|20511082|P1|STARTED|ITT at 1 Month|ITT population|222
8318935|NCT01435018|20511183|P3|NOT COMPLETED|Overall Study||41
8318936|NCT01435018|20511184|P2|NOT COMPLETED|Overall Study||34
8318937|NCT01435018|20511185|P1|NOT COMPLETED|Overall Study||47
8318938|NCT01435018|20511183|P3|COMPLETED|Overall Study||98
8318939|NCT01435018|20511184|P2|COMPLETED|Overall Study||26
8318940|NCT01435018|20511185|P1|COMPLETED|Overall Study||88
8318941|NCT01435018|20511183|P3|STARTED|Overall Study||139
8318942|NCT01435018|20511184|P2|STARTED|Overall Study||60
8318943|NCT01435018|20511185|P1|STARTED|Overall Study||135
8318944|NCT01434823|20511278|P2|NOT COMPLETED|Overall Study||7
8318945|NCT01434823|20511279|P1|NOT COMPLETED|Overall Study||4
8318946|NCT01434823|20511278|P2|COMPLETED|Overall Study||778
8318947|NCT01434823|20511279|P1|COMPLETED|Overall Study||820
8318948|NCT01434823|20511278|P2|STARTED|Overall Study||785
8318949|NCT01434823|20511279|P1|STARTED|Overall Study||824
8318950|NCT01434810|20511297|P2|NOT COMPLETED|Overall Study||10
8318951|NCT01434810|20511298|P1|NOT COMPLETED|Overall Study||23
8318952|NCT01434810|20511297|P2|COMPLETED|Overall Study||213
8318953|NCT01434810|20511298|P1|COMPLETED|Overall Study||201
8318954|NCT01434810|20511297|P2|STARTED|Overall Study||223
8318955|NCT01434810|20511298|P1|STARTED|Overall Study||224
8318956|NCT01434745|20511310|P2|NOT COMPLETED|Overall Study||0
8318957|NCT01434745|20511311|P1|NOT COMPLETED|Overall Study||0
8318958|NCT01434745|20511310|P2|COMPLETED|Overall Study||0
8318959|NCT01434745|20511311|P1|COMPLETED|Overall Study||0
8318960|NCT01434745|20511310|P2|STARTED|Overall Study||0
8318961|NCT01434745|20511311|P1|STARTED|Overall Study||0
8318962|NCT01434693|20511333|P4|NOT COMPLETED|Overall Study||1
8318963|NCT01434693|20511334|P3|NOT COMPLETED|Overall Study||1
8318964|NCT01434693|20511335|P2|NOT COMPLETED|Overall Study||0
8318965|NCT01434693|20511336|P1|NOT COMPLETED|Overall Study||3
8318966|NCT01434693|20511333|P4|COMPLETED|Overall Study||8
8318967|NCT01434693|20511334|P3|COMPLETED|Overall Study||8
8318968|NCT01434693|20511335|P2|COMPLETED|Overall Study||9
8318969|NCT01434693|20511336|P1|COMPLETED|Overall Study||6
8318970|NCT01434693|20511333|P4|STARTED|Overall Study||9
8318971|NCT01434693|20511334|P3|STARTED|Overall Study||9
8318972|NCT01434693|20511335|P2|STARTED|Overall Study||9
8318973|NCT01434693|20511336|P1|STARTED|Overall Study||9
8318974|NCT01434680|20511350|P4|NOT COMPLETED|Overall Study||0
8318975|NCT01434680|20511351|P3|NOT COMPLETED|Overall Study||2
8318976|NCT01434680|20511352|P2|NOT COMPLETED|Overall Study||2
8318977|NCT01434680|20511353|P1|NOT COMPLETED|Overall Study||3
8318978|NCT01434680|20511350|P4|COMPLETED|Overall Study||119
8318979|NCT01434680|20511351|P3|COMPLETED|Overall Study||304
8318980|NCT01434680|20511352|P2|COMPLETED|Overall Study||266
8318981|NCT01434680|20511353|P1|COMPLETED|Overall Study||296
8318982|NCT01434680|20511350|P4|STARTED|Overall Study||119
8318983|NCT01434680|20511351|P3|STARTED|Overall Study||306
8318984|NCT01434680|20511352|P2|STARTED|Overall Study||268
8318985|NCT01434680|20511353|P1|STARTED|Overall Study||299
8318986|NCT01434667|20511370|P2|NOT COMPLETED|Overall Study||10
8318987|NCT01434667|20511371|P1|NOT COMPLETED|Overall Study||5
8318988|NCT01434667|20511370|P2|COMPLETED|Overall Study||65
8318989|NCT01434667|20511371|P1|COMPLETED|Overall Study||34
8318990|NCT01434667|20511370|P2|STARTED|Overall Study||75
8318991|NCT01434667|20511371|P1|STARTED|Overall Study||39
8318992|NCT01434654|20511397|P2|NOT COMPLETED|Overall Study||0
8318993|NCT01434654|20511398|P1|NOT COMPLETED|Overall Study||2
8318994|NCT01434654|20511397|P2|COMPLETED|Overall Study||12
8318995|NCT01434654|20511398|P1|COMPLETED|Overall Study||5
8318996|NCT01434654|20511397|P2|STARTED|Overall Study||12
8318997|NCT01434654|20511398|P1|STARTED|Overall Study||7
8318998|NCT01434641|20511410|P1|NOT COMPLETED|Overall Study||0
8318999|NCT01434641|20511410|P1|COMPLETED|Overall Study||102
8319000|NCT01434641|20511410|P1|STARTED|Overall Study||102
8319001|NCT01434511|20511415|P1|NOT COMPLETED|Overall Study||0
8319002|NCT01434511|20511415|P1|COMPLETED|Overall Study||1
8319003|NCT01434511|20511415|P1|STARTED|Overall Study||1
8319004|NCT01434342|20511434|P2|NOT COMPLETED|Overall Study||17
8319005|NCT01434342|20511435|P1|NOT COMPLETED|Overall Study||48
8319006|NCT01434342|20511434|P2|COMPLETED|Overall Study||31
8319007|NCT01434342|20511435|P1|COMPLETED|Overall Study||50
8319008|NCT01434342|20511434|P2|STARTED|Overall Study||48
8319009|NCT01434342|20511435|P1|STARTED|Overall Study||98
8319010|NCT01434290|20511445|P2|NOT COMPLETED|Overall Study||7
8319011|NCT01434290|20511446|P1|NOT COMPLETED|Overall Study||8
8319012|NCT01434290|20511445|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
8319013|NCT01434290|20511446|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
8319014|NCT01434290|20511445|P2|STARTED|Overall Study||128
8319015|NCT01434290|20511446|P1|STARTED|Overall Study||127
8319016|NCT01434186|20511474|P2|NOT COMPLETED|Overall Study||0
8319017|NCT01434186|20511475|P1|NOT COMPLETED|Overall Study||0
8319018|NCT01434186|20511474|P2|COMPLETED|Overall Study||4
8319019|NCT01434186|20511475|P1|COMPLETED|Overall Study||2
8319020|NCT01434186|20511474|P2|STARTED|Overall Study||4
8319021|NCT01434186|20511475|P1|STARTED|Overall Study||2
8319022|NCT01434121|20511484|P3|NOT COMPLETED|Overall Study||0
8319023|NCT01434121|20511485|P2|NOT COMPLETED|Overall Study||0
8319024|NCT01434121|20511486|P1|NOT COMPLETED|Overall Study||0
8319025|NCT01434121|20511484|P3|COMPLETED|Overall Study||8
8319026|NCT01434121|20511485|P2|COMPLETED|Overall Study||8
8319027|NCT01434121|20511486|P1|COMPLETED|Overall Study||8
8319028|NCT01434121|20511484|P3|STARTED|Overall Study||8
8319029|NCT01434121|20511485|P2|STARTED|Overall Study||8
8319030|NCT01434121|20511486|P1|STARTED|Overall Study||8
8319031|NCT01434030|20511512|P1|NOT COMPLETED|Overall Study||1
8319032|NCT01434030|20511512|P1|COMPLETED|Overall Study||56
8319033|NCT01434030|20511512|P1|STARTED|Overall Study||57
8319034|NCT01433978|20511519|P3|NOT COMPLETED|Extension Phase||6
8319035|NCT01433978|20511520|P2|NOT COMPLETED|Extension Phase||0
8319036|NCT01433978|20511521|P1|NOT COMPLETED|Extension Phase||0
8319037|NCT01433978|20511519|P3|COMPLETED|Extension Phase||0
8319038|NCT01433978|20511520|P2|COMPLETED|Extension Phase||0
8319039|NCT01433978|20511521|P1|COMPLETED|Extension Phase||0
8319040|NCT01433978|20511519|P3|STARTED|Extension Phase||6
8319041|NCT01433978|20511520|P2|STARTED|Extension Phase||0
8319042|NCT01433978|20511521|P1|STARTED|Extension Phase||0
8319043|NCT01433978|20511519|P3|NOT COMPLETED|Core Study||0
8319044|NCT01433978|20511520|P2|NOT COMPLETED|Core Study||11
8319045|NCT01433978|20511521|P1|NOT COMPLETED|Core Study||11
8319046|NCT01433978|20511519|P3|COMPLETED|Core Study||0
8319047|NCT01433978|20511520|P2|COMPLETED|Core Study||1
8319048|NCT01433978|20511521|P1|COMPLETED|Core Study||0
8319049|NCT01433978|20511519|P3|STARTED|Core Study||0
8319050|NCT01433978|20511520|P2|STARTED|Core Study||12
8319051|NCT01433978|20511521|P1|STARTED|Core Study||11
8319052|NCT01433913|20511530|P2|NOT COMPLETED|Overall Study||0
8319053|NCT01433913|20511531|P1|NOT COMPLETED|Overall Study||1
8319054|NCT01433913|20511530|P2|COMPLETED|Overall Study||10
8319055|NCT01433913|20511531|P1|COMPLETED|Overall Study||9
8319056|NCT01433913|20511530|P2|STARTED|Overall Study||10
8319057|NCT01433913|20511531|P1|STARTED|Overall Study||10
8319058|NCT01433731|20511567|P4|NOT COMPLETED|Overall Study||0
8319059|NCT01433731|20511568|P3|NOT COMPLETED|Overall Study||0
8319060|NCT01433731|20511569|P2|NOT COMPLETED|Overall Study||0
8319061|NCT01433731|20511570|P1|NOT COMPLETED|Overall Study||0
8319062|NCT01433731|20511567|P4|COMPLETED|Overall Study||5
8319063|NCT01433731|20511568|P3|COMPLETED|Overall Study||5
8319064|NCT01433731|20511569|P2|COMPLETED|Overall Study||5
8319065|NCT01433731|20511570|P1|COMPLETED|Overall Study||3
8319066|NCT01433731|20511567|P4|STARTED|Overall Study||5
8319067|NCT01433731|20511568|P3|STARTED|Overall Study||5
8319068|NCT01433731|20511569|P2|STARTED|Overall Study||5
8319069|NCT01433731|20511570|P1|STARTED|Overall Study||3
8319070|NCT01433549|20511578|P2|NOT COMPLETED|Phase 2: Second Study Product||1
8319071|NCT01433549|20511579|P1|NOT COMPLETED|Phase 2: Second Study Product||0
8319072|NCT01433549|20511578|P2|COMPLETED|Phase 2: Second Study Product||12
8319073|NCT01433549|20511579|P1|COMPLETED|Phase 2: Second Study Product||12
8319074|NCT01433549|20511578|P2|STARTED|Phase 2: Second Study Product||13
8319075|NCT01433549|20511579|P1|STARTED|Phase 2: Second Study Product||12
8319076|NCT01433549|20511578|P2|NOT COMPLETED|Phase 1: First Study Product||0
8319077|NCT01433549|20511579|P1|NOT COMPLETED|Phase 1: First Study Product||0
8319078|NCT01433549|20511578|P2|COMPLETED|Phase 1: First Study Product||13
8319079|NCT01433549|20511579|P1|COMPLETED|Phase 1: First Study Product||12
8319080|NCT01433549|20511578|P2|STARTED|Phase 1: First Study Product||13
8319081|NCT01433549|20511579|P1|STARTED|Phase 1: First Study Product||12
8319082|NCT01433471|20511589|P2|NOT COMPLETED|Overall Study||1
8319083|NCT01433471|20511590|P1|NOT COMPLETED|Overall Study||0
8319084|NCT01433471|20511589|P2|COMPLETED|Overall Study||1
8319085|NCT01433471|20511590|P1|COMPLETED|Overall Study||2
8319086|NCT01433471|20511589|P2|STARTED|Overall Study||2
8319087|NCT01433471|20511590|P1|STARTED|Overall Study||2
8319088|NCT01433354|20511606|P1|NOT COMPLETED|Overall Study||119
8319089|NCT01433354|20511606|P1|COMPLETED|Overall Study||0
8319090|NCT01433354|20511606|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
8319091|NCT01433263|20511622|P2|NOT COMPLETED|Overall Study||12
8319092|NCT01433263|20511623|P1|NOT COMPLETED|Overall Study||19
8319093|NCT01433263|20511622|P2|COMPLETED|Overall Study||16
8319094|NCT01433263|20511623|P1|COMPLETED|Overall Study||10
8319095|NCT01433263|20511622|P2|STARTED|Overall Study||28
8319096|NCT01433263|20511623|P1|STARTED|Overall Study||29
8319097|NCT01433250|20511652|P2|NOT COMPLETED|Overall Study||3
8319098|NCT01433250|20511653|P1|NOT COMPLETED|Overall Study||3
8319099|NCT01433250|20511652|P2|COMPLETED|Overall Study||14
8319100|NCT01433250|20511653|P1|COMPLETED|Overall Study||19
8319101|NCT01433250|20511652|P2|STARTED|Overall Study||17
8319102|NCT01433250|20511653|P1|STARTED|Overall Study||22
8319103|NCT01433172|20511672|P3|NOT COMPLETED|Overall Study||1
8319104|NCT01433172|20511673|P2|NOT COMPLETED|Overall Study||3
8319105|NCT01433172|20511674|P1|NOT COMPLETED|Overall Study||0
8319106|NCT01433172|20511672|P3|COMPLETED|Overall Study||32
8319107|NCT01433172|20511673|P2|COMPLETED|Overall Study||34
8319108|NCT01433172|20511674|P1|COMPLETED|Overall Study||3
8319109|NCT01433172|20511672|P3|STARTED|Overall Study||33
8319110|NCT01433172|20511673|P2|STARTED|Overall Study||37
8319111|NCT01433172|20511674|P1|STARTED|Overall Study||3
8319112|NCT01433159|20511686|P2|NOT COMPLETED|Overall Study||1
8319113|NCT01433159|20511687|P1|NOT COMPLETED|Overall Study||2
8319114|NCT01433159|20511686|P2|COMPLETED|Overall Study||9
8319115|NCT01433159|20511687|P1|COMPLETED|Overall Study||7
8319116|NCT01433159|20511686|P2|STARTED|Overall Study||10
8319117|NCT01433159|20511687|P1|STARTED|Overall Study||9
8319118|NCT01433107|20511695|P2|NOT COMPLETED|Overall Study||17
8319119|NCT01433107|20511696|P1|NOT COMPLETED|Overall Study||27
8319120|NCT01433107|20511695|P2|COMPLETED|Overall Study||128
8319121|NCT01433107|20511696|P1|COMPLETED|Overall Study||118
8319122|NCT01433107|20511695|P2|STARTED|Overall Study||145
8319123|NCT01433107|20511696|P1|STARTED|Overall Study||145
8319124|NCT01433081|20511708|P2|NOT COMPLETED|Overall Study||2
8319125|NCT01433081|20511709|P1|NOT COMPLETED|Overall Study||2
8319126|NCT01433081|20511708|P2|COMPLETED|Overall Study||23
8319127|NCT01433081|20511709|P1|COMPLETED|Overall Study||23
8319128|NCT01433081|20511708|P2|STARTED|Overall Study||25
8319129|NCT01433081|20511709|P1|STARTED|Overall Study||25
8319130|NCT01433055|20511719|P2|NOT COMPLETED|Overall Study||0
8319131|NCT01433055|20511720|P1|NOT COMPLETED|Overall Study||2
8319132|NCT01433055|20511719|P2|COMPLETED|Overall Study||23
8319133|NCT01433055|20511720|P1|COMPLETED|Overall Study||27
8319134|NCT01433055|20511719|P2|STARTED|Overall Study||23
8319135|NCT01433055|20511720|P1|STARTED|Overall Study||29
8319136|NCT01433042|20511734|P1|NOT COMPLETED|Overall Study||1
8319137|NCT01433042|20511734|P1|COMPLETED|Overall Study||224
8319138|NCT01433042|20511734|P1|STARTED|Overall Study||225
8319139|NCT01433016|20511738|P1|NOT COMPLETED|Overall Study||0
8319140|NCT01433016|20511738|P1|COMPLETED|Overall Study||20
8319141|NCT01433016|20511738|P1|STARTED|Overall Study||20
8319142|NCT01432951|20511742|P1|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
8319143|NCT01432951|20511742|P1|COMPLETED|Safety Extension Day 30 to End of Study||15
8319144|NCT01432951|20511742|P1|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
8319145|NCT01432951|20511742|P1|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
8319146|NCT01432951|20511742|P1|COMPLETED|Treatment Phase (Day 1 to 30)||25
8319147|NCT01432951|20511742|P1|Progressive Disease|Treatment Phase (Day 1 to 30)||10
8319148|NCT01432951|20511742|P1|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
8319149|NCT01432951|20511742|P1|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
8319150|NCT01432951|20511742|P1|STARTED|Treatment Phase (Day 1 to 30)||26
8319151|NCT01432938|20511751|P2|NOT COMPLETED|Second Intervention||0
8319152|NCT01432938|20511752|P1|NOT COMPLETED|Second Intervention||1
8319153|NCT01432938|20511751|P2|COMPLETED|Second Intervention||14
8319154|NCT01432938|20511752|P1|COMPLETED|Second Intervention||11
8319155|NCT01432938|20511751|P2|STARTED|Second Intervention||14
8319156|NCT01432938|20511752|P1|STARTED|Second Intervention||12
8319157|NCT01432938|20511751|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
8319158|NCT01432938|20511752|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
8319159|NCT01432938|20511751|P2|COMPLETED|Washout Period of at Least 24 Days||14
8319160|NCT01432938|20511752|P1|COMPLETED|Washout Period of at Least 24 Days||12
8319161|NCT01432938|20511751|P2|STARTED|Washout Period of at Least 24 Days||14
8319162|NCT01432938|20511752|P1|STARTED|Washout Period of at Least 24 Days||12
8319163|NCT01432938|20511751|P2|NOT COMPLETED|First Intervention||0
8319164|NCT01432938|20511752|P1|NOT COMPLETED|First Intervention||2
8319165|NCT01432938|20511751|P2|COMPLETED|First Intervention||14
8319166|NCT01432938|20511752|P1|COMPLETED|First Intervention||12
8319167|NCT01432938|20511751|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
8319168|NCT01432938|20511752|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
8319169|NCT01432938|20511751|P2|STARTED|First Intervention||14
8319170|NCT01432938|20511752|P1|STARTED|First Intervention||14
8319171|NCT01432886|20511769|P2|NOT COMPLETED|Overall Study||0
8319172|NCT01432886|20511770|P1|NOT COMPLETED|Overall Study||0
8319173|NCT01432886|20511769|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
8319174|NCT01432886|20511770|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
8319175|NCT01432886|20511769|P2|STARTED|Overall Study||6
8319176|NCT01432886|20511770|P1|STARTED|Overall Study||6
8319177|NCT01432756|20511782|P4|NOT COMPLETED|Overall Study||1
8319178|NCT01432756|20511783|P3|NOT COMPLETED|Overall Study||2
8319179|NCT01432756|20511784|P2|NOT COMPLETED|Overall Study||0
8319180|NCT01432756|20511785|P1|NOT COMPLETED|Overall Study||1
8319181|NCT01432756|20511782|P4|COMPLETED|Overall Study||33
8319182|NCT01432756|20511783|P3|COMPLETED|Overall Study||30
8319183|NCT01432756|20511784|P2|COMPLETED|Overall Study||34
8319184|NCT01432756|20511785|P1|COMPLETED|Overall Study||31
8319185|NCT01432756|20511782|P4|STARTED|Overall Study||34
8319186|NCT01432756|20511783|P3|STARTED|Overall Study||32
8319187|NCT01432756|20511784|P2|STARTED|Overall Study||34
8319188|NCT01432756|20511785|P1|STARTED|Overall Study||32
8319189|NCT01432730|20511793|P2|NOT COMPLETED|Period 2||4
8319190|NCT01432730|20511794|P1|NOT COMPLETED|Period 2||0
8319191|NCT01432730|20511793|P2|COMPLETED|Period 2||8
8319192|NCT01432730|20511794|P1|COMPLETED|Period 2||10
8319193|NCT01432730|20511793|P2|STARTED|Period 2||12
8319194|NCT01432730|20511794|P1|STARTED|Period 2||10
8319195|NCT01432730|20511793|P2|NOT COMPLETED|Period 1||0
8319196|NCT01432730|20511794|P1|NOT COMPLETED|Period 1||2
8319197|NCT01432730|20511793|P2|COMPLETED|Period 1||12
8319198|NCT01432730|20511794|P1|COMPLETED|Period 1||10
8319199|NCT01432730|20511793|P2|STARTED|Period 1||12
8319200|NCT01432730|20511794|P1|STARTED|Period 1||12
8319201|NCT01432626|20511830|P1|NOT COMPLETED|Overall Study||7
8319202|NCT01432626|20511830|P1|COMPLETED|Overall Study|Completed both images|3
8319203|NCT01432626|20511830|P1|STARTED|Overall Study||10
8319204|NCT01432600|20511837|P3|NOT COMPLETED|Overall Study||1
8319205|NCT01432600|20511838|P2|NOT COMPLETED|Overall Study||1
8319206|NCT01432600|20511839|P1|NOT COMPLETED|Overall Study||0
8319207|NCT01432600|20511837|P3|COMPLETED|Overall Study||33
8319208|NCT01432600|20511838|P2|COMPLETED|Overall Study||35
8319209|NCT01432600|20511839|P1|COMPLETED|Overall Study||10
8319210|NCT01432600|20511837|P3|STARTED|Overall Study||34
8319211|NCT01432600|20511838|P2|STARTED|Overall Study||36
8319212|NCT01432600|20511839|P1|STARTED|Overall Study||10
8319213|NCT01432574|20511855|P1|NOT COMPLETED|Overall Study||3
8319214|NCT01432574|20511855|P1|COMPLETED|Overall Study||147
8319215|NCT01432574|20511855|P1|STARTED|Overall Study||150
8319216|NCT01432561|20511861|P1|NOT COMPLETED|Overall Study||0
8319217|NCT01432561|20511861|P1|COMPLETED|Overall Study||8
8319218|NCT01432561|20511861|P1|STARTED|Overall Study||8
8319219|NCT01432535|20511870|P3|NOT COMPLETED|Overall Study||0
8319220|NCT01432535|20511871|P2|NOT COMPLETED|Overall Study||0
8319221|NCT01432535|20511872|P1|NOT COMPLETED|Overall Study||0
8319222|NCT01432535|20511870|P3|COMPLETED|Overall Study||6
8319223|NCT01432535|20511871|P2|COMPLETED|Overall Study||7
8319224|NCT01432535|20511872|P1|COMPLETED|Overall Study||12
8319225|NCT01432535|20511870|P3|STARTED|Overall Study||6
8319226|NCT01432535|20511871|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
8319227|NCT01432535|20511872|P1|STARTED|Overall Study||12
8319228|NCT01432457|20511901|P3|NOT COMPLETED|Overall Study||59
8319229|NCT01432457|20511902|P2|NOT COMPLETED|Overall Study||48
8319230|NCT01432457|20511903|P1|NOT COMPLETED|Overall Study||37
8319231|NCT01432457|20511901|P3|COMPLETED|Overall Study||253
8319232|NCT01432457|20511902|P2|COMPLETED|Overall Study||258
8319233|NCT01432457|20511903|P1|COMPLETED|Overall Study||269
8319234|NCT01432457|20511901|P3|STARTED|Overall Study||312
8319235|NCT01432457|20511902|P2|STARTED|Overall Study||306
8319236|NCT01432457|20511903|P1|STARTED|Overall Study||306
8319237|NCT01432444|20511932|P3|NOT COMPLETED|Extension Phase||192
8319238|NCT01432444|20511933|P2|NOT COMPLETED|Extension Phase||0
8319239|NCT01432444|20511934|P1|NOT COMPLETED|Extension Phase||0
8319240|NCT01432444|20511932|P3|COMPLETED|Extension Phase||0
8319241|NCT01432444|20511933|P2|COMPLETED|Extension Phase||0
8319242|NCT01432444|20511934|P1|COMPLETED|Extension Phase||0
8319243|NCT01432444|20511932|P3|STARTED|Extension Phase||192
8319244|NCT01432444|20511933|P2|STARTED|Extension Phase||0
8319245|NCT01432444|20511934|P1|STARTED|Extension Phase||0
8319246|NCT01432444|20511932|P3|NOT COMPLETED|Treatment Phase||0
8319247|NCT01432444|20511933|P2|NOT COMPLETED|Treatment Phase||140
8319248|NCT01432444|20511934|P1|NOT COMPLETED|Treatment Phase||0
8319249|NCT01432444|20511932|P3|COMPLETED|Treatment Phase||0
8319250|NCT01432444|20511933|P2|COMPLETED|Treatment Phase||293
8319251|NCT01432444|20511934|P1|COMPLETED|Treatment Phase||0
8319252|NCT01432444|20511932|P3|STARTED|Treatment Phase||0
8319253|NCT01432444|20511933|P2|STARTED|Treatment Phase||433
8319254|NCT01432444|20511934|P1|STARTED|Treatment Phase||0
8319255|NCT01432444|20511932|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
8319256|NCT01432444|20511933|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
8319257|NCT01432444|20511934|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
8319258|NCT01432444|20511932|P3|COMPLETED|Tolerability/Cross-titration Phase||0
8319259|NCT01432444|20511933|P2|COMPLETED|Tolerability/Cross-titration Phase||0
8319260|NCT01432444|20511934|P1|COMPLETED|Tolerability/Cross-titration Phase||265
8319261|NCT01432444|20511932|P3|STARTED|Tolerability/Cross-titration Phase||0
8319262|NCT01432444|20511933|P2|STARTED|Tolerability/Cross-titration Phase||0
8319263|NCT01432444|20511934|P1|STARTED|Tolerability/Cross-titration Phase||325
8319264|NCT01432405|20511946|P2|NOT COMPLETED|Overall Study||2
8319265|NCT01432405|20511947|P1|NOT COMPLETED|Overall Study||1
8319266|NCT01432405|20511946|P2|COMPLETED|Overall Study||10
8319267|NCT01432405|20511947|P1|COMPLETED|Overall Study||11
8319268|NCT01432405|20511946|P2|STARTED|Overall Study||12
8319269|NCT01432405|20511947|P1|STARTED|Overall Study||12
8319270|NCT01432379|20511955|P1|NOT COMPLETED|Overall Study||385
8319271|NCT01432379|20511955|P1|COMPLETED|Overall Study||783
8319272|NCT01432379|20511955|P1|STARTED|Overall Study||1168
8319273|NCT01432366|20511960|P1|NOT COMPLETED|Overall Study||68
8319274|NCT01432366|20511960|P1|COMPLETED|Overall Study||392
8319275|NCT01432366|20511960|P1|STARTED|Overall Study||460
8319276|NCT01432327|20511982|P4|NOT COMPLETED|Posttest 1 Year||23
8319277|NCT01432327|20511983|P3|NOT COMPLETED|Posttest 1 Year||20
8319278|NCT01432327|20511984|P2|NOT COMPLETED|Posttest 1 Year||28
8319279|NCT01432327|20511985|P1|NOT COMPLETED|Posttest 1 Year||24
8319280|NCT01432327|20511982|P4|COMPLETED|Posttest 1 Year||31
8319281|NCT01432327|20511983|P3|COMPLETED|Posttest 1 Year||30
8319282|NCT01432327|20511984|P2|COMPLETED|Posttest 1 Year||27
8319283|NCT01432327|20511985|P1|COMPLETED|Posttest 1 Year||28
8319284|NCT01432327|20511982|P4|STARTED|Posttest 1 Year||54
8319285|NCT01432327|20511983|P3|STARTED|Posttest 1 Year||50
8319286|NCT01432327|20511984|P2|STARTED|Posttest 1 Year||55
8319287|NCT01432327|20511985|P1|STARTED|Posttest 1 Year||52
8319288|NCT01432327|20511982|P4|NOT COMPLETED|Posttest 6 Months||2
8319289|NCT01432327|20511983|P3|NOT COMPLETED|Posttest 6 Months||5
8319290|NCT01432327|20511984|P2|NOT COMPLETED|Posttest 6 Months||0
8319291|NCT01432327|20511985|P1|NOT COMPLETED|Posttest 6 Months||0
8319292|NCT01432327|20511982|P4|COMPLETED|Posttest 6 Months||54
8319293|NCT01432327|20511983|P3|COMPLETED|Posttest 6 Months||50
8319294|NCT01432327|20511984|P2|COMPLETED|Posttest 6 Months||55
8319295|NCT01432327|20511985|P1|COMPLETED|Posttest 6 Months||52
8319296|NCT01432327|20511982|P4|STARTED|Posttest 6 Months||56
8319297|NCT01432327|20511983|P3|STARTED|Posttest 6 Months||55
8319298|NCT01432327|20511984|P2|STARTED|Posttest 6 Months||55
8319299|NCT01432327|20511985|P1|STARTED|Posttest 6 Months||52
8319300|NCT01432327|20511982|P4|NOT COMPLETED|Posttest 3 Months||1
8319301|NCT01432327|20511983|P3|NOT COMPLETED|Posttest 3 Months||2
8319302|NCT01432327|20511984|P2|NOT COMPLETED|Posttest 3 Months||2
8319303|NCT01432327|20511985|P1|NOT COMPLETED|Posttest 3 Months||4
8319304|NCT01432327|20511982|P4|COMPLETED|Posttest 3 Months||56
8319305|NCT01432327|20511983|P3|COMPLETED|Posttest 3 Months||55
8319306|NCT01432327|20511984|P2|COMPLETED|Posttest 3 Months||55
8319307|NCT01432327|20511985|P1|COMPLETED|Posttest 3 Months||52
8319308|NCT01432327|20511982|P4|STARTED|Posttest 3 Months||57
8319309|NCT01432327|20511983|P3|STARTED|Posttest 3 Months||57
8319310|NCT01432327|20511984|P2|STARTED|Posttest 3 Months||57
8319311|NCT01432327|20511985|P1|STARTED|Posttest 3 Months||56
8319312|NCT01432327|20511982|P4|NOT COMPLETED|Baseline||0
8319313|NCT01432327|20511983|P3|NOT COMPLETED|Baseline||0
8319314|NCT01432327|20511984|P2|NOT COMPLETED|Baseline||0
8319315|NCT01432327|20511985|P1|NOT COMPLETED|Baseline||0
8319316|NCT01432327|20511982|P4|COMPLETED|Baseline||57
8319317|NCT01432327|20511983|P3|COMPLETED|Baseline||57
8319318|NCT01432327|20511984|P2|COMPLETED|Baseline||57
8319319|NCT01432327|20511985|P1|COMPLETED|Baseline||56
8319320|NCT01432327|20511982|P4|STARTED|Baseline||57
8319321|NCT01432327|20511983|P3|STARTED|Baseline||57
8319322|NCT01432327|20511984|P2|STARTED|Baseline||57
8319323|NCT01432327|20511985|P1|STARTED|Baseline||56
8319324|NCT01432275|20511995|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
8319325|NCT01432275|20511996|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
8319326|NCT01432275|20511995|P2|COMPLETED|ADC With Calculator (10 Days)||79
8319327|NCT01432275|20511996|P1|COMPLETED|ADC With Calculator (10 Days)||85
8319328|NCT01432275|20511995|P2|STARTED|ADC With Calculator (10 Days)||81
8319329|NCT01432275|20511996|P1|STARTED|ADC With Calculator (10 Days)||88
8319330|NCT01432275|20511995|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
8319331|NCT01432275|20511996|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
8319332|NCT01432275|20511995|P2|COMPLETED|Second BG Meter System (7 Days)||81
8319333|NCT01432275|20511996|P1|COMPLETED|Second BG Meter System (7 Days)||88
8319334|NCT01432275|20511995|P2|STARTED|Second BG Meter System (7 Days)||84
8319335|NCT01432275|20511996|P1|STARTED|Second BG Meter System (7 Days)||90
8319336|NCT01432275|20511995|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
8319337|NCT01432275|20511996|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
8319338|NCT01432275|20511995|P2|COMPLETED|First BG Meter System (7 Days)||84
8319339|NCT01432275|20511996|P1|COMPLETED|First BG Meter System (7 Days)||90
8319340|NCT01432275|20511995|P2|STARTED|First BG Meter System (7 Days)||87
8319341|NCT01432275|20511996|P1|STARTED|First BG Meter System (7 Days)||90
8319342|NCT01432262|20512005|P2|NOT COMPLETED|Overall Study||1
8319343|NCT01432262|20512006|P1|NOT COMPLETED|Overall Study||2
8319344|NCT01432262|20512005|P2|COMPLETED|Overall Study||161
8319345|NCT01432262|20512006|P1|COMPLETED|Overall Study||160
8319346|NCT01432262|20512005|P2|Vaccinated|Overall Study||161
8319347|NCT01432262|20512006|P1|Vaccinated|Overall Study||162
8319348|NCT01432262|20512005|P2|STARTED|Overall Study||162
8319349|NCT01432262|20512006|P1|STARTED|Overall Study||162
8319350|NCT01432236|20512024|P2|NOT COMPLETED|Overall Study||18
8319351|NCT01432236|20512025|P1|NOT COMPLETED|Overall Study||26
8319352|NCT01432236|20512024|P2|COMPLETED|Overall Study||79
8319353|NCT01432236|20512025|P1|COMPLETED|Overall Study||70
8319354|NCT01432236|20512024|P2|STARTED|Overall Study||97
8319355|NCT01432236|20512025|P1|STARTED|Overall Study||96
8319356|NCT01432171|20512072|P2|NOT COMPLETED|Overall Study||11
8319357|NCT01432171|20512073|P1|NOT COMPLETED|Overall Study||14
8319358|NCT01432171|20512072|P2|COMPLETED|Overall Study||8
8319359|NCT01432171|20512073|P1|COMPLETED|Overall Study||4
8319360|NCT01432171|20512072|P2|STARTED|Overall Study||19
8319361|NCT01432171|20512073|P1|STARTED|Overall Study||18
8319362|NCT01432145|20512079|P1|NOT COMPLETED|Overall Study||7
8319363|NCT01432145|20512079|P1|COMPLETED|Overall Study||67
8319364|NCT01432145|20512079|P1|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
8319365|NCT01432015|20512086|P2|NOT COMPLETED|Overall Study||0
8319366|NCT01432015|20512087|P1|NOT COMPLETED|Overall Study||0
8319367|NCT01432015|20512086|P2|COMPLETED|Overall Study||10
8319368|NCT01432015|20512087|P1|COMPLETED|Overall Study||10
8319369|NCT01432015|20512086|P2|STARTED|Overall Study||10
8319370|NCT01432015|20512087|P1|STARTED|Overall Study||10
8319371|NCT01431989|20512095|P2|NOT COMPLETED|Period 2||0
8319372|NCT01431989|20512096|P1|NOT COMPLETED|Period 2||0
8319373|NCT01431989|20512095|P2|COMPLETED|Period 2||14
8319374|NCT01431989|20512096|P1|COMPLETED|Period 2||14
8319375|NCT01431989|20512095|P2|STARTED|Period 2||14
8319376|NCT01431989|20512096|P1|STARTED|Period 2||14
8319377|NCT01431989|20512095|P2|NOT COMPLETED|14-Day Washout Period||0
8319378|NCT01431989|20512096|P1|NOT COMPLETED|14-Day Washout Period||0
8319379|NCT01431989|20512095|P2|COMPLETED|14-Day Washout Period||14
8319380|NCT01431989|20512096|P1|COMPLETED|14-Day Washout Period||14
8319381|NCT01431989|20512095|P2|STARTED|14-Day Washout Period||14
8319382|NCT01431989|20512096|P1|STARTED|14-Day Washout Period||14
8319383|NCT01431989|20512095|P2|NOT COMPLETED|Period 1||0
8319384|NCT01431989|20512096|P1|NOT COMPLETED|Period 1||0
8319385|NCT01431989|20512095|P2|COMPLETED|Period 1||14
8319386|NCT01431989|20512096|P1|COMPLETED|Period 1||14
8319387|NCT01431989|20512095|P2|STARTED|Period 1||14
8319388|NCT01431989|20512096|P1|STARTED|Period 1||14
8319389|NCT01431976|20512114|P1|NOT COMPLETED|Overall Study||14
8319390|NCT01431976|20512114|P1|COMPLETED|Overall Study||6
8319391|NCT01431976|20512114|P1|STARTED|Overall Study||20
8319392|NCT01431963|20512125|P1|NOT COMPLETED|Overall Study||35
8319393|NCT01431963|20512125|P1|COMPLETED|Overall Study||32
8319394|NCT01431963|20512125|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
8319395|NCT01431963|20512125|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
8319396|NCT01431963|20512125|P1|Complete MP (24 Weeks)|Overall Study||42
8319397|NCT01431963|20512125|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
8319398|NCT01431963|20512125|P1|Complete EP (6 Weeks)|Overall Study||52
8319399|NCT01431963|20512125|P1|Received Treatment|Overall Study||65
8319400|NCT01431963|20512125|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
8319401|NCT01431963|20512125|P1|STARTED|Overall Study||67
8319402|NCT01431950|20512133|P2|NOT COMPLETED|Overall Study||15
8319403|NCT01431950|20512134|P1|NOT COMPLETED|Overall Study||19
8319404|NCT01431950|20512133|P2|COMPLETED|Overall Study||104
8319405|NCT01431950|20512134|P1|COMPLETED|Overall Study||100
8319406|NCT01431950|20512133|P2|STARTED|Overall Study||119
8319407|NCT01431950|20512134|P1|STARTED|Overall Study||119
8319408|NCT01431846|20512151|P3|NOT COMPLETED|Overall Study||0
8319409|NCT01431846|20512152|P2|NOT COMPLETED|Overall Study||0
8319410|NCT01431846|20512153|P1|NOT COMPLETED|Overall Study||0
8319411|NCT01431846|20512151|P3|COMPLETED|Overall Study||8
8319412|NCT01431846|20512152|P2|COMPLETED|Overall Study||3
8319413|NCT01431846|20512153|P1|COMPLETED|Overall Study||8
8319414|NCT01431846|20512151|P3|STARTED|Overall Study||8
8319415|NCT01431846|20512152|P2|STARTED|Overall Study||3
8319416|NCT01431846|20512153|P1|STARTED|Overall Study||8
8319417|NCT01431794|20512166|P5|NOT COMPLETED|Overall Study||0
8319418|NCT01431794|20512167|P4|NOT COMPLETED|Overall Study||0
8319419|NCT01431794|20512168|P3|NOT COMPLETED|Overall Study||0
8319420|NCT01431794|20512169|P2|NOT COMPLETED|Overall Study||0
8319421|NCT01431794|20512170|P1|NOT COMPLETED|Overall Study||0
8319422|NCT01431794|20512166|P5|COMPLETED|Overall Study|not started due to early study's termination|0
8319423|NCT01431794|20512167|P4|COMPLETED|Overall Study|not started due to early study's termination|0
8319424|NCT01431794|20512168|P3|COMPLETED|Overall Study|not started due to early study's termination|0
8319425|NCT01431794|20512169|P2|COMPLETED|Overall Study|not started due to early study's termination|0
8319426|NCT01431794|20512170|P1|COMPLETED|Overall Study||13
8319427|NCT01431794|20512166|P5|STARTED|Overall Study|not started due to early study's termination|0
8319428|NCT01431794|20512167|P4|STARTED|Overall Study|not started due to early study's termination|0
8319429|NCT01431794|20512168|P3|STARTED|Overall Study|not started due to early study's termination|0
8319430|NCT01431794|20512169|P2|STARTED|Overall Study|not started due to early study's termination|0
8319431|NCT01431794|20512170|P1|STARTED|Overall Study||13
8319432|NCT01431755|20512188|P1|NOT COMPLETED|Overall Study||5
8319433|NCT01431755|20512188|P1|COMPLETED|Overall Study||49
8319434|NCT01431755|20512188|P1|STARTED|Overall Study||54
8319435|NCT01431716|20512199|P1|NOT COMPLETED|Overall Study||1
8319436|NCT01431716|20512199|P1|COMPLETED|Overall Study||41
8319437|NCT01431716|20512199|P1|STARTED|Overall Study||42
8319438|NCT01431703|20512216|P1|NOT COMPLETED|Overall Study||0
8319439|NCT01431703|20512216|P1|COMPLETED|Overall Study||326
8319440|NCT01431703|20512216|P1|STARTED|Overall Study||326
8319441|NCT01431534|20512223|P3|NOT COMPLETED|Extension Phase||0
8319442|NCT01431534|20512224|P2|NOT COMPLETED|Extension Phase||0
8319443|NCT01431534|20512225|P1|NOT COMPLETED|Extension Phase||0
8319444|NCT01431534|20512223|P3|COMPLETED|Extension Phase||2
8319445|NCT01431534|20512224|P2|COMPLETED|Extension Phase||0
8319446|NCT01431534|20512225|P1|COMPLETED|Extension Phase||0
8319447|NCT01431534|20512223|P3|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
8319448|NCT01431534|20512224|P2|STARTED|Extension Phase|No participants continued in Extension Phase.|0
8319449|NCT01431534|20512225|P1|STARTED|Extension Phase|No participants continued in Extension Phase.|0
8319450|NCT01431534|20512223|P3|NOT COMPLETED|Treatment Phase||11
8319451|NCT01431534|20512224|P2|NOT COMPLETED|Treatment Phase||3
8319452|NCT01431534|20512225|P1|NOT COMPLETED|Treatment Phase||4
8319453|NCT01431534|20512223|P3|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
8319454|NCT01431534|20512224|P2|COMPLETED|Treatment Phase||0
8319455|NCT01431534|20512225|P1|COMPLETED|Treatment Phase||0
8319456|NCT01431534|20512223|P3|STARTED|Treatment Phase||13
8319457|NCT01431534|20512224|P2|STARTED|Treatment Phase||3
8319458|NCT01431534|20512225|P1|STARTED|Treatment Phase||4
8319459|NCT01431521|20512240|P4|NOT COMPLETED|Overall Study||0
8319460|NCT01431521|20512241|P3|NOT COMPLETED|Overall Study||1
8319461|NCT01431521|20512242|P2|NOT COMPLETED|Overall Study||0
8319462|NCT01431521|20512243|P1|NOT COMPLETED|Overall Study||0
8319463|NCT01431521|20512240|P4|COMPLETED|Overall Study||5
8319464|NCT01431521|20512241|P3|COMPLETED|Overall Study||10
8319465|NCT01431521|20512242|P2|COMPLETED|Overall Study||5
8319466|NCT01431521|20512243|P1|COMPLETED|Overall Study||10
8319467|NCT01431521|20512240|P4|Treated|Overall Study||5
8319468|NCT01431521|20512241|P3|Treated|Overall Study||10
8319469|NCT01431521|20512242|P2|Treated|Overall Study||5
8319470|NCT01431521|20512243|P1|Treated|Overall Study||10
8319471|NCT01431521|20512240|P4|STARTED|Overall Study||5
8319472|NCT01431521|20512241|P3|STARTED|Overall Study||11
8319473|NCT01431521|20512242|P2|STARTED|Overall Study||5
8319474|NCT01431521|20512243|P1|STARTED|Overall Study||10
8319475|NCT01431508|20512264|P1|NOT COMPLETED|Overall Study||2
8319476|NCT01431508|20512264|P1|COMPLETED|Overall Study||13
8319477|NCT01431508|20512264|P1|STARTED|Overall Study||15
8319478|NCT01431391|20512270|P2|NOT COMPLETED|Overall Study||4
8319479|NCT01431391|20512271|P1|NOT COMPLETED|Overall Study||8
8319480|NCT01431391|20512270|P2|COMPLETED|Overall Study||30
8319481|NCT01431391|20512271|P1|COMPLETED|Overall Study||26
8319482|NCT01431391|20512270|P2|Received ≥1 Leaukapheresis|Overall Study||34
8319483|NCT01431391|20512271|P1|Received ≥1 Leaukapheresis|Overall Study||34
8319484|NCT01431391|20512270|P2|STARTED|Overall Study||34
8319485|NCT01431391|20512271|P1|STARTED|Overall Study||34
8319486|NCT01431339|20512281|P2|NOT COMPLETED|Overall Study||35
8319487|NCT01431339|20512282|P1|NOT COMPLETED|Overall Study||39
8319488|NCT01431339|20512281|P2|COMPLETED|Overall Study||333
8319489|NCT01431339|20512282|P1|COMPLETED|Overall Study||332
8319490|NCT01431339|20512281|P2|Safety Population|Overall Study||367
8319491|NCT01431339|20512282|P1|Safety Population|Overall Study||368
8319492|NCT01431339|20512281|P2|STARTED|Overall Study||368
8319493|NCT01431339|20512282|P1|STARTED|Overall Study||371
8319494|NCT01431313|20512297|P3|NOT COMPLETED|Overall Study||0
8319495|NCT01431313|20512298|P2|NOT COMPLETED|Overall Study||0
8319496|NCT01431313|20512299|P1|NOT COMPLETED|Overall Study||0
8319497|NCT01431313|20512297|P3|COMPLETED|Overall Study||8
8319498|NCT01431313|20512298|P2|COMPLETED|Overall Study||20
8319499|NCT01431313|20512299|P1|COMPLETED|Overall Study||20
8319500|NCT01431313|20512297|P3|STARTED|Overall Study||8
8319501|NCT01431313|20512298|P2|STARTED|Overall Study||20
8319502|NCT01431313|20512299|P1|STARTED|Overall Study||20
8319503|NCT01431300|20512331|P3|NOT COMPLETED|Overall Study||0
8319504|NCT01431300|20512332|P2|NOT COMPLETED|Overall Study||0
8319505|NCT01431300|20512333|P1|NOT COMPLETED|Overall Study||1
8319506|NCT01431300|20512331|P3|COMPLETED|Overall Study||10
8319507|NCT01431300|20512332|P2|COMPLETED|Overall Study||10
8319508|NCT01431300|20512333|P1|COMPLETED|Overall Study||10
8319509|NCT01431300|20512331|P3|STARTED|Overall Study||10
8319510|NCT01431300|20512332|P2|STARTED|Overall Study||10
8319511|NCT01431300|20512333|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
8319512|NCT01431287|20512349|P5|NOT COMPLETED|Overall Study||77
8319513|NCT01431287|20512350|P4|NOT COMPLETED|Overall Study||63
8319514|NCT01431287|20512351|P3|NOT COMPLETED|Overall Study||97
8319515|NCT01431287|20512352|P2|NOT COMPLETED|Overall Study||98
8319516|NCT01431287|20512353|P1|NOT COMPLETED|Overall Study||98
8319517|NCT01431287|20512349|P5|COMPLETED|Overall Study||430
8319518|NCT01431287|20512350|P4|COMPLETED|Overall Study||445
8319519|NCT01431287|20512351|P3|COMPLETED|Overall Study||410
8319520|NCT01431287|20512352|P2|COMPLETED|Overall Study||409
8319521|NCT01431287|20512353|P1|COMPLETED|Overall Study||412
8319522|NCT01431287|20512349|P5|STARTED|Overall Study||507
8319523|NCT01431287|20512350|P4|STARTED|Overall Study||508
8319524|NCT01431287|20512351|P3|STARTED|Overall Study||507
8319525|NCT01431287|20512352|P2|STARTED|Overall Study||507
8319526|NCT01431287|20512353|P1|STARTED|Overall Study|started are actually the randomized|510
8319527|NCT01431274|20512515|P5|NOT COMPLETED|Overall Study||56
8319528|NCT01431274|20512516|P4|NOT COMPLETED|Overall Study||60
8319529|NCT01431274|20512517|P3|NOT COMPLETED|Overall Study||72
8319530|NCT01431274|20512518|P2|NOT COMPLETED|Overall Study||77
8319531|NCT01431274|20512519|P1|NOT COMPLETED|Overall Study||97
8319532|NCT01431274|20512515|P5|COMPLETED|Overall Study||466
8319533|NCT01431274|20512516|P4|COMPLETED|Overall Study||462
8319534|NCT01431274|20512517|P3|COMPLETED|Overall Study||455
8319535|NCT01431274|20512518|P2|COMPLETED|Overall Study||448
8319536|NCT01431274|20512519|P1|COMPLETED|Overall Study||431
8319537|NCT01431274|20512515|P5|STARTED|Overall Study||522
8319538|NCT01431274|20512516|P4|STARTED|Overall Study||522
8319539|NCT01431274|20512517|P3|STARTED|Overall Study||527
8319540|NCT01431274|20512518|P2|STARTED|Overall Study||525
8319541|NCT01431274|20512519|P1|STARTED|Overall Study||528
8319542|NCT01431170|20512678|P2|NOT COMPLETED|Overall Study||1
8319543|NCT01431170|20512679|P1|NOT COMPLETED|Overall Study||3
8319544|NCT01431170|20512678|P2|COMPLETED|Overall Study||11
8319545|NCT01431170|20512679|P1|COMPLETED|Overall Study||9
8319546|NCT01431170|20512678|P2|STARTED|Overall Study||12
8319547|NCT01431170|20512679|P1|STARTED|Overall Study||12
8319548|NCT01431144|20512697|P2|NOT COMPLETED|Overall Study||0
8319549|NCT01431144|20512698|P1|NOT COMPLETED|Overall Study||2
8319550|NCT01431144|20512697|P2|COMPLETED|Overall Study||14
8319551|NCT01431144|20512698|P1|COMPLETED|Overall Study||11
8319552|NCT01431144|20512697|P2|STARTED|Overall Study||14
8319553|NCT01431144|20512698|P1|STARTED|Overall Study||13
8319554|NCT01431131|20512706|P2|NOT COMPLETED|Overall Study||0
8319555|NCT01431131|20512707|P1|NOT COMPLETED|Overall Study||0
8319556|NCT01431131|20512706|P2|COMPLETED|Overall Study||12
8319557|NCT01431131|20512707|P1|COMPLETED|Overall Study||12
8319558|NCT01431131|20512706|P2|STARTED|Overall Study||12
8319559|NCT01431131|20512707|P1|STARTED|Overall Study||12
8319560|NCT01431105|20512715|P1|NOT COMPLETED|Overall Study||0
8319561|NCT01431105|20512715|P1|COMPLETED|Overall Study||34
8319562|NCT01431105|20512715|P1|STARTED|Overall Study||34
8319563|NCT01431079|20512721|P2|NOT COMPLETED|Overall Study||39
8319564|NCT01431079|20512722|P1|NOT COMPLETED|Overall Study||35
8319565|NCT01431079|20512721|P2|COMPLETED|Overall Study||6
8319566|NCT01431079|20512722|P1|COMPLETED|Overall Study||10
8319567|NCT01431079|20512721|P2|Post-test|Overall Study||45
8319568|NCT01431079|20512722|P1|Post-test|Overall Study||45
8319569|NCT01431079|20512721|P2|STARTED|Overall Study||45
8319570|NCT01431079|20512722|P1|STARTED|Overall Study||45
8319571|NCT01431014|20512776|P2|NOT COMPLETED|Overall Study||9
8319572|NCT01431014|20512777|P1|NOT COMPLETED|Overall Study||3
8319573|NCT01431014|20512776|P2|COMPLETED|Overall Study||25
8319574|NCT01431014|20512777|P1|COMPLETED|Overall Study||31
8319575|NCT01431014|20512776|P2|STARTED|Overall Study||34
8319576|NCT01431014|20512777|P1|STARTED|Overall Study||34
8319577|NCT01430819|20512785|P2|NOT COMPLETED|Overall Study||0
8319578|NCT01430819|20512786|P1|NOT COMPLETED|Overall Study||0
8319579|NCT01430819|20512785|P2|COMPLETED|Overall Study||150
8319580|NCT01430819|20512786|P1|COMPLETED|Overall Study||150
8319581|NCT01430819|20512785|P2|STARTED|Overall Study||150
8319582|NCT01430819|20512786|P1|STARTED|Overall Study||150
8319583|NCT01430754|20512801|P2|NOT COMPLETED|Randomized Phase||0
8319584|NCT01430754|20512802|P1|NOT COMPLETED|Randomized Phase||0
8319585|NCT01430754|20512801|P2|COMPLETED|Randomized Phase||10
8319586|NCT01430754|20512802|P1|COMPLETED|Randomized Phase||10
8319587|NCT01430754|20512801|P2|STARTED|Randomized Phase||10
8319588|NCT01430754|20512802|P1|STARTED|Randomized Phase||10
8319589|NCT01430754|20512801|P2|NOT COMPLETED|Run-In Phase||0
8319590|NCT01430754|20512802|P1|NOT COMPLETED|Run-In Phase||37
8319591|NCT01430754|20512801|P2|COMPLETED|Run-In Phase||0
8319592|NCT01430754|20512802|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
8319593|NCT01430754|20512801|P2|Entrained - After Run-In Phase|Run-In Phase||0
8319594|NCT01430754|20512802|P1|Entrained - After Run-In Phase|Run-In Phase||24
8319595|NCT01430754|20512801|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
8319596|NCT01430754|20512802|P1|STARTED|Run-In Phase||57
8319597|NCT01430741|20512824|P4|NOT COMPLETED|Overall Study||0
8319598|NCT01430741|20512825|P3|NOT COMPLETED|Overall Study||10
8319599|NCT01430741|20512826|P2|NOT COMPLETED|Overall Study||0
8319600|NCT01430741|20512827|P1|NOT COMPLETED|Overall Study||0
8319601|NCT01430741|20512824|P4|COMPLETED|Overall Study||81
8319602|NCT01430741|20512825|P3|COMPLETED|Overall Study||37
8319603|NCT01430741|20512826|P2|COMPLETED|Overall Study||87
8319604|NCT01430741|20512827|P1|COMPLETED|Overall Study||22
8319605|NCT01430741|20512824|P4|STARTED|Overall Study||81
8319606|NCT01430741|20512825|P3|STARTED|Overall Study||47
8319607|NCT01430741|20512826|P2|STARTED|Overall Study||87
8319608|NCT01430741|20512827|P1|STARTED|Overall Study||22
8319609|NCT01430624|20512860|P3|NOT COMPLETED|Overall Study||29
8319610|NCT01430624|20512861|P2|NOT COMPLETED|Overall Study||34
8319611|NCT01430624|20512862|P1|NOT COMPLETED|Overall Study||28
8319612|NCT01430624|20512860|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
8319613|NCT01430624|20512861|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
8319614|NCT01430624|20512862|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
8319615|NCT01430624|20512860|P3|Eligible Baseline Completes|Overall Study||79
8319616|NCT01430624|20512861|P2|Eligible Baseline Completes|Overall Study||77
8319617|NCT01430624|20512862|P1|Eligible Baseline Completes|Overall Study||77
8319618|NCT01430624|20512860|P3|STARTED|Overall Study||81
8319619|NCT01430624|20512861|P2|STARTED|Overall Study||82
8319620|NCT01430624|20512862|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
8319621|NCT01430611|20512893|P2|NOT COMPLETED|Overall Study||15
8319622|NCT01430611|20512894|P1|NOT COMPLETED|Overall Study||17
8319623|NCT01430611|20512893|P2|COMPLETED|Overall Study||318
8319624|NCT01430611|20512894|P1|COMPLETED|Overall Study||315
8319625|NCT01430611|20512893|P2|STARTED|Overall Study||333
8319626|NCT01430611|20512894|P1|STARTED|Overall Study||332
8319627|NCT01430585|20512912|P1|NOT COMPLETED|Overall Study||14
8319628|NCT01430585|20512912|P1|COMPLETED|Overall Study||0
8319629|NCT01430585|20512912|P1|STARTED|Overall Study||14
8319630|NCT01430559|20512947|P2|NOT COMPLETED|Overall Study||12
8319631|NCT01430559|20512948|P1|NOT COMPLETED|Overall Study||20
8319632|NCT01430559|20512947|P2|COMPLETED|Overall Study||135
8319633|NCT01430559|20512948|P1|COMPLETED|Overall Study||126
8319634|NCT01430559|20512947|P2|Treated|Overall Study||144
8319635|NCT01430559|20512948|P1|Treated|Overall Study||143
8319636|NCT01430559|20512947|P2|STARTED|Overall Study||147
8319637|NCT01430559|20512948|P1|STARTED|Overall Study||146
8319638|NCT01430468|20512984|P2|NOT COMPLETED|Overall Study||6
8319639|NCT01430468|20512985|P1|NOT COMPLETED|Overall Study||7
8319640|NCT01430468|20512984|P2|COMPLETED|Overall Study||16
8319641|NCT01430468|20512985|P1|COMPLETED|Overall Study||15
8319642|NCT01430468|20512984|P2|STARTED|Overall Study||22
8319643|NCT01430468|20512985|P1|STARTED|Overall Study||22
8319644|NCT01430455|20512993|P1|NOT COMPLETED|Overall Study||2
8319645|NCT01430455|20512993|P1|COMPLETED|Overall Study||5
8319646|NCT01430455|20512993|P1|STARTED|Overall Study||7
8319647|NCT01430442|20513005|P8|NOT COMPLETED|Overall Study||9
8319648|NCT01430442|20513006|P7|NOT COMPLETED|Overall Study||19
8319649|NCT01430442|20513007|P6|NOT COMPLETED|Overall Study||8
8319650|NCT01430442|20513008|P5|NOT COMPLETED|Overall Study||9
8319651|NCT01430442|20513009|P4|NOT COMPLETED|Overall Study||4
8319652|NCT01430442|20513010|P3|NOT COMPLETED|Overall Study||5
8319653|NCT01430442|20513011|P2|NOT COMPLETED|Overall Study||6
8319654|NCT01430442|20513012|P1|NOT COMPLETED|Overall Study||13
8319655|NCT01430442|20513005|P8|COMPLETED|Overall Study||100
8319656|NCT01430442|20513006|P7|COMPLETED|Overall Study||210
8319657|NCT01430442|20513007|P6|COMPLETED|Overall Study||84
8319658|NCT01430442|20513008|P5|COMPLETED|Overall Study||112
8319659|NCT01430442|20513009|P4|COMPLETED|Overall Study||86
8319660|NCT01430442|20513010|P3|COMPLETED|Overall Study||86
8319661|NCT01430442|20513011|P2|COMPLETED|Overall Study||62
8319662|NCT01430442|20513012|P1|COMPLETED|Overall Study||72
8319663|NCT01430442|20513005|P8|STARTED|Overall Study||109
8319664|NCT01430442|20513006|P7|STARTED|Overall Study||229
8319665|NCT01430442|20513007|P6|STARTED|Overall Study||92
8319666|NCT01430442|20513008|P5|STARTED|Overall Study||121
8319667|NCT01430442|20513009|P4|STARTED|Overall Study||90
8319668|NCT01430442|20513010|P3|STARTED|Overall Study||91
8319669|NCT01430442|20513011|P2|STARTED|Overall Study||68
8319670|NCT01430442|20513012|P1|STARTED|Overall Study||85
8319671|NCT01430403|20513065|P3|NOT COMPLETED|Overall Study||8
8319672|NCT01430403|20513066|P2|NOT COMPLETED|Overall Study||9
8319673|NCT01430403|20513067|P1|NOT COMPLETED|Overall Study||17
8319674|NCT01430403|20513065|P3|COMPLETED|Overall Study||81
8319675|NCT01430403|20513066|P2|COMPLETED|Overall Study||121
8319676|NCT01430403|20513067|P1|COMPLETED|Overall Study||242
8319677|NCT01430403|20513065|P3|STARTED|Overall Study|Intent-to-treat|89
8319678|NCT01430403|20513066|P2|STARTED|Overall Study|Intent-to-treat|130
8319679|NCT01430403|20513067|P1|STARTED|Overall Study|Intent-to-treat|259
8319680|NCT01430325|20513120|P4|NOT COMPLETED|Overall Study||0
8319681|NCT01430325|20513121|P3|NOT COMPLETED|Overall Study||0
8319682|NCT01430325|20513122|P2|NOT COMPLETED|Overall Study||0
8319683|NCT01430325|20513123|P1|NOT COMPLETED|Overall Study||0
8319684|NCT01430325|20513120|P4|COMPLETED|Overall Study||12
8319685|NCT01430325|20513121|P3|COMPLETED|Overall Study||8
8319686|NCT01430325|20513122|P2|COMPLETED|Overall Study||12
8319687|NCT01430325|20513123|P1|COMPLETED|Overall Study||10
8319688|NCT01430325|20513120|P4|STARTED|Overall Study||12
8319689|NCT01430325|20513121|P3|STARTED|Overall Study||8
8319690|NCT01430325|20513122|P2|STARTED|Overall Study||12
8319691|NCT01430325|20513123|P1|STARTED|Overall Study||10
8319692|NCT01430299|20513143|P2|NOT COMPLETED|Overall Study||2
8319693|NCT01430299|20513144|P1|NOT COMPLETED|Overall Study||4
8319694|NCT01430299|20513143|P2|COMPLETED|Overall Study||21
8319695|NCT01430299|20513144|P1|COMPLETED|Overall Study||16
8319696|NCT01430299|20513143|P2|STARTED|Overall Study||23
8319697|NCT01430299|20513144|P1|STARTED|Overall Study||20
8319698|NCT01430182|20513152|P2|NOT COMPLETED|Overall Study||0
8319699|NCT01430182|20513153|P1|NOT COMPLETED|Overall Study||0
8319700|NCT01430182|20513152|P2|COMPLETED|Overall Study||8
8319701|NCT01430182|20513153|P1|COMPLETED|Overall Study||9
8319702|NCT01430182|20513152|P2|STARTED|Overall Study||8
8319703|NCT01430182|20513153|P1|STARTED|Overall Study||9
8319704|NCT01430169|20513159|P1|NOT COMPLETED|Overall Study||0
8319705|NCT01430169|20513159|P1|COMPLETED|Overall Study||20
8319706|NCT01430169|20513159|P1|STARTED|Overall Study||20
8319707|NCT01430130|20513174|P1|NOT COMPLETED|Overall Study||2
8319708|NCT01430130|20513174|P1|COMPLETED|Overall Study||10
8319709|NCT01430130|20513174|P1|STARTED|Overall Study||12
8319710|NCT01430104|20513180|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
8319711|NCT01430104|20513180|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
8319712|NCT01430104|20513180|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
8319713|NCT01430104|20513180|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
8319714|NCT01430104|20513180|P1|NOT COMPLETED|14-Day Lead-In Period||0
8319715|NCT01430104|20513180|P1|COMPLETED|14-Day Lead-In Period||30
8319716|NCT01430104|20513180|P1|STARTED|14-Day Lead-In Period||30
8319717|NCT01430091|20513192|P1|NOT COMPLETED|Overall Study||0
8319718|NCT01430091|20513192|P1|COMPLETED|Overall Study||18
8319719|NCT01430091|20513192|P1|STARTED|Overall Study||18
8319720|NCT01429987|20513218|P4|NOT COMPLETED|Overall Study||66
8319721|NCT01429987|20513219|P3|NOT COMPLETED|Overall Study||36
8319722|NCT01429987|20513220|P2|NOT COMPLETED|Overall Study||62
8319723|NCT01429987|20513221|P1|NOT COMPLETED|Overall Study||49
8319724|NCT01429987|20513218|P4|COMPLETED|Overall Study||171
8319725|NCT01429987|20513219|P3|COMPLETED|Overall Study||202
8319726|NCT01429987|20513220|P2|COMPLETED|Overall Study||176
8319727|NCT01429987|20513221|P1|COMPLETED|Overall Study||189
8319728|NCT01429987|20513218|P4|STARTED|Overall Study||237
8319729|NCT01429987|20513219|P3|STARTED|Overall Study||238
8319730|NCT01429987|20513220|P2|STARTED|Overall Study||238
8319731|NCT01429987|20513221|P1|STARTED|Overall Study||238
8319732|NCT01429792|20513247|P1|NOT COMPLETED|Overall Study||406
8319733|NCT01429792|20513247|P1|COMPLETED|Overall Study||607
8319734|NCT01429792|20513247|P1|Genotype 4|Overall Study||5
8319735|NCT01429792|20513247|P1|Genotype 2 & 3|Overall Study||305
8319736|NCT01429792|20513247|P1|Genotype 1|Overall Study||687
8319737|NCT01429792|20513247|P1|STARTED|Overall Study||1013
8319738|NCT01429623|20513261|P2|NOT COMPLETED|Overall Study||59
8319739|NCT01429623|20513262|P1|NOT COMPLETED|Overall Study||51
8319740|NCT01429623|20513261|P2|COMPLETED|Overall Study||48
8319741|NCT01429623|20513262|P1|COMPLETED|Overall Study||51
8319742|NCT01429623|20513261|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
8319743|NCT01429623|20513262|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
8319744|NCT01429623|20513261|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
8319745|NCT01429623|20513262|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
8319746|NCT01429584|20513276|P2|NOT COMPLETED|Overall Study||1
8319747|NCT01429584|20513277|P1|NOT COMPLETED|Overall Study||1
8319748|NCT01429584|20513276|P2|COMPLETED|Overall Study||14
8319749|NCT01429584|20513277|P1|COMPLETED|Overall Study||14
8319750|NCT01429584|20513276|P2|STARTED|Overall Study||15
8319751|NCT01429584|20513277|P1|STARTED|Overall Study||15
8319752|NCT01429532|20513290|P3|NOT COMPLETED|Overall Study||0
8319753|NCT01429532|20513291|P2|NOT COMPLETED|Overall Study||0
8319754|NCT01429532|20513292|P1|NOT COMPLETED|Overall Study||0
8319755|NCT01429532|20513290|P3|COMPLETED|Overall Study||40
8319756|NCT01429532|20513291|P2|COMPLETED|Overall Study||40
8319757|NCT01429532|20513292|P1|COMPLETED|Overall Study||40
8319758|NCT01429532|20513290|P3|STARTED|Overall Study||40
8319759|NCT01429532|20513291|P2|STARTED|Overall Study||40
8319760|NCT01429532|20513292|P1|STARTED|Overall Study||40
8319767|NCT01429441|20513319|P2|NOT COMPLETED|Overall Study||23
8319768|NCT01429441|20513320|P1|NOT COMPLETED|Overall Study||38
8319769|NCT01429441|20513319|P2|COMPLETED|Overall Study||51
8319770|NCT01429441|20513320|P1|COMPLETED|Overall Study||108
8319771|NCT01429441|20513319|P2|STARTED|Overall Study||74
8319772|NCT01429441|20513320|P1|STARTED|Overall Study||146
8319773|NCT01429350|20513330|P2|NOT COMPLETED|Overall Study||5
8319774|NCT01429350|20513331|P1|NOT COMPLETED|Overall Study||7
8319775|NCT01429350|20513330|P2|COMPLETED|Overall Study||50
8319776|NCT01429350|20513331|P1|COMPLETED|Overall Study||46
8319777|NCT01429350|20513330|P2|90 Day|Overall Study||50
8319778|NCT01429350|20513331|P1|90 Day|Overall Study||46
8319779|NCT01429350|20513330|P2|Per Protocol|Overall Study||37
8319780|NCT01429350|20513331|P1|Per Protocol|Overall Study||41
8319781|NCT01429350|20513330|P2|As-Treated|Overall Study||43
8319782|NCT01429350|20513331|P1|As-Treated|Overall Study||62
8319783|NCT01429350|20513330|P2|STARTED|Overall Study||55
8319784|NCT01429350|20513331|P1|STARTED|Overall Study||53
8319785|NCT01429298|20513345|P2|NOT COMPLETED|Overall Study||6
8319786|NCT01429298|20513346|P1|NOT COMPLETED|Overall Study||4
8319787|NCT01429298|20513345|P2|COMPLETED|Overall Study||169
8319788|NCT01429298|20513346|P1|COMPLETED|Overall Study||171
8319789|NCT01429298|20513345|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
8319790|NCT01429298|20513346|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
8319791|NCT01429298|20513345|P2|STARTED|Overall Study||175
8319792|NCT01429298|20513346|P1|STARTED|Overall Study||175
8319793|NCT01429285|20513362|P2|NOT COMPLETED|Overall Study||9
8319794|NCT01429285|20513363|P1|NOT COMPLETED|Overall Study||22
8319795|NCT01429285|20513362|P2|COMPLETED|Overall Study||166
8319796|NCT01429285|20513363|P1|COMPLETED|Overall Study||153
8319797|NCT01429285|20513362|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
8319886|NCT01428453|20513525|P1|NOT COMPLETED|Overall Study||6
8319887|NCT01428453|20513524|P2|COMPLETED|Overall Study||52
8319798|NCT01429285|20513363|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
8319799|NCT01429285|20513362|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
8319800|NCT01429285|20513363|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
8319801|NCT01429285|20513362|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
8319802|NCT01429285|20513363|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
8319803|NCT01429285|20513362|P2|STARTED|Overall Study||175
8319804|NCT01429285|20513363|P1|STARTED|Overall Study||175
8319805|NCT01429272|20513385|P4|NOT COMPLETED|Overall Study||5
8319806|NCT01429272|20513386|P3|NOT COMPLETED|Overall Study||4
8319807|NCT01429272|20513387|P2|NOT COMPLETED|Overall Study||9
8319808|NCT01429272|20513388|P1|NOT COMPLETED|Overall Study||6
8319809|NCT01429272|20513385|P4|COMPLETED|Overall Study||14
8319810|NCT01429272|20513386|P3|COMPLETED|Overall Study||15
8319811|NCT01429272|20513387|P2|COMPLETED|Overall Study||22
8319812|NCT01429272|20513388|P1|COMPLETED|Overall Study||24
8319813|NCT01429272|20513385|P4|STARTED|Overall Study||19
8319814|NCT01429272|20513386|P3|STARTED|Overall Study||19
8319815|NCT01429272|20513387|P2|STARTED|Overall Study||31
8319816|NCT01429272|20513388|P1|STARTED|Overall Study||30
8319817|NCT01429259|20513402|P1|NOT COMPLETED|Overall Study||0
8319818|NCT01429259|20513402|P1|COMPLETED|Overall Study||30
8319819|NCT01429259|20513402|P1|STARTED|Overall Study||30
8319820|NCT01429077|20513409|P2|NOT COMPLETED|Overall Study||3
8319821|NCT01429077|20513410|P1|NOT COMPLETED|Overall Study||0
8319822|NCT01429077|20513409|P2|COMPLETED|Overall Study||14
8319823|NCT01429077|20513410|P1|COMPLETED|Overall Study||19
8319824|NCT01429077|20513409|P2|Completed 6-week Intervention|Overall Study||17
8319825|NCT01429077|20513410|P1|Completed 6-week Intervention|Overall Study||19
8319826|NCT01429077|20513409|P2|STARTED|Overall Study||17
8319827|NCT01429077|20513410|P1|STARTED|Overall Study||19
8319828|NCT01429064|20513420|P4|NOT COMPLETED|Overall Study||0
8319829|NCT01429064|20513421|P3|NOT COMPLETED|Overall Study||0
8319830|NCT01429064|20513422|P2|NOT COMPLETED|Overall Study||0
8319831|NCT01429064|20513423|P1|NOT COMPLETED|Overall Study||0
8319832|NCT01429064|20513420|P4|COMPLETED|Overall Study||16
8319833|NCT01429064|20513421|P3|COMPLETED|Overall Study||19
8319834|NCT01429064|20513422|P2|COMPLETED|Overall Study||22
8319835|NCT01429064|20513423|P1|COMPLETED|Overall Study||19
8319836|NCT01429064|20513420|P4|STARTED|Overall Study||16
8319837|NCT01429064|20513421|P3|STARTED|Overall Study||19
8319838|NCT01429064|20513422|P2|STARTED|Overall Study||22
8319839|NCT01429064|20513423|P1|STARTED|Overall Study||19
8319840|NCT01429051|20513433|P1|NOT COMPLETED|Tolerability Phase||15
8319841|NCT01429051|20513433|P1|COMPLETED|Tolerability Phase||16
8319842|NCT01429051|20513433|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
8319843|NCT01429051|20513433|P1|NOT COMPLETED|Efficacy Phase||2
8319844|NCT01429051|20513433|P1|COMPLETED|Efficacy Phase||13
8319845|NCT01429051|20513433|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
8319846|NCT01429051|20513433|P1|NOT COMPLETED|Titration Phase||12
8319847|NCT01429051|20513433|P1|COMPLETED|Titration Phase||33
8319848|NCT01429051|20513433|P1|STARTED|Titration Phase||45
8319849|NCT01428882|20513456|P2|NOT COMPLETED|Overall Study||10
8319850|NCT01428882|20513457|P1|NOT COMPLETED|Overall Study||6
8319851|NCT01428882|20513456|P2|COMPLETED|Overall Study||58
8319852|NCT01428882|20513457|P1|COMPLETED|Overall Study||61
8319853|NCT01428882|20513456|P2|STARTED|Overall Study||68
8319854|NCT01428882|20513457|P1|STARTED|Overall Study||67
8319855|NCT01428765|20513469|P1|NOT COMPLETED|Overall Study||0
8319856|NCT01428765|20513469|P1|COMPLETED|Overall Study||1063
8319857|NCT01428765|20513469|P1|STARTED|Overall Study||1063
8319858|NCT01428713|20513480|P2|NOT COMPLETED|Overall Study||5
8319859|NCT01428713|20513481|P1|NOT COMPLETED|Overall Study||3
8319860|NCT01428713|20513480|P2|COMPLETED|Overall Study||3
8319861|NCT01428713|20513481|P1|COMPLETED|Overall Study||6
8319862|NCT01428713|20513480|P2|STARTED|Overall Study||8
8319863|NCT01428713|20513481|P1|STARTED|Overall Study||9
8319864|NCT01428661|20513490|P3|NOT COMPLETED|Open Label Extension||320
8319865|NCT01428661|20513491|P2|NOT COMPLETED|Open Label Extension||0
8319866|NCT01428661|20513492|P1|NOT COMPLETED|Open Label Extension||0
8319867|NCT01428661|20513490|P3|COMPLETED|Open Label Extension||19
8319868|NCT01428661|20513491|P2|COMPLETED|Open Label Extension|Does not apply.|0
8319869|NCT01428661|20513492|P1|COMPLETED|Open Label Extension|Does not apply.|0
8319870|NCT01428661|20513490|P3|STARTED|Open Label Extension||339
8319871|NCT01428661|20513491|P2|STARTED|Open Label Extension|Does not apply.|0
8319872|NCT01428661|20513492|P1|STARTED|Open Label Extension|Does not apply.|0
8319873|NCT01428661|20513490|P3|NOT COMPLETED|Double-Masked Phase||0
8319874|NCT01428661|20513491|P2|NOT COMPLETED|Double-Masked Phase||49
8319875|NCT01428661|20513492|P1|NOT COMPLETED|Double-Masked Phase||57
8319876|NCT01428661|20513490|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
8319877|NCT01428661|20513491|P2|COMPLETED|Double-Masked Phase||204
8319878|NCT01428661|20513492|P1|COMPLETED|Double-Masked Phase||197
8319879|NCT01428661|20513490|P3|STARTED|Double-Masked Phase|Does not apply.|0
8319880|NCT01428661|20513491|P2|STARTED|Double-Masked Phase||253
8319881|NCT01428661|20513492|P1|STARTED|Double-Masked Phase||254
8319882|NCT01428583|20513500|P1|NOT COMPLETED|Overall Study||237
8319883|NCT01428583|20513500|P1|COMPLETED|Overall Study||158
8319884|NCT01428583|20513500|P1|STARTED|Overall Study||395
8319885|NCT01428453|20513524|P2|NOT COMPLETED|Overall Study||9
8319888|NCT01428453|20513525|P1|COMPLETED|Overall Study||56
8319889|NCT01428453|20513524|P2|STARTED|Overall Study||61
8319890|NCT01428453|20513525|P1|STARTED|Overall Study||62
8319891|NCT01428336|20513551|P2|NOT COMPLETED|Overall Study||0
8319892|NCT01428336|20513552|P1|NOT COMPLETED|Overall Study||0
8319893|NCT01428336|20513551|P2|COMPLETED|Overall Study||12
8319894|NCT01428336|20513552|P1|COMPLETED|Overall Study||10
8319895|NCT01428336|20513551|P2|STARTED|Overall Study||12
8319896|NCT01428336|20513552|P1|STARTED|Overall Study||10
8319897|NCT01428258|20513564|P2|NOT COMPLETED|Intervention 2||0
8319898|NCT01428258|20513565|P1|NOT COMPLETED|Intervention 2||0
8319899|NCT01428258|20513564|P2|COMPLETED|Intervention 2||15
8319900|NCT01428258|20513565|P1|COMPLETED|Intervention 2||15
8319901|NCT01428258|20513564|P2|STARTED|Intervention 2||15
8319902|NCT01428258|20513565|P1|STARTED|Intervention 2||15
8319903|NCT01428258|20513564|P2|NOT COMPLETED|Intervention 1||0
8319904|NCT01428258|20513565|P1|NOT COMPLETED|Intervention 1||2
8319905|NCT01428258|20513564|P2|COMPLETED|Intervention 1||15
8319906|NCT01428258|20513565|P1|COMPLETED|Intervention 1||15
8319907|NCT01428258|20513564|P2|STARTED|Intervention 1||15
8319908|NCT01428258|20513565|P1|STARTED|Intervention 1||17
8319909|NCT01428245|20513583|P1|NOT COMPLETED|Overall Study||0
8319910|NCT01428245|20513583|P1|COMPLETED|Overall Study||1
8319911|NCT01428245|20513583|P1|STARTED|Overall Study||1
8319912|NCT01428219|20513587|P1|NOT COMPLETED|Overall Study||3
8319913|NCT01428219|20513587|P1|COMPLETED|Overall Study||22
8319914|NCT01428219|20513587|P1|STARTED|Overall Study||25
8319915|NCT01428193|20513598|P1|NOT COMPLETED|Overall Study||2
8319916|NCT01428193|20513598|P1|COMPLETED|Overall Study||2
8319917|NCT01428193|20513598|P1|STARTED|Overall Study||4
8319918|NCT01428128|20513602|P1|NOT COMPLETED|Overall Study||17
8319919|NCT01428128|20513602|P1|COMPLETED|Overall Study||33
8319920|NCT01428128|20513602|P1|STARTED|Overall Study||50
8319921|NCT01428115|20513607|P1|NOT COMPLETED|Overall Study||21
8319922|NCT01428115|20513607|P1|COMPLETED|Overall Study||62
8319923|NCT01428115|20513607|P1|STARTED|Overall Study||83
8319924|NCT01428076|20513622|P2|NOT COMPLETED|Overall Study||1
8319925|NCT01428076|20513623|P1|NOT COMPLETED|Overall Study||0
8319926|NCT01428076|20513622|P2|COMPLETED|Overall Study||11
8319927|NCT01428076|20513623|P1|COMPLETED|Overall Study||9
8319928|NCT01428076|20513622|P2|STARTED|Overall Study||12
8319929|NCT01428076|20513623|P1|STARTED|Overall Study||9
8319930|NCT01428063|20513634|P3|NOT COMPLETED|Overall Study||1
8319931|NCT01428063|20513635|P2|NOT COMPLETED|Overall Study||10
8319932|NCT01428063|20513636|P1|NOT COMPLETED|Overall Study||10
8319933|NCT01428063|20513634|P3|COMPLETED|Overall Study||5
8319934|NCT01428063|20513635|P2|COMPLETED|Overall Study||112
8319935|NCT01428063|20513636|P1|COMPLETED|Overall Study||89
8319936|NCT01428063|20513634|P3|STARTED|Overall Study||6
8319937|NCT01428063|20513635|P2|STARTED|Overall Study||122
8319938|NCT01428063|20513636|P1|STARTED|Overall Study||99
8319939|NCT01428024|20513707|P2|NOT COMPLETED|Overall Study||1
8319940|NCT01428024|20513708|P1|NOT COMPLETED|Overall Study||1
8319941|NCT01428024|20513707|P2|COMPLETED|Overall Study||29
8319942|NCT01428024|20513708|P1|COMPLETED|Overall Study||29
8319943|NCT01428024|20513707|P2|STARTED|Overall Study||30
8319944|NCT01428024|20513708|P1|STARTED|Overall Study||30
8319945|NCT01427972|20513737|P12|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319946|NCT01427972|20513738|P11|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319947|NCT01427972|20513739|P10|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319948|NCT01427972|20513740|P9|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319949|NCT01427972|20513741|P8|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319950|NCT01427972|20513742|P7|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319951|NCT01427972|20513743|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319952|NCT01427972|20513744|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319953|NCT01427972|20513745|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319954|NCT01427972|20513746|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319955|NCT01427972|20513747|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||1
8319956|NCT01427972|20513748|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319957|NCT01427972|20513737|P12|COMPLETED|Treatment Period 2 (21 Days)||4
8319958|NCT01427972|20513738|P11|COMPLETED|Treatment Period 2 (21 Days)||3
8319959|NCT01427972|20513739|P10|COMPLETED|Treatment Period 2 (21 Days)||3
8319960|NCT01427972|20513740|P9|COMPLETED|Treatment Period 2 (21 Days)||3
8319961|NCT01427972|20513741|P8|COMPLETED|Treatment Period 2 (21 Days)||4
8319962|NCT01427972|20513742|P7|COMPLETED|Treatment Period 2 (21 Days)||3
8319963|NCT01427972|20513743|P6|COMPLETED|Treatment Period 2 (21 Days)||1
8319964|NCT01427972|20513744|P5|COMPLETED|Treatment Period 2 (21 Days)||4
8319965|NCT01427972|20513745|P4|COMPLETED|Treatment Period 2 (21 Days)||3
8319966|NCT01427972|20513746|P3|COMPLETED|Treatment Period 2 (21 Days)||4
8319967|NCT01427972|20513747|P2|COMPLETED|Treatment Period 2 (21 Days)||3
8319968|NCT01427972|20513748|P1|COMPLETED|Treatment Period 2 (21 Days)||3
8319969|NCT01427972|20513737|P12|STARTED|Treatment Period 2 (21 Days)||4
8319970|NCT01427972|20513738|P11|STARTED|Treatment Period 2 (21 Days)||3
8319971|NCT01427972|20513739|P10|STARTED|Treatment Period 2 (21 Days)||3
8319972|NCT01427972|20513740|P9|STARTED|Treatment Period 2 (21 Days)||3
8319973|NCT01427972|20513741|P8|STARTED|Treatment Period 2 (21 Days)||4
8319974|NCT01427972|20513742|P7|STARTED|Treatment Period 2 (21 Days)||3
8319975|NCT01427972|20513743|P6|STARTED|Treatment Period 2 (21 Days)||1
8319976|NCT01427972|20513744|P5|STARTED|Treatment Period 2 (21 Days)||4
8319977|NCT01427972|20513745|P4|STARTED|Treatment Period 2 (21 Days)||3
8319978|NCT01427972|20513746|P3|STARTED|Treatment Period 2 (21 Days)||4
8319979|NCT01427972|20513747|P2|STARTED|Treatment Period 2 (21 Days)||4
8319980|NCT01427972|20513748|P1|STARTED|Treatment Period 2 (21 Days)||3
8319981|NCT01427972|20513737|P12|NOT COMPLETED|Washout (at Least 28 Days)||0
8319982|NCT01427972|20513738|P11|NOT COMPLETED|Washout (at Least 28 Days)||0
8319983|NCT01427972|20513739|P10|NOT COMPLETED|Washout (at Least 28 Days)||0
8319984|NCT01427972|20513740|P9|NOT COMPLETED|Washout (at Least 28 Days)||0
8319985|NCT01427972|20513741|P8|NOT COMPLETED|Washout (at Least 28 Days)||0
8319986|NCT01427972|20513742|P7|NOT COMPLETED|Washout (at Least 28 Days)||0
8319987|NCT01427972|20513743|P6|NOT COMPLETED|Washout (at Least 28 Days)||2
8319988|NCT01427972|20513744|P5|NOT COMPLETED|Washout (at Least 28 Days)||0
8319989|NCT01427972|20513745|P4|NOT COMPLETED|Washout (at Least 28 Days)||0
8319990|NCT01427972|20513746|P3|NOT COMPLETED|Washout (at Least 28 Days)||0
8319991|NCT01427972|20513747|P2|NOT COMPLETED|Washout (at Least 28 Days)||0
8319992|NCT01427972|20513748|P1|NOT COMPLETED|Washout (at Least 28 Days)||0
8319993|NCT01427972|20513737|P12|COMPLETED|Washout (at Least 28 Days)||4
8319994|NCT01427972|20513738|P11|COMPLETED|Washout (at Least 28 Days)||3
8319995|NCT01427972|20513739|P10|COMPLETED|Washout (at Least 28 Days)||3
8319996|NCT01427972|20513740|P9|COMPLETED|Washout (at Least 28 Days)||3
8319997|NCT01427972|20513741|P8|COMPLETED|Washout (at Least 28 Days)||4
8319998|NCT01427972|20513742|P7|COMPLETED|Washout (at Least 28 Days)||3
8319999|NCT01427972|20513743|P6|COMPLETED|Washout (at Least 28 Days)||1
8320000|NCT01427972|20513744|P5|COMPLETED|Washout (at Least 28 Days)||4
8320001|NCT01427972|20513745|P4|COMPLETED|Washout (at Least 28 Days)||3
8320002|NCT01427972|20513746|P3|COMPLETED|Washout (at Least 28 Days)||4
8320003|NCT01427972|20513747|P2|COMPLETED|Washout (at Least 28 Days)||4
8320004|NCT01427972|20513748|P1|COMPLETED|Washout (at Least 28 Days)||3
8320005|NCT01427972|20513737|P12|STARTED|Washout (at Least 28 Days)||4
8320006|NCT01427972|20513738|P11|STARTED|Washout (at Least 28 Days)||3
8320007|NCT01427972|20513739|P10|STARTED|Washout (at Least 28 Days)||3
8320008|NCT01427972|20513740|P9|STARTED|Washout (at Least 28 Days)||3
8320009|NCT01427972|20513741|P8|STARTED|Washout (at Least 28 Days)||4
8320010|NCT01427972|20513742|P7|STARTED|Washout (at Least 28 Days)||3
8320011|NCT01427972|20513743|P6|STARTED|Washout (at Least 28 Days)||3
8320012|NCT01427972|20513744|P5|STARTED|Washout (at Least 28 Days)||4
8320013|NCT01427972|20513745|P4|STARTED|Washout (at Least 28 Days)||3
8320014|NCT01427972|20513746|P3|STARTED|Washout (at Least 28 Days)||4
8320015|NCT01427972|20513747|P2|STARTED|Washout (at Least 28 Days)||4
8320016|NCT01427972|20513748|P1|STARTED|Washout (at Least 28 Days)||3
8320017|NCT01427972|20513737|P12|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320018|NCT01427972|20513738|P11|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320019|NCT01427972|20513739|P10|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320020|NCT01427972|20513740|P9|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320021|NCT01427972|20513741|P8|NOT COMPLETED|Treatment Period 1 (21 Days)||1
8320022|NCT01427972|20513742|P7|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320023|NCT01427972|20513743|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320024|NCT01427972|20513744|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320025|NCT01427972|20513745|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320026|NCT01427972|20513746|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320027|NCT01427972|20513747|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320028|NCT01427972|20513748|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320029|NCT01427972|20513737|P12|COMPLETED|Treatment Period 1 (21 Days)||4
8320030|NCT01427972|20513738|P11|COMPLETED|Treatment Period 1 (21 Days)||3
8320031|NCT01427972|20513739|P10|COMPLETED|Treatment Period 1 (21 Days)||3
8320032|NCT01427972|20513740|P9|COMPLETED|Treatment Period 1 (21 Days)||3
8320033|NCT01427972|20513741|P8|COMPLETED|Treatment Period 1 (21 Days)||4
8320034|NCT01427972|20513742|P7|COMPLETED|Treatment Period 1 (21 Days)||3
8320035|NCT01427972|20513743|P6|COMPLETED|Treatment Period 1 (21 Days)||3
8320036|NCT01427972|20513744|P5|COMPLETED|Treatment Period 1 (21 Days)||4
8320037|NCT01427972|20513745|P4|COMPLETED|Treatment Period 1 (21 Days)||3
8320038|NCT01427972|20513746|P3|COMPLETED|Treatment Period 1 (21 Days)||4
8320039|NCT01427972|20513747|P2|COMPLETED|Treatment Period 1 (21 Days)||4
8320040|NCT01427972|20513748|P1|COMPLETED|Treatment Period 1 (21 Days)||3
8320041|NCT01427972|20513737|P12|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320042|NCT01427972|20513738|P11|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320043|NCT01427972|20513739|P10|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320044|NCT01427972|20513740|P9|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320045|NCT01427972|20513741|P8|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
8320046|NCT01427972|20513742|P7|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320047|NCT01427972|20513743|P6|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320048|NCT01427972|20513744|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320049|NCT01427972|20513745|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320050|NCT01427972|20513746|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320051|NCT01427972|20513747|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320052|NCT01427972|20513748|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320053|NCT01427972|20513737|P12|STARTED|Treatment Period 1 (21 Days)||4
8320054|NCT01427972|20513738|P11|STARTED|Treatment Period 1 (21 Days)||3
8320055|NCT01427972|20513739|P10|STARTED|Treatment Period 1 (21 Days)||3
8320056|NCT01427972|20513740|P9|STARTED|Treatment Period 1 (21 Days)||3
8320057|NCT01427972|20513741|P8|STARTED|Treatment Period 1 (21 Days)||5
8320058|NCT01427972|20513742|P7|STARTED|Treatment Period 1 (21 Days)||3
8320059|NCT01427972|20513743|P6|STARTED|Treatment Period 1 (21 Days)||3
8320060|NCT01427972|20513744|P5|STARTED|Treatment Period 1 (21 Days)||4
8320061|NCT01427972|20513745|P4|STARTED|Treatment Period 1 (21 Days)||3
8320062|NCT01427972|20513746|P3|STARTED|Treatment Period 1 (21 Days)||4
8320063|NCT01427972|20513747|P2|STARTED|Treatment Period 1 (21 Days)||4
8320064|NCT01427972|20513748|P1|STARTED|Treatment Period 1 (21 Days)||3
8320065|NCT01427933|20513774|P2|NOT COMPLETED|Overall Study||13
8320066|NCT01427933|20513775|P1|NOT COMPLETED|Overall Study||8
8320067|NCT01427933|20513774|P2|COMPLETED|Overall Study||57
8320068|NCT01427933|20513775|P1|COMPLETED|Overall Study||63
8320069|NCT01427933|20513774|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
8320070|NCT01427933|20513775|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
8320071|NCT01427933|20513774|P2|STARTED|Overall Study||70
8320072|NCT01427933|20513775|P1|STARTED|Overall Study||71
8320073|NCT01427920|20513795|P2|NOT COMPLETED|Overall Study||17
8320074|NCT01427920|20513796|P1|NOT COMPLETED|Overall Study||9
8320075|NCT01427920|20513795|P2|COMPLETED|Overall Study||157
8320076|NCT01427920|20513796|P1|COMPLETED|Overall Study||165
8320077|NCT01427920|20513795|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
8320078|NCT01427920|20513796|P1|Exposed|Overall Study||174
8320079|NCT01427920|20513795|P2|STARTED|Overall Study||174
8320080|NCT01427920|20513796|P1|STARTED|Overall Study||174
8320081|NCT01427907|20513816|P2|NOT COMPLETED|Overall Study||4
8320082|NCT01427907|20513817|P1|NOT COMPLETED|Overall Study||3
8320083|NCT01427907|20513816|P2|COMPLETED|Overall Study|Completed study|14
8320084|NCT01427907|20513817|P1|COMPLETED|Overall Study|Completed study|17
8320085|NCT01427907|20513816|P2|STARTED|Overall Study|Randomized|18
8320086|NCT01427907|20513817|P1|STARTED|Overall Study|Randomized|20
8320087|NCT01427881|20513823|P1|NOT COMPLETED|Overall Study||0
8320088|NCT01427881|20513823|P1|COMPLETED|Overall Study||43
8320089|NCT01427881|20513823|P1|STARTED|Overall Study||43
8320090|NCT01427803|20513838|P2|NOT COMPLETED|Overall Study||26
8320091|NCT01427803|20513839|P1|NOT COMPLETED|Overall Study||63
8320092|NCT01427803|20513838|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
8320093|NCT01427803|20513839|P1|COMPLETED|Overall Study||463
8320094|NCT01427803|20513838|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
8320095|NCT01427803|20513839|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
8320096|NCT01427803|20513838|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
8320097|NCT01427803|20513839|P1|Baseline Assessment|Overall Study||516
8320098|NCT01427803|20513838|P2|Purchased Product|Overall Study||252
8320099|NCT01427803|20513839|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
8320100|NCT01427803|20513838|P2|STARTED|Overall Study||252
8320101|NCT01427803|20513839|P1|STARTED|Overall Study||526
8320102|NCT01427751|20513853|P2|NOT COMPLETED|Overall Study||14
8320103|NCT01427751|20513854|P1|NOT COMPLETED|Overall Study||42
8320104|NCT01427751|20513853|P2|COMPLETED|Overall Study||139
8320105|NCT01427751|20513854|P1|COMPLETED|Overall Study||112
8320106|NCT01427751|20513853|P2|STARTED|Overall Study||153
8320107|NCT01427751|20513854|P1|STARTED|Overall Study||154
8320108|NCT01427738|20513874|P2|NOT COMPLETED|Overall Study||21
8320109|NCT01427738|20513875|P1|NOT COMPLETED|Overall Study||19
8320110|NCT01427738|20513874|P2|COMPLETED|Overall Study||90
8320111|NCT01427738|20513875|P1|COMPLETED|Overall Study||91
8320112|NCT01427738|20513874|P2|STARTED|Overall Study||111
8320113|NCT01427738|20513875|P1|STARTED|Overall Study||110
8320114|NCT01427608|20513895|P2|NOT COMPLETED|Overall Study||38
8320115|NCT01427608|20513896|P1|NOT COMPLETED|Overall Study||21
8320116|NCT01427608|20513895|P2|COMPLETED|Overall Study||24
8320117|NCT01427608|20513896|P1|COMPLETED|Overall Study||43
8320118|NCT01427608|20513895|P2|STARTED|Overall Study||62
8320119|NCT01427608|20513896|P1|STARTED|Overall Study||64
8320120|NCT01427595|20513908|P1|NOT COMPLETED|Overall Study||13
8320121|NCT01427595|20513908|P1|COMPLETED|Overall Study||12
8320122|NCT01427595|20513908|P1|STARTED|Overall Study||25
8320123|NCT01427517|20513915|P3|NOT COMPLETED|Overall Study||0
8320124|NCT01427517|20513916|P2|NOT COMPLETED|Overall Study||0
8320125|NCT01427517|20513917|P1|NOT COMPLETED|Overall Study||0
8320126|NCT01427517|20513915|P3|COMPLETED|Overall Study||3
8320127|NCT01427517|20513916|P2|COMPLETED|Overall Study||3
8320128|NCT01427517|20513917|P1|COMPLETED|Overall Study||3
8320129|NCT01427517|20513915|P3|STARTED|Overall Study||3
8320130|NCT01427517|20513916|P2|STARTED|Overall Study||3
8320131|NCT01427517|20513917|P1|STARTED|Overall Study||3
8320132|NCT01427504|20513931|P6|NOT COMPLETED|Overall Study||2
8320133|NCT01427504|20513932|P5|NOT COMPLETED|Overall Study||1
8320134|NCT01427504|20513933|P4|NOT COMPLETED|Overall Study||1
8320135|NCT01427504|20513934|P3|NOT COMPLETED|Overall Study||1
8320136|NCT01427504|20513935|P2|NOT COMPLETED|Overall Study||1
8320137|NCT01427504|20513936|P1|NOT COMPLETED|Overall Study||0
8320138|NCT01427504|20513931|P6|COMPLETED|Overall Study||4
8320139|NCT01427504|20513932|P5|COMPLETED|Overall Study||2
8320140|NCT01427504|20513933|P4|COMPLETED|Overall Study||5
8320141|NCT01427504|20513934|P3|COMPLETED|Overall Study||3
8320142|NCT01427504|20513935|P2|COMPLETED|Overall Study||2
8320143|NCT01427504|20513936|P1|COMPLETED|Overall Study||4
8320144|NCT01427504|20513931|P6|Received Combination|Overall Study||6
8320145|NCT01427504|20513932|P5|Received Combination|Overall Study||3
8320146|NCT01427504|20513933|P4|Received Combination|Overall Study||6
8320147|NCT01427504|20513934|P3|Received Combination|Overall Study||3
8320148|NCT01427504|20513935|P2|Received Combination|Overall Study||3
8320149|NCT01427504|20513936|P1|Received Combination|Overall Study||4
8320150|NCT01427504|20513931|P6|Received Etravirine|Overall Study||4
8320151|NCT01427504|20513932|P5|Received Etravirine|Overall Study||2
8320152|NCT01427504|20513933|P4|Received Etravirine|Overall Study||6
8320153|NCT01427504|20513934|P3|Received Etravirine|Overall Study||4
8320154|NCT01427504|20513935|P2|Received Etravirine|Overall Study||2
8320155|NCT01427504|20513936|P1|Received Etravirine|Overall Study||4
8320156|NCT01427504|20513931|P6|Received Boceprevir|Overall Study||4
8320157|NCT01427504|20513932|P5|Received Boceprevir|Overall Study||2
8320158|NCT01427504|20513933|P4|Received Boceprevir|Overall Study||5
8320159|NCT01427504|20513934|P3|Received Boceprevir|Overall Study||3
8320160|NCT01427504|20513935|P2|Received Boceprevir|Overall Study||3
8320161|NCT01427504|20513936|P1|Received Boceprevir|Overall Study||4
8320162|NCT01427504|20513931|P6|STARTED|Overall Study||6
8320163|NCT01427504|20513932|P5|STARTED|Overall Study||3
8320164|NCT01427504|20513933|P4|STARTED|Overall Study||6
8320165|NCT01427504|20513934|P3|STARTED|Overall Study||4
8320166|NCT01427504|20513935|P2|STARTED|Overall Study||3
8320167|NCT01427504|20513936|P1|STARTED|Overall Study||4
8320168|NCT01427309|20513957|P4|NOT COMPLETED|Overall Study||376
8320169|NCT01427309|20513958|P3|NOT COMPLETED|Overall Study||361
8320170|NCT01427309|20513959|P2|NOT COMPLETED|Overall Study||407
8320171|NCT01427309|20513960|P1|NOT COMPLETED|Overall Study||372
8320172|NCT01427309|20513957|P4|COMPLETED|Overall Study||8373
8320173|NCT01427309|20513958|P3|COMPLETED|Overall Study||8376
8320174|NCT01427309|20513959|P2|COMPLETED|Overall Study||6837
8320175|NCT01427309|20513960|P1|COMPLETED|Overall Study||6881
8320176|NCT01427309|20513957|P4|STARTED|Overall Study||8749
8320177|NCT01427309|20513958|P3|STARTED|Overall Study||8737
8320178|NCT01427309|20513959|P2|STARTED|Overall Study||7244
8320179|NCT01427309|20513960|P1|STARTED|Overall Study||7253
8320180|NCT01427296|20514000|P2|NOT COMPLETED|Overall Study||0
8320181|NCT01427296|20514001|P1|NOT COMPLETED|Overall Study||0
8320182|NCT01427296|20514000|P2|COMPLETED|Overall Study||1051
8320183|NCT01427296|20514001|P1|COMPLETED|Overall Study||1041
8320184|NCT01427296|20514000|P2|STARTED|Overall Study||1051
8320185|NCT01427296|20514001|P1|STARTED|Overall Study||1041
8320186|NCT01426958|20514007|P1|NOT COMPLETED|Overall Study||2
8320187|NCT01426958|20514007|P1|COMPLETED|Overall Study||22
8320188|NCT01426958|20514007|P1|STARTED|Overall Study||24
8320189|NCT01426867|20514024|P3|NOT COMPLETED|Overall Study||0
8320190|NCT01426867|20514025|P2|NOT COMPLETED|Overall Study||0
8320191|NCT01426867|20514026|P1|NOT COMPLETED|Overall Study||0
8320192|NCT01426867|20514024|P3|COMPLETED|Overall Study||34
8320193|NCT01426867|20514025|P2|COMPLETED|Overall Study||34
8320194|NCT01426867|20514026|P1|COMPLETED|Overall Study||33
8320195|NCT01426867|20514024|P3|STARTED|Overall Study||34
8320196|NCT01426867|20514025|P2|STARTED|Overall Study||34
8320197|NCT01426867|20514026|P1|STARTED|Overall Study||33
8320198|NCT01426854|20514036|P2|NOT COMPLETED|Overall Study||31
8320199|NCT01426854|20514037|P1|NOT COMPLETED|Overall Study||12
8320200|NCT01426854|20514036|P2|COMPLETED|Overall Study||98
8320201|NCT01426854|20514037|P1|COMPLETED|Overall Study||119
8320202|NCT01426854|20514036|P2|STARTED|Overall Study||129
8320203|NCT01426854|20514037|P1|STARTED|Overall Study||131
8320204|NCT01426828|20514047|P2|NOT COMPLETED|Immune Response Analysis||7
8320205|NCT01426828|20514048|P1|NOT COMPLETED|Immune Response Analysis||9
8320206|NCT01426828|20514047|P2|COMPLETED|Immune Response Analysis||8
8320207|NCT01426828|20514048|P1|COMPLETED|Immune Response Analysis||8
8320208|NCT01426828|20514047|P2|STARTED|Immune Response Analysis||15
8320209|NCT01426828|20514048|P1|STARTED|Immune Response Analysis||17
8320210|NCT01426828|20514047|P2|NOT COMPLETED|Overall Study Evaluations||3
8320211|NCT01426828|20514048|P1|NOT COMPLETED|Overall Study Evaluations||5
8320212|NCT01426828|20514047|P2|COMPLETED|Overall Study Evaluations||15
8320213|NCT01426828|20514048|P1|COMPLETED|Overall Study Evaluations||17
8320214|NCT01426828|20514047|P2|STARTED|Overall Study Evaluations||18
8320215|NCT01426828|20514048|P1|STARTED|Overall Study Evaluations||22
8320216|NCT01426789|20514056|P6|NOT COMPLETED|Part 2||0
8320217|NCT01426789|20514057|P5|NOT COMPLETED|Part 2||8
8320218|NCT01426789|20514058|P4|NOT COMPLETED|Part 2||1
8320219|NCT01426789|20514059|P3|NOT COMPLETED|Part 2||15
8320220|NCT01426789|20514060|P2|NOT COMPLETED|Part 2||0
8320221|NCT01426789|20514061|P1|NOT COMPLETED|Part 2||0
8320222|NCT01426789|20514056|P6|COMPLETED|Part 2||1
8320223|NCT01426789|20514057|P5|COMPLETED|Part 2||19
8320224|NCT01426789|20514058|P4|COMPLETED|Part 2||12
8320225|NCT01426789|20514059|P3|COMPLETED|Part 2||34
8320226|NCT01426789|20514060|P2|COMPLETED|Part 2||0
8320227|NCT01426789|20514061|P1|COMPLETED|Part 2||0
8320228|NCT01426789|20514056|P6|STARTED|Part 2||1
8320229|NCT01426789|20514057|P5|STARTED|Part 2||27
8320230|NCT01426789|20514058|P4|STARTED|Part 2||13
8320231|NCT01426789|20514059|P3|STARTED|Part 2||49
8320232|NCT01426789|20514060|P2|STARTED|Part 2||0
8320233|NCT01426789|20514061|P1|STARTED|Part 2||0
8320234|NCT01426789|20514056|P6|NOT COMPLETED|Part 1||0
8320235|NCT01426789|20514057|P5|NOT COMPLETED|Part 1||0
8320236|NCT01426789|20514058|P4|NOT COMPLETED|Part 1||0
8320237|NCT01426789|20514059|P3|NOT COMPLETED|Part 1||0
8320238|NCT01426789|20514060|P2|NOT COMPLETED|Part 1||4
8320239|NCT01426789|20514061|P1|NOT COMPLETED|Part 1||6
8320240|NCT01426789|20514056|P6|COMPLETED|Part 1||0
8320241|NCT01426789|20514057|P5|COMPLETED|Part 1||0
8320242|NCT01426789|20514058|P4|COMPLETED|Part 1||0
8320243|NCT01426789|20514059|P3|COMPLETED|Part 1||0
8320244|NCT01426789|20514060|P2|COMPLETED|Part 1||28
8320245|NCT01426789|20514061|P1|COMPLETED|Part 1||62
8320246|NCT01426789|20514056|P6|STARTED|Part 1||0
8320247|NCT01426789|20514057|P5|STARTED|Part 1||0
8320248|NCT01426789|20514058|P4|STARTED|Part 1||0
8320249|NCT01426789|20514059|P3|STARTED|Part 1||0
8320250|NCT01426789|20514060|P2|STARTED|Part 1||32
8320251|NCT01426789|20514061|P1|STARTED|Part 1||68
8320252|NCT01426763|20514077|P2|NOT COMPLETED|Overall Study||0
8320253|NCT01426763|20514078|P1|NOT COMPLETED|Overall Study||0
8320254|NCT01426763|20514077|P2|COMPLETED|Overall Study||6
8320255|NCT01426763|20514078|P1|COMPLETED|Overall Study||6
8320256|NCT01426763|20514077|P2|STARTED|Overall Study||6
8320257|NCT01426763|20514078|P1|STARTED|Overall Study||6
8320258|NCT01426581|20514086|P2|NOT COMPLETED|Overall Study||0
8320259|NCT01426581|20514087|P1|NOT COMPLETED|Overall Study||0
8320260|NCT01426581|20514086|P2|COMPLETED|Overall Study||58
8320261|NCT01426581|20514087|P1|COMPLETED|Overall Study||62
8320262|NCT01426581|20514086|P2|STARTED|Overall Study||58
8320263|NCT01426581|20514087|P1|STARTED|Overall Study||62
8320264|NCT01426555|20514103|P2|NOT COMPLETED|Overall Study||15
8320265|NCT01426555|20514104|P1|NOT COMPLETED|Overall Study||18
8320266|NCT01426555|20514103|P2|COMPLETED|Overall Study||20
8320267|NCT01426555|20514104|P1|COMPLETED|Overall Study||17
8320268|NCT01426555|20514103|P2|STARTED|Overall Study||35
8320269|NCT01426555|20514104|P1|STARTED|Overall Study||35
8320270|NCT01426516|20514114|P2|NOT COMPLETED|Overall Study||0
8320271|NCT01426516|20514115|P1|NOT COMPLETED|Overall Study||0
8320272|NCT01426516|20514114|P2|COMPLETED|Overall Study||17
8320273|NCT01426516|20514115|P1|COMPLETED|Overall Study||12
8320274|NCT01426516|20514114|P2|STARTED|Overall Study||17
8320275|NCT01426516|20514115|P1|STARTED|Overall Study||12
8320276|NCT01426438|20514123|P2|NOT COMPLETED|Overall Study||10
8320277|NCT01426438|20514124|P1|NOT COMPLETED|Overall Study||15
8320278|NCT01426438|20514123|P2|COMPLETED|Overall Study||39
8320279|NCT01426438|20514124|P1|COMPLETED|Overall Study||35
8320280|NCT01426438|20514123|P2|STARTED|Overall Study||49
8320281|NCT01426438|20514124|P1|STARTED|Overall Study||50
8320282|NCT01426425|20514156|P1|NOT COMPLETED|Overall Study||175
8320283|NCT01426425|20514156|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
8320284|NCT01426425|20514156|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
8320285|NCT01426425|20514156|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
8320286|NCT01426425|20514156|P1|STARTED|Overall Study||572
8320287|NCT01426412|20514171|P9|NOT COMPLETED|Overall Study||1
8320288|NCT01426412|20514172|P8|NOT COMPLETED|Overall Study||3
8320289|NCT01426412|20514173|P7|NOT COMPLETED|Overall Study||0
8320290|NCT01426412|20514174|P6|NOT COMPLETED|Overall Study||0
8320291|NCT01426412|20514175|P5|NOT COMPLETED|Overall Study||1
8320292|NCT01426412|20514176|P4|NOT COMPLETED|Overall Study||0
8320293|NCT01426412|20514177|P3|NOT COMPLETED|Overall Study||0
8320294|NCT01426412|20514178|P2|NOT COMPLETED|Overall Study||0
8320295|NCT01426412|20514179|P1|NOT COMPLETED|Overall Study||1
8320296|NCT01426412|20514171|P9|COMPLETED|Overall Study||16
8320297|NCT01426412|20514172|P8|COMPLETED|Overall Study||7
8320298|NCT01426412|20514173|P7|COMPLETED|Overall Study||6
8320299|NCT01426412|20514174|P6|COMPLETED|Overall Study||6
8320300|NCT01426412|20514175|P5|COMPLETED|Overall Study||5
8320301|NCT01426412|20514176|P4|COMPLETED|Overall Study||6
8320302|NCT01426412|20514177|P3|COMPLETED|Overall Study||6
8320303|NCT01426412|20514178|P2|COMPLETED|Overall Study||6
8320304|NCT01426412|20514179|P1|COMPLETED|Overall Study||5
8320305|NCT01426412|20514171|P9|Received at Least 1 Dose of Study Drug|Overall Study||17
8320306|NCT01426412|20514172|P8|Received at Least 1 Dose of Study Drug|Overall Study||10
8320307|NCT01426412|20514173|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8320308|NCT01426412|20514174|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
8320309|NCT01426412|20514175|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8320310|NCT01426412|20514176|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8320311|NCT01426412|20514177|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8320312|NCT01426412|20514178|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8320313|NCT01426412|20514179|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8320314|NCT01426412|20514171|P9|STARTED|Overall Study||17
8320315|NCT01426412|20514172|P8|STARTED|Overall Study||10
8320316|NCT01426412|20514173|P7|STARTED|Overall Study||6
8320317|NCT01426412|20514174|P6|STARTED|Overall Study||6
8320318|NCT01426412|20514175|P5|STARTED|Overall Study||6
8320319|NCT01426412|20514176|P4|STARTED|Overall Study||6
8320320|NCT01426412|20514177|P3|STARTED|Overall Study||6
8320321|NCT01426412|20514178|P2|STARTED|Overall Study||6
8320322|NCT01426412|20514179|P1|STARTED|Overall Study||6
8320323|NCT01426386|20514242|P6|NOT COMPLETED|Overall Study||1
8320324|NCT01426386|20514243|P5|NOT COMPLETED|Overall Study||4
8320325|NCT01426386|20514244|P4|NOT COMPLETED|Overall Study||0
8320326|NCT01426386|20514245|P3|NOT COMPLETED|Overall Study||2
8320327|NCT01426386|20514246|P2|NOT COMPLETED|Overall Study||6
8320328|NCT01426386|20514247|P1|NOT COMPLETED|Overall Study||3
8320329|NCT01426386|20514242|P6|COMPLETED|Overall Study||42
8320330|NCT01426386|20514243|P5|COMPLETED|Overall Study||43
8320331|NCT01426386|20514244|P4|COMPLETED|Overall Study||44
8320332|NCT01426386|20514245|P3|COMPLETED|Overall Study||42
8320333|NCT01426386|20514246|P2|COMPLETED|Overall Study||39
8320334|NCT01426386|20514247|P1|COMPLETED|Overall Study||39
8320335|NCT01426386|20514242|P6|STARTED|Overall Study||43
8320336|NCT01426386|20514243|P5|STARTED|Overall Study||47
8320337|NCT01426386|20514244|P4|STARTED|Overall Study||44
8320338|NCT01426386|20514245|P3|STARTED|Overall Study||44
8320339|NCT01426386|20514246|P2|STARTED|Overall Study||45
8320340|NCT01426386|20514247|P1|STARTED|Overall Study||42
8320341|NCT01426373|20514303|P1|NOT COMPLETED|Overall Study||34
8320342|NCT01426373|20514303|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
8320343|NCT01426373|20514303|P1|STARTED|Overall Study||165
8320344|NCT01426360|20514321|P2|NOT COMPLETED|Overall Study||0
8320345|NCT01426360|20514322|P1|NOT COMPLETED|Overall Study||0
8320346|NCT01426360|20514321|P2|COMPLETED|Overall Study||41
8320347|NCT01426360|20514322|P1|COMPLETED|Overall Study||38
8320348|NCT01426360|20514321|P2|STARTED|Overall Study||41
8320349|NCT01426360|20514322|P1|STARTED|Overall Study||38
8320350|NCT01426347|20514336|P2|NOT COMPLETED|Overall Study||3
8320351|NCT01426347|20514337|P1|NOT COMPLETED|Overall Study||7
8320352|NCT01426347|20514336|P2|COMPLETED|Overall Study||39
8320353|NCT01426347|20514337|P1|COMPLETED|Overall Study||34
8320354|NCT01426347|20514336|P2|STARTED|Overall Study||42
8320355|NCT01426347|20514337|P1|STARTED|Overall Study||41
8320356|NCT01426269|20514345|P3|NOT COMPLETED|Period 2: 40 Weeks||47
8320357|NCT01426269|20514346|P2|NOT COMPLETED|Period 2: 40 Weeks||38
8320358|NCT01426269|20514347|P1|NOT COMPLETED|Period 2: 40 Weeks||0
8320359|NCT01426269|20514345|P3|COMPLETED|Period 2: 40 Weeks||18
8320360|NCT01426269|20514346|P2|COMPLETED|Period 2: 40 Weeks||27
8320361|NCT01426269|20514347|P1|COMPLETED|Period 2: 40 Weeks||0
8320362|NCT01426269|20514345|P3|STARTED|Period 2: 40 Weeks||65
8320363|NCT01426269|20514346|P2|STARTED|Period 2: 40 Weeks||65
8320364|NCT01426269|20514347|P1|STARTED|Period 2: 40 Weeks||0
8320365|NCT01426269|20514345|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
8320366|NCT01426269|20514346|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
8320367|NCT01426269|20514347|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
8320368|NCT01426269|20514345|P3|COMPLETED|Eligibility for Period 2, Randomization||0
8320369|NCT01426269|20514346|P2|COMPLETED|Eligibility for Period 2, Randomization||0
8320370|NCT01426269|20514347|P1|COMPLETED|Eligibility for Period 2, Randomization||130
8320371|NCT01426269|20514345|P3|STARTED|Eligibility for Period 2, Randomization||0
8320372|NCT01426269|20514346|P2|STARTED|Eligibility for Period 2, Randomization||0
8320373|NCT01426269|20514347|P1|STARTED|Eligibility for Period 2, Randomization||180
8320374|NCT01426269|20514345|P3|NOT COMPLETED|Period 1: 12 Weeks||0
8320375|NCT01426269|20514346|P2|NOT COMPLETED|Period 1: 12 Weeks||0
8320376|NCT01426269|20514347|P1|NOT COMPLETED|Period 1: 12 Weeks||55
8320377|NCT01426269|20514345|P3|COMPLETED|Period 1: 12 Weeks||0
8320378|NCT01426269|20514346|P2|COMPLETED|Period 1: 12 Weeks||0
8320379|NCT01426269|20514347|P1|COMPLETED|Period 1: 12 Weeks||180
8320380|NCT01426269|20514345|P3|STARTED|Period 1: 12 Weeks||0
8320381|NCT01426269|20514346|P2|STARTED|Period 1: 12 Weeks||0
8320382|NCT01426269|20514347|P1|STARTED|Period 1: 12 Weeks||235
8320383|NCT01426230|20514374|P2|NOT COMPLETED|Overall Study||27
8320384|NCT01426230|20514375|P1|NOT COMPLETED|Overall Study||31
8320385|NCT01426230|20514374|P2|COMPLETED|Overall Study||84
8320386|NCT01426230|20514375|P1|COMPLETED|Overall Study||55
8320387|NCT01426230|20514374|P2|STARTED|Overall Study||111
8320388|NCT01426230|20514375|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
8320389|NCT01426217|20514382|P2|NOT COMPLETED|Overall Study||14
8320390|NCT01426217|20514383|P1|NOT COMPLETED|Overall Study||8
8320391|NCT01426217|20514382|P2|COMPLETED|Overall Study||266
8320392|NCT01426217|20514383|P1|COMPLETED|Overall Study||306
8320393|NCT01426217|20514382|P2|STARTED|Overall Study||280
8320394|NCT01426217|20514383|P1|STARTED|Overall Study||314
8320395|NCT01426191|20514389|P1|NOT COMPLETED|Overall Study||0
8320396|NCT01426191|20514389|P1|COMPLETED|Overall Study||2032
8320397|NCT01426191|20514389|P1|STARTED|Overall Study||2032
8320398|NCT01426113|20514396|P2|NOT COMPLETED|Overall Study||2
8320399|NCT01426113|20514397|P1|NOT COMPLETED|Overall Study||1
8320400|NCT01426113|20514396|P2|COMPLETED|Overall Study||1
8320401|NCT01426113|20514397|P1|COMPLETED|Overall Study||2
8320402|NCT01426113|20514396|P2|STARTED|Overall Study||3
8320403|NCT01426113|20514397|P1|STARTED|Overall Study||3
8320404|NCT01426009|20514403|P1|NOT COMPLETED|Washout 4||1
8320405|NCT01426009|20514403|P1|COMPLETED|Washout 4||126
8320406|NCT01426009|20514403|P1|STARTED|Washout 4||127
8320407|NCT01426009|20514403|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
8320408|NCT01426009|20514403|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
8320409|NCT01426009|20514403|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
8320410|NCT01426009|20514403|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
8320411|NCT01426009|20514403|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
8320412|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
8320413|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
8320414|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
8320415|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
8320416|NCT01426009|20514403|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
8320417|NCT01426009|20514403|P1|NOT COMPLETED|Washout 3||1
8320418|NCT01426009|20514403|P1|COMPLETED|Washout 3||128
8320419|NCT01426009|20514403|P1|STARTED|Washout 3||129
8320420|NCT01426009|20514403|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
8320421|NCT01426009|20514403|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
8320422|NCT01426009|20514403|P1|Placebo|Period 3-Third Intervention (7 Days)||22
8320423|NCT01426009|20514403|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
8320424|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
8320425|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
8320426|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
8320427|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
8320428|NCT01426009|20514403|P1|STARTED|Period 3-Third Intervention (7 Days)||129
8320429|NCT01426009|20514403|P1|NOT COMPLETED|Washout 2||1
8320430|NCT01426009|20514403|P1|COMPLETED|Washout 2||129
8320431|NCT01426009|20514403|P1|STARTED|Washout 2||130
8320432|NCT01426009|20514403|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
8320433|NCT01426009|20514403|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
8320434|NCT01426009|20514403|P1|Placebo|Period 2-Second Intervention (7 Days)||21
8320435|NCT01426009|20514403|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
8320436|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
8320437|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
8320438|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
8320439|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
8320440|NCT01426009|20514403|P1|STARTED|Period 2-Second Intervention (7 Days)||135
8320441|NCT01426009|20514403|P1|NOT COMPLETED|Washout 1||2
8320442|NCT01426009|20514403|P1|COMPLETED|Washout 1||135
8320443|NCT01426009|20514403|P1|STARTED|Washout 1||137
8320444|NCT01426009|20514403|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
8320445|NCT01426009|20514403|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
8320446|NCT01426009|20514403|P1|Placebo|Period 1-First Intervention (7 Days)||24
8320447|NCT01426009|20514403|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
8320448|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
8320449|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
8320450|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
8320451|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
8320452|NCT01426009|20514403|P1|STARTED|Period 1-First Intervention (7 Days)||139
8320453|NCT01425879|20514459|P1|NOT COMPLETED|Overall Study||0
8320454|NCT01425879|20514459|P1|COMPLETED|Overall Study||8
8320455|NCT01425879|20514459|P1|STARTED|Overall Study||8
8320456|NCT01425853|20514468|P2|NOT COMPLETED|Overall Study||77
8320457|NCT01425853|20514469|P1|NOT COMPLETED|Overall Study||64
8320458|NCT01425853|20514468|P2|COMPLETED|Overall Study||225
8320459|NCT01425853|20514469|P1|COMPLETED|Overall Study||240
8320460|NCT01425853|20514468|P2|Per Protocol (PP)|Overall Study||258
8320461|NCT01425853|20514469|P1|Per Protocol (PP)|Overall Study||264
8320462|NCT01425853|20514468|P2|Safety Population|Overall Study||299
8320463|NCT01425853|20514469|P1|Safety Population|Overall Study||304
8320464|NCT01425853|20514468|P2|STARTED|Overall Study||302
8320465|NCT01425853|20514469|P1|STARTED|Overall Study||304
8320466|NCT01425814|20514499|P6|NOT COMPLETED|Period 5||1
8320467|NCT01425814|20514500|P5|NOT COMPLETED|Period 5||0
8320468|NCT01425814|20514501|P4|NOT COMPLETED|Period 5||0
8320469|NCT01425814|20514502|P3|NOT COMPLETED|Period 5||1
8320470|NCT01425814|20514503|P2|NOT COMPLETED|Period 5||0
8320471|NCT01425814|20514504|P1|NOT COMPLETED|Period 5||0
8320472|NCT01425814|20514499|P6|COMPLETED|Period 5||11
8320473|NCT01425814|20514500|P5|COMPLETED|Period 5||12
8320474|NCT01425814|20514501|P4|COMPLETED|Period 5||10
8320475|NCT01425814|20514502|P3|COMPLETED|Period 5||10
8320476|NCT01425814|20514503|P2|COMPLETED|Period 5||9
8320477|NCT01425814|20514504|P1|COMPLETED|Period 5||11
8320478|NCT01425814|20514499|P6|STARTED|Period 5||12
8320479|NCT01425814|20514500|P5|STARTED|Period 5||12
8320480|NCT01425814|20514501|P4|STARTED|Period 5||10
8320481|NCT01425814|20514502|P3|STARTED|Period 5||11
8320482|NCT01425814|20514503|P2|STARTED|Period 5||9
8320483|NCT01425814|20514504|P1|STARTED|Period 5||11
8320484|NCT01425814|20514499|P6|NOT COMPLETED|Period 4||0
8320485|NCT01425814|20514500|P5|NOT COMPLETED|Period 4||0
8320486|NCT01425814|20514501|P4|NOT COMPLETED|Period 4||0
8320487|NCT01425814|20514502|P3|NOT COMPLETED|Period 4||1
8320488|NCT01425814|20514503|P2|NOT COMPLETED|Period 4||0
8320489|NCT01425814|20514504|P1|NOT COMPLETED|Period 4||1
8320490|NCT01425814|20514499|P6|COMPLETED|Period 4||12
8320491|NCT01425814|20514500|P5|COMPLETED|Period 4||12
8320492|NCT01425814|20514501|P4|COMPLETED|Period 4||10
8320493|NCT01425814|20514502|P3|COMPLETED|Period 4||11
8320494|NCT01425814|20514503|P2|COMPLETED|Period 4||9
8320495|NCT01425814|20514504|P1|COMPLETED|Period 4||11
8320496|NCT01425814|20514499|P6|STARTED|Period 4||12
8320497|NCT01425814|20514500|P5|STARTED|Period 4||12
8320498|NCT01425814|20514501|P4|STARTED|Period 4||10
8320499|NCT01425814|20514502|P3|STARTED|Period 4||12
8320500|NCT01425814|20514503|P2|STARTED|Period 4||9
8320501|NCT01425814|20514504|P1|STARTED|Period 4||12
8320502|NCT01425814|20514499|P6|NOT COMPLETED|Period 3||1
8320503|NCT01425814|20514500|P5|NOT COMPLETED|Period 3||0
8320504|NCT01425814|20514501|P4|NOT COMPLETED|Period 3||0
8320505|NCT01425814|20514502|P3|NOT COMPLETED|Period 3||0
8320506|NCT01425814|20514503|P2|NOT COMPLETED|Period 3||0
8320507|NCT01425814|20514504|P1|NOT COMPLETED|Period 3||0
8320508|NCT01425814|20514499|P6|COMPLETED|Period 3||12
8320509|NCT01425814|20514500|P5|COMPLETED|Period 3||12
8320510|NCT01425814|20514501|P4|COMPLETED|Period 3||10
8320511|NCT01425814|20514502|P3|COMPLETED|Period 3||12
8320512|NCT01425814|20514503|P2|COMPLETED|Period 3||9
8320513|NCT01425814|20514504|P1|COMPLETED|Period 3||12
8320514|NCT01425814|20514499|P6|STARTED|Period 3||13
8320515|NCT01425814|20514500|P5|STARTED|Period 3||12
8320516|NCT01425814|20514501|P4|STARTED|Period 3||10
8320517|NCT01425814|20514502|P3|STARTED|Period 3||12
8320518|NCT01425814|20514503|P2|STARTED|Period 3||9
8320519|NCT01425814|20514504|P1|STARTED|Period 3||12
8320520|NCT01425814|20514499|P6|NOT COMPLETED|Period 2||0
8320521|NCT01425814|20514500|P5|NOT COMPLETED|Period 2||0
8320522|NCT01425814|20514501|P4|NOT COMPLETED|Period 2||0
8320523|NCT01425814|20514502|P3|NOT COMPLETED|Period 2||0
8320524|NCT01425814|20514503|P2|NOT COMPLETED|Period 2||1
8320525|NCT01425814|20514504|P1|NOT COMPLETED|Period 2||0
8320526|NCT01425814|20514499|P6|COMPLETED|Period 2||13
8320527|NCT01425814|20514500|P5|COMPLETED|Period 2||12
8320528|NCT01425814|20514501|P4|COMPLETED|Period 2||10
8320529|NCT01425814|20514502|P3|COMPLETED|Period 2||12
8320530|NCT01425814|20514503|P2|COMPLETED|Period 2||9
8320531|NCT01425814|20514504|P1|COMPLETED|Period 2||12
8320532|NCT01425814|20514499|P6|STARTED|Period 2||13
8320533|NCT01425814|20514500|P5|STARTED|Period 2||12
8320534|NCT01425814|20514501|P4|STARTED|Period 2||10
8320535|NCT01425814|20514502|P3|STARTED|Period 2||12
8320536|NCT01425814|20514503|P2|STARTED|Period 2||10
8320537|NCT01425814|20514504|P1|STARTED|Period 2||12
8320538|NCT01425814|20514499|P6|NOT COMPLETED|Period 1||0
8320539|NCT01425814|20514500|P5|NOT COMPLETED|Period 1||0
8320540|NCT01425814|20514501|P4|NOT COMPLETED|Period 1||0
8320541|NCT01425814|20514502|P3|NOT COMPLETED|Period 1||0
8320542|NCT01425814|20514503|P2|NOT COMPLETED|Period 1||1
8320543|NCT01425814|20514504|P1|NOT COMPLETED|Period 1||0
8320544|NCT01425814|20514499|P6|COMPLETED|Period 1||13
8320545|NCT01425814|20514500|P5|COMPLETED|Period 1||12
8320546|NCT01425814|20514501|P4|COMPLETED|Period 1||10
8320547|NCT01425814|20514502|P3|COMPLETED|Period 1||12
8320548|NCT01425814|20514503|P2|COMPLETED|Period 1||10
8320549|NCT01425814|20514504|P1|COMPLETED|Period 1||12
8320550|NCT01425814|20514499|P6|STARTED|Period 1||13
8320551|NCT01425814|20514500|P5|STARTED|Period 1||12
8320552|NCT01425814|20514501|P4|STARTED|Period 1||10
8320553|NCT01425814|20514502|P3|STARTED|Period 1||12
8320554|NCT01425814|20514503|P2|STARTED|Period 1||11
8320555|NCT01425814|20514504|P1|STARTED|Period 1||12
8320556|NCT01425801|20514596|P6|NOT COMPLETED|Period 6||0
8320557|NCT01425801|20514597|P5|NOT COMPLETED|Period 6||0
8320558|NCT01425801|20514598|P4|NOT COMPLETED|Period 6||0
8320559|NCT01425801|20514599|P3|NOT COMPLETED|Period 6||0
8320560|NCT01425801|20514600|P2|NOT COMPLETED|Period 6||0
8320561|NCT01425801|20514601|P1|NOT COMPLETED|Period 6||0
8320562|NCT01425801|20514596|P6|COMPLETED|Period 6||10
8320563|NCT01425801|20514597|P5|COMPLETED|Period 6||11
8320564|NCT01425801|20514598|P4|COMPLETED|Period 6||12
8320565|NCT01425801|20514599|P3|COMPLETED|Period 6||7
8320566|NCT01425801|20514600|P2|COMPLETED|Period 6||9
8320567|NCT01425801|20514601|P1|COMPLETED|Period 6||9
8320568|NCT01425801|20514596|P6|STARTED|Period 6||10
8320569|NCT01425801|20514597|P5|STARTED|Period 6||11
8320570|NCT01425801|20514598|P4|STARTED|Period 6||12
8320571|NCT01425801|20514599|P3|STARTED|Period 6||7
8320572|NCT01425801|20514600|P2|STARTED|Period 6||9
8320573|NCT01425801|20514601|P1|STARTED|Period 6||9
8320574|NCT01425801|20514596|P6|NOT COMPLETED|Period 5||0
8320575|NCT01425801|20514597|P5|NOT COMPLETED|Period 5||0
8320576|NCT01425801|20514598|P4|NOT COMPLETED|Period 5||0
8320577|NCT01425801|20514599|P3|NOT COMPLETED|Period 5||0
8320578|NCT01425801|20514600|P2|NOT COMPLETED|Period 5||0
8320579|NCT01425801|20514601|P1|NOT COMPLETED|Period 5||0
8320580|NCT01425801|20514596|P6|COMPLETED|Period 5||10
8320581|NCT01425801|20514597|P5|COMPLETED|Period 5||11
8320582|NCT01425801|20514598|P4|COMPLETED|Period 5||12
8320583|NCT01425801|20514599|P3|COMPLETED|Period 5||7
8320584|NCT01425801|20514600|P2|COMPLETED|Period 5||9
8320585|NCT01425801|20514601|P1|COMPLETED|Period 5||9
8320586|NCT01425801|20514596|P6|STARTED|Period 5||10
8320587|NCT01425801|20514597|P5|STARTED|Period 5||11
8320588|NCT01425801|20514598|P4|STARTED|Period 5||12
8320589|NCT01425801|20514599|P3|STARTED|Period 5||7
8320590|NCT01425801|20514600|P2|STARTED|Period 5||9
8320591|NCT01425801|20514601|P1|STARTED|Period 5||9
8320592|NCT01425801|20514596|P6|NOT COMPLETED|Period 4||0
8320593|NCT01425801|20514597|P5|NOT COMPLETED|Period 4||0
8320594|NCT01425801|20514598|P4|NOT COMPLETED|Period 4||0
8320595|NCT01425801|20514599|P3|NOT COMPLETED|Period 4||1
8320596|NCT01425801|20514600|P2|NOT COMPLETED|Period 4||0
8320597|NCT01425801|20514601|P1|NOT COMPLETED|Period 4||0
8320598|NCT01425801|20514596|P6|COMPLETED|Period 4||10
8320599|NCT01425801|20514597|P5|COMPLETED|Period 4||11
8320600|NCT01425801|20514598|P4|COMPLETED|Period 4||12
8320601|NCT01425801|20514599|P3|COMPLETED|Period 4||7
8320602|NCT01425801|20514600|P2|COMPLETED|Period 4||9
8320603|NCT01425801|20514601|P1|COMPLETED|Period 4||9
8320604|NCT01425801|20514596|P6|STARTED|Period 4||10
8320605|NCT01425801|20514597|P5|STARTED|Period 4||11
8320606|NCT01425801|20514598|P4|STARTED|Period 4||12
8320607|NCT01425801|20514599|P3|STARTED|Period 4||8
8320608|NCT01425801|20514600|P2|STARTED|Period 4||9
8320609|NCT01425801|20514601|P1|STARTED|Period 4||9
8320610|NCT01425801|20514596|P6|NOT COMPLETED|Period 3||0
8320611|NCT01425801|20514597|P5|NOT COMPLETED|Period 3||0
8320612|NCT01425801|20514598|P4|NOT COMPLETED|Period 3||0
8320613|NCT01425801|20514599|P3|NOT COMPLETED|Period 3||1
8320614|NCT01425801|20514600|P2|NOT COMPLETED|Period 3||0
8320615|NCT01425801|20514601|P1|NOT COMPLETED|Period 3||0
8320616|NCT01425801|20514596|P6|COMPLETED|Period 3||10
8320617|NCT01425801|20514597|P5|COMPLETED|Period 3||11
8320618|NCT01425801|20514598|P4|COMPLETED|Period 3||12
8320619|NCT01425801|20514599|P3|COMPLETED|Period 3||8
8320620|NCT01425801|20514600|P2|COMPLETED|Period 3||9
8320621|NCT01425801|20514601|P1|COMPLETED|Period 3||9
8320622|NCT01425801|20514596|P6|STARTED|Period 3||10
8320623|NCT01425801|20514597|P5|STARTED|Period 3||11
8320624|NCT01425801|20514598|P4|STARTED|Period 3||12
8320625|NCT01425801|20514599|P3|STARTED|Period 3||9
8320626|NCT01425801|20514600|P2|STARTED|Period 3||9
8320627|NCT01425801|20514601|P1|STARTED|Period 3||9
8320628|NCT01425801|20514596|P6|NOT COMPLETED|Period 2||0
8320629|NCT01425801|20514597|P5|NOT COMPLETED|Period 2||1
8320630|NCT01425801|20514598|P4|NOT COMPLETED|Period 2||0
8320631|NCT01425801|20514599|P3|NOT COMPLETED|Period 2||0
8320632|NCT01425801|20514600|P2|NOT COMPLETED|Period 2||0
8320633|NCT01425801|20514601|P1|NOT COMPLETED|Period 2||0
8320634|NCT01425801|20514596|P6|COMPLETED|Period 2||10
8320635|NCT01425801|20514597|P5|COMPLETED|Period 2||11
8320636|NCT01425801|20514598|P4|COMPLETED|Period 2||12
8320637|NCT01425801|20514599|P3|COMPLETED|Period 2||9
8320638|NCT01425801|20514600|P2|COMPLETED|Period 2||9
8320639|NCT01425801|20514601|P1|COMPLETED|Period 2||9
8320640|NCT01425801|20514596|P6|STARTED|Period 2||10
8320641|NCT01425801|20514597|P5|STARTED|Period 2||12
8320642|NCT01425801|20514598|P4|STARTED|Period 2||12
8320643|NCT01425801|20514599|P3|STARTED|Period 2||9
8320644|NCT01425801|20514600|P2|STARTED|Period 2||9
8320645|NCT01425801|20514601|P1|STARTED|Period 2||9
8320646|NCT01425801|20514596|P6|NOT COMPLETED|Period 1||0
8320647|NCT01425801|20514597|P5|NOT COMPLETED|Period 1||1
8320648|NCT01425801|20514598|P4|NOT COMPLETED|Period 1||0
8320649|NCT01425801|20514599|P3|NOT COMPLETED|Period 1||0
8320650|NCT01425801|20514600|P2|NOT COMPLETED|Period 1||0
8320651|NCT01425801|20514601|P1|NOT COMPLETED|Period 1||0
8320652|NCT01425801|20514596|P6|COMPLETED|Period 1||10
8320653|NCT01425801|20514597|P5|COMPLETED|Period 1||12
8320654|NCT01425801|20514598|P4|COMPLETED|Period 1||12
8320655|NCT01425801|20514599|P3|COMPLETED|Period 1||9
8320656|NCT01425801|20514600|P2|COMPLETED|Period 1||9
8320657|NCT01425801|20514601|P1|COMPLETED|Period 1||9
8320658|NCT01425801|20514596|P6|STARTED|Period 1||10
8320659|NCT01425801|20514597|P5|STARTED|Period 1||13
8320660|NCT01425801|20514598|P4|STARTED|Period 1||12
8320661|NCT01425801|20514599|P3|STARTED|Period 1||9
8320662|NCT01425801|20514600|P2|STARTED|Period 1||9
8320663|NCT01425801|20514601|P1|STARTED|Period 1||9
8320664|NCT01425749|20514707|P2|NOT COMPLETED|Overall Study||1
8320665|NCT01425749|20514708|P1|NOT COMPLETED|Overall Study||0
8320666|NCT01425749|20514707|P2|COMPLETED|Overall Study||11
8320667|NCT01425749|20514708|P1|COMPLETED|Overall Study||13
8320668|NCT01425749|20514707|P2|STARTED|Overall Study||12
8320669|NCT01425749|20514708|P1|STARTED|Overall Study||13
8320670|NCT01425723|20514725|P2|NOT COMPLETED|Overall Study||18
8320671|NCT01425723|20514726|P1|NOT COMPLETED|Overall Study||4
8320672|NCT01425723|20514725|P2|COMPLETED|Overall Study||75
8320673|NCT01425723|20514726|P1|COMPLETED|Overall Study||23
8320674|NCT01425723|20514725|P2|Surgery Subgroup|Overall Study||15
8320675|NCT01425723|20514726|P1|Surgery Subgroup|Overall Study||1
8320676|NCT01425723|20514725|P2|Episodic|Overall Study||15
8320677|NCT01425723|20514726|P1|Episodic|Overall Study||0
8320678|NCT01425723|20514725|P2|Personalized Prophylaxis|Overall Study||17
8320679|NCT01425723|20514726|P1|Personalized Prophylaxis|Overall Study||2
8320680|NCT01425723|20514725|P2|Individualized Prophylaxis|Overall Study||31
8320681|NCT01425723|20514726|P1|Individualized Prophylaxis|Overall Study||5
8320682|NCT01425723|20514725|P2|Weekly Prophylaxis|Overall Study||51
8320683|NCT01425723|20514726|P1|Weekly Prophylaxis|Overall Study||23
8320684|NCT01425723|20514725|P2|STARTED|Overall Study||93
8320685|NCT01425723|20514726|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
8320686|NCT01425632|20514756|P3|NOT COMPLETED|Overall Study||4
8320687|NCT01425632|20514757|P2|NOT COMPLETED|Overall Study||1
8320688|NCT01425632|20514758|P1|NOT COMPLETED|Overall Study||1
8320689|NCT01425632|20514756|P3|COMPLETED|Overall Study||159
8320690|NCT01425632|20514757|P2|COMPLETED|Overall Study||165
8320691|NCT01425632|20514758|P1|COMPLETED|Overall Study||160
8320692|NCT01425632|20514756|P3|STARTED|Overall Study||163
8320693|NCT01425632|20514757|P2|STARTED|Overall Study||166
8320694|NCT01425632|20514758|P1|STARTED|Overall Study||161
8320695|NCT01425528|20514768|P2|NOT COMPLETED|Overall Study||1
8320696|NCT01425528|20514769|P1|NOT COMPLETED|Overall Study||1
8320697|NCT01425528|20514768|P2|COMPLETED|Overall Study||5
8320698|NCT01425528|20514769|P1|COMPLETED|Overall Study||5
8320699|NCT01425528|20514768|P2|STARTED|Overall Study||6
8320700|NCT01425528|20514769|P1|STARTED|Overall Study||6
8320701|NCT01425463|20514777|P2|NOT COMPLETED|Overall Study||24
8320702|NCT01425463|20514778|P1|NOT COMPLETED|Overall Study||24
8320703|NCT01425463|20514777|P2|COMPLETED|Overall Study||102
8320704|NCT01425463|20514778|P1|COMPLETED|Overall Study||106
8320705|NCT01425463|20514777|P2|Full Analysis Set|Overall Study||116
8320706|NCT01425463|20514778|P1|Full Analysis Set|Overall Study||122
8320707|NCT01425463|20514777|P2|Safety Set|Overall Study||122
8320708|NCT01425463|20514778|P1|Safety Set|Overall Study||126
8320709|NCT01425463|20514777|P2|STARTED|Overall Study||126
8320710|NCT01425463|20514778|P1|STARTED|Overall Study||130
8320711|NCT01425359|20514794|P2|NOT COMPLETED|Overall Study||22
8320712|NCT01425359|20514795|P1|NOT COMPLETED|Overall Study||19
8320713|NCT01425359|20514794|P2|COMPLETED|Overall Study||451
8320714|NCT01425359|20514795|P1|COMPLETED|Overall Study||457
8320715|NCT01425359|20514794|P2|STARTED|Overall Study||473
8320716|NCT01425359|20514795|P1|STARTED|Overall Study||476
8320717|NCT01425307|20514813|P2|NOT COMPLETED|Overall Study||19
8320718|NCT01425307|20514814|P1|NOT COMPLETED|Overall Study||19
8320719|NCT01425307|20514813|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
8320720|NCT01425307|20514814|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
8320721|NCT01425307|20514813|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
8320722|NCT01425307|20514814|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
8320723|NCT01425281|20514826|P2|NOT COMPLETED|At 5-year Clinical Follow-up||11
8320724|NCT01425281|20514827|P1|NOT COMPLETED|At 5-year Clinical Follow-up||32
8320725|NCT01425281|20514826|P2|COMPLETED|At 5-year Clinical Follow-up||125
8320726|NCT01425281|20514827|P1|COMPLETED|At 5-year Clinical Follow-up||256
8320727|NCT01425281|20514826|P2|STARTED|At 5-year Clinical Follow-up||136
8320728|NCT01425281|20514827|P1|STARTED|At 5-year Clinical Follow-up||288
8320729|NCT01425281|20514826|P2|NOT COMPLETED|At 4-year Clinical Follow-up||21
8320730|NCT01425281|20514827|P1|NOT COMPLETED|At 4-year Clinical Follow-up||30
8320731|NCT01425281|20514826|P2|COMPLETED|At 4-year Clinical Follow-up||136
8320732|NCT01425281|20514827|P1|COMPLETED|At 4-year Clinical Follow-up||288
8320733|NCT01425281|20514826|P2|STARTED|At 4-year Clinical Follow-up||157
8320734|NCT01425281|20514827|P1|STARTED|At 4-year Clinical Follow-up||318
8320735|NCT01425281|20514826|P2|NOT COMPLETED|At 3-year Clinical Follow-up||6
8320736|NCT01425281|20514827|P1|NOT COMPLETED|At 3-year Clinical Follow-up||5
8320737|NCT01425281|20514826|P2|COMPLETED|At 3-year Clinical Follow-up||157
8320738|NCT01425281|20514827|P1|COMPLETED|At 3-year Clinical Follow-up||318
8320739|NCT01425281|20514826|P2|STARTED|At 3-year Clinical Follow-up||163
8320740|NCT01425281|20514827|P1|STARTED|At 3-year Clinical Follow-up||323
8320741|NCT01425281|20514826|P2|NOT COMPLETED|At 2-year Clinical Follow-up||1
8320742|NCT01425281|20514827|P1|NOT COMPLETED|At 2-year Clinical Follow-up||6
8320743|NCT01425281|20514826|P2|COMPLETED|At 2-year Clinical Follow-up||163
8320744|NCT01425281|20514827|P1|COMPLETED|At 2-year Clinical Follow-up||323
8320745|NCT01425281|20514826|P2|STARTED|At 2-year Clinical Follow-up||164
8320746|NCT01425281|20514827|P1|STARTED|At 2-year Clinical Follow-up||329
8320747|NCT01425281|20514826|P2|NOT COMPLETED|At 1-year Clinical Follow-up||1
8320748|NCT01425281|20514827|P1|NOT COMPLETED|At 1-year Clinical Follow-up||2
8320749|NCT01425281|20514826|P2|COMPLETED|At 1-year Clinical Follow-up||164
8320750|NCT01425281|20514827|P1|COMPLETED|At 1-year Clinical Follow-up||329
8320751|NCT01425281|20514826|P2|STARTED|At 1-year Clinical Follow-up||165
8320752|NCT01425281|20514827|P1|STARTED|At 1-year Clinical Follow-up||331
8320753|NCT01425281|20514826|P2|NOT COMPLETED|At 180-day Clinical Follow-up||1
8320754|NCT01425281|20514827|P1|NOT COMPLETED|At 180-day Clinical Follow-up||3
8320755|NCT01425281|20514826|P2|COMPLETED|At 180-day Clinical Follow-up||165
8320756|NCT01425281|20514827|P1|COMPLETED|At 180-day Clinical Follow-up||331
8320757|NCT01425281|20514826|P2|STARTED|At 180-day Clinical Follow-up||166
8320758|NCT01425281|20514827|P1|STARTED|At 180-day Clinical Follow-up||334
8320759|NCT01425281|20514826|P2|NOT COMPLETED|At 30-day Clinical Follow-up||0
8320760|NCT01425281|20514827|P1|NOT COMPLETED|At 30-day Clinical Follow-up||1
8320761|NCT01425281|20514826|P2|COMPLETED|At 30-day Clinical Follow-up||166
8320762|NCT01425281|20514827|P1|COMPLETED|At 30-day Clinical Follow-up||334
8320763|NCT01425281|20514826|P2|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
8320764|NCT01425281|20514827|P1|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
8320765|NCT01425268|20515045|P2|NOT COMPLETED|Overall Study||0
8320766|NCT01425268|20515046|P1|NOT COMPLETED|Overall Study||8
8320767|NCT01425268|20515045|P2|COMPLETED|Overall Study||52
8320768|NCT01425268|20515046|P1|COMPLETED|Overall Study||98
8320769|NCT01425268|20515045|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
8320770|NCT01425268|20515046|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
8320771|NCT01425229|20515054|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
8320772|NCT01425229|20515054|P1|COMPLETED|Bosentan During Clarithromycin||16
8320773|NCT01425229|20515054|P1|STARTED|Bosentan During Clarithromycin||16
8320774|NCT01425229|20515054|P1|NOT COMPLETED|Bosentan Steady-state||0
8320775|NCT01425229|20515054|P1|COMPLETED|Bosentan Steady-state||16
8320776|NCT01425229|20515054|P1|STARTED|Bosentan Steady-state||16
8320777|NCT01425229|20515054|P1|NOT COMPLETED|Bosentan Single Dose||0
8320778|NCT01425229|20515054|P1|COMPLETED|Bosentan Single Dose||16
8320779|NCT01425229|20515054|P1|STARTED|Bosentan Single Dose||16
8320810|NCT01425190|20515086|P3|NOT COMPLETED|Overall Study||0
8320811|NCT01425190|20515087|P2|NOT COMPLETED|Overall Study||0
8320812|NCT01425190|20515088|P1|NOT COMPLETED|Overall Study||1
8320813|NCT01425190|20515086|P3|COMPLETED|Overall Study||0
8320814|NCT01425190|20515087|P2|COMPLETED|Overall Study||0
8320815|NCT01425190|20515088|P1|COMPLETED|Overall Study||15
8320816|NCT01425190|20515086|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
8320817|NCT01425190|20515087|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
8320818|NCT01425190|20515088|P1|STARTED|Overall Study||16
8320819|NCT01425008|20515124|P19|NOT COMPLETED|Dose Expansion Phase||19
8320820|NCT01425008|20515125|P18|NOT COMPLETED|Dose Expansion Phase||2
8320821|NCT01425008|20515126|P17|NOT COMPLETED|Dose Expansion Phase||20
8320822|NCT01425008|20515127|P16|NOT COMPLETED|Dose Expansion Phase||11
8320823|NCT01425008|20515128|P15|NOT COMPLETED|Dose Expansion Phase||6
8320824|NCT01425008|20515129|P14|NOT COMPLETED|Dose Expansion Phase||1
8320825|NCT01425008|20515130|P13|NOT COMPLETED|Dose Expansion Phase||16
8320826|NCT01425008|20515131|P12|NOT COMPLETED|Dose Expansion Phase||8
8320827|NCT01425008|20515132|P11|NOT COMPLETED|Dose Expansion Phase||15
8320828|NCT01425008|20515133|P10|NOT COMPLETED|Dose Expansion Phase||0
8320829|NCT01425008|20515134|P9|NOT COMPLETED|Dose Expansion Phase||0
8320830|NCT01425008|20515135|P8|NOT COMPLETED|Dose Expansion Phase||0
8320831|NCT01425008|20515136|P7|NOT COMPLETED|Dose Expansion Phase||0
8320832|NCT01425008|20515137|P6|NOT COMPLETED|Dose Expansion Phase||0
8320833|NCT01425008|20515138|P5|NOT COMPLETED|Dose Expansion Phase||0
8320834|NCT01425008|20515139|P4|NOT COMPLETED|Dose Expansion Phase||0
8320835|NCT01425008|20515140|P3|NOT COMPLETED|Dose Expansion Phase||0
8320836|NCT01425008|20515141|P2|NOT COMPLETED|Dose Expansion Phase||0
8320837|NCT01425008|20515142|P1|NOT COMPLETED|Dose Expansion Phase||0
8320838|NCT01425008|20515124|P19|COMPLETED|Dose Expansion Phase||0
8320839|NCT01425008|20515125|P18|COMPLETED|Dose Expansion Phase||0
8320840|NCT01425008|20515126|P17|COMPLETED|Dose Expansion Phase||0
8320841|NCT01425008|20515127|P16|COMPLETED|Dose Expansion Phase||0
8320842|NCT01425008|20515128|P15|COMPLETED|Dose Expansion Phase||0
8320843|NCT01425008|20515129|P14|COMPLETED|Dose Expansion Phase||0
8320844|NCT01425008|20515130|P13|COMPLETED|Dose Expansion Phase||0
8320845|NCT01425008|20515131|P12|COMPLETED|Dose Expansion Phase||0
8320846|NCT01425008|20515132|P11|COMPLETED|Dose Expansion Phase||1
8320847|NCT01425008|20515133|P10|COMPLETED|Dose Expansion Phase||0
8320848|NCT01425008|20515134|P9|COMPLETED|Dose Expansion Phase||0
8320849|NCT01425008|20515135|P8|COMPLETED|Dose Expansion Phase||0
8320850|NCT01425008|20515136|P7|COMPLETED|Dose Expansion Phase||0
8320851|NCT01425008|20515137|P6|COMPLETED|Dose Expansion Phase||0
8320852|NCT01425008|20515138|P5|COMPLETED|Dose Expansion Phase||0
8320853|NCT01425008|20515139|P4|COMPLETED|Dose Expansion Phase||0
8320854|NCT01425008|20515140|P3|COMPLETED|Dose Expansion Phase||0
8320855|NCT01425008|20515141|P2|COMPLETED|Dose Expansion Phase||0
8320856|NCT01425008|20515142|P1|COMPLETED|Dose Expansion Phase||0
8320857|NCT01425008|20515124|P19|STARTED|Dose Expansion Phase||19
8320858|NCT01425008|20515125|P18|STARTED|Dose Expansion Phase||2
8320859|NCT01425008|20515126|P17|STARTED|Dose Expansion Phase||20
8320860|NCT01425008|20515127|P16|STARTED|Dose Expansion Phase||11
8320861|NCT01425008|20515128|P15|STARTED|Dose Expansion Phase||6
8320862|NCT01425008|20515129|P14|STARTED|Dose Expansion Phase||1
8320863|NCT01425008|20515130|P13|STARTED|Dose Expansion Phase||16
8320864|NCT01425008|20515131|P12|STARTED|Dose Expansion Phase||8
8320865|NCT01425008|20515132|P11|STARTED|Dose Expansion Phase||16
8320866|NCT01425008|20515133|P10|STARTED|Dose Expansion Phase||0
8320867|NCT01425008|20515134|P9|STARTED|Dose Expansion Phase||0
8320868|NCT01425008|20515135|P8|STARTED|Dose Expansion Phase||0
8320869|NCT01425008|20515136|P7|STARTED|Dose Expansion Phase||0
8320870|NCT01425008|20515137|P6|STARTED|Dose Expansion Phase||0
8320871|NCT01425008|20515138|P5|STARTED|Dose Expansion Phase||0
8320872|NCT01425008|20515139|P4|STARTED|Dose Expansion Phase||0
8320873|NCT01425008|20515140|P3|STARTED|Dose Expansion Phase||0
8320874|NCT01425008|20515141|P2|STARTED|Dose Expansion Phase||0
8320875|NCT01425008|20515142|P1|STARTED|Dose Expansion Phase||0
8320876|NCT01425008|20515124|P19|NOT COMPLETED|Dose Escalation Phase||0
8320877|NCT01425008|20515125|P18|NOT COMPLETED|Dose Escalation Phase||0
8320878|NCT01425008|20515126|P17|NOT COMPLETED|Dose Escalation Phase||0
8320879|NCT01425008|20515127|P16|NOT COMPLETED|Dose Escalation Phase||0
8320880|NCT01425008|20515128|P15|NOT COMPLETED|Dose Escalation Phase||0
8320881|NCT01425008|20515129|P14|NOT COMPLETED|Dose Escalation Phase||0
8320882|NCT01425008|20515130|P13|NOT COMPLETED|Dose Escalation Phase||0
8320883|NCT01425008|20515131|P12|NOT COMPLETED|Dose Escalation Phase||0
8320884|NCT01425008|20515132|P11|NOT COMPLETED|Dose Escalation Phase||0
8320885|NCT01425008|20515133|P10|NOT COMPLETED|Dose Escalation Phase||4
8320886|NCT01425008|20515134|P9|NOT COMPLETED|Dose Escalation Phase||13
8320887|NCT01425008|20515135|P8|NOT COMPLETED|Dose Escalation Phase||3
8320888|NCT01425008|20515136|P7|NOT COMPLETED|Dose Escalation Phase||3
8320889|NCT01425008|20515137|P6|NOT COMPLETED|Dose Escalation Phase||7
8320890|NCT01425008|20515138|P5|NOT COMPLETED|Dose Escalation Phase||7
8320891|NCT01425008|20515139|P4|NOT COMPLETED|Dose Escalation Phase||3
8320892|NCT01425008|20515140|P3|NOT COMPLETED|Dose Escalation Phase||3
8320893|NCT01425008|20515141|P2|NOT COMPLETED|Dose Escalation Phase||3
8320894|NCT01425008|20515142|P1|NOT COMPLETED|Dose Escalation Phase||4
8320895|NCT01425008|20515124|P19|COMPLETED|Dose Escalation Phase||0
8320896|NCT01425008|20515125|P18|COMPLETED|Dose Escalation Phase||0
8320897|NCT01425008|20515126|P17|COMPLETED|Dose Escalation Phase||0
8320898|NCT01425008|20515127|P16|COMPLETED|Dose Escalation Phase||0
8320899|NCT01425008|20515128|P15|COMPLETED|Dose Escalation Phase||0
8320900|NCT01425008|20515129|P14|COMPLETED|Dose Escalation Phase||0
8320901|NCT01425008|20515130|P13|COMPLETED|Dose Escalation Phase||0
8320902|NCT01425008|20515131|P12|COMPLETED|Dose Escalation Phase||0
8320903|NCT01425008|20515132|P11|COMPLETED|Dose Escalation Phase||0
8320904|NCT01425008|20515133|P10|COMPLETED|Dose Escalation Phase||0
8320905|NCT01425008|20515134|P9|COMPLETED|Dose Escalation Phase||0
8320906|NCT01425008|20515135|P8|COMPLETED|Dose Escalation Phase||0
8320907|NCT01425008|20515136|P7|COMPLETED|Dose Escalation Phase||0
8320908|NCT01425008|20515137|P6|COMPLETED|Dose Escalation Phase||0
8320909|NCT01425008|20515138|P5|COMPLETED|Dose Escalation Phase||0
8320910|NCT01425008|20515139|P4|COMPLETED|Dose Escalation Phase||0
8320911|NCT01425008|20515140|P3|COMPLETED|Dose Escalation Phase||0
8320912|NCT01425008|20515141|P2|COMPLETED|Dose Escalation Phase||0
8320913|NCT01425008|20515142|P1|COMPLETED|Dose Escalation Phase||0
8320914|NCT01425008|20515124|P19|STARTED|Dose Escalation Phase||0
8320915|NCT01425008|20515125|P18|STARTED|Dose Escalation Phase||0
8320916|NCT01425008|20515126|P17|STARTED|Dose Escalation Phase||0
8320917|NCT01425008|20515127|P16|STARTED|Dose Escalation Phase||0
8320918|NCT01425008|20515128|P15|STARTED|Dose Escalation Phase||0
8320919|NCT01425008|20515129|P14|STARTED|Dose Escalation Phase||0
8320920|NCT01425008|20515130|P13|STARTED|Dose Escalation Phase||0
8320921|NCT01425008|20515131|P12|STARTED|Dose Escalation Phase||0
8320922|NCT01425008|20515132|P11|STARTED|Dose Escalation Phase||0
8320923|NCT01425008|20515133|P10|STARTED|Dose Escalation Phase||4
8320924|NCT01425008|20515134|P9|STARTED|Dose Escalation Phase||13
8320925|NCT01425008|20515135|P8|STARTED|Dose Escalation Phase||3
8320926|NCT01425008|20515136|P7|STARTED|Dose Escalation Phase||3
8320927|NCT01425008|20515137|P6|STARTED|Dose Escalation Phase||7
8320928|NCT01425008|20515138|P5|STARTED|Dose Escalation Phase||7
8320929|NCT01425008|20515139|P4|STARTED|Dose Escalation Phase||3
8320930|NCT01425008|20515140|P3|STARTED|Dose Escalation Phase||3
8320931|NCT01425008|20515141|P2|STARTED|Dose Escalation Phase||3
8320932|NCT01425008|20515142|P1|STARTED|Dose Escalation Phase||4
8320933|NCT01424943|20515428|P2|NOT COMPLETED|Overall Study||1
8320934|NCT01424943|20515429|P1|NOT COMPLETED|Overall Study||13
8320935|NCT01424943|20515428|P2|COMPLETED|Overall Study||23
8320936|NCT01424943|20515429|P1|COMPLETED|Overall Study||12
8320937|NCT01424943|20515428|P2|STARTED|Overall Study||24
8320938|NCT01424943|20515429|P1|STARTED|Overall Study||25
8320939|NCT01424930|20515445|P2|NOT COMPLETED|Overall Study||14
8320940|NCT01424930|20515446|P1|NOT COMPLETED|Overall Study||4
8320941|NCT01424930|20515445|P2|COMPLETED|Overall Study||4
8320942|NCT01424930|20515446|P1|COMPLETED|Overall Study||3
8320943|NCT01424930|20515445|P2|Completed Food Safety Evaluation|Overall Study||18
8320944|NCT01424930|20515446|P1|Completed Food Safety Evaluation|Overall Study||6
8320945|NCT01424930|20515445|P2|STARTED|Overall Study||18
8320946|NCT01424930|20515446|P1|STARTED|Overall Study||7
8320947|NCT01424813|20515460|P2|NOT COMPLETED|Overall Study||2
8320948|NCT01424813|20515461|P1|NOT COMPLETED|Overall Study||5
8320949|NCT01424813|20515460|P2|COMPLETED|Overall Study||77
8320950|NCT01424813|20515461|P1|COMPLETED|Overall Study||74
8320951|NCT01424813|20515460|P2|Treated|Overall Study|Safety set and full analysis set|78
8320952|NCT01424813|20515461|P1|Treated|Overall Study|Safety set and full analysis set|79
8320953|NCT01424813|20515460|P2|STARTED|Overall Study||79
8320954|NCT01424813|20515461|P1|STARTED|Overall Study||79
8320955|NCT01424670|20515481|P2|NOT COMPLETED|Continuation Period||14
8320956|NCT01424670|20515482|P1|NOT COMPLETED|Continuation Period||34
8320957|NCT01424670|20515481|P2|COMPLETED|Continuation Period||142
8320958|NCT01424670|20515482|P1|COMPLETED|Continuation Period||288
8320959|NCT01424670|20515481|P2|STARTED|Continuation Period||156
8320960|NCT01424670|20515482|P1|STARTED|Continuation Period||322
8320961|NCT01424670|20515481|P2|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
8320962|NCT01424670|20515482|P1|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
8320963|NCT01424670|20515481|P2|COMPLETED|6-Month Intensive Period (182 Days)||156
8320964|NCT01424670|20515482|P1|COMPLETED|6-Month Intensive Period (182 Days)||322
8320965|NCT01424670|20515481|P2|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
8320966|NCT01424670|20515482|P1|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
8320967|NCT01424670|20515481|P2|STARTED|6-Month Intensive Period (182 Days)||170
8320968|NCT01424670|20515482|P1|STARTED|6-Month Intensive Period (182 Days)||341
8320969|NCT01424644|20515504|P2|NOT COMPLETED|Overall Study||27
8320970|NCT01424644|20515505|P1|NOT COMPLETED|Overall Study||33
8320971|NCT01424644|20515504|P2|COMPLETED|Overall Study||372
8320972|NCT01424644|20515505|P1|COMPLETED|Overall Study||369
8320973|NCT01424644|20515504|P2|STARTED|Overall Study||399
8320974|NCT01424644|20515505|P1|STARTED|Overall Study||402
8320975|NCT01424566|20515519|P3|NOT COMPLETED|Double-blind Treatment||15
8320976|NCT01424566|20515520|P2|NOT COMPLETED|Double-blind Treatment||25
8320977|NCT01424566|20515521|P1|NOT COMPLETED|Double-blind Treatment||0
8320978|NCT01424566|20515519|P3|COMPLETED|Double-blind Treatment||88
8320979|NCT01424566|20515520|P2|COMPLETED|Double-blind Treatment||78
8320980|NCT01424566|20515521|P1|COMPLETED|Double-blind Treatment||0
8320981|NCT01424566|20515519|P3|ITT Population|Double-blind Treatment||103
8320982|NCT01424566|20515520|P2|ITT Population|Double-blind Treatment||103
8320983|NCT01424566|20515521|P1|ITT Population|Double-blind Treatment||0
8320984|NCT01424566|20515519|P3|Randomized Safety Population|Double-blind Treatment||103
8320985|NCT01424566|20515520|P2|Randomized Safety Population|Double-blind Treatment||103
8320986|NCT01424566|20515521|P1|Randomized Safety Population|Double-blind Treatment||0
8320987|NCT01424566|20515519|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
8320988|NCT01424566|20515520|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
8320989|NCT01424566|20515521|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
8320990|NCT01424566|20515519|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
8320991|NCT01424566|20515520|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
8320992|NCT01424566|20515521|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
8320993|NCT01424566|20515519|P3|NOT COMPLETED|Single-blind Treatment||0
8320994|NCT01424566|20515520|P2|NOT COMPLETED|Single-blind Treatment||0
8320995|NCT01424566|20515521|P1|NOT COMPLETED|Single-blind Treatment||200
8320996|NCT01424566|20515519|P3|COMPLETED|Single-blind Treatment||0
8320997|NCT01424566|20515520|P2|COMPLETED|Single-blind Treatment||0
8320998|NCT01424566|20515521|P1|COMPLETED|Single-blind Treatment||206
8320999|NCT01424566|20515519|P3|Met Randomization Criteria|Single-blind Treatment||0
8321000|NCT01424566|20515520|P2|Met Randomization Criteria|Single-blind Treatment||0
8321001|NCT01424566|20515521|P1|Met Randomization Criteria|Single-blind Treatment||206
8321002|NCT01424566|20515519|P3|Single-blind Safety Population|Single-blind Treatment||0
8321003|NCT01424566|20515520|P2|Single-blind Safety Population|Single-blind Treatment||0
8321004|NCT01424566|20515521|P1|Single-blind Safety Population|Single-blind Treatment||404
8321005|NCT01424566|20515519|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
8321006|NCT01424566|20515520|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
8321007|NCT01424566|20515521|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
8321008|NCT01424566|20515519|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
8321009|NCT01424566|20515520|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
8321010|NCT01424566|20515521|P1|STARTED|Single-blind Treatment||406
8321011|NCT01424514|20515548|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
8321012|NCT01424514|20515549|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
8321013|NCT01424514|20515548|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
8321014|NCT01424514|20515549|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
8321015|NCT01424514|20515548|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
8321016|NCT01424514|20515549|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
8321017|NCT01424514|20515548|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
8321018|NCT01424514|20515549|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
8321019|NCT01424514|20515548|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
8321020|NCT01424514|20515549|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
8321021|NCT01424514|20515548|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
8321022|NCT01424514|20515549|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
8321023|NCT01424514|20515548|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
8321024|NCT01424514|20515549|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
8321025|NCT01424514|20515548|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
8321026|NCT01424514|20515549|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
8321027|NCT01424514|20515548|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
8321028|NCT01424514|20515549|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
8321029|NCT01424501|20515594|P6|NOT COMPLETED|Overall Study||0
8321030|NCT01424501|20515595|P5|NOT COMPLETED|Overall Study||0
8321031|NCT01424501|20515596|P4|NOT COMPLETED|Overall Study||0
8321032|NCT01424501|20515597|P3|NOT COMPLETED|Overall Study||2
8321033|NCT01424501|20515598|P2|NOT COMPLETED|Overall Study||1
8321034|NCT01424501|20515599|P1|NOT COMPLETED|Overall Study||1
8321035|NCT01424501|20515594|P6|COMPLETED|Overall Study||40
8321036|NCT01424501|20515595|P5|COMPLETED|Overall Study||40
8321037|NCT01424501|20515596|P4|COMPLETED|Overall Study||25
8321038|NCT01424501|20515597|P3|COMPLETED|Overall Study||22
8321039|NCT01424501|20515598|P2|COMPLETED|Overall Study||5
8321040|NCT01424501|20515599|P1|COMPLETED|Overall Study||6
8321041|NCT01424501|20515594|P6|STARTED|Overall Study||40
8321042|NCT01424501|20515595|P5|STARTED|Overall Study||40
8321043|NCT01424501|20515596|P4|STARTED|Overall Study||25
8321044|NCT01424501|20515597|P3|STARTED|Overall Study||24
8321045|NCT01424501|20515598|P2|STARTED|Overall Study||6
8321046|NCT01424501|20515599|P1|STARTED|Overall Study||7
8321047|NCT01424397|20515775|P12|NOT COMPLETED|Period-3 (8 Days)||0
8321048|NCT01424397|20515776|P11|NOT COMPLETED|Period-3 (8 Days)||0
8321049|NCT01424397|20515777|P10|NOT COMPLETED|Period-3 (8 Days)||0
8321050|NCT01424397|20515778|P9|NOT COMPLETED|Period-3 (8 Days)||0
8321051|NCT01424397|20515779|P8|NOT COMPLETED|Period-3 (8 Days)||0
8321052|NCT01424397|20515780|P7|NOT COMPLETED|Period-3 (8 Days)||0
8321053|NCT01424397|20515781|P6|NOT COMPLETED|Period-3 (8 Days)||0
8321054|NCT01424397|20515782|P5|NOT COMPLETED|Period-3 (8 Days)||0
8321055|NCT01424397|20515783|P4|NOT COMPLETED|Period-3 (8 Days)||0
8321056|NCT01424397|20515784|P3|NOT COMPLETED|Period-3 (8 Days)||0
8321057|NCT01424397|20515785|P2|NOT COMPLETED|Period-3 (8 Days)||0
8321058|NCT01424397|20515786|P1|NOT COMPLETED|Period-3 (8 Days)||0
8321059|NCT01424397|20515775|P12|COMPLETED|Period-3 (8 Days)||4
8321060|NCT01424397|20515776|P11|COMPLETED|Period-3 (8 Days)||4
8321061|NCT01424397|20515777|P10|COMPLETED|Period-3 (8 Days)||3
8321062|NCT01424397|20515778|P9|COMPLETED|Period-3 (8 Days)||4
8321063|NCT01424397|20515779|P8|COMPLETED|Period-3 (8 Days)||4
8321064|NCT01424397|20515780|P7|COMPLETED|Period-3 (8 Days)||4
8321065|NCT01424397|20515781|P6|COMPLETED|Period-3 (8 Days)||8
8321066|NCT01424397|20515782|P5|COMPLETED|Period-3 (8 Days)||8
8321067|NCT01424397|20515783|P4|COMPLETED|Period-3 (8 Days)||8
8321068|NCT01424397|20515784|P3|COMPLETED|Period-3 (8 Days)||7
8321069|NCT01424397|20515785|P2|COMPLETED|Period-3 (8 Days)||8
8321070|NCT01424397|20515786|P1|COMPLETED|Period-3 (8 Days)||7
8321071|NCT01424397|20515775|P12|STARTED|Period-3 (8 Days)||4
8321072|NCT01424397|20515776|P11|STARTED|Period-3 (8 Days)||4
8321073|NCT01424397|20515777|P10|STARTED|Period-3 (8 Days)||3
8321074|NCT01424397|20515778|P9|STARTED|Period-3 (8 Days)||4
8321075|NCT01424397|20515779|P8|STARTED|Period-3 (8 Days)||4
8321076|NCT01424397|20515780|P7|STARTED|Period-3 (8 Days)||4
8321077|NCT01424397|20515781|P6|STARTED|Period-3 (8 Days)||8
8321078|NCT01424397|20515782|P5|STARTED|Period-3 (8 Days)||8
8321079|NCT01424397|20515783|P4|STARTED|Period-3 (8 Days)||8
8321080|NCT01424397|20515784|P3|STARTED|Period-3 (8 Days)||7
8321081|NCT01424397|20515785|P2|STARTED|Period-3 (8 Days)||8
8321082|NCT01424397|20515786|P1|STARTED|Period-3 (8 Days)||7
8321083|NCT01424397|20515775|P12|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321084|NCT01424397|20515776|P11|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321085|NCT01424397|20515777|P10|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321086|NCT01424397|20515778|P9|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321087|NCT01424397|20515779|P8|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321088|NCT01424397|20515780|P7|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321089|NCT01424397|20515781|P6|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321090|NCT01424397|20515782|P5|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321091|NCT01424397|20515783|P4|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321092|NCT01424397|20515784|P3|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321093|NCT01424397|20515785|P2|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321094|NCT01424397|20515786|P1|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321095|NCT01424397|20515775|P12|COMPLETED|Washout Period-2 (14-20 Days)||4
8321096|NCT01424397|20515776|P11|COMPLETED|Washout Period-2 (14-20 Days)||4
8321097|NCT01424397|20515777|P10|COMPLETED|Washout Period-2 (14-20 Days)||3
8321098|NCT01424397|20515778|P9|COMPLETED|Washout Period-2 (14-20 Days)||4
8321099|NCT01424397|20515779|P8|COMPLETED|Washout Period-2 (14-20 Days)||4
8321100|NCT01424397|20515780|P7|COMPLETED|Washout Period-2 (14-20 Days)||4
8321101|NCT01424397|20515781|P6|COMPLETED|Washout Period-2 (14-20 Days)||8
8321102|NCT01424397|20515782|P5|COMPLETED|Washout Period-2 (14-20 Days)||8
8321103|NCT01424397|20515783|P4|COMPLETED|Washout Period-2 (14-20 Days)||8
8321104|NCT01424397|20515784|P3|COMPLETED|Washout Period-2 (14-20 Days)||7
8321105|NCT01424397|20515785|P2|COMPLETED|Washout Period-2 (14-20 Days)||8
8321106|NCT01424397|20515786|P1|COMPLETED|Washout Period-2 (14-20 Days)||7
8321107|NCT01424397|20515775|P12|STARTED|Washout Period-2 (14-20 Days)||4
8321108|NCT01424397|20515776|P11|STARTED|Washout Period-2 (14-20 Days)||4
8321109|NCT01424397|20515777|P10|STARTED|Washout Period-2 (14-20 Days)||3
8321110|NCT01424397|20515778|P9|STARTED|Washout Period-2 (14-20 Days)||4
8321111|NCT01424397|20515779|P8|STARTED|Washout Period-2 (14-20 Days)||4
8321112|NCT01424397|20515780|P7|STARTED|Washout Period-2 (14-20 Days)||4
8321113|NCT01424397|20515781|P6|STARTED|Washout Period-2 (14-20 Days)||8
8321114|NCT01424397|20515782|P5|STARTED|Washout Period-2 (14-20 Days)||8
8321115|NCT01424397|20515783|P4|STARTED|Washout Period-2 (14-20 Days)||8
8321116|NCT01424397|20515784|P3|STARTED|Washout Period-2 (14-20 Days)||7
8321117|NCT01424397|20515785|P2|STARTED|Washout Period-2 (14-20 Days)||8
8321118|NCT01424397|20515786|P1|STARTED|Washout Period-2 (14-20 Days)||7
8321119|NCT01424397|20515775|P12|NOT COMPLETED|Period-2 (8 Days)||0
8321120|NCT01424397|20515776|P11|NOT COMPLETED|Period-2 (8 Days)||0
8321121|NCT01424397|20515777|P10|NOT COMPLETED|Period-2 (8 Days)||0
8321122|NCT01424397|20515778|P9|NOT COMPLETED|Period-2 (8 Days)||0
8321123|NCT01424397|20515779|P8|NOT COMPLETED|Period-2 (8 Days)||0
8321124|NCT01424397|20515780|P7|NOT COMPLETED|Period-2 (8 Days)||0
8321125|NCT01424397|20515781|P6|NOT COMPLETED|Period-2 (8 Days)||0
8321126|NCT01424397|20515782|P5|NOT COMPLETED|Period-2 (8 Days)||0
8321127|NCT01424397|20515783|P4|NOT COMPLETED|Period-2 (8 Days)||0
8321128|NCT01424397|20515784|P3|NOT COMPLETED|Period-2 (8 Days)||1
8321129|NCT01424397|20515785|P2|NOT COMPLETED|Period-2 (8 Days)||0
8321130|NCT01424397|20515786|P1|NOT COMPLETED|Period-2 (8 Days)||0
8321131|NCT01424397|20515775|P12|COMPLETED|Period-2 (8 Days)||4
8321132|NCT01424397|20515776|P11|COMPLETED|Period-2 (8 Days)||4
8321133|NCT01424397|20515777|P10|COMPLETED|Period-2 (8 Days)||3
8321134|NCT01424397|20515778|P9|COMPLETED|Period-2 (8 Days)||4
8321135|NCT01424397|20515779|P8|COMPLETED|Period-2 (8 Days)||4
8321136|NCT01424397|20515780|P7|COMPLETED|Period-2 (8 Days)||4
8321137|NCT01424397|20515781|P6|COMPLETED|Period-2 (8 Days)||8
8321138|NCT01424397|20515782|P5|COMPLETED|Period-2 (8 Days)||8
8321139|NCT01424397|20515783|P4|COMPLETED|Period-2 (8 Days)||8
8321140|NCT01424397|20515784|P3|COMPLETED|Period-2 (8 Days)||7
8321141|NCT01424397|20515785|P2|COMPLETED|Period-2 (8 Days)||8
8321142|NCT01424397|20515786|P1|COMPLETED|Period-2 (8 Days)||7
8321143|NCT01424397|20515775|P12|STARTED|Period-2 (8 Days)||4
8321144|NCT01424397|20515776|P11|STARTED|Period-2 (8 Days)||4
8321145|NCT01424397|20515777|P10|STARTED|Period-2 (8 Days)||3
8321146|NCT01424397|20515778|P9|STARTED|Period-2 (8 Days)||4
8321147|NCT01424397|20515779|P8|STARTED|Period-2 (8 Days)||4
8321148|NCT01424397|20515780|P7|STARTED|Period-2 (8 Days)||4
8321149|NCT01424397|20515781|P6|STARTED|Period-2 (8 Days)||8
8321150|NCT01424397|20515782|P5|STARTED|Period-2 (8 Days)||8
8321151|NCT01424397|20515783|P4|STARTED|Period-2 (8 Days)||8
8321152|NCT01424397|20515784|P3|STARTED|Period-2 (8 Days)||8
8321153|NCT01424397|20515785|P2|STARTED|Period-2 (8 Days)||8
8321154|NCT01424397|20515786|P1|STARTED|Period-2 (8 Days)||7
8321155|NCT01424397|20515775|P12|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321156|NCT01424397|20515776|P11|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321157|NCT01424397|20515777|P10|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321158|NCT01424397|20515778|P9|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321159|NCT01424397|20515779|P8|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321160|NCT01424397|20515780|P7|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321161|NCT01424397|20515781|P6|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321162|NCT01424397|20515782|P5|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321163|NCT01424397|20515783|P4|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321164|NCT01424397|20515784|P3|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321165|NCT01424397|20515785|P2|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321166|NCT01424397|20515786|P1|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321167|NCT01424397|20515775|P12|COMPLETED|Washout Period-1 (14-20 Days)||4
8321168|NCT01424397|20515776|P11|COMPLETED|Washout Period-1 (14-20 Days)||4
8321169|NCT01424397|20515777|P10|COMPLETED|Washout Period-1 (14-20 Days)||3
8321170|NCT01424397|20515778|P9|COMPLETED|Washout Period-1 (14-20 Days)||4
8321171|NCT01424397|20515779|P8|COMPLETED|Washout Period-1 (14-20 Days)||4
8321172|NCT01424397|20515780|P7|COMPLETED|Washout Period-1 (14-20 Days)||4
8321173|NCT01424397|20515781|P6|COMPLETED|Washout Period-1 (14-20 Days)||8
8321174|NCT01424397|20515782|P5|COMPLETED|Washout Period-1 (14-20 Days)||8
8321175|NCT01424397|20515783|P4|COMPLETED|Washout Period-1 (14-20 Days)||8
8321176|NCT01424397|20515784|P3|COMPLETED|Washout Period-1 (14-20 Days)||8
8321177|NCT01424397|20515785|P2|COMPLETED|Washout Period-1 (14-20 Days)||8
8321178|NCT01424397|20515786|P1|COMPLETED|Washout Period-1 (14-20 Days)||7
8321179|NCT01424397|20515775|P12|STARTED|Washout Period-1 (14-20 Days)||4
8321180|NCT01424397|20515776|P11|STARTED|Washout Period-1 (14-20 Days)||4
8321181|NCT01424397|20515777|P10|STARTED|Washout Period-1 (14-20 Days)||3
8321182|NCT01424397|20515778|P9|STARTED|Washout Period-1 (14-20 Days)||4
8321183|NCT01424397|20515779|P8|STARTED|Washout Period-1 (14-20 Days)||4
8321184|NCT01424397|20515780|P7|STARTED|Washout Period-1 (14-20 Days)||4
8321185|NCT01424397|20515781|P6|STARTED|Washout Period-1 (14-20 Days)||8
8321186|NCT01424397|20515782|P5|STARTED|Washout Period-1 (14-20 Days)||8
8321187|NCT01424397|20515783|P4|STARTED|Washout Period-1 (14-20 Days)||8
8321188|NCT01424397|20515784|P3|STARTED|Washout Period-1 (14-20 Days)||8
8321189|NCT01424397|20515785|P2|STARTED|Washout Period-1 (14-20 Days)||8
8321190|NCT01424397|20515786|P1|STARTED|Washout Period-1 (14-20 Days)||7
8321191|NCT01424397|20515775|P12|NOT COMPLETED|Period-1 (8 Days)||0
8321192|NCT01424397|20515776|P11|NOT COMPLETED|Period-1 (8 Days)||0
8321193|NCT01424397|20515777|P10|NOT COMPLETED|Period-1 (8 Days)||0
8321194|NCT01424397|20515778|P9|NOT COMPLETED|Period-1 (8 Days)||0
8321195|NCT01424397|20515779|P8|NOT COMPLETED|Period-1 (8 Days)||0
8321196|NCT01424397|20515780|P7|NOT COMPLETED|Period-1 (8 Days)||0
8321197|NCT01424397|20515781|P6|NOT COMPLETED|Period-1 (8 Days)||0
8321198|NCT01424397|20515782|P5|NOT COMPLETED|Period-1 (8 Days)||0
8321199|NCT01424397|20515783|P4|NOT COMPLETED|Period-1 (8 Days)||0
8321200|NCT01424397|20515784|P3|NOT COMPLETED|Period-1 (8 Days)||0
8321201|NCT01424397|20515785|P2|NOT COMPLETED|Period-1 (8 Days)||0
8321202|NCT01424397|20515786|P1|NOT COMPLETED|Period-1 (8 Days)||0
8321203|NCT01424397|20515775|P12|COMPLETED|Period-1 (8 Days)||4
8321204|NCT01424397|20515776|P11|COMPLETED|Period-1 (8 Days)||4
8321205|NCT01424397|20515777|P10|COMPLETED|Period-1 (8 Days)||3
8321206|NCT01424397|20515778|P9|COMPLETED|Period-1 (8 Days)||4
8321207|NCT01424397|20515779|P8|COMPLETED|Period-1 (8 Days)||4
8321208|NCT01424397|20515780|P7|COMPLETED|Period-1 (8 Days)||4
8321209|NCT01424397|20515781|P6|COMPLETED|Period-1 (8 Days)||8
8321210|NCT01424397|20515782|P5|COMPLETED|Period-1 (8 Days)||8
8321211|NCT01424397|20515783|P4|COMPLETED|Period-1 (8 Days)||8
8321212|NCT01424397|20515784|P3|COMPLETED|Period-1 (8 Days)||8
8321213|NCT01424397|20515785|P2|COMPLETED|Period-1 (8 Days)||8
8321214|NCT01424397|20515786|P1|COMPLETED|Period-1 (8 Days)||7
8321215|NCT01424397|20515775|P12|STARTED|Period-1 (8 Days)||4
8321216|NCT01424397|20515776|P11|STARTED|Period-1 (8 Days)||4
8321217|NCT01424397|20515777|P10|STARTED|Period-1 (8 Days)||3
8321218|NCT01424397|20515778|P9|STARTED|Period-1 (8 Days)||4
8321219|NCT01424397|20515779|P8|STARTED|Period-1 (8 Days)||4
8321220|NCT01424397|20515780|P7|STARTED|Period-1 (8 Days)||4
8321221|NCT01424397|20515781|P6|STARTED|Period-1 (8 Days)||8
8321222|NCT01424397|20515782|P5|STARTED|Period-1 (8 Days)||8
8321223|NCT01424397|20515783|P4|STARTED|Period-1 (8 Days)||8
8321224|NCT01424397|20515784|P3|STARTED|Period-1 (8 Days)||8
8321225|NCT01424397|20515785|P2|STARTED|Period-1 (8 Days)||8
8321226|NCT01424397|20515786|P1|STARTED|Period-1 (8 Days)||7
8321227|NCT01424306|20515832|P6|NOT COMPLETED|Overall Study||0
8321228|NCT01424306|20515833|P5|NOT COMPLETED|Overall Study||1
8321229|NCT01424306|20515834|P4|NOT COMPLETED|Overall Study||0
8321230|NCT01424306|20515835|P3|NOT COMPLETED|Overall Study||0
8321231|NCT01424306|20515836|P2|NOT COMPLETED|Overall Study||0
8321232|NCT01424306|20515837|P1|NOT COMPLETED|Overall Study||0
8321233|NCT01424306|20515832|P6|COMPLETED|Overall Study||6
8321234|NCT01424306|20515833|P5|COMPLETED|Overall Study||4
8321235|NCT01424306|20515834|P4|COMPLETED|Overall Study||3
8321236|NCT01424306|20515835|P3|COMPLETED|Overall Study||3
8321237|NCT01424306|20515836|P2|COMPLETED|Overall Study||4
8321238|NCT01424306|20515837|P1|COMPLETED|Overall Study||4
8321239|NCT01424306|20515832|P6|STARTED|Overall Study||6
8321240|NCT01424306|20515833|P5|STARTED|Overall Study||5
8321241|NCT01424306|20515834|P4|STARTED|Overall Study||3
8321242|NCT01424306|20515835|P3|STARTED|Overall Study||3
8321243|NCT01424306|20515836|P2|STARTED|Overall Study||4
8321244|NCT01424306|20515837|P1|STARTED|Overall Study||4
8321245|NCT01424228|20515886|P2|NOT COMPLETED|Overall Study||47
8321246|NCT01424228|20515887|P1|NOT COMPLETED|Overall Study||56
8321247|NCT01424228|20515886|P2|COMPLETED|Overall Study||135
8321248|NCT01424228|20515887|P1|COMPLETED|Overall Study||126
8321249|NCT01424228|20515886|P2|STARTED|Overall Study||182
8321250|NCT01424228|20515887|P1|STARTED|Overall Study||182
8321251|NCT01424215|20515927|P2|NOT COMPLETED|Overall Study||0
8321252|NCT01424215|20515928|P1|NOT COMPLETED|Overall Study||0
8321253|NCT01424215|20515927|P2|COMPLETED|Overall Study||50
8321254|NCT01424215|20515928|P1|COMPLETED|Overall Study||50
8321255|NCT01424215|20515927|P2|STARTED|Overall Study||50
8321256|NCT01424215|20515928|P1|STARTED|Overall Study||50
8321257|NCT01424189|20515938|P2|NOT COMPLETED|Overall Study||6
8321258|NCT01424189|20515939|P1|NOT COMPLETED|Overall Study||13
8321259|NCT01424189|20515938|P2|COMPLETED|Overall Study||182
8321260|NCT01424189|20515939|P1|COMPLETED|Overall Study||373
8321261|NCT01424189|20515938|P2|STARTED|Overall Study||188
8321262|NCT01424189|20515939|P1|STARTED|Overall Study||386
8321263|NCT01424072|20515954|P3|NOT COMPLETED|Overall Study||0
8321264|NCT01424072|20515955|P2|NOT COMPLETED|Overall Study||0
8321265|NCT01424072|20515956|P1|NOT COMPLETED|Overall Study||0
8321266|NCT01424072|20515954|P3|COMPLETED|Overall Study||22
8321267|NCT01424072|20515955|P2|COMPLETED|Overall Study||26
8321268|NCT01424072|20515956|P1|COMPLETED|Overall Study||27
8321269|NCT01424072|20515954|P3|STARTED|Overall Study||22
8321270|NCT01424072|20515955|P2|STARTED|Overall Study||26
8321271|NCT01424072|20515956|P1|STARTED|Overall Study||27
8321272|NCT01424033|20515973|P1|NOT COMPLETED|Overall Study||5
8321273|NCT01424033|20515973|P1|COMPLETED|Overall Study||0
8321274|NCT01424033|20515973|P1|STARTED|Overall Study||5
8321275|NCT01423916|20515980|P3|NOT COMPLETED|Overall Study||7
8321276|NCT01423916|20515981|P2|NOT COMPLETED|Overall Study||20
8321277|NCT01423916|20515982|P1|NOT COMPLETED|Overall Study||11
8321278|NCT01423916|20515980|P3|COMPLETED|Overall Study||64
8321279|NCT01423916|20515981|P2|COMPLETED|Overall Study||53
8321280|NCT01423916|20515982|P1|COMPLETED|Overall Study||63
8321281|NCT01423916|20515980|P3|STARTED|Overall Study||71
8321282|NCT01423916|20515981|P2|STARTED|Overall Study||73
8321283|NCT01423916|20515982|P1|STARTED|Overall Study||74
8321284|NCT01423812|20516038|P2|NOT COMPLETED|Overall Study||4
8321285|NCT01423812|20516039|P1|NOT COMPLETED|Overall Study||3
8321286|NCT01423812|20516038|P2|COMPLETED|Overall Study||26
8321287|NCT01423812|20516039|P1|COMPLETED|Overall Study||27
8321288|NCT01423812|20516038|P2|STARTED|Overall Study||30
8321289|NCT01423812|20516039|P1|STARTED|Overall Study||30
8321290|NCT01423773|20516047|P2|NOT COMPLETED|Period 2, 2 Days||0
8321291|NCT01423773|20516048|P1|NOT COMPLETED|Period 2, 2 Days||0
8321292|NCT01423773|20516047|P2|COMPLETED|Period 2, 2 Days||10
8321293|NCT01423773|20516048|P1|COMPLETED|Period 2, 2 Days||10
8321294|NCT01423773|20516047|P2|STARTED|Period 2, 2 Days||10
8321295|NCT01423773|20516048|P1|STARTED|Period 2, 2 Days||10
8321296|NCT01423773|20516047|P2|NOT COMPLETED|Period One, 2 Days||0
8321297|NCT01423773|20516048|P1|NOT COMPLETED|Period One, 2 Days||0
8321298|NCT01423773|20516047|P2|COMPLETED|Period One, 2 Days||10
8321299|NCT01423773|20516048|P1|COMPLETED|Period One, 2 Days||10
8321300|NCT01423773|20516047|P2|STARTED|Period One, 2 Days||10
8321301|NCT01423773|20516048|P1|STARTED|Period One, 2 Days||10
8321302|NCT01423760|20516056|P2|NOT COMPLETED|Overall Study||0
8321303|NCT01423760|20516057|P1|NOT COMPLETED|Overall Study||0
8321304|NCT01423760|20516056|P2|COMPLETED|Overall Study||13
8321305|NCT01423760|20516057|P1|COMPLETED|Overall Study||14
8321306|NCT01423760|20516056|P2|Safety Analysis Set|Overall Study||8
8321307|NCT01423760|20516057|P1|Safety Analysis Set|Overall Study||12
8321308|NCT01423760|20516056|P2|Number of Non-treatment Subjects|Overall Study||5
8321309|NCT01423760|20516057|P1|Number of Non-treatment Subjects|Overall Study||2
8321310|NCT01423760|20516056|P2|Number of Tecemotide Subjects|Overall Study||8
8321311|NCT01423760|20516057|P1|Number of Tecemotide Subjects|Overall Study||12
8321312|NCT01423760|20516056|P2|STARTED|Overall Study||13
8321313|NCT01423760|20516057|P1|STARTED|Overall Study||14
8321314|NCT01423617|20516067|P2|NOT COMPLETED|Overall Study||1
8321315|NCT01423617|20516068|P1|NOT COMPLETED|Overall Study||0
8321316|NCT01423617|20516067|P2|COMPLETED|Overall Study||45
8321317|NCT01423617|20516068|P1|COMPLETED|Overall Study||46
8321318|NCT01423617|20516067|P2|STARTED|Overall Study||46
8321319|NCT01423617|20516068|P1|STARTED|Overall Study||46
8321320|NCT01423604|20516085|P2|NOT COMPLETED|Randomized||63
8321321|NCT01423604|20516086|P1|NOT COMPLETED|Randomized||63
8321322|NCT01423604|20516085|P2|COMPLETED|Randomized||0
8321323|NCT01423604|20516086|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
8321324|NCT01423604|20516085|P2|STARTED|Randomized||63
8321325|NCT01423604|20516086|P1|STARTED|Randomized||64
8321326|NCT01423604|20516085|P2|NOT COMPLETED|Safety Run-In||0
8321327|NCT01423604|20516086|P1|NOT COMPLETED|Safety Run-In||9
8321328|NCT01423604|20516085|P2|COMPLETED|Safety Run-In||0
8321329|NCT01423604|20516086|P1|COMPLETED|Safety Run-In||0
8321330|NCT01423604|20516085|P2|STARTED|Safety Run-In||0
8321331|NCT01423604|20516086|P1|STARTED|Safety Run-In||9
8321332|NCT01423253|20516101|P1|NOT COMPLETED|Overall Study||9
8321333|NCT01423253|20516101|P1|COMPLETED|Overall Study||39
8321334|NCT01423253|20516101|P1|STARTED|Overall Study||48
8321335|NCT01423162|20516114|P2|NOT COMPLETED|Overall Study||0
8321336|NCT01423162|20516115|P1|NOT COMPLETED|Overall Study||0
8321337|NCT01423162|20516114|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
8321338|NCT01423162|20516115|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
8321339|NCT01423162|20516114|P2|STARTED|Overall Study||9
8321340|NCT01423162|20516115|P1|STARTED|Overall Study||11
8321341|NCT01423084|20516123|P2|NOT COMPLETED|Overall Study||4
8321342|NCT01423084|20516124|P1|NOT COMPLETED|Overall Study||2
8321343|NCT01423084|20516123|P2|COMPLETED|Overall Study||170
8321344|NCT01423084|20516124|P1|COMPLETED|Overall Study||168
8321345|NCT01423084|20516123|P2|STARTED|Overall Study||174
8321346|NCT01423084|20516124|P1|STARTED|Overall Study||170
8321347|NCT01422915|20516154|P1|NOT COMPLETED|Overall Study||1
8321348|NCT01422915|20516154|P1|COMPLETED|Overall Study||3
8321349|NCT01422915|20516154|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
8321350|NCT01422889|20516159|P1|NOT COMPLETED|Overall Study||9
8321351|NCT01422889|20516159|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
8321352|NCT01422889|20516159|P1|STARTED|Overall Study||1120
8321353|NCT01422876|20516174|P10|NOT COMPLETED|Week 52||17
8321354|NCT01422876|20516175|P9|NOT COMPLETED|Week 52||21
8321355|NCT01422876|20516176|P8|NOT COMPLETED|Week 52||23
8321356|NCT01422876|20516177|P7|NOT COMPLETED|Week 52||16
8321357|NCT01422876|20516178|P6|NOT COMPLETED|Week 52||17
8321358|NCT01422876|20516179|P5|NOT COMPLETED|Week 52||15
8321359|NCT01422876|20516180|P4|NOT COMPLETED|Week 52||18
8321360|NCT01422876|20516181|P3|NOT COMPLETED|Week 52||13
8321361|NCT01422876|20516182|P2|NOT COMPLETED|Week 52||10
8321362|NCT01422876|20516183|P1|NOT COMPLETED|Week 52||12
8321363|NCT01422876|20516174|P10|COMPLETED|Week 52||118
8321364|NCT01422876|20516175|P9|COMPLETED|Week 52||113
8321365|NCT01422876|20516176|P8|COMPLETED|Week 52||112
8321366|NCT01422876|20516177|P7|COMPLETED|Week 52||120
8321367|NCT01422876|20516178|P6|COMPLETED|Week 52||120
8321368|NCT01422876|20516179|P5|COMPLETED|Week 52||117
8321369|NCT01422876|20516180|P4|COMPLETED|Week 52||122
8321370|NCT01422876|20516181|P3|COMPLETED|Week 52||128
8321371|NCT01422876|20516182|P2|COMPLETED|Week 52||126
8321372|NCT01422876|20516183|P1|COMPLETED|Week 52||125
8321373|NCT01422876|20516174|P10|STARTED|Week 52||135
8321374|NCT01422876|20516175|P9|STARTED|Week 52||134
8321375|NCT01422876|20516176|P8|STARTED|Week 52||135
8321376|NCT01422876|20516177|P7|STARTED|Week 52||136
8321377|NCT01422876|20516178|P6|STARTED|Week 52||137
8321378|NCT01422876|20516179|P5|STARTED|Week 52||132
8321379|NCT01422876|20516180|P4|STARTED|Week 52||140
8321380|NCT01422876|20516181|P3|STARTED|Week 52||141
8321381|NCT01422876|20516182|P2|STARTED|Week 52||136
8321382|NCT01422876|20516183|P1|STARTED|Week 52||137
8321383|NCT01422876|20516174|P10|NOT COMPLETED|Week 24||10
8321384|NCT01422876|20516175|P9|NOT COMPLETED|Week 24||6
8321385|NCT01422876|20516176|P8|NOT COMPLETED|Week 24||7
8321386|NCT01422876|20516177|P7|NOT COMPLETED|Week 24||6
8321387|NCT01422876|20516178|P6|NOT COMPLETED|Week 24||6
8321388|NCT01422876|20516179|P5|NOT COMPLETED|Week 24||7
8321389|NCT01422876|20516180|P4|NOT COMPLETED|Week 24||8
8321390|NCT01422876|20516181|P3|NOT COMPLETED|Week 24||5
8321391|NCT01422876|20516182|P2|NOT COMPLETED|Week 24||3
8321392|NCT01422876|20516183|P1|NOT COMPLETED|Week 24||6
8321393|NCT01422876|20516174|P10|COMPLETED|Week 24||125
8321394|NCT01422876|20516175|P9|COMPLETED|Week 24||128
8321395|NCT01422876|20516176|P8|COMPLETED|Week 24||128
8321396|NCT01422876|20516177|P7|COMPLETED|Week 24||130
8321397|NCT01422876|20516178|P6|COMPLETED|Week 24||131
8321398|NCT01422876|20516179|P5|COMPLETED|Week 24||125
8321399|NCT01422876|20516180|P4|COMPLETED|Week 24||132
8321400|NCT01422876|20516181|P3|COMPLETED|Week 24||136
8321401|NCT01422876|20516182|P2|COMPLETED|Week 24||133
8321402|NCT01422876|20516183|P1|COMPLETED|Week 24||131
8321403|NCT01422876|20516174|P10|STARTED|Week 24||135
8321404|NCT01422876|20516175|P9|STARTED|Week 24||134
8321405|NCT01422876|20516176|P8|STARTED|Week 24||135
8321406|NCT01422876|20516177|P7|STARTED|Week 24||136
8321407|NCT01422876|20516178|P6|STARTED|Week 24||137
8321408|NCT01422876|20516179|P5|STARTED|Week 24||132
8321409|NCT01422876|20516180|P4|STARTED|Week 24||140
8321410|NCT01422876|20516181|P3|STARTED|Week 24||141
8321411|NCT01422876|20516182|P2|STARTED|Week 24||136
8321412|NCT01422876|20516183|P1|STARTED|Week 24||137
8321413|NCT01422850|20516230|P1|NOT COMPLETED|Overall Study||3
8321414|NCT01422850|20516230|P1|COMPLETED|Overall Study||18
8321415|NCT01422850|20516230|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
8321416|NCT01422850|20516230|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
8321417|NCT01422850|20516230|P1|Week 9 - Second Treatment|Overall Study||20
8321418|NCT01422850|20516230|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
8321419|NCT01422850|20516230|P1|Week 4 - First Treatment|Overall Study||21
8321420|NCT01422850|20516230|P1|STARTED|Overall Study||21
8321421|NCT01422824|20516236|P1|NOT COMPLETED|Overall Study||38
8321422|NCT01422824|20516236|P1|COMPLETED|Overall Study||147
8321423|NCT01422824|20516236|P1|Treated|Overall Study||184
8321424|NCT01422824|20516236|P1|STARTED|Overall Study||185
8321425|NCT01422720|20516241|P1|NOT COMPLETED|Overall Study||22
8321426|NCT01422720|20516241|P1|COMPLETED|Overall Study||50
8321427|NCT01422720|20516241|P1|Per-Protocol Set (PPS)|Overall Study||55
8321428|NCT01422720|20516241|P1|Full Analysis Set (FAS)|Overall Study||71
8321429|NCT01422720|20516241|P1|Safety Set|Overall Study||72
8321430|NCT01422720|20516241|P1|STARTED|Overall Study||72
8321431|NCT01422538|20516252|P3|NOT COMPLETED|Overall Study||2
8321432|NCT01422538|20516253|P2|NOT COMPLETED|Overall Study||2
8321433|NCT01422538|20516254|P1|NOT COMPLETED|Overall Study||0
8321434|NCT01422538|20516252|P3|COMPLETED|Overall Study||8
8321435|NCT01422538|20516253|P2|COMPLETED|Overall Study||8
8321436|NCT01422538|20516254|P1|COMPLETED|Overall Study||10
8321437|NCT01422538|20516252|P3|STARTED|Overall Study||10
8321438|NCT01422538|20516253|P2|STARTED|Overall Study||10
8321439|NCT01422538|20516254|P1|STARTED|Overall Study||10
8321440|NCT01422434|20516279|P3|NOT COMPLETED|Overall Study||6
8321441|NCT01422434|20516280|P2|NOT COMPLETED|Overall Study||5
8321442|NCT01422434|20516281|P1|NOT COMPLETED|Overall Study||11
8321443|NCT01422434|20516279|P3|COMPLETED|Overall Study||217
8321444|NCT01422434|20516280|P2|COMPLETED|Overall Study||221
8321445|NCT01422434|20516281|P1|COMPLETED|Overall Study||216
8321446|NCT01422434|20516279|P3|STARTED|Overall Study||223
8321447|NCT01422434|20516280|P2|STARTED|Overall Study||226
8321448|NCT01422434|20516281|P1|STARTED|Overall Study||227
8321449|NCT01422408|20516298|P1|NOT COMPLETED|Overall Study||4
8321450|NCT01422408|20516298|P1|COMPLETED|Overall Study||30
8321451|NCT01422408|20516298|P1|STARTED|Overall Study||34
8321452|NCT01422382|20516327|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
8321453|NCT01422382|20516327|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
8321454|NCT01422382|20516327|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
8321455|NCT01422382|20516327|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
8321456|NCT01422382|20516327|P1|COMPLETED|Diltiazem 240 mg QD||28
8321457|NCT01422382|20516327|P1|STARTED|Diltiazem 240 mg QD||28
8321458|NCT01422382|20516327|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
8321459|NCT01422382|20516327|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
8321460|NCT01422382|20516327|P1|STARTED|NK-104 4mg Once Daily (QD)||28
8321461|NCT01422369|20516332|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
8321462|NCT01422369|20516332|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
8321463|NCT01422369|20516332|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
8321464|NCT01422369|20516332|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
8321465|NCT01422369|20516332|P1|COMPLETED|Prezista 800mg/100mg QD||28
8321466|NCT01422369|20516332|P1|STARTED|Prezista 800mg/100mg QD||28
8321467|NCT01422369|20516332|P1|NOT COMPLETED|NK-104 4mg QD||0
8321468|NCT01422369|20516332|P1|COMPLETED|NK-104 4mg QD||28
8321469|NCT01422369|20516332|P1|STARTED|NK-104 4mg QD||28
8321470|NCT01422356|20516337|P1|NOT COMPLETED|Overall Study||31
8321471|NCT01422356|20516337|P1|COMPLETED|Overall Study||169
8321472|NCT01422356|20516337|P1|STARTED|Overall Study||200
8321481|NCT01422239|20516376|P2|NOT COMPLETED|Overall Study||3
8321482|NCT01422239|20516377|P1|NOT COMPLETED|Overall Study||4
8321483|NCT01422239|20516376|P2|COMPLETED|Overall Study||3
8321484|NCT01422239|20516377|P1|COMPLETED|Overall Study||10
8321485|NCT01422239|20516376|P2|STARTED|Overall Study||6
8321486|NCT01422239|20516377|P1|STARTED|Overall Study||14
8321487|NCT01422226|20516389|P2|NOT COMPLETED|Overall Study||0
8321488|NCT01422226|20516390|P1|NOT COMPLETED|Overall Study||0
8321489|NCT01422226|20516389|P2|COMPLETED|Overall Study||2
8321490|NCT01422226|20516390|P1|COMPLETED|Overall Study||1
8321491|NCT01422226|20516389|P2|STARTED|Overall Study||2
8321492|NCT01422226|20516390|P1|STARTED|Overall Study||1
8321493|NCT01422213|20516399|P3|NOT COMPLETED|Overall Study||29
8321494|NCT01422213|20516400|P2|NOT COMPLETED|Overall Study||22
8321495|NCT01422213|20516401|P1|NOT COMPLETED|Overall Study||33
8321496|NCT01422213|20516399|P3|COMPLETED|Overall Study||178
8321497|NCT01422213|20516400|P2|COMPLETED|Overall Study||173
8321498|NCT01422213|20516401|P1|COMPLETED|Overall Study||163
8321499|NCT01422213|20516399|P3|STARTED|Overall Study||207
8321500|NCT01422213|20516400|P2|STARTED|Overall Study||195
8321501|NCT01422213|20516401|P1|STARTED|Overall Study||196
8321502|NCT01422200|20516461|P2|NOT COMPLETED|Overall Study||0
8321503|NCT01422200|20516462|P1|NOT COMPLETED|Overall Study||0
8321504|NCT01422200|20516461|P2|COMPLETED|Overall Study||11
8321505|NCT01422200|20516462|P1|COMPLETED|Overall Study||11
8321506|NCT01422200|20516461|P2|STARTED|Overall Study||11
8321507|NCT01422200|20516462|P1|STARTED|Overall Study||11
8321508|NCT01422187|20516473|P3|NOT COMPLETED|Overall Study||0
8321509|NCT01422187|20516474|P2|NOT COMPLETED|Overall Study||1
8321510|NCT01422187|20516475|P1|NOT COMPLETED|Overall Study||1
8321511|NCT01422187|20516473|P3|COMPLETED|Overall Study||2
8321512|NCT01422187|20516474|P2|COMPLETED|Overall Study||8
8321513|NCT01422187|20516475|P1|COMPLETED|Overall Study||7
8321514|NCT01422187|20516473|P3|STARTED|Overall Study||2
8321515|NCT01422187|20516474|P2|STARTED|Overall Study||9
8321516|NCT01422187|20516475|P1|STARTED|Overall Study||8
8321517|NCT01422161|20516494|P2|NOT COMPLETED|Overall Study||0
8321518|NCT01422161|20516495|P1|NOT COMPLETED|Overall Study||0
8321519|NCT01422161|20516494|P2|COMPLETED|Overall Study||6
8321520|NCT01422161|20516495|P1|COMPLETED|Overall Study||10
8321521|NCT01422161|20516494|P2|STARTED|Overall Study||6
8321522|NCT01422161|20516495|P1|STARTED|Overall Study||10
8321523|NCT01422135|20516511|P6|NOT COMPLETED|Overall Study||1
8321524|NCT01422135|20516512|P5|NOT COMPLETED|Overall Study||0
8321525|NCT01422135|20516513|P4|NOT COMPLETED|Overall Study||0
8321526|NCT01422135|20516514|P3|NOT COMPLETED|Overall Study||1
8321527|NCT01422135|20516515|P2|NOT COMPLETED|Overall Study||0
8321528|NCT01422135|20516516|P1|NOT COMPLETED|Overall Study||0
8321529|NCT01422135|20516511|P6|COMPLETED|Overall Study||3
8321530|NCT01422135|20516512|P5|COMPLETED|Overall Study||4
8321531|NCT01422135|20516513|P4|COMPLETED|Overall Study||4
8321532|NCT01422135|20516514|P3|COMPLETED|Overall Study||3
8321533|NCT01422135|20516515|P2|COMPLETED|Overall Study||4
8321534|NCT01422135|20516516|P1|COMPLETED|Overall Study||4
8321535|NCT01422135|20516511|P6|STARTED|Overall Study||4
8321536|NCT01422135|20516512|P5|STARTED|Overall Study||4
8321537|NCT01422135|20516513|P4|STARTED|Overall Study||4
8321538|NCT01422135|20516514|P3|STARTED|Overall Study||4
8321539|NCT01422135|20516515|P2|STARTED|Overall Study||4
8321540|NCT01422135|20516516|P1|STARTED|Overall Study||4
8321541|NCT01422070|20516527|P2|NOT COMPLETED|Overall Study||0
8321542|NCT01422070|20516528|P1|NOT COMPLETED|Overall Study||0
8321543|NCT01422070|20516527|P2|COMPLETED|Overall Study||803
8321544|NCT01422070|20516528|P1|COMPLETED|Overall Study||5031
8321545|NCT01422070|20516527|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
8321546|NCT01422070|20516528|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
8321547|NCT01421719|20516539|P1|NOT COMPLETED|Overall Study||4
8321548|NCT01421719|20516539|P1|COMPLETED|Overall Study||16
8321549|NCT01421719|20516539|P1|STARTED|Overall Study||20
8321550|NCT01421667|20516548|P4|NOT COMPLETED|Overall Study||1
8321551|NCT01421667|20516549|P3|NOT COMPLETED|Overall Study||2
8321552|NCT01421667|20516550|P2|NOT COMPLETED|Overall Study||2
8321553|NCT01421667|20516551|P1|NOT COMPLETED|Overall Study||0
8321554|NCT01421667|20516548|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
8321555|NCT01421667|20516549|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
8321556|NCT01421667|20516550|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
8321557|NCT01421667|20516551|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
8321558|NCT01421667|20516548|P4|STARTED|Overall Study||16
8321559|NCT01421667|20516549|P3|STARTED|Overall Study||53
8321560|NCT01421667|20516550|P2|STARTED|Overall Study||68
8321561|NCT01421667|20516551|P1|STARTED|Overall Study||35
8321562|NCT01421654|20516603|P2|NOT COMPLETED|Overall Study||0
8321563|NCT01421654|20516604|P1|NOT COMPLETED|Overall Study||0
8321564|NCT01421654|20516603|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
8321565|NCT01421654|20516604|P1|COMPLETED|Overall Study||11
8321566|NCT01421654|20516603|P2|STARTED|Overall Study||9
8321567|NCT01421654|20516604|P1|STARTED|Overall Study||11
8321568|NCT01421641|20516612|P2|NOT COMPLETED|Overall Study||2
8321569|NCT01421641|20516613|P1|NOT COMPLETED|Overall Study||2
8321570|NCT01421641|20516612|P2|COMPLETED|Overall Study||35
8321571|NCT01421641|20516613|P1|COMPLETED|Overall Study||35
8321572|NCT01421641|20516612|P2|STARTED|Overall Study||37
8321573|NCT01421641|20516613|P1|STARTED|Overall Study||37
8321574|NCT01421589|20516623|P1|NOT COMPLETED|Overall Study||0
8321575|NCT01421589|20516623|P1|COMPLETED|Overall Study||15
8321576|NCT01421589|20516623|P1|STARTED|Overall Study||15
8321577|NCT01421511|20516635|P2|NOT COMPLETED|Overall Study||28
8321578|NCT01421511|20516636|P1|NOT COMPLETED|Overall Study||19
8321579|NCT01421511|20516635|P2|COMPLETED|Overall Study||306
8321580|NCT01421511|20516636|P1|COMPLETED|Overall Study||313
8321581|NCT01421511|20516635|P2|STARTED|Overall Study||334
8321582|NCT01421511|20516636|P1|STARTED|Overall Study||332
8321583|NCT01421498|20516658|P2|NOT COMPLETED|Overall Study||11
8321584|NCT01421498|20516659|P1|NOT COMPLETED|Overall Study||12
8321585|NCT01421498|20516658|P2|COMPLETED|Overall Study||284
8321586|NCT01421498|20516659|P1|COMPLETED|Overall Study||281
8321587|NCT01421498|20516658|P2|STARTED|Overall Study||295
8321588|NCT01421498|20516659|P1|STARTED|Overall Study||293
8321589|NCT01421472|20516671|P4|NOT COMPLETED|Overall Study||0
8321590|NCT01421472|20516672|P3|NOT COMPLETED|Overall Study||0
8321591|NCT01421472|20516673|P2|NOT COMPLETED|Overall Study||0
8321592|NCT01421472|20516674|P1|NOT COMPLETED|Overall Study||0
8321593|NCT01421472|20516671|P4|COMPLETED|Overall Study||32
8321594|NCT01421472|20516672|P3|COMPLETED|Overall Study||64
8321595|NCT01421472|20516673|P2|COMPLETED|Overall Study||33
8321596|NCT01421472|20516674|P1|COMPLETED|Overall Study||67
8321597|NCT01421472|20516671|P4|STARTED|Overall Study||32
8321598|NCT01421472|20516672|P3|STARTED|Overall Study||64
8321599|NCT01421472|20516673|P2|STARTED|Overall Study||33
8321600|NCT01421472|20516674|P1|STARTED|Overall Study||67
8321601|NCT01421459|20516686|P2|NOT COMPLETED|Overall Study||52
8321602|NCT01421459|20516687|P1|NOT COMPLETED|Overall Study||45
8321603|NCT01421459|20516686|P2|COMPLETED|Overall Study||328
8321604|NCT01421459|20516687|P1|COMPLETED|Overall Study||334
8321605|NCT01421459|20516686|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
8321606|NCT01421459|20516687|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
8321607|NCT01421459|20516686|P2|STARTED|Overall Study||380
8321608|NCT01421459|20516687|P1|STARTED|Overall Study||379
8321609|NCT01421355|20516721|P1|NOT COMPLETED|Overall Study||6
8321610|NCT01421355|20516721|P1|COMPLETED|Overall Study||15
8321611|NCT01421355|20516721|P1|STARTED|Overall Study||21
8321612|NCT01421342|20516728|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
8321613|NCT01421342|20516729|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
8321614|NCT01421342|20516730|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
8321615|NCT01421342|20516728|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
8321616|NCT01421342|20516729|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
8321617|NCT01421342|20516730|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
8321618|NCT01421342|20516728|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
8321619|NCT01421342|20516729|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
8321620|NCT01421342|20516730|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
8321621|NCT01421342|20516728|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
8321622|NCT01421342|20516729|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
8321623|NCT01421342|20516730|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
8321624|NCT01421342|20516728|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
8321625|NCT01421342|20516729|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
8321626|NCT01421342|20516730|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
8321627|NCT01421342|20516728|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
8321628|NCT01421342|20516729|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
8321629|NCT01421342|20516730|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
8321630|NCT01421342|20516728|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
8321631|NCT01421342|20516729|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
8321632|NCT01421342|20516730|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
8321633|NCT01421342|20516728|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
8321634|NCT01421342|20516729|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
8321635|NCT01421342|20516730|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
8321636|NCT01421342|20516728|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
8321637|NCT01421342|20516729|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
8321638|NCT01421342|20516730|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
8321639|NCT01421303|20516747|P1|NOT COMPLETED|Overall Study||22
8321640|NCT01421303|20516747|P1|COMPLETED|Overall Study||58
8321641|NCT01421303|20516747|P1|STARTED|Overall Study||80
8321642|NCT01421277|20516774|P2|NOT COMPLETED|Overall Study||92
8321643|NCT01421277|20516775|P1|NOT COMPLETED|Overall Study||0
8321644|NCT01421277|20516774|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
8321645|NCT01421277|20516775|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
8321646|NCT01421277|20516774|P2|STARTED|Overall Study||191
8321647|NCT01421277|20516775|P1|STARTED|Overall Study||25
8321648|NCT01421225|20516787|P2|NOT COMPLETED|Overall Study||1
8321649|NCT01421225|20516788|P1|NOT COMPLETED|Overall Study||0
8321650|NCT01421225|20516787|P2|COMPLETED|Overall Study||5
8321651|NCT01421225|20516788|P1|COMPLETED|Overall Study||4
8321652|NCT01421225|20516787|P2|STARTED|Overall Study||6
8321653|NCT01421225|20516788|P1|STARTED|Overall Study||4
8321654|NCT01421147|20516802|P2|NOT COMPLETED|Extension Period||11
8321655|NCT01421147|20516803|P1|NOT COMPLETED|Extension Period||8
8321656|NCT01421147|20516802|P2|COMPLETED|Extension Period||245
8321657|NCT01421147|20516803|P1|COMPLETED|Extension Period||245
8321658|NCT01421147|20516802|P2|STARTED|Extension Period||256
8321659|NCT01421147|20516803|P1|STARTED|Extension Period||253
8321660|NCT01421147|20516802|P2|NOT COMPLETED|Treatment Period||11
8321661|NCT01421147|20516803|P1|NOT COMPLETED|Treatment Period||16
8321662|NCT01421147|20516802|P2|COMPLETED|Treatment Period||256
8321663|NCT01421147|20516803|P1|COMPLETED|Treatment Period||253
8321664|NCT01421147|20516802|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
8321665|NCT01421147|20516803|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
8321666|NCT01421147|20516802|P2|STARTED|Treatment Period||267
8321667|NCT01421147|20516803|P1|STARTED|Treatment Period||269
8321668|NCT01421134|20516835|P2|NOT COMPLETED|Overall Study||15
8321669|NCT01421134|20516836|P1|NOT COMPLETED|Overall Study||7
8321670|NCT01421134|20516835|P2|COMPLETED|Overall Study||87
8321671|NCT01421134|20516836|P1|COMPLETED|Overall Study||102
8321672|NCT01421134|20516835|P2|STARTED|Overall Study||102
8321673|NCT01421134|20516836|P1|STARTED|Overall Study||109
8321674|NCT01420965|20516857|P3|NOT COMPLETED|Overall Study||0
8321675|NCT01420965|20516858|P2|NOT COMPLETED|Overall Study||1
8321676|NCT01420965|20516859|P1|NOT COMPLETED|Overall Study||1
8321677|NCT01420965|20516857|P3|COMPLETED|Overall Study||3
8321678|NCT01420965|20516858|P2|COMPLETED|Overall Study||1
8321679|NCT01420965|20516859|P1|COMPLETED|Overall Study||1
8321680|NCT01420965|20516857|P3|STARTED|Overall Study||3
8321681|NCT01420965|20516858|P2|STARTED|Overall Study||2
8321682|NCT01420965|20516859|P1|STARTED|Overall Study||2
8321689|NCT01420848|20516890|P3|NOT COMPLETED|Overall Study||0
8321690|NCT01420848|20516891|P2|NOT COMPLETED|Overall Study||0
8321691|NCT01420848|20516892|P1|NOT COMPLETED|Overall Study||0
8321692|NCT01420848|20516890|P3|COMPLETED|Overall Study||22
8321693|NCT01420848|20516891|P2|COMPLETED|Overall Study||25
8321694|NCT01420848|20516892|P1|COMPLETED|Overall Study||24
8321695|NCT01420848|20516890|P3|STARTED|Overall Study||22
8321696|NCT01420848|20516891|P2|STARTED|Overall Study||25
8321697|NCT01420848|20516892|P1|STARTED|Overall Study||24
8321698|NCT01420653|20516907|P4|NOT COMPLETED|Overall Study||7
8321699|NCT01420653|20516908|P3|NOT COMPLETED|Overall Study||4
8321700|NCT01420653|20516909|P2|NOT COMPLETED|Overall Study||3
8321701|NCT01420653|20516910|P1|NOT COMPLETED|Overall Study||3
8321702|NCT01420653|20516907|P4|COMPLETED|Overall Study||68
8321703|NCT01420653|20516908|P3|COMPLETED|Overall Study||108
8321704|NCT01420653|20516909|P2|COMPLETED|Overall Study||108
8321705|NCT01420653|20516910|P1|COMPLETED|Overall Study||107
8321706|NCT01420653|20516907|P4|STARTED|Overall Study||75
8321707|NCT01420653|20516908|P3|STARTED|Overall Study||112
8321708|NCT01420653|20516909|P2|STARTED|Overall Study||111
8321709|NCT01420653|20516910|P1|STARTED|Overall Study||110
8321710|NCT01420627|20516920|P1|NOT COMPLETED|EZN-2279 Maintenance Period||0
8321711|NCT01420627|20516920|P1|COMPLETED|EZN-2279 Maintenance Period||6
8321712|NCT01420627|20516920|P1|STARTED|EZN-2279 Maintenance Period||6
8321713|NCT01420627|20516920|P1|NOT COMPLETED|EZN-2279 Treatment Period||1
8321714|NCT01420627|20516920|P1|COMPLETED|EZN-2279 Treatment Period||6
8321715|NCT01420627|20516920|P1|STARTED|EZN-2279 Treatment Period||7
8321716|NCT01420627|20516920|P1|NOT COMPLETED|Adagen Lead-in Period||0
8321717|NCT01420627|20516920|P1|COMPLETED|Adagen Lead-in Period||7
8321718|NCT01420627|20516920|P1|STARTED|Adagen Lead-in Period||7
8321719|NCT01420549|20516936|P2|NOT COMPLETED|Overall Study||5
8321720|NCT01420549|20516937|P1|NOT COMPLETED|Overall Study||7
8321721|NCT01420549|20516936|P2|COMPLETED|Overall Study||58
8321722|NCT01420549|20516937|P1|COMPLETED|Overall Study||59
8321723|NCT01420549|20516936|P2|STARTED|Overall Study||63
8321724|NCT01420549|20516937|P1|STARTED|Overall Study||66
8321725|NCT01420536|20516945|P2|NOT COMPLETED|Period 2 (30 Days)||0
8321726|NCT01420536|20516946|P1|NOT COMPLETED|Period 2 (30 Days)||0
8321727|NCT01420536|20516945|P2|COMPLETED|Period 2 (30 Days)||22
8321728|NCT01420536|20516946|P1|COMPLETED|Period 2 (30 Days)||19
8321729|NCT01420536|20516945|P2|STARTED|Period 2 (30 Days)||22
8321730|NCT01420536|20516946|P1|STARTED|Period 2 (30 Days)||19
8321731|NCT01420536|20516945|P2|NOT COMPLETED|Period 1 (30 Days)||0
8321732|NCT01420536|20516946|P1|NOT COMPLETED|Period 1 (30 Days)||3
8321733|NCT01420536|20516945|P2|COMPLETED|Period 1 (30 Days)||22
8321734|NCT01420536|20516946|P1|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
8321735|NCT01420536|20516945|P2|STARTED|Period 1 (30 Days)||22
8321736|NCT01420536|20516946|P1|STARTED|Period 1 (30 Days)||22
8321737|NCT01420289|20516978|P2|NOT COMPLETED|Overall Study||0
8321738|NCT01420289|20516979|P1|NOT COMPLETED|Overall Study||0
8321739|NCT01420289|20516978|P2|COMPLETED|Overall Study||16
8321740|NCT01420289|20516979|P1|COMPLETED|Overall Study||18
8321741|NCT01420289|20516978|P2|STARTED|Overall Study||16
8321742|NCT01420289|20516979|P1|STARTED|Overall Study||18
8321743|NCT01420146|20516991|P1|NOT COMPLETED|Overall Study||0
8321744|NCT01420146|20516991|P1|COMPLETED|Overall Study||20
8321745|NCT01420146|20516991|P1|STARTED|Overall Study||20
8321746|NCT01420081|20517004|P9|NOT COMPLETED|Overall Study||3
8321747|NCT01420081|20517005|P8|NOT COMPLETED|Overall Study||3
8321748|NCT01420081|20517006|P7|NOT COMPLETED|Overall Study||3
8321749|NCT01420081|20517007|P6|NOT COMPLETED|Overall Study||20
8321750|NCT01420081|20517008|P5|NOT COMPLETED|Overall Study||20
8321751|NCT01420081|20517009|P4|NOT COMPLETED|Overall Study||3
8321752|NCT01420081|20517010|P3|NOT COMPLETED|Overall Study||11
8321753|NCT01420081|20517011|P2|NOT COMPLETED|Overall Study||1
8321754|NCT01420081|20517012|P1|NOT COMPLETED|Overall Study||3
8321755|NCT01420081|20517004|P9|COMPLETED|Overall Study||0
8321756|NCT01420081|20517005|P8|COMPLETED|Overall Study||0
8321757|NCT01420081|20517006|P7|COMPLETED|Overall Study||0
8321758|NCT01420081|20517007|P6|COMPLETED|Overall Study||0
8321759|NCT01420081|20517008|P5|COMPLETED|Overall Study||0
8321760|NCT01420081|20517009|P4|COMPLETED|Overall Study||0
8321761|NCT01420081|20517010|P3|COMPLETED|Overall Study||0
8321762|NCT01420081|20517011|P2|COMPLETED|Overall Study||0
8321763|NCT01420081|20517012|P1|COMPLETED|Overall Study||0
8321764|NCT01420081|20517004|P9|STARTED|Overall Study||3
8321765|NCT01420081|20517005|P8|STARTED|Overall Study||3
8321766|NCT01420081|20517006|P7|STARTED|Overall Study||3
8321767|NCT01420081|20517007|P6|STARTED|Overall Study||20
8321768|NCT01420081|20517008|P5|STARTED|Overall Study||20
8321769|NCT01420081|20517009|P4|STARTED|Overall Study||3
8321770|NCT01420081|20517010|P3|STARTED|Overall Study||11
8321771|NCT01420081|20517011|P2|STARTED|Overall Study||1
8321772|NCT01420081|20517012|P1|STARTED|Overall Study||3
8321773|NCT01420068|20517093|P2|NOT COMPLETED|Overall Study||5
8321774|NCT01420068|20517094|P1|NOT COMPLETED|Overall Study||2
8321775|NCT01420068|20517093|P2|COMPLETED|Overall Study||50
8321776|NCT01420068|20517094|P1|COMPLETED|Overall Study||49
8321777|NCT01420068|20517093|P2|STARTED|Overall Study||55
8321778|NCT01420068|20517094|P1|STARTED|Overall Study||51
8321779|NCT01420016|20517116|P4|NOT COMPLETED|Safety Analysis||0
8321780|NCT01420016|20517117|P3|NOT COMPLETED|Safety Analysis||0
8321781|NCT01420016|20517118|P2|NOT COMPLETED|Safety Analysis||0
8321782|NCT01420016|20517119|P1|NOT COMPLETED|Safety Analysis||0
8321783|NCT01420016|20517116|P4|COMPLETED|Safety Analysis||5159
8321784|NCT01420016|20517117|P3|COMPLETED|Safety Analysis||6392
8321785|NCT01420016|20517118|P2|COMPLETED|Safety Analysis||0
8321786|NCT01420016|20517119|P1|COMPLETED|Safety Analysis||0
8321787|NCT01420016|20517116|P4|STARTED|Safety Analysis||5159
8321788|NCT01420016|20517117|P3|STARTED|Safety Analysis||6392
8321789|NCT01420016|20517118|P2|STARTED|Safety Analysis||0
8321790|NCT01420016|20517119|P1|STARTED|Safety Analysis||0
8321791|NCT01420016|20517116|P4|NOT COMPLETED|Primary Analysis||0
8321792|NCT01420016|20517117|P3|NOT COMPLETED|Primary Analysis||0
8321793|NCT01420016|20517118|P2|NOT COMPLETED|Primary Analysis||2540
8321794|NCT01420016|20517119|P1|NOT COMPLETED|Primary Analysis||2927
8321795|NCT01420016|20517116|P4|COMPLETED|Primary Analysis||0
8321796|NCT01420016|20517117|P3|COMPLETED|Primary Analysis||0
8321797|NCT01420016|20517118|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
8321798|NCT01420016|20517119|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
8321799|NCT01420016|20517116|P4|STARTED|Primary Analysis||0
8321800|NCT01420016|20517117|P3|STARTED|Primary Analysis||0
8321801|NCT01420016|20517118|P2|STARTED|Primary Analysis||6411
8321802|NCT01420016|20517119|P1|STARTED|Primary Analysis||6970
8321803|NCT01419977|20517127|P2|NOT COMPLETED|Overall Study||0
8321804|NCT01419977|20517128|P1|NOT COMPLETED|Overall Study||0
8321805|NCT01419977|20517127|P2|COMPLETED|Overall Study||13
8321806|NCT01419977|20517128|P1|COMPLETED|Overall Study||16
8321807|NCT01419977|20517127|P2|STARTED|Overall Study||13
8321808|NCT01419977|20517128|P1|STARTED|Overall Study||16
8321809|NCT01419795|20517142|P2|NOT COMPLETED|Overall Study||0
8321810|NCT01419795|20517143|P1|NOT COMPLETED|Overall Study||0
8321811|NCT01419795|20517142|P2|COMPLETED|Overall Study||0
8321812|NCT01419795|20517143|P1|COMPLETED|Overall Study||3
8321813|NCT01419795|20517142|P2|STARTED|Overall Study||0
8321814|NCT01419795|20517143|P1|STARTED|Overall Study||3
8321815|NCT01419769|20517165|P1|NOT COMPLETED|Overall Study||4
8321816|NCT01419769|20517165|P1|COMPLETED|Overall Study||29
8321817|NCT01419769|20517165|P1|STARTED|Overall Study||33
8321818|NCT01419717|20517178|P1|NOT COMPLETED|Overall Study||125
8321819|NCT01419717|20517178|P1|COMPLETED|Overall Study||4
8321820|NCT01419717|20517178|P1|Received Denosumab|Overall Study||128
8321821|NCT01419717|20517178|P1|STARTED|Overall Study||129
8321822|NCT01419639|20517183|P1|NOT COMPLETED|Overall Study||1
8321823|NCT01419639|20517183|P1|COMPLETED|Overall Study||9
8321824|NCT01419639|20517183|P1|STARTED|Overall Study||10
8321825|NCT01419626|20517192|P3|NOT COMPLETED|Overall Study||3
8321826|NCT01419626|20517193|P2|NOT COMPLETED|Overall Study||3
8321827|NCT01419626|20517194|P1|NOT COMPLETED|Overall Study||4
8321828|NCT01419626|20517192|P3|COMPLETED|Overall Study||44
8321829|NCT01419626|20517193|P2|COMPLETED|Overall Study||44
8321830|NCT01419626|20517194|P1|COMPLETED|Overall Study||42
8321831|NCT01419626|20517192|P3|STARTED|Overall Study||47
8321832|NCT01419626|20517193|P2|STARTED|Overall Study||47
8321833|NCT01419626|20517194|P1|STARTED|Overall Study||46
8321834|NCT01419314|20517225|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
8321835|NCT01419314|20517226|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
8321836|NCT01419314|20517225|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
8321837|NCT01419314|20517226|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
8321838|NCT01419314|20517225|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
8321839|NCT01419314|20517226|P1|STARTED|Follow-up at Week 6 of the Trial||17
8321840|NCT01419314|20517225|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
8321841|NCT01419314|20517226|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
8321842|NCT01419314|20517225|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
8321843|NCT01419314|20517226|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
8321844|NCT01419314|20517225|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
8321845|NCT01419314|20517226|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
8321846|NCT01419314|20517225|P2|NOT COMPLETED|Start of Study||0
8321847|NCT01419314|20517226|P1|NOT COMPLETED|Start of Study||0
8321848|NCT01419314|20517225|P2|COMPLETED|Start of Study||22
8321849|NCT01419314|20517226|P1|COMPLETED|Start of Study||23
8321850|NCT01419314|20517225|P2|STARTED|Start of Study|No comfort issues reported.|22
8321851|NCT01419314|20517226|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
8321852|NCT01419275|20517246|P1|NOT COMPLETED|Overall Study||0
8321853|NCT01419275|20517246|P1|COMPLETED|Overall Study||126
8321854|NCT01419275|20517246|P1|STARTED|Overall Study||126
8321855|NCT01419249|20517252|P2|NOT COMPLETED|Overall Study||0
8321856|NCT01419249|20517253|P1|NOT COMPLETED|Overall Study||0
8321857|NCT01419249|20517252|P2|COMPLETED|Overall Study||140
8321858|NCT01419249|20517253|P1|COMPLETED|Overall Study||318
8321859|NCT01419249|20517252|P2|STARTED|Overall Study||140
8321860|NCT01419249|20517253|P1|STARTED|Overall Study||318
8321861|NCT01419236|20517267|P2|NOT COMPLETED|Overall Study||5
8321862|NCT01419236|20517268|P1|NOT COMPLETED|Overall Study||5
8321863|NCT01419236|20517267|P2|COMPLETED|Overall Study||35
8321864|NCT01419236|20517268|P1|COMPLETED|Overall Study||31
8321865|NCT01419236|20517267|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
8321866|NCT01419236|20517268|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
8321867|NCT01419236|20517267|P2|STARTED|Overall Study||40
8321868|NCT01419236|20517268|P1|STARTED|Overall Study||36
8321869|NCT01419197|20517292|P2|NOT COMPLETED|Overall Study||198
8321870|NCT01419197|20517293|P1|NOT COMPLETED|Overall Study||404
8321871|NCT01419197|20517292|P2|COMPLETED|Overall Study||0
8321872|NCT01419197|20517293|P1|COMPLETED|Overall Study||0
8321873|NCT01419197|20517292|P2|Switched to Trastuzumab Emtansine|Overall Study||94
8321874|NCT01419197|20517293|P1|Switched to Trastuzumab Emtansine|Overall Study||0
8321875|NCT01419197|20517292|P2|STARTED|Overall Study||198
8321876|NCT01419197|20517293|P1|STARTED|Overall Study||404
8321877|NCT01419184|20517318|P2|NOT COMPLETED|Overall Study||15
8321878|NCT01419184|20517319|P1|NOT COMPLETED|Overall Study||10
8321879|NCT01419184|20517318|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
8321880|NCT01419184|20517319|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
8321881|NCT01419184|20517318|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
8321882|NCT01419184|20517319|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
8321883|NCT01419184|20517318|P2|STARTED|Overall Study||121
8321884|NCT01419184|20517319|P1|STARTED|Overall Study||128
8321885|NCT01419171|20517335|P1|NOT COMPLETED|Overall Study||0
8321886|NCT01419171|20517335|P1|COMPLETED|Overall Study||328
8321887|NCT01419171|20517335|P1|STARTED|Overall Study||328
8321888|NCT01419080|20517352|P1|NOT COMPLETED|Overall Study||131
8321889|NCT01419080|20517352|P1|COMPLETED|Overall Study||666
8321890|NCT01419080|20517352|P1|STARTED|Overall Study||797
8321891|NCT01419028|20517358|P1|NOT COMPLETED|Overall Study||0
8321892|NCT01419028|20517358|P1|COMPLETED|Overall Study||48
8321893|NCT01419028|20517358|P1|STARTED|Overall Study||48
8321894|NCT01419015|20517363|P1|NOT COMPLETED|Overall Study||2
8321895|NCT01419015|20517363|P1|COMPLETED|Overall Study||15
8321896|NCT01419015|20517363|P1|STARTED|Overall Study||17
8321897|NCT01418937|20517367|P1|NOT COMPLETED|Overall Study||8
8321898|NCT01418937|20517367|P1|COMPLETED|Overall Study||156
8321899|NCT01418937|20517367|P1|STARTED|Overall Study||164
8321900|NCT01418703|20517376|P4|NOT COMPLETED|Overall Study||0
8321901|NCT01418703|20517377|P3|NOT COMPLETED|Overall Study||0
8321902|NCT01418703|20517378|P2|NOT COMPLETED|Overall Study||0
8321903|NCT01418703|20517379|P1|NOT COMPLETED|Overall Study||0
8321904|NCT01418703|20517376|P4|COMPLETED|Overall Study||6
8321905|NCT01418703|20517377|P3|COMPLETED|Overall Study||6
8321906|NCT01418703|20517378|P2|COMPLETED|Overall Study||13
8321907|NCT01418703|20517379|P1|COMPLETED|Overall Study||13
8321908|NCT01418703|20517376|P4|STARTED|Overall Study||6
8321909|NCT01418703|20517377|P3|STARTED|Overall Study||6
8321910|NCT01418703|20517378|P2|STARTED|Overall Study||13
8321911|NCT01418703|20517379|P1|STARTED|Overall Study||13
8321912|NCT01418482|20517390|P1|NOT COMPLETED|Overall Study||0
8321913|NCT01418482|20517390|P1|COMPLETED|Overall Study||15
8321914|NCT01418482|20517390|P1|STARTED|Overall Study||15
8321915|NCT01418378|20517398|P2|NOT COMPLETED|Overall Study||5
8321916|NCT01418378|20517399|P1|NOT COMPLETED|Overall Study||1
8321917|NCT01418378|20517398|P2|COMPLETED|Overall Study||83
8321918|NCT01418378|20517399|P1|COMPLETED|Overall Study||89
8321919|NCT01418378|20517398|P2|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
8321920|NCT01418378|20517399|P1|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
8321921|NCT01418378|20517398|P2|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
8321922|NCT01418378|20517399|P1|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
8321923|NCT01418365|20517473|P2|NOT COMPLETED|Second Intervention||1
8321924|NCT01418365|20517474|P1|NOT COMPLETED|Second Intervention||0
8321925|NCT01418365|20517473|P2|COMPLETED|Second Intervention||13
8321926|NCT01418365|20517474|P1|COMPLETED|Second Intervention||14
8321927|NCT01418365|20517473|P2|STARTED|Second Intervention||14
8321928|NCT01418365|20517474|P1|STARTED|Second Intervention||14
8321929|NCT01418365|20517473|P2|NOT COMPLETED|First Intervention||1
8321930|NCT01418365|20517474|P1|NOT COMPLETED|First Intervention||1
8321931|NCT01418365|20517473|P2|COMPLETED|First Intervention||14
8321932|NCT01418365|20517474|P1|COMPLETED|First Intervention||14
8321933|NCT01418365|20517473|P2|STARTED|First Intervention||15
8321934|NCT01418365|20517474|P1|STARTED|First Intervention||15
8321935|NCT01418209|20517485|P3|NOT COMPLETED|Overall Study||4
8321936|NCT01418209|20517486|P2|NOT COMPLETED|Overall Study||3
8321937|NCT01418209|20517487|P1|NOT COMPLETED|Overall Study||2
8321938|NCT01418209|20517485|P3|COMPLETED|Overall Study||142
8321939|NCT01418209|20517486|P2|COMPLETED|Overall Study||93
8321940|NCT01418209|20517487|P1|COMPLETED|Overall Study||95
8321941|NCT01418209|20517485|P3|STARTED|Overall Study||146
8321942|NCT01418209|20517486|P2|STARTED|Overall Study||96
8321943|NCT01418209|20517487|P1|STARTED|Overall Study||97
8321944|NCT01418001|20517516|P1|NOT COMPLETED|Overall Study||0
8321945|NCT01418001|20517516|P1|COMPLETED|Overall Study||5
8321946|NCT01418001|20517516|P1|STARTED|Overall Study||5
8321947|NCT01417936|20517521|P1|NOT COMPLETED|Overall Study||0
8321948|NCT01417936|20517521|P1|COMPLETED|Overall Study||26
8321949|NCT01417936|20517521|P1|STARTED|Overall Study||26
8321950|NCT01417741|20517542|P2|NOT COMPLETED|Overall Study||0
8321951|NCT01417741|20517543|P1|NOT COMPLETED|Overall Study||0
8321952|NCT01417741|20517542|P2|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
8321953|NCT01417741|20517543|P1|COMPLETED|Overall Study||75
8321954|NCT01417741|20517542|P2|STARTED|Overall Study||86
8321955|NCT01417741|20517543|P1|STARTED|Overall Study||75
8321956|NCT01417481|20517551|P2|NOT COMPLETED|Second Period (8 Weeks)||0
8321957|NCT01417481|20517552|P1|NOT COMPLETED|Second Period (8 Weeks)||0
8321958|NCT01417481|20517551|P2|COMPLETED|Second Period (8 Weeks)||5
8321959|NCT01417481|20517552|P1|COMPLETED|Second Period (8 Weeks)||8
8321960|NCT01417481|20517551|P2|STARTED|Second Period (8 Weeks)||5
8321961|NCT01417481|20517552|P1|STARTED|Second Period (8 Weeks)||8
8321962|NCT01417481|20517551|P2|NOT COMPLETED|Washout (2 Weeks)||0
8321963|NCT01417481|20517552|P1|NOT COMPLETED|Washout (2 Weeks)||0
8321964|NCT01417481|20517551|P2|COMPLETED|Washout (2 Weeks)||5
8321965|NCT01417481|20517552|P1|COMPLETED|Washout (2 Weeks)||8
8321966|NCT01417481|20517551|P2|STARTED|Washout (2 Weeks)||5
8321967|NCT01417481|20517552|P1|STARTED|Washout (2 Weeks)||8
8321968|NCT01417481|20517551|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
8321969|NCT01417481|20517552|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8321970|NCT01417481|20517551|P2|COMPLETED|First Intervention (8 Weeks)||5
8321971|NCT01417481|20517552|P1|COMPLETED|First Intervention (8 Weeks)||8
8321972|NCT01417481|20517551|P2|STARTED|First Intervention (8 Weeks)||7
8321973|NCT01417481|20517552|P1|STARTED|First Intervention (8 Weeks)||8
8321974|NCT01417455|20517584|P8|NOT COMPLETED|Overall Study||0
8321975|NCT01417455|20517585|P7|NOT COMPLETED|Overall Study||0
8321976|NCT01417455|20517586|P6|NOT COMPLETED|Overall Study||0
8321977|NCT01417455|20517587|P5|NOT COMPLETED|Overall Study||0
8321978|NCT01417455|20517588|P4|NOT COMPLETED|Overall Study||0
8321979|NCT01417455|20517589|P3|NOT COMPLETED|Overall Study||0
8321980|NCT01417455|20517590|P2|NOT COMPLETED|Overall Study||0
8321981|NCT01417455|20517591|P1|NOT COMPLETED|Overall Study||0
8321982|NCT01417455|20517584|P8|COMPLETED|Overall Study||25
8321983|NCT01417455|20517585|P7|COMPLETED|Overall Study||13
8321984|NCT01417455|20517586|P6|COMPLETED|Overall Study||13
8321985|NCT01417455|20517587|P5|COMPLETED|Overall Study||30
8321986|NCT01417455|20517588|P4|COMPLETED|Overall Study||17
8321987|NCT01417455|20517589|P3|COMPLETED|Overall Study||17
8321988|NCT01417455|20517590|P2|COMPLETED|Overall Study||16
8321989|NCT01417455|20517591|P1|COMPLETED|Overall Study||16
8321990|NCT01417455|20517584|P8|STARTED|Overall Study||25
8321991|NCT01417455|20517585|P7|STARTED|Overall Study||13
8321992|NCT01417455|20517586|P6|STARTED|Overall Study||13
8321993|NCT01417455|20517587|P5|STARTED|Overall Study||30
8321994|NCT01417455|20517588|P4|STARTED|Overall Study||17
8321995|NCT01417455|20517589|P3|STARTED|Overall Study||17
8321996|NCT01417455|20517590|P2|STARTED|Overall Study||16
8321997|NCT01417455|20517591|P1|STARTED|Overall Study||16
8321998|NCT01417377|20517617|P1|NOT COMPLETED|Overall Study||13
8321999|NCT01417377|20517617|P1|COMPLETED|Overall Study||9
8322000|NCT01417377|20517617|P1|Treated|Overall Study||21
8322001|NCT01417377|20517617|P1|STARTED|Overall Study||22
8322002|NCT01417234|20517624|P1|NOT COMPLETED|Overall Study||3
8322003|NCT01417234|20517624|P1|COMPLETED|Overall Study||27
8322004|NCT01417234|20517624|P1|STARTED|Overall Study||30
8322005|NCT01417195|20517633|P2|NOT COMPLETED|Overall Study||1
8322006|NCT01417195|20517634|P1|NOT COMPLETED|Overall Study||3
8322007|NCT01417195|20517633|P2|COMPLETED|Overall Study||61
8322008|NCT01417195|20517634|P1|COMPLETED|Overall Study||57
8322009|NCT01417195|20517633|P2|STARTED|Overall Study||62
8322010|NCT01417195|20517634|P1|STARTED|Overall Study||60
8322011|NCT01417156|20517650|P1|NOT COMPLETED|Overall Study||14
8322012|NCT01417156|20517650|P1|COMPLETED|Overall Study||6
8322013|NCT01417156|20517650|P1|STARTED|Overall Study||20
8322014|NCT01417104|20517660|P2|NOT COMPLETED|Overall Study||2
8322015|NCT01417104|20517661|P1|NOT COMPLETED|Overall Study||6
8322016|NCT01417104|20517660|P2|COMPLETED|Overall Study||35
8322017|NCT01417104|20517661|P1|COMPLETED|Overall Study||28
8322018|NCT01417104|20517660|P2|STARTED|Overall Study||37
8322019|NCT01417104|20517661|P1|STARTED|Overall Study||34
8322020|NCT01417078|20517671|P1|NOT COMPLETED|Overall Study||1
8322021|NCT01417078|20517671|P1|COMPLETED|Overall Study||30
8322022|NCT01417078|20517671|P1|STARTED|Overall Study||31
8322023|NCT01417026|20517683|P2|NOT COMPLETED|Overall Study||0
8322024|NCT01417026|20517684|P1|NOT COMPLETED|Overall Study||2
8322025|NCT01417026|20517683|P2|COMPLETED|Overall Study||13
8322026|NCT01417026|20517684|P1|COMPLETED|Overall Study||14
8322027|NCT01417026|20517683|P2|STARTED|Overall Study||13
8322028|NCT01417026|20517684|P1|STARTED|Overall Study||16
8322029|NCT01417000|20517696|P2|NOT COMPLETED|Overall Study||29
8322030|NCT01417000|20517697|P1|NOT COMPLETED|Overall Study||61
8322031|NCT01417000|20517696|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
8322032|NCT01417000|20517697|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
8322033|NCT01417000|20517696|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
8322034|NCT01417000|20517697|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
8322035|NCT01416987|20517705|P1|NOT COMPLETED|Overall Study||0
8322036|NCT01416987|20517705|P1|COMPLETED|Overall Study||600
8322037|NCT01416987|20517705|P1|STARTED|Overall Study||600
8322038|NCT01416805|20517714|P2|NOT COMPLETED|Overall Study||4
8322039|NCT01416805|20517715|P1|NOT COMPLETED|Overall Study||4
8322040|NCT01416805|20517714|P2|COMPLETED|Overall Study||47
8322041|NCT01416805|20517715|P1|COMPLETED|Overall Study||45
8322042|NCT01416805|20517714|P2|STARTED|Overall Study||51
8322043|NCT01416805|20517715|P1|STARTED|Overall Study||49
8322044|NCT01416636|20517725|P2|NOT COMPLETED|Overall Study||6
8322045|NCT01416636|20517726|P1|NOT COMPLETED|Overall Study||8
8322046|NCT01416636|20517725|P2|COMPLETED|Overall Study||46
8322047|NCT01416636|20517726|P1|COMPLETED|Overall Study||45
8322048|NCT01416636|20517725|P2|STARTED|Overall Study||52
8322049|NCT01416636|20517726|P1|STARTED|Overall Study||53
8322050|NCT01416610|20517754|P1|NOT COMPLETED|Overall Study||43
8322051|NCT01416610|20517754|P1|COMPLETED|Overall Study||45
8322052|NCT01416610|20517754|P1|Completed Follow-up|Overall Study||45
8322053|NCT01416610|20517754|P1|Completed Treatment|Overall Study||47
8322054|NCT01416610|20517754|P1|Per Protocol|Overall Study||83
8322055|NCT01416610|20517754|P1|Safety Population|Overall Study||86
8322056|NCT01416610|20517754|P1|Intention to Treat|Overall Study||88
8322057|NCT01416610|20517754|P1|STARTED|Overall Study||88
8322058|NCT01416584|20517771|P3|NOT COMPLETED|Overall Study||1
8322059|NCT01416584|20517772|P2|NOT COMPLETED|Overall Study||2
8322060|NCT01416584|20517773|P1|NOT COMPLETED|Overall Study||3
8322061|NCT01416584|20517771|P3|COMPLETED|Overall Study||32
8322062|NCT01416584|20517772|P2|COMPLETED|Overall Study||33
8322063|NCT01416584|20517773|P1|COMPLETED|Overall Study||27
8322064|NCT01416584|20517771|P3|STARTED|Overall Study||33
8322065|NCT01416584|20517772|P2|STARTED|Overall Study||35
8322066|NCT01416584|20517773|P1|STARTED|Overall Study||30
8322067|NCT01416571|20517808|P1|NOT COMPLETED|Overall Study||2
8322068|NCT01416571|20517808|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
8322069|NCT01416571|20517808|P1|STARTED|Overall Study||78
8322070|NCT01416389|20517837|P2|NOT COMPLETED|Overall Study||0
8322071|NCT01416389|20517838|P1|NOT COMPLETED|Overall Study||3
8322072|NCT01416389|20517837|P2|COMPLETED|Overall Study||13
8322073|NCT01416389|20517838|P1|COMPLETED|Overall Study||23
8322074|NCT01416389|20517837|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8322075|NCT01416389|20517838|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
8322076|NCT01416389|20517837|P2|STARTED|Overall Study||13
8322077|NCT01416389|20517838|P1|STARTED|Overall Study||26
8322078|NCT01416272|20517855|P1|NOT COMPLETED|Overall Study||4
8322079|NCT01416272|20517855|P1|COMPLETED|Overall Study||8
8322080|NCT01416272|20517855|P1|STARTED|Overall Study||12
8322081|NCT01416194|20517864|P3|NOT COMPLETED|Overall Study||0
8322082|NCT01416194|20517865|P2|NOT COMPLETED|Overall Study||0
8322083|NCT01416194|20517866|P1|NOT COMPLETED|Overall Study||0
8322084|NCT01416194|20517864|P3|COMPLETED|Overall Study||6666
8322085|NCT01416194|20517865|P2|COMPLETED|Overall Study||2720
8322086|NCT01416194|20517866|P1|COMPLETED|Overall Study||1111
8322087|NCT01416194|20517864|P3|STARTED|Overall Study||6666
8322088|NCT01416194|20517865|P2|STARTED|Overall Study||2720
8322089|NCT01416194|20517866|P1|STARTED|Overall Study||1111
8322090|NCT01416181|20517912|P2|NOT COMPLETED|Part 2||286
8322091|NCT01416181|20517913|P1|NOT COMPLETED|Part 2||271
8322092|NCT01416181|20517912|P2|COMPLETED|Part 2||6
8322093|NCT01416181|20517913|P1|COMPLETED|Part 2||3
8322094|NCT01416181|20517912|P2|Completed Treatment for > 96 Weeks|Part 2||0
8322095|NCT01416181|20517913|P1|Completed Treatment for > 96 Weeks|Part 2||1
8322096|NCT01416181|20517912|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
8322097|NCT01416181|20517913|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
8322098|NCT01416181|20517912|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
8322099|NCT01416181|20517913|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
8322100|NCT01416181|20517912|P2|STARTED|Part 2||292
8322101|NCT01416181|20517913|P1|STARTED|Part 2||274
8322102|NCT01416181|20517912|P2|NOT COMPLETED|Part 1||114
8322103|NCT01416181|20517913|P1|NOT COMPLETED|Part 1||137
8322104|NCT01416181|20517912|P2|COMPLETED|Part 1|Completed Study through Week 108|326
8322105|NCT01416181|20517913|P1|COMPLETED|Part 1|Completed Study through Week 108|312
8322106|NCT01416181|20517912|P2|Withdrew Prior to Dosing|Part 1||1
8322107|NCT01416181|20517913|P1|Withdrew Prior to Dosing|Part 1||0
8322108|NCT01416181|20517912|P2|STARTED|Part 1||440
8322109|NCT01416181|20517913|P1|STARTED|Part 1||449
8322110|NCT01416155|20517975|P1|NOT COMPLETED|Overall Study||58
8322111|NCT01416155|20517975|P1|COMPLETED|Overall Study||39
8322112|NCT01416155|20517975|P1|STARTED|Overall Study||97
8322113|NCT01416142|20517982|P3|NOT COMPLETED|PureVision2 HD||1
8322114|NCT01416142|20517983|P2|NOT COMPLETED|PureVision2 HD||0
8322115|NCT01416142|20517984|P1|NOT COMPLETED|PureVision2 HD||0
8322116|NCT01416142|20517982|P3|COMPLETED|PureVision2 HD||62
8322117|NCT01416142|20517983|P2|COMPLETED|PureVision2 HD||0
8322118|NCT01416142|20517984|P1|COMPLETED|PureVision2 HD||0
8322119|NCT01416142|20517982|P3|STARTED|PureVision2 HD||63
8322120|NCT01416142|20517983|P2|STARTED|PureVision2 HD||0
8322121|NCT01416142|20517984|P1|STARTED|PureVision2 HD||0
8322122|NCT01416142|20517982|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
8322123|NCT01416142|20517983|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
8322124|NCT01416142|20517984|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
8322125|NCT01416142|20517982|P3|COMPLETED|Cross Over at Movie Intermission||0
8322126|NCT01416142|20517983|P2|COMPLETED|Cross Over at Movie Intermission||31
8322127|NCT01416142|20517984|P1|COMPLETED|Cross Over at Movie Intermission||32
8322128|NCT01416142|20517982|P3|STARTED|Cross Over at Movie Intermission||0
8322129|NCT01416142|20517983|P2|STARTED|Cross Over at Movie Intermission||31
8322130|NCT01416142|20517984|P1|STARTED|Cross Over at Movie Intermission||32
8322131|NCT01416129|20517995|P2|NOT COMPLETED|Experimental Condition: Brimless||0
8322132|NCT01416129|20517996|P1|NOT COMPLETED|Experimental Condition: Brimless||0
8322133|NCT01416129|20517995|P2|COMPLETED|Experimental Condition: Brimless||5
8322134|NCT01416129|20517996|P1|COMPLETED|Experimental Condition: Brimless||5
8322135|NCT01416129|20517995|P2|STARTED|Experimental Condition: Brimless||5
8322136|NCT01416129|20517996|P1|STARTED|Experimental Condition: Brimless||5
8322137|NCT01416129|20517995|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
8322138|NCT01416129|20517996|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
8322139|NCT01416129|20517995|P2|COMPLETED|Control Condition: Ischial Containment||5
8322140|NCT01416129|20517996|P1|COMPLETED|Control Condition: Ischial Containment||5
8322141|NCT01416129|20517995|P2|STARTED|Control Condition: Ischial Containment||5
8322142|NCT01416129|20517996|P1|STARTED|Control Condition: Ischial Containment||5
8322143|NCT01416025|20518004|P2|NOT COMPLETED|Overall Study||0
8322144|NCT01416025|20518005|P1|NOT COMPLETED|Overall Study||0
8322145|NCT01416025|20518004|P2|COMPLETED|Overall Study||15
8322146|NCT01416025|20518005|P1|COMPLETED|Overall Study||14
8322147|NCT01416025|20518004|P2|STARTED|Overall Study||15
8322148|NCT01416025|20518005|P1|STARTED|Overall Study||14
8322149|NCT01415986|20518011|P1|NOT COMPLETED|Overall Study||1
8322150|NCT01415986|20518011|P1|COMPLETED|Overall Study|Study terminated|0
8322151|NCT01415986|20518011|P1|STARTED|Overall Study||1
8322152|NCT01415960|20518016|P1|NOT COMPLETED|Overall Study||12
8322153|NCT01415960|20518016|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
8322154|NCT01415960|20518016|P1|PK Subgroup|Overall Study||30
8322155|NCT01415960|20518016|P1|ITT|Overall Study||161
8322156|NCT01415960|20518016|P1|STARTED|Overall Study||163
8322157|NCT01415934|20518028|P2|NOT COMPLETED|Overall Study||7
8322158|NCT01415934|20518029|P1|NOT COMPLETED|Overall Study||3
8322159|NCT01415934|20518028|P2|COMPLETED|Overall Study||182
8322160|NCT01415934|20518029|P1|COMPLETED|Overall Study||189
8322161|NCT01415934|20518028|P2|STARTED|Overall Study||189
8322162|NCT01415934|20518029|P1|STARTED|Overall Study||192
8322163|NCT01415921|20518037|P2|NOT COMPLETED|Overall Study||3
8322164|NCT01415921|20518038|P1|NOT COMPLETED|Overall Study||3
8322165|NCT01415921|20518037|P2|COMPLETED|Overall Study||14
8322166|NCT01415921|20518038|P1|COMPLETED|Overall Study||13
8322167|NCT01415921|20518037|P2|STARTED|Overall Study||17
8322168|NCT01415921|20518038|P1|STARTED|Overall Study||16
8322169|NCT01415908|20518048|P2|NOT COMPLETED|Overall Study||0
8322170|NCT01415908|20518049|P1|NOT COMPLETED|Overall Study||1
8322171|NCT01415908|20518048|P2|COMPLETED|Overall Study||4
8322172|NCT01415908|20518049|P1|COMPLETED|Overall Study||10
8322173|NCT01415908|20518048|P2|STARTED|Overall Study||4
8322174|NCT01415908|20518049|P1|STARTED|Overall Study||11
8322175|NCT01415583|20518077|P2|NOT COMPLETED|Overall Study||0
8322176|NCT01415583|20518078|P1|NOT COMPLETED|Overall Study||0
8322177|NCT01415583|20518077|P2|COMPLETED|Overall Study||157
8322178|NCT01415583|20518078|P1|COMPLETED|Overall Study||157
8322179|NCT01415583|20518077|P2|STARTED|Overall Study||157
8322180|NCT01415583|20518078|P1|STARTED|Overall Study||157
8322181|NCT01415531|20518086|P2|NOT COMPLETED|Overall Study||37
8322182|NCT01415531|20518087|P1|NOT COMPLETED|Overall Study||25
8322183|NCT01415531|20518086|P2|COMPLETED|Overall Study||390
8322184|NCT01415531|20518087|P1|COMPLETED|Overall Study||189
8322185|NCT01415531|20518086|P2|STARTED|Overall Study||427
8322186|NCT01415531|20518087|P1|STARTED|Overall Study||214
8322187|NCT01415518|20518097|P2|NOT COMPLETED|Overall Study||31
8322188|NCT01415518|20518098|P1|NOT COMPLETED|Overall Study||16
8322189|NCT01415518|20518097|P2|COMPLETED|Overall Study||261
8322190|NCT01415518|20518098|P1|COMPLETED|Overall Study||276
8322191|NCT01415518|20518097|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
8322192|NCT01415518|20518098|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
8322193|NCT01415518|20518097|P2|Patients Who Received Study Treatment|Overall Study||292
8322194|NCT01415518|20518098|P1|Patients Who Received Study Treatment|Overall Study||290
8322195|NCT01415518|20518097|P2|STARTED|Overall Study||292
8322196|NCT01415518|20518098|P1|STARTED|Overall Study||292
8322197|NCT01415453|20518150|P1|NOT COMPLETED|Overall Study||0
8322198|NCT01415453|20518150|P1|COMPLETED|Overall Study||1
8322199|NCT01415453|20518150|P1|Imaging Study|Overall Study||1
8322200|NCT01415453|20518150|P1|STARTED|Overall Study||1
8322201|NCT01415440|20518157|P3|NOT COMPLETED|Overall Study||2
8322202|NCT01415440|20518158|P2|NOT COMPLETED|Overall Study||1
8322203|NCT01415440|20518159|P1|NOT COMPLETED|Overall Study||4
8322204|NCT01415440|20518157|P3|COMPLETED|Overall Study||27
8322205|NCT01415440|20518158|P2|COMPLETED|Overall Study||28
8322206|NCT01415440|20518159|P1|COMPLETED|Overall Study||37
8322207|NCT01415440|20518157|P3|STARTED|Overall Study||29
8322208|NCT01415440|20518158|P2|STARTED|Overall Study||29
8322209|NCT01415440|20518159|P1|STARTED|Overall Study||41
8322210|NCT01415427|20518170|P4|NOT COMPLETED|Overall Study||56
8322211|NCT01415427|20518171|P3|NOT COMPLETED|Overall Study||58
8322212|NCT01415427|20518172|P2|NOT COMPLETED|Overall Study||29
8322213|NCT01415427|20518173|P1|NOT COMPLETED|Overall Study||29
8322214|NCT01415427|20518170|P4|COMPLETED|Overall Study||0
8322215|NCT01415427|20518171|P3|COMPLETED|Overall Study||1
8322216|NCT01415427|20518172|P2|COMPLETED|Overall Study||0
8322217|NCT01415427|20518173|P1|COMPLETED|Overall Study||0
8322218|NCT01415427|20518170|P4|STARTED|Overall Study||56
8322219|NCT01415427|20518171|P3|STARTED|Overall Study||59
8322220|NCT01415427|20518172|P2|STARTED|Overall Study||29
8322221|NCT01415427|20518173|P1|STARTED|Overall Study||29
8322222|NCT01415401|20518210|P1|NOT COMPLETED|Overall Study||7
8322223|NCT01415401|20518210|P1|COMPLETED|Overall Study||47
8322224|NCT01415401|20518210|P1|STARTED|Overall Study||54
8322225|NCT01415349|20518215|P2|NOT COMPLETED|Treatment Period 2||0
8322226|NCT01415349|20518216|P1|NOT COMPLETED|Treatment Period 2||0
8322227|NCT01415349|20518215|P2|COMPLETED|Treatment Period 2||19
8322228|NCT01415349|20518216|P1|COMPLETED|Treatment Period 2||21
8322229|NCT01415349|20518215|P2|STARTED|Treatment Period 2||19
8322230|NCT01415349|20518216|P1|STARTED|Treatment Period 2||21
8322231|NCT01415349|20518215|P2|NOT COMPLETED|Treatment Period 1||2
8322232|NCT01415349|20518216|P1|NOT COMPLETED|Treatment Period 1||0
8322233|NCT01415349|20518215|P2|COMPLETED|Treatment Period 1||19
8322234|NCT01415349|20518216|P1|COMPLETED|Treatment Period 1||21
8322235|NCT01415349|20518215|P2|STARTED|Treatment Period 1||21
8322236|NCT01415349|20518216|P1|STARTED|Treatment Period 1||21
8322237|NCT01415232|20518224|P1|NOT COMPLETED|Overall Study||0
8322238|NCT01415232|20518224|P1|COMPLETED|Overall Study||160
8322239|NCT01415232|20518224|P1|STARTED|Overall Study||160
8322240|NCT01414855|20518228|P1|NOT COMPLETED|Overall Study||29
8322241|NCT01414855|20518228|P1|COMPLETED|Overall Study||71
8322242|NCT01414855|20518228|P1|STARTED|Overall Study||100
8322243|NCT01414738|20518244|P1|NOT COMPLETED|Overall Study||44
8322244|NCT01414738|20518244|P1|COMPLETED|Overall Study||5
8322245|NCT01414738|20518244|P1|Follow-up (9 Months)|Overall Study||5
8322246|NCT01414738|20518244|P1|Follow-up (6 Months)|Overall Study||8
8322247|NCT01414738|20518244|P1|Follow-up (3 Months)|Overall Study||18
8322248|NCT01414738|20518244|P1|STARTED|Overall Study||49
8322249|NCT01414634|20518265|P8|NOT COMPLETED|Overall Study||0
8322250|NCT01414634|20518266|P7|NOT COMPLETED|Overall Study||0
8322251|NCT01414634|20518267|P6|NOT COMPLETED|Overall Study||0
8322252|NCT01414634|20518268|P5|NOT COMPLETED|Overall Study||0
8322253|NCT01414634|20518269|P4|NOT COMPLETED|Overall Study||0
8322254|NCT01414634|20518270|P3|NOT COMPLETED|Overall Study||0
8322255|NCT01414634|20518271|P2|NOT COMPLETED|Overall Study||0
8322256|NCT01414634|20518272|P1|NOT COMPLETED|Overall Study||0
8322257|NCT01414634|20518265|P8|COMPLETED|Overall Study||1
8322258|NCT01414634|20518266|P7|COMPLETED|Overall Study||1
8322259|NCT01414634|20518267|P6|COMPLETED|Overall Study||2
8322260|NCT01414634|20518268|P5|COMPLETED|Overall Study||1
8322261|NCT01414634|20518269|P4|COMPLETED|Overall Study||1
8322262|NCT01414634|20518270|P3|COMPLETED|Overall Study||1
8322263|NCT01414634|20518271|P2|COMPLETED|Overall Study||1
8322264|NCT01414634|20518272|P1|COMPLETED|Overall Study||1
8322265|NCT01414634|20518265|P8|STARTED|Overall Study||1
8322266|NCT01414634|20518266|P7|STARTED|Overall Study||1
8322267|NCT01414634|20518267|P6|STARTED|Overall Study||2
8322268|NCT01414634|20518268|P5|STARTED|Overall Study||1
8322269|NCT01414634|20518269|P4|STARTED|Overall Study||1
8322270|NCT01414634|20518270|P3|STARTED|Overall Study||1
8322271|NCT01414634|20518271|P2|STARTED|Overall Study||1
8322272|NCT01414634|20518272|P1|STARTED|Overall Study||1
8322273|NCT01414426|20518285|P2|NOT COMPLETED|Overall Study||2
8322274|NCT01414426|20518286|P1|NOT COMPLETED|Overall Study||1
8322275|NCT01414426|20518285|P2|COMPLETED|Overall Study||8
8322276|NCT01414426|20518286|P1|COMPLETED|Overall Study||9
8322277|NCT01414426|20518285|P2|STARTED|Overall Study||10
8322278|NCT01414426|20518286|P1|STARTED|Overall Study||10
8322279|NCT01414413|20518302|P2|NOT COMPLETED|Overall Study||0
8322280|NCT01414413|20518303|P1|NOT COMPLETED|Overall Study||0
8322281|NCT01414413|20518302|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
8322282|NCT01414413|20518303|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
8322283|NCT01414413|20518302|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
8322284|NCT01414413|20518303|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
8322285|NCT01414257|20518315|P1|NOT COMPLETED|Overall Study||22
8322286|NCT01414257|20518315|P1|COMPLETED|Overall Study||2838
8322287|NCT01414257|20518315|P1|STARTED|Overall Study||2860
8322288|NCT01414244|20518328|P2|NOT COMPLETED|Overall Study||0
8322289|NCT01414244|20518329|P1|NOT COMPLETED|Overall Study||0
8322290|NCT01414244|20518328|P2|COMPLETED|Overall Study||52
8322291|NCT01414244|20518329|P1|COMPLETED|Overall Study||54
8322292|NCT01414244|20518328|P2|STARTED|Overall Study||52
8322293|NCT01414244|20518329|P1|STARTED|Overall Study||54
8322294|NCT01414205|20518343|P2|NOT COMPLETED|Overall Study||7
8322295|NCT01414205|20518344|P1|NOT COMPLETED|Overall Study||7
8322296|NCT01414205|20518343|P2|COMPLETED|Overall Study||32
8322297|NCT01414205|20518344|P1|COMPLETED|Overall Study||34
8322298|NCT01414205|20518343|P2|Received Study Drug|Overall Study||38
8322299|NCT01414205|20518344|P1|Received Study Drug|Overall Study||40
8322300|NCT01414205|20518343|P2|STARTED|Overall Study||39
8322301|NCT01414205|20518344|P1|STARTED|Overall Study||41
8322302|NCT01414192|20518380|P4|NOT COMPLETED|Overall Study||0
8322303|NCT01414192|20518381|P3|NOT COMPLETED|Overall Study||0
8322304|NCT01414192|20518382|P2|NOT COMPLETED|Overall Study||0
8322305|NCT01414192|20518383|P1|NOT COMPLETED|Overall Study||0
8322306|NCT01414192|20518380|P4|COMPLETED|Overall Study||1726
8322307|NCT01414192|20518381|P3|COMPLETED|Overall Study||424
8322308|NCT01414192|20518382|P2|COMPLETED|Overall Study||575
8322309|NCT01414192|20518383|P1|COMPLETED|Overall Study||490
8322310|NCT01414192|20518380|P4|STARTED|Overall Study||1726
8322311|NCT01414192|20518381|P3|STARTED|Overall Study||424
8322312|NCT01414192|20518382|P2|STARTED|Overall Study||575
8322313|NCT01414192|20518383|P1|STARTED|Overall Study||490
8322314|NCT01414166|20518413|P2|NOT COMPLETED|Overall Study||83
8322315|NCT01414166|20518414|P1|NOT COMPLETED|Overall Study||91
8322316|NCT01414166|20518413|P2|COMPLETED|Overall Study||39
8322317|NCT01414166|20518414|P1|COMPLETED|Overall Study||31
8322318|NCT01414166|20518413|P2|Treated|Overall Study||121
8322319|NCT01414166|20518414|P1|Treated|Overall Study||120
8322320|NCT01414166|20518413|P2|STARTED|Overall Study||122
8322321|NCT01414166|20518414|P1|STARTED|Overall Study||122
8322322|NCT01414153|20518440|P4|NOT COMPLETED|Overall Study||4
8322323|NCT01414153|20518441|P3|NOT COMPLETED|Overall Study||4
8322324|NCT01414153|20518442|P2|NOT COMPLETED|Overall Study||2
8322325|NCT01414153|20518443|P1|NOT COMPLETED|Overall Study||8
8322326|NCT01414153|20518440|P4|COMPLETED|Overall Study||37
8322327|NCT01414153|20518441|P3|COMPLETED|Overall Study||35
8322328|NCT01414153|20518442|P2|COMPLETED|Overall Study||38
8322329|NCT01414153|20518443|P1|COMPLETED|Overall Study||30
8322330|NCT01414153|20518440|P4|STARTED|Overall Study||41
8322331|NCT01414153|20518441|P3|STARTED|Overall Study||39
8322332|NCT01414153|20518442|P2|STARTED|Overall Study||40
8322333|NCT01414153|20518443|P1|STARTED|Overall Study||38
8322334|NCT01414114|20518477|P1|NOT COMPLETED|Overall Study||5
8322335|NCT01414114|20518477|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
8322336|NCT01414114|20518477|P1|STARTED|Overall Study||37
8322337|NCT01414036|20518497|P2|NOT COMPLETED|Completed 3 Month Survey||5
8322338|NCT01414036|20518498|P1|NOT COMPLETED|Completed 3 Month Survey||9
8322339|NCT01414036|20518497|P2|COMPLETED|Completed 3 Month Survey||19
8322340|NCT01414036|20518498|P1|COMPLETED|Completed 3 Month Survey||14
8322341|NCT01414036|20518497|P2|STARTED|Completed 3 Month Survey||24
8322342|NCT01414036|20518498|P1|STARTED|Completed 3 Month Survey||23
8322343|NCT01414036|20518497|P2|NOT COMPLETED|Received Allocated Intervention||13
8322344|NCT01414036|20518498|P1|NOT COMPLETED|Received Allocated Intervention||0
8322345|NCT01414036|20518497|P2|COMPLETED|Received Allocated Intervention||11
8322346|NCT01414036|20518498|P1|COMPLETED|Received Allocated Intervention||23
8322347|NCT01414036|20518497|P2|STARTED|Received Allocated Intervention||24
8322348|NCT01414036|20518498|P1|STARTED|Received Allocated Intervention||23
8322349|NCT01414010|20518512|P4|NOT COMPLETED|Overall Study||0
8322350|NCT01414010|20518513|P3|NOT COMPLETED|Overall Study||0
8322351|NCT01414010|20518514|P2|NOT COMPLETED|Overall Study||0
8322352|NCT01414010|20518515|P1|NOT COMPLETED|Overall Study||2
8322353|NCT01414010|20518512|P4|COMPLETED|Overall Study||8
8322354|NCT01414010|20518513|P3|COMPLETED|Overall Study||8
8322355|NCT01414010|20518514|P2|COMPLETED|Overall Study||8
8322356|NCT01414010|20518515|P1|COMPLETED|Overall Study||6
8322357|NCT01414010|20518512|P4|STARTED|Overall Study||8
8322358|NCT01414010|20518513|P3|STARTED|Overall Study||8
8322359|NCT01414010|20518514|P2|STARTED|Overall Study||8
8322360|NCT01414010|20518515|P1|STARTED|Overall Study||8
8322361|NCT01413958|20518533|P2|NOT COMPLETED|Overall Study||1
8322362|NCT01413958|20518534|P1|NOT COMPLETED|Overall Study||0
8322363|NCT01413958|20518533|P2|COMPLETED|Overall Study||286
8322364|NCT01413958|20518534|P1|COMPLETED|Overall Study||288
8322365|NCT01413958|20518533|P2|STARTED|Overall Study||287
8322366|NCT01413958|20518534|P1|STARTED|Overall Study||288
8322367|NCT01413750|20518569|P4|NOT COMPLETED|Overall Study||0
8322368|NCT01413750|20518570|P3|NOT COMPLETED|Overall Study||0
8322369|NCT01413750|20518571|P2|NOT COMPLETED|Overall Study||0
8322370|NCT01413750|20518572|P1|NOT COMPLETED|Overall Study||0
8322371|NCT01413750|20518569|P4|COMPLETED|Overall Study||7
8322372|NCT01413750|20518570|P3|COMPLETED|Overall Study||4
8322373|NCT01413750|20518571|P2|COMPLETED|Overall Study||6
8322374|NCT01413750|20518572|P1|COMPLETED|Overall Study||6
8322375|NCT01413750|20518569|P4|STARTED|Overall Study||7
8322376|NCT01413750|20518570|P3|STARTED|Overall Study||4
8322377|NCT01413750|20518571|P2|STARTED|Overall Study||6
8322378|NCT01413750|20518572|P1|STARTED|Overall Study||6
8322379|NCT01413542|20518585|P4|NOT COMPLETED|Overall Study||1
8322380|NCT01413542|20518586|P3|NOT COMPLETED|Overall Study||3
8322381|NCT01413542|20518587|P2|NOT COMPLETED|Overall Study||0
8322382|NCT01413542|20518588|P1|NOT COMPLETED|Overall Study||1
8322383|NCT01413542|20518585|P4|COMPLETED|Overall Study||7
8322384|NCT01413542|20518586|P3|COMPLETED|Overall Study||6
8322385|NCT01413542|20518587|P2|COMPLETED|Overall Study||6
8322386|NCT01413542|20518588|P1|COMPLETED|Overall Study||5
8322387|NCT01413542|20518585|P4|STARTED|Overall Study||8
8322388|NCT01413542|20518586|P3|STARTED|Overall Study||9
8322389|NCT01413542|20518587|P2|STARTED|Overall Study||6
8322390|NCT01413542|20518588|P1|STARTED|Overall Study||6
8322391|NCT01413516|20518603|P2|NOT COMPLETED|Overall Study||0
8322392|NCT01413516|20518604|P1|NOT COMPLETED|Overall Study||0
8322393|NCT01413516|20518603|P2|COMPLETED|Overall Study||9
8322394|NCT01413516|20518604|P1|COMPLETED|Overall Study||8
8322395|NCT01413516|20518603|P2|STARTED|Overall Study||9
8322396|NCT01413516|20518604|P1|STARTED|Overall Study||8
8322397|NCT01413503|20518610|P1|NOT COMPLETED|Overall Study||1
8322398|NCT01413503|20518610|P1|COMPLETED|Overall Study||49
8322399|NCT01413503|20518610|P1|STARTED|Overall Study||50
8322400|NCT01413360|20518614|P1|NOT COMPLETED|Overall Study||3
8322401|NCT01413360|20518614|P1|COMPLETED|Overall Study||7
8322402|NCT01413360|20518614|P1|STARTED|Overall Study||10
8322403|NCT01413204|20518622|P3|NOT COMPLETED|Overall Study||19
8322404|NCT01413204|20518623|P2|NOT COMPLETED|Overall Study||6
8322405|NCT01413204|20518624|P1|NOT COMPLETED|Overall Study||6
8322406|NCT01413204|20518622|P3|COMPLETED|Overall Study||74
8322407|NCT01413204|20518623|P2|COMPLETED|Overall Study||83
8322408|NCT01413204|20518624|P1|COMPLETED|Overall Study||84
8322409|NCT01413204|20518622|P3|STARTED|Overall Study||93
8322410|NCT01413204|20518623|P2|STARTED|Overall Study||89
8322411|NCT01413204|20518624|P1|STARTED|Overall Study||90
8322412|NCT01413191|20518632|P1|NOT COMPLETED|Overall Study||11
8322413|NCT01413191|20518632|P1|COMPLETED|Overall Study||7
8322414|NCT01413191|20518632|P1|STARTED|Overall Study||18
8322415|NCT01413178|20518644|P2|NOT COMPLETED|Overall Study||2
8322416|NCT01413178|20518645|P1|NOT COMPLETED|Overall Study||1
8322417|NCT01413178|20518644|P2|COMPLETED|Overall Study||98
8322418|NCT01413178|20518645|P1|COMPLETED|Overall Study||104
8322419|NCT01413178|20518644|P2|STARTED|Overall Study||100
8322420|NCT01413178|20518645|P1|STARTED|Overall Study||105
8322421|NCT01413087|20518661|P2|NOT COMPLETED|Overall Study||0
8322422|NCT01413087|20518662|P1|NOT COMPLETED|Overall Study||0
8322423|NCT01413087|20518661|P2|COMPLETED|Overall Study||6
8322424|NCT01413087|20518662|P1|COMPLETED|Overall Study||6
8322425|NCT01413087|20518661|P2|STARTED|Overall Study||6
8322426|NCT01413087|20518662|P1|STARTED|Overall Study||6
8322427|NCT01412983|20518688|P2|NOT COMPLETED|2nd Period||0
8322428|NCT01412983|20518689|P1|NOT COMPLETED|2nd Period||0
8322429|NCT01412983|20518688|P2|COMPLETED|2nd Period||46
8322430|NCT01412983|20518689|P1|COMPLETED|2nd Period||50
8322431|NCT01412983|20518688|P2|STARTED|2nd Period||46
8322432|NCT01412983|20518689|P1|STARTED|2nd Period||50
8322433|NCT01412983|20518688|P2|NOT COMPLETED|1st Period||4
8322434|NCT01412983|20518689|P1|NOT COMPLETED|1st Period||0
8322435|NCT01412983|20518688|P2|COMPLETED|1st Period||46
8322436|NCT01412983|20518689|P1|COMPLETED|1st Period||50
8322437|NCT01412983|20518688|P2|STARTED|1st Period||50
8322438|NCT01412983|20518689|P1|STARTED|1st Period||50
8322439|NCT01412957|20518699|P2|NOT COMPLETED|Overall Study||157
8322440|NCT01412957|20518700|P1|NOT COMPLETED|Overall Study||149
8322441|NCT01412957|20518699|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
8322442|NCT01412957|20518700|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
8322443|NCT01412957|20518699|P2|STARTED|Overall Study||188
8322444|NCT01412957|20518700|P1|STARTED|Overall Study||189
8322445|NCT01412944|20518722|P6|NOT COMPLETED|Follow-up||0
8322446|NCT01412944|20518723|P5|NOT COMPLETED|Follow-up||0
8322447|NCT01412944|20518724|P4|NOT COMPLETED|Follow-up||0
8322448|NCT01412944|20518725|P3|NOT COMPLETED|Follow-up||0
8322449|NCT01412944|20518726|P2|NOT COMPLETED|Follow-up||0
8322450|NCT01412944|20518727|P1|NOT COMPLETED|Follow-up||0
8322451|NCT01412944|20518722|P6|COMPLETED|Follow-up||0
8322452|NCT01412944|20518723|P5|COMPLETED|Follow-up||2
8322453|NCT01412944|20518724|P4|COMPLETED|Follow-up||1
8322454|NCT01412944|20518725|P3|COMPLETED|Follow-up||2
8322455|NCT01412944|20518726|P2|COMPLETED|Follow-up||0
8322456|NCT01412944|20518727|P1|COMPLETED|Follow-up||0
8322457|NCT01412944|20518722|P6|STARTED|Follow-up||0
8322458|NCT01412944|20518723|P5|STARTED|Follow-up||2
8322459|NCT01412944|20518724|P4|STARTED|Follow-up||1
8322460|NCT01412944|20518725|P3|STARTED|Follow-up||2
8322461|NCT01412944|20518726|P2|STARTED|Follow-up||0
8322462|NCT01412944|20518727|P1|STARTED|Follow-up||0
8322463|NCT01412944|20518722|P6|NOT COMPLETED|Entire: IV + Maintenance||0
8322464|NCT01412944|20518723|P5|NOT COMPLETED|Entire: IV + Maintenance||0
8322465|NCT01412944|20518724|P4|NOT COMPLETED|Entire: IV + Maintenance||0
8322466|NCT01412944|20518725|P3|NOT COMPLETED|Entire: IV + Maintenance||0
8322467|NCT01412944|20518726|P2|NOT COMPLETED|Entire: IV + Maintenance||5
8322468|NCT01412944|20518727|P1|NOT COMPLETED|Entire: IV + Maintenance||2
8322469|NCT01412944|20518722|P6|COMPLETED|Entire: IV + Maintenance||0
8322470|NCT01412944|20518723|P5|COMPLETED|Entire: IV + Maintenance||0
8322471|NCT01412944|20518724|P4|COMPLETED|Entire: IV + Maintenance||0
8322472|NCT01412944|20518725|P3|COMPLETED|Entire: IV + Maintenance||0
8322473|NCT01412944|20518726|P2|COMPLETED|Entire: IV + Maintenance||17
8322474|NCT01412944|20518727|P1|COMPLETED|Entire: IV + Maintenance||19
8322475|NCT01412944|20518722|P6|STARTED|Entire: IV + Maintenance||0
8322476|NCT01412944|20518723|P5|STARTED|Entire: IV + Maintenance||0
8322477|NCT01412944|20518724|P4|STARTED|Entire: IV + Maintenance||0
8322478|NCT01412944|20518725|P3|STARTED|Entire: IV + Maintenance||0
8322479|NCT01412944|20518726|P2|STARTED|Entire: IV + Maintenance||22
8322480|NCT01412944|20518727|P1|STARTED|Entire: IV + Maintenance||21
8322481|NCT01412944|20518722|P6|NOT COMPLETED|Entire: IV + Maintenance||2
8322482|NCT01412944|20518723|P5|NOT COMPLETED|Entire: IV + Maintenance||3
8322483|NCT01412944|20518724|P4|NOT COMPLETED|Entire: IV + Maintenance||1
8322484|NCT01412944|20518725|P3|NOT COMPLETED|Entire: IV + Maintenance||1
8322485|NCT01412944|20518726|P2|NOT COMPLETED|Entire: IV + Maintenance||0
8322486|NCT01412944|20518727|P1|NOT COMPLETED|Entire: IV + Maintenance||0
8322487|NCT01412944|20518722|P6|COMPLETED|Entire: IV + Maintenance||6
8322488|NCT01412944|20518723|P5|COMPLETED|Entire: IV + Maintenance||11
8322489|NCT01412944|20518724|P4|COMPLETED|Entire: IV + Maintenance||5
8322490|NCT01412944|20518725|P3|COMPLETED|Entire: IV + Maintenance||14
8322491|NCT01412944|20518726|P2|COMPLETED|Entire: IV + Maintenance||0
8322492|NCT01412944|20518727|P1|COMPLETED|Entire: IV + Maintenance||0
8322493|NCT01412944|20518722|P6|STARTED|Entire: IV + Maintenance||8
8322494|NCT01412944|20518723|P5|STARTED|Entire: IV + Maintenance||14
8322495|NCT01412944|20518724|P4|STARTED|Entire: IV + Maintenance||6
8322496|NCT01412944|20518725|P3|STARTED|Entire: IV + Maintenance||15
8322497|NCT01412944|20518726|P2|STARTED|Entire: IV + Maintenance||0
8322498|NCT01412944|20518727|P1|STARTED|Entire: IV + Maintenance||0
8322499|NCT01412944|20518722|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
8322500|NCT01412944|20518723|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
8322501|NCT01412944|20518724|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
8322502|NCT01412944|20518725|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
8322503|NCT01412944|20518726|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
8322504|NCT01412944|20518727|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
8322505|NCT01412944|20518722|P6|COMPLETED|IV: Per CAIN457A2307||0
8322506|NCT01412944|20518723|P5|COMPLETED|IV: Per CAIN457A2307||0
8322507|NCT01412944|20518724|P4|COMPLETED|IV: Per CAIN457A2307||0
8322508|NCT01412944|20518725|P3|COMPLETED|IV: Per CAIN457A2307||0
8322509|NCT01412944|20518726|P2|COMPLETED|IV: Per CAIN457A2307||20
8322510|NCT01412944|20518727|P1|COMPLETED|IV: Per CAIN457A2307||20
8322511|NCT01412944|20518722|P6|STARTED|IV: Per CAIN457A2307||0
8322512|NCT01412944|20518723|P5|STARTED|IV: Per CAIN457A2307||0
8322513|NCT01412944|20518724|P4|STARTED|IV: Per CAIN457A2307||0
8322514|NCT01412944|20518725|P3|STARTED|IV: Per CAIN457A2307||0
8322515|NCT01412944|20518726|P2|STARTED|IV: Per CAIN457A2307||22
8322516|NCT01412944|20518727|P1|STARTED|IV: Per CAIN457A2307||21
8322517|NCT01412944|20518722|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
8322518|NCT01412944|20518723|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322519|NCT01412944|20518724|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322520|NCT01412944|20518725|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
8322521|NCT01412944|20518726|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322522|NCT01412944|20518727|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322523|NCT01412944|20518722|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
8322524|NCT01412944|20518723|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
8322525|NCT01412944|20518724|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
8322526|NCT01412944|20518725|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
8322527|NCT01412944|20518726|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322528|NCT01412944|20518727|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322529|NCT01412944|20518722|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
8322530|NCT01412944|20518723|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
8322531|NCT01412944|20518724|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
8322532|NCT01412944|20518725|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
8322533|NCT01412944|20518726|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
8322534|NCT01412944|20518727|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
8322535|NCT01412918|20518763|P2|NOT COMPLETED|Overall Study||0
8322536|NCT01412918|20518764|P1|NOT COMPLETED|Overall Study||0
8322537|NCT01412918|20518763|P2|COMPLETED|Overall Study||1
8322538|NCT01412918|20518764|P1|COMPLETED|Overall Study||20
8322539|NCT01412918|20518763|P2|STARTED|Overall Study||1
8322540|NCT01412918|20518764|P1|STARTED|Overall Study||20
8322541|NCT01412879|20518773|P3|NOT COMPLETED|Consolidation Therapy||0
8322542|NCT01412879|20518774|P2|NOT COMPLETED|Consolidation Therapy||0
8322543|NCT01412879|20518775|P1|NOT COMPLETED|Consolidation Therapy||0
8322544|NCT01412879|20518773|P3|COMPLETED|Consolidation Therapy||26
8322545|NCT01412879|20518774|P2|COMPLETED|Consolidation Therapy||0
8322546|NCT01412879|20518775|P1|COMPLETED|Consolidation Therapy||0
8322547|NCT01412879|20518773|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
8322548|NCT01412879|20518774|P2|STARTED|Consolidation Therapy||0
8322549|NCT01412879|20518775|P1|STARTED|Consolidation Therapy||0
8322550|NCT01412879|20518773|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
8322551|NCT01412879|20518774|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
8322552|NCT01412879|20518775|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
8322553|NCT01412879|20518773|P3|COMPLETED|Initial Registration (Induction Therapy)||0
8322554|NCT01412879|20518774|P2|COMPLETED|Initial Registration (Induction Therapy)||27
8322555|NCT01412879|20518775|P1|COMPLETED|Initial Registration (Induction Therapy)||5
8322556|NCT01412879|20518773|P3|Treatment Started|Initial Registration (Induction Therapy)||0
8322557|NCT01412879|20518774|P2|Treatment Started|Initial Registration (Induction Therapy)||35
8322558|NCT01412879|20518775|P1|Treatment Started|Initial Registration (Induction Therapy)||17
8322559|NCT01412879|20518773|P3|STARTED|Initial Registration (Induction Therapy)||0
8322560|NCT01412879|20518774|P2|STARTED|Initial Registration (Induction Therapy)||35
8322561|NCT01412879|20518775|P1|STARTED|Initial Registration (Induction Therapy)||18
8322562|NCT01412866|20518791|P2|NOT COMPLETED|Overall Study||2
8322563|NCT01412866|20518792|P1|NOT COMPLETED|Overall Study||1
8322564|NCT01412866|20518791|P2|COMPLETED|Overall Study||64
8322565|NCT01412866|20518792|P1|COMPLETED|Overall Study||57
8322566|NCT01412866|20518791|P2|STARTED|Overall Study||66
8322567|NCT01412866|20518792|P1|STARTED|Overall Study||58
8322568|NCT01412801|20518804|P6|NOT COMPLETED|Overall Study||3
8322569|NCT01412801|20518805|P5|NOT COMPLETED|Overall Study||3
8322570|NCT01412801|20518806|P4|NOT COMPLETED|Overall Study||4
8322571|NCT01412801|20518807|P3|NOT COMPLETED|Overall Study||7
8322572|NCT01412801|20518808|P2|NOT COMPLETED|Overall Study||5
8322573|NCT01412801|20518809|P1|NOT COMPLETED|Overall Study||4
8322574|NCT01412801|20518804|P6|COMPLETED|Overall Study||84
8322575|NCT01412801|20518805|P5|COMPLETED|Overall Study||85
8322576|NCT01412801|20518806|P4|COMPLETED|Overall Study||87
8322577|NCT01412801|20518807|P3|COMPLETED|Overall Study||83
8322578|NCT01412801|20518808|P2|COMPLETED|Overall Study||84
8322579|NCT01412801|20518809|P1|COMPLETED|Overall Study||87
8322580|NCT01412801|20518804|P6|STARTED|Overall Study||87
8322581|NCT01412801|20518805|P5|STARTED|Overall Study||88
8322582|NCT01412801|20518806|P4|STARTED|Overall Study||91
8322583|NCT01412801|20518807|P3|STARTED|Overall Study||90
8322584|NCT01412801|20518808|P2|STARTED|Overall Study||89
8322585|NCT01412801|20518809|P1|STARTED|Overall Study||91
8322586|NCT01412710|20518848|P2|NOT COMPLETED|Overall Study||5
8322587|NCT01412710|20518849|P1|NOT COMPLETED|Overall Study||4
8322588|NCT01412710|20518848|P2|COMPLETED|Overall Study||22
8322589|NCT01412710|20518849|P1|COMPLETED|Overall Study||46
8322590|NCT01412710|20518848|P2|STARTED|Overall Study||27
8322591|NCT01412710|20518849|P1|STARTED|Overall Study||50
8322592|NCT01412554|20518857|P1|NOT COMPLETED|Overall Study||0
8322593|NCT01412554|20518857|P1|COMPLETED|Overall Study||103
8322594|NCT01412554|20518857|P1|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
8322595|NCT01412541|20518863|P2|NOT COMPLETED|Overall Study||43
8322596|NCT01412541|20518864|P1|NOT COMPLETED|Overall Study||126
8322597|NCT01412541|20518863|P2|COMPLETED|Overall Study||117
8322598|NCT01412541|20518864|P1|COMPLETED|Overall Study||246
8322599|NCT01412541|20518863|P2|STARTED|Overall Study||160
8322600|NCT01412541|20518864|P1|STARTED|Overall Study||372
8322601|NCT01412424|20518904|P1|NOT COMPLETED|Extension Treatment Period||6
8322602|NCT01412424|20518904|P1|COMPLETED|Extension Treatment Period||82
8322603|NCT01412424|20518904|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
8322604|NCT01412424|20518904|P1|NOT COMPLETED|Core Treatment Period||53
8322605|NCT01412424|20518904|P1|COMPLETED|Core Treatment Period||102
8322606|NCT01412424|20518904|P1|STARTED|Core Treatment Period||155
8322607|NCT01412372|20518922|P2|NOT COMPLETED|Overall Study||3
8322608|NCT01412372|20518923|P1|NOT COMPLETED|Overall Study||4
8322609|NCT01412372|20518922|P2|COMPLETED|Overall Study||28
8322610|NCT01412372|20518923|P1|COMPLETED|Overall Study||26
8322611|NCT01412372|20518922|P2|STARTED|Overall Study||31
8322612|NCT01412372|20518923|P1|STARTED|Overall Study||30
8322613|NCT01412333|20518941|P2|NOT COMPLETED|Overall Study||57
8322614|NCT01412333|20518942|P1|NOT COMPLETED|Overall Study||98
8322615|NCT01412333|20518941|P2|COMPLETED|Overall Study||360
8322616|NCT01412333|20518942|P1|COMPLETED|Overall Study||320
8322617|NCT01412333|20518941|P2|STARTED|Overall Study||417
8322618|NCT01412333|20518942|P1|STARTED|Overall Study||418
8322619|NCT01412281|20518977|P4|NOT COMPLETED|Overall Study||0
8322620|NCT01412281|20518978|P3|NOT COMPLETED|Overall Study||0
8322621|NCT01412281|20518979|P2|NOT COMPLETED|Overall Study||0
8322622|NCT01412281|20518980|P1|NOT COMPLETED|Overall Study||0
8322623|NCT01412281|20518977|P4|COMPLETED|Overall Study||110
8322624|NCT01412281|20518978|P3|COMPLETED|Overall Study||110
8322625|NCT01412281|20518979|P2|COMPLETED|Overall Study||110
8322626|NCT01412281|20518980|P1|COMPLETED|Overall Study||110
8322627|NCT01412281|20518977|P4|STARTED|Overall Study||110
8322628|NCT01412281|20518978|P3|STARTED|Overall Study||110
8322629|NCT01412281|20518979|P2|STARTED|Overall Study||110
8322630|NCT01412281|20518980|P1|STARTED|Overall Study||110
8322631|NCT01412229|20519002|P1|NOT COMPLETED|Overall Study||1
8322632|NCT01412229|20519002|P1|COMPLETED|Overall Study||38
8322633|NCT01412229|20519002|P1|STARTED|Overall Study||39
8322634|NCT01412164|20519014|P1|NOT COMPLETED|Overall Study||47
8322635|NCT01412164|20519014|P1|COMPLETED|Overall Study||683
8322636|NCT01412164|20519014|P1|STARTED|Overall Study||730
8322637|NCT01412151|20519025|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
8322638|NCT01412151|20519025|P1|COMPLETED|Week 306 - 310 - Washout Period||3
8322639|NCT01412151|20519025|P1|STARTED|Week 306 - 310 - Washout Period||5
8322640|NCT01412151|20519025|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
8322641|NCT01412151|20519025|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
8322642|NCT01412151|20519025|P1|STARTED|Week 0 - 306 - Treatment Period||10
8322643|NCT01412086|20519031|P1|NOT COMPLETED|Overall Study||0
8322644|NCT01412086|20519031|P1|COMPLETED|Overall Study||112
8322645|NCT01412086|20519031|P1|STARTED|Overall Study||112
8322646|NCT01412060|20519036|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
8322647|NCT01412060|20519037|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
8322648|NCT01412060|20519038|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
8322649|NCT01412060|20519036|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
8322650|NCT01412060|20519037|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
8322651|NCT01412060|20519038|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
8322652|NCT01412060|20519036|P3|STARTED|Double-blind Treatment Phase (DBP)||101
8322653|NCT01412060|20519037|P2|STARTED|Double-blind Treatment Phase (DBP)||99
8322654|NCT01412060|20519038|P1|STARTED|Double-blind Treatment Phase (DBP)||0
8322655|NCT01412060|20519036|P3|NOT COMPLETED|Period Between SP and DBP||0
8322656|NCT01412060|20519037|P2|NOT COMPLETED|Period Between SP and DBP||0
8322657|NCT01412060|20519038|P1|NOT COMPLETED|Period Between SP and DBP||64
8322658|NCT01412060|20519036|P3|COMPLETED|Period Between SP and DBP||0
8322659|NCT01412060|20519037|P2|COMPLETED|Period Between SP and DBP||0
8322660|NCT01412060|20519038|P1|COMPLETED|Period Between SP and DBP||200
8322661|NCT01412060|20519036|P3|STARTED|Period Between SP and DBP||0
8322662|NCT01412060|20519037|P2|STARTED|Period Between SP and DBP||0
8322663|NCT01412060|20519038|P1|STARTED|Period Between SP and DBP||264
8322664|NCT01412060|20519036|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
8322665|NCT01412060|20519037|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
8322666|NCT01412060|20519038|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
8322667|NCT01412060|20519036|P3|COMPLETED|Open-label Stabilization Period (SP)||0
8322668|NCT01412060|20519037|P2|COMPLETED|Open-label Stabilization Period (SP)||0
8322669|NCT01412060|20519038|P1|COMPLETED|Open-label Stabilization Period (SP)||264
8322670|NCT01412060|20519036|P3|STARTED|Open-label Stabilization Period (SP)||0
8322671|NCT01412060|20519037|P2|STARTED|Open-label Stabilization Period (SP)||0
8322672|NCT01412060|20519038|P1|STARTED|Open-label Stabilization Period (SP)||364
8322673|NCT01412060|20519036|P3|NOT COMPLETED|Period Between RIP and SP||0
8322674|NCT01412060|20519037|P2|NOT COMPLETED|Period Between RIP and SP||0
8322675|NCT01412060|20519038|P1|NOT COMPLETED|Period Between RIP and SP||54
8322676|NCT01412060|20519036|P3|COMPLETED|Period Between RIP and SP||0
8322677|NCT01412060|20519037|P2|COMPLETED|Period Between RIP and SP||0
8322678|NCT01412060|20519038|P1|COMPLETED|Period Between RIP and SP||364
8322679|NCT01412060|20519036|P3|STARTED|Period Between RIP and SP||0
8322680|NCT01412060|20519037|P2|STARTED|Period Between RIP and SP||0
8322681|NCT01412060|20519038|P1|STARTED|Period Between RIP and SP||418
8322682|NCT01412060|20519036|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
8322683|NCT01412060|20519037|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
8322684|NCT01412060|20519038|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
8322685|NCT01412060|20519036|P3|COMPLETED|Open-label Run-in Period (RIP)||0
8322686|NCT01412060|20519037|P2|COMPLETED|Open-label Run-in Period (RIP)||0
8322687|NCT01412060|20519038|P1|COMPLETED|Open-label Run-in Period (RIP)||418
8322688|NCT01412060|20519036|P3|STARTED|Open-label Run-in Period (RIP)||0
8322689|NCT01412060|20519037|P2|STARTED|Open-label Run-in Period (RIP)||0
8322690|NCT01412060|20519038|P1|STARTED|Open-label Run-in Period (RIP)||765
8322691|NCT01412021|20519048|P1|NOT COMPLETED|Overall Study||19
8322692|NCT01412021|20519048|P1|COMPLETED|Overall Study||356
8322693|NCT01412021|20519048|P1|Case Report Forms Locked|Overall Study||368
8322694|NCT01412021|20519048|P1|STARTED|Overall Study||375
8322695|NCT01411995|20519085|P2|NOT COMPLETED|Overall Study||1
8322696|NCT01411995|20519086|P1|NOT COMPLETED|Overall Study||0
8322697|NCT01411995|20519085|P2|COMPLETED|Overall Study||99
8322698|NCT01411995|20519086|P1|COMPLETED|Overall Study||100
8322699|NCT01411995|20519085|P2|STARTED|Overall Study||100
8322700|NCT01411995|20519086|P1|STARTED|Overall Study||100
8322701|NCT01411917|20519094|P2|NOT COMPLETED|Overall Study||1
8322702|NCT01411917|20519095|P1|NOT COMPLETED|Overall Study||0
8322703|NCT01411917|20519094|P2|COMPLETED|Overall Study||36
8322704|NCT01411917|20519095|P1|COMPLETED|Overall Study||32
8322705|NCT01411917|20519094|P2|STARTED|Overall Study||37
8322706|NCT01411917|20519095|P1|STARTED|Overall Study||32
8322707|NCT01411891|20519117|P2|NOT COMPLETED|Overall Study||2
8322708|NCT01411891|20519118|P1|NOT COMPLETED|Overall Study||3
8322709|NCT01411891|20519117|P2|COMPLETED|Overall Study||48
8322710|NCT01411891|20519118|P1|COMPLETED|Overall Study||47
8322711|NCT01411891|20519117|P2|STARTED|Overall Study||50
8322712|NCT01411891|20519118|P1|STARTED|Overall Study||50
8322713|NCT01411852|20519128|P2|NOT COMPLETED|Hospital Intervention Phase||18
8322714|NCT01411852|20519129|P1|NOT COMPLETED|Hospital Intervention Phase||24
8322715|NCT01411852|20519128|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
8322716|NCT01411852|20519129|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
8322717|NCT01411852|20519128|P2|STARTED|Hospital Intervention Phase||89
8322718|NCT01411852|20519129|P1|STARTED|Hospital Intervention Phase||83
8322719|NCT01411852|20519128|P2|NOT COMPLETED|Prehospital Intervention Phase||7
8322720|NCT01411852|20519129|P1|NOT COMPLETED|Prehospital Intervention Phase||12
8322721|NCT01411852|20519128|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
8322722|NCT01411852|20519129|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
8322723|NCT01411852|20519128|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
8322724|NCT01411852|20519129|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
8322725|NCT01411839|20519174|P2|NOT COMPLETED|Overall Study||3
8322726|NCT01411839|20519175|P1|NOT COMPLETED|Overall Study||4
8322727|NCT01411839|20519174|P2|COMPLETED|Overall Study||17
8322728|NCT01411839|20519175|P1|COMPLETED|Overall Study||16
8322729|NCT01411839|20519174|P2|STARTED|Overall Study||20
8322730|NCT01411839|20519175|P1|STARTED|Overall Study||20
8322731|NCT01411774|20519187|P2|NOT COMPLETED|Overall Study||3
8322732|NCT01411774|20519188|P1|NOT COMPLETED|Overall Study||0
8322733|NCT01411774|20519187|P2|COMPLETED|Overall Study||67
8322734|NCT01411774|20519188|P1|COMPLETED|Overall Study||72
8322735|NCT01411774|20519187|P2|STARTED|Overall Study||70
8322736|NCT01411774|20519188|P1|STARTED|Overall Study||72
8322737|NCT01411696|20519196|P1|NOT COMPLETED|Overall Study||0
8322738|NCT01411696|20519196|P1|COMPLETED|Overall Study||289
8322739|NCT01411696|20519196|P1|STARTED|Overall Study||289
8322740|NCT01411592|20519205|P2|NOT COMPLETED|Overall Study||0
8322741|NCT01411592|20519206|P1|NOT COMPLETED|Overall Study||0
8322742|NCT01411592|20519205|P2|COMPLETED|Overall Study||16
8322743|NCT01411592|20519206|P1|COMPLETED|Overall Study||14
8322744|NCT01411592|20519205|P2|5-Year Time Frame|Overall Study||16
8322745|NCT01411592|20519206|P1|5-Year Time Frame|Overall Study||14
8322746|NCT01411592|20519205|P2|STARTED|Overall Study||16
8322747|NCT01411592|20519206|P1|STARTED|Overall Study||14
8322748|NCT01411527|20519216|P2|NOT COMPLETED|Overall Study||0
8322749|NCT01411527|20519217|P1|NOT COMPLETED|Overall Study||0
8322750|NCT01411527|20519216|P2|COMPLETED|Overall Study||93
8322751|NCT01411527|20519217|P1|COMPLETED|Overall Study||1864
8322752|NCT01411527|20519216|P2|STARTED|Overall Study||93
8322753|NCT01411527|20519217|P1|STARTED|Overall Study||1864
8322754|NCT01411501|20519226|P4|NOT COMPLETED|Overall Study||7
8322755|NCT01411501|20519227|P3|NOT COMPLETED|Overall Study||6
8322756|NCT01411501|20519228|P2|NOT COMPLETED|Overall Study||6
8322757|NCT01411501|20519229|P1|NOT COMPLETED|Overall Study||10
8322758|NCT01411501|20519226|P4|COMPLETED|Overall Study||163
8322759|NCT01411501|20519227|P3|COMPLETED|Overall Study||159
8322760|NCT01411501|20519228|P2|COMPLETED|Overall Study||166
8322761|NCT01411501|20519229|P1|COMPLETED|Overall Study||158
8322762|NCT01411501|20519226|P4|STARTED|Overall Study||170
8322763|NCT01411501|20519227|P3|STARTED|Overall Study||165
8322764|NCT01411501|20519228|P2|STARTED|Overall Study||172
8322765|NCT01411501|20519229|P1|STARTED|Overall Study||168
8322766|NCT01411488|20519261|P2|NOT COMPLETED|Overall Study||0
8322767|NCT01411488|20519262|P1|NOT COMPLETED|Overall Study||0
8322768|NCT01411488|20519261|P2|COMPLETED|Overall Study||38
8322769|NCT01411488|20519262|P1|COMPLETED|Overall Study||41
8322770|NCT01411488|20519261|P2|STARTED|Overall Study||38
8322771|NCT01411488|20519262|P1|STARTED|Overall Study||41
8322772|NCT01411267|20519274|P10|NOT COMPLETED|Overall Study||0
8322773|NCT01411267|20519275|P9|NOT COMPLETED|Overall Study||0
8322774|NCT01411267|20519276|P8|NOT COMPLETED|Overall Study||0
8322775|NCT01411267|20519277|P7|NOT COMPLETED|Overall Study||0
8322776|NCT01411267|20519278|P6|NOT COMPLETED|Overall Study||2
8322777|NCT01411267|20519279|P5|NOT COMPLETED|Overall Study||2
8322778|NCT01411267|20519280|P4|NOT COMPLETED|Overall Study||1
8322779|NCT01411267|20519281|P3|NOT COMPLETED|Overall Study||0
8322780|NCT01411267|20519282|P2|NOT COMPLETED|Overall Study||0
8322781|NCT01411267|20519283|P1|NOT COMPLETED|Overall Study||0
8322782|NCT01411267|20519274|P10|COMPLETED|Overall Study||0
8322783|NCT01411267|20519275|P9|COMPLETED|Overall Study||0
8322784|NCT01411267|20519276|P8|COMPLETED|Overall Study||0
8322785|NCT01411267|20519277|P7|COMPLETED|Overall Study||0
8322786|NCT01411267|20519278|P6|COMPLETED|Overall Study||10
8322787|NCT01411267|20519279|P5|COMPLETED|Overall Study||0
8322788|NCT01411267|20519280|P4|COMPLETED|Overall Study||4
8322789|NCT01411267|20519281|P3|COMPLETED|Overall Study||2
8322790|NCT01411267|20519282|P2|COMPLETED|Overall Study||3
8322791|NCT01411267|20519283|P1|COMPLETED|Overall Study||0
8322792|NCT01411267|20519274|P10|STARTED|Overall Study||0
8322793|NCT01411267|20519275|P9|STARTED|Overall Study||0
8322794|NCT01411267|20519276|P8|STARTED|Overall Study||0
8322795|NCT01411267|20519277|P7|STARTED|Overall Study||0
8322796|NCT01411267|20519278|P6|STARTED|Overall Study||12
8322797|NCT01411267|20519279|P5|STARTED|Overall Study||2
8322798|NCT01411267|20519280|P4|STARTED|Overall Study||5
8322799|NCT01411267|20519281|P3|STARTED|Overall Study||2
8322800|NCT01411267|20519282|P2|STARTED|Overall Study||3
8322801|NCT01411267|20519283|P1|STARTED|Overall Study||0
8322802|NCT01411241|20519303|P2|NOT COMPLETED|Overall Study||22
8322803|NCT01411241|20519304|P1|NOT COMPLETED|Overall Study||11
8322804|NCT01411241|20519303|P2|COMPLETED|Overall Study||293
8322805|NCT01411241|20519304|P1|COMPLETED|Overall Study||298
8322806|NCT01411241|20519303|P2|STARTED|Overall Study||315
8322807|NCT01411241|20519304|P1|STARTED|Overall Study||309
8322808|NCT01411228|20519329|P3|NOT COMPLETED|Overall Study||1
8322809|NCT01411228|20519330|P2|NOT COMPLETED|Overall Study||0
8322810|NCT01411228|20519331|P1|NOT COMPLETED|Overall Study||1
8322811|NCT01411228|20519329|P3|COMPLETED|Overall Study||4
8322812|NCT01411228|20519330|P2|COMPLETED|Overall Study||5
8322813|NCT01411228|20519331|P1|COMPLETED|Overall Study||4
8322814|NCT01411228|20519329|P3|STARTED|Overall Study||5
8322815|NCT01411228|20519330|P2|STARTED|Overall Study||5
8322816|NCT01411228|20519331|P1|STARTED|Overall Study||5
8322817|NCT01411215|20519353|P2|NOT COMPLETED|Overall Study||84
8322818|NCT01411215|20519354|P1|NOT COMPLETED|Overall Study||66
8322819|NCT01411215|20519353|P2|COMPLETED|Overall Study||7
8322820|NCT01411215|20519354|P1|COMPLETED|Overall Study||3
8322821|NCT01411215|20519353|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
8322822|NCT01411215|20519354|P1|Treated|Overall Study||69
8322823|NCT01411215|20519353|P2|STARTED|Overall Study||91
8322824|NCT01411215|20519354|P1|STARTED|Overall Study||69
8322825|NCT01411137|20519387|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
8322826|NCT01411137|20519387|P1|COMPLETED|Part 3: Open-Label Extension||12
8322827|NCT01411137|20519387|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
8322828|NCT01411137|20519387|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
8322829|NCT01411137|20519387|P1|COMPLETED|Part 2: Open-Label Extension||25
8322830|NCT01411137|20519387|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
8322831|NCT01411137|20519387|P1|NOT COMPLETED|Part 1: Dose Conversion||10
8322832|NCT01411137|20519387|P1|COMPLETED|Part 1: Dose Conversion||33
8322833|NCT01411137|20519387|P1|STARTED|Part 1: Dose Conversion||43
8322834|NCT01411085|20519406|P1|NOT COMPLETED|Overall Study||3
8322835|NCT01411085|20519406|P1|COMPLETED|Overall Study||7
8322836|NCT01411085|20519406|P1|STARTED|Overall Study||10
8322837|NCT01410812|20519413|P3|NOT COMPLETED|Overall Study||0
8322838|NCT01410812|20519414|P2|NOT COMPLETED|Overall Study||0
8322839|NCT01410812|20519415|P1|NOT COMPLETED|Overall Study||0
8322840|NCT01410812|20519413|P3|COMPLETED|Overall Study||76
8322841|NCT01410812|20519414|P2|COMPLETED|Overall Study||75
8322842|NCT01410812|20519415|P1|COMPLETED|Overall Study||75
8322843|NCT01410812|20519413|P3|STARTED|Overall Study||76
8322844|NCT01410812|20519414|P2|STARTED|Overall Study||75
8322845|NCT01410812|20519415|P1|STARTED|Overall Study||75
8322846|NCT01410799|20519426|P1|NOT COMPLETED|Overall Study||13
8322847|NCT01410799|20519426|P1|COMPLETED|Overall Study||0
8322848|NCT01410799|20519426|P1|STARTED|Overall Study||13
8322849|NCT01410773|20519435|P1|NOT COMPLETED|Overall Study||0
8322850|NCT01410773|20519435|P1|COMPLETED|Overall Study||110
8322851|NCT01410773|20519435|P1|STARTED|Overall Study||110
8322852|NCT01410604|20519442|P2|NOT COMPLETED|Overall Study||2
8322853|NCT01410604|20519443|P1|NOT COMPLETED|Overall Study||3
8322854|NCT01410604|20519442|P2|COMPLETED|Overall Study||14
8322855|NCT01410604|20519443|P1|COMPLETED|Overall Study||12
8322856|NCT01410604|20519442|P2|STARTED|Overall Study||16
8322857|NCT01410604|20519443|P1|STARTED|Overall Study||15
8322858|NCT01410565|20519465|P3|NOT COMPLETED|Double Blind Phase||0
8322859|NCT01410565|20519466|P2|NOT COMPLETED|Double Blind Phase||15
8322860|NCT01410565|20519467|P1|NOT COMPLETED|Double Blind Phase||13
8322861|NCT01410565|20519465|P3|COMPLETED|Double Blind Phase||0
8322862|NCT01410565|20519466|P2|COMPLETED|Double Blind Phase||0
8322863|NCT01410565|20519467|P1|COMPLETED|Double Blind Phase||0
8322864|NCT01410565|20519465|P3|STARTED|Double Blind Phase||0
8322865|NCT01410565|20519466|P2|STARTED|Double Blind Phase||15
8322866|NCT01410565|20519467|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
8322867|NCT01410565|20519465|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
8322868|NCT01410565|20519466|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
8322869|NCT01410565|20519467|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
8322870|NCT01410565|20519465|P3|COMPLETED|Open Label Phase Apaziquone||58
8322871|NCT01410565|20519466|P2|COMPLETED|Open Label Phase Apaziquone||0
8322872|NCT01410565|20519467|P1|COMPLETED|Open Label Phase Apaziquone||0
8322873|NCT01410565|20519465|P3|STARTED|Open Label Phase Apaziquone||66
8322874|NCT01410565|20519466|P2|STARTED|Open Label Phase Apaziquone||0
8322875|NCT01410565|20519467|P1|STARTED|Open Label Phase Apaziquone||0
8322876|NCT01410552|20519477|P1|NOT COMPLETED|Overall Study||136
8322877|NCT01410552|20519477|P1|COMPLETED|Overall Study||877
8322878|NCT01410552|20519477|P1|STARTED|Overall Study||1013
8322879|NCT01410474|20519484|P2|NOT COMPLETED|Overall Study||1
8322880|NCT01410474|20519485|P1|NOT COMPLETED|Overall Study||0
8322881|NCT01410474|20519484|P2|COMPLETED|Overall Study||167
8322882|NCT01410474|20519485|P1|COMPLETED|Overall Study||173
8322883|NCT01410474|20519484|P2|STARTED|Overall Study||168
8322884|NCT01410474|20519485|P1|STARTED|Overall Study||173
8322885|NCT01410448|20519508|P2|NOT COMPLETED|Overall Study||35
8322886|NCT01410448|20519509|P1|NOT COMPLETED|Overall Study||12
8322887|NCT01410448|20519508|P2|COMPLETED|Overall Study||155
8322888|NCT01410448|20519509|P1|COMPLETED|Overall Study||181
8322889|NCT01410448|20519508|P2|Modified ITT Analysis Set|Overall Study||149
8322890|NCT01410448|20519509|P1|Modified ITT Analysis Set|Overall Study||161
8322891|NCT01410448|20519508|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
8322892|NCT01410448|20519509|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
8322893|NCT01410448|20519508|P2|STARTED|Overall Study||190
8322894|NCT01410448|20519509|P1|STARTED|Overall Study||193
8322895|NCT01410409|20519549|P2|NOT COMPLETED|Overall Study||4
8322896|NCT01410409|20519550|P1|NOT COMPLETED|Overall Study||1
8322897|NCT01410409|20519549|P2|COMPLETED|Overall Study||46
8322898|NCT01410409|20519550|P1|COMPLETED|Overall Study||49
8322899|NCT01410409|20519549|P2|STARTED|Overall Study||50
8322900|NCT01410409|20519550|P1|STARTED|Overall Study||50
8322901|NCT01410357|20519574|P2|NOT COMPLETED|Overall Study||24
8322902|NCT01410357|20519575|P1|NOT COMPLETED|Overall Study||26
8322903|NCT01410357|20519574|P2|COMPLETED|Overall Study||76
8322904|NCT01410357|20519575|P1|COMPLETED|Overall Study||74
8322905|NCT01410357|20519574|P2|STARTED|Overall Study||100
8322906|NCT01410357|20519575|P1|STARTED|Overall Study||100
8322907|NCT01410344|20519629|P1|NOT COMPLETED|Overall Study||3
8322908|NCT01410344|20519629|P1|COMPLETED|Overall Study||17
8322909|NCT01410344|20519629|P1|STARTED|Overall Study||20
8322910|NCT01410240|20519646|P3|NOT COMPLETED|Overall Study||2
8322911|NCT01410240|20519647|P2|NOT COMPLETED|Overall Study||1
8322912|NCT01410240|20519648|P1|NOT COMPLETED|Overall Study||1
8322913|NCT01410240|20519646|P3|COMPLETED|Overall Study||10
8322914|NCT01410240|20519647|P2|COMPLETED|Overall Study||52
8322915|NCT01410240|20519648|P1|COMPLETED|Overall Study||52
8322916|NCT01410240|20519646|P3|STARTED|Overall Study||12
8322917|NCT01410240|20519647|P2|STARTED|Overall Study||53
8322918|NCT01410240|20519648|P1|STARTED|Overall Study||53
8322919|NCT01410227|20519719|P4|NOT COMPLETED|Overall Study||1
8322920|NCT01410227|20519720|P3|NOT COMPLETED|Overall Study||2
8322921|NCT01410227|20519721|P2|NOT COMPLETED|Overall Study||0
8322922|NCT01410227|20519722|P1|NOT COMPLETED|Overall Study||4
8322923|NCT01410227|20519719|P4|COMPLETED|Overall Study||5
8322924|NCT01410227|20519720|P3|COMPLETED|Overall Study||13
8322925|NCT01410227|20519721|P2|COMPLETED|Overall Study||8
8322926|NCT01410227|20519722|P1|COMPLETED|Overall Study||4
8322927|NCT01410227|20519719|P4|STARTED|Overall Study||6
8322928|NCT01410227|20519720|P3|STARTED|Overall Study||15
8322929|NCT01410227|20519721|P2|STARTED|Overall Study||8
8322930|NCT01410227|20519722|P1|STARTED|Overall Study||8
8322931|NCT01410110|20519794|P2|NOT COMPLETED|Overall Study||2
8322932|NCT01410110|20519795|P1|NOT COMPLETED|Overall Study||4
8322933|NCT01410110|20519794|P2|COMPLETED|Overall Study||22
8322934|NCT01410110|20519795|P1|COMPLETED|Overall Study||20
8322935|NCT01410110|20519794|P2|6 Month Follow-up|Overall Study||22
8322936|NCT01410110|20519795|P1|6 Month Follow-up|Overall Study||20
8322937|NCT01410110|20519794|P2|3 Months (End of Intervention)|Overall Study||22
8322938|NCT01410110|20519795|P1|3 Months (End of Intervention)|Overall Study||20
8322939|NCT01410110|20519794|P2|Randomization|Overall Study||24
8322940|NCT01410110|20519795|P1|Randomization|Overall Study||24
8322941|NCT01410110|20519794|P2|STARTED|Overall Study||24
8322942|NCT01410110|20519795|P1|STARTED|Overall Study||24
8322943|NCT01410097|20519819|P2|NOT COMPLETED|Overall Study||3
8322944|NCT01410097|20519820|P1|NOT COMPLETED|Overall Study||5
8322945|NCT01410097|20519819|P2|COMPLETED|Overall Study||530
8322946|NCT01410097|20519820|P1|COMPLETED|Overall Study||551
8322947|NCT01410097|20519819|P2|STARTED|Overall Study||533
8322948|NCT01410097|20519820|P1|STARTED|Overall Study||556
8322949|NCT01410084|20519844|P2|NOT COMPLETED|Overall Study||3
8322950|NCT01410084|20519845|P1|NOT COMPLETED|Overall Study||1
8322951|NCT01410084|20519844|P2|COMPLETED|Overall Study||27
8322952|NCT01410084|20519845|P1|COMPLETED|Overall Study||37
8322953|NCT01410084|20519844|P2|STARTED|Overall Study||30
8322954|NCT01410084|20519845|P1|STARTED|Overall Study||38
8322955|NCT01410058|20519857|P2|NOT COMPLETED|Day 35||0
8322956|NCT01410058|20519858|P1|NOT COMPLETED|Day 35||0
8322957|NCT01410058|20519857|P2|COMPLETED|Day 35||6
8322958|NCT01410058|20519858|P1|COMPLETED|Day 35||13
8322959|NCT01410058|20519857|P2|STARTED|Day 35||6
8322960|NCT01410058|20519858|P1|STARTED|Day 35||13
8322961|NCT01410058|20519857|P2|NOT COMPLETED|Baseline Day 22||0
8322962|NCT01410058|20519858|P1|NOT COMPLETED|Baseline Day 22||0
8322963|NCT01410058|20519857|P2|COMPLETED|Baseline Day 22||6
8322964|NCT01410058|20519858|P1|COMPLETED|Baseline Day 22||13
8322965|NCT01410058|20519857|P2|STARTED|Baseline Day 22||6
8322966|NCT01410058|20519858|P1|STARTED|Baseline Day 22||13
8322967|NCT01410058|20519857|P2|NOT COMPLETED|Washout Day 0||0
8322968|NCT01410058|20519858|P1|NOT COMPLETED|Washout Day 0||0
8322969|NCT01410058|20519857|P2|COMPLETED|Washout Day 0||6
8322970|NCT01410058|20519858|P1|COMPLETED|Washout Day 0||13
8322971|NCT01410058|20519857|P2|STARTED|Washout Day 0||6
8322972|NCT01410058|20519858|P1|STARTED|Washout Day 0||13
8322973|NCT01409993|20519870|P4|NOT COMPLETED|Overall Study||5
8322974|NCT01409993|20519871|P3|NOT COMPLETED|Overall Study||3
8322975|NCT01409993|20519872|P2|NOT COMPLETED|Overall Study||5
8322976|NCT01409993|20519873|P1|NOT COMPLETED|Overall Study||4
8322977|NCT01409993|20519870|P4|COMPLETED|Overall Study||8
8322978|NCT01409993|20519871|P3|COMPLETED|Overall Study||11
8322979|NCT01409993|20519872|P2|COMPLETED|Overall Study||21
8322980|NCT01409993|20519873|P1|COMPLETED|Overall Study||21
8322981|NCT01409993|20519870|P4|STARTED|Overall Study||13
8322982|NCT01409993|20519871|P3|STARTED|Overall Study||14
8322983|NCT01409993|20519872|P2|STARTED|Overall Study||26
8322984|NCT01409993|20519873|P1|STARTED|Overall Study||25
8322985|NCT01409928|20519891|P1|NOT COMPLETED|Overall Study||12
8322986|NCT01409928|20519891|P1|COMPLETED|Overall Study||4
8322987|NCT01409928|20519891|P1|STARTED|Overall Study||16
8322988|NCT01409837|20519897|P2|NOT COMPLETED|Overall Study||2
8322989|NCT01409837|20519898|P1|NOT COMPLETED|Overall Study||3
8322990|NCT01409837|20519897|P2|COMPLETED|Overall Study||14
8322991|NCT01409837|20519898|P1|COMPLETED|Overall Study||14
8322992|NCT01409837|20519897|P2|282nd Week|Overall Study||14
8322993|NCT01409837|20519898|P1|282nd Week|Overall Study||14
8322994|NCT01409837|20519897|P2|186th Week|Overall Study||14
8322995|NCT01409837|20519898|P1|186th Week|Overall Study|Moved away to another location|14
8322996|NCT01409837|20519897|P2|138th Week|Overall Study||14
8322997|NCT01409837|20519898|P1|138th Week|Overall Study||15
8322998|NCT01409837|20519897|P2|114th Week|Overall Study||14
8322999|NCT01409837|20519898|P1|114th Week|Overall Study||15
8323000|NCT01409837|20519897|P2|102nd Week|Overall Study|Married another wife|14
8323001|NCT01409837|20519898|P1|102nd Week|Overall Study||15
8323002|NCT01409837|20519897|P2|96th Week|Overall Study||15
8323003|NCT01409837|20519898|P1|96th Week|Overall Study||15
8323004|NCT01409837|20519897|P2|48th Week|Overall Study||15
8323005|NCT01409837|20519898|P1|48th Week|Overall Study|Lost to follow-up|15
8323006|NCT01409837|20519897|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
8323007|NCT01409837|20519898|P1|24th Week|Overall Study||16
8323008|NCT01409837|20519897|P2|12th Week|Overall Study||16
8323009|NCT01409837|20519898|P1|12th Week|Overall Study|Moved away to another location|16
8323010|NCT01409837|20519897|P2|6th Week|Overall Study||16
8323011|NCT01409837|20519898|P1|6th Week|Overall Study||17
8323012|NCT01409837|20519897|P2|STARTED|Overall Study||16
8323013|NCT01409837|20519898|P1|STARTED|Overall Study||17
8323014|NCT01409811|20519920|P1|NOT COMPLETED|Overall Study||1
8323015|NCT01409811|20519920|P1|COMPLETED|Overall Study||8
8323016|NCT01409811|20519920|P1|STARTED|Overall Study||9
8323017|NCT01409707|20519927|P3|NOT COMPLETED|Overall Study||16
8323018|NCT01409707|20519928|P2|NOT COMPLETED|Overall Study||17
8323019|NCT01409707|20519929|P1|NOT COMPLETED|Overall Study||5
8323020|NCT01409707|20519927|P3|COMPLETED|Overall Study||24
8323021|NCT01409707|20519928|P2|COMPLETED|Overall Study||28
8323022|NCT01409707|20519929|P1|COMPLETED|Overall Study||36
8323023|NCT01409707|20519927|P3|STARTED|Overall Study||40
8323024|NCT01409707|20519928|P2|STARTED|Overall Study||45
8323025|NCT01409707|20519929|P1|STARTED|Overall Study||41
8323026|NCT01409564|20519941|P2|NOT COMPLETED|Overall Study||5
8323027|NCT01409564|20519942|P1|NOT COMPLETED|Overall Study||5
8323028|NCT01409564|20519941|P2|COMPLETED|Overall Study||18
8323029|NCT01409564|20519942|P1|COMPLETED|Overall Study||18
8323030|NCT01409564|20519941|P2|STARTED|Overall Study||23
8323031|NCT01409564|20519942|P1|STARTED|Overall Study||23
8323032|NCT01409434|20519960|P1|NOT COMPLETED|Overall Study||4
8323033|NCT01409434|20519960|P1|COMPLETED|Overall Study||40
8323034|NCT01409434|20519960|P1|STARTED|Overall Study||44
8323035|NCT01409382|20519970|P2|NOT COMPLETED|Overall Study||80
8323036|NCT01409382|20519971|P1|NOT COMPLETED|Overall Study||81
8323037|NCT01409382|20519970|P2|COMPLETED|Overall Study||160
8323038|NCT01409382|20519971|P1|COMPLETED|Overall Study||159
8323039|NCT01409382|20519970|P2|STARTED|Overall Study||240
8323040|NCT01409382|20519971|P1|STARTED|Overall Study||240
8323041|NCT01409291|20519985|P2|NOT COMPLETED|Overall Study||9
8323042|NCT01409291|20519986|P1|NOT COMPLETED|Overall Study||7
8323043|NCT01409291|20519985|P2|COMPLETED|Overall Study||19
8323044|NCT01409291|20519986|P1|COMPLETED|Overall Study||29
8323045|NCT01409291|20519985|P2|STARTED|Overall Study||28
8323046|NCT01409291|20519986|P1|STARTED|Overall Study||36
8323047|NCT01409239|20519996|P2|NOT COMPLETED|Overall Study||0
8323048|NCT01409239|20519997|P1|NOT COMPLETED|Overall Study||0
8323049|NCT01409239|20519996|P2|COMPLETED|Overall Study||17
8323050|NCT01409239|20519997|P1|COMPLETED|Overall Study||16
8323051|NCT01409239|20519996|P2|STARTED|Overall Study||17
8323052|NCT01409239|20519997|P1|STARTED|Overall Study||16
8323053|NCT01409213|20520003|P1|NOT COMPLETED|Overall Study||0
8323054|NCT01409213|20520003|P1|COMPLETED|Overall Study||1523
8323055|NCT01409213|20520003|P1|STARTED|Overall Study||1523
8323056|NCT01409096|20520010|P2|NOT COMPLETED|Overall Study||5
8323057|NCT01409096|20520011|P1|NOT COMPLETED|Overall Study||2
8323058|NCT01409096|20520010|P2|COMPLETED|Overall Study||35
8323059|NCT01409096|20520011|P1|COMPLETED|Overall Study||38
8323060|NCT01409096|20520010|P2|STARTED|Overall Study||40
8323061|NCT01409096|20520011|P1|STARTED|Overall Study||40
8323062|NCT01409031|20520025|P2|NOT COMPLETED|Overall Study||0
8323063|NCT01409031|20520026|P1|NOT COMPLETED|Overall Study||1
8323064|NCT01409031|20520025|P2|COMPLETED|Overall Study||2
8323065|NCT01409031|20520026|P1|COMPLETED|Overall Study||0
8323066|NCT01409031|20520025|P2|STARTED|Overall Study||2
8323067|NCT01409031|20520026|P1|STARTED|Overall Study||1
8323068|NCT01408992|20520042|P1|NOT COMPLETED|Overall Study||0
8323069|NCT01408992|20520042|P1|COMPLETED|Overall Study||558
8323070|NCT01408992|20520042|P1|STARTED|Overall Study||558
8323071|NCT01408914|20520057|P3|NOT COMPLETED|Overall Study||13
8323072|NCT01408914|20520058|P2|NOT COMPLETED|Overall Study||12
8323073|NCT01408914|20520059|P1|NOT COMPLETED|Overall Study||12
8323074|NCT01408914|20520057|P3|COMPLETED|Overall Study||47
8323075|NCT01408914|20520058|P2|COMPLETED|Overall Study||48
8323076|NCT01408914|20520059|P1|COMPLETED|Overall Study||48
8323077|NCT01408914|20520057|P3|STARTED|Overall Study||60
8323078|NCT01408914|20520058|P2|STARTED|Overall Study||60
8323079|NCT01408914|20520059|P1|STARTED|Overall Study||60
8323080|NCT01408901|20520077|P4|NOT COMPLETED|26-Week Follow-Up||1
8323081|NCT01408901|20520078|P3|NOT COMPLETED|26-Week Follow-Up||0
8323082|NCT01408901|20520079|P2|NOT COMPLETED|26-Week Follow-Up||2
8323083|NCT01408901|20520080|P1|NOT COMPLETED|26-Week Follow-Up||1
8323084|NCT01408901|20520077|P4|COMPLETED|26-Week Follow-Up||46
8323085|NCT01408901|20520078|P3|COMPLETED|26-Week Follow-Up||50
8323086|NCT01408901|20520079|P2|COMPLETED|26-Week Follow-Up||50
8323087|NCT01408901|20520080|P1|COMPLETED|26-Week Follow-Up||48
8323088|NCT01408901|20520077|P4|STARTED|26-Week Follow-Up||47
8323089|NCT01408901|20520078|P3|STARTED|26-Week Follow-Up||50
8323090|NCT01408901|20520079|P2|STARTED|26-Week Follow-Up||52
8323091|NCT01408901|20520080|P1|STARTED|26-Week Follow-Up||49
8323092|NCT01408901|20520077|P4|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
8323093|NCT01408901|20520078|P3|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
8323094|NCT01408901|20520079|P2|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
8323095|NCT01408901|20520080|P1|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
8323096|NCT01408901|20520077|P4|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
8323097|NCT01408901|20520078|P3|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
8323098|NCT01408901|20520079|P2|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
8323099|NCT01408901|20520080|P1|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
8323100|NCT01408901|20520077|P4|STARTED|12-Week Follow-Up (Primary Endpoint)||49
8323101|NCT01408901|20520078|P3|STARTED|12-Week Follow-Up (Primary Endpoint)||50
8323102|NCT01408901|20520079|P2|STARTED|12-Week Follow-Up (Primary Endpoint)||52
8323103|NCT01408901|20520080|P1|STARTED|12-Week Follow-Up (Primary Endpoint)||50
8323104|NCT01408901|20520077|P4|NOT COMPLETED|6-Week Follow-Up||4
8323105|NCT01408901|20520078|P3|NOT COMPLETED|6-Week Follow-Up||3
8323106|NCT01408901|20520079|P2|NOT COMPLETED|6-Week Follow-Up||2
8323107|NCT01408901|20520080|P1|NOT COMPLETED|6-Week Follow-Up||3
8323108|NCT01408901|20520077|P4|COMPLETED|6-Week Follow-Up||47
8323109|NCT01408901|20520078|P3|COMPLETED|6-Week Follow-Up||50
8323110|NCT01408901|20520079|P2|COMPLETED|6-Week Follow-Up||51
8323111|NCT01408901|20520080|P1|COMPLETED|6-Week Follow-Up||50
8323112|NCT01408901|20520077|P4|STARTED|6-Week Follow-Up||51
8323113|NCT01408901|20520078|P3|STARTED|6-Week Follow-Up||53
8323114|NCT01408901|20520079|P2|STARTED|6-Week Follow-Up||53
8323115|NCT01408901|20520080|P1|STARTED|6-Week Follow-Up||53
8323116|NCT01408888|20520106|P2|NOT COMPLETED|Second Intervention||0
8323117|NCT01408888|20520107|P1|NOT COMPLETED|Second Intervention||2
8323118|NCT01408888|20520106|P2|COMPLETED|Second Intervention||8
8323119|NCT01408888|20520107|P1|COMPLETED|Second Intervention||16
8323120|NCT01408888|20520106|P2|STARTED|Second Intervention||8
8323121|NCT01408888|20520107|P1|STARTED|Second Intervention||18
8323122|NCT01408888|20520106|P2|NOT COMPLETED|Washout of at Least 21 Days||0
8323123|NCT01408888|20520107|P1|NOT COMPLETED|Washout of at Least 21 Days||0
8323124|NCT01408888|20520106|P2|COMPLETED|Washout of at Least 21 Days||8
8323125|NCT01408888|20520107|P1|COMPLETED|Washout of at Least 21 Days||18
8323126|NCT01408888|20520106|P2|STARTED|Washout of at Least 21 Days||8
8323127|NCT01408888|20520107|P1|STARTED|Washout of at Least 21 Days||18
8323128|NCT01408888|20520106|P2|NOT COMPLETED|First Intervention||3
8323129|NCT01408888|20520107|P1|NOT COMPLETED|First Intervention||0
8323130|NCT01408888|20520106|P2|COMPLETED|First Intervention||8
8323131|NCT01408888|20520107|P1|COMPLETED|First Intervention||18
8323132|NCT01408888|20520106|P2|Received at Least 1 Dose of Drug|First Intervention||11
8323133|NCT01408888|20520107|P1|Received at Least 1 Dose of Drug|First Intervention||18
8323134|NCT01408888|20520106|P2|STARTED|First Intervention||11
8323135|NCT01408888|20520107|P1|STARTED|First Intervention||18
8323136|NCT01408862|20520130|P1|NOT COMPLETED|Overall Study||0
8323137|NCT01408862|20520130|P1|COMPLETED|Overall Study||20
8323138|NCT01408862|20520130|P1|STARTED|Overall Study||20
8323139|NCT01408732|20520135|P2|NOT COMPLETED|Overall Study||2
8323140|NCT01408732|20520136|P1|NOT COMPLETED|Overall Study||2
8323141|NCT01408732|20520135|P2|COMPLETED|Overall Study||7
8323142|NCT01408732|20520136|P1|COMPLETED|Overall Study||7
8323143|NCT01408732|20520135|P2|STARTED|Overall Study||9
8323144|NCT01408732|20520136|P1|STARTED|Overall Study||9
8323145|NCT01408719|20520162|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323146|NCT01408719|20520163|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323147|NCT01408719|20520164|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323148|NCT01408719|20520165|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323149|NCT01408719|20520166|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323150|NCT01408719|20520167|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323151|NCT01408719|20520168|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323152|NCT01408719|20520169|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323153|NCT01408719|20520170|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323154|NCT01408719|20520171|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323155|NCT01408719|20520172|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323156|NCT01408719|20520173|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323157|NCT01408719|20520174|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323158|NCT01408719|20520175|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323159|NCT01408719|20520176|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323160|NCT01408719|20520177|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323161|NCT01408719|20520178|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323162|NCT01408719|20520179|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323163|NCT01408719|20520180|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323164|NCT01408719|20520181|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323165|NCT01408719|20520162|P20|COMPLETED|Fourth Intervention (35 Days)||1
8323166|NCT01408719|20520163|P19|COMPLETED|Fourth Intervention (35 Days)||0
8323167|NCT01408719|20520164|P18|COMPLETED|Fourth Intervention (35 Days)||2
8323168|NCT01408719|20520165|P17|COMPLETED|Fourth Intervention (35 Days)||2
8323169|NCT01408719|20520166|P16|COMPLETED|Fourth Intervention (35 Days)||1
8323170|NCT01408719|20520167|P15|COMPLETED|Fourth Intervention (35 Days)||1
8323171|NCT01408719|20520168|P14|COMPLETED|Fourth Intervention (35 Days)||3
8323172|NCT01408719|20520169|P13|COMPLETED|Fourth Intervention (35 Days)||1
8323173|NCT01408719|20520170|P12|COMPLETED|Fourth Intervention (35 Days)||2
8323174|NCT01408719|20520171|P11|COMPLETED|Fourth Intervention (35 Days)||2
8323175|NCT01408719|20520172|P10|COMPLETED|Fourth Intervention (35 Days)||1
8323176|NCT01408719|20520173|P9|COMPLETED|Fourth Intervention (35 Days)||1
8323177|NCT01408719|20520174|P8|COMPLETED|Fourth Intervention (35 Days)||2
8323178|NCT01408719|20520175|P7|COMPLETED|Fourth Intervention (35 Days)||2
8323179|NCT01408719|20520176|P6|COMPLETED|Fourth Intervention (35 Days)||3
8323180|NCT01408719|20520177|P5|COMPLETED|Fourth Intervention (35 Days)||3
8323181|NCT01408719|20520178|P4|COMPLETED|Fourth Intervention (35 Days)||2
8323182|NCT01408719|20520179|P3|COMPLETED|Fourth Intervention (35 Days)||1
8323183|NCT01408719|20520180|P2|COMPLETED|Fourth Intervention (35 Days)||3
8323184|NCT01408719|20520181|P1|COMPLETED|Fourth Intervention (35 Days)||2
8323185|NCT01408719|20520162|P20|STARTED|Fourth Intervention (35 Days)||1
8323186|NCT01408719|20520163|P19|STARTED|Fourth Intervention (35 Days)||0
8323187|NCT01408719|20520164|P18|STARTED|Fourth Intervention (35 Days)||2
8323188|NCT01408719|20520165|P17|STARTED|Fourth Intervention (35 Days)||2
8323189|NCT01408719|20520166|P16|STARTED|Fourth Intervention (35 Days)||1
8323190|NCT01408719|20520167|P15|STARTED|Fourth Intervention (35 Days)||1
8323191|NCT01408719|20520168|P14|STARTED|Fourth Intervention (35 Days)||3
8323192|NCT01408719|20520169|P13|STARTED|Fourth Intervention (35 Days)||1
8323193|NCT01408719|20520170|P12|STARTED|Fourth Intervention (35 Days)||2
8323194|NCT01408719|20520171|P11|STARTED|Fourth Intervention (35 Days)||2
8323195|NCT01408719|20520172|P10|STARTED|Fourth Intervention (35 Days)||1
8323196|NCT01408719|20520173|P9|STARTED|Fourth Intervention (35 Days)||1
8323197|NCT01408719|20520174|P8|STARTED|Fourth Intervention (35 Days)||2
8323198|NCT01408719|20520175|P7|STARTED|Fourth Intervention (35 Days)||2
8323199|NCT01408719|20520176|P6|STARTED|Fourth Intervention (35 Days)||3
8323200|NCT01408719|20520177|P5|STARTED|Fourth Intervention (35 Days)||3
8323201|NCT01408719|20520178|P4|STARTED|Fourth Intervention (35 Days)||2
8323202|NCT01408719|20520179|P3|STARTED|Fourth Intervention (35 Days)||1
8323203|NCT01408719|20520180|P2|STARTED|Fourth Intervention (35 Days)||3
8323204|NCT01408719|20520181|P1|STARTED|Fourth Intervention (35 Days)||2
8323205|NCT01408719|20520162|P20|NOT COMPLETED|Washout Period (28 Days)||0
8323206|NCT01408719|20520163|P19|NOT COMPLETED|Washout Period (28 Days)||0
8323207|NCT01408719|20520164|P18|NOT COMPLETED|Washout Period (28 Days)||0
8323208|NCT01408719|20520165|P17|NOT COMPLETED|Washout Period (28 Days)||0
8323209|NCT01408719|20520166|P16|NOT COMPLETED|Washout Period (28 Days)||0
8323210|NCT01408719|20520167|P15|NOT COMPLETED|Washout Period (28 Days)||0
8323211|NCT01408719|20520168|P14|NOT COMPLETED|Washout Period (28 Days)||0
8323212|NCT01408719|20520169|P13|NOT COMPLETED|Washout Period (28 Days)||0
8323213|NCT01408719|20520170|P12|NOT COMPLETED|Washout Period (28 Days)||0
8323214|NCT01408719|20520171|P11|NOT COMPLETED|Washout Period (28 Days)||0
8323215|NCT01408719|20520172|P10|NOT COMPLETED|Washout Period (28 Days)||0
8323216|NCT01408719|20520173|P9|NOT COMPLETED|Washout Period (28 Days)||0
8323217|NCT01408719|20520174|P8|NOT COMPLETED|Washout Period (28 Days)||0
8323218|NCT01408719|20520175|P7|NOT COMPLETED|Washout Period (28 Days)||0
8323219|NCT01408719|20520176|P6|NOT COMPLETED|Washout Period (28 Days)||0
8323220|NCT01408719|20520177|P5|NOT COMPLETED|Washout Period (28 Days)||0
8323221|NCT01408719|20520178|P4|NOT COMPLETED|Washout Period (28 Days)||0
8323222|NCT01408719|20520179|P3|NOT COMPLETED|Washout Period (28 Days)||0
8323223|NCT01408719|20520180|P2|NOT COMPLETED|Washout Period (28 Days)||0
8323224|NCT01408719|20520181|P1|NOT COMPLETED|Washout Period (28 Days)||0
8323225|NCT01408719|20520162|P20|COMPLETED|Washout Period (28 Days)||1
8323226|NCT01408719|20520163|P19|COMPLETED|Washout Period (28 Days)||0
8323227|NCT01408719|20520164|P18|COMPLETED|Washout Period (28 Days)||2
8323228|NCT01408719|20520165|P17|COMPLETED|Washout Period (28 Days)||2
8323229|NCT01408719|20520166|P16|COMPLETED|Washout Period (28 Days)||1
8323230|NCT01408719|20520167|P15|COMPLETED|Washout Period (28 Days)||1
8323231|NCT01408719|20520168|P14|COMPLETED|Washout Period (28 Days)||3
8323232|NCT01408719|20520169|P13|COMPLETED|Washout Period (28 Days)||1
8323233|NCT01408719|20520170|P12|COMPLETED|Washout Period (28 Days)||2
8323234|NCT01408719|20520171|P11|COMPLETED|Washout Period (28 Days)||2
8323235|NCT01408719|20520172|P10|COMPLETED|Washout Period (28 Days)||1
8323236|NCT01408719|20520173|P9|COMPLETED|Washout Period (28 Days)||1
8323237|NCT01408719|20520174|P8|COMPLETED|Washout Period (28 Days)||2
8323238|NCT01408719|20520175|P7|COMPLETED|Washout Period (28 Days)||2
8323239|NCT01408719|20520176|P6|COMPLETED|Washout Period (28 Days)||3
8323240|NCT01408719|20520177|P5|COMPLETED|Washout Period (28 Days)||3
8323241|NCT01408719|20520178|P4|COMPLETED|Washout Period (28 Days)||2
8323242|NCT01408719|20520179|P3|COMPLETED|Washout Period (28 Days)||1
8323243|NCT01408719|20520180|P2|COMPLETED|Washout Period (28 Days)||3
8323244|NCT01408719|20520181|P1|COMPLETED|Washout Period (28 Days)||2
8323245|NCT01408719|20520162|P20|STARTED|Washout Period (28 Days)||1
8323246|NCT01408719|20520163|P19|STARTED|Washout Period (28 Days)||0
8323247|NCT01408719|20520164|P18|STARTED|Washout Period (28 Days)||2
8323248|NCT01408719|20520165|P17|STARTED|Washout Period (28 Days)||2
8323249|NCT01408719|20520166|P16|STARTED|Washout Period (28 Days)||1
8323250|NCT01408719|20520167|P15|STARTED|Washout Period (28 Days)||1
8323251|NCT01408719|20520168|P14|STARTED|Washout Period (28 Days)||3
8323252|NCT01408719|20520169|P13|STARTED|Washout Period (28 Days)||1
8323253|NCT01408719|20520170|P12|STARTED|Washout Period (28 Days)||2
8323254|NCT01408719|20520171|P11|STARTED|Washout Period (28 Days)||2
8323255|NCT01408719|20520172|P10|STARTED|Washout Period (28 Days)||1
8323256|NCT01408719|20520173|P9|STARTED|Washout Period (28 Days)||1
8323257|NCT01408719|20520174|P8|STARTED|Washout Period (28 Days)||2
8323258|NCT01408719|20520175|P7|STARTED|Washout Period (28 Days)||2
8323259|NCT01408719|20520176|P6|STARTED|Washout Period (28 Days)||3
8323260|NCT01408719|20520177|P5|STARTED|Washout Period (28 Days)||3
8323261|NCT01408719|20520178|P4|STARTED|Washout Period (28 Days)||2
8323262|NCT01408719|20520179|P3|STARTED|Washout Period (28 Days)||1
8323263|NCT01408719|20520180|P2|STARTED|Washout Period (28 Days)||3
8323264|NCT01408719|20520181|P1|STARTED|Washout Period (28 Days)||2
8323265|NCT01408719|20520162|P20|NOT COMPLETED|Third Intervention (35 Days)||0
8323266|NCT01408719|20520163|P19|NOT COMPLETED|Third Intervention (35 Days)||0
8323267|NCT01408719|20520164|P18|NOT COMPLETED|Third Intervention (35 Days)||0
8323268|NCT01408719|20520165|P17|NOT COMPLETED|Third Intervention (35 Days)||0
8323269|NCT01408719|20520166|P16|NOT COMPLETED|Third Intervention (35 Days)||0
8323270|NCT01408719|20520167|P15|NOT COMPLETED|Third Intervention (35 Days)||0
8323271|NCT01408719|20520168|P14|NOT COMPLETED|Third Intervention (35 Days)||0
8323272|NCT01408719|20520169|P13|NOT COMPLETED|Third Intervention (35 Days)||0
8323273|NCT01408719|20520170|P12|NOT COMPLETED|Third Intervention (35 Days)||0
8323274|NCT01408719|20520171|P11|NOT COMPLETED|Third Intervention (35 Days)||0
8323275|NCT01408719|20520172|P10|NOT COMPLETED|Third Intervention (35 Days)||0
8323276|NCT01408719|20520173|P9|NOT COMPLETED|Third Intervention (35 Days)||0
8323277|NCT01408719|20520174|P8|NOT COMPLETED|Third Intervention (35 Days)||1
8323278|NCT01408719|20520175|P7|NOT COMPLETED|Third Intervention (35 Days)||0
8323279|NCT01408719|20520176|P6|NOT COMPLETED|Third Intervention (35 Days)||0
8323280|NCT01408719|20520177|P5|NOT COMPLETED|Third Intervention (35 Days)||0
8323281|NCT01408719|20520178|P4|NOT COMPLETED|Third Intervention (35 Days)||0
8323282|NCT01408719|20520179|P3|NOT COMPLETED|Third Intervention (35 Days)||0
8323283|NCT01408719|20520180|P2|NOT COMPLETED|Third Intervention (35 Days)||0
8323284|NCT01408719|20520181|P1|NOT COMPLETED|Third Intervention (35 Days)||0
8323285|NCT01408719|20520162|P20|COMPLETED|Third Intervention (35 Days)||1
8323286|NCT01408719|20520163|P19|COMPLETED|Third Intervention (35 Days)||0
8323287|NCT01408719|20520164|P18|COMPLETED|Third Intervention (35 Days)||2
8323288|NCT01408719|20520165|P17|COMPLETED|Third Intervention (35 Days)||2
8323289|NCT01408719|20520166|P16|COMPLETED|Third Intervention (35 Days)||1
8323290|NCT01408719|20520167|P15|COMPLETED|Third Intervention (35 Days)||1
8323291|NCT01408719|20520168|P14|COMPLETED|Third Intervention (35 Days)||3
8323292|NCT01408719|20520169|P13|COMPLETED|Third Intervention (35 Days)||2
8323293|NCT01408719|20520170|P12|COMPLETED|Third Intervention (35 Days)||2
8323294|NCT01408719|20520171|P11|COMPLETED|Third Intervention (35 Days)||2
8323295|NCT01408719|20520172|P10|COMPLETED|Third Intervention (35 Days)||1
8323296|NCT01408719|20520173|P9|COMPLETED|Third Intervention (35 Days)||1
8323297|NCT01408719|20520174|P8|COMPLETED|Third Intervention (35 Days)||2
8323298|NCT01408719|20520175|P7|COMPLETED|Third Intervention (35 Days)||2
8323299|NCT01408719|20520176|P6|COMPLETED|Third Intervention (35 Days)||3
8323300|NCT01408719|20520177|P5|COMPLETED|Third Intervention (35 Days)||3
8323301|NCT01408719|20520178|P4|COMPLETED|Third Intervention (35 Days)||2
8323302|NCT01408719|20520179|P3|COMPLETED|Third Intervention (35 Days)||1
8323303|NCT01408719|20520180|P2|COMPLETED|Third Intervention (35 Days)||3
8323304|NCT01408719|20520181|P1|COMPLETED|Third Intervention (35 Days)||2
8323305|NCT01408719|20520162|P20|STARTED|Third Intervention (35 Days)||1
8323306|NCT01408719|20520163|P19|STARTED|Third Intervention (35 Days)||0
8323307|NCT01408719|20520164|P18|STARTED|Third Intervention (35 Days)||2
8323308|NCT01408719|20520165|P17|STARTED|Third Intervention (35 Days)||2
8323309|NCT01408719|20520166|P16|STARTED|Third Intervention (35 Days)||1
8323310|NCT01408719|20520167|P15|STARTED|Third Intervention (35 Days)||1
8323311|NCT01408719|20520168|P14|STARTED|Third Intervention (35 Days)||3
8323312|NCT01408719|20520169|P13|STARTED|Third Intervention (35 Days)||2
8323313|NCT01408719|20520170|P12|STARTED|Third Intervention (35 Days)||2
8323314|NCT01408719|20520171|P11|STARTED|Third Intervention (35 Days)||2
8323315|NCT01408719|20520172|P10|STARTED|Third Intervention (35 Days)||1
8323316|NCT01408719|20520173|P9|STARTED|Third Intervention (35 Days)||1
8323317|NCT01408719|20520174|P8|STARTED|Third Intervention (35 Days)||3
8323318|NCT01408719|20520175|P7|STARTED|Third Intervention (35 Days)||2
8323319|NCT01408719|20520176|P6|STARTED|Third Intervention (35 Days)||3
8323320|NCT01408719|20520177|P5|STARTED|Third Intervention (35 Days)||3
8323321|NCT01408719|20520178|P4|STARTED|Third Intervention (35 Days)||2
8323322|NCT01408719|20520179|P3|STARTED|Third Intervention (35 Days)||1
8323323|NCT01408719|20520180|P2|STARTED|Third Intervention (35 Days)||3
8323324|NCT01408719|20520181|P1|STARTED|Third Intervention (35 Days)||2
8323325|NCT01408719|20520162|P20|NOT COMPLETED|Washout Period (28 Days)||0
8323326|NCT01408719|20520163|P19|NOT COMPLETED|Washout Period (28 Days)||0
8323327|NCT01408719|20520164|P18|NOT COMPLETED|Washout Period (28 Days)||0
8323328|NCT01408719|20520165|P17|NOT COMPLETED|Washout Period (28 Days)||0
8323329|NCT01408719|20520166|P16|NOT COMPLETED|Washout Period (28 Days)||0
8323330|NCT01408719|20520167|P15|NOT COMPLETED|Washout Period (28 Days)||0
8323331|NCT01408719|20520168|P14|NOT COMPLETED|Washout Period (28 Days)||0
8323332|NCT01408719|20520169|P13|NOT COMPLETED|Washout Period (28 Days)||0
8323333|NCT01408719|20520170|P12|NOT COMPLETED|Washout Period (28 Days)||0
8323334|NCT01408719|20520171|P11|NOT COMPLETED|Washout Period (28 Days)||0
8323335|NCT01408719|20520172|P10|NOT COMPLETED|Washout Period (28 Days)||0
8323336|NCT01408719|20520173|P9|NOT COMPLETED|Washout Period (28 Days)||0
8323337|NCT01408719|20520174|P8|NOT COMPLETED|Washout Period (28 Days)||0
8323338|NCT01408719|20520175|P7|NOT COMPLETED|Washout Period (28 Days)||0
8323339|NCT01408719|20520176|P6|NOT COMPLETED|Washout Period (28 Days)||0
8323340|NCT01408719|20520177|P5|NOT COMPLETED|Washout Period (28 Days)||0
8323341|NCT01408719|20520178|P4|NOT COMPLETED|Washout Period (28 Days)||0
8323342|NCT01408719|20520179|P3|NOT COMPLETED|Washout Period (28 Days)||0
8323343|NCT01408719|20520180|P2|NOT COMPLETED|Washout Period (28 Days)||0
8323344|NCT01408719|20520181|P1|NOT COMPLETED|Washout Period (28 Days)||0
8323345|NCT01408719|20520162|P20|COMPLETED|Washout Period (28 Days)||1
8323346|NCT01408719|20520163|P19|COMPLETED|Washout Period (28 Days)||0
8323347|NCT01408719|20520164|P18|COMPLETED|Washout Period (28 Days)||2
8323348|NCT01408719|20520165|P17|COMPLETED|Washout Period (28 Days)||2
8323349|NCT01408719|20520166|P16|COMPLETED|Washout Period (28 Days)||1
8323350|NCT01408719|20520167|P15|COMPLETED|Washout Period (28 Days)||1
8323351|NCT01408719|20520168|P14|COMPLETED|Washout Period (28 Days)||3
8323352|NCT01408719|20520169|P13|COMPLETED|Washout Period (28 Days)||2
8323353|NCT01408719|20520170|P12|COMPLETED|Washout Period (28 Days)||2
8323354|NCT01408719|20520171|P11|COMPLETED|Washout Period (28 Days)||2
8323355|NCT01408719|20520172|P10|COMPLETED|Washout Period (28 Days)||1
8323356|NCT01408719|20520173|P9|COMPLETED|Washout Period (28 Days)||1
8323357|NCT01408719|20520174|P8|COMPLETED|Washout Period (28 Days)||3
8323358|NCT01408719|20520175|P7|COMPLETED|Washout Period (28 Days)||2
8323359|NCT01408719|20520176|P6|COMPLETED|Washout Period (28 Days)||3
8323360|NCT01408719|20520177|P5|COMPLETED|Washout Period (28 Days)||3
8323361|NCT01408719|20520178|P4|COMPLETED|Washout Period (28 Days)||2
8323362|NCT01408719|20520179|P3|COMPLETED|Washout Period (28 Days)||1
8323363|NCT01408719|20520180|P2|COMPLETED|Washout Period (28 Days)||3
8323364|NCT01408719|20520181|P1|COMPLETED|Washout Period (28 Days)||2
8323365|NCT01408719|20520162|P20|STARTED|Washout Period (28 Days)||1
8323366|NCT01408719|20520163|P19|STARTED|Washout Period (28 Days)||0
8323367|NCT01408719|20520164|P18|STARTED|Washout Period (28 Days)||2
8323368|NCT01408719|20520165|P17|STARTED|Washout Period (28 Days)||2
8323369|NCT01408719|20520166|P16|STARTED|Washout Period (28 Days)||1
8323370|NCT01408719|20520167|P15|STARTED|Washout Period (28 Days)||1
8323371|NCT01408719|20520168|P14|STARTED|Washout Period (28 Days)||3
8323372|NCT01408719|20520169|P13|STARTED|Washout Period (28 Days)||2
8323373|NCT01408719|20520170|P12|STARTED|Washout Period (28 Days)||2
8323374|NCT01408719|20520171|P11|STARTED|Washout Period (28 Days)||2
8323375|NCT01408719|20520172|P10|STARTED|Washout Period (28 Days)||1
8323376|NCT01408719|20520173|P9|STARTED|Washout Period (28 Days)||1
8323377|NCT01408719|20520174|P8|STARTED|Washout Period (28 Days)||3
8323378|NCT01408719|20520175|P7|STARTED|Washout Period (28 Days)||2
8323379|NCT01408719|20520176|P6|STARTED|Washout Period (28 Days)||3
8323380|NCT01408719|20520177|P5|STARTED|Washout Period (28 Days)||3
8323381|NCT01408719|20520178|P4|STARTED|Washout Period (28 Days)||2
8323382|NCT01408719|20520179|P3|STARTED|Washout Period (28 Days)||1
8323383|NCT01408719|20520180|P2|STARTED|Washout Period (28 Days)||3
8323384|NCT01408719|20520181|P1|STARTED|Washout Period (28 Days)||2
8323385|NCT01408719|20520162|P20|NOT COMPLETED|Second Intervention (35 Days)||0
8323386|NCT01408719|20520163|P19|NOT COMPLETED|Second Intervention (35 Days)||0
8323387|NCT01408719|20520164|P18|NOT COMPLETED|Second Intervention (35 Days)||0
8323388|NCT01408719|20520165|P17|NOT COMPLETED|Second Intervention (35 Days)||0
8323389|NCT01408719|20520166|P16|NOT COMPLETED|Second Intervention (35 Days)||0
8323390|NCT01408719|20520167|P15|NOT COMPLETED|Second Intervention (35 Days)||0
8323391|NCT01408719|20520168|P14|NOT COMPLETED|Second Intervention (35 Days)||1
8323392|NCT01408719|20520169|P13|NOT COMPLETED|Second Intervention (35 Days)||0
8323393|NCT01408719|20520170|P12|NOT COMPLETED|Second Intervention (35 Days)||0
8323394|NCT01408719|20520171|P11|NOT COMPLETED|Second Intervention (35 Days)||0
8323395|NCT01408719|20520172|P10|NOT COMPLETED|Second Intervention (35 Days)||0
8323396|NCT01408719|20520173|P9|NOT COMPLETED|Second Intervention (35 Days)||0
8323397|NCT01408719|20520174|P8|NOT COMPLETED|Second Intervention (35 Days)||0
8323398|NCT01408719|20520175|P7|NOT COMPLETED|Second Intervention (35 Days)||0
8323399|NCT01408719|20520176|P6|NOT COMPLETED|Second Intervention (35 Days)||0
8323400|NCT01408719|20520177|P5|NOT COMPLETED|Second Intervention (35 Days)||0
8323401|NCT01408719|20520178|P4|NOT COMPLETED|Second Intervention (35 Days)||0
8323402|NCT01408719|20520179|P3|NOT COMPLETED|Second Intervention (35 Days)||0
8323403|NCT01408719|20520180|P2|NOT COMPLETED|Second Intervention (35 Days)||0
8323404|NCT01408719|20520181|P1|NOT COMPLETED|Second Intervention (35 Days)||0
8323405|NCT01408719|20520162|P20|COMPLETED|Second Intervention (35 Days)||1
8323406|NCT01408719|20520163|P19|COMPLETED|Second Intervention (35 Days)||0
8323407|NCT01408719|20520164|P18|COMPLETED|Second Intervention (35 Days)||2
8323408|NCT01408719|20520165|P17|COMPLETED|Second Intervention (35 Days)||2
8323409|NCT01408719|20520166|P16|COMPLETED|Second Intervention (35 Days)||2
8323410|NCT01408719|20520167|P15|COMPLETED|Second Intervention (35 Days)||1
8323411|NCT01408719|20520168|P14|COMPLETED|Second Intervention (35 Days)||3
8323412|NCT01408719|20520169|P13|COMPLETED|Second Intervention (35 Days)||2
8323413|NCT01408719|20520170|P12|COMPLETED|Second Intervention (35 Days)||2
8323414|NCT01408719|20520171|P11|COMPLETED|Second Intervention (35 Days)||2
8323415|NCT01408719|20520172|P10|COMPLETED|Second Intervention (35 Days)||1
8323416|NCT01408719|20520173|P9|COMPLETED|Second Intervention (35 Days)||1
8323417|NCT01408719|20520174|P8|COMPLETED|Second Intervention (35 Days)||3
8323418|NCT01408719|20520175|P7|COMPLETED|Second Intervention (35 Days)||2
8323419|NCT01408719|20520176|P6|COMPLETED|Second Intervention (35 Days)||3
8323420|NCT01408719|20520177|P5|COMPLETED|Second Intervention (35 Days)||3
8323421|NCT01408719|20520178|P4|COMPLETED|Second Intervention (35 Days)||2
8323422|NCT01408719|20520179|P3|COMPLETED|Second Intervention (35 Days)||1
8323423|NCT01408719|20520180|P2|COMPLETED|Second Intervention (35 Days)||3
8323424|NCT01408719|20520181|P1|COMPLETED|Second Intervention (35 Days)||2
8323425|NCT01408719|20520162|P20|STARTED|Second Intervention (35 Days)||1
8323426|NCT01408719|20520163|P19|STARTED|Second Intervention (35 Days)||0
8323427|NCT01408719|20520164|P18|STARTED|Second Intervention (35 Days)||2
8323428|NCT01408719|20520165|P17|STARTED|Second Intervention (35 Days)||2
8323429|NCT01408719|20520166|P16|STARTED|Second Intervention (35 Days)||2
8323430|NCT01408719|20520167|P15|STARTED|Second Intervention (35 Days)||1
8323431|NCT01408719|20520168|P14|STARTED|Second Intervention (35 Days)||4
8323432|NCT01408719|20520169|P13|STARTED|Second Intervention (35 Days)||2
8323433|NCT01408719|20520170|P12|STARTED|Second Intervention (35 Days)||2
8323434|NCT01408719|20520171|P11|STARTED|Second Intervention (35 Days)||2
8323435|NCT01408719|20520172|P10|STARTED|Second Intervention (35 Days)||1
8323436|NCT01408719|20520173|P9|STARTED|Second Intervention (35 Days)||1
8323437|NCT01408719|20520174|P8|STARTED|Second Intervention (35 Days)||3
8323438|NCT01408719|20520175|P7|STARTED|Second Intervention (35 Days)||2
8323439|NCT01408719|20520176|P6|STARTED|Second Intervention (35 Days)||3
8323440|NCT01408719|20520177|P5|STARTED|Second Intervention (35 Days)||3
8323441|NCT01408719|20520178|P4|STARTED|Second Intervention (35 Days)||2
8323442|NCT01408719|20520179|P3|STARTED|Second Intervention (35 Days)||1
8323443|NCT01408719|20520180|P2|STARTED|Second Intervention (35 Days)||3
8323444|NCT01408719|20520181|P1|STARTED|Second Intervention (35 Days)||2
8323445|NCT01408719|20520162|P20|NOT COMPLETED|Washout Period (28 Days)||0
8323446|NCT01408719|20520163|P19|NOT COMPLETED|Washout Period (28 Days)||0
8323447|NCT01408719|20520164|P18|NOT COMPLETED|Washout Period (28 Days)||0
8323448|NCT01408719|20520165|P17|NOT COMPLETED|Washout Period (28 Days)||0
8323449|NCT01408719|20520166|P16|NOT COMPLETED|Washout Period (28 Days)||0
8323450|NCT01408719|20520167|P15|NOT COMPLETED|Washout Period (28 Days)||0
8323451|NCT01408719|20520168|P14|NOT COMPLETED|Washout Period (28 Days)||0
8323452|NCT01408719|20520169|P13|NOT COMPLETED|Washout Period (28 Days)||0
8323453|NCT01408719|20520170|P12|NOT COMPLETED|Washout Period (28 Days)||0
8323454|NCT01408719|20520171|P11|NOT COMPLETED|Washout Period (28 Days)||0
8323455|NCT01408719|20520172|P10|NOT COMPLETED|Washout Period (28 Days)||0
8323456|NCT01408719|20520173|P9|NOT COMPLETED|Washout Period (28 Days)||0
8323457|NCT01408719|20520174|P8|NOT COMPLETED|Washout Period (28 Days)||0
8323458|NCT01408719|20520175|P7|NOT COMPLETED|Washout Period (28 Days)||0
8323459|NCT01408719|20520176|P6|NOT COMPLETED|Washout Period (28 Days)||0
8323460|NCT01408719|20520177|P5|NOT COMPLETED|Washout Period (28 Days)||0
8323461|NCT01408719|20520178|P4|NOT COMPLETED|Washout Period (28 Days)||0
8323462|NCT01408719|20520179|P3|NOT COMPLETED|Washout Period (28 Days)||0
8323463|NCT01408719|20520180|P2|NOT COMPLETED|Washout Period (28 Days)||0
8323464|NCT01408719|20520181|P1|NOT COMPLETED|Washout Period (28 Days)||0
8323465|NCT01408719|20520162|P20|COMPLETED|Washout Period (28 Days)||1
8323466|NCT01408719|20520163|P19|COMPLETED|Washout Period (28 Days)||0
8323467|NCT01408719|20520164|P18|COMPLETED|Washout Period (28 Days)||2
8323468|NCT01408719|20520165|P17|COMPLETED|Washout Period (28 Days)||2
8323469|NCT01408719|20520166|P16|COMPLETED|Washout Period (28 Days)||2
8323470|NCT01408719|20520167|P15|COMPLETED|Washout Period (28 Days)||1
8323471|NCT01408719|20520168|P14|COMPLETED|Washout Period (28 Days)||4
8323472|NCT01408719|20520169|P13|COMPLETED|Washout Period (28 Days)||2
8323473|NCT01408719|20520170|P12|COMPLETED|Washout Period (28 Days)||2
8323474|NCT01408719|20520171|P11|COMPLETED|Washout Period (28 Days)||2
8323475|NCT01408719|20520172|P10|COMPLETED|Washout Period (28 Days)||1
8323476|NCT01408719|20520173|P9|COMPLETED|Washout Period (28 Days)||1
8323477|NCT01408719|20520174|P8|COMPLETED|Washout Period (28 Days)||3
8323478|NCT01408719|20520175|P7|COMPLETED|Washout Period (28 Days)||2
8323479|NCT01408719|20520176|P6|COMPLETED|Washout Period (28 Days)||3
8323480|NCT01408719|20520177|P5|COMPLETED|Washout Period (28 Days)||3
8323481|NCT01408719|20520178|P4|COMPLETED|Washout Period (28 Days)||2
8323482|NCT01408719|20520179|P3|COMPLETED|Washout Period (28 Days)||1
8323483|NCT01408719|20520180|P2|COMPLETED|Washout Period (28 Days)||3
8323484|NCT01408719|20520181|P1|COMPLETED|Washout Period (28 Days)||2
8323485|NCT01408719|20520162|P20|STARTED|Washout Period (28 Days)||1
8323486|NCT01408719|20520163|P19|STARTED|Washout Period (28 Days)||0
8323487|NCT01408719|20520164|P18|STARTED|Washout Period (28 Days)||2
8323488|NCT01408719|20520165|P17|STARTED|Washout Period (28 Days)||2
8323489|NCT01408719|20520166|P16|STARTED|Washout Period (28 Days)||2
8323490|NCT01408719|20520167|P15|STARTED|Washout Period (28 Days)||1
8323491|NCT01408719|20520168|P14|STARTED|Washout Period (28 Days)||4
8323492|NCT01408719|20520169|P13|STARTED|Washout Period (28 Days)||2
8323493|NCT01408719|20520170|P12|STARTED|Washout Period (28 Days)||2
8323494|NCT01408719|20520171|P11|STARTED|Washout Period (28 Days)||2
8323495|NCT01408719|20520172|P10|STARTED|Washout Period (28 Days)||1
8323496|NCT01408719|20520173|P9|STARTED|Washout Period (28 Days)||1
8323497|NCT01408719|20520174|P8|STARTED|Washout Period (28 Days)||3
8323498|NCT01408719|20520175|P7|STARTED|Washout Period (28 Days)||2
8323499|NCT01408719|20520176|P6|STARTED|Washout Period (28 Days)||3
8323500|NCT01408719|20520177|P5|STARTED|Washout Period (28 Days)||3
8323501|NCT01408719|20520178|P4|STARTED|Washout Period (28 Days)||2
8323502|NCT01408719|20520179|P3|STARTED|Washout Period (28 Days)||1
8323503|NCT01408719|20520180|P2|STARTED|Washout Period (28 Days)||3
8323504|NCT01408719|20520181|P1|STARTED|Washout Period (28 Days)||2
8323505|NCT01408719|20520162|P20|NOT COMPLETED|First Intervention (35 Days)||0
8323506|NCT01408719|20520163|P19|NOT COMPLETED|First Intervention (35 Days)||1
8323507|NCT01408719|20520164|P18|NOT COMPLETED|First Intervention (35 Days)||0
8323508|NCT01408719|20520165|P17|NOT COMPLETED|First Intervention (35 Days)||1
8323509|NCT01408719|20520166|P16|NOT COMPLETED|First Intervention (35 Days)||0
8323510|NCT01408719|20520167|P15|NOT COMPLETED|First Intervention (35 Days)||0
8323511|NCT01408719|20520168|P14|NOT COMPLETED|First Intervention (35 Days)||1
8323512|NCT01408719|20520169|P13|NOT COMPLETED|First Intervention (35 Days)||0
8323513|NCT01408719|20520170|P12|NOT COMPLETED|First Intervention (35 Days)||0
8323514|NCT01408719|20520171|P11|NOT COMPLETED|First Intervention (35 Days)||0
8323515|NCT01408719|20520172|P10|NOT COMPLETED|First Intervention (35 Days)||0
8323516|NCT01408719|20520173|P9|NOT COMPLETED|First Intervention (35 Days)||1
8323517|NCT01408719|20520174|P8|NOT COMPLETED|First Intervention (35 Days)||0
8323518|NCT01408719|20520175|P7|NOT COMPLETED|First Intervention (35 Days)||0
8323519|NCT01408719|20520176|P6|NOT COMPLETED|First Intervention (35 Days)||0
8323520|NCT01408719|20520177|P5|NOT COMPLETED|First Intervention (35 Days)||1
8323521|NCT01408719|20520178|P4|NOT COMPLETED|First Intervention (35 Days)||0
8323522|NCT01408719|20520179|P3|NOT COMPLETED|First Intervention (35 Days)||1
8323523|NCT01408719|20520180|P2|NOT COMPLETED|First Intervention (35 Days)||0
8323524|NCT01408719|20520181|P1|NOT COMPLETED|First Intervention (35 Days)||0
8323525|NCT01408719|20520162|P20|COMPLETED|First Intervention (35 Days)||1
8323526|NCT01408719|20520163|P19|COMPLETED|First Intervention (35 Days)||0
8323527|NCT01408719|20520164|P18|COMPLETED|First Intervention (35 Days)||2
8323528|NCT01408719|20520165|P17|COMPLETED|First Intervention (35 Days)||2
8323529|NCT01408719|20520166|P16|COMPLETED|First Intervention (35 Days)||2
8323530|NCT01408719|20520167|P15|COMPLETED|First Intervention (35 Days)||1
8323531|NCT01408719|20520168|P14|COMPLETED|First Intervention (35 Days)||4
8323532|NCT01408719|20520169|P13|COMPLETED|First Intervention (35 Days)||2
8323533|NCT01408719|20520170|P12|COMPLETED|First Intervention (35 Days)||2
8323534|NCT01408719|20520171|P11|COMPLETED|First Intervention (35 Days)||2
8323535|NCT01408719|20520172|P10|COMPLETED|First Intervention (35 Days)||1
8323536|NCT01408719|20520173|P9|COMPLETED|First Intervention (35 Days)||1
8323537|NCT01408719|20520174|P8|COMPLETED|First Intervention (35 Days)||3
8323538|NCT01408719|20520175|P7|COMPLETED|First Intervention (35 Days)||2
8323539|NCT01408719|20520176|P6|COMPLETED|First Intervention (35 Days)||3
8323540|NCT01408719|20520177|P5|COMPLETED|First Intervention (35 Days)||3
8323541|NCT01408719|20520178|P4|COMPLETED|First Intervention (35 Days)||2
8323542|NCT01408719|20520179|P3|COMPLETED|First Intervention (35 Days)||1
8323543|NCT01408719|20520180|P2|COMPLETED|First Intervention (35 Days)||3
8323544|NCT01408719|20520181|P1|COMPLETED|First Intervention (35 Days)||2
8323545|NCT01408719|20520162|P20|STARTED|First Intervention (35 Days)||1
8323546|NCT01408719|20520163|P19|STARTED|First Intervention (35 Days)||1
8323547|NCT01408719|20520164|P18|STARTED|First Intervention (35 Days)||2
8323548|NCT01408719|20520165|P17|STARTED|First Intervention (35 Days)||3
8323549|NCT01408719|20520166|P16|STARTED|First Intervention (35 Days)||2
8323550|NCT01408719|20520167|P15|STARTED|First Intervention (35 Days)||1
8323551|NCT01408719|20520168|P14|STARTED|First Intervention (35 Days)||5
8323552|NCT01408719|20520169|P13|STARTED|First Intervention (35 Days)||2
8323553|NCT01408719|20520170|P12|STARTED|First Intervention (35 Days)||2
8323554|NCT01408719|20520171|P11|STARTED|First Intervention (35 Days)||2
8323555|NCT01408719|20520172|P10|STARTED|First Intervention (35 Days)||1
8323556|NCT01408719|20520173|P9|STARTED|First Intervention (35 Days)||2
8323557|NCT01408719|20520174|P8|STARTED|First Intervention (35 Days)||3
8323558|NCT01408719|20520175|P7|STARTED|First Intervention (35 Days)||2
8323559|NCT01408719|20520176|P6|STARTED|First Intervention (35 Days)||3
8323560|NCT01408719|20520177|P5|STARTED|First Intervention (35 Days)||4
8323561|NCT01408719|20520178|P4|STARTED|First Intervention (35 Days)||2
8323562|NCT01408719|20520179|P3|STARTED|First Intervention (35 Days)||2
8323563|NCT01408719|20520180|P2|STARTED|First Intervention (35 Days)||3
8323564|NCT01408719|20520181|P1|STARTED|First Intervention (35 Days)||2
8323565|NCT01408706|20520193|P2|NOT COMPLETED|Overall Study||0
8323566|NCT01408706|20520194|P1|NOT COMPLETED|Overall Study||1
8323567|NCT01408706|20520193|P2|COMPLETED|Overall Study||30
8323568|NCT01408706|20520194|P1|COMPLETED|Overall Study||29
8323569|NCT01408706|20520193|P2|STARTED|Overall Study||30
8323570|NCT01408706|20520194|P1|STARTED|Overall Study||30
8323571|NCT01408641|20520206|P2|NOT COMPLETED|Overall Study||0
8323572|NCT01408641|20520207|P1|NOT COMPLETED|Overall Study||1
8323573|NCT01408641|20520206|P2|COMPLETED|Overall Study||0
8323574|NCT01408641|20520207|P1|COMPLETED|Overall Study||0
8323575|NCT01408641|20520206|P2|STARTED|Overall Study||0
8323576|NCT01408641|20520207|P1|STARTED|Overall Study||1
8323577|NCT01408628|20520215|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
8323578|NCT01408628|20520215|P1|COMPLETED|Completed 6 Month Follow-Up||25
8323579|NCT01408628|20520215|P1|STARTED|Completed 6 Month Follow-Up||39
8323580|NCT01408628|20520215|P1|NOT COMPLETED|Started Classes/Intervention||0
8323581|NCT01408628|20520215|P1|COMPLETED|Started Classes/Intervention||39
8323582|NCT01408628|20520215|P1|STARTED|Started Classes/Intervention||39
8323583|NCT01408628|20520215|P1|NOT COMPLETED|Consented||12
8323584|NCT01408628|20520215|P1|COMPLETED|Consented||39
8323585|NCT01408628|20520215|P1|STARTED|Consented||51
8323586|NCT01408576|20520224|P3|NOT COMPLETED|Overall Study||508
8323587|NCT01408576|20520225|P2|NOT COMPLETED|Overall Study||498
8323588|NCT01408576|20520226|P1|NOT COMPLETED|Overall Study||188
8323589|NCT01408576|20520224|P3|COMPLETED|Overall Study||0
8323590|NCT01408576|20520225|P2|COMPLETED|Overall Study||0
8323591|NCT01408576|20520226|P1|COMPLETED|Overall Study||56
8323592|NCT01408576|20520224|P3|STARTED|Overall Study||508
8323593|NCT01408576|20520225|P2|STARTED|Overall Study||498
8323594|NCT01408576|20520226|P1|STARTED|Overall Study||244
8323595|NCT01408563|20520273|P1|NOT COMPLETED|Overall Study||2
8323596|NCT01408563|20520273|P1|COMPLETED|Overall Study||31
8323597|NCT01408563|20520273|P1|Received Transplant|Overall Study||31
8323598|NCT01408563|20520273|P1|STARTED|Overall Study||33
8323599|NCT01408537|20520289|P1|NOT COMPLETED|Overall Study||8
8323600|NCT01408537|20520289|P1|COMPLETED|Overall Study||144
8323601|NCT01408537|20520289|P1|STARTED|Overall Study||152
8323602|NCT01408485|20520305|P1|NOT COMPLETED|Overall Study||21
8323603|NCT01408485|20520305|P1|COMPLETED|Overall Study||179
8323604|NCT01408485|20520305|P1|STARTED|Overall Study||200
8323605|NCT01408329|20520313|P2|NOT COMPLETED|Overall Study||4
8323606|NCT01408329|20520314|P1|NOT COMPLETED|Overall Study||3
8323607|NCT01408329|20520313|P2|COMPLETED|Overall Study||11
8323608|NCT01408329|20520314|P1|COMPLETED|Overall Study||10
8323609|NCT01408329|20520313|P2|STARTED|Overall Study||15
8323610|NCT01408329|20520314|P1|STARTED|Overall Study||13
8323611|NCT01408303|20520323|P3|NOT COMPLETED|Overall Study||6
8323612|NCT01408303|20520324|P2|NOT COMPLETED|Overall Study||12
8323613|NCT01408303|20520325|P1|NOT COMPLETED|Overall Study||6
8323614|NCT01408303|20520323|P3|COMPLETED|Overall Study||210
8323615|NCT01408303|20520324|P2|COMPLETED|Overall Study||204
8323616|NCT01408303|20520325|P1|COMPLETED|Overall Study||209
8323617|NCT01408303|20520323|P3|STARTED|Overall Study||216
8323618|NCT01408303|20520324|P2|STARTED|Overall Study||216
8323619|NCT01408303|20520325|P1|STARTED|Overall Study||215
8323620|NCT01408277|20520335|P2|NOT COMPLETED|Overall Study||4
8323621|NCT01408277|20520336|P1|NOT COMPLETED|Overall Study||8
8323622|NCT01408277|20520335|P2|COMPLETED|Overall Study||23
8323623|NCT01408277|20520336|P1|COMPLETED|Overall Study||20
8323624|NCT01408277|20520335|P2|STARTED|Overall Study||27
8323625|NCT01408277|20520336|P1|STARTED|Overall Study||28
8323626|NCT01408147|20520344|P2|NOT COMPLETED|Overall Study||1
8323627|NCT01408147|20520345|P1|NOT COMPLETED|Overall Study||0
8323628|NCT01408147|20520344|P2|COMPLETED|Overall Study||196
8323629|NCT01408147|20520345|P1|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
8323630|NCT01408147|20520344|P2|STARTED|Overall Study|197 participants|197
8323631|NCT01408147|20520345|P1|STARTED|Overall Study|174 participants|174
8323632|NCT01408043|20520353|P1|NOT COMPLETED|Overall Study||1
8323633|NCT01408043|20520353|P1|COMPLETED|Overall Study||24
8323634|NCT01408043|20520353|P1|STARTED|Overall Study||25
8323635|NCT01408030|20520372|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
8323636|NCT01408030|20520373|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
8323637|NCT01408030|20520374|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
8323638|NCT01408030|20520375|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
8323639|NCT01408030|20520372|P4|COMPLETED|Observation Phase (Off Drug)||21
8323640|NCT01408030|20520373|P3|COMPLETED|Observation Phase (Off Drug)||26
8323641|NCT01408030|20520374|P2|COMPLETED|Observation Phase (Off Drug)||18
8323642|NCT01408030|20520375|P1|COMPLETED|Observation Phase (Off Drug)||22
8323643|NCT01408030|20520372|P4|STARTED|Observation Phase (Off Drug)||25
8323644|NCT01408030|20520373|P3|STARTED|Observation Phase (Off Drug)||32
8323645|NCT01408030|20520374|P2|STARTED|Observation Phase (Off Drug)||24
8323646|NCT01408030|20520375|P1|STARTED|Observation Phase (Off Drug)||26
8323647|NCT01408030|20520372|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
8323648|NCT01408030|20520373|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
8323649|NCT01408030|20520374|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
8323650|NCT01408030|20520375|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
8323651|NCT01408030|20520372|P4|COMPLETED|Treatment Phase (on Drug)||25
8323652|NCT01408030|20520373|P3|COMPLETED|Treatment Phase (on Drug)||32
8323653|NCT01408030|20520374|P2|COMPLETED|Treatment Phase (on Drug)||24
8323654|NCT01408030|20520375|P1|COMPLETED|Treatment Phase (on Drug)||26
8323655|NCT01408030|20520372|P4|STARTED|Treatment Phase (on Drug)||28
8323656|NCT01408030|20520373|P3|STARTED|Treatment Phase (on Drug)||33
8323657|NCT01408030|20520374|P2|STARTED|Treatment Phase (on Drug)||31
8323658|NCT01408030|20520375|P1|STARTED|Treatment Phase (on Drug)||29
8323659|NCT01407952|20520407|P2|NOT COMPLETED|Overall Study||37
8323660|NCT01407952|20520408|P1|NOT COMPLETED|Overall Study||46
8323661|NCT01407952|20520407|P2|COMPLETED|Overall Study||266
8323662|NCT01407952|20520408|P1|COMPLETED|Overall Study||251
8323663|NCT01407952|20520407|P2|STARTED|Overall Study||303
8323664|NCT01407952|20520408|P1|STARTED|Overall Study||297
8323665|NCT01407926|20520434|P1|NOT COMPLETED|Overall Study||55
8323666|NCT01407926|20520434|P1|COMPLETED|Overall Study||87
8323667|NCT01407926|20520434|P1|STARTED|Overall Study||142
8323668|NCT01407575|20520451|P2|NOT COMPLETED|Overall Study||1
8323669|NCT01407575|20520452|P1|NOT COMPLETED|Overall Study||2
8323670|NCT01407575|20520451|P2|COMPLETED|Overall Study||5
8323671|NCT01407575|20520452|P1|COMPLETED|Overall Study||5
8323672|NCT01407575|20520451|P2|STARTED|Overall Study||6
8323673|NCT01407575|20520452|P1|STARTED|Overall Study||7
8323674|NCT01407523|20520470|P1|NOT COMPLETED|Overall Study||0
8323675|NCT01407523|20520470|P1|COMPLETED|Overall Study||16
8323676|NCT01407523|20520470|P1|STARTED|Overall Study||16
8323677|NCT01407367|20520482|P2|NOT COMPLETED|Overall Study||78
8323678|NCT01407367|20520483|P1|NOT COMPLETED|Overall Study||40
8323679|NCT01407367|20520482|P2|COMPLETED|Overall Study||164
8323680|NCT01407367|20520483|P1|COMPLETED|Overall Study||68
8323681|NCT01407367|20520482|P2|STARTED|Overall Study||242
8323682|NCT01407367|20520483|P1|STARTED|Overall Study||108
8323683|NCT01407354|20520497|P2|NOT COMPLETED|Second Intervention||2
8323684|NCT01407354|20520498|P1|NOT COMPLETED|Second Intervention||0
8323685|NCT01407354|20520497|P2|COMPLETED|Second Intervention||13
8323686|NCT01407354|20520498|P1|COMPLETED|Second Intervention||18
8323687|NCT01407354|20520497|P2|STARTED|Second Intervention||15
8323688|NCT01407354|20520498|P1|STARTED|Second Intervention||18
8323689|NCT01407354|20520497|P2|NOT COMPLETED|First Intervention||2
8323690|NCT01407354|20520498|P1|NOT COMPLETED|First Intervention||2
8323691|NCT01407354|20520497|P2|COMPLETED|First Intervention||15
8323692|NCT01407354|20520498|P1|COMPLETED|First Intervention||18
8323693|NCT01407354|20520497|P2|STARTED|First Intervention||17
8323694|NCT01407354|20520498|P1|STARTED|First Intervention||20
8323695|NCT01407276|20520514|P8|NOT COMPLETED|Overall Study||1
8323696|NCT01407276|20520515|P7|NOT COMPLETED|Overall Study||0
8323697|NCT01407276|20520516|P6|NOT COMPLETED|Overall Study||0
8323698|NCT01407276|20520517|P5|NOT COMPLETED|Overall Study||0
8323699|NCT01407276|20520518|P4|NOT COMPLETED|Overall Study||0
8323700|NCT01407276|20520519|P3|NOT COMPLETED|Overall Study||0
8323701|NCT01407276|20520520|P2|NOT COMPLETED|Overall Study||0
8323702|NCT01407276|20520521|P1|NOT COMPLETED|Overall Study||0
8323703|NCT01407276|20520514|P8|COMPLETED|Overall Study||6
8323704|NCT01407276|20520515|P7|COMPLETED|Overall Study||6
8323705|NCT01407276|20520516|P6|COMPLETED|Overall Study||6
8323706|NCT01407276|20520517|P5|COMPLETED|Overall Study||6
8323707|NCT01407276|20520518|P4|COMPLETED|Overall Study||6
8323708|NCT01407276|20520519|P3|COMPLETED|Overall Study||6
8323709|NCT01407276|20520520|P2|COMPLETED|Overall Study||6
8323710|NCT01407276|20520521|P1|COMPLETED|Overall Study||6
8323711|NCT01407276|20520514|P8|STARTED|Overall Study||7
8323712|NCT01407276|20520515|P7|STARTED|Overall Study||6
8323713|NCT01407276|20520516|P6|STARTED|Overall Study||6
8323714|NCT01407276|20520517|P5|STARTED|Overall Study||6
8323715|NCT01407276|20520518|P4|STARTED|Overall Study||6
8323716|NCT01407276|20520519|P3|STARTED|Overall Study||6
8323717|NCT01407276|20520520|P2|STARTED|Overall Study||6
8323718|NCT01407276|20520521|P1|STARTED|Overall Study||6
8323719|NCT01407107|20520648|P3|NOT COMPLETED|Overall Study||0
8323720|NCT01407107|20520649|P2|NOT COMPLETED|Overall Study||0
8323721|NCT01407107|20520650|P1|NOT COMPLETED|Overall Study||0
8323722|NCT01407107|20520648|P3|COMPLETED|Overall Study||3
8323723|NCT01407107|20520649|P2|COMPLETED|Overall Study||3
8323724|NCT01407107|20520650|P1|COMPLETED|Overall Study||7
8323725|NCT01407107|20520648|P3|STARTED|Overall Study||3
8323726|NCT01407107|20520649|P2|STARTED|Overall Study||3
8323727|NCT01407107|20520650|P1|STARTED|Overall Study||7
8323728|NCT01407094|20520664|P3|NOT COMPLETED|Stage 2||15
8323729|NCT01407094|20520665|P2|NOT COMPLETED|Stage 2||11
8323730|NCT01407094|20520666|P1|NOT COMPLETED|Stage 2||21
8323731|NCT01407094|20520664|P3|COMPLETED|Stage 2||38
8323732|NCT01407094|20520665|P2|COMPLETED|Stage 2||35
8323733|NCT01407094|20520666|P1|COMPLETED|Stage 2||113
8323734|NCT01407094|20520664|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
8323735|NCT01407094|20520665|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
8323736|NCT01407094|20520666|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
8323737|NCT01407094|20520664|P3|NOT COMPLETED|Stage 1||0
8323738|NCT01407094|20520665|P2|NOT COMPLETED|Stage 1||27
8323739|NCT01407094|20520666|P1|NOT COMPLETED|Stage 1||34
8323740|NCT01407094|20520664|P3|COMPLETED|Stage 1||0
8323741|NCT01407094|20520665|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
8323742|NCT01407094|20520666|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
8323743|NCT01407094|20520664|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
8323744|NCT01407094|20520665|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
8323745|NCT01407094|20520666|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
8323746|NCT01407068|20520674|P1|NOT COMPLETED|Overall Study||0
8323747|NCT01407068|20520674|P1|COMPLETED|Overall Study||60
8323748|NCT01407068|20520674|P1|STARTED|Overall Study||60
8323749|NCT01406990|20520683|P1|NOT COMPLETED|Overall Study||0
8323750|NCT01406990|20520683|P1|COMPLETED|Overall Study||15
8323751|NCT01406990|20520683|P1|STARTED|Overall Study||15
8323752|NCT01406938|20520689|P6|NOT COMPLETED|Follow up||3
8323753|NCT01406938|20520690|P5|NOT COMPLETED|Follow up||9
8323754|NCT01406938|20520691|P4|NOT COMPLETED|Follow up||3
8323755|NCT01406938|20520692|P3|NOT COMPLETED|Follow up||8
8323756|NCT01406938|20520693|P2|NOT COMPLETED|Follow up||5
8323757|NCT01406938|20520694|P1|NOT COMPLETED|Follow up||8
8323758|NCT01406938|20520689|P6|COMPLETED|Follow up||32
8323759|NCT01406938|20520690|P5|COMPLETED|Follow up||31
8323760|NCT01406938|20520691|P4|COMPLETED|Follow up||36
8323761|NCT01406938|20520692|P3|COMPLETED|Follow up||32
8323762|NCT01406938|20520693|P2|COMPLETED|Follow up||18
8323763|NCT01406938|20520694|P1|COMPLETED|Follow up||18
8323764|NCT01406938|20520689|P6|STARTED|Follow up||35
8323765|NCT01406938|20520690|P5|STARTED|Follow up||40
8323766|NCT01406938|20520691|P4|STARTED|Follow up||39
8323767|NCT01406938|20520692|P3|STARTED|Follow up||40
8323768|NCT01406938|20520693|P2|STARTED|Follow up||23
8323769|NCT01406938|20520694|P1|STARTED|Follow up||26
8323770|NCT01406938|20520689|P6|NOT COMPLETED|Maintenance Period||16
8323771|NCT01406938|20520690|P5|NOT COMPLETED|Maintenance Period||25
8323772|NCT01406938|20520691|P4|NOT COMPLETED|Maintenance Period||18
8323773|NCT01406938|20520692|P3|NOT COMPLETED|Maintenance Period||17
8323774|NCT01406938|20520693|P2|NOT COMPLETED|Maintenance Period||0
8323775|NCT01406938|20520694|P1|NOT COMPLETED|Maintenance Period||0
8323776|NCT01406938|20520689|P6|COMPLETED|Maintenance Period||201
8323777|NCT01406938|20520690|P5|COMPLETED|Maintenance Period||181
8323778|NCT01406938|20520691|P4|COMPLETED|Maintenance Period||199
8323779|NCT01406938|20520692|P3|COMPLETED|Maintenance Period||186
8323780|NCT01406938|20520693|P2|COMPLETED|Maintenance Period||0
8323781|NCT01406938|20520694|P1|COMPLETED|Maintenance Period||0
8323782|NCT01406938|20520689|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
8323783|NCT01406938|20520690|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
8323784|NCT01406938|20520691|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
8323785|NCT01406938|20520692|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
8323786|NCT01406938|20520693|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
8323787|NCT01406938|20520694|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
8323788|NCT01406938|20520689|P6|STARTED|Maintenance Period||217
8323789|NCT01406938|20520690|P5|STARTED|Maintenance Period||206
8323790|NCT01406938|20520691|P4|STARTED|Maintenance Period||217
8323791|NCT01406938|20520692|P3|STARTED|Maintenance Period||203
8323792|NCT01406938|20520693|P2|STARTED|Maintenance Period||0
8323793|NCT01406938|20520694|P1|STARTED|Maintenance Period||0
8323794|NCT01406938|20520689|P6|NOT COMPLETED|Induction Period||0
8323795|NCT01406938|20520690|P5|NOT COMPLETED|Induction Period||0
8323796|NCT01406938|20520691|P4|NOT COMPLETED|Induction Period||0
8323797|NCT01406938|20520692|P3|NOT COMPLETED|Induction Period||0
8323798|NCT01406938|20520693|P2|NOT COMPLETED|Induction Period||20
8323799|NCT01406938|20520694|P1|NOT COMPLETED|Induction Period||18
8323800|NCT01406938|20520689|P6|COMPLETED|Induction Period||0
8323801|NCT01406938|20520690|P5|COMPLETED|Induction Period||0
8323802|NCT01406938|20520691|P4|COMPLETED|Induction Period||0
8323803|NCT01406938|20520692|P3|COMPLETED|Induction Period||0
8323804|NCT01406938|20520693|P2|COMPLETED|Induction Period||464
8323805|NCT01406938|20520694|P1|COMPLETED|Induction Period||464
8323806|NCT01406938|20520689|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
8323807|NCT01406938|20520690|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
8323808|NCT01406938|20520691|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
8323809|NCT01406938|20520692|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
8323810|NCT01406938|20520693|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
8323811|NCT01406938|20520694|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
8323812|NCT01406938|20520689|P6|STARTED|Induction Period||0
8323813|NCT01406938|20520690|P5|STARTED|Induction Period||0
8323814|NCT01406938|20520691|P4|STARTED|Induction Period||0
8323815|NCT01406938|20520692|P3|STARTED|Induction Period||0
8323816|NCT01406938|20520693|P2|STARTED|Induction Period||484
8323817|NCT01406938|20520694|P1|STARTED|Induction Period||482
8323818|NCT01406873|20520812|P2|NOT COMPLETED|Overall Study||1
8323819|NCT01406873|20520813|P1|NOT COMPLETED|Overall Study||1
8323820|NCT01406873|20520812|P2|COMPLETED|Overall Study||20
8323821|NCT01406873|20520813|P1|COMPLETED|Overall Study||20
8323822|NCT01406873|20520812|P2|STARTED|Overall Study||21
8323823|NCT01406873|20520813|P1|STARTED|Overall Study||21
8323824|NCT01406860|20520831|P2|NOT COMPLETED|Overall Study||0
8323825|NCT01406860|20520832|P1|NOT COMPLETED|Overall Study||0
8323826|NCT01406860|20520831|P2|COMPLETED|Overall Study||8
8323827|NCT01406860|20520832|P1|COMPLETED|Overall Study||11
8323828|NCT01406860|20520831|P2|STARTED|Overall Study||8
8323829|NCT01406860|20520832|P1|STARTED|Overall Study||11
8323830|NCT01406795|20520844|P1|NOT COMPLETED|Overall Study||1
8323831|NCT01406795|20520844|P1|COMPLETED|Overall Study||0
8323832|NCT01406795|20520844|P1|STARTED|Overall Study||1
8323833|NCT01406717|20520860|P2|NOT COMPLETED|Overall Study||31
8323834|NCT01406717|20520861|P1|NOT COMPLETED|Overall Study||43
8323835|NCT01406717|20520860|P2|COMPLETED|Overall Study||149
8323836|NCT01406717|20520861|P1|COMPLETED|Overall Study||137
8323837|NCT01406717|20520860|P2|STARTED|Overall Study||180
8323838|NCT01406717|20520861|P1|STARTED|Overall Study||180
8323839|NCT01406652|20520891|P2|NOT COMPLETED|Overall Study||20
8323840|NCT01406652|20520892|P1|NOT COMPLETED|Overall Study||20
8323841|NCT01406652|20520891|P2|COMPLETED|Overall Study||95
8323842|NCT01406652|20520892|P1|COMPLETED|Overall Study||89
8323843|NCT01406652|20520891|P2|STARTED|Overall Study||115
8323844|NCT01406652|20520892|P1|STARTED|Overall Study||109
8323845|NCT01406574|20520900|P4|NOT COMPLETED|Overall Study||4
8323846|NCT01406574|20520901|P3|NOT COMPLETED|Overall Study||1
8323847|NCT01406574|20520902|P2|NOT COMPLETED|Overall Study||1
8323848|NCT01406574|20520903|P1|NOT COMPLETED|Overall Study||1
8323849|NCT01406574|20520900|P4|COMPLETED|Overall Study||1
8323850|NCT01406574|20520901|P3|COMPLETED|Overall Study||6
8323851|NCT01406574|20520902|P2|COMPLETED|Overall Study||3
8323852|NCT01406574|20520903|P1|COMPLETED|Overall Study||6
8323853|NCT01406574|20520900|P4|STARTED|Overall Study||5
8323854|NCT01406574|20520901|P3|STARTED|Overall Study||7
8323855|NCT01406574|20520902|P2|STARTED|Overall Study||4
8323856|NCT01406574|20520903|P1|STARTED|Overall Study||7
8323857|NCT01406444|20520918|P3|NOT COMPLETED|Overall Study||2
8323858|NCT01406444|20520919|P2|NOT COMPLETED|Overall Study||9
8323859|NCT01406444|20520920|P1|NOT COMPLETED|Overall Study||10
8323860|NCT01406444|20520918|P3|COMPLETED|Overall Study||14
8323861|NCT01406444|20520919|P2|COMPLETED|Overall Study||24
8323862|NCT01406444|20520920|P1|COMPLETED|Overall Study||23
8323863|NCT01406444|20520918|P3|STARTED|Overall Study||16
8323864|NCT01406444|20520919|P2|STARTED|Overall Study||33
8323865|NCT01406444|20520920|P1|STARTED|Overall Study||33
8323866|NCT01406223|20520935|P4|NOT COMPLETED|Overall Study||16
8323867|NCT01406223|20520936|P3|NOT COMPLETED|Overall Study||18
8323868|NCT01406223|20520937|P2|NOT COMPLETED|Overall Study||12
8323869|NCT01406223|20520938|P1|NOT COMPLETED|Overall Study||12
8323870|NCT01406223|20520935|P4|COMPLETED|Overall Study||3
8323871|NCT01406223|20520936|P3|COMPLETED|Overall Study||2
8323872|NCT01406223|20520937|P2|COMPLETED|Overall Study||7
8323873|NCT01406223|20520938|P1|COMPLETED|Overall Study||6
8323874|NCT01406223|20520935|P4|STARTED|Overall Study||19
8323875|NCT01406223|20520936|P3|STARTED|Overall Study||20
8323876|NCT01406223|20520937|P2|STARTED|Overall Study||19
8323877|NCT01406223|20520938|P1|STARTED|Overall Study||18
8323878|NCT01406015|20520954|P2|NOT COMPLETED|Overall Study||3
8323879|NCT01406015|20520955|P1|NOT COMPLETED|Overall Study||3
8323880|NCT01406015|20520954|P2|COMPLETED|Overall Study||16
8323881|NCT01406015|20520955|P1|COMPLETED|Overall Study||16
8323882|NCT01406015|20520954|P2|STARTED|Overall Study||19
8323883|NCT01406015|20520955|P1|STARTED|Overall Study||19
8323884|NCT01405950|20520971|P4|NOT COMPLETED|Overall Study||0
8323885|NCT01405950|20520972|P3|NOT COMPLETED|Overall Study||0
8323886|NCT01405950|20520973|P2|NOT COMPLETED|Overall Study||0
8323887|NCT01405950|20520974|P1|NOT COMPLETED|Overall Study||1
8323888|NCT01405950|20520971|P4|COMPLETED|Overall Study||0
8323889|NCT01405950|20520972|P3|COMPLETED|Overall Study||0
8323890|NCT01405950|20520973|P2|COMPLETED|Overall Study||2
8323891|NCT01405950|20520974|P1|COMPLETED|Overall Study||7
8323892|NCT01405950|20520971|P4|STARTED|Overall Study||0
8323893|NCT01405950|20520972|P3|STARTED|Overall Study||0
8323894|NCT01405950|20520973|P2|STARTED|Overall Study||2
8323895|NCT01405950|20520974|P1|STARTED|Overall Study||8
8323896|NCT01405937|20520988|P2|NOT COMPLETED|Overall Study||0
8323897|NCT01405937|20520989|P1|NOT COMPLETED|Overall Study||0
8323898|NCT01405937|20520988|P2|COMPLETED|Overall Study||26
8323899|NCT01405937|20520989|P1|COMPLETED|Overall Study||25
8323900|NCT01405937|20520988|P2|STARTED|Overall Study||26
8323901|NCT01405937|20520989|P1|STARTED|Overall Study||25
8323902|NCT01405924|20521009|P1|NOT COMPLETED|Overall Study||10
8323903|NCT01405924|20521009|P1|COMPLETED|Overall Study||101
8323904|NCT01405924|20521009|P1|STARTED|Overall Study||111
8323905|NCT01405911|20521022|P3|NOT COMPLETED|Overall Study||1
8323906|NCT01405911|20521023|P2|NOT COMPLETED|Overall Study||3
8323907|NCT01405911|20521024|P1|NOT COMPLETED|Overall Study||4
8323908|NCT01405911|20521022|P3|COMPLETED|Overall Study||76
8323909|NCT01405911|20521023|P2|COMPLETED|Overall Study||79
8323910|NCT01405911|20521024|P1|COMPLETED|Overall Study||79
8323911|NCT01405911|20521022|P3|Treated|Overall Study||77
8323912|NCT01405911|20521023|P2|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
8323913|NCT01405911|20521024|P1|Treated|Overall Study||82
8323914|NCT01405911|20521022|P3|STARTED|Overall Study||77
8323915|NCT01405911|20521023|P2|STARTED|Overall Study||82
8323916|NCT01405911|20521024|P1|STARTED|Overall Study||83
8323917|NCT01405898|20521043|P2|NOT COMPLETED|Overall Study||2
8323918|NCT01405898|20521044|P1|NOT COMPLETED|Overall Study||2
8323919|NCT01405898|20521043|P2|COMPLETED|Overall Study||32
8323920|NCT01405898|20521044|P1|COMPLETED|Overall Study||32
8323921|NCT01405898|20521043|P2|STARTED|Overall Study||34
8323922|NCT01405898|20521044|P1|STARTED|Overall Study||34
8323923|NCT01405820|20521068|P6|NOT COMPLETED|Open-Label Treatment Period||2
8323924|NCT01405820|20521069|P5|NOT COMPLETED|Open-Label Treatment Period||2
8323925|NCT01405820|20521070|P4|NOT COMPLETED|Open-Label Treatment Period||5
8323926|NCT01405820|20521071|P3|NOT COMPLETED|Open-Label Treatment Period||3
8323927|NCT01405820|20521072|P2|NOT COMPLETED|Open-Label Treatment Period||2
8323928|NCT01405820|20521073|P1|NOT COMPLETED|Open-Label Treatment Period||4
8323929|NCT01405820|20521068|P6|COMPLETED|Open-Label Treatment Period||30
8323930|NCT01405820|20521069|P5|COMPLETED|Open-Label Treatment Period||40
8323931|NCT01405820|20521070|P4|COMPLETED|Open-Label Treatment Period||37
8323932|NCT01405820|20521071|P3|COMPLETED|Open-Label Treatment Period||39
8323933|NCT01405820|20521072|P2|COMPLETED|Open-Label Treatment Period||33
8323934|NCT01405820|20521073|P1|COMPLETED|Open-Label Treatment Period||40
8323935|NCT01405820|20521068|P6|STARTED|Open-Label Treatment Period||32
8323936|NCT01405820|20521069|P5|STARTED|Open-Label Treatment Period||42
8323937|NCT01405820|20521070|P4|STARTED|Open-Label Treatment Period||42
8323938|NCT01405820|20521071|P3|STARTED|Open-Label Treatment Period||42
8323939|NCT01405820|20521072|P2|STARTED|Open-Label Treatment Period||35
8323940|NCT01405820|20521073|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
8323941|NCT01405820|20521068|P6|NOT COMPLETED|Randomized Treatment Period||37
8323942|NCT01405820|20521069|P5|NOT COMPLETED|Randomized Treatment Period||45
8323943|NCT01405820|20521070|P4|NOT COMPLETED|Randomized Treatment Period||51
8323944|NCT01405820|20521071|P3|NOT COMPLETED|Randomized Treatment Period||43
8323945|NCT01405820|20521072|P2|NOT COMPLETED|Randomized Treatment Period||10
8323946|NCT01405820|20521073|P1|NOT COMPLETED|Randomized Treatment Period||11
8323947|NCT01405820|20521068|P6|COMPLETED|Randomized Treatment Period||1
8323948|NCT01405820|20521069|P5|COMPLETED|Randomized Treatment Period||2
8323949|NCT01405820|20521070|P4|COMPLETED|Randomized Treatment Period||3
8323950|NCT01405820|20521071|P3|COMPLETED|Randomized Treatment Period||9
8323951|NCT01405820|20521072|P2|COMPLETED|Randomized Treatment Period||35
8323952|NCT01405820|20521073|P1|COMPLETED|Randomized Treatment Period||43
8323953|NCT01405820|20521068|P6|Safety Population|Randomized Treatment Period||38
8323954|NCT01405820|20521069|P5|Safety Population|Randomized Treatment Period||47
8323955|NCT01405820|20521070|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
8323956|NCT01405820|20521071|P3|Safety Population|Randomized Treatment Period||52
8323957|NCT01405820|20521072|P2|Safety Population|Randomized Treatment Period||45
8323958|NCT01405820|20521073|P1|Safety Population|Randomized Treatment Period||54
8323959|NCT01405820|20521068|P6|STARTED|Randomized Treatment Period||38
8323960|NCT01405820|20521069|P5|STARTED|Randomized Treatment Period||47
8323961|NCT01405820|20521070|P4|STARTED|Randomized Treatment Period||54
8323962|NCT01405820|20521071|P3|STARTED|Randomized Treatment Period||52
8323963|NCT01405820|20521072|P2|STARTED|Randomized Treatment Period||45
8323964|NCT01405820|20521073|P1|STARTED|Randomized Treatment Period||54
8323965|NCT01405794|20521093|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
8323966|NCT01405794|20521093|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
8323967|NCT01405794|20521093|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
8323968|NCT01405794|20521093|P1|NOT COMPLETED|72 hr Washout||0
8323969|NCT01405794|20521093|P1|COMPLETED|72 hr Washout||12
8323970|NCT01405794|20521093|P1|STARTED|72 hr Washout||12
8323971|NCT01405794|20521093|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
8323972|NCT01405794|20521093|P1|COMPLETED|First Dose Placebo (14 Days)||12
8323973|NCT01405794|20521093|P1|STARTED|First Dose Placebo (14 Days)||12
8323974|NCT01405768|20521169|P2|NOT COMPLETED|Overall Study||0
8323975|NCT01405768|20521170|P1|NOT COMPLETED|Overall Study||4
8323976|NCT01405768|20521169|P2|COMPLETED|Overall Study||28
8323977|NCT01405768|20521170|P1|COMPLETED|Overall Study||24
8323978|NCT01405768|20521169|P2|STARTED|Overall Study||28
8323979|NCT01405768|20521170|P1|STARTED|Overall Study||28
8323980|NCT01405742|20521182|P2|NOT COMPLETED|Overall Study||0
8323981|NCT01405742|20521183|P1|NOT COMPLETED|Overall Study||1
8323982|NCT01405742|20521182|P2|COMPLETED|Overall Study||2
8323983|NCT01405742|20521183|P1|COMPLETED|Overall Study||1
8323984|NCT01405742|20521182|P2|STARTED|Overall Study||2
8323985|NCT01405742|20521183|P1|STARTED|Overall Study||2
8323986|NCT01405560|20521193|P1|NOT COMPLETED|Overall Study||1
8323987|NCT01405560|20521193|P1|COMPLETED|Overall Study||41
8323988|NCT01405560|20521193|P1|STARTED|Overall Study||42
8323989|NCT01405508|20521208|P4|NOT COMPLETED|Overall Study||0
8323990|NCT01405508|20521209|P3|NOT COMPLETED|Overall Study||0
8323991|NCT01405508|20521210|P2|NOT COMPLETED|Overall Study||1
8323992|NCT01405508|20521211|P1|NOT COMPLETED|Overall Study||1
8323993|NCT01405508|20521208|P4|COMPLETED|Overall Study||26
8323994|NCT01405508|20521209|P3|COMPLETED|Overall Study||27
8323995|NCT01405508|20521210|P2|COMPLETED|Overall Study||25
8323996|NCT01405508|20521211|P1|COMPLETED|Overall Study||25
8323997|NCT01405508|20521208|P4|STARTED|Overall Study||26
8323998|NCT01405508|20521209|P3|STARTED|Overall Study||27
8323999|NCT01405508|20521210|P2|STARTED|Overall Study||26
8324000|NCT01405508|20521211|P1|STARTED|Overall Study||26
8324001|NCT01405469|20521229|P1|NOT COMPLETED|Overall Study||0
8324002|NCT01405469|20521229|P1|COMPLETED|Overall Study||16
8324003|NCT01405469|20521229|P1|STARTED|Overall Study||16
8324004|NCT01405456|20521243|P2|NOT COMPLETED|Overall Study||1
8324005|NCT01405456|20521244|P1|NOT COMPLETED|Overall Study||3
8324006|NCT01405456|20521243|P2|COMPLETED|Overall Study||20
8324007|NCT01405456|20521244|P1|COMPLETED|Overall Study||22
8324008|NCT01405456|20521243|P2|STARTED|Overall Study||21
8324009|NCT01405456|20521244|P1|STARTED|Overall Study||25
8324010|NCT01405313|20521272|P1|NOT COMPLETED|Overall Study||0
8324011|NCT01405313|20521272|P1|COMPLETED|Overall Study||21
8324012|NCT01405313|20521272|P1|STARTED|Overall Study||21
8324013|NCT01405196|20521284|P4|NOT COMPLETED|Overall Study||9
8324014|NCT01405196|20521285|P3|NOT COMPLETED|Overall Study||23
8324015|NCT01405196|20521286|P2|NOT COMPLETED|Overall Study||12
8324016|NCT01405196|20521287|P1|NOT COMPLETED|Overall Study||11
8324017|NCT01405196|20521284|P4|COMPLETED|Overall Study||36
8324018|NCT01405196|20521285|P3|COMPLETED|Overall Study||23
8324019|NCT01405196|20521286|P2|COMPLETED|Overall Study||35
8324020|NCT01405196|20521287|P1|COMPLETED|Overall Study||34
8324021|NCT01405196|20521284|P4|STARTED|Overall Study||45
8324022|NCT01405196|20521285|P3|STARTED|Overall Study||46
8324023|NCT01405196|20521286|P2|STARTED|Overall Study||47
8324024|NCT01405196|20521287|P1|STARTED|Overall Study||45
8324025|NCT01405053|20521374|P2|NOT COMPLETED|Overall Study||8
8324026|NCT01405053|20521375|P1|NOT COMPLETED|Overall Study||10
8324027|NCT01405053|20521374|P2|COMPLETED|Overall Study||4
8324028|NCT01405053|20521375|P1|COMPLETED|Overall Study||15
8324029|NCT01405053|20521374|P2|STARTED|Overall Study||12
8324030|NCT01405053|20521375|P1|STARTED|Overall Study||25
8324031|NCT01405027|20521401|P2|NOT COMPLETED|Overall Study||51
8324032|NCT01405027|20521402|P1|NOT COMPLETED|Overall Study||32
8324033|NCT01405027|20521401|P2|COMPLETED|Overall Study||62
8324034|NCT01405027|20521402|P1|COMPLETED|Overall Study||52
8324035|NCT01405027|20521401|P2|STARTED|Overall Study||113
8324036|NCT01405027|20521402|P1|STARTED|Overall Study||84
8324037|NCT01404988|20521419|P3|NOT COMPLETED|Overall Study||3
8324038|NCT01404988|20521420|P2|NOT COMPLETED|Overall Study||4
8324039|NCT01404988|20521421|P1|NOT COMPLETED|Overall Study||6
8324040|NCT01404988|20521419|P3|COMPLETED|Overall Study||30
8324041|NCT01404988|20521420|P2|COMPLETED|Overall Study||29
8324042|NCT01404988|20521421|P1|COMPLETED|Overall Study||27
8324043|NCT01404988|20521419|P3|STARTED|Overall Study||33
8324044|NCT01404988|20521420|P2|STARTED|Overall Study||33
8324045|NCT01404988|20521421|P1|STARTED|Overall Study||33
8324046|NCT01404936|20521438|P1|NOT COMPLETED|Overall Study||0
8324047|NCT01404936|20521438|P1|COMPLETED|Overall Study||30
8324048|NCT01404936|20521438|P1|STARTED|Overall Study||30
8324049|NCT01404923|20521444|P2|NOT COMPLETED|Overall Study||17
8324050|NCT01404923|20521445|P1|NOT COMPLETED|Overall Study||23
8324051|NCT01404923|20521444|P2|COMPLETED|Overall Study||197
8324052|NCT01404923|20521445|P1|COMPLETED|Overall Study||199
8324053|NCT01404923|20521444|P2|STARTED|Overall Study||214
8324054|NCT01404923|20521445|P1|STARTED|Overall Study||222
8324055|NCT01404832|20521453|P1|NOT COMPLETED|Overall Study||0
8324056|NCT01404832|20521453|P1|COMPLETED|Overall Study||21
8324057|NCT01404832|20521453|P1|STARTED|Overall Study||21
8324058|NCT01404650|20521458|P1|NOT COMPLETED|Overall Study||0
8324059|NCT01404650|20521458|P1|COMPLETED|Overall Study||25
8324060|NCT01404650|20521458|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
8324061|NCT01404611|20521468|P3|NOT COMPLETED|Overall Study||5
8324062|NCT01404611|20521469|P2|NOT COMPLETED|Overall Study||19
8324063|NCT01404611|20521470|P1|NOT COMPLETED|Overall Study||8
8324064|NCT01404611|20521468|P3|COMPLETED|Overall Study||106
8324065|NCT01404611|20521469|P2|COMPLETED|Overall Study||89
8324066|NCT01404611|20521470|P1|COMPLETED|Overall Study||104
8324067|NCT01404611|20521468|P3|STARTED|Overall Study||111
8324068|NCT01404611|20521469|P2|STARTED|Overall Study||108
8324069|NCT01404611|20521470|P1|STARTED|Overall Study||112
8324070|NCT01404572|20521478|P3|NOT COMPLETED|Overall Study||0
8324071|NCT01404572|20521479|P2|NOT COMPLETED|Overall Study||0
8324072|NCT01404572|20521480|P1|NOT COMPLETED|Overall Study||0
8324073|NCT01404572|20521478|P3|COMPLETED|Overall Study||4
8324074|NCT01404572|20521479|P2|COMPLETED|Overall Study||4
8324075|NCT01404572|20521480|P1|COMPLETED|Overall Study||4
8324076|NCT01404572|20521478|P3|STARTED|Overall Study||4
8324077|NCT01404572|20521479|P2|STARTED|Overall Study||4
8324078|NCT01404572|20521480|P1|STARTED|Overall Study||4
8324079|NCT01404559|20521511|P4|NOT COMPLETED|Overall Study||0
8324080|NCT01404559|20521512|P3|NOT COMPLETED|Overall Study||0
8324081|NCT01404559|20521513|P2|NOT COMPLETED|Overall Study||0
8324082|NCT01404559|20521514|P1|NOT COMPLETED|Overall Study||0
8324083|NCT01404559|20521511|P4|COMPLETED|Overall Study||14
8324084|NCT01404559|20521512|P3|COMPLETED|Overall Study||4
8324085|NCT01404559|20521513|P2|COMPLETED|Overall Study||5
8324086|NCT01404559|20521514|P1|COMPLETED|Overall Study||5
8324087|NCT01404559|20521511|P4|STARTED|Overall Study||14
8324088|NCT01404559|20521512|P3|STARTED|Overall Study||4
8324089|NCT01404559|20521513|P2|STARTED|Overall Study||5
8324090|NCT01404559|20521514|P1|STARTED|Overall Study||5
8324091|NCT01404429|20521527|P2|NOT COMPLETED|Overall Study||7
8324092|NCT01404429|20521528|P1|NOT COMPLETED|Overall Study||9
8324093|NCT01404429|20521527|P2|COMPLETED|Overall Study||46
8324094|NCT01404429|20521528|P1|COMPLETED|Overall Study||38
8324095|NCT01404429|20521527|P2|STARTED|Overall Study||53
8324096|NCT01404429|20521528|P1|STARTED|Overall Study||47
8324097|NCT01404325|20521542|P2|NOT COMPLETED|Overall Study||2
8324098|NCT01404325|20521543|P1|NOT COMPLETED|Overall Study||4
8324099|NCT01404325|20521542|P2|COMPLETED|Overall Study||61
8324100|NCT01404325|20521543|P1|COMPLETED|Overall Study||63
8324101|NCT01404325|20521542|P2|STARTED|Overall Study||63
8324102|NCT01404325|20521543|P1|STARTED|Overall Study||67
8324103|NCT01404312|20521601|P2|NOT COMPLETED|Overall Study||311
8324104|NCT01404312|20521602|P1|NOT COMPLETED|Overall Study||298
8324105|NCT01404312|20521601|P2|COMPLETED|Overall Study||1193
8324106|NCT01404312|20521602|P1|COMPLETED|Overall Study||1198
8324107|NCT01404312|20521601|P2|STARTED|Overall Study||1504
8324108|NCT01404312|20521602|P1|STARTED|Overall Study||1496
8324109|NCT01404260|20521625|P2|NOT COMPLETED|Overall Study||9
8324110|NCT01404260|20521626|P1|NOT COMPLETED|Overall Study||3
8324111|NCT01404260|20521625|P2|COMPLETED|Overall Study||101
8324112|NCT01404260|20521626|P1|COMPLETED|Overall Study||106
8324113|NCT01404260|20521625|P2|STARTED|Overall Study||110
8324114|NCT01404260|20521626|P1|STARTED|Overall Study||109
8324115|NCT01404234|20521632|P1|NOT COMPLETED|Overall Study||2
8324116|NCT01404234|20521632|P1|COMPLETED|Overall Study||59
8324117|NCT01404234|20521632|P1|STARTED|Overall Study||61
8324118|NCT01404208|20521648|P2|NOT COMPLETED|Overall Study||0
8324119|NCT01404208|20521649|P1|NOT COMPLETED|Overall Study||3
8324120|NCT01404208|20521648|P2|COMPLETED|Overall Study||72
8324121|NCT01404208|20521649|P1|COMPLETED|Overall Study||67
8324122|NCT01404208|20521648|P2|STARTED|Overall Study||72
8324123|NCT01404208|20521649|P1|STARTED|Overall Study||70
8324124|NCT01404078|20521659|P2|NOT COMPLETED|Overall Study||20
8324125|NCT01404078|20521660|P1|NOT COMPLETED|Overall Study||18
8324126|NCT01404078|20521659|P2|COMPLETED|Overall Study||237
8324127|NCT01404078|20521660|P1|COMPLETED|Overall Study||243
8324128|NCT01404078|20521659|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
8324129|NCT01404078|20521660|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
8324130|NCT01404039|20521675|P13|NOT COMPLETED|Overall Study||0
8324131|NCT01404039|20521676|P12|NOT COMPLETED|Overall Study||0
8324132|NCT01404039|20521677|P11|NOT COMPLETED|Overall Study||1
8324133|NCT01404039|20521678|P10|NOT COMPLETED|Overall Study||1
8324134|NCT01404039|20521679|P9|NOT COMPLETED|Overall Study||0
8324135|NCT01404039|20521680|P8|NOT COMPLETED|Overall Study||0
8324136|NCT01404039|20521681|P7|NOT COMPLETED|Overall Study||0
8324137|NCT01404039|20521682|P6|NOT COMPLETED|Overall Study||0
8324138|NCT01404039|20521683|P5|NOT COMPLETED|Overall Study||0
8324139|NCT01404039|20521684|P4|NOT COMPLETED|Overall Study||0
8324140|NCT01404039|20521685|P3|NOT COMPLETED|Overall Study||0
8324141|NCT01404039|20521686|P2|NOT COMPLETED|Overall Study||0
8324142|NCT01404039|20521687|P1|NOT COMPLETED|Overall Study||1
8324143|NCT01404039|20521675|P13|COMPLETED|Overall Study||0
8324144|NCT01404039|20521676|P12|COMPLETED|Overall Study||0
8324145|NCT01404039|20521677|P11|COMPLETED|Overall Study||14
8324146|NCT01404039|20521678|P10|COMPLETED|Overall Study||14
8324147|NCT01404039|20521679|P9|COMPLETED|Overall Study||15
8324148|NCT01404039|20521680|P8|COMPLETED|Overall Study||15
8324149|NCT01404039|20521681|P7|COMPLETED|Overall Study||10
8324150|NCT01404039|20521682|P6|COMPLETED|Overall Study||10
8324151|NCT01404039|20521683|P5|COMPLETED|Overall Study||10
8324152|NCT01404039|20521684|P4|COMPLETED|Overall Study||10
8324153|NCT01404039|20521685|P3|COMPLETED|Overall Study||5
8324154|NCT01404039|20521686|P2|COMPLETED|Overall Study||5
8324155|NCT01404039|20521687|P1|COMPLETED|Overall Study||4
8324156|NCT01404039|20521675|P13|STARTED|Overall Study||0
8324157|NCT01404039|20521676|P12|STARTED|Overall Study||0
8324158|NCT01404039|20521677|P11|STARTED|Overall Study||15
8324159|NCT01404039|20521678|P10|STARTED|Overall Study||15
8324160|NCT01404039|20521679|P9|STARTED|Overall Study||15
8324161|NCT01404039|20521680|P8|STARTED|Overall Study||15
8324162|NCT01404039|20521681|P7|STARTED|Overall Study||10
8324163|NCT01404039|20521682|P6|STARTED|Overall Study||10
8324164|NCT01404039|20521683|P5|STARTED|Overall Study||10
8324165|NCT01404039|20521684|P4|STARTED|Overall Study||10
8324166|NCT01404039|20521685|P3|STARTED|Overall Study||5
8324167|NCT01404039|20521686|P2|STARTED|Overall Study||5
8324168|NCT01404039|20521687|P1|STARTED|Overall Study||5
8324169|NCT01403987|20521714|P3|NOT COMPLETED|Overall Study||18
8324170|NCT01403987|20521715|P2|NOT COMPLETED|Overall Study||17
8324171|NCT01403987|20521716|P1|NOT COMPLETED|Overall Study||18
8324172|NCT01403987|20521714|P3|COMPLETED|Overall Study||50
8324173|NCT01403987|20521715|P2|COMPLETED|Overall Study||17
8324174|NCT01403987|20521716|P1|COMPLETED|Overall Study||16
8324175|NCT01403987|20521714|P3|STARTED|Overall Study||68
8324176|NCT01403987|20521715|P2|STARTED|Overall Study||34
8324177|NCT01403987|20521716|P1|STARTED|Overall Study||34
8324178|NCT01403948|20521740|P10|NOT COMPLETED|Overall Study||7
8324179|NCT01403948|20521741|P9|NOT COMPLETED|Overall Study||6
8324180|NCT01403948|20521742|P8|NOT COMPLETED|Overall Study||4
8324181|NCT01403948|20521743|P7|NOT COMPLETED|Overall Study||6
8324182|NCT01403948|20521744|P6|NOT COMPLETED|Overall Study||7
8324183|NCT01403948|20521745|P5|NOT COMPLETED|Overall Study||6
8324184|NCT01403948|20521746|P4|NOT COMPLETED|Overall Study||4
8324185|NCT01403948|20521747|P3|NOT COMPLETED|Overall Study||3
8324186|NCT01403948|20521748|P2|NOT COMPLETED|Overall Study||4
8324187|NCT01403948|20521749|P1|NOT COMPLETED|Overall Study||1
8324188|NCT01403948|20521740|P10|COMPLETED|Overall Study||0
8324189|NCT01403948|20521741|P9|COMPLETED|Overall Study||0
8324190|NCT01403948|20521742|P8|COMPLETED|Overall Study||0
8324191|NCT01403948|20521743|P7|COMPLETED|Overall Study||0
8324192|NCT01403948|20521744|P6|COMPLETED|Overall Study||0
8324193|NCT01403948|20521745|P5|COMPLETED|Overall Study||0
8324194|NCT01403948|20521746|P4|COMPLETED|Overall Study||0
8324195|NCT01403948|20521747|P3|COMPLETED|Overall Study||0
8324196|NCT01403948|20521748|P2|COMPLETED|Overall Study||0
8324197|NCT01403948|20521749|P1|COMPLETED|Overall Study||0
8324198|NCT01403948|20521740|P10|STARTED|Overall Study||7
8324199|NCT01403948|20521741|P9|STARTED|Overall Study||6
8324200|NCT01403948|20521742|P8|STARTED|Overall Study||4
8324201|NCT01403948|20521743|P7|STARTED|Overall Study||6
8324202|NCT01403948|20521744|P6|STARTED|Overall Study||7
8324203|NCT01403948|20521745|P5|STARTED|Overall Study||6
8324204|NCT01403948|20521746|P4|STARTED|Overall Study||4
8324205|NCT01403948|20521747|P3|STARTED|Overall Study||3
8324206|NCT01403948|20521748|P2|STARTED|Overall Study||4
8324207|NCT01403948|20521749|P1|STARTED|Overall Study||1
8324208|NCT01403805|20521822|P2|NOT COMPLETED|Overall Study||7
8324209|NCT01403805|20521823|P1|NOT COMPLETED|Overall Study||0
8324210|NCT01403805|20521822|P2|COMPLETED|Overall Study||98
8324211|NCT01403805|20521823|P1|COMPLETED|Overall Study||94
8324212|NCT01403805|20521822|P2|Pneumonia Diagnosis|Overall Study||2
8324213|NCT01403805|20521823|P1|Pneumonia Diagnosis|Overall Study||21
8324214|NCT01403805|20521822|P2|STARTED|Overall Study||105
8324215|NCT01403805|20521823|P1|STARTED|Overall Study||94
8324216|NCT01403610|20521839|P4|NOT COMPLETED|Overall Study||0
8324217|NCT01403610|20521840|P3|NOT COMPLETED|Overall Study||0
8324218|NCT01403610|20521841|P2|NOT COMPLETED|Overall Study||3
8324219|NCT01403610|20521842|P1|NOT COMPLETED|Overall Study||2
8324220|NCT01403610|20521839|P4|COMPLETED|Overall Study||13
8324221|NCT01403610|20521840|P3|COMPLETED|Overall Study||4
8324222|NCT01403610|20521841|P2|COMPLETED|Overall Study||3
8324223|NCT01403610|20521842|P1|COMPLETED|Overall Study||3
8324224|NCT01403610|20521839|P4|STARTED|Overall Study||13
8324225|NCT01403610|20521840|P3|STARTED|Overall Study||4
8324226|NCT01403610|20521841|P2|STARTED|Overall Study||6
8324227|NCT01403610|20521842|P1|STARTED|Overall Study||5
8324228|NCT01403441|20521852|P1|NOT COMPLETED|Overall Study||0
8324229|NCT01403441|20521852|P1|COMPLETED|Overall Study||3
8324230|NCT01403441|20521852|P1|STARTED|Overall Study||3
8324231|NCT01403376|20521862|P3|NOT COMPLETED|Overall Study||0
8324232|NCT01403376|20521863|P2|NOT COMPLETED|Overall Study||0
8324233|NCT01403376|20521864|P1|NOT COMPLETED|Overall Study||0
8324234|NCT01403376|20521862|P3|COMPLETED|Overall Study||46
8324235|NCT01403376|20521863|P2|COMPLETED|Overall Study||41
8324236|NCT01403376|20521864|P1|COMPLETED|Overall Study||41
8324237|NCT01403376|20521862|P3|STARTED|Overall Study||46
8324238|NCT01403376|20521863|P2|STARTED|Overall Study||41
8324239|NCT01403376|20521864|P1|STARTED|Overall Study||41
8324240|NCT01403246|20521884|P1|NOT COMPLETED|Overall Study||0
8324241|NCT01403246|20521884|P1|COMPLETED|Overall Study||9
8324242|NCT01403246|20521884|P1|STARTED|Overall Study||9
8324243|NCT01403194|20521888|P1|NOT COMPLETED|Overall Study||10
8324244|NCT01403194|20521888|P1|COMPLETED|Overall Study||1
8324245|NCT01403194|20521888|P1|STARTED|Overall Study||11
8324246|NCT01403116|20521896|P2|NOT COMPLETED|Overall Study||27
8324247|NCT01403116|20521897|P1|NOT COMPLETED|Overall Study||32
8324248|NCT01403116|20521896|P2|COMPLETED|Overall Study||133
8324249|NCT01403116|20521897|P1|COMPLETED|Overall Study||129
8324250|NCT01403116|20521896|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
8324251|NCT01403116|20521897|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
8324252|NCT01403116|20521896|P2|Randomized|Overall Study||163
8324253|NCT01403116|20521897|P1|Randomized|Overall Study||162
8324254|NCT01403116|20521896|P2|STARTED|Overall Study||160
8324255|NCT01403116|20521897|P1|STARTED|Overall Study||161
8324256|NCT01403090|20521904|P1|NOT COMPLETED|Overall Study||0
8324257|NCT01403090|20521904|P1|COMPLETED|Overall Study||8
8324258|NCT01403090|20521904|P1|STARTED|Overall Study||8
8324259|NCT01403051|20521910|P2|NOT COMPLETED|Overall Study||6
8324260|NCT01403051|20521911|P1|NOT COMPLETED|Overall Study||10
8324261|NCT01403051|20521910|P2|COMPLETED|Overall Study||80
8324262|NCT01403051|20521911|P1|COMPLETED|Overall Study||71
8324263|NCT01403051|20521910|P2|Initiated Study Treatment|Overall Study||86
8324264|NCT01403051|20521911|P1|Initiated Study Treatment|Overall Study||81
8324265|NCT01403051|20521910|P2|STARTED|Overall Study||86
8324266|NCT01403051|20521911|P1|STARTED|Overall Study||81
8324267|NCT01402986|20521947|P4|NOT COMPLETED|Overall Study||22
8324268|NCT01402986|20521948|P3|NOT COMPLETED|Overall Study||8
8324269|NCT01402986|20521949|P2|NOT COMPLETED|Overall Study||15
8324270|NCT01402986|20521950|P1|NOT COMPLETED|Overall Study||9
8324271|NCT01402986|20521947|P4|COMPLETED|Overall Study||129
8324272|NCT01402986|20521948|P3|COMPLETED|Overall Study||67
8324273|NCT01402986|20521949|P2|COMPLETED|Overall Study||135
8324274|NCT01402986|20521950|P1|COMPLETED|Overall Study||67
8324275|NCT01402986|20521947|P4|STARTED|Overall Study||151
8324276|NCT01402986|20521948|P3|STARTED|Overall Study||75
8324277|NCT01402986|20521949|P2|STARTED|Overall Study||150
8324278|NCT01402986|20521950|P1|STARTED|Overall Study||76
8324279|NCT01402947|20522085|P2|NOT COMPLETED|Second Intervention||0
8324280|NCT01402947|20522086|P1|NOT COMPLETED|Second Intervention||0
8324281|NCT01402947|20522085|P2|COMPLETED|Second Intervention||14
8324282|NCT01402947|20522086|P1|COMPLETED|Second Intervention||15
8324283|NCT01402947|20522085|P2|STARTED|Second Intervention||14
8324284|NCT01402947|20522086|P1|STARTED|Second Intervention||15
8324285|NCT01402947|20522085|P2|NOT COMPLETED|First Intervention||1
8324286|NCT01402947|20522086|P1|NOT COMPLETED|First Intervention||0
8324287|NCT01402947|20522085|P2|COMPLETED|First Intervention||14
8324288|NCT01402947|20522086|P1|COMPLETED|First Intervention||15
8324289|NCT01402947|20522085|P2|STARTED|First Intervention||15
8324290|NCT01402947|20522086|P1|STARTED|First Intervention||15
8324291|NCT01402908|20522096|P2|NOT COMPLETED|Overall Study||18
8324292|NCT01402908|20522097|P1|NOT COMPLETED|Overall Study||34
8324293|NCT01402908|20522096|P2|COMPLETED|Overall Study||243
8324294|NCT01402908|20522097|P1|COMPLETED|Overall Study||224
8324295|NCT01402908|20522096|P2|STARTED|Overall Study||261
8324296|NCT01402908|20522097|P1|STARTED|Overall Study||258
8324297|NCT01402869|20522112|P3|NOT COMPLETED|Overall Study||1
8324298|NCT01402869|20522113|P2|NOT COMPLETED|Overall Study||0
8324299|NCT01402869|20522114|P1|NOT COMPLETED|Overall Study||0
8324300|NCT01402869|20522112|P3|COMPLETED|Overall Study||30
8324301|NCT01402869|20522113|P2|COMPLETED|Overall Study||30
8324302|NCT01402869|20522114|P1|COMPLETED|Overall Study||30
8324303|NCT01402869|20522112|P3|STARTED|Overall Study||31
8324304|NCT01402869|20522113|P2|STARTED|Overall Study||30
8324305|NCT01402869|20522114|P1|STARTED|Overall Study||30
8324306|NCT01402817|20522128|P1|NOT COMPLETED|Overall Study||11
8324307|NCT01402817|20522128|P1|COMPLETED|Overall Study||8
8324308|NCT01402817|20522128|P1|STARTED|Overall Study||19
8324309|NCT01402700|20522133|P1|NOT COMPLETED|Overall Study||7
8324310|NCT01402700|20522133|P1|COMPLETED|Overall Study||68
8324311|NCT01402700|20522133|P1|STARTED|Overall Study||75
8324312|NCT01402570|20522137|P1|NOT COMPLETED|Overall Study||1
8324313|NCT01402570|20522137|P1|COMPLETED|Overall Study||19
8324314|NCT01402570|20522137|P1|STARTED|Overall Study||20
8324315|NCT01402544|20522144|P1|NOT COMPLETED|Overall Study||6
8324316|NCT01402544|20522144|P1|COMPLETED|Overall Study||6
8324317|NCT01402544|20522144|P1|STARTED|Overall Study||12
8324318|NCT01402531|20522150|P1|NOT COMPLETED|Overall Study||0
8324319|NCT01402531|20522150|P1|COMPLETED|Overall Study||0
8324320|NCT01402531|20522150|P1|STARTED|Overall Study||0
8324321|NCT01402427|20522156|P2|NOT COMPLETED|Overall Study||0
8324322|NCT01402427|20522157|P1|NOT COMPLETED|Overall Study||0
8324323|NCT01402427|20522156|P2|COMPLETED|Overall Study||294
8324324|NCT01402427|20522157|P1|COMPLETED|Overall Study||297
8324325|NCT01402427|20522156|P2|STARTED|Overall Study||294
8324326|NCT01402427|20522157|P1|STARTED|Overall Study||297
8324327|NCT01402375|20522181|P6|NOT COMPLETED|Overall Study||0
8324328|NCT01402375|20522182|P5|NOT COMPLETED|Overall Study||0
8324329|NCT01402375|20522183|P4|NOT COMPLETED|Overall Study||0
8324330|NCT01402375|20522184|P3|NOT COMPLETED|Overall Study||0
8324331|NCT01402375|20522185|P2|NOT COMPLETED|Overall Study||0
8324332|NCT01402375|20522186|P1|NOT COMPLETED|Overall Study||0
8324333|NCT01402375|20522181|P6|COMPLETED|Overall Study||120
8324334|NCT01402375|20522182|P5|COMPLETED|Overall Study||120
8324335|NCT01402375|20522183|P4|COMPLETED|Overall Study||120
8324336|NCT01402375|20522184|P3|COMPLETED|Overall Study||120
8324337|NCT01402375|20522185|P2|COMPLETED|Overall Study||120
8324338|NCT01402375|20522186|P1|COMPLETED|Overall Study||120
8324339|NCT01402375|20522181|P6|STARTED|Overall Study||120
8324340|NCT01402375|20522182|P5|STARTED|Overall Study||120
8324341|NCT01402375|20522183|P4|STARTED|Overall Study||120
8324342|NCT01402375|20522184|P3|STARTED|Overall Study||120
8324343|NCT01402375|20522185|P2|STARTED|Overall Study||120
8324344|NCT01402375|20522186|P1|STARTED|Overall Study||120
8324345|NCT01402284|20522218|P1|NOT COMPLETED|Overall Study||14
8324346|NCT01402284|20522218|P1|COMPLETED|Overall Study||31
8324347|NCT01402284|20522218|P1|STARTED|Overall Study||45
8324348|NCT01402141|20522231|P2|NOT COMPLETED|Overall Study||2
8324349|NCT01402141|20522232|P1|NOT COMPLETED|Overall Study||1
8324350|NCT01402141|20522231|P2|COMPLETED|Overall Study||28
8324351|NCT01402141|20522232|P1|COMPLETED|Overall Study||29
8324352|NCT01402141|20522231|P2|STARTED|Overall Study||30
8324353|NCT01402141|20522232|P1|STARTED|Overall Study||30
8324354|NCT01402128|20522254|P2|NOT COMPLETED|Overall Study||0
8324355|NCT01402128|20522255|P1|NOT COMPLETED|Overall Study||1
8324356|NCT01402128|20522254|P2|COMPLETED|Overall Study||40
8324357|NCT01402128|20522255|P1|COMPLETED|Overall Study||39
8324358|NCT01402128|20522254|P2|STARTED|Overall Study||40
8324359|NCT01402128|20522255|P1|STARTED|Overall Study||40
8324360|NCT01402115|20522283|P2|NOT COMPLETED|Overall Study||1
8324361|NCT01402115|20522284|P1|NOT COMPLETED|Overall Study||1
8324362|NCT01402115|20522283|P2|COMPLETED|Overall Study||29
8324363|NCT01402115|20522284|P1|COMPLETED|Overall Study||29
8324364|NCT01402115|20522283|P2|STARTED|Overall Study||30
8324365|NCT01402115|20522284|P1|STARTED|Overall Study||30
8324366|NCT01402102|20522300|P2|NOT COMPLETED|Overall Study||3
8324367|NCT01402102|20522301|P1|NOT COMPLETED|Overall Study||2
8324368|NCT01402102|20522300|P2|COMPLETED|Overall Study||27
8324369|NCT01402102|20522301|P1|COMPLETED|Overall Study||28
8324370|NCT01402102|20522300|P2|STARTED|Overall Study||30
8324371|NCT01402102|20522301|P1|STARTED|Overall Study||30
8324372|NCT01402063|20522321|P2|NOT COMPLETED|Overall Study||3
8324373|NCT01402063|20522322|P1|NOT COMPLETED|Overall Study||3
8324374|NCT01402063|20522321|P2|COMPLETED|Overall Study||18
8324375|NCT01402063|20522322|P1|COMPLETED|Overall Study||39
8324376|NCT01402063|20522321|P2|STARTED|Overall Study||21
8324377|NCT01402063|20522322|P1|STARTED|Overall Study||42
8324378|NCT01402050|20522330|P2|NOT COMPLETED|Overall Study||0
8324379|NCT01402050|20522331|P1|NOT COMPLETED|Overall Study||0
8324380|NCT01402050|20522330|P2|COMPLETED|Overall Study||191
8324381|NCT01402050|20522331|P1|COMPLETED|Overall Study||185
8324382|NCT01402050|20522330|P2|STARTED|Overall Study||191
8324383|NCT01402050|20522331|P1|STARTED|Overall Study||185
8324384|NCT01402011|20522340|P3|NOT COMPLETED|Nine Month Follow-up||0
8324385|NCT01402011|20522341|P2|NOT COMPLETED|Nine Month Follow-up||1
8324386|NCT01402011|20522342|P1|NOT COMPLETED|Nine Month Follow-up||0
8324387|NCT01402011|20522340|P3|COMPLETED|Nine Month Follow-up||26
8324388|NCT01402011|20522341|P2|COMPLETED|Nine Month Follow-up||19
8324389|NCT01402011|20522342|P1|COMPLETED|Nine Month Follow-up||27
8324390|NCT01402011|20522340|P3|STARTED|Nine Month Follow-up||26
8324391|NCT01402011|20522341|P2|STARTED|Nine Month Follow-up||20
8324392|NCT01402011|20522342|P1|STARTED|Nine Month Follow-up||27
8324393|NCT01402011|20522340|P3|NOT COMPLETED|Active Treatment Period||0
8324394|NCT01402011|20522341|P2|NOT COMPLETED|Active Treatment Period||3
8324395|NCT01402011|20522342|P1|NOT COMPLETED|Active Treatment Period||1
8324396|NCT01402011|20522340|P3|COMPLETED|Active Treatment Period||26
8324397|NCT01402011|20522341|P2|COMPLETED|Active Treatment Period||20
8324398|NCT01402011|20522342|P1|COMPLETED|Active Treatment Period||27
8324399|NCT01402011|20522340|P3|STARTED|Active Treatment Period||26
8324400|NCT01402011|20522341|P2|STARTED|Active Treatment Period||23
8324401|NCT01402011|20522342|P1|STARTED|Active Treatment Period||28
8324402|NCT01402011|20522340|P3|NOT COMPLETED|Delayed Treatment Period||0
8324403|NCT01402011|20522341|P2|NOT COMPLETED|Delayed Treatment Period||0
8324404|NCT01402011|20522342|P1|NOT COMPLETED|Delayed Treatment Period||1
8324405|NCT01402011|20522340|P3|COMPLETED|Delayed Treatment Period||26
8324406|NCT01402011|20522341|P2|COMPLETED|Delayed Treatment Period||23
8324407|NCT01402011|20522342|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
8324408|NCT01402011|20522340|P3|STARTED|Delayed Treatment Period||26
8324409|NCT01402011|20522341|P2|STARTED|Delayed Treatment Period||23
8324410|NCT01402011|20522342|P1|STARTED|Delayed Treatment Period||29
8324411|NCT01401959|20522371|P3|NOT COMPLETED|Treated||5
8324412|NCT01401959|20522372|P2|NOT COMPLETED|Treated||8
8324413|NCT01401959|20522373|P1|NOT COMPLETED|Treated||7
8324414|NCT01401959|20522371|P3|COMPLETED|Treated||26
8324415|NCT01401959|20522372|P2|COMPLETED|Treated||34
8324416|NCT01401959|20522373|P1|COMPLETED|Treated||46
8324417|NCT01401959|20522371|P3|STARTED|Treated||31
8324418|NCT01401959|20522372|P2|STARTED|Treated||42
8324419|NCT01401959|20522373|P1|STARTED|Treated||53
8324420|NCT01401959|20522371|P3|NOT COMPLETED|Enrolled||0
8324421|NCT01401959|20522372|P2|NOT COMPLETED|Enrolled||0
8324422|NCT01401959|20522373|P1|NOT COMPLETED|Enrolled||1
8324423|NCT01401959|20522371|P3|COMPLETED|Enrolled||31
8324424|NCT01401959|20522372|P2|COMPLETED|Enrolled||42
8324425|NCT01401959|20522373|P1|COMPLETED|Enrolled||53
8324426|NCT01401959|20522371|P3|STARTED|Enrolled||31
8324427|NCT01401959|20522372|P2|STARTED|Enrolled||42
8324428|NCT01401959|20522373|P1|STARTED|Enrolled||54
8324429|NCT01401907|20522389|P2|NOT COMPLETED|Overall Study||51
8324430|NCT01401907|20522390|P1|NOT COMPLETED|Overall Study||57
8324431|NCT01401907|20522389|P2|COMPLETED|Overall Study||124
8324432|NCT01401907|20522390|P1|COMPLETED|Overall Study||118
8324433|NCT01401907|20522389|P2|12 Week Outcomes|Overall Study||153
8324434|NCT01401907|20522390|P1|12 Week Outcomes|Overall Study||148
8324435|NCT01401907|20522389|P2|STARTED|Overall Study||175
8324436|NCT01401907|20522390|P1|STARTED|Overall Study||175
8324437|NCT01401842|20522412|P2|NOT COMPLETED|Overall Study||67
8324438|NCT01401842|20522413|P1|NOT COMPLETED|Overall Study||68
8324439|NCT01401842|20522412|P2|COMPLETED|Overall Study||217
8324440|NCT01401842|20522413|P1|COMPLETED|Overall Study||230
8324441|NCT01401842|20522412|P2|STARTED|Overall Study||284
8324442|NCT01401842|20522413|P1|STARTED|Overall Study||298
8324443|NCT01401699|20522423|P1|NOT COMPLETED|Overall Study||0
8324444|NCT01401699|20522423|P1|COMPLETED|Overall Study||109
8324445|NCT01401699|20522423|P1|STARTED|Overall Study||109
8324446|NCT01401647|20522430|P3|NOT COMPLETED|Overall Study||3
8324447|NCT01401647|20522431|P2|NOT COMPLETED|Overall Study||8
8324448|NCT01401647|20522432|P1|NOT COMPLETED|Overall Study||4
8324449|NCT01401647|20522430|P3|COMPLETED|Overall Study||1056
8324450|NCT01401647|20522431|P2|COMPLETED|Overall Study||985
8324451|NCT01401647|20522432|P1|COMPLETED|Overall Study||968
8324452|NCT01401647|20522430|P3|STARTED|Overall Study||1059
8324453|NCT01401647|20522431|P2|STARTED|Overall Study||993
8324454|NCT01401647|20522432|P1|STARTED|Overall Study||972
8324455|NCT01401595|20522445|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
8324456|NCT01401595|20522446|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
8324457|NCT01401595|20522445|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
8324458|NCT01401595|20522446|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
8324459|NCT01401595|20522445|P2|STARTED|Imaging and Treatment (for NE Arm)||10
8324460|NCT01401595|20522446|P1|STARTED|Imaging and Treatment (for NE Arm)||32
8324461|NCT01401595|20522445|P2|NOT COMPLETED|Recruitment and Screening||2
8324462|NCT01401595|20522446|P1|NOT COMPLETED|Recruitment and Screening||43
8324463|NCT01401595|20522445|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
8324464|NCT01401595|20522446|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
8324465|NCT01401595|20522445|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
8324466|NCT01401595|20522446|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
8324475|NCT01401543|20522474|P4|NOT COMPLETED|Fourth Intervention||0
8324476|NCT01401543|20522475|P3|NOT COMPLETED|Fourth Intervention||0
8324477|NCT01401543|20522476|P2|NOT COMPLETED|Fourth Intervention||0
8324478|NCT01401543|20522477|P1|NOT COMPLETED|Fourth Intervention||0
8324479|NCT01401543|20522474|P4|COMPLETED|Fourth Intervention||6
8324480|NCT01401543|20522475|P3|COMPLETED|Fourth Intervention||6
8324481|NCT01401543|20522476|P2|COMPLETED|Fourth Intervention||6
8324482|NCT01401543|20522477|P1|COMPLETED|Fourth Intervention||6
8324483|NCT01401543|20522474|P4|STARTED|Fourth Intervention||6
8324484|NCT01401543|20522475|P3|STARTED|Fourth Intervention||6
8324485|NCT01401543|20522476|P2|STARTED|Fourth Intervention||6
8324486|NCT01401543|20522477|P1|STARTED|Fourth Intervention||6
8324487|NCT01401543|20522474|P4|NOT COMPLETED|Third Washout Period of 1 Week||0
8324488|NCT01401543|20522475|P3|NOT COMPLETED|Third Washout Period of 1 Week||0
8324489|NCT01401543|20522476|P2|NOT COMPLETED|Third Washout Period of 1 Week||0
8324490|NCT01401543|20522477|P1|NOT COMPLETED|Third Washout Period of 1 Week||0
8324491|NCT01401543|20522474|P4|COMPLETED|Third Washout Period of 1 Week||6
8324492|NCT01401543|20522475|P3|COMPLETED|Third Washout Period of 1 Week||6
8324493|NCT01401543|20522476|P2|COMPLETED|Third Washout Period of 1 Week||6
8324494|NCT01401543|20522477|P1|COMPLETED|Third Washout Period of 1 Week||6
8324495|NCT01401543|20522474|P4|STARTED|Third Washout Period of 1 Week||6
8324496|NCT01401543|20522475|P3|STARTED|Third Washout Period of 1 Week||6
8324497|NCT01401543|20522476|P2|STARTED|Third Washout Period of 1 Week||6
8324498|NCT01401543|20522477|P1|STARTED|Third Washout Period of 1 Week||6
8324499|NCT01401543|20522474|P4|NOT COMPLETED|Third Intervention||0
8324500|NCT01401543|20522475|P3|NOT COMPLETED|Third Intervention||0
8324501|NCT01401543|20522476|P2|NOT COMPLETED|Third Intervention||0
8324502|NCT01401543|20522477|P1|NOT COMPLETED|Third Intervention||0
8324503|NCT01401543|20522474|P4|COMPLETED|Third Intervention||6
8324504|NCT01401543|20522475|P3|COMPLETED|Third Intervention||6
8324505|NCT01401543|20522476|P2|COMPLETED|Third Intervention||6
8324506|NCT01401543|20522477|P1|COMPLETED|Third Intervention||6
8324507|NCT01401543|20522474|P4|STARTED|Third Intervention||6
8324508|NCT01401543|20522475|P3|STARTED|Third Intervention||6
8324509|NCT01401543|20522476|P2|STARTED|Third Intervention||6
8324510|NCT01401543|20522477|P1|STARTED|Third Intervention||6
8324511|NCT01401543|20522474|P4|NOT COMPLETED|Second Washout Period of 1 Week||0
8324512|NCT01401543|20522475|P3|NOT COMPLETED|Second Washout Period of 1 Week||0
8324513|NCT01401543|20522476|P2|NOT COMPLETED|Second Washout Period of 1 Week||0
8324514|NCT01401543|20522477|P1|NOT COMPLETED|Second Washout Period of 1 Week||0
8324515|NCT01401543|20522474|P4|COMPLETED|Second Washout Period of 1 Week||6
8324516|NCT01401543|20522475|P3|COMPLETED|Second Washout Period of 1 Week||6
8324517|NCT01401543|20522476|P2|COMPLETED|Second Washout Period of 1 Week||6
8324518|NCT01401543|20522477|P1|COMPLETED|Second Washout Period of 1 Week||6
8324519|NCT01401543|20522474|P4|STARTED|Second Washout Period of 1 Week||6
8324520|NCT01401543|20522475|P3|STARTED|Second Washout Period of 1 Week||6
8324521|NCT01401543|20522476|P2|STARTED|Second Washout Period of 1 Week||6
8324522|NCT01401543|20522477|P1|STARTED|Second Washout Period of 1 Week||6
8324523|NCT01401543|20522474|P4|NOT COMPLETED|Second Intervention||0
8324524|NCT01401543|20522475|P3|NOT COMPLETED|Second Intervention||0
8324525|NCT01401543|20522476|P2|NOT COMPLETED|Second Intervention||0
8324526|NCT01401543|20522477|P1|NOT COMPLETED|Second Intervention||0
8324527|NCT01401543|20522474|P4|COMPLETED|Second Intervention||6
8324528|NCT01401543|20522475|P3|COMPLETED|Second Intervention||6
8324529|NCT01401543|20522476|P2|COMPLETED|Second Intervention||6
8324530|NCT01401543|20522477|P1|COMPLETED|Second Intervention||6
8324531|NCT01401543|20522474|P4|STARTED|Second Intervention||6
8324532|NCT01401543|20522475|P3|STARTED|Second Intervention||6
8324533|NCT01401543|20522476|P2|STARTED|Second Intervention||6
8324534|NCT01401543|20522477|P1|STARTED|Second Intervention||6
8324535|NCT01401543|20522474|P4|NOT COMPLETED|First Washout Period of 1 Week||0
8324536|NCT01401543|20522475|P3|NOT COMPLETED|First Washout Period of 1 Week||0
8324537|NCT01401543|20522476|P2|NOT COMPLETED|First Washout Period of 1 Week||0
8324538|NCT01401543|20522477|P1|NOT COMPLETED|First Washout Period of 1 Week||0
8324539|NCT01401543|20522474|P4|COMPLETED|First Washout Period of 1 Week||6
8324540|NCT01401543|20522475|P3|COMPLETED|First Washout Period of 1 Week||6
8324541|NCT01401543|20522476|P2|COMPLETED|First Washout Period of 1 Week||6
8324542|NCT01401543|20522477|P1|COMPLETED|First Washout Period of 1 Week||6
8324543|NCT01401543|20522474|P4|STARTED|First Washout Period of 1 Week||6
8324544|NCT01401543|20522475|P3|STARTED|First Washout Period of 1 Week||6
8324545|NCT01401543|20522476|P2|STARTED|First Washout Period of 1 Week||6
8324546|NCT01401543|20522477|P1|STARTED|First Washout Period of 1 Week||6
8324547|NCT01401543|20522474|P4|NOT COMPLETED|First Intervention||0
8324548|NCT01401543|20522475|P3|NOT COMPLETED|First Intervention||0
8324549|NCT01401543|20522476|P2|NOT COMPLETED|First Intervention||0
8324550|NCT01401543|20522477|P1|NOT COMPLETED|First Intervention||0
8324551|NCT01401543|20522474|P4|COMPLETED|First Intervention||6
8324552|NCT01401543|20522475|P3|COMPLETED|First Intervention||6
8324553|NCT01401543|20522476|P2|COMPLETED|First Intervention||6
8324554|NCT01401543|20522477|P1|COMPLETED|First Intervention||6
8324555|NCT01401543|20522474|P4|STARTED|First Intervention||6
8324556|NCT01401543|20522475|P3|STARTED|First Intervention||6
8324557|NCT01401543|20522476|P2|STARTED|First Intervention||6
8324558|NCT01401543|20522477|P1|STARTED|First Intervention||6
8324559|NCT01401530|20522502|P3|NOT COMPLETED|Overall Study||3
8324560|NCT01401530|20522503|P2|NOT COMPLETED|Overall Study||6
8324561|NCT01401530|20522504|P1|NOT COMPLETED|Overall Study||3
8324562|NCT01401530|20522502|P3|COMPLETED|Overall Study||0
8324563|NCT01401530|20522503|P2|COMPLETED|Overall Study||1
8324564|NCT01401530|20522504|P1|COMPLETED|Overall Study||0
8324565|NCT01401530|20522502|P3|STARTED|Overall Study||3
8324566|NCT01401530|20522503|P2|STARTED|Overall Study||7
8324567|NCT01401530|20522504|P1|STARTED|Overall Study||3
8324568|NCT01401517|20522544|P3|NOT COMPLETED|Overall Study||3
8324569|NCT01401517|20522545|P2|NOT COMPLETED|Overall Study||2
8324570|NCT01401517|20522546|P1|NOT COMPLETED|Overall Study||3
8324571|NCT01401517|20522544|P3|COMPLETED|Overall Study||15
8324572|NCT01401517|20522545|P2|COMPLETED|Overall Study||17
8324573|NCT01401517|20522546|P1|COMPLETED|Overall Study||15
8324574|NCT01401517|20522544|P3|STARTED|Overall Study||18
8324575|NCT01401517|20522545|P2|STARTED|Overall Study||19
8324576|NCT01401517|20522546|P1|STARTED|Overall Study||18
8324577|NCT01401478|20522563|P1|NOT COMPLETED|Overall Study||31
8324578|NCT01401478|20522563|P1|COMPLETED|Overall Study||55
8324579|NCT01401478|20522563|P1|STARTED|Overall Study||86
8324580|NCT01401465|20522576|P2|NOT COMPLETED|Treatment Period 2||2
8324581|NCT01401465|20522577|P1|NOT COMPLETED|Treatment Period 2||0
8324582|NCT01401465|20522576|P2|COMPLETED|Treatment Period 2||144
8324583|NCT01401465|20522577|P1|COMPLETED|Treatment Period 2||150
8324584|NCT01401465|20522576|P2|STARTED|Treatment Period 2||146
8324585|NCT01401465|20522577|P1|STARTED|Treatment Period 2||150
8324586|NCT01401465|20522576|P2|NOT COMPLETED|Washout||0
8324587|NCT01401465|20522577|P1|NOT COMPLETED|Washout||0
8324588|NCT01401465|20522576|P2|COMPLETED|Washout||146
8324589|NCT01401465|20522577|P1|COMPLETED|Washout||150
8324590|NCT01401465|20522576|P2|STARTED|Washout||146
8324591|NCT01401465|20522577|P1|STARTED|Washout||150
8324592|NCT01401465|20522576|P2|NOT COMPLETED|Treatment Period 1||16
8324593|NCT01401465|20522577|P1|NOT COMPLETED|Treatment Period 1||15
8324594|NCT01401465|20522576|P2|COMPLETED|Treatment Period 1||146
8324595|NCT01401465|20522577|P1|COMPLETED|Treatment Period 1||150
8324596|NCT01401465|20522576|P2|STARTED|Treatment Period 1||162
8324597|NCT01401465|20522577|P1|STARTED|Treatment Period 1||165
8324598|NCT01401452|20522640|P1|NOT COMPLETED|Overall Study||72
8324599|NCT01401452|20522640|P1|COMPLETED|Overall Study||174
8324600|NCT01401452|20522640|P1|Visit 5 (9 Months)|Overall Study||175
8324601|NCT01401452|20522640|P1|Visit 4 (6 Months)|Overall Study||172
8324602|NCT01401452|20522640|P1|Visit 3 (3 Months)|Overall Study||217
8324603|NCT01401452|20522640|P1|Visit 2 (1 Month)|Overall Study||225
8324604|NCT01401452|20522640|P1|Visit 1 (Baseline)|Overall Study||246
8324605|NCT01401452|20522640|P1|STARTED|Overall Study||246
8324606|NCT01401361|20522652|P1|NOT COMPLETED|Overall Study||28
8324607|NCT01401361|20522652|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
8324608|NCT01401361|20522652|P1|STARTED|Overall Study||150
8324609|NCT01401322|20522658|P1|NOT COMPLETED|Overall Study||2
8324610|NCT01401322|20522658|P1|COMPLETED|Overall Study||3
8324611|NCT01401322|20522658|P1|STARTED|Overall Study||5
8324612|NCT01401283|20522664|P2|NOT COMPLETED|Overall Study||10
8324613|NCT01401283|20522665|P1|NOT COMPLETED|Overall Study||10
8324614|NCT01401283|20522664|P2|COMPLETED|Overall Study||81
8324615|NCT01401283|20522665|P1|COMPLETED|Overall Study||79
8324616|NCT01401283|20522664|P2|STARTED|Overall Study||91
8324617|NCT01401283|20522665|P1|STARTED|Overall Study||89
8324618|NCT01401257|20522677|P4|NOT COMPLETED|Overall Study||2
8324619|NCT01401257|20522678|P3|NOT COMPLETED|Overall Study||3
8324620|NCT01401257|20522679|P2|NOT COMPLETED|Overall Study||2
8324621|NCT01401257|20522680|P1|NOT COMPLETED|Overall Study||0
8324622|NCT01401257|20522677|P4|COMPLETED|Overall Study||17
8324623|NCT01401257|20522678|P3|COMPLETED|Overall Study||16
8324624|NCT01401257|20522679|P2|COMPLETED|Overall Study||19
8324625|NCT01401257|20522680|P1|COMPLETED|Overall Study||21
8324626|NCT01401257|20522677|P4|STARTED|Overall Study||19
8324627|NCT01401257|20522678|P3|STARTED|Overall Study||19
8324628|NCT01401257|20522679|P2|STARTED|Overall Study||21
8324629|NCT01401257|20522680|P1|STARTED|Overall Study||21
8324630|NCT01401166|20522692|P4|NOT COMPLETED|Safety Follow-Up Period||19
8324631|NCT01401166|20522693|P3|NOT COMPLETED|Safety Follow-Up Period||17
8324632|NCT01401166|20522694|P2|NOT COMPLETED|Safety Follow-Up Period||18
8324633|NCT01401166|20522695|P1|NOT COMPLETED|Safety Follow-Up Period||25
8324634|NCT01401166|20522692|P4|COMPLETED|Safety Follow-Up Period||100
8324635|NCT01401166|20522693|P3|COMPLETED|Safety Follow-Up Period||104
8324636|NCT01401166|20522694|P2|COMPLETED|Safety Follow-Up Period||106
8324637|NCT01401166|20522695|P1|COMPLETED|Safety Follow-Up Period||99
8324638|NCT01401166|20522692|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
8324639|NCT01401166|20522693|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
8324640|NCT01401166|20522694|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
8324641|NCT01401166|20522695|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
8324642|NCT01401166|20522692|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
8324643|NCT01401166|20522693|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
8324644|NCT01401166|20522694|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
8324645|NCT01401166|20522695|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
8324646|NCT01401166|20522692|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
8324647|NCT01401166|20522693|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
8324648|NCT01401166|20522694|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
8324649|NCT01401166|20522695|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
8324650|NCT01401166|20522692|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
8324651|NCT01401166|20522693|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
8324652|NCT01401166|20522694|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
8324653|NCT01401166|20522695|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
8324654|NCT01401166|20522692|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
8324655|NCT01401166|20522693|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
8324656|NCT01401166|20522694|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
8324657|NCT01401166|20522695|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
8324658|NCT01401166|20522692|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
8324659|NCT01401166|20522693|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
8324660|NCT01401166|20522694|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
8324661|NCT01401166|20522695|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
8324662|NCT01401166|20522692|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
8324663|NCT01401166|20522693|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
8324664|NCT01401166|20522694|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
8324665|NCT01401166|20522695|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
8324666|NCT01401166|20522692|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8324667|NCT01401166|20522693|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8324668|NCT01401166|20522694|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8324669|NCT01401166|20522695|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
8324670|NCT01401166|20522692|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
8324671|NCT01401166|20522693|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
8324672|NCT01401166|20522694|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
8324673|NCT01401166|20522695|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
8324674|NCT01401166|20522692|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
8324675|NCT01401166|20522693|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
8324676|NCT01401166|20522694|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
8324677|NCT01401166|20522695|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
8324678|NCT01401153|20522731|P2|NOT COMPLETED|Second Test Day||5
8324679|NCT01401153|20522732|P1|NOT COMPLETED|Second Test Day||0
8324680|NCT01401153|20522731|P2|COMPLETED|Second Test Day||60
8324681|NCT01401153|20522732|P1|COMPLETED|Second Test Day||45
8324682|NCT01401153|20522731|P2|STARTED|Second Test Day||65
8324683|NCT01401153|20522732|P1|STARTED|Second Test Day||45
8324684|NCT01401153|20522731|P2|NOT COMPLETED|First Test Day||10
8324685|NCT01401153|20522732|P1|NOT COMPLETED|First Test Day||1
8324686|NCT01401153|20522731|P2|COMPLETED|First Test Day||45
8324687|NCT01401153|20522732|P1|COMPLETED|First Test Day||65
8324688|NCT01401153|20522731|P2|STARTED|First Test Day||55
8324689|NCT01401153|20522732|P1|STARTED|First Test Day||66
8324690|NCT01401101|20522766|P2|NOT COMPLETED|Overall Study||27
8324691|NCT01401101|20522767|P1|NOT COMPLETED|Overall Study||22
8324692|NCT01401101|20522766|P2|COMPLETED|Overall Study||171
8324693|NCT01401101|20522767|P1|COMPLETED|Overall Study||184
8324694|NCT01401101|20522766|P2|STARTED|Overall Study||198
8324695|NCT01401101|20522767|P1|STARTED|Overall Study||206
8324696|NCT01401062|20522779|P2|NOT COMPLETED|Overall Study||8
8324697|NCT01401062|20522780|P1|NOT COMPLETED|Overall Study||11
8324698|NCT01401062|20522779|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
8324699|NCT01401062|20522780|P1|COMPLETED|Overall Study||0
8324700|NCT01401062|20522779|P2|STARTED|Overall Study||12
8324701|NCT01401062|20522780|P1|STARTED|Overall Study||11
8324702|NCT01401049|20522788|P2|NOT COMPLETED|Overall Study||0
8324703|NCT01401049|20522789|P1|NOT COMPLETED|Overall Study||0
8324704|NCT01401049|20522788|P2|COMPLETED|Overall Study||0
8324705|NCT01401049|20522789|P1|COMPLETED|Overall Study||0
8324706|NCT01401049|20522788|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
8324707|NCT01401049|20522789|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
8324708|NCT01401023|20522797|P1|NOT COMPLETED|Overall Study||0
8324709|NCT01401023|20522797|P1|COMPLETED|Overall Study||10
8324710|NCT01401023|20522797|P1|STARTED|Overall Study||10
8324711|NCT01401010|20522807|P2|NOT COMPLETED|Overall Study||0
8324712|NCT01401010|20522808|P1|NOT COMPLETED|Overall Study||1
8324713|NCT01401010|20522807|P2|COMPLETED|Overall Study||6
8324714|NCT01401010|20522808|P1|COMPLETED|Overall Study||5
8324715|NCT01401010|20522807|P2|STARTED|Overall Study||6
8324716|NCT01401010|20522808|P1|STARTED|Overall Study||6
8324717|NCT01400971|20522831|P1|NOT COMPLETED|Overall Study||917
8324718|NCT01400971|20522831|P1|COMPLETED|Overall Study||3382
8324719|NCT01400971|20522831|P1|Complete Treatment Data|Overall Study||2528
8324720|NCT01400971|20522831|P1|STARTED|Overall Study||4299
8324721|NCT01400958|20522840|P2|NOT COMPLETED|Overall Study||2
8324722|NCT01400958|20522841|P1|NOT COMPLETED|Overall Study||1
8324723|NCT01400958|20522840|P2|COMPLETED|Overall Study||1
8324724|NCT01400958|20522841|P1|COMPLETED|Overall Study||2
8324725|NCT01400958|20522840|P2|STARTED|Overall Study||3
8324726|NCT01400958|20522841|P1|STARTED|Overall Study||3
8324727|NCT01400932|20522851|P2|NOT COMPLETED|Overall Study||15
8324728|NCT01400932|20522852|P1|NOT COMPLETED|Overall Study||14
8324729|NCT01400932|20522851|P2|COMPLETED|Overall Study||167
8324730|NCT01400932|20522852|P1|COMPLETED|Overall Study||164
8324731|NCT01400932|20522851|P2|STARTED|Overall Study||182
8324732|NCT01400932|20522852|P1|STARTED|Overall Study||178
8324733|NCT01400919|20522874|P1|NOT COMPLETED|Overall Study||8
8324734|NCT01400919|20522874|P1|COMPLETED|Overall Study||67
8324735|NCT01400919|20522874|P1|STARTED|Overall Study||75
8324736|NCT01400906|20522878|P6|NOT COMPLETED|Treatment Period 3||0
8324737|NCT01400906|20522879|P5|NOT COMPLETED|Treatment Period 3||0
8324738|NCT01400906|20522880|P4|NOT COMPLETED|Treatment Period 3||0
8324739|NCT01400906|20522881|P3|NOT COMPLETED|Treatment Period 3||0
8324740|NCT01400906|20522882|P2|NOT COMPLETED|Treatment Period 3||0
8324741|NCT01400906|20522883|P1|NOT COMPLETED|Treatment Period 3||0
8324742|NCT01400906|20522878|P6|COMPLETED|Treatment Period 3||5
8324743|NCT01400906|20522879|P5|COMPLETED|Treatment Period 3||6
8324744|NCT01400906|20522880|P4|COMPLETED|Treatment Period 3||6
8324745|NCT01400906|20522881|P3|COMPLETED|Treatment Period 3||6
8324746|NCT01400906|20522882|P2|COMPLETED|Treatment Period 3||6
8324747|NCT01400906|20522883|P1|COMPLETED|Treatment Period 3||6
8324748|NCT01400906|20522878|P6|STARTED|Treatment Period 3||5
8324749|NCT01400906|20522879|P5|STARTED|Treatment Period 3||6
8324750|NCT01400906|20522880|P4|STARTED|Treatment Period 3||6
8324751|NCT01400906|20522881|P3|STARTED|Treatment Period 3||6
8324752|NCT01400906|20522882|P2|STARTED|Treatment Period 3||6
8324753|NCT01400906|20522883|P1|STARTED|Treatment Period 3||6
8324754|NCT01400906|20522878|P6|NOT COMPLETED|Washout Period 2||0
8324755|NCT01400906|20522879|P5|NOT COMPLETED|Washout Period 2||0
8324756|NCT01400906|20522880|P4|NOT COMPLETED|Washout Period 2||0
8324757|NCT01400906|20522881|P3|NOT COMPLETED|Washout Period 2||0
8324758|NCT01400906|20522882|P2|NOT COMPLETED|Washout Period 2||0
8324759|NCT01400906|20522883|P1|NOT COMPLETED|Washout Period 2||0
8324760|NCT01400906|20522878|P6|COMPLETED|Washout Period 2||5
8324761|NCT01400906|20522879|P5|COMPLETED|Washout Period 2||6
8324762|NCT01400906|20522880|P4|COMPLETED|Washout Period 2||6
8324763|NCT01400906|20522881|P3|COMPLETED|Washout Period 2||6
8324764|NCT01400906|20522882|P2|COMPLETED|Washout Period 2||6
8324765|NCT01400906|20522883|P1|COMPLETED|Washout Period 2||6
8324766|NCT01400906|20522878|P6|STARTED|Washout Period 2||5
8324767|NCT01400906|20522879|P5|STARTED|Washout Period 2||6
8324768|NCT01400906|20522880|P4|STARTED|Washout Period 2||6
8324769|NCT01400906|20522881|P3|STARTED|Washout Period 2||6
8324770|NCT01400906|20522882|P2|STARTED|Washout Period 2||6
8324771|NCT01400906|20522883|P1|STARTED|Washout Period 2||6
8324772|NCT01400906|20522878|P6|NOT COMPLETED|Treatment Period 2||0
8324773|NCT01400906|20522879|P5|NOT COMPLETED|Treatment Period 2||0
8324774|NCT01400906|20522880|P4|NOT COMPLETED|Treatment Period 2||0
8324775|NCT01400906|20522881|P3|NOT COMPLETED|Treatment Period 2||0
8324776|NCT01400906|20522882|P2|NOT COMPLETED|Treatment Period 2||0
8324777|NCT01400906|20522883|P1|NOT COMPLETED|Treatment Period 2||0
8324778|NCT01400906|20522878|P6|COMPLETED|Treatment Period 2||5
8324779|NCT01400906|20522879|P5|COMPLETED|Treatment Period 2||6
8324780|NCT01400906|20522880|P4|COMPLETED|Treatment Period 2||6
8324781|NCT01400906|20522881|P3|COMPLETED|Treatment Period 2||6
8324782|NCT01400906|20522882|P2|COMPLETED|Treatment Period 2||6
8324783|NCT01400906|20522883|P1|COMPLETED|Treatment Period 2||6
8324784|NCT01400906|20522878|P6|STARTED|Treatment Period 2||5
8324785|NCT01400906|20522879|P5|STARTED|Treatment Period 2||6
8324786|NCT01400906|20522880|P4|STARTED|Treatment Period 2||6
8324787|NCT01400906|20522881|P3|STARTED|Treatment Period 2||6
8324788|NCT01400906|20522882|P2|STARTED|Treatment Period 2||6
8324789|NCT01400906|20522883|P1|STARTED|Treatment Period 2||6
8324790|NCT01400906|20522878|P6|NOT COMPLETED|Washout Period 1||0
8324791|NCT01400906|20522879|P5|NOT COMPLETED|Washout Period 1||0
8324792|NCT01400906|20522880|P4|NOT COMPLETED|Washout Period 1||0
8324793|NCT01400906|20522881|P3|NOT COMPLETED|Washout Period 1||0
8324794|NCT01400906|20522882|P2|NOT COMPLETED|Washout Period 1||0
8324795|NCT01400906|20522883|P1|NOT COMPLETED|Washout Period 1||0
8324796|NCT01400906|20522878|P6|COMPLETED|Washout Period 1||5
8324797|NCT01400906|20522879|P5|COMPLETED|Washout Period 1||6
8324798|NCT01400906|20522880|P4|COMPLETED|Washout Period 1||6
8324799|NCT01400906|20522881|P3|COMPLETED|Washout Period 1||6
8324800|NCT01400906|20522882|P2|COMPLETED|Washout Period 1||6
8324801|NCT01400906|20522883|P1|COMPLETED|Washout Period 1||6
8324802|NCT01400906|20522878|P6|STARTED|Washout Period 1||5
8324803|NCT01400906|20522879|P5|STARTED|Washout Period 1||6
8324804|NCT01400906|20522880|P4|STARTED|Washout Period 1||6
8324805|NCT01400906|20522881|P3|STARTED|Washout Period 1||6
8324806|NCT01400906|20522882|P2|STARTED|Washout Period 1||6
8324807|NCT01400906|20522883|P1|STARTED|Washout Period 1||6
8324808|NCT01400906|20522878|P6|NOT COMPLETED|Treatment Period 1||0
8324809|NCT01400906|20522879|P5|NOT COMPLETED|Treatment Period 1||0
8324810|NCT01400906|20522880|P4|NOT COMPLETED|Treatment Period 1||0
8324811|NCT01400906|20522881|P3|NOT COMPLETED|Treatment Period 1||0
8324812|NCT01400906|20522882|P2|NOT COMPLETED|Treatment Period 1||0
8324813|NCT01400906|20522883|P1|NOT COMPLETED|Treatment Period 1||0
8324814|NCT01400906|20522878|P6|COMPLETED|Treatment Period 1||5
8324815|NCT01400906|20522879|P5|COMPLETED|Treatment Period 1||6
8324816|NCT01400906|20522880|P4|COMPLETED|Treatment Period 1||6
8324817|NCT01400906|20522881|P3|COMPLETED|Treatment Period 1||6
8324818|NCT01400906|20522882|P2|COMPLETED|Treatment Period 1||6
8324819|NCT01400906|20522883|P1|COMPLETED|Treatment Period 1||6
8324820|NCT01400906|20522878|P6|STARTED|Treatment Period 1||5
8324821|NCT01400906|20522879|P5|STARTED|Treatment Period 1||6
8324822|NCT01400906|20522880|P4|STARTED|Treatment Period 1||6
8324823|NCT01400906|20522881|P3|STARTED|Treatment Period 1||6
8324824|NCT01400906|20522882|P2|STARTED|Treatment Period 1||6
8324825|NCT01400906|20522883|P1|STARTED|Treatment Period 1||6
8324826|NCT01400893|20522917|P2|NOT COMPLETED|Overall Study||27
8324827|NCT01400893|20522918|P1|NOT COMPLETED|Overall Study||27
8324828|NCT01400893|20522917|P2|COMPLETED|Overall Study||38
8324829|NCT01400893|20522918|P1|COMPLETED|Overall Study||42
8324830|NCT01400893|20522917|P2|STARTED|Overall Study||65
8324831|NCT01400893|20522918|P1|STARTED|Overall Study||69
8324832|NCT01400880|20522926|P1|NOT COMPLETED|Overall Study||2
8324833|NCT01400880|20522926|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
8324834|NCT01400880|20522926|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
8324835|NCT01400841|20522930|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
8324836|NCT01400841|20522930|P1|COMPLETED|Extended Study Phase (2 Years)||11
8324837|NCT01400841|20522930|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation
~1 subject death prior to agreeing to extended follow-up"|13
8324838|NCT01400841|20522930|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
8324839|NCT01400841|20522930|P1|COMPLETED|Initial Study Phase (6 Months)||15
8324840|NCT01400841|20522930|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
8324841|NCT01400698|20522968|P6|NOT COMPLETED|Overall Study||6
8324842|NCT01400698|20522969|P5|NOT COMPLETED|Overall Study||7
8324843|NCT01400698|20522970|P4|NOT COMPLETED|Overall Study||8
8324844|NCT01400698|20522971|P3|NOT COMPLETED|Overall Study||2
8324845|NCT01400698|20522972|P2|NOT COMPLETED|Overall Study||11
8324846|NCT01400698|20522973|P1|NOT COMPLETED|Overall Study||15
8324847|NCT01400698|20522968|P6|COMPLETED|Overall Study||9
8324848|NCT01400698|20522969|P5|COMPLETED|Overall Study||7
8324849|NCT01400698|20522970|P4|COMPLETED|Overall Study||6
8324850|NCT01400698|20522971|P3|COMPLETED|Overall Study||0
8324851|NCT01400698|20522972|P2|COMPLETED|Overall Study||12
8324852|NCT01400698|20522973|P1|COMPLETED|Overall Study||8
8324853|NCT01400698|20522968|P6|STARTED|Overall Study||15
8324854|NCT01400698|20522969|P5|STARTED|Overall Study||14
8324855|NCT01400698|20522970|P4|STARTED|Overall Study||14
8324856|NCT01400698|20522971|P3|STARTED|Overall Study||2
8324857|NCT01400698|20522972|P2|STARTED|Overall Study||23
8324858|NCT01400698|20522973|P1|STARTED|Overall Study||23
8324859|NCT01400516|20522997|P2|NOT COMPLETED|Extension Trial||0
8324860|NCT01400516|20522998|P1|NOT COMPLETED|Extension Trial||0
8324861|NCT01400516|20522997|P2|COMPLETED|Extension Trial||7
8324862|NCT01400516|20522998|P1|COMPLETED|Extension Trial||6
8324863|NCT01400516|20522997|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
8324864|NCT01400516|20522998|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
8324865|NCT01400516|20522997|P2|NOT COMPLETED|Primary Trial||2
8324866|NCT01400516|20522998|P1|NOT COMPLETED|Primary Trial||0
8324867|NCT01400516|20522997|P2|COMPLETED|Primary Trial||12
8324868|NCT01400516|20522998|P1|COMPLETED|Primary Trial||12
8324869|NCT01400516|20522997|P2|STARTED|Primary Trial||14
8324870|NCT01400516|20522998|P1|STARTED|Primary Trial||12
8324871|NCT01400503|20523008|P1|NOT COMPLETED|Overall Study||60
8324872|NCT01400503|20523008|P1|COMPLETED|Overall Study||0
8324873|NCT01400503|20523008|P1|STARTED|Overall Study||60
8324874|NCT01400477|20523019|P2|NOT COMPLETED|Overall Study||0
8324875|NCT01400477|20523020|P1|NOT COMPLETED|Overall Study||2
8324876|NCT01400477|20523019|P2|COMPLETED|Overall Study||40
8324877|NCT01400477|20523020|P1|COMPLETED|Overall Study||38
8324878|NCT01400477|20523019|P2|STARTED|Overall Study||40
8324879|NCT01400477|20523020|P1|STARTED|Overall Study||40
8324880|NCT01400451|20523031|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
8324881|NCT01400451|20523032|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
8324882|NCT01400451|20523033|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
8324883|NCT01400451|20523031|P3|COMPLETED|Combination Treatment (or Intended)||0
8324884|NCT01400451|20523032|P2|COMPLETED|Combination Treatment (or Intended)||0
8324885|NCT01400451|20523033|P1|COMPLETED|Combination Treatment (or Intended)||0
8324886|NCT01400451|20523031|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
8324887|NCT01400451|20523032|P2|STARTED|Combination Treatment (or Intended)||4
8324888|NCT01400451|20523033|P1|STARTED|Combination Treatment (or Intended)||6
8324889|NCT01400451|20523031|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8324890|NCT01400451|20523032|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8324891|NCT01400451|20523033|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8324892|NCT01400451|20523031|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
8324893|NCT01400451|20523032|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
8324894|NCT01400451|20523033|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
8324895|NCT01400451|20523031|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
8324896|NCT01400451|20523032|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
8324897|NCT01400451|20523033|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
8324898|NCT01400425|20523047|P1|NOT COMPLETED|Overall Study||10
8324899|NCT01400425|20523047|P1|COMPLETED|Overall Study||229
8324900|NCT01400425|20523047|P1|STARTED|Overall Study||239
8324901|NCT01400412|20523060|P2|NOT COMPLETED|Overall Study||17
8324902|NCT01400412|20523061|P1|NOT COMPLETED|Overall Study||10
8324903|NCT01400412|20523060|P2|COMPLETED|Overall Study||115
8324904|NCT01400412|20523061|P1|COMPLETED|Overall Study||120
8324905|NCT01400412|20523060|P2|STARTED|Overall Study||132
8324906|NCT01400412|20523061|P1|STARTED|Overall Study||130
8324907|NCT01400243|20523107|P2|NOT COMPLETED|Overall Study||11
8324908|NCT01400243|20523108|P1|NOT COMPLETED|Overall Study||8
8324909|NCT01400243|20523107|P2|COMPLETED|Overall Study||52
8324910|NCT01400243|20523108|P1|COMPLETED|Overall Study||56
8324911|NCT01400243|20523107|P2|STARTED|Overall Study||63
8324912|NCT01400243|20523108|P1|STARTED|Overall Study||64
8324913|NCT01400139|20523130|P1|NOT COMPLETED|HYD Extension Period||23
8324914|NCT01400139|20523130|P1|COMPLETED|HYD Extension Period||83
8324915|NCT01400139|20523130|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
8324916|NCT01400139|20523130|P1|NOT COMPLETED|HYD Core Study||512
8324917|NCT01400139|20523130|P1|COMPLETED|HYD Core Study||410
8324918|NCT01400139|20523130|P1|STARTED|HYD Core Study||922
8324919|NCT01400113|20523153|P2|NOT COMPLETED|Overall Study||1
8324920|NCT01400113|20523154|P1|NOT COMPLETED|Overall Study||1
8324921|NCT01400113|20523153|P2|COMPLETED|Overall Study||59
8324922|NCT01400113|20523154|P1|COMPLETED|Overall Study||59
8324923|NCT01400113|20523153|P2|STARTED|Overall Study||60
8324924|NCT01400113|20523154|P1|STARTED|Overall Study||60
8324925|NCT01399905|20523162|P2|NOT COMPLETED|Overall Study||1
8324926|NCT01399905|20523163|P1|NOT COMPLETED|Overall Study||1
8324927|NCT01399905|20523162|P2|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
8324928|NCT01399905|20523163|P1|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
8324929|NCT01399905|20523162|P2|STARTED|Overall Study||7
8324930|NCT01399905|20523163|P1|STARTED|Overall Study||7
8324931|NCT01399866|20523177|P2|NOT COMPLETED|Overall Study||2
8324932|NCT01399866|20523178|P1|NOT COMPLETED|Overall Study||4
8324933|NCT01399866|20523177|P2|COMPLETED|Overall Study||28
8324934|NCT01399866|20523178|P1|COMPLETED|Overall Study||28
8324935|NCT01399866|20523177|P2|STARTED|Overall Study||30
8324936|NCT01399866|20523178|P1|STARTED|Overall Study||32
8324937|NCT01399827|20523196|P2|NOT COMPLETED|Overall Study||0
8324938|NCT01399827|20523197|P1|NOT COMPLETED|Overall Study||0
8324939|NCT01399827|20523196|P2|COMPLETED|Overall Study||1
8324940|NCT01399827|20523197|P1|COMPLETED|Overall Study||1
8324941|NCT01399827|20523196|P2|STARTED|Overall Study||1
8324942|NCT01399827|20523197|P1|STARTED|Overall Study||1
8324943|NCT01399788|20523211|P2|NOT COMPLETED|Second Intervention Period||0
8324944|NCT01399788|20523212|P1|NOT COMPLETED|Second Intervention Period||0
8324945|NCT01399788|20523211|P2|COMPLETED|Second Intervention Period||18
8324946|NCT01399788|20523212|P1|COMPLETED|Second Intervention Period||17
8324947|NCT01399788|20523211|P2|STARTED|Second Intervention Period||18
8324948|NCT01399788|20523212|P1|STARTED|Second Intervention Period||17
8324949|NCT01399788|20523211|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
8324950|NCT01399788|20523212|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
8324951|NCT01399788|20523211|P2|COMPLETED|Washout Period (at Least 1 Week)||18
8324952|NCT01399788|20523212|P1|COMPLETED|Washout Period (at Least 1 Week)||17
8324953|NCT01399788|20523211|P2|STARTED|Washout Period (at Least 1 Week)||18
8324954|NCT01399788|20523212|P1|STARTED|Washout Period (at Least 1 Week)||17
8324955|NCT01399788|20523211|P2|NOT COMPLETED|First Intervention Period||0
8324956|NCT01399788|20523212|P1|NOT COMPLETED|First Intervention Period||1
8324957|NCT01399788|20523211|P2|COMPLETED|First Intervention Period||18
8324958|NCT01399788|20523212|P1|COMPLETED|First Intervention Period||17
8324959|NCT01399788|20523211|P2|STARTED|First Intervention Period||18
8324960|NCT01399788|20523212|P1|STARTED|First Intervention Period||18
8324961|NCT01399736|20523234|P2|NOT COMPLETED|Overall Study||4
8324962|NCT01399736|20523235|P1|NOT COMPLETED|Overall Study||4
8324963|NCT01399736|20523234|P2|COMPLETED|Overall Study||586
8324964|NCT01399736|20523235|P1|COMPLETED|Overall Study||291
8324965|NCT01399736|20523234|P2|STARTED|Overall Study||590
8324966|NCT01399736|20523235|P1|STARTED|Overall Study||295
8324967|NCT01399723|20523311|P2|NOT COMPLETED|Overall Study||1
8324968|NCT01399723|20523312|P1|NOT COMPLETED|Overall Study||0
8324969|NCT01399723|20523311|P2|COMPLETED|Overall Study||263
8324970|NCT01399723|20523312|P1|COMPLETED|Overall Study||263
8324971|NCT01399723|20523311|P2|STARTED|Overall Study||264
8324972|NCT01399723|20523312|P1|STARTED|Overall Study||263
8324973|NCT01399697|20523325|P3|NOT COMPLETED|Overall Study||4
8324974|NCT01399697|20523326|P2|NOT COMPLETED|Overall Study||3
8324975|NCT01399697|20523327|P1|NOT COMPLETED|Overall Study||41
8324976|NCT01399697|20523325|P3|COMPLETED|Overall Study||78
8324977|NCT01399697|20523326|P2|COMPLETED|Overall Study||80
8324978|NCT01399697|20523327|P1|COMPLETED|Overall Study||55
8324979|NCT01399697|20523325|P3|STARTED|Overall Study||82
8324980|NCT01399697|20523326|P2|STARTED|Overall Study||83
8324981|NCT01399697|20523327|P1|STARTED|Overall Study||96
8324982|NCT01399619|20523354|P4|NOT COMPLETED|Overall Study||17
8324983|NCT01399619|20523355|P3|NOT COMPLETED|Overall Study||12
8324984|NCT01399619|20523356|P2|NOT COMPLETED|Overall Study||0
8324985|NCT01399619|20523357|P1|NOT COMPLETED|Overall Study||25
8324986|NCT01399619|20523354|P4|COMPLETED|Overall Study||0
8324987|NCT01399619|20523355|P3|COMPLETED|Overall Study||74
8324988|NCT01399619|20523356|P2|COMPLETED|Overall Study||84
8324989|NCT01399619|20523357|P1|COMPLETED|Overall Study||98
8324990|NCT01399619|20523354|P4|STARTED|Overall Study||17
8324991|NCT01399619|20523355|P3|STARTED|Overall Study||86
8324992|NCT01399619|20523356|P2|STARTED|Overall Study||84
8324993|NCT01399619|20523357|P1|STARTED|Overall Study||123
8324994|NCT01399593|20523420|P2|NOT COMPLETED|Overall Study||2
8324995|NCT01399593|20523421|P1|NOT COMPLETED|Overall Study||3
8324996|NCT01399593|20523420|P2|COMPLETED|Overall Study||49
8324997|NCT01399593|20523421|P1|COMPLETED|Overall Study||48
8324998|NCT01399593|20523420|P2|STARTED|Overall Study||51
8324999|NCT01399593|20523421|P1|STARTED|Overall Study||51
8325000|NCT01399268|20523429|P2|NOT COMPLETED|Overall Study||0
8325001|NCT01399268|20523430|P1|NOT COMPLETED|Overall Study||0
8325002|NCT01399268|20523429|P2|COMPLETED|Overall Study||15
8325003|NCT01399268|20523430|P1|COMPLETED|Overall Study||15
8325004|NCT01399268|20523429|P2|STARTED|Overall Study||15
8325005|NCT01399268|20523430|P1|STARTED|Overall Study||15
8325006|NCT01399229|20523448|P3|NOT COMPLETED|Overall Study||0
8325007|NCT01399229|20523449|P2|NOT COMPLETED|Overall Study||0
8325008|NCT01399229|20523450|P1|NOT COMPLETED|Overall Study||0
8325009|NCT01399229|20523448|P3|COMPLETED|Overall Study||5
8325010|NCT01399229|20523449|P2|COMPLETED|Overall Study||5
8325011|NCT01399229|20523450|P1|COMPLETED|Overall Study||20
8325012|NCT01399229|20523448|P3|STARTED|Overall Study||5
8325013|NCT01399229|20523449|P2|STARTED|Overall Study||5
8325014|NCT01399229|20523450|P1|STARTED|Overall Study||20
8325015|NCT01399190|20523454|P1|NOT COMPLETED|Overall Study||20
8325016|NCT01399190|20523454|P1|COMPLETED|Overall Study||48
8325017|NCT01399190|20523454|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
8325018|NCT01399190|20523454|P1|Included in Final Analysis|Overall Study||63
8325019|NCT01399190|20523454|P1|STARTED|Overall Study||68
8325020|NCT01399125|20523462|P2|NOT COMPLETED|Overall Study||60
8325021|NCT01399125|20523463|P1|NOT COMPLETED|Overall Study||51
8325022|NCT01399125|20523462|P2|COMPLETED|Overall Study||193
8325023|NCT01399125|20523463|P1|COMPLETED|Overall Study||197
8325024|NCT01399125|20523462|P2|Per Protocol (PP) Population|Overall Study||188
8325025|NCT01399125|20523463|P1|Per Protocol (PP) Population|Overall Study||192
8325026|NCT01399125|20523462|P2|STARTED|Overall Study||253
8325027|NCT01399125|20523463|P1|STARTED|Overall Study||248
8325028|NCT01399099|20523477|P1|NOT COMPLETED|Overall Study||31
8325029|NCT01399099|20523477|P1|COMPLETED|Overall Study||36
8325030|NCT01399099|20523477|P1|6 Months|Overall Study||47
8325031|NCT01399099|20523477|P1|STARTED|Overall Study||67
8325032|NCT01399047|20523484|P2|NOT COMPLETED|Overall Study||1
8325033|NCT01399047|20523485|P1|NOT COMPLETED|Overall Study||0
8325034|NCT01399047|20523484|P2|COMPLETED|Overall Study||8
8325035|NCT01399047|20523485|P1|COMPLETED|Overall Study||10
8325036|NCT01399047|20523484|P2|STARTED|Overall Study||9
8325037|NCT01399047|20523485|P1|STARTED|Overall Study||10
8325038|NCT01399008|20523502|P3|NOT COMPLETED|Overall Study||2
8325039|NCT01399008|20523503|P2|NOT COMPLETED|Overall Study||5
8325040|NCT01399008|20523504|P1|NOT COMPLETED|Overall Study||3
8325041|NCT01399008|20523502|P3|COMPLETED|Overall Study||31
8325042|NCT01399008|20523503|P2|COMPLETED|Overall Study||27
8325043|NCT01399008|20523504|P1|COMPLETED|Overall Study||32
8325044|NCT01399008|20523502|P3|STARTED|Overall Study||33
8325045|NCT01399008|20523503|P2|STARTED|Overall Study||32
8325046|NCT01399008|20523504|P1|STARTED|Overall Study||35
8325047|NCT01398982|20523514|P2|NOT COMPLETED|Overall Study||2
8325048|NCT01398982|20523515|P1|NOT COMPLETED|Overall Study||6
8325049|NCT01398982|20523514|P2|COMPLETED|Overall Study||47
8325050|NCT01398982|20523515|P1|COMPLETED|Overall Study||38
8325051|NCT01398982|20523514|P2|STARTED|Overall Study||49
8325052|NCT01398982|20523515|P1|STARTED|Overall Study||44
8325053|NCT01398956|20523521|P1|NOT COMPLETED|Overall Study||10
8325054|NCT01398956|20523521|P1|COMPLETED|Overall Study||34
8325055|NCT01398956|20523521|P1|STARTED|Overall Study||44
8325056|NCT01398943|20523529|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8325057|NCT01398943|20523530|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8325058|NCT01398943|20523531|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8325059|NCT01398943|20523532|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8325060|NCT01398943|20523529|P4|COMPLETED|Second Intervention (1 Day)||15
8325061|NCT01398943|20523530|P3|COMPLETED|Second Intervention (1 Day)||15
8325062|NCT01398943|20523531|P2|COMPLETED|Second Intervention (1 Day)||15
8325063|NCT01398943|20523532|P1|COMPLETED|Second Intervention (1 Day)||15
8325064|NCT01398943|20523529|P4|STARTED|Second Intervention (1 Day)||15
8325065|NCT01398943|20523530|P3|STARTED|Second Intervention (1 Day)||15
8325066|NCT01398943|20523531|P2|STARTED|Second Intervention (1 Day)||15
8325067|NCT01398943|20523532|P1|STARTED|Second Intervention (1 Day)||15
8325068|NCT01398943|20523529|P4|NOT COMPLETED|Washout (2-7 Days)||0
8325069|NCT01398943|20523530|P3|NOT COMPLETED|Washout (2-7 Days)||0
8325070|NCT01398943|20523531|P2|NOT COMPLETED|Washout (2-7 Days)||0
8325071|NCT01398943|20523532|P1|NOT COMPLETED|Washout (2-7 Days)||0
8325072|NCT01398943|20523529|P4|COMPLETED|Washout (2-7 Days)||15
8325073|NCT01398943|20523530|P3|COMPLETED|Washout (2-7 Days)||15
8325074|NCT01398943|20523531|P2|COMPLETED|Washout (2-7 Days)||15
8325075|NCT01398943|20523532|P1|COMPLETED|Washout (2-7 Days)||15
8325076|NCT01398943|20523529|P4|STARTED|Washout (2-7 Days)||15
8325077|NCT01398943|20523530|P3|STARTED|Washout (2-7 Days)||15
8325078|NCT01398943|20523531|P2|STARTED|Washout (2-7 Days)||15
8325079|NCT01398943|20523532|P1|STARTED|Washout (2-7 Days)||15
8325080|NCT01398943|20523529|P4|NOT COMPLETED|First Intervention (1 Day)||0
8325081|NCT01398943|20523530|P3|NOT COMPLETED|First Intervention (1 Day)||0
8325082|NCT01398943|20523531|P2|NOT COMPLETED|First Intervention (1 Day)||0
8325083|NCT01398943|20523532|P1|NOT COMPLETED|First Intervention (1 Day)||0
8325084|NCT01398943|20523529|P4|COMPLETED|First Intervention (1 Day)||15
8325085|NCT01398943|20523530|P3|COMPLETED|First Intervention (1 Day)||15
8325086|NCT01398943|20523531|P2|COMPLETED|First Intervention (1 Day)||15
8325087|NCT01398943|20523532|P1|COMPLETED|First Intervention (1 Day)||15
8325088|NCT01398943|20523529|P4|STARTED|First Intervention (1 Day)||15
8325089|NCT01398943|20523530|P3|STARTED|First Intervention (1 Day)||15
8325090|NCT01398943|20523531|P2|STARTED|First Intervention (1 Day)||15
8325091|NCT01398943|20523532|P1|STARTED|First Intervention (1 Day)||15
8325092|NCT01398852|20523540|P1|NOT COMPLETED|Overall Study||372
8325093|NCT01398852|20523540|P1|COMPLETED|Overall Study||0
8325094|NCT01398852|20523540|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
8325095|NCT01398839|20523546|P2|NOT COMPLETED|Overall Study||0
8325096|NCT01398839|20523547|P1|NOT COMPLETED|Overall Study||0
8325097|NCT01398839|20523546|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
8325098|NCT01398839|20523547|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
8325099|NCT01398839|20523546|P2|STARTED|Overall Study||37
8325100|NCT01398839|20523547|P1|STARTED|Overall Study||35
8325101|NCT01398787|20523553|P1|NOT COMPLETED|Overall Study||1
8325102|NCT01398787|20523553|P1|COMPLETED|Overall Study||197
8325103|NCT01398787|20523553|P1|STARTED|Overall Study||198
8325104|NCT01398514|20523571|P2|NOT COMPLETED|Overall Study||6
8325105|NCT01398514|20523572|P1|NOT COMPLETED|Overall Study||8
8325106|NCT01398514|20523571|P2|COMPLETED|Overall Study||20
8325107|NCT01398514|20523572|P1|COMPLETED|Overall Study||18
8325108|NCT01398514|20523571|P2|STARTED|Overall Study||26
8325109|NCT01398514|20523572|P1|STARTED|Overall Study||26
8325110|NCT01398475|20523584|P4|NOT COMPLETED|Overall Study||0
8325111|NCT01398475|20523585|P3|NOT COMPLETED|Overall Study||0
8325112|NCT01398475|20523586|P2|NOT COMPLETED|Overall Study||0
8325113|NCT01398475|20523587|P1|NOT COMPLETED|Overall Study||0
8325114|NCT01398475|20523584|P4|COMPLETED|Overall Study||4
8325115|NCT01398475|20523585|P3|COMPLETED|Overall Study||4
8325116|NCT01398475|20523586|P2|COMPLETED|Overall Study||3
8325117|NCT01398475|20523587|P1|COMPLETED|Overall Study||4
8325118|NCT01398475|20523584|P4|Received Fourth Intervention|Overall Study||4
8325119|NCT01398475|20523585|P3|Received Fourth Intervention|Overall Study||4
8325120|NCT01398475|20523586|P2|Received Fourth Intervention|Overall Study||3
8325121|NCT01398475|20523587|P1|Received Fourth Intervention|Overall Study||4
8325122|NCT01398475|20523584|P4|Received Third Intervention|Overall Study||4
8325123|NCT01398475|20523585|P3|Received Third Intervention|Overall Study||4
8325124|NCT01398475|20523586|P2|Received Third Intervention|Overall Study||3
8325125|NCT01398475|20523587|P1|Received Third Intervention|Overall Study||4
8325126|NCT01398475|20523584|P4|Received Second Intervention|Overall Study||4
8325127|NCT01398475|20523585|P3|Received Second Intervention|Overall Study||4
8325128|NCT01398475|20523586|P2|Received Second Intervention|Overall Study||3
8325129|NCT01398475|20523587|P1|Received Second Intervention|Overall Study||4
8325130|NCT01398475|20523584|P4|Received First Intervention|Overall Study||4
8325131|NCT01398475|20523585|P3|Received First Intervention|Overall Study||4
8325132|NCT01398475|20523586|P2|Received First Intervention|Overall Study||3
8325133|NCT01398475|20523587|P1|Received First Intervention|Overall Study||4
8325134|NCT01398475|20523584|P4|STARTED|Overall Study||4
8325135|NCT01398475|20523585|P3|STARTED|Overall Study||4
8325136|NCT01398475|20523586|P2|STARTED|Overall Study||3
8325137|NCT01398475|20523587|P1|STARTED|Overall Study||4
8325138|NCT01398410|20523607|P2|NOT COMPLETED|Overall Study||56
8325139|NCT01398410|20523608|P1|NOT COMPLETED|Overall Study||58
8325140|NCT01398410|20523607|P2|COMPLETED|Overall Study||148
8325141|NCT01398410|20523608|P1|COMPLETED|Overall Study||143
8325142|NCT01398410|20523607|P2|STARTED|Overall Study||204
8325143|NCT01398410|20523608|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
8325144|NCT01398358|20523619|P3|NOT COMPLETED|Overall Study||21
8325145|NCT01398358|20523620|P2|NOT COMPLETED|Overall Study||23
8325146|NCT01398358|20523621|P1|NOT COMPLETED|Overall Study||15
8325147|NCT01398358|20523619|P3|COMPLETED|Overall Study||234
8325148|NCT01398358|20523620|P2|COMPLETED|Overall Study||201
8325149|NCT01398358|20523621|P1|COMPLETED|Overall Study||203
8325150|NCT01398358|20523619|P3|STARTED|Overall Study||255
8325151|NCT01398358|20523620|P2|STARTED|Overall Study||224
8325152|NCT01398358|20523621|P1|STARTED|Overall Study||218
8325153|NCT01398280|20523634|P2|NOT COMPLETED|Overall Study||0
8325154|NCT01398280|20523635|P1|NOT COMPLETED|Overall Study||4
8325155|NCT01398280|20523634|P2|COMPLETED|Overall Study||4
8325156|NCT01398280|20523635|P1|COMPLETED|Overall Study||7
8325157|NCT01398280|20523634|P2|STARTED|Overall Study||4
8325158|NCT01398280|20523635|P1|STARTED|Overall Study||11
8325159|NCT01398176|20523643|P2|NOT COMPLETED|Overall Study||6
8325160|NCT01398176|20523644|P1|NOT COMPLETED|Overall Study||3
8325161|NCT01398176|20523643|P2|COMPLETED|Overall Study||19
8325162|NCT01398176|20523644|P1|COMPLETED|Overall Study||23
8325163|NCT01398176|20523643|P2|STARTED|Overall Study||25
8325164|NCT01398176|20523644|P1|STARTED|Overall Study||26
8325165|NCT01398059|20523650|P6|NOT COMPLETED|Overall Study||0
8325166|NCT01398059|20523651|P5|NOT COMPLETED|Overall Study||0
8325167|NCT01398059|20523652|P4|NOT COMPLETED|Overall Study||0
8325168|NCT01398059|20523653|P3|NOT COMPLETED|Overall Study||0
8325169|NCT01398059|20523654|P2|NOT COMPLETED|Overall Study||0
8325170|NCT01398059|20523655|P1|NOT COMPLETED|Overall Study||0
8325171|NCT01398059|20523650|P6|COMPLETED|Overall Study||2
8325172|NCT01398059|20523651|P5|COMPLETED|Overall Study||4
8325173|NCT01398059|20523652|P4|COMPLETED|Overall Study||2
8325174|NCT01398059|20523653|P3|COMPLETED|Overall Study||4
8325175|NCT01398059|20523654|P2|COMPLETED|Overall Study||3
8325176|NCT01398059|20523655|P1|COMPLETED|Overall Study||4
8325177|NCT01398059|20523650|P6|STARTED|Overall Study||2
8325178|NCT01398059|20523651|P5|STARTED|Overall Study||4
8325179|NCT01398059|20523652|P4|STARTED|Overall Study||2
8325180|NCT01398059|20523653|P3|STARTED|Overall Study||4
8325181|NCT01398059|20523654|P2|STARTED|Overall Study||3
8325182|NCT01398059|20523655|P1|STARTED|Overall Study||4
8325183|NCT01397890|20523677|P2|NOT COMPLETED|Overall Study||31
8325184|NCT01397890|20523678|P1|NOT COMPLETED|Overall Study||23
8325185|NCT01397890|20523677|P2|COMPLETED|Overall Study||260
8325186|NCT01397890|20523678|P1|COMPLETED|Overall Study||264
8325187|NCT01397890|20523677|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
8325188|NCT01397890|20523678|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
8325189|NCT01397890|20523677|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
8325190|NCT01397890|20523678|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
8325191|NCT01397890|20523677|P2|STARTED|Overall Study||291
8325192|NCT01397890|20523678|P1|STARTED|Overall Study||287
8325193|NCT01397851|20523732|P2|NOT COMPLETED|Overall Study||46
8325194|NCT01397851|20523733|P1|NOT COMPLETED|Overall Study||79
8325195|NCT01397851|20523732|P2|COMPLETED|Overall Study||39917
8325196|NCT01397851|20523733|P1|COMPLETED|Overall Study||41555
8325197|NCT01397851|20523732|P2|STARTED|Overall Study||39963
8325198|NCT01397851|20523733|P1|STARTED|Overall Study||41634
8325199|NCT01397825|20523749|P5|NOT COMPLETED|Overall Study||0
8325200|NCT01397825|20523750|P4|NOT COMPLETED|Overall Study||3
8325201|NCT01397825|20523751|P3|NOT COMPLETED|Overall Study||25
8325202|NCT01397825|20523752|P2|NOT COMPLETED|Overall Study||4
8325203|NCT01397825|20523753|P1|NOT COMPLETED|Overall Study||13
8325204|NCT01397825|20523749|P5|COMPLETED|Overall Study||0
8325205|NCT01397825|20523750|P4|COMPLETED|Overall Study||0
8325206|NCT01397825|20523751|P3|COMPLETED|Overall Study||0
8325207|NCT01397825|20523752|P2|COMPLETED|Overall Study||0
8325208|NCT01397825|20523753|P1|COMPLETED|Overall Study||0
8325209|NCT01397825|20523749|P5|STARTED|Overall Study||0
8325210|NCT01397825|20523750|P4|STARTED|Overall Study||3
8325211|NCT01397825|20523751|P3|STARTED|Overall Study||25
8325212|NCT01397825|20523752|P2|STARTED|Overall Study||4
8325213|NCT01397825|20523753|P1|STARTED|Overall Study||13
8325214|NCT01397786|20523823|P3|NOT COMPLETED|Phase B||138
8325215|NCT01397786|20523824|P2|NOT COMPLETED|Phase B||95
8325216|NCT01397786|20523825|P1|NOT COMPLETED|Phase B||303
8325217|NCT01397786|20523823|P3|COMPLETED|Phase B||91
8325218|NCT01397786|20523824|P2|COMPLETED|Phase B||109
8325219|NCT01397786|20523825|P1|COMPLETED|Phase B||308
8325220|NCT01397786|20523823|P3|STARTED|Phase B||229
8325221|NCT01397786|20523824|P2|STARTED|Phase B||204
8325222|NCT01397786|20523825|P1|STARTED|Phase B||611
8325223|NCT01397786|20523823|P3|NOT COMPLETED|Phase A||28
8325224|NCT01397786|20523824|P2|NOT COMPLETED|Phase A||0
8325225|NCT01397786|20523825|P1|NOT COMPLETED|Phase A||0
8325226|NCT01397786|20523823|P3|COMPLETED|Phase A||199
8325227|NCT01397786|20523824|P2|COMPLETED|Phase A||0
8325228|NCT01397786|20523825|P1|COMPLETED|Phase A||12
8325229|NCT01397786|20523823|P3|STARTED|Phase A||227
8325230|NCT01397786|20523824|P2|STARTED|Phase A||0
8325231|NCT01397786|20523825|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
8325232|NCT01397747|20523891|P1|NOT COMPLETED|Overall Study||1027
8325233|NCT01397747|20523891|P1|COMPLETED|Overall Study||9989
8325234|NCT01397747|20523891|P1|STARTED|Overall Study||11016
8325235|NCT01397695|20523896|P1|NOT COMPLETED|Overall Study||0
8325236|NCT01397695|20523896|P1|COMPLETED|Overall Study||0
8325237|NCT01397695|20523896|P1|STARTED|Overall Study||0
8325238|NCT01397656|20523902|P2|NOT COMPLETED|Overall Study||0
8325239|NCT01397656|20523903|P1|NOT COMPLETED|Overall Study||0
8325240|NCT01397656|20523902|P2|COMPLETED|Overall Study||30
8325241|NCT01397656|20523903|P1|COMPLETED|Overall Study||33
8325242|NCT01397656|20523902|P2|STARTED|Overall Study||30
8325243|NCT01397656|20523903|P1|STARTED|Overall Study||33
8325244|NCT01397617|20523918|P3|NOT COMPLETED|Overall Study||29
8325245|NCT01397617|20523919|P2|NOT COMPLETED|Overall Study||23
8325246|NCT01397617|20523920|P1|NOT COMPLETED|Overall Study||31
8325247|NCT01397617|20523918|P3|COMPLETED|Overall Study||31
8325248|NCT01397617|20523919|P2|COMPLETED|Overall Study||30
8325249|NCT01397617|20523920|P1|COMPLETED|Overall Study||33
8325250|NCT01397617|20523918|P3|STARTED|Overall Study||60
8325251|NCT01397617|20523919|P2|STARTED|Overall Study||53
8325252|NCT01397617|20523920|P1|STARTED|Overall Study||64
8325253|NCT01397591|20523931|P1|NOT COMPLETED|Overall Study||0
8325254|NCT01397591|20523931|P1|COMPLETED|Overall Study||2
8325255|NCT01397591|20523931|P1|STARTED|Overall Study||2
8325256|NCT01397552|20523941|P2|NOT COMPLETED|Overall Study||1
8325257|NCT01397552|20523942|P1|NOT COMPLETED|Overall Study||3
8325258|NCT01397552|20523941|P2|COMPLETED|Overall Study||3
8325259|NCT01397552|20523942|P1|COMPLETED|Overall Study||1
8325260|NCT01397552|20523941|P2|STARTED|Overall Study||4
8325261|NCT01397552|20523942|P1|STARTED|Overall Study||4
8325262|NCT01397461|20523951|P3|NOT COMPLETED|Overall Study||2
8325263|NCT01397461|20523952|P2|NOT COMPLETED|Overall Study||6
8325264|NCT01397461|20523953|P1|NOT COMPLETED|Overall Study||2
8325265|NCT01397461|20523951|P3|COMPLETED|Overall Study||152
8325266|NCT01397461|20523952|P2|COMPLETED|Overall Study||150
8325267|NCT01397461|20523953|P1|COMPLETED|Overall Study||153
8325268|NCT01397461|20523951|P3|STARTED|Overall Study||154
8325269|NCT01397461|20523952|P2|STARTED|Overall Study||156
8325270|NCT01397461|20523953|P1|STARTED|Overall Study||155
8325271|NCT01397448|20523964|P3|NOT COMPLETED|Overall Study||18
8325272|NCT01397448|20523965|P2|NOT COMPLETED|Overall Study||15
8325273|NCT01397448|20523966|P1|NOT COMPLETED|Overall Study||18
8325274|NCT01397448|20523964|P3|COMPLETED|Overall Study||140
8325275|NCT01397448|20523965|P2|COMPLETED|Overall Study||142
8325276|NCT01397448|20523966|P1|COMPLETED|Overall Study||138
8325277|NCT01397448|20523964|P3|STARTED|Overall Study||158
8325278|NCT01397448|20523965|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
8325279|NCT01397448|20523966|P1|STARTED|Overall Study||156
8325280|NCT01397422|20523981|P4|NOT COMPLETED|Overall Study||8
8325281|NCT01397422|20523982|P3|NOT COMPLETED|Overall Study||3
8325282|NCT01397422|20523983|P2|NOT COMPLETED|Overall Study||3
8325283|NCT01397422|20523984|P1|NOT COMPLETED|Overall Study||2
8325284|NCT01397422|20523981|P4|COMPLETED|Overall Study||12
8325285|NCT01397422|20523982|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
8325286|NCT01397422|20523983|P2|COMPLETED|Overall Study||17
8325287|NCT01397422|20523984|P1|COMPLETED|Overall Study||20
8325288|NCT01397422|20523981|P4|STARTED|Overall Study||20
8325289|NCT01397422|20523982|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
8325290|NCT01397422|20523983|P2|STARTED|Overall Study||20
8325291|NCT01397422|20523984|P1|STARTED|Overall Study||22
8325292|NCT01397409|20524024|P10|NOT COMPLETED|Stage 3||0
8325293|NCT01397409|20524025|P9|NOT COMPLETED|Stage 3||0
8325294|NCT01397409|20524026|P8|NOT COMPLETED|Stage 3||2
8325295|NCT01397409|20524027|P7|NOT COMPLETED|Stage 3||0
8325296|NCT01397409|20524028|P6|NOT COMPLETED|Stage 3||0
8325297|NCT01397409|20524029|P5|NOT COMPLETED|Stage 3||0
8325298|NCT01397409|20524030|P4|NOT COMPLETED|Stage 3||0
8325299|NCT01397409|20524031|P3|NOT COMPLETED|Stage 3||0
8325300|NCT01397409|20524032|P2|NOT COMPLETED|Stage 3||0
8325301|NCT01397409|20524033|P1|NOT COMPLETED|Stage 3||0
8325302|NCT01397409|20524024|P10|COMPLETED|Stage 3||16
8325303|NCT01397409|20524025|P9|COMPLETED|Stage 3||25
8325304|NCT01397409|20524026|P8|COMPLETED|Stage 3||21
8325305|NCT01397409|20524027|P7|COMPLETED|Stage 3||0
8325306|NCT01397409|20524028|P6|COMPLETED|Stage 3||0
8325307|NCT01397409|20524029|P5|COMPLETED|Stage 3||0
8325308|NCT01397409|20524030|P4|COMPLETED|Stage 3||0
8325309|NCT01397409|20524031|P3|COMPLETED|Stage 3||0
8325310|NCT01397409|20524032|P2|COMPLETED|Stage 3||0
8325311|NCT01397409|20524033|P1|COMPLETED|Stage 3||0
8325312|NCT01397409|20524024|P10|STARTED|Stage 3||16
8325313|NCT01397409|20524025|P9|STARTED|Stage 3||25
8325314|NCT01397409|20524026|P8|STARTED|Stage 3||23
8325315|NCT01397409|20524027|P7|STARTED|Stage 3||0
8325316|NCT01397409|20524028|P6|STARTED|Stage 3||0
8325317|NCT01397409|20524029|P5|STARTED|Stage 3||0
8325318|NCT01397409|20524030|P4|STARTED|Stage 3||0
8325319|NCT01397409|20524031|P3|STARTED|Stage 3||0
8325320|NCT01397409|20524032|P2|STARTED|Stage 3||0
8325321|NCT01397409|20524033|P1|STARTED|Stage 3||0
8325322|NCT01397409|20524024|P10|NOT COMPLETED|Stage 2||0
8325323|NCT01397409|20524025|P9|NOT COMPLETED|Stage 2||0
8325324|NCT01397409|20524026|P8|NOT COMPLETED|Stage 2||0
8325325|NCT01397409|20524027|P7|NOT COMPLETED|Stage 2||0
8325326|NCT01397409|20524028|P6|NOT COMPLETED|Stage 2||4
8325327|NCT01397409|20524029|P5|NOT COMPLETED|Stage 2||8
8325328|NCT01397409|20524030|P4|NOT COMPLETED|Stage 2||0
8325329|NCT01397409|20524031|P3|NOT COMPLETED|Stage 2||0
8325330|NCT01397409|20524032|P2|NOT COMPLETED|Stage 2||0
8325331|NCT01397409|20524033|P1|NOT COMPLETED|Stage 2||0
8325332|NCT01397409|20524024|P10|COMPLETED|Stage 2||0
8325333|NCT01397409|20524025|P9|COMPLETED|Stage 2||0
8325334|NCT01397409|20524026|P8|COMPLETED|Stage 2||0
8325335|NCT01397409|20524027|P7|COMPLETED|Stage 2||58
8325336|NCT01397409|20524028|P6|COMPLETED|Stage 2||54
8325337|NCT01397409|20524029|P5|COMPLETED|Stage 2||59
8325338|NCT01397409|20524030|P4|COMPLETED|Stage 2||0
8325339|NCT01397409|20524031|P3|COMPLETED|Stage 2||0
8325340|NCT01397409|20524032|P2|COMPLETED|Stage 2||0
8325341|NCT01397409|20524033|P1|COMPLETED|Stage 2||0
8325342|NCT01397409|20524024|P10|STARTED|Stage 2||0
8325343|NCT01397409|20524025|P9|STARTED|Stage 2||0
8325344|NCT01397409|20524026|P8|STARTED|Stage 2||0
8325345|NCT01397409|20524027|P7|STARTED|Stage 2||58
8325346|NCT01397409|20524028|P6|STARTED|Stage 2||58
8325347|NCT01397409|20524029|P5|STARTED|Stage 2||67
8325348|NCT01397409|20524030|P4|STARTED|Stage 2||0
8325349|NCT01397409|20524031|P3|STARTED|Stage 2||0
8325350|NCT01397409|20524032|P2|STARTED|Stage 2||0
8325351|NCT01397409|20524033|P1|STARTED|Stage 2||0
8325352|NCT01397409|20524024|P10|NOT COMPLETED|Stage 1||0
8325353|NCT01397409|20524025|P9|NOT COMPLETED|Stage 1||0
8325354|NCT01397409|20524026|P8|NOT COMPLETED|Stage 1||0
8325355|NCT01397409|20524027|P7|NOT COMPLETED|Stage 1||0
8325356|NCT01397409|20524028|P6|NOT COMPLETED|Stage 1||0
8325357|NCT01397409|20524029|P5|NOT COMPLETED|Stage 1||0
8325358|NCT01397409|20524030|P4|NOT COMPLETED|Stage 1||0
8325359|NCT01397409|20524031|P3|NOT COMPLETED|Stage 1||0
8325360|NCT01397409|20524032|P2|NOT COMPLETED|Stage 1||0
8325361|NCT01397409|20524033|P1|NOT COMPLETED|Stage 1||0
8325362|NCT01397409|20524024|P10|COMPLETED|Stage 1||0
8325363|NCT01397409|20524025|P9|COMPLETED|Stage 1||0
8325364|NCT01397409|20524026|P8|COMPLETED|Stage 1||0
8325365|NCT01397409|20524027|P7|COMPLETED|Stage 1||0
8325366|NCT01397409|20524028|P6|COMPLETED|Stage 1||0
8325367|NCT01397409|20524029|P5|COMPLETED|Stage 1||0
8325368|NCT01397409|20524030|P4|COMPLETED|Stage 1||3
8325369|NCT01397409|20524031|P3|COMPLETED|Stage 1||6
8325370|NCT01397409|20524032|P2|COMPLETED|Stage 1||6
8325371|NCT01397409|20524033|P1|COMPLETED|Stage 1||9
8325372|NCT01397409|20524024|P10|STARTED|Stage 1||0
8325373|NCT01397409|20524025|P9|STARTED|Stage 1||0
8325374|NCT01397409|20524026|P8|STARTED|Stage 1||0
8325375|NCT01397409|20524027|P7|STARTED|Stage 1||0
8325376|NCT01397409|20524028|P6|STARTED|Stage 1||0
8325377|NCT01397409|20524029|P5|STARTED|Stage 1||0
8325378|NCT01397409|20524030|P4|STARTED|Stage 1||3
8325379|NCT01397409|20524031|P3|STARTED|Stage 1||6
8325380|NCT01397409|20524032|P2|STARTED|Stage 1||6
8325381|NCT01397409|20524033|P1|STARTED|Stage 1||9
8325382|NCT01397253|20524073|P2|NOT COMPLETED|Overall Study||149
8325383|NCT01397253|20524074|P1|NOT COMPLETED|Overall Study||126
8325384|NCT01397253|20524073|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
8325385|NCT01397253|20524074|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
8325386|NCT01397253|20524073|P2|STARTED|Overall Study||392
8325387|NCT01397253|20524074|P1|STARTED|Overall Study||443
8325388|NCT01397084|20524080|P1|NOT COMPLETED|Overall Study||8
8325389|NCT01397084|20524080|P1|COMPLETED|Overall Study||100
8325390|NCT01397084|20524080|P1|STARTED|Overall Study||108
8325391|NCT01397071|20524087|P1|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
8325392|NCT01397071|20524087|P1|COMPLETED|Consumption of Beef Patty With Avocado||11
8325393|NCT01397071|20524087|P1|STARTED|Consumption of Beef Patty With Avocado||11
8325394|NCT01397071|20524087|P1|NOT COMPLETED|Consumption of Beef Patty Alone||0
8325395|NCT01397071|20524087|P1|COMPLETED|Consumption of Beef Patty Alone||11
8325396|NCT01397071|20524087|P1|STARTED|Consumption of Beef Patty Alone||11
8325397|NCT01396837|20524095|P1|NOT COMPLETED|Overall Study||4
8325398|NCT01396837|20524095|P1|COMPLETED|Overall Study||16
8325399|NCT01396837|20524095|P1|STARTED|Overall Study||20
8325400|NCT01396551|20524102|P1|NOT COMPLETED|Overall Study||0
8325401|NCT01396551|20524102|P1|COMPLETED|Overall Study||69
8325402|NCT01396551|20524102|P1|STARTED|Overall Study||69
8325403|NCT01396525|20524106|P1|NOT COMPLETED|Overall Study||26
8325404|NCT01396525|20524106|P1|COMPLETED|Overall Study||127
8325405|NCT01396525|20524106|P1|STARTED|Overall Study||153
8325406|NCT01396512|20524206|P2|NOT COMPLETED|Overall Study||1
8325407|NCT01396512|20524207|P1|NOT COMPLETED|Overall Study||0
8325408|NCT01396512|20524206|P2|COMPLETED|Overall Study||136
8325409|NCT01396512|20524207|P1|COMPLETED|Overall Study||137
8325410|NCT01396512|20524206|P2|STARTED|Overall Study||137
8325411|NCT01396512|20524207|P1|STARTED|Overall Study||137
8325412|NCT01396486|20524222|P3|NOT COMPLETED|Overall Study||12
8325413|NCT01396486|20524223|P2|NOT COMPLETED|Overall Study||12
8325414|NCT01396486|20524224|P1|NOT COMPLETED|Overall Study||10
8325415|NCT01396486|20524222|P3|COMPLETED|Overall Study||10
8325416|NCT01396486|20524223|P2|COMPLETED|Overall Study||7
8325417|NCT01396486|20524224|P1|COMPLETED|Overall Study||10
8325418|NCT01396486|20524222|P3|Exposed|Overall Study||17
8325419|NCT01396486|20524223|P2|Exposed|Overall Study||16
8325420|NCT01396486|20524224|P1|Exposed|Overall Study||19
8325421|NCT01396486|20524222|P3|STARTED|Overall Study||22
8325422|NCT01396486|20524223|P2|STARTED|Overall Study||19
8325423|NCT01396486|20524224|P1|STARTED|Overall Study||20
8325424|NCT01396447|20524239|P4|NOT COMPLETED|Overall Study||52
8325425|NCT01396447|20524240|P3|NOT COMPLETED|Overall Study||30
8325426|NCT01396447|20524241|P2|NOT COMPLETED|Overall Study||40
8325427|NCT01396447|20524242|P1|NOT COMPLETED|Overall Study||43
8325428|NCT01396447|20524239|P4|COMPLETED|Overall Study||94
8325429|NCT01396447|20524240|P3|COMPLETED|Overall Study||117
8325430|NCT01396447|20524241|P2|COMPLETED|Overall Study||103
8325431|NCT01396447|20524242|P1|COMPLETED|Overall Study||105
8325432|NCT01396447|20524239|P4|Received Treatment|Overall Study||146
8325433|NCT01396447|20524240|P3|Received Treatment|Overall Study||146
8325434|NCT01396447|20524241|P2|Received Treatment|Overall Study||141
8325435|NCT01396447|20524242|P1|Received Treatment|Overall Study||145
8325436|NCT01396447|20524239|P4|STARTED|Overall Study||146
8325437|NCT01396447|20524240|P3|STARTED|Overall Study||147
8325438|NCT01396447|20524241|P2|STARTED|Overall Study||143
8325439|NCT01396447|20524242|P1|STARTED|Overall Study||148
8325440|NCT01396434|20524259|P3|NOT COMPLETED|Overall Study||0
8325441|NCT01396434|20524260|P2|NOT COMPLETED|Overall Study||0
8325442|NCT01396434|20524261|P1|NOT COMPLETED|Overall Study||11
8325443|NCT01396434|20524259|P3|COMPLETED|Overall Study||14
8325444|NCT01396434|20524260|P2|COMPLETED|Overall Study||175
8325445|NCT01396434|20524261|P1|COMPLETED|Overall Study||2806
8325446|NCT01396434|20524259|P3|STARTED|Overall Study||14
8325447|NCT01396434|20524260|P2|STARTED|Overall Study||175
8325448|NCT01396434|20524261|P1|STARTED|Overall Study||2817
8325449|NCT01396421|20524273|P4|NOT COMPLETED|Overall Study||75
8325450|NCT01396421|20524274|P3|NOT COMPLETED|Overall Study||34
8325451|NCT01396421|20524275|P2|NOT COMPLETED|Overall Study||58
8325452|NCT01396421|20524276|P1|NOT COMPLETED|Overall Study||59
8325453|NCT01396421|20524273|P4|COMPLETED|Overall Study||109
8325454|NCT01396421|20524274|P3|COMPLETED|Overall Study||56
8325455|NCT01396421|20524275|P2|COMPLETED|Overall Study||124
8325456|NCT01396421|20524276|P1|COMPLETED|Overall Study||121
8325457|NCT01396421|20524273|P4|STARTED|Overall Study||184
8325458|NCT01396421|20524274|P3|STARTED|Overall Study||90
8325459|NCT01396421|20524275|P2|STARTED|Overall Study||182
8325460|NCT01396421|20524276|P1|STARTED|Overall Study||180
8325461|NCT01396395|20524348|P2|NOT COMPLETED|Overall Study||27
8325462|NCT01396395|20524349|P1|NOT COMPLETED|Overall Study||40
8325463|NCT01396395|20524348|P2|COMPLETED|Overall Study||175
8325464|NCT01396395|20524349|P1|COMPLETED|Overall Study||160
8325465|NCT01396395|20524348|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
8325466|NCT01396395|20524349|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
8325467|NCT01396395|20524348|P2|STARTED|Overall Study||202
8325468|NCT01396395|20524349|P1|STARTED|Overall Study||200
8325469|NCT01396382|20524384|P1|NOT COMPLETED|Overall Study||0
8325470|NCT01396382|20524384|P1|COMPLETED|Overall Study||97
8325471|NCT01396382|20524384|P1|STARTED|Overall Study||97
8325472|NCT01396317|20524391|P2|NOT COMPLETED|Overall Study||0
8325473|NCT01396317|20524392|P1|NOT COMPLETED|Overall Study||1
8325474|NCT01396317|20524391|P2|COMPLETED|Overall Study||10
8325475|NCT01396317|20524392|P1|COMPLETED|Overall Study||9
8325476|NCT01396317|20524391|P2|STARTED|Overall Study||10
8325477|NCT01396317|20524392|P1|STARTED|Overall Study||10
8325478|NCT01396265|20524406|P1|NOT COMPLETED|Rifa+Afatinib||1
8325479|NCT01396265|20524406|P1|COMPLETED|Rifa+Afatinib||21
8325480|NCT01396265|20524406|P1|STARTED|Rifa+Afatinib||22
8325481|NCT01396265|20524406|P1|NOT COMPLETED|Washout||0
8325482|NCT01396265|20524406|P1|COMPLETED|Washout||22
8325483|NCT01396265|20524406|P1|STARTED|Washout||22
8325484|NCT01396265|20524406|P1|NOT COMPLETED|Afatinib||0
8325485|NCT01396265|20524406|P1|COMPLETED|Afatinib||22
8325486|NCT01396265|20524406|P1|STARTED|Afatinib||22
8325487|NCT01396239|20524433|P4|NOT COMPLETED|Overall Study||0
8325488|NCT01396239|20524434|P3|NOT COMPLETED|Overall Study||0
8325489|NCT01396239|20524435|P2|NOT COMPLETED|Overall Study||0
8325490|NCT01396239|20524436|P1|NOT COMPLETED|Overall Study||0
8325491|NCT01396239|20524433|P4|COMPLETED|Overall Study||2
8325492|NCT01396239|20524434|P3|COMPLETED|Overall Study||4
8325493|NCT01396239|20524435|P2|COMPLETED|Overall Study||2
8325494|NCT01396239|20524436|P1|COMPLETED|Overall Study||4
8325495|NCT01396239|20524433|P4|STARTED|Overall Study||2
8325496|NCT01396239|20524434|P3|STARTED|Overall Study||4
8325497|NCT01396239|20524435|P2|STARTED|Overall Study||2
8325498|NCT01396239|20524436|P1|STARTED|Overall Study||4
8325499|NCT01396226|20524459|P2|NOT COMPLETED|Overall Study||0
8325500|NCT01396226|20524460|P1|NOT COMPLETED|Overall Study||0
8325501|NCT01396226|20524459|P2|COMPLETED|Overall Study||6
8325502|NCT01396226|20524460|P1|COMPLETED|Overall Study||12
8325503|NCT01396226|20524459|P2|Patients Who Completed Treatment|Overall Study||6
8325504|NCT01396226|20524460|P1|Patients Who Completed Treatment|Overall Study||12
8325505|NCT01396226|20524459|P2|Patients Who Received Treatment|Overall Study||6
8325506|NCT01396226|20524460|P1|Patients Who Received Treatment|Overall Study||12
8325507|NCT01396226|20524459|P2|STARTED|Overall Study||6
8325508|NCT01396226|20524460|P1|STARTED|Overall Study||12
8325509|NCT01396187|20524495|P5|NOT COMPLETED|Overall Study||1
8325510|NCT01396187|20524496|P4|NOT COMPLETED|Overall Study||0
8325511|NCT01396187|20524497|P3|NOT COMPLETED|Overall Study||1
8325512|NCT01396187|20524498|P2|NOT COMPLETED|Overall Study||3
8325513|NCT01396187|20524499|P1|NOT COMPLETED|Overall Study||1
8325514|NCT01396187|20524495|P5|COMPLETED|Overall Study||9
8325515|NCT01396187|20524496|P4|COMPLETED|Overall Study||10
8325516|NCT01396187|20524497|P3|COMPLETED|Overall Study||9
8325517|NCT01396187|20524498|P2|COMPLETED|Overall Study||9
8325518|NCT01396187|20524499|P1|COMPLETED|Overall Study||7
8325519|NCT01396187|20524495|P5|STARTED|Overall Study||10
8325520|NCT01396187|20524496|P4|STARTED|Overall Study||10
8325521|NCT01396187|20524497|P3|STARTED|Overall Study||10
8325522|NCT01396187|20524498|P2|STARTED|Overall Study||12
8325523|NCT01396187|20524499|P1|STARTED|Overall Study||8
8325524|NCT01396161|20524599|P7|NOT COMPLETED|Overall Study||1
8325525|NCT01396161|20524600|P6|NOT COMPLETED|Overall Study||0
8325526|NCT01396161|20524601|P5|NOT COMPLETED|Overall Study||1
8325527|NCT01396161|20524602|P4|NOT COMPLETED|Overall Study||0
8325528|NCT01396161|20524603|P3|NOT COMPLETED|Overall Study||0
8325529|NCT01396161|20524604|P2|NOT COMPLETED|Overall Study||0
8325530|NCT01396161|20524605|P1|NOT COMPLETED|Overall Study||0
8325531|NCT01396161|20524599|P7|COMPLETED|Overall Study||10
8325532|NCT01396161|20524600|P6|COMPLETED|Overall Study||9
8325533|NCT01396161|20524601|P5|COMPLETED|Overall Study||8
8325534|NCT01396161|20524602|P4|COMPLETED|Overall Study||9
8325535|NCT01396161|20524603|P3|COMPLETED|Overall Study||9
8325536|NCT01396161|20524604|P2|COMPLETED|Overall Study||5
8325537|NCT01396161|20524605|P1|COMPLETED|Overall Study||12
8325538|NCT01396161|20524599|P7|STARTED|Overall Study||11
8325539|NCT01396161|20524600|P6|STARTED|Overall Study||9
8325540|NCT01396161|20524601|P5|STARTED|Overall Study||9
8325541|NCT01396161|20524602|P4|STARTED|Overall Study||9
8325542|NCT01396161|20524603|P3|STARTED|Overall Study||9
8325543|NCT01396161|20524604|P2|STARTED|Overall Study||5
8325544|NCT01396161|20524605|P1|STARTED|Overall Study||12
8325545|NCT01396148|20524658|P1|NOT COMPLETED|Overall Study||1
8325546|NCT01396148|20524658|P1|COMPLETED|Overall Study||5
8325547|NCT01396148|20524658|P1|STARTED|Overall Study||6
8325548|NCT01396083|20524688|P2|NOT COMPLETED|Overall Study||47
8325549|NCT01396083|20524689|P1|NOT COMPLETED|Overall Study||11
8325550|NCT01396083|20524688|P2|COMPLETED|Overall Study||72
8325551|NCT01396083|20524689|P1|COMPLETED|Overall Study||113
8325552|NCT01396083|20524688|P2|STARTED|Overall Study||119
8325553|NCT01396083|20524689|P1|STARTED|Overall Study||124
8325554|NCT01396070|20524713|P1|NOT COMPLETED|Overall Study||19
8325555|NCT01396070|20524713|P1|COMPLETED|Overall Study||17
8325556|NCT01396070|20524713|P1|STARTED|Overall Study||36
8325557|NCT01396057|20524722|P2|NOT COMPLETED|Overall Study||18
8325558|NCT01396057|20524723|P1|NOT COMPLETED|Overall Study||11
8325559|NCT01396057|20524722|P2|COMPLETED|Overall Study||100
8325560|NCT01396057|20524723|P1|COMPLETED|Overall Study||115
8325561|NCT01396057|20524722|P2|STARTED|Overall Study||118
8325562|NCT01396057|20524723|P1|STARTED|Overall Study||126
8325563|NCT01396044|20524749|P2|NOT COMPLETED|Overall Study||0
8325564|NCT01396044|20524750|P1|NOT COMPLETED|Overall Study||0
8325565|NCT01396044|20524749|P2|COMPLETED|Overall Study||171
8325566|NCT01396044|20524750|P1|COMPLETED|Overall Study||125
8325567|NCT01396044|20524749|P2|STARTED|Overall Study||171
8325568|NCT01396044|20524750|P1|STARTED|Overall Study||125
8325569|NCT01396005|20524772|P2|NOT COMPLETED|Overall Study||2
8325570|NCT01396005|20524773|P1|NOT COMPLETED|Overall Study||0
8325571|NCT01396005|20524772|P2|COMPLETED|Overall Study||9
8325572|NCT01396005|20524773|P1|COMPLETED|Overall Study||10
8325573|NCT01396005|20524772|P2|STARTED|Overall Study||11
8325574|NCT01396005|20524773|P1|STARTED|Overall Study||10
8325575|NCT01395966|20524792|P3|NOT COMPLETED|Overall Study||8
8325576|NCT01395966|20524793|P2|NOT COMPLETED|Overall Study||19
8325577|NCT01395966|20524794|P1|NOT COMPLETED|Overall Study||10
8325578|NCT01395966|20524792|P3|COMPLETED|Overall Study||104
8325579|NCT01395966|20524793|P2|COMPLETED|Overall Study||91
8325580|NCT01395966|20524794|P1|COMPLETED|Overall Study||99
8325581|NCT01395966|20524792|P3|STARTED|Overall Study||112
8325582|NCT01395966|20524793|P2|STARTED|Overall Study||110
8325583|NCT01395966|20524794|P1|STARTED|Overall Study||109
8325584|NCT01395914|20524804|P2|NOT COMPLETED|Overall Study||37
8325585|NCT01395914|20524805|P1|NOT COMPLETED|Overall Study||72
8325586|NCT01395914|20524804|P2|COMPLETED|Overall Study||131
8325587|NCT01395914|20524805|P1|COMPLETED|Overall Study||273
8325588|NCT01395914|20524804|P2|Safety Population|Overall Study||167
8325589|NCT01395914|20524805|P1|Safety Population|Overall Study||343
8325590|NCT01395914|20524804|P2|ITT Population|Overall Study||168
8325591|NCT01395914|20524805|P1|ITT Population|Overall Study||345
8325592|NCT01395914|20524804|P2|STARTED|Overall Study||168
8325593|NCT01395914|20524805|P1|STARTED|Overall Study||345
8325594|NCT01395901|20524819|P2|NOT COMPLETED|Overall Study||5
8325595|NCT01395901|20524820|P1|NOT COMPLETED|Overall Study||10
8325596|NCT01395901|20524819|P2|COMPLETED|Overall Study|Treated patients completing the study|329
8325597|NCT01395901|20524820|P1|COMPLETED|Overall Study|Treated patients completing the study|326
8325598|NCT01395901|20524819|P2|STARTED|Overall Study|Randomized Population|334
8325599|NCT01395901|20524820|P1|STARTED|Overall Study|Randomized Population|336
8325600|NCT01395888|20524836|P3|NOT COMPLETED|Treatment Period (TP)||17
8325601|NCT01395888|20524837|P2|NOT COMPLETED|Treatment Period (TP)||15
8325602|NCT01395888|20524838|P1|NOT COMPLETED|Treatment Period (TP)||0
8325603|NCT01395888|20524836|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
8325604|NCT01395888|20524837|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
8325605|NCT01395888|20524838|P1|COMPLETED|Treatment Period (TP)||0
8325606|NCT01395888|20524836|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
8325607|NCT01395888|20524837|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
8325608|NCT01395888|20524838|P1|Completed the Treatment Period|Treatment Period (TP)||0
8325609|NCT01395888|20524836|P3|STARTED|Treatment Period (TP)||130
8325610|NCT01395888|20524837|P2|STARTED|Treatment Period (TP)||127
8325611|NCT01395888|20524838|P1|STARTED|Treatment Period (TP)||0
8325612|NCT01395888|20524836|P3|NOT COMPLETED|2-week Run-in Period||0
8325613|NCT01395888|20524837|P2|NOT COMPLETED|2-week Run-in Period||0
8325614|NCT01395888|20524838|P1|NOT COMPLETED|2-week Run-in Period||22
8325615|NCT01395888|20524836|P3|COMPLETED|2-week Run-in Period||0
8325616|NCT01395888|20524837|P2|COMPLETED|2-week Run-in Period||0
8325617|NCT01395888|20524838|P1|COMPLETED|2-week Run-in Period||257
8325618|NCT01395888|20524836|P3|STARTED|2-week Run-in Period||0
8325619|NCT01395888|20524837|P2|STARTED|2-week Run-in Period||0
8325620|NCT01395888|20524838|P1|STARTED|2-week Run-in Period||279
8325621|NCT01395823|20524846|P2|NOT COMPLETED|Overall Study||9
8325622|NCT01395823|20524847|P1|NOT COMPLETED|Overall Study||15
8325623|NCT01395823|20524846|P2|COMPLETED|Overall Study||130
8325624|NCT01395823|20524847|P1|COMPLETED|Overall Study||122
8325625|NCT01395823|20524846|P2|STARTED|Overall Study||139
8325626|NCT01395823|20524847|P1|STARTED|Overall Study||137
8325627|NCT01395810|20524857|P4|NOT COMPLETED|Overall Study||0
8325628|NCT01395810|20524858|P3|NOT COMPLETED|Overall Study||0
8325629|NCT01395810|20524859|P2|NOT COMPLETED|Overall Study||4
8325630|NCT01395810|20524860|P1|NOT COMPLETED|Overall Study||2
8325631|NCT01395810|20524857|P4|COMPLETED|Overall Study||5
8325632|NCT01395810|20524858|P3|COMPLETED|Overall Study||0
8325633|NCT01395810|20524859|P2|COMPLETED|Overall Study||44
8325634|NCT01395810|20524860|P1|COMPLETED|Overall Study||16
8325635|NCT01395810|20524857|P4|After Switching the Arms|Overall Study||5
8325636|NCT01395810|20524858|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
8325637|NCT01395810|20524859|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
8325638|NCT01395810|20524860|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
8325639|NCT01395810|20524857|P4|STARTED|Overall Study||5
8325640|NCT01395810|20524858|P3|STARTED|Overall Study||0
8325641|NCT01395810|20524859|P2|STARTED|Overall Study||48
8325642|NCT01395810|20524860|P1|STARTED|Overall Study||18
8325643|NCT01395797|20524894|P6|NOT COMPLETED|Overall Study||3
8325644|NCT01395797|20524895|P5|NOT COMPLETED|Overall Study||2
8325645|NCT01395797|20524896|P4|NOT COMPLETED|Overall Study||2
8325646|NCT01395797|20524897|P3|NOT COMPLETED|Overall Study||4
8325647|NCT01395797|20524898|P2|NOT COMPLETED|Overall Study||1
8325648|NCT01395797|20524899|P1|NOT COMPLETED|Overall Study||3
8325649|NCT01395797|20524894|P6|COMPLETED|Overall Study||14
8325650|NCT01395797|20524895|P5|COMPLETED|Overall Study||7
8325651|NCT01395797|20524896|P4|COMPLETED|Overall Study||13
8325652|NCT01395797|20524897|P3|COMPLETED|Overall Study||14
8325653|NCT01395797|20524898|P2|COMPLETED|Overall Study||3
8325654|NCT01395797|20524899|P1|COMPLETED|Overall Study||16
8325655|NCT01395797|20524894|P6|STARTED|Overall Study||17
8325656|NCT01395797|20524895|P5|STARTED|Overall Study||9
8325657|NCT01395797|20524896|P4|STARTED|Overall Study||15
8325658|NCT01395797|20524897|P3|STARTED|Overall Study||18
8325659|NCT01395797|20524898|P2|STARTED|Overall Study||4
8325660|NCT01395797|20524899|P1|STARTED|Overall Study||19
8325661|NCT01395784|20524919|P1|NOT COMPLETED|Overall Study||15
8325662|NCT01395784|20524919|P1|COMPLETED|Overall Study||17
8325663|NCT01395784|20524919|P1|STARTED|Overall Study||32
8325664|NCT01395758|20524926|P3|NOT COMPLETED|Crossover Period||0
8325665|NCT01395758|20524927|P2|NOT COMPLETED|Crossover Period||0
8325666|NCT01395758|20524928|P1|NOT COMPLETED|Crossover Period||0
8325667|NCT01395758|20524926|P3|COMPLETED|Crossover Period||26
8325668|NCT01395758|20524927|P2|COMPLETED|Crossover Period||0
8325669|NCT01395758|20524928|P1|COMPLETED|Crossover Period||0
8325670|NCT01395758|20524926|P3|STARTED|Crossover Period||26
8325671|NCT01395758|20524927|P2|STARTED|Crossover Period||0
8325672|NCT01395758|20524928|P1|STARTED|Crossover Period||0
8325673|NCT01395758|20524926|P3|NOT COMPLETED|Open-label Treatment Period||0
8325674|NCT01395758|20524927|P2|NOT COMPLETED|Open-label Treatment Period||0
8325675|NCT01395758|20524928|P1|NOT COMPLETED|Open-label Treatment Period||4
8325676|NCT01395758|20524926|P3|COMPLETED|Open-label Treatment Period||0
8325677|NCT01395758|20524927|P2|COMPLETED|Open-label Treatment Period||45
8325678|NCT01395758|20524928|P1|COMPLETED|Open-label Treatment Period||47
8325679|NCT01395758|20524926|P3|STARTED|Open-label Treatment Period||0
8325680|NCT01395758|20524927|P2|STARTED|Open-label Treatment Period||45
8325681|NCT01395758|20524928|P1|STARTED|Open-label Treatment Period||51
8325682|NCT01395537|20524939|P1|NOT COMPLETED|Phase II||0
8325683|NCT01395537|20524939|P1|COMPLETED|Phase II||1
8325684|NCT01395537|20524939|P1|STARTED|Phase II||1
8325685|NCT01395537|20524939|P1|NOT COMPLETED|Phase I||0
8325686|NCT01395537|20524939|P1|COMPLETED|Phase I||13
8325687|NCT01395537|20524939|P1|STARTED|Phase I||13
8325688|NCT01395524|20524948|P3|NOT COMPLETED|Overall Study||17
8325689|NCT01395524|20524949|P2|NOT COMPLETED|Overall Study||16
8325690|NCT01395524|20524950|P1|NOT COMPLETED|Overall Study||18
8325691|NCT01395524|20524948|P3|COMPLETED|Overall Study||89
8325692|NCT01395524|20524949|P2|COMPLETED|Overall Study||83
8325693|NCT01395524|20524950|P1|COMPLETED|Overall Study||79
8325694|NCT01395524|20524948|P3|STARTED|Overall Study||106
8325695|NCT01395524|20524949|P2|STARTED|Overall Study||99
8325696|NCT01395524|20524950|P1|STARTED|Overall Study||97
8325697|NCT01395394|20524973|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8325698|NCT01395394|20524974|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8325699|NCT01395394|20524975|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8325700|NCT01395394|20524973|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
8325701|NCT01395394|20524974|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
8325702|NCT01395394|20524975|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
8325703|NCT01395394|20524973|P3|STARTED|Study Visit 2 (Non-responders Only)||0
8325704|NCT01395394|20524974|P2|STARTED|Study Visit 2 (Non-responders Only)||0
8325705|NCT01395394|20524975|P1|STARTED|Study Visit 2 (Non-responders Only)||3
8325706|NCT01395394|20524973|P3|NOT COMPLETED|Baseline Study Visit||0
8325707|NCT01395394|20524974|P2|NOT COMPLETED|Baseline Study Visit||0
8325708|NCT01395394|20524975|P1|NOT COMPLETED|Baseline Study Visit||1
8325709|NCT01395394|20524973|P3|COMPLETED|Baseline Study Visit||5
8325710|NCT01395394|20524974|P2|COMPLETED|Baseline Study Visit||3
8325711|NCT01395394|20524975|P1|COMPLETED|Baseline Study Visit||3
8325712|NCT01395394|20524973|P3|STARTED|Baseline Study Visit||5
8325713|NCT01395394|20524974|P2|STARTED|Baseline Study Visit||3
8325714|NCT01395394|20524975|P1|STARTED|Baseline Study Visit||4
8325715|NCT01395368|20524986|P1|NOT COMPLETED|Overall Study||16
8325716|NCT01395368|20524986|P1|COMPLETED|Overall Study||92
8325717|NCT01395368|20524986|P1|STARTED|Overall Study||108
8325718|NCT01395329|20524993|P3|NOT COMPLETED|Overall Study||0
8325719|NCT01395329|20524994|P2|NOT COMPLETED|Overall Study||0
8325720|NCT01395329|20524995|P1|NOT COMPLETED|Overall Study||0
8325721|NCT01395329|20524993|P3|COMPLETED|Overall Study||14
8325722|NCT01395329|20524994|P2|COMPLETED|Overall Study||14
8325723|NCT01395329|20524995|P1|COMPLETED|Overall Study||14
8325724|NCT01395329|20524993|P3|STARTED|Overall Study||14
8325725|NCT01395329|20524994|P2|STARTED|Overall Study||14
8325726|NCT01395329|20524995|P1|STARTED|Overall Study||14
8325727|NCT01395316|20525042|P1|NOT COMPLETED|Overall Study||3
8325728|NCT01395316|20525042|P1|COMPLETED|Overall Study||5
8325729|NCT01395316|20525042|P1|STARTED|Overall Study||8
8325730|NCT01395277|20525048|P2|NOT COMPLETED|Overall Study||0
8325731|NCT01395277|20525049|P1|NOT COMPLETED|Overall Study||0
8325732|NCT01395277|20525048|P2|COMPLETED|Overall Study||15
8325733|NCT01395277|20525049|P1|COMPLETED|Overall Study||15
8325734|NCT01395277|20525048|P2|STARTED|Overall Study||15
8325735|NCT01395277|20525049|P1|STARTED|Overall Study||15
8325736|NCT01395043|20525057|P1|NOT COMPLETED|Overall Study||0
8325737|NCT01395043|20525057|P1|COMPLETED|Overall Study||15
8325738|NCT01395043|20525057|P1|STARTED|Overall Study||15
8325739|NCT01395030|20525062|P1|NOT COMPLETED|Overall Study||7
8325740|NCT01395030|20525062|P1|COMPLETED|Overall Study||57
8325741|NCT01395030|20525062|P1|Adequate Tissue for Analysis|Overall Study||50
8325742|NCT01395030|20525062|P1|Complete FCH PET/CT|Overall Study||57
8325743|NCT01395030|20525062|P1|STARTED|Overall Study||64
8325744|NCT01395017|20525072|P2|NOT COMPLETED|Overall Study||102
8325745|NCT01395017|20525073|P1|NOT COMPLETED|Overall Study||100
8325746|NCT01395017|20525072|P2|COMPLETED|Overall Study||0
8325747|NCT01395017|20525073|P1|COMPLETED|Overall Study||0
8325748|NCT01395017|20525072|P2|Treated|Overall Study||101
8325749|NCT01395017|20525073|P1|Treated|Overall Study||98
8325750|NCT01395017|20525072|P2|STARTED|Overall Study||102
8325751|NCT01395017|20525073|P1|STARTED|Overall Study||100
8325752|NCT01394991|20525083|P2|NOT COMPLETED|Overall Study||72
8325753|NCT01394991|20525084|P1|NOT COMPLETED|Overall Study||59
8325754|NCT01394991|20525083|P2|COMPLETED|Overall Study||190
8325755|NCT01394991|20525084|P1|COMPLETED|Overall Study||183
8325756|NCT01394991|20525083|P2|STARTED|Overall Study||262
8325757|NCT01394991|20525084|P1|STARTED|Overall Study||242
8325758|NCT01394978|20525106|P2|NOT COMPLETED|Overall Study||31
8325759|NCT01394978|20525107|P1|NOT COMPLETED|Overall Study||21
8325760|NCT01394978|20525106|P2|COMPLETED|Overall Study||245
8325761|NCT01394978|20525107|P1|COMPLETED|Overall Study||147
8325762|NCT01394978|20525106|P2|STARTED|Overall Study||276
8325763|NCT01394978|20525107|P1|STARTED|Overall Study||168
8325764|NCT01394952|20525115|P2|NOT COMPLETED|Overall Study||17
8325765|NCT01394952|20525116|P1|NOT COMPLETED|Overall Study||17
8325766|NCT01394952|20525115|P2|COMPLETED|Overall Study||4932
8325767|NCT01394952|20525116|P1|COMPLETED|Overall Study||4935
8325768|NCT01394952|20525115|P2|Received at Least One Dose of Study Drug|Overall Study||4943
8325769|NCT01394952|20525116|P1|Received at Least One Dose of Study Drug|Overall Study||4949
8325770|NCT01394952|20525115|P2|STARTED|Overall Study||4949
8325771|NCT01394952|20525116|P1|STARTED|Overall Study||4952
8325772|NCT01394939|20525136|P4|NOT COMPLETED|Overall Study||7
8325773|NCT01394939|20525137|P3|NOT COMPLETED|Overall Study||0
8325774|NCT01394939|20525138|P2|NOT COMPLETED|Overall Study||10
8325775|NCT01394939|20525139|P1|NOT COMPLETED|Overall Study||1
8325776|NCT01394939|20525136|P4|COMPLETED|Overall Study||10
8325777|NCT01394939|20525137|P3|COMPLETED|Overall Study||4
8325778|NCT01394939|20525138|P2|COMPLETED|Overall Study||15
8325779|NCT01394939|20525139|P1|COMPLETED|Overall Study||3
8325780|NCT01394939|20525136|P4|STARTED|Overall Study||17
8325781|NCT01394939|20525137|P3|STARTED|Overall Study||4
8325782|NCT01394939|20525138|P2|STARTED|Overall Study||25
8325783|NCT01394939|20525139|P1|STARTED|Overall Study||4
8325784|NCT01394926|20525149|P1|NOT COMPLETED|Overall Study||0
8325785|NCT01394926|20525149|P1|COMPLETED|Overall Study||21
8325786|NCT01394926|20525149|P1|STARTED|Overall Study||21
8325787|NCT01394718|20525160|P2|NOT COMPLETED|Overall Study||1
8325788|NCT01394718|20525161|P1|NOT COMPLETED|Overall Study||2
8325789|NCT01394718|20525160|P2|COMPLETED|Overall Study||29
8325790|NCT01394718|20525161|P1|COMPLETED|Overall Study||28
8325791|NCT01394718|20525160|P2|STARTED|Overall Study||30
8325792|NCT01394718|20525161|P1|STARTED|Overall Study||30
8325793|NCT01394705|20525175|P2|NOT COMPLETED|Overall Study||2
8325794|NCT01394705|20525176|P1|NOT COMPLETED|Overall Study||2
8325795|NCT01394705|20525175|P2|COMPLETED|Overall Study||19
8325796|NCT01394705|20525176|P1|COMPLETED|Overall Study||19
8325797|NCT01394705|20525175|P2|STARTED|Overall Study||21
8325798|NCT01394705|20525176|P1|STARTED|Overall Study||21
8325799|NCT01394692|20525186|P2|NOT COMPLETED|Overall Study||0
8325800|NCT01394692|20525187|P1|NOT COMPLETED|Overall Study||0
8325801|NCT01394692|20525186|P2|COMPLETED|Overall Study||29
8325802|NCT01394692|20525187|P1|COMPLETED|Overall Study||29
8325803|NCT01394692|20525186|P2|STARTED|Overall Study||29
8325804|NCT01394692|20525187|P1|STARTED|Overall Study||29
8325805|NCT01394627|20525193|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8325806|NCT01394627|20525194|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8325807|NCT01394627|20525193|P2|COMPLETED|Second Intervention (1 Day)||12
8325808|NCT01394627|20525194|P1|COMPLETED|Second Intervention (1 Day)||7
8325809|NCT01394627|20525193|P2|STARTED|Second Intervention (1 Day)||12
8325810|NCT01394627|20525194|P1|STARTED|Second Intervention (1 Day)||7
8325811|NCT01394627|20525193|P2|NOT COMPLETED|Washout (1-3 Months)||0
8325812|NCT01394627|20525194|P1|NOT COMPLETED|Washout (1-3 Months)||1
8325813|NCT01394627|20525193|P2|COMPLETED|Washout (1-3 Months)||12
8325814|NCT01394627|20525194|P1|COMPLETED|Washout (1-3 Months)||7
8325815|NCT01394627|20525193|P2|STARTED|Washout (1-3 Months)||12
8325816|NCT01394627|20525194|P1|STARTED|Washout (1-3 Months)||8
8325817|NCT01394627|20525193|P2|NOT COMPLETED|First Intervention (1 Day)||1
8325818|NCT01394627|20525194|P1|NOT COMPLETED|First Intervention (1 Day)||0
8325819|NCT01394627|20525193|P2|COMPLETED|First Intervention (1 Day)||12
8325820|NCT01394627|20525194|P1|COMPLETED|First Intervention (1 Day)||8
8325821|NCT01394627|20525193|P2|STARTED|First Intervention (1 Day)||13
8325822|NCT01394627|20525194|P1|STARTED|First Intervention (1 Day)||8
8325823|NCT01394614|20525204|P2|NOT COMPLETED|Overall Study||0
8325824|NCT01394614|20525205|P1|NOT COMPLETED|Overall Study||0
8325825|NCT01394614|20525204|P2|COMPLETED|Overall Study||16
8325826|NCT01394614|20525205|P1|COMPLETED|Overall Study||8
8325827|NCT01394614|20525204|P2|STARTED|Overall Study||16
8325828|NCT01394614|20525205|P1|STARTED|Overall Study||8
8325829|NCT01394523|20525214|P3|NOT COMPLETED|Overall Study||0
8325830|NCT01394523|20525215|P2|NOT COMPLETED|Overall Study||0
8325831|NCT01394523|20525216|P1|NOT COMPLETED|Overall Study||1
8325832|NCT01394523|20525214|P3|COMPLETED|Overall Study||13
8325833|NCT01394523|20525215|P2|COMPLETED|Overall Study||13
8325834|NCT01394523|20525216|P1|COMPLETED|Overall Study||12
8325835|NCT01394523|20525214|P3|STARTED|Overall Study||13
8325836|NCT01394523|20525215|P2|STARTED|Overall Study||13
8325837|NCT01394523|20525216|P1|STARTED|Overall Study||13
8325838|NCT01394510|20525224|P1|NOT COMPLETED|Overall Study||0
8325839|NCT01394510|20525224|P1|COMPLETED|Overall Study||13
8325840|NCT01394510|20525224|P1|STARTED|Overall Study||13
8325841|NCT01394276|20525230|P1|NOT COMPLETED|Overall Study||62
8325842|NCT01394276|20525230|P1|COMPLETED|Overall Study||260
8325843|NCT01394276|20525230|P1|STARTED|Overall Study||322
8325844|NCT01394250|20525254|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
8325845|NCT01394250|20525255|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
8325846|NCT01394250|20525254|P2|COMPLETED|Successful IV Placement & Follow-Up||110
8325847|NCT01394250|20525255|P1|COMPLETED|Successful IV Placement & Follow-Up||114
8325848|NCT01394250|20525254|P2|STARTED|Successful IV Placement & Follow-Up||121
8325849|NCT01394250|20525255|P1|STARTED|Successful IV Placement & Follow-Up||120
8325850|NCT01394250|20525254|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
8325851|NCT01394250|20525255|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
8325852|NCT01394250|20525254|P2|COMPLETED|Randomization and IV Placement Attempt||121
8325853|NCT01394250|20525255|P1|COMPLETED|Randomization and IV Placement Attempt||120
8325854|NCT01394250|20525254|P2|STARTED|Randomization and IV Placement Attempt||134
8325855|NCT01394250|20525255|P1|STARTED|Randomization and IV Placement Attempt||134
8325856|NCT01394211|20525263|P1|NOT COMPLETED|Overall Study||2
8325857|NCT01394211|20525263|P1|COMPLETED|Overall Study||0
8325858|NCT01394211|20525263|P1|STARTED|Overall Study||2
8325859|NCT01394185|20525269|P6|NOT COMPLETED|Overall Study||1
8325860|NCT01394185|20525270|P5|NOT COMPLETED|Overall Study||4
8325861|NCT01394185|20525271|P4|NOT COMPLETED|Overall Study||1
8325862|NCT01394185|20525272|P3|NOT COMPLETED|Overall Study||0
8325863|NCT01394185|20525273|P2|NOT COMPLETED|Overall Study||0
8325864|NCT01394185|20525274|P1|NOT COMPLETED|Overall Study||6
8325865|NCT01394185|20525269|P6|COMPLETED|Overall Study||2
8325866|NCT01394185|20525270|P5|COMPLETED|Overall Study||2
8325867|NCT01394185|20525271|P4|COMPLETED|Overall Study||3
8325868|NCT01394185|20525272|P3|COMPLETED|Overall Study||2
8325869|NCT01394185|20525273|P2|COMPLETED|Overall Study||2
8325870|NCT01394185|20525274|P1|COMPLETED|Overall Study||2
8325871|NCT01394185|20525269|P6|STARTED|Overall Study||3
8325872|NCT01394185|20525270|P5|STARTED|Overall Study||6
8325873|NCT01394185|20525271|P4|STARTED|Overall Study||4
8325874|NCT01394185|20525272|P3|STARTED|Overall Study||2
8325875|NCT01394185|20525273|P2|STARTED|Overall Study||2
8325876|NCT01394185|20525274|P1|STARTED|Overall Study||8
8325877|NCT01394159|20525287|P2|NOT COMPLETED|Overall Study||0
8325878|NCT01394159|20525288|P1|NOT COMPLETED|Overall Study||0
8325879|NCT01394159|20525287|P2|COMPLETED|Overall Study||28
8325880|NCT01394159|20525288|P1|COMPLETED|Overall Study||28
8325881|NCT01394159|20525287|P2|STARTED|Overall Study||28
8325882|NCT01394159|20525288|P1|STARTED|Overall Study||28
8325883|NCT01394081|20525300|P2|NOT COMPLETED|Overall Study||0
8325884|NCT01394081|20525301|P1|NOT COMPLETED|Overall Study||0
8325885|NCT01394081|20525300|P2|COMPLETED|Overall Study||102
8325886|NCT01394081|20525301|P1|COMPLETED|Overall Study||101
8325887|NCT01394081|20525300|P2|STARTED|Overall Study||102
8325888|NCT01394081|20525301|P1|STARTED|Overall Study||101
8325889|NCT01394003|20525317|P8|NOT COMPLETED|Overall Study||0
8325890|NCT01394003|20525318|P7|NOT COMPLETED|Overall Study||0
8325891|NCT01394003|20525319|P6|NOT COMPLETED|Overall Study||0
8325892|NCT01394003|20525320|P5|NOT COMPLETED|Overall Study||0
8325893|NCT01394003|20525321|P4|NOT COMPLETED|Overall Study||0
8325894|NCT01394003|20525322|P3|NOT COMPLETED|Overall Study||0
8325895|NCT01394003|20525323|P2|NOT COMPLETED|Overall Study||0
8325896|NCT01394003|20525324|P1|NOT COMPLETED|Overall Study||0
8325897|NCT01394003|20525317|P8|COMPLETED|Overall Study||2
8325898|NCT01394003|20525318|P7|COMPLETED|Overall Study||6
8325899|NCT01394003|20525319|P6|COMPLETED|Overall Study||3
8325900|NCT01394003|20525320|P5|COMPLETED|Overall Study||3
8325901|NCT01394003|20525321|P4|COMPLETED|Overall Study||6
8325902|NCT01394003|20525322|P3|COMPLETED|Overall Study||3
8325903|NCT01394003|20525323|P2|COMPLETED|Overall Study||8
8325904|NCT01394003|20525324|P1|COMPLETED|Overall Study||3
8325905|NCT01394003|20525317|P8|Received at Least 1 Dose of Study Drug|Overall Study||2
8325906|NCT01394003|20525318|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8325907|NCT01394003|20525319|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8325908|NCT01394003|20525320|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8325909|NCT01394003|20525321|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8325910|NCT01394003|20525322|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8325911|NCT01394003|20525323|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8325912|NCT01394003|20525324|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8325913|NCT01394003|20525317|P8|STARTED|Overall Study||2
8325914|NCT01394003|20525318|P7|STARTED|Overall Study||6
8325915|NCT01394003|20525319|P6|STARTED|Overall Study||3
8325916|NCT01394003|20525320|P5|STARTED|Overall Study||3
8325917|NCT01394003|20525321|P4|STARTED|Overall Study||6
8325918|NCT01394003|20525322|P3|STARTED|Overall Study||3
8325919|NCT01394003|20525323|P2|STARTED|Overall Study||8
8325920|NCT01394003|20525324|P1|STARTED|Overall Study||3
8325921|NCT01393990|20525378|P18|NOT COMPLETED|Overall Study||0
8325922|NCT01393990|20525379|P17|NOT COMPLETED|Overall Study||0
8325923|NCT01393990|20525380|P16|NOT COMPLETED|Overall Study||3
8325924|NCT01393990|20525381|P15|NOT COMPLETED|Overall Study||9
8325925|NCT01393990|20525382|P14|NOT COMPLETED|Overall Study||2
8325926|NCT01393990|20525383|P13|NOT COMPLETED|Overall Study||0
8325927|NCT01393990|20525384|P12|NOT COMPLETED|Overall Study||0
8325928|NCT01393990|20525385|P11|NOT COMPLETED|Overall Study||0
8325929|NCT01393990|20525386|P10|NOT COMPLETED|Overall Study||1
8325930|NCT01393990|20525387|P9|NOT COMPLETED|Overall Study||3
8325931|NCT01393990|20525388|P8|NOT COMPLETED|Overall Study||1
8325932|NCT01393990|20525389|P7|NOT COMPLETED|Overall Study||1
8325933|NCT01393990|20525390|P6|NOT COMPLETED|Overall Study||1
8325934|NCT01393990|20525391|P5|NOT COMPLETED|Overall Study||2
8325935|NCT01393990|20525392|P4|NOT COMPLETED|Overall Study||1
8325936|NCT01393990|20525393|P3|NOT COMPLETED|Overall Study||0
8325937|NCT01393990|20525394|P2|NOT COMPLETED|Overall Study||0
8325938|NCT01393990|20525395|P1|NOT COMPLETED|Overall Study||1
8325939|NCT01393990|20525378|P18|COMPLETED|Overall Study||6
8325940|NCT01393990|20525379|P17|COMPLETED|Overall Study||3
8325941|NCT01393990|20525380|P16|COMPLETED|Overall Study||5
8325942|NCT01393990|20525381|P15|COMPLETED|Overall Study||9
8325943|NCT01393990|20525382|P14|COMPLETED|Overall Study||3
8325944|NCT01393990|20525383|P13|COMPLETED|Overall Study||3
8325945|NCT01393990|20525384|P12|COMPLETED|Overall Study||3
8325946|NCT01393990|20525385|P11|COMPLETED|Overall Study||3
8325947|NCT01393990|20525386|P10|COMPLETED|Overall Study||2
8325948|NCT01393990|20525387|P9|COMPLETED|Overall Study||3
8325949|NCT01393990|20525388|P8|COMPLETED|Overall Study||6
8325950|NCT01393990|20525389|P7|COMPLETED|Overall Study||2
8325951|NCT01393990|20525390|P6|COMPLETED|Overall Study||2
8325952|NCT01393990|20525391|P5|COMPLETED|Overall Study||3
8325953|NCT01393990|20525392|P4|COMPLETED|Overall Study||2
8325954|NCT01393990|20525393|P3|COMPLETED|Overall Study||3
8325955|NCT01393990|20525394|P2|COMPLETED|Overall Study||3
8325956|NCT01393990|20525395|P1|COMPLETED|Overall Study||3
8325957|NCT01393990|20525378|P18|Received at Least 1 Dose of Study Drug|Overall Study||6
8325958|NCT01393990|20525379|P17|Received at Least 1 Dose of Study Drug|Overall Study||3
8325959|NCT01393990|20525380|P16|Received at Least 1 Dose of Study Drug|Overall Study||8
8325960|NCT01393990|20525381|P15|Received at Least 1 Dose of Study Drug|Overall Study||18
8325961|NCT01393990|20525382|P14|Received at Least 1 Dose of Study Drug|Overall Study||5
8325962|NCT01393990|20525383|P13|Received at Least 1 Dose of Study Drug|Overall Study||3
8325963|NCT01393990|20525384|P12|Received at Least 1 Dose of Study Drug|Overall Study||3
8325964|NCT01393990|20525385|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
8325965|NCT01393990|20525386|P10|Received at Least 1 Dose of Study Drug|Overall Study||3
8325966|NCT01393990|20525387|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
8325967|NCT01393990|20525388|P8|Received at Least 1 Dose of Study Drug|Overall Study||7
8325968|NCT01393990|20525389|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
8325969|NCT01393990|20525390|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8325970|NCT01393990|20525391|P5|Received at Least 1 Dose of Study Drug|Overall Study||5
8325971|NCT01393990|20525392|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8325972|NCT01393990|20525393|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8325973|NCT01393990|20525394|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8325974|NCT01393990|20525395|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8325975|NCT01393990|20525378|P18|STARTED|Overall Study||6
8325976|NCT01393990|20525379|P17|STARTED|Overall Study||3
8325977|NCT01393990|20525380|P16|STARTED|Overall Study||8
8325978|NCT01393990|20525381|P15|STARTED|Overall Study||18
8325979|NCT01393990|20525382|P14|STARTED|Overall Study||5
8325980|NCT01393990|20525383|P13|STARTED|Overall Study||3
8325981|NCT01393990|20525384|P12|STARTED|Overall Study||3
8325982|NCT01393990|20525385|P11|STARTED|Overall Study||3
8325983|NCT01393990|20525386|P10|STARTED|Overall Study||3
8325984|NCT01393990|20525387|P9|STARTED|Overall Study||6
8325985|NCT01393990|20525388|P8|STARTED|Overall Study||7
8325986|NCT01393990|20525389|P7|STARTED|Overall Study||3
8325987|NCT01393990|20525390|P6|STARTED|Overall Study||3
8325988|NCT01393990|20525391|P5|STARTED|Overall Study||5
8325989|NCT01393990|20525392|P4|STARTED|Overall Study||3
8325990|NCT01393990|20525393|P3|STARTED|Overall Study||3
8325991|NCT01393990|20525394|P2|STARTED|Overall Study||3
8325992|NCT01393990|20525395|P1|STARTED|Overall Study||4
8325993|NCT01393964|20525486|P3|NOT COMPLETED|Overall Study||9
8325994|NCT01393964|20525487|P2|NOT COMPLETED|Overall Study||9
8325995|NCT01393964|20525488|P1|NOT COMPLETED|Overall Study||8
8325996|NCT01393964|20525486|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
8325997|NCT01393964|20525487|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
8325998|NCT01393964|20525488|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
8325999|NCT01393964|20525486|P3|STARTED|Overall Study||9
8326000|NCT01393964|20525487|P2|STARTED|Overall Study||9
8326001|NCT01393964|20525488|P1|STARTED|Overall Study||8
8326002|NCT01393899|20525529|P3|NOT COMPLETED|Overall Study||23
8326003|NCT01393899|20525530|P2|NOT COMPLETED|Overall Study||28
8326004|NCT01393899|20525531|P1|NOT COMPLETED|Overall Study||32
8326005|NCT01393899|20525529|P3|COMPLETED|Overall Study||38
8326006|NCT01393899|20525530|P2|COMPLETED|Overall Study||32
8326007|NCT01393899|20525531|P1|COMPLETED|Overall Study||27
8326008|NCT01393899|20525529|P3|STARTED|Overall Study||61
8326009|NCT01393899|20525530|P2|STARTED|Overall Study||60
8326010|NCT01393899|20525531|P1|STARTED|Overall Study||59
8326011|NCT01393821|20525585|P2|NOT COMPLETED|Overall Study||3
8326012|NCT01393821|20525586|P1|NOT COMPLETED|Overall Study||5
8326013|NCT01393821|20525585|P2|COMPLETED|Overall Study||10
8326014|NCT01393821|20525586|P1|COMPLETED|Overall Study||9
8326015|NCT01393821|20525585|P2|STARTED|Overall Study||13
8326016|NCT01393821|20525586|P1|STARTED|Overall Study||14
8326017|NCT01393743|20525600|P3|NOT COMPLETED|Extension Phase||60
8326018|NCT01393743|20525601|P2|NOT COMPLETED|Extension Phase||0
8326019|NCT01393743|20525602|P1|NOT COMPLETED|Extension Phase||0
8326020|NCT01393743|20525600|P3|COMPLETED|Extension Phase||78
8326021|NCT01393743|20525601|P2|COMPLETED|Extension Phase||0
8326022|NCT01393743|20525602|P1|COMPLETED|Extension Phase||0
8326023|NCT01393743|20525600|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
8326024|NCT01393743|20525601|P2|STARTED|Extension Phase||0
8326025|NCT01393743|20525602|P1|STARTED|Extension Phase||0
8326026|NCT01393743|20525600|P3|NOT COMPLETED|Core Study||0
8326027|NCT01393743|20525601|P2|NOT COMPLETED|Core Study||13
8326028|NCT01393743|20525602|P1|NOT COMPLETED|Core Study||10
8326029|NCT01393743|20525600|P3|COMPLETED|Core Study||0
8326030|NCT01393743|20525601|P2|COMPLETED|Core Study||68
8326031|NCT01393743|20525602|P1|COMPLETED|Core Study||72
8326032|NCT01393743|20525600|P3|STARTED|Core Study||0
8326033|NCT01393743|20525601|P2|STARTED|Core Study|Treated|81
8326034|NCT01393743|20525602|P1|STARTED|Core Study|Treated|82
8326035|NCT01393730|20525625|P1|NOT COMPLETED|Overall Study||6
8326036|NCT01393730|20525625|P1|COMPLETED|Overall Study||34
8326037|NCT01393730|20525625|P1|Evaluable AR Mutation|Overall Study||14
8326038|NCT01393730|20525625|P1|Evaluable AR Amplification|Overall Study||21
8326039|NCT01393730|20525625|P1|Treated|Overall Study||38
8326040|NCT01393730|20525625|P1|STARTED|Overall Study||40
8326041|NCT01393717|20525637|P2|NOT COMPLETED|Overall Study||0
8326042|NCT01393717|20525638|P1|NOT COMPLETED|Overall Study||0
8326043|NCT01393717|20525637|P2|COMPLETED|Overall Study||20
8326044|NCT01393717|20525638|P1|COMPLETED|Overall Study||37
8326045|NCT01393717|20525637|P2|STARTED|Overall Study||20
8326046|NCT01393717|20525638|P1|STARTED|Overall Study||37
8326047|NCT01393704|20525652|P2|NOT COMPLETED|Overall Study||0
8326048|NCT01393704|20525653|P1|NOT COMPLETED|Overall Study||0
8326049|NCT01393704|20525652|P2|COMPLETED|Overall Study||76
8326050|NCT01393704|20525653|P1|COMPLETED|Overall Study||76
8326051|NCT01393704|20525652|P2|STARTED|Overall Study||76
8326052|NCT01393704|20525653|P1|STARTED|Overall Study||76
8326053|NCT01393626|20525671|P4|NOT COMPLETED|Overall Study||1
8326054|NCT01393626|20525672|P3|NOT COMPLETED|Overall Study||12
8326055|NCT01393626|20525673|P2|NOT COMPLETED|Overall Study||12
8326056|NCT01393626|20525674|P1|NOT COMPLETED|Overall Study||18
8326057|NCT01393626|20525671|P4|COMPLETED|Overall Study||15
8326058|NCT01393626|20525672|P3|COMPLETED|Overall Study||74
8326059|NCT01393626|20525673|P2|COMPLETED|Overall Study||74
8326060|NCT01393626|20525674|P1|COMPLETED|Overall Study||73
8326061|NCT01393626|20525671|P4|STARTED|Overall Study||16
8326062|NCT01393626|20525672|P3|STARTED|Overall Study||86
8326063|NCT01393626|20525673|P2|STARTED|Overall Study||86
8326064|NCT01393626|20525674|P1|STARTED|Overall Study||91
8326065|NCT01393613|20525754|P4|NOT COMPLETED|Overall Study||66
8326066|NCT01393613|20525755|P3|NOT COMPLETED|Overall Study||54
8326067|NCT01393613|20525756|P2|NOT COMPLETED|Overall Study||57
8326068|NCT01393613|20525757|P1|NOT COMPLETED|Overall Study||39
8326069|NCT01393613|20525754|P4|COMPLETED|Overall Study||118
8326070|NCT01393613|20525755|P3|COMPLETED|Overall Study||130
8326071|NCT01393613|20525756|P2|COMPLETED|Overall Study||129
8326072|NCT01393613|20525757|P1|COMPLETED|Overall Study||81
8326073|NCT01393613|20525754|P4|STARTED|Overall Study||184
8326074|NCT01393613|20525755|P3|STARTED|Overall Study||184
8326075|NCT01393613|20525756|P2|STARTED|Overall Study||186
8326076|NCT01393613|20525757|P1|STARTED|Overall Study||120
8326077|NCT01393600|20525819|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8326078|NCT01393600|20525820|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
8326079|NCT01393600|20525821|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8326080|NCT01393600|20525822|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8326081|NCT01393600|20525819|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
8326082|NCT01393600|20525820|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
8326083|NCT01393600|20525821|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
8326084|NCT01393600|20525822|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
8326085|NCT01393600|20525819|P4|STARTED|Follow-up Period (Day 29 to 35)||8
8326086|NCT01393600|20525820|P3|STARTED|Follow-up Period (Day 29 to 35)||7
8326087|NCT01393600|20525821|P2|STARTED|Follow-up Period (Day 29 to 35)||7
8326088|NCT01393600|20525822|P1|STARTED|Follow-up Period (Day 29 to 35)||9
8326089|NCT01393600|20525819|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
8326090|NCT01393600|20525820|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
8326091|NCT01393600|20525821|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
8326092|NCT01393600|20525822|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
8326093|NCT01393600|20525819|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
8326094|NCT01393600|20525820|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
8326095|NCT01393600|20525821|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
8326096|NCT01393600|20525822|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
8326097|NCT01393600|20525819|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
8326098|NCT01393600|20525820|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
8326099|NCT01393600|20525821|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
8326100|NCT01393600|20525822|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
8326101|NCT01393600|20525819|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8326102|NCT01393600|20525820|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8326103|NCT01393600|20525821|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8326104|NCT01393600|20525822|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
8326105|NCT01393600|20525819|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8326106|NCT01393600|20525820|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8326107|NCT01393600|20525821|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
8326108|NCT01393600|20525822|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8326109|NCT01393600|20525819|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
8326110|NCT01393600|20525820|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
8326111|NCT01393600|20525821|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
8326112|NCT01393600|20525822|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
8326113|NCT01393457|20525841|P4|NOT COMPLETED|Overall Study||12
8326114|NCT01393457|20525842|P3|NOT COMPLETED|Overall Study||15
8326115|NCT01393457|20525843|P2|NOT COMPLETED|Overall Study||12
8326116|NCT01393457|20525844|P1|NOT COMPLETED|Overall Study||12
8326117|NCT01393457|20525841|P4|COMPLETED|Overall Study||15
8326118|NCT01393457|20525842|P3|COMPLETED|Overall Study||16
8326119|NCT01393457|20525843|P2|COMPLETED|Overall Study||14
8326120|NCT01393457|20525844|P1|COMPLETED|Overall Study||14
8326121|NCT01393457|20525841|P4|STARTED|Overall Study||27
8326122|NCT01393457|20525842|P3|STARTED|Overall Study||31
8326123|NCT01393457|20525843|P2|STARTED|Overall Study||26
8326124|NCT01393457|20525844|P1|STARTED|Overall Study||26
8326125|NCT01393444|20525858|P1|NOT COMPLETED|Overall Study||3
8326126|NCT01393444|20525858|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
8326127|NCT01393444|20525858|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
8326128|NCT01393444|20525858|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
8326129|NCT01393444|20525858|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
8326130|NCT01393444|20525858|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
8326131|NCT01393444|20525858|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
8326132|NCT01393444|20525858|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
8326133|NCT01393444|20525858|P1|STARTED|Overall Study||6
8326134|NCT01393405|20525863|P3|NOT COMPLETED|Maintenance Period Week||24
8326135|NCT01393405|20525864|P2|NOT COMPLETED|Maintenance Period Week||29
8326136|NCT01393405|20525865|P1|NOT COMPLETED|Maintenance Period Week||0
8326137|NCT01393405|20525863|P3|COMPLETED|Maintenance Period Week||16
8326138|NCT01393405|20525864|P2|COMPLETED|Maintenance Period Week||15
8326139|NCT01393405|20525865|P1|COMPLETED|Maintenance Period Week||0
8326140|NCT01393405|20525863|P3|STARTED|Maintenance Period Week||40
8326141|NCT01393405|20525864|P2|STARTED|Maintenance Period Week||44
8326142|NCT01393405|20525865|P1|STARTED|Maintenance Period Week||0
8326143|NCT01393405|20525863|P3|NOT COMPLETED|Induction Period (week1-16)||0
8326144|NCT01393405|20525864|P2|NOT COMPLETED|Induction Period (week1-16)||0
8326145|NCT01393405|20525865|P1|NOT COMPLETED|Induction Period (week1-16)||95
8326146|NCT01393405|20525863|P3|COMPLETED|Induction Period (week1-16)||0
8326147|NCT01393405|20525864|P2|COMPLETED|Induction Period (week1-16)||0
8326148|NCT01393405|20525865|P1|COMPLETED|Induction Period (week1-16)||84
8326149|NCT01393405|20525863|P3|STARTED|Induction Period (week1-16)||0
8326150|NCT01393405|20525864|P2|STARTED|Induction Period (week1-16)||0
8326151|NCT01393405|20525865|P1|STARTED|Induction Period (week1-16)||179
8326152|NCT01393392|20525884|P2|NOT COMPLETED|Overall Study||19
8326153|NCT01393392|20525885|P1|NOT COMPLETED|Overall Study||11
8326154|NCT01393392|20525884|P2|COMPLETED|Overall Study||24
8326155|NCT01393392|20525885|P1|COMPLETED|Overall Study||33
8326156|NCT01393392|20525884|P2|STARTED|Overall Study||43
8326157|NCT01393392|20525885|P1|STARTED|Overall Study||44
8326158|NCT01393301|20525903|P2|NOT COMPLETED|Overall Study||3
8326159|NCT01393301|20525904|P1|NOT COMPLETED|Overall Study||9
8326160|NCT01393301|20525903|P2|COMPLETED|Overall Study||24
8326161|NCT01393301|20525904|P1|COMPLETED|Overall Study||17
8326162|NCT01393301|20525903|P2|STARTED|Overall Study||27
8326163|NCT01393301|20525904|P1|STARTED|Overall Study||26
8326164|NCT01393158|20525917|P2|NOT COMPLETED|Overall Study||0
8326165|NCT01393158|20525918|P1|NOT COMPLETED|Overall Study||1
8326166|NCT01393158|20525917|P2|COMPLETED|Overall Study||10
8326167|NCT01393158|20525918|P1|COMPLETED|Overall Study||5
8326168|NCT01393158|20525917|P2|STARTED|Overall Study||10
8326169|NCT01393158|20525918|P1|STARTED|Overall Study||6
8326170|NCT01393132|20525932|P2|NOT COMPLETED|Overall Study||0
8326171|NCT01393132|20525933|P1|NOT COMPLETED|Overall Study||0
8326172|NCT01393132|20525932|P2|COMPLETED|Overall Study||3
8326173|NCT01393132|20525933|P1|COMPLETED|Overall Study||6
8326174|NCT01393132|20525932|P2|STARTED|Overall Study||3
8326175|NCT01393132|20525933|P1|STARTED|Overall Study||6
8326176|NCT01393106|20525945|P1|NOT COMPLETED|Overall Study||5
8326177|NCT01393106|20525945|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
8326178|NCT01393106|20525945|P1|STARTED|Overall Study||25
8326179|NCT01392989|20525962|P1|NOT COMPLETED|CIK Cell Infusion||0
8326180|NCT01392989|20525962|P1|COMPLETED|CIK Cell Infusion||31
8326181|NCT01392989|20525962|P1|STARTED|CIK Cell Infusion||31
8326182|NCT01392989|20525962|P1|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
8326183|NCT01392989|20525962|P1|COMPLETED|Total Lymphoid Irradiation (TLI)||44
8326184|NCT01392989|20525962|P1|STARTED|Total Lymphoid Irradiation (TLI)||44
8326185|NCT01392963|20525972|P2|NOT COMPLETED|Week 24 Follow-up||0
8326186|NCT01392963|20525973|P1|NOT COMPLETED|Week 24 Follow-up||2
8326187|NCT01392963|20525972|P2|COMPLETED|Week 24 Follow-up||17
8326188|NCT01392963|20525973|P1|COMPLETED|Week 24 Follow-up||9
8326189|NCT01392963|20525972|P2|STARTED|Week 24 Follow-up||17
8326190|NCT01392963|20525973|P1|STARTED|Week 24 Follow-up||11
8326191|NCT01392963|20525972|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
8326192|NCT01392963|20525973|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
8326193|NCT01392963|20525972|P2|COMPLETED|Week 12 (Second Intervention)||17
8326194|NCT01392963|20525973|P1|COMPLETED|Week 12 (Second Intervention)||11
8326195|NCT01392963|20525972|P2|STARTED|Week 12 (Second Intervention)||17
8326196|NCT01392963|20525973|P1|STARTED|Week 12 (Second Intervention)||11
8326197|NCT01392963|20525972|P2|NOT COMPLETED|Week 0 (First Intervention)||2
8326198|NCT01392963|20525973|P1|NOT COMPLETED|Week 0 (First Intervention)||0
8326199|NCT01392963|20525972|P2|COMPLETED|Week 0 (First Intervention)||17
8326200|NCT01392963|20525973|P1|COMPLETED|Week 0 (First Intervention)||11
8326201|NCT01392963|20525972|P2|STARTED|Week 0 (First Intervention)||19
8326202|NCT01392963|20525973|P1|STARTED|Week 0 (First Intervention)||11
8326203|NCT01392742|20525981|P1|NOT COMPLETED|Overall Study||201
8326204|NCT01392742|20525981|P1|COMPLETED|Overall Study||242
8326205|NCT01392742|20525981|P1|STARTED|Overall Study||443
8326206|NCT01392703|20525996|P3|NOT COMPLETED|Day 9||0
8326207|NCT01392703|20525997|P2|NOT COMPLETED|Day 9||0
8326208|NCT01392703|20525998|P1|NOT COMPLETED|Day 9||0
8326209|NCT01392703|20525996|P3|COMPLETED|Day 9||25
8326210|NCT01392703|20525997|P2|COMPLETED|Day 9||26
8326211|NCT01392703|20525998|P1|COMPLETED|Day 9||26
8326212|NCT01392703|20525996|P3|STARTED|Day 9||25
8326213|NCT01392703|20525997|P2|STARTED|Day 9||26
8326214|NCT01392703|20525998|P1|STARTED|Day 9||26
8326215|NCT01392703|20525996|P3|NOT COMPLETED|Day 5||0
8326216|NCT01392703|20525997|P2|NOT COMPLETED|Day 5||0
8326217|NCT01392703|20525998|P1|NOT COMPLETED|Day 5||0
8326218|NCT01392703|20525996|P3|COMPLETED|Day 5||26
8326219|NCT01392703|20525997|P2|COMPLETED|Day 5||25
8326220|NCT01392703|20525998|P1|COMPLETED|Day 5||26
8326221|NCT01392703|20525996|P3|STARTED|Day 5||26
8326222|NCT01392703|20525997|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
8326223|NCT01392703|20525998|P1|STARTED|Day 5||26
8326224|NCT01392703|20525996|P3|NOT COMPLETED|Day 1||0
8326225|NCT01392703|20525997|P2|NOT COMPLETED|Day 1||0
8326226|NCT01392703|20525998|P1|NOT COMPLETED|Day 1||0
8326227|NCT01392703|20525996|P3|COMPLETED|Day 1||26
8326228|NCT01392703|20525997|P2|COMPLETED|Day 1||26
8326229|NCT01392703|20525998|P1|COMPLETED|Day 1||26
8326230|NCT01392703|20525996|P3|STARTED|Day 1||26
8326231|NCT01392703|20525997|P2|STARTED|Day 1||26
8326232|NCT01392703|20525998|P1|STARTED|Day 1||26
8326233|NCT01392677|20526027|P2|NOT COMPLETED|Overall Study||8
8326234|NCT01392677|20526028|P1|NOT COMPLETED|Overall Study||8
8326235|NCT01392677|20526027|P2|COMPLETED|Overall Study||101
8326236|NCT01392677|20526028|P1|COMPLETED|Overall Study||101
8326237|NCT01392677|20526027|P2|STARTED|Overall Study||109
8326238|NCT01392677|20526028|P1|STARTED|Overall Study||109
8326239|NCT01392625|20526044|P2|NOT COMPLETED|Overall Study||1
8326240|NCT01392625|20526045|P1|NOT COMPLETED|Overall Study||2
8326241|NCT01392625|20526044|P2|COMPLETED|Overall Study||18
8326242|NCT01392625|20526045|P1|COMPLETED|Overall Study||16
8326243|NCT01392625|20526044|P2|STARTED|Overall Study||19
8326244|NCT01392625|20526045|P1|STARTED|Overall Study||18
8326245|NCT01392573|20526063|P2|NOT COMPLETED|Overall Study||35
8326246|NCT01392573|20526064|P1|NOT COMPLETED|Overall Study||32
8326247|NCT01392573|20526063|P2|COMPLETED|Overall Study||171
8326248|NCT01392573|20526064|P1|COMPLETED|Overall Study||175
8326249|NCT01392573|20526063|P2|Exposed|Overall Study||206
8326250|NCT01392573|20526064|P1|Exposed|Overall Study||207
8326251|NCT01392573|20526063|P2|STARTED|Overall Study||206
8326252|NCT01392573|20526064|P1|STARTED|Overall Study||207
8326253|NCT01392560|20526072|P1|NOT COMPLETED|Overall Study||12
8326254|NCT01392560|20526072|P1|COMPLETED|Overall Study||40
8326255|NCT01392560|20526072|P1|STARTED|Overall Study||52
8326256|NCT01392547|20526078|P1|NOT COMPLETED|Overall Study||8
8326257|NCT01392547|20526078|P1|COMPLETED|Overall Study||64
8326258|NCT01392547|20526078|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
8326259|NCT01392495|20526092|P1|NOT COMPLETED|Overall Study||16
8326260|NCT01392495|20526092|P1|COMPLETED|Overall Study||1
8326261|NCT01392495|20526092|P1|Received 400 mg|Overall Study||13
8326262|NCT01392495|20526092|P1|Received 200 mg|Overall Study||4
8326263|NCT01392495|20526092|P1|STARTED|Overall Study||17
8326264|NCT01392443|20526104|P1|NOT COMPLETED|Overall Study||68
8326265|NCT01392443|20526104|P1|COMPLETED|Overall Study||52
8326266|NCT01392443|20526104|P1|STARTED|Overall Study||120
8326267|NCT01392378|20526117|P5|NOT COMPLETED|Toddler Dose||1
8326268|NCT01392378|20526118|P4|NOT COMPLETED|Toddler Dose||2
8326269|NCT01392378|20526119|P3|NOT COMPLETED|Toddler Dose||0
8326270|NCT01392378|20526120|P2|NOT COMPLETED|Toddler Dose||1
8326271|NCT01392378|20526121|P1|NOT COMPLETED|Toddler Dose||0
8326272|NCT01392378|20526117|P5|COMPLETED|Toddler Dose||208
8326273|NCT01392378|20526118|P4|COMPLETED|Toddler Dose||173
8326274|NCT01392378|20526119|P3|COMPLETED|Toddler Dose||170
8326275|NCT01392378|20526120|P2|COMPLETED|Toddler Dose||172
8326276|NCT01392378|20526121|P1|COMPLETED|Toddler Dose||169
8326277|NCT01392378|20526117|P5|STARTED|Toddler Dose||209
8326278|NCT01392378|20526118|P4|STARTED|Toddler Dose||175
8326279|NCT01392378|20526119|P3|STARTED|Toddler Dose||170
8326280|NCT01392378|20526120|P2|STARTED|Toddler Dose||173
8326281|NCT01392378|20526121|P1|STARTED|Toddler Dose||169
8326282|NCT01392378|20526117|P5|NOT COMPLETED|After Infant Series||1
8326283|NCT01392378|20526118|P4|NOT COMPLETED|After Infant Series||0
8326284|NCT01392378|20526119|P3|NOT COMPLETED|After Infant Series||2
8326285|NCT01392378|20526120|P2|NOT COMPLETED|After Infant Series||1
8326286|NCT01392378|20526121|P1|NOT COMPLETED|After Infant Series||0
8326287|NCT01392378|20526117|P5|COMPLETED|After Infant Series||209
8326288|NCT01392378|20526118|P4|COMPLETED|After Infant Series||175
8326289|NCT01392378|20526119|P3|COMPLETED|After Infant Series||170
8326290|NCT01392378|20526120|P2|COMPLETED|After Infant Series||173
8326291|NCT01392378|20526121|P1|COMPLETED|After Infant Series||169
8326292|NCT01392378|20526117|P5|STARTED|After Infant Series||210
8326293|NCT01392378|20526118|P4|STARTED|After Infant Series||175
8326294|NCT01392378|20526119|P3|STARTED|After Infant Series||172
8326295|NCT01392378|20526120|P2|STARTED|After Infant Series||174
8326296|NCT01392378|20526121|P1|STARTED|After Infant Series||169
8326297|NCT01392378|20526117|P5|NOT COMPLETED|Infant Series||0
8326298|NCT01392378|20526118|P4|NOT COMPLETED|Infant Series||2
8326299|NCT01392378|20526119|P3|NOT COMPLETED|Infant Series||0
8326300|NCT01392378|20526120|P2|NOT COMPLETED|Infant Series||2
8326301|NCT01392378|20526121|P1|NOT COMPLETED|Infant Series||4
8326302|NCT01392378|20526117|P5|COMPLETED|Infant Series||210
8326303|NCT01392378|20526118|P4|COMPLETED|Infant Series||175
8326304|NCT01392378|20526119|P3|COMPLETED|Infant Series||172
8326305|NCT01392378|20526120|P2|COMPLETED|Infant Series||174
8326306|NCT01392378|20526121|P1|COMPLETED|Infant Series||169
8326307|NCT01392378|20526117|P5|Vaccinated Dose 3|Infant Series||210
8326308|NCT01392378|20526118|P4|Vaccinated Dose 3|Infant Series||176
8326309|NCT01392378|20526119|P3|Vaccinated Dose 3|Infant Series||172
8326310|NCT01392378|20526120|P2|Vaccinated Dose 3|Infant Series||174
8326311|NCT01392378|20526121|P1|Vaccinated Dose 3|Infant Series||170
8326312|NCT01392378|20526117|P5|Vaccinated Dose 2|Infant Series||210
8326313|NCT01392378|20526118|P4|Vaccinated Dose 2|Infant Series||177
8326314|NCT01392378|20526119|P3|Vaccinated Dose 2|Infant Series||172
8326315|NCT01392378|20526120|P2|Vaccinated Dose 2|Infant Series||174
8326316|NCT01392378|20526121|P1|Vaccinated Dose 2|Infant Series||171
8326317|NCT01392378|20526117|P5|Vaccinated Dose 1|Infant Series||210
8326318|NCT01392378|20526118|P4|Vaccinated Dose 1|Infant Series||177
8326319|NCT01392378|20526119|P3|Vaccinated Dose 1|Infant Series||172
8326320|NCT01392378|20526120|P2|Vaccinated Dose 1|Infant Series||176
8326321|NCT01392378|20526121|P1|Vaccinated Dose 1|Infant Series||173
8326322|NCT01392378|20526117|P5|STARTED|Infant Series||210
8326323|NCT01392378|20526118|P4|STARTED|Infant Series||177
8326324|NCT01392378|20526119|P3|STARTED|Infant Series||172
8326325|NCT01392378|20526120|P2|STARTED|Infant Series||176
8326326|NCT01392378|20526121|P1|STARTED|Infant Series||173
8326327|NCT01392326|20526261|P3|NOT COMPLETED|Overall Study||48
8326328|NCT01392326|20526262|P2|NOT COMPLETED|Overall Study||35
8326329|NCT01392326|20526263|P1|NOT COMPLETED|Overall Study||47
8326330|NCT01392326|20526261|P3|COMPLETED|Overall Study||154
8326331|NCT01392326|20526262|P2|COMPLETED|Overall Study||167
8326332|NCT01392326|20526263|P1|COMPLETED|Overall Study||155
8326333|NCT01392326|20526261|P3|STARTED|Overall Study||202
8326334|NCT01392326|20526262|P2|STARTED|Overall Study||202
8326335|NCT01392326|20526263|P1|STARTED|Overall Study||202
8326336|NCT01392300|20526300|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
8326337|NCT01392300|20526301|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
8326338|NCT01392300|20526302|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
8326339|NCT01392300|20526300|P3|COMPLETED|Open Label Extension (OLEX) Period||248
8326340|NCT01392300|20526301|P2|COMPLETED|Open Label Extension (OLEX) Period||0
8326341|NCT01392300|20526302|P1|COMPLETED|Open Label Extension (OLEX) Period||0
8326342|NCT01392300|20526300|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
8326343|NCT01392300|20526301|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
8326344|NCT01392300|20526302|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
8326345|NCT01392300|20526300|P3|NOT COMPLETED|Main Period (MP)||0
8326346|NCT01392300|20526301|P2|NOT COMPLETED|Main Period (MP)||7
8326347|NCT01392300|20526302|P1|NOT COMPLETED|Main Period (MP)||11
8326348|NCT01392300|20526300|P3|COMPLETED|Main Period (MP)||0
8326349|NCT01392300|20526301|P2|COMPLETED|Main Period (MP)||100
8326350|NCT01392300|20526302|P1|COMPLETED|Main Period (MP)||199
8326351|NCT01392300|20526300|P3|STARTED|Main Period (MP)||0
8326352|NCT01392300|20526301|P2|STARTED|Main Period (MP)||107
8326353|NCT01392300|20526302|P1|STARTED|Main Period (MP)||210
8326354|NCT01392170|20526407|P1|NOT COMPLETED|Overall Study||2
8326355|NCT01392170|20526407|P1|COMPLETED|Overall Study||0
8326356|NCT01392170|20526407|P1|STARTED|Overall Study||2
8326357|NCT01392053|20526413|P2|NOT COMPLETED|Overall Study||0
8326358|NCT01392053|20526414|P1|NOT COMPLETED|Overall Study||0
8326359|NCT01392053|20526413|P2|COMPLETED|Overall Study||23
8326360|NCT01392053|20526414|P1|COMPLETED|Overall Study||23
8326361|NCT01392053|20526413|P2|STARTED|Overall Study||23
8326362|NCT01392053|20526414|P1|STARTED|Overall Study||23
8326363|NCT01391858|20526434|P2|NOT COMPLETED|Overall Study||0
8326364|NCT01391858|20526435|P1|NOT COMPLETED|Overall Study||2
8326365|NCT01391858|20526434|P2|COMPLETED|Overall Study||24
8326366|NCT01391858|20526435|P1|COMPLETED|Overall Study||23
8326367|NCT01391858|20526434|P2|STARTED|Overall Study||24
8326368|NCT01391858|20526435|P1|STARTED|Overall Study||25
8326369|NCT01391832|20526457|P2|NOT COMPLETED|Overall Study||23
8326370|NCT01391832|20526458|P1|NOT COMPLETED|Overall Study||21
8326371|NCT01391832|20526457|P2|COMPLETED|Overall Study||31
8326372|NCT01391832|20526458|P1|COMPLETED|Overall Study||28
8326373|NCT01391832|20526457|P2|3 Month Follow-Up|Overall Study||29
8326374|NCT01391832|20526458|P1|3 Month Follow-Up|Overall Study||28
8326375|NCT01391832|20526457|P2|1 Month Follow-Up|Overall Study||31
8326376|NCT01391832|20526458|P1|1 Month Follow-Up|Overall Study||30
8326377|NCT01391832|20526457|P2|STARTED|Overall Study||54
8326378|NCT01391832|20526458|P1|STARTED|Overall Study||49
8326379|NCT01391819|20526466|P1|NOT COMPLETED|Overall Study||402
8326380|NCT01391819|20526466|P1|COMPLETED|Overall Study||1714
8326381|NCT01391819|20526466|P1|STARTED|Overall Study||2116
8326382|NCT01391793|20526510|P2|NOT COMPLETED|Overall Study||144
8326383|NCT01391793|20526511|P1|NOT COMPLETED|Overall Study||147
8326384|NCT01391793|20526510|P2|COMPLETED|Overall Study||131
8326385|NCT01391793|20526511|P1|COMPLETED|Overall Study||124
8326386|NCT01391793|20526510|P2|Had a Positive Urine Culture|Overall Study||188
8326387|NCT01391793|20526511|P1|Had a Positive Urine Culture|Overall Study||197
8326388|NCT01391793|20526510|P2|STARTED|Overall Study||275
8326389|NCT01391793|20526511|P1|STARTED|Overall Study||271
8326390|NCT01391663|20526525|P4|NOT COMPLETED|Overall Study||0
8326391|NCT01391663|20526526|P3|NOT COMPLETED|Overall Study||1
8326392|NCT01391663|20526527|P2|NOT COMPLETED|Overall Study||0
8326393|NCT01391663|20526528|P1|NOT COMPLETED|Overall Study||0
8326394|NCT01391663|20526525|P4|COMPLETED|Overall Study||12
8326395|NCT01391663|20526526|P3|COMPLETED|Overall Study||11
8326396|NCT01391663|20526527|P2|COMPLETED|Overall Study||12
8326397|NCT01391663|20526528|P1|COMPLETED|Overall Study||12
8326398|NCT01391663|20526525|P4|STARTED|Overall Study||12
8326399|NCT01391663|20526526|P3|STARTED|Overall Study||12
8326400|NCT01391663|20526527|P2|STARTED|Overall Study||12
8326401|NCT01391663|20526528|P1|STARTED|Overall Study||12
8326402|NCT01391611|20526558|P1|NOT COMPLETED|Overall Study||22
8326403|NCT01391611|20526558|P1|COMPLETED|Overall Study||3
8326404|NCT01391611|20526558|P1|STARTED|Overall Study||25
8326405|NCT01391559|20526563|P2|NOT COMPLETED|Second Intervention||0
8326406|NCT01391559|20526564|P1|NOT COMPLETED|Second Intervention||0
8326407|NCT01391559|20526563|P2|COMPLETED|Second Intervention||10
8326408|NCT01391559|20526564|P1|COMPLETED|Second Intervention||10
8326409|NCT01391559|20526563|P2|STARTED|Second Intervention||10
8326410|NCT01391559|20526564|P1|STARTED|Second Intervention||10
8326411|NCT01391559|20526563|P2|NOT COMPLETED|First Intervention||0
8326412|NCT01391559|20526564|P1|NOT COMPLETED|First Intervention||0
8326413|NCT01391559|20526563|P2|COMPLETED|First Intervention||10
8326414|NCT01391559|20526564|P1|COMPLETED|First Intervention||10
8326415|NCT01391559|20526563|P2|STARTED|First Intervention||10
8326416|NCT01391559|20526564|P1|STARTED|First Intervention||10
8326417|NCT01391546|20526572|P2|NOT COMPLETED|Overall Study||0
8326418|NCT01391546|20526573|P1|NOT COMPLETED|Overall Study||1
8326419|NCT01391546|20526572|P2|COMPLETED|Overall Study||177
8326420|NCT01391546|20526573|P1|COMPLETED|Overall Study||176
8326421|NCT01391546|20526572|P2|Vaccinated|Overall Study||177
8326422|NCT01391546|20526573|P1|Vaccinated|Overall Study||176
8326423|NCT01391546|20526572|P2|STARTED|Overall Study||177
8326424|NCT01391546|20526573|P1|STARTED|Overall Study||177
8326425|NCT01391507|20526595|P4|NOT COMPLETED|Overall Study||7
8326426|NCT01391507|20526596|P3|NOT COMPLETED|Overall Study||4
8326427|NCT01391507|20526597|P2|NOT COMPLETED|Overall Study||4
8326428|NCT01391507|20526598|P1|NOT COMPLETED|Overall Study||4
8326429|NCT01391507|20526595|P4|COMPLETED|Overall Study||5
8326430|NCT01391507|20526596|P3|COMPLETED|Overall Study||2
8326431|NCT01391507|20526597|P2|COMPLETED|Overall Study||4
8326432|NCT01391507|20526598|P1|COMPLETED|Overall Study||6
8326433|NCT01391507|20526595|P4|STARTED|Overall Study||12
8326434|NCT01391507|20526596|P3|STARTED|Overall Study||6
8326435|NCT01391507|20526597|P2|STARTED|Overall Study||8
8326436|NCT01391507|20526598|P1|STARTED|Overall Study||10
8326437|NCT01391468|20526646|P2|NOT COMPLETED|Overall Study||2
8326438|NCT01391468|20526647|P1|NOT COMPLETED|Overall Study||6
8326439|NCT01391468|20526646|P2|COMPLETED|Overall Study||21
8326440|NCT01391468|20526647|P1|COMPLETED|Overall Study||18
8326441|NCT01391468|20526646|P2|STARTED|Overall Study||23
8326442|NCT01391468|20526647|P1|STARTED|Overall Study||24
8326443|NCT01391364|20526661|P2|NOT COMPLETED|Overall Study||2
8326444|NCT01391364|20526662|P1|NOT COMPLETED|Overall Study||5
8326445|NCT01391364|20526661|P2|COMPLETED|Overall Study||214
8326446|NCT01391364|20526662|P1|COMPLETED|Overall Study||217
8326447|NCT01391364|20526661|P2|STARTED|Overall Study||216
8326448|NCT01391364|20526662|P1|STARTED|Overall Study||222
8326449|NCT01391325|20526672|P1|NOT COMPLETED|Overall Study||494
8326450|NCT01391325|20526672|P1|COMPLETED|Overall Study||1238
8326451|NCT01391325|20526672|P1|STARTED|Overall Study||1732
8326452|NCT01391312|20526681|P2|NOT COMPLETED|Overall Study||1
8326453|NCT01391312|20526682|P1|NOT COMPLETED|Overall Study||2
8326454|NCT01391312|20526681|P2|COMPLETED|Overall Study||19
8326455|NCT01391312|20526682|P1|COMPLETED|Overall Study||18
8326456|NCT01391312|20526681|P2|STARTED|Overall Study||20
8326457|NCT01391312|20526682|P1|STARTED|Overall Study||20
8326458|NCT01391299|20526695|P3|NOT COMPLETED|Overall Study||2
8326459|NCT01391299|20526696|P2|NOT COMPLETED|Overall Study||1
8326460|NCT01391299|20526697|P1|NOT COMPLETED|Overall Study||0
8326461|NCT01391299|20526695|P3|COMPLETED|Overall Study||56
8326462|NCT01391299|20526696|P2|COMPLETED|Overall Study||59
8326463|NCT01391299|20526697|P1|COMPLETED|Overall Study||57
8326464|NCT01391299|20526695|P3|STARTED|Overall Study||58
8326465|NCT01391299|20526696|P2|STARTED|Overall Study||60
8326466|NCT01391299|20526697|P1|STARTED|Overall Study||57
8326467|NCT01391286|20526719|P2|NOT COMPLETED|Overall Study||0
8326468|NCT01391286|20526720|P1|NOT COMPLETED|Overall Study||0
8326469|NCT01391286|20526719|P2|COMPLETED|Overall Study||18
8326470|NCT01391286|20526720|P1|COMPLETED|Overall Study||18
8326471|NCT01391286|20526719|P2|STARTED|Overall Study||18
8326472|NCT01391286|20526720|P1|STARTED|Overall Study||18
8326473|NCT01391273|20526734|P2|NOT COMPLETED|Overall Study||2
8326474|NCT01391273|20526735|P1|NOT COMPLETED|Overall Study||4
8326475|NCT01391273|20526734|P2|COMPLETED|Overall Study||83
8326476|NCT01391273|20526735|P1|COMPLETED|Overall Study||84
8326477|NCT01391273|20526734|P2|STARTED|Overall Study||85
8326478|NCT01391273|20526735|P1|STARTED|Overall Study||88
8326479|NCT01391130|20526749|P2|NOT COMPLETED|Overall Study||6
8326480|NCT01391130|20526750|P1|NOT COMPLETED|Overall Study||6
8326481|NCT01391130|20526749|P2|COMPLETED|Overall Study||31
8326482|NCT01391130|20526750|P1|COMPLETED|Overall Study||67
8326483|NCT01391130|20526749|P2|Received At Least One Dose of Study Drug|Overall Study||36
8326484|NCT01391130|20526750|P1|Received At Least One Dose of Study Drug|Overall Study||72
8326485|NCT01391130|20526749|P2|STARTED|Overall Study||37
8326486|NCT01391130|20526750|P1|STARTED|Overall Study||73
8326487|NCT01391013|20526766|P2|NOT COMPLETED|Overall Study||0
8326488|NCT01391013|20526767|P1|NOT COMPLETED|Overall Study||0
8326489|NCT01391013|20526766|P2|COMPLETED|Overall Study||15
8326490|NCT01391013|20526767|P1|COMPLETED|Overall Study||15
8326491|NCT01391013|20526766|P2|STARTED|Overall Study||15
8326492|NCT01391013|20526767|P1|STARTED|Overall Study||15
8326493|NCT01391000|20526807|P2|NOT COMPLETED|Overall Study||0
8326494|NCT01391000|20526808|P1|NOT COMPLETED|Overall Study||2
8326495|NCT01391000|20526807|P2|COMPLETED|Overall Study||35
8326496|NCT01391000|20526808|P1|COMPLETED|Overall Study||33
8326497|NCT01391000|20526807|P2|STARTED|Overall Study||35
8326498|NCT01391000|20526808|P1|STARTED|Overall Study||35
8326499|NCT01390948|20526821|P3|NOT COMPLETED|Overall Study||1
8326500|NCT01390948|20526822|P2|NOT COMPLETED|Overall Study||18
8326501|NCT01390948|20526823|P1|NOT COMPLETED|Overall Study||15
8326502|NCT01390948|20526821|P3|COMPLETED|Overall Study||2
8326503|NCT01390948|20526822|P2|COMPLETED|Overall Study||44
8326504|NCT01390948|20526823|P1|COMPLETED|Overall Study||44
8326505|NCT01390948|20526821|P3|Treated|Overall Study||3
8326506|NCT01390948|20526822|P2|Treated|Overall Study||60
8326507|NCT01390948|20526823|P1|Treated|Overall Study||56
8326508|NCT01390948|20526821|P3|STARTED|Overall Study||3
8326509|NCT01390948|20526822|P2|STARTED|Overall Study||62
8326510|NCT01390948|20526823|P1|STARTED|Overall Study||59
8326511|NCT01390909|20526864|P6|NOT COMPLETED|Overall Study||0
8326512|NCT01390909|20526865|P5|NOT COMPLETED|Overall Study||0
8326513|NCT01390909|20526866|P4|NOT COMPLETED|Overall Study||0
8326514|NCT01390909|20526867|P3|NOT COMPLETED|Overall Study||0
8326515|NCT01390909|20526868|P2|NOT COMPLETED|Overall Study||0
8326516|NCT01390909|20526869|P1|NOT COMPLETED|Overall Study||0
8326517|NCT01390909|20526864|P6|COMPLETED|Overall Study||613
8326518|NCT01390909|20526865|P5|COMPLETED|Overall Study||613
8326519|NCT01390909|20526866|P4|COMPLETED|Overall Study||602
8326520|NCT01390909|20526867|P3|COMPLETED|Overall Study||3552
8326521|NCT01390909|20526868|P2|COMPLETED|Overall Study||3552
8326522|NCT01390909|20526869|P1|COMPLETED|Overall Study||3454
8326523|NCT01390909|20526864|P6|Participants in Subgroup|Overall Study||0
8326524|NCT01390909|20526865|P5|Participants in Subgroup|Overall Study||602
8326525|NCT01390909|20526866|P4|Participants in Subgroup|Overall Study||0
8326526|NCT01390909|20526867|P3|Participants in Subgroup|Overall Study||0
8326527|NCT01390909|20526868|P2|Participants in Subgroup|Overall Study||3454
8326528|NCT01390909|20526869|P1|Participants in Subgroup|Overall Study||0
8326529|NCT01390909|20526864|P6|STARTED|Overall Study||613
8326530|NCT01390909|20526865|P5|STARTED|Overall Study||613
8326531|NCT01390909|20526866|P4|STARTED|Overall Study||602
8326532|NCT01390909|20526867|P3|STARTED|Overall Study||3552
8326533|NCT01390909|20526868|P2|STARTED|Overall Study||3552
8326534|NCT01390909|20526869|P1|STARTED|Overall Study||3454
8326535|NCT01390870|20526887|P1|NOT COMPLETED|Overall Study||0
8326536|NCT01390870|20526887|P1|COMPLETED|Overall Study||400
8326537|NCT01390870|20526887|P1|STARTED|Overall Study||400
8326538|NCT01390857|20526891|P1|NOT COMPLETED|Overall Study||10
8326539|NCT01390857|20526891|P1|COMPLETED|Overall Study||369
8326540|NCT01390857|20526891|P1|STARTED|Overall Study||379
8326541|NCT01390844|20526902|P4|NOT COMPLETED|Follow-Up Phase||0
8326542|NCT01390844|20526903|P3|NOT COMPLETED|Follow-Up Phase||1
8326543|NCT01390844|20526904|P2|NOT COMPLETED|Follow-Up Phase||1
8326544|NCT01390844|20526905|P1|NOT COMPLETED|Follow-Up Phase||1
8326545|NCT01390844|20526902|P4|COMPLETED|Follow-Up Phase||8
8326546|NCT01390844|20526903|P3|COMPLETED|Follow-Up Phase||25
8326547|NCT01390844|20526904|P2|COMPLETED|Follow-Up Phase||36
8326548|NCT01390844|20526905|P1|COMPLETED|Follow-Up Phase||92
8326549|NCT01390844|20526902|P4|STARTED|Follow-Up Phase||8
8326550|NCT01390844|20526903|P3|STARTED|Follow-Up Phase||26
8326551|NCT01390844|20526904|P2|STARTED|Follow-Up Phase||37
8326552|NCT01390844|20526905|P1|STARTED|Follow-Up Phase||93
8326553|NCT01390844|20526902|P4|NOT COMPLETED|Treatment Phase||19
8326554|NCT01390844|20526903|P3|NOT COMPLETED|Treatment Phase||31
8326555|NCT01390844|20526904|P2|NOT COMPLETED|Treatment Phase||28
8326556|NCT01390844|20526905|P1|NOT COMPLETED|Treatment Phase||40
8326557|NCT01390844|20526902|P4|COMPLETED|Treatment Phase||8
8326558|NCT01390844|20526903|P3|COMPLETED|Treatment Phase||26
8326559|NCT01390844|20526904|P2|COMPLETED|Treatment Phase||37
8326560|NCT01390844|20526905|P1|COMPLETED|Treatment Phase||93
8326561|NCT01390844|20526902|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
8326562|NCT01390844|20526903|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
8326563|NCT01390844|20526904|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
8326564|NCT01390844|20526905|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
8326565|NCT01390844|20526902|P4|STARTED|Treatment Phase||27
8326566|NCT01390844|20526903|P3|STARTED|Treatment Phase||57
8326567|NCT01390844|20526904|P2|STARTED|Treatment Phase||65
8326568|NCT01390844|20526905|P1|STARTED|Treatment Phase||133
8326569|NCT01390818|20526946|P15|NOT COMPLETED|Overall Study||0
8326570|NCT01390818|20526947|P14|NOT COMPLETED|Overall Study||0
8326571|NCT01390818|20526948|P13|NOT COMPLETED|Overall Study||0
8326572|NCT01390818|20526949|P12|NOT COMPLETED|Overall Study||0
8326573|NCT01390818|20526950|P11|NOT COMPLETED|Overall Study||0
8326574|NCT01390818|20526951|P10|NOT COMPLETED|Overall Study||0
8326575|NCT01390818|20526952|P9|NOT COMPLETED|Overall Study||0
8326576|NCT01390818|20526953|P8|NOT COMPLETED|Overall Study||0
8326577|NCT01390818|20526954|P7|NOT COMPLETED|Overall Study||0
8326578|NCT01390818|20526955|P6|NOT COMPLETED|Overall Study||0
8326579|NCT01390818|20526956|P5|NOT COMPLETED|Overall Study||0
8326580|NCT01390818|20526957|P4|NOT COMPLETED|Overall Study||0
8326581|NCT01390818|20526958|P3|NOT COMPLETED|Overall Study||0
8326582|NCT01390818|20526959|P2|NOT COMPLETED|Overall Study||0
8326583|NCT01390818|20526960|P1|NOT COMPLETED|Overall Study||0
8326584|NCT01390818|20526946|P15|COMPLETED|Overall Study||15
8326585|NCT01390818|20526947|P14|COMPLETED|Overall Study||18
8326586|NCT01390818|20526948|P13|COMPLETED|Overall Study||24
8326587|NCT01390818|20526949|P12|COMPLETED|Overall Study||26
8326588|NCT01390818|20526950|P11|COMPLETED|Overall Study||4
8326589|NCT01390818|20526951|P10|COMPLETED|Overall Study||3
8326590|NCT01390818|20526952|P9|COMPLETED|Overall Study||3
8326591|NCT01390818|20526953|P8|COMPLETED|Overall Study||14
8326592|NCT01390818|20526954|P7|COMPLETED|Overall Study||19
8326593|NCT01390818|20526955|P6|COMPLETED|Overall Study||3
8326594|NCT01390818|20526956|P5|COMPLETED|Overall Study||4
8326595|NCT01390818|20526957|P4|COMPLETED|Overall Study||4
8326596|NCT01390818|20526958|P3|COMPLETED|Overall Study||3
8326597|NCT01390818|20526959|P2|COMPLETED|Overall Study||3
8326598|NCT01390818|20526960|P1|COMPLETED|Overall Study||3
8326599|NCT01390818|20526946|P15|STARTED|Overall Study||15
8326600|NCT01390818|20526947|P14|STARTED|Overall Study||18
8326601|NCT01390818|20526948|P13|STARTED|Overall Study||24
8326602|NCT01390818|20526949|P12|STARTED|Overall Study||26
8326603|NCT01390818|20526950|P11|STARTED|Overall Study||4
8326604|NCT01390818|20526951|P10|STARTED|Overall Study||3
8326605|NCT01390818|20526952|P9|STARTED|Overall Study||3
8326606|NCT01390818|20526953|P8|STARTED|Overall Study||14
8326607|NCT01390818|20526954|P7|STARTED|Overall Study||19
8326608|NCT01390818|20526955|P6|STARTED|Overall Study||3
8326609|NCT01390818|20526956|P5|STARTED|Overall Study||4
8326610|NCT01390818|20526957|P4|STARTED|Overall Study||4
8326611|NCT01390818|20526958|P3|STARTED|Overall Study||3
8326612|NCT01390818|20526959|P2|STARTED|Overall Study||3
8326613|NCT01390818|20526960|P1|STARTED|Overall Study||3
8326614|NCT01390779|20527232|P1|NOT COMPLETED|Overall Study||1
8326615|NCT01390779|20527232|P1|COMPLETED|Overall Study||32
8326616|NCT01390779|20527232|P1|STARTED|Overall Study||33
8326617|NCT01390649|20527237|P1|NOT COMPLETED|Overall Study||1
8326618|NCT01390649|20527237|P1|COMPLETED|Overall Study||56
8326619|NCT01390649|20527237|P1|STARTED|Overall Study|Subjects treated with Privigen|57
8326620|NCT01390584|20527244|P3|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326621|NCT01390584|20527245|P2|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326622|NCT01390584|20527246|P1|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326623|NCT01390584|20527244|P3|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326624|NCT01390584|20527245|P2|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
8326625|NCT01390584|20527246|P1|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
8326626|NCT01390584|20527244|P3|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
8326627|NCT01390584|20527245|P2|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
8326628|NCT01390584|20527246|P1|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
8326629|NCT01390584|20527244|P3|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326630|NCT01390584|20527245|P2|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8326631|NCT01390584|20527246|P1|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8326632|NCT01390584|20527244|P3|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8326633|NCT01390584|20527245|P2|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326634|NCT01390584|20527246|P1|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
8326635|NCT01390584|20527244|P3|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326636|NCT01390584|20527245|P2|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326637|NCT01390584|20527246|P1|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
8326638|NCT01390441|20527268|P5|NOT COMPLETED|Extension Period||0
8326639|NCT01390441|20527269|P4|NOT COMPLETED|Extension Period||1
8326640|NCT01390441|20527270|P3|NOT COMPLETED|Extension Period||0
8326641|NCT01390441|20527271|P2|NOT COMPLETED|Extension Period||1
8326642|NCT01390441|20527272|P1|NOT COMPLETED|Extension Period||3
8326643|NCT01390441|20527268|P5|COMPLETED|Extension Period||3
8326644|NCT01390441|20527269|P4|COMPLETED|Extension Period||0
8326645|NCT01390441|20527270|P3|COMPLETED|Extension Period||1
8326646|NCT01390441|20527271|P2|COMPLETED|Extension Period||12
8326647|NCT01390441|20527272|P1|COMPLETED|Extension Period||12
8326648|NCT01390441|20527268|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
8326649|NCT01390441|20527269|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
8326650|NCT01390441|20527270|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
8326651|NCT01390441|20527271|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
8326652|NCT01390441|20527272|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
8326653|NCT01390441|20527268|P5|NOT COMPLETED|Treatment Period||11
8326654|NCT01390441|20527269|P4|NOT COMPLETED|Treatment Period||13
8326655|NCT01390441|20527270|P3|NOT COMPLETED|Treatment Period||10
8326656|NCT01390441|20527271|P2|NOT COMPLETED|Treatment Period||1
8326657|NCT01390441|20527272|P1|NOT COMPLETED|Treatment Period||1
8326658|NCT01390441|20527268|P5|COMPLETED|Treatment Period||7
8326659|NCT01390441|20527269|P4|COMPLETED|Treatment Period||6
8326660|NCT01390441|20527270|P3|COMPLETED|Treatment Period||8
8326661|NCT01390441|20527271|P2|COMPLETED|Treatment Period||21
8326662|NCT01390441|20527272|P1|COMPLETED|Treatment Period||22
8326663|NCT01390441|20527268|P5|STARTED|Treatment Period||18
8326664|NCT01390441|20527269|P4|STARTED|Treatment Period||19
8326665|NCT01390441|20527270|P3|STARTED|Treatment Period||18
8326666|NCT01390441|20527271|P2|STARTED|Treatment Period||22
8326667|NCT01390441|20527272|P1|STARTED|Treatment Period||23
8326668|NCT01390428|20527337|P6|NOT COMPLETED|Overall Study||0
8326669|NCT01390428|20527338|P5|NOT COMPLETED|Overall Study||1
8326670|NCT01390428|20527339|P4|NOT COMPLETED|Overall Study||0
8326671|NCT01390428|20527340|P3|NOT COMPLETED|Overall Study||1
8326672|NCT01390428|20527341|P2|NOT COMPLETED|Overall Study||0
8326673|NCT01390428|20527342|P1|NOT COMPLETED|Overall Study||0
8326674|NCT01390428|20527337|P6|COMPLETED|Overall Study||8
8326675|NCT01390428|20527338|P5|COMPLETED|Overall Study||7
8326676|NCT01390428|20527339|P4|COMPLETED|Overall Study||9
8326677|NCT01390428|20527340|P3|COMPLETED|Overall Study||8
8326678|NCT01390428|20527341|P2|COMPLETED|Overall Study||8
8326679|NCT01390428|20527342|P1|COMPLETED|Overall Study||8
8326680|NCT01390428|20527337|P6|STARTED|Overall Study||8
8326681|NCT01390428|20527338|P5|STARTED|Overall Study||8
8326682|NCT01390428|20527339|P4|STARTED|Overall Study||9
8326683|NCT01390428|20527340|P3|STARTED|Overall Study||9
8326684|NCT01390428|20527341|P2|STARTED|Overall Study||8
8326685|NCT01390428|20527342|P1|STARTED|Overall Study||8
8326686|NCT01390415|20527394|P2|NOT COMPLETED|Overall Study||0
8326687|NCT01390415|20527395|P1|NOT COMPLETED|Overall Study||0
8326688|NCT01390415|20527394|P2|COMPLETED|Overall Study||37
8326689|NCT01390415|20527395|P1|COMPLETED|Overall Study||99
8326690|NCT01390415|20527394|P2|STARTED|Overall Study||37
8326691|NCT01390415|20527395|P1|STARTED|Overall Study||99
8326692|NCT01390402|20527405|P1|NOT COMPLETED|Overall Study||5
8326693|NCT01390402|20527405|P1|COMPLETED|Overall Study||1
8326694|NCT01390402|20527405|P1|STARTED|Overall Study||6
8326695|NCT01390389|20527411|P2|NOT COMPLETED|Overall Study||1
8326696|NCT01390389|20527412|P1|NOT COMPLETED|Overall Study||4
8326697|NCT01390389|20527411|P2|COMPLETED|Overall Study||8
8326698|NCT01390389|20527412|P1|COMPLETED|Overall Study||6
8326699|NCT01390389|20527411|P2|STARTED|Overall Study||9
8326700|NCT01390389|20527412|P1|STARTED|Overall Study||10
8326701|NCT01390298|20527422|P1|NOT COMPLETED|Overall Study||24
8326702|NCT01390298|20527422|P1|COMPLETED|Overall Study||31
8326703|NCT01390298|20527422|P1|STARTED|Overall Study||55
8326704|NCT01390272|20527428|P2|NOT COMPLETED|Overall Study||15
8326705|NCT01390272|20527429|P1|NOT COMPLETED|Overall Study||17
8326706|NCT01390272|20527428|P2|COMPLETED|Overall Study||178
8326707|NCT01390272|20527429|P1|COMPLETED|Overall Study||175
8326708|NCT01390272|20527428|P2|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
8326709|NCT01390272|20527429|P1|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
8326710|NCT01390272|20527428|P2|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
8326711|NCT01390272|20527429|P1|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
8326712|NCT01390272|20527428|P2|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
8326713|NCT01390272|20527429|P1|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
8326714|NCT01390272|20527428|P2|STARTED|Overall Study||193
8326715|NCT01390272|20527429|P1|STARTED|Overall Study||192
8326716|NCT01390259|20527459|P2|NOT COMPLETED|Overall Study||0
8326717|NCT01390259|20527460|P1|NOT COMPLETED|Overall Study||0
8326718|NCT01390259|20527459|P2|COMPLETED|Overall Study||6
8326719|NCT01390259|20527460|P1|COMPLETED|Overall Study||5
8326720|NCT01390259|20527459|P2|STARTED|Overall Study||6
8326721|NCT01390259|20527460|P1|STARTED|Overall Study||5
8326722|NCT01390246|20527471|P2|NOT COMPLETED|Overall Study||25
8326723|NCT01390246|20527472|P1|NOT COMPLETED|Overall Study||20
8326724|NCT01390246|20527471|P2|COMPLETED|Overall Study||10
8326725|NCT01390246|20527472|P1|COMPLETED|Overall Study||10
8326726|NCT01390246|20527471|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
8326727|NCT01390246|20527472|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
8326728|NCT01390246|20527471|P2|Visit 6: End of Treatment|Overall Study||15
8326729|NCT01390246|20527472|P1|Visit 6: End of Treatment|Overall Study||15
8326730|NCT01390246|20527471|P2|Visit 2: Quit Day|Overall Study||24
8326731|NCT01390246|20527472|P1|Visit 2: Quit Day|Overall Study||24
8326732|NCT01390246|20527471|P2|STARTED|Overall Study||35
8326733|NCT01390246|20527472|P1|STARTED|Overall Study||30
8326734|NCT01390233|20527487|P3|NOT COMPLETED|Overall Study||6
8326735|NCT01390233|20527488|P2|NOT COMPLETED|Overall Study||2
8326736|NCT01390233|20527489|P1|NOT COMPLETED|Overall Study||5
8326737|NCT01390233|20527487|P3|COMPLETED|Overall Study||30
8326738|NCT01390233|20527488|P2|COMPLETED|Overall Study||29
8326739|NCT01390233|20527489|P1|COMPLETED|Overall Study||30
8326740|NCT01390233|20527487|P3|STARTED|Overall Study||36
8326741|NCT01390233|20527488|P2|STARTED|Overall Study||31
8326742|NCT01390233|20527489|P1|STARTED|Overall Study||35
8326743|NCT01390220|20527497|P3|NOT COMPLETED|Comparative Phase||0
8326744|NCT01390220|20527498|P2|NOT COMPLETED|Comparative Phase||1
8326745|NCT01390220|20527499|P1|NOT COMPLETED|Comparative Phase||0
8326746|NCT01390220|20527497|P3|COMPLETED|Comparative Phase||67
8326747|NCT01390220|20527498|P2|COMPLETED|Comparative Phase||133
8326748|NCT01390220|20527499|P1|COMPLETED|Comparative Phase|This arm not applicable in CP|0
8326749|NCT01390220|20527497|P3|STARTED|Comparative Phase||67
8326750|NCT01390220|20527498|P2|STARTED|Comparative Phase||134
8326751|NCT01390220|20527499|P1|STARTED|Comparative Phase|This arm not applicable in CP|0
8326752|NCT01390220|20527497|P3|NOT COMPLETED|Test Dose Phase||0
8326753|NCT01390220|20527498|P2|NOT COMPLETED|Test Dose Phase||0
8326754|NCT01390220|20527499|P1|NOT COMPLETED|Test Dose Phase||91
8326755|NCT01390220|20527497|P3|COMPLETED|Test Dose Phase||0
8326756|NCT01390220|20527498|P2|COMPLETED|Test Dose Phase||0
8326757|NCT01390220|20527499|P1|COMPLETED|Test Dose Phase||201
8326758|NCT01390220|20527497|P3|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
8326759|NCT01390220|20527498|P2|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
8326760|NCT01390220|20527499|P1|STARTED|Test Dose Phase||292
8326761|NCT01390181|20527514|P1|NOT COMPLETED|Overall Study||4
8326762|NCT01390181|20527514|P1|COMPLETED|Overall Study||0
8326763|NCT01390181|20527514|P1|STARTED|Overall Study||4
8326764|NCT01390064|20527520|P2|NOT COMPLETED|Overall Study||0
8326765|NCT01390064|20527521|P1|NOT COMPLETED|Overall Study||0
8326766|NCT01390064|20527520|P2|COMPLETED|Overall Study||3
8326767|NCT01390064|20527521|P1|COMPLETED|Overall Study||3
8326768|NCT01390064|20527520|P2|STARTED|Overall Study||3
8326769|NCT01390064|20527521|P1|STARTED|Overall Study||3
8326770|NCT01390038|20527527|P1|NOT COMPLETED|Overall Study||8
8326771|NCT01390038|20527527|P1|COMPLETED|Overall Study||149
8326772|NCT01390038|20527527|P1|STARTED|Overall Study||157
8326773|NCT01389973|20527537|P1|NOT COMPLETED|Overall Study||20
8326774|NCT01389973|20527537|P1|COMPLETED|Overall Study||0
8326775|NCT01389973|20527537|P1|STARTED|Overall Study||20
8326776|NCT01389882|20527547|P2|NOT COMPLETED|Overall Study||4
8326777|NCT01389882|20527548|P1|NOT COMPLETED|Overall Study||1
8326778|NCT01389882|20527547|P2|COMPLETED|Overall Study||7
8326779|NCT01389882|20527548|P1|COMPLETED|Overall Study||12
8326780|NCT01389882|20527547|P2|STARTED|Overall Study||11
8326781|NCT01389882|20527548|P1|STARTED|Overall Study||13
8326782|NCT01389856|20527578|P2|NOT COMPLETED|Overall Study||0
8326783|NCT01389856|20527579|P1|NOT COMPLETED|Overall Study||0
8326784|NCT01389856|20527578|P2|COMPLETED|Overall Study||8
8326785|NCT01389856|20527579|P1|COMPLETED|Overall Study||13
8326786|NCT01389856|20527578|P2|STARTED|Overall Study|Randomized and treated.|8
8326787|NCT01389856|20527579|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
8326788|NCT01389817|20527636|P2|NOT COMPLETED|Overall Study||0
8326789|NCT01389817|20527637|P1|NOT COMPLETED|Overall Study||4
8326790|NCT01389817|20527636|P2|COMPLETED|Overall Study||0
8326791|NCT01389817|20527637|P1|COMPLETED|Overall Study||0
8326792|NCT01389817|20527636|P2|STARTED|Overall Study||0
8326793|NCT01389817|20527637|P1|STARTED|Overall Study||4
8326794|NCT01389765|20527643|P2|NOT COMPLETED|Second Intervention (Day 1)||0
8326795|NCT01389765|20527644|P1|NOT COMPLETED|Second Intervention (Day 1)||0
8326796|NCT01389765|20527643|P2|COMPLETED|Second Intervention (Day 1)||12
8326797|NCT01389765|20527644|P1|COMPLETED|Second Intervention (Day 1)||12
8326798|NCT01389765|20527643|P2|STARTED|Second Intervention (Day 1)||12
8326799|NCT01389765|20527644|P1|STARTED|Second Intervention (Day 1)||12
8326800|NCT01389765|20527643|P2|NOT COMPLETED|Washout Period (7 Days)||0
8326801|NCT01389765|20527644|P1|NOT COMPLETED|Washout Period (7 Days)||0
8326802|NCT01389765|20527643|P2|COMPLETED|Washout Period (7 Days)||12
8326803|NCT01389765|20527644|P1|COMPLETED|Washout Period (7 Days)||12
8326804|NCT01389765|20527643|P2|STARTED|Washout Period (7 Days)||12
8326805|NCT01389765|20527644|P1|STARTED|Washout Period (7 Days)||12
8326806|NCT01389765|20527643|P2|NOT COMPLETED|First Intervention (Day 1)||0
8326807|NCT01389765|20527644|P1|NOT COMPLETED|First Intervention (Day 1)||0
8326808|NCT01389765|20527643|P2|COMPLETED|First Intervention (Day 1)||12
8326809|NCT01389765|20527644|P1|COMPLETED|First Intervention (Day 1)||12
8326810|NCT01389765|20527643|P2|STARTED|First Intervention (Day 1)||12
8326811|NCT01389765|20527644|P1|STARTED|First Intervention (Day 1)||12
8326812|NCT01389752|20527654|P2|NOT COMPLETED|Study Period 2||0
8326813|NCT01389752|20527655|P1|NOT COMPLETED|Study Period 2||1
8326814|NCT01389752|20527654|P2|COMPLETED|Study Period 2||9
8326815|NCT01389752|20527655|P1|COMPLETED|Study Period 2||10
8326816|NCT01389752|20527654|P2|STARTED|Study Period 2||9
8326817|NCT01389752|20527655|P1|STARTED|Study Period 2||11
8326818|NCT01389752|20527654|P2|NOT COMPLETED|Study Period 1||2
8326819|NCT01389752|20527655|P1|NOT COMPLETED|Study Period 1||0
8326820|NCT01389752|20527654|P2|COMPLETED|Study Period 1||9
8326821|NCT01389752|20527655|P1|COMPLETED|Study Period 1||11
8326822|NCT01389752|20527654|P2|STARTED|Study Period 1||11
8326823|NCT01389752|20527655|P1|STARTED|Study Period 1||11
8326824|NCT01389596|20527668|P3|NOT COMPLETED|Overall Study||10
8326825|NCT01389596|20527669|P2|NOT COMPLETED|Overall Study||16
8326826|NCT01389596|20527670|P1|NOT COMPLETED|Overall Study||10
8326827|NCT01389596|20527668|P3|COMPLETED|Overall Study||84
8326828|NCT01389596|20527669|P2|COMPLETED|Overall Study||81
8326829|NCT01389596|20527670|P1|COMPLETED|Overall Study||94
8326830|NCT01389596|20527668|P3|STARTED|Overall Study||94
8326831|NCT01389596|20527669|P2|STARTED|Overall Study||97
8326832|NCT01389596|20527670|P1|STARTED|Overall Study||104
8326833|NCT01389323|20527729|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
8326834|NCT01389323|20527729|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
8326835|NCT01389323|20527729|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
8326836|NCT01389323|20527729|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
8326837|NCT01389323|20527729|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
8326838|NCT01389323|20527729|P1|STARTED|Treatment Period (up to 48 Weeks)||246
8326839|NCT01389284|20527752|P3|NOT COMPLETED|Overall Study||0
8326840|NCT01389284|20527753|P2|NOT COMPLETED|Overall Study||0
8326841|NCT01389284|20527754|P1|NOT COMPLETED|Overall Study||0
8326842|NCT01389284|20527752|P3|COMPLETED|Overall Study||60
8326843|NCT01389284|20527753|P2|COMPLETED|Overall Study||120
8326844|NCT01389284|20527754|P1|COMPLETED|Overall Study||120
8326845|NCT01389284|20527752|P3|STARTED|Overall Study||60
8326846|NCT01389284|20527753|P2|STARTED|Overall Study||120
8326847|NCT01389284|20527754|P1|STARTED|Overall Study||120
8326848|NCT01389258|20527786|P1|NOT COMPLETED|Overall Study||5
8326849|NCT01389258|20527786|P1|COMPLETED|Overall Study||40
8326850|NCT01389258|20527786|P1|STARTED|Overall Study||45
8326851|NCT01389245|20527796|P1|NOT COMPLETED|Overall Study||15
8326852|NCT01389245|20527796|P1|COMPLETED|Overall Study||27
8326853|NCT01389245|20527796|P1|STARTED|Overall Study||42
8326854|NCT01389128|20527806|P2|NOT COMPLETED|Overall Study||6
8326855|NCT01389128|20527807|P1|NOT COMPLETED|Overall Study||5
8326856|NCT01389128|20527806|P2|COMPLETED|Overall Study||34
8326857|NCT01389128|20527807|P1|COMPLETED|Overall Study||35
8326858|NCT01389128|20527806|P2|STARTED|Overall Study||40
8326859|NCT01389128|20527807|P1|STARTED|Overall Study||40
8326860|NCT01389102|20527831|P6|NOT COMPLETED|Overall Study||8
8326861|NCT01389102|20527832|P5|NOT COMPLETED|Overall Study||13
8326862|NCT01389102|20527833|P4|NOT COMPLETED|Overall Study||7
8326863|NCT01389102|20527834|P3|NOT COMPLETED|Overall Study||19
8326864|NCT01389102|20527835|P2|NOT COMPLETED|Overall Study||12
8326865|NCT01389102|20527836|P1|NOT COMPLETED|Overall Study||18
8326866|NCT01389102|20527831|P6|COMPLETED|Overall Study||68
8326867|NCT01389102|20527832|P5|COMPLETED|Overall Study||61
8326868|NCT01389102|20527833|P4|COMPLETED|Overall Study||69
8326869|NCT01389102|20527834|P3|COMPLETED|Overall Study||58
8326870|NCT01389102|20527835|P2|COMPLETED|Overall Study||64
8326871|NCT01389102|20527836|P1|COMPLETED|Overall Study||57
8326872|NCT01389102|20527831|P6|STARTED|Overall Study||76
8326873|NCT01389102|20527832|P5|STARTED|Overall Study||74
8326874|NCT01389102|20527833|P4|STARTED|Overall Study||76
8326875|NCT01389102|20527834|P3|STARTED|Overall Study||77
8326876|NCT01389102|20527835|P2|STARTED|Overall Study||76
8326877|NCT01389102|20527836|P1|STARTED|Overall Study||75
8326878|NCT01389076|20527856|P1|NOT COMPLETED|Overall Study||0
8326879|NCT01389076|20527856|P1|COMPLETED|Overall Study||22
8326880|NCT01389076|20527856|P1|STARTED|Overall Study||22
8326881|NCT01388985|20527866|P2|NOT COMPLETED|Overall Study||38
8326882|NCT01388985|20527867|P1|NOT COMPLETED|Overall Study||49
8326883|NCT01388985|20527866|P2|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
8326884|NCT01388985|20527867|P1|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
8326885|NCT01388985|20527866|P2|Primary Vaccination Period|Overall Study||238
8326886|NCT01388985|20527867|P1|Primary Vaccination Period|Overall Study||231
8326887|NCT01388985|20527866|P2|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
8326888|NCT01388985|20527867|P1|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
8326889|NCT01388946|20527883|P2|NOT COMPLETED|Overall Study||3
8326890|NCT01388946|20527884|P1|NOT COMPLETED|Overall Study||6
8326891|NCT01388946|20527883|P2|COMPLETED|Overall Study||52
8326892|NCT01388946|20527884|P1|COMPLETED|Overall Study||49
8326893|NCT01388946|20527883|P2|STARTED|Overall Study||55
8326894|NCT01388946|20527884|P1|STARTED|Overall Study||55
8326895|NCT01388920|20527919|P3|NOT COMPLETED|Overall Study||0
8326896|NCT01388920|20527920|P2|NOT COMPLETED|Overall Study||0
8326897|NCT01388920|20527921|P1|NOT COMPLETED|Overall Study||0
8326898|NCT01388920|20527919|P3|COMPLETED|Overall Study||0
8326899|NCT01388920|20527920|P2|COMPLETED|Overall Study||1
8326900|NCT01388920|20527921|P1|COMPLETED|Overall Study||1
8326901|NCT01388920|20527919|P3|STARTED|Overall Study||0
8326902|NCT01388920|20527920|P2|STARTED|Overall Study||1
8326903|NCT01388920|20527921|P1|STARTED|Overall Study||1
8326904|NCT01388907|20527931|P2|NOT COMPLETED|Overall Study||0
8326905|NCT01388907|20527932|P1|NOT COMPLETED|Overall Study||2
8326906|NCT01388907|20527931|P2|COMPLETED|Overall Study||28
8326907|NCT01388907|20527932|P1|COMPLETED|Overall Study||31
8326908|NCT01388907|20527931|P2|STARTED|Overall Study||28
8326909|NCT01388907|20527932|P1|STARTED|Overall Study||33
8326910|NCT01388816|20527948|P4|NOT COMPLETED|Overall Study||0
8326911|NCT01388816|20527949|P3|NOT COMPLETED|Overall Study||3
8326912|NCT01388816|20527950|P2|NOT COMPLETED|Overall Study||4
8326913|NCT01388816|20527951|P1|NOT COMPLETED|Overall Study||2
8326914|NCT01388816|20527948|P4|COMPLETED|Overall Study||44
8326915|NCT01388816|20527949|P3|COMPLETED|Overall Study||41
8326916|NCT01388816|20527950|P2|COMPLETED|Overall Study||39
8326917|NCT01388816|20527951|P1|COMPLETED|Overall Study||43
8326918|NCT01388816|20527948|P4|STARTED|Overall Study||44
8326919|NCT01388816|20527949|P3|STARTED|Overall Study||44
8326920|NCT01388816|20527950|P2|STARTED|Overall Study||43
8326921|NCT01388816|20527951|P1|STARTED|Overall Study||45
8326922|NCT01388790|20527980|P1|NOT COMPLETED|Overall Study||8
8326923|NCT01388790|20527980|P1|COMPLETED|Overall Study||32
8326924|NCT01388790|20527980|P1|STARTED|Overall Study||40
8326925|NCT01388777|20527985|P1|NOT COMPLETED|Overall Study||0
8326926|NCT01388777|20527985|P1|COMPLETED|Overall Study||1
8326927|NCT01388777|20527985|P1|Cryoablation|Overall Study||1
8326928|NCT01388777|20527985|P1|STARTED|Overall Study||1
8326929|NCT01388647|20527991|P2|NOT COMPLETED|Overall Study||2
8326930|NCT01388647|20527992|P1|NOT COMPLETED|Overall Study||1
8326931|NCT01388647|20527991|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
8326932|NCT01388647|20527992|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
8326933|NCT01388647|20527991|P2|STARTED|Overall Study||6
8326934|NCT01388647|20527992|P1|STARTED|Overall Study||6
8326935|NCT01388543|20528005|P2|NOT COMPLETED|Day 14||4
8326936|NCT01388543|20528006|P1|NOT COMPLETED|Day 14||1
8326937|NCT01388543|20528005|P2|COMPLETED|Day 14||12
8326938|NCT01388543|20528006|P1|COMPLETED|Day 14||14
8326939|NCT01388543|20528005|P2|STARTED|Day 14||16
8326940|NCT01388543|20528006|P1|STARTED|Day 14||15
8326941|NCT01388543|20528005|P2|NOT COMPLETED|Day 7, Primary End Point||0
8326942|NCT01388543|20528006|P1|NOT COMPLETED|Day 7, Primary End Point||0
8326943|NCT01388543|20528005|P2|COMPLETED|Day 7, Primary End Point||16
8326944|NCT01388543|20528006|P1|COMPLETED|Day 7, Primary End Point||15
8326945|NCT01388543|20528005|P2|STARTED|Day 7, Primary End Point||16
8326946|NCT01388543|20528006|P1|STARTED|Day 7, Primary End Point||15
8326947|NCT01388530|20528012|P1|NOT COMPLETED|Overall Study||5
8326948|NCT01388530|20528012|P1|COMPLETED|Overall Study||20
8326949|NCT01388530|20528012|P1|STARTED|Overall Study||25
8326950|NCT01388491|20528021|P2|NOT COMPLETED|Overall Study||29
8326951|NCT01388491|20528022|P1|NOT COMPLETED|Overall Study||34
8326952|NCT01388491|20528021|P2|COMPLETED|Overall Study||114
8326953|NCT01388491|20528022|P1|COMPLETED|Overall Study||116
8326954|NCT01388491|20528021|P2|Per Protocol (PP) Population|Overall Study||121
8326955|NCT01388491|20528022|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
8326956|NCT01388491|20528021|P2|Intent-to-Treat (ITT) Population|Overall Study||136
8326957|NCT01388491|20528022|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
8326958|NCT01388491|20528021|P2|Safety Population|Overall Study||142
8326959|NCT01388491|20528022|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
8326960|NCT01388491|20528021|P2|STARTED|Overall Study||143
8326961|NCT01388491|20528022|P1|STARTED|Overall Study|number randomized|150
8326962|NCT01388361|20528057|P3|NOT COMPLETED|Overall Study||14
8326963|NCT01388361|20528058|P2|NOT COMPLETED|Overall Study||12
8326964|NCT01388361|20528059|P1|NOT COMPLETED|Overall Study||12
8326965|NCT01388361|20528057|P3|COMPLETED|Overall Study||75
8326966|NCT01388361|20528058|P2|COMPLETED|Overall Study||76
8326967|NCT01388361|20528059|P1|COMPLETED|Overall Study||224
8326968|NCT01388361|20528057|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
8326969|NCT01388361|20528058|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
8326970|NCT01388361|20528059|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
8326971|NCT01388361|20528057|P3|STARTED|Overall Study||89
8326972|NCT01388361|20528058|P2|STARTED|Overall Study||88
8326973|NCT01388361|20528059|P1|STARTED|Overall Study||236
8326974|NCT01388335|20528076|P1|NOT COMPLETED|Safety Extension||7
8326975|NCT01388335|20528076|P1|COMPLETED|Safety Extension||0
8326976|NCT01388335|20528076|P1|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
8326977|NCT01388335|20528076|P1|NOT COMPLETED|Period 2||3
8326978|NCT01388335|20528076|P1|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
8326979|NCT01388335|20528076|P1|Received at Least 1 Dose of Study Drug|Period 2||12
8326980|NCT01388335|20528076|P1|STARTED|Period 2||12
8326981|NCT01388335|20528076|P1|NOT COMPLETED|Period 1||1
8326982|NCT01388335|20528076|P1|COMPLETED|Period 1||12
8326983|NCT01388335|20528076|P1|Received at Least 1 Dose of Study Drug|Period 1||13
8326984|NCT01388335|20528076|P1|STARTED|Period 1||13
8326985|NCT01388166|20528103|P1|NOT COMPLETED|Overall Study||59
8326986|NCT01388166|20528103|P1|COMPLETED|Overall Study||1194
8326987|NCT01388166|20528103|P1|STARTED|Overall Study||1253
8326988|NCT01387815|20528111|P2|NOT COMPLETED|Overall Study||104
8326989|NCT01387815|20528112|P1|NOT COMPLETED|Overall Study||140
8326990|NCT01387815|20528111|P2|COMPLETED|Overall Study||189
8326991|NCT01387815|20528112|P1|COMPLETED|Overall Study||162
8326992|NCT01387815|20528111|P2|STARTED|Overall Study||293
8326993|NCT01387815|20528112|P1|STARTED|Overall Study||302
8326994|NCT01387789|20528406|P1|NOT COMPLETED|Overall Study||8
8326995|NCT01387789|20528406|P1|COMPLETED|Overall Study||63
8326996|NCT01387789|20528406|P1|STARTED|Overall Study||71
8326997|NCT01387737|20528420|P2|NOT COMPLETED|Overall Study||74
8326998|NCT01387737|20528421|P1|NOT COMPLETED|Overall Study||52
8326999|NCT01387737|20528420|P2|COMPLETED|Overall Study||641
8327000|NCT01387737|20528421|P1|COMPLETED|Overall Study||532
8327001|NCT01387737|20528420|P2|STARTED|Overall Study||715
8327002|NCT01387737|20528421|P1|STARTED|Overall Study||584
8327003|NCT01387672|20528433|P6|NOT COMPLETED|Overall Study||0
8327004|NCT01387672|20528434|P5|NOT COMPLETED|Overall Study||4
8327005|NCT01387672|20528435|P4|NOT COMPLETED|Overall Study||4
8327006|NCT01387672|20528436|P3|NOT COMPLETED|Overall Study||5
8327007|NCT01387672|20528437|P2|NOT COMPLETED|Overall Study||7
8327008|NCT01387672|20528438|P1|NOT COMPLETED|Overall Study||7
8327009|NCT01387672|20528433|P6|COMPLETED|Overall Study||37
8327010|NCT01387672|20528434|P5|COMPLETED|Overall Study||34
8327011|NCT01387672|20528435|P4|COMPLETED|Overall Study||35
8327012|NCT01387672|20528436|P3|COMPLETED|Overall Study||33
8327013|NCT01387672|20528437|P2|COMPLETED|Overall Study||31
8327014|NCT01387672|20528438|P1|COMPLETED|Overall Study||32
8327015|NCT01387672|20528433|P6|STARTED|Overall Study||37
8327016|NCT01387672|20528434|P5|STARTED|Overall Study||38
8327017|NCT01387672|20528435|P4|STARTED|Overall Study||39
8327018|NCT01387672|20528436|P3|STARTED|Overall Study||38
8327019|NCT01387672|20528437|P2|STARTED|Overall Study||38
8327020|NCT01387672|20528438|P1|STARTED|Overall Study||39
8327021|NCT01387594|20528455|P2|NOT COMPLETED|Overall Study||3
8327022|NCT01387594|20528456|P1|NOT COMPLETED|Overall Study||0
8327023|NCT01387594|20528455|P2|COMPLETED|Overall Study||36
8327024|NCT01387594|20528456|P1|COMPLETED|Overall Study||10
8327025|NCT01387594|20528455|P2|STARTED|Overall Study||39
8327026|NCT01387594|20528456|P1|STARTED|Overall Study||10
8327027|NCT01387581|20528471|P3|NOT COMPLETED|Overall Study||3
8327028|NCT01387581|20528472|P2|NOT COMPLETED|Overall Study||6
8327029|NCT01387581|20528473|P1|NOT COMPLETED|Overall Study||7
8327030|NCT01387581|20528471|P3|COMPLETED|Overall Study||9
8327031|NCT01387581|20528472|P2|COMPLETED|Overall Study||101
8327032|NCT01387581|20528473|P1|COMPLETED|Overall Study||101
8327033|NCT01387581|20528471|P3|STARTED|Overall Study||12
8327034|NCT01387581|20528472|P2|STARTED|Overall Study||107
8327035|NCT01387581|20528473|P1|STARTED|Overall Study||108
8327036|NCT01387542|20528484|P1|NOT COMPLETED|Overall Study||8
8327037|NCT01387542|20528484|P1|COMPLETED|Overall Study||32
8327038|NCT01387542|20528484|P1|Treated|Overall Study||38
8327039|NCT01387542|20528484|P1|STARTED|Overall Study||40
8327040|NCT01387516|20528495|P4|NOT COMPLETED|Overall Study||4
8327041|NCT01387516|20528496|P3|NOT COMPLETED|Overall Study||4
8327042|NCT01387516|20528497|P2|NOT COMPLETED|Overall Study||5
8327043|NCT01387516|20528498|P1|NOT COMPLETED|Overall Study||5
8327044|NCT01387516|20528495|P4|COMPLETED|Overall Study||65
8327045|NCT01387516|20528496|P3|COMPLETED|Overall Study||75
8327046|NCT01387516|20528497|P2|COMPLETED|Overall Study||63
8327047|NCT01387516|20528498|P1|COMPLETED|Overall Study||75
8327048|NCT01387516|20528495|P4|STARTED|Overall Study||69
8327049|NCT01387516|20528496|P3|STARTED|Overall Study||79
8327050|NCT01387516|20528497|P2|STARTED|Overall Study||68
8327051|NCT01387516|20528498|P1|STARTED|Overall Study||80
8327052|NCT01387464|20528522|P2|NOT COMPLETED|Overall Study||1
8327053|NCT01387464|20528523|P1|NOT COMPLETED|Overall Study||1
8327054|NCT01387464|20528522|P2|COMPLETED|Overall Study||29
8327055|NCT01387464|20528523|P1|COMPLETED|Overall Study||29
8327056|NCT01387464|20528522|P2|Per-Protocol Population|Overall Study||29
8327057|NCT01387464|20528523|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
8327058|NCT01387464|20528522|P2|Safety Population|Overall Study||29
8327059|NCT01387464|20528523|P1|Safety Population|Overall Study||30
8327060|NCT01387464|20528522|P2|STARTED|Overall Study||30
8327061|NCT01387464|20528523|P1|STARTED|Overall Study||30
8327062|NCT01387347|20528531|P2|NOT COMPLETED|Overall Study||1
8327063|NCT01387347|20528532|P1|NOT COMPLETED|Overall Study||2
8327064|NCT01387347|20528531|P2|COMPLETED|Overall Study||35
8327065|NCT01387347|20528532|P1|COMPLETED|Overall Study||34
8327066|NCT01387347|20528531|P2|STARTED|Overall Study||36
8327067|NCT01387347|20528532|P1|STARTED|Overall Study||36
8327068|NCT01387282|20528544|P2|NOT COMPLETED|Overall Study||47
8327069|NCT01387282|20528545|P1|NOT COMPLETED|Overall Study||97
8327070|NCT01387282|20528544|P2|COMPLETED|Overall Study||118
8327071|NCT01387282|20528545|P1|COMPLETED|Overall Study||233
8327072|NCT01387282|20528544|P2|Safety Population|Overall Study||161
8327073|NCT01387282|20528545|P1|Safety Population|Overall Study||330
8327074|NCT01387282|20528544|P2|MITT Population|Overall Study||136
8327075|NCT01387282|20528545|P1|MITT Population|Overall Study||268
8327076|NCT01387282|20528544|P2|ITT Population|Overall Study||165
8327077|NCT01387282|20528545|P1|ITT Population|Overall Study||330
8327078|NCT01387282|20528544|P2|STARTED|Overall Study||165
8327079|NCT01387282|20528545|P1|STARTED|Overall Study||330
8327080|NCT01387269|20528561|P2|NOT COMPLETED|Overall Study||40
8327081|NCT01387269|20528562|P1|NOT COMPLETED|Overall Study||92
8327082|NCT01387269|20528561|P2|COMPLETED|Overall Study||121
8327083|NCT01387269|20528562|P1|COMPLETED|Overall Study||231
8327084|NCT01387269|20528561|P2|Safety Population|Overall Study||161
8327085|NCT01387269|20528562|P1|Safety Population|Overall Study||320
8327086|NCT01387269|20528561|P2|MITT Population|Overall Study||141
8327087|NCT01387269|20528562|P1|MITT Population|Overall Study||284
8327088|NCT01387269|20528561|P2|ITT Population|Overall Study||161
8327089|NCT01387269|20528562|P1|ITT Population|Overall Study||323
8327090|NCT01387269|20528561|P2|STARTED|Overall Study||161
8327091|NCT01387269|20528562|P1|STARTED|Overall Study||323
8327092|NCT01387230|20528579|P3|NOT COMPLETED|Overall Study||13
8327093|NCT01387230|20528580|P2|NOT COMPLETED|Overall Study||7
8327094|NCT01387230|20528581|P1|NOT COMPLETED|Overall Study||18
8327095|NCT01387230|20528579|P3|COMPLETED|Overall Study||56
8327096|NCT01387230|20528580|P2|COMPLETED|Overall Study||62
8327097|NCT01387230|20528581|P1|COMPLETED|Overall Study||50
8327098|NCT01387230|20528579|P3|STARTED|Overall Study||69
8327099|NCT01387230|20528580|P2|STARTED|Overall Study||69
8327100|NCT01387230|20528581|P1|STARTED|Overall Study||68
8327101|NCT01387178|20528597|P2|NOT COMPLETED|Overall Study||0
8327102|NCT01387178|20528598|P1|NOT COMPLETED|Overall Study||0
8327103|NCT01387178|20528597|P2|COMPLETED|Overall Study||10641
8327104|NCT01387178|20528598|P1|COMPLETED|Overall Study||11582
8327105|NCT01387178|20528597|P2|STARTED|Overall Study||10641
8327106|NCT01387178|20528598|P1|STARTED|Overall Study||11582
8327107|NCT01387139|20528610|P2|NOT COMPLETED|Overall Study||0
8327108|NCT01387139|20528611|P1|NOT COMPLETED|Overall Study||0
8327109|NCT01387139|20528610|P2|COMPLETED|Overall Study||84
8327110|NCT01387139|20528611|P1|COMPLETED|Overall Study||99
8327111|NCT01387139|20528610|P2|STARTED|Overall Study||84
8327112|NCT01387139|20528611|P1|STARTED|Overall Study||99
8327113|NCT01387074|20528627|P1|NOT COMPLETED|Overall Study||8
8327114|NCT01387074|20528627|P1|COMPLETED|Overall Study||100
8327115|NCT01387074|20528627|P1|STARTED|Overall Study||108
8327116|NCT01387022|20528640|P2|NOT COMPLETED|Overall Study||4
8327117|NCT01387022|20528641|P1|NOT COMPLETED|Overall Study||1
8327118|NCT01387022|20528640|P2|COMPLETED|Overall Study||26
8327119|NCT01387022|20528641|P1|COMPLETED|Overall Study||28
8327120|NCT01387022|20528640|P2|STARTED|Overall Study||30
8327121|NCT01387022|20528641|P1|STARTED|Overall Study||29
8327122|NCT01386983|20528659|P2|NOT COMPLETED|Overall Study||0
8327123|NCT01386983|20528660|P1|NOT COMPLETED|Overall Study||0
8327124|NCT01386983|20528659|P2|COMPLETED|Overall Study||68
8327125|NCT01386983|20528660|P1|COMPLETED|Overall Study||264
8327126|NCT01386983|20528659|P2|STARTED|Overall Study||68
8327127|NCT01386983|20528660|P1|STARTED|Overall Study||264
8327128|NCT01386970|20528670|P2|NOT COMPLETED|Overall Study||2
8327129|NCT01386970|20528671|P1|NOT COMPLETED|Overall Study||4
8327130|NCT01386970|20528670|P2|COMPLETED|Overall Study||21
8327131|NCT01386970|20528671|P1|COMPLETED|Overall Study||16
8327132|NCT01386970|20528670|P2|STARTED|Overall Study||23
8327133|NCT01386970|20528671|P1|STARTED|Overall Study||20
8327134|NCT01386944|20528679|P1|NOT COMPLETED|Overall Study||56
8327135|NCT01386944|20528679|P1|COMPLETED|Overall Study||46
8327136|NCT01386944|20528679|P1|STARTED|Overall Study||102
8327137|NCT01386788|20528689|P1|NOT COMPLETED|Overall Study||2
8327138|NCT01386788|20528689|P1|COMPLETED|Overall Study||100
8327139|NCT01386788|20528689|P1|STARTED|Overall Study||102
8327140|NCT01386684|20528694|P1|NOT COMPLETED|Overall Study||293
8327141|NCT01386684|20528694|P1|COMPLETED|Overall Study||259
8327142|NCT01386684|20528694|P1|STARTED|Overall Study||552
8327143|NCT01386658|20528735|P2|NOT COMPLETED|Icatibant Exposure 3||0
8327144|NCT01386658|20528736|P1|NOT COMPLETED|Icatibant Exposure 3||0
8327145|NCT01386658|20528735|P2|COMPLETED|Icatibant Exposure 3||9
8327146|NCT01386658|20528736|P1|COMPLETED|Icatibant Exposure 3||0
8327147|NCT01386658|20528735|P2|STARTED|Icatibant Exposure 3||9
8327148|NCT01386658|20528736|P1|STARTED|Icatibant Exposure 3||0
8327149|NCT01386658|20528735|P2|NOT COMPLETED|Icatibant Exposure 2||0
8327150|NCT01386658|20528736|P1|NOT COMPLETED|Icatibant Exposure 2||0
8327151|NCT01386658|20528735|P2|COMPLETED|Icatibant Exposure 2||9
8327152|NCT01386658|20528736|P1|COMPLETED|Icatibant Exposure 2||0
8327153|NCT01386658|20528735|P2|STARTED|Icatibant Exposure 2||9
8327154|NCT01386658|20528736|P1|STARTED|Icatibant Exposure 2||0
8327155|NCT01386658|20528735|P2|NOT COMPLETED|Initial Icatibant Exposure||12
8327156|NCT01386658|20528736|P1|NOT COMPLETED|Initial Icatibant Exposure||0
8327157|NCT01386658|20528735|P2|COMPLETED|Initial Icatibant Exposure||9
8327158|NCT01386658|20528736|P1|COMPLETED|Initial Icatibant Exposure||11
8327159|NCT01386658|20528735|P2|STARTED|Initial Icatibant Exposure||21
8327160|NCT01386658|20528736|P1|STARTED|Initial Icatibant Exposure||11
8327161|NCT01386645|20528802|P3|NOT COMPLETED|Overall Study||2
8327162|NCT01386645|20528803|P2|NOT COMPLETED|Overall Study||1
8327163|NCT01386645|20528804|P1|NOT COMPLETED|Overall Study||0
8327164|NCT01386645|20528802|P3|COMPLETED|Overall Study||17
8327165|NCT01386645|20528803|P2|COMPLETED|Overall Study||18
8327166|NCT01386645|20528804|P1|COMPLETED|Overall Study||18
8327167|NCT01386645|20528802|P3|STARTED|Overall Study||19
8327168|NCT01386645|20528803|P2|STARTED|Overall Study||19
8327169|NCT01386645|20528804|P1|STARTED|Overall Study||18
8327170|NCT01386632|20528820|P2|NOT COMPLETED|Overall Study||4
8327171|NCT01386632|20528821|P1|NOT COMPLETED|Overall Study||5
8327172|NCT01386632|20528820|P2|COMPLETED|Overall Study||21
8327173|NCT01386632|20528821|P1|COMPLETED|Overall Study||20
8327174|NCT01386632|20528820|P2|STARTED|Overall Study||25
8327175|NCT01386632|20528821|P1|STARTED|Overall Study||25
8327176|NCT01386606|20528833|P4|NOT COMPLETED|Overall Study||1
8327177|NCT01386606|20528834|P3|NOT COMPLETED|Overall Study||3
8327178|NCT01386606|20528835|P2|NOT COMPLETED|Overall Study||4
8327179|NCT01386606|20528836|P1|NOT COMPLETED|Overall Study||4
8327180|NCT01386606|20528833|P4|COMPLETED|Overall Study||13
8327181|NCT01386606|20528834|P3|COMPLETED|Overall Study||13
8327182|NCT01386606|20528835|P2|COMPLETED|Overall Study||10
8327183|NCT01386606|20528836|P1|COMPLETED|Overall Study||12
8327184|NCT01386606|20528833|P4|STARTED|Overall Study||14
8327185|NCT01386606|20528834|P3|STARTED|Overall Study||16
8327186|NCT01386606|20528835|P2|STARTED|Overall Study||14
8327187|NCT01386606|20528836|P1|STARTED|Overall Study||16
8327188|NCT01386554|20528867|P3|NOT COMPLETED|Overall Study||6
8327189|NCT01386554|20528868|P2|NOT COMPLETED|Overall Study||9
8327190|NCT01386554|20528869|P1|NOT COMPLETED|Overall Study||3
8327191|NCT01386554|20528867|P3|COMPLETED|Overall Study||15
8327192|NCT01386554|20528868|P2|COMPLETED|Overall Study||26
8327193|NCT01386554|20528869|P1|COMPLETED|Overall Study||1
8327194|NCT01386554|20528867|P3|STARTED|Overall Study||21
8327195|NCT01386554|20528868|P2|STARTED|Overall Study||35
8327196|NCT01386554|20528869|P1|STARTED|Overall Study||4
8327197|NCT01386528|20528880|P1|NOT COMPLETED|Overall Study||0
8327198|NCT01386528|20528880|P1|COMPLETED|Overall Study||13
8327199|NCT01386528|20528880|P1|STARTED|Overall Study||13
8327200|NCT01386125|20528892|P2|NOT COMPLETED|Overall Study||37
8327201|NCT01386125|20528893|P1|NOT COMPLETED|Overall Study||25
8327202|NCT01386125|20528892|P2|COMPLETED|Overall Study||336
8327203|NCT01386125|20528893|P1|COMPLETED|Overall Study||350
8327204|NCT01386125|20528892|P2|STARTED|Overall Study||373
8327205|NCT01386125|20528893|P1|STARTED|Overall Study||375
8327206|NCT01386008|20528901|P1|NOT COMPLETED|Overall Study||20
8327207|NCT01386008|20528901|P1|COMPLETED|Overall Study||0
8327208|NCT01386008|20528901|P1|STARTED|Overall Study||20
8327209|NCT01385995|20528910|P2|NOT COMPLETED|Period 2, 2 Months||0
8327210|NCT01385995|20528911|P1|NOT COMPLETED|Period 2, 2 Months||0
8327211|NCT01385995|20528910|P2|COMPLETED|Period 2, 2 Months||25
8327212|NCT01385995|20528911|P1|COMPLETED|Period 2, 2 Months||24
8327213|NCT01385995|20528910|P2|STARTED|Period 2, 2 Months||25
8327214|NCT01385995|20528911|P1|STARTED|Period 2, 2 Months||24
8327215|NCT01385995|20528910|P2|NOT COMPLETED|Washout Period, 1 Month||0
8327216|NCT01385995|20528911|P1|NOT COMPLETED|Washout Period, 1 Month||0
8327217|NCT01385995|20528910|P2|COMPLETED|Washout Period, 1 Month||25
8327218|NCT01385995|20528911|P1|COMPLETED|Washout Period, 1 Month||24
8327219|NCT01385995|20528910|P2|STARTED|Washout Period, 1 Month||25
8327220|NCT01385995|20528911|P1|STARTED|Washout Period, 1 Month||24
8327221|NCT01385995|20528910|P2|NOT COMPLETED|Period 1, 2 Months||0
8327222|NCT01385995|20528911|P1|NOT COMPLETED|Period 1, 2 Months||1
8327223|NCT01385995|20528910|P2|COMPLETED|Period 1, 2 Months||25
8327224|NCT01385995|20528911|P1|COMPLETED|Period 1, 2 Months||24
8327225|NCT01385995|20528910|P2|STARTED|Period 1, 2 Months||25
8327226|NCT01385995|20528911|P1|STARTED|Period 1, 2 Months||25
8327227|NCT01385748|20528928|P3|NOT COMPLETED|Overall Study||13
8327228|NCT01385748|20528929|P2|NOT COMPLETED|Overall Study||14
8327229|NCT01385748|20528930|P1|NOT COMPLETED|Overall Study||15
8327230|NCT01385748|20528928|P3|COMPLETED|Overall Study||49
8327231|NCT01385748|20528929|P2|COMPLETED|Overall Study||51
8327232|NCT01385748|20528930|P1|COMPLETED|Overall Study||41
8327233|NCT01385748|20528928|P3|STARTED|Overall Study||62
8327234|NCT01385748|20528929|P2|STARTED|Overall Study||65
8327235|NCT01385748|20528930|P1|STARTED|Overall Study||56
8327236|NCT01385696|20528975|P2|NOT COMPLETED|Overall Study||0
8327237|NCT01385696|20528976|P1|NOT COMPLETED|Overall Study||0
8327238|NCT01385696|20528975|P2|COMPLETED|Overall Study||64
8327239|NCT01385696|20528976|P1|COMPLETED|Overall Study||66
8327240|NCT01385696|20528975|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
8327241|NCT01385696|20528976|P1|STARTED|Overall Study||66
8327242|NCT01385644|20528987|P2|NOT COMPLETED|Overall Study||0
8327243|NCT01385644|20528988|P1|NOT COMPLETED|Overall Study||0
8327244|NCT01385644|20528987|P2|COMPLETED|Overall Study||4
8327245|NCT01385644|20528988|P1|COMPLETED|Overall Study||4
8327246|NCT01385644|20528987|P2|STARTED|Overall Study||4
8327247|NCT01385644|20528988|P1|STARTED|Overall Study||4
8327248|NCT01385579|20529002|P2|NOT COMPLETED|Overall Study||0
8327249|NCT01385579|20529003|P1|NOT COMPLETED|Overall Study||0
8327250|NCT01385579|20529002|P2|COMPLETED|Overall Study||104
8327251|NCT01385579|20529003|P1|COMPLETED|Overall Study||98
8327252|NCT01385579|20529002|P2|STARTED|Overall Study||104
8327253|NCT01385579|20529003|P1|STARTED|Overall Study||98
8327254|NCT01385566|20529015|P6|NOT COMPLETED|Overall Study||0
8327255|NCT01385566|20529016|P5|NOT COMPLETED|Overall Study||0
8327256|NCT01385566|20529017|P4|NOT COMPLETED|Overall Study||1
8327257|NCT01385566|20529018|P3|NOT COMPLETED|Overall Study||0
8327258|NCT01385566|20529019|P2|NOT COMPLETED|Overall Study||0
8327259|NCT01385566|20529020|P1|NOT COMPLETED|Overall Study||1
8327260|NCT01385566|20529015|P6|COMPLETED|Overall Study||34
8327261|NCT01385566|20529016|P5|COMPLETED|Overall Study||34
8327262|NCT01385566|20529017|P4|COMPLETED|Overall Study||34
8327263|NCT01385566|20529018|P3|COMPLETED|Overall Study||34
8327264|NCT01385566|20529019|P2|COMPLETED|Overall Study||34
8327265|NCT01385566|20529020|P1|COMPLETED|Overall Study||51
8327266|NCT01385566|20529015|P6|STARTED|Overall Study||34
8327267|NCT01385566|20529016|P5|STARTED|Overall Study||34
8327268|NCT01385566|20529017|P4|STARTED|Overall Study||35
8327269|NCT01385566|20529018|P3|STARTED|Overall Study||34
8327270|NCT01385566|20529019|P2|STARTED|Overall Study||34
8327271|NCT01385566|20529020|P1|STARTED|Overall Study||52
8327272|NCT01385371|20529074|P2|NOT COMPLETED|Overall Study||97
8327273|NCT01385371|20529075|P1|NOT COMPLETED|Overall Study||149
8327274|NCT01385371|20529074|P2|COMPLETED|Overall Study||652
8327275|NCT01385371|20529075|P1|COMPLETED|Overall Study||603
8327276|NCT01385371|20529074|P2|STARTED|Overall Study||749
8327277|NCT01385371|20529075|P1|STARTED|Overall Study||752
8327278|NCT01385306|20529095|P1|NOT COMPLETED|Overall Study||0
8327279|NCT01385306|20529095|P1|COMPLETED|Overall Study||6
8327280|NCT01385306|20529095|P1|STARTED|Overall Study||6
8327281|NCT01385293|20529103|P1|NOT COMPLETED|Overall Study||0
8327282|NCT01385293|20529103|P1|COMPLETED|Overall Study||30
8327283|NCT01385293|20529103|P1|STARTED|Overall Study||30
8327284|NCT01385280|20529113|P1|NOT COMPLETED|Overall Study||0
8327285|NCT01385280|20529113|P1|COMPLETED|Overall Study||13
8327286|NCT01385280|20529113|P1|STARTED|Overall Study||13
8327287|NCT01385202|20529123|P1|NOT COMPLETED|Overall Study||18
8327288|NCT01385202|20529123|P1|COMPLETED|Overall Study||154
8327289|NCT01385202|20529123|P1|Undergoing Ablation|Overall Study||160
8327290|NCT01385202|20529123|P1|Study Catheter Inserted|Overall Study||161
8327291|NCT01385202|20529123|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
8327292|NCT01385189|20529135|P5|NOT COMPLETED|Overall Study||2
8327293|NCT01385189|20529136|P4|NOT COMPLETED|Overall Study||1
8327294|NCT01385189|20529137|P3|NOT COMPLETED|Overall Study||0
8327295|NCT01385189|20529138|P2|NOT COMPLETED|Overall Study||1
8327296|NCT01385189|20529139|P1|NOT COMPLETED|Overall Study||1
8327297|NCT01385189|20529135|P5|COMPLETED|Overall Study||6
8327298|NCT01385189|20529136|P4|COMPLETED|Overall Study||3
8327299|NCT01385189|20529137|P3|COMPLETED|Overall Study||4
8327300|NCT01385189|20529138|P2|COMPLETED|Overall Study||11
8327301|NCT01385189|20529139|P1|COMPLETED|Overall Study||11
8327302|NCT01385189|20529135|P5|STARTED|Overall Study||8
8327303|NCT01385189|20529136|P4|STARTED|Overall Study||4
8327304|NCT01385189|20529137|P3|STARTED|Overall Study||4
8327305|NCT01385189|20529138|P2|STARTED|Overall Study||12
8327306|NCT01385189|20529139|P1|STARTED|Overall Study||12
8327307|NCT01385176|20529160|P2|NOT COMPLETED|6-18 Month All VNS Active||3
8327308|NCT01385176|20529161|P1|NOT COMPLETED|6-18 Month All VNS Active||4
8327309|NCT01385176|20529160|P2|COMPLETED|6-18 Month All VNS Active||27
8327310|NCT01385176|20529161|P1|COMPLETED|6-18 Month All VNS Active||58
8327311|NCT01385176|20529160|P2|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
8327312|NCT01385176|20529161|P1|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
8327313|NCT01385176|20529160|P2|NOT COMPLETED|Randomization Phase||2
8327314|NCT01385176|20529161|P1|NOT COMPLETED|Randomization Phase||1
8327315|NCT01385176|20529160|P2|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
8327316|NCT01385176|20529161|P1|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
8327317|NCT01385176|20529160|P2|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
8327318|NCT01385176|20529161|P1|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
8327319|NCT01385137|20529177|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
8327320|NCT01385137|20529178|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
8327321|NCT01385137|20529177|P2|COMPLETED|Evaluable for Primary Endpoint||107
8327322|NCT01385137|20529178|P1|COMPLETED|Evaluable for Primary Endpoint||102
8327323|NCT01385137|20529177|P2|STARTED|Evaluable for Primary Endpoint||131
8327324|NCT01385137|20529178|P1|STARTED|Evaluable for Primary Endpoint||131
8327325|NCT01385137|20529177|P2|NOT COMPLETED|Evaluable at Baseline||4
8327326|NCT01385137|20529178|P1|NOT COMPLETED|Evaluable at Baseline||9
8327327|NCT01385137|20529177|P2|COMPLETED|Evaluable at Baseline||127
8327328|NCT01385137|20529178|P1|COMPLETED|Evaluable at Baseline||122
8327329|NCT01385137|20529177|P2|STARTED|Evaluable at Baseline||131
8327330|NCT01385137|20529178|P1|STARTED|Evaluable at Baseline||131
8327331|NCT01385098|20529192|P1|NOT COMPLETED|Overall Study||14
8327332|NCT01385098|20529192|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
8327333|NCT01385098|20529192|P1|STARTED|Overall Study||37
8327334|NCT01385033|20529200|P6|NOT COMPLETED|Part III||0
8327335|NCT01385033|20529201|P5|NOT COMPLETED|Part III||0
8327336|NCT01385033|20529202|P4|NOT COMPLETED|Part III||0
8327337|NCT01385033|20529203|P3|NOT COMPLETED|Part III||0
8327338|NCT01385033|20529204|P2|NOT COMPLETED|Part III||0
8327339|NCT01385033|20529205|P1|NOT COMPLETED|Part III||0
8327340|NCT01385033|20529200|P6|COMPLETED|Part III||0
8327341|NCT01385033|20529201|P5|COMPLETED|Part III||0
8327342|NCT01385033|20529202|P4|COMPLETED|Part III||0
8327343|NCT01385033|20529203|P3|COMPLETED|Part III||0
8327344|NCT01385033|20529204|P2|COMPLETED|Part III||0
8327345|NCT01385033|20529205|P1|COMPLETED|Part III||0
8327346|NCT01385033|20529200|P6|STARTED|Part III||0
8327347|NCT01385033|20529201|P5|STARTED|Part III||0
8327348|NCT01385033|20529202|P4|STARTED|Part III||0
8327349|NCT01385033|20529203|P3|STARTED|Part III||0
8327350|NCT01385033|20529204|P2|STARTED|Part III||0
8327351|NCT01385033|20529205|P1|STARTED|Part III||0
8327352|NCT01385033|20529200|P6|NOT COMPLETED|Part II||0
8327353|NCT01385033|20529201|P5|NOT COMPLETED|Part II||0
8327354|NCT01385033|20529202|P4|NOT COMPLETED|Part II||0
8327355|NCT01385033|20529203|P3|NOT COMPLETED|Part II||0
8327356|NCT01385033|20529204|P2|NOT COMPLETED|Part II||0
8327357|NCT01385033|20529205|P1|NOT COMPLETED|Part II||0
8327358|NCT01385033|20529200|P6|COMPLETED|Part II||0
8327359|NCT01385033|20529201|P5|COMPLETED|Part II||0
8327360|NCT01385033|20529202|P4|COMPLETED|Part II||0
8327361|NCT01385033|20529203|P3|COMPLETED|Part II||0
8327362|NCT01385033|20529204|P2|COMPLETED|Part II||0
8327363|NCT01385033|20529205|P1|COMPLETED|Part II||0
8327364|NCT01385033|20529200|P6|STARTED|Part II||0
8327365|NCT01385033|20529201|P5|STARTED|Part II||0
8327366|NCT01385033|20529202|P4|STARTED|Part II||0
8327367|NCT01385033|20529203|P3|STARTED|Part II||0
8327368|NCT01385033|20529204|P2|STARTED|Part II||0
8327369|NCT01385033|20529205|P1|STARTED|Part II||0
8327370|NCT01385033|20529200|P6|NOT COMPLETED|Part I||0
8327371|NCT01385033|20529201|P5|NOT COMPLETED|Part I||0
8327372|NCT01385033|20529202|P4|NOT COMPLETED|Part I||0
8327373|NCT01385033|20529203|P3|NOT COMPLETED|Part I||0
8327374|NCT01385033|20529204|P2|NOT COMPLETED|Part I||0
8327375|NCT01385033|20529205|P1|NOT COMPLETED|Part I||0
8327376|NCT01385033|20529200|P6|COMPLETED|Part I||0
8327377|NCT01385033|20529201|P5|COMPLETED|Part I||0
8327378|NCT01385033|20529202|P4|COMPLETED|Part I||0
8327379|NCT01385033|20529203|P3|COMPLETED|Part I||0
8327380|NCT01385033|20529204|P2|COMPLETED|Part I||14
8327381|NCT01385033|20529205|P1|COMPLETED|Part I||6
8327382|NCT01385033|20529200|P6|STARTED|Part I||0
8327383|NCT01385033|20529201|P5|STARTED|Part I||0
8327384|NCT01385033|20529202|P4|STARTED|Part I||0
8327385|NCT01385033|20529203|P3|STARTED|Part I||0
8327386|NCT01385033|20529204|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
8327387|NCT01385033|20529205|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
8327388|NCT01384877|20529214|P2|NOT COMPLETED|Treatment 2||2
8327389|NCT01384877|20529215|P1|NOT COMPLETED|Treatment 2||2
8327390|NCT01384877|20529214|P2|COMPLETED|Treatment 2||11
8327391|NCT01384877|20529215|P1|COMPLETED|Treatment 2||14
8327392|NCT01384877|20529214|P2|STARTED|Treatment 2|2 Patients died between treatment periods|13
8327393|NCT01384877|20529215|P1|STARTED|Treatment 2|1 Patient died between treatment periods|16
8327394|NCT01384877|20529214|P2|NOT COMPLETED|Treatment 1||0
8327395|NCT01384877|20529215|P1|NOT COMPLETED|Treatment 1||0
8327396|NCT01384877|20529214|P2|COMPLETED|Treatment 1||15
8327397|NCT01384877|20529215|P1|COMPLETED|Treatment 1||17
8327398|NCT01384877|20529214|P2|STARTED|Treatment 1||15
8327399|NCT01384877|20529215|P1|STARTED|Treatment 1||17
8327400|NCT01384760|20529241|P2|NOT COMPLETED|Overall Study||6
8327401|NCT01384760|20529242|P1|NOT COMPLETED|Overall Study||16
8327402|NCT01384760|20529241|P2|COMPLETED|Overall Study||37
8327403|NCT01384760|20529242|P1|COMPLETED|Overall Study||45
8327404|NCT01384760|20529241|P2|Randomized|Overall Study||43
8327405|NCT01384760|20529242|P1|Randomized|Overall Study||61
8327406|NCT01384760|20529241|P2|STARTED|Overall Study||43
8327407|NCT01384760|20529242|P1|STARTED|Overall Study||61
8327408|NCT01384734|20529255|P5|NOT COMPLETED|Overall Study||29
8327409|NCT01384734|20529256|P4|NOT COMPLETED|Overall Study||28
8327410|NCT01384734|20529257|P3|NOT COMPLETED|Overall Study||23
8327411|NCT01384734|20529258|P2|NOT COMPLETED|Overall Study||24
8327412|NCT01384734|20529259|P1|NOT COMPLETED|Overall Study||17
8327413|NCT01384734|20529255|P5|COMPLETED|Overall Study||22
8327414|NCT01384734|20529256|P4|COMPLETED|Overall Study||22
8327415|NCT01384734|20529257|P3|COMPLETED|Overall Study||28
8327416|NCT01384734|20529258|P2|COMPLETED|Overall Study||25
8327417|NCT01384734|20529259|P1|COMPLETED|Overall Study||33
8327418|NCT01384734|20529255|P5|STARTED|Overall Study||51
8327419|NCT01384734|20529256|P4|STARTED|Overall Study||50
8327420|NCT01384734|20529257|P3|STARTED|Overall Study||51
8327421|NCT01384734|20529258|P2|STARTED|Overall Study||49
8327422|NCT01384734|20529259|P1|STARTED|Overall Study||50
8327423|NCT01384591|20529342|P3|NOT COMPLETED|Overall Study||0
8327424|NCT01384591|20529343|P2|NOT COMPLETED|Overall Study||0
8327425|NCT01384591|20529344|P1|NOT COMPLETED|Overall Study||0
8327426|NCT01384591|20529342|P3|COMPLETED|Overall Study||2
8327427|NCT01384591|20529343|P2|COMPLETED|Overall Study||2
8327428|NCT01384591|20529344|P1|COMPLETED|Overall Study||2
8327429|NCT01384591|20529342|P3|STARTED|Overall Study||2
8327430|NCT01384591|20529343|P2|STARTED|Overall Study||2
8327431|NCT01384591|20529344|P1|STARTED|Overall Study||2
8327432|NCT01384539|20529474|P2|NOT COMPLETED|Overall Study||7
8327433|NCT01384539|20529475|P1|NOT COMPLETED|Overall Study||6
8327434|NCT01384539|20529474|P2|COMPLETED|Overall Study||57
8327435|NCT01384539|20529475|P1|COMPLETED|Overall Study||58
8327436|NCT01384539|20529474|P2|STARTED|Overall Study||64
8327437|NCT01384539|20529475|P1|STARTED|Overall Study||64
8327438|NCT01384292|20529488|P3|NOT COMPLETED|Part B||0
8327439|NCT01384292|20529489|P2|NOT COMPLETED|Part B||0
8327440|NCT01384292|20529490|P1|NOT COMPLETED|Part B||1
8327441|NCT01384292|20529488|P3|COMPLETED|Part B||0
8327442|NCT01384292|20529489|P2|COMPLETED|Part B||6
8327443|NCT01384292|20529490|P1|COMPLETED|Part B||2
8327444|NCT01384292|20529488|P3|STARTED|Part B||0
8327445|NCT01384292|20529489|P2|STARTED|Part B||6
8327446|NCT01384292|20529490|P1|STARTED|Part B||3
8327447|NCT01384292|20529488|P3|NOT COMPLETED|Part A||0
8327448|NCT01384292|20529489|P2|NOT COMPLETED|Part A||0
8327449|NCT01384292|20529490|P1|NOT COMPLETED|Part A||0
8327450|NCT01384292|20529488|P3|COMPLETED|Part A||4
8327451|NCT01384292|20529489|P2|COMPLETED|Part A||5
8327452|NCT01384292|20529490|P1|COMPLETED|Part A||5
8327453|NCT01384292|20529488|P3|STARTED|Part A||4
8327454|NCT01384292|20529489|P2|STARTED|Part A||5
8327455|NCT01384292|20529490|P1|STARTED|Part A||5
8327456|NCT01384019|20529502|P2|NOT COMPLETED|Overall Study||6
8327457|NCT01384019|20529503|P1|NOT COMPLETED|Overall Study||10
8327458|NCT01384019|20529502|P2|COMPLETED|Overall Study||55
8327459|NCT01384019|20529503|P1|COMPLETED|Overall Study||55
8327460|NCT01384019|20529502|P2|STARTED|Overall Study||61
8327461|NCT01384019|20529503|P1|STARTED|Overall Study||65
8327462|NCT01383993|20529512|P3|NOT COMPLETED|Overall Study||1
8327463|NCT01383993|20529513|P2|NOT COMPLETED|Overall Study||1
8327464|NCT01383993|20529514|P1|NOT COMPLETED|Overall Study||3
8327465|NCT01383993|20529512|P3|COMPLETED|Overall Study||1
8327466|NCT01383993|20529513|P2|COMPLETED|Overall Study||3
8327467|NCT01383993|20529514|P1|COMPLETED|Overall Study||12
8327468|NCT01383993|20529512|P3|STARTED|Overall Study||2
8327469|NCT01383993|20529513|P2|STARTED|Overall Study||4
8327470|NCT01383993|20529514|P1|STARTED|Overall Study||15
8327471|NCT01383954|20529561|P1|NOT COMPLETED|Overall Study||14
8327472|NCT01383954|20529561|P1|COMPLETED|Overall Study||38
8327473|NCT01383954|20529561|P1|Safety Population: Received Treatment|Overall Study||48
8327474|NCT01383954|20529561|P1|STARTED|Overall Study||52
8327475|NCT01383928|20529569|P3|NOT COMPLETED|Overall Study||40
8327476|NCT01383928|20529570|P2|NOT COMPLETED|Overall Study||7
8327477|NCT01383928|20529571|P1|NOT COMPLETED|Overall Study||5
8327478|NCT01383928|20529569|P3|COMPLETED|Overall Study||10
8327479|NCT01383928|20529570|P2|COMPLETED|Overall Study||0
8327480|NCT01383928|20529571|P1|COMPLETED|Overall Study||2
8327481|NCT01383928|20529569|P3|STARTED|Overall Study||50
8327482|NCT01383928|20529570|P2|STARTED|Overall Study||7
8327483|NCT01383928|20529571|P1|STARTED|Overall Study||7
8327484|NCT01383759|20529615|P2|NOT COMPLETED|Overall Study||0
8327485|NCT01383759|20529616|P1|NOT COMPLETED|Overall Study||0
8327486|NCT01383759|20529615|P2|COMPLETED|Overall Study||1
8327487|NCT01383759|20529616|P1|COMPLETED|Overall Study||19
8327488|NCT01383759|20529615|P2|STARTED|Overall Study||1
8327489|NCT01383759|20529616|P1|STARTED|Overall Study||19
8327490|NCT01383720|20529630|P1|NOT COMPLETED|Overall Study||0
8327491|NCT01383720|20529630|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
8327492|NCT01383720|20529630|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
8327493|NCT01383720|20529630|P1|STARTED|Overall Study||11
8327494|NCT01383707|20529652|P1|NOT COMPLETED|Overall Study||72
8327495|NCT01383707|20529652|P1|COMPLETED|Overall Study||5
8327496|NCT01383707|20529652|P1|STARTED|Overall Study||77
8327497|NCT01383681|20529661|P1|NOT COMPLETED|Overall Study||46
8327498|NCT01383681|20529661|P1|COMPLETED|Overall Study||189
8327499|NCT01383681|20529661|P1|STARTED|Overall Study||235
8327500|NCT01383616|20529668|P2|NOT COMPLETED|Overall Study||23
8327501|NCT01383616|20529669|P1|NOT COMPLETED|Overall Study||17
8327502|NCT01383616|20529668|P2|COMPLETED|Overall Study||21
8327503|NCT01383616|20529669|P1|COMPLETED|Overall Study||23
8327504|NCT01383616|20529668|P2|STARTED|Overall Study||44
8327505|NCT01383616|20529669|P1|STARTED|Overall Study||40
8327506|NCT01383499|20529692|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
8327507|NCT01383499|20529693|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
8327508|NCT01383499|20529694|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
8327509|NCT01383499|20529695|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
8327510|NCT01383499|20529692|P4|COMPLETED|Period 3 (4 Weeks)||25
8327511|NCT01383499|20529693|P3|COMPLETED|Period 3 (4 Weeks)||25
8327512|NCT01383499|20529694|P2|COMPLETED|Period 3 (4 Weeks)||24
8327513|NCT01383499|20529695|P1|COMPLETED|Period 3 (4 Weeks)||26
8327514|NCT01383499|20529692|P4|STARTED|Period 3 (4 Weeks)||25
8327515|NCT01383499|20529693|P3|STARTED|Period 3 (4 Weeks)||25
8327516|NCT01383499|20529694|P2|STARTED|Period 3 (4 Weeks)||24
8327517|NCT01383499|20529695|P1|STARTED|Period 3 (4 Weeks)||26
8327518|NCT01383499|20529692|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
8327519|NCT01383499|20529693|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
8327520|NCT01383499|20529694|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8327521|NCT01383499|20529695|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
8327522|NCT01383499|20529692|P4|COMPLETED|Period 2 (4 Weeks)||25
8327523|NCT01383499|20529693|P3|COMPLETED|Period 2 (4 Weeks)||25
8327524|NCT01383499|20529694|P2|COMPLETED|Period 2 (4 Weeks)||24
8327525|NCT01383499|20529695|P1|COMPLETED|Period 2 (4 Weeks)||26
8327526|NCT01383499|20529692|P4|STARTED|Period 2 (4 Weeks)||25
8327527|NCT01383499|20529693|P3|STARTED|Period 2 (4 Weeks)||25
8327528|NCT01383499|20529694|P2|STARTED|Period 2 (4 Weeks)||24
8327529|NCT01383499|20529695|P1|STARTED|Period 2 (4 Weeks)||26
8327530|NCT01383499|20529692|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8327531|NCT01383499|20529693|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
8327532|NCT01383499|20529694|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
8327533|NCT01383499|20529695|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
8327534|NCT01383499|20529692|P4|COMPLETED|Period 1 (4 Weeks)||25
8327535|NCT01383499|20529693|P3|COMPLETED|Period 1 (4 Weeks)||25
8327536|NCT01383499|20529694|P2|COMPLETED|Period 1 (4 Weeks)||24
8327537|NCT01383499|20529695|P1|COMPLETED|Period 1 (4 Weeks)||26
8327538|NCT01383499|20529692|P4|STARTED|Period 1 (4 Weeks)||25
8327539|NCT01383499|20529693|P3|STARTED|Period 1 (4 Weeks)||25
8327540|NCT01383499|20529694|P2|STARTED|Period 1 (4 Weeks)||24
8327541|NCT01383499|20529695|P1|STARTED|Period 1 (4 Weeks)||27
8327542|NCT01383486|20529745|P1|NOT COMPLETED|Overall Study||18
8327543|NCT01383486|20529745|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
8327544|NCT01383486|20529745|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
8327545|NCT01383486|20529745|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
8327546|NCT01383447|20529751|P1|NOT COMPLETED|Overall Study||2
8327547|NCT01383447|20529751|P1|COMPLETED|Overall Study||0
8327548|NCT01383447|20529751|P1|STARTED|Overall Study||2
8327549|NCT01383421|20529759|P1|NOT COMPLETED|Overall Study||346
8327550|NCT01383421|20529759|P1|COMPLETED|Overall Study||679
8327551|NCT01383421|20529759|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
8327552|NCT01383356|20529822|P2|NOT COMPLETED|Period 2||0
8327553|NCT01383356|20529823|P1|NOT COMPLETED|Period 2||0
8327554|NCT01383356|20529822|P2|COMPLETED|Period 2|Completed period 2.|23
8327555|NCT01383356|20529823|P1|COMPLETED|Period 2|Completed period 2.|21
8327556|NCT01383356|20529822|P2|STARTED|Period 2|Entered and treated.|23
8327557|NCT01383356|20529823|P1|STARTED|Period 2|Entered and treated.|21
8327558|NCT01383356|20529822|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
8327559|NCT01383356|20529823|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
8327560|NCT01383356|20529822|P2|COMPLETED|Washout Period (at Least 35 Days)||23
8327561|NCT01383356|20529823|P1|COMPLETED|Washout Period (at Least 35 Days)||21
8327562|NCT01383356|20529822|P2|STARTED|Washout Period (at Least 35 Days)||23
8327563|NCT01383356|20529823|P1|STARTED|Washout Period (at Least 35 Days)||21
8327564|NCT01383356|20529822|P2|NOT COMPLETED|Period 1||6
8327565|NCT01383356|20529823|P1|NOT COMPLETED|Period 1||8
8327566|NCT01383356|20529822|P2|COMPLETED|Period 1|Completed period 1.|23
8327567|NCT01383356|20529823|P1|COMPLETED|Period 1|Completed period 1.|21
8327568|NCT01383356|20529822|P2|STARTED|Period 1|Entered and treated.|29
8327569|NCT01383356|20529823|P1|STARTED|Period 1|Entered and treated.|29
8327570|NCT01383317|20529835|P2|NOT COMPLETED|Overall Study||2
8327571|NCT01383317|20529836|P1|NOT COMPLETED|Overall Study||3
8327572|NCT01383317|20529835|P2|COMPLETED|Overall Study||33
8327573|NCT01383317|20529836|P1|COMPLETED|Overall Study||26
8327574|NCT01383317|20529835|P2|STARTED|Overall Study||35
8327575|NCT01383317|20529836|P1|STARTED|Overall Study||29
8327576|NCT01383213|20529860|P2|NOT COMPLETED|Overall Study||0
8327577|NCT01383213|20529861|P1|NOT COMPLETED|Overall Study||0
8327578|NCT01383213|20529860|P2|COMPLETED|Overall Study||41
8327579|NCT01383213|20529861|P1|COMPLETED|Overall Study||40
8327580|NCT01383213|20529860|P2|STARTED|Overall Study||41
8327581|NCT01383213|20529861|P1|STARTED|Overall Study||40
8327582|NCT01383200|20529869|P2|NOT COMPLETED|Overall Study||0
8327583|NCT01383200|20529870|P1|NOT COMPLETED|Overall Study||0
8327584|NCT01383200|20529869|P2|COMPLETED|Overall Study||6
8327585|NCT01383200|20529870|P1|COMPLETED|Overall Study||5
8327586|NCT01383200|20529869|P2|STARTED|Overall Study||6
8327587|NCT01383200|20529870|P1|STARTED|Overall Study||5
8327588|NCT01383174|20529878|P2|NOT COMPLETED|6 Month Assessment||1
8327589|NCT01383174|20529879|P1|NOT COMPLETED|6 Month Assessment||5
8327590|NCT01383174|20529878|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
8327591|NCT01383174|20529879|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
8327592|NCT01383174|20529878|P2|STARTED|6 Month Assessment||74
8327593|NCT01383174|20529879|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
8327594|NCT01383174|20529878|P2|NOT COMPLETED|3 Month Assessment||1
8327595|NCT01383174|20529879|P1|NOT COMPLETED|3 Month Assessment||6
8327596|NCT01383174|20529878|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
8327597|NCT01383174|20529879|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
8327598|NCT01383174|20529878|P2|STARTED|3 Month Assessment||75
8327599|NCT01383174|20529879|P1|STARTED|3 Month Assessment||76
8327600|NCT01383174|20529878|P2|NOT COMPLETED|Baseline Assessment||0
8327601|NCT01383174|20529879|P1|NOT COMPLETED|Baseline Assessment||0
8327602|NCT01383174|20529878|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
8327603|NCT01383174|20529879|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
8327604|NCT01383174|20529878|P2|STARTED|Baseline Assessment||75
8327605|NCT01383174|20529879|P1|STARTED|Baseline Assessment||76
8327606|NCT01383161|20529905|P2|NOT COMPLETED|Overall Study||4
8327607|NCT01383161|20529906|P1|NOT COMPLETED|Overall Study||5
8327608|NCT01383161|20529905|P2|COMPLETED|Overall Study||17
8327609|NCT01383161|20529906|P1|COMPLETED|Overall Study||20
8327610|NCT01383161|20529905|P2|STARTED|Overall Study||21
8327611|NCT01383161|20529906|P1|STARTED|Overall Study||25
8327612|NCT01383096|20529925|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
8327613|NCT01383096|20529926|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
8327614|NCT01383096|20529927|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
8327615|NCT01383096|20529925|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327616|NCT01383096|20529926|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
8327617|NCT01383096|20529927|P1|COMPLETED|Fifth Intervention (8 Days)||11
8327618|NCT01383096|20529925|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327619|NCT01383096|20529926|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
8327620|NCT01383096|20529927|P1|STARTED|Fifth Intervention (8 Days)||13
8327621|NCT01383096|20529925|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
8327622|NCT01383096|20529926|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
8327623|NCT01383096|20529927|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
8327624|NCT01383096|20529925|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327625|NCT01383096|20529926|P2|COMPLETED|Fourth Intervention (8 Days)||12
8327626|NCT01383096|20529927|P1|COMPLETED|Fourth Intervention (8 Days)||13
8327627|NCT01383096|20529925|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327628|NCT01383096|20529926|P2|STARTED|Fourth Intervention (8 Days)||12
8327629|NCT01383096|20529927|P1|STARTED|Fourth Intervention (8 Days)||15
8327630|NCT01383096|20529925|P3|NOT COMPLETED|Third Intervention (8 Days)||0
8327631|NCT01383096|20529926|P2|NOT COMPLETED|Third Intervention (8 Days)||4
8327632|NCT01383096|20529927|P1|NOT COMPLETED|Third Intervention (8 Days)||4
8327633|NCT01383096|20529925|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327634|NCT01383096|20529926|P2|COMPLETED|Third Intervention (8 Days)||12
8327635|NCT01383096|20529927|P1|COMPLETED|Third Intervention (8 Days)||15
8327636|NCT01383096|20529925|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327637|NCT01383096|20529926|P2|STARTED|Third Intervention (8 Days)||16
8327638|NCT01383096|20529927|P1|STARTED|Third Intervention (8 Days)||19
8327639|NCT01383096|20529925|P3|NOT COMPLETED|Second Intervention (8 Days)||2
8327640|NCT01383096|20529926|P2|NOT COMPLETED|Second Intervention (8 Days)||1
8327641|NCT01383096|20529927|P1|NOT COMPLETED|Second Intervention (8 Days)||0
8327642|NCT01383096|20529925|P3|COMPLETED|Second Intervention (8 Days)||14
8327643|NCT01383096|20529926|P2|COMPLETED|Second Intervention (8 Days)||16
8327644|NCT01383096|20529927|P1|COMPLETED|Second Intervention (8 Days)||19
8327645|NCT01383096|20529925|P3|STARTED|Second Intervention (8 Days)||16
8327646|NCT01383096|20529926|P2|STARTED|Second Intervention (8 Days)||17
8327647|NCT01383096|20529927|P1|STARTED|Second Intervention (8 Days)||19
8327648|NCT01383096|20529925|P3|NOT COMPLETED|First Intervention (8 Days)||0
8327649|NCT01383096|20529926|P2|NOT COMPLETED|First Intervention (8 Days)||0
8327650|NCT01383096|20529927|P1|NOT COMPLETED|First Intervention (8 Days)||0
8327651|NCT01383096|20529925|P3|COMPLETED|First Intervention (8 Days)||16
8327652|NCT01383096|20529926|P2|COMPLETED|First Intervention (8 Days)||17
8327653|NCT01383096|20529927|P1|COMPLETED|First Intervention (8 Days)||19
8327654|NCT01383096|20529925|P3|STARTED|First Intervention (8 Days)||16
8327655|NCT01383096|20529926|P2|STARTED|First Intervention (8 Days)||17
8327656|NCT01383096|20529927|P1|STARTED|First Intervention (8 Days)||19
8327660|NCT01383005|20530015|P2|NOT COMPLETED|Overall Study||0
8327661|NCT01383005|20530016|P1|NOT COMPLETED|Overall Study||0
8327662|NCT01383005|20530015|P2|COMPLETED|Overall Study||60
8327663|NCT01383005|20530016|P1|COMPLETED|Overall Study||34
8327664|NCT01383005|20530015|P2|STARTED|Overall Study||60
8327665|NCT01383005|20530016|P1|STARTED|Overall Study||34
8327666|NCT01382940|20530035|P1|NOT COMPLETED|Overall Study||73
8327667|NCT01382940|20530035|P1|COMPLETED|Overall Study||278
8327668|NCT01382940|20530035|P1|Received Day 182 Infusion|Overall Study||278
8327669|NCT01382940|20530035|P1|Received Day 168 Infusion|Overall Study||290
8327670|NCT01382940|20530035|P1|Received Day 15 Infusions|Overall Study||341
8327671|NCT01382940|20530035|P1|Received Day 1 Infusion|Overall Study||351
8327672|NCT01382940|20530035|P1|STARTED|Overall Study||351
8327673|NCT01382901|20530047|P2|NOT COMPLETED|Overall Study||14
8327674|NCT01382901|20530048|P1|NOT COMPLETED|Overall Study||17
8327675|NCT01382901|20530047|P2|COMPLETED|Overall Study||7
8327676|NCT01382901|20530048|P1|COMPLETED|Overall Study||7
8327677|NCT01382901|20530047|P2|STARTED|Overall Study||21
8327678|NCT01382901|20530048|P1|STARTED|Overall Study||24
8327679|NCT01382719|20530058|P4|NOT COMPLETED|Overall Study||33
8327680|NCT01382719|20530059|P3|NOT COMPLETED|Overall Study||34
8327681|NCT01382719|20530060|P2|NOT COMPLETED|Overall Study||19
8327682|NCT01382719|20530061|P1|NOT COMPLETED|Overall Study||18
8327683|NCT01382719|20530058|P4|COMPLETED|Overall Study||66
8327684|NCT01382719|20530059|P3|COMPLETED|Overall Study||66
8327685|NCT01382719|20530060|P2|COMPLETED|Overall Study||81
8327686|NCT01382719|20530061|P1|COMPLETED|Overall Study||80
8327687|NCT01382719|20530058|P4|Subjects Not Dosed|Overall Study||1
8327688|NCT01382719|20530059|P3|Subjects Not Dosed|Overall Study||1
8327689|NCT01382719|20530060|P2|Subjects Not Dosed|Overall Study||0
8327690|NCT01382719|20530061|P1|Subjects Not Dosed|Overall Study||1
8327691|NCT01382719|20530058|P4|STARTED|Overall Study||99
8327692|NCT01382719|20530059|P3|STARTED|Overall Study||100
8327693|NCT01382719|20530060|P2|STARTED|Overall Study||100
8327694|NCT01382719|20530061|P1|STARTED|Overall Study||98
8327695|NCT01382602|20530097|P2|NOT COMPLETED|Overall Study||4
8327696|NCT01382602|20530098|P1|NOT COMPLETED|Overall Study||0
8327697|NCT01382602|20530097|P2|COMPLETED|Overall Study||46
8327698|NCT01382602|20530098|P1|COMPLETED|Overall Study||93
8327699|NCT01382602|20530097|P2|STARTED|Overall Study||50
8327700|NCT01382602|20530098|P1|STARTED|Overall Study||93
8327701|NCT01382446|20530106|P2|NOT COMPLETED|Overall Study||4
8327702|NCT01382446|20530107|P1|NOT COMPLETED|Overall Study||3
8327703|NCT01382446|20530106|P2|COMPLETED|Overall Study||29
8327704|NCT01382446|20530107|P1|COMPLETED|Overall Study||30
8327705|NCT01382446|20530106|P2|STARTED|Overall Study||33
8327706|NCT01382446|20530107|P1|STARTED|Overall Study||33
8327707|NCT01382303|20530115|P2|NOT COMPLETED|Overall Study||17
8327708|NCT01382303|20530116|P1|NOT COMPLETED|Overall Study||35
8327709|NCT01382303|20530115|P2|COMPLETED|Overall Study||70
8327710|NCT01382303|20530116|P1|COMPLETED|Overall Study||52
8327711|NCT01382303|20530115|P2|STARTED|Overall Study||87
8327712|NCT01382303|20530116|P1|STARTED|Overall Study||87
8327713|NCT01382251|20530134|P2|NOT COMPLETED|Overall Study||21
8327714|NCT01382251|20530135|P1|NOT COMPLETED|Overall Study||21
8327715|NCT01382251|20530134|P2|COMPLETED|Overall Study||102
8327716|NCT01382251|20530135|P1|COMPLETED|Overall Study||102
8327717|NCT01382251|20530134|P2|STARTED|Overall Study||123
8327718|NCT01382251|20530135|P1|STARTED|Overall Study||123
8327719|NCT01382225|20530148|P2|NOT COMPLETED|Overall Study||7
8327720|NCT01382225|20530149|P1|NOT COMPLETED|Overall Study||14
8327721|NCT01382225|20530148|P2|COMPLETED|Overall Study||722
8327722|NCT01382225|20530149|P1|COMPLETED|Overall Study||711
8327723|NCT01382225|20530148|P2|STARTED|Overall Study||729
8327724|NCT01382225|20530149|P1|STARTED|Overall Study||725
8327725|NCT01382212|20530171|P1|NOT COMPLETED|Overall Study||2
8327726|NCT01382212|20530171|P1|COMPLETED|Overall Study||11
8327727|NCT01382212|20530171|P1|STARTED|Overall Study||13
8327728|NCT01382186|20530197|P2|NOT COMPLETED|Overall Study||0
8327729|NCT01382186|20530198|P1|NOT COMPLETED|Overall Study||1
8327730|NCT01382186|20530197|P2|COMPLETED|Overall Study||819
8327731|NCT01382186|20530198|P1|COMPLETED|Overall Study||32
8327732|NCT01382186|20530197|P2|STARTED|Overall Study||819
8327733|NCT01382186|20530198|P1|STARTED|Overall Study||33
8327734|NCT01382108|20530214|P2|NOT COMPLETED|Overall Study||0
8327735|NCT01382108|20530215|P1|NOT COMPLETED|Overall Study||0
8327736|NCT01382108|20530214|P2|COMPLETED|Overall Study||19
8327737|NCT01382108|20530215|P1|COMPLETED|Overall Study||20
8327738|NCT01382108|20530214|P2|STARTED|Overall Study||19
8327739|NCT01382108|20530215|P1|STARTED|Overall Study||20
8327740|NCT01381952|20530225|P1|NOT COMPLETED|Overall Study||0
8327741|NCT01381952|20530225|P1|COMPLETED|Overall Study||20
8327742|NCT01381952|20530225|P1|Collected Dose and Image Information|Overall Study||20
8327743|NCT01381952|20530225|P1|STARTED|Overall Study||20
8327744|NCT01381926|20530234|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
8327745|NCT01381926|20530235|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
8327746|NCT01381926|20530234|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
8327747|NCT01381926|20530235|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
8327748|NCT01381926|20530234|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
8327749|NCT01381926|20530235|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
8327750|NCT01381926|20530234|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
8327751|NCT01381926|20530235|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
8327752|NCT01381926|20530234|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
8327753|NCT01381926|20530235|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
8327754|NCT01381926|20530234|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
8327755|NCT01381926|20530235|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
8327756|NCT01381900|20530248|P3|NOT COMPLETED|Overall Study||12
8327757|NCT01381900|20530249|P2|NOT COMPLETED|Overall Study||9
8327758|NCT01381900|20530250|P1|NOT COMPLETED|Overall Study||9
8327759|NCT01381900|20530248|P3|COMPLETED|Overall Study||215
8327760|NCT01381900|20530249|P2|COMPLETED|Overall Study||214
8327761|NCT01381900|20530250|P1|COMPLETED|Overall Study||217
8327762|NCT01381900|20530248|P3|STARTED|Overall Study||227
8327763|NCT01381900|20530249|P2|STARTED|Overall Study||223
8327764|NCT01381900|20530250|P1|STARTED|Overall Study||226
8327765|NCT01381874|20530273|P3|NOT COMPLETED|Overall Study||76
8327766|NCT01381874|20530274|P2|NOT COMPLETED|Overall Study||63
8327767|NCT01381874|20530275|P1|NOT COMPLETED|Overall Study||77
8327768|NCT01381874|20530273|P3|COMPLETED|Overall Study||30
8327769|NCT01381874|20530274|P2|COMPLETED|Overall Study||26
8327770|NCT01381874|20530275|P1|COMPLETED|Overall Study||25
8327771|NCT01381874|20530273|P3|Treated|Overall Study||104
8327772|NCT01381874|20530274|P2|Treated|Overall Study||87
8327773|NCT01381874|20530275|P1|Treated|Overall Study||102
8327774|NCT01381874|20530273|P3|STARTED|Overall Study||106
8327775|NCT01381874|20530274|P2|STARTED|Overall Study||89
8327776|NCT01381874|20530275|P1|STARTED|Overall Study||102
8327777|NCT01381861|20530301|P1|NOT COMPLETED|Overall Study||0
8327778|NCT01381861|20530301|P1|COMPLETED|Overall Study||23
8327779|NCT01381861|20530301|P1|STARTED|Overall Study||23
8327780|NCT01381679|20530312|P1|NOT COMPLETED|Overall Study||888
8327781|NCT01381679|20530312|P1|COMPLETED|Overall Study||794
8327782|NCT01381679|20530312|P1|STARTED|Overall Study||1682
8327783|NCT01381575|20530327|P3|NOT COMPLETED|Overall Study||20
8327784|NCT01381575|20530328|P2|NOT COMPLETED|Overall Study||39
8327785|NCT01381575|20530329|P1|NOT COMPLETED|Overall Study||26
8327786|NCT01381575|20530327|P3|COMPLETED|Overall Study||395
8327787|NCT01381575|20530328|P2|COMPLETED|Overall Study||443
8327788|NCT01381575|20530329|P1|COMPLETED|Overall Study||524
8327789|NCT01381575|20530327|P3|STARTED|Overall Study||415
8327790|NCT01381575|20530328|P2|STARTED|Overall Study||482
8327791|NCT01381575|20530329|P1|STARTED|Overall Study||550
8327792|NCT01381562|20530386|P3|NOT COMPLETED|Overall Study||0
8327793|NCT01381562|20530387|P2|NOT COMPLETED|Overall Study||1
8327794|NCT01381562|20530388|P1|NOT COMPLETED|Overall Study||0
8327795|NCT01381562|20530386|P3|COMPLETED|Overall Study||5
8327796|NCT01381562|20530387|P2|COMPLETED|Overall Study||3
8327797|NCT01381562|20530388|P1|COMPLETED|Overall Study||5
8327798|NCT01381562|20530386|P3|STARTED|Overall Study||5
8327799|NCT01381562|20530387|P2|STARTED|Overall Study||4
8327800|NCT01381562|20530388|P1|STARTED|Overall Study||5
8327801|NCT01381549|20530456|P3|NOT COMPLETED|Overall Study||1
8327802|NCT01381549|20530457|P2|NOT COMPLETED|Overall Study||0
8327803|NCT01381549|20530458|P1|NOT COMPLETED|Overall Study||0
8327804|NCT01381549|20530456|P3|COMPLETED|Overall Study||5
8327805|NCT01381549|20530457|P2|COMPLETED|Overall Study||8
8327806|NCT01381549|20530458|P1|COMPLETED|Overall Study||6
8327807|NCT01381549|20530456|P3|STARTED|Overall Study||6
8327808|NCT01381549|20530457|P2|STARTED|Overall Study||8
8327809|NCT01381549|20530458|P1|STARTED|Overall Study||6
8327810|NCT01381471|20530553|P1|NOT COMPLETED|Overall Study||0
8327811|NCT01381471|20530553|P1|COMPLETED|Overall Study||11060
8327812|NCT01381471|20530553|P1|STARTED|Overall Study||11060
8327813|NCT01381406|20530560|P2|NOT COMPLETED|Overall Study||0
8327814|NCT01381406|20530561|P1|NOT COMPLETED|Overall Study||0
8327815|NCT01381406|20530560|P2|COMPLETED|Overall Study||852
8327816|NCT01381406|20530561|P1|COMPLETED|Overall Study||2481
8327817|NCT01381406|20530560|P2|STARTED|Overall Study||852
8327818|NCT01381406|20530561|P1|STARTED|Overall Study||2481
8327819|NCT01381120|20530573|P2|NOT COMPLETED|Overall Study||9
8327820|NCT01381120|20530574|P1|NOT COMPLETED|Overall Study||11
8327821|NCT01381120|20530573|P2|COMPLETED|Overall Study||18
8327822|NCT01381120|20530574|P1|COMPLETED|Overall Study||39
8327823|NCT01381120|20530573|P2|STARTED|Overall Study||27
8327824|NCT01381120|20530574|P1|STARTED|Overall Study||50
8327825|NCT01381068|20530584|P2|NOT COMPLETED|Overall Study||0
8327826|NCT01381068|20530585|P1|NOT COMPLETED|Overall Study||1
8327827|NCT01381068|20530584|P2|COMPLETED|Overall Study||24
8327828|NCT01381068|20530585|P1|COMPLETED|Overall Study||24
8327829|NCT01381068|20530584|P2|STARTED|Overall Study||24
8327830|NCT01381068|20530585|P1|STARTED|Overall Study||25
8327831|NCT01381016|20530605|P2|NOT COMPLETED|Overall Study||6
8327832|NCT01381016|20530606|P1|NOT COMPLETED|Overall Study||3
8327833|NCT01381016|20530605|P2|COMPLETED|Overall Study||11
8327834|NCT01381016|20530606|P1|COMPLETED|Overall Study||10
8327835|NCT01381016|20530605|P2|STARTED|Overall Study||17
8327836|NCT01381016|20530606|P1|STARTED|Overall Study||13
8327837|NCT01380834|20530616|P2|NOT COMPLETED|Overall Study||0
8327838|NCT01380834|20530617|P1|NOT COMPLETED|Overall Study||1
8327839|NCT01380834|20530616|P2|COMPLETED|Overall Study||42
8327840|NCT01380834|20530617|P1|COMPLETED|Overall Study||41
8327841|NCT01380834|20530616|P2|STARTED|Overall Study||42
8327842|NCT01380834|20530617|P1|STARTED|Overall Study||42
8327843|NCT01380782|20530629|P4|NOT COMPLETED|Overall Study||4
8327844|NCT01380782|20530630|P3|NOT COMPLETED|Overall Study||11
8327845|NCT01380782|20530631|P2|NOT COMPLETED|Overall Study||10
8327846|NCT01380782|20530632|P1|NOT COMPLETED|Overall Study||12
8327847|NCT01380782|20530629|P4|COMPLETED|Overall Study||0
8327848|NCT01380782|20530630|P3|COMPLETED|Overall Study||0
8327849|NCT01380782|20530631|P2|COMPLETED|Overall Study||0
8327850|NCT01380782|20530632|P1|COMPLETED|Overall Study||0
8327851|NCT01380782|20530629|P4|STARTED|Overall Study||4
8327852|NCT01380782|20530630|P3|STARTED|Overall Study||11
8327853|NCT01380782|20530631|P2|STARTED|Overall Study||10
8327854|NCT01380782|20530632|P1|STARTED|Overall Study||12
8327855|NCT01380769|20530655|P2|NOT COMPLETED|Overall Study||14
8327856|NCT01380769|20530656|P1|NOT COMPLETED|Overall Study||9
8327857|NCT01380769|20530655|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
8327858|NCT01380769|20530656|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
8327859|NCT01380769|20530655|P2|STARTED|Overall Study||57
8327860|NCT01380769|20530656|P1|STARTED|Overall Study||100
8327861|NCT01380743|20530668|P4|NOT COMPLETED|Overall Study||0
8327862|NCT01380743|20530669|P3|NOT COMPLETED|Overall Study||0
8327863|NCT01380743|20530670|P2|NOT COMPLETED|Overall Study||0
8327864|NCT01380743|20530671|P1|NOT COMPLETED|Overall Study||0
8327865|NCT01380743|20530668|P4|COMPLETED|Overall Study||7
8327866|NCT01380743|20530669|P3|COMPLETED|Overall Study||6
8327867|NCT01380743|20530670|P2|COMPLETED|Overall Study||6
8327868|NCT01380743|20530671|P1|COMPLETED|Overall Study||6
8327869|NCT01380743|20530668|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8327870|NCT01380743|20530669|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8327871|NCT01380743|20530670|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8327872|NCT01380743|20530671|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8327873|NCT01380743|20530668|P4|STARTED|Overall Study||7
8327874|NCT01380743|20530669|P3|STARTED|Overall Study||6
8327875|NCT01380743|20530670|P2|STARTED|Overall Study||6
8327876|NCT01380743|20530671|P1|STARTED|Overall Study||6
8327877|NCT01380730|20530717|P8|NOT COMPLETED|Overall Study||0
8327878|NCT01380730|20530718|P7|NOT COMPLETED|Overall Study||0
8327879|NCT01380730|20530719|P6|NOT COMPLETED|Overall Study||0
8327880|NCT01380730|20530720|P5|NOT COMPLETED|Overall Study||1
8327881|NCT01380730|20530721|P4|NOT COMPLETED|Overall Study||0
8327882|NCT01380730|20530722|P3|NOT COMPLETED|Overall Study||0
8327883|NCT01380730|20530723|P2|NOT COMPLETED|Overall Study||0
8327884|NCT01380730|20530724|P1|NOT COMPLETED|Overall Study||0
8327885|NCT01380730|20530717|P8|COMPLETED|Overall Study||80
8327886|NCT01380730|20530718|P7|COMPLETED|Overall Study||79
8327887|NCT01380730|20530719|P6|COMPLETED|Overall Study||79
8327888|NCT01380730|20530720|P5|COMPLETED|Overall Study||77
8327889|NCT01380730|20530721|P4|COMPLETED|Overall Study||79
8327890|NCT01380730|20530722|P3|COMPLETED|Overall Study||79
8327891|NCT01380730|20530723|P2|COMPLETED|Overall Study||79
8327892|NCT01380730|20530724|P1|COMPLETED|Overall Study||78
8327893|NCT01380730|20530717|P8|Received Treatment|Overall Study||80
8327894|NCT01380730|20530718|P7|Received Treatment|Overall Study||79
8327895|NCT01380730|20530719|P6|Received Treatment|Overall Study||79
8327896|NCT01380730|20530720|P5|Received Treatment|Overall Study||78
8327897|NCT01380730|20530721|P4|Received Treatment|Overall Study||79
8327898|NCT01380730|20530722|P3|Received Treatment|Overall Study||79
8327899|NCT01380730|20530723|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
8327900|NCT01380730|20530724|P1|Received Treatment|Overall Study||78
8327901|NCT01380730|20530717|P8|STARTED|Overall Study||80
8327902|NCT01380730|20530718|P7|STARTED|Overall Study||79
8327903|NCT01380730|20530719|P6|STARTED|Overall Study||79
8327904|NCT01380730|20530720|P5|STARTED|Overall Study||78
8327905|NCT01380730|20530721|P4|STARTED|Overall Study||79
8327906|NCT01380730|20530722|P3|STARTED|Overall Study||79
8327907|NCT01380730|20530723|P2|STARTED|Overall Study||79
8327908|NCT01380730|20530724|P1|STARTED|Overall Study||78
8327909|NCT01380691|20530782|P4|NOT COMPLETED|Period 2||0
8327910|NCT01380691|20530783|P3|NOT COMPLETED|Period 2||0
8327911|NCT01380691|20530784|P2|NOT COMPLETED|Period 2||0
8327912|NCT01380691|20530785|P1|NOT COMPLETED|Period 2||0
8327913|NCT01380691|20530782|P4|COMPLETED|Period 2||6
8327914|NCT01380691|20530783|P3|COMPLETED|Period 2||6
8327915|NCT01380691|20530784|P2|COMPLETED|Period 2||7
8327916|NCT01380691|20530785|P1|COMPLETED|Period 2||7
8327917|NCT01380691|20530782|P4|STARTED|Period 2||6
8327918|NCT01380691|20530783|P3|STARTED|Period 2||6
8327919|NCT01380691|20530784|P2|STARTED|Period 2||7
8327920|NCT01380691|20530785|P1|STARTED|Period 2||7
8327921|NCT01380691|20530782|P4|NOT COMPLETED|Washout (7 Days)||1
8327922|NCT01380691|20530783|P3|NOT COMPLETED|Washout (7 Days)||1
8327923|NCT01380691|20530784|P2|NOT COMPLETED|Washout (7 Days)||0
8327924|NCT01380691|20530785|P1|NOT COMPLETED|Washout (7 Days)||0
8327925|NCT01380691|20530782|P4|COMPLETED|Washout (7 Days)||6
8327926|NCT01380691|20530783|P3|COMPLETED|Washout (7 Days)||6
8327927|NCT01380691|20530784|P2|COMPLETED|Washout (7 Days)||7
8327928|NCT01380691|20530785|P1|COMPLETED|Washout (7 Days)||7
8327929|NCT01380691|20530782|P4|STARTED|Washout (7 Days)||7
8327930|NCT01380691|20530783|P3|STARTED|Washout (7 Days)||7
8327931|NCT01380691|20530784|P2|STARTED|Washout (7 Days)||7
8327932|NCT01380691|20530785|P1|STARTED|Washout (7 Days)||7
8327933|NCT01380691|20530782|P4|NOT COMPLETED|Period 1||0
8327934|NCT01380691|20530783|P3|NOT COMPLETED|Period 1||0
8327935|NCT01380691|20530784|P2|NOT COMPLETED|Period 1||0
8327936|NCT01380691|20530785|P1|NOT COMPLETED|Period 1||0
8327937|NCT01380691|20530782|P4|COMPLETED|Period 1||7
8327938|NCT01380691|20530783|P3|COMPLETED|Period 1||7
8327939|NCT01380691|20530784|P2|COMPLETED|Period 1||7
8327940|NCT01380691|20530785|P1|COMPLETED|Period 1||7
8327941|NCT01380691|20530782|P4|STARTED|Period 1||7
8327942|NCT01380691|20530783|P3|STARTED|Period 1||7
8327943|NCT01380691|20530784|P2|STARTED|Period 1||7
8327944|NCT01380691|20530785|P1|STARTED|Period 1||7
8327945|NCT01380639|20530837|P2|NOT COMPLETED|Overall Study||4
8327946|NCT01380639|20530838|P1|NOT COMPLETED|Overall Study||6
8327947|NCT01380639|20530837|P2|COMPLETED|Overall Study||36
8327948|NCT01380639|20530838|P1|COMPLETED|Overall Study||36
8327949|NCT01380639|20530837|P2|STARTED|Overall Study||40
8327950|NCT01380639|20530838|P1|STARTED|Overall Study||42
8327951|NCT01380535|20530846|P2|NOT COMPLETED|Overall Study||15
8327952|NCT01380535|20530847|P1|NOT COMPLETED|Overall Study||7
8327953|NCT01380535|20530846|P2|COMPLETED|Overall Study||16
8327954|NCT01380535|20530847|P1|COMPLETED|Overall Study||22
8327955|NCT01380535|20530846|P2|Intent-to-treat Population|Overall Study||24
8327956|NCT01380535|20530847|P1|Intent-to-treat Population|Overall Study||29
8327957|NCT01380535|20530846|P2|Safety Population|Overall Study||28
8327958|NCT01380535|20530847|P1|Safety Population|Overall Study||28
8327959|NCT01380535|20530846|P2|Baseline Population|Overall Study||31
8327960|NCT01380535|20530847|P1|Baseline Population|Overall Study||29
8327961|NCT01380535|20530846|P2|STARTED|Overall Study||31
8327962|NCT01380535|20530847|P1|STARTED|Overall Study||29
8327963|NCT01380379|20530853|P1|NOT COMPLETED|Overall Study||1
8327964|NCT01380379|20530853|P1|COMPLETED|Overall Study||8
8327965|NCT01380379|20530853|P1|STARTED|Overall Study||9
8327966|NCT01380366|20530858|P1|NOT COMPLETED|Overall Study||0
8327967|NCT01380366|20530858|P1|COMPLETED|Overall Study||15
8327968|NCT01380366|20530858|P1|STARTED|Overall Study||15
8327969|NCT01380327|20530866|P3|NOT COMPLETED|Overall Study||7
8327970|NCT01380327|20530867|P2|NOT COMPLETED|Overall Study||3
8327971|NCT01380327|20530868|P1|NOT COMPLETED|Overall Study||3
8327972|NCT01380327|20530866|P3|COMPLETED|Overall Study||21
8327973|NCT01380327|20530867|P2|COMPLETED|Overall Study||28
8327974|NCT01380327|20530868|P1|COMPLETED|Overall Study||27
8327975|NCT01380327|20530866|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
8327976|NCT01380327|20530867|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
8327977|NCT01380327|20530868|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
8327978|NCT01380197|20530890|P2|NOT COMPLETED|Overall Study||0
8327979|NCT01380197|20530891|P1|NOT COMPLETED|Overall Study||0
8327980|NCT01380197|20530890|P2|COMPLETED|Overall Study||20
8327981|NCT01380197|20530891|P1|COMPLETED|Overall Study||20
8327982|NCT01380197|20530890|P2|STARTED|Overall Study||20
8327983|NCT01380197|20530891|P1|STARTED|Overall Study||20
8327984|NCT01380184|20530899|P1|NOT COMPLETED|Part 2||14
8327985|NCT01380184|20530899|P1|COMPLETED|Part 2||0
8327986|NCT01380184|20530899|P1|STARTED|Part 2||14
8327987|NCT01380184|20530899|P1|NOT COMPLETED|Washout Period (≥2 Days)||0
8327988|NCT01380184|20530899|P1|COMPLETED|Washout Period (≥2 Days)||14
8327989|NCT01380184|20530899|P1|STARTED|Washout Period (≥2 Days)||14
8327990|NCT01380184|20530899|P1|NOT COMPLETED|Part 1 (19 Days)||1
8327991|NCT01380184|20530899|P1|COMPLETED|Part 1 (19 Days)||14
8327992|NCT01380184|20530899|P1|STARTED|Part 1 (19 Days)||15
8327993|NCT01380145|20530910|P1|NOT COMPLETED|Overall Study||4
8327994|NCT01380145|20530910|P1|COMPLETED|Overall Study||9
8327995|NCT01380145|20530910|P1|STARTED|Overall Study||13
8327996|NCT01380106|20530920|P2|NOT COMPLETED|Overall Study||0
8327997|NCT01380106|20530921|P1|NOT COMPLETED|Overall Study||0
8327998|NCT01380106|20530920|P2|COMPLETED|Overall Study||17
8327999|NCT01380106|20530921|P1|COMPLETED|Overall Study||16
8328000|NCT01380106|20530920|P2|STARTED|Overall Study||17
8328001|NCT01380106|20530921|P1|STARTED|Overall Study||16
8328002|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
8328003|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328004|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328005|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328006|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328007|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328008|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328009|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328010|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328011|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Third Intervention||4
8328012|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Third Intervention||6
8328013|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Third Intervention||6
8328014|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Third Intervention||6
8328015|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Third Intervention||6
8328016|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Third Intervention||5
8328017|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Third Intervention||0
8328018|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Third Intervention||0
8328019|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Third Intervention||0
8328020|NCT01380093|20530929|P9|STARTED|Treatment Phase: Third Intervention||6
8328021|NCT01380093|20530930|P8|STARTED|Treatment Phase: Third Intervention||6
8328022|NCT01380093|20530931|P7|STARTED|Treatment Phase: Third Intervention||6
8328023|NCT01380093|20530932|P6|STARTED|Treatment Phase: Third Intervention||6
8328024|NCT01380093|20530933|P5|STARTED|Treatment Phase: Third Intervention||6
8328025|NCT01380093|20530934|P4|STARTED|Treatment Phase: Third Intervention||5
8328026|NCT01380093|20530935|P3|STARTED|Treatment Phase: Third Intervention||0
8328027|NCT01380093|20530936|P2|STARTED|Treatment Phase: Third Intervention||0
8328028|NCT01380093|20530937|P1|STARTED|Treatment Phase: Third Intervention||0
8328029|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
8328030|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
8328031|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
8328032|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
8328033|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
8328034|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
8328035|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
8328036|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
8328037|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
8328038|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Washout Period||6
8328039|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Washout Period||6
8328040|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Washout Period||6
8328041|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Washout Period||6
8328042|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Washout Period||6
8328043|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Washout Period||5
8328044|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Washout Period||0
8328045|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Washout Period||0
8328046|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Washout Period||0
8328047|NCT01380093|20530929|P9|STARTED|Treatment Phase: Washout Period||6
8328048|NCT01380093|20530930|P8|STARTED|Treatment Phase: Washout Period||6
8328049|NCT01380093|20530931|P7|STARTED|Treatment Phase: Washout Period||6
8328050|NCT01380093|20530932|P6|STARTED|Treatment Phase: Washout Period||6
8328051|NCT01380093|20530933|P5|STARTED|Treatment Phase: Washout Period||6
8328052|NCT01380093|20530934|P4|STARTED|Treatment Phase: Washout Period||5
8328053|NCT01380093|20530935|P3|STARTED|Treatment Phase: Washout Period||0
8328054|NCT01380093|20530936|P2|STARTED|Treatment Phase: Washout Period||0
8328055|NCT01380093|20530937|P1|STARTED|Treatment Phase: Washout Period||0
8328056|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328057|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328058|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328059|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328060|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328061|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
8328062|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328063|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328064|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328065|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Second Intervention||6
8328066|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Second Intervention||6
8328067|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Second Intervention||6
8328068|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Second Intervention||6
8328069|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Second Intervention||6
8328070|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Second Intervention||5
8328071|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Second Intervention||0
8328072|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Second Intervention||0
8328073|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Second Intervention||0
8328074|NCT01380093|20530929|P9|STARTED|Treatment Phase: Second Intervention||6
8328075|NCT01380093|20530930|P8|STARTED|Treatment Phase: Second Intervention||6
8328076|NCT01380093|20530931|P7|STARTED|Treatment Phase: Second Intervention||6
8328077|NCT01380093|20530932|P6|STARTED|Treatment Phase: Second Intervention||6
8328078|NCT01380093|20530933|P5|STARTED|Treatment Phase: Second Intervention||6
8328079|NCT01380093|20530934|P4|STARTED|Treatment Phase: Second Intervention||6
8328080|NCT01380093|20530935|P3|STARTED|Treatment Phase: Second Intervention||0
8328081|NCT01380093|20530936|P2|STARTED|Treatment Phase: Second Intervention||0
8328082|NCT01380093|20530937|P1|STARTED|Treatment Phase: Second Intervention||0
8328083|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
8328084|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
8328085|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
8328086|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
8328087|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
8328088|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
8328089|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
8328090|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
8328091|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
8328092|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Washout Period||6
8328093|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Washout Period||6
8328094|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Washout Period||6
8328095|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Washout Period||6
8328096|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Washout Period||6
8328097|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Washout Period||6
8328098|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Washout Period||0
8328099|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Washout Period||0
8328100|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Washout Period||0
8328101|NCT01380093|20530929|P9|STARTED|Treatment Phase: Washout Period||6
8328102|NCT01380093|20530930|P8|STARTED|Treatment Phase: Washout Period||6
8328103|NCT01380093|20530931|P7|STARTED|Treatment Phase: Washout Period||6
8328104|NCT01380093|20530932|P6|STARTED|Treatment Phase: Washout Period||6
8328105|NCT01380093|20530933|P5|STARTED|Treatment Phase: Washout Period||6
8328106|NCT01380093|20530934|P4|STARTED|Treatment Phase: Washout Period||6
8328107|NCT01380093|20530935|P3|STARTED|Treatment Phase: Washout Period||0
8328108|NCT01380093|20530936|P2|STARTED|Treatment Phase: Washout Period||0
8328109|NCT01380093|20530937|P1|STARTED|Treatment Phase: Washout Period||0
8328110|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
8328111|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
8328112|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
8328113|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
8328114|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
8328115|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
8328116|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
8328117|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
8328118|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
8328119|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: First Intervention||6
8328120|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: First Intervention||6
8328121|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: First Intervention||6
8328122|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: First Intervention||6
8328123|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: First Intervention||6
8328124|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: First Intervention||6
8328125|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: First Intervention||0
8328126|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: First Intervention||0
8328127|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: First Intervention||0
8328128|NCT01380093|20530929|P9|STARTED|Treatment Phase: First Intervention||6
8328129|NCT01380093|20530930|P8|STARTED|Treatment Phase: First Intervention||6
8328130|NCT01380093|20530931|P7|STARTED|Treatment Phase: First Intervention||6
8328131|NCT01380093|20530932|P6|STARTED|Treatment Phase: First Intervention||6
8328132|NCT01380093|20530933|P5|STARTED|Treatment Phase: First Intervention||6
8328133|NCT01380093|20530934|P4|STARTED|Treatment Phase: First Intervention||6
8328134|NCT01380093|20530935|P3|STARTED|Treatment Phase: First Intervention||0
8328135|NCT01380093|20530936|P2|STARTED|Treatment Phase: First Intervention||0
8328136|NCT01380093|20530937|P1|STARTED|Treatment Phase: First Intervention||0
8328137|NCT01380093|20530929|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328138|NCT01380093|20530930|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328139|NCT01380093|20530931|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328140|NCT01380093|20530932|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328141|NCT01380093|20530933|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328142|NCT01380093|20530934|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328143|NCT01380093|20530935|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
8328144|NCT01380093|20530936|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
8328145|NCT01380093|20530937|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328146|NCT01380093|20530929|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
8328147|NCT01380093|20530930|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
8328148|NCT01380093|20530931|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
8328149|NCT01380093|20530932|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
8328150|NCT01380093|20530933|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
8328151|NCT01380093|20530934|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
8328152|NCT01380093|20530935|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
8328153|NCT01380093|20530936|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
8328154|NCT01380093|20530937|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
8328155|NCT01380093|20530929|P9|STARTED|Drug Discrimination Phase: Day 2||0
8328156|NCT01380093|20530930|P8|STARTED|Drug Discrimination Phase: Day 2||0
8328157|NCT01380093|20530931|P7|STARTED|Drug Discrimination Phase: Day 2||0
8328158|NCT01380093|20530932|P6|STARTED|Drug Discrimination Phase: Day 2||0
8328159|NCT01380093|20530933|P5|STARTED|Drug Discrimination Phase: Day 2||0
8328160|NCT01380093|20530934|P4|STARTED|Drug Discrimination Phase: Day 2||0
8328161|NCT01380093|20530935|P3|STARTED|Drug Discrimination Phase: Day 2||29
8328162|NCT01380093|20530936|P2|STARTED|Drug Discrimination Phase: Day 2||29
8328163|NCT01380093|20530937|P1|STARTED|Drug Discrimination Phase: Day 2||0
8328164|NCT01380093|20530929|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328165|NCT01380093|20530930|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328166|NCT01380093|20530931|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328167|NCT01380093|20530932|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328168|NCT01380093|20530933|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328169|NCT01380093|20530934|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328170|NCT01380093|20530935|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328171|NCT01380093|20530936|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
8328172|NCT01380093|20530937|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328173|NCT01380093|20530929|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
8328174|NCT01380093|20530930|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
8328175|NCT01380093|20530931|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
8328176|NCT01380093|20530932|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
8328177|NCT01380093|20530933|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
8328178|NCT01380093|20530934|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
8328179|NCT01380093|20530935|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
8328180|NCT01380093|20530936|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
8328181|NCT01380093|20530937|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
8328182|NCT01380093|20530929|P9|STARTED|Drug Discrimination Phase: Day 1||0
8328183|NCT01380093|20530930|P8|STARTED|Drug Discrimination Phase: Day 1||0
8328184|NCT01380093|20530931|P7|STARTED|Drug Discrimination Phase: Day 1||0
8328185|NCT01380093|20530932|P6|STARTED|Drug Discrimination Phase: Day 1||0
8328186|NCT01380093|20530933|P5|STARTED|Drug Discrimination Phase: Day 1||0
8328187|NCT01380093|20530934|P4|STARTED|Drug Discrimination Phase: Day 1||0
8328188|NCT01380093|20530935|P3|STARTED|Drug Discrimination Phase: Day 1||29
8328189|NCT01380093|20530936|P2|STARTED|Drug Discrimination Phase: Day 1||30
8328190|NCT01380093|20530937|P1|STARTED|Drug Discrimination Phase: Day 1||0
8328191|NCT01380093|20530929|P9|NOT COMPLETED|Naloxone Challenge Phase||0
8328192|NCT01380093|20530930|P8|NOT COMPLETED|Naloxone Challenge Phase||0
8328193|NCT01380093|20530931|P7|NOT COMPLETED|Naloxone Challenge Phase||0
8328194|NCT01380093|20530932|P6|NOT COMPLETED|Naloxone Challenge Phase||0
8328195|NCT01380093|20530933|P5|NOT COMPLETED|Naloxone Challenge Phase||0
8328196|NCT01380093|20530934|P4|NOT COMPLETED|Naloxone Challenge Phase||0
8328197|NCT01380093|20530935|P3|NOT COMPLETED|Naloxone Challenge Phase||0
8328198|NCT01380093|20530936|P2|NOT COMPLETED|Naloxone Challenge Phase||0
8328199|NCT01380093|20530937|P1|NOT COMPLETED|Naloxone Challenge Phase||21
8328200|NCT01380093|20530929|P9|COMPLETED|Naloxone Challenge Phase||0
8328201|NCT01380093|20530930|P8|COMPLETED|Naloxone Challenge Phase||0
8328202|NCT01380093|20530931|P7|COMPLETED|Naloxone Challenge Phase||0
8328203|NCT01380093|20530932|P6|COMPLETED|Naloxone Challenge Phase||0
8328204|NCT01380093|20530933|P5|COMPLETED|Naloxone Challenge Phase||0
8328205|NCT01380093|20530934|P4|COMPLETED|Naloxone Challenge Phase||0
8328206|NCT01380093|20530935|P3|COMPLETED|Naloxone Challenge Phase||0
8328207|NCT01380093|20530936|P2|COMPLETED|Naloxone Challenge Phase||0
8328208|NCT01380093|20530937|P1|COMPLETED|Naloxone Challenge Phase||59
8328209|NCT01380093|20530929|P9|TREATED|Naloxone Challenge Phase||0
8328210|NCT01380093|20530930|P8|TREATED|Naloxone Challenge Phase||0
8328211|NCT01380093|20530931|P7|TREATED|Naloxone Challenge Phase||0
8328212|NCT01380093|20530932|P6|TREATED|Naloxone Challenge Phase||0
8328213|NCT01380093|20530933|P5|TREATED|Naloxone Challenge Phase||0
8328214|NCT01380093|20530934|P4|TREATED|Naloxone Challenge Phase||0
8328215|NCT01380093|20530935|P3|TREATED|Naloxone Challenge Phase||0
8328216|NCT01380093|20530936|P2|TREATED|Naloxone Challenge Phase||0
8328217|NCT01380093|20530937|P1|TREATED|Naloxone Challenge Phase||59
8328218|NCT01380093|20530929|P9|STARTED|Naloxone Challenge Phase||0
8328219|NCT01380093|20530930|P8|STARTED|Naloxone Challenge Phase||0
8328220|NCT01380093|20530931|P7|STARTED|Naloxone Challenge Phase||0
8328221|NCT01380093|20530932|P6|STARTED|Naloxone Challenge Phase||0
8328222|NCT01380093|20530933|P5|STARTED|Naloxone Challenge Phase||0
8328223|NCT01380093|20530934|P4|STARTED|Naloxone Challenge Phase||0
8328224|NCT01380093|20530935|P3|STARTED|Naloxone Challenge Phase||0
8328225|NCT01380093|20530936|P2|STARTED|Naloxone Challenge Phase||0
8328226|NCT01380093|20530937|P1|STARTED|Naloxone Challenge Phase||80
8328227|NCT01379963|20531227|P1|NOT COMPLETED|Overall Study||0
8328228|NCT01379963|20531227|P1|COMPLETED|Overall Study||780
8328229|NCT01379963|20531227|P1|STARTED|Overall Study||780
8328230|NCT01379937|20531236|P4|NOT COMPLETED|Overall Study||1
8328231|NCT01379937|20531237|P3|NOT COMPLETED|Overall Study||2
8328232|NCT01379937|20531238|P2|NOT COMPLETED|Overall Study||3
8328233|NCT01379937|20531239|P1|NOT COMPLETED|Overall Study||1
8328234|NCT01379937|20531236|P4|COMPLETED|Overall Study||103
8328235|NCT01379937|20531237|P3|COMPLETED|Overall Study||102
8328236|NCT01379937|20531238|P2|COMPLETED|Overall Study||153
8328237|NCT01379937|20531239|P1|COMPLETED|Overall Study||155
8328238|NCT01379937|20531236|P4|STARTED|Overall Study||104
8328239|NCT01379937|20531237|P3|STARTED|Overall Study||104
8328240|NCT01379937|20531238|P2|STARTED|Overall Study||156
8328241|NCT01379937|20531239|P1|STARTED|Overall Study||156
8328242|NCT01379924|20531321|P2|NOT COMPLETED|36-month Assessment||4
8328243|NCT01379924|20531322|P1|NOT COMPLETED|36-month Assessment||3
8328244|NCT01379924|20531321|P2|COMPLETED|36-month Assessment||48
8328245|NCT01379924|20531322|P1|COMPLETED|36-month Assessment||52
8328246|NCT01379924|20531321|P2|STARTED|36-month Assessment||52
8328247|NCT01379924|20531322|P1|STARTED|36-month Assessment||55
8328248|NCT01379924|20531321|P2|NOT COMPLETED|24-month Assessment||3
8328249|NCT01379924|20531322|P1|NOT COMPLETED|24-month Assessment||7
8328250|NCT01379924|20531321|P2|COMPLETED|24-month Assessment||52
8328251|NCT01379924|20531322|P1|COMPLETED|24-month Assessment||55
8328252|NCT01379924|20531321|P2|STARTED|24-month Assessment||55
8328253|NCT01379924|20531322|P1|STARTED|24-month Assessment||62
8328254|NCT01379924|20531321|P2|NOT COMPLETED|12-month Assessment||13
8328255|NCT01379924|20531322|P1|NOT COMPLETED|12-month Assessment||10
8328256|NCT01379924|20531321|P2|COMPLETED|12-month Assessment||55
8328257|NCT01379924|20531322|P1|COMPLETED|12-month Assessment||62
8328258|NCT01379924|20531321|P2|STARTED|12-month Assessment||68
8328259|NCT01379924|20531322|P1|STARTED|12-month Assessment||72
8328260|NCT01379924|20531321|P2|NOT COMPLETED|Baseline||0
8328261|NCT01379924|20531322|P1|NOT COMPLETED|Baseline||0
8328262|NCT01379924|20531321|P2|COMPLETED|Baseline||68
8328263|NCT01379924|20531322|P1|COMPLETED|Baseline||72
8328264|NCT01379924|20531321|P2|STARTED|Baseline||68
8328265|NCT01379924|20531322|P1|STARTED|Baseline||72
8328266|NCT01379781|20531359|P2|NOT COMPLETED|Overall Study||8
8328267|NCT01379781|20531360|P1|NOT COMPLETED|Overall Study||11
8328268|NCT01379781|20531359|P2|COMPLETED|Overall Study||19
8328269|NCT01379781|20531360|P1|COMPLETED|Overall Study||16
8328270|NCT01379781|20531359|P2|STARTED|Overall Study||27
8328271|NCT01379781|20531360|P1|STARTED|Overall Study||27
8328272|NCT01379768|20531369|P3|NOT COMPLETED|Overall Study||0
8328273|NCT01379768|20531370|P2|NOT COMPLETED|Overall Study||1
8328274|NCT01379768|20531371|P1|NOT COMPLETED|Overall Study||3
8328275|NCT01379768|20531369|P3|COMPLETED|Overall Study||20
8328276|NCT01379768|20531370|P2|COMPLETED|Overall Study||21
8328277|NCT01379768|20531371|P1|COMPLETED|Overall Study||20
8328278|NCT01379768|20531369|P3|STARTED|Overall Study||20
8328279|NCT01379768|20531370|P2|STARTED|Overall Study||22
8328280|NCT01379768|20531371|P1|STARTED|Overall Study||23
8328281|NCT01379703|20531394|P3|NOT COMPLETED|9 Months Through 18 Months||0
8328282|NCT01379703|20531395|P2|NOT COMPLETED|9 Months Through 18 Months||230
8328283|NCT01379703|20531396|P1|NOT COMPLETED|9 Months Through 18 Months||0
8328284|NCT01379703|20531394|P3|COMPLETED|9 Months Through 18 Months||0
8328285|NCT01379703|20531395|P2|COMPLETED|9 Months Through 18 Months||854
8328286|NCT01379703|20531396|P1|COMPLETED|9 Months Through 18 Months||0
8328287|NCT01379703|20531394|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
8328288|NCT01379703|20531395|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
8328289|NCT01379703|20531396|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
8328290|NCT01379703|20531394|P3|NOT COMPLETED|Study Start Through 9 Months||143
8328291|NCT01379703|20531395|P2|NOT COMPLETED|Study Start Through 9 Months||122
8328292|NCT01379703|20531396|P1|NOT COMPLETED|Study Start Through 9 Months||4
8328293|NCT01379703|20531394|P3|COMPLETED|Study Start Through 9 Months||873
8328294|NCT01379703|20531395|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
8328295|NCT01379703|20531396|P1|COMPLETED|Study Start Through 9 Months||62
8328296|NCT01379703|20531394|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
8328297|NCT01379703|20531395|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
8328298|NCT01379703|20531396|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
8328299|NCT01379664|20531459|P2|NOT COMPLETED|Overall Study||0
8328300|NCT01379664|20531460|P1|NOT COMPLETED|Overall Study||0
8328301|NCT01379664|20531459|P2|COMPLETED|Overall Study||870
8328302|NCT01379664|20531460|P1|COMPLETED|Overall Study||714
8328303|NCT01379664|20531459|P2|STARTED|Overall Study||870
8328304|NCT01379664|20531460|P1|STARTED|Overall Study||714
8328305|NCT01379651|20531472|P2|NOT COMPLETED|Overall Study||0
8328306|NCT01379651|20531473|P1|NOT COMPLETED|Overall Study||0
8328307|NCT01379651|20531472|P2|COMPLETED|Overall Study||10
8328308|NCT01379651|20531473|P1|COMPLETED|Overall Study||10
8328309|NCT01379651|20531472|P2|STARTED|Overall Study||10
8328310|NCT01379651|20531473|P1|STARTED|Overall Study||10
8328311|NCT01379625|20531483|P2|NOT COMPLETED|Overall Study||0
8328312|NCT01379625|20531484|P1|NOT COMPLETED|Overall Study||0
8328313|NCT01379625|20531483|P2|COMPLETED|Overall Study||16
8328314|NCT01379625|20531484|P1|COMPLETED|Overall Study||16
8328315|NCT01379625|20531483|P2|STARTED|Overall Study||16
8328316|NCT01379625|20531484|P1|STARTED|Overall Study||16
8328320|NCT01379534|20531508|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
8328321|NCT01379534|20531509|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
8328322|NCT01379534|20531508|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
8328323|NCT01379534|20531509|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
8328324|NCT01379534|20531508|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
8328325|NCT01379534|20531509|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
8328326|NCT01379534|20531508|P2|NOT COMPLETED|Treatment Phase||31
8328327|NCT01379534|20531509|P1|NOT COMPLETED|Treatment Phase||22
8328328|NCT01379534|20531508|P2|COMPLETED|Treatment Phase||0
8328329|NCT01379534|20531509|P1|COMPLETED|Treatment Phase||0
8328330|NCT01379534|20531508|P2|STARTED|Treatment Phase||31
8328331|NCT01379534|20531509|P1|STARTED|Treatment Phase||22
8328332|NCT01379521|20531529|P2|NOT COMPLETED|Post-Treatment Evaluations||21
8328333|NCT01379521|20531530|P1|NOT COMPLETED|Post-Treatment Evaluations||25
8328334|NCT01379521|20531529|P2|COMPLETED|Post-Treatment Evaluations||0
8328335|NCT01379521|20531530|P1|COMPLETED|Post-Treatment Evaluations||0
8328336|NCT01379521|20531529|P2|STARTED|Post-Treatment Evaluations||21
8328337|NCT01379521|20531530|P1|STARTED|Post-Treatment Evaluations||25
8328338|NCT01379521|20531529|P2|NOT COMPLETED|Overall Study -Treatment Period||26
8328339|NCT01379521|20531530|P1|NOT COMPLETED|Overall Study -Treatment Period||33
8328340|NCT01379521|20531529|P2|COMPLETED|Overall Study -Treatment Period||0
8328341|NCT01379521|20531530|P1|COMPLETED|Overall Study -Treatment Period||0
8328342|NCT01379521|20531529|P2|STARTED|Overall Study -Treatment Period||26
8328343|NCT01379521|20531530|P1|STARTED|Overall Study -Treatment Period||33
8328344|NCT01379508|20531552|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
8328345|NCT01379508|20531553|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
8328346|NCT01379508|20531554|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
8328347|NCT01379508|20531555|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
8328348|NCT01379508|20531552|P4|COMPLETED|Extension Period Weeks 109-156||10
8328349|NCT01379508|20531553|P3|COMPLETED|Extension Period Weeks 109-156||65
8328350|NCT01379508|20531554|P2|COMPLETED|Extension Period Weeks 109-156||14
8328351|NCT01379508|20531555|P1|COMPLETED|Extension Period Weeks 109-156||45
8328352|NCT01379508|20531552|P4|STARTED|Extension Period Weeks 109-156||10
8328353|NCT01379508|20531553|P3|STARTED|Extension Period Weeks 109-156||79
8328354|NCT01379508|20531554|P2|STARTED|Extension Period Weeks 109-156||17
8328355|NCT01379508|20531555|P1|STARTED|Extension Period Weeks 109-156||64
8328356|NCT01379508|20531552|P4|NOT COMPLETED|Treatment to Week 104||0
8328357|NCT01379508|20531553|P3|NOT COMPLETED|Treatment to Week 104||13
8328358|NCT01379508|20531554|P2|NOT COMPLETED|Treatment to Week 104||3
8328359|NCT01379508|20531555|P1|NOT COMPLETED|Treatment to Week 104||19
8328360|NCT01379508|20531552|P4|COMPLETED|Treatment to Week 104||11
8328361|NCT01379508|20531553|P3|COMPLETED|Treatment to Week 104||96
8328362|NCT01379508|20531554|P2|COMPLETED|Treatment to Week 104||19
8328363|NCT01379508|20531555|P1|COMPLETED|Treatment to Week 104||80
8328364|NCT01379508|20531552|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
8328365|NCT01379508|20531553|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
8328366|NCT01379508|20531554|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
8328367|NCT01379508|20531555|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
8328368|NCT01379508|20531552|P4|Completed Wk 24|Treatment to Week 104||11
8328369|NCT01379508|20531553|P3|Completed Wk 24|Treatment to Week 104||107
8328370|NCT01379508|20531554|P2|Completed Wk 24|Treatment to Week 104||22
8328371|NCT01379508|20531555|P1|Completed Wk 24|Treatment to Week 104||93
8328372|NCT01379508|20531552|P4|STARTED|Treatment to Week 104||11
8328373|NCT01379508|20531553|P3|STARTED|Treatment to Week 104||109
8328374|NCT01379508|20531554|P2|STARTED|Treatment to Week 104||22
8328375|NCT01379508|20531555|P1|STARTED|Treatment to Week 104||99
8328376|NCT01379274|20531581|P1|NOT COMPLETED|Overall Study||1
8328377|NCT01379274|20531581|P1|COMPLETED|Overall Study||1
8328378|NCT01379274|20531581|P1|STARTED|Overall Study||2
8328379|NCT01379222|20531585|P1|NOT COMPLETED|Overall Study||73
8328380|NCT01379222|20531585|P1|COMPLETED|Overall Study||105
8328381|NCT01379222|20531585|P1|STARTED|Overall Study||178
8328382|NCT01379183|20531591|P2|NOT COMPLETED|Overall Study||0
8328383|NCT01379183|20531592|P1|NOT COMPLETED|Overall Study||0
8328384|NCT01379183|20531591|P2|COMPLETED|Overall Study||21
8328385|NCT01379183|20531592|P1|COMPLETED|Overall Study||19
8328386|NCT01379183|20531591|P2|STARTED|Overall Study||21
8328387|NCT01379183|20531592|P1|STARTED|Overall Study||19
8328388|NCT01378988|20531610|P2|NOT COMPLETED|Overall Study||0
8328389|NCT01378988|20531611|P1|NOT COMPLETED|Overall Study||0
8328390|NCT01378988|20531610|P2|COMPLETED|Overall Study||3
8328391|NCT01378988|20531611|P1|COMPLETED|Overall Study||2
8328392|NCT01378988|20531610|P2|STARTED|Overall Study||3
8328393|NCT01378988|20531611|P1|STARTED|Overall Study||2
8328394|NCT01378975|20531641|P2|NOT COMPLETED|Overall Study||50
8328395|NCT01378975|20531642|P1|NOT COMPLETED|Overall Study||86
8328396|NCT01378975|20531641|P2|COMPLETED|Overall Study||6
8328397|NCT01378975|20531642|P1|COMPLETED|Overall Study||4
8328398|NCT01378975|20531641|P2|STARTED|Overall Study||56
8328399|NCT01378975|20531642|P1|STARTED|Overall Study||90
8328400|NCT01378962|20531668|P1|NOT COMPLETED|Overall Study||17
8328401|NCT01378962|20531668|P1|COMPLETED|Overall Study||33
8328402|NCT01378962|20531668|P1|STARTED|Overall Study||50
8328403|NCT01378520|20531681|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
8328404|NCT01378520|20531682|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
8328405|NCT01378520|20531681|P2|COMPLETED|Second Intervention (Day 4-6)||10
8328406|NCT01378520|20531682|P1|COMPLETED|Second Intervention (Day 4-6)||10
8328407|NCT01378520|20531681|P2|STARTED|Second Intervention (Day 4-6)||10
8328408|NCT01378520|20531682|P1|STARTED|Second Intervention (Day 4-6)||10
8328409|NCT01378520|20531681|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
8328410|NCT01378520|20531682|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
8328411|NCT01378520|20531681|P2|COMPLETED|First Intervention (Day 2-3)||10
8328412|NCT01378520|20531682|P1|COMPLETED|First Intervention (Day 2-3)||10
8328413|NCT01378520|20531681|P2|STARTED|First Intervention (Day 2-3)||10
8328414|NCT01378520|20531682|P1|STARTED|First Intervention (Day 2-3)||10
8328415|NCT01378429|20531694|P2|NOT COMPLETED|Overall Study||0
8328416|NCT01378429|20531695|P1|NOT COMPLETED|Overall Study||1
8328417|NCT01378429|20531694|P2|COMPLETED|Overall Study||47
8328418|NCT01378429|20531695|P1|COMPLETED|Overall Study||41
8328419|NCT01378429|20531694|P2|STARTED|Overall Study||47
8328420|NCT01378429|20531695|P1|STARTED|Overall Study||42
8328421|NCT01378416|20531727|P1|NOT COMPLETED|Overall Study||0
8328422|NCT01378416|20531727|P1|COMPLETED|Overall Study||16
8328423|NCT01378416|20531727|P1|STARTED|Overall Study||16
8328424|NCT01378377|20531738|P3|NOT COMPLETED|Overall Study||0
8328425|NCT01378377|20531739|P2|NOT COMPLETED|Overall Study||0
8328426|NCT01378377|20531740|P1|NOT COMPLETED|Overall Study||0
8328427|NCT01378377|20531738|P3|COMPLETED|Overall Study||6
8328428|NCT01378377|20531739|P2|COMPLETED|Overall Study||23
8328429|NCT01378377|20531740|P1|COMPLETED|Overall Study||4
8328430|NCT01378377|20531738|P3|STARTED|Overall Study||6
8328431|NCT01378377|20531739|P2|STARTED|Overall Study||23
8328432|NCT01378377|20531740|P1|STARTED|Overall Study||4
8328433|NCT01378325|20531808|P2|NOT COMPLETED|Overall Study||1
8328434|NCT01378325|20531809|P1|NOT COMPLETED|Overall Study||0
8328435|NCT01378325|20531808|P2|COMPLETED|Overall Study||39
8328436|NCT01378325|20531809|P1|COMPLETED|Overall Study||40
8328437|NCT01378325|20531808|P2|STARTED|Overall Study||40
8328438|NCT01378325|20531809|P1|STARTED|Overall Study||40
8328439|NCT01378299|20531815|P1|NOT COMPLETED|Overall Study||31
8328440|NCT01378299|20531815|P1|COMPLETED|Overall Study||74
8328441|NCT01378299|20531815|P1|BMI Group 3|Overall Study||27
8328442|NCT01378299|20531815|P1|BMI Group 2|Overall Study||40
8328443|NCT01378299|20531815|P1|BMI group1|Overall Study||38
8328444|NCT01378299|20531815|P1|STARTED|Overall Study||105
8328445|NCT01378273|20531854|P2|NOT COMPLETED|Overall Study||1
8328446|NCT01378273|20531855|P1|NOT COMPLETED|Overall Study||4
8328447|NCT01378273|20531854|P2|COMPLETED|Overall Study||476
8328448|NCT01378273|20531855|P1|COMPLETED|Overall Study||460
8328449|NCT01378273|20531854|P2|STARTED|Overall Study||477
8328450|NCT01378273|20531855|P1|STARTED|Overall Study||464
8328451|NCT01378221|20531869|P2|NOT COMPLETED|Overall Study||9
8328452|NCT01378221|20531870|P1|NOT COMPLETED|Overall Study||7
8328453|NCT01378221|20531869|P2|COMPLETED|Overall Study||30
8328454|NCT01378221|20531870|P1|COMPLETED|Overall Study||29
8328455|NCT01378221|20531869|P2|STARTED|Overall Study||39
8328456|NCT01378221|20531870|P1|STARTED|Overall Study||36
8328457|NCT01378195|20531878|P2|NOT COMPLETED|Overall Study||18
8328458|NCT01378195|20531879|P1|NOT COMPLETED|Overall Study||29
8328459|NCT01378195|20531878|P2|COMPLETED|Overall Study||57
8328460|NCT01378195|20531879|P1|COMPLETED|Overall Study||46
8328461|NCT01378195|20531878|P2|STARTED|Overall Study||75
8328462|NCT01378195|20531879|P1|STARTED|Overall Study||75
8328463|NCT01378117|20531892|P3|NOT COMPLETED|Overall Study||3
8328464|NCT01378117|20531893|P2|NOT COMPLETED|Overall Study||1
8328465|NCT01378117|20531894|P1|NOT COMPLETED|Overall Study||4
8328466|NCT01378117|20531892|P3|COMPLETED|Overall Study||26
8328467|NCT01378117|20531893|P2|COMPLETED|Overall Study||29
8328468|NCT01378117|20531894|P1|COMPLETED|Overall Study||27
8328469|NCT01378117|20531892|P3|STARTED|Overall Study||29
8328470|NCT01378117|20531893|P2|STARTED|Overall Study||30
8328471|NCT01378117|20531894|P1|STARTED|Overall Study||31
8328472|NCT01378104|20531928|P2|NOT COMPLETED|Overall Study||26
8328473|NCT01378104|20531929|P1|NOT COMPLETED|Overall Study||27
8328474|NCT01378104|20531928|P2|COMPLETED|Overall Study||60
8328475|NCT01378104|20531929|P1|COMPLETED|Overall Study||65
8328476|NCT01378104|20531928|P2|STARTED|Overall Study||86
8328477|NCT01378104|20531929|P1|STARTED|Overall Study||92
8328478|NCT01378065|20531937|P1|NOT COMPLETED|Overall Study||0
8328479|NCT01378065|20531937|P1|COMPLETED|Overall Study||30
8328480|NCT01378065|20531937|P1|12 Months|Overall Study||30
8328481|NCT01378065|20531937|P1|6 Months|Overall Study||30
8328482|NCT01378065|20531937|P1|3 Months|Overall Study||30
8328483|NCT01378065|20531937|P1|6 Week|Overall Study||30
8328484|NCT01378065|20531937|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
8328485|NCT01377987|20531974|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8328486|NCT01377987|20531975|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8328487|NCT01377987|20531974|P2|COMPLETED|Second Intervention (7 Days)||14
8328488|NCT01377987|20531975|P1|COMPLETED|Second Intervention (7 Days)||13
8328489|NCT01377987|20531974|P2|STARTED|Second Intervention (7 Days)||14
8328490|NCT01377987|20531975|P1|STARTED|Second Intervention (7 Days)||13
8328491|NCT01377987|20531974|P2|NOT COMPLETED|Washout (7 Days)||1
8328492|NCT01377987|20531975|P1|NOT COMPLETED|Washout (7 Days)||1
8328493|NCT01377987|20531974|P2|COMPLETED|Washout (7 Days)||14
8328494|NCT01377987|20531975|P1|COMPLETED|Washout (7 Days)||13
8328495|NCT01377987|20531974|P2|STARTED|Washout (7 Days)||15
8328496|NCT01377987|20531975|P1|STARTED|Washout (7 Days)||14
8328497|NCT01377987|20531974|P2|NOT COMPLETED|First Intervention (7 Days)||0
8328498|NCT01377987|20531975|P1|NOT COMPLETED|First Intervention (7 Days)||0
8328499|NCT01377987|20531974|P2|COMPLETED|First Intervention (7 Days)||15
8328500|NCT01377987|20531975|P1|COMPLETED|First Intervention (7 Days)||14
8328501|NCT01377987|20531974|P2|STARTED|First Intervention (7 Days)||15
8328502|NCT01377987|20531975|P1|STARTED|First Intervention (7 Days)||14
8328503|NCT01377922|20531993|P2|NOT COMPLETED|Overall Study||0
8328504|NCT01377922|20531994|P1|NOT COMPLETED|Overall Study||1
8328505|NCT01377922|20531993|P2|COMPLETED|Overall Study||16
8328506|NCT01377922|20531994|P1|COMPLETED|Overall Study||21
8328507|NCT01377922|20531993|P2|STARTED|Overall Study||16
8328508|NCT01377922|20531994|P1|STARTED|Overall Study||22
8328509|NCT01377636|20532006|P1|NOT COMPLETED|Overall Study||0
8328510|NCT01377636|20532006|P1|COMPLETED|Overall Study||20
8328511|NCT01377636|20532006|P1|STARTED|Overall Study||20
8328512|NCT01377623|20532020|P2|NOT COMPLETED|Overall Study||5
8328513|NCT01377623|20532021|P1|NOT COMPLETED|Overall Study||7
8328514|NCT01377623|20532020|P2|COMPLETED|Overall Study||28
8328515|NCT01377623|20532021|P1|COMPLETED|Overall Study||26
8328516|NCT01377623|20532020|P2|STARTED|Overall Study||33
8328517|NCT01377623|20532021|P1|STARTED|Overall Study||33
8328518|NCT01377584|20532041|P6|NOT COMPLETED|Overall Study||3
8328519|NCT01377584|20532042|P5|NOT COMPLETED|Overall Study||3
8328520|NCT01377584|20532043|P4|NOT COMPLETED|Overall Study||4
8328521|NCT01377584|20532044|P3|NOT COMPLETED|Overall Study||4
8328522|NCT01377584|20532045|P2|NOT COMPLETED|Overall Study||3
8328523|NCT01377584|20532046|P1|NOT COMPLETED|Overall Study||3
8328524|NCT01377584|20532041|P6|COMPLETED|Overall Study||9
8328525|NCT01377584|20532042|P5|COMPLETED|Overall Study||9
8328526|NCT01377584|20532043|P4|COMPLETED|Overall Study||6
8328527|NCT01377584|20532044|P3|COMPLETED|Overall Study||6
8328528|NCT01377584|20532045|P2|COMPLETED|Overall Study||5
8328529|NCT01377584|20532046|P1|COMPLETED|Overall Study||5
8328530|NCT01377584|20532041|P6|STARTED|Overall Study||12
8328531|NCT01377584|20532042|P5|STARTED|Overall Study||12
8328532|NCT01377584|20532043|P4|STARTED|Overall Study||10
8328533|NCT01377584|20532044|P3|STARTED|Overall Study||10
8328534|NCT01377584|20532045|P2|STARTED|Overall Study||8
8328535|NCT01377584|20532046|P1|STARTED|Overall Study||8
8328536|NCT01377480|20532079|P4|NOT COMPLETED|Overall Study||11
8328537|NCT01377480|20532080|P3|NOT COMPLETED|Overall Study||10
8328538|NCT01377480|20532081|P2|NOT COMPLETED|Overall Study||1
8328539|NCT01377480|20532082|P1|NOT COMPLETED|Overall Study||0
8328540|NCT01377480|20532079|P4|COMPLETED|Overall Study||19
8328541|NCT01377480|20532080|P3|COMPLETED|Overall Study||18
8328542|NCT01377480|20532081|P2|COMPLETED|Overall Study||29
8328543|NCT01377480|20532082|P1|COMPLETED|Overall Study||32
8328544|NCT01377480|20532079|P4|STARTED|Overall Study||30
8328545|NCT01377480|20532080|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
8328546|NCT01377480|20532081|P2|STARTED|Overall Study||30
8328547|NCT01377480|20532082|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
8328548|NCT01377467|20532094|P2|NOT COMPLETED|Overall Study||0
8328549|NCT01377467|20532095|P1|NOT COMPLETED|Overall Study||0
8328550|NCT01377467|20532094|P2|COMPLETED|Overall Study||44
8328551|NCT01377467|20532095|P1|COMPLETED|Overall Study||46
8328552|NCT01377467|20532094|P2|STARTED|Overall Study||44
8328553|NCT01377467|20532095|P1|STARTED|Overall Study||46
8328554|NCT01377441|20532143|P2|NOT COMPLETED|Overall Study||0
8328555|NCT01377441|20532144|P1|NOT COMPLETED|Overall Study||0
8328556|NCT01377441|20532143|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
8328557|NCT01377441|20532144|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
8328558|NCT01377441|20532143|P2|STARTED|Overall Study||0
8328559|NCT01377441|20532144|P1|STARTED|Overall Study||0
8328560|NCT01377402|20532152|P1|NOT COMPLETED|Overall Study||0
8328561|NCT01377402|20532152|P1|COMPLETED|Overall Study||982
8328562|NCT01377402|20532152|P1|STARTED|Overall Study||982
8328563|NCT01377389|20532158|P1|NOT COMPLETED|Overall Study||3
8328564|NCT01377389|20532158|P1|COMPLETED|Overall Study||27
8328565|NCT01377389|20532158|P1|STARTED|Overall Study||30
8328566|NCT01377233|20532172|P5|NOT COMPLETED|Double-blind||2
8328567|NCT01377233|20532173|P4|NOT COMPLETED|Double-blind||4
8328568|NCT01377233|20532174|P3|NOT COMPLETED|Double-blind||2
8328569|NCT01377233|20532175|P2|NOT COMPLETED|Double-blind||1
8328570|NCT01377233|20532176|P1|NOT COMPLETED|Double-blind||0
8328571|NCT01377233|20532172|P5|COMPLETED|Double-blind||8
8328572|NCT01377233|20532173|P4|COMPLETED|Double-blind||7
8328573|NCT01377233|20532174|P3|COMPLETED|Double-blind||8
8328574|NCT01377233|20532175|P2|COMPLETED|Double-blind||10
8328575|NCT01377233|20532176|P1|COMPLETED|Double-blind||0
8328576|NCT01377233|20532172|P5|STARTED|Double-blind||10
8328577|NCT01377233|20532173|P4|STARTED|Double-blind||11
8328578|NCT01377233|20532174|P3|STARTED|Double-blind||10
8328579|NCT01377233|20532175|P2|STARTED|Double-blind||11
8328580|NCT01377233|20532176|P1|STARTED|Double-blind||0
8328581|NCT01377233|20532172|P5|NOT COMPLETED|Open-label||0
8328582|NCT01377233|20532173|P4|NOT COMPLETED|Open-label||0
8328583|NCT01377233|20532174|P3|NOT COMPLETED|Open-label||0
8328584|NCT01377233|20532175|P2|NOT COMPLETED|Open-label||0
8328585|NCT01377233|20532176|P1|NOT COMPLETED|Open-label||4
8328586|NCT01377233|20532172|P5|COMPLETED|Open-label||0
8328587|NCT01377233|20532173|P4|COMPLETED|Open-label||0
8328588|NCT01377233|20532174|P3|COMPLETED|Open-label||0
8328589|NCT01377233|20532175|P2|COMPLETED|Open-label||0
8328590|NCT01377233|20532176|P1|COMPLETED|Open-label||42
8328591|NCT01377233|20532172|P5|STARTED|Open-label||0
8328592|NCT01377233|20532173|P4|STARTED|Open-label||0
8328593|NCT01377233|20532174|P3|STARTED|Open-label||0
8328594|NCT01377233|20532175|P2|STARTED|Open-label||0
8328595|NCT01377233|20532176|P1|STARTED|Open-label||46
8328596|NCT01377194|20532203|P3|NOT COMPLETED|Overall Study||46
8328597|NCT01377194|20532204|P2|NOT COMPLETED|Overall Study||43
8328598|NCT01377194|20532205|P1|NOT COMPLETED|Overall Study||32
8328599|NCT01377194|20532203|P3|COMPLETED|Overall Study||142
8328600|NCT01377194|20532204|P2|COMPLETED|Overall Study||145
8328601|NCT01377194|20532205|P1|COMPLETED|Overall Study||154
8328602|NCT01377194|20532203|P3|STARTED|Overall Study||188
8328603|NCT01377194|20532204|P2|STARTED|Overall Study||188
8328604|NCT01377194|20532205|P1|STARTED|Overall Study||186
8328605|NCT01377012|20532219|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
8328606|NCT01377012|20532220|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
8328607|NCT01377012|20532221|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
8328608|NCT01377012|20532219|P3|COMPLETED|Extension Study, Weeks 104-260||0
8328609|NCT01377012|20532220|P2|COMPLETED|Extension Study, Weeks 104-260||0
8328610|NCT01377012|20532221|P1|COMPLETED|Extension Study, Weeks 104-260||0
8328611|NCT01377012|20532219|P3|STARTED|Extension Study, Weeks 104-260||68
8328612|NCT01377012|20532220|P2|STARTED|Extension Study, Weeks 104-260||71
8328613|NCT01377012|20532221|P1|STARTED|Extension Study, Weeks 104-260||57
8328614|NCT01377012|20532219|P3|NOT COMPLETED|Core Study||134
8328615|NCT01377012|20532220|P2|NOT COMPLETED|Core Study||132
8328616|NCT01377012|20532221|P1|NOT COMPLETED|Core Study||134
8328617|NCT01377012|20532219|P3|COMPLETED|Core Study||80
8328618|NCT01377012|20532220|P2|COMPLETED|Core Study||81
8328619|NCT01377012|20532221|P1|COMPLETED|Core Study||76
8328620|NCT01377012|20532219|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
8328621|NCT01377012|20532220|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
8328622|NCT01377012|20532221|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
8328623|NCT01377012|20532219|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
8328624|NCT01377012|20532220|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
8328625|NCT01377012|20532221|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
8328626|NCT01377012|20532219|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
8328627|NCT01377012|20532220|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
8328628|NCT01377012|20532221|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
8328629|NCT01377012|20532219|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
8328630|NCT01377012|20532220|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
8328631|NCT01377012|20532221|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
8328632|NCT01377012|20532219|P3|STARTED|Core Study||214
8328633|NCT01377012|20532220|P2|STARTED|Core Study||213
8328634|NCT01377012|20532221|P1|STARTED|Core Study||210
8328635|NCT01376908|20532258|P2|NOT COMPLETED|Overall Study||3
8328636|NCT01376908|20532259|P1|NOT COMPLETED|Overall Study||2
8328637|NCT01376908|20532258|P2|COMPLETED|Overall Study||26
8328638|NCT01376908|20532259|P1|COMPLETED|Overall Study||25
8328639|NCT01376908|20532258|P2|STARTED|Overall Study||29
8328640|NCT01376908|20532259|P1|STARTED|Overall Study||27
8328641|NCT01376804|20532292|P1|NOT COMPLETED|Follow-up Period||0
8328642|NCT01376804|20532292|P1|COMPLETED|Follow-up Period||55
8328643|NCT01376804|20532292|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
8328644|NCT01376804|20532292|P1|NOT COMPLETED|Treatment Period||8
8328645|NCT01376804|20532292|P1|COMPLETED|Treatment Period||49
8328646|NCT01376804|20532292|P1|Received Study Drug|Treatment Period||56
8328647|NCT01376804|20532292|P1|STARTED|Treatment Period||57
8328648|NCT01376700|20532303|P1|NOT COMPLETED|Overall Study||16
8328649|NCT01376700|20532303|P1|COMPLETED|Overall Study||3
8328650|NCT01376700|20532303|P1|STARTED|Overall Study||19
8328651|NCT01376557|20532324|P5|NOT COMPLETED|Overall Study||7
8328652|NCT01376557|20532325|P4|NOT COMPLETED|Overall Study||6
8328653|NCT01376557|20532326|P3|NOT COMPLETED|Overall Study||5
8328654|NCT01376557|20532327|P2|NOT COMPLETED|Overall Study||6
8328655|NCT01376557|20532328|P1|NOT COMPLETED|Overall Study||8
8328656|NCT01376557|20532324|P5|COMPLETED|Overall Study||53
8328657|NCT01376557|20532325|P4|COMPLETED|Overall Study||54
8328658|NCT01376557|20532326|P3|COMPLETED|Overall Study||55
8328659|NCT01376557|20532327|P2|COMPLETED|Overall Study||54
8328660|NCT01376557|20532328|P1|COMPLETED|Overall Study||51
8328661|NCT01376557|20532324|P5|STARTED|Overall Study||60
8328662|NCT01376557|20532325|P4|STARTED|Overall Study||60
8328663|NCT01376557|20532326|P3|STARTED|Overall Study||60
8328664|NCT01376557|20532327|P2|STARTED|Overall Study||60
8328665|NCT01376557|20532328|P1|STARTED|Overall Study||59
8328666|NCT01376388|20532365|P1|NOT COMPLETED|Overall Study||18
8328667|NCT01376388|20532365|P1|COMPLETED|Overall Study||112
8328668|NCT01376388|20532365|P1|STARTED|Overall Study||130
8328669|NCT01376362|20532380|P1|NOT COMPLETED|Overall Study||0
8328670|NCT01376362|20532380|P1|COMPLETED|Overall Study||5
8328671|NCT01376362|20532380|P1|STARTED|Overall Study||5
8328672|NCT01376349|20532403|P3|NOT COMPLETED|Optional Continuation Phase||0
8328673|NCT01376349|20532404|P2|NOT COMPLETED|Optional Continuation Phase||0
8328674|NCT01376349|20532405|P1|NOT COMPLETED|Optional Continuation Phase||0
8328675|NCT01376349|20532403|P3|COMPLETED|Optional Continuation Phase||94
8328676|NCT01376349|20532404|P2|COMPLETED|Optional Continuation Phase||0
8328677|NCT01376349|20532405|P1|COMPLETED|Optional Continuation Phase||0
8328678|NCT01376349|20532403|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
8328679|NCT01376349|20532404|P2|STARTED|Optional Continuation Phase||0
8328680|NCT01376349|20532405|P1|STARTED|Optional Continuation Phase||0
8328681|NCT01376349|20532403|P3|NOT COMPLETED|Raondomized Treatment||29
8328682|NCT01376349|20532404|P2|NOT COMPLETED|Raondomized Treatment||35
8328683|NCT01376349|20532405|P1|NOT COMPLETED|Raondomized Treatment||24
8328684|NCT01376349|20532403|P3|COMPLETED|Raondomized Treatment||118
8328685|NCT01376349|20532404|P2|COMPLETED|Raondomized Treatment||114
8328686|NCT01376349|20532405|P1|COMPLETED|Raondomized Treatment||123
8328687|NCT01376349|20532403|P3|STARTED|Raondomized Treatment||147
8328688|NCT01376349|20532404|P2|STARTED|Raondomized Treatment||149
8328689|NCT01376349|20532405|P1|STARTED|Raondomized Treatment||147
8328690|NCT01376323|20532419|P5|NOT COMPLETED|Overall Study||1
8328691|NCT01376323|20532420|P4|NOT COMPLETED|Overall Study||5
8328692|NCT01376323|20532421|P3|NOT COMPLETED|Overall Study||3
8328693|NCT01376323|20532422|P2|NOT COMPLETED|Overall Study||1
8328694|NCT01376323|20532423|P1|NOT COMPLETED|Overall Study||2
8328695|NCT01376323|20532419|P5|COMPLETED|Overall Study||17
8328696|NCT01376323|20532420|P4|COMPLETED|Overall Study||14
8328697|NCT01376323|20532421|P3|COMPLETED|Overall Study||16
8328698|NCT01376323|20532422|P2|COMPLETED|Overall Study||17
8328699|NCT01376323|20532423|P1|COMPLETED|Overall Study||18
8328700|NCT01376323|20532419|P5|STARTED|Overall Study||18
8328701|NCT01376323|20532420|P4|STARTED|Overall Study||19
8328702|NCT01376323|20532421|P3|STARTED|Overall Study||19
8328703|NCT01376323|20532422|P2|STARTED|Overall Study||18
8328704|NCT01376323|20532423|P1|STARTED|Overall Study||20
8328705|NCT01376310|20532507|P2|NOT COMPLETED|Overall Study||11
8328706|NCT01376310|20532508|P1|NOT COMPLETED|Overall Study||36
8328707|NCT01376310|20532507|P2|COMPLETED|Overall Study||22
8328708|NCT01376310|20532508|P1|COMPLETED|Overall Study||90
8328709|NCT01376310|20532507|P2|STARTED|Overall Study||33
8328710|NCT01376310|20532508|P1|STARTED|Overall Study||126
8328711|NCT01376297|20532516|P2|NOT COMPLETED|Overall Study||49
8328712|NCT01376297|20532517|P1|NOT COMPLETED|Overall Study||128
8328713|NCT01376297|20532516|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
8328714|NCT01376297|20532517|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
8328715|NCT01376297|20532516|P2|STARTED|Overall Study|number of randomised patients|104
8328716|NCT01376297|20532517|P1|STARTED|Overall Study|number of randomised patients|309
8328717|NCT01376245|20532527|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
8328718|NCT01376245|20532528|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
8328719|NCT01376245|20532529|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
8328720|NCT01376245|20532530|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
8328721|NCT01376245|20532531|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8328722|NCT01376245|20532527|P5|COMPLETED|24-week, Double-blind Treatment Period||134
8328723|NCT01376245|20532528|P4|COMPLETED|24-week, Double-blind Treatment Period||138
8328724|NCT01376245|20532529|P3|COMPLETED|24-week, Double-blind Treatment Period||135
8328725|NCT01376245|20532530|P2|COMPLETED|24-week, Double-blind Treatment Period||130
8328726|NCT01376245|20532531|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8328727|NCT01376245|20532527|P5|STARTED|24-week, Double-blind Treatment Period||160
8328728|NCT01376245|20532528|P4|STARTED|24-week, Double-blind Treatment Period||161
8328729|NCT01376245|20532529|P3|STARTED|24-week, Double-blind Treatment Period||160
8328730|NCT01376245|20532530|P2|STARTED|24-week, Double-blind Treatment Period||162
8328731|NCT01376245|20532531|P1|STARTED|24-week, Double-blind Treatment Period||0
8328732|NCT01376245|20532527|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328733|NCT01376245|20532528|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328734|NCT01376245|20532529|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328735|NCT01376245|20532530|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328736|NCT01376245|20532531|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
8328737|NCT01376245|20532527|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328738|NCT01376245|20532528|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328739|NCT01376245|20532529|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328740|NCT01376245|20532530|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328741|NCT01376245|20532531|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
8328742|NCT01376245|20532527|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328743|NCT01376245|20532528|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328744|NCT01376245|20532529|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328745|NCT01376245|20532530|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328746|NCT01376245|20532531|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
8328747|NCT01376167|20532548|P3|NOT COMPLETED|Overall Study||6
8328748|NCT01376167|20532549|P2|NOT COMPLETED|Overall Study||10
8328749|NCT01376167|20532550|P1|NOT COMPLETED|Overall Study||4
8328750|NCT01376167|20532548|P3|COMPLETED|Overall Study||123
8328751|NCT01376167|20532549|P2|COMPLETED|Overall Study||250
8328752|NCT01376167|20532550|P1|COMPLETED|Overall Study||129
8328753|NCT01376167|20532548|P3|STARTED|Overall Study||129
8328754|NCT01376167|20532549|P2|STARTED|Overall Study||260
8328755|NCT01376167|20532550|P1|STARTED|Overall Study||133
8328756|NCT01376089|20532621|P2|NOT COMPLETED|Overall Study||4
8328757|NCT01376089|20532622|P1|NOT COMPLETED|Overall Study||3
8328758|NCT01376089|20532621|P2|COMPLETED|Overall Study||144
8328759|NCT01376089|20532622|P1|COMPLETED|Overall Study||148
8328760|NCT01376089|20532621|P2|STARTED|Overall Study||148
8328761|NCT01376089|20532622|P1|STARTED|Overall Study||151
8328762|NCT01376050|20532634|P2|NOT COMPLETED|Overall Study||0
8328763|NCT01376050|20532635|P1|NOT COMPLETED|Overall Study||0
8328764|NCT01376050|20532634|P2|COMPLETED|Overall Study||11
8328765|NCT01376050|20532635|P1|COMPLETED|Overall Study||13
8328766|NCT01376050|20532634|P2|STARTED|Overall Study||11
8328767|NCT01376050|20532635|P1|STARTED|Overall Study||13
8328768|NCT01376037|20532645|P2|NOT COMPLETED|Overall Study||2
8328769|NCT01376037|20532646|P1|NOT COMPLETED|Overall Study||0
8328770|NCT01376037|20532645|P2|COMPLETED|Overall Study||29
8328771|NCT01376037|20532646|P1|COMPLETED|Overall Study||31
8328772|NCT01376037|20532645|P2|STARTED|Overall Study||31
8328773|NCT01376037|20532646|P1|STARTED|Overall Study||31
8328774|NCT01375959|20532654|P2|NOT COMPLETED|Second Intervention (6 Weeks)||3
8328775|NCT01375959|20532655|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8328776|NCT01375959|20532654|P2|COMPLETED|Second Intervention (6 Weeks)||15
8328777|NCT01375959|20532655|P1|COMPLETED|Second Intervention (6 Weeks)||15
8328778|NCT01375959|20532654|P2|STARTED|Second Intervention (6 Weeks)||18
8328779|NCT01375959|20532655|P1|STARTED|Second Intervention (6 Weeks)||15
8328780|NCT01375959|20532654|P2|NOT COMPLETED|Wash-Out (3 Weeks)||0
8328781|NCT01375959|20532655|P1|NOT COMPLETED|Wash-Out (3 Weeks)||0
8328782|NCT01375959|20532654|P2|COMPLETED|Wash-Out (3 Weeks)||18
8328783|NCT01375959|20532655|P1|COMPLETED|Wash-Out (3 Weeks)||15
8328784|NCT01375959|20532654|P2|STARTED|Wash-Out (3 Weeks)||18
8328785|NCT01375959|20532655|P1|STARTED|Wash-Out (3 Weeks)||15
8328786|NCT01375959|20532654|P2|NOT COMPLETED|First Intervention (6 Weeks)||3
8328787|NCT01375959|20532655|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
8328788|NCT01375959|20532654|P2|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
8328789|NCT01375959|20532655|P1|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
8328790|NCT01375959|20532654|P2|Received Invertention|First Intervention (6 Weeks)||21
8328791|NCT01375959|20532655|P1|Received Invertention|First Intervention (6 Weeks)||17
8328792|NCT01375959|20532654|P2|STARTED|First Intervention (6 Weeks)||21
8328793|NCT01375959|20532655|P1|STARTED|First Intervention (6 Weeks)||17
8328794|NCT01375946|20532661|P6|NOT COMPLETED|Overall Study||0
8328795|NCT01375946|20532662|P5|NOT COMPLETED|Overall Study||0
8328796|NCT01375946|20532663|P4|NOT COMPLETED|Overall Study||0
8328797|NCT01375946|20532664|P3|NOT COMPLETED|Overall Study||0
8328798|NCT01375946|20532665|P2|NOT COMPLETED|Overall Study||0
8328799|NCT01375946|20532666|P1|NOT COMPLETED|Overall Study||0
8328800|NCT01375946|20532661|P6|COMPLETED|Overall Study||4
8328801|NCT01375946|20532662|P5|COMPLETED|Overall Study||4
8328802|NCT01375946|20532663|P4|COMPLETED|Overall Study||4
8328803|NCT01375946|20532664|P3|COMPLETED|Overall Study||4
8328804|NCT01375946|20532665|P2|COMPLETED|Overall Study||4
8328805|NCT01375946|20532666|P1|COMPLETED|Overall Study||4
8328806|NCT01375946|20532661|P6|STARTED|Overall Study||4
8328807|NCT01375946|20532662|P5|STARTED|Overall Study||4
8328808|NCT01375946|20532663|P4|STARTED|Overall Study||4
8328809|NCT01375946|20532664|P3|STARTED|Overall Study||4
8328810|NCT01375946|20532665|P2|STARTED|Overall Study||4
8328811|NCT01375946|20532666|P1|STARTED|Overall Study||4
8328812|NCT01375777|20532683|P9|NOT COMPLETED|Overall Study||2
8328813|NCT01375777|20532684|P8|NOT COMPLETED|Overall Study||2
8328814|NCT01375777|20532685|P7|NOT COMPLETED|Overall Study||2
8328815|NCT01375777|20532686|P6|NOT COMPLETED|Overall Study||1
8328816|NCT01375777|20532687|P5|NOT COMPLETED|Overall Study||1
8328817|NCT01375777|20532688|P4|NOT COMPLETED|Overall Study||0
8328818|NCT01375777|20532689|P3|NOT COMPLETED|Overall Study||1
8328819|NCT01375777|20532690|P2|NOT COMPLETED|Overall Study||3
8328820|NCT01375777|20532691|P1|NOT COMPLETED|Overall Study||2
8328821|NCT01375777|20532683|P9|COMPLETED|Overall Study||44
8328822|NCT01375777|20532684|P8|COMPLETED|Overall Study||44
8328823|NCT01375777|20532685|P7|COMPLETED|Overall Study||44
8328824|NCT01375777|20532686|P6|COMPLETED|Overall Study||44
8328825|NCT01375777|20532687|P5|COMPLETED|Overall Study||45
8328826|NCT01375777|20532688|P4|COMPLETED|Overall Study||45
8328827|NCT01375777|20532689|P3|COMPLETED|Overall Study||45
8328828|NCT01375777|20532690|P2|COMPLETED|Overall Study||42
8328829|NCT01375777|20532691|P1|COMPLETED|Overall Study||44
8328830|NCT01375777|20532683|P9|Received Treatment|Overall Study||45
8328831|NCT01375777|20532684|P8|Received Treatment|Overall Study||45
8328832|NCT01375777|20532685|P7|Received Treatment|Overall Study||45
8328833|NCT01375777|20532686|P6|Received Treatment|Overall Study||45
8328834|NCT01375777|20532687|P5|Received Treatment|Overall Study||46
8328835|NCT01375777|20532688|P4|Received Treatment|Overall Study||45
8328836|NCT01375777|20532689|P3|Received Treatment|Overall Study||45
8328837|NCT01375777|20532690|P2|Received Treatment|Overall Study||45
8328838|NCT01375777|20532691|P1|Received Treatment|Overall Study||45
8328839|NCT01375777|20532683|P9|STARTED|Overall Study||46
8328840|NCT01375777|20532684|P8|STARTED|Overall Study||46
8328841|NCT01375777|20532685|P7|STARTED|Overall Study||46
8328842|NCT01375777|20532686|P6|STARTED|Overall Study||45
8328843|NCT01375777|20532687|P5|STARTED|Overall Study||46
8328844|NCT01375777|20532688|P4|STARTED|Overall Study||45
8328845|NCT01375777|20532689|P3|STARTED|Overall Study||46
8328846|NCT01375777|20532690|P2|STARTED|Overall Study||45
8328847|NCT01375777|20532691|P1|STARTED|Overall Study||46
8328848|NCT01375764|20532761|P5|NOT COMPLETED|Overall Study||1
8328849|NCT01375764|20532762|P4|NOT COMPLETED|Overall Study||1
8328850|NCT01375764|20532763|P3|NOT COMPLETED|Overall Study||0
8328851|NCT01375764|20532764|P2|NOT COMPLETED|Overall Study||1
8328852|NCT01375764|20532765|P1|NOT COMPLETED|Overall Study||2
8328853|NCT01375764|20532761|P5|COMPLETED|Overall Study||31
8328854|NCT01375764|20532762|P4|COMPLETED|Overall Study||31
8328855|NCT01375764|20532763|P3|COMPLETED|Overall Study||32
8328856|NCT01375764|20532764|P2|COMPLETED|Overall Study||30
8328857|NCT01375764|20532765|P1|COMPLETED|Overall Study||31
8328858|NCT01375764|20532761|P5|Received Treatment|Overall Study||32
8328859|NCT01375764|20532762|P4|Received Treatment|Overall Study||31
8328860|NCT01375764|20532763|P3|Received Treatment|Overall Study||32
8328861|NCT01375764|20532764|P2|Received Treatment|Overall Study||30
8328862|NCT01375764|20532765|P1|Received Treatment|Overall Study||32
8328863|NCT01375764|20532761|P5|STARTED|Overall Study||32
8328864|NCT01375764|20532762|P4|STARTED|Overall Study||32
8328865|NCT01375764|20532763|P3|STARTED|Overall Study||32
8328866|NCT01375764|20532764|P2|STARTED|Overall Study||31
8328867|NCT01375764|20532765|P1|STARTED|Overall Study||33
8328868|NCT01375751|20532811|P3|NOT COMPLETED|Overall Study||0
8328869|NCT01375751|20532812|P2|NOT COMPLETED|Overall Study||1
8328870|NCT01375751|20532813|P1|NOT COMPLETED|Overall Study||0
8328871|NCT01375751|20532811|P3|COMPLETED|Overall Study||56
8328872|NCT01375751|20532812|P2|COMPLETED|Overall Study||55
8328873|NCT01375751|20532813|P1|COMPLETED|Overall Study||56
8328874|NCT01375751|20532811|P3|Received Treatment|Overall Study||56
8328875|NCT01375751|20532812|P2|Received Treatment|Overall Study||55
8328876|NCT01375751|20532813|P1|Received Treatment|Overall Study||56
8328877|NCT01375751|20532811|P3|STARTED|Overall Study||56
8328878|NCT01375751|20532812|P2|STARTED|Overall Study||56
8328879|NCT01375751|20532813|P1|STARTED|Overall Study||56
8328880|NCT01375673|20532838|P2|NOT COMPLETED|Overall Study||1
8328881|NCT01375673|20532839|P1|NOT COMPLETED|Overall Study||0
8328882|NCT01375673|20532838|P2|COMPLETED|Overall Study||6
8328883|NCT01375673|20532839|P1|COMPLETED|Overall Study||7
8328884|NCT01375673|20532838|P2|STARTED|Overall Study||7
8328885|NCT01375673|20532839|P1|STARTED|Overall Study||7
8328886|NCT01375660|20532851|P2|NOT COMPLETED|Overall Study||16
8328887|NCT01375660|20532852|P1|NOT COMPLETED|Overall Study||16
8328888|NCT01375660|20532851|P2|COMPLETED|Overall Study||87
8328889|NCT01375660|20532852|P1|COMPLETED|Overall Study||86
8328890|NCT01375660|20532851|P2|STARTED|Overall Study||103
8328891|NCT01375660|20532852|P1|STARTED|Overall Study||102
8328892|NCT01375608|20532870|P1|NOT COMPLETED|Overall Study||2
8328893|NCT01375608|20532870|P1|COMPLETED|Overall Study||8
8328894|NCT01375608|20532870|P1|STARTED|Overall Study||10
8328895|NCT01375569|20532874|P1|NOT COMPLETED|Overall Study||0
8328896|NCT01375569|20532874|P1|COMPLETED|Overall Study||11
8328897|NCT01375569|20532874|P1|STARTED|Overall Study||11
8328898|NCT01375491|20532882|P3|NOT COMPLETED|Overall Study||0
8328899|NCT01375491|20532883|P2|NOT COMPLETED|Overall Study||1
8328900|NCT01375491|20532884|P1|NOT COMPLETED|Overall Study||2
8328901|NCT01375491|20532882|P3|COMPLETED|Overall Study||15
8328902|NCT01375491|20532883|P2|COMPLETED|Overall Study||12
8328903|NCT01375491|20532884|P1|COMPLETED|Overall Study||9
8328904|NCT01375491|20532882|P3|STARTED|Overall Study||15
8328905|NCT01375491|20532883|P2|STARTED|Overall Study||13
8328906|NCT01375491|20532884|P1|STARTED|Overall Study||11
8328907|NCT01375374|20532898|P1|NOT COMPLETED|Overall Study||1
8328908|NCT01375374|20532898|P1|COMPLETED|Overall Study||10
8328909|NCT01375374|20532898|P1|STARTED|Overall Study||11
8328910|NCT01375205|20532907|P2|NOT COMPLETED|Overall Study||13
8328911|NCT01375205|20532908|P1|NOT COMPLETED|Overall Study||21
8328912|NCT01375205|20532907|P2|COMPLETED|Overall Study||33
8328913|NCT01375205|20532908|P1|COMPLETED|Overall Study||33
8328914|NCT01375205|20532907|P2|STARTED|Overall Study||46
8328915|NCT01375205|20532908|P1|STARTED|Overall Study||54
8328916|NCT01375140|20532928|P1|NOT COMPLETED|Overall Study||0
8328917|NCT01375140|20532928|P1|COMPLETED|Overall Study||31
8328918|NCT01375140|20532928|P1|STARTED|Overall Study||31
8328919|NCT01375127|20532938|P6|NOT COMPLETED|Overall Study||0
8328920|NCT01375127|20532939|P5|NOT COMPLETED|Overall Study||0
8328921|NCT01375127|20532940|P4|NOT COMPLETED|Overall Study||0
8328922|NCT01375127|20532941|P3|NOT COMPLETED|Overall Study||0
8328923|NCT01375127|20532942|P2|NOT COMPLETED|Overall Study||0
8328924|NCT01375127|20532943|P1|NOT COMPLETED|Overall Study||0
8328925|NCT01375127|20532938|P6|COMPLETED|Overall Study||3
8328926|NCT01375127|20532939|P5|COMPLETED|Overall Study||5
8328927|NCT01375127|20532940|P4|COMPLETED|Overall Study||33
8328928|NCT01375127|20532941|P3|COMPLETED|Overall Study||40
8328929|NCT01375127|20532942|P2|COMPLETED|Overall Study||1
8328930|NCT01375127|20532943|P1|COMPLETED|Overall Study||1
8328931|NCT01375127|20532938|P6|STARTED|Overall Study||3
8328932|NCT01375127|20532939|P5|STARTED|Overall Study||5
8328933|NCT01375127|20532940|P4|STARTED|Overall Study||33
8328934|NCT01375127|20532941|P3|STARTED|Overall Study||40
8328935|NCT01375127|20532942|P2|STARTED|Overall Study||1
8328936|NCT01375127|20532943|P1|STARTED|Overall Study||1
8328937|NCT01375075|20532981|P6|NOT COMPLETED|Overall Study||3
8328938|NCT01375075|20532982|P5|NOT COMPLETED|Overall Study||0
8328939|NCT01375075|20532983|P4|NOT COMPLETED|Overall Study||1
8328940|NCT01375075|20532984|P3|NOT COMPLETED|Overall Study||3
8328941|NCT01375075|20532985|P2|NOT COMPLETED|Overall Study||1
8328942|NCT01375075|20532986|P1|NOT COMPLETED|Overall Study||1
8328943|NCT01375075|20532981|P6|COMPLETED|Overall Study||25
8328944|NCT01375075|20532982|P5|COMPLETED|Overall Study||27
8328945|NCT01375075|20532983|P4|COMPLETED|Overall Study||27
8328946|NCT01375075|20532984|P3|COMPLETED|Overall Study||24
8328947|NCT01375075|20532985|P2|COMPLETED|Overall Study||27
8328948|NCT01375075|20532986|P1|COMPLETED|Overall Study||26
8328949|NCT01375075|20532981|P6|Received at Least One Dose of Study Drug|Overall Study||28
8328950|NCT01375075|20532982|P5|Received at Least One Dose of Study Drug|Overall Study||27
8328951|NCT01375075|20532983|P4|Received at Least One Dose of Study Drug|Overall Study||28
8328952|NCT01375075|20532984|P3|Received at Least One Dose of Study Drug|Overall Study||27
8328953|NCT01375075|20532985|P2|Received at Least One Dose of Study Drug|Overall Study||28
8328954|NCT01375075|20532986|P1|Received at Least One Dose of Study Drug|Overall Study||27
8328955|NCT01375075|20532981|P6|STARTED|Overall Study||28
8328956|NCT01375075|20532982|P5|STARTED|Overall Study||27
8328957|NCT01375075|20532983|P4|STARTED|Overall Study||28
8328958|NCT01375075|20532984|P3|STARTED|Overall Study||27
8328959|NCT01375075|20532985|P2|STARTED|Overall Study||28
8328960|NCT01375075|20532986|P1|STARTED|Overall Study||27
8328961|NCT01375049|20533070|P1|NOT COMPLETED|Overall Study||50
8328962|NCT01375049|20533070|P1|COMPLETED|Overall Study||55
8328963|NCT01375049|20533070|P1|STARTED|Overall Study||105
8328964|NCT01375010|20533087|P2|NOT COMPLETED|Overall Study||4
8328965|NCT01375010|20533088|P1|NOT COMPLETED|Overall Study||12
8328966|NCT01375010|20533087|P2|COMPLETED|Overall Study||38
8328967|NCT01375010|20533088|P1|COMPLETED|Overall Study||31
8328968|NCT01375010|20533087|P2|STARTED|Overall Study||42
8328969|NCT01375010|20533088|P1|STARTED|Overall Study||43
8328970|NCT01374971|20533102|P1|NOT COMPLETED|Overall Study||1
8328971|NCT01374971|20533102|P1|COMPLETED|Overall Study||11
8328972|NCT01374971|20533102|P1|STARTED|Overall Study||12
8328973|NCT01374919|20533107|P1|NOT COMPLETED|Overall Study||2
8328974|NCT01374919|20533107|P1|COMPLETED|Overall Study||58
8328975|NCT01374919|20533107|P1|STARTED|Overall Study||60
8328976|NCT01374906|20533114|P2|NOT COMPLETED|Overall Study||48
8328977|NCT01374906|20533115|P1|NOT COMPLETED|Overall Study||40
8328978|NCT01374906|20533114|P2|COMPLETED|Overall Study||28
8328979|NCT01374906|20533115|P1|COMPLETED|Overall Study||34
8328980|NCT01374906|20533114|P2|Completed Extension Phase|Overall Study||15
8328981|NCT01374906|20533115|P1|Completed Extension Phase|Overall Study||24
8328982|NCT01374906|20533114|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
8328983|NCT01374906|20533115|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
8328984|NCT01374906|20533114|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
8328985|NCT01374906|20533115|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
8328986|NCT01374906|20533114|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
8328987|NCT01374906|20533115|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
8328988|NCT01374906|20533114|P2|Completed Core Phase|Overall Study||54
8328989|NCT01374906|20533115|P1|Completed Core Phase|Overall Study||50
8328990|NCT01374906|20533114|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
8328991|NCT01374906|20533115|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
8328992|NCT01374906|20533114|P2|STARTED|Overall Study||76
8328993|NCT01374906|20533115|P1|STARTED|Overall Study||74
8328994|NCT01374802|20533182|P1|NOT COMPLETED|Overall Study||0
8328995|NCT01374802|20533182|P1|COMPLETED|Overall Study||14
8328996|NCT01374802|20533182|P1|STARTED|Overall Study||14
8328997|NCT01374568|20533196|P2|NOT COMPLETED|Overall Study||2
8328998|NCT01374568|20533197|P1|NOT COMPLETED|Overall Study||0
8328999|NCT01374568|20533196|P2|COMPLETED|Overall Study||1
8329000|NCT01374568|20533197|P1|COMPLETED|Overall Study||2
8329001|NCT01374568|20533196|P2|STARTED|Overall Study||3
8329002|NCT01374568|20533197|P1|STARTED|Overall Study||2
8329003|NCT01374516|20533207|P2|NOT COMPLETED|Surveillance Expansion Period||1253
8329004|NCT01374516|20533208|P1|NOT COMPLETED|Surveillance Expansion Period||2349
8329005|NCT01374516|20533207|P2|COMPLETED|Surveillance Expansion Period||5387
8329006|NCT01374516|20533208|P1|COMPLETED|Surveillance Expansion Period||10932
8329007|NCT01374516|20533207|P2|STARTED|Surveillance Expansion Period||6640
8329008|NCT01374516|20533208|P1|STARTED|Surveillance Expansion Period||13281
8329009|NCT01374516|20533207|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
8329010|NCT01374516|20533208|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
8329011|NCT01374516|20533207|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
8329012|NCT01374516|20533208|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
8329013|NCT01374516|20533207|P2|STARTED|Vaccination Phase (Up to 25 Months)||6949
8329014|NCT01374516|20533208|P1|STARTED|Vaccination Phase (Up to 25 Months)||13920
8329015|NCT01374490|20533240|P1|NOT COMPLETED|Overall Study||60
8329016|NCT01374490|20533240|P1|COMPLETED|Overall Study||190
8329017|NCT01374490|20533240|P1|STARTED|Overall Study||250
8329018|NCT01374451|20533246|P2|NOT COMPLETED|Overall Study||0
8329019|NCT01374451|20533247|P1|NOT COMPLETED|Overall Study||1
8329020|NCT01374451|20533246|P2|COMPLETED|Overall Study||81
8329021|NCT01374451|20533247|P1|COMPLETED|Overall Study||78
8329022|NCT01374451|20533246|P2|STARTED|Overall Study||81
8329023|NCT01374451|20533247|P1|STARTED|Overall Study||79
8329024|NCT01374438|20533276|P2|NOT COMPLETED|Overall Study||0
8329025|NCT01374438|20533277|P1|NOT COMPLETED|Overall Study||0
8329026|NCT01374438|20533276|P2|COMPLETED|Overall Study||13
8329027|NCT01374438|20533277|P1|COMPLETED|Overall Study||16
8329028|NCT01374438|20533276|P2|STARTED|Overall Study||13
8329029|NCT01374438|20533277|P1|STARTED|Overall Study||16
8329030|NCT01374425|20533293|P2|NOT COMPLETED|Overall Study||188
8329031|NCT01374425|20533294|P1|NOT COMPLETED|Overall Study||188
8329032|NCT01374425|20533293|P2|COMPLETED|Overall Study||0
8329033|NCT01374425|20533294|P1|COMPLETED|Overall Study||0
8329034|NCT01374425|20533293|P2|STARTED|Overall Study||188
8329035|NCT01374425|20533294|P1|STARTED|Overall Study||188
8329036|NCT01374269|20533374|P2|NOT COMPLETED|Overall Study||5
8329037|NCT01374269|20533375|P1|NOT COMPLETED|Overall Study||6
8329038|NCT01374269|20533374|P2|COMPLETED|Overall Study||39
8329039|NCT01374269|20533375|P1|COMPLETED|Overall Study||40
8329040|NCT01374269|20533374|P2|STARTED|Overall Study||44
8329041|NCT01374269|20533375|P1|STARTED|Overall Study||46
8329042|NCT01374217|20533503|P1|NOT COMPLETED|Overall Study||13
8329043|NCT01374217|20533503|P1|COMPLETED|Overall Study||0
8329044|NCT01374217|20533503|P1|STARTED|Overall Study||13
8329045|NCT01374178|20533511|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
8329046|NCT01374178|20533512|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
8329047|NCT01374178|20533511|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
8329048|NCT01374178|20533512|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
8329049|NCT01374178|20533511|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
8329050|NCT01374178|20533512|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
8329051|NCT01374178|20533511|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
8329052|NCT01374178|20533512|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
8329053|NCT01374178|20533511|P2|COMPLETED|Washout Period of at Least 7 Days||5
8329054|NCT01374178|20533512|P1|COMPLETED|Washout Period of at Least 7 Days||10
8329055|NCT01374178|20533511|P2|STARTED|Washout Period of at Least 7 Days||5
8329056|NCT01374178|20533512|P1|STARTED|Washout Period of at Least 7 Days||11
8329057|NCT01374178|20533511|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
8329058|NCT01374178|20533512|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
8329059|NCT01374178|20533511|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
8329060|NCT01374178|20533512|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
8329061|NCT01374178|20533511|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
8329062|NCT01374178|20533512|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
8329063|NCT01374178|20533511|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
8329064|NCT01374178|20533512|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
8329065|NCT01374087|20533530|P2|NOT COMPLETED|Overall Study||15
8329066|NCT01374087|20533531|P1|NOT COMPLETED|Overall Study||16
8329067|NCT01374087|20533530|P2|COMPLETED|Overall Study||0
8329068|NCT01374087|20533531|P1|COMPLETED|Overall Study||0
8329069|NCT01374087|20533530|P2|STARTED|Overall Study||15
8329070|NCT01374087|20533531|P1|STARTED|Overall Study||16
8329071|NCT01373931|20533551|P2|NOT COMPLETED|Period 2||0
8329072|NCT01373931|20533552|P1|NOT COMPLETED|Period 2||0
8329073|NCT01373931|20533551|P2|COMPLETED|Period 2||8
8329074|NCT01373931|20533552|P1|COMPLETED|Period 2||6
8329075|NCT01373931|20533551|P2|STARTED|Period 2||8
8329076|NCT01373931|20533552|P1|STARTED|Period 2||6
8329077|NCT01373931|20533551|P2|NOT COMPLETED|Period 1||2
8329078|NCT01373931|20533552|P1|NOT COMPLETED|Period 1||2
8329079|NCT01373931|20533551|P2|COMPLETED|Period 1||8
8329080|NCT01373931|20533552|P1|COMPLETED|Period 1||6
8329081|NCT01373931|20533551|P2|STARTED|Period 1||10
8329082|NCT01373931|20533552|P1|STARTED|Period 1||8
8329083|NCT01373931|20533551|P2|NOT COMPLETED|Lead-in Period||0
8329084|NCT01373931|20533552|P1|NOT COMPLETED|Lead-in Period||2
8329085|NCT01373931|20533551|P2|COMPLETED|Lead-in Period||10
8329086|NCT01373931|20533552|P1|COMPLETED|Lead-in Period||8
8329087|NCT01373931|20533551|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
8329088|NCT01373931|20533552|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
8329089|NCT01373931|20533551|P2|STARTED|Lead-in Period||10
8329090|NCT01373931|20533552|P1|STARTED|Lead-in Period||10
8329091|NCT01373918|20533565|P2|NOT COMPLETED|Overall Study||1
8329092|NCT01373918|20533566|P1|NOT COMPLETED|Overall Study||0
8329093|NCT01373918|20533565|P2|COMPLETED|Overall Study||15
8329094|NCT01373918|20533566|P1|COMPLETED|Overall Study||20
8329095|NCT01373918|20533565|P2|STARTED|Overall Study||16
8329096|NCT01373918|20533566|P1|STARTED|Overall Study||20
8329097|NCT01373671|20533578|P1|NOT COMPLETED|Overall Study||92
8329098|NCT01373671|20533578|P1|COMPLETED|Overall Study||672
8329099|NCT01373671|20533578|P1|STARTED|Overall Study||764
8329100|NCT01373580|20533583|P1|NOT COMPLETED|Overall Study||56
8329101|NCT01373580|20533583|P1|COMPLETED|Overall Study||317
8329102|NCT01373580|20533583|P1|STARTED|Overall Study||373
8329103|NCT01373489|20533591|P2|NOT COMPLETED|Overall Study||13
8329104|NCT01373489|20533592|P1|NOT COMPLETED|Overall Study||15
8329105|NCT01373489|20533591|P2|COMPLETED|Overall Study||41
8329106|NCT01373489|20533592|P1|COMPLETED|Overall Study||44
8329107|NCT01373489|20533591|P2|STARTED|Overall Study||54
8329108|NCT01373489|20533592|P1|STARTED|Overall Study||59
8329109|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 4||0
8329110|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 4||0
8329111|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 4||0
8329112|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 4||0
8329113|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 4||0
8329114|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 4||0
8329115|NCT01373450|20533598|P6|COMPLETED|Crossover Period 4||2
8329116|NCT01373450|20533599|P5|COMPLETED|Crossover Period 4||2
8329117|NCT01373450|20533600|P4|COMPLETED|Crossover Period 4||2
8329118|NCT01373450|20533601|P3|COMPLETED|Crossover Period 4||2
8329119|NCT01373450|20533602|P2|COMPLETED|Crossover Period 4||2
8329120|NCT01373450|20533603|P1|COMPLETED|Crossover Period 4||2
8329121|NCT01373450|20533598|P6|STARTED|Crossover Period 4||2
8329122|NCT01373450|20533599|P5|STARTED|Crossover Period 4||2
8329123|NCT01373450|20533600|P4|STARTED|Crossover Period 4||2
8329124|NCT01373450|20533601|P3|STARTED|Crossover Period 4||2
8329125|NCT01373450|20533602|P2|STARTED|Crossover Period 4||2
8329126|NCT01373450|20533603|P1|STARTED|Crossover Period 4||2
8329127|NCT01373450|20533598|P6|NOT COMPLETED|7 Day Wash-out||0
8329128|NCT01373450|20533599|P5|NOT COMPLETED|7 Day Wash-out||0
8329129|NCT01373450|20533600|P4|NOT COMPLETED|7 Day Wash-out||0
8329130|NCT01373450|20533601|P3|NOT COMPLETED|7 Day Wash-out||0
8329131|NCT01373450|20533602|P2|NOT COMPLETED|7 Day Wash-out||0
8329132|NCT01373450|20533603|P1|NOT COMPLETED|7 Day Wash-out||0
8329133|NCT01373450|20533598|P6|COMPLETED|7 Day Wash-out||2
8329134|NCT01373450|20533599|P5|COMPLETED|7 Day Wash-out||2
8329135|NCT01373450|20533600|P4|COMPLETED|7 Day Wash-out||2
8329136|NCT01373450|20533601|P3|COMPLETED|7 Day Wash-out||2
8329137|NCT01373450|20533602|P2|COMPLETED|7 Day Wash-out||2
8329138|NCT01373450|20533603|P1|COMPLETED|7 Day Wash-out||2
8329139|NCT01373450|20533598|P6|STARTED|7 Day Wash-out||2
8329140|NCT01373450|20533599|P5|STARTED|7 Day Wash-out||2
8329141|NCT01373450|20533600|P4|STARTED|7 Day Wash-out||2
8329142|NCT01373450|20533601|P3|STARTED|7 Day Wash-out||2
8329143|NCT01373450|20533602|P2|STARTED|7 Day Wash-out||2
8329144|NCT01373450|20533603|P1|STARTED|7 Day Wash-out||2
8329145|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 3||0
8329146|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 3||0
8329147|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 3||0
8329148|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 3||0
8329149|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 3||0
8329150|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 3||0
8329151|NCT01373450|20533598|P6|COMPLETED|Crossover Period 3||2
8329152|NCT01373450|20533599|P5|COMPLETED|Crossover Period 3||2
8329153|NCT01373450|20533600|P4|COMPLETED|Crossover Period 3||2
8329154|NCT01373450|20533601|P3|COMPLETED|Crossover Period 3||2
8329155|NCT01373450|20533602|P2|COMPLETED|Crossover Period 3||2
8329156|NCT01373450|20533603|P1|COMPLETED|Crossover Period 3||2
8329157|NCT01373450|20533598|P6|STARTED|Crossover Period 3||2
8329158|NCT01373450|20533599|P5|STARTED|Crossover Period 3||2
8329159|NCT01373450|20533600|P4|STARTED|Crossover Period 3||2
8329160|NCT01373450|20533601|P3|STARTED|Crossover Period 3||2
8329161|NCT01373450|20533602|P2|STARTED|Crossover Period 3||2
8329162|NCT01373450|20533603|P1|STARTED|Crossover Period 3||2
8329163|NCT01373450|20533598|P6|NOT COMPLETED|7 Day Wash-out||0
8329164|NCT01373450|20533599|P5|NOT COMPLETED|7 Day Wash-out||0
8329165|NCT01373450|20533600|P4|NOT COMPLETED|7 Day Wash-out||0
8329166|NCT01373450|20533601|P3|NOT COMPLETED|7 Day Wash-out||0
8329167|NCT01373450|20533602|P2|NOT COMPLETED|7 Day Wash-out||0
8329168|NCT01373450|20533603|P1|NOT COMPLETED|7 Day Wash-out||0
8329169|NCT01373450|20533598|P6|COMPLETED|7 Day Wash-out||2
8329170|NCT01373450|20533599|P5|COMPLETED|7 Day Wash-out||2
8329171|NCT01373450|20533600|P4|COMPLETED|7 Day Wash-out||2
8329172|NCT01373450|20533601|P3|COMPLETED|7 Day Wash-out||2
8329173|NCT01373450|20533602|P2|COMPLETED|7 Day Wash-out||2
8329174|NCT01373450|20533603|P1|COMPLETED|7 Day Wash-out||2
8329175|NCT01373450|20533598|P6|STARTED|7 Day Wash-out||2
8329176|NCT01373450|20533599|P5|STARTED|7 Day Wash-out||2
8329177|NCT01373450|20533600|P4|STARTED|7 Day Wash-out||2
8329178|NCT01373450|20533601|P3|STARTED|7 Day Wash-out||2
8329179|NCT01373450|20533602|P2|STARTED|7 Day Wash-out||2
8329180|NCT01373450|20533603|P1|STARTED|7 Day Wash-out||2
8329181|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 2||0
8329182|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 2||0
8329183|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 2||0
8329184|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 2||0
8329185|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 2||0
8329186|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 2||0
8329187|NCT01373450|20533598|P6|COMPLETED|Crossover Period 2||2
8329188|NCT01373450|20533599|P5|COMPLETED|Crossover Period 2||2
8329189|NCT01373450|20533600|P4|COMPLETED|Crossover Period 2||2
8329190|NCT01373450|20533601|P3|COMPLETED|Crossover Period 2||2
8329191|NCT01373450|20533602|P2|COMPLETED|Crossover Period 2||2
8329192|NCT01373450|20533603|P1|COMPLETED|Crossover Period 2||2
8329193|NCT01373450|20533598|P6|STARTED|Crossover Period 2||2
8329194|NCT01373450|20533599|P5|STARTED|Crossover Period 2||2
8329195|NCT01373450|20533600|P4|STARTED|Crossover Period 2||2
8329196|NCT01373450|20533601|P3|STARTED|Crossover Period 2||2
8329197|NCT01373450|20533602|P2|STARTED|Crossover Period 2||2
8329198|NCT01373450|20533603|P1|STARTED|Crossover Period 2||2
8329199|NCT01373450|20533598|P6|NOT COMPLETED|7 Day Wash-out||0
8329200|NCT01373450|20533599|P5|NOT COMPLETED|7 Day Wash-out||0
8329201|NCT01373450|20533600|P4|NOT COMPLETED|7 Day Wash-out||0
8329202|NCT01373450|20533601|P3|NOT COMPLETED|7 Day Wash-out||0
8329203|NCT01373450|20533602|P2|NOT COMPLETED|7 Day Wash-out||0
8329204|NCT01373450|20533603|P1|NOT COMPLETED|7 Day Wash-out||0
8329205|NCT01373450|20533598|P6|COMPLETED|7 Day Wash-out||2
8329206|NCT01373450|20533599|P5|COMPLETED|7 Day Wash-out||2
8329207|NCT01373450|20533600|P4|COMPLETED|7 Day Wash-out||2
8329208|NCT01373450|20533601|P3|COMPLETED|7 Day Wash-out||2
8329209|NCT01373450|20533602|P2|COMPLETED|7 Day Wash-out||2
8329210|NCT01373450|20533603|P1|COMPLETED|7 Day Wash-out||2
8329211|NCT01373450|20533598|P6|STARTED|7 Day Wash-out||2
8329212|NCT01373450|20533599|P5|STARTED|7 Day Wash-out||2
8329213|NCT01373450|20533600|P4|STARTED|7 Day Wash-out||2
8329214|NCT01373450|20533601|P3|STARTED|7 Day Wash-out||2
8329215|NCT01373450|20533602|P2|STARTED|7 Day Wash-out||2
8329216|NCT01373450|20533603|P1|STARTED|7 Day Wash-out||2
8329217|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 1||0
8329218|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 1||0
8329219|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 1||0
8329220|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 1||0
8329221|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 1||0
8329222|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 1||0
8329223|NCT01373450|20533598|P6|COMPLETED|Crossover Period 1||2
8329224|NCT01373450|20533599|P5|COMPLETED|Crossover Period 1||2
8329225|NCT01373450|20533600|P4|COMPLETED|Crossover Period 1||2
8329226|NCT01373450|20533601|P3|COMPLETED|Crossover Period 1||2
8329227|NCT01373450|20533602|P2|COMPLETED|Crossover Period 1||2
8329228|NCT01373450|20533603|P1|COMPLETED|Crossover Period 1||2
8329229|NCT01373450|20533598|P6|STARTED|Crossover Period 1||2
8329230|NCT01373450|20533599|P5|STARTED|Crossover Period 1||2
8329231|NCT01373450|20533600|P4|STARTED|Crossover Period 1||2
8329232|NCT01373450|20533601|P3|STARTED|Crossover Period 1||2
8329233|NCT01373450|20533602|P2|STARTED|Crossover Period 1||2
8329234|NCT01373450|20533603|P1|STARTED|Crossover Period 1||2
8329235|NCT01373346|20533625|P1|NOT COMPLETED|Overall Study||1
8329236|NCT01373346|20533625|P1|COMPLETED|Overall Study||14
8329237|NCT01373346|20533625|P1|STARTED|Overall Study||15
8329238|NCT01373294|20533648|P2|NOT COMPLETED|Overall Study||0
8329239|NCT01373294|20533649|P1|NOT COMPLETED|Overall Study||1
8329240|NCT01373294|20533648|P2|COMPLETED|Overall Study||2
8329241|NCT01373294|20533649|P1|COMPLETED|Overall Study||14
8329242|NCT01373294|20533648|P2|STARTED|Overall Study||2
8329243|NCT01373294|20533649|P1|STARTED|Overall Study||15
8329244|NCT01373281|20533658|P2|NOT COMPLETED|Surveillance Expansion Period||118
8329245|NCT01373281|20533659|P1|NOT COMPLETED|Surveillance Expansion Period||202
8329246|NCT01373281|20533658|P2|COMPLETED|Surveillance Expansion Period||3279
8329247|NCT01373281|20533659|P1|COMPLETED|Surveillance Expansion Period||6595
8329248|NCT01373281|20533658|P2|STARTED|Surveillance Expansion Period||3397
8329249|NCT01373281|20533659|P1|STARTED|Surveillance Expansion Period||6797
8329250|NCT01373281|20533658|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
8329251|NCT01373281|20533659|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
8329252|NCT01373281|20533658|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
8329253|NCT01373281|20533659|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
8329254|NCT01373281|20533658|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
8329255|NCT01373281|20533659|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
8329256|NCT01373242|20533691|P1|NOT COMPLETED|Overall Study||16
8329257|NCT01373242|20533691|P1|COMPLETED|Overall Study||38
8329258|NCT01373242|20533691|P1|STARTED|Overall Study||54
8329259|NCT01373229|20533707|P1|NOT COMPLETED|Overall Study||6
8329260|NCT01373229|20533707|P1|COMPLETED|Overall Study||9
8329261|NCT01373229|20533707|P1|STARTED|Overall Study||15
8329262|NCT01373164|20533721|P5|NOT COMPLETED|Overall Study||2
8329263|NCT01373164|20533722|P4|NOT COMPLETED|Overall Study||12
8329264|NCT01373164|20533723|P3|NOT COMPLETED|Overall Study||1
8329265|NCT01373164|20533724|P2|NOT COMPLETED|Overall Study||1
8329266|NCT01373164|20533725|P1|NOT COMPLETED|Overall Study||0
8329267|NCT01373164|20533721|P5|COMPLETED|Overall Study||50
8329268|NCT01373164|20533722|P4|COMPLETED|Overall Study||92
8329269|NCT01373164|20533723|P3|COMPLETED|Overall Study||4
8329270|NCT01373164|20533724|P2|COMPLETED|Overall Study||3
8329271|NCT01373164|20533725|P1|COMPLETED|Overall Study||5
8329272|NCT01373164|20533721|P5|Received at Least One Dose|Overall Study||52
8329273|NCT01373164|20533722|P4|Received at Least One Dose|Overall Study||103
8329274|NCT01373164|20533723|P3|Received at Least One Dose|Overall Study||5
8329275|NCT01373164|20533724|P2|Received at Least One Dose|Overall Study||4
8329276|NCT01373164|20533725|P1|Received at Least One Dose|Overall Study||5
8329277|NCT01373164|20533721|P5|STARTED|Overall Study||52
8329278|NCT01373164|20533722|P4|STARTED|Overall Study||104
8329279|NCT01373164|20533723|P3|STARTED|Overall Study||5
8329280|NCT01373164|20533724|P2|STARTED|Overall Study||4
8329281|NCT01373164|20533725|P1|STARTED|Overall Study||5
8329282|NCT01372995|20533759|P3|NOT COMPLETED|Overall Study||1
8329283|NCT01372995|20533760|P2|NOT COMPLETED|Overall Study||1
8329284|NCT01372995|20533761|P1|NOT COMPLETED|Overall Study||0
8329285|NCT01372995|20533759|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
8329286|NCT01372995|20533760|P2|COMPLETED|Overall Study||9
8329287|NCT01372995|20533761|P1|COMPLETED|Overall Study||10
8329288|NCT01372995|20533759|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
8329289|NCT01372995|20533760|P2|STARTED|Overall Study||10
8329290|NCT01372995|20533761|P1|STARTED|Overall Study||10
8329291|NCT01372878|20533808|P1|NOT COMPLETED|Overall Study||184
8329292|NCT01372878|20533808|P1|COMPLETED|Overall Study||700
8329293|NCT01372878|20533808|P1|STARTED|Overall Study||884
8329294|NCT01372813|20533813|P1|NOT COMPLETED|Overall Study||0
8329295|NCT01372813|20533813|P1|COMPLETED|Overall Study||3
8329296|NCT01372813|20533813|P1|STARTED|Overall Study||3
8329297|NCT01372774|20533828|P2|NOT COMPLETED|Overall Study||5
8329298|NCT01372774|20533829|P1|NOT COMPLETED|Overall Study||4
8329299|NCT01372774|20533828|P2|COMPLETED|Overall Study||93
8329300|NCT01372774|20533829|P1|COMPLETED|Overall Study||92
8329301|NCT01372774|20533828|P2|STARTED|Overall Study||98
8329302|NCT01372774|20533829|P1|STARTED|Overall Study||96
8329303|NCT01372748|20533845|P2|NOT COMPLETED|Overall Study||39
8329304|NCT01372748|20533846|P1|NOT COMPLETED|Overall Study||23
8329305|NCT01372748|20533845|P2|COMPLETED|Overall Study|defined as having vital status|12603
8329306|NCT01372748|20533846|P1|COMPLETED|Overall Study|defined as having vital status|11022
8329307|NCT01372748|20533845|P2|STARTED|Overall Study||12642
8329308|NCT01372748|20533846|P1|STARTED|Overall Study||11045
8329309|NCT01372618|20533854|P1|NOT COMPLETED|Overall Study||9
8329310|NCT01372618|20533854|P1|COMPLETED|Overall Study||0
8329311|NCT01372618|20533854|P1|STARTED|Overall Study||9
8329312|NCT01372605|20533862|P2|NOT COMPLETED|Overall Study||10
8329313|NCT01372605|20533863|P1|NOT COMPLETED|Overall Study||12
8329314|NCT01372605|20533862|P2|COMPLETED|Overall Study||145
8329315|NCT01372605|20533863|P1|COMPLETED|Overall Study||137
8329316|NCT01372605|20533862|P2|STARTED|Overall Study||155
8329317|NCT01372605|20533863|P1|STARTED|Overall Study||149
8329318|NCT01372501|20533889|P1|NOT COMPLETED|Overall Study||5
8329319|NCT01372501|20533889|P1|COMPLETED|Overall Study||14
8329320|NCT01372501|20533889|P1|STARTED|Overall Study||19
8329321|NCT01372462|20533894|P1|NOT COMPLETED|No Treatment Control||0
8329322|NCT01372462|20533894|P1|COMPLETED|No Treatment Control||15
8329323|NCT01372462|20533894|P1|STARTED|No Treatment Control||15
8329324|NCT01372462|20533894|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
8329325|NCT01372462|20533894|P1|COMPLETED|Oxygen Nasal Cannula||15
8329326|NCT01372462|20533894|P1|STARTED|Oxygen Nasal Cannula||15
8329327|NCT01372462|20533894|P1|NOT COMPLETED|NIOV - Oxygen||0
8329328|NCT01372462|20533894|P1|COMPLETED|NIOV - Oxygen||15
8329329|NCT01372462|20533894|P1|STARTED|NIOV - Oxygen||15
8329330|NCT01372462|20533894|P1|NOT COMPLETED|NIOV - Room Air||0
8329331|NCT01372462|20533894|P1|COMPLETED|NIOV - Room Air||15
8329332|NCT01372462|20533894|P1|STARTED|NIOV - Room Air||15
8329333|NCT01372410|20533912|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329334|NCT01372410|20533913|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329335|NCT01372410|20533914|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8329336|NCT01372410|20533915|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329337|NCT01372410|20533916|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329338|NCT01372410|20533917|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8329339|NCT01372410|20533918|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329340|NCT01372410|20533919|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329341|NCT01372410|20533912|P8|COMPLETED|Treatment Period 3 (7 Days)||18
8329342|NCT01372410|20533913|P7|COMPLETED|Treatment Period 3 (7 Days)||15
8329343|NCT01372410|20533914|P6|COMPLETED|Treatment Period 3 (7 Days)||18
8329344|NCT01372410|20533915|P5|COMPLETED|Treatment Period 3 (7 Days)||20
8329345|NCT01372410|20533916|P4|COMPLETED|Treatment Period 3 (7 Days)||22
8329346|NCT01372410|20533917|P3|COMPLETED|Treatment Period 3 (7 Days)||15
8329347|NCT01372410|20533918|P2|COMPLETED|Treatment Period 3 (7 Days)||18
8329348|NCT01372410|20533919|P1|COMPLETED|Treatment Period 3 (7 Days)||21
8329349|NCT01372410|20533912|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
8329350|NCT01372410|20533913|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
8329351|NCT01372410|20533914|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329352|NCT01372410|20533915|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
8329353|NCT01372410|20533916|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8329354|NCT01372410|20533917|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
8329355|NCT01372410|20533918|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
8329356|NCT01372410|20533919|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8329357|NCT01372410|20533912|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
8329358|NCT01372410|20533913|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
8329359|NCT01372410|20533914|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329360|NCT01372410|20533915|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
8329361|NCT01372410|20533916|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329362|NCT01372410|20533917|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329363|NCT01372410|20533918|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329364|NCT01372410|20533919|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329365|NCT01372410|20533912|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8329366|NCT01372410|20533913|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8329367|NCT01372410|20533914|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
8329368|NCT01372410|20533915|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8329369|NCT01372410|20533916|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8329370|NCT01372410|20533917|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
8329371|NCT01372410|20533918|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8329372|NCT01372410|20533919|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329373|NCT01372410|20533912|P8|STARTED|Washout Period 2 (10-14 Days)||19
8329374|NCT01372410|20533913|P7|STARTED|Washout Period 2 (10-14 Days)||21
8329375|NCT01372410|20533914|P6|STARTED|Washout Period 2 (10-14 Days)||16
8329376|NCT01372410|20533915|P5|STARTED|Washout Period 2 (10-14 Days)||19
8329377|NCT01372410|20533916|P4|STARTED|Washout Period 2 (10-14 Days)||17
8329378|NCT01372410|20533917|P3|STARTED|Washout Period 2 (10-14 Days)||22
8329379|NCT01372410|20533918|P2|STARTED|Washout Period 2 (10-14 Days)||21
8329380|NCT01372410|20533919|P1|STARTED|Washout Period 2 (10-14 Days)||19
8329381|NCT01372410|20533912|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329382|NCT01372410|20533913|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329383|NCT01372410|20533914|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329384|NCT01372410|20533915|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329385|NCT01372410|20533916|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329386|NCT01372410|20533917|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329387|NCT01372410|20533918|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329388|NCT01372410|20533919|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329389|NCT01372410|20533912|P8|COMPLETED|Treatment Period 2 (7 Days)||19
8329390|NCT01372410|20533913|P7|COMPLETED|Treatment Period 2 (7 Days)||21
8329391|NCT01372410|20533914|P6|COMPLETED|Treatment Period 2 (7 Days)||16
8329392|NCT01372410|20533915|P5|COMPLETED|Treatment Period 2 (7 Days)||19
8329393|NCT01372410|20533916|P4|COMPLETED|Treatment Period 2 (7 Days)||17
8329394|NCT01372410|20533917|P3|COMPLETED|Treatment Period 2 (7 Days)||22
8329395|NCT01372410|20533918|P2|COMPLETED|Treatment Period 2 (7 Days)||21
8329396|NCT01372410|20533919|P1|COMPLETED|Treatment Period 2 (7 Days)||19
8329397|NCT01372410|20533912|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329398|NCT01372410|20533913|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8329399|NCT01372410|20533914|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
8329400|NCT01372410|20533915|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329401|NCT01372410|20533916|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
8329402|NCT01372410|20533917|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8329403|NCT01372410|20533918|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8329404|NCT01372410|20533919|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329405|NCT01372410|20533912|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
8329406|NCT01372410|20533913|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329407|NCT01372410|20533914|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329408|NCT01372410|20533915|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329409|NCT01372410|20533916|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329410|NCT01372410|20533917|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329411|NCT01372410|20533918|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329412|NCT01372410|20533919|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
8329413|NCT01372410|20533912|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8329414|NCT01372410|20533913|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8329415|NCT01372410|20533914|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8329416|NCT01372410|20533915|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329417|NCT01372410|20533916|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8329418|NCT01372410|20533917|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329419|NCT01372410|20533918|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329420|NCT01372410|20533919|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8329421|NCT01372410|20533912|P8|STARTED|Washout Period 1 (10-14 Days)||19
8329422|NCT01372410|20533913|P7|STARTED|Washout Period 1 (10-14 Days)||20
8329423|NCT01372410|20533914|P6|STARTED|Washout Period 1 (10-14 Days)||21
8329424|NCT01372410|20533915|P5|STARTED|Washout Period 1 (10-14 Days)||19
8329425|NCT01372410|20533916|P4|STARTED|Washout Period 1 (10-14 Days)||20
8329426|NCT01372410|20533917|P3|STARTED|Washout Period 1 (10-14 Days)||19
8329427|NCT01372410|20533918|P2|STARTED|Washout Period 1 (10-14 Days)||19
8329428|NCT01372410|20533919|P1|STARTED|Washout Period 1 (10-14 Days)||19
8329429|NCT01372410|20533912|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329430|NCT01372410|20533913|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8329431|NCT01372410|20533914|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329432|NCT01372410|20533915|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8329433|NCT01372410|20533916|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329434|NCT01372410|20533917|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329435|NCT01372410|20533918|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8329436|NCT01372410|20533919|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
8329437|NCT01372410|20533912|P8|COMPLETED|Treatment Period 1 (7 Days)||19
8329438|NCT01372410|20533913|P7|COMPLETED|Treatment Period 1 (7 Days)||20
8329439|NCT01372410|20533914|P6|COMPLETED|Treatment Period 1 (7 Days)||21
8329440|NCT01372410|20533915|P5|COMPLETED|Treatment Period 1 (7 Days)||19
8329441|NCT01372410|20533916|P4|COMPLETED|Treatment Period 1 (7 Days)||20
8329442|NCT01372410|20533917|P3|COMPLETED|Treatment Period 1 (7 Days)||19
8329443|NCT01372410|20533918|P2|COMPLETED|Treatment Period 1 (7 Days)||19
8329444|NCT01372410|20533919|P1|COMPLETED|Treatment Period 1 (7 Days)||19
8329445|NCT01372410|20533912|P8|STARTED|Treatment Period 1 (7 Days)||19
8329446|NCT01372410|20533913|P7|STARTED|Treatment Period 1 (7 Days)||22
8329447|NCT01372410|20533914|P6|STARTED|Treatment Period 1 (7 Days)||21
8329448|NCT01372410|20533915|P5|STARTED|Treatment Period 1 (7 Days)||21
8329449|NCT01372410|20533916|P4|STARTED|Treatment Period 1 (7 Days)||20
8329450|NCT01372410|20533917|P3|STARTED|Treatment Period 1 (7 Days)||19
8329451|NCT01372410|20533918|P2|STARTED|Treatment Period 1 (7 Days)||21
8329452|NCT01372410|20533919|P1|STARTED|Treatment Period 1 (7 Days)||20
8329453|NCT01372384|20533956|P1|NOT COMPLETED|Overall Study||3
8329454|NCT01372384|20533956|P1|COMPLETED|Overall Study||3
8329455|NCT01372384|20533956|P1|STARTED|Overall Study||6
8329456|NCT01372254|20533965|P2|NOT COMPLETED|Overall Study||3
8329457|NCT01372254|20533966|P1|NOT COMPLETED|Overall Study||4
8329458|NCT01372254|20533965|P2|COMPLETED|Overall Study||46
8329459|NCT01372254|20533966|P1|COMPLETED|Overall Study||43
8329460|NCT01372254|20533965|P2|STARTED|Overall Study||49
8329461|NCT01372254|20533966|P1|STARTED|Overall Study||47
8329462|NCT01372202|20533975|P3|NOT COMPLETED|Overall Study||0
8329463|NCT01372202|20533976|P2|NOT COMPLETED|Overall Study||0
8329464|NCT01372202|20533977|P1|NOT COMPLETED|Overall Study||0
8329465|NCT01372202|20533975|P3|COMPLETED|Overall Study||9
8329466|NCT01372202|20533976|P2|COMPLETED|Overall Study||9
8329467|NCT01372202|20533977|P1|COMPLETED|Overall Study||13
8329468|NCT01372202|20533975|P3|STARTED|Overall Study||9
8329469|NCT01372202|20533976|P2|STARTED|Overall Study||9
8329470|NCT01372202|20533977|P1|STARTED|Overall Study||13
8329471|NCT01372150|20533997|P3|NOT COMPLETED|Overall Study||16
8329472|NCT01372150|20533998|P2|NOT COMPLETED|Overall Study||14
8329473|NCT01372150|20533999|P1|NOT COMPLETED|Overall Study||13
8329474|NCT01372150|20533997|P3|COMPLETED|Overall Study||99
8329475|NCT01372150|20533998|P2|COMPLETED|Overall Study||99
8329476|NCT01372150|20533999|P1|COMPLETED|Overall Study||99
8329477|NCT01372150|20533997|P3|Treated|Overall Study||115
8329478|NCT01372150|20533998|P2|Treated|Overall Study||112
8329479|NCT01372150|20533999|P1|Treated|Overall Study||112
8329480|NCT01372150|20533997|P3|STARTED|Overall Study||115
8329481|NCT01372150|20533998|P2|STARTED|Overall Study||113
8329482|NCT01372150|20533999|P1|STARTED|Overall Study||112
8329483|NCT01372085|20534026|P10|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329484|NCT01372085|20534027|P9|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329485|NCT01372085|20534028|P8|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329486|NCT01372085|20534029|P7|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329487|NCT01372085|20534030|P6|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329488|NCT01372085|20534031|P5|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329489|NCT01372085|20534032|P4|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329490|NCT01372085|20534033|P3|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329491|NCT01372085|20534034|P2|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329492|NCT01372085|20534035|P1|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329493|NCT01372085|20534026|P10|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329494|NCT01372085|20534027|P9|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329495|NCT01372085|20534028|P8|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329496|NCT01372085|20534029|P7|COMPLETED|Forth Intervention (Period 4a/4b)||3
8329497|NCT01372085|20534030|P6|COMPLETED|Forth Intervention (Period 4a/4b)||5
8329498|NCT01372085|20534031|P5|COMPLETED|Forth Intervention (Period 4a/4b)||2
8329499|NCT01372085|20534032|P4|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329500|NCT01372085|20534033|P3|COMPLETED|Forth Intervention (Period 4a/4b)||2
8329501|NCT01372085|20534034|P2|COMPLETED|Forth Intervention (Period 4a/4b)||0
8329502|NCT01372085|20534035|P1|COMPLETED|Forth Intervention (Period 4a/4b)||0
8329503|NCT01372085|20534026|P10|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
8329504|NCT01372085|20534027|P9|STARTED|Forth Intervention (Period 4a/4b)||1
8329505|NCT01372085|20534028|P8|STARTED|Forth Intervention (Period 4a/4b)||1
8329506|NCT01372085|20534029|P7|STARTED|Forth Intervention (Period 4a/4b)||3
8329507|NCT01372085|20534030|P6|STARTED|Forth Intervention (Period 4a/4b)||5
8329508|NCT01372085|20534031|P5|STARTED|Forth Intervention (Period 4a/4b)||2
8329509|NCT01372085|20534032|P4|STARTED|Forth Intervention (Period 4a/4b)||1
8329510|NCT01372085|20534033|P3|STARTED|Forth Intervention (Period 4a/4b)||2
8329511|NCT01372085|20534034|P2|STARTED|Forth Intervention (Period 4a/4b)||0
8329512|NCT01372085|20534035|P1|STARTED|Forth Intervention (Period 4a/4b)||0
8329513|NCT01372085|20534026|P10|NOT COMPLETED|Washout Period 3||0
8329514|NCT01372085|20534027|P9|NOT COMPLETED|Washout Period 3||0
8329515|NCT01372085|20534028|P8|NOT COMPLETED|Washout Period 3||0
8329516|NCT01372085|20534029|P7|NOT COMPLETED|Washout Period 3||0
8329517|NCT01372085|20534030|P6|NOT COMPLETED|Washout Period 3||2
8329518|NCT01372085|20534031|P5|NOT COMPLETED|Washout Period 3||0
8329519|NCT01372085|20534032|P4|NOT COMPLETED|Washout Period 3||0
8329520|NCT01372085|20534033|P3|NOT COMPLETED|Washout Period 3||0
8329521|NCT01372085|20534034|P2|NOT COMPLETED|Washout Period 3||0
8329522|NCT01372085|20534035|P1|NOT COMPLETED|Washout Period 3||0
8329523|NCT01372085|20534026|P10|COMPLETED|Washout Period 3||0
8329524|NCT01372085|20534027|P9|COMPLETED|Washout Period 3||1
8329525|NCT01372085|20534028|P8|COMPLETED|Washout Period 3||1
8329526|NCT01372085|20534029|P7|COMPLETED|Washout Period 3||3
8329527|NCT01372085|20534030|P6|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
8329528|NCT01372085|20534031|P5|COMPLETED|Washout Period 3||2
8329529|NCT01372085|20534032|P4|COMPLETED|Washout Period 3||1
8329530|NCT01372085|20534033|P3|COMPLETED|Washout Period 3||2
8329531|NCT01372085|20534034|P2|COMPLETED|Washout Period 3||0
8329532|NCT01372085|20534035|P1|COMPLETED|Washout Period 3||0
8329533|NCT01372085|20534026|P10|STARTED|Washout Period 3||0
8329534|NCT01372085|20534027|P9|STARTED|Washout Period 3||1
8329535|NCT01372085|20534028|P8|STARTED|Washout Period 3||1
8329536|NCT01372085|20534029|P7|STARTED|Washout Period 3||3
8329537|NCT01372085|20534030|P6|STARTED|Washout Period 3||7
8329538|NCT01372085|20534031|P5|STARTED|Washout Period 3||2
8329539|NCT01372085|20534032|P4|STARTED|Washout Period 3||1
8329540|NCT01372085|20534033|P3|STARTED|Washout Period 3||2
8329541|NCT01372085|20534034|P2|STARTED|Washout Period 3||0
8329542|NCT01372085|20534035|P1|STARTED|Washout Period 3||0
8329543|NCT01372085|20534026|P10|NOT COMPLETED|Third Intervention (Period 3)||0
8329544|NCT01372085|20534027|P9|NOT COMPLETED|Third Intervention (Period 3)||0
8329545|NCT01372085|20534028|P8|NOT COMPLETED|Third Intervention (Period 3)||0
8329546|NCT01372085|20534029|P7|NOT COMPLETED|Third Intervention (Period 3)||0
8329547|NCT01372085|20534030|P6|NOT COMPLETED|Third Intervention (Period 3)||0
8329548|NCT01372085|20534031|P5|NOT COMPLETED|Third Intervention (Period 3)||0
8329549|NCT01372085|20534032|P4|NOT COMPLETED|Third Intervention (Period 3)||0
8329550|NCT01372085|20534033|P3|NOT COMPLETED|Third Intervention (Period 3)||0
8329551|NCT01372085|20534034|P2|NOT COMPLETED|Third Intervention (Period 3)||0
8329552|NCT01372085|20534035|P1|NOT COMPLETED|Third Intervention (Period 3)||0
8329553|NCT01372085|20534026|P10|COMPLETED|Third Intervention (Period 3)||0
8329554|NCT01372085|20534027|P9|COMPLETED|Third Intervention (Period 3)||1
8329555|NCT01372085|20534028|P8|COMPLETED|Third Intervention (Period 3)||1
8329556|NCT01372085|20534029|P7|COMPLETED|Third Intervention (Period 3)||3
8329557|NCT01372085|20534030|P6|COMPLETED|Third Intervention (Period 3)||7
8329558|NCT01372085|20534031|P5|COMPLETED|Third Intervention (Period 3)||2
8329559|NCT01372085|20534032|P4|COMPLETED|Third Intervention (Period 3)||1
8329560|NCT01372085|20534033|P3|COMPLETED|Third Intervention (Period 3)||2
8329561|NCT01372085|20534034|P2|COMPLETED|Third Intervention (Period 3)||0
8329562|NCT01372085|20534035|P1|COMPLETED|Third Intervention (Period 3)||0
8329563|NCT01372085|20534026|P10|STARTED|Third Intervention (Period 3)||0
8329564|NCT01372085|20534027|P9|STARTED|Third Intervention (Period 3)||1
8329565|NCT01372085|20534028|P8|STARTED|Third Intervention (Period 3)||1
8329566|NCT01372085|20534029|P7|STARTED|Third Intervention (Period 3)||3
8329567|NCT01372085|20534030|P6|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
8329568|NCT01372085|20534031|P5|STARTED|Third Intervention (Period 3)||2
8329569|NCT01372085|20534032|P4|STARTED|Third Intervention (Period 3)||1
8329570|NCT01372085|20534033|P3|STARTED|Third Intervention (Period 3)||2
8329571|NCT01372085|20534034|P2|STARTED|Third Intervention (Period 3)||0
8329572|NCT01372085|20534035|P1|STARTED|Third Intervention (Period 3)||0
8329573|NCT01372085|20534026|P10|NOT COMPLETED|Washout Period 2||0
8329574|NCT01372085|20534027|P9|NOT COMPLETED|Washout Period 2||0
8329575|NCT01372085|20534028|P8|NOT COMPLETED|Washout Period 2||0
8329576|NCT01372085|20534029|P7|NOT COMPLETED|Washout Period 2||0
8329577|NCT01372085|20534030|P6|NOT COMPLETED|Washout Period 2||0
8329578|NCT01372085|20534031|P5|NOT COMPLETED|Washout Period 2||1
8329579|NCT01372085|20534032|P4|NOT COMPLETED|Washout Period 2||0
8329580|NCT01372085|20534033|P3|NOT COMPLETED|Washout Period 2||0
8329581|NCT01372085|20534034|P2|NOT COMPLETED|Washout Period 2||0
8329582|NCT01372085|20534035|P1|NOT COMPLETED|Washout Period 2||0
8329583|NCT01372085|20534026|P10|COMPLETED|Washout Period 2||0
8329584|NCT01372085|20534027|P9|COMPLETED|Washout Period 2||1
8329585|NCT01372085|20534028|P8|COMPLETED|Washout Period 2||1
8329586|NCT01372085|20534029|P7|COMPLETED|Washout Period 2||3
8329587|NCT01372085|20534030|P6|COMPLETED|Washout Period 2||5
8329588|NCT01372085|20534031|P5|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
8329589|NCT01372085|20534032|P4|COMPLETED|Washout Period 2||1
8329590|NCT01372085|20534033|P3|COMPLETED|Washout Period 2||2
8329591|NCT01372085|20534034|P2|COMPLETED|Washout Period 2||0
8329592|NCT01372085|20534035|P1|COMPLETED|Washout Period 2||0
8329593|NCT01372085|20534026|P10|STARTED|Washout Period 2||0
8329594|NCT01372085|20534027|P9|STARTED|Washout Period 2||1
8329595|NCT01372085|20534028|P8|STARTED|Washout Period 2||1
8329596|NCT01372085|20534029|P7|STARTED|Washout Period 2||3
8329597|NCT01372085|20534030|P6|STARTED|Washout Period 2||5
8329598|NCT01372085|20534031|P5|STARTED|Washout Period 2||3
8329599|NCT01372085|20534032|P4|STARTED|Washout Period 2||1
8329600|NCT01372085|20534033|P3|STARTED|Washout Period 2||2
8329601|NCT01372085|20534034|P2|STARTED|Washout Period 2||0
8329602|NCT01372085|20534035|P1|STARTED|Washout Period 2||0
8329603|NCT01372085|20534026|P10|NOT COMPLETED|Second Intervention (Period 2)||0
8329604|NCT01372085|20534027|P9|NOT COMPLETED|Second Intervention (Period 2)||0
8329605|NCT01372085|20534028|P8|NOT COMPLETED|Second Intervention (Period 2)||0
8329606|NCT01372085|20534029|P7|NOT COMPLETED|Second Intervention (Period 2)||0
8329607|NCT01372085|20534030|P6|NOT COMPLETED|Second Intervention (Period 2)||0
8329608|NCT01372085|20534031|P5|NOT COMPLETED|Second Intervention (Period 2)||0
8329609|NCT01372085|20534032|P4|NOT COMPLETED|Second Intervention (Period 2)||0
8329610|NCT01372085|20534033|P3|NOT COMPLETED|Second Intervention (Period 2)||0
8329611|NCT01372085|20534034|P2|NOT COMPLETED|Second Intervention (Period 2)||0
8329612|NCT01372085|20534035|P1|NOT COMPLETED|Second Intervention (Period 2)||0
8329613|NCT01372085|20534026|P10|COMPLETED|Second Intervention (Period 2)||0
8329614|NCT01372085|20534027|P9|COMPLETED|Second Intervention (Period 2)||1
8329615|NCT01372085|20534028|P8|COMPLETED|Second Intervention (Period 2)||1
8329616|NCT01372085|20534029|P7|COMPLETED|Second Intervention (Period 2)||3
8329617|NCT01372085|20534030|P6|COMPLETED|Second Intervention (Period 2)||5
8329618|NCT01372085|20534031|P5|COMPLETED|Second Intervention (Period 2)||3
8329619|NCT01372085|20534032|P4|COMPLETED|Second Intervention (Period 2)||1
8329620|NCT01372085|20534033|P3|COMPLETED|Second Intervention (Period 2)||2
8329621|NCT01372085|20534034|P2|COMPLETED|Second Intervention (Period 2)||0
8329622|NCT01372085|20534035|P1|COMPLETED|Second Intervention (Period 2)||0
8329623|NCT01372085|20534026|P10|STARTED|Second Intervention (Period 2)||0
8329624|NCT01372085|20534027|P9|STARTED|Second Intervention (Period 2)||1
8329625|NCT01372085|20534028|P8|STARTED|Second Intervention (Period 2)||1
8329626|NCT01372085|20534029|P7|STARTED|Second Intervention (Period 2)||3
8329627|NCT01372085|20534030|P6|STARTED|Second Intervention (Period 2)||5
8329628|NCT01372085|20534031|P5|STARTED|Second Intervention (Period 2)||3
8329629|NCT01372085|20534032|P4|STARTED|Second Intervention (Period 2)||1
8329630|NCT01372085|20534033|P3|STARTED|Second Intervention (Period 2)||2
8329631|NCT01372085|20534034|P2|STARTED|Second Intervention (Period 2)||0
8329632|NCT01372085|20534035|P1|STARTED|Second Intervention (Period 2)||0
8329633|NCT01372085|20534026|P10|NOT COMPLETED|Washout Period 1||0
8329634|NCT01372085|20534027|P9|NOT COMPLETED|Washout Period 1||0
8329635|NCT01372085|20534028|P8|NOT COMPLETED|Washout Period 1||0
8329636|NCT01372085|20534029|P7|NOT COMPLETED|Washout Period 1||0
8329637|NCT01372085|20534030|P6|NOT COMPLETED|Washout Period 1||0
8329638|NCT01372085|20534031|P5|NOT COMPLETED|Washout Period 1||0
8329639|NCT01372085|20534032|P4|NOT COMPLETED|Washout Period 1||0
8329640|NCT01372085|20534033|P3|NOT COMPLETED|Washout Period 1||0
8329641|NCT01372085|20534034|P2|NOT COMPLETED|Washout Period 1||0
8329642|NCT01372085|20534035|P1|NOT COMPLETED|Washout Period 1||0
8329643|NCT01372085|20534026|P10|COMPLETED|Washout Period 1||0
8329644|NCT01372085|20534027|P9|COMPLETED|Washout Period 1||1
8329645|NCT01372085|20534028|P8|COMPLETED|Washout Period 1||1
8329646|NCT01372085|20534029|P7|COMPLETED|Washout Period 1||3
8329647|NCT01372085|20534030|P6|COMPLETED|Washout Period 1||5
8329648|NCT01372085|20534031|P5|COMPLETED|Washout Period 1||3
8329649|NCT01372085|20534032|P4|COMPLETED|Washout Period 1||1
8329650|NCT01372085|20534033|P3|COMPLETED|Washout Period 1||2
8329651|NCT01372085|20534034|P2|COMPLETED|Washout Period 1||0
8329652|NCT01372085|20534035|P1|COMPLETED|Washout Period 1||0
8329653|NCT01372085|20534026|P10|STARTED|Washout Period 1||0
8329654|NCT01372085|20534027|P9|STARTED|Washout Period 1||1
8329655|NCT01372085|20534028|P8|STARTED|Washout Period 1||1
8329656|NCT01372085|20534029|P7|STARTED|Washout Period 1||3
8329657|NCT01372085|20534030|P6|STARTED|Washout Period 1||5
8329658|NCT01372085|20534031|P5|STARTED|Washout Period 1||3
8329659|NCT01372085|20534032|P4|STARTED|Washout Period 1||1
8329660|NCT01372085|20534033|P3|STARTED|Washout Period 1||2
8329661|NCT01372085|20534034|P2|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
8329662|NCT01372085|20534035|P1|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
8329663|NCT01372085|20534026|P10|NOT COMPLETED|First Intervention (Period 1)||0
8329664|NCT01372085|20534027|P9|NOT COMPLETED|First Intervention (Period 1)||0
8329665|NCT01372085|20534028|P8|NOT COMPLETED|First Intervention (Period 1)||0
8329666|NCT01372085|20534029|P7|NOT COMPLETED|First Intervention (Period 1)||0
8329667|NCT01372085|20534030|P6|NOT COMPLETED|First Intervention (Period 1)||0
8329668|NCT01372085|20534031|P5|NOT COMPLETED|First Intervention (Period 1)||0
8329669|NCT01372085|20534032|P4|NOT COMPLETED|First Intervention (Period 1)||0
8329670|NCT01372085|20534033|P3|NOT COMPLETED|First Intervention (Period 1)||0
8329671|NCT01372085|20534034|P2|NOT COMPLETED|First Intervention (Period 1)||0
8329672|NCT01372085|20534035|P1|NOT COMPLETED|First Intervention (Period 1)||0
8329673|NCT01372085|20534026|P10|COMPLETED|First Intervention (Period 1)||0
8329674|NCT01372085|20534027|P9|COMPLETED|First Intervention (Period 1)||1
8329675|NCT01372085|20534028|P8|COMPLETED|First Intervention (Period 1)||1
8329676|NCT01372085|20534029|P7|COMPLETED|First Intervention (Period 1)||3
8329677|NCT01372085|20534030|P6|COMPLETED|First Intervention (Period 1)||5
8329678|NCT01372085|20534031|P5|COMPLETED|First Intervention (Period 1)||3
8329679|NCT01372085|20534032|P4|COMPLETED|First Intervention (Period 1)||1
8329680|NCT01372085|20534033|P3|COMPLETED|First Intervention (Period 1)||2
8329681|NCT01372085|20534034|P2|COMPLETED|First Intervention (Period 1)||2
8329682|NCT01372085|20534035|P1|COMPLETED|First Intervention (Period 1)||8
8329683|NCT01372085|20534026|P10|STARTED|First Intervention (Period 1)||0
8329684|NCT01372085|20534027|P9|STARTED|First Intervention (Period 1)||1
8329685|NCT01372085|20534028|P8|STARTED|First Intervention (Period 1)||1
8329686|NCT01372085|20534029|P7|STARTED|First Intervention (Period 1)||3
8329687|NCT01372085|20534030|P6|STARTED|First Intervention (Period 1)||5
8329688|NCT01372085|20534031|P5|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
8329689|NCT01372085|20534032|P4|STARTED|First Intervention (Period 1)||1
8329690|NCT01372085|20534033|P3|STARTED|First Intervention (Period 1)||2
8329691|NCT01372085|20534034|P2|STARTED|First Intervention (Period 1)||2
8329692|NCT01372085|20534035|P1|STARTED|First Intervention (Period 1)||8
8329693|NCT01371994|20534067|P2|NOT COMPLETED|Overall Study||42
8329694|NCT01371994|20534068|P1|NOT COMPLETED|Overall Study||57
8329695|NCT01371994|20534067|P2|COMPLETED|Overall Study||278
8329696|NCT01371994|20534068|P1|COMPLETED|Overall Study||263
8329697|NCT01371994|20534067|P2|Received Treatment|Overall Study||313
8329698|NCT01371994|20534068|P1|Received Treatment|Overall Study||310
8329699|NCT01371994|20534067|P2|STARTED|Overall Study||320
8329700|NCT01371994|20534068|P1|STARTED|Overall Study||320
8329701|NCT01371981|20534116|P6|NOT COMPLETED|Overall Study||14
8329702|NCT01371981|20534117|P5|NOT COMPLETED|Overall Study||32
8329703|NCT01371981|20534118|P4|NOT COMPLETED|Overall Study||21
8329704|NCT01371981|20534119|P3|NOT COMPLETED|Overall Study||6
8329705|NCT01371981|20534120|P2|NOT COMPLETED|Overall Study||192
8329706|NCT01371981|20534121|P1|NOT COMPLETED|Overall Study||184
8329707|NCT01371981|20534116|P6|COMPLETED|Overall Study||368
8329708|NCT01371981|20534117|P5|COMPLETED|Overall Study||15
8329709|NCT01371981|20534118|P4|COMPLETED|Overall Study||12
8329710|NCT01371981|20534119|P3|COMPLETED|Overall Study||6
8329711|NCT01371981|20534120|P2|COMPLETED|Overall Study||399
8329712|NCT01371981|20534121|P1|COMPLETED|Overall Study||396
8329713|NCT01371981|20534116|P6|STARTED|Overall Study||382
8329714|NCT01371981|20534117|P5|STARTED|Overall Study||47
8329715|NCT01371981|20534118|P4|STARTED|Overall Study||33
8329716|NCT01371981|20534119|P3|STARTED|Overall Study||12
8329717|NCT01371981|20534120|P2|STARTED|Overall Study||591
8329718|NCT01371981|20534121|P1|STARTED|Overall Study||580
8329719|NCT01371877|20534180|P2|NOT COMPLETED|Overall Study||4
8329720|NCT01371877|20534181|P1|NOT COMPLETED|Overall Study||0
8329721|NCT01371877|20534180|P2|COMPLETED|Overall Study||17
8329722|NCT01371877|20534181|P1|COMPLETED|Overall Study||21
8329723|NCT01371877|20534180|P2|STARTED|Overall Study||21
8329724|NCT01371877|20534181|P1|STARTED|Overall Study||21
8329725|NCT01371851|20534193|P2|NOT COMPLETED|Overall Study||9
8329726|NCT01371851|20534194|P1|NOT COMPLETED|Overall Study||8
8329727|NCT01371851|20534193|P2|COMPLETED|Overall Study||2
8329728|NCT01371851|20534194|P1|COMPLETED|Overall Study||3
8329729|NCT01371851|20534193|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
8329730|NCT01371851|20534194|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
8329731|NCT01371838|20534202|P2|NOT COMPLETED|Overall Study||66
8329732|NCT01371838|20534203|P1|NOT COMPLETED|Overall Study||49
8329733|NCT01371838|20534202|P2|COMPLETED|Overall Study||317
8329734|NCT01371838|20534203|P1|COMPLETED|Overall Study||332
8329735|NCT01371838|20534202|P2|STARTED|Overall Study||383
8329736|NCT01371838|20534203|P1|STARTED|Overall Study||381
8329737|NCT01371825|20534239|P1|NOT COMPLETED|Overall Study||4
8329738|NCT01371825|20534239|P1|COMPLETED|Overall Study||5
8329739|NCT01371825|20534239|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
8329740|NCT01371825|20534239|P1|STARTED|Overall Study||9
8329741|NCT01371786|20534252|P2|NOT COMPLETED|Overall Study||0
8329742|NCT01371786|20534253|P1|NOT COMPLETED|Overall Study||0
8329743|NCT01371786|20534252|P2|COMPLETED|Overall Study||7
8329744|NCT01371786|20534253|P1|COMPLETED|Overall Study||7
8329745|NCT01371786|20534252|P2|STARTED|Overall Study||7
8329746|NCT01371786|20534253|P1|STARTED|Overall Study||7
8329747|NCT01371747|20534273|P6|NOT COMPLETED|Overall Study||14
8329748|NCT01371747|20534274|P5|NOT COMPLETED|Overall Study||7
8329749|NCT01371747|20534275|P4|NOT COMPLETED|Overall Study||9
8329750|NCT01371747|20534276|P3|NOT COMPLETED|Overall Study||24
8329751|NCT01371747|20534277|P2|NOT COMPLETED|Overall Study||23
8329752|NCT01371747|20534278|P1|NOT COMPLETED|Overall Study||18
8329753|NCT01371747|20534273|P6|COMPLETED|Overall Study||16
8329754|NCT01371747|20534274|P5|COMPLETED|Overall Study||21
8329755|NCT01371747|20534275|P4|COMPLETED|Overall Study||17
8329756|NCT01371747|20534276|P3|COMPLETED|Overall Study||50
8329757|NCT01371747|20534277|P2|COMPLETED|Overall Study||51
8329758|NCT01371747|20534278|P1|COMPLETED|Overall Study||56
8329759|NCT01371747|20534273|P6|STARTED|Overall Study||30
8329760|NCT01371747|20534274|P5|STARTED|Overall Study||28
8329761|NCT01371747|20534275|P4|STARTED|Overall Study||26
8329762|NCT01371747|20534276|P3|STARTED|Overall Study||74
8329763|NCT01371747|20534277|P2|STARTED|Overall Study||74
8329764|NCT01371747|20534278|P1|STARTED|Overall Study||74
8329765|NCT01371734|20534343|P3|NOT COMPLETED|Overall Study||17
8329766|NCT01371734|20534344|P2|NOT COMPLETED|Overall Study||19
8329767|NCT01371734|20534345|P1|NOT COMPLETED|Overall Study||23
8329768|NCT01371734|20534343|P3|COMPLETED|Overall Study||104
8329769|NCT01371734|20534344|P2|COMPLETED|Overall Study||103
8329770|NCT01371734|20534345|P1|COMPLETED|Overall Study||97
8329771|NCT01371734|20534343|P3|STARTED|Overall Study||121
8329772|NCT01371734|20534344|P2|STARTED|Overall Study||122
8329773|NCT01371734|20534345|P1|STARTED|Overall Study||120
8329774|NCT01371721|20534365|P3|NOT COMPLETED|Overall Study||30
8329775|NCT01371721|20534366|P2|NOT COMPLETED|Overall Study||24
8329776|NCT01371721|20534367|P1|NOT COMPLETED|Overall Study||29
8329777|NCT01371721|20534365|P3|COMPLETED|Overall Study||62
8329778|NCT01371721|20534366|P2|COMPLETED|Overall Study||65
8329779|NCT01371721|20534367|P1|COMPLETED|Overall Study||59
8329780|NCT01371721|20534365|P3|Treated|Overall Study||92
8329781|NCT01371721|20534366|P2|Treated|Overall Study||89
8329782|NCT01371721|20534367|P1|Treated|Overall Study||87
8329783|NCT01371721|20534365|P3|STARTED|Overall Study||92
8329784|NCT01371721|20534366|P2|STARTED|Overall Study||89
8329785|NCT01371721|20534367|P1|STARTED|Overall Study||88
8329786|NCT01371708|20534400|P3|NOT COMPLETED|Overall Study||39
8329787|NCT01371708|20534401|P2|NOT COMPLETED|Overall Study||30
8329788|NCT01371708|20534402|P1|NOT COMPLETED|Overall Study||26
8329789|NCT01371708|20534400|P3|COMPLETED|Overall Study||59
8329790|NCT01371708|20534401|P2|COMPLETED|Overall Study||63
8329791|NCT01371708|20534402|P1|COMPLETED|Overall Study||66
8329792|NCT01371708|20534400|P3|Received Treatment|Overall Study||97
8329793|NCT01371708|20534401|P2|Received Treatment|Overall Study||93
8329794|NCT01371708|20534402|P1|Received Treatment|Overall Study||91
8329795|NCT01371708|20534400|P3|STARTED|Overall Study||98
8329796|NCT01371708|20534401|P2|STARTED|Overall Study||93
8329797|NCT01371708|20534402|P1|STARTED|Overall Study||92
8329798|NCT01371656|20534434|P2|NOT COMPLETED|Overall Study||14
8329799|NCT01371656|20534435|P1|NOT COMPLETED|Overall Study||64
8329800|NCT01371656|20534434|P2|COMPLETED|Overall Study||296
8329801|NCT01371656|20534435|P1|COMPLETED|Overall Study||250
8329802|NCT01371656|20534434|P2|STARTED|Overall Study||310
8329803|NCT01371656|20534435|P1|STARTED|Overall Study||314
8329804|NCT01371643|20534455|P2|NOT COMPLETED|Overall Study||0
8329805|NCT01371643|20534456|P1|NOT COMPLETED|Overall Study||3
8329806|NCT01371643|20534455|P2|COMPLETED|Overall Study||26
8329807|NCT01371643|20534456|P1|COMPLETED|Overall Study||12
8329808|NCT01371643|20534455|P2|STARTED|Overall Study||26
8329809|NCT01371643|20534456|P1|STARTED|Overall Study||15
8329810|NCT01371565|20534466|P1|NOT COMPLETED|Overall Study||3
8329811|NCT01371565|20534466|P1|COMPLETED|Overall Study||1
8329812|NCT01371565|20534466|P1|STARTED|Overall Study||4
8329813|NCT01371552|20534470|P6|NOT COMPLETED|Part 2, One Week||0
8329814|NCT01371552|20534471|P5|NOT COMPLETED|Part 2, One Week||0
8329815|NCT01371552|20534472|P4|NOT COMPLETED|Part 2, One Week||0
8329816|NCT01371552|20534473|P3|NOT COMPLETED|Part 2, One Week||0
8329817|NCT01371552|20534474|P2|NOT COMPLETED|Part 2, One Week||0
8329818|NCT01371552|20534475|P1|NOT COMPLETED|Part 2, One Week||0
8329819|NCT01371552|20534470|P6|COMPLETED|Part 2, One Week||18
8329820|NCT01371552|20534471|P5|COMPLETED|Part 2, One Week||15
8329821|NCT01371552|20534472|P4|COMPLETED|Part 2, One Week||20
8329822|NCT01371552|20534473|P3|COMPLETED|Part 2, One Week||18
8329823|NCT01371552|20534474|P2|COMPLETED|Part 2, One Week||17
8329824|NCT01371552|20534475|P1|COMPLETED|Part 2, One Week||18
8329825|NCT01371552|20534470|P6|STARTED|Part 2, One Week||18
8329826|NCT01371552|20534471|P5|STARTED|Part 2, One Week||15
8329827|NCT01371552|20534472|P4|STARTED|Part 2, One Week||20
8329828|NCT01371552|20534473|P3|STARTED|Part 2, One Week||18
8329829|NCT01371552|20534474|P2|STARTED|Part 2, One Week||17
8329830|NCT01371552|20534475|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
8329831|NCT01371552|20534470|P6|NOT COMPLETED|Part 1, Third 3 Days||1
8329832|NCT01371552|20534471|P5|NOT COMPLETED|Part 1, Third 3 Days||1
8329833|NCT01371552|20534472|P4|NOT COMPLETED|Part 1, Third 3 Days||0
8329834|NCT01371552|20534473|P3|NOT COMPLETED|Part 1, Third 3 Days||0
8329835|NCT01371552|20534474|P2|NOT COMPLETED|Part 1, Third 3 Days||0
8329836|NCT01371552|20534475|P1|NOT COMPLETED|Part 1, Third 3 Days||0
8329837|NCT01371552|20534470|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
8329838|NCT01371552|20534471|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
8329839|NCT01371552|20534472|P4|COMPLETED|Part 1, Third 3 Days||20
8329840|NCT01371552|20534473|P3|COMPLETED|Part 1, Third 3 Days||18
8329841|NCT01371552|20534474|P2|COMPLETED|Part 1, Third 3 Days||17
8329842|NCT01371552|20534475|P1|COMPLETED|Part 1, Third 3 Days||19
8329843|NCT01371552|20534470|P6|STARTED|Part 1, Third 3 Days||18
8329844|NCT01371552|20534471|P5|STARTED|Part 1, Third 3 Days||15
8329845|NCT01371552|20534472|P4|STARTED|Part 1, Third 3 Days||20
8329846|NCT01371552|20534473|P3|STARTED|Part 1, Third 3 Days||18
8329847|NCT01371552|20534474|P2|STARTED|Part 1, Third 3 Days||17
8329848|NCT01371552|20534475|P1|STARTED|Part 1, Third 3 Days||19
8329849|NCT01371552|20534470|P6|NOT COMPLETED|Part 1, Second 3 Days||0
8329850|NCT01371552|20534471|P5|NOT COMPLETED|Part 1, Second 3 Days||0
8329851|NCT01371552|20534472|P4|NOT COMPLETED|Part 1, Second 3 Days||0
8329852|NCT01371552|20534473|P3|NOT COMPLETED|Part 1, Second 3 Days||0
8329853|NCT01371552|20534474|P2|NOT COMPLETED|Part 1, Second 3 Days||0
8329854|NCT01371552|20534475|P1|NOT COMPLETED|Part 1, Second 3 Days||1
8329855|NCT01371552|20534470|P6|COMPLETED|Part 1, Second 3 Days||18
8329856|NCT01371552|20534471|P5|COMPLETED|Part 1, Second 3 Days||15
8329857|NCT01371552|20534472|P4|COMPLETED|Part 1, Second 3 Days||20
8329858|NCT01371552|20534473|P3|COMPLETED|Part 1, Second 3 Days||18
8329859|NCT01371552|20534474|P2|COMPLETED|Part 1, Second 3 Days||17
8329860|NCT01371552|20534475|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
8329861|NCT01371552|20534470|P6|STARTED|Part 1, Second 3 Days||18
8329862|NCT01371552|20534471|P5|STARTED|Part 1, Second 3 Days||15
8329863|NCT01371552|20534472|P4|STARTED|Part 1, Second 3 Days||20
8329864|NCT01371552|20534473|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
8329865|NCT01371552|20534474|P2|STARTED|Part 1, Second 3 Days||17
8329866|NCT01371552|20534475|P1|STARTED|Part 1, Second 3 Days||19
8329867|NCT01371552|20534470|P6|NOT COMPLETED|Part 1, First 3 Days||0
8329868|NCT01371552|20534471|P5|NOT COMPLETED|Part 1, First 3 Days||0
8329869|NCT01371552|20534472|P4|NOT COMPLETED|Part 1, First 3 Days||0
8329870|NCT01371552|20534473|P3|NOT COMPLETED|Part 1, First 3 Days||1
8329871|NCT01371552|20534474|P2|NOT COMPLETED|Part 1, First 3 Days||0
8329872|NCT01371552|20534475|P1|NOT COMPLETED|Part 1, First 3 Days||0
8329873|NCT01371552|20534470|P6|COMPLETED|Part 1, First 3 Days||18
8329874|NCT01371552|20534471|P5|COMPLETED|Part 1, First 3 Days||15
8329875|NCT01371552|20534472|P4|COMPLETED|Part 1, First 3 Days||20
8329876|NCT01371552|20534473|P3|COMPLETED|Part 1, First 3 Days||19
8329877|NCT01371552|20534474|P2|COMPLETED|Part 1, First 3 Days||17
8329878|NCT01371552|20534475|P1|COMPLETED|Part 1, First 3 Days||19
8329879|NCT01371552|20534470|P6|STARTED|Part 1, First 3 Days||18
8329880|NCT01371552|20534471|P5|STARTED|Part 1, First 3 Days||15
8329881|NCT01371552|20534472|P4|STARTED|Part 1, First 3 Days||20
8329882|NCT01371552|20534473|P3|STARTED|Part 1, First 3 Days||20
8329883|NCT01371552|20534474|P2|STARTED|Part 1, First 3 Days||17
8329884|NCT01371552|20534475|P1|STARTED|Part 1, First 3 Days||19
8329885|NCT01371539|20534502|P2|NOT COMPLETED|Period Two: One Week||3
8329886|NCT01371539|20534503|P1|NOT COMPLETED|Period Two: One Week||0
8329887|NCT01371539|20534502|P2|COMPLETED|Period Two: One Week||47
8329888|NCT01371539|20534503|P1|COMPLETED|Period Two: One Week||53
8329889|NCT01371539|20534502|P2|STARTED|Period Two: One Week||50
8329890|NCT01371539|20534503|P1|STARTED|Period Two: One Week||53
8329891|NCT01371539|20534502|P2|NOT COMPLETED|Period One: One Week||1
8329892|NCT01371539|20534503|P1|NOT COMPLETED|Period One: One Week||0
8329893|NCT01371539|20534502|P2|COMPLETED|Period One: One Week||50
8329894|NCT01371539|20534503|P1|COMPLETED|Period One: One Week||53
8329895|NCT01371539|20534502|P2|STARTED|Period One: One Week||51
8329896|NCT01371539|20534503|P1|STARTED|Period One: One Week||53
8329897|NCT01371305|20534517|P6|NOT COMPLETED|Overall Study||2
8329898|NCT01371305|20534518|P5|NOT COMPLETED|Overall Study||4
8329899|NCT01371305|20534519|P4|NOT COMPLETED|Overall Study||2
8329900|NCT01371305|20534520|P3|NOT COMPLETED|Overall Study||0
8329901|NCT01371305|20534521|P2|NOT COMPLETED|Overall Study||0
8329902|NCT01371305|20534522|P1|NOT COMPLETED|Overall Study||0
8329903|NCT01371305|20534517|P6|COMPLETED|Overall Study||8
8329904|NCT01371305|20534518|P5|COMPLETED|Overall Study||2
8329905|NCT01371305|20534519|P4|COMPLETED|Overall Study||5
8329906|NCT01371305|20534520|P3|COMPLETED|Overall Study||6
8329907|NCT01371305|20534521|P2|COMPLETED|Overall Study||6
8329908|NCT01371305|20534522|P1|COMPLETED|Overall Study||6
8329909|NCT01371305|20534517|P6|STARTED|Overall Study||10
8329910|NCT01371305|20534518|P5|STARTED|Overall Study||6
8329911|NCT01371305|20534519|P4|STARTED|Overall Study||7
8329912|NCT01371305|20534520|P3|STARTED|Overall Study||6
8329913|NCT01371305|20534521|P2|STARTED|Overall Study||6
8329914|NCT01371305|20534522|P1|STARTED|Overall Study||6
8329915|NCT01371110|20534595|P2|NOT COMPLETED|Overall Study||0
8329916|NCT01371110|20534596|P1|NOT COMPLETED|Overall Study||0
8329917|NCT01371110|20534595|P2|COMPLETED|Overall Study||2
8329918|NCT01371110|20534596|P1|COMPLETED|Overall Study||1
8329919|NCT01371110|20534595|P2|STARTED|Overall Study||2
8329920|NCT01371110|20534596|P1|STARTED|Overall Study||1
8329921|NCT01371006|20534606|P2|NOT COMPLETED|Overall Study||0
8329922|NCT01371006|20534607|P1|NOT COMPLETED|Overall Study||1
8329923|NCT01371006|20534606|P2|COMPLETED|Overall Study||15
8329924|NCT01371006|20534607|P1|COMPLETED|Overall Study||13
8329925|NCT01371006|20534606|P2|STARTED|Overall Study||15
8329926|NCT01371006|20534607|P1|STARTED|Overall Study||14
8329927|NCT01370863|20534648|P2|NOT COMPLETED|Overall Study||3
8329928|NCT01370863|20534649|P1|NOT COMPLETED|Overall Study||2
8329929|NCT01370863|20534648|P2|COMPLETED|Overall Study||30
8329930|NCT01370863|20534649|P1|COMPLETED|Overall Study||32
8329931|NCT01370863|20534648|P2|STARTED|Overall Study||33
8329932|NCT01370863|20534649|P1|STARTED|Overall Study||34
8329933|NCT01370837|20534662|P3|NOT COMPLETED|Overall Study||0
8329934|NCT01370837|20534663|P2|NOT COMPLETED|Overall Study||0
8329935|NCT01370837|20534664|P1|NOT COMPLETED|Overall Study||0
8329936|NCT01370837|20534662|P3|COMPLETED|Overall Study||17
8329937|NCT01370837|20534663|P2|COMPLETED|Overall Study||12
8329938|NCT01370837|20534664|P1|COMPLETED|Overall Study||12
8329939|NCT01370837|20534662|P3|STARTED|Overall Study||17
8329940|NCT01370837|20534663|P2|STARTED|Overall Study||12
8329941|NCT01370837|20534664|P1|STARTED|Overall Study||12
8329942|NCT01370733|20534674|P2|NOT COMPLETED|Overall Study||22
8329943|NCT01370733|20534675|P1|NOT COMPLETED|Overall Study||17
8329944|NCT01370733|20534674|P2|COMPLETED|Overall Study||77
8329945|NCT01370733|20534675|P1|COMPLETED|Overall Study||86
8329946|NCT01370733|20534674|P2|STARTED|Overall Study||99
8329947|NCT01370733|20534675|P1|STARTED|Overall Study||103
8329948|NCT01370694|20534697|P1|NOT COMPLETED|Overall Study||6
8329949|NCT01370694|20534697|P1|COMPLETED|Overall Study||1
8329950|NCT01370694|20534697|P1|STARTED|Overall Study||7
8329951|NCT01370655|20534719|P12|NOT COMPLETED|Period 2||0
8329952|NCT01370655|20534720|P11|NOT COMPLETED|Period 2||1
8329953|NCT01370655|20534721|P10|NOT COMPLETED|Period 2||0
8329954|NCT01370655|20534722|P9|NOT COMPLETED|Period 2||2
8329955|NCT01370655|20534723|P8|NOT COMPLETED|Period 2||1
8329956|NCT01370655|20534724|P7|NOT COMPLETED|Period 2||1
8329957|NCT01370655|20534725|P6|NOT COMPLETED|Period 2||0
8329958|NCT01370655|20534726|P5|NOT COMPLETED|Period 2||1
8329959|NCT01370655|20534727|P4|NOT COMPLETED|Period 2||0
8329960|NCT01370655|20534728|P3|NOT COMPLETED|Period 2||2
8329961|NCT01370655|20534729|P2|NOT COMPLETED|Period 2||0
8329962|NCT01370655|20534730|P1|NOT COMPLETED|Period 2||0
8329963|NCT01370655|20534719|P12|COMPLETED|Period 2||3
8329964|NCT01370655|20534720|P11|COMPLETED|Period 2||2
8329965|NCT01370655|20534721|P10|COMPLETED|Period 2||2
8329966|NCT01370655|20534722|P9|COMPLETED|Period 2||1
8329967|NCT01370655|20534723|P8|COMPLETED|Period 2||3
8329968|NCT01370655|20534724|P7|COMPLETED|Period 2||2
8329969|NCT01370655|20534725|P6|COMPLETED|Period 2||4
8329970|NCT01370655|20534726|P5|COMPLETED|Period 2||2
8329971|NCT01370655|20534727|P4|COMPLETED|Period 2||3
8329972|NCT01370655|20534728|P3|COMPLETED|Period 2||1
8329973|NCT01370655|20534729|P2|COMPLETED|Period 2||7
8329974|NCT01370655|20534730|P1|COMPLETED|Period 2||5
8329975|NCT01370655|20534719|P12|STARTED|Period 2||3
8329976|NCT01370655|20534720|P11|STARTED|Period 2||3
8329977|NCT01370655|20534721|P10|STARTED|Period 2||2
8329978|NCT01370655|20534722|P9|STARTED|Period 2||3
8329979|NCT01370655|20534723|P8|STARTED|Period 2||4
8329980|NCT01370655|20534724|P7|STARTED|Period 2||3
8329981|NCT01370655|20534725|P6|STARTED|Period 2||4
8329982|NCT01370655|20534726|P5|STARTED|Period 2||3
8329983|NCT01370655|20534727|P4|STARTED|Period 2||3
8329984|NCT01370655|20534728|P3|STARTED|Period 2||3
8329985|NCT01370655|20534729|P2|STARTED|Period 2||7
8329986|NCT01370655|20534730|P1|STARTED|Period 2||5
8329987|NCT01370655|20534719|P12|NOT COMPLETED|Period 1||0
8329988|NCT01370655|20534720|P11|NOT COMPLETED|Period 1||0
8329989|NCT01370655|20534721|P10|NOT COMPLETED|Period 1||0
8329990|NCT01370655|20534722|P9|NOT COMPLETED|Period 1||0
8329991|NCT01370655|20534723|P8|NOT COMPLETED|Period 1||0
8329992|NCT01370655|20534724|P7|NOT COMPLETED|Period 1||1
8329993|NCT01370655|20534725|P6|NOT COMPLETED|Period 1||0
8329994|NCT01370655|20534726|P5|NOT COMPLETED|Period 1||0
8329995|NCT01370655|20534727|P4|NOT COMPLETED|Period 1||0
8329996|NCT01370655|20534728|P3|NOT COMPLETED|Period 1||0
8329997|NCT01370655|20534729|P2|NOT COMPLETED|Period 1||0
8329998|NCT01370655|20534730|P1|NOT COMPLETED|Period 1||2
8329999|NCT01370655|20534719|P12|COMPLETED|Period 1||3
8330000|NCT01370655|20534720|P11|COMPLETED|Period 1||3
8330001|NCT01370655|20534721|P10|COMPLETED|Period 1||2
8330002|NCT01370655|20534722|P9|COMPLETED|Period 1||3
8330003|NCT01370655|20534723|P8|COMPLETED|Period 1||4
8330004|NCT01370655|20534724|P7|COMPLETED|Period 1||3
8330005|NCT01370655|20534725|P6|COMPLETED|Period 1||4
8330006|NCT01370655|20534726|P5|COMPLETED|Period 1||3
8330007|NCT01370655|20534727|P4|COMPLETED|Period 1||3
8330008|NCT01370655|20534728|P3|COMPLETED|Period 1||3
8330009|NCT01370655|20534729|P2|COMPLETED|Period 1||7
8330010|NCT01370655|20534730|P1|COMPLETED|Period 1||5
8330011|NCT01370655|20534719|P12|STARTED|Period 1||3
8330012|NCT01370655|20534720|P11|STARTED|Period 1||3
8330013|NCT01370655|20534721|P10|STARTED|Period 1||2
8330014|NCT01370655|20534722|P9|STARTED|Period 1||3
8330015|NCT01370655|20534723|P8|STARTED|Period 1||4
8330016|NCT01370655|20534724|P7|STARTED|Period 1||4
8330017|NCT01370655|20534725|P6|STARTED|Period 1||4
8330018|NCT01370655|20534726|P5|STARTED|Period 1||3
8330019|NCT01370655|20534727|P4|STARTED|Period 1||3
8330020|NCT01370655|20534728|P3|STARTED|Period 1||3
8330021|NCT01370655|20534729|P2|STARTED|Period 1||7
8330022|NCT01370655|20534730|P1|STARTED|Period 1||7
8330023|NCT01370642|20534767|P3|NOT COMPLETED|Overall Study||29
8330024|NCT01370642|20534768|P2|NOT COMPLETED|Overall Study||6
8330025|NCT01370642|20534769|P1|NOT COMPLETED|Overall Study||8
8330026|NCT01370642|20534767|P3|COMPLETED|Overall Study||69
8330027|NCT01370642|20534768|P2|COMPLETED|Overall Study||92
8330028|NCT01370642|20534769|P1|COMPLETED|Overall Study||90
8330029|NCT01370642|20534767|P3|FAS Population|Overall Study||98
8330030|NCT01370642|20534768|P2|FAS Population|Overall Study||97
8330031|NCT01370642|20534769|P1|FAS Population|Overall Study||98
8330032|NCT01370642|20534767|P3|STARTED|Overall Study||98
8330033|NCT01370642|20534768|P2|STARTED|Overall Study||98
8330034|NCT01370642|20534769|P1|STARTED|Overall Study||98
8330035|NCT01370629|20534798|P1|NOT COMPLETED|Overall Study||6
8330036|NCT01370629|20534798|P1|COMPLETED|Overall Study||2009
8330037|NCT01370629|20534798|P1|STARTED|Overall Study||2015
8330038|NCT01370616|20534808|P2|NOT COMPLETED|Overall Study||67
8330039|NCT01370616|20534809|P1|NOT COMPLETED|Overall Study||62
8330040|NCT01370616|20534808|P2|COMPLETED|Overall Study||216
8330041|NCT01370616|20534809|P1|COMPLETED|Overall Study||220
8330042|NCT01370616|20534808|P2|Treated|Overall Study||275
8330043|NCT01370616|20534809|P1|Treated|Overall Study||275
8330044|NCT01370616|20534808|P2|STARTED|Overall Study|Participants randomized|283
8330045|NCT01370616|20534809|P1|STARTED|Overall Study|Participants randomized|282
8330046|NCT01370603|20534833|P2|NOT COMPLETED|Period 2||4
8330047|NCT01370603|20534834|P1|NOT COMPLETED|Period 2||3
8330048|NCT01370603|20534833|P2|COMPLETED|Period 2||146
8330049|NCT01370603|20534834|P1|COMPLETED|Period 2||138
8330050|NCT01370603|20534833|P2|STARTED|Period 2||150
8330051|NCT01370603|20534834|P1|STARTED|Period 2||141
8330052|NCT01370603|20534833|P2|NOT COMPLETED|Crossover Washout||4
8330053|NCT01370603|20534834|P1|NOT COMPLETED|Crossover Washout||9
8330054|NCT01370603|20534833|P2|COMPLETED|Crossover Washout||150
8330055|NCT01370603|20534834|P1|COMPLETED|Crossover Washout||141
8330056|NCT01370603|20534833|P2|STARTED|Crossover Washout||154
8330057|NCT01370603|20534834|P1|STARTED|Crossover Washout||150
8330058|NCT01370603|20534833|P2|NOT COMPLETED|Period 1||10
8330059|NCT01370603|20534834|P1|NOT COMPLETED|Period 1||14
8330060|NCT01370603|20534833|P2|COMPLETED|Period 1||154
8330061|NCT01370603|20534834|P1|COMPLETED|Period 1||150
8330062|NCT01370603|20534833|P2|STARTED|Period 1||164
8330063|NCT01370603|20534834|P1|STARTED|Period 1||164
8330064|NCT01370590|20534852|P2|NOT COMPLETED|Period 2||2
8330065|NCT01370590|20534853|P1|NOT COMPLETED|Period 2||1
8330066|NCT01370590|20534852|P2|COMPLETED|Period 2||184
8330067|NCT01370590|20534853|P1|COMPLETED|Period 2||180
8330068|NCT01370590|20534852|P2|STARTED|Period 2||186
8330069|NCT01370590|20534853|P1|STARTED|Period 2||181
8330070|NCT01370590|20534852|P2|NOT COMPLETED|Crossover Washout Period||6
8330071|NCT01370590|20534853|P1|NOT COMPLETED|Crossover Washout Period||6
8330072|NCT01370590|20534852|P2|COMPLETED|Crossover Washout Period||186
8330073|NCT01370590|20534853|P1|COMPLETED|Crossover Washout Period||181
8330074|NCT01370590|20534852|P2|STARTED|Crossover Washout Period||192
8330075|NCT01370590|20534853|P1|STARTED|Crossover Washout Period||187
8330076|NCT01370590|20534852|P2|NOT COMPLETED|Period 1||11
8330077|NCT01370590|20534853|P1|NOT COMPLETED|Period 1||16
8330078|NCT01370590|20534852|P2|COMPLETED|Period 1||192
8330079|NCT01370590|20534853|P1|COMPLETED|Period 1||187
8330080|NCT01370590|20534852|P2|STARTED|Period 1||203
8330081|NCT01370590|20534853|P1|STARTED|Period 1||203
8330082|NCT01370564|20534869|P1|NOT COMPLETED|Overall Study||0
8330083|NCT01370564|20534869|P1|COMPLETED|Overall Study||21
8330084|NCT01370564|20534869|P1|STARTED|Overall Study||21
8330085|NCT01370538|20534881|P2|NOT COMPLETED|Overall Study||19
8330086|NCT01370538|20534882|P1|NOT COMPLETED|Overall Study||19
8330087|NCT01370538|20534881|P2|COMPLETED|Overall Study||152
8330088|NCT01370538|20534882|P1|COMPLETED|Overall Study||151
8330089|NCT01370538|20534881|P2|Patients Who Completed Treatment|Overall Study||152
8330090|NCT01370538|20534882|P1|Patients Who Completed Treatment|Overall Study||151
8330091|NCT01370538|20534881|P2|Patients Who Received Treatment|Overall Study||161
8330092|NCT01370538|20534882|P1|Patients Who Received Treatment|Overall Study||165
8330093|NCT01370538|20534881|P2|STARTED|Overall Study||171
8330094|NCT01370538|20534882|P1|STARTED|Overall Study||170
8330095|NCT01370525|20534898|P2|NOT COMPLETED|Overall Study||11
8330096|NCT01370525|20534899|P1|NOT COMPLETED|Overall Study||8
8330097|NCT01370525|20534898|P2|COMPLETED|Overall Study||158
8330098|NCT01370525|20534899|P1|COMPLETED|Overall Study||163
8330099|NCT01370525|20534898|P2|Patients Who Completed Treatment|Overall Study||158
8330100|NCT01370525|20534899|P1|Patients Who Completed Treatment|Overall Study||163
8330101|NCT01370525|20534898|P2|Patients Who Received Treatment|Overall Study||163
8330102|NCT01370525|20534899|P1|Patients Who Received Treatment|Overall Study||168
8330103|NCT01370525|20534898|P2|STARTED|Overall Study||169
8330104|NCT01370525|20534899|P1|STARTED|Overall Study||171
8330105|NCT01370499|20534915|P2|NOT COMPLETED|Overall Study||44
8330106|NCT01370499|20534916|P1|NOT COMPLETED|Overall Study||111
8330107|NCT01370499|20534915|P2|COMPLETED|Overall Study||49
8330108|NCT01370499|20534916|P1|COMPLETED|Overall Study||84
8330109|NCT01370499|20534915|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
8330110|NCT01370499|20534916|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
8330111|NCT01370499|20534915|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
8330112|NCT01370499|20534916|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
8330113|NCT01370499|20534915|P2|STARTED|Overall Study||93
8330114|NCT01370499|20534916|P1|STARTED|Overall Study||195
8330115|NCT01370460|20534950|P2|NOT COMPLETED|Overall Study||0
8330116|NCT01370460|20534951|P1|NOT COMPLETED|Overall Study||0
8330117|NCT01370460|20534950|P2|COMPLETED|Overall Study||51
8330118|NCT01370460|20534951|P1|COMPLETED|Overall Study||50
8330119|NCT01370460|20534950|P2|STARTED|Overall Study||51
8330120|NCT01370460|20534951|P1|STARTED|Overall Study||50
8330121|NCT01370408|20534958|P1|NOT COMPLETED|Overall Study||9
8330122|NCT01370408|20534958|P1|COMPLETED|Overall Study||76
8330123|NCT01370408|20534958|P1|STARTED|Overall Study||85
8330124|NCT01370369|20534969|P1|NOT COMPLETED|Overall Study||0
8330125|NCT01370369|20534969|P1|COMPLETED|Overall Study||20
8330126|NCT01370369|20534969|P1|STARTED|Overall Study||20
8330127|NCT01370356|20535018|P2|NOT COMPLETED|Overall Study||227
8330128|NCT01370356|20535019|P1|NOT COMPLETED|Overall Study||192
8330129|NCT01370356|20535018|P2|COMPLETED|Overall Study||515
8330130|NCT01370356|20535019|P1|COMPLETED|Overall Study||559
8330131|NCT01370356|20535018|P2|STARTED|Overall Study||742
8330132|NCT01370356|20535019|P1|STARTED|Overall Study||751
8330133|NCT01370317|20535035|P2|NOT COMPLETED|Overall Study||1
8330134|NCT01370317|20535036|P1|NOT COMPLETED|Overall Study||1
8330135|NCT01370317|20535035|P2|COMPLETED|Overall Study||8
8330136|NCT01370317|20535036|P1|COMPLETED|Overall Study||17
8330137|NCT01370317|20535035|P2|STARTED|Overall Study||9
8330138|NCT01370317|20535036|P1|STARTED|Overall Study||18
8330139|NCT01370265|20535047|P2|NOT COMPLETED|Second Intervention||0
8330140|NCT01370265|20535048|P1|NOT COMPLETED|Second Intervention||0
8330141|NCT01370265|20535047|P2|COMPLETED|Second Intervention||5
8330142|NCT01370265|20535048|P1|COMPLETED|Second Intervention||5
8330143|NCT01370265|20535047|P2|STARTED|Second Intervention||5
8330144|NCT01370265|20535048|P1|STARTED|Second Intervention||5
8330145|NCT01370265|20535047|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330146|NCT01370265|20535048|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330147|NCT01370265|20535047|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
8330148|NCT01370265|20535048|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
8330149|NCT01370265|20535047|P2|STARTED|Washout Period (50-minute Period Decay)||5
8330150|NCT01370265|20535048|P1|STARTED|Washout Period (50-minute Period Decay)||5
8330151|NCT01370265|20535047|P2|NOT COMPLETED|First Intervention||1
8330152|NCT01370265|20535048|P1|NOT COMPLETED|First Intervention||1
8330153|NCT01370265|20535047|P2|COMPLETED|First Intervention||5
8330154|NCT01370265|20535048|P1|COMPLETED|First Intervention||5
8330155|NCT01370265|20535047|P2|STARTED|First Intervention||6
8330156|NCT01370265|20535048|P1|STARTED|First Intervention||6
8330157|NCT01370265|20535047|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330158|NCT01370265|20535048|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330159|NCT01370265|20535047|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
8330160|NCT01370265|20535048|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
8330161|NCT01370265|20535047|P2|STARTED|Washout Period (50-minute Period Decay)||6
8330162|NCT01370265|20535048|P1|STARTED|Washout Period (50-minute Period Decay)||6
8330163|NCT01370265|20535047|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
8330164|NCT01370265|20535048|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
8330165|NCT01370265|20535047|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
8330166|NCT01370265|20535048|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
8330167|NCT01370265|20535047|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
8330168|NCT01370265|20535048|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
8330169|NCT01370213|20535068|P3|NOT COMPLETED|Overall Study||0
8330170|NCT01370213|20535069|P2|NOT COMPLETED|Overall Study||2
8330171|NCT01370213|20535070|P1|NOT COMPLETED|Overall Study||1
8330172|NCT01370213|20535068|P3|COMPLETED|Overall Study||1
8330173|NCT01370213|20535069|P2|COMPLETED|Overall Study||15
8330174|NCT01370213|20535070|P1|COMPLETED|Overall Study||6
8330175|NCT01370213|20535068|P3|STARTED|Overall Study||1
8330176|NCT01370213|20535069|P2|STARTED|Overall Study||17
8330177|NCT01370213|20535070|P1|STARTED|Overall Study||7
8330178|NCT01370083|20535090|P2|NOT COMPLETED|Overall Study||1
8330179|NCT01370083|20535091|P1|NOT COMPLETED|Overall Study||2
8330180|NCT01370083|20535090|P2|COMPLETED|Overall Study||6
8330181|NCT01370083|20535091|P1|COMPLETED|Overall Study||5
8330182|NCT01370083|20535090|P2|STARTED|Overall Study||7
8330183|NCT01370083|20535091|P1|STARTED|Overall Study||7
8330184|NCT01370005|20535104|P3|NOT COMPLETED|Overall Study||11
8330185|NCT01370005|20535105|P2|NOT COMPLETED|Overall Study||11
8330186|NCT01370005|20535106|P1|NOT COMPLETED|Overall Study||16
8330187|NCT01370005|20535104|P3|COMPLETED|Overall Study||266
8330188|NCT01370005|20535105|P2|COMPLETED|Overall Study||265
8330189|NCT01370005|20535106|P1|COMPLETED|Overall Study||256
8330190|NCT01370005|20535104|P3|STARTED|Overall Study||277
8330191|NCT01370005|20535105|P2|STARTED|Overall Study||276
8330192|NCT01370005|20535106|P1|STARTED|Overall Study||272
8330193|NCT01369888|20535163|P4|NOT COMPLETED|Overall Study||0
8330194|NCT01369888|20535164|P3|NOT COMPLETED|Overall Study||0
8330195|NCT01369888|20535165|P2|NOT COMPLETED|Overall Study||0
8330196|NCT01369888|20535166|P1|NOT COMPLETED|Overall Study||0
8330197|NCT01369888|20535163|P4|COMPLETED|Overall Study||0
8330198|NCT01369888|20535164|P3|COMPLETED|Overall Study||0
8330199|NCT01369888|20535165|P2|COMPLETED|Overall Study||2
8330200|NCT01369888|20535166|P1|COMPLETED|Overall Study||1
8330201|NCT01369888|20535163|P4|STARTED|Overall Study||0
8330202|NCT01369888|20535164|P3|STARTED|Overall Study||0
8330203|NCT01369888|20535165|P2|STARTED|Overall Study||2
8330204|NCT01369888|20535166|P1|STARTED|Overall Study||1
8330205|NCT01369875|20535176|P2|NOT COMPLETED|Overall Study||0
8330206|NCT01369875|20535177|P1|NOT COMPLETED|Overall Study||0
8330207|NCT01369875|20535176|P2|COMPLETED|Overall Study||1
8330208|NCT01369875|20535177|P1|COMPLETED|Overall Study||1
8330209|NCT01369875|20535176|P2|STARTED|Overall Study||1
8330210|NCT01369875|20535177|P1|STARTED|Overall Study||1
8330211|NCT01369849|20535188|P3|NOT COMPLETED|Overall Study||1
8330212|NCT01369849|20535189|P2|NOT COMPLETED|Overall Study||1
8330213|NCT01369849|20535190|P1|NOT COMPLETED|Overall Study||0
8330214|NCT01369849|20535188|P3|COMPLETED|Overall Study||4
8330215|NCT01369849|20535189|P2|COMPLETED|Overall Study||3
8330216|NCT01369849|20535190|P1|COMPLETED|Overall Study||6
8330217|NCT01369849|20535188|P3|STARTED|Overall Study||5
8330218|NCT01369849|20535189|P2|STARTED|Overall Study||4
8330219|NCT01369849|20535190|P1|STARTED|Overall Study||6
8330220|NCT01369784|20535212|P1|NOT COMPLETED|Overall Study||12
8330221|NCT01369784|20535212|P1|COMPLETED|Overall Study||146
8330222|NCT01369784|20535212|P1|STARTED|Overall Study||158
8330223|NCT01369758|20535237|P1|NOT COMPLETED|Overall Study||0
8330224|NCT01369758|20535237|P1|COMPLETED|Overall Study||290
8330225|NCT01369758|20535237|P1|STARTED|Overall Study||290
8330226|NCT01369745|20535247|P5|NOT COMPLETED|Overall Study||18
8330227|NCT01369745|20535248|P4|NOT COMPLETED|Overall Study||20
8330228|NCT01369745|20535249|P3|NOT COMPLETED|Overall Study||2
8330229|NCT01369745|20535250|P2|NOT COMPLETED|Overall Study||13
8330230|NCT01369745|20535251|P1|NOT COMPLETED|Overall Study||7
8330231|NCT01369745|20535247|P5|COMPLETED|Overall Study||65
8330232|NCT01369745|20535248|P4|COMPLETED|Overall Study||64
8330233|NCT01369745|20535249|P3|COMPLETED|Overall Study||16
8330234|NCT01369745|20535250|P2|COMPLETED|Overall Study||28
8330235|NCT01369745|20535251|P1|COMPLETED|Overall Study||25
8330236|NCT01369745|20535247|P5|STARTED|Overall Study||83
8330237|NCT01369745|20535248|P4|STARTED|Overall Study||84
8330238|NCT01369745|20535249|P3|STARTED|Overall Study||18
8330239|NCT01369745|20535250|P2|STARTED|Overall Study||41
8330240|NCT01369745|20535251|P1|STARTED|Overall Study||32
8330241|NCT01369732|20535285|P2|NOT COMPLETED|Overall Study||2
8330242|NCT01369732|20535286|P1|NOT COMPLETED|Overall Study||4
8330243|NCT01369732|20535285|P2|COMPLETED|Overall Study||31
8330244|NCT01369732|20535286|P1|COMPLETED|Overall Study||29
8330245|NCT01369732|20535285|P2|STARTED|Overall Study||33
8330246|NCT01369732|20535286|P1|STARTED|Overall Study||33
8330247|NCT01369706|20535292|P1|NOT COMPLETED|Overall Study||0
8330248|NCT01369706|20535292|P1|COMPLETED|Overall Study||388
8330249|NCT01369706|20535292|P1|STARTED|Overall Study||388
8330250|NCT01369680|20535300|P4|NOT COMPLETED|Overall Study||2
8330251|NCT01369680|20535301|P3|NOT COMPLETED|Overall Study||1
8330252|NCT01369680|20535302|P2|NOT COMPLETED|Overall Study||0
8330253|NCT01369680|20535303|P1|NOT COMPLETED|Overall Study||0
8330254|NCT01369680|20535300|P4|COMPLETED|Overall Study||1
8330255|NCT01369680|20535301|P3|COMPLETED|Overall Study||2
8330256|NCT01369680|20535302|P2|COMPLETED|Overall Study||3
8330257|NCT01369680|20535303|P1|COMPLETED|Overall Study||3
8330258|NCT01369680|20535300|P4|STARTED|Overall Study||3
8330259|NCT01369680|20535301|P3|STARTED|Overall Study||3
8330260|NCT01369680|20535302|P2|STARTED|Overall Study||3
8330261|NCT01369680|20535303|P1|STARTED|Overall Study||3
8330262|NCT01369641|20535324|P1|NOT COMPLETED|Overall Study||1
8330263|NCT01369641|20535324|P1|COMPLETED|Overall Study||0
8330264|NCT01369641|20535324|P1|STARTED|Overall Study||1
8330265|NCT01369615|20535330|P2|NOT COMPLETED|Overall Study||2
8330266|NCT01369615|20535331|P1|NOT COMPLETED|Overall Study||0
8330267|NCT01369615|20535330|P2|COMPLETED|Overall Study||12
8330268|NCT01369615|20535331|P1|COMPLETED|Overall Study||9
8330269|NCT01369615|20535330|P2|STARTED|Overall Study||14
8330270|NCT01369615|20535331|P1|STARTED|Overall Study||9
8330271|NCT01369511|20535341|P4|NOT COMPLETED|Overall Study||11
8330272|NCT01369511|20535342|P3|NOT COMPLETED|Overall Study||11
8330273|NCT01369511|20535343|P2|NOT COMPLETED|Overall Study||13
8330274|NCT01369511|20535344|P1|NOT COMPLETED|Overall Study||13
8330275|NCT01369511|20535341|P4|COMPLETED|Overall Study||89
8330276|NCT01369511|20535342|P3|COMPLETED|Overall Study||87
8330277|NCT01369511|20535343|P2|COMPLETED|Overall Study||91
8330278|NCT01369511|20535344|P1|COMPLETED|Overall Study||85
8330279|NCT01369511|20535341|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
8330280|NCT01369511|20535342|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
8330281|NCT01369511|20535343|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
8330282|NCT01369511|20535344|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
8330283|NCT01369511|20535341|P4|STARTED|Overall Study||100
8330284|NCT01369511|20535342|P3|STARTED|Overall Study||98
8330285|NCT01369511|20535343|P2|STARTED|Overall Study||104
8330286|NCT01369511|20535344|P1|STARTED|Overall Study||98
8330287|NCT01369498|20535362|P4|NOT COMPLETED|Overall Study||15
8330288|NCT01369498|20535363|P3|NOT COMPLETED|Overall Study||15
8330289|NCT01369498|20535364|P2|NOT COMPLETED|Overall Study||12
8330290|NCT01369498|20535365|P1|NOT COMPLETED|Overall Study||12
8330291|NCT01369498|20535362|P4|COMPLETED|Overall Study||0
8330292|NCT01369498|20535363|P3|COMPLETED|Overall Study||0
8330293|NCT01369498|20535364|P2|COMPLETED|Overall Study||0
8330294|NCT01369498|20535365|P1|COMPLETED|Overall Study||0
8330295|NCT01369498|20535362|P4|STARTED|Overall Study||15
8330296|NCT01369498|20535363|P3|STARTED|Overall Study||15
8330297|NCT01369498|20535364|P2|STARTED|Overall Study||12
8330298|NCT01369498|20535365|P1|STARTED|Overall Study||12
8330299|NCT01369485|20535397|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
8330300|NCT01369485|20535398|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
8330301|NCT01369485|20535397|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
8330302|NCT01369485|20535398|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
8330303|NCT01369485|20535397|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
8330304|NCT01369485|20535398|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
8330305|NCT01369485|20535397|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
8330306|NCT01369485|20535398|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
8330307|NCT01369485|20535397|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
8330308|NCT01369485|20535398|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
8330309|NCT01369485|20535397|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
8330310|NCT01369485|20535398|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
8330311|NCT01369433|20535440|P2|NOT COMPLETED|Overall Study||16
8330312|NCT01369433|20535441|P1|NOT COMPLETED|Overall Study||209
8330313|NCT01369433|20535440|P2|COMPLETED|Overall Study||0
8330314|NCT01369433|20535441|P1|COMPLETED|Overall Study||0
8330315|NCT01369433|20535440|P2|STARTED|Overall Study||16
8330316|NCT01369433|20535441|P1|STARTED|Overall Study||209
8330317|NCT01369355|20535453|P9|NOT COMPLETED|Long-term Extension (Week 44-272)||171
8330318|NCT01369355|20535454|P8|NOT COMPLETED|Long-term Extension (Week 44-272)||106
8330319|NCT01369355|20535455|P7|NOT COMPLETED|Long-term Extension (Week 44-272)||151
8330320|NCT01369355|20535456|P6|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330321|NCT01369355|20535457|P5|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330322|NCT01369355|20535458|P4|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330323|NCT01369355|20535459|P3|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330324|NCT01369355|20535460|P2|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330325|NCT01369355|20535461|P1|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330326|NCT01369355|20535453|P9|COMPLETED|Long-term Extension (Week 44-272)||183
8330327|NCT01369355|20535454|P8|COMPLETED|Long-term Extension (Week 44-272)||107
8330328|NCT01369355|20535455|P7|COMPLETED|Long-term Extension (Week 44-272)||0
8330329|NCT01369355|20535456|P6|COMPLETED|Long-term Extension (Week 44-272)||0
8330330|NCT01369355|20535457|P5|COMPLETED|Long-term Extension (Week 44-272)||0
8330331|NCT01369355|20535458|P4|COMPLETED|Long-term Extension (Week 44-272)||0
8330332|NCT01369355|20535459|P3|COMPLETED|Long-term Extension (Week 44-272)||0
8330333|NCT01369355|20535460|P2|COMPLETED|Long-term Extension (Week 44-272)||0
8330334|NCT01369355|20535461|P1|COMPLETED|Long-term Extension (Week 44-272)||0
8330335|NCT01369355|20535453|P9|STARTED|Long-term Extension (Week 44-272)||354
8330336|NCT01369355|20535454|P8|STARTED|Long-term Extension (Week 44-272)||213
8330337|NCT01369355|20535455|P7|STARTED|Long-term Extension (Week 44-272)||151
8330338|NCT01369355|20535456|P6|STARTED|Long-term Extension (Week 44-272)||0
8330339|NCT01369355|20535457|P5|STARTED|Long-term Extension (Week 44-272)||0
8330340|NCT01369355|20535458|P4|STARTED|Long-term Extension (Week 44-272)||0
8330341|NCT01369355|20535459|P3|STARTED|Long-term Extension (Week 44-272)||0
8330342|NCT01369355|20535460|P2|STARTED|Long-term Extension (Week 44-272)||0
8330343|NCT01369355|20535461|P1|STARTED|Long-term Extension (Week 44-272)||0
8330344|NCT01369355|20535453|P9|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330345|NCT01369355|20535454|P8|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330346|NCT01369355|20535455|P7|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330347|NCT01369355|20535456|P6|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
8330348|NCT01369355|20535457|P5|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
8330349|NCT01369355|20535458|P4|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
8330350|NCT01369355|20535459|P3|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
8330351|NCT01369355|20535460|P2|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
8330352|NCT01369355|20535461|P1|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
8330353|NCT01369355|20535453|P9|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330354|NCT01369355|20535454|P8|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330355|NCT01369355|20535455|P7|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330356|NCT01369355|20535456|P6|COMPLETED|Week 0 - Week 44 (Maintenance)||204
8330357|NCT01369355|20535457|P5|COMPLETED|Week 0 - Week 44 (Maintenance)||131
8330358|NCT01369355|20535458|P4|COMPLETED|Week 0 - Week 44 (Maintenance)||93
8330359|NCT01369355|20535459|P3|COMPLETED|Week 0 - Week 44 (Maintenance)||101
8330360|NCT01369355|20535460|P2|COMPLETED|Week 0 - Week 44 (Maintenance)||103
8330361|NCT01369355|20535461|P1|COMPLETED|Week 0 - Week 44 (Maintenance)||102
8330362|NCT01369355|20535453|P9|STARTED|Week 0 - Week 44 (Maintenance)||0
8330363|NCT01369355|20535454|P8|STARTED|Week 0 - Week 44 (Maintenance)||0
8330364|NCT01369355|20535455|P7|STARTED|Week 0 - Week 44 (Maintenance)||0
8330365|NCT01369355|20535456|P6|STARTED|Week 0 - Week 44 (Maintenance)||476
8330366|NCT01369355|20535457|P5|STARTED|Week 0 - Week 44 (Maintenance)||285
8330367|NCT01369355|20535458|P4|STARTED|Week 0 - Week 44 (Maintenance)||123
8330368|NCT01369355|20535459|P3|STARTED|Week 0 - Week 44 (Maintenance)||132
8330369|NCT01369355|20535460|P2|STARTED|Week 0 - Week 44 (Maintenance)||132
8330370|NCT01369355|20535461|P1|STARTED|Week 0 - Week 44 (Maintenance)||133
8330371|NCT01369342|20535493|P3|NOT COMPLETED|Overall Study||3
8330372|NCT01369342|20535494|P2|NOT COMPLETED|Overall Study||9
8330373|NCT01369342|20535495|P1|NOT COMPLETED|Overall Study||13
8330374|NCT01369342|20535493|P3|COMPLETED|Overall Study||210
8330375|NCT01369342|20535494|P2|COMPLETED|Overall Study||204
8330376|NCT01369342|20535495|P1|COMPLETED|Overall Study||201
8330377|NCT01369342|20535493|P3|STARTED|Overall Study||213
8330378|NCT01369342|20535494|P2|STARTED|Overall Study||213
8330379|NCT01369342|20535495|P1|STARTED|Overall Study||214
8330380|NCT01369329|20535518|P3|NOT COMPLETED|Overall Study||14
8330381|NCT01369329|20535519|P2|NOT COMPLETED|Overall Study||11
8330382|NCT01369329|20535520|P1|NOT COMPLETED|Overall Study||12
8330383|NCT01369329|20535518|P3|COMPLETED|Overall Study||245
8330384|NCT01369329|20535519|P2|COMPLETED|Overall Study||243
8330385|NCT01369329|20535520|P1|COMPLETED|Overall Study||244
8330386|NCT01369329|20535518|P3|STARTED|Overall Study||259
8330387|NCT01369329|20535519|P2|STARTED|Overall Study||254
8330388|NCT01369329|20535520|P1|STARTED|Overall Study||256
8330389|NCT01369225|20535546|P6|NOT COMPLETED|Overall Study||0
8330390|NCT01369225|20535547|P5|NOT COMPLETED|Overall Study||2
8330391|NCT01369225|20535548|P4|NOT COMPLETED|Overall Study||2
8330392|NCT01369225|20535549|P3|NOT COMPLETED|Overall Study||3
8330393|NCT01369225|20535550|P2|NOT COMPLETED|Overall Study||0
8330394|NCT01369225|20535551|P1|NOT COMPLETED|Overall Study||2
8330395|NCT01369225|20535546|P6|COMPLETED|Overall Study||9
8330396|NCT01369225|20535547|P5|COMPLETED|Overall Study||10
8330397|NCT01369225|20535548|P4|COMPLETED|Overall Study||8
8330398|NCT01369225|20535549|P3|COMPLETED|Overall Study||9
8330399|NCT01369225|20535550|P2|COMPLETED|Overall Study||3
8330400|NCT01369225|20535551|P1|COMPLETED|Overall Study||4
8330401|NCT01369225|20535546|P6|STARTED|Overall Study||9
8330402|NCT01369225|20535547|P5|STARTED|Overall Study||12
8330403|NCT01369225|20535548|P4|STARTED|Overall Study||10
8330404|NCT01369225|20535549|P3|STARTED|Overall Study||12
8330405|NCT01369225|20535550|P2|STARTED|Overall Study||3
8330406|NCT01369225|20535551|P1|STARTED|Overall Study||6
8330407|NCT01369199|20535643|P1|NOT COMPLETED|Overall Study||3
8330408|NCT01369199|20535643|P1|COMPLETED|Overall Study||25
8330409|NCT01369199|20535643|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
8330410|NCT01369199|20535643|P1|STARTED|Overall Study||28
8330411|NCT01369108|20535666|P1|NOT COMPLETED|Overall Study||11
8330412|NCT01369108|20535666|P1|COMPLETED|Overall Study||49
8330413|NCT01369108|20535666|P1|STARTED|Overall Study|120 teeth|60
8330414|NCT01369069|20535675|P2|NOT COMPLETED|Overall Study||16
8330415|NCT01369069|20535676|P1|NOT COMPLETED|Overall Study||17
8330416|NCT01369069|20535675|P2|COMPLETED|Overall Study||554
8330417|NCT01369069|20535676|P1|COMPLETED|Overall Study||564
8330418|NCT01369069|20535675|P2|STARTED|Overall Study||570
8330419|NCT01369069|20535676|P1|STARTED|Overall Study||581
8330420|NCT01369030|20535692|P1|NOT COMPLETED|Overall Study||40
8330421|NCT01369030|20535692|P1|COMPLETED|Overall Study||554
8330422|NCT01369030|20535692|P1|STARTED|Overall Study||594
8330423|NCT01368965|20535698|P1|NOT COMPLETED|Overall Study||12
8330424|NCT01368965|20535698|P1|COMPLETED|Overall Study||40
8330425|NCT01368965|20535698|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
8330426|NCT01368965|20535698|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
8330427|NCT01368900|20535707|P1|NOT COMPLETED|Overall Study||7
8330428|NCT01368900|20535707|P1|COMPLETED|Overall Study||61
8330429|NCT01368900|20535707|P1|STARTED|Overall Study||68
8330430|NCT01368874|20535720|P3|NOT COMPLETED|Overall Study||1
8330431|NCT01368874|20535721|P2|NOT COMPLETED|Overall Study||0
8330432|NCT01368874|20535722|P1|NOT COMPLETED|Overall Study||3
8330433|NCT01368874|20535720|P3|COMPLETED|Overall Study||24
8330434|NCT01368874|20535721|P2|COMPLETED|Overall Study||5
8330435|NCT01368874|20535722|P1|COMPLETED|Overall Study||31
8330436|NCT01368874|20535720|P3|STARTED|Overall Study||25
8330437|NCT01368874|20535721|P2|STARTED|Overall Study||5
8330438|NCT01368874|20535722|P1|STARTED|Overall Study||34
8330439|NCT01368835|20535782|P1|NOT COMPLETED|Overall Study||33
8330440|NCT01368835|20535782|P1|COMPLETED|Overall Study||70
8330441|NCT01368835|20535782|P1|STARTED|Overall Study|103 Subjects Enrolled|103
8330442|NCT01368809|20535791|P2|NOT COMPLETED|Overall Study||0
8330443|NCT01368809|20535792|P1|NOT COMPLETED|Overall Study||0
8330444|NCT01368809|20535791|P2|COMPLETED|Overall Study||50
8330445|NCT01368809|20535792|P1|COMPLETED|Overall Study||50
8330446|NCT01368809|20535791|P2|STARTED|Overall Study||50
8330447|NCT01368809|20535792|P1|STARTED|Overall Study||50
8330448|NCT01368653|20535804|P2|NOT COMPLETED|Overall Study||9
8330449|NCT01368653|20535805|P1|NOT COMPLETED|Overall Study||6
8330450|NCT01368653|20535804|P2|COMPLETED|Overall Study||37
8330451|NCT01368653|20535805|P1|COMPLETED|Overall Study||41
8330452|NCT01368653|20535804|P2|Randomized to Advice Only in Phase 2|Overall Study||10
8330453|NCT01368653|20535805|P1|Randomized to Advice Only in Phase 2|Overall Study||10
8330454|NCT01368653|20535804|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
8330455|NCT01368653|20535805|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
8330456|NCT01368653|20535804|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
8330457|NCT01368653|20535805|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
8330458|NCT01368653|20535804|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
8330459|NCT01368653|20535805|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
8330460|NCT01368653|20535804|P2|Completed 4-week Follow-up|Overall Study||37
8330461|NCT01368653|20535805|P1|Completed 4-week Follow-up|Overall Study||44
8330462|NCT01368653|20535804|P2|STARTED|Overall Study||46
8330463|NCT01368653|20535805|P1|STARTED|Overall Study||47
8330464|NCT01368614|20535821|P4|NOT COMPLETED|Study Period||3
8330465|NCT01368614|20535822|P3|NOT COMPLETED|Study Period||2
8330466|NCT01368614|20535823|P2|NOT COMPLETED|Study Period||1
8330467|NCT01368614|20535824|P1|NOT COMPLETED|Study Period||0
8330468|NCT01368614|20535821|P4|COMPLETED|Study Period||8
8330469|NCT01368614|20535822|P3|COMPLETED|Study Period||8
8330470|NCT01368614|20535823|P2|COMPLETED|Study Period||10
8330471|NCT01368614|20535824|P1|COMPLETED|Study Period||0
8330472|NCT01368614|20535821|P4|STARTED|Study Period||11
8330473|NCT01368614|20535822|P3|STARTED|Study Period||10
8330474|NCT01368614|20535823|P2|STARTED|Study Period||11
8330475|NCT01368614|20535824|P1|STARTED|Study Period||0
8330476|NCT01368614|20535821|P4|NOT COMPLETED|Screening Period||0
8330477|NCT01368614|20535822|P3|NOT COMPLETED|Screening Period||0
8330478|NCT01368614|20535823|P2|NOT COMPLETED|Screening Period||0
8330479|NCT01368614|20535824|P1|NOT COMPLETED|Screening Period||58
8330480|NCT01368614|20535821|P4|COMPLETED|Screening Period||0
8330481|NCT01368614|20535822|P3|COMPLETED|Screening Period||0
8330482|NCT01368614|20535823|P2|COMPLETED|Screening Period||0
8330483|NCT01368614|20535824|P1|COMPLETED|Screening Period||32
8330484|NCT01368614|20535821|P4|STARTED|Screening Period||0
8330485|NCT01368614|20535822|P3|STARTED|Screening Period||0
8330486|NCT01368614|20535823|P2|STARTED|Screening Period||0
8330487|NCT01368614|20535824|P1|STARTED|Screening Period||90
8330488|NCT01368562|20535877|P1|NOT COMPLETED|Overall Study||19
8330489|NCT01368562|20535877|P1|COMPLETED|Overall Study||7
8330490|NCT01368562|20535877|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
8330491|NCT01368562|20535877|P1|STARTED|Overall Study||26
8330492|NCT01368536|20535884|P3|NOT COMPLETED|Overall Study||59
8330493|NCT01368536|20535885|P2|NOT COMPLETED|Overall Study||59
8330494|NCT01368536|20535886|P1|NOT COMPLETED|Overall Study||51
8330495|NCT01368536|20535884|P3|COMPLETED|Overall Study||83
8330496|NCT01368536|20535885|P2|COMPLETED|Overall Study||78
8330497|NCT01368536|20535886|P1|COMPLETED|Overall Study||87
8330498|NCT01368536|20535884|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
8330499|NCT01368536|20535885|P2|Full Analysis Set|Overall Study||137
8330500|NCT01368536|20535886|P1|Full Analysis Set|Overall Study||138
8330501|NCT01368536|20535884|P3|STARTED|Overall Study||142
8330502|NCT01368536|20535885|P2|STARTED|Overall Study||137
8330503|NCT01368536|20535886|P1|STARTED|Overall Study||138
8330504|NCT01368497|20535907|P1|NOT COMPLETED|Overall Study||2
8330505|NCT01368497|20535907|P1|COMPLETED|Overall Study||58
8330506|NCT01368497|20535907|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
8330507|NCT01368497|20535907|P1|STARTED|Overall Study||60
8330508|NCT01368432|20535936|P2|NOT COMPLETED|Overall Study||1
8330509|NCT01368432|20535937|P1|NOT COMPLETED|Overall Study||0
8330510|NCT01368432|20535936|P2|COMPLETED|Overall Study||7
8330511|NCT01368432|20535937|P1|COMPLETED|Overall Study||6
8330512|NCT01368432|20535936|P2|STARTED|Overall Study||8
8330513|NCT01368432|20535937|P1|STARTED|Overall Study||6
8330514|NCT01368406|20535971|P2|NOT COMPLETED|Overall Study||13
8330515|NCT01368406|20535972|P1|NOT COMPLETED|Overall Study||21
8330516|NCT01368406|20535971|P2|COMPLETED|Overall Study||66
8330517|NCT01368406|20535972|P1|COMPLETED|Overall Study||60
8330518|NCT01368406|20535971|P2|STARTED|Overall Study||79
8330519|NCT01368406|20535972|P1|STARTED|Overall Study||81
8330520|NCT01368276|20535980|P2|NOT COMPLETED|Overall Study||10
8330521|NCT01368276|20535981|P1|NOT COMPLETED|Overall Study||1
8330522|NCT01368276|20535980|P2|COMPLETED|Overall Study||18
8330523|NCT01368276|20535981|P1|COMPLETED|Overall Study||2
8330524|NCT01368276|20535980|P2|STARTED|Overall Study||28
8330525|NCT01368276|20535981|P1|STARTED|Overall Study||3
8330526|NCT01368263|20535994|P3|NOT COMPLETED|Overall Study||0
8330527|NCT01368263|20535995|P2|NOT COMPLETED|Overall Study||0
8330528|NCT01368263|20535996|P1|NOT COMPLETED|Overall Study||0
8330529|NCT01368263|20535994|P3|COMPLETED|Overall Study||1
8330530|NCT01368263|20535995|P2|COMPLETED|Overall Study||1
8330531|NCT01368263|20535996|P1|COMPLETED|Overall Study||6
8330532|NCT01368263|20535994|P3|STARTED|Overall Study||1
8330533|NCT01368263|20535995|P2|STARTED|Overall Study||1
8330534|NCT01368263|20535996|P1|STARTED|Overall Study||6
8330535|NCT01368211|20536018|P2|NOT COMPLETED|Second Platelets Transfusion||2
8330536|NCT01368211|20536019|P1|NOT COMPLETED|Second Platelets Transfusion||1
8330537|NCT01368211|20536018|P2|COMPLETED|Second Platelets Transfusion||5
8330538|NCT01368211|20536019|P1|COMPLETED|Second Platelets Transfusion||7
8330539|NCT01368211|20536018|P2|STARTED|Second Platelets Transfusion||7
8330540|NCT01368211|20536019|P1|STARTED|Second Platelets Transfusion||8
8330541|NCT01368211|20536018|P2|NOT COMPLETED|First Platelets Transfusion||0
8330542|NCT01368211|20536019|P1|NOT COMPLETED|First Platelets Transfusion||0
8330543|NCT01368211|20536018|P2|COMPLETED|First Platelets Transfusion||7
8330544|NCT01368211|20536019|P1|COMPLETED|First Platelets Transfusion||8
8330545|NCT01368211|20536018|P2|STARTED|First Platelets Transfusion||7
8330546|NCT01368211|20536019|P1|STARTED|First Platelets Transfusion||8
8330547|NCT01368185|20536027|P1|NOT COMPLETED|Overall Study||0
8330548|NCT01368185|20536027|P1|COMPLETED|Overall Study||1705
8330549|NCT01368185|20536027|P1|STARTED|Overall Study||1705
8330550|NCT01368081|20536047|P13|NOT COMPLETED|Overall Study||7
8330551|NCT01368081|20536048|P12|NOT COMPLETED|Overall Study||3
8330552|NCT01368081|20536049|P11|NOT COMPLETED|Overall Study||9
8330553|NCT01368081|20536050|P10|NOT COMPLETED|Overall Study||10
8330554|NCT01368081|20536051|P9|NOT COMPLETED|Overall Study||8
8330555|NCT01368081|20536052|P8|NOT COMPLETED|Overall Study||7
8330556|NCT01368081|20536053|P7|NOT COMPLETED|Overall Study||12
8330557|NCT01368081|20536054|P6|NOT COMPLETED|Overall Study||10
8330558|NCT01368081|20536055|P5|NOT COMPLETED|Overall Study||2
8330559|NCT01368081|20536056|P4|NOT COMPLETED|Overall Study||5
8330560|NCT01368081|20536057|P3|NOT COMPLETED|Overall Study||4
8330561|NCT01368081|20536058|P2|NOT COMPLETED|Overall Study||9
8330562|NCT01368081|20536059|P1|NOT COMPLETED|Overall Study||10
8330563|NCT01368081|20536047|P13|COMPLETED|Overall Study||63
8330564|NCT01368081|20536048|P12|COMPLETED|Overall Study||67
8330565|NCT01368081|20536049|P11|COMPLETED|Overall Study||62
8330566|NCT01368081|20536050|P10|COMPLETED|Overall Study||58
8330567|NCT01368081|20536051|P9|COMPLETED|Overall Study||62
8330568|NCT01368081|20536052|P8|COMPLETED|Overall Study||62
8330569|NCT01368081|20536053|P7|COMPLETED|Overall Study||124
8330570|NCT01368081|20536054|P6|COMPLETED|Overall Study||127
8330571|NCT01368081|20536055|P5|COMPLETED|Overall Study||63
8330572|NCT01368081|20536056|P4|COMPLETED|Overall Study||63
8330573|NCT01368081|20536057|P3|COMPLETED|Overall Study||59
8330574|NCT01368081|20536058|P2|COMPLETED|Overall Study||128
8330575|NCT01368081|20536059|P1|COMPLETED|Overall Study||126
8330576|NCT01368081|20536047|P13|STARTED|Overall Study||70
8330577|NCT01368081|20536048|P12|STARTED|Overall Study||70
8330578|NCT01368081|20536049|P11|STARTED|Overall Study||71
8330579|NCT01368081|20536050|P10|STARTED|Overall Study||68
8330580|NCT01368081|20536051|P9|STARTED|Overall Study||70
8330581|NCT01368081|20536052|P8|STARTED|Overall Study||69
8330582|NCT01368081|20536053|P7|STARTED|Overall Study||136
8330583|NCT01368081|20536054|P6|STARTED|Overall Study||137
8330584|NCT01368081|20536055|P5|STARTED|Overall Study||65
8330585|NCT01368081|20536056|P4|STARTED|Overall Study||68
8330586|NCT01368081|20536057|P3|STARTED|Overall Study||63
8330587|NCT01368081|20536058|P2|STARTED|Overall Study||137
8330588|NCT01368081|20536059|P1|STARTED|Overall Study||136
8330589|NCT01368042|20536113|P1|NOT COMPLETED|Overall Study||30
8330590|NCT01368042|20536113|P1|COMPLETED|Overall Study||235
8330591|NCT01368042|20536113|P1|STARTED|Overall Study||265
8330592|NCT01367886|20536133|P1|NOT COMPLETED|Overall Study||7
8330593|NCT01367886|20536133|P1|COMPLETED|Overall Study||14
8330594|NCT01367886|20536133|P1|STARTED|Overall Study||21
8330595|NCT01367860|20536142|P2|NOT COMPLETED|Overall Study||0
8330596|NCT01367860|20536143|P1|NOT COMPLETED|Overall Study||0
8330597|NCT01367860|20536142|P2|COMPLETED|Overall Study||20
8330598|NCT01367860|20536143|P1|COMPLETED|Overall Study||20
8330599|NCT01367860|20536142|P2|STARTED|Overall Study||20
8330600|NCT01367860|20536143|P1|STARTED|Overall Study||20
8330601|NCT01367847|20536183|P2|NOT COMPLETED|Overall Study||2
8330602|NCT01367847|20536184|P1|NOT COMPLETED|Overall Study||2
8330603|NCT01367847|20536183|P2|COMPLETED|Overall Study||7
8330604|NCT01367847|20536184|P1|COMPLETED|Overall Study||8
8330605|NCT01367847|20536183|P2|STARTED|Overall Study||9
8330606|NCT01367847|20536184|P1|STARTED|Overall Study||10
8330607|NCT01367834|20536200|P2|NOT COMPLETED|Overall Study||3
8330608|NCT01367834|20536201|P1|NOT COMPLETED|Overall Study||2
8330609|NCT01367834|20536200|P2|COMPLETED|Overall Study||3
8330610|NCT01367834|20536201|P1|COMPLETED|Overall Study||9
8330611|NCT01367834|20536200|P2|STARTED|Overall Study||6
8330612|NCT01367834|20536201|P1|STARTED|Overall Study||11
8330613|NCT01367704|20536225|P2|NOT COMPLETED|Overall Study||161
8330614|NCT01367704|20536226|P1|NOT COMPLETED|Overall Study||47
8330615|NCT01367704|20536225|P2|COMPLETED|Overall Study||847
8330616|NCT01367704|20536226|P1|COMPLETED|Overall Study||951
8330617|NCT01367704|20536225|P2|STARTED|Overall Study||1008
8330618|NCT01367704|20536226|P1|STARTED|Overall Study||998
8330619|NCT01367665|20536238|P2|NOT COMPLETED|Overall Study||55
8330620|NCT01367665|20536239|P1|NOT COMPLETED|Overall Study||442
8330621|NCT01367665|20536238|P2|COMPLETED|Overall Study||41
8330622|NCT01367665|20536239|P1|COMPLETED|Overall Study||677
8330623|NCT01367665|20536238|P2|STARTED|Overall Study||96
8330624|NCT01367665|20536239|P1|STARTED|Overall Study||1119
8330625|NCT01367457|20536270|P3|NOT COMPLETED|Overall Study||0
8330626|NCT01367457|20536271|P2|NOT COMPLETED|Overall Study||0
8330627|NCT01367457|20536272|P1|NOT COMPLETED|Overall Study||188
8330628|NCT01367457|20536270|P3|COMPLETED|Overall Study||26
8330629|NCT01367457|20536271|P2|COMPLETED|Overall Study||23
8330630|NCT01367457|20536272|P1|COMPLETED|Overall Study||5
8330631|NCT01367457|20536270|P3|STARTED|Overall Study||26
8330632|NCT01367457|20536271|P2|STARTED|Overall Study||23
8330633|NCT01367457|20536272|P1|STARTED|Overall Study||193
8330634|NCT01367444|20536299|P7|NOT COMPLETED|Overall Study||0
8330635|NCT01367444|20536300|P6|NOT COMPLETED|Overall Study||0
8330636|NCT01367444|20536301|P5|NOT COMPLETED|Overall Study||0
8330637|NCT01367444|20536302|P4|NOT COMPLETED|Overall Study||0
8330638|NCT01367444|20536303|P3|NOT COMPLETED|Overall Study||0
8330639|NCT01367444|20536304|P2|NOT COMPLETED|Overall Study||0
8330640|NCT01367444|20536305|P1|NOT COMPLETED|Overall Study||0
8330641|NCT01367444|20536299|P7|COMPLETED|Overall Study||1
8330642|NCT01367444|20536300|P6|COMPLETED|Overall Study||4
8330643|NCT01367444|20536301|P5|COMPLETED|Overall Study||6
8330644|NCT01367444|20536302|P4|COMPLETED|Overall Study||4
8330645|NCT01367444|20536303|P3|COMPLETED|Overall Study||4
8330646|NCT01367444|20536304|P2|COMPLETED|Overall Study||4
8330647|NCT01367444|20536305|P1|COMPLETED|Overall Study||4
8330648|NCT01367444|20536299|P7|STARTED|Overall Study||1
8330649|NCT01367444|20536300|P6|STARTED|Overall Study||4
8330650|NCT01367444|20536301|P5|STARTED|Overall Study||6
8330651|NCT01367444|20536302|P4|STARTED|Overall Study||4
8330652|NCT01367444|20536303|P3|STARTED|Overall Study||4
8330653|NCT01367444|20536304|P2|STARTED|Overall Study||4
8330654|NCT01367444|20536305|P1|STARTED|Overall Study||4
8330655|NCT01367275|20536328|P1|NOT COMPLETED|Overall Study||3
8330656|NCT01367275|20536328|P1|COMPLETED|Overall Study||5
8330657|NCT01367275|20536328|P1|STARTED|Overall Study||8
8330658|NCT01367262|20536332|P1|NOT COMPLETED|Overall Study||0
8330659|NCT01367262|20536332|P1|COMPLETED|Overall Study||6
8330660|NCT01367262|20536332|P1|STARTED|Overall Study||6
8330661|NCT01367249|20536345|P2|NOT COMPLETED|Overall Study||16
8330662|NCT01367249|20536346|P1|NOT COMPLETED|Overall Study||9
8330663|NCT01367249|20536345|P2|COMPLETED|Overall Study||202
8330664|NCT01367249|20536346|P1|COMPLETED|Overall Study||213
8330665|NCT01367249|20536345|P2|STARTED|Overall Study||218
8330666|NCT01367249|20536346|P1|STARTED|Overall Study||222
8330667|NCT01367236|20536356|P2|NOT COMPLETED|Overall Study||1
8330668|NCT01367236|20536357|P1|NOT COMPLETED|Overall Study||3
8330669|NCT01367236|20536356|P2|COMPLETED|Overall Study||29
8330670|NCT01367236|20536357|P1|COMPLETED|Overall Study||27
8330671|NCT01367236|20536356|P2|STARTED|Overall Study||30
8330672|NCT01367236|20536357|P1|STARTED|Overall Study||30
8330673|NCT01367158|20536376|P11|NOT COMPLETED|Overall Study||1
8330674|NCT01367158|20536377|P10|NOT COMPLETED|Overall Study||0
8330675|NCT01367158|20536378|P9|NOT COMPLETED|Overall Study||0
8330676|NCT01367158|20536379|P8|NOT COMPLETED|Overall Study||2
8330677|NCT01367158|20536380|P7|NOT COMPLETED|Overall Study||0
8330678|NCT01367158|20536381|P6|NOT COMPLETED|Overall Study||2
8330679|NCT01367158|20536382|P5|NOT COMPLETED|Overall Study||2
8330680|NCT01367158|20536383|P4|NOT COMPLETED|Overall Study||1
8330681|NCT01367158|20536384|P3|NOT COMPLETED|Overall Study||1
8330682|NCT01367158|20536385|P2|NOT COMPLETED|Overall Study||3
8330683|NCT01367158|20536386|P1|NOT COMPLETED|Overall Study||0
8330684|NCT01367158|20536376|P11|COMPLETED|Overall Study||72
8330685|NCT01367158|20536377|P10|COMPLETED|Overall Study||50
8330686|NCT01367158|20536378|P9|COMPLETED|Overall Study||23
8330687|NCT01367158|20536379|P8|COMPLETED|Overall Study||47
8330688|NCT01367158|20536380|P7|COMPLETED|Overall Study||25
8330689|NCT01367158|20536381|P6|COMPLETED|Overall Study||46
8330690|NCT01367158|20536382|P5|COMPLETED|Overall Study||23
8330691|NCT01367158|20536383|P4|COMPLETED|Overall Study||48
8330692|NCT01367158|20536384|P3|COMPLETED|Overall Study||23
8330693|NCT01367158|20536385|P2|COMPLETED|Overall Study||46
8330694|NCT01367158|20536386|P1|COMPLETED|Overall Study||25
8330695|NCT01367158|20536376|P11|STARTED|Overall Study||73
8330696|NCT01367158|20536377|P10|STARTED|Overall Study||50
8330697|NCT01367158|20536378|P9|STARTED|Overall Study||23
8330698|NCT01367158|20536379|P8|STARTED|Overall Study||49
8330699|NCT01367158|20536380|P7|STARTED|Overall Study||25
8330700|NCT01367158|20536381|P6|STARTED|Overall Study||48
8330701|NCT01367158|20536382|P5|STARTED|Overall Study||25
8330702|NCT01367158|20536383|P4|STARTED|Overall Study||49
8330703|NCT01367158|20536384|P3|STARTED|Overall Study||24
8330704|NCT01367158|20536385|P2|STARTED|Overall Study||49
8330705|NCT01367158|20536386|P1|STARTED|Overall Study||25
8330706|NCT01367119|20536530|P2|NOT COMPLETED|Overall Study||1
8330707|NCT01367119|20536531|P1|NOT COMPLETED|Overall Study||2
8330708|NCT01367119|20536530|P2|COMPLETED|Overall Study||16
8330709|NCT01367119|20536531|P1|COMPLETED|Overall Study||19
8330710|NCT01367119|20536530|P2|STARTED|Overall Study||17
8330711|NCT01367119|20536531|P1|STARTED|Overall Study||21
8330712|NCT01367080|20536543|P2|NOT COMPLETED|2nd Administration||0
8330713|NCT01367080|20536544|P1|NOT COMPLETED|2nd Administration||0
8330714|NCT01367080|20536543|P2|COMPLETED|2nd Administration||6
8330715|NCT01367080|20536544|P1|COMPLETED|2nd Administration||6
8330716|NCT01367080|20536543|P2|STARTED|2nd Administration||6
8330717|NCT01367080|20536544|P1|STARTED|2nd Administration||6
8330718|NCT01367080|20536543|P2|NOT COMPLETED|1st Administration||0
8330719|NCT01367080|20536544|P1|NOT COMPLETED|1st Administration||0
8330720|NCT01367080|20536543|P2|COMPLETED|1st Administration||6
8330721|NCT01367080|20536544|P1|COMPLETED|1st Administration||6
8330722|NCT01367080|20536543|P2|STARTED|1st Administration||6
8330723|NCT01367080|20536544|P1|STARTED|1st Administration||6
8330724|NCT01366976|20536558|P2|NOT COMPLETED|Overall Study||0
8330725|NCT01366976|20536559|P1|NOT COMPLETED|Overall Study||0
8330726|NCT01366976|20536558|P2|COMPLETED|Overall Study||30
8330727|NCT01366976|20536559|P1|COMPLETED|Overall Study||30
8330728|NCT01366976|20536558|P2|STARTED|Overall Study||30
8330729|NCT01366976|20536559|P1|STARTED|Overall Study||30
8330730|NCT01366885|20536571|P1|NOT COMPLETED|Overall Study||1
8330731|NCT01366885|20536571|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
8330732|NCT01366885|20536571|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
8330733|NCT01366872|20536576|P1|NOT COMPLETED|Overall Study||0
8330734|NCT01366872|20536576|P1|COMPLETED|Overall Study||50
8330735|NCT01366872|20536576|P1|STARTED|Overall Study||50
8330736|NCT01366846|20536586|P4|NOT COMPLETED|Overall Study||1
8330737|NCT01366846|20536587|P3|NOT COMPLETED|Overall Study||1
8330738|NCT01366846|20536588|P2|NOT COMPLETED|Overall Study||4
8330739|NCT01366846|20536589|P1|NOT COMPLETED|Overall Study||3
8330740|NCT01366846|20536586|P4|COMPLETED|Overall Study||45
8330741|NCT01366846|20536587|P3|COMPLETED|Overall Study||46
8330742|NCT01366846|20536588|P2|COMPLETED|Overall Study||224
8330743|NCT01366846|20536589|P1|COMPLETED|Overall Study||232
8330744|NCT01366846|20536586|P4|STARTED|Overall Study||46
8330745|NCT01366846|20536587|P3|STARTED|Overall Study||47
8330746|NCT01366846|20536588|P2|STARTED|Overall Study||228
8330747|NCT01366846|20536589|P1|STARTED|Overall Study||235
8330748|NCT01366638|20536612|P3|NOT COMPLETED|Overall Study||6
8330749|NCT01366638|20536613|P2|NOT COMPLETED|Overall Study||0
8330750|NCT01366638|20536614|P1|NOT COMPLETED|Overall Study||1
8330751|NCT01366638|20536612|P3|COMPLETED|Overall Study||20
8330752|NCT01366638|20536613|P2|COMPLETED|Overall Study||29
8330753|NCT01366638|20536614|P1|COMPLETED|Overall Study||23
8330754|NCT01366638|20536612|P3|STARTED|Overall Study||26
8330755|NCT01366638|20536613|P2|STARTED|Overall Study||29
8330756|NCT01366638|20536614|P1|STARTED|Overall Study||24
8330757|NCT01366534|20536651|P3|NOT COMPLETED|Overall Study||0
8330758|NCT01366534|20536652|P2|NOT COMPLETED|Overall Study||2
8330759|NCT01366534|20536653|P1|NOT COMPLETED|Overall Study||2
8330760|NCT01366534|20536651|P3|COMPLETED|Overall Study||12
8330761|NCT01366534|20536652|P2|COMPLETED|Overall Study||25
8330762|NCT01366534|20536653|P1|COMPLETED|Overall Study||26
8330763|NCT01366534|20536651|P3|STARTED|Overall Study||12
8330764|NCT01366534|20536652|P2|STARTED|Overall Study||27
8330765|NCT01366534|20536653|P1|STARTED|Overall Study||28
8330766|NCT01366521|20536703|P4|NOT COMPLETED|Overall Study||0
8330767|NCT01366521|20536704|P3|NOT COMPLETED|Overall Study||2
8330768|NCT01366521|20536705|P2|NOT COMPLETED|Overall Study||1
8330769|NCT01366521|20536706|P1|NOT COMPLETED|Overall Study||1
8330770|NCT01366521|20536703|P4|COMPLETED|Overall Study||11
8330771|NCT01366521|20536704|P3|COMPLETED|Overall Study||21
8330772|NCT01366521|20536705|P2|COMPLETED|Overall Study||14
8330773|NCT01366521|20536706|P1|COMPLETED|Overall Study||20
8330774|NCT01366521|20536703|P4|STARTED|Overall Study||11
8330775|NCT01366521|20536704|P3|STARTED|Overall Study||23
8330776|NCT01366521|20536705|P2|STARTED|Overall Study||15
8330777|NCT01366521|20536706|P1|STARTED|Overall Study||21
8330778|NCT01366495|20536785|P4|NOT COMPLETED|HIV Study||0
8330779|NCT01366495|20536786|P3|NOT COMPLETED|HIV Study||0
8330780|NCT01366495|20536787|P2|NOT COMPLETED|HIV Study||0
8330781|NCT01366495|20536788|P1|NOT COMPLETED|HIV Study||1
8330782|NCT01366495|20536785|P4|COMPLETED|HIV Study||0
8330783|NCT01366495|20536786|P3|COMPLETED|HIV Study||0
8330784|NCT01366495|20536787|P2|COMPLETED|HIV Study||50
8330785|NCT01366495|20536788|P1|COMPLETED|HIV Study||49
8330786|NCT01366495|20536785|P4|STARTED|HIV Study||0
8330787|NCT01366495|20536786|P3|STARTED|HIV Study||0
8330788|NCT01366495|20536787|P2|STARTED|HIV Study||50
8330789|NCT01366495|20536788|P1|STARTED|HIV Study||50
8330790|NCT01366495|20536785|P4|NOT COMPLETED|Testing Study||0
8330791|NCT01366495|20536786|P3|NOT COMPLETED|Testing Study||0
8330792|NCT01366495|20536787|P2|NOT COMPLETED|Testing Study||0
8330793|NCT01366495|20536788|P1|NOT COMPLETED|Testing Study||0
8330794|NCT01366495|20536785|P4|COMPLETED|Testing Study||348
8330795|NCT01366495|20536786|P3|COMPLETED|Testing Study||349
8330796|NCT01366495|20536787|P2|COMPLETED|Testing Study||0
8330797|NCT01366495|20536788|P1|COMPLETED|Testing Study||0
8330798|NCT01366495|20536785|P4|STARTED|Testing Study||348
8330799|NCT01366495|20536786|P3|STARTED|Testing Study||349
8330800|NCT01366495|20536787|P2|STARTED|Testing Study||0
8330801|NCT01366495|20536788|P1|STARTED|Testing Study||0
8330802|NCT01366443|20536802|P1|NOT COMPLETED|Overall Study||3
8330803|NCT01366443|20536802|P1|COMPLETED|Overall Study||285
8330804|NCT01366443|20536802|P1|STARTED|Overall Study||288
8330805|NCT01366417|20536807|P1|NOT COMPLETED|Overall Study||18
8330806|NCT01366417|20536807|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
8330807|NCT01366417|20536807|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
8330808|NCT01366417|20536807|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
8330809|NCT01366417|20536807|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
8330810|NCT01366417|20536807|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
8330811|NCT01366417|20536807|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
8330812|NCT01366417|20536807|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
8330813|NCT01366417|20536807|P1|STARTED|Overall Study||43
8330814|NCT01366209|20536816|P2|NOT COMPLETED|Overall Study||36
8330815|NCT01366209|20536817|P1|NOT COMPLETED|Overall Study||35
8330816|NCT01366209|20536816|P2|COMPLETED|Overall Study||241
8330817|NCT01366209|20536817|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
8330818|NCT01366209|20536816|P2|STARTED|Overall Study||277
8330819|NCT01366209|20536817|P1|STARTED|Overall Study||278
8330820|NCT01366196|20536825|P2|NOT COMPLETED|Overall Study||0
8330821|NCT01366196|20536826|P1|NOT COMPLETED|Overall Study||0
8330822|NCT01366196|20536825|P2|COMPLETED|Overall Study||43
8330823|NCT01366196|20536826|P1|COMPLETED|Overall Study||43
8330824|NCT01366196|20536825|P2|STARTED|Overall Study||43
8330825|NCT01366196|20536826|P1|STARTED|Overall Study||43
8330826|NCT01365910|20536840|P1|NOT COMPLETED|Overall Study||30
8330827|NCT01365910|20536840|P1|COMPLETED|Overall Study||0
8330828|NCT01365910|20536840|P1|STARTED|Overall Study||30
8330829|NCT01365845|20536847|P3|NOT COMPLETED|Treatment Phase||0
8330830|NCT01365845|20536848|P2|NOT COMPLETED|Treatment Phase||0
8330831|NCT01365845|20536849|P1|NOT COMPLETED|Treatment Phase||0
8330832|NCT01365845|20536847|P3|COMPLETED|Treatment Phase||18
8330833|NCT01365845|20536848|P2|COMPLETED|Treatment Phase||0
8330834|NCT01365845|20536849|P1|COMPLETED|Treatment Phase||0
8330835|NCT01365845|20536847|P3|STARTED|Treatment Phase||18
8330836|NCT01365845|20536848|P2|STARTED|Treatment Phase||0
8330837|NCT01365845|20536849|P1|STARTED|Treatment Phase||0
8330838|NCT01365845|20536847|P3|NOT COMPLETED|Induction Phase||0
8330839|NCT01365845|20536848|P2|NOT COMPLETED|Induction Phase||0
8330840|NCT01365845|20536849|P1|NOT COMPLETED|Induction Phase||0
8330841|NCT01365845|20536847|P3|COMPLETED|Induction Phase||0
8330842|NCT01365845|20536848|P2|COMPLETED|Induction Phase||0
8330843|NCT01365845|20536849|P1|COMPLETED|Induction Phase||18
8330844|NCT01365845|20536847|P3|STARTED|Induction Phase||0
8330845|NCT01365845|20536848|P2|STARTED|Induction Phase||0
8330846|NCT01365845|20536849|P1|STARTED|Induction Phase||18
8330847|NCT01365819|20536856|P2|NOT COMPLETED|Overall Study||13
8330848|NCT01365819|20536857|P1|NOT COMPLETED|Overall Study||13
8330849|NCT01365819|20536856|P2|COMPLETED|Overall Study||14
8330850|NCT01365819|20536857|P1|COMPLETED|Overall Study||12
8330851|NCT01365819|20536856|P2|STARTED|Overall Study||27
8330852|NCT01365819|20536857|P1|STARTED|Overall Study||25
8330853|NCT01365793|20536875|P4|NOT COMPLETED|Overall Study||2
8330854|NCT01365793|20536876|P3|NOT COMPLETED|Overall Study||7
8330855|NCT01365793|20536877|P2|NOT COMPLETED|Overall Study||7
8330856|NCT01365793|20536878|P1|NOT COMPLETED|Overall Study||2
8330857|NCT01365793|20536875|P4|COMPLETED|Overall Study||347
8330858|NCT01365793|20536876|P3|COMPLETED|Overall Study||338
8330859|NCT01365793|20536877|P2|COMPLETED|Overall Study||344
8330860|NCT01365793|20536878|P1|COMPLETED|Overall Study||342
8330861|NCT01365793|20536875|P4|STARTED|Overall Study||349
8330862|NCT01365793|20536876|P3|STARTED|Overall Study||345
8330863|NCT01365793|20536877|P2|STARTED|Overall Study||351
8330864|NCT01365793|20536878|P1|STARTED|Overall Study||344
8330865|NCT01365650|20536904|P1|NOT COMPLETED|Treatment C||0
8330866|NCT01365650|20536904|P1|COMPLETED|Treatment C||24
8330867|NCT01365650|20536904|P1|STARTED|Treatment C||24
8330868|NCT01365650|20536904|P1|NOT COMPLETED|Treatment B||0
8330869|NCT01365650|20536904|P1|COMPLETED|Treatment B||24
8330870|NCT01365650|20536904|P1|STARTED|Treatment B||24
8330871|NCT01365650|20536904|P1|NOT COMPLETED|Treatment A||0
8330872|NCT01365650|20536904|P1|COMPLETED|Treatment A||24
8330873|NCT01365650|20536904|P1|STARTED|Treatment A||24
8330874|NCT01365624|20536929|P2|NOT COMPLETED|Overall Study||0
8330875|NCT01365624|20536930|P1|NOT COMPLETED|Overall Study||0
8330876|NCT01365624|20536929|P2|COMPLETED|Overall Study||15
8330877|NCT01365624|20536930|P1|COMPLETED|Overall Study||15
8330878|NCT01365624|20536929|P2|STARTED|Overall Study||15
8330879|NCT01365624|20536930|P1|STARTED|Overall Study||15
8330880|NCT01365611|20536946|P1|NOT COMPLETED|Overall Study||0
8330881|NCT01365611|20536946|P1|COMPLETED|Overall Study||36
8330882|NCT01365611|20536946|P1|STARTED|Overall Study||36
8330886|NCT01365546|20536976|P1|NOT COMPLETED|Overall Study||11
8330887|NCT01365546|20536976|P1|COMPLETED|Overall Study||30
8330888|NCT01365546|20536976|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
8330889|NCT01365507|20536986|P2|NOT COMPLETED|Overall Study||9
8330890|NCT01365507|20536987|P1|NOT COMPLETED|Overall Study||9
8330891|NCT01365507|20536986|P2|COMPLETED|Overall Study||131
8330892|NCT01365507|20536987|P1|COMPLETED|Overall Study||127
8330893|NCT01365507|20536986|P2|Exposed|Overall Study||140
8330894|NCT01365507|20536987|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
8330895|NCT01365507|20536986|P2|STARTED|Overall Study||140
8330896|NCT01365507|20536987|P1|STARTED|Overall Study||136
8330897|NCT01365494|20537003|P2|NOT COMPLETED|Overall Study||3
8330898|NCT01365494|20537004|P1|NOT COMPLETED|Overall Study||2
8330899|NCT01365494|20537003|P2|COMPLETED|Overall Study||121
8330900|NCT01365494|20537004|P1|COMPLETED|Overall Study||124
8330901|NCT01365494|20537003|P2|STARTED|Overall Study||124
8330902|NCT01365494|20537004|P1|STARTED|Overall Study||126
8330903|NCT01365481|20537020|P4|NOT COMPLETED|Overall Study||7
8330904|NCT01365481|20537021|P3|NOT COMPLETED|Overall Study||4
8330905|NCT01365481|20537022|P2|NOT COMPLETED|Overall Study||15
8330906|NCT01365481|20537023|P1|NOT COMPLETED|Overall Study||7
8330907|NCT01365481|20537020|P4|COMPLETED|Overall Study||50
8330908|NCT01365481|20537021|P3|COMPLETED|Overall Study||14
8330909|NCT01365481|20537022|P2|COMPLETED|Overall Study||37
8330910|NCT01365481|20537023|P1|COMPLETED|Overall Study||16
8330911|NCT01365481|20537020|P4|STARTED|Overall Study||57
8330912|NCT01365481|20537021|P3|STARTED|Overall Study||18
8330913|NCT01365481|20537022|P2|STARTED|Overall Study||52
8330914|NCT01365481|20537023|P1|STARTED|Overall Study||23
8330915|NCT01365468|20537043|P2|NOT COMPLETED|Overall Study||0
8330916|NCT01365468|20537044|P1|NOT COMPLETED|Overall Study||4
8330917|NCT01365468|20537043|P2|COMPLETED|Overall Study||5
8330918|NCT01365468|20537044|P1|COMPLETED|Overall Study||0
8330919|NCT01365468|20537043|P2|STARTED|Overall Study||5
8330920|NCT01365468|20537044|P1|STARTED|Overall Study||4
8330921|NCT01365455|20537059|P5|NOT COMPLETED|Follow-up Period||0
8330922|NCT01365455|20537060|P4|NOT COMPLETED|Follow-up Period||0
8330923|NCT01365455|20537061|P3|NOT COMPLETED|Follow-up Period||0
8330924|NCT01365455|20537062|P2|NOT COMPLETED|Follow-up Period||0
8330925|NCT01365455|20537063|P1|NOT COMPLETED|Follow-up Period||0
8330926|NCT01365455|20537059|P5|COMPLETED|Follow-up Period||0
8330927|NCT01365455|20537060|P4|COMPLETED|Follow-up Period||0
8330928|NCT01365455|20537061|P3|COMPLETED|Follow-up Period||18
8330929|NCT01365455|20537062|P2|COMPLETED|Follow-up Period||47
8330930|NCT01365455|20537063|P1|COMPLETED|Follow-up Period||58
8330931|NCT01365455|20537059|P5|STARTED|Follow-up Period||0
8330932|NCT01365455|20537060|P4|STARTED|Follow-up Period||0
8330933|NCT01365455|20537061|P3|STARTED|Follow-up Period||18
8330934|NCT01365455|20537062|P2|STARTED|Follow-up Period||47
8330935|NCT01365455|20537063|P1|STARTED|Follow-up Period||58
8330936|NCT01365455|20537059|P5|NOT COMPLETED|Maintenance Period||13
8330937|NCT01365455|20537060|P4|NOT COMPLETED|Maintenance Period||9
8330938|NCT01365455|20537061|P3|NOT COMPLETED|Maintenance Period||3
8330939|NCT01365455|20537062|P2|NOT COMPLETED|Maintenance Period||23
8330940|NCT01365455|20537063|P1|NOT COMPLETED|Maintenance Period||29
8330941|NCT01365455|20537059|P5|COMPLETED|Maintenance Period||92
8330942|NCT01365455|20537060|P4|COMPLETED|Maintenance Period||100
8330943|NCT01365455|20537061|P3|COMPLETED|Maintenance Period||15
8330944|NCT01365455|20537062|P2|COMPLETED|Maintenance Period||215
8330945|NCT01365455|20537063|P1|COMPLETED|Maintenance Period||201
8330946|NCT01365455|20537059|P5|STARTED|Maintenance Period||105
8330947|NCT01365455|20537060|P4|STARTED|Maintenance Period||109
8330948|NCT01365455|20537061|P3|STARTED|Maintenance Period||18
8330949|NCT01365455|20537062|P2|STARTED|Maintenance Period||238
8330950|NCT01365455|20537063|P1|STARTED|Maintenance Period||230
8330951|NCT01365455|20537059|P5|NOT COMPLETED|Induction Period||0
8330952|NCT01365455|20537060|P4|NOT COMPLETED|Induction Period||0
8330953|NCT01365455|20537061|P3|NOT COMPLETED|Induction Period||16
8330954|NCT01365455|20537062|P2|NOT COMPLETED|Induction Period||7
8330955|NCT01365455|20537063|P1|NOT COMPLETED|Induction Period||15
8330956|NCT01365455|20537059|P5|COMPLETED|Induction Period||0
8330957|NCT01365455|20537060|P4|COMPLETED|Induction Period||0
8330958|NCT01365455|20537061|P3|COMPLETED|Induction Period||232
8330959|NCT01365455|20537062|P2|COMPLETED|Induction Period||238
8330960|NCT01365455|20537063|P1|COMPLETED|Induction Period||230
8330961|NCT01365455|20537059|P5|STARTED|Induction Period||0
8330962|NCT01365455|20537060|P4|STARTED|Induction Period||0
8330963|NCT01365455|20537061|P3|STARTED|Induction Period||248
8330964|NCT01365455|20537062|P2|STARTED|Induction Period||245
8330965|NCT01365455|20537063|P1|STARTED|Induction Period||245
8330966|NCT01365273|20537153|P2|NOT COMPLETED|Overall Study||1
8330967|NCT01365273|20537154|P1|NOT COMPLETED|Overall Study||2
8330968|NCT01365273|20537153|P2|COMPLETED|Overall Study||20
8330969|NCT01365273|20537154|P1|COMPLETED|Overall Study||20
8330970|NCT01365273|20537153|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
8330971|NCT01365273|20537154|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
8330972|NCT01365273|20537153|P2|STARTED|Overall Study||21
8330973|NCT01365273|20537154|P1|STARTED|Overall Study||22
8330974|NCT01365130|20537164|P1|NOT COMPLETED|Overall Study||2
8330975|NCT01365130|20537164|P1|COMPLETED|Overall Study||13
8330976|NCT01365130|20537164|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
8330977|NCT01365091|20537173|P4|NOT COMPLETED|Period 2||0
8330978|NCT01365091|20537174|P3|NOT COMPLETED|Period 2||1
8330979|NCT01365091|20537175|P2|NOT COMPLETED|Period 2||0
8330980|NCT01365091|20537176|P1|NOT COMPLETED|Period 2||1
8330981|NCT01365091|20537173|P4|COMPLETED|Period 2||25
8330982|NCT01365091|20537174|P3|COMPLETED|Period 2||24
8330983|NCT01365091|20537175|P2|COMPLETED|Period 2||26
8330984|NCT01365091|20537176|P1|COMPLETED|Period 2||25
8330985|NCT01365091|20537173|P4|STARTED|Period 2||25
8330986|NCT01365091|20537174|P3|STARTED|Period 2||25
8330987|NCT01365091|20537175|P2|STARTED|Period 2||26
8330988|NCT01365091|20537176|P1|STARTED|Period 2||26
8330989|NCT01365091|20537173|P4|NOT COMPLETED|Period 1||3
8330990|NCT01365091|20537174|P3|NOT COMPLETED|Period 1||3
8330991|NCT01365091|20537175|P2|NOT COMPLETED|Period 1||2
8330992|NCT01365091|20537176|P1|NOT COMPLETED|Period 1||2
8330993|NCT01365091|20537173|P4|COMPLETED|Period 1||25
8330994|NCT01365091|20537174|P3|COMPLETED|Period 1||25
8330995|NCT01365091|20537175|P2|COMPLETED|Period 1||26
8330996|NCT01365091|20537176|P1|COMPLETED|Period 1||26
8330997|NCT01365091|20537173|P4|STARTED|Period 1||28
8330998|NCT01365091|20537174|P3|STARTED|Period 1||28
8330999|NCT01365091|20537175|P2|STARTED|Period 1||28
8331000|NCT01365091|20537176|P1|STARTED|Period 1||28
8331001|NCT01365052|20537204|P2|NOT COMPLETED|Overall Study||4
8331002|NCT01365052|20537205|P1|NOT COMPLETED|Overall Study||4
8331003|NCT01365052|20537204|P2|COMPLETED|Overall Study||105
8331004|NCT01365052|20537205|P1|COMPLETED|Overall Study||213
8331005|NCT01365052|20537204|P2|STARTED|Overall Study||109
8331006|NCT01365052|20537205|P1|STARTED|Overall Study||217
8331007|NCT01365039|20537221|P2|NOT COMPLETED|Overall Study||0
8331008|NCT01365039|20537222|P1|NOT COMPLETED|Overall Study||1
8331009|NCT01365039|20537221|P2|COMPLETED|Overall Study||87
8331010|NCT01365039|20537222|P1|COMPLETED|Overall Study||85
8331011|NCT01365039|20537221|P2|STARTED|Overall Study||87
8331012|NCT01365039|20537222|P1|STARTED|Overall Study||86
8331013|NCT01364922|20537233|P3|NOT COMPLETED|Double-Blind (DB) Period||5
8331014|NCT01364922|20537234|P2|NOT COMPLETED|Double-Blind (DB) Period||5
8331015|NCT01364922|20537235|P1|NOT COMPLETED|Double-Blind (DB) Period||0
8331016|NCT01364922|20537233|P3|COMPLETED|Double-Blind (DB) Period||42
8331017|NCT01364922|20537234|P2|COMPLETED|Double-Blind (DB) Period||94
8331018|NCT01364922|20537235|P1|COMPLETED|Double-Blind (DB) Period||0
8331019|NCT01364922|20537233|P3|STARTED|Double-Blind (DB) Period||47
8331020|NCT01364922|20537234|P2|STARTED|Double-Blind (DB) Period||99
8331021|NCT01364922|20537235|P1|STARTED|Double-Blind (DB) Period||0
8331022|NCT01364922|20537233|P3|NOT COMPLETED|Open-label (OL) Period||0
8331023|NCT01364922|20537234|P2|NOT COMPLETED|Open-label (OL) Period||0
8331024|NCT01364922|20537235|P1|NOT COMPLETED|Open-label (OL) Period||22
8331025|NCT01364922|20537233|P3|COMPLETED|Open-label (OL) Period||0
8331026|NCT01364922|20537234|P2|COMPLETED|Open-label (OL) Period||0
8331027|NCT01364922|20537235|P1|COMPLETED|Open-label (OL) Period||146
8331028|NCT01364922|20537233|P3|STARTED|Open-label (OL) Period||0
8331029|NCT01364922|20537234|P2|STARTED|Open-label (OL) Period||0
8331030|NCT01364922|20537235|P1|STARTED|Open-label (OL) Period||168
8331031|NCT01364896|20537246|P1|NOT COMPLETED|Overall Study||0
8331032|NCT01364896|20537246|P1|COMPLETED|Overall Study||46
8331033|NCT01364896|20537246|P1|STARTED|Overall Study||46
8331034|NCT01364870|20537257|P3|NOT COMPLETED|Overall Study||14
8331035|NCT01364870|20537258|P2|NOT COMPLETED|Overall Study||30
8331036|NCT01364870|20537259|P1|NOT COMPLETED|Overall Study||22
8331037|NCT01364870|20537257|P3|COMPLETED|Overall Study||58
8331038|NCT01364870|20537258|P2|COMPLETED|Overall Study||93
8331039|NCT01364870|20537259|P1|COMPLETED|Overall Study||100
8331040|NCT01364870|20537257|P3|STARTED|Overall Study||72
8331041|NCT01364870|20537258|P2|STARTED|Overall Study||123
8331042|NCT01364870|20537259|P1|STARTED|Overall Study||122
8331043|NCT01364740|20537270|P1|NOT COMPLETED|Overall Study||0
8331044|NCT01364740|20537270|P1|COMPLETED|Overall Study||10
8331045|NCT01364740|20537270|P1|STARTED|Overall Study||10
8331046|NCT01364727|20537278|P1|NOT COMPLETED|Overall Study||2
8331047|NCT01364727|20537278|P1|COMPLETED|Overall Study||33
8331048|NCT01364727|20537278|P1|STARTED|Overall Study||35
8331049|NCT01364649|20537286|P2|NOT COMPLETED|Overall Study||43
8331050|NCT01364649|20537287|P1|NOT COMPLETED|Overall Study||56
8331051|NCT01364649|20537286|P2|COMPLETED|Overall Study||179
8331052|NCT01364649|20537287|P1|COMPLETED|Overall Study||169
8331053|NCT01364649|20537286|P2|STARTED|Overall Study||222
8331054|NCT01364649|20537287|P1|STARTED|Overall Study||225
8331055|NCT01364623|20537300|P4|NOT COMPLETED|Multiple Dose||0
8331056|NCT01364623|20537301|P3|NOT COMPLETED|Multiple Dose||0
8331057|NCT01364623|20537302|P2|NOT COMPLETED|Multiple Dose||0
8331058|NCT01364623|20537303|P1|NOT COMPLETED|Multiple Dose||0
8331059|NCT01364623|20537300|P4|COMPLETED|Multiple Dose||8
8331060|NCT01364623|20537301|P3|COMPLETED|Multiple Dose||0
8331061|NCT01364623|20537302|P2|COMPLETED|Multiple Dose||0
8331062|NCT01364623|20537303|P1|COMPLETED|Multiple Dose||0
8331063|NCT01364623|20537300|P4|STARTED|Multiple Dose||8
8331064|NCT01364623|20537301|P3|STARTED|Multiple Dose||0
8331065|NCT01364623|20537302|P2|STARTED|Multiple Dose||0
8331066|NCT01364623|20537303|P1|STARTED|Multiple Dose||0
8331067|NCT01364623|20537300|P4|NOT COMPLETED|Single Dose||0
8331068|NCT01364623|20537301|P3|NOT COMPLETED|Single Dose||0
8331069|NCT01364623|20537302|P2|NOT COMPLETED|Single Dose||0
8331070|NCT01364623|20537303|P1|NOT COMPLETED|Single Dose||0
8331071|NCT01364623|20537300|P4|COMPLETED|Single Dose||0
8331072|NCT01364623|20537301|P3|COMPLETED|Single Dose||8
8331073|NCT01364623|20537302|P2|COMPLETED|Single Dose||8
8331074|NCT01364623|20537303|P1|COMPLETED|Single Dose||8
8331075|NCT01364623|20537300|P4|STARTED|Single Dose||0
8331076|NCT01364623|20537301|P3|STARTED|Single Dose||8
8331077|NCT01364623|20537302|P2|STARTED|Single Dose||8
8331078|NCT01364623|20537303|P1|STARTED|Single Dose||8
8331079|NCT01364584|20537328|P2|NOT COMPLETED|Overall Study||0
8331080|NCT01364584|20537329|P1|NOT COMPLETED|Overall Study||0
8331081|NCT01364584|20537328|P2|COMPLETED|Overall Study||12
8331082|NCT01364584|20537329|P1|COMPLETED|Overall Study||11
8331083|NCT01364584|20537328|P2|STARTED|Overall Study||12
8331084|NCT01364584|20537329|P1|STARTED|Overall Study||11
8331085|NCT01364558|20537363|P3|NOT COMPLETED|Dose Three||0
8331086|NCT01364558|20537364|P2|NOT COMPLETED|Dose Three||0
8331087|NCT01364558|20537365|P1|NOT COMPLETED|Dose Three||0
8331088|NCT01364558|20537363|P3|COMPLETED|Dose Three||8
8331089|NCT01364558|20537364|P2|COMPLETED|Dose Three||8
8331090|NCT01364558|20537365|P1|COMPLETED|Dose Three||8
8331091|NCT01364558|20537363|P3|STARTED|Dose Three||8
8331092|NCT01364558|20537364|P2|STARTED|Dose Three||8
8331093|NCT01364558|20537365|P1|STARTED|Dose Three||8
8331094|NCT01364558|20537363|P3|NOT COMPLETED|Dose Two||0
8331095|NCT01364558|20537364|P2|NOT COMPLETED|Dose Two||0
8331096|NCT01364558|20537365|P1|NOT COMPLETED|Dose Two||0
8331097|NCT01364558|20537363|P3|COMPLETED|Dose Two||8
8331098|NCT01364558|20537364|P2|COMPLETED|Dose Two||8
8331099|NCT01364558|20537365|P1|COMPLETED|Dose Two||8
8331100|NCT01364558|20537363|P3|STARTED|Dose Two||8
8331101|NCT01364558|20537364|P2|STARTED|Dose Two||8
8331102|NCT01364558|20537365|P1|STARTED|Dose Two||8
8331103|NCT01364558|20537363|P3|NOT COMPLETED|Dose One||0
8331104|NCT01364558|20537364|P2|NOT COMPLETED|Dose One||0
8331105|NCT01364558|20537365|P1|NOT COMPLETED|Dose One||0
8331106|NCT01364558|20537363|P3|COMPLETED|Dose One||8
8331107|NCT01364558|20537364|P2|COMPLETED|Dose One||8
8331108|NCT01364558|20537365|P1|COMPLETED|Dose One||8
8331109|NCT01364558|20537363|P3|STARTED|Dose One||8
8331110|NCT01364558|20537364|P2|STARTED|Dose One||8
8331111|NCT01364558|20537365|P1|STARTED|Dose One||8
8331112|NCT01364467|20537375|P2|NOT COMPLETED|Overall Study||2
8331113|NCT01364467|20537376|P1|NOT COMPLETED|Overall Study||1
8331114|NCT01364467|20537375|P2|COMPLETED|Overall Study||18
8331115|NCT01364467|20537376|P1|COMPLETED|Overall Study||9
8331116|NCT01364467|20537375|P2|STARTED|Overall Study||20
8331117|NCT01364467|20537376|P1|STARTED|Overall Study||10
8331118|NCT01364428|20537388|P2|NOT COMPLETED|Overall Study||15
8331119|NCT01364428|20537389|P1|NOT COMPLETED|Overall Study||20
8331120|NCT01364428|20537388|P2|COMPLETED|Overall Study||172
8331121|NCT01364428|20537389|P1|COMPLETED|Overall Study||166
8331122|NCT01364428|20537388|P2|Exposed|Overall Study||187
8331123|NCT01364428|20537389|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
8331124|NCT01364428|20537388|P2|STARTED|Overall Study||187
8331125|NCT01364428|20537389|P1|STARTED|Overall Study||186
8331138|NCT01364298|20537427|P2|NOT COMPLETED|Overall Study||23
8331139|NCT01364298|20537428|P1|NOT COMPLETED|Overall Study||14
8331140|NCT01364298|20537427|P2|COMPLETED|Overall Study||154
8331141|NCT01364298|20537428|P1|COMPLETED|Overall Study||162
8331142|NCT01364298|20537427|P2|Treated|Overall Study||174
8331143|NCT01364298|20537428|P1|Treated|Overall Study||174
8331144|NCT01364298|20537427|P2|STARTED|Overall Study||177
8331145|NCT01364298|20537428|P1|STARTED|Overall Study||176
8331146|NCT01364259|20537452|P2|NOT COMPLETED|Overall Study||0
8331147|NCT01364259|20537453|P1|NOT COMPLETED|Overall Study||0
8331148|NCT01364259|20537452|P2|COMPLETED|Overall Study||8
8331149|NCT01364259|20537453|P1|COMPLETED|Overall Study||9
8331150|NCT01364259|20537452|P2|STARTED|Overall Study||8
8331151|NCT01364259|20537453|P1|STARTED|Overall Study||9
8331152|NCT01364233|20537461|P1|NOT COMPLETED|Overall Study||1
8331153|NCT01364233|20537461|P1|COMPLETED|Overall Study||9
8331154|NCT01364233|20537461|P1|STARTED|Overall Study||10
8331155|NCT01364207|20537465|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
8331156|NCT01364207|20537466|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
8331157|NCT01364207|20537465|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
8331158|NCT01364207|20537466|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
8331159|NCT01364207|20537465|P2|STARTED|Second Visit (~1.5-2 Hours)||54
8331160|NCT01364207|20537466|P1|STARTED|Second Visit (~1.5-2 Hours)||52
8331161|NCT01364207|20537465|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
8331162|NCT01364207|20537466|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
8331163|NCT01364207|20537465|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
8331164|NCT01364207|20537466|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
8331165|NCT01364207|20537465|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
8331166|NCT01364207|20537466|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
8331167|NCT01364207|20537465|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
8331168|NCT01364207|20537466|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
8331169|NCT01364207|20537465|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
8331170|NCT01364207|20537466|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
8331171|NCT01364207|20537465|P2|STARTED|First Visit (~1.5-2 Hours)||58
8331172|NCT01364207|20537466|P1|STARTED|First Visit (~1.5-2 Hours)||54
8331173|NCT01364090|20537477|P3|NOT COMPLETED|Overall Study||6
8331174|NCT01364090|20537478|P2|NOT COMPLETED|Overall Study||14
8331175|NCT01364090|20537479|P1|NOT COMPLETED|Overall Study||3
8331176|NCT01364090|20537477|P3|COMPLETED|Overall Study||0
8331177|NCT01364090|20537478|P2|COMPLETED|Overall Study||12
8331178|NCT01364090|20537479|P1|COMPLETED|Overall Study||58
8331179|NCT01364090|20537477|P3|STARTED|Overall Study||6
8331180|NCT01364090|20537478|P2|STARTED|Overall Study||26
8331181|NCT01364090|20537479|P1|STARTED|Overall Study||61
8331182|NCT01363999|20537487|P1|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
8331183|NCT01363999|20537487|P1|COMPLETED|D: RO4607381/ F49 Tablet||24
8331184|NCT01363999|20537487|P1|STARTED|D: RO4607381/ F49 Tablet||24
8331185|NCT01363999|20537487|P1|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
8331186|NCT01363999|20537487|P1|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
8331187|NCT01363999|20537487|P1|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
8331188|NCT01363999|20537487|P1|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
8331189|NCT01363999|20537487|P1|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
8331190|NCT01363999|20537487|P1|STARTED|B: RO5317116/F03 Bilayer Tablet||24
8331191|NCT01363999|20537487|P1|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
8331192|NCT01363999|20537487|P1|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
8331193|NCT01363999|20537487|P1|STARTED|A: RO5317116/F01 Bilayer Tablet||24
8331194|NCT01363986|20537506|P1|NOT COMPLETED|Overall Study||1
8331195|NCT01363986|20537506|P1|COMPLETED|Overall Study||2
8331196|NCT01363986|20537506|P1|STARTED|Overall Study||3
8331197|NCT01363908|20537516|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
8331198|NCT01363908|20537517|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
8331199|NCT01363908|20537516|P2|COMPLETED|Chronic Dosing (CD) Phase||10
8331200|NCT01363908|20537517|P1|COMPLETED|Chronic Dosing (CD) Phase||3
8331201|NCT01363908|20537516|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
8331202|NCT01363908|20537517|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
8331203|NCT01363908|20537516|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
8331204|NCT01363908|20537517|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
8331205|NCT01363908|20537516|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
8331206|NCT01363908|20537517|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
8331207|NCT01363908|20537516|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
8331208|NCT01363908|20537517|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
8331209|NCT01363908|20537516|P2|NOT COMPLETED|Screening/Enrollment||0
8331210|NCT01363908|20537517|P1|NOT COMPLETED|Screening/Enrollment||1
8331211|NCT01363908|20537516|P2|COMPLETED|Screening/Enrollment||16
8331212|NCT01363908|20537517|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
8331213|NCT01363908|20537516|P2|STARTED|Screening/Enrollment||16
8331214|NCT01363908|20537517|P1|STARTED|Screening/Enrollment||14
8331215|NCT01363843|20537547|P1|NOT COMPLETED|Overall Study||1
8331216|NCT01363843|20537547|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
8331217|NCT01363843|20537547|P1|STARTED|Overall Study||39
8331218|NCT01363765|20537554|P2|NOT COMPLETED|Overall Study||4731
8331219|NCT01363765|20537555|P1|NOT COMPLETED|Overall Study||5800
8331220|NCT01363765|20537554|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
8331221|NCT01363765|20537555|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
8331222|NCT01363765|20537554|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
8331223|NCT01363765|20537555|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
8331224|NCT01363713|20537567|P1|NOT COMPLETED|Overall Study||6
8331225|NCT01363713|20537567|P1|COMPLETED|Overall Study|Analysed (n=130)|124
8331226|NCT01363713|20537567|P1|ALLOCATED|Overall Study||130
8331227|NCT01363713|20537567|P1|STARTED|Overall Study|Assessed for eligibility|130
8331228|NCT01363700|20537576|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331229|NCT01363700|20537577|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331230|NCT01363700|20537578|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331231|NCT01363700|20537579|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331232|NCT01363700|20537580|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331233|NCT01363700|20537576|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
8331234|NCT01363700|20537577|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
8331235|NCT01363700|20537578|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
8331236|NCT01363700|20537579|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
8331237|NCT01363700|20537580|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
8331238|NCT01363700|20537576|P5|STARTED|Epinastine vs Olopatadine Period2||43
8331239|NCT01363700|20537577|P4|STARTED|Epinastine vs Olopatadine Period2||43
8331240|NCT01363700|20537578|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8331241|NCT01363700|20537579|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8331242|NCT01363700|20537580|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8331243|NCT01363700|20537576|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331244|NCT01363700|20537577|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331245|NCT01363700|20537578|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331246|NCT01363700|20537579|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
8331247|NCT01363700|20537580|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331248|NCT01363700|20537576|P5|COMPLETED|Epinastine vs Placebo Period1||0
8331249|NCT01363700|20537577|P4|COMPLETED|Epinastine vs Placebo Period1||0
8331250|NCT01363700|20537578|P3|COMPLETED|Epinastine vs Placebo Period1||22
8331251|NCT01363700|20537579|P2|COMPLETED|Epinastine vs Placebo Period1||21
8331252|NCT01363700|20537580|P1|COMPLETED|Epinastine vs Placebo Period1||43
8331253|NCT01363700|20537576|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
8331254|NCT01363700|20537577|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
8331255|NCT01363700|20537578|P3|STARTED|Epinastine vs Placebo Period1||22
8331256|NCT01363700|20537579|P2|STARTED|Epinastine vs Placebo Period1||22
8331257|NCT01363700|20537580|P1|STARTED|Epinastine vs Placebo Period1||43
8331258|NCT01363661|20537599|P2|NOT COMPLETED|Overall Study||4
8331259|NCT01363661|20537600|P1|NOT COMPLETED|Overall Study||14
8331260|NCT01363661|20537599|P2|COMPLETED|Overall Study||28
8331261|NCT01363661|20537600|P1|COMPLETED|Overall Study||18
8331262|NCT01363661|20537599|P2|STARTED|Overall Study||32
8331263|NCT01363661|20537600|P1|STARTED|Overall Study||32
8331264|NCT01363492|20537616|P1|NOT COMPLETED|Overall Study||0
8331265|NCT01363492|20537616|P1|COMPLETED|Overall Study||14
8331266|NCT01363492|20537616|P1|STARTED|Overall Study||14
8331267|NCT01363479|20537631|P2|NOT COMPLETED|Overall Study||21
8331268|NCT01363479|20537632|P1|NOT COMPLETED|Overall Study||12
8331269|NCT01363479|20537631|P2|COMPLETED|Overall Study||351
8331270|NCT01363479|20537632|P1|COMPLETED|Overall Study||359
8331271|NCT01363479|20537631|P2|STARTED|Overall Study|number of randomised patients|372
8331272|NCT01363479|20537632|P1|STARTED|Overall Study|number of randomised patients|371
8331273|NCT01363440|20537641|P3|NOT COMPLETED|Overall Study||27
8331274|NCT01363440|20537642|P2|NOT COMPLETED|Overall Study||31
8331275|NCT01363440|20537643|P1|NOT COMPLETED|Overall Study||23
8331276|NCT01363440|20537641|P3|COMPLETED|Overall Study|Completed Week 100|127
8331277|NCT01363440|20537642|P2|COMPLETED|Overall Study|Completed Week 100|125
8331278|NCT01363440|20537643|P1|COMPLETED|Overall Study|Completed Week 100|133
8331279|NCT01363440|20537641|P3|Completed Week 100|Overall Study||127
8331280|NCT01363440|20537642|P2|Completed Week 100|Overall Study||125
8331281|NCT01363440|20537643|P1|Completed Week 100|Overall Study||133
8331282|NCT01363440|20537641|P3|Completed Week 52|Overall Study||144
8331283|NCT01363440|20537642|P2|Completed Week 52|Overall Study||146
8331284|NCT01363440|20537643|P1|Completed Week 52|Overall Study||145
8331285|NCT01363440|20537641|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
8331286|NCT01363440|20537642|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
8331287|NCT01363440|20537643|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
8331288|NCT01363440|20537641|P3|STARTED|Overall Study|randomized|154
8331289|NCT01363440|20537642|P2|STARTED|Overall Study|randomized|156
8331290|NCT01363440|20537643|P1|STARTED|Overall Study|randomized|156
8331291|NCT01363401|20537674|P2|NOT COMPLETED|Overall Study||4
8331292|NCT01363401|20537675|P1|NOT COMPLETED|Overall Study||2
8331293|NCT01363401|20537674|P2|COMPLETED|Overall Study||27
8331294|NCT01363401|20537675|P1|COMPLETED|Overall Study||39
8331295|NCT01363401|20537674|P2|STARTED|Overall Study||31
8331296|NCT01363401|20537675|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
8331297|NCT01363388|20537690|P3|NOT COMPLETED|Overall Study||4
8331298|NCT01363388|20537691|P2|NOT COMPLETED|Overall Study||3
8331299|NCT01363388|20537692|P1|NOT COMPLETED|Overall Study||5
8331300|NCT01363388|20537690|P3|COMPLETED|Overall Study||18
8331301|NCT01363388|20537691|P2|COMPLETED|Overall Study||19
8331302|NCT01363388|20537692|P1|COMPLETED|Overall Study||18
8331303|NCT01363388|20537690|P3|STARTED|Overall Study||22
8331304|NCT01363388|20537691|P2|STARTED|Overall Study||22
8331305|NCT01363388|20537692|P1|STARTED|Overall Study||23
8331306|NCT01363349|20537702|P2|NOT COMPLETED|Overall Study||70
8331307|NCT01363349|20537703|P1|NOT COMPLETED|Overall Study||67
8331308|NCT01363349|20537702|P2|COMPLETED|Overall Study||66
8331309|NCT01363349|20537703|P1|COMPLETED|Overall Study||66
8331310|NCT01363349|20537702|P2|Randomized|Overall Study||136
8331311|NCT01363349|20537703|P1|Randomized|Overall Study||133
8331312|NCT01363349|20537702|P2|STARTED|Overall Study||136
8331313|NCT01363349|20537703|P1|STARTED|Overall Study||133
8331314|NCT01363297|20537714|P5|NOT COMPLETED|Overall Study||31
8331315|NCT01363297|20537715|P4|NOT COMPLETED|Overall Study||10
8331316|NCT01363297|20537716|P3|NOT COMPLETED|Overall Study||6
8331317|NCT01363297|20537717|P2|NOT COMPLETED|Overall Study||6
8331318|NCT01363297|20537718|P1|NOT COMPLETED|Overall Study||3
8331319|NCT01363297|20537714|P5|COMPLETED|Overall Study||4
8331320|NCT01363297|20537715|P4|COMPLETED|Overall Study||3
8331321|NCT01363297|20537716|P3|COMPLETED|Overall Study||3
8331322|NCT01363297|20537717|P2|COMPLETED|Overall Study||6
8331323|NCT01363297|20537718|P1|COMPLETED|Overall Study||0
8331324|NCT01363297|20537714|P5|STARTED|Overall Study||35
8331325|NCT01363297|20537715|P4|STARTED|Overall Study||13
8331326|NCT01363297|20537716|P3|STARTED|Overall Study||9
8331327|NCT01363297|20537717|P2|STARTED|Overall Study||12
8331328|NCT01363297|20537718|P1|STARTED|Overall Study||3
8331329|NCT01363258|20537810|P2|NOT COMPLETED|Overall Study||0
8331330|NCT01363258|20537811|P1|NOT COMPLETED|Overall Study||0
8331331|NCT01363258|20537810|P2|COMPLETED|Overall Study||46
8331332|NCT01363258|20537811|P1|COMPLETED|Overall Study||54
8331333|NCT01363258|20537810|P2|STARTED|Overall Study||46
8331334|NCT01363258|20537811|P1|STARTED|Overall Study||54
8331335|NCT01363076|20537821|P2|NOT COMPLETED|Overall Study||1
8331336|NCT01363076|20537822|P1|NOT COMPLETED|Overall Study||0
8331337|NCT01363076|20537821|P2|COMPLETED|Overall Study||12
8331338|NCT01363076|20537822|P1|COMPLETED|Overall Study||7
8331339|NCT01363076|20537821|P2|STARTED|Overall Study||13
8331340|NCT01363076|20537822|P1|STARTED|Overall Study||7
8331341|NCT01363050|20537840|P1|NOT COMPLETED|Overall Study||0
8331342|NCT01363050|20537840|P1|COMPLETED|Overall Study||15
8331343|NCT01363050|20537840|P1|STARTED|Overall Study||15
8331344|NCT01363011|20537854|P2|NOT COMPLETED|Extension Phase||8
8331345|NCT01363011|20537855|P1|NOT COMPLETED|Extension Phase||5
8331346|NCT01363011|20537854|P2|COMPLETED|Extension Phase||41
8331347|NCT01363011|20537855|P1|COMPLETED|Extension Phase||13
8331348|NCT01363011|20537854|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
8331349|NCT01363011|20537855|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
8331350|NCT01363011|20537854|P2|NOT COMPLETED|Main Study||9
8331351|NCT01363011|20537855|P1|NOT COMPLETED|Main Study||4
8331352|NCT01363011|20537854|P2|COMPLETED|Main Study||64
8331353|NCT01363011|20537855|P1|COMPLETED|Main Study||29
8331354|NCT01363011|20537854|P2|STARTED|Main Study||73
8331355|NCT01363011|20537855|P1|STARTED|Main Study||33
8331356|NCT01362959|20537897|P2|NOT COMPLETED|Overall Study||0
8331357|NCT01362959|20537898|P1|NOT COMPLETED|Overall Study||0
8331358|NCT01362959|20537897|P2|COMPLETED|Overall Study||26
8331359|NCT01362959|20537898|P1|COMPLETED|Overall Study||21
8331360|NCT01362959|20537897|P2|STARTED|Overall Study||26
8331361|NCT01362959|20537898|P1|STARTED|Overall Study||21
8331362|NCT01362946|20537912|P2|NOT COMPLETED|Second Behavior Modification Block||0
8331363|NCT01362946|20537913|P1|NOT COMPLETED|Second Behavior Modification Block||0
8331364|NCT01362946|20537912|P2|COMPLETED|Second Behavior Modification Block||24
8331365|NCT01362946|20537913|P1|COMPLETED|Second Behavior Modification Block||23
8331366|NCT01362946|20537912|P2|STARTED|Second Behavior Modification Block||24
8331367|NCT01362946|20537913|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
8331368|NCT01362946|20537912|P2|NOT COMPLETED|First Behavior Modification Block||0
8331369|NCT01362946|20537913|P1|NOT COMPLETED|First Behavior Modification Block||0
8331370|NCT01362946|20537912|P2|COMPLETED|First Behavior Modification Block||24
8331371|NCT01362946|20537913|P1|COMPLETED|First Behavior Modification Block||24
8331372|NCT01362946|20537912|P2|STARTED|First Behavior Modification Block||24
8331373|NCT01362946|20537913|P1|STARTED|First Behavior Modification Block||24
8331374|NCT01362907|20537946|P2|NOT COMPLETED|Period 2, One Week||0
8331375|NCT01362907|20537947|P1|NOT COMPLETED|Period 2, One Week||0
8331376|NCT01362907|20537946|P2|COMPLETED|Period 2, One Week||20
8331377|NCT01362907|20537947|P1|COMPLETED|Period 2, One Week||20
8331378|NCT01362907|20537946|P2|STARTED|Period 2, One Week||20
8331379|NCT01362907|20537947|P1|STARTED|Period 2, One Week||20
8331380|NCT01362907|20537946|P2|NOT COMPLETED|Period 1, One Week||0
8331381|NCT01362907|20537947|P1|NOT COMPLETED|Period 1, One Week||0
8331382|NCT01362907|20537946|P2|COMPLETED|Period 1, One Week||20
8331383|NCT01362907|20537947|P1|COMPLETED|Period 1, One Week||20
8331384|NCT01362907|20537946|P2|STARTED|Period 1, One Week||20
8331385|NCT01362907|20537947|P1|STARTED|Period 1, One Week||20
8331386|NCT01362894|20537961|P2|NOT COMPLETED|Period Two, 1 Week||0
8331387|NCT01362894|20537962|P1|NOT COMPLETED|Period Two, 1 Week||0
8331388|NCT01362894|20537961|P2|COMPLETED|Period Two, 1 Week||115
8331389|NCT01362894|20537962|P1|COMPLETED|Period Two, 1 Week||118
8331390|NCT01362894|20537961|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
8331391|NCT01362894|20537962|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
8331392|NCT01362894|20537961|P2|NOT COMPLETED|Period One, 1 Week||0
8331393|NCT01362894|20537962|P1|NOT COMPLETED|Period One, 1 Week||0
8331394|NCT01362894|20537961|P2|COMPLETED|Period One, 1 Week||117
8331395|NCT01362894|20537962|P1|COMPLETED|Period One, 1 Week||119
8331396|NCT01362894|20537961|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
8331397|NCT01362894|20537962|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
8331398|NCT01362790|20537982|P7|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331399|NCT01362790|20537983|P6|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331400|NCT01362790|20537984|P5|NOT COMPLETED|Dose De-escalation of Regimen A||6
8331401|NCT01362790|20537985|P4|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331402|NCT01362790|20537986|P3|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331403|NCT01362790|20537987|P2|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331404|NCT01362790|20537988|P1|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331405|NCT01362790|20537982|P7|COMPLETED|Dose De-escalation of Regimen A||0
8331406|NCT01362790|20537983|P6|COMPLETED|Dose De-escalation of Regimen A||0
8331407|NCT01362790|20537984|P5|COMPLETED|Dose De-escalation of Regimen A||2
8331408|NCT01362790|20537985|P4|COMPLETED|Dose De-escalation of Regimen A||0
8331409|NCT01362790|20537986|P3|COMPLETED|Dose De-escalation of Regimen A||0
8331410|NCT01362790|20537987|P2|COMPLETED|Dose De-escalation of Regimen A||0
8331411|NCT01362790|20537988|P1|COMPLETED|Dose De-escalation of Regimen A||0
8331412|NCT01362790|20537982|P7|STARTED|Dose De-escalation of Regimen A||0
8331413|NCT01362790|20537983|P6|STARTED|Dose De-escalation of Regimen A||0
8331414|NCT01362790|20537984|P5|STARTED|Dose De-escalation of Regimen A||8
8331415|NCT01362790|20537985|P4|STARTED|Dose De-escalation of Regimen A||0
8331416|NCT01362790|20537986|P3|STARTED|Dose De-escalation of Regimen A||0
8331417|NCT01362790|20537987|P2|STARTED|Dose De-escalation of Regimen A||0
8331418|NCT01362790|20537988|P1|STARTED|Dose De-escalation of Regimen A||0
8331419|NCT01362790|20537982|P7|NOT COMPLETED|Pilot Phase & Phase 2||0
8331420|NCT01362790|20537983|P6|NOT COMPLETED|Pilot Phase & Phase 2||4
8331421|NCT01362790|20537984|P5|NOT COMPLETED|Pilot Phase & Phase 2||0
8331422|NCT01362790|20537985|P4|NOT COMPLETED|Pilot Phase & Phase 2||14
8331423|NCT01362790|20537986|P3|NOT COMPLETED|Pilot Phase & Phase 2||5
8331424|NCT01362790|20537987|P2|NOT COMPLETED|Pilot Phase & Phase 2||8
8331425|NCT01362790|20537988|P1|NOT COMPLETED|Pilot Phase & Phase 2||10
8331426|NCT01362790|20537982|P7|COMPLETED|Pilot Phase & Phase 2||0
8331427|NCT01362790|20537983|P6|COMPLETED|Pilot Phase & Phase 2||0
8331428|NCT01362790|20537984|P5|COMPLETED|Pilot Phase & Phase 2||0
8331429|NCT01362790|20537985|P4|COMPLETED|Pilot Phase & Phase 2||1
8331430|NCT01362790|20537986|P3|COMPLETED|Pilot Phase & Phase 2||2
8331431|NCT01362790|20537987|P2|COMPLETED|Pilot Phase & Phase 2||0
8331432|NCT01362790|20537988|P1|COMPLETED|Pilot Phase & Phase 2||1
8331433|NCT01362790|20537982|P7|STARTED|Pilot Phase & Phase 2||0
8331434|NCT01362790|20537983|P6|STARTED|Pilot Phase & Phase 2||4
8331435|NCT01362790|20537984|P5|STARTED|Pilot Phase & Phase 2||0
8331436|NCT01362790|20537985|P4|STARTED|Pilot Phase & Phase 2||15
8331437|NCT01362790|20537986|P3|STARTED|Pilot Phase & Phase 2||7
8331438|NCT01362790|20537987|P2|STARTED|Pilot Phase & Phase 2||8
8331439|NCT01362790|20537988|P1|STARTED|Pilot Phase & Phase 2||11
8331440|NCT01362686|20538038|P3|NOT COMPLETED|Overall Study||10
8331441|NCT01362686|20538039|P2|NOT COMPLETED|Overall Study||12
8331442|NCT01362686|20538040|P1|NOT COMPLETED|Overall Study||8
8331443|NCT01362686|20538038|P3|COMPLETED|Overall Study||53
8331444|NCT01362686|20538039|P2|COMPLETED|Overall Study||54
8331445|NCT01362686|20538040|P1|COMPLETED|Overall Study||59
8331446|NCT01362686|20538038|P3|STARTED|Overall Study||63
8331447|NCT01362686|20538039|P2|STARTED|Overall Study||66
8331448|NCT01362686|20538040|P1|STARTED|Overall Study||67
8331449|NCT01362608|20538056|P2|NOT COMPLETED|Overall Study||8
8331450|NCT01362608|20538057|P1|NOT COMPLETED|Overall Study||4
8331451|NCT01362608|20538056|P2|COMPLETED|Overall Study||61
8331452|NCT01362608|20538057|P1|COMPLETED|Overall Study||63
8331453|NCT01362608|20538056|P2|STARTED|Overall Study||69
8331454|NCT01362608|20538057|P1|STARTED|Overall Study||67
8331455|NCT01362530|20538095|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
8331456|NCT01362530|20538096|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
8331457|NCT01362530|20538095|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
8331458|NCT01362530|20538096|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
8331459|NCT01362530|20538095|P2|STARTED|Optional Extension (Cycles 2-6)||0
8331460|NCT01362530|20538096|P1|STARTED|Optional Extension (Cycles 2-6)||171
8331461|NCT01362530|20538095|P2|NOT COMPLETED|Base Study (Cycle 1)||3
8331462|NCT01362530|20538096|P1|NOT COMPLETED|Base Study (Cycle 1)||5
8331463|NCT01362530|20538095|P2|COMPLETED|Base Study (Cycle 1)||149
8331464|NCT01362530|20538096|P1|COMPLETED|Base Study (Cycle 1)||150
8331465|NCT01362530|20538095|P2|Received Study Treatment|Base Study (Cycle 1)||150
8331466|NCT01362530|20538096|P1|Received Study Treatment|Base Study (Cycle 1)||152
8331467|NCT01362530|20538095|P2|STARTED|Base Study (Cycle 1)||152
8331468|NCT01362530|20538096|P1|STARTED|Base Study (Cycle 1)||155
8331469|NCT01362517|20538109|P1|NOT COMPLETED|Overall Study||2
8331470|NCT01362517|20538109|P1|COMPLETED|Overall Study||129
8331471|NCT01362517|20538109|P1|STARTED|Overall Study||131
8331472|NCT01362491|20538120|P3|NOT COMPLETED|Overall Study||0
8331473|NCT01362491|20538121|P2|NOT COMPLETED|Overall Study||0
8331474|NCT01362491|20538122|P1|NOT COMPLETED|Overall Study||1
8331475|NCT01362491|20538120|P3|COMPLETED|Overall Study||46
8331476|NCT01362491|20538121|P2|COMPLETED|Overall Study||89
8331477|NCT01362491|20538122|P1|COMPLETED|Overall Study||90
8331478|NCT01362491|20538120|P3|STARTED|Overall Study||46
8331479|NCT01362491|20538121|P2|STARTED|Overall Study||89
8331480|NCT01362491|20538122|P1|STARTED|Overall Study||91
8331481|NCT01362439|20538170|P1|NOT COMPLETED|Overall Study||15
8331482|NCT01362439|20538170|P1|COMPLETED|Overall Study||118
8331483|NCT01362439|20538170|P1|STARTED|Overall Study||133
8331484|NCT01362348|20538185|P1|NOT COMPLETED|Overall Study||14
8331485|NCT01362348|20538185|P1|COMPLETED|Overall Study||5
8331486|NCT01362348|20538185|P1|STARTED|Overall Study||19
8331487|NCT01362322|20538204|P2|NOT COMPLETED|Overall Study||7
8331488|NCT01362322|20538205|P1|NOT COMPLETED|Overall Study||5
8331489|NCT01362322|20538204|P2|COMPLETED|Overall Study||329
8331490|NCT01362322|20538205|P1|COMPLETED|Overall Study||330
8331491|NCT01362322|20538204|P2|STARTED|Overall Study||336
8331492|NCT01362322|20538205|P1|STARTED|Overall Study||335
8331493|NCT01362296|20538237|P4|NOT COMPLETED|Crossover Phase||2
8331494|NCT01362296|20538238|P3|NOT COMPLETED|Crossover Phase||23
8331495|NCT01362296|20538239|P2|NOT COMPLETED|Crossover Phase||0
8331496|NCT01362296|20538240|P1|NOT COMPLETED|Crossover Phase||0
8331497|NCT01362296|20538237|P4|COMPLETED|Crossover Phase||0
8331498|NCT01362296|20538238|P3|COMPLETED|Crossover Phase||0
8331499|NCT01362296|20538239|P2|COMPLETED|Crossover Phase||0
8331500|NCT01362296|20538240|P1|COMPLETED|Crossover Phase||0
8331501|NCT01362296|20538237|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
8331502|NCT01362296|20538238|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
8331503|NCT01362296|20538239|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
8331504|NCT01362296|20538240|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
8331505|NCT01362296|20538237|P4|NOT COMPLETED|Randomized Phase (RP)||0
8331506|NCT01362296|20538238|P3|NOT COMPLETED|Randomized Phase (RP)||0
8331507|NCT01362296|20538239|P2|NOT COMPLETED|Randomized Phase (RP)||43
8331508|NCT01362296|20538240|P1|NOT COMPLETED|Randomized Phase (RP)||87
8331509|NCT01362296|20538237|P4|COMPLETED|Randomized Phase (RP)||0
8331510|NCT01362296|20538238|P3|COMPLETED|Randomized Phase (RP)||0
8331511|NCT01362296|20538239|P2|COMPLETED|Randomized Phase (RP)||0
8331512|NCT01362296|20538240|P1|COMPLETED|Randomized Phase (RP)||0
8331513|NCT01362296|20538237|P4|STARTED|Randomized Phase (RP)||0
8331514|NCT01362296|20538238|P3|STARTED|Randomized Phase (RP)||0
8331515|NCT01362296|20538239|P2|STARTED|Randomized Phase (RP)||43
8331516|NCT01362296|20538240|P1|STARTED|Randomized Phase (RP)||87
8331517|NCT01362270|20538288|P2|NOT COMPLETED|Overall Study||2
8331518|NCT01362270|20538289|P1|NOT COMPLETED|Overall Study||2
8331519|NCT01362270|20538288|P2|COMPLETED|Overall Study||6
8331520|NCT01362270|20538289|P1|COMPLETED|Overall Study||5
8331521|NCT01362270|20538288|P2|STARTED|Overall Study||8
8331522|NCT01362270|20538289|P1|STARTED|Overall Study||7
8331523|NCT01362244|20538301|P2|NOT COMPLETED|Overall Study||32
8331524|NCT01362244|20538302|P1|NOT COMPLETED|Overall Study||32
8331525|NCT01362244|20538301|P2|COMPLETED|Overall Study||19
8331526|NCT01362244|20538302|P1|COMPLETED|Overall Study||22
8331527|NCT01362244|20538301|P2|STARTED|Overall Study||51
8331528|NCT01362244|20538302|P1|STARTED|Overall Study||54
8331529|NCT01362205|20538375|P2|NOT COMPLETED|Overall Study||0
8331530|NCT01362205|20538376|P1|NOT COMPLETED|Overall Study||0
8331531|NCT01362205|20538375|P2|COMPLETED|Overall Study||27
8331532|NCT01362205|20538376|P1|COMPLETED|Overall Study||22
8331533|NCT01362205|20538375|P2|STARTED|Overall Study||27
8331534|NCT01362205|20538376|P1|STARTED|Overall Study||22
8331535|NCT01362192|20538402|P1|NOT COMPLETED|Overall Study||4
8331536|NCT01362192|20538402|P1|COMPLETED|Overall Study||16
8331537|NCT01362192|20538402|P1|STARTED|Overall Study||20
8331538|NCT01362140|20538414|P2|NOT COMPLETED|Overall Study||11
8331539|NCT01362140|20538415|P1|NOT COMPLETED|Overall Study||10
8331540|NCT01362140|20538414|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
8331541|NCT01362140|20538415|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
8331542|NCT01362140|20538414|P2|Received Treatment|Overall Study||97
8331543|NCT01362140|20538415|P1|Received Treatment|Overall Study||49
8331544|NCT01362140|20538414|P2|STARTED|Overall Study||98
8331545|NCT01362140|20538415|P1|STARTED|Overall Study||49
8331546|NCT01362127|20538439|P2|NOT COMPLETED|Overall Study||0
8331547|NCT01362127|20538440|P1|NOT COMPLETED|Overall Study||0
8331548|NCT01362127|20538439|P2|COMPLETED|Overall Study||91
8331549|NCT01362127|20538440|P1|COMPLETED|Overall Study||90
8331550|NCT01362127|20538439|P2|STARTED|Overall Study||91
8331551|NCT01362127|20538440|P1|STARTED|Overall Study||90
8331552|NCT01362062|20538452|P2|NOT COMPLETED|Overall Study||0
8331553|NCT01362062|20538453|P1|NOT COMPLETED|Overall Study||26
8331554|NCT01362062|20538452|P2|COMPLETED|Overall Study||62
8331555|NCT01362062|20538453|P1|COMPLETED|Overall Study||22
8331556|NCT01362062|20538452|P2|STARTED|Overall Study||62
8331557|NCT01362062|20538453|P1|STARTED|Overall Study||48
8331558|NCT01362049|20538474|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
8331559|NCT01362049|20538475|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
8331560|NCT01362049|20538476|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
8331561|NCT01362049|20538477|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
8331562|NCT01362049|20538474|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
8331563|NCT01362049|20538475|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
8331564|NCT01362049|20538476|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
8331565|NCT01362049|20538477|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
8331566|NCT01362049|20538474|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
8331567|NCT01362049|20538475|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
8331568|NCT01362049|20538476|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
8331569|NCT01362049|20538477|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
8331570|NCT01362049|20538474|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
8331571|NCT01362049|20538475|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
8331572|NCT01362049|20538476|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
8331573|NCT01362049|20538477|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
8331574|NCT01362049|20538474|P4|COMPLETED|Follow-Up at 7 Weeks||24
8331575|NCT01362049|20538475|P3|COMPLETED|Follow-Up at 7 Weeks||30
8331576|NCT01362049|20538476|P2|COMPLETED|Follow-Up at 7 Weeks||16
8331577|NCT01362049|20538477|P1|COMPLETED|Follow-Up at 7 Weeks||23
8331578|NCT01362049|20538474|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
8331579|NCT01362049|20538475|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
8331580|NCT01362049|20538476|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
8331581|NCT01362049|20538477|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
8331582|NCT01362049|20538474|P4|STARTED|Follow-Up at 7 Weeks||25
8331583|NCT01362049|20538475|P3|STARTED|Follow-Up at 7 Weeks||32
8331584|NCT01362049|20538476|P2|STARTED|Follow-Up at 7 Weeks||19
8331585|NCT01362049|20538477|P1|STARTED|Follow-Up at 7 Weeks||26
8331586|NCT01361919|20538518|P3|NOT COMPLETED|Overall Study||10
8331587|NCT01361919|20538519|P2|NOT COMPLETED|Overall Study||12
8331588|NCT01361919|20538520|P1|NOT COMPLETED|Overall Study||10
8331589|NCT01361919|20538518|P3|COMPLETED|Overall Study||88
8331590|NCT01361919|20538519|P2|COMPLETED|Overall Study||88
8331591|NCT01361919|20538520|P1|COMPLETED|Overall Study||90
8331592|NCT01361919|20538518|P3|STARTED|Overall Study||98
8331593|NCT01361919|20538519|P2|STARTED|Overall Study||100
8331594|NCT01361919|20538520|P1|STARTED|Overall Study||100
8331595|NCT01361867|20538534|P1|NOT COMPLETED|Overall Study||0
8331596|NCT01361867|20538534|P1|COMPLETED|Overall Study||15
8331597|NCT01361867|20538534|P1|STARTED|Overall Study||15
8331598|NCT01361854|20538539|P2|NOT COMPLETED|Second Intervention||0
8331599|NCT01361854|20538540|P1|NOT COMPLETED|Second Intervention||0
8331600|NCT01361854|20538539|P2|COMPLETED|Second Intervention||48
8331601|NCT01361854|20538540|P1|COMPLETED|Second Intervention||47
8331602|NCT01361854|20538539|P2|STARTED|Second Intervention||48
8331603|NCT01361854|20538540|P1|STARTED|Second Intervention||47
8331604|NCT01361854|20538539|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
8331605|NCT01361854|20538540|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
8331606|NCT01361854|20538539|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
8331607|NCT01361854|20538540|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
8331608|NCT01361854|20538539|P2|STARTED|Wash-out, Maximum 2 Weeks||48
8331609|NCT01361854|20538540|P1|STARTED|Wash-out, Maximum 2 Weeks||47
8331610|NCT01361854|20538539|P2|NOT COMPLETED|Day 1||3
8331611|NCT01361854|20538540|P1|NOT COMPLETED|Day 1||4
8331612|NCT01361854|20538539|P2|COMPLETED|Day 1||48
8331613|NCT01361854|20538540|P1|COMPLETED|Day 1||47
8331614|NCT01361854|20538539|P2|STARTED|Day 1||51
8331615|NCT01361854|20538540|P1|STARTED|Day 1||51
8331616|NCT01361711|20538546|P1|NOT COMPLETED|10 Year Follow-up||50
8331617|NCT01361711|20538546|P1|COMPLETED|10 Year Follow-up||2
8331618|NCT01361711|20538546|P1|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
8331619|NCT01361711|20538546|P1|NOT COMPLETED|Completed Week 18 of Treatment||11
8331620|NCT01361711|20538546|P1|COMPLETED|Completed Week 18 of Treatment||30
8331621|NCT01361711|20538546|P1|STARTED|Completed Week 18 of Treatment||41
8331622|NCT01361711|20538546|P1|NOT COMPLETED|Continued Treatment After 12 Weeks||3
8331623|NCT01361711|20538546|P1|COMPLETED|Continued Treatment After 12 Weeks||41
8331624|NCT01361711|20538546|P1|STARTED|Continued Treatment After 12 Weeks||44
8331625|NCT01361711|20538546|P1|NOT COMPLETED|Continued Treatment After 9 Weeks||7
8331626|NCT01361711|20538546|P1|COMPLETED|Continued Treatment After 9 Weeks||44
8331627|NCT01361711|20538546|P1|STARTED|Continued Treatment After 9 Weeks||51
8331628|NCT01361711|20538546|P1|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
8331629|NCT01361711|20538546|P1|COMPLETED|Week 9 Bone Marrow Response Assessment||51
8331630|NCT01361711|20538546|P1|STARTED|Week 9 Bone Marrow Response Assessment||52
8331631|NCT01361711|20538546|P1|NOT COMPLETED|Trial Entry (Registration)||1
8331632|NCT01361711|20538546|P1|COMPLETED|Trial Entry (Registration)||52
8331633|NCT01361711|20538546|P1|Received Dose of Study Drug|Trial Entry (Registration)||52
8331634|NCT01361711|20538546|P1|STARTED|Trial Entry (Registration)||53
8331641|NCT01361620|20538559|P1|NOT COMPLETED|Overall Study||0
8331642|NCT01361620|20538559|P1|COMPLETED|Overall Study||132
8331643|NCT01361620|20538559|P1|STARTED|Overall Study||132
8331644|NCT01361607|20538565|P2|NOT COMPLETED|Overall Study||41
8331645|NCT01361607|20538566|P1|NOT COMPLETED|Overall Study||64
8331646|NCT01361607|20538565|P2|COMPLETED|Overall Study||158
8331647|NCT01361607|20538566|P1|COMPLETED|Overall Study||136
8331648|NCT01361607|20538565|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
8331649|NCT01361607|20538566|P1|ITT Population|Overall Study||198
8331650|NCT01361607|20538565|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
8331651|NCT01361607|20538566|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
8331652|NCT01361607|20538565|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
8331653|NCT01361607|20538566|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
8331654|NCT01361607|20538565|P2|STARTED|Overall Study||199
8331655|NCT01361607|20538566|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
8331656|NCT01361594|20538594|P2|NOT COMPLETED|Overall Study||2
8331657|NCT01361594|20538595|P1|NOT COMPLETED|Overall Study||1
8331658|NCT01361594|20538594|P2|COMPLETED|Overall Study||151
8331659|NCT01361594|20538595|P1|COMPLETED|Overall Study||151
8331660|NCT01361594|20538594|P2|STARTED|Overall Study||153
8331661|NCT01361594|20538595|P1|STARTED|Overall Study||152
8331662|NCT01361568|20538609|P6|NOT COMPLETED|Overall Study||2
8331663|NCT01361568|20538610|P5|NOT COMPLETED|Overall Study||1
8331664|NCT01361568|20538611|P4|NOT COMPLETED|Overall Study||0
8331665|NCT01361568|20538612|P3|NOT COMPLETED|Overall Study||0
8331666|NCT01361568|20538613|P2|NOT COMPLETED|Overall Study||1
8331667|NCT01361568|20538614|P1|NOT COMPLETED|Overall Study||2
8331668|NCT01361568|20538609|P6|COMPLETED|Overall Study||11
8331669|NCT01361568|20538610|P5|COMPLETED|Overall Study||6
8331670|NCT01361568|20538611|P4|COMPLETED|Overall Study||21
8331671|NCT01361568|20538612|P3|COMPLETED|Overall Study||20
8331672|NCT01361568|20538613|P2|COMPLETED|Overall Study||70
8331673|NCT01361568|20538614|P1|COMPLETED|Overall Study||69
8331674|NCT01361568|20538609|P6|STARTED|Overall Study||13
8331675|NCT01361568|20538610|P5|STARTED|Overall Study||7
8331676|NCT01361568|20538611|P4|STARTED|Overall Study||21
8331677|NCT01361568|20538612|P3|STARTED|Overall Study||20
8331678|NCT01361568|20538613|P2|STARTED|Overall Study||71
8331679|NCT01361568|20538614|P1|STARTED|Overall Study||71
8331680|NCT01361464|20538644|P1|NOT COMPLETED|Overall Study||3
8331681|NCT01361464|20538644|P1|COMPLETED|Overall Study||18
8331682|NCT01361464|20538644|P1|STARTED|Overall Study||21
8331683|NCT01361308|20538653|P2|NOT COMPLETED|Overall Study||30
8331684|NCT01361308|20538654|P1|NOT COMPLETED|Overall Study||35
8331685|NCT01361308|20538653|P2|COMPLETED|Overall Study||278
8331686|NCT01361308|20538654|P1|COMPLETED|Overall Study||271
8331687|NCT01361308|20538653|P2|STARTED|Overall Study||308
8331688|NCT01361308|20538654|P1|STARTED|Overall Study||306
8331689|NCT01361217|20538694|P1|NOT COMPLETED|Overall Study||0
8331690|NCT01361217|20538694|P1|COMPLETED|Overall Study||10
8331691|NCT01361217|20538694|P1|STARTED|Overall Study||10
8331692|NCT01361178|20538702|P2|NOT COMPLETED|Overall Study||0
8331693|NCT01361178|20538703|P1|NOT COMPLETED|Overall Study||13
8331694|NCT01361178|20538702|P2|COMPLETED|Overall Study||11
8331695|NCT01361178|20538703|P1|COMPLETED|Overall Study||109
8331696|NCT01361178|20538702|P2|STARTED|Overall Study||11
8331697|NCT01361178|20538703|P1|STARTED|Overall Study||122
8331698|NCT01361126|20538711|P2|NOT COMPLETED|Overall Study||2
8331699|NCT01361126|20538712|P1|NOT COMPLETED|Overall Study||0
8331700|NCT01361126|20538711|P2|COMPLETED|Overall Study||2
8331701|NCT01361126|20538712|P1|COMPLETED|Overall Study||13
8331702|NCT01361126|20538711|P2|STARTED|Overall Study||4
8331703|NCT01361126|20538712|P1|STARTED|Overall Study||13
8331704|NCT01361113|20538727|P1|NOT COMPLETED|Overall Study||0
8331705|NCT01361113|20538727|P1|COMPLETED|Overall Study||21
8331706|NCT01361113|20538727|P1|STARTED|Overall Study||21
8331707|NCT01361048|20538738|P3|NOT COMPLETED|Overall Study||1
8331708|NCT01361048|20538739|P2|NOT COMPLETED|Overall Study||0
8331709|NCT01361048|20538740|P1|NOT COMPLETED|Overall Study||0
8331710|NCT01361048|20538738|P3|COMPLETED|Overall Study||9
8331711|NCT01361048|20538739|P2|COMPLETED|Overall Study||10
8331712|NCT01361048|20538740|P1|COMPLETED|Overall Study||20
8331713|NCT01361048|20538738|P3|STARTED|Overall Study||10
8331714|NCT01361048|20538739|P2|STARTED|Overall Study||10
8331715|NCT01361048|20538740|P1|STARTED|Overall Study||20
8331716|NCT01361009|20538751|P1|NOT COMPLETED|Overall Study||116
8331717|NCT01361009|20538751|P1|COMPLETED|Overall Study||1901
8331718|NCT01361009|20538751|P1|STARTED|Overall Study||2017
8331719|NCT01360996|20538761|P3|NOT COMPLETED|Overall Study||2
8331720|NCT01360996|20538762|P2|NOT COMPLETED|Overall Study||3
8331721|NCT01360996|20538763|P1|NOT COMPLETED|Overall Study||6
8331722|NCT01360996|20538761|P3|COMPLETED|Overall Study||21
8331723|NCT01360996|20538762|P2|COMPLETED|Overall Study||18
8331724|NCT01360996|20538763|P1|COMPLETED|Overall Study||14
8331725|NCT01360996|20538761|P3|STARTED|Overall Study||23
8331726|NCT01360996|20538762|P2|STARTED|Overall Study||21
8331727|NCT01360996|20538763|P1|STARTED|Overall Study||20
8331728|NCT01360866|20538786|P4|NOT COMPLETED|Overall Study||22
8331729|NCT01360866|20538787|P3|NOT COMPLETED|Overall Study||519
8331730|NCT01360866|20538788|P2|NOT COMPLETED|Overall Study||287
8331731|NCT01360866|20538789|P1|NOT COMPLETED|Overall Study||221
8331732|NCT01360866|20538786|P4|COMPLETED|Overall Study||54
8331733|NCT01360866|20538787|P3|COMPLETED|Overall Study||1126
8331734|NCT01360866|20538788|P2|COMPLETED|Overall Study||420
8331735|NCT01360866|20538789|P1|COMPLETED|Overall Study||295
8331736|NCT01360866|20538786|P4|STARTED|Overall Study||76
8331737|NCT01360866|20538787|P3|STARTED|Overall Study||1645
8331738|NCT01360866|20538788|P2|STARTED|Overall Study||707
8331739|NCT01360866|20538789|P1|STARTED|Overall Study||516
8331740|NCT01360840|20538818|P3|NOT COMPLETED|Overall Study||9
8331741|NCT01360840|20538819|P2|NOT COMPLETED|Overall Study||10
8331742|NCT01360840|20538820|P1|NOT COMPLETED|Overall Study||10
8331743|NCT01360840|20538818|P3|COMPLETED|Overall Study||51
8331744|NCT01360840|20538819|P2|COMPLETED|Overall Study||50
8331745|NCT01360840|20538820|P1|COMPLETED|Overall Study||50
8331746|NCT01360840|20538818|P3|STARTED|Overall Study||60
8331747|NCT01360840|20538819|P2|STARTED|Overall Study||60
8331748|NCT01360840|20538820|P1|STARTED|Overall Study||60
8331749|NCT01360762|20538870|P1|NOT COMPLETED|Whole Study Period||36
8331750|NCT01360762|20538870|P1|COMPLETED|Whole Study Period||38
8331751|NCT01360762|20538870|P1|STARTED|Whole Study Period||74
8331752|NCT01360762|20538870|P1|NOT COMPLETED|Main Study Period (12-month Treatment)||29
8331753|NCT01360762|20538870|P1|COMPLETED|Main Study Period (12-month Treatment)||45
8331754|NCT01360762|20538870|P1|STARTED|Main Study Period (12-month Treatment)||74
8331755|NCT01360645|20538880|P4|NOT COMPLETED|Phase A+||24
8331756|NCT01360645|20538881|P3|NOT COMPLETED|Phase A+||0
8331757|NCT01360645|20538882|P2|NOT COMPLETED|Phase A+||0
8331758|NCT01360645|20538883|P1|NOT COMPLETED|Phase A+||0
8331759|NCT01360645|20538880|P4|COMPLETED|Phase A+||307
8331760|NCT01360645|20538881|P3|COMPLETED|Phase A+||0
8331761|NCT01360645|20538882|P2|COMPLETED|Phase A+||0
8331762|NCT01360645|20538883|P1|COMPLETED|Phase A+||0
8331763|NCT01360645|20538880|P4|STARTED|Phase A+||331
8331764|NCT01360645|20538881|P3|STARTED|Phase A+||0
8331765|NCT01360645|20538882|P2|STARTED|Phase A+||0
8331766|NCT01360645|20538883|P1|STARTED|Phase A+||0
8331767|NCT01360645|20538880|P4|NOT COMPLETED|Phase B (6 Weeks)||0
8331768|NCT01360645|20538881|P3|NOT COMPLETED|Phase B (6 Weeks)||13
8331769|NCT01360645|20538882|P2|NOT COMPLETED|Phase B (6 Weeks)||14
8331770|NCT01360645|20538883|P1|NOT COMPLETED|Phase B (6 Weeks)||0
8331771|NCT01360645|20538880|P4|COMPLETED|Phase B (6 Weeks)||0
8331772|NCT01360645|20538881|P3|COMPLETED|Phase B (6 Weeks)||178
8331773|NCT01360645|20538882|P2|COMPLETED|Phase B (6 Weeks)||174
8331774|NCT01360645|20538883|P1|COMPLETED|Phase B (6 Weeks)||0
8331775|NCT01360645|20538880|P4|STARTED|Phase B (6 Weeks)||0
8331776|NCT01360645|20538881|P3|STARTED|Phase B (6 Weeks)||191
8331777|NCT01360645|20538882|P2|STARTED|Phase B (6 Weeks)||188
8331778|NCT01360645|20538883|P1|STARTED|Phase B (6 Weeks)||0
8331779|NCT01360645|20538880|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331780|NCT01360645|20538881|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331781|NCT01360645|20538882|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331782|NCT01360645|20538883|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
8331783|NCT01360645|20538880|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331784|NCT01360645|20538881|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331785|NCT01360645|20538882|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331786|NCT01360645|20538883|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
8331787|NCT01360645|20538880|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331788|NCT01360645|20538881|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331789|NCT01360645|20538882|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331790|NCT01360645|20538883|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
8331791|NCT01360632|20538938|P5|NOT COMPLETED|Phase A+||25
8331792|NCT01360632|20538939|P4|NOT COMPLETED|Phase A+||0
8331793|NCT01360632|20538940|P3|NOT COMPLETED|Phase A+||0
8331794|NCT01360632|20538941|P2|NOT COMPLETED|Phase A+||0
8331795|NCT01360632|20538942|P1|NOT COMPLETED|Phase A+||0
8331796|NCT01360632|20538938|P5|COMPLETED|Phase A+||575
8331797|NCT01360632|20538939|P4|COMPLETED|Phase A+||0
8331798|NCT01360632|20538940|P3|COMPLETED|Phase A+||0
8331799|NCT01360632|20538941|P2|COMPLETED|Phase A+||0
8331800|NCT01360632|20538942|P1|COMPLETED|Phase A+||0
8331801|NCT01360632|20538938|P5|STARTED|Phase A+||600
8331802|NCT01360632|20538939|P4|STARTED|Phase A+||0
8331803|NCT01360632|20538940|P3|STARTED|Phase A+||0
8331804|NCT01360632|20538941|P2|STARTED|Phase A+||0
8331805|NCT01360632|20538942|P1|STARTED|Phase A+||0
8331806|NCT01360632|20538938|P5|NOT COMPLETED|Phase B (6 Weeks)||0
8331807|NCT01360632|20538939|P4|NOT COMPLETED|Phase B (6 Weeks)||13
8331808|NCT01360632|20538940|P3|NOT COMPLETED|Phase B (6 Weeks)||20
8331809|NCT01360632|20538941|P2|NOT COMPLETED|Phase B (6 Weeks)||10
8331810|NCT01360632|20538942|P1|NOT COMPLETED|Phase B (6 Weeks)||0
8331811|NCT01360632|20538938|P5|COMPLETED|Phase B (6 Weeks)||0
8331812|NCT01360632|20538939|P4|COMPLETED|Phase B (6 Weeks)||208
8331813|NCT01360632|20538940|P3|COMPLETED|Phase B (6 Weeks)||210
8331814|NCT01360632|20538941|P2|COMPLETED|Phase B (6 Weeks)||216
8331815|NCT01360632|20538942|P1|COMPLETED|Phase B (6 Weeks)||0
8331816|NCT01360632|20538938|P5|STARTED|Phase B (6 Weeks)||0
8331817|NCT01360632|20538939|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
8331818|NCT01360632|20538940|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
8331819|NCT01360632|20538941|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
8331820|NCT01360632|20538942|P1|STARTED|Phase B (6 Weeks)||0
8331821|NCT01360632|20538938|P5|NOT COMPLETED|Phase A (8 Weeks)||0
8331822|NCT01360632|20538939|P4|NOT COMPLETED|Phase A (8 Weeks)||0
8331823|NCT01360632|20538940|P3|NOT COMPLETED|Phase A (8 Weeks)||0
8331824|NCT01360632|20538941|P2|NOT COMPLETED|Phase A (8 Weeks)||0
8331825|NCT01360632|20538942|P1|NOT COMPLETED|Phase A (8 Weeks)||255
8331826|NCT01360632|20538938|P5|COMPLETED|Phase A (8 Weeks)||0
8331827|NCT01360632|20538939|P4|COMPLETED|Phase A (8 Weeks)||0
8331828|NCT01360632|20538940|P3|COMPLETED|Phase A (8 Weeks)||0
8331829|NCT01360632|20538941|P2|COMPLETED|Phase A (8 Weeks)||0
8331830|NCT01360632|20538942|P1|COMPLETED|Phase A (8 Weeks)||1277
8331831|NCT01360632|20538938|P5|STARTED|Phase A (8 Weeks)||0
8331832|NCT01360632|20538939|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8331833|NCT01360632|20538940|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8331834|NCT01360632|20538941|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8331921|NCT01359748|20539231|P2|COMPLETED|Overall Study||20
8331835|NCT01360632|20538942|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
8331836|NCT01360554|20539021|P2|NOT COMPLETED|Overall Study||439
8331837|NCT01360554|20539022|P1|NOT COMPLETED|Overall Study||439
8331838|NCT01360554|20539021|P2|COMPLETED|Overall Study||0
8331839|NCT01360554|20539022|P1|COMPLETED|Overall Study||0
8331840|NCT01360554|20539021|P2|Treated|Overall Study||436
8331841|NCT01360554|20539022|P1|Treated|Overall Study||436
8331842|NCT01360554|20539021|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
8331843|NCT01360554|20539022|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
8331844|NCT01360450|20539060|P2|NOT COMPLETED|Overall Study||0
8331845|NCT01360450|20539061|P1|NOT COMPLETED|Overall Study||0
8331846|NCT01360450|20539060|P2|COMPLETED|Overall Study||6
8331847|NCT01360450|20539061|P1|COMPLETED|Overall Study||6
8331848|NCT01360450|20539060|P2|Completed Treatment|Overall Study||6
8331849|NCT01360450|20539061|P1|Completed Treatment|Overall Study||6
8331850|NCT01360450|20539060|P2|STARTED|Overall Study||6
8331851|NCT01360450|20539061|P1|STARTED|Overall Study||6
8331852|NCT01360398|20539071|P1|NOT COMPLETED|Overall Study||22
8331853|NCT01360398|20539071|P1|COMPLETED|Overall Study||105
8331854|NCT01360398|20539071|P1|STARTED|Overall Study||127
8331855|NCT01360229|20539095|P2|NOT COMPLETED|Overall Study||2
8331856|NCT01360229|20539096|P1|NOT COMPLETED|Overall Study||3
8331857|NCT01360229|20539095|P2|COMPLETED|Overall Study||45
8331858|NCT01360229|20539096|P1|COMPLETED|Overall Study||44
8331859|NCT01360229|20539095|P2|STARTED|Overall Study||47
8331860|NCT01360229|20539096|P1|STARTED|Overall Study||47
8331861|NCT01360021|20539105|P3|NOT COMPLETED|Overall Study||7
8331862|NCT01360021|20539106|P2|NOT COMPLETED|Overall Study||4
8331863|NCT01360021|20539107|P1|NOT COMPLETED|Overall Study||8
8331864|NCT01360021|20539105|P3|COMPLETED|Overall Study|Patients who completed study|65
8331865|NCT01360021|20539106|P2|COMPLETED|Overall Study|Patients who completed study|67
8331866|NCT01360021|20539107|P1|COMPLETED|Overall Study|Patients who completed study|63
8331867|NCT01360021|20539105|P3|STARTED|Overall Study|Patients randomized|72
8331868|NCT01360021|20539106|P2|STARTED|Overall Study|Patients randomized|71
8331869|NCT01360021|20539107|P1|STARTED|Overall Study|Patients randomized|71
8331870|NCT01359956|20539134|P4|NOT COMPLETED|Overall Study||58
8331871|NCT01359956|20539135|P3|NOT COMPLETED|Overall Study||67
8331872|NCT01359956|20539136|P2|NOT COMPLETED|Overall Study||64
8331873|NCT01359956|20539137|P1|NOT COMPLETED|Overall Study||61
8331874|NCT01359956|20539134|P4|COMPLETED|Overall Study||4
8331875|NCT01359956|20539135|P3|COMPLETED|Overall Study||4
8331876|NCT01359956|20539136|P2|COMPLETED|Overall Study||5
8331877|NCT01359956|20539137|P1|COMPLETED|Overall Study||6
8331878|NCT01359956|20539134|P4|STARTED|Overall Study||62
8331879|NCT01359956|20539135|P3|STARTED|Overall Study||71
8331880|NCT01359956|20539136|P2|STARTED|Overall Study||69
8331881|NCT01359956|20539137|P1|STARTED|Overall Study||67
8331882|NCT01359943|20539162|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
8331883|NCT01359943|20539163|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
8331884|NCT01359943|20539164|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
8331885|NCT01359943|20539162|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
8331886|NCT01359943|20539163|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
8331887|NCT01359943|20539164|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
8331888|NCT01359943|20539162|P3|STARTED|Follow-up (Weeks 52 - 60)||44
8331889|NCT01359943|20539163|P2|STARTED|Follow-up (Weeks 52 - 60)||84
8331890|NCT01359943|20539164|P1|STARTED|Follow-up (Weeks 52 - 60)||86
8331891|NCT01359943|20539162|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
8331892|NCT01359943|20539163|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
8331893|NCT01359943|20539164|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
8331894|NCT01359943|20539162|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
8331895|NCT01359943|20539163|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
8331896|NCT01359943|20539164|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
8331897|NCT01359943|20539162|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
8331898|NCT01359943|20539163|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
8331899|NCT01359943|20539164|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
8331900|NCT01359943|20539162|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
8331901|NCT01359943|20539163|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
8331902|NCT01359943|20539164|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
8331903|NCT01359943|20539162|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
8331904|NCT01359943|20539163|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
8331905|NCT01359943|20539164|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
8331906|NCT01359943|20539162|P3|STARTED|Double-blind (Weeks 0 - 16)||44
8331907|NCT01359943|20539163|P2|STARTED|Double-blind (Weeks 0 - 16)||89
8331908|NCT01359943|20539164|P1|STARTED|Double-blind (Weeks 0 - 16)||88
8331909|NCT01359904|20539212|P2|NOT COMPLETED|Overall Study||0
8331910|NCT01359904|20539213|P1|NOT COMPLETED|Overall Study||1
8331911|NCT01359904|20539212|P2|COMPLETED|Overall Study||19
8331912|NCT01359904|20539213|P1|COMPLETED|Overall Study||14
8331913|NCT01359904|20539212|P2|STARTED|Overall Study||19
8331914|NCT01359904|20539213|P1|STARTED|Overall Study||15
8331915|NCT01359748|20539229|P4|NOT COMPLETED|Overall Study||0
8331916|NCT01359748|20539230|P3|NOT COMPLETED|Overall Study||0
8331917|NCT01359748|20539231|P2|NOT COMPLETED|Overall Study||0
8331918|NCT01359748|20539232|P1|NOT COMPLETED|Overall Study||0
8331919|NCT01359748|20539229|P4|COMPLETED|Overall Study||11
8331920|NCT01359748|20539230|P3|COMPLETED|Overall Study||10
8331922|NCT01359748|20539232|P1|COMPLETED|Overall Study||48
8331923|NCT01359748|20539229|P4|STARTED|Overall Study||11
8331924|NCT01359748|20539230|P3|STARTED|Overall Study||10
8331925|NCT01359748|20539231|P2|STARTED|Overall Study||20
8331926|NCT01359748|20539232|P1|STARTED|Overall Study||48
8331927|NCT01359735|20539242|P2|NOT COMPLETED|Overall Study||0
8331928|NCT01359735|20539243|P1|NOT COMPLETED|Overall Study||0
8331929|NCT01359735|20539242|P2|COMPLETED|Overall Study||4
8331930|NCT01359735|20539243|P1|COMPLETED|Overall Study||4
8331931|NCT01359735|20539242|P2|STARTED|Overall Study||4
8331932|NCT01359735|20539243|P1|STARTED|Overall Study||4
8331933|NCT01359644|20539267|P10|NOT COMPLETED|Follow-up Period||0
8331934|NCT01359644|20539268|P9|NOT COMPLETED|Follow-up Period||0
8331935|NCT01359644|20539269|P8|NOT COMPLETED|Follow-up Period||2
8331936|NCT01359644|20539270|P7|NOT COMPLETED|Follow-up Period||1
8331937|NCT01359644|20539271|P6|NOT COMPLETED|Follow-up Period||1
8331938|NCT01359644|20539272|P5|NOT COMPLETED|Follow-up Period||0
8331939|NCT01359644|20539273|P4|NOT COMPLETED|Follow-up Period||0
8331940|NCT01359644|20539274|P3|NOT COMPLETED|Follow-up Period||0
8331941|NCT01359644|20539275|P2|NOT COMPLETED|Follow-up Period||0
8331942|NCT01359644|20539276|P1|NOT COMPLETED|Follow-up Period||0
8331943|NCT01359644|20539267|P10|COMPLETED|Follow-up Period||20
8331944|NCT01359644|20539268|P9|COMPLETED|Follow-up Period||21
8331945|NCT01359644|20539269|P8|COMPLETED|Follow-up Period||39
8331946|NCT01359644|20539270|P7|COMPLETED|Follow-up Period||40
8331947|NCT01359644|20539271|P6|COMPLETED|Follow-up Period||12
8331948|NCT01359644|20539272|P5|COMPLETED|Follow-up Period||15
8331949|NCT01359644|20539273|P4|COMPLETED|Follow-up Period||14
8331950|NCT01359644|20539274|P3|COMPLETED|Follow-up Period||14
8331951|NCT01359644|20539275|P2|COMPLETED|Follow-up Period||16
8331952|NCT01359644|20539276|P1|COMPLETED|Follow-up Period||15
8331953|NCT01359644|20539267|P10|STARTED|Follow-up Period||20
8331954|NCT01359644|20539268|P9|STARTED|Follow-up Period||21
8331955|NCT01359644|20539269|P8|STARTED|Follow-up Period||41
8331956|NCT01359644|20539270|P7|STARTED|Follow-up Period||41
8331957|NCT01359644|20539271|P6|STARTED|Follow-up Period||13
8331958|NCT01359644|20539272|P5|STARTED|Follow-up Period||15
8331959|NCT01359644|20539273|P4|STARTED|Follow-up Period||14
8331960|NCT01359644|20539274|P3|STARTED|Follow-up Period||14
8331961|NCT01359644|20539275|P2|STARTED|Follow-up Period||16
8331962|NCT01359644|20539276|P1|STARTED|Follow-up Period||15
8331963|NCT01359644|20539267|P10|NOT COMPLETED|Treatment Period||0
8331964|NCT01359644|20539268|P9|NOT COMPLETED|Treatment Period||0
8331965|NCT01359644|20539269|P8|NOT COMPLETED|Treatment Period||0
8331966|NCT01359644|20539270|P7|NOT COMPLETED|Treatment Period||0
8331967|NCT01359644|20539271|P6|NOT COMPLETED|Treatment Period||2
8331968|NCT01359644|20539272|P5|NOT COMPLETED|Treatment Period||0
8331969|NCT01359644|20539273|P4|NOT COMPLETED|Treatment Period||0
8331970|NCT01359644|20539274|P3|NOT COMPLETED|Treatment Period||1
8331971|NCT01359644|20539275|P2|NOT COMPLETED|Treatment Period||1
8331972|NCT01359644|20539276|P1|NOT COMPLETED|Treatment Period||0
8331973|NCT01359644|20539267|P10|COMPLETED|Treatment Period||20
8331974|NCT01359644|20539268|P9|COMPLETED|Treatment Period||21
8331975|NCT01359644|20539269|P8|COMPLETED|Treatment Period||41
8331976|NCT01359644|20539270|P7|COMPLETED|Treatment Period||41
8331977|NCT01359644|20539271|P6|COMPLETED|Treatment Period||12
8331978|NCT01359644|20539272|P5|COMPLETED|Treatment Period||15
8331979|NCT01359644|20539273|P4|COMPLETED|Treatment Period||14
8331980|NCT01359644|20539274|P3|COMPLETED|Treatment Period||13
8331981|NCT01359644|20539275|P2|COMPLETED|Treatment Period||15
8331982|NCT01359644|20539276|P1|COMPLETED|Treatment Period||15
8331983|NCT01359644|20539267|P10|STARTED|Treatment Period||20
8331984|NCT01359644|20539268|P9|STARTED|Treatment Period||21
8331985|NCT01359644|20539269|P8|STARTED|Treatment Period||41
8331986|NCT01359644|20539270|P7|STARTED|Treatment Period||41
8331987|NCT01359644|20539271|P6|STARTED|Treatment Period||14
8331988|NCT01359644|20539272|P5|STARTED|Treatment Period||15
8331989|NCT01359644|20539273|P4|STARTED|Treatment Period||14
8331990|NCT01359644|20539274|P3|STARTED|Treatment Period||14
8331991|NCT01359644|20539275|P2|STARTED|Treatment Period||16
8331992|NCT01359644|20539276|P1|STARTED|Treatment Period||15
8331993|NCT01359449|20539320|P2|NOT COMPLETED|Overall Study||4
8331994|NCT01359449|20539321|P1|NOT COMPLETED|Overall Study||4
8331995|NCT01359449|20539320|P2|COMPLETED|Overall Study||58
8331996|NCT01359449|20539321|P1|COMPLETED|Overall Study||57
8331997|NCT01359449|20539320|P2|STARTED|Overall Study||62
8331998|NCT01359449|20539321|P1|STARTED|Overall Study||61
8331999|NCT01359410|20539345|P2|NOT COMPLETED|Overall Study||0
8332000|NCT01359410|20539346|P1|NOT COMPLETED|Overall Study||0
8332001|NCT01359410|20539345|P2|COMPLETED|Overall Study||46
8332002|NCT01359410|20539346|P1|COMPLETED|Overall Study||54
8332003|NCT01359410|20539345|P2|STARTED|Overall Study||46
8332004|NCT01359410|20539346|P1|STARTED|Overall Study||54
8332005|NCT01359371|20539360|P1|NOT COMPLETED|Overall Study||0
8332006|NCT01359371|20539360|P1|COMPLETED|Overall Study||131
8332007|NCT01359371|20539360|P1|STARTED|Overall Study||131
8332008|NCT01359254|20539371|P2|NOT COMPLETED|Overall Study||0
8332009|NCT01359254|20539372|P1|NOT COMPLETED|Overall Study||1
8332010|NCT01359254|20539371|P2|COMPLETED|Overall Study||0
8332011|NCT01359254|20539372|P1|COMPLETED|Overall Study||0
8332012|NCT01359254|20539371|P2|STARTED|Overall Study||0
8332013|NCT01359254|20539372|P1|STARTED|Overall Study||1
8332014|NCT01359150|20539382|P2|NOT COMPLETED|Overall Study||5
8332015|NCT01359150|20539383|P1|NOT COMPLETED|Overall Study||7
8332016|NCT01359150|20539382|P2|COMPLETED|Overall Study||106
8332017|NCT01359150|20539383|P1|COMPLETED|Overall Study||105
8332018|NCT01359150|20539382|P2|STARTED|Overall Study||111
8332019|NCT01359150|20539383|P1|STARTED|Overall Study||112
8332020|NCT01359111|20539405|P1|NOT COMPLETED|Overall Study||0
8332021|NCT01359111|20539405|P1|COMPLETED|Overall Study||20
8332022|NCT01359111|20539405|P1|STARTED|Overall Study||20
8332023|NCT01359046|20539414|P2|NOT COMPLETED|Overall Study||17
8332024|NCT01359046|20539415|P1|NOT COMPLETED|Overall Study||7
8332025|NCT01359046|20539414|P2|COMPLETED|Overall Study||127
8332026|NCT01359046|20539415|P1|COMPLETED|Overall Study||137
8332027|NCT01359046|20539414|P2|STARTED|Overall Study||144
8332028|NCT01359046|20539415|P1|STARTED|Overall Study||144
8332029|NCT01359007|20539423|P1|NOT COMPLETED|Overall Study||2
8332030|NCT01359007|20539423|P1|COMPLETED|Overall Study||3
8332031|NCT01359007|20539423|P1|STARTED|Overall Study||5
8332032|NCT01358981|20539438|P7|NOT COMPLETED|Period 4||0
8332033|NCT01358981|20539439|P6|NOT COMPLETED|Period 4||0
8332034|NCT01358981|20539440|P5|NOT COMPLETED|Period 4||0
8332035|NCT01358981|20539441|P4|NOT COMPLETED|Period 4||0
8332036|NCT01358981|20539442|P3|NOT COMPLETED|Period 4||0
8332037|NCT01358981|20539443|P2|NOT COMPLETED|Period 4||0
8332038|NCT01358981|20539444|P1|NOT COMPLETED|Period 4||0
8332039|NCT01358981|20539438|P7|COMPLETED|Period 4||0
8332040|NCT01358981|20539439|P6|COMPLETED|Period 4||0
8332041|NCT01358981|20539440|P5|COMPLETED|Period 4||0
8332042|NCT01358981|20539441|P4|COMPLETED|Period 4||2
8332043|NCT01358981|20539442|P3|COMPLETED|Period 4||2
8332044|NCT01358981|20539443|P2|COMPLETED|Period 4||2
8332045|NCT01358981|20539444|P1|COMPLETED|Period 4||2
8332046|NCT01358981|20539438|P7|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8332047|NCT01358981|20539439|P6|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8332048|NCT01358981|20539440|P5|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8332049|NCT01358981|20539441|P4|STARTED|Period 4||2
8332050|NCT01358981|20539442|P3|STARTED|Period 4||2
8332051|NCT01358981|20539443|P2|STARTED|Period 4||2
8332052|NCT01358981|20539444|P1|STARTED|Period 4||2
8332053|NCT01358981|20539438|P7|NOT COMPLETED|Period 3||0
8332054|NCT01358981|20539439|P6|NOT COMPLETED|Period 3||0
8332055|NCT01358981|20539440|P5|NOT COMPLETED|Period 3||0
8332056|NCT01358981|20539441|P4|NOT COMPLETED|Period 3||0
8332057|NCT01358981|20539442|P3|NOT COMPLETED|Period 3||0
8332058|NCT01358981|20539443|P2|NOT COMPLETED|Period 3||0
8332059|NCT01358981|20539444|P1|NOT COMPLETED|Period 3||0
8332060|NCT01358981|20539438|P7|COMPLETED|Period 3||3
8332061|NCT01358981|20539439|P6|COMPLETED|Period 3||3
8332062|NCT01358981|20539440|P5|COMPLETED|Period 3||3
8332063|NCT01358981|20539441|P4|COMPLETED|Period 3||2
8332064|NCT01358981|20539442|P3|COMPLETED|Period 3||2
8332065|NCT01358981|20539443|P2|COMPLETED|Period 3||2
8332066|NCT01358981|20539444|P1|COMPLETED|Period 3||2
8332067|NCT01358981|20539438|P7|STARTED|Period 3||3
8332068|NCT01358981|20539439|P6|STARTED|Period 3||3
8332069|NCT01358981|20539440|P5|STARTED|Period 3||3
8332070|NCT01358981|20539441|P4|STARTED|Period 3||2
8332071|NCT01358981|20539442|P3|STARTED|Period 3||2
8332072|NCT01358981|20539443|P2|STARTED|Period 3||2
8332073|NCT01358981|20539444|P1|STARTED|Period 3||2
8332074|NCT01358981|20539438|P7|NOT COMPLETED|Period 2||0
8332075|NCT01358981|20539439|P6|NOT COMPLETED|Period 2||0
8332076|NCT01358981|20539440|P5|NOT COMPLETED|Period 2||0
8332077|NCT01358981|20539441|P4|NOT COMPLETED|Period 2||0
8332078|NCT01358981|20539442|P3|NOT COMPLETED|Period 2||0
8332079|NCT01358981|20539443|P2|NOT COMPLETED|Period 2||0
8332080|NCT01358981|20539444|P1|NOT COMPLETED|Period 2||0
8332081|NCT01358981|20539438|P7|COMPLETED|Period 2||3
8332082|NCT01358981|20539439|P6|COMPLETED|Period 2||3
8332083|NCT01358981|20539440|P5|COMPLETED|Period 2||3
8332084|NCT01358981|20539441|P4|COMPLETED|Period 2||2
8332085|NCT01358981|20539442|P3|COMPLETED|Period 2||2
8332086|NCT01358981|20539443|P2|COMPLETED|Period 2||2
8332087|NCT01358981|20539444|P1|COMPLETED|Period 2||2
8332088|NCT01358981|20539438|P7|STARTED|Period 2||3
8332089|NCT01358981|20539439|P6|STARTED|Period 2||3
8332090|NCT01358981|20539440|P5|STARTED|Period 2||3
8332091|NCT01358981|20539441|P4|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
8332092|NCT01358981|20539442|P3|STARTED|Period 2||2
8332093|NCT01358981|20539443|P2|STARTED|Period 2||2
8332094|NCT01358981|20539444|P1|STARTED|Period 2||2
8332095|NCT01358981|20539438|P7|NOT COMPLETED|Period 1||0
8332096|NCT01358981|20539439|P6|NOT COMPLETED|Period 1||0
8332097|NCT01358981|20539440|P5|NOT COMPLETED|Period 1||0
8332098|NCT01358981|20539441|P4|NOT COMPLETED|Period 1||1
8332099|NCT01358981|20539442|P3|NOT COMPLETED|Period 1||0
8332100|NCT01358981|20539443|P2|NOT COMPLETED|Period 1||0
8332101|NCT01358981|20539444|P1|NOT COMPLETED|Period 1||0
8332102|NCT01358981|20539438|P7|COMPLETED|Period 1||3
8332103|NCT01358981|20539439|P6|COMPLETED|Period 1||3
8332104|NCT01358981|20539440|P5|COMPLETED|Period 1||3
8332105|NCT01358981|20539441|P4|COMPLETED|Period 1||1
8332106|NCT01358981|20539442|P3|COMPLETED|Period 1||2
8332107|NCT01358981|20539443|P2|COMPLETED|Period 1||2
8332108|NCT01358981|20539444|P1|COMPLETED|Period 1||2
8332109|NCT01358981|20539438|P7|Received at Least 1dose of Study Drug|Period 1||3
8332110|NCT01358981|20539439|P6|Received at Least 1dose of Study Drug|Period 1||3
8332111|NCT01358981|20539440|P5|Received at Least 1dose of Study Drug|Period 1||3
8332112|NCT01358981|20539441|P4|Received at Least 1dose of Study Drug|Period 1||2
8332113|NCT01358981|20539442|P3|Received at Least 1dose of Study Drug|Period 1||2
8332114|NCT01358981|20539443|P2|Received at Least 1dose of Study Drug|Period 1||2
8332115|NCT01358981|20539444|P1|Received at Least 1dose of Study Drug|Period 1||2
8332116|NCT01358981|20539438|P7|STARTED|Period 1||3
8332117|NCT01358981|20539439|P6|STARTED|Period 1||3
8332118|NCT01358981|20539440|P5|STARTED|Period 1||3
8332119|NCT01358981|20539441|P4|STARTED|Period 1||2
8332120|NCT01358981|20539442|P3|STARTED|Period 1||2
8332121|NCT01358981|20539443|P2|STARTED|Period 1||2
8332122|NCT01358981|20539444|P1|STARTED|Period 1||2
8332123|NCT01358968|20539505|P4|NOT COMPLETED|Continued Access Phase||7
8332124|NCT01358968|20539506|P3|NOT COMPLETED|Continued Access Phase||12
8332125|NCT01358968|20539507|P2|NOT COMPLETED|Continued Access Phase||0
8332126|NCT01358968|20539508|P1|NOT COMPLETED|Continued Access Phase||0
8332127|NCT01358968|20539505|P4|COMPLETED|Continued Access Phase||0
8332128|NCT01358968|20539506|P3|COMPLETED|Continued Access Phase||0
8332129|NCT01358968|20539507|P2|COMPLETED|Continued Access Phase||0
8332130|NCT01358968|20539508|P1|COMPLETED|Continued Access Phase||0
8332131|NCT01358968|20539505|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
8332132|NCT01358968|20539506|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
8332133|NCT01358968|20539507|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
8332134|NCT01358968|20539508|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
8332135|NCT01358968|20539505|P4|STARTED|Continued Access Phase||7
8332136|NCT01358968|20539506|P3|STARTED|Continued Access Phase||12
8332137|NCT01358968|20539507|P2|STARTED|Continued Access Phase||0
8332138|NCT01358968|20539508|P1|STARTED|Continued Access Phase||0
8332139|NCT01358968|20539505|P4|NOT COMPLETED|Period 2||0
8332140|NCT01358968|20539506|P3|NOT COMPLETED|Period 2||0
8332141|NCT01358968|20539507|P2|NOT COMPLETED|Period 2||1
8332142|NCT01358968|20539508|P1|NOT COMPLETED|Period 2||0
8332143|NCT01358968|20539505|P4|COMPLETED|Period 2||0
8332144|NCT01358968|20539506|P3|COMPLETED|Period 2||0
8332145|NCT01358968|20539507|P2|COMPLETED|Period 2||19
8332146|NCT01358968|20539508|P1|COMPLETED|Period 2||0
8332147|NCT01358968|20539505|P4|Received at Least 1 Dose of Study Drug|Period 2||0
8332148|NCT01358968|20539506|P3|Received at Least 1 Dose of Study Drug|Period 2||0
8332149|NCT01358968|20539507|P2|Received at Least 1 Dose of Study Drug|Period 2||19
8332150|NCT01358968|20539508|P1|Received at Least 1 Dose of Study Drug|Period 2||0
8332151|NCT01358968|20539505|P4|STARTED|Period 2||0
8332152|NCT01358968|20539506|P3|STARTED|Period 2||0
8332153|NCT01358968|20539507|P2|STARTED|Period 2||20
8332154|NCT01358968|20539508|P1|STARTED|Period 2||0
8332155|NCT01358968|20539505|P4|NOT COMPLETED|Period 1||0
8332156|NCT01358968|20539506|P3|NOT COMPLETED|Period 1||0
8332157|NCT01358968|20539507|P2|NOT COMPLETED|Period 1||0
8332158|NCT01358968|20539508|P1|NOT COMPLETED|Period 1||0
8332159|NCT01358968|20539505|P4|COMPLETED|Period 1||0
8332160|NCT01358968|20539506|P3|COMPLETED|Period 1||0
8332161|NCT01358968|20539507|P2|COMPLETED|Period 1||0
8332162|NCT01358968|20539508|P1|COMPLETED|Period 1||20
8332163|NCT01358968|20539505|P4|Received at Least 1 Dose of Study Drug|Period 1||0
8332164|NCT01358968|20539506|P3|Received at Least 1 Dose of Study Drug|Period 1||0
8332165|NCT01358968|20539507|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8332166|NCT01358968|20539508|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8332167|NCT01358968|20539505|P4|STARTED|Period 1||0
8332168|NCT01358968|20539506|P3|STARTED|Period 1||0
8332169|NCT01358968|20539507|P2|STARTED|Period 1||0
8332170|NCT01358968|20539508|P1|STARTED|Period 1||20
8332171|NCT01358877|20539524|P2|NOT COMPLETED|Overall Study||2404
8332172|NCT01358877|20539525|P1|NOT COMPLETED|Overall Study||2400
8332173|NCT01358877|20539524|P2|COMPLETED|Overall Study||0
8332174|NCT01358877|20539525|P1|COMPLETED|Overall Study||0
8332175|NCT01358877|20539524|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
8332176|NCT01358877|20539525|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
8332177|NCT01358877|20539524|P2|Did Not Receive Study Drug|Overall Study||13
8332178|NCT01358877|20539525|P1|Did Not Receive Study Drug|Overall Study||22
8332179|NCT01358877|20539524|P2|STARTED|Overall Study||2404
8332180|NCT01358877|20539525|P1|STARTED|Overall Study||2400
8332181|NCT01358864|20539595|P8|NOT COMPLETED|Overall Study||55
8332182|NCT01358864|20539596|P7|NOT COMPLETED|Overall Study||65
8332183|NCT01358864|20539597|P6|NOT COMPLETED|Overall Study||13
8332184|NCT01358864|20539598|P5|NOT COMPLETED|Overall Study||11
8332185|NCT01358864|20539599|P4|NOT COMPLETED|Overall Study||19
8332186|NCT01358864|20539600|P3|NOT COMPLETED|Overall Study||16
8332187|NCT01358864|20539601|P2|NOT COMPLETED|Overall Study||13
8332188|NCT01358864|20539602|P1|NOT COMPLETED|Overall Study||31
8332189|NCT01358864|20539595|P8|COMPLETED|Overall Study||85
8332190|NCT01358864|20539596|P7|COMPLETED|Overall Study||81
8332191|NCT01358864|20539597|P6|COMPLETED|Overall Study||42
8332192|NCT01358864|20539598|P5|COMPLETED|Overall Study||46
8332193|NCT01358864|20539599|P4|COMPLETED|Overall Study||10
8332194|NCT01358864|20539600|P3|COMPLETED|Overall Study||87
8332195|NCT01358864|20539601|P2|COMPLETED|Overall Study||86
8332196|NCT01358864|20539602|P1|COMPLETED|Overall Study||18
8332197|NCT01358864|20539595|P8|STARTED|Overall Study||140
8332198|NCT01358864|20539596|P7|STARTED|Overall Study||146
8332199|NCT01358864|20539597|P6|STARTED|Overall Study||55
8332200|NCT01358864|20539598|P5|STARTED|Overall Study||57
8332201|NCT01358864|20539599|P4|STARTED|Overall Study||29
8332202|NCT01358864|20539600|P3|STARTED|Overall Study||103
8332203|NCT01358864|20539601|P2|STARTED|Overall Study||99
8332204|NCT01358864|20539602|P1|STARTED|Overall Study||49
8332205|NCT01358825|20539693|P2|NOT COMPLETED|Overall Study||1
8332206|NCT01358825|20539694|P1|NOT COMPLETED|Overall Study||0
8332207|NCT01358825|20539693|P2|COMPLETED|Overall Study||45
8332208|NCT01358825|20539694|P1|COMPLETED|Overall Study||12
8332209|NCT01358825|20539693|P2|STARTED|Overall Study||46
8332210|NCT01358825|20539694|P1|STARTED|Overall Study||12
8332211|NCT01358760|20539718|P3|NOT COMPLETED|Overall Study||25
8332212|NCT01358760|20539719|P2|NOT COMPLETED|Overall Study||20
8332213|NCT01358760|20539720|P1|NOT COMPLETED|Overall Study||22
8332214|NCT01358760|20539718|P3|COMPLETED|Overall Study||125
8332215|NCT01358760|20539719|P2|COMPLETED|Overall Study||128
8332216|NCT01358760|20539720|P1|COMPLETED|Overall Study||130
8332217|NCT01358760|20539718|P3|ITT Population|Overall Study||134
8332218|NCT01358760|20539719|P2|ITT Population|Overall Study||134
8332219|NCT01358760|20539720|P1|ITT Population|Overall Study||139
8332220|NCT01358760|20539718|P3|Safety Population|Overall Study||148
8332221|NCT01358760|20539719|P2|Safety Population|Overall Study||143
8332222|NCT01358760|20539720|P1|Safety Population|Overall Study||150
8332223|NCT01358760|20539718|P3|STARTED|Overall Study||150
8332224|NCT01358760|20539719|P2|STARTED|Overall Study||148
8332225|NCT01358760|20539720|P1|STARTED|Overall Study||152
8332226|NCT01358734|20539755|P3|NOT COMPLETED|Overall Study||34
8332227|NCT01358734|20539756|P2|NOT COMPLETED|Overall Study||39
8332228|NCT01358734|20539757|P1|NOT COMPLETED|Overall Study||15
8332229|NCT01358734|20539755|P3|COMPLETED|Overall Study||0
8332230|NCT01358734|20539756|P2|COMPLETED|Overall Study||0
8332231|NCT01358734|20539757|P1|COMPLETED|Overall Study||0
8332232|NCT01358734|20539755|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
8332233|NCT01358734|20539756|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
8332234|NCT01358734|20539757|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
8332235|NCT01358734|20539755|P3|STARTED|Overall Study||34
8332236|NCT01358734|20539756|P2|STARTED|Overall Study||39
8332237|NCT01358734|20539757|P1|STARTED|Overall Study||15
8332238|NCT01358721|20539805|P4|NOT COMPLETED|Overall Study||24
8332239|NCT01358721|20539806|P3|NOT COMPLETED|Overall Study||22
8332240|NCT01358721|20539807|P2|NOT COMPLETED|Overall Study||22
8332241|NCT01358721|20539808|P1|NOT COMPLETED|Overall Study||21
8332242|NCT01358721|20539805|P4|COMPLETED|Overall Study||0
8332243|NCT01358721|20539806|P3|COMPLETED|Overall Study||1
8332244|NCT01358721|20539807|P2|COMPLETED|Overall Study||0
8332245|NCT01358721|20539808|P1|COMPLETED|Overall Study||1
8332246|NCT01358721|20539805|P4|STARTED|Overall Study||24
8332247|NCT01358721|20539806|P3|STARTED|Overall Study||23
8332248|NCT01358721|20539807|P2|STARTED|Overall Study||22
8332249|NCT01358721|20539808|P1|STARTED|Overall Study||22
8332250|NCT01358708|20539860|P2|NOT COMPLETED|Open-Label Treatment Phase||0
8332251|NCT01358708|20539861|P1|NOT COMPLETED|Open-Label Treatment Phase||0
8332252|NCT01358708|20539860|P2|COMPLETED|Open-Label Treatment Phase||12
8332253|NCT01358708|20539861|P1|COMPLETED|Open-Label Treatment Phase||5
8332254|NCT01358708|20539860|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
8332255|NCT01358708|20539861|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
8332256|NCT01358708|20539860|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
8332257|NCT01358708|20539861|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
8332258|NCT01358708|20539860|P2|COMPLETED|Double-Blind Treatment Phase||13
8332259|NCT01358708|20539861|P1|COMPLETED|Double-Blind Treatment Phase||10
8332260|NCT01358708|20539860|P2|Received Study Medication|Double-Blind Treatment Phase||13
8332261|NCT01358708|20539861|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
8332262|NCT01358708|20539860|P2|Randomized|Double-Blind Treatment Phase||13
8332263|NCT01358708|20539861|P1|Randomized|Double-Blind Treatment Phase||13
8332264|NCT01358708|20539860|P2|STARTED|Double-Blind Treatment Phase||13
8332265|NCT01358708|20539861|P1|STARTED|Double-Blind Treatment Phase||13
8332266|NCT01358578|20539884|P6|NOT COMPLETED|Follow-up Period||0
8332267|NCT01358578|20539885|P5|NOT COMPLETED|Follow-up Period||0
8332268|NCT01358578|20539886|P4|NOT COMPLETED|Follow-up Period||19
8332269|NCT01358578|20539887|P3|NOT COMPLETED|Follow-up Period||5
8332270|NCT01358578|20539888|P2|NOT COMPLETED|Follow-up Period||6
8332271|NCT01358578|20539889|P1|NOT COMPLETED|Follow-up Period||10
8332272|NCT01358578|20539884|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332273|NCT01358578|20539885|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332274|NCT01358578|20539886|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
8332275|NCT01358578|20539887|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
8332276|NCT01358578|20539888|P2|COMPLETED|Follow-up Period||119
8332277|NCT01358578|20539889|P1|COMPLETED|Follow-up Period||138
8332278|NCT01358578|20539884|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332279|NCT01358578|20539885|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332280|NCT01358578|20539886|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
8332281|NCT01358578|20539887|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
8332282|NCT01358578|20539888|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
8332283|NCT01358578|20539889|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
8332284|NCT01358578|20539884|P6|NOT COMPLETED|Maintenance Period||11
8332285|NCT01358578|20539885|P5|NOT COMPLETED|Maintenance Period||17
8332286|NCT01358578|20539886|P4|NOT COMPLETED|Maintenance Period||42
8332287|NCT01358578|20539887|P3|NOT COMPLETED|Maintenance Period||2
8332288|NCT01358578|20539888|P2|NOT COMPLETED|Maintenance Period||22
8332289|NCT01358578|20539889|P1|NOT COMPLETED|Maintenance Period||39
8332290|NCT01358578|20539884|P6|COMPLETED|Maintenance Period||131
8332291|NCT01358578|20539885|P5|COMPLETED|Maintenance Period||125
8332292|NCT01358578|20539886|P4|COMPLETED|Maintenance Period||263
8332293|NCT01358578|20539887|P3|COMPLETED|Maintenance Period||15
8332294|NCT01358578|20539888|P2|COMPLETED|Maintenance Period||290
8332295|NCT01358578|20539889|P1|COMPLETED|Maintenance Period||276
8332296|NCT01358578|20539884|P6|STARTED|Maintenance Period||142
8332297|NCT01358578|20539885|P5|STARTED|Maintenance Period||142
8332298|NCT01358578|20539886|P4|STARTED|Maintenance Period||305
8332299|NCT01358578|20539887|P3|STARTED|Maintenance Period||17
8332300|NCT01358578|20539888|P2|STARTED|Maintenance Period||312
8332301|NCT01358578|20539889|P1|STARTED|Maintenance Period||315
8332302|NCT01358578|20539884|P6|NOT COMPLETED|Induction Period||0
8332303|NCT01358578|20539885|P5|NOT COMPLETED|Induction Period||0
8332304|NCT01358578|20539886|P4|NOT COMPLETED|Induction Period||21
8332305|NCT01358578|20539887|P3|NOT COMPLETED|Induction Period||25
8332306|NCT01358578|20539888|P2|NOT COMPLETED|Induction Period||15
8332307|NCT01358578|20539889|P1|NOT COMPLETED|Induction Period||12
8332308|NCT01358578|20539884|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
8332309|NCT01358578|20539885|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
8332310|NCT01358578|20539886|P4|COMPLETED|Induction Period||305
8332311|NCT01358578|20539887|P3|COMPLETED|Induction Period||301
8332312|NCT01358578|20539888|P2|COMPLETED|Induction Period||312
8332313|NCT01358578|20539889|P1|COMPLETED|Induction Period||315
8332314|NCT01358578|20539884|P6|STARTED|Induction Period|These groups are populated after the induction period|0
8332315|NCT01358578|20539885|P5|STARTED|Induction Period|These groups are populated after the induction period|0
8332316|NCT01358578|20539886|P4|STARTED|Induction Period||326
8332317|NCT01358578|20539887|P3|STARTED|Induction Period||326
8332318|NCT01358578|20539888|P2|STARTED|Induction Period||327
8332319|NCT01358578|20539889|P1|STARTED|Induction Period||327
8332320|NCT01358526|20539941|P3|NOT COMPLETED|Double-blind Phase||121
8332321|NCT01358526|20539942|P2|NOT COMPLETED|Double-blind Phase||80
8332322|NCT01358526|20539943|P1|NOT COMPLETED|Double-blind Phase||0
8332323|NCT01358526|20539941|P3|COMPLETED|Double-blind Phase||181
8332324|NCT01358526|20539942|P2|COMPLETED|Double-blind Phase||218
8332325|NCT01358526|20539943|P1|COMPLETED|Double-blind Phase||0
8332326|NCT01358526|20539941|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
8332327|NCT01358526|20539942|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
8332328|NCT01358526|20539943|P1|STARTED|Double-blind Phase||0
8332329|NCT01358526|20539941|P3|NOT COMPLETED|Open-label Titration Period||0
8332330|NCT01358526|20539942|P2|NOT COMPLETED|Open-label Titration Period||0
8332331|NCT01358526|20539943|P1|NOT COMPLETED|Open-label Titration Period||494
8332332|NCT01358526|20539941|P3|COMPLETED|Open-label Titration Period||0
8332333|NCT01358526|20539942|P2|COMPLETED|Open-label Titration Period||0
8332334|NCT01358526|20539943|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
8332335|NCT01358526|20539941|P3|STARTED|Open-label Titration Period||0
8332336|NCT01358526|20539942|P2|STARTED|Open-label Titration Period||0
8332337|NCT01358526|20539943|P1|STARTED|Open-label Titration Period||1095
8332338|NCT01358357|20539960|P3|NOT COMPLETED|Double-Blind Phase||0
8332339|NCT01358357|20539961|P2|NOT COMPLETED|Double-Blind Phase||100
8332340|NCT01358357|20539962|P1|NOT COMPLETED|Double-Blind Phase||80
8332341|NCT01358357|20539960|P3|COMPLETED|Double-Blind Phase||0
8332342|NCT01358357|20539961|P2|COMPLETED|Double-Blind Phase||150
8332343|NCT01358357|20539962|P1|COMPLETED|Double-Blind Phase||166
8332344|NCT01358357|20539960|P3|STARTED|Double-Blind Phase||0
8332345|NCT01358357|20539961|P2|STARTED|Double-Blind Phase||250
8332346|NCT01358357|20539962|P1|STARTED|Double-Blind Phase||246
8332347|NCT01358357|20539960|P3|NOT COMPLETED|Open Label Phase||462
8332348|NCT01358357|20539961|P2|NOT COMPLETED|Open Label Phase||0
8332349|NCT01358357|20539962|P1|NOT COMPLETED|Open Label Phase||0
8332350|NCT01358357|20539960|P3|COMPLETED|Open Label Phase||503
8332351|NCT01358357|20539961|P2|COMPLETED|Open Label Phase||0
8332352|NCT01358357|20539962|P1|COMPLETED|Open Label Phase||0
8332353|NCT01358357|20539960|P3|STARTED|Open Label Phase||965
8332354|NCT01358357|20539961|P2|STARTED|Open Label Phase||0
8332355|NCT01358357|20539962|P1|STARTED|Open Label Phase||0
8332356|NCT01358331|20540001|P6|NOT COMPLETED|Overall Study||6
8332357|NCT01358331|20540002|P5|NOT COMPLETED|Overall Study||7
8332358|NCT01358331|20540003|P4|NOT COMPLETED|Overall Study||3
8332359|NCT01358331|20540004|P3|NOT COMPLETED|Overall Study||4
8332360|NCT01358331|20540005|P2|NOT COMPLETED|Overall Study||3
8332361|NCT01358331|20540006|P1|NOT COMPLETED|Overall Study||2
8332362|NCT01358331|20540001|P6|COMPLETED|Overall Study||0
8332363|NCT01358331|20540002|P5|COMPLETED|Overall Study||0
8332364|NCT01358331|20540003|P4|COMPLETED|Overall Study||0
8332365|NCT01358331|20540004|P3|COMPLETED|Overall Study||0
8332366|NCT01358331|20540005|P2|COMPLETED|Overall Study||0
8332367|NCT01358331|20540006|P1|COMPLETED|Overall Study||0
8332368|NCT01358331|20540001|P6|STARTED|Overall Study||6
8332369|NCT01358331|20540002|P5|STARTED|Overall Study||7
8332370|NCT01358331|20540003|P4|STARTED|Overall Study||3
8332371|NCT01358331|20540004|P3|STARTED|Overall Study||4
8332372|NCT01358331|20540005|P2|STARTED|Overall Study||3
8332373|NCT01358331|20540006|P1|STARTED|Overall Study||2
8332374|NCT01358266|20540029|P3|NOT COMPLETED|Open-Label Period||70
8332375|NCT01358266|20540030|P2|NOT COMPLETED|Open-Label Period||44
8332376|NCT01358266|20540031|P1|NOT COMPLETED|Open-Label Period||56
8332377|NCT01358266|20540029|P3|COMPLETED|Open-Label Period||44
8332378|NCT01358266|20540030|P2|COMPLETED|Open-Label Period||58
8332379|NCT01358266|20540031|P1|COMPLETED|Open-Label Period||63
8332380|NCT01358266|20540029|P3|STARTED|Open-Label Period||114
8332381|NCT01358266|20540030|P2|STARTED|Open-Label Period||102
8332382|NCT01358266|20540031|P1|STARTED|Open-Label Period||119
8332383|NCT01358266|20540029|P3|NOT COMPLETED|Double-Masked Period||39
8332384|NCT01358266|20540030|P2|NOT COMPLETED|Double-Masked Period||46
8332385|NCT01358266|20540031|P1|NOT COMPLETED|Double-Masked Period||33
8332386|NCT01358266|20540029|P3|COMPLETED|Double-Masked Period||137
8332387|NCT01358266|20540030|P2|COMPLETED|Double-Masked Period||162
8332388|NCT01358266|20540031|P1|COMPLETED|Double-Masked Period||175
8332389|NCT01358266|20540029|P3|STARTED|Double-Masked Period||176
8332390|NCT01358266|20540030|P2|STARTED|Double-Masked Period||208
8332391|NCT01358266|20540031|P1|STARTED|Double-Masked Period||208
8332392|NCT01358175|20540058|P3|NOT COMPLETED|Overall Study||32
8332393|NCT01358175|20540059|P2|NOT COMPLETED|Overall Study||28
8332394|NCT01358175|20540060|P1|NOT COMPLETED|Overall Study||21
8332395|NCT01358175|20540058|P3|COMPLETED|Overall Study||90
8332396|NCT01358175|20540059|P2|COMPLETED|Overall Study||97
8332397|NCT01358175|20540060|P1|COMPLETED|Overall Study||103
8332398|NCT01358175|20540058|P3|STARTED|Overall Study||122
8332399|NCT01358175|20540059|P2|STARTED|Overall Study||125
8332400|NCT01358175|20540060|P1|STARTED|Overall Study||124
8332401|NCT01357980|20540097|P4|NOT COMPLETED|Overall Study||0
8332402|NCT01357980|20540098|P3|NOT COMPLETED|Overall Study||1
8332403|NCT01357980|20540099|P2|NOT COMPLETED|Overall Study||1
8332404|NCT01357980|20540100|P1|NOT COMPLETED|Overall Study||0
8332405|NCT01357980|20540097|P4|COMPLETED|Overall Study||7
8332406|NCT01357980|20540098|P3|COMPLETED|Overall Study||16
8332407|NCT01357980|20540099|P2|COMPLETED|Overall Study||6
8332408|NCT01357980|20540100|P1|COMPLETED|Overall Study||16
8332409|NCT01357980|20540097|P4|STARTED|Overall Study||7
8332410|NCT01357980|20540098|P3|STARTED|Overall Study||17
8332411|NCT01357980|20540099|P2|STARTED|Overall Study||7
8332412|NCT01357980|20540100|P1|STARTED|Overall Study||16
8332413|NCT01357915|20540144|P2|NOT COMPLETED|Overall Study||0
8332414|NCT01357915|20540145|P1|NOT COMPLETED|Overall Study||3
8332415|NCT01357915|20540144|P2|COMPLETED|Overall Study||17
8332416|NCT01357915|20540145|P1|COMPLETED|Overall Study||27
8332417|NCT01357915|20540144|P2|STARTED|Overall Study||17
8332418|NCT01357915|20540145|P1|STARTED|Overall Study||30
8332419|NCT01357889|20540163|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
8332420|NCT01357889|20540164|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
8332421|NCT01357889|20540163|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
8332422|NCT01357889|20540164|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
8332423|NCT01357889|20540163|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
8332424|NCT01357889|20540164|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
8332425|NCT01357889|20540163|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
8332426|NCT01357889|20540164|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
8332427|NCT01357889|20540163|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
8332428|NCT01357889|20540164|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
8332429|NCT01357889|20540163|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
8332430|NCT01357889|20540164|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
8332431|NCT01357889|20540163|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
8332432|NCT01357889|20540164|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
8332433|NCT01357889|20540163|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
8332434|NCT01357889|20540164|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
8332435|NCT01357889|20540163|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
8332436|NCT01357889|20540164|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
8332437|NCT01357850|20540208|P4|NOT COMPLETED|Overall Study||0
8332438|NCT01357850|20540209|P3|NOT COMPLETED|Overall Study||0
8332439|NCT01357850|20540210|P2|NOT COMPLETED|Overall Study||0
8332440|NCT01357850|20540211|P1|NOT COMPLETED|Overall Study||1
8332441|NCT01357850|20540208|P4|COMPLETED|Overall Study||27
8332442|NCT01357850|20540209|P3|COMPLETED|Overall Study||13
8332443|NCT01357850|20540210|P2|COMPLETED|Overall Study||12
8332444|NCT01357850|20540211|P1|COMPLETED|Overall Study||29
8332445|NCT01357850|20540208|P4|STARTED|Overall Study||27
8332446|NCT01357850|20540209|P3|STARTED|Overall Study||13
8332447|NCT01357850|20540210|P2|STARTED|Overall Study||12
8332448|NCT01357850|20540211|P1|STARTED|Overall Study||30
8332449|NCT01357720|20540285|P2|NOT COMPLETED|Overall Study||5
8332450|NCT01357720|20540286|P1|NOT COMPLETED|Overall Study||2
8332451|NCT01357720|20540285|P2|COMPLETED|Overall Study||195
8332452|NCT01357720|20540286|P1|COMPLETED|Overall Study||198
8332453|NCT01357720|20540285|P2|STARTED|Overall Study||200
8332454|NCT01357720|20540286|P1|STARTED|Overall Study||200
8332455|NCT01357655|20540302|P2|NOT COMPLETED|Overall Study||0
8332456|NCT01357655|20540303|P1|NOT COMPLETED|Overall Study||66
8332457|NCT01357655|20540302|P2|COMPLETED|Overall Study||0
8332458|NCT01357655|20540303|P1|COMPLETED|Overall Study||0
8332459|NCT01357655|20540302|P2|STARTED|Overall Study||0
8332460|NCT01357655|20540303|P1|STARTED|Overall Study||66
8332461|NCT01357616|20540320|P2|NOT COMPLETED|Overall Study||9
8332462|NCT01357616|20540321|P1|NOT COMPLETED|Overall Study||10
8332463|NCT01357616|20540320|P2|COMPLETED|Overall Study||153
8332464|NCT01357616|20540321|P1|COMPLETED|Overall Study||156
8332465|NCT01357616|20540320|P2|STARTED|Overall Study||162
8332466|NCT01357616|20540321|P1|STARTED|Overall Study||166
8332467|NCT01357577|20540335|P2|NOT COMPLETED|Overall Study||26
8332468|NCT01357577|20540336|P1|NOT COMPLETED|Overall Study||37
8332469|NCT01357577|20540335|P2|COMPLETED|Overall Study||39
8332470|NCT01357577|20540336|P1|COMPLETED|Overall Study||27
8332471|NCT01357577|20540335|P2|Post-Treatment Assessment Completed|Overall Study||39
8332472|NCT01357577|20540336|P1|Post-Treatment Assessment Completed|Overall Study||24
8332473|NCT01357577|20540335|P2|STARTED|Overall Study||65
8332474|NCT01357577|20540336|P1|STARTED|Overall Study||64
8332475|NCT01357564|20540352|P2|NOT COMPLETED|Long-term (8-month) Follow-up||16
8332476|NCT01357564|20540353|P1|NOT COMPLETED|Long-term (8-month) Follow-up||2
8332477|NCT01357564|20540352|P2|COMPLETED|Long-term (8-month) Follow-up||102
8332478|NCT01357564|20540353|P1|COMPLETED|Long-term (8-month) Follow-up||104
8332479|NCT01357564|20540352|P2|STARTED|Long-term (8-month) Follow-up||118
8332480|NCT01357564|20540353|P1|STARTED|Long-term (8-month) Follow-up||106
8332481|NCT01357564|20540352|P2|NOT COMPLETED|Short-term (4-month) Follow up||50
8332482|NCT01357564|20540353|P1|NOT COMPLETED|Short-term (4-month) Follow up||48
8332483|NCT01357564|20540352|P2|COMPLETED|Short-term (4-month) Follow up||118
8332484|NCT01357564|20540353|P1|COMPLETED|Short-term (4-month) Follow up||106
8332485|NCT01357564|20540352|P2|STARTED|Short-term (4-month) Follow up||168
8332486|NCT01357564|20540353|P1|STARTED|Short-term (4-month) Follow up||154
8332487|NCT01357551|20540363|P2|NOT COMPLETED|Overall Study||11
8332488|NCT01357551|20540364|P1|NOT COMPLETED|Overall Study||22
8332489|NCT01357551|20540363|P2|COMPLETED|Overall Study||101
8332490|NCT01357551|20540364|P1|COMPLETED|Overall Study||88
8332491|NCT01357551|20540363|P2|STARTED|Overall Study||112
8332492|NCT01357551|20540364|P1|STARTED|Overall Study||110
8332493|NCT01357512|20540378|P2|NOT COMPLETED|Overall Study||5
8332494|NCT01357512|20540379|P1|NOT COMPLETED|Overall Study||12
8332495|NCT01357512|20540378|P2|COMPLETED|Overall Study||60
8332496|NCT01357512|20540379|P1|COMPLETED|Overall Study||53
8332497|NCT01357512|20540378|P2|STARTED|Overall Study||65
8332498|NCT01357512|20540379|P1|STARTED|Overall Study||65
8332499|NCT01357356|20540391|P4|NOT COMPLETED|Overall Study||17
8332500|NCT01357356|20540392|P3|NOT COMPLETED|Overall Study||28
8332501|NCT01357356|20540393|P2|NOT COMPLETED|Overall Study||25
8332502|NCT01357356|20540394|P1|NOT COMPLETED|Overall Study||22
8332503|NCT01357356|20540391|P4|COMPLETED|Overall Study||171
8332504|NCT01357356|20540392|P3|COMPLETED|Overall Study||158
8332505|NCT01357356|20540393|P2|COMPLETED|Overall Study||163
8332506|NCT01357356|20540394|P1|COMPLETED|Overall Study||166
8332507|NCT01357356|20540391|P4|STARTED|Overall Study||188
8332508|NCT01357356|20540392|P3|STARTED|Overall Study||186
8332509|NCT01357356|20540393|P2|STARTED|Overall Study||188
8332510|NCT01357356|20540394|P1|STARTED|Overall Study||188
8332511|NCT01357239|20540412|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
8332512|NCT01357239|20540413|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
8332513|NCT01357239|20540414|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
8332514|NCT01357239|20540415|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
8332515|NCT01357239|20540412|P4|COMPLETED|Stratum II: Partially-Methylated||18
8332516|NCT01357239|20540413|P3|COMPLETED|Stratum II: Partially-Methylated||21
8332517|NCT01357239|20540414|P2|COMPLETED|Stratum II: Partially-Methylated||21
8332518|NCT01357239|20540415|P1|COMPLETED|Stratum II: Partially-Methylated||23
8332519|NCT01357239|20540412|P4|STARTED|Stratum II: Partially-Methylated||20
8332520|NCT01357239|20540413|P3|STARTED|Stratum II: Partially-Methylated||22
8332521|NCT01357239|20540414|P2|STARTED|Stratum II: Partially-Methylated||21
8332522|NCT01357239|20540415|P1|STARTED|Stratum II: Partially-Methylated||23
8332523|NCT01357239|20540412|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
8332524|NCT01357239|20540413|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
8332525|NCT01357239|20540414|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
8332526|NCT01357239|20540415|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
8332527|NCT01357239|20540412|P4|COMPLETED|Stratum I: Fully-Methylated||22
8332528|NCT01357239|20540413|P3|COMPLETED|Stratum I: Fully-Methylated||16
8332529|NCT01357239|20540414|P2|COMPLETED|Stratum I: Fully-Methylated||6
8332530|NCT01357239|20540415|P1|COMPLETED|Stratum I: Fully-Methylated||8
8332531|NCT01357239|20540412|P4|STARTED|Stratum I: Fully-Methylated||22
8332532|NCT01357239|20540413|P3|STARTED|Stratum I: Fully-Methylated||17
8332533|NCT01357239|20540414|P2|STARTED|Stratum I: Fully-Methylated||6
8332534|NCT01357239|20540415|P1|STARTED|Stratum I: Fully-Methylated||8
8332535|NCT01357239|20540412|P4|NOT COMPLETED|Stratum: All Patients||2
8332536|NCT01357239|20540413|P3|NOT COMPLETED|Stratum: All Patients||2
8332537|NCT01357239|20540414|P2|NOT COMPLETED|Stratum: All Patients||0
8332538|NCT01357239|20540415|P1|NOT COMPLETED|Stratum: All Patients||0
8332539|NCT01357239|20540412|P4|COMPLETED|Stratum: All Patients||40
8332540|NCT01357239|20540413|P3|COMPLETED|Stratum: All Patients||37
8332541|NCT01357239|20540414|P2|COMPLETED|Stratum: All Patients||27
8332542|NCT01357239|20540415|P1|COMPLETED|Stratum: All Patients||31
8332543|NCT01357239|20540412|P4|STARTED|Stratum: All Patients||42
8332544|NCT01357239|20540413|P3|STARTED|Stratum: All Patients||39
8332545|NCT01357239|20540414|P2|STARTED|Stratum: All Patients||27
8332546|NCT01357239|20540415|P1|STARTED|Stratum: All Patients||31
8332547|NCT01357161|20540473|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
8332548|NCT01357161|20540474|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
8332549|NCT01357161|20540475|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
8332550|NCT01357161|20540473|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
8332551|NCT01357161|20540474|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
8332552|NCT01357161|20540475|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
8332553|NCT01357161|20540473|P3|Treated|Part 2 (Double-Blind Comparison)||60
8332554|NCT01357161|20540474|P2|Treated|Part 2 (Double-Blind Comparison)||59
8332555|NCT01357161|20540475|P1|Treated|Part 2 (Double-Blind Comparison)||0
8332556|NCT01357161|20540473|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
8332557|NCT01357161|20540474|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
8332558|NCT01357161|20540475|P1|STARTED|Part 2 (Double-Blind Comparison)||0
8332559|NCT01357161|20540473|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
8332560|NCT01357161|20540474|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
8332561|NCT01357161|20540475|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
8332562|NCT01357161|20540473|P3|COMPLETED|Part 1 (Open Label Run-in)||0
8332563|NCT01357161|20540474|P2|COMPLETED|Part 1 (Open Label Run-in)||0
8332564|NCT01357161|20540475|P1|COMPLETED|Part 1 (Open Label Run-in)||0
8332565|NCT01357161|20540473|P3|STARTED|Part 1 (Open Label Run-in)||0
8332566|NCT01357161|20540474|P2|STARTED|Part 1 (Open Label Run-in)||0
8332567|NCT01357161|20540475|P1|STARTED|Part 1 (Open Label Run-in)||15
8332568|NCT01357148|20540504|P1|NOT COMPLETED|Overall Study||0
8332569|NCT01357148|20540504|P1|COMPLETED|Overall Study||143
8332570|NCT01357148|20540504|P1|STARTED|Overall Study||143
8332571|NCT01357135|20540514|P3|NOT COMPLETED|Overall Study||263
8332572|NCT01357135|20540515|P2|NOT COMPLETED|Overall Study||223
8332573|NCT01357135|20540516|P1|NOT COMPLETED|Overall Study||598
8332574|NCT01357135|20540514|P3|COMPLETED|Overall Study||583
8332575|NCT01357135|20540515|P2|COMPLETED|Overall Study||510
8332576|NCT01357135|20540516|P1|COMPLETED|Overall Study||1276
8332577|NCT01357135|20540514|P3|STARTED|Overall Study||846
8332578|NCT01357135|20540515|P2|STARTED|Overall Study||733
8332579|NCT01357135|20540516|P1|STARTED|Overall Study||1874
8332580|NCT01356966|20540527|P2|NOT COMPLETED|Overall Study||2
8332581|NCT01356966|20540528|P1|NOT COMPLETED|Overall Study||2
8332582|NCT01356966|20540527|P2|COMPLETED|Overall Study||12
8332583|NCT01356966|20540528|P1|COMPLETED|Overall Study||16
8332584|NCT01356966|20540527|P2|STARTED|Overall Study||14
8332585|NCT01356966|20540528|P1|STARTED|Overall Study||18
8332586|NCT01356940|20540540|P2|NOT COMPLETED|Second Intervention (28 Days)||0
8332587|NCT01356940|20540541|P1|NOT COMPLETED|Second Intervention (28 Days)||1
8332588|NCT01356940|20540540|P2|COMPLETED|Second Intervention (28 Days)||21
8332589|NCT01356940|20540541|P1|COMPLETED|Second Intervention (28 Days)||20
8332590|NCT01356940|20540540|P2|STARTED|Second Intervention (28 Days)||21
8332591|NCT01356940|20540541|P1|STARTED|Second Intervention (28 Days)||21
8332592|NCT01356940|20540540|P2|NOT COMPLETED|Washout (14 Days)||0
8332593|NCT01356940|20540541|P1|NOT COMPLETED|Washout (14 Days)||0
8332594|NCT01356940|20540540|P2|COMPLETED|Washout (14 Days)||21
8332595|NCT01356940|20540541|P1|COMPLETED|Washout (14 Days)||21
8332596|NCT01356940|20540540|P2|STARTED|Washout (14 Days)||21
8332597|NCT01356940|20540541|P1|STARTED|Washout (14 Days)||21
8332598|NCT01356940|20540540|P2|NOT COMPLETED|First Intervention (28 Days)||0
8332599|NCT01356940|20540541|P1|NOT COMPLETED|First Intervention (28 Days)||1
8332600|NCT01356940|20540540|P2|COMPLETED|First Intervention (28 Days)||21
8332601|NCT01356940|20540541|P1|COMPLETED|First Intervention (28 Days)||21
8332602|NCT01356940|20540540|P2|STARTED|First Intervention (28 Days)||21
8332603|NCT01356940|20540541|P1|STARTED|First Intervention (28 Days)||22
8332604|NCT01356667|20540551|P2|NOT COMPLETED|Overall Study||6
8332605|NCT01356667|20540552|P1|NOT COMPLETED|Overall Study||4
8332606|NCT01356667|20540551|P2|COMPLETED|Overall Study||0
8332607|NCT01356667|20540552|P1|COMPLETED|Overall Study||0
8332608|NCT01356667|20540551|P2|STARTED|Overall Study||6
8332609|NCT01356667|20540552|P1|STARTED|Overall Study||4
8332610|NCT01356628|20540562|P1|NOT COMPLETED|Overall Study||0
8332611|NCT01356628|20540562|P1|COMPLETED|Overall Study||23
8332612|NCT01356628|20540562|P1|STARTED|Overall Study||23
8332613|NCT01356602|20540570|P3|NOT COMPLETED|Overall Study||24
8332614|NCT01356602|20540571|P2|NOT COMPLETED|Overall Study||15
8332615|NCT01356602|20540572|P1|NOT COMPLETED|Overall Study||9
8332616|NCT01356602|20540570|P3|COMPLETED|Overall Study||108
8332617|NCT01356602|20540571|P2|COMPLETED|Overall Study||117
8332618|NCT01356602|20540572|P1|COMPLETED|Overall Study||124
8332619|NCT01356602|20540570|P3|Full Analysis Set|Overall Study||129
8332620|NCT01356602|20540571|P2|Full Analysis Set|Overall Study||129
8332621|NCT01356602|20540572|P1|Full Analysis Set|Overall Study||131
8332622|NCT01356602|20540570|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
8332623|NCT01356602|20540571|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
8332624|NCT01356602|20540572|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
8332625|NCT01356602|20540570|P3|STARTED|Overall Study||132
8332626|NCT01356602|20540571|P2|STARTED|Overall Study||132
8332627|NCT01356602|20540572|P1|STARTED|Overall Study||133
8332628|NCT01356589|20540631|P1|NOT COMPLETED|Overall Study||5
8332629|NCT01356589|20540631|P1|COMPLETED|Overall Study||1283
8332630|NCT01356589|20540631|P1|Treated|Overall Study||1285
8332631|NCT01356589|20540631|P1|STARTED|Overall Study||1288
8332632|NCT01356498|20540643|P6|NOT COMPLETED|Overall Study||14
8332633|NCT01356498|20540644|P5|NOT COMPLETED|Overall Study||20
8332634|NCT01356498|20540645|P4|NOT COMPLETED|Overall Study||14
8332635|NCT01356498|20540646|P3|NOT COMPLETED|Overall Study||12
8332636|NCT01356498|20540647|P2|NOT COMPLETED|Overall Study||8
8332637|NCT01356498|20540648|P1|NOT COMPLETED|Overall Study||11
8332638|NCT01356498|20540643|P6|COMPLETED|Overall Study||2
8332639|NCT01356498|20540644|P5|COMPLETED|Overall Study||8
8332640|NCT01356498|20540645|P4|COMPLETED|Overall Study||8
8332641|NCT01356498|20540646|P3|COMPLETED|Overall Study||11
8332642|NCT01356498|20540647|P2|COMPLETED|Overall Study||17
8332643|NCT01356498|20540648|P1|COMPLETED|Overall Study||24
8332644|NCT01356498|20540643|P6|STARTED|Overall Study||16
8332645|NCT01356498|20540644|P5|STARTED|Overall Study||28
8332646|NCT01356498|20540645|P4|STARTED|Overall Study||22
8332647|NCT01356498|20540646|P3|STARTED|Overall Study||23
8332648|NCT01356498|20540647|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
8332649|NCT01356498|20540648|P1|STARTED|Overall Study||35
8332650|NCT01356407|20540688|P2|NOT COMPLETED|Overall Study||4
8332651|NCT01356407|20540689|P1|NOT COMPLETED|Overall Study||6
8332652|NCT01356407|20540688|P2|COMPLETED|Overall Study||146
8332653|NCT01356407|20540689|P1|COMPLETED|Overall Study||144
8332654|NCT01356407|20540688|P2|STARTED|Overall Study||150
8332655|NCT01356407|20540689|P1|STARTED|Overall Study||150
8332656|NCT01356277|20540707|P2|NOT COMPLETED|Intervention Interval||7
8332657|NCT01356277|20540708|P1|NOT COMPLETED|Intervention Interval||10
8332658|NCT01356277|20540707|P2|COMPLETED|Intervention Interval||81
8332659|NCT01356277|20540708|P1|COMPLETED|Intervention Interval||66
8332660|NCT01356277|20540707|P2|STARTED|Intervention Interval||88
8332661|NCT01356277|20540708|P1|STARTED|Intervention Interval||76
8332662|NCT01356277|20540707|P2|NOT COMPLETED|Run-in||0
8332663|NCT01356277|20540708|P1|NOT COMPLETED|Run-in||5
8332664|NCT01356277|20540707|P2|COMPLETED|Run-in||88
8332665|NCT01356277|20540708|P1|COMPLETED|Run-in||76
8332666|NCT01356277|20540707|P2|STARTED|Run-in||88
8332667|NCT01356277|20540708|P1|STARTED|Run-in||81
8332668|NCT01356147|20540728|P2|NOT COMPLETED|Overall Study||0
8332669|NCT01356147|20540729|P1|NOT COMPLETED|Overall Study||0
8332670|NCT01356147|20540728|P2|COMPLETED|Overall Study||6
8332671|NCT01356147|20540729|P1|COMPLETED|Overall Study||5
8332672|NCT01356147|20540728|P2|STARTED|Overall Study||6
8332673|NCT01356147|20540729|P1|STARTED|Overall Study||5
8332674|NCT01355978|20540739|P1|NOT COMPLETED|Overall Study||4
8332675|NCT01355978|20540739|P1|COMPLETED|Overall Study||18
8332676|NCT01355978|20540739|P1|STARTED|Overall Study||22
8332677|NCT01355796|20540745|P2|NOT COMPLETED|Overall Study||0
8332678|NCT01355796|20540746|P1|NOT COMPLETED|Overall Study||0
8332679|NCT01355796|20540745|P2|COMPLETED|Overall Study||15
8332680|NCT01355796|20540746|P1|COMPLETED|Overall Study||15
8332681|NCT01355796|20540745|P2|Second Intervention for 14 Days|Overall Study||15
8332682|NCT01355796|20540746|P1|Second Intervention for 14 Days|Overall Study||15
8332683|NCT01355796|20540745|P2|Washout Period for 7 Days|Overall Study||15
8332684|NCT01355796|20540746|P1|Washout Period for 7 Days|Overall Study||15
8332685|NCT01355796|20540745|P2|First Intervention for 14 Days|Overall Study||15
8332686|NCT01355796|20540746|P1|First Intervention for 14 Days|Overall Study||15
8332687|NCT01355796|20540745|P2|STARTED|Overall Study||15
8332688|NCT01355796|20540746|P1|STARTED|Overall Study||15
8332689|NCT01355705|20540754|P1|NOT COMPLETED|Overall Study||0
8332690|NCT01355705|20540754|P1|COMPLETED|Overall Study||14
8332691|NCT01355705|20540754|P1|STARTED|Overall Study||14
8332692|NCT01355679|20540761|P1|NOT COMPLETED|Overall Study||2
8332693|NCT01355679|20540761|P1|COMPLETED|Overall Study||14
8332694|NCT01355679|20540761|P1|STARTED|Overall Study||16
8332695|NCT01355627|20540770|P2|NOT COMPLETED|Overall Study||38
8332696|NCT01355627|20540771|P1|NOT COMPLETED|Overall Study||33
8332697|NCT01355627|20540770|P2|COMPLETED|Overall Study||326
8332698|NCT01355627|20540771|P1|COMPLETED|Overall Study||329
8332699|NCT01355627|20540770|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
8332700|NCT01355627|20540771|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
8332701|NCT01355627|20540770|P2|Safety Analysis Set|Overall Study||364
8332702|NCT01355627|20540771|P1|Safety Analysis Set|Overall Study||362
8332703|NCT01355627|20540770|P2|STARTED|Overall Study||364
8332704|NCT01355627|20540771|P1|STARTED|Overall Study||362
8332705|NCT01355588|20540783|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332706|NCT01355588|20540784|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332707|NCT01355588|20540785|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332708|NCT01355588|20540786|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332709|NCT01355588|20540783|P4|COMPLETED|Fourth Intervention (After Washout)||4
8332710|NCT01355588|20540784|P3|COMPLETED|Fourth Intervention (After Washout)||4
8332711|NCT01355588|20540785|P2|COMPLETED|Fourth Intervention (After Washout)||4
8332712|NCT01355588|20540786|P1|COMPLETED|Fourth Intervention (After Washout)||4
8332713|NCT01355588|20540783|P4|STARTED|Fourth Intervention (After Washout)||4
8332714|NCT01355588|20540784|P3|STARTED|Fourth Intervention (After Washout)||4
8332715|NCT01355588|20540785|P2|STARTED|Fourth Intervention (After Washout)||4
8332716|NCT01355588|20540786|P1|STARTED|Fourth Intervention (After Washout)||4
8332717|NCT01355588|20540783|P4|NOT COMPLETED|Washout (3-7 Days)||0
8332718|NCT01355588|20540784|P3|NOT COMPLETED|Washout (3-7 Days)||0
8332719|NCT01355588|20540785|P2|NOT COMPLETED|Washout (3-7 Days)||0
8332720|NCT01355588|20540786|P1|NOT COMPLETED|Washout (3-7 Days)||0
8332721|NCT01355588|20540783|P4|COMPLETED|Washout (3-7 Days)||4
8332722|NCT01355588|20540784|P3|COMPLETED|Washout (3-7 Days)||4
8332723|NCT01355588|20540785|P2|COMPLETED|Washout (3-7 Days)||4
8332724|NCT01355588|20540786|P1|COMPLETED|Washout (3-7 Days)||4
8332725|NCT01355588|20540783|P4|STARTED|Washout (3-7 Days)||4
8332726|NCT01355588|20540784|P3|STARTED|Washout (3-7 Days)||4
8332727|NCT01355588|20540785|P2|STARTED|Washout (3-7 Days)||4
8332728|NCT01355588|20540786|P1|STARTED|Washout (3-7 Days)||4
8332729|NCT01355588|20540783|P4|NOT COMPLETED|Third Intervention (After Washout)||0
8332730|NCT01355588|20540784|P3|NOT COMPLETED|Third Intervention (After Washout)||0
8332731|NCT01355588|20540785|P2|NOT COMPLETED|Third Intervention (After Washout)||0
8332732|NCT01355588|20540786|P1|NOT COMPLETED|Third Intervention (After Washout)||0
8332733|NCT01355588|20540783|P4|COMPLETED|Third Intervention (After Washout)||4
8332734|NCT01355588|20540784|P3|COMPLETED|Third Intervention (After Washout)||4
8332735|NCT01355588|20540785|P2|COMPLETED|Third Intervention (After Washout)||4
8332736|NCT01355588|20540786|P1|COMPLETED|Third Intervention (After Washout)||4
8332737|NCT01355588|20540783|P4|STARTED|Third Intervention (After Washout)||4
8332738|NCT01355588|20540784|P3|STARTED|Third Intervention (After Washout)||4
8332739|NCT01355588|20540785|P2|STARTED|Third Intervention (After Washout)||4
8332740|NCT01355588|20540786|P1|STARTED|Third Intervention (After Washout)||4
8332741|NCT01355588|20540783|P4|NOT COMPLETED|Washout (3-7 Days)||0
8332742|NCT01355588|20540784|P3|NOT COMPLETED|Washout (3-7 Days)||0
8332743|NCT01355588|20540785|P2|NOT COMPLETED|Washout (3-7 Days)||0
8332744|NCT01355588|20540786|P1|NOT COMPLETED|Washout (3-7 Days)||0
8332745|NCT01355588|20540783|P4|COMPLETED|Washout (3-7 Days)||4
8332746|NCT01355588|20540784|P3|COMPLETED|Washout (3-7 Days)||4
8332747|NCT01355588|20540785|P2|COMPLETED|Washout (3-7 Days)||4
8332748|NCT01355588|20540786|P1|COMPLETED|Washout (3-7 Days)||4
8332749|NCT01355588|20540783|P4|STARTED|Washout (3-7 Days)||4
8332750|NCT01355588|20540784|P3|STARTED|Washout (3-7 Days)||4
8332751|NCT01355588|20540785|P2|STARTED|Washout (3-7 Days)||4
8332752|NCT01355588|20540786|P1|STARTED|Washout (3-7 Days)||4
8332753|NCT01355588|20540783|P4|NOT COMPLETED|Second Intervention (After Washout)||0
8332754|NCT01355588|20540784|P3|NOT COMPLETED|Second Intervention (After Washout)||0
8332755|NCT01355588|20540785|P2|NOT COMPLETED|Second Intervention (After Washout)||0
8332756|NCT01355588|20540786|P1|NOT COMPLETED|Second Intervention (After Washout)||0
8332757|NCT01355588|20540783|P4|COMPLETED|Second Intervention (After Washout)||4
8332758|NCT01355588|20540784|P3|COMPLETED|Second Intervention (After Washout)||4
8332759|NCT01355588|20540785|P2|COMPLETED|Second Intervention (After Washout)||4
8332760|NCT01355588|20540786|P1|COMPLETED|Second Intervention (After Washout)||4
8332761|NCT01355588|20540783|P4|STARTED|Second Intervention (After Washout)||4
8332762|NCT01355588|20540784|P3|STARTED|Second Intervention (After Washout)||4
8332763|NCT01355588|20540785|P2|STARTED|Second Intervention (After Washout)||4
8332764|NCT01355588|20540786|P1|STARTED|Second Intervention (After Washout)||4
8332765|NCT01355588|20540783|P4|NOT COMPLETED|Washout (3-7 Days)||0
8332766|NCT01355588|20540784|P3|NOT COMPLETED|Washout (3-7 Days)||0
8332767|NCT01355588|20540785|P2|NOT COMPLETED|Washout (3-7 Days)||0
8332768|NCT01355588|20540786|P1|NOT COMPLETED|Washout (3-7 Days)||0
8332769|NCT01355588|20540783|P4|COMPLETED|Washout (3-7 Days)||4
8332770|NCT01355588|20540784|P3|COMPLETED|Washout (3-7 Days)||4
8332771|NCT01355588|20540785|P2|COMPLETED|Washout (3-7 Days)||4
8332772|NCT01355588|20540786|P1|COMPLETED|Washout (3-7 Days)||4
8332773|NCT01355588|20540783|P4|STARTED|Washout (3-7 Days)||4
8332774|NCT01355588|20540784|P3|STARTED|Washout (3-7 Days)||4
8332775|NCT01355588|20540785|P2|STARTED|Washout (3-7 Days)||4
8332776|NCT01355588|20540786|P1|STARTED|Washout (3-7 Days)||4
8332777|NCT01355588|20540783|P4|NOT COMPLETED|First Intervention (Day 1)||0
8332778|NCT01355588|20540784|P3|NOT COMPLETED|First Intervention (Day 1)||0
8332779|NCT01355588|20540785|P2|NOT COMPLETED|First Intervention (Day 1)||0
8332780|NCT01355588|20540786|P1|NOT COMPLETED|First Intervention (Day 1)||0
8332781|NCT01355588|20540783|P4|COMPLETED|First Intervention (Day 1)||4
8332782|NCT01355588|20540784|P3|COMPLETED|First Intervention (Day 1)||4
8332783|NCT01355588|20540785|P2|COMPLETED|First Intervention (Day 1)||4
8332784|NCT01355588|20540786|P1|COMPLETED|First Intervention (Day 1)||4
8332785|NCT01355588|20540783|P4|STARTED|First Intervention (Day 1)||4
8332786|NCT01355588|20540784|P3|STARTED|First Intervention (Day 1)||4
8332787|NCT01355588|20540785|P2|STARTED|First Intervention (Day 1)||4
8332788|NCT01355588|20540786|P1|STARTED|First Intervention (Day 1)||4
8332789|NCT01355575|20540808|P1|NOT COMPLETED|Overall Study||2
8332790|NCT01355575|20540808|P1|COMPLETED|Overall Study||13
8332791|NCT01355575|20540808|P1|STARTED|Overall Study||15
8332792|NCT01355523|20540820|P2|NOT COMPLETED|Overall Study||10
8332793|NCT01355523|20540821|P1|NOT COMPLETED|Overall Study||1
8332794|NCT01355523|20540820|P2|COMPLETED|Overall Study||16
8332795|NCT01355523|20540821|P1|COMPLETED|Overall Study||27
8332796|NCT01355523|20540820|P2|STARTED|Overall Study||26
8332797|NCT01355523|20540821|P1|STARTED|Overall Study||28
8332798|NCT01355497|20540865|P2|NOT COMPLETED|Overall Study||63
8332799|NCT01355497|20540866|P1|NOT COMPLETED|Overall Study||66
8332800|NCT01355497|20540865|P2|COMPLETED|Overall Study||102
8332801|NCT01355497|20540866|P1|COMPLETED|Overall Study||99
8332802|NCT01355497|20540865|P2|STARTED|Overall Study||165
8332803|NCT01355497|20540866|P1|STARTED|Overall Study||165
8332804|NCT01355484|20540876|P2|NOT COMPLETED|Overall Study||54
8332805|NCT01355484|20540877|P1|NOT COMPLETED|Overall Study||51
8332806|NCT01355484|20540876|P2|COMPLETED|Overall Study||107
8332807|NCT01355484|20540877|P1|COMPLETED|Overall Study||109
8332808|NCT01355484|20540876|P2|STARTED|Overall Study||161
8332809|NCT01355484|20540877|P1|STARTED|Overall Study||160
8332822|NCT01355419|20540903|P1|NOT COMPLETED|Overall Study||8
8332823|NCT01355419|20540903|P1|COMPLETED|Overall Study||142
8332824|NCT01355419|20540903|P1|STARTED|Overall Study||150
8332825|NCT01355302|20540908|P3|NOT COMPLETED|Phase 2||0
8332826|NCT01355302|20540909|P2|NOT COMPLETED|Phase 2||0
8332827|NCT01355302|20540910|P1|NOT COMPLETED|Phase 2||0
8332828|NCT01355302|20540908|P3|COMPLETED|Phase 2||0
8332829|NCT01355302|20540909|P2|COMPLETED|Phase 2||0
8332830|NCT01355302|20540910|P1|COMPLETED|Phase 2||0
8332831|NCT01355302|20540908|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
8332832|NCT01355302|20540909|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
8332833|NCT01355302|20540910|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
8332834|NCT01355302|20540908|P3|NOT COMPLETED|Phase 1b||0
8332835|NCT01355302|20540909|P2|NOT COMPLETED|Phase 1b||0
8332836|NCT01355302|20540910|P1|NOT COMPLETED|Phase 1b||6
8332837|NCT01355302|20540908|P3|COMPLETED|Phase 1b||0
8332838|NCT01355302|20540909|P2|COMPLETED|Phase 1b||0
8332839|NCT01355302|20540910|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
8332840|NCT01355302|20540908|P3|STARTED|Phase 1b||0
8332841|NCT01355302|20540909|P2|STARTED|Phase 1b||0
8332842|NCT01355302|20540910|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
8332843|NCT01355289|20540925|P5|NOT COMPLETED|Open Label Extension||34
8332844|NCT01355289|20540926|P4|NOT COMPLETED|Open Label Extension||0
8332845|NCT01355289|20540927|P3|NOT COMPLETED|Open Label Extension||0
8332846|NCT01355289|20540928|P2|NOT COMPLETED|Open Label Extension||0
8332847|NCT01355289|20540929|P1|NOT COMPLETED|Open Label Extension||0
8332848|NCT01355289|20540925|P5|COMPLETED|Open Label Extension||28
8332849|NCT01355289|20540926|P4|COMPLETED|Open Label Extension||0
8332850|NCT01355289|20540927|P3|COMPLETED|Open Label Extension||0
8332851|NCT01355289|20540928|P2|COMPLETED|Open Label Extension||0
8332852|NCT01355289|20540929|P1|COMPLETED|Open Label Extension||0
8332853|NCT01355289|20540925|P5|STARTED|Open Label Extension||62
8332854|NCT01355289|20540926|P4|STARTED|Open Label Extension||0
8332855|NCT01355289|20540927|P3|STARTED|Open Label Extension||0
8332856|NCT01355289|20540928|P2|STARTED|Open Label Extension||0
8332857|NCT01355289|20540929|P1|STARTED|Open Label Extension||0
8332858|NCT01355289|20540925|P5|NOT COMPLETED|Core Study||0
8332859|NCT01355289|20540926|P4|NOT COMPLETED|Core Study||2
8332860|NCT01355289|20540927|P3|NOT COMPLETED|Core Study||0
8332861|NCT01355289|20540928|P2|NOT COMPLETED|Core Study||0
8332862|NCT01355289|20540929|P1|NOT COMPLETED|Core Study||1
8332863|NCT01355289|20540925|P5|COMPLETED|Core Study||0
8332864|NCT01355289|20540926|P4|COMPLETED|Core Study||12
8332865|NCT01355289|20540927|P3|COMPLETED|Core Study||18
8332866|NCT01355289|20540928|P2|COMPLETED|Core Study||16
8332867|NCT01355289|20540929|P1|COMPLETED|Core Study||16
8332868|NCT01355289|20540925|P5|STARTED|Core Study||0
8332869|NCT01355289|20540926|P4|STARTED|Core Study||14
8332870|NCT01355289|20540927|P3|STARTED|Core Study||18
8332871|NCT01355289|20540928|P2|STARTED|Core Study||16
8332872|NCT01355289|20540929|P1|STARTED|Core Study||17
8332873|NCT01355224|20540956|P4|NOT COMPLETED|Overall Study||29
8332874|NCT01355224|20540957|P3|NOT COMPLETED|Overall Study||19
8332875|NCT01355224|20540958|P2|NOT COMPLETED|Overall Study||23
8332876|NCT01355224|20540959|P1|NOT COMPLETED|Overall Study||31
8332877|NCT01355224|20540956|P4|COMPLETED|Overall Study||172
8332878|NCT01355224|20540957|P3|COMPLETED|Overall Study||177
8332879|NCT01355224|20540958|P2|COMPLETED|Overall Study||180
8332880|NCT01355224|20540959|P1|COMPLETED|Overall Study||167
8332881|NCT01355224|20540956|P4|Competed Baseline|Overall Study||193
8332882|NCT01355224|20540957|P3|Competed Baseline|Overall Study||193
8332883|NCT01355224|20540958|P2|Competed Baseline|Overall Study||200
8332884|NCT01355224|20540959|P1|Competed Baseline|Overall Study||191
8332885|NCT01355224|20540956|P4|STARTED|Overall Study||201
8332886|NCT01355224|20540957|P3|STARTED|Overall Study||196
8332887|NCT01355224|20540958|P2|STARTED|Overall Study||203
8332888|NCT01355224|20540959|P1|STARTED|Overall Study||198
8332889|NCT01355159|20540981|P2|NOT COMPLETED|Overall Study||79
8332890|NCT01355159|20540982|P1|NOT COMPLETED|Overall Study||84
8332891|NCT01355159|20540981|P2|COMPLETED|Overall Study||1157
8332892|NCT01355159|20540982|P1|COMPLETED|Overall Study||1144
8332893|NCT01355159|20540981|P2|STARTED|Overall Study||1236
8332894|NCT01355159|20540982|P1|STARTED|Overall Study||1228
8332895|NCT01355081|20541039|P3|NOT COMPLETED|Overall Study||11
8332896|NCT01355081|20541040|P2|NOT COMPLETED|Overall Study||10
8332897|NCT01355081|20541041|P1|NOT COMPLETED|Overall Study||7
8332898|NCT01355081|20541039|P3|COMPLETED|Overall Study||113
8332899|NCT01355081|20541040|P2|COMPLETED|Overall Study||113
8332900|NCT01355081|20541041|P1|COMPLETED|Overall Study||112
8332901|NCT01355081|20541039|P3|STARTED|Overall Study||124
8332902|NCT01355081|20541040|P2|STARTED|Overall Study||123
8332903|NCT01355081|20541041|P1|STARTED|Overall Study||119
8332904|NCT01354990|20541064|P1|NOT COMPLETED|Overall Study||0
8332905|NCT01354990|20541064|P1|COMPLETED|Overall Study||2974
8332906|NCT01354990|20541064|P1|STARTED|Overall Study||2974
8332907|NCT01354964|20541073|P2|NOT COMPLETED|Overall Study||1
8332908|NCT01354964|20541074|P1|NOT COMPLETED|Overall Study||4
8332909|NCT01354964|20541073|P2|COMPLETED|Overall Study||7
8332910|NCT01354964|20541074|P1|COMPLETED|Overall Study||7
8332911|NCT01354964|20541073|P2|STARTED|Overall Study||8
8332912|NCT01354964|20541074|P1|STARTED|Overall Study||11
8332913|NCT01354951|20541090|P1|NOT COMPLETED|Overall Study||2
8332914|NCT01354951|20541090|P1|COMPLETED|Overall Study||1
8332915|NCT01354951|20541090|P1|STARTED|Overall Study||3
8332916|NCT01354938|20541097|P1|NOT COMPLETED|Overall Study||1
8332917|NCT01354938|20541097|P1|COMPLETED|Overall Study||219
8332918|NCT01354938|20541097|P1|STARTED|Overall Study||220
8332919|NCT01354899|20541103|P1|NOT COMPLETED|Overall Study||3
8332920|NCT01354899|20541103|P1|COMPLETED|Overall Study||21
8332921|NCT01354899|20541103|P1|STARTED|Overall Study||24
8332922|NCT01354691|20541110|P2|NOT COMPLETED|Overall Study||22
8332923|NCT01354691|20541111|P1|NOT COMPLETED|Overall Study||21
8332924|NCT01354691|20541110|P2|COMPLETED|Overall Study||77
8332925|NCT01354691|20541111|P1|COMPLETED|Overall Study||80
8332926|NCT01354691|20541110|P2|PP|Overall Study||75
8332927|NCT01354691|20541111|P1|PP|Overall Study||79
8332928|NCT01354691|20541110|P2|ITT|Overall Study||96
8332929|NCT01354691|20541111|P1|ITT|Overall Study||99
8332930|NCT01354691|20541110|P2|STARTED|Overall Study||99
8332931|NCT01354691|20541111|P1|STARTED|Overall Study||101
8332932|NCT01354652|20541128|P3|NOT COMPLETED|Overall Study||0
8332933|NCT01354652|20541129|P2|NOT COMPLETED|Overall Study||2
8332934|NCT01354652|20541130|P1|NOT COMPLETED|Overall Study||3
8332935|NCT01354652|20541128|P3|COMPLETED|Overall Study||0
8332936|NCT01354652|20541129|P2|COMPLETED|Overall Study||0
8332937|NCT01354652|20541130|P1|COMPLETED|Overall Study||0
8332938|NCT01354652|20541128|P3|STARTED|Overall Study||0
8332939|NCT01354652|20541129|P2|STARTED|Overall Study||2
8332940|NCT01354652|20541130|P1|STARTED|Overall Study||3
8332941|NCT01354496|20541155|P6|NOT COMPLETED|Period 3||0
8332942|NCT01354496|20541156|P5|NOT COMPLETED|Period 3||0
8332943|NCT01354496|20541157|P4|NOT COMPLETED|Period 3||0
8332944|NCT01354496|20541158|P3|NOT COMPLETED|Period 3||0
8332945|NCT01354496|20541159|P2|NOT COMPLETED|Period 3||0
8332946|NCT01354496|20541160|P1|NOT COMPLETED|Period 3||0
8332947|NCT01354496|20541155|P6|COMPLETED|Period 3||6
8332948|NCT01354496|20541156|P5|COMPLETED|Period 3||5
8332949|NCT01354496|20541157|P4|COMPLETED|Period 3||4
8332950|NCT01354496|20541158|P3|COMPLETED|Period 3||4
8332951|NCT01354496|20541159|P2|COMPLETED|Period 3||5
8332952|NCT01354496|20541160|P1|COMPLETED|Period 3||6
8332953|NCT01354496|20541155|P6|STARTED|Period 3||6
8332954|NCT01354496|20541156|P5|STARTED|Period 3||5
8332955|NCT01354496|20541157|P4|STARTED|Period 3||4
8332956|NCT01354496|20541158|P3|STARTED|Period 3||4
8332957|NCT01354496|20541159|P2|STARTED|Period 3||5
8332958|NCT01354496|20541160|P1|STARTED|Period 3||6
8332959|NCT01354496|20541155|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
8332960|NCT01354496|20541156|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
8332961|NCT01354496|20541157|P4|NOT COMPLETED|Washout (at Least 14 Days)||1
8332962|NCT01354496|20541158|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
8332963|NCT01354496|20541159|P2|NOT COMPLETED|Washout (at Least 14 Days)||1
8332964|NCT01354496|20541160|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8332965|NCT01354496|20541155|P6|COMPLETED|Washout (at Least 14 Days)||6
8332966|NCT01354496|20541156|P5|COMPLETED|Washout (at Least 14 Days)||5
8332967|NCT01354496|20541157|P4|COMPLETED|Washout (at Least 14 Days)||4
8332968|NCT01354496|20541158|P3|COMPLETED|Washout (at Least 14 Days)||4
8332969|NCT01354496|20541159|P2|COMPLETED|Washout (at Least 14 Days)||5
8332970|NCT01354496|20541160|P1|COMPLETED|Washout (at Least 14 Days)||6
8332971|NCT01354496|20541155|P6|STARTED|Washout (at Least 14 Days)||6
8332972|NCT01354496|20541156|P5|STARTED|Washout (at Least 14 Days)||5
8332973|NCT01354496|20541157|P4|STARTED|Washout (at Least 14 Days)||5
8332974|NCT01354496|20541158|P3|STARTED|Washout (at Least 14 Days)||4
8332975|NCT01354496|20541159|P2|STARTED|Washout (at Least 14 Days)||6
8332976|NCT01354496|20541160|P1|STARTED|Washout (at Least 14 Days)||6
8332977|NCT01354496|20541155|P6|NOT COMPLETED|Period 2||0
8332978|NCT01354496|20541156|P5|NOT COMPLETED|Period 2||0
8332979|NCT01354496|20541157|P4|NOT COMPLETED|Period 2||1
8332980|NCT01354496|20541158|P3|NOT COMPLETED|Period 2||0
8332981|NCT01354496|20541159|P2|NOT COMPLETED|Period 2||0
8332982|NCT01354496|20541160|P1|NOT COMPLETED|Period 2||0
8332983|NCT01354496|20541155|P6|COMPLETED|Period 2||6
8332984|NCT01354496|20541156|P5|COMPLETED|Period 2||5
8332985|NCT01354496|20541157|P4|COMPLETED|Period 2||5
8332986|NCT01354496|20541158|P3|COMPLETED|Period 2||4
8332987|NCT01354496|20541159|P2|COMPLETED|Period 2||6
8332988|NCT01354496|20541160|P1|COMPLETED|Period 2||6
8332989|NCT01354496|20541155|P6|STARTED|Period 2||6
8332990|NCT01354496|20541156|P5|STARTED|Period 2||5
8332991|NCT01354496|20541157|P4|STARTED|Period 2||6
8332992|NCT01354496|20541158|P3|STARTED|Period 2||4
8332993|NCT01354496|20541159|P2|STARTED|Period 2||6
8332994|NCT01354496|20541160|P1|STARTED|Period 2||6
8332995|NCT01354496|20541155|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
8332996|NCT01354496|20541156|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
8332997|NCT01354496|20541157|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
8332998|NCT01354496|20541158|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
8332999|NCT01354496|20541159|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8333000|NCT01354496|20541160|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8333001|NCT01354496|20541155|P6|COMPLETED|Washout (at Least 14 Days)||6
8333002|NCT01354496|20541156|P5|COMPLETED|Washout (at Least 14 Days)||5
8333003|NCT01354496|20541157|P4|COMPLETED|Washout (at Least 14 Days)||6
8333004|NCT01354496|20541158|P3|COMPLETED|Washout (at Least 14 Days)||4
8333005|NCT01354496|20541159|P2|COMPLETED|Washout (at Least 14 Days)||6
8333006|NCT01354496|20541160|P1|COMPLETED|Washout (at Least 14 Days)||6
8333007|NCT01354496|20541155|P6|STARTED|Washout (at Least 14 Days)||6
8333008|NCT01354496|20541156|P5|STARTED|Washout (at Least 14 Days)||5
8333009|NCT01354496|20541157|P4|STARTED|Washout (at Least 14 Days)||6
8333010|NCT01354496|20541158|P3|STARTED|Washout (at Least 14 Days)||4
8333011|NCT01354496|20541159|P2|STARTED|Washout (at Least 14 Days)||6
8333012|NCT01354496|20541160|P1|STARTED|Washout (at Least 14 Days)||6
8333013|NCT01354496|20541155|P6|NOT COMPLETED|Period 1||0
8333014|NCT01354496|20541156|P5|NOT COMPLETED|Period 1||0
8333015|NCT01354496|20541157|P4|NOT COMPLETED|Period 1||0
8333016|NCT01354496|20541158|P3|NOT COMPLETED|Period 1||2
8333017|NCT01354496|20541159|P2|NOT COMPLETED|Period 1||0
8333018|NCT01354496|20541160|P1|NOT COMPLETED|Period 1||0
8333019|NCT01354496|20541155|P6|COMPLETED|Period 1||6
8333020|NCT01354496|20541156|P5|COMPLETED|Period 1||5
8333021|NCT01354496|20541157|P4|COMPLETED|Period 1||6
8333022|NCT01354496|20541158|P3|COMPLETED|Period 1||4
8333023|NCT01354496|20541159|P2|COMPLETED|Period 1||6
8333024|NCT01354496|20541160|P1|COMPLETED|Period 1||6
8333025|NCT01354496|20541155|P6|Received at Least 1 Dose of Study Drug|Period 1||6
8333026|NCT01354496|20541156|P5|Received at Least 1 Dose of Study Drug|Period 1||5
8333027|NCT01354496|20541157|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8333028|NCT01354496|20541158|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8333029|NCT01354496|20541159|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8333030|NCT01354496|20541160|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8333031|NCT01354496|20541155|P6|STARTED|Period 1||6
8333032|NCT01354496|20541156|P5|STARTED|Period 1||5
8333033|NCT01354496|20541157|P4|STARTED|Period 1||6
8333034|NCT01354496|20541158|P3|STARTED|Period 1||6
8333035|NCT01354496|20541159|P2|STARTED|Period 1||6
8333036|NCT01354496|20541160|P1|STARTED|Period 1||6
8333037|NCT01354444|20541189|P2|NOT COMPLETED|Overall Study||4
8333038|NCT01354444|20541190|P1|NOT COMPLETED|Overall Study||8
8333039|NCT01354444|20541189|P2|COMPLETED|Overall Study||11
8333040|NCT01354444|20541190|P1|COMPLETED|Overall Study||6
8333041|NCT01354444|20541189|P2|STARTED|Overall Study||15
8333042|NCT01354444|20541190|P1|STARTED|Overall Study||14
8333043|NCT01354431|20541203|P3|NOT COMPLETED|Participants Treated||54
8333044|NCT01354431|20541204|P2|NOT COMPLETED|Participants Treated||54
8333045|NCT01354431|20541205|P1|NOT COMPLETED|Participants Treated||59
8333046|NCT01354431|20541203|P3|COMPLETED|Participants Treated||0
8333047|NCT01354431|20541204|P2|COMPLETED|Participants Treated||0
8333048|NCT01354431|20541205|P1|COMPLETED|Participants Treated||0
8333049|NCT01354431|20541203|P3|STARTED|Participants Treated||54
8333050|NCT01354431|20541204|P2|STARTED|Participants Treated||54
8333051|NCT01354431|20541205|P1|STARTED|Participants Treated||59
8333052|NCT01354431|20541203|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
8333053|NCT01354431|20541204|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
8333054|NCT01354431|20541205|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
8333055|NCT01354431|20541203|P3|COMPLETED|Randomized to Enter Treatment Period||54
8333056|NCT01354431|20541204|P2|COMPLETED|Randomized to Enter Treatment Period||54
8333057|NCT01354431|20541205|P1|COMPLETED|Randomized to Enter Treatment Period||59
8333058|NCT01354431|20541203|P3|STARTED|Randomized to Enter Treatment Period||54
8333059|NCT01354431|20541204|P2|STARTED|Randomized to Enter Treatment Period||54
8333060|NCT01354431|20541205|P1|STARTED|Randomized to Enter Treatment Period||60
8333061|NCT01354314|20541229|P4|NOT COMPLETED|Overall Study||6
8333062|NCT01354314|20541230|P3|NOT COMPLETED|Overall Study||8
8333063|NCT01354314|20541231|P2|NOT COMPLETED|Overall Study||3
8333064|NCT01354314|20541232|P1|NOT COMPLETED|Overall Study||6
8333065|NCT01354314|20541229|P4|COMPLETED|Overall Study||5
8333066|NCT01354314|20541230|P3|COMPLETED|Overall Study||3
8333067|NCT01354314|20541231|P2|COMPLETED|Overall Study||8
8333068|NCT01354314|20541232|P1|COMPLETED|Overall Study||6
8333069|NCT01354314|20541229|P4|Completed (ITT)|Overall Study||10
8333070|NCT01354314|20541230|P3|Completed (ITT)|Overall Study||9
8333071|NCT01354314|20541231|P2|Completed (ITT)|Overall Study||11
8333072|NCT01354314|20541232|P1|Completed (ITT)|Overall Study||11
8333073|NCT01354314|20541229|P4|STARTED|Overall Study||11
8333074|NCT01354314|20541230|P3|STARTED|Overall Study||11
8333075|NCT01354314|20541231|P2|STARTED|Overall Study||11
8333076|NCT01354314|20541232|P1|STARTED|Overall Study||12
8333077|NCT01354223|20541368|P2|NOT COMPLETED|Overall Study||1
8333078|NCT01354223|20541369|P1|NOT COMPLETED|Overall Study||3
8333079|NCT01354223|20541368|P2|COMPLETED|Overall Study||29
8333080|NCT01354223|20541369|P1|COMPLETED|Overall Study||57
8333081|NCT01354223|20541368|P2|STARTED|Overall Study||30
8333082|NCT01354223|20541369|P1|STARTED|Overall Study||60
8333083|NCT01354197|20541385|P1|NOT COMPLETED|Overall Study||0
8333084|NCT01354197|20541385|P1|COMPLETED|Overall Study||4652
8333085|NCT01354197|20541385|P1|STARTED|Overall Study||4652
8333086|NCT01354145|20541393|P2|NOT COMPLETED|Overall Study||34
8333087|NCT01354145|20541394|P1|NOT COMPLETED|Overall Study||39
8333088|NCT01354145|20541393|P2|COMPLETED|Overall Study||63
8333089|NCT01354145|20541394|P1|COMPLETED|Overall Study||58
8333090|NCT01354145|20541393|P2|STARTED|Overall Study||97
8333091|NCT01354145|20541394|P1|STARTED|Overall Study||97
8333092|NCT01354132|20541428|P2|NOT COMPLETED|1 Month Post Study Medication||3
8333093|NCT01354132|20541429|P1|NOT COMPLETED|1 Month Post Study Medication||1
8333094|NCT01354132|20541428|P2|COMPLETED|1 Month Post Study Medication||16
8333095|NCT01354132|20541429|P1|COMPLETED|1 Month Post Study Medication||21
8333096|NCT01354132|20541428|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
8333097|NCT01354132|20541429|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
8333098|NCT01354132|20541428|P2|STARTED|1 Month Post Study Medication||19
8333099|NCT01354132|20541429|P1|STARTED|1 Month Post Study Medication||22
8333100|NCT01354132|20541428|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
8333101|NCT01354132|20541429|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
8333102|NCT01354132|20541428|P2|COMPLETED|Double Blind (Visits 1-7)||19
8333103|NCT01354132|20541429|P1|COMPLETED|Double Blind (Visits 1-7)||22
8333104|NCT01354132|20541428|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
8333105|NCT01354132|20541429|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
8333106|NCT01354132|20541428|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
8333107|NCT01354132|20541429|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
8333108|NCT01354132|20541428|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
8333109|NCT01354132|20541429|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
8333110|NCT01354132|20541428|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
8333111|NCT01354132|20541429|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
8333112|NCT01354132|20541428|P2|NOT COMPLETED|Randomization||1
8333113|NCT01354132|20541429|P1|NOT COMPLETED|Randomization||1
8333114|NCT01354132|20541428|P2|COMPLETED|Randomization||30
8333115|NCT01354132|20541429|P1|COMPLETED|Randomization||31
8333116|NCT01354132|20541428|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
8333117|NCT01354132|20541429|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
8333118|NCT01354106|20541467|P1|NOT COMPLETED|Overall Study||2
8333119|NCT01354106|20541467|P1|COMPLETED|Overall Study||24
8333120|NCT01354106|20541467|P1|STARTED|Overall Study||26
8333121|NCT01354028|20541473|P2|NOT COMPLETED|Overall Study||5
8333122|NCT01354028|20541474|P1|NOT COMPLETED|Overall Study||2
8333123|NCT01354028|20541473|P2|COMPLETED|Overall Study||10
8333124|NCT01354028|20541474|P1|COMPLETED|Overall Study||13
8333125|NCT01354028|20541473|P2|STARTED|Overall Study||15
8333126|NCT01354028|20541474|P1|STARTED|Overall Study||15
8333127|NCT01354015|20541488|P2|NOT COMPLETED|Overall Study||5
8333128|NCT01354015|20541489|P1|NOT COMPLETED|Overall Study||6
8333129|NCT01354015|20541488|P2|COMPLETED|Overall Study||43
8333130|NCT01354015|20541489|P1|COMPLETED|Overall Study||44
8333131|NCT01354015|20541488|P2|STARTED|Overall Study||48
8333132|NCT01354015|20541489|P1|STARTED|Overall Study||50
8333133|NCT01353976|20541499|P2|NOT COMPLETED|Overall Study||51
8333134|NCT01353976|20541500|P1|NOT COMPLETED|Overall Study||48
8333135|NCT01353976|20541499|P2|COMPLETED|Overall Study||83
8333136|NCT01353976|20541500|P1|COMPLETED|Overall Study||82
8333137|NCT01353976|20541499|P2|STARTED|Overall Study||134
8333138|NCT01353976|20541500|P1|STARTED|Overall Study||130
8333139|NCT01353963|20541510|P1|NOT COMPLETED|Overall Study||2
8333140|NCT01353963|20541510|P1|COMPLETED|Overall Study||11
8333141|NCT01353963|20541510|P1|STARTED|Overall Study||13
8333142|NCT01353911|20541528|P8|NOT COMPLETED|Overall Study||15
8333143|NCT01353911|20541529|P7|NOT COMPLETED|Overall Study||6
8333144|NCT01353911|20541530|P6|NOT COMPLETED|Overall Study||7
8333145|NCT01353911|20541531|P5|NOT COMPLETED|Overall Study||6
8333146|NCT01353911|20541532|P4|NOT COMPLETED|Overall Study||2
8333147|NCT01353911|20541533|P3|NOT COMPLETED|Overall Study||9
8333148|NCT01353911|20541534|P2|NOT COMPLETED|Overall Study||9
8333149|NCT01353911|20541535|P1|NOT COMPLETED|Overall Study||8
8333150|NCT01353911|20541528|P8|COMPLETED|Overall Study||51
8333151|NCT01353911|20541529|P7|COMPLETED|Overall Study||30
8333152|NCT01353911|20541530|P6|COMPLETED|Overall Study||36
8333153|NCT01353911|20541531|P5|COMPLETED|Overall Study||23
8333154|NCT01353911|20541532|P4|COMPLETED|Overall Study||22
8333155|NCT01353911|20541533|P3|COMPLETED|Overall Study||59
8333156|NCT01353911|20541534|P2|COMPLETED|Overall Study||57
8333157|NCT01353911|20541535|P1|COMPLETED|Overall Study||28
8333158|NCT01353911|20541528|P8|STARTED|Overall Study||66
8333159|NCT01353911|20541529|P7|STARTED|Overall Study||36
8333160|NCT01353911|20541530|P6|STARTED|Overall Study||43
8333161|NCT01353911|20541531|P5|STARTED|Overall Study||29
8333162|NCT01353911|20541532|P4|STARTED|Overall Study||24
8333163|NCT01353911|20541533|P3|STARTED|Overall Study||68
8333164|NCT01353911|20541534|P2|STARTED|Overall Study||66
8333165|NCT01353911|20541535|P1|STARTED|Overall Study||36
8333166|NCT01353898|20541615|P6|NOT COMPLETED|Overall Study||1
8333167|NCT01353898|20541616|P5|NOT COMPLETED|Overall Study||0
8333168|NCT01353898|20541617|P4|NOT COMPLETED|Overall Study||0
8333169|NCT01353898|20541618|P3|NOT COMPLETED|Overall Study||0
8333170|NCT01353898|20541619|P2|NOT COMPLETED|Overall Study||0
8333171|NCT01353898|20541620|P1|NOT COMPLETED|Overall Study||0
8333172|NCT01353898|20541615|P6|COMPLETED|Overall Study||1
8333173|NCT01353898|20541616|P5|COMPLETED|Overall Study||2
8333174|NCT01353898|20541617|P4|COMPLETED|Overall Study||2
8333175|NCT01353898|20541618|P3|COMPLETED|Overall Study||2
8333176|NCT01353898|20541619|P2|COMPLETED|Overall Study||2
8333177|NCT01353898|20541620|P1|COMPLETED|Overall Study||2
8333178|NCT01353898|20541615|P6|STARTED|Overall Study||2
8333179|NCT01353898|20541616|P5|STARTED|Overall Study||2
8333180|NCT01353898|20541617|P4|STARTED|Overall Study||2
8333181|NCT01353898|20541618|P3|STARTED|Overall Study||2
8333182|NCT01353898|20541619|P2|STARTED|Overall Study||2
8333183|NCT01353898|20541620|P1|STARTED|Overall Study||2
8333184|NCT01353859|20541646|P1|NOT COMPLETED|Overall Study||4
8333185|NCT01353859|20541646|P1|COMPLETED|Overall Study||35
8333186|NCT01353859|20541646|P1|STARTED|Overall Study||39
8333187|NCT01353703|20541661|P2|NOT COMPLETED|Overall Study||0
8333188|NCT01353703|20541662|P1|NOT COMPLETED|Overall Study||1
8333189|NCT01353703|20541661|P2|COMPLETED|Overall Study||112
8333190|NCT01353703|20541662|P1|COMPLETED|Overall Study||111
8333191|NCT01353703|20541661|P2|STARTED|Overall Study||112
8333192|NCT01353703|20541662|P1|STARTED|Overall Study||112
8333193|NCT01353664|20541708|P1|NOT COMPLETED|Overall Study||19
8333194|NCT01353664|20541708|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
8333195|NCT01353664|20541708|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
8333196|NCT01353586|20541714|P2|NOT COMPLETED|Overall Study||2
8333197|NCT01353586|20541715|P1|NOT COMPLETED|Overall Study||7
8333198|NCT01353586|20541714|P2|COMPLETED|Overall Study||17
8333199|NCT01353586|20541715|P1|COMPLETED|Overall Study||160
8333200|NCT01353586|20541714|P2|Participated in SNA Substudy|Overall Study||19
8333201|NCT01353586|20541715|P1|Participated in SNA Substudy|Overall Study||19
8333202|NCT01353586|20541714|P2|Participated in Roll-in Phase|Overall Study||0
8333203|NCT01353586|20541715|P1|Participated in Roll-in Phase|Overall Study||22
8333204|NCT01353586|20541714|P2|Participated in Workflow Phase|Overall Study||0
8333205|NCT01353586|20541715|P1|Participated in Workflow Phase|Overall Study||20
8333206|NCT01353586|20541714|P2|STARTED|Overall Study||19
8333207|NCT01353586|20541715|P1|STARTED|Overall Study||167
8333208|NCT01353508|20541733|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8333209|NCT01353508|20541734|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8333210|NCT01353508|20541735|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8333211|NCT01353508|20541736|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
8333212|NCT01353508|20541733|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
8333213|NCT01353508|20541734|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
8333214|NCT01353508|20541735|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
8333215|NCT01353508|20541736|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
8333216|NCT01353508|20541733|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
8333217|NCT01353508|20541734|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
8333218|NCT01353508|20541735|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
8333219|NCT01353508|20541736|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
8333220|NCT01353508|20541733|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
8333221|NCT01353508|20541734|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8333222|NCT01353508|20541735|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8333223|NCT01353508|20541736|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8333224|NCT01353508|20541733|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
8333225|NCT01353508|20541734|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
8333226|NCT01353508|20541735|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
8333227|NCT01353508|20541736|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
8333228|NCT01353508|20541733|P4|STARTED|Period 1 - First Intervention (7 Days)||8
8333229|NCT01353508|20541734|P3|STARTED|Period 1 - First Intervention (7 Days)||8
8333230|NCT01353508|20541735|P2|STARTED|Period 1 - First Intervention (7 Days)||8
8333231|NCT01353508|20541736|P1|STARTED|Period 1 - First Intervention (7 Days)||8
8333232|NCT01353274|20541814|P1|NOT COMPLETED|Overall Study||28
8333233|NCT01353274|20541814|P1|COMPLETED|Overall Study||1129
8333234|NCT01353274|20541814|P1|STARTED|Overall Study||1157
8333235|NCT01353222|20541824|P2|NOT COMPLETED|Overall Study||72
8333236|NCT01353222|20541825|P1|NOT COMPLETED|Overall Study||70
8333237|NCT01353222|20541824|P2|COMPLETED|Overall Study||0
8333238|NCT01353222|20541825|P1|COMPLETED|Overall Study||0
8333239|NCT01353222|20541824|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
8333240|NCT01353222|20541825|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
8333241|NCT01353222|20541824|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
8333242|NCT01353222|20541825|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
8333243|NCT01353222|20541824|P2|STARTED|Overall Study||72
8333244|NCT01353222|20541825|P1|STARTED|Overall Study||70
8333245|NCT01353196|20541833|P2|NOT COMPLETED|Overall Study||11
8333246|NCT01353196|20541834|P1|NOT COMPLETED|Overall Study||29
8333247|NCT01353196|20541833|P2|COMPLETED|Overall Study||59
8333248|NCT01353196|20541834|P1|COMPLETED|Overall Study||71
8333249|NCT01353196|20541833|P2|STARTED|Overall Study||70
8333250|NCT01353196|20541834|P1|STARTED|Overall Study||100
8333251|NCT01353144|20541842|P2|NOT COMPLETED|Overall Study||8
8333252|NCT01353144|20541843|P1|NOT COMPLETED|Overall Study||9
8333253|NCT01353144|20541842|P2|COMPLETED|Overall Study||81
8333254|NCT01353144|20541843|P1|COMPLETED|Overall Study||80
8333255|NCT01353144|20541842|P2|STARTED|Overall Study||89
8333256|NCT01353144|20541843|P1|STARTED|Overall Study||89
8333257|NCT01353079|20541853|P2|NOT COMPLETED|Overall Study||21
8333258|NCT01353079|20541854|P1|NOT COMPLETED|Overall Study||27
8333259|NCT01353079|20541853|P2|COMPLETED|Overall Study||190
8333260|NCT01353079|20541854|P1|COMPLETED|Overall Study||191
8333261|NCT01353079|20541853|P2|STARTED|Overall Study||211
8333262|NCT01353079|20541854|P1|STARTED|Overall Study||218
8333263|NCT01352845|20541868|P2|NOT COMPLETED|Overall Study||203
8333264|NCT01352845|20541869|P1|NOT COMPLETED|Overall Study||671
8333265|NCT01352845|20541868|P2|COMPLETED|Overall Study||619
8333266|NCT01352845|20541869|P1|COMPLETED|Overall Study||1800
8333267|NCT01352845|20541868|P2|STARTED|Overall Study||822
8333268|NCT01352845|20541869|P1|STARTED|Overall Study||2471
8333269|NCT01352793|20541958|P2|NOT COMPLETED|Overall Study||245
8333270|NCT01352793|20541959|P1|NOT COMPLETED|Overall Study||585
8333271|NCT01352793|20541958|P2|COMPLETED|Overall Study||1663
8333272|NCT01352793|20541959|P1|COMPLETED|Overall Study||3219
8333273|NCT01352793|20541958|P2|Vaccination 3|Overall Study||1710
8333274|NCT01352793|20541959|P1|Vaccination 3|Overall Study||3314
8333275|NCT01352793|20541958|P2|Vaccination 2|Overall Study||1806
8333276|NCT01352793|20541959|P1|Vaccination 2|Overall Study||3530
8333277|NCT01352793|20541958|P2|Vaccination 1|Overall Study||1908
8333278|NCT01352793|20541959|P1|Vaccination 1|Overall Study||3796
8333279|NCT01352793|20541958|P2|STARTED|Overall Study||1908
8333280|NCT01352793|20541959|P1|STARTED|Overall Study||3804
8333281|NCT01352741|20541983|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8333282|NCT01352741|20541984|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8333283|NCT01352741|20541983|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8333284|NCT01352741|20541984|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
8333285|NCT01352741|20541983|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
8333286|NCT01352741|20541984|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
8333287|NCT01352741|20541983|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
8333288|NCT01352741|20541984|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
8333289|NCT01352741|20541983|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
8333290|NCT01352741|20541984|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
8333291|NCT01352741|20541983|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
8333292|NCT01352741|20541984|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
8333293|NCT01352741|20541983|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
8333294|NCT01352741|20541984|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
8333295|NCT01352741|20541983|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
8333296|NCT01352741|20541984|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
8333297|NCT01352741|20541983|P2|NOT COMPLETED|Double-blind Comparative Period||26
8333298|NCT01352741|20541984|P1|NOT COMPLETED|Double-blind Comparative Period||28
8333299|NCT01352741|20541983|P2|COMPLETED|Double-blind Comparative Period||133
8333300|NCT01352741|20541984|P1|COMPLETED|Double-blind Comparative Period||126
8333301|NCT01352741|20541983|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
8333302|NCT01352741|20541984|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
8333303|NCT01352741|20541983|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
8333304|NCT01352741|20541984|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
8333305|NCT01352741|20541983|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
8333306|NCT01352741|20541984|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
8333307|NCT01352741|20541983|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
8333308|NCT01352741|20541984|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
8333309|NCT01352741|20541983|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
8333310|NCT01352741|20541984|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
8333311|NCT01352741|20541983|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
8333312|NCT01352741|20541984|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
8333313|NCT01352741|20541983|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
8333314|NCT01352741|20541984|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
8333315|NCT01352741|20541983|P2|Per Protocol Set|Double-blind Comparative Period||149
8333316|NCT01352741|20541984|P1|Per Protocol Set|Double-blind Comparative Period||139
8333317|NCT01352741|20541983|P2|Major Protocol Deviations|Double-blind Comparative Period||8
8333318|NCT01352741|20541984|P1|Major Protocol Deviations|Double-blind Comparative Period||13
8333319|NCT01352741|20541983|P2|Full Analysis Set|Double-blind Comparative Period||157
8333320|NCT01352741|20541984|P1|Full Analysis Set|Double-blind Comparative Period||152
8333321|NCT01352741|20541983|P2|No Pain Assessments Available|Double-blind Comparative Period||2
8333322|NCT01352741|20541984|P1|No Pain Assessments Available|Double-blind Comparative Period||2
8333323|NCT01352741|20541983|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
8333324|NCT01352741|20541984|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
8333325|NCT01352741|20541983|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
8333326|NCT01352741|20541984|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
8333327|NCT01352741|20541983|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
8333328|NCT01352741|20541984|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
8333329|NCT01352741|20541983|P2|COMPLETED|Open-label Tapentadol Titration Period||0
8333330|NCT01352741|20541984|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
8333331|NCT01352741|20541983|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
8333332|NCT01352741|20541984|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
8333333|NCT01352741|20541983|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
8333334|NCT01352741|20541984|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
8333335|NCT01352741|20541983|P2|STARTED|Open-label Tapentadol Titration Period||0
8333336|NCT01352741|20541984|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
8333337|NCT01352715|20542078|P2|NOT COMPLETED|Overall Study||46
8333338|NCT01352715|20542079|P1|NOT COMPLETED|Overall Study||45
8333339|NCT01352715|20542078|P2|COMPLETED|Overall Study||209
8333340|NCT01352715|20542079|P1|COMPLETED|Overall Study||215
8333341|NCT01352715|20542078|P2|STARTED|Overall Study||255
8333342|NCT01352715|20542079|P1|STARTED|Overall Study||260
8333343|NCT01352637|20542105|P4|NOT COMPLETED|Drug||35
8333344|NCT01352637|20542106|P3|NOT COMPLETED|Drug||25
8333345|NCT01352637|20542107|P2|NOT COMPLETED|Drug||0
8333346|NCT01352637|20542108|P1|NOT COMPLETED|Drug||0
8333347|NCT01352637|20542105|P4|COMPLETED|Drug||62
8333348|NCT01352637|20542106|P3|COMPLETED|Drug||70
8333349|NCT01352637|20542107|P2|COMPLETED|Drug||0
8333350|NCT01352637|20542108|P1|COMPLETED|Drug||0
8333351|NCT01352637|20542105|P4|STARTED|Drug||97
8333352|NCT01352637|20542106|P3|STARTED|Drug||95
8333353|NCT01352637|20542107|P2|STARTED|Drug||0
8333354|NCT01352637|20542108|P1|STARTED|Drug||0
8333355|NCT01352637|20542105|P4|NOT COMPLETED|Exposure Therapy||0
8333356|NCT01352637|20542106|P3|NOT COMPLETED|Exposure Therapy||0
8333357|NCT01352637|20542107|P2|NOT COMPLETED|Exposure Therapy||33
8333358|NCT01352637|20542108|P1|NOT COMPLETED|Exposure Therapy||27
8333359|NCT01352637|20542105|P4|COMPLETED|Exposure Therapy||0
8333360|NCT01352637|20542106|P3|COMPLETED|Exposure Therapy||0
8333361|NCT01352637|20542107|P2|COMPLETED|Exposure Therapy||62
8333362|NCT01352637|20542108|P1|COMPLETED|Exposure Therapy||70
8333363|NCT01352637|20542105|P4|STARTED|Exposure Therapy||0
8333364|NCT01352637|20542106|P3|STARTED|Exposure Therapy||0
8333365|NCT01352637|20542107|P2|STARTED|Exposure Therapy||95
8333366|NCT01352637|20542108|P1|STARTED|Exposure Therapy||97
8333367|NCT01352598|20542118|P1|NOT COMPLETED|Overall Study||12
8333368|NCT01352598|20542118|P1|COMPLETED|Overall Study||72
8333369|NCT01352598|20542118|P1|STARTED|Overall Study||84
8333370|NCT01352585|20542123|P1|NOT COMPLETED|Overall Study||11
8333371|NCT01352585|20542123|P1|COMPLETED|Overall Study||36
8333372|NCT01352585|20542123|P1|STARTED|Overall Study||47
8333373|NCT01352546|20542134|P1|NOT COMPLETED|Overall Study||0
8333374|NCT01352546|20542134|P1|COMPLETED|Overall Study||31
8333375|NCT01352546|20542134|P1|STARTED|Overall Study||31
8333376|NCT01352507|20542140|P2|NOT COMPLETED|Extension Phase||0
8333377|NCT01352507|20542141|P1|NOT COMPLETED|Extension Phase||0
8333378|NCT01352507|20542140|P2|COMPLETED|Extension Phase||173
8333379|NCT01352507|20542141|P1|COMPLETED|Extension Phase||164
8333380|NCT01352507|20542140|P2|STARTED|Extension Phase||173
8333381|NCT01352507|20542141|P1|STARTED|Extension Phase||164
8333382|NCT01352507|20542140|P2|NOT COMPLETED|Treatment Period 2||3
8333383|NCT01352507|20542141|P1|NOT COMPLETED|Treatment Period 2||6
8333384|NCT01352507|20542140|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
8333385|NCT01352507|20542141|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
8333386|NCT01352507|20542140|P2|Received Treatment|Treatment Period 2||181
8333387|NCT01352507|20542141|P1|Received Treatment|Treatment Period 2||173
8333388|NCT01352507|20542140|P2|STARTED|Treatment Period 2||183
8333389|NCT01352507|20542141|P1|STARTED|Treatment Period 2||176
8333390|NCT01352507|20542140|P2|NOT COMPLETED|Washout Period||1
8333391|NCT01352507|20542141|P1|NOT COMPLETED|Washout Period||0
8333392|NCT01352507|20542140|P2|COMPLETED|Washout Period||183
8333393|NCT01352507|20542141|P1|COMPLETED|Washout Period||176
8333394|NCT01352507|20542140|P2|STARTED|Washout Period||184
8333395|NCT01352507|20542141|P1|STARTED|Washout Period||176
8333396|NCT01352507|20542140|P2|NOT COMPLETED|Treatment Period 1||9
8333397|NCT01352507|20542141|P1|NOT COMPLETED|Treatment Period 1||14
8333398|NCT01352507|20542140|P2|COMPLETED|Treatment Period 1||184
8333399|NCT01352507|20542141|P1|COMPLETED|Treatment Period 1||176
8333400|NCT01352507|20542140|P2|Received Treatment|Treatment Period 1||188
8333401|NCT01352507|20542141|P1|Received Treatment|Treatment Period 1||182
8333402|NCT01352507|20542140|P2|STARTED|Treatment Period 1||193
8333403|NCT01352507|20542141|P1|STARTED|Treatment Period 1||190
8333404|NCT01352468|20542174|P2|NOT COMPLETED|Overall Study||4
8333405|NCT01352468|20542175|P1|NOT COMPLETED|Overall Study||5
8333406|NCT01352468|20542174|P2|COMPLETED|Overall Study||18
8333407|NCT01352468|20542175|P1|COMPLETED|Overall Study||17
8333408|NCT01352468|20542174|P2|STARTED|Overall Study||22
8333409|NCT01352468|20542175|P1|STARTED|Overall Study||22
8333410|NCT01352442|20542185|P1|NOT COMPLETED|Overall Study||12
8333411|NCT01352442|20542185|P1|COMPLETED|Overall Study||139
8333412|NCT01352442|20542185|P1|STARTED|Overall Study||151
8333413|NCT01352416|20542194|P4|NOT COMPLETED|Overall Study||1
8333414|NCT01352416|20542195|P3|NOT COMPLETED|Overall Study||2
8333415|NCT01352416|20542196|P2|NOT COMPLETED|Overall Study||2
8333416|NCT01352416|20542197|P1|NOT COMPLETED|Overall Study||1
8333417|NCT01352416|20542194|P4|COMPLETED|Overall Study||1
8333418|NCT01352416|20542195|P3|COMPLETED|Overall Study||0
8333419|NCT01352416|20542196|P2|COMPLETED|Overall Study||5
8333420|NCT01352416|20542197|P1|COMPLETED|Overall Study||3
8333421|NCT01352416|20542194|P4|STARTED|Overall Study||2
8333422|NCT01352416|20542195|P3|STARTED|Overall Study||2
8333423|NCT01352416|20542196|P2|STARTED|Overall Study||7
8333424|NCT01352416|20542197|P1|STARTED|Overall Study||4
8333425|NCT01352286|20542207|P1|NOT COMPLETED|Overall Study||0
8333426|NCT01352286|20542207|P1|COMPLETED|Overall Study||25
8333427|NCT01352286|20542207|P1|Received T-cells|Overall Study||25
8333428|NCT01352286|20542207|P1|STARTED|Overall Study||25
8333429|NCT01352221|20542219|P4|NOT COMPLETED|Open-label Phase||11
8333430|NCT01352221|20542220|P3|NOT COMPLETED|Open-label Phase||13
8333431|NCT01352221|20542221|P2|NOT COMPLETED|Open-label Phase||0
8333432|NCT01352221|20542222|P1|NOT COMPLETED|Open-label Phase||0
8333433|NCT01352221|20542219|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
8333434|NCT01352221|20542220|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
8333435|NCT01352221|20542221|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8333436|NCT01352221|20542222|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8333437|NCT01352221|20542219|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
8333438|NCT01352221|20542220|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
8333439|NCT01352221|20542221|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8333440|NCT01352221|20542222|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8333441|NCT01352221|20542219|P4|NOT COMPLETED|Double-blind Phase||0
8333442|NCT01352221|20542220|P3|NOT COMPLETED|Double-blind Phase||0
8333443|NCT01352221|20542221|P2|NOT COMPLETED|Double-blind Phase||11
8333444|NCT01352221|20542222|P1|NOT COMPLETED|Double-blind Phase||9
8333445|NCT01352221|20542219|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8333446|NCT01352221|20542220|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8333447|NCT01352221|20542221|P2|COMPLETED|Double-blind Phase||53
8333448|NCT01352221|20542222|P1|COMPLETED|Double-blind Phase||55
8333449|NCT01352221|20542219|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8333450|NCT01352221|20542220|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8333451|NCT01352221|20542221|P2|STARTED|Double-blind Phase||64
8333452|NCT01352221|20542222|P1|STARTED|Double-blind Phase||64
8333453|NCT01352182|20542282|P2|NOT COMPLETED|Overall Study||0
8333454|NCT01352182|20542283|P1|NOT COMPLETED|Overall Study||0
8333455|NCT01352182|20542282|P2|COMPLETED|Overall Study||4
8333456|NCT01352182|20542283|P1|COMPLETED|Overall Study||8
8333457|NCT01352182|20542282|P2|STARTED|Overall Study||4
8333458|NCT01352182|20542283|P1|STARTED|Overall Study||8
8333459|NCT01352117|20542301|P2|NOT COMPLETED|Overall Study||24
8333460|NCT01352117|20542302|P1|NOT COMPLETED|Overall Study||21
8333461|NCT01352117|20542301|P2|COMPLETED|Overall Study||72
8333462|NCT01352117|20542302|P1|COMPLETED|Overall Study||75
8333463|NCT01352117|20542301|P2|Study Week 96 Data Potential|Overall Study||61
8333464|NCT01352117|20542302|P1|Study Week 96 Data Potential|Overall Study||58
8333465|NCT01352117|20542301|P2|Study Week 48 Data Potential|Overall Study||83
8333466|NCT01352117|20542302|P1|Study Week 48 Data Potential|Overall Study||80
8333467|NCT01352117|20542301|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
8333468|NCT01352117|20542302|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
8333469|NCT01352117|20542301|P2|STARTED|Overall Study||96
8333470|NCT01352117|20542302|P1|STARTED|Overall Study||96
8333491|NCT01351766|20542383|P1|NOT COMPLETED|Overall Study||3
8333492|NCT01351766|20542383|P1|COMPLETED|Overall Study||36
8333493|NCT01351766|20542383|P1|STARTED|Overall Study||39
8333494|NCT01351740|20542389|P2|NOT COMPLETED|Overall Study||6
8333495|NCT01351740|20542390|P1|NOT COMPLETED|Overall Study||2
8333496|NCT01351740|20542389|P2|COMPLETED|Overall Study||19
8333497|NCT01351740|20542390|P1|COMPLETED|Overall Study||23
8333498|NCT01351740|20542389|P2|STARTED|Overall Study||25
8333499|NCT01351740|20542390|P1|STARTED|Overall Study||25
8333500|NCT01351623|20542398|P1|NOT COMPLETED|Overall Study||9
8333501|NCT01351623|20542398|P1|COMPLETED|Overall Study||35
8333502|NCT01351623|20542398|P1|STARTED|Overall Study||44
8333503|NCT01351506|20542404|P1|NOT COMPLETED|Overall Study||137
8333504|NCT01351506|20542404|P1|COMPLETED|Overall Study||465
8333505|NCT01351506|20542404|P1|STARTED|Overall Study||602
8333506|NCT01351480|20542414|P1|NOT COMPLETED|Overall Study||8
8333507|NCT01351480|20542414|P1|COMPLETED|Overall Study||26
8333508|NCT01351480|20542414|P1|STARTED|Overall Study||34
8333509|NCT01351415|20542424|P2|NOT COMPLETED|Overall Study||240
8333510|NCT01351415|20542425|P1|NOT COMPLETED|Overall Study||245
8333511|NCT01351415|20542424|P2|COMPLETED|Overall Study||0
8333512|NCT01351415|20542425|P1|COMPLETED|Overall Study||0
8333513|NCT01351415|20542424|P2|Treated Participants|Overall Study||232
8333514|NCT01351415|20542425|P1|Treated Participants|Overall Study||243
8333515|NCT01351415|20542424|P2|STARTED|Overall Study||240
8333516|NCT01351415|20542425|P1|STARTED|Overall Study||245
8333517|NCT01351376|20542447|P2|NOT COMPLETED|Overall Study||0
8333518|NCT01351376|20542448|P1|NOT COMPLETED|Overall Study||0
8333519|NCT01351376|20542447|P2|COMPLETED|Overall Study||11
8333520|NCT01351376|20542448|P1|COMPLETED|Overall Study||10
8333521|NCT01351376|20542447|P2|STARTED|Overall Study||11
8333522|NCT01351376|20542448|P1|STARTED|Overall Study||10
8333523|NCT01351350|20542461|P5|NOT COMPLETED|Overall Study||7
8333524|NCT01351350|20542462|P4|NOT COMPLETED|Overall Study||13
8333525|NCT01351350|20542463|P3|NOT COMPLETED|Overall Study||11
8333526|NCT01351350|20542464|P2|NOT COMPLETED|Overall Study||29
8333527|NCT01351350|20542465|P1|NOT COMPLETED|Overall Study||8
8333528|NCT01351350|20542461|P5|COMPLETED|Overall Study||0
8333529|NCT01351350|20542462|P4|COMPLETED|Overall Study||0
8333530|NCT01351350|20542463|P3|COMPLETED|Overall Study||0
8333531|NCT01351350|20542464|P2|COMPLETED|Overall Study||0
8333532|NCT01351350|20542465|P1|COMPLETED|Overall Study||0
8333533|NCT01351350|20542461|P5|Dose-escalation Evaluable|Overall Study||0
8333534|NCT01351350|20542462|P4|Dose-escalation Evaluable|Overall Study||0
8333535|NCT01351350|20542463|P3|Dose-escalation Evaluable|Overall Study||10
8333536|NCT01351350|20542464|P2|Dose-escalation Evaluable|Overall Study||23
8333537|NCT01351350|20542465|P1|Dose-escalation Evaluable|Overall Study||7
8333538|NCT01351350|20542461|P5|Treated|Overall Study||7
8333539|NCT01351350|20542462|P4|Treated|Overall Study||13
8333540|NCT01351350|20542463|P3|Treated|Overall Study||10
8333541|NCT01351350|20542464|P2|Treated|Overall Study||29
8333542|NCT01351350|20542465|P1|Treated|Overall Study||8
8333543|NCT01351350|20542461|P5|STARTED|Overall Study||7
8333544|NCT01351350|20542462|P4|STARTED|Overall Study||13
8333545|NCT01351350|20542463|P3|STARTED|Overall Study||11
8333546|NCT01351350|20542464|P2|STARTED|Overall Study||29
8333547|NCT01351350|20542465|P1|STARTED|Overall Study||8
8333548|NCT01351337|20542578|P1|NOT COMPLETED|Overall Study||0
8333549|NCT01351337|20542578|P1|COMPLETED|Overall Study||58
8333550|NCT01351337|20542578|P1|STARTED|Overall Study||58
8333551|NCT01351090|20542587|P3|NOT COMPLETED|Overall Study||6
8333552|NCT01351090|20542588|P2|NOT COMPLETED|Overall Study||11
8333553|NCT01351090|20542589|P1|NOT COMPLETED|Overall Study||11
8333554|NCT01351090|20542587|P3|COMPLETED|Overall Study||36
8333555|NCT01351090|20542588|P2|COMPLETED|Overall Study||31
8333556|NCT01351090|20542589|P1|COMPLETED|Overall Study||32
8333557|NCT01351090|20542587|P3|STARTED|Overall Study||42
8333558|NCT01351090|20542588|P2|STARTED|Overall Study||42
8333559|NCT01351090|20542589|P1|STARTED|Overall Study||43
8333560|NCT01351077|20542608|P2|NOT COMPLETED|Overall Study||0
8333561|NCT01351077|20542609|P1|NOT COMPLETED|Overall Study||0
8333562|NCT01351077|20542608|P2|COMPLETED|Overall Study||180
8333563|NCT01351077|20542609|P1|COMPLETED|Overall Study||180
8333564|NCT01351077|20542608|P2|STARTED|Overall Study||180
8333565|NCT01351077|20542609|P1|STARTED|Overall Study||180
8333566|NCT01351064|20542625|P2|NOT COMPLETED|Overall Study||0
8333567|NCT01351064|20542626|P1|NOT COMPLETED|Overall Study||0
8333568|NCT01351064|20542625|P2|COMPLETED|Overall Study||42
8333569|NCT01351064|20542626|P1|COMPLETED|Overall Study||42
8333570|NCT01351064|20542625|P2|STARTED|Overall Study||42
8333571|NCT01351064|20542626|P1|STARTED|Overall Study||42
8333572|NCT01351025|20542636|P2|NOT COMPLETED|Week 44 - 48||0
8333573|NCT01351025|20542637|P1|NOT COMPLETED|Week 44 - 48||0
8333574|NCT01351025|20542636|P2|COMPLETED|Week 44 - 48||43
8333575|NCT01351025|20542637|P1|COMPLETED|Week 44 - 48||42
8333576|NCT01351025|20542636|P2|STARTED|Week 44 - 48||43
8333577|NCT01351025|20542637|P1|STARTED|Week 44 - 48||42
8333578|NCT01351025|20542636|P2|NOT COMPLETED|Week 24 - 44||4
8333579|NCT01351025|20542637|P1|NOT COMPLETED|Week 24 - 44||1
8333580|NCT01351025|20542636|P2|COMPLETED|Week 24 - 44||43
8333581|NCT01351025|20542637|P1|COMPLETED|Week 24 - 44||42
8333582|NCT01351025|20542636|P2|STARTED|Week 24 - 44||47
8333583|NCT01351025|20542637|P1|STARTED|Week 24 - 44||43
8333584|NCT01351025|20542636|P2|NOT COMPLETED|Week 20 - 24||0
8333585|NCT01351025|20542637|P1|NOT COMPLETED|Week 20 - 24||0
8333586|NCT01351025|20542636|P2|COMPLETED|Week 20 - 24||47
8333587|NCT01351025|20542637|P1|COMPLETED|Week 20 - 24||43
8333588|NCT01351025|20542636|P2|STARTED|Week 20 - 24||47
8333589|NCT01351025|20542637|P1|STARTED|Week 20 - 24||43
8333590|NCT01351025|20542636|P2|NOT COMPLETED|Week 0 - 20||1
8333591|NCT01351025|20542637|P1|NOT COMPLETED|Week 0 - 20||3
8333592|NCT01351025|20542636|P2|COMPLETED|Week 0 - 20||47
8333593|NCT01351025|20542637|P1|COMPLETED|Week 0 - 20||43
8333594|NCT01351025|20542636|P2|STARTED|Week 0 - 20||48
8333595|NCT01351025|20542637|P1|STARTED|Week 0 - 20||46
8333596|NCT01350999|20542670|P3|NOT COMPLETED|Overall Study||21
8333597|NCT01350999|20542671|P2|NOT COMPLETED|Overall Study||14
8333598|NCT01350999|20542672|P1|NOT COMPLETED|Overall Study||8
8333599|NCT01350999|20542670|P3|COMPLETED|Overall Study||146
8333600|NCT01350999|20542671|P2|COMPLETED|Overall Study||157
8333601|NCT01350999|20542672|P1|COMPLETED|Overall Study||157
8333602|NCT01350999|20542670|P3|Treated|Overall Study||167
8333603|NCT01350999|20542671|P2|Treated|Overall Study||171
8333604|NCT01350999|20542672|P1|Treated|Overall Study||165
8333605|NCT01350999|20542670|P3|STARTED|Overall Study||167
8333606|NCT01350999|20542671|P2|STARTED|Overall Study||171
8333607|NCT01350999|20542672|P1|STARTED|Overall Study||165
8333608|NCT01350973|20542710|P3|NOT COMPLETED|Overall Study||8
8333609|NCT01350973|20542711|P2|NOT COMPLETED|Overall Study||8
8333610|NCT01350973|20542712|P1|NOT COMPLETED|Overall Study||6
8333611|NCT01350973|20542710|P3|COMPLETED|Overall Study||187
8333612|NCT01350973|20542711|P2|COMPLETED|Overall Study||202
8333613|NCT01350973|20542712|P1|COMPLETED|Overall Study||200
8333614|NCT01350973|20542710|P3|Received Treatment|Overall Study||195
8333615|NCT01350973|20542711|P2|Received Treatment|Overall Study||210
8333616|NCT01350973|20542712|P1|Received Treatment|Overall Study||205
8333617|NCT01350973|20542710|P3|STARTED|Overall Study||195
8333618|NCT01350973|20542711|P2|STARTED|Overall Study||210
8333619|NCT01350973|20542712|P1|STARTED|Overall Study||206
8333620|NCT01350947|20542747|P1|NOT COMPLETED|Overall Study||0
8333621|NCT01350947|20542747|P1|COMPLETED|Overall Study||11
8333622|NCT01350947|20542747|P1|STARTED|Overall Study||11
8333623|NCT01350934|20542753|P2|NOT COMPLETED|Extension Study||4
8333624|NCT01350934|20542754|P1|NOT COMPLETED|Extension Study||5
8333625|NCT01350934|20542753|P2|COMPLETED|Extension Study||101
8333626|NCT01350934|20542754|P1|COMPLETED|Extension Study||95
8333627|NCT01350934|20542753|P2|STARTED|Extension Study||105
8333628|NCT01350934|20542754|P1|STARTED|Extension Study||100
8333629|NCT01350934|20542753|P2|NOT COMPLETED|Base Study||3
8333630|NCT01350934|20542754|P1|NOT COMPLETED|Base Study||11
8333631|NCT01350934|20542753|P2|COMPLETED|Base Study||105
8333632|NCT01350934|20542754|P1|COMPLETED|Base Study||100
8333633|NCT01350934|20542753|P2|STARTED|Base Study||108
8333634|NCT01350934|20542754|P1|STARTED|Base Study||111
8333635|NCT01350804|20542776|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
8333636|NCT01350804|20542777|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
8333637|NCT01350804|20542778|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
8333638|NCT01350804|20542779|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
8333639|NCT01350804|20542776|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
8333640|NCT01350804|20542777|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
8333641|NCT01350804|20542778|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
8333642|NCT01350804|20542779|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
8333643|NCT01350804|20542776|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
8333644|NCT01350804|20542777|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
8333645|NCT01350804|20542778|P2|STARTED|Extension Study, Weeks 52 - 260||79
8333646|NCT01350804|20542779|P1|STARTED|Extension Study, Weeks 52 - 260||80
8333647|NCT01350804|20542776|P4|NOT COMPLETED|Core Study||26
8333648|NCT01350804|20542777|P3|NOT COMPLETED|Core Study||47
8333649|NCT01350804|20542778|P2|NOT COMPLETED|Core Study||47
8333650|NCT01350804|20542779|P1|NOT COMPLETED|Core Study||41
8333651|NCT01350804|20542776|P4|COMPLETED|Core Study||112
8333652|NCT01350804|20542777|P3|COMPLETED|Core Study||91
8333653|NCT01350804|20542778|P2|COMPLETED|Core Study||90
8333654|NCT01350804|20542779|P1|COMPLETED|Core Study||97
8333655|NCT01350804|20542776|P4|Full Analysis Set|Core Study||138
8333656|NCT01350804|20542777|P3|Full Analysis Set|Core Study||138
8333657|NCT01350804|20542778|P2|Full Analysis Set|Core Study||137
8333658|NCT01350804|20542779|P1|Full Analysis Set|Core Study||138
8333659|NCT01350804|20542776|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
8333660|NCT01350804|20542777|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
8333661|NCT01350804|20542778|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
8333662|NCT01350804|20542779|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
8333663|NCT01350804|20542776|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
8333664|NCT01350804|20542777|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
8333665|NCT01350804|20542778|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
8333666|NCT01350804|20542779|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
8333667|NCT01350804|20542776|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
8333668|NCT01350804|20542777|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
8333669|NCT01350804|20542778|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
8333670|NCT01350804|20542779|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
8333671|NCT01350804|20542776|P4|STARTED|Core Study||138
8333672|NCT01350804|20542777|P3|STARTED|Core Study||138
8333673|NCT01350804|20542778|P2|STARTED|Core Study||137
8333674|NCT01350804|20542779|P1|STARTED|Core Study||138
8333675|NCT01350583|20542868|P1|NOT COMPLETED|Overall Study||0
8333676|NCT01350583|20542868|P1|COMPLETED|Overall Study||2
8333677|NCT01350583|20542868|P1|STARTED|Overall Study||2
8333678|NCT01350544|20542876|P2|NOT COMPLETED|Overall Study||22
8333679|NCT01350544|20542877|P1|NOT COMPLETED|Overall Study||23
8333680|NCT01350544|20542876|P2|COMPLETED|Overall Study||86
8333681|NCT01350544|20542877|P1|COMPLETED|Overall Study||85
8333682|NCT01350544|20542876|P2|STARTED|Overall Study||108
8333683|NCT01350544|20542877|P1|STARTED|Overall Study||108
8333684|NCT01350505|20542883|P1|NOT COMPLETED|Overall Study||4
8333685|NCT01350505|20542883|P1|COMPLETED|Overall Study||17
8333686|NCT01350505|20542883|P1|STARTED|Overall Study||21
8333687|NCT01350492|20542889|P2|NOT COMPLETED|Post Intervention Follow-Up||2
8333688|NCT01350492|20542890|P1|NOT COMPLETED|Post Intervention Follow-Up||6
8333689|NCT01350492|20542889|P2|COMPLETED|Post Intervention Follow-Up||18
8333690|NCT01350492|20542890|P1|COMPLETED|Post Intervention Follow-Up||17
8333691|NCT01350492|20542889|P2|6-month MRI Scan|Post Intervention Follow-Up||20
8333692|NCT01350492|20542890|P1|6-month MRI Scan|Post Intervention Follow-Up||20
8333693|NCT01350492|20542889|P2|STARTED|Post Intervention Follow-Up||20
8333694|NCT01350492|20542890|P1|STARTED|Post Intervention Follow-Up||23
8333695|NCT01350492|20542889|P2|NOT COMPLETED|Intervention||6
8333696|NCT01350492|20542890|P1|NOT COMPLETED|Intervention||5
8333697|NCT01350492|20542889|P2|COMPLETED|Intervention||20
8333698|NCT01350492|20542890|P1|COMPLETED|Intervention||23
8333699|NCT01350492|20542889|P2|11-week MRI Scan|Intervention||21
8333700|NCT01350492|20542890|P1|11-week MRI Scan|Intervention||23
8333701|NCT01350492|20542889|P2|6-week MRI Scan|Intervention||22
8333702|NCT01350492|20542890|P1|6-week MRI Scan|Intervention||24
8333703|NCT01350492|20542889|P2|STARTED|Intervention||26
8333704|NCT01350492|20542890|P1|STARTED|Intervention||28
8333705|NCT01350479|20542908|P2|NOT COMPLETED|Overall Study||0
8333706|NCT01350479|20542909|P1|NOT COMPLETED|Overall Study||0
8333707|NCT01350479|20542908|P2|COMPLETED|Overall Study||106
8333708|NCT01350479|20542909|P1|COMPLETED|Overall Study||94
8333709|NCT01350479|20542908|P2|STARTED|Overall Study||106
8333710|NCT01350479|20542909|P1|STARTED|Overall Study||94
8333711|NCT01350453|20542917|P2|NOT COMPLETED|Overall Study||1
8333712|NCT01350453|20542918|P1|NOT COMPLETED|Overall Study||2
8333713|NCT01350453|20542917|P2|COMPLETED|Overall Study||7
8333714|NCT01350453|20542918|P1|COMPLETED|Overall Study||9
8333715|NCT01350453|20542917|P2|STARTED|Overall Study||8
8333716|NCT01350453|20542918|P1|STARTED|Overall Study||11
8333717|NCT01350414|20542932|P1|NOT COMPLETED|Overall Study||19
8333718|NCT01350414|20542932|P1|COMPLETED|Overall Study||162
8333719|NCT01350414|20542932|P1|Year 5|Overall Study||162
8333720|NCT01350414|20542932|P1|Year 4|Overall Study||159
8333721|NCT01350414|20542932|P1|Year 3|Overall Study||162
8333722|NCT01350414|20542932|P1|Year 2|Overall Study||165
8333723|NCT01350414|20542932|P1|STARTED|Overall Study||181
8333724|NCT01350401|20542949|P1|NOT COMPLETED|Overall Study||0
8333725|NCT01350401|20542949|P1|COMPLETED|Overall Study||4
8333726|NCT01350401|20542949|P1|STARTED|Overall Study||4
8333727|NCT01350388|20542961|P2|NOT COMPLETED|Overall Study||1
8333728|NCT01350388|20542962|P1|NOT COMPLETED|Overall Study||3
8333729|NCT01350388|20542961|P2|COMPLETED|Overall Study||39
8333730|NCT01350388|20542962|P1|COMPLETED|Overall Study||37
8333731|NCT01350388|20542961|P2|STARTED|Overall Study||40
8333732|NCT01350388|20542962|P1|STARTED|Overall Study||40
8333733|NCT01350271|20542981|P3|NOT COMPLETED|Overall Study||26
8333734|NCT01350271|20542982|P2|NOT COMPLETED|Overall Study||17
8333735|NCT01350271|20542983|P1|NOT COMPLETED|Overall Study||21
8333736|NCT01350271|20542981|P3|COMPLETED|Overall Study||48
8333737|NCT01350271|20542982|P2|COMPLETED|Overall Study||53
8333738|NCT01350271|20542983|P1|COMPLETED|Overall Study||49
8333739|NCT01350271|20542981|P3|STARTED|Overall Study||74
8333740|NCT01350271|20542982|P2|STARTED|Overall Study||70
8333741|NCT01350271|20542983|P1|STARTED|Overall Study||70
8333742|NCT01350258|20542997|P1|NOT COMPLETED|Overall Study||0
8333743|NCT01350258|20542997|P1|COMPLETED|Overall Study||8
8333744|NCT01350258|20542997|P1|STARTED|Overall Study||8
8333745|NCT01350245|20543006|P1|NOT COMPLETED|Overall Study||0
8333746|NCT01350245|20543006|P1|COMPLETED|Overall Study||28
8333747|NCT01350245|20543006|P1|STARTED|Overall Study||28
8333748|NCT01350232|20543011|P1|NOT COMPLETED|Overall Study||0
8333749|NCT01350232|20543011|P1|COMPLETED|Overall Study||2
8333750|NCT01350232|20543011|P1|STARTED|Overall Study||2
8333751|NCT01350141|20543025|P3|NOT COMPLETED|Overall Study||1
8333752|NCT01350141|20543026|P2|NOT COMPLETED|Overall Study||0
8333753|NCT01350141|20543027|P1|NOT COMPLETED|Overall Study||3
8333754|NCT01350141|20543025|P3|COMPLETED|Overall Study||15
8333755|NCT01350141|20543026|P2|COMPLETED|Overall Study||15
8333756|NCT01350141|20543027|P1|COMPLETED|Overall Study||12
8333757|NCT01350141|20543025|P3|Treated|Overall Study||16
8333758|NCT01350141|20543026|P2|Treated|Overall Study||15
8333759|NCT01350141|20543027|P1|Treated|Overall Study||14
8333760|NCT01350141|20543025|P3|STARTED|Overall Study||16
8333761|NCT01350141|20543026|P2|STARTED|Overall Study||15
8333762|NCT01350141|20543027|P1|STARTED|Overall Study||15
8333763|NCT01350128|20543061|P1|NOT COMPLETED|Overall Study||14
8333764|NCT01350128|20543061|P1|COMPLETED|Overall Study||89
8333765|NCT01350128|20543061|P1|Atrovent HFA 34 µg BID|Overall Study||48
8333766|NCT01350128|20543061|P1|Placebo MDI BID|Overall Study||48
8333767|NCT01350128|20543061|P1|GP MDI 4.6 µg BID|Overall Study||45
8333768|NCT01350128|20543061|P1|GP MDI 9 µg BID|Overall Study||49
8333769|NCT01350128|20543061|P1|GP MDI 18 µg BID|Overall Study||49
8333770|NCT01350128|20543061|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
8333771|NCT01350128|20543061|P1|STARTED|Overall Study||103
8333772|NCT01350115|20543125|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
8333773|NCT01350115|20543126|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
8333774|NCT01350115|20543125|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
8333775|NCT01350115|20543126|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
8333776|NCT01350115|20543125|P2|STARTED|Long Term Follow-Up (All Patients)||2
8333777|NCT01350115|20543126|P1|STARTED|Long Term Follow-Up (All Patients)||8
8333778|NCT01350115|20543125|P2|NOT COMPLETED|Core Study (All Patients)||0
8333779|NCT01350115|20543126|P1|NOT COMPLETED|Core Study (All Patients)||0
8333780|NCT01350115|20543125|P2|COMPLETED|Core Study (All Patients)||2
8333781|NCT01350115|20543126|P1|COMPLETED|Core Study (All Patients)||8
8333782|NCT01350115|20543125|P2|Pharmacodynamic Set|Core Study (All Patients)||2
8333783|NCT01350115|20543126|P1|Pharmacodynamic Set|Core Study (All Patients)||7
8333784|NCT01350115|20543125|P2|Safety Anlysis Set|Core Study (All Patients)||2
8333785|NCT01350115|20543126|P1|Safety Anlysis Set|Core Study (All Patients)||8
8333786|NCT01350115|20543125|P2|STARTED|Core Study (All Patients)||2
8333787|NCT01350115|20543126|P1|STARTED|Core Study (All Patients)||8
8333788|NCT01350102|20543142|P4|NOT COMPLETED|Overall Study||0
8333789|NCT01350102|20543143|P3|NOT COMPLETED|Overall Study||1
8333790|NCT01350102|20543144|P2|NOT COMPLETED|Overall Study||0
8333791|NCT01350102|20543145|P1|NOT COMPLETED|Overall Study||0
8333792|NCT01350102|20543142|P4|COMPLETED|Overall Study||0
8333793|NCT01350102|20543143|P3|COMPLETED|Overall Study||0
8333794|NCT01350102|20543144|P2|COMPLETED|Overall Study||1
8333795|NCT01350102|20543145|P1|COMPLETED|Overall Study||0
8333796|NCT01350102|20543142|P4|STARTED|Overall Study||0
8333797|NCT01350102|20543143|P3|STARTED|Overall Study||1
8333798|NCT01350102|20543144|P2|STARTED|Overall Study||1
8333799|NCT01350102|20543145|P1|STARTED|Overall Study||0
8333800|NCT01349972|20543165|P2|NOT COMPLETED|Overall Study||2
8333801|NCT01349972|20543166|P1|NOT COMPLETED|Overall Study||5
8333802|NCT01349972|20543165|P2|COMPLETED|Overall Study||56
8333803|NCT01349972|20543166|P1|COMPLETED|Overall Study||109
8333804|NCT01349972|20543165|P2|STARTED|Overall Study||58
8333805|NCT01349972|20543166|P1|STARTED|Overall Study||114
8333806|NCT01349959|20543182|P1|NOT COMPLETED|Overall Study||7
8333807|NCT01349959|20543182|P1|COMPLETED|Overall Study||33
8333808|NCT01349959|20543182|P1|STARTED|Overall Study||40
8333809|NCT01349933|20543193|P1|NOT COMPLETED|Overall Study||0
8333810|NCT01349933|20543193|P1|COMPLETED|Overall Study||21
8333811|NCT01349933|20543193|P1|STARTED|Overall Study||21
8333812|NCT01349920|20543203|P1|NOT COMPLETED|Overall Study||0
8333813|NCT01349920|20543203|P1|COMPLETED|Overall Study||15
8333814|NCT01349920|20543203|P1|STARTED|Overall Study||15
8333821|NCT01349829|20543262|P2|NOT COMPLETED|Overall Study||23
8333822|NCT01349829|20543263|P1|NOT COMPLETED|Overall Study||9
8333823|NCT01349829|20543262|P2|COMPLETED|Overall Study||102
8333824|NCT01349829|20543263|P1|COMPLETED|Overall Study||117
8333825|NCT01349829|20543262|P2|STARTED|Overall Study||125
8333826|NCT01349829|20543263|P1|STARTED|Overall Study||126
8333827|NCT01349816|20543281|P1|NOT COMPLETED|Overall Study||30
8333828|NCT01349816|20543281|P1|COMPLETED|Overall Study||155
8333829|NCT01349816|20543281|P1|FF MDI 9.6 µg|Overall Study||61
8333830|NCT01349816|20543281|P1|GFF MDI 9/9.6 µg|Overall Study||57
8333831|NCT01349816|20543281|P1|GFF MDI 18/9.6 µg|Overall Study||57
8333832|NCT01349816|20543281|P1|GFF MDI 36/9.6 µg|Overall Study||56
8333833|NCT01349816|20543281|P1|GFF MDI 36/7.2 µg|Overall Study||58
8333834|NCT01349816|20543281|P1|GP MDI 36 µg|Overall Study||61
8333835|NCT01349816|20543281|P1|STARTED|Overall Study||185
8333836|NCT01349803|20543347|P4|NOT COMPLETED|Overall Study||2
8333837|NCT01349803|20543348|P3|NOT COMPLETED|Overall Study||3
8333838|NCT01349803|20543349|P2|NOT COMPLETED|Overall Study||1
8333839|NCT01349803|20543350|P1|NOT COMPLETED|Overall Study||1
8333840|NCT01349803|20543347|P4|COMPLETED|Overall Study||57
8333841|NCT01349803|20543348|P3|COMPLETED|Overall Study||57
8333842|NCT01349803|20543349|P2|COMPLETED|Overall Study||57
8333843|NCT01349803|20543350|P1|COMPLETED|Overall Study||59
8333844|NCT01349803|20543347|P4|STARTED|Overall Study||59
8333845|NCT01349803|20543348|P3|STARTED|Overall Study||60
8333846|NCT01349803|20543349|P2|STARTED|Overall Study||58
8333847|NCT01349803|20543350|P1|STARTED|Overall Study||60
8333848|NCT01349790|20543420|P1|NOT COMPLETED|Overall Study||9
8333849|NCT01349790|20543420|P1|COMPLETED|Overall Study||31
8333850|NCT01349790|20543420|P1|STARTED|Overall Study||40
8333851|NCT01349673|20543439|P1|NOT COMPLETED|Overall Study||114
8333852|NCT01349673|20543439|P1|COMPLETED|Overall Study||0
8333853|NCT01349673|20543439|P1|Received At Least 1 Dose Of Study Drug|Overall Study||114
8333854|NCT01349673|20543439|P1|Participants Entered Cycle 8|Overall Study||1
8333855|NCT01349673|20543439|P1|Participants Entered Cycle 7|Overall Study||3
8333856|NCT01349673|20543439|P1|Participants Entered Cycle 6|Overall Study||5
8333857|NCT01349673|20543439|P1|Participants Entered Cycle 5|Overall Study||12
8333858|NCT01349673|20543439|P1|Participants Entered Cycle 4|Overall Study||22
8333859|NCT01349673|20543439|P1|Participants Entered Cycle 3|Overall Study||41
8333860|NCT01349673|20543439|P1|Participants Entered Cycle 2|Overall Study||65
8333861|NCT01349673|20543439|P1|Participants Entered Cycle 1|Overall Study||114
8333862|NCT01349673|20543439|P1|STARTED|Overall Study||114
8333863|NCT01349660|20543449|P3|NOT COMPLETED|Overall Study||76
8333864|NCT01349660|20543450|P2|NOT COMPLETED|Overall Study||6
8333865|NCT01349660|20543451|P1|NOT COMPLETED|Overall Study||6
8333866|NCT01349660|20543449|P3|COMPLETED|Overall Study||0
8333867|NCT01349660|20543450|P2|COMPLETED|Overall Study||0
8333868|NCT01349660|20543451|P1|COMPLETED|Overall Study||0
8333869|NCT01349660|20543449|P3|STARTED|Overall Study||76
8333870|NCT01349660|20543450|P2|STARTED|Overall Study||6
8333871|NCT01349660|20543451|P1|STARTED|Overall Study||6
8333872|NCT01349595|20543469|P2|NOT COMPLETED|Overall Study||2
8333873|NCT01349595|20543470|P1|NOT COMPLETED|Overall Study||2
8333874|NCT01349595|20543469|P2|COMPLETED|Overall Study||0
8333875|NCT01349595|20543470|P1|COMPLETED|Overall Study||0
8333876|NCT01349595|20543469|P2|STARTED|Overall Study||2
8333877|NCT01349595|20543470|P1|STARTED|Overall Study||2
8333878|NCT01349569|20543476|P1|NOT COMPLETED|Overall Study||4
8333879|NCT01349569|20543476|P1|COMPLETED|Overall Study||12
8333880|NCT01349569|20543476|P1|STARTED|Overall Study||16
8333881|NCT01349491|20543488|P2|NOT COMPLETED|Overall Study||0
8333882|NCT01349491|20543489|P1|NOT COMPLETED|Overall Study||0
8333883|NCT01349491|20543488|P2|COMPLETED|Overall Study||5
8333884|NCT01349491|20543489|P1|COMPLETED|Overall Study||5
8333885|NCT01349491|20543488|P2|STARTED|Overall Study||5
8333886|NCT01349491|20543489|P1|STARTED|Overall Study||5
8333887|NCT01349465|20543497|P2|NOT COMPLETED|Overall Study||22
8333888|NCT01349465|20543498|P1|NOT COMPLETED|Overall Study||18
8333889|NCT01349465|20543497|P2|COMPLETED|Overall Study||27
8333890|NCT01349465|20543498|P1|COMPLETED|Overall Study||182
8333891|NCT01349465|20543497|P2|STARTED|Overall Study||49
8333892|NCT01349465|20543498|P1|STARTED|Overall Study||200
8333893|NCT01349231|20543510|P1|NOT COMPLETED|Overall Study||0
8333894|NCT01349231|20543510|P1|COMPLETED|Overall Study||10
8333895|NCT01349231|20543510|P1|STARTED|Overall Study||10
8333896|NCT01349192|20543519|P2|NOT COMPLETED|Overall Study||6
8333897|NCT01349192|20543520|P1|NOT COMPLETED|Overall Study||3
8333898|NCT01349192|20543519|P2|COMPLETED|Overall Study||17
8333899|NCT01349192|20543520|P1|COMPLETED|Overall Study||21
8333900|NCT01349192|20543519|P2|Withdrawals|Overall Study||6
8333901|NCT01349192|20543520|P1|Withdrawals|Overall Study||3
8333902|NCT01349192|20543519|P2|Evaluable for Primary Endpoint|Overall Study||19
8333903|NCT01349192|20543520|P1|Evaluable for Primary Endpoint|Overall Study||22
8333904|NCT01349192|20543519|P2|STARTED|Overall Study||23
8333905|NCT01349192|20543520|P1|STARTED|Overall Study||24
8333906|NCT01349114|20543534|P2|NOT COMPLETED|Overall Study||0
8333907|NCT01349114|20543535|P1|NOT COMPLETED|Overall Study||0
8333908|NCT01349114|20543534|P2|COMPLETED|Overall Study||11
8333909|NCT01349114|20543535|P1|COMPLETED|Overall Study||10
8333910|NCT01349114|20543534|P2|STARTED|Overall Study||11
8333911|NCT01349114|20543535|P1|STARTED|Overall Study||10
8333912|NCT01349049|20543552|P9|NOT COMPLETED|Overall Study||55
8333913|NCT01349049|20543553|P8|NOT COMPLETED|Overall Study||4
8333914|NCT01349049|20543554|P7|NOT COMPLETED|Overall Study||5
8333915|NCT01349049|20543555|P6|NOT COMPLETED|Overall Study||6
8333916|NCT01349049|20543556|P5|NOT COMPLETED|Overall Study||3
8333917|NCT01349049|20543557|P4|NOT COMPLETED|Overall Study||3
8333918|NCT01349049|20543558|P3|NOT COMPLETED|Overall Study||3
8333919|NCT01349049|20543559|P2|NOT COMPLETED|Overall Study||7
8333920|NCT01349049|20543560|P1|NOT COMPLETED|Overall Study||3
8333921|NCT01349049|20543552|P9|COMPLETED|Overall Study||1
8333922|NCT01349049|20543553|P8|COMPLETED|Overall Study||0
8333923|NCT01349049|20543554|P7|COMPLETED|Overall Study||0
8333924|NCT01349049|20543555|P6|COMPLETED|Overall Study||0
8333925|NCT01349049|20543556|P5|COMPLETED|Overall Study||0
8333926|NCT01349049|20543557|P4|COMPLETED|Overall Study||0
8333927|NCT01349049|20543558|P3|COMPLETED|Overall Study||0
8333928|NCT01349049|20543559|P2|COMPLETED|Overall Study||0
8333929|NCT01349049|20543560|P1|COMPLETED|Overall Study||0
8333930|NCT01349049|20543552|P9|STARTED|Overall Study||56
8333931|NCT01349049|20543553|P8|STARTED|Overall Study||4
8333932|NCT01349049|20543554|P7|STARTED|Overall Study||5
8333933|NCT01349049|20543555|P6|STARTED|Overall Study||6
8333934|NCT01349049|20543556|P5|STARTED|Overall Study||3
8333935|NCT01349049|20543557|P4|STARTED|Overall Study||3
8333936|NCT01349049|20543558|P3|STARTED|Overall Study||3
8333937|NCT01349049|20543559|P2|STARTED|Overall Study||7
8333938|NCT01349049|20543560|P1|STARTED|Overall Study||3
8333939|NCT01349036|20543614|P2|NOT COMPLETED|Overall Study||24
8333940|NCT01349036|20543615|P1|NOT COMPLETED|Overall Study||14
8333941|NCT01349036|20543614|P2|COMPLETED|Overall Study||0
8333942|NCT01349036|20543615|P1|COMPLETED|Overall Study||0
8333943|NCT01349036|20543614|P2|STARTED|Overall Study||24
8333944|NCT01349036|20543615|P1|STARTED|Overall Study||14
8333945|NCT01348854|20543633|P2|NOT COMPLETED|Overall Study||1
8333946|NCT01348854|20543634|P1|NOT COMPLETED|Overall Study||3
8333947|NCT01348854|20543633|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
8333948|NCT01348854|20543634|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
8333949|NCT01348854|20543633|P2|STARTED|Overall Study|10 eyes of 6 participants|6
8333950|NCT01348854|20543634|P1|STARTED|Overall Study|53 eyes of 34 participants|34
8333951|NCT01348789|20543642|P1|NOT COMPLETED|Overall Study||4
8333952|NCT01348789|20543642|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
8333953|NCT01348789|20543642|P1|STARTED|Overall Study||37
8333954|NCT01348776|20543653|P1|NOT COMPLETED|Overall Study||3
8333955|NCT01348776|20543653|P1|COMPLETED|Overall Study||84
8333956|NCT01348776|20543653|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
8333957|NCT01348763|20543666|P1|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
8333958|NCT01348763|20543666|P1|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
8333959|NCT01348763|20543666|P1|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
8333960|NCT01348763|20543666|P1|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
8333961|NCT01348763|20543666|P1|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
8333962|NCT01348763|20543666|P1|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
8333963|NCT01348698|20543671|P1|NOT COMPLETED|Overall Study||72
8333964|NCT01348698|20543671|P1|COMPLETED|Overall Study||2
8333965|NCT01348698|20543671|P1|STARTED|Overall Study||74
8333966|NCT01348607|20543681|P3|NOT COMPLETED|Overall Study||0
8333967|NCT01348607|20543682|P2|NOT COMPLETED|Overall Study||0
8333968|NCT01348607|20543683|P1|NOT COMPLETED|Overall Study||0
8333969|NCT01348607|20543681|P3|COMPLETED|Overall Study||0
8333970|NCT01348607|20543682|P2|COMPLETED|Overall Study||0
8333971|NCT01348607|20543683|P1|COMPLETED|Overall Study||1
8333972|NCT01348607|20543681|P3|STARTED|Overall Study||0
8333973|NCT01348607|20543682|P2|STARTED|Overall Study||0
8333974|NCT01348607|20543683|P1|STARTED|Overall Study||1
8333975|NCT01348542|20543696|P2|NOT COMPLETED|Overall Study||0
8333976|NCT01348542|20543697|P1|NOT COMPLETED|Overall Study||3
8333977|NCT01348542|20543696|P2|COMPLETED|Overall Study||11
8333978|NCT01348542|20543697|P1|COMPLETED|Overall Study||10
8333979|NCT01348542|20543696|P2|STARTED|Overall Study||11
8333980|NCT01348542|20543697|P1|STARTED|Overall Study||13
8333981|NCT01348490|20543713|P1|NOT COMPLETED|Overall Study||24
8333982|NCT01348490|20543713|P1|COMPLETED|Overall Study||42
8333983|NCT01348490|20543713|P1|STARTED|Overall Study||66
8333984|NCT01348425|20543771|P2|NOT COMPLETED|Overall Study||1
8333985|NCT01348425|20543772|P1|NOT COMPLETED|Overall Study||1
8333986|NCT01348425|20543771|P2|COMPLETED|Overall Study||13
8333987|NCT01348425|20543772|P1|COMPLETED|Overall Study||30
8333988|NCT01348425|20543771|P2|STARTED|Overall Study||14
8333989|NCT01348425|20543772|P1|STARTED|Overall Study||31
8333990|NCT01348347|20543780|P3|NOT COMPLETED|Overall Study||6
8333991|NCT01348347|20543781|P2|NOT COMPLETED|Overall Study||6
8333992|NCT01348347|20543782|P1|NOT COMPLETED|Overall Study||3
8333993|NCT01348347|20543780|P3|COMPLETED|Overall Study||0
8333994|NCT01348347|20543781|P2|COMPLETED|Overall Study||0
8333995|NCT01348347|20543782|P1|COMPLETED|Overall Study||0
8333996|NCT01348347|20543780|P3|STARTED|Overall Study||6
8333997|NCT01348347|20543781|P2|STARTED|Overall Study||6
8333998|NCT01348347|20543782|P1|STARTED|Overall Study||3
8333999|NCT01348165|20543813|P7|NOT COMPLETED|Overall Study||1
8334000|NCT01348165|20543814|P6|NOT COMPLETED|Overall Study||0
8334001|NCT01348165|20543815|P5|NOT COMPLETED|Overall Study||0
8334002|NCT01348165|20543816|P4|NOT COMPLETED|Overall Study||0
8334003|NCT01348165|20543817|P3|NOT COMPLETED|Overall Study||0
8334004|NCT01348165|20543818|P2|NOT COMPLETED|Overall Study||0
8334005|NCT01348165|20543819|P1|NOT COMPLETED|Overall Study||0
8334006|NCT01348165|20543813|P7|COMPLETED|Overall Study||5
8334007|NCT01348165|20543814|P6|COMPLETED|Overall Study||1
8334008|NCT01348165|20543815|P5|COMPLETED|Overall Study||6
8334009|NCT01348165|20543816|P4|COMPLETED|Overall Study||6
8334010|NCT01348165|20543817|P3|COMPLETED|Overall Study||6
8334011|NCT01348165|20543818|P2|COMPLETED|Overall Study||5
8334012|NCT01348165|20543819|P1|COMPLETED|Overall Study||10
8334013|NCT01348165|20543813|P7|STARTED|Overall Study||6
8334014|NCT01348165|20543814|P6|STARTED|Overall Study||1
8334015|NCT01348165|20543815|P5|STARTED|Overall Study||6
8334016|NCT01348165|20543816|P4|STARTED|Overall Study||6
8334017|NCT01348165|20543817|P3|STARTED|Overall Study||6
8334018|NCT01348165|20543818|P2|STARTED|Overall Study||5
8334019|NCT01348165|20543819|P1|STARTED|Overall Study||10
8334020|NCT01348139|20543948|P6|NOT COMPLETED|Period 6||0
8334021|NCT01348139|20543949|P5|NOT COMPLETED|Period 6||0
8334022|NCT01348139|20543950|P4|NOT COMPLETED|Period 6||0
8334023|NCT01348139|20543951|P3|NOT COMPLETED|Period 6||0
8334024|NCT01348139|20543952|P2|NOT COMPLETED|Period 6||0
8334025|NCT01348139|20543953|P1|NOT COMPLETED|Period 6||0
8334026|NCT01348139|20543948|P6|COMPLETED|Period 6||4
8334027|NCT01348139|20543949|P5|COMPLETED|Period 6||5
8334028|NCT01348139|20543950|P4|COMPLETED|Period 6||4
8334029|NCT01348139|20543951|P3|COMPLETED|Period 6||4
8334030|NCT01348139|20543952|P2|COMPLETED|Period 6||4
8334031|NCT01348139|20543953|P1|COMPLETED|Period 6||4
8334032|NCT01348139|20543948|P6|STARTED|Period 6||4
8334033|NCT01348139|20543949|P5|STARTED|Period 6||5
8334034|NCT01348139|20543950|P4|STARTED|Period 6||4
8334035|NCT01348139|20543951|P3|STARTED|Period 6||4
8334036|NCT01348139|20543952|P2|STARTED|Period 6||4
8334037|NCT01348139|20543953|P1|STARTED|Period 6||4
8334038|NCT01348139|20543948|P6|NOT COMPLETED|Period 5||0
8334039|NCT01348139|20543949|P5|NOT COMPLETED|Period 5||0
8334040|NCT01348139|20543950|P4|NOT COMPLETED|Period 5||0
8334041|NCT01348139|20543951|P3|NOT COMPLETED|Period 5||0
8334042|NCT01348139|20543952|P2|NOT COMPLETED|Period 5||0
8334043|NCT01348139|20543953|P1|NOT COMPLETED|Period 5||0
8334044|NCT01348139|20543948|P6|COMPLETED|Period 5||4
8334045|NCT01348139|20543949|P5|COMPLETED|Period 5||5
8334046|NCT01348139|20543950|P4|COMPLETED|Period 5||4
8334047|NCT01348139|20543951|P3|COMPLETED|Period 5||4
8334048|NCT01348139|20543952|P2|COMPLETED|Period 5||4
8334049|NCT01348139|20543953|P1|COMPLETED|Period 5||4
8334050|NCT01348139|20543948|P6|STARTED|Period 5||4
8334051|NCT01348139|20543949|P5|STARTED|Period 5||5
8334052|NCT01348139|20543950|P4|STARTED|Period 5||4
8334053|NCT01348139|20543951|P3|STARTED|Period 5||4
8334054|NCT01348139|20543952|P2|STARTED|Period 5||4
8334055|NCT01348139|20543953|P1|STARTED|Period 5||4
8334056|NCT01348139|20543948|P6|NOT COMPLETED|Period 4||0
8334057|NCT01348139|20543949|P5|NOT COMPLETED|Period 4||0
8334058|NCT01348139|20543950|P4|NOT COMPLETED|Period 4||0
8334059|NCT01348139|20543951|P3|NOT COMPLETED|Period 4||0
8334060|NCT01348139|20543952|P2|NOT COMPLETED|Period 4||0
8334061|NCT01348139|20543953|P1|NOT COMPLETED|Period 4||0
8334062|NCT01348139|20543948|P6|COMPLETED|Period 4||4
8334063|NCT01348139|20543949|P5|COMPLETED|Period 4||5
8334064|NCT01348139|20543950|P4|COMPLETED|Period 4||4
8334065|NCT01348139|20543951|P3|COMPLETED|Period 4||4
8334066|NCT01348139|20543952|P2|COMPLETED|Period 4||4
8334067|NCT01348139|20543953|P1|COMPLETED|Period 4||4
8334068|NCT01348139|20543948|P6|STARTED|Period 4||4
8334069|NCT01348139|20543949|P5|STARTED|Period 4||5
8334070|NCT01348139|20543950|P4|STARTED|Period 4||4
8334071|NCT01348139|20543951|P3|STARTED|Period 4||4
8334072|NCT01348139|20543952|P2|STARTED|Period 4||4
8334073|NCT01348139|20543953|P1|STARTED|Period 4||4
8334074|NCT01348139|20543948|P6|NOT COMPLETED|Period 3||0
8334075|NCT01348139|20543949|P5|NOT COMPLETED|Period 3||0
8334076|NCT01348139|20543950|P4|NOT COMPLETED|Period 3||0
8334077|NCT01348139|20543951|P3|NOT COMPLETED|Period 3||0
8334078|NCT01348139|20543952|P2|NOT COMPLETED|Period 3||0
8334079|NCT01348139|20543953|P1|NOT COMPLETED|Period 3||0
8334080|NCT01348139|20543948|P6|COMPLETED|Period 3||4
8334081|NCT01348139|20543949|P5|COMPLETED|Period 3||5
8334082|NCT01348139|20543950|P4|COMPLETED|Period 3||4
8334083|NCT01348139|20543951|P3|COMPLETED|Period 3||4
8334084|NCT01348139|20543952|P2|COMPLETED|Period 3||4
8334085|NCT01348139|20543953|P1|COMPLETED|Period 3||4
8334086|NCT01348139|20543948|P6|STARTED|Period 3||4
8334087|NCT01348139|20543949|P5|STARTED|Period 3||5
8334088|NCT01348139|20543950|P4|STARTED|Period 3||4
8334089|NCT01348139|20543951|P3|STARTED|Period 3||4
8334090|NCT01348139|20543952|P2|STARTED|Period 3||4
8334091|NCT01348139|20543953|P1|STARTED|Period 3||4
8334092|NCT01348139|20543948|P6|NOT COMPLETED|Period 2||0
8334093|NCT01348139|20543949|P5|NOT COMPLETED|Period 2||0
8334094|NCT01348139|20543950|P4|NOT COMPLETED|Period 2||0
8334095|NCT01348139|20543951|P3|NOT COMPLETED|Period 2||0
8334096|NCT01348139|20543952|P2|NOT COMPLETED|Period 2||0
8334097|NCT01348139|20543953|P1|NOT COMPLETED|Period 2||0
8334098|NCT01348139|20543948|P6|COMPLETED|Period 2||4
8334099|NCT01348139|20543949|P5|COMPLETED|Period 2||5
8334100|NCT01348139|20543950|P4|COMPLETED|Period 2||4
8334101|NCT01348139|20543951|P3|COMPLETED|Period 2||4
8334102|NCT01348139|20543952|P2|COMPLETED|Period 2||4
8334103|NCT01348139|20543953|P1|COMPLETED|Period 2||4
8334104|NCT01348139|20543948|P6|STARTED|Period 2||4
8334105|NCT01348139|20543949|P5|STARTED|Period 2||5
8334106|NCT01348139|20543950|P4|STARTED|Period 2||4
8334107|NCT01348139|20543951|P3|STARTED|Period 2||4
8334108|NCT01348139|20543952|P2|STARTED|Period 2||4
8334109|NCT01348139|20543953|P1|STARTED|Period 2||4
8334110|NCT01348139|20543948|P6|NOT COMPLETED|Period 1||0
8334111|NCT01348139|20543949|P5|NOT COMPLETED|Period 1||0
8334112|NCT01348139|20543950|P4|NOT COMPLETED|Period 1||0
8334113|NCT01348139|20543951|P3|NOT COMPLETED|Period 1||0
8334114|NCT01348139|20543952|P2|NOT COMPLETED|Period 1||0
8334115|NCT01348139|20543953|P1|NOT COMPLETED|Period 1||1
8334116|NCT01348139|20543948|P6|COMPLETED|Period 1||4
8334117|NCT01348139|20543949|P5|COMPLETED|Period 1||5
8334118|NCT01348139|20543950|P4|COMPLETED|Period 1||4
8334119|NCT01348139|20543951|P3|COMPLETED|Period 1||4
8334120|NCT01348139|20543952|P2|COMPLETED|Period 1||4
8334121|NCT01348139|20543953|P1|COMPLETED|Period 1||4
8334122|NCT01348139|20543948|P6|STARTED|Period 1||4
8334123|NCT01348139|20543949|P5|STARTED|Period 1||5
8334124|NCT01348139|20543950|P4|STARTED|Period 1||4
8334125|NCT01348139|20543951|P3|STARTED|Period 1||4
8334126|NCT01348139|20543952|P2|STARTED|Period 1||4
8334127|NCT01348139|20543953|P1|STARTED|Period 1||5
8334128|NCT01348100|20544034|P7|NOT COMPLETED|Overall Study||3
8334129|NCT01348100|20544035|P6|NOT COMPLETED|Overall Study||2
8334130|NCT01348100|20544036|P5|NOT COMPLETED|Overall Study||1
8334131|NCT01348100|20544037|P4|NOT COMPLETED|Overall Study||1
8334132|NCT01348100|20544038|P3|NOT COMPLETED|Overall Study||2
8334133|NCT01348100|20544039|P2|NOT COMPLETED|Overall Study||0
8334134|NCT01348100|20544040|P1|NOT COMPLETED|Overall Study||0
8334135|NCT01348100|20544034|P7|COMPLETED|Overall Study||13
8334136|NCT01348100|20544035|P6|COMPLETED|Overall Study||14
8334137|NCT01348100|20544036|P5|COMPLETED|Overall Study||14
8334138|NCT01348100|20544037|P4|COMPLETED|Overall Study||14
8334139|NCT01348100|20544038|P3|COMPLETED|Overall Study||13
8334140|NCT01348100|20544039|P2|COMPLETED|Overall Study||2
8334141|NCT01348100|20544040|P1|COMPLETED|Overall Study||2
8334142|NCT01348100|20544034|P7|STARTED|Overall Study||16
8334143|NCT01348100|20544035|P6|STARTED|Overall Study||16
8334144|NCT01348100|20544036|P5|STARTED|Overall Study||15
8334145|NCT01348100|20544037|P4|STARTED|Overall Study||15
8334146|NCT01348100|20544038|P3|STARTED|Overall Study||15
8334147|NCT01348100|20544039|P2|STARTED|Overall Study||2
8334148|NCT01348100|20544040|P1|STARTED|Overall Study||2
8334149|NCT01348087|20544085|P1|NOT COMPLETED|Overall Study||148
8334150|NCT01348087|20544085|P1|COMPLETED|Overall Study||0
8334151|NCT01348087|20544085|P1|STARTED|Overall Study||148
8334152|NCT01347931|20544099|P1|NOT COMPLETED|NIOV System||0
8334153|NCT01347931|20544099|P1|COMPLETED|NIOV System||29
8334154|NCT01347931|20544099|P1|STARTED|NIOV System||29
8334155|NCT01347931|20544099|P1|NOT COMPLETED|Standard Oxygen Therapy||1
8334156|NCT01347931|20544099|P1|COMPLETED|Standard Oxygen Therapy||29
8334157|NCT01347931|20544099|P1|STARTED|Standard Oxygen Therapy||30
8334158|NCT01347879|20544111|P2|NOT COMPLETED|Overall Study||17
8334159|NCT01347879|20544112|P1|NOT COMPLETED|Overall Study||7
8334160|NCT01347879|20544111|P2|COMPLETED|Overall Study||83
8334161|NCT01347879|20544112|P1|COMPLETED|Overall Study||46
8334162|NCT01347879|20544111|P2|STARTED|Overall Study||100
8334163|NCT01347879|20544112|P1|STARTED|Overall Study||53
8334164|NCT01347866|20544161|P17|NOT COMPLETED|Overall Study||2
8334165|NCT01347866|20544162|P16|NOT COMPLETED|Overall Study||4
8334166|NCT01347866|20544163|P15|NOT COMPLETED|Overall Study||3
8334167|NCT01347866|20544164|P14|NOT COMPLETED|Overall Study||7
8334168|NCT01347866|20544165|P13|NOT COMPLETED|Overall Study||7
8334169|NCT01347866|20544166|P12|NOT COMPLETED|Overall Study||4
8334170|NCT01347866|20544167|P11|NOT COMPLETED|Overall Study||3
8334171|NCT01347866|20544168|P10|NOT COMPLETED|Overall Study||7
8334172|NCT01347866|20544169|P9|NOT COMPLETED|Overall Study||31
8334173|NCT01347866|20544170|P8|NOT COMPLETED|Overall Study||4
8334174|NCT01347866|20544171|P7|NOT COMPLETED|Overall Study||6
8334175|NCT01347866|20544172|P6|NOT COMPLETED|Overall Study||3
8334176|NCT01347866|20544173|P5|NOT COMPLETED|Overall Study||7
8334177|NCT01347866|20544174|P4|NOT COMPLETED|Overall Study||7
8334178|NCT01347866|20544175|P3|NOT COMPLETED|Overall Study||1
8334179|NCT01347866|20544176|P2|NOT COMPLETED|Overall Study||1
8334180|NCT01347866|20544177|P1|NOT COMPLETED|Overall Study||5
8334181|NCT01347866|20544161|P17|COMPLETED|Overall Study||0
8334182|NCT01347866|20544162|P16|COMPLETED|Overall Study||0
8334183|NCT01347866|20544163|P15|COMPLETED|Overall Study||0
8334184|NCT01347866|20544164|P14|COMPLETED|Overall Study||0
8334185|NCT01347866|20544165|P13|COMPLETED|Overall Study||0
8334186|NCT01347866|20544166|P12|COMPLETED|Overall Study||0
8334187|NCT01347866|20544167|P11|COMPLETED|Overall Study||0
8334188|NCT01347866|20544168|P10|COMPLETED|Overall Study||0
8334189|NCT01347866|20544169|P9|COMPLETED|Overall Study||0
8334190|NCT01347866|20544170|P8|COMPLETED|Overall Study||0
8334191|NCT01347866|20544171|P7|COMPLETED|Overall Study||0
8334192|NCT01347866|20544172|P6|COMPLETED|Overall Study||0
8334193|NCT01347866|20544173|P5|COMPLETED|Overall Study||0
8334194|NCT01347866|20544174|P4|COMPLETED|Overall Study||0
8334195|NCT01347866|20544175|P3|COMPLETED|Overall Study||0
8334196|NCT01347866|20544176|P2|COMPLETED|Overall Study||0
8334197|NCT01347866|20544177|P1|COMPLETED|Overall Study||0
8334198|NCT01347866|20544161|P17|STARTED|Overall Study||2
8334199|NCT01347866|20544162|P16|STARTED|Overall Study||4
8334200|NCT01347866|20544163|P15|STARTED|Overall Study||3
8334201|NCT01347866|20544164|P14|STARTED|Overall Study||7
8334202|NCT01347866|20544165|P13|STARTED|Overall Study||7
8334203|NCT01347866|20544166|P12|STARTED|Overall Study||4
8334204|NCT01347866|20544167|P11|STARTED|Overall Study||3
8334205|NCT01347866|20544168|P10|STARTED|Overall Study||7
8334206|NCT01347866|20544169|P9|STARTED|Overall Study||31
8334207|NCT01347866|20544170|P8|STARTED|Overall Study||4
8334208|NCT01347866|20544171|P7|STARTED|Overall Study||6
8334209|NCT01347866|20544172|P6|STARTED|Overall Study||3
8334210|NCT01347866|20544173|P5|STARTED|Overall Study||7
8334211|NCT01347866|20544174|P4|STARTED|Overall Study||7
8334212|NCT01347866|20544175|P3|STARTED|Overall Study||1
8334213|NCT01347866|20544176|P2|STARTED|Overall Study||1
8334214|NCT01347866|20544177|P1|STARTED|Overall Study||5
8334215|NCT01347840|20544551|P1|NOT COMPLETED|Overall Study||1
8334216|NCT01347840|20544551|P1|COMPLETED|Overall Study||0
8334217|NCT01347840|20544551|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
8334218|NCT01347788|20544564|P3|NOT COMPLETED|Overall Study||0
8334219|NCT01347788|20544565|P2|NOT COMPLETED|Overall Study||0
8334220|NCT01347788|20544566|P1|NOT COMPLETED|Overall Study||0
8334221|NCT01347788|20544564|P3|COMPLETED|Overall Study||13
8334222|NCT01347788|20544565|P2|COMPLETED|Overall Study||10
8334223|NCT01347788|20544566|P1|COMPLETED|Overall Study||11
8334224|NCT01347788|20544564|P3|STARTED|Overall Study||13
8334225|NCT01347788|20544565|P2|STARTED|Overall Study||10
8334226|NCT01347788|20544566|P1|STARTED|Overall Study||11
8334227|NCT01347762|20544578|P4|NOT COMPLETED|Overall Study||8
8334228|NCT01347762|20544579|P3|NOT COMPLETED|Overall Study||9
8334229|NCT01347762|20544580|P2|NOT COMPLETED|Overall Study||2
8334230|NCT01347762|20544581|P1|NOT COMPLETED|Overall Study||4
8334231|NCT01347762|20544578|P4|COMPLETED|Overall Study||10
8334232|NCT01347762|20544579|P3|COMPLETED|Overall Study||7
8334233|NCT01347762|20544580|P2|COMPLETED|Overall Study||6
8334234|NCT01347762|20544581|P1|COMPLETED|Overall Study||6
8334235|NCT01347762|20544578|P4|STARTED|Overall Study||18
8334236|NCT01347762|20544579|P3|STARTED|Overall Study||16
8334237|NCT01347762|20544580|P2|STARTED|Overall Study||8
8334238|NCT01347762|20544581|P1|STARTED|Overall Study||10
8334239|NCT01347710|20544607|P1|NOT COMPLETED|Overall Study||31
8334240|NCT01347710|20544607|P1|COMPLETED|Overall Study||764
8334241|NCT01347710|20544607|P1|STARTED|Overall Study||795
8334242|NCT01347632|20544622|P1|NOT COMPLETED|Overall Study||2
8334243|NCT01347632|20544622|P1|COMPLETED|Overall Study||33
8334244|NCT01347632|20544622|P1|STARTED|Overall Study||35
8334245|NCT01347580|20544629|P2|NOT COMPLETED|Overall Study||56
8334246|NCT01347580|20544630|P1|NOT COMPLETED|Overall Study||65
8334247|NCT01347580|20544629|P2|COMPLETED|Overall Study|based on randomized treatment|897
8334248|NCT01347580|20544630|P1|COMPLETED|Overall Study|based on randomized treatment|844
8334249|NCT01347580|20544629|P2|Safety Population|Overall Study|based on actual treatment|950
8334250|NCT01347580|20544630|P1|Safety Population|Overall Study|based on actual treatment|908
8334251|NCT01347580|20544629|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
8334252|NCT01347580|20544630|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
8334253|NCT01347580|20544629|P2|STARTED|Overall Study|based on randomized treatment|953
8334254|NCT01347580|20544630|P1|STARTED|Overall Study|based on randomized treatment|909
8334255|NCT01347554|20544660|P2|NOT COMPLETED|Overall Study||11
8334256|NCT01347554|20544661|P1|NOT COMPLETED|Overall Study||7
8334257|NCT01347554|20544660|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
8334258|NCT01347554|20544661|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
8334259|NCT01347554|20544660|P2|STARTED|Overall Study||242
8334260|NCT01347554|20544661|P1|STARTED|Overall Study||237
8334261|NCT01347333|20544675|P2|NOT COMPLETED|Overall Study||0
8334262|NCT01347333|20544676|P1|NOT COMPLETED|Overall Study||0
8334263|NCT01347333|20544675|P2|COMPLETED|Overall Study||0
8334264|NCT01347333|20544676|P1|COMPLETED|Overall Study||23
8334265|NCT01347333|20544675|P2|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
8334266|NCT01347333|20544676|P1|STARTED|Overall Study||23
8334267|NCT01347307|20544686|P2|NOT COMPLETED|Overall Study||5
8334268|NCT01347307|20544687|P1|NOT COMPLETED|Overall Study||0
8334269|NCT01347307|20544686|P2|COMPLETED|Overall Study||28
8334270|NCT01347307|20544687|P1|COMPLETED|Overall Study||3
8334271|NCT01347307|20544686|P2|STARTED|Overall Study||33
8334272|NCT01347307|20544687|P1|STARTED|Overall Study||3
8334273|NCT01347255|20544697|P1|NOT COMPLETED|Overall Study||0
8334274|NCT01347255|20544697|P1|COMPLETED|Overall Study||24
8334275|NCT01347255|20544697|P1|STARTED|Overall Study||24
8334276|NCT01347112|20544722|P2|NOT COMPLETED|Overall Study||12
8334277|NCT01347112|20544723|P1|NOT COMPLETED|Overall Study||4
8334278|NCT01347112|20544722|P2|COMPLETED|Overall Study||5
8334279|NCT01347112|20544723|P1|COMPLETED|Overall Study||12
8334280|NCT01347112|20544722|P2|STARTED|Overall Study||17
8334281|NCT01347112|20544723|P1|STARTED|Overall Study||16
8334282|NCT01347086|20544743|P10|NOT COMPLETED|Overall Study||1
8334283|NCT01347086|20544744|P9|NOT COMPLETED|Overall Study||0
8334284|NCT01347086|20544745|P8|NOT COMPLETED|Overall Study||1
8334285|NCT01347086|20544746|P7|NOT COMPLETED|Overall Study||1
8334286|NCT01347086|20544747|P6|NOT COMPLETED|Overall Study||0
8334287|NCT01347086|20544748|P5|NOT COMPLETED|Overall Study||0
8334288|NCT01347086|20544749|P4|NOT COMPLETED|Overall Study||0
8334289|NCT01347086|20544750|P3|NOT COMPLETED|Overall Study||1
8334290|NCT01347086|20544751|P2|NOT COMPLETED|Overall Study||0
8334291|NCT01347086|20544752|P1|NOT COMPLETED|Overall Study||0
8334292|NCT01347086|20544743|P10|COMPLETED|Overall Study||6
8334293|NCT01347086|20544744|P9|COMPLETED|Overall Study||6
8334294|NCT01347086|20544745|P8|COMPLETED|Overall Study||6
8334295|NCT01347086|20544746|P7|COMPLETED|Overall Study||6
8334296|NCT01347086|20544747|P6|COMPLETED|Overall Study||6
8334297|NCT01347086|20544748|P5|COMPLETED|Overall Study||6
8334298|NCT01347086|20544749|P4|COMPLETED|Overall Study||6
8334299|NCT01347086|20544750|P3|COMPLETED|Overall Study||6
8334300|NCT01347086|20544751|P2|COMPLETED|Overall Study||6
8334301|NCT01347086|20544752|P1|COMPLETED|Overall Study||2
8334302|NCT01347086|20544743|P10|STARTED|Overall Study|One subject was not treated.|7
8334303|NCT01347086|20544744|P9|STARTED|Overall Study||6
8334304|NCT01347086|20544745|P8|STARTED|Overall Study|One subject was not treated.|7
8334305|NCT01347086|20544746|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
8334306|NCT01347086|20544747|P6|STARTED|Overall Study||6
8334307|NCT01347086|20544748|P5|STARTED|Overall Study||6
8334308|NCT01347086|20544749|P4|STARTED|Overall Study||6
8334309|NCT01347086|20544750|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
8334310|NCT01347086|20544751|P2|STARTED|Overall Study||6
8334311|NCT01347086|20544752|P1|STARTED|Overall Study||2
8334312|NCT01347073|20544851|P1|NOT COMPLETED|Overall Study||2
8334313|NCT01347073|20544851|P1|COMPLETED|Overall Study||21
8334314|NCT01347073|20544851|P1|STARTED|Overall Study||23
8334315|NCT01347060|20544865|P2|NOT COMPLETED|Overall Study||0
8334316|NCT01347060|20544866|P1|NOT COMPLETED|Overall Study||0
8334317|NCT01347060|20544865|P2|COMPLETED|Overall Study||7580
8334318|NCT01347060|20544866|P1|COMPLETED|Overall Study||9868
8334319|NCT01347060|20544865|P2|STARTED|Overall Study||7580
8334320|NCT01347060|20544866|P1|STARTED|Overall Study||9868
8334321|NCT01347034|20544878|P2|NOT COMPLETED|Overall Study||0
8334322|NCT01347034|20544879|P1|NOT COMPLETED|Overall Study||0
8334323|NCT01347034|20544878|P2|COMPLETED|Overall Study||14
8334324|NCT01347034|20544879|P1|COMPLETED|Overall Study||6
8334325|NCT01347034|20544878|P2|STARTED|Overall Study||14
8334326|NCT01347034|20544879|P1|STARTED|Overall Study||6
8334327|NCT01347008|20544889|P2|NOT COMPLETED|Overall Study||0
8334328|NCT01347008|20544890|P1|NOT COMPLETED|Overall Study||0
8334329|NCT01347008|20544889|P2|COMPLETED|Overall Study||20
8334330|NCT01347008|20544890|P1|COMPLETED|Overall Study||21
8334331|NCT01347008|20544889|P2|STARTED|Overall Study||20
8334332|NCT01347008|20544890|P1|STARTED|Overall Study||21
8334333|NCT01346852|20544902|P2|NOT COMPLETED|Overall Study||0
8334334|NCT01346852|20544903|P1|NOT COMPLETED|Overall Study||0
8334335|NCT01346852|20544902|P2|COMPLETED|Overall Study||59684
8334336|NCT01346852|20544903|P1|COMPLETED|Overall Study||41753
8334337|NCT01346852|20544902|P2|STARTED|Overall Study||59684
8334338|NCT01346852|20544903|P1|STARTED|Overall Study||41753
8334339|NCT01346839|20544913|P2|NOT COMPLETED|Overall Study||209
8334340|NCT01346839|20544914|P1|NOT COMPLETED|Overall Study||314
8334341|NCT01346839|20544913|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
8334342|NCT01346839|20544914|P1|COMPLETED|Overall Study||369
8334343|NCT01346839|20544913|P2|STARTED|Overall Study||573
8334344|NCT01346839|20544914|P1|STARTED|Overall Study||683
8334345|NCT01346774|20544930|P2|NOT COMPLETED|Overall Study||17
8334346|NCT01346774|20544931|P1|NOT COMPLETED|Overall Study||13
8334347|NCT01346774|20544930|P2|COMPLETED|Overall Study||63
8334348|NCT01346774|20544931|P1|COMPLETED|Overall Study||67
8334349|NCT01346774|20544930|P2|STARTED|Overall Study||80
8334350|NCT01346774|20544931|P1|STARTED|Overall Study||80
8334351|NCT01346696|20544937|P1|NOT COMPLETED|Overall Study||1
8334352|NCT01346696|20544937|P1|COMPLETED|Overall Study||44
8334353|NCT01346696|20544937|P1|STARTED|Overall Study||45
8334354|NCT01346683|20544948|P1|NOT COMPLETED|Overall Study||0
8334355|NCT01346683|20544948|P1|COMPLETED|Overall Study||45
8334356|NCT01346683|20544948|P1|STARTED|Overall Study||45
8334357|NCT01346592|20544959|P3|NOT COMPLETED|Overall Study||78
8334358|NCT01346592|20544960|P2|NOT COMPLETED|Overall Study||89
8334359|NCT01346592|20544961|P1|NOT COMPLETED|Overall Study||153
8334360|NCT01346592|20544959|P3|COMPLETED|Overall Study||1408
8334361|NCT01346592|20544960|P2|COMPLETED|Overall Study||1389
8334362|NCT01346592|20544961|P1|COMPLETED|Overall Study||2983
8334363|NCT01346592|20544959|P3|STARTED|Overall Study||1486
8334364|NCT01346592|20544960|P2|STARTED|Overall Study||1478
8334365|NCT01346592|20544961|P1|STARTED|Overall Study||3136
8334366|NCT01346540|20545053|P2|NOT COMPLETED|Overall Study||12
8334367|NCT01346540|20545054|P1|NOT COMPLETED|Overall Study||3
8334368|NCT01346540|20545053|P2|COMPLETED|Overall Study||0
8334369|NCT01346540|20545054|P1|COMPLETED|Overall Study||1
8334370|NCT01346540|20545053|P2|STARTED|Overall Study||12
8334371|NCT01346540|20545054|P1|STARTED|Overall Study||4
8334372|NCT01346514|20545065|P2|NOT COMPLETED|Overall Study||37
8334373|NCT01346514|20545066|P1|NOT COMPLETED|Overall Study||29
8334374|NCT01346514|20545065|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
8334375|NCT01346514|20545066|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
8334376|NCT01346514|20545065|P2|12 Month Assessment|Overall Study||53
8334377|NCT01346514|20545066|P1|12 Month Assessment|Overall Study||62
8334378|NCT01346514|20545065|P2|9 Month Assessment|Overall Study||59
8334379|NCT01346514|20545066|P1|9 Month Assessment|Overall Study||67
8334380|NCT01346514|20545065|P2|6 Month Assessment|Overall Study||61
8334381|NCT01346514|20545066|P1|6 Month Assessment|Overall Study||74
8334382|NCT01346514|20545065|P2|3 Month Assessment|Overall Study||68
8334383|NCT01346514|20545066|P1|3 Month Assessment|Overall Study||83
8334384|NCT01346514|20545065|P2|STARTED|Overall Study||90
8334385|NCT01346514|20545066|P1|STARTED|Overall Study||91
8334386|NCT01346501|20545086|P2|NOT COMPLETED|Overall Study||13
8334387|NCT01346501|20545087|P1|NOT COMPLETED|Overall Study||11
8334388|NCT01346501|20545086|P2|COMPLETED|Overall Study||80
8334389|NCT01346501|20545087|P1|COMPLETED|Overall Study||68
8334390|NCT01346501|20545086|P2|STARTED|Overall Study||93
8334391|NCT01346501|20545087|P1|STARTED|Overall Study||79
8334392|NCT01346488|20545100|P1|NOT COMPLETED|Overall Study||706
8334393|NCT01346488|20545100|P1|COMPLETED|Overall Study||1262
8334394|NCT01346488|20545100|P1|STARTED|Overall Study||1968
8334395|NCT01346475|20545120|P2|NOT COMPLETED|Second Intervention||0
8334396|NCT01346475|20545121|P1|NOT COMPLETED|Second Intervention||0
8334397|NCT01346475|20545120|P2|COMPLETED|Second Intervention||25
8334398|NCT01346475|20545121|P1|COMPLETED|Second Intervention||18
8334399|NCT01346475|20545120|P2|STARTED|Second Intervention||25
8334400|NCT01346475|20545121|P1|STARTED|Second Intervention||18
8334401|NCT01346475|20545120|P2|NOT COMPLETED|First Intervention||3
8334402|NCT01346475|20545121|P1|NOT COMPLETED|First Intervention||4
8334403|NCT01346475|20545120|P2|COMPLETED|First Intervention||25
8334404|NCT01346475|20545121|P1|COMPLETED|First Intervention||18
8334405|NCT01346475|20545120|P2|STARTED|First Intervention||28
8334406|NCT01346475|20545121|P1|STARTED|First Intervention||22
8334407|NCT01346410|20545133|P1|NOT COMPLETED|Overall Study||1
8334408|NCT01346410|20545133|P1|COMPLETED|Overall Study||0
8334409|NCT01346410|20545133|P1|STARTED|Overall Study||1
8334410|NCT01346397|20545140|P2|NOT COMPLETED|Overall Study||0
8334411|NCT01346397|20545141|P1|NOT COMPLETED|Overall Study||0
8334412|NCT01346397|20545140|P2|COMPLETED|Overall Study||85
8334413|NCT01346397|20545141|P1|COMPLETED|Overall Study||85
8334414|NCT01346397|20545140|P2|STARTED|Overall Study||85
8334415|NCT01346397|20545141|P1|STARTED|Overall Study||85
8334416|NCT01346371|20545151|P2|NOT COMPLETED|Overall Study||0
8334417|NCT01346371|20545152|P1|NOT COMPLETED|Overall Study||2
8334418|NCT01346371|20545151|P2|COMPLETED|Overall Study||20
8334419|NCT01346371|20545152|P1|COMPLETED|Overall Study||18
8334420|NCT01346371|20545151|P2|STARTED|Overall Study||20
8334421|NCT01346371|20545152|P1|STARTED|Overall Study||20
8334422|NCT01346293|20545160|P2|NOT COMPLETED|Overall Study||21
8334423|NCT01346293|20545161|P1|NOT COMPLETED|Overall Study||67
8334424|NCT01346293|20545160|P2|COMPLETED|Overall Study||608
8334425|NCT01346293|20545161|P1|COMPLETED|Overall Study||2676
8334426|NCT01346293|20545160|P2|STARTED|Overall Study||629
8334427|NCT01346293|20545161|P1|STARTED|Overall Study||2743
8334428|NCT01346189|20545191|P4|NOT COMPLETED|Overall Study||11
8334429|NCT01346189|20545192|P3|NOT COMPLETED|Overall Study||14
8334430|NCT01346189|20545193|P2|NOT COMPLETED|Overall Study||17
8334431|NCT01346189|20545194|P1|NOT COMPLETED|Overall Study||16
8334432|NCT01346189|20545191|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
8334433|NCT01346189|20545192|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
8334434|NCT01346189|20545193|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
8334435|NCT01346189|20545194|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
8334436|NCT01346189|20545191|P4|STARTED|Overall Study||366
8334437|NCT01346189|20545192|P3|STARTED|Overall Study||346
8334438|NCT01346189|20545193|P2|STARTED|Overall Study||358
8334439|NCT01346189|20545194|P1|STARTED|Overall Study||433
8334440|NCT01346176|20545211|P3|NOT COMPLETED|Completed Satisfaction Survey||6
8334441|NCT01346176|20545212|P2|NOT COMPLETED|Completed Satisfaction Survey||4
8334442|NCT01346176|20545213|P1|NOT COMPLETED|Completed Satisfaction Survey||6
8334443|NCT01346176|20545211|P3|COMPLETED|Completed Satisfaction Survey||27
8334444|NCT01346176|20545212|P2|COMPLETED|Completed Satisfaction Survey||22
8334445|NCT01346176|20545213|P1|COMPLETED|Completed Satisfaction Survey||29
8334446|NCT01346176|20545211|P3|STARTED|Completed Satisfaction Survey||33
8334447|NCT01346176|20545212|P2|STARTED|Completed Satisfaction Survey||26
8334448|NCT01346176|20545213|P1|STARTED|Completed Satisfaction Survey||35
8334449|NCT01346176|20545211|P3|NOT COMPLETED|Completed Advance Directive||10
8334450|NCT01346176|20545212|P2|NOT COMPLETED|Completed Advance Directive||14
8334451|NCT01346176|20545213|P1|NOT COMPLETED|Completed Advance Directive||13
8334452|NCT01346176|20545211|P3|COMPLETED|Completed Advance Directive||33
8334453|NCT01346176|20545212|P2|COMPLETED|Completed Advance Directive||26
8334454|NCT01346176|20545213|P1|COMPLETED|Completed Advance Directive||35
8334455|NCT01346176|20545211|P3|STARTED|Completed Advance Directive||43
8334456|NCT01346176|20545212|P2|STARTED|Completed Advance Directive||40
8334457|NCT01346176|20545213|P1|STARTED|Completed Advance Directive||48
8334458|NCT01346176|20545211|P3|NOT COMPLETED|Recruited||0
8334459|NCT01346176|20545212|P2|NOT COMPLETED|Recruited||0
8334460|NCT01346176|20545213|P1|NOT COMPLETED|Recruited||1
8334461|NCT01346176|20545211|P3|COMPLETED|Recruited||43
8334462|NCT01346176|20545212|P2|COMPLETED|Recruited||40
8334463|NCT01346176|20545213|P1|COMPLETED|Recruited||48
8334464|NCT01346176|20545211|P3|STARTED|Recruited||43
8334465|NCT01346176|20545212|P2|STARTED|Recruited||40
8334466|NCT01346176|20545213|P1|STARTED|Recruited||49
8334467|NCT01346085|20545224|P1|NOT COMPLETED|Overall Study||0
8334468|NCT01346085|20545224|P1|COMPLETED|Overall Study||10
8334469|NCT01346085|20545224|P1|STARTED|Overall Study||10
8334470|NCT01346072|20545231|P2|NOT COMPLETED|Overall Study||0
8334471|NCT01346072|20545232|P1|NOT COMPLETED|Overall Study||0
8334472|NCT01346072|20545231|P2|COMPLETED|Overall Study||10
8334473|NCT01346072|20545232|P1|COMPLETED|Overall Study||11
8334474|NCT01346072|20545231|P2|STARTED|Overall Study||10
8334475|NCT01346072|20545232|P1|STARTED|Overall Study||11
8334476|NCT01346059|20545242|P2|NOT COMPLETED|Overall Study||0
8334477|NCT01346059|20545243|P1|NOT COMPLETED|Overall Study||1
8334478|NCT01346059|20545242|P2|COMPLETED|Overall Study||1
8334479|NCT01346059|20545243|P1|COMPLETED|Overall Study||0
8334480|NCT01346059|20545242|P2|STARTED|Overall Study||1
8334481|NCT01346059|20545243|P1|STARTED|Overall Study||1
8334482|NCT01345929|20545255|P2|NOT COMPLETED|Overall Study||19
8334483|NCT01345929|20545256|P1|NOT COMPLETED|Overall Study||21
8334484|NCT01345929|20545255|P2|COMPLETED|Overall Study||516
8334485|NCT01345929|20545256|P1|COMPLETED|Overall Study||512
8334486|NCT01345929|20545255|P2|STARTED|Overall Study||535
8334487|NCT01345929|20545256|P1|STARTED|Overall Study||533
8334488|NCT01345786|20545268|P4|NOT COMPLETED|Overall Study||3
8334489|NCT01345786|20545269|P3|NOT COMPLETED|Overall Study||5
8334490|NCT01345786|20545270|P2|NOT COMPLETED|Overall Study||8
8334491|NCT01345786|20545271|P1|NOT COMPLETED|Overall Study||6
8334492|NCT01345786|20545268|P4|COMPLETED|Overall Study||35
8334493|NCT01345786|20545269|P3|COMPLETED|Overall Study||33
8334494|NCT01345786|20545270|P2|COMPLETED|Overall Study||33
8334495|NCT01345786|20545271|P1|COMPLETED|Overall Study||35
8334496|NCT01345786|20545268|P4|Treated|Overall Study||37
8334497|NCT01345786|20545269|P3|Treated|Overall Study||37
8334498|NCT01345786|20545270|P2|Treated|Overall Study||41
8334499|NCT01345786|20545271|P1|Treated|Overall Study||41
8334500|NCT01345786|20545268|P4|STARTED|Overall Study|Number randomized|38
8334501|NCT01345786|20545269|P3|STARTED|Overall Study|Number randomized|38
8334502|NCT01345786|20545270|P2|STARTED|Overall Study|Number randomized|41
8334503|NCT01345786|20545271|P1|STARTED|Overall Study|Number randomized|41
8334504|NCT01345721|20545320|P3|NOT COMPLETED|Overall Study||0
8334505|NCT01345721|20545321|P2|NOT COMPLETED|Overall Study||0
8334506|NCT01345721|20545322|P1|NOT COMPLETED|Overall Study||0
8334507|NCT01345721|20545320|P3|COMPLETED|Overall Study||65
8334508|NCT01345721|20545321|P2|COMPLETED|Overall Study||66
8334509|NCT01345721|20545322|P1|COMPLETED|Overall Study||74
8334510|NCT01345721|20545320|P3|STARTED|Overall Study||65
8334511|NCT01345721|20545321|P2|STARTED|Overall Study||66
8334512|NCT01345721|20545322|P1|STARTED|Overall Study||74
8334513|NCT01345682|20545351|P2|NOT COMPLETED|Overall Study||161
8334514|NCT01345682|20545352|P1|NOT COMPLETED|Overall Study||322
8334515|NCT01345682|20545351|P2|COMPLETED|Overall Study||0
8334516|NCT01345682|20545352|P1|COMPLETED|Overall Study||0
8334517|NCT01345682|20545351|P2|STARTED|Overall Study|Randomised|161
8334518|NCT01345682|20545352|P1|STARTED|Overall Study|Randomised|322
8334519|NCT01345669|20545386|P2|NOT COMPLETED|Overall Study||119
8334520|NCT01345669|20545387|P1|NOT COMPLETED|Overall Study||287
8334521|NCT01345669|20545386|P2|COMPLETED|Overall Study||87
8334522|NCT01345669|20545387|P1|COMPLETED|Overall Study||124
8334523|NCT01345669|20545386|P2|STARTED|Overall Study||206
8334524|NCT01345669|20545387|P1|STARTED|Overall Study||411
8334525|NCT01345630|20545405|P2|NOT COMPLETED|Overall Study||359
8334526|NCT01345630|20545406|P1|NOT COMPLETED|Overall Study||361
8334527|NCT01345630|20545405|P2|COMPLETED|Overall Study||42
8334528|NCT01345630|20545406|P1|COMPLETED|Overall Study||35
8334529|NCT01345630|20545405|P2|STARTED|Overall Study||401
8334530|NCT01345630|20545406|P1|STARTED|Overall Study||396
8334531|NCT01345591|20545462|P1|NOT COMPLETED|Overall Study||1
8334532|NCT01345591|20545462|P1|COMPLETED|Overall Study||19
8334533|NCT01345591|20545462|P1|STARTED|Overall Study||20
8334534|NCT01345513|20545471|P1|NOT COMPLETED|Overall Study||0
8334535|NCT01345513|20545471|P1|COMPLETED|Overall Study||50
8334536|NCT01345513|20545471|P1|STARTED|Overall Study||50
8334537|NCT01345318|20545478|P1|NOT COMPLETED|Overall Study||80
8334538|NCT01345318|20545478|P1|COMPLETED|Overall Study||111
8334539|NCT01345318|20545478|P1|STARTED|Overall Study||191
8334540|NCT01345292|20545486|P3|NOT COMPLETED|Overall Study||1
8334541|NCT01345292|20545487|P2|NOT COMPLETED|Overall Study||0
8334542|NCT01345292|20545488|P1|NOT COMPLETED|Overall Study||2
8334543|NCT01345292|20545486|P3|COMPLETED|Overall Study||74
8334544|NCT01345292|20545487|P2|COMPLETED|Overall Study||76
8334545|NCT01345292|20545488|P1|COMPLETED|Overall Study||73
8334546|NCT01345292|20545486|P3|STARTED|Overall Study||75
8334547|NCT01345292|20545487|P2|STARTED|Overall Study||76
8334548|NCT01345292|20545488|P1|STARTED|Overall Study||75
8334549|NCT01345253|20545519|P2|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
8334550|NCT01345253|20545520|P1|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
8334551|NCT01345253|20545519|P2|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
8334552|NCT01345253|20545520|P1|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
8334553|NCT01345253|20545519|P2|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
8334554|NCT01345253|20545520|P1|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
8334555|NCT01345253|20545519|P2|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
8334556|NCT01345253|20545520|P1|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
8334557|NCT01345253|20545519|P2|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
8334558|NCT01345253|20545520|P1|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
8334559|NCT01345253|20545519|P2|STARTED|Double-blind (DB) Phase (52 Weeks)||451
8334560|NCT01345253|20545520|P1|STARTED|Double-blind (DB) Phase (52 Weeks)||226
8334561|NCT01345240|20545541|P5|NOT COMPLETED|Overall Study||10
8334562|NCT01345240|20545542|P4|NOT COMPLETED|Overall Study||9
8334563|NCT01345240|20545543|P3|NOT COMPLETED|Overall Study||18
8334564|NCT01345240|20545544|P2|NOT COMPLETED|Overall Study||14
8334565|NCT01345240|20545545|P1|NOT COMPLETED|Overall Study||11
8334566|NCT01345240|20545541|P5|COMPLETED|Overall Study||129
8334567|NCT01345240|20545542|P4|COMPLETED|Overall Study||132
8334568|NCT01345240|20545543|P3|COMPLETED|Overall Study||123
8334569|NCT01345240|20545544|P2|COMPLETED|Overall Study||128
8334570|NCT01345240|20545545|P1|COMPLETED|Overall Study||131
8334571|NCT01345240|20545541|P5|STARTED|Overall Study||139
8334572|NCT01345240|20545542|P4|STARTED|Overall Study||141
8334573|NCT01345240|20545543|P3|STARTED|Overall Study||141
8334574|NCT01345240|20545544|P2|STARTED|Overall Study||142
8334575|NCT01345240|20545545|P1|STARTED|Overall Study||142
8334576|NCT01345188|20545665|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
8334577|NCT01345188|20545665|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
8334578|NCT01345188|20545665|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
8334579|NCT01345188|20545665|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
8334580|NCT01345188|20545665|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
8334581|NCT01345188|20545665|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
8334582|NCT01345162|20545677|P2|NOT COMPLETED|Overall Study||4
8334583|NCT01345162|20545678|P1|NOT COMPLETED|Overall Study||2
8334584|NCT01345162|20545677|P2|COMPLETED|Overall Study||96
8334585|NCT01345162|20545678|P1|COMPLETED|Overall Study||98
8334586|NCT01345162|20545677|P2|STARTED|Overall Study||100
8334587|NCT01345162|20545678|P1|STARTED|Overall Study||100
8334588|NCT01345123|20545687|P3|NOT COMPLETED|Overall Study||88
8334589|NCT01345123|20545688|P2|NOT COMPLETED|Overall Study||85
8334590|NCT01345123|20545689|P1|NOT COMPLETED|Overall Study||79
8334591|NCT01345123|20545687|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
8334592|NCT01345123|20545688|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
8334593|NCT01345123|20545689|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
8334594|NCT01345123|20545687|P3|STARTED|Overall Study||3291
8334595|NCT01345123|20545688|P2|STARTED|Overall Study||3311
8334596|NCT01345123|20545689|P1|STARTED|Overall Study||3323
8334597|NCT01345058|20545711|P2|NOT COMPLETED|Overall Study||0
8334598|NCT01345058|20545712|P1|NOT COMPLETED|Overall Study||5
8334599|NCT01345058|20545711|P2|COMPLETED|Overall Study||36
8334600|NCT01345058|20545712|P1|COMPLETED|Overall Study||15
8334601|NCT01345058|20545711|P2|Received Lacosamide|Overall Study||0
8334602|NCT01345058|20545712|P1|Received Lacosamide|Overall Study||19
8334603|NCT01345058|20545711|P2|STARTED|Overall Study||36
8334604|NCT01345058|20545712|P1|STARTED|Overall Study||20
8334605|NCT01345019|20545728|P2|NOT COMPLETED|Open Label Treatment Phase||193
8334606|NCT01345019|20545729|P1|NOT COMPLETED|Open Label Treatment Phase||191
8334607|NCT01345019|20545728|P2|COMPLETED|Open Label Treatment Phase||233
8334608|NCT01345019|20545729|P1|COMPLETED|Open Label Treatment Phase||227
8334609|NCT01345019|20545728|P2|STARTED|Open Label Treatment Phase||426
8334610|NCT01345019|20545729|P1|STARTED|Open Label Treatment Phase||418
8334611|NCT01345019|20545728|P2|NOT COMPLETED|Blinded Treatment Phase||304
8334612|NCT01345019|20545729|P1|NOT COMPLETED|Blinded Treatment Phase||318
8334613|NCT01345019|20545728|P2|COMPLETED|Blinded Treatment Phase||555
8334614|NCT01345019|20545729|P1|COMPLETED|Blinded Treatment Phase||541
8334615|NCT01345019|20545728|P2|Received Treatment|Blinded Treatment Phase||850
8334616|NCT01345019|20545729|P1|Received Treatment|Blinded Treatment Phase||852
8334617|NCT01345019|20545728|P2|STARTED|Blinded Treatment Phase||859
8334618|NCT01345019|20545729|P1|STARTED|Blinded Treatment Phase||859
8334619|NCT01344876|20545751|P5|NOT COMPLETED|Overall Study||1
8334620|NCT01344876|20545752|P4|NOT COMPLETED|Overall Study||3
8334621|NCT01344876|20545753|P3|NOT COMPLETED|Overall Study||1
8334622|NCT01344876|20545754|P2|NOT COMPLETED|Overall Study||0
8334623|NCT01344876|20545755|P1|NOT COMPLETED|Overall Study||1
8334624|NCT01344876|20545751|P5|COMPLETED|Overall Study||2
8334625|NCT01344876|20545752|P4|COMPLETED|Overall Study||3
8334626|NCT01344876|20545753|P3|COMPLETED|Overall Study||3
8334627|NCT01344876|20545754|P2|COMPLETED|Overall Study||3
8334628|NCT01344876|20545755|P1|COMPLETED|Overall Study||3
8334629|NCT01344876|20545751|P5|STARTED|Overall Study||3
8334630|NCT01344876|20545752|P4|STARTED|Overall Study||6
8334631|NCT01344876|20545753|P3|STARTED|Overall Study||4
8334632|NCT01344876|20545754|P2|STARTED|Overall Study||3
8334633|NCT01344876|20545755|P1|STARTED|Overall Study||4
8334634|NCT01344824|20545769|P1|NOT COMPLETED|Overall Study||37
8334635|NCT01344824|20545769|P1|COMPLETED|Overall Study||1
8334636|NCT01344824|20545769|P1|STARTED|Overall Study||38
8334637|NCT01344759|20545777|P2|NOT COMPLETED|Overall Study||2
8334638|NCT01344759|20545778|P1|NOT COMPLETED|Overall Study||0
8334639|NCT01344759|20545777|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
8334640|NCT01344759|20545778|P1|COMPLETED|Overall Study||30
8334641|NCT01344759|20545777|P2|STARTED|Overall Study||30
8334642|NCT01344759|20545778|P1|STARTED|Overall Study||30
8334643|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 4||0
8334644|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 4||0
8334645|NCT01344629|20545810|P2|COMPLETED|Crossover Period 4||31
8334646|NCT01344629|20545811|P1|COMPLETED|Crossover Period 4||32
8334647|NCT01344629|20545810|P2|STARTED|Crossover Period 4||31
8334648|NCT01344629|20545811|P1|STARTED|Crossover Period 4||32
8334649|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 3||0
8334650|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 3||0
8334651|NCT01344629|20545810|P2|COMPLETED|Crossover Period 3||31
8334652|NCT01344629|20545811|P1|COMPLETED|Crossover Period 3||32
8334653|NCT01344629|20545810|P2|STARTED|Crossover Period 3||31
8334654|NCT01344629|20545811|P1|STARTED|Crossover Period 3||32
8334655|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 2||1
8334656|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 2||0
8334657|NCT01344629|20545810|P2|COMPLETED|Crossover Period 2||31
8334658|NCT01344629|20545811|P1|COMPLETED|Crossover Period 2||32
8334659|NCT01344629|20545810|P2|STARTED|Crossover Period 2||32
8334660|NCT01344629|20545811|P1|STARTED|Crossover Period 2||32
8334661|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 1||0
8334662|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 1||0
8334663|NCT01344629|20545810|P2|COMPLETED|Crossover Period 1||32
8334664|NCT01344629|20545811|P1|COMPLETED|Crossover Period 1||32
8334665|NCT01344629|20545810|P2|STARTED|Crossover Period 1||32
8334666|NCT01344629|20545811|P1|STARTED|Crossover Period 1||32
8334667|NCT01344616|20545831|P2|NOT COMPLETED|Overall Study||44
8334668|NCT01344616|20545832|P1|NOT COMPLETED|Overall Study||35
8334669|NCT01344616|20545831|P2|COMPLETED|Overall Study||194
8334670|NCT01344616|20545832|P1|COMPLETED|Overall Study||209
8334671|NCT01344616|20545831|P2|STARTED|Overall Study||238
8334672|NCT01344616|20545832|P1|STARTED|Overall Study||244
8334673|NCT01344538|20545840|P2|NOT COMPLETED|Overall Study||1
8334674|NCT01344538|20545841|P1|NOT COMPLETED|Overall Study||2
8334675|NCT01344538|20545840|P2|COMPLETED|Overall Study||16
8334676|NCT01344538|20545841|P1|COMPLETED|Overall Study||14
8334677|NCT01344538|20545840|P2|STARTED|Overall Study||17
8334678|NCT01344538|20545841|P1|STARTED|Overall Study||16
8334679|NCT01344460|20545847|P1|NOT COMPLETED|Overall Study||3
8334680|NCT01344460|20545847|P1|COMPLETED|Overall Study||312
8334681|NCT01344460|20545847|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
8334682|NCT01344460|20545847|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
8334683|NCT01344447|20545892|P1|NOT COMPLETED|Overall Study||8
8334684|NCT01344447|20545892|P1|COMPLETED|Overall Study||471
8334685|NCT01344447|20545892|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
8334686|NCT01344447|20545892|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
8334687|NCT01344369|20545936|P2|NOT COMPLETED|Second Intervention||1
8334688|NCT01344369|20545937|P1|NOT COMPLETED|Second Intervention||0
8334689|NCT01344369|20545936|P2|COMPLETED|Second Intervention||16
8334690|NCT01344369|20545937|P1|COMPLETED|Second Intervention||17
8334691|NCT01344369|20545936|P2|STARTED|Second Intervention||17
8334692|NCT01344369|20545937|P1|STARTED|Second Intervention||17
8334693|NCT01344369|20545936|P2|NOT COMPLETED|Washout of 28 Days||1
8334694|NCT01344369|20545937|P1|NOT COMPLETED|Washout of 28 Days||1
8334695|NCT01344369|20545936|P2|COMPLETED|Washout of 28 Days||17
8334696|NCT01344369|20545937|P1|COMPLETED|Washout of 28 Days||17
8334697|NCT01344369|20545936|P2|STARTED|Washout of 28 Days||18
8334698|NCT01344369|20545937|P1|STARTED|Washout of 28 Days||18
8334699|NCT01344369|20545936|P2|NOT COMPLETED|First Intervention||0
8334700|NCT01344369|20545937|P1|NOT COMPLETED|First Intervention||0
8334701|NCT01344369|20545936|P2|COMPLETED|First Intervention||18
8334702|NCT01344369|20545937|P1|COMPLETED|First Intervention||18
8334703|NCT01344369|20545936|P2|STARTED|First Intervention||18
8334704|NCT01344369|20545937|P1|STARTED|First Intervention||18
8334705|NCT01344356|20545955|P2|NOT COMPLETED|Overall Study||9
8334706|NCT01344356|20545956|P1|NOT COMPLETED|Overall Study||0
8334707|NCT01344356|20545955|P2|COMPLETED|Overall Study||9
8334708|NCT01344356|20545956|P1|COMPLETED|Overall Study||1
8334709|NCT01344356|20545955|P2|STARTED|Overall Study||18
8334710|NCT01344356|20545956|P1|STARTED|Overall Study||1
8334711|NCT01344226|20545968|P1|NOT COMPLETED|Overall Study||8
8334712|NCT01344226|20545968|P1|COMPLETED|Overall Study||41
8334713|NCT01344226|20545968|P1|STARTED|Overall Study||49
8334714|NCT01344161|20545977|P2|NOT COMPLETED|Overall Study||3
8334715|NCT01344161|20545978|P1|NOT COMPLETED|Overall Study||5
8334716|NCT01344161|20545977|P2|COMPLETED|Overall Study||39
8334717|NCT01344161|20545978|P1|COMPLETED|Overall Study||38
8334718|NCT01344161|20545977|P2|STARTED|Overall Study||42
8334719|NCT01344161|20545978|P1|STARTED|Overall Study||43
8334720|NCT01344057|20545990|P1|NOT COMPLETED|Overall Study||1
8334721|NCT01344057|20545990|P1|COMPLETED|Overall Study||62
8334722|NCT01344057|20545990|P1|STARTED|Overall Study||63
8334723|NCT01343901|20545997|P1|NOT COMPLETED|Overall Study||113
8334724|NCT01343901|20545997|P1|COMPLETED|Overall Study||97
8334725|NCT01343901|20545997|P1|Efficacy Population|Overall Study||205
8334726|NCT01343901|20545997|P1|STARTED|Overall Study||210
8334727|NCT01343888|20546021|P3|NOT COMPLETED|Overall Study||22
8334728|NCT01343888|20546022|P2|NOT COMPLETED|Overall Study||39
8334729|NCT01343888|20546023|P1|NOT COMPLETED|Overall Study||25
8334730|NCT01343888|20546021|P3|COMPLETED|Overall Study||110
8334731|NCT01343888|20546022|P2|COMPLETED|Overall Study||222
8334732|NCT01343888|20546023|P1|COMPLETED|Overall Study||234
8334733|NCT01343888|20546021|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
8334734|NCT01343888|20546022|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
8334735|NCT01343888|20546023|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
8334736|NCT01343823|20546065|P4|NOT COMPLETED|Overall Study||1
8334737|NCT01343823|20546066|P3|NOT COMPLETED|Overall Study||0
8334738|NCT01343823|20546067|P2|NOT COMPLETED|Overall Study||0
8334739|NCT01343823|20546068|P1|NOT COMPLETED|Overall Study||2
8334740|NCT01343823|20546065|P4|COMPLETED|Overall Study||19
8334741|NCT01343823|20546066|P3|COMPLETED|Overall Study||19
8334742|NCT01343823|20546067|P2|COMPLETED|Overall Study||20
8334743|NCT01343823|20546068|P1|COMPLETED|Overall Study||18
8334744|NCT01343823|20546065|P4|STARTED|Overall Study||20
8334745|NCT01343823|20546066|P3|STARTED|Overall Study||19
8334746|NCT01343823|20546067|P2|STARTED|Overall Study||20
8334747|NCT01343823|20546068|P1|STARTED|Overall Study||20
8334748|NCT01343693|20546082|P1|NOT COMPLETED|Overall Study||9
8334749|NCT01343693|20546082|P1|COMPLETED|Overall Study||110
8334750|NCT01343693|20546082|P1|STARTED|Overall Study||119
8334751|NCT01343667|20546089|P2|NOT COMPLETED|Overall Study||56
8334752|NCT01343667|20546090|P1|NOT COMPLETED|Overall Study||12
8334753|NCT01343667|20546089|P2|COMPLETED|Overall Study||916
8334754|NCT01343667|20546090|P1|COMPLETED|Overall Study||413
8334755|NCT01343667|20546089|P2|STARTED|Overall Study||972
8334756|NCT01343667|20546090|P1|STARTED|Overall Study||425
8334757|NCT01343485|20546098|P2|NOT COMPLETED|Overall Study||134
8334758|NCT01343485|20546099|P1|NOT COMPLETED|Overall Study||149
8334759|NCT01343485|20546098|P2|COMPLETED|Overall Study||46
8334760|NCT01343485|20546099|P1|COMPLETED|Overall Study||36
8334761|NCT01343485|20546098|P2|STARTED|Overall Study||180
8334762|NCT01343485|20546099|P1|STARTED|Overall Study||185
8334763|NCT01343407|20546105|P6|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334764|NCT01343407|20546106|P5|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334765|NCT01343407|20546107|P4|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334766|NCT01343407|20546108|P3|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334767|NCT01343407|20546109|P2|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334768|NCT01343407|20546110|P1|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334769|NCT01343407|20546105|P6|COMPLETED|Third Treatment Period (Part 2)||3
8334770|NCT01343407|20546106|P5|COMPLETED|Third Treatment Period (Part 2)||3
8334771|NCT01343407|20546107|P4|COMPLETED|Third Treatment Period (Part 2)||3
8334772|NCT01343407|20546108|P3|COMPLETED|Third Treatment Period (Part 2)||1
8334773|NCT01343407|20546109|P2|COMPLETED|Third Treatment Period (Part 2)||2
8334774|NCT01343407|20546110|P1|COMPLETED|Third Treatment Period (Part 2)||2
8334775|NCT01343407|20546105|P6|STARTED|Third Treatment Period (Part 2)||3
8334776|NCT01343407|20546106|P5|STARTED|Third Treatment Period (Part 2)||3
8334777|NCT01343407|20546107|P4|STARTED|Third Treatment Period (Part 2)||3
8334778|NCT01343407|20546108|P3|STARTED|Third Treatment Period (Part 2)||1
8334779|NCT01343407|20546109|P2|STARTED|Third Treatment Period (Part 2)||2
8334780|NCT01343407|20546110|P1|STARTED|Third Treatment Period (Part 2)||2
8334781|NCT01343407|20546105|P6|NOT COMPLETED|Second Washout (Part 2)||0
8334782|NCT01343407|20546106|P5|NOT COMPLETED|Second Washout (Part 2)||0
8334783|NCT01343407|20546107|P4|NOT COMPLETED|Second Washout (Part 2)||0
8334784|NCT01343407|20546108|P3|NOT COMPLETED|Second Washout (Part 2)||1
8334785|NCT01343407|20546109|P2|NOT COMPLETED|Second Washout (Part 2)||0
8334786|NCT01343407|20546110|P1|NOT COMPLETED|Second Washout (Part 2)||0
8334787|NCT01343407|20546105|P6|COMPLETED|Second Washout (Part 2)||3
8334788|NCT01343407|20546106|P5|COMPLETED|Second Washout (Part 2)||3
8334789|NCT01343407|20546107|P4|COMPLETED|Second Washout (Part 2)||3
8334790|NCT01343407|20546108|P3|COMPLETED|Second Washout (Part 2)||1
8334791|NCT01343407|20546109|P2|COMPLETED|Second Washout (Part 2)||2
8334792|NCT01343407|20546110|P1|COMPLETED|Second Washout (Part 2)||2
8334793|NCT01343407|20546105|P6|STARTED|Second Washout (Part 2)||3
8334794|NCT01343407|20546106|P5|STARTED|Second Washout (Part 2)||3
8334795|NCT01343407|20546107|P4|STARTED|Second Washout (Part 2)||3
8334796|NCT01343407|20546108|P3|STARTED|Second Washout (Part 2)||2
8334797|NCT01343407|20546109|P2|STARTED|Second Washout (Part 2)||2
8334798|NCT01343407|20546110|P1|STARTED|Second Washout (Part 2)||2
8334799|NCT01343407|20546105|P6|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334800|NCT01343407|20546106|P5|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334801|NCT01343407|20546107|P4|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334802|NCT01343407|20546108|P3|NOT COMPLETED|Second Treatment Period (Part 2)||1
8334803|NCT01343407|20546109|P2|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334804|NCT01343407|20546110|P1|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334805|NCT01343407|20546105|P6|COMPLETED|Second Treatment Period (Part 2)||3
8334806|NCT01343407|20546106|P5|COMPLETED|Second Treatment Period (Part 2)||3
8334807|NCT01343407|20546107|P4|COMPLETED|Second Treatment Period (Part 2)||3
8334808|NCT01343407|20546108|P3|COMPLETED|Second Treatment Period (Part 2)||2
8334809|NCT01343407|20546109|P2|COMPLETED|Second Treatment Period (Part 2)||2
8334810|NCT01343407|20546110|P1|COMPLETED|Second Treatment Period (Part 2)||2
8334811|NCT01343407|20546105|P6|STARTED|Second Treatment Period (Part 2)||3
8334812|NCT01343407|20546106|P5|STARTED|Second Treatment Period (Part 2)||3
8334813|NCT01343407|20546107|P4|STARTED|Second Treatment Period (Part 2)||3
8334814|NCT01343407|20546108|P3|STARTED|Second Treatment Period (Part 2)||3
8334815|NCT01343407|20546109|P2|STARTED|Second Treatment Period (Part 2)||2
8334816|NCT01343407|20546110|P1|STARTED|Second Treatment Period (Part 2)||2
8334817|NCT01343407|20546105|P6|NOT COMPLETED|First Washout (Part 2)||0
8334818|NCT01343407|20546106|P5|NOT COMPLETED|First Washout (Part 2)||0
8334819|NCT01343407|20546107|P4|NOT COMPLETED|First Washout (Part 2)||0
8334820|NCT01343407|20546108|P3|NOT COMPLETED|First Washout (Part 2)||0
8334821|NCT01343407|20546109|P2|NOT COMPLETED|First Washout (Part 2)||0
8334822|NCT01343407|20546110|P1|NOT COMPLETED|First Washout (Part 2)||0
8334823|NCT01343407|20546105|P6|COMPLETED|First Washout (Part 2)||3
8334824|NCT01343407|20546106|P5|COMPLETED|First Washout (Part 2)||3
8334825|NCT01343407|20546107|P4|COMPLETED|First Washout (Part 2)||3
8334826|NCT01343407|20546108|P3|COMPLETED|First Washout (Part 2)||3
8334827|NCT01343407|20546109|P2|COMPLETED|First Washout (Part 2)||2
8334828|NCT01343407|20546110|P1|COMPLETED|First Washout (Part 2)||2
8334829|NCT01343407|20546105|P6|STARTED|First Washout (Part 2)||3
8334830|NCT01343407|20546106|P5|STARTED|First Washout (Part 2)||3
8334831|NCT01343407|20546107|P4|STARTED|First Washout (Part 2)||3
8334832|NCT01343407|20546108|P3|STARTED|First Washout (Part 2)||3
8334833|NCT01343407|20546109|P2|STARTED|First Washout (Part 2)||2
8334834|NCT01343407|20546110|P1|STARTED|First Washout (Part 2)||2
8334835|NCT01343407|20546105|P6|NOT COMPLETED|First Treatment Period (Part 2)||0
8334836|NCT01343407|20546106|P5|NOT COMPLETED|First Treatment Period (Part 2)||0
8334837|NCT01343407|20546107|P4|NOT COMPLETED|First Treatment Period (Part 2)||0
8334838|NCT01343407|20546108|P3|NOT COMPLETED|First Treatment Period (Part 2)||0
8334839|NCT01343407|20546109|P2|NOT COMPLETED|First Treatment Period (Part 2)||0
8334840|NCT01343407|20546110|P1|NOT COMPLETED|First Treatment Period (Part 2)||0
8334841|NCT01343407|20546105|P6|COMPLETED|First Treatment Period (Part 2)||3
8334842|NCT01343407|20546106|P5|COMPLETED|First Treatment Period (Part 2)||3
8334843|NCT01343407|20546107|P4|COMPLETED|First Treatment Period (Part 2)||3
8334844|NCT01343407|20546108|P3|COMPLETED|First Treatment Period (Part 2)||3
8334845|NCT01343407|20546109|P2|COMPLETED|First Treatment Period (Part 2)||2
8334846|NCT01343407|20546110|P1|COMPLETED|First Treatment Period (Part 2)||2
8334847|NCT01343407|20546105|P6|STARTED|First Treatment Period (Part 2)||3
8334848|NCT01343407|20546106|P5|STARTED|First Treatment Period (Part 2)||3
8334849|NCT01343407|20546107|P4|STARTED|First Treatment Period (Part 2)||3
8334850|NCT01343407|20546108|P3|STARTED|First Treatment Period (Part 2)||3
8334851|NCT01343407|20546109|P2|STARTED|First Treatment Period (Part 2)||2
8334852|NCT01343407|20546110|P1|STARTED|First Treatment Period (Part 2)||2
8334853|NCT01343368|20546138|P2|NOT COMPLETED|Overall Study||0
8334854|NCT01343368|20546139|P1|NOT COMPLETED|Overall Study||2
8334855|NCT01343368|20546138|P2|COMPLETED|Overall Study||10
8334856|NCT01343368|20546139|P1|COMPLETED|Overall Study||7
8334857|NCT01343368|20546138|P2|STARTED|Overall Study||10
8334858|NCT01343368|20546139|P1|STARTED|Overall Study||9
8334859|NCT01343277|20546175|P2|NOT COMPLETED|Overall Study||193
8334860|NCT01343277|20546176|P1|NOT COMPLETED|Overall Study||384
8334861|NCT01343277|20546175|P2|COMPLETED|Overall Study||0
8334862|NCT01343277|20546176|P1|COMPLETED|Overall Study||0
8334863|NCT01343277|20546175|P2|Treated|Overall Study||172
8334864|NCT01343277|20546176|P1|Treated|Overall Study||378
8334865|NCT01343277|20546175|P2|STARTED|Overall Study||193
8334866|NCT01343277|20546176|P1|STARTED|Overall Study||384
8334867|NCT01343251|20546194|P2|NOT COMPLETED|Overall Study||0
8334868|NCT01343251|20546195|P1|NOT COMPLETED|Overall Study||0
8334869|NCT01343251|20546194|P2|COMPLETED|Overall Study||17
8334870|NCT01343251|20546195|P1|COMPLETED|Overall Study||16
8334871|NCT01343251|20546194|P2|STARTED|Overall Study||17
8334872|NCT01343251|20546195|P1|STARTED|Overall Study||16
8334873|NCT01343095|20546212|P3|NOT COMPLETED|Overall Study||0
8334874|NCT01343095|20546213|P2|NOT COMPLETED|Overall Study||0
8334875|NCT01343095|20546214|P1|NOT COMPLETED|Overall Study||0
8334876|NCT01343095|20546212|P3|COMPLETED|Overall Study||3
8334877|NCT01343095|20546213|P2|COMPLETED|Overall Study||3
8334878|NCT01343095|20546214|P1|COMPLETED|Overall Study||2
8334879|NCT01343095|20546212|P3|STARTED|Overall Study||3
8334880|NCT01343095|20546213|P2|STARTED|Overall Study||3
8334881|NCT01343095|20546214|P1|STARTED|Overall Study||2
8334882|NCT01343082|20546237|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
8334883|NCT01343082|20546238|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
8334884|NCT01343082|20546239|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
8334885|NCT01343082|20546237|P3|COMPLETED|Treatment Period , Switched to DE-111||31
8334886|NCT01343082|20546238|P2|COMPLETED|Treatment Period , Switched to DE-111||36
8334887|NCT01343082|20546239|P1|COMPLETED|Treatment Period , Switched to DE-111||43
8334888|NCT01343082|20546237|P3|STARTED|Treatment Period , Switched to DE-111||43
8334889|NCT01343082|20546238|P2|STARTED|Treatment Period , Switched to DE-111||45
8334890|NCT01343082|20546239|P1|STARTED|Treatment Period , Switched to DE-111||48
8334891|NCT01343082|20546237|P3|NOT COMPLETED|The run-in Period||5
8334892|NCT01343082|20546238|P2|NOT COMPLETED|The run-in Period||4
8334893|NCT01343082|20546239|P1|NOT COMPLETED|The run-in Period||3
8334894|NCT01343082|20546237|P3|COMPLETED|The run-in Period||43
8334895|NCT01343082|20546238|P2|COMPLETED|The run-in Period||45
8334896|NCT01343082|20546239|P1|COMPLETED|The run-in Period||48
8334897|NCT01343082|20546237|P3|STARTED|The run-in Period||48
8334898|NCT01343082|20546238|P2|STARTED|The run-in Period||49
8334899|NCT01343082|20546239|P1|STARTED|The run-in Period||51
8334900|NCT01343056|20546247|P4|NOT COMPLETED|Overall Study||9
8334901|NCT01343056|20546248|P3|NOT COMPLETED|Overall Study||3
8334902|NCT01343056|20546249|P2|NOT COMPLETED|Overall Study||5
8334903|NCT01343056|20546250|P1|NOT COMPLETED|Overall Study||7
8334904|NCT01343056|20546247|P4|COMPLETED|Overall Study||29
8334905|NCT01343056|20546248|P3|COMPLETED|Overall Study||29
8334906|NCT01343056|20546249|P2|COMPLETED|Overall Study||31
8334907|NCT01343056|20546250|P1|COMPLETED|Overall Study||28
8334908|NCT01343056|20546247|P4|STARTED|Overall Study||38
8334909|NCT01343056|20546248|P3|STARTED|Overall Study||32
8334910|NCT01343056|20546249|P2|STARTED|Overall Study||36
8334911|NCT01343056|20546250|P1|STARTED|Overall Study||35
8334912|NCT01343043|20546292|P4|NOT COMPLETED|Overall Study||1
8334913|NCT01343043|20546293|P3|NOT COMPLETED|Overall Study||0
8334914|NCT01343043|20546294|P2|NOT COMPLETED|Overall Study||1
8334915|NCT01343043|20546295|P1|NOT COMPLETED|Overall Study||3
8334916|NCT01343043|20546292|P4|COMPLETED|Overall Study||15
8334917|NCT01343043|20546293|P3|COMPLETED|Overall Study||5
8334918|NCT01343043|20546294|P2|COMPLETED|Overall Study||13
8334919|NCT01343043|20546295|P1|COMPLETED|Overall Study||12
8334920|NCT01343043|20546292|P4|Received T-cell Infusion|Overall Study||15
8334921|NCT01343043|20546293|P3|Received T-cell Infusion|Overall Study||5
8334922|NCT01343043|20546294|P2|Received T-cell Infusion|Overall Study||13
8334923|NCT01343043|20546295|P1|Received T-cell Infusion|Overall Study||12
8334924|NCT01343043|20546292|P4|STARTED|Overall Study||16
8334925|NCT01343043|20546293|P3|STARTED|Overall Study||5
8334926|NCT01343043|20546294|P2|STARTED|Overall Study||14
8334927|NCT01343043|20546295|P1|STARTED|Overall Study||15
8334928|NCT01343004|20546356|P3|NOT COMPLETED|Overall Study||160
8334929|NCT01343004|20546357|P2|NOT COMPLETED|Overall Study||218
8334930|NCT01343004|20546358|P1|NOT COMPLETED|Overall Study||184
8334931|NCT01343004|20546356|P3|COMPLETED|Overall Study||658
8334932|NCT01343004|20546357|P2|COMPLETED|Overall Study||606
8334933|NCT01343004|20546358|P1|COMPLETED|Overall Study||637
8334934|NCT01343004|20546356|P3|STARTED|Overall Study||818
8334935|NCT01343004|20546357|P2|STARTED|Overall Study||824
8334936|NCT01343004|20546358|P1|STARTED|Overall Study||821
8334937|NCT01342965|20546383|P2|NOT COMPLETED|Overall Study||107
8334938|NCT01342965|20546384|P1|NOT COMPLETED|Overall Study||109
8334939|NCT01342965|20546383|P2|COMPLETED|Overall Study||0
8334940|NCT01342965|20546384|P1|COMPLETED|Overall Study||1
8334941|NCT01342965|20546383|P2|Received Treatment|Overall Study||104
8334942|NCT01342965|20546384|P1|Received Treatment|Overall Study||110
8334943|NCT01342965|20546383|P2|STARTED|Overall Study||107
8334944|NCT01342965|20546384|P1|STARTED|Overall Study||110
8334945|NCT01342926|20546402|P4|NOT COMPLETED|Overall Study||12
8334946|NCT01342926|20546403|P3|NOT COMPLETED|Overall Study||14
8334947|NCT01342926|20546404|P2|NOT COMPLETED|Overall Study||15
8334948|NCT01342926|20546405|P1|NOT COMPLETED|Overall Study||9
8334949|NCT01342926|20546402|P4|COMPLETED|Overall Study||39
8334950|NCT01342926|20546403|P3|COMPLETED|Overall Study||34
8334951|NCT01342926|20546404|P2|COMPLETED|Overall Study||31
8334952|NCT01342926|20546405|P1|COMPLETED|Overall Study||37
8334953|NCT01342926|20546402|P4|STARTED|Overall Study||51
8334954|NCT01342926|20546403|P3|STARTED|Overall Study||48
8334955|NCT01342926|20546404|P2|STARTED|Overall Study||46
8334956|NCT01342926|20546405|P1|STARTED|Overall Study||46
8334957|NCT01342913|20546485|P3|NOT COMPLETED|Double-Blind Treatment Period||23
8334958|NCT01342913|20546486|P2|NOT COMPLETED|Double-Blind Treatment Period||16
8334959|NCT01342913|20546487|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8334960|NCT01342913|20546485|P3|COMPLETED|Double-Blind Treatment Period||243
8334961|NCT01342913|20546486|P2|COMPLETED|Double-Blind Treatment Period||246
8334962|NCT01342913|20546487|P1|COMPLETED|Double-Blind Treatment Period||0
8334963|NCT01342913|20546485|P3|STARTED|Double-Blind Treatment Period||266
8334964|NCT01342913|20546486|P2|STARTED|Double-Blind Treatment Period||262
8334965|NCT01342913|20546487|P1|STARTED|Double-Blind Treatment Period||0
8334966|NCT01342913|20546485|P3|NOT COMPLETED|2-week Run-in Period||0
8334967|NCT01342913|20546486|P2|NOT COMPLETED|2-week Run-in Period||0
8334968|NCT01342913|20546487|P1|NOT COMPLETED|2-week Run-in Period||174
8334969|NCT01342913|20546485|P3|COMPLETED|2-week Run-in Period||0
8334970|NCT01342913|20546486|P2|COMPLETED|2-week Run-in Period||0
8334971|NCT01342913|20546487|P1|COMPLETED|2-week Run-in Period||528
8334972|NCT01342913|20546485|P3|STARTED|2-week Run-in Period||0
8334973|NCT01342913|20546486|P2|STARTED|2-week Run-in Period||0
8334974|NCT01342913|20546487|P1|STARTED|2-week Run-in Period||702
8334975|NCT01342887|20546497|P1|NOT COMPLETED|Overall Study||2
8334976|NCT01342887|20546497|P1|COMPLETED|Overall Study||4
8334977|NCT01342887|20546497|P1|STARTED|Overall Study||6
8334978|NCT01342770|20546504|P1|NOT COMPLETED|Overall Study||0
8334979|NCT01342770|20546504|P1|COMPLETED|Overall Study||6
8334980|NCT01342770|20546504|P1|STARTED|Overall Study||6
8334981|NCT01342757|20546522|P1|NOT COMPLETED|Overall Study||0
8334982|NCT01342757|20546522|P1|COMPLETED|Overall Study||12
8334983|NCT01342757|20546522|P1|STARTED|Overall Study||12
8334984|NCT01342666|20546531|P2|NOT COMPLETED|Overall Study||0
8334985|NCT01342666|20546532|P1|NOT COMPLETED|Overall Study||0
8334986|NCT01342666|20546531|P2|COMPLETED|Overall Study||24
8334987|NCT01342666|20546532|P1|COMPLETED|Overall Study||26
8334988|NCT01342666|20546531|P2|STARTED|Overall Study||24
8334989|NCT01342666|20546532|P1|STARTED|Overall Study||26
8334990|NCT01342640|20546538|P1|NOT COMPLETED|Overall Study||41
8334991|NCT01342640|20546538|P1|COMPLETED|Overall Study||29
8334992|NCT01342640|20546538|P1|STARTED|Overall Study||70
8334993|NCT01342549|20546546|P2|NOT COMPLETED|Overall Study||0
8334994|NCT01342549|20546547|P1|NOT COMPLETED|Overall Study||0
8334995|NCT01342549|20546546|P2|COMPLETED|Overall Study||31
8334996|NCT01342549|20546547|P1|COMPLETED|Overall Study||31
8334997|NCT01342549|20546546|P2|STARTED|Overall Study||31
8334998|NCT01342549|20546547|P1|STARTED|Overall Study||31
8334999|NCT01342523|20546585|P32|NOT COMPLETED|Overall Study||1
8335000|NCT01342523|20546586|P31|NOT COMPLETED|Overall Study||1
8335001|NCT01342523|20546587|P30|NOT COMPLETED|Overall Study||1
8335002|NCT01342523|20546588|P29|NOT COMPLETED|Overall Study||1
8335003|NCT01342523|20546589|P28|NOT COMPLETED|Overall Study||1
8335004|NCT01342523|20546590|P27|NOT COMPLETED|Overall Study||1
8335005|NCT01342523|20546591|P26|NOT COMPLETED|Overall Study||2
8335006|NCT01342523|20546592|P25|NOT COMPLETED|Overall Study||1
8335007|NCT01342523|20546593|P24|NOT COMPLETED|Overall Study||1
8335008|NCT01342523|20546594|P23|NOT COMPLETED|Overall Study||0
8335009|NCT01342523|20546595|P22|NOT COMPLETED|Overall Study||0
8335010|NCT01342523|20546596|P21|NOT COMPLETED|Overall Study||0
8335011|NCT01342523|20546597|P20|NOT COMPLETED|Overall Study||0
8335012|NCT01342523|20546598|P19|NOT COMPLETED|Overall Study||0
8335013|NCT01342523|20546599|P18|NOT COMPLETED|Overall Study||0
8335014|NCT01342523|20546600|P17|NOT COMPLETED|Overall Study||1
8335015|NCT01342523|20546601|P16|NOT COMPLETED|Overall Study||0
8335016|NCT01342523|20546602|P15|NOT COMPLETED|Overall Study||1
8335017|NCT01342523|20546603|P14|NOT COMPLETED|Overall Study||2
8335018|NCT01342523|20546604|P13|NOT COMPLETED|Overall Study||0
8335019|NCT01342523|20546605|P12|NOT COMPLETED|Overall Study||2
8335020|NCT01342523|20546606|P11|NOT COMPLETED|Overall Study||0
8335021|NCT01342523|20546607|P10|NOT COMPLETED|Overall Study||0
8335022|NCT01342523|20546608|P9|NOT COMPLETED|Overall Study||0
8335023|NCT01342523|20546609|P8|NOT COMPLETED|Overall Study||0
8335024|NCT01342523|20546610|P7|NOT COMPLETED|Overall Study||0
8335025|NCT01342523|20546611|P6|NOT COMPLETED|Overall Study||0
8335026|NCT01342523|20546612|P5|NOT COMPLETED|Overall Study||0
8335027|NCT01342523|20546613|P4|NOT COMPLETED|Overall Study||1
8335028|NCT01342523|20546614|P3|NOT COMPLETED|Overall Study||0
8335029|NCT01342523|20546615|P2|NOT COMPLETED|Overall Study||0
8335030|NCT01342523|20546616|P1|NOT COMPLETED|Overall Study||1
8335031|NCT01342523|20546585|P32|COMPLETED|Overall Study||27
8335032|NCT01342523|20546586|P31|COMPLETED|Overall Study||30
8335033|NCT01342523|20546587|P30|COMPLETED|Overall Study||28
8335034|NCT01342523|20546588|P29|COMPLETED|Overall Study||34
8335035|NCT01342523|20546589|P28|COMPLETED|Overall Study||30
8335036|NCT01342523|20546590|P27|COMPLETED|Overall Study||33
8335037|NCT01342523|20546591|P26|COMPLETED|Overall Study||36
8335038|NCT01342523|20546592|P25|COMPLETED|Overall Study||36
8335039|NCT01342523|20546593|P24|COMPLETED|Overall Study||35
8335040|NCT01342523|20546594|P23|COMPLETED|Overall Study||36
8335041|NCT01342523|20546595|P22|COMPLETED|Overall Study||30
8335042|NCT01342523|20546596|P21|COMPLETED|Overall Study||29
8335043|NCT01342523|20546597|P20|COMPLETED|Overall Study||27
8335044|NCT01342523|20546598|P19|COMPLETED|Overall Study||21
8335045|NCT01342523|20546599|P18|COMPLETED|Overall Study||27
8335046|NCT01342523|20546600|P17|COMPLETED|Overall Study||28
8335047|NCT01342523|20546601|P16|COMPLETED|Overall Study||32
8335048|NCT01342523|20546602|P15|COMPLETED|Overall Study||37
8335049|NCT01342523|20546603|P14|COMPLETED|Overall Study||36
8335050|NCT01342523|20546604|P13|COMPLETED|Overall Study||39
8335051|NCT01342523|20546605|P12|COMPLETED|Overall Study||36
8335052|NCT01342523|20546606|P11|COMPLETED|Overall Study||38
8335053|NCT01342523|20546607|P10|COMPLETED|Overall Study||28
8335054|NCT01342523|20546608|P9|COMPLETED|Overall Study||28
8335055|NCT01342523|20546609|P8|COMPLETED|Overall Study||27
8335056|NCT01342523|20546610|P7|COMPLETED|Overall Study||22
8335057|NCT01342523|20546611|P6|COMPLETED|Overall Study||36
8335058|NCT01342523|20546612|P5|COMPLETED|Overall Study||36
8335059|NCT01342523|20546613|P4|COMPLETED|Overall Study||32
8335060|NCT01342523|20546614|P3|COMPLETED|Overall Study||36
8335061|NCT01342523|20546615|P2|COMPLETED|Overall Study||32
8335062|NCT01342523|20546616|P1|COMPLETED|Overall Study||34
8335063|NCT01342523|20546585|P32|STARTED|Overall Study||28
8335064|NCT01342523|20546586|P31|STARTED|Overall Study||31
8335065|NCT01342523|20546587|P30|STARTED|Overall Study||29
8335066|NCT01342523|20546588|P29|STARTED|Overall Study||35
8335067|NCT01342523|20546589|P28|STARTED|Overall Study||31
8335068|NCT01342523|20546590|P27|STARTED|Overall Study||34
8335069|NCT01342523|20546591|P26|STARTED|Overall Study||38
8335070|NCT01342523|20546592|P25|STARTED|Overall Study||37
8335071|NCT01342523|20546593|P24|STARTED|Overall Study||36
8335072|NCT01342523|20546594|P23|STARTED|Overall Study||36
8335073|NCT01342523|20546595|P22|STARTED|Overall Study||30
8335074|NCT01342523|20546596|P21|STARTED|Overall Study||29
8335075|NCT01342523|20546597|P20|STARTED|Overall Study||27
8335076|NCT01342523|20546598|P19|STARTED|Overall Study||21
8335077|NCT01342523|20546599|P18|STARTED|Overall Study||27
8335078|NCT01342523|20546600|P17|STARTED|Overall Study||29
8335079|NCT01342523|20546601|P16|STARTED|Overall Study||32
8335080|NCT01342523|20546602|P15|STARTED|Overall Study||38
8335081|NCT01342523|20546603|P14|STARTED|Overall Study||38
8335082|NCT01342523|20546604|P13|STARTED|Overall Study||39
8335083|NCT01342523|20546605|P12|STARTED|Overall Study||38
8335084|NCT01342523|20546606|P11|STARTED|Overall Study||38
8335085|NCT01342523|20546607|P10|STARTED|Overall Study||28
8335086|NCT01342523|20546608|P9|STARTED|Overall Study||28
8335087|NCT01342523|20546609|P8|STARTED|Overall Study||27
8335088|NCT01342523|20546610|P7|STARTED|Overall Study||22
8335089|NCT01342523|20546611|P6|STARTED|Overall Study||36
8335090|NCT01342523|20546612|P5|STARTED|Overall Study||36
8335091|NCT01342523|20546613|P4|STARTED|Overall Study||33
8335092|NCT01342523|20546614|P3|STARTED|Overall Study||36
8335093|NCT01342523|20546615|P2|STARTED|Overall Study||32
8335094|NCT01342523|20546616|P1|STARTED|Overall Study||35
8335095|NCT01342510|20546633|P4|NOT COMPLETED|Overall Study||11
8335096|NCT01342510|20546634|P3|NOT COMPLETED|Overall Study||13
8335097|NCT01342510|20546635|P2|NOT COMPLETED|Overall Study||6
8335098|NCT01342510|20546636|P1|NOT COMPLETED|Overall Study||12
8335099|NCT01342510|20546633|P4|COMPLETED|Overall Study||39
8335100|NCT01342510|20546634|P3|COMPLETED|Overall Study||37
8335101|NCT01342510|20546635|P2|COMPLETED|Overall Study||44
8335102|NCT01342510|20546636|P1|COMPLETED|Overall Study||38
8335103|NCT01342510|20546633|P4|STARTED|Overall Study||50
8335104|NCT01342510|20546634|P3|STARTED|Overall Study||50
8335105|NCT01342510|20546635|P2|STARTED|Overall Study||50
8335106|NCT01342510|20546636|P1|STARTED|Overall Study||50
8335107|NCT01342484|20546653|P3|NOT COMPLETED|Overall Study||1
8335108|NCT01342484|20546654|P2|NOT COMPLETED|Overall Study||0
8335109|NCT01342484|20546655|P1|NOT COMPLETED|Overall Study||2
8335110|NCT01342484|20546653|P3|COMPLETED|Overall Study||13
8335111|NCT01342484|20546654|P2|COMPLETED|Overall Study||10
8335112|NCT01342484|20546655|P1|COMPLETED|Overall Study||13
8335113|NCT01342484|20546653|P3|STARTED|Overall Study||14
8335114|NCT01342484|20546654|P2|STARTED|Overall Study||10
8335115|NCT01342484|20546655|P1|STARTED|Overall Study||15
8335116|NCT01342471|20546671|P2|NOT COMPLETED|Overall Study||6
8335117|NCT01342471|20546672|P1|NOT COMPLETED|Overall Study||5
8335118|NCT01342471|20546671|P2|COMPLETED|Overall Study||23
8335119|NCT01342471|20546672|P1|COMPLETED|Overall Study||24
8335120|NCT01342471|20546671|P2|STARTED|Overall Study||29
8335121|NCT01342471|20546672|P1|STARTED|Overall Study||29
8335122|NCT01342458|20546688|P2|NOT COMPLETED|Overall Study||4
8335123|NCT01342458|20546689|P1|NOT COMPLETED|Overall Study||2
8335124|NCT01342458|20546688|P2|COMPLETED|Overall Study||24
8335125|NCT01342458|20546689|P1|COMPLETED|Overall Study||26
8335126|NCT01342458|20546688|P2|STARTED|Overall Study||28
8335127|NCT01342458|20546689|P1|STARTED|Overall Study||28
8335128|NCT01342445|20546711|P2|NOT COMPLETED|Overall Study||2
8335129|NCT01342445|20546712|P1|NOT COMPLETED|Overall Study||0
8335130|NCT01342445|20546711|P2|COMPLETED|Overall Study||22
8335131|NCT01342445|20546712|P1|COMPLETED|Overall Study||26
8335132|NCT01342445|20546711|P2|STARTED|Overall Study||24
8335133|NCT01342445|20546712|P1|STARTED|Overall Study||26
8335134|NCT01342341|20546728|P2|NOT COMPLETED|Overall Study||4
8335135|NCT01342341|20546729|P1|NOT COMPLETED|Overall Study||4
8335136|NCT01342341|20546728|P2|COMPLETED|Overall Study||20
8335137|NCT01342341|20546729|P1|COMPLETED|Overall Study||20
8335138|NCT01342341|20546728|P2|STARTED|Overall Study||24
8335139|NCT01342341|20546729|P1|STARTED|Overall Study||24
8335140|NCT01342211|20546740|P5|NOT COMPLETED|Overall Study||2
8335141|NCT01342211|20546741|P4|NOT COMPLETED|Overall Study||2
8335142|NCT01342211|20546742|P3|NOT COMPLETED|Overall Study||0
8335143|NCT01342211|20546743|P2|NOT COMPLETED|Overall Study||2
8335144|NCT01342211|20546744|P1|NOT COMPLETED|Overall Study||0
8335145|NCT01342211|20546740|P5|COMPLETED|Overall Study||16
8335146|NCT01342211|20546741|P4|COMPLETED|Overall Study||17
8335147|NCT01342211|20546742|P3|COMPLETED|Overall Study||18
8335148|NCT01342211|20546743|P2|COMPLETED|Overall Study||17
8335149|NCT01342211|20546744|P1|COMPLETED|Overall Study||19
8335150|NCT01342211|20546740|P5|Treated|Overall Study||17
8335151|NCT01342211|20546741|P4|Treated|Overall Study||19
8335152|NCT01342211|20546742|P3|Treated|Overall Study||18
8335153|NCT01342211|20546743|P2|Treated|Overall Study||17
8335154|NCT01342211|20546744|P1|Treated|Overall Study||19
8335155|NCT01342211|20546740|P5|STARTED|Overall Study||18
8335156|NCT01342211|20546741|P4|STARTED|Overall Study||19
8335157|NCT01342211|20546742|P3|STARTED|Overall Study||18
8335158|NCT01342211|20546743|P2|STARTED|Overall Study||19
8335159|NCT01342211|20546744|P1|STARTED|Overall Study||19
8335160|NCT01342172|20546810|P1|NOT COMPLETED|Overall Study||0
8335161|NCT01342172|20546810|P1|COMPLETED|Overall Study||9
8335162|NCT01342172|20546810|P1|STARTED|Overall Study||9
8335163|NCT01342107|20546823|P2|NOT COMPLETED|Overall Study||0
8335164|NCT01342107|20546824|P1|NOT COMPLETED|Overall Study||0
8335165|NCT01342107|20546823|P2|COMPLETED|Overall Study||32
8335166|NCT01342107|20546824|P1|COMPLETED|Overall Study||34
8335167|NCT01342107|20546823|P2|STARTED|Overall Study||32
8335168|NCT01342107|20546824|P1|STARTED|Overall Study||34
8335169|NCT01342094|20546832|P2|NOT COMPLETED|Overall Study||3
8335170|NCT01342094|20546833|P1|NOT COMPLETED|Overall Study||5
8335171|NCT01342094|20546832|P2|COMPLETED|Overall Study||81
8335172|NCT01342094|20546833|P1|COMPLETED|Overall Study||77
8335173|NCT01342094|20546832|P2|STARTED|Overall Study||84
8335174|NCT01342094|20546833|P1|STARTED|Overall Study||82
8335175|NCT01342081|20546842|P3|NOT COMPLETED|Overall Study||1
8335176|NCT01342081|20546843|P2|NOT COMPLETED|Overall Study||2
8335177|NCT01342081|20546844|P1|NOT COMPLETED|Overall Study||2
8335178|NCT01342081|20546842|P3|COMPLETED|Overall Study||163
8335179|NCT01342081|20546843|P2|COMPLETED|Overall Study||162
8335180|NCT01342081|20546844|P1|COMPLETED|Overall Study||159
8335181|NCT01342081|20546842|P3|STARTED|Overall Study||164
8335182|NCT01342081|20546843|P2|STARTED|Overall Study||164
8335183|NCT01342081|20546844|P1|STARTED|Overall Study||161
8335184|NCT01342029|20546852|P2|NOT COMPLETED|Period 2||0
8335185|NCT01342029|20546853|P1|NOT COMPLETED|Period 2||2
8335186|NCT01342029|20546852|P2|COMPLETED|Period 2||67
8335187|NCT01342029|20546853|P1|COMPLETED|Period 2||65
8335188|NCT01342029|20546852|P2|Dropout|Period 2||0
8335189|NCT01342029|20546853|P1|Dropout|Period 2||2
8335190|NCT01342029|20546852|P2|STARTED|Period 2||67
8335191|NCT01342029|20546853|P1|STARTED|Period 2||67
8335192|NCT01342029|20546852|P2|NOT COMPLETED|Washout||4
8335193|NCT01342029|20546853|P1|NOT COMPLETED|Washout||0
8335194|NCT01342029|20546852|P2|COMPLETED|Washout||67
8335195|NCT01342029|20546853|P1|COMPLETED|Washout||67
8335196|NCT01342029|20546852|P2|STARTED|Washout||71
8335197|NCT01342029|20546853|P1|STARTED|Washout||67
8335198|NCT01342029|20546852|P2|NOT COMPLETED|Period 1||1
8335199|NCT01342029|20546853|P1|NOT COMPLETED|Period 1||3
8335200|NCT01342029|20546852|P2|COMPLETED|Period 1||71
8335201|NCT01342029|20546853|P1|COMPLETED|Period 1||67
8335202|NCT01342029|20546852|P2|Dropout|Period 1||1
8335203|NCT01342029|20546853|P1|Dropout|Period 1||3
8335204|NCT01342029|20546852|P2|STARTED|Period 1||72
8335205|NCT01342029|20546853|P1|STARTED|Period 1||70
8335206|NCT01341990|20546863|P2|NOT COMPLETED|Overall Study||1
8335207|NCT01341990|20546864|P1|NOT COMPLETED|Overall Study||3
8335208|NCT01341990|20546863|P2|COMPLETED|Overall Study||32
8335209|NCT01341990|20546864|P1|COMPLETED|Overall Study||32
8335210|NCT01341990|20546863|P2|STARTED|Overall Study||33
8335211|NCT01341990|20546864|P1|STARTED|Overall Study||35
8335212|NCT01341977|20546874|P2|NOT COMPLETED|Overall Study||15
8335213|NCT01341977|20546875|P1|NOT COMPLETED|Overall Study||14
8335214|NCT01341977|20546874|P2|COMPLETED|Overall Study||270
8335215|NCT01341977|20546875|P1|COMPLETED|Overall Study||274
8335216|NCT01341977|20546874|P2|STARTED|Overall Study||285
8335217|NCT01341977|20546875|P1|STARTED|Overall Study||288
8335218|NCT01341912|20546881|P1|NOT COMPLETED|Overall Study||0
8335219|NCT01341912|20546881|P1|COMPLETED|Overall Study||3
8335220|NCT01341912|20546881|P1|STARTED|Overall Study||3
8335221|NCT01341782|20546888|P2|NOT COMPLETED|Overall Study||14
8335222|NCT01341782|20546889|P1|NOT COMPLETED|Overall Study||15
8335223|NCT01341782|20546888|P2|COMPLETED|Overall Study||114
8335224|NCT01341782|20546889|P1|COMPLETED|Overall Study||112
8335225|NCT01341782|20546888|P2|STARTED|Overall Study||128
8335226|NCT01341782|20546889|P1|STARTED|Overall Study||127
8335227|NCT01341730|20546907|P2|NOT COMPLETED|Overall Study||4
8335228|NCT01341730|20546908|P1|NOT COMPLETED|Overall Study||4
8335229|NCT01341730|20546907|P2|COMPLETED|Overall Study||17
8335230|NCT01341730|20546908|P1|COMPLETED|Overall Study||16
8335231|NCT01341730|20546907|P2|STARTED|Overall Study||21
8335232|NCT01341730|20546908|P1|STARTED|Overall Study||20
8335233|NCT01341652|20546918|P2|NOT COMPLETED|Overall Study||2
8335234|NCT01341652|20546919|P1|NOT COMPLETED|Overall Study||0
8335235|NCT01341652|20546918|P2|COMPLETED|Overall Study||48
8335236|NCT01341652|20546919|P1|COMPLETED|Overall Study||49
8335237|NCT01341652|20546918|P2|STARTED|Overall Study||50
8335238|NCT01341652|20546919|P1|STARTED|Overall Study||49
8335239|NCT01341639|20546935|P2|NOT COMPLETED|Post-Treatment||3
8335240|NCT01341639|20546936|P1|NOT COMPLETED|Post-Treatment||0
8335241|NCT01341639|20546935|P2|COMPLETED|Post-Treatment||545
8335242|NCT01341639|20546936|P1|COMPLETED|Post-Treatment||539
8335243|NCT01341639|20546935|P2|STARTED|Post-Treatment||548
8335244|NCT01341639|20546936|P1|STARTED|Post-Treatment||539
8335245|NCT01341639|20546935|P2|NOT COMPLETED|Toddler Dose||34
8335246|NCT01341639|20546936|P1|NOT COMPLETED|Toddler Dose||51
8335247|NCT01341639|20546935|P2|COMPLETED|Toddler Dose||548
8335248|NCT01341639|20546936|P1|COMPLETED|Toddler Dose||539
8335249|NCT01341639|20546935|P2|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
8335250|NCT01341639|20546936|P1|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
8335251|NCT01341639|20546935|P2|NOT COMPLETED|Interim Period||9
8335252|NCT01341639|20546936|P1|NOT COMPLETED|Interim Period||8
8335253|NCT01341639|20546935|P2|COMPLETED|Interim Period||581
8335254|NCT01341639|20546936|P1|COMPLETED|Interim Period||591
8335255|NCT01341639|20546935|P2|STARTED|Interim Period||590
8335256|NCT01341639|20546936|P1|STARTED|Interim Period||599
8335257|NCT01341639|20546935|P2|NOT COMPLETED|Infant Series||32
8335258|NCT01341639|20546936|P1|NOT COMPLETED|Infant Series||29
8335259|NCT01341639|20546935|P2|COMPLETED|Infant Series||590
8335260|NCT01341639|20546936|P1|COMPLETED|Infant Series||599
8335261|NCT01341639|20546935|P2|Treated|Infant Series||605
8335262|NCT01341639|20546936|P1|Treated|Infant Series||610
8335263|NCT01341639|20546935|P2|Site 0048 Excluded|Infant Series||606
8335264|NCT01341639|20546936|P1|Site 0048 Excluded|Infant Series||611
8335265|NCT01341639|20546935|P2|STARTED|Infant Series||622
8335266|NCT01341639|20546936|P1|STARTED|Infant Series||628
8335267|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8335268|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8335269|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8335270|NCT01341600|20546960|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
8335271|NCT01341600|20546961|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
8335272|NCT01341600|20546962|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
8335273|NCT01341600|20546960|P3|STARTED|Clopidogrel Plus Omeprazole||4
8335274|NCT01341600|20546961|P2|STARTED|Clopidogrel Plus Omeprazole||5
8335275|NCT01341600|20546962|P1|STARTED|Clopidogrel Plus Omeprazole||5
8335276|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel 225 mg||0
8335277|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel 225 mg||0
8335278|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel 225 mg||0
8335279|NCT01341600|20546960|P3|COMPLETED|Clopidogrel 225 mg||6
8335280|NCT01341600|20546961|P2|COMPLETED|Clopidogrel 225 mg||6
8335281|NCT01341600|20546962|P1|COMPLETED|Clopidogrel 225 mg||6
8335282|NCT01341600|20546960|P3|STARTED|Clopidogrel 225 mg||6
8335283|NCT01341600|20546961|P2|STARTED|Clopidogrel 225 mg||6
8335284|NCT01341600|20546962|P1|STARTED|Clopidogrel 225 mg||6
8335285|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel 150 mg||0
8335286|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel 150 mg||0
8335287|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel 150 mg||0
8335288|NCT01341600|20546960|P3|COMPLETED|Clopidogrel 150 mg||6
8335289|NCT01341600|20546961|P2|COMPLETED|Clopidogrel 150 mg||6
8335290|NCT01341600|20546962|P1|COMPLETED|Clopidogrel 150 mg||6
8335291|NCT01341600|20546960|P3|STARTED|Clopidogrel 150 mg||6
8335292|NCT01341600|20546961|P2|STARTED|Clopidogrel 150 mg||6
8335293|NCT01341600|20546962|P1|STARTED|Clopidogrel 150 mg||6
8335294|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel 75 mg||0
8335295|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel 75 mg||0
8335296|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel 75 mg||0
8335297|NCT01341600|20546960|P3|COMPLETED|Clopidogrel 75 mg||6
8335298|NCT01341600|20546961|P2|COMPLETED|Clopidogrel 75 mg||6
8335299|NCT01341600|20546962|P1|COMPLETED|Clopidogrel 75 mg||6
8335300|NCT01341600|20546960|P3|STARTED|Clopidogrel 75 mg||6
8335301|NCT01341600|20546961|P2|STARTED|Clopidogrel 75 mg||6
8335302|NCT01341600|20546962|P1|STARTED|Clopidogrel 75 mg||6
8335303|NCT01341587|20546981|P2|NOT COMPLETED|Overall Study||10
8335304|NCT01341587|20546982|P1|NOT COMPLETED|Overall Study||4
8335305|NCT01341587|20546981|P2|COMPLETED|Overall Study||0
8335306|NCT01341587|20546982|P1|COMPLETED|Overall Study||0
8335307|NCT01341587|20546981|P2|STARTED|Overall Study||10
8335308|NCT01341587|20546982|P1|STARTED|Overall Study||4
8335309|NCT01341470|20546994|P6|NOT COMPLETED|Overall Study||1
8335310|NCT01341470|20546995|P5|NOT COMPLETED|Overall Study||0
8335311|NCT01341470|20546996|P4|NOT COMPLETED|Overall Study||1
8335312|NCT01341470|20546997|P3|NOT COMPLETED|Overall Study||1
8335313|NCT01341470|20546998|P2|NOT COMPLETED|Overall Study||0
8335314|NCT01341470|20546999|P1|NOT COMPLETED|Overall Study||0
8335315|NCT01341470|20546994|P6|COMPLETED|Overall Study||9
8335316|NCT01341470|20546995|P5|COMPLETED|Overall Study||2
8335317|NCT01341470|20546996|P4|COMPLETED|Overall Study||9
8335318|NCT01341470|20546997|P3|COMPLETED|Overall Study||9
8335319|NCT01341470|20546998|P2|COMPLETED|Overall Study||9
8335320|NCT01341470|20546999|P1|COMPLETED|Overall Study||6
8335321|NCT01341470|20546994|P6|Received at Least 1 Dose of Study Drug|Overall Study||10
8335322|NCT01341470|20546995|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
8335323|NCT01341470|20546996|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
8335324|NCT01341470|20546997|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
8335325|NCT01341470|20546998|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
8335326|NCT01341470|20546999|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8335327|NCT01341470|20546994|P6|STARTED|Overall Study||10
8335328|NCT01341470|20546995|P5|STARTED|Overall Study||2
8335329|NCT01341470|20546996|P4|STARTED|Overall Study||10
8335330|NCT01341470|20546997|P3|STARTED|Overall Study||10
8335331|NCT01341470|20546998|P2|STARTED|Overall Study||9
8335332|NCT01341470|20546999|P1|STARTED|Overall Study||6
8335333|NCT01341457|20547033|P2|NOT COMPLETED|Overall Study||0
8335334|NCT01341457|20547034|P1|NOT COMPLETED|Overall Study||2
8335335|NCT01341457|20547033|P2|COMPLETED|Overall Study||10
8335336|NCT01341457|20547034|P1|COMPLETED|Overall Study||5
8335337|NCT01341457|20547033|P2|Received at Least One Dose of Study Drug|Overall Study||10
8335338|NCT01341457|20547034|P1|Received at Least One Dose of Study Drug|Overall Study||7
8335339|NCT01341457|20547033|P2|STARTED|Overall Study||10
8335340|NCT01341457|20547034|P1|STARTED|Overall Study||7
8335341|NCT01341444|20547052|P2|NOT COMPLETED|Overall Study||3
8335342|NCT01341444|20547053|P1|NOT COMPLETED|Overall Study||5
8335343|NCT01341444|20547052|P2|COMPLETED|Overall Study||29
8335344|NCT01341444|20547053|P1|COMPLETED|Overall Study||26
8335345|NCT01341444|20547052|P2|STARTED|Overall Study||32
8335346|NCT01341444|20547053|P1|STARTED|Overall Study||31
8335347|NCT01341301|20547059|P1|NOT COMPLETED|Overall Study||0
8335348|NCT01341301|20547059|P1|COMPLETED|Overall Study||25
8335349|NCT01341301|20547059|P1|STARTED|Overall Study||25
8335350|NCT01341067|20547066|P1|NOT COMPLETED|Overall Study||4
8335351|NCT01341067|20547066|P1|COMPLETED|Overall Study||26
8335352|NCT01341067|20547066|P1|STARTED|Overall Study||30
8335353|NCT01340976|20547079|P6|NOT COMPLETED|Overall Study||1
8335354|NCT01340976|20547080|P5|NOT COMPLETED|Overall Study||2
8335355|NCT01340976|20547081|P4|NOT COMPLETED|Overall Study||3
8335356|NCT01340976|20547082|P3|NOT COMPLETED|Overall Study||3
8335357|NCT01340976|20547083|P2|NOT COMPLETED|Overall Study||2
8335358|NCT01340976|20547084|P1|NOT COMPLETED|Overall Study||4
8335359|NCT01340976|20547079|P6|COMPLETED|Overall Study||6
8335360|NCT01340976|20547080|P5|COMPLETED|Overall Study||5
8335361|NCT01340976|20547081|P4|COMPLETED|Overall Study||2
8335362|NCT01340976|20547082|P3|COMPLETED|Overall Study||4
8335363|NCT01340976|20547083|P2|COMPLETED|Overall Study||1
8335364|NCT01340976|20547084|P1|COMPLETED|Overall Study||0
8335365|NCT01340976|20547079|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
8335366|NCT01340976|20547080|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
8335367|NCT01340976|20547081|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8335368|NCT01340976|20547082|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
8335369|NCT01340976|20547083|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8335370|NCT01340976|20547084|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8335371|NCT01340976|20547079|P6|STARTED|Overall Study||7
8335372|NCT01340976|20547080|P5|STARTED|Overall Study||7
8335373|NCT01340976|20547081|P4|STARTED|Overall Study||5
8335374|NCT01340976|20547082|P3|STARTED|Overall Study||7
8335375|NCT01340976|20547083|P2|STARTED|Overall Study||3
8335376|NCT01340976|20547084|P1|STARTED|Overall Study||4
8335377|NCT01340937|20547122|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
8335378|NCT01340937|20547123|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
8335379|NCT01340937|20547124|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
8335380|NCT01340937|20547125|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
8335381|NCT01340937|20547122|P4|COMPLETED|Period 3: Toddler Vaccinations||319
8335382|NCT01340937|20547123|P3|COMPLETED|Period 3: Toddler Vaccinations||660
8335383|NCT01340937|20547124|P2|COMPLETED|Period 3: Toddler Vaccinations||641
8335384|NCT01340937|20547125|P1|COMPLETED|Period 3: Toddler Vaccinations||666
8335385|NCT01340937|20547122|P4|STARTED|Period 3: Toddler Vaccinations||329
8335386|NCT01340937|20547123|P3|STARTED|Period 3: Toddler Vaccinations||669
8335387|NCT01340937|20547124|P2|STARTED|Period 3: Toddler Vaccinations||658
8335388|NCT01340937|20547125|P1|STARTED|Period 3: Toddler Vaccinations||675
8335389|NCT01340937|20547122|P4|NOT COMPLETED|Period 2: Interim Period||41
8335390|NCT01340937|20547123|P3|NOT COMPLETED|Period 2: Interim Period||84
8335391|NCT01340937|20547124|P2|NOT COMPLETED|Period 2: Interim Period||79
8335392|NCT01340937|20547125|P1|NOT COMPLETED|Period 2: Interim Period||67
8335393|NCT01340937|20547122|P4|COMPLETED|Period 2: Interim Period||329
8335394|NCT01340937|20547123|P3|COMPLETED|Period 2: Interim Period||669
8335395|NCT01340937|20547124|P2|COMPLETED|Period 2: Interim Period||658
8335396|NCT01340937|20547125|P1|COMPLETED|Period 2: Interim Period||675
8335397|NCT01340937|20547122|P4|STARTED|Period 2: Interim Period||370
8335398|NCT01340937|20547123|P3|STARTED|Period 2: Interim Period||753
8335399|NCT01340937|20547124|P2|STARTED|Period 2: Interim Period||737
8335400|NCT01340937|20547125|P1|STARTED|Period 2: Interim Period||742
8335401|NCT01340937|20547122|P4|NOT COMPLETED|Period 1: Infant Series||32
8335402|NCT01340937|20547123|P3|NOT COMPLETED|Period 1: Infant Series||56
8335403|NCT01340937|20547124|P2|NOT COMPLETED|Period 1: Infant Series||60
8335404|NCT01340937|20547125|P1|NOT COMPLETED|Period 1: Infant Series||58
8335405|NCT01340937|20547122|P4|COMPLETED|Period 1: Infant Series||370
8335406|NCT01340937|20547123|P3|COMPLETED|Period 1: Infant Series||753
8335407|NCT01340937|20547124|P2|COMPLETED|Period 1: Infant Series||737
8335408|NCT01340937|20547125|P1|COMPLETED|Period 1: Infant Series||742
8335409|NCT01340937|20547122|P4|STARTED|Period 1: Infant Series||402
8335410|NCT01340937|20547123|P3|STARTED|Period 1: Infant Series||809
8335411|NCT01340937|20547124|P2|STARTED|Period 1: Infant Series||797
8335412|NCT01340937|20547125|P1|STARTED|Period 1: Infant Series||800
8335413|NCT01340898|20547285|P3|NOT COMPLETED|Booster Phase||7
8335414|NCT01340898|20547286|P2|NOT COMPLETED|Booster Phase||2
8335415|NCT01340898|20547287|P1|NOT COMPLETED|Booster Phase||10
8335416|NCT01340898|20547285|P3|COMPLETED|Booster Phase||163
8335417|NCT01340898|20547286|P2|COMPLETED|Booster Phase||164
8335418|NCT01340898|20547287|P1|COMPLETED|Booster Phase||332
8335419|NCT01340898|20547285|P3|STARTED|Booster Phase||170
8335420|NCT01340898|20547286|P2|STARTED|Booster Phase||166
8335421|NCT01340898|20547287|P1|STARTED|Booster Phase||342
8335422|NCT01340898|20547285|P3|NOT COMPLETED|Primary Phase||6
8335423|NCT01340898|20547286|P2|NOT COMPLETED|Primary Phase||9
8335424|NCT01340898|20547287|P1|NOT COMPLETED|Primary Phase||16
8335425|NCT01340898|20547285|P3|COMPLETED|Primary Phase||181
8335426|NCT01340898|20547286|P2|COMPLETED|Primary Phase||178
8335427|NCT01340898|20547287|P1|COMPLETED|Primary Phase||360
8335428|NCT01340898|20547285|P3|STARTED|Primary Phase||187
8335429|NCT01340898|20547286|P2|STARTED|Primary Phase||187
8335430|NCT01340898|20547287|P1|STARTED|Primary Phase||376
8335431|NCT01340885|20547390|P3|NOT COMPLETED|Overall Study||0
8335432|NCT01340885|20547391|P2|NOT COMPLETED|Overall Study||0
8335433|NCT01340885|20547392|P1|NOT COMPLETED|Overall Study||0
8335434|NCT01340885|20547390|P3|COMPLETED|Overall Study||0
8335435|NCT01340885|20547391|P2|COMPLETED|Overall Study||0
8335436|NCT01340885|20547392|P1|COMPLETED|Overall Study||0
8335437|NCT01340885|20547390|P3|STARTED|Overall Study||0
8335438|NCT01340885|20547391|P2|STARTED|Overall Study||0
8335439|NCT01340885|20547392|P1|STARTED|Overall Study||0
8335440|NCT01340872|20547417|P4|NOT COMPLETED|Open-label Phase||11
8335441|NCT01340872|20547418|P3|NOT COMPLETED|Open-label Phase||13
8335442|NCT01340872|20547419|P2|NOT COMPLETED|Open-label Phase||0
8335443|NCT01340872|20547420|P1|NOT COMPLETED|Open-label Phase||0
8335444|NCT01340872|20547417|P4|COMPLETED|Open-label Phase||36
8335445|NCT01340872|20547418|P3|COMPLETED|Open-label Phase||37
8335446|NCT01340872|20547419|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8335447|NCT01340872|20547420|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8335448|NCT01340872|20547417|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
8335449|NCT01340872|20547418|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
8335450|NCT01340872|20547419|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8335451|NCT01340872|20547420|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8335452|NCT01340872|20547417|P4|NOT COMPLETED|Double-blind Phase||0
8335453|NCT01340872|20547418|P3|NOT COMPLETED|Double-blind Phase||0
8335454|NCT01340872|20547419|P2|NOT COMPLETED|Double-blind Phase||11
8335455|NCT01340872|20547420|P1|NOT COMPLETED|Double-blind Phase||9
8335456|NCT01340872|20547417|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8335457|NCT01340872|20547418|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8335458|NCT01340872|20547419|P2|COMPLETED|Double-blind Phase||53
8335459|NCT01340872|20547420|P1|COMPLETED|Double-blind Phase||55
8335460|NCT01340872|20547417|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8335461|NCT01340872|20547418|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8335462|NCT01340872|20547419|P2|STARTED|Double-blind Phase||64
8335463|NCT01340872|20547420|P1|STARTED|Double-blind Phase||64
8335464|NCT01340794|20547480|P2|NOT COMPLETED|Overall Study||1
8335465|NCT01340794|20547481|P1|NOT COMPLETED|Overall Study||0
8335466|NCT01340794|20547480|P2|COMPLETED|Overall Study||4
8335467|NCT01340794|20547481|P1|COMPLETED|Overall Study||2
8335468|NCT01340794|20547480|P2|STARTED|Overall Study||5
8335469|NCT01340794|20547481|P1|STARTED|Overall Study||2
8335470|NCT01340768|20547497|P2|NOT COMPLETED|Overall Study||5
8335471|NCT01340768|20547498|P1|NOT COMPLETED|Overall Study||17
8335472|NCT01340768|20547497|P2|COMPLETED|Overall Study||429
8335473|NCT01340768|20547498|P1|COMPLETED|Overall Study||419
8335474|NCT01340768|20547497|P2|STARTED|Overall Study||434
8335475|NCT01340768|20547498|P1|STARTED|Overall Study||436
8335476|NCT01340664|20547509|P3|NOT COMPLETED|Overall Study||13
8335477|NCT01340664|20547510|P2|NOT COMPLETED|Overall Study||8
8335478|NCT01340664|20547511|P1|NOT COMPLETED|Overall Study||7
8335479|NCT01340664|20547509|P3|COMPLETED|Overall Study||80
8335480|NCT01340664|20547510|P2|COMPLETED|Overall Study||85
8335481|NCT01340664|20547511|P1|COMPLETED|Overall Study||86
8335482|NCT01340664|20547509|P3|STARTED|Overall Study||93
8335483|NCT01340664|20547510|P2|STARTED|Overall Study||93
8335484|NCT01340664|20547511|P1|STARTED|Overall Study||93
8335485|NCT01340651|20547528|P1|NOT COMPLETED|Overall Study||17
8335486|NCT01340651|20547528|P1|COMPLETED|Overall Study||24
8335487|NCT01340651|20547528|P1|STARTED|Overall Study||41
8335488|NCT01340625|20547544|P2|NOT COMPLETED|Second Intervention||0
8335489|NCT01340625|20547545|P1|NOT COMPLETED|Second Intervention||0
8335490|NCT01340625|20547544|P2|COMPLETED|Second Intervention||18
8335491|NCT01340625|20547545|P1|COMPLETED|Second Intervention||16
8335492|NCT01340625|20547544|P2|STARTED|Second Intervention||18
8335493|NCT01340625|20547545|P1|STARTED|Second Intervention||16
8335494|NCT01340625|20547544|P2|NOT COMPLETED|Washout Period of 28 Days||0
8335495|NCT01340625|20547545|P1|NOT COMPLETED|Washout Period of 28 Days||1
8335496|NCT01340625|20547544|P2|COMPLETED|Washout Period of 28 Days||18
8335497|NCT01340625|20547545|P1|COMPLETED|Washout Period of 28 Days||16
8335498|NCT01340625|20547544|P2|STARTED|Washout Period of 28 Days||18
8335499|NCT01340625|20547545|P1|STARTED|Washout Period of 28 Days||17
8335500|NCT01340625|20547544|P2|NOT COMPLETED|First Intervention||0
8335501|NCT01340625|20547545|P1|NOT COMPLETED|First Intervention||1
8335502|NCT01340625|20547544|P2|COMPLETED|First Intervention||18
8335503|NCT01340625|20547545|P1|COMPLETED|First Intervention||17
8335504|NCT01340625|20547544|P2|STARTED|First Intervention||18
8335505|NCT01340625|20547545|P1|STARTED|First Intervention||18
8335506|NCT01340586|20547563|P2|NOT COMPLETED|Overall Study||0
8335507|NCT01340586|20547564|P1|NOT COMPLETED|Overall Study||0
8335508|NCT01340586|20547563|P2|COMPLETED|Overall Study||8
8335509|NCT01340586|20547564|P1|COMPLETED|Overall Study||8
8335510|NCT01340586|20547563|P2|STARTED|Overall Study||8
8335511|NCT01340586|20547564|P1|STARTED|Overall Study||8
8335512|NCT01340573|20547629|P1|NOT COMPLETED|Overall Study||3
8335513|NCT01340573|20547629|P1|COMPLETED|Overall Study||0
8335514|NCT01340573|20547629|P1|STARTED|Overall Study||3
8335515|NCT01340495|20547650|P1|NOT COMPLETED|Overall Study||1
8335516|NCT01340495|20547650|P1|COMPLETED|Overall Study||69
8335517|NCT01340495|20547650|P1|STARTED|Overall Study||70
8335518|NCT01340482|20547660|P3|NOT COMPLETED|Overall Study||0
8335519|NCT01340482|20547661|P2|NOT COMPLETED|Overall Study||0
8335520|NCT01340482|20547662|P1|NOT COMPLETED|Overall Study||2
8335521|NCT01340482|20547660|P3|COMPLETED|Overall Study||1
8335522|NCT01340482|20547661|P2|COMPLETED|Overall Study||1
8335523|NCT01340482|20547662|P1|COMPLETED|Overall Study||25
8335524|NCT01340482|20547660|P3|STARTED|Overall Study||1
8335525|NCT01340482|20547661|P2|STARTED|Overall Study||1
8335526|NCT01340482|20547662|P1|STARTED|Overall Study||27
8335527|NCT01340300|20547677|P4|NOT COMPLETED|Overall Study||14
8335528|NCT01340300|20547678|P3|NOT COMPLETED|Overall Study||15
8335529|NCT01340300|20547679|P2|NOT COMPLETED|Overall Study||9
8335530|NCT01340300|20547680|P1|NOT COMPLETED|Overall Study||9
8335531|NCT01340300|20547677|P4|COMPLETED|Overall Study||20
8335532|NCT01340300|20547678|P3|COMPLETED|Overall Study||20
8335533|NCT01340300|20547679|P2|COMPLETED|Overall Study||26
8335534|NCT01340300|20547680|P1|COMPLETED|Overall Study||26
8335535|NCT01340300|20547677|P4|Follow-up Blood Sample|Overall Study||18
8335536|NCT01340300|20547678|P3|Follow-up Blood Sample|Overall Study||19
8335537|NCT01340300|20547679|P2|Follow-up Blood Sample|Overall Study||26
8335538|NCT01340300|20547680|P1|Follow-up Blood Sample|Overall Study||25
8335539|NCT01340300|20547677|P4|Baseline Blood Sample|Overall Study||29
8335540|NCT01340300|20547678|P3|Baseline Blood Sample|Overall Study||32
8335541|NCT01340300|20547679|P2|Baseline Blood Sample|Overall Study||34
8335542|NCT01340300|20547680|P1|Baseline Blood Sample|Overall Study||33
8335543|NCT01340300|20547677|P4|STARTED|Overall Study||34
8335544|NCT01340300|20547678|P3|STARTED|Overall Study||35
8335545|NCT01340300|20547679|P2|STARTED|Overall Study||35
8335546|NCT01340300|20547680|P1|STARTED|Overall Study||35
8335547|NCT01340209|20547713|P3|NOT COMPLETED|Overall Study||8
8335548|NCT01340209|20547714|P2|NOT COMPLETED|Overall Study||8
8335549|NCT01340209|20547715|P1|NOT COMPLETED|Overall Study||5
8335550|NCT01340209|20547713|P3|COMPLETED|Overall Study||106
8335551|NCT01340209|20547714|P2|COMPLETED|Overall Study||106
8335552|NCT01340209|20547715|P1|COMPLETED|Overall Study||52
8335553|NCT01340209|20547713|P3|STARTED|Overall Study||114
8335554|NCT01340209|20547714|P2|STARTED|Overall Study||114
8335555|NCT01340209|20547715|P1|STARTED|Overall Study||57
8335556|NCT01340196|20547750|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
8335557|NCT01340196|20547750|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
8335558|NCT01340196|20547750|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
8335559|NCT01340196|20547750|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
8335560|NCT01340196|20547750|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
8335561|NCT01340196|20547750|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
8335562|NCT01340196|20547750|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
8335563|NCT01340196|20547750|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
8335564|NCT01340196|20547750|P1|STARTED|Treat. Period 1 (Tenofovir)||16
8335565|NCT01340144|20547781|P2|NOT COMPLETED|Overall Study||58
8335566|NCT01340144|20547782|P1|NOT COMPLETED|Overall Study||72
8335567|NCT01340144|20547781|P2|COMPLETED|Overall Study||567
8335568|NCT01340144|20547782|P1|COMPLETED|Overall Study||553
8335569|NCT01340144|20547781|P2|STARTED|Overall Study||625
8335570|NCT01340144|20547782|P1|STARTED|Overall Study||625
8335571|NCT01340066|20547790|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
8335572|NCT01340066|20547791|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
8335573|NCT01340066|20547792|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
8335574|NCT01340066|20547790|P3|COMPLETED|5 Week Double Blind Randomization Period||31
8335575|NCT01340066|20547791|P2|COMPLETED|5 Week Double Blind Randomization Period||28
8335576|NCT01340066|20547792|P1|COMPLETED|5 Week Double Blind Randomization Period||0
8335577|NCT01340066|20547790|P3|STARTED|5 Week Double Blind Randomization Period||34
8335578|NCT01340066|20547791|P2|STARTED|5 Week Double Blind Randomization Period||33
8335579|NCT01340066|20547792|P1|STARTED|5 Week Double Blind Randomization Period||0
8335580|NCT01340066|20547790|P3|NOT COMPLETED|Placebo Run in Period||0
8335581|NCT01340066|20547791|P2|NOT COMPLETED|Placebo Run in Period||0
8335582|NCT01340066|20547792|P1|NOT COMPLETED|Placebo Run in Period||27
8335583|NCT01340066|20547790|P3|COMPLETED|Placebo Run in Period||0
8335584|NCT01340066|20547791|P2|COMPLETED|Placebo Run in Period||0
8335585|NCT01340066|20547792|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
8335586|NCT01340066|20547790|P3|STARTED|Placebo Run in Period||0
8335587|NCT01340066|20547791|P2|STARTED|Placebo Run in Period||0
8335588|NCT01340066|20547792|P1|STARTED|Placebo Run in Period||94
8335589|NCT01340053|20547803|P4|NOT COMPLETED|Overall Study||3
8335590|NCT01340053|20547804|P3|NOT COMPLETED|Overall Study||4
8335591|NCT01340053|20547805|P2|NOT COMPLETED|Overall Study||2
8335592|NCT01340053|20547806|P1|NOT COMPLETED|Overall Study||4
8335593|NCT01340053|20547803|P4|COMPLETED|Overall Study||43
8335594|NCT01340053|20547804|P3|COMPLETED|Overall Study||43
8335595|NCT01340053|20547805|P2|COMPLETED|Overall Study||44
8335596|NCT01340053|20547806|P1|COMPLETED|Overall Study||43
8335597|NCT01340053|20547803|P4|STARTED|Overall Study||46
8335598|NCT01340053|20547804|P3|STARTED|Overall Study||47
8335599|NCT01340053|20547805|P2|STARTED|Overall Study||46
8335600|NCT01340053|20547806|P1|STARTED|Overall Study||47
8335601|NCT01340027|20547832|P12|NOT COMPLETED|Overall Study||4
8335602|NCT01340027|20547833|P11|NOT COMPLETED|Overall Study||2
8335603|NCT01340027|20547834|P10|NOT COMPLETED|Overall Study||6
8335604|NCT01340027|20547835|P9|NOT COMPLETED|Overall Study||8
8335605|NCT01340027|20547836|P8|NOT COMPLETED|Overall Study||7
8335606|NCT01340027|20547837|P7|NOT COMPLETED|Overall Study||7
8335607|NCT01340027|20547838|P6|NOT COMPLETED|Overall Study||4
8335608|NCT01340027|20547839|P5|NOT COMPLETED|Overall Study||10
8335609|NCT01340027|20547840|P4|NOT COMPLETED|Overall Study||4
8335610|NCT01340027|20547841|P3|NOT COMPLETED|Overall Study||4
8335611|NCT01340027|20547842|P2|NOT COMPLETED|Overall Study||7
8335612|NCT01340027|20547843|P1|NOT COMPLETED|Overall Study||5
8335613|NCT01340027|20547832|P12|COMPLETED|Overall Study||77
8335614|NCT01340027|20547833|P11|COMPLETED|Overall Study||79
8335615|NCT01340027|20547834|P10|COMPLETED|Overall Study||146
8335616|NCT01340027|20547835|P9|COMPLETED|Overall Study||136
8335617|NCT01340027|20547836|P8|COMPLETED|Overall Study||142
8335618|NCT01340027|20547837|P7|COMPLETED|Overall Study||142
8335619|NCT01340027|20547838|P6|COMPLETED|Overall Study||74
8335620|NCT01340027|20547839|P5|COMPLETED|Overall Study||146
8335621|NCT01340027|20547840|P4|COMPLETED|Overall Study||75
8335622|NCT01340027|20547841|P3|COMPLETED|Overall Study||75
8335623|NCT01340027|20547842|P2|COMPLETED|Overall Study||71
8335624|NCT01340027|20547843|P1|COMPLETED|Overall Study||76
8335625|NCT01340027|20547832|P12|Received Treatment|Overall Study||81
8335626|NCT01340027|20547833|P11|Received Treatment|Overall Study||81
8335627|NCT01340027|20547834|P10|Received Treatment|Overall Study||152
8335628|NCT01340027|20547835|P9|Received Treatment|Overall Study||144
8335629|NCT01340027|20547836|P8|Received Treatment|Overall Study||149
8335630|NCT01340027|20547837|P7|Received Treatment|Overall Study||149
8335631|NCT01340027|20547838|P6|Received Treatment|Overall Study||78
8335632|NCT01340027|20547839|P5|Received Treatment|Overall Study||156
8335633|NCT01340027|20547840|P4|Received Treatment|Overall Study||79
8335634|NCT01340027|20547841|P3|Received Treatment|Overall Study||78
8335635|NCT01340027|20547842|P2|Received Treatment|Overall Study||78
8335636|NCT01340027|20547843|P1|Received Treatment|Overall Study||81
8335637|NCT01340027|20547832|P12|STARTED|Overall Study||81
8335638|NCT01340027|20547833|P11|STARTED|Overall Study||81
8335639|NCT01340027|20547834|P10|STARTED|Overall Study||152
8335640|NCT01340027|20547835|P9|STARTED|Overall Study||144
8335641|NCT01340027|20547836|P8|STARTED|Overall Study||149
8335642|NCT01340027|20547837|P7|STARTED|Overall Study||149
8335643|NCT01340027|20547838|P6|STARTED|Overall Study||78
8335644|NCT01340027|20547839|P5|STARTED|Overall Study||156
8335645|NCT01340027|20547840|P4|STARTED|Overall Study||79
8335646|NCT01340027|20547841|P3|STARTED|Overall Study||79
8335647|NCT01340027|20547842|P2|STARTED|Overall Study||78
8335648|NCT01340027|20547843|P1|STARTED|Overall Study||81
8335649|NCT01340014|20548219|P2|NOT COMPLETED|Period 2, Second 7 Days||1
8335650|NCT01340014|20548220|P1|NOT COMPLETED|Period 2, Second 7 Days||0
8335651|NCT01340014|20548219|P2|COMPLETED|Period 2, Second 7 Days||56
8335652|NCT01340014|20548220|P1|COMPLETED|Period 2, Second 7 Days||53
8335653|NCT01340014|20548219|P2|STARTED|Period 2, Second 7 Days||57
8335654|NCT01340014|20548220|P1|STARTED|Period 2, Second 7 Days||53
8335655|NCT01340014|20548219|P2|NOT COMPLETED|Period 1, First 7 Days||0
8335656|NCT01340014|20548220|P1|NOT COMPLETED|Period 1, First 7 Days||2
8335657|NCT01340014|20548219|P2|COMPLETED|Period 1, First 7 Days||57
8335658|NCT01340014|20548220|P1|COMPLETED|Period 1, First 7 Days||53
8335659|NCT01340014|20548219|P2|STARTED|Period 1, First 7 Days||57
8335660|NCT01340014|20548220|P1|STARTED|Period 1, First 7 Days||55
8335661|NCT01339936|20548228|P1|NOT COMPLETED|Overall Study||2
8335662|NCT01339936|20548228|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
8335663|NCT01339936|20548228|P1|STARTED|Overall Study|plus 2 screen failures|38
8335664|NCT01339923|20548241|P7|NOT COMPLETED|Overall Study||14
8335665|NCT01339923|20548242|P6|NOT COMPLETED|Overall Study||9
8335666|NCT01339923|20548243|P5|NOT COMPLETED|Overall Study||5
8335667|NCT01339923|20548244|P4|NOT COMPLETED|Overall Study||4
8335668|NCT01339923|20548245|P3|NOT COMPLETED|Overall Study||8
8335669|NCT01339923|20548246|P2|NOT COMPLETED|Overall Study||16
8335670|NCT01339923|20548247|P1|NOT COMPLETED|Overall Study||14
8335671|NCT01339923|20548241|P7|COMPLETED|Overall Study||111
8335672|NCT01339923|20548242|P6|COMPLETED|Overall Study||117
8335673|NCT01339923|20548243|P5|COMPLETED|Overall Study||295
8335674|NCT01339923|20548244|P4|COMPLETED|Overall Study||100
8335675|NCT01339923|20548245|P3|COMPLETED|Overall Study||243
8335676|NCT01339923|20548246|P2|COMPLETED|Overall Study||234
8335677|NCT01339923|20548247|P1|COMPLETED|Overall Study||239
8335678|NCT01339923|20548241|P7|STARTED|Overall Study||125
8335679|NCT01339923|20548242|P6|STARTED|Overall Study||126
8335680|NCT01339923|20548243|P5|STARTED|Overall Study||300
8335681|NCT01339923|20548244|P4|STARTED|Overall Study||104
8335682|NCT01339923|20548245|P3|STARTED|Overall Study||251
8335683|NCT01339923|20548246|P2|STARTED|Overall Study||250
8335684|NCT01339923|20548247|P1|STARTED|Overall Study||253
8335685|NCT01339910|20548318|P2|NOT COMPLETED|Overall Study||4
8335686|NCT01339910|20548319|P1|NOT COMPLETED|Overall Study||3
8335687|NCT01339910|20548318|P2|COMPLETED|Overall Study||133
8335688|NCT01339910|20548319|P1|COMPLETED|Overall Study||132
8335689|NCT01339910|20548318|P2|STARTED|Overall Study||137
8335690|NCT01339910|20548319|P1|STARTED|Overall Study||135
8335691|NCT01339897|20548357|P4|NOT COMPLETED|Overall Study||1
8335692|NCT01339897|20548358|P3|NOT COMPLETED|Overall Study||0
8335693|NCT01339897|20548359|P2|NOT COMPLETED|Overall Study||0
8335694|NCT01339897|20548360|P1|NOT COMPLETED|Overall Study||1
8335695|NCT01339897|20548357|P4|COMPLETED|Overall Study||5
8335696|NCT01339897|20548358|P3|COMPLETED|Overall Study||6
8335697|NCT01339897|20548359|P2|COMPLETED|Overall Study||6
8335698|NCT01339897|20548360|P1|COMPLETED|Overall Study||6
8335699|NCT01339897|20548357|P4|STARTED|Overall Study||6
8335700|NCT01339897|20548358|P3|STARTED|Overall Study||6
8335701|NCT01339897|20548359|P2|STARTED|Overall Study||6
8335702|NCT01339897|20548360|P1|STARTED|Overall Study||7
8335703|NCT01339858|20548388|P2|NOT COMPLETED|Overall Study||12
8335704|NCT01339858|20548389|P1|NOT COMPLETED|Overall Study||16
8335705|NCT01339858|20548388|P2|COMPLETED|Overall Study||18
8335706|NCT01339858|20548389|P1|COMPLETED|Overall Study||14
8335707|NCT01339858|20548388|P2|STARTED|Overall Study||30
8335708|NCT01339858|20548389|P1|STARTED|Overall Study||30
8335709|NCT01339832|20548413|P1|NOT COMPLETED|Overall Study||14
8335710|NCT01339832|20548413|P1|COMPLETED|Overall Study||37
8335711|NCT01339832|20548413|P1|STARTED|Overall Study||51
8335712|NCT01339559|20548424|P1|NOT COMPLETED|Overall Study||398
8335713|NCT01339559|20548424|P1|COMPLETED|Overall Study||368
8335714|NCT01339559|20548424|P1|STARTED|Overall Study||766
8335715|NCT01339429|20548433|P1|NOT COMPLETED|Overall Study||4
8335716|NCT01339429|20548433|P1|COMPLETED|Overall Study||37
8335717|NCT01339429|20548433|P1|STARTED|Overall Study||41
8335718|NCT01339416|20548438|P1|NOT COMPLETED|Overall Study||0
8335719|NCT01339416|20548438|P1|COMPLETED|Overall Study||8202
8335720|NCT01339416|20548438|P1|STARTED|Overall Study||8202
8335721|NCT01339403|20548450|P2|NOT COMPLETED|Overall Study||0
8335722|NCT01339403|20548451|P1|NOT COMPLETED|Overall Study||0
8335723|NCT01339403|20548450|P2|COMPLETED|Overall Study||257600
8335724|NCT01339403|20548451|P1|COMPLETED|Overall Study||24768
8335725|NCT01339403|20548450|P2|STARTED|Overall Study||257600
8335726|NCT01339403|20548451|P1|STARTED|Overall Study||24768
8335727|NCT01339390|20548473|P2|NOT COMPLETED|Overall Study||156
8335728|NCT01339390|20548474|P1|NOT COMPLETED|Overall Study||157
8335729|NCT01339390|20548473|P2|COMPLETED|Overall Study||1442
8335730|NCT01339390|20548474|P1|COMPLETED|Overall Study||1414
8335731|NCT01339390|20548473|P2|STARTED|Overall Study||1598
8335732|NCT01339390|20548474|P1|STARTED|Overall Study||1571
8335733|NCT01339299|20548482|P2|NOT COMPLETED|Overall Study||0
8335734|NCT01339299|20548483|P1|NOT COMPLETED|Overall Study||0
8335735|NCT01339299|20548482|P2|COMPLETED|Overall Study||50
8335736|NCT01339299|20548483|P1|COMPLETED|Overall Study||50
8335737|NCT01339299|20548482|P2|STARTED|Overall Study||50
8335738|NCT01339299|20548483|P1|STARTED|Overall Study||50
8335739|NCT01339273|20548491|P2|NOT COMPLETED|Overall Study||8
8335740|NCT01339273|20548492|P1|NOT COMPLETED|Overall Study||8
8335741|NCT01339273|20548491|P2|COMPLETED|Overall Study||28
8335742|NCT01339273|20548492|P1|COMPLETED|Overall Study||28
8335743|NCT01339273|20548491|P2|STARTED|Overall Study||36
8335744|NCT01339273|20548492|P1|STARTED|Overall Study||36
8335745|NCT01339260|20548526|P2|NOT COMPLETED|Multi-cycle Extension||193
8335746|NCT01339260|20548527|P1|NOT COMPLETED|Multi-cycle Extension||186
8335747|NCT01339260|20548526|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
8335748|NCT01339260|20548527|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
8335749|NCT01339260|20548526|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
8335750|NCT01339260|20548527|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
8335751|NCT01339260|20548526|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
8335752|NCT01339260|20548527|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
8335753|NCT01339260|20548526|P2|NOT COMPLETED|Cycle 1||10
8335754|NCT01339260|20548527|P1|NOT COMPLETED|Cycle 1||7
8335755|NCT01339260|20548526|P2|COMPLETED|Cycle 1||719
8335756|NCT01339260|20548527|P1|COMPLETED|Cycle 1||719
8335757|NCT01339260|20548526|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
8335758|NCT01339260|20548527|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
8335759|NCT01339260|20548526|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
8335760|NCT01339260|20548527|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
8335761|NCT01339260|20548526|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
8335762|NCT01339260|20548527|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
8335763|NCT01339247|20548539|P2|NOT COMPLETED|Period 2||0
8335764|NCT01339247|20548540|P1|NOT COMPLETED|Period 2||0
8335765|NCT01339247|20548539|P2|COMPLETED|Period 2||30
8335766|NCT01339247|20548540|P1|COMPLETED|Period 2||30
8335767|NCT01339247|20548539|P2|STARTED|Period 2||30
8335768|NCT01339247|20548540|P1|STARTED|Period 2||30
8335769|NCT01339247|20548539|P2|NOT COMPLETED|Period 1||0
8335770|NCT01339247|20548540|P1|NOT COMPLETED|Period 1||0
8335771|NCT01339247|20548539|P2|COMPLETED|Period 1||30
8335772|NCT01339247|20548540|P1|COMPLETED|Period 1||30
8335773|NCT01339247|20548539|P2|STARTED|Period 1||30
8335774|NCT01339247|20548540|P1|STARTED|Period 1||30
8335775|NCT01339091|20548552|P2|NOT COMPLETED|Overall Study||28
8335776|NCT01339091|20548553|P1|NOT COMPLETED|Overall Study||27
8335777|NCT01339091|20548552|P2|COMPLETED|Overall Study||257
8335778|NCT01339091|20548553|P1|COMPLETED|Overall Study||261
8335779|NCT01339091|20548552|P2|Safety Population|Overall Study||284
8335780|NCT01339091|20548553|P1|Safety Population|Overall Study||284
8335781|NCT01339091|20548552|P2|STARTED|Overall Study||285
8335782|NCT01339091|20548553|P1|STARTED|Overall Study||288
8335783|NCT01339052|20548567|P2|NOT COMPLETED|Overall Study||50
8335784|NCT01339052|20548568|P1|NOT COMPLETED|Overall Study||15
8335785|NCT01339052|20548567|P2|COMPLETED|Overall Study||0
8335786|NCT01339052|20548568|P1|COMPLETED|Overall Study||0
8335787|NCT01339052|20548567|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
8335788|NCT01339052|20548568|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
8335789|NCT01339052|20548567|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
8335790|NCT01339052|20548568|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
8335791|NCT01339052|20548567|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
8335792|NCT01339052|20548568|P1|Measurable Disease|Overall Study||11
8335793|NCT01339052|20548567|P2|STARTED|Overall Study||50
8335794|NCT01339052|20548568|P1|STARTED|Overall Study||15
8335795|NCT01339013|20548588|P1|NOT COMPLETED|Overall Study||0
8335796|NCT01339013|20548588|P1|COMPLETED|Overall Study||6
8335797|NCT01339013|20548588|P1|STARTED|Overall Study||6
8335798|NCT01339000|20548594|P2|NOT COMPLETED|Overall Study||0
8335799|NCT01339000|20548595|P1|NOT COMPLETED|Overall Study||1
8335800|NCT01339000|20548594|P2|COMPLETED|Overall Study||0
8335801|NCT01339000|20548595|P1|COMPLETED|Overall Study||0
8335802|NCT01339000|20548594|P2|STARTED|Overall Study||0
8335803|NCT01339000|20548595|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
8335819|NCT01338870|20548639|P6|NOT COMPLETED|Overall Study||6
8335820|NCT01338870|20548640|P5|NOT COMPLETED|Overall Study||6
8335821|NCT01338870|20548641|P4|NOT COMPLETED|Overall Study||9
8335822|NCT01338870|20548642|P3|NOT COMPLETED|Overall Study||11
8335823|NCT01338870|20548643|P2|NOT COMPLETED|Overall Study||12
8335824|NCT01338870|20548644|P1|NOT COMPLETED|Overall Study||9
8335825|NCT01338870|20548639|P6|COMPLETED|Overall Study||44
8335826|NCT01338870|20548640|P5|COMPLETED|Overall Study||46
8335827|NCT01338870|20548641|P4|COMPLETED|Overall Study||41
8335828|NCT01338870|20548642|P3|COMPLETED|Overall Study||39
8335829|NCT01338870|20548643|P2|COMPLETED|Overall Study||37
8335830|NCT01338870|20548644|P1|COMPLETED|Overall Study||41
8335831|NCT01338870|20548639|P6|STARTED|Overall Study||50
8335832|NCT01338870|20548640|P5|STARTED|Overall Study||52
8335833|NCT01338870|20548641|P4|STARTED|Overall Study||50
8335834|NCT01338870|20548642|P3|STARTED|Overall Study||50
8335835|NCT01338870|20548643|P2|STARTED|Overall Study||49
8335836|NCT01338870|20548644|P1|STARTED|Overall Study||50
8335837|NCT01338857|20548694|P1|NOT COMPLETED|Overall Study||11
8335838|NCT01338857|20548694|P1|COMPLETED|Overall Study||1
8335839|NCT01338857|20548694|P1|STARTED|Overall Study||12
8335840|NCT01338818|20548699|P1|NOT COMPLETED|Overall Study||36
8335841|NCT01338818|20548699|P1|COMPLETED|Overall Study||262
8335842|NCT01338818|20548699|P1|STARTED|Overall Study||298
8335843|NCT01338792|20548705|P1|NOT COMPLETED|Overall Study||4
8335844|NCT01338792|20548705|P1|COMPLETED|Overall Study||43
8335845|NCT01338792|20548705|P1|STARTED|Overall Study||47
8335846|NCT01338649|20548713|P2|NOT COMPLETED|Overall Study||0
8335847|NCT01338649|20548714|P1|NOT COMPLETED|Overall Study||0
8335848|NCT01338649|20548713|P2|COMPLETED|Overall Study||14
8335849|NCT01338649|20548714|P1|COMPLETED|Overall Study||13
8335850|NCT01338649|20548713|P2|STARTED|Overall Study||14
8335851|NCT01338649|20548714|P1|STARTED|Overall Study||13
8335852|NCT01338636|20548720|P1|NOT COMPLETED|Overall Study||8
8335853|NCT01338636|20548720|P1|COMPLETED|Overall Study||22
8335854|NCT01338636|20548720|P1|STARTED|Overall Study||30
8335855|NCT01338610|20548734|P3|NOT COMPLETED|Overall Study||1
8335856|NCT01338610|20548735|P2|NOT COMPLETED|Overall Study||1
8335857|NCT01338610|20548736|P1|NOT COMPLETED|Overall Study||5
8335858|NCT01338610|20548734|P3|COMPLETED|Overall Study||28
8335859|NCT01338610|20548735|P2|COMPLETED|Overall Study||55
8335860|NCT01338610|20548736|P1|COMPLETED|Overall Study||34
8335861|NCT01338610|20548734|P3|STARTED|Overall Study||29
8335862|NCT01338610|20548735|P2|STARTED|Overall Study||56
8335863|NCT01338610|20548736|P1|STARTED|Overall Study||39
8335864|NCT01338506|20548745|P2|NOT COMPLETED|Overall Study||14
8335865|NCT01338506|20548746|P1|NOT COMPLETED|Overall Study||25
8335866|NCT01338506|20548745|P2|COMPLETED|Overall Study||13
8335867|NCT01338506|20548746|P1|COMPLETED|Overall Study||29
8335868|NCT01338506|20548745|P2|STARTED|Overall Study||27
8335869|NCT01338506|20548746|P1|STARTED|Overall Study||54
8335870|NCT01338493|20548762|P1|NOT COMPLETED|24 Months Follow up||0
8335871|NCT01338493|20548762|P1|COMPLETED|24 Months Follow up||104
8335872|NCT01338493|20548762|P1|STARTED|24 Months Follow up||104
8335873|NCT01338493|20548762|P1|NOT COMPLETED|12 Months Follow up||9
8335874|NCT01338493|20548762|P1|COMPLETED|12 Months Follow up||104
8335875|NCT01338493|20548762|P1|STARTED|12 Months Follow up||113
8335876|NCT01338493|20548762|P1|NOT COMPLETED|6 Months Follow up||19
8335877|NCT01338493|20548762|P1|COMPLETED|6 Months Follow up||113
8335878|NCT01338493|20548762|P1|STARTED|6 Months Follow up||132
8335879|NCT01338493|20548762|P1|NOT COMPLETED|Discharge||2
8335880|NCT01338493|20548762|P1|COMPLETED|Discharge||132
8335881|NCT01338493|20548762|P1|STARTED|Discharge||134
8335882|NCT01338493|20548762|P1|NOT COMPLETED|Implant||0
8335883|NCT01338493|20548762|P1|COMPLETED|Implant||134
8335884|NCT01338493|20548762|P1|STARTED|Implant||134
8335885|NCT01338493|20548762|P1|NOT COMPLETED|Enrolled||5
8335886|NCT01338493|20548762|P1|COMPLETED|Enrolled||134
8335887|NCT01338493|20548762|P1|STARTED|Enrolled||139
8335888|NCT01338415|20548769|P2|NOT COMPLETED|Overall Study||9
8335889|NCT01338415|20548770|P1|NOT COMPLETED|Overall Study||10
8335890|NCT01338415|20548769|P2|COMPLETED|Overall Study||22
8335891|NCT01338415|20548770|P1|COMPLETED|Overall Study||23
8335892|NCT01338415|20548769|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
8335893|NCT01338415|20548770|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
8335894|NCT01338415|20548769|P2|STARTED|Overall Study||31
8335895|NCT01338415|20548770|P1|STARTED|Overall Study||33
8335896|NCT01338298|20548792|P2|NOT COMPLETED|Overall Study||3
8335897|NCT01338298|20548793|P1|NOT COMPLETED|Overall Study||4
8335898|NCT01338298|20548792|P2|COMPLETED|Overall Study||15
8335899|NCT01338298|20548793|P1|COMPLETED|Overall Study||20
8335900|NCT01338298|20548792|P2|STARTED|Overall Study||18
8335901|NCT01338298|20548793|P1|STARTED|Overall Study||24
8335902|NCT01338025|20548803|P2|NOT COMPLETED|Overall Study||11
8335903|NCT01338025|20548804|P1|NOT COMPLETED|Overall Study||11
8335904|NCT01338025|20548803|P2|COMPLETED|Overall Study||6
8335905|NCT01338025|20548804|P1|COMPLETED|Overall Study||5
8335906|NCT01338025|20548803|P2|STARTED|Overall Study||17
8335907|NCT01338025|20548804|P1|STARTED|Overall Study||16
8335908|NCT01338012|20548816|P1|NOT COMPLETED|Overall Study||8
8335909|NCT01338012|20548816|P1|COMPLETED|Overall Study||0
8335910|NCT01338012|20548816|P1|STARTED|Overall Study||8
8335911|NCT01337986|20548822|P2|NOT COMPLETED|Overall Study||5
8335912|NCT01337986|20548823|P1|NOT COMPLETED|Overall Study||3
8335913|NCT01337986|20548822|P2|COMPLETED|Overall Study||18
8335914|NCT01337986|20548823|P1|COMPLETED|Overall Study||20
8335915|NCT01337986|20548822|P2|STARTED|Overall Study||23
8335916|NCT01337986|20548823|P1|STARTED|Overall Study||23
8335917|NCT01337973|20548860|P3|NOT COMPLETED|Overall Study||11
8335918|NCT01337973|20548861|P2|NOT COMPLETED|Overall Study||15
8335919|NCT01337973|20548862|P1|NOT COMPLETED|Overall Study||16
8335920|NCT01337973|20548860|P3|COMPLETED|Overall Study||49
8335921|NCT01337973|20548861|P2|COMPLETED|Overall Study||45
8335922|NCT01337973|20548862|P1|COMPLETED|Overall Study||44
8335923|NCT01337973|20548860|P3|STARTED|Overall Study||60
8335924|NCT01337973|20548861|P2|STARTED|Overall Study||60
8335925|NCT01337973|20548862|P1|STARTED|Overall Study||60
8335926|NCT01337960|20548876|P3|NOT COMPLETED|Overall Study||0
8335927|NCT01337960|20548877|P2|NOT COMPLETED|Overall Study||0
8335928|NCT01337960|20548878|P1|NOT COMPLETED|Overall Study||2
8335929|NCT01337960|20548876|P3|COMPLETED|Overall Study||6
8335930|NCT01337960|20548877|P2|COMPLETED|Overall Study||14
8335931|NCT01337960|20548878|P1|COMPLETED|Overall Study||12
8335932|NCT01337960|20548876|P3|STARTED|Overall Study||6
8335933|NCT01337960|20548877|P2|STARTED|Overall Study||14
8335934|NCT01337960|20548878|P1|STARTED|Overall Study||14
8335935|NCT01337739|20548900|P2|NOT COMPLETED|Overall Study||0
8335936|NCT01337739|20548901|P1|NOT COMPLETED|Overall Study||0
8335937|NCT01337739|20548900|P2|COMPLETED|Overall Study||4
8335938|NCT01337739|20548901|P1|COMPLETED|Overall Study||6
8335939|NCT01337739|20548900|P2|STARTED|Overall Study||4
8335940|NCT01337739|20548901|P1|STARTED|Overall Study||6
8335941|NCT01337700|20548911|P2|NOT COMPLETED|Overall Study||0
8335942|NCT01337700|20548912|P1|NOT COMPLETED|Overall Study||0
8335943|NCT01337700|20548911|P2|COMPLETED|Overall Study||5
8335944|NCT01337700|20548912|P1|COMPLETED|Overall Study||5
8335945|NCT01337700|20548911|P2|STARTED|Overall Study||5
8335946|NCT01337700|20548912|P1|STARTED|Overall Study||5
8335947|NCT01337687|20548928|P2|NOT COMPLETED|Overall Study||0
8335948|NCT01337687|20548929|P1|NOT COMPLETED|Overall Study||0
8335949|NCT01337687|20548928|P2|COMPLETED|Overall Study||9
8335950|NCT01337687|20548929|P1|COMPLETED|Overall Study||10
8335951|NCT01337687|20548928|P2|STARTED|Overall Study||9
8335952|NCT01337687|20548929|P1|STARTED|Overall Study||10
8335953|NCT01337674|20548943|P4|NOT COMPLETED|Treatment Period 2||0
8335954|NCT01337674|20548944|P3|NOT COMPLETED|Treatment Period 2||1
8335955|NCT01337674|20548945|P2|NOT COMPLETED|Treatment Period 2||0
8335956|NCT01337674|20548946|P1|NOT COMPLETED|Treatment Period 2||0
8335957|NCT01337674|20548943|P4|COMPLETED|Treatment Period 2||6
8335958|NCT01337674|20548944|P3|COMPLETED|Treatment Period 2||5
8335959|NCT01337674|20548945|P2|COMPLETED|Treatment Period 2||6
8335960|NCT01337674|20548946|P1|COMPLETED|Treatment Period 2||6
8335961|NCT01337674|20548943|P4|STARTED|Treatment Period 2||6
8335962|NCT01337674|20548944|P3|STARTED|Treatment Period 2||6
8335963|NCT01337674|20548945|P2|STARTED|Treatment Period 2||6
8335964|NCT01337674|20548946|P1|STARTED|Treatment Period 2||6
8335965|NCT01337674|20548943|P4|NOT COMPLETED|Two-week Washout Period||0
8335966|NCT01337674|20548944|P3|NOT COMPLETED|Two-week Washout Period||0
8335967|NCT01337674|20548945|P2|NOT COMPLETED|Two-week Washout Period||0
8335968|NCT01337674|20548946|P1|NOT COMPLETED|Two-week Washout Period||0
8335969|NCT01337674|20548943|P4|COMPLETED|Two-week Washout Period||6
8335970|NCT01337674|20548944|P3|COMPLETED|Two-week Washout Period||6
8335971|NCT01337674|20548945|P2|COMPLETED|Two-week Washout Period||6
8335972|NCT01337674|20548946|P1|COMPLETED|Two-week Washout Period||6
8335973|NCT01337674|20548943|P4|STARTED|Two-week Washout Period||6
8335974|NCT01337674|20548944|P3|STARTED|Two-week Washout Period||6
8335975|NCT01337674|20548945|P2|STARTED|Two-week Washout Period||6
8335976|NCT01337674|20548946|P1|STARTED|Two-week Washout Period||6
8335977|NCT01337674|20548943|P4|NOT COMPLETED|Treatment Period 1||1
8335978|NCT01337674|20548944|P3|NOT COMPLETED|Treatment Period 1||0
8335979|NCT01337674|20548945|P2|NOT COMPLETED|Treatment Period 1||1
8335980|NCT01337674|20548946|P1|NOT COMPLETED|Treatment Period 1||0
8335981|NCT01337674|20548943|P4|COMPLETED|Treatment Period 1||6
8335982|NCT01337674|20548944|P3|COMPLETED|Treatment Period 1||6
8335983|NCT01337674|20548945|P2|COMPLETED|Treatment Period 1||6
8335984|NCT01337674|20548946|P1|COMPLETED|Treatment Period 1||6
8335985|NCT01337674|20548943|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
8335986|NCT01337674|20548944|P3|STARTED|Treatment Period 1||6
8335987|NCT01337674|20548945|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
8335988|NCT01337674|20548946|P1|STARTED|Treatment Period 1||6
8335989|NCT01337635|20548964|P2|NOT COMPLETED|Overall Study||1
8335990|NCT01337635|20548965|P1|NOT COMPLETED|Overall Study||0
8335991|NCT01337635|20548964|P2|COMPLETED|Overall Study||3
8335992|NCT01337635|20548965|P1|COMPLETED|Overall Study||3
8335993|NCT01337635|20548964|P2|STARTED|Overall Study||4
8335994|NCT01337635|20548965|P1|STARTED|Overall Study||3
8335995|NCT01337609|20548976|P3|NOT COMPLETED|Overall Study||0
8335996|NCT01337609|20548977|P2|NOT COMPLETED|Overall Study||0
8335997|NCT01337609|20548978|P1|NOT COMPLETED|Overall Study||1
8335998|NCT01337609|20548976|P3|COMPLETED|Overall Study||2
8335999|NCT01337609|20548977|P2|COMPLETED|Overall Study||2
8336000|NCT01337609|20548978|P1|COMPLETED|Overall Study||0
8336001|NCT01337609|20548976|P3|STARTED|Overall Study||2
8336002|NCT01337609|20548977|P2|STARTED|Overall Study||2
8336003|NCT01337609|20548978|P1|STARTED|Overall Study||1
8336004|NCT01337596|20549007|P9|NOT COMPLETED|Overall Study||0
8336005|NCT01337596|20549008|P8|NOT COMPLETED|Overall Study||0
8336006|NCT01337596|20549009|P7|NOT COMPLETED|Overall Study||0
8336007|NCT01337596|20549010|P6|NOT COMPLETED|Overall Study||0
8336008|NCT01337596|20549011|P5|NOT COMPLETED|Overall Study||2
8336009|NCT01337596|20549012|P4|NOT COMPLETED|Overall Study||0
8336010|NCT01337596|20549013|P3|NOT COMPLETED|Overall Study||0
8336011|NCT01337596|20549014|P2|NOT COMPLETED|Overall Study||0
8336012|NCT01337596|20549015|P1|NOT COMPLETED|Overall Study||0
8336013|NCT01337596|20549007|P9|COMPLETED|Overall Study||7
8336014|NCT01337596|20549008|P8|COMPLETED|Overall Study||2
8336015|NCT01337596|20549009|P7|COMPLETED|Overall Study||12
8336016|NCT01337596|20549010|P6|COMPLETED|Overall Study||7
8336017|NCT01337596|20549011|P5|COMPLETED|Overall Study||5
8336018|NCT01337596|20549012|P4|COMPLETED|Overall Study||7
8336019|NCT01337596|20549013|P3|COMPLETED|Overall Study||7
8336020|NCT01337596|20549014|P2|COMPLETED|Overall Study||7
8336021|NCT01337596|20549015|P1|COMPLETED|Overall Study||7
8336022|NCT01337596|20549007|P9|Safety Population|Overall Study||7
8336023|NCT01337596|20549008|P8|Safety Population|Overall Study||2
8336024|NCT01337596|20549009|P7|Safety Population|Overall Study||12
8336025|NCT01337596|20549010|P6|Safety Population|Overall Study||7
8336026|NCT01337596|20549011|P5|Safety Population|Overall Study||7
8336027|NCT01337596|20549012|P4|Safety Population|Overall Study||7
8336028|NCT01337596|20549013|P3|Safety Population|Overall Study||7
8336029|NCT01337596|20549014|P2|Safety Population|Overall Study||7
8336030|NCT01337596|20549015|P1|Safety Population|Overall Study||7
8336031|NCT01337596|20549007|P9|STARTED|Overall Study||7
8336032|NCT01337596|20549008|P8|STARTED|Overall Study||2
8336033|NCT01337596|20549009|P7|STARTED|Overall Study||12
8336034|NCT01337596|20549010|P6|STARTED|Overall Study||7
8336035|NCT01337596|20549011|P5|STARTED|Overall Study||7
8336036|NCT01337596|20549012|P4|STARTED|Overall Study||7
8336037|NCT01337596|20549013|P3|STARTED|Overall Study||7
8336038|NCT01337596|20549014|P2|STARTED|Overall Study||7
8336039|NCT01337596|20549015|P1|STARTED|Overall Study||7
8336040|NCT01337336|20549051|P2|NOT COMPLETED|Overall Study||0
8336041|NCT01337336|20549052|P1|NOT COMPLETED|Overall Study||0
8336042|NCT01337336|20549051|P2|COMPLETED|Overall Study||2923
8336043|NCT01337336|20549052|P1|COMPLETED|Overall Study||1078
8336044|NCT01337336|20549051|P2|STARTED|Overall Study||2923
8336045|NCT01337336|20549052|P1|STARTED|Overall Study||1078
8336046|NCT01337297|20549066|P2|NOT COMPLETED|Overall Study||6
8336047|NCT01337297|20549067|P1|NOT COMPLETED|Overall Study||5
8336048|NCT01337297|20549066|P2|COMPLETED|Overall Study||3
8336049|NCT01337297|20549067|P1|COMPLETED|Overall Study||6
8336050|NCT01337297|20549066|P2|STARTED|Overall Study||9
8336051|NCT01337297|20549067|P1|STARTED|Overall Study||11
8336052|NCT01337167|20549075|P2|NOT COMPLETED|Toddler Vaccinations||13
8336053|NCT01337167|20549076|P1|NOT COMPLETED|Toddler Vaccinations||14
8336054|NCT01337167|20549075|P2|COMPLETED|Toddler Vaccinations||407
8336055|NCT01337167|20549076|P1|COMPLETED|Toddler Vaccinations||829
8336056|NCT01337167|20549075|P2|STARTED|Toddler Vaccinations||420
8336057|NCT01337167|20549076|P1|STARTED|Toddler Vaccinations||843
8336058|NCT01337167|20549075|P2|NOT COMPLETED|Interim Period||40
8336059|NCT01337167|20549076|P1|NOT COMPLETED|Interim Period||81
8336060|NCT01337167|20549075|P2|COMPLETED|Interim Period||420
8336061|NCT01337167|20549076|P1|COMPLETED|Interim Period||843
8336062|NCT01337167|20549075|P2|STARTED|Interim Period||460
8336063|NCT01337167|20549076|P1|STARTED|Interim Period||924
8336064|NCT01337167|20549075|P2|NOT COMPLETED|Infant Series||27
8336065|NCT01337167|20549076|P1|NOT COMPLETED|Infant Series||62
8336066|NCT01337167|20549075|P2|COMPLETED|Infant Series||460
8336067|NCT01337167|20549076|P1|COMPLETED|Infant Series||924
8336068|NCT01337167|20549075|P2|STARTED|Infant Series||487
8336069|NCT01337167|20549076|P1|STARTED|Infant Series||986
8336070|NCT01337115|20549144|P2|NOT COMPLETED|Overall Study||0
8336071|NCT01337115|20549145|P1|NOT COMPLETED|Overall Study||2
8336072|NCT01337115|20549144|P2|COMPLETED|Overall Study||25
8336073|NCT01337115|20549145|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
8336074|NCT01337115|20549144|P2|STARTED|Overall Study||25
8336075|NCT01337115|20549145|P1|STARTED|Overall Study||25
8336076|NCT01337089|20549157|P1|NOT COMPLETED|Overall Study||404
8336077|NCT01337089|20549157|P1|COMPLETED|Overall Study||256
8336078|NCT01337089|20549157|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
8336079|NCT01337089|20549157|P1|Safety Population|Overall Study||660
8336080|NCT01337089|20549157|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
8336081|NCT01337089|20549157|P1|STARTED|Overall Study||660
8336082|NCT01337076|20549165|P1|NOT COMPLETED|Overall Study||2
8336083|NCT01337076|20549165|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
8336084|NCT01337076|20549165|P1|STARTED|Overall Study|subjects implanted|21
8336085|NCT01337050|20549172|P3|NOT COMPLETED|Overall Study||19
8336086|NCT01337050|20549173|P2|NOT COMPLETED|Overall Study||13
8336087|NCT01337050|20549174|P1|NOT COMPLETED|Overall Study||4
8336088|NCT01337050|20549172|P3|COMPLETED|Overall Study||0
8336089|NCT01337050|20549173|P2|COMPLETED|Overall Study||0
8336090|NCT01337050|20549174|P1|COMPLETED|Overall Study||0
8336091|NCT01337050|20549172|P3|STARTED|Overall Study||19
8336092|NCT01337050|20549173|P2|STARTED|Overall Study||13
8336093|NCT01337050|20549174|P1|STARTED|Overall Study||4
8336094|NCT01336972|20549235|P3|NOT COMPLETED|Overall Study||0
8336095|NCT01336972|20549236|P2|NOT COMPLETED|Overall Study||1
8336096|NCT01336972|20549237|P1|NOT COMPLETED|Overall Study||1
8336097|NCT01336972|20549235|P3|COMPLETED|Overall Study||9
8336098|NCT01336972|20549236|P2|COMPLETED|Overall Study||9
8336099|NCT01336972|20549237|P1|COMPLETED|Overall Study||9
8336100|NCT01336972|20549235|P3|STARTED|Overall Study||9
8336101|NCT01336972|20549236|P2|STARTED|Overall Study||10
8336102|NCT01336972|20549237|P1|STARTED|Overall Study||10
8336103|NCT01336959|20549275|P3|NOT COMPLETED|Overall Study||1
8336104|NCT01336959|20549276|P2|NOT COMPLETED|Overall Study||5
8336105|NCT01336959|20549277|P1|NOT COMPLETED|Overall Study||0
8336106|NCT01336959|20549275|P3|COMPLETED|Overall Study||40
8336107|NCT01336959|20549276|P2|COMPLETED|Overall Study||37
8336108|NCT01336959|20549277|P1|COMPLETED|Overall Study||8
8336109|NCT01336959|20549275|P3|STARTED|Overall Study||41
8336110|NCT01336959|20549276|P2|STARTED|Overall Study||42
8336111|NCT01336959|20549277|P1|STARTED|Overall Study||8
8336112|NCT01336933|20549288|P1|NOT COMPLETED|Overall Study||1
8336113|NCT01336933|20549288|P1|COMPLETED|Overall Study||33
8336114|NCT01336933|20549288|P1|STARTED|Overall Study||34
8336115|NCT01336894|20549299|P2|NOT COMPLETED|Follow-up||7
8336116|NCT01336894|20549300|P1|NOT COMPLETED|Follow-up||2
8336117|NCT01336894|20549299|P2|COMPLETED|Follow-up||0
8336118|NCT01336894|20549300|P1|COMPLETED|Follow-up||2
8336119|NCT01336894|20549299|P2|STARTED|Follow-up||7
8336120|NCT01336894|20549300|P1|STARTED|Follow-up||4
8336121|NCT01336894|20549299|P2|NOT COMPLETED|Protocol Interventions||0
8336122|NCT01336894|20549300|P1|NOT COMPLETED|Protocol Interventions||0
8336123|NCT01336894|20549299|P2|COMPLETED|Protocol Interventions||7
8336124|NCT01336894|20549300|P1|COMPLETED|Protocol Interventions||4
8336125|NCT01336894|20549299|P2|STARTED|Protocol Interventions||7
8336126|NCT01336894|20549300|P1|STARTED|Protocol Interventions||4
8336127|NCT01336803|20549318|P1|NOT COMPLETED|Overall Study||0
8336128|NCT01336803|20549318|P1|COMPLETED|Overall Study||21
8336129|NCT01336803|20549318|P1|Lymphoma|Overall Study||7
8336130|NCT01336803|20549318|P1|Osteomyelitis|Overall Study||4
8336131|NCT01336803|20549318|P1|Bone Sarcoma|Overall Study||10
8336132|NCT01336803|20549318|P1|STARTED|Overall Study||21
8336133|NCT01336764|20549332|P2|NOT COMPLETED|Overall Study||5
8336134|NCT01336764|20549333|P1|NOT COMPLETED|Overall Study||5
8336135|NCT01336764|20549332|P2|COMPLETED|Overall Study||5
8336136|NCT01336764|20549333|P1|COMPLETED|Overall Study||7
8336137|NCT01336764|20549332|P2|STARTED|Overall Study||10
8336138|NCT01336764|20549333|P1|STARTED|Overall Study||12
8336139|NCT01336738|20549344|P5|NOT COMPLETED|Overall Study||10
8336140|NCT01336738|20549345|P4|NOT COMPLETED|Overall Study||7
8336141|NCT01336738|20549346|P3|NOT COMPLETED|Overall Study||8
8336142|NCT01336738|20549347|P2|NOT COMPLETED|Overall Study||9
8336143|NCT01336738|20549348|P1|NOT COMPLETED|Overall Study||7
8336144|NCT01336738|20549344|P5|COMPLETED|Overall Study||43
8336145|NCT01336738|20549345|P4|COMPLETED|Overall Study||47
8336146|NCT01336738|20549346|P3|COMPLETED|Overall Study||45
8336147|NCT01336738|20549347|P2|COMPLETED|Overall Study||45
8336148|NCT01336738|20549348|P1|COMPLETED|Overall Study||45
8336149|NCT01336738|20549344|P5|STARTED|Overall Study||53
8336150|NCT01336738|20549345|P4|STARTED|Overall Study||54
8336151|NCT01336738|20549346|P3|STARTED|Overall Study||53
8336152|NCT01336738|20549347|P2|STARTED|Overall Study||54
8336153|NCT01336738|20549348|P1|STARTED|Overall Study||52
8336154|NCT01336712|20549390|P1|NOT COMPLETED|Overall Study||3
8336155|NCT01336712|20549390|P1|COMPLETED|Overall Study||27
8336156|NCT01336712|20549390|P1|STARTED|Overall Study||30
8336157|NCT01336647|20549403|P3|NOT COMPLETED|Overall Study||3
8336158|NCT01336647|20549404|P2|NOT COMPLETED|Overall Study||1
8336159|NCT01336647|20549405|P1|NOT COMPLETED|Overall Study||4
8336160|NCT01336647|20549403|P3|COMPLETED|Overall Study||44
8336161|NCT01336647|20549404|P2|COMPLETED|Overall Study||48
8336162|NCT01336647|20549405|P1|COMPLETED|Overall Study||42
8336163|NCT01336647|20549403|P3|STARTED|Overall Study||47
8336164|NCT01336647|20549404|P2|STARTED|Overall Study||49
8336165|NCT01336647|20549405|P1|STARTED|Overall Study||46
8336166|NCT01336621|20549416|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
8336167|NCT01336621|20549416|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
8336168|NCT01336621|20549416|P1|STARTED|SFUCP (up to 2.6 Years)||9
8336169|NCT01336621|20549416|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
8336170|NCT01336621|20549416|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
8336171|NCT01336621|20549416|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
8336172|NCT01336608|20549466|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
8336173|NCT01336608|20549467|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
8336174|NCT01336608|20549468|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
8336175|NCT01336608|20549469|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8336176|NCT01336608|20549466|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
8336177|NCT01336608|20549467|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
8336178|NCT01336608|20549468|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
8336179|NCT01336608|20549469|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8336180|NCT01336608|20549466|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
8336181|NCT01336608|20549467|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
8336182|NCT01336608|20549468|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
8336183|NCT01336608|20549469|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
8336184|NCT01336608|20549466|P4|STARTED|24-week, Double-blind Treatment Period||135
8336185|NCT01336608|20549467|P3|STARTED|24-week, Double-blind Treatment Period||154
8336186|NCT01336608|20549468|P2|STARTED|24-week, Double-blind Treatment Period||141
8336187|NCT01336608|20549469|P1|STARTED|24-week, Double-blind Treatment Period||0
8336188|NCT01336608|20549466|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8336189|NCT01336608|20549467|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8336190|NCT01336608|20549468|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8336191|NCT01336608|20549469|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
8336192|NCT01336608|20549466|P4|COMPLETED|2-week, Single-blind Run-In Period||0
8336193|NCT01336608|20549467|P3|COMPLETED|2-week, Single-blind Run-In Period||0
8336194|NCT01336608|20549468|P2|COMPLETED|2-week, Single-blind Run-In Period||0
8336195|NCT01336608|20549469|P1|COMPLETED|2-week, Single-blind Run-In Period||444
8336196|NCT01336608|20549466|P4|STARTED|2-week, Single-blind Run-In Period||0
8336197|NCT01336608|20549467|P3|STARTED|2-week, Single-blind Run-In Period||0
8336198|NCT01336608|20549468|P2|STARTED|2-week, Single-blind Run-In Period||0
8336199|NCT01336608|20549469|P1|STARTED|2-week, Single-blind Run-In Period||559
8336200|NCT01336569|20549483|P1|NOT COMPLETED|Overall Study||4
8336201|NCT01336569|20549483|P1|COMPLETED|Overall Study||45
8336202|NCT01336569|20549483|P1|STARTED|Overall Study||49
8336203|NCT01336413|20549489|P2|NOT COMPLETED|Overall Study||8
8336204|NCT01336413|20549490|P1|NOT COMPLETED|Overall Study||1
8336205|NCT01336413|20549489|P2|COMPLETED|Overall Study||18
8336206|NCT01336413|20549490|P1|COMPLETED|Overall Study||26
8336207|NCT01336413|20549489|P2|STARTED|Overall Study||26
8336208|NCT01336413|20549490|P1|STARTED|Overall Study||27
8336209|NCT01336296|20549514|P2|NOT COMPLETED|Overall Study||4
8336210|NCT01336296|20549515|P1|NOT COMPLETED|Overall Study||5
8336211|NCT01336296|20549514|P2|COMPLETED|Overall Study||17
8336212|NCT01336296|20549515|P1|COMPLETED|Overall Study||35
8336213|NCT01336296|20549514|P2|STARTED|Overall Study||21
8336214|NCT01336296|20549515|P1|STARTED|Overall Study||40
8336215|NCT01336205|20549531|P2|NOT COMPLETED|Overall Study||89
8336216|NCT01336205|20549532|P1|NOT COMPLETED|Overall Study||233
8336217|NCT01336205|20549531|P2|COMPLETED|Overall Study||192
8336218|NCT01336205|20549532|P1|COMPLETED|Overall Study||330
8336219|NCT01336205|20549531|P2|STARTED|Overall Study||281
8336220|NCT01336205|20549532|P1|STARTED|Overall Study||563
8336221|NCT01336140|20549544|P2|NOT COMPLETED|Overall Study||0
8336222|NCT01336140|20549545|P1|NOT COMPLETED|Overall Study||0
8336223|NCT01336140|20549544|P2|COMPLETED|Overall Study||150
8336224|NCT01336140|20549545|P1|COMPLETED|Overall Study||150
8336225|NCT01336140|20549544|P2|STARTED|Overall Study||150
8336226|NCT01336140|20549545|P1|STARTED|Overall Study||150
8336227|NCT01336023|20549560|P3|NOT COMPLETED|Week 27 to 52||28
8336228|NCT01336023|20549561|P2|NOT COMPLETED|Week 27 to 52||44
8336229|NCT01336023|20549562|P1|NOT COMPLETED|Week 27 to 52||28
8336230|NCT01336023|20549560|P3|COMPLETED|Week 27 to 52||285
8336231|NCT01336023|20549561|P2|COMPLETED|Week 27 to 52||621
8336232|NCT01336023|20549562|P1|COMPLETED|Week 27 to 52||305
8336233|NCT01336023|20549560|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
8336234|NCT01336023|20549561|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
8336235|NCT01336023|20549562|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
8336236|NCT01336023|20549560|P3|NOT COMPLETED|Week 0 to Week 26||73
8336237|NCT01336023|20549561|P2|NOT COMPLETED|Week 0 to Week 26||98
8336238|NCT01336023|20549562|P1|NOT COMPLETED|Week 0 to Week 26||48
8336239|NCT01336023|20549560|P3|COMPLETED|Week 0 to Week 26||342
8336240|NCT01336023|20549561|P2|COMPLETED|Week 0 to Week 26||736
8336241|NCT01336023|20549562|P1|COMPLETED|Week 0 to Week 26||366
8336242|NCT01336023|20549560|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
8336243|NCT01336023|20549561|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
8336244|NCT01336023|20549562|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
8336245|NCT01336023|20549560|P3|STARTED|Week 0 to Week 26||415
8336246|NCT01336023|20549561|P2|STARTED|Week 0 to Week 26||834
8336247|NCT01336023|20549562|P1|STARTED|Week 0 to Week 26||414
8336248|NCT01335997|20549583|P2|NOT COMPLETED|Period III||79
8336249|NCT01335997|20549584|P1|NOT COMPLETED|Period III||78
8336250|NCT01335997|20549583|P2|COMPLETED|Period III||4
8336251|NCT01335997|20549584|P1|COMPLETED|Period III||6
8336252|NCT01335997|20549583|P2|STARTED|Period III||83
8336253|NCT01335997|20549584|P1|STARTED|Period III||84
8336254|NCT01335997|20549583|P2|NOT COMPLETED|Period I and II||479
8336255|NCT01335997|20549584|P1|NOT COMPLETED|Period I and II||493
8336256|NCT01335997|20549583|P2|COMPLETED|Period I and II||83
8336257|NCT01335997|20549584|P1|COMPLETED|Period I and II||84
8336258|NCT01335997|20549583|P2|STARTED|Period I and II||562
8336259|NCT01335997|20549584|P1|STARTED|Period I and II||577
8336260|NCT01335971|20549597|P3|NOT COMPLETED|Overall Study||1
8336261|NCT01335971|20549598|P2|NOT COMPLETED|Overall Study||1
8336262|NCT01335971|20549599|P1|NOT COMPLETED|Overall Study||2
8336263|NCT01335971|20549597|P3|COMPLETED|Overall Study||28
8336264|NCT01335971|20549598|P2|COMPLETED|Overall Study||28
8336265|NCT01335971|20549599|P1|COMPLETED|Overall Study||29
8336266|NCT01335971|20549597|P3|STARTED|Overall Study||29
8336267|NCT01335971|20549598|P2|STARTED|Overall Study||29
8336268|NCT01335971|20549599|P1|STARTED|Overall Study||31
8336269|NCT01335932|20549636|P2|NOT COMPLETED|Overall Study||4
8336270|NCT01335932|20549637|P1|NOT COMPLETED|Overall Study||0
8336271|NCT01335932|20549636|P2|COMPLETED|Overall Study||72
8336272|NCT01335932|20549637|P1|COMPLETED|Overall Study||84
8336273|NCT01335932|20549636|P2|STARTED|Overall Study||76
8336274|NCT01335932|20549637|P1|STARTED|Overall Study||84
8336275|NCT01335867|20549777|P2|NOT COMPLETED|Overall Study||4
8336276|NCT01335867|20549778|P1|NOT COMPLETED|Overall Study||7
8336277|NCT01335867|20549777|P2|COMPLETED|Overall Study||12
8336278|NCT01335867|20549778|P1|COMPLETED|Overall Study||9
8336279|NCT01335867|20549777|P2|STARTED|Overall Study||16
8336280|NCT01335867|20549778|P1|STARTED|Overall Study||16
8336281|NCT01335789|20549794|P2|NOT COMPLETED|Overall Study||0
8336282|NCT01335789|20549795|P1|NOT COMPLETED|Overall Study||0
8336283|NCT01335789|20549794|P2|COMPLETED|Overall Study||8
8336284|NCT01335789|20549795|P1|COMPLETED|Overall Study||8
8336285|NCT01335789|20549794|P2|STARTED|Overall Study||8
8336286|NCT01335789|20549795|P1|STARTED|Overall Study||8
8336287|NCT01335750|20549805|P1|NOT COMPLETED|Overall Study||0
8336288|NCT01335750|20549805|P1|COMPLETED|Overall Study||32
8336289|NCT01335750|20549805|P1|STARTED|Overall Study||32
8336290|NCT01335724|20549826|P2|NOT COMPLETED|Overall Study||0
8336291|NCT01335724|20549827|P1|NOT COMPLETED|Overall Study||0
8336292|NCT01335724|20549826|P2|COMPLETED|Overall Study||36
8336293|NCT01335724|20549827|P1|COMPLETED|Overall Study||36
8336294|NCT01335724|20549826|P2|STARTED|Overall Study||36
8336295|NCT01335724|20549827|P1|STARTED|Overall Study||36
8336296|NCT01335698|20549842|P5|NOT COMPLETED|Treatment Stage 2||1
8336297|NCT01335698|20549843|P4|NOT COMPLETED|Treatment Stage 2||8
8336298|NCT01335698|20549844|P3|NOT COMPLETED|Treatment Stage 2||5
8336299|NCT01335698|20549845|P2|NOT COMPLETED|Treatment Stage 2||3
8336300|NCT01335698|20549846|P1|NOT COMPLETED|Treatment Stage 2||11
8336301|NCT01335698|20549842|P5|COMPLETED|Treatment Stage 2||5
8336302|NCT01335698|20549843|P4|COMPLETED|Treatment Stage 2||18
8336303|NCT01335698|20549844|P3|COMPLETED|Treatment Stage 2||11
8336304|NCT01335698|20549845|P2|COMPLETED|Treatment Stage 2||1
8336305|NCT01335698|20549846|P1|COMPLETED|Treatment Stage 2||4
8336306|NCT01335698|20549842|P5|STARTED|Treatment Stage 2||6
8336307|NCT01335698|20549843|P4|STARTED|Treatment Stage 2||26
8336308|NCT01335698|20549844|P3|STARTED|Treatment Stage 2||16
8336309|NCT01335698|20549845|P2|STARTED|Treatment Stage 2||4
8336310|NCT01335698|20549846|P1|STARTED|Treatment Stage 2||15
8336311|NCT01335698|20549842|P5|NOT COMPLETED|Treatment Stage 1||2
8336312|NCT01335698|20549843|P4|NOT COMPLETED|Treatment Stage 1||9
8336313|NCT01335698|20549844|P3|NOT COMPLETED|Treatment Stage 1||5
8336314|NCT01335698|20549845|P2|NOT COMPLETED|Treatment Stage 1||8
8336315|NCT01335698|20549846|P1|NOT COMPLETED|Treatment Stage 1||8
8336316|NCT01335698|20549842|P5|COMPLETED|Treatment Stage 1||6
8336317|NCT01335698|20549843|P4|COMPLETED|Treatment Stage 1||26
8336318|NCT01335698|20549844|P3|COMPLETED|Treatment Stage 1||16
8336319|NCT01335698|20549845|P2|COMPLETED|Treatment Stage 1||4
8336320|NCT01335698|20549846|P1|COMPLETED|Treatment Stage 1||15
8336321|NCT01335698|20549842|P5|STARTED|Treatment Stage 1||8
8336322|NCT01335698|20549843|P4|STARTED|Treatment Stage 1||35
8336323|NCT01335698|20549844|P3|STARTED|Treatment Stage 1||21
8336324|NCT01335698|20549845|P2|STARTED|Treatment Stage 1||12
8336325|NCT01335698|20549846|P1|STARTED|Treatment Stage 1||23
8336326|NCT01335685|20549911|P8|NOT COMPLETED|Overall Study||3
8336327|NCT01335685|20549912|P7|NOT COMPLETED|Overall Study||2
8336328|NCT01335685|20549913|P6|NOT COMPLETED|Overall Study||5
8336329|NCT01335685|20549914|P5|NOT COMPLETED|Overall Study||0
8336330|NCT01335685|20549915|P4|NOT COMPLETED|Overall Study||11
8336331|NCT01335685|20549916|P3|NOT COMPLETED|Overall Study||2
8336332|NCT01335685|20549917|P2|NOT COMPLETED|Overall Study||1
8336333|NCT01335685|20549918|P1|NOT COMPLETED|Overall Study||3
8336334|NCT01335685|20549911|P8|COMPLETED|Overall Study||3
8336335|NCT01335685|20549912|P7|COMPLETED|Overall Study||2
8336336|NCT01335685|20549913|P6|COMPLETED|Overall Study||1
8336337|NCT01335685|20549914|P5|COMPLETED|Overall Study||5
8336338|NCT01335685|20549915|P4|COMPLETED|Overall Study||15
8336339|NCT01335685|20549916|P3|COMPLETED|Overall Study||1
8336340|NCT01335685|20549917|P2|COMPLETED|Overall Study||3
8336341|NCT01335685|20549918|P1|COMPLETED|Overall Study||4
8336342|NCT01335685|20549911|P8|STARTED|Overall Study||6
8336343|NCT01335685|20549912|P7|STARTED|Overall Study||4
8336344|NCT01335685|20549913|P6|STARTED|Overall Study||6
8336345|NCT01335685|20549914|P5|STARTED|Overall Study||5
8336346|NCT01335685|20549915|P4|STARTED|Overall Study||26
8336347|NCT01335685|20549916|P3|STARTED|Overall Study||3
8336348|NCT01335685|20549917|P2|STARTED|Overall Study||4
8336349|NCT01335685|20549918|P1|STARTED|Overall Study||7
8336350|NCT01335620|20550020|P1|NOT COMPLETED|Overall Study||0
8336351|NCT01335620|20550020|P1|COMPLETED|Overall Study||19
8336352|NCT01335620|20550020|P1|STARTED|Overall Study||19
8336353|NCT01335581|20550027|P1|NOT COMPLETED|Overall Study||10
8336354|NCT01335581|20550027|P1|COMPLETED|Overall Study||8
8336355|NCT01335581|20550027|P1|STARTED|Overall Study||18
8336356|NCT01335542|20550033|P2|NOT COMPLETED|Overall Study||0
8336357|NCT01335542|20550034|P1|NOT COMPLETED|Overall Study||0
8336358|NCT01335542|20550033|P2|COMPLETED|Overall Study||45
8336359|NCT01335542|20550034|P1|COMPLETED|Overall Study||45
8336360|NCT01335542|20550033|P2|STARTED|Overall Study||45
8336361|NCT01335542|20550034|P1|STARTED|Overall Study||45
8336362|NCT01335477|20550042|P2|NOT COMPLETED|Overall Study||59
8336363|NCT01335477|20550043|P1|NOT COMPLETED|Overall Study||41
8336364|NCT01335477|20550042|P2|COMPLETED|Overall Study||272
8336365|NCT01335477|20550043|P1|COMPLETED|Overall Study||179
8336366|NCT01335477|20550042|P2|STARTED|Overall Study||331
8336367|NCT01335477|20550043|P1|STARTED|Overall Study||220
8336368|NCT01335464|20550107|P2|NOT COMPLETED|Overall Study||49
8336369|NCT01335464|20550108|P1|NOT COMPLETED|Overall Study||32
8336370|NCT01335464|20550107|P2|COMPLETED|Overall Study||260
8336371|NCT01335464|20550108|P1|COMPLETED|Overall Study||174
8336372|NCT01335464|20550107|P2|STARTED|Overall Study||309
8336373|NCT01335464|20550108|P1|STARTED|Overall Study||206
8336374|NCT01335399|20550172|P2|NOT COMPLETED|Treatment Period||339
8336375|NCT01335399|20550173|P1|NOT COMPLETED|Treatment Period||333
8336376|NCT01335399|20550172|P2|COMPLETED|Treatment Period||32
8336377|NCT01335399|20550173|P1|COMPLETED|Treatment Period||38
8336378|NCT01335399|20550172|P2|STARTED|Treatment Period||371
8336379|NCT01335399|20550173|P1|STARTED|Treatment Period||371
8336380|NCT01335399|20550172|P2|NOT COMPLETED|Pre-treatment Period||3
8336381|NCT01335399|20550173|P1|NOT COMPLETED|Pre-treatment Period||3
8336382|NCT01335399|20550172|P2|COMPLETED|Pre-treatment Period||371
8336383|NCT01335399|20550173|P1|COMPLETED|Pre-treatment Period||371
8336384|NCT01335399|20550172|P2|STARTED|Pre-treatment Period||374
8336385|NCT01335399|20550173|P1|STARTED|Pre-treatment Period||374
8336386|NCT01335308|20550190|P3|NOT COMPLETED|Overall Study||81
8336387|NCT01335308|20550191|P2|NOT COMPLETED|Overall Study||67
8336388|NCT01335308|20550192|P1|NOT COMPLETED|Overall Study||40
8336389|NCT01335308|20550190|P3|COMPLETED|Overall Study||154
8336390|NCT01335308|20550191|P2|COMPLETED|Overall Study||145
8336391|NCT01335308|20550192|P1|COMPLETED|Overall Study||158
8336392|NCT01335308|20550190|P3|STARTED|Overall Study||235
8336393|NCT01335308|20550191|P2|STARTED|Overall Study||212
8336394|NCT01335308|20550192|P1|STARTED|Overall Study||198
8336395|NCT01335230|20550213|P4|NOT COMPLETED|Overall Study||0
8336396|NCT01335230|20550214|P3|NOT COMPLETED|Overall Study||0
8336397|NCT01335230|20550215|P2|NOT COMPLETED|Overall Study||0
8336398|NCT01335230|20550216|P1|NOT COMPLETED|Overall Study||0
8336399|NCT01335230|20550213|P4|COMPLETED|Overall Study|subjects|10
8336400|NCT01335230|20550214|P3|COMPLETED|Overall Study|subjects|10
8336401|NCT01335230|20550215|P2|COMPLETED|Overall Study|subjects|10
8336402|NCT01335230|20550216|P1|COMPLETED|Overall Study|subjects|10
8336403|NCT01335230|20550213|P4|STARTED|Overall Study|subjects|10
8336404|NCT01335230|20550214|P3|STARTED|Overall Study|subjects|10
8336405|NCT01335230|20550215|P2|STARTED|Overall Study|subjects|10
8336406|NCT01335230|20550216|P1|STARTED|Overall Study|subjects|10
8336407|NCT01335204|20550226|P1|NOT COMPLETED|Overall Study||0
8336408|NCT01335204|20550226|P1|COMPLETED|Overall Study||4
8336409|NCT01335204|20550226|P1|STARTED|Overall Study||4
8336410|NCT01335191|20550237|P2|NOT COMPLETED|Overall Study||0
8336411|NCT01335191|20550238|P1|NOT COMPLETED|Overall Study||0
8336412|NCT01335191|20550237|P2|COMPLETED|Overall Study||11
8336413|NCT01335191|20550238|P1|COMPLETED|Overall Study||16
8336414|NCT01335191|20550237|P2|STARTED|Overall Study||11
8336415|NCT01335191|20550238|P1|STARTED|Overall Study||16
8336416|NCT01335061|20550244|P1|NOT COMPLETED|Overall Study||0
8336417|NCT01335061|20550244|P1|COMPLETED|Overall Study||25
8336418|NCT01335061|20550244|P1|STARTED|Overall Study||25
8336419|NCT01334957|20550259|P1|NOT COMPLETED|Overall Study||0
8336420|NCT01334957|20550259|P1|COMPLETED|Overall Study||300
8336421|NCT01334957|20550259|P1|Received Multiple Doses|Overall Study||48
8336422|NCT01334957|20550259|P1|Received Single Dose|Overall Study||252
8336423|NCT01334957|20550259|P1|STARTED|Overall Study||300
8336424|NCT01334944|20550267|P2|NOT COMPLETED|Overall Study||0
8336425|NCT01334944|20550268|P1|NOT COMPLETED|Overall Study||0
8336426|NCT01334944|20550267|P2|COMPLETED|Overall Study||139
8336427|NCT01334944|20550268|P1|COMPLETED|Overall Study||11
8336428|NCT01334944|20550267|P2|Received Multiple Doses|Overall Study||43
8336429|NCT01334944|20550268|P1|Received Multiple Doses|Overall Study||10
8336430|NCT01334944|20550267|P2|Received Singel Dose|Overall Study||96
8336431|NCT01334944|20550268|P1|Received Singel Dose|Overall Study||1
8336432|NCT01334944|20550267|P2|STARTED|Overall Study||139
8336433|NCT01334944|20550268|P1|STARTED|Overall Study||11
8336434|NCT01334918|20550294|P2|NOT COMPLETED|Overall Study||1
8336435|NCT01334918|20550295|P1|NOT COMPLETED|Overall Study||8
8336436|NCT01334918|20550294|P2|COMPLETED|Overall Study||60
8336437|NCT01334918|20550295|P1|COMPLETED|Overall Study||55
8336438|NCT01334918|20550294|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
8336439|NCT01334918|20550295|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
8336440|NCT01334918|20550294|P2|STARTED|Overall Study||61
8336441|NCT01334918|20550295|P1|STARTED|Overall Study||63
8336442|NCT01334866|20550321|P1|NOT COMPLETED|Overall Study||19
8336443|NCT01334866|20550321|P1|COMPLETED|Overall Study||72
8336444|NCT01334866|20550321|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
8336445|NCT01334827|20550331|P1|NOT COMPLETED|Overall Study||0
8336446|NCT01334827|20550331|P1|COMPLETED|Overall Study||48
8336447|NCT01334827|20550331|P1|STARTED|Overall Study||48
8336448|NCT01334723|20550339|P2|NOT COMPLETED|Overall Study||0
8336449|NCT01334723|20550340|P1|NOT COMPLETED|Overall Study||0
8336450|NCT01334723|20550339|P2|COMPLETED|Overall Study||17739
8336451|NCT01334723|20550340|P1|COMPLETED|Overall Study||17293
8336452|NCT01334723|20550339|P2|STARTED|Overall Study||17739
8336453|NCT01334723|20550340|P1|STARTED|Overall Study||17293
8336454|NCT01334710|20550366|P1|NOT COMPLETED|Overall Study||3
8336455|NCT01334710|20550366|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
8336456|NCT01334710|20550366|P1|STARTED|Overall Study||3
8336457|NCT01334606|20550371|P1|NOT COMPLETED|Overall Study||18
8336458|NCT01334606|20550371|P1|COMPLETED|Overall Study||3
8336459|NCT01334606|20550371|P1|STARTED|Overall Study||21
8336460|NCT01334554|20550379|P2|NOT COMPLETED|Overall Study||2
8336461|NCT01334554|20550380|P1|NOT COMPLETED|Overall Study||4
8336462|NCT01334554|20550379|P2|COMPLETED|Overall Study||21
8336463|NCT01334554|20550380|P1|COMPLETED|Overall Study||19
8336464|NCT01334554|20550379|P2|STARTED|Overall Study||23
8336465|NCT01334554|20550380|P1|STARTED|Overall Study||23
8336466|NCT01334515|20550390|P2|NOT COMPLETED|Overall Study||29
8336467|NCT01334515|20550391|P1|NOT COMPLETED|Overall Study||12
8336468|NCT01334515|20550390|P2|COMPLETED|Overall Study||7
8336469|NCT01334515|20550391|P1|COMPLETED|Overall Study||4
8336470|NCT01334515|20550390|P2|STARTED|Overall Study||36
8336471|NCT01334515|20550391|P1|STARTED|Overall Study||16
8336472|NCT01334229|20550401|P2|NOT COMPLETED|Overall Study||0
8336473|NCT01334229|20550402|P1|NOT COMPLETED|Overall Study||0
8336474|NCT01334229|20550401|P2|COMPLETED|Overall Study||11
8336475|NCT01334229|20550402|P1|COMPLETED|Overall Study||11
8336476|NCT01334229|20550401|P2|STARTED|Overall Study||11
8336477|NCT01334229|20550402|P1|STARTED|Overall Study||11
8336478|NCT01334216|20550420|P2|NOT COMPLETED|Overall Study||0
8336479|NCT01334216|20550421|P1|NOT COMPLETED|Overall Study||0
8336480|NCT01334216|20550420|P2|COMPLETED|Overall Study||194
8336481|NCT01334216|20550421|P1|COMPLETED|Overall Study||168
8336482|NCT01334216|20550420|P2|STARTED|Overall Study||194
8336483|NCT01334216|20550421|P1|STARTED|Overall Study||168
8336484|NCT01334125|20550429|P2|NOT COMPLETED|Overall Study||3
8336485|NCT01334125|20550430|P1|NOT COMPLETED|Overall Study||3
8336486|NCT01334125|20550429|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
8336487|NCT01334125|20550430|P1|COMPLETED|Overall Study|3 subjects move to another city|12
8336488|NCT01334125|20550429|P2|STARTED|Overall Study||13
8336489|NCT01334125|20550430|P1|STARTED|Overall Study||15
8336490|NCT01333956|20550446|P4|NOT COMPLETED|Overall Study||2
8336491|NCT01333956|20550447|P3|NOT COMPLETED|Overall Study||1
8336492|NCT01333956|20550448|P2|NOT COMPLETED|Overall Study||4
8336493|NCT01333956|20550449|P1|NOT COMPLETED|Overall Study||2
8336494|NCT01333956|20550446|P4|COMPLETED|Overall Study||28
8336495|NCT01333956|20550447|P3|COMPLETED|Overall Study||29
8336496|NCT01333956|20550448|P2|COMPLETED|Overall Study||26
8336497|NCT01333956|20550449|P1|COMPLETED|Overall Study||28
8336498|NCT01333956|20550446|P4|STARTED|Overall Study||30
8336499|NCT01333956|20550447|P3|STARTED|Overall Study||30
8336500|NCT01333956|20550448|P2|STARTED|Overall Study||30
8336501|NCT01333956|20550449|P1|STARTED|Overall Study||30
8336502|NCT01333943|20550485|P2|NOT COMPLETED|Overall Study||0
8336503|NCT01333943|20550486|P1|NOT COMPLETED|Overall Study||1
8336504|NCT01333943|20550485|P2|COMPLETED|Overall Study||47
8336505|NCT01333943|20550486|P1|COMPLETED|Overall Study||46
8336506|NCT01333943|20550485|P2|STARTED|Overall Study||47
8336507|NCT01333943|20550486|P1|STARTED|Overall Study||47
8336508|NCT01333865|20550502|P1|NOT COMPLETED|Overall Study||2
8336509|NCT01333865|20550502|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
8336510|NCT01333865|20550502|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
8336511|NCT01333813|20550507|P1|NOT COMPLETED|Overall Study||0
8336512|NCT01333813|20550507|P1|COMPLETED|Overall Study||297
8336513|NCT01333813|20550507|P1|STARTED|Overall Study||297
8336514|NCT01333722|20550522|P2|NOT COMPLETED|Overall Study||3
8336515|NCT01333722|20550523|P1|NOT COMPLETED|Overall Study||0
8336516|NCT01333722|20550522|P2|COMPLETED|Overall Study||46
8336517|NCT01333722|20550523|P1|COMPLETED|Overall Study||51
8336518|NCT01333722|20550522|P2|STARTED|Overall Study||49
8336519|NCT01333722|20550523|P1|STARTED|Overall Study||51
8336520|NCT01333592|20550537|P2|NOT COMPLETED|Overall Study||17
8336521|NCT01333592|20550538|P1|NOT COMPLETED|Overall Study||9
8336522|NCT01333592|20550537|P2|COMPLETED|Overall Study||52
8336523|NCT01333592|20550538|P1|COMPLETED|Overall Study||58
8336524|NCT01333592|20550537|P2|STARTED|Overall Study||69
8336525|NCT01333592|20550538|P1|STARTED|Overall Study||67
8336526|NCT01333501|20550548|P2|NOT COMPLETED|Overall Study||21
8336527|NCT01333501|20550549|P1|NOT COMPLETED|Overall Study||9
8336528|NCT01333501|20550548|P2|COMPLETED|Overall Study||30
8336529|NCT01333501|20550549|P1|COMPLETED|Overall Study||97
8336530|NCT01333501|20550548|P2|Safety Population|Overall Study||47
8336531|NCT01333501|20550549|P1|Safety Population|Overall Study||104
8336532|NCT01333501|20550548|P2|Full Analysis Set (FAS)|Overall Study||28
8336533|NCT01333501|20550549|P1|Full Analysis Set (FAS)|Overall Study||80
8336534|NCT01333501|20550548|P2|STARTED|Overall Study||51
8336535|NCT01333501|20550549|P1|STARTED|Overall Study||106
8336536|NCT01333488|20550598|P3|NOT COMPLETED|Overall Study||0
8336537|NCT01333488|20550599|P2|NOT COMPLETED|Overall Study||0
8336538|NCT01333488|20550600|P1|NOT COMPLETED|Overall Study||0
8336539|NCT01333488|20550598|P3|COMPLETED|Overall Study||3
8336540|NCT01333488|20550599|P2|COMPLETED|Overall Study||1
8336541|NCT01333488|20550600|P1|COMPLETED|Overall Study||2
8336542|NCT01333488|20550598|P3|STARTED|Overall Study||3
8336543|NCT01333488|20550599|P2|STARTED|Overall Study||1
8336544|NCT01333488|20550600|P1|STARTED|Overall Study||2
8336545|NCT01333475|20550616|P2|NOT COMPLETED|Overall Study||3
8336546|NCT01333475|20550617|P1|NOT COMPLETED|Overall Study||2
8336547|NCT01333475|20550616|P2|COMPLETED|Overall Study||6
8336548|NCT01333475|20550617|P1|COMPLETED|Overall Study||10
8336549|NCT01333475|20550616|P2|STARTED|Overall Study||9
8336550|NCT01333475|20550617|P1|STARTED|Overall Study||12
8336551|NCT01333436|20550627|P2|NOT COMPLETED|Overall Study||0
8336552|NCT01333436|20550628|P1|NOT COMPLETED|Overall Study||0
8336553|NCT01333436|20550627|P2|COMPLETED|Overall Study||50
8336554|NCT01333436|20550628|P1|COMPLETED|Overall Study||43
8336555|NCT01333436|20550627|P2|STARTED|Overall Study||50
8336556|NCT01333436|20550628|P1|STARTED|Overall Study||43
8336557|NCT01333397|20550643|P5|NOT COMPLETED|Overall Study||0
8336558|NCT01333397|20550644|P4|NOT COMPLETED|Overall Study||1
8336559|NCT01333397|20550645|P3|NOT COMPLETED|Overall Study||0
8336560|NCT01333397|20550646|P2|NOT COMPLETED|Overall Study||0
8336561|NCT01333397|20550647|P1|NOT COMPLETED|Overall Study||1
8336562|NCT01333397|20550643|P5|COMPLETED|Overall Study||35
8336563|NCT01333397|20550644|P4|COMPLETED|Overall Study||34
8336564|NCT01333397|20550645|P3|COMPLETED|Overall Study||35
8336565|NCT01333397|20550646|P2|COMPLETED|Overall Study||36
8336566|NCT01333397|20550647|P1|COMPLETED|Overall Study||34
8336567|NCT01333397|20550643|P5|STARTED|Overall Study||35
8336568|NCT01333397|20550644|P4|STARTED|Overall Study||35
8336569|NCT01333397|20550645|P3|STARTED|Overall Study||35
8336570|NCT01333397|20550646|P2|STARTED|Overall Study||36
8336571|NCT01333397|20550647|P1|STARTED|Overall Study||35
8336572|NCT01333189|20550721|P2|NOT COMPLETED|Overall Study||2
8336573|NCT01333189|20550722|P1|NOT COMPLETED|Overall Study||2
8336574|NCT01333189|20550721|P2|COMPLETED|Overall Study||11
8336575|NCT01333189|20550722|P1|COMPLETED|Overall Study||11
8336576|NCT01333189|20550721|P2|STARTED|Overall Study||13
8336577|NCT01333189|20550722|P1|STARTED|Overall Study||13
8336578|NCT01333111|20550753|P3|NOT COMPLETED|Overall Study||2
8336579|NCT01333111|20550754|P2|NOT COMPLETED|Overall Study||3
8336580|NCT01333111|20550755|P1|NOT COMPLETED|Overall Study||2
8336581|NCT01333111|20550753|P3|COMPLETED|Overall Study||13
8336582|NCT01333111|20550754|P2|COMPLETED|Overall Study||26
8336583|NCT01333111|20550755|P1|COMPLETED|Overall Study||28
8336584|NCT01333111|20550753|P3|STARTED|Overall Study||15
8336585|NCT01333111|20550754|P2|STARTED|Overall Study||29
8336586|NCT01333111|20550755|P1|STARTED|Overall Study||30
8336587|NCT01333098|20550779|P1|NOT COMPLETED|Overall Study||3
8336588|NCT01333098|20550779|P1|COMPLETED|Overall Study||12
8336589|NCT01333098|20550779|P1|STARTED|Overall Study||15
8336590|NCT01333072|20550790|P2|NOT COMPLETED|Overall Study||4
8336591|NCT01333072|20550791|P1|NOT COMPLETED|Overall Study||6
8336592|NCT01333072|20550790|P2|COMPLETED|Overall Study||27
8336593|NCT01333072|20550791|P1|COMPLETED|Overall Study||24
8336594|NCT01333072|20550790|P2|STARTED|Overall Study||31
8336595|NCT01333072|20550791|P1|STARTED|Overall Study||30
8336596|NCT01333059|20550799|P2|NOT COMPLETED|Overall Study||3
8336597|NCT01333059|20550800|P1|NOT COMPLETED|Overall Study||6
8336598|NCT01333059|20550799|P2|COMPLETED|Overall Study||8
8336599|NCT01333059|20550800|P1|COMPLETED|Overall Study||8
8336600|NCT01333059|20550799|P2|STARTED|Overall Study||11
8336601|NCT01333059|20550800|P1|STARTED|Overall Study||14
8336602|NCT01332994|20550810|P1|NOT COMPLETED|Overall Study||71
8336603|NCT01332994|20550810|P1|COMPLETED|Overall Study||448
8336604|NCT01332994|20550810|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
8336605|NCT01332994|20550810|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
8336606|NCT01332994|20550810|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
8336607|NCT01332994|20550810|P1|Completed Week 16|Overall Study||463
8336608|NCT01332994|20550810|P1|STARTED|Overall Study||519
8336609|NCT01332981|20550866|P1|NOT COMPLETED|Overall Study||0
8336610|NCT01332981|20550866|P1|COMPLETED|Overall Study||220
8336611|NCT01332981|20550866|P1|STARTED|Overall Study||220
8336612|NCT01332968|20550879|P8|NOT COMPLETED|Follow-Up Period||531
8336613|NCT01332968|20550880|P7|NOT COMPLETED|Follow-Up Period||542
8336614|NCT01332968|20550881|P6|NOT COMPLETED|Follow-Up Period||0
8336615|NCT01332968|20550882|P5|NOT COMPLETED|Follow-Up Period||0
8336616|NCT01332968|20550883|P4|NOT COMPLETED|Follow-Up Period||0
8336617|NCT01332968|20550884|P3|NOT COMPLETED|Follow-Up Period||0
8336618|NCT01332968|20550885|P2|NOT COMPLETED|Follow-Up Period||0
8336619|NCT01332968|20550886|P1|NOT COMPLETED|Follow-Up Period||0
8336620|NCT01332968|20550879|P8|COMPLETED|Follow-Up Period||0
8336621|NCT01332968|20550880|P7|COMPLETED|Follow-Up Period||0
8336622|NCT01332968|20550881|P6|COMPLETED|Follow-Up Period||0
8336623|NCT01332968|20550882|P5|COMPLETED|Follow-Up Period||0
8336624|NCT01332968|20550883|P4|COMPLETED|Follow-Up Period||0
8336625|NCT01332968|20550884|P3|COMPLETED|Follow-Up Period||0
8336626|NCT01332968|20550885|P2|COMPLETED|Follow-Up Period||0
8336627|NCT01332968|20550886|P1|COMPLETED|Follow-Up Period||0
8336628|NCT01332968|20550879|P8|STARTED|Follow-Up Period||531
8336629|NCT01332968|20550880|P7|STARTED|Follow-Up Period||542
8336630|NCT01332968|20550881|P6|STARTED|Follow-Up Period||0
8336631|NCT01332968|20550882|P5|STARTED|Follow-Up Period||0
8336632|NCT01332968|20550883|P4|STARTED|Follow-Up Period||0
8336633|NCT01332968|20550884|P3|STARTED|Follow-Up Period||0
8336634|NCT01332968|20550885|P2|STARTED|Follow-Up Period||0
8336635|NCT01332968|20550886|P1|STARTED|Follow-Up Period||0
8336636|NCT01332968|20550879|P8|NOT COMPLETED|Maintenance/Observation Period||0
8336637|NCT01332968|20550880|P7|NOT COMPLETED|Maintenance/Observation Period||0
8336638|NCT01332968|20550881|P6|NOT COMPLETED|Maintenance/Observation Period||9
8336639|NCT01332968|20550882|P5|NOT COMPLETED|Maintenance/Observation Period||10
8336640|NCT01332968|20550883|P4|NOT COMPLETED|Maintenance/Observation Period||207
8336641|NCT01332968|20550884|P3|NOT COMPLETED|Maintenance/Observation Period||213
8336642|NCT01332968|20550885|P2|NOT COMPLETED|Maintenance/Observation Period||0
8336643|NCT01332968|20550886|P1|NOT COMPLETED|Maintenance/Observation Period||0
8336644|NCT01332968|20550879|P8|COMPLETED|Maintenance/Observation Period||0
8336645|NCT01332968|20550880|P7|COMPLETED|Maintenance/Observation Period||0
8336646|NCT01332968|20550881|P6|COMPLETED|Maintenance/Observation Period||2
8336647|NCT01332968|20550882|P5|COMPLETED|Maintenance/Observation Period||2
8336648|NCT01332968|20550883|P4|COMPLETED|Maintenance/Observation Period||417
8336649|NCT01332968|20550884|P3|COMPLETED|Maintenance/Observation Period||399
8336650|NCT01332968|20550885|P2|COMPLETED|Maintenance/Observation Period||0
8336651|NCT01332968|20550886|P1|COMPLETED|Maintenance/Observation Period||0
8336652|NCT01332968|20550879|P8|STARTED|Maintenance/Observation Period||0
8336653|NCT01332968|20550880|P7|STARTED|Maintenance/Observation Period||0
8336654|NCT01332968|20550881|P6|STARTED|Maintenance/Observation Period||11
8336655|NCT01332968|20550882|P5|STARTED|Maintenance/Observation Period||12
8336656|NCT01332968|20550883|P4|STARTED|Maintenance/Observation Period||624
8336657|NCT01332968|20550884|P3|STARTED|Maintenance/Observation Period||612
8336658|NCT01332968|20550885|P2|STARTED|Maintenance/Observation Period||0
8336659|NCT01332968|20550886|P1|STARTED|Maintenance/Observation Period||0
8336660|NCT01332968|20550879|P8|NOT COMPLETED|Induction Period||0
8336661|NCT01332968|20550880|P7|NOT COMPLETED|Induction Period||0
8336662|NCT01332968|20550881|P6|NOT COMPLETED|Induction Period||0
8336663|NCT01332968|20550882|P5|NOT COMPLETED|Induction Period||0
8336664|NCT01332968|20550883|P4|NOT COMPLETED|Induction Period||0
8336665|NCT01332968|20550884|P3|NOT COMPLETED|Induction Period||0
8336666|NCT01332968|20550885|P2|NOT COMPLETED|Induction Period||56
8336667|NCT01332968|20550886|P1|NOT COMPLETED|Induction Period||58
8336668|NCT01332968|20550879|P8|COMPLETED|Induction Period||0
8336669|NCT01332968|20550880|P7|COMPLETED|Induction Period||0
8336670|NCT01332968|20550881|P6|COMPLETED|Induction Period||0
8336671|NCT01332968|20550882|P5|COMPLETED|Induction Period||0
8336672|NCT01332968|20550883|P4|COMPLETED|Induction Period||0
8336673|NCT01332968|20550884|P3|COMPLETED|Induction Period||0
8336674|NCT01332968|20550885|P2|COMPLETED|Induction Period||646
8336675|NCT01332968|20550886|P1|COMPLETED|Induction Period||641
8336676|NCT01332968|20550879|P8|STARTED|Induction Period||0
8336677|NCT01332968|20550880|P7|STARTED|Induction Period||0
8336678|NCT01332968|20550881|P6|STARTED|Induction Period||0
8336679|NCT01332968|20550882|P5|STARTED|Induction Period||0
8336680|NCT01332968|20550883|P4|STARTED|Induction Period||0
8336681|NCT01332968|20550884|P3|STARTED|Induction Period||0
8336682|NCT01332968|20550885|P2|STARTED|Induction Period||702
8336683|NCT01332968|20550886|P1|STARTED|Induction Period||699
8336684|NCT01332851|20550952|P2|NOT COMPLETED|Overall Study||13
8336685|NCT01332851|20550953|P1|NOT COMPLETED|Overall Study||11
8336686|NCT01332851|20550952|P2|COMPLETED|Overall Study||110
8336687|NCT01332851|20550953|P1|COMPLETED|Overall Study||113
8336688|NCT01332851|20550952|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
8336689|NCT01332851|20550953|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
8336690|NCT01332851|20550952|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
8336691|NCT01332851|20550953|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
8336692|NCT01332851|20550952|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
8336693|NCT01332851|20550953|P1|Completed Follow up 1|Overall Study||116
8336694|NCT01332851|20550952|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
8336695|NCT01332851|20550953|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
8336696|NCT01332851|20550952|P2|STARTED|Overall Study||123
8336697|NCT01332851|20550953|P1|STARTED|Overall Study||124
8336698|NCT01332799|20550987|P2|NOT COMPLETED|Overall Study||10
8336699|NCT01332799|20550988|P1|NOT COMPLETED|Overall Study||10
8336700|NCT01332799|20550987|P2|COMPLETED|Overall Study||0
8336701|NCT01332799|20550988|P1|COMPLETED|Overall Study||0
8336702|NCT01332799|20550987|P2|STARTED|Overall Study||10
8336703|NCT01332799|20550988|P1|STARTED|Overall Study||10
8336704|NCT01332721|20550998|P1|NOT COMPLETED|Overall Study||0
8336705|NCT01332721|20550998|P1|COMPLETED|Overall Study||38
8336706|NCT01332721|20550998|P1|STARTED|Overall Study||38
8336707|NCT01332630|20551004|P1|NOT COMPLETED|Overall Study||3
8336708|NCT01332630|20551004|P1|COMPLETED|Overall Study||21
8336709|NCT01332630|20551004|P1|STARTED|Overall Study||24
8336710|NCT01332578|20551008|P2|NOT COMPLETED|Period II||0
8336711|NCT01332578|20551009|P1|NOT COMPLETED|Period II||0
8336712|NCT01332578|20551008|P2|COMPLETED|Period II||13
8336713|NCT01332578|20551009|P1|COMPLETED|Period II||12
8336714|NCT01332578|20551008|P2|STARTED|Period II||13
8336715|NCT01332578|20551009|P1|STARTED|Period II||12
8336716|NCT01332578|20551008|P2|NOT COMPLETED|Washout Period||0
8336717|NCT01332578|20551009|P1|NOT COMPLETED|Washout Period||0
8336718|NCT01332578|20551008|P2|COMPLETED|Washout Period||13
8336719|NCT01332578|20551009|P1|COMPLETED|Washout Period||12
8336720|NCT01332578|20551008|P2|STARTED|Washout Period||13
8336721|NCT01332578|20551009|P1|STARTED|Washout Period||12
8336722|NCT01332578|20551008|P2|NOT COMPLETED|Period I||0
8336723|NCT01332578|20551009|P1|NOT COMPLETED|Period I||0
8336724|NCT01332578|20551008|P2|COMPLETED|Period I||13
8336725|NCT01332578|20551009|P1|COMPLETED|Period I||12
8336726|NCT01332578|20551008|P2|STARTED|Period I||13
8336727|NCT01332578|20551009|P1|STARTED|Period I||12
8336728|NCT01332500|20551032|P4|NOT COMPLETED|Overall Study||0
8336729|NCT01332500|20551033|P3|NOT COMPLETED|Overall Study||0
8336730|NCT01332500|20551034|P2|NOT COMPLETED|Overall Study||0
8336731|NCT01332500|20551035|P1|NOT COMPLETED|Overall Study||0
8336732|NCT01332500|20551032|P4|COMPLETED|Overall Study||5806
8336733|NCT01332500|20551033|P3|COMPLETED|Overall Study||2903
8336734|NCT01332500|20551034|P2|COMPLETED|Overall Study||39771
8336735|NCT01332500|20551035|P1|COMPLETED|Overall Study||13257
8336736|NCT01332500|20551032|P4|STARTED|Overall Study||5806
8336737|NCT01332500|20551033|P3|STARTED|Overall Study||2903
8336738|NCT01332500|20551034|P2|STARTED|Overall Study||39771
8336739|NCT01332500|20551035|P1|STARTED|Overall Study||13257
8336740|NCT01332487|20551055|P2|NOT COMPLETED|Overall Study||0
8336741|NCT01332487|20551056|P1|NOT COMPLETED|Overall Study||0
8336742|NCT01332487|20551055|P2|COMPLETED|Overall Study||3063
8336743|NCT01332487|20551056|P1|COMPLETED|Overall Study||5554
8336744|NCT01332487|20551055|P2|STARTED|Overall Study||3063
8336745|NCT01332487|20551056|P1|STARTED|Overall Study||5554
8336746|NCT01332461|20551066|P2|NOT COMPLETED|Overall Study||0
8336747|NCT01332461|20551067|P1|NOT COMPLETED|Overall Study||0
8336748|NCT01332461|20551066|P2|COMPLETED|Overall Study||4386
8336749|NCT01332461|20551067|P1|COMPLETED|Overall Study||1291
8336750|NCT01332461|20551066|P2|STARTED|Overall Study||4386
8336751|NCT01332461|20551067|P1|STARTED|Overall Study||1291
8336752|NCT01332435|20551081|P4|NOT COMPLETED|Overall Study||0
8336753|NCT01332435|20551082|P3|NOT COMPLETED|Overall Study||0
8336754|NCT01332435|20551083|P2|NOT COMPLETED|Overall Study||0
8336755|NCT01332435|20551084|P1|NOT COMPLETED|Overall Study||0
8336756|NCT01332435|20551081|P4|COMPLETED|Overall Study||1656
8336757|NCT01332435|20551082|P3|COMPLETED|Overall Study||2604
8336758|NCT01332435|20551083|P2|COMPLETED|Overall Study||1064
8336759|NCT01332435|20551084|P1|COMPLETED|Overall Study||1572
8336760|NCT01332435|20551081|P4|STARTED|Overall Study||1656
8336761|NCT01332435|20551082|P3|STARTED|Overall Study||2604
8336762|NCT01332435|20551083|P2|STARTED|Overall Study||1064
8336763|NCT01332435|20551084|P1|STARTED|Overall Study||1572
8336764|NCT01332357|20551114|P1|NOT COMPLETED|Overall Study||0
8336765|NCT01332357|20551114|P1|COMPLETED|Overall Study||6139
8336766|NCT01332357|20551114|P1|STARTED|Overall Study||6139
8336767|NCT01332331|20551120|P2|NOT COMPLETED|Overall Study||2
8336768|NCT01332331|20551121|P1|NOT COMPLETED|Overall Study||2
8336769|NCT01332331|20551120|P2|COMPLETED|Overall Study||18
8336770|NCT01332331|20551121|P1|COMPLETED|Overall Study||19
8336771|NCT01332331|20551120|P2|STARTED|Overall Study||20
8336772|NCT01332331|20551121|P1|STARTED|Overall Study||21
8336773|NCT01332318|20551173|P4|NOT COMPLETED|Overall Study||2
8336774|NCT01332318|20551174|P3|NOT COMPLETED|Overall Study||1
8336775|NCT01332318|20551175|P2|NOT COMPLETED|Overall Study||4
8336776|NCT01332318|20551176|P1|NOT COMPLETED|Overall Study||2
8336777|NCT01332318|20551173|P4|COMPLETED|Overall Study||28
8336778|NCT01332318|20551174|P3|COMPLETED|Overall Study||33
8336779|NCT01332318|20551175|P2|COMPLETED|Overall Study||28
8336780|NCT01332318|20551176|P1|COMPLETED|Overall Study||32
8336781|NCT01332318|20551173|P4|STARTED|Overall Study||30
8336782|NCT01332318|20551174|P3|STARTED|Overall Study||34
8336783|NCT01332318|20551175|P2|STARTED|Overall Study||32
8336784|NCT01332318|20551176|P1|STARTED|Overall Study||34
8336785|NCT01332305|20551287|P5|NOT COMPLETED|Overall Study||12
8336786|NCT01332305|20551288|P4|NOT COMPLETED|Overall Study||8
8336787|NCT01332305|20551289|P3|NOT COMPLETED|Overall Study||14
8336788|NCT01332305|20551290|P2|NOT COMPLETED|Overall Study||14
8336789|NCT01332305|20551291|P1|NOT COMPLETED|Overall Study||10
8336790|NCT01332305|20551287|P5|COMPLETED|Overall Study||33
8336791|NCT01332305|20551288|P4|COMPLETED|Overall Study||30
8336792|NCT01332305|20551289|P3|COMPLETED|Overall Study||31
8336793|NCT01332305|20551290|P2|COMPLETED|Overall Study||34
8336794|NCT01332305|20551291|P1|COMPLETED|Overall Study||31
8336795|NCT01332305|20551287|P5|STARTED|Overall Study||45
8336796|NCT01332305|20551288|P4|STARTED|Overall Study||38
8336797|NCT01332305|20551289|P3|STARTED|Overall Study||45
8336798|NCT01332305|20551290|P2|STARTED|Overall Study||48
8336799|NCT01332305|20551291|P1|STARTED|Overall Study||41
8336800|NCT01332292|20551313|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8336801|NCT01332292|20551314|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8336802|NCT01332292|20551313|P2|COMPLETED|Treatment Period 2 (14 Days)||11
8336803|NCT01332292|20551314|P1|COMPLETED|Treatment Period 2 (14 Days)||11
8336804|NCT01332292|20551313|P2|STARTED|Treatment Period 2 (14 Days)||12
8336805|NCT01332292|20551314|P1|STARTED|Treatment Period 2 (14 Days)||12
8336806|NCT01332292|20551313|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
8336807|NCT01332292|20551314|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
8336808|NCT01332292|20551313|P2|COMPLETED|Washout Period (>=7 Days)||12
8336809|NCT01332292|20551314|P1|COMPLETED|Washout Period (>=7 Days)||12
8336810|NCT01332292|20551313|P2|STARTED|Washout Period (>=7 Days)||12
8336811|NCT01332292|20551314|P1|STARTED|Washout Period (>=7 Days)||12
8336812|NCT01332292|20551313|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8336813|NCT01332292|20551314|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8336814|NCT01332292|20551313|P2|COMPLETED|Treatment Period 1 (14 Days)||12
8336815|NCT01332292|20551314|P1|COMPLETED|Treatment Period 1 (14 Days)||12
8336816|NCT01332292|20551313|P2|STARTED|Treatment Period 1 (14 Days)||13
8336817|NCT01332292|20551314|P1|STARTED|Treatment Period 1 (14 Days)||14
8336818|NCT01332253|20551376|P2|NOT COMPLETED|Overall Study||0
8336819|NCT01332253|20551377|P1|NOT COMPLETED|Overall Study||0
8336820|NCT01332253|20551376|P2|COMPLETED|Overall Study||79
8336821|NCT01332253|20551377|P1|COMPLETED|Overall Study||82
8336822|NCT01332253|20551376|P2|STARTED|Overall Study||79
8336823|NCT01332253|20551377|P1|STARTED|Overall Study||82
8336824|NCT01332227|20551405|P2|NOT COMPLETED|Overall Study||5
8336825|NCT01332227|20551406|P1|NOT COMPLETED|Overall Study||16
8336826|NCT01332227|20551405|P2|COMPLETED|Overall Study||32
8336827|NCT01332227|20551406|P1|COMPLETED|Overall Study||56
8336828|NCT01332227|20551405|P2|STARTED|Overall Study|Participants who received treatment|37
8336829|NCT01332227|20551406|P1|STARTED|Overall Study|Participants who received treatment|72
8336830|NCT01332188|20551428|P4|NOT COMPLETED|Overall Study||0
8336831|NCT01332188|20551429|P3|NOT COMPLETED|Overall Study||4
8336832|NCT01332188|20551430|P2|NOT COMPLETED|Overall Study||1
8336833|NCT01332188|20551431|P1|NOT COMPLETED|Overall Study||2
8336834|NCT01332188|20551428|P4|COMPLETED|Overall Study||25
8336835|NCT01332188|20551429|P3|COMPLETED|Overall Study||21
8336836|NCT01332188|20551430|P2|COMPLETED|Overall Study||25
8336837|NCT01332188|20551431|P1|COMPLETED|Overall Study||23
8336838|NCT01332188|20551428|P4|STARTED|Overall Study||25
8336839|NCT01332188|20551429|P3|STARTED|Overall Study||25
8336840|NCT01332188|20551430|P2|STARTED|Overall Study||26
8336841|NCT01332188|20551431|P1|STARTED|Overall Study||25
8336842|NCT01332123|20551585|P1|NOT COMPLETED|Overall Study||0
8336843|NCT01332123|20551585|P1|COMPLETED|Overall Study||10
8336844|NCT01332123|20551585|P1|STARTED|Overall Study||10
8336845|NCT01332071|20551590|P2|NOT COMPLETED|Period 2||0
8336846|NCT01332071|20551591|P1|NOT COMPLETED|Period 2||0
8336847|NCT01332071|20551590|P2|COMPLETED|Period 2||13
8336848|NCT01332071|20551591|P1|COMPLETED|Period 2||13
8336849|NCT01332071|20551590|P2|STARTED|Period 2||13
8336850|NCT01332071|20551591|P1|STARTED|Period 2||13
8336851|NCT01332071|20551590|P2|NOT COMPLETED|7-Day Washout Period||0
8336852|NCT01332071|20551591|P1|NOT COMPLETED|7-Day Washout Period||0
8336853|NCT01332071|20551590|P2|COMPLETED|7-Day Washout Period||13
8336854|NCT01332071|20551591|P1|COMPLETED|7-Day Washout Period||13
8336855|NCT01332071|20551590|P2|STARTED|7-Day Washout Period||13
8336856|NCT01332071|20551591|P1|STARTED|7-Day Washout Period||13
8336857|NCT01332071|20551590|P2|NOT COMPLETED|Period 1||0
8336858|NCT01332071|20551591|P1|NOT COMPLETED|Period 1||0
8336859|NCT01332071|20551590|P2|COMPLETED|Period 1||13
8336860|NCT01332071|20551591|P1|COMPLETED|Period 1||13
8336861|NCT01332071|20551590|P2|STARTED|Period 1||13
8336862|NCT01332071|20551591|P1|STARTED|Period 1||13
8336863|NCT01332019|20551609|P2|NOT COMPLETED|Overall Study||122
8336864|NCT01332019|20551610|P1|NOT COMPLETED|Overall Study||113
8336865|NCT01332019|20551609|P2|COMPLETED|Overall Study||425
8336866|NCT01332019|20551610|P1|COMPLETED|Overall Study||417
8336867|NCT01332019|20551609|P2|STARTED|Overall Study||547
8336868|NCT01332019|20551610|P1|STARTED|Overall Study||530
8336869|NCT01331837|20551694|P2|NOT COMPLETED|Overall Study||67
8336870|NCT01331837|20551695|P1|NOT COMPLETED|Overall Study||56
8336871|NCT01331837|20551694|P2|COMPLETED|Overall Study||1475
8336872|NCT01331837|20551695|P1|COMPLETED|Overall Study||1482
8336873|NCT01331837|20551694|P2|STARTED|Overall Study||1542
8336874|NCT01331837|20551695|P1|STARTED|Overall Study||1538
8336875|NCT01331824|20551735|P1|NOT COMPLETED|Overall Study||13
8336876|NCT01331824|20551735|P1|COMPLETED|Overall Study||9
8336877|NCT01331824|20551735|P1|STARTED|Overall Study||22
8336878|NCT01331694|20551748|P6|NOT COMPLETED|Overall Study||0
8336879|NCT01331694|20551749|P5|NOT COMPLETED|Overall Study||0
8336880|NCT01331694|20551750|P4|NOT COMPLETED|Overall Study||0
8336881|NCT01331694|20551751|P3|NOT COMPLETED|Overall Study||0
8336882|NCT01331694|20551752|P2|NOT COMPLETED|Overall Study||0
8336883|NCT01331694|20551753|P1|NOT COMPLETED|Overall Study||0
8336884|NCT01331694|20551748|P6|COMPLETED|Overall Study||9126
8336885|NCT01331694|20551749|P5|COMPLETED|Overall Study||10617
8336886|NCT01331694|20551750|P4|COMPLETED|Overall Study||12595
8336887|NCT01331694|20551751|P3|COMPLETED|Overall Study||12659
8336888|NCT01331694|20551752|P2|COMPLETED|Overall Study||14449
8336889|NCT01331694|20551753|P1|COMPLETED|Overall Study||16684
8336890|NCT01331694|20551748|P6|STARTED|Overall Study||9126
8336891|NCT01331694|20551749|P5|STARTED|Overall Study||10617
8336892|NCT01331694|20551750|P4|STARTED|Overall Study||12595
8336893|NCT01331694|20551751|P3|STARTED|Overall Study||12659
8336894|NCT01331694|20551752|P2|STARTED|Overall Study||14449
8336895|NCT01331694|20551753|P1|STARTED|Overall Study||16684
8336896|NCT01331681|20551770|P3|NOT COMPLETED|Overall Study||35
8336897|NCT01331681|20551771|P2|NOT COMPLETED|Overall Study||34
8336898|NCT01331681|20551772|P1|NOT COMPLETED|Overall Study||35
8336899|NCT01331681|20551770|P3|COMPLETED|Overall Study|Completed Week 148|100
8336900|NCT01331681|20551771|P2|COMPLETED|Overall Study|Completed Week 148|101
8336901|NCT01331681|20551772|P1|COMPLETED|Overall Study|Completed Week 148|101
8336902|NCT01331681|20551770|P3|Completed Week 148|Overall Study||100
8336903|NCT01331681|20551771|P2|Completed Week 148|Overall Study||101
8336904|NCT01331681|20551772|P1|Completed Week 148|Overall Study||101
8336905|NCT01331681|20551770|P3|Completed Week 100|Overall Study||105
8336906|NCT01331681|20551771|P2|Completed Week 100|Overall Study||110
8336907|NCT01331681|20551772|P1|Completed Week 100|Overall Study||115
8336908|NCT01331681|20551770|P3|Completed Week 52|Overall Study||115
8336909|NCT01331681|20551771|P2|Completed Week 52|Overall Study||121
8336910|NCT01331681|20551772|P1|Completed Week 52|Overall Study||125
8336911|NCT01331681|20551770|P3|Participants Received Treatment|Overall Study|safety population|133
8336912|NCT01331681|20551771|P2|Participants Received Treatment|Overall Study|safety population|135
8336913|NCT01331681|20551772|P1|Participants Received Treatment|Overall Study|safety population|136
8336914|NCT01331681|20551770|P3|STARTED|Overall Study|randomized|135
8336915|NCT01331681|20551771|P2|STARTED|Overall Study|randomized|135
8336916|NCT01331681|20551772|P1|STARTED|Overall Study|randomized|136
8336917|NCT01331408|20551798|P1|NOT COMPLETED|Overall Study||11
8336918|NCT01331408|20551798|P1|COMPLETED|Overall Study||50
8336919|NCT01331408|20551798|P1|STARTED|Overall Study||61
8336920|NCT01331304|20551806|P2|NOT COMPLETED|Overall Study||60
8336921|NCT01331304|20551807|P1|NOT COMPLETED|Overall Study||58
8336922|NCT01331304|20551806|P2|COMPLETED|Overall Study||182
8336923|NCT01331304|20551807|P1|COMPLETED|Overall Study||182
8336924|NCT01331304|20551806|P2|STARTED|Overall Study||242
8336925|NCT01331304|20551807|P1|STARTED|Overall Study||240
8336926|NCT01331291|20551821|P2|NOT COMPLETED|Overall Study||9
8336927|NCT01331291|20551822|P1|NOT COMPLETED|Overall Study||2
8336928|NCT01331291|20551821|P2|COMPLETED|Overall Study||0
8336929|NCT01331291|20551822|P1|COMPLETED|Overall Study||0
8336930|NCT01331291|20551821|P2|STARTED|Overall Study||9
8336931|NCT01331291|20551822|P1|STARTED|Overall Study||2
8336932|NCT01331239|20551835|P3|NOT COMPLETED|Part II: Core Study||1
8336933|NCT01331239|20551836|P2|NOT COMPLETED|Part II: Core Study||8
8336934|NCT01331239|20551837|P1|NOT COMPLETED|Part II: Core Study||0
8336935|NCT01331239|20551835|P3|COMPLETED|Part II: Core Study||3
8336936|NCT01331239|20551836|P2|COMPLETED|Part II: Core Study||7
8336937|NCT01331239|20551837|P1|COMPLETED|Part II: Core Study||0
8336938|NCT01331239|20551835|P3|STARTED|Part II: Core Study||4
8336939|NCT01331239|20551836|P2|STARTED|Part II: Core Study||15
8336940|NCT01331239|20551837|P1|STARTED|Part II: Core Study||0
8336941|NCT01331239|20551835|P3|NOT COMPLETED|Part I: Core Study||0
8336942|NCT01331239|20551836|P2|NOT COMPLETED|Part I: Core Study||0
8336943|NCT01331239|20551837|P1|NOT COMPLETED|Part I: Core Study||0
8336944|NCT01331239|20551835|P3|COMPLETED|Part I: Core Study||0
8336945|NCT01331239|20551836|P2|COMPLETED|Part I: Core Study||0
8336946|NCT01331239|20551837|P1|COMPLETED|Part I: Core Study||12
8336947|NCT01331239|20551835|P3|STARTED|Part I: Core Study||0
8336948|NCT01331239|20551836|P2|STARTED|Part I: Core Study||0
8336949|NCT01331239|20551837|P1|STARTED|Part I: Core Study||12
8336950|NCT01331213|20551909|P2|NOT COMPLETED|Overall Study||0
8336951|NCT01331213|20551910|P1|NOT COMPLETED|Overall Study||0
8336952|NCT01331213|20551909|P2|COMPLETED|Overall Study||10
8336953|NCT01331213|20551910|P1|COMPLETED|Overall Study||8
8336954|NCT01331213|20551909|P2|STARTED|Overall Study||10
8336955|NCT01331213|20551910|P1|STARTED|Overall Study||8
8336956|NCT01331161|20551930|P2|NOT COMPLETED|Overall Study||2
8336957|NCT01331161|20551931|P1|NOT COMPLETED|Overall Study||1
8336958|NCT01331161|20551930|P2|COMPLETED|Overall Study||31
8336959|NCT01331161|20551931|P1|COMPLETED|Overall Study||43
8336960|NCT01331161|20551930|P2|STARTED|Overall Study||33
8336961|NCT01331161|20551931|P1|STARTED|Overall Study||44
8336962|NCT01331109|20551939|P1|NOT COMPLETED|Overall Study||57
8336963|NCT01331109|20551939|P1|COMPLETED|Overall Study||0
8336964|NCT01331109|20551939|P1|STARTED|Overall Study||57
8336965|NCT01331083|20551951|P2|NOT COMPLETED|Overall Study||0
8336966|NCT01331083|20551952|P1|NOT COMPLETED|Overall Study||0
8336967|NCT01331083|20551951|P2|COMPLETED|Overall Study||25
8336968|NCT01331083|20551952|P1|COMPLETED|Overall Study||43
8336969|NCT01331083|20551951|P2|STARTED|Overall Study||25
8336970|NCT01331083|20551952|P1|STARTED|Overall Study||43
8336971|NCT01331005|20551966|P2|NOT COMPLETED|Overall Study||4
8336972|NCT01331005|20551967|P1|NOT COMPLETED|Overall Study||4
8336973|NCT01331005|20551966|P2|COMPLETED|Overall Study||57
8336974|NCT01331005|20551967|P1|COMPLETED|Overall Study||60
8336975|NCT01331005|20551966|P2|STARTED|Overall Study||61
8336976|NCT01331005|20551967|P1|STARTED|Overall Study||64
8336977|NCT01330966|20551977|P1|NOT COMPLETED|Overall Study||5
8336978|NCT01330966|20551977|P1|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
8336979|NCT01330966|20551977|P1|STARTED|Overall Study||47
8336980|NCT01330953|20551988|P5|NOT COMPLETED|Overall Study||0
8336981|NCT01330953|20551989|P4|NOT COMPLETED|Overall Study||0
8336982|NCT01330953|20551990|P3|NOT COMPLETED|Overall Study||0
8336983|NCT01330953|20551991|P2|NOT COMPLETED|Overall Study||0
8336984|NCT01330953|20551992|P1|NOT COMPLETED|Overall Study||0
8336985|NCT01330953|20551988|P5|COMPLETED|Overall Study||6
8336986|NCT01330953|20551989|P4|COMPLETED|Overall Study||6
8336987|NCT01330953|20551990|P3|COMPLETED|Overall Study||6
8336988|NCT01330953|20551991|P2|COMPLETED|Overall Study||6
8336989|NCT01330953|20551992|P1|COMPLETED|Overall Study||8
8336990|NCT01330953|20551988|P5|STARTED|Overall Study||6
8336991|NCT01330953|20551989|P4|STARTED|Overall Study||6
8336992|NCT01330953|20551990|P3|STARTED|Overall Study||6
8336993|NCT01330953|20551991|P2|STARTED|Overall Study||6
8336994|NCT01330953|20551992|P1|STARTED|Overall Study||8
8336995|NCT01330914|20552038|P1|NOT COMPLETED|Overall Study||7
8336996|NCT01330914|20552038|P1|COMPLETED|Overall Study||48
8336997|NCT01330914|20552038|P1|STARTED|Overall Study||55
8336998|NCT01330628|20552046|P2|NOT COMPLETED|Overall Study||40
8336999|NCT01330628|20552047|P1|NOT COMPLETED|Overall Study||70
8337000|NCT01330628|20552046|P2|COMPLETED|Overall Study||42
8337001|NCT01330628|20552047|P1|COMPLETED|Overall Study||100
8337002|NCT01330628|20552046|P2|6 Month Follow-up|Overall Study||60
8337003|NCT01330628|20552047|P1|6 Month Follow-up|Overall Study||135
8337004|NCT01330628|20552046|P2|30 Day Follow-up|Overall Study||73
8337005|NCT01330628|20552047|P1|30 Day Follow-up|Overall Study||165
8337006|NCT01330628|20552046|P2|STARTED|Overall Study||82
8337007|NCT01330628|20552047|P1|STARTED|Overall Study||170
8337008|NCT01330459|20552057|P2|NOT COMPLETED|Overall Study||2
8337009|NCT01330459|20552058|P1|NOT COMPLETED|Overall Study||0
8337010|NCT01330459|20552057|P2|COMPLETED|Overall Study||58
8337011|NCT01330459|20552058|P1|COMPLETED|Overall Study||61
8337012|NCT01330459|20552057|P2|STARTED|Overall Study||60
8337013|NCT01330459|20552058|P1|STARTED|Overall Study||61
8337014|NCT01330433|20552074|P2|NOT COMPLETED|Overall Study||3
8337015|NCT01330433|20552075|P1|NOT COMPLETED|Overall Study||2
8337016|NCT01330433|20552074|P2|COMPLETED|Overall Study||16
8337017|NCT01330433|20552075|P1|COMPLETED|Overall Study||14
8337018|NCT01330433|20552074|P2|STARTED|Overall Study||19
8337019|NCT01330433|20552075|P1|STARTED|Overall Study||16
8337020|NCT01330420|20552095|P1|NOT COMPLETED|Overall Study||4
8337021|NCT01330420|20552095|P1|COMPLETED|Overall Study||24
8337022|NCT01330420|20552095|P1|STARTED|Overall Study||28
8337023|NCT01330394|20552105|P2|NOT COMPLETED|Overall Study||0
8337024|NCT01330394|20552106|P1|NOT COMPLETED|Overall Study||0
8337025|NCT01330394|20552105|P2|COMPLETED|Overall Study||16
8337026|NCT01330394|20552106|P1|COMPLETED|Overall Study||17
8337027|NCT01330394|20552105|P2|STARTED|Overall Study||16
8337028|NCT01330394|20552106|P1|STARTED|Overall Study||17
8337029|NCT01330381|20552114|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
8337030|NCT01330381|20552115|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
8337031|NCT01330381|20552116|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
8337032|NCT01330381|20552114|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
8337033|NCT01330381|20552115|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
8337034|NCT01330381|20552116|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
8337035|NCT01330381|20552114|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
8337036|NCT01330381|20552115|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
8337037|NCT01330381|20552116|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
8337038|NCT01330381|20552114|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
8337039|NCT01330381|20552115|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
8337040|NCT01330381|20552116|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
8337041|NCT01330381|20552114|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
8337042|NCT01330381|20552115|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
8337043|NCT01330381|20552116|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
8337044|NCT01330381|20552114|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
8337045|NCT01330381|20552115|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
8337046|NCT01330381|20552116|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
8337047|NCT01330381|20552114|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
8337048|NCT01330381|20552115|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
8337049|NCT01330381|20552116|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
8337050|NCT01330355|20552162|P2|NOT COMPLETED|Overall Study||0
8337051|NCT01330355|20552163|P1|NOT COMPLETED|Overall Study||0
8337052|NCT01330355|20552162|P2|COMPLETED|Overall Study||17
8337053|NCT01330355|20552163|P1|COMPLETED|Overall Study||16
8337054|NCT01330355|20552162|P2|STARTED|Overall Study||17
8337055|NCT01330355|20552163|P1|STARTED|Overall Study||16
8337056|NCT01330316|20552177|P2|NOT COMPLETED|Overall Study||15
8337057|NCT01330316|20552178|P1|NOT COMPLETED|Overall Study||2
8337058|NCT01330316|20552177|P2|COMPLETED|Overall Study||60
8337059|NCT01330316|20552178|P1|COMPLETED|Overall Study||41
8337060|NCT01330316|20552177|P2|STARTED|Overall Study||75
8337061|NCT01330316|20552178|P1|STARTED|Overall Study||43
8337062|NCT01330303|20552214|P2|NOT COMPLETED|Period 2||0
8337063|NCT01330303|20552215|P1|NOT COMPLETED|Period 2||0
8337064|NCT01330303|20552214|P2|COMPLETED|Period 2||18
8337065|NCT01330303|20552215|P1|COMPLETED|Period 2||19
8337066|NCT01330303|20552214|P2|STARTED|Period 2||18
8337067|NCT01330303|20552215|P1|STARTED|Period 2||19
8337068|NCT01330303|20552214|P2|NOT COMPLETED|7-Day Washout Period||0
8337069|NCT01330303|20552215|P1|NOT COMPLETED|7-Day Washout Period||0
8337070|NCT01330303|20552214|P2|COMPLETED|7-Day Washout Period||18
8337071|NCT01330303|20552215|P1|COMPLETED|7-Day Washout Period||19
8337072|NCT01330303|20552214|P2|STARTED|7-Day Washout Period||18
8337073|NCT01330303|20552215|P1|STARTED|7-Day Washout Period||19
8337074|NCT01330303|20552214|P2|NOT COMPLETED|Period 1||2
8337075|NCT01330303|20552215|P1|NOT COMPLETED|Period 1||1
8337076|NCT01330303|20552214|P2|COMPLETED|Period 1||18
8337077|NCT01330303|20552215|P1|COMPLETED|Period 1||19
8337078|NCT01330303|20552214|P2|STARTED|Period 1||20
8337079|NCT01330303|20552215|P1|STARTED|Period 1||20
8337080|NCT01330290|20552225|P1|NOT COMPLETED|Overall Study||0
8337081|NCT01330290|20552225|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
8337082|NCT01330290|20552225|P1|STARTED|Overall Study||148
8337083|NCT01330134|20552251|P2|NOT COMPLETED|Overall Study||0
8337084|NCT01330134|20552252|P1|NOT COMPLETED|Overall Study||0
8337085|NCT01330134|20552251|P2|COMPLETED|Overall Study||237
8337086|NCT01330134|20552252|P1|COMPLETED|Overall Study||244
8337087|NCT01330134|20552251|P2|STARTED|Overall Study||237
8337088|NCT01330134|20552252|P1|STARTED|Overall Study||244
8337089|NCT01330108|20552262|P1|NOT COMPLETED|Overall Study||4
8337090|NCT01330108|20552262|P1|COMPLETED|Overall Study||28
8337091|NCT01330108|20552262|P1|STARTED|Overall Study||32
8337092|NCT01330043|20552269|P2|NOT COMPLETED|Overall Study||4
8337093|NCT01330043|20552270|P1|NOT COMPLETED|Overall Study||0
8337094|NCT01330043|20552269|P2|COMPLETED|Overall Study||108
8337095|NCT01330043|20552270|P1|COMPLETED|Overall Study||111
8337096|NCT01330043|20552269|P2|STARTED|Overall Study||112
8337097|NCT01330043|20552270|P1|STARTED|Overall Study||111
8337098|NCT01330030|20552280|P2|NOT COMPLETED|Overall Study||17
8337099|NCT01330030|20552281|P1|NOT COMPLETED|Overall Study||16
8337100|NCT01330030|20552280|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
8337101|NCT01330030|20552281|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
8337102|NCT01330030|20552280|P2|STARTED|Overall Study||122
8337103|NCT01330030|20552281|P1|STARTED|Overall Study||121
8337104|NCT01330017|20552292|P5|NOT COMPLETED|Overall Study||3
8337105|NCT01330017|20552293|P4|NOT COMPLETED|Overall Study||12
8337106|NCT01330017|20552294|P3|NOT COMPLETED|Overall Study||8
8337107|NCT01330017|20552295|P2|NOT COMPLETED|Overall Study||4
8337108|NCT01330017|20552296|P1|NOT COMPLETED|Overall Study||5
8337109|NCT01330017|20552292|P5|COMPLETED|Overall Study||100
8337110|NCT01330017|20552293|P4|COMPLETED|Overall Study||100
8337111|NCT01330017|20552294|P3|COMPLETED|Overall Study||99
8337112|NCT01330017|20552295|P2|COMPLETED|Overall Study||104
8337113|NCT01330017|20552296|P1|COMPLETED|Overall Study||104
8337114|NCT01330017|20552292|P5|STARTED|Overall Study||103
8337115|NCT01330017|20552293|P4|STARTED|Overall Study||112
8337116|NCT01330017|20552294|P3|STARTED|Overall Study||107
8337117|NCT01330017|20552295|P2|STARTED|Overall Study||108
8337118|NCT01330017|20552296|P1|STARTED|Overall Study||109
8337119|NCT01329978|20552345|P5|NOT COMPLETED|Rerandomization Treatment Period||4
8337120|NCT01329978|20552346|P4|NOT COMPLETED|Rerandomization Treatment Period||5
8337121|NCT01329978|20552347|P3|NOT COMPLETED|Rerandomization Treatment Period||0
8337122|NCT01329978|20552348|P2|NOT COMPLETED|Rerandomization Treatment Period||0
8337123|NCT01329978|20552349|P1|NOT COMPLETED|Rerandomization Treatment Period||0
8337124|NCT01329978|20552345|P5|COMPLETED|Rerandomization Treatment Period||71
8337125|NCT01329978|20552346|P4|COMPLETED|Rerandomization Treatment Period||70
8337126|NCT01329978|20552347|P3|COMPLETED|Rerandomization Treatment Period||0
8337127|NCT01329978|20552348|P2|COMPLETED|Rerandomization Treatment Period||0
8337128|NCT01329978|20552349|P1|COMPLETED|Rerandomization Treatment Period||0
8337129|NCT01329978|20552345|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
8337130|NCT01329978|20552346|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
8337131|NCT01329978|20552347|P3|STARTED|Rerandomization Treatment Period||0
8337132|NCT01329978|20552348|P2|STARTED|Rerandomization Treatment Period||0
8337133|NCT01329978|20552349|P1|STARTED|Rerandomization Treatment Period||0
8337134|NCT01329978|20552345|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337135|NCT01329978|20552346|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337136|NCT01329978|20552347|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
8337137|NCT01329978|20552348|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
8337138|NCT01329978|20552349|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
8337139|NCT01329978|20552345|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337140|NCT01329978|20552346|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337141|NCT01329978|20552347|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
8337142|NCT01329978|20552348|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
8337143|NCT01329978|20552349|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
8337144|NCT01329978|20552345|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
8337145|NCT01329978|20552346|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
8337146|NCT01329978|20552347|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
8337147|NCT01329978|20552348|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
8337148|NCT01329978|20552349|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
8337149|NCT01329939|20552423|P4|NOT COMPLETED|Overall Study||5
8337150|NCT01329939|20552424|P3|NOT COMPLETED|Overall Study||1
8337151|NCT01329939|20552425|P2|NOT COMPLETED|Overall Study||1
8337152|NCT01329939|20552426|P1|NOT COMPLETED|Overall Study||3
8337153|NCT01329939|20552423|P4|COMPLETED|Overall Study||4
8337154|NCT01329939|20552424|P3|COMPLETED|Overall Study||4
8337155|NCT01329939|20552425|P2|COMPLETED|Overall Study||4
8337156|NCT01329939|20552426|P1|COMPLETED|Overall Study||4
8337157|NCT01329939|20552423|P4|STARTED|Overall Study||9
8337158|NCT01329939|20552424|P3|STARTED|Overall Study||5
8337159|NCT01329939|20552425|P2|STARTED|Overall Study||5
8337160|NCT01329939|20552426|P1|STARTED|Overall Study||7
8337161|NCT01329900|20552464|P1|NOT COMPLETED|Overall Study||1
8337162|NCT01329900|20552464|P1|COMPLETED|Overall Study||49
8337163|NCT01329900|20552464|P1|STARTED|Overall Study||50
8337164|NCT01329848|20552468|P1|NOT COMPLETED|Overall Study||29
8337165|NCT01329848|20552468|P1|COMPLETED|Overall Study||54
8337166|NCT01329848|20552468|P1|STARTED|Overall Study||83
8337167|NCT01329679|20552473|P2|NOT COMPLETED|Overall Study||0
8337168|NCT01329679|20552474|P1|NOT COMPLETED|Overall Study||0
8337169|NCT01329679|20552473|P2|COMPLETED|Overall Study||13
8337170|NCT01329679|20552474|P1|COMPLETED|Overall Study||13
8337171|NCT01329679|20552473|P2|STARTED|Overall Study||13
8337172|NCT01329679|20552474|P1|STARTED|Overall Study||13
8337173|NCT01329562|20552494|P2|NOT COMPLETED|Overall Study||7
8337174|NCT01329562|20552495|P1|NOT COMPLETED|Overall Study||9
8337175|NCT01329562|20552494|P2|COMPLETED|Overall Study||14
8337176|NCT01329562|20552495|P1|COMPLETED|Overall Study||11
8337177|NCT01329562|20552494|P2|STARTED|Overall Study||21
8337178|NCT01329562|20552495|P1|STARTED|Overall Study||20
8337179|NCT01329549|20552544|P1|NOT COMPLETED|Overall Study||2
8337180|NCT01329549|20552544|P1|COMPLETED|Overall Study||0
8337181|NCT01329549|20552544|P1|STARTED|Overall Study||2
8337182|NCT01329419|20552555|P1|NOT COMPLETED|Overall Study||235
8337183|NCT01329419|20552555|P1|COMPLETED|Overall Study||4158
8337184|NCT01329419|20552555|P1|STARTED|Overall Study||4393
8337185|NCT01329380|20552561|P1|NOT COMPLETED|Overall Study||29
8337186|NCT01329380|20552561|P1|COMPLETED|Overall Study||374
8337187|NCT01329380|20552561|P1|Safety Population|Overall Study||396
8337188|NCT01329380|20552561|P1|STARTED|Overall Study||403
8337189|NCT01329328|20552574|P3|NOT COMPLETED|Overall Study||3
8337190|NCT01329328|20552575|P2|NOT COMPLETED|Overall Study||4
8337191|NCT01329328|20552576|P1|NOT COMPLETED|Overall Study||2
8337192|NCT01329328|20552574|P3|COMPLETED|Overall Study||15
8337193|NCT01329328|20552575|P2|COMPLETED|Overall Study||13
8337194|NCT01329328|20552576|P1|COMPLETED|Overall Study||13
8337195|NCT01329328|20552574|P3|STARTED|Overall Study||18
8337196|NCT01329328|20552575|P2|STARTED|Overall Study||17
8337197|NCT01329328|20552576|P1|STARTED|Overall Study||15
8337198|NCT01329263|20552589|P2|NOT COMPLETED|Overall Study||23
8337199|NCT01329263|20552590|P1|NOT COMPLETED|Overall Study||5
8337200|NCT01329263|20552589|P2|COMPLETED|Overall Study||22
8337201|NCT01329263|20552590|P1|COMPLETED|Overall Study||10
8337202|NCT01329263|20552589|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
8337203|NCT01329263|20552590|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
8337204|NCT01329263|20552589|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
8337205|NCT01329263|20552590|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
8337206|NCT01329263|20552589|P2|Completed Period 1 Own Menthol|Overall Study||45
8337207|NCT01329263|20552590|P1|Completed Period 1 Own Menthol|Overall Study||15
8337208|NCT01329263|20552589|P2|STARTED|Overall Study||45
8337209|NCT01329263|20552590|P1|STARTED|Overall Study||15
8337210|NCT01329198|20552604|P2|NOT COMPLETED|Overall Study||0
8337211|NCT01329198|20552605|P1|NOT COMPLETED|Overall Study||0
8337212|NCT01329198|20552604|P2|COMPLETED|Overall Study||2
8337213|NCT01329198|20552605|P1|COMPLETED|Overall Study||3
8337214|NCT01329198|20552604|P2|STARTED|Overall Study||2
8337215|NCT01329198|20552605|P1|STARTED|Overall Study||3
8337216|NCT01329185|20552618|P2|NOT COMPLETED|Overall Study||0
8337217|NCT01329185|20552619|P1|NOT COMPLETED|Overall Study||0
8337218|NCT01329185|20552618|P2|COMPLETED|Overall Study||7
8337219|NCT01329185|20552619|P1|COMPLETED|Overall Study||10
8337220|NCT01329185|20552618|P2|PTLD|Overall Study||0
8337221|NCT01329185|20552619|P1|PTLD|Overall Study||1
8337222|NCT01329185|20552618|P2|CMV Disease|Overall Study||0
8337223|NCT01329185|20552619|P1|CMV Disease|Overall Study||1
8337224|NCT01329185|20552618|P2|STARTED|Overall Study||7
8337225|NCT01329185|20552619|P1|STARTED|Overall Study||10
8337226|NCT01329029|20552627|P2|NOT COMPLETED|Overall Study||192
8337227|NCT01329029|20552628|P1|NOT COMPLETED|Overall Study||269
8337228|NCT01329029|20552627|P2|COMPLETED|Overall Study||780
8337229|NCT01329029|20552628|P1|COMPLETED|Overall Study||704
8337230|NCT01329029|20552627|P2|Safety Population|Overall Study||967
8337231|NCT01329029|20552628|P1|Safety Population|Overall Study||968
8337232|NCT01329029|20552627|P2|Full Analysis Set (FAS)|Overall Study||966
8337233|NCT01329029|20552628|P1|Full Analysis Set (FAS)|Overall Study||969
8337234|NCT01329029|20552627|P2|STARTED|Overall Study||972
8337235|NCT01329029|20552628|P1|STARTED|Overall Study||973
8337236|NCT01328964|20552701|P3|NOT COMPLETED|Overall Study||0
8337237|NCT01328964|20552702|P2|NOT COMPLETED|Overall Study||0
8337238|NCT01328964|20552703|P1|NOT COMPLETED|Overall Study||0
8337239|NCT01328964|20552701|P3|COMPLETED|Overall Study||4424
8337240|NCT01328964|20552702|P2|COMPLETED|Overall Study||3270
8337241|NCT01328964|20552703|P1|COMPLETED|Overall Study||2212
8337242|NCT01328964|20552701|P3|STARTED|Overall Study||4424
8337243|NCT01328964|20552702|P2|STARTED|Overall Study||3270
8337244|NCT01328964|20552703|P1|STARTED|Overall Study||2212
8337245|NCT01328951|20552718|P2|NOT COMPLETED|Overall Study||322
8337246|NCT01328951|20552719|P1|NOT COMPLETED|Overall Study||321
8337247|NCT01328951|20552718|P2|COMPLETED|Overall Study||0
8337248|NCT01328951|20552719|P1|COMPLETED|Overall Study||0
8337249|NCT01328951|20552718|P2|STARTED|Overall Study||322
8337250|NCT01328951|20552719|P1|STARTED|Overall Study||321
8337251|NCT01328873|20552743|P1|NOT COMPLETED|Overall Study||0
8337252|NCT01328873|20552743|P1|COMPLETED|Overall Study||49
8337253|NCT01328873|20552743|P1|STARTED|Overall Study||49
8337254|NCT01328782|20552755|P3|NOT COMPLETED|Overall Study||0
8337255|NCT01328782|20552756|P2|NOT COMPLETED|Overall Study||0
8337256|NCT01328782|20552757|P1|NOT COMPLETED|Overall Study||0
8337257|NCT01328782|20552755|P3|COMPLETED|Overall Study||39
8337258|NCT01328782|20552756|P2|COMPLETED|Overall Study||42
8337259|NCT01328782|20552757|P1|COMPLETED|Overall Study||43
8337260|NCT01328782|20552755|P3|STARTED|Overall Study||39
8337261|NCT01328782|20552756|P2|STARTED|Overall Study||42
8337262|NCT01328782|20552757|P1|STARTED|Overall Study||43
8337263|NCT01328769|20552779|P2|NOT COMPLETED|Overall Study||1
8337264|NCT01328769|20552780|P1|NOT COMPLETED|Overall Study||0
8337265|NCT01328769|20552779|P2|COMPLETED|Overall Study||23
8337266|NCT01328769|20552780|P1|COMPLETED|Overall Study||25
8337267|NCT01328769|20552779|P2|STARTED|Overall Study||24
8337268|NCT01328769|20552780|P1|STARTED|Overall Study||25
8337269|NCT01328756|20552788|P1|NOT COMPLETED|Overall Study||123
8337270|NCT01328756|20552788|P1|COMPLETED|Overall Study||191
8337271|NCT01328756|20552788|P1|STARTED|Overall Study||314
8337272|NCT01328743|20552807|P2|NOT COMPLETED|Overall Study||10
8337273|NCT01328743|20552808|P1|NOT COMPLETED|Overall Study||9
8337274|NCT01328743|20552807|P2|COMPLETED|Overall Study||79
8337275|NCT01328743|20552808|P1|COMPLETED|Overall Study||82
8337276|NCT01328743|20552807|P2|STARTED|Overall Study||89
8337277|NCT01328743|20552808|P1|STARTED|Overall Study||91
8337278|NCT01328717|20552824|P1|NOT COMPLETED|Overall Study||1
8337279|NCT01328717|20552824|P1|COMPLETED|Overall Study||77
8337280|NCT01328717|20552824|P1|STARTED|Overall Study||78
8337281|NCT01328587|20552829|P1|NOT COMPLETED|Overall Study||0
8337282|NCT01328587|20552829|P1|COMPLETED|Overall Study||34
8337283|NCT01328587|20552829|P1|STARTED|Overall Study||34
8337284|NCT01328574|20552833|P1|NOT COMPLETED|Overall Study||1
8337285|NCT01328574|20552833|P1|COMPLETED|Overall Study||12
8337286|NCT01328574|20552833|P1|STARTED|Overall Study||13
8337287|NCT01328548|20552847|P2|NOT COMPLETED|Overall Study||0
8337288|NCT01328548|20552848|P1|NOT COMPLETED|Overall Study||4
8337289|NCT01328548|20552847|P2|COMPLETED|Overall Study||50
8337290|NCT01328548|20552848|P1|COMPLETED|Overall Study||187
8337291|NCT01328548|20552847|P2|STARTED|Overall Study||50
8337292|NCT01328548|20552848|P1|STARTED|Overall Study||191
8337293|NCT01328535|20552866|P1|NOT COMPLETED|Overall Study||1
8337294|NCT01328535|20552866|P1|COMPLETED|Overall Study||24
8337295|NCT01328535|20552866|P1|STARTED|Overall Study||25
8337296|NCT01328496|20552877|P2|NOT COMPLETED|Overall Study||0
8337297|NCT01328496|20552878|P1|NOT COMPLETED|Overall Study||1
8337298|NCT01328496|20552877|P2|COMPLETED|Overall Study||4
8337299|NCT01328496|20552878|P1|COMPLETED|Overall Study||9
8337300|NCT01328496|20552877|P2|STARTED|Overall Study||4
8337301|NCT01328496|20552878|P1|STARTED|Overall Study||10
8337302|NCT01328444|20552896|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
8337303|NCT01328444|20552897|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
8337304|NCT01328444|20552898|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
8337305|NCT01328444|20552899|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8337306|NCT01328444|20552900|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
8337307|NCT01328444|20552901|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
8337308|NCT01328444|20552896|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
8337309|NCT01328444|20552897|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
8337310|NCT01328444|20552898|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
8337311|NCT01328444|20552899|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
8337312|NCT01328444|20552900|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
8337313|NCT01328444|20552901|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
8337314|NCT01328444|20552896|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
8337315|NCT01328444|20552897|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
8337316|NCT01328444|20552898|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
8337317|NCT01328444|20552899|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8337318|NCT01328444|20552900|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
8337319|NCT01328444|20552901|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
8337320|NCT01328444|20552896|P6|NOT COMPLETED|Washout Period (14 Days)||4
8337321|NCT01328444|20552897|P5|NOT COMPLETED|Washout Period (14 Days)||1
8337322|NCT01328444|20552898|P4|NOT COMPLETED|Washout Period (14 Days)||1
8337323|NCT01328444|20552899|P3|NOT COMPLETED|Washout Period (14 Days)||0
8337324|NCT01328444|20552900|P2|NOT COMPLETED|Washout Period (14 Days)||1
8337325|NCT01328444|20552901|P1|NOT COMPLETED|Washout Period (14 Days)||1
8337326|NCT01328444|20552896|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
8337327|NCT01328444|20552897|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
8337328|NCT01328444|20552898|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
8337329|NCT01328444|20552899|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
8337330|NCT01328444|20552900|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8337331|NCT01328444|20552901|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
8337332|NCT01328444|20552896|P6|STARTED|Washout Period (14 Days)||72
8337333|NCT01328444|20552897|P5|STARTED|Washout Period (14 Days)||67
8337334|NCT01328444|20552898|P4|STARTED|Washout Period (14 Days)||33
8337335|NCT01328444|20552899|P3|STARTED|Washout Period (14 Days)||25
8337336|NCT01328444|20552900|P2|STARTED|Washout Period (14 Days)||21
8337337|NCT01328444|20552901|P1|STARTED|Washout Period (14 Days)||83
8337338|NCT01328444|20552896|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
8337339|NCT01328444|20552897|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
8337340|NCT01328444|20552898|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
8337341|NCT01328444|20552899|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
8337342|NCT01328444|20552900|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8337343|NCT01328444|20552901|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
8337344|NCT01328444|20552896|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
8337345|NCT01328444|20552897|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
8337346|NCT01328444|20552898|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
8337347|NCT01328444|20552899|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
8337348|NCT01328444|20552900|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
8337349|NCT01328444|20552901|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
8337350|NCT01328444|20552896|P6|STARTED|Treatment Period 1 (12 Weeks)||78
8337351|NCT01328444|20552897|P5|STARTED|Treatment Period 1 (12 Weeks)||81
8337352|NCT01328444|20552898|P4|STARTED|Treatment Period 1 (12 Weeks)||41
8337353|NCT01328444|20552899|P3|STARTED|Treatment Period 1 (12 Weeks)||28
8337354|NCT01328444|20552900|P2|STARTED|Treatment Period 1 (12 Weeks)||26
8337355|NCT01328444|20552901|P1|STARTED|Treatment Period 1 (12 Weeks)||94
8337356|NCT01328431|20552947|P2|NOT COMPLETED|12 Month (12M)||97
8337357|NCT01328431|20552948|P1|NOT COMPLETED|12 Month (12M)||84
8337358|NCT01328431|20552947|P2|COMPLETED|12 Month (12M)||289
8337359|NCT01328431|20552948|P1|COMPLETED|12 Month (12M)||304
8337360|NCT01328431|20552947|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
8337361|NCT01328431|20552948|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
8337362|NCT01328431|20552947|P2|NOT COMPLETED|3 Month (3M)||72
8337363|NCT01328431|20552948|P1|NOT COMPLETED|3 Month (3M)||77
8337364|NCT01328431|20552947|P2|COMPLETED|3 Month (3M)||316
8337365|NCT01328431|20552948|P1|COMPLETED|3 Month (3M)||313
8337366|NCT01328431|20552947|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
8337367|NCT01328431|20552948|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
8337368|NCT01328431|20552947|P2|NOT COMPLETED|1 Month (1M)||58
8337369|NCT01328431|20552948|P1|NOT COMPLETED|1 Month (1M)||55
8337370|NCT01328431|20552947|P2|COMPLETED|1 Month (1M)||330
8337371|NCT01328431|20552948|P1|COMPLETED|1 Month (1M)||335
8337372|NCT01328431|20552947|P2|STARTED|1 Month (1M)||388
8337373|NCT01328431|20552948|P1|STARTED|1 Month (1M)||390
8337374|NCT01328431|20552947|P2|NOT COMPLETED|Baseline||2
8337375|NCT01328431|20552948|P1|NOT COMPLETED|Baseline||0
8337376|NCT01328431|20552947|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
8337377|NCT01328431|20552948|P1|COMPLETED|Baseline||390
8337378|NCT01328431|20552947|P2|STARTED|Baseline||390
8337379|NCT01328431|20552948|P1|STARTED|Baseline||390
8337380|NCT01328405|20552958|P2|NOT COMPLETED|Overall Study||0
8337381|NCT01328405|20552959|P1|NOT COMPLETED|Overall Study||0
8337382|NCT01328405|20552958|P2|COMPLETED|Overall Study||48
8337383|NCT01328405|20552959|P1|COMPLETED|Overall Study||52
8337384|NCT01328405|20552958|P2|STARTED|Overall Study||48
8337385|NCT01328405|20552959|P1|STARTED|Overall Study||52
8337386|NCT01328379|20552976|P3|NOT COMPLETED|Overall Study||0
8337387|NCT01328379|20552977|P2|NOT COMPLETED|Overall Study||0
8337388|NCT01328379|20552978|P1|NOT COMPLETED|Overall Study||1
8337389|NCT01328379|20552976|P3|COMPLETED|Overall Study||143
8337390|NCT01328379|20552977|P2|COMPLETED|Overall Study||144
8337391|NCT01328379|20552978|P1|COMPLETED|Overall Study||142
8337392|NCT01328379|20552976|P3|STARTED|Overall Study||143
8337393|NCT01328379|20552977|P2|STARTED|Overall Study||144
8337394|NCT01328379|20552978|P1|STARTED|Overall Study||143
8337395|NCT01328366|20553004|P1|NOT COMPLETED|Overall Study||10
8337396|NCT01328366|20553004|P1|COMPLETED|Overall Study||143
8337397|NCT01328366|20553004|P1|STARTED|Overall Study||153
8337398|NCT01328249|20553024|P2|NOT COMPLETED|Overall Study||3
8337399|NCT01328249|20553025|P1|NOT COMPLETED|Overall Study||7
8337400|NCT01328249|20553024|P2|COMPLETED|Overall Study||23
8337401|NCT01328249|20553025|P1|COMPLETED|Overall Study||48
8337402|NCT01328249|20553024|P2|STARTED|Overall Study||26
8337403|NCT01328249|20553025|P1|STARTED|Overall Study||55
8337404|NCT01328184|20553033|P1|NOT COMPLETED|Overall Study||0
8337405|NCT01328184|20553033|P1|COMPLETED|Overall Study||18
8337406|NCT01328184|20553033|P1|STARTED|Overall Study||18
8337407|NCT01328158|20553073|P1|NOT COMPLETED|Overall Study||0
8337408|NCT01328158|20553073|P1|COMPLETED|Overall Study||220
8337409|NCT01328158|20553073|P1|STARTED|Overall Study||220
8337410|NCT01328080|20553111|P1|NOT COMPLETED|Overall Study||5
8337411|NCT01328080|20553111|P1|COMPLETED|Overall Study||6
8337412|NCT01328080|20553111|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
8337413|NCT01328054|20553115|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
8337414|NCT01328054|20553116|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8337415|NCT01328054|20553115|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
8337416|NCT01328054|20553116|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8337417|NCT01328054|20553115|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
8337418|NCT01328054|20553116|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8337419|NCT01328054|20553115|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8337420|NCT01328054|20553116|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8337421|NCT01328054|20553115|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8337422|NCT01328054|20553116|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
8337423|NCT01328054|20553115|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
8337424|NCT01328054|20553116|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
8337425|NCT01328041|20553141|P1|NOT COMPLETED|Overall Study||57
8337426|NCT01328041|20553141|P1|COMPLETED|Overall Study||126
8337427|NCT01328041|20553141|P1|STARTED|Overall Study||183
8337428|NCT01328002|20553163|P2|NOT COMPLETED|Double-Blind Period||0
8337429|NCT01328002|20553164|P1|NOT COMPLETED|Double-Blind Period||2
8337430|NCT01328002|20553163|P2|COMPLETED|Double-Blind Period||6
8337431|NCT01328002|20553164|P1|COMPLETED|Double-Blind Period||12
8337432|NCT01328002|20553163|P2|STARTED|Double-Blind Period||6
8337433|NCT01328002|20553164|P1|STARTED|Double-Blind Period||14
8337434|NCT01328002|20553163|P2|NOT COMPLETED|Open-Label Period||0
8337435|NCT01328002|20553164|P1|NOT COMPLETED|Open-Label Period||96
8337436|NCT01328002|20553163|P2|COMPLETED|Open-Label Period||0
8337437|NCT01328002|20553164|P1|COMPLETED|Open-Label Period||20
8337438|NCT01328002|20553163|P2|STARTED|Open-Label Period||0
8337439|NCT01328002|20553164|P1|STARTED|Open-Label Period||116
8337440|NCT01327989|20553173|P1|NOT COMPLETED|Overall Study||14
8337441|NCT01327989|20553173|P1|COMPLETED|Overall Study||188
8337442|NCT01327989|20553173|P1|STARTED|Overall Study||202
8337443|NCT01327976|20553187|P2|NOT COMPLETED|Overall Study||7
8337444|NCT01327976|20553188|P1|NOT COMPLETED|Overall Study||8
8337445|NCT01327976|20553187|P2|COMPLETED|Overall Study||70
8337446|NCT01327976|20553188|P1|COMPLETED|Overall Study||154
8337447|NCT01327976|20553187|P2|STARTED|Overall Study||77
8337448|NCT01327976|20553188|P1|STARTED|Overall Study||162
8337449|NCT01327963|20553198|P1|NOT COMPLETED|Overall Study||0
8337450|NCT01327963|20553198|P1|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
8337451|NCT01327963|20553198|P1|STARTED|Overall Study||110
8337452|NCT01327885|20553209|P2|NOT COMPLETED|Overall Study||224
8337453|NCT01327885|20553210|P1|NOT COMPLETED|Overall Study||228
8337454|NCT01327885|20553209|P2|COMPLETED|Overall Study||0
8337455|NCT01327885|20553210|P1|COMPLETED|Overall Study||0
8337456|NCT01327885|20553209|P2|STARTED|Overall Study||224
8337457|NCT01327885|20553210|P1|STARTED|Overall Study||228
8337458|NCT01327846|20553226|P4|NOT COMPLETED|Extension Phase||1706
8337459|NCT01327846|20553227|P3|NOT COMPLETED|Extension Phase||1092
8337460|NCT01327846|20553228|P2|NOT COMPLETED|Extension Phase||1144
8337461|NCT01327846|20553229|P1|NOT COMPLETED|Extension Phase||1099
8337462|NCT01327846|20553226|P4|COMPLETED|Extension Phase||238
8337463|NCT01327846|20553227|P3|COMPLETED|Extension Phase||187
8337464|NCT01327846|20553228|P2|COMPLETED|Extension Phase||143
8337465|NCT01327846|20553229|P1|COMPLETED|Extension Phase||168
8337466|NCT01327846|20553226|P4|Details Missing|Extension Phase||0
8337467|NCT01327846|20553227|P3|Details Missing|Extension Phase||1
8337468|NCT01327846|20553228|P2|Details Missing|Extension Phase||1
8337469|NCT01327846|20553229|P1|Details Missing|Extension Phase||0
8337470|NCT01327846|20553226|P4|Completed Treatment Period|Extension Phase||60
8337471|NCT01327846|20553227|P3|Completed Treatment Period|Extension Phase||49
8337472|NCT01327846|20553228|P2|Completed Treatment Period|Extension Phase||45
8337473|NCT01327846|20553229|P1|Completed Treatment Period|Extension Phase||41
8337474|NCT01327846|20553226|P4|Stopped/Discontinued Study at Washout|Extension Phase||178
8337475|NCT01327846|20553227|P3|Stopped/Discontinued Study at Washout|Extension Phase||137
8337476|NCT01327846|20553228|P2|Stopped/Discontinued Study at Washout|Extension Phase||97
8337477|NCT01327846|20553229|P1|Stopped/Discontinued Study at Washout|Extension Phase||127
8337478|NCT01327846|20553226|P4|STARTED|Extension Phase||1944
8337479|NCT01327846|20553227|P3|STARTED|Extension Phase||1279
8337480|NCT01327846|20553228|P2|STARTED|Extension Phase||1287
8337481|NCT01327846|20553229|P1|STARTED|Extension Phase||1267
8337482|NCT01327846|20553226|P4|NOT COMPLETED|Core Phase||33
8337483|NCT01327846|20553227|P3|NOT COMPLETED|Core Phase||26
8337484|NCT01327846|20553228|P2|NOT COMPLETED|Core Phase||32
8337485|NCT01327846|20553229|P1|NOT COMPLETED|Core Phase||28
8337486|NCT01327846|20553226|P4|COMPLETED|Core Phase||3311
8337487|NCT01327846|20553227|P3|COMPLETED|Core Phase||2144
8337488|NCT01327846|20553228|P2|COMPLETED|Core Phase||2252
8337489|NCT01327846|20553229|P1|COMPLETED|Core Phase||2235
8337490|NCT01327846|20553226|P4|STARTED|Core Phase||3344
8337491|NCT01327846|20553227|P3|STARTED|Core Phase||2170
8337492|NCT01327846|20553228|P2|STARTED|Core Phase||2284
8337493|NCT01327846|20553229|P1|STARTED|Core Phase||2263
8337494|NCT01327703|20553304|P2|NOT COMPLETED|Second Treatment Period||2
8337495|NCT01327703|20553305|P1|NOT COMPLETED|Second Treatment Period||1
8337496|NCT01327703|20553304|P2|COMPLETED|Second Treatment Period||42
8337497|NCT01327703|20553305|P1|COMPLETED|Second Treatment Period||39
8337498|NCT01327703|20553304|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
8337499|NCT01327703|20553305|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
8337500|NCT01327703|20553304|P2|NOT COMPLETED|First Treatment Period||0
8337501|NCT01327703|20553305|P1|NOT COMPLETED|First Treatment Period||0
8337502|NCT01327703|20553304|P2|COMPLETED|First Treatment Period||45
8337503|NCT01327703|20553305|P1|COMPLETED|First Treatment Period||42
8337504|NCT01327703|20553304|P2|STARTED|First Treatment Period||45
8337505|NCT01327703|20553305|P1|STARTED|First Treatment Period||42
8337506|NCT01327677|20553339|P2|NOT COMPLETED|Overall Study||13
8337507|NCT01327677|20553340|P1|NOT COMPLETED|Overall Study||20
8337508|NCT01327677|20553339|P2|COMPLETED|Overall Study||56
8337509|NCT01327677|20553340|P1|COMPLETED|Overall Study||48
8337510|NCT01327677|20553339|P2|STARTED|Overall Study||69
8337511|NCT01327677|20553340|P1|STARTED|Overall Study||68
8337512|NCT01327651|20553361|P9|NOT COMPLETED|Post Study Follow-up||2
8337513|NCT01327651|20553362|P8|NOT COMPLETED|Post Study Follow-up||1
8337514|NCT01327651|20553363|P7|NOT COMPLETED|Post Study Follow-up||4
8337515|NCT01327651|20553364|P6|NOT COMPLETED|Post Study Follow-up||0
8337516|NCT01327651|20553365|P5|NOT COMPLETED|Post Study Follow-up||0
8337517|NCT01327651|20553366|P4|NOT COMPLETED|Post Study Follow-up||0
8337518|NCT01327651|20553367|P3|NOT COMPLETED|Post Study Follow-up||1
8337519|NCT01327651|20553368|P2|NOT COMPLETED|Post Study Follow-up||1
8337520|NCT01327651|20553369|P1|NOT COMPLETED|Post Study Follow-up||0
8337521|NCT01327651|20553361|P9|COMPLETED|Post Study Follow-up||47
8337522|NCT01327651|20553362|P8|COMPLETED|Post Study Follow-up||49
8337523|NCT01327651|20553363|P7|COMPLETED|Post Study Follow-up||45
8337524|NCT01327651|20553364|P6|COMPLETED|Post Study Follow-up||59
8337525|NCT01327651|20553365|P5|COMPLETED|Post Study Follow-up||56
8337526|NCT01327651|20553366|P4|COMPLETED|Post Study Follow-up||57
8337527|NCT01327651|20553367|P3|COMPLETED|Post Study Follow-up||55
8337528|NCT01327651|20553368|P2|COMPLETED|Post Study Follow-up||55
8337529|NCT01327651|20553369|P1|COMPLETED|Post Study Follow-up||56
8337530|NCT01327651|20553361|P9|STARTED|Post Study Follow-up||49
8337531|NCT01327651|20553362|P8|STARTED|Post Study Follow-up||50
8337532|NCT01327651|20553363|P7|STARTED|Post Study Follow-up||49
8337533|NCT01327651|20553364|P6|STARTED|Post Study Follow-up||59
8337534|NCT01327651|20553365|P5|STARTED|Post Study Follow-up||56
8337535|NCT01327651|20553366|P4|STARTED|Post Study Follow-up||57
8337536|NCT01327651|20553367|P3|STARTED|Post Study Follow-up||56
8337537|NCT01327651|20553368|P2|STARTED|Post Study Follow-up||56
8337538|NCT01327651|20553369|P1|STARTED|Post Study Follow-up||56
8337539|NCT01327651|20553361|P9|NOT COMPLETED|Self-administered Dosing Period||11
8337540|NCT01327651|20553362|P8|NOT COMPLETED|Self-administered Dosing Period||10
8337541|NCT01327651|20553363|P7|NOT COMPLETED|Self-administered Dosing Period||10
8337542|NCT01327651|20553364|P6|NOT COMPLETED|Self-administered Dosing Period||0
8337543|NCT01327651|20553365|P5|NOT COMPLETED|Self-administered Dosing Period||3
8337544|NCT01327651|20553366|P4|NOT COMPLETED|Self-administered Dosing Period||3
8337545|NCT01327651|20553367|P3|NOT COMPLETED|Self-administered Dosing Period||4
8337546|NCT01327651|20553368|P2|NOT COMPLETED|Self-administered Dosing Period||3
8337547|NCT01327651|20553369|P1|NOT COMPLETED|Self-administered Dosing Period||4
8337548|NCT01327651|20553361|P9|COMPLETED|Self-administered Dosing Period||49
8337549|NCT01327651|20553362|P8|COMPLETED|Self-administered Dosing Period||50
8337550|NCT01327651|20553363|P7|COMPLETED|Self-administered Dosing Period||49
8337551|NCT01327651|20553364|P6|COMPLETED|Self-administered Dosing Period||59
8337552|NCT01327651|20553365|P5|COMPLETED|Self-administered Dosing Period||56
8337553|NCT01327651|20553366|P4|COMPLETED|Self-administered Dosing Period||57
8337554|NCT01327651|20553367|P3|COMPLETED|Self-administered Dosing Period||56
8337555|NCT01327651|20553368|P2|COMPLETED|Self-administered Dosing Period||56
8337556|NCT01327651|20553369|P1|COMPLETED|Self-administered Dosing Period||56
8337557|NCT01327651|20553361|P9|Week 26|Self-administered Dosing Period||49
8337558|NCT01327651|20553362|P8|Week 26|Self-administered Dosing Period||51
8337559|NCT01327651|20553363|P7|Week 26|Self-administered Dosing Period||50
8337560|NCT01327651|20553364|P6|Week 26|Self-administered Dosing Period||58
8337561|NCT01327651|20553365|P5|Week 26|Self-administered Dosing Period||56
8337562|NCT01327651|20553366|P4|Week 26|Self-administered Dosing Period||57
8337563|NCT01327651|20553367|P3|Week 26|Self-administered Dosing Period||53
8337564|NCT01327651|20553368|P2|Week 26|Self-administered Dosing Period||56
8337565|NCT01327651|20553369|P1|Week 26|Self-administered Dosing Period||58
8337566|NCT01327651|20553361|P9|Week 22|Self-administered Dosing Period||51
8337567|NCT01327651|20553362|P8|Week 22|Self-administered Dosing Period||50
8337568|NCT01327651|20553363|P7|Week 22|Self-administered Dosing Period||50
8337569|NCT01327651|20553364|P6|Week 22|Self-administered Dosing Period||59
8337570|NCT01327651|20553365|P5|Week 22|Self-administered Dosing Period||56
8337571|NCT01327651|20553366|P4|Week 22|Self-administered Dosing Period||58
8337572|NCT01327651|20553367|P3|Week 22|Self-administered Dosing Period||55
8337573|NCT01327651|20553368|P2|Week 22|Self-administered Dosing Period||56
8337574|NCT01327651|20553369|P1|Week 22|Self-administered Dosing Period||59
8337575|NCT01327651|20553361|P9|Week 18|Self-administered Dosing Period||53
8337576|NCT01327651|20553362|P8|Week 18|Self-administered Dosing Period||49
8337577|NCT01327651|20553363|P7|Week 18|Self-administered Dosing Period||53
8337578|NCT01327651|20553364|P6|Week 18|Self-administered Dosing Period||59
8337579|NCT01327651|20553365|P5|Week 18|Self-administered Dosing Period||57
8337580|NCT01327651|20553366|P4|Week 18|Self-administered Dosing Period||60
8337581|NCT01327651|20553367|P3|Week 18|Self-administered Dosing Period||56
8337582|NCT01327651|20553368|P2|Week 18|Self-administered Dosing Period||56
8337583|NCT01327651|20553369|P1|Week 18|Self-administered Dosing Period||57
8337584|NCT01327651|20553361|P9|Week 14|Self-administered Dosing Period||54
8337585|NCT01327651|20553362|P8|Week 14|Self-administered Dosing Period||51
8337586|NCT01327651|20553363|P7|Week 14|Self-administered Dosing Period||54
8337587|NCT01327651|20553364|P6|Week 14|Self-administered Dosing Period||59
8337588|NCT01327651|20553365|P5|Week 14|Self-administered Dosing Period||58
8337589|NCT01327651|20553366|P4|Week 14|Self-administered Dosing Period||60
8337590|NCT01327651|20553367|P3|Week 14|Self-administered Dosing Period||57
8337591|NCT01327651|20553368|P2|Week 14|Self-administered Dosing Period||55
8337592|NCT01327651|20553369|P1|Week 14|Self-administered Dosing Period||59
8337593|NCT01327651|20553361|P9|Week 10|Self-administered Dosing Period||56
8337594|NCT01327651|20553362|P8|Week 10|Self-administered Dosing Period||57
8337595|NCT01327651|20553363|P7|Week 10|Self-administered Dosing Period||57
8337596|NCT01327651|20553364|P6|Week 10|Self-administered Dosing Period||59
8337597|NCT01327651|20553365|P5|Week 10|Self-administered Dosing Period||59
8337598|NCT01327651|20553366|P4|Week 10|Self-administered Dosing Period||60
8337599|NCT01327651|20553367|P3|Week 10|Self-administered Dosing Period||60
8337600|NCT01327651|20553368|P2|Week 10|Self-administered Dosing Period||58
8337601|NCT01327651|20553369|P1|Week 10|Self-administered Dosing Period||59
8337602|NCT01327651|20553361|P9|STARTED|Self-administered Dosing Period||60
8337603|NCT01327651|20553362|P8|STARTED|Self-administered Dosing Period||60
8337604|NCT01327651|20553363|P7|STARTED|Self-administered Dosing Period||59
8337605|NCT01327651|20553364|P6|STARTED|Self-administered Dosing Period||59
8337606|NCT01327651|20553365|P5|STARTED|Self-administered Dosing Period||59
8337607|NCT01327651|20553366|P4|STARTED|Self-administered Dosing Period||60
8337608|NCT01327651|20553367|P3|STARTED|Self-administered Dosing Period||60
8337609|NCT01327651|20553368|P2|STARTED|Self-administered Dosing Period||59
8337610|NCT01327651|20553369|P1|STARTED|Self-administered Dosing Period||60
8337611|NCT01327599|20553488|P1|NOT COMPLETED|Overall Study||3
8337612|NCT01327599|20553488|P1|COMPLETED|Overall Study||57
8337613|NCT01327599|20553488|P1|STARTED|Overall Study||60
8337614|NCT01327573|20553498|P2|NOT COMPLETED|Overall Study||1
8337615|NCT01327573|20553499|P1|NOT COMPLETED|Overall Study||3
8337616|NCT01327573|20553498|P2|COMPLETED|Overall Study||4
8337617|NCT01327573|20553499|P1|COMPLETED|Overall Study||8
8337618|NCT01327573|20553498|P2|Received Treatment/Control as Allocated|Overall Study||5
8337619|NCT01327573|20553499|P1|Received Treatment/Control as Allocated|Overall Study||10
8337620|NCT01327573|20553498|P2|STARTED|Overall Study||5
8337621|NCT01327573|20553499|P1|STARTED|Overall Study||11
8337622|NCT01327547|20553510|P2|NOT COMPLETED|Overall Study||22
8337623|NCT01327547|20553511|P1|NOT COMPLETED|Overall Study||20
8337624|NCT01327547|20553510|P2|COMPLETED|Overall Study||45
8337625|NCT01327547|20553511|P1|COMPLETED|Overall Study||50
8337626|NCT01327547|20553510|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
8337627|NCT01327547|20553511|P1|Randomized and Not Treated|Overall Study||0
8337628|NCT01327547|20553510|P2|STARTED|Overall Study||67
8337629|NCT01327547|20553511|P1|STARTED|Overall Study||70
8337630|NCT01327508|20553564|P2|NOT COMPLETED|Overall Study||0
8337631|NCT01327508|20553565|P1|NOT COMPLETED|Overall Study||0
8337632|NCT01327508|20553564|P2|COMPLETED|Overall Study||30
8337633|NCT01327508|20553565|P1|COMPLETED|Overall Study||30
8337634|NCT01327508|20553564|P2|STARTED|Overall Study||30
8337635|NCT01327508|20553565|P1|STARTED|Overall Study||30
8337636|NCT01327495|20553579|P6|NOT COMPLETED|Overall Study||2
8337637|NCT01327495|20553580|P5|NOT COMPLETED|Overall Study||3
8337638|NCT01327495|20553581|P4|NOT COMPLETED|Overall Study||0
8337639|NCT01327495|20553582|P3|NOT COMPLETED|Overall Study||2
8337640|NCT01327495|20553583|P2|NOT COMPLETED|Overall Study||2
8337641|NCT01327495|20553584|P1|NOT COMPLETED|Overall Study||2
8337642|NCT01327495|20553579|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
8337643|NCT01327495|20553580|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
8337644|NCT01327495|20553581|P4|COMPLETED|Overall Study||9
8337645|NCT01327495|20553582|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
8337646|NCT01327495|20553583|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
8337647|NCT01327495|20553584|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
8337648|NCT01327495|20553579|P6|STARTED|Overall Study||11
8337649|NCT01327495|20553580|P5|STARTED|Overall Study||11
8337650|NCT01327495|20553581|P4|STARTED|Overall Study||9
8337651|NCT01327495|20553582|P3|STARTED|Overall Study||10
8337652|NCT01327495|20553583|P2|STARTED|Overall Study||11
8337653|NCT01327495|20553584|P1|STARTED|Overall Study||10
8337654|NCT01327482|20553676|P1|NOT COMPLETED|Overall Study||1
8337655|NCT01327482|20553676|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
8337656|NCT01327482|20553676|P1|STARTED|Overall Study||10
8337657|NCT01327339|20553681|P1|NOT COMPLETED|Overall Study||8
8337658|NCT01327339|20553681|P1|COMPLETED|Overall Study||747
8337659|NCT01327339|20553681|P1|STARTED|Overall Study||755
8337660|NCT01327313|20553691|P4|NOT COMPLETED|Overall Study||0
8337661|NCT01327313|20553692|P3|NOT COMPLETED|Overall Study||0
8337662|NCT01327313|20553693|P2|NOT COMPLETED|Overall Study||0
8337663|NCT01327313|20553694|P1|NOT COMPLETED|Overall Study||0
8337664|NCT01327313|20553691|P4|COMPLETED|Overall Study||7
8337665|NCT01327313|20553692|P3|COMPLETED|Overall Study||6
8337666|NCT01327313|20553693|P2|COMPLETED|Overall Study||6
8337667|NCT01327313|20553694|P1|COMPLETED|Overall Study||8
8337668|NCT01327313|20553691|P4|STARTED|Overall Study||7
8337669|NCT01327313|20553692|P3|STARTED|Overall Study||6
8337670|NCT01327313|20553693|P2|STARTED|Overall Study||6
8337671|NCT01327313|20553694|P1|STARTED|Overall Study||8
8337672|NCT01327300|20553816|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8337673|NCT01327300|20553817|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8337674|NCT01327300|20553816|P2|COMPLETED|Second Intervention (12 Weeks)||2
8337675|NCT01327300|20553817|P1|COMPLETED|Second Intervention (12 Weeks)||4
8337676|NCT01327300|20553816|P2|STARTED|Second Intervention (12 Weeks)||2
8337677|NCT01327300|20553817|P1|STARTED|Second Intervention (12 Weeks)||4
8337678|NCT01327300|20553816|P2|NOT COMPLETED|Washout (3 Weeks)||0
8337679|NCT01327300|20553817|P1|NOT COMPLETED|Washout (3 Weeks)||1
8337680|NCT01327300|20553816|P2|COMPLETED|Washout (3 Weeks)||2
8337681|NCT01327300|20553817|P1|COMPLETED|Washout (3 Weeks)||4
8337682|NCT01327300|20553816|P2|STARTED|Washout (3 Weeks)||2
8337683|NCT01327300|20553817|P1|STARTED|Washout (3 Weeks)||5
8337684|NCT01327300|20553816|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
8337685|NCT01327300|20553817|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8337686|NCT01327300|20553816|P2|COMPLETED|First Intervention (12 Weeks)||2
8337687|NCT01327300|20553817|P1|COMPLETED|First Intervention (12 Weeks)||5
8337688|NCT01327300|20553816|P2|STARTED|First Intervention (12 Weeks)||2
8337689|NCT01327300|20553817|P1|STARTED|First Intervention (12 Weeks)||5
8337690|NCT01327274|20553833|P1|NOT COMPLETED|Overall Study||0
8337691|NCT01327274|20553833|P1|COMPLETED|Overall Study||15
8337692|NCT01327274|20553833|P1|STARTED|Overall Study||15
8337693|NCT01327157|20553842|P2|NOT COMPLETED|91-180||0
8337694|NCT01327157|20553843|P1|NOT COMPLETED|91-180||0
8337695|NCT01327157|20553842|P2|COMPLETED|91-180||0
8337696|NCT01327157|20553843|P1|COMPLETED|91-180||7
8337697|NCT01327157|20553842|P2|STARTED|91-180||0
8337698|NCT01327157|20553843|P1|STARTED|91-180||7
8337699|NCT01327157|20553842|P2|NOT COMPLETED|01-90||0
8337700|NCT01327157|20553843|P1|NOT COMPLETED|01-90||0
8337701|NCT01327157|20553842|P2|COMPLETED|01-90||7
8337702|NCT01327157|20553843|P1|COMPLETED|01-90||7
8337703|NCT01327157|20553842|P2|STARTED|01-90||7
8337704|NCT01327157|20553843|P1|STARTED|01-90||7
8337705|NCT01327053|20553857|P2|NOT COMPLETED|Overall Study||151
8337706|NCT01327053|20553858|P1|NOT COMPLETED|Overall Study||79
8337707|NCT01327053|20553857|P2|COMPLETED|Overall Study||0
8337708|NCT01327053|20553858|P1|COMPLETED|Overall Study||0
8337709|NCT01327053|20553857|P2|Post-treatment Follow-up|Overall Study||40
8337710|NCT01327053|20553858|P1|Post-treatment Follow-up|Overall Study||19
8337711|NCT01327053|20553857|P2|Survival Follow-up|Overall Study||49
8337712|NCT01327053|20553858|P1|Survival Follow-up|Overall Study||33
8337713|NCT01327053|20553857|P2|Patients Cont. to Next Phase of Trial|Overall Study||89
8337714|NCT01327053|20553858|P1|Patients Cont. to Next Phase of Trial|Overall Study||52
8337715|NCT01327053|20553857|P2|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
8337716|NCT01327053|20553858|P1|Untreated|Overall Study||0
8337717|NCT01327053|20553857|P2|STARTED|Overall Study||151
8337718|NCT01327053|20553858|P1|STARTED|Overall Study||79
8337719|NCT01326962|20553932|P1|NOT COMPLETED|Overall Study||7
8337720|NCT01326962|20553932|P1|COMPLETED|Overall Study||21
8337721|NCT01326962|20553932|P1|STARTED|Overall Study||28
8337722|NCT01326923|20553948|P1|NOT COMPLETED|Overall Study||0
8337723|NCT01326923|20553948|P1|COMPLETED|Overall Study||7
8337724|NCT01326923|20553948|P1|STARTED|Overall Study||7
8337725|NCT01326910|20553955|P2|NOT COMPLETED|Overall Study||3
8337726|NCT01326910|20553956|P1|NOT COMPLETED|Overall Study||4
8337727|NCT01326910|20553955|P2|COMPLETED|Overall Study||42
8337728|NCT01326910|20553956|P1|COMPLETED|Overall Study||41
8337729|NCT01326910|20553955|P2|STARTED|Overall Study||45
8337730|NCT01326910|20553956|P1|STARTED|Overall Study||45
8337731|NCT01326845|20553970|P2|NOT COMPLETED|Overall Study||5
8337732|NCT01326845|20553971|P1|NOT COMPLETED|Overall Study||7
8337733|NCT01326845|20553970|P2|COMPLETED|Overall Study|Study terminated early|0
8337734|NCT01326845|20553971|P1|COMPLETED|Overall Study|Study terminated early|0
8337735|NCT01326845|20553970|P2|STARTED|Overall Study||5
8337736|NCT01326845|20553971|P1|STARTED|Overall Study||7
8337737|NCT01326780|20553997|P4|NOT COMPLETED|Overall Study||13
8337738|NCT01326780|20553998|P3|NOT COMPLETED|Overall Study||6
8337739|NCT01326780|20553999|P2|NOT COMPLETED|Overall Study||9
8337740|NCT01326780|20554000|P1|NOT COMPLETED|Overall Study||13
8337741|NCT01326780|20553997|P4|COMPLETED|Overall Study||94
8337742|NCT01326780|20553998|P3|COMPLETED|Overall Study||103
8337743|NCT01326780|20553999|P2|COMPLETED|Overall Study||100
8337744|NCT01326780|20554000|P1|COMPLETED|Overall Study||93
8337745|NCT01326780|20553997|P4|STARTED|Overall Study||107
8337746|NCT01326780|20553998|P3|STARTED|Overall Study||109
8337747|NCT01326780|20553999|P2|STARTED|Overall Study||109
8337748|NCT01326780|20554000|P1|STARTED|Overall Study||106
8337749|NCT01326728|20554032|P2|NOT COMPLETED|Overall Study||9
8337750|NCT01326728|20554033|P1|NOT COMPLETED|Overall Study||47
8337751|NCT01326728|20554032|P2|COMPLETED|Overall Study||0
8337752|NCT01326728|20554033|P1|COMPLETED|Overall Study||0
8337753|NCT01326728|20554032|P2|STARTED|Overall Study||9
8337754|NCT01326728|20554033|P1|STARTED|Overall Study||47
8337755|NCT01326702|20554057|P7|NOT COMPLETED|Overall Study||7
8337756|NCT01326702|20554058|P6|NOT COMPLETED|Overall Study||8
8337757|NCT01326702|20554059|P5|NOT COMPLETED|Overall Study||4
8337758|NCT01326702|20554060|P4|NOT COMPLETED|Overall Study||3
8337759|NCT01326702|20554061|P3|NOT COMPLETED|Overall Study||5
8337760|NCT01326702|20554062|P2|NOT COMPLETED|Overall Study||2
8337761|NCT01326702|20554063|P1|NOT COMPLETED|Overall Study||2
8337762|NCT01326702|20554057|P7|COMPLETED|Overall Study||0
8337763|NCT01326702|20554058|P6|COMPLETED|Overall Study||7
8337764|NCT01326702|20554059|P5|COMPLETED|Overall Study||1
8337765|NCT01326702|20554060|P4|COMPLETED|Overall Study||1
8337766|NCT01326702|20554061|P3|COMPLETED|Overall Study||1
8337767|NCT01326702|20554062|P2|COMPLETED|Overall Study||1
8337768|NCT01326702|20554063|P1|COMPLETED|Overall Study||1
8337769|NCT01326702|20554057|P7|STARTED|Overall Study||7
8337770|NCT01326702|20554058|P6|STARTED|Overall Study||15
8337771|NCT01326702|20554059|P5|STARTED|Overall Study||5
8337772|NCT01326702|20554060|P4|STARTED|Overall Study||4
8337773|NCT01326702|20554061|P3|STARTED|Overall Study||6
8337774|NCT01326702|20554062|P2|STARTED|Overall Study||3
8337775|NCT01326702|20554063|P1|STARTED|Overall Study||3
8337776|NCT01326546|20554119|P2|NOT COMPLETED|Overall Study||13
8337777|NCT01326546|20554120|P1|NOT COMPLETED|Overall Study||17
8337778|NCT01326546|20554119|P2|COMPLETED|Overall Study||176
8337779|NCT01326546|20554120|P1|COMPLETED|Overall Study||172
8337780|NCT01326546|20554119|P2|STARTED|Overall Study||189
8337781|NCT01326546|20554120|P1|STARTED|Overall Study||189
8337782|NCT01326533|20554128|P2|NOT COMPLETED|Overall Study||0
8337783|NCT01326533|20554129|P1|NOT COMPLETED|Overall Study||4
8337784|NCT01326533|20554128|P2|COMPLETED|Overall Study||15
8337785|NCT01326533|20554129|P1|COMPLETED|Overall Study||13
8337786|NCT01326533|20554128|P2|STARTED|Overall Study||15
8337787|NCT01326533|20554129|P1|STARTED|Overall Study||17
8337788|NCT01326481|20554137|P1|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
8337789|NCT01326481|20554137|P1|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
8337790|NCT01326481|20554137|P1|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
8337791|NCT01326481|20554137|P1|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
8337792|NCT01326481|20554137|P1|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
8337793|NCT01326481|20554137|P1|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
8337794|NCT01326026|20554146|P2|NOT COMPLETED|Overall Study||13
8337795|NCT01326026|20554147|P1|NOT COMPLETED|Overall Study||12
8337796|NCT01326026|20554146|P2|COMPLETED|Overall Study||98
8337797|NCT01326026|20554147|P1|COMPLETED|Overall Study||99
8337798|NCT01326026|20554146|P2|Exposed|Overall Study||111
8337799|NCT01326026|20554147|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
8337800|NCT01326026|20554146|P2|STARTED|Overall Study||111
8337801|NCT01326026|20554147|P1|STARTED|Overall Study||111
8337802|NCT01325870|20554164|P3|NOT COMPLETED|Overall Study||8
8337803|NCT01325870|20554165|P2|NOT COMPLETED|Overall Study||13
8337804|NCT01325870|20554166|P1|NOT COMPLETED|Overall Study||11
8337805|NCT01325870|20554164|P3|COMPLETED|Overall Study||6
8337806|NCT01325870|20554165|P2|COMPLETED|Overall Study||3
8337807|NCT01325870|20554166|P1|COMPLETED|Overall Study||7
8337808|NCT01325870|20554164|P3|STARTED|Overall Study||14
8337809|NCT01325870|20554165|P2|STARTED|Overall Study||16
8337810|NCT01325870|20554166|P1|STARTED|Overall Study||18
8337811|NCT01325792|20554180|P1|NOT COMPLETED|Overall Study||17
8337812|NCT01325792|20554180|P1|COMPLETED|Overall Study||87
8337813|NCT01325792|20554180|P1|STARTED|Overall Study||104
8337814|NCT01325714|20554187|P2|NOT COMPLETED|Overall Study||31
8337815|NCT01325714|20554188|P1|NOT COMPLETED|Overall Study||34
8337816|NCT01325714|20554187|P2|COMPLETED|Overall Study||71
8337817|NCT01325714|20554188|P1|COMPLETED|Overall Study||67
8337818|NCT01325714|20554187|P2|12 Month Assessment|Overall Study||71
8337819|NCT01325714|20554188|P1|12 Month Assessment|Overall Study||67
8337820|NCT01325714|20554187|P2|6 Month Asessment|Overall Study||82
8337821|NCT01325714|20554188|P1|6 Month Asessment|Overall Study||75
8337822|NCT01325714|20554187|P2|3 Month Assessment|Overall Study||86
8337823|NCT01325714|20554188|P1|3 Month Assessment|Overall Study||82
8337824|NCT01325714|20554187|P2|STARTED|Overall Study||102
8337825|NCT01325714|20554188|P1|STARTED|Overall Study||101
8337826|NCT01325701|20554212|P2|NOT COMPLETED|Overall Study||3
8337827|NCT01325701|20554213|P1|NOT COMPLETED|Overall Study||21
8337828|NCT01325701|20554212|P2|COMPLETED|Overall Study||5
8337829|NCT01325701|20554213|P1|COMPLETED|Overall Study||49
8337830|NCT01325701|20554212|P2|STARTED|Overall Study||8
8337831|NCT01325701|20554213|P1|STARTED|Overall Study||70
8337832|NCT01325623|20554223|P1|NOT COMPLETED|Overall Study||3
8337833|NCT01325623|20554223|P1|COMPLETED|Overall Study||28
8337834|NCT01325623|20554223|P1|STARTED|Overall Study||31
8337835|NCT01325584|20554265|P1|NOT COMPLETED|Overall Study||1
8337836|NCT01325584|20554265|P1|COMPLETED|Overall Study||11
8337837|NCT01325584|20554265|P1|STARTED|Overall Study||12
8337838|NCT01325532|20554275|P2|NOT COMPLETED|Overall Study||0
8337839|NCT01325532|20554276|P1|NOT COMPLETED|Overall Study||2
8337840|NCT01325532|20554275|P2|COMPLETED|Overall Study||13
8337841|NCT01325532|20554276|P1|COMPLETED|Overall Study||15
8337842|NCT01325532|20554275|P2|STARTED|Overall Study||13
8337843|NCT01325532|20554276|P1|STARTED|Overall Study||17
8337844|NCT01325493|20554288|P2|NOT COMPLETED|Overall Study||3
8337845|NCT01325493|20554289|P1|NOT COMPLETED|Overall Study||1
8337846|NCT01325493|20554288|P2|COMPLETED|Overall Study||21
8337847|NCT01325493|20554289|P1|COMPLETED|Overall Study||29
8337848|NCT01325493|20554288|P2|STARTED|Overall Study||24
8337849|NCT01325493|20554289|P1|STARTED|Overall Study||30
8337850|NCT01325428|20554301|P1|NOT COMPLETED|Part B||3
8337851|NCT01325428|20554301|P1|COMPLETED|Part B||7
8337852|NCT01325428|20554301|P1|STARTED|Part B||10
8337853|NCT01325428|20554301|P1|NOT COMPLETED|Part A||16
8337854|NCT01325428|20554301|P1|COMPLETED|Part A||10
8337855|NCT01325428|20554301|P1|STARTED|Part A||26
8337856|NCT01325350|20554321|P5|NOT COMPLETED|Overall Study||12
8337857|NCT01325350|20554322|P4|NOT COMPLETED|Overall Study||9
8337858|NCT01325350|20554323|P3|NOT COMPLETED|Overall Study||17
8337859|NCT01325350|20554324|P2|NOT COMPLETED|Overall Study||5
8337860|NCT01325350|20554325|P1|NOT COMPLETED|Overall Study||6
8337861|NCT01325350|20554321|P5|COMPLETED|Overall Study||50
8337862|NCT01325350|20554322|P4|COMPLETED|Overall Study||52
8337863|NCT01325350|20554323|P3|COMPLETED|Overall Study||44
8337864|NCT01325350|20554324|P2|COMPLETED|Overall Study||56
8337865|NCT01325350|20554325|P1|COMPLETED|Overall Study||55
8337866|NCT01325350|20554321|P5|STARTED|Overall Study||62
8337867|NCT01325350|20554322|P4|STARTED|Overall Study||61
8337868|NCT01325350|20554323|P3|STARTED|Overall Study||61
8337869|NCT01325350|20554324|P2|STARTED|Overall Study||61
8337870|NCT01325350|20554325|P1|STARTED|Overall Study||61
8337871|NCT01325337|20554367|P5|NOT COMPLETED|Overall Study||8
8337872|NCT01325337|20554368|P4|NOT COMPLETED|Overall Study||10
8337873|NCT01325337|20554369|P3|NOT COMPLETED|Overall Study||9
8337874|NCT01325337|20554370|P2|NOT COMPLETED|Overall Study||9
8337875|NCT01325337|20554371|P1|NOT COMPLETED|Overall Study||5
8337876|NCT01325337|20554367|P5|COMPLETED|Overall Study||53
8337877|NCT01325337|20554368|P4|COMPLETED|Overall Study||52
8337878|NCT01325337|20554369|P3|COMPLETED|Overall Study||53
8337879|NCT01325337|20554370|P2|COMPLETED|Overall Study||52
8337880|NCT01325337|20554371|P1|COMPLETED|Overall Study||56
8337881|NCT01325337|20554367|P5|STARTED|Overall Study||61
8337882|NCT01325337|20554368|P4|STARTED|Overall Study||62
8337883|NCT01325337|20554369|P3|STARTED|Overall Study||62
8337884|NCT01325337|20554370|P2|STARTED|Overall Study||61
8337885|NCT01325337|20554371|P1|STARTED|Overall Study||61
8337886|NCT01325311|20554410|P2|NOT COMPLETED|Overall Study||0
8337887|NCT01325311|20554411|P1|NOT COMPLETED|Overall Study||0
8337888|NCT01325311|20554410|P2|COMPLETED|Overall Study||7
8337889|NCT01325311|20554411|P1|COMPLETED|Overall Study||8
8337890|NCT01325311|20554410|P2|STARTED|Overall Study||7
8337891|NCT01325311|20554411|P1|STARTED|Overall Study||8
8337892|NCT01325207|20554451|P6|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
8337893|NCT01325207|20554452|P5|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
8337894|NCT01325207|20554453|P4|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337895|NCT01325207|20554454|P3|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337896|NCT01325207|20554455|P2|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337897|NCT01325207|20554456|P1|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337898|NCT01325207|20554451|P6|COMPLETED|Follow-up Every 3 Months Until Death||18
8337899|NCT01325207|20554452|P5|COMPLETED|Follow-up Every 3 Months Until Death||6
8337900|NCT01325207|20554453|P4|COMPLETED|Follow-up Every 3 Months Until Death||1
8337901|NCT01325207|20554454|P3|COMPLETED|Follow-up Every 3 Months Until Death||1
8337902|NCT01325207|20554455|P2|COMPLETED|Follow-up Every 3 Months Until Death||3
8337903|NCT01325207|20554456|P1|COMPLETED|Follow-up Every 3 Months Until Death||3
8337904|NCT01325207|20554451|P6|STARTED|Follow-up Every 3 Months Until Death||19
8337905|NCT01325207|20554452|P5|STARTED|Follow-up Every 3 Months Until Death||7
8337906|NCT01325207|20554453|P4|STARTED|Follow-up Every 3 Months Until Death||1
8337907|NCT01325207|20554454|P3|STARTED|Follow-up Every 3 Months Until Death||1
8337908|NCT01325207|20554455|P2|STARTED|Follow-up Every 3 Months Until Death||3
8337909|NCT01325207|20554456|P1|STARTED|Follow-up Every 3 Months Until Death||3
8337910|NCT01325207|20554451|P6|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
8337911|NCT01325207|20554452|P5|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337912|NCT01325207|20554453|P4|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337913|NCT01325207|20554454|P3|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337914|NCT01325207|20554455|P2|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
8337915|NCT01325207|20554456|P1|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337916|NCT01325207|20554451|P6|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
8337917|NCT01325207|20554452|P5|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
8337918|NCT01325207|20554453|P4|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337919|NCT01325207|20554454|P3|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337920|NCT01325207|20554455|P2|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337921|NCT01325207|20554456|P1|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337922|NCT01325207|20554451|P6|STARTED|Started 9th Week/Cycle 3 of Treatment||14
8337923|NCT01325207|20554452|P5|STARTED|Started 9th Week/Cycle 3 of Treatment||3
8337924|NCT01325207|20554453|P4|STARTED|Started 9th Week/Cycle 3 of Treatment||1
8337925|NCT01325207|20554454|P3|STARTED|Started 9th Week/Cycle 3 of Treatment||1
8337926|NCT01325207|20554455|P2|STARTED|Started 9th Week/Cycle 3 of Treatment||2
8337927|NCT01325207|20554456|P1|STARTED|Started 9th Week/Cycle 3 of Treatment||2
8337928|NCT01325207|20554451|P6|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
8337929|NCT01325207|20554452|P5|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8337930|NCT01325207|20554453|P4|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
8337931|NCT01325207|20554454|P3|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
8337932|NCT01325207|20554455|P2|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337933|NCT01325207|20554456|P1|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337934|NCT01325207|20554451|P6|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
8337935|NCT01325207|20554452|P5|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
8337936|NCT01325207|20554453|P4|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337937|NCT01325207|20554454|P3|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337938|NCT01325207|20554455|P2|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8337939|NCT01325207|20554456|P1|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8337940|NCT01325207|20554451|P6|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
8337941|NCT01325207|20554452|P5|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
8337942|NCT01325207|20554453|P4|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
8337943|NCT01325207|20554454|P3|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
8337944|NCT01325207|20554455|P2|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
8337945|NCT01325207|20554456|P1|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
8337946|NCT01325207|20554451|P6|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337947|NCT01325207|20554452|P5|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
8337948|NCT01325207|20554453|P4|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337949|NCT01325207|20554454|P3|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337950|NCT01325207|20554455|P2|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337951|NCT01325207|20554456|P1|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337952|NCT01325207|20554451|P6|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
8337953|NCT01325207|20554452|P5|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
8337954|NCT01325207|20554453|P4|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
8337955|NCT01325207|20554454|P3|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
8337956|NCT01325207|20554455|P2|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
8337957|NCT01325207|20554456|P1|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
8337958|NCT01325207|20554451|P6|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
8337959|NCT01325207|20554452|P5|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
8337960|NCT01325207|20554453|P4|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
8337961|NCT01325207|20554454|P3|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
8337962|NCT01325207|20554455|P2|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
8337963|NCT01325207|20554456|P1|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
8337964|NCT01325181|20554481|P2|NOT COMPLETED|Overall Study||2
8337965|NCT01325181|20554482|P1|NOT COMPLETED|Overall Study||0
8337966|NCT01325181|20554481|P2|COMPLETED|Overall Study||14
8337967|NCT01325181|20554482|P1|COMPLETED|Overall Study||18
8337968|NCT01325181|20554481|P2|STARTED|Overall Study||16
8337969|NCT01325181|20554482|P1|STARTED|Overall Study||18
8337970|NCT01324999|20554488|P1|NOT COMPLETED|Overall Study||5
8337971|NCT01324999|20554488|P1|COMPLETED|Overall Study||7
8337972|NCT01324999|20554488|P1|STARTED|Overall Study||12
8337973|NCT01324947|20554499|P1|NOT COMPLETED|Overall Study||74
8337974|NCT01324947|20554499|P1|COMPLETED|Overall Study||0
8337975|NCT01324947|20554499|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
8337976|NCT01324947|20554499|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
8337977|NCT01324947|20554499|P1|STARTED|Overall Study||74
8337978|NCT01324882|20554512|P2|NOT COMPLETED|Overall Study||0
8337979|NCT01324882|20554513|P1|NOT COMPLETED|Overall Study||0
8337980|NCT01324882|20554512|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
8337981|NCT01324882|20554513|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
8337982|NCT01324882|20554512|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
8337983|NCT01324882|20554513|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
8337984|NCT01324830|20554540|P19|NOT COMPLETED|Overall Study||6
8337985|NCT01324830|20554541|P18|NOT COMPLETED|Overall Study||6
8337986|NCT01324830|20554542|P17|NOT COMPLETED|Overall Study||3
8337987|NCT01324830|20554543|P16|NOT COMPLETED|Overall Study||3
8337988|NCT01324830|20554544|P15|NOT COMPLETED|Overall Study||1
8337989|NCT01324830|20554545|P14|NOT COMPLETED|Overall Study||1
8337990|NCT01324830|20554546|P13|NOT COMPLETED|Overall Study||1
8337991|NCT01324830|20554547|P12|NOT COMPLETED|Overall Study||1
8337992|NCT01324830|20554548|P11|NOT COMPLETED|Overall Study||4
8337993|NCT01324830|20554549|P10|NOT COMPLETED|Overall Study||6
8337994|NCT01324830|20554550|P9|NOT COMPLETED|Overall Study||5
8337995|NCT01324830|20554551|P8|NOT COMPLETED|Overall Study||3
8337996|NCT01324830|20554552|P7|NOT COMPLETED|Overall Study||3
8337997|NCT01324830|20554553|P6|NOT COMPLETED|Overall Study||7
8337998|NCT01324830|20554554|P5|NOT COMPLETED|Overall Study||7
8337999|NCT01324830|20554555|P4|NOT COMPLETED|Overall Study||3
8338000|NCT01324830|20554556|P3|NOT COMPLETED|Overall Study||3
8338001|NCT01324830|20554557|P2|NOT COMPLETED|Overall Study||3
8338002|NCT01324830|20554558|P1|NOT COMPLETED|Overall Study||3
8338003|NCT01324830|20554540|P19|COMPLETED|Overall Study||0
8338004|NCT01324830|20554541|P18|COMPLETED|Overall Study||0
8338005|NCT01324830|20554542|P17|COMPLETED|Overall Study||0
8338006|NCT01324830|20554543|P16|COMPLETED|Overall Study||0
8338007|NCT01324830|20554544|P15|COMPLETED|Overall Study||0
8338008|NCT01324830|20554545|P14|COMPLETED|Overall Study||0
8338009|NCT01324830|20554546|P13|COMPLETED|Overall Study||0
8338010|NCT01324830|20554547|P12|COMPLETED|Overall Study||0
8338011|NCT01324830|20554548|P11|COMPLETED|Overall Study||0
8338012|NCT01324830|20554549|P10|COMPLETED|Overall Study||0
8338013|NCT01324830|20554550|P9|COMPLETED|Overall Study||0
8338014|NCT01324830|20554551|P8|COMPLETED|Overall Study||0
8338015|NCT01324830|20554552|P7|COMPLETED|Overall Study||0
8338016|NCT01324830|20554553|P6|COMPLETED|Overall Study||0
8338017|NCT01324830|20554554|P5|COMPLETED|Overall Study||0
8338018|NCT01324830|20554555|P4|COMPLETED|Overall Study||0
8338019|NCT01324830|20554556|P3|COMPLETED|Overall Study||0
8338020|NCT01324830|20554557|P2|COMPLETED|Overall Study||0
8338021|NCT01324830|20554558|P1|COMPLETED|Overall Study||0
8338022|NCT01324830|20554540|P19|STARTED|Overall Study||6
8338023|NCT01324830|20554541|P18|STARTED|Overall Study||6
8338024|NCT01324830|20554542|P17|STARTED|Overall Study||3
8338025|NCT01324830|20554543|P16|STARTED|Overall Study||3
8338026|NCT01324830|20554544|P15|STARTED|Overall Study||1
8338027|NCT01324830|20554545|P14|STARTED|Overall Study||1
8338028|NCT01324830|20554546|P13|STARTED|Overall Study||1
8338029|NCT01324830|20554547|P12|STARTED|Overall Study||1
8338030|NCT01324830|20554548|P11|STARTED|Overall Study||4
8338031|NCT01324830|20554549|P10|STARTED|Overall Study||6
8338032|NCT01324830|20554550|P9|STARTED|Overall Study||5
8338033|NCT01324830|20554551|P8|STARTED|Overall Study||3
8338034|NCT01324830|20554552|P7|STARTED|Overall Study||3
8338035|NCT01324830|20554553|P6|STARTED|Overall Study||7
8338036|NCT01324830|20554554|P5|STARTED|Overall Study||7
8338037|NCT01324830|20554555|P4|STARTED|Overall Study||3
8338038|NCT01324830|20554556|P3|STARTED|Overall Study||3
8338039|NCT01324830|20554557|P2|STARTED|Overall Study||3
8338040|NCT01324830|20554558|P1|STARTED|Overall Study||3
8338041|NCT01324700|20554674|P4|NOT COMPLETED|Overall Study||11
8338042|NCT01324700|20554675|P3|NOT COMPLETED|Overall Study||16
8338043|NCT01324700|20554676|P2|NOT COMPLETED|Overall Study||4
8338044|NCT01324700|20554677|P1|NOT COMPLETED|Overall Study||9
8338045|NCT01324700|20554674|P4|COMPLETED|Overall Study||37
8338046|NCT01324700|20554675|P3|COMPLETED|Overall Study||33
8338047|NCT01324700|20554676|P2|COMPLETED|Overall Study||16
8338048|NCT01324700|20554677|P1|COMPLETED|Overall Study||13
8338049|NCT01324700|20554674|P4|STARTED|Overall Study||48
8338050|NCT01324700|20554675|P3|STARTED|Overall Study||49
8338051|NCT01324700|20554676|P2|STARTED|Overall Study||20
8338052|NCT01324700|20554677|P1|STARTED|Overall Study||22
8338053|NCT01324687|20554693|P2|NOT COMPLETED|Overall Study||15
8338054|NCT01324687|20554694|P1|NOT COMPLETED|Overall Study||0
8338055|NCT01324687|20554693|P2|COMPLETED|Overall Study||479
8338056|NCT01324687|20554694|P1|COMPLETED|Overall Study||1058
8338057|NCT01324687|20554693|P2|STARTED|Overall Study||494
8338058|NCT01324687|20554694|P1|STARTED|Overall Study||1058
8338059|NCT01324622|20554704|P2|NOT COMPLETED|Overall Study||7
8338060|NCT01324622|20554705|P1|NOT COMPLETED|Overall Study||9
8338061|NCT01324622|20554704|P2|COMPLETED|Overall Study||4
8338062|NCT01324622|20554705|P1|COMPLETED|Overall Study||4
8338063|NCT01324622|20554704|P2|STARTED|Overall Study||11
8338064|NCT01324622|20554705|P1|STARTED|Overall Study||13
8338065|NCT01324570|20554735|P2|NOT COMPLETED|Overall Study||14
8338066|NCT01324570|20554736|P1|NOT COMPLETED|Overall Study||4
8338067|NCT01324570|20554735|P2|COMPLETED|Overall Study||21
8338068|NCT01324570|20554736|P1|COMPLETED|Overall Study||2
8338069|NCT01324570|20554735|P2|STARTED|Overall Study||35
8338070|NCT01324570|20554736|P1|STARTED|Overall Study||6
8338071|NCT01324453|20554750|P2|NOT COMPLETED|Overall Study||0
8338072|NCT01324453|20554751|P1|NOT COMPLETED|Overall Study||0
8338073|NCT01324453|20554750|P2|COMPLETED|Overall Study||49
8338074|NCT01324453|20554751|P1|COMPLETED|Overall Study||54
8338075|NCT01324453|20554750|P2|STARTED|Overall Study||49
8338076|NCT01324453|20554751|P1|STARTED|Overall Study||54
8338077|NCT01324440|20554773|P2|NOT COMPLETED|Overall Study||1
8338078|NCT01324440|20554774|P1|NOT COMPLETED|Overall Study||0
8338079|NCT01324440|20554773|P2|COMPLETED|Overall Study||31
8338080|NCT01324440|20554774|P1|COMPLETED|Overall Study||32
8338081|NCT01324440|20554773|P2|STARTED|Overall Study||32
8338082|NCT01324440|20554774|P1|STARTED|Overall Study||32
8338083|NCT01324401|20554788|P2|NOT COMPLETED|Overall Study||6
8338084|NCT01324401|20554789|P1|NOT COMPLETED|Overall Study||1
8338085|NCT01324401|20554788|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
8338086|NCT01324401|20554789|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
8338087|NCT01324401|20554788|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
8338088|NCT01324401|20554789|P1|STARTED|Overall Study||4
8338089|NCT01324388|20554800|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8338090|NCT01324388|20554801|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
8338091|NCT01324388|20554802|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8338092|NCT01324388|20554803|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8338093|NCT01324388|20554800|P4|COMPLETED|Part 2 of Study: Second Intervention||9
8338094|NCT01324388|20554801|P3|COMPLETED|Part 2 of Study: Second Intervention||9
8338095|NCT01324388|20554802|P2|COMPLETED|Part 2 of Study: Second Intervention||0
8338096|NCT01324388|20554803|P1|COMPLETED|Part 2 of Study: Second Intervention||0
8338097|NCT01324388|20554800|P4|STARTED|Part 2 of Study: Second Intervention||9
8338098|NCT01324388|20554801|P3|STARTED|Part 2 of Study: Second Intervention||10
8338099|NCT01324388|20554802|P2|STARTED|Part 2 of Study: Second Intervention||0
8338100|NCT01324388|20554803|P1|STARTED|Part 2 of Study: Second Intervention||0
8338101|NCT01324388|20554800|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338102|NCT01324388|20554801|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338103|NCT01324388|20554802|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338104|NCT01324388|20554803|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338105|NCT01324388|20554800|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
8338106|NCT01324388|20554801|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
8338107|NCT01324388|20554802|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
8338108|NCT01324388|20554803|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
8338109|NCT01324388|20554800|P4|STARTED|Part 2: Washout of at Least 21 Days||9
8338110|NCT01324388|20554801|P3|STARTED|Part 2: Washout of at Least 21 Days||10
8338111|NCT01324388|20554802|P2|STARTED|Part 2: Washout of at Least 21 Days||0
8338112|NCT01324388|20554803|P1|STARTED|Part 2: Washout of at Least 21 Days||0
8338113|NCT01324388|20554800|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
8338114|NCT01324388|20554801|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
8338115|NCT01324388|20554802|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
8338116|NCT01324388|20554803|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
8338117|NCT01324388|20554800|P4|COMPLETED|Part 2 of Study: First Intervention||9
8338118|NCT01324388|20554801|P3|COMPLETED|Part 2 of Study: First Intervention||10
8338119|NCT01324388|20554802|P2|COMPLETED|Part 2 of Study: First Intervention||0
8338120|NCT01324388|20554803|P1|COMPLETED|Part 2 of Study: First Intervention||0
8338121|NCT01324388|20554800|P4|STARTED|Part 2 of Study: First Intervention||10
8338122|NCT01324388|20554801|P3|STARTED|Part 2 of Study: First Intervention||10
8338123|NCT01324388|20554802|P2|STARTED|Part 2 of Study: First Intervention||0
8338124|NCT01324388|20554803|P1|STARTED|Part 2 of Study: First Intervention||0
8338125|NCT01324388|20554800|P4|NOT COMPLETED|Part 1 of Study||0
8338126|NCT01324388|20554801|P3|NOT COMPLETED|Part 1 of Study||0
8338127|NCT01324388|20554802|P2|NOT COMPLETED|Part 1 of Study||2
8338128|NCT01324388|20554803|P1|NOT COMPLETED|Part 1 of Study||4
8338129|NCT01324388|20554800|P4|COMPLETED|Part 1 of Study||0
8338130|NCT01324388|20554801|P3|COMPLETED|Part 1 of Study||0
8338131|NCT01324388|20554802|P2|COMPLETED|Part 1 of Study||6
8338132|NCT01324388|20554803|P1|COMPLETED|Part 1 of Study||19
8338133|NCT01324388|20554800|P4|Received at Least 1 Dose|Part 1 of Study||0
8338134|NCT01324388|20554801|P3|Received at Least 1 Dose|Part 1 of Study||0
8338135|NCT01324388|20554802|P2|Received at Least 1 Dose|Part 1 of Study||8
8338136|NCT01324388|20554803|P1|Received at Least 1 Dose|Part 1 of Study||23
8338137|NCT01324388|20554800|P4|STARTED|Part 1 of Study||0
8338138|NCT01324388|20554801|P3|STARTED|Part 1 of Study||0
8338139|NCT01324388|20554802|P2|STARTED|Part 1 of Study||8
8338140|NCT01324388|20554803|P1|STARTED|Part 1 of Study||23
8338141|NCT01324349|20554824|P2|NOT COMPLETED|Overall Study||2
8338142|NCT01324349|20554825|P1|NOT COMPLETED|Overall Study||1
8338143|NCT01324349|20554824|P2|COMPLETED|Overall Study||16
8338144|NCT01324349|20554825|P1|COMPLETED|Overall Study||31
8338145|NCT01324349|20554824|P2|STARTED|Overall Study||18
8338146|NCT01324349|20554825|P1|STARTED|Overall Study||32
8338147|NCT01324323|20554835|P1|NOT COMPLETED|Overall Study||1
8338148|NCT01324323|20554835|P1|COMPLETED|Overall Study||13
8338149|NCT01324323|20554835|P1|STARTED|Overall Study||14
8338150|NCT01324310|20554855|P1|NOT COMPLETED|Overall Study||2
8338151|NCT01324310|20554855|P1|COMPLETED|Overall Study||13
8338152|NCT01324310|20554855|P1|STARTED|Overall Study||15
8338153|NCT01324271|20554875|P2|NOT COMPLETED|Overall Study||0
8338154|NCT01324271|20554876|P1|NOT COMPLETED|Overall Study||4
8338155|NCT01324271|20554875|P2|COMPLETED|Overall Study||28
8338156|NCT01324271|20554876|P1|COMPLETED|Overall Study||53
8338157|NCT01324271|20554875|P2|STARTED|Overall Study||28
8338158|NCT01324271|20554876|P1|STARTED|Overall Study||57
8338159|NCT01324128|20554884|P4|NOT COMPLETED|Stage 2||3
8338160|NCT01324128|20554885|P3|NOT COMPLETED|Stage 2||8
8338161|NCT01324128|20554886|P2|NOT COMPLETED|Stage 2||0
8338162|NCT01324128|20554887|P1|NOT COMPLETED|Stage 2||0
8338163|NCT01324128|20554884|P4|COMPLETED|Stage 2||46
8338164|NCT01324128|20554885|P3|COMPLETED|Stage 2||42
8338165|NCT01324128|20554886|P2|COMPLETED|Stage 2||0
8338166|NCT01324128|20554887|P1|COMPLETED|Stage 2||0
8338167|NCT01324128|20554884|P4|STARTED|Stage 2||49
8338168|NCT01324128|20554885|P3|STARTED|Stage 2||50
8338169|NCT01324128|20554886|P2|STARTED|Stage 2||0
8338170|NCT01324128|20554887|P1|STARTED|Stage 2||0
8338171|NCT01324128|20554884|P4|NOT COMPLETED|Stage 1||0
8338172|NCT01324128|20554885|P3|NOT COMPLETED|Stage 1||0
8338173|NCT01324128|20554886|P2|NOT COMPLETED|Stage 1||56
8338174|NCT01324128|20554887|P1|NOT COMPLETED|Stage 1||195
8338175|NCT01324128|20554884|P4|COMPLETED|Stage 1||0
8338176|NCT01324128|20554885|P3|COMPLETED|Stage 1||0
8338177|NCT01324128|20554886|P2|COMPLETED|Stage 1||293
8338178|NCT01324128|20554887|P1|COMPLETED|Stage 1||515
8338179|NCT01324128|20554884|P4|STARTED|Stage 1||0
8338180|NCT01324128|20554885|P3|STARTED|Stage 1||0
8338181|NCT01324128|20554886|P2|STARTED|Stage 1||349
8338182|NCT01324128|20554887|P1|STARTED|Stage 1||710
8338183|NCT01324102|20554899|P2|NOT COMPLETED|Overall Study||6
8338184|NCT01324102|20554900|P1|NOT COMPLETED|Overall Study||1
8338185|NCT01324102|20554899|P2|COMPLETED|Overall Study||6
8338186|NCT01324102|20554900|P1|COMPLETED|Overall Study||10
8338187|NCT01324102|20554899|P2|STARTED|Overall Study|Yoga group 4 and 6|12
8338188|NCT01324102|20554900|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
8338189|NCT01324024|20554907|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8338190|NCT01324024|20554908|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
8338191|NCT01324024|20554907|P2|COMPLETED|Second Intervention (4 Weeks)||16
8338192|NCT01324024|20554908|P1|COMPLETED|Second Intervention (4 Weeks)||16
8338193|NCT01324024|20554907|P2|STARTED|Second Intervention (4 Weeks)||17
8338194|NCT01324024|20554908|P1|STARTED|Second Intervention (4 Weeks)||18
8338195|NCT01324024|20554907|P2|NOT COMPLETED|Washout (2 Weeks)||0
8338196|NCT01324024|20554908|P1|NOT COMPLETED|Washout (2 Weeks)||0
8338197|NCT01324024|20554907|P2|COMPLETED|Washout (2 Weeks)||17
8338198|NCT01324024|20554908|P1|COMPLETED|Washout (2 Weeks)||18
8338199|NCT01324024|20554907|P2|STARTED|Washout (2 Weeks)||17
8338200|NCT01324024|20554908|P1|STARTED|Washout (2 Weeks)||18
8338201|NCT01324024|20554907|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8338202|NCT01324024|20554908|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8338203|NCT01324024|20554907|P2|COMPLETED|First Intervention (4 Weeks)||17
8338204|NCT01324024|20554908|P1|COMPLETED|First Intervention (4 Weeks)||18
8338205|NCT01324024|20554907|P2|STARTED|First Intervention (4 Weeks)||17
8338206|NCT01324024|20554908|P1|STARTED|First Intervention (4 Weeks)||18
8338207|NCT01323998|20554926|P5|NOT COMPLETED|Overall Study||0
8338208|NCT01323998|20554927|P4|NOT COMPLETED|Overall Study||0
8338209|NCT01323998|20554928|P3|NOT COMPLETED|Overall Study||0
8338210|NCT01323998|20554929|P2|NOT COMPLETED|Overall Study||0
8338211|NCT01323998|20554930|P1|NOT COMPLETED|Overall Study||0
8338212|NCT01323998|20554926|P5|COMPLETED|Overall Study||6735
8338213|NCT01323998|20554927|P4|COMPLETED|Overall Study||12052
8338214|NCT01323998|20554928|P3|COMPLETED|Overall Study||10294
8338215|NCT01323998|20554929|P2|COMPLETED|Overall Study||18681
8338216|NCT01323998|20554930|P1|COMPLETED|Overall Study||200631
8338217|NCT01323998|20554926|P5|STARTED|Overall Study||6735
8338218|NCT01323998|20554927|P4|STARTED|Overall Study||12052
8338219|NCT01323998|20554928|P3|STARTED|Overall Study||10294
8338220|NCT01323998|20554929|P2|STARTED|Overall Study||18681
8338221|NCT01323998|20554930|P1|STARTED|Overall Study||200631
8338222|NCT01323972|20554946|P4|NOT COMPLETED|Overall Study||1
8338223|NCT01323972|20554947|P3|NOT COMPLETED|Overall Study||2
8338224|NCT01323972|20554948|P2|NOT COMPLETED|Overall Study||3
8338225|NCT01323972|20554949|P1|NOT COMPLETED|Overall Study||2
8338226|NCT01323972|20554946|P4|COMPLETED|Overall Study||79
8338227|NCT01323972|20554947|P3|COMPLETED|Overall Study||78
8338228|NCT01323972|20554948|P2|COMPLETED|Overall Study||76
8338229|NCT01323972|20554949|P1|COMPLETED|Overall Study||79
8338230|NCT01323972|20554946|P4|STARTED|Overall Study||80
8338231|NCT01323972|20554947|P3|STARTED|Overall Study||80
8338232|NCT01323972|20554948|P2|STARTED|Overall Study||79
8338233|NCT01323972|20554949|P1|STARTED|Overall Study||81
8338234|NCT01323959|20554984|P3|NOT COMPLETED|Overall Study||0
8338235|NCT01323959|20554985|P2|NOT COMPLETED|Overall Study||0
8338236|NCT01323959|20554986|P1|NOT COMPLETED|Overall Study||0
8338237|NCT01323959|20554984|P3|COMPLETED|Overall Study||72
8338238|NCT01323959|20554985|P2|COMPLETED|Overall Study||72
8338239|NCT01323959|20554986|P1|COMPLETED|Overall Study||67
8338240|NCT01323959|20554984|P3|STARTED|Overall Study||72
8338241|NCT01323959|20554985|P2|STARTED|Overall Study||72
8338242|NCT01323959|20554986|P1|STARTED|Overall Study||67
8338243|NCT01323946|20555045|P3|NOT COMPLETED|Overall Study||0
8338244|NCT01323946|20555046|P2|NOT COMPLETED|Overall Study||3
8338245|NCT01323946|20555047|P1|NOT COMPLETED|Overall Study||3
8338246|NCT01323946|20555045|P3|COMPLETED|Overall Study||33
8338247|NCT01323946|20555046|P2|COMPLETED|Overall Study||31
8338248|NCT01323946|20555047|P1|COMPLETED|Overall Study||43
8338249|NCT01323946|20555045|P3|STARTED|Overall Study||33
8338250|NCT01323946|20555046|P2|STARTED|Overall Study||34
8338251|NCT01323946|20555047|P1|STARTED|Overall Study||46
8338252|NCT01323920|20555168|P1|NOT COMPLETED|Overall Study||6
8338253|NCT01323920|20555168|P1|COMPLETED|Overall Study||29
8338254|NCT01323920|20555168|P1|STARTED|Overall Study||35
8338255|NCT01323855|20555180|P5|NOT COMPLETED|Overall Study||0
8338256|NCT01323855|20555181|P4|NOT COMPLETED|Overall Study||0
8338257|NCT01323855|20555182|P3|NOT COMPLETED|Overall Study||0
8338258|NCT01323855|20555183|P2|NOT COMPLETED|Overall Study||0
8338259|NCT01323855|20555184|P1|NOT COMPLETED|Overall Study||0
8338260|NCT01323855|20555180|P5|COMPLETED|Overall Study||11
8338261|NCT01323855|20555181|P4|COMPLETED|Overall Study||9
8338262|NCT01323855|20555182|P3|COMPLETED|Overall Study||8
8338263|NCT01323855|20555183|P2|COMPLETED|Overall Study||9
8338264|NCT01323855|20555184|P1|COMPLETED|Overall Study||9
8338265|NCT01323855|20555180|P5|STARTED|Overall Study||11
8338266|NCT01323855|20555181|P4|STARTED|Overall Study||9
8338267|NCT01323855|20555182|P3|STARTED|Overall Study||8
8338268|NCT01323855|20555183|P2|STARTED|Overall Study||9
8338269|NCT01323855|20555184|P1|STARTED|Overall Study||9
8338270|NCT01323790|20555209|P3|NOT COMPLETED|Overall Study||45
8338271|NCT01323790|20555210|P2|NOT COMPLETED|Overall Study||60
8338272|NCT01323790|20555211|P1|NOT COMPLETED|Overall Study||55
8338273|NCT01323790|20555209|P3|COMPLETED|Overall Study||188
8338274|NCT01323790|20555210|P2|COMPLETED|Overall Study||174
8338275|NCT01323790|20555211|P1|COMPLETED|Overall Study||178
8338276|NCT01323790|20555209|P3|STARTED|Overall Study||233
8338277|NCT01323790|20555210|P2|STARTED|Overall Study||234
8338278|NCT01323790|20555211|P1|STARTED|Overall Study||233
8338279|NCT01323777|20555249|P1|NOT COMPLETED|Overall Study||0
8338280|NCT01323777|20555249|P1|COMPLETED|Overall Study||65
8338281|NCT01323777|20555249|P1|STARTED|Overall Study||65
8338282|NCT01323673|20555262|P2|NOT COMPLETED|Overall Study||5
8338283|NCT01323673|20555263|P1|NOT COMPLETED|Overall Study||3
8338284|NCT01323673|20555262|P2|COMPLETED|Overall Study||58
8338285|NCT01323673|20555263|P1|COMPLETED|Overall Study||59
8338286|NCT01323673|20555262|P2|STARTED|Overall Study||63
8338287|NCT01323673|20555263|P1|STARTED|Overall Study||62
8338288|NCT01323660|20555283|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
8338289|NCT01323660|20555284|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
8338290|NCT01323660|20555285|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8338291|NCT01323660|20555286|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8338292|NCT01323660|20555287|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
8338293|NCT01323660|20555288|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
8338294|NCT01323660|20555283|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
8338295|NCT01323660|20555284|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
8338296|NCT01323660|20555285|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
8338297|NCT01323660|20555286|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
8338298|NCT01323660|20555287|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
8338299|NCT01323660|20555288|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
8338300|NCT01323660|20555283|P6|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
8338301|NCT01323660|20555284|P5|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
8338302|NCT01323660|20555285|P4|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
8338303|NCT01323660|20555286|P3|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
8338304|NCT01323660|20555287|P2|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
8338305|NCT01323660|20555288|P1|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
8338306|NCT01323660|20555283|P6|NOT COMPLETED|Washout Period (14 Days)||2
8338307|NCT01323660|20555284|P5|NOT COMPLETED|Washout Period (14 Days)||3
8338308|NCT01323660|20555285|P4|NOT COMPLETED|Washout Period (14 Days)||3
8338309|NCT01323660|20555286|P3|NOT COMPLETED|Washout Period (14 Days)||1
8338310|NCT01323660|20555287|P2|NOT COMPLETED|Washout Period (14 Days)||0
8338311|NCT01323660|20555288|P1|NOT COMPLETED|Washout Period (14 Days)||0
8338312|NCT01323660|20555283|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
8338313|NCT01323660|20555284|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
8338314|NCT01323660|20555285|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
8338315|NCT01323660|20555286|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8338316|NCT01323660|20555287|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8338317|NCT01323660|20555288|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
8338318|NCT01323660|20555283|P6|STARTED|Washout Period (14 Days)||61
8338319|NCT01323660|20555284|P5|STARTED|Washout Period (14 Days)||61
8338320|NCT01323660|20555285|P4|STARTED|Washout Period (14 Days)||31
8338321|NCT01323660|20555286|P3|STARTED|Washout Period (14 Days)||19
8338322|NCT01323660|20555287|P2|STARTED|Washout Period (14 Days)||21
8338323|NCT01323660|20555288|P1|STARTED|Washout Period (14 Days)||65
8338324|NCT01323660|20555283|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
8338325|NCT01323660|20555284|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
8338326|NCT01323660|20555285|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8338327|NCT01323660|20555286|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8338328|NCT01323660|20555287|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
8338329|NCT01323660|20555288|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
8338330|NCT01323660|20555283|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
8338331|NCT01323660|20555284|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
8338332|NCT01323660|20555285|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
8338333|NCT01323660|20555286|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
8338334|NCT01323660|20555287|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
8338335|NCT01323660|20555288|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
8338336|NCT01323660|20555283|P6|STARTED|Treatment Period 1 (12 Weeks)||70
8338337|NCT01323660|20555284|P5|STARTED|Treatment Period 1 (12 Weeks)||71
8338338|NCT01323660|20555285|P4|STARTED|Treatment Period 1 (12 Weeks)||36
8338339|NCT01323660|20555286|P3|STARTED|Treatment Period 1 (12 Weeks)||24
8338340|NCT01323660|20555287|P2|STARTED|Treatment Period 1 (12 Weeks)||22
8338341|NCT01323660|20555288|P1|STARTED|Treatment Period 1 (12 Weeks)||84
8338342|NCT01323647|20555334|P2|NOT COMPLETED|Overall Study||0
8338343|NCT01323647|20555335|P1|NOT COMPLETED|Overall Study||9
8338344|NCT01323647|20555334|P2|COMPLETED|Overall Study||487
8338345|NCT01323647|20555335|P1|COMPLETED|Overall Study||461
8338346|NCT01323647|20555334|P2|STARTED|Overall Study||487
8338347|NCT01323647|20555335|P1|STARTED|Overall Study||470
8338348|NCT01323634|20555352|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
8338349|NCT01323634|20555353|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
8338350|NCT01323634|20555354|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8338351|NCT01323634|20555352|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
8338352|NCT01323634|20555353|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
8338353|NCT01323634|20555354|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
8338354|NCT01323634|20555352|P3|STARTED|Double-Blind (DB) Treatment Period||261
8338355|NCT01323634|20555353|P2|STARTED|Double-Blind (DB) Treatment Period||260
8338356|NCT01323634|20555354|P1|STARTED|Double-Blind (DB) Treatment Period||0
8338357|NCT01323634|20555352|P3|NOT COMPLETED|2-week Run-in Period||0
8338358|NCT01323634|20555353|P2|NOT COMPLETED|2-week Run-in Period||0
8338359|NCT01323634|20555354|P1|NOT COMPLETED|2-week Run-in Period||212
8338360|NCT01323634|20555352|P3|COMPLETED|2-week Run-in Period||0
8338361|NCT01323634|20555353|P2|COMPLETED|2-week Run-in Period||0
8338362|NCT01323634|20555354|P1|COMPLETED|2-week Run-in Period||521
8338363|NCT01323634|20555352|P3|STARTED|2-week Run-in Period||0
8338364|NCT01323634|20555353|P2|STARTED|2-week Run-in Period||0
8338365|NCT01323634|20555354|P1|STARTED|2-week Run-in Period||733
8338366|NCT01323621|20555364|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
8338367|NCT01323621|20555365|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
8338368|NCT01323621|20555366|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
8338369|NCT01323621|20555364|P3|COMPLETED|12-week, Double-blind Treatment Period||239
8338370|NCT01323621|20555365|P2|COMPLETED|12-week, Double-blind Treatment Period||237
8338371|NCT01323621|20555366|P1|COMPLETED|12-week, Double-blind Treatment Period||0
8338372|NCT01323621|20555364|P3|STARTED|12-week, Double-blind Treatment Period||259
8338373|NCT01323621|20555365|P2|STARTED|12-week, Double-blind Treatment Period||252
8338374|NCT01323621|20555366|P1|STARTED|12-week, Double-blind Treatment Period||0
8338375|NCT01323621|20555364|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
8338376|NCT01323621|20555365|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
8338377|NCT01323621|20555366|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
8338378|NCT01323621|20555364|P3|COMPLETED|2-week, Single-blind Run In Period||0
8338379|NCT01323621|20555365|P2|COMPLETED|2-week, Single-blind Run In Period||0
8338380|NCT01323621|20555366|P1|COMPLETED|2-week, Single-blind Run In Period||511
8338381|NCT01323621|20555364|P3|STARTED|2-week, Single-blind Run In Period||0
8338382|NCT01323621|20555365|P2|STARTED|2-week, Single-blind Run In Period||0
8338383|NCT01323621|20555366|P1|STARTED|2-week, Single-blind Run In Period||739
8338384|NCT01323595|20555376|P2|NOT COMPLETED|Overall Study||21
8338385|NCT01323595|20555377|P1|NOT COMPLETED|Overall Study||23
8338386|NCT01323595|20555376|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
8338387|NCT01323595|20555377|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
8338388|NCT01323595|20555376|P2|STARTED|Overall Study||39
8338389|NCT01323595|20555377|P1|STARTED|Overall Study||39
8338390|NCT01323582|20555387|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
8338391|NCT01323582|20555388|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
8338392|NCT01323582|20555387|P2|COMPLETED|Weeks 8-11 (Period 2)||10
8338393|NCT01323582|20555388|P1|COMPLETED|Weeks 8-11 (Period 2)||10
8338394|NCT01323582|20555387|P2|STARTED|Weeks 8-11 (Period 2)||11
8338395|NCT01323582|20555388|P1|STARTED|Weeks 8-11 (Period 2)||10
8338396|NCT01323582|20555387|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
8338397|NCT01323582|20555388|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
8338398|NCT01323582|20555387|P2|COMPLETED|Weeks 5-7 (Washout)||11
8338399|NCT01323582|20555388|P1|COMPLETED|Weeks 5-7 (Washout)||10
8338400|NCT01323582|20555387|P2|STARTED|Weeks 5-7 (Washout)||12
8338401|NCT01323582|20555388|P1|STARTED|Weeks 5-7 (Washout)||10
8338402|NCT01323582|20555387|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
8338403|NCT01323582|20555388|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
8338404|NCT01323582|20555387|P2|COMPLETED|Weeks 1-4 (First Period)||12
8338405|NCT01323582|20555388|P1|COMPLETED|Weeks 1-4 (First Period)||10
8338406|NCT01323582|20555387|P2|STARTED|Weeks 1-4 (First Period)||14
8338407|NCT01323582|20555388|P1|STARTED|Weeks 1-4 (First Period)||12
8338408|NCT01323530|20555411|P7|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
8338409|NCT01323530|20555412|P6|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338410|NCT01323530|20555413|P5|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338411|NCT01323530|20555414|P4|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338412|NCT01323530|20555415|P3|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338413|NCT01323530|20555416|P2|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338414|NCT01323530|20555417|P1|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338415|NCT01323530|20555411|P7|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
8338416|NCT01323530|20555412|P6|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338417|NCT01323530|20555413|P5|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338418|NCT01323530|20555414|P4|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338419|NCT01323530|20555415|P3|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338420|NCT01323530|20555416|P2|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338421|NCT01323530|20555417|P1|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338422|NCT01323530|20555411|P7|STARTED|Phase 2 (Dose-confirmation Phase)||42
8338423|NCT01323530|20555412|P6|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338424|NCT01323530|20555413|P5|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338425|NCT01323530|20555414|P4|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338426|NCT01323530|20555415|P3|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338427|NCT01323530|20555416|P2|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338428|NCT01323530|20555417|P1|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338429|NCT01323530|20555411|P7|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
8338430|NCT01323530|20555412|P6|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338431|NCT01323530|20555413|P5|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338432|NCT01323530|20555414|P4|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
8338433|NCT01323530|20555415|P3|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
8338434|NCT01323530|20555416|P2|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
8338435|NCT01323530|20555417|P1|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338436|NCT01323530|20555411|P7|COMPLETED|Phase 1b (Dose Escalation Phase)||0
8338437|NCT01323530|20555412|P6|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338438|NCT01323530|20555413|P5|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338439|NCT01323530|20555414|P4|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338440|NCT01323530|20555415|P3|COMPLETED|Phase 1b (Dose Escalation Phase)||4
8338441|NCT01323530|20555416|P2|COMPLETED|Phase 1b (Dose Escalation Phase)||4
8338442|NCT01323530|20555417|P1|COMPLETED|Phase 1b (Dose Escalation Phase)||5
8338443|NCT01323530|20555411|P7|STARTED|Phase 1b (Dose Escalation Phase)||0
8338444|NCT01323530|20555412|P6|STARTED|Phase 1b (Dose Escalation Phase)||6
8338445|NCT01323530|20555413|P5|STARTED|Phase 1b (Dose Escalation Phase)||6
8338446|NCT01323530|20555414|P4|STARTED|Phase 1b (Dose Escalation Phase)||3
8338447|NCT01323530|20555415|P3|STARTED|Phase 1b (Dose Escalation Phase)||5
8338448|NCT01323530|20555416|P2|STARTED|Phase 1b (Dose Escalation Phase)||6
8338449|NCT01323530|20555417|P1|STARTED|Phase 1b (Dose Escalation Phase)||8
8338450|NCT01323517|20555447|P1|NOT COMPLETED|Overall Study||0
8338451|NCT01323517|20555447|P1|COMPLETED|Overall Study||26
8338452|NCT01323517|20555447|P1|STARTED|Overall Study||26
8338453|NCT01323478|20555454|P1|NOT COMPLETED|Overall Study||24
8338454|NCT01323478|20555454|P1|COMPLETED|Overall Study||47
8338455|NCT01323478|20555454|P1|STARTED|Overall Study||71
8338456|NCT01323387|20555467|P1|NOT COMPLETED|Overall Study||84
8338457|NCT01323387|20555467|P1|COMPLETED|Overall Study||94
8338458|NCT01323387|20555467|P1|STARTED|Overall Study||178
8338459|NCT01323270|20555480|P2|NOT COMPLETED|Overall Study||29
8338460|NCT01323270|20555481|P1|NOT COMPLETED|Overall Study||43
8338461|NCT01323270|20555480|P2|COMPLETED|Overall Study||347
8338462|NCT01323270|20555481|P1|COMPLETED|Overall Study||330
8338463|NCT01323270|20555480|P2|STARTED|Overall Study||376
8338464|NCT01323270|20555481|P1|STARTED|Overall Study||373
8338465|NCT01323192|20555503|P2|NOT COMPLETED|Overall Study||6
8338466|NCT01323192|20555504|P1|NOT COMPLETED|Overall Study||9
8338467|NCT01323192|20555503|P2|COMPLETED|Overall Study||135
8338468|NCT01323192|20555504|P1|COMPLETED|Overall Study||134
8338469|NCT01323192|20555503|P2|STARTED|Overall Study||141
8338470|NCT01323192|20555504|P1|STARTED|Overall Study||143
8338471|NCT01323153|20555522|P2|NOT COMPLETED|Overall Study||8
8338472|NCT01323153|20555523|P1|NOT COMPLETED|Overall Study||17
8338473|NCT01323153|20555522|P2|COMPLETED|Overall Study||142
8338474|NCT01323153|20555523|P1|COMPLETED|Overall Study||133
8338475|NCT01323153|20555522|P2|STARTED|Overall Study||150
8338476|NCT01323153|20555523|P1|STARTED|Overall Study||150
8338477|NCT01323140|20555529|P1|NOT COMPLETED|Overall Study||2
8338478|NCT01323140|20555529|P1|COMPLETED|Overall Study||38
8338479|NCT01323140|20555529|P1|STARTED|Overall Study||40
8338480|NCT01323010|20555535|P2|NOT COMPLETED|Overall Study||0
8338481|NCT01323010|20555536|P1|NOT COMPLETED|Overall Study||0
8338482|NCT01323010|20555535|P2|COMPLETED|Overall Study||59
8338483|NCT01323010|20555536|P1|COMPLETED|Overall Study||60
8338484|NCT01323010|20555535|P2|STARTED|Overall Study||59
8338485|NCT01323010|20555536|P1|STARTED|Overall Study||60
8338486|NCT01322971|20555587|P2|NOT COMPLETED|Overall Study||1
8338487|NCT01322971|20555588|P1|NOT COMPLETED|Overall Study||1
8338488|NCT01322971|20555587|P2|COMPLETED|Overall Study||0
8338489|NCT01322971|20555588|P1|COMPLETED|Overall Study||0
8338490|NCT01322971|20555587|P2|STARTED|Overall Study||1
8338491|NCT01322971|20555588|P1|STARTED|Overall Study||1
8338492|NCT01322945|20555602|P2|NOT COMPLETED|Overall Study||0
8338493|NCT01322945|20555603|P1|NOT COMPLETED|Overall Study||0
8338494|NCT01322945|20555602|P2|COMPLETED|Overall Study||42
8338495|NCT01322945|20555603|P1|COMPLETED|Overall Study||52
8338496|NCT01322945|20555602|P2|STARTED|Overall Study||42
8338497|NCT01322945|20555603|P1|STARTED|Overall Study||52
8338498|NCT01322841|20555613|P2|NOT COMPLETED|Overall Study||0
8338499|NCT01322841|20555614|P1|NOT COMPLETED|Overall Study||0
8338500|NCT01322841|20555613|P2|COMPLETED|Overall Study||1123
8338501|NCT01322841|20555614|P1|COMPLETED|Overall Study||1116
8338502|NCT01322841|20555613|P2|STARTED|Overall Study||1123
8338503|NCT01322841|20555614|P1|STARTED|Overall Study||1116
8338504|NCT01322815|20555624|P2|NOT COMPLETED|Overall Study||0
8338505|NCT01322815|20555625|P1|NOT COMPLETED|Overall Study||0
8338506|NCT01322815|20555624|P2|COMPLETED|Overall Study||4
8338507|NCT01322815|20555625|P1|COMPLETED|Overall Study||7
8338508|NCT01322815|20555624|P2|STARTED|Overall Study||4
8338509|NCT01322815|20555625|P1|STARTED|Overall Study||7
8338510|NCT01322633|20555633|P2|NOT COMPLETED|Overall Study||0
8338511|NCT01322633|20555634|P1|NOT COMPLETED|Overall Study||0
8338512|NCT01322633|20555633|P2|COMPLETED|Overall Study||27686
8338513|NCT01322633|20555634|P1|COMPLETED|Overall Study||34178
8338514|NCT01322633|20555633|P2|STARTED|Overall Study||27686
8338515|NCT01322633|20555634|P1|STARTED|Overall Study||34178
8338516|NCT01322607|20555646|P2|NOT COMPLETED|Overall Study||0
8338517|NCT01322607|20555647|P1|NOT COMPLETED|Overall Study||1
8338518|NCT01322607|20555646|P2|COMPLETED|Overall Study||9
8338519|NCT01322607|20555647|P1|COMPLETED|Overall Study||10
8338520|NCT01322607|20555646|P2|STARTED|Overall Study||9
8338521|NCT01322607|20555647|P1|STARTED|Overall Study||11
8338522|NCT01322594|20555665|P6|NOT COMPLETED|Overall Study||0
8338523|NCT01322594|20555666|P5|NOT COMPLETED|Overall Study||0
8338524|NCT01322594|20555667|P4|NOT COMPLETED|Overall Study||0
8338525|NCT01322594|20555668|P3|NOT COMPLETED|Overall Study||0
8338526|NCT01322594|20555669|P2|NOT COMPLETED|Overall Study||0
8338527|NCT01322594|20555670|P1|NOT COMPLETED|Overall Study||0
8338528|NCT01322594|20555665|P6|COMPLETED|Overall Study||6
8338529|NCT01322594|20555666|P5|COMPLETED|Overall Study||7
8338530|NCT01322594|20555667|P4|COMPLETED|Overall Study||6
8338531|NCT01322594|20555668|P3|COMPLETED|Overall Study||3
8338532|NCT01322594|20555669|P2|COMPLETED|Overall Study||3
8338533|NCT01322594|20555670|P1|COMPLETED|Overall Study||6
8338534|NCT01322594|20555665|P6|STARTED|Overall Study||6
8338535|NCT01322594|20555666|P5|STARTED|Overall Study||7
8338536|NCT01322594|20555667|P4|STARTED|Overall Study||6
8338537|NCT01322594|20555668|P3|STARTED|Overall Study||3
8338538|NCT01322594|20555669|P2|STARTED|Overall Study||3
8338539|NCT01322594|20555670|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
8338540|NCT01322490|20555753|P3|NOT COMPLETED|Long Term Follow-up Period||413
8338541|NCT01322490|20555754|P2|NOT COMPLETED|Long Term Follow-up Period||408
8338542|NCT01322490|20555755|P1|NOT COMPLETED|Long Term Follow-up Period||409
8338543|NCT01322490|20555753|P3|COMPLETED|Long Term Follow-up Period||0
8338544|NCT01322490|20555754|P2|COMPLETED|Long Term Follow-up Period||0
8338545|NCT01322490|20555755|P1|COMPLETED|Long Term Follow-up Period||0
8338546|NCT01322490|20555753|P3|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
8338547|NCT01322490|20555754|P2|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
8338548|NCT01322490|20555755|P1|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
8338549|NCT01322490|20555753|P3|NOT COMPLETED|Treatment Period||153
8338550|NCT01322490|20555754|P2|NOT COMPLETED|Treatment Period||153
8338551|NCT01322490|20555755|P1|NOT COMPLETED|Treatment Period||132
8338552|NCT01322490|20555753|P3|COMPLETED|Treatment Period||280
8338553|NCT01322490|20555754|P2|COMPLETED|Treatment Period||279
8338554|NCT01322490|20555755|P1|COMPLETED|Treatment Period||300
8338555|NCT01322490|20555753|P3|Treated|Treatment Period||428
8338556|NCT01322490|20555754|P2|Treated|Treatment Period||429
8338557|NCT01322490|20555755|P1|Treated|Treatment Period||429
8338558|NCT01322490|20555753|P3|STARTED|Treatment Period||433
8338559|NCT01322490|20555754|P2|STARTED|Treatment Period||432
8338560|NCT01322490|20555755|P1|STARTED|Treatment Period||432
8338561|NCT01322386|20555768|P2|NOT COMPLETED|Overall Study||2
8338562|NCT01322386|20555769|P1|NOT COMPLETED|Overall Study||0
8338563|NCT01322386|20555768|P2|COMPLETED|Overall Study||9
8338564|NCT01322386|20555769|P1|COMPLETED|Overall Study||10
8338565|NCT01322386|20555768|P2|STARTED|Overall Study||11
8338566|NCT01322386|20555769|P1|STARTED|Overall Study||10
8338567|NCT01322360|20555777|P1|NOT COMPLETED|Overall Study||0
8338568|NCT01322360|20555777|P1|COMPLETED|Overall Study||50
8338569|NCT01322360|20555777|P1|STARTED|Overall Study||50
8338570|NCT01322347|20555784|P2|NOT COMPLETED|Overall Study||35
8338571|NCT01322347|20555785|P1|NOT COMPLETED|Overall Study||51
8338572|NCT01322347|20555784|P2|COMPLETED|Overall Study||112
8338573|NCT01322347|20555785|P1|COMPLETED|Overall Study||96
8338574|NCT01322347|20555784|P2|Completed St 3|Overall Study||86
8338575|NCT01322347|20555785|P1|Completed St 3|Overall Study||82
8338576|NCT01322347|20555784|P2|Enrolled in St 3|Overall Study||113
8338577|NCT01322347|20555785|P1|Enrolled in St 3|Overall Study||101
8338578|NCT01322347|20555784|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
8338579|NCT01322347|20555785|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
8338580|NCT01322347|20555784|P2|Completed 48 Wks in St 2|Overall Study||22
8338581|NCT01322347|20555785|P1|Completed 48 Wks in St 2|Overall Study||28
8338582|NCT01322347|20555784|P2|STARTED|Overall Study||147
8338583|NCT01322347|20555785|P1|STARTED|Overall Study||147
8338584|NCT01322048|20555822|P2|NOT COMPLETED|Overall Study||0
8338585|NCT01322048|20555823|P1|NOT COMPLETED|Overall Study||0
8338586|NCT01322048|20555822|P2|COMPLETED|Overall Study||26
8338587|NCT01322048|20555823|P1|COMPLETED|Overall Study||21
8338588|NCT01322048|20555822|P2|STARTED|Overall Study||26
8338589|NCT01322048|20555823|P1|STARTED|Overall Study||21
8338590|NCT01322022|20555833|P2|NOT COMPLETED|Overall Study||2
8338591|NCT01322022|20555834|P1|NOT COMPLETED|Overall Study||5
8338592|NCT01322022|20555833|P2|COMPLETED|Overall Study||18
8338593|NCT01322022|20555834|P1|COMPLETED|Overall Study||15
8338594|NCT01322022|20555833|P2|Week 4|Overall Study||18
8338595|NCT01322022|20555834|P1|Week 4|Overall Study||15
8338596|NCT01322022|20555833|P2|STARTED|Overall Study||20
8338597|NCT01322022|20555834|P1|STARTED|Overall Study||20
8338598|NCT01322009|20555848|P2|NOT COMPLETED|Overall Study||3
8338599|NCT01322009|20555849|P1|NOT COMPLETED|Overall Study||0
8338600|NCT01322009|20555848|P2|COMPLETED|Overall Study||4
8338601|NCT01322009|20555849|P1|COMPLETED|Overall Study||7
8338602|NCT01322009|20555848|P2|STARTED|Overall Study||7
8338603|NCT01322009|20555849|P1|STARTED|Overall Study||7
8338604|NCT01321879|20555857|P1|NOT COMPLETED|Overall Study||14
8338605|NCT01321879|20555857|P1|COMPLETED|Overall Study||25
8338606|NCT01321879|20555857|P1|STARTED|Overall Study||39
8338607|NCT01321749|20555863|P2|NOT COMPLETED|Overall Study||22
8338608|NCT01321749|20555864|P1|NOT COMPLETED|Overall Study||13
8338609|NCT01321749|20555863|P2|COMPLETED|Overall Study||30
8338610|NCT01321749|20555864|P1|COMPLETED|Overall Study||38
8338611|NCT01321749|20555863|P2|STARTED|Overall Study||52
8338612|NCT01321749|20555864|P1|STARTED|Overall Study||51
8338613|NCT01321723|20555873|P3|NOT COMPLETED|Overall Study||4
8338614|NCT01321723|20555874|P2|NOT COMPLETED|Overall Study||5
8338615|NCT01321723|20555875|P1|NOT COMPLETED|Overall Study||5
8338616|NCT01321723|20555873|P3|COMPLETED|Overall Study||28
8338617|NCT01321723|20555874|P2|COMPLETED|Overall Study||28
8338618|NCT01321723|20555875|P1|COMPLETED|Overall Study||27
8338619|NCT01321723|20555873|P3|STARTED|Overall Study||32
8338620|NCT01321723|20555874|P2|STARTED|Overall Study||33
8338621|NCT01321723|20555875|P1|STARTED|Overall Study||32
8338622|NCT01321710|20555897|P3|NOT COMPLETED|Overall Study||0
8338623|NCT01321710|20555898|P2|NOT COMPLETED|Overall Study||5
8338624|NCT01321710|20555899|P1|NOT COMPLETED|Overall Study||4
8338625|NCT01321710|20555897|P3|COMPLETED|Overall Study||44
8338626|NCT01321710|20555898|P2|COMPLETED|Overall Study||53
8338627|NCT01321710|20555899|P1|COMPLETED|Overall Study||46
8338628|NCT01321710|20555897|P3|STARTED|Overall Study||44
8338629|NCT01321710|20555898|P2|STARTED|Overall Study||58
8338630|NCT01321710|20555899|P1|STARTED|Overall Study||50
8338631|NCT01321697|20555914|P1|NOT COMPLETED|Overall Study||7
8338632|NCT01321697|20555914|P1|COMPLETED|Overall Study||0
8338633|NCT01321697|20555914|P1|STARTED|Overall Study||7
8338634|NCT01321606|20555920|P4|NOT COMPLETED|Overall Study||1
8338635|NCT01321606|20555921|P3|NOT COMPLETED|Overall Study||0
8338636|NCT01321606|20555922|P2|NOT COMPLETED|Overall Study||0
8338637|NCT01321606|20555923|P1|NOT COMPLETED|Overall Study||0
8338638|NCT01321606|20555920|P4|COMPLETED|Overall Study||28
8338639|NCT01321606|20555921|P3|COMPLETED|Overall Study||34
8338640|NCT01321606|20555922|P2|COMPLETED|Overall Study||32
8338641|NCT01321606|20555923|P1|COMPLETED|Overall Study||18
8338642|NCT01321606|20555920|P4|STARTED|Overall Study||29
8338643|NCT01321606|20555921|P3|STARTED|Overall Study||34
8338644|NCT01321606|20555922|P2|STARTED|Overall Study||32
8338645|NCT01321606|20555923|P1|STARTED|Overall Study||18
8338646|NCT01321554|20555943|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338647|NCT01321554|20555944|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338648|NCT01321554|20555945|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338649|NCT01321554|20555946|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338650|NCT01321554|20555943|P4|COMPLETED|OOL Lenvatinib Treatment Period||30
8338651|NCT01321554|20555944|P3|COMPLETED|OOL Lenvatinib Treatment Period||85
8338652|NCT01321554|20555945|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
8338653|NCT01321554|20555946|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
8338654|NCT01321554|20555943|P4|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
8338655|NCT01321554|20555944|P3|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
8338656|NCT01321554|20555945|P2|STARTED|OOL Lenvatinib Treatment Period||0
8338657|NCT01321554|20555946|P1|STARTED|OOL Lenvatinib Treatment Period||0
8338658|NCT01321554|20555943|P4|NOT COMPLETED|Randomization Phase||0
8338659|NCT01321554|20555944|P3|NOT COMPLETED|Randomization Phase||0
8338660|NCT01321554|20555945|P2|NOT COMPLETED|Randomization Phase||0
8338661|NCT01321554|20555946|P1|NOT COMPLETED|Randomization Phase||0
8338662|NCT01321554|20555943|P4|COMPLETED|Randomization Phase||0
8338663|NCT01321554|20555944|P3|COMPLETED|Randomization Phase||0
8338664|NCT01321554|20555945|P2|COMPLETED|Randomization Phase||131
8338665|NCT01321554|20555946|P1|COMPLETED|Randomization Phase||261
8338666|NCT01321554|20555943|P4|STARTED|Randomization Phase||0
8338667|NCT01321554|20555944|P3|STARTED|Randomization Phase||0
8338668|NCT01321554|20555945|P2|STARTED|Randomization Phase||131
8338669|NCT01321554|20555946|P1|STARTED|Randomization Phase||261
8338670|NCT01321437|20555959|P1|NOT COMPLETED|Overall Study||0
8338671|NCT01321437|20555959|P1|COMPLETED|Overall Study||11
8338672|NCT01321437|20555959|P1|STARTED|Overall Study||11
8338673|NCT01321073|20555967|P1|NOT COMPLETED|Overall Study||7
8338674|NCT01321073|20555967|P1|COMPLETED|Overall Study||57
8338675|NCT01321073|20555967|P1|STARTED|Overall Study||64
8338676|NCT01321008|20555971|P1|NOT COMPLETED|Overall Study||1
8338677|NCT01321008|20555971|P1|COMPLETED|Overall Study||0
8338678|NCT01321008|20555971|P1|STARTED|Overall Study||1
8338679|NCT01320943|20555977|P2|NOT COMPLETED|Overall Study||2
8338680|NCT01320943|20555978|P1|NOT COMPLETED|Overall Study||1
8338681|NCT01320943|20555977|P2|COMPLETED|Overall Study||20
8338682|NCT01320943|20555978|P1|COMPLETED|Overall Study||20
8338683|NCT01320943|20555977|P2|STARTED|Overall Study||22
8338684|NCT01320943|20555978|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
8338685|NCT01320826|20555997|P1|NOT COMPLETED|Overall Study||0
8338686|NCT01320826|20555997|P1|COMPLETED|Overall Study||577
8338687|NCT01320826|20555997|P1|STARTED|Overall Study||577
8338688|NCT01320735|20556012|P1|NOT COMPLETED|Overall Study||106
8338689|NCT01320735|20556012|P1|COMPLETED|Overall Study||194
8338690|NCT01320735|20556012|P1|STARTED|Overall Study||300
8338691|NCT01320722|20556034|P5|NOT COMPLETED|Overall Study||8
8338692|NCT01320722|20556035|P4|NOT COMPLETED|Overall Study||14
8338693|NCT01320722|20556036|P3|NOT COMPLETED|Overall Study||7
8338694|NCT01320722|20556037|P2|NOT COMPLETED|Overall Study||6
8338695|NCT01320722|20556038|P1|NOT COMPLETED|Overall Study||3
8338696|NCT01320722|20556034|P5|COMPLETED|Overall Study||45
8338697|NCT01320722|20556035|P4|COMPLETED|Overall Study||35
8338698|NCT01320722|20556036|P3|COMPLETED|Overall Study||40
8338699|NCT01320722|20556037|P2|COMPLETED|Overall Study||41
8338700|NCT01320722|20556038|P1|COMPLETED|Overall Study||43
8338701|NCT01320722|20556034|P5|Received Intervention|Overall Study||51
8338702|NCT01320722|20556035|P4|Received Intervention|Overall Study||48
8338703|NCT01320722|20556036|P3|Received Intervention|Overall Study||46
8338704|NCT01320722|20556037|P2|Received Intervention|Overall Study||45
8338705|NCT01320722|20556038|P1|Received Intervention|Overall Study||43
8338706|NCT01320722|20556034|P5|STARTED|Overall Study||53
8338707|NCT01320722|20556035|P4|STARTED|Overall Study||49
8338708|NCT01320722|20556036|P3|STARTED|Overall Study||47
8338709|NCT01320722|20556037|P2|STARTED|Overall Study||47
8338710|NCT01320722|20556038|P1|STARTED|Overall Study||46
8338711|NCT01320683|20556075|P1|NOT COMPLETED|Overall Study||1
8338712|NCT01320683|20556075|P1|COMPLETED|Overall Study||0
8338713|NCT01320683|20556075|P1|STARTED|Overall Study||1
8338714|NCT01320553|20556084|P4|NOT COMPLETED|Overall Study||1
8338715|NCT01320553|20556085|P3|NOT COMPLETED|Overall Study||2
8338716|NCT01320553|20556086|P2|NOT COMPLETED|Overall Study||4
8338717|NCT01320553|20556087|P1|NOT COMPLETED|Overall Study||1
8338718|NCT01320553|20556084|P4|COMPLETED|Overall Study||29
8338719|NCT01320553|20556085|P3|COMPLETED|Overall Study||29
8338720|NCT01320553|20556086|P2|COMPLETED|Overall Study||26
8338721|NCT01320553|20556087|P1|COMPLETED|Overall Study||30
8338722|NCT01320553|20556084|P4|STARTED|Overall Study||30
8338723|NCT01320553|20556085|P3|STARTED|Overall Study||31
8338724|NCT01320553|20556086|P2|STARTED|Overall Study||30
8338725|NCT01320553|20556087|P1|STARTED|Overall Study||31
8338726|NCT01320293|20556101|P1|NOT COMPLETED|Overall Study||2
8338727|NCT01320293|20556101|P1|COMPLETED|Overall Study||16
8338728|NCT01320293|20556101|P1|STARTED|Overall Study||18
8338729|NCT01320202|20556109|P2|NOT COMPLETED|Overall Study||44
8338730|NCT01320202|20556110|P1|NOT COMPLETED|Overall Study||56
8338731|NCT01320202|20556109|P2|COMPLETED|Overall Study||109
8338732|NCT01320202|20556110|P1|COMPLETED|Overall Study||96
8338733|NCT01320202|20556109|P2|Completed St 3|Overall Study||82
8338734|NCT01320202|20556110|P1|Completed St 3|Overall Study||79
8338735|NCT01320202|20556109|P2|Enrolled in St 3|Overall Study||109
8338736|NCT01320202|20556110|P1|Enrolled in St 3|Overall Study||98
8338737|NCT01320202|20556109|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
8338738|NCT01320202|20556110|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
8338739|NCT01320202|20556109|P2|Comp 48 Wks in St 2|Overall Study||27
8338740|NCT01320202|20556110|P1|Comp 48 Wks in St 2|Overall Study||27
8338741|NCT01320202|20556109|P2|STARTED|Overall Study||153
8338742|NCT01320202|20556110|P1|STARTED|Overall Study||152
8338743|NCT01320150|20556147|P1|NOT COMPLETED|Overall Study||66
8338744|NCT01320150|20556147|P1|COMPLETED|Overall Study||245
8338745|NCT01320150|20556147|P1|Non-PPP|Overall Study||211
8338746|NCT01320150|20556147|P1|PPP|Overall Study||34
8338747|NCT01320150|20556147|P1|STARTED|Overall Study||311
8338748|NCT01320137|20556153|P2|NOT COMPLETED|Overall Study||0
8338749|NCT01320137|20556154|P1|NOT COMPLETED|Overall Study||0
8338750|NCT01320137|20556153|P2|COMPLETED|Overall Study||40
8338751|NCT01320137|20556154|P1|COMPLETED|Overall Study||40
8338752|NCT01320137|20556153|P2|STARTED|Overall Study||40
8338753|NCT01320137|20556154|P1|STARTED|Overall Study||40
8338754|NCT01320085|20556169|P3|NOT COMPLETED|Overall Study||25
8338755|NCT01320085|20556170|P2|NOT COMPLETED|Overall Study||117
8338756|NCT01320085|20556171|P1|NOT COMPLETED|Overall Study||41
8338757|NCT01320085|20556169|P3|COMPLETED|Overall Study||0
8338758|NCT01320085|20556170|P2|COMPLETED|Overall Study||0
8338759|NCT01320085|20556171|P1|COMPLETED|Overall Study||0
8338760|NCT01320085|20556169|P3|STARTED|Overall Study||25
8338761|NCT01320085|20556170|P2|STARTED|Overall Study||117
8338762|NCT01320085|20556171|P1|STARTED|Overall Study||41
8338763|NCT01320072|20556268|P2|NOT COMPLETED|Overall Study||0
8338764|NCT01320072|20556269|P1|NOT COMPLETED|Overall Study||0
8338765|NCT01320072|20556268|P2|COMPLETED|Overall Study||13
8338766|NCT01320072|20556269|P1|COMPLETED|Overall Study||16
8338767|NCT01320072|20556268|P2|STARTED|Overall Study||13
8338768|NCT01320072|20556269|P1|STARTED|Overall Study||16
8338778|NCT01319994|20556311|P2|NOT COMPLETED|Overall Study||6
8338779|NCT01319994|20556312|P1|NOT COMPLETED|Overall Study||7
8338780|NCT01319994|20556311|P2|COMPLETED|Overall Study||21
8338781|NCT01319994|20556312|P1|COMPLETED|Overall Study||19
8338782|NCT01319994|20556311|P2|Did Not Develop Overt Diabetes|Overall Study||21
8338783|NCT01319994|20556312|P1|Did Not Develop Overt Diabetes|Overall Study||19
8338784|NCT01319994|20556311|P2|Glucocorticoid Dose as Inc Cri|Overall Study||22
8338785|NCT01319994|20556312|P1|Glucocorticoid Dose as Inc Cri|Overall Study||19
8338786|NCT01319994|20556311|P2|Tolerated at Least 1.7g/Day Dose|Overall Study||24
8338787|NCT01319994|20556312|P1|Tolerated at Least 1.7g/Day Dose|Overall Study||19
8338788|NCT01319994|20556311|P2|Abto Keep Appoinment Shedule|Overall Study||24
8338789|NCT01319994|20556312|P1|Abto Keep Appoinment Shedule|Overall Study||23
8338790|NCT01319994|20556311|P2|STARTED|Overall Study||27
8338791|NCT01319994|20556312|P1|STARTED|Overall Study||26
8338792|NCT01319929|20556322|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
8338793|NCT01319929|20556323|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
8338794|NCT01319929|20556322|P2|COMPLETED|Second Treatment Period (4 Weeks)||16
8338795|NCT01319929|20556323|P1|COMPLETED|Second Treatment Period (4 Weeks)||16
8338796|NCT01319929|20556322|P2|STARTED|Second Treatment Period (4 Weeks)||17
8338797|NCT01319929|20556323|P1|STARTED|Second Treatment Period (4 Weeks)||17
8338798|NCT01319929|20556322|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
8338799|NCT01319929|20556323|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
8338800|NCT01319929|20556322|P2|COMPLETED|Washout Period (3 Weeks)||17
8338801|NCT01319929|20556323|P1|COMPLETED|Washout Period (3 Weeks)||17
8338802|NCT01319929|20556322|P2|STARTED|Washout Period (3 Weeks)||17
8338803|NCT01319929|20556323|P1|STARTED|Washout Period (3 Weeks)||17
8338804|NCT01319929|20556322|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||2
8338805|NCT01319929|20556323|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||3
8338806|NCT01319929|20556322|P2|COMPLETED|First Treatment Period (4 Weeks)||17
8338807|NCT01319929|20556323|P1|COMPLETED|First Treatment Period (4 Weeks)||17
8338808|NCT01319929|20556322|P2|STARTED|First Treatment Period (4 Weeks)||19
8338809|NCT01319929|20556323|P1|STARTED|First Treatment Period (4 Weeks)||20
8338810|NCT01319877|20556355|P2|NOT COMPLETED|Overall Study||45
8338811|NCT01319877|20556356|P1|NOT COMPLETED|Overall Study||108
8338812|NCT01319877|20556355|P2|COMPLETED|Overall Study||108
8338813|NCT01319877|20556356|P1|COMPLETED|Overall Study||345
8338814|NCT01319877|20556355|P2|STARTED|Overall Study||153
8338815|NCT01319877|20556356|P1|STARTED|Overall Study||453
8338816|NCT01319851|20556391|P1|NOT COMPLETED|Overall Study||0
8338817|NCT01319851|20556391|P1|COMPLETED|Overall Study||3
8338818|NCT01319851|20556391|P1|STARTED|Overall Study||3
8338819|NCT01319812|20556403|P2|NOT COMPLETED|Overall Study||22
8338820|NCT01319812|20556404|P1|NOT COMPLETED|Overall Study||16
8338821|NCT01319812|20556403|P2|COMPLETED|Overall Study||280
8338822|NCT01319812|20556404|P1|COMPLETED|Overall Study||145
8338823|NCT01319812|20556403|P2|STARTED|Overall Study||302
8338824|NCT01319812|20556404|P1|STARTED|Overall Study||161
8338825|NCT01319799|20556485|P1|NOT COMPLETED|Overall Study||0
8338826|NCT01319799|20556485|P1|COMPLETED|Overall Study||10
8338827|NCT01319799|20556485|P1|STARTED|Overall Study||10
8338828|NCT01319773|20556495|P5|NOT COMPLETED|Overall Study||0
8338829|NCT01319773|20556496|P4|NOT COMPLETED|Overall Study||0
8338830|NCT01319773|20556497|P3|NOT COMPLETED|Overall Study||0
8338831|NCT01319773|20556498|P2|NOT COMPLETED|Overall Study||0
8338832|NCT01319773|20556499|P1|NOT COMPLETED|Overall Study||0
8338833|NCT01319773|20556495|P5|COMPLETED|Overall Study||8
8338834|NCT01319773|20556496|P4|COMPLETED|Overall Study||8
8338835|NCT01319773|20556497|P3|COMPLETED|Overall Study||8
8338836|NCT01319773|20556498|P2|COMPLETED|Overall Study||10
8338837|NCT01319773|20556499|P1|COMPLETED|Overall Study||10
8338838|NCT01319773|20556495|P5|STARTED|Overall Study||8
8338839|NCT01319773|20556496|P4|STARTED|Overall Study||8
8338840|NCT01319773|20556497|P3|STARTED|Overall Study||8
8338841|NCT01319773|20556498|P2|STARTED|Overall Study||10
8338842|NCT01319773|20556499|P1|STARTED|Overall Study||10
8338843|NCT01319760|20556515|P2|NOT COMPLETED|Overall Study||0
8338844|NCT01319760|20556516|P1|NOT COMPLETED|Overall Study||0
8338845|NCT01319760|20556515|P2|COMPLETED|Overall Study||5
8338846|NCT01319760|20556516|P1|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
8338847|NCT01319760|20556515|P2|STARTED|Overall Study||5
8338848|NCT01319760|20556516|P1|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
8338849|NCT01319721|20556524|P2|NOT COMPLETED|Overall Study||6
8338850|NCT01319721|20556525|P1|NOT COMPLETED|Overall Study||1
8338851|NCT01319721|20556524|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
8338852|NCT01319721|20556525|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
8338853|NCT01319721|20556524|P2|STARTED|Overall Study|The unit of measure is eyes.|48
8338854|NCT01319721|20556525|P1|STARTED|Overall Study|The unit of measure is eyes.|48
8338855|NCT01319617|20556539|P1|NOT COMPLETED|Overall Study||1
8338856|NCT01319617|20556539|P1|COMPLETED|Overall Study||40
8338857|NCT01319617|20556539|P1|STARTED|Overall Study||41
8338858|NCT01319552|20556543|P1|NOT COMPLETED|Overall Study||0
8338859|NCT01319552|20556543|P1|COMPLETED|Overall Study||14
8338860|NCT01319552|20556543|P1|STARTED|Overall Study||14
8338861|NCT01319539|20556548|P1|NOT COMPLETED|Overall Study||0
8338862|NCT01319539|20556548|P1|COMPLETED|Overall Study||12
8338863|NCT01319539|20556548|P1|STARTED|Overall Study||12
8338864|NCT01319500|20556558|P2|NOT COMPLETED|Overall Study||0
8338865|NCT01319500|20556559|P1|NOT COMPLETED|Overall Study||0
8338866|NCT01319500|20556558|P2|COMPLETED|Overall Study||2589
8338867|NCT01319500|20556559|P1|COMPLETED|Overall Study||1187
8338868|NCT01319500|20556558|P2|STARTED|Overall Study||2589
8338869|NCT01319500|20556559|P1|STARTED|Overall Study||1187
8338870|NCT01319422|20556578|P2|NOT COMPLETED|Overall Study||0
8338871|NCT01319422|20556579|P1|NOT COMPLETED|Overall Study||1
8338872|NCT01319422|20556578|P2|COMPLETED|Overall Study||20
8338873|NCT01319422|20556579|P1|COMPLETED|Overall Study||19
8338874|NCT01319422|20556578|P2|STARTED|Overall Study||20
8338875|NCT01319422|20556579|P1|STARTED|Overall Study||20
8338876|NCT01319396|20556593|P1|NOT COMPLETED|Overall Study||0
8338877|NCT01319396|20556593|P1|COMPLETED|Overall Study||24
8338878|NCT01319396|20556593|P1|STARTED|Overall Study||24
8338879|NCT01319383|20556597|P2|NOT COMPLETED|Overall Study||10
8338880|NCT01319383|20556598|P1|NOT COMPLETED|Overall Study||12
8338881|NCT01319383|20556597|P2|COMPLETED|Overall Study||3
8338882|NCT01319383|20556598|P1|COMPLETED|Overall Study||0
8338883|NCT01319383|20556597|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
8338884|NCT01319383|20556598|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
8338885|NCT01319383|20556597|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
8338886|NCT01319383|20556598|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
8338887|NCT01319383|20556597|P2|Step 2|Overall Study||0
8338888|NCT01319383|20556598|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
8338889|NCT01319383|20556597|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
8338983|NCT01318512|20556885|P1|STARTED|Titration Period (4 Months)||340
8338890|NCT01319383|20556598|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
8338891|NCT01319383|20556597|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
8338892|NCT01319383|20556598|P1|Step 1|Overall Study||8
8338893|NCT01319383|20556597|P2|STARTED|Overall Study||13
8338894|NCT01319383|20556598|P1|STARTED|Overall Study||12
8338895|NCT01319318|20556615|P1|NOT COMPLETED|Overall Study||0
8338896|NCT01319318|20556615|P1|COMPLETED|Overall Study||25
8338897|NCT01319318|20556615|P1|STARTED|Overall Study||25
8338898|NCT01319110|20556621|P2|NOT COMPLETED|Overall Study||0
8338899|NCT01319110|20556622|P1|NOT COMPLETED|Overall Study||0
8338900|NCT01319110|20556621|P2|COMPLETED|Overall Study||5
8338901|NCT01319110|20556622|P1|COMPLETED|Overall Study||5
8338902|NCT01319110|20556621|P2|STARTED|Overall Study||5
8338903|NCT01319110|20556622|P1|STARTED|Overall Study||5
8338904|NCT01319045|20556630|P1|NOT COMPLETED|Overall Study||2
8338905|NCT01319045|20556630|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
8338906|NCT01319045|20556630|P1|STARTED|Overall Study||5
8338907|NCT01318993|20556637|P1|NOT COMPLETED|Overall Study||398
8338908|NCT01318993|20556637|P1|COMPLETED|Overall Study||0
8338909|NCT01318993|20556637|P1|STARTED|Overall Study||398
8338910|NCT01318967|20556653|P1|NOT COMPLETED|Overall Study||0
8338911|NCT01318967|20556653|P1|COMPLETED|Overall Study||10
8338912|NCT01318967|20556653|P1|STARTED|Overall Study||10
8338913|NCT01318915|20556658|P1|NOT COMPLETED|Overall Study||1
8338914|NCT01318915|20556658|P1|COMPLETED|Overall Study||9
8338915|NCT01318915|20556658|P1|STARTED|Overall Study||10
8338916|NCT01318902|20556687|P4|NOT COMPLETED|Overall Study||6
8338917|NCT01318902|20556688|P3|NOT COMPLETED|Overall Study||2
8338918|NCT01318902|20556689|P2|NOT COMPLETED|Overall Study||3
8338919|NCT01318902|20556690|P1|NOT COMPLETED|Overall Study||1
8338920|NCT01318902|20556687|P4|COMPLETED|Overall Study||5
8338921|NCT01318902|20556688|P3|COMPLETED|Overall Study||3
8338922|NCT01318902|20556689|P2|COMPLETED|Overall Study||2
8338923|NCT01318902|20556690|P1|COMPLETED|Overall Study||5
8338924|NCT01318902|20556687|P4|STARTED|Overall Study||11
8338925|NCT01318902|20556688|P3|STARTED|Overall Study||5
8338926|NCT01318902|20556689|P2|STARTED|Overall Study||5
8338927|NCT01318902|20556690|P1|STARTED|Overall Study||6
8338928|NCT01318876|20556767|P1|NOT COMPLETED|Day 29 Survey||1825
8338929|NCT01318876|20556767|P1|COMPLETED|Day 29 Survey||5724
8338930|NCT01318876|20556767|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
8338931|NCT01318876|20556767|P1|NOT COMPLETED|Day 8 Survey||1820
8338932|NCT01318876|20556767|P1|COMPLETED|Day 8 Survey||5825
8338933|NCT01318876|20556767|P1|STARTED|Day 8 Survey||7645
8338934|NCT01318811|20556774|P2|NOT COMPLETED|Overall Study||4
8338935|NCT01318811|20556775|P1|NOT COMPLETED|Overall Study||1
8338936|NCT01318811|20556774|P2|COMPLETED|Overall Study||4
8338937|NCT01318811|20556775|P1|COMPLETED|Overall Study||3
8338938|NCT01318811|20556774|P2|STARTED|Overall Study||8
8338939|NCT01318811|20556775|P1|STARTED|Overall Study||4
8338943|NCT01318694|20556791|P4|NOT COMPLETED|Overall Study||68
8338944|NCT01318694|20556792|P3|NOT COMPLETED|Overall Study||43
8338945|NCT01318694|20556793|P2|NOT COMPLETED|Overall Study||58
8338946|NCT01318694|20556794|P1|NOT COMPLETED|Overall Study||52
8338947|NCT01318694|20556791|P4|COMPLETED|Overall Study||200
8338948|NCT01318694|20556792|P3|COMPLETED|Overall Study||225
8338949|NCT01318694|20556793|P2|COMPLETED|Overall Study||212
8338950|NCT01318694|20556794|P1|COMPLETED|Overall Study||223
8338951|NCT01318694|20556791|P4|Safety Set|Overall Study||265
8338952|NCT01318694|20556792|P3|Safety Set|Overall Study||265
8338953|NCT01318694|20556793|P2|Safety Set|Overall Study||268
8338954|NCT01318694|20556794|P1|Safety Set|Overall Study||273
8338955|NCT01318694|20556791|P4|Full Analysis Set|Overall Study||268
8338956|NCT01318694|20556792|P3|Full Analysis Set|Overall Study||265
8338957|NCT01318694|20556793|P2|Full Analysis Set|Overall Study||270
8338958|NCT01318694|20556794|P1|Full Analysis Set|Overall Study||274
8338959|NCT01318694|20556791|P4|STARTED|Overall Study||268
8338960|NCT01318694|20556792|P3|STARTED|Overall Study||268
8338961|NCT01318694|20556793|P2|STARTED|Overall Study||270
8338962|NCT01318694|20556794|P1|STARTED|Overall Study||275
8338963|NCT01318577|20556850|P2|NOT COMPLETED|Overall Study||8
8338964|NCT01318577|20556851|P1|NOT COMPLETED|Overall Study||13
8338965|NCT01318577|20556850|P2|COMPLETED|Overall Study||212
8338966|NCT01318577|20556851|P1|COMPLETED|Overall Study||211
8338967|NCT01318577|20556850|P2|STARTED|Overall Study||220
8338968|NCT01318577|20556851|P1|STARTED|Overall Study||224
8338969|NCT01318538|20556859|P3|NOT COMPLETED|Overall Study||0
8338970|NCT01318538|20556860|P2|NOT COMPLETED|Overall Study||0
8338971|NCT01318538|20556861|P1|NOT COMPLETED|Overall Study||0
8338972|NCT01318538|20556859|P3|COMPLETED|Overall Study||8
8338973|NCT01318538|20556860|P2|COMPLETED|Overall Study||106
8338974|NCT01318538|20556861|P1|COMPLETED|Overall Study||52
8338975|NCT01318538|20556859|P3|STARTED|Overall Study||8
8338976|NCT01318538|20556860|P2|STARTED|Overall Study||106
8338977|NCT01318538|20556861|P1|STARTED|Overall Study||52
8338978|NCT01318512|20556885|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
8338979|NCT01318512|20556885|P1|COMPLETED|Maintenance Period (6 Months)||329
8338980|NCT01318512|20556885|P1|STARTED|Maintenance Period (6 Months)||340
8338981|NCT01318512|20556885|P1|NOT COMPLETED|Titration Period (4 Months)||0
8338982|NCT01318512|20556885|P1|COMPLETED|Titration Period (4 Months)||340
8338984|NCT01318499|20556904|P3|NOT COMPLETED|Overall Study||147
8338985|NCT01318499|20556905|P2|NOT COMPLETED|Overall Study||76
8338986|NCT01318499|20556906|P1|NOT COMPLETED|Overall Study||65
8338987|NCT01318499|20556904|P3|COMPLETED|Overall Study||121
8338988|NCT01318499|20556905|P2|COMPLETED|Overall Study||458
8338989|NCT01318499|20556906|P1|COMPLETED|Overall Study||475
8338990|NCT01318499|20556904|P3|STARTED|Overall Study||268
8338991|NCT01318499|20556905|P2|STARTED|Overall Study||534
8338992|NCT01318499|20556906|P1|STARTED|Overall Study||540
8338993|NCT01318408|20556924|P1|NOT COMPLETED|Overall Study||8
8338994|NCT01318408|20556924|P1|COMPLETED|Overall Study||16
8338995|NCT01318408|20556924|P1|STARTED|Overall Study||24
8338996|NCT01318382|20556929|P1|NOT COMPLETED|Overall Study||13
8338997|NCT01318382|20556929|P1|COMPLETED|Overall Study||289
8338998|NCT01318382|20556929|P1|STARTED|Overall Study||302
8338999|NCT01318278|20556939|P3|NOT COMPLETED|Overall Study||0
8339000|NCT01318278|20556940|P2|NOT COMPLETED|Overall Study||0
8339001|NCT01318278|20556941|P1|NOT COMPLETED|Overall Study||0
8339002|NCT01318278|20556939|P3|COMPLETED|Overall Study||50
8339003|NCT01318278|20556940|P2|COMPLETED|Overall Study||10
8339004|NCT01318278|20556941|P1|COMPLETED|Overall Study||10
8339005|NCT01318278|20556939|P3|STARTED|Overall Study||50
8339006|NCT01318278|20556940|P2|STARTED|Overall Study||10
8339007|NCT01318278|20556941|P1|STARTED|Overall Study||10
8339008|NCT01318135|20556987|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
8339009|NCT01318135|20556988|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
8339010|NCT01318135|20556989|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
8339011|NCT01318135|20556990|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
8339012|NCT01318135|20556991|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
8339013|NCT01318135|20556992|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
8339014|NCT01318135|20556993|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
8339015|NCT01318135|20556994|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
8339016|NCT01318135|20556987|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
8339017|NCT01318135|20556988|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
8339018|NCT01318135|20556989|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
8339019|NCT01318135|20556990|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
8339020|NCT01318135|20556991|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
8339021|NCT01318135|20556992|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
8339022|NCT01318135|20556993|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
8339023|NCT01318135|20556994|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
8339024|NCT01318135|20556987|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
8339025|NCT01318135|20556988|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
8339026|NCT01318135|20556989|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
8339027|NCT01318135|20556990|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
8339028|NCT01318135|20556991|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
8339029|NCT01318135|20556992|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
8339030|NCT01318135|20556993|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
8339031|NCT01318135|20556994|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
8339032|NCT01318135|20556987|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339033|NCT01318135|20556988|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339034|NCT01318135|20556989|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339035|NCT01318135|20556990|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339036|NCT01318135|20556991|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339037|NCT01318135|20556992|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339038|NCT01318135|20556993|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339039|NCT01318135|20556994|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8339040|NCT01318135|20556987|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
8339041|NCT01318135|20556988|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
8339042|NCT01318135|20556989|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
8339043|NCT01318135|20556990|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
8339044|NCT01318135|20556991|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
8339045|NCT01318135|20556992|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
8339046|NCT01318135|20556993|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
8339047|NCT01318135|20556994|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
8339048|NCT01318135|20556987|P8|STARTED|Enrolled - Long-Term Extension Study||49
8339049|NCT01318135|20556988|P7|STARTED|Enrolled - Long-Term Extension Study||50
8339050|NCT01318135|20556989|P6|STARTED|Enrolled - Long-Term Extension Study||90
8339051|NCT01318135|20556990|P5|STARTED|Enrolled - Long-Term Extension Study||91
8339052|NCT01318135|20556991|P4|STARTED|Enrolled - Long-Term Extension Study||49
8339053|NCT01318135|20556992|P3|STARTED|Enrolled - Long-Term Extension Study||46
8339054|NCT01318135|20556993|P2|STARTED|Enrolled - Long-Term Extension Study||102
8339055|NCT01318135|20556994|P1|STARTED|Enrolled - Long-Term Extension Study||99
8339056|NCT01318122|20557126|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
8339057|NCT01318122|20557127|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
8339058|NCT01318122|20557128|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
8339059|NCT01318122|20557129|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
8339060|NCT01318122|20557126|P4|COMPLETED|Entered - Long-Term Extension Study||48
8339061|NCT01318122|20557127|P3|COMPLETED|Entered - Long-Term Extension Study||49
8339062|NCT01318122|20557128|P2|COMPLETED|Entered - Long-Term Extension Study||99
8339063|NCT01318122|20557129|P1|COMPLETED|Entered - Long-Term Extension Study||96
8339064|NCT01318122|20557126|P4|STARTED|Entered - Long-Term Extension Study||52
8339065|NCT01318122|20557127|P3|STARTED|Entered - Long-Term Extension Study||55
8339066|NCT01318122|20557128|P2|STARTED|Entered - Long-Term Extension Study||110
8339067|NCT01318122|20557129|P1|STARTED|Entered - Long-Term Extension Study||105
8339068|NCT01318122|20557126|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8339069|NCT01318122|20557127|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8339070|NCT01318122|20557128|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339071|NCT01318122|20557129|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8339072|NCT01318122|20557126|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
8339073|NCT01318122|20557127|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
8339074|NCT01318122|20557128|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
8339075|NCT01318122|20557129|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
8339076|NCT01318122|20557126|P4|STARTED|Enrolled - Long-Term Extension Study||53
8339077|NCT01318122|20557127|P3|STARTED|Enrolled - Long-Term Extension Study||57
8339078|NCT01318122|20557128|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
8339079|NCT01318122|20557129|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
8339080|NCT01318109|20557198|P3|NOT COMPLETED|Overall Study||0
8339081|NCT01318109|20557199|P2|NOT COMPLETED|Overall Study||3
8339082|NCT01318109|20557200|P1|NOT COMPLETED|Overall Study||1
8339083|NCT01318109|20557198|P3|COMPLETED|Overall Study||100
8339084|NCT01318109|20557199|P2|COMPLETED|Overall Study||93
8339085|NCT01318109|20557200|P1|COMPLETED|Overall Study||91
8339086|NCT01318109|20557198|P3|STARTED|Overall Study||100
8339087|NCT01318109|20557199|P2|STARTED|Overall Study||96
8339088|NCT01318109|20557200|P1|STARTED|Overall Study||92
8339089|NCT01318083|20557235|P3|NOT COMPLETED|Overall Study||5
8339090|NCT01318083|20557236|P2|NOT COMPLETED|Overall Study||2
8339091|NCT01318083|20557237|P1|NOT COMPLETED|Overall Study||6
8339092|NCT01318083|20557235|P3|COMPLETED|Overall Study||98
8339093|NCT01318083|20557236|P2|COMPLETED|Overall Study||102
8339094|NCT01318083|20557237|P1|COMPLETED|Overall Study||99
8339095|NCT01318083|20557235|P3|STARTED|Overall Study||103
8339096|NCT01318083|20557236|P2|STARTED|Overall Study||104
8339097|NCT01318083|20557237|P1|STARTED|Overall Study||105
8339098|NCT01318070|20557272|P3|NOT COMPLETED|Overall Study||7
8339099|NCT01318070|20557273|P2|NOT COMPLETED|Overall Study||2
8339100|NCT01318070|20557274|P1|NOT COMPLETED|Overall Study||2
8339101|NCT01318070|20557272|P3|COMPLETED|Overall Study||108
8339102|NCT01318070|20557273|P2|COMPLETED|Overall Study||111
8339103|NCT01318070|20557274|P1|COMPLETED|Overall Study||109
8339104|NCT01318070|20557272|P3|STARTED|Overall Study||115
8339105|NCT01318070|20557273|P2|STARTED|Overall Study||113
8339106|NCT01318070|20557274|P1|STARTED|Overall Study||111
8339107|NCT01318018|20557308|P2|NOT COMPLETED|Overall Study||0
8339108|NCT01318018|20557309|P1|NOT COMPLETED|Overall Study||0
8339109|NCT01318018|20557308|P2|COMPLETED|Overall Study||10
8339110|NCT01318018|20557309|P1|COMPLETED|Overall Study||10
8339111|NCT01318018|20557308|P2|STARTED|Overall Study||10
8339112|NCT01318018|20557309|P1|STARTED|Overall Study||10
8339113|NCT01317940|20557321|P6|NOT COMPLETED|Overall Study||0
8339114|NCT01317940|20557322|P5|NOT COMPLETED|Overall Study||1
8339115|NCT01317940|20557323|P4|NOT COMPLETED|Overall Study||1
8339116|NCT01317940|20557324|P3|NOT COMPLETED|Overall Study||5
8339117|NCT01317940|20557325|P2|NOT COMPLETED|Overall Study||0
8339118|NCT01317940|20557326|P1|NOT COMPLETED|Overall Study||1
8339119|NCT01317940|20557321|P6|COMPLETED|Overall Study||4
8339120|NCT01317940|20557322|P5|COMPLETED|Overall Study||12
8339121|NCT01317940|20557323|P4|COMPLETED|Overall Study||5
8339122|NCT01317940|20557324|P3|COMPLETED|Overall Study||15
8339123|NCT01317940|20557325|P2|COMPLETED|Overall Study||10
8339124|NCT01317940|20557326|P1|COMPLETED|Overall Study||18
8339125|NCT01317940|20557321|P6|STARTED|Overall Study||4
8339126|NCT01317940|20557322|P5|STARTED|Overall Study||13
8339127|NCT01317940|20557323|P4|STARTED|Overall Study||6
8339128|NCT01317940|20557324|P3|STARTED|Overall Study||20
8339129|NCT01317940|20557325|P2|STARTED|Overall Study||10
8339130|NCT01317940|20557326|P1|STARTED|Overall Study||19
8339131|NCT01317901|20557347|P2|NOT COMPLETED|Overall Study||0
8339132|NCT01317901|20557348|P1|NOT COMPLETED|Overall Study||0
8339133|NCT01317901|20557347|P2|COMPLETED|Overall Study||6
8339134|NCT01317901|20557348|P1|COMPLETED|Overall Study||6
8339135|NCT01317901|20557347|P2|STARTED|Overall Study||6
8339136|NCT01317901|20557348|P1|STARTED|Overall Study||6
8339137|NCT01317797|20557357|P3|NOT COMPLETED|Overall Study||1
8339138|NCT01317797|20557358|P2|NOT COMPLETED|Overall Study||1
8339139|NCT01317797|20557359|P1|NOT COMPLETED|Overall Study||0
8339140|NCT01317797|20557357|P3|COMPLETED|Overall Study||8
8339141|NCT01317797|20557358|P2|COMPLETED|Overall Study||6
8339142|NCT01317797|20557359|P1|COMPLETED|Overall Study||8
8339143|NCT01317797|20557357|P3|STARTED|Overall Study||9
8339144|NCT01317797|20557358|P2|STARTED|Overall Study||7
8339145|NCT01317797|20557359|P1|STARTED|Overall Study||8
8339146|NCT01317667|20557414|P3|NOT COMPLETED|Overall Study||0
8339147|NCT01317667|20557415|P2|NOT COMPLETED|Overall Study||0
8339148|NCT01317667|20557416|P1|NOT COMPLETED|Overall Study||0
8339149|NCT01317667|20557414|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
8339150|NCT01317667|20557415|P2|COMPLETED|Overall Study||10
8339151|NCT01317667|20557416|P1|COMPLETED|Overall Study||10
8339152|NCT01317667|20557414|P3|STARTED|Overall Study||10
8339153|NCT01317667|20557415|P2|STARTED|Overall Study||10
8339154|NCT01317667|20557416|P1|STARTED|Overall Study||10
8339155|NCT01317641|20557436|P9|NOT COMPLETED|Overall Study||5
8339156|NCT01317641|20557437|P8|NOT COMPLETED|Overall Study||5
8339157|NCT01317641|20557438|P7|NOT COMPLETED|Overall Study||3
8339158|NCT01317641|20557439|P6|NOT COMPLETED|Overall Study||0
8339159|NCT01317641|20557440|P5|NOT COMPLETED|Overall Study||0
8339160|NCT01317641|20557441|P4|NOT COMPLETED|Overall Study||1
8339161|NCT01317641|20557442|P3|NOT COMPLETED|Overall Study||0
8339162|NCT01317641|20557443|P2|NOT COMPLETED|Overall Study||1
8339163|NCT01317641|20557444|P1|NOT COMPLETED|Overall Study||1
8339164|NCT01317641|20557436|P9|COMPLETED|Overall Study||31
8339165|NCT01317641|20557437|P8|COMPLETED|Overall Study||33
8339166|NCT01317641|20557438|P7|COMPLETED|Overall Study||35
8339167|NCT01317641|20557439|P6|COMPLETED|Overall Study||3
8339168|NCT01317641|20557440|P5|COMPLETED|Overall Study||3
8339169|NCT01317641|20557441|P4|COMPLETED|Overall Study||3
8339170|NCT01317641|20557442|P3|COMPLETED|Overall Study||3
8339171|NCT01317641|20557443|P2|COMPLETED|Overall Study||6
8339172|NCT01317641|20557444|P1|COMPLETED|Overall Study||3
8339173|NCT01317641|20557436|P9|STARTED|Overall Study||36
8339174|NCT01317641|20557437|P8|STARTED|Overall Study||38
8339175|NCT01317641|20557438|P7|STARTED|Overall Study||38
8339176|NCT01317641|20557439|P6|STARTED|Overall Study||3
8339177|NCT01317641|20557440|P5|STARTED|Overall Study||3
8339178|NCT01317641|20557441|P4|STARTED|Overall Study||4
8339179|NCT01317641|20557442|P3|STARTED|Overall Study||3
8339180|NCT01317641|20557443|P2|STARTED|Overall Study||7
8339181|NCT01317641|20557444|P1|STARTED|Overall Study||4
8339182|NCT01317615|20557546|P1|NOT COMPLETED|Overall Study||49
8339183|NCT01317615|20557546|P1|COMPLETED|Overall Study||0
8339184|NCT01317615|20557546|P1|STARTED|Overall Study||49
8339185|NCT01317550|20557559|P4|NOT COMPLETED|Overall Study||0
8339186|NCT01317550|20557560|P3|NOT COMPLETED|Overall Study||0
8339187|NCT01317550|20557561|P2|NOT COMPLETED|Overall Study||0
8339188|NCT01317550|20557562|P1|NOT COMPLETED|Overall Study||2
8339189|NCT01317550|20557559|P4|COMPLETED|Overall Study||3
8339190|NCT01317550|20557560|P3|COMPLETED|Overall Study||3
8339191|NCT01317550|20557561|P2|COMPLETED|Overall Study||3
8339192|NCT01317550|20557562|P1|COMPLETED|Overall Study||3
8339193|NCT01317550|20557559|P4|STARTED|Overall Study||3
8339194|NCT01317550|20557560|P3|STARTED|Overall Study||3
8339195|NCT01317550|20557561|P2|STARTED|Overall Study||3
8339196|NCT01317550|20557562|P1|STARTED|Overall Study||5
8339197|NCT01317472|20557574|P2|NOT COMPLETED|Overall Study||0
8339198|NCT01317472|20557575|P1|NOT COMPLETED|Overall Study||2
8339199|NCT01317472|20557574|P2|COMPLETED|Overall Study||2
8339200|NCT01317472|20557575|P1|COMPLETED|Overall Study||7
8339201|NCT01317472|20557574|P2|STARTED|Overall Study||2
8339202|NCT01317472|20557575|P1|STARTED|Overall Study||9
8339203|NCT01317199|20557585|P4|NOT COMPLETED|Randomized Phase 2||17
8339204|NCT01317199|20557586|P3|NOT COMPLETED|Randomized Phase 2||21
8339205|NCT01317199|20557587|P2|NOT COMPLETED|Randomized Phase 2||11
8339206|NCT01317199|20557588|P1|NOT COMPLETED|Randomized Phase 2||0
8339207|NCT01317199|20557585|P4|COMPLETED|Randomized Phase 2||32
8339208|NCT01317199|20557586|P3|COMPLETED|Randomized Phase 2||35
8339209|NCT01317199|20557587|P2|COMPLETED|Randomized Phase 2||13
8339210|NCT01317199|20557588|P1|COMPLETED|Randomized Phase 2||0
8339211|NCT01317199|20557585|P4|STARTED|Randomized Phase 2||49
8339212|NCT01317199|20557586|P3|STARTED|Randomized Phase 2||56
8339213|NCT01317199|20557587|P2|STARTED|Randomized Phase 2||24
8339214|NCT01317199|20557588|P1|STARTED|Randomized Phase 2||0
8339215|NCT01317199|20557585|P4|NOT COMPLETED|Dose-escalation Phase 1||0
8339216|NCT01317199|20557586|P3|NOT COMPLETED|Dose-escalation Phase 1||0
8339217|NCT01317199|20557587|P2|NOT COMPLETED|Dose-escalation Phase 1||0
8339218|NCT01317199|20557588|P1|NOT COMPLETED|Dose-escalation Phase 1||7
8339219|NCT01317199|20557585|P4|COMPLETED|Dose-escalation Phase 1||0
8339220|NCT01317199|20557586|P3|COMPLETED|Dose-escalation Phase 1||0
8339221|NCT01317199|20557587|P2|COMPLETED|Dose-escalation Phase 1||0
8339222|NCT01317199|20557588|P1|COMPLETED|Dose-escalation Phase 1||7
8339223|NCT01317199|20557585|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339224|NCT01317199|20557586|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339225|NCT01317199|20557587|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339226|NCT01317199|20557588|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
8339227|NCT01317199|20557585|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339228|NCT01317199|20557586|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339229|NCT01317199|20557587|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339230|NCT01317199|20557588|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8339231|NCT01317199|20557585|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339232|NCT01317199|20557586|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339233|NCT01317199|20557587|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339234|NCT01317199|20557588|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8339235|NCT01317199|20557585|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339236|NCT01317199|20557586|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339237|NCT01317199|20557587|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8339238|NCT01317199|20557588|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8339239|NCT01317199|20557585|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8339240|NCT01317199|20557586|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8339241|NCT01317199|20557587|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8339242|NCT01317199|20557588|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
8339243|NCT01317199|20557585|P4|STARTED|Dose-escalation Phase 1||0
8339244|NCT01317199|20557586|P3|STARTED|Dose-escalation Phase 1||0
8339245|NCT01317199|20557587|P2|STARTED|Dose-escalation Phase 1||0
8339246|NCT01317199|20557588|P1|STARTED|Dose-escalation Phase 1||14
8339247|NCT01317160|20557617|P2|NOT COMPLETED|Overall Study||6
8339248|NCT01317160|20557618|P1|NOT COMPLETED|Overall Study||4
8339249|NCT01317160|20557617|P2|COMPLETED|Overall Study||69
8339250|NCT01317160|20557618|P1|COMPLETED|Overall Study||71
8339251|NCT01317160|20557617|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
8339252|NCT01317160|20557618|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
8339253|NCT01317160|20557617|P2|STARTED|Overall Study||75
8339254|NCT01317160|20557618|P1|STARTED|Overall Study||75
8339255|NCT01317095|20557628|P2|NOT COMPLETED|Overall Study||0
8339256|NCT01317095|20557629|P1|NOT COMPLETED|Overall Study||0
8339257|NCT01317095|20557628|P2|COMPLETED|Overall Study||41
8339258|NCT01317095|20557629|P1|COMPLETED|Overall Study||39
8339259|NCT01317095|20557628|P2|STARTED|Overall Study||41
8339260|NCT01317095|20557629|P1|STARTED|Overall Study||39
8339261|NCT01317030|20557643|P2|NOT COMPLETED|Overall Study||0
8339262|NCT01317030|20557644|P1|NOT COMPLETED|Overall Study||0
8339263|NCT01317030|20557643|P2|COMPLETED|Overall Study||13
8339264|NCT01317030|20557644|P1|COMPLETED|Overall Study||12
8339265|NCT01317030|20557643|P2|STARTED|Overall Study||13
8339266|NCT01317030|20557644|P1|STARTED|Overall Study||12
8339267|NCT01317004|20557652|P2|NOT COMPLETED|Overall Study||9
8339268|NCT01317004|20557653|P1|NOT COMPLETED|Overall Study||4
8339269|NCT01317004|20557652|P2|COMPLETED|Overall Study||5
8339270|NCT01317004|20557653|P1|COMPLETED|Overall Study||47
8339271|NCT01317004|20557652|P2|Safety Set|Overall Study||11
8339272|NCT01317004|20557653|P1|Safety Set|Overall Study||50
8339273|NCT01317004|20557652|P2|STARTED|Overall Study||14
8339274|NCT01317004|20557653|P1|STARTED|Overall Study||51
8339275|NCT01316939|20557674|P3|NOT COMPLETED|Overall Study||69
8339276|NCT01316939|20557675|P2|NOT COMPLETED|Overall Study||68
8339277|NCT01316939|20557676|P1|NOT COMPLETED|Overall Study||63
8339278|NCT01316939|20557674|P3|COMPLETED|Overall Study||7
8339279|NCT01316939|20557675|P2|COMPLETED|Overall Study||9
8339280|NCT01316939|20557676|P1|COMPLETED|Overall Study||13
8339281|NCT01316939|20557674|P3|STARTED|Overall Study||76
8339282|NCT01316939|20557675|P2|STARTED|Overall Study||77
8339283|NCT01316939|20557676|P1|STARTED|Overall Study||76
8339284|NCT01316926|20557756|P2|NOT COMPLETED|Period 2||0
8339285|NCT01316926|20557757|P1|NOT COMPLETED|Period 2||0
8339286|NCT01316926|20557756|P2|COMPLETED|Period 2||30
8339287|NCT01316926|20557757|P1|COMPLETED|Period 2||29
8339288|NCT01316926|20557756|P2|STARTED|Period 2||30
8339289|NCT01316926|20557757|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
8339290|NCT01316926|20557756|P2|NOT COMPLETED|Period 1||0
8339291|NCT01316926|20557757|P1|NOT COMPLETED|Period 1||0
8339292|NCT01316926|20557756|P2|COMPLETED|Period 1||30
8339293|NCT01316926|20557757|P1|COMPLETED|Period 1||30
8339294|NCT01316926|20557756|P2|STARTED|Period 1||30
8339295|NCT01316926|20557757|P1|STARTED|Period 1||30
8339296|NCT01316913|20557771|P4|NOT COMPLETED|Overall Study||39
8339297|NCT01316913|20557772|P3|NOT COMPLETED|Overall Study||49
8339298|NCT01316913|20557773|P2|NOT COMPLETED|Overall Study||54
8339299|NCT01316913|20557774|P1|NOT COMPLETED|Overall Study||57
8339300|NCT01316913|20557771|P4|COMPLETED|Overall Study||176
8339301|NCT01316913|20557772|P3|COMPLETED|Overall Study||166
8339302|NCT01316913|20557773|P2|COMPLETED|Overall Study||163
8339303|NCT01316913|20557774|P1|COMPLETED|Overall Study||165
8339304|NCT01316913|20557771|P4|STARTED|Overall Study||215
8339305|NCT01316913|20557772|P3|STARTED|Overall Study||215
8339306|NCT01316913|20557773|P2|STARTED|Overall Study||217
8339307|NCT01316913|20557774|P1|STARTED|Overall Study||222
8339308|NCT01316900|20557796|P4|NOT COMPLETED|Overall Study||31
8339309|NCT01316900|20557797|P3|NOT COMPLETED|Overall Study||41
8339310|NCT01316900|20557798|P2|NOT COMPLETED|Overall Study||31
8339311|NCT01316900|20557799|P1|NOT COMPLETED|Overall Study||44
8339312|NCT01316900|20557796|P4|COMPLETED|Overall Study||177
8339313|NCT01316900|20557797|P3|COMPLETED|Overall Study||173
8339314|NCT01316900|20557798|P2|COMPLETED|Overall Study||181
8339315|NCT01316900|20557799|P1|COMPLETED|Overall Study||165
8339316|NCT01316900|20557796|P4|STARTED|Overall Study||208
8339317|NCT01316900|20557797|P3|STARTED|Overall Study||214
8339318|NCT01316900|20557798|P2|STARTED|Overall Study||212
8339319|NCT01316900|20557799|P1|STARTED|Overall Study||209
8339320|NCT01316887|20557820|P3|NOT COMPLETED|Overall Study||83
8339321|NCT01316887|20557821|P2|NOT COMPLETED|Overall Study||94
8339322|NCT01316887|20557822|P1|NOT COMPLETED|Overall Study||43
8339323|NCT01316887|20557820|P3|COMPLETED|Overall Study||143
8339324|NCT01316887|20557821|P2|COMPLETED|Overall Study||133
8339325|NCT01316887|20557822|P1|COMPLETED|Overall Study||66
8339326|NCT01316887|20557820|P3|STARTED|Overall Study||226
8339327|NCT01316887|20557821|P2|STARTED|Overall Study||227
8339328|NCT01316887|20557822|P1|STARTED|Overall Study||109
8339329|NCT01316770|20557884|P2|NOT COMPLETED|Overall Study||0
8339330|NCT01316770|20557885|P1|NOT COMPLETED|Overall Study||0
8339331|NCT01316770|20557884|P2|COMPLETED|Overall Study||9
8339332|NCT01316770|20557885|P1|COMPLETED|Overall Study||9
8339333|NCT01316770|20557884|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
8339334|NCT01316770|20557885|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
8339335|NCT01316692|20557947|P1|NOT COMPLETED|Overall Study||12
8339336|NCT01316692|20557947|P1|COMPLETED|Overall Study||0
8339337|NCT01316692|20557947|P1|STARTED|Overall Study||12
8339338|NCT01316614|20557956|P1|NOT COMPLETED|Overall Study||37
8339339|NCT01316614|20557956|P1|COMPLETED|Overall Study||100
8339340|NCT01316614|20557956|P1|STARTED|Overall Study||137
8339341|NCT01316575|20557973|P2|NOT COMPLETED|Overall Study||1
8339342|NCT01316575|20557974|P1|NOT COMPLETED|Overall Study||2
8339343|NCT01316575|20557973|P2|COMPLETED|Overall Study||19
8339344|NCT01316575|20557974|P1|COMPLETED|Overall Study||18
8339345|NCT01316575|20557973|P2|STARTED|Overall Study||20
8339346|NCT01316575|20557974|P1|STARTED|Overall Study||20
8339347|NCT01316510|20557988|P2|NOT COMPLETED|Overall Study||0
8339348|NCT01316510|20557989|P1|NOT COMPLETED|Overall Study||0
8339349|NCT01316510|20557988|P2|COMPLETED|Overall Study||12
8339350|NCT01316510|20557989|P1|COMPLETED|Overall Study||12
8339351|NCT01316510|20557988|P2|STARTED|Overall Study||12
8339352|NCT01316510|20557989|P1|STARTED|Overall Study||12
8339353|NCT01316419|20557997|P1|NOT COMPLETED|Overall Study||265
8339354|NCT01316419|20557997|P1|COMPLETED|Overall Study||1824
8339355|NCT01316419|20557997|P1|STARTED|Overall Study||2089
8339356|NCT01316380|20558023|P3|NOT COMPLETED|Overall Study||3
8339357|NCT01316380|20558024|P2|NOT COMPLETED|Overall Study||5
8339358|NCT01316380|20558025|P1|NOT COMPLETED|Overall Study||2
8339359|NCT01316380|20558023|P3|COMPLETED|Overall Study||152
8339360|NCT01316380|20558024|P2|COMPLETED|Overall Study||149
8339361|NCT01316380|20558025|P1|COMPLETED|Overall Study||154
8339362|NCT01316380|20558023|P3|STARTED|Overall Study||155
8339363|NCT01316380|20558024|P2|STARTED|Overall Study||154
8339364|NCT01316380|20558025|P1|STARTED|Overall Study||156
8339365|NCT01316341|20558066|P3|NOT COMPLETED|Overall Study||0
8339366|NCT01316341|20558067|P2|NOT COMPLETED|Overall Study||0
8339367|NCT01316341|20558068|P1|NOT COMPLETED|Overall Study||0
8339368|NCT01316341|20558066|P3|COMPLETED|Overall Study||9
8339369|NCT01316341|20558067|P2|COMPLETED|Overall Study||9
8339370|NCT01316341|20558068|P1|COMPLETED|Overall Study||6
8339371|NCT01316341|20558066|P3|STARTED|Overall Study||9
8339372|NCT01316341|20558067|P2|STARTED|Overall Study||9
8339373|NCT01316341|20558068|P1|STARTED|Overall Study||6
8339374|NCT01316315|20558136|P2|NOT COMPLETED|Sequence 2||0
8339375|NCT01316315|20558137|P1|NOT COMPLETED|Sequence 2||0
8339376|NCT01316315|20558136|P2|COMPLETED|Sequence 2||7
8339377|NCT01316315|20558137|P1|COMPLETED|Sequence 2||7
8339378|NCT01316315|20558136|P2|STARTED|Sequence 2||7
8339379|NCT01316315|20558137|P1|STARTED|Sequence 2||7
8339380|NCT01316315|20558136|P2|NOT COMPLETED|Sequence 1||0
8339381|NCT01316315|20558137|P1|NOT COMPLETED|Sequence 1||0
8339382|NCT01316315|20558136|P2|COMPLETED|Sequence 1||7
8339383|NCT01316315|20558137|P1|COMPLETED|Sequence 1||7
8339384|NCT01316315|20558136|P2|STARTED|Sequence 1||7
8339385|NCT01316315|20558137|P1|STARTED|Sequence 1||7
8339386|NCT01316302|20558151|P2|NOT COMPLETED|Overall Study||11
8339387|NCT01316302|20558152|P1|NOT COMPLETED|Overall Study||10
8339388|NCT01316302|20558151|P2|COMPLETED|Overall Study||22
8339389|NCT01316302|20558152|P1|COMPLETED|Overall Study||20
8339390|NCT01316302|20558151|P2|STARTED|Overall Study||33
8339391|NCT01316302|20558152|P1|STARTED|Overall Study||30
8339392|NCT01316276|20558162|P1|NOT COMPLETED|Overall Study||67
8339393|NCT01316276|20558162|P1|COMPLETED|Overall Study||139
8339394|NCT01316276|20558162|P1|STARTED|Overall Study||206
8339395|NCT01316263|20558183|P2|NOT COMPLETED|Overall Study||0
8339396|NCT01316263|20558184|P1|NOT COMPLETED|Overall Study||0
8339397|NCT01316263|20558183|P2|COMPLETED|Overall Study||14
8339398|NCT01316263|20558184|P1|COMPLETED|Overall Study||7
8339399|NCT01316263|20558183|P2|Received Any Study Drug|Overall Study||14
8339400|NCT01316263|20558184|P1|Received Any Study Drug|Overall Study||7
8339401|NCT01316263|20558183|P2|STARTED|Overall Study||14
8339402|NCT01316263|20558184|P1|STARTED|Overall Study||7
8339403|NCT01316224|20558210|P1|NOT COMPLETED|Overall Study||10
8339404|NCT01316224|20558210|P1|COMPLETED|Overall Study||42
8339405|NCT01316224|20558210|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
8339406|NCT01316224|20558210|P1|Completed Visit 4 to Dermatologist|Overall Study||42
8339407|NCT01316224|20558210|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
8339408|NCT01316224|20558210|P1|Completed Visit 3 to Dermatologist|Overall Study||48
8339409|NCT01316224|20558210|P1|Completed Visit 2 to Dermatologist|Overall Study||51
8339410|NCT01316224|20558210|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
8339411|NCT01316224|20558210|P1|Completed Visit 1 to Dermatologist|Overall Study||52
8339412|NCT01316224|20558210|P1|STARTED|Overall Study||52
8339413|NCT01316211|20558226|P2|NOT COMPLETED|Overall Study||12
8339414|NCT01316211|20558227|P1|NOT COMPLETED|Overall Study||11
8339415|NCT01316211|20558226|P2|COMPLETED|Overall Study||111
8339416|NCT01316211|20558227|P1|COMPLETED|Overall Study||105
8339417|NCT01316211|20558226|P2|STARTED|Overall Study||123
8339418|NCT01316211|20558227|P1|STARTED|Overall Study||116
8339419|NCT01316055|20558263|P3|NOT COMPLETED|Overall Study||0
8339420|NCT01316055|20558264|P2|NOT COMPLETED|Overall Study||0
8339421|NCT01316055|20558265|P1|NOT COMPLETED|Overall Study||1
8339422|NCT01316055|20558263|P3|COMPLETED|Overall Study||12
8339423|NCT01316055|20558264|P2|COMPLETED|Overall Study||17
8339424|NCT01316055|20558265|P1|COMPLETED|Overall Study||12
8339425|NCT01316055|20558263|P3|STARTED|Overall Study||12
8339426|NCT01316055|20558264|P2|STARTED|Overall Study||17
8339427|NCT01316055|20558265|P1|STARTED|Overall Study||13
8339428|NCT01316042|20558281|P2|NOT COMPLETED|Overall Study||1
8339429|NCT01316042|20558282|P1|NOT COMPLETED|Overall Study||0
8339430|NCT01316042|20558281|P2|COMPLETED|Overall Study||1
8339431|NCT01316042|20558282|P1|COMPLETED|Overall Study||2
8339432|NCT01316042|20558281|P2|STARTED|Overall Study||2
8339433|NCT01316042|20558282|P1|STARTED|Overall Study||2
8339434|NCT01315873|20558288|P1|NOT COMPLETED|Overall Study||0
8339435|NCT01315873|20558288|P1|COMPLETED|Overall Study||24
8339436|NCT01315873|20558288|P1|STARTED|Overall Study||24
8339437|NCT01315847|20558296|P2|NOT COMPLETED|Part III, Period 2||0
8339438|NCT01315847|20558297|P1|NOT COMPLETED|Part III, Period 2||0
8339439|NCT01315847|20558296|P2|COMPLETED|Part III, Period 2||3
8339440|NCT01315847|20558297|P1|COMPLETED|Part III, Period 2||0
8339441|NCT01315847|20558296|P2|Received [11C]MK-4232|Part III, Period 2||3
8339442|NCT01315847|20558297|P1|Received [11C]MK-4232|Part III, Period 2||0
8339443|NCT01315847|20558296|P2|Received Telcagepant|Part III, Period 2||3
8339444|NCT01315847|20558297|P1|Received Telcagepant|Part III, Period 2||0
8339445|NCT01315847|20558296|P2|STARTED|Part III, Period 2||3
8339446|NCT01315847|20558297|P1|STARTED|Part III, Period 2||0
8339447|NCT01315847|20558296|P2|NOT COMPLETED|Part III, Period 1||1
8339448|NCT01315847|20558297|P1|NOT COMPLETED|Part III, Period 1||0
8339449|NCT01315847|20558296|P2|COMPLETED|Part III, Period 1||3
8339450|NCT01315847|20558297|P1|COMPLETED|Part III, Period 1||0
8339451|NCT01315847|20558296|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
8339452|NCT01315847|20558297|P1|Received [11C]MK-4232|Part III, Period 1||0
8339453|NCT01315847|20558296|P2|Received Telcagepant|Part III, Period 1||4
8339454|NCT01315847|20558297|P1|Received Telcagepant|Part III, Period 1||0
8339455|NCT01315847|20558296|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
8339456|NCT01315847|20558297|P1|STARTED|Part III, Period 1||0
8339457|NCT01315847|20558296|P2|NOT COMPLETED|Part I, Period 2||0
8339458|NCT01315847|20558297|P1|NOT COMPLETED|Part I, Period 2||0
8339459|NCT01315847|20558296|P2|COMPLETED|Part I, Period 2||0
8339460|NCT01315847|20558297|P1|COMPLETED|Part I, Period 2||3
8339461|NCT01315847|20558296|P2|Received [11C]MK-4232|Part I, Period 2||0
8339462|NCT01315847|20558297|P1|Received [11C]MK-4232|Part I, Period 2||3
8339463|NCT01315847|20558296|P2|Received Telcagepant|Part I, Period 2||0
8339464|NCT01315847|20558297|P1|Received Telcagepant|Part I, Period 2||3
8339465|NCT01315847|20558296|P2|STARTED|Part I, Period 2||0
8339466|NCT01315847|20558297|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
8339467|NCT01315847|20558296|P2|NOT COMPLETED|Part I, Period 1||0
8339468|NCT01315847|20558297|P1|NOT COMPLETED|Part I, Period 1||3
8339469|NCT01315847|20558296|P2|COMPLETED|Part I, Period 1||0
8339470|NCT01315847|20558297|P1|COMPLETED|Part I, Period 1||2
8339471|NCT01315847|20558296|P2|Received [11C]MK-4232|Part I, Period 1||0
8339472|NCT01315847|20558297|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
8339473|NCT01315847|20558296|P2|Received Telcagepant|Part I, Period 1||0
8339474|NCT01315847|20558297|P1|Received Telcagepant|Part I, Period 1||5
8339475|NCT01315847|20558296|P2|STARTED|Part I, Period 1||0
8339476|NCT01315847|20558297|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
8339477|NCT01315678|20558311|P2|NOT COMPLETED|Overall Study||6
8339478|NCT01315678|20558312|P1|NOT COMPLETED|Overall Study||14
8339479|NCT01315678|20558311|P2|COMPLETED|Overall Study||140
8339480|NCT01315678|20558312|P1|COMPLETED|Overall Study||134
8339481|NCT01315678|20558311|P2|STARTED|Overall Study||146
8339482|NCT01315678|20558312|P1|STARTED|Overall Study||148
8339483|NCT01315665|20558332|P2|NOT COMPLETED|Overall Study||0
8339484|NCT01315665|20558333|P1|NOT COMPLETED|Overall Study||0
8339485|NCT01315665|20558332|P2|COMPLETED|Overall Study||5
8339486|NCT01315665|20558333|P1|COMPLETED|Overall Study||10
8339487|NCT01315665|20558332|P2|STARTED|Overall Study||5
8339488|NCT01315665|20558333|P1|STARTED|Overall Study||10
8339489|NCT01315574|20558349|P2|NOT COMPLETED|Overall Study||0
8339490|NCT01315574|20558350|P1|NOT COMPLETED|Overall Study||0
8339491|NCT01315574|20558349|P2|COMPLETED|Overall Study||7
8339492|NCT01315574|20558350|P1|COMPLETED|Overall Study||7
8339493|NCT01315574|20558349|P2|STARTED|Overall Study||7
8339494|NCT01315574|20558350|P1|STARTED|Overall Study||7
8339495|NCT01315353|20558363|P3|NOT COMPLETED|Overall Study||13
8339496|NCT01315353|20558364|P2|NOT COMPLETED|Overall Study||23
8339497|NCT01315353|20558365|P1|NOT COMPLETED|Overall Study||29
8339498|NCT01315353|20558363|P3|COMPLETED|Overall Study||166
8339499|NCT01315353|20558364|P2|COMPLETED|Overall Study||120
8339500|NCT01315353|20558365|P1|COMPLETED|Overall Study||116
8339501|NCT01315353|20558363|P3|STARTED|Overall Study||179
8339502|NCT01315353|20558364|P2|STARTED|Overall Study||143
8339503|NCT01315353|20558365|P1|STARTED|Overall Study||145
8339504|NCT01315249|20558392|P2|NOT COMPLETED|Overall Study||47
8339505|NCT01315249|20558393|P1|NOT COMPLETED|Overall Study||44
8339506|NCT01315249|20558392|P2|COMPLETED|Overall Study||217
8339507|NCT01315249|20558393|P1|COMPLETED|Overall Study||215
8339508|NCT01315249|20558392|P2|STARTED|Overall Study||264
8339509|NCT01315249|20558393|P1|STARTED|Overall Study||259
8339510|NCT01315236|20558421|P2|NOT COMPLETED|12-Month Follow-up Period||1
8339511|NCT01315236|20558422|P1|NOT COMPLETED|12-Month Follow-up Period||1
8339512|NCT01315236|20558421|P2|COMPLETED|12-Month Follow-up Period||31
8339513|NCT01315236|20558422|P1|COMPLETED|12-Month Follow-up Period||26
8339514|NCT01315236|20558421|P2|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
8339515|NCT01315236|20558422|P1|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
8339516|NCT01315236|20558421|P2|NOT COMPLETED|Open-label Phase||2
8339517|NCT01315236|20558422|P1|NOT COMPLETED|Open-label Phase||1
8339518|NCT01315236|20558421|P2|COMPLETED|Open-label Phase||41
8339519|NCT01315236|20558422|P1|COMPLETED|Open-label Phase||34
8339520|NCT01315236|20558421|P2|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
8339521|NCT01315236|20558422|P1|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
8339522|NCT01315236|20558421|P2|NOT COMPLETED|Double-blind Phase||0
8339523|NCT01315236|20558422|P1|NOT COMPLETED|Double-blind Phase||4
8339524|NCT01315236|20558421|P2|COMPLETED|Double-blind Phase||45
8339525|NCT01315236|20558422|P1|COMPLETED|Double-blind Phase||40
8339526|NCT01315236|20558421|P2|STARTED|Double-blind Phase||45
8339527|NCT01315236|20558422|P1|STARTED|Double-blind Phase||44
8339528|NCT01315158|20558446|P2|NOT COMPLETED|Overall Study||0
8339529|NCT01315158|20558447|P1|NOT COMPLETED|Overall Study||0
8339530|NCT01315158|20558446|P2|COMPLETED|Overall Study||19
8339531|NCT01315158|20558447|P1|COMPLETED|Overall Study||17
8339532|NCT01315158|20558446|P2|STARTED|Overall Study||19
8339533|NCT01315158|20558447|P1|STARTED|Overall Study||17
8339534|NCT01315145|20558471|P2|NOT COMPLETED|Overall Study||5
8339535|NCT01315145|20558472|P1|NOT COMPLETED|Overall Study||17
8339536|NCT01315145|20558471|P2|COMPLETED|Overall Study||11
8339537|NCT01315145|20558472|P1|COMPLETED|Overall Study||105
8339538|NCT01315145|20558471|P2|STARTED|Overall Study||16
8339539|NCT01315145|20558472|P1|STARTED|Overall Study||122
8339540|NCT01315132|20558478|P1|NOT COMPLETED|Overall Study||1
8339541|NCT01315132|20558478|P1|COMPLETED|Overall Study||46
8339542|NCT01315132|20558478|P1|STARTED|Overall Study||47
8339543|NCT01315028|20558485|P2|NOT COMPLETED|Overall Study||1
8339544|NCT01315028|20558486|P1|NOT COMPLETED|Overall Study||1
8339545|NCT01315028|20558485|P2|COMPLETED|Overall Study||9
8339546|NCT01315028|20558486|P1|COMPLETED|Overall Study||9
8339547|NCT01315028|20558485|P2|STARTED|Overall Study||10
8339548|NCT01315028|20558486|P1|STARTED|Overall Study||10
8339549|NCT01315002|20558498|P2|NOT COMPLETED|Overall Study||5
8339550|NCT01315002|20558499|P1|NOT COMPLETED|Overall Study||5
8339551|NCT01315002|20558498|P2|COMPLETED|Overall Study||55
8339552|NCT01315002|20558499|P1|COMPLETED|Overall Study||56
8339553|NCT01315002|20558498|P2|STARTED|Overall Study||60
8339554|NCT01315002|20558499|P1|STARTED|Overall Study||61
8339555|NCT01314963|20558505|P1|NOT COMPLETED|Overall Study||0
8339556|NCT01314963|20558505|P1|COMPLETED|Overall Study||50
8339557|NCT01314963|20558505|P1|STARTED|Overall Study||50
8339558|NCT01314911|20558513|P2|NOT COMPLETED|Overall Study||6
8339559|NCT01314911|20558514|P1|NOT COMPLETED|Overall Study||5
8339560|NCT01314911|20558513|P2|COMPLETED|Overall Study||274
8339561|NCT01314911|20558514|P1|COMPLETED|Overall Study||273
8339562|NCT01314911|20558513|P2|STARTED|Overall Study||280
8339563|NCT01314911|20558514|P1|STARTED|Overall Study||278
8339564|NCT01314872|20558565|P15|NOT COMPLETED|Period 2||24
8339565|NCT01314872|20558566|P14|NOT COMPLETED|Period 2||53
8339566|NCT01314872|20558567|P13|NOT COMPLETED|Period 2||60
8339567|NCT01314872|20558568|P12|NOT COMPLETED|Period 2||48
8339568|NCT01314872|20558569|P11|NOT COMPLETED|Period 2||0
8339569|NCT01314872|20558570|P10|NOT COMPLETED|Period 2||0
8339570|NCT01314872|20558571|P9|NOT COMPLETED|Period 2||0
8339571|NCT01314872|20558572|P8|NOT COMPLETED|Period 2||0
8339572|NCT01314872|20558573|P7|NOT COMPLETED|Period 2||0
8339573|NCT01314872|20558574|P6|NOT COMPLETED|Period 2||0
8339574|NCT01314872|20558575|P5|NOT COMPLETED|Period 2||0
8339575|NCT01314872|20558576|P4|NOT COMPLETED|Period 2||0
8339576|NCT01314872|20558577|P3|NOT COMPLETED|Period 2||0
8339577|NCT01314872|20558578|P2|NOT COMPLETED|Period 2||0
8339578|NCT01314872|20558579|P1|NOT COMPLETED|Period 2||0
8339579|NCT01314872|20558565|P15|COMPLETED|Period 2||110
8339580|NCT01314872|20558566|P14|COMPLETED|Period 2||187
8339581|NCT01314872|20558567|P13|COMPLETED|Period 2||188
8339582|NCT01314872|20558568|P12|COMPLETED|Period 2||175
8339583|NCT01314872|20558569|P11|COMPLETED|Period 2||0
8339584|NCT01314872|20558570|P10|COMPLETED|Period 2||0
8339585|NCT01314872|20558571|P9|COMPLETED|Period 2||0
8339586|NCT01314872|20558572|P8|COMPLETED|Period 2||0
8339587|NCT01314872|20558573|P7|COMPLETED|Period 2||0
8339588|NCT01314872|20558574|P6|COMPLETED|Period 2||0
8339589|NCT01314872|20558575|P5|COMPLETED|Period 2||0
8339590|NCT01314872|20558576|P4|COMPLETED|Period 2||0
8339591|NCT01314872|20558577|P3|COMPLETED|Period 2||0
8339592|NCT01314872|20558578|P2|COMPLETED|Period 2||0
8339593|NCT01314872|20558579|P1|COMPLETED|Period 2||0
8339594|NCT01314872|20558565|P15|STARTED|Period 2||134
8339595|NCT01314872|20558566|P14|STARTED|Period 2||240
8339596|NCT01314872|20558567|P13|STARTED|Period 2||248
8339597|NCT01314872|20558568|P12|STARTED|Period 2||223
8339598|NCT01314872|20558569|P11|STARTED|Period 2||0
8339599|NCT01314872|20558570|P10|STARTED|Period 2||0
8339600|NCT01314872|20558571|P9|STARTED|Period 2||0
8339601|NCT01314872|20558572|P8|STARTED|Period 2||0
8339602|NCT01314872|20558573|P7|STARTED|Period 2||0
8339603|NCT01314872|20558574|P6|STARTED|Period 2||0
8339604|NCT01314872|20558575|P5|STARTED|Period 2||0
8339605|NCT01314872|20558576|P4|STARTED|Period 2||0
8339606|NCT01314872|20558577|P3|STARTED|Period 2||0
8339607|NCT01314872|20558578|P2|STARTED|Period 2||0
8339608|NCT01314872|20558579|P1|STARTED|Period 2||0
8339609|NCT01314872|20558565|P15|NOT COMPLETED|Treatment Period 1||0
8339610|NCT01314872|20558566|P14|NOT COMPLETED|Treatment Period 1||0
8339611|NCT01314872|20558567|P13|NOT COMPLETED|Treatment Period 1||0
8339612|NCT01314872|20558568|P12|NOT COMPLETED|Treatment Period 1||0
8339613|NCT01314872|20558569|P11|NOT COMPLETED|Treatment Period 1||3
8339614|NCT01314872|20558570|P10|NOT COMPLETED|Treatment Period 1||4
8339615|NCT01314872|20558571|P9|NOT COMPLETED|Treatment Period 1||6
8339616|NCT01314872|20558572|P8|NOT COMPLETED|Treatment Period 1||7
8339617|NCT01314872|20558573|P7|NOT COMPLETED|Treatment Period 1||8
8339618|NCT01314872|20558574|P6|NOT COMPLETED|Treatment Period 1||7
8339619|NCT01314872|20558575|P5|NOT COMPLETED|Treatment Period 1||7
8339620|NCT01314872|20558576|P4|NOT COMPLETED|Treatment Period 1||7
8339621|NCT01314872|20558577|P3|NOT COMPLETED|Treatment Period 1||6
8339622|NCT01314872|20558578|P2|NOT COMPLETED|Treatment Period 1||6
8339623|NCT01314872|20558579|P1|NOT COMPLETED|Treatment Period 1||10
8339624|NCT01314872|20558565|P15|COMPLETED|Treatment Period 1||0
8339625|NCT01314872|20558566|P14|COMPLETED|Treatment Period 1||0
8339626|NCT01314872|20558567|P13|COMPLETED|Treatment Period 1||0
8339627|NCT01314872|20558568|P12|COMPLETED|Treatment Period 1||0
8339628|NCT01314872|20558569|P11|COMPLETED|Treatment Period 1||107
8339629|NCT01314872|20558570|P10|COMPLETED|Treatment Period 1||118
8339630|NCT01314872|20558571|P9|COMPLETED|Treatment Period 1||106
8339631|NCT01314872|20558572|P8|COMPLETED|Treatment Period 1||57
8339632|NCT01314872|20558573|P7|COMPLETED|Treatment Period 1||126
8339633|NCT01314872|20558574|P6|COMPLETED|Treatment Period 1||128
8339634|NCT01314872|20558575|P5|COMPLETED|Treatment Period 1||142
8339635|NCT01314872|20558576|P4|COMPLETED|Treatment Period 1||143
8339636|NCT01314872|20558577|P3|COMPLETED|Treatment Period 1||128
8339637|NCT01314872|20558578|P2|COMPLETED|Treatment Period 1||138
8339638|NCT01314872|20558579|P1|COMPLETED|Treatment Period 1||131
8339639|NCT01314872|20558565|P15|STARTED|Treatment Period 1||0
8339640|NCT01314872|20558566|P14|STARTED|Treatment Period 1||0
8339641|NCT01314872|20558567|P13|STARTED|Treatment Period 1||0
8339642|NCT01314872|20558568|P12|STARTED|Treatment Period 1||0
8339643|NCT01314872|20558569|P11|STARTED|Treatment Period 1||110
8339644|NCT01314872|20558570|P10|STARTED|Treatment Period 1||122
8339645|NCT01314872|20558571|P9|STARTED|Treatment Period 1||112
8339646|NCT01314872|20558572|P8|STARTED|Treatment Period 1||64
8339647|NCT01314872|20558573|P7|STARTED|Treatment Period 1||134
8339648|NCT01314872|20558574|P6|STARTED|Treatment Period 1||135
8339649|NCT01314872|20558575|P5|STARTED|Treatment Period 1||149
8339650|NCT01314872|20558576|P4|STARTED|Treatment Period 1||150
8339651|NCT01314872|20558577|P3|STARTED|Treatment Period 1||134
8339652|NCT01314872|20558578|P2|STARTED|Treatment Period 1||144
8339653|NCT01314872|20558579|P1|STARTED|Treatment Period 1||141
8339654|NCT01314742|20558672|P2|NOT COMPLETED|Overall Study||0
8339655|NCT01314742|20558673|P1|NOT COMPLETED|Overall Study||0
8339656|NCT01314742|20558672|P2|COMPLETED|Overall Study||21
8339657|NCT01314742|20558673|P1|COMPLETED|Overall Study||20
8339658|NCT01314742|20558672|P2|STARTED|Overall Study||21
8339659|NCT01314742|20558673|P1|STARTED|Overall Study||20
8339660|NCT01314716|20558683|P2|NOT COMPLETED|Open-Label Phase||12
8339661|NCT01314716|20558684|P1|NOT COMPLETED|Open-Label Phase||10
8339662|NCT01314716|20558683|P2|COMPLETED|Open-Label Phase||98
8339663|NCT01314716|20558684|P1|COMPLETED|Open-Label Phase||102
8339664|NCT01314716|20558683|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
8339665|NCT01314716|20558684|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
8339666|NCT01314716|20558683|P2|NOT COMPLETED|Double-Blind Phase||15
8339667|NCT01314716|20558684|P1|NOT COMPLETED|Double-Blind Phase||17
8339668|NCT01314716|20558683|P2|COMPLETED|Double-Blind Phase||123
8339669|NCT01314716|20558684|P1|COMPLETED|Double-Blind Phase||119
8339670|NCT01314716|20558683|P2|Randomized and Treated|Double-Blind Phase||137
8339671|NCT01314716|20558684|P1|Randomized and Treated|Double-Blind Phase||135
8339672|NCT01314716|20558683|P2|STARTED|Double-Blind Phase||138
8339673|NCT01314716|20558684|P1|STARTED|Double-Blind Phase||136
8339674|NCT01314703|20558696|P1|NOT COMPLETED|Overall Study||8
8339675|NCT01314703|20558696|P1|COMPLETED|Overall Study||27
8339676|NCT01314703|20558696|P1|Discontinued When Enrollment Completed|Overall Study||3
8339677|NCT01314703|20558696|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
8339678|NCT01314703|20558696|P1|Excluded Prior to Screening Baseline|Overall Study||2
8339679|NCT01314703|20558696|P1|Completed Study|Overall Study||27
8339680|NCT01314703|20558696|P1|Completed Treatment Visit|Overall Study||27
8339681|NCT01314703|20558696|P1|Completed Screen Visit|Overall Study||33
8339682|NCT01314703|20558696|P1|Signed Informed Consent|Overall Study||35
8339683|NCT01314703|20558696|P1|STARTED|Overall Study||35
8339684|NCT01314443|20558705|P4|NOT COMPLETED|Overall Study||2
8339685|NCT01314443|20558706|P3|NOT COMPLETED|Overall Study||2
8339686|NCT01314443|20558707|P2|NOT COMPLETED|Overall Study||3
8339687|NCT01314443|20558708|P1|NOT COMPLETED|Overall Study||4
8339688|NCT01314443|20558705|P4|COMPLETED|Overall Study||13
8339689|NCT01314443|20558706|P3|COMPLETED|Overall Study||13
8339690|NCT01314443|20558707|P2|COMPLETED|Overall Study||16
8339691|NCT01314443|20558708|P1|COMPLETED|Overall Study||14
8339692|NCT01314443|20558705|P4|STARTED|Overall Study||15
8339693|NCT01314443|20558706|P3|STARTED|Overall Study||15
8339694|NCT01314443|20558707|P2|STARTED|Overall Study||19
8339695|NCT01314443|20558708|P1|STARTED|Overall Study||18
8339696|NCT01314417|20558726|P1|NOT COMPLETED|Overall Study||0
8339697|NCT01314417|20558726|P1|COMPLETED|Overall Study||2
8339698|NCT01314417|20558726|P1|STARTED|Overall Study||2
8339699|NCT01314313|20558757|P2|NOT COMPLETED|Overall Study||311
8339700|NCT01314313|20558758|P1|NOT COMPLETED|Overall Study||227
8339701|NCT01314313|20558757|P2|COMPLETED|Overall Study||710
8339702|NCT01314313|20558758|P1|COMPLETED|Overall Study||784
8339703|NCT01314313|20558757|P2|Valve Implanted|Overall Study||936
8339704|NCT01314313|20558758|P1|Valve Implanted|Overall Study||974
8339705|NCT01314313|20558757|P2|As Treated|Overall Study||944
8339706|NCT01314313|20558758|P1|As Treated|Overall Study||994
8339707|NCT01314313|20558757|P2|STARTED|Overall Study||1021
8339708|NCT01314313|20558758|P1|STARTED|Overall Study||1011
8339709|NCT01314261|20558778|P4|NOT COMPLETED|Overall Study||3
8339710|NCT01314261|20558779|P3|NOT COMPLETED|Overall Study||3
8339711|NCT01314261|20558780|P2|NOT COMPLETED|Overall Study||4
8339712|NCT01314261|20558781|P1|NOT COMPLETED|Overall Study||2
8339713|NCT01314261|20558778|P4|COMPLETED|Overall Study||6
8339714|NCT01314261|20558779|P3|COMPLETED|Overall Study||7
8339715|NCT01314261|20558780|P2|COMPLETED|Overall Study||5
8339716|NCT01314261|20558781|P1|COMPLETED|Overall Study||7
8339717|NCT01314261|20558778|P4|Discontinued pegIFN/RBV|Overall Study||1
8339718|NCT01314261|20558779|P3|Discontinued pegIFN/RBV|Overall Study||5
8339719|NCT01314261|20558780|P2|Discontinued pegIFN/RBV|Overall Study||4
8339720|NCT01314261|20558781|P1|Discontinued pegIFN/RBV|Overall Study||1
8339721|NCT01314261|20558778|P4|Discontinued ABT-267 or Placebo|Overall Study||0
8339722|NCT01314261|20558779|P3|Discontinued ABT-267 or Placebo|Overall Study||1
8339723|NCT01314261|20558780|P2|Discontinued ABT-267 or Placebo|Overall Study||0
8339724|NCT01314261|20558781|P1|Discontinued ABT-267 or Placebo|Overall Study||1
8339725|NCT01314261|20558778|P4|STARTED|Overall Study||9
8339726|NCT01314261|20558779|P3|STARTED|Overall Study||10
8339727|NCT01314261|20558780|P2|STARTED|Overall Study||9
8339728|NCT01314261|20558781|P1|STARTED|Overall Study||9
8339729|NCT01314118|20558832|P1|NOT COMPLETED|Overall Study||131
8339730|NCT01314118|20558832|P1|COMPLETED|Overall Study||0
8339731|NCT01314118|20558832|P1|STARTED|Overall Study||131
8339732|NCT01314105|20558841|P2|NOT COMPLETED|Overall Study||12
8339733|NCT01314105|20558842|P1|NOT COMPLETED|Overall Study||7
8339734|NCT01314105|20558841|P2|COMPLETED|Overall Study||0
8339735|NCT01314105|20558842|P1|COMPLETED|Overall Study||0
8339736|NCT01314105|20558841|P2|STARTED|Overall Study||12
8339737|NCT01314105|20558842|P1|STARTED|Overall Study||7
8339738|NCT01314014|20558884|P1|NOT COMPLETED|Overall Study||0
8339739|NCT01314014|20558884|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
8339740|NCT01314014|20558884|P1|STARTED|Overall Study||22
8339741|NCT01314001|20558895|P6|NOT COMPLETED|Overall Study||71
8339742|NCT01314001|20558896|P5|NOT COMPLETED|Overall Study||72
8339743|NCT01314001|20558897|P4|NOT COMPLETED|Overall Study||69
8339744|NCT01314001|20558898|P3|NOT COMPLETED|Overall Study||69
8339745|NCT01314001|20558899|P2|NOT COMPLETED|Overall Study||69
8339746|NCT01314001|20558900|P1|NOT COMPLETED|Overall Study||75
8339747|NCT01314001|20558895|P6|COMPLETED|Overall Study||129
8339748|NCT01314001|20558896|P5|COMPLETED|Overall Study||148
8339749|NCT01314001|20558897|P4|COMPLETED|Overall Study||122
8339750|NCT01314001|20558898|P3|COMPLETED|Overall Study||158
8339751|NCT01314001|20558899|P2|COMPLETED|Overall Study||124
8339752|NCT01314001|20558900|P1|COMPLETED|Overall Study||140
8339753|NCT01314001|20558895|P6|6-Month Follow Up Survey|Overall Study||139
8339754|NCT01314001|20558896|P5|6-Month Follow Up Survey|Overall Study||157
8339755|NCT01314001|20558897|P4|6-Month Follow Up Survey|Overall Study||135
8339756|NCT01314001|20558898|P3|6-Month Follow Up Survey|Overall Study||165
8339757|NCT01314001|20558899|P2|6-Month Follow Up Survey|Overall Study||137
8339758|NCT01314001|20558900|P1|6-Month Follow Up Survey|Overall Study||146
8339759|NCT01314001|20558895|P6|End-of-Treatment Visit|Overall Study||160
8339760|NCT01314001|20558896|P5|End-of-Treatment Visit|Overall Study||174
8339761|NCT01314001|20558897|P4|End-of-Treatment Visit|Overall Study||146
8339762|NCT01314001|20558898|P3|End-of-Treatment Visit|Overall Study||179
8339763|NCT01314001|20558899|P2|End-of-Treatment Visit|Overall Study||141
8339764|NCT01314001|20558900|P1|End-of-Treatment Visit|Overall Study||156
8339765|NCT01314001|20558895|P6|STARTED|Overall Study||200
8339766|NCT01314001|20558896|P5|STARTED|Overall Study||220
8339767|NCT01314001|20558897|P4|STARTED|Overall Study||191
8339768|NCT01314001|20558898|P3|STARTED|Overall Study||227
8339769|NCT01314001|20558899|P2|STARTED|Overall Study||193
8339770|NCT01314001|20558900|P1|STARTED|Overall Study||215
8339771|NCT01313936|20558946|P2|NOT COMPLETED|Overall Study||0
8339772|NCT01313936|20558947|P1|NOT COMPLETED|Overall Study||0
8339773|NCT01313936|20558946|P2|COMPLETED|Overall Study||26
8339774|NCT01313936|20558947|P1|COMPLETED|Overall Study||6
8339775|NCT01313936|20558946|P2|STARTED|Overall Study||26
8339776|NCT01313936|20558947|P1|STARTED|Overall Study||6
8339777|NCT01313923|20558960|P1|NOT COMPLETED|Overall Study||3
8339778|NCT01313923|20558960|P1|COMPLETED|Overall Study||0
8339779|NCT01313923|20558960|P1|STARTED|Overall Study||3
8339780|NCT01313910|20558964|P1|NOT COMPLETED|Overall Study||0
8339781|NCT01313910|20558964|P1|COMPLETED|Overall Study||8
8339782|NCT01313910|20558964|P1|STARTED|Overall Study||8
8339783|NCT01313897|20558972|P1|NOT COMPLETED|Overall Study||2
8339784|NCT01313897|20558972|P1|COMPLETED|Overall Study||8
8339785|NCT01313897|20558972|P1|STARTED|Overall Study||10
8339786|NCT01313884|20558976|P1|NOT COMPLETED|Overall Study||1
8339787|NCT01313884|20558976|P1|COMPLETED|Overall Study||2
8339788|NCT01313884|20558976|P1|STARTED|Overall Study||3
8339789|NCT01313858|20558984|P3|NOT COMPLETED|Overall Study||238
8339790|NCT01313858|20558985|P2|NOT COMPLETED|Overall Study||270
8339791|NCT01313858|20558986|P1|NOT COMPLETED|Overall Study||286
8339792|NCT01313858|20558984|P3|COMPLETED|Overall Study||305
8339793|NCT01313858|20558985|P2|COMPLETED|Overall Study||276
8339794|NCT01313858|20558986|P1|COMPLETED|Overall Study||238
8339795|NCT01313858|20558984|P3|STARTED|Overall Study||543
8339796|NCT01313858|20558985|P2|STARTED|Overall Study||546
8339797|NCT01313858|20558986|P1|STARTED|Overall Study||524
8339798|NCT01313780|20559009|P2|NOT COMPLETED|Overall Study||28
8339799|NCT01313780|20559010|P1|NOT COMPLETED|Overall Study||25
8339800|NCT01313780|20559009|P2|COMPLETED|Overall Study|PPS|31
8339801|NCT01313780|20559010|P1|COMPLETED|Overall Study|PPS|33
8339802|NCT01313780|20559009|P2|STARTED|Overall Study|FAS|59
8339803|NCT01313780|20559010|P1|STARTED|Overall Study|FAS|58
8339804|NCT01313767|20559020|P2|NOT COMPLETED|Overall Study||2
8339805|NCT01313767|20559021|P1|NOT COMPLETED|Overall Study||7
8339806|NCT01313767|20559020|P2|COMPLETED|Overall Study||96
8339807|NCT01313767|20559021|P1|COMPLETED|Overall Study||91
8339808|NCT01313767|20559020|P2|STARTED|Overall Study||98
8339809|NCT01313767|20559021|P1|STARTED|Overall Study||98
8339810|NCT01313728|20559063|P1|NOT COMPLETED|Baseline to Completion||0
8339811|NCT01313728|20559063|P1|COMPLETED|Baseline to Completion||25
8339812|NCT01313728|20559063|P1|STARTED|Baseline to Completion||25
8339813|NCT01313728|20559063|P1|NOT COMPLETED|Informed Consent to Baseline||1
8339814|NCT01313728|20559063|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
8339815|NCT01313728|20559063|P1|STARTED|Informed Consent to Baseline||26
8339816|NCT01313689|20559083|P5|NOT COMPLETED|24-Week Randomization 2||15
8339817|NCT01313689|20559084|P4|NOT COMPLETED|24-Week Randomization 2||1
8339818|NCT01313689|20559085|P3|NOT COMPLETED|24-Week Randomization 2||3
8339819|NCT01313689|20559086|P2|NOT COMPLETED|24-Week Randomization 2||0
8339820|NCT01313689|20559087|P1|NOT COMPLETED|24-Week Randomization 2||0
8339821|NCT01313689|20559083|P5|COMPLETED|24-Week Randomization 2||27
8339822|NCT01313689|20559084|P4|COMPLETED|24-Week Randomization 2||12
8339823|NCT01313689|20559085|P3|COMPLETED|24-Week Randomization 2||21
8339824|NCT01313689|20559086|P2|COMPLETED|24-Week Randomization 2||0
8339825|NCT01313689|20559087|P1|COMPLETED|24-Week Randomization 2||0
8339826|NCT01313689|20559083|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
8339827|NCT01313689|20559084|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
8339828|NCT01313689|20559085|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
8339829|NCT01313689|20559086|P2|STARTED|24-Week Randomization 2||0
8339830|NCT01313689|20559087|P1|STARTED|24-Week Randomization 2||0
8339831|NCT01313689|20559083|P5|NOT COMPLETED|24-Week Randomization 1||0
8339832|NCT01313689|20559084|P4|NOT COMPLETED|24-Week Randomization 1||0
8339833|NCT01313689|20559085|P3|NOT COMPLETED|24-Week Randomization 1||0
8339834|NCT01313689|20559086|P2|NOT COMPLETED|24-Week Randomization 1||10
8339835|NCT01313689|20559087|P1|NOT COMPLETED|24-Week Randomization 1||19
8339836|NCT01313689|20559083|P5|COMPLETED|24-Week Randomization 1||0
8339837|NCT01313689|20559084|P4|COMPLETED|24-Week Randomization 1||0
8339838|NCT01313689|20559085|P3|COMPLETED|24-Week Randomization 1||0
8339839|NCT01313689|20559086|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
8339840|NCT01313689|20559087|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
8339841|NCT01313689|20559083|P5|STARTED|24-Week Randomization 1||0
8339842|NCT01313689|20559084|P4|STARTED|24-Week Randomization 1||0
8339843|NCT01313689|20559085|P3|STARTED|24-Week Randomization 1||0
8339844|NCT01313689|20559086|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
8339845|NCT01313689|20559087|P1|STARTED|24-Week Randomization 1||79
8339846|NCT01313676|20559166|P4|NOT COMPLETED|Overall Study||994
8339847|NCT01313676|20559167|P3|NOT COMPLETED|Overall Study||1088
8339848|NCT01313676|20559168|P2|NOT COMPLETED|Overall Study||1113
8339849|NCT01313676|20559169|P1|NOT COMPLETED|Overall Study||1250
8339850|NCT01313676|20559166|P4|COMPLETED|Overall Study||3146
8339851|NCT01313676|20559167|P3|COMPLETED|Overall Study||3052
8339852|NCT01313676|20559168|P2|COMPLETED|Overall Study||3044
8339853|NCT01313676|20559169|P1|COMPLETED|Overall Study||2881
8339854|NCT01313676|20559166|P4|STARTED|Overall Study||4140
8339855|NCT01313676|20559167|P3|STARTED|Overall Study||4140
8339856|NCT01313676|20559168|P2|STARTED|Overall Study||4157
8339857|NCT01313676|20559169|P1|STARTED|Overall Study||4131
8339858|NCT01313663|20559189|P2|NOT COMPLETED|Overall Study||8
8339859|NCT01313663|20559190|P1|NOT COMPLETED|Overall Study||4
8339860|NCT01313663|20559189|P2|COMPLETED|Overall Study||3
8339861|NCT01313663|20559190|P1|COMPLETED|Overall Study||5
8339862|NCT01313663|20559189|P2|STARTED|Overall Study||11
8339863|NCT01313663|20559190|P1|STARTED|Overall Study||9
8339864|NCT01313650|20559228|P4|NOT COMPLETED|Overall Study||81
8339865|NCT01313650|20559229|P3|NOT COMPLETED|Overall Study||103
8339866|NCT01313650|20559230|P2|NOT COMPLETED|Overall Study||94
8339867|NCT01313650|20559231|P1|NOT COMPLETED|Overall Study||76
8339868|NCT01313650|20559228|P4|COMPLETED|Overall Study||332
8339869|NCT01313650|20559229|P3|COMPLETED|Overall Study||318
8339870|NCT01313650|20559230|P2|COMPLETED|Overall Study||324
8339871|NCT01313650|20559231|P1|COMPLETED|Overall Study||204
8339872|NCT01313650|20559228|P4|STARTED|Overall Study||413
8339873|NCT01313650|20559229|P3|STARTED|Overall Study||421
8339874|NCT01313650|20559230|P2|STARTED|Overall Study||418
8339875|NCT01313650|20559231|P1|STARTED|Overall Study||280
8339876|NCT01313637|20559257|P4|NOT COMPLETED|Overall Study||78
8339877|NCT01313637|20559258|P3|NOT COMPLETED|Overall Study||106
8339878|NCT01313637|20559259|P2|NOT COMPLETED|Overall Study||95
8339879|NCT01313637|20559260|P1|NOT COMPLETED|Overall Study||92
8339880|NCT01313637|20559257|P4|COMPLETED|Overall Study||325
8339881|NCT01313637|20559258|P3|COMPLETED|Overall Study||298
8339882|NCT01313637|20559259|P2|COMPLETED|Overall Study||312
8339883|NCT01313637|20559260|P1|COMPLETED|Overall Study||183
8339884|NCT01313637|20559257|P4|STARTED|Overall Study||403
8339885|NCT01313637|20559258|P3|STARTED|Overall Study||404
8339886|NCT01313637|20559259|P2|STARTED|Overall Study||407
8339887|NCT01313637|20559260|P1|STARTED|Overall Study||275
8339888|NCT01313624|20559284|P2|NOT COMPLETED|Open-Label Phase||13
8339889|NCT01313624|20559285|P1|NOT COMPLETED|Open-Label Phase||4
8339890|NCT01313624|20559284|P2|COMPLETED|Open-Label Phase||109
8339891|NCT01313624|20559285|P1|COMPLETED|Open-Label Phase||92
8339892|NCT01313624|20559284|P2|STARTED|Open-Label Phase||122
8339893|NCT01313624|20559285|P1|STARTED|Open-Label Phase||96
8339894|NCT01313624|20559284|P2|NOT COMPLETED|Double-Blind Phase||10
8339895|NCT01313624|20559285|P1|NOT COMPLETED|Double-Blind Phase||38
8339896|NCT01313624|20559284|P2|COMPLETED|Double-Blind Phase||122
8339897|NCT01313624|20559285|P1|COMPLETED|Double-Blind Phase||96
8339898|NCT01313624|20559284|P2|STARTED|Double-Blind Phase||132
8339899|NCT01313624|20559285|P1|STARTED|Double-Blind Phase||134
8339900|NCT01313559|20559299|P2|NOT COMPLETED|Overall Study||2
8339901|NCT01313559|20559300|P1|NOT COMPLETED|Overall Study||4
8339902|NCT01313559|20559299|P2|COMPLETED|Overall Study||0
8339903|NCT01313559|20559300|P1|COMPLETED|Overall Study||0
8339904|NCT01313559|20559299|P2|STARTED|Overall Study||2
8339905|NCT01313559|20559300|P1|STARTED|Overall Study||4
8339906|NCT01313520|20559314|P2|NOT COMPLETED|Overall Study||0
8339907|NCT01313520|20559315|P1|NOT COMPLETED|Overall Study||0
8339908|NCT01313520|20559314|P2|COMPLETED|Overall Study||31
8339909|NCT01313520|20559315|P1|COMPLETED|Overall Study||30
8339910|NCT01313520|20559314|P2|STARTED|Overall Study||31
8339911|NCT01313520|20559315|P1|STARTED|Overall Study||30
8339912|NCT01313507|20559335|P1|NOT COMPLETED|Overall Study||0
8339913|NCT01313507|20559335|P1|COMPLETED|Overall Study||21
8339914|NCT01313507|20559335|P1|STARTED|Overall Study||21
8339915|NCT01313494|20559343|P2|NOT COMPLETED|Overall Study||50
8339916|NCT01313494|20559344|P1|NOT COMPLETED|Overall Study||67
8339917|NCT01313494|20559343|P2|COMPLETED|Overall Study||263
8339918|NCT01313494|20559344|P1|COMPLETED|Overall Study||246
8339919|NCT01313494|20559343|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
8339920|NCT01313494|20559344|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
8339921|NCT01313494|20559343|P2|STARTED|Overall Study||313
8339922|NCT01313494|20559344|P1|STARTED|Overall Study||313
8339923|NCT01313416|20559396|P1|NOT COMPLETED|Overall Study||0
8339924|NCT01313416|20559396|P1|COMPLETED|Overall Study||2
8339925|NCT01313416|20559396|P1|STARTED|Overall Study||2
8339926|NCT01313312|20559401|P1|NOT COMPLETED|Overall Study||36
8339927|NCT01313312|20559401|P1|COMPLETED|Overall Study||222
8339928|NCT01313312|20559401|P1|Cycle 5|Overall Study||11
8339929|NCT01313312|20559401|P1|Cycle 4|Overall Study||81
8339930|NCT01313312|20559401|P1|Cycle 3|Overall Study||175
8339931|NCT01313312|20559401|P1|Cycle 2|Overall Study||229
8339932|NCT01313312|20559401|P1|Cycle 1|Overall Study||254
8339933|NCT01313312|20559401|P1|STARTED|Overall Study||258
8339934|NCT01313299|20559448|P3|NOT COMPLETED|Overall Study||4
8339935|NCT01313299|20559449|P2|NOT COMPLETED|Overall Study||3
8339936|NCT01313299|20559450|P1|NOT COMPLETED|Overall Study||7
8339937|NCT01313299|20559448|P3|COMPLETED|Overall Study||77
8339938|NCT01313299|20559449|P2|COMPLETED|Overall Study||78
8339939|NCT01313299|20559450|P1|COMPLETED|Overall Study||74
8339940|NCT01313299|20559448|P3|STARTED|Overall Study||81
8339941|NCT01313299|20559449|P2|STARTED|Overall Study||81
8339942|NCT01313299|20559450|P1|STARTED|Overall Study||81
8339943|NCT01313286|20559464|P2|NOT COMPLETED|Period 2||0
8339944|NCT01313286|20559465|P1|NOT COMPLETED|Period 2||0
8339945|NCT01313286|20559464|P2|COMPLETED|Period 2||8
8339946|NCT01313286|20559465|P1|COMPLETED|Period 2||6
8339947|NCT01313286|20559464|P2|STARTED|Period 2||8
8339948|NCT01313286|20559465|P1|STARTED|Period 2||6
8339949|NCT01313286|20559464|P2|NOT COMPLETED|Period 1||0
8339950|NCT01313286|20559465|P1|NOT COMPLETED|Period 1||2
8339951|NCT01313286|20559464|P2|COMPLETED|Period 1||8
8339952|NCT01313286|20559465|P1|COMPLETED|Period 1||6
8339953|NCT01313286|20559464|P2|STARTED|Period 1||8
8339954|NCT01313286|20559465|P1|STARTED|Period 1||8
8339955|NCT01313273|20559475|P2|NOT COMPLETED|Overall Study||1
8339956|NCT01313273|20559476|P1|NOT COMPLETED|Overall Study||2
8339957|NCT01313273|20559475|P2|COMPLETED|Overall Study||0
8339958|NCT01313273|20559476|P1|COMPLETED|Overall Study||0
8339959|NCT01313273|20559475|P2|STARTED|Overall Study||1
8339960|NCT01313273|20559476|P1|STARTED|Overall Study||2
8339961|NCT01313221|20559491|P3|NOT COMPLETED|Overall Study||23
8339962|NCT01313221|20559492|P2|NOT COMPLETED|Overall Study||8
8339963|NCT01313221|20559493|P1|NOT COMPLETED|Overall Study||12
8339964|NCT01313221|20559491|P3|COMPLETED|Overall Study||0
8339965|NCT01313221|20559492|P2|COMPLETED|Overall Study||135
8339966|NCT01313221|20559493|P1|COMPLETED|Overall Study||132
8339967|NCT01313221|20559491|P3|Randomized|Overall Study||0
8339968|NCT01313221|20559492|P2|Randomized|Overall Study||143
8339969|NCT01313221|20559493|P1|Randomized|Overall Study||144
8339970|NCT01313221|20559491|P3|STARTED|Overall Study||23
8339971|NCT01313221|20559492|P2|STARTED|Overall Study||143
8339972|NCT01313221|20559493|P1|STARTED|Overall Study||144
8339973|NCT01313208|20559545|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
8339974|NCT01313208|20559546|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
8339975|NCT01313208|20559545|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
8339976|NCT01313208|20559546|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
8339977|NCT01313208|20559545|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
8339978|NCT01313208|20559546|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
8339979|NCT01313208|20559545|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
8339980|NCT01313208|20559546|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
8339981|NCT01313208|20559545|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
8339982|NCT01313208|20559546|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
8339983|NCT01313208|20559545|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
8339984|NCT01313208|20559546|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
8339985|NCT01313182|20559636|P2|NOT COMPLETED|Overall Study||92
8339986|NCT01313182|20559637|P1|NOT COMPLETED|Overall Study||66
8339987|NCT01313182|20559636|P2|COMPLETED|Overall Study||763
8339988|NCT01313182|20559637|P1|COMPLETED|Overall Study||776
8339989|NCT01313182|20559636|P2|STARTED|Overall Study||855
8339990|NCT01313182|20559637|P1|STARTED|Overall Study||842
8339991|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
8339992|NCT01313117|20559649|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
8339993|NCT01313117|20559649|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
8339994|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
8339995|NCT01313117|20559649|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
8339996|NCT01313117|20559649|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
8339997|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
8339998|NCT01313117|20559649|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
8339999|NCT01313117|20559649|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
8340000|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
8340001|NCT01313117|20559649|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
8340002|NCT01313117|20559649|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
8340003|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
8340004|NCT01313117|20559649|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
8340005|NCT01313117|20559649|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
8340006|NCT01313078|20559656|P1|NOT COMPLETED|Overall Study||3
8340007|NCT01313078|20559656|P1|COMPLETED|Overall Study||1
8340008|NCT01313078|20559656|P1|STARTED|Overall Study||4
8340009|NCT01313039|20559661|P1|NOT COMPLETED|Overall Study||2
8340010|NCT01313039|20559661|P1|COMPLETED|Overall Study||2
8340011|NCT01313039|20559661|P1|STARTED|Overall Study||4
8340012|NCT01312961|20559667|P2|NOT COMPLETED|Overall Study||7
8340013|NCT01312961|20559668|P1|NOT COMPLETED|Overall Study||17
8340014|NCT01312961|20559667|P2|COMPLETED|Overall Study||45
8340015|NCT01312961|20559668|P1|COMPLETED|Overall Study||35
8340016|NCT01312961|20559667|P2|Treated|Overall Study||52
8340017|NCT01312961|20559668|P1|Treated|Overall Study||52
8340018|NCT01312961|20559667|P2|STARTED|Overall Study||52
8340019|NCT01312961|20559668|P1|STARTED|Overall Study||52
8340020|NCT01312948|20559694|P1|NOT COMPLETED|Overall Study||0
8340021|NCT01312948|20559694|P1|COMPLETED|Overall Study||6
8340022|NCT01312948|20559694|P1|STARTED|Overall Study||6
8340023|NCT01312909|20559704|P3|NOT COMPLETED|Overall Study||47
8340024|NCT01312909|20559705|P2|NOT COMPLETED|Overall Study||36
8340025|NCT01312909|20559706|P1|NOT COMPLETED|Overall Study||42
8340026|NCT01312909|20559704|P3|COMPLETED|Overall Study||53
8340027|NCT01312909|20559705|P2|COMPLETED|Overall Study||67
8340028|NCT01312909|20559706|P1|COMPLETED|Overall Study||67
8340029|NCT01312909|20559704|P3|Treated|Overall Study||99
8340030|NCT01312909|20559705|P2|Treated|Overall Study||100
8340031|NCT01312909|20559706|P1|Treated|Overall Study||108
8340032|NCT01312909|20559704|P3|STARTED|Overall Study||100
8340033|NCT01312909|20559705|P2|STARTED|Overall Study||103
8340034|NCT01312909|20559706|P1|STARTED|Overall Study||109
8340035|NCT01312844|20559755|P2|NOT COMPLETED|Overall Study||0
8340036|NCT01312844|20559756|P1|NOT COMPLETED|Overall Study||0
8340037|NCT01312844|20559755|P2|COMPLETED|Overall Study||3
8340038|NCT01312844|20559756|P1|COMPLETED|Overall Study||4
8340039|NCT01312844|20559755|P2|STARTED|Overall Study||3
8340040|NCT01312844|20559756|P1|STARTED|Overall Study||4
8340041|NCT01312818|20559778|P1|NOT COMPLETED|Overall Study||0
8340042|NCT01312818|20559778|P1|COMPLETED|Overall Study||2
8340043|NCT01312818|20559778|P1|STARTED|Overall Study||2
8340044|NCT01312805|20559786|P2|NOT COMPLETED|Overall Study||0
8340045|NCT01312805|20559787|P1|NOT COMPLETED|Overall Study||0
8340046|NCT01312805|20559786|P2|COMPLETED|Overall Study||1082
8340047|NCT01312805|20559787|P1|COMPLETED|Overall Study||1016
8340048|NCT01312805|20559786|P2|STARTED|Overall Study||1082
8340049|NCT01312805|20559787|P1|STARTED|Overall Study||1016
8340050|NCT01312779|20559793|P1|NOT COMPLETED|Overall Study||32
8340051|NCT01312779|20559793|P1|COMPLETED|Overall Study||7
8340052|NCT01312779|20559793|P1|Implanted With Device|Overall Study||12
8340053|NCT01312779|20559793|P1|STARTED|Overall Study||39
8340054|NCT01312766|20559825|P2|NOT COMPLETED|Overall Study||5
8340055|NCT01312766|20559826|P1|NOT COMPLETED|Overall Study||6
8340056|NCT01312766|20559825|P2|COMPLETED|Overall Study||130
8340057|NCT01312766|20559826|P1|COMPLETED|Overall Study||129
8340058|NCT01312766|20559825|P2|STARTED|Overall Study||135
8340059|NCT01312766|20559826|P1|STARTED|Overall Study||135
8340060|NCT01312675|20559858|P2|NOT COMPLETED|Overall Study||0
8340061|NCT01312675|20559859|P1|NOT COMPLETED|Overall Study||0
8340062|NCT01312675|20559858|P2|COMPLETED|Overall Study||7
8340063|NCT01312675|20559859|P1|COMPLETED|Overall Study||9
8340064|NCT01312675|20559858|P2|STARTED|Overall Study||7
8340065|NCT01312675|20559859|P1|STARTED|Overall Study||9
8340066|NCT01312519|20559867|P2|NOT COMPLETED|Overall Study||0
8340067|NCT01312519|20559868|P1|NOT COMPLETED|Overall Study||0
8340068|NCT01312519|20559867|P2|COMPLETED|Overall Study||24
8340069|NCT01312519|20559868|P1|COMPLETED|Overall Study||26
8340070|NCT01312519|20559867|P2|STARTED|Overall Study||24
8340071|NCT01312519|20559868|P1|STARTED|Overall Study||26
8340072|NCT01312467|20559876|P1|NOT COMPLETED|Overall Study||13
8340073|NCT01312467|20559876|P1|COMPLETED|Overall Study||32
8340074|NCT01312467|20559876|P1|STARTED|Overall Study||45
8340075|NCT01312428|20559885|P2|NOT COMPLETED|Overall Study||4
8340076|NCT01312428|20559886|P1|NOT COMPLETED|Overall Study||3
8340077|NCT01312428|20559885|P2|COMPLETED|Overall Study||0
8340078|NCT01312428|20559886|P1|COMPLETED|Overall Study||0
8340079|NCT01312428|20559885|P2|STARTED|Overall Study||4
8340080|NCT01312428|20559886|P1|STARTED|Overall Study||3
8340081|NCT01312272|20559896|P2|NOT COMPLETED|Overall Study||1
8340082|NCT01312272|20559897|P1|NOT COMPLETED|Overall Study||0
8340083|NCT01312272|20559896|P2|COMPLETED|Overall Study||11
8340084|NCT01312272|20559897|P1|COMPLETED|Overall Study||12
8340085|NCT01312272|20559896|P2|STARTED|Overall Study||12
8340086|NCT01312272|20559897|P1|STARTED|Overall Study||12
8340087|NCT01312233|20559916|P3|NOT COMPLETED|Overall Study||7
8340088|NCT01312233|20559917|P2|NOT COMPLETED|Overall Study||0
8340089|NCT01312233|20559918|P1|NOT COMPLETED|Overall Study||2
8340090|NCT01312233|20559916|P3|COMPLETED|Overall Study||36
8340091|NCT01312233|20559917|P2|COMPLETED|Overall Study||44
8340092|NCT01312233|20559918|P1|COMPLETED|Overall Study||42
8340093|NCT01312233|20559916|P3|STARTED|Overall Study||43
8340094|NCT01312233|20559917|P2|STARTED|Overall Study||44
8340095|NCT01312233|20559918|P1|STARTED|Overall Study||44
8340096|NCT01312181|20559941|P3|NOT COMPLETED|Overall Study||8
8340097|NCT01312181|20559942|P2|NOT COMPLETED|Overall Study||6
8340098|NCT01312181|20559943|P1|NOT COMPLETED|Overall Study||2
8340099|NCT01312181|20559941|P3|COMPLETED|Overall Study||75
8340100|NCT01312181|20559942|P2|COMPLETED|Overall Study||71
8340101|NCT01312181|20559943|P1|COMPLETED|Overall Study||78
8340102|NCT01312181|20559941|P3|STARTED|Overall Study||83
8340103|NCT01312181|20559942|P2|STARTED|Overall Study||77
8340104|NCT01312181|20559943|P1|STARTED|Overall Study||80
8340105|NCT01312129|20559956|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
8340106|NCT01312129|20559957|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
8340107|NCT01312129|20559956|P2|COMPLETED|Second Intervention (24 Hours)||6
8340108|NCT01312129|20559957|P1|COMPLETED|Second Intervention (24 Hours)||6
8340109|NCT01312129|20559956|P2|Alcohol Cue|Second Intervention (24 Hours)||6
8340110|NCT01312129|20559957|P1|Alcohol Cue|Second Intervention (24 Hours)||6
8340111|NCT01312129|20559956|P2|Control Cue|Second Intervention (24 Hours)||6
8340112|NCT01312129|20559957|P1|Control Cue|Second Intervention (24 Hours)||6
8340113|NCT01312129|20559956|P2|STARTED|Second Intervention (24 Hours)||7
8340114|NCT01312129|20559957|P1|STARTED|Second Intervention (24 Hours)||6
8340115|NCT01312129|20559956|P2|NOT COMPLETED|Washout (1 Week)||0
8340116|NCT01312129|20559957|P1|NOT COMPLETED|Washout (1 Week)||0
8340117|NCT01312129|20559956|P2|COMPLETED|Washout (1 Week)||7
8340118|NCT01312129|20559957|P1|COMPLETED|Washout (1 Week)||6
8340119|NCT01312129|20559956|P2|STARTED|Washout (1 Week)||7
8340120|NCT01312129|20559957|P1|STARTED|Washout (1 Week)||6
8340121|NCT01312129|20559956|P2|NOT COMPLETED|First Intervention (24 Hours)||0
8340122|NCT01312129|20559957|P1|NOT COMPLETED|First Intervention (24 Hours)||0
8340123|NCT01312129|20559956|P2|COMPLETED|First Intervention (24 Hours)||7
8340124|NCT01312129|20559957|P1|COMPLETED|First Intervention (24 Hours)||6
8340125|NCT01312129|20559956|P2|Alcohol Cue|First Intervention (24 Hours)||7
8340126|NCT01312129|20559957|P1|Alcohol Cue|First Intervention (24 Hours)||6
8340127|NCT01312129|20559956|P2|Control Cue|First Intervention (24 Hours)||7
8340128|NCT01312129|20559957|P1|Control Cue|First Intervention (24 Hours)||6
8340129|NCT01312129|20559956|P2|STARTED|First Intervention (24 Hours)||7
8340130|NCT01312129|20559957|P1|STARTED|First Intervention (24 Hours)||6
8340131|NCT01312038|20559965|P2|NOT COMPLETED|Overall Study||0
8340132|NCT01312038|20559966|P1|NOT COMPLETED|Overall Study||0
8340133|NCT01312038|20559965|P2|COMPLETED|Overall Study||12
8340134|NCT01312038|20559966|P1|COMPLETED|Overall Study||13
8340135|NCT01312038|20559965|P2|STARTED|Overall Study||12
8340136|NCT01312038|20559966|P1|STARTED|Overall Study||13
8340137|NCT01311895|20559974|P2|NOT COMPLETED|Overall Study||0
8340138|NCT01311895|20559975|P1|NOT COMPLETED|Overall Study||0
8340139|NCT01311895|20559974|P2|COMPLETED|Overall Study||175
8340140|NCT01311895|20559975|P1|COMPLETED|Overall Study||175
8340141|NCT01311895|20559974|P2|STARTED|Overall Study||175
8340142|NCT01311895|20559975|P1|STARTED|Overall Study||175
8340143|NCT01311687|20559987|P2|NOT COMPLETED|PFS Follow-up Phase||0
8340144|NCT01311687|20559988|P1|NOT COMPLETED|PFS Follow-up Phase||0
8340145|NCT01311687|20559987|P2|COMPLETED|PFS Follow-up Phase||8
8340146|NCT01311687|20559988|P1|COMPLETED|PFS Follow-up Phase||11
8340147|NCT01311687|20559987|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
8340148|NCT01311687|20559988|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
8340149|NCT01311687|20559987|P2|STARTED|PFS Follow-up Phase||8
8340150|NCT01311687|20559988|P1|STARTED|PFS Follow-up Phase||11
8340151|NCT01311687|20559987|P2|NOT COMPLETED|Treatment Phase||0
8340152|NCT01311687|20559988|P1|NOT COMPLETED|Treatment Phase||0
8340153|NCT01311687|20559987|P2|COMPLETED|Treatment Phase||153
8340154|NCT01311687|20559988|P1|COMPLETED|Treatment Phase||302
8340155|NCT01311687|20559987|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
8340156|NCT01311687|20559988|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
8340157|NCT01311687|20559987|P2|Received Study Drug|Treatment Phase||150
8340158|NCT01311687|20559988|P1|Received Study Drug|Treatment Phase||300
8340159|NCT01311687|20559987|P2|STARTED|Treatment Phase||153
8340160|NCT01311687|20559988|P1|STARTED|Treatment Phase||302
8340161|NCT01311661|20560042|P1|NOT COMPLETED|Overall Study||7
8340162|NCT01311661|20560042|P1|COMPLETED|Overall Study||199
8340163|NCT01311661|20560042|P1|Received Olo 10 mcg qd|Overall Study||102
8340164|NCT01311661|20560042|P1|Received Olo 5 mcg Bid|Overall Study||101
8340165|NCT01311661|20560042|P1|Received Olo 5 mcg qd|Overall Study||101
8340166|NCT01311661|20560042|P1|Received Olo 2.5 mcg Bid|Overall Study||101
8340167|NCT01311661|20560042|P1|Received Placebo|Overall Study||201
8340168|NCT01311661|20560042|P1|STARTED|Overall Study|Entered and treated|206
8340169|NCT01311648|20560187|P3|NOT COMPLETED|Overall Study||21
8340170|NCT01311648|20560188|P2|NOT COMPLETED|Overall Study||0
8340171|NCT01311648|20560189|P1|NOT COMPLETED|Overall Study||0
8340172|NCT01311648|20560187|P3|COMPLETED|Overall Study||22
8340173|NCT01311648|20560188|P2|COMPLETED|Overall Study||26
8340174|NCT01311648|20560189|P1|COMPLETED|Overall Study||25
8340175|NCT01311648|20560187|P3|STARTED|Overall Study||43
8340176|NCT01311648|20560188|P2|STARTED|Overall Study||26
8340177|NCT01311648|20560189|P1|STARTED|Overall Study||25
8340178|NCT01311557|20560234|P2|NOT COMPLETED|Overall Study||6
8340179|NCT01311557|20560235|P1|NOT COMPLETED|Overall Study||5
8340180|NCT01311557|20560234|P2|COMPLETED|Overall Study||645
8340181|NCT01311557|20560235|P1|COMPLETED|Overall Study||646
8340182|NCT01311557|20560234|P2|STARTED|Overall Study||651
8340183|NCT01311557|20560235|P1|STARTED|Overall Study||651
8340184|NCT01311505|20560251|P2|NOT COMPLETED|Second Intervention Period||0
8340185|NCT01311505|20560252|P1|NOT COMPLETED|Second Intervention Period||0
8340186|NCT01311505|20560251|P2|COMPLETED|Second Intervention Period||10
8340187|NCT01311505|20560252|P1|COMPLETED|Second Intervention Period||10
8340188|NCT01311505|20560251|P2|STARTED|Second Intervention Period||10
8340189|NCT01311505|20560252|P1|STARTED|Second Intervention Period||10
8340190|NCT01311505|20560251|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8340191|NCT01311505|20560252|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8340192|NCT01311505|20560251|P2|COMPLETED|Washout Period (at Least 7 Days)||10
8340193|NCT01311505|20560252|P1|COMPLETED|Washout Period (at Least 7 Days)||10
8340194|NCT01311505|20560251|P2|STARTED|Washout Period (at Least 7 Days)||10
8340195|NCT01311505|20560252|P1|STARTED|Washout Period (at Least 7 Days)||10
8340196|NCT01311505|20560251|P2|NOT COMPLETED|First Intervention Period||1
8340197|NCT01311505|20560252|P1|NOT COMPLETED|First Intervention Period||0
8340198|NCT01311505|20560251|P2|COMPLETED|First Intervention Period||10
8340199|NCT01311505|20560252|P1|COMPLETED|First Intervention Period||10
8340200|NCT01311505|20560251|P2|STARTED|First Intervention Period||11
8340201|NCT01311505|20560252|P1|STARTED|First Intervention Period||10
8340202|NCT01311362|20560280|P1|NOT COMPLETED|Ambrisentan and SJW||0
8340203|NCT01311362|20560280|P1|COMPLETED|Ambrisentan and SJW||20
8340204|NCT01311362|20560280|P1|STARTED|Ambrisentan and SJW||20
8340205|NCT01311362|20560280|P1|NOT COMPLETED|Ambrisentan Steady-state||0
8340206|NCT01311362|20560280|P1|COMPLETED|Ambrisentan Steady-state||20
8340207|NCT01311362|20560280|P1|STARTED|Ambrisentan Steady-state||20
8340208|NCT01311362|20560280|P1|NOT COMPLETED|Ambrisentan Single Dose||0
8340209|NCT01311362|20560280|P1|COMPLETED|Ambrisentan Single Dose||20
8340210|NCT01311362|20560280|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
8340211|NCT01311102|20560293|P2|NOT COMPLETED|Overall Study||0
8340212|NCT01311102|20560294|P1|NOT COMPLETED|Overall Study||0
8340213|NCT01311102|20560293|P2|COMPLETED|Overall Study||20
8340214|NCT01311102|20560294|P1|COMPLETED|Overall Study||20
8340215|NCT01311102|20560293|P2|STARTED|Overall Study||20
8340216|NCT01311102|20560294|P1|STARTED|Overall Study||20
8340223|NCT01310868|20560315|P1|NOT COMPLETED|Overall Study||13
8340224|NCT01310868|20560315|P1|COMPLETED|Overall Study||59
8340225|NCT01310868|20560315|P1|STARTED|Overall Study||72
8340226|NCT01310855|20560323|P2|NOT COMPLETED|Overall Study||0
8340227|NCT01310855|20560324|P1|NOT COMPLETED|Overall Study||0
8340228|NCT01310855|20560323|P2|COMPLETED|Overall Study||19
8340229|NCT01310855|20560324|P1|COMPLETED|Overall Study||19
8340230|NCT01310855|20560323|P2|STARTED|Overall Study||19
8340231|NCT01310855|20560324|P1|STARTED|Overall Study||19
8340232|NCT01310803|20560332|P2|NOT COMPLETED|Overall Study||0
8340233|NCT01310803|20560333|P1|NOT COMPLETED|Overall Study||1
8340234|NCT01310803|20560332|P2|COMPLETED|Overall Study||0
8340235|NCT01310803|20560333|P1|COMPLETED|Overall Study||0
8340236|NCT01310803|20560332|P2|STARTED|Overall Study||0
8340237|NCT01310803|20560333|P1|STARTED|Overall Study||1
8340238|NCT01310777|20560344|P3|NOT COMPLETED|Overall Study||30
8340239|NCT01310777|20560345|P2|NOT COMPLETED|Overall Study||14
8340240|NCT01310777|20560346|P1|NOT COMPLETED|Overall Study||33
8340241|NCT01310777|20560344|P3|COMPLETED|Overall Study||145
8340242|NCT01310777|20560345|P2|COMPLETED|Overall Study||178
8340243|NCT01310777|20560346|P1|COMPLETED|Overall Study||160
8340244|NCT01310777|20560344|P3|STARTED|Overall Study||175
8340245|NCT01310777|20560345|P2|STARTED|Overall Study||192
8340246|NCT01310777|20560346|P1|STARTED|Overall Study||193
8340247|NCT01310699|20560356|P2|NOT COMPLETED|Overall Study||6
8340248|NCT01310699|20560357|P1|NOT COMPLETED|Overall Study||4
8340249|NCT01310699|20560356|P2|COMPLETED|Overall Study||143
8340250|NCT01310699|20560357|P1|COMPLETED|Overall Study||128
8340251|NCT01310699|20560356|P2|STARTED|Overall Study||149
8340252|NCT01310699|20560357|P1|STARTED|Overall Study||132
8340253|NCT01310582|20560369|P2|NOT COMPLETED|Overall Study||0
8340254|NCT01310582|20560370|P1|NOT COMPLETED|Overall Study||0
8340255|NCT01310582|20560369|P2|COMPLETED|Overall Study||26
8340256|NCT01310582|20560370|P1|COMPLETED|Overall Study||31
8340257|NCT01310582|20560369|P2|STARTED|Overall Study||26
8340258|NCT01310582|20560370|P1|STARTED|Overall Study||31
8340259|NCT01310413|20560384|P7|NOT COMPLETED|From Day U0 to Day U385||3
8340260|NCT01310413|20560385|P6|NOT COMPLETED|From Day U0 to Day U385||0
8340261|NCT01310413|20560386|P5|NOT COMPLETED|From Day U0 to Day U385||0
8340262|NCT01310413|20560387|P4|NOT COMPLETED|From Day U0 to Day U385||0
8340263|NCT01310413|20560388|P3|NOT COMPLETED|From Day U0 to Day U385||0
8340264|NCT01310413|20560389|P2|NOT COMPLETED|From Day U0 to Day U385||0
8340265|NCT01310413|20560390|P1|NOT COMPLETED|From Day U0 to Day U385||0
8340266|NCT01310413|20560384|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
8340267|NCT01310413|20560385|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340268|NCT01310413|20560386|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340269|NCT01310413|20560387|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340270|NCT01310413|20560388|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340271|NCT01310413|20560389|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340272|NCT01310413|20560390|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340273|NCT01310413|20560384|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
8340274|NCT01310413|20560385|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340275|NCT01310413|20560386|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340276|NCT01310413|20560387|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340277|NCT01310413|20560388|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340278|NCT01310413|20560389|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340279|NCT01310413|20560390|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340280|NCT01310413|20560384|P7|NOT COMPLETED|Day 0 to Day 385||0
8340281|NCT01310413|20560385|P6|NOT COMPLETED|Day 0 to Day 385||3
8340282|NCT01310413|20560386|P5|NOT COMPLETED|Day 0 to Day 385||3
8340283|NCT01310413|20560387|P4|NOT COMPLETED|Day 0 to Day 385||8
8340284|NCT01310413|20560388|P3|NOT COMPLETED|Day 0 to Day 385||7
8340285|NCT01310413|20560389|P2|NOT COMPLETED|Day 0 to Day 385||8
8340286|NCT01310413|20560390|P1|NOT COMPLETED|Day 0 to Day 385||27
8340287|NCT01310413|20560384|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
8340288|NCT01310413|20560385|P6|COMPLETED|Day 0 to Day 385||77
8340289|NCT01310413|20560386|P5|COMPLETED|Day 0 to Day 385||73
8340290|NCT01310413|20560387|P4|COMPLETED|Day 0 to Day 385||67
8340291|NCT01310413|20560388|P3|COMPLETED|Day 0 to Day 385||203
8340292|NCT01310413|20560389|P2|COMPLETED|Day 0 to Day 385||190
8340293|NCT01310413|20560390|P1|COMPLETED|Day 0 to Day 385||172
8340294|NCT01310413|20560384|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
8340295|NCT01310413|20560385|P6|STARTED|Day 0 to Day 385||80
8340296|NCT01310413|20560386|P5|STARTED|Day 0 to Day 385||76
8340297|NCT01310413|20560387|P4|STARTED|Day 0 to Day 385||75
8340298|NCT01310413|20560388|P3|STARTED|Day 0 to Day 385||210
8340299|NCT01310413|20560389|P2|STARTED|Day 0 to Day 385||198
8340300|NCT01310413|20560390|P1|STARTED|Day 0 to Day 385||199
8340301|NCT01310400|20560546|P3|NOT COMPLETED|Overall Study||30
8340302|NCT01310400|20560547|P2|NOT COMPLETED|Overall Study||32
8340303|NCT01310400|20560548|P1|NOT COMPLETED|Overall Study||28
8340304|NCT01310400|20560546|P3|COMPLETED|Overall Study||422
8340305|NCT01310400|20560547|P2|COMPLETED|Overall Study||420
8340306|NCT01310400|20560548|P1|COMPLETED|Overall Study||424
8340307|NCT01310400|20560546|P3|STARTED|Overall Study||452
8340308|NCT01310400|20560547|P2|STARTED|Overall Study||452
8340309|NCT01310400|20560548|P1|STARTED|Overall Study||452
8340310|NCT01310179|20560565|P1|NOT COMPLETED|Overall Study||0
8340311|NCT01310179|20560565|P1|COMPLETED|Overall Study||12
8340312|NCT01310179|20560565|P1|STARTED|Overall Study||12
8340313|NCT01310127|20560572|P2|NOT COMPLETED|Overall Study||1
8340314|NCT01310127|20560573|P1|NOT COMPLETED|Overall Study||2
8340315|NCT01310127|20560572|P2|COMPLETED|Overall Study||10
8340316|NCT01310127|20560573|P1|COMPLETED|Overall Study||10
8340317|NCT01310127|20560572|P2|STARTED|Overall Study||11
8340318|NCT01310127|20560573|P1|STARTED|Overall Study||12
8340319|NCT01310075|20560587|P2|NOT COMPLETED|Overall Study||10
8340320|NCT01310075|20560588|P1|NOT COMPLETED|Overall Study||14
8340321|NCT01310075|20560587|P2|COMPLETED|Overall Study||35
8340322|NCT01310075|20560588|P1|COMPLETED|Overall Study||31
8340323|NCT01310075|20560587|P2|STARTED|Overall Study||45
8340324|NCT01310075|20560588|P1|STARTED|Overall Study||45
8340325|NCT01310036|20560594|P1|NOT COMPLETED|Overall Study||202
8340326|NCT01310036|20560594|P1|COMPLETED|Overall Study||6
8340327|NCT01310036|20560594|P1|STARTED|Overall Study||208
8340328|NCT01309997|20560607|P2|NOT COMPLETED|Overall Study||6
8340329|NCT01309997|20560608|P1|NOT COMPLETED|Overall Study||5
8340330|NCT01309997|20560607|P2|COMPLETED|Overall Study||31
8340331|NCT01309997|20560608|P1|COMPLETED|Overall Study||30
8340332|NCT01309997|20560607|P2|Crossed Over to Second Arm|Overall Study||23
8340333|NCT01309997|20560608|P1|Crossed Over to Second Arm|Overall Study||19
8340334|NCT01309997|20560607|P2|Remained on First Arm Only|Overall Study||14
8340335|NCT01309997|20560608|P1|Remained on First Arm Only|Overall Study||16
8340336|NCT01309997|20560607|P2|STARTED|Overall Study||37
8340337|NCT01309997|20560608|P1|STARTED|Overall Study||35
8340338|NCT01309919|20560632|P2|NOT COMPLETED|Overall Study||48
8340339|NCT01309919|20560633|P1|NOT COMPLETED|Overall Study||17
8340340|NCT01309919|20560632|P2|COMPLETED|Overall Study||27
8340341|NCT01309919|20560633|P1|COMPLETED|Overall Study||58
8340342|NCT01309919|20560632|P2|STARTED|Overall Study||75
8340343|NCT01309919|20560633|P1|STARTED|Overall Study||75
8340344|NCT01309906|20560645|P2|NOT COMPLETED|Overall Study||1
8340345|NCT01309906|20560646|P1|NOT COMPLETED|Overall Study||1
8340346|NCT01309906|20560645|P2|COMPLETED|Overall Study||32
8340347|NCT01309906|20560646|P1|COMPLETED|Overall Study||32
8340348|NCT01309906|20560645|P2|STARTED|Overall Study||33
8340349|NCT01309906|20560646|P1|STARTED|Overall Study||33
8340350|NCT01309893|20560656|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
8340351|NCT01309893|20560657|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
8340352|NCT01309893|20560656|P2|COMPLETED|Week 2 - Crossover Intervention||32
8340353|NCT01309893|20560657|P1|COMPLETED|Week 2 - Crossover Intervention||32
8340354|NCT01309893|20560656|P2|STARTED|Week 2 - Crossover Intervention||33
8340355|NCT01309893|20560657|P1|STARTED|Week 2 - Crossover Intervention||33
8340356|NCT01309893|20560656|P2|NOT COMPLETED|Week 1 - First Intervention||0
8340357|NCT01309893|20560657|P1|NOT COMPLETED|Week 1 - First Intervention||0
8340358|NCT01309893|20560656|P2|COMPLETED|Week 1 - First Intervention||33
8340359|NCT01309893|20560657|P1|COMPLETED|Week 1 - First Intervention||33
8340360|NCT01309893|20560656|P2|STARTED|Week 1 - First Intervention||33
8340361|NCT01309893|20560657|P1|STARTED|Week 1 - First Intervention||33
8340362|NCT01309880|20560667|P2|NOT COMPLETED|Overall Study||0
8340363|NCT01309880|20560668|P1|NOT COMPLETED|Overall Study||0
8340364|NCT01309880|20560667|P2|COMPLETED|Overall Study||33
8340365|NCT01309880|20560668|P1|COMPLETED|Overall Study||33
8340366|NCT01309880|20560667|P2|STARTED|Overall Study||33
8340367|NCT01309880|20560668|P1|STARTED|Overall Study||33
8340368|NCT01309867|20560678|P2|NOT COMPLETED|Overall Study||12
8340369|NCT01309867|20560679|P1|NOT COMPLETED|Overall Study||3
8340370|NCT01309867|20560678|P2|COMPLETED|Overall Study||139
8340371|NCT01309867|20560679|P1|COMPLETED|Overall Study||148
8340372|NCT01309867|20560678|P2|STARTED|Overall Study||151
8340373|NCT01309867|20560679|P1|STARTED|Overall Study||151
8340374|NCT01309841|20560694|P3|NOT COMPLETED|Overall Study||37
8340375|NCT01309841|20560695|P2|NOT COMPLETED|Overall Study||41
8340376|NCT01309841|20560696|P1|NOT COMPLETED|Overall Study||39
8340377|NCT01309841|20560694|P3|COMPLETED|Overall Study||180
8340378|NCT01309841|20560695|P2|COMPLETED|Overall Study||177
8340379|NCT01309841|20560696|P1|COMPLETED|Overall Study||178
8340380|NCT01309841|20560694|P3|STARTED|Overall Study||217
8340381|NCT01309841|20560695|P2|STARTED|Overall Study||218
8340382|NCT01309841|20560696|P1|STARTED|Overall Study||217
8340383|NCT01309828|20560736|P2|NOT COMPLETED|Overall Study||16
8340384|NCT01309828|20560737|P1|NOT COMPLETED|Overall Study||16
8340385|NCT01309828|20560736|P2|COMPLETED|Overall Study||60
8340386|NCT01309828|20560737|P1|COMPLETED|Overall Study||61
8340387|NCT01309828|20560736|P2|STARTED|Overall Study||76
8340388|NCT01309828|20560737|P1|STARTED|Overall Study||77
8340389|NCT01309802|20560751|P2|NOT COMPLETED|Overall Study||9
8340390|NCT01309802|20560752|P1|NOT COMPLETED|Overall Study||12
8340391|NCT01309802|20560751|P2|COMPLETED|Overall Study||14
8340392|NCT01309802|20560752|P1|COMPLETED|Overall Study||13
8340393|NCT01309802|20560751|P2|STARTED|Overall Study||23
8340394|NCT01309802|20560752|P1|STARTED|Overall Study||25
8340395|NCT01309737|20560771|P5|NOT COMPLETED|Week 16 to 52||33
8340396|NCT01309737|20560772|P4|NOT COMPLETED|Week 16 to 52||34
8340397|NCT01309737|20560773|P3|NOT COMPLETED|Week 16 to 52||0
8340398|NCT01309737|20560774|P2|NOT COMPLETED|Week 16 to 52||103
8340399|NCT01309737|20560775|P1|NOT COMPLETED|Week 16 to 52||133
8340400|NCT01309737|20560771|P5|COMPLETED|Week 16 to 52||44
8340401|NCT01309737|20560772|P4|COMPLETED|Week 16 to 52||41
8340402|NCT01309737|20560773|P3|COMPLETED|Week 16 to 52||0
8340403|NCT01309737|20560774|P2|COMPLETED|Week 16 to 52||238
8340404|NCT01309737|20560775|P1|COMPLETED|Week 16 to 52||198
8340405|NCT01309737|20560771|P5|STARTED|Week 16 to 52||77
8340406|NCT01309737|20560772|P4|STARTED|Week 16 to 52||75
8340407|NCT01309737|20560773|P3|STARTED|Week 16 to 52||0
8340408|NCT01309737|20560774|P2|STARTED|Week 16 to 52||341
8340409|NCT01309737|20560775|P1|STARTED|Week 16 to 52||331
8340410|NCT01309737|20560771|P5|NOT COMPLETED|Week 0 to 16||0
8340411|NCT01309737|20560772|P4|NOT COMPLETED|Week 0 to 16||0
8340412|NCT01309737|20560773|P3|NOT COMPLETED|Week 0 to 16||44
8340413|NCT01309737|20560774|P2|NOT COMPLETED|Week 0 to 16||40
8340414|NCT01309737|20560775|P1|NOT COMPLETED|Week 0 to 16||52
8340415|NCT01309737|20560771|P5|COMPLETED|Week 0 to 16||0
8340416|NCT01309737|20560772|P4|COMPLETED|Week 0 to 16||0
8340417|NCT01309737|20560773|P3|COMPLETED|Week 0 to 16||152
8340418|NCT01309737|20560774|P2|COMPLETED|Week 0 to 16||341
8340419|NCT01309737|20560775|P1|COMPLETED|Week 0 to 16||331
8340420|NCT01309737|20560771|P5|Treated|Week 0 to 16||0
8340421|NCT01309737|20560772|P4|Treated|Week 0 to 16||0
8340422|NCT01309737|20560773|P3|Treated|Week 0 to 16||196
8340423|NCT01309737|20560774|P2|Treated|Week 0 to 16||381
8340424|NCT01309737|20560775|P1|Treated|Week 0 to 16||382
8340425|NCT01309737|20560771|P5|STARTED|Week 0 to 16||0
8340426|NCT01309737|20560772|P4|STARTED|Week 0 to 16||0
8340427|NCT01309737|20560773|P3|STARTED|Week 0 to 16||196
8340428|NCT01309737|20560774|P2|STARTED|Week 0 to 16||381
8340429|NCT01309737|20560775|P1|STARTED|Week 0 to 16||383
8340430|NCT01309672|20560970|P1|NOT COMPLETED|Overall Study||37
8340431|NCT01309672|20560970|P1|COMPLETED|Overall Study||4
8340432|NCT01309672|20560970|P1|Received Protocol Treatment|Overall Study||40
8340433|NCT01309672|20560970|P1|STARTED|Overall Study||41
8340434|NCT01309659|20560980|P2|NOT COMPLETED|Overall Study||1
8340435|NCT01309659|20560981|P1|NOT COMPLETED|Overall Study||0
8340436|NCT01309659|20560980|P2|COMPLETED|Overall Study||9
8340437|NCT01309659|20560981|P1|COMPLETED|Overall Study||9
8340438|NCT01309659|20560980|P2|STARTED|Overall Study||10
8340439|NCT01309659|20560981|P1|STARTED|Overall Study||9
8340440|NCT01309646|20561023|P2|NOT COMPLETED|Overall Study||0
8340441|NCT01309646|20561024|P1|NOT COMPLETED|Overall Study||0
8340442|NCT01309646|20561023|P2|COMPLETED|Overall Study||227
8340443|NCT01309646|20561024|P1|COMPLETED|Overall Study||224
8340444|NCT01309646|20561023|P2|STARTED|Overall Study||227
8340445|NCT01309646|20561024|P1|STARTED|Overall Study||224
8340446|NCT01309581|20561064|P2|NOT COMPLETED|Overall Study||0
8340447|NCT01309581|20561065|P1|NOT COMPLETED|Overall Study||0
8340448|NCT01309581|20561064|P2|COMPLETED|Overall Study||1
8340449|NCT01309581|20561065|P1|COMPLETED|Overall Study||2
8340450|NCT01309581|20561064|P2|STARTED|Overall Study||1
8340451|NCT01309581|20561065|P1|STARTED|Overall Study||2
8340452|NCT01309451|20561075|P2|NOT COMPLETED|Overall Study||3
8340453|NCT01309451|20561076|P1|NOT COMPLETED|Overall Study||2
8340454|NCT01309451|20561075|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
8340455|NCT01309451|20561076|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
8340456|NCT01309451|20561075|P2|STARTED|Overall Study|unit of measure is number of eyes|21
8340457|NCT01309451|20561076|P1|STARTED|Overall Study|unit of measure is number of eyes|19
8340458|NCT01309386|20561086|P2|NOT COMPLETED|Overall Study||21
8340459|NCT01309386|20561087|P1|NOT COMPLETED|Overall Study||22
8340460|NCT01309386|20561086|P2|COMPLETED|Overall Study||29
8340461|NCT01309386|20561087|P1|COMPLETED|Overall Study||28
8340462|NCT01309386|20561086|P2|STARTED|Overall Study||50
8340463|NCT01309386|20561087|P1|STARTED|Overall Study||50
8340464|NCT01309360|20561108|P3|NOT COMPLETED|Overall Study||0
8340465|NCT01309360|20561109|P2|NOT COMPLETED|Overall Study||0
8340466|NCT01309360|20561110|P1|NOT COMPLETED|Overall Study||0
8340467|NCT01309360|20561108|P3|COMPLETED|Overall Study||40
8340468|NCT01309360|20561109|P2|COMPLETED|Overall Study||40
8340469|NCT01309360|20561110|P1|COMPLETED|Overall Study||40
8340470|NCT01309360|20561108|P3|STARTED|Overall Study||40
8340471|NCT01309360|20561109|P2|STARTED|Overall Study||40
8340472|NCT01309360|20561110|P1|STARTED|Overall Study||40
8340473|NCT01309308|20561135|P2|NOT COMPLETED|Overall Study||4
8340474|NCT01309308|20561136|P1|NOT COMPLETED|Overall Study||6
8340475|NCT01309308|20561135|P2|COMPLETED|Overall Study||71
8340476|NCT01309308|20561136|P1|COMPLETED|Overall Study||69
8340477|NCT01309308|20561135|P2|STARTED|Overall Study||75
8340478|NCT01309308|20561136|P1|STARTED|Overall Study||75
8340479|NCT01309282|20561144|P1|NOT COMPLETED|Overall Study||1
8340480|NCT01309282|20561144|P1|COMPLETED|Overall Study||8
8340481|NCT01309282|20561144|P1|STARTED|Overall Study||9
8340482|NCT01309269|20561161|P1|NOT COMPLETED|Overall Study||840
8340483|NCT01309269|20561161|P1|COMPLETED|Overall Study||245
8340484|NCT01309269|20561161|P1|Treated|Overall Study||978
8340485|NCT01309269|20561161|P1|STARTED|Overall Study||1085
8340486|NCT01309243|20561169|P2|NOT COMPLETED|Extension Phase||0
8340487|NCT01309243|20561170|P1|NOT COMPLETED|Extension Phase||6
8340488|NCT01309243|20561169|P2|COMPLETED|Extension Phase||117
8340489|NCT01309243|20561170|P1|COMPLETED|Extension Phase||34
8340490|NCT01309243|20561169|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
8340491|NCT01309243|20561170|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
8340492|NCT01309243|20561169|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
8340493|NCT01309243|20561170|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
8340494|NCT01309243|20561169|P2|COMPLETED|Randomized Phase Through Week 96||290
8340495|NCT01309243|20561170|P1|COMPLETED|Randomized Phase Through Week 96||316
8340496|NCT01309243|20561169|P2|Randomized and Treated|Randomized Phase Through Week 96||392
8340497|NCT01309243|20561170|P1|Randomized and Treated|Randomized Phase Through Week 96||394
8340498|NCT01309243|20561169|P2|STARTED|Randomized Phase Through Week 96||399
8340499|NCT01309243|20561170|P1|STARTED|Randomized Phase Through Week 96||400
8340500|NCT01309204|20561196|P2|NOT COMPLETED|Overall Study||75
8340501|NCT01309204|20561197|P1|NOT COMPLETED|Overall Study||67
8340502|NCT01309204|20561196|P2|COMPLETED|Overall Study||361
8340503|NCT01309204|20561197|P1|COMPLETED|Overall Study||385
8340504|NCT01309204|20561196|P2|STARTED|Overall Study||436
8340505|NCT01309204|20561197|P1|STARTED|Overall Study||452
8340506|NCT01309165|20561205|P2|NOT COMPLETED|Overall Study||7
8340507|NCT01309165|20561206|P1|NOT COMPLETED|Overall Study||6
8340508|NCT01309165|20561205|P2|COMPLETED|Overall Study||9
8340509|NCT01309165|20561206|P1|COMPLETED|Overall Study||13
8340510|NCT01309165|20561205|P2|Included in Primary Analysis|Overall Study||12
8340511|NCT01309165|20561206|P1|Included in Primary Analysis|Overall Study||14
8340512|NCT01309165|20561205|P2|Received Allocated Intervention|Overall Study||14
8340513|NCT01309165|20561206|P1|Received Allocated Intervention|Overall Study||16
8340514|NCT01309165|20561205|P2|STARTED|Overall Study||16
8340515|NCT01309165|20561206|P1|STARTED|Overall Study||19
8340516|NCT01309100|20561218|P1|NOT COMPLETED|Overall Study||2
8340517|NCT01309100|20561218|P1|COMPLETED|Overall Study||142
8340518|NCT01309100|20561218|P1|STARTED|Overall Study||144
8340519|NCT01308918|20561229|P1|NOT COMPLETED|Overall Study||0
8340520|NCT01308918|20561229|P1|COMPLETED|Overall Study||50
8340521|NCT01308918|20561229|P1|STARTED|Overall Study||50
8340522|NCT01308853|20561236|P1|NOT COMPLETED|Overall Study||4
8340523|NCT01308853|20561236|P1|COMPLETED|Overall Study||20
8340524|NCT01308853|20561236|P1|STARTED|Overall Study||24
8340525|NCT01308840|20561241|P1|NOT COMPLETED|Overall Study||0
8340526|NCT01308840|20561241|P1|COMPLETED|Overall Study||31
8340527|NCT01308840|20561241|P1|STARTED|Overall Study||31
8340528|NCT01308814|20561250|P2|NOT COMPLETED|Overall Study||23
8340529|NCT01308814|20561251|P1|NOT COMPLETED|Overall Study||17
8340530|NCT01308814|20561250|P2|COMPLETED|Overall Study||63
8340531|NCT01308814|20561251|P1|COMPLETED|Overall Study||69
8340532|NCT01308814|20561250|P2|STARTED|Overall Study||86
8340533|NCT01308814|20561251|P1|STARTED|Overall Study||86
8340534|NCT01308788|20561271|P2|NOT COMPLETED|2-year Treatment||11
8340535|NCT01308788|20561272|P1|NOT COMPLETED|2-year Treatment||4
8340536|NCT01308788|20561271|P2|COMPLETED|2-year Treatment||10
8340537|NCT01308788|20561272|P1|COMPLETED|2-year Treatment||10
8340538|NCT01308788|20561271|P2|STARTED|2-year Treatment||21
8340539|NCT01308788|20561272|P1|STARTED|2-year Treatment||14
8340540|NCT01308788|20561271|P2|NOT COMPLETED|6-month Treatment||0
8340541|NCT01308788|20561272|P1|NOT COMPLETED|6-month Treatment||0
8340542|NCT01308788|20561271|P2|COMPLETED|6-month Treatment||21
8340543|NCT01308788|20561272|P1|COMPLETED|6-month Treatment||14
8340544|NCT01308788|20561271|P2|STARTED|6-month Treatment||21
8340545|NCT01308788|20561272|P1|STARTED|6-month Treatment||14
8340546|NCT01308762|20561307|P3|NOT COMPLETED|Overall Study||0
8340547|NCT01308762|20561308|P2|NOT COMPLETED|Overall Study||1
8340548|NCT01308762|20561309|P1|NOT COMPLETED|Overall Study||0
8340549|NCT01308762|20561307|P3|COMPLETED|Overall Study||6
8340550|NCT01308762|20561308|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
8340551|NCT01308762|20561309|P1|COMPLETED|Overall Study||6
8340552|NCT01308762|20561307|P3|STARTED|Overall Study||6
8340553|NCT01308762|20561308|P2|STARTED|Overall Study||7
8340554|NCT01308762|20561309|P1|STARTED|Overall Study||6
8340555|NCT01308749|20561322|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
8340556|NCT01308749|20561323|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
8340557|NCT01308749|20561322|P2|COMPLETED|Period 2: Open Label Treatment||11
8340558|NCT01308749|20561323|P1|COMPLETED|Period 2: Open Label Treatment||11
8340559|NCT01308749|20561322|P2|STARTED|Period 2: Open Label Treatment||13
8340560|NCT01308749|20561323|P1|STARTED|Period 2: Open Label Treatment||11
8340561|NCT01308749|20561322|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
8340562|NCT01308749|20561323|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
8340563|NCT01308749|20561322|P2|COMPLETED|Period 1: Double Blind Treatment||13
8340564|NCT01308749|20561323|P1|COMPLETED|Period 1: Double Blind Treatment||11
8340565|NCT01308749|20561322|P2|STARTED|Period 1: Double Blind Treatment||13
8340566|NCT01308749|20561323|P1|STARTED|Period 1: Double Blind Treatment||12
8340567|NCT01308736|20561353|P2|NOT COMPLETED|Overall Study||5
8340568|NCT01308736|20561354|P1|NOT COMPLETED|Overall Study||6
8340569|NCT01308736|20561353|P2|COMPLETED|Overall Study||27
8340570|NCT01308736|20561354|P1|COMPLETED|Overall Study||25
8340571|NCT01308736|20561353|P2|STARTED|Overall Study||32
8340572|NCT01308736|20561354|P1|STARTED|Overall Study||31
8340573|NCT01308619|20561362|P2|NOT COMPLETED|Overall Study||3
8340574|NCT01308619|20561363|P1|NOT COMPLETED|Overall Study||7
8340575|NCT01308619|20561362|P2|COMPLETED|Overall Study||83
8340576|NCT01308619|20561363|P1|COMPLETED|Overall Study||77
8340577|NCT01308619|20561362|P2|STARTED|Overall Study||86
8340578|NCT01308619|20561363|P1|STARTED|Overall Study||84
8340579|NCT01308580|20561377|P2|NOT COMPLETED|Overall Study||7
8340580|NCT01308580|20561378|P1|NOT COMPLETED|Overall Study||12
8340581|NCT01308580|20561377|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
8340582|NCT01308580|20561378|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
8340583|NCT01308580|20561377|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
8340584|NCT01308580|20561378|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
8340585|NCT01308580|20561377|P2|STARTED|Overall Study||602
8340586|NCT01308580|20561378|P1|STARTED|Overall Study||598
8340587|NCT01308567|20561421|P3|NOT COMPLETED|Overall Study||4
8340588|NCT01308567|20561422|P2|NOT COMPLETED|Overall Study||4
8340589|NCT01308567|20561423|P1|NOT COMPLETED|Overall Study||2
8340590|NCT01308567|20561421|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
8340591|NCT01308567|20561422|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
8340592|NCT01308567|20561423|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
8340593|NCT01308567|20561421|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
8340594|NCT01308567|20561422|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
8340595|NCT01308567|20561423|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
8340596|NCT01308567|20561421|P3|STARTED|Overall Study|Randomized|388
8340597|NCT01308567|20561422|P2|STARTED|Overall Study|Randomized|389
8340598|NCT01308567|20561423|P1|STARTED|Overall Study|Randomized|391
8340599|NCT01308476|20561463|P2|NOT COMPLETED|Overall Study||2
8340600|NCT01308476|20561464|P1|NOT COMPLETED|Overall Study||3
8340601|NCT01308476|20561463|P2|COMPLETED|Overall Study||45
8340602|NCT01308476|20561464|P1|COMPLETED|Overall Study||45
8340603|NCT01308476|20561463|P2|STARTED|Overall Study|Entered and treated.|47
8340604|NCT01308476|20561464|P1|STARTED|Overall Study|Entered and treated.|48
8340605|NCT01308463|20561484|P1|NOT COMPLETED|Overall Study||29
8340606|NCT01308463|20561484|P1|COMPLETED|Overall Study||0
8340607|NCT01308463|20561484|P1|12 Years|Overall Study||2
8340608|NCT01308463|20561484|P1|11 Years|Overall Study||8
8340609|NCT01308463|20561484|P1|10 Years|Overall Study||8
8340610|NCT01308463|20561484|P1|9 Years|Overall Study||11
8340611|NCT01308463|20561484|P1|8 Years|Overall Study||14
8340612|NCT01308463|20561484|P1|7 Years|Overall Study||12
8340613|NCT01308463|20561484|P1|6 Years|Overall Study||11
8340614|NCT01308463|20561484|P1|5 Years|Overall Study||20
8340615|NCT01308463|20561484|P1|4 Years|Overall Study||20
8340616|NCT01308463|20561484|P1|3 Years|Overall Study||17
8340617|NCT01308463|20561484|P1|2 Years|Overall Study||18
8340618|NCT01308463|20561484|P1|1 Year|Overall Study||21
8340619|NCT01308463|20561484|P1|6 Months|Overall Study||23
8340620|NCT01308463|20561484|P1|STARTED|Overall Study||29
8340621|NCT01308450|20561491|P1|NOT COMPLETED|Overall Study||2
8340622|NCT01308450|20561491|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
8340623|NCT01308450|20561491|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
8340624|NCT01308424|20561497|P3|NOT COMPLETED|Randomization||2
8340625|NCT01308424|20561498|P2|NOT COMPLETED|Randomization||3
8340626|NCT01308424|20561499|P1|NOT COMPLETED|Randomization||0
8340627|NCT01308424|20561497|P3|COMPLETED|Randomization||82
8340628|NCT01308424|20561498|P2|COMPLETED|Randomization||84
8340629|NCT01308424|20561499|P1|COMPLETED|Randomization||0
8340630|NCT01308424|20561497|P3|STARTED|Randomization||84
8340631|NCT01308424|20561498|P2|STARTED|Randomization||87
8340632|NCT01308424|20561499|P1|STARTED|Randomization||0
8340633|NCT01308424|20561497|P3|NOT COMPLETED|Baseline Eligibility||0
8340634|NCT01308424|20561498|P2|NOT COMPLETED|Baseline Eligibility||0
8340635|NCT01308424|20561499|P1|NOT COMPLETED|Baseline Eligibility||71
8340636|NCT01308424|20561497|P3|COMPLETED|Baseline Eligibility||0
8340637|NCT01308424|20561498|P2|COMPLETED|Baseline Eligibility||0
8340638|NCT01308424|20561499|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
8340639|NCT01308424|20561497|P3|STARTED|Baseline Eligibility||0
8340640|NCT01308424|20561498|P2|STARTED|Baseline Eligibility||0
8340641|NCT01308424|20561499|P1|STARTED|Baseline Eligibility||242
8340642|NCT01308294|20561509|P3|NOT COMPLETED|Cycle 3||0
8340643|NCT01308294|20561510|P2|NOT COMPLETED|Cycle 3||1
8340644|NCT01308294|20561511|P1|NOT COMPLETED|Cycle 3||0
8340645|NCT01308294|20561509|P3|COMPLETED|Cycle 3||0
8340646|NCT01308294|20561510|P2|COMPLETED|Cycle 3||4
8340647|NCT01308294|20561511|P1|COMPLETED|Cycle 3||10
8340648|NCT01308294|20561509|P3|STARTED|Cycle 3||0
8340649|NCT01308294|20561510|P2|STARTED|Cycle 3||5
8340650|NCT01308294|20561511|P1|STARTED|Cycle 3||10
8340651|NCT01308294|20561509|P3|NOT COMPLETED|Cycle 2||0
8340652|NCT01308294|20561510|P2|NOT COMPLETED|Cycle 2||1
8340653|NCT01308294|20561511|P1|NOT COMPLETED|Cycle 2||0
8340654|NCT01308294|20561509|P3|COMPLETED|Cycle 2||0
8340655|NCT01308294|20561510|P2|COMPLETED|Cycle 2||5
8340656|NCT01308294|20561511|P1|COMPLETED|Cycle 2||10
8340657|NCT01308294|20561509|P3|STARTED|Cycle 2||0
8340658|NCT01308294|20561510|P2|STARTED|Cycle 2||6
8340659|NCT01308294|20561511|P1|STARTED|Cycle 2||10
8340660|NCT01308294|20561509|P3|NOT COMPLETED|Cycle 1||0
8340661|NCT01308294|20561510|P2|NOT COMPLETED|Cycle 1||0
8340662|NCT01308294|20561511|P1|NOT COMPLETED|Cycle 1||0
8340663|NCT01308294|20561509|P3|COMPLETED|Cycle 1||0
8340664|NCT01308294|20561510|P2|COMPLETED|Cycle 1||6
8340665|NCT01308294|20561511|P1|COMPLETED|Cycle 1||10
8340666|NCT01308294|20561509|P3|STARTED|Cycle 1||0
8340667|NCT01308294|20561510|P2|STARTED|Cycle 1||6
8340668|NCT01308294|20561511|P1|STARTED|Cycle 1||10
8340669|NCT01308060|20561539|P2|NOT COMPLETED|Part B||8
8340670|NCT01308060|20561540|P1|NOT COMPLETED|Part B||19
8340671|NCT01308060|20561539|P2|COMPLETED|Part B||69
8340672|NCT01308060|20561540|P1|COMPLETED|Part B||219
8340673|NCT01308060|20561539|P2|STARTED|Part B||77
8340674|NCT01308060|20561540|P1|STARTED|Part B||238
8340675|NCT01308060|20561539|P2|NOT COMPLETED|Part A||6
8340676|NCT01308060|20561540|P1|NOT COMPLETED|Part A||14
8340677|NCT01308060|20561539|P2|COMPLETED|Part A||77
8340678|NCT01308060|20561540|P1|COMPLETED|Part A||238
8340679|NCT01308060|20561539|P2|STARTED|Part A||83
8340680|NCT01308060|20561540|P1|STARTED|Part A||252
8340681|NCT01308008|20561551|P2|NOT COMPLETED|12 Months||4
8340682|NCT01308008|20561552|P1|NOT COMPLETED|12 Months||8
8340683|NCT01308008|20561551|P2|COMPLETED|12 Months||58
8340684|NCT01308008|20561552|P1|COMPLETED|12 Months||46
8340685|NCT01308008|20561551|P2|STARTED|12 Months||62
8340686|NCT01308008|20561552|P1|STARTED|12 Months||54
8340687|NCT01308008|20561551|P2|NOT COMPLETED|6 Months||9
8340688|NCT01308008|20561552|P1|NOT COMPLETED|6 Months||8
8340689|NCT01308008|20561551|P2|COMPLETED|6 Months||62
8340690|NCT01308008|20561552|P1|COMPLETED|6 Months||54
8340691|NCT01308008|20561551|P2|STARTED|6 Months||71
8340692|NCT01308008|20561552|P1|STARTED|6 Months||62
8340693|NCT01308008|20561551|P2|NOT COMPLETED|4 Weeks||2
8340694|NCT01308008|20561552|P1|NOT COMPLETED|4 Weeks||9
8340695|NCT01308008|20561551|P2|COMPLETED|4 Weeks||71
8340696|NCT01308008|20561552|P1|COMPLETED|4 Weeks||62
8340697|NCT01308008|20561551|P2|STARTED|4 Weeks||73
8340698|NCT01308008|20561552|P1|STARTED|4 Weeks||71
8340699|NCT01307956|20561562|P1|NOT COMPLETED|Overall Study||0
8340700|NCT01307956|20561562|P1|COMPLETED|Overall Study||11
8340701|NCT01307956|20561562|P1|STARTED|Overall Study||11
8340702|NCT01307930|20561569|P1|NOT COMPLETED|Overall Study||2
8340703|NCT01307930|20561569|P1|COMPLETED|Overall Study||18
8340704|NCT01307930|20561569|P1|STARTED|Overall Study||20
8340705|NCT01307891|20561575|P2|NOT COMPLETED|Overall Study||1
8340706|NCT01307891|20561576|P1|NOT COMPLETED|Overall Study||3
8340707|NCT01307891|20561575|P2|COMPLETED|Overall Study||21
8340708|NCT01307891|20561576|P1|COMPLETED|Overall Study||39
8340709|NCT01307891|20561575|P2|STARTED|Overall Study||22
8340710|NCT01307891|20561576|P1|STARTED|Overall Study||42
8340711|NCT01307787|20561588|P2|NOT COMPLETED|Overall Study||0
8340712|NCT01307787|20561589|P1|NOT COMPLETED|Overall Study||2
8340713|NCT01307787|20561588|P2|COMPLETED|Overall Study||15
8340714|NCT01307787|20561589|P1|COMPLETED|Overall Study||17
8340715|NCT01307787|20561588|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
8340716|NCT01307787|20561589|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
8340717|NCT01307787|20561588|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
8340718|NCT01307787|20561589|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
8340719|NCT01307787|20561588|P2|STARTED|Overall Study||15
8340720|NCT01307787|20561589|P1|STARTED|Overall Study||19
8340721|NCT01307748|20561612|P3|NOT COMPLETED|Overall Study||0
8340722|NCT01307748|20561613|P2|NOT COMPLETED|Overall Study||0
8340723|NCT01307748|20561614|P1|NOT COMPLETED|Overall Study||0
8340724|NCT01307748|20561612|P3|COMPLETED|Overall Study||30
8340725|NCT01307748|20561613|P2|COMPLETED|Overall Study||31
8340726|NCT01307748|20561614|P1|COMPLETED|Overall Study||31
8340727|NCT01307748|20561612|P3|STARTED|Overall Study||30
8340728|NCT01307748|20561613|P2|STARTED|Overall Study||31
8340729|NCT01307748|20561614|P1|STARTED|Overall Study||31
8340730|NCT01307631|20561628|P2|NOT COMPLETED|Overall Study||0
8340731|NCT01307631|20561629|P1|NOT COMPLETED|Overall Study||0
8340732|NCT01307631|20561628|P2|COMPLETED|Overall Study||28
8340733|NCT01307631|20561629|P1|COMPLETED|Overall Study||9
8340734|NCT01307631|20561628|P2|STARTED|Overall Study||28
8340735|NCT01307631|20561629|P1|STARTED|Overall Study||9
8340736|NCT01307618|20561639|P2|NOT COMPLETED|Overall Study||0
8340737|NCT01307618|20561640|P1|NOT COMPLETED|Overall Study||0
8340738|NCT01307618|20561639|P2|COMPLETED|Overall Study||5
8340739|NCT01307618|20561640|P1|COMPLETED|Overall Study||5
8340740|NCT01307618|20561639|P2|STARTED|Overall Study||5
8340741|NCT01307618|20561640|P1|STARTED|Overall Study||5
8340742|NCT01307579|20561658|P2|NOT COMPLETED|Overall Study||145
8340743|NCT01307579|20561659|P1|NOT COMPLETED|Overall Study||140
8340744|NCT01307579|20561658|P2|COMPLETED|Overall Study||115
8340745|NCT01307579|20561659|P1|COMPLETED|Overall Study||117
8340746|NCT01307579|20561658|P2|STARTED|Overall Study||260
8340747|NCT01307579|20561659|P1|STARTED|Overall Study||257
8340748|NCT01307501|20561671|P1|NOT COMPLETED|Overall Study||23
8340749|NCT01307501|20561671|P1|COMPLETED|Overall Study||17
8340750|NCT01307501|20561671|P1|Intent-to-Treat (ITT) Population|Overall Study||40
8340751|NCT01307501|20561671|P1|STARTED|Overall Study||40
8340752|NCT01307462|20561684|P1|NOT COMPLETED|Overall Study||1
8340753|NCT01307462|20561684|P1|COMPLETED|Overall Study||35
8340754|NCT01307462|20561684|P1|STARTED|Overall Study||36
8340755|NCT01307449|20561701|P4|NOT COMPLETED|Overall Study||0
8340756|NCT01307449|20561702|P3|NOT COMPLETED|Overall Study||0
8340757|NCT01307449|20561703|P2|NOT COMPLETED|Overall Study||0
8340758|NCT01307449|20561704|P1|NOT COMPLETED|Overall Study||1
8340759|NCT01307449|20561701|P4|COMPLETED|Overall Study||11
8340760|NCT01307449|20561702|P3|COMPLETED|Overall Study||11
8340761|NCT01307449|20561703|P2|COMPLETED|Overall Study||33
8340762|NCT01307449|20561704|P1|COMPLETED|Overall Study||32
8340763|NCT01307449|20561701|P4|STARTED|Overall Study||11
8340764|NCT01307449|20561702|P3|STARTED|Overall Study||11
8340765|NCT01307449|20561703|P2|STARTED|Overall Study||33
8340766|NCT01307449|20561704|P1|STARTED|Overall Study||33
8340767|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
8340768|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
8340769|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340770|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340771|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340772|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340773|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
8340774|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
8340775|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340776|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
8340777|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
8340778|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
8340779|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
8340780|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
8340781|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
8340782|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
8340783|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
8340784|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
8340785|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 5)||44
8340786|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 5)||38
8340787|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 5)||0
8340788|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 5)||0
8340789|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 5)||0
8340790|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 5)||0
8340791|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 5)||86
8340792|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 5)||81
8340793|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 5)||0
8340794|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
8340795|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
8340796|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340797|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340798|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340799|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340800|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
8340801|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
8340802|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340803|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
8340804|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
8340805|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
8340806|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
8340807|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
8340808|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
8340809|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
8340810|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
8340811|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
8340812|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 4)||49
8340813|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 4)||40
8340814|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 4)||0
8340815|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 4)||0
8340816|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 4)||0
8340817|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 4)||0
8340818|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 4)||91
8340819|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
8340820|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 4)||0
8340821|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8340822|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
8340823|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340824|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340825|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340826|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340827|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
8340828|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
8340829|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340830|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
8340831|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
8340832|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
8340833|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
8340834|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
8340835|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
8340836|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
8340837|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
8340838|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
8340839|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 3)||60
8340840|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 3)||48
8340841|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 3)||0
8340842|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 3)||0
8340843|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 3)||0
8340844|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 3)||0
8340845|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 3)||109
8340846|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 3)||99
8340847|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 3)||0
8340848|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
8340849|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
8340850|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340851|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340852|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340853|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340854|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
8340855|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
8340856|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340857|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
8340858|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
8340859|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
8340860|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
8340861|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
8340862|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
8340863|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
8340864|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
8340865|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
8340866|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
8340867|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
8340868|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 2)||0
8340869|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 2)||0
8340870|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 2)||0
8340871|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 2)||0
8340872|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
8340873|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
8340874|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 2)||0
8340875|NCT01307423|20561737|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8340876|NCT01307423|20561738|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8340877|NCT01307423|20561739|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
8340878|NCT01307423|20561740|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
8340879|NCT01307423|20561741|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
8340880|NCT01307423|20561742|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
8340881|NCT01307423|20561743|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
8340882|NCT01307423|20561744|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
8340883|NCT01307423|20561745|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8340884|NCT01307423|20561737|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
8340885|NCT01307423|20561738|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
8340886|NCT01307423|20561739|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
8340887|NCT01307423|20561740|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
8340888|NCT01307423|20561741|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
8340889|NCT01307423|20561742|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
8340890|NCT01307423|20561743|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
8340891|NCT01307423|20561744|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
8340892|NCT01307423|20561745|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
8340893|NCT01307423|20561737|P9|STARTED|Active Treatment Phase (Week 25-52)||0
8340894|NCT01307423|20561738|P8|STARTED|Active Treatment Phase (Week 25-52)||0
8340895|NCT01307423|20561739|P7|STARTED|Active Treatment Phase (Week 25-52)||26
8340896|NCT01307423|20561740|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
8340897|NCT01307423|20561741|P5|STARTED|Active Treatment Phase (Week 25-52)||26
8340898|NCT01307423|20561742|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
8340899|NCT01307423|20561743|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
8340900|NCT01307423|20561744|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
8340901|NCT01307423|20561745|P1|STARTED|Active Treatment Phase (Week 25-52)||0
8340902|NCT01307423|20561737|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340903|NCT01307423|20561738|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340904|NCT01307423|20561739|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340905|NCT01307423|20561740|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340906|NCT01307423|20561741|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340907|NCT01307423|20561742|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340908|NCT01307423|20561743|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8340909|NCT01307423|20561744|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
8340910|NCT01307423|20561745|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
8340911|NCT01307423|20561737|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340912|NCT01307423|20561738|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340913|NCT01307423|20561739|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340914|NCT01307423|20561740|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340915|NCT01307423|20561741|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340916|NCT01307423|20561742|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340917|NCT01307423|20561743|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
8340918|NCT01307423|20561744|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
8340919|NCT01307423|20561745|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
8340920|NCT01307423|20561737|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340921|NCT01307423|20561738|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340922|NCT01307423|20561739|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340923|NCT01307423|20561740|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340924|NCT01307423|20561741|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340925|NCT01307423|20561742|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340926|NCT01307423|20561743|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
8340927|NCT01307423|20561744|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
8340928|NCT01307423|20561745|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
8340929|NCT01307423|20561737|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340930|NCT01307423|20561738|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340931|NCT01307423|20561739|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340932|NCT01307423|20561740|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340933|NCT01307423|20561741|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340934|NCT01307423|20561742|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340935|NCT01307423|20561743|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
8340936|NCT01307423|20561744|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
8340937|NCT01307423|20561745|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
8340938|NCT01307423|20561737|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340939|NCT01307423|20561738|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340940|NCT01307423|20561739|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340941|NCT01307423|20561740|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340942|NCT01307423|20561741|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340943|NCT01307423|20561742|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340944|NCT01307423|20561743|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
8340945|NCT01307423|20561744|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
8340946|NCT01307423|20561745|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
8340947|NCT01307423|20561737|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340948|NCT01307423|20561738|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340949|NCT01307423|20561739|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340950|NCT01307423|20561740|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340951|NCT01307423|20561741|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340952|NCT01307423|20561742|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340953|NCT01307423|20561743|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
8340954|NCT01307423|20561744|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
8340955|NCT01307423|20561745|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
8340956|NCT01307397|20561929|P1|NOT COMPLETED|Overall Study||0
8340957|NCT01307397|20561929|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
8340958|NCT01307397|20561929|P1|STARTED|Overall Study||3219
8340959|NCT01307319|20561951|P3|NOT COMPLETED|Overall Study||7
8340960|NCT01307319|20561952|P2|NOT COMPLETED|Overall Study||8
8340961|NCT01307319|20561953|P1|NOT COMPLETED|Overall Study||4
8340962|NCT01307319|20561951|P3|COMPLETED|Overall Study||227
8340963|NCT01307319|20561952|P2|COMPLETED|Overall Study||234
8340964|NCT01307319|20561953|P1|COMPLETED|Overall Study||235
8340965|NCT01307319|20561951|P3|ITT Population|Overall Study||234
8340966|NCT01307319|20561952|P2|ITT Population|Overall Study||241
8340967|NCT01307319|20561953|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
8340968|NCT01307319|20561951|P3|Safety Population|Overall Study||234
8340969|NCT01307319|20561952|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
8340970|NCT01307319|20561953|P1|Safety Population|Overall Study||239
8340971|NCT01307319|20561951|P3|STARTED|Overall Study|Randomized|234
8340972|NCT01307319|20561952|P2|STARTED|Overall Study|Randomized|242
8340973|NCT01307319|20561953|P1|STARTED|Overall Study|Randomized|239
8340974|NCT01307267|20561987|P23|NOT COMPLETED|Overall Study||4
8340975|NCT01307267|20561988|P22|NOT COMPLETED|Overall Study||5
8340976|NCT01307267|20561989|P21|NOT COMPLETED|Overall Study||3
8340977|NCT01307267|20561990|P20|NOT COMPLETED|Overall Study||32
8340978|NCT01307267|20561991|P19|NOT COMPLETED|Overall Study||2
8340979|NCT01307267|20561992|P18|NOT COMPLETED|Overall Study||1
8340980|NCT01307267|20561993|P17|NOT COMPLETED|Overall Study||1
8340981|NCT01307267|20561994|P16|NOT COMPLETED|Overall Study||1
8340982|NCT01307267|20561995|P15|NOT COMPLETED|Overall Study||2
8340983|NCT01307267|20561996|P14|NOT COMPLETED|Overall Study||0
8340984|NCT01307267|20561997|P13|NOT COMPLETED|Overall Study||1
8340985|NCT01307267|20561998|P12|NOT COMPLETED|Overall Study||11
8340986|NCT01307267|20561999|P11|NOT COMPLETED|Overall Study||6
8340987|NCT01307267|20562000|P10|NOT COMPLETED|Overall Study||5
8340988|NCT01307267|20562001|P9|NOT COMPLETED|Overall Study||30
8340989|NCT01307267|20562002|P8|NOT COMPLETED|Overall Study||4
8340990|NCT01307267|20562003|P7|NOT COMPLETED|Overall Study||2
8340991|NCT01307267|20562004|P6|NOT COMPLETED|Overall Study||41
8340992|NCT01307267|20562005|P5|NOT COMPLETED|Overall Study||1
8340993|NCT01307267|20562006|P4|NOT COMPLETED|Overall Study||3
8340994|NCT01307267|20562007|P3|NOT COMPLETED|Overall Study||5
8340995|NCT01307267|20562008|P2|NOT COMPLETED|Overall Study||3
8340996|NCT01307267|20562009|P1|NOT COMPLETED|Overall Study||4
8340997|NCT01307267|20561987|P23|COMPLETED|Overall Study||0
8340998|NCT01307267|20561988|P22|COMPLETED|Overall Study||0
8340999|NCT01307267|20561989|P21|COMPLETED|Overall Study||0
8341000|NCT01307267|20561990|P20|COMPLETED|Overall Study||0
8341001|NCT01307267|20561991|P19|COMPLETED|Overall Study||2
8341002|NCT01307267|20561992|P18|COMPLETED|Overall Study||2
8341003|NCT01307267|20561993|P17|COMPLETED|Overall Study||2
8341004|NCT01307267|20561994|P16|COMPLETED|Overall Study||2
8341005|NCT01307267|20561995|P15|COMPLETED|Overall Study||2
8341006|NCT01307267|20561996|P14|COMPLETED|Overall Study||3
8341007|NCT01307267|20561997|P13|COMPLETED|Overall Study||2
8341008|NCT01307267|20561998|P12|COMPLETED|Overall Study||0
8341009|NCT01307267|20561999|P11|COMPLETED|Overall Study||0
8341010|NCT01307267|20562000|P10|COMPLETED|Overall Study||0
8341011|NCT01307267|20562001|P9|COMPLETED|Overall Study||1
8341012|NCT01307267|20562002|P8|COMPLETED|Overall Study||0
8341013|NCT01307267|20562003|P7|COMPLETED|Overall Study||1
8341014|NCT01307267|20562004|P6|COMPLETED|Overall Study||1
8341015|NCT01307267|20562005|P5|COMPLETED|Overall Study||2
8341016|NCT01307267|20562006|P4|COMPLETED|Overall Study||1
8341017|NCT01307267|20562007|P3|COMPLETED|Overall Study||1
8341018|NCT01307267|20562008|P2|COMPLETED|Overall Study||0
8341019|NCT01307267|20562009|P1|COMPLETED|Overall Study||0
8341020|NCT01307267|20561987|P23|STARTED|Overall Study||4
8341021|NCT01307267|20561988|P22|STARTED|Overall Study||5
8341022|NCT01307267|20561989|P21|STARTED|Overall Study||3
8341023|NCT01307267|20561990|P20|STARTED|Overall Study||32
8341024|NCT01307267|20561991|P19|STARTED|Overall Study||4
8341025|NCT01307267|20561992|P18|STARTED|Overall Study||3
8341026|NCT01307267|20561993|P17|STARTED|Overall Study||3
8341027|NCT01307267|20561994|P16|STARTED|Overall Study||3
8341028|NCT01307267|20561995|P15|STARTED|Overall Study||4
8341029|NCT01307267|20561996|P14|STARTED|Overall Study||3
8341030|NCT01307267|20561997|P13|STARTED|Overall Study||3
8341031|NCT01307267|20561998|P12|STARTED|Overall Study||11
8341032|NCT01307267|20561999|P11|STARTED|Overall Study||6
8341033|NCT01307267|20562000|P10|STARTED|Overall Study||5
8341034|NCT01307267|20562001|P9|STARTED|Overall Study||31
8341035|NCT01307267|20562002|P8|STARTED|Overall Study||4
8341036|NCT01307267|20562003|P7|STARTED|Overall Study||3
8341037|NCT01307267|20562004|P6|STARTED|Overall Study||42
8341038|NCT01307267|20562005|P5|STARTED|Overall Study||3
8341039|NCT01307267|20562006|P4|STARTED|Overall Study||4
8341040|NCT01307267|20562007|P3|STARTED|Overall Study||6
8341041|NCT01307267|20562008|P2|STARTED|Overall Study||3
8341042|NCT01307267|20562009|P1|STARTED|Overall Study||4
8341043|NCT01307111|20562600|P2|NOT COMPLETED|1-2 Week IUD Check up||2
8341044|NCT01307111|20562601|P1|NOT COMPLETED|1-2 Week IUD Check up||2
8341045|NCT01307111|20562600|P2|COMPLETED|1-2 Week IUD Check up||38
8341046|NCT01307111|20562601|P1|COMPLETED|1-2 Week IUD Check up||38
8341047|NCT01307111|20562600|P2|STARTED|1-2 Week IUD Check up||40
8341048|NCT01307111|20562601|P1|STARTED|1-2 Week IUD Check up||40
8341049|NCT01307111|20562600|P2|NOT COMPLETED|IUD Insertion||0
8341050|NCT01307111|20562601|P1|NOT COMPLETED|IUD Insertion||2
8341051|NCT01307111|20562600|P2|COMPLETED|IUD Insertion||40
8341052|NCT01307111|20562601|P1|COMPLETED|IUD Insertion||40
8341053|NCT01307111|20562600|P2|STARTED|IUD Insertion||40
8341054|NCT01307111|20562601|P1|STARTED|IUD Insertion||42
8341055|NCT01307098|20562612|P3|NOT COMPLETED|Overall Study||0
8341056|NCT01307098|20562613|P2|NOT COMPLETED|Overall Study||0
8341057|NCT01307098|20562614|P1|NOT COMPLETED|Overall Study||0
8341058|NCT01307098|20562612|P3|COMPLETED|Overall Study||3
8341059|NCT01307098|20562613|P2|COMPLETED|Overall Study||3
8341060|NCT01307098|20562614|P1|COMPLETED|Overall Study||3
8341061|NCT01307098|20562612|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8341062|NCT01307098|20562613|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8341063|NCT01307098|20562614|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8341064|NCT01307098|20562612|P3|STARTED|Overall Study||3
8341065|NCT01307098|20562613|P2|STARTED|Overall Study||3
8341066|NCT01307098|20562614|P1|STARTED|Overall Study||3
8341067|NCT01307046|20562624|P2|NOT COMPLETED|Overall Study||11
8341068|NCT01307046|20562625|P1|NOT COMPLETED|Overall Study||12
8341069|NCT01307046|20562624|P2|COMPLETED|Overall Study||159
8341070|NCT01307046|20562625|P1|COMPLETED|Overall Study||154
8341071|NCT01307046|20562624|P2|STARTED|Overall Study||170
8341072|NCT01307046|20562625|P1|STARTED|Overall Study||166
8341073|NCT01307033|20562637|P4|NOT COMPLETED|44-week Open-label Extension||12
8341074|NCT01307033|20562638|P3|NOT COMPLETED|44-week Open-label Extension||11
8341075|NCT01307033|20562639|P2|NOT COMPLETED|44-week Open-label Extension||0
8341076|NCT01307033|20562640|P1|NOT COMPLETED|44-week Open-label Extension||0
8341077|NCT01307033|20562637|P4|COMPLETED|44-week Open-label Extension||115
8341078|NCT01307033|20562638|P3|COMPLETED|44-week Open-label Extension||120
8341079|NCT01307033|20562639|P2|COMPLETED|44-week Open-label Extension||0
8341080|NCT01307033|20562640|P1|COMPLETED|44-week Open-label Extension||0
8341081|NCT01307033|20562637|P4|STARTED|44-week Open-label Extension||127
8341082|NCT01307033|20562638|P3|STARTED|44-week Open-label Extension||131
8341083|NCT01307033|20562639|P2|STARTED|44-week Open-label Extension||0
8341084|NCT01307033|20562640|P1|STARTED|44-week Open-label Extension||0
8341085|NCT01307033|20562637|P4|NOT COMPLETED|8-week Double-blind Period||0
8341086|NCT01307033|20562638|P3|NOT COMPLETED|8-week Double-blind Period||0
8341087|NCT01307033|20562639|P2|NOT COMPLETED|8-week Double-blind Period||7
8341088|NCT01307033|20562640|P1|NOT COMPLETED|8-week Double-blind Period||13
8341089|NCT01307033|20562637|P4|COMPLETED|8-week Double-blind Period||0
8341090|NCT01307033|20562638|P3|COMPLETED|8-week Double-blind Period||0
8341091|NCT01307033|20562639|P2|COMPLETED|8-week Double-blind Period||127
8341092|NCT01307033|20562640|P1|COMPLETED|8-week Double-blind Period||131
8341093|NCT01307033|20562637|P4|STARTED|8-week Double-blind Period||0
8341094|NCT01307033|20562638|P3|STARTED|8-week Double-blind Period||0
8341095|NCT01307033|20562639|P2|STARTED|8-week Double-blind Period||134
8341096|NCT01307033|20562640|P1|STARTED|8-week Double-blind Period||144
8341097|NCT01307020|20562662|P10|NOT COMPLETED|Overall Study||0
8341098|NCT01307020|20562663|P9|NOT COMPLETED|Overall Study||0
8341099|NCT01307020|20562664|P8|NOT COMPLETED|Overall Study||0
8341100|NCT01307020|20562665|P7|NOT COMPLETED|Overall Study||1
8341101|NCT01307020|20562666|P6|NOT COMPLETED|Overall Study||0
8341102|NCT01307020|20562667|P5|NOT COMPLETED|Overall Study||0
8341103|NCT01307020|20562668|P4|NOT COMPLETED|Overall Study||1
8341104|NCT01307020|20562669|P3|NOT COMPLETED|Overall Study||1
8341105|NCT01307020|20562670|P2|NOT COMPLETED|Overall Study||1
8341106|NCT01307020|20562671|P1|NOT COMPLETED|Overall Study||0
8341107|NCT01307020|20562662|P10|COMPLETED|Overall Study||62
8341108|NCT01307020|20562663|P9|COMPLETED|Overall Study||61
8341109|NCT01307020|20562664|P8|COMPLETED|Overall Study||60
8341110|NCT01307020|20562665|P7|COMPLETED|Overall Study||58
8341111|NCT01307020|20562666|P6|COMPLETED|Overall Study||61
8341112|NCT01307020|20562667|P5|COMPLETED|Overall Study||60
8341113|NCT01307020|20562668|P4|COMPLETED|Overall Study||60
8341114|NCT01307020|20562669|P3|COMPLETED|Overall Study||62
8341115|NCT01307020|20562670|P2|COMPLETED|Overall Study||62
8341116|NCT01307020|20562671|P1|COMPLETED|Overall Study||61
8341117|NCT01307020|20562662|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
8341118|NCT01307020|20562663|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341119|NCT01307020|20562664|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
8341120|NCT01307020|20562665|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
8341121|NCT01307020|20562666|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341122|NCT01307020|20562667|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341123|NCT01307020|20562668|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
8341124|NCT01307020|20562669|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
8341125|NCT01307020|20562670|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
8341126|NCT01307020|20562671|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341127|NCT01307020|20562662|P10|Safety Population|Overall Study||62
8341128|NCT01307020|20562663|P9|Safety Population|Overall Study||61
8341129|NCT01307020|20562664|P8|Safety Population|Overall Study||60
8341130|NCT01307020|20562665|P7|Safety Population|Overall Study||59
8341131|NCT01307020|20562666|P6|Safety Population|Overall Study||61
8341132|NCT01307020|20562667|P5|Safety Population|Overall Study||60
8341133|NCT01307020|20562668|P4|Safety Population|Overall Study||61
8341134|NCT01307020|20562669|P3|Safety Population|Overall Study||63
8341135|NCT01307020|20562670|P2|Safety Population|Overall Study||63
8341136|NCT01307020|20562671|P1|Safety Population|Overall Study||61
8341137|NCT01307020|20562662|P10|STARTED|Overall Study||62
8341138|NCT01307020|20562663|P9|STARTED|Overall Study||61
8341139|NCT01307020|20562664|P8|STARTED|Overall Study||60
8341140|NCT01307020|20562665|P7|STARTED|Overall Study||59
8341141|NCT01307020|20562666|P6|STARTED|Overall Study||61
8341142|NCT01307020|20562667|P5|STARTED|Overall Study||60
8341143|NCT01307020|20562668|P4|STARTED|Overall Study||61
8341144|NCT01307020|20562669|P3|STARTED|Overall Study||63
8341145|NCT01307020|20562670|P2|STARTED|Overall Study||63
8341146|NCT01307020|20562671|P1|STARTED|Overall Study||61
8341147|NCT01307007|20562715|P2|NOT COMPLETED|Overall Study||0
8341148|NCT01307007|20562716|P1|NOT COMPLETED|Overall Study||0
8341149|NCT01307007|20562715|P2|COMPLETED|Overall Study||30
8341150|NCT01307007|20562716|P1|COMPLETED|Overall Study||25
8341151|NCT01307007|20562715|P2|STARTED|Overall Study||30
8341152|NCT01307007|20562716|P1|STARTED|Overall Study||25
8341153|NCT01306968|20562726|P4|NOT COMPLETED|Overall Study||4
8341154|NCT01306968|20562727|P3|NOT COMPLETED|Overall Study||1
8341155|NCT01306968|20562728|P2|NOT COMPLETED|Overall Study||3
8341156|NCT01306968|20562729|P1|NOT COMPLETED|Overall Study||1
8341157|NCT01306968|20562726|P4|COMPLETED|Overall Study||21
8341158|NCT01306968|20562727|P3|COMPLETED|Overall Study||23
8341159|NCT01306968|20562728|P2|COMPLETED|Overall Study||20
8341160|NCT01306968|20562729|P1|COMPLETED|Overall Study||6
8341161|NCT01306968|20562726|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
8341162|NCT01306968|20562727|P3|STARTED|Overall Study||24
8341163|NCT01306968|20562728|P2|STARTED|Overall Study||23
8341164|NCT01306968|20562729|P1|STARTED|Overall Study||7
8341165|NCT01306942|20562754|P4|NOT COMPLETED|Phase II||16
8341166|NCT01306942|20562755|P3|NOT COMPLETED|Phase II||0
8341167|NCT01306942|20562756|P2|NOT COMPLETED|Phase II||0
8341168|NCT01306942|20562757|P1|NOT COMPLETED|Phase II||2
8341169|NCT01306942|20562754|P4|COMPLETED|Phase II||11
8341170|NCT01306942|20562755|P3|COMPLETED|Phase II||0
8341171|NCT01306942|20562756|P2|COMPLETED|Phase II||0
8341172|NCT01306942|20562757|P1|COMPLETED|Phase II||0
8341173|NCT01306942|20562754|P4|STARTED|Phase II||27
8341174|NCT01306942|20562755|P3|STARTED|Phase II||0
8341175|NCT01306942|20562756|P2|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
8341176|NCT01306942|20562757|P1|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
8341177|NCT01306942|20562754|P4|NOT COMPLETED|Phase I||0
8341178|NCT01306942|20562755|P3|NOT COMPLETED|Phase I||0
8341179|NCT01306942|20562756|P2|NOT COMPLETED|Phase I||3
8341180|NCT01306942|20562757|P1|NOT COMPLETED|Phase I||5
8341181|NCT01306942|20562754|P4|COMPLETED|Phase I||0
8341182|NCT01306942|20562755|P3|COMPLETED|Phase I||0
8341183|NCT01306942|20562756|P2|COMPLETED|Phase I||1
8341184|NCT01306942|20562757|P1|COMPLETED|Phase I||1
8341185|NCT01306942|20562754|P4|STARTED|Phase I||0
8341186|NCT01306942|20562755|P3|STARTED|Phase I||0
8341187|NCT01306942|20562756|P2|STARTED|Phase I||4
8341188|NCT01306942|20562757|P1|STARTED|Phase I||6
8341189|NCT01306890|20562789|P1|NOT COMPLETED|Overall Study||1519
8341190|NCT01306890|20562789|P1|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
8341191|NCT01306890|20562789|P1|STARTED|Overall Study||1976
8341192|NCT01306877|20562796|P2|NOT COMPLETED|Overall Study||4
8341193|NCT01306877|20562797|P1|NOT COMPLETED|Overall Study||3
8341194|NCT01306877|20562796|P2|COMPLETED|Overall Study||67
8341195|NCT01306877|20562797|P1|COMPLETED|Overall Study||75
8341196|NCT01306877|20562796|P2|STARTED|Overall Study||71
8341197|NCT01306877|20562797|P1|STARTED|Overall Study||78
8341198|NCT01306656|20562817|P2|NOT COMPLETED|Overall Study||0
8341199|NCT01306656|20562818|P1|NOT COMPLETED|Overall Study||1
8341200|NCT01306656|20562817|P2|COMPLETED|Overall Study||2
8341201|NCT01306656|20562818|P1|COMPLETED|Overall Study||6
8341202|NCT01306656|20562817|P2|STARTED|Overall Study||2
8341203|NCT01306656|20562818|P1|STARTED|Overall Study||7
8341204|NCT01306643|20562830|P1|NOT COMPLETED|Overall Study||13
8341205|NCT01306643|20562830|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
8341206|NCT01306643|20562830|P1|STARTED|Overall Study||18
8341207|NCT01306617|20562842|P3|NOT COMPLETED|Overall Study||5
8341208|NCT01306617|20562843|P2|NOT COMPLETED|Overall Study||1
8341209|NCT01306617|20562844|P1|NOT COMPLETED|Overall Study||1
8341210|NCT01306617|20562842|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
8341211|NCT01306617|20562843|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
8341212|NCT01306617|20562844|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
8341213|NCT01306617|20562842|P3|STARTED|Overall Study||17
8341214|NCT01306617|20562843|P2|STARTED|Overall Study||14
8341215|NCT01306617|20562844|P1|STARTED|Overall Study||19
8341216|NCT01306331|20562887|P2|NOT COMPLETED|Overall Study||877
8341217|NCT01306331|20562888|P1|NOT COMPLETED|Overall Study||901
8341218|NCT01306331|20562887|P2|COMPLETED|Overall Study||788
8341219|NCT01306331|20562888|P1|COMPLETED|Overall Study||758
8341220|NCT01306331|20562887|P2|STARTED|Overall Study||1665
8341221|NCT01306331|20562888|P1|STARTED|Overall Study||1659
8341222|NCT01306305|20562898|P2|NOT COMPLETED|Overall Study||0
8341223|NCT01306305|20562899|P1|NOT COMPLETED|Overall Study||2
8341224|NCT01306305|20562898|P2|COMPLETED|Overall Study||55
8341225|NCT01306305|20562899|P1|COMPLETED|Overall Study||53
8341226|NCT01306305|20562898|P2|STARTED|Overall Study||55
8341227|NCT01306305|20562899|P1|STARTED|Overall Study||55
8341228|NCT01306292|20562915|P4|NOT COMPLETED|Second Injection||0
8341229|NCT01306292|20562916|P3|NOT COMPLETED|Second Injection||1
8341230|NCT01306292|20562917|P2|NOT COMPLETED|Second Injection||0
8341231|NCT01306292|20562918|P1|NOT COMPLETED|Second Injection||0
8341232|NCT01306292|20562915|P4|COMPLETED|Second Injection||10
8341233|NCT01306292|20562916|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
8341234|NCT01306292|20562917|P2|COMPLETED|Second Injection||8
8341235|NCT01306292|20562918|P1|COMPLETED|Second Injection||10
8341236|NCT01306292|20562915|P4|STARTED|Second Injection||10
8341237|NCT01306292|20562916|P3|STARTED|Second Injection||8
8341238|NCT01306292|20562917|P2|STARTED|Second Injection||8
8341239|NCT01306292|20562918|P1|STARTED|Second Injection||10
8341240|NCT01306292|20562915|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341241|NCT01306292|20562916|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341242|NCT01306292|20562917|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341243|NCT01306292|20562918|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341244|NCT01306292|20562915|P4|COMPLETED|Washout (at Least 10 Minutes)||10
8341245|NCT01306292|20562916|P3|COMPLETED|Washout (at Least 10 Minutes)||8
8341246|NCT01306292|20562917|P2|COMPLETED|Washout (at Least 10 Minutes)||8
8341247|NCT01306292|20562918|P1|COMPLETED|Washout (at Least 10 Minutes)||10
8341248|NCT01306292|20562915|P4|STARTED|Washout (at Least 10 Minutes)||10
8341249|NCT01306292|20562916|P3|STARTED|Washout (at Least 10 Minutes)||8
8341250|NCT01306292|20562917|P2|STARTED|Washout (at Least 10 Minutes)||8
8341251|NCT01306292|20562918|P1|STARTED|Washout (at Least 10 Minutes)||10
8341252|NCT01306292|20562915|P4|NOT COMPLETED|First Injection||0
8341253|NCT01306292|20562916|P3|NOT COMPLETED|First Injection||0
8341254|NCT01306292|20562917|P2|NOT COMPLETED|First Injection||0
8341255|NCT01306292|20562918|P1|NOT COMPLETED|First Injection||0
8341256|NCT01306292|20562915|P4|COMPLETED|First Injection||10
8341257|NCT01306292|20562916|P3|COMPLETED|First Injection||8
8341258|NCT01306292|20562917|P2|COMPLETED|First Injection||8
8341259|NCT01306292|20562918|P1|COMPLETED|First Injection||10
8341260|NCT01306292|20562915|P4|STARTED|First Injection||10
8341261|NCT01306292|20562916|P3|STARTED|First Injection||8
8341262|NCT01306292|20562917|P2|STARTED|First Injection||8
8341263|NCT01306292|20562918|P1|STARTED|First Injection||10
8341264|NCT01306253|20562936|P2|NOT COMPLETED|Overall Study||1
8341265|NCT01306253|20562937|P1|NOT COMPLETED|Overall Study||1
8341266|NCT01306253|20562936|P2|COMPLETED|Overall Study||56
8341267|NCT01306253|20562937|P1|COMPLETED|Overall Study||56
8341268|NCT01306253|20562936|P2|STARTED|Overall Study||57
8341269|NCT01306253|20562937|P1|STARTED|Overall Study||57
8341270|NCT01306214|20562954|P3|NOT COMPLETED|Overall Study||22
8341271|NCT01306214|20562955|P2|NOT COMPLETED|Overall Study||28
8341272|NCT01306214|20562956|P1|NOT COMPLETED|Overall Study||28
8341273|NCT01306214|20562954|P3|COMPLETED|Overall Study||168
8341274|NCT01306214|20562955|P2|COMPLETED|Overall Study||159
8341275|NCT01306214|20562956|P1|COMPLETED|Overall Study||161
8341276|NCT01306214|20562954|P3|STARTED|Overall Study||190
8341277|NCT01306214|20562955|P2|STARTED|Overall Study||187
8341278|NCT01306214|20562956|P1|STARTED|Overall Study||189
8341279|NCT01306201|20562973|P1|NOT COMPLETED|Overall Study||10
8341280|NCT01306201|20562973|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
8341281|NCT01306201|20562973|P1|STARTED|Overall Study||63
8341282|NCT01306175|20562981|P1|NOT COMPLETED|Second Intervention||0
8341283|NCT01306175|20562981|P1|COMPLETED|Second Intervention||20
8341284|NCT01306175|20562981|P1|STARTED|Second Intervention||20
8341285|NCT01306175|20562981|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
8341286|NCT01306175|20562981|P1|COMPLETED|Washout Period of at Least 14 Days||20
8341287|NCT01306175|20562981|P1|STARTED|Washout Period of at Least 14 Days||20
8341288|NCT01306175|20562981|P1|NOT COMPLETED|First Intervention||0
8341289|NCT01306175|20562981|P1|COMPLETED|First Intervention||20
8341290|NCT01306175|20562981|P1|STARTED|First Intervention||20
8341291|NCT01306162|20562995|P4|NOT COMPLETED|Period 4||0
8341292|NCT01306162|20562996|P3|NOT COMPLETED|Period 4||0
8341293|NCT01306162|20562997|P2|NOT COMPLETED|Period 4||0
8341294|NCT01306162|20562998|P1|NOT COMPLETED|Period 4||0
8341295|NCT01306162|20562995|P4|COMPLETED|Period 4||8
8341296|NCT01306162|20562996|P3|COMPLETED|Period 4||9
8341297|NCT01306162|20562997|P2|COMPLETED|Period 4||8
8341298|NCT01306162|20562998|P1|COMPLETED|Period 4||9
8341299|NCT01306162|20562995|P4|STARTED|Period 4||8
8341300|NCT01306162|20562996|P3|STARTED|Period 4||9
8341301|NCT01306162|20562997|P2|STARTED|Period 4||8
8341302|NCT01306162|20562998|P1|STARTED|Period 4||9
8341303|NCT01306162|20562995|P4|NOT COMPLETED|Washout 2||0
8341304|NCT01306162|20562996|P3|NOT COMPLETED|Washout 2||0
8341305|NCT01306162|20562997|P2|NOT COMPLETED|Washout 2||0
8341306|NCT01306162|20562998|P1|NOT COMPLETED|Washout 2||0
8341307|NCT01306162|20562995|P4|COMPLETED|Washout 2||8
8341308|NCT01306162|20562996|P3|COMPLETED|Washout 2||9
8341309|NCT01306162|20562997|P2|COMPLETED|Washout 2||8
8341310|NCT01306162|20562998|P1|COMPLETED|Washout 2||9
8341311|NCT01306162|20562995|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
8341312|NCT01306162|20562996|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
8341313|NCT01306162|20562997|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
8341314|NCT01306162|20562998|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
8341315|NCT01306162|20562995|P4|NOT COMPLETED|Period 3||0
8341316|NCT01306162|20562996|P3|NOT COMPLETED|Period 3||0
8341317|NCT01306162|20562997|P2|NOT COMPLETED|Period 3||0
8341318|NCT01306162|20562998|P1|NOT COMPLETED|Period 3||0
8341319|NCT01306162|20562995|P4|COMPLETED|Period 3||8
8341320|NCT01306162|20562996|P3|COMPLETED|Period 3||9
8341321|NCT01306162|20562997|P2|COMPLETED|Period 3||8
8341322|NCT01306162|20562998|P1|COMPLETED|Period 3||9
8341323|NCT01306162|20562995|P4|STARTED|Period 3||8
8341324|NCT01306162|20562996|P3|STARTED|Period 3||9
8341325|NCT01306162|20562997|P2|STARTED|Period 3||8
8341326|NCT01306162|20562998|P1|STARTED|Period 3||9
8341327|NCT01306162|20562995|P4|NOT COMPLETED|Period 2||0
8341328|NCT01306162|20562996|P3|NOT COMPLETED|Period 2||0
8341329|NCT01306162|20562997|P2|NOT COMPLETED|Period 2||0
8341330|NCT01306162|20562998|P1|NOT COMPLETED|Period 2||0
8341331|NCT01306162|20562995|P4|COMPLETED|Period 2||8
8341332|NCT01306162|20562996|P3|COMPLETED|Period 2||9
8341333|NCT01306162|20562997|P2|COMPLETED|Period 2||8
8341334|NCT01306162|20562998|P1|COMPLETED|Period 2||9
8341335|NCT01306162|20562995|P4|STARTED|Period 2|No washout phase after Period 2.|8
8341336|NCT01306162|20562996|P3|STARTED|Period 2|No washout phase after Period 2.|9
8341337|NCT01306162|20562997|P2|STARTED|Period 2|No washout phase after Period 2.|8
8341338|NCT01306162|20562998|P1|STARTED|Period 2|No washout phase after Period 2.|9
8341339|NCT01306162|20562995|P4|NOT COMPLETED|Washout 1||0
8341340|NCT01306162|20562996|P3|NOT COMPLETED|Washout 1||0
8341341|NCT01306162|20562997|P2|NOT COMPLETED|Washout 1||1
8341342|NCT01306162|20562998|P1|NOT COMPLETED|Washout 1||0
8341343|NCT01306162|20562995|P4|COMPLETED|Washout 1||8
8341344|NCT01306162|20562996|P3|COMPLETED|Washout 1||9
8341345|NCT01306162|20562997|P2|COMPLETED|Washout 1||8
8341346|NCT01306162|20562998|P1|COMPLETED|Washout 1||9
8341347|NCT01306162|20562995|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
8341348|NCT01306162|20562996|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
8341349|NCT01306162|20562997|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
8341350|NCT01306162|20562998|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
8341351|NCT01306162|20562995|P4|NOT COMPLETED|Period 1||1
8341352|NCT01306162|20562996|P3|NOT COMPLETED|Period 1||0
8341353|NCT01306162|20562997|P2|NOT COMPLETED|Period 1||0
8341354|NCT01306162|20562998|P1|NOT COMPLETED|Period 1||0
8341355|NCT01306162|20562995|P4|COMPLETED|Period 1||8
8341356|NCT01306162|20562996|P3|COMPLETED|Period 1||9
8341357|NCT01306162|20562997|P2|COMPLETED|Period 1||9
8341358|NCT01306162|20562998|P1|COMPLETED|Period 1||9
8341359|NCT01306162|20562995|P4|STARTED|Period 1||9
8341360|NCT01306162|20562996|P3|STARTED|Period 1||9
8341361|NCT01306162|20562997|P2|STARTED|Period 1||9
8341362|NCT01306162|20562998|P1|STARTED|Period 1||9
8341363|NCT01306058|20563026|P1|NOT COMPLETED|Overall Study||2
8341364|NCT01306058|20563026|P1|COMPLETED|Overall Study||25
8341365|NCT01306058|20563026|P1|STARTED|Overall Study||27
8341366|NCT01306032|20563053|P6|NOT COMPLETED|Disease Progression/Crossover||0
8341367|NCT01306032|20563054|P5|NOT COMPLETED|Disease Progression/Crossover||0
8341368|NCT01306032|20563055|P4|NOT COMPLETED|Disease Progression/Crossover||3
8341369|NCT01306032|20563056|P3|NOT COMPLETED|Disease Progression/Crossover||0
8341370|NCT01306032|20563057|P2|NOT COMPLETED|Disease Progression/Crossover||2
8341371|NCT01306032|20563058|P1|NOT COMPLETED|Disease Progression/Crossover||0
8341372|NCT01306032|20563053|P6|COMPLETED|Disease Progression/Crossover||0
8341373|NCT01306032|20563054|P5|COMPLETED|Disease Progression/Crossover||0
8341374|NCT01306032|20563055|P4|COMPLETED|Disease Progression/Crossover||26
8341375|NCT01306032|20563056|P3|COMPLETED|Disease Progression/Crossover||0
8341376|NCT01306032|20563057|P2|COMPLETED|Disease Progression/Crossover||14
8341377|NCT01306032|20563058|P1|COMPLETED|Disease Progression/Crossover||0
8341378|NCT01306032|20563053|P6|STARTED|Disease Progression/Crossover||0
8341379|NCT01306032|20563054|P5|STARTED|Disease Progression/Crossover||0
8341380|NCT01306032|20563055|P4|STARTED|Disease Progression/Crossover||29
8341381|NCT01306032|20563056|P3|STARTED|Disease Progression/Crossover||0
8341382|NCT01306032|20563057|P2|STARTED|Disease Progression/Crossover||16
8341383|NCT01306032|20563058|P1|STARTED|Disease Progression/Crossover||0
8341384|NCT01306032|20563053|P6|NOT COMPLETED|First Intervention||2
8341385|NCT01306032|20563054|P5|NOT COMPLETED|First Intervention||2
8341386|NCT01306032|20563055|P4|NOT COMPLETED|First Intervention||1
8341387|NCT01306032|20563056|P3|NOT COMPLETED|First Intervention||2
8341388|NCT01306032|20563057|P2|NOT COMPLETED|First Intervention||2
8341389|NCT01306032|20563058|P1|NOT COMPLETED|First Intervention||1
8341390|NCT01306032|20563053|P6|COMPLETED|First Intervention||0
8341391|NCT01306032|20563054|P5|COMPLETED|First Intervention||0
8341392|NCT01306032|20563055|P4|COMPLETED|First Intervention||37
8341393|NCT01306032|20563056|P3|COMPLETED|First Intervention||35
8341394|NCT01306032|20563057|P2|COMPLETED|First Intervention||18
8341395|NCT01306032|20563058|P1|COMPLETED|First Intervention||21
8341396|NCT01306032|20563053|P6|STARTED|First Intervention||2
8341397|NCT01306032|20563054|P5|STARTED|First Intervention||2
8341398|NCT01306032|20563055|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
8341399|NCT01306032|20563056|P3|STARTED|First Intervention||37
8341400|NCT01306032|20563057|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
8341401|NCT01306032|20563058|P1|STARTED|First Intervention||22
8341402|NCT01305941|20563110|P1|NOT COMPLETED|Overall Study||10
8341403|NCT01305941|20563110|P1|COMPLETED|Overall Study||22
8341404|NCT01305941|20563110|P1|STARTED|Overall Study||32
8341405|NCT01305811|20563124|P2|NOT COMPLETED|Overall Study||11
8341406|NCT01305811|20563125|P1|NOT COMPLETED|Overall Study||8
8341407|NCT01305811|20563124|P2|COMPLETED|Overall Study||41
8341408|NCT01305811|20563125|P1|COMPLETED|Overall Study||44
8341409|NCT01305811|20563124|P2|STARTED|Overall Study||52
8341410|NCT01305811|20563125|P1|STARTED|Overall Study||52
8341411|NCT01305772|20563135|P2|NOT COMPLETED|Overall Study||0
8341412|NCT01305772|20563136|P1|NOT COMPLETED|Overall Study||0
8341413|NCT01305772|20563135|P2|COMPLETED|Overall Study||1
8341414|NCT01305772|20563136|P1|COMPLETED|Overall Study||5
8341415|NCT01305772|20563135|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
8341416|NCT01305772|20563136|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
8341417|NCT01305772|20563135|P2|Surgery/Biopsy #2|Overall Study||1
8341418|NCT01305772|20563136|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
8341419|NCT01305772|20563135|P2|Research PET/CT #2|Overall Study||1
8341420|NCT01305772|20563136|P1|Research PET/CT #2|Overall Study||5
8341421|NCT01305772|20563135|P2|Panitumumab Dose #1|Overall Study||1
8341422|NCT01305772|20563136|P1|Panitumumab Dose #1|Overall Study||5
8341423|NCT01305772|20563135|P2|Research PET/CT #1|Overall Study||1
8341424|NCT01305772|20563136|P1|Research PET/CT #1|Overall Study||5
8341425|NCT01305772|20563135|P2|Genomic Screening + Biopsy #1|Overall Study||1
8341426|NCT01305772|20563136|P1|Genomic Screening + Biopsy #1|Overall Study||5
8341427|NCT01305772|20563135|P2|STARTED|Overall Study||1
8341428|NCT01305772|20563136|P1|STARTED|Overall Study||5
8341429|NCT01305655|20563143|P1|NOT COMPLETED|Overall Study||0
8341430|NCT01305655|20563143|P1|COMPLETED|Overall Study|December 31, 2014|47
8341431|NCT01305655|20563143|P1|STARTED|Overall Study|July 2008|47
8341432|NCT01305577|20563150|P3|NOT COMPLETED|Overall Study||10
8341433|NCT01305577|20563151|P2|NOT COMPLETED|Overall Study||11
8341434|NCT01305577|20563152|P1|NOT COMPLETED|Overall Study||13
8341435|NCT01305577|20563150|P3|COMPLETED|Overall Study||112
8341436|NCT01305577|20563151|P2|COMPLETED|Overall Study||110
8341437|NCT01305577|20563152|P1|COMPLETED|Overall Study||107
8341438|NCT01305577|20563150|P3|Received Treatment|Overall Study||122
8341439|NCT01305577|20563151|P2|Received Treatment|Overall Study||121
8341440|NCT01305577|20563152|P1|Received Treatment|Overall Study||119
8341441|NCT01305577|20563150|P3|STARTED|Overall Study||122
8341442|NCT01305577|20563151|P2|STARTED|Overall Study||121
8341443|NCT01305577|20563152|P1|STARTED|Overall Study||120
8341444|NCT01305564|20563181|P1|NOT COMPLETED|Overall Study||37
8341445|NCT01305564|20563181|P1|COMPLETED|Overall Study||163
8341446|NCT01305564|20563181|P1|STARTED|Overall Study||200
8341447|NCT01305473|20563196|P1|NOT COMPLETED|Overall Study||0
8341448|NCT01305473|20563196|P1|COMPLETED|Overall Study||90
8341449|NCT01305473|20563196|P1|STARTED|Overall Study||90
8341450|NCT01305408|20563208|P2|NOT COMPLETED|Overall Study||31
8341451|NCT01305408|20563209|P1|NOT COMPLETED|Overall Study||32
8341452|NCT01305408|20563208|P2|COMPLETED|Overall Study||169
8341453|NCT01305408|20563209|P1|COMPLETED|Overall Study||167
8341454|NCT01305408|20563208|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
8341455|NCT01305408|20563209|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
8341456|NCT01305408|20563208|P2|Safety Population|Overall Study|Treated participants.|200
8341457|NCT01305408|20563209|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
8341458|NCT01305408|20563208|P2|STARTED|Overall Study||200
8341459|NCT01305408|20563209|P1|STARTED|Overall Study||199
8341460|NCT01305356|20563261|P2|NOT COMPLETED|Overall Study||0
8341461|NCT01305356|20563262|P1|NOT COMPLETED|Overall Study||0
8341462|NCT01305356|20563261|P2|COMPLETED|Overall Study||167
8341463|NCT01305356|20563262|P1|COMPLETED|Overall Study||132
8341464|NCT01305356|20563261|P2|STARTED|Overall Study||167
8341465|NCT01305356|20563262|P1|STARTED|Overall Study||132
8341466|NCT01305265|20563278|P2|NOT COMPLETED|Overall Study||6
8341467|NCT01305265|20563279|P1|NOT COMPLETED|Overall Study||2
8341468|NCT01305265|20563278|P2|COMPLETED|Overall Study||64
8341469|NCT01305265|20563279|P1|COMPLETED|Overall Study||69
8341470|NCT01305265|20563278|P2|STARTED|Overall Study||70
8341471|NCT01305265|20563279|P1|STARTED|Overall Study||71
8341472|NCT01305252|20563287|P2|NOT COMPLETED|Overall Study||0
8341473|NCT01305252|20563288|P1|NOT COMPLETED|Overall Study||1
8341474|NCT01305252|20563287|P2|COMPLETED|Overall Study||11
8341475|NCT01305252|20563288|P1|COMPLETED|Overall Study||9
8341476|NCT01305252|20563287|P2|STARTED|Overall Study||11
8341477|NCT01305252|20563288|P1|STARTED|Overall Study||10
8341478|NCT01305239|20563302|P1|NOT COMPLETED|Overall Study||23
8341479|NCT01305239|20563302|P1|COMPLETED|Overall Study||375
8341480|NCT01305239|20563302|P1|Intent to Treat Population|Overall Study||287
8341481|NCT01305239|20563302|P1|Safety Set|Overall Study||397
8341482|NCT01305239|20563302|P1|STARTED|Overall Study||398
8341483|NCT01305213|20563312|P2|NOT COMPLETED|Overall Study||0
8341484|NCT01305213|20563313|P1|NOT COMPLETED|Overall Study||0
8341485|NCT01305213|20563312|P2|COMPLETED|Overall Study||54
8341486|NCT01305213|20563313|P1|COMPLETED|Overall Study||53
8341487|NCT01305213|20563312|P2|STARTED|Overall Study||54
8341488|NCT01305213|20563313|P1|STARTED|Overall Study||53
8341489|NCT01305200|20563332|P3|NOT COMPLETED|Overall Study||3
8341490|NCT01305200|20563333|P2|NOT COMPLETED|Overall Study||31
8341491|NCT01305200|20563334|P1|NOT COMPLETED|Overall Study||29
8341492|NCT01305200|20563332|P3|COMPLETED|Overall Study||0
8341493|NCT01305200|20563333|P2|COMPLETED|Overall Study||81
8341494|NCT01305200|20563334|P1|COMPLETED|Overall Study||82
8341495|NCT01305200|20563332|P3|STARTED|Overall Study||3
8341496|NCT01305200|20563333|P2|STARTED|Overall Study||112
8341497|NCT01305200|20563334|P1|STARTED|Overall Study||111
8341498|NCT01305044|20563364|P2|NOT COMPLETED|Overall Study||6
8341499|NCT01305044|20563365|P1|NOT COMPLETED|Overall Study||3
8341500|NCT01305044|20563364|P2|COMPLETED|Overall Study||25
8341501|NCT01305044|20563365|P1|COMPLETED|Overall Study||29
8341502|NCT01305044|20563364|P2|STARTED|Overall Study||31
8341503|NCT01305044|20563365|P1|STARTED|Overall Study||32
8341504|NCT01304966|20563389|P1|NOT COMPLETED|Overall Study||0
8341505|NCT01304966|20563389|P1|COMPLETED|Overall Study||15
8341506|NCT01304966|20563389|P1|STARTED|Overall Study||15
8341507|NCT01304940|20563397|P2|NOT COMPLETED|Overall Study||0
8341508|NCT01304940|20563398|P1|NOT COMPLETED|Overall Study||3
8341509|NCT01304940|20563397|P2|COMPLETED|Overall Study||25
8341510|NCT01304940|20563398|P1|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
8341511|NCT01304940|20563397|P2|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
8341512|NCT01304940|20563398|P1|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
8341513|NCT01304940|20563397|P2|STARTED|Overall Study||25
8341514|NCT01304940|20563398|P1|STARTED|Overall Study||25
8341515|NCT01304706|20563404|P1|NOT COMPLETED|Overall Study||17
8341516|NCT01304706|20563404|P1|COMPLETED|Overall Study||104
8341517|NCT01304706|20563404|P1|STARTED|Overall Study||121
8341518|NCT01304693|20563413|P5|NOT COMPLETED|Overall Study||1
8341519|NCT01304693|20563414|P4|NOT COMPLETED|Overall Study||1
8341520|NCT01304693|20563415|P3|NOT COMPLETED|Overall Study||1
8341521|NCT01304693|20563416|P2|NOT COMPLETED|Overall Study||0
8341522|NCT01304693|20563417|P1|NOT COMPLETED|Overall Study||0
8341523|NCT01304693|20563413|P5|COMPLETED|Overall Study||60
8341524|NCT01304693|20563414|P4|COMPLETED|Overall Study||39
8341525|NCT01304693|20563415|P3|COMPLETED|Overall Study||47
8341526|NCT01304693|20563416|P2|COMPLETED|Overall Study||35
8341527|NCT01304693|20563417|P1|COMPLETED|Overall Study||10
8341528|NCT01304693|20563413|P5|STARTED|Overall Study||61
8341529|NCT01304693|20563414|P4|STARTED|Overall Study||40
8341530|NCT01304693|20563415|P3|STARTED|Overall Study||48
8341531|NCT01304693|20563416|P2|STARTED|Overall Study||35
8341532|NCT01304693|20563417|P1|STARTED|Overall Study||10
8341539|NCT01304589|20563455|P1|NOT COMPLETED|Overall Study||13
8341540|NCT01304589|20563455|P1|COMPLETED|Overall Study||18
8341541|NCT01304589|20563455|P1|STARTED|Overall Study||31
8341542|NCT01304498|20563464|P2|NOT COMPLETED|Overall Study||5
8341543|NCT01304498|20563465|P1|NOT COMPLETED|Overall Study||6
8341544|NCT01304498|20563464|P2|COMPLETED|Overall Study||295
8341545|NCT01304498|20563465|P1|COMPLETED|Overall Study||294
8341546|NCT01304498|20563464|P2|Received ≥1 Dose|Overall Study||300
8341547|NCT01304498|20563465|P1|Received ≥1 Dose|Overall Study||300
8341548|NCT01304498|20563464|P2|STARTED|Overall Study||300
8341549|NCT01304498|20563465|P1|STARTED|Overall Study||300
8341550|NCT01304407|20563485|P1|NOT COMPLETED|Overall Study||0
8341551|NCT01304407|20563485|P1|COMPLETED|Overall Study||29
8341552|NCT01304407|20563485|P1|STARTED|Overall Study||29
8341553|NCT01304329|20563489|P6|NOT COMPLETED|Third Intervention (3 Days)||0
8341554|NCT01304329|20563490|P5|NOT COMPLETED|Third Intervention (3 Days)||0
8341555|NCT01304329|20563491|P4|NOT COMPLETED|Third Intervention (3 Days)||0
8341556|NCT01304329|20563492|P3|NOT COMPLETED|Third Intervention (3 Days)||0
8341557|NCT01304329|20563493|P2|NOT COMPLETED|Third Intervention (3 Days)||1
8341558|NCT01304329|20563494|P1|NOT COMPLETED|Third Intervention (3 Days)||0
8341559|NCT01304329|20563489|P6|COMPLETED|Third Intervention (3 Days)||3
8341560|NCT01304329|20563490|P5|COMPLETED|Third Intervention (3 Days)||3
8341561|NCT01304329|20563491|P4|COMPLETED|Third Intervention (3 Days)||3
8341562|NCT01304329|20563492|P3|COMPLETED|Third Intervention (3 Days)||3
8341563|NCT01304329|20563493|P2|COMPLETED|Third Intervention (3 Days)||2
8341564|NCT01304329|20563494|P1|COMPLETED|Third Intervention (3 Days)||3
8341565|NCT01304329|20563489|P6|STARTED|Third Intervention (3 Days)||3
8341566|NCT01304329|20563490|P5|STARTED|Third Intervention (3 Days)||3
8341567|NCT01304329|20563491|P4|STARTED|Third Intervention (3 Days)||3
8341568|NCT01304329|20563492|P3|STARTED|Third Intervention (3 Days)||3
8341569|NCT01304329|20563493|P2|STARTED|Third Intervention (3 Days)||3
8341570|NCT01304329|20563494|P1|STARTED|Third Intervention (3 Days)||3
8341571|NCT01304329|20563489|P6|NOT COMPLETED|Second Intervention (3 Days)||0
8341572|NCT01304329|20563490|P5|NOT COMPLETED|Second Intervention (3 Days)||0
8341573|NCT01304329|20563491|P4|NOT COMPLETED|Second Intervention (3 Days)||0
8341574|NCT01304329|20563492|P3|NOT COMPLETED|Second Intervention (3 Days)||0
8341575|NCT01304329|20563493|P2|NOT COMPLETED|Second Intervention (3 Days)||0
8341576|NCT01304329|20563494|P1|NOT COMPLETED|Second Intervention (3 Days)||0
8341577|NCT01304329|20563489|P6|COMPLETED|Second Intervention (3 Days)||3
8341578|NCT01304329|20563490|P5|COMPLETED|Second Intervention (3 Days)||3
8341579|NCT01304329|20563491|P4|COMPLETED|Second Intervention (3 Days)||3
8341580|NCT01304329|20563492|P3|COMPLETED|Second Intervention (3 Days)||3
8341581|NCT01304329|20563493|P2|COMPLETED|Second Intervention (3 Days)||3
8341582|NCT01304329|20563494|P1|COMPLETED|Second Intervention (3 Days)||3
8341583|NCT01304329|20563489|P6|STARTED|Second Intervention (3 Days)||3
8341584|NCT01304329|20563490|P5|STARTED|Second Intervention (3 Days)||3
8341585|NCT01304329|20563491|P4|STARTED|Second Intervention (3 Days)||3
8341586|NCT01304329|20563492|P3|STARTED|Second Intervention (3 Days)||3
8341587|NCT01304329|20563493|P2|STARTED|Second Intervention (3 Days)||3
8341588|NCT01304329|20563494|P1|STARTED|Second Intervention (3 Days)||3
8341589|NCT01304329|20563489|P6|NOT COMPLETED|First Intervention (3 Days)||0
8341590|NCT01304329|20563490|P5|NOT COMPLETED|First Intervention (3 Days)||0
8341591|NCT01304329|20563491|P4|NOT COMPLETED|First Intervention (3 Days)||0
8341592|NCT01304329|20563492|P3|NOT COMPLETED|First Intervention (3 Days)||0
8341593|NCT01304329|20563493|P2|NOT COMPLETED|First Intervention (3 Days)||0
8341594|NCT01304329|20563494|P1|NOT COMPLETED|First Intervention (3 Days)||0
8341595|NCT01304329|20563489|P6|COMPLETED|First Intervention (3 Days)||3
8341596|NCT01304329|20563490|P5|COMPLETED|First Intervention (3 Days)||3
8341597|NCT01304329|20563491|P4|COMPLETED|First Intervention (3 Days)||3
8341598|NCT01304329|20563492|P3|COMPLETED|First Intervention (3 Days)||3
8341599|NCT01304329|20563493|P2|COMPLETED|First Intervention (3 Days)||3
8341600|NCT01304329|20563494|P1|COMPLETED|First Intervention (3 Days)||3
8341601|NCT01304329|20563489|P6|STARTED|First Intervention (3 Days)||3
8341602|NCT01304329|20563490|P5|STARTED|First Intervention (3 Days)||3
8341603|NCT01304329|20563491|P4|STARTED|First Intervention (3 Days)||3
8341604|NCT01304329|20563492|P3|STARTED|First Intervention (3 Days)||3
8341605|NCT01304329|20563493|P2|STARTED|First Intervention (3 Days)||3
8341606|NCT01304329|20563494|P1|STARTED|First Intervention (3 Days)||3
8341607|NCT01304316|20563511|P1|NOT COMPLETED|Overall Study||0
8341608|NCT01304316|20563511|P1|COMPLETED|Overall Study||12
8341609|NCT01304316|20563511|P1|STARTED|Overall Study||12
8341610|NCT01304277|20563525|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
8341611|NCT01304277|20563525|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
8341612|NCT01304277|20563525|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
8341613|NCT01304277|20563525|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
8341614|NCT01304277|20563525|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
8341615|NCT01304277|20563525|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
8341616|NCT01304238|20563547|P10|NOT COMPLETED|Overall Study||0
8341617|NCT01304238|20563548|P9|NOT COMPLETED|Overall Study||0
8341618|NCT01304238|20563549|P8|NOT COMPLETED|Overall Study||0
8341619|NCT01304238|20563550|P7|NOT COMPLETED|Overall Study||0
8341620|NCT01304238|20563551|P6|NOT COMPLETED|Overall Study||0
8341621|NCT01304238|20563552|P5|NOT COMPLETED|Overall Study||0
8341622|NCT01304238|20563553|P4|NOT COMPLETED|Overall Study||0
8341623|NCT01304238|20563554|P3|NOT COMPLETED|Overall Study||0
8341624|NCT01304238|20563555|P2|NOT COMPLETED|Overall Study||0
8341625|NCT01304238|20563556|P1|NOT COMPLETED|Overall Study||0
8341626|NCT01304238|20563547|P10|COMPLETED|Overall Study||3
8341627|NCT01304238|20563548|P9|COMPLETED|Overall Study||1
8341628|NCT01304238|20563549|P8|COMPLETED|Overall Study||4
8341629|NCT01304238|20563550|P7|COMPLETED|Overall Study||5
8341630|NCT01304238|20563551|P6|COMPLETED|Overall Study||11
8341631|NCT01304238|20563552|P5|COMPLETED|Overall Study||11
8341632|NCT01304238|20563553|P4|COMPLETED|Overall Study||78
8341633|NCT01304238|20563554|P3|COMPLETED|Overall Study||46
8341634|NCT01304238|20563555|P2|COMPLETED|Overall Study||4
8341635|NCT01304238|20563556|P1|COMPLETED|Overall Study||32
8341636|NCT01304238|20563547|P10|STARTED|Overall Study||3
8341637|NCT01304238|20563548|P9|STARTED|Overall Study||1
8341638|NCT01304238|20563549|P8|STARTED|Overall Study||4
8341639|NCT01304238|20563550|P7|STARTED|Overall Study||5
8341640|NCT01304238|20563551|P6|STARTED|Overall Study||11
8341641|NCT01304238|20563552|P5|STARTED|Overall Study||11
8341642|NCT01304238|20563553|P4|STARTED|Overall Study||78
8341643|NCT01304238|20563554|P3|STARTED|Overall Study||46
8341644|NCT01304238|20563555|P2|STARTED|Overall Study||4
8341645|NCT01304238|20563556|P1|STARTED|Overall Study||32
8341646|NCT01304147|20563628|P2|NOT COMPLETED|Second Intervention (7days)||1
8341647|NCT01304147|20563629|P1|NOT COMPLETED|Second Intervention (7days)||1
8341648|NCT01304147|20563628|P2|COMPLETED|Second Intervention (7days)||9
8341649|NCT01304147|20563629|P1|COMPLETED|Second Intervention (7days)||9
8341650|NCT01304147|20563628|P2|STARTED|Second Intervention (7days)||10
8341651|NCT01304147|20563629|P1|STARTED|Second Intervention (7days)||10
8341652|NCT01304147|20563628|P2|NOT COMPLETED|Washout (1 Day)||0
8341653|NCT01304147|20563629|P1|NOT COMPLETED|Washout (1 Day)||0
8341654|NCT01304147|20563628|P2|COMPLETED|Washout (1 Day)||10
8341655|NCT01304147|20563629|P1|COMPLETED|Washout (1 Day)||10
8341656|NCT01304147|20563628|P2|STARTED|Washout (1 Day)||10
8341657|NCT01304147|20563629|P1|STARTED|Washout (1 Day)||10
8341658|NCT01304147|20563628|P2|NOT COMPLETED|First Intervention (7days)||0
8341659|NCT01304147|20563629|P1|NOT COMPLETED|First Intervention (7days)||0
8341660|NCT01304147|20563628|P2|COMPLETED|First Intervention (7days)||10
8341661|NCT01304147|20563629|P1|COMPLETED|First Intervention (7days)||10
8341662|NCT01304147|20563628|P2|STARTED|First Intervention (7days)||10
8341663|NCT01304147|20563629|P1|STARTED|First Intervention (7days)||10
8341664|NCT01304082|20563637|P5|NOT COMPLETED|Overall Study||0
8341665|NCT01304082|20563638|P4|NOT COMPLETED|Overall Study||0
8341666|NCT01304082|20563639|P3|NOT COMPLETED|Overall Study||0
8341667|NCT01304082|20563640|P2|NOT COMPLETED|Overall Study||0
8341668|NCT01304082|20563641|P1|NOT COMPLETED|Overall Study||0
8341669|NCT01304082|20563637|P5|COMPLETED|Overall Study||5
8341670|NCT01304082|20563638|P4|COMPLETED|Overall Study||8
8341671|NCT01304082|20563639|P3|COMPLETED|Overall Study||11
8341672|NCT01304082|20563640|P2|COMPLETED|Overall Study||2
8341673|NCT01304082|20563641|P1|COMPLETED|Overall Study||3
8341674|NCT01304082|20563637|P5|Third Intervention|Overall Study||5
8341675|NCT01304082|20563638|P4|Third Intervention|Overall Study||8
8341676|NCT01304082|20563639|P3|Third Intervention|Overall Study||11
8341677|NCT01304082|20563640|P2|Third Intervention|Overall Study||2
8341678|NCT01304082|20563641|P1|Third Intervention|Overall Study||3
8341679|NCT01304082|20563637|P5|Second Intervention|Overall Study||5
8341680|NCT01304082|20563638|P4|Second Intervention|Overall Study||8
8341681|NCT01304082|20563639|P3|Second Intervention|Overall Study||11
8341682|NCT01304082|20563640|P2|Second Intervention|Overall Study||2
8341683|NCT01304082|20563641|P1|Second Intervention|Overall Study||3
8341684|NCT01304082|20563637|P5|First Intervention|Overall Study||5
8341685|NCT01304082|20563638|P4|First Intervention|Overall Study||8
8341686|NCT01304082|20563639|P3|First Intervention|Overall Study||11
8341687|NCT01304082|20563640|P2|First Intervention|Overall Study||2
8341688|NCT01304082|20563641|P1|First Intervention|Overall Study||3
8341689|NCT01304082|20563637|P5|STARTED|Overall Study||5
8341690|NCT01304082|20563638|P4|STARTED|Overall Study||8
8341691|NCT01304082|20563639|P3|STARTED|Overall Study||11
8341692|NCT01304082|20563640|P2|STARTED|Overall Study||2
8341693|NCT01304082|20563641|P1|STARTED|Overall Study||3
8341694|NCT01303965|20563660|P2|NOT COMPLETED|Overall Study||10
8341695|NCT01303965|20563661|P1|NOT COMPLETED|Overall Study||3
8341696|NCT01303965|20563660|P2|COMPLETED|Overall Study||1
8341697|NCT01303965|20563661|P1|COMPLETED|Overall Study||0
8341698|NCT01303965|20563660|P2|STARTED|Overall Study||11
8341699|NCT01303965|20563661|P1|STARTED|Overall Study||3
8341700|NCT01303939|20563675|P2|NOT COMPLETED|Overall Study||0
8341701|NCT01303939|20563676|P1|NOT COMPLETED|Overall Study||7
8341702|NCT01303939|20563675|P2|COMPLETED|Overall Study||15
8341703|NCT01303939|20563676|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
8341704|NCT01303939|20563675|P2|STARTED|Overall Study||15
8341705|NCT01303939|20563676|P1|STARTED|Overall Study||22
8341706|NCT01303861|20563689|P4|NOT COMPLETED|Overall Study||59
8341707|NCT01303861|20563690|P3|NOT COMPLETED|Overall Study||36
8341708|NCT01303861|20563691|P2|NOT COMPLETED|Overall Study||25
8341709|NCT01303861|20563692|P1|NOT COMPLETED|Overall Study||58
8341710|NCT01303861|20563689|P4|COMPLETED|Overall Study||54
8341711|NCT01303861|20563690|P3|COMPLETED|Overall Study||19
8341712|NCT01303861|20563691|P2|COMPLETED|Overall Study||25
8341713|NCT01303861|20563692|P1|COMPLETED|Overall Study||51
8341714|NCT01303861|20563689|P4|Finished Treatment Phase|Overall Study||72
8341715|NCT01303861|20563690|P3|Finished Treatment Phase|Overall Study||39
8341716|NCT01303861|20563691|P2|Finished Treatment Phase|Overall Study||34
8341717|NCT01303861|20563692|P1|Finished Treatment Phase|Overall Study||71
8341718|NCT01303861|20563689|P4|STARTED|Overall Study||113
8341719|NCT01303861|20563690|P3|STARTED|Overall Study||55
8341720|NCT01303861|20563691|P2|STARTED|Overall Study||50
8341721|NCT01303861|20563692|P1|STARTED|Overall Study||109
8341722|NCT01303835|20563713|P2|NOT COMPLETED|Overall Study||25
8341723|NCT01303835|20563714|P1|NOT COMPLETED|Overall Study||19
8341724|NCT01303835|20563713|P2|COMPLETED|Overall Study||31
8341725|NCT01303835|20563714|P1|COMPLETED|Overall Study||35
8341726|NCT01303835|20563713|P2|STARTED|Overall Study||56
8341727|NCT01303835|20563714|P1|STARTED|Overall Study||54
8341728|NCT01303744|20563728|P4|NOT COMPLETED|Overall Study||0
8341729|NCT01303744|20563729|P3|NOT COMPLETED|Overall Study||0
8341730|NCT01303744|20563730|P2|NOT COMPLETED|Overall Study||0
8341731|NCT01303744|20563731|P1|NOT COMPLETED|Overall Study||0
8341732|NCT01303744|20563728|P4|COMPLETED|Overall Study||24
8341733|NCT01303744|20563729|P3|COMPLETED|Overall Study||24
8341734|NCT01303744|20563730|P2|COMPLETED|Overall Study||24
8341735|NCT01303744|20563731|P1|COMPLETED|Overall Study||24
8341736|NCT01303744|20563728|P4|STARTED|Overall Study||24
8341737|NCT01303744|20563729|P3|STARTED|Overall Study||24
8341738|NCT01303744|20563730|P2|STARTED|Overall Study||24
8341739|NCT01303744|20563731|P1|STARTED|Overall Study||24
8341740|NCT01303627|20563751|P2|NOT COMPLETED|Overall Study||1
8341741|NCT01303627|20563752|P1|NOT COMPLETED|Overall Study||0
8341742|NCT01303627|20563751|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
8341743|NCT01303627|20563752|P1|COMPLETED|Overall Study||21
8341744|NCT01303627|20563751|P2|STARTED|Overall Study||21
8341745|NCT01303627|20563752|P1|STARTED|Overall Study||21
8341746|NCT01303510|20563760|P2|NOT COMPLETED|Overall Study||0
8341747|NCT01303510|20563761|P1|NOT COMPLETED|Overall Study||1
8341748|NCT01303510|20563760|P2|COMPLETED|Overall Study||56
8341749|NCT01303510|20563761|P1|COMPLETED|Overall Study||54
8341750|NCT01303510|20563760|P2|STARTED|Overall Study||56
8341751|NCT01303510|20563761|P1|STARTED|Overall Study||55
8341752|NCT01303445|20563775|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
8341753|NCT01303445|20563776|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
8341754|NCT01303445|20563775|P2|COMPLETED|Follow-up Period (14 Days)||25
8341755|NCT01303445|20563776|P1|COMPLETED|Follow-up Period (14 Days)||26
8341756|NCT01303445|20563775|P2|STARTED|Follow-up Period (14 Days)||26
8341757|NCT01303445|20563776|P1|STARTED|Follow-up Period (14 Days)||26
8341758|NCT01303445|20563775|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
8341759|NCT01303445|20563776|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
8341760|NCT01303445|20563775|P2|COMPLETED|Fourth Intervention (7 Days)||26
8341761|NCT01303445|20563776|P1|COMPLETED|Fourth Intervention (7 Days)||26
8341762|NCT01303445|20563775|P2|STARTED|Fourth Intervention (7 Days)||26
8341763|NCT01303445|20563776|P1|STARTED|Fourth Intervention (7 Days)||27
8341764|NCT01303445|20563775|P2|NOT COMPLETED|Third Intervention (7 Days)||0
8341765|NCT01303445|20563776|P1|NOT COMPLETED|Third Intervention (7 Days)||0
8341766|NCT01303445|20563775|P2|COMPLETED|Third Intervention (7 Days)||26
8341767|NCT01303445|20563776|P1|COMPLETED|Third Intervention (7 Days)||27
8341768|NCT01303445|20563775|P2|STARTED|Third Intervention (7 Days)||26
8341769|NCT01303445|20563776|P1|STARTED|Third Intervention (7 Days)||27
8341770|NCT01303445|20563775|P2|NOT COMPLETED|Washout (14 Days)||2
8341771|NCT01303445|20563776|P1|NOT COMPLETED|Washout (14 Days)||1
8341772|NCT01303445|20563775|P2|COMPLETED|Washout (14 Days)||26
8341773|NCT01303445|20563776|P1|COMPLETED|Washout (14 Days)||27
8341774|NCT01303445|20563775|P2|STARTED|Washout (14 Days)||28
8341775|NCT01303445|20563776|P1|STARTED|Washout (14 Days)||28
8341776|NCT01303445|20563775|P2|NOT COMPLETED|Second Intervention (7 Days)||2
8341777|NCT01303445|20563776|P1|NOT COMPLETED|Second Intervention (7 Days)||1
8341778|NCT01303445|20563775|P2|COMPLETED|Second Intervention (7 Days)||28
8341779|NCT01303445|20563776|P1|COMPLETED|Second Intervention (7 Days)||28
8341780|NCT01303445|20563775|P2|STARTED|Second Intervention (7 Days)||30
8341781|NCT01303445|20563776|P1|STARTED|Second Intervention (7 Days)||29
8341782|NCT01303445|20563775|P2|NOT COMPLETED|First Intervention (7 Days)||0
8341783|NCT01303445|20563776|P1|NOT COMPLETED|First Intervention (7 Days)||1
8341784|NCT01303445|20563775|P2|COMPLETED|First Intervention (7 Days)||30
8341785|NCT01303445|20563776|P1|COMPLETED|First Intervention (7 Days)||29
8341786|NCT01303445|20563775|P2|STARTED|First Intervention (7 Days)||30
8341787|NCT01303445|20563776|P1|STARTED|First Intervention (7 Days)||30
8341788|NCT01303419|20563806|P1|NOT COMPLETED|Overall Study||96
8341789|NCT01303419|20563806|P1|COMPLETED|Overall Study||128
8341790|NCT01303419|20563806|P1|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
8341791|NCT01303406|20563816|P2|NOT COMPLETED|Overall Study||1
8341792|NCT01303406|20563817|P1|NOT COMPLETED|Overall Study||0
8341793|NCT01303406|20563816|P2|COMPLETED|Overall Study||15
8341794|NCT01303406|20563817|P1|COMPLETED|Overall Study||13
8341795|NCT01303406|20563816|P2|STARTED|Overall Study||16
8341796|NCT01303406|20563817|P1|STARTED|Overall Study||13
8341797|NCT01303380|20563825|P1|NOT COMPLETED|Overall Study||1
8341798|NCT01303380|20563825|P1|COMPLETED|Overall Study||8
8341799|NCT01303380|20563825|P1|STARTED|Overall Study||9
8341800|NCT01303224|20563855|P4|NOT COMPLETED|Overall Study||10
8341801|NCT01303224|20563856|P3|NOT COMPLETED|Overall Study||6
8341802|NCT01303224|20563857|P2|NOT COMPLETED|Overall Study||11
8341803|NCT01303224|20563858|P1|NOT COMPLETED|Overall Study||11
8341804|NCT01303224|20563855|P4|COMPLETED|Overall Study||133
8341805|NCT01303224|20563856|P3|COMPLETED|Overall Study||133
8341806|NCT01303224|20563857|P2|COMPLETED|Overall Study||131
8341807|NCT01303224|20563858|P1|COMPLETED|Overall Study||130
8341808|NCT01303224|20563855|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
8341809|NCT01303224|20563856|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
8341810|NCT01303224|20563857|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
8341811|NCT01303224|20563858|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
8341812|NCT01303224|20563855|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
8341813|NCT01303224|20563856|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
8341814|NCT01303224|20563857|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
8341815|NCT01303224|20563858|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
8341816|NCT01303159|20563884|P1|NOT COMPLETED|Overall Study||23
8341817|NCT01303159|20563884|P1|COMPLETED|Overall Study||6
8341818|NCT01303159|20563884|P1|STARTED|Overall Study||29
8341819|NCT01303003|20563891|P2|NOT COMPLETED|Overall Study||0
8341820|NCT01303003|20563892|P1|NOT COMPLETED|Overall Study||0
8341821|NCT01303003|20563891|P2|COMPLETED|Overall Study||0
8341822|NCT01303003|20563892|P1|COMPLETED|Overall Study||0
8341823|NCT01303003|20563891|P2|STARTED|Overall Study||0
8341824|NCT01303003|20563892|P1|STARTED|Overall Study||0
8341825|NCT01302964|20563902|P2|NOT COMPLETED|Overall Study||0
8341826|NCT01302964|20563903|P1|NOT COMPLETED|Overall Study||1
8341827|NCT01302964|20563902|P2|COMPLETED|Overall Study||10
8341828|NCT01302964|20563903|P1|COMPLETED|Overall Study||19
8341829|NCT01302964|20563902|P2|STARTED|Overall Study||10
8341830|NCT01302964|20563903|P1|STARTED|Overall Study||20
8341831|NCT01302899|20563913|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
8341832|NCT01302899|20563914|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
8341833|NCT01302899|20563913|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
8341834|NCT01302899|20563914|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
8341835|NCT01302899|20563913|P2|STARTED|Period 4 (Weeks 19 to 26)||3
8341836|NCT01302899|20563914|P1|STARTED|Period 4 (Weeks 19 to 26)||3
8341837|NCT01302899|20563913|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
8341838|NCT01302899|20563914|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
8341839|NCT01302899|20563913|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
8341840|NCT01302899|20563914|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
8341841|NCT01302899|20563913|P2|STARTED|Period 3 (Weeks 13 to 18)||3
8341842|NCT01302899|20563914|P1|STARTED|Period 3 (Weeks 13 to 18)||3
8341843|NCT01302899|20563913|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
8341844|NCT01302899|20563914|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
8341845|NCT01302899|20563913|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
8341846|NCT01302899|20563914|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
8341847|NCT01302899|20563913|P2|STARTED|Period 2 (Weeks 7 to 12)||4
8341848|NCT01302899|20563914|P1|STARTED|Period 2 (Weeks 7 to 12)||4
8341849|NCT01302899|20563913|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
8341850|NCT01302899|20563914|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
8341851|NCT01302899|20563913|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
8341852|NCT01302899|20563914|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
8341853|NCT01302899|20563913|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
8341854|NCT01302899|20563914|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
8341855|NCT01302860|20563964|P1|NOT COMPLETED|Overall Study||0
8341856|NCT01302860|20563964|P1|COMPLETED|Overall Study||17
8341857|NCT01302860|20563964|P1|STARTED|Overall Study||17
8341890|NCT01302808|20564025|P4|NOT COMPLETED|Overall Study||0
8341891|NCT01302808|20564026|P3|NOT COMPLETED|Overall Study||0
8341892|NCT01302808|20564027|P2|NOT COMPLETED|Overall Study||0
8341893|NCT01302808|20564028|P1|NOT COMPLETED|Overall Study||0
8341894|NCT01302808|20564025|P4|COMPLETED|Overall Study||3
8341895|NCT01302808|20564026|P3|COMPLETED|Overall Study||4
8341896|NCT01302808|20564027|P2|COMPLETED|Overall Study||7
8341897|NCT01302808|20564028|P1|COMPLETED|Overall Study||3
8341898|NCT01302808|20564025|P4|STARTED|Overall Study||3
8341899|NCT01302808|20564026|P3|STARTED|Overall Study||4
8341900|NCT01302808|20564027|P2|STARTED|Overall Study||7
8341901|NCT01302808|20564028|P1|STARTED|Overall Study||3
8341902|NCT01302743|20564043|P3|NOT COMPLETED|Overall Study||2
8341903|NCT01302743|20564044|P2|NOT COMPLETED|Overall Study||1
8341904|NCT01302743|20564045|P1|NOT COMPLETED|Overall Study||1
8341905|NCT01302743|20564043|P3|COMPLETED|Overall Study||8
8341906|NCT01302743|20564044|P2|COMPLETED|Overall Study||7
8341907|NCT01302743|20564045|P1|COMPLETED|Overall Study||6
8341908|NCT01302743|20564043|P3|STARTED|Overall Study||10
8341909|NCT01302743|20564044|P2|STARTED|Overall Study||8
8341910|NCT01302743|20564045|P1|STARTED|Overall Study||7
8341911|NCT01302691|20564058|P2|NOT COMPLETED|Overall Study||6
8341912|NCT01302691|20564059|P1|NOT COMPLETED|Overall Study||10
8341913|NCT01302691|20564058|P2|COMPLETED|Overall Study||157
8341914|NCT01302691|20564059|P1|COMPLETED|Overall Study||154
8341915|NCT01302691|20564058|P2|STARTED|Overall Study||163
8341916|NCT01302691|20564059|P1|STARTED|Overall Study||164
8341917|NCT01302548|20564079|P2|NOT COMPLETED|Overall Study||1
8341918|NCT01302548|20564080|P1|NOT COMPLETED|Overall Study||2
8341919|NCT01302548|20564079|P2|COMPLETED|Overall Study||18
8341920|NCT01302548|20564080|P1|COMPLETED|Overall Study||12
8341921|NCT01302548|20564079|P2|STARTED|Overall Study||19
8341922|NCT01302548|20564080|P1|STARTED|Overall Study||14
8341923|NCT01302483|20564092|P2|NOT COMPLETED|Overall Study||0
8341924|NCT01302483|20564093|P1|NOT COMPLETED|Overall Study||0
8341925|NCT01302483|20564092|P2|COMPLETED|Overall Study||15
8341926|NCT01302483|20564093|P1|COMPLETED|Overall Study||30
8341927|NCT01302483|20564092|P2|STARTED|Overall Study||15
8341928|NCT01302483|20564093|P1|STARTED|Overall Study||30
8341929|NCT01302444|20564109|P2|NOT COMPLETED|Overall Study||0
8341930|NCT01302444|20564110|P1|NOT COMPLETED|Overall Study||0
8341931|NCT01302444|20564109|P2|COMPLETED|Overall Study||0
8341932|NCT01302444|20564110|P1|COMPLETED|Overall Study||1
8341933|NCT01302444|20564109|P2|STARTED|Overall Study||0
8341934|NCT01302444|20564110|P1|STARTED|Overall Study||1
8341935|NCT01302418|20564130|P1|NOT COMPLETED|Overall Study||18
8341936|NCT01302418|20564130|P1|COMPLETED|Overall Study||254
8341937|NCT01302418|20564130|P1|STARTED|Overall Study||272
8341938|NCT01302392|20564136|P2|NOT COMPLETED|Overall Study||1
8341939|NCT01302392|20564137|P1|NOT COMPLETED|Overall Study||7
8341940|NCT01302392|20564136|P2|COMPLETED|Overall Study||156
8341941|NCT01302392|20564137|P1|COMPLETED|Overall Study||151
8341942|NCT01302392|20564136|P2|Treated|Overall Study||157
8341943|NCT01302392|20564137|P1|Treated|Overall Study||153
8341944|NCT01302392|20564136|P2|STARTED|Overall Study||157
8341945|NCT01302392|20564137|P1|STARTED|Overall Study||158
8341946|NCT01302379|20564161|P4|NOT COMPLETED|Overall Study||4
8341947|NCT01302379|20564162|P3|NOT COMPLETED|Overall Study||4
8341948|NCT01302379|20564163|P2|NOT COMPLETED|Overall Study||5
8341949|NCT01302379|20564164|P1|NOT COMPLETED|Overall Study||7
8341950|NCT01302379|20564161|P4|COMPLETED|Overall Study||79
8341951|NCT01302379|20564162|P3|COMPLETED|Overall Study||80
8341952|NCT01302379|20564163|P2|COMPLETED|Overall Study||78
8341953|NCT01302379|20564164|P1|COMPLETED|Overall Study||76
8341954|NCT01302379|20564161|P4|STARTED|Overall Study||83
8341955|NCT01302379|20564162|P3|STARTED|Overall Study||84
8341956|NCT01302379|20564163|P2|STARTED|Overall Study||83
8341957|NCT01302379|20564164|P1|STARTED|Overall Study||83
8341958|NCT01302366|20564188|P1|NOT COMPLETED|Overall Study||5
8341959|NCT01302366|20564188|P1|COMPLETED|Overall Study||15
8341960|NCT01302366|20564188|P1|STARTED|Overall Study||20
8341961|NCT01302119|20564196|P2|NOT COMPLETED|Overall Study||28
8341962|NCT01302119|20564197|P1|NOT COMPLETED|Overall Study||50
8341963|NCT01302119|20564196|P2|COMPLETED|Overall Study||177
8341964|NCT01302119|20564197|P1|COMPLETED|Overall Study||349
8341965|NCT01302119|20564196|P2|STARTED|Overall Study||205
8341966|NCT01302119|20564197|P1|STARTED|Overall Study||399
8341967|NCT01302067|20564212|P3|NOT COMPLETED|Overall Study||98
8341968|NCT01302067|20564213|P2|NOT COMPLETED|Overall Study||34
8341969|NCT01302067|20564214|P1|NOT COMPLETED|Overall Study||78
8341970|NCT01302067|20564212|P3|COMPLETED|Overall Study||681
8341971|NCT01302067|20564213|P2|COMPLETED|Overall Study||352
8341972|NCT01302067|20564214|P1|COMPLETED|Overall Study||712
8341973|NCT01302067|20564212|P3|STARTED|Overall Study||779
8341974|NCT01302067|20564213|P2|STARTED|Overall Study||386
8341975|NCT01302067|20564214|P1|STARTED|Overall Study||790
8341976|NCT01302054|20564285|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
8341977|NCT01302054|20564286|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
8341978|NCT01302054|20564287|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
8341979|NCT01302054|20564285|P3|COMPLETED|Double-Blind Treatment Phase||255
8341980|NCT01302054|20564286|P2|COMPLETED|Double-Blind Treatment Phase||281
8341981|NCT01302054|20564287|P1|COMPLETED|Double-Blind Treatment Phase||0
8341982|NCT01302054|20564285|P3|STARTED|Double-Blind Treatment Phase||301
8341983|NCT01302054|20564286|P2|STARTED|Double-Blind Treatment Phase||308
8341984|NCT01302054|20564287|P1|STARTED|Double-Blind Treatment Phase||0
8341985|NCT01302054|20564285|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
8341986|NCT01302054|20564286|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
8341987|NCT01302054|20564287|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
8341988|NCT01302054|20564285|P3|COMPLETED|Between Open-Label and Double Blind||0
8341989|NCT01302054|20564286|P2|COMPLETED|Between Open-Label and Double Blind||0
8341990|NCT01302054|20564287|P1|COMPLETED|Between Open-Label and Double Blind||609
8341991|NCT01302054|20564285|P3|STARTED|Between Open-Label and Double Blind||0
8341992|NCT01302054|20564286|P2|STARTED|Between Open-Label and Double Blind||0
8341993|NCT01302054|20564287|P1|STARTED|Between Open-Label and Double Blind||611
8341994|NCT01302054|20564285|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341995|NCT01302054|20564286|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341996|NCT01302054|20564287|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
8341997|NCT01302054|20564285|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341998|NCT01302054|20564286|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341999|NCT01302054|20564287|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
8342000|NCT01302054|20564285|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
8342001|NCT01302054|20564286|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
8342002|NCT01302054|20564287|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
8342003|NCT01302041|20564314|P1|NOT COMPLETED|Overall Study||40
8342004|NCT01302041|20564314|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
8342005|NCT01302041|20564314|P1|Treatment Received|Overall Study||67
8342006|NCT01302041|20564314|P1|STARTED|Overall Study||67
8342007|NCT01301963|20564345|P2|NOT COMPLETED|Overall Study||0
8342008|NCT01301963|20564346|P1|NOT COMPLETED|Overall Study||0
8342009|NCT01301963|20564345|P2|COMPLETED|Overall Study||4
8342010|NCT01301963|20564346|P1|COMPLETED|Overall Study||5
8342011|NCT01301963|20564345|P2|STARTED|Overall Study||4
8342012|NCT01301963|20564346|P1|STARTED|Overall Study||5
8342013|NCT01301950|20564356|P2|NOT COMPLETED|Overall Study||1
8342014|NCT01301950|20564357|P1|NOT COMPLETED|Overall Study||0
8342015|NCT01301950|20564356|P2|COMPLETED|Overall Study||14
8342016|NCT01301950|20564357|P1|COMPLETED|Overall Study||15
8342017|NCT01301950|20564356|P2|STARTED|Overall Study||15
8342018|NCT01301950|20564357|P1|STARTED|Overall Study||15
8342019|NCT01301833|20564375|P4|NOT COMPLETED|Overall Study||7
8342020|NCT01301833|20564376|P3|NOT COMPLETED|Overall Study||7
8342021|NCT01301833|20564377|P2|NOT COMPLETED|Overall Study||8
8342022|NCT01301833|20564378|P1|NOT COMPLETED|Overall Study||15
8342023|NCT01301833|20564375|P4|COMPLETED|Overall Study||68
8342024|NCT01301833|20564376|P3|COMPLETED|Overall Study||88
8342025|NCT01301833|20564377|P2|COMPLETED|Overall Study||72
8342026|NCT01301833|20564378|P1|COMPLETED|Overall Study||197
8342027|NCT01301833|20564375|P4|STARTED|Overall Study||75
8342028|NCT01301833|20564376|P3|STARTED|Overall Study||95
8342029|NCT01301833|20564377|P2|STARTED|Overall Study||80
8342030|NCT01301833|20564378|P1|STARTED|Overall Study||212
8342031|NCT01301742|20564404|P2|NOT COMPLETED|Second Intervention||0
8342032|NCT01301742|20564405|P1|NOT COMPLETED|Second Intervention||0
8342033|NCT01301742|20564404|P2|COMPLETED|Second Intervention||9
8342034|NCT01301742|20564405|P1|COMPLETED|Second Intervention||9
8342035|NCT01301742|20564404|P2|STARTED|Second Intervention||9
8342036|NCT01301742|20564405|P1|STARTED|Second Intervention||9
8342037|NCT01301742|20564404|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
8342038|NCT01301742|20564405|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
8342039|NCT01301742|20564404|P2|COMPLETED|Washout Period of at Least 7 Days||9
8342040|NCT01301742|20564405|P1|COMPLETED|Washout Period of at Least 7 Days||9
8342041|NCT01301742|20564404|P2|STARTED|Washout Period of at Least 7 Days||9
8342042|NCT01301742|20564405|P1|STARTED|Washout Period of at Least 7 Days||9
8342043|NCT01301742|20564404|P2|NOT COMPLETED|First Intervention||0
8342044|NCT01301742|20564405|P1|NOT COMPLETED|First Intervention||0
8342045|NCT01301742|20564404|P2|COMPLETED|First Intervention||9
8342046|NCT01301742|20564405|P1|COMPLETED|First Intervention||9
8342047|NCT01301742|20564404|P2|STARTED|First Intervention||9
8342048|NCT01301742|20564405|P1|STARTED|First Intervention||9
8342049|NCT01301729|20564416|P1|NOT COMPLETED|Overall Study||4
8342050|NCT01301729|20564416|P1|COMPLETED|Overall Study||28
8342051|NCT01301729|20564416|P1|STARTED|Overall Study||32
8342052|NCT01301625|20564427|P1|NOT COMPLETED|Overall Study||35
8342053|NCT01301625|20564427|P1|COMPLETED|Overall Study||43
8342054|NCT01301625|20564427|P1|STARTED|Overall Study||78
8342055|NCT01301508|20564499|P2|NOT COMPLETED|Overall Study||3
8342056|NCT01301508|20564500|P1|NOT COMPLETED|Overall Study||1
8342057|NCT01301508|20564499|P2|COMPLETED|Overall Study||22
8342058|NCT01301508|20564500|P1|COMPLETED|Overall Study||20
8342059|NCT01301508|20564499|P2|STARTED|Overall Study||25
8342060|NCT01301508|20564500|P1|STARTED|Overall Study||21
8342061|NCT01301456|20564530|P12|NOT COMPLETED|Stage 2||0
8342062|NCT01301456|20564531|P11|NOT COMPLETED|Stage 2||1
8342063|NCT01301456|20564532|P10|NOT COMPLETED|Stage 2||0
8342064|NCT01301456|20564533|P9|NOT COMPLETED|Stage 2||0
8342065|NCT01301456|20564534|P8|NOT COMPLETED|Stage 2||0
8342066|NCT01301456|20564535|P7|NOT COMPLETED|Stage 2||0
8342067|NCT01301456|20564536|P6|NOT COMPLETED|Stage 2||0
8342068|NCT01301456|20564537|P5|NOT COMPLETED|Stage 2||0
8342069|NCT01301456|20564538|P4|NOT COMPLETED|Stage 2||0
8342070|NCT01301456|20564539|P3|NOT COMPLETED|Stage 2||0
8342071|NCT01301456|20564540|P2|NOT COMPLETED|Stage 2||0
8342072|NCT01301456|20564541|P1|NOT COMPLETED|Stage 2||0
8342073|NCT01301456|20564530|P12|COMPLETED|Stage 2||6
8342074|NCT01301456|20564531|P11|COMPLETED|Stage 2||6
8342075|NCT01301456|20564532|P10|COMPLETED|Stage 2||7
8342076|NCT01301456|20564533|P9|COMPLETED|Stage 2||5
8342077|NCT01301456|20564534|P8|COMPLETED|Stage 2||7
8342078|NCT01301456|20564535|P7|COMPLETED|Stage 2||0
8342079|NCT01301456|20564536|P6|COMPLETED|Stage 2||0
8342080|NCT01301456|20564537|P5|COMPLETED|Stage 2||0
8342081|NCT01301456|20564538|P4|COMPLETED|Stage 2||0
8342082|NCT01301456|20564539|P3|COMPLETED|Stage 2||0
8342083|NCT01301456|20564540|P2|COMPLETED|Stage 2||0
8342084|NCT01301456|20564541|P1|COMPLETED|Stage 2||0
8342085|NCT01301456|20564530|P12|Received Treatment|Stage 2||6
8342086|NCT01301456|20564531|P11|Received Treatment|Stage 2||7
8342087|NCT01301456|20564532|P10|Received Treatment|Stage 2||7
8342088|NCT01301456|20564533|P9|Received Treatment|Stage 2||5
8342089|NCT01301456|20564534|P8|Received Treatment|Stage 2||7
8342090|NCT01301456|20564535|P7|Received Treatment|Stage 2||0
8342091|NCT01301456|20564536|P6|Received Treatment|Stage 2||0
8342092|NCT01301456|20564537|P5|Received Treatment|Stage 2||0
8342093|NCT01301456|20564538|P4|Received Treatment|Stage 2||0
8342094|NCT01301456|20564539|P3|Received Treatment|Stage 2||0
8342095|NCT01301456|20564540|P2|Received Treatment|Stage 2||0
8342096|NCT01301456|20564541|P1|Received Treatment|Stage 2||0
8342097|NCT01301456|20564530|P12|STARTED|Stage 2||6
8342098|NCT01301456|20564531|P11|STARTED|Stage 2||7
8342099|NCT01301456|20564532|P10|STARTED|Stage 2||7
8342100|NCT01301456|20564533|P9|STARTED|Stage 2||5
8342101|NCT01301456|20564534|P8|STARTED|Stage 2||7
8342102|NCT01301456|20564535|P7|STARTED|Stage 2||0
8342103|NCT01301456|20564536|P6|STARTED|Stage 2||0
8342104|NCT01301456|20564537|P5|STARTED|Stage 2||0
8342105|NCT01301456|20564538|P4|STARTED|Stage 2||0
8342106|NCT01301456|20564539|P3|STARTED|Stage 2||0
8342107|NCT01301456|20564540|P2|STARTED|Stage 2||0
8342108|NCT01301456|20564541|P1|STARTED|Stage 2||0
8342109|NCT01301456|20564530|P12|NOT COMPLETED|Stage 1||0
8342110|NCT01301456|20564531|P11|NOT COMPLETED|Stage 1||0
8342111|NCT01301456|20564532|P10|NOT COMPLETED|Stage 1||0
8342112|NCT01301456|20564533|P9|NOT COMPLETED|Stage 1||0
8342113|NCT01301456|20564534|P8|NOT COMPLETED|Stage 1||0
8342114|NCT01301456|20564535|P7|NOT COMPLETED|Stage 1||1
8342115|NCT01301456|20564536|P6|NOT COMPLETED|Stage 1||0
8342116|NCT01301456|20564537|P5|NOT COMPLETED|Stage 1||1
8342117|NCT01301456|20564538|P4|NOT COMPLETED|Stage 1||0
8342118|NCT01301456|20564539|P3|NOT COMPLETED|Stage 1||1
8342119|NCT01301456|20564540|P2|NOT COMPLETED|Stage 1||0
8342120|NCT01301456|20564541|P1|NOT COMPLETED|Stage 1||0
8342121|NCT01301456|20564530|P12|COMPLETED|Stage 1||0
8342122|NCT01301456|20564531|P11|COMPLETED|Stage 1||0
8342123|NCT01301456|20564532|P10|COMPLETED|Stage 1||0
8342124|NCT01301456|20564533|P9|COMPLETED|Stage 1||0
8342125|NCT01301456|20564534|P8|COMPLETED|Stage 1||0
8342126|NCT01301456|20564535|P7|COMPLETED|Stage 1||7
8342127|NCT01301456|20564536|P6|COMPLETED|Stage 1||5
8342128|NCT01301456|20564537|P5|COMPLETED|Stage 1||6
8342129|NCT01301456|20564538|P4|COMPLETED|Stage 1||6
8342130|NCT01301456|20564539|P3|COMPLETED|Stage 1||5
8342131|NCT01301456|20564540|P2|COMPLETED|Stage 1||5
8342132|NCT01301456|20564541|P1|COMPLETED|Stage 1||15
8342133|NCT01301456|20564530|P12|Received Treatment|Stage 1||0
8342134|NCT01301456|20564531|P11|Received Treatment|Stage 1||0
8342135|NCT01301456|20564532|P10|Received Treatment|Stage 1||0
8342136|NCT01301456|20564533|P9|Received Treatment|Stage 1||0
8342137|NCT01301456|20564534|P8|Received Treatment|Stage 1||0
8342138|NCT01301456|20564535|P7|Received Treatment|Stage 1||7
8342139|NCT01301456|20564536|P6|Received Treatment|Stage 1||5
8342140|NCT01301456|20564537|P5|Received Treatment|Stage 1||7
8342141|NCT01301456|20564538|P4|Received Treatment|Stage 1||6
8342142|NCT01301456|20564539|P3|Received Treatment|Stage 1||6
8342143|NCT01301456|20564540|P2|Received Treatment|Stage 1||5
8342144|NCT01301456|20564541|P1|Received Treatment|Stage 1||15
8342145|NCT01301456|20564530|P12|STARTED|Stage 1||0
8342146|NCT01301456|20564531|P11|STARTED|Stage 1||0
8342147|NCT01301456|20564532|P10|STARTED|Stage 1||0
8342148|NCT01301456|20564533|P9|STARTED|Stage 1||0
8342149|NCT01301456|20564534|P8|STARTED|Stage 1||0
8342150|NCT01301456|20564535|P7|STARTED|Stage 1||8
8342151|NCT01301456|20564536|P6|STARTED|Stage 1||5
8342152|NCT01301456|20564537|P5|STARTED|Stage 1||7
8342153|NCT01301456|20564538|P4|STARTED|Stage 1||6
8342154|NCT01301456|20564539|P3|STARTED|Stage 1||6
8342155|NCT01301456|20564540|P2|STARTED|Stage 1||5
8342156|NCT01301456|20564541|P1|STARTED|Stage 1||15
8342157|NCT01301391|20564767|P1|NOT COMPLETED|Overall Study||26
8342158|NCT01301391|20564767|P1|COMPLETED|Overall Study||4
8342159|NCT01301391|20564767|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
8342160|NCT01301274|20564779|P2|NOT COMPLETED|Overall Study||1
8342161|NCT01301274|20564780|P1|NOT COMPLETED|Overall Study||2
8342162|NCT01301274|20564779|P2|COMPLETED|Overall Study||31
8342163|NCT01301274|20564780|P1|COMPLETED|Overall Study||32
8342164|NCT01301274|20564779|P2|STARTED|Overall Study||32
8342165|NCT01301274|20564780|P1|STARTED|Overall Study||34
8342166|NCT01301092|20564795|P3|NOT COMPLETED|Overall Study||1
8342167|NCT01301092|20564796|P2|NOT COMPLETED|Overall Study||0
8342168|NCT01301092|20564797|P1|NOT COMPLETED|Overall Study||0
8342169|NCT01301092|20564795|P3|COMPLETED|Overall Study||7
8342170|NCT01301092|20564796|P2|COMPLETED|Overall Study||16
8342171|NCT01301092|20564797|P1|COMPLETED|Overall Study||6
8342172|NCT01301092|20564795|P3|STARTED|Overall Study||8
8342173|NCT01301092|20564796|P2|STARTED|Overall Study||16
8342174|NCT01301092|20564797|P1|STARTED|Overall Study||6
8342175|NCT01301079|20564814|P2|NOT COMPLETED|Overall Study||2
8342176|NCT01301079|20564815|P1|NOT COMPLETED|Overall Study||2
8342177|NCT01301079|20564814|P2|COMPLETED|Overall Study||28
8342178|NCT01301079|20564815|P1|COMPLETED|Overall Study||28
8342179|NCT01301079|20564814|P2|STARTED|Overall Study||30
8342180|NCT01301079|20564815|P1|STARTED|Overall Study||30
8342181|NCT01301066|20564893|P2|NOT COMPLETED|Overall Study||35
8342182|NCT01301066|20564894|P1|NOT COMPLETED|Overall Study||27
8342183|NCT01301066|20564893|P2|COMPLETED|Overall Study||91
8342184|NCT01301066|20564894|P1|COMPLETED|Overall Study||99
8342185|NCT01301066|20564893|P2|STARTED|Overall Study||126
8342186|NCT01301066|20564894|P1|STARTED|Overall Study||126
8342187|NCT01301027|20564902|P2|NOT COMPLETED|Overall Study||10
8342188|NCT01301027|20564903|P1|NOT COMPLETED|Overall Study||8
8342189|NCT01301027|20564902|P2|COMPLETED|Overall Study||37
8342190|NCT01301027|20564903|P1|COMPLETED|Overall Study||40
8342191|NCT01301027|20564902|P2|STARTED|Overall Study||47
8342192|NCT01301027|20564903|P1|STARTED|Overall Study||48
8342193|NCT01301001|20564915|P2|NOT COMPLETED|Second Intervention||0
8342194|NCT01301001|20564916|P1|NOT COMPLETED|Second Intervention||4
8342195|NCT01301001|20564915|P2|COMPLETED|Second Intervention||36
8342196|NCT01301001|20564916|P1|COMPLETED|Second Intervention||30
8342197|NCT01301001|20564915|P2|STARTED|Second Intervention||36
8342198|NCT01301001|20564916|P1|STARTED|Second Intervention||34
8342199|NCT01301001|20564915|P2|NOT COMPLETED|Washout (2 Weeks)||0
8342200|NCT01301001|20564916|P1|NOT COMPLETED|Washout (2 Weeks)||0
8342201|NCT01301001|20564915|P2|COMPLETED|Washout (2 Weeks)||36
8342202|NCT01301001|20564916|P1|COMPLETED|Washout (2 Weeks)||34
8342203|NCT01301001|20564915|P2|STARTED|Washout (2 Weeks)||36
8342204|NCT01301001|20564916|P1|STARTED|Washout (2 Weeks)||34
8342205|NCT01301001|20564915|P2|NOT COMPLETED|First Intervention||9
8342206|NCT01301001|20564916|P1|NOT COMPLETED|First Intervention||10
8342207|NCT01301001|20564915|P2|COMPLETED|First Intervention||36
8342208|NCT01301001|20564916|P1|COMPLETED|First Intervention||34
8342209|NCT01301001|20564915|P2|STARTED|First Intervention||45
8342210|NCT01301001|20564916|P1|STARTED|First Intervention||44
8342211|NCT01300949|20564929|P3|NOT COMPLETED|Overall Study||0
8342212|NCT01300949|20564930|P2|NOT COMPLETED|Overall Study||0
8342213|NCT01300949|20564931|P1|NOT COMPLETED|Overall Study||0
8342214|NCT01300949|20564929|P3|COMPLETED|Overall Study||35
8342215|NCT01300949|20564930|P2|COMPLETED|Overall Study||125
8342216|NCT01300949|20564931|P1|COMPLETED|Overall Study||154
8342217|NCT01300949|20564929|P3|STARTED|Overall Study||35
8342218|NCT01300949|20564930|P2|STARTED|Overall Study||125
8342219|NCT01300949|20564931|P1|STARTED|Overall Study||154
8342220|NCT01300923|20564939|P2|NOT COMPLETED|Overall Study||2
8342221|NCT01300923|20564940|P1|NOT COMPLETED|Overall Study||0
8342222|NCT01300923|20564939|P2|COMPLETED|Overall Study||0
8342223|NCT01300923|20564940|P1|COMPLETED|Overall Study||12
8342224|NCT01300923|20564939|P2|STARTED|Overall Study||2
8342225|NCT01300923|20564940|P1|STARTED|Overall Study||12
8342226|NCT01300819|20564953|P2|NOT COMPLETED|Overall Study||44
8342227|NCT01300819|20564954|P1|NOT COMPLETED|Overall Study||22
8342228|NCT01300819|20564953|P2|COMPLETED|Overall Study||180
8342229|NCT01300819|20564954|P1|COMPLETED|Overall Study||103
8342230|NCT01300819|20564953|P2|STARTED|Overall Study||224
8342231|NCT01300819|20564954|P1|STARTED|Overall Study||125
8342232|NCT01300767|20564982|P1|NOT COMPLETED|Overall Study||4
8342233|NCT01300767|20564982|P1|COMPLETED|Overall Study||70
8342234|NCT01300767|20564982|P1|STARTED|Overall Study||74
8342235|NCT01300741|20565010|P1|NOT COMPLETED|Overall Study||3
8342236|NCT01300741|20565010|P1|COMPLETED|Overall Study||72
8342237|NCT01300741|20565010|P1|STARTED|Overall Study||75
8342238|NCT01300728|20565040|P2|NOT COMPLETED|Overall Study||1
8342239|NCT01300728|20565041|P1|NOT COMPLETED|Overall Study||2
8342240|NCT01300728|20565040|P2|COMPLETED|Overall Study||25
8342241|NCT01300728|20565041|P1|COMPLETED|Overall Study||24
8342242|NCT01300728|20565040|P2|STARTED|Overall Study||26
8342243|NCT01300728|20565041|P1|STARTED|Overall Study||26
8342244|NCT01300650|20565055|P1|NOT COMPLETED|Overall Study||1
8342245|NCT01300650|20565055|P1|COMPLETED|Overall Study||7
8342246|NCT01300650|20565055|P1|STARTED|Overall Study||8
8342247|NCT01300624|20565061|P1|NOT COMPLETED|Overall Study||0
8342248|NCT01300624|20565061|P1|COMPLETED|Overall Study||11
8342249|NCT01300624|20565061|P1|STARTED|Overall Study||11
8342250|NCT01300572|20565071|P1|NOT COMPLETED|Overall Study||1
8342251|NCT01300572|20565071|P1|COMPLETED|Overall Study||15
8342252|NCT01300572|20565071|P1|STARTED|Overall Study||16
8342253|NCT01300559|20565086|P2|NOT COMPLETED|Overall Study||0
8342254|NCT01300559|20565087|P1|NOT COMPLETED|Overall Study||0
8342255|NCT01300559|20565086|P2|COMPLETED|Overall Study||30
8342256|NCT01300559|20565087|P1|COMPLETED|Overall Study||30
8342257|NCT01300559|20565086|P2|STARTED|Overall Study||30
8342258|NCT01300559|20565087|P1|STARTED|Overall Study||30
8342259|NCT01300546|20565095|P2|NOT COMPLETED|Overall Study||6
8342260|NCT01300546|20565096|P1|NOT COMPLETED|Overall Study||1
8342261|NCT01300546|20565095|P2|COMPLETED|Overall Study||14
8342262|NCT01300546|20565096|P1|COMPLETED|Overall Study||18
8342263|NCT01300546|20565095|P2|STARTED|Overall Study||20
8342264|NCT01300546|20565096|P1|STARTED|Overall Study||19
8342265|NCT01300455|20565126|P2|NOT COMPLETED|Period 2||0
8342266|NCT01300455|20565127|P1|NOT COMPLETED|Period 2||0
8342267|NCT01300455|20565126|P2|COMPLETED|Period 2||13
8342268|NCT01300455|20565127|P1|COMPLETED|Period 2||12
8342269|NCT01300455|20565126|P2|STARTED|Period 2||13
8342270|NCT01300455|20565127|P1|STARTED|Period 2||12
8342271|NCT01300455|20565126|P2|NOT COMPLETED|Washout||0
8342272|NCT01300455|20565127|P1|NOT COMPLETED|Washout||1
8342273|NCT01300455|20565126|P2|COMPLETED|Washout||13
8342274|NCT01300455|20565127|P1|COMPLETED|Washout||12
8342275|NCT01300455|20565126|P2|STARTED|Washout||13
8342276|NCT01300455|20565127|P1|STARTED|Washout||13
8342277|NCT01300455|20565126|P2|NOT COMPLETED|Period 1||0
8342278|NCT01300455|20565127|P1|NOT COMPLETED|Period 1||0
8342279|NCT01300455|20565126|P2|COMPLETED|Period 1||13
8342280|NCT01300455|20565127|P1|COMPLETED|Period 1||13
8342281|NCT01300455|20565126|P2|STARTED|Period 1||13
8342282|NCT01300455|20565127|P1|STARTED|Period 1||13
8342283|NCT01300351|20565147|P2|NOT COMPLETED|Overall Study||38
8342284|NCT01300351|20565148|P1|NOT COMPLETED|Overall Study||36
8342285|NCT01300351|20565147|P2|COMPLETED|Overall Study||72
8342286|NCT01300351|20565148|P1|COMPLETED|Overall Study||75
8342287|NCT01300351|20565147|P2|Received Study Treatment|Overall Study||110
8342288|NCT01300351|20565148|P1|Received Study Treatment|Overall Study||109
8342289|NCT01300351|20565147|P2|STARTED|Overall Study||110
8342290|NCT01300351|20565148|P1|STARTED|Overall Study||111
8342291|NCT01300338|20565164|P2|NOT COMPLETED|Overall Study||0
8342292|NCT01300338|20565165|P1|NOT COMPLETED|Overall Study||5
8342293|NCT01300338|20565164|P2|COMPLETED|Overall Study||25
8342294|NCT01300338|20565165|P1|COMPLETED|Overall Study||20
8342295|NCT01300338|20565164|P2|STARTED|Overall Study||25
8342296|NCT01300338|20565165|P1|STARTED|Overall Study||25
8342297|NCT01300286|20565173|P1|NOT COMPLETED|Overall Study||1
8342298|NCT01300286|20565173|P1|COMPLETED|Overall Study||22
8342299|NCT01300286|20565173|P1|STARTED|Overall Study||23
8342300|NCT01300260|20565183|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
8342301|NCT01300260|20565184|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
8342302|NCT01300260|20565183|P2|COMPLETED|Period 2 of Study: Second Intervention||15
8342303|NCT01300260|20565184|P1|COMPLETED|Period 2 of Study: Second Intervention||14
8342304|NCT01300260|20565183|P2|STARTED|Period 2 of Study: Second Intervention||16
8342305|NCT01300260|20565184|P1|STARTED|Period 2 of Study: Second Intervention||14
8342306|NCT01300260|20565183|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
8342307|NCT01300260|20565184|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
8342308|NCT01300260|20565183|P2|COMPLETED|Washout Period of at Least 28 Days||16
8342309|NCT01300260|20565184|P1|COMPLETED|Washout Period of at Least 28 Days||14
8342310|NCT01300260|20565183|P2|STARTED|Washout Period of at Least 28 Days||16
8342311|NCT01300260|20565184|P1|STARTED|Washout Period of at Least 28 Days||14
8342312|NCT01300260|20565183|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
8342313|NCT01300260|20565184|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
8342314|NCT01300260|20565183|P2|COMPLETED|Period 1 of Study: First Intervention||16
8342315|NCT01300260|20565184|P1|COMPLETED|Period 1 of Study: First Intervention||14
8342316|NCT01300260|20565183|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
8342317|NCT01300260|20565184|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
8342318|NCT01300260|20565183|P2|STARTED|Period 1 of Study: First Intervention||17
8342319|NCT01300260|20565184|P1|STARTED|Period 1 of Study: First Intervention||15
8342320|NCT01300247|20565216|P2|NOT COMPLETED|Overall Study||2
8342321|NCT01300247|20565217|P1|NOT COMPLETED|Overall Study||4
8342322|NCT01300247|20565216|P2|COMPLETED|Overall Study||18
8342323|NCT01300247|20565217|P1|COMPLETED|Overall Study||17
8342324|NCT01300247|20565216|P2|STARTED|Overall Study||20
8342325|NCT01300247|20565217|P1|STARTED|Overall Study||21
8342326|NCT01300234|20565249|P2|NOT COMPLETED|Overall Study||27
8342327|NCT01300234|20565250|P1|NOT COMPLETED|Overall Study||28
8342328|NCT01300234|20565249|P2|COMPLETED|Overall Study||228
8342329|NCT01300234|20565250|P1|COMPLETED|Overall Study||229
8342330|NCT01300234|20565249|P2|STARTED|Overall Study||255
8342331|NCT01300234|20565250|P1|STARTED|Overall Study||257
8342332|NCT01300065|20565286|P2|NOT COMPLETED|Overall Study||3
8342333|NCT01300065|20565287|P1|NOT COMPLETED|Overall Study||6
8342334|NCT01300065|20565286|P2|COMPLETED|Overall Study||217
8342335|NCT01300065|20565287|P1|COMPLETED|Overall Study||215
8342336|NCT01300065|20565286|P2|STARTED|Overall Study||220
8342337|NCT01300065|20565287|P1|STARTED|Overall Study||221
8342338|NCT01300052|20565297|P2|NOT COMPLETED|Overall Study||3
8342339|NCT01300052|20565298|P1|NOT COMPLETED|Overall Study||6
8342340|NCT01300052|20565297|P2|COMPLETED|Overall Study||19
8342341|NCT01300052|20565298|P1|COMPLETED|Overall Study||40
8342342|NCT01300052|20565297|P2|STARTED|Overall Study||22
8342343|NCT01300052|20565298|P1|STARTED|Overall Study||46
8342344|NCT01299961|20565316|P1|NOT COMPLETED|Overall Study||6
8342345|NCT01299961|20565316|P1|COMPLETED|Overall Study||19
8342346|NCT01299961|20565316|P1|STARTED|Overall Study||25
8342347|NCT01299909|20565325|P3|NOT COMPLETED|Overall Study||17
8342348|NCT01299909|20565326|P2|NOT COMPLETED|Overall Study||18
8342349|NCT01299909|20565327|P1|NOT COMPLETED|Overall Study||22
8342350|NCT01299909|20565325|P3|COMPLETED|Overall Study||23
8342351|NCT01299909|20565326|P2|COMPLETED|Overall Study||49
8342352|NCT01299909|20565327|P1|COMPLETED|Overall Study||46
8342353|NCT01299909|20565325|P3|STARTED|Overall Study||40
8342354|NCT01299909|20565326|P2|STARTED|Overall Study||67
8342355|NCT01299909|20565327|P1|STARTED|Overall Study||68
8342356|NCT01299896|20565342|P2|NOT COMPLETED|Overall Study||18
8342357|NCT01299896|20565343|P1|NOT COMPLETED|Overall Study||1
8342358|NCT01299896|20565342|P2|COMPLETED|Overall Study||296
8342359|NCT01299896|20565343|P1|COMPLETED|Overall Study||318
8342360|NCT01299896|20565342|P2|STARTED|Overall Study||314
8342361|NCT01299896|20565343|P1|STARTED|Overall Study||319
8342362|NCT01299805|20565351|P2|NOT COMPLETED|Overall Study||0
8342363|NCT01299805|20565352|P1|NOT COMPLETED|Overall Study||2
8342364|NCT01299805|20565351|P2|COMPLETED|Overall Study||5
8342365|NCT01299805|20565352|P1|COMPLETED|Overall Study||10
8342366|NCT01299805|20565351|P2|STARTED|Overall Study||5
8342367|NCT01299805|20565352|P1|STARTED|Overall Study||12
8342368|NCT01299766|20565382|P2|NOT COMPLETED|Overall Study||23
8342369|NCT01299766|20565383|P1|NOT COMPLETED|Overall Study||34
8342370|NCT01299766|20565382|P2|COMPLETED|Overall Study||87
8342371|NCT01299766|20565383|P1|COMPLETED|Overall Study||77
8342372|NCT01299766|20565382|P2|STARTED|Overall Study||110
8342373|NCT01299766|20565383|P1|STARTED|Overall Study||111
8342374|NCT01299727|20565394|P3|NOT COMPLETED|Overall Study||4
8342375|NCT01299727|20565395|P2|NOT COMPLETED|Overall Study||4
8342376|NCT01299727|20565396|P1|NOT COMPLETED|Overall Study||4
8342377|NCT01299727|20565394|P3|COMPLETED|Overall Study||0
8342378|NCT01299727|20565395|P2|COMPLETED|Overall Study||0
8342379|NCT01299727|20565396|P1|COMPLETED|Overall Study||0
8342380|NCT01299727|20565394|P3|STARTED|Overall Study||4
8342381|NCT01299727|20565395|P2|STARTED|Overall Study||4
8342382|NCT01299727|20565396|P1|STARTED|Overall Study||4
8342383|NCT01299610|20565443|P3|NOT COMPLETED|Overall Study||0
8342384|NCT01299610|20565444|P2|NOT COMPLETED|Overall Study||0
8342385|NCT01299610|20565445|P1|NOT COMPLETED|Overall Study||0
8342386|NCT01299610|20565443|P3|COMPLETED|Overall Study||10
8342387|NCT01299610|20565444|P2|COMPLETED|Overall Study||5
8342388|NCT01299610|20565445|P1|COMPLETED|Overall Study||10
8342389|NCT01299610|20565443|P3|STARTED|Overall Study||10
8342390|NCT01299610|20565444|P2|STARTED|Overall Study||5
8342391|NCT01299610|20565445|P1|STARTED|Overall Study||10
8342392|NCT01299584|20565490|P1|NOT COMPLETED|Overall Study||9
8342393|NCT01299584|20565490|P1|COMPLETED|Overall Study||766
8342394|NCT01299584|20565490|P1|STARTED|Overall Study||775
8342395|NCT01299571|20565497|P1|NOT COMPLETED|Overall Study||107
8342396|NCT01299571|20565497|P1|COMPLETED|Overall Study||3870
8342397|NCT01299571|20565497|P1|STARTED|Overall Study||3977
8342398|NCT01299480|20565508|P5|NOT COMPLETED|Overall Study||20
8342399|NCT01299480|20565509|P4|NOT COMPLETED|Overall Study||25
8342400|NCT01299480|20565510|P3|NOT COMPLETED|Overall Study||41
8342401|NCT01299480|20565511|P2|NOT COMPLETED|Overall Study||35
8342402|NCT01299480|20565512|P1|NOT COMPLETED|Overall Study||42
8342403|NCT01299480|20565508|P5|COMPLETED|Overall Study||123
8342404|NCT01299480|20565509|P4|COMPLETED|Overall Study||261
8342405|NCT01299480|20565510|P3|COMPLETED|Overall Study||386
8342406|NCT01299480|20565511|P2|COMPLETED|Overall Study||395
8342407|NCT01299480|20565512|P1|COMPLETED|Overall Study||385
8342408|NCT01299480|20565508|P5|STARTED|Overall Study||143
8342409|NCT01299480|20565509|P4|STARTED|Overall Study||286
8342410|NCT01299480|20565510|P3|STARTED|Overall Study||427
8342411|NCT01299480|20565511|P2|STARTED|Overall Study||430
8342412|NCT01299480|20565512|P1|STARTED|Overall Study||427
8342413|NCT01299454|20565551|P4|NOT COMPLETED|Overall Study||0
8342414|NCT01299454|20565552|P3|NOT COMPLETED|Overall Study||0
8342415|NCT01299454|20565553|P2|NOT COMPLETED|Overall Study||0
8342416|NCT01299454|20565554|P1|NOT COMPLETED|Overall Study||0
8342417|NCT01299454|20565551|P4|COMPLETED|Overall Study||23
8342418|NCT01299454|20565552|P3|COMPLETED|Overall Study||6
8342419|NCT01299454|20565553|P2|COMPLETED|Overall Study||8
8342420|NCT01299454|20565554|P1|COMPLETED|Overall Study||8
8342421|NCT01299454|20565551|P4|STARTED|Overall Study||23
8342422|NCT01299454|20565552|P3|STARTED|Overall Study||6
8342423|NCT01299454|20565553|P2|STARTED|Overall Study||8
8342424|NCT01299454|20565554|P1|STARTED|Overall Study||8
8342425|NCT01299389|20565714|P4|NOT COMPLETED|Post-observational||6
8342426|NCT01299389|20565715|P3|NOT COMPLETED|Post-observational||12
8342427|NCT01299389|20565716|P2|NOT COMPLETED|Post-observational||0
8342428|NCT01299389|20565717|P1|NOT COMPLETED|Post-observational||0
8342429|NCT01299389|20565714|P4|COMPLETED|Post-observational||149
8342430|NCT01299389|20565715|P3|COMPLETED|Post-observational||144
8342431|NCT01299389|20565716|P2|COMPLETED|Post-observational||0
8342432|NCT01299389|20565717|P1|COMPLETED|Post-observational||0
8342433|NCT01299389|20565714|P4|STARTED|Post-observational||155
8342434|NCT01299389|20565715|P3|STARTED|Post-observational||156
8342435|NCT01299389|20565716|P2|STARTED|Post-observational||0
8342436|NCT01299389|20565717|P1|STARTED|Post-observational||0
8342437|NCT01299389|20565714|P4|NOT COMPLETED|Double-blind||0
8342438|NCT01299389|20565715|P3|NOT COMPLETED|Double-blind||0
8342439|NCT01299389|20565716|P2|NOT COMPLETED|Double-blind||64
8342440|NCT01299389|20565717|P1|NOT COMPLETED|Double-blind||109
8342441|NCT01299389|20565714|P4|COMPLETED|Double-blind||0
8342442|NCT01299389|20565715|P3|COMPLETED|Double-blind||0
8342443|NCT01299389|20565716|P2|COMPLETED|Double-blind||95
8342444|NCT01299389|20565717|P1|COMPLETED|Double-blind||55
8342445|NCT01299389|20565714|P4|STARTED|Double-blind||0
8342446|NCT01299389|20565715|P3|STARTED|Double-blind||0
8342447|NCT01299389|20565716|P2|STARTED|Double-blind||159
8342448|NCT01299389|20565717|P1|STARTED|Double-blind||164
8342449|NCT01299376|20565739|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
8342450|NCT01299376|20565740|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
8342451|NCT01299376|20565739|P2|COMPLETED|Extension (Weeks 9 to 52)||118
8342452|NCT01299376|20565740|P1|COMPLETED|Extension (Weeks 9 to 52)||124
8342453|NCT01299376|20565739|P2|STARTED|Extension (Weeks 9 to 52)||133
8342454|NCT01299376|20565740|P1|STARTED|Extension (Weeks 9 to 52)||134
8342455|NCT01299376|20565739|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
8342456|NCT01299376|20565740|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
8342457|NCT01299376|20565739|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
8342458|NCT01299376|20565740|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
8342459|NCT01299376|20565739|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
8342460|NCT01299376|20565740|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
8342461|NCT01299285|20565770|P1|NOT COMPLETED|Overall Study||0
8342462|NCT01299285|20565770|P1|COMPLETED|Overall Study||6
8342463|NCT01299285|20565770|P1|STARTED|Overall Study||6
8342464|NCT01299272|20565783|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
8342465|NCT01299272|20565784|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
8342466|NCT01299272|20565785|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
8342467|NCT01299272|20565786|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
8342468|NCT01299272|20565783|P4|COMPLETED|Double-blind (DB) Randomized Period||234
8342469|NCT01299272|20565784|P3|COMPLETED|Double-blind (DB) Randomized Period||224
8342470|NCT01299272|20565785|P2|COMPLETED|Double-blind (DB) Randomized Period||0
8342471|NCT01299272|20565786|P1|COMPLETED|Double-blind (DB) Randomized Period||0
8342472|NCT01299272|20565783|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
8342473|NCT01299272|20565784|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
8342474|NCT01299272|20565785|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
8342475|NCT01299272|20565786|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
8342476|NCT01299272|20565783|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8342477|NCT01299272|20565784|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
8342478|NCT01299272|20565785|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8342479|NCT01299272|20565786|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8342480|NCT01299272|20565783|P4|STARTED|Double-blind (DB) Randomized Period||292
8342481|NCT01299272|20565784|P3|STARTED|Double-blind (DB) Randomized Period||294
8342482|NCT01299272|20565785|P2|STARTED|Double-blind (DB) Randomized Period||0
8342483|NCT01299272|20565786|P1|STARTED|Double-blind (DB) Randomized Period||0
8342484|NCT01299272|20565783|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8342485|NCT01299272|20565784|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8342486|NCT01299272|20565785|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
8342487|NCT01299272|20565786|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8342488|NCT01299272|20565783|P4|COMPLETED|Stabilization Open-label (OL) Period||0
8342489|NCT01299272|20565784|P3|COMPLETED|Stabilization Open-label (OL) Period||0
8342490|NCT01299272|20565785|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
8342491|NCT01299272|20565786|P1|COMPLETED|Stabilization Open-label (OL) Period||0
8342492|NCT01299272|20565783|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8342493|NCT01299272|20565784|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8342494|NCT01299272|20565785|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
8342495|NCT01299272|20565786|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8342496|NCT01299272|20565783|P4|STARTED|Stabilization Open-label (OL) Period||0
8342497|NCT01299272|20565784|P3|STARTED|Stabilization Open-label (OL) Period||0
8342498|NCT01299272|20565785|P2|STARTED|Stabilization Open-label (OL) Period||835
8342499|NCT01299272|20565786|P1|STARTED|Stabilization Open-label (OL) Period||0
8342500|NCT01299272|20565783|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
8342501|NCT01299272|20565784|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
8342502|NCT01299272|20565785|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
8342503|NCT01299272|20565786|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
8342504|NCT01299272|20565783|P4|COMPLETED|Acute Open-label (OL) Period||0
8342505|NCT01299272|20565784|P3|COMPLETED|Acute Open-label (OL) Period||0
8342506|NCT01299272|20565785|P2|COMPLETED|Acute Open-label (OL) Period||0
8342507|NCT01299272|20565786|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
8342508|NCT01299272|20565783|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8342509|NCT01299272|20565784|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8342510|NCT01299272|20565785|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8342511|NCT01299272|20565786|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
8342512|NCT01299272|20565783|P4|STARTED|Acute Open-label (OL) Period||0
8342513|NCT01299272|20565784|P3|STARTED|Acute Open-label (OL) Period||0
8342514|NCT01299272|20565785|P2|STARTED|Acute Open-label (OL) Period||0
8342515|NCT01299272|20565786|P1|STARTED|Acute Open-label (OL) Period||1249
8342516|NCT01299116|20565841|P3|NOT COMPLETED|Overall Study||11
8342517|NCT01299116|20565842|P2|NOT COMPLETED|Overall Study||9
8342518|NCT01299116|20565843|P1|NOT COMPLETED|Overall Study||65
8342519|NCT01299116|20565841|P3|COMPLETED|Overall Study||184
8342520|NCT01299116|20565842|P2|COMPLETED|Overall Study||168
8342521|NCT01299116|20565843|P1|COMPLETED|Overall Study||457
8342522|NCT01299116|20565841|P3|STARTED|Overall Study||195
8342523|NCT01299116|20565842|P2|STARTED|Overall Study||177
8342524|NCT01299116|20565843|P1|STARTED|Overall Study||522
8342525|NCT01299103|20565860|P3|NOT COMPLETED|Overall Study||2
8342526|NCT01299103|20565861|P2|NOT COMPLETED|Overall Study||2
8342527|NCT01299103|20565862|P1|NOT COMPLETED|Overall Study||0
8342528|NCT01299103|20565860|P3|COMPLETED|Overall Study||8
8342529|NCT01299103|20565861|P2|COMPLETED|Overall Study||13
8342530|NCT01299103|20565862|P1|COMPLETED|Overall Study||15
8342531|NCT01299103|20565860|P3|STARTED|Overall Study||10
8342532|NCT01299103|20565861|P2|STARTED|Overall Study||15
8342533|NCT01299103|20565862|P1|STARTED|Overall Study||15
8342534|NCT01299090|20565873|P1|NOT COMPLETED|Overall Study||0
8342535|NCT01299090|20565873|P1|COMPLETED|Overall Study||49
8342536|NCT01299090|20565873|P1|STARTED|Overall Study||49
8342537|NCT01299077|20565878|P1|NOT COMPLETED|Overall Study||0
8342538|NCT01299077|20565878|P1|COMPLETED|Overall Study||478
8342539|NCT01299077|20565878|P1|STARTED|Overall Study||478
8342540|NCT01299038|20565888|P2|NOT COMPLETED|Overall Study||0
8342541|NCT01299038|20565889|P1|NOT COMPLETED|Overall Study||1
8342542|NCT01299038|20565888|P2|COMPLETED|Overall Study|Evaluable|10
8342543|NCT01299038|20565889|P1|COMPLETED|Overall Study|Evaluable|9
8342544|NCT01299038|20565888|P2|STARTED|Overall Study|Consented|10
8342545|NCT01299038|20565889|P1|STARTED|Overall Study|Consented|10
8342546|NCT01299025|20565897|P2|NOT COMPLETED|Overall Study||1
8342547|NCT01299025|20565898|P1|NOT COMPLETED|Overall Study||3
8342548|NCT01299025|20565897|P2|COMPLETED|Overall Study||41
8342549|NCT01299025|20565898|P1|COMPLETED|Overall Study||39
8342550|NCT01299025|20565897|P2|STARTED|Overall Study||42
8342551|NCT01299025|20565898|P1|STARTED|Overall Study||42
8342552|NCT01298921|20565912|P2|NOT COMPLETED|Overall Study||0
8342553|NCT01298921|20565913|P1|NOT COMPLETED|Overall Study||0
8342554|NCT01298921|20565912|P2|COMPLETED|Overall Study||0
8342555|NCT01298921|20565913|P1|COMPLETED|Overall Study||0
8342556|NCT01298921|20565912|P2|STARTED|Overall Study||0
8342557|NCT01298921|20565913|P1|STARTED|Overall Study||0
8342558|NCT01298778|20565923|P2|NOT COMPLETED|Overall Study||6
8342559|NCT01298778|20565924|P1|NOT COMPLETED|Overall Study||3
8342560|NCT01298778|20565923|P2|COMPLETED|Overall Study||30
8342561|NCT01298778|20565924|P1|COMPLETED|Overall Study||30
8342562|NCT01298778|20565923|P2|STARTED|Overall Study||36
8342563|NCT01298778|20565924|P1|STARTED|Overall Study||33
8342564|NCT01298765|20565944|P1|NOT COMPLETED|Long-Term Treatment Period||99
8342565|NCT01298765|20565944|P1|COMPLETED|Long-Term Treatment Period||127
8342566|NCT01298765|20565944|P1|STARTED|Long-Term Treatment Period||226
8342567|NCT01298765|20565944|P1|NOT COMPLETED|Titration Period||76
8342568|NCT01298765|20565944|P1|COMPLETED|Titration Period||226
8342569|NCT01298765|20565944|P1|STARTED|Titration Period||302
8342570|NCT01298752|20565954|P2|NOT COMPLETED|Overall Study||26
8342571|NCT01298752|20565955|P1|NOT COMPLETED|Overall Study||43
8342572|NCT01298752|20565954|P2|COMPLETED|Overall Study||31
8342573|NCT01298752|20565955|P1|COMPLETED|Overall Study||77
8342574|NCT01298752|20565954|P2|STARTED|Overall Study||57
8342575|NCT01298752|20565955|P1|STARTED|Overall Study||120
8342576|NCT01298700|20565965|P2|NOT COMPLETED|Overall Study||100
8342577|NCT01298700|20565966|P1|NOT COMPLETED|Overall Study||101
8342578|NCT01298700|20565965|P2|COMPLETED|Overall Study||303
8342579|NCT01298700|20565966|P1|COMPLETED|Overall Study||302
8342580|NCT01298700|20565965|P2|Safety Population: Received Study Drug|Overall Study||398
8342581|NCT01298700|20565966|P1|Safety Population: Received Study Drug|Overall Study||400
8342582|NCT01298700|20565965|P2|STARTED|Overall Study||403
8342583|NCT01298700|20565966|P1|STARTED|Overall Study||403
8342584|NCT01298661|20565977|P3|NOT COMPLETED|Overall Study||2
8342585|NCT01298661|20565978|P2|NOT COMPLETED|Overall Study||0
8342586|NCT01298661|20565979|P1|NOT COMPLETED|Overall Study||2
8342587|NCT01298661|20565977|P3|COMPLETED|Overall Study||32
8342588|NCT01298661|20565978|P2|COMPLETED|Overall Study||24
8342589|NCT01298661|20565979|P1|COMPLETED|Overall Study||31
8342590|NCT01298661|20565977|P3|STARTED|Overall Study||34
8342591|NCT01298661|20565978|P2|STARTED|Overall Study||24
8342592|NCT01298661|20565979|P1|STARTED|Overall Study||33
8342593|NCT01298648|20566057|P1|NOT COMPLETED|Overall Study||23
8342594|NCT01298648|20566057|P1|COMPLETED|Overall Study||1693
8342595|NCT01298648|20566057|P1|STARTED|Overall Study||1716
8342596|NCT01298596|20566068|P2|NOT COMPLETED|Overall Study||33
8342597|NCT01298596|20566069|P1|NOT COMPLETED|Overall Study||28
8342598|NCT01298596|20566068|P2|COMPLETED|Overall Study||167
8342599|NCT01298596|20566069|P1|COMPLETED|Overall Study||172
8342600|NCT01298596|20566068|P2|STARTED|Overall Study||200
8342601|NCT01298596|20566069|P1|STARTED|Overall Study||200
8342602|NCT01298570|20566079|P2|NOT COMPLETED|Overall Study||61
8342603|NCT01298570|20566080|P1|NOT COMPLETED|Overall Study||120
8342604|NCT01298570|20566079|P2|COMPLETED|Overall Study||0
8342605|NCT01298570|20566080|P1|COMPLETED|Overall Study||0
8342606|NCT01298570|20566079|P2|STARTED|Overall Study||61
8342607|NCT01298570|20566080|P1|STARTED|Overall Study||120
8342608|NCT01298544|20566096|P1|NOT COMPLETED|Overall Study||0
8342609|NCT01298544|20566096|P1|COMPLETED|Overall Study||335
8342610|NCT01298544|20566096|P1|STARTED|Overall Study||335
8342611|NCT01298531|20566107|P2|NOT COMPLETED|Overall Study||7
8342612|NCT01298531|20566108|P1|NOT COMPLETED|Overall Study||9
8342613|NCT01298531|20566107|P2|COMPLETED|Overall Study||41
8342614|NCT01298531|20566108|P1|COMPLETED|Overall Study||33
8342615|NCT01298531|20566107|P2|STARTED|Overall Study||48
8342616|NCT01298531|20566108|P1|STARTED|Overall Study||42
8342617|NCT01298518|20566237|P3|NOT COMPLETED|Overall Study||1
8342618|NCT01298518|20566238|P2|NOT COMPLETED|Overall Study||0
8342619|NCT01298518|20566239|P1|NOT COMPLETED|Overall Study||0
8342620|NCT01298518|20566237|P3|COMPLETED|Overall Study||15
8342621|NCT01298518|20566238|P2|COMPLETED|Overall Study||16
8342622|NCT01298518|20566239|P1|COMPLETED|Overall Study||16
8342623|NCT01298518|20566237|P3|STARTED|Overall Study||16
8342624|NCT01298518|20566238|P2|STARTED|Overall Study||16
8342625|NCT01298518|20566239|P1|STARTED|Overall Study||16
8342626|NCT01298492|20566291|P1|NOT COMPLETED|Overall Study||119
8342627|NCT01298492|20566291|P1|COMPLETED|Overall Study||149
8342628|NCT01298492|20566291|P1|STARTED|Overall Study||268
8342629|NCT01298362|20566299|P2|NOT COMPLETED|Overall Study||43
8342630|NCT01298362|20566300|P1|NOT COMPLETED|Overall Study||38
8342631|NCT01298362|20566299|P2|COMPLETED|Overall Study||123
8342632|NCT01298362|20566300|P1|COMPLETED|Overall Study||86
8342633|NCT01298362|20566299|P2|STARTED|Overall Study||166
8342634|NCT01298362|20566300|P1|STARTED|Overall Study||124
8342635|NCT01298323|20566320|P2|NOT COMPLETED|Overall Study||88
8342636|NCT01298323|20566321|P1|NOT COMPLETED|Overall Study||86
8342637|NCT01298323|20566320|P2|COMPLETED|Overall Study||15
8342638|NCT01298323|20566321|P1|COMPLETED|Overall Study||16
8342639|NCT01298323|20566320|P2|Ongoing|Overall Study||55
8342640|NCT01298323|20566321|P1|Ongoing|Overall Study||55
8342641|NCT01298323|20566320|P2|STARTED|Overall Study||103
8342642|NCT01298323|20566321|P1|STARTED|Overall Study||102
8342643|NCT01298219|20566329|P2|NOT COMPLETED|Overall Study||36
8342644|NCT01298219|20566330|P1|NOT COMPLETED|Overall Study||50
8342645|NCT01298219|20566329|P2|COMPLETED|Overall Study||184
8342646|NCT01298219|20566330|P1|COMPLETED|Overall Study||169
8342647|NCT01298219|20566329|P2|Safety Analysis Set|Overall Study||220
8342648|NCT01298219|20566330|P1|Safety Analysis Set|Overall Study||219
8342649|NCT01298219|20566329|P2|Intention to Treat (ITT)|Overall Study||220
8342650|NCT01298219|20566330|P1|Intention to Treat (ITT)|Overall Study||219
8342651|NCT01298219|20566329|P2|STARTED|Overall Study||220
8342652|NCT01298219|20566330|P1|STARTED|Overall Study||219
8342653|NCT01298193|20566344|P1|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
8342654|NCT01298193|20566344|P1|COMPLETED|Efficacy Phase (Second Cycle)||23
8342655|NCT01298193|20566344|P1|STARTED|Efficacy Phase (Second Cycle)||24
8342656|NCT01298193|20566344|P1|NOT COMPLETED|Observational Phase (First Cycle)||27
8342657|NCT01298193|20566344|P1|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
8342658|NCT01298193|20566344|P1|STARTED|Observational Phase (First Cycle)||212
8342659|NCT01298167|20566359|P2|NOT COMPLETED|Overall Study||0
8342660|NCT01298167|20566360|P1|NOT COMPLETED|Overall Study||1
8342661|NCT01298167|20566359|P2|COMPLETED|Overall Study||8
8342662|NCT01298167|20566360|P1|COMPLETED|Overall Study||5
8342663|NCT01298167|20566359|P2|STARTED|Overall Study||8
8342664|NCT01298167|20566360|P1|STARTED|Overall Study||6
8342665|NCT01298141|20566366|P1|NOT COMPLETED|Overall Study||31
8342666|NCT01298141|20566366|P1|COMPLETED|Overall Study||140
8342667|NCT01298141|20566366|P1|Treated|Overall Study||167
8342668|NCT01298141|20566366|P1|STARTED|Overall Study||171
8342669|NCT01298128|20566378|P2|NOT COMPLETED|Overall Study||8
8342670|NCT01298128|20566379|P1|NOT COMPLETED|Overall Study||9
8342671|NCT01298128|20566378|P2|COMPLETED|Overall Study||27
8342672|NCT01298128|20566379|P1|COMPLETED|Overall Study||26
8342673|NCT01298128|20566378|P2|STARTED|Overall Study||35
8342674|NCT01298128|20566379|P1|STARTED|Overall Study||35
8342675|NCT01298063|20566390|P5|NOT COMPLETED|Overall Study||0
8342676|NCT01298063|20566391|P4|NOT COMPLETED|Overall Study||0
8342677|NCT01298063|20566392|P3|NOT COMPLETED|Overall Study||0
8342678|NCT01298063|20566393|P2|NOT COMPLETED|Overall Study||0
8342679|NCT01298063|20566394|P1|NOT COMPLETED|Overall Study||0
8342680|NCT01298063|20566390|P5|COMPLETED|Overall Study||8
8342681|NCT01298063|20566391|P4|COMPLETED|Overall Study||8
8342682|NCT01298063|20566392|P3|COMPLETED|Overall Study||8
8342683|NCT01298063|20566393|P2|COMPLETED|Overall Study||3
8342684|NCT01298063|20566394|P1|COMPLETED|Overall Study||8
8342685|NCT01298063|20566390|P5|STARTED|Overall Study||8
8342686|NCT01298063|20566391|P4|STARTED|Overall Study||8
8342687|NCT01298063|20566392|P3|STARTED|Overall Study||8
8342688|NCT01298063|20566393|P2|STARTED|Overall Study||3
8342689|NCT01298063|20566394|P1|STARTED|Overall Study||8
8342690|NCT01297985|20566423|P2|NOT COMPLETED|Overall Study||53
8342691|NCT01297985|20566424|P1|NOT COMPLETED|Overall Study||55
8342692|NCT01297985|20566423|P2|COMPLETED|Overall Study||163
8342693|NCT01297985|20566424|P1|COMPLETED|Overall Study||157
8342694|NCT01297985|20566423|P2|STARTED|Overall Study||216
8342695|NCT01297985|20566424|P1|STARTED|Overall Study||212
8342702|NCT01297920|20566490|P3|NOT COMPLETED|Overall Study||57
8342703|NCT01297920|20566491|P2|NOT COMPLETED|Overall Study||27
8342704|NCT01297920|20566492|P1|NOT COMPLETED|Overall Study||58
8342705|NCT01297920|20566490|P3|COMPLETED|Overall Study||178
8342706|NCT01297920|20566491|P2|COMPLETED|Overall Study||207
8342707|NCT01297920|20566492|P1|COMPLETED|Overall Study||163
8342708|NCT01297920|20566490|P3|STARTED|Overall Study||235
8342709|NCT01297920|20566491|P2|STARTED|Overall Study||234
8342710|NCT01297920|20566492|P1|STARTED|Overall Study||221
8342711|NCT01297595|20566500|P2|NOT COMPLETED|Second Intervention Period||0
8342712|NCT01297595|20566501|P1|NOT COMPLETED|Second Intervention Period||0
8342713|NCT01297595|20566500|P2|COMPLETED|Second Intervention Period||11
8342714|NCT01297595|20566501|P1|COMPLETED|Second Intervention Period||11
8342715|NCT01297595|20566500|P2|STARTED|Second Intervention Period||11
8342716|NCT01297595|20566501|P1|STARTED|Second Intervention Period||11
8342717|NCT01297595|20566500|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
8342718|NCT01297595|20566501|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
8342719|NCT01297595|20566500|P2|COMPLETED|Washout Period (At Least 14 Days)||11
8342720|NCT01297595|20566501|P1|COMPLETED|Washout Period (At Least 14 Days)||11
8342721|NCT01297595|20566500|P2|STARTED|Washout Period (At Least 14 Days)||11
8342722|NCT01297595|20566501|P1|STARTED|Washout Period (At Least 14 Days)||11
8342723|NCT01297595|20566500|P2|NOT COMPLETED|First Intervention Period||0
8342724|NCT01297595|20566501|P1|NOT COMPLETED|First Intervention Period||0
8342725|NCT01297595|20566500|P2|COMPLETED|First Intervention Period||11
8342726|NCT01297595|20566501|P1|COMPLETED|First Intervention Period||11
8342727|NCT01297595|20566500|P2|STARTED|First Intervention Period||11
8342728|NCT01297595|20566501|P1|STARTED|First Intervention Period||11
8342729|NCT01297517|20566536|P3|NOT COMPLETED|Overall Study||27
8342730|NCT01297517|20566537|P2|NOT COMPLETED|Overall Study||12
8342731|NCT01297517|20566538|P1|NOT COMPLETED|Overall Study||27
8342732|NCT01297517|20566536|P3|COMPLETED|Overall Study||193
8342733|NCT01297517|20566537|P2|COMPLETED|Overall Study||214
8342734|NCT01297517|20566538|P1|COMPLETED|Overall Study||187
8342735|NCT01297517|20566536|P3|STARTED|Overall Study||220
8342736|NCT01297517|20566537|P2|STARTED|Overall Study||226
8342737|NCT01297517|20566538|P1|STARTED|Overall Study||214
8342738|NCT01297504|20566546|P1|NOT COMPLETED|Overall Study||67
8342739|NCT01297504|20566546|P1|COMPLETED|Overall Study||397
8342740|NCT01297504|20566546|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
8342741|NCT01297504|20566546|P1|STARTED|Overall Study||464
8342742|NCT01297491|20566560|P2|NOT COMPLETED|Overall Study||33
8342743|NCT01297491|20566561|P1|NOT COMPLETED|Overall Study||30
8342744|NCT01297491|20566560|P2|COMPLETED|Overall Study||0
8342745|NCT01297491|20566561|P1|COMPLETED|Overall Study||0
8342746|NCT01297491|20566560|P2|STARTED|Overall Study||33
8342747|NCT01297491|20566561|P1|STARTED|Overall Study||30
8342748|NCT01297465|20566579|P2|NOT COMPLETED|Overall Study||10
8342749|NCT01297465|20566580|P1|NOT COMPLETED|Overall Study||8
8342750|NCT01297465|20566579|P2|COMPLETED|Overall Study||93
8342751|NCT01297465|20566580|P1|COMPLETED|Overall Study||91
8342752|NCT01297465|20566579|P2|STARTED|Overall Study||103
8342753|NCT01297465|20566580|P1|STARTED|Overall Study||99
8342754|NCT01297348|20566614|P2|NOT COMPLETED|Overall Study||0
8342755|NCT01297348|20566615|P1|NOT COMPLETED|Overall Study||0
8342756|NCT01297348|20566614|P2|COMPLETED|Overall Study||586401
8342757|NCT01297348|20566615|P1|COMPLETED|Overall Study||12281
8342758|NCT01297348|20566614|P2|STARTED|Overall Study||586401
8342759|NCT01297348|20566615|P1|STARTED|Overall Study||12281
8342760|NCT01297335|20566625|P1|NOT COMPLETED|Overall Study||0
8342761|NCT01297335|20566625|P1|COMPLETED|Overall Study||10
8342762|NCT01297335|20566625|P1|STARTED|Overall Study||10
8342763|NCT01297322|20566633|P2|NOT COMPLETED|Overall Study||4
8342764|NCT01297322|20566634|P1|NOT COMPLETED|Overall Study||1
8342765|NCT01297322|20566633|P2|COMPLETED|Overall Study||274
8342766|NCT01297322|20566634|P1|COMPLETED|Overall Study||141
8342767|NCT01297322|20566633|P2|STARTED|Overall Study||278
8342768|NCT01297322|20566634|P1|STARTED|Overall Study||142
8342769|NCT01297309|20566653|P1|NOT COMPLETED|Overall Study||14
8342770|NCT01297309|20566653|P1|COMPLETED|Overall Study||37
8342771|NCT01297309|20566653|P1|Started Extension Period|Overall Study||46
8342772|NCT01297309|20566653|P1|Treated|Overall Study||49
8342773|NCT01297309|20566653|P1|STARTED|Overall Study||51
8342774|NCT01297283|20566670|P1|NOT COMPLETED|Overall Study||19
8342775|NCT01297283|20566670|P1|COMPLETED|Overall Study||176
8342776|NCT01297283|20566670|P1|STARTED|Overall Study||195
8342777|NCT01297270|20566678|P3|NOT COMPLETED|Overall Study||29
8342778|NCT01297270|20566679|P2|NOT COMPLETED|Overall Study||72
8342779|NCT01297270|20566680|P1|NOT COMPLETED|Overall Study||45
8342780|NCT01297270|20566678|P3|COMPLETED|Overall Study||103
8342781|NCT01297270|20566679|P2|COMPLETED|Overall Study||192
8342782|NCT01297270|20566680|P1|COMPLETED|Overall Study||217
8342783|NCT01297270|20566678|P3|STARTED|Overall Study||132
8342784|NCT01297270|20566679|P2|STARTED|Overall Study||264
8342785|NCT01297270|20566680|P1|STARTED|Overall Study||262
8342786|NCT01297257|20566718|P1|NOT COMPLETED|Overall Study||0
8342787|NCT01297257|20566718|P1|COMPLETED|Overall Study||7740
8342788|NCT01297257|20566718|P1|STARTED|Overall Study||7740
8342789|NCT01297244|20566725|P2|NOT COMPLETED|Overall Study||6
8342790|NCT01297244|20566726|P1|NOT COMPLETED|Overall Study||35
8342791|NCT01297244|20566725|P2|COMPLETED|Overall Study||9
8342792|NCT01297244|20566726|P1|COMPLETED|Overall Study||55
8342793|NCT01297244|20566725|P2|STARTED|Overall Study||15
8342794|NCT01297244|20566726|P1|STARTED|Overall Study||90
8342795|NCT01297062|20566746|P7|NOT COMPLETED|Overall Study||8
8342796|NCT01297062|20566747|P6|NOT COMPLETED|Overall Study||1
8342797|NCT01297062|20566748|P5|NOT COMPLETED|Overall Study||2
8342798|NCT01297062|20566749|P4|NOT COMPLETED|Overall Study||1
8342799|NCT01297062|20566750|P3|NOT COMPLETED|Overall Study||2
8342800|NCT01297062|20566751|P2|NOT COMPLETED|Overall Study||1
8342801|NCT01297062|20566752|P1|NOT COMPLETED|Overall Study||4
8342802|NCT01297062|20566746|P7|COMPLETED|Overall Study||0
8342803|NCT01297062|20566747|P6|COMPLETED|Overall Study||13
8342804|NCT01297062|20566748|P5|COMPLETED|Overall Study||13
8342805|NCT01297062|20566749|P4|COMPLETED|Overall Study||13
8342806|NCT01297062|20566750|P3|COMPLETED|Overall Study||12
8342807|NCT01297062|20566751|P2|COMPLETED|Overall Study||13
8342808|NCT01297062|20566752|P1|COMPLETED|Overall Study||11
8342809|NCT01297062|20566746|P7|Evaluable Population|Overall Study||0
8342810|NCT01297062|20566747|P6|Evaluable Population|Overall Study||13
8342811|NCT01297062|20566748|P5|Evaluable Population|Overall Study||13
8342812|NCT01297062|20566749|P4|Evaluable Population|Overall Study||13
8342813|NCT01297062|20566750|P3|Evaluable Population|Overall Study||12
8342814|NCT01297062|20566751|P2|Evaluable Population|Overall Study||12
8342815|NCT01297062|20566752|P1|Evaluable Population|Overall Study||11
8342816|NCT01297062|20566746|P7|Intent to Treat (ITT)|Overall Study||0
8342817|NCT01297062|20566747|P6|Intent to Treat (ITT)|Overall Study||14
8342818|NCT01297062|20566748|P5|Intent to Treat (ITT)|Overall Study||15
8342819|NCT01297062|20566749|P4|Intent to Treat (ITT)|Overall Study||14
8342820|NCT01297062|20566750|P3|Intent to Treat (ITT)|Overall Study||14
8342821|NCT01297062|20566751|P2|Intent to Treat (ITT)|Overall Study||14
8342822|NCT01297062|20566752|P1|Intent to Treat (ITT)|Overall Study||15
8342823|NCT01297062|20566746|P7|STARTED|Overall Study||8
8342824|NCT01297062|20566747|P6|STARTED|Overall Study||14
8342825|NCT01297062|20566748|P5|STARTED|Overall Study||15
8342826|NCT01297062|20566749|P4|STARTED|Overall Study||14
8342827|NCT01297062|20566750|P3|STARTED|Overall Study||14
8342828|NCT01297062|20566751|P2|STARTED|Overall Study||14
8342829|NCT01297062|20566752|P1|STARTED|Overall Study||15
8342830|NCT01296932|20566783|P9|NOT COMPLETED|Overall Study||4
8342831|NCT01296932|20566784|P8|NOT COMPLETED|Overall Study||2
8342832|NCT01296932|20566785|P7|NOT COMPLETED|Overall Study||6
8342833|NCT01296932|20566786|P6|NOT COMPLETED|Overall Study||3
8342834|NCT01296932|20566787|P5|NOT COMPLETED|Overall Study||3
8342835|NCT01296932|20566788|P4|NOT COMPLETED|Overall Study||6
8342836|NCT01296932|20566789|P3|NOT COMPLETED|Overall Study||6
8342837|NCT01296932|20566790|P2|NOT COMPLETED|Overall Study||3
8342838|NCT01296932|20566791|P1|NOT COMPLETED|Overall Study||3
8342839|NCT01296932|20566783|P9|COMPLETED|Overall Study||0
8342840|NCT01296932|20566784|P8|COMPLETED|Overall Study||1
8342841|NCT01296932|20566785|P7|COMPLETED|Overall Study||0
8342842|NCT01296932|20566786|P6|COMPLETED|Overall Study||0
8342843|NCT01296932|20566787|P5|COMPLETED|Overall Study||0
8342844|NCT01296932|20566788|P4|COMPLETED|Overall Study||0
8342845|NCT01296932|20566789|P3|COMPLETED|Overall Study||0
8342846|NCT01296932|20566790|P2|COMPLETED|Overall Study||0
8342847|NCT01296932|20566791|P1|COMPLETED|Overall Study||0
8342848|NCT01296932|20566783|P9|STARTED|Overall Study||4
8342849|NCT01296932|20566784|P8|STARTED|Overall Study||3
8342850|NCT01296932|20566785|P7|STARTED|Overall Study||6
8342851|NCT01296932|20566786|P6|STARTED|Overall Study||3
8342852|NCT01296932|20566787|P5|STARTED|Overall Study||3
8342853|NCT01296932|20566788|P4|STARTED|Overall Study||6
8342854|NCT01296932|20566789|P3|STARTED|Overall Study||6
8342855|NCT01296932|20566790|P2|STARTED|Overall Study||3
8342856|NCT01296932|20566791|P1|STARTED|Overall Study||3
8342857|NCT01296841|20566877|P2|NOT COMPLETED|Overall Study||0
8342858|NCT01296841|20566878|P1|NOT COMPLETED|Overall Study||0
8342859|NCT01296841|20566877|P2|COMPLETED|Overall Study||15
8342860|NCT01296841|20566878|P1|COMPLETED|Overall Study||19
8342861|NCT01296841|20566877|P2|STARTED|Overall Study||15
8342862|NCT01296841|20566878|P1|STARTED|Overall Study||19
8342863|NCT01296815|20566890|P2|NOT COMPLETED|Overall Study||0
8342864|NCT01296815|20566891|P1|NOT COMPLETED|Overall Study||0
8342865|NCT01296815|20566890|P2|COMPLETED|Overall Study||7
8342866|NCT01296815|20566891|P1|COMPLETED|Overall Study||7
8342867|NCT01296815|20566890|P2|STARTED|Overall Study||7
8342868|NCT01296815|20566891|P1|STARTED|Overall Study||7
8342869|NCT01296763|20566900|P3|NOT COMPLETED|Overall Study||0
8342870|NCT01296763|20566901|P2|NOT COMPLETED|Overall Study||0
8342871|NCT01296763|20566902|P1|NOT COMPLETED|Overall Study||0
8342872|NCT01296763|20566900|P3|COMPLETED|Overall Study||6
8342873|NCT01296763|20566901|P2|COMPLETED|Overall Study||5
8342874|NCT01296763|20566902|P1|COMPLETED|Overall Study||7
8342875|NCT01296763|20566900|P3|STARTED|Overall Study||6
8342876|NCT01296763|20566901|P2|STARTED|Overall Study||5
8342877|NCT01296763|20566902|P1|STARTED|Overall Study||7
8342878|NCT01296698|20566915|P2|NOT COMPLETED|Overall Study||13
8342879|NCT01296698|20566916|P1|NOT COMPLETED|Overall Study||244
8342880|NCT01296698|20566915|P2|COMPLETED|Overall Study||0
8342881|NCT01296698|20566916|P1|COMPLETED|Overall Study||0
8342882|NCT01296698|20566915|P2|STARTED|Overall Study||13
8342883|NCT01296698|20566916|P1|STARTED|Overall Study||244
8342884|NCT01296672|20566970|P2|NOT COMPLETED|Overall Study||18
8342885|NCT01296672|20566971|P1|NOT COMPLETED|Overall Study||73
8342886|NCT01296672|20566970|P2|COMPLETED|Overall Study||59
8342887|NCT01296672|20566971|P1|COMPLETED|Overall Study||233
8342888|NCT01296672|20566970|P2|STARTED|Overall Study||77
8342889|NCT01296672|20566971|P1|STARTED|Overall Study||306
8342890|NCT01296646|20566983|P2|NOT COMPLETED|Overall Study||11
8342891|NCT01296646|20566984|P1|NOT COMPLETED|Overall Study||11
8342892|NCT01296646|20566983|P2|COMPLETED|Overall Study||29
8342893|NCT01296646|20566984|P1|COMPLETED|Overall Study||29
8342894|NCT01296646|20566983|P2|STARTED|Overall Study||40
8342895|NCT01296646|20566984|P1|STARTED|Overall Study||40
8342896|NCT01296568|20566992|P1|NOT COMPLETED|Continued Access Phase||3
8342897|NCT01296568|20566992|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
8342898|NCT01296568|20566992|P1|STARTED|Continued Access Phase||3
8342899|NCT01296568|20566992|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
8342900|NCT01296568|20566992|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
8342901|NCT01296568|20566992|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
8342902|NCT01296542|20567008|P2|NOT COMPLETED|Overall Study||2
8342903|NCT01296542|20567009|P1|NOT COMPLETED|Overall Study||0
8342904|NCT01296542|20567008|P2|COMPLETED|Overall Study||28
8342905|NCT01296542|20567009|P1|COMPLETED|Overall Study||30
8342906|NCT01296542|20567008|P2|STARTED|Overall Study||30
8342907|NCT01296542|20567009|P1|STARTED|Overall Study||30
8342908|NCT01296412|20567017|P2|NOT COMPLETED|Overall Study||70
8342909|NCT01296412|20567018|P1|NOT COMPLETED|Overall Study||51
8342910|NCT01296412|20567017|P2|COMPLETED|Overall Study||257
8342911|NCT01296412|20567018|P1|COMPLETED|Overall Study||275
8342912|NCT01296412|20567017|P2|STARTED|Overall Study||327
8342913|NCT01296412|20567018|P1|STARTED|Overall Study||326
8342914|NCT01296360|20567032|P2|NOT COMPLETED|Overall Study||8
8342915|NCT01296360|20567033|P1|NOT COMPLETED|Overall Study||6
8342916|NCT01296360|20567032|P2|COMPLETED|Overall Study||142
8342917|NCT01296360|20567033|P1|COMPLETED|Overall Study||144
8342918|NCT01296360|20567032|P2|Visit 2a (Month 13)|Overall Study||0
8342919|NCT01296360|20567033|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
8342920|NCT01296360|20567032|P2|Visit 2 (Month 12)|Overall Study||149
8342921|NCT01296360|20567033|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
8342922|NCT01296360|20567032|P2|STARTED|Overall Study||150
8342923|NCT01296360|20567033|P1|STARTED|Overall Study||150
8342924|NCT01296347|20567041|P2|NOT COMPLETED|12 Month Follow up||3
8342925|NCT01296347|20567042|P1|NOT COMPLETED|12 Month Follow up||4
8342926|NCT01296347|20567041|P2|COMPLETED|12 Month Follow up||28
8342927|NCT01296347|20567042|P1|COMPLETED|12 Month Follow up||28
8342928|NCT01296347|20567041|P2|STARTED|12 Month Follow up||31
8342929|NCT01296347|20567042|P1|STARTED|12 Month Follow up||32
8342930|NCT01296347|20567041|P2|NOT COMPLETED|6 Month Follow up||2
8342931|NCT01296347|20567042|P1|NOT COMPLETED|6 Month Follow up||2
8342932|NCT01296347|20567041|P2|COMPLETED|6 Month Follow up||31
8342933|NCT01296347|20567042|P1|COMPLETED|6 Month Follow up||32
8342934|NCT01296347|20567041|P2|STARTED|6 Month Follow up||33
8342935|NCT01296347|20567042|P1|STARTED|6 Month Follow up||34
8342936|NCT01296347|20567041|P2|NOT COMPLETED|3 Month Follow up||1
8342937|NCT01296347|20567042|P1|NOT COMPLETED|3 Month Follow up||1
8342938|NCT01296347|20567041|P2|COMPLETED|3 Month Follow up||33
8342939|NCT01296347|20567042|P1|COMPLETED|3 Month Follow up||34
8342940|NCT01296347|20567041|P2|STARTED|3 Month Follow up||34
8342941|NCT01296347|20567042|P1|STARTED|3 Month Follow up||35
8342942|NCT01296347|20567041|P2|NOT COMPLETED|6 Week Follow up||1
8342943|NCT01296347|20567042|P1|NOT COMPLETED|6 Week Follow up||0
8342944|NCT01296347|20567041|P2|COMPLETED|6 Week Follow up||34
8342945|NCT01296347|20567042|P1|COMPLETED|6 Week Follow up||35
8342946|NCT01296347|20567041|P2|STARTED|6 Week Follow up||35
8342947|NCT01296347|20567042|P1|STARTED|6 Week Follow up||35
8342948|NCT01296347|20567041|P2|NOT COMPLETED|Allocation||4
8342949|NCT01296347|20567042|P1|NOT COMPLETED|Allocation||3
8342950|NCT01296347|20567041|P2|COMPLETED|Allocation||35
8342951|NCT01296347|20567042|P1|COMPLETED|Allocation||35
8342952|NCT01296347|20567041|P2|STARTED|Allocation||39
8342953|NCT01296347|20567042|P1|STARTED|Allocation||38
8342954|NCT01296191|20567060|P2|NOT COMPLETED|Overall Study||1
8342955|NCT01296191|20567061|P1|NOT COMPLETED|Overall Study||3
8342956|NCT01296191|20567060|P2|COMPLETED|Overall Study||59
8342957|NCT01296191|20567061|P1|COMPLETED|Overall Study||57
8342958|NCT01296191|20567060|P2|STARTED|Overall Study||60
8342959|NCT01296191|20567061|P1|STARTED|Overall Study||60
8342960|NCT01296152|20567067|P1|NOT COMPLETED|Overall Study||1
8342961|NCT01296152|20567067|P1|COMPLETED|Overall Study||24
8342962|NCT01296152|20567067|P1|STARTED|Overall Study||25
8342963|NCT01296035|20567094|P1|NOT COMPLETED|Overall Study||1
8342964|NCT01296035|20567094|P1|COMPLETED|Overall Study||7
8342965|NCT01296035|20567094|P1|STARTED|Overall Study||8
8342966|NCT01295905|20567101|P2|NOT COMPLETED|Overall Study||0
8342967|NCT01295905|20567102|P1|NOT COMPLETED|Overall Study||2
8342968|NCT01295905|20567101|P2|COMPLETED|Overall Study||30
8342969|NCT01295905|20567102|P1|COMPLETED|Overall Study||58
8342970|NCT01295905|20567101|P2|STARTED|Overall Study||30
8342971|NCT01295905|20567102|P1|STARTED|Overall Study||60
8342972|NCT01295879|20567114|P1|NOT COMPLETED|Overall Study||0
8342973|NCT01295879|20567114|P1|COMPLETED|Overall Study||29
8342974|NCT01295879|20567114|P1|STARTED|Overall Study||29
8342975|NCT01295840|20567120|P1|NOT COMPLETED|Overall Study||1
8342976|NCT01295840|20567120|P1|COMPLETED|Overall Study||50
8342977|NCT01295840|20567120|P1|STARTED|Overall Study||51
8342978|NCT01295827|20567146|P15|NOT COMPLETED|Overall Study||0
8342979|NCT01295827|20567147|P14|NOT COMPLETED|Overall Study||0
8342980|NCT01295827|20567148|P13|NOT COMPLETED|Overall Study||0
8342981|NCT01295827|20567149|P12|NOT COMPLETED|Overall Study||186
8342982|NCT01295827|20567150|P11|NOT COMPLETED|Overall Study||276
8342983|NCT01295827|20567151|P10|NOT COMPLETED|Overall Study||55
8342984|NCT01295827|20567152|P9|NOT COMPLETED|Overall Study||169
8342985|NCT01295827|20567153|P8|NOT COMPLETED|Overall Study||297
8342986|NCT01295827|20567154|P7|NOT COMPLETED|Overall Study||146
8342987|NCT01295827|20567155|P6|NOT COMPLETED|Overall Study||6
8342988|NCT01295827|20567156|P5|NOT COMPLETED|Overall Study||2
8342989|NCT01295827|20567157|P4|NOT COMPLETED|Overall Study||4
8342990|NCT01295827|20567158|P3|NOT COMPLETED|Overall Study||12
8342991|NCT01295827|20567159|P2|NOT COMPLETED|Overall Study||3
8342992|NCT01295827|20567160|P1|NOT COMPLETED|Overall Study||4
8342993|NCT01295827|20567146|P15|COMPLETED|Overall Study||0
8342994|NCT01295827|20567147|P14|COMPLETED|Overall Study||0
8342995|NCT01295827|20567148|P13|COMPLETED|Overall Study||0
8342996|NCT01295827|20567149|P12|COMPLETED|Overall Study||17
8342997|NCT01295827|20567150|P11|COMPLETED|Overall Study||20
8342998|NCT01295827|20567151|P10|COMPLETED|Overall Study||6
8342999|NCT01295827|20567152|P9|COMPLETED|Overall Study||14
8343000|NCT01295827|20567153|P8|COMPLETED|Overall Study||24
8343001|NCT01295827|20567154|P7|COMPLETED|Overall Study||18
8343002|NCT01295827|20567155|P6|COMPLETED|Overall Study||0
8343003|NCT01295827|20567156|P5|COMPLETED|Overall Study||1
8343004|NCT01295827|20567157|P4|COMPLETED|Overall Study||0
8343005|NCT01295827|20567158|P3|COMPLETED|Overall Study||0
8343006|NCT01295827|20567159|P2|COMPLETED|Overall Study||0
8343007|NCT01295827|20567160|P1|COMPLETED|Overall Study||0
8343008|NCT01295827|20567146|P15|Treated (All Treated Population)|Overall Study||0
8343009|NCT01295827|20567147|P14|Treated (All Treated Population)|Overall Study||0
8343010|NCT01295827|20567148|P13|Treated (All Treated Population)|Overall Study||0
8343011|NCT01295827|20567149|P12|Treated (All Treated Population)|Overall Study||202
8343012|NCT01295827|20567150|P11|Treated (All Treated Population)|Overall Study||287
8343013|NCT01295827|20567151|P10|Treated (All Treated Population)|Overall Study||61
8343014|NCT01295827|20567152|P9|Treated (All Treated Population)|Overall Study||180
8343015|NCT01295827|20567153|P8|Treated (All Treated Population)|Overall Study||313
8343016|NCT01295827|20567154|P7|Treated (All Treated Population)|Overall Study||162
8343017|NCT01295827|20567155|P6|Treated (All Treated Population)|Overall Study||6
8343018|NCT01295827|20567156|P5|Treated (All Treated Population)|Overall Study||3
8343019|NCT01295827|20567157|P4|Treated (All Treated Population)|Overall Study||4
8343020|NCT01295827|20567158|P3|Treated (All Treated Population)|Overall Study||10
8343021|NCT01295827|20567159|P2|Treated (All Treated Population)|Overall Study||3
8343022|NCT01295827|20567160|P1|Treated (All Treated Population)|Overall Study||4
8343023|NCT01295827|20567146|P15|STARTED|Overall Study||0
8343024|NCT01295827|20567147|P14|STARTED|Overall Study||0
8343025|NCT01295827|20567148|P13|STARTED|Overall Study||0
8343026|NCT01295827|20567149|P12|STARTED|Overall Study||203
8343027|NCT01295827|20567150|P11|STARTED|Overall Study||296
8343028|NCT01295827|20567151|P10|STARTED|Overall Study||61
8343029|NCT01295827|20567152|P9|STARTED|Overall Study||183
8343030|NCT01295827|20567153|P8|STARTED|Overall Study||321
8343031|NCT01295827|20567154|P7|STARTED|Overall Study||164
8343032|NCT01295827|20567155|P6|STARTED|Overall Study||6
8343033|NCT01295827|20567156|P5|STARTED|Overall Study||3
8343034|NCT01295827|20567157|P4|STARTED|Overall Study||4
8343035|NCT01295827|20567158|P3|STARTED|Overall Study||12
8343036|NCT01295827|20567159|P2|STARTED|Overall Study||3
8343037|NCT01295827|20567160|P1|STARTED|Overall Study||4
8343038|NCT01295814|20567533|P2|NOT COMPLETED|Overall Study||2
8343039|NCT01295814|20567534|P1|NOT COMPLETED|Overall Study||2
8343040|NCT01295814|20567533|P2|COMPLETED|Overall Study||19
8343041|NCT01295814|20567534|P1|COMPLETED|Overall Study||20
8343042|NCT01295814|20567533|P2|STARTED|Overall Study||21
8343043|NCT01295814|20567534|P1|STARTED|Overall Study||22
8343044|NCT01295710|20567550|P2|NOT COMPLETED|Overall Study||50
8343045|NCT01295710|20567551|P1|NOT COMPLETED|Overall Study||78
8343046|NCT01295710|20567550|P2|COMPLETED|Overall Study||78
8343047|NCT01295710|20567551|P1|COMPLETED|Overall Study||48
8343048|NCT01295710|20567550|P2|STARTED|Overall Study|Randomized and treated|128
8343049|NCT01295710|20567551|P1|STARTED|Overall Study|Randomized and treated|126
8343050|NCT01295671|20567614|P3|NOT COMPLETED|Overall Study||3
8343051|NCT01295671|20567615|P2|NOT COMPLETED|Overall Study||7
8343052|NCT01295671|20567616|P1|NOT COMPLETED|Overall Study||7
8343053|NCT01295671|20567614|P3|COMPLETED|Overall Study||66
8343054|NCT01295671|20567615|P2|COMPLETED|Overall Study||60
8343055|NCT01295671|20567616|P1|COMPLETED|Overall Study||60
8343056|NCT01295671|20567614|P3|STARTED|Overall Study||69
8343057|NCT01295671|20567615|P2|STARTED|Overall Study||67
8343058|NCT01295671|20567616|P1|STARTED|Overall Study||67
8343059|NCT01295515|20567654|P1|NOT COMPLETED|Overall Study||0
8343060|NCT01295515|20567654|P1|COMPLETED|Overall Study||7
8343061|NCT01295515|20567654|P1|STARTED|Overall Study||7
8343062|NCT01295320|20567662|P1|NOT COMPLETED|Overall Study||10
8343063|NCT01295320|20567662|P1|COMPLETED|Overall Study||119
8343064|NCT01295320|20567662|P1|STARTED|Overall Study||129
8343065|NCT01295281|20567679|P2|NOT COMPLETED|Second Intervention (7days)||0
8343066|NCT01295281|20567680|P1|NOT COMPLETED|Second Intervention (7days)||0
8343067|NCT01295281|20567679|P2|COMPLETED|Second Intervention (7days)||51
8343068|NCT01295281|20567680|P1|COMPLETED|Second Intervention (7days)||53
8343069|NCT01295281|20567679|P2|STARTED|Second Intervention (7days)||51
8343070|NCT01295281|20567680|P1|STARTED|Second Intervention (7days)||53
8343071|NCT01295281|20567679|P2|NOT COMPLETED|First Intervention (7 Days)||1
8343072|NCT01295281|20567680|P1|NOT COMPLETED|First Intervention (7 Days)||0
8343073|NCT01295281|20567679|P2|COMPLETED|First Intervention (7 Days)||51
8343074|NCT01295281|20567680|P1|COMPLETED|First Intervention (7 Days)||53
8343075|NCT01295281|20567679|P2|STARTED|First Intervention (7 Days)||52
8343076|NCT01295281|20567680|P1|STARTED|First Intervention (7 Days)||53
8343077|NCT01295216|20567688|P2|NOT COMPLETED|Overall Study||34
8343078|NCT01295216|20567689|P1|NOT COMPLETED|Overall Study||50
8343079|NCT01295216|20567688|P2|COMPLETED|Overall Study||287
8343080|NCT01295216|20567689|P1|COMPLETED|Overall Study||266
8343081|NCT01295216|20567688|P2|STARTED|Overall Study||321
8343082|NCT01295216|20567689|P1|STARTED|Overall Study||316
8343083|NCT01295112|20567707|P2|NOT COMPLETED|Overall Study||0
8343084|NCT01295112|20567708|P1|NOT COMPLETED|Overall Study||0
8343085|NCT01295112|20567707|P2|COMPLETED|Overall Study||33
8343086|NCT01295112|20567708|P1|COMPLETED|Overall Study||35
8343087|NCT01295112|20567707|P2|STARTED|Overall Study||33
8343088|NCT01295112|20567708|P1|STARTED|Overall Study||35
8343089|NCT01295034|20567718|P2|NOT COMPLETED|Overall Study||5
8343090|NCT01295034|20567719|P1|NOT COMPLETED|Overall Study||5
8343091|NCT01295034|20567718|P2|COMPLETED|Overall Study||25
8343092|NCT01295034|20567719|P1|COMPLETED|Overall Study||27
8343093|NCT01295034|20567718|P2|STARTED|Overall Study||30
8343094|NCT01295034|20567719|P1|STARTED|Overall Study||32
8343095|NCT01294917|20567727|P1|NOT COMPLETED|Overall Study||6
8343096|NCT01294917|20567727|P1|COMPLETED|Overall Study||36
8343097|NCT01294917|20567727|P1|Received OptiFree RepleniSH MPS|Overall Study||36
8343098|NCT01294917|20567727|P1|Received Clear Care|Overall Study||36
8343099|NCT01294917|20567727|P1|Received Investigational MPS|Overall Study||36
8343100|NCT01294917|20567727|P1|STARTED|Overall Study||42
8343101|NCT01294800|20567737|P4|NOT COMPLETED|Overall Study||16
8343102|NCT01294800|20567738|P3|NOT COMPLETED|Overall Study||17
8343103|NCT01294800|20567739|P2|NOT COMPLETED|Overall Study||10
8343104|NCT01294800|20567740|P1|NOT COMPLETED|Overall Study||11
8343105|NCT01294800|20567737|P4|COMPLETED|Overall Study||97
8343106|NCT01294800|20567738|P3|COMPLETED|Overall Study||96
8343107|NCT01294800|20567739|P2|COMPLETED|Overall Study||103
8343108|NCT01294800|20567740|P1|COMPLETED|Overall Study||100
8343109|NCT01294800|20567737|P4|STARTED|Overall Study||113
8343110|NCT01294800|20567738|P3|STARTED|Overall Study||113
8343111|NCT01294800|20567739|P2|STARTED|Overall Study||113
8343112|NCT01294800|20567740|P1|STARTED|Overall Study||111
8343113|NCT01294787|20567766|P6|NOT COMPLETED|Period 3||0
8343114|NCT01294787|20567767|P5|NOT COMPLETED|Period 3||1
8343115|NCT01294787|20567768|P4|NOT COMPLETED|Period 3||0
8343116|NCT01294787|20567769|P3|NOT COMPLETED|Period 3||0
8343117|NCT01294787|20567770|P2|NOT COMPLETED|Period 3||0
8343118|NCT01294787|20567771|P1|NOT COMPLETED|Period 3||0
8343119|NCT01294787|20567766|P6|COMPLETED|Period 3||13
8343120|NCT01294787|20567767|P5|COMPLETED|Period 3||13
8343121|NCT01294787|20567768|P4|COMPLETED|Period 3||9
8343122|NCT01294787|20567769|P3|COMPLETED|Period 3||13
8343123|NCT01294787|20567770|P2|COMPLETED|Period 3||13
8343124|NCT01294787|20567771|P1|COMPLETED|Period 3||12
8343125|NCT01294787|20567766|P6|STARTED|Period 3||13
8343126|NCT01294787|20567767|P5|STARTED|Period 3||14
8343127|NCT01294787|20567768|P4|STARTED|Period 3||9
8343128|NCT01294787|20567769|P3|STARTED|Period 3||13
8343129|NCT01294787|20567770|P2|STARTED|Period 3||13
8343130|NCT01294787|20567771|P1|STARTED|Period 3||12
8343131|NCT01294787|20567766|P6|NOT COMPLETED|Period 2||0
8343132|NCT01294787|20567767|P5|NOT COMPLETED|Period 2||0
8343133|NCT01294787|20567768|P4|NOT COMPLETED|Period 2||2
8343134|NCT01294787|20567769|P3|NOT COMPLETED|Period 2||0
8343135|NCT01294787|20567770|P2|NOT COMPLETED|Period 2||3
8343136|NCT01294787|20567771|P1|NOT COMPLETED|Period 2||0
8343137|NCT01294787|20567766|P6|COMPLETED|Period 2||13
8343138|NCT01294787|20567767|P5|COMPLETED|Period 2||14
8343139|NCT01294787|20567768|P4|COMPLETED|Period 2||9
8343140|NCT01294787|20567769|P3|COMPLETED|Period 2||13
8343141|NCT01294787|20567770|P2|COMPLETED|Period 2||13
8343142|NCT01294787|20567771|P1|COMPLETED|Period 2||12
8343143|NCT01294787|20567766|P6|STARTED|Period 2||13
8343144|NCT01294787|20567767|P5|STARTED|Period 2||14
8343145|NCT01294787|20567768|P4|STARTED|Period 2||11
8343146|NCT01294787|20567769|P3|STARTED|Period 2||13
8343147|NCT01294787|20567770|P2|STARTED|Period 2||16
8343148|NCT01294787|20567771|P1|STARTED|Period 2||12
8343149|NCT01294787|20567766|P6|NOT COMPLETED|Period 1||2
8343150|NCT01294787|20567767|P5|NOT COMPLETED|Period 1||2
8343151|NCT01294787|20567768|P4|NOT COMPLETED|Period 1||1
8343152|NCT01294787|20567769|P3|NOT COMPLETED|Period 1||1
8343153|NCT01294787|20567770|P2|NOT COMPLETED|Period 1||0
8343154|NCT01294787|20567771|P1|NOT COMPLETED|Period 1||0
8343155|NCT01294787|20567766|P6|COMPLETED|Period 1||13
8343156|NCT01294787|20567767|P5|COMPLETED|Period 1||14
8343157|NCT01294787|20567768|P4|COMPLETED|Period 1||11
8343158|NCT01294787|20567769|P3|COMPLETED|Period 1||13
8343159|NCT01294787|20567770|P2|COMPLETED|Period 1||16
8343160|NCT01294787|20567771|P1|COMPLETED|Period 1||12
8343161|NCT01294787|20567766|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
8343162|NCT01294787|20567767|P5|STARTED|Period 1||16
8343163|NCT01294787|20567768|P4|STARTED|Period 1||12
8343164|NCT01294787|20567769|P3|STARTED|Period 1||14
8343165|NCT01294787|20567770|P2|STARTED|Period 1||16
8343166|NCT01294787|20567771|P1|STARTED|Period 1||12
8343167|NCT01294748|20567815|P2|NOT COMPLETED|Overall Study||2
8343168|NCT01294748|20567816|P1|NOT COMPLETED|Overall Study||5
8343169|NCT01294748|20567815|P2|COMPLETED|Overall Study|At 270 days|59
8343170|NCT01294748|20567816|P1|COMPLETED|Overall Study|At 270 days|118
8343171|NCT01294748|20567815|P2|STARTED|Overall Study||61
8343172|NCT01294748|20567816|P1|STARTED|Overall Study||123
8343173|NCT01294709|20567842|P2|NOT COMPLETED|Period 2||0
8343174|NCT01294709|20567843|P1|NOT COMPLETED|Period 2||1
8343175|NCT01294709|20567842|P2|COMPLETED|Period 2||31
8343176|NCT01294709|20567843|P1|COMPLETED|Period 2||28
8343177|NCT01294709|20567842|P2|STARTED|Period 2||31
8343178|NCT01294709|20567843|P1|STARTED|Period 2||29
8343179|NCT01294709|20567842|P2|NOT COMPLETED|Washout Period||1
8343180|NCT01294709|20567843|P1|NOT COMPLETED|Washout Period||1
8343181|NCT01294709|20567842|P2|COMPLETED|Washout Period||31
8343182|NCT01294709|20567843|P1|COMPLETED|Washout Period||29
8343183|NCT01294709|20567842|P2|STARTED|Washout Period||32
8343184|NCT01294709|20567843|P1|STARTED|Washout Period||30
8343185|NCT01294709|20567842|P2|NOT COMPLETED|Period 1||1
8343186|NCT01294709|20567843|P1|NOT COMPLETED|Period 1||1
8343187|NCT01294709|20567842|P2|COMPLETED|Period 1||32
8343188|NCT01294709|20567843|P1|COMPLETED|Period 1||30
8343189|NCT01294709|20567842|P2|STARTED|Period 1||33
8343190|NCT01294709|20567843|P1|STARTED|Period 1||31
8343191|NCT01294696|20567862|P1|NOT COMPLETED|Overall Study||74
8343192|NCT01294696|20567862|P1|COMPLETED|Overall Study||1187
8343193|NCT01294696|20567862|P1|STARTED|Overall Study||1261
8343194|NCT01294683|20567876|P2|NOT COMPLETED|Post Crossover (Period III)||32
8343195|NCT01294683|20567877|P1|NOT COMPLETED|Post Crossover (Period III)||33
8343196|NCT01294683|20567876|P2|COMPLETED|Post Crossover (Period III)||190
8343197|NCT01294683|20567877|P1|COMPLETED|Post Crossover (Period III)||199
8343198|NCT01294683|20567876|P2|STARTED|Post Crossover (Period III)||222
8343199|NCT01294683|20567877|P1|STARTED|Post Crossover (Period III)||232
8343200|NCT01294683|20567876|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
8343201|NCT01294683|20567877|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
8343202|NCT01294683|20567876|P2|COMPLETED|Precrossover (Periods I/II)||222
8343203|NCT01294683|20567877|P1|COMPLETED|Precrossover (Periods I/II)||232
8343204|NCT01294683|20567876|P2|Treated|Precrossover (Periods I/II)||486
8343205|NCT01294683|20567877|P1|Treated|Precrossover (Periods I/II)||486
8343206|NCT01294683|20567876|P2|STARTED|Precrossover (Periods I/II)||488
8343207|NCT01294683|20567877|P1|STARTED|Precrossover (Periods I/II)||489
8343208|NCT01294644|20567930|P3|NOT COMPLETED|Overall Study||14
8343209|NCT01294644|20567931|P2|NOT COMPLETED|Overall Study||10
8343210|NCT01294644|20567932|P1|NOT COMPLETED|Overall Study||10
8343211|NCT01294644|20567930|P3|COMPLETED|Overall Study||103
8343212|NCT01294644|20567931|P2|COMPLETED|Overall Study||112
8343213|NCT01294644|20567932|P1|COMPLETED|Overall Study||111
8343214|NCT01294644|20567930|P3|Received Treatment|Overall Study||114
8343215|NCT01294644|20567931|P2|Received Treatment|Overall Study||122
8343216|NCT01294644|20567932|P1|Received Treatment|Overall Study||118
8343217|NCT01294644|20567930|P3|STARTED|Overall Study||117
8343218|NCT01294644|20567931|P2|STARTED|Overall Study||122
8343219|NCT01294644|20567932|P1|STARTED|Overall Study||121
8343220|NCT01294592|20567963|P2|NOT COMPLETED|Overall Study||73
8343221|NCT01294592|20567964|P1|NOT COMPLETED|Overall Study||77
8343222|NCT01294592|20567963|P2|COMPLETED|Overall Study||300
8343223|NCT01294592|20567964|P1|COMPLETED|Overall Study||292
8343224|NCT01294592|20567963|P2|STARTED|Overall Study||373
8343225|NCT01294592|20567964|P1|STARTED|Overall Study||369
8343226|NCT01294579|20567992|P1|NOT COMPLETED|Overall Study||35
8343227|NCT01294579|20567992|P1|COMPLETED|Overall Study||14
8343228|NCT01294579|20567992|P1|STARTED|Overall Study||49
8343229|NCT01294553|20568002|P1|NOT COMPLETED|Overall Study||269
8343230|NCT01294553|20568002|P1|COMPLETED|Overall Study||713
8343231|NCT01294553|20568002|P1|STARTED|Overall Study||982
8343232|NCT01294514|20568008|P1|NOT COMPLETED|Overall Study||1
8343233|NCT01294514|20568008|P1|COMPLETED|Overall Study||26
8343234|NCT01294514|20568008|P1|STARTED|Overall Study||27
8343235|NCT01294462|20568018|P2|NOT COMPLETED|Overall Study||63
8343236|NCT01294462|20568019|P1|NOT COMPLETED|Overall Study||66
8343237|NCT01294462|20568018|P2|COMPLETED|Overall Study||337
8343238|NCT01294462|20568019|P1|COMPLETED|Overall Study||335
8343239|NCT01294462|20568018|P2|Received Randomized Treatment|Overall Study||380
8343240|NCT01294462|20568019|P1|Received Randomized Treatment|Overall Study||387
8343241|NCT01294462|20568018|P2|STARTED|Overall Study||400
8343242|NCT01294462|20568019|P1|STARTED|Overall Study||401
8343243|NCT01294449|20568033|P2|NOT COMPLETED|Overall Study||15
8343244|NCT01294449|20568034|P1|NOT COMPLETED|Overall Study||12
8343245|NCT01294449|20568033|P2|COMPLETED|Overall Study||237
8343246|NCT01294449|20568034|P1|COMPLETED|Overall Study||144
8343247|NCT01294449|20568033|P2|Consent to Registry|Overall Study||245
8343248|NCT01294449|20568034|P1|Consent to Registry|Overall Study||149
8343249|NCT01294449|20568033|P2|STARTED|Overall Study||252
8343250|NCT01294449|20568034|P1|STARTED|Overall Study||156
8343251|NCT01294436|20568042|P2|NOT COMPLETED|Overall Study||70
8343252|NCT01294436|20568043|P1|NOT COMPLETED|Overall Study||28
8343253|NCT01294436|20568042|P2|COMPLETED|Overall Study||409
8343254|NCT01294436|20568043|P1|COMPLETED|Overall Study||221
8343255|NCT01294436|20568042|P2|STARTED|Overall Study||479
8343256|NCT01294436|20568043|P1|STARTED|Overall Study||249
8343257|NCT01294423|20568078|P3|NOT COMPLETED|Overall Study||8
8343258|NCT01294423|20568079|P2|NOT COMPLETED|Overall Study||9
8343259|NCT01294423|20568080|P1|NOT COMPLETED|Overall Study||5
8343260|NCT01294423|20568078|P3|COMPLETED|Overall Study||79
8343261|NCT01294423|20568079|P2|COMPLETED|Overall Study||79
8343262|NCT01294423|20568080|P1|COMPLETED|Overall Study||81
8343263|NCT01294423|20568078|P3|STARTED|Overall Study||87
8343264|NCT01294423|20568079|P2|STARTED|Overall Study||88
8343265|NCT01294423|20568080|P1|STARTED|Overall Study||86
8343266|NCT01294397|20568094|P1|NOT COMPLETED|Overall Study||2
8343267|NCT01294397|20568094|P1|COMPLETED|Overall Study||17
8343268|NCT01294397|20568094|P1|STARTED|Overall Study||19
8343269|NCT01294384|20568107|P3|NOT COMPLETED|Overall Study||9
8343270|NCT01294384|20568108|P2|NOT COMPLETED|Overall Study||6
8343271|NCT01294384|20568109|P1|NOT COMPLETED|Overall Study||4
8343272|NCT01294384|20568107|P3|COMPLETED|Overall Study||95
8343273|NCT01294384|20568108|P2|COMPLETED|Overall Study||94
8343274|NCT01294384|20568109|P1|COMPLETED|Overall Study||97
8343275|NCT01294384|20568107|P3|STARTED|Overall Study||104
8343276|NCT01294384|20568108|P2|STARTED|Overall Study||100
8343277|NCT01294384|20568109|P1|STARTED|Overall Study||101
8343278|NCT01294371|20568138|P1|NOT COMPLETED|Overall Study||34
8343279|NCT01294371|20568138|P1|COMPLETED|Overall Study||357
8343280|NCT01294371|20568138|P1|Treated|Overall Study||390
8343281|NCT01294371|20568138|P1|STARTED|Overall Study||391
8343282|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
8343283|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343284|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343285|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343286|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343287|NCT01294358|20568146|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343288|NCT01294358|20568147|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343289|NCT01294358|20568148|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343290|NCT01294358|20568149|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343291|NCT01294358|20568150|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343292|NCT01294358|20568146|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
8343293|NCT01294358|20568147|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343294|NCT01294358|20568148|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343295|NCT01294358|20568149|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343296|NCT01294358|20568150|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343297|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343298|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
8343299|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343300|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343301|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343302|NCT01294358|20568146|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343303|NCT01294358|20568147|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
8343304|NCT01294358|20568148|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343305|NCT01294358|20568149|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343306|NCT01294358|20568150|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343307|NCT01294358|20568146|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343308|NCT01294358|20568147|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
8343309|NCT01294358|20568148|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343310|NCT01294358|20568149|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343311|NCT01294358|20568150|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343312|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343313|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343314|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
8343315|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343316|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343317|NCT01294358|20568146|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343318|NCT01294358|20568147|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343319|NCT01294358|20568148|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
8343320|NCT01294358|20568149|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343321|NCT01294358|20568150|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343322|NCT01294358|20568146|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343323|NCT01294358|20568147|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343324|NCT01294358|20568148|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
8343325|NCT01294358|20568149|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343326|NCT01294358|20568150|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343327|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343328|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343329|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343330|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
8343331|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343332|NCT01294358|20568146|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343333|NCT01294358|20568147|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343334|NCT01294358|20568148|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343335|NCT01294358|20568149|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
8343336|NCT01294358|20568150|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343337|NCT01294358|20568146|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343338|NCT01294358|20568147|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343339|NCT01294358|20568148|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343340|NCT01294358|20568149|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
8343341|NCT01294358|20568150|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343342|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343343|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343344|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343345|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343346|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343347|NCT01294358|20568146|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343348|NCT01294358|20568147|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343349|NCT01294358|20568148|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343350|NCT01294358|20568149|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343351|NCT01294358|20568150|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
8343352|NCT01294358|20568146|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343353|NCT01294358|20568147|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343354|NCT01294358|20568148|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343355|NCT01294358|20568149|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343356|NCT01294358|20568150|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
8343357|NCT01294319|20568212|P8|NOT COMPLETED|Overall Study||0
8343358|NCT01294319|20568213|P7|NOT COMPLETED|Overall Study||0
8343359|NCT01294319|20568214|P6|NOT COMPLETED|Overall Study||0
8343360|NCT01294319|20568215|P5|NOT COMPLETED|Overall Study||0
8343361|NCT01294319|20568216|P4|NOT COMPLETED|Overall Study||0
8343362|NCT01294319|20568217|P3|NOT COMPLETED|Overall Study||0
8343363|NCT01294319|20568218|P2|NOT COMPLETED|Overall Study||0
8343364|NCT01294319|20568219|P1|NOT COMPLETED|Overall Study||0
8343365|NCT01294319|20568212|P8|COMPLETED|Overall Study||5
8343366|NCT01294319|20568213|P7|COMPLETED|Overall Study||5
8343367|NCT01294319|20568214|P6|COMPLETED|Overall Study||4
8343368|NCT01294319|20568215|P5|COMPLETED|Overall Study||5
8343369|NCT01294319|20568216|P4|COMPLETED|Overall Study||5
8343370|NCT01294319|20568217|P3|COMPLETED|Overall Study||5
8343371|NCT01294319|20568218|P2|COMPLETED|Overall Study||6
8343372|NCT01294319|20568219|P1|COMPLETED|Overall Study||4
8343373|NCT01294319|20568212|P8|STARTED|Overall Study||5
8343374|NCT01294319|20568213|P7|STARTED|Overall Study||5
8343375|NCT01294319|20568214|P6|STARTED|Overall Study||4
8343376|NCT01294319|20568215|P5|STARTED|Overall Study||5
8343377|NCT01294319|20568216|P4|STARTED|Overall Study||5
8343378|NCT01294319|20568217|P3|STARTED|Overall Study||5
8343379|NCT01294319|20568218|P2|STARTED|Overall Study||6
8343380|NCT01294319|20568219|P1|STARTED|Overall Study||4
8343381|NCT01294306|20568229|P2|NOT COMPLETED|Overall Study||0
8343382|NCT01294306|20568230|P1|NOT COMPLETED|Overall Study||0
8343383|NCT01294306|20568229|P2|COMPLETED|Overall Study||35
8343384|NCT01294306|20568230|P1|COMPLETED|Overall Study||45
8343385|NCT01294306|20568229|P2|STARTED|Overall Study||35
8343386|NCT01294306|20568230|P1|STARTED|Overall Study||45
8343387|NCT01294267|20568244|P1|NOT COMPLETED|Overall Study||0
8343388|NCT01294267|20568244|P1|COMPLETED|Overall Study||20
8343389|NCT01294267|20568244|P1|STARTED|Overall Study||20
8343390|NCT01294241|20568250|P1|NOT COMPLETED|Overall Study||0
8343391|NCT01294241|20568250|P1|COMPLETED|Overall Study||10
8343392|NCT01294241|20568250|P1|STARTED|Overall Study||10
8343393|NCT01294228|20568258|P1|NOT COMPLETED|Overall Study||0
8343394|NCT01294228|20568258|P1|COMPLETED|Overall Study||1001
8343395|NCT01294228|20568258|P1|STARTED|Overall Study||1001
8343396|NCT01294163|20568265|P3|NOT COMPLETED|Overall Study||3
8343397|NCT01294163|20568266|P2|NOT COMPLETED|Overall Study||0
8343398|NCT01294163|20568267|P1|NOT COMPLETED|Overall Study||1
8343399|NCT01294163|20568265|P3|COMPLETED|Overall Study||163
8343400|NCT01294163|20568266|P2|COMPLETED|Overall Study||165
8343401|NCT01294163|20568267|P1|COMPLETED|Overall Study||177
8343402|NCT01294163|20568265|P3|STARTED|Overall Study||166
8343403|NCT01294163|20568266|P2|STARTED|Overall Study||165
8343404|NCT01294163|20568267|P1|STARTED|Overall Study||178
8343405|NCT01294150|20568278|P2|NOT COMPLETED|Overall Study||2
8343406|NCT01294150|20568279|P1|NOT COMPLETED|Overall Study||2
8343407|NCT01294150|20568278|P2|COMPLETED|Overall Study||64
8343408|NCT01294150|20568279|P1|COMPLETED|Overall Study||138
8343409|NCT01294150|20568278|P2|STARTED|Overall Study||66
8343410|NCT01294150|20568279|P1|STARTED|Overall Study||140
8343411|NCT01294098|20568292|P3|NOT COMPLETED|Overall Study||1
8343412|NCT01294098|20568293|P2|NOT COMPLETED|Overall Study||1
8343413|NCT01294098|20568294|P1|NOT COMPLETED|Overall Study||0
8343414|NCT01294098|20568292|P3|COMPLETED|Overall Study||0
8343415|NCT01294098|20568293|P2|COMPLETED|Overall Study||0
8343416|NCT01294098|20568294|P1|COMPLETED|Overall Study||0
8343417|NCT01294098|20568292|P3|STARTED|Overall Study||1
8343418|NCT01294098|20568293|P2|STARTED|Overall Study||1
8343419|NCT01294098|20568294|P1|STARTED|Overall Study||0
8343420|NCT01294046|20568308|P1|NOT COMPLETED|Overall Study||3
8343421|NCT01294046|20568308|P1|COMPLETED|Overall Study||0
8343422|NCT01294046|20568308|P1|STARTED|Overall Study||3
8343423|NCT01293968|20568323|P2|NOT COMPLETED|Overall Study||3
8343424|NCT01293968|20568324|P1|NOT COMPLETED|Overall Study||3
8343425|NCT01293968|20568323|P2|COMPLETED|Overall Study||14
8343426|NCT01293968|20568324|P1|COMPLETED|Overall Study||17
8343427|NCT01293968|20568323|P2|STARTED|Overall Study||17
8343428|NCT01293968|20568324|P1|STARTED|Overall Study||20
8343429|NCT01293825|20568330|P1|NOT COMPLETED|Overall Study||10
8343430|NCT01293825|20568330|P1|COMPLETED|Overall Study||20
8343431|NCT01293825|20568330|P1|STARTED|Overall Study||30
8343432|NCT01293695|20568344|P2|NOT COMPLETED|Overall Study||7
8343433|NCT01293695|20568345|P1|NOT COMPLETED|Overall Study||15
8343434|NCT01293695|20568344|P2|COMPLETED|Overall Study||87
8343435|NCT01293695|20568345|P1|COMPLETED|Overall Study||78
8343436|NCT01293695|20568344|P2|STARTED|Overall Study||94
8343437|NCT01293695|20568345|P1|STARTED|Overall Study||93
8343438|NCT01293682|20568359|P1|NOT COMPLETED|Overall Study||0
8343439|NCT01293682|20568359|P1|COMPLETED|Overall Study||12
8343440|NCT01293682|20568359|P1|STARTED|Overall Study||12
8343441|NCT01293539|20568364|P1|NOT COMPLETED|Overall Study||1
8343442|NCT01293539|20568364|P1|COMPLETED|Overall Study||9
8343443|NCT01293539|20568364|P1|STARTED|Overall Study||10
8343444|NCT01293240|20568368|P1|NOT COMPLETED|Overall Study||2
8343445|NCT01293240|20568368|P1|COMPLETED|Overall Study||115
8343446|NCT01293240|20568368|P1|STARTED|Overall Study||117
8343447|NCT01293123|20568385|P2|NOT COMPLETED|Overall Study||1
8343448|NCT01293123|20568386|P1|NOT COMPLETED|Overall Study||0
8343449|NCT01293123|20568385|P2|COMPLETED|Overall Study||0
8343450|NCT01293123|20568386|P1|COMPLETED|Overall Study||1
8343451|NCT01293123|20568385|P2|STARTED|Overall Study||1
8343452|NCT01293123|20568386|P1|STARTED|Overall Study||1
8343453|NCT01293084|20568400|P1|NOT COMPLETED|Overall Study||5
8343454|NCT01293084|20568400|P1|COMPLETED|Overall Study||12
8343455|NCT01293084|20568400|P1|STARTED|Overall Study||17
8343456|NCT01293032|20568412|P4|NOT COMPLETED|Treatment||1
8343457|NCT01293032|20568413|P3|NOT COMPLETED|Treatment||1
8343458|NCT01293032|20568414|P2|NOT COMPLETED|Treatment||5
8343459|NCT01293032|20568415|P1|NOT COMPLETED|Treatment||2
8343460|NCT01293032|20568412|P4|COMPLETED|Treatment||13
8343461|NCT01293032|20568413|P3|COMPLETED|Treatment||10
8343462|NCT01293032|20568414|P2|COMPLETED|Treatment||14
8343463|NCT01293032|20568415|P1|COMPLETED|Treatment||10
8343464|NCT01293032|20568412|P4|STARTED|Treatment||14
8343465|NCT01293032|20568413|P3|STARTED|Treatment||11
8343466|NCT01293032|20568414|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
8343467|NCT01293032|20568415|P1|STARTED|Treatment||12
8343468|NCT01293032|20568412|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8343469|NCT01293032|20568413|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
8343470|NCT01293032|20568414|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8343471|NCT01293032|20568415|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8343472|NCT01293032|20568412|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
8343473|NCT01293032|20568413|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
8343474|NCT01293032|20568414|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
8343475|NCT01293032|20568415|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
8343476|NCT01293032|20568412|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
8343477|NCT01293032|20568413|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
8343478|NCT01293032|20568414|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
8343479|NCT01293032|20568415|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
8343480|NCT01293032|20568412|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
8343481|NCT01293032|20568413|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
8343482|NCT01293032|20568414|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
8343483|NCT01293032|20568415|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
8343484|NCT01293006|20568426|P4|NOT COMPLETED|Period 2||0
8343485|NCT01293006|20568427|P3|NOT COMPLETED|Period 2||0
8343486|NCT01293006|20568428|P2|NOT COMPLETED|Period 2||0
8343487|NCT01293006|20568429|P1|NOT COMPLETED|Period 2||1
8343488|NCT01293006|20568426|P4|COMPLETED|Period 2||3
8343489|NCT01293006|20568427|P3|COMPLETED|Period 2||9
8343490|NCT01293006|20568428|P2|COMPLETED|Period 2||2
8343491|NCT01293006|20568429|P1|COMPLETED|Period 2||10
8343492|NCT01293006|20568426|P4|STARTED|Period 2||3
8343493|NCT01293006|20568427|P3|STARTED|Period 2||9
8343494|NCT01293006|20568428|P2|STARTED|Period 2||2
8343495|NCT01293006|20568429|P1|STARTED|Period 2||11
8343496|NCT01293006|20568426|P4|NOT COMPLETED|Washout||0
8343497|NCT01293006|20568427|P3|NOT COMPLETED|Washout||0
8343498|NCT01293006|20568428|P2|NOT COMPLETED|Washout||0
8343499|NCT01293006|20568429|P1|NOT COMPLETED|Washout||0
8343500|NCT01293006|20568426|P4|COMPLETED|Washout||3
8343501|NCT01293006|20568427|P3|COMPLETED|Washout||9
8343502|NCT01293006|20568428|P2|COMPLETED|Washout||2
8343503|NCT01293006|20568429|P1|COMPLETED|Washout||11
8343504|NCT01293006|20568426|P4|STARTED|Washout||3
8343505|NCT01293006|20568427|P3|STARTED|Washout||9
8343506|NCT01293006|20568428|P2|STARTED|Washout||2
8343507|NCT01293006|20568429|P1|STARTED|Washout||11
8343508|NCT01293006|20568426|P4|NOT COMPLETED|Period 1||0
8343509|NCT01293006|20568427|P3|NOT COMPLETED|Period 1||0
8343510|NCT01293006|20568428|P2|NOT COMPLETED|Period 1||0
8343511|NCT01293006|20568429|P1|NOT COMPLETED|Period 1||0
8343512|NCT01293006|20568426|P4|COMPLETED|Period 1||3
8343513|NCT01293006|20568427|P3|COMPLETED|Period 1||9
8343514|NCT01293006|20568428|P2|COMPLETED|Period 1||2
8343515|NCT01293006|20568429|P1|COMPLETED|Period 1||11
8343516|NCT01293006|20568426|P4|STARTED|Period 1||3
8343517|NCT01293006|20568427|P3|STARTED|Period 1||9
8343518|NCT01293006|20568428|P2|STARTED|Period 1||2
8343519|NCT01293006|20568429|P1|STARTED|Period 1||11
8343520|NCT01292928|20568450|P1|NOT COMPLETED|Overall Study||24
8343521|NCT01292928|20568450|P1|COMPLETED|Overall Study||275
8343522|NCT01292928|20568450|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
8343523|NCT01292928|20568450|P1|STARTED|Overall Study||299
8343524|NCT01292876|20568467|P1|NOT COMPLETED|Overall Study||4
8343525|NCT01292876|20568467|P1|COMPLETED|Overall Study||13
8343526|NCT01292876|20568467|P1|STARTED|Overall Study||17
8343527|NCT01292837|20568473|P1|NOT COMPLETED|Overall Study||2
8343528|NCT01292837|20568473|P1|COMPLETED|Overall Study||11
8343529|NCT01292837|20568473|P1|STARTED|Overall Study||13
8343530|NCT01292798|20568482|P1|NOT COMPLETED|Overall Study||0
8343531|NCT01292798|20568482|P1|COMPLETED|Overall Study||43
8343532|NCT01292798|20568482|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
8343533|NCT01292798|20568482|P1|STARTED|Overall Study||43
8343534|NCT01292746|20568488|P1|NOT COMPLETED|Overall Study||0
8343535|NCT01292746|20568488|P1|COMPLETED|Overall Study||14
8343536|NCT01292746|20568488|P1|STARTED|Overall Study||14
8343537|NCT01292642|20568492|P1|NOT COMPLETED|Overall Study||5
8343538|NCT01292642|20568492|P1|COMPLETED|Overall Study||7
8343539|NCT01292642|20568492|P1|STARTED|Overall Study||12
8343540|NCT01292629|20568500|P1|NOT COMPLETED|Overall Study||0
8343541|NCT01292629|20568500|P1|COMPLETED|Overall Study||125
8343542|NCT01292629|20568500|P1|STARTED|Overall Study||125
8343543|NCT01292603|20568510|P6|NOT COMPLETED|Overall Survival Status||10
8343544|NCT01292603|20568511|P5|NOT COMPLETED|Overall Survival Status||16
8343545|NCT01292603|20568512|P4|NOT COMPLETED|Overall Survival Status||1
8343546|NCT01292603|20568513|P3|NOT COMPLETED|Overall Survival Status||3
8343547|NCT01292603|20568514|P2|NOT COMPLETED|Overall Survival Status||1
8343548|NCT01292603|20568515|P1|NOT COMPLETED|Overall Survival Status||3
8343549|NCT01292603|20568510|P6|COMPLETED|Overall Survival Status||78
8343550|NCT01292603|20568511|P5|COMPLETED|Overall Survival Status||72
8343551|NCT01292603|20568512|P4|COMPLETED|Overall Survival Status||7
8343552|NCT01292603|20568513|P3|COMPLETED|Overall Survival Status||20
8343553|NCT01292603|20568514|P2|COMPLETED|Overall Survival Status||16
8343554|NCT01292603|20568515|P1|COMPLETED|Overall Survival Status||13
8343555|NCT01292603|20568510|P6|STARTED|Overall Survival Status||88
8343556|NCT01292603|20568511|P5|STARTED|Overall Survival Status||88
8343557|NCT01292603|20568512|P4|STARTED|Overall Survival Status||8
8343558|NCT01292603|20568513|P3|STARTED|Overall Survival Status||23
8343559|NCT01292603|20568514|P2|STARTED|Overall Survival Status||17
8343560|NCT01292603|20568515|P1|STARTED|Overall Survival Status||16
8343561|NCT01292603|20568510|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
8343562|NCT01292603|20568511|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
8343563|NCT01292603|20568512|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343564|NCT01292603|20568513|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343565|NCT01292603|20568514|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343566|NCT01292603|20568515|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343567|NCT01292603|20568510|P6|COMPLETED|Part 2: Regular Follow-Up||75
8343568|NCT01292603|20568511|P5|COMPLETED|Part 2: Regular Follow-Up||68
8343569|NCT01292603|20568512|P4|COMPLETED|Part 2: Regular Follow-Up||0
8343570|NCT01292603|20568513|P3|COMPLETED|Part 2: Regular Follow-Up||0
8343571|NCT01292603|20568514|P2|COMPLETED|Part 2: Regular Follow-Up||0
8343572|NCT01292603|20568515|P1|COMPLETED|Part 2: Regular Follow-Up||0
8343573|NCT01292603|20568510|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
8343574|NCT01292603|20568511|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
8343575|NCT01292603|20568512|P4|STARTED|Part 2: Regular Follow-Up||0
8343576|NCT01292603|20568513|P3|STARTED|Part 2: Regular Follow-Up||0
8343577|NCT01292603|20568514|P2|STARTED|Part 2: Regular Follow-Up||0
8343578|NCT01292603|20568515|P1|STARTED|Part 2: Regular Follow-Up||0
8343579|NCT01292603|20568510|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
8343580|NCT01292603|20568511|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
8343581|NCT01292603|20568512|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343582|NCT01292603|20568513|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343583|NCT01292603|20568514|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343584|NCT01292603|20568515|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343585|NCT01292603|20568510|P6|COMPLETED|Part 2: Dose Confirmation Period||73
8343586|NCT01292603|20568511|P5|COMPLETED|Part 2: Dose Confirmation Period||72
8343587|NCT01292603|20568512|P4|COMPLETED|Part 2: Dose Confirmation Period||0
8343588|NCT01292603|20568513|P3|COMPLETED|Part 2: Dose Confirmation Period||0
8343589|NCT01292603|20568514|P2|COMPLETED|Part 2: Dose Confirmation Period||0
8343590|NCT01292603|20568515|P1|COMPLETED|Part 2: Dose Confirmation Period||0
8343591|NCT01292603|20568510|P6|STARTED|Part 2: Dose Confirmation Period||88
8343592|NCT01292603|20568511|P5|STARTED|Part 2: Dose Confirmation Period||88
8343593|NCT01292603|20568512|P4|STARTED|Part 2: Dose Confirmation Period||0
8343594|NCT01292603|20568513|P3|STARTED|Part 2: Dose Confirmation Period||0
8343595|NCT01292603|20568514|P2|STARTED|Part 2: Dose Confirmation Period||0
8343596|NCT01292603|20568515|P1|STARTED|Part 2: Dose Confirmation Period||0
8343597|NCT01292603|20568510|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
8343598|NCT01292603|20568511|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
8343599|NCT01292603|20568512|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
8343600|NCT01292603|20568513|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
8343601|NCT01292603|20568514|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
8343602|NCT01292603|20568515|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
8343603|NCT01292603|20568510|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
8343604|NCT01292603|20568511|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
8343605|NCT01292603|20568512|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
8343606|NCT01292603|20568513|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
8343694|NCT01292057|20568744|P2|STARTED|Overall Study||50
8343607|NCT01292603|20568514|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
8343608|NCT01292603|20568515|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
8343609|NCT01292603|20568510|P6|STARTED|Part 1: Regular Follow-Up Period||0
8343610|NCT01292603|20568511|P5|STARTED|Part 1: Regular Follow-Up Period||0
8343611|NCT01292603|20568512|P4|STARTED|Part 1: Regular Follow-Up Period||8
8343612|NCT01292603|20568513|P3|STARTED|Part 1: Regular Follow-Up Period||23
8343613|NCT01292603|20568514|P2|STARTED|Part 1: Regular Follow-Up Period||17
8343614|NCT01292603|20568515|P1|STARTED|Part 1: Regular Follow-Up Period||16
8343615|NCT01292603|20568510|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343616|NCT01292603|20568511|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343617|NCT01292603|20568512|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
8343618|NCT01292603|20568513|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343619|NCT01292603|20568514|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343620|NCT01292603|20568515|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343621|NCT01292603|20568510|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
8343622|NCT01292603|20568511|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
8343623|NCT01292603|20568512|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
8343624|NCT01292603|20568513|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
8343625|NCT01292603|20568514|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
8343626|NCT01292603|20568515|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
8343627|NCT01292603|20568510|P6|STARTED|Part 1: Pilot Dose Selection Period||0
8343628|NCT01292603|20568511|P5|STARTED|Part 1: Pilot Dose Selection Period||0
8343629|NCT01292603|20568512|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
8343630|NCT01292603|20568513|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
8343631|NCT01292603|20568514|P2|STARTED|Part 1: Pilot Dose Selection Period||17
8343632|NCT01292603|20568515|P1|STARTED|Part 1: Pilot Dose Selection Period||16
8343633|NCT01292538|20568561|P2|NOT COMPLETED|Overall Study||0
8343634|NCT01292538|20568562|P1|NOT COMPLETED|Overall Study||0
8343635|NCT01292538|20568561|P2|COMPLETED|Overall Study||32
8343636|NCT01292538|20568562|P1|COMPLETED|Overall Study||35
8343637|NCT01292538|20568561|P2|STARTED|Overall Study||32
8343638|NCT01292538|20568562|P1|STARTED|Overall Study||35
8343639|NCT01292486|20568568|P1|NOT COMPLETED|Overall Study||6
8343640|NCT01292486|20568568|P1|COMPLETED|Overall Study||26
8343641|NCT01292486|20568568|P1|STARTED|Overall Study||32
8343642|NCT01292473|20568582|P4|NOT COMPLETED|Overall Study||12
8343643|NCT01292473|20568583|P3|NOT COMPLETED|Overall Study||9
8343644|NCT01292473|20568584|P2|NOT COMPLETED|Overall Study||7
8343645|NCT01292473|20568585|P1|NOT COMPLETED|Overall Study||5
8343646|NCT01292473|20568582|P4|COMPLETED|Overall Study||67
8343647|NCT01292473|20568583|P3|COMPLETED|Overall Study||74
8343648|NCT01292473|20568584|P2|COMPLETED|Overall Study||75
8343649|NCT01292473|20568585|P1|COMPLETED|Overall Study||74
8343650|NCT01292473|20568582|P4|STARTED|Overall Study||79
8343651|NCT01292473|20568583|P3|STARTED|Overall Study||83
8343652|NCT01292473|20568584|P2|STARTED|Overall Study||82
8343653|NCT01292473|20568585|P1|STARTED|Overall Study||79
8343654|NCT01292447|20568629|P2|NOT COMPLETED|Overall Study||3
8343655|NCT01292447|20568630|P1|NOT COMPLETED|Overall Study||2
8343656|NCT01292447|20568629|P2|COMPLETED|Overall Study||72
8343657|NCT01292447|20568630|P1|COMPLETED|Overall Study||73
8343658|NCT01292447|20568629|P2|STARTED|Overall Study||75
8343659|NCT01292447|20568630|P1|STARTED|Overall Study||75
8343660|NCT01292304|20568636|P1|NOT COMPLETED|Overall Study||0
8343661|NCT01292304|20568636|P1|COMPLETED|Overall Study||10
8343662|NCT01292304|20568636|P1|STARTED|Overall Study||10
8343663|NCT01292265|20568644|P1|NOT COMPLETED|Overall Study||0
8343664|NCT01292265|20568644|P1|COMPLETED|Overall Study||3
8343665|NCT01292265|20568644|P1|STARTED|Overall Study||3
8343666|NCT01292239|20568653|P2|NOT COMPLETED|Overall Study||7
8343667|NCT01292239|20568654|P1|NOT COMPLETED|Overall Study||4
8343668|NCT01292239|20568653|P2|COMPLETED|Overall Study||53
8343669|NCT01292239|20568654|P1|COMPLETED|Overall Study||119
8343670|NCT01292239|20568653|P2|STARTED|Overall Study||60
8343671|NCT01292239|20568654|P1|STARTED|Overall Study||123
8343672|NCT01292226|20568675|P1|NOT COMPLETED|Overall Study||13
8343673|NCT01292226|20568675|P1|COMPLETED|Overall Study||32
8343674|NCT01292226|20568675|P1|STARTED|Overall Study||45
8343675|NCT01292187|20568708|P2|NOT COMPLETED|Overall Study||13
8343676|NCT01292187|20568709|P1|NOT COMPLETED|Overall Study||17
8343677|NCT01292187|20568708|P2|COMPLETED|Overall Study||30
8343678|NCT01292187|20568709|P1|COMPLETED|Overall Study||69
8343679|NCT01292187|20568708|P2|STARTED|Overall Study||43
8343680|NCT01292187|20568709|P1|STARTED|Overall Study||86
8343681|NCT01292135|20568719|P2|NOT COMPLETED|Overall Study||9
8343682|NCT01292135|20568720|P1|NOT COMPLETED|Overall Study||0
8343683|NCT01292135|20568719|P2|COMPLETED|Overall Study||21
8343684|NCT01292135|20568720|P1|COMPLETED|Overall Study||3
8343685|NCT01292135|20568719|P2|STARTED|Overall Study||30
8343686|NCT01292135|20568720|P1|STARTED|Overall Study||3
8343687|NCT01292070|20568738|P1|NOT COMPLETED|Overall Study||0
8343688|NCT01292070|20568738|P1|COMPLETED|Overall Study||4
8343689|NCT01292070|20568738|P1|STARTED|Overall Study||4
8343690|NCT01292057|20568744|P2|NOT COMPLETED|Overall Study||2
8343691|NCT01292057|20568745|P1|NOT COMPLETED|Overall Study||2
8343692|NCT01292057|20568744|P2|COMPLETED|Overall Study||48
8343693|NCT01292057|20568745|P1|COMPLETED|Overall Study||47
8343695|NCT01292057|20568745|P1|STARTED|Overall Study||49
8343696|NCT01292005|20568755|P2|NOT COMPLETED|Overall Study||0
8343697|NCT01292005|20568756|P1|NOT COMPLETED|Overall Study||0
8343698|NCT01292005|20568755|P2|COMPLETED|Overall Study||14
8343699|NCT01292005|20568756|P1|COMPLETED|Overall Study||14
8343700|NCT01292005|20568755|P2|STARTED|Overall Study||14
8343701|NCT01292005|20568756|P1|STARTED|Overall Study||14
8343702|NCT01291836|20568780|P2|NOT COMPLETED|Overall Study||0
8343703|NCT01291836|20568781|P1|NOT COMPLETED|Overall Study||0
8343704|NCT01291836|20568780|P2|COMPLETED|Overall Study||71
8343705|NCT01291836|20568781|P1|COMPLETED|Overall Study||930
8343706|NCT01291836|20568780|P2|STARTED|Overall Study||71
8343707|NCT01291836|20568781|P1|STARTED|Overall Study||930
8343708|NCT01291784|20568787|P3|NOT COMPLETED|Overall Study||0
8343709|NCT01291784|20568788|P2|NOT COMPLETED|Overall Study||1
8343710|NCT01291784|20568789|P1|NOT COMPLETED|Overall Study||0
8343711|NCT01291784|20568787|P3|COMPLETED|Overall Study||1
8343712|NCT01291784|20568788|P2|COMPLETED|Overall Study||0
8343713|NCT01291784|20568789|P1|COMPLETED|Overall Study||1
8343714|NCT01291784|20568787|P3|STARTED|Overall Study||1
8343715|NCT01291784|20568788|P2|STARTED|Overall Study||1
8343716|NCT01291784|20568789|P1|STARTED|Overall Study||1
8343717|NCT01291498|20568809|P1|NOT COMPLETED|Overall Study||1
8343718|NCT01291498|20568809|P1|COMPLETED|Overall Study||0
8343719|NCT01291498|20568809|P1|STARTED|Overall Study||1
8343720|NCT01291277|20568817|P2|NOT COMPLETED|Overall Study||3
8343721|NCT01291277|20568818|P1|NOT COMPLETED|Overall Study||5
8343722|NCT01291277|20568817|P2|COMPLETED|Overall Study||42
8343723|NCT01291277|20568818|P1|COMPLETED|Overall Study||40
8343724|NCT01291277|20568817|P2|STARTED|Overall Study||45
8343725|NCT01291277|20568818|P1|STARTED|Overall Study||45
8343726|NCT01291264|20568824|P1|NOT COMPLETED|Overall Study||0
8343727|NCT01291264|20568824|P1|COMPLETED|Overall Study||260
8343728|NCT01291264|20568824|P1|STARTED|Overall Study||260
8343729|NCT01291225|20568830|P2|NOT COMPLETED|Overall Study||39
8343730|NCT01291225|20568831|P1|NOT COMPLETED|Overall Study||85
8343731|NCT01291225|20568830|P2|COMPLETED|Overall Study||121
8343732|NCT01291225|20568831|P1|COMPLETED|Overall Study||66
8343733|NCT01291225|20568830|P2|STARTED|Overall Study||160
8343734|NCT01291225|20568831|P1|STARTED|Overall Study||151
8343735|NCT01291173|20568845|P4|NOT COMPLETED|Overall Study||13
8343736|NCT01291173|20568846|P3|NOT COMPLETED|Overall Study||13
8343737|NCT01291173|20568847|P2|NOT COMPLETED|Overall Study||15
8343738|NCT01291173|20568848|P1|NOT COMPLETED|Overall Study||17
8343739|NCT01291173|20568845|P4|COMPLETED|Overall Study||52
8343740|NCT01291173|20568846|P3|COMPLETED|Overall Study||52
8343741|NCT01291173|20568847|P2|COMPLETED|Overall Study||51
8343742|NCT01291173|20568848|P1|COMPLETED|Overall Study||47
8343743|NCT01291173|20568845|P4|STARTED|Overall Study||65
8343744|NCT01291173|20568846|P3|STARTED|Overall Study||65
8343745|NCT01291173|20568847|P2|STARTED|Overall Study||66
8343746|NCT01291173|20568848|P1|STARTED|Overall Study||64
8343747|NCT01291160|20568912|P2|NOT COMPLETED|Overall Study||16
8343748|NCT01291160|20568913|P1|NOT COMPLETED|Overall Study||18
8343749|NCT01291160|20568912|P2|COMPLETED|Overall Study||48
8343750|NCT01291160|20568913|P1|COMPLETED|Overall Study||48
8343751|NCT01291160|20568912|P2|STARTED|Overall Study||64
8343752|NCT01291160|20568913|P1|STARTED|Overall Study||66
8343753|NCT01291108|20568923|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
8343754|NCT01291108|20568924|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343755|NCT01291108|20568925|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343756|NCT01291108|20568926|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343757|NCT01291108|20568927|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
8343758|NCT01291108|20568928|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343759|NCT01291108|20568923|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
8343760|NCT01291108|20568924|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
8343761|NCT01291108|20568925|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
8343762|NCT01291108|20568926|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
8343763|NCT01291108|20568927|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
8343764|NCT01291108|20568928|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
8343765|NCT01291108|20568923|P6|STARTED|Month 2 (Adjunctive Therapy)||26
8343766|NCT01291108|20568924|P5|STARTED|Month 2 (Adjunctive Therapy)||34
8343767|NCT01291108|20568925|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
8343768|NCT01291108|20568926|P3|STARTED|Month 2 (Adjunctive Therapy)||24
8343769|NCT01291108|20568927|P2|STARTED|Month 2 (Adjunctive Therapy)||40
8343770|NCT01291108|20568928|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
8343771|NCT01291108|20568923|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
8343772|NCT01291108|20568924|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
8343773|NCT01291108|20568925|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
8343774|NCT01291108|20568926|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
8343775|NCT01291108|20568927|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
8343776|NCT01291108|20568928|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
8343777|NCT01291108|20568923|P6|COMPLETED|Month 1 (Monotherapy)||0
8343778|NCT01291108|20568924|P5|COMPLETED|Month 1 (Monotherapy)||0
8343779|NCT01291108|20568925|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
8343780|NCT01291108|20568926|P3|COMPLETED|Month 1 (Monotherapy)||0
8343781|NCT01291108|20568927|P2|COMPLETED|Month 1 (Monotherapy)||0
8343782|NCT01291108|20568928|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
8343783|NCT01291108|20568923|P6|STARTED|Month 1 (Monotherapy)||0
8343784|NCT01291108|20568924|P5|STARTED|Month 1 (Monotherapy)||0
8343785|NCT01291108|20568925|P4|STARTED|Month 1 (Monotherapy)||60
8343786|NCT01291108|20568926|P3|STARTED|Month 1 (Monotherapy)||0
8343787|NCT01291108|20568927|P2|STARTED|Month 1 (Monotherapy)||0
8343788|NCT01291108|20568928|P1|STARTED|Month 1 (Monotherapy)||65
8343789|NCT01291056|20568944|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
8343790|NCT01291056|20568945|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
8343791|NCT01291056|20568944|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
8343792|NCT01291056|20568945|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
8343793|NCT01291056|20568944|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
8343794|NCT01291056|20568945|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
8343795|NCT01291056|20568944|P2|NOT COMPLETED|Washout||0
8343796|NCT01291056|20568945|P1|NOT COMPLETED|Washout||0
8343797|NCT01291056|20568944|P2|COMPLETED|Washout||10
8343798|NCT01291056|20568945|P1|COMPLETED|Washout||10
8343799|NCT01291056|20568944|P2|STARTED|Washout||10
8343800|NCT01291056|20568945|P1|STARTED|Washout||10
8343801|NCT01291056|20568944|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
8343802|NCT01291056|20568945|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
8343803|NCT01291056|20568944|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
8343804|NCT01291056|20568945|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
8343805|NCT01291056|20568944|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
8343806|NCT01291056|20568945|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
8343807|NCT01291017|20568957|P1|NOT COMPLETED|Overall Study||5
8343808|NCT01291017|20568957|P1|COMPLETED|Overall Study||14
8343809|NCT01291017|20568957|P1|STARTED|Overall Study||19
8343810|NCT01290978|20568965|P1|NOT COMPLETED|Overall Study||0
8343811|NCT01290978|20568965|P1|COMPLETED|Overall Study||22
8343812|NCT01290978|20568965|P1|STARTED|Overall Study||22
8343813|NCT01290952|20568974|P2|NOT COMPLETED|Overall Study||14
8343814|NCT01290952|20568975|P1|NOT COMPLETED|Overall Study||12
8343815|NCT01290952|20568974|P2|COMPLETED|Overall Study||193
8343816|NCT01290952|20568975|P1|COMPLETED|Overall Study||192
8343817|NCT01290952|20568974|P2|STARTED|Overall Study||207
8343818|NCT01290952|20568975|P1|STARTED|Overall Study||204
8343819|NCT01290913|20568983|P1|NOT COMPLETED|Overall Study||1
8343820|NCT01290913|20568983|P1|COMPLETED|Overall Study||12
8343821|NCT01290913|20568983|P1|STARTED|Overall Study||13
8343822|NCT01290887|20568990|P2|NOT COMPLETED|Overall Study||536
8343823|NCT01290887|20568991|P1|NOT COMPLETED|Overall Study||466
8343824|NCT01290887|20568990|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
8343825|NCT01290887|20568991|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
8343826|NCT01290887|20568990|P2|Safety Analysis Set|Overall Study||571
8343827|NCT01290887|20568991|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
8343828|NCT01290887|20568990|P2|STARTED|Overall Study||571
8343829|NCT01290887|20568991|P1|STARTED|Overall Study||481
8343830|NCT01290874|20569031|P2|NOT COMPLETED|Overall Study||404
8343831|NCT01290874|20569032|P1|NOT COMPLETED|Overall Study||410
8343832|NCT01290874|20569031|P2|COMPLETED|Overall Study||134
8343833|NCT01290874|20569032|P1|COMPLETED|Overall Study||122
8343834|NCT01290874|20569031|P2|STARTED|Overall Study||538
8343835|NCT01290874|20569032|P1|STARTED|Overall Study||532
8343836|NCT01290822|20569052|P1|NOT COMPLETED|Overall Study||11
8343837|NCT01290822|20569052|P1|COMPLETED|Overall Study||1
8343838|NCT01290822|20569052|P1|STARTED|Overall Study||12
8343839|NCT01290796|20569061|P1|NOT COMPLETED|Overall Study||30
8343840|NCT01290796|20569061|P1|COMPLETED|Overall Study||123
8343841|NCT01290796|20569061|P1|STARTED|Overall Study||153
8343842|NCT01290757|20569077|P2|NOT COMPLETED|Overall Study||2
8343843|NCT01290757|20569078|P1|NOT COMPLETED|Overall Study||2
8343844|NCT01290757|20569077|P2|COMPLETED|Overall Study||88
8343845|NCT01290757|20569078|P1|COMPLETED|Overall Study||88
8343846|NCT01290757|20569077|P2|STARTED|Overall Study||90
8343847|NCT01290757|20569078|P1|STARTED|Overall Study||90
8343848|NCT01290731|20569094|P1|NOT COMPLETED|Overall Study||1
8343849|NCT01290731|20569094|P1|COMPLETED|Overall Study||48
8343850|NCT01290731|20569094|P1|STARTED|Overall Study||49
8343851|NCT01290718|20569106|P1|NOT COMPLETED|Overall Study||4
8343852|NCT01290718|20569106|P1|COMPLETED|Overall Study||0
8343853|NCT01290718|20569106|P1|STARTED|Overall Study||4
8343854|NCT01290679|20569115|P2|NOT COMPLETED|Overall Study||21
8343855|NCT01290679|20569116|P1|NOT COMPLETED|Overall Study||16
8343856|NCT01290679|20569115|P2|COMPLETED|Overall Study||113
8343857|NCT01290679|20569116|P1|COMPLETED|Overall Study||241
8343858|NCT01290679|20569115|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
8343859|NCT01290679|20569116|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
8343860|NCT01290666|20569185|P1|NOT COMPLETED|Overall Study||38
8343861|NCT01290666|20569185|P1|COMPLETED|Overall Study||55
8343862|NCT01290666|20569185|P1|STARTED|Overall Study||93
8343863|NCT01290640|20569191|P2|NOT COMPLETED|Overall Study||0
8343864|NCT01290640|20569192|P1|NOT COMPLETED|Overall Study||0
8343865|NCT01290640|20569191|P2|COMPLETED|Overall Study||10
8343866|NCT01290640|20569192|P1|COMPLETED|Overall Study||12
8343867|NCT01290640|20569191|P2|STARTED|Overall Study||10
8343868|NCT01290640|20569192|P1|STARTED|Overall Study||12
8343869|NCT01290627|20569203|P3|NOT COMPLETED|Overall Study||0
8343870|NCT01290627|20569204|P2|NOT COMPLETED|Overall Study||0
8343871|NCT01290627|20569205|P1|NOT COMPLETED|Overall Study||0
8343872|NCT01290627|20569203|P3|COMPLETED|Overall Study||10
8343873|NCT01290627|20569204|P2|COMPLETED|Overall Study||10
8343874|NCT01290627|20569205|P1|COMPLETED|Overall Study||10
8343875|NCT01290627|20569203|P3|STARTED|Overall Study||10
8343876|NCT01290627|20569204|P2|STARTED|Overall Study||10
8343877|NCT01290627|20569205|P1|STARTED|Overall Study||10
8343878|NCT01290614|20569227|P2|NOT COMPLETED|Overall Study||0
8343879|NCT01290614|20569228|P1|NOT COMPLETED|Overall Study||552
8343880|NCT01290614|20569227|P2|COMPLETED|Overall Study||1129
8343881|NCT01290614|20569228|P1|COMPLETED|Overall Study||518
8343882|NCT01290614|20569227|P2|STARTED|Overall Study||1129
8343883|NCT01290614|20569228|P1|STARTED|Overall Study||1070
8343884|NCT01290601|20569238|P4|NOT COMPLETED|Overall Study||0
8343885|NCT01290601|20569239|P3|NOT COMPLETED|Overall Study||0
8343886|NCT01290601|20569240|P2|NOT COMPLETED|Overall Study||5
8343887|NCT01290601|20569241|P1|NOT COMPLETED|Overall Study||11
8343888|NCT01290601|20569238|P4|COMPLETED|Overall Study||0
8343889|NCT01290601|20569239|P3|COMPLETED|Overall Study||0
8343890|NCT01290601|20569240|P2|COMPLETED|Overall Study||19
8343891|NCT01290601|20569241|P1|COMPLETED|Overall Study||35
8343892|NCT01290601|20569238|P4|STARTED|Overall Study||0
8343893|NCT01290601|20569239|P3|STARTED|Overall Study||0
8343894|NCT01290601|20569240|P2|STARTED|Overall Study||24
8343895|NCT01290601|20569241|P1|STARTED|Overall Study||46
8343896|NCT01290536|20569255|P1|NOT COMPLETED|Overall Study||0
8343897|NCT01290536|20569255|P1|COMPLETED|Overall Study||42
8343898|NCT01290536|20569255|P1|STARTED|Overall Study||42
8343899|NCT01290523|20569262|P1|NOT COMPLETED|Overall Study||3
8343900|NCT01290523|20569262|P1|COMPLETED|Overall Study||11
8343901|NCT01290523|20569262|P1|STARTED|Overall Study||14
8343902|NCT01290484|20569267|P1|NOT COMPLETED|Overall Study||0
8343903|NCT01290484|20569267|P1|COMPLETED|Overall Study||7
8343904|NCT01290484|20569267|P1|STARTED|Overall Study||7
8343905|NCT01290445|20569274|P3|NOT COMPLETED|Overall Study||0
8343906|NCT01290445|20569275|P2|NOT COMPLETED|Overall Study||0
8343907|NCT01290445|20569276|P1|NOT COMPLETED|Overall Study||0
8343908|NCT01290445|20569274|P3|COMPLETED|Overall Study||806438
8343909|NCT01290445|20569275|P2|COMPLETED|Overall Study||78412
8343910|NCT01290445|20569276|P1|COMPLETED|Overall Study||335
8343911|NCT01290445|20569274|P3|STARTED|Overall Study||806438
8343912|NCT01290445|20569275|P2|STARTED|Overall Study||78412
8343913|NCT01290445|20569276|P1|STARTED|Overall Study||335
8343914|NCT01290341|20569301|P2|NOT COMPLETED|Overall Study||29
8343915|NCT01290341|20569302|P1|NOT COMPLETED|Overall Study||92
8343916|NCT01290341|20569301|P2|COMPLETED|Overall Study||258
8343917|NCT01290341|20569302|P1|COMPLETED|Overall Study||481
8343918|NCT01290341|20569301|P2|STARTED|Overall Study||287
8343919|NCT01290341|20569302|P1|STARTED|Overall Study||573
8343920|NCT01290315|20569314|P4|NOT COMPLETED|Overall Study||5
8343921|NCT01290315|20569315|P3|NOT COMPLETED|Overall Study||0
8343922|NCT01290315|20569316|P2|NOT COMPLETED|Overall Study||3
8343923|NCT01290315|20569317|P1|NOT COMPLETED|Overall Study||3
8343924|NCT01290315|20569314|P4|COMPLETED|Overall Study||8
8343925|NCT01290315|20569315|P3|COMPLETED|Overall Study||10
8343926|NCT01290315|20569316|P2|COMPLETED|Overall Study||9
8343927|NCT01290315|20569317|P1|COMPLETED|Overall Study||11
8343928|NCT01290315|20569314|P4|STARTED|Overall Study||13
8343929|NCT01290315|20569315|P3|STARTED|Overall Study||10
8343930|NCT01290315|20569316|P2|STARTED|Overall Study||12
8343931|NCT01290315|20569317|P1|STARTED|Overall Study||14
8343932|NCT01290263|20569339|P5|NOT COMPLETED|Overall Study||37
8343933|NCT01290263|20569340|P4|NOT COMPLETED|Overall Study||27
8343934|NCT01290263|20569341|P3|NOT COMPLETED|Overall Study||7
8343935|NCT01290263|20569342|P2|NOT COMPLETED|Overall Study||3
8343936|NCT01290263|20569343|P1|NOT COMPLETED|Overall Study||11
8343937|NCT01290263|20569339|P5|COMPLETED|Overall Study||0
8343938|NCT01290263|20569340|P4|COMPLETED|Overall Study||0
8343939|NCT01290263|20569341|P3|COMPLETED|Overall Study||0
8343940|NCT01290263|20569342|P2|COMPLETED|Overall Study||0
8343941|NCT01290263|20569343|P1|COMPLETED|Overall Study||0
8343942|NCT01290263|20569339|P5|STARTED|Overall Study||37
8343943|NCT01290263|20569340|P4|STARTED|Overall Study||27
8343944|NCT01290263|20569341|P3|STARTED|Overall Study||7
8343945|NCT01290263|20569342|P2|STARTED|Overall Study||3
8343946|NCT01290263|20569343|P1|STARTED|Overall Study||11
8343947|NCT01290237|20569361|P2|NOT COMPLETED|Overall Study||2
8343948|NCT01290237|20569362|P1|NOT COMPLETED|Overall Study||11
8343949|NCT01290237|20569361|P2|COMPLETED|Overall Study||27
8343950|NCT01290237|20569362|P1|COMPLETED|Overall Study||19
8343951|NCT01290237|20569361|P2|STARTED|Overall Study||29
8343952|NCT01290237|20569362|P1|STARTED|Overall Study||30
8343953|NCT01290224|20569370|P1|NOT COMPLETED|Overall Study||5
8343954|NCT01290224|20569370|P1|COMPLETED|Overall Study||5
8343955|NCT01290224|20569370|P1|STARTED|Overall Study||10
8343956|NCT01290094|20569381|P1|NOT COMPLETED|Overall Study||6
8343957|NCT01290094|20569381|P1|COMPLETED|Overall Study||35
8343958|NCT01290094|20569381|P1|STARTED|Overall Study||41
8343959|NCT01290068|20569394|P2|NOT COMPLETED|Overall Study||6
8343960|NCT01290068|20569395|P1|NOT COMPLETED|Overall Study||7
8343961|NCT01290068|20569394|P2|COMPLETED|Overall Study||94
8343962|NCT01290068|20569395|P1|COMPLETED|Overall Study||101
8343963|NCT01290068|20569394|P2|Implanted|Overall Study||98
8343964|NCT01290068|20569395|P1|Implanted|Overall Study||108
8343965|NCT01290068|20569394|P2|STARTED|Overall Study||100
8343966|NCT01290068|20569395|P1|STARTED|Overall Study||108
8343967|NCT01290029|20569407|P1|NOT COMPLETED|Overall Study||2
8343968|NCT01290029|20569407|P1|COMPLETED|Overall Study||12
8343969|NCT01290029|20569407|P1|Received Study Treatment|Overall Study||12
8343970|NCT01290029|20569407|P1|STARTED|Overall Study||14
8343971|NCT01289990|20569433|P13|NOT COMPLETED|Overall Study||98
8343972|NCT01289990|20569434|P12|NOT COMPLETED|Overall Study||68
8343973|NCT01289990|20569435|P11|NOT COMPLETED|Overall Study||76
8343974|NCT01289990|20569436|P10|NOT COMPLETED|Overall Study||86
8343975|NCT01289990|20569437|P9|NOT COMPLETED|Overall Study||75
8343976|NCT01289990|20569438|P8|NOT COMPLETED|Overall Study||55
8343977|NCT01289990|20569439|P7|NOT COMPLETED|Overall Study||88
8343978|NCT01289990|20569440|P6|NOT COMPLETED|Overall Study||74
8343979|NCT01289990|20569441|P5|NOT COMPLETED|Overall Study||72
8343980|NCT01289990|20569442|P4|NOT COMPLETED|Overall Study||87
8343981|NCT01289990|20569443|P3|NOT COMPLETED|Overall Study||109
8343982|NCT01289990|20569444|P2|NOT COMPLETED|Overall Study||81
8343983|NCT01289990|20569445|P1|NOT COMPLETED|Overall Study||77
8343984|NCT01289990|20569433|P13|COMPLETED|Overall Study||127
8343985|NCT01289990|20569434|P12|COMPLETED|Overall Study||150
8343986|NCT01289990|20569435|P11|COMPLETED|Overall Study||150
8343987|NCT01289990|20569436|P10|COMPLETED|Overall Study||121
8343988|NCT01289990|20569437|P9|COMPLETED|Overall Study||139
8343989|NCT01289990|20569438|P8|COMPLETED|Overall Study||162
8343990|NCT01289990|20569439|P7|COMPLETED|Overall Study||78
8343991|NCT01289990|20569440|P6|COMPLETED|Overall Study||94
8343992|NCT01289990|20569441|P5|COMPLETED|Overall Study||93
8343993|NCT01289990|20569442|P4|COMPLETED|Overall Study||136
8343994|NCT01289990|20569443|P3|COMPLETED|Overall Study||119
8343995|NCT01289990|20569444|P2|COMPLETED|Overall Study||143
8343996|NCT01289990|20569445|P1|COMPLETED|Overall Study||147
8343997|NCT01289990|20569433|P13|STARTED|Overall Study||225
8343998|NCT01289990|20569434|P12|STARTED|Overall Study||218
8343999|NCT01289990|20569435|P11|STARTED|Overall Study||226
8344000|NCT01289990|20569436|P10|STARTED|Overall Study||207
8344001|NCT01289990|20569437|P9|STARTED|Overall Study||214
8344002|NCT01289990|20569438|P8|STARTED|Overall Study||217
8344003|NCT01289990|20569439|P7|STARTED|Overall Study||166
8344004|NCT01289990|20569440|P6|STARTED|Overall Study||168
8344005|NCT01289990|20569441|P5|STARTED|Overall Study||165
8344006|NCT01289990|20569442|P4|STARTED|Overall Study||223
8344007|NCT01289990|20569443|P3|STARTED|Overall Study||228
8344008|NCT01289990|20569444|P2|STARTED|Overall Study||224
8344009|NCT01289990|20569445|P1|STARTED|Overall Study||224
8344010|NCT01289912|20569631|P2|NOT COMPLETED|Overall Study||2
8344011|NCT01289912|20569632|P1|NOT COMPLETED|Overall Study||3
8344012|NCT01289912|20569631|P2|COMPLETED|Overall Study||13
8344013|NCT01289912|20569632|P1|COMPLETED|Overall Study||29
8344014|NCT01289912|20569631|P2|STARTED|Overall Study||15
8344015|NCT01289912|20569632|P1|STARTED|Overall Study||32
8344016|NCT01289847|20569662|P1|NOT COMPLETED|Overall Study||1
8344017|NCT01289847|20569662|P1|COMPLETED|Overall Study||24
8344018|NCT01289847|20569662|P1|STARTED|Overall Study||25
8344019|NCT01289821|20569671|P1|NOT COMPLETED|Survival Follow-up Period||18
8344020|NCT01289821|20569671|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
8344021|NCT01289821|20569671|P1|STARTED|Survival Follow-up Period||52
8344022|NCT01289821|20569671|P1|NOT COMPLETED|Safety Follow-up Period||5
8344023|NCT01289821|20569671|P1|COMPLETED|Safety Follow-up Period||49
8344024|NCT01289821|20569671|P1|STARTED|Safety Follow-up Period||54
8344025|NCT01289821|20569671|P1|NOT COMPLETED|Treatment Period||54
8344026|NCT01289821|20569671|P1|COMPLETED|Treatment Period||0
8344027|NCT01289821|20569671|P1|Participants Received Regorafenib|Treatment Period||54
8344028|NCT01289821|20569671|P1|STARTED|Treatment Period||54
8344029|NCT01289782|20569682|P2|NOT COMPLETED|Overall Study||12
8344030|NCT01289782|20569683|P1|NOT COMPLETED|Overall Study||25
8344031|NCT01289782|20569682|P2|COMPLETED|Overall Study||118
8344032|NCT01289782|20569683|P1|COMPLETED|Overall Study||239
8344033|NCT01289782|20569682|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
8344034|NCT01289782|20569683|P1|STARTED|Overall Study||264
8344035|NCT01289678|20569752|P1|NOT COMPLETED|Overall Study||6
8344036|NCT01289678|20569752|P1|COMPLETED|Overall Study||12
8344037|NCT01289678|20569752|P1|STARTED|Overall Study||18
8344038|NCT01289665|20569758|P2|NOT COMPLETED|Overall Study||0
8344039|NCT01289665|20569759|P1|NOT COMPLETED|Overall Study||1
8344040|NCT01289665|20569758|P2|COMPLETED|Overall Study||60
8344041|NCT01289665|20569759|P1|COMPLETED|Overall Study||59
8344042|NCT01289665|20569758|P2|STARTED|Overall Study||60
8344043|NCT01289665|20569759|P1|STARTED|Overall Study||60
8344044|NCT01289639|20569768|P3|NOT COMPLETED|Overall Study||0
8344045|NCT01289639|20569769|P2|NOT COMPLETED|Overall Study||0
8344046|NCT01289639|20569770|P1|NOT COMPLETED|Overall Study||1
8344047|NCT01289639|20569768|P3|COMPLETED|Overall Study||0
8344048|NCT01289639|20569769|P2|COMPLETED|Overall Study||6
8344049|NCT01289639|20569770|P1|COMPLETED|Overall Study||4
8344050|NCT01289639|20569768|P3|STARTED|Overall Study||0
8344051|NCT01289639|20569769|P2|STARTED|Overall Study||6
8344052|NCT01289639|20569770|P1|STARTED|Overall Study||5
8344053|NCT01289574|20569796|P3|NOT COMPLETED|Overall Study||3
8344054|NCT01289574|20569797|P2|NOT COMPLETED|Overall Study||3
8344055|NCT01289574|20569798|P1|NOT COMPLETED|Overall Study||7
8344056|NCT01289574|20569796|P3|COMPLETED|Overall Study||60
8344057|NCT01289574|20569797|P2|COMPLETED|Overall Study||57
8344058|NCT01289574|20569798|P1|COMPLETED|Overall Study||51
8344059|NCT01289574|20569796|P3|STARTED|Overall Study||63
8344060|NCT01289574|20569797|P2|STARTED|Overall Study||60
8344061|NCT01289574|20569798|P1|STARTED|Overall Study||58
8344062|NCT01289548|20569815|P3|NOT COMPLETED|Overall Study||0
8344063|NCT01289548|20569816|P2|NOT COMPLETED|Overall Study||0
8344064|NCT01289548|20569817|P1|NOT COMPLETED|Overall Study||0
8344065|NCT01289548|20569815|P3|COMPLETED|Overall Study||40
8344066|NCT01289548|20569816|P2|COMPLETED|Overall Study||40
8344067|NCT01289548|20569817|P1|COMPLETED|Overall Study||40
8344068|NCT01289548|20569815|P3|Recipients|Overall Study||20
8344069|NCT01289548|20569816|P2|Recipients|Overall Study||20
8344070|NCT01289548|20569817|P1|Recipients|Overall Study||20
8344071|NCT01289548|20569815|P3|Donors|Overall Study||20
8344072|NCT01289548|20569816|P2|Donors|Overall Study||20
8344073|NCT01289548|20569817|P1|Donors|Overall Study||20
8344074|NCT01289548|20569815|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8344075|NCT01289548|20569816|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8344076|NCT01289548|20569817|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8344077|NCT01289522|20569861|P1|NOT COMPLETED|Overall Study||11
8344078|NCT01289522|20569861|P1|COMPLETED|Overall Study||43
8344079|NCT01289522|20569861|P1|STARTED|Overall Study||54
8344080|NCT01289457|20569870|P3|NOT COMPLETED|Overall Study||0
8344081|NCT01289457|20569871|P2|NOT COMPLETED|Overall Study||0
8344082|NCT01289457|20569872|P1|NOT COMPLETED|Overall Study||0
8344083|NCT01289457|20569870|P3|COMPLETED|Overall Study||113
8344084|NCT01289457|20569871|P2|COMPLETED|Overall Study||157
8344085|NCT01289457|20569872|P1|COMPLETED|Overall Study||12
8344086|NCT01289457|20569870|P3|STARTED|Overall Study||113
8344087|NCT01289457|20569871|P2|STARTED|Overall Study||157
8344088|NCT01289457|20569872|P1|STARTED|Overall Study||12
8344089|NCT01289431|20569896|P7|NOT COMPLETED|Overall Study||1
8344090|NCT01289431|20569897|P6|NOT COMPLETED|Overall Study||2
8344091|NCT01289431|20569898|P5|NOT COMPLETED|Overall Study||2
8344092|NCT01289431|20569899|P4|NOT COMPLETED|Overall Study||5
8344093|NCT01289431|20569900|P3|NOT COMPLETED|Overall Study||4
8344094|NCT01289431|20569901|P2|NOT COMPLETED|Overall Study||2
8344095|NCT01289431|20569902|P1|NOT COMPLETED|Overall Study||5
8344096|NCT01289431|20569896|P7|COMPLETED|Overall Study||33
8344097|NCT01289431|20569897|P6|COMPLETED|Overall Study||31
8344098|NCT01289431|20569898|P5|COMPLETED|Overall Study||32
8344099|NCT01289431|20569899|P4|COMPLETED|Overall Study||28
8344100|NCT01289431|20569900|P3|COMPLETED|Overall Study||30
8344101|NCT01289431|20569901|P2|COMPLETED|Overall Study||32
8344102|NCT01289431|20569902|P1|COMPLETED|Overall Study||29
8344103|NCT01289431|20569896|P7|STARTED|Overall Study||34
8344104|NCT01289431|20569897|P6|STARTED|Overall Study||33
8344105|NCT01289431|20569898|P5|STARTED|Overall Study||34
8344106|NCT01289431|20569899|P4|STARTED|Overall Study||33
8344107|NCT01289431|20569900|P3|STARTED|Overall Study||34
8344108|NCT01289431|20569901|P2|STARTED|Overall Study||34
8344109|NCT01289431|20569902|P1|STARTED|Overall Study||34
8344110|NCT01289418|20569942|P1|NOT COMPLETED|Day 29 Survey||2468
8344111|NCT01289418|20569942|P1|COMPLETED|Day 29 Survey||4057
8344112|NCT01289418|20569942|P1|STARTED|Day 29 Survey||6525
8344113|NCT01289418|20569942|P1|NOT COMPLETED|Day 8 Survey||2218
8344114|NCT01289418|20569942|P1|COMPLETED|Day 8 Survey||4307
8344115|NCT01289418|20569942|P1|STARTED|Day 8 Survey||6525
8344116|NCT01289392|20569951|P3|NOT COMPLETED|Overall Study||0
8344117|NCT01289392|20569952|P2|NOT COMPLETED|Overall Study||0
8344118|NCT01289392|20569953|P1|NOT COMPLETED|Overall Study||0
8344119|NCT01289392|20569951|P3|COMPLETED|Overall Study||7
8344120|NCT01289392|20569952|P2|COMPLETED|Overall Study||9
8344121|NCT01289392|20569953|P1|COMPLETED|Overall Study||9
8344122|NCT01289392|20569951|P3|STARTED|Overall Study||7
8344123|NCT01289392|20569952|P2|STARTED|Overall Study||9
8344124|NCT01289392|20569953|P1|STARTED|Overall Study||9
8344125|NCT01289353|20569961|P1|NOT COMPLETED|Overall Study||2
8344126|NCT01289353|20569961|P1|COMPLETED|Overall Study||90
8344127|NCT01289353|20569961|P1|STARTED|Overall Study||92
8344128|NCT01289275|20569971|P4|NOT COMPLETED|Overall Study||0
8344129|NCT01289275|20569972|P3|NOT COMPLETED|Overall Study||0
8344130|NCT01289275|20569973|P2|NOT COMPLETED|Overall Study||0
8344131|NCT01289275|20569974|P1|NOT COMPLETED|Overall Study||0
8344132|NCT01289275|20569971|P4|COMPLETED|Overall Study||316
8344133|NCT01289275|20569972|P3|COMPLETED|Overall Study||317
8344134|NCT01289275|20569973|P2|COMPLETED|Overall Study||320
8344135|NCT01289275|20569974|P1|COMPLETED|Overall Study||317
8344136|NCT01289275|20569971|P4|STARTED|Overall Study||316
8344137|NCT01289275|20569972|P3|STARTED|Overall Study||317
8344138|NCT01289275|20569973|P2|STARTED|Overall Study||320
8344139|NCT01289275|20569974|P1|STARTED|Overall Study||317
8344140|NCT01289210|20569996|P1|NOT COMPLETED|Overall Study||1
8344141|NCT01289210|20569996|P1|COMPLETED|Overall Study||1
8344142|NCT01289210|20569996|P1|STARTED|Overall Study||2
8344143|NCT01289119|20570006|P6|NOT COMPLETED|Overall Study||4
8344144|NCT01289119|20570007|P5|NOT COMPLETED|Overall Study||5
8344145|NCT01289119|20570008|P4|NOT COMPLETED|Overall Study||6
8344146|NCT01289119|20570009|P3|NOT COMPLETED|Overall Study||9
8344147|NCT01289119|20570010|P2|NOT COMPLETED|Overall Study||9
8344148|NCT01289119|20570011|P1|NOT COMPLETED|Overall Study||9
8344149|NCT01289119|20570006|P6|COMPLETED|Overall Study||57
8344150|NCT01289119|20570007|P5|COMPLETED|Overall Study||58
8344151|NCT01289119|20570008|P4|COMPLETED|Overall Study||93
8344152|NCT01289119|20570009|P3|COMPLETED|Overall Study||89
8344153|NCT01289119|20570010|P2|COMPLETED|Overall Study||83
8344154|NCT01289119|20570011|P1|COMPLETED|Overall Study||84
8344155|NCT01289119|20570006|P6|Treated|Overall Study||61
8344156|NCT01289119|20570007|P5|Treated|Overall Study||63
8344157|NCT01289119|20570008|P4|Treated|Overall Study||99
8344158|NCT01289119|20570009|P3|Treated|Overall Study||98
8344159|NCT01289119|20570010|P2|Treated|Overall Study||92
8344160|NCT01289119|20570011|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
8344161|NCT01289119|20570006|P6|STARTED|Overall Study||61
8344162|NCT01289119|20570007|P5|STARTED|Overall Study||63
8344163|NCT01289119|20570008|P4|STARTED|Overall Study||99
8344164|NCT01289119|20570009|P3|STARTED|Overall Study||98
8344165|NCT01289119|20570010|P2|STARTED|Overall Study||92
8344166|NCT01289119|20570011|P1|STARTED|Overall Study||93
8344167|NCT01289080|20570093|P2|NOT COMPLETED|Overall Study||0
8344168|NCT01289080|20570094|P1|NOT COMPLETED|Overall Study||0
8344169|NCT01289080|20570093|P2|COMPLETED|Overall Study||10
8344170|NCT01289080|20570094|P1|COMPLETED|Overall Study||9
8344171|NCT01289080|20570093|P2|STARTED|Overall Study||10
8344172|NCT01289080|20570094|P1|STARTED|Overall Study||9
8344173|NCT01289067|20570125|P1|NOT COMPLETED|Overall Study||0
8344174|NCT01289067|20570125|P1|COMPLETED|Overall Study||13
8344175|NCT01289067|20570125|P1|STARTED|Overall Study||13
8344176|NCT01289041|20570132|P1|NOT COMPLETED|Overall Study||70
8344177|NCT01289041|20570132|P1|COMPLETED|Overall Study||0
8344178|NCT01289041|20570132|P1|STARTED|Overall Study||70
8344179|NCT01289028|20570144|P1|NOT COMPLETED|Overall Study||83
8344180|NCT01289028|20570144|P1|COMPLETED|Overall Study||42
8344181|NCT01289028|20570144|P1|STARTED|Overall Study||125
8344182|NCT01289015|20570158|P2|NOT COMPLETED|Overall Study||54
8344183|NCT01289015|20570159|P1|NOT COMPLETED|Overall Study||99
8344184|NCT01289015|20570158|P2|COMPLETED|Overall Study||230
8344185|NCT01289015|20570159|P1|COMPLETED|Overall Study||472
8344186|NCT01289015|20570158|P2|STARTED|Overall Study||284
8344187|NCT01289015|20570159|P1|STARTED|Overall Study||571
8344188|NCT01288989|20570172|P5|NOT COMPLETED|Overall Study||6
8344189|NCT01288989|20570173|P4|NOT COMPLETED|Overall Study||1
8344190|NCT01288989|20570174|P3|NOT COMPLETED|Overall Study||0
8344191|NCT01288989|20570175|P2|NOT COMPLETED|Overall Study||0
8344192|NCT01288989|20570176|P1|NOT COMPLETED|Overall Study||1
8344193|NCT01288989|20570172|P5|COMPLETED|Overall Study||15
8344194|NCT01288989|20570173|P4|COMPLETED|Overall Study||10
8344195|NCT01288989|20570174|P3|COMPLETED|Overall Study||3
8344196|NCT01288989|20570175|P2|COMPLETED|Overall Study||3
8344197|NCT01288989|20570176|P1|COMPLETED|Overall Study||5
8344198|NCT01288989|20570172|P5|Received at Least 1 Dose of Study Drug|Overall Study||21
8344199|NCT01288989|20570173|P4|Received at Least 1 Dose of Study Drug|Overall Study||11
8344200|NCT01288989|20570174|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8344201|NCT01288989|20570175|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8344202|NCT01288989|20570176|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8344203|NCT01288989|20570172|P5|STARTED|Overall Study||21
8344204|NCT01288989|20570173|P4|STARTED|Overall Study||11
8344205|NCT01288989|20570174|P3|STARTED|Overall Study||3
8344206|NCT01288989|20570175|P2|STARTED|Overall Study||3
8344207|NCT01288989|20570176|P1|STARTED|Overall Study||6
8344208|NCT01288976|20570237|P3|NOT COMPLETED|Overall Study||20
8344209|NCT01288976|20570238|P2|NOT COMPLETED|Overall Study||27
8344210|NCT01288976|20570239|P1|NOT COMPLETED|Overall Study||178
8344211|NCT01288976|20570237|P3|COMPLETED|Overall Study||85
8344212|NCT01288976|20570238|P2|COMPLETED|Overall Study||22
8344213|NCT01288976|20570239|P1|COMPLETED|Overall Study||389
8344214|NCT01288976|20570237|P3|STARTED|Overall Study||105
8344215|NCT01288976|20570238|P2|STARTED|Overall Study||49
8344216|NCT01288976|20570239|P1|STARTED|Overall Study||567
8344217|NCT01288937|20570268|P2|NOT COMPLETED|Overall Study||0
8344218|NCT01288937|20570269|P1|NOT COMPLETED|Overall Study||1
8344219|NCT01288937|20570268|P2|COMPLETED|Overall Study||2
8344220|NCT01288937|20570269|P1|COMPLETED|Overall Study||3
8344221|NCT01288937|20570268|P2|STARTED|Overall Study||2
8344222|NCT01288937|20570269|P1|STARTED|Overall Study||4
8344223|NCT01288911|20570277|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
8344224|NCT01288911|20570278|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
8344225|NCT01288911|20570277|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
8344226|NCT01288911|20570278|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
8344227|NCT01288911|20570277|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
8344228|NCT01288911|20570278|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
8344229|NCT01288911|20570277|P2|STARTED|Open-label Period (All Enzalutamide)||9
8344230|NCT01288911|20570278|P1|STARTED|Open-label Period (All Enzalutamide)||42
8344231|NCT01288911|20570277|P2|NOT COMPLETED|Double-blind Period||182
8344232|NCT01288911|20570278|P1|NOT COMPLETED|Double-blind Period||142
8344233|NCT01288911|20570277|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
8344234|NCT01288911|20570278|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
8344235|NCT01288911|20570277|P2|Received Treatment|Double-blind Period||189
8344236|NCT01288911|20570278|P1|Received Treatment|Double-blind Period||183
8344237|NCT01288911|20570277|P2|STARTED|Double-blind Period||191
8344238|NCT01288911|20570278|P1|STARTED|Double-blind Period||184
8344239|NCT01288859|20570309|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344240|NCT01288859|20570310|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344241|NCT01288859|20570311|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344242|NCT01288859|20570312|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344243|NCT01288859|20570313|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344244|NCT01288859|20570314|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344245|NCT01288859|20570309|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344246|NCT01288859|20570310|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
8344247|NCT01288859|20570311|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
8344248|NCT01288859|20570312|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344249|NCT01288859|20570313|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344250|NCT01288859|20570314|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344251|NCT01288859|20570309|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344252|NCT01288859|20570310|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
8344253|NCT01288859|20570311|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
8344254|NCT01288859|20570312|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344255|NCT01288859|20570313|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344256|NCT01288859|20570314|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344257|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344258|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344259|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344260|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344261|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344262|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344263|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||0
8344264|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||5
8344265|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||5
8344266|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344267|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344268|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||0
8344269|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||0
8344270|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||5
8344271|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||5
8344272|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344273|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344274|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||0
8344275|NCT01288859|20570309|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344276|NCT01288859|20570310|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344277|NCT01288859|20570311|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344278|NCT01288859|20570312|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344279|NCT01288859|20570313|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344280|NCT01288859|20570314|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344281|NCT01288859|20570309|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344282|NCT01288859|20570310|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
8344283|NCT01288859|20570311|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
8344284|NCT01288859|20570312|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344285|NCT01288859|20570313|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344286|NCT01288859|20570314|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344287|NCT01288859|20570309|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344288|NCT01288859|20570310|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
8344289|NCT01288859|20570311|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
8344290|NCT01288859|20570312|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344291|NCT01288859|20570313|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344292|NCT01288859|20570314|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344293|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344294|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344295|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344296|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344297|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344298|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344299|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||0
8344300|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||5
8344301|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||5
8344302|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344303|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344304|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||0
8344305|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||0
8344306|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||5
8344307|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||5
8344308|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344309|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344310|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||0
8344311|NCT01288859|20570309|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344312|NCT01288859|20570310|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344313|NCT01288859|20570311|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344314|NCT01288859|20570312|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344315|NCT01288859|20570313|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344316|NCT01288859|20570314|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344317|NCT01288859|20570309|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344318|NCT01288859|20570310|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344319|NCT01288859|20570311|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344320|NCT01288859|20570312|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344321|NCT01288859|20570313|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344322|NCT01288859|20570314|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344323|NCT01288859|20570309|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344324|NCT01288859|20570310|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344325|NCT01288859|20570311|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344326|NCT01288859|20570312|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344327|NCT01288859|20570313|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344328|NCT01288859|20570314|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344329|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344330|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344331|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344332|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344333|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344334|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344335|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||0
8344336|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||0
8344337|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||0
8344338|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||5
8344339|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||5
8344340|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||0
8344341|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||0
8344342|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||0
8344343|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||0
8344344|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||5
8344345|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||5
8344346|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||0
8344347|NCT01288859|20570309|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344348|NCT01288859|20570310|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344349|NCT01288859|20570311|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344350|NCT01288859|20570312|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344351|NCT01288859|20570313|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344352|NCT01288859|20570314|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344353|NCT01288859|20570309|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344354|NCT01288859|20570310|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344355|NCT01288859|20570311|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344356|NCT01288859|20570312|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344357|NCT01288859|20570313|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344358|NCT01288859|20570314|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344359|NCT01288859|20570309|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344360|NCT01288859|20570310|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344361|NCT01288859|20570311|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344362|NCT01288859|20570312|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344363|NCT01288859|20570313|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344364|NCT01288859|20570314|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344365|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344366|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344367|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344368|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344369|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344370|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344371|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||5
8344372|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||0
8344373|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||0
8344374|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344375|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344376|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||5
8344377|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||5
8344378|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||0
8344379|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||0
8344380|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344381|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344382|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||5
8344383|NCT01288859|20570309|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344384|NCT01288859|20570310|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344385|NCT01288859|20570311|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344386|NCT01288859|20570312|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344387|NCT01288859|20570313|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344388|NCT01288859|20570314|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344389|NCT01288859|20570309|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
8344390|NCT01288859|20570310|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344391|NCT01288859|20570311|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344392|NCT01288859|20570312|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344393|NCT01288859|20570313|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344394|NCT01288859|20570314|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
8344395|NCT01288859|20570309|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
8344396|NCT01288859|20570310|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344397|NCT01288859|20570311|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344398|NCT01288859|20570312|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344399|NCT01288859|20570313|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344400|NCT01288859|20570314|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
8344401|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344402|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344403|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344404|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344405|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344406|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344407|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||5
8344408|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||0
8344409|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||0
8344410|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344411|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344412|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||5
8344413|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||5
8344414|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||0
8344415|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||0
8344416|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344417|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344418|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||5
8344419|NCT01288859|20570309|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344420|NCT01288859|20570310|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344421|NCT01288859|20570311|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344422|NCT01288859|20570312|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344423|NCT01288859|20570313|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344424|NCT01288859|20570314|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344425|NCT01288859|20570309|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
8344426|NCT01288859|20570310|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344427|NCT01288859|20570311|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344428|NCT01288859|20570312|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344429|NCT01288859|20570313|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344430|NCT01288859|20570314|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
8344431|NCT01288859|20570309|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
8344432|NCT01288859|20570310|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344433|NCT01288859|20570311|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344434|NCT01288859|20570312|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344435|NCT01288859|20570313|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344436|NCT01288859|20570314|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
8344437|NCT01288833|20570342|P2|NOT COMPLETED|Overall Study||0
8344438|NCT01288833|20570343|P1|NOT COMPLETED|Overall Study||0
8344439|NCT01288833|20570342|P2|COMPLETED|Overall Study||281
8344440|NCT01288833|20570343|P1|COMPLETED|Overall Study||277
8344441|NCT01288833|20570342|P2|STARTED|Overall Study||281
8344442|NCT01288833|20570343|P1|STARTED|Overall Study||277
8344443|NCT01288807|20570357|P1|NOT COMPLETED|Overall Study||0
8344444|NCT01288807|20570357|P1|COMPLETED|Overall Study||8
8344445|NCT01288807|20570357|P1|STARTED|Overall Study||8
8344446|NCT01288781|20570367|P2|NOT COMPLETED|Overall Study||0
8344447|NCT01288781|20570368|P1|NOT COMPLETED|Overall Study||0
8344448|NCT01288781|20570367|P2|COMPLETED|Overall Study||12
8344449|NCT01288781|20570368|P1|COMPLETED|Overall Study||11
8344450|NCT01288781|20570367|P2|STARTED|Overall Study||12
8344451|NCT01288781|20570368|P1|STARTED|Overall Study||11
8344452|NCT01288729|20570388|P2|NOT COMPLETED|Overall Study||0
8344453|NCT01288729|20570389|P1|NOT COMPLETED|Overall Study||1
8344454|NCT01288729|20570388|P2|COMPLETED|Overall Study||10
8344455|NCT01288729|20570389|P1|COMPLETED|Overall Study||9
8344456|NCT01288729|20570388|P2|STARTED|Overall Study||10
8344457|NCT01288729|20570389|P1|STARTED|Overall Study||10
8344458|NCT01288612|20570398|P3|NOT COMPLETED|Overall Study||82
8344459|NCT01288612|20570399|P2|NOT COMPLETED|Overall Study||82
8344460|NCT01288612|20570400|P1|NOT COMPLETED|Overall Study||89
8344461|NCT01288612|20570398|P3|COMPLETED|Overall Study||76
8344462|NCT01288612|20570399|P2|COMPLETED|Overall Study||69
8344463|NCT01288612|20570400|P1|COMPLETED|Overall Study||61
8344464|NCT01288612|20570398|P3|Agreed to Take Part|Overall Study||76
8344465|NCT01288612|20570399|P2|Agreed to Take Part|Overall Study||72
8344466|NCT01288612|20570400|P1|Agreed to Take Part|Overall Study||61
8344467|NCT01288612|20570398|P3|Contacted|Overall Study||138
8344468|NCT01288612|20570399|P2|Contacted|Overall Study||135
8344469|NCT01288612|20570400|P1|Contacted|Overall Study||139
8344470|NCT01288612|20570398|P3|STARTED|Overall Study||158
8344471|NCT01288612|20570399|P2|STARTED|Overall Study||151
8344472|NCT01288612|20570400|P1|STARTED|Overall Study||150
8344473|NCT01288534|20570429|P1|NOT COMPLETED|Overall Study||0
8344474|NCT01288534|20570429|P1|COMPLETED|Overall Study||68
8344475|NCT01288534|20570429|P1|STARTED|Overall Study||68
8344476|NCT01288521|20570439|P2|NOT COMPLETED|Overall Study||0
8344477|NCT01288521|20570440|P1|NOT COMPLETED|Overall Study||0
8344478|NCT01288521|20570439|P2|COMPLETED|Overall Study||5
8344479|NCT01288521|20570440|P1|COMPLETED|Overall Study||3
8344480|NCT01288521|20570439|P2|STARTED|Overall Study||5
8344481|NCT01288521|20570440|P1|STARTED|Overall Study||3
8344482|NCT01288469|20570449|P3|NOT COMPLETED|Overall Study||2
8344483|NCT01288469|20570450|P2|NOT COMPLETED|Overall Study||3
8344484|NCT01288469|20570451|P1|NOT COMPLETED|Overall Study||7
8344485|NCT01288469|20570449|P3|COMPLETED|Overall Study||28
8344486|NCT01288469|20570450|P2|COMPLETED|Overall Study||28
8344487|NCT01288469|20570451|P1|COMPLETED|Overall Study||24
8344488|NCT01288469|20570449|P3|Treated|Overall Study||30
8344489|NCT01288469|20570450|P2|Treated|Overall Study||31
8344490|NCT01288469|20570451|P1|Treated|Overall Study||31
8344491|NCT01288469|20570449|P3|STARTED|Overall Study|Randomized|30
8344492|NCT01288469|20570450|P2|STARTED|Overall Study|Randomized|31
8344493|NCT01288469|20570451|P1|STARTED|Overall Study|Randomized|31
8344494|NCT01288443|20570483|P6|NOT COMPLETED|Overall Study||5
8344495|NCT01288443|20570484|P5|NOT COMPLETED|Overall Study||7
8344496|NCT01288443|20570485|P4|NOT COMPLETED|Overall Study||4
8344497|NCT01288443|20570486|P3|NOT COMPLETED|Overall Study||1
8344498|NCT01288443|20570487|P2|NOT COMPLETED|Overall Study||1
8344499|NCT01288443|20570488|P1|NOT COMPLETED|Overall Study||0
8344500|NCT01288443|20570483|P6|COMPLETED|Overall Study||25
8344501|NCT01288443|20570484|P5|COMPLETED|Overall Study||23
8344502|NCT01288443|20570485|P4|COMPLETED|Overall Study||27
8344503|NCT01288443|20570486|P3|COMPLETED|Overall Study||30
8344504|NCT01288443|20570487|P2|COMPLETED|Overall Study||29
8344505|NCT01288443|20570488|P1|COMPLETED|Overall Study||31
8344506|NCT01288443|20570483|P6|Treated|Overall Study||30
8344507|NCT01288443|20570484|P5|Treated|Overall Study||29
8344508|NCT01288443|20570485|P4|Treated|Overall Study||31
8344509|NCT01288443|20570486|P3|Treated|Overall Study||31
8344510|NCT01288443|20570487|P2|Treated|Overall Study||30
8344511|NCT01288443|20570488|P1|Treated|Overall Study||31
8344512|NCT01288443|20570483|P6|STARTED|Overall Study|Randomized|30
8344513|NCT01288443|20570484|P5|STARTED|Overall Study|Randomized|30
8344514|NCT01288443|20570485|P4|STARTED|Overall Study|Randomized|31
8344515|NCT01288443|20570486|P3|STARTED|Overall Study|Randomized|31
8344516|NCT01288443|20570487|P2|STARTED|Overall Study|Randomized|30
8344517|NCT01288443|20570488|P1|STARTED|Overall Study|Randomized|31
8344518|NCT01288430|20570548|P10|NOT COMPLETED|Part 2||3
8344519|NCT01288430|20570549|P9|NOT COMPLETED|Part 2||12
8344520|NCT01288430|20570550|P8|NOT COMPLETED|Part 2||12
8344521|NCT01288430|20570551|P7|NOT COMPLETED|Part 2||0
8344522|NCT01288430|20570552|P6|NOT COMPLETED|Part 2||0
8344523|NCT01288430|20570553|P5|NOT COMPLETED|Part 2||0
8344524|NCT01288430|20570554|P4|NOT COMPLETED|Part 2||0
8344525|NCT01288430|20570555|P3|NOT COMPLETED|Part 2||0
8344526|NCT01288430|20570556|P2|NOT COMPLETED|Part 2||0
8344527|NCT01288430|20570557|P1|NOT COMPLETED|Part 2||0
8344528|NCT01288430|20570548|P10|COMPLETED|Part 2||0
8344529|NCT01288430|20570549|P9|COMPLETED|Part 2||0
8344530|NCT01288430|20570550|P8|COMPLETED|Part 2||0
8344531|NCT01288430|20570551|P7|COMPLETED|Part 2||0
8344532|NCT01288430|20570552|P6|COMPLETED|Part 2||0
8344533|NCT01288430|20570553|P5|COMPLETED|Part 2||0
8344534|NCT01288430|20570554|P4|COMPLETED|Part 2||0
8344535|NCT01288430|20570555|P3|COMPLETED|Part 2||0
8344536|NCT01288430|20570556|P2|COMPLETED|Part 2||0
8344537|NCT01288430|20570557|P1|COMPLETED|Part 2||0
8344538|NCT01288430|20570548|P10|STARTED|Part 2||3
8344539|NCT01288430|20570549|P9|STARTED|Part 2||12
8344540|NCT01288430|20570550|P8|STARTED|Part 2||12
8344541|NCT01288430|20570551|P7|STARTED|Part 2||0
8344542|NCT01288430|20570552|P6|STARTED|Part 2||0
8344543|NCT01288430|20570553|P5|STARTED|Part 2||0
8344544|NCT01288430|20570554|P4|STARTED|Part 2||0
8344545|NCT01288430|20570555|P3|STARTED|Part 2||0
8344546|NCT01288430|20570556|P2|STARTED|Part 2||0
8344547|NCT01288430|20570557|P1|STARTED|Part 2||0
8344548|NCT01288430|20570548|P10|NOT COMPLETED|Part 1||0
8344549|NCT01288430|20570549|P9|NOT COMPLETED|Part 1||0
8344550|NCT01288430|20570550|P8|NOT COMPLETED|Part 1||0
8344551|NCT01288430|20570551|P7|NOT COMPLETED|Part 1||7
8344552|NCT01288430|20570552|P6|NOT COMPLETED|Part 1||6
8344553|NCT01288430|20570553|P5|NOT COMPLETED|Part 1||3
8344554|NCT01288430|20570554|P4|NOT COMPLETED|Part 1||7
8344555|NCT01288430|20570555|P3|NOT COMPLETED|Part 1||5
8344556|NCT01288430|20570556|P2|NOT COMPLETED|Part 1||3
8344557|NCT01288430|20570557|P1|NOT COMPLETED|Part 1||2
8344558|NCT01288430|20570548|P10|COMPLETED|Part 1||0
8344559|NCT01288430|20570549|P9|COMPLETED|Part 1||0
8344560|NCT01288430|20570550|P8|COMPLETED|Part 1||0
8344561|NCT01288430|20570551|P7|COMPLETED|Part 1||0
8344562|NCT01288430|20570552|P6|COMPLETED|Part 1||0
8344563|NCT01288430|20570553|P5|COMPLETED|Part 1||0
8344564|NCT01288430|20570554|P4|COMPLETED|Part 1||0
8344565|NCT01288430|20570555|P3|COMPLETED|Part 1||0
8344566|NCT01288430|20570556|P2|COMPLETED|Part 1||0
8344567|NCT01288430|20570557|P1|COMPLETED|Part 1||0
8344568|NCT01288430|20570548|P10|STARTED|Part 1||0
8344569|NCT01288430|20570549|P9|STARTED|Part 1||0
8344570|NCT01288430|20570550|P8|STARTED|Part 1||0
8344571|NCT01288430|20570551|P7|STARTED|Part 1||7
8344572|NCT01288430|20570552|P6|STARTED|Part 1||6
8344573|NCT01288430|20570553|P5|STARTED|Part 1||3
8344574|NCT01288430|20570554|P4|STARTED|Part 1||7
8344575|NCT01288430|20570555|P3|STARTED|Part 1||5
8344576|NCT01288430|20570556|P2|STARTED|Part 1||3
8344577|NCT01288430|20570557|P1|STARTED|Part 1||2
8344578|NCT01288287|20570681|P1|NOT COMPLETED|Overall Study||46
8344579|NCT01288287|20570681|P1|COMPLETED|Overall Study||103
8344580|NCT01288287|20570681|P1|Full Analysis Set|Overall Study||111
8344581|NCT01288287|20570681|P1|Safety Set|Overall Study||147
8344582|NCT01288287|20570681|P1|STARTED|Overall Study||149
8344583|NCT01288209|20570696|P2|NOT COMPLETED|Overall Study||3
8344584|NCT01288209|20570697|P1|NOT COMPLETED|Overall Study||2
8344585|NCT01288209|20570696|P2|COMPLETED|Overall Study||50
8344586|NCT01288209|20570697|P1|COMPLETED|Overall Study||51
8344587|NCT01288209|20570696|P2|STARTED|Overall Study||53
8344588|NCT01288209|20570697|P1|STARTED|Overall Study||53
8344589|NCT01288079|20570727|P4|NOT COMPLETED|Overall Study||17
8344590|NCT01288079|20570728|P3|NOT COMPLETED|Overall Study||19
8344591|NCT01288079|20570729|P2|NOT COMPLETED|Overall Study||27
8344592|NCT01288079|20570730|P1|NOT COMPLETED|Overall Study||20
8344593|NCT01288079|20570727|P4|COMPLETED|Overall Study||18
8344594|NCT01288079|20570728|P3|COMPLETED|Overall Study||18
8344595|NCT01288079|20570729|P2|COMPLETED|Overall Study||9
8344596|NCT01288079|20570730|P1|COMPLETED|Overall Study||17
8344597|NCT01288079|20570727|P4|STARTED|Overall Study||35
8344598|NCT01288079|20570728|P3|STARTED|Overall Study||37
8344599|NCT01288079|20570729|P2|STARTED|Overall Study||36
8344600|NCT01288079|20570730|P1|STARTED|Overall Study||37
8344601|NCT01288053|20570740|P1|NOT COMPLETED|Overall Study||1
8344602|NCT01288053|20570740|P1|COMPLETED|Overall Study||8
8344603|NCT01288053|20570740|P1|STARTED|Overall Study||9
8344604|NCT01288027|20570744|P1|NOT COMPLETED|Overall Study||0
8344605|NCT01288027|20570744|P1|COMPLETED|Overall Study||16
8344606|NCT01288027|20570744|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
8344607|NCT01288027|20570744|P1|STARTED|Overall Study||16
8344608|NCT01287897|20570758|P4|NOT COMPLETED|Overall Study||7
8344609|NCT01287897|20570759|P3|NOT COMPLETED|Overall Study||12
8344610|NCT01287897|20570760|P2|NOT COMPLETED|Overall Study||11
8344611|NCT01287897|20570761|P1|NOT COMPLETED|Overall Study||11
8344612|NCT01287897|20570758|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
8344613|NCT01287897|20570759|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
8344614|NCT01287897|20570760|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
8344615|NCT01287897|20570761|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
8344616|NCT01287897|20570758|P4|Enrolled in NCT01345318|Overall Study||29
8344617|NCT01287897|20570759|P3|Enrolled in NCT01345318|Overall Study||56
8344618|NCT01287897|20570760|P2|Enrolled in NCT01345318|Overall Study||50
8344619|NCT01287897|20570761|P1|Enrolled in NCT01345318|Overall Study||56
8344620|NCT01287897|20570758|P4|Completed Follow-up Period|Overall Study||4
8344621|NCT01287897|20570759|P3|Completed Follow-up Period|Overall Study||3
8344622|NCT01287897|20570760|P2|Completed Follow-up Period|Overall Study||8
8344623|NCT01287897|20570761|P1|Completed Follow-up Period|Overall Study||3
8344624|NCT01287897|20570758|P4|Completed Treatment Period|Overall Study||29
8344625|NCT01287897|20570759|P3|Completed Treatment Period|Overall Study||58
8344626|NCT01287897|20570760|P2|Completed Treatment Period|Overall Study||52
8344627|NCT01287897|20570761|P1|Completed Treatment Period|Overall Study||58
8344628|NCT01287897|20570758|P4|Treated|Overall Study||40
8344629|NCT01287897|20570759|P3|Treated|Overall Study||71
8344630|NCT01287897|20570760|P2|Treated|Overall Study||67
8344631|NCT01287897|20570761|P1|Treated|Overall Study||69
8344632|NCT01287897|20570758|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
8344633|NCT01287897|20570759|P3|STARTED|Overall Study||71
8344634|NCT01287897|20570760|P2|STARTED|Overall Study||69
8344635|NCT01287897|20570761|P1|STARTED|Overall Study||70
8344636|NCT01287832|20570812|P2|NOT COMPLETED|Overall Study||1
8344637|NCT01287832|20570813|P1|NOT COMPLETED|Overall Study||1
8344638|NCT01287832|20570812|P2|COMPLETED|Overall Study||4
8344639|NCT01287832|20570813|P1|COMPLETED|Overall Study||5
8344640|NCT01287832|20570812|P2|STARTED|Overall Study||5
8344641|NCT01287832|20570813|P1|STARTED|Overall Study||6
8344642|NCT01287754|20570821|P2|NOT COMPLETED|Overall Study||21
8344643|NCT01287754|20570822|P1|NOT COMPLETED|Overall Study||3
8344644|NCT01287754|20570821|P2|COMPLETED|Overall Study||0
8344645|NCT01287754|20570822|P1|COMPLETED|Overall Study||0
8344646|NCT01287754|20570821|P2|STARTED|Overall Study||21
8344647|NCT01287754|20570822|P1|STARTED|Overall Study||3
8344648|NCT01287741|20570834|P2|NOT COMPLETED|Overall Study||615
8344649|NCT01287741|20570835|P1|NOT COMPLETED|Overall Study||626
8344650|NCT01287741|20570834|P2|COMPLETED|Overall Study||91
8344651|NCT01287741|20570835|P1|COMPLETED|Overall Study||86
8344652|NCT01287741|20570834|P2|STARTED|Overall Study||706
8344653|NCT01287741|20570835|P1|STARTED|Overall Study||712
8344654|NCT01287611|20570871|P2|NOT COMPLETED|Overall Study||19
8344655|NCT01287611|20570872|P1|NOT COMPLETED|Overall Study||33
8344656|NCT01287611|20570871|P2|COMPLETED|Overall Study||65
8344657|NCT01287611|20570872|P1|COMPLETED|Overall Study||51
8344658|NCT01287611|20570871|P2|The Number of Patients Who Underwent C/S|Overall Study||84
8344659|NCT01287611|20570872|P1|The Number of Patients Who Underwent C/S|Overall Study||84
8344660|NCT01287611|20570871|P2|STARTED|Overall Study||84
8344661|NCT01287611|20570872|P1|STARTED|Overall Study||84
8344662|NCT01287520|20570889|P9|NOT COMPLETED|Overall Study||5
8344663|NCT01287520|20570890|P8|NOT COMPLETED|Overall Study||5
8344664|NCT01287520|20570891|P7|NOT COMPLETED|Overall Study||2
8344665|NCT01287520|20570892|P6|NOT COMPLETED|Overall Study||4
8344666|NCT01287520|20570893|P5|NOT COMPLETED|Overall Study||3
8344667|NCT01287520|20570894|P4|NOT COMPLETED|Overall Study||7
8344668|NCT01287520|20570895|P3|NOT COMPLETED|Overall Study||5
8344669|NCT01287520|20570896|P2|NOT COMPLETED|Overall Study||7
8344670|NCT01287520|20570897|P1|NOT COMPLETED|Overall Study||3
8344671|NCT01287520|20570889|P9|COMPLETED|Overall Study||0
8344672|NCT01287520|20570890|P8|COMPLETED|Overall Study||0
8344673|NCT01287520|20570891|P7|COMPLETED|Overall Study||0
8344674|NCT01287520|20570892|P6|COMPLETED|Overall Study||0
8344675|NCT01287520|20570893|P5|COMPLETED|Overall Study||0
8344676|NCT01287520|20570894|P4|COMPLETED|Overall Study||0
8344677|NCT01287520|20570895|P3|COMPLETED|Overall Study||0
8344678|NCT01287520|20570896|P2|COMPLETED|Overall Study||0
8344679|NCT01287520|20570897|P1|COMPLETED|Overall Study||0
8344680|NCT01287520|20570889|P9|STARTED|Overall Study||5
8344681|NCT01287520|20570890|P8|STARTED|Overall Study||5
8344682|NCT01287520|20570891|P7|STARTED|Overall Study||2
8344683|NCT01287520|20570892|P6|STARTED|Overall Study||4
8344684|NCT01287520|20570893|P5|STARTED|Overall Study||3
8344685|NCT01287520|20570894|P4|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
8344686|NCT01287520|20570895|P3|STARTED|Overall Study||5
8344687|NCT01287520|20570896|P2|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
8344688|NCT01287520|20570897|P1|STARTED|Overall Study||3
8344689|NCT01287416|20570961|P2|NOT COMPLETED|6 Month Follow-up||2
8344690|NCT01287416|20570962|P1|NOT COMPLETED|6 Month Follow-up||3
8344691|NCT01287416|20570961|P2|COMPLETED|6 Month Follow-up||22
8344692|NCT01287416|20570962|P1|COMPLETED|6 Month Follow-up||28
8344693|NCT01287416|20570961|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
8344694|NCT01287416|20570962|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
8344695|NCT01287416|20570961|P2|NOT COMPLETED|Pre-post Training||25
8344696|NCT01287416|20570962|P1|NOT COMPLETED|Pre-post Training||22
8344697|NCT01287416|20570961|P2|COMPLETED|Pre-post Training||23
8344698|NCT01287416|20570962|P1|COMPLETED|Pre-post Training||26
8344699|NCT01287416|20570961|P2|Post Training Questionnaire|Pre-post Training||23
8344700|NCT01287416|20570962|P1|Post Training Questionnaire|Pre-post Training||26
8344701|NCT01287416|20570961|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
8344702|NCT01287416|20570962|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
8344703|NCT01287416|20570961|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
8344704|NCT01287416|20570962|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
8344705|NCT01287403|20570998|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
8344706|NCT01287403|20570998|P1|COMPLETED|6th and Last Intervention (1 Day)||13
8344707|NCT01287403|20570998|P1|STARTED|6th and Last Intervention (1 Day)||13
8344708|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344709|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344710|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344711|NCT01287403|20570998|P1|NOT COMPLETED|5th Intervention (1 Day)||0
8344712|NCT01287403|20570998|P1|COMPLETED|5th Intervention (1 Day)||13
8344713|NCT01287403|20570998|P1|STARTED|5th Intervention (1 Day)||13
8344714|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344715|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344716|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344717|NCT01287403|20570998|P1|NOT COMPLETED|4th Intervention (1 Day)||0
8344718|NCT01287403|20570998|P1|COMPLETED|4th Intervention (1 Day)||13
8344719|NCT01287403|20570998|P1|STARTED|4th Intervention (1 Day)||13
8344720|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344721|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344722|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344723|NCT01287403|20570998|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
8344724|NCT01287403|20570998|P1|COMPLETED|3rd Intervention (1 Day)||13
8344725|NCT01287403|20570998|P1|STARTED|3rd Intervention (1 Day)||13
8344726|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344727|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344728|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344729|NCT01287403|20570998|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
8344730|NCT01287403|20570998|P1|COMPLETED|2nd Intervention (1 Day)||13
8344731|NCT01287403|20570998|P1|STARTED|2nd Intervention (1 Day)||13
8344732|NCT01287403|20570998|P1|NOT COMPLETED|Washout 7 Days||0
8344733|NCT01287403|20570998|P1|COMPLETED|Washout 7 Days||13
8344734|NCT01287403|20570998|P1|STARTED|Washout 7 Days||13
8344735|NCT01287403|20570998|P1|NOT COMPLETED|1st Intervention (1 Day)||1
8344736|NCT01287403|20570998|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
8344737|NCT01287403|20570998|P1|STARTED|1st Intervention (1 Day)||14
8344738|NCT01287403|20570998|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
8344739|NCT01287403|20570998|P1|COMPLETED|Diet Restriction (7 Days)||14
8344740|NCT01287403|20570998|P1|STARTED|Diet Restriction (7 Days)||14
8344741|NCT01287377|20571015|P3|NOT COMPLETED|Overall Study||0
8344742|NCT01287377|20571016|P2|NOT COMPLETED|Overall Study||0
8344743|NCT01287377|20571017|P1|NOT COMPLETED|Overall Study||0
8344744|NCT01287377|20571015|P3|COMPLETED|Overall Study|Study Complete|82
8344745|NCT01287377|20571016|P2|COMPLETED|Overall Study|Study Complete|81
8344746|NCT01287377|20571017|P1|COMPLETED|Overall Study|Study Complete|80
8344747|NCT01287377|20571015|P3|STARTED|Overall Study||82
8344748|NCT01287377|20571016|P2|STARTED|Overall Study||81
8344749|NCT01287377|20571017|P1|STARTED|Overall Study||80
8344750|NCT01287364|20571030|P2|NOT COMPLETED|Overall Study||10
8344751|NCT01287364|20571031|P1|NOT COMPLETED|Overall Study||9
8344752|NCT01287364|20571030|P2|COMPLETED|Overall Study||81
8344753|NCT01287364|20571031|P1|COMPLETED|Overall Study||85
8344754|NCT01287364|20571030|P2|STARTED|Overall Study||91
8344755|NCT01287364|20571031|P1|STARTED|Overall Study||94
8344756|NCT01287221|20571053|P2|NOT COMPLETED|Overall Study||5
8344757|NCT01287221|20571054|P1|NOT COMPLETED|Overall Study||4
8344758|NCT01287221|20571053|P2|COMPLETED|Overall Study||45
8344759|NCT01287221|20571054|P1|COMPLETED|Overall Study||46
8344760|NCT01287221|20571053|P2|Completed 12 Months Follow-up|Overall Study||39
8344761|NCT01287221|20571054|P1|Completed 12 Months Follow-up|Overall Study||40
8344762|NCT01287221|20571053|P2|Completed 9 Months Follow-up|Overall Study||40
8344763|NCT01287221|20571054|P1|Completed 9 Months Follow-up|Overall Study||42
8344764|NCT01287221|20571053|P2|Completed 6 Months Follow-up|Overall Study||43
8344765|NCT01287221|20571054|P1|Completed 6 Months Follow-up|Overall Study||47
8344766|NCT01287221|20571053|P2|Completed 3 Months Follow-up|Overall Study||50
8344767|NCT01287221|20571054|P1|Completed 3 Months Follow-up|Overall Study||49
8344768|NCT01287221|20571053|P2|STARTED|Overall Study||50
8344769|NCT01287221|20571054|P1|STARTED|Overall Study||50
8344770|NCT01287208|20571074|P2|NOT COMPLETED|Phase 2: Team Competition||0
8344771|NCT01287208|20571075|P1|NOT COMPLETED|Phase 2: Team Competition||0
8344772|NCT01287208|20571074|P2|COMPLETED|Phase 2: Team Competition||49
8344773|NCT01287208|20571075|P1|COMPLETED|Phase 2: Team Competition||50
8344774|NCT01287208|20571074|P2|STARTED|Phase 2: Team Competition||49
8344775|NCT01287208|20571075|P1|STARTED|Phase 2: Team Competition||50
8344776|NCT01287208|20571074|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
8344777|NCT01287208|20571075|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
8344778|NCT01287208|20571074|P2|COMPLETED|Phase 1: Randomized Phase||49
8344779|NCT01287208|20571075|P1|COMPLETED|Phase 1: Randomized Phase||50
8344780|NCT01287208|20571074|P2|STARTED|Phase 1: Randomized Phase||52
8344781|NCT01287208|20571075|P1|STARTED|Phase 1: Randomized Phase||52
8344782|NCT01287195|20571089|P1|NOT COMPLETED|Overall Study||2
8344783|NCT01287195|20571089|P1|COMPLETED|Overall Study||4
8344784|NCT01287195|20571089|P1|STARTED|Overall Study||6
8344785|NCT01287117|20571104|P4|NOT COMPLETED|Overall Study||12
8344786|NCT01287117|20571105|P3|NOT COMPLETED|Overall Study||16
8344787|NCT01287117|20571106|P2|NOT COMPLETED|Overall Study||14
8344788|NCT01287117|20571107|P1|NOT COMPLETED|Overall Study||15
8344789|NCT01287117|20571104|P4|COMPLETED|Overall Study||69
8344790|NCT01287117|20571105|P3|COMPLETED|Overall Study||64
8344791|NCT01287117|20571106|P2|COMPLETED|Overall Study||64
8344792|NCT01287117|20571107|P1|COMPLETED|Overall Study||65
8344793|NCT01287117|20571104|P4|Received Treatment|Overall Study||81
8344794|NCT01287117|20571105|P3|Received Treatment|Overall Study||80
8344795|NCT01287117|20571106|P2|Received Treatment|Overall Study||77
8344796|NCT01287117|20571107|P1|Received Treatment|Overall Study||80
8344797|NCT01287117|20571104|P4|STARTED|Overall Study||81
8344798|NCT01287117|20571105|P3|STARTED|Overall Study||80
8344799|NCT01287117|20571106|P2|STARTED|Overall Study||78
8344800|NCT01287117|20571107|P1|STARTED|Overall Study||80
8344801|NCT01287104|20571157|P4|NOT COMPLETED|Overall Study||3
8344802|NCT01287104|20571158|P3|NOT COMPLETED|Overall Study||7
8344803|NCT01287104|20571159|P2|NOT COMPLETED|Overall Study||5
8344804|NCT01287104|20571160|P1|NOT COMPLETED|Overall Study||1
8344805|NCT01287104|20571157|P4|COMPLETED|Overall Study||8
8344806|NCT01287104|20571158|P3|COMPLETED|Overall Study||5
8344807|NCT01287104|20571159|P2|COMPLETED|Overall Study||2
8344808|NCT01287104|20571160|P1|COMPLETED|Overall Study||3
8344809|NCT01287104|20571157|P4|STARTED|Overall Study||11
8344810|NCT01287104|20571158|P3|STARTED|Overall Study||12
8344811|NCT01287104|20571159|P2|STARTED|Overall Study||7
8344812|NCT01287104|20571160|P1|STARTED|Overall Study||4
8344813|NCT01287078|20571195|P2|NOT COMPLETED|Overall Study||2
8344814|NCT01287078|20571196|P1|NOT COMPLETED|Overall Study||10
8344815|NCT01287078|20571195|P2|COMPLETED|Overall Study||1
8344816|NCT01287078|20571196|P1|COMPLETED|Overall Study||10
8344817|NCT01287078|20571195|P2|STARTED|Overall Study||3
8344818|NCT01287078|20571196|P1|STARTED|Overall Study||20
8344819|NCT01287065|20571216|P6|NOT COMPLETED|Treatment Period 3||0
8344820|NCT01287065|20571217|P5|NOT COMPLETED|Treatment Period 3||0
8344821|NCT01287065|20571218|P4|NOT COMPLETED|Treatment Period 3||0
8344822|NCT01287065|20571219|P3|NOT COMPLETED|Treatment Period 3||0
8344823|NCT01287065|20571220|P2|NOT COMPLETED|Treatment Period 3||0
8344824|NCT01287065|20571221|P1|NOT COMPLETED|Treatment Period 3||0
8344825|NCT01287065|20571216|P6|COMPLETED|Treatment Period 3||4
8344826|NCT01287065|20571217|P5|COMPLETED|Treatment Period 3||4
8344827|NCT01287065|20571218|P4|COMPLETED|Treatment Period 3||4
8344828|NCT01287065|20571219|P3|COMPLETED|Treatment Period 3||4
8344829|NCT01287065|20571220|P2|COMPLETED|Treatment Period 3||4
8344830|NCT01287065|20571221|P1|COMPLETED|Treatment Period 3||4
8344831|NCT01287065|20571216|P6|STARTED|Treatment Period 3||4
8344832|NCT01287065|20571217|P5|STARTED|Treatment Period 3||4
8344833|NCT01287065|20571218|P4|STARTED|Treatment Period 3||4
8344834|NCT01287065|20571219|P3|STARTED|Treatment Period 3||4
8344835|NCT01287065|20571220|P2|STARTED|Treatment Period 3||4
8344836|NCT01287065|20571221|P1|STARTED|Treatment Period 3||4
8344837|NCT01287065|20571216|P6|NOT COMPLETED|Washout Period 2||0
8344838|NCT01287065|20571217|P5|NOT COMPLETED|Washout Period 2||0
8344839|NCT01287065|20571218|P4|NOT COMPLETED|Washout Period 2||0
8344840|NCT01287065|20571219|P3|NOT COMPLETED|Washout Period 2||0
8344841|NCT01287065|20571220|P2|NOT COMPLETED|Washout Period 2||0
8344842|NCT01287065|20571221|P1|NOT COMPLETED|Washout Period 2||0
8344843|NCT01287065|20571216|P6|COMPLETED|Washout Period 2||4
8344844|NCT01287065|20571217|P5|COMPLETED|Washout Period 2||4
8344845|NCT01287065|20571218|P4|COMPLETED|Washout Period 2||4
8344846|NCT01287065|20571219|P3|COMPLETED|Washout Period 2||4
8344847|NCT01287065|20571220|P2|COMPLETED|Washout Period 2||4
8344848|NCT01287065|20571221|P1|COMPLETED|Washout Period 2||4
8344849|NCT01287065|20571216|P6|STARTED|Washout Period 2||4
8344850|NCT01287065|20571217|P5|STARTED|Washout Period 2||4
8344851|NCT01287065|20571218|P4|STARTED|Washout Period 2||4
8344852|NCT01287065|20571219|P3|STARTED|Washout Period 2||4
8344853|NCT01287065|20571220|P2|STARTED|Washout Period 2||4
8344854|NCT01287065|20571221|P1|STARTED|Washout Period 2||4
8344855|NCT01287065|20571216|P6|NOT COMPLETED|Treatment Period 2||0
8344856|NCT01287065|20571217|P5|NOT COMPLETED|Treatment Period 2||0
8344857|NCT01287065|20571218|P4|NOT COMPLETED|Treatment Period 2||0
8344858|NCT01287065|20571219|P3|NOT COMPLETED|Treatment Period 2||0
8344859|NCT01287065|20571220|P2|NOT COMPLETED|Treatment Period 2||0
8344860|NCT01287065|20571221|P1|NOT COMPLETED|Treatment Period 2||0
8344861|NCT01287065|20571216|P6|COMPLETED|Treatment Period 2||4
8344862|NCT01287065|20571217|P5|COMPLETED|Treatment Period 2||4
8344863|NCT01287065|20571218|P4|COMPLETED|Treatment Period 2||4
8344864|NCT01287065|20571219|P3|COMPLETED|Treatment Period 2||4
8344865|NCT01287065|20571220|P2|COMPLETED|Treatment Period 2||4
8344866|NCT01287065|20571221|P1|COMPLETED|Treatment Period 2||4
8344867|NCT01287065|20571216|P6|STARTED|Treatment Period 2||4
8344868|NCT01287065|20571217|P5|STARTED|Treatment Period 2||4
8344869|NCT01287065|20571218|P4|STARTED|Treatment Period 2||4
8344870|NCT01287065|20571219|P3|STARTED|Treatment Period 2||4
8344871|NCT01287065|20571220|P2|STARTED|Treatment Period 2||4
8344872|NCT01287065|20571221|P1|STARTED|Treatment Period 2||4
8344873|NCT01287065|20571216|P6|NOT COMPLETED|Washout Period 1||0
8344874|NCT01287065|20571217|P5|NOT COMPLETED|Washout Period 1||0
8344875|NCT01287065|20571218|P4|NOT COMPLETED|Washout Period 1||0
8344876|NCT01287065|20571219|P3|NOT COMPLETED|Washout Period 1||0
8344877|NCT01287065|20571220|P2|NOT COMPLETED|Washout Period 1||0
8344878|NCT01287065|20571221|P1|NOT COMPLETED|Washout Period 1||0
8344879|NCT01287065|20571216|P6|COMPLETED|Washout Period 1||4
8344880|NCT01287065|20571217|P5|COMPLETED|Washout Period 1||4
8344881|NCT01287065|20571218|P4|COMPLETED|Washout Period 1||4
8344882|NCT01287065|20571219|P3|COMPLETED|Washout Period 1||4
8344883|NCT01287065|20571220|P2|COMPLETED|Washout Period 1||4
8344884|NCT01287065|20571221|P1|COMPLETED|Washout Period 1||4
8344885|NCT01287065|20571216|P6|STARTED|Washout Period 1||4
8344886|NCT01287065|20571217|P5|STARTED|Washout Period 1||4
8344887|NCT01287065|20571218|P4|STARTED|Washout Period 1||4
8344888|NCT01287065|20571219|P3|STARTED|Washout Period 1||4
8344889|NCT01287065|20571220|P2|STARTED|Washout Period 1||4
8344890|NCT01287065|20571221|P1|STARTED|Washout Period 1||4
8344891|NCT01287065|20571216|P6|NOT COMPLETED|Treatment Period 1||1
8344892|NCT01287065|20571217|P5|NOT COMPLETED|Treatment Period 1||1
8344893|NCT01287065|20571218|P4|NOT COMPLETED|Treatment Period 1||0
8344894|NCT01287065|20571219|P3|NOT COMPLETED|Treatment Period 1||0
8344895|NCT01287065|20571220|P2|NOT COMPLETED|Treatment Period 1||0
8344896|NCT01287065|20571221|P1|NOT COMPLETED|Treatment Period 1||0
8344897|NCT01287065|20571216|P6|COMPLETED|Treatment Period 1||4
8344898|NCT01287065|20571217|P5|COMPLETED|Treatment Period 1||4
8344899|NCT01287065|20571218|P4|COMPLETED|Treatment Period 1||4
8344900|NCT01287065|20571219|P3|COMPLETED|Treatment Period 1||4
8344901|NCT01287065|20571220|P2|COMPLETED|Treatment Period 1||4
8344902|NCT01287065|20571221|P1|COMPLETED|Treatment Period 1||4
8344903|NCT01287065|20571216|P6|STARTED|Treatment Period 1||5
8344904|NCT01287065|20571217|P5|STARTED|Treatment Period 1||5
8344905|NCT01287065|20571218|P4|STARTED|Treatment Period 1||4
8344906|NCT01287065|20571219|P3|STARTED|Treatment Period 1||4
8344907|NCT01287065|20571220|P2|STARTED|Treatment Period 1||4
8344908|NCT01287065|20571221|P1|STARTED|Treatment Period 1||4
8344909|NCT01287039|20571240|P2|NOT COMPLETED|Overall Study||27
8344910|NCT01287039|20571241|P1|NOT COMPLETED|Overall Study||29
8344911|NCT01287039|20571240|P2|COMPLETED|Overall Study||218
8344912|NCT01287039|20571241|P1|COMPLETED|Overall Study||215
8344913|NCT01287039|20571240|P2|STARTED|Overall Study||245
8344914|NCT01287039|20571241|P1|STARTED|Overall Study||244
8344915|NCT01287013|20571274|P3|NOT COMPLETED|Overall Study||21
8344916|NCT01287013|20571275|P2|NOT COMPLETED|Overall Study||5
8344917|NCT01287013|20571276|P1|NOT COMPLETED|Overall Study||3
8344918|NCT01287013|20571274|P3|COMPLETED|Overall Study||0
8344919|NCT01287013|20571275|P2|COMPLETED|Overall Study||29
8344920|NCT01287013|20571276|P1|COMPLETED|Overall Study||29
8344921|NCT01287013|20571274|P3|STARTED|Overall Study||21
8344922|NCT01287013|20571275|P2|STARTED|Overall Study||34
8344923|NCT01287013|20571276|P1|STARTED|Overall Study||32
8344924|NCT01286987|20571306|P15|NOT COMPLETED|Part 2: Dose Expansion||2
8344925|NCT01286987|20571307|P14|NOT COMPLETED|Part 2: Dose Expansion||24
8344926|NCT01286987|20571308|P13|NOT COMPLETED|Part 2: Dose Expansion||12
8344927|NCT01286987|20571309|P12|NOT COMPLETED|Part 2: Dose Expansion||10
8344928|NCT01286987|20571310|P11|NOT COMPLETED|Part 2: Dose Expansion||10
8344929|NCT01286987|20571311|P10|NOT COMPLETED|Part 2: Dose Expansion||11
8344930|NCT01286987|20571312|P9|NOT COMPLETED|Part 2: Dose Expansion||0
8344931|NCT01286987|20571313|P8|NOT COMPLETED|Part 2: Dose Expansion||0
8344932|NCT01286987|20571314|P7|NOT COMPLETED|Part 2: Dose Expansion||0
8344933|NCT01286987|20571315|P6|NOT COMPLETED|Part 2: Dose Expansion||0
8344934|NCT01286987|20571316|P5|NOT COMPLETED|Part 2: Dose Expansion||0
8344935|NCT01286987|20571317|P4|NOT COMPLETED|Part 2: Dose Expansion||0
8344936|NCT01286987|20571318|P3|NOT COMPLETED|Part 2: Dose Expansion||0
8344937|NCT01286987|20571319|P2|NOT COMPLETED|Part 2: Dose Expansion||0
8344938|NCT01286987|20571320|P1|NOT COMPLETED|Part 2: Dose Expansion||0
8344939|NCT01286987|20571306|P15|COMPLETED|Part 2: Dose Expansion||1
8344940|NCT01286987|20571307|P14|COMPLETED|Part 2: Dose Expansion||0
8344941|NCT01286987|20571308|P13|COMPLETED|Part 2: Dose Expansion||0
8344942|NCT01286987|20571309|P12|COMPLETED|Part 2: Dose Expansion||1
8344943|NCT01286987|20571310|P11|COMPLETED|Part 2: Dose Expansion||2
8344944|NCT01286987|20571311|P10|COMPLETED|Part 2: Dose Expansion||1
8344945|NCT01286987|20571312|P9|COMPLETED|Part 2: Dose Expansion||0
8344946|NCT01286987|20571313|P8|COMPLETED|Part 2: Dose Expansion||0
8344947|NCT01286987|20571314|P7|COMPLETED|Part 2: Dose Expansion||0
8344948|NCT01286987|20571315|P6|COMPLETED|Part 2: Dose Expansion||0
8344949|NCT01286987|20571316|P5|COMPLETED|Part 2: Dose Expansion||0
8344950|NCT01286987|20571317|P4|COMPLETED|Part 2: Dose Expansion||0
8344951|NCT01286987|20571318|P3|COMPLETED|Part 2: Dose Expansion||0
8344952|NCT01286987|20571319|P2|COMPLETED|Part 2: Dose Expansion||0
8344953|NCT01286987|20571320|P1|COMPLETED|Part 2: Dose Expansion||0
8344954|NCT01286987|20571306|P15|Treated|Part 2: Dose Expansion||3
8344955|NCT01286987|20571307|P14|Treated|Part 2: Dose Expansion||23
8344956|NCT01286987|20571308|P13|Treated|Part 2: Dose Expansion||12
8344957|NCT01286987|20571309|P12|Treated|Part 2: Dose Expansion||10
8344958|NCT01286987|20571310|P11|Treated|Part 2: Dose Expansion||11
8344959|NCT01286987|20571311|P10|Treated|Part 2: Dose Expansion||12
8344960|NCT01286987|20571312|P9|Treated|Part 2: Dose Expansion||0
8344961|NCT01286987|20571313|P8|Treated|Part 2: Dose Expansion||0
8344962|NCT01286987|20571314|P7|Treated|Part 2: Dose Expansion||0
8344963|NCT01286987|20571315|P6|Treated|Part 2: Dose Expansion||0
8344964|NCT01286987|20571316|P5|Treated|Part 2: Dose Expansion||0
8344965|NCT01286987|20571317|P4|Treated|Part 2: Dose Expansion||0
8344966|NCT01286987|20571318|P3|Treated|Part 2: Dose Expansion||0
8344967|NCT01286987|20571319|P2|Treated|Part 2: Dose Expansion||0
8344968|NCT01286987|20571320|P1|Treated|Part 2: Dose Expansion||0
8344969|NCT01286987|20571306|P15|STARTED|Part 2: Dose Expansion||3
8344970|NCT01286987|20571307|P14|STARTED|Part 2: Dose Expansion||24
8344971|NCT01286987|20571308|P13|STARTED|Part 2: Dose Expansion||12
8344972|NCT01286987|20571309|P12|STARTED|Part 2: Dose Expansion||11
8344973|NCT01286987|20571310|P11|STARTED|Part 2: Dose Expansion||12
8344974|NCT01286987|20571311|P10|STARTED|Part 2: Dose Expansion||12
8344975|NCT01286987|20571312|P9|STARTED|Part 2: Dose Expansion||0
8344976|NCT01286987|20571313|P8|STARTED|Part 2: Dose Expansion||0
8344977|NCT01286987|20571314|P7|STARTED|Part 2: Dose Expansion||0
8344978|NCT01286987|20571315|P6|STARTED|Part 2: Dose Expansion||0
8344979|NCT01286987|20571316|P5|STARTED|Part 2: Dose Expansion||0
8344980|NCT01286987|20571317|P4|STARTED|Part 2: Dose Expansion||0
8344981|NCT01286987|20571318|P3|STARTED|Part 2: Dose Expansion||0
8344982|NCT01286987|20571319|P2|STARTED|Part 2: Dose Expansion||0
8344983|NCT01286987|20571320|P1|STARTED|Part 2: Dose Expansion||0
8344984|NCT01286987|20571306|P15|NOT COMPLETED|Part 1: Dose Escalation||0
8344985|NCT01286987|20571307|P14|NOT COMPLETED|Part 1: Dose Escalation||0
8344986|NCT01286987|20571308|P13|NOT COMPLETED|Part 1: Dose Escalation||0
8344987|NCT01286987|20571309|P12|NOT COMPLETED|Part 1: Dose Escalation||0
8344988|NCT01286987|20571310|P11|NOT COMPLETED|Part 1: Dose Escalation||0
8344989|NCT01286987|20571311|P10|NOT COMPLETED|Part 1: Dose Escalation||0
8344990|NCT01286987|20571312|P9|NOT COMPLETED|Part 1: Dose Escalation||6
8344991|NCT01286987|20571313|P8|NOT COMPLETED|Part 1: Dose Escalation||5
8344992|NCT01286987|20571314|P7|NOT COMPLETED|Part 1: Dose Escalation||5
8344993|NCT01286987|20571315|P6|NOT COMPLETED|Part 1: Dose Escalation||6
8344994|NCT01286987|20571316|P5|NOT COMPLETED|Part 1: Dose Escalation||3
8344995|NCT01286987|20571317|P4|NOT COMPLETED|Part 1: Dose Escalation||3
8344996|NCT01286987|20571318|P3|NOT COMPLETED|Part 1: Dose Escalation||3
8344997|NCT01286987|20571319|P2|NOT COMPLETED|Part 1: Dose Escalation||3
8344998|NCT01286987|20571320|P1|NOT COMPLETED|Part 1: Dose Escalation||3
8344999|NCT01286987|20571306|P15|COMPLETED|Part 1: Dose Escalation||0
8345000|NCT01286987|20571307|P14|COMPLETED|Part 1: Dose Escalation||0
8345001|NCT01286987|20571308|P13|COMPLETED|Part 1: Dose Escalation||0
8345002|NCT01286987|20571309|P12|COMPLETED|Part 1: Dose Escalation||0
8345003|NCT01286987|20571310|P11|COMPLETED|Part 1: Dose Escalation||0
8345004|NCT01286987|20571311|P10|COMPLETED|Part 1: Dose Escalation||0
8345005|NCT01286987|20571312|P9|COMPLETED|Part 1: Dose Escalation||0
8345006|NCT01286987|20571313|P8|COMPLETED|Part 1: Dose Escalation||1
8345007|NCT01286987|20571314|P7|COMPLETED|Part 1: Dose Escalation||1
8345008|NCT01286987|20571315|P6|COMPLETED|Part 1: Dose Escalation||0
8345009|NCT01286987|20571316|P5|COMPLETED|Part 1: Dose Escalation||0
8345010|NCT01286987|20571317|P4|COMPLETED|Part 1: Dose Escalation||0
8345011|NCT01286987|20571318|P3|COMPLETED|Part 1: Dose Escalation||0
8345012|NCT01286987|20571319|P2|COMPLETED|Part 1: Dose Escalation||0
8345013|NCT01286987|20571320|P1|COMPLETED|Part 1: Dose Escalation||0
8345014|NCT01286987|20571306|P15|Breast Cancer|Part 1: Dose Escalation||0
8345015|NCT01286987|20571307|P14|Breast Cancer|Part 1: Dose Escalation||0
8345016|NCT01286987|20571308|P13|Breast Cancer|Part 1: Dose Escalation||0
8345017|NCT01286987|20571309|P12|Breast Cancer|Part 1: Dose Escalation||0
8345018|NCT01286987|20571310|P11|Breast Cancer|Part 1: Dose Escalation||0
8345019|NCT01286987|20571311|P10|Breast Cancer|Part 1: Dose Escalation||0
8345020|NCT01286987|20571312|P9|Breast Cancer|Part 1: Dose Escalation||3
8345021|NCT01286987|20571313|P8|Breast Cancer|Part 1: Dose Escalation||2
8345022|NCT01286987|20571314|P7|Breast Cancer|Part 1: Dose Escalation||2
8345023|NCT01286987|20571315|P6|Breast Cancer|Part 1: Dose Escalation||1
8345024|NCT01286987|20571316|P5|Breast Cancer|Part 1: Dose Escalation||0
8345025|NCT01286987|20571317|P4|Breast Cancer|Part 1: Dose Escalation||0
8345026|NCT01286987|20571318|P3|Breast Cancer|Part 1: Dose Escalation||0
8345027|NCT01286987|20571319|P2|Breast Cancer|Part 1: Dose Escalation||0
8345028|NCT01286987|20571320|P1|Breast Cancer|Part 1: Dose Escalation||0
8345029|NCT01286987|20571306|P15|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345030|NCT01286987|20571307|P14|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345031|NCT01286987|20571308|P13|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345032|NCT01286987|20571309|P12|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345033|NCT01286987|20571310|P11|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345034|NCT01286987|20571311|P10|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345035|NCT01286987|20571312|P9|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
8345036|NCT01286987|20571313|P8|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8345037|NCT01286987|20571314|P7|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
8345038|NCT01286987|20571315|P6|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
8345039|NCT01286987|20571316|P5|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8345040|NCT01286987|20571317|P4|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8345041|NCT01286987|20571318|P3|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
8345042|NCT01286987|20571319|P2|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
8345043|NCT01286987|20571320|P1|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
8345044|NCT01286987|20571306|P15|Pancreatic Cancer|Part 1: Dose Escalation||0
8345045|NCT01286987|20571307|P14|Pancreatic Cancer|Part 1: Dose Escalation||0
8345046|NCT01286987|20571308|P13|Pancreatic Cancer|Part 1: Dose Escalation||0
8345047|NCT01286987|20571309|P12|Pancreatic Cancer|Part 1: Dose Escalation||0
8345048|NCT01286987|20571310|P11|Pancreatic Cancer|Part 1: Dose Escalation||0
8345049|NCT01286987|20571311|P10|Pancreatic Cancer|Part 1: Dose Escalation||0
8345050|NCT01286987|20571312|P9|Pancreatic Cancer|Part 1: Dose Escalation||0
8345051|NCT01286987|20571313|P8|Pancreatic Cancer|Part 1: Dose Escalation||0
8345052|NCT01286987|20571314|P7|Pancreatic Cancer|Part 1: Dose Escalation||0
8345053|NCT01286987|20571315|P6|Pancreatic Cancer|Part 1: Dose Escalation||0
8345054|NCT01286987|20571316|P5|Pancreatic Cancer|Part 1: Dose Escalation||0
8345055|NCT01286987|20571317|P4|Pancreatic Cancer|Part 1: Dose Escalation||0
8345056|NCT01286987|20571318|P3|Pancreatic Cancer|Part 1: Dose Escalation||0
8345057|NCT01286987|20571319|P2|Pancreatic Cancer|Part 1: Dose Escalation||2
8345058|NCT01286987|20571320|P1|Pancreatic Cancer|Part 1: Dose Escalation||1
8345059|NCT01286987|20571306|P15|Ewing Cancer|Part 1: Dose Escalation||0
8345060|NCT01286987|20571307|P14|Ewing Cancer|Part 1: Dose Escalation||0
8345061|NCT01286987|20571308|P13|Ewing Cancer|Part 1: Dose Escalation||0
8345062|NCT01286987|20571309|P12|Ewing Cancer|Part 1: Dose Escalation||0
8345063|NCT01286987|20571310|P11|Ewing Cancer|Part 1: Dose Escalation||0
8345064|NCT01286987|20571311|P10|Ewing Cancer|Part 1: Dose Escalation||0
8345065|NCT01286987|20571312|P9|Ewing Cancer|Part 1: Dose Escalation||1
8345066|NCT01286987|20571313|P8|Ewing Cancer|Part 1: Dose Escalation||1
8345067|NCT01286987|20571314|P7|Ewing Cancer|Part 1: Dose Escalation||0
8345068|NCT01286987|20571315|P6|Ewing Cancer|Part 1: Dose Escalation||0
8345069|NCT01286987|20571316|P5|Ewing Cancer|Part 1: Dose Escalation||0
8345070|NCT01286987|20571317|P4|Ewing Cancer|Part 1: Dose Escalation||0
8345071|NCT01286987|20571318|P3|Ewing Cancer|Part 1: Dose Escalation||0
8345072|NCT01286987|20571319|P2|Ewing Cancer|Part 1: Dose Escalation||0
8345073|NCT01286987|20571320|P1|Ewing Cancer|Part 1: Dose Escalation||0
8345074|NCT01286987|20571306|P15|Prostate Cancer|Part 1: Dose Escalation||0
8345075|NCT01286987|20571307|P14|Prostate Cancer|Part 1: Dose Escalation||0
8345076|NCT01286987|20571308|P13|Prostate Cancer|Part 1: Dose Escalation||0
8345077|NCT01286987|20571309|P12|Prostate Cancer|Part 1: Dose Escalation||0
8345078|NCT01286987|20571310|P11|Prostate Cancer|Part 1: Dose Escalation||0
8345079|NCT01286987|20571311|P10|Prostate Cancer|Part 1: Dose Escalation||0
8345080|NCT01286987|20571312|P9|Prostate Cancer|Part 1: Dose Escalation||0
8345081|NCT01286987|20571313|P8|Prostate Cancer|Part 1: Dose Escalation||0
8345082|NCT01286987|20571314|P7|Prostate Cancer|Part 1: Dose Escalation||0
8345083|NCT01286987|20571315|P6|Prostate Cancer|Part 1: Dose Escalation||1
8345084|NCT01286987|20571316|P5|Prostate Cancer|Part 1: Dose Escalation||0
8345085|NCT01286987|20571317|P4|Prostate Cancer|Part 1: Dose Escalation||0
8345086|NCT01286987|20571318|P3|Prostate Cancer|Part 1: Dose Escalation||0
8345087|NCT01286987|20571319|P2|Prostate Cancer|Part 1: Dose Escalation||0
8345088|NCT01286987|20571320|P1|Prostate Cancer|Part 1: Dose Escalation||0
8345089|NCT01286987|20571306|P15|Colorectal Cancer|Part 1: Dose Escalation||0
8345090|NCT01286987|20571307|P14|Colorectal Cancer|Part 1: Dose Escalation||0
8345091|NCT01286987|20571308|P13|Colorectal Cancer|Part 1: Dose Escalation||0
8345092|NCT01286987|20571309|P12|Colorectal Cancer|Part 1: Dose Escalation||0
8345093|NCT01286987|20571310|P11|Colorectal Cancer|Part 1: Dose Escalation||0
8345094|NCT01286987|20571311|P10|Colorectal Cancer|Part 1: Dose Escalation||0
8345095|NCT01286987|20571312|P9|Colorectal Cancer|Part 1: Dose Escalation||0
8345096|NCT01286987|20571313|P8|Colorectal Cancer|Part 1: Dose Escalation||0
8345097|NCT01286987|20571314|P7|Colorectal Cancer|Part 1: Dose Escalation||0
8345098|NCT01286987|20571315|P6|Colorectal Cancer|Part 1: Dose Escalation||0
8345099|NCT01286987|20571316|P5|Colorectal Cancer|Part 1: Dose Escalation||0
8345100|NCT01286987|20571317|P4|Colorectal Cancer|Part 1: Dose Escalation||0
8345101|NCT01286987|20571318|P3|Colorectal Cancer|Part 1: Dose Escalation||1
8345102|NCT01286987|20571319|P2|Colorectal Cancer|Part 1: Dose Escalation||0
8345103|NCT01286987|20571320|P1|Colorectal Cancer|Part 1: Dose Escalation||1
8345104|NCT01286987|20571306|P15|STARTED|Part 1: Dose Escalation||0
8345105|NCT01286987|20571307|P14|STARTED|Part 1: Dose Escalation||0
8345106|NCT01286987|20571308|P13|STARTED|Part 1: Dose Escalation||0
8345107|NCT01286987|20571309|P12|STARTED|Part 1: Dose Escalation||0
8345108|NCT01286987|20571310|P11|STARTED|Part 1: Dose Escalation||0
8345109|NCT01286987|20571311|P10|STARTED|Part 1: Dose Escalation||0
8345110|NCT01286987|20571312|P9|STARTED|Part 1: Dose Escalation||6
8345111|NCT01286987|20571313|P8|STARTED|Part 1: Dose Escalation||6
8345112|NCT01286987|20571314|P7|STARTED|Part 1: Dose Escalation||6
8345113|NCT01286987|20571315|P6|STARTED|Part 1: Dose Escalation||6
8345114|NCT01286987|20571316|P5|STARTED|Part 1: Dose Escalation||3
8345115|NCT01286987|20571317|P4|STARTED|Part 1: Dose Escalation||3
8345116|NCT01286987|20571318|P3|STARTED|Part 1: Dose Escalation||3
8345117|NCT01286987|20571319|P2|STARTED|Part 1: Dose Escalation||3
8345118|NCT01286987|20571320|P1|STARTED|Part 1: Dose Escalation||3
8345119|NCT01286870|20571461|P1|NOT COMPLETED|Overall Study||0
8345120|NCT01286870|20571461|P1|COMPLETED|Overall Study||11
8345121|NCT01286870|20571461|P1|STARTED|Overall Study||11
8345122|NCT01286818|20571466|P1|NOT COMPLETED|Overall Study||0
8345123|NCT01286818|20571466|P1|COMPLETED|Overall Study||6
8345124|NCT01286818|20571466|P1|Completed DLT Assessment Period|Overall Study||5
8345125|NCT01286818|20571466|P1|STARTED|Overall Study||6
8345126|NCT01286805|20571480|P2|NOT COMPLETED|Overall Study||1
8345127|NCT01286805|20571481|P1|NOT COMPLETED|Overall Study||0
8345128|NCT01286805|20571480|P2|COMPLETED|Overall Study||41
8345129|NCT01286805|20571481|P1|COMPLETED|Overall Study||41
8345130|NCT01286805|20571480|P2|STARTED|Overall Study||42
8345131|NCT01286805|20571481|P1|STARTED|Overall Study||41
8345132|NCT01286779|20571501|P1|NOT COMPLETED|Overall Study||19
8345133|NCT01286779|20571501|P1|COMPLETED|Overall Study||96
8345134|NCT01286779|20571501|P1|STARTED|Overall Study||115
8345135|NCT01286753|20571553|P2|NOT COMPLETED|Overall Study||25
8345136|NCT01286753|20571554|P1|NOT COMPLETED|Overall Study||26
8345137|NCT01286753|20571553|P2|COMPLETED|Overall Study||0
8345138|NCT01286753|20571554|P1|COMPLETED|Overall Study||0
8345139|NCT01286753|20571553|P2|STARTED|Overall Study||25
8345140|NCT01286753|20571554|P1|STARTED|Overall Study||26
8345141|NCT01286740|20571572|P1|NOT COMPLETED|Overall Study||2
8345142|NCT01286740|20571572|P1|COMPLETED|Overall Study||48
8345143|NCT01286740|20571572|P1|Week 12 (Primary Endpoint)|Overall Study||49
8345144|NCT01286740|20571572|P1|Enrolled and Treated|Overall Study||49
8345145|NCT01286740|20571572|P1|STARTED|Overall Study||50
8345146|NCT01286558|20571590|P2|NOT COMPLETED|Overall Study||2
8345147|NCT01286558|20571591|P1|NOT COMPLETED|Overall Study||1
8345148|NCT01286558|20571590|P2|COMPLETED|Overall Study||111
8345149|NCT01286558|20571591|P1|COMPLETED|Overall Study||111
8345150|NCT01286558|20571590|P2|STARTED|Overall Study||113
8345151|NCT01286558|20571591|P1|STARTED|Overall Study||112
8345152|NCT01286493|20571621|P1|NOT COMPLETED|Overall Study||3
8345153|NCT01286493|20571621|P1|COMPLETED|Overall Study||30
8345154|NCT01286493|20571621|P1|STARTED|Overall Study||33
8345155|NCT01286480|20571627|P2|NOT COMPLETED|Overall Study||3
8345156|NCT01286480|20571628|P1|NOT COMPLETED|Overall Study||5
8345157|NCT01286480|20571627|P2|COMPLETED|Overall Study||31
8345158|NCT01286480|20571628|P1|COMPLETED|Overall Study||27
8345159|NCT01286480|20571627|P2|STARTED|Overall Study||34
8345160|NCT01286480|20571628|P1|STARTED|Overall Study||32
8345161|NCT01286454|20571636|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345162|NCT01286454|20571637|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345163|NCT01286454|20571638|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345164|NCT01286454|20571639|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345165|NCT01286454|20571640|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345166|NCT01286454|20571641|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345167|NCT01286454|20571642|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345168|NCT01286454|20571643|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345169|NCT01286454|20571644|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345170|NCT01286454|20571645|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345171|NCT01286454|20571646|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345172|NCT01286454|20571636|P11|COMPLETED|Part II- Sixth Intervention Period||20
8345173|NCT01286454|20571637|P10|COMPLETED|Part II- Sixth Intervention Period||0
8345174|NCT01286454|20571638|P9|COMPLETED|Part II- Sixth Intervention Period||0
8345175|NCT01286454|20571639|P8|COMPLETED|Part II- Sixth Intervention Period||0
8345176|NCT01286454|20571640|P7|COMPLETED|Part II- Sixth Intervention Period||0
8345177|NCT01286454|20571641|P6|COMPLETED|Part II- Sixth Intervention Period||0
8345178|NCT01286454|20571642|P5|COMPLETED|Part II- Sixth Intervention Period||0
8345179|NCT01286454|20571643|P4|COMPLETED|Part II- Sixth Intervention Period||0
8345180|NCT01286454|20571644|P3|COMPLETED|Part II- Sixth Intervention Period||0
8345181|NCT01286454|20571645|P2|COMPLETED|Part II- Sixth Intervention Period||0
8345182|NCT01286454|20571646|P1|COMPLETED|Part II- Sixth Intervention Period||0
8345183|NCT01286454|20571636|P11|STARTED|Part II- Sixth Intervention Period||20
8345184|NCT01286454|20571637|P10|STARTED|Part II- Sixth Intervention Period||0
8345185|NCT01286454|20571638|P9|STARTED|Part II- Sixth Intervention Period||0
8345186|NCT01286454|20571639|P8|STARTED|Part II- Sixth Intervention Period||0
8345187|NCT01286454|20571640|P7|STARTED|Part II- Sixth Intervention Period||0
8345188|NCT01286454|20571641|P6|STARTED|Part II- Sixth Intervention Period||0
8345189|NCT01286454|20571642|P5|STARTED|Part II- Sixth Intervention Period||0
8345190|NCT01286454|20571643|P4|STARTED|Part II- Sixth Intervention Period||0
8345191|NCT01286454|20571644|P3|STARTED|Part II- Sixth Intervention Period||0
8345192|NCT01286454|20571645|P2|STARTED|Part II- Sixth Intervention Period||0
8345193|NCT01286454|20571646|P1|STARTED|Part II- Sixth Intervention Period||0
8345194|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345195|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345196|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345197|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345198|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345199|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345200|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345201|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345202|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345203|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345204|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345205|NCT01286454|20571636|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345206|NCT01286454|20571637|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345207|NCT01286454|20571638|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345208|NCT01286454|20571639|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345209|NCT01286454|20571640|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345210|NCT01286454|20571641|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345211|NCT01286454|20571642|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345212|NCT01286454|20571643|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345213|NCT01286454|20571644|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345214|NCT01286454|20571645|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345215|NCT01286454|20571646|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345216|NCT01286454|20571636|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
8345217|NCT01286454|20571637|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
8345218|NCT01286454|20571638|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
8345219|NCT01286454|20571639|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
8345220|NCT01286454|20571640|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
8345221|NCT01286454|20571641|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
8345222|NCT01286454|20571642|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
8345223|NCT01286454|20571643|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
8345224|NCT01286454|20571644|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
8345225|NCT01286454|20571645|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
8345226|NCT01286454|20571646|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
8345227|NCT01286454|20571636|P11|NOT COMPLETED|Fifth Intervention Period||0
8345228|NCT01286454|20571637|P10|NOT COMPLETED|Fifth Intervention Period||0
8345229|NCT01286454|20571638|P9|NOT COMPLETED|Fifth Intervention Period||0
8345230|NCT01286454|20571639|P8|NOT COMPLETED|Fifth Intervention Period||0
8345231|NCT01286454|20571640|P7|NOT COMPLETED|Fifth Intervention Period||0
8345232|NCT01286454|20571641|P6|NOT COMPLETED|Fifth Intervention Period||0
8345233|NCT01286454|20571642|P5|NOT COMPLETED|Fifth Intervention Period||0
8345234|NCT01286454|20571643|P4|NOT COMPLETED|Fifth Intervention Period||0
8345235|NCT01286454|20571644|P3|NOT COMPLETED|Fifth Intervention Period||0
8345236|NCT01286454|20571645|P2|NOT COMPLETED|Fifth Intervention Period||0
8345237|NCT01286454|20571646|P1|NOT COMPLETED|Fifth Intervention Period||0
8345238|NCT01286454|20571636|P11|COMPLETED|Fifth Intervention Period||0
8345239|NCT01286454|20571637|P10|COMPLETED|Fifth Intervention Period||2
8345240|NCT01286454|20571638|P9|COMPLETED|Fifth Intervention Period||2
8345241|NCT01286454|20571639|P8|COMPLETED|Fifth Intervention Period||2
8345242|NCT01286454|20571640|P7|COMPLETED|Fifth Intervention Period||2
8345243|NCT01286454|20571641|P6|COMPLETED|Fifth Intervention Period||2
8345244|NCT01286454|20571642|P5|COMPLETED|Fifth Intervention Period||2
8345245|NCT01286454|20571643|P4|COMPLETED|Fifth Intervention Period||2
8345246|NCT01286454|20571644|P3|COMPLETED|Fifth Intervention Period||2
8345247|NCT01286454|20571645|P2|COMPLETED|Fifth Intervention Period||2
8345248|NCT01286454|20571646|P1|COMPLETED|Fifth Intervention Period||2
8345249|NCT01286454|20571636|P11|STARTED|Fifth Intervention Period||0
8345250|NCT01286454|20571637|P10|STARTED|Fifth Intervention Period||2
8345251|NCT01286454|20571638|P9|STARTED|Fifth Intervention Period||2
8345252|NCT01286454|20571639|P8|STARTED|Fifth Intervention Period||2
8345253|NCT01286454|20571640|P7|STARTED|Fifth Intervention Period||2
8345254|NCT01286454|20571641|P6|STARTED|Fifth Intervention Period||2
8345255|NCT01286454|20571642|P5|STARTED|Fifth Intervention Period||2
8345256|NCT01286454|20571643|P4|STARTED|Fifth Intervention Period||2
8345257|NCT01286454|20571644|P3|STARTED|Fifth Intervention Period||2
8345258|NCT01286454|20571645|P2|STARTED|Fifth Intervention Period||2
8345259|NCT01286454|20571646|P1|STARTED|Fifth Intervention Period||2
8345260|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345261|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345262|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345263|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345264|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345265|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345266|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345267|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345268|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345269|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345270|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345271|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345272|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345273|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345274|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345275|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345276|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345277|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345278|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345279|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345280|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345281|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345282|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345283|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345284|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345285|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345286|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345287|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345288|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345289|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345290|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345291|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345292|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345293|NCT01286454|20571636|P11|NOT COMPLETED|Fourth Intervention Period||0
8345294|NCT01286454|20571637|P10|NOT COMPLETED|Fourth Intervention Period||0
8345295|NCT01286454|20571638|P9|NOT COMPLETED|Fourth Intervention Period||0
8345296|NCT01286454|20571639|P8|NOT COMPLETED|Fourth Intervention Period||0
8345297|NCT01286454|20571640|P7|NOT COMPLETED|Fourth Intervention Period||0
8345298|NCT01286454|20571641|P6|NOT COMPLETED|Fourth Intervention Period||0
8345299|NCT01286454|20571642|P5|NOT COMPLETED|Fourth Intervention Period||0
8345300|NCT01286454|20571643|P4|NOT COMPLETED|Fourth Intervention Period||0
8345301|NCT01286454|20571644|P3|NOT COMPLETED|Fourth Intervention Period||0
8345302|NCT01286454|20571645|P2|NOT COMPLETED|Fourth Intervention Period||0
8345303|NCT01286454|20571646|P1|NOT COMPLETED|Fourth Intervention Period||0
8345304|NCT01286454|20571636|P11|COMPLETED|Fourth Intervention Period||0
8345305|NCT01286454|20571637|P10|COMPLETED|Fourth Intervention Period||2
8345306|NCT01286454|20571638|P9|COMPLETED|Fourth Intervention Period||2
8345307|NCT01286454|20571639|P8|COMPLETED|Fourth Intervention Period||2
8345308|NCT01286454|20571640|P7|COMPLETED|Fourth Intervention Period||2
8345309|NCT01286454|20571641|P6|COMPLETED|Fourth Intervention Period||2
8345310|NCT01286454|20571642|P5|COMPLETED|Fourth Intervention Period||2
8345311|NCT01286454|20571643|P4|COMPLETED|Fourth Intervention Period||2
8345312|NCT01286454|20571644|P3|COMPLETED|Fourth Intervention Period||2
8345313|NCT01286454|20571645|P2|COMPLETED|Fourth Intervention Period||2
8345314|NCT01286454|20571646|P1|COMPLETED|Fourth Intervention Period||2
8345315|NCT01286454|20571636|P11|STARTED|Fourth Intervention Period||0
8345316|NCT01286454|20571637|P10|STARTED|Fourth Intervention Period||2
8345317|NCT01286454|20571638|P9|STARTED|Fourth Intervention Period||2
8345318|NCT01286454|20571639|P8|STARTED|Fourth Intervention Period||2
8345319|NCT01286454|20571640|P7|STARTED|Fourth Intervention Period||2
8345320|NCT01286454|20571641|P6|STARTED|Fourth Intervention Period||2
8345321|NCT01286454|20571642|P5|STARTED|Fourth Intervention Period||2
8345322|NCT01286454|20571643|P4|STARTED|Fourth Intervention Period||2
8345323|NCT01286454|20571644|P3|STARTED|Fourth Intervention Period||2
8345324|NCT01286454|20571645|P2|STARTED|Fourth Intervention Period||2
8345325|NCT01286454|20571646|P1|STARTED|Fourth Intervention Period||2
8345326|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345327|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345328|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345329|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345330|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345331|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345332|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345333|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345334|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345335|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345336|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345337|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345338|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345339|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345340|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345341|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345342|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345343|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345344|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345345|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345346|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345347|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345348|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345349|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345350|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345351|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345352|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345353|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345354|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345355|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345356|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345357|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345358|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345359|NCT01286454|20571636|P11|NOT COMPLETED|Third Intervention Period||0
8345360|NCT01286454|20571637|P10|NOT COMPLETED|Third Intervention Period||0
8345361|NCT01286454|20571638|P9|NOT COMPLETED|Third Intervention Period||0
8345362|NCT01286454|20571639|P8|NOT COMPLETED|Third Intervention Period||0
8345363|NCT01286454|20571640|P7|NOT COMPLETED|Third Intervention Period||0
8345364|NCT01286454|20571641|P6|NOT COMPLETED|Third Intervention Period||0
8345365|NCT01286454|20571642|P5|NOT COMPLETED|Third Intervention Period||0
8345366|NCT01286454|20571643|P4|NOT COMPLETED|Third Intervention Period||0
8345367|NCT01286454|20571644|P3|NOT COMPLETED|Third Intervention Period||0
8345368|NCT01286454|20571645|P2|NOT COMPLETED|Third Intervention Period||0
8345369|NCT01286454|20571646|P1|NOT COMPLETED|Third Intervention Period||0
8345370|NCT01286454|20571636|P11|COMPLETED|Third Intervention Period||0
8345371|NCT01286454|20571637|P10|COMPLETED|Third Intervention Period||2
8345372|NCT01286454|20571638|P9|COMPLETED|Third Intervention Period||2
8345373|NCT01286454|20571639|P8|COMPLETED|Third Intervention Period||2
8345374|NCT01286454|20571640|P7|COMPLETED|Third Intervention Period||2
8345375|NCT01286454|20571641|P6|COMPLETED|Third Intervention Period||2
8345376|NCT01286454|20571642|P5|COMPLETED|Third Intervention Period||2
8345377|NCT01286454|20571643|P4|COMPLETED|Third Intervention Period||2
8345378|NCT01286454|20571644|P3|COMPLETED|Third Intervention Period||2
8345379|NCT01286454|20571645|P2|COMPLETED|Third Intervention Period||2
8345380|NCT01286454|20571646|P1|COMPLETED|Third Intervention Period||2
8345381|NCT01286454|20571636|P11|STARTED|Third Intervention Period||0
8345382|NCT01286454|20571637|P10|STARTED|Third Intervention Period||2
8345383|NCT01286454|20571638|P9|STARTED|Third Intervention Period||2
8345384|NCT01286454|20571639|P8|STARTED|Third Intervention Period||2
8345385|NCT01286454|20571640|P7|STARTED|Third Intervention Period||2
8345386|NCT01286454|20571641|P6|STARTED|Third Intervention Period||2
8345387|NCT01286454|20571642|P5|STARTED|Third Intervention Period||2
8345388|NCT01286454|20571643|P4|STARTED|Third Intervention Period||2
8345389|NCT01286454|20571644|P3|STARTED|Third Intervention Period||2
8345390|NCT01286454|20571645|P2|STARTED|Third Intervention Period||2
8345391|NCT01286454|20571646|P1|STARTED|Third Intervention Period||2
8345392|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345393|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345394|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345395|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345396|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345397|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345398|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345399|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345400|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345401|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345402|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345403|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345404|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345405|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345406|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345407|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345408|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345409|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345410|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345411|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345412|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345413|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345414|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345415|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345416|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345417|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345418|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345419|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345420|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345421|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345422|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345423|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345424|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345425|NCT01286454|20571636|P11|NOT COMPLETED|Second Intervention Period||0
8345426|NCT01286454|20571637|P10|NOT COMPLETED|Second Intervention Period||0
8345427|NCT01286454|20571638|P9|NOT COMPLETED|Second Intervention Period||0
8345428|NCT01286454|20571639|P8|NOT COMPLETED|Second Intervention Period||0
8345429|NCT01286454|20571640|P7|NOT COMPLETED|Second Intervention Period||0
8345430|NCT01286454|20571641|P6|NOT COMPLETED|Second Intervention Period||0
8345431|NCT01286454|20571642|P5|NOT COMPLETED|Second Intervention Period||0
8345432|NCT01286454|20571643|P4|NOT COMPLETED|Second Intervention Period||0
8345433|NCT01286454|20571644|P3|NOT COMPLETED|Second Intervention Period||0
8345434|NCT01286454|20571645|P2|NOT COMPLETED|Second Intervention Period||0
8345435|NCT01286454|20571646|P1|NOT COMPLETED|Second Intervention Period||0
8345436|NCT01286454|20571636|P11|COMPLETED|Second Intervention Period||0
8345437|NCT01286454|20571637|P10|COMPLETED|Second Intervention Period||2
8345438|NCT01286454|20571638|P9|COMPLETED|Second Intervention Period||2
8345439|NCT01286454|20571639|P8|COMPLETED|Second Intervention Period||2
8345440|NCT01286454|20571640|P7|COMPLETED|Second Intervention Period||2
8345441|NCT01286454|20571641|P6|COMPLETED|Second Intervention Period||2
8345442|NCT01286454|20571642|P5|COMPLETED|Second Intervention Period||2
8345443|NCT01286454|20571643|P4|COMPLETED|Second Intervention Period||2
8345444|NCT01286454|20571644|P3|COMPLETED|Second Intervention Period||2
8345445|NCT01286454|20571645|P2|COMPLETED|Second Intervention Period||2
8345446|NCT01286454|20571646|P1|COMPLETED|Second Intervention Period||2
8345447|NCT01286454|20571636|P11|STARTED|Second Intervention Period||0
8345448|NCT01286454|20571637|P10|STARTED|Second Intervention Period||2
8345449|NCT01286454|20571638|P9|STARTED|Second Intervention Period||2
8345450|NCT01286454|20571639|P8|STARTED|Second Intervention Period||2
8345451|NCT01286454|20571640|P7|STARTED|Second Intervention Period||2
8345452|NCT01286454|20571641|P6|STARTED|Second Intervention Period||2
8345453|NCT01286454|20571642|P5|STARTED|Second Intervention Period||2
8345454|NCT01286454|20571643|P4|STARTED|Second Intervention Period||2
8345455|NCT01286454|20571644|P3|STARTED|Second Intervention Period||2
8345456|NCT01286454|20571645|P2|STARTED|Second Intervention Period||2
8345457|NCT01286454|20571646|P1|STARTED|Second Intervention Period||2
8345458|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345459|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345460|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345461|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345462|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345463|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345464|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345465|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345466|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345467|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345468|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345469|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345470|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345471|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345472|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345473|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345474|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345475|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345476|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345477|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345478|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345479|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345480|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345481|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345482|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345483|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345484|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345485|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345486|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345487|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345488|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345489|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345490|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345491|NCT01286454|20571636|P11|NOT COMPLETED|Part I- First Intervention Period||0
8345492|NCT01286454|20571637|P10|NOT COMPLETED|Part I- First Intervention Period||0
8345493|NCT01286454|20571638|P9|NOT COMPLETED|Part I- First Intervention Period||0
8345494|NCT01286454|20571639|P8|NOT COMPLETED|Part I- First Intervention Period||0
8345495|NCT01286454|20571640|P7|NOT COMPLETED|Part I- First Intervention Period||0
8345496|NCT01286454|20571641|P6|NOT COMPLETED|Part I- First Intervention Period||0
8345497|NCT01286454|20571642|P5|NOT COMPLETED|Part I- First Intervention Period||0
8345498|NCT01286454|20571643|P4|NOT COMPLETED|Part I- First Intervention Period||0
8345499|NCT01286454|20571644|P3|NOT COMPLETED|Part I- First Intervention Period||0
8345500|NCT01286454|20571645|P2|NOT COMPLETED|Part I- First Intervention Period||0
8345501|NCT01286454|20571646|P1|NOT COMPLETED|Part I- First Intervention Period||0
8345502|NCT01286454|20571636|P11|COMPLETED|Part I- First Intervention Period||0
8345503|NCT01286454|20571637|P10|COMPLETED|Part I- First Intervention Period||2
8345504|NCT01286454|20571638|P9|COMPLETED|Part I- First Intervention Period||2
8345505|NCT01286454|20571639|P8|COMPLETED|Part I- First Intervention Period||2
8345506|NCT01286454|20571640|P7|COMPLETED|Part I- First Intervention Period||2
8345507|NCT01286454|20571641|P6|COMPLETED|Part I- First Intervention Period||2
8345508|NCT01286454|20571642|P5|COMPLETED|Part I- First Intervention Period||2
8345509|NCT01286454|20571643|P4|COMPLETED|Part I- First Intervention Period||2
8345510|NCT01286454|20571644|P3|COMPLETED|Part I- First Intervention Period||2
8345511|NCT01286454|20571645|P2|COMPLETED|Part I- First Intervention Period||2
8345512|NCT01286454|20571646|P1|COMPLETED|Part I- First Intervention Period||2
8345513|NCT01286454|20571636|P11|STARTED|Part I- First Intervention Period||0
8345514|NCT01286454|20571637|P10|STARTED|Part I- First Intervention Period||2
8345515|NCT01286454|20571638|P9|STARTED|Part I- First Intervention Period||2
8345516|NCT01286454|20571639|P8|STARTED|Part I- First Intervention Period||2
8345517|NCT01286454|20571640|P7|STARTED|Part I- First Intervention Period||2
8345518|NCT01286454|20571641|P6|STARTED|Part I- First Intervention Period||2
8345519|NCT01286454|20571642|P5|STARTED|Part I- First Intervention Period||2
8345520|NCT01286454|20571643|P4|STARTED|Part I- First Intervention Period||2
8345521|NCT01286454|20571644|P3|STARTED|Part I- First Intervention Period||2
8345522|NCT01286454|20571645|P2|STARTED|Part I- First Intervention Period||2
8345523|NCT01286454|20571646|P1|STARTED|Part I- First Intervention Period||2
8345524|NCT01286441|20571688|P4|NOT COMPLETED|Overall Study||11
8345525|NCT01286441|20571689|P3|NOT COMPLETED|Overall Study||7
8345526|NCT01286441|20571690|P2|NOT COMPLETED|Overall Study||7
8345527|NCT01286441|20571691|P1|NOT COMPLETED|Overall Study||7
8345528|NCT01286441|20571688|P4|COMPLETED|Overall Study||37
8345529|NCT01286441|20571689|P3|COMPLETED|Overall Study||39
8345530|NCT01286441|20571690|P2|COMPLETED|Overall Study||37
8345531|NCT01286441|20571691|P1|COMPLETED|Overall Study||38
8345532|NCT01286441|20571688|P4|STARTED|Overall Study||48
8345533|NCT01286441|20571689|P3|STARTED|Overall Study||46
8345534|NCT01286441|20571690|P2|STARTED|Overall Study||44
8345535|NCT01286441|20571691|P1|STARTED|Overall Study||45
8345536|NCT01286402|20571707|P2|NOT COMPLETED|Overall Study||0
8345537|NCT01286402|20571708|P1|NOT COMPLETED|Overall Study||0
8345538|NCT01286402|20571707|P2|COMPLETED|Overall Study||6
8345539|NCT01286402|20571708|P1|COMPLETED|Overall Study||5
8345540|NCT01286402|20571707|P2|STARTED|Overall Study||6
8345541|NCT01286402|20571708|P1|STARTED|Overall Study||5
8345542|NCT01286324|20571716|P2|NOT COMPLETED|Overall Study||0
8345543|NCT01286324|20571717|P1|NOT COMPLETED|Overall Study||0
8345544|NCT01286324|20571716|P2|COMPLETED|Overall Study||17
8345545|NCT01286324|20571717|P1|COMPLETED|Overall Study||17
8345546|NCT01286324|20571716|P2|STARTED|Overall Study||17
8345547|NCT01286324|20571717|P1|STARTED|Overall Study||17
8345548|NCT01286311|20571735|P2|NOT COMPLETED|Overall Study||0
8345549|NCT01286311|20571736|P1|NOT COMPLETED|Overall Study||14
8345550|NCT01286311|20571735|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
8345551|NCT01286311|20571736|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
8345552|NCT01286311|20571735|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
8345553|NCT01286311|20571736|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
8345554|NCT01286272|20571752|P2|NOT COMPLETED|Overall Study||3
8345555|NCT01286272|20571753|P1|NOT COMPLETED|Overall Study||1
8345556|NCT01286272|20571752|P2|COMPLETED|Overall Study||62
8345557|NCT01286272|20571753|P1|COMPLETED|Overall Study||66
8345558|NCT01286272|20571752|P2|STARTED|Overall Study||65
8345559|NCT01286272|20571753|P1|STARTED|Overall Study||67
8345560|NCT01286259|20571763|P1|NOT COMPLETED|Overall Study||0
8345561|NCT01286259|20571763|P1|COMPLETED|Overall Study||16
8345562|NCT01286259|20571763|P1|STARTED|Overall Study||16
8345563|NCT01286207|20571773|P3|NOT COMPLETED|Overall Study||90
8345564|NCT01286207|20571774|P2|NOT COMPLETED|Overall Study||248
8345565|NCT01286207|20571775|P1|NOT COMPLETED|Overall Study||298
8345566|NCT01286207|20571773|P3|COMPLETED|Overall Study||261
8345567|NCT01286207|20571774|P2|COMPLETED|Overall Study||609
8345568|NCT01286207|20571775|P1|COMPLETED|Overall Study||453
8345569|NCT01286207|20571773|P3|STARTED|Overall Study||351
8345570|NCT01286207|20571774|P2|STARTED|Overall Study||857
8345571|NCT01286207|20571775|P1|STARTED|Overall Study||751
8345572|NCT01286168|20571795|P1|NOT COMPLETED|Overall Study||3
8345573|NCT01286168|20571795|P1|COMPLETED|Overall Study||101
8345574|NCT01286168|20571795|P1|STARTED|Overall Study||104
8345575|NCT01286129|20571809|P2|NOT COMPLETED|Overall Study||5
8345576|NCT01286129|20571810|P1|NOT COMPLETED|Overall Study||8
8345577|NCT01286129|20571809|P2|COMPLETED|Overall Study||13
8345578|NCT01286129|20571810|P1|COMPLETED|Overall Study||19
8345579|NCT01286129|20571809|P2|STARTED|Overall Study||18
8345580|NCT01286129|20571810|P1|STARTED|Overall Study||27
8345581|NCT01286077|20571820|P2|NOT COMPLETED|Overall Study||7
8345582|NCT01286077|20571821|P1|NOT COMPLETED|Overall Study||10
8345583|NCT01286077|20571820|P2|COMPLETED|Overall Study||46
8345584|NCT01286077|20571821|P1|COMPLETED|Overall Study||41
8345585|NCT01286077|20571820|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
8345586|NCT01286077|20571821|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
8345587|NCT01286012|20571857|P2|NOT COMPLETED|Overall Study||14
8345588|NCT01286012|20571858|P1|NOT COMPLETED|Overall Study||13
8345589|NCT01286012|20571857|P2|COMPLETED|Overall Study||40
8345590|NCT01286012|20571858|P1|COMPLETED|Overall Study||41
8345591|NCT01286012|20571857|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
8345592|NCT01286012|20571858|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
8345593|NCT01285960|20571872|P1|NOT COMPLETED|Overall Study||6
8345594|NCT01285960|20571872|P1|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
8345595|NCT01285960|20571872|P1|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
8345596|NCT01285947|20571878|P2|NOT COMPLETED|Overall Study||0
8345597|NCT01285947|20571879|P1|NOT COMPLETED|Overall Study||0
8345598|NCT01285947|20571878|P2|COMPLETED|Overall Study||10
8345599|NCT01285947|20571879|P1|COMPLETED|Overall Study||10
8345600|NCT01285947|20571878|P2|STARTED|Overall Study||10
8345601|NCT01285947|20571879|P1|STARTED|Overall Study||10
8345602|NCT01285908|20571885|P3|NOT COMPLETED|Treatment Crossover||0
8345603|NCT01285908|20571886|P2|NOT COMPLETED|Treatment Crossover||0
8345604|NCT01285908|20571887|P1|NOT COMPLETED|Treatment Crossover||0
8345605|NCT01285908|20571885|P3|COMPLETED|Treatment Crossover||2
8345606|NCT01285908|20571886|P2|COMPLETED|Treatment Crossover||2
8345607|NCT01285908|20571887|P1|COMPLETED|Treatment Crossover||0
8345608|NCT01285908|20571885|P3|STARTED|Treatment Crossover||2
8345609|NCT01285908|20571886|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
8345610|NCT01285908|20571887|P1|STARTED|Treatment Crossover||0
8345611|NCT01285908|20571885|P3|NOT COMPLETED|Baseline Measurement||0
8345612|NCT01285908|20571886|P2|NOT COMPLETED|Baseline Measurement||0
8345613|NCT01285908|20571887|P1|NOT COMPLETED|Baseline Measurement||3
8345614|NCT01285908|20571885|P3|COMPLETED|Baseline Measurement||0
8345615|NCT01285908|20571886|P2|COMPLETED|Baseline Measurement||0
8345616|NCT01285908|20571887|P1|COMPLETED|Baseline Measurement||3
8345617|NCT01285908|20571885|P3|STARTED|Baseline Measurement||0
8345618|NCT01285908|20571886|P2|STARTED|Baseline Measurement||0
8345619|NCT01285908|20571887|P1|STARTED|Baseline Measurement||6
8345620|NCT01285843|20571921|P2|NOT COMPLETED|Overall Study||2
8345621|NCT01285843|20571922|P1|NOT COMPLETED|Overall Study||2
8345622|NCT01285843|20571921|P2|COMPLETED|Overall Study||18
8345623|NCT01285843|20571922|P1|COMPLETED|Overall Study||18
8345624|NCT01285843|20571921|P2|STARTED|Overall Study||20
8345625|NCT01285843|20571922|P1|STARTED|Overall Study||20
8345626|NCT01285791|20571937|P3|NOT COMPLETED|Overall Study||0
8345627|NCT01285791|20571938|P2|NOT COMPLETED|Overall Study||0
8345628|NCT01285791|20571939|P1|NOT COMPLETED|Overall Study||0
8345629|NCT01285791|20571937|P3|COMPLETED|Overall Study||13
8345630|NCT01285791|20571938|P2|COMPLETED|Overall Study||15
8345631|NCT01285791|20571939|P1|COMPLETED|Overall Study||11
8345632|NCT01285791|20571937|P3|STARTED|Overall Study||13
8345633|NCT01285791|20571938|P2|STARTED|Overall Study||15
8345634|NCT01285791|20571939|P1|STARTED|Overall Study||11
8345635|NCT01285713|20571949|P2|NOT COMPLETED|Overall Study||0
8345636|NCT01285713|20571950|P1|NOT COMPLETED|Overall Study||0
8345637|NCT01285713|20571949|P2|COMPLETED|Overall Study||41
8345638|NCT01285713|20571950|P1|COMPLETED|Overall Study||42
8345639|NCT01285713|20571949|P2|STARTED|Overall Study||41
8345640|NCT01285713|20571950|P1|STARTED|Overall Study||42
8345641|NCT01285635|20571959|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8345642|NCT01285635|20571960|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8345643|NCT01285635|20571961|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8345644|NCT01285635|20571959|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
8345645|NCT01285635|20571960|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
8345646|NCT01285635|20571961|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
8345647|NCT01285635|20571959|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
8345648|NCT01285635|20571960|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
8345649|NCT01285635|20571961|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
8345650|NCT01285635|20571959|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
8345651|NCT01285635|20571960|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8345652|NCT01285635|20571961|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8345653|NCT01285635|20571959|P3|COMPLETED|First Intervention (2 Weeks)||11
8345654|NCT01285635|20571960|P2|COMPLETED|First Intervention (2 Weeks)||11
8345655|NCT01285635|20571961|P1|COMPLETED|First Intervention (2 Weeks)||13
8345656|NCT01285635|20571959|P3|STARTED|First Intervention (2 Weeks)||11
8345657|NCT01285635|20571960|P2|STARTED|First Intervention (2 Weeks)||11
8345658|NCT01285635|20571961|P1|STARTED|First Intervention (2 Weeks)||13
8345659|NCT01285609|20571981|P2|NOT COMPLETED|Treated With Blinded Therapy||359
8345660|NCT01285609|20571982|P1|NOT COMPLETED|Treated With Blinded Therapy||387
8345661|NCT01285609|20571981|P2|COMPLETED|Treated With Blinded Therapy||2
8345662|NCT01285609|20571982|P1|COMPLETED|Treated With Blinded Therapy||1
8345663|NCT01285609|20571981|P2|STARTED|Treated With Blinded Therapy||361
8345664|NCT01285609|20571982|P1|STARTED|Treated With Blinded Therapy||388
8345665|NCT01285609|20571981|P2|NOT COMPLETED|Randomized||116
8345666|NCT01285609|20571982|P1|NOT COMPLETED|Randomized||91
8345667|NCT01285609|20571981|P2|COMPLETED|Randomized||361
8345668|NCT01285609|20571982|P1|COMPLETED|Randomized||388
8345669|NCT01285609|20571981|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
8345670|NCT01285609|20571982|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
8345671|NCT01285609|20571981|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
8345672|NCT01285609|20571982|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
8345673|NCT01285518|20572000|P8|NOT COMPLETED|Overall Study||0
8345674|NCT01285518|20572001|P7|NOT COMPLETED|Overall Study||0
8345675|NCT01285518|20572002|P6|NOT COMPLETED|Overall Study||1
8345676|NCT01285518|20572003|P5|NOT COMPLETED|Overall Study||0
8345677|NCT01285518|20572004|P4|NOT COMPLETED|Overall Study||0
8345678|NCT01285518|20572005|P3|NOT COMPLETED|Overall Study||0
8345679|NCT01285518|20572006|P2|NOT COMPLETED|Overall Study||0
8345680|NCT01285518|20572007|P1|NOT COMPLETED|Overall Study||0
8345681|NCT01285518|20572000|P8|COMPLETED|Overall Study||14
8345682|NCT01285518|20572001|P7|COMPLETED|Overall Study||10
8345683|NCT01285518|20572002|P6|COMPLETED|Overall Study||9
8345684|NCT01285518|20572003|P5|COMPLETED|Overall Study||10
8345685|NCT01285518|20572004|P4|COMPLETED|Overall Study||10
8345686|NCT01285518|20572005|P3|COMPLETED|Overall Study||10
8345687|NCT01285518|20572006|P2|COMPLETED|Overall Study||10
8345688|NCT01285518|20572007|P1|COMPLETED|Overall Study||10
8345689|NCT01285518|20572000|P8|STARTED|Overall Study||14
8345690|NCT01285518|20572001|P7|STARTED|Overall Study||10
8345691|NCT01285518|20572002|P6|STARTED|Overall Study||10
8345692|NCT01285518|20572003|P5|STARTED|Overall Study||10
8345693|NCT01285518|20572004|P4|STARTED|Overall Study||10
8345694|NCT01285518|20572005|P3|STARTED|Overall Study||10
8345695|NCT01285518|20572006|P2|STARTED|Overall Study||10
8345696|NCT01285518|20572007|P1|STARTED|Overall Study||10
8345697|NCT01285492|20572267|P2|NOT COMPLETED|Overall Study||1
8345698|NCT01285492|20572268|P1|NOT COMPLETED|Overall Study||17
8345699|NCT01285492|20572267|P2|COMPLETED|Overall Study||38
8345700|NCT01285492|20572268|P1|COMPLETED|Overall Study||104
8345701|NCT01285492|20572267|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
8345702|NCT01285492|20572268|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
8345703|NCT01285492|20572267|P2|STARTED|Overall Study|All patients randomized to this group|39
8345704|NCT01285492|20572268|P1|STARTED|Overall Study|All patients randomized to this group|121
8345705|NCT01285427|20572286|P1|NOT COMPLETED|Overall Study||1
8345706|NCT01285427|20572286|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
8345707|NCT01285427|20572286|P1|STARTED|Overall Study||300
8345708|NCT01285401|20572300|P2|NOT COMPLETED|Overall Study||29
8345709|NCT01285401|20572301|P1|NOT COMPLETED|Overall Study||17
8345710|NCT01285401|20572300|P2|COMPLETED|Overall Study||88
8345711|NCT01285401|20572301|P1|COMPLETED|Overall Study||98
8345712|NCT01285401|20572300|P2|Treated|Overall Study||116
8345713|NCT01285401|20572301|P1|Treated|Overall Study||113
8345714|NCT01285401|20572300|P2|STARTED|Overall Study||117
8345715|NCT01285401|20572301|P1|STARTED|Overall Study||115
8345716|NCT01285349|20572342|P3|NOT COMPLETED|Overall Study||27
8345717|NCT01285349|20572343|P2|NOT COMPLETED|Overall Study||20
8345718|NCT01285349|20572344|P1|NOT COMPLETED|Overall Study||27
8345719|NCT01285349|20572342|P3|COMPLETED|Overall Study||157
8345720|NCT01285349|20572343|P2|COMPLETED|Overall Study||170
8345721|NCT01285349|20572344|P1|COMPLETED|Overall Study||163
8345722|NCT01285349|20572342|P3|STARTED|Overall Study||184
8345723|NCT01285349|20572343|P2|STARTED|Overall Study||190
8345724|NCT01285349|20572344|P1|STARTED|Overall Study||190
8345725|NCT01285323|20572357|P2|NOT COMPLETED|Overall Study||30
8345726|NCT01285323|20572358|P1|NOT COMPLETED|Overall Study||33
8345727|NCT01285323|20572357|P2|COMPLETED|Overall Study||202
8345728|NCT01285323|20572358|P1|COMPLETED|Overall Study||199
8345729|NCT01285323|20572357|P2|Safety Analysis Set|Overall Study||232
8345730|NCT01285323|20572358|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
8345731|NCT01285323|20572357|P2|Full Analysis Set|Overall Study||232
8345732|NCT01285323|20572358|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
8345733|NCT01285323|20572357|P2|STARTED|Overall Study||232
8345734|NCT01285323|20572358|P1|STARTED|Overall Study||232
8345735|NCT01285310|20572393|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
8345736|NCT01285310|20572394|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
8345737|NCT01285310|20572395|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
8345738|NCT01285310|20572396|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
8345739|NCT01285310|20572397|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
8345740|NCT01285310|20572393|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
8345741|NCT01285310|20572394|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
8345742|NCT01285310|20572395|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
8345743|NCT01285310|20572396|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
8345744|NCT01285310|20572397|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
8345745|NCT01285310|20572393|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
8345746|NCT01285310|20572394|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
8345747|NCT01285310|20572395|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
8345748|NCT01285310|20572396|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
8345749|NCT01285310|20572397|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
8345750|NCT01285310|20572393|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345751|NCT01285310|20572394|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345752|NCT01285310|20572395|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
8345753|NCT01285310|20572396|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
8345754|NCT01285310|20572397|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
8345755|NCT01285310|20572393|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345756|NCT01285310|20572394|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345757|NCT01285310|20572395|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
8345758|NCT01285310|20572396|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
8345759|NCT01285310|20572397|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
8345760|NCT01285310|20572393|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
8345761|NCT01285310|20572394|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
8345762|NCT01285310|20572395|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
8345763|NCT01285310|20572396|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
8345764|NCT01285310|20572397|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
8345765|NCT01285076|20572630|P1|NOT COMPLETED|Overall Study||0
8345766|NCT01285076|20572630|P1|COMPLETED|Overall Study||834
8345767|NCT01285076|20572630|P1|STARTED|Overall Study||834
8345768|NCT01285050|20572643|P1|NOT COMPLETED|Overall Study||1
8345769|NCT01285050|20572643|P1|COMPLETED|Overall Study||19
8345770|NCT01285050|20572643|P1|STARTED|Overall Study||20
8345771|NCT01285024|20572650|P2|NOT COMPLETED|Overall Study||0
8345772|NCT01285024|20572651|P1|NOT COMPLETED|Overall Study||0
8345773|NCT01285024|20572650|P2|COMPLETED|Overall Study||60
8345774|NCT01285024|20572651|P1|COMPLETED|Overall Study||49
8345775|NCT01285024|20572650|P2|STARTED|Overall Study||60
8345776|NCT01285024|20572651|P1|STARTED|Overall Study||49
8345777|NCT01284959|20572662|P3|NOT COMPLETED|Overall Study||1
8345778|NCT01284959|20572663|P2|NOT COMPLETED|Overall Study||0
8345779|NCT01284959|20572664|P1|NOT COMPLETED|Overall Study||1
8345780|NCT01284959|20572662|P3|COMPLETED|Overall Study||10
8345781|NCT01284959|20572663|P2|COMPLETED|Overall Study||12
8345782|NCT01284959|20572664|P1|COMPLETED|Overall Study||10
8345783|NCT01284959|20572662|P3|STARTED|Overall Study||11
8345784|NCT01284959|20572663|P2|STARTED|Overall Study||12
8345785|NCT01284959|20572664|P1|STARTED|Overall Study||11
8345786|NCT01284634|20572694|P4|NOT COMPLETED|Overall Study||1
8345787|NCT01284634|20572695|P3|NOT COMPLETED|Overall Study||2
8345788|NCT01284634|20572696|P2|NOT COMPLETED|Overall Study||0
8345789|NCT01284634|20572697|P1|NOT COMPLETED|Overall Study||1
8345790|NCT01284634|20572694|P4|COMPLETED|Overall Study||4
8345791|NCT01284634|20572695|P3|COMPLETED|Overall Study||5
8345792|NCT01284634|20572696|P2|COMPLETED|Overall Study||6
8345793|NCT01284634|20572697|P1|COMPLETED|Overall Study||6
8345794|NCT01284634|20572694|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
8345795|NCT01284634|20572695|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
8345796|NCT01284634|20572696|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
8345797|NCT01284634|20572697|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
8345798|NCT01284634|20572694|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8345799|NCT01284634|20572695|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
8345800|NCT01284634|20572696|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8345801|NCT01284634|20572697|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8345802|NCT01284634|20572694|P4|STARTED|Overall Study||5
8345803|NCT01284634|20572695|P3|STARTED|Overall Study||7
8345804|NCT01284634|20572696|P2|STARTED|Overall Study||6
8345805|NCT01284634|20572697|P1|STARTED|Overall Study||7
8345806|NCT01284621|20572727|P6|NOT COMPLETED|Third Intervention (8 Days)||0
8345807|NCT01284621|20572728|P5|NOT COMPLETED|Third Intervention (8 Days)||0
8345808|NCT01284621|20572729|P4|NOT COMPLETED|Third Intervention (8 Days)||0
8345809|NCT01284621|20572730|P3|NOT COMPLETED|Third Intervention (8 Days)||0
8345810|NCT01284621|20572731|P2|NOT COMPLETED|Third Intervention (8 Days)||0
8345811|NCT01284621|20572732|P1|NOT COMPLETED|Third Intervention (8 Days)||0
8345812|NCT01284621|20572727|P6|COMPLETED|Third Intervention (8 Days)||4
8345813|NCT01284621|20572728|P5|COMPLETED|Third Intervention (8 Days)||3
8345814|NCT01284621|20572729|P4|COMPLETED|Third Intervention (8 Days)||4
8345815|NCT01284621|20572730|P3|COMPLETED|Third Intervention (8 Days)||4
8345816|NCT01284621|20572731|P2|COMPLETED|Third Intervention (8 Days)||4
8345817|NCT01284621|20572732|P1|COMPLETED|Third Intervention (8 Days)||3
8345818|NCT01284621|20572727|P6|STARTED|Third Intervention (8 Days)||4
8345819|NCT01284621|20572728|P5|STARTED|Third Intervention (8 Days)||3
8345820|NCT01284621|20572729|P4|STARTED|Third Intervention (8 Days)||4
8345821|NCT01284621|20572730|P3|STARTED|Third Intervention (8 Days)||4
8345822|NCT01284621|20572731|P2|STARTED|Third Intervention (8 Days)||4
8345823|NCT01284621|20572732|P1|STARTED|Third Intervention (8 Days)||3
8345824|NCT01284621|20572727|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345825|NCT01284621|20572728|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345826|NCT01284621|20572729|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345827|NCT01284621|20572730|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345828|NCT01284621|20572731|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345829|NCT01284621|20572732|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345830|NCT01284621|20572727|P6|COMPLETED|Washout Period 2 (7 Days)||4
8345831|NCT01284621|20572728|P5|COMPLETED|Washout Period 2 (7 Days)||3
8345832|NCT01284621|20572729|P4|COMPLETED|Washout Period 2 (7 Days)||4
8345833|NCT01284621|20572730|P3|COMPLETED|Washout Period 2 (7 Days)||4
8345834|NCT01284621|20572731|P2|COMPLETED|Washout Period 2 (7 Days)||4
8345835|NCT01284621|20572732|P1|COMPLETED|Washout Period 2 (7 Days)||3
8345836|NCT01284621|20572727|P6|STARTED|Washout Period 2 (7 Days)||4
8345837|NCT01284621|20572728|P5|STARTED|Washout Period 2 (7 Days)||3
8345838|NCT01284621|20572729|P4|STARTED|Washout Period 2 (7 Days)||4
8345839|NCT01284621|20572730|P3|STARTED|Washout Period 2 (7 Days)||4
8345840|NCT01284621|20572731|P2|STARTED|Washout Period 2 (7 Days)||4
8345841|NCT01284621|20572732|P1|STARTED|Washout Period 2 (7 Days)||3
8345842|NCT01284621|20572727|P6|NOT COMPLETED|Second Intervention (8 Days)||0
8345843|NCT01284621|20572728|P5|NOT COMPLETED|Second Intervention (8 Days)||0
8345844|NCT01284621|20572729|P4|NOT COMPLETED|Second Intervention (8 Days)||0
8345845|NCT01284621|20572730|P3|NOT COMPLETED|Second Intervention (8 Days)||0
8345846|NCT01284621|20572731|P2|NOT COMPLETED|Second Intervention (8 Days)||0
8345847|NCT01284621|20572732|P1|NOT COMPLETED|Second Intervention (8 Days)||0
8345848|NCT01284621|20572727|P6|COMPLETED|Second Intervention (8 Days)||4
8345849|NCT01284621|20572728|P5|COMPLETED|Second Intervention (8 Days)||3
8345850|NCT01284621|20572729|P4|COMPLETED|Second Intervention (8 Days)||4
8345851|NCT01284621|20572730|P3|COMPLETED|Second Intervention (8 Days)||4
8345852|NCT01284621|20572731|P2|COMPLETED|Second Intervention (8 Days)||4
8345853|NCT01284621|20572732|P1|COMPLETED|Second Intervention (8 Days)||3
8345854|NCT01284621|20572727|P6|STARTED|Second Intervention (8 Days)||4
8345855|NCT01284621|20572728|P5|STARTED|Second Intervention (8 Days)||3
8345856|NCT01284621|20572729|P4|STARTED|Second Intervention (8 Days)||4
8345857|NCT01284621|20572730|P3|STARTED|Second Intervention (8 Days)||4
8345858|NCT01284621|20572731|P2|STARTED|Second Intervention (8 Days)||4
8345859|NCT01284621|20572732|P1|STARTED|Second Intervention (8 Days)||3
8345860|NCT01284621|20572727|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345861|NCT01284621|20572728|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
8345862|NCT01284621|20572729|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345863|NCT01284621|20572730|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345864|NCT01284621|20572731|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345865|NCT01284621|20572732|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345866|NCT01284621|20572727|P6|COMPLETED|Washout Period 1 (7 Days)||4
8345867|NCT01284621|20572728|P5|COMPLETED|Washout Period 1 (7 Days)||3
8345868|NCT01284621|20572729|P4|COMPLETED|Washout Period 1 (7 Days)||4
8345869|NCT01284621|20572730|P3|COMPLETED|Washout Period 1 (7 Days)||4
8345870|NCT01284621|20572731|P2|COMPLETED|Washout Period 1 (7 Days)||4
8345871|NCT01284621|20572732|P1|COMPLETED|Washout Period 1 (7 Days)||3
8345872|NCT01284621|20572727|P6|STARTED|Washout Period 1 (7 Days)||4
8345873|NCT01284621|20572728|P5|STARTED|Washout Period 1 (7 Days)||4
8345874|NCT01284621|20572729|P4|STARTED|Washout Period 1 (7 Days)||4
8345875|NCT01284621|20572730|P3|STARTED|Washout Period 1 (7 Days)||4
8345876|NCT01284621|20572731|P2|STARTED|Washout Period 1 (7 Days)||4
8345877|NCT01284621|20572732|P1|STARTED|Washout Period 1 (7 Days)||3
8345878|NCT01284621|20572727|P6|NOT COMPLETED|First Intervention (8 Days)||0
8345879|NCT01284621|20572728|P5|NOT COMPLETED|First Intervention (8 Days)||0
8345880|NCT01284621|20572729|P4|NOT COMPLETED|First Intervention (8 Days)||0
8345881|NCT01284621|20572730|P3|NOT COMPLETED|First Intervention (8 Days)||0
8345882|NCT01284621|20572731|P2|NOT COMPLETED|First Intervention (8 Days)||0
8345883|NCT01284621|20572732|P1|NOT COMPLETED|First Intervention (8 Days)||0
8345884|NCT01284621|20572727|P6|COMPLETED|First Intervention (8 Days)||4
8345885|NCT01284621|20572728|P5|COMPLETED|First Intervention (8 Days)||4
8345886|NCT01284621|20572729|P4|COMPLETED|First Intervention (8 Days)||4
8345887|NCT01284621|20572730|P3|COMPLETED|First Intervention (8 Days)||4
8345888|NCT01284621|20572731|P2|COMPLETED|First Intervention (8 Days)||4
8345889|NCT01284621|20572732|P1|COMPLETED|First Intervention (8 Days)||3
8345890|NCT01284621|20572727|P6|STARTED|First Intervention (8 Days)||4
8345891|NCT01284621|20572728|P5|STARTED|First Intervention (8 Days)||4
8345892|NCT01284621|20572729|P4|STARTED|First Intervention (8 Days)||4
8345893|NCT01284621|20572730|P3|STARTED|First Intervention (8 Days)||4
8345894|NCT01284621|20572731|P2|STARTED|First Intervention (8 Days)||4
8345895|NCT01284621|20572732|P1|STARTED|First Intervention (8 Days)||3
8345896|NCT01284517|20572776|P2|NOT COMPLETED|Overall Study||36
8345897|NCT01284517|20572777|P1|NOT COMPLETED|Overall Study||32
8345898|NCT01284517|20572776|P2|COMPLETED|Overall Study||140
8345899|NCT01284517|20572777|P1|COMPLETED|Overall Study||148
8345900|NCT01284517|20572776|P2|STARTED|Overall Study||176
8345901|NCT01284517|20572777|P1|STARTED|Overall Study||180
8345902|NCT01284504|20572789|P2|NOT COMPLETED|Overall Study||0
8345903|NCT01284504|20572790|P1|NOT COMPLETED|Overall Study||0
8345904|NCT01284504|20572789|P2|COMPLETED|Overall Study||0
8345905|NCT01284504|20572790|P1|COMPLETED|Overall Study||0
8345906|NCT01284504|20572789|P2|STARTED|Overall Study||0
8345907|NCT01284504|20572790|P1|STARTED|Overall Study||0
8345908|NCT01284491|20572800|P1|NOT COMPLETED|Overall Study||13
8345909|NCT01284491|20572800|P1|COMPLETED|Overall Study||0
8345910|NCT01284491|20572800|P1|STARTED|Overall Study||13
8345911|NCT01284426|20572806|P1|NOT COMPLETED|Overall Study||2
8345912|NCT01284426|20572806|P1|COMPLETED|Overall Study||92
8345913|NCT01284426|20572806|P1|STARTED|Overall Study||94
8345914|NCT01284361|20572810|P1|NOT COMPLETED|Overall Study||9
8345915|NCT01284361|20572810|P1|COMPLETED|Overall Study||82
8345916|NCT01284361|20572810|P1|STARTED|Overall Study||91
8345917|NCT01284335|20572830|P13|NOT COMPLETED|Overall Study||0
8345918|NCT01284335|20572831|P12|NOT COMPLETED|Overall Study||0
8345919|NCT01284335|20572832|P11|NOT COMPLETED|Overall Study||0
8345920|NCT01284335|20572833|P10|NOT COMPLETED|Overall Study||0
8345921|NCT01284335|20572834|P9|NOT COMPLETED|Overall Study||0
8345922|NCT01284335|20572835|P8|NOT COMPLETED|Overall Study||0
8345923|NCT01284335|20572836|P7|NOT COMPLETED|Overall Study||0
8345924|NCT01284335|20572837|P6|NOT COMPLETED|Overall Study||0
8345925|NCT01284335|20572838|P5|NOT COMPLETED|Overall Study||0
8345926|NCT01284335|20572839|P4|NOT COMPLETED|Overall Study||0
8345927|NCT01284335|20572840|P3|NOT COMPLETED|Overall Study||0
8345928|NCT01284335|20572841|P2|NOT COMPLETED|Overall Study||0
8345929|NCT01284335|20572842|P1|NOT COMPLETED|Overall Study||0
8345930|NCT01284335|20572830|P13|COMPLETED|Overall Study||12
8345931|NCT01284335|20572831|P12|COMPLETED|Overall Study||16
8345932|NCT01284335|20572832|P11|COMPLETED|Overall Study||45
8345933|NCT01284335|20572833|P10|COMPLETED|Overall Study||14
8345934|NCT01284335|20572834|P9|COMPLETED|Overall Study||4
8345935|NCT01284335|20572835|P8|COMPLETED|Overall Study||6
8345936|NCT01284335|20572836|P7|COMPLETED|Overall Study||19
8345937|NCT01284335|20572837|P6|COMPLETED|Overall Study||26
8345938|NCT01284335|20572838|P5|COMPLETED|Overall Study||24
8345939|NCT01284335|20572839|P4|COMPLETED|Overall Study||5
8345940|NCT01284335|20572840|P3|COMPLETED|Overall Study||5
8345941|NCT01284335|20572841|P2|COMPLETED|Overall Study||33
8345942|NCT01284335|20572842|P1|COMPLETED|Overall Study||25
8345943|NCT01284335|20572830|P13|Received at Least One Dose of Study Drug|Overall Study||12
8345944|NCT01284335|20572831|P12|Received at Least One Dose of Study Drug|Overall Study||16
8346121|NCT01283334|20573368|P1|STARTED|Overall Study||20
8345945|NCT01284335|20572832|P11|Received at Least One Dose of Study Drug|Overall Study||45
8345946|NCT01284335|20572833|P10|Received at Least One Dose of Study Drug|Overall Study||14
8345947|NCT01284335|20572834|P9|Received at Least One Dose of Study Drug|Overall Study||4
8345948|NCT01284335|20572835|P8|Received at Least One Dose of Study Drug|Overall Study||6
8345949|NCT01284335|20572836|P7|Received at Least One Dose of Study Drug|Overall Study||19
8345950|NCT01284335|20572837|P6|Received at Least One Dose of Study Drug|Overall Study||26
8345951|NCT01284335|20572838|P5|Received at Least One Dose of Study Drug|Overall Study||24
8345952|NCT01284335|20572839|P4|Received at Least One Dose of Study Drug|Overall Study||5
8345953|NCT01284335|20572840|P3|Received at Least One Dose of Study Drug|Overall Study||5
8345954|NCT01284335|20572841|P2|Received at Least One Dose of Study Drug|Overall Study||33
8345955|NCT01284335|20572842|P1|Received at Least One Dose of Study Drug|Overall Study||25
8345956|NCT01284335|20572830|P13|STARTED|Overall Study||12
8345957|NCT01284335|20572831|P12|STARTED|Overall Study||16
8345958|NCT01284335|20572832|P11|STARTED|Overall Study||45
8345959|NCT01284335|20572833|P10|STARTED|Overall Study||14
8345960|NCT01284335|20572834|P9|STARTED|Overall Study||4
8345961|NCT01284335|20572835|P8|STARTED|Overall Study||6
8345962|NCT01284335|20572836|P7|STARTED|Overall Study||19
8345963|NCT01284335|20572837|P6|STARTED|Overall Study||26
8345964|NCT01284335|20572838|P5|STARTED|Overall Study||24
8345965|NCT01284335|20572839|P4|STARTED|Overall Study||5
8345966|NCT01284335|20572840|P3|STARTED|Overall Study||5
8345967|NCT01284335|20572841|P2|STARTED|Overall Study||33
8345968|NCT01284335|20572842|P1|STARTED|Overall Study||25
8345969|NCT01284296|20572890|P1|NOT COMPLETED|Overall Study||0
8345970|NCT01284296|20572890|P1|COMPLETED|Overall Study||20
8345971|NCT01284296|20572890|P1|STARTED|Overall Study||20
8345972|NCT01284244|20572897|P2|NOT COMPLETED|Overall Study||0
8345973|NCT01284244|20572898|P1|NOT COMPLETED|Overall Study||0
8345974|NCT01284244|20572897|P2|COMPLETED|Overall Study||18
8345975|NCT01284244|20572898|P1|COMPLETED|Overall Study||18
8345976|NCT01284244|20572897|P2|STARTED|Overall Study||18
8345977|NCT01284244|20572898|P1|STARTED|Overall Study||18
8345978|NCT01284140|20572906|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
8345979|NCT01284140|20572907|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
8345980|NCT01284140|20572906|P2|COMPLETED|Subjects With Paired 24hr Collections||5
8345981|NCT01284140|20572907|P1|COMPLETED|Subjects With Paired 24hr Collections||6
8345982|NCT01284140|20572906|P2|STARTED|Subjects With Paired 24hr Collections||11
8345983|NCT01284140|20572907|P1|STARTED|Subjects With Paired 24hr Collections||11
8345984|NCT01284140|20572906|P2|NOT COMPLETED|Randomization and Intervention||0
8345985|NCT01284140|20572907|P1|NOT COMPLETED|Randomization and Intervention||0
8345986|NCT01284140|20572906|P2|COMPLETED|Randomization and Intervention||11
8345987|NCT01284140|20572907|P1|COMPLETED|Randomization and Intervention||11
8345988|NCT01284140|20572906|P2|STARTED|Randomization and Intervention||11
8345989|NCT01284140|20572907|P1|STARTED|Randomization and Intervention||11
8345990|NCT01284127|20572921|P1|NOT COMPLETED|Overall Study||7
8345991|NCT01284127|20572921|P1|COMPLETED|Overall Study||31
8345992|NCT01284127|20572921|P1|STARTED|Overall Study||38
8345993|NCT01284114|20572930|P1|NOT COMPLETED|Overall Study||4
8345994|NCT01284114|20572930|P1|COMPLETED|Overall Study||19
8345995|NCT01284114|20572930|P1|STARTED|Overall Study||23
8345996|NCT01284062|20572942|P4|NOT COMPLETED|Overall Study||14
8345997|NCT01284062|20572943|P3|NOT COMPLETED|Overall Study||6
8345998|NCT01284062|20572944|P2|NOT COMPLETED|Overall Study||8
8345999|NCT01284062|20572945|P1|NOT COMPLETED|Overall Study||11
8346000|NCT01284062|20572942|P4|COMPLETED|Overall Study||7
8346001|NCT01284062|20572943|P3|COMPLETED|Overall Study||15
8346002|NCT01284062|20572944|P2|COMPLETED|Overall Study||13
8346003|NCT01284062|20572945|P1|COMPLETED|Overall Study||10
8346004|NCT01284062|20572942|P4|STARTED|Overall Study||21
8346005|NCT01284062|20572943|P3|STARTED|Overall Study||21
8346006|NCT01284062|20572944|P2|STARTED|Overall Study||21
8346007|NCT01284062|20572945|P1|STARTED|Overall Study||21
8346008|NCT01283971|20573019|P2|NOT COMPLETED|Overall Study||12
8346009|NCT01283971|20573020|P1|NOT COMPLETED|Overall Study||15
8346010|NCT01283971|20573019|P2|COMPLETED|Overall Study||36
8346011|NCT01283971|20573020|P1|COMPLETED|Overall Study||33
8346012|NCT01283971|20573019|P2|Intent to Treat Population|Overall Study||48
8346013|NCT01283971|20573020|P1|Intent to Treat Population|Overall Study||46
8346014|NCT01283971|20573019|P2|STARTED|Overall Study||48
8346015|NCT01283971|20573020|P1|STARTED|Overall Study||48
8346016|NCT01283581|20573067|P3|NOT COMPLETED|Overall Study||20
8346017|NCT01283581|20573068|P2|NOT COMPLETED|Overall Study||14
8346018|NCT01283581|20573069|P1|NOT COMPLETED|Overall Study||12
8346019|NCT01283581|20573067|P3|COMPLETED|Overall Study||78
8346020|NCT01283581|20573068|P2|COMPLETED|Overall Study||63
8346021|NCT01283581|20573069|P1|COMPLETED|Overall Study||69
8346022|NCT01283581|20573067|P3|STARTED|Overall Study||98
8346023|NCT01283581|20573068|P2|STARTED|Overall Study||77
8346024|NCT01283581|20573069|P1|STARTED|Overall Study||81
8346025|NCT01283555|20573095|P2|NOT COMPLETED|Second Intervention||0
8346026|NCT01283555|20573096|P1|NOT COMPLETED|Second Intervention||0
8346027|NCT01283555|20573095|P2|COMPLETED|Second Intervention||12
8346028|NCT01283555|20573096|P1|COMPLETED|Second Intervention||13
8346029|NCT01283555|20573095|P2|STARTED|Second Intervention||12
8346030|NCT01283555|20573096|P1|STARTED|Second Intervention||13
8346031|NCT01283555|20573095|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
8346032|NCT01283555|20573096|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
8346033|NCT01283555|20573095|P2|COMPLETED|Washout Period of at Least 21 Days||12
8346034|NCT01283555|20573096|P1|COMPLETED|Washout Period of at Least 21 Days||13
8346035|NCT01283555|20573095|P2|STARTED|Washout Period of at Least 21 Days||12
8346036|NCT01283555|20573096|P1|STARTED|Washout Period of at Least 21 Days||13
8346037|NCT01283555|20573095|P2|NOT COMPLETED|First Intervention||0
8346038|NCT01283555|20573096|P1|NOT COMPLETED|First Intervention||0
8346039|NCT01283555|20573095|P2|COMPLETED|First Intervention||12
8346040|NCT01283555|20573096|P1|COMPLETED|First Intervention||13
8346041|NCT01283555|20573095|P2|STARTED|First Intervention||12
8346042|NCT01283555|20573096|P1|STARTED|First Intervention||13
8346043|NCT01283542|20573139|P1|NOT COMPLETED|Extension Phase||3
8346044|NCT01283542|20573139|P1|COMPLETED|Extension Phase||10
8346045|NCT01283542|20573139|P1|Safety Analysis Set|Extension Phase||13
8346046|NCT01283542|20573139|P1|Full Analysis Set (FAS)|Extension Phase||13
8346047|NCT01283542|20573139|P1|STARTED|Extension Phase||13
8346048|NCT01283542|20573139|P1|NOT COMPLETED|Main Phase||7
8346049|NCT01283542|20573139|P1|COMPLETED|Main Phase||13
8346050|NCT01283542|20573139|P1|Safety Analysis Set|Main Phase||20
8346051|NCT01283542|20573139|P1|Full Analysis Set (FAS)|Main Phase||20
8346052|NCT01283542|20573139|P1|STARTED|Main Phase||20
8346053|NCT01283516|20573204|P9|NOT COMPLETED|Overall Study||255
8346054|NCT01283516|20573205|P8|NOT COMPLETED|Overall Study||5
8346055|NCT01283516|20573206|P7|NOT COMPLETED|Overall Study||10
8346056|NCT01283516|20573207|P6|NOT COMPLETED|Overall Study||10
8346057|NCT01283516|20573208|P5|NOT COMPLETED|Overall Study||14
8346058|NCT01283516|20573209|P4|NOT COMPLETED|Overall Study||3
8346059|NCT01283516|20573210|P3|NOT COMPLETED|Overall Study||3
8346060|NCT01283516|20573211|P2|NOT COMPLETED|Overall Study||2
8346061|NCT01283516|20573212|P1|NOT COMPLETED|Overall Study||2
8346062|NCT01283516|20573204|P9|COMPLETED|Overall Study||0
8346063|NCT01283516|20573205|P8|COMPLETED|Overall Study||0
8346064|NCT01283516|20573206|P7|COMPLETED|Overall Study||0
8346065|NCT01283516|20573207|P6|COMPLETED|Overall Study||0
8346066|NCT01283516|20573208|P5|COMPLETED|Overall Study||0
8346067|NCT01283516|20573209|P4|COMPLETED|Overall Study||0
8346068|NCT01283516|20573210|P3|COMPLETED|Overall Study||0
8346069|NCT01283516|20573211|P2|COMPLETED|Overall Study||0
8346070|NCT01283516|20573212|P1|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
8346071|NCT01283516|20573204|P9|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
8346072|NCT01283516|20573205|P8|Non-NSCLC|Overall Study||0
8346073|NCT01283516|20573206|P7|Non-NSCLC|Overall Study||1
8346074|NCT01283516|20573207|P6|Non-NSCLC|Overall Study||0
8346075|NCT01283516|20573208|P5|Non-NSCLC|Overall Study||2
8346076|NCT01283516|20573209|P4|Non-NSCLC|Overall Study||0
8346077|NCT01283516|20573210|P3|Non-NSCLC|Overall Study||1
8346078|NCT01283516|20573211|P2|Non-NSCLC|Overall Study||1
8346079|NCT01283516|20573212|P1|Non-NSCLC|Overall Study||0
8346080|NCT01283516|20573204|P9|Dose-Determining Set (DDS)|Overall Study||8
8346081|NCT01283516|20573205|P8|Dose-Determining Set (DDS)|Overall Study||5
8346082|NCT01283516|20573206|P7|Dose-Determining Set (DDS)|Overall Study||10
8346083|NCT01283516|20573207|P6|Dose-Determining Set (DDS)|Overall Study||8
8346084|NCT01283516|20573208|P5|Dose-Determining Set (DDS)|Overall Study||14
8346085|NCT01283516|20573209|P4|Dose-Determining Set (DDS)|Overall Study||3
8346086|NCT01283516|20573210|P3|Dose-Determining Set (DDS)|Overall Study||3
8346087|NCT01283516|20573211|P2|Dose-Determining Set (DDS)|Overall Study||1
8346088|NCT01283516|20573212|P1|Dose-Determining Set (DDS)|Overall Study||2
8346089|NCT01283516|20573204|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
8346090|NCT01283516|20573205|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
8346091|NCT01283516|20573206|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
8346092|NCT01283516|20573207|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
8346093|NCT01283516|20573208|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
8346094|NCT01283516|20573209|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
8346095|NCT01283516|20573210|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
8346096|NCT01283516|20573211|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
8346097|NCT01283516|20573212|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
8346098|NCT01283516|20573204|P9|STARTED|Overall Study||255
8346099|NCT01283516|20573205|P8|STARTED|Overall Study||5
8346100|NCT01283516|20573206|P7|STARTED|Overall Study||10
8346101|NCT01283516|20573207|P6|STARTED|Overall Study||10
8346102|NCT01283516|20573208|P5|STARTED|Overall Study||14
8346103|NCT01283516|20573209|P4|STARTED|Overall Study||3
8346104|NCT01283516|20573210|P3|STARTED|Overall Study||3
8346105|NCT01283516|20573211|P2|STARTED|Overall Study||2
8346106|NCT01283516|20573212|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
8346107|NCT01283464|20573334|P2|NOT COMPLETED|Overall Study||1
8346108|NCT01283464|20573335|P1|NOT COMPLETED|Overall Study||2
8346109|NCT01283464|20573334|P2|COMPLETED|Overall Study||11
8346110|NCT01283464|20573335|P1|COMPLETED|Overall Study||10
8346111|NCT01283464|20573334|P2|STARTED|Overall Study||12
8346112|NCT01283464|20573335|P1|STARTED|Overall Study||12
8346113|NCT01283386|20573343|P2|NOT COMPLETED|Overall Study||12
8346114|NCT01283386|20573344|P1|NOT COMPLETED|Overall Study||8
8346115|NCT01283386|20573343|P2|COMPLETED|Overall Study||4
8346116|NCT01283386|20573344|P1|COMPLETED|Overall Study||2
8346117|NCT01283386|20573343|P2|STARTED|Overall Study||16
8346118|NCT01283386|20573344|P1|STARTED|Overall Study||10
8346119|NCT01283334|20573368|P1|NOT COMPLETED|Overall Study||7
8346120|NCT01283334|20573368|P1|COMPLETED|Overall Study||13
8346122|NCT01283321|20573376|P2|NOT COMPLETED|Overall Study||0
8346123|NCT01283321|20573377|P1|NOT COMPLETED|Overall Study||0
8346124|NCT01283321|20573376|P2|COMPLETED|Overall Study||10
8346125|NCT01283321|20573377|P1|COMPLETED|Overall Study||10
8346126|NCT01283321|20573376|P2|STARTED|Overall Study||10
8346127|NCT01283321|20573377|P1|STARTED|Overall Study||10
8346128|NCT01283282|20573391|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8346129|NCT01283282|20573392|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8346130|NCT01283282|20573391|P2|COMPLETED|Second Intervention (6 Weeks)||19
8346131|NCT01283282|20573392|P1|COMPLETED|Second Intervention (6 Weeks)||22
8346132|NCT01283282|20573391|P2|STARTED|Second Intervention (6 Weeks)||19
8346133|NCT01283282|20573392|P1|STARTED|Second Intervention (6 Weeks)||22
8346134|NCT01283282|20573391|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
8346135|NCT01283282|20573392|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
8346136|NCT01283282|20573391|P2|COMPLETED|First Intervention (6 Weeks)||19
8346137|NCT01283282|20573392|P1|COMPLETED|First Intervention (6 Weeks)||22
8346138|NCT01283282|20573391|P2|STARTED|First Intervention (6 Weeks)||23
8346139|NCT01283282|20573392|P1|STARTED|First Intervention (6 Weeks)||25
8346140|NCT01283152|20573412|P2|NOT COMPLETED|Overall Study||0
8346141|NCT01283152|20573413|P1|NOT COMPLETED|Overall Study||2
8346142|NCT01283152|20573412|P2|COMPLETED|Overall Study||25
8346143|NCT01283152|20573413|P1|COMPLETED|Overall Study||23
8346144|NCT01283152|20573412|P2|24-hr HESA Attempted|Overall Study||25
8346145|NCT01283152|20573413|P1|24-hr HESA Attempted|Overall Study||25
8346146|NCT01283152|20573412|P2|Study Treatment Received|Overall Study||25
8346147|NCT01283152|20573413|P1|Study Treatment Received|Overall Study||25
8346148|NCT01283152|20573412|P2|ITT Population|Overall Study||25
8346149|NCT01283152|20573413|P1|ITT Population|Overall Study||25
8346150|NCT01283152|20573412|P2|STARTED|Overall Study||25
8346151|NCT01283152|20573413|P1|STARTED|Overall Study||25
8346152|NCT01283139|20573427|P4|NOT COMPLETED|Overall Study||15
8346153|NCT01283139|20573428|P3|NOT COMPLETED|Overall Study||18
8346154|NCT01283139|20573429|P2|NOT COMPLETED|Overall Study||18
8346155|NCT01283139|20573430|P1|NOT COMPLETED|Overall Study||17
8346156|NCT01283139|20573427|P4|COMPLETED|Overall Study||92
8346157|NCT01283139|20573428|P3|COMPLETED|Overall Study||91
8346158|NCT01283139|20573429|P2|COMPLETED|Overall Study||90
8346159|NCT01283139|20573430|P1|COMPLETED|Overall Study||91
8346160|NCT01283139|20573427|P4|STARTED|Overall Study||107
8346161|NCT01283139|20573428|P3|STARTED|Overall Study||109
8346162|NCT01283139|20573429|P2|STARTED|Overall Study||108
8346163|NCT01283139|20573430|P1|STARTED|Overall Study||108
8346164|NCT01283035|20573472|P1|NOT COMPLETED|Overall Study||1
8346165|NCT01283035|20573472|P1|COMPLETED|Overall Study||5
8346166|NCT01283035|20573472|P1|STARTED|Overall Study||6
8346167|NCT01283022|20573481|P1|NOT COMPLETED|Overall Study||0
8346168|NCT01283022|20573481|P1|COMPLETED|Overall Study||24
8346169|NCT01283022|20573481|P1|STARTED|Overall Study||24
8346170|NCT01283009|20573489|P2|NOT COMPLETED|Overall Study||117
8346171|NCT01283009|20573490|P1|NOT COMPLETED|Overall Study||118
8346172|NCT01283009|20573489|P2|COMPLETED|Overall Study||180
8346173|NCT01283009|20573490|P1|COMPLETED|Overall Study||169
8346174|NCT01283009|20573489|P2|STARTED|Overall Study||297
8346175|NCT01283009|20573490|P1|STARTED|Overall Study||287
8346176|NCT01282866|20573496|P1|NOT COMPLETED|Overall Study||1
8346177|NCT01282866|20573496|P1|COMPLETED|Overall Study||34
8346178|NCT01282866|20573496|P1|STARTED|Overall Study||35
8346179|NCT01282814|20573504|P2|NOT COMPLETED|Second Intervention||0
8346180|NCT01282814|20573505|P1|NOT COMPLETED|Second Intervention||0
8346181|NCT01282814|20573504|P2|COMPLETED|Second Intervention||9
8346182|NCT01282814|20573505|P1|COMPLETED|Second Intervention||10
8346183|NCT01282814|20573504|P2|STARTED|Second Intervention||9
8346184|NCT01282814|20573505|P1|STARTED|Second Intervention||10
8346185|NCT01282814|20573504|P2|NOT COMPLETED|Washout of 7 Days||0
8346186|NCT01282814|20573505|P1|NOT COMPLETED|Washout of 7 Days||2
8346187|NCT01282814|20573504|P2|COMPLETED|Washout of 7 Days||9
8346188|NCT01282814|20573505|P1|COMPLETED|Washout of 7 Days||10
8346189|NCT01282814|20573504|P2|STARTED|Washout of 7 Days||9
8346190|NCT01282814|20573505|P1|STARTED|Washout of 7 Days||12
8346191|NCT01282814|20573504|P2|NOT COMPLETED|First Intervention||3
8346192|NCT01282814|20573505|P1|NOT COMPLETED|First Intervention||0
8346193|NCT01282814|20573504|P2|COMPLETED|First Intervention||9
8346194|NCT01282814|20573505|P1|COMPLETED|First Intervention||12
8346195|NCT01282814|20573504|P2|STARTED|First Intervention||12
8346196|NCT01282814|20573505|P1|STARTED|First Intervention||12
8346197|NCT01282801|20573517|P2|NOT COMPLETED|Second Intervention||1
8346198|NCT01282801|20573518|P1|NOT COMPLETED|Second Intervention||0
8346199|NCT01282801|20573517|P2|COMPLETED|Second Intervention||8
8346200|NCT01282801|20573518|P1|COMPLETED|Second Intervention||9
8346201|NCT01282801|20573517|P2|STARTED|Second Intervention||9
8346202|NCT01282801|20573518|P1|STARTED|Second Intervention||9
8346203|NCT01282801|20573517|P2|NOT COMPLETED|Washout of 7 Days||0
8346204|NCT01282801|20573518|P1|NOT COMPLETED|Washout of 7 Days||0
8346205|NCT01282801|20573517|P2|COMPLETED|Washout of 7 Days||9
8346206|NCT01282801|20573518|P1|COMPLETED|Washout of 7 Days||9
8346207|NCT01282801|20573517|P2|STARTED|Washout of 7 Days||9
8346208|NCT01282801|20573518|P1|STARTED|Washout of 7 Days||9
8346209|NCT01282801|20573517|P2|NOT COMPLETED|First Intervention||0
8346210|NCT01282801|20573518|P1|NOT COMPLETED|First Intervention||0
8346211|NCT01282801|20573517|P2|COMPLETED|First Intervention||9
8346212|NCT01282801|20573518|P1|COMPLETED|First Intervention||9
8346213|NCT01282801|20573517|P2|STARTED|First Intervention||9
8346214|NCT01282801|20573518|P1|STARTED|First Intervention||9
8346215|NCT01282723|20573534|P1|NOT COMPLETED|Overall Study||0
8346216|NCT01282723|20573534|P1|COMPLETED|Overall Study||20
8346217|NCT01282723|20573534|P1|STARTED|Overall Study||20
8346218|NCT01282710|20573538|P1|NOT COMPLETED|Overall Study||0
8346219|NCT01282710|20573538|P1|COMPLETED|Overall Study||20
8346220|NCT01282710|20573538|P1|STARTED|Overall Study||20
8346221|NCT01282476|20573542|P1|NOT COMPLETED|Overall Study||11
8346222|NCT01282476|20573542|P1|COMPLETED|Overall Study||7
8346223|NCT01282476|20573542|P1|STARTED|Overall Study||18
8346224|NCT01282463|20573551|P3|NOT COMPLETED|Overall Study||4
8346225|NCT01282463|20573552|P2|NOT COMPLETED|Overall Study||4
8346226|NCT01282463|20573553|P1|NOT COMPLETED|Overall Study||8
8346227|NCT01282463|20573551|P3|COMPLETED|Overall Study||46
8346228|NCT01282463|20573552|P2|COMPLETED|Overall Study||45
8346229|NCT01282463|20573553|P1|COMPLETED|Overall Study||41
8346230|NCT01282463|20573551|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
8346231|NCT01282463|20573552|P2|Received at Least 1 Dose of Study Drug|Overall Study||46
8346232|NCT01282463|20573553|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
8346233|NCT01282463|20573551|P3|STARTED|Overall Study||50
8346234|NCT01282463|20573552|P2|STARTED|Overall Study||49
8346235|NCT01282463|20573553|P1|STARTED|Overall Study||49
8346236|NCT01282424|20573591|P1|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
8346237|NCT01282424|20573591|P1|COMPLETED|Long-term Follow-up Period (5 Years)||20
8346238|NCT01282424|20573591|P1|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
8346239|NCT01282424|20573591|P1|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
8346240|NCT01282424|20573591|P1|COMPLETED|Treatment Period (TP) (81 Months)||79
8346241|NCT01282424|20573591|P1|Completed: Death|Treatment Period (TP) (81 Months)||9
8346242|NCT01282424|20573591|P1|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
8346243|NCT01282424|20573591|P1|STARTED|Treatment Period (TP) (81 Months)||125
8346244|NCT01282372|20573608|P1|NOT COMPLETED|Overall Study||79
8346245|NCT01282372|20573608|P1|COMPLETED|Overall Study||421
8346246|NCT01282372|20573608|P1|STARTED|Overall Study||500
8346247|NCT01282294|20573636|P1|NOT COMPLETED|Overall Study||19
8346248|NCT01282294|20573636|P1|COMPLETED|Overall Study||81
8346249|NCT01282294|20573636|P1|12 Months|Overall Study||86
8346250|NCT01282294|20573636|P1|6 Months|Overall Study||94
8346251|NCT01282294|20573636|P1|3 Months|Overall Study||95
8346252|NCT01282294|20573636|P1|6 Weeks|Overall Study||95
8346253|NCT01282294|20573636|P1|Post-operative|Overall Study||99
8346254|NCT01282294|20573636|P1|Intra-operative|Overall Study||99
8346255|NCT01282294|20573636|P1|STARTED|Overall Study||100
8346256|NCT01282242|20573656|P2|NOT COMPLETED|Overall Study||0
8346257|NCT01282242|20573657|P1|NOT COMPLETED|Overall Study||0
8346258|NCT01282242|20573656|P2|COMPLETED|Overall Study||8
8346259|NCT01282242|20573657|P1|COMPLETED|Overall Study||80
8346260|NCT01282242|20573656|P2|STARTED|Overall Study||8
8346261|NCT01282242|20573657|P1|STARTED|Overall Study||80
8346262|NCT01282229|20573665|P1|NOT COMPLETED|Overall Study||2
8346263|NCT01282229|20573665|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
8346264|NCT01282229|20573665|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
8346265|NCT01282216|20573697|P4|NOT COMPLETED|Overall Study||8
8346266|NCT01282216|20573698|P3|NOT COMPLETED|Overall Study||33
8346267|NCT01282216|20573699|P2|NOT COMPLETED|Overall Study||0
8346268|NCT01282216|20573700|P1|NOT COMPLETED|Overall Study||0
8346269|NCT01282216|20573697|P4|COMPLETED|Overall Study||0
8346270|NCT01282216|20573698|P3|COMPLETED|Overall Study||19
8346271|NCT01282216|20573699|P2|COMPLETED|Overall Study||26
8346272|NCT01282216|20573700|P1|COMPLETED|Overall Study||18
8346273|NCT01282216|20573697|P4|STARTED|Overall Study||8
8346274|NCT01282216|20573698|P3|STARTED|Overall Study||52
8346275|NCT01282216|20573699|P2|STARTED|Overall Study||26
8346276|NCT01282216|20573700|P1|STARTED|Overall Study||18
8346277|NCT01282203|20573710|P1|NOT COMPLETED|Overall Study||1
8346278|NCT01282203|20573710|P1|COMPLETED|Overall Study||1121
8346279|NCT01282203|20573710|P1|STARTED|Overall Study||1122
8346280|NCT01282164|20573732|P2|NOT COMPLETED|Overall Study||0
8346281|NCT01282164|20573733|P1|NOT COMPLETED|Overall Study||1
8346282|NCT01282164|20573732|P2|COMPLETED|Overall Study||14
8346283|NCT01282164|20573733|P1|COMPLETED|Overall Study||28
8346284|NCT01282164|20573732|P2|STARTED|Overall Study||14
8346285|NCT01282164|20573733|P1|STARTED|Overall Study||29
8346286|NCT01282138|20573758|P2|NOT COMPLETED|CAPT||0
8346287|NCT01282138|20573759|P1|NOT COMPLETED|CAPT||0
8346288|NCT01282138|20573758|P2|COMPLETED|CAPT||7
8346289|NCT01282138|20573759|P1|COMPLETED|CAPT||6
8346290|NCT01282138|20573758|P2|STARTED|CAPT||7
8346291|NCT01282138|20573759|P1|STARTED|CAPT||6
8346292|NCT01282138|20573758|P2|NOT COMPLETED|EEC||0
8346293|NCT01282138|20573759|P1|NOT COMPLETED|EEC||0
8346294|NCT01282138|20573758|P2|COMPLETED|EEC||7
8346295|NCT01282138|20573759|P1|COMPLETED|EEC||6
8346296|NCT01282138|20573758|P2|STARTED|EEC||7
8346297|NCT01282138|20573759|P1|STARTED|EEC||6
8346298|NCT01282086|20573767|P1|NOT COMPLETED|Overall Study||0
8346299|NCT01282086|20573767|P1|COMPLETED|Overall Study||1365
8346300|NCT01282086|20573767|P1|STARTED|Overall Study||1365
8346301|NCT01281969|20573786|P3|NOT COMPLETED|Overall Study||12
8346302|NCT01281969|20573787|P2|NOT COMPLETED|Overall Study||0
8346303|NCT01281969|20573788|P1|NOT COMPLETED|Overall Study||1
8346304|NCT01281969|20573786|P3|COMPLETED|Overall Study||0
8346305|NCT01281969|20573787|P2|COMPLETED|Overall Study||18
8346306|NCT01281969|20573788|P1|COMPLETED|Overall Study||17
8346307|NCT01281969|20573786|P3|STARTED|Overall Study||12
8346308|NCT01281969|20573787|P2|STARTED|Overall Study||18
8346309|NCT01281969|20573788|P1|STARTED|Overall Study||18
8346310|NCT01281956|20573800|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
8346311|NCT01281956|20573801|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
8346312|NCT01281956|20573800|P2|COMPLETED|2nd Intervention (3 Months)||5
8346313|NCT01281956|20573801|P1|COMPLETED|2nd Intervention (3 Months)||4
8346314|NCT01281956|20573800|P2|STARTED|2nd Intervention (3 Months)||5
8346315|NCT01281956|20573801|P1|STARTED|2nd Intervention (3 Months)||5
8346316|NCT01281956|20573800|P2|NOT COMPLETED|1st Intervention (3 Months)||0
8346317|NCT01281956|20573801|P1|NOT COMPLETED|1st Intervention (3 Months)||0
8346318|NCT01281956|20573800|P2|COMPLETED|1st Intervention (3 Months)||5
8346319|NCT01281956|20573801|P1|COMPLETED|1st Intervention (3 Months)||5
8346320|NCT01281956|20573800|P2|STARTED|1st Intervention (3 Months)||5
8346321|NCT01281956|20573801|P1|STARTED|1st Intervention (3 Months)||5
8346322|NCT01281917|20573832|P1|NOT COMPLETED|Overall Study||1
8346323|NCT01281917|20573832|P1|COMPLETED|Overall Study||39
8346324|NCT01281917|20573832|P1|STARTED|Overall Study||40
8346325|NCT01281865|20573844|P2|NOT COMPLETED|Overall Study||1
8346326|NCT01281865|20573845|P1|NOT COMPLETED|Overall Study||3
8346327|NCT01281865|20573844|P2|COMPLETED|Overall Study||1
8346328|NCT01281865|20573845|P1|COMPLETED|Overall Study||9
8346329|NCT01281865|20573844|P2|STARTED|Overall Study||2
8346330|NCT01281865|20573845|P1|STARTED|Overall Study||12
8346331|NCT01281839|20573853|P2|NOT COMPLETED|Overall Study||14
8346332|NCT01281839|20573854|P1|NOT COMPLETED|Overall Study||10
8346333|NCT01281839|20573853|P2|COMPLETED|Overall Study||119
8346334|NCT01281839|20573854|P1|COMPLETED|Overall Study||250
8346335|NCT01281839|20573853|P2|STARTED|Overall Study||133
8346336|NCT01281839|20573854|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
8346337|NCT01281644|20573915|P1|NOT COMPLETED|Overall Study||5
8346338|NCT01281644|20573915|P1|COMPLETED|Overall Study||18
8346339|NCT01281644|20573915|P1|STARTED|Overall Study||23
8346340|NCT01281501|20573925|P2|NOT COMPLETED|Overall Study||0
8346341|NCT01281501|20573926|P1|NOT COMPLETED|Overall Study||0
8346342|NCT01281501|20573925|P2|COMPLETED|Overall Study||43
8346343|NCT01281501|20573926|P1|COMPLETED|Overall Study||44
8346344|NCT01281501|20573925|P2|STARTED|Overall Study||43
8346345|NCT01281501|20573926|P1|STARTED|Overall Study||44
8346346|NCT01281475|20573940|P2|NOT COMPLETED|Overall Study||8
8346347|NCT01281475|20573941|P1|NOT COMPLETED|Overall Study||4
8346348|NCT01281475|20573940|P2|COMPLETED|Overall Study||26
8346349|NCT01281475|20573941|P1|COMPLETED|Overall Study||29
8346350|NCT01281475|20573940|P2|STARTED|Overall Study||34
8346351|NCT01281475|20573941|P1|STARTED|Overall Study||33
8346352|NCT01281306|20573956|P7|NOT COMPLETED|Overall Study||7
8346353|NCT01281306|20573957|P6|NOT COMPLETED|Overall Study||7
8346354|NCT01281306|20573958|P5|NOT COMPLETED|Overall Study||9
8346355|NCT01281306|20573959|P4|NOT COMPLETED|Overall Study||11
8346356|NCT01281306|20573960|P3|NOT COMPLETED|Overall Study||8
8346357|NCT01281306|20573961|P2|NOT COMPLETED|Overall Study||4
8346358|NCT01281306|20573962|P1|NOT COMPLETED|Overall Study||8
8346359|NCT01281306|20573956|P7|COMPLETED|Overall Study||51
8346360|NCT01281306|20573957|P6|COMPLETED|Overall Study||135
8346361|NCT01281306|20573958|P5|COMPLETED|Overall Study||134
8346362|NCT01281306|20573959|P4|COMPLETED|Overall Study||123
8346363|NCT01281306|20573960|P3|COMPLETED|Overall Study||133
8346364|NCT01281306|20573961|P2|COMPLETED|Overall Study||141
8346365|NCT01281306|20573962|P1|COMPLETED|Overall Study||136
8346366|NCT01281306|20573956|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
8346367|NCT01281306|20573957|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
8346368|NCT01281306|20573958|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
8346369|NCT01281306|20573959|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
8346370|NCT01281306|20573960|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
8346371|NCT01281306|20573961|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
8346372|NCT01281306|20573962|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
8346373|NCT01281306|20573956|P7|Safety Set|Overall Study||58
8346374|NCT01281306|20573957|P6|Safety Set|Overall Study||142
8346375|NCT01281306|20573958|P5|Safety Set|Overall Study||143
8346376|NCT01281306|20573959|P4|Safety Set|Overall Study||133
8346377|NCT01281306|20573960|P3|Safety Set|Overall Study||141
8346378|NCT01281306|20573961|P2|Safety Set|Overall Study||145
8346379|NCT01281306|20573962|P1|Safety Set|Overall Study||143
8346380|NCT01281306|20573956|P7|Full Analysis Set|Overall Study||58
8346381|NCT01281306|20573957|P6|Full Analysis Set|Overall Study||142
8346382|NCT01281306|20573958|P5|Full Analysis Set|Overall Study||143
8346383|NCT01281306|20573959|P4|Full Analysis Set|Overall Study||133
8346384|NCT01281306|20573960|P3|Full Analysis Set|Overall Study||141
8346385|NCT01281306|20573961|P2|Full Analysis Set|Overall Study||145
8346386|NCT01281306|20573962|P1|Full Analysis Set|Overall Study||143
8346387|NCT01281306|20573956|P7|STARTED|Overall Study||58
8346388|NCT01281306|20573957|P6|STARTED|Overall Study||142
8346389|NCT01281306|20573958|P5|STARTED|Overall Study||143
8346390|NCT01281306|20573959|P4|STARTED|Overall Study||134
8346391|NCT01281306|20573960|P3|STARTED|Overall Study||141
8346392|NCT01281306|20573961|P2|STARTED|Overall Study||145
8346393|NCT01281306|20573962|P1|STARTED|Overall Study||144
8346394|NCT01281202|20574078|P2|NOT COMPLETED|Overall Study||36
8346395|NCT01281202|20574079|P1|NOT COMPLETED|Overall Study||28
8346396|NCT01281202|20574078|P2|COMPLETED|Overall Study||68
8346397|NCT01281202|20574079|P1|COMPLETED|Overall Study||75
8346398|NCT01281202|20574078|P2|STARTED|Overall Study||104
8346399|NCT01281202|20574079|P1|STARTED|Overall Study||103
8346400|NCT01281124|20574087|P1|NOT COMPLETED|Overall Study||1
8346401|NCT01281124|20574087|P1|COMPLETED|Overall Study||0
8346402|NCT01281124|20574087|P1|STARTED|Overall Study||1
8346403|NCT01281007|20574095|P2|NOT COMPLETED|Overall Study||8
8346404|NCT01281007|20574096|P1|NOT COMPLETED|Overall Study||4
8346405|NCT01281007|20574095|P2|COMPLETED|Overall Study||67
8346406|NCT01281007|20574096|P1|COMPLETED|Overall Study||71
8346407|NCT01281007|20574095|P2|STARTED|Overall Study||75
8346408|NCT01281007|20574096|P1|STARTED|Overall Study||75
8346409|NCT01280981|20574102|P1|NOT COMPLETED|Overall Study||92
8346410|NCT01280981|20574102|P1|COMPLETED|Overall Study||196
8346411|NCT01280981|20574102|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
8346412|NCT01280981|20574102|P1|STARTED|Overall Study||288
8346413|NCT01280968|20574113|P2|NOT COMPLETED|Overall Study||3
8346414|NCT01280968|20574114|P1|NOT COMPLETED|Overall Study||18
8346415|NCT01280968|20574113|P2|COMPLETED|Overall Study||4
8346416|NCT01280968|20574114|P1|COMPLETED|Overall Study||27
8346417|NCT01280968|20574113|P2|STARTED|Overall Study||7
8346418|NCT01280968|20574114|P1|STARTED|Overall Study||45
8346419|NCT01280955|20574130|P1|NOT COMPLETED|Overall Study||3
8346420|NCT01280955|20574130|P1|COMPLETED|Overall Study||27
8346421|NCT01280955|20574130|P1|STARTED|Overall Study||30
8346422|NCT01280942|20574163|P2|NOT COMPLETED|Overall Study||0
8346423|NCT01280942|20574164|P1|NOT COMPLETED|Overall Study||0
8346424|NCT01280942|20574163|P2|COMPLETED|Overall Study||9911
8346425|NCT01280942|20574164|P1|COMPLETED|Overall Study||10120
8346426|NCT01280942|20574163|P2|STARTED|Overall Study||9911
8346427|NCT01280942|20574164|P1|STARTED|Overall Study||10120
8346428|NCT01280903|20574174|P2|NOT COMPLETED|Overall Study||16
8346429|NCT01280903|20574175|P1|NOT COMPLETED|Overall Study||23
8346430|NCT01280903|20574174|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
8346431|NCT01280903|20574175|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
8346432|NCT01280903|20574174|P2|STARTED|Overall Study||91
8346433|NCT01280903|20574175|P1|STARTED|Overall Study||91
8346434|NCT01280812|20574242|P3|NOT COMPLETED|Overall Study||1
8346435|NCT01280812|20574243|P2|NOT COMPLETED|Overall Study||2
8346436|NCT01280812|20574244|P1|NOT COMPLETED|Overall Study||3
8346437|NCT01280812|20574242|P3|COMPLETED|Overall Study||68
8346438|NCT01280812|20574243|P2|COMPLETED|Overall Study||69
8346439|NCT01280812|20574244|P1|COMPLETED|Overall Study||67
8346440|NCT01280812|20574242|P3|STARTED|Overall Study||69
8346441|NCT01280812|20574243|P2|STARTED|Overall Study||71
8346442|NCT01280812|20574244|P1|STARTED|Overall Study||70
8346443|NCT01280721|20574267|P1|NOT COMPLETED|Overall Study||22
8346444|NCT01280721|20574267|P1|COMPLETED|Overall Study||113
8346445|NCT01280721|20574267|P1|STARTED|Overall Study||135
8346446|NCT01280695|20574287|P5|NOT COMPLETED|Overall Study||2
8346447|NCT01280695|20574288|P4|NOT COMPLETED|Overall Study||4
8346448|NCT01280695|20574289|P3|NOT COMPLETED|Overall Study||5
8346449|NCT01280695|20574290|P2|NOT COMPLETED|Overall Study||1
8346450|NCT01280695|20574291|P1|NOT COMPLETED|Overall Study||0
8346451|NCT01280695|20574287|P5|COMPLETED|Overall Study||24
8346452|NCT01280695|20574288|P4|COMPLETED|Overall Study||22
8346453|NCT01280695|20574289|P3|COMPLETED|Overall Study||21
8346454|NCT01280695|20574290|P2|COMPLETED|Overall Study||24
8346455|NCT01280695|20574291|P1|COMPLETED|Overall Study||26
8346456|NCT01280695|20574287|P5|STARTED|Overall Study||26
8346457|NCT01280695|20574288|P4|STARTED|Overall Study||26
8346458|NCT01280695|20574289|P3|STARTED|Overall Study||26
8346459|NCT01280695|20574290|P2|STARTED|Overall Study||25
8346460|NCT01280695|20574291|P1|STARTED|Overall Study||26
8346461|NCT01280656|20574331|P3|NOT COMPLETED|Overall Study||63
8346462|NCT01280656|20574332|P2|NOT COMPLETED|Overall Study||47
8346463|NCT01280656|20574333|P1|NOT COMPLETED|Overall Study||3
8346464|NCT01280656|20574331|P3|COMPLETED|Overall Study||223
8346465|NCT01280656|20574332|P2|COMPLETED|Overall Study||265
8346466|NCT01280656|20574333|P1|COMPLETED|Overall Study||59
8346467|NCT01280656|20574331|P3|STARTED|Overall Study||286
8346468|NCT01280656|20574332|P2|STARTED|Overall Study||312
8346469|NCT01280656|20574333|P1|STARTED|Overall Study||62
8346470|NCT01280604|20574379|P2|NOT COMPLETED|Overall Study||5
8346471|NCT01280604|20574380|P1|NOT COMPLETED|Overall Study||9
8346472|NCT01280604|20574379|P2|COMPLETED|Overall Study||28
8346473|NCT01280604|20574380|P1|COMPLETED|Overall Study||24
8346474|NCT01280604|20574379|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
8346475|NCT01280604|20574380|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
8346476|NCT01280604|20574379|P2|STARTED|Overall Study||33
8346477|NCT01280604|20574380|P1|STARTED|Overall Study||33
8346478|NCT01280591|20574400|P4|NOT COMPLETED|Overall Study||3
8346479|NCT01280591|20574401|P3|NOT COMPLETED|Overall Study||0
8346480|NCT01280591|20574402|P2|NOT COMPLETED|Overall Study||0
8346481|NCT01280591|20574403|P1|NOT COMPLETED|Overall Study||0
8346482|NCT01280591|20574400|P4|COMPLETED|Overall Study||99
8346483|NCT01280591|20574401|P3|COMPLETED|Overall Study||203
8346484|NCT01280591|20574402|P2|COMPLETED|Overall Study||204
8346485|NCT01280591|20574403|P1|COMPLETED|Overall Study||203
8346486|NCT01280591|20574400|P4|STARTED|Overall Study||102
8346487|NCT01280591|20574401|P3|STARTED|Overall Study||203
8346488|NCT01280591|20574402|P2|STARTED|Overall Study||204
8346489|NCT01280591|20574403|P1|STARTED|Overall Study||203
8346490|NCT01280552|20574495|P2|NOT COMPLETED|Overall Study||1
8346491|NCT01280552|20574496|P1|NOT COMPLETED|Overall Study||6
8346492|NCT01280552|20574495|P2|COMPLETED|Overall Study||42
8346493|NCT01280552|20574496|P1|COMPLETED|Overall Study|Survival is still being assessed|75
8346494|NCT01280552|20574495|P2|STARTED|Overall Study||43
8346495|NCT01280552|20574496|P1|STARTED|Overall Study||81
8346496|NCT01280409|20574510|P2|NOT COMPLETED|Overall Study||19
8346497|NCT01280409|20574511|P1|NOT COMPLETED|Overall Study||16
8346498|NCT01280409|20574510|P2|COMPLETED|Overall Study||36
8346499|NCT01280409|20574511|P1|COMPLETED|Overall Study||43
8346500|NCT01280409|20574510|P2|STARTED|Overall Study||55
8346501|NCT01280409|20574511|P1|STARTED|Overall Study||59
8346502|NCT01280357|20574541|P1|NOT COMPLETED|Overall Study||26
8346503|NCT01280357|20574541|P1|COMPLETED|Overall Study||34
8346504|NCT01280357|20574541|P1|STARTED|Overall Study||60
8346505|NCT01280266|20574550|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
8346506|NCT01280266|20574551|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
8346507|NCT01280266|20574550|P2|COMPLETED|Second Intervention (Week 5-9)||12
8346508|NCT01280266|20574551|P1|COMPLETED|Second Intervention (Week 5-9)||14
8346509|NCT01280266|20574550|P2|STARTED|Second Intervention (Week 5-9)||12
8346510|NCT01280266|20574551|P1|STARTED|Second Intervention (Week 5-9)||14
8346511|NCT01280266|20574550|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
8346512|NCT01280266|20574551|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
8346513|NCT01280266|20574550|P2|COMPLETED|Washout Period (Week 4-5)||12
8346514|NCT01280266|20574551|P1|COMPLETED|Washout Period (Week 4-5)||14
8346515|NCT01280266|20574550|P2|STARTED|Washout Period (Week 4-5)||12
8346516|NCT01280266|20574551|P1|STARTED|Washout Period (Week 4-5)||14
8346517|NCT01280266|20574550|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
8346518|NCT01280266|20574551|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
8346519|NCT01280266|20574550|P2|COMPLETED|First Intervention (Week 1-4)||12
8346520|NCT01280266|20574551|P1|COMPLETED|First Intervention (Week 1-4)||14
8346521|NCT01280266|20574550|P2|STARTED|First Intervention (Week 1-4)||14
8346522|NCT01280266|20574551|P1|STARTED|First Intervention (Week 1-4)||15
8346523|NCT01280201|20574573|P1|NOT COMPLETED|Overall Study||0
8346524|NCT01280201|20574573|P1|COMPLETED|Overall Study||44
8346525|NCT01280201|20574573|P1|STARTED|Overall Study||44
8346526|NCT01280123|20574585|P3|NOT COMPLETED|Overall Study||1
8346527|NCT01280123|20574586|P2|NOT COMPLETED|Overall Study||4
8346528|NCT01280123|20574587|P1|NOT COMPLETED|Overall Study||1
8346529|NCT01280123|20574585|P3|COMPLETED|Overall Study||70
8346530|NCT01280123|20574586|P2|COMPLETED|Overall Study||63
8346531|NCT01280123|20574587|P1|COMPLETED|Overall Study||71
8346532|NCT01280123|20574585|P3|STARTED|Overall Study||71
8346533|NCT01280123|20574586|P2|STARTED|Overall Study||67
8346534|NCT01280123|20574587|P1|STARTED|Overall Study||72
8346535|NCT01280110|20574612|P2|NOT COMPLETED|Overall Study||0
8346536|NCT01280110|20574613|P1|NOT COMPLETED|Overall Study||0
8346537|NCT01280110|20574612|P2|COMPLETED|Overall Study||22
8346538|NCT01280110|20574613|P1|COMPLETED|Overall Study||22
8346539|NCT01280110|20574612|P2|STARTED|Overall Study||22
8346540|NCT01280110|20574613|P1|STARTED|Overall Study||22
8346541|NCT01280058|20574623|P2|NOT COMPLETED|Overall Study||0
8346542|NCT01280058|20574624|P1|NOT COMPLETED|Overall Study||0
8346543|NCT01280058|20574623|P2|COMPLETED|Overall Study||37
8346544|NCT01280058|20574624|P1|COMPLETED|Overall Study||36
8346545|NCT01280058|20574623|P2|STARTED|Overall Study||37
8346546|NCT01280058|20574624|P1|STARTED|Overall Study||36
8346547|NCT01279954|20574642|P2|NOT COMPLETED|Overall Study||4
8346548|NCT01279954|20574643|P1|NOT COMPLETED|Overall Study||3
8346549|NCT01279954|20574642|P2|COMPLETED|Overall Study||1
8346550|NCT01279954|20574643|P1|COMPLETED|Overall Study||2
8346551|NCT01279954|20574642|P2|STARTED|Overall Study||5
8346552|NCT01279954|20574643|P1|STARTED|Overall Study||5
8346553|NCT01279850|20574654|P1|NOT COMPLETED|Overall Study||91
8346554|NCT01279850|20574654|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
8346555|NCT01279850|20574654|P1|STARTED|Overall Study||891
8346556|NCT01279681|20574670|P2|NOT COMPLETED|Overall Study||17
8346557|NCT01279681|20574671|P1|NOT COMPLETED|Overall Study||15
8346558|NCT01279681|20574670|P2|COMPLETED|Overall Study||0
8346559|NCT01279681|20574671|P1|COMPLETED|Overall Study||0
8346560|NCT01279681|20574670|P2|STARTED|Overall Study||17
8346561|NCT01279681|20574671|P1|STARTED|Overall Study||15
8346562|NCT01279616|20574683|P1|NOT COMPLETED|Overall Study||7
8346563|NCT01279616|20574683|P1|COMPLETED|Overall Study||1
8346564|NCT01279616|20574683|P1|STARTED|Overall Study||8
8346565|NCT01279564|20574689|P2|NOT COMPLETED|Overall Study||0
8346566|NCT01279564|20574690|P1|NOT COMPLETED|Overall Study||0
8346567|NCT01279564|20574689|P2|COMPLETED|Overall Study||32
8346568|NCT01279564|20574690|P1|COMPLETED|Overall Study||40
8346569|NCT01279564|20574689|P2|STARTED|Overall Study||32
8346570|NCT01279564|20574690|P1|STARTED|Overall Study||40
8346571|NCT01279486|20574696|P1|NOT COMPLETED|Overall Study||1
8346572|NCT01279486|20574696|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
8346573|NCT01279486|20574696|P1|STARTED|Overall Study||120
8346574|NCT01279447|20574702|P2|NOT COMPLETED|Overall Study||1
8346575|NCT01279447|20574703|P1|NOT COMPLETED|Overall Study||3
8346576|NCT01279447|20574702|P2|COMPLETED|Overall Study||33
8346577|NCT01279447|20574703|P1|COMPLETED|Overall Study||31
8346578|NCT01279447|20574702|P2|STARTED|Overall Study||34
8346579|NCT01279447|20574703|P1|STARTED|Overall Study||34
8346580|NCT01279343|20574711|P2|NOT COMPLETED|Overall Study||6
8346581|NCT01279343|20574712|P1|NOT COMPLETED|Overall Study||2
8346582|NCT01279343|20574711|P2|COMPLETED|Overall Study||58
8346583|NCT01279343|20574712|P1|COMPLETED|Overall Study||57
8346584|NCT01279343|20574711|P2|STARTED|Overall Study||64
8346585|NCT01279343|20574712|P1|STARTED|Overall Study||59
8346586|NCT01279317|20574736|P2|NOT COMPLETED|Period 2||0
8346587|NCT01279317|20574737|P1|NOT COMPLETED|Period 2||0
8346588|NCT01279317|20574736|P2|COMPLETED|Period 2||6
8346589|NCT01279317|20574737|P1|COMPLETED|Period 2||6
8346590|NCT01279317|20574736|P2|STARTED|Period 2||6
8346591|NCT01279317|20574737|P1|STARTED|Period 2||6
8346592|NCT01279317|20574736|P2|NOT COMPLETED|Washout||0
8346593|NCT01279317|20574737|P1|NOT COMPLETED|Washout||0
8346594|NCT01279317|20574736|P2|COMPLETED|Washout||6
8346595|NCT01279317|20574737|P1|COMPLETED|Washout||6
8346596|NCT01279317|20574736|P2|STARTED|Washout||6
8346597|NCT01279317|20574737|P1|STARTED|Washout||6
8346598|NCT01279317|20574736|P2|NOT COMPLETED|Period 1||0
8346599|NCT01279317|20574737|P1|NOT COMPLETED|Period 1||0
8346600|NCT01279317|20574736|P2|COMPLETED|Period 1||6
8346601|NCT01279317|20574737|P1|COMPLETED|Period 1||6
8346602|NCT01279317|20574736|P2|STARTED|Period 1||6
8346603|NCT01279317|20574737|P1|STARTED|Period 1||6
8346604|NCT01279265|20574744|P2|NOT COMPLETED|Overall Study||6
8346605|NCT01279265|20574745|P1|NOT COMPLETED|Overall Study||4
8346606|NCT01279265|20574744|P2|COMPLETED|Overall Study||11
8346607|NCT01279265|20574745|P1|COMPLETED|Overall Study||9
8346608|NCT01279265|20574744|P2|STARTED|Overall Study||17
8346609|NCT01279265|20574745|P1|STARTED|Overall Study||13
8346610|NCT01279200|20574757|P2|NOT COMPLETED|Overall Study||7
8346611|NCT01279200|20574758|P1|NOT COMPLETED|Overall Study||2
8346612|NCT01279200|20574757|P2|COMPLETED|Overall Study||4
8346613|NCT01279200|20574758|P1|COMPLETED|Overall Study||8
8346614|NCT01279200|20574757|P2|STARTED|Overall Study||11
8346615|NCT01279200|20574758|P1|STARTED|Overall Study||10
8346616|NCT01279187|20574768|P2|NOT COMPLETED|Overall Study||0
8346617|NCT01279187|20574769|P1|NOT COMPLETED|Overall Study||0
8346618|NCT01279187|20574768|P2|COMPLETED|Overall Study||13
8346619|NCT01279187|20574769|P1|COMPLETED|Overall Study||14
8346620|NCT01279187|20574768|P2|STARTED|Overall Study||13
8346621|NCT01279187|20574769|P1|STARTED|Overall Study||14
8346622|NCT01279109|20574785|P2|NOT COMPLETED|Overall Study||12
8346623|NCT01279109|20574786|P1|NOT COMPLETED|Overall Study||13
8346624|NCT01279109|20574785|P2|COMPLETED|Overall Study||55
8346625|NCT01279109|20574786|P1|COMPLETED|Overall Study||55
8346626|NCT01279109|20574785|P2|STARTED|Overall Study||67
8346627|NCT01279109|20574786|P1|STARTED|Overall Study||68
8346628|NCT01279070|20574796|P2|NOT COMPLETED|Overall Study||4
8346629|NCT01279070|20574797|P1|NOT COMPLETED|Overall Study||5
8346630|NCT01279070|20574796|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
8346631|NCT01279070|20574797|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
8346632|NCT01279070|20574796|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
8346633|NCT01279070|20574797|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
8346634|NCT01279044|20574816|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
8346635|NCT01279044|20574817|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
8346636|NCT01279044|20574818|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
8346637|NCT01279044|20574816|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
8346638|NCT01279044|20574817|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
8346639|NCT01279044|20574818|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
8346640|NCT01279044|20574816|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
8346641|NCT01279044|20574817|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
8346642|NCT01279044|20574818|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
8346643|NCT01279044|20574816|P3|NOT COMPLETED|PHASE 1 - Formative||0
8346644|NCT01279044|20574817|P2|NOT COMPLETED|PHASE 1 - Formative||0
8346645|NCT01279044|20574818|P1|NOT COMPLETED|PHASE 1 - Formative||0
8346646|NCT01279044|20574816|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346647|NCT01279044|20574817|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346648|NCT01279044|20574818|P1|COMPLETED|PHASE 1 - Formative||59
8346649|NCT01279044|20574816|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346650|NCT01279044|20574817|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346651|NCT01279044|20574818|P1|STARTED|PHASE 1 - Formative||59
8346652|NCT01278953|20574838|P2|NOT COMPLETED|Overall Study||11
8346653|NCT01278953|20574839|P1|NOT COMPLETED|Overall Study||9
8346654|NCT01278953|20574838|P2|COMPLETED|Overall Study||134
8346655|NCT01278953|20574839|P1|COMPLETED|Overall Study||146
8346656|NCT01278953|20574838|P2|STARTED|Overall Study||145
8346657|NCT01278953|20574839|P1|STARTED|Overall Study||155
8346658|NCT01278927|20574851|P4|NOT COMPLETED|Overall Study||0
8346659|NCT01278927|20574852|P3|NOT COMPLETED|Overall Study||0
8346660|NCT01278927|20574853|P2|NOT COMPLETED|Overall Study||0
8346661|NCT01278927|20574854|P1|NOT COMPLETED|Overall Study||0
8346662|NCT01278927|20574851|P4|COMPLETED|Overall Study||175
8346663|NCT01278927|20574852|P3|COMPLETED|Overall Study||178
8346664|NCT01278927|20574853|P2|COMPLETED|Overall Study||178
8346665|NCT01278927|20574854|P1|COMPLETED|Overall Study||180
8346666|NCT01278927|20574851|P4|STARTED|Overall Study||175
8346667|NCT01278927|20574852|P3|STARTED|Overall Study||178
8346668|NCT01278927|20574853|P2|STARTED|Overall Study||178
8346669|NCT01278927|20574854|P1|STARTED|Overall Study||180
8346670|NCT01278862|20574894|P2|NOT COMPLETED|Overall Study||1
8346671|NCT01278862|20574895|P1|NOT COMPLETED|Overall Study||1
8346672|NCT01278862|20574894|P2|COMPLETED|Overall Study||42
8346673|NCT01278862|20574895|P1|COMPLETED|Overall Study||44
8346674|NCT01278862|20574894|P2|STARTED|Overall Study||43
8346675|NCT01278862|20574895|P1|STARTED|Overall Study||45
8346676|NCT01278797|20574903|P2|NOT COMPLETED|Period 2||0
8346677|NCT01278797|20574904|P1|NOT COMPLETED|Period 2||0
8346678|NCT01278797|20574903|P2|COMPLETED|Period 2||13
8346679|NCT01278797|20574904|P1|COMPLETED|Period 2||13
8346680|NCT01278797|20574903|P2|STARTED|Period 2||13
8346681|NCT01278797|20574904|P1|STARTED|Period 2||13
8346682|NCT01278797|20574903|P2|NOT COMPLETED|Washout Period of 21 Days||0
8346683|NCT01278797|20574904|P1|NOT COMPLETED|Washout Period of 21 Days||0
8346684|NCT01278797|20574903|P2|COMPLETED|Washout Period of 21 Days||13
8346685|NCT01278797|20574904|P1|COMPLETED|Washout Period of 21 Days||13
8346686|NCT01278797|20574903|P2|STARTED|Washout Period of 21 Days||13
8346687|NCT01278797|20574904|P1|STARTED|Washout Period of 21 Days||13
8346688|NCT01278797|20574903|P2|NOT COMPLETED|Period 1||1
8346689|NCT01278797|20574904|P1|NOT COMPLETED|Period 1||1
8346690|NCT01278797|20574903|P2|COMPLETED|Period 1||13
8346691|NCT01278797|20574904|P1|COMPLETED|Period 1||13
8346692|NCT01278797|20574903|P2|STARTED|Period 1||14
8346693|NCT01278797|20574904|P1|STARTED|Period 1||14
8346694|NCT01278745|20574916|P4|NOT COMPLETED|Overall Study||78
8346695|NCT01278745|20574917|P3|NOT COMPLETED|Overall Study||121
8346696|NCT01278745|20574918|P2|NOT COMPLETED|Overall Study||6
8346697|NCT01278745|20574919|P1|NOT COMPLETED|Overall Study||5
8346698|NCT01278745|20574916|P4|COMPLETED|Overall Study||0
8346699|NCT01278745|20574917|P3|COMPLETED|Overall Study||0
8346700|NCT01278745|20574918|P2|COMPLETED|Overall Study||68
8346701|NCT01278745|20574919|P1|COMPLETED|Overall Study||84
8346702|NCT01278745|20574916|P4|STARTED|Overall Study||78
8346703|NCT01278745|20574917|P3|STARTED|Overall Study||121
8346704|NCT01278745|20574918|P2|STARTED|Overall Study||74
8346705|NCT01278745|20574919|P1|STARTED|Overall Study||89
8346706|NCT01278615|20574951|P1|NOT COMPLETED|Overall Study||2
8346707|NCT01278615|20574951|P1|COMPLETED|Overall Study||14
8346708|NCT01278615|20574951|P1|STARTED|Overall Study||16
8346709|NCT01278485|20574961|P1|NOT COMPLETED|Overall Study||0
8346710|NCT01278485|20574961|P1|COMPLETED|Overall Study||719
8346711|NCT01278485|20574961|P1|STARTED|Overall Study||719
8346712|NCT01278407|20574977|P5|NOT COMPLETED|Extension Phase||30
8346713|NCT01278407|20574978|P4|NOT COMPLETED|Extension Phase||12
8346714|NCT01278407|20574979|P3|NOT COMPLETED|Extension Phase||0
8346715|NCT01278407|20574980|P2|NOT COMPLETED|Extension Phase||0
8346716|NCT01278407|20574981|P1|NOT COMPLETED|Extension Phase||0
8346717|NCT01278407|20574977|P5|COMPLETED|Extension Phase||66
8346718|NCT01278407|20574978|P4|COMPLETED|Extension Phase||34
8346719|NCT01278407|20574979|P3|COMPLETED|Extension Phase||0
8346720|NCT01278407|20574980|P2|COMPLETED|Extension Phase||0
8346721|NCT01278407|20574981|P1|COMPLETED|Extension Phase||0
8346722|NCT01278407|20574977|P5|STARTED|Extension Phase||96
8346723|NCT01278407|20574978|P4|STARTED|Extension Phase||46
8346724|NCT01278407|20574979|P3|STARTED|Extension Phase||0
8346725|NCT01278407|20574980|P2|STARTED|Extension Phase||0
8346726|NCT01278407|20574981|P1|STARTED|Extension Phase||0
8346727|NCT01278407|20574977|P5|NOT COMPLETED|Confirmatory Phase||0
8346728|NCT01278407|20574978|P4|NOT COMPLETED|Confirmatory Phase||0
8346729|NCT01278407|20574979|P3|NOT COMPLETED|Confirmatory Phase||6
8346730|NCT01278407|20574980|P2|NOT COMPLETED|Confirmatory Phase||16
8346731|NCT01278407|20574981|P1|NOT COMPLETED|Confirmatory Phase||9
8346732|NCT01278407|20574977|P5|COMPLETED|Confirmatory Phase||0
8346733|NCT01278407|20574978|P4|COMPLETED|Confirmatory Phase||0
8346734|NCT01278407|20574979|P3|COMPLETED|Confirmatory Phase||43
8346735|NCT01278407|20574980|P2|COMPLETED|Confirmatory Phase||31
8346736|NCT01278407|20574981|P1|COMPLETED|Confirmatory Phase||37
8346737|NCT01278407|20574977|P5|STARTED|Confirmatory Phase||0
8346738|NCT01278407|20574978|P4|STARTED|Confirmatory Phase||0
8346739|NCT01278407|20574979|P3|STARTED|Confirmatory Phase||49
8346740|NCT01278407|20574980|P2|STARTED|Confirmatory Phase||47
8346741|NCT01278407|20574981|P1|STARTED|Confirmatory Phase||46
8346742|NCT01278394|20574994|P1|NOT COMPLETED|Overall Study||1
8346743|NCT01278394|20574994|P1|COMPLETED|Overall Study||28
8346744|NCT01278394|20574994|P1|STARTED|Overall Study||29
8346745|NCT01278342|20575007|P3|NOT COMPLETED|Overall Study||0
8346746|NCT01278342|20575008|P2|NOT COMPLETED|Overall Study||1
8346747|NCT01278342|20575009|P1|NOT COMPLETED|Overall Study||4
8346748|NCT01278342|20575007|P3|COMPLETED|Overall Study||32
8346749|NCT01278342|20575008|P2|COMPLETED|Overall Study||30
8346750|NCT01278342|20575009|P1|COMPLETED|Overall Study||3
8346751|NCT01278342|20575007|P3|STARTED|Overall Study||32
8346752|NCT01278342|20575008|P2|STARTED|Overall Study||31
8346753|NCT01278342|20575009|P1|STARTED|Overall Study||7
8346754|NCT01278303|20575023|P1|NOT COMPLETED|Overall Study||0
8346755|NCT01278303|20575023|P1|COMPLETED|Overall Study||82
8346756|NCT01278303|20575023|P1|STARTED|Overall Study||82
8346757|NCT01278173|20575029|P1|NOT COMPLETED|Overall Study||27
8346758|NCT01278173|20575029|P1|COMPLETED|Overall Study||38
8346759|NCT01278173|20575029|P1|STARTED|Overall Study||65
8346760|NCT01278160|20575036|P2|NOT COMPLETED|Overall Study||6
8346761|NCT01278160|20575037|P1|NOT COMPLETED|Overall Study||5
8346762|NCT01278160|20575036|P2|COMPLETED|Overall Study||84
8346763|NCT01278160|20575037|P1|COMPLETED|Overall Study||84
8346764|NCT01278160|20575036|P2|STARTED|Overall Study||90
8346765|NCT01278160|20575037|P1|STARTED|Overall Study||89
8346766|NCT01278030|20575053|P2|NOT COMPLETED|Overall Study||4
8346767|NCT01278030|20575054|P1|NOT COMPLETED|Overall Study||8
8346768|NCT01278030|20575053|P2|COMPLETED|Overall Study||31
8346769|NCT01278030|20575054|P1|COMPLETED|Overall Study||35
8346770|NCT01278030|20575053|P2|STARTED|Overall Study||35
8346771|NCT01278030|20575054|P1|STARTED|Overall Study||43
8346772|NCT01277887|20575062|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
8346773|NCT01277887|20575063|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
8346774|NCT01277887|20575062|P2|COMPLETED|Post-Quit Treatment Phase||5
8346775|NCT01277887|20575063|P1|COMPLETED|Post-Quit Treatment Phase||3
8346776|NCT01277887|20575062|P2|STARTED|Post-Quit Treatment Phase||10
8346777|NCT01277887|20575063|P1|STARTED|Post-Quit Treatment Phase||6
8346778|NCT01277887|20575062|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
8346779|NCT01277887|20575063|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
8346780|NCT01277887|20575062|P2|COMPLETED|Pre-Quit Treatment Phase||10
8346781|NCT01277887|20575063|P1|COMPLETED|Pre-Quit Treatment Phase||6
8346782|NCT01277887|20575062|P2|Entered Study|Pre-Quit Treatment Phase||10
8346783|NCT01277887|20575063|P1|Entered Study|Pre-Quit Treatment Phase||7
8346784|NCT01277887|20575062|P2|STARTED|Pre-Quit Treatment Phase||10
8346785|NCT01277887|20575063|P1|STARTED|Pre-Quit Treatment Phase||9
8346786|NCT01277861|20575075|P2|NOT COMPLETED|Overall Study||2
8346787|NCT01277861|20575076|P1|NOT COMPLETED|Overall Study||2
8346788|NCT01277861|20575075|P2|COMPLETED|Overall Study||47
8346789|NCT01277861|20575076|P1|COMPLETED|Overall Study||49
8346790|NCT01277861|20575075|P2|STARTED|Overall Study||49
8346791|NCT01277861|20575076|P1|STARTED|Overall Study||51
8346792|NCT01277822|20575088|P2|NOT COMPLETED|Overall Study||11
8346793|NCT01277822|20575089|P1|NOT COMPLETED|Overall Study||15
8346794|NCT01277822|20575088|P2|COMPLETED|Overall Study||155
8346795|NCT01277822|20575089|P1|COMPLETED|Overall Study||153
8346796|NCT01277822|20575088|P2|STARTED|Overall Study||166
8346797|NCT01277822|20575089|P1|STARTED|Overall Study||168
8346798|NCT01277783|20575109|P1|NOT COMPLETED|Overall Study||0
8346799|NCT01277783|20575109|P1|COMPLETED|Overall Study||138
8346800|NCT01277783|20575109|P1|STARTED|Overall Study||138
8346801|NCT01277757|20575125|P1|NOT COMPLETED|Overall Study||2
8346802|NCT01277757|20575125|P1|COMPLETED|Overall Study||28
8346803|NCT01277757|20575125|P1|STARTED|Overall Study||30
8346804|NCT01277744|20575132|P1|NOT COMPLETED|Overall Study||2
8346805|NCT01277744|20575132|P1|COMPLETED|Overall Study||20
8346806|NCT01277744|20575132|P1|STARTED|Overall Study||22
8346807|NCT01277718|20575137|P2|NOT COMPLETED|Period 3 - Third Intervention||0
8346808|NCT01277718|20575138|P1|NOT COMPLETED|Period 3 - Third Intervention||0
8346809|NCT01277718|20575137|P2|COMPLETED|Period 3 - Third Intervention||7
8346810|NCT01277718|20575138|P1|COMPLETED|Period 3 - Third Intervention||10
8346811|NCT01277718|20575137|P2|STARTED|Period 3 - Third Intervention||7
8346812|NCT01277718|20575138|P1|STARTED|Period 3 - Third Intervention||10
8346813|NCT01277718|20575137|P2|NOT COMPLETED|Washout Period of 13 Days||0
8346814|NCT01277718|20575138|P1|NOT COMPLETED|Washout Period of 13 Days||0
8346815|NCT01277718|20575137|P2|COMPLETED|Washout Period of 13 Days||7
8346816|NCT01277718|20575138|P1|COMPLETED|Washout Period of 13 Days||10
8346817|NCT01277718|20575137|P2|STARTED|Washout Period of 13 Days||7
8346818|NCT01277718|20575138|P1|STARTED|Washout Period of 13 Days||10
8346819|NCT01277718|20575137|P2|NOT COMPLETED|Period 2 - Second Intervention||3
8346820|NCT01277718|20575138|P1|NOT COMPLETED|Period 2 - Second Intervention||0
8346821|NCT01277718|20575137|P2|COMPLETED|Period 2 - Second Intervention||7
8346822|NCT01277718|20575138|P1|COMPLETED|Period 2 - Second Intervention||10
8346823|NCT01277718|20575137|P2|STARTED|Period 2 - Second Intervention||10
8346824|NCT01277718|20575138|P1|STARTED|Period 2 - Second Intervention||10
8346825|NCT01277718|20575137|P2|NOT COMPLETED|Washout Period of 13 Days||0
8346826|NCT01277718|20575138|P1|NOT COMPLETED|Washout Period of 13 Days||0
8346827|NCT01277718|20575137|P2|COMPLETED|Washout Period of 13 Days||10
8346828|NCT01277718|20575138|P1|COMPLETED|Washout Period of 13 Days||10
8346829|NCT01277718|20575137|P2|STARTED|Washout Period of 13 Days||10
8346830|NCT01277718|20575138|P1|STARTED|Washout Period of 13 Days||10
8346831|NCT01277718|20575137|P2|NOT COMPLETED|Period 1 - First Intervention||0
8346832|NCT01277718|20575138|P1|NOT COMPLETED|Period 1 - First Intervention||0
8346833|NCT01277718|20575137|P2|COMPLETED|Period 1 - First Intervention||10
8346834|NCT01277718|20575138|P1|COMPLETED|Period 1 - First Intervention||10
8346835|NCT01277718|20575137|P2|STARTED|Period 1 - First Intervention||10
8346836|NCT01277718|20575138|P1|STARTED|Period 1 - First Intervention||10
8346837|NCT01277666|20575152|P3|NOT COMPLETED|Overall Study||49
8346838|NCT01277666|20575153|P2|NOT COMPLETED|Overall Study||59
8346839|NCT01277666|20575154|P1|NOT COMPLETED|Overall Study||45
8346840|NCT01277666|20575152|P3|COMPLETED|Overall Study||153
8346841|NCT01277666|20575153|P2|COMPLETED|Overall Study||144
8346842|NCT01277666|20575154|P1|COMPLETED|Overall Study||158
8346843|NCT01277666|20575152|P3|STARTED|Overall Study||202
8346844|NCT01277666|20575153|P2|STARTED|Overall Study||203
8346845|NCT01277666|20575154|P1|STARTED|Overall Study||203
8346846|NCT01277601|20575187|P4|NOT COMPLETED|Overall Study||36
8346847|NCT01277601|20575188|P3|NOT COMPLETED|Overall Study||27
8346848|NCT01277601|20575189|P2|NOT COMPLETED|Overall Study||48
8346849|NCT01277601|20575190|P1|NOT COMPLETED|Overall Study||37
8346850|NCT01277601|20575187|P4|COMPLETED|Overall Study||150
8346851|NCT01277601|20575188|P3|COMPLETED|Overall Study||163
8346852|NCT01277601|20575189|P2|COMPLETED|Overall Study||139
8346853|NCT01277601|20575190|P1|COMPLETED|Overall Study||151
8346854|NCT01277601|20575187|P4|STARTED|Overall Study||186
8346855|NCT01277601|20575188|P3|STARTED|Overall Study||190
8346856|NCT01277601|20575189|P2|STARTED|Overall Study||187
8346857|NCT01277601|20575190|P1|STARTED|Overall Study||188
8346858|NCT01277549|20575281|P2|NOT COMPLETED|Overall Study||14
8346859|NCT01277549|20575282|P1|NOT COMPLETED|Overall Study||26
8346860|NCT01277549|20575281|P2|COMPLETED|Overall Study||15
8346861|NCT01277549|20575282|P1|COMPLETED|Overall Study||15
8346862|NCT01277549|20575281|P2|STARTED|Overall Study||29
8346863|NCT01277549|20575282|P1|STARTED|Overall Study||41
8346864|NCT01277523|20575299|P3|NOT COMPLETED|Overall Study||0
8346865|NCT01277523|20575300|P2|NOT COMPLETED|Overall Study||1
8346866|NCT01277523|20575301|P1|NOT COMPLETED|Overall Study||3
8346867|NCT01277523|20575299|P3|COMPLETED|Overall Study||130
8346868|NCT01277523|20575300|P2|COMPLETED|Overall Study||126
8346869|NCT01277523|20575301|P1|COMPLETED|Overall Study||132
8346870|NCT01277523|20575299|P3|STARTED|Overall Study||130
8346871|NCT01277523|20575300|P2|STARTED|Overall Study||127
8346872|NCT01277523|20575301|P1|STARTED|Overall Study||135
8346873|NCT01277510|20575353|P2|NOT COMPLETED|Open-label Phase||3
8346874|NCT01277510|20575354|P1|NOT COMPLETED|Open-label Phase||7
8346875|NCT01277510|20575353|P2|COMPLETED|Open-label Phase|Completed investigational product|1
8346876|NCT01277510|20575354|P1|COMPLETED|Open-label Phase|Completed investigational product|1
8346877|NCT01277510|20575353|P2|Received Investigational Product|Open-label Phase||4
8346878|NCT01277510|20575354|P1|Received Investigational Product|Open-label Phase||6
8346879|NCT01277510|20575353|P2|STARTED|Open-label Phase||4
8346880|NCT01277510|20575354|P1|STARTED|Open-label Phase||8
8346881|NCT01277510|20575353|P2|NOT COMPLETED|Double-blind Phase||18
8346882|NCT01277510|20575354|P1|NOT COMPLETED|Double-blind Phase||13
8346883|NCT01277510|20575353|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
8346884|NCT01277510|20575354|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
8346885|NCT01277510|20575353|P2|Received Investigational Product|Double-blind Phase||22
8346886|NCT01277510|20575354|P1|Received Investigational Product|Double-blind Phase||21
8346887|NCT01277510|20575353|P2|STARTED|Double-blind Phase||22
8346888|NCT01277510|20575354|P1|STARTED|Double-blind Phase||21
8346889|NCT01277354|20575378|P2|NOT COMPLETED|Overall Study||0
8346890|NCT01277354|20575379|P1|NOT COMPLETED|Overall Study||0
8346891|NCT01277354|20575378|P2|COMPLETED|Overall Study||1
8346892|NCT01277354|20575379|P1|COMPLETED|Overall Study||1
8346893|NCT01277354|20575378|P2|STARTED|Overall Study||1
8346894|NCT01277354|20575379|P1|STARTED|Overall Study||1
8346895|NCT01277341|20575389|P4|NOT COMPLETED|Overall Study||6
8346896|NCT01277341|20575390|P3|NOT COMPLETED|Overall Study||4
8346897|NCT01277341|20575391|P2|NOT COMPLETED|Overall Study||5
8346898|NCT01277341|20575392|P1|NOT COMPLETED|Overall Study||4
8346899|NCT01277341|20575389|P4|COMPLETED|Overall Study||146
8346900|NCT01277341|20575390|P3|COMPLETED|Overall Study||145
8346901|NCT01277341|20575391|P2|COMPLETED|Overall Study||145
8346902|NCT01277341|20575392|P1|COMPLETED|Overall Study||146
8346903|NCT01277341|20575389|P4|STARTED|Overall Study||152
8346904|NCT01277341|20575390|P3|STARTED|Overall Study||149
8346905|NCT01277341|20575391|P2|STARTED|Overall Study||150
8346906|NCT01277341|20575392|P1|STARTED|Overall Study||150
8346907|NCT01277302|20575405|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
8346908|NCT01277302|20575406|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
8346909|NCT01277302|20575407|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
8346910|NCT01277302|20575405|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
8346911|NCT01277302|20575406|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
8346912|NCT01277302|20575407|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
8346913|NCT01277302|20575405|P3|STARTED|8-Month Alternate Dose Regimen Period||19
8346914|NCT01277302|20575406|P2|STARTED|8-Month Alternate Dose Regimen Period||86
8346915|NCT01277302|20575407|P1|STARTED|8-Month Alternate Dose Regimen Period||85
8346916|NCT01277302|20575405|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
8346917|NCT01277302|20575406|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
8346918|NCT01277302|20575407|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
8346919|NCT01277302|20575405|P3|COMPLETED|7-Month Fixed Treatment Period||19
8346920|NCT01277302|20575406|P2|COMPLETED|7-Month Fixed Treatment Period||86
8346921|NCT01277302|20575407|P1|COMPLETED|7-Month Fixed Treatment Period||85
8346922|NCT01277302|20575405|P3|STARTED|7-Month Fixed Treatment Period||31
8346923|NCT01277302|20575406|P2|STARTED|7-Month Fixed Treatment Period||86
8346924|NCT01277302|20575407|P1|STARTED|7-Month Fixed Treatment Period||85
8346925|NCT01277211|20575439|P2|NOT COMPLETED|Overall Study||63
8346926|NCT01277211|20575440|P1|NOT COMPLETED|Overall Study||150
8346927|NCT01277211|20575439|P2|COMPLETED|Overall Study||182
8346928|NCT01277211|20575440|P1|COMPLETED|Overall Study||588
8346929|NCT01277211|20575439|P2|Treated|Overall Study||232
8346930|NCT01277211|20575440|P1|Treated|Overall Study||714
8346931|NCT01277211|20575439|P2|STARTED|Overall Study||245
8346932|NCT01277211|20575440|P1|STARTED|Overall Study||738
8346933|NCT01277159|20575455|P5|NOT COMPLETED|Overall Study||5
8346934|NCT01277159|20575456|P4|NOT COMPLETED|Overall Study||3
8346935|NCT01277159|20575457|P3|NOT COMPLETED|Overall Study||3
8346936|NCT01277159|20575458|P2|NOT COMPLETED|Overall Study||1
8346937|NCT01277159|20575459|P1|NOT COMPLETED|Overall Study||4
8346938|NCT01277159|20575455|P5|COMPLETED|Overall Study||16
8346939|NCT01277159|20575456|P4|COMPLETED|Overall Study||19
8346940|NCT01277159|20575457|P3|COMPLETED|Overall Study||19
8346941|NCT01277159|20575458|P2|COMPLETED|Overall Study||21
8346942|NCT01277159|20575459|P1|COMPLETED|Overall Study||17
8346943|NCT01277159|20575455|P5|STARTED|Overall Study||21
8346944|NCT01277159|20575456|P4|STARTED|Overall Study||22
8346945|NCT01277159|20575457|P3|STARTED|Overall Study||22
8346946|NCT01277159|20575458|P2|STARTED|Overall Study||22
8346947|NCT01277159|20575459|P1|STARTED|Overall Study||21
8346948|NCT01277081|20575473|P2|NOT COMPLETED|Overall Study||0
8346949|NCT01277081|20575474|P1|NOT COMPLETED|Overall Study||0
8346950|NCT01277081|20575473|P2|COMPLETED|Overall Study||100
8346951|NCT01277081|20575474|P1|COMPLETED|Overall Study||100
8346952|NCT01277081|20575473|P2|STARTED|Overall Study||100
8346953|NCT01277081|20575474|P1|STARTED|Overall Study||100
8346954|NCT01277042|20575492|P2|NOT COMPLETED|Overall Study||5
8346955|NCT01277042|20575493|P1|NOT COMPLETED|Overall Study||8
8346956|NCT01277042|20575492|P2|COMPLETED|Overall Study||601
8346957|NCT01277042|20575493|P1|COMPLETED|Overall Study||598
8346958|NCT01277042|20575492|P2|STARTED|Overall Study||606
8346959|NCT01277042|20575493|P1|STARTED|Overall Study||606
8346960|NCT01276860|20575517|P2|NOT COMPLETED|Overall Study||0
8346961|NCT01276860|20575518|P1|NOT COMPLETED|Overall Study||0
8346962|NCT01276860|20575517|P2|COMPLETED|Overall Study||2
8346963|NCT01276860|20575518|P1|COMPLETED|Overall Study||5
8346964|NCT01276860|20575517|P2|STARTED|Overall Study||2
8346965|NCT01276860|20575518|P1|STARTED|Overall Study||5
8346966|NCT01276847|20575529|P3|NOT COMPLETED|Overall Study||0
8346967|NCT01276847|20575530|P2|NOT COMPLETED|Overall Study||0
8346968|NCT01276847|20575531|P1|NOT COMPLETED|Overall Study||1
8346969|NCT01276847|20575529|P3|COMPLETED|Overall Study||20
8346970|NCT01276847|20575530|P2|COMPLETED|Overall Study||10
8346971|NCT01276847|20575531|P1|COMPLETED|Overall Study||9
8346972|NCT01276847|20575529|P3|STARTED|Overall Study||20
8346973|NCT01276847|20575530|P2|STARTED|Overall Study||10
8346974|NCT01276847|20575531|P1|STARTED|Overall Study||10
8346975|NCT01276821|20575541|P2|NOT COMPLETED|Overall Study||1
8346976|NCT01276821|20575542|P1|NOT COMPLETED|Overall Study||0
8346977|NCT01276821|20575541|P2|COMPLETED|Overall Study||49
8346978|NCT01276821|20575542|P1|COMPLETED|Overall Study||50
8346979|NCT01276821|20575541|P2|STARTED|Overall Study||50
8346980|NCT01276821|20575542|P1|STARTED|Overall Study||50
8346981|NCT01276756|20575562|P2|NOT COMPLETED|Overall Study||2
8346982|NCT01276756|20575563|P1|NOT COMPLETED|Overall Study||5
8346983|NCT01276756|20575562|P2|COMPLETED|Overall Study||48
8346984|NCT01276756|20575563|P1|COMPLETED|Overall Study||45
8346985|NCT01276756|20575562|P2|STARTED|Overall Study||50
8346986|NCT01276756|20575563|P1|STARTED|Overall Study||50
8346987|NCT01276652|20575580|P3|NOT COMPLETED|Period 2: Observational||0
8346988|NCT01276652|20575581|P2|NOT COMPLETED|Period 2: Observational||0
8346989|NCT01276652|20575582|P1|NOT COMPLETED|Period 2: Observational||0
8346990|NCT01276652|20575580|P3|COMPLETED|Period 2: Observational||5
8346991|NCT01276652|20575581|P2|COMPLETED|Period 2: Observational||8
8346992|NCT01276652|20575582|P1|COMPLETED|Period 2: Observational||9
8346993|NCT01276652|20575580|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
8346994|NCT01276652|20575581|P2|STARTED|Period 2: Observational||8
8346995|NCT01276652|20575582|P1|STARTED|Period 2: Observational||9
8346996|NCT01276652|20575580|P3|NOT COMPLETED|Period 1: Randomization||0
8346997|NCT01276652|20575581|P2|NOT COMPLETED|Period 1: Randomization||0
8346998|NCT01276652|20575582|P1|NOT COMPLETED|Period 1: Randomization||0
8346999|NCT01276652|20575580|P3|COMPLETED|Period 1: Randomization||0
8347000|NCT01276652|20575581|P2|COMPLETED|Period 1: Randomization||8
8347001|NCT01276652|20575582|P1|COMPLETED|Period 1: Randomization||9
8347002|NCT01276652|20575580|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
8347003|NCT01276652|20575581|P2|STARTED|Period 1: Randomization||8
8347004|NCT01276652|20575582|P1|STARTED|Period 1: Randomization||9
8347005|NCT01276639|20575608|P5|NOT COMPLETED|Week 16 to 52||21
8347006|NCT01276639|20575609|P4|NOT COMPLETED|Week 16 to 52||16
8347007|NCT01276639|20575610|P3|NOT COMPLETED|Week 16 to 52||0
8347008|NCT01276639|20575611|P2|NOT COMPLETED|Week 16 to 52||101
8347009|NCT01276639|20575612|P1|NOT COMPLETED|Week 16 to 52||127
8347010|NCT01276639|20575608|P5|COMPLETED|Week 16 to 52||45
8347011|NCT01276639|20575609|P4|COMPLETED|Week 16 to 52||50
8347012|NCT01276639|20575610|P3|COMPLETED|Week 16 to 52||0
8347013|NCT01276639|20575611|P2|COMPLETED|Week 16 to 52||219
8347014|NCT01276639|20575612|P1|COMPLETED|Week 16 to 52||186
8347015|NCT01276639|20575608|P5|STARTED|Week 16 to 52||66
8347016|NCT01276639|20575609|P4|STARTED|Week 16 to 52||66
8347017|NCT01276639|20575610|P3|STARTED|Week 16 to 52||0
8347018|NCT01276639|20575611|P2|STARTED|Week 16 to 52||320
8347019|NCT01276639|20575612|P1|STARTED|Week 16 to 52||313
8347020|NCT01276639|20575608|P5|NOT COMPLETED|Week 0 to 16||0
8347021|NCT01276639|20575609|P4|NOT COMPLETED|Week 0 to 16||0
8347022|NCT01276639|20575610|P3|NOT COMPLETED|Week 0 to 16||45
8347023|NCT01276639|20575611|P2|NOT COMPLETED|Week 0 to 16||41
8347024|NCT01276639|20575612|P1|NOT COMPLETED|Week 0 to 16||50
8347025|NCT01276639|20575608|P5|COMPLETED|Week 0 to 16||0
8347026|NCT01276639|20575609|P4|COMPLETED|Week 0 to 16||0
8347027|NCT01276639|20575610|P3|COMPLETED|Week 0 to 16||132
8347028|NCT01276639|20575611|P2|COMPLETED|Week 0 to 16||320
8347029|NCT01276639|20575612|P1|COMPLETED|Week 0 to 16||313
8347030|NCT01276639|20575608|P5|Treated|Week 0 to 16||0
8347031|NCT01276639|20575609|P4|Treated|Week 0 to 16||0
8347032|NCT01276639|20575610|P3|Treated|Week 0 to 16||177
8347033|NCT01276639|20575611|P2|Treated|Week 0 to 16||360
8347034|NCT01276639|20575612|P1|Treated|Week 0 to 16||363
8347035|NCT01276639|20575608|P5|STARTED|Week 0 to 16||0
8347036|NCT01276639|20575609|P4|STARTED|Week 0 to 16||0
8347037|NCT01276639|20575610|P3|STARTED|Week 0 to 16||177
8347038|NCT01276639|20575611|P2|STARTED|Week 0 to 16||361
8347039|NCT01276639|20575612|P1|STARTED|Week 0 to 16||363
8347040|NCT01276535|20575807|P1|NOT COMPLETED|Overall Study||0
8347041|NCT01276535|20575807|P1|COMPLETED|Overall Study||12
8347042|NCT01276535|20575807|P1|STARTED|Overall Study||12
8347043|NCT01276509|20575817|P4|NOT COMPLETED|Overall Study||5
8347044|NCT01276509|20575818|P3|NOT COMPLETED|Overall Study||5
8347045|NCT01276509|20575819|P2|NOT COMPLETED|Overall Study||12
8347046|NCT01276509|20575820|P1|NOT COMPLETED|Overall Study||13
8347047|NCT01276509|20575817|P4|COMPLETED|Overall Study||58
8347048|NCT01276509|20575818|P3|COMPLETED|Overall Study||63
8347049|NCT01276509|20575819|P2|COMPLETED|Overall Study||53
8347050|NCT01276509|20575820|P1|COMPLETED|Overall Study||53
8347051|NCT01276509|20575817|P4|STARTED|Overall Study||63
8347052|NCT01276509|20575818|P3|STARTED|Overall Study||68
8347053|NCT01276509|20575819|P2|STARTED|Overall Study||65
8347054|NCT01276509|20575820|P1|STARTED|Overall Study||66
8347055|NCT01276457|20575873|P2|NOT COMPLETED|Extension Study||2
8347056|NCT01276457|20575874|P1|NOT COMPLETED|Extension Study||6
8347057|NCT01276457|20575873|P2|COMPLETED|Extension Study||110
8347058|NCT01276457|20575874|P1|COMPLETED|Extension Study||105
8347059|NCT01276457|20575873|P2|STARTED|Extension Study||112
8347060|NCT01276457|20575874|P1|STARTED|Extension Study||111
8347061|NCT01276457|20575873|P2|NOT COMPLETED|Core Study||20
8347062|NCT01276457|20575874|P1|NOT COMPLETED|Core Study||13
8347063|NCT01276457|20575873|P2|COMPLETED|Core Study||123
8347064|NCT01276457|20575874|P1|COMPLETED|Core Study||129
8347065|NCT01276457|20575873|P2|STARTED|Core Study||143
8347066|NCT01276457|20575874|P1|STARTED|Core Study||142
8347067|NCT01276353|20575888|P2|NOT COMPLETED|Extension||9
8347068|NCT01276353|20575889|P1|NOT COMPLETED|Extension||7
8347069|NCT01276353|20575888|P2|COMPLETED|Extension||14
8347070|NCT01276353|20575889|P1|COMPLETED|Extension||12
8347071|NCT01276353|20575888|P2|STARTED|Extension||23
8347072|NCT01276353|20575889|P1|STARTED|Extension||19
8347073|NCT01276353|20575888|P2|NOT COMPLETED|Double-blind||0
8347074|NCT01276353|20575889|P1|NOT COMPLETED|Double-blind||3
8347075|NCT01276353|20575888|P2|COMPLETED|Double-blind||23
8347076|NCT01276353|20575889|P1|COMPLETED|Double-blind||19
8347077|NCT01276353|20575888|P2|STARTED|Double-blind||23
8347078|NCT01276353|20575889|P1|STARTED|Double-blind||22
8347079|NCT01276327|20575901|P2|NOT COMPLETED|Overall Study||3
8347080|NCT01276327|20575902|P1|NOT COMPLETED|Overall Study||2
8347081|NCT01276327|20575901|P2|COMPLETED|Overall Study||29
8347082|NCT01276327|20575902|P1|COMPLETED|Overall Study||30
8347083|NCT01276327|20575901|P2|STARTED|Overall Study||32
8347084|NCT01276327|20575902|P1|STARTED|Overall Study||32
8347085|NCT01276314|20575928|P4|NOT COMPLETED|Overall Study||5
8347086|NCT01276314|20575929|P3|NOT COMPLETED|Overall Study||4
8347087|NCT01276314|20575930|P2|NOT COMPLETED|Overall Study||10
8347088|NCT01276314|20575931|P1|NOT COMPLETED|Overall Study||10
8347089|NCT01276314|20575928|P4|COMPLETED|Overall Study||17
8347090|NCT01276314|20575929|P3|COMPLETED|Overall Study||18
8347091|NCT01276314|20575930|P2|COMPLETED|Overall Study||33
8347092|NCT01276314|20575931|P1|COMPLETED|Overall Study||38
8347093|NCT01276314|20575928|P4|STARTED|Overall Study||22
8347094|NCT01276314|20575929|P3|STARTED|Overall Study||22
8347095|NCT01276314|20575930|P2|STARTED|Overall Study||43
8347096|NCT01276314|20575931|P1|STARTED|Overall Study||48
8347097|NCT01276301|20575941|P2|NOT COMPLETED|Second Intervention||0
8347098|NCT01276301|20575942|P1|NOT COMPLETED|Second Intervention||0
8347099|NCT01276301|20575941|P2|COMPLETED|Second Intervention||8
8347100|NCT01276301|20575942|P1|COMPLETED|Second Intervention||8
8347101|NCT01276301|20575941|P2|STARTED|Second Intervention||8
8347102|NCT01276301|20575942|P1|STARTED|Second Intervention||8
8347103|NCT01276301|20575941|P2|NOT COMPLETED|Washout Period of 7 Days||0
8347104|NCT01276301|20575942|P1|NOT COMPLETED|Washout Period of 7 Days||0
8347105|NCT01276301|20575941|P2|COMPLETED|Washout Period of 7 Days||8
8347106|NCT01276301|20575942|P1|COMPLETED|Washout Period of 7 Days||8
8347107|NCT01276301|20575941|P2|STARTED|Washout Period of 7 Days||8
8347108|NCT01276301|20575942|P1|STARTED|Washout Period of 7 Days||8
8347109|NCT01276301|20575941|P2|NOT COMPLETED|First Intervention||0
8347110|NCT01276301|20575942|P1|NOT COMPLETED|First Intervention||0
8347111|NCT01276301|20575941|P2|COMPLETED|First Intervention||8
8347112|NCT01276301|20575942|P1|COMPLETED|First Intervention||8
8347113|NCT01276301|20575941|P2|STARTED|First Intervention||8
8347114|NCT01276301|20575942|P1|STARTED|First Intervention||8
8347115|NCT01276288|20575969|P4|NOT COMPLETED|Overall Study||0
8347116|NCT01276288|20575970|P3|NOT COMPLETED|Overall Study||0
8347117|NCT01276288|20575971|P2|NOT COMPLETED|Overall Study||1
8347118|NCT01276288|20575972|P1|NOT COMPLETED|Overall Study||2
8347119|NCT01276288|20575969|P4|COMPLETED|Overall Study||5
8347120|NCT01276288|20575970|P3|COMPLETED|Overall Study||5
8347121|NCT01276288|20575971|P2|COMPLETED|Overall Study||5
8347122|NCT01276288|20575972|P1|COMPLETED|Overall Study||5
8347123|NCT01276288|20575969|P4|Received EMPA+TOR|Overall Study||5
8347124|NCT01276288|20575970|P3|Received EMPA+TOR|Overall Study||5
8347125|NCT01276288|20575971|P2|Received EMPA+TOR|Overall Study||0
8347126|NCT01276288|20575972|P1|Received EMPA+TOR|Overall Study||0
8347127|NCT01276288|20575969|P4|Received EMPA+HCT|Overall Study||0
8347128|NCT01276288|20575970|P3|Received EMPA+HCT|Overall Study||0
8347129|NCT01276288|20575971|P2|Received EMPA+HCT|Overall Study||5
8347130|NCT01276288|20575972|P1|Received EMPA+HCT|Overall Study||5
8347131|NCT01276288|20575969|P4|Received EMPA|Overall Study||5
8347132|NCT01276288|20575970|P3|Received EMPA|Overall Study||5
8347133|NCT01276288|20575971|P2|Received EMPA|Overall Study||5
8347134|NCT01276288|20575972|P1|Received EMPA|Overall Study||6
8347135|NCT01276288|20575969|P4|STARTED|Overall Study||5
8347136|NCT01276288|20575970|P3|STARTED|Overall Study||5
8347137|NCT01276288|20575971|P2|STARTED|Overall Study||6
8347138|NCT01276288|20575972|P1|STARTED|Overall Study||7
8347139|NCT01276223|20576099|P3|NOT COMPLETED|Overall Study||3
8347140|NCT01276223|20576100|P2|NOT COMPLETED|Overall Study||4
8347141|NCT01276223|20576101|P1|NOT COMPLETED|Overall Study||11
8347142|NCT01276223|20576099|P3|COMPLETED|Overall Study||101
8347143|NCT01276223|20576100|P2|COMPLETED|Overall Study||103
8347144|NCT01276223|20576101|P1|COMPLETED|Overall Study||67
8347145|NCT01276223|20576099|P3|STARTED|Overall Study||104
8347146|NCT01276223|20576100|P2|STARTED|Overall Study||107
8347147|NCT01276223|20576101|P1|STARTED|Overall Study||78
8347148|NCT01276197|20576110|P2|NOT COMPLETED|Overall Study||110
8347149|NCT01276197|20576111|P1|NOT COMPLETED|Overall Study||108
8347150|NCT01276197|20576110|P2|COMPLETED|Overall Study||200
8347151|NCT01276197|20576111|P1|COMPLETED|Overall Study||200
8347152|NCT01276197|20576110|P2|STARTED|Overall Study||310
8347153|NCT01276197|20576111|P1|STARTED|Overall Study||308
8347154|NCT01276171|20576122|P3|NOT COMPLETED|Overall Study||0
8347155|NCT01276171|20576123|P2|NOT COMPLETED|Overall Study||0
8347156|NCT01276171|20576124|P1|NOT COMPLETED|Overall Study||0
8347157|NCT01276171|20576122|P3|COMPLETED|Overall Study||256
8347158|NCT01276171|20576123|P2|COMPLETED|Overall Study||244
8347159|NCT01276171|20576124|P1|COMPLETED|Overall Study||249
8347160|NCT01276171|20576122|P3|STARTED|Overall Study||256
8347161|NCT01276171|20576123|P2|STARTED|Overall Study||244
8347162|NCT01276171|20576124|P1|STARTED|Overall Study||249
8347163|NCT01276106|20576142|P4|NOT COMPLETED|Overall Study||13
8347164|NCT01276106|20576143|P3|NOT COMPLETED|Overall Study||16
8347165|NCT01276106|20576144|P2|NOT COMPLETED|Overall Study||9
8347166|NCT01276106|20576145|P1|NOT COMPLETED|Overall Study||12
8347167|NCT01276106|20576142|P4|COMPLETED|Overall Study||52
8347168|NCT01276106|20576143|P3|COMPLETED|Overall Study||49
8347169|NCT01276106|20576144|P2|COMPLETED|Overall Study||55
8347170|NCT01276106|20576145|P1|COMPLETED|Overall Study||53
8347171|NCT01276106|20576142|P4|STARTED|Overall Study||65
8347172|NCT01276106|20576143|P3|STARTED|Overall Study||65
8347173|NCT01276106|20576144|P2|STARTED|Overall Study||64
8347174|NCT01276106|20576145|P1|STARTED|Overall Study||65
8347175|NCT01276054|20576157|P2|NOT COMPLETED|Overall Study||2
8347176|NCT01276054|20576158|P1|NOT COMPLETED|Overall Study||2
8347177|NCT01276054|20576157|P2|COMPLETED|Overall Study||0
8347178|NCT01276054|20576158|P1|COMPLETED|Overall Study||0
8347179|NCT01276054|20576157|P2|STARTED|Overall Study||2
8347180|NCT01276054|20576158|P1|STARTED|Overall Study||2
8347181|NCT01276041|20576164|P1|NOT COMPLETED|Overall Study||3
8347182|NCT01276041|20576164|P1|COMPLETED|Overall Study||67
8347183|NCT01276041|20576164|P1|STARTED|Overall Study||70
8347184|NCT01275833|20576173|P2|NOT COMPLETED|Overall Study||1
8347185|NCT01275833|20576174|P1|NOT COMPLETED|Overall Study||1
8347186|NCT01275833|20576173|P2|COMPLETED|Overall Study||0
8347187|NCT01275833|20576174|P1|COMPLETED|Overall Study||0
8347188|NCT01275833|20576173|P2|STARTED|Overall Study||1
8347189|NCT01275833|20576174|P1|STARTED|Overall Study||1
8347190|NCT01275755|20576182|P2|NOT COMPLETED|Run-out Placebo Period||0
8347191|NCT01275755|20576183|P1|NOT COMPLETED|Run-out Placebo Period||1
8347192|NCT01275755|20576182|P2|COMPLETED|Run-out Placebo Period||37
8347193|NCT01275755|20576183|P1|COMPLETED|Run-out Placebo Period||38
8347194|NCT01275755|20576182|P2|STARTED|Run-out Placebo Period||37
8347195|NCT01275755|20576183|P1|STARTED|Run-out Placebo Period||39
8347196|NCT01275755|20576182|P2|NOT COMPLETED|Double-blind Treatment Period||3
8347197|NCT01275755|20576183|P1|NOT COMPLETED|Double-blind Treatment Period||2
8347198|NCT01275755|20576182|P2|COMPLETED|Double-blind Treatment Period||37
8347199|NCT01275755|20576183|P1|COMPLETED|Double-blind Treatment Period||39
8347200|NCT01275755|20576182|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
8347201|NCT01275755|20576183|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
8347202|NCT01275755|20576182|P2|STARTED|Double-blind Treatment Period||40
8347203|NCT01275755|20576183|P1|STARTED|Double-blind Treatment Period||41
8347204|NCT01275755|20576182|P2|NOT COMPLETED|Run-in Placebo Period||0
8347205|NCT01275755|20576183|P1|NOT COMPLETED|Run-in Placebo Period||0
8347206|NCT01275755|20576182|P2|COMPLETED|Run-in Placebo Period||40
8347207|NCT01275755|20576183|P1|COMPLETED|Run-in Placebo Period||41
8347208|NCT01275755|20576182|P2|STARTED|Run-in Placebo Period||40
8347209|NCT01275755|20576183|P1|STARTED|Run-in Placebo Period||41
8347216|NCT01275664|20576210|P1|NOT COMPLETED|Overall Study||0
8347217|NCT01275664|20576210|P1|COMPLETED|Overall Study||4
8347218|NCT01275664|20576210|P1|STARTED|Overall Study||4
8347219|NCT01275625|20576218|P1|NOT COMPLETED|Overall Study||13
8347220|NCT01275625|20576218|P1|COMPLETED|Overall Study||64
8347221|NCT01275625|20576218|P1|Treated|Overall Study||77
8347222|NCT01275625|20576218|P1|STARTED|Overall Study||77
8347223|NCT01275586|20576232|P1|NOT COMPLETED|Overall Study||3
8347224|NCT01275586|20576232|P1|COMPLETED|Overall Study||3
8347225|NCT01275586|20576232|P1|STARTED|Overall Study||6
8347226|NCT01275430|20576236|P1|NOT COMPLETED|Overall Study||9
8347227|NCT01275430|20576236|P1|COMPLETED|Overall Study||18
8347228|NCT01275430|20576236|P1|STARTED|Overall Study||27
8347229|NCT01275365|20576248|P4|NOT COMPLETED|Overall Study||3
8347230|NCT01275365|20576249|P3|NOT COMPLETED|Overall Study||5
8347231|NCT01275365|20576250|P2|NOT COMPLETED|Overall Study||3
8347232|NCT01275365|20576251|P1|NOT COMPLETED|Overall Study||3
8347233|NCT01275365|20576248|P4|COMPLETED|Overall Study||19
8347234|NCT01275365|20576249|P3|COMPLETED|Overall Study||17
8347235|NCT01275365|20576250|P2|COMPLETED|Overall Study||21
8347236|NCT01275365|20576251|P1|COMPLETED|Overall Study||21
8347237|NCT01275365|20576248|P4|STARTED|Overall Study||22
8347238|NCT01275365|20576249|P3|STARTED|Overall Study||22
8347239|NCT01275365|20576250|P2|STARTED|Overall Study||24
8347240|NCT01275365|20576251|P1|STARTED|Overall Study||24
8347241|NCT01275339|20576301|P4|NOT COMPLETED|Overall Study||0
8347242|NCT01275339|20576302|P3|NOT COMPLETED|Overall Study||1
8347243|NCT01275339|20576303|P2|NOT COMPLETED|Overall Study||0
8347244|NCT01275339|20576304|P1|NOT COMPLETED|Overall Study||1
8347245|NCT01275339|20576301|P4|COMPLETED|Overall Study||4
8347246|NCT01275339|20576302|P3|COMPLETED|Overall Study||3
8347247|NCT01275339|20576303|P2|COMPLETED|Overall Study||0
8347248|NCT01275339|20576304|P1|COMPLETED|Overall Study||1
8347249|NCT01275339|20576301|P4|STARTED|Overall Study||4
8347250|NCT01275339|20576302|P3|STARTED|Overall Study||4
8347251|NCT01275339|20576303|P2|STARTED|Overall Study||0
8347252|NCT01275339|20576304|P1|STARTED|Overall Study||2
8347253|NCT01275313|20576316|P2|NOT COMPLETED|Overall Study||52
8347254|NCT01275313|20576317|P1|NOT COMPLETED|Overall Study||25
8347255|NCT01275313|20576316|P2|COMPLETED|Overall Study||79
8347256|NCT01275313|20576317|P1|COMPLETED|Overall Study||102
8347257|NCT01275313|20576316|P2|STARTED|Overall Study||131
8347258|NCT01275313|20576317|P1|STARTED|Overall Study||127
8347259|NCT01275300|20576323|P2|NOT COMPLETED|Phase 2: Open-label 6days)||0
8347260|NCT01275300|20576324|P1|NOT COMPLETED|Phase 2: Open-label 6days)||0
8347261|NCT01275300|20576323|P2|COMPLETED|Phase 2: Open-label 6days)||4
8347262|NCT01275300|20576324|P1|COMPLETED|Phase 2: Open-label 6days)||5
8347263|NCT01275300|20576323|P2|STARTED|Phase 2: Open-label 6days)||4
8347264|NCT01275300|20576324|P1|STARTED|Phase 2: Open-label 6days)||5
8347265|NCT01275300|20576323|P2|NOT COMPLETED|Washout (14 Days)||0
8347266|NCT01275300|20576324|P1|NOT COMPLETED|Washout (14 Days)||0
8347267|NCT01275300|20576323|P2|COMPLETED|Washout (14 Days)||4
8347268|NCT01275300|20576324|P1|COMPLETED|Washout (14 Days)||5
8347269|NCT01275300|20576323|P2|STARTED|Washout (14 Days)||4
8347270|NCT01275300|20576324|P1|STARTED|Washout (14 Days)||5
8347271|NCT01275300|20576323|P2|NOT COMPLETED|2nd Intervention(5 Days)||0
8347272|NCT01275300|20576324|P1|NOT COMPLETED|2nd Intervention(5 Days)||0
8347273|NCT01275300|20576323|P2|COMPLETED|2nd Intervention(5 Days)||4
8347274|NCT01275300|20576324|P1|COMPLETED|2nd Intervention(5 Days)||5
8347275|NCT01275300|20576323|P2|STARTED|2nd Intervention(5 Days)||4
8347276|NCT01275300|20576324|P1|STARTED|2nd Intervention(5 Days)||5
8347277|NCT01275300|20576323|P2|NOT COMPLETED|Washout (14 Days)||0
8347278|NCT01275300|20576324|P1|NOT COMPLETED|Washout (14 Days)||0
8347279|NCT01275300|20576323|P2|COMPLETED|Washout (14 Days)||4
8347280|NCT01275300|20576324|P1|COMPLETED|Washout (14 Days)||5
8347281|NCT01275300|20576323|P2|STARTED|Washout (14 Days)||4
8347282|NCT01275300|20576324|P1|STARTED|Washout (14 Days)||5
8347283|NCT01275300|20576323|P2|NOT COMPLETED|1st Intervention (5 Days)||0
8347284|NCT01275300|20576324|P1|NOT COMPLETED|1st Intervention (5 Days)||0
8347285|NCT01275300|20576323|P2|COMPLETED|1st Intervention (5 Days)||4
8347286|NCT01275300|20576324|P1|COMPLETED|1st Intervention (5 Days)||5
8347287|NCT01275300|20576323|P2|STARTED|1st Intervention (5 Days)||4
8347288|NCT01275300|20576324|P1|STARTED|1st Intervention (5 Days)||5
8347289|NCT01275196|20576332|P2|NOT COMPLETED|Overall Study||21
8347290|NCT01275196|20576333|P1|NOT COMPLETED|Overall Study||20
8347291|NCT01275196|20576332|P2|COMPLETED|Overall Study||113
8347292|NCT01275196|20576333|P1|COMPLETED|Overall Study||113
8347293|NCT01275196|20576332|P2|Intended to Continue Into Extension|Overall Study||113
8347294|NCT01275196|20576333|P1|Intended to Continue Into Extension|Overall Study||112
8347295|NCT01275196|20576332|P2|STARTED|Overall Study||134
8347296|NCT01275196|20576333|P1|STARTED|Overall Study||133
8347297|NCT01275170|20576380|P8|NOT COMPLETED|Part 2: Period 2||0
8347298|NCT01275170|20576381|P7|NOT COMPLETED|Part 2: Period 2||0
8347299|NCT01275170|20576382|P6|NOT COMPLETED|Part 2: Period 2||0
8347300|NCT01275170|20576383|P5|NOT COMPLETED|Part 2: Period 2||0
8347301|NCT01275170|20576384|P4|NOT COMPLETED|Part 2: Period 2||0
8347302|NCT01275170|20576385|P3|NOT COMPLETED|Part 2: Period 2||0
8347303|NCT01275170|20576386|P2|NOT COMPLETED|Part 2: Period 2||0
8347304|NCT01275170|20576387|P1|NOT COMPLETED|Part 2: Period 2||0
8347305|NCT01275170|20576380|P8|COMPLETED|Part 2: Period 2||6
8347306|NCT01275170|20576381|P7|COMPLETED|Part 2: Period 2||6
8347307|NCT01275170|20576382|P6|COMPLETED|Part 2: Period 2||0
8347308|NCT01275170|20576383|P5|COMPLETED|Part 2: Period 2||0
8347309|NCT01275170|20576384|P4|COMPLETED|Part 2: Period 2||0
8347310|NCT01275170|20576385|P3|COMPLETED|Part 2: Period 2||0
8347311|NCT01275170|20576386|P2|COMPLETED|Part 2: Period 2||0
8347312|NCT01275170|20576387|P1|COMPLETED|Part 2: Period 2||0
8347313|NCT01275170|20576380|P8|STARTED|Part 2: Period 2||6
8347314|NCT01275170|20576381|P7|STARTED|Part 2: Period 2||6
8347315|NCT01275170|20576382|P6|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
8347316|NCT01275170|20576383|P5|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8347317|NCT01275170|20576384|P4|STARTED|Part 2: Period 2||0
8347318|NCT01275170|20576385|P3|STARTED|Part 2: Period 2||0
8347319|NCT01275170|20576386|P2|STARTED|Part 2: Period 2||0
8347320|NCT01275170|20576387|P1|STARTED|Part 2: Period 2||0
8347321|NCT01275170|20576380|P8|NOT COMPLETED|Part 2: Period 1||0
8347322|NCT01275170|20576381|P7|NOT COMPLETED|Part 2: Period 1||0
8347323|NCT01275170|20576382|P6|NOT COMPLETED|Part 2: Period 1||0
8347324|NCT01275170|20576383|P5|NOT COMPLETED|Part 2: Period 1||0
8347325|NCT01275170|20576384|P4|NOT COMPLETED|Part 2: Period 1||0
8347326|NCT01275170|20576385|P3|NOT COMPLETED|Part 2: Period 1||0
8347327|NCT01275170|20576386|P2|NOT COMPLETED|Part 2: Period 1||0
8347328|NCT01275170|20576387|P1|NOT COMPLETED|Part 2: Period 1||0
8347329|NCT01275170|20576380|P8|COMPLETED|Part 2: Period 1||6
8347330|NCT01275170|20576381|P7|COMPLETED|Part 2: Period 1||6
8347331|NCT01275170|20576382|P6|COMPLETED|Part 2: Period 1||6
8347332|NCT01275170|20576383|P5|COMPLETED|Part 2: Period 1||6
8347333|NCT01275170|20576384|P4|COMPLETED|Part 2: Period 1||0
8347334|NCT01275170|20576385|P3|COMPLETED|Part 2: Period 1||0
8347335|NCT01275170|20576386|P2|COMPLETED|Part 2: Period 1||0
8347336|NCT01275170|20576387|P1|COMPLETED|Part 2: Period 1||0
8347337|NCT01275170|20576380|P8|STARTED|Part 2: Period 1||6
8347338|NCT01275170|20576381|P7|STARTED|Part 2: Period 1||6
8347339|NCT01275170|20576382|P6|STARTED|Part 2: Period 1||6
8347340|NCT01275170|20576383|P5|STARTED|Part 2: Period 1||6
8347341|NCT01275170|20576384|P4|STARTED|Part 2: Period 1||0
8347342|NCT01275170|20576385|P3|STARTED|Part 2: Period 1||0
8347343|NCT01275170|20576386|P2|STARTED|Part 2: Period 1||0
8347344|NCT01275170|20576387|P1|STARTED|Part 2: Period 1||0
8347345|NCT01275170|20576380|P8|NOT COMPLETED|Part 1: Period 2||0
8347346|NCT01275170|20576381|P7|NOT COMPLETED|Part 1: Period 2||0
8347347|NCT01275170|20576382|P6|NOT COMPLETED|Part 1: Period 2||0
8347348|NCT01275170|20576383|P5|NOT COMPLETED|Part 1: Period 2||0
8347349|NCT01275170|20576384|P4|NOT COMPLETED|Part 1: Period 2||0
8347350|NCT01275170|20576385|P3|NOT COMPLETED|Part 1: Period 2||0
8347351|NCT01275170|20576386|P2|NOT COMPLETED|Part 1: Period 2||0
8347352|NCT01275170|20576387|P1|NOT COMPLETED|Part 1: Period 2||0
8347353|NCT01275170|20576380|P8|COMPLETED|Part 1: Period 2||6
8347354|NCT01275170|20576381|P7|COMPLETED|Part 1: Period 2||6
8347355|NCT01275170|20576382|P6|COMPLETED|Part 1: Period 2||0
8347356|NCT01275170|20576383|P5|COMPLETED|Part 1: Period 2||0
8347357|NCT01275170|20576384|P4|COMPLETED|Part 1: Period 2||0
8347358|NCT01275170|20576385|P3|COMPLETED|Part 1: Period 2||0
8347359|NCT01275170|20576386|P2|COMPLETED|Part 1: Period 2||0
8347360|NCT01275170|20576387|P1|COMPLETED|Part 1: Period 2||0
8347361|NCT01275170|20576380|P8|STARTED|Part 1: Period 2||6
8347362|NCT01275170|20576381|P7|STARTED|Part 1: Period 2||6
8347363|NCT01275170|20576382|P6|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8347364|NCT01275170|20576383|P5|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8347365|NCT01275170|20576384|P4|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
8347366|NCT01275170|20576385|P3|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
8347367|NCT01275170|20576386|P2|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
8347368|NCT01275170|20576387|P1|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
8347369|NCT01275170|20576380|P8|NOT COMPLETED|Part 1: Period 1||0
8347370|NCT01275170|20576381|P7|NOT COMPLETED|Part 1: Period 1||0
8347371|NCT01275170|20576382|P6|NOT COMPLETED|Part 1: Period 1||0
8347372|NCT01275170|20576383|P5|NOT COMPLETED|Part 1: Period 1||0
8347373|NCT01275170|20576384|P4|NOT COMPLETED|Part 1: Period 1||0
8347374|NCT01275170|20576385|P3|NOT COMPLETED|Part 1: Period 1||0
8347375|NCT01275170|20576386|P2|NOT COMPLETED|Part 1: Period 1||0
8347376|NCT01275170|20576387|P1|NOT COMPLETED|Part 1: Period 1||1
8347377|NCT01275170|20576380|P8|COMPLETED|Part 1: Period 1||6
8347378|NCT01275170|20576381|P7|COMPLETED|Part 1: Period 1||6
8347379|NCT01275170|20576382|P6|COMPLETED|Part 1: Period 1||6
8347380|NCT01275170|20576383|P5|COMPLETED|Part 1: Period 1||6
8347381|NCT01275170|20576384|P4|COMPLETED|Part 1: Period 1||6
8347382|NCT01275170|20576385|P3|COMPLETED|Part 1: Period 1||6
8347383|NCT01275170|20576386|P2|COMPLETED|Part 1: Period 1||6
8347384|NCT01275170|20576387|P1|COMPLETED|Part 1: Period 1||6
8347385|NCT01275170|20576380|P8|Treated|Part 1: Period 1||6
8347386|NCT01275170|20576381|P7|Treated|Part 1: Period 1||6
8347387|NCT01275170|20576382|P6|Treated|Part 1: Period 1||6
8347388|NCT01275170|20576383|P5|Treated|Part 1: Period 1||6
8347389|NCT01275170|20576384|P4|Treated|Part 1: Period 1||6
8347390|NCT01275170|20576385|P3|Treated|Part 1: Period 1||6
8347391|NCT01275170|20576386|P2|Treated|Part 1: Period 1||6
8347392|NCT01275170|20576387|P1|Treated|Part 1: Period 1||6
8347393|NCT01275170|20576380|P8|STARTED|Part 1: Period 1||6
8347394|NCT01275170|20576381|P7|STARTED|Part 1: Period 1||6
8347395|NCT01275170|20576382|P6|STARTED|Part 1: Period 1||6
8347396|NCT01275170|20576383|P5|STARTED|Part 1: Period 1||6
8347397|NCT01275170|20576384|P4|STARTED|Part 1: Period 1||6
8347398|NCT01275170|20576385|P3|STARTED|Part 1: Period 1||6
8347399|NCT01275170|20576386|P2|STARTED|Part 1: Period 1||6
8347400|NCT01275170|20576387|P1|STARTED|Part 1: Period 1||7
8347401|NCT01275144|20576605|P2|NOT COMPLETED|Second Intervention (6 Days)||0
8347402|NCT01275144|20576606|P1|NOT COMPLETED|Second Intervention (6 Days)||1
8347403|NCT01275144|20576605|P2|COMPLETED|Second Intervention (6 Days)||14
8347404|NCT01275144|20576606|P1|COMPLETED|Second Intervention (6 Days)||13
8347405|NCT01275144|20576605|P2|STARTED|Second Intervention (6 Days)||14
8347406|NCT01275144|20576606|P1|STARTED|Second Intervention (6 Days)||14
8347407|NCT01275144|20576605|P2|NOT COMPLETED|Washout (7 Days)||0
8347408|NCT01275144|20576606|P1|NOT COMPLETED|Washout (7 Days)||0
8347409|NCT01275144|20576605|P2|COMPLETED|Washout (7 Days)||14
8347410|NCT01275144|20576606|P1|COMPLETED|Washout (7 Days)||14
8347411|NCT01275144|20576605|P2|STARTED|Washout (7 Days)||14
8347412|NCT01275144|20576606|P1|STARTED|Washout (7 Days)||14
8347413|NCT01275144|20576605|P2|NOT COMPLETED|First Intervention (6 Days)||0
8347414|NCT01275144|20576606|P1|NOT COMPLETED|First Intervention (6 Days)||0
8347415|NCT01275144|20576605|P2|COMPLETED|First Intervention (6 Days)||14
8347416|NCT01275144|20576606|P1|COMPLETED|First Intervention (6 Days)||14
8347417|NCT01275144|20576605|P2|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
8347418|NCT01275144|20576606|P1|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
8347419|NCT01275144|20576605|P2|STARTED|First Intervention (6 Days)||14
8347420|NCT01275144|20576606|P1|STARTED|First Intervention (6 Days)||14
8347421|NCT01275131|20576664|P4|NOT COMPLETED|Period 2 (Crossover)||2
8347422|NCT01275131|20576665|P3|NOT COMPLETED|Period 2 (Crossover)||1
8347423|NCT01275131|20576666|P2|NOT COMPLETED|Period 2 (Crossover)||1
8347424|NCT01275131|20576667|P1|NOT COMPLETED|Period 2 (Crossover)||1
8347425|NCT01275131|20576664|P4|COMPLETED|Period 2 (Crossover)||8
8347426|NCT01275131|20576665|P3|COMPLETED|Period 2 (Crossover)||9
8347427|NCT01275131|20576666|P2|COMPLETED|Period 2 (Crossover)||8
8347428|NCT01275131|20576667|P1|COMPLETED|Period 2 (Crossover)||8
8347429|NCT01275131|20576664|P4|STARTED|Period 2 (Crossover)||10
8347430|NCT01275131|20576665|P3|STARTED|Period 2 (Crossover)||10
8347431|NCT01275131|20576666|P2|STARTED|Period 2 (Crossover)||9
8347432|NCT01275131|20576667|P1|STARTED|Period 2 (Crossover)||9
8347433|NCT01275131|20576664|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
8347434|NCT01275131|20576665|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
8347435|NCT01275131|20576666|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
8347436|NCT01275131|20576667|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
8347437|NCT01275131|20576664|P4|COMPLETED|5- to 14-Day Washout Period||10
8347438|NCT01275131|20576665|P3|COMPLETED|5- to 14-Day Washout Period||10
8347439|NCT01275131|20576666|P2|COMPLETED|5- to 14-Day Washout Period||9
8347440|NCT01275131|20576667|P1|COMPLETED|5- to 14-Day Washout Period||9
8347441|NCT01275131|20576664|P4|STARTED|5- to 14-Day Washout Period||10
8347442|NCT01275131|20576665|P3|STARTED|5- to 14-Day Washout Period||10
8347443|NCT01275131|20576666|P2|STARTED|5- to 14-Day Washout Period||9
8347444|NCT01275131|20576667|P1|STARTED|5- to 14-Day Washout Period||9
8347445|NCT01275131|20576664|P4|NOT COMPLETED|Period 1||2
8347446|NCT01275131|20576665|P3|NOT COMPLETED|Period 1||3
8347447|NCT01275131|20576666|P2|NOT COMPLETED|Period 1||0
8347448|NCT01275131|20576667|P1|NOT COMPLETED|Period 1||2
8347449|NCT01275131|20576664|P4|COMPLETED|Period 1||10
8347450|NCT01275131|20576665|P3|COMPLETED|Period 1||10
8347451|NCT01275131|20576666|P2|COMPLETED|Period 1||9
8347452|NCT01275131|20576667|P1|COMPLETED|Period 1||9
8347453|NCT01275131|20576664|P4|Received at Least One Dose of Study Drug|Period 1||12
8347454|NCT01275131|20576665|P3|Received at Least One Dose of Study Drug|Period 1||13
8347455|NCT01275131|20576666|P2|Received at Least One Dose of Study Drug|Period 1||9
8347456|NCT01275131|20576667|P1|Received at Least One Dose of Study Drug|Period 1||11
8347457|NCT01275131|20576664|P4|STARTED|Period 1||12
8347458|NCT01275131|20576665|P3|STARTED|Period 1||13
8347459|NCT01275131|20576666|P2|STARTED|Period 1||9
8347460|NCT01275131|20576667|P1|STARTED|Period 1||11
8347461|NCT01275092|20576701|P1|NOT COMPLETED|Overall Study||0
8347462|NCT01275092|20576701|P1|COMPLETED|Overall Study||164
8347463|NCT01275092|20576701|P1|STARTED|Overall Study||164
8347464|NCT01275066|20576710|P3|NOT COMPLETED|Overall Study||1
8347465|NCT01275066|20576711|P2|NOT COMPLETED|Overall Study||0
8347466|NCT01275066|20576712|P1|NOT COMPLETED|Overall Study||1
8347467|NCT01275066|20576710|P3|COMPLETED|Overall Study||57
8347468|NCT01275066|20576711|P2|COMPLETED|Overall Study||59
8347469|NCT01275066|20576712|P1|COMPLETED|Overall Study||59
8347470|NCT01275066|20576710|P3|Treated|Overall Study||58
8347471|NCT01275066|20576711|P2|Treated|Overall Study||59
8347472|NCT01275066|20576712|P1|Treated|Overall Study||59
8347473|NCT01275066|20576710|P3|STARTED|Overall Study||58
8347474|NCT01275066|20576711|P2|STARTED|Overall Study||59
8347475|NCT01275066|20576712|P1|STARTED|Overall Study||60
8347476|NCT01275053|20576726|P1|NOT COMPLETED|Overall Study||0
8347477|NCT01275053|20576726|P1|COMPLETED|Overall Study||12
8347478|NCT01275053|20576726|P1|STARTED|Overall Study||12
8347479|NCT01274897|20576732|P2|NOT COMPLETED|Overall Study||0
8347480|NCT01274897|20576733|P1|NOT COMPLETED|Overall Study||0
8347481|NCT01274897|20576732|P2|COMPLETED|Overall Study||153
8347482|NCT01274897|20576733|P1|COMPLETED|Overall Study||297
8347483|NCT01274897|20576732|P2|STARTED|Overall Study||153
8347484|NCT01274897|20576733|P1|STARTED|Overall Study||297
8347485|NCT01274715|20576745|P1|NOT COMPLETED|Overall Study||4
8347486|NCT01274715|20576745|P1|COMPLETED|Overall Study||8
8347487|NCT01274715|20576745|P1|Screened Out at Baseline|Overall Study||3
8347488|NCT01274715|20576745|P1|STARTED|Overall Study||12
8347489|NCT01274637|20576752|P2|NOT COMPLETED|Overall Study||2
8347490|NCT01274637|20576753|P1|NOT COMPLETED|Overall Study||0
8347491|NCT01274637|20576752|P2|COMPLETED|Overall Study||30
8347492|NCT01274637|20576753|P1|COMPLETED|Overall Study||30
8347493|NCT01274637|20576752|P2|STARTED|Overall Study||32
8347494|NCT01274637|20576753|P1|STARTED|Overall Study||30
8347495|NCT01274611|20576769|P1|NOT COMPLETED|Overall Study||0
8347496|NCT01274611|20576769|P1|COMPLETED|Overall Study||20
8347497|NCT01274611|20576769|P1|STARTED|Overall Study||20
8347498|NCT01274585|20576779|P2|NOT COMPLETED|Overall Study||0
8347499|NCT01274585|20576780|P1|NOT COMPLETED|Overall Study||0
8347500|NCT01274585|20576779|P2|COMPLETED|Overall Study||3
8347501|NCT01274585|20576780|P1|COMPLETED|Overall Study||2
8347502|NCT01274585|20576779|P2|STARTED|Overall Study||3
8347503|NCT01274585|20576780|P1|STARTED|Overall Study||2
8347504|NCT01274559|20576792|P2|NOT COMPLETED|Overall Study||145
8347505|NCT01274559|20576793|P1|NOT COMPLETED|Overall Study||197
8347506|NCT01274559|20576792|P2|COMPLETED|Overall Study||441
8347507|NCT01274559|20576793|P1|COMPLETED|Overall Study||390
8347508|NCT01274559|20576792|P2|Treated|Overall Study||572
8347509|NCT01274559|20576793|P1|Treated|Overall Study||572
8347510|NCT01274559|20576792|P2|STARTED|Overall Study||586
8347511|NCT01274559|20576793|P1|STARTED|Overall Study||587
8347512|NCT01274533|20576843|P1|NOT COMPLETED|Overall Study||4
8347513|NCT01274533|20576843|P1|COMPLETED|Overall Study||0
8347514|NCT01274533|20576843|P1|STARTED|Overall Study||4
8347515|NCT01274520|20576850|P2|NOT COMPLETED|Overall Study||0
8347516|NCT01274520|20576851|P1|NOT COMPLETED|Overall Study||0
8347517|NCT01274520|20576850|P2|COMPLETED|Overall Study||24
8347518|NCT01274520|20576851|P1|COMPLETED|Overall Study||25
8347519|NCT01274520|20576850|P2|STARTED|Overall Study||24
8347520|NCT01274520|20576851|P1|STARTED|Overall Study||25
8347521|NCT01274429|20576879|P1|NOT COMPLETED|Overall Study||5
8347522|NCT01274429|20576879|P1|COMPLETED|Overall Study||0
8347523|NCT01274429|20576879|P1|STARTED|Overall Study||5
8347524|NCT01274351|20576884|P1|NOT COMPLETED|Overall Study||20
8347525|NCT01274351|20576884|P1|COMPLETED|Overall Study||92
8347526|NCT01274351|20576884|P1|STARTED|Overall Study||112
8347527|NCT01274182|20576896|P3|NOT COMPLETED|Overall Study||12
8347528|NCT01274182|20576897|P2|NOT COMPLETED|Overall Study||18
8347529|NCT01274182|20576898|P1|NOT COMPLETED|Overall Study||21
8347530|NCT01274182|20576896|P3|COMPLETED|Overall Study||80
8347531|NCT01274182|20576897|P2|COMPLETED|Overall Study||69
8347532|NCT01274182|20576898|P1|COMPLETED|Overall Study||112
8347533|NCT01274182|20576896|P3|24 Weeks|Overall Study||84
8347534|NCT01274182|20576897|P2|24 Weeks|Overall Study||83
8347535|NCT01274182|20576898|P1|24 Weeks|Overall Study||123
8347536|NCT01274182|20576896|P3|STARTED|Overall Study||92
8347537|NCT01274182|20576897|P2|STARTED|Overall Study||87
8347538|NCT01274182|20576898|P1|STARTED|Overall Study||133
8347539|NCT01273896|20576935|P1|NOT COMPLETED|Overall Study||0
8347540|NCT01273896|20576935|P1|COMPLETED|Overall Study||22
8347541|NCT01273896|20576935|P1|STARTED|Overall Study||22
8347542|NCT01273883|20576939|P2|NOT COMPLETED|Second Intervention||1
8347543|NCT01273883|20576940|P1|NOT COMPLETED|Second Intervention||2
8347544|NCT01273883|20576939|P2|COMPLETED|Second Intervention||17
8347545|NCT01273883|20576940|P1|COMPLETED|Second Intervention||15
8347546|NCT01273883|20576939|P2|STARTED|Second Intervention||18
8347547|NCT01273883|20576940|P1|STARTED|Second Intervention||17
8347548|NCT01273883|20576939|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8347549|NCT01273883|20576940|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8347550|NCT01273883|20576939|P2|COMPLETED|Washout Period of 2 Weeks||18
8347551|NCT01273883|20576940|P1|COMPLETED|Washout Period of 2 Weeks||17
8347552|NCT01273883|20576939|P2|STARTED|Washout Period of 2 Weeks||18
8347553|NCT01273883|20576940|P1|STARTED|Washout Period of 2 Weeks||17
8347554|NCT01273883|20576939|P2|NOT COMPLETED|First Intervention||1
8347555|NCT01273883|20576940|P1|NOT COMPLETED|First Intervention||2
8347556|NCT01273883|20576939|P2|COMPLETED|First Intervention||18
8347557|NCT01273883|20576940|P1|COMPLETED|First Intervention||17
8347558|NCT01273883|20576939|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
8347559|NCT01273883|20576940|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
8347560|NCT01273857|20576954|P2|NOT COMPLETED|Overall Study||0
8347561|NCT01273857|20576955|P1|NOT COMPLETED|Overall Study||0
8347562|NCT01273857|20576954|P2|COMPLETED|Overall Study||7
8347563|NCT01273857|20576955|P1|COMPLETED|Overall Study||7
8347564|NCT01273857|20576954|P2|STARTED|Overall Study||7
8347565|NCT01273857|20576955|P1|STARTED|Overall Study||7
8347566|NCT01273818|20576966|P3|NOT COMPLETED|Overall Study||9
8347567|NCT01273818|20576967|P2|NOT COMPLETED|Overall Study||2
8347568|NCT01273818|20576968|P1|NOT COMPLETED|Overall Study||13
8347569|NCT01273818|20576966|P3|COMPLETED|Overall Study||91
8347570|NCT01273818|20576967|P2|COMPLETED|Overall Study||98
8347571|NCT01273818|20576968|P1|COMPLETED|Overall Study||87
8347572|NCT01273818|20576966|P3|STARTED|Overall Study||100
8347573|NCT01273818|20576967|P2|STARTED|Overall Study||100
8347574|NCT01273818|20576968|P1|STARTED|Overall Study||100
8347575|NCT01273805|20576978|P2|NOT COMPLETED|Overall Study||10
8347576|NCT01273805|20576979|P1|NOT COMPLETED|Overall Study||10
8347577|NCT01273805|20576978|P2|COMPLETED|Overall Study||0
8347578|NCT01273805|20576979|P1|COMPLETED|Overall Study||0
8347579|NCT01273805|20576978|P2|STARTED|Overall Study||10
8347580|NCT01273805|20576979|P1|STARTED|Overall Study||10
8347581|NCT01273766|20576998|P3|NOT COMPLETED|Overall Study||0
8347582|NCT01273766|20576999|P2|NOT COMPLETED|Overall Study||0
8347583|NCT01273766|20577000|P1|NOT COMPLETED|Overall Study||0
8347584|NCT01273766|20576998|P3|COMPLETED|Overall Study||5
8347585|NCT01273766|20576999|P2|COMPLETED|Overall Study||7
8347586|NCT01273766|20577000|P1|COMPLETED|Overall Study||4
8347587|NCT01273766|20576998|P3|STARTED|Overall Study||5
8347588|NCT01273766|20576999|P2|STARTED|Overall Study||7
8347589|NCT01273766|20577000|P1|STARTED|Overall Study||4
8347590|NCT01273623|20577010|P1|NOT COMPLETED|Overall Study||29
8347591|NCT01273623|20577010|P1|COMPLETED|Overall Study|met IVUS criteria|26
8347592|NCT01273623|20577010|P1|STARTED|Overall Study|met angiographic criteria|55
8347593|NCT01273597|20577017|P1|NOT COMPLETED|Overall Study||8
8347594|NCT01273597|20577017|P1|COMPLETED|Overall Study||52
8347595|NCT01273597|20577017|P1|STARTED|Overall Study||60
8347596|NCT01273519|20577032|P3|NOT COMPLETED|Overall Study||8
8347597|NCT01273519|20577033|P2|NOT COMPLETED|Overall Study||5
8347598|NCT01273519|20577034|P1|NOT COMPLETED|Overall Study||19
8347599|NCT01273519|20577032|P3|COMPLETED|Overall Study||39
8347600|NCT01273519|20577033|P2|COMPLETED|Overall Study||25
8347601|NCT01273519|20577034|P1|COMPLETED|Overall Study||59
8347602|NCT01273519|20577032|P3|STARTED|Overall Study||47
8347603|NCT01273519|20577033|P2|STARTED|Overall Study||30
8347604|NCT01273519|20577034|P1|STARTED|Overall Study||78
8347605|NCT01273207|20577067|P1|NOT COMPLETED|Overall Study||5
8347606|NCT01273207|20577067|P1|COMPLETED|Overall Study||2
8347607|NCT01273207|20577067|P1|STARTED|Overall Study||7
8347608|NCT01273181|20577077|P4|NOT COMPLETED|Phase 2, Dose 2||1
8347609|NCT01273181|20577078|P3|NOT COMPLETED|Phase 2, Dose 2||0
8347610|NCT01273181|20577079|P2|NOT COMPLETED|Phase 2, Dose 2||0
8347611|NCT01273181|20577080|P1|NOT COMPLETED|Phase 2, Dose 2||0
8347612|NCT01273181|20577077|P4|COMPLETED|Phase 2, Dose 2||0
8347613|NCT01273181|20577078|P3|COMPLETED|Phase 2, Dose 2||0
8347614|NCT01273181|20577079|P2|COMPLETED|Phase 2, Dose 2||0
8347615|NCT01273181|20577080|P1|COMPLETED|Phase 2, Dose 2||0
8347616|NCT01273181|20577077|P4|STARTED|Phase 2, Dose 2||1
8347617|NCT01273181|20577078|P3|STARTED|Phase 2, Dose 2||0
8347618|NCT01273181|20577079|P2|STARTED|Phase 2, Dose 2||0
8347619|NCT01273181|20577080|P1|STARTED|Phase 2, Dose 2||0
8347620|NCT01273181|20577077|P4|NOT COMPLETED|Phase 2, Dose 1||0
8347621|NCT01273181|20577078|P3|NOT COMPLETED|Phase 2, Dose 1||1
8347622|NCT01273181|20577079|P2|NOT COMPLETED|Phase 2, Dose 1||0
8347623|NCT01273181|20577080|P1|NOT COMPLETED|Phase 2, Dose 1||0
8347624|NCT01273181|20577077|P4|COMPLETED|Phase 2, Dose 1||0
8347625|NCT01273181|20577078|P3|COMPLETED|Phase 2, Dose 1||1
8347626|NCT01273181|20577079|P2|COMPLETED|Phase 2, Dose 1||0
8347627|NCT01273181|20577080|P1|COMPLETED|Phase 2, Dose 1||0
8347628|NCT01273181|20577077|P4|STARTED|Phase 2, Dose 1||0
8347629|NCT01273181|20577078|P3|STARTED|Phase 2, Dose 1||2
8347630|NCT01273181|20577079|P2|STARTED|Phase 2, Dose 1||0
8347631|NCT01273181|20577080|P1|STARTED|Phase 2, Dose 1||0
8347632|NCT01273181|20577077|P4|NOT COMPLETED|Phase I, Dose 2||0
8347633|NCT01273181|20577078|P3|NOT COMPLETED|Phase I, Dose 2||0
8347634|NCT01273181|20577079|P2|NOT COMPLETED|Phase I, Dose 2||1
8347635|NCT01273181|20577080|P1|NOT COMPLETED|Phase I, Dose 2||0
8347636|NCT01273181|20577077|P4|COMPLETED|Phase I, Dose 2||0
8347637|NCT01273181|20577078|P3|COMPLETED|Phase I, Dose 2||0
8347638|NCT01273181|20577079|P2|COMPLETED|Phase I, Dose 2||2
8347639|NCT01273181|20577080|P1|COMPLETED|Phase I, Dose 2||0
8347640|NCT01273181|20577077|P4|STARTED|Phase I, Dose 2||0
8347641|NCT01273181|20577078|P3|STARTED|Phase I, Dose 2||0
8347642|NCT01273181|20577079|P2|STARTED|Phase I, Dose 2||3
8347643|NCT01273181|20577080|P1|STARTED|Phase I, Dose 2||0
8347644|NCT01273181|20577077|P4|NOT COMPLETED|Phase I, Dose 1||0
8347645|NCT01273181|20577078|P3|NOT COMPLETED|Phase I, Dose 1||0
8347646|NCT01273181|20577079|P2|NOT COMPLETED|Phase I, Dose 1||0
8347647|NCT01273181|20577080|P1|NOT COMPLETED|Phase I, Dose 1||1
8347648|NCT01273181|20577077|P4|COMPLETED|Phase I, Dose 1||0
8347649|NCT01273181|20577078|P3|COMPLETED|Phase I, Dose 1||0
8347650|NCT01273181|20577079|P2|COMPLETED|Phase I, Dose 1||0
8347651|NCT01273181|20577080|P1|COMPLETED|Phase I, Dose 1||2
8347652|NCT01273181|20577077|P4|STARTED|Phase I, Dose 1||0
8347653|NCT01273181|20577078|P3|STARTED|Phase I, Dose 1||0
8347654|NCT01273181|20577079|P2|STARTED|Phase I, Dose 1||0
8347655|NCT01273181|20577080|P1|STARTED|Phase I, Dose 1||3
8347656|NCT01273155|20577098|P7|NOT COMPLETED|Overall Study||6
8347657|NCT01273155|20577099|P6|NOT COMPLETED|Overall Study||5
8347658|NCT01273155|20577100|P5|NOT COMPLETED|Overall Study||2
8347659|NCT01273155|20577101|P4|NOT COMPLETED|Overall Study||1
8347660|NCT01273155|20577102|P3|NOT COMPLETED|Overall Study||12
8347661|NCT01273155|20577103|P2|NOT COMPLETED|Overall Study||4
8347662|NCT01273155|20577104|P1|NOT COMPLETED|Overall Study||2
8347663|NCT01273155|20577098|P7|COMPLETED|Overall Study||2
8347664|NCT01273155|20577099|P6|COMPLETED|Overall Study||5
8347665|NCT01273155|20577100|P5|COMPLETED|Overall Study||3
8347666|NCT01273155|20577101|P4|COMPLETED|Overall Study||4
8347667|NCT01273155|20577102|P3|COMPLETED|Overall Study||6
8347668|NCT01273155|20577103|P2|COMPLETED|Overall Study||8
8347669|NCT01273155|20577104|P1|COMPLETED|Overall Study||12
8347670|NCT01273155|20577098|P7|STARTED|Overall Study||8
8347671|NCT01273155|20577099|P6|STARTED|Overall Study||10
8347672|NCT01273155|20577100|P5|STARTED|Overall Study||5
8347673|NCT01273155|20577101|P4|STARTED|Overall Study||5
8347674|NCT01273155|20577102|P3|STARTED|Overall Study||18
8347675|NCT01273155|20577103|P2|STARTED|Overall Study||12
8347676|NCT01273155|20577104|P1|STARTED|Overall Study||14
8347677|NCT01273064|20577181|P5|NOT COMPLETED|Overall Study||10
8347678|NCT01273064|20577182|P4|NOT COMPLETED|Overall Study||20
8347679|NCT01273064|20577183|P3|NOT COMPLETED|Overall Study||31
8347680|NCT01273064|20577184|P2|NOT COMPLETED|Overall Study||30
8347681|NCT01273064|20577185|P1|NOT COMPLETED|Overall Study||23
8347682|NCT01273064|20577181|P5|COMPLETED|Overall Study||0
8347683|NCT01273064|20577182|P4|COMPLETED|Overall Study||0
8347684|NCT01273064|20577183|P3|COMPLETED|Overall Study||0
8347685|NCT01273064|20577184|P2|COMPLETED|Overall Study||0
8347686|NCT01273064|20577185|P1|COMPLETED|Overall Study||0
8347687|NCT01273064|20577181|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
8347688|NCT01273064|20577182|P4|STARTED|Overall Study||20
8347689|NCT01273064|20577183|P3|STARTED|Overall Study||31
8347690|NCT01273064|20577184|P2|STARTED|Overall Study||30
8347691|NCT01273064|20577185|P1|STARTED|Overall Study||23
8347692|NCT01273038|20577204|P2|NOT COMPLETED|Second Intervention (14 Days)||2
8347693|NCT01273038|20577205|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8347694|NCT01273038|20577204|P2|COMPLETED|Second Intervention (14 Days)||8
8347695|NCT01273038|20577205|P1|COMPLETED|Second Intervention (14 Days)||10
8347696|NCT01273038|20577204|P2|STARTED|Second Intervention (14 Days)||10
8347697|NCT01273038|20577205|P1|STARTED|Second Intervention (14 Days)||10
8347698|NCT01273038|20577204|P2|NOT COMPLETED|First Intervention (14 Days)||0
8347699|NCT01273038|20577205|P1|NOT COMPLETED|First Intervention (14 Days)||0
8347700|NCT01273038|20577204|P2|COMPLETED|First Intervention (14 Days)||10
8347701|NCT01273038|20577205|P1|COMPLETED|First Intervention (14 Days)||10
8347702|NCT01273038|20577204|P2|STARTED|First Intervention (14 Days)||10
8347703|NCT01273038|20577205|P1|STARTED|First Intervention (14 Days)||10
8347704|NCT01272999|20577213|P2|NOT COMPLETED|Overall Study||0
8347705|NCT01272999|20577214|P1|NOT COMPLETED|Overall Study||0
8347706|NCT01272999|20577213|P2|COMPLETED|Overall Study||34
8347707|NCT01272999|20577214|P1|COMPLETED|Overall Study||357
8347708|NCT01272999|20577213|P2|STARTED|Overall Study||34
8347709|NCT01272999|20577214|P1|STARTED|Overall Study||357
8347710|NCT01272960|20577240|P2|NOT COMPLETED|Overall Study||0
8347711|NCT01272960|20577241|P1|NOT COMPLETED|Overall Study||0
8347712|NCT01272960|20577240|P2|COMPLETED|Overall Study||15
8347713|NCT01272960|20577241|P1|COMPLETED|Overall Study||14
8347714|NCT01272960|20577240|P2|STARTED|Overall Study||15
8347715|NCT01272960|20577241|P1|STARTED|Overall Study||14
8347716|NCT01272947|20577255|P2|NOT COMPLETED|Overall Study||2
8347717|NCT01272947|20577256|P1|NOT COMPLETED|Overall Study||2
8347718|NCT01272947|20577255|P2|COMPLETED|Overall Study||98
8347719|NCT01272947|20577256|P1|COMPLETED|Overall Study||102
8347720|NCT01272947|20577255|P2|STARTED|Overall Study||100
8347721|NCT01272947|20577256|P1|STARTED|Overall Study||104
8347722|NCT01272934|20577266|P2|NOT COMPLETED|Overall Study||2
8347723|NCT01272934|20577267|P1|NOT COMPLETED|Overall Study||0
8347724|NCT01272934|20577266|P2|COMPLETED|Overall Study||101
8347725|NCT01272934|20577267|P1|COMPLETED|Overall Study||102
8347726|NCT01272934|20577266|P2|STARTED|Overall Study||103
8347727|NCT01272934|20577267|P1|STARTED|Overall Study||102
8347728|NCT01272921|20577277|P2|NOT COMPLETED|Overall Study||1
8347729|NCT01272921|20577278|P1|NOT COMPLETED|Overall Study||2
8347730|NCT01272921|20577277|P2|COMPLETED|Overall Study||70
8347731|NCT01272921|20577278|P1|COMPLETED|Overall Study||69
8347732|NCT01272921|20577277|P2|STARTED|Overall Study||71
8347733|NCT01272921|20577278|P1|STARTED|Overall Study||71
8347734|NCT01272908|20577286|P1|NOT COMPLETED|Re-Treatment Period||6
8347735|NCT01272908|20577286|P1|COMPLETED|Re-Treatment Period||71
8347736|NCT01272908|20577286|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
8347737|NCT01272908|20577286|P1|NOT COMPLETED|Initial Treatment Period||8
8347738|NCT01272908|20577286|P1|COMPLETED|Initial Treatment Period||112
8347739|NCT01272908|20577286|P1|STARTED|Initial Treatment Period||120
8347740|NCT01272882|20577320|P1|NOT COMPLETED|Overall Study||0
8347741|NCT01272882|20577320|P1|COMPLETED|Overall Study||13
8347742|NCT01272882|20577320|P1|STARTED|Overall Study||13
8347743|NCT01272869|20577326|P2|NOT COMPLETED|Period 2 (14 Days)||0
8347744|NCT01272869|20577327|P1|NOT COMPLETED|Period 2 (14 Days)||1
8347745|NCT01272869|20577326|P2|COMPLETED|Period 2 (14 Days)||10
8347746|NCT01272869|20577327|P1|COMPLETED|Period 2 (14 Days)||9
8347747|NCT01272869|20577326|P2|STARTED|Period 2 (14 Days)||10
8347748|NCT01272869|20577327|P1|STARTED|Period 2 (14 Days)||10
8347749|NCT01272869|20577326|P2|NOT COMPLETED|Period 1 (14 Days)||0
8347750|NCT01272869|20577327|P1|NOT COMPLETED|Period 1 (14 Days)||0
8347751|NCT01272869|20577326|P2|COMPLETED|Period 1 (14 Days)||10
8347752|NCT01272869|20577327|P1|COMPLETED|Period 1 (14 Days)||10
8347753|NCT01272869|20577326|P2|STARTED|Period 1 (14 Days)||10
8347754|NCT01272869|20577327|P1|STARTED|Period 1 (14 Days)||10
8347755|NCT01272830|20577335|P2|NOT COMPLETED|Overall Study||5
8347756|NCT01272830|20577336|P1|NOT COMPLETED|Overall Study||8
8347757|NCT01272830|20577335|P2|COMPLETED|Overall Study||21
8347758|NCT01272830|20577336|P1|COMPLETED|Overall Study||17
8347759|NCT01272830|20577335|P2|STARTED|Overall Study||26
8347760|NCT01272830|20577336|P1|STARTED|Overall Study||25
8347761|NCT01272804|20577354|P6|NOT COMPLETED|Overall Study||1
8347762|NCT01272804|20577355|P5|NOT COMPLETED|Overall Study||2
8347763|NCT01272804|20577356|P4|NOT COMPLETED|Overall Study||0
8347764|NCT01272804|20577357|P3|NOT COMPLETED|Overall Study||0
8347765|NCT01272804|20577358|P2|NOT COMPLETED|Overall Study||0
8347766|NCT01272804|20577359|P1|NOT COMPLETED|Overall Study||1
8347767|NCT01272804|20577354|P6|COMPLETED|Overall Study||15
8347768|NCT01272804|20577355|P5|COMPLETED|Overall Study||7
8347769|NCT01272804|20577356|P4|COMPLETED|Overall Study||9
8347770|NCT01272804|20577357|P3|COMPLETED|Overall Study||9
8347771|NCT01272804|20577358|P2|COMPLETED|Overall Study||9
8347772|NCT01272804|20577359|P1|COMPLETED|Overall Study||8
8347773|NCT01272804|20577354|P6|STARTED|Overall Study||16
8347774|NCT01272804|20577355|P5|STARTED|Overall Study||9
8347775|NCT01272804|20577356|P4|STARTED|Overall Study||9
8347776|NCT01272804|20577357|P3|STARTED|Overall Study||9
8347777|NCT01272804|20577358|P2|STARTED|Overall Study||9
8347778|NCT01272804|20577359|P1|STARTED|Overall Study||9
8347779|NCT01272661|20577517|P3|NOT COMPLETED|Overall Study||72
8347780|NCT01272661|20577518|P2|NOT COMPLETED|Overall Study||209
8347781|NCT01272661|20577519|P1|NOT COMPLETED|Overall Study||126
8347782|NCT01272661|20577517|P3|COMPLETED|Overall Study||314
8347783|NCT01272661|20577518|P2|COMPLETED|Overall Study||288
8347784|NCT01272661|20577519|P1|COMPLETED|Overall Study||287
8347785|NCT01272661|20577517|P3|STARTED|Overall Study||386
8347786|NCT01272661|20577518|P2|STARTED|Overall Study||497
8347787|NCT01272661|20577519|P1|STARTED|Overall Study||413
8347788|NCT01272635|20577544|P4|NOT COMPLETED|Overall Study||23
8347789|NCT01272635|20577545|P3|NOT COMPLETED|Overall Study||31
8347790|NCT01272635|20577546|P2|NOT COMPLETED|Overall Study||20
8347791|NCT01272635|20577547|P1|NOT COMPLETED|Overall Study||31
8347792|NCT01272635|20577544|P4|COMPLETED|Overall Study||129
8347793|NCT01272635|20577545|P3|COMPLETED|Overall Study||117
8347794|NCT01272635|20577546|P2|COMPLETED|Overall Study||134
8347795|NCT01272635|20577547|P1|COMPLETED|Overall Study||122
8347796|NCT01272635|20577544|P4|STARTED|Overall Study||152
8347797|NCT01272635|20577545|P3|STARTED|Overall Study||148
8347798|NCT01272635|20577546|P2|STARTED|Overall Study||154
8347799|NCT01272635|20577547|P1|STARTED|Overall Study||153
8347800|NCT01272583|20577565|P2|NOT COMPLETED|Overall Study||0
8347801|NCT01272583|20577566|P1|NOT COMPLETED|Overall Study||0
8347802|NCT01272583|20577565|P2|COMPLETED|Overall Study||8
8347803|NCT01272583|20577566|P1|COMPLETED|Overall Study||8
8347804|NCT01272583|20577565|P2|STARTED|Overall Study||8
8347805|NCT01272583|20577566|P1|STARTED|Overall Study||8
8347806|NCT01272388|20577597|P2|NOT COMPLETED|Overall Study||0
8347807|NCT01272388|20577598|P1|NOT COMPLETED|Overall Study||0
8347808|NCT01272388|20577597|P2|COMPLETED|Overall Study||0
8347809|NCT01272388|20577598|P1|COMPLETED|Overall Study||1
8347810|NCT01272388|20577597|P2|STARTED|Overall Study||0
8347811|NCT01272388|20577598|P1|STARTED|Overall Study||1
8347821|NCT01272245|20577620|P1|NOT COMPLETED|Overall Study||0
8347822|NCT01272245|20577620|P1|COMPLETED|Overall Study||36
8347823|NCT01272245|20577620|P1|STARTED|Overall Study||36
8347824|NCT01272232|20577631|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
8347825|NCT01272232|20577632|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
8347826|NCT01272232|20577633|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
8347827|NCT01272232|20577631|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
8347828|NCT01272232|20577632|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
8347829|NCT01272232|20577633|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
8347830|NCT01272232|20577631|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
8347831|NCT01272232|20577632|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
8347832|NCT01272232|20577633|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
8347833|NCT01272232|20577631|P3|NOT COMPLETED|Weeks 0-56||72
8347834|NCT01272232|20577632|P2|NOT COMPLETED|Weeks 0-56||47
8347835|NCT01272232|20577633|P1|NOT COMPLETED|Weeks 0-56||99
8347836|NCT01272232|20577631|P3|COMPLETED|Weeks 0-56||140
8347837|NCT01272232|20577632|P2|COMPLETED|Weeks 0-56||164
8347838|NCT01272232|20577633|P1|COMPLETED|Weeks 0-56||324
8347839|NCT01272232|20577631|P3|Exposed|Weeks 0-56||212
8347840|NCT01272232|20577632|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
8347841|NCT01272232|20577633|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
8347842|NCT01272232|20577631|P3|STARTED|Weeks 0-56||212
8347843|NCT01272232|20577632|P2|STARTED|Weeks 0-56||211
8347844|NCT01272232|20577633|P1|STARTED|Weeks 0-56||423
8347845|NCT01272219|20577678|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
8347846|NCT01272219|20577679|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
8347847|NCT01272219|20577680|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347848|NCT01272219|20577681|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347849|NCT01272219|20577682|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347850|NCT01272219|20577683|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347851|NCT01272219|20577678|P6|COMPLETED|Main + Extension Period: Week 0-172||327
8347852|NCT01272219|20577679|P5|COMPLETED|Main + Extension Period: Week 0-172||783
8347853|NCT01272219|20577680|P4|COMPLETED|Main + Extension Period: Week 0-172||0
8347854|NCT01272219|20577681|P3|COMPLETED|Main + Extension Period: Week 0-172||0
8347855|NCT01272219|20577682|P2|COMPLETED|Main + Extension Period: Week 0-172||0
8347856|NCT01272219|20577683|P1|COMPLETED|Main + Extension Period: Week 0-172||0
8347857|NCT01272219|20577678|P6|Exposed|Main + Extension Period: Week 0-172||747
8347858|NCT01272219|20577679|P5|Exposed|Main + Extension Period: Week 0-172||1501
8347859|NCT01272219|20577680|P4|Exposed|Main + Extension Period: Week 0-172||0
8347860|NCT01272219|20577681|P3|Exposed|Main + Extension Period: Week 0-172||0
8347861|NCT01272219|20577682|P2|Exposed|Main + Extension Period: Week 0-172||0
8347862|NCT01272219|20577683|P1|Exposed|Main + Extension Period: Week 0-172||0
8347863|NCT01272219|20577678|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
8347864|NCT01272219|20577679|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
8347865|NCT01272219|20577680|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
8347866|NCT01272219|20577681|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
8347867|NCT01272219|20577682|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
8347868|NCT01272219|20577683|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
8347869|NCT01272219|20577678|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347870|NCT01272219|20577679|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347871|NCT01272219|20577680|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
8347872|NCT01272219|20577681|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
8347873|NCT01272219|20577682|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
8347874|NCT01272219|20577683|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347875|NCT01272219|20577678|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347876|NCT01272219|20577679|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347877|NCT01272219|20577680|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
8347878|NCT01272219|20577681|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
8347879|NCT01272219|20577682|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
8347880|NCT01272219|20577683|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347881|NCT01272219|20577678|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8347882|NCT01272219|20577679|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8347883|NCT01272219|20577680|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
8347884|NCT01272219|20577681|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
8347885|NCT01272219|20577682|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
8347886|NCT01272219|20577683|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8347887|NCT01272219|20577678|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
8347888|NCT01272219|20577679|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
8347889|NCT01272219|20577680|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
8347890|NCT01272219|20577681|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
8347891|NCT01272219|20577682|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
8347892|NCT01272219|20577683|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
8347893|NCT01272219|20577678|P6|COMPLETED|Main Period: Week 0 to Week 56||505
8347894|NCT01272219|20577679|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
8347895|NCT01272219|20577680|P4|COMPLETED|Main Period: Week 0 to Week 56||296
8347896|NCT01272219|20577681|P3|COMPLETED|Main Period: Week 0 to Week 56||0
8347897|NCT01272219|20577682|P2|COMPLETED|Main Period: Week 0 to Week 56||0
8347898|NCT01272219|20577683|P1|COMPLETED|Main Period: Week 0 to Week 56||679
8347899|NCT01272219|20577678|P6|Exposed|Main Period: Week 0 to Week 56||755
8347900|NCT01272219|20577679|P5|Exposed|Main Period: Week 0 to Week 56||1524
8347901|NCT01272219|20577680|P4|Exposed|Main Period: Week 0 to Week 56||487
8347902|NCT01272219|20577681|P3|Exposed|Main Period: Week 0 to Week 56||0
8347903|NCT01272219|20577682|P2|Exposed|Main Period: Week 0 to Week 56||0
8347904|NCT01272219|20577683|P1|Exposed|Main Period: Week 0 to Week 56||957
8347905|NCT01272219|20577678|P6|STARTED|Main Period: Week 0 to Week 56||757
8347906|NCT01272219|20577679|P5|STARTED|Main Period: Week 0 to Week 56||1528
8347907|NCT01272219|20577680|P4|STARTED|Main Period: Week 0 to Week 56||487
8347908|NCT01272219|20577681|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
8347909|NCT01272219|20577682|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
8347910|NCT01272219|20577683|P1|STARTED|Main Period: Week 0 to Week 56||959
8347911|NCT01272193|20577717|P2|NOT COMPLETED|Overall Study||12
8347912|NCT01272193|20577718|P1|NOT COMPLETED|Overall Study||10
8347913|NCT01272193|20577717|P2|COMPLETED|Overall Study||137
8347914|NCT01272193|20577718|P1|COMPLETED|Overall Study||137
8347915|NCT01272193|20577717|P2|STARTED|Overall Study||149
8347916|NCT01272193|20577718|P1|STARTED|Overall Study||147
8347917|NCT01272180|20577738|P4|NOT COMPLETED|Overall Study||14
8347918|NCT01272180|20577739|P3|NOT COMPLETED|Overall Study||13
8347919|NCT01272180|20577740|P2|NOT COMPLETED|Overall Study||21
8347920|NCT01272180|20577741|P1|NOT COMPLETED|Overall Study||17
8347921|NCT01272180|20577738|P4|COMPLETED|Overall Study||107
8347922|NCT01272180|20577739|P3|COMPLETED|Overall Study||109
8347923|NCT01272180|20577740|P2|COMPLETED|Overall Study||100
8347924|NCT01272180|20577741|P1|COMPLETED|Overall Study||103
8347925|NCT01272180|20577738|P4|STARTED|Overall Study||121
8347926|NCT01272180|20577739|P3|STARTED|Overall Study||122
8347927|NCT01272180|20577740|P2|STARTED|Overall Study||121
8347928|NCT01272180|20577741|P1|STARTED|Overall Study||120
8347929|NCT01272141|20577781|P1|NOT COMPLETED|Overall Study||0
8347930|NCT01272141|20577781|P1|COMPLETED|Overall Study||5
8347931|NCT01272141|20577781|P1|STARTED|Overall Study||5
8347932|NCT01272076|20577786|P1|NOT COMPLETED|Overall Study||0
8347933|NCT01272076|20577786|P1|COMPLETED|Overall Study||52
8347934|NCT01272076|20577786|P1|STARTED|Overall Study||52
8347935|NCT01272011|20577793|P3|NOT COMPLETED|Overall Study||0
8347936|NCT01272011|20577794|P2|NOT COMPLETED|Overall Study||2
8347937|NCT01272011|20577795|P1|NOT COMPLETED|Overall Study||0
8347938|NCT01272011|20577793|P3|COMPLETED|Overall Study||3
8347939|NCT01272011|20577794|P2|COMPLETED|Overall Study||8
8347940|NCT01272011|20577795|P1|COMPLETED|Overall Study||3
8347941|NCT01272011|20577793|P3|STARTED|Overall Study||3
8347942|NCT01272011|20577794|P2|STARTED|Overall Study||10
8347943|NCT01272011|20577795|P1|STARTED|Overall Study||3
8347944|NCT01271946|20577808|P2|NOT COMPLETED|Overall Study||0
8347945|NCT01271946|20577809|P1|NOT COMPLETED|Overall Study||0
8347946|NCT01271946|20577808|P2|COMPLETED|Overall Study||5
8347947|NCT01271946|20577809|P1|COMPLETED|Overall Study||346
8347948|NCT01271946|20577808|P2|STARTED|Overall Study||5
8347949|NCT01271946|20577809|P1|STARTED|Overall Study||346
8347950|NCT01271933|20577831|P3|NOT COMPLETED|Double-Blind Phase||12
8347951|NCT01271933|20577832|P2|NOT COMPLETED|Double-Blind Phase||17
8347952|NCT01271933|20577833|P1|NOT COMPLETED|Double-Blind Phase||0
8347953|NCT01271933|20577831|P3|COMPLETED|Double-Blind Phase||47
8347954|NCT01271933|20577832|P2|COMPLETED|Double-Blind Phase||46
8347955|NCT01271933|20577833|P1|COMPLETED|Double-Blind Phase||0
8347956|NCT01271933|20577831|P3|Treated|Double-Blind Phase||58
8347957|NCT01271933|20577832|P2|Treated|Double-Blind Phase||63
8347958|NCT01271933|20577833|P1|Treated|Double-Blind Phase||0
8347959|NCT01271933|20577831|P3|STARTED|Double-Blind Phase||59
8347960|NCT01271933|20577832|P2|STARTED|Double-Blind Phase||63
8347961|NCT01271933|20577833|P1|STARTED|Double-Blind Phase||0
8347962|NCT01271933|20577831|P3|NOT COMPLETED|Single-Blind Phase||0
8347963|NCT01271933|20577832|P2|NOT COMPLETED|Single-Blind Phase||0
8347964|NCT01271933|20577833|P1|NOT COMPLETED|Single-Blind Phase||121
8347965|NCT01271933|20577831|P3|COMPLETED|Single-Blind Phase||0
8347966|NCT01271933|20577832|P2|COMPLETED|Single-Blind Phase||0
8347967|NCT01271933|20577833|P1|COMPLETED|Single-Blind Phase||320
8347968|NCT01271933|20577831|P3|STARTED|Single-Blind Phase||0
8347969|NCT01271933|20577832|P2|STARTED|Single-Blind Phase||0
8347970|NCT01271933|20577833|P1|STARTED|Single-Blind Phase||441
8347971|NCT01271907|20577933|P3|NOT COMPLETED|Overall Study||0
8347972|NCT01271907|20577934|P2|NOT COMPLETED|Overall Study||0
8347973|NCT01271907|20577935|P1|NOT COMPLETED|Overall Study||0
8347974|NCT01271907|20577933|P3|COMPLETED|Overall Study||0
8347975|NCT01271907|20577934|P2|COMPLETED|Overall Study||0
8347976|NCT01271907|20577935|P1|COMPLETED|Overall Study||3
8347977|NCT01271907|20577933|P3|STARTED|Overall Study||0
8347978|NCT01271907|20577934|P2|STARTED|Overall Study||0
8347979|NCT01271907|20577935|P1|STARTED|Overall Study||3
8347980|NCT01271868|20577949|P1|NOT COMPLETED|Treatment Study||0
8347981|NCT01271868|20577949|P1|COMPLETED|Treatment Study||9
8347982|NCT01271868|20577949|P1|STARTED|Treatment Study||9
8347983|NCT01271868|20577949|P1|NOT COMPLETED|Pharmacokinetic Study||0
8347984|NCT01271868|20577949|P1|COMPLETED|Pharmacokinetic Study||9
8347985|NCT01271868|20577949|P1|STARTED|Pharmacokinetic Study||9
8347986|NCT01271855|20577962|P2|NOT COMPLETED|Overall Study||0
8347987|NCT01271855|20577963|P1|NOT COMPLETED|Overall Study||0
8347988|NCT01271855|20577962|P2|COMPLETED|Overall Study||52
8347989|NCT01271855|20577963|P1|COMPLETED|Overall Study||48
8347990|NCT01271855|20577962|P2|STARTED|Overall Study||52
8347991|NCT01271855|20577963|P1|STARTED|Overall Study||48
8347992|NCT01271803|20577976|P3|NOT COMPLETED|Overall Study||2
8347993|NCT01271803|20577977|P2|NOT COMPLETED|Overall Study||39
8347994|NCT01271803|20577978|P1|NOT COMPLETED|Overall Study||55
8347995|NCT01271803|20577976|P3|COMPLETED|Overall Study||0
8347996|NCT01271803|20577977|P2|COMPLETED|Overall Study||24
8347997|NCT01271803|20577978|P1|COMPLETED|Overall Study||11
8347998|NCT01271803|20577976|P3|STARTED|Overall Study||2
8347999|NCT01271803|20577977|P2|STARTED|Overall Study||63
8348000|NCT01271803|20577978|P1|STARTED|Overall Study||66
8348001|NCT01271725|20578140|P2|NOT COMPLETED|Part B||12
8348002|NCT01271725|20578141|P1|NOT COMPLETED|Part B||0
8348003|NCT01271725|20578140|P2|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
8348004|NCT01271725|20578141|P1|COMPLETED|Part B||0
8348005|NCT01271725|20578140|P2|STARTED|Part B||39
8348006|NCT01271725|20578141|P1|STARTED|Part B||0
8348007|NCT01271725|20578140|P2|NOT COMPLETED|Part A||0
8348008|NCT01271725|20578141|P1|NOT COMPLETED|Part A||35
8348009|NCT01271725|20578140|P2|COMPLETED|Part A||0
8348010|NCT01271725|20578141|P1|COMPLETED|Part A||39
8348011|NCT01271725|20578140|P2|STARTED|Part A||0
8348012|NCT01271725|20578141|P1|STARTED|Part A|Started are the treated patients|74
8348013|NCT01271686|20578168|P1|NOT COMPLETED|Overall Study||0
8348014|NCT01271686|20578168|P1|COMPLETED|Overall Study||16
8348015|NCT01271686|20578168|P1|STARTED|Overall Study||16
8348016|NCT01271543|20578174|P2|NOT COMPLETED|Overall Study||1
8348017|NCT01271543|20578175|P1|NOT COMPLETED|Overall Study||1
8348018|NCT01271543|20578174|P2|COMPLETED|Overall Study||29
8348019|NCT01271543|20578175|P1|COMPLETED|Overall Study||29
8348020|NCT01271543|20578174|P2|STARTED|Overall Study||30
8348021|NCT01271543|20578175|P1|STARTED|Overall Study||30
8348022|NCT01271452|20578185|P2|NOT COMPLETED|Overall Study||8
8348023|NCT01271452|20578186|P1|NOT COMPLETED|Overall Study||7
8348024|NCT01271452|20578185|P2|COMPLETED|Overall Study||104
8348025|NCT01271452|20578186|P1|COMPLETED|Overall Study||105
8348026|NCT01271452|20578185|P2|STARTED|Overall Study||112
8348027|NCT01271452|20578186|P1|STARTED|Overall Study||112
8348028|NCT01271413|20578208|P2|NOT COMPLETED|Overall Study||8
8348029|NCT01271413|20578209|P1|NOT COMPLETED|Overall Study||9
8348030|NCT01271413|20578208|P2|COMPLETED|Overall Study||28
8348031|NCT01271413|20578209|P1|COMPLETED|Overall Study||28
8348032|NCT01271413|20578208|P2|STARTED|Overall Study||36
8348033|NCT01271413|20578209|P1|STARTED|Overall Study||37
8348034|NCT01271244|20578217|P2|NOT COMPLETED|Overall Study||3
8348035|NCT01271244|20578218|P1|NOT COMPLETED|Overall Study||7
8348036|NCT01271244|20578217|P2|COMPLETED|Overall Study||5
8348037|NCT01271244|20578218|P1|COMPLETED|Overall Study||11
8348038|NCT01271244|20578217|P2|STARTED|Overall Study||8
8348039|NCT01271244|20578218|P1|STARTED|Overall Study||18
8348040|NCT01271036|20578228|P2|NOT COMPLETED|Overall Study||0
8348041|NCT01271036|20578229|P1|NOT COMPLETED|Overall Study||0
8348042|NCT01271036|20578228|P2|COMPLETED|Overall Study||62
8348043|NCT01271036|20578229|P1|COMPLETED|Overall Study||62
8348044|NCT01271036|20578228|P2|STARTED|Overall Study||62
8348045|NCT01271036|20578229|P1|STARTED|Overall Study||62
8348046|NCT01271010|20578243|P1|NOT COMPLETED|Overall Study||61
8348047|NCT01271010|20578243|P1|COMPLETED|Overall Study||28
8348048|NCT01271010|20578243|P1|STARTED|Overall Study||89
8348049|NCT01270971|20578258|P2|NOT COMPLETED|Overall Study||23
8348050|NCT01270971|20578259|P1|NOT COMPLETED|Overall Study||52
8348051|NCT01270971|20578258|P2|COMPLETED|Overall Study||171
8348052|NCT01270971|20578259|P1|COMPLETED|Overall Study||348
8348053|NCT01270971|20578258|P2|STARTED|Overall Study||194
8348054|NCT01270971|20578259|P1|STARTED|Overall Study||400
8348055|NCT01270958|20578271|P1|NOT COMPLETED|Overall Study||4
8348056|NCT01270958|20578271|P1|COMPLETED|Overall Study||56
8348057|NCT01270958|20578271|P1|STARTED|Overall Study||60
8348058|NCT01270919|20578295|P1|NOT COMPLETED|Overall Study||0
8348059|NCT01270919|20578295|P1|COMPLETED|Overall Study||0
8348060|NCT01270919|20578295|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
8348061|NCT01270880|20578300|P1|NOT COMPLETED|Overall Study||1
8348062|NCT01270880|20578300|P1|COMPLETED|Overall Study||17
8348063|NCT01270880|20578300|P1|STARTED|Overall Study||18
8348064|NCT01270867|20578311|P2|NOT COMPLETED|Overall Study||0
8348065|NCT01270867|20578312|P1|NOT COMPLETED|Overall Study||1
8348066|NCT01270867|20578311|P2|COMPLETED|Overall Study||88
8348067|NCT01270867|20578312|P1|COMPLETED|Overall Study||89
8348068|NCT01270867|20578311|P2|STARTED|Overall Study||88
8348069|NCT01270867|20578312|P1|STARTED|Overall Study||90
8348070|NCT01270841|20578330|P4|NOT COMPLETED|Overall Study||13
8348071|NCT01270841|20578331|P3|NOT COMPLETED|Overall Study||11
8348072|NCT01270841|20578332|P2|NOT COMPLETED|Overall Study||14
8348073|NCT01270841|20578333|P1|NOT COMPLETED|Overall Study||13
8348074|NCT01270841|20578330|P4|COMPLETED|Overall Study||20
8348075|NCT01270841|20578331|P3|COMPLETED|Overall Study||18
8348076|NCT01270841|20578332|P2|COMPLETED|Overall Study||19
8348077|NCT01270841|20578333|P1|COMPLETED|Overall Study||16
8348078|NCT01270841|20578330|P4|STARTED|Overall Study||33
8348079|NCT01270841|20578331|P3|STARTED|Overall Study||29
8348080|NCT01270841|20578332|P2|STARTED|Overall Study||33
8348081|NCT01270841|20578333|P1|STARTED|Overall Study||29
8348082|NCT01270802|20578357|P2|NOT COMPLETED|Overall Study||1
8348083|NCT01270802|20578358|P1|NOT COMPLETED|Overall Study||2
8348084|NCT01270802|20578357|P2|COMPLETED|Overall Study||14
8348085|NCT01270802|20578358|P1|COMPLETED|Overall Study||13
8348086|NCT01270802|20578357|P2|STARTED|Overall Study||15
8348087|NCT01270802|20578358|P1|STARTED|Overall Study||15
8348088|NCT01270711|20578374|P8|NOT COMPLETED|Part 2: Effectiveness||0
8348089|NCT01270711|20578375|P7|NOT COMPLETED|Part 2: Effectiveness||0
8348090|NCT01270711|20578376|P6|NOT COMPLETED|Part 2: Effectiveness||0
8348091|NCT01270711|20578377|P5|NOT COMPLETED|Part 2: Effectiveness||0
8348092|NCT01270711|20578378|P4|NOT COMPLETED|Part 2: Effectiveness||0
8348093|NCT01270711|20578379|P3|NOT COMPLETED|Part 2: Effectiveness||0
8348094|NCT01270711|20578380|P2|NOT COMPLETED|Part 2: Effectiveness||0
8348095|NCT01270711|20578381|P1|NOT COMPLETED|Part 2: Effectiveness||0
8348096|NCT01270711|20578374|P8|COMPLETED|Part 2: Effectiveness||48
8348097|NCT01270711|20578375|P7|COMPLETED|Part 2: Effectiveness||2
8348098|NCT01270711|20578376|P6|COMPLETED|Part 2: Effectiveness||11
8348099|NCT01270711|20578377|P5|COMPLETED|Part 2: Effectiveness||0
8348100|NCT01270711|20578378|P4|COMPLETED|Part 2: Effectiveness||0
8348101|NCT01270711|20578379|P3|COMPLETED|Part 2: Effectiveness||0
8348102|NCT01270711|20578380|P2|COMPLETED|Part 2: Effectiveness||0
8348103|NCT01270711|20578381|P1|COMPLETED|Part 2: Effectiveness||0
8348104|NCT01270711|20578374|P8|STARTED|Part 2: Effectiveness||48
8348105|NCT01270711|20578375|P7|STARTED|Part 2: Effectiveness||2
8348106|NCT01270711|20578376|P6|STARTED|Part 2: Effectiveness||11
8348107|NCT01270711|20578377|P5|STARTED|Part 2: Effectiveness||0
8348108|NCT01270711|20578378|P4|STARTED|Part 2: Effectiveness||0
8348109|NCT01270711|20578379|P3|STARTED|Part 2: Effectiveness||0
8348110|NCT01270711|20578380|P2|STARTED|Part 2: Effectiveness||0
8348111|NCT01270711|20578381|P1|STARTED|Part 2: Effectiveness||0
8348112|NCT01270711|20578374|P8|NOT COMPLETED|Part 1: Compliance||0
8348113|NCT01270711|20578375|P7|NOT COMPLETED|Part 1: Compliance||0
8348114|NCT01270711|20578376|P6|NOT COMPLETED|Part 1: Compliance||0
8348115|NCT01270711|20578377|P5|NOT COMPLETED|Part 1: Compliance||0
8348116|NCT01270711|20578378|P4|NOT COMPLETED|Part 1: Compliance||0
8348117|NCT01270711|20578379|P3|NOT COMPLETED|Part 1: Compliance||0
8348118|NCT01270711|20578380|P2|NOT COMPLETED|Part 1: Compliance||0
8348119|NCT01270711|20578381|P1|NOT COMPLETED|Part 1: Compliance||0
8348120|NCT01270711|20578374|P8|COMPLETED|Part 1: Compliance||0
8348121|NCT01270711|20578375|P7|COMPLETED|Part 1: Compliance||0
8348122|NCT01270711|20578376|P6|COMPLETED|Part 1: Compliance||0
8348123|NCT01270711|20578377|P5|COMPLETED|Part 1: Compliance||2024
8348124|NCT01270711|20578378|P4|COMPLETED|Part 1: Compliance||5486
8348125|NCT01270711|20578379|P3|COMPLETED|Part 1: Compliance||326
8348126|NCT01270711|20578380|P2|COMPLETED|Part 1: Compliance||6580
8348127|NCT01270711|20578381|P1|COMPLETED|Part 1: Compliance||7537
8348128|NCT01270711|20578374|P8|STARTED|Part 1: Compliance||0
8348129|NCT01270711|20578375|P7|STARTED|Part 1: Compliance||0
8348130|NCT01270711|20578376|P6|STARTED|Part 1: Compliance||0
8348131|NCT01270711|20578377|P5|STARTED|Part 1: Compliance||2024
8348132|NCT01270711|20578378|P4|STARTED|Part 1: Compliance||5486
8348133|NCT01270711|20578379|P3|STARTED|Part 1: Compliance||326
8348134|NCT01270711|20578380|P2|STARTED|Part 1: Compliance||6580
8348135|NCT01270711|20578381|P1|STARTED|Part 1: Compliance||7537
8348136|NCT01270659|20578482|P4|NOT COMPLETED|Overall Study||0
8348137|NCT01270659|20578483|P3|NOT COMPLETED|Overall Study||0
8348138|NCT01270659|20578484|P2|NOT COMPLETED|Overall Study||0
8348139|NCT01270659|20578485|P1|NOT COMPLETED|Overall Study||0
8348140|NCT01270659|20578482|P4|COMPLETED|Overall Study||25
8348141|NCT01270659|20578483|P3|COMPLETED|Overall Study||4
8348142|NCT01270659|20578484|P2|COMPLETED|Overall Study||25
8348143|NCT01270659|20578485|P1|COMPLETED|Overall Study||6
8348144|NCT01270659|20578482|P4|STARTED|Overall Study||25
8348145|NCT01270659|20578483|P3|STARTED|Overall Study||4
8348146|NCT01270659|20578484|P2|STARTED|Overall Study||25
8348147|NCT01270659|20578485|P1|STARTED|Overall Study||6
8348148|NCT01270620|20578505|P2|NOT COMPLETED|Overall Study||3
8348149|NCT01270620|20578506|P1|NOT COMPLETED|Overall Study||1
8348150|NCT01270620|20578505|P2|COMPLETED|Overall Study||47
8348151|NCT01270620|20578506|P1|COMPLETED|Overall Study||49
8348152|NCT01270620|20578505|P2|STARTED|Overall Study||50
8348153|NCT01270620|20578506|P1|STARTED|Overall Study||50
8348154|NCT01270581|20578558|P2|NOT COMPLETED|Overall Study||0
8348155|NCT01270581|20578559|P1|NOT COMPLETED|Overall Study||1
8348156|NCT01270581|20578558|P2|COMPLETED|Overall Study||3
8348157|NCT01270581|20578559|P1|COMPLETED|Overall Study||3
8348158|NCT01270581|20578558|P2|STARTED|Overall Study||3
8348159|NCT01270581|20578559|P1|STARTED|Overall Study||4
8348160|NCT01270555|20578565|P1|NOT COMPLETED|Overall Study||13
8348161|NCT01270555|20578565|P1|COMPLETED|Overall Study||19
8348162|NCT01270555|20578565|P1|STARTED|Overall Study||32
8348163|NCT01270542|20578577|P2|NOT COMPLETED|Overall Study||1
8348164|NCT01270542|20578578|P1|NOT COMPLETED|Overall Study||1
8348165|NCT01270542|20578577|P2|COMPLETED|Overall Study||8
8348166|NCT01270542|20578578|P1|COMPLETED|Overall Study||9
8348167|NCT01270542|20578577|P2|STARTED|Overall Study||9
8348168|NCT01270542|20578578|P1|STARTED|Overall Study||10
8348169|NCT01270529|20578591|P3|NOT COMPLETED|Overall Study||0
8348170|NCT01270529|20578592|P2|NOT COMPLETED|Overall Study||0
8348171|NCT01270529|20578593|P1|NOT COMPLETED|Overall Study||0
8348172|NCT01270529|20578591|P3|COMPLETED|Overall Study||25
8348173|NCT01270529|20578592|P2|COMPLETED|Overall Study||7
8348174|NCT01270529|20578593|P1|COMPLETED|Overall Study||12
8348175|NCT01270529|20578591|P3|STARTED|Overall Study||25
8348176|NCT01270529|20578592|P2|STARTED|Overall Study||7
8348177|NCT01270529|20578593|P1|STARTED|Overall Study||12
8348178|NCT01270503|20578601|P1|NOT COMPLETED|Overall Study||1
8348179|NCT01270503|20578601|P1|COMPLETED|Overall Study||537
8348180|NCT01270503|20578601|P1|STARTED|Overall Study||538
8348181|NCT01270464|20578609|P3|NOT COMPLETED|Overall Study||18
8348182|NCT01270464|20578610|P2|NOT COMPLETED|Overall Study||12
8348183|NCT01270464|20578611|P1|NOT COMPLETED|Overall Study||20
8348184|NCT01270464|20578609|P3|COMPLETED|Overall Study||88
8348185|NCT01270464|20578610|P2|COMPLETED|Overall Study||92
8348186|NCT01270464|20578611|P1|COMPLETED|Overall Study||85
8348187|NCT01270464|20578609|P3|Pharmacokinetic Analysis Set|Overall Study||103
8348188|NCT01270464|20578610|P2|Pharmacokinetic Analysis Set|Overall Study||103
8348189|NCT01270464|20578611|P1|Pharmacokinetic Analysis Set|Overall Study||105
8348190|NCT01270464|20578609|P3|Full Analysis Set|Overall Study||103
8348191|NCT01270464|20578610|P2|Full Analysis Set|Overall Study||103
8348192|NCT01270464|20578611|P1|Full Analysis Set|Overall Study||105
8348193|NCT01270464|20578609|P3|Safety Analysis Set|Overall Study||103
8348194|NCT01270464|20578610|P2|Safety Analysis Set|Overall Study||103
8348195|NCT01270464|20578611|P1|Safety Analysis Set|Overall Study||105
8348196|NCT01270464|20578609|P3|STARTED|Overall Study||106
8348197|NCT01270464|20578610|P2|STARTED|Overall Study||104
8348198|NCT01270464|20578611|P1|STARTED|Overall Study||105
8348208|NCT01270256|20578676|P2|NOT COMPLETED|Overall Study||0
8348209|NCT01270256|20578677|P1|NOT COMPLETED|Overall Study||1
8348210|NCT01270256|20578676|P2|COMPLETED|Overall Study||20
8348211|NCT01270256|20578677|P1|COMPLETED|Overall Study||20
8348212|NCT01270256|20578676|P2|STARTED|Overall Study||20
8348213|NCT01270256|20578677|P1|STARTED|Overall Study||21
8348214|NCT01270139|20578686|P3|NOT COMPLETED|Overall Study||20
8348215|NCT01270139|20578687|P2|NOT COMPLETED|Overall Study||26
8348216|NCT01270139|20578688|P1|NOT COMPLETED|Overall Study||18
8348217|NCT01270139|20578686|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
8348218|NCT01270139|20578687|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
8348219|NCT01270139|20578688|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
8348220|NCT01270139|20578686|P3|STARTED|Overall Study|Intention-to-treat population|60
8348221|NCT01270139|20578687|P2|STARTED|Overall Study|Intention-to-treat population|60
8348222|NCT01270139|20578688|P1|STARTED|Overall Study|Intention-to-treat population|60
8348223|NCT01270126|20578748|P2|NOT COMPLETED|Overall Study||0
8348224|NCT01270126|20578749|P1|NOT COMPLETED|Overall Study||0
8348225|NCT01270126|20578748|P2|COMPLETED|Overall Study||10
8348226|NCT01270126|20578749|P1|COMPLETED|Overall Study||12
8348227|NCT01270126|20578748|P2|STARTED|Overall Study||10
8348228|NCT01270126|20578749|P1|STARTED|Overall Study||12
8348229|NCT01269918|20578757|P2|NOT COMPLETED|Overall Study||3
8348230|NCT01269918|20578758|P1|NOT COMPLETED|Overall Study||0
8348231|NCT01269918|20578757|P2|COMPLETED|Overall Study||68
8348232|NCT01269918|20578758|P1|COMPLETED|Overall Study||71
8348233|NCT01269918|20578757|P2|STARTED|Overall Study||71
8348234|NCT01269918|20578758|P1|STARTED|Overall Study||71
8348235|NCT01269801|20578792|P2|NOT COMPLETED|Overall Study||3
8348236|NCT01269801|20578793|P1|NOT COMPLETED|Overall Study||0
8348237|NCT01269801|20578792|P2|COMPLETED|Overall Study||77
8348238|NCT01269801|20578793|P1|COMPLETED|Overall Study||74
8348239|NCT01269801|20578792|P2|STARTED|Overall Study||80
8348240|NCT01269801|20578793|P1|STARTED|Overall Study||74
8348241|NCT01269749|20578801|P2|NOT COMPLETED|Overall Study||0
8348242|NCT01269749|20578802|P1|NOT COMPLETED|Overall Study||0
8348243|NCT01269749|20578801|P2|COMPLETED|Overall Study||3
8348244|NCT01269749|20578802|P1|COMPLETED|Overall Study||16
8348245|NCT01269749|20578801|P2|STARTED|Overall Study||3
8348246|NCT01269749|20578802|P1|STARTED|Overall Study||16
8348247|NCT01269736|20578812|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
8348248|NCT01269736|20578813|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
8348249|NCT01269736|20578812|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
8348250|NCT01269736|20578813|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
8348251|NCT01269736|20578812|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
8348252|NCT01269736|20578813|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
8348253|NCT01269736|20578812|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
8348254|NCT01269736|20578813|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
8348255|NCT01269736|20578812|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
8348256|NCT01269736|20578813|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
8348257|NCT01269736|20578812|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
8348258|NCT01269736|20578813|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
8348259|NCT01269736|20578812|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
8348260|NCT01269736|20578813|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
8348261|NCT01269736|20578812|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
8348262|NCT01269736|20578813|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
8348263|NCT01269736|20578812|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
8348264|NCT01269736|20578813|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
8348265|NCT01269736|20578812|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
8348266|NCT01269736|20578813|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
8348267|NCT01269736|20578812|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
8348268|NCT01269736|20578813|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
8348269|NCT01269736|20578812|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
8348270|NCT01269736|20578813|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
8348271|NCT01269736|20578812|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
8348272|NCT01269736|20578813|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
8348273|NCT01269736|20578812|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
8348274|NCT01269736|20578813|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
8348275|NCT01269736|20578812|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
8348276|NCT01269736|20578813|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
8348277|NCT01269736|20578812|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
8348278|NCT01269736|20578813|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
8348279|NCT01269736|20578812|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
8348280|NCT01269736|20578813|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
8348281|NCT01269736|20578812|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
8348282|NCT01269736|20578813|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
8348283|NCT01269710|20578825|P1|NOT COMPLETED|Overall Study||3
8348284|NCT01269710|20578825|P1|COMPLETED|Overall Study|This refers to Week 52.|1
8348285|NCT01269710|20578825|P1|Week 36|Overall Study||2
8348286|NCT01269710|20578825|P1|Week 12|Overall Study||3
8348287|NCT01269710|20578825|P1|STARTED|Overall Study||4
8348288|NCT01269385|20578833|P4|NOT COMPLETED|Overall Study||0
8348289|NCT01269385|20578834|P3|NOT COMPLETED|Overall Study||0
8348290|NCT01269385|20578835|P2|NOT COMPLETED|Overall Study||1
8348291|NCT01269385|20578836|P1|NOT COMPLETED|Overall Study||1
8348292|NCT01269385|20578833|P4|COMPLETED|Overall Study||8
8348293|NCT01269385|20578834|P3|COMPLETED|Overall Study||6
8348294|NCT01269385|20578835|P2|COMPLETED|Overall Study||3
8348295|NCT01269385|20578836|P1|COMPLETED|Overall Study||3
8348296|NCT01269385|20578833|P4|STARTED|Overall Study||8
8348297|NCT01269385|20578834|P3|STARTED|Overall Study||6
8348298|NCT01269385|20578835|P2|STARTED|Overall Study||4
8348299|NCT01269385|20578836|P1|STARTED|Overall Study||4
8348300|NCT01269372|20578850|P1|NOT COMPLETED|Overall Study||0
8348301|NCT01269372|20578850|P1|COMPLETED|Overall Study||30
8348302|NCT01269372|20578850|P1|STARTED|Overall Study||30
8348303|NCT01269346|20578861|P1|NOT COMPLETED|Extension Phase||43
8348304|NCT01269346|20578861|P1|COMPLETED|Extension Phase||0
8348305|NCT01269346|20578861|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
8348306|NCT01269346|20578861|P1|NOT COMPLETED|Treatment Phase||9
8348307|NCT01269346|20578861|P1|COMPLETED|Treatment Phase||43
8348308|NCT01269346|20578861|P1|Completed 6 Cycles|Treatment Phase||45
8348309|NCT01269346|20578861|P1|STARTED|Treatment Phase||52
8348310|NCT01269125|20578872|P3|NOT COMPLETED|Overall Study||0
8348311|NCT01269125|20578873|P2|NOT COMPLETED|Overall Study||5
8348312|NCT01269125|20578874|P1|NOT COMPLETED|Overall Study||7
8348313|NCT01269125|20578872|P3|COMPLETED|Overall Study||60
8348314|NCT01269125|20578873|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
8348315|NCT01269125|20578874|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
8348316|NCT01269125|20578872|P3|STARTED|Overall Study||60
8348317|NCT01269125|20578873|P2|STARTED|Overall Study||60
8348318|NCT01269125|20578874|P1|STARTED|Overall Study||60
8348319|NCT01269047|20578897|P3|NOT COMPLETED|Overall Study||1
8348320|NCT01269047|20578898|P2|NOT COMPLETED|Overall Study||2
8348321|NCT01269047|20578899|P1|NOT COMPLETED|Overall Study||1
8348322|NCT01269047|20578897|P3|COMPLETED|Overall Study||10
8348323|NCT01269047|20578898|P2|COMPLETED|Overall Study||11
8348324|NCT01269047|20578899|P1|COMPLETED|Overall Study||12
8348325|NCT01269047|20578897|P3|STARTED|Overall Study||11
8348326|NCT01269047|20578898|P2|STARTED|Overall Study||13
8348327|NCT01269047|20578899|P1|STARTED|Overall Study||13
8348328|NCT01268943|20578918|P4|NOT COMPLETED|Overall Study||0
8348329|NCT01268943|20578919|P3|NOT COMPLETED|Overall Study||0
8348330|NCT01268943|20578920|P2|NOT COMPLETED|Overall Study||0
8348331|NCT01268943|20578921|P1|NOT COMPLETED|Overall Study||0
8348332|NCT01268943|20578918|P4|COMPLETED|Overall Study||6
8348333|NCT01268943|20578919|P3|COMPLETED|Overall Study||3
8348334|NCT01268943|20578920|P2|COMPLETED|Overall Study||3
8348335|NCT01268943|20578921|P1|COMPLETED|Overall Study||6
8348336|NCT01268943|20578918|P4|STARTED|Overall Study||6
8348337|NCT01268943|20578919|P3|STARTED|Overall Study||3
8348338|NCT01268943|20578920|P2|STARTED|Overall Study||3
8348339|NCT01268943|20578921|P1|STARTED|Overall Study||6
8348340|NCT01268891|20578933|P2|NOT COMPLETED|Overall Study||8
8348341|NCT01268891|20578934|P1|NOT COMPLETED|Overall Study||8
8348342|NCT01268891|20578933|P2|COMPLETED|Overall Study||58
8348343|NCT01268891|20578934|P1|COMPLETED|Overall Study||58
8348344|NCT01268891|20578933|P2|STARTED|Overall Study||66
8348345|NCT01268891|20578934|P1|STARTED|Overall Study||66
8348346|NCT01268683|20578946|P1|NOT COMPLETED|Overall Study||0
8348347|NCT01268683|20578946|P1|COMPLETED|Overall Study||10
8348348|NCT01268683|20578946|P1|STARTED|Overall Study||10
8348349|NCT01268644|20578953|P1|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
8348350|NCT01268644|20578953|P1|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
8348351|NCT01268644|20578953|P1|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
8348352|NCT01268644|20578953|P1|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
8348353|NCT01268644|20578953|P1|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
8348354|NCT01268644|20578953|P1|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
8348355|NCT01268644|20578953|P1|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
8348356|NCT01268644|20578953|P1|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
8348357|NCT01268644|20578953|P1|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
8348358|NCT01268644|20578953|P1|NOT COMPLETED|Baseline Period (Week 0)||0
8348359|NCT01268644|20578953|P1|COMPLETED|Baseline Period (Week 0)||8
8348360|NCT01268644|20578953|P1|STARTED|Baseline Period (Week 0)||8
8348361|NCT01268566|20578960|P1|NOT COMPLETED|Overall Study||43
8348362|NCT01268566|20578960|P1|COMPLETED|Overall Study||13
8348363|NCT01268566|20578960|P1|STARTED|Overall Study||56
8348364|NCT01268553|20578978|P1|NOT COMPLETED|Overall Study||0
8348365|NCT01268553|20578978|P1|COMPLETED|Overall Study||6
8348366|NCT01268553|20578978|P1|STARTED|Overall Study||6
8348367|NCT01268514|20578987|P1|NOT COMPLETED|Overall Study||41
8348368|NCT01268514|20578987|P1|COMPLETED|Overall Study||74
8348369|NCT01268514|20578987|P1|Participants Who Received the Device|Overall Study||114
8348370|NCT01268514|20578987|P1|STARTED|Overall Study||115
8348371|NCT01268501|20578996|P1|NOT COMPLETED|Overall Study||9
8348372|NCT01268501|20578996|P1|COMPLETED|Overall Study||87
8348373|NCT01268501|20578996|P1|STARTED|Overall Study||96
8348374|NCT01268488|20579000|P1|NOT COMPLETED|Overall Study||5
8348375|NCT01268488|20579000|P1|COMPLETED|Overall Study||93
8348376|NCT01268488|20579000|P1|STARTED|Overall Study||98
8348377|NCT01268306|20579007|P1|NOT COMPLETED|Overall Study||1
8348378|NCT01268306|20579007|P1|COMPLETED|Overall Study||7
8348379|NCT01268306|20579007|P1|STARTED|Overall Study||8
8348380|NCT01268293|20579011|P1|NOT COMPLETED|Overall Study||9
8348381|NCT01268293|20579011|P1|COMPLETED|Overall Study||0
8348382|NCT01268293|20579011|P1|Completed Cycle 1|Overall Study||9
8348383|NCT01268293|20579011|P1|STARTED|Overall Study||9
8348384|NCT01268267|20579016|P1|NOT COMPLETED|Overall Study||1
8348385|NCT01268267|20579016|P1|COMPLETED|Overall Study||93
8348386|NCT01268267|20579016|P1|STARTED|Overall Study||94
8348387|NCT01268189|20579023|P1|NOT COMPLETED|Overall Study||3
8348388|NCT01268189|20579023|P1|COMPLETED|Overall Study||17
8348389|NCT01268189|20579023|P1|STARTED|Overall Study||20
8348390|NCT01268150|20579037|P1|NOT COMPLETED|Extension Phase||27
8348391|NCT01268150|20579037|P1|COMPLETED|Extension Phase||1
8348392|NCT01268150|20579037|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
8348393|NCT01268150|20579037|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
8348394|NCT01268150|20579037|P1|NOT COMPLETED|Treatment Phase||28
8348395|NCT01268150|20579037|P1|COMPLETED|Treatment Phase||28
8348396|NCT01268150|20579037|P1|STARTED|Treatment Phase||56
8348397|NCT01268111|20579047|P2|NOT COMPLETED|Overall Study||0
8348398|NCT01268111|20579048|P1|NOT COMPLETED|Overall Study||0
8348399|NCT01268111|20579047|P2|COMPLETED|Overall Study||6
8348400|NCT01268111|20579048|P1|COMPLETED|Overall Study||6
8348401|NCT01268111|20579047|P2|STARTED|Overall Study||6
8348402|NCT01268111|20579048|P1|STARTED|Overall Study||6
8348403|NCT01268098|20579056|P2|NOT COMPLETED|Overall Study||0
8348404|NCT01268098|20579057|P1|NOT COMPLETED|Overall Study||1
8348405|NCT01268098|20579056|P2|COMPLETED|Overall Study||23
8348406|NCT01268098|20579057|P1|COMPLETED|Overall Study||18
8348407|NCT01268098|20579056|P2|STARTED|Overall Study||23
8348408|NCT01268098|20579057|P1|STARTED|Overall Study||19
8348409|NCT01268059|20579069|P4|NOT COMPLETED|Overall Study||5
8348410|NCT01268059|20579070|P3|NOT COMPLETED|Overall Study||3
8348411|NCT01268059|20579071|P2|NOT COMPLETED|Overall Study||35
8348412|NCT01268059|20579072|P1|NOT COMPLETED|Overall Study||28
8348413|NCT01268059|20579069|P4|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
8348414|NCT01268059|20579070|P3|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
8348415|NCT01268059|20579071|P2|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
8348416|NCT01268059|20579072|P1|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
8348417|NCT01268059|20579069|P4|STARTED|Overall Study||8
8348418|NCT01268059|20579070|P3|STARTED|Overall Study||6
8348419|NCT01268059|20579071|P2|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
8348420|NCT01268059|20579072|P1|STARTED|Overall Study||40
8348421|NCT01268046|20579133|P4|NOT COMPLETED|Overall Study||1
8348422|NCT01268046|20579134|P3|NOT COMPLETED|Overall Study||1
8348423|NCT01268046|20579135|P2|NOT COMPLETED|Overall Study||0
8348424|NCT01268046|20579136|P1|NOT COMPLETED|Overall Study||1
8348425|NCT01268046|20579133|P4|COMPLETED|Overall Study||7
8348426|NCT01268046|20579134|P3|COMPLETED|Overall Study||7
8348427|NCT01268046|20579135|P2|COMPLETED|Overall Study||9
8348428|NCT01268046|20579136|P1|COMPLETED|Overall Study||12
8348429|NCT01268046|20579133|P4|STARTED|Overall Study||8
8348430|NCT01268046|20579134|P3|STARTED|Overall Study||8
8348431|NCT01268046|20579135|P2|STARTED|Overall Study||9
8348432|NCT01268046|20579136|P1|STARTED|Overall Study||13
8348433|NCT01267994|20579146|P1|NOT COMPLETED|Overall Study||2
8348434|NCT01267994|20579146|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
8348435|NCT01267994|20579146|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
8348436|NCT01267955|20579151|P1|NOT COMPLETED|Stage 2 (6 Months)||6
8348437|NCT01267955|20579151|P1|COMPLETED|Stage 2 (6 Months)||39
8348438|NCT01267955|20579151|P1|STARTED|Stage 2 (6 Months)||45
8348439|NCT01267955|20579151|P1|NOT COMPLETED|Stage 1 (6 Months)||3
8348440|NCT01267955|20579151|P1|COMPLETED|Stage 1 (6 Months)||17
8348441|NCT01267955|20579151|P1|STARTED|Stage 1 (6 Months)||20
8348442|NCT01267929|20579157|P2|NOT COMPLETED|Overall Study||0
8348443|NCT01267929|20579158|P1|NOT COMPLETED|Overall Study||0
8348444|NCT01267929|20579157|P2|COMPLETED|Overall Study||15
8348445|NCT01267929|20579158|P1|COMPLETED|Overall Study||15
8348446|NCT01267929|20579157|P2|STARTED|Overall Study||15
8348447|NCT01267929|20579158|P1|STARTED|Overall Study||15
8348448|NCT01267864|20579167|P3|NOT COMPLETED|Overall Study||0
8348449|NCT01267864|20579168|P2|NOT COMPLETED|Overall Study||0
8348450|NCT01267864|20579169|P1|NOT COMPLETED|Overall Study||0
8348451|NCT01267864|20579167|P3|COMPLETED|Overall Study||110
8348452|NCT01267864|20579168|P2|COMPLETED|Overall Study||110
8348453|NCT01267864|20579169|P1|COMPLETED|Overall Study||110
8348454|NCT01267864|20579167|P3|STARTED|Overall Study||110
8348455|NCT01267864|20579168|P2|STARTED|Overall Study||110
8348456|NCT01267864|20579169|P1|STARTED|Overall Study||110
8348457|NCT01267825|20579188|P2|NOT COMPLETED|Overall Study||0
8348458|NCT01267825|20579189|P1|NOT COMPLETED|Overall Study||1
8348459|NCT01267825|20579188|P2|COMPLETED|Overall Study||0
8348460|NCT01267825|20579189|P1|COMPLETED|Overall Study||0
8348461|NCT01267825|20579188|P2|STARTED|Overall Study||0
8348462|NCT01267825|20579189|P1|STARTED|Overall Study||1
8348463|NCT01267656|20579199|P2|NOT COMPLETED|Overall Study||1
8348464|NCT01267656|20579200|P1|NOT COMPLETED|Overall Study||1
8348465|NCT01267656|20579199|P2|COMPLETED|Overall Study||82
8348466|NCT01267656|20579200|P1|COMPLETED|Overall Study||82
8348467|NCT01267656|20579199|P2|STARTED|Overall Study||83
8348468|NCT01267656|20579200|P1|STARTED|Overall Study||83
8348469|NCT01267422|20579206|P2|NOT COMPLETED|Safety and Efficacy Study||0
8348470|NCT01267422|20579207|P1|NOT COMPLETED|Safety and Efficacy Study||0
8348471|NCT01267422|20579206|P2|COMPLETED|Safety and Efficacy Study||4
8348472|NCT01267422|20579207|P1|COMPLETED|Safety and Efficacy Study||5
8348473|NCT01267422|20579206|P2|STARTED|Safety and Efficacy Study||4
8348474|NCT01267422|20579207|P1|STARTED|Safety and Efficacy Study||5
8348475|NCT01267422|20579206|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
8348476|NCT01267422|20579207|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
8348477|NCT01267422|20579206|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
8348478|NCT01267422|20579207|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
8348479|NCT01267422|20579206|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
8348480|NCT01267422|20579207|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
8348481|NCT01267292|20579227|P2|NOT COMPLETED|Overall Study||6
8348482|NCT01267292|20579228|P1|NOT COMPLETED|Overall Study||4
8348483|NCT01267292|20579227|P2|COMPLETED|Overall Study||20
8348484|NCT01267292|20579228|P1|COMPLETED|Overall Study||20
8348485|NCT01267292|20579227|P2|STARTED|Overall Study||26
8348486|NCT01267292|20579228|P1|STARTED|Overall Study||24
8348487|NCT01267279|20579264|P2|NOT COMPLETED|Overall Study||6
8348488|NCT01267279|20579265|P1|NOT COMPLETED|Overall Study||2
8348489|NCT01267279|20579264|P2|COMPLETED|Overall Study||21
8348490|NCT01267279|20579265|P1|COMPLETED|Overall Study||22
8348491|NCT01267279|20579264|P2|STARTED|Overall Study||27
8348492|NCT01267279|20579265|P1|STARTED|Overall Study||24
8348493|NCT01267266|20579271|P2|NOT COMPLETED|Randomized Phase||0
8348494|NCT01267266|20579272|P1|NOT COMPLETED|Randomized Phase||0
8348495|NCT01267266|20579271|P2|COMPLETED|Randomized Phase||5
8348496|NCT01267266|20579272|P1|COMPLETED|Randomized Phase||3
8348497|NCT01267266|20579271|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
8348498|NCT01267266|20579272|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
8348499|NCT01267266|20579271|P2|NOT COMPLETED|Lead-in Phase||0
8348500|NCT01267266|20579272|P1|NOT COMPLETED|Lead-in Phase||23
8348501|NCT01267266|20579271|P2|COMPLETED|Lead-in Phase||0
8348502|NCT01267266|20579272|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
8348503|NCT01267266|20579271|P2|STARTED|Lead-in Phase||0
8348504|NCT01267266|20579272|P1|STARTED|Lead-in Phase||31
8348505|NCT01267266|20579271|P2|NOT COMPLETED|Enrollment Phase||0
8348506|NCT01267266|20579272|P1|NOT COMPLETED|Enrollment Phase||2
8348507|NCT01267266|20579271|P2|COMPLETED|Enrollment Phase||0
8348508|NCT01267266|20579272|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
8348509|NCT01267266|20579271|P2|STARTED|Enrollment Phase||0
8348510|NCT01267266|20579272|P1|STARTED|Enrollment Phase||33
8348511|NCT01267253|20579285|P1|NOT COMPLETED|Overall Study||3
8348512|NCT01267253|20579285|P1|COMPLETED|Overall Study|Eligible and treated patients|28
8348513|NCT01267253|20579285|P1|STARTED|Overall Study||31
8348514|NCT01267240|20579293|P1|NOT COMPLETED|Overall Study||0
8348515|NCT01267240|20579293|P1|COMPLETED|Overall Study||25
8348516|NCT01267240|20579293|P1|STARTED|Overall Study||25
8348517|NCT01267227|20579303|P4|NOT COMPLETED|Overall Study||3
8348518|NCT01267227|20579304|P3|NOT COMPLETED|Overall Study||2
8348519|NCT01267227|20579305|P2|NOT COMPLETED|Overall Study||1
8348520|NCT01267227|20579306|P1|NOT COMPLETED|Overall Study||1
8348521|NCT01267227|20579303|P4|COMPLETED|Overall Study||17
8348522|NCT01267227|20579304|P3|COMPLETED|Overall Study||18
8348523|NCT01267227|20579305|P2|COMPLETED|Overall Study||19
8348524|NCT01267227|20579306|P1|COMPLETED|Overall Study||19
8348525|NCT01267227|20579303|P4|STARTED|Overall Study||20
8348526|NCT01267227|20579304|P3|STARTED|Overall Study||20
8348527|NCT01267227|20579305|P2|STARTED|Overall Study||20
8348528|NCT01267227|20579306|P1|STARTED|Overall Study||20
8348529|NCT01267201|20579324|P6|NOT COMPLETED|Third Intervention Period||0
8348530|NCT01267201|20579325|P5|NOT COMPLETED|Third Intervention Period||0
8348531|NCT01267201|20579326|P4|NOT COMPLETED|Third Intervention Period||0
8348532|NCT01267201|20579327|P3|NOT COMPLETED|Third Intervention Period||0
8348533|NCT01267201|20579328|P2|NOT COMPLETED|Third Intervention Period||0
8348534|NCT01267201|20579329|P1|NOT COMPLETED|Third Intervention Period||0
8348535|NCT01267201|20579324|P6|COMPLETED|Third Intervention Period||4
8348536|NCT01267201|20579325|P5|COMPLETED|Third Intervention Period||4
8348537|NCT01267201|20579326|P4|COMPLETED|Third Intervention Period||4
8348538|NCT01267201|20579327|P3|COMPLETED|Third Intervention Period||4
8348539|NCT01267201|20579328|P2|COMPLETED|Third Intervention Period||3
8348540|NCT01267201|20579329|P1|COMPLETED|Third Intervention Period||3
8348541|NCT01267201|20579324|P6|STARTED|Third Intervention Period||4
8348542|NCT01267201|20579325|P5|STARTED|Third Intervention Period||4
8348543|NCT01267201|20579326|P4|STARTED|Third Intervention Period||4
8348544|NCT01267201|20579327|P3|STARTED|Third Intervention Period||4
8348545|NCT01267201|20579328|P2|STARTED|Third Intervention Period||3
8348546|NCT01267201|20579329|P1|STARTED|Third Intervention Period||3
8348547|NCT01267201|20579324|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348548|NCT01267201|20579325|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348549|NCT01267201|20579326|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348550|NCT01267201|20579327|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348551|NCT01267201|20579328|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348552|NCT01267201|20579329|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348553|NCT01267201|20579324|P6|COMPLETED|Washout Period (At Least 2 Days)||4
8348554|NCT01267201|20579325|P5|COMPLETED|Washout Period (At Least 2 Days)||4
8348555|NCT01267201|20579326|P4|COMPLETED|Washout Period (At Least 2 Days)||4
8348556|NCT01267201|20579327|P3|COMPLETED|Washout Period (At Least 2 Days)||4
8348557|NCT01267201|20579328|P2|COMPLETED|Washout Period (At Least 2 Days)||3
8348558|NCT01267201|20579329|P1|COMPLETED|Washout Period (At Least 2 Days)||3
8348559|NCT01267201|20579324|P6|STARTED|Washout Period (At Least 2 Days)||4
8348560|NCT01267201|20579325|P5|STARTED|Washout Period (At Least 2 Days)||4
8348561|NCT01267201|20579326|P4|STARTED|Washout Period (At Least 2 Days)||4
8348562|NCT01267201|20579327|P3|STARTED|Washout Period (At Least 2 Days)||4
8348563|NCT01267201|20579328|P2|STARTED|Washout Period (At Least 2 Days)||3
8348564|NCT01267201|20579329|P1|STARTED|Washout Period (At Least 2 Days)||3
8348565|NCT01267201|20579324|P6|NOT COMPLETED|Second Intervention Period||0
8348566|NCT01267201|20579325|P5|NOT COMPLETED|Second Intervention Period||0
8348567|NCT01267201|20579326|P4|NOT COMPLETED|Second Intervention Period||0
8348568|NCT01267201|20579327|P3|NOT COMPLETED|Second Intervention Period||0
8348569|NCT01267201|20579328|P2|NOT COMPLETED|Second Intervention Period||1
8348570|NCT01267201|20579329|P1|NOT COMPLETED|Second Intervention Period||0
8348571|NCT01267201|20579324|P6|COMPLETED|Second Intervention Period||4
8348572|NCT01267201|20579325|P5|COMPLETED|Second Intervention Period||4
8348573|NCT01267201|20579326|P4|COMPLETED|Second Intervention Period||4
8348574|NCT01267201|20579327|P3|COMPLETED|Second Intervention Period||4
8348575|NCT01267201|20579328|P2|COMPLETED|Second Intervention Period||3
8348576|NCT01267201|20579329|P1|COMPLETED|Second Intervention Period||3
8348577|NCT01267201|20579324|P6|STARTED|Second Intervention Period||4
8348578|NCT01267201|20579325|P5|STARTED|Second Intervention Period||4
8348579|NCT01267201|20579326|P4|STARTED|Second Intervention Period||4
8348580|NCT01267201|20579327|P3|STARTED|Second Intervention Period||4
8348581|NCT01267201|20579328|P2|STARTED|Second Intervention Period||4
8348582|NCT01267201|20579329|P1|STARTED|Second Intervention Period||3
8348583|NCT01267201|20579324|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348584|NCT01267201|20579325|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348585|NCT01267201|20579326|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348586|NCT01267201|20579327|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348587|NCT01267201|20579328|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348588|NCT01267201|20579329|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348589|NCT01267201|20579324|P6|COMPLETED|Washout Period (At Least 2 Days)||4
8348590|NCT01267201|20579325|P5|COMPLETED|Washout Period (At Least 2 Days)||4
8348591|NCT01267201|20579326|P4|COMPLETED|Washout Period (At Least 2 Days)||4
8348592|NCT01267201|20579327|P3|COMPLETED|Washout Period (At Least 2 Days)||4
8348593|NCT01267201|20579328|P2|COMPLETED|Washout Period (At Least 2 Days)||4
8348594|NCT01267201|20579329|P1|COMPLETED|Washout Period (At Least 2 Days)||3
8348595|NCT01267201|20579324|P6|STARTED|Washout Period (At Least 2 Days)||4
8348596|NCT01267201|20579325|P5|STARTED|Washout Period (At Least 2 Days)||4
8348597|NCT01267201|20579326|P4|STARTED|Washout Period (At Least 2 Days)||4
8348598|NCT01267201|20579327|P3|STARTED|Washout Period (At Least 2 Days)||4
8348599|NCT01267201|20579328|P2|STARTED|Washout Period (At Least 2 Days)||4
8348600|NCT01267201|20579329|P1|STARTED|Washout Period (At Least 2 Days)||3
8348601|NCT01267201|20579324|P6|NOT COMPLETED|First Intervention Period||0
8348602|NCT01267201|20579325|P5|NOT COMPLETED|First Intervention Period||0
8348603|NCT01267201|20579326|P4|NOT COMPLETED|First Intervention Period||0
8348604|NCT01267201|20579327|P3|NOT COMPLETED|First Intervention Period||0
8348605|NCT01267201|20579328|P2|NOT COMPLETED|First Intervention Period||0
8348606|NCT01267201|20579329|P1|NOT COMPLETED|First Intervention Period||1
8348607|NCT01267201|20579324|P6|COMPLETED|First Intervention Period||4
8348608|NCT01267201|20579325|P5|COMPLETED|First Intervention Period||4
8348609|NCT01267201|20579326|P4|COMPLETED|First Intervention Period||4
8348610|NCT01267201|20579327|P3|COMPLETED|First Intervention Period||4
8348611|NCT01267201|20579328|P2|COMPLETED|First Intervention Period||4
8348612|NCT01267201|20579329|P1|COMPLETED|First Intervention Period||3
8348613|NCT01267201|20579324|P6|STARTED|First Intervention Period||4
8348614|NCT01267201|20579325|P5|STARTED|First Intervention Period||4
8348615|NCT01267201|20579326|P4|STARTED|First Intervention Period||4
8348616|NCT01267201|20579327|P3|STARTED|First Intervention Period||4
8348617|NCT01267201|20579328|P2|STARTED|First Intervention Period||4
8348618|NCT01267201|20579329|P1|STARTED|First Intervention Period||4
8348619|NCT01267175|20579346|P1|NOT COMPLETED|Overall Study||2
8348620|NCT01267175|20579346|P1|COMPLETED|Overall Study||29
8348621|NCT01267175|20579346|P1|STARTED|Overall Study||31
8348622|NCT01267136|20579353|P2|NOT COMPLETED|Overall Study||6
8348623|NCT01267136|20579354|P1|NOT COMPLETED|Overall Study||4
8348624|NCT01267136|20579353|P2|COMPLETED|Overall Study||36
8348625|NCT01267136|20579354|P1|COMPLETED|Overall Study||38
8348626|NCT01267136|20579353|P2|STARTED|Overall Study||42
8348627|NCT01267136|20579354|P1|STARTED|Overall Study||42
8348628|NCT01267045|20579364|P2|NOT COMPLETED|6-month Outcome||3
8348629|NCT01267045|20579365|P1|NOT COMPLETED|6-month Outcome||0
8348630|NCT01267045|20579364|P2|COMPLETED|6-month Outcome||23
8348631|NCT01267045|20579365|P1|COMPLETED|6-month Outcome||22
8348632|NCT01267045|20579364|P2|STARTED|6-month Outcome||26
8348633|NCT01267045|20579365|P1|STARTED|6-month Outcome||22
8348634|NCT01267045|20579364|P2|NOT COMPLETED|2-month Outcomes||3
8348635|NCT01267045|20579365|P1|NOT COMPLETED|2-month Outcomes||4
8348636|NCT01267045|20579364|P2|COMPLETED|2-month Outcomes||26
8348637|NCT01267045|20579365|P1|COMPLETED|2-month Outcomes||22
8348638|NCT01267045|20579364|P2|STARTED|2-month Outcomes||29
8348639|NCT01267045|20579365|P1|STARTED|2-month Outcomes||26
8348640|NCT01267019|20579400|P3|NOT COMPLETED|Overall Study||6
8348641|NCT01267019|20579401|P2|NOT COMPLETED|Overall Study||6
8348642|NCT01267019|20579402|P1|NOT COMPLETED|Overall Study||6
8348643|NCT01267019|20579400|P3|COMPLETED|Overall Study||47
8348644|NCT01267019|20579401|P2|COMPLETED|Overall Study||47
8348645|NCT01267019|20579402|P1|COMPLETED|Overall Study||41
8348646|NCT01267019|20579400|P3|STARTED|Overall Study||53
8348647|NCT01267019|20579401|P2|STARTED|Overall Study||53
8348648|NCT01267019|20579402|P1|STARTED|Overall Study||47
8348649|NCT01266993|20579418|P2|NOT COMPLETED|Booster Phase (Month 68-69)||2
8348650|NCT01266993|20579419|P1|NOT COMPLETED|Booster Phase (Month 68-69)||5
8348651|NCT01266993|20579418|P2|COMPLETED|Booster Phase (Month 68-69)||60
8348652|NCT01266993|20579419|P1|COMPLETED|Booster Phase (Month 68-69)||174
8348653|NCT01266993|20579418|P2|STARTED|Booster Phase (Month 68-69)||62
8348654|NCT01266993|20579419|P1|STARTED|Booster Phase (Month 68-69)||179
8348655|NCT01266993|20579418|P2|NOT COMPLETED|Persistence Phase (Month 56-68)||0
8348656|NCT01266993|20579419|P1|NOT COMPLETED|Persistence Phase (Month 56-68)||0
8348657|NCT01266993|20579418|P2|COMPLETED|Persistence Phase (Month 56-68)||67
8348658|NCT01266993|20579419|P1|COMPLETED|Persistence Phase (Month 56-68)||193
8348659|NCT01266993|20579418|P2|STARTED|Persistence Phase (Month 56-68)||67
8348660|NCT01266993|20579419|P1|STARTED|Persistence Phase (Month 56-68)||193
8348661|NCT01266993|20579418|P2|NOT COMPLETED|Persistence Phase (Month 44-56)||0
8348662|NCT01266993|20579419|P1|NOT COMPLETED|Persistence Phase (Month 44-56)||0
8348663|NCT01266993|20579418|P2|COMPLETED|Persistence Phase (Month 44-56)||68
8348664|NCT01266993|20579419|P1|COMPLETED|Persistence Phase (Month 44-56)||193
8348665|NCT01266993|20579418|P2|STARTED|Persistence Phase (Month 44-56)||68
8348666|NCT01266993|20579419|P1|STARTED|Persistence Phase (Month 44-56)||193
8348667|NCT01266993|20579418|P2|NOT COMPLETED|Persistence Phase (Month 32-44)||0
8348668|NCT01266993|20579419|P1|NOT COMPLETED|Persistence Phase (Month 32-44)||0
8348669|NCT01266993|20579418|P2|COMPLETED|Persistence Phase (Month 32-44)||72
8348670|NCT01266993|20579419|P1|COMPLETED|Persistence Phase (Month 32-44)||199
8348671|NCT01266993|20579418|P2|STARTED|Persistence Phase (Month 32-44)||72
8348672|NCT01266993|20579419|P1|STARTED|Persistence Phase (Month 32-44)||199
8348673|NCT01266967|20579489|P2|NOT COMPLETED|Overall Study||83
8348674|NCT01266967|20579490|P1|NOT COMPLETED|Overall Study||89
8348675|NCT01266967|20579489|P2|COMPLETED|Overall Study||0
8348676|NCT01266967|20579490|P1|COMPLETED|Overall Study||0
8348677|NCT01266967|20579489|P2|STARTED|Overall Study||83
8348678|NCT01266967|20579490|P1|STARTED|Overall Study||89
8348679|NCT01266876|20579542|P5|NOT COMPLETED|Overall Study||0
8348680|NCT01266876|20579543|P4|NOT COMPLETED|Overall Study||1
8348681|NCT01266876|20579544|P3|NOT COMPLETED|Overall Study||0
8348682|NCT01266876|20579545|P2|NOT COMPLETED|Overall Study||0
8348683|NCT01266876|20579546|P1|NOT COMPLETED|Overall Study||0
8348684|NCT01266876|20579542|P5|COMPLETED|Overall Study||16
8348685|NCT01266876|20579543|P4|COMPLETED|Overall Study||14
8348686|NCT01266876|20579544|P3|COMPLETED|Overall Study||16
8348687|NCT01266876|20579545|P2|COMPLETED|Overall Study||15
8348688|NCT01266876|20579546|P1|COMPLETED|Overall Study||15
8348689|NCT01266876|20579542|P5|STARTED|Overall Study||16
8348690|NCT01266876|20579543|P4|STARTED|Overall Study||15
8348691|NCT01266876|20579544|P3|STARTED|Overall Study||16
8348692|NCT01266876|20579545|P2|STARTED|Overall Study||15
8348693|NCT01266876|20579546|P1|STARTED|Overall Study||15
8348694|NCT01266850|20579653|P5|NOT COMPLETED|Overall Study||30
8348695|NCT01266850|20579654|P4|NOT COMPLETED|Overall Study||28
8348696|NCT01266850|20579655|P3|NOT COMPLETED|Overall Study||24
8348697|NCT01266850|20579656|P2|NOT COMPLETED|Overall Study||36
8348698|NCT01266850|20579657|P1|NOT COMPLETED|Overall Study||30
8348699|NCT01266850|20579653|P5|COMPLETED|Overall Study||297
8348700|NCT01266850|20579654|P4|COMPLETED|Overall Study||301
8348701|NCT01266850|20579655|P3|COMPLETED|Overall Study||214
8348702|NCT01266850|20579656|P2|COMPLETED|Overall Study||212
8348703|NCT01266850|20579657|P1|COMPLETED|Overall Study||212
8348704|NCT01266850|20579653|P5|Received Third Vaccine|Overall Study||299
8348705|NCT01266850|20579654|P4|Received Third Vaccine|Overall Study||0
8348706|NCT01266850|20579655|P3|Received Third Vaccine|Overall Study||217
8348707|NCT01266850|20579656|P2|Received Third Vaccine|Overall Study||221
8348708|NCT01266850|20579657|P1|Received Third Vaccine|Overall Study||221
8348709|NCT01266850|20579653|P5|Received Second Vaccine|Overall Study||307
8348710|NCT01266850|20579654|P4|Received Second Vaccine|Overall Study||311
8348711|NCT01266850|20579655|P3|Received Second Vaccine|Overall Study||227
8348712|NCT01266850|20579656|P2|Received Second Vaccine|Overall Study||233
8348713|NCT01266850|20579657|P1|Received Second Vaccine|Overall Study||231
8348714|NCT01266850|20579653|P5|STARTED|Overall Study||327
8348715|NCT01266850|20579654|P4|STARTED|Overall Study||329
8348716|NCT01266850|20579655|P3|STARTED|Overall Study||238
8348717|NCT01266850|20579656|P2|STARTED|Overall Study||248
8348718|NCT01266850|20579657|P1|STARTED|Overall Study||242
8348719|NCT01266824|20579711|P2|NOT COMPLETED|Overall Study||3
8348720|NCT01266824|20579712|P1|NOT COMPLETED|Overall Study||2
8348721|NCT01266824|20579711|P2|COMPLETED|Overall Study||0
8348722|NCT01266824|20579712|P1|COMPLETED|Overall Study||0
8348723|NCT01266824|20579711|P2|STARTED|Overall Study||3
8348724|NCT01266824|20579712|P1|STARTED|Overall Study||2
8348725|NCT01266603|20579724|P1|NOT COMPLETED|Overall Study||42
8348726|NCT01266603|20579724|P1|COMPLETED|Overall Study||2
8348727|NCT01266603|20579724|P1|Maintenance Completion|Overall Study||2
8348728|NCT01266603|20579724|P1|Continued to Maintenance- MAGE-A3|Overall Study||4
8348729|NCT01266603|20579724|P1|Patients Evaluable for Response|Overall Study||16
8348730|NCT01266603|20579724|P1|Patients Evaluable for Safety|Overall Study||17
8348731|NCT01266603|20579724|P1|MAGE-A3 Positive Tumor|Overall Study||18
8348732|NCT01266603|20579724|P1|STARTED|Overall Study||44
8348733|NCT01266590|20579730|P1|NOT COMPLETED|Overall Study||6
8348734|NCT01266590|20579730|P1|COMPLETED|Overall Study||24
8348735|NCT01266590|20579730|P1|STARTED|Overall Study||30
8348736|NCT01266460|20579741|P1|NOT COMPLETED|Overall Study||34
8348737|NCT01266460|20579741|P1|COMPLETED|Overall Study||16
8348738|NCT01266460|20579741|P1|STARTED|Overall Study||50
8348739|NCT01266447|20579750|P1|NOT COMPLETED|Overall Study||0
8348740|NCT01266447|20579750|P1|COMPLETED|Overall Study|Eligible and treated patients|27
8348741|NCT01266447|20579750|P1|STARTED|Overall Study||27
8348742|NCT01266317|20579759|P1|NOT COMPLETED|Overall Study||2
8348743|NCT01266317|20579759|P1|COMPLETED|Overall Study||7
8348744|NCT01266317|20579759|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
8348745|NCT01266291|20579764|P1|NOT COMPLETED|Overall Study||1
8348746|NCT01266291|20579764|P1|COMPLETED|Overall Study||0
8348747|NCT01266291|20579764|P1|STARTED|Overall Study||1
8348748|NCT01266265|20579771|P2|NOT COMPLETED|Overall Study||190
8348749|NCT01266265|20579772|P1|NOT COMPLETED|Overall Study||205
8348750|NCT01266265|20579771|P2|COMPLETED|Overall Study||477
8348751|NCT01266265|20579772|P1|COMPLETED|Overall Study||461
8348752|NCT01266265|20579771|P2|STARTED|Overall Study||667
8348753|NCT01266265|20579772|P1|STARTED|Overall Study||666
8348754|NCT01266161|20579780|P2|NOT COMPLETED|Overall Study||1
8348755|NCT01266161|20579781|P1|NOT COMPLETED|Overall Study||4
8348756|NCT01266161|20579780|P2|COMPLETED|Overall Study||53
8348757|NCT01266161|20579781|P1|COMPLETED|Overall Study||48
8348758|NCT01266161|20579780|P2|STARTED|Overall Study||54
8348759|NCT01266161|20579781|P1|STARTED|Overall Study||52
8348760|NCT01266148|20579813|P2|NOT COMPLETED|Overall Study||3
8348761|NCT01266148|20579814|P1|NOT COMPLETED|Overall Study||7
8348762|NCT01266148|20579813|P2|COMPLETED|Overall Study||56
8348763|NCT01266148|20579814|P1|COMPLETED|Overall Study||49
8348764|NCT01266148|20579813|P2|STARTED|Overall Study||59
8348765|NCT01266148|20579814|P1|STARTED|Overall Study||56
8348766|NCT01266122|20579842|P2|NOT COMPLETED|Overall Study||6
8348767|NCT01266122|20579843|P1|NOT COMPLETED|Overall Study||6
8348768|NCT01266122|20579842|P2|COMPLETED|Overall Study||42
8348769|NCT01266122|20579843|P1|COMPLETED|Overall Study||42
8348770|NCT01266122|20579842|P2|STARTED|Overall Study||48
8348771|NCT01266122|20579843|P1|STARTED|Overall Study||48
8348772|NCT01266070|20579851|P1|NOT COMPLETED|Overall Study||4
8348773|NCT01266070|20579851|P1|COMPLETED|Overall Study||2
8348774|NCT01266070|20579851|P1|STARTED|Overall Study||6
8348775|NCT01266031|20579859|P3|NOT COMPLETED|Overall Study||2
8348776|NCT01266031|20579860|P2|NOT COMPLETED|Overall Study||3
8348777|NCT01266031|20579861|P1|NOT COMPLETED|Overall Study||0
8348778|NCT01266031|20579859|P3|COMPLETED|Overall Study||47
8348779|NCT01266031|20579860|P2|COMPLETED|Overall Study||38
8348780|NCT01266031|20579861|P1|COMPLETED|Overall Study||6
8348781|NCT01266031|20579859|P3|STARTED|Overall Study||49
8348782|NCT01266031|20579860|P2|STARTED|Overall Study||41
8348783|NCT01266031|20579861|P1|STARTED|Overall Study||6
8348784|NCT01266018|20579888|P2|NOT COMPLETED|Overall Study||1
8348785|NCT01266018|20579889|P1|NOT COMPLETED|Overall Study||1
8348786|NCT01266018|20579888|P2|COMPLETED|Overall Study||12
8348787|NCT01266018|20579889|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
8348788|NCT01266018|20579888|P2|STARTED|Overall Study||13
8348789|NCT01266018|20579889|P1|STARTED|Overall Study||9
8348790|NCT01265992|20579900|P1|NOT COMPLETED|Overall Study||9
8348791|NCT01265992|20579900|P1|COMPLETED|Overall Study||41
8348792|NCT01265992|20579900|P1|Received Treatment|Overall Study||49
8348793|NCT01265992|20579900|P1|STARTED|Overall Study||50
8348794|NCT01265966|20579916|P3|NOT COMPLETED|Overall Study||2
8348795|NCT01265966|20579917|P2|NOT COMPLETED|Overall Study||2
8348796|NCT01265966|20579918|P1|NOT COMPLETED|Overall Study||3
8348797|NCT01265966|20579916|P3|COMPLETED|Overall Study||27
8348798|NCT01265966|20579917|P2|COMPLETED|Overall Study||39
8348799|NCT01265966|20579918|P1|COMPLETED|Overall Study||44
8348800|NCT01265966|20579916|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
8348801|NCT01265966|20579917|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
8348802|NCT01265966|20579918|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
8348803|NCT01265966|20579916|P3|STARTED|Overall Study||29
8348804|NCT01265966|20579917|P2|STARTED|Overall Study||41
8348805|NCT01265966|20579918|P1|STARTED|Overall Study||47
8348806|NCT01265953|20579928|P2|NOT COMPLETED|Overall Study||3
8348807|NCT01265953|20579929|P1|NOT COMPLETED|Overall Study||5
8348808|NCT01265953|20579928|P2|COMPLETED|Overall Study||45
8348809|NCT01265953|20579929|P1|COMPLETED|Overall Study||45
8348810|NCT01265953|20579928|P2|STARTED|Overall Study||48
8348811|NCT01265953|20579929|P1|STARTED|Overall Study||50
8348812|NCT01265875|20579941|P1|NOT COMPLETED|Overall Study||1
8348813|NCT01265875|20579941|P1|COMPLETED|Overall Study||11
8348814|NCT01265875|20579941|P1|STARTED|Overall Study||12
8348815|NCT01265823|20579949|P1|NOT COMPLETED|Overall Study||7
8348816|NCT01265823|20579949|P1|COMPLETED|Overall Study||143
8348817|NCT01265823|20579949|P1|STARTED|Overall Study||150
8348818|NCT01265797|20579978|P2|NOT COMPLETED|Open Label Month||1
8348819|NCT01265797|20579979|P1|NOT COMPLETED|Open Label Month||0
8348820|NCT01265797|20579978|P2|COMPLETED|Open Label Month||26
8348821|NCT01265797|20579979|P1|COMPLETED|Open Label Month||24
8348822|NCT01265797|20579978|P2|STARTED|Open Label Month||27
8348823|NCT01265797|20579979|P1|STARTED|Open Label Month||24
8348824|NCT01265797|20579978|P2|NOT COMPLETED|Blinded Month||2
8348825|NCT01265797|20579979|P1|NOT COMPLETED|Blinded Month||10
8348826|NCT01265797|20579978|P2|COMPLETED|Blinded Month||27
8348827|NCT01265797|20579979|P1|COMPLETED|Blinded Month||24
8348828|NCT01265797|20579978|P2|STARTED|Blinded Month||29
8348829|NCT01265797|20579979|P1|STARTED|Blinded Month||34
8348830|NCT01265797|20579978|P2|NOT COMPLETED|Run-in Month||5
8348831|NCT01265797|20579979|P1|NOT COMPLETED|Run-in Month||0
8348832|NCT01265797|20579978|P2|COMPLETED|Run-in Month||29
8348833|NCT01265797|20579979|P1|COMPLETED|Run-in Month||34
8348834|NCT01265797|20579978|P2|STARTED|Run-in Month||34
8348835|NCT01265797|20579979|P1|STARTED|Run-in Month||34
8348836|NCT01265784|20580010|P3|NOT COMPLETED|Overall Study||4
8348837|NCT01265784|20580011|P2|NOT COMPLETED|Overall Study||8
8348838|NCT01265784|20580012|P1|NOT COMPLETED|Overall Study||12
8348839|NCT01265784|20580010|P3|COMPLETED|Overall Study||26
8348840|NCT01265784|20580011|P2|COMPLETED|Overall Study||49
8348841|NCT01265784|20580012|P1|COMPLETED|Overall Study||44
8348842|NCT01265784|20580010|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
8348843|NCT01265784|20580011|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
8348844|NCT01265784|20580012|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
8348845|NCT01265784|20580010|P3|STARTED|Overall Study||30
8348846|NCT01265784|20580011|P2|STARTED|Overall Study||57
8348847|NCT01265784|20580012|P1|STARTED|Overall Study||56
8348854|NCT01265667|20580115|P2|NOT COMPLETED|Overall Study||13
8348855|NCT01265667|20580116|P1|NOT COMPLETED|Overall Study||20
8348856|NCT01265667|20580115|P2|COMPLETED|Overall Study||135
8348857|NCT01265667|20580116|P1|COMPLETED|Overall Study||125
8348858|NCT01265667|20580115|P2|STARTED|Overall Study||148
8348859|NCT01265667|20580116|P1|STARTED|Overall Study||145
8348860|NCT01265615|20580132|P4|NOT COMPLETED|Overall Study||3
8348861|NCT01265615|20580133|P3|NOT COMPLETED|Overall Study||4
8348862|NCT01265615|20580134|P2|NOT COMPLETED|Overall Study||2
8348863|NCT01265615|20580135|P1|NOT COMPLETED|Overall Study||2
8348864|NCT01265615|20580132|P4|COMPLETED|Overall Study||27
8348865|NCT01265615|20580133|P3|COMPLETED|Overall Study||26
8348866|NCT01265615|20580134|P2|COMPLETED|Overall Study||28
8348867|NCT01265615|20580135|P1|COMPLETED|Overall Study||28
8348868|NCT01265615|20580132|P4|STARTED|Overall Study||30
8348869|NCT01265615|20580133|P3|STARTED|Overall Study||30
8348870|NCT01265615|20580134|P2|STARTED|Overall Study||30
8348871|NCT01265615|20580135|P1|STARTED|Overall Study||30
8348872|NCT01265563|20580186|P5|NOT COMPLETED|Overall Study||2
8348873|NCT01265563|20580187|P4|NOT COMPLETED|Overall Study||0
8348874|NCT01265563|20580188|P3|NOT COMPLETED|Overall Study||1
8348875|NCT01265563|20580189|P2|NOT COMPLETED|Overall Study||1
8348876|NCT01265563|20580190|P1|NOT COMPLETED|Overall Study||0
8348877|NCT01265563|20580186|P5|COMPLETED|Overall Study||14
8348878|NCT01265563|20580187|P4|COMPLETED|Overall Study||16
8348879|NCT01265563|20580188|P3|COMPLETED|Overall Study||16
8348880|NCT01265563|20580189|P2|COMPLETED|Overall Study||12
8348881|NCT01265563|20580190|P1|COMPLETED|Overall Study||16
8348882|NCT01265563|20580186|P5|STARTED|Overall Study||16
8348883|NCT01265563|20580187|P4|STARTED|Overall Study||16
8348884|NCT01265563|20580188|P3|STARTED|Overall Study||17
8348885|NCT01265563|20580189|P2|STARTED|Overall Study||13
8348886|NCT01265563|20580190|P1|STARTED|Overall Study||16
8348887|NCT01265550|20580216|P4|NOT COMPLETED|Post Randomization||0
8348888|NCT01265550|20580217|P3|NOT COMPLETED|Post Randomization||20
8348889|NCT01265550|20580218|P2|NOT COMPLETED|Post Randomization||8
8348890|NCT01265550|20580219|P1|NOT COMPLETED|Post Randomization||15
8348891|NCT01265550|20580216|P4|COMPLETED|Post Randomization||0
8348892|NCT01265550|20580217|P3|COMPLETED|Post Randomization||6
8348893|NCT01265550|20580218|P2|COMPLETED|Post Randomization||19
8348894|NCT01265550|20580219|P1|COMPLETED|Post Randomization||10
8348895|NCT01265550|20580216|P4|STARTED|Post Randomization||0
8348896|NCT01265550|20580217|P3|STARTED|Post Randomization||26
8348897|NCT01265550|20580218|P2|STARTED|Post Randomization||27
8348898|NCT01265550|20580219|P1|STARTED|Post Randomization||25
8348899|NCT01265550|20580216|P4|NOT COMPLETED|Pre Randomization||288
8348900|NCT01265550|20580217|P3|NOT COMPLETED|Pre Randomization||0
8348901|NCT01265550|20580218|P2|NOT COMPLETED|Pre Randomization||0
8348902|NCT01265550|20580219|P1|NOT COMPLETED|Pre Randomization||0
8348903|NCT01265550|20580216|P4|COMPLETED|Pre Randomization||78
8348904|NCT01265550|20580217|P3|COMPLETED|Pre Randomization||0
8348905|NCT01265550|20580218|P2|COMPLETED|Pre Randomization||0
8348906|NCT01265550|20580219|P1|COMPLETED|Pre Randomization||0
8348907|NCT01265550|20580216|P4|STARTED|Pre Randomization||366
8348908|NCT01265550|20580217|P3|STARTED|Pre Randomization||0
8348909|NCT01265550|20580218|P2|STARTED|Pre Randomization||0
8348910|NCT01265550|20580219|P1|STARTED|Pre Randomization||0
8348911|NCT01265537|20580311|P2|NOT COMPLETED|Overall Study||2
8348912|NCT01265537|20580312|P1|NOT COMPLETED|Overall Study||2
8348913|NCT01265537|20580311|P2|COMPLETED|Overall Study||13
8348914|NCT01265537|20580312|P1|COMPLETED|Overall Study||13
8348915|NCT01265537|20580311|P2|STARTED|Overall Study||15
8348916|NCT01265537|20580312|P1|STARTED|Overall Study||15
8348917|NCT01265524|20580342|P2|NOT COMPLETED|Overall Study||6
8348918|NCT01265524|20580343|P1|NOT COMPLETED|Overall Study||18
8348919|NCT01265524|20580342|P2|COMPLETED|Overall Study||46
8348920|NCT01265524|20580343|P1|COMPLETED|Overall Study||41
8348921|NCT01265524|20580342|P2|STARTED|Overall Study||52
8348922|NCT01265524|20580343|P1|STARTED|Overall Study||59
8348923|NCT01265511|20580363|P2|NOT COMPLETED|Overall Study||3
8348924|NCT01265511|20580364|P1|NOT COMPLETED|Overall Study||2
8348925|NCT01265511|20580363|P2|COMPLETED|Overall Study||5
8348926|NCT01265511|20580364|P1|COMPLETED|Overall Study||0
8348927|NCT01265511|20580363|P2|STARTED|Overall Study||8
8348928|NCT01265511|20580364|P1|STARTED|Overall Study||2
8348929|NCT01265498|20580378|P2|NOT COMPLETED|Overall Study||33
8348930|NCT01265498|20580379|P1|NOT COMPLETED|Overall Study||31
8348931|NCT01265498|20580378|P2|COMPLETED|Overall Study||109
8348932|NCT01265498|20580379|P1|COMPLETED|Overall Study||110
8348933|NCT01265498|20580378|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
8348934|NCT01265498|20580379|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
8348935|NCT01265498|20580378|P2|STARTED|Overall Study||142
8348936|NCT01265498|20580379|P1|STARTED|Overall Study||141
8348937|NCT01265459|20580482|P3|NOT COMPLETED|Overall Study||2
8348938|NCT01265459|20580483|P2|NOT COMPLETED|Overall Study||0
8348939|NCT01265459|20580484|P1|NOT COMPLETED|Overall Study||0
8348940|NCT01265459|20580482|P3|COMPLETED|Overall Study||20
8348941|NCT01265459|20580483|P2|COMPLETED|Overall Study||23
8348942|NCT01265459|20580484|P1|COMPLETED|Overall Study||23
8348943|NCT01265459|20580482|P3|STARTED|Overall Study||22
8348944|NCT01265459|20580483|P2|STARTED|Overall Study||23
8348945|NCT01265459|20580484|P1|STARTED|Overall Study||23
8348946|NCT01265446|20580506|P2|NOT COMPLETED|Overall Study||0
8348947|NCT01265446|20580507|P1|NOT COMPLETED|Overall Study||1
8348948|NCT01265446|20580506|P2|COMPLETED|Overall Study||125
8348949|NCT01265446|20580507|P1|COMPLETED|Overall Study||124
8348950|NCT01265446|20580506|P2|STARTED|Overall Study||125
8348951|NCT01265446|20580507|P1|STARTED|Overall Study||125
8348952|NCT01265420|20580515|P1|NOT COMPLETED|Overall Study||1
8348953|NCT01265420|20580515|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
8348954|NCT01265420|20580515|P1|STARTED|Overall Study||7
8348955|NCT01265394|20580519|P1|NOT COMPLETED|Overall Study||37
8348956|NCT01265394|20580519|P1|COMPLETED|Overall Study||181
8348957|NCT01265394|20580519|P1|STARTED|Overall Study||218
8348958|NCT01265056|20580526|P2|NOT COMPLETED|Follow up||3
8348959|NCT01265056|20580527|P1|NOT COMPLETED|Follow up||7
8348960|NCT01265056|20580526|P2|COMPLETED|Follow up||24
8348961|NCT01265056|20580527|P1|COMPLETED|Follow up||19
8348962|NCT01265056|20580526|P2|STARTED|Follow up||27
8348963|NCT01265056|20580527|P1|STARTED|Follow up||26
8348964|NCT01265056|20580526|P2|NOT COMPLETED|Initial Study Period||2
8348965|NCT01265056|20580527|P1|NOT COMPLETED|Initial Study Period||2
8348966|NCT01265056|20580526|P2|COMPLETED|Initial Study Period||25
8348967|NCT01265056|20580527|P1|COMPLETED|Initial Study Period||24
8348968|NCT01265056|20580526|P2|STARTED|Initial Study Period||27
8348969|NCT01265056|20580527|P1|STARTED|Initial Study Period||26
8348970|NCT01264965|20580537|P1|NOT COMPLETED|Overall Study||10
8348971|NCT01264965|20580537|P1|COMPLETED|Overall Study||15
8348972|NCT01264965|20580537|P1|STARTED|Overall Study||25
8348973|NCT01264952|20580545|P3|NOT COMPLETED|Overall Study||0
8348974|NCT01264952|20580546|P2|NOT COMPLETED|Overall Study||0
8348975|NCT01264952|20580547|P1|NOT COMPLETED|Overall Study||0
8348976|NCT01264952|20580545|P3|COMPLETED|Overall Study||8
8348977|NCT01264952|20580546|P2|COMPLETED|Overall Study||2
8348978|NCT01264952|20580547|P1|COMPLETED|Overall Study||6
8348979|NCT01264952|20580545|P3|STARTED|Overall Study||8
8348980|NCT01264952|20580546|P2|STARTED|Overall Study||2
8348981|NCT01264952|20580547|P1|STARTED|Overall Study||6
8348982|NCT01264939|20580563|P2|NOT COMPLETED|Overall Study||28
8348983|NCT01264939|20580564|P1|NOT COMPLETED|Overall Study||18
8348984|NCT01264939|20580563|P2|COMPLETED|Overall Study||224
8348985|NCT01264939|20580564|P1|COMPLETED|Overall Study||66
8348986|NCT01264939|20580563|P2|STARTED|Overall Study||252
8348987|NCT01264939|20580564|P1|STARTED|Overall Study||84
8348988|NCT01264887|20580590|P1|NOT COMPLETED|Overall Study||31
8348989|NCT01264887|20580590|P1|COMPLETED|Overall Study||0
8348990|NCT01264887|20580590|P1|STARTED|Overall Study||31
8348991|NCT01264835|20580601|P1|NOT COMPLETED|Overall Study||1
8348992|NCT01264835|20580601|P1|COMPLETED|Overall Study||1
8348993|NCT01264835|20580601|P1|STARTED|Overall Study||2
8348994|NCT01264770|20580611|P6|NOT COMPLETED|Overall Study||6
8348995|NCT01264770|20580612|P5|NOT COMPLETED|Overall Study||8
8348996|NCT01264770|20580613|P4|NOT COMPLETED|Overall Study||6
8348997|NCT01264770|20580614|P3|NOT COMPLETED|Overall Study||16
8348998|NCT01264770|20580615|P2|NOT COMPLETED|Overall Study||10
8348999|NCT01264770|20580616|P1|NOT COMPLETED|Overall Study||18
8349000|NCT01264770|20580611|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
8349001|NCT01264770|20580612|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
8349002|NCT01264770|20580613|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
8349003|NCT01264770|20580614|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
8349004|NCT01264770|20580615|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
8349005|NCT01264770|20580616|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
8349006|NCT01264770|20580611|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
8349007|NCT01264770|20580612|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8349008|NCT01264770|20580613|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
8349009|NCT01264770|20580614|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8349010|NCT01264770|20580615|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
8349011|NCT01264770|20580616|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8349012|NCT01264770|20580611|P6|STARTED|Overall Study|Patients who received treatment|25
8349013|NCT01264770|20580612|P5|STARTED|Overall Study|Patients who received treatment|27
8349014|NCT01264770|20580613|P4|STARTED|Overall Study|Patients who received treatment|54
8349015|NCT01264770|20580614|P3|STARTED|Overall Study|Patients who received treatment|57
8349016|NCT01264770|20580615|P2|STARTED|Overall Study|Patients who received treatment|48
8349017|NCT01264770|20580616|P1|STARTED|Overall Study|Patients who received treatment|54
8349018|NCT01264718|20580702|P2|NOT COMPLETED|Overall Study||43
8349019|NCT01264718|20580703|P1|NOT COMPLETED|Overall Study||49
8349020|NCT01264718|20580702|P2|COMPLETED|Overall Study||114
8349021|NCT01264718|20580703|P1|COMPLETED|Overall Study||123
8349022|NCT01264718|20580702|P2|STARTED|Overall Study||157
8349023|NCT01264718|20580703|P1|STARTED|Overall Study||172
8349024|NCT01264705|20580718|P3|NOT COMPLETED|Overall Study||0
8349025|NCT01264705|20580719|P2|NOT COMPLETED|Overall Study||0
8349026|NCT01264705|20580720|P1|NOT COMPLETED|Overall Study||0
8349027|NCT01264705|20580718|P3|COMPLETED|Overall Study||41
8349028|NCT01264705|20580719|P2|COMPLETED|Overall Study||3
8349029|NCT01264705|20580720|P1|COMPLETED|Overall Study||3
8349030|NCT01264705|20580718|P3|STARTED|Overall Study||41
8349031|NCT01264705|20580719|P2|STARTED|Overall Study||3
8349032|NCT01264705|20580720|P1|STARTED|Overall Study||3
8349033|NCT01264679|20580740|P1|NOT COMPLETED|Overall Study||5
8349034|NCT01264679|20580740|P1|COMPLETED|Overall Study||3
8349035|NCT01264679|20580740|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8349036|NCT01264679|20580740|P1|STARTED|Overall Study||8
8349037|NCT01264614|20580748|P2|NOT COMPLETED|Overall Study||2
8349038|NCT01264614|20580749|P1|NOT COMPLETED|Overall Study||1
8349039|NCT01264614|20580748|P2|COMPLETED|Overall Study||7
8349040|NCT01264614|20580749|P1|COMPLETED|Overall Study||12
8349041|NCT01264614|20580748|P2|STARTED|Overall Study||9
8349042|NCT01264614|20580749|P1|STARTED|Overall Study||13
8349043|NCT01264601|20580765|P2|NOT COMPLETED|Overall Study||0
8349044|NCT01264601|20580766|P1|NOT COMPLETED|Overall Study||0
8349045|NCT01264601|20580765|P2|COMPLETED|Overall Study||14
8349046|NCT01264601|20580766|P1|COMPLETED|Overall Study||17
8349047|NCT01264601|20580765|P2|STARTED|Overall Study||14
8349048|NCT01264601|20580766|P1|STARTED|Overall Study||17
8349049|NCT01264419|20580774|P1|NOT COMPLETED|Overall Study||3
8349050|NCT01264419|20580774|P1|COMPLETED|Overall Study||72
8349051|NCT01264419|20580774|P1|STARTED|Overall Study||75
8349052|NCT01264380|20580779|P3|NOT COMPLETED|Period C||14
8349053|NCT01264380|20580780|P2|NOT COMPLETED|Period C||0
8349054|NCT01264380|20580781|P1|NOT COMPLETED|Period C||0
8349055|NCT01264380|20580779|P3|COMPLETED|Period C||2
8349056|NCT01264380|20580780|P2|COMPLETED|Period C||0
8349057|NCT01264380|20580781|P1|COMPLETED|Period C||0
8349058|NCT01264380|20580779|P3|STARTED|Period C||16
8349059|NCT01264380|20580780|P2|STARTED|Period C||0
8349060|NCT01264380|20580781|P1|STARTED|Period C||0
8349061|NCT01264380|20580779|P3|NOT COMPLETED|Period B||0
8349062|NCT01264380|20580780|P2|NOT COMPLETED|Period B||0
8349063|NCT01264380|20580781|P1|NOT COMPLETED|Period B||0
8349064|NCT01264380|20580779|P3|COMPLETED|Period B||0
8349065|NCT01264380|20580780|P2|COMPLETED|Period B||8
8349066|NCT01264380|20580781|P1|COMPLETED|Period B||8
8349067|NCT01264380|20580779|P3|STARTED|Period B||0
8349068|NCT01264380|20580780|P2|STARTED|Period B||8
8349069|NCT01264380|20580781|P1|STARTED|Period B||8
8349070|NCT01264380|20580779|P3|NOT COMPLETED|Period A||0
8349071|NCT01264380|20580780|P2|NOT COMPLETED|Period A||0
8349072|NCT01264380|20580781|P1|NOT COMPLETED|Period A||0
8349073|NCT01264380|20580779|P3|COMPLETED|Period A||0
8349074|NCT01264380|20580780|P2|COMPLETED|Period A||8
8349075|NCT01264380|20580781|P1|COMPLETED|Period A||8
8349076|NCT01264380|20580779|P3|STARTED|Period A||0
8349077|NCT01264380|20580780|P2|STARTED|Period A||8
8349078|NCT01264380|20580781|P1|STARTED|Period A||8
8349079|NCT01264081|20580802|P1|NOT COMPLETED|Analysis||0
8349080|NCT01264081|20580802|P1|COMPLETED|Analysis||2
8349081|NCT01264081|20580802|P1|STARTED|Analysis||2
8349082|NCT01264081|20580802|P1|NOT COMPLETED|Started Treatment||2
8349083|NCT01264081|20580802|P1|COMPLETED|Started Treatment||2
8349084|NCT01264081|20580802|P1|STARTED|Started Treatment||4
8349085|NCT01264081|20580802|P1|NOT COMPLETED|Participants Screened||30
8349086|NCT01264081|20580802|P1|COMPLETED|Participants Screened||4
8349087|NCT01264081|20580802|P1|STARTED|Participants Screened||34
8349088|NCT01264016|20580807|P1|NOT COMPLETED|Overall Study||2
8349089|NCT01264016|20580807|P1|COMPLETED|Overall Study||94
8349090|NCT01264016|20580807|P1|STARTED|Overall Study||96
8349091|NCT01263938|20580813|P1|NOT COMPLETED|Overall Study||0
8349092|NCT01263938|20580813|P1|COMPLETED|Overall Study||5
8349093|NCT01263938|20580813|P1|STARTED|Overall Study||5
8349094|NCT01263925|20580822|P2|NOT COMPLETED|Overall Study||52
8349095|NCT01263925|20580823|P1|NOT COMPLETED|Overall Study||51
8349096|NCT01263925|20580822|P2|COMPLETED|Overall Study||233
8349097|NCT01263925|20580823|P1|COMPLETED|Overall Study||225
8349098|NCT01263925|20580822|P2|Full Analysis Set|Overall Study||272
8349099|NCT01263925|20580823|P1|Full Analysis Set|Overall Study||269
8349100|NCT01263925|20580822|P2|STARTED|Overall Study||285
8349101|NCT01263925|20580823|P1|STARTED|Overall Study||276
8349102|NCT01263873|20580857|P2|NOT COMPLETED|Overall Study||1
8349103|NCT01263873|20580858|P1|NOT COMPLETED|Overall Study||1
8349104|NCT01263873|20580857|P2|COMPLETED|Overall Study||29
8349105|NCT01263873|20580858|P1|COMPLETED|Overall Study||29
8349106|NCT01263873|20580857|P2|STARTED|Overall Study||30
8349107|NCT01263873|20580858|P1|STARTED|Overall Study||30
8349108|NCT01263782|20580872|P4|NOT COMPLETED|Overall Study||1
8349109|NCT01263782|20580873|P3|NOT COMPLETED|Overall Study||3
8349110|NCT01263782|20580874|P2|NOT COMPLETED|Overall Study||0
8349111|NCT01263782|20580875|P1|NOT COMPLETED|Overall Study||0
8349112|NCT01263782|20580872|P4|COMPLETED|Overall Study||5
8349113|NCT01263782|20580873|P3|COMPLETED|Overall Study||3
8349114|NCT01263782|20580874|P2|COMPLETED|Overall Study||6
8349115|NCT01263782|20580875|P1|COMPLETED|Overall Study||6
8349116|NCT01263782|20580872|P4|STARTED|Overall Study||6
8349117|NCT01263782|20580873|P3|STARTED|Overall Study||6
8349118|NCT01263782|20580874|P2|STARTED|Overall Study||6
8349119|NCT01263782|20580875|P1|STARTED|Overall Study||6
8349120|NCT01263717|20580891|P2|NOT COMPLETED|Overall Study||6
8349121|NCT01263717|20580892|P1|NOT COMPLETED|Overall Study||5
8349122|NCT01263717|20580891|P2|COMPLETED|Overall Study||20
8349123|NCT01263717|20580892|P1|COMPLETED|Overall Study||23
8349124|NCT01263717|20580891|P2|Baseline Visit|Overall Study||22
8349125|NCT01263717|20580892|P1|Baseline Visit|Overall Study||28
8349126|NCT01263717|20580891|P2|STARTED|Overall Study||26
8349127|NCT01263717|20580892|P1|STARTED|Overall Study||28
8349128|NCT01263704|20580920|P1|NOT COMPLETED|Overall Study||29
8349129|NCT01263704|20580920|P1|COMPLETED|Overall Study||13
8349130|NCT01263704|20580920|P1|STARTED|Overall Study||42
8349131|NCT01263691|20580935|P6|NOT COMPLETED|Overall Study||0
8349132|NCT01263691|20580936|P5|NOT COMPLETED|Overall Study||0
8349133|NCT01263691|20580937|P4|NOT COMPLETED|Overall Study||1
8349134|NCT01263691|20580938|P3|NOT COMPLETED|Overall Study||1
8349135|NCT01263691|20580939|P2|NOT COMPLETED|Overall Study||0
8349136|NCT01263691|20580940|P1|NOT COMPLETED|Overall Study||3
8349137|NCT01263691|20580935|P6|COMPLETED|Overall Study||15
8349138|NCT01263691|20580936|P5|COMPLETED|Overall Study||18
8349139|NCT01263691|20580937|P4|COMPLETED|Overall Study||18
8349140|NCT01263691|20580938|P3|COMPLETED|Overall Study||16
8349141|NCT01263691|20580939|P2|COMPLETED|Overall Study||18
8349142|NCT01263691|20580940|P1|COMPLETED|Overall Study||15
8349143|NCT01263691|20580935|P6|STARTED|Overall Study||15
8349144|NCT01263691|20580936|P5|STARTED|Overall Study||18
8349145|NCT01263691|20580937|P4|STARTED|Overall Study||19
8349146|NCT01263691|20580938|P3|STARTED|Overall Study||17
8349147|NCT01263691|20580939|P2|STARTED|Overall Study||18
8349148|NCT01263691|20580940|P1|STARTED|Overall Study||18
8349149|NCT01263665|20581050|P1|NOT COMPLETED|Overall Study||9
8349150|NCT01263665|20581050|P1|COMPLETED|Overall Study||62
8349151|NCT01263665|20581050|P1|STARTED|Overall Study||71
8349152|NCT01263639|20581057|P2|NOT COMPLETED|Overall Study||79
8349153|NCT01263639|20581058|P1|NOT COMPLETED|Overall Study||73
8349154|NCT01263639|20581057|P2|COMPLETED|Overall Study||42
8349155|NCT01263639|20581058|P1|COMPLETED|Overall Study||34
8349156|NCT01263639|20581057|P2|STARTED|Overall Study||121
8349157|NCT01263639|20581058|P1|STARTED|Overall Study||107
8349158|NCT01263561|20581066|P2|NOT COMPLETED|Overall Study||2
8349159|NCT01263561|20581067|P1|NOT COMPLETED|Overall Study||1
8349160|NCT01263561|20581066|P2|COMPLETED|Overall Study||31
8349161|NCT01263561|20581067|P1|COMPLETED|Overall Study||30
8349162|NCT01263561|20581066|P2|STARTED|Overall Study||33
8349163|NCT01263561|20581067|P1|STARTED|Overall Study||31
8349164|NCT01263509|20581079|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
8349165|NCT01263509|20581080|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
8349166|NCT01263509|20581081|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
8349167|NCT01263509|20581082|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
8349168|NCT01263509|20581079|P4|COMPLETED|Entered - Long-Term Extension Study||24
8349169|NCT01263509|20581080|P3|COMPLETED|Entered - Long-Term Extension Study||27
8349170|NCT01263509|20581081|P2|COMPLETED|Entered - Long-Term Extension Study||48
8349171|NCT01263509|20581082|P1|COMPLETED|Entered - Long-Term Extension Study||53
8349172|NCT01263509|20581079|P4|STARTED|Entered - Long-Term Extension Study||26
8349173|NCT01263509|20581080|P3|STARTED|Entered - Long-Term Extension Study||32
8349174|NCT01263509|20581081|P2|STARTED|Entered - Long-Term Extension Study||60
8349175|NCT01263509|20581082|P1|STARTED|Entered - Long-Term Extension Study||61
8349176|NCT01263509|20581079|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349177|NCT01263509|20581080|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349178|NCT01263509|20581081|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349179|NCT01263509|20581082|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349180|NCT01263509|20581079|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
8349181|NCT01263509|20581080|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
8349182|NCT01263509|20581081|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
8349183|NCT01263509|20581082|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
8349184|NCT01263509|20581079|P4|STARTED|Enrolled - Long-Term Extension Study||26
8349185|NCT01263509|20581080|P3|STARTED|Enrolled - Long-Term Extension Study||32
8349186|NCT01263509|20581081|P2|STARTED|Enrolled - Long-Term Extension Study||60
8349187|NCT01263509|20581082|P1|STARTED|Enrolled - Long-Term Extension Study||61
8349188|NCT01263496|20581211|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
8349189|NCT01263496|20581212|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
8349190|NCT01263496|20581213|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
8349191|NCT01263496|20581214|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
8349192|NCT01263496|20581215|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
8349193|NCT01263496|20581216|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
8349194|NCT01263496|20581217|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
8349195|NCT01263496|20581218|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
8349196|NCT01263496|20581219|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
8349197|NCT01263496|20581211|P9|COMPLETED|Entered - Long-Term Extension Study||15
8349198|NCT01263496|20581212|P8|COMPLETED|Entered - Long-Term Extension Study||16
8349199|NCT01263496|20581213|P7|COMPLETED|Entered - Long-Term Extension Study||16
8349200|NCT01263496|20581214|P6|COMPLETED|Entered - Long-Term Extension Study||16
8349201|NCT01263496|20581215|P5|COMPLETED|Entered - Long-Term Extension Study||61
8349202|NCT01263496|20581216|P4|COMPLETED|Entered - Long-Term Extension Study||68
8349203|NCT01263496|20581217|P3|COMPLETED|Entered - Long-Term Extension Study||62
8349204|NCT01263496|20581218|P2|COMPLETED|Entered - Long-Term Extension Study||59
8349205|NCT01263496|20581219|P1|COMPLETED|Entered - Long-Term Extension Study||62
8349206|NCT01263496|20581211|P9|STARTED|Entered - Long-Term Extension Study||18
8349207|NCT01263496|20581212|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
8349208|NCT01263496|20581213|P7|STARTED|Entered - Long-Term Extension Study||17
8349209|NCT01263496|20581214|P6|STARTED|Entered - Long-Term Extension Study||17
8349210|NCT01263496|20581215|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
8349211|NCT01263496|20581216|P4|STARTED|Entered - Long-Term Extension Study||74
8349212|NCT01263496|20581217|P3|STARTED|Entered - Long-Term Extension Study||72
8349213|NCT01263496|20581218|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
8349214|NCT01263496|20581219|P1|STARTED|Entered - Long-Term Extension Study||71
8349215|NCT01263496|20581211|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349216|NCT01263496|20581212|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349217|NCT01263496|20581213|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349218|NCT01263496|20581214|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349219|NCT01263496|20581215|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8349220|NCT01263496|20581216|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8349221|NCT01263496|20581217|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349222|NCT01263496|20581218|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349223|NCT01263496|20581219|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8349224|NCT01263496|20581211|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
8349225|NCT01263496|20581212|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
8349226|NCT01263496|20581213|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
8349227|NCT01263496|20581214|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
8349228|NCT01263496|20581215|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
8349229|NCT01263496|20581216|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
8349230|NCT01263496|20581217|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
8349231|NCT01263496|20581218|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
8349232|NCT01263496|20581219|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
8349233|NCT01263496|20581211|P9|STARTED|Enrolled - Long-Term Extension Study||18
8349234|NCT01263496|20581212|P8|STARTED|Enrolled - Long-Term Extension Study||18
8349235|NCT01263496|20581213|P7|STARTED|Enrolled - Long-Term Extension Study||17
8349236|NCT01263496|20581214|P6|STARTED|Enrolled - Long-Term Extension Study||17
8349237|NCT01263496|20581215|P5|STARTED|Enrolled - Long-Term Extension Study||74
8349238|NCT01263496|20581216|P4|STARTED|Enrolled - Long-Term Extension Study||75
8349239|NCT01263496|20581217|P3|STARTED|Enrolled - Long-Term Extension Study||72
8349240|NCT01263496|20581218|P2|STARTED|Enrolled - Long-Term Extension Study||75
8349241|NCT01263496|20581219|P1|STARTED|Enrolled - Long-Term Extension Study||72
8349242|NCT01263483|20581514|P3|NOT COMPLETED|Overall Study||5
8349243|NCT01263483|20581515|P2|NOT COMPLETED|Overall Study||2
8349244|NCT01263483|20581516|P1|NOT COMPLETED|Overall Study||7
8349245|NCT01263483|20581514|P3|COMPLETED|Overall Study||74
8349246|NCT01263483|20581515|P2|COMPLETED|Overall Study||74
8349247|NCT01263483|20581516|P1|COMPLETED|Overall Study||68
8349248|NCT01263483|20581514|P3|STARTED|Overall Study||79
8349249|NCT01263483|20581515|P2|STARTED|Overall Study||76
8349250|NCT01263483|20581516|P1|STARTED|Overall Study||75
8349251|NCT01263470|20581578|P6|NOT COMPLETED|Overall Study||5
8349252|NCT01263470|20581579|P5|NOT COMPLETED|Overall Study||3
8349253|NCT01263470|20581580|P4|NOT COMPLETED|Overall Study||3
8349254|NCT01263470|20581581|P3|NOT COMPLETED|Overall Study||4
8349255|NCT01263470|20581582|P2|NOT COMPLETED|Overall Study||5
8349256|NCT01263470|20581583|P1|NOT COMPLETED|Overall Study||2
8349257|NCT01263470|20581578|P6|COMPLETED|Overall Study||78
8349258|NCT01263470|20581579|P5|COMPLETED|Overall Study||76
8349259|NCT01263470|20581580|P4|COMPLETED|Overall Study||77
8349260|NCT01263470|20581581|P3|COMPLETED|Overall Study||80
8349261|NCT01263470|20581582|P2|COMPLETED|Overall Study||74
8349262|NCT01263470|20581583|P1|COMPLETED|Overall Study||73
8349263|NCT01263470|20581578|P6|STARTED|Overall Study||83
8349264|NCT01263470|20581579|P5|STARTED|Overall Study||79
8349265|NCT01263470|20581580|P4|STARTED|Overall Study||80
8349266|NCT01263470|20581581|P3|STARTED|Overall Study||84
8349267|NCT01263470|20581582|P2|STARTED|Overall Study||79
8349268|NCT01263470|20581583|P1|STARTED|Overall Study||75
8349269|NCT01263444|20581693|P1|NOT COMPLETED|Overall Study||10
8349270|NCT01263444|20581693|P1|COMPLETED|Overall Study||37
8349271|NCT01263444|20581693|P1|STARTED|Overall Study||47
8349272|NCT01263314|20581702|P8|NOT COMPLETED|Period 3||0
8349273|NCT01263314|20581703|P7|NOT COMPLETED|Period 3||0
8349274|NCT01263314|20581704|P6|NOT COMPLETED|Period 3||0
8349275|NCT01263314|20581705|P5|NOT COMPLETED|Period 3||0
8349276|NCT01263314|20581706|P4|NOT COMPLETED|Period 3||0
8349277|NCT01263314|20581707|P3|NOT COMPLETED|Period 3||0
8349278|NCT01263314|20581708|P2|NOT COMPLETED|Period 3||0
8349279|NCT01263314|20581709|P1|NOT COMPLETED|Period 3||0
8349280|NCT01263314|20581702|P8|COMPLETED|Period 3||2
8349281|NCT01263314|20581703|P7|COMPLETED|Period 3||2
8349282|NCT01263314|20581704|P6|COMPLETED|Period 3||2
8349283|NCT01263314|20581705|P5|COMPLETED|Period 3||2
8349284|NCT01263314|20581706|P4|COMPLETED|Period 3||2
8349285|NCT01263314|20581707|P3|COMPLETED|Period 3||2
8349286|NCT01263314|20581708|P2|COMPLETED|Period 3||2
8349287|NCT01263314|20581709|P1|COMPLETED|Period 3||2
8349288|NCT01263314|20581702|P8|STARTED|Period 3||2
8349289|NCT01263314|20581703|P7|STARTED|Period 3||2
8349290|NCT01263314|20581704|P6|STARTED|Period 3||2
8349291|NCT01263314|20581705|P5|STARTED|Period 3||2
8349292|NCT01263314|20581706|P4|STARTED|Period 3||2
8349293|NCT01263314|20581707|P3|STARTED|Period 3||2
8349294|NCT01263314|20581708|P2|STARTED|Period 3||2
8349295|NCT01263314|20581709|P1|STARTED|Period 3||2
8349296|NCT01263314|20581702|P8|NOT COMPLETED|Period 2||0
8349297|NCT01263314|20581703|P7|NOT COMPLETED|Period 2||0
8349298|NCT01263314|20581704|P6|NOT COMPLETED|Period 2||0
8349299|NCT01263314|20581705|P5|NOT COMPLETED|Period 2||0
8349300|NCT01263314|20581706|P4|NOT COMPLETED|Period 2||0
8349301|NCT01263314|20581707|P3|NOT COMPLETED|Period 2||0
8349302|NCT01263314|20581708|P2|NOT COMPLETED|Period 2||0
8349303|NCT01263314|20581709|P1|NOT COMPLETED|Period 2||0
8349304|NCT01263314|20581702|P8|COMPLETED|Period 2||2
8349305|NCT01263314|20581703|P7|COMPLETED|Period 2||2
8349306|NCT01263314|20581704|P6|COMPLETED|Period 2||2
8349307|NCT01263314|20581705|P5|COMPLETED|Period 2||2
8349308|NCT01263314|20581706|P4|COMPLETED|Period 2||2
8349309|NCT01263314|20581707|P3|COMPLETED|Period 2||2
8349310|NCT01263314|20581708|P2|COMPLETED|Period 2||2
8349311|NCT01263314|20581709|P1|COMPLETED|Period 2||2
8349312|NCT01263314|20581702|P8|STARTED|Period 2||2
8349313|NCT01263314|20581703|P7|STARTED|Period 2||2
8349314|NCT01263314|20581704|P6|STARTED|Period 2||2
8349315|NCT01263314|20581705|P5|STARTED|Period 2||2
8349316|NCT01263314|20581706|P4|STARTED|Period 2||2
8349317|NCT01263314|20581707|P3|STARTED|Period 2||2
8349318|NCT01263314|20581708|P2|STARTED|Period 2||2
8349319|NCT01263314|20581709|P1|STARTED|Period 2||2
8349320|NCT01263314|20581702|P8|NOT COMPLETED|Period 1||0
8349321|NCT01263314|20581703|P7|NOT COMPLETED|Period 1||0
8349322|NCT01263314|20581704|P6|NOT COMPLETED|Period 1||0
8349323|NCT01263314|20581705|P5|NOT COMPLETED|Period 1||0
8349324|NCT01263314|20581706|P4|NOT COMPLETED|Period 1||0
8349325|NCT01263314|20581707|P3|NOT COMPLETED|Period 1||0
8349326|NCT01263314|20581708|P2|NOT COMPLETED|Period 1||0
8349327|NCT01263314|20581709|P1|NOT COMPLETED|Period 1||0
8349328|NCT01263314|20581702|P8|COMPLETED|Period 1||2
8349329|NCT01263314|20581703|P7|COMPLETED|Period 1||2
8349330|NCT01263314|20581704|P6|COMPLETED|Period 1||2
8349331|NCT01263314|20581705|P5|COMPLETED|Period 1||2
8349332|NCT01263314|20581706|P4|COMPLETED|Period 1||2
8349333|NCT01263314|20581707|P3|COMPLETED|Period 1||2
8349334|NCT01263314|20581708|P2|COMPLETED|Period 1||2
8349335|NCT01263314|20581709|P1|COMPLETED|Period 1||2
8349336|NCT01263314|20581702|P8|STARTED|Period 1||2
8349337|NCT01263314|20581703|P7|STARTED|Period 1||2
8349338|NCT01263314|20581704|P6|STARTED|Period 1||2
8349339|NCT01263314|20581705|P5|STARTED|Period 1||2
8349340|NCT01263314|20581706|P4|STARTED|Period 1||2
8349341|NCT01263314|20581707|P3|STARTED|Period 1||2
8349342|NCT01263314|20581708|P2|STARTED|Period 1||2
8349343|NCT01263314|20581709|P1|STARTED|Period 1||2
8349344|NCT01263301|20581817|P2|NOT COMPLETED|Overall Study||0
8349345|NCT01263301|20581818|P1|NOT COMPLETED|Overall Study||0
8349346|NCT01263301|20581817|P2|COMPLETED|Overall Study||11
8349347|NCT01263301|20581818|P1|COMPLETED|Overall Study||5
8349348|NCT01263301|20581817|P2|STARTED|Overall Study||11
8349349|NCT01263301|20581818|P1|STARTED|Overall Study||5
8349350|NCT01263223|20581830|P2|NOT COMPLETED|7-day Follow-up||1
8349351|NCT01263223|20581831|P1|NOT COMPLETED|7-day Follow-up||1
8349352|NCT01263223|20581830|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
8349353|NCT01263223|20581831|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
8349354|NCT01263223|20581830|P2|STARTED|7-day Follow-up||11
8349355|NCT01263223|20581831|P1|STARTED|7-day Follow-up||12
8349356|NCT01263223|20581830|P2|NOT COMPLETED|Period 3||0
8349357|NCT01263223|20581831|P1|NOT COMPLETED|Period 3||0
8349358|NCT01263223|20581830|P2|COMPLETED|Period 3||11
8349359|NCT01263223|20581831|P1|COMPLETED|Period 3||12
8349360|NCT01263223|20581830|P2|STARTED|Period 3||11
8349361|NCT01263223|20581831|P1|STARTED|Period 3||12
8349362|NCT01263223|20581830|P2|NOT COMPLETED|Period 2||1
8349363|NCT01263223|20581831|P1|NOT COMPLETED|Period 2||0
8349364|NCT01263223|20581830|P2|COMPLETED|Period 2||11
8349365|NCT01263223|20581831|P1|COMPLETED|Period 2||12
8349366|NCT01263223|20581830|P2|STARTED|Period 2||12
8349367|NCT01263223|20581831|P1|STARTED|Period 2||12
8349368|NCT01263223|20581830|P2|NOT COMPLETED|3-Day Washout||0
8349369|NCT01263223|20581831|P1|NOT COMPLETED|3-Day Washout||0
8349370|NCT01263223|20581830|P2|COMPLETED|3-Day Washout||12
8349371|NCT01263223|20581831|P1|COMPLETED|3-Day Washout||12
8349372|NCT01263223|20581830|P2|STARTED|3-Day Washout||12
8349373|NCT01263223|20581831|P1|STARTED|3-Day Washout||12
8349374|NCT01263223|20581830|P2|NOT COMPLETED|Period 1||0
8349375|NCT01263223|20581831|P1|NOT COMPLETED|Period 1||0
8349376|NCT01263223|20581830|P2|COMPLETED|Period 1||12
8349377|NCT01263223|20581831|P1|COMPLETED|Period 1||12
8349378|NCT01263223|20581830|P2|STARTED|Period 1||12
8349379|NCT01263223|20581831|P1|STARTED|Period 1||12
8349380|NCT01263197|20581854|P6|NOT COMPLETED|Third Intervention (Period 3)||0
8349381|NCT01263197|20581855|P5|NOT COMPLETED|Third Intervention (Period 3)||0
8349382|NCT01263197|20581856|P4|NOT COMPLETED|Third Intervention (Period 3)||0
8349383|NCT01263197|20581857|P3|NOT COMPLETED|Third Intervention (Period 3)||0
8349384|NCT01263197|20581858|P2|NOT COMPLETED|Third Intervention (Period 3)||1
8349385|NCT01263197|20581859|P1|NOT COMPLETED|Third Intervention (Period 3)||0
8349386|NCT01263197|20581854|P6|COMPLETED|Third Intervention (Period 3)||6
8349387|NCT01263197|20581855|P5|COMPLETED|Third Intervention (Period 3)||7
8349388|NCT01263197|20581856|P4|COMPLETED|Third Intervention (Period 3)||7
8349389|NCT01263197|20581857|P3|COMPLETED|Third Intervention (Period 3)||8
8349390|NCT01263197|20581858|P2|COMPLETED|Third Intervention (Period 3)||7
8349391|NCT01263197|20581859|P1|COMPLETED|Third Intervention (Period 3)||8
8349392|NCT01263197|20581854|P6|STARTED|Third Intervention (Period 3)||6
8349393|NCT01263197|20581855|P5|STARTED|Third Intervention (Period 3)||7
8349394|NCT01263197|20581856|P4|STARTED|Third Intervention (Period 3)||7
8349395|NCT01263197|20581857|P3|STARTED|Third Intervention (Period 3)||8
8349396|NCT01263197|20581858|P2|STARTED|Third Intervention (Period 3)||8
8349397|NCT01263197|20581859|P1|STARTED|Third Intervention (Period 3)||8
8349398|NCT01263197|20581854|P6|NOT COMPLETED|Washout Period 2||1
8349399|NCT01263197|20581855|P5|NOT COMPLETED|Washout Period 2||0
8349400|NCT01263197|20581856|P4|NOT COMPLETED|Washout Period 2||1
8349401|NCT01263197|20581857|P3|NOT COMPLETED|Washout Period 2||0
8349402|NCT01263197|20581858|P2|NOT COMPLETED|Washout Period 2||0
8349403|NCT01263197|20581859|P1|NOT COMPLETED|Washout Period 2||0
8349404|NCT01263197|20581854|P6|COMPLETED|Washout Period 2||6
8349405|NCT01263197|20581855|P5|COMPLETED|Washout Period 2||7
8349406|NCT01263197|20581856|P4|COMPLETED|Washout Period 2||7
8349407|NCT01263197|20581857|P3|COMPLETED|Washout Period 2||8
8349408|NCT01263197|20581858|P2|COMPLETED|Washout Period 2||8
8349409|NCT01263197|20581859|P1|COMPLETED|Washout Period 2||8
8349410|NCT01263197|20581854|P6|STARTED|Washout Period 2||7
8349411|NCT01263197|20581855|P5|STARTED|Washout Period 2||7
8349412|NCT01263197|20581856|P4|STARTED|Washout Period 2||8
8349413|NCT01263197|20581857|P3|STARTED|Washout Period 2||8
8349414|NCT01263197|20581858|P2|STARTED|Washout Period 2||8
8349415|NCT01263197|20581859|P1|STARTED|Washout Period 2||8
8349416|NCT01263197|20581854|P6|NOT COMPLETED|Second Intervention (Period 2)||0
8349417|NCT01263197|20581855|P5|NOT COMPLETED|Second Intervention (Period 2)||0
8349418|NCT01263197|20581856|P4|NOT COMPLETED|Second Intervention (Period 2)||0
8349419|NCT01263197|20581857|P3|NOT COMPLETED|Second Intervention (Period 2)||0
8349420|NCT01263197|20581858|P2|NOT COMPLETED|Second Intervention (Period 2)||0
8349421|NCT01263197|20581859|P1|NOT COMPLETED|Second Intervention (Period 2)||0
8349422|NCT01263197|20581854|P6|COMPLETED|Second Intervention (Period 2)||7
8349423|NCT01263197|20581855|P5|COMPLETED|Second Intervention (Period 2)||7
8349424|NCT01263197|20581856|P4|COMPLETED|Second Intervention (Period 2)||8
8349425|NCT01263197|20581857|P3|COMPLETED|Second Intervention (Period 2)||8
8349426|NCT01263197|20581858|P2|COMPLETED|Second Intervention (Period 2)||8
8349427|NCT01263197|20581859|P1|COMPLETED|Second Intervention (Period 2)||8
8349428|NCT01263197|20581854|P6|STARTED|Second Intervention (Period 2)||7
8349429|NCT01263197|20581855|P5|STARTED|Second Intervention (Period 2)||7
8349430|NCT01263197|20581856|P4|STARTED|Second Intervention (Period 2)||8
8349431|NCT01263197|20581857|P3|STARTED|Second Intervention (Period 2)||8
8349432|NCT01263197|20581858|P2|STARTED|Second Intervention (Period 2)||8
8349433|NCT01263197|20581859|P1|STARTED|Second Intervention (Period 2)||8
8349434|NCT01263197|20581854|P6|NOT COMPLETED|Washout Period 1||0
8349435|NCT01263197|20581855|P5|NOT COMPLETED|Washout Period 1||1
8349436|NCT01263197|20581856|P4|NOT COMPLETED|Washout Period 1||0
8349437|NCT01263197|20581857|P3|NOT COMPLETED|Washout Period 1||0
8349438|NCT01263197|20581858|P2|NOT COMPLETED|Washout Period 1||0
8349439|NCT01263197|20581859|P1|NOT COMPLETED|Washout Period 1||0
8349440|NCT01263197|20581854|P6|COMPLETED|Washout Period 1||7
8349441|NCT01263197|20581855|P5|COMPLETED|Washout Period 1||7
8349442|NCT01263197|20581856|P4|COMPLETED|Washout Period 1||8
8349443|NCT01263197|20581857|P3|COMPLETED|Washout Period 1||8
8349444|NCT01263197|20581858|P2|COMPLETED|Washout Period 1||8
8349445|NCT01263197|20581859|P1|COMPLETED|Washout Period 1||8
8349446|NCT01263197|20581854|P6|STARTED|Washout Period 1||7
8349447|NCT01263197|20581855|P5|STARTED|Washout Period 1||8
8349448|NCT01263197|20581856|P4|STARTED|Washout Period 1||8
8349449|NCT01263197|20581857|P3|STARTED|Washout Period 1||8
8349450|NCT01263197|20581858|P2|STARTED|Washout Period 1||8
8349451|NCT01263197|20581859|P1|STARTED|Washout Period 1||8
8349452|NCT01263197|20581854|P6|NOT COMPLETED|First Intervention (Period 1)||1
8349453|NCT01263197|20581855|P5|NOT COMPLETED|First Intervention (Period 1)||0
8349454|NCT01263197|20581856|P4|NOT COMPLETED|First Intervention (Period 1)||0
8349455|NCT01263197|20581857|P3|NOT COMPLETED|First Intervention (Period 1)||0
8349456|NCT01263197|20581858|P2|NOT COMPLETED|First Intervention (Period 1)||0
8349457|NCT01263197|20581859|P1|NOT COMPLETED|First Intervention (Period 1)||0
8349458|NCT01263197|20581854|P6|COMPLETED|First Intervention (Period 1)||7
8349459|NCT01263197|20581855|P5|COMPLETED|First Intervention (Period 1)||8
8349460|NCT01263197|20581856|P4|COMPLETED|First Intervention (Period 1)||8
8349461|NCT01263197|20581857|P3|COMPLETED|First Intervention (Period 1)||8
8349462|NCT01263197|20581858|P2|COMPLETED|First Intervention (Period 1)||8
8349463|NCT01263197|20581859|P1|COMPLETED|First Intervention (Period 1)||8
8349464|NCT01263197|20581854|P6|STARTED|First Intervention (Period 1)||8
8349465|NCT01263197|20581855|P5|STARTED|First Intervention (Period 1)||8
8349466|NCT01263197|20581856|P4|STARTED|First Intervention (Period 1)||8
8349467|NCT01263197|20581857|P3|STARTED|First Intervention (Period 1)||8
8349468|NCT01263197|20581858|P2|STARTED|First Intervention (Period 1)||8
8349469|NCT01263197|20581859|P1|STARTED|First Intervention (Period 1)||8
8349470|NCT01263132|20581887|P2|NOT COMPLETED|Overall Study||0
8349471|NCT01263132|20581888|P1|NOT COMPLETED|Overall Study||0
8349472|NCT01263132|20581887|P2|COMPLETED|Overall Study||37
8349473|NCT01263132|20581888|P1|COMPLETED|Overall Study||38
8349474|NCT01263132|20581887|P2|STARTED|Overall Study||37
8349475|NCT01263132|20581888|P1|STARTED|Overall Study||38
8349476|NCT01263119|20581902|P1|NOT COMPLETED|Period 2||2
8349477|NCT01263119|20581902|P1|COMPLETED|Period 2||14
8349478|NCT01263119|20581902|P1|STARTED|Period 2||16
8349479|NCT01263119|20581902|P1|NOT COMPLETED|Period 1||2
8349480|NCT01263119|20581902|P1|COMPLETED|Period 1||16
8349481|NCT01263119|20581902|P1|STARTED|Period 1||18
8349482|NCT01263106|20581923|P2|NOT COMPLETED|Period 2 (7 Days)||0
8349483|NCT01263106|20581924|P1|NOT COMPLETED|Period 2 (7 Days)||0
8349484|NCT01263106|20581923|P2|COMPLETED|Period 2 (7 Days)||9
8349485|NCT01263106|20581924|P1|COMPLETED|Period 2 (7 Days)||10
8349486|NCT01263106|20581923|P2|STARTED|Period 2 (7 Days)||9
8349487|NCT01263106|20581924|P1|STARTED|Period 2 (7 Days)||10
8349488|NCT01263106|20581923|P2|NOT COMPLETED|Washout (at Least 7 Days)||1
8349489|NCT01263106|20581924|P1|NOT COMPLETED|Washout (at Least 7 Days)||1
8349490|NCT01263106|20581923|P2|COMPLETED|Washout (at Least 7 Days)||9
8349491|NCT01263106|20581924|P1|COMPLETED|Washout (at Least 7 Days)||10
8349492|NCT01263106|20581923|P2|STARTED|Washout (at Least 7 Days)||10
8349493|NCT01263106|20581924|P1|STARTED|Washout (at Least 7 Days)||11
8349494|NCT01263106|20581923|P2|NOT COMPLETED|Period 1 (7 Days)||0
8349495|NCT01263106|20581924|P1|NOT COMPLETED|Period 1 (7 Days)||0
8349496|NCT01263106|20581923|P2|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
8349497|NCT01263106|20581924|P1|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
8349498|NCT01263106|20581923|P2|STARTED|Period 1 (7 Days)||10
8349499|NCT01263106|20581924|P1|STARTED|Period 1 (7 Days)||11
8349500|NCT01263093|20581939|P2|NOT COMPLETED|Period 2||0
8349501|NCT01263093|20581940|P1|NOT COMPLETED|Period 2||1
8349502|NCT01263093|20581939|P2|COMPLETED|Period 2||23
8349503|NCT01263093|20581940|P1|COMPLETED|Period 2||22
8349504|NCT01263093|20581939|P2|STARTED|Period 2||23
8349505|NCT01263093|20581940|P1|STARTED|Period 2||23
8349506|NCT01263093|20581939|P2|NOT COMPLETED|Washout||0
8349507|NCT01263093|20581940|P1|NOT COMPLETED|Washout||1
8349508|NCT01263093|20581939|P2|COMPLETED|Washout||23
8349509|NCT01263093|20581940|P1|COMPLETED|Washout||23
8349510|NCT01263093|20581939|P2|STARTED|Washout||23
8349511|NCT01263093|20581940|P1|STARTED|Washout||24
8349512|NCT01263093|20581939|P2|NOT COMPLETED|Period 1||0
8349513|NCT01263093|20581940|P1|NOT COMPLETED|Period 1||0
8349514|NCT01263093|20581939|P2|COMPLETED|Period 1||23
8349515|NCT01263093|20581940|P1|COMPLETED|Period 1||24
8349516|NCT01263093|20581939|P2|STARTED|Period 1||23
8349517|NCT01263093|20581940|P1|STARTED|Period 1||24
8349518|NCT01263054|20581957|P2|NOT COMPLETED|Overall Study||6
8349519|NCT01263054|20581958|P1|NOT COMPLETED|Overall Study||5
8349520|NCT01263054|20581957|P2|COMPLETED|Overall Study||28
8349521|NCT01263054|20581958|P1|COMPLETED|Overall Study||24
8349522|NCT01263054|20581957|P2|STARTED|Overall Study||34
8349523|NCT01263054|20581958|P1|STARTED|Overall Study||29
8349524|NCT01263028|20581976|P1|NOT COMPLETED|Overall Study||6
8349525|NCT01263028|20581976|P1|COMPLETED|Overall Study||0
8349526|NCT01263028|20581976|P1|STARTED|Overall Study||6
8349527|NCT01263015|20581986|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
8349528|NCT01263015|20581987|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
8349529|NCT01263015|20581986|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
8349530|NCT01263015|20581987|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
8349531|NCT01263015|20581986|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
8349532|NCT01263015|20581987|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
8349533|NCT01263015|20581986|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
8349534|NCT01263015|20581987|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
8349535|NCT01263015|20581986|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
8349536|NCT01263015|20581987|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
8349537|NCT01263015|20581986|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
8349538|NCT01263015|20581987|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
8349539|NCT01262989|20582013|P2|NOT COMPLETED|Period 2||1
8349540|NCT01262989|20582014|P1|NOT COMPLETED|Period 2||0
8349541|NCT01262989|20582013|P2|COMPLETED|Period 2||16
8349542|NCT01262989|20582014|P1|COMPLETED|Period 2||19
8349543|NCT01262989|20582013|P2|STARTED|Period 2||17
8349544|NCT01262989|20582014|P1|STARTED|Period 2||19
8349545|NCT01262989|20582013|P2|NOT COMPLETED|7-Day Washout Period||0
8349546|NCT01262989|20582014|P1|NOT COMPLETED|7-Day Washout Period||0
8349547|NCT01262989|20582013|P2|COMPLETED|7-Day Washout Period||17
8349548|NCT01262989|20582014|P1|COMPLETED|7-Day Washout Period||19
8349549|NCT01262989|20582013|P2|STARTED|7-Day Washout Period||17
8349550|NCT01262989|20582014|P1|STARTED|7-Day Washout Period||19
8349551|NCT01262989|20582013|P2|NOT COMPLETED|Period 1||3
8349552|NCT01262989|20582014|P1|NOT COMPLETED|Period 1||1
8349553|NCT01262989|20582013|P2|COMPLETED|Period 1||17
8349554|NCT01262989|20582014|P1|COMPLETED|Period 1||19
8349555|NCT01262989|20582013|P2|STARTED|Period 1||20
8349556|NCT01262989|20582014|P1|STARTED|Period 1||20
8349557|NCT01262976|20582030|P6|NOT COMPLETED|Up to Year 3||4
8349558|NCT01262976|20582031|P5|NOT COMPLETED|Up to Year 3||2
8349559|NCT01262976|20582032|P4|NOT COMPLETED|Up to Year 3||5
8349560|NCT01262976|20582033|P3|NOT COMPLETED|Up to Year 3||7
8349561|NCT01262976|20582034|P2|NOT COMPLETED|Up to Year 3||2
8349562|NCT01262976|20582035|P1|NOT COMPLETED|Up to Year 3||6
8349563|NCT01262976|20582030|P6|COMPLETED|Up to Year 3||36
8349564|NCT01262976|20582031|P5|COMPLETED|Up to Year 3||38
8349565|NCT01262976|20582032|P4|COMPLETED|Up to Year 3||35
8349566|NCT01262976|20582033|P3|COMPLETED|Up to Year 3||33
8349567|NCT01262976|20582034|P2|COMPLETED|Up to Year 3||38
8349568|NCT01262976|20582035|P1|COMPLETED|Up to Year 3||34
8349569|NCT01262976|20582030|P6|STARTED|Up to Year 3||40
8349570|NCT01262976|20582031|P5|STARTED|Up to Year 3||40
8349571|NCT01262976|20582032|P4|STARTED|Up to Year 3||40
8349572|NCT01262976|20582033|P3|STARTED|Up to Year 3||40
8349573|NCT01262976|20582034|P2|STARTED|Up to Year 3||40
8349574|NCT01262976|20582035|P1|STARTED|Up to Year 3||40
8349575|NCT01262976|20582030|P6|NOT COMPLETED|Up to Year 2||5
8349576|NCT01262976|20582031|P5|NOT COMPLETED|Up to Year 2||4
8349577|NCT01262976|20582032|P4|NOT COMPLETED|Up to Year 2||4
8349578|NCT01262976|20582033|P3|NOT COMPLETED|Up to Year 2||5
8349579|NCT01262976|20582034|P2|NOT COMPLETED|Up to Year 2||1
8349580|NCT01262976|20582035|P1|NOT COMPLETED|Up to Year 2||5
8349581|NCT01262976|20582030|P6|COMPLETED|Up to Year 2||35
8349582|NCT01262976|20582031|P5|COMPLETED|Up to Year 2||36
8349583|NCT01262976|20582032|P4|COMPLETED|Up to Year 2||36
8349584|NCT01262976|20582033|P3|COMPLETED|Up to Year 2||35
8349585|NCT01262976|20582034|P2|COMPLETED|Up to Year 2||39
8349586|NCT01262976|20582035|P1|COMPLETED|Up to Year 2||35
8349587|NCT01262976|20582030|P6|STARTED|Up to Year 2||40
8349588|NCT01262976|20582031|P5|STARTED|Up to Year 2||40
8349589|NCT01262976|20582032|P4|STARTED|Up to Year 2||40
8349590|NCT01262976|20582033|P3|STARTED|Up to Year 2||40
8349591|NCT01262976|20582034|P2|STARTED|Up to Year 2||40
8349592|NCT01262976|20582035|P1|STARTED|Up to Year 2||40
8349593|NCT01262976|20582030|P6|NOT COMPLETED|Up to Year 1||9
8349594|NCT01262976|20582031|P5|NOT COMPLETED|Up to Year 1||11
8349595|NCT01262976|20582032|P4|NOT COMPLETED|Up to Year 1||4
8349596|NCT01262976|20582033|P3|NOT COMPLETED|Up to Year 1||3
8349597|NCT01262976|20582034|P2|NOT COMPLETED|Up to Year 1||1
8349598|NCT01262976|20582035|P1|NOT COMPLETED|Up to Year 1||9
8349599|NCT01262976|20582030|P6|COMPLETED|Up to Year 1||31
8349600|NCT01262976|20582031|P5|COMPLETED|Up to Year 1||29
8349601|NCT01262976|20582032|P4|COMPLETED|Up to Year 1||36
8349602|NCT01262976|20582033|P3|COMPLETED|Up to Year 1||37
8349603|NCT01262976|20582034|P2|COMPLETED|Up to Year 1||39
8349604|NCT01262976|20582035|P1|COMPLETED|Up to Year 1||31
8349605|NCT01262976|20582030|P6|STARTED|Up to Year 1||40
8349606|NCT01262976|20582031|P5|STARTED|Up to Year 1||40
8349607|NCT01262976|20582032|P4|STARTED|Up to Year 1||40
8349608|NCT01262976|20582033|P3|STARTED|Up to Year 1||40
8349609|NCT01262976|20582034|P2|STARTED|Up to Year 1||40
8349610|NCT01262976|20582035|P1|STARTED|Up to Year 1||40
8349611|NCT01262976|20582030|P6|NOT COMPLETED|Up to Month 7||4
8349612|NCT01262976|20582031|P5|NOT COMPLETED|Up to Month 7||2
8349613|NCT01262976|20582032|P4|NOT COMPLETED|Up to Month 7||6
8349614|NCT01262976|20582033|P3|NOT COMPLETED|Up to Month 7||6
8349615|NCT01262976|20582034|P2|NOT COMPLETED|Up to Month 7||0
8349616|NCT01262976|20582035|P1|NOT COMPLETED|Up to Month 7||5
8349617|NCT01262976|20582030|P6|COMPLETED|Up to Month 7||36
8349618|NCT01262976|20582031|P5|COMPLETED|Up to Month 7||38
8349619|NCT01262976|20582032|P4|COMPLETED|Up to Month 7||34
8349620|NCT01262976|20582033|P3|COMPLETED|Up to Month 7||34
8349621|NCT01262976|20582034|P2|COMPLETED|Up to Month 7||40
8349622|NCT01262976|20582035|P1|COMPLETED|Up to Month 7||35
8349623|NCT01262976|20582030|P6|STARTED|Up to Month 7||40
8349624|NCT01262976|20582031|P5|STARTED|Up to Month 7||40
8349625|NCT01262976|20582032|P4|STARTED|Up to Month 7||40
8349626|NCT01262976|20582033|P3|STARTED|Up to Month 7||40
8349627|NCT01262976|20582034|P2|STARTED|Up to Month 7||40
8349628|NCT01262976|20582035|P1|STARTED|Up to Month 7||40
8349629|NCT01262976|20582030|P6|NOT COMPLETED|Up to Month 2||4
8349630|NCT01262976|20582031|P5|NOT COMPLETED|Up to Month 2||2
8349631|NCT01262976|20582032|P4|NOT COMPLETED|Up to Month 2||2
8349632|NCT01262976|20582033|P3|NOT COMPLETED|Up to Month 2||1
8349633|NCT01262976|20582034|P2|NOT COMPLETED|Up to Month 2||1
8349634|NCT01262976|20582035|P1|NOT COMPLETED|Up to Month 2||3
8349635|NCT01262976|20582030|P6|COMPLETED|Up to Month 2||36
8349636|NCT01262976|20582031|P5|COMPLETED|Up to Month 2||38
8349637|NCT01262976|20582032|P4|COMPLETED|Up to Month 2||38
8349638|NCT01262976|20582033|P3|COMPLETED|Up to Month 2||39
8349639|NCT01262976|20582034|P2|COMPLETED|Up to Month 2||39
8349640|NCT01262976|20582035|P1|COMPLETED|Up to Month 2||37
8349641|NCT01262976|20582030|P6|STARTED|Up to Month 2||40
8349642|NCT01262976|20582031|P5|STARTED|Up to Month 2||40
8349643|NCT01262976|20582032|P4|STARTED|Up to Month 2||40
8349644|NCT01262976|20582033|P3|STARTED|Up to Month 2||40
8349645|NCT01262976|20582034|P2|STARTED|Up to Month 2||40
8349646|NCT01262976|20582035|P1|STARTED|Up to Month 2||40
8349647|NCT01262898|20582191|P4|NOT COMPLETED|Overall Study||0
8349648|NCT01262898|20582192|P3|NOT COMPLETED|Overall Study||0
8349649|NCT01262898|20582193|P2|NOT COMPLETED|Overall Study||2
8349650|NCT01262898|20582194|P1|NOT COMPLETED|Overall Study||3
8349651|NCT01262898|20582191|P4|COMPLETED|Overall Study||22
8349652|NCT01262898|20582192|P3|COMPLETED|Overall Study||18
8349653|NCT01262898|20582193|P2|COMPLETED|Overall Study||16
8349654|NCT01262898|20582194|P1|COMPLETED|Overall Study||18
8349655|NCT01262898|20582191|P4|STARTED|Overall Study||22
8349656|NCT01262898|20582192|P3|STARTED|Overall Study||18
8349657|NCT01262898|20582193|P2|STARTED|Overall Study||18
8349658|NCT01262898|20582194|P1|STARTED|Overall Study||21
8349659|NCT01262872|20582322|P8|NOT COMPLETED|Step 2||6
8349660|NCT01262872|20582323|P7|NOT COMPLETED|Step 2||9
8349661|NCT01262872|20582324|P6|NOT COMPLETED|Step 2||9
8349662|NCT01262872|20582325|P5|NOT COMPLETED|Step 2||5
8349663|NCT01262872|20582326|P4|NOT COMPLETED|Step 2||10
8349664|NCT01262872|20582327|P3|NOT COMPLETED|Step 2||9
8349665|NCT01262872|20582328|P2|NOT COMPLETED|Step 2||0
8349666|NCT01262872|20582329|P1|NOT COMPLETED|Step 2||0
8349667|NCT01262872|20582322|P8|COMPLETED|Step 2||194
8349668|NCT01262872|20582323|P7|COMPLETED|Step 2||191
8349669|NCT01262872|20582324|P6|COMPLETED|Step 2||191
8349670|NCT01262872|20582325|P5|COMPLETED|Step 2||195
8349671|NCT01262872|20582326|P4|COMPLETED|Step 2||190
8349672|NCT01262872|20582327|P3|COMPLETED|Step 2||191
8349673|NCT01262872|20582328|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349674|NCT01262872|20582329|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349675|NCT01262872|20582322|P8|STARTED|Step 2||200
8349676|NCT01262872|20582323|P7|STARTED|Step 2||200
8349677|NCT01262872|20582324|P6|STARTED|Step 2||200
8349678|NCT01262872|20582325|P5|STARTED|Step 2||200
8349679|NCT01262872|20582326|P4|STARTED|Step 2||200
8349680|NCT01262872|20582327|P3|STARTED|Step 2||200
8349681|NCT01262872|20582328|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349682|NCT01262872|20582329|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349683|NCT01262872|20582322|P8|NOT COMPLETED|Step 1||0
8349684|NCT01262872|20582323|P7|NOT COMPLETED|Step 1||0
8349685|NCT01262872|20582324|P6|NOT COMPLETED|Step 1||0
8349686|NCT01262872|20582325|P5|NOT COMPLETED|Step 1||0
8349687|NCT01262872|20582326|P4|NOT COMPLETED|Step 1||0
8349688|NCT01262872|20582327|P3|NOT COMPLETED|Step 1||0
8349689|NCT01262872|20582328|P2|NOT COMPLETED|Step 1||0
8349690|NCT01262872|20582329|P1|NOT COMPLETED|Step 1||0
8349691|NCT01262872|20582322|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349692|NCT01262872|20582323|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349693|NCT01262872|20582324|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349694|NCT01262872|20582325|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349695|NCT01262872|20582326|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
8349696|NCT01262872|20582327|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349697|NCT01262872|20582328|P2|COMPLETED|Step 1||60
8349698|NCT01262872|20582329|P1|COMPLETED|Step 1||60
8349699|NCT01262872|20582322|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349700|NCT01262872|20582323|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349701|NCT01262872|20582324|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349702|NCT01262872|20582325|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349703|NCT01262872|20582326|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349704|NCT01262872|20582327|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349705|NCT01262872|20582328|P2|STARTED|Step 1||60
8349706|NCT01262872|20582329|P1|STARTED|Step 1||60
8349707|NCT01262846|20582596|P2|NOT COMPLETED|Overall Study||3
8349708|NCT01262846|20582597|P1|NOT COMPLETED|Overall Study||2
8349709|NCT01262846|20582596|P2|COMPLETED|Overall Study||97
8349710|NCT01262846|20582597|P1|COMPLETED|Overall Study||93
8349711|NCT01262846|20582596|P2|STARTED|Overall Study||100
8349712|NCT01262846|20582597|P1|STARTED|Overall Study||95
8349713|NCT01262820|20582603|P1|NOT COMPLETED|Overall Study||15
8349714|NCT01262820|20582603|P1|COMPLETED|Overall Study||0
8349715|NCT01262820|20582603|P1|STARTED|Overall Study||15
8349716|NCT01262755|20582610|P1|NOT COMPLETED|Overall Study||0
8349717|NCT01262755|20582610|P1|COMPLETED|Overall Study||450
8349718|NCT01262755|20582610|P1|STARTED|Overall Study||450
8349719|NCT01262677|20582617|P3|NOT COMPLETED|Overall Study||12
8349720|NCT01262677|20582618|P2|NOT COMPLETED|Overall Study||15
8349721|NCT01262677|20582619|P1|NOT COMPLETED|Overall Study||9
8349722|NCT01262677|20582617|P3|COMPLETED|Overall Study||98
8349723|NCT01262677|20582618|P2|COMPLETED|Overall Study||98
8349724|NCT01262677|20582619|P1|COMPLETED|Overall Study||91
8349725|NCT01262677|20582617|P3|STARTED|Overall Study||110
8349726|NCT01262677|20582618|P2|STARTED|Overall Study||113
8349727|NCT01262677|20582619|P1|STARTED|Overall Study||100
8349728|NCT01262651|20582710|P2|NOT COMPLETED|Overall Study||48
8349729|NCT01262651|20582711|P1|NOT COMPLETED|Overall Study||58
8349730|NCT01262651|20582710|P2|COMPLETED|Overall Study||150
8349731|NCT01262651|20582711|P1|COMPLETED|Overall Study||141
8349732|NCT01262651|20582710|P2|ITT Population|Overall Study||198
8349733|NCT01262651|20582711|P1|ITT Population|Overall Study||199
8349734|NCT01262651|20582710|P2|Safety Population|Overall Study||198
8349735|NCT01262651|20582711|P1|Safety Population|Overall Study||199
8349736|NCT01262651|20582710|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
8349737|NCT01262651|20582711|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
8349738|NCT01262651|20582710|P2|STARTED|Overall Study||198
8349739|NCT01262651|20582711|P1|STARTED|Overall Study||199
8349740|NCT01262599|20582739|P2|NOT COMPLETED|Overall Study||0
8349741|NCT01262599|20582740|P1|NOT COMPLETED|Overall Study||0
8349742|NCT01262599|20582739|P2|COMPLETED|Overall Study||16
8349743|NCT01262599|20582740|P1|COMPLETED|Overall Study||16
8349744|NCT01262599|20582739|P2|STARTED|Overall Study||16
8349745|NCT01262599|20582740|P1|STARTED|Overall Study||16
8349746|NCT01262573|20582752|P2|NOT COMPLETED|Overall Study||1
8349747|NCT01262573|20582753|P1|NOT COMPLETED|Overall Study||0
8349748|NCT01262573|20582752|P2|COMPLETED|Overall Study||31
8349749|NCT01262573|20582753|P1|COMPLETED|Overall Study||32
8349750|NCT01262573|20582752|P2|STARTED|Overall Study||32
8349751|NCT01262573|20582753|P1|STARTED|Overall Study||32
8349752|NCT01262560|20582764|P3|NOT COMPLETED|Overall Study||2
8349753|NCT01262560|20582765|P2|NOT COMPLETED|Overall Study||1
8349754|NCT01262560|20582766|P1|NOT COMPLETED|Overall Study||0
8349755|NCT01262560|20582764|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
8349756|NCT01262560|20582765|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
8349757|NCT01262560|20582766|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
8349758|NCT01262560|20582764|P3|STARTED|Overall Study||56
8349759|NCT01262560|20582765|P2|STARTED|Overall Study||54
8349760|NCT01262560|20582766|P1|STARTED|Overall Study||53
8349761|NCT01262547|20582801|P1|NOT COMPLETED|Overall Study||0
8349762|NCT01262547|20582801|P1|COMPLETED|Overall Study||3
8349763|NCT01262547|20582801|P1|STARTED|Overall Study||3
8349764|NCT01262456|20582815|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
8349765|NCT01262456|20582816|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
8349766|NCT01262456|20582817|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
8349767|NCT01262456|20582815|P3|COMPLETED|1-Month Open-Label Extension Period||98
8349768|NCT01262456|20582816|P2|COMPLETED|1-Month Open-Label Extension Period||97
8349769|NCT01262456|20582817|P1|COMPLETED|1-Month Open-Label Extension Period||120
8349770|NCT01262456|20582815|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
8349771|NCT01262456|20582816|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
8349772|NCT01262456|20582817|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
8349773|NCT01262456|20582815|P3|STARTED|1-Month Open-Label Extension Period||103
8349774|NCT01262456|20582816|P2|STARTED|1-Month Open-Label Extension Period||100
8349775|NCT01262456|20582817|P1|STARTED|1-Month Open-Label Extension Period||124
8349776|NCT01262456|20582815|P3|NOT COMPLETED|3-Month Double-Blind Period||26
8349777|NCT01262456|20582816|P2|NOT COMPLETED|3-Month Double-Blind Period||23
8349778|NCT01262456|20582817|P1|NOT COMPLETED|3-Month Double-Blind Period||19
8349779|NCT01262456|20582815|P3|COMPLETED|3-Month Double-Blind Period||103
8349780|NCT01262456|20582816|P2|COMPLETED|3-Month Double-Blind Period||100
8349781|NCT01262456|20582817|P1|COMPLETED|3-Month Double-Blind Period||124
8349782|NCT01262456|20582815|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
8349866|NCT01262092|20582969|P2|COMPLETED|Buprenorphine Taper||12
8349867|NCT01262092|20582970|P1|COMPLETED|Buprenorphine Taper||11
8349783|NCT01262456|20582816|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
8349784|NCT01262456|20582817|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
8349785|NCT01262456|20582815|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
8349786|NCT01262456|20582816|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
8349787|NCT01262456|20582817|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
8349788|NCT01262456|20582815|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
8349789|NCT01262456|20582816|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
8349790|NCT01262456|20582817|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
8349791|NCT01262365|20582861|P3|NOT COMPLETED|Overall Study||94
8349792|NCT01262365|20582862|P2|NOT COMPLETED|Overall Study||81
8349793|NCT01262365|20582863|P1|NOT COMPLETED|Overall Study||90
8349794|NCT01262365|20582861|P3|COMPLETED|Overall Study||171
8349795|NCT01262365|20582862|P2|COMPLETED|Overall Study||181
8349796|NCT01262365|20582863|P1|COMPLETED|Overall Study||176
8349797|NCT01262365|20582861|P3|STARTED|Overall Study||265
8349798|NCT01262365|20582862|P2|STARTED|Overall Study||262
8349799|NCT01262365|20582863|P1|STARTED|Overall Study||266
8349800|NCT01262352|20582888|P2|NOT COMPLETED|Period 2||0
8349801|NCT01262352|20582889|P1|NOT COMPLETED|Period 2||0
8349802|NCT01262352|20582888|P2|COMPLETED|Period 2||8
8349803|NCT01262352|20582889|P1|COMPLETED|Period 2||9
8349804|NCT01262352|20582888|P2|Dosed|Period 2||8
8349805|NCT01262352|20582889|P1|Dosed|Period 2||9
8349806|NCT01262352|20582888|P2|STARTED|Period 2||8
8349807|NCT01262352|20582889|P1|STARTED|Period 2||9
8349808|NCT01262352|20582888|P2|NOT COMPLETED|Washout||2
8349809|NCT01262352|20582889|P1|NOT COMPLETED|Washout||1
8349810|NCT01262352|20582888|P2|COMPLETED|Washout||8
8349811|NCT01262352|20582889|P1|COMPLETED|Washout||9
8349812|NCT01262352|20582888|P2|STARTED|Washout||10
8349813|NCT01262352|20582889|P1|STARTED|Washout||10
8349814|NCT01262352|20582888|P2|NOT COMPLETED|Period 1||0
8349815|NCT01262352|20582889|P1|NOT COMPLETED|Period 1||1
8349816|NCT01262352|20582888|P2|COMPLETED|Period 1||10
8349817|NCT01262352|20582889|P1|COMPLETED|Period 1||10
8349818|NCT01262352|20582888|P2|Dosed|Period 1||10
8349819|NCT01262352|20582889|P1|Dosed|Period 1||10
8349820|NCT01262352|20582888|P2|STARTED|Period 1||10
8349821|NCT01262352|20582889|P1|STARTED|Period 1||11
8349822|NCT01262339|20582901|P1|NOT COMPLETED|Overall Study||0
8349823|NCT01262339|20582901|P1|COMPLETED|Overall Study||2
8349824|NCT01262339|20582901|P1|STARTED|Overall Study||2
8349825|NCT01262287|20582907|P2|NOT COMPLETED|Overall Study||1
8349826|NCT01262287|20582908|P1|NOT COMPLETED|Overall Study||2
8349827|NCT01262287|20582907|P2|COMPLETED|Overall Study||18
8349828|NCT01262287|20582908|P1|COMPLETED|Overall Study||18
8349829|NCT01262287|20582907|P2|STARTED|Overall Study||19
8349830|NCT01262287|20582908|P1|STARTED|Overall Study||20
8349831|NCT01262131|20582921|P3|NOT COMPLETED|Overall Study||0
8349832|NCT01262131|20582922|P2|NOT COMPLETED|Overall Study||0
8349833|NCT01262131|20582923|P1|NOT COMPLETED|Overall Study||0
8349834|NCT01262131|20582921|P3|COMPLETED|Overall Study||4
8349835|NCT01262131|20582922|P2|COMPLETED|Overall Study||4
8349836|NCT01262131|20582923|P1|COMPLETED|Overall Study||5
8349837|NCT01262131|20582921|P3|STARTED|Overall Study||4
8349838|NCT01262131|20582922|P2|STARTED|Overall Study||4
8349839|NCT01262131|20582923|P1|STARTED|Overall Study||5
8349840|NCT01262118|20582933|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
8349841|NCT01262118|20582934|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
8349842|NCT01262118|20582933|P2|COMPLETED|Treatment Period (6 Weeks)||0
8349843|NCT01262118|20582934|P1|COMPLETED|Treatment Period (6 Weeks)||36
8349844|NCT01262118|20582933|P2|STARTED|Treatment Period (6 Weeks)||0
8349845|NCT01262118|20582934|P1|STARTED|Treatment Period (6 Weeks)||36
8349846|NCT01262118|20582933|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
8349847|NCT01262118|20582934|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
8349848|NCT01262118|20582933|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
8349849|NCT01262118|20582934|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
8349850|NCT01262118|20582933|P2|STARTED|Baseline Assessment Period (3 Days)||33
8349851|NCT01262118|20582934|P1|STARTED|Baseline Assessment Period (3 Days)||36
8349852|NCT01262105|20582960|P2|NOT COMPLETED|Overall Study||0
8349853|NCT01262105|20582961|P1|NOT COMPLETED|Overall Study||0
8349854|NCT01262105|20582960|P2|COMPLETED|Overall Study||10
8349855|NCT01262105|20582961|P1|COMPLETED|Overall Study||13
8349856|NCT01262105|20582960|P2|STARTED|Overall Study||10
8349857|NCT01262105|20582961|P1|STARTED|Overall Study||13
8349858|NCT01262092|20582969|P2|NOT COMPLETED|Gabapentin Taper||0
8349859|NCT01262092|20582970|P1|NOT COMPLETED|Gabapentin Taper||1
8349860|NCT01262092|20582969|P2|COMPLETED|Gabapentin Taper||11
8349861|NCT01262092|20582970|P1|COMPLETED|Gabapentin Taper||9
8349862|NCT01262092|20582969|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
8349863|NCT01262092|20582970|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
8349864|NCT01262092|20582969|P2|NOT COMPLETED|Buprenorphine Taper||1
8349865|NCT01262092|20582970|P1|NOT COMPLETED|Buprenorphine Taper||1
8349868|NCT01262092|20582969|P2|STARTED|Buprenorphine Taper||13
8349869|NCT01262092|20582970|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
8349870|NCT01262092|20582969|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
8349871|NCT01262092|20582970|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
8349872|NCT01262092|20582969|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
8349873|NCT01262092|20582970|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
8349874|NCT01262092|20582969|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
8349875|NCT01262092|20582970|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
8349876|NCT01262027|20582976|P1|NOT COMPLETED|Overall Study||5
8349877|NCT01262027|20582976|P1|COMPLETED|Overall Study||17
8349878|NCT01262027|20582976|P1|STARTED|Overall Study||22
8349879|NCT01261975|20582981|P1|NOT COMPLETED|Overall Study||1
8349880|NCT01261975|20582981|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
8349881|NCT01261975|20582981|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
8349882|NCT01261819|20583002|P2|NOT COMPLETED|Overall Study||0
8349883|NCT01261819|20583003|P1|NOT COMPLETED|Overall Study||0
8349884|NCT01261819|20583002|P2|COMPLETED|Overall Study||33
8349885|NCT01261819|20583003|P1|COMPLETED|Overall Study||33
8349886|NCT01261819|20583002|P2|STARTED|Overall Study||33
8349887|NCT01261819|20583003|P1|STARTED|Overall Study||33
8349888|NCT01261793|20583012|P3|NOT COMPLETED|Overall Study||82
8349889|NCT01261793|20583013|P2|NOT COMPLETED|Overall Study||91
8349890|NCT01261793|20583014|P1|NOT COMPLETED|Overall Study||85
8349891|NCT01261793|20583012|P3|COMPLETED|Overall Study||184
8349892|NCT01261793|20583013|P2|COMPLETED|Overall Study||171
8349893|NCT01261793|20583014|P1|COMPLETED|Overall Study||178
8349894|NCT01261793|20583012|P3|STARTED|Overall Study||266
8349895|NCT01261793|20583013|P2|STARTED|Overall Study||262
8349896|NCT01261793|20583014|P1|STARTED|Overall Study||263
8349897|NCT01261780|20583039|P2|NOT COMPLETED|Overall Study||2
8349898|NCT01261780|20583040|P1|NOT COMPLETED|Overall Study||2
8349899|NCT01261780|20583039|P2|COMPLETED|Overall Study||5
8349900|NCT01261780|20583040|P1|COMPLETED|Overall Study||5
8349901|NCT01261780|20583039|P2|STARTED|Overall Study||7
8349902|NCT01261780|20583040|P1|STARTED|Overall Study||7
8349903|NCT01261624|20583050|P2|NOT COMPLETED|Week 13 to Week 24||1
8349904|NCT01261624|20583051|P1|NOT COMPLETED|Week 13 to Week 24||0
8349905|NCT01261624|20583050|P2|COMPLETED|Week 13 to Week 24||10
8349906|NCT01261624|20583051|P1|COMPLETED|Week 13 to Week 24||1
8349907|NCT01261624|20583050|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
8349908|NCT01261624|20583051|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
8349909|NCT01261624|20583050|P2|NOT COMPLETED|Week 0 to Week 12||3
8349910|NCT01261624|20583051|P1|NOT COMPLETED|Week 0 to Week 12||1
8349911|NCT01261624|20583050|P2|COMPLETED|Week 0 to Week 12||3
8349912|NCT01261624|20583051|P1|COMPLETED|Week 0 to Week 12||9
8349913|NCT01261624|20583050|P2|STARTED|Week 0 to Week 12||6
8349914|NCT01261624|20583051|P1|STARTED|Week 0 to Week 12||10
8349915|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 5||0
8349916|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 5||0
8349917|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 5||3
8349918|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 5||0
8349919|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 5||0
8349920|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 5||217
8349921|NCT01261611|20583071|P3|STARTED|Treatment Cycle 5||0
8349922|NCT01261611|20583072|P2|STARTED|Treatment Cycle 5||0
8349923|NCT01261611|20583073|P1|STARTED|Treatment Cycle 5||220
8349924|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 4||0
8349925|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 4||0
8349926|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 4||96
8349927|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 4||0
8349928|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 4||0
8349929|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 4||220
8349930|NCT01261611|20583071|P3|STARTED|Treatment Cycle 4||0
8349931|NCT01261611|20583072|P2|STARTED|Treatment Cycle 4||0
8349932|NCT01261611|20583073|P1|STARTED|Treatment Cycle 4||316
8349933|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 3||0
8349934|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 3||0
8349935|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 3||30
8349936|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 3||0
8349937|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 3||0
8349938|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 3||316
8349939|NCT01261611|20583071|P3|STARTED|Treatment Cycle 3||0
8349940|NCT01261611|20583072|P2|STARTED|Treatment Cycle 3||0
8349941|NCT01261611|20583073|P1|STARTED|Treatment Cycle 3||346
8349942|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 2||0
8349943|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 2||0
8349944|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 2||13
8349945|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 2||0
8349946|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 2||0
8349947|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 2||346
8349948|NCT01261611|20583071|P3|STARTED|Treatment Cycle 2||0
8349949|NCT01261611|20583072|P2|STARTED|Treatment Cycle 2||0
8349950|NCT01261611|20583073|P1|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
8349951|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 1||2
8349952|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 1||3
8349953|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 1||4
8349954|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 1||52
8349955|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 1||156
8349956|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 1||152
8349957|NCT01261611|20583071|P3|STARTED|Treatment Cycle 1||54
8349958|NCT01261611|20583072|P2|STARTED|Treatment Cycle 1||159
8349959|NCT01261611|20583073|P1|STARTED|Treatment Cycle 1||156
8349960|NCT01261559|20583111|P2|NOT COMPLETED|Overall Study||0
8349961|NCT01261559|20583112|P1|NOT COMPLETED|Overall Study||0
8349962|NCT01261559|20583111|P2|COMPLETED|Overall Study||36
8349963|NCT01261559|20583112|P1|COMPLETED|Overall Study||36
8349964|NCT01261559|20583111|P2|STARTED|Overall Study||36
8349965|NCT01261559|20583112|P1|STARTED|Overall Study||36
8349966|NCT01261507|20583124|P1|NOT COMPLETED|Overall Study||0
8349967|NCT01261507|20583124|P1|COMPLETED|Overall Study||15
8349968|NCT01261507|20583124|P1|STARTED|Overall Study||15
8349969|NCT01261390|20583137|P4|NOT COMPLETED|Overall Study||8
8349970|NCT01261390|20583138|P3|NOT COMPLETED|Overall Study||7
8349971|NCT01261390|20583139|P2|NOT COMPLETED|Overall Study||9
8349972|NCT01261390|20583140|P1|NOT COMPLETED|Overall Study||7
8349973|NCT01261390|20583137|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
8349974|NCT01261390|20583138|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
8349975|NCT01261390|20583139|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
8349976|NCT01261390|20583140|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
8349977|NCT01261390|20583137|P4|12-Month Visit|Overall Study||19
8349978|NCT01261390|20583138|P3|12-Month Visit|Overall Study||19
8349979|NCT01261390|20583139|P2|12-Month Visit|Overall Study||21
8349980|NCT01261390|20583140|P1|12-Month Visit|Overall Study||23
8349981|NCT01261390|20583137|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
8349982|NCT01261390|20583138|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
8349983|NCT01261390|20583139|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
8349984|NCT01261390|20583140|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
8349985|NCT01261390|20583137|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
8349986|NCT01261390|20583138|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
8349987|NCT01261390|20583139|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
8349988|NCT01261390|20583140|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
8349989|NCT01261338|20583304|P2|NOT COMPLETED|Overall Study||2
8349990|NCT01261338|20583305|P1|NOT COMPLETED|Overall Study||3
8349991|NCT01261338|20583304|P2|COMPLETED|Overall Study||12
8349992|NCT01261338|20583305|P1|COMPLETED|Overall Study||11
8349993|NCT01261338|20583304|P2|STARTED|Overall Study||14
8349994|NCT01261338|20583305|P1|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
8349995|NCT01261325|20583316|P3|NOT COMPLETED|Overall Study||26
8349996|NCT01261325|20583317|P2|NOT COMPLETED|Overall Study||29
8349997|NCT01261325|20583318|P1|NOT COMPLETED|Overall Study||17
8349998|NCT01261325|20583316|P3|COMPLETED|Overall Study||225
8349999|NCT01261325|20583317|P2|COMPLETED|Overall Study||225
8350000|NCT01261325|20583318|P1|COMPLETED|Overall Study||246
8350001|NCT01261325|20583316|P3|STARTED|Overall Study||251
8350002|NCT01261325|20583317|P2|STARTED|Overall Study||254
8350003|NCT01261325|20583318|P1|STARTED|Overall Study||263
8350004|NCT01261247|20583350|P1|NOT COMPLETED|Overall Study||2
8350005|NCT01261247|20583350|P1|COMPLETED|Overall Study||39
8350006|NCT01261247|20583350|P1|STARTED|Overall Study||41
8350007|NCT01261052|20583357|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
8350008|NCT01261052|20583357|P1|COMPLETED|APD Only Intervention (33 Hours)||14
8350009|NCT01261052|20583357|P1|STARTED|APD Only Intervention (33 Hours)||14
8350010|NCT01261052|20583357|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
8350011|NCT01261052|20583357|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
8350012|NCT01261052|20583357|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
8350013|NCT01261000|20583363|P1|NOT COMPLETED|Overall Study||1
8350014|NCT01261000|20583363|P1|COMPLETED|Overall Study||7
8350015|NCT01261000|20583363|P1|STARTED|Overall Study||8
8350016|NCT01260948|20583369|P2|NOT COMPLETED|Second Intervention||1
8350017|NCT01260948|20583370|P1|NOT COMPLETED|Second Intervention||0
8350018|NCT01260948|20583369|P2|COMPLETED|Second Intervention||9
8350019|NCT01260948|20583370|P1|COMPLETED|Second Intervention||12
8350020|NCT01260948|20583369|P2|STARTED|Second Intervention||10
8350021|NCT01260948|20583370|P1|STARTED|Second Intervention||12
8350022|NCT01260948|20583369|P2|NOT COMPLETED|Washout of 28 Days||3
8350023|NCT01260948|20583370|P1|NOT COMPLETED|Washout of 28 Days||1
8350024|NCT01260948|20583369|P2|COMPLETED|Washout of 28 Days||10
8350025|NCT01260948|20583370|P1|COMPLETED|Washout of 28 Days||12
8350026|NCT01260948|20583369|P2|STARTED|Washout of 28 Days||13
8350027|NCT01260948|20583370|P1|STARTED|Washout of 28 Days||13
8350028|NCT01260948|20583369|P2|NOT COMPLETED|First Intervention||0
8350029|NCT01260948|20583370|P1|NOT COMPLETED|First Intervention||0
8350030|NCT01260948|20583369|P2|COMPLETED|First Intervention||13
8350031|NCT01260948|20583370|P1|COMPLETED|First Intervention||13
8350032|NCT01260948|20583369|P2|STARTED|First Intervention||13
8350033|NCT01260948|20583370|P1|STARTED|First Intervention||13
8350034|NCT01260922|20583380|P2|NOT COMPLETED|Second Intervention||2
8350035|NCT01260922|20583381|P1|NOT COMPLETED|Second Intervention||0
8350036|NCT01260922|20583380|P2|COMPLETED|Second Intervention||8
8350037|NCT01260922|20583381|P1|COMPLETED|Second Intervention||9
8350038|NCT01260922|20583380|P2|STARTED|Second Intervention||10
8350039|NCT01260922|20583381|P1|STARTED|Second Intervention||9
8350040|NCT01260922|20583380|P2|NOT COMPLETED|Washout of 28 Days||2
8350041|NCT01260922|20583381|P1|NOT COMPLETED|Washout of 28 Days||4
8350042|NCT01260922|20583380|P2|COMPLETED|Washout of 28 Days||10
8350043|NCT01260922|20583381|P1|COMPLETED|Washout of 28 Days||9
8350044|NCT01260922|20583380|P2|STARTED|Washout of 28 Days||12
8350045|NCT01260922|20583381|P1|STARTED|Washout of 28 Days||13
8350046|NCT01260922|20583380|P2|NOT COMPLETED|First Intervention||1
8350047|NCT01260922|20583381|P1|NOT COMPLETED|First Intervention||0
8350048|NCT01260922|20583380|P2|COMPLETED|First Intervention||12
8350049|NCT01260922|20583381|P1|COMPLETED|First Intervention||13
8350050|NCT01260922|20583380|P2|STARTED|First Intervention||13
8350051|NCT01260922|20583381|P1|STARTED|First Intervention||13
8350052|NCT01260896|20583391|P2|NOT COMPLETED|Second Intervention||0
8350053|NCT01260896|20583392|P1|NOT COMPLETED|Second Intervention||0
8350054|NCT01260896|20583391|P2|COMPLETED|Second Intervention||12
8350055|NCT01260896|20583392|P1|COMPLETED|Second Intervention||10
8350056|NCT01260896|20583391|P2|STARTED|Second Intervention||12
8350057|NCT01260896|20583392|P1|STARTED|Second Intervention||10
8350058|NCT01260896|20583391|P2|NOT COMPLETED|Washout of 7 Days||0
8350059|NCT01260896|20583392|P1|NOT COMPLETED|Washout of 7 Days||0
8350060|NCT01260896|20583391|P2|COMPLETED|Washout of 7 Days||12
8350061|NCT01260896|20583392|P1|COMPLETED|Washout of 7 Days||10
8350062|NCT01260896|20583391|P2|STARTED|Washout of 7 Days||12
8350063|NCT01260896|20583392|P1|STARTED|Washout of 7 Days||10
8350064|NCT01260896|20583391|P2|NOT COMPLETED|First Intervention||0
8350065|NCT01260896|20583392|P1|NOT COMPLETED|First Intervention||2
8350066|NCT01260896|20583391|P2|COMPLETED|First Intervention||12
8350067|NCT01260896|20583392|P1|COMPLETED|First Intervention||10
8350068|NCT01260896|20583391|P2|STARTED|First Intervention||12
8350069|NCT01260896|20583392|P1|STARTED|First Intervention||12
8350070|NCT01260883|20583411|P3|NOT COMPLETED|Overall Study||0
8350071|NCT01260883|20583412|P2|NOT COMPLETED|Overall Study||0
8350072|NCT01260883|20583413|P1|NOT COMPLETED|Overall Study||0
8350073|NCT01260883|20583411|P3|COMPLETED|Overall Study||18
8350074|NCT01260883|20583412|P2|COMPLETED|Overall Study||11
8350075|NCT01260883|20583413|P1|COMPLETED|Overall Study||22
8350076|NCT01260883|20583411|P3|STARTED|Overall Study||18
8350077|NCT01260883|20583412|P2|STARTED|Overall Study||11
8350078|NCT01260883|20583413|P1|STARTED|Overall Study||22
8350079|NCT01260701|20583450|P1|NOT COMPLETED|Overall Study||75
8350080|NCT01260701|20583450|P1|COMPLETED|Overall Study||0
8350081|NCT01260701|20583450|P1|Eligible and Began Protocol Therapy|Overall Study||70
8350082|NCT01260701|20583450|P1|Eligible|Overall Study||71
8350083|NCT01260701|20583450|P1|STARTED|Overall Study||75
8350084|NCT01260688|20583459|P2|NOT COMPLETED|Overall Study||0
8350085|NCT01260688|20583460|P1|NOT COMPLETED|Overall Study||0
8350086|NCT01260688|20583459|P2|COMPLETED|Overall Study||11
8350087|NCT01260688|20583460|P1|COMPLETED|Overall Study||11
8350088|NCT01260688|20583459|P2|STARTED|Overall Study||11
8350089|NCT01260688|20583460|P1|STARTED|Overall Study||11
8350090|NCT01260662|20583497|P3|NOT COMPLETED|Overall Study||0
8350091|NCT01260662|20583498|P2|NOT COMPLETED|Overall Study||0
8350092|NCT01260662|20583499|P1|NOT COMPLETED|Overall Study||0
8350093|NCT01260662|20583497|P3|COMPLETED|Overall Study||96
8350094|NCT01260662|20583498|P2|COMPLETED|Overall Study||85
8350095|NCT01260662|20583499|P1|COMPLETED|Overall Study||90
8350096|NCT01260662|20583497|P3|STARTED|Overall Study||96
8350097|NCT01260662|20583498|P2|STARTED|Overall Study||85
8350098|NCT01260662|20583499|P1|STARTED|Overall Study||90
8350099|NCT01260649|20583518|P2|NOT COMPLETED|Overall Study||1
8350100|NCT01260649|20583519|P1|NOT COMPLETED|Overall Study||2
8350101|NCT01260649|20583518|P2|COMPLETED|Overall Study||8
8350102|NCT01260649|20583519|P1|COMPLETED|Overall Study||6
8350103|NCT01260649|20583518|P2|STARTED|Overall Study||9
8350104|NCT01260649|20583519|P1|STARTED|Overall Study||8
8350105|NCT01260584|20583531|P4|NOT COMPLETED|Period 2||1
8350106|NCT01260584|20583532|P3|NOT COMPLETED|Period 2||5
8350107|NCT01260584|20583533|P2|NOT COMPLETED|Period 2||3
8350108|NCT01260584|20583534|P1|NOT COMPLETED|Period 2||1
8350109|NCT01260584|20583531|P4|COMPLETED|Period 2||26
8350110|NCT01260584|20583532|P3|COMPLETED|Period 2||20
8350111|NCT01260584|20583533|P2|COMPLETED|Period 2||25
8350112|NCT01260584|20583534|P1|COMPLETED|Period 2||26
8350113|NCT01260584|20583531|P4|STARTED|Period 2||27
8350114|NCT01260584|20583532|P3|STARTED|Period 2||25
8350115|NCT01260584|20583533|P2|STARTED|Period 2||28
8350116|NCT01260584|20583534|P1|STARTED|Period 2||27
8350117|NCT01260584|20583531|P4|NOT COMPLETED|Period 1||1
8350118|NCT01260584|20583532|P3|NOT COMPLETED|Period 1||2
8350119|NCT01260584|20583533|P2|NOT COMPLETED|Period 1||0
8350120|NCT01260584|20583534|P1|NOT COMPLETED|Period 1||0
8350121|NCT01260584|20583531|P4|COMPLETED|Period 1||27
8350122|NCT01260584|20583532|P3|COMPLETED|Period 1||25
8350123|NCT01260584|20583533|P2|COMPLETED|Period 1||28
8350124|NCT01260584|20583534|P1|COMPLETED|Period 1||27
8350125|NCT01260584|20583531|P4|STARTED|Period 1||28
8350126|NCT01260584|20583532|P3|STARTED|Period 1||27
8350127|NCT01260584|20583533|P2|STARTED|Period 1||28
8350128|NCT01260584|20583534|P1|STARTED|Period 1||27
8350129|NCT01260493|20583570|P2|NOT COMPLETED|Overall Study||4
8350130|NCT01260493|20583571|P1|NOT COMPLETED|Overall Study||16
8350131|NCT01260493|20583570|P2|COMPLETED|Overall Study||85
8350132|NCT01260493|20583571|P1|COMPLETED|Overall Study||76
8350133|NCT01260493|20583570|P2|STARTED|Overall Study||89
8350134|NCT01260493|20583571|P1|STARTED|Overall Study||92
8350135|NCT01260467|20583577|P1|NOT COMPLETED|Overall Study||2
8350136|NCT01260467|20583577|P1|COMPLETED|Overall Study||2
8350137|NCT01260467|20583577|P1|STARTED|Overall Study||4
8350138|NCT01260454|20583583|P1|NOT COMPLETED|Overall Study||0
8350139|NCT01260454|20583583|P1|COMPLETED|Overall Study||6
8350140|NCT01260454|20583583|P1|STARTED|Overall Study||6
8350141|NCT01260350|20583609|P22|NOT COMPLETED|Overall Study||0
8350142|NCT01260350|20583610|P21|NOT COMPLETED|Overall Study||3
8350143|NCT01260350|20583611|P20|NOT COMPLETED|Overall Study||0
8350144|NCT01260350|20583612|P19|NOT COMPLETED|Overall Study||0
8350145|NCT01260350|20583613|P18|NOT COMPLETED|Overall Study||1
8350146|NCT01260350|20583614|P17|NOT COMPLETED|Overall Study||0
8350147|NCT01260350|20583615|P16|NOT COMPLETED|Overall Study||0
8350148|NCT01260350|20583616|P15|NOT COMPLETED|Overall Study||0
8350149|NCT01260350|20583617|P14|NOT COMPLETED|Overall Study||0
8350150|NCT01260350|20583618|P13|NOT COMPLETED|Overall Study||0
8350151|NCT01260350|20583619|P12|NOT COMPLETED|Overall Study||0
8350152|NCT01260350|20583620|P11|NOT COMPLETED|Overall Study||0
8350153|NCT01260350|20583621|P10|NOT COMPLETED|Overall Study||0
8350154|NCT01260350|20583622|P9|NOT COMPLETED|Overall Study||1
8350155|NCT01260350|20583623|P8|NOT COMPLETED|Overall Study||0
8350156|NCT01260350|20583624|P7|NOT COMPLETED|Overall Study||0
8350157|NCT01260350|20583625|P6|NOT COMPLETED|Overall Study||0
8350158|NCT01260350|20583626|P5|NOT COMPLETED|Overall Study||0
8350159|NCT01260350|20583627|P4|NOT COMPLETED|Overall Study||0
8350160|NCT01260350|20583628|P3|NOT COMPLETED|Overall Study||0
8350161|NCT01260350|20583629|P2|NOT COMPLETED|Overall Study||0
8350162|NCT01260350|20583630|P1|NOT COMPLETED|Overall Study||0
8350163|NCT01260350|20583609|P22|COMPLETED|Overall Study||0
8350164|NCT01260350|20583610|P21|COMPLETED|Overall Study||22
8350165|NCT01260350|20583611|P20|COMPLETED|Overall Study||14
8350166|NCT01260350|20583612|P19|COMPLETED|Overall Study||0
8350167|NCT01260350|20583613|P18|COMPLETED|Overall Study||9
8350168|NCT01260350|20583614|P17|COMPLETED|Overall Study||9
8350169|NCT01260350|20583615|P16|COMPLETED|Overall Study||10
8350170|NCT01260350|20583616|P15|COMPLETED|Overall Study||25
8350171|NCT01260350|20583617|P14|COMPLETED|Overall Study||10
8350172|NCT01260350|20583618|P13|COMPLETED|Overall Study||25
8350173|NCT01260350|20583619|P12|COMPLETED|Overall Study||9
8350174|NCT01260350|20583620|P11|COMPLETED|Overall Study||10
8350175|NCT01260350|20583621|P10|COMPLETED|Overall Study||25
8350176|NCT01260350|20583622|P9|COMPLETED|Overall Study||24
8350177|NCT01260350|20583623|P8|COMPLETED|Overall Study||25
8350178|NCT01260350|20583624|P7|COMPLETED|Overall Study||10
8350179|NCT01260350|20583625|P6|COMPLETED|Overall Study||10
8350180|NCT01260350|20583626|P5|COMPLETED|Overall Study||10
8350181|NCT01260350|20583627|P4|COMPLETED|Overall Study||11
8350182|NCT01260350|20583628|P3|COMPLETED|Overall Study||10
8350183|NCT01260350|20583629|P2|COMPLETED|Overall Study||9
8350184|NCT01260350|20583630|P1|COMPLETED|Overall Study||10
8350185|NCT01260350|20583609|P22|STARTED|Overall Study||0
8350186|NCT01260350|20583610|P21|STARTED|Overall Study||25
8350187|NCT01260350|20583611|P20|STARTED|Overall Study||14
8350188|NCT01260350|20583612|P19|STARTED|Overall Study||0
8350189|NCT01260350|20583613|P18|STARTED|Overall Study||10
8350190|NCT01260350|20583614|P17|STARTED|Overall Study||9
8350191|NCT01260350|20583615|P16|STARTED|Overall Study||10
8350192|NCT01260350|20583616|P15|STARTED|Overall Study||25
8350193|NCT01260350|20583617|P14|STARTED|Overall Study||10
8350194|NCT01260350|20583618|P13|STARTED|Overall Study||25
8350195|NCT01260350|20583619|P12|STARTED|Overall Study||9
8350196|NCT01260350|20583620|P11|STARTED|Overall Study||10
8350197|NCT01260350|20583621|P10|STARTED|Overall Study||25
8350198|NCT01260350|20583622|P9|STARTED|Overall Study||25
8350199|NCT01260350|20583623|P8|STARTED|Overall Study||25
8350200|NCT01260350|20583624|P7|STARTED|Overall Study||10
8350201|NCT01260350|20583625|P6|STARTED|Overall Study||10
8350202|NCT01260350|20583626|P5|STARTED|Overall Study||10
8350203|NCT01260350|20583627|P4|STARTED|Overall Study||11
8350204|NCT01260350|20583628|P3|STARTED|Overall Study||10
8350205|NCT01260350|20583629|P2|STARTED|Overall Study||9
8350206|NCT01260350|20583630|P1|STARTED|Overall Study||10
8350213|NCT01260311|20583837|P1|NOT COMPLETED|Overall Study||127
8350214|NCT01260311|20583837|P1|COMPLETED|Overall Study||381
8350215|NCT01260311|20583837|P1|STARTED|Overall Study||508
8350216|NCT01260272|20583847|P2|NOT COMPLETED|Overall Study||2
8350217|NCT01260272|20583848|P1|NOT COMPLETED|Overall Study||2
8350218|NCT01260272|20583847|P2|COMPLETED|Overall Study||30
8350219|NCT01260272|20583848|P1|COMPLETED|Overall Study||15
8350220|NCT01260272|20583847|P2|STARTED|Overall Study||32
8350221|NCT01260272|20583848|P1|STARTED|Overall Study||17
8350222|NCT01260194|20583868|P1|NOT COMPLETED|Overall Study||1
8350223|NCT01260194|20583868|P1|COMPLETED|Overall Study||3
8350224|NCT01260194|20583868|P1|STARTED|Overall Study||4
8350225|NCT01260181|20583880|P1|NOT COMPLETED|Overall Study||1
8350226|NCT01260181|20583880|P1|COMPLETED|Overall Study||29
8350227|NCT01260181|20583880|P1|STARTED|Overall Study||30
8350228|NCT01260142|20583895|P6|NOT COMPLETED|Treatment Period 2||0
8350229|NCT01260142|20583896|P5|NOT COMPLETED|Treatment Period 2||0
8350230|NCT01260142|20583897|P4|NOT COMPLETED|Treatment Period 2||0
8350231|NCT01260142|20583898|P3|NOT COMPLETED|Treatment Period 2||0
8350232|NCT01260142|20583899|P2|NOT COMPLETED|Treatment Period 2||0
8350233|NCT01260142|20583900|P1|NOT COMPLETED|Treatment Period 2||0
8350234|NCT01260142|20583895|P6|COMPLETED|Treatment Period 2||3
8350235|NCT01260142|20583896|P5|COMPLETED|Treatment Period 2||4
8350236|NCT01260142|20583897|P4|COMPLETED|Treatment Period 2||6
8350237|NCT01260142|20583898|P3|COMPLETED|Treatment Period 2||6
8350238|NCT01260142|20583899|P2|COMPLETED|Treatment Period 2||5
8350239|NCT01260142|20583900|P1|COMPLETED|Treatment Period 2||5
8350240|NCT01260142|20583895|P6|STARTED|Treatment Period 2||3
8350241|NCT01260142|20583896|P5|STARTED|Treatment Period 2||4
8350242|NCT01260142|20583897|P4|STARTED|Treatment Period 2||6
8350243|NCT01260142|20583898|P3|STARTED|Treatment Period 2||6
8350244|NCT01260142|20583899|P2|STARTED|Treatment Period 2||5
8350245|NCT01260142|20583900|P1|STARTED|Treatment Period 2||5
8350246|NCT01260142|20583895|P6|NOT COMPLETED|Treatment Period 1||3
8350247|NCT01260142|20583896|P5|NOT COMPLETED|Treatment Period 1||2
8350248|NCT01260142|20583897|P4|NOT COMPLETED|Treatment Period 1||0
8350249|NCT01260142|20583898|P3|NOT COMPLETED|Treatment Period 1||0
8350250|NCT01260142|20583899|P2|NOT COMPLETED|Treatment Period 1||1
8350251|NCT01260142|20583900|P1|NOT COMPLETED|Treatment Period 1||1
8350252|NCT01260142|20583895|P6|COMPLETED|Treatment Period 1||3
8350253|NCT01260142|20583896|P5|COMPLETED|Treatment Period 1||4
8350254|NCT01260142|20583897|P4|COMPLETED|Treatment Period 1||6
8350255|NCT01260142|20583898|P3|COMPLETED|Treatment Period 1||6
8350256|NCT01260142|20583899|P2|COMPLETED|Treatment Period 1||5
8350257|NCT01260142|20583900|P1|COMPLETED|Treatment Period 1||5
8350258|NCT01260142|20583895|P6|STARTED|Treatment Period 1||6
8350259|NCT01260142|20583896|P5|STARTED|Treatment Period 1||6
8350260|NCT01260142|20583897|P4|STARTED|Treatment Period 1||6
8350261|NCT01260142|20583898|P3|STARTED|Treatment Period 1||6
8350262|NCT01260142|20583899|P2|STARTED|Treatment Period 1||6
8350263|NCT01260142|20583900|P1|STARTED|Treatment Period 1||6
8350264|NCT01259869|20583950|P1|NOT COMPLETED|Overall Study||1
8350265|NCT01259869|20583950|P1|COMPLETED|Overall Study||33
8350266|NCT01259869|20583950|P1|STARTED|Overall Study||34
8350267|NCT01259856|20583956|P2|NOT COMPLETED|Overall Study||74
8350268|NCT01259856|20583957|P1|NOT COMPLETED|Overall Study||69
8350269|NCT01259856|20583956|P2|COMPLETED|Overall Study||12
8350270|NCT01259856|20583957|P1|COMPLETED|Overall Study||13
8350271|NCT01259856|20583956|P2|STARTED|Overall Study||86
8350272|NCT01259856|20583957|P1|STARTED|Overall Study||82
8350273|NCT01259726|20583981|P4|NOT COMPLETED|Overall Study||5
8350274|NCT01259726|20583982|P3|NOT COMPLETED|Overall Study||4
8350275|NCT01259726|20583983|P2|NOT COMPLETED|Overall Study||4
8350276|NCT01259726|20583984|P1|NOT COMPLETED|Overall Study||5
8350277|NCT01259726|20583981|P4|COMPLETED|Overall Study||36
8350278|NCT01259726|20583982|P3|COMPLETED|Overall Study||39
8350279|NCT01259726|20583983|P2|COMPLETED|Overall Study||37
8350280|NCT01259726|20583984|P1|COMPLETED|Overall Study||38
8350281|NCT01259726|20583981|P4|Treated|Overall Study||39
8350282|NCT01259726|20583982|P3|Treated|Overall Study||41
8350283|NCT01259726|20583983|P2|Treated|Overall Study||37
8350284|NCT01259726|20583984|P1|Treated|Overall Study||40
8350285|NCT01259726|20583981|P4|STARTED|Overall Study||41
8350286|NCT01259726|20583982|P3|STARTED|Overall Study||43
8350287|NCT01259726|20583983|P2|STARTED|Overall Study||41
8350288|NCT01259726|20583984|P1|STARTED|Overall Study||43
8350289|NCT01259713|20584016|P2|NOT COMPLETED|Overall Study||41
8350290|NCT01259713|20584017|P1|NOT COMPLETED|Overall Study||95
8350291|NCT01259713|20584016|P2|COMPLETED|Overall Study||77
8350292|NCT01259713|20584017|P1|COMPLETED|Overall Study||142
8350293|NCT01259713|20584016|P2|STARTED|Overall Study||118
8350294|NCT01259713|20584017|P1|STARTED|Overall Study||237
8350295|NCT01259596|20584041|P2|NOT COMPLETED|Overall Study||6
8350296|NCT01259596|20584042|P1|NOT COMPLETED|Overall Study||4
8350297|NCT01259596|20584041|P2|COMPLETED|Overall Study||65
8350298|NCT01259596|20584042|P1|COMPLETED|Overall Study||66
8350299|NCT01259596|20584041|P2|STARTED|Overall Study||71
8350300|NCT01259596|20584042|P1|STARTED|Overall Study||70
8350301|NCT01259492|20584064|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
8350302|NCT01259492|20584065|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
8350303|NCT01259492|20584066|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
8350304|NCT01259492|20584067|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
8350305|NCT01259492|20584064|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
8350306|NCT01259492|20584065|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
8350307|NCT01259492|20584066|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
8350308|NCT01259492|20584067|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
8350309|NCT01259492|20584064|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
8350310|NCT01259492|20584065|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
8350311|NCT01259492|20584066|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
8350312|NCT01259492|20584067|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
8350313|NCT01259492|20584064|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
8350314|NCT01259492|20584065|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
8350315|NCT01259492|20584066|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
8350399|NCT01259297|20584201|P1|COMPLETED|Double Blind Randomized Period||242
8350316|NCT01259492|20584067|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
8350317|NCT01259492|20584064|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
8350318|NCT01259492|20584065|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
8350319|NCT01259492|20584066|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
8350320|NCT01259492|20584067|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
8350321|NCT01259492|20584064|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
8350322|NCT01259492|20584065|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
8350323|NCT01259492|20584066|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
8350324|NCT01259492|20584067|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
8350325|NCT01259492|20584064|P4|STARTED|Period 2 (Week 10 to Week 14)||153
8350326|NCT01259492|20584065|P3|STARTED|Period 2 (Week 10 to Week 14)||138
8350327|NCT01259492|20584066|P2|STARTED|Period 2 (Week 10 to Week 14)||141
8350328|NCT01259492|20584067|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
8350329|NCT01259492|20584064|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
8350330|NCT01259492|20584065|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
8350331|NCT01259492|20584066|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
8350332|NCT01259492|20584067|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
8350333|NCT01259492|20584064|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
8350334|NCT01259492|20584065|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
8350335|NCT01259492|20584066|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
8350336|NCT01259492|20584067|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
8350337|NCT01259492|20584064|P4|Full Analysis Set|Period 1 (9 Weeks)||172
8350338|NCT01259492|20584065|P3|Full Analysis Set|Period 1 (9 Weeks)||179
8350339|NCT01259492|20584066|P2|Full Analysis Set|Period 1 (9 Weeks)||175
8350340|NCT01259492|20584067|P1|Full Analysis Set|Period 1 (9 Weeks)||174
8350341|NCT01259492|20584064|P4|STARTED|Period 1 (9 Weeks)||181
8350342|NCT01259492|20584065|P3|STARTED|Period 1 (9 Weeks)||181
8350343|NCT01259492|20584066|P2|STARTED|Period 1 (9 Weeks)||182
8350344|NCT01259492|20584067|P1|STARTED|Period 1 (9 Weeks)||181
8350345|NCT01259466|20584116|P2|NOT COMPLETED|Overall Study||9
8350346|NCT01259466|20584117|P1|NOT COMPLETED|Overall Study||1
8350347|NCT01259466|20584116|P2|COMPLETED|Overall Study||18
8350348|NCT01259466|20584117|P1|COMPLETED|Overall Study||26
8350349|NCT01259466|20584116|P2|STARTED|Overall Study||27
8350350|NCT01259466|20584117|P1|STARTED|Overall Study||27
8350351|NCT01259440|20584127|P2|NOT COMPLETED|Overall Study||0
8350352|NCT01259440|20584128|P1|NOT COMPLETED|Overall Study||0
8350353|NCT01259440|20584127|P2|COMPLETED|Overall Study||10
8350354|NCT01259440|20584128|P1|COMPLETED|Overall Study||13
8350355|NCT01259440|20584127|P2|STARTED|Overall Study||10
8350356|NCT01259440|20584128|P1|STARTED|Overall Study||13
8350357|NCT01259427|20584136|P2|NOT COMPLETED|Overall Study||14
8350358|NCT01259427|20584137|P1|NOT COMPLETED|Overall Study||18
8350359|NCT01259427|20584136|P2|COMPLETED|Overall Study||110
8350360|NCT01259427|20584137|P1|COMPLETED|Overall Study||106
8350361|NCT01259427|20584136|P2|STARTED|Overall Study||124
8350362|NCT01259427|20584137|P1|STARTED|Overall Study||124
8350363|NCT01259401|20584155|P2|NOT COMPLETED|4-month Follow-up||2
8350364|NCT01259401|20584156|P1|NOT COMPLETED|4-month Follow-up||0
8350365|NCT01259401|20584155|P2|COMPLETED|4-month Follow-up||19
8350366|NCT01259401|20584156|P1|COMPLETED|4-month Follow-up||21
8350367|NCT01259401|20584155|P2|STARTED|4-month Follow-up||21
8350368|NCT01259401|20584156|P1|STARTED|4-month Follow-up||21
8350369|NCT01259401|20584155|P2|NOT COMPLETED|End of 4-week Intervention||0
8350370|NCT01259401|20584156|P1|NOT COMPLETED|End of 4-week Intervention||0
8350371|NCT01259401|20584155|P2|COMPLETED|End of 4-week Intervention||21
8350372|NCT01259401|20584156|P1|COMPLETED|End of 4-week Intervention||21
8350373|NCT01259401|20584155|P2|STARTED|End of 4-week Intervention||21
8350374|NCT01259401|20584156|P1|STARTED|End of 4-week Intervention||21
8350375|NCT01259388|20584166|P2|NOT COMPLETED|Overall Study||1
8350376|NCT01259388|20584167|P1|NOT COMPLETED|Overall Study||5
8350377|NCT01259388|20584166|P2|COMPLETED|Overall Study||11
8350378|NCT01259388|20584167|P1|COMPLETED|Overall Study||6
8350379|NCT01259388|20584166|P2|STARTED|Overall Study||12
8350380|NCT01259388|20584167|P1|STARTED|Overall Study||11
8350381|NCT01259375|20584177|P1|NOT COMPLETED|Overall Study||1
8350382|NCT01259375|20584177|P1|COMPLETED|Overall Study||23
8350383|NCT01259375|20584177|P1|STARTED|Overall Study||24
8350384|NCT01259297|20584194|P8|NOT COMPLETED|Double Blind Randomized Period||3
8350385|NCT01259297|20584195|P7|NOT COMPLETED|Double Blind Randomized Period||6
8350386|NCT01259297|20584196|P6|NOT COMPLETED|Double Blind Randomized Period||8
8350387|NCT01259297|20584197|P5|NOT COMPLETED|Double Blind Randomized Period||4
8350388|NCT01259297|20584198|P4|NOT COMPLETED|Double Blind Randomized Period||4
8350389|NCT01259297|20584199|P3|NOT COMPLETED|Double Blind Randomized Period||1
8350390|NCT01259297|20584200|P2|NOT COMPLETED|Double Blind Randomized Period||3
8350391|NCT01259297|20584201|P1|NOT COMPLETED|Double Blind Randomized Period||2
8350392|NCT01259297|20584194|P8|COMPLETED|Double Blind Randomized Period||196
8350393|NCT01259297|20584195|P7|COMPLETED|Double Blind Randomized Period||190
8350394|NCT01259297|20584196|P6|COMPLETED|Double Blind Randomized Period||245
8350395|NCT01259297|20584197|P5|COMPLETED|Double Blind Randomized Period||247
8350396|NCT01259297|20584198|P4|COMPLETED|Double Blind Randomized Period||191
8350397|NCT01259297|20584199|P3|COMPLETED|Double Blind Randomized Period||188
8350398|NCT01259297|20584200|P2|COMPLETED|Double Blind Randomized Period||229
8350400|NCT01259297|20584194|P8|STARTED|Double Blind Randomized Period||199
8350401|NCT01259297|20584195|P7|STARTED|Double Blind Randomized Period||196
8350402|NCT01259297|20584196|P6|STARTED|Double Blind Randomized Period||253
8350403|NCT01259297|20584197|P5|STARTED|Double Blind Randomized Period||251
8350404|NCT01259297|20584198|P4|STARTED|Double Blind Randomized Period||195
8350405|NCT01259297|20584199|P3|STARTED|Double Blind Randomized Period||189
8350406|NCT01259297|20584200|P2|STARTED|Double Blind Randomized Period||232
8350407|NCT01259297|20584201|P1|STARTED|Double Blind Randomized Period||244
8350408|NCT01259297|20584194|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350409|NCT01259297|20584195|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350410|NCT01259297|20584196|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350411|NCT01259297|20584197|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350412|NCT01259297|20584198|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350413|NCT01259297|20584199|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
8350414|NCT01259297|20584200|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350415|NCT01259297|20584201|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
8350416|NCT01259297|20584194|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350417|NCT01259297|20584195|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350418|NCT01259297|20584196|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350419|NCT01259297|20584197|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350420|NCT01259297|20584198|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350421|NCT01259297|20584199|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
8350422|NCT01259297|20584200|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350423|NCT01259297|20584201|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
8350424|NCT01259297|20584194|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350425|NCT01259297|20584195|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350426|NCT01259297|20584196|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350427|NCT01259297|20584197|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350428|NCT01259297|20584198|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350429|NCT01259297|20584199|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
8350430|NCT01259297|20584200|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350431|NCT01259297|20584201|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
8350432|NCT01259284|20584232|P3|NOT COMPLETED|Overall Study||0
8350433|NCT01259284|20584233|P2|NOT COMPLETED|Overall Study||0
8350434|NCT01259284|20584234|P1|NOT COMPLETED|Overall Study||2
8350435|NCT01259284|20584232|P3|COMPLETED|Overall Study||0
8350436|NCT01259284|20584233|P2|COMPLETED|Overall Study||0
8350437|NCT01259284|20584234|P1|COMPLETED|Overall Study||0
8350438|NCT01259284|20584232|P3|STARTED|Overall Study||0
8350439|NCT01259284|20584233|P2|STARTED|Overall Study||0
8350440|NCT01259284|20584234|P1|STARTED|Overall Study||2
8350441|NCT01259245|20584244|P2|NOT COMPLETED|Overall Study||26
8350442|NCT01259245|20584245|P1|NOT COMPLETED|Overall Study||28
8350443|NCT01259245|20584244|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
8350444|NCT01259245|20584245|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
8350445|NCT01259245|20584244|P2|STARTED|Overall Study||94
8350446|NCT01259245|20584245|P1|STARTED|Overall Study||98
8350447|NCT01259128|20584271|P2|NOT COMPLETED|Overall Study||2
8350448|NCT01259128|20584272|P1|NOT COMPLETED|Overall Study||0
8350449|NCT01259128|20584271|P2|COMPLETED|Overall Study||15
8350450|NCT01259128|20584272|P1|COMPLETED|Overall Study||15
8350451|NCT01259128|20584271|P2|STARTED|Overall Study||17
8350452|NCT01259128|20584272|P1|STARTED|Overall Study||15
8350453|NCT01259115|20584282|P2|NOT COMPLETED|Period 2||0
8350454|NCT01259115|20584283|P1|NOT COMPLETED|Period 2||1
8350455|NCT01259115|20584282|P2|COMPLETED|Period 2||9
8350456|NCT01259115|20584283|P1|COMPLETED|Period 2||6
8350457|NCT01259115|20584282|P2|STARTED|Period 2||9
8350458|NCT01259115|20584283|P1|STARTED|Period 2||7
8350459|NCT01259115|20584282|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
8350460|NCT01259115|20584283|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
8350461|NCT01259115|20584282|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
8350462|NCT01259115|20584283|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
8350463|NCT01259115|20584282|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
8350464|NCT01259115|20584283|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
8350465|NCT01259115|20584282|P2|NOT COMPLETED|Period 1||1
8350466|NCT01259115|20584283|P1|NOT COMPLETED|Period 1||3
8350467|NCT01259115|20584282|P2|COMPLETED|Period 1||9
8350468|NCT01259115|20584283|P1|COMPLETED|Period 1||7
8350469|NCT01259115|20584282|P2|STARTED|Period 1||10
8350470|NCT01259115|20584283|P1|STARTED|Period 1||10
8350471|NCT01259102|20584319|P5|NOT COMPLETED|Overall Study||1
8350472|NCT01259102|20584320|P4|NOT COMPLETED|Overall Study||2
8350473|NCT01259102|20584321|P3|NOT COMPLETED|Overall Study||2
8350474|NCT01259102|20584322|P2|NOT COMPLETED|Overall Study||0
8350475|NCT01259102|20584323|P1|NOT COMPLETED|Overall Study||1
8350476|NCT01259102|20584319|P5|COMPLETED|Overall Study||13
8350477|NCT01259102|20584320|P4|COMPLETED|Overall Study||12
8350478|NCT01259102|20584321|P3|COMPLETED|Overall Study||13
8350479|NCT01259102|20584322|P2|COMPLETED|Overall Study||14
8350480|NCT01259102|20584323|P1|COMPLETED|Overall Study||12
8350481|NCT01259102|20584319|P5|STARTED|Overall Study||14
8350482|NCT01259102|20584320|P4|STARTED|Overall Study||14
8350483|NCT01259102|20584321|P3|STARTED|Overall Study||15
8350484|NCT01259102|20584322|P2|STARTED|Overall Study||14
8350485|NCT01259102|20584323|P1|STARTED|Overall Study||13
8350486|NCT01259089|20584380|P6|NOT COMPLETED|Survival Follow up for Two Years||19
8350487|NCT01259089|20584381|P5|NOT COMPLETED|Survival Follow up for Two Years||6
8350488|NCT01259089|20584382|P4|NOT COMPLETED|Survival Follow up for Two Years||3
8350489|NCT01259089|20584383|P3|NOT COMPLETED|Survival Follow up for Two Years||2
8350490|NCT01259089|20584384|P2|NOT COMPLETED|Survival Follow up for Two Years||2
8350491|NCT01259089|20584385|P1|NOT COMPLETED|Survival Follow up for Two Years||3
8350492|NCT01259089|20584380|P6|COMPLETED|Survival Follow up for Two Years||0
8350493|NCT01259089|20584381|P5|COMPLETED|Survival Follow up for Two Years||0
8350494|NCT01259089|20584382|P4|COMPLETED|Survival Follow up for Two Years||0
8350495|NCT01259089|20584383|P3|COMPLETED|Survival Follow up for Two Years||1
8350496|NCT01259089|20584384|P2|COMPLETED|Survival Follow up for Two Years||1
8350497|NCT01259089|20584385|P1|COMPLETED|Survival Follow up for Two Years||0
8350498|NCT01259089|20584380|P6|STARTED|Survival Follow up for Two Years||19
8350499|NCT01259089|20584381|P5|STARTED|Survival Follow up for Two Years||6
8350500|NCT01259089|20584382|P4|STARTED|Survival Follow up for Two Years||3
8350501|NCT01259089|20584383|P3|STARTED|Survival Follow up for Two Years||3
8350502|NCT01259089|20584384|P2|STARTED|Survival Follow up for Two Years||3
8350503|NCT01259089|20584385|P1|STARTED|Survival Follow up for Two Years||3
8350504|NCT01259089|20584380|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350505|NCT01259089|20584381|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
8350506|NCT01259089|20584382|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350507|NCT01259089|20584383|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350508|NCT01259089|20584384|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350509|NCT01259089|20584385|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
8350510|NCT01259089|20584380|P6|COMPLETED|Continued Treatment After 8 Weeks||7
8350511|NCT01259089|20584381|P5|COMPLETED|Continued Treatment After 8 Weeks||0
8350512|NCT01259089|20584382|P4|COMPLETED|Continued Treatment After 8 Weeks||1
8350513|NCT01259089|20584383|P3|COMPLETED|Continued Treatment After 8 Weeks||1
8350514|NCT01259089|20584384|P2|COMPLETED|Continued Treatment After 8 Weeks||2
8350515|NCT01259089|20584385|P1|COMPLETED|Continued Treatment After 8 Weeks||1
8350516|NCT01259089|20584380|P6|STARTED|Continued Treatment After 8 Weeks||8
8350517|NCT01259089|20584381|P5|STARTED|Continued Treatment After 8 Weeks||2
8350518|NCT01259089|20584382|P4|STARTED|Continued Treatment After 8 Weeks||2
8350519|NCT01259089|20584383|P3|STARTED|Continued Treatment After 8 Weeks||2
8350520|NCT01259089|20584384|P2|STARTED|Continued Treatment After 8 Weeks||3
8350521|NCT01259089|20584385|P1|STARTED|Continued Treatment After 8 Weeks||3
8350522|NCT01259089|20584380|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
8350523|NCT01259089|20584381|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
8350524|NCT01259089|20584382|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
8350525|NCT01259089|20584383|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
8350526|NCT01259089|20584384|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
8350527|NCT01259089|20584385|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
8350528|NCT01259089|20584380|P6|COMPLETED|Confirmed Response at 8 Weeks||8
8350529|NCT01259089|20584381|P5|COMPLETED|Confirmed Response at 8 Weeks||2
8350530|NCT01259089|20584382|P4|COMPLETED|Confirmed Response at 8 Weeks||2
8350531|NCT01259089|20584383|P3|COMPLETED|Confirmed Response at 8 Weeks||2
8350532|NCT01259089|20584384|P2|COMPLETED|Confirmed Response at 8 Weeks||3
8350533|NCT01259089|20584385|P1|COMPLETED|Confirmed Response at 8 Weeks||3
8350534|NCT01259089|20584380|P6|STARTED|Confirmed Response at 8 Weeks||18
8350535|NCT01259089|20584381|P5|STARTED|Confirmed Response at 8 Weeks||6
8350536|NCT01259089|20584382|P4|STARTED|Confirmed Response at 8 Weeks||3
8350537|NCT01259089|20584383|P3|STARTED|Confirmed Response at 8 Weeks||3
8350538|NCT01259089|20584384|P2|STARTED|Confirmed Response at 8 Weeks||3
8350539|NCT01259089|20584385|P1|STARTED|Confirmed Response at 8 Weeks||3
8350540|NCT01259089|20584380|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
8350541|NCT01259089|20584381|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350542|NCT01259089|20584382|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350543|NCT01259089|20584383|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350544|NCT01259089|20584384|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350545|NCT01259089|20584385|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350546|NCT01259089|20584380|P6|COMPLETED|Reached First Response at 4 Weeks||18
8350547|NCT01259089|20584381|P5|COMPLETED|Reached First Response at 4 Weeks||6
8350548|NCT01259089|20584382|P4|COMPLETED|Reached First Response at 4 Weeks||3
8350549|NCT01259089|20584383|P3|COMPLETED|Reached First Response at 4 Weeks||3
8350550|NCT01259089|20584384|P2|COMPLETED|Reached First Response at 4 Weeks||3
8350551|NCT01259089|20584385|P1|COMPLETED|Reached First Response at 4 Weeks||3
8350552|NCT01259089|20584380|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
8350553|NCT01259089|20584381|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
8350554|NCT01259089|20584382|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350555|NCT01259089|20584383|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350556|NCT01259089|20584384|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350557|NCT01259089|20584385|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350558|NCT01259089|20584380|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
8350559|NCT01259089|20584381|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
8350560|NCT01259089|20584382|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350561|NCT01259089|20584383|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350562|NCT01259089|20584384|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350563|NCT01259089|20584385|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350564|NCT01259089|20584380|P6|STARTED|Reached First Response at 4 Weeks||20
8350565|NCT01259089|20584381|P5|STARTED|Reached First Response at 4 Weeks||6
8350566|NCT01259089|20584382|P4|STARTED|Reached First Response at 4 Weeks||3
8350567|NCT01259089|20584383|P3|STARTED|Reached First Response at 4 Weeks||3
8350568|NCT01259089|20584384|P2|STARTED|Reached First Response at 4 Weeks||3
8350569|NCT01259089|20584385|P1|STARTED|Reached First Response at 4 Weeks||3
8350570|NCT01259063|20584404|P1|NOT COMPLETED|Overall Study||0
8350571|NCT01259063|20584404|P1|COMPLETED|Overall Study||33
8350572|NCT01259063|20584404|P1|STARTED|Overall Study||33
8350573|NCT01259024|20584413|P1|NOT COMPLETED|Overall Study||1
8350574|NCT01259024|20584413|P1|COMPLETED|Overall Study||0
8350575|NCT01259024|20584413|P1|STARTED|Overall Study||1
8350576|NCT01259011|20584422|P2|NOT COMPLETED|After Patient Death||0
8350577|NCT01259011|20584423|P1|NOT COMPLETED|After Patient Death||0
8350578|NCT01259011|20584422|P2|COMPLETED|After Patient Death||28
8350579|NCT01259011|20584423|P1|COMPLETED|After Patient Death||17
8350580|NCT01259011|20584422|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
8350581|NCT01259011|20584423|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
8350582|NCT01259011|20584422|P2|NOT COMPLETED|Main Study Period||0
8350583|NCT01259011|20584423|P1|NOT COMPLETED|Main Study Period||0
8350584|NCT01259011|20584422|P2|COMPLETED|Main Study Period||109
8350585|NCT01259011|20584423|P1|COMPLETED|Main Study Period||101
8350586|NCT01259011|20584422|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
8350587|NCT01259011|20584423|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
8350588|NCT01258998|20584433|P1|NOT COMPLETED|Overall Study||1
8350589|NCT01258998|20584433|P1|COMPLETED|Overall Study||59
8350590|NCT01258998|20584433|P1|STARTED|Overall Study||60
8350591|NCT01258985|20584446|P2|NOT COMPLETED|Overall Study||0
8350592|NCT01258985|20584447|P1|NOT COMPLETED|Overall Study||0
8350593|NCT01258985|20584446|P2|COMPLETED|Overall Study||98
8350594|NCT01258985|20584447|P1|COMPLETED|Overall Study||106
8350595|NCT01258985|20584446|P2|STARTED|Overall Study||98
8350596|NCT01258985|20584447|P1|STARTED|Overall Study||106
8350597|NCT01258855|20584475|P2|NOT COMPLETED|Overall Study||0
8350598|NCT01258855|20584476|P1|NOT COMPLETED|Overall Study||0
8350599|NCT01258855|20584475|P2|COMPLETED|Overall Study||29
8350600|NCT01258855|20584476|P1|COMPLETED|Overall Study||55
8350601|NCT01258855|20584475|P2|STARTED|Overall Study||29
8350602|NCT01258855|20584476|P1|STARTED|Overall Study||55
8350603|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350604|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350605|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350606|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350607|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350608|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350609|NCT01258803|20584494|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
8350610|NCT01258803|20584495|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
8350611|NCT01258803|20584496|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
8350612|NCT01258803|20584497|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
8350613|NCT01258803|20584498|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
8350614|NCT01258803|20584499|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
8350615|NCT01258803|20584494|P6|STARTED|Treatment Period 4 (1 Dose)||15
8350616|NCT01258803|20584495|P5|STARTED|Treatment Period 4 (1 Dose)||15
8350617|NCT01258803|20584496|P4|STARTED|Treatment Period 4 (1 Dose)||15
8350618|NCT01258803|20584497|P3|STARTED|Treatment Period 4 (1 Dose)||14
8350619|NCT01258803|20584498|P2|STARTED|Treatment Period 4 (1 Dose)||14
8350620|NCT01258803|20584499|P1|STARTED|Treatment Period 4 (1 Dose)||14
8350621|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350622|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350623|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350624|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
8350625|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350626|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350627|NCT01258803|20584494|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
8350628|NCT01258803|20584495|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
8350629|NCT01258803|20584496|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
8350630|NCT01258803|20584497|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
8350631|NCT01258803|20584498|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
8350632|NCT01258803|20584499|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
8350633|NCT01258803|20584494|P6|STARTED|Treatment Period 3 (1 Dose)||15
8350634|NCT01258803|20584495|P5|STARTED|Treatment Period 3 (1 Dose)||15
8350635|NCT01258803|20584496|P4|STARTED|Treatment Period 3 (1 Dose)||15
8350636|NCT01258803|20584497|P3|STARTED|Treatment Period 3 (1 Dose)||15
8350637|NCT01258803|20584498|P2|STARTED|Treatment Period 3 (1 Dose)||14
8350638|NCT01258803|20584499|P1|STARTED|Treatment Period 3 (1 Dose)||14
8350639|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
8350640|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8350641|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8350642|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8350643|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
8350644|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
8350645|NCT01258803|20584494|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
8350646|NCT01258803|20584495|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
8350647|NCT01258803|20584496|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
8350648|NCT01258803|20584497|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
8350649|NCT01258803|20584498|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
8350650|NCT01258803|20584499|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
8350651|NCT01258803|20584494|P6|STARTED|Treatment Period 2 (1 Dose)||16
8350652|NCT01258803|20584495|P5|STARTED|Treatment Period 2 (1 Dose)||15
8350653|NCT01258803|20584496|P4|STARTED|Treatment Period 2 (1 Dose)||15
8350654|NCT01258803|20584497|P3|STARTED|Treatment Period 2 (1 Dose)||15
8350655|NCT01258803|20584498|P2|STARTED|Treatment Period 2 (1 Dose)||16
8350656|NCT01258803|20584499|P1|STARTED|Treatment Period 2 (1 Dose)||15
8350657|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350658|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350659|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350660|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350661|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350662|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350663|NCT01258803|20584494|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
8350664|NCT01258803|20584495|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
8350665|NCT01258803|20584496|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
8350666|NCT01258803|20584497|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
8350667|NCT01258803|20584498|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
8350668|NCT01258803|20584499|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
8350669|NCT01258803|20584494|P6|STARTED|Treatment Period 1 (1 Dose)||16
8350670|NCT01258803|20584495|P5|STARTED|Treatment Period 1 (1 Dose)||15
8350671|NCT01258803|20584496|P4|STARTED|Treatment Period 1 (1 Dose)||15
8350672|NCT01258803|20584497|P3|STARTED|Treatment Period 1 (1 Dose)||15
8350673|NCT01258803|20584498|P2|STARTED|Treatment Period 1 (1 Dose)||16
8350674|NCT01258803|20584499|P1|STARTED|Treatment Period 1 (1 Dose)||15
8350675|NCT01258790|20584527|P2|NOT COMPLETED|Overall Study||0
8350676|NCT01258790|20584528|P1|NOT COMPLETED|Overall Study||0
8350677|NCT01258790|20584527|P2|COMPLETED|Overall Study||6
8350678|NCT01258790|20584528|P1|COMPLETED|Overall Study||6
8350679|NCT01258790|20584527|P2|STARTED|Overall Study||6
8350680|NCT01258790|20584528|P1|STARTED|Overall Study||6
8350681|NCT01258738|20584536|P2|NOT COMPLETED|Open-label Period||21
8350682|NCT01258738|20584537|P1|NOT COMPLETED|Open-label Period||17
8350683|NCT01258738|20584536|P2|COMPLETED|Open-label Period||85
8350684|NCT01258738|20584537|P1|COMPLETED|Open-label Period||85
8350685|NCT01258738|20584536|P2|STARTED|Open-label Period||106
8350686|NCT01258738|20584537|P1|STARTED|Open-label Period||102
8350687|NCT01258738|20584536|P2|NOT COMPLETED|Double-blind Period||7
8350688|NCT01258738|20584537|P1|NOT COMPLETED|Double-blind Period||9
8350689|NCT01258738|20584536|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
8350690|NCT01258738|20584537|P1|COMPLETED|Double-blind Period||102
8350691|NCT01258738|20584536|P2|Treated|Double-blind Period||113
8350692|NCT01258738|20584537|P1|Treated|Double-blind Period||111
8350693|NCT01258738|20584536|P2|STARTED|Double-blind Period||114
8350694|NCT01258738|20584537|P1|STARTED|Double-blind Period||111
8350695|NCT01258660|20584675|P2|NOT COMPLETED|Overall Study||11
8350696|NCT01258660|20584676|P1|NOT COMPLETED|Overall Study||11
8350697|NCT01258660|20584675|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
8350698|NCT01258660|20584676|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
8350699|NCT01258660|20584675|P2|Completed Treatment|Overall Study||81
8350700|NCT01258660|20584676|P1|Completed Treatment|Overall Study||79
8350701|NCT01258660|20584675|P2|Received Treatment|Overall Study||82
8350702|NCT01258660|20584676|P1|Received Treatment|Overall Study||79
8350703|NCT01258660|20584675|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
8350704|NCT01258660|20584676|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
8350705|NCT01258608|20584695|P2|NOT COMPLETED|Overall Study||19
8350706|NCT01258608|20584696|P1|NOT COMPLETED|Overall Study||21
8350707|NCT01258608|20584695|P2|COMPLETED|Overall Study||31
8350708|NCT01258608|20584696|P1|COMPLETED|Overall Study||30
8350709|NCT01258608|20584695|P2|STARTED|Overall Study||50
8350710|NCT01258608|20584696|P1|STARTED|Overall Study||51
8350711|NCT01258595|20584744|P2|NOT COMPLETED|Overall Study||1
8350712|NCT01258595|20584745|P1|NOT COMPLETED|Overall Study||1
8350713|NCT01258595|20584744|P2|COMPLETED|Overall Study||151
8350714|NCT01258595|20584745|P1|COMPLETED|Overall Study||147
8350715|NCT01258595|20584744|P2|STARTED|Overall Study||152
8350716|NCT01258595|20584745|P1|STARTED|Overall Study||148
8350717|NCT01258582|20584761|P2|NOT COMPLETED|Overall Study||258
8350718|NCT01258582|20584762|P1|NOT COMPLETED|Overall Study||282
8350719|NCT01258582|20584761|P2|COMPLETED|Overall Study||563
8350720|NCT01258582|20584762|P1|COMPLETED|Overall Study||548
8350721|NCT01258582|20584761|P2|STARTED|Overall Study||821
8350722|NCT01258582|20584762|P1|STARTED|Overall Study||830
8350723|NCT01258504|20584768|P1|NOT COMPLETED|Bosentan and SJW||0
8350724|NCT01258504|20584768|P1|COMPLETED|Bosentan and SJW||13
8350725|NCT01258504|20584768|P1|STARTED|Bosentan and SJW||13
8350726|NCT01258504|20584768|P1|NOT COMPLETED|Bosentan Steady-state||0
8350727|NCT01258504|20584768|P1|COMPLETED|Bosentan Steady-state||13
8350728|NCT01258504|20584768|P1|STARTED|Bosentan Steady-state||13
8350729|NCT01258504|20584768|P1|NOT COMPLETED|Bosentan Single Dose||0
8350730|NCT01258504|20584768|P1|COMPLETED|Bosentan Single Dose||13
8350731|NCT01258504|20584768|P1|STARTED|Bosentan Single Dose||13
8350732|NCT01258387|20584787|P7|NOT COMPLETED|Overall Study||0
8350733|NCT01258387|20584788|P6|NOT COMPLETED|Overall Study||0
8350734|NCT01258387|20584789|P5|NOT COMPLETED|Overall Study||0
8350735|NCT01258387|20584790|P4|NOT COMPLETED|Overall Study||0
8350736|NCT01258387|20584791|P3|NOT COMPLETED|Overall Study||0
8350737|NCT01258387|20584792|P2|NOT COMPLETED|Overall Study||0
8350738|NCT01258387|20584793|P1|NOT COMPLETED|Overall Study||0
8350739|NCT01258387|20584787|P7|COMPLETED|Overall Study||4
8350740|NCT01258387|20584788|P6|COMPLETED|Overall Study||6
8350741|NCT01258387|20584789|P5|COMPLETED|Overall Study||6
8350742|NCT01258387|20584790|P4|COMPLETED|Overall Study||6
8350743|NCT01258387|20584791|P3|COMPLETED|Overall Study||6
8350744|NCT01258387|20584792|P2|COMPLETED|Overall Study||6
8350745|NCT01258387|20584793|P1|COMPLETED|Overall Study||6
8350746|NCT01258387|20584787|P7|Patients Randomized to Placebo|Overall Study||1
8350747|NCT01258387|20584788|P6|Patients Randomized to Placebo|Overall Study||2
8350748|NCT01258387|20584789|P5|Patients Randomized to Placebo|Overall Study||2
8350749|NCT01258387|20584790|P4|Patients Randomized to Placebo|Overall Study||2
8350750|NCT01258387|20584791|P3|Patients Randomized to Placebo|Overall Study||2
8350751|NCT01258387|20584792|P2|Patients Randomized to Placebo|Overall Study||2
8350752|NCT01258387|20584793|P1|Patients Randomized to Placebo|Overall Study||2
8350753|NCT01258387|20584787|P7|Patients Randomized to GGF2|Overall Study||3
8350754|NCT01258387|20584788|P6|Patients Randomized to GGF2|Overall Study||4
8350755|NCT01258387|20584789|P5|Patients Randomized to GGF2|Overall Study||4
8350756|NCT01258387|20584790|P4|Patients Randomized to GGF2|Overall Study||4
8350757|NCT01258387|20584791|P3|Patients Randomized to GGF2|Overall Study||4
8350758|NCT01258387|20584792|P2|Patients Randomized to GGF2|Overall Study||4
8350759|NCT01258387|20584793|P1|Patients Randomized to GGF2|Overall Study||4
8350760|NCT01258387|20584787|P7|STARTED|Overall Study||4
8350761|NCT01258387|20584788|P6|STARTED|Overall Study||6
8350762|NCT01258387|20584789|P5|STARTED|Overall Study||6
8350763|NCT01258387|20584790|P4|STARTED|Overall Study||6
8350764|NCT01258387|20584791|P3|STARTED|Overall Study||6
8350765|NCT01258387|20584792|P2|STARTED|Overall Study||6
8350766|NCT01258387|20584793|P1|STARTED|Overall Study||6
8350767|NCT01258374|20584835|P1|NOT COMPLETED|Overall Study||0
8350768|NCT01258374|20584835|P1|COMPLETED|Overall Study||15
8350769|NCT01258374|20584835|P1|STARTED|Overall Study||15
8350770|NCT01258348|20584842|P5|NOT COMPLETED|Overall Study||6
8350771|NCT01258348|20584843|P4|NOT COMPLETED|Overall Study||6
8350772|NCT01258348|20584844|P3|NOT COMPLETED|Overall Study||3
8350773|NCT01258348|20584845|P2|NOT COMPLETED|Overall Study||5
8350774|NCT01258348|20584846|P1|NOT COMPLETED|Overall Study||1
8350775|NCT01258348|20584842|P5|COMPLETED|Overall Study||0
8350776|NCT01258348|20584843|P4|COMPLETED|Overall Study||0
8350777|NCT01258348|20584844|P3|COMPLETED|Overall Study||0
8350778|NCT01258348|20584845|P2|COMPLETED|Overall Study||0
8350779|NCT01258348|20584846|P1|COMPLETED|Overall Study||0
8350780|NCT01258348|20584842|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8350781|NCT01258348|20584843|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8350782|NCT01258348|20584844|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8350783|NCT01258348|20584845|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
8350784|NCT01258348|20584846|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
8350785|NCT01258348|20584842|P5|STARTED|Overall Study||6
8350786|NCT01258348|20584843|P4|STARTED|Overall Study||6
8350787|NCT01258348|20584844|P3|STARTED|Overall Study||3
8350788|NCT01258348|20584845|P2|STARTED|Overall Study||5
8350789|NCT01258348|20584846|P1|STARTED|Overall Study||1
8350790|NCT01258153|20584874|P3|NOT COMPLETED|Overall Study||1
8350791|NCT01258153|20584875|P2|NOT COMPLETED|Overall Study||1
8350792|NCT01258153|20584876|P1|NOT COMPLETED|Overall Study||1
8350793|NCT01258153|20584874|P3|COMPLETED|Overall Study||36
8350794|NCT01258153|20584875|P2|COMPLETED|Overall Study||37
8350795|NCT01258153|20584876|P1|COMPLETED|Overall Study||39
8350796|NCT01258153|20584874|P3|STARTED|Overall Study||37
8350797|NCT01258153|20584875|P2|STARTED|Overall Study||38
8350798|NCT01258153|20584876|P1|STARTED|Overall Study||40
8350799|NCT01258101|20584903|P4|NOT COMPLETED|Overall Study||25
8350800|NCT01258101|20584904|P3|NOT COMPLETED|Overall Study||11
8350801|NCT01258101|20584905|P2|NOT COMPLETED|Overall Study||34
8350802|NCT01258101|20584906|P1|NOT COMPLETED|Overall Study||33
8350803|NCT01258101|20584903|P4|COMPLETED|Overall Study||27
8350804|NCT01258101|20584904|P3|COMPLETED|Overall Study||22
8350805|NCT01258101|20584905|P2|COMPLETED|Overall Study||110
8350806|NCT01258101|20584906|P1|COMPLETED|Overall Study||118
8350807|NCT01258101|20584903|P4|Standard Analysis Population|Overall Study||26
8350808|NCT01258101|20584904|P3|Standard Analysis Population|Overall Study||21
8350809|NCT01258101|20584905|P2|Standard Analysis Population|Overall Study||110
8350810|NCT01258101|20584906|P1|Standard Analysis Population|Overall Study||115
8350811|NCT01258101|20584903|P4|Safety Analysis Population|Overall Study||48
8350812|NCT01258101|20584904|P3|Safety Analysis Population|Overall Study||30
8350813|NCT01258101|20584905|P2|Safety Analysis Population|Overall Study||141
8350814|NCT01258101|20584906|P1|Safety Analysis Population|Overall Study||144
8350815|NCT01258101|20584903|P4|STARTED|Overall Study||52
8350816|NCT01258101|20584904|P3|STARTED|Overall Study||33
8350817|NCT01258101|20584905|P2|STARTED|Overall Study||144
8350818|NCT01258101|20584906|P1|STARTED|Overall Study||151
8350825|NCT01258049|20584967|P2|NOT COMPLETED|Overall Study||2
8350826|NCT01258049|20584968|P1|NOT COMPLETED|Overall Study||2
8350827|NCT01258049|20584967|P2|COMPLETED|Overall Study||72
8350828|NCT01258049|20584968|P1|COMPLETED|Overall Study||75
8350829|NCT01258049|20584967|P2|STARTED|Overall Study||74
8350830|NCT01258049|20584968|P1|STARTED|Overall Study||77
8350831|NCT01257880|20585006|P2|NOT COMPLETED|Overall Study||0
8350832|NCT01257880|20585007|P1|NOT COMPLETED|Overall Study||0
8350833|NCT01257880|20585006|P2|COMPLETED|Overall Study||19
8350834|NCT01257880|20585007|P1|COMPLETED|Overall Study||12
8350835|NCT01257880|20585006|P2|STARTED|Overall Study||19
8350836|NCT01257880|20585007|P1|STARTED|Overall Study||12
8350837|NCT01257802|20585017|P2|NOT COMPLETED|Overall Study||6
8350838|NCT01257802|20585018|P1|NOT COMPLETED|Overall Study||1
8350839|NCT01257802|20585017|P2|COMPLETED|Overall Study||2
8350840|NCT01257802|20585018|P1|COMPLETED|Overall Study||5
8350841|NCT01257802|20585017|P2|6 Month / 24 Week Visit|Overall Study||2
8350842|NCT01257802|20585018|P1|6 Month / 24 Week Visit|Overall Study||5
8350843|NCT01257802|20585017|P2|STARTED|Overall Study||8
8350844|NCT01257802|20585018|P1|STARTED|Overall Study||6
8350845|NCT01257750|20585032|P1|NOT COMPLETED|Overall Study||0
8350846|NCT01257750|20585032|P1|COMPLETED|Overall Study||20
8350847|NCT01257750|20585032|P1|STARTED|Overall Study||20
8350848|NCT01257737|20585045|P2|NOT COMPLETED|Overall Study||4
8350849|NCT01257737|20585046|P1|NOT COMPLETED|Overall Study||2
8350850|NCT01257737|20585045|P2|COMPLETED|Overall Study||39
8350851|NCT01257737|20585046|P1|COMPLETED|Overall Study||43
8350852|NCT01257737|20585045|P2|STARTED|Overall Study||43
8350853|NCT01257737|20585046|P1|STARTED|Overall Study||45
8350854|NCT01257698|20585066|P2|NOT COMPLETED|Overall Study||0
8350855|NCT01257698|20585067|P1|NOT COMPLETED|Overall Study||4
8350856|NCT01257698|20585066|P2|COMPLETED|Overall Study||9
8350857|NCT01257698|20585067|P1|COMPLETED|Overall Study||8
8350858|NCT01257698|20585066|P2|STARTED|Overall Study||9
8350859|NCT01257698|20585067|P1|STARTED|Overall Study||12
8350860|NCT01257581|20585076|P3|NOT COMPLETED|Overall Study||6
8350861|NCT01257581|20585077|P2|NOT COMPLETED|Overall Study||3
8350862|NCT01257581|20585078|P1|NOT COMPLETED|Overall Study||5
8350863|NCT01257581|20585076|P3|COMPLETED|Overall Study||11
8350864|NCT01257581|20585077|P2|COMPLETED|Overall Study||18
8350865|NCT01257581|20585078|P1|COMPLETED|Overall Study||17
8350866|NCT01257581|20585076|P3|STARTED|Overall Study||17
8350867|NCT01257581|20585077|P2|STARTED|Overall Study||21
8350868|NCT01257581|20585078|P1|STARTED|Overall Study||22
8350869|NCT01257568|20585116|P1|NOT COMPLETED|Overall Study||33
8350870|NCT01257568|20585116|P1|COMPLETED|Overall Study||7
8350871|NCT01257568|20585116|P1|STARTED|Overall Study||40
8350872|NCT01257542|20585130|P2|NOT COMPLETED|Overall Study||7
8350873|NCT01257542|20585131|P1|NOT COMPLETED|Overall Study||3
8350874|NCT01257542|20585130|P2|COMPLETED|Overall Study||45
8350875|NCT01257542|20585131|P1|COMPLETED|Overall Study||52
8350876|NCT01257542|20585130|P2|STARTED|Overall Study||52
8350877|NCT01257542|20585131|P1|STARTED|Overall Study||55
8350878|NCT01257503|20585151|P2|NOT COMPLETED|Overall Study||11
8350879|NCT01257503|20585152|P1|NOT COMPLETED|Overall Study||8
8350880|NCT01257503|20585151|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
8350881|NCT01257503|20585152|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
8350882|NCT01257503|20585151|P2|Returned Dosage Logbooks|Overall Study||80
8350883|NCT01257503|20585152|P1|Returned Dosage Logbooks|Overall Study||75
8350884|NCT01257503|20585151|P2|Returned Symptom Diaries|Overall Study||83
8350885|NCT01257503|20585152|P1|Returned Symptom Diaries|Overall Study||80
8350886|NCT01257503|20585151|P2|STARTED|Overall Study||130
8350887|NCT01257503|20585152|P1|STARTED|Overall Study||133
8350888|NCT01257438|20585168|P2|NOT COMPLETED|Overall Study||46
8350889|NCT01257438|20585169|P1|NOT COMPLETED|Overall Study||30
8350890|NCT01257438|20585168|P2|COMPLETED|Overall Study||97
8350891|NCT01257438|20585169|P1|COMPLETED|Overall Study||102
8350892|NCT01257438|20585168|P2|STARTED|Overall Study||143
8350893|NCT01257438|20585169|P1|STARTED|Overall Study||132
8350894|NCT01257425|20585181|P2|NOT COMPLETED|Overall Study||6
8350895|NCT01257425|20585182|P1|NOT COMPLETED|Overall Study||6
8350896|NCT01257425|20585181|P2|COMPLETED|Overall Study||45
8350897|NCT01257425|20585182|P1|COMPLETED|Overall Study||46
8350898|NCT01257425|20585181|P2|STARTED|Overall Study||51
8350899|NCT01257425|20585182|P1|STARTED|Overall Study||52
8350900|NCT01257347|20585204|P4|NOT COMPLETED|Overall Study||0
8350901|NCT01257347|20585205|P3|NOT COMPLETED|Overall Study||0
8350902|NCT01257347|20585206|P2|NOT COMPLETED|Overall Study||0
8350903|NCT01257347|20585207|P1|NOT COMPLETED|Overall Study||0
8350904|NCT01257347|20585204|P4|COMPLETED|Overall Study||65
8350905|NCT01257347|20585205|P3|COMPLETED|Overall Study||35
8350906|NCT01257347|20585206|P2|COMPLETED|Overall Study||12
8350907|NCT01257347|20585207|P1|COMPLETED|Overall Study||12
8350908|NCT01257347|20585204|P4|STARTED|Overall Study||65
8350909|NCT01257347|20585205|P3|STARTED|Overall Study||35
8350910|NCT01257347|20585206|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
8350911|NCT01257347|20585207|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
8350912|NCT01257230|20585224|P3|NOT COMPLETED|Overall Study||6
8350913|NCT01257230|20585225|P2|NOT COMPLETED|Overall Study||10
8350914|NCT01257230|20585226|P1|NOT COMPLETED|Overall Study||6
8350915|NCT01257230|20585224|P3|COMPLETED|Overall Study||129
8350916|NCT01257230|20585225|P2|COMPLETED|Overall Study||115
8350917|NCT01257230|20585226|P1|COMPLETED|Overall Study||132
8350918|NCT01257230|20585224|P3|STARTED|Overall Study||135
8350919|NCT01257230|20585225|P2|STARTED|Overall Study||125
8350920|NCT01257230|20585226|P1|STARTED|Overall Study||138
8350921|NCT01257217|20585281|P2|NOT COMPLETED|Overall Study||0
8350922|NCT01257217|20585282|P1|NOT COMPLETED|Overall Study||2
8350923|NCT01257217|20585281|P2|COMPLETED|Overall Study||10
8350924|NCT01257217|20585282|P1|COMPLETED|Overall Study||13
8350925|NCT01257217|20585281|P2|STARTED|Overall Study||10
8350926|NCT01257217|20585282|P1|STARTED|Overall Study||15
8350927|NCT01257204|20585303|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
8350928|NCT01257204|20585304|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
8350929|NCT01257204|20585305|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
8350930|NCT01257204|20585303|P3|COMPLETED|Follow-up Period (up to Week 48)||39
8350931|NCT01257204|20585304|P2|COMPLETED|Follow-up Period (up to Week 48)||41
8350932|NCT01257204|20585305|P1|COMPLETED|Follow-up Period (up to Week 48)||48
8350933|NCT01257204|20585303|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
8350934|NCT01257204|20585304|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
8350935|NCT01257204|20585305|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
8350936|NCT01257204|20585303|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
8350937|NCT01257204|20585304|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
8350938|NCT01257204|20585305|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
8350939|NCT01257204|20585303|P3|COMPLETED|Treatment Period (up to Week 24)||42
8350940|NCT01257204|20585304|P2|COMPLETED|Treatment Period (up to Week 24)||44
8350941|NCT01257204|20585305|P1|COMPLETED|Treatment Period (up to Week 24)||45
8350942|NCT01257204|20585303|P3|STARTED|Treatment Period (up to Week 24)||51
8350943|NCT01257204|20585304|P2|STARTED|Treatment Period (up to Week 24)||50
8350944|NCT01257204|20585305|P1|STARTED|Treatment Period (up to Week 24)||50
8350945|NCT01257087|20585351|P2|NOT COMPLETED|Overall Study||0
8350946|NCT01257087|20585352|P1|NOT COMPLETED|Overall Study||0
8350947|NCT01257087|20585351|P2|COMPLETED|Overall Study||17
8350948|NCT01257087|20585352|P1|COMPLETED|Overall Study||18
8350949|NCT01257087|20585351|P2|STARTED|Overall Study||17
8350950|NCT01257087|20585352|P1|STARTED|Overall Study||18
8350951|NCT01256983|20585364|P2|NOT COMPLETED|Overall Study||3
8350952|NCT01256983|20585365|P1|NOT COMPLETED|Overall Study||1
8350953|NCT01256983|20585364|P2|COMPLETED|Overall Study||12
8350954|NCT01256983|20585365|P1|COMPLETED|Overall Study||14
8350955|NCT01256983|20585364|P2|STARTED|Overall Study||15
8350956|NCT01256983|20585365|P1|STARTED|Overall Study||15
8350957|NCT01256944|20585373|P2|NOT COMPLETED|Overall Study||0
8350958|NCT01256944|20585374|P1|NOT COMPLETED|Overall Study||0
8350959|NCT01256944|20585373|P2|COMPLETED|Overall Study||220
8350960|NCT01256944|20585374|P1|COMPLETED|Overall Study||70
8350961|NCT01256944|20585373|P2|STARTED|Overall Study||220
8350962|NCT01256944|20585374|P1|STARTED|Overall Study||70
8350963|NCT01256918|20585402|P1|NOT COMPLETED|Overall Study||0
8350964|NCT01256918|20585402|P1|COMPLETED|Overall Study||200
8350965|NCT01256918|20585402|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
8350966|NCT01256918|20585402|P1|STARTED|Overall Study||200
8350967|NCT01256879|20585413|P1|NOT COMPLETED|Overall Study||1
8350968|NCT01256879|20585413|P1|COMPLETED|Overall Study||24
8350969|NCT01256879|20585413|P1|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
8350970|NCT01256879|20585413|P1|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
8350971|NCT01256879|20585413|P1|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
8350972|NCT01256879|20585413|P1|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
8350973|NCT01256879|20585413|P1|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
8350974|NCT01256840|20585426|P3|NOT COMPLETED|Overall Study||0
8350975|NCT01256840|20585427|P2|NOT COMPLETED|Overall Study||0
8350976|NCT01256840|20585428|P1|NOT COMPLETED|Overall Study||0
8350977|NCT01256840|20585426|P3|COMPLETED|Overall Study||25
8350978|NCT01256840|20585427|P2|COMPLETED|Overall Study||16
8350979|NCT01256840|20585428|P1|COMPLETED|Overall Study||30
8350980|NCT01256840|20585426|P3|STARTED|Overall Study||25
8350981|NCT01256840|20585427|P2|STARTED|Overall Study||16
8350982|NCT01256840|20585428|P1|STARTED|Overall Study||30
8350983|NCT01256788|20585439|P3|NOT COMPLETED|Overall Study||3
8350984|NCT01256788|20585440|P2|NOT COMPLETED|Overall Study||8
8350985|NCT01256788|20585441|P1|NOT COMPLETED|Overall Study||5
8350986|NCT01256788|20585439|P3|COMPLETED|Overall Study||5
8350987|NCT01256788|20585440|P2|COMPLETED|Overall Study||6
8350988|NCT01256788|20585441|P1|COMPLETED|Overall Study||7
8350989|NCT01256788|20585439|P3|STARTED|Overall Study||8
8350990|NCT01256788|20585440|P2|STARTED|Overall Study||14
8350991|NCT01256788|20585441|P1|STARTED|Overall Study||12
8350992|NCT01256684|20585452|P3|NOT COMPLETED|Overall Study||11
8350993|NCT01256684|20585453|P2|NOT COMPLETED|Overall Study||13
8350994|NCT01256684|20585454|P1|NOT COMPLETED|Overall Study||9
8350995|NCT01256684|20585452|P3|COMPLETED|Overall Study||76
8350996|NCT01256684|20585453|P2|COMPLETED|Overall Study||74
8350997|NCT01256684|20585454|P1|COMPLETED|Overall Study||72
8350998|NCT01256684|20585452|P3|ITT Population|Overall Study||81
8350999|NCT01256684|20585453|P2|ITT Population|Overall Study||79
8351000|NCT01256684|20585454|P1|ITT Population|Overall Study||77
8351001|NCT01256684|20585452|P3|Safety Population|Overall Study||87
8351002|NCT01256684|20585453|P2|Safety Population|Overall Study||86
8351003|NCT01256684|20585454|P1|Safety Population|Overall Study||80
8351004|NCT01256684|20585452|P3|STARTED|Overall Study||87
8351005|NCT01256684|20585453|P2|STARTED|Overall Study||87
8351006|NCT01256684|20585454|P1|STARTED|Overall Study||81
8351007|NCT01256671|20585486|P1|NOT COMPLETED|Overall Study||95
8351008|NCT01256671|20585486|P1|COMPLETED|Overall Study||435
8351009|NCT01256671|20585486|P1|Safety Population|Overall Study||521
8351010|NCT01256671|20585486|P1|STARTED|Overall Study||530
8351011|NCT01256658|20585499|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
8351012|NCT01256658|20585500|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
8351013|NCT01256658|20585499|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
8351014|NCT01256658|20585500|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
8351015|NCT01256658|20585499|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
8351016|NCT01256658|20585500|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
8351017|NCT01256658|20585499|P2|Death|Period 2 - Follow up Only - No Treatment||8
8351018|NCT01256658|20585500|P1|Death|Period 2 - Follow up Only - No Treatment||6
8351019|NCT01256658|20585499|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
8351020|NCT01256658|20585500|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
8351021|NCT01256658|20585499|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
8351022|NCT01256658|20585500|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
8351023|NCT01256658|20585499|P2|NOT COMPLETED|Period 1||748
8351024|NCT01256658|20585500|P1|NOT COMPLETED|Period 1||920
8351025|NCT01256658|20585499|P2|COMPLETED|Period 1||6510
8351026|NCT01256658|20585500|P1|COMPLETED|Period 1||5897
8351027|NCT01256658|20585499|P2|STARTED|Period 1||7258
8351028|NCT01256658|20585500|P1|STARTED|Period 1||6817
8351029|NCT01256593|20585550|P1|NOT COMPLETED|Overall Study||214
8351030|NCT01256593|20585550|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
8351031|NCT01256593|20585550|P1|STARTED|Overall Study||3827
8351032|NCT01256567|20585564|P1|NOT COMPLETED|Overall Study||1
8351033|NCT01256567|20585564|P1|COMPLETED|Overall Study||6
8351034|NCT01256567|20585564|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8351035|NCT01256567|20585564|P1|STARTED|Overall Study||7
8351036|NCT01256502|20585574|P1|NOT COMPLETED|Overall Study||10
8351037|NCT01256502|20585574|P1|COMPLETED|Overall Study||129
8351038|NCT01256502|20585574|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
8351039|NCT01256476|20585586|P2|NOT COMPLETED|Overall Study||7
8351040|NCT01256476|20585587|P1|NOT COMPLETED|Overall Study||6
8351041|NCT01256476|20585586|P2|COMPLETED|Overall Study||157
8351042|NCT01256476|20585587|P1|COMPLETED|Overall Study||158
8351043|NCT01256476|20585586|P2|STARTED|Overall Study||164
8351044|NCT01256476|20585587|P1|STARTED|Overall Study||164
8351045|NCT01256450|20585595|P3|NOT COMPLETED|Double-blind Treatment||37
8351046|NCT01256450|20585596|P2|NOT COMPLETED|Double-blind Treatment||28
8351047|NCT01256450|20585597|P1|NOT COMPLETED|Double-blind Treatment||0
8351048|NCT01256450|20585595|P3|COMPLETED|Double-blind Treatment||81
8351049|NCT01256450|20585596|P2|COMPLETED|Double-blind Treatment||89
8351050|NCT01256450|20585597|P1|COMPLETED|Double-blind Treatment||0
8351051|NCT01256450|20585595|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
8351052|NCT01256450|20585596|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
8351053|NCT01256450|20585597|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8351054|NCT01256450|20585595|P3|NOT COMPLETED|Open-label Titration||0
8351055|NCT01256450|20585596|P2|NOT COMPLETED|Open-label Titration||0
8351056|NCT01256450|20585597|P1|NOT COMPLETED|Open-label Titration||99
8351057|NCT01256450|20585595|P3|COMPLETED|Open-label Titration||0
8351058|NCT01256450|20585596|P2|COMPLETED|Open-label Titration||0
8351059|NCT01256450|20585597|P1|COMPLETED|Open-label Titration||235
8351060|NCT01256450|20585595|P3|STARTED|Open-label Titration||0
8351061|NCT01256450|20585596|P2|STARTED|Open-label Titration||0
8351062|NCT01256450|20585597|P1|STARTED|Open-label Titration||334
8351063|NCT01256424|20585626|P4|NOT COMPLETED|Overall Study||7
8351064|NCT01256424|20585627|P3|NOT COMPLETED|Overall Study||7
8351065|NCT01256424|20585628|P2|NOT COMPLETED|Overall Study||8
8351066|NCT01256424|20585629|P1|NOT COMPLETED|Overall Study||9
8351067|NCT01256424|20585626|P4|COMPLETED|Overall Study||61
8351068|NCT01256424|20585627|P3|COMPLETED|Overall Study||55
8351069|NCT01256424|20585628|P2|COMPLETED|Overall Study||59
8351070|NCT01256424|20585629|P1|COMPLETED|Overall Study||56
8351071|NCT01256424|20585626|P4|STARTED|Overall Study||68
8351072|NCT01256424|20585627|P3|STARTED|Overall Study||62
8351073|NCT01256424|20585628|P2|STARTED|Overall Study||67
8351074|NCT01256424|20585629|P1|STARTED|Overall Study||65
8351075|NCT01256411|20585655|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
8351076|NCT01256411|20585656|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
8351077|NCT01256411|20585657|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351078|NCT01256411|20585658|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351079|NCT01256411|20585659|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351080|NCT01256411|20585660|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351081|NCT01256411|20585655|P6|COMPLETED|Extension by Mono or Combination Therapy||109
8351082|NCT01256411|20585656|P5|COMPLETED|Extension by Mono or Combination Therapy||211
8351083|NCT01256411|20585657|P4|COMPLETED|Extension by Mono or Combination Therapy||0
8351084|NCT01256411|20585658|P3|COMPLETED|Extension by Mono or Combination Therapy||0
8351085|NCT01256411|20585659|P2|COMPLETED|Extension by Mono or Combination Therapy||0
8351086|NCT01256411|20585660|P1|COMPLETED|Extension by Mono or Combination Therapy||0
8351087|NCT01256411|20585655|P6|STARTED|Extension by Mono or Combination Therapy||113
8351088|NCT01256411|20585656|P5|STARTED|Extension by Mono or Combination Therapy||228
8351089|NCT01256411|20585657|P4|STARTED|Extension by Mono or Combination Therapy||0
8351090|NCT01256411|20585658|P3|STARTED|Extension by Mono or Combination Therapy||0
8351091|NCT01256411|20585659|P2|STARTED|Extension by Mono or Combination Therapy||0
8351092|NCT01256411|20585660|P1|STARTED|Extension by Mono or Combination Therapy||0
8351093|NCT01256411|20585655|P6|NOT COMPLETED|Extension by Maximum Treatment||0
8351094|NCT01256411|20585656|P5|NOT COMPLETED|Extension by Maximum Treatment||0
8351095|NCT01256411|20585657|P4|NOT COMPLETED|Extension by Maximum Treatment||0
8351096|NCT01256411|20585658|P3|NOT COMPLETED|Extension by Maximum Treatment||4
8351097|NCT01256411|20585659|P2|NOT COMPLETED|Extension by Maximum Treatment||10
8351098|NCT01256411|20585660|P1|NOT COMPLETED|Extension by Maximum Treatment||7
8351099|NCT01256411|20585655|P6|COMPLETED|Extension by Maximum Treatment||0
8351100|NCT01256411|20585656|P5|COMPLETED|Extension by Maximum Treatment||0
8351101|NCT01256411|20585657|P4|COMPLETED|Extension by Maximum Treatment||4
8351102|NCT01256411|20585658|P3|COMPLETED|Extension by Maximum Treatment||105
8351103|NCT01256411|20585659|P2|COMPLETED|Extension by Maximum Treatment||79
8351104|NCT01256411|20585660|P1|COMPLETED|Extension by Maximum Treatment||132
8351105|NCT01256411|20585655|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351106|NCT01256411|20585656|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351107|NCT01256411|20585657|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351108|NCT01256411|20585658|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351109|NCT01256411|20585659|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351110|NCT01256411|20585660|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
8351111|NCT01256411|20585655|P6|STARTED|Extension by Maximum Treatment||0
8351112|NCT01256411|20585656|P5|STARTED|Extension by Maximum Treatment||0
8351113|NCT01256411|20585657|P4|STARTED|Extension by Maximum Treatment||4
8351114|NCT01256411|20585658|P3|STARTED|Extension by Maximum Treatment||109
8351115|NCT01256411|20585659|P2|STARTED|Extension by Maximum Treatment||89
8351116|NCT01256411|20585660|P1|STARTED|Extension by Maximum Treatment||139
8351117|NCT01256398|20585684|P1|NOT COMPLETED|Overall Study||1
8351118|NCT01256398|20585684|P1|COMPLETED|Overall Study||65
8351119|NCT01256398|20585684|P1|STARTED|Overall Study||66
8351120|NCT01256385|20585690|P2|NOT COMPLETED|Overall Study||3
8351121|NCT01256385|20585691|P1|NOT COMPLETED|Overall Study||3
8351122|NCT01256385|20585690|P2|COMPLETED|Overall Study||40
8351123|NCT01256385|20585691|P1|COMPLETED|Overall Study||40
8351124|NCT01256385|20585690|P2|Crossover From Arm B to Arm A|Overall Study||15
8351125|NCT01256385|20585691|P1|Crossover From Arm B to Arm A|Overall Study||0
8351126|NCT01256385|20585690|P2|STARTED|Overall Study||43
8351127|NCT01256385|20585691|P1|STARTED|Overall Study||43
8351128|NCT01256294|20585711|P2|NOT COMPLETED|Overall Study||2
8351129|NCT01256294|20585712|P1|NOT COMPLETED|Overall Study||4
8351130|NCT01256294|20585711|P2|COMPLETED|Overall Study||33
8351131|NCT01256294|20585712|P1|COMPLETED|Overall Study||32
8351132|NCT01256294|20585711|P2|STARTED|Overall Study||35
8351133|NCT01256294|20585712|P1|STARTED|Overall Study||36
8351134|NCT01256281|20585728|P1|NOT COMPLETED|Overall Study||0
8351135|NCT01256281|20585728|P1|COMPLETED|Overall Study||2
8351136|NCT01256281|20585728|P1|STARTED|Overall Study||2
8351137|NCT01256190|20585734|P2|NOT COMPLETED|Overall Study||0
8351138|NCT01256190|20585735|P1|NOT COMPLETED|Overall Study||2
8351139|NCT01256190|20585734|P2|COMPLETED|Overall Study||17
8351140|NCT01256190|20585735|P1|COMPLETED|Overall Study||37
8351141|NCT01256190|20585734|P2|STARTED|Overall Study||17
8351142|NCT01256190|20585735|P1|STARTED|Overall Study||39
8351143|NCT01256177|20585751|P2|NOT COMPLETED|Overall Study||37
8351144|NCT01256177|20585752|P1|NOT COMPLETED|Overall Study||50
8351145|NCT01256177|20585751|P2|COMPLETED|Overall Study||111
8351146|NCT01256177|20585752|P1|COMPLETED|Overall Study||98
8351147|NCT01256177|20585751|P2|STARTED|Overall Study||148
8351148|NCT01256177|20585752|P1|STARTED|Overall Study||148
8351149|NCT01256164|20585776|P2|NOT COMPLETED|Overall Study||0
8351150|NCT01256164|20585777|P1|NOT COMPLETED|Overall Study||0
8351151|NCT01256164|20585776|P2|COMPLETED|Overall Study||23
8351152|NCT01256164|20585777|P1|COMPLETED|Overall Study||47
8351153|NCT01256164|20585776|P2|STARTED|Overall Study||23
8351154|NCT01256164|20585777|P1|STARTED|Overall Study||47
8351155|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 4||0
8351156|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 4||0
8351157|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 4||0
8351158|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 4||0
8351159|NCT01256086|20585795|P4|COMPLETED|Treatment Day 4||11
8351160|NCT01256086|20585796|P3|COMPLETED|Treatment Day 4||9
8351161|NCT01256086|20585797|P2|COMPLETED|Treatment Day 4||10
8351162|NCT01256086|20585798|P1|COMPLETED|Treatment Day 4||11
8351163|NCT01256086|20585795|P4|STARTED|Treatment Day 4||11
8351164|NCT01256086|20585796|P3|STARTED|Treatment Day 4||9
8351165|NCT01256086|20585797|P2|STARTED|Treatment Day 4||10
8351166|NCT01256086|20585798|P1|STARTED|Treatment Day 4||11
8351167|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 3||0
8351168|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 3||0
8351169|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 3||0
8351170|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 3||0
8351171|NCT01256086|20585795|P4|COMPLETED|Treatment Day 3||11
8351172|NCT01256086|20585796|P3|COMPLETED|Treatment Day 3||9
8351173|NCT01256086|20585797|P2|COMPLETED|Treatment Day 3||10
8351174|NCT01256086|20585798|P1|COMPLETED|Treatment Day 3||11
8351175|NCT01256086|20585795|P4|STARTED|Treatment Day 3||11
8351176|NCT01256086|20585796|P3|STARTED|Treatment Day 3||9
8351177|NCT01256086|20585797|P2|STARTED|Treatment Day 3||10
8351178|NCT01256086|20585798|P1|STARTED|Treatment Day 3||11
8351179|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 2||0
8351180|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 2||0
8351181|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 2||0
8351182|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 2||0
8351183|NCT01256086|20585795|P4|COMPLETED|Treatment Day 2||11
8351184|NCT01256086|20585796|P3|COMPLETED|Treatment Day 2||9
8351185|NCT01256086|20585797|P2|COMPLETED|Treatment Day 2||10
8351186|NCT01256086|20585798|P1|COMPLETED|Treatment Day 2||11
8351187|NCT01256086|20585795|P4|STARTED|Treatment Day 2||11
8351188|NCT01256086|20585796|P3|STARTED|Treatment Day 2||9
8351189|NCT01256086|20585797|P2|STARTED|Treatment Day 2||10
8351190|NCT01256086|20585798|P1|STARTED|Treatment Day 2||11
8351191|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 1||0
8351192|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 1||0
8351193|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 1||0
8351194|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 1||0
8351195|NCT01256086|20585795|P4|COMPLETED|Treatment Day 1||11
8351196|NCT01256086|20585796|P3|COMPLETED|Treatment Day 1||11
8351197|NCT01256086|20585797|P2|COMPLETED|Treatment Day 1||11
8351198|NCT01256086|20585798|P1|COMPLETED|Treatment Day 1||11
8351199|NCT01256086|20585795|P4|STARTED|Treatment Day 1||11
8351200|NCT01256086|20585796|P3|STARTED|Treatment Day 1||11
8351201|NCT01256086|20585797|P2|STARTED|Treatment Day 1||11
8351202|NCT01256086|20585798|P1|STARTED|Treatment Day 1||11
8351203|NCT01256060|20585808|P4|NOT COMPLETED|Overall Study||0
8351204|NCT01256060|20585809|P3|NOT COMPLETED|Overall Study||0
8351205|NCT01256060|20585810|P2|NOT COMPLETED|Overall Study||1
8351206|NCT01256060|20585811|P1|NOT COMPLETED|Overall Study||0
8351207|NCT01256060|20585808|P4|COMPLETED|Overall Study||6
8351208|NCT01256060|20585809|P3|COMPLETED|Overall Study||3
8351209|NCT01256060|20585810|P2|COMPLETED|Overall Study||2
8351210|NCT01256060|20585811|P1|COMPLETED|Overall Study||3
8351211|NCT01256060|20585808|P4|STARTED|Overall Study||6
8351212|NCT01256060|20585809|P3|STARTED|Overall Study||3
8351213|NCT01256060|20585810|P2|STARTED|Overall Study||3
8351214|NCT01256060|20585811|P1|STARTED|Overall Study||3
8351215|NCT01256034|20585820|P2|NOT COMPLETED|Overall Study||25
8351216|NCT01256034|20585821|P1|NOT COMPLETED|Overall Study||25
8351217|NCT01256034|20585820|P2|COMPLETED|Overall Study||0
8351218|NCT01256034|20585821|P1|COMPLETED|Overall Study||0
8351219|NCT01256034|20585820|P2|STARTED|Overall Study||25
8351220|NCT01256034|20585821|P1|STARTED|Overall Study||25
8351221|NCT01256008|20585830|P3|NOT COMPLETED|Overall Study||21
8351222|NCT01256008|20585831|P2|NOT COMPLETED|Overall Study||7
8351223|NCT01256008|20585832|P1|NOT COMPLETED|Overall Study||8
8351224|NCT01256008|20585830|P3|COMPLETED|Overall Study||175
8351225|NCT01256008|20585831|P2|COMPLETED|Overall Study||91
8351226|NCT01256008|20585832|P1|COMPLETED|Overall Study||90
8351227|NCT01256008|20585830|P3|STARTED|Overall Study||196
8351228|NCT01256008|20585831|P2|STARTED|Overall Study||98
8351229|NCT01256008|20585832|P1|STARTED|Overall Study||98
8351230|NCT01255904|20585854|P2|NOT COMPLETED|Overall Study||4
8351231|NCT01255904|20585855|P1|NOT COMPLETED|Overall Study||1
8351232|NCT01255904|20585854|P2|COMPLETED|Overall Study||41
8351233|NCT01255904|20585855|P1|COMPLETED|Overall Study||44
8351234|NCT01255904|20585854|P2|STARTED|Overall Study||45
8351235|NCT01255904|20585855|P1|STARTED|Overall Study||45
8351236|NCT01255865|20585868|P7|NOT COMPLETED|Overall Study||0
8351237|NCT01255865|20585869|P6|NOT COMPLETED|Overall Study||0
8351238|NCT01255865|20585870|P5|NOT COMPLETED|Overall Study||0
8351239|NCT01255865|20585871|P4|NOT COMPLETED|Overall Study||0
8351240|NCT01255865|20585872|P3|NOT COMPLETED|Overall Study||0
8351241|NCT01255865|20585873|P2|NOT COMPLETED|Overall Study||0
8351242|NCT01255865|20585874|P1|NOT COMPLETED|Overall Study||0
8351243|NCT01255865|20585868|P7|COMPLETED|Overall Study||20
8351244|NCT01255865|20585869|P6|COMPLETED|Overall Study||20
8351245|NCT01255865|20585870|P5|COMPLETED|Overall Study||20
8351246|NCT01255865|20585871|P4|COMPLETED|Overall Study||30
8351247|NCT01255865|20585872|P3|COMPLETED|Overall Study||10
8351248|NCT01255865|20585873|P2|COMPLETED|Overall Study||10
8351249|NCT01255865|20585874|P1|COMPLETED|Overall Study||1
8351250|NCT01255865|20585868|P7|STARTED|Overall Study||20
8351251|NCT01255865|20585869|P6|STARTED|Overall Study||20
8351252|NCT01255865|20585870|P5|STARTED|Overall Study||20
8351253|NCT01255865|20585871|P4|STARTED|Overall Study||30
8351254|NCT01255865|20585872|P3|STARTED|Overall Study||10
8351255|NCT01255865|20585873|P2|STARTED|Overall Study||10
8351256|NCT01255865|20585874|P1|STARTED|Overall Study||1
8351257|NCT01255787|20585894|P4|NOT COMPLETED|Overall Study||22
8351258|NCT01255787|20585895|P3|NOT COMPLETED|Overall Study||18
8351259|NCT01255787|20585896|P2|NOT COMPLETED|Overall Study||17
8351260|NCT01255787|20585897|P1|NOT COMPLETED|Overall Study||16
8351261|NCT01255787|20585894|P4|COMPLETED|Overall Study||132
8351262|NCT01255787|20585895|P3|COMPLETED|Overall Study||132
8351263|NCT01255787|20585896|P2|COMPLETED|Overall Study||127
8351264|NCT01255787|20585897|P1|COMPLETED|Overall Study||136
8351265|NCT01255787|20585894|P4|Treated|Overall Study||150
8351266|NCT01255787|20585895|P3|Treated|Overall Study||148
8351267|NCT01255787|20585896|P2|Treated|Overall Study||144
8351268|NCT01255787|20585897|P1|Treated|Overall Study||152
8351269|NCT01255787|20585894|P4|STARTED|Overall Study||154
8351270|NCT01255787|20585895|P3|STARTED|Overall Study||150
8351271|NCT01255787|20585896|P2|STARTED|Overall Study||144
8351272|NCT01255787|20585897|P1|STARTED|Overall Study||152
8351273|NCT01255761|20585925|P2|NOT COMPLETED|Overall Study||175
8351274|NCT01255761|20585926|P1|NOT COMPLETED|Overall Study||182
8351275|NCT01255761|20585925|P2|COMPLETED|Overall Study||192
8351276|NCT01255761|20585926|P1|COMPLETED|Overall Study||187
8351277|NCT01255761|20585925|P2|STARTED|Overall Study||367
8351278|NCT01255761|20585926|P1|STARTED|Overall Study||369
8351279|NCT01255722|20586011|P3|NOT COMPLETED|Overall Study||1
8351280|NCT01255722|20586012|P2|NOT COMPLETED|Overall Study||1
8351281|NCT01255722|20586013|P1|NOT COMPLETED|Overall Study||3
8351282|NCT01255722|20586011|P3|COMPLETED|Overall Study||152
8351283|NCT01255722|20586012|P2|COMPLETED|Overall Study||159
8351284|NCT01255722|20586013|P1|COMPLETED|Overall Study||152
8351285|NCT01255722|20586011|P3|STARTED|Overall Study||153
8351286|NCT01255722|20586012|P2|STARTED|Overall Study||160
8351287|NCT01255722|20586013|P1|STARTED|Overall Study||155
8351288|NCT01255631|20586038|P2|NOT COMPLETED|Overall Study||6
8351289|NCT01255631|20586039|P1|NOT COMPLETED|Overall Study||9
8351290|NCT01255631|20586038|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
8351291|NCT01255631|20586039|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
8351292|NCT01255631|20586038|P2|STARTED|Overall Study||9
8351293|NCT01255631|20586039|P1|STARTED|Overall Study||13
8351294|NCT01255592|20586057|P2|NOT COMPLETED|Overall Study||1
8351295|NCT01255592|20586058|P1|NOT COMPLETED|Overall Study||6
8351296|NCT01255592|20586057|P2|COMPLETED|Overall Study||25
8351297|NCT01255592|20586058|P1|COMPLETED|Overall Study||20
8351298|NCT01255592|20586057|P2|STARTED|Overall Study||26
8351299|NCT01255592|20586058|P1|STARTED|Overall Study||26
8351300|NCT01255449|20586114|P1|NOT COMPLETED|Overall Study||0
8351301|NCT01255449|20586114|P1|COMPLETED|Overall Study||26
8351302|NCT01255449|20586114|P1|STARTED|Overall Study||26
8351303|NCT01255436|20586121|P2|NOT COMPLETED|Overall Study||194
8351304|NCT01255436|20586122|P1|NOT COMPLETED|Overall Study||182
8351305|NCT01255436|20586121|P2|COMPLETED|Overall Study||135
8351306|NCT01255436|20586122|P1|COMPLETED|Overall Study||151
8351307|NCT01255436|20586121|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
8351308|NCT01255436|20586122|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
8351309|NCT01255423|20586136|P2|NOT COMPLETED|Overall Study||3
8351310|NCT01255423|20586137|P1|NOT COMPLETED|Overall Study||3
8351311|NCT01255423|20586136|P2|COMPLETED|Overall Study||99
8351312|NCT01255423|20586137|P1|COMPLETED|Overall Study||101
8351313|NCT01255423|20586136|P2|STARTED|Overall Study||102
8351314|NCT01255423|20586137|P1|STARTED|Overall Study||104
8351315|NCT01255306|20586153|P2|NOT COMPLETED|Overall Study||1
8351316|NCT01255306|20586154|P1|NOT COMPLETED|Overall Study||1
8351317|NCT01255306|20586153|P2|COMPLETED|Overall Study||32
8351318|NCT01255306|20586154|P1|COMPLETED|Overall Study||25
8351319|NCT01255306|20586153|P2|STARTED|Overall Study||33
8351320|NCT01255306|20586154|P1|STARTED|Overall Study||26
8351321|NCT01255163|20586165|P2|NOT COMPLETED|Overall Study||5
8351322|NCT01255163|20586166|P1|NOT COMPLETED|Overall Study||4
8351323|NCT01255163|20586165|P2|COMPLETED|Overall Study||9
8351324|NCT01255163|20586166|P1|COMPLETED|Overall Study||9
8351325|NCT01255163|20586165|P2|STARTED|Overall Study||14
8351326|NCT01255163|20586166|P1|STARTED|Overall Study||13
8351327|NCT01255137|20586188|P1|NOT COMPLETED|Overall Study||0
8351328|NCT01255137|20586188|P1|COMPLETED|Overall Study||13
8351329|NCT01255137|20586188|P1|STARTED|Overall Study||13
8351330|NCT01254890|20586195|P2|NOT COMPLETED|Overall Study||10
8351331|NCT01254890|20586196|P1|NOT COMPLETED|Overall Study||1
8351332|NCT01254890|20586195|P2|COMPLETED|Overall Study||47
8351333|NCT01254890|20586196|P1|COMPLETED|Overall Study||2
8351334|NCT01254890|20586195|P2|STARTED|Overall Study||57
8351335|NCT01254890|20586196|P1|STARTED|Overall Study||3
8351336|NCT01254877|20586205|P3|NOT COMPLETED|Overall Study||5
8351337|NCT01254877|20586206|P2|NOT COMPLETED|Overall Study||11
8351338|NCT01254877|20586207|P1|NOT COMPLETED|Overall Study||10
8351339|NCT01254877|20586205|P3|COMPLETED|Overall Study||64
8351340|NCT01254877|20586206|P2|COMPLETED|Overall Study||58
8351341|NCT01254877|20586207|P1|COMPLETED|Overall Study||57
8351342|NCT01254877|20586205|P3|STARTED|Overall Study||69
8351343|NCT01254877|20586206|P2|STARTED|Overall Study||69
8351344|NCT01254877|20586207|P1|STARTED|Overall Study||67
8351345|NCT01254851|20586232|P2|NOT COMPLETED|Overall Study||9
8351346|NCT01254851|20586233|P1|NOT COMPLETED|Overall Study||8
8351347|NCT01254851|20586232|P2|COMPLETED|Overall Study||68
8351348|NCT01254851|20586233|P1|COMPLETED|Overall Study||61
8351349|NCT01254851|20586232|P2|STARTED|Overall Study||77
8351350|NCT01254851|20586233|P1|STARTED|Overall Study||69
8351351|NCT01254760|20586239|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
8351352|NCT01254760|20586240|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
8351353|NCT01254760|20586239|P2|COMPLETED|Second Period, 5 Days of Wear||38
8351354|NCT01254760|20586240|P1|COMPLETED|Second Period, 5 Days of Wear||34
8351355|NCT01254760|20586239|P2|STARTED|Second Period, 5 Days of Wear||38
8351356|NCT01254760|20586240|P1|STARTED|Second Period, 5 Days of Wear||34
8351357|NCT01254760|20586239|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
8351358|NCT01254760|20586240|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
8351359|NCT01254760|20586239|P2|COMPLETED|First Period, 5 Days of Wear||38
8351360|NCT01254760|20586240|P1|COMPLETED|First Period, 5 Days of Wear||34
8351361|NCT01254760|20586239|P2|STARTED|First Period, 5 Days of Wear||38
8351362|NCT01254760|20586240|P1|STARTED|First Period, 5 Days of Wear||34
8351363|NCT01254747|20586258|P4|NOT COMPLETED|Overall Study||2
8351364|NCT01254747|20586259|P3|NOT COMPLETED|Overall Study||4
8351365|NCT01254747|20586260|P2|NOT COMPLETED|Overall Study||6
8351366|NCT01254747|20586261|P1|NOT COMPLETED|Overall Study||0
8351367|NCT01254747|20586258|P4|COMPLETED|Overall Study||28
8351368|NCT01254747|20586259|P3|COMPLETED|Overall Study||26
8351369|NCT01254747|20586260|P2|COMPLETED|Overall Study||23
8351370|NCT01254747|20586261|P1|COMPLETED|Overall Study||40
8351371|NCT01254747|20586258|P4|STARTED|Overall Study||30
8351372|NCT01254747|20586259|P3|STARTED|Overall Study||30
8351373|NCT01254747|20586260|P2|STARTED|Overall Study||29
8351374|NCT01254747|20586261|P1|STARTED|Overall Study||40
8351375|NCT01254721|20586301|P2|NOT COMPLETED|Overall Study||22
8351376|NCT01254721|20586302|P1|NOT COMPLETED|Overall Study||15
8351377|NCT01254721|20586301|P2|COMPLETED|Overall Study||42
8351378|NCT01254721|20586302|P1|COMPLETED|Overall Study||52
8351379|NCT01254721|20586301|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
8351380|NCT01254721|20586302|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
8351381|NCT01254669|20586312|P2|NOT COMPLETED|Overall Study||4
8351382|NCT01254669|20586313|P1|NOT COMPLETED|Overall Study||3
8351383|NCT01254669|20586312|P2|COMPLETED|Overall Study||96
8351384|NCT01254669|20586313|P1|COMPLETED|Overall Study||97
8351385|NCT01254669|20586312|P2|STARTED|Overall Study||100
8351386|NCT01254669|20586313|P1|STARTED|Overall Study||100
8351387|NCT01254656|20586324|P3|NOT COMPLETED|Overall Study||18
8351388|NCT01254656|20586325|P2|NOT COMPLETED|Overall Study||43
8351389|NCT01254656|20586326|P1|NOT COMPLETED|Overall Study||47
8351390|NCT01254656|20586324|P3|COMPLETED|Overall Study||0
8351391|NCT01254656|20586325|P2|COMPLETED|Overall Study||0
8351392|NCT01254656|20586326|P1|COMPLETED|Overall Study||0
8351393|NCT01254656|20586324|P3|Treated|Overall Study||18
8351394|NCT01254656|20586325|P2|Treated|Overall Study||43
8351395|NCT01254656|20586326|P1|Treated|Overall Study||47
8351396|NCT01254656|20586324|P3|STARTED|Overall Study||18
8351397|NCT01254656|20586325|P2|STARTED|Overall Study||43
8351398|NCT01254656|20586326|P1|STARTED|Overall Study||47
8351399|NCT01254643|20586352|P1|NOT COMPLETED|Overall Study||1
8351400|NCT01254643|20586352|P1|COMPLETED|Overall Study||99
8351401|NCT01254643|20586352|P1|Vaccination 3|Overall Study||99
8351402|NCT01254643|20586352|P1|Vaccination 2|Overall Study||99
8351403|NCT01254643|20586352|P1|Vaccination 1|Overall Study||100
8351404|NCT01254643|20586352|P1|STARTED|Overall Study||100
8351405|NCT01254630|20586364|P4|NOT COMPLETED|Overall Study||1285
8351406|NCT01254630|20586365|P3|NOT COMPLETED|Overall Study||812
8351407|NCT01254630|20586366|P2|NOT COMPLETED|Overall Study||1288
8351408|NCT01254630|20586367|P1|NOT COMPLETED|Overall Study||802
8351409|NCT01254630|20586364|P4|COMPLETED|Overall Study||0
8351410|NCT01254630|20586365|P3|COMPLETED|Overall Study||552
8351411|NCT01254630|20586366|P2|COMPLETED|Overall Study||0
8351412|NCT01254630|20586367|P1|COMPLETED|Overall Study||546
8351413|NCT01254630|20586364|P4|Received Vaccination 4|Overall Study||1160
8351414|NCT01254630|20586365|P3|Received Vaccination 4|Overall Study||1212
8351415|NCT01254630|20586366|P2|Received Vaccination 4|Overall Study||1145
8351416|NCT01254630|20586367|P1|Received Vaccination 4|Overall Study||1155
8351417|NCT01254630|20586364|P4|Received Vaccination 3|Overall Study||1194
8351418|NCT01254630|20586365|P3|Received Vaccination 3|Overall Study||1247
8351419|NCT01254630|20586366|P2|Received Vaccination 3|Overall Study||1178
8351420|NCT01254630|20586367|P1|Received Vaccination 3|Overall Study||1198
8351421|NCT01254630|20586364|P4|Received Vaccination 2|Overall Study||1226
8351422|NCT01254630|20586365|P3|Received Vaccination 2|Overall Study||1286
8351423|NCT01254630|20586366|P2|Received Vaccination 2|Overall Study||1217
8351424|NCT01254630|20586367|P1|Received Vaccination 2|Overall Study||1255
8351425|NCT01254630|20586364|P4|Received Vaccination 1|Overall Study||1275
8351426|NCT01254630|20586365|P3|Received Vaccination 1|Overall Study||1350
8351427|NCT01254630|20586366|P2|Received Vaccination 1|Overall Study||1277
8351428|NCT01254630|20586367|P1|Received Vaccination 1|Overall Study||1328
8351429|NCT01254630|20586364|P4|STARTED|Overall Study||1285
8351430|NCT01254630|20586365|P3|STARTED|Overall Study||1364
8351431|NCT01254630|20586366|P2|STARTED|Overall Study||1288
8351432|NCT01254630|20586367|P1|STARTED|Overall Study||1348
8351433|NCT01254604|20586387|P2|NOT COMPLETED|Overall Study||9
8351434|NCT01254604|20586388|P1|NOT COMPLETED|Overall Study||8
8351435|NCT01254604|20586387|P2|COMPLETED|Overall Study||86
8351436|NCT01254604|20586388|P1|COMPLETED|Overall Study||87
8351437|NCT01254604|20586387|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
8351438|NCT01254604|20586388|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
8351439|NCT01254604|20586387|P2|STARTED|Overall Study||95
8351440|NCT01254604|20586388|P1|STARTED|Overall Study||95
8351441|NCT01254565|20586406|P6|NOT COMPLETED|Overall Study||4
8351442|NCT01254565|20586407|P5|NOT COMPLETED|Overall Study||4
8351443|NCT01254565|20586408|P4|NOT COMPLETED|Overall Study||1
8351444|NCT01254565|20586409|P3|NOT COMPLETED|Overall Study||0
8351445|NCT01254565|20586410|P2|NOT COMPLETED|Overall Study||1
8351446|NCT01254565|20586411|P1|NOT COMPLETED|Overall Study||1
8351447|NCT01254565|20586406|P6|COMPLETED|Overall Study||13
8351448|NCT01254565|20586407|P5|COMPLETED|Overall Study||12
8351449|NCT01254565|20586408|P4|COMPLETED|Overall Study||20
8351450|NCT01254565|20586409|P3|COMPLETED|Overall Study||21
8351451|NCT01254565|20586410|P2|COMPLETED|Overall Study||6
8351452|NCT01254565|20586411|P1|COMPLETED|Overall Study||4
8351453|NCT01254565|20586406|P6|Received Treatment|Overall Study||13
8351454|NCT01254565|20586407|P5|Received Treatment|Overall Study||13
8351455|NCT01254565|20586408|P4|Received Treatment|Overall Study||21
8351456|NCT01254565|20586409|P3|Received Treatment|Overall Study||21
8351457|NCT01254565|20586410|P2|Received Treatment|Overall Study||6
8351458|NCT01254565|20586411|P1|Received Treatment|Overall Study||4
8351459|NCT01254565|20586406|P6|STARTED|Overall Study||17
8351460|NCT01254565|20586407|P5|STARTED|Overall Study||16
8351461|NCT01254565|20586408|P4|STARTED|Overall Study||21
8351462|NCT01254565|20586409|P3|STARTED|Overall Study||21
8351463|NCT01254565|20586410|P2|STARTED|Overall Study||7
8351464|NCT01254565|20586411|P1|STARTED|Overall Study||5
8351465|NCT01254552|20586461|P1|NOT COMPLETED|CCTA With Xenetix 350||6
8351466|NCT01254552|20586461|P1|COMPLETED|CCTA With Xenetix 350||322
8351467|NCT01254552|20586461|P1|STARTED|CCTA With Xenetix 350||328
8351468|NCT01254552|20586461|P1|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
8351469|NCT01254552|20586461|P1|COMPLETED|Delayed-enhanced MRI With Dotarem||328
8351470|NCT01254552|20586461|P1|STARTED|Delayed-enhanced MRI With Dotarem||348
8351471|NCT01254552|20586461|P1|NOT COMPLETED|Screening Visit||3
8351472|NCT01254552|20586461|P1|COMPLETED|Screening Visit||348
8351473|NCT01254552|20586461|P1|STARTED|Screening Visit||351
8351474|NCT01254422|20586471|P2|NOT COMPLETED|Overall Study||1
8351475|NCT01254422|20586472|P1|NOT COMPLETED|Overall Study||3
8351476|NCT01254422|20586471|P2|COMPLETED|Overall Study||50
8351477|NCT01254422|20586472|P1|COMPLETED|Overall Study||196
8351478|NCT01254422|20586471|P2|STARTED|Overall Study||51
8351479|NCT01254422|20586472|P1|STARTED|Overall Study||199
8351510|NCT01254344|20586572|P2|NOT COMPLETED|Overall Study||19
8351511|NCT01254344|20586573|P1|NOT COMPLETED|Overall Study||13
8351512|NCT01254344|20586572|P2|COMPLETED|Overall Study||281
8351513|NCT01254344|20586573|P1|COMPLETED|Overall Study||286
8351514|NCT01254344|20586572|P2|Treated|Overall Study||297
8351515|NCT01254344|20586573|P1|Treated|Overall Study||290
8351516|NCT01254344|20586572|P2|STARTED|Overall Study||300
8351517|NCT01254344|20586573|P1|STARTED|Overall Study||299
8351518|NCT01254331|20586581|P1|NOT COMPLETED|Extension Phase||4
8351519|NCT01254331|20586581|P1|COMPLETED|Extension Phase||41
8351520|NCT01254331|20586581|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
8351521|NCT01254331|20586581|P1|NOT COMPLETED|Initial Phase||5
8351522|NCT01254331|20586581|P1|COMPLETED|Initial Phase||46
8351523|NCT01254331|20586581|P1|STARTED|Initial Phase||51
8351524|NCT01254318|20586599|P1|NOT COMPLETED|Overall Study||52
8351525|NCT01254318|20586599|P1|COMPLETED|Overall Study|Alive at end of study|78
8351526|NCT01254318|20586599|P1|STARTED|Overall Study|Alive at start of study|130
8351527|NCT01254305|20586608|P3|NOT COMPLETED|Overall Study||17
8351528|NCT01254305|20586609|P2|NOT COMPLETED|Overall Study||18
8351529|NCT01254305|20586610|P1|NOT COMPLETED|Overall Study||22
8351530|NCT01254305|20586608|P3|COMPLETED|Overall Study||62
8351531|NCT01254305|20586609|P2|COMPLETED|Overall Study||72
8351532|NCT01254305|20586610|P1|COMPLETED|Overall Study||71
8351533|NCT01254305|20586608|P3|Safety Population|Overall Study||77
8351534|NCT01254305|20586609|P2|Safety Population|Overall Study||85
8351535|NCT01254305|20586610|P1|Safety Population|Overall Study||89
8351536|NCT01254305|20586608|P3|STARTED|Overall Study||79
8351537|NCT01254305|20586609|P2|STARTED|Overall Study||90
8351538|NCT01254305|20586610|P1|STARTED|Overall Study||93
8351539|NCT01254292|20586626|P2|NOT COMPLETED|LCS12 Extension Phase||0
8351540|NCT01254292|20586627|P1|NOT COMPLETED|LCS12 Extension Phase||37
8351541|NCT01254292|20586626|P2|COMPLETED|LCS12 Extension Phase||0
8351542|NCT01254292|20586627|P1|COMPLETED|LCS12 Extension Phase||163
8351543|NCT01254292|20586626|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
8351544|NCT01254292|20586627|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
8351545|NCT01254292|20586626|P2|NOT COMPLETED|Comparative Phase||81
8351546|NCT01254292|20586627|P1|NOT COMPLETED|Comparative Phase||55
8351547|NCT01254292|20586626|P2|COMPLETED|Comparative Phase||204
8351548|NCT01254292|20586627|P1|COMPLETED|Comparative Phase||227
8351549|NCT01254292|20586626|P2|Participants Received Treatment|Comparative Phase|safety population|281
8351550|NCT01254292|20586627|P1|Participants Received Treatment|Comparative Phase|safety population|279
8351551|NCT01254292|20586626|P2|STARTED|Comparative Phase||285
8351552|NCT01254292|20586627|P1|STARTED|Comparative Phase||282
8351553|NCT01254214|20586689|P2|NOT COMPLETED|Overall Study||1
8351554|NCT01254214|20586690|P1|NOT COMPLETED|Overall Study||3
8351555|NCT01254214|20586689|P2|COMPLETED|Overall Study||27
8351556|NCT01254214|20586690|P1|COMPLETED|Overall Study||24
8351557|NCT01254214|20586689|P2|STARTED|Overall Study||28
8351558|NCT01254214|20586690|P1|STARTED|Overall Study||27
8351559|NCT01254188|20586704|P1|NOT COMPLETED|Overall Study||93
8351560|NCT01254188|20586704|P1|COMPLETED|Overall Study||328
8351561|NCT01254188|20586704|P1|STARTED|Overall Study||421
8351562|NCT01254045|20586715|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351563|NCT01254045|20586716|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351564|NCT01254045|20586717|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351565|NCT01254045|20586718|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351566|NCT01254045|20586719|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351567|NCT01254045|20586720|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351568|NCT01254045|20586715|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351569|NCT01254045|20586716|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351570|NCT01254045|20586717|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351571|NCT01254045|20586718|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
8351572|NCT01254045|20586719|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
8351573|NCT01254045|20586720|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351574|NCT01254045|20586715|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351575|NCT01254045|20586716|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351576|NCT01254045|20586717|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351577|NCT01254045|20586718|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
8351578|NCT01254045|20586719|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
8351579|NCT01254045|20586720|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351580|NCT01254045|20586715|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351581|NCT01254045|20586716|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351582|NCT01254045|20586717|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351583|NCT01254045|20586718|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351584|NCT01254045|20586719|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351585|NCT01254045|20586720|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351586|NCT01254045|20586715|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351587|NCT01254045|20586716|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351588|NCT01254045|20586717|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351589|NCT01254045|20586718|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
8351590|NCT01254045|20586719|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
8351591|NCT01254045|20586720|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351592|NCT01254045|20586715|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351593|NCT01254045|20586716|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351594|NCT01254045|20586717|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351595|NCT01254045|20586718|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
8351596|NCT01254045|20586719|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
8351597|NCT01254045|20586720|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351598|NCT01254045|20586715|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351599|NCT01254045|20586716|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351600|NCT01254045|20586717|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351601|NCT01254045|20586718|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351602|NCT01254045|20586719|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351603|NCT01254045|20586720|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351604|NCT01254045|20586715|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351605|NCT01254045|20586716|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351606|NCT01254045|20586717|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351607|NCT01254045|20586718|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
8351608|NCT01254045|20586719|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
8351609|NCT01254045|20586720|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351610|NCT01254045|20586715|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
8351611|NCT01254045|20586716|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
8351612|NCT01254045|20586717|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
8351613|NCT01254045|20586718|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
8351614|NCT01254045|20586719|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
8351615|NCT01254045|20586720|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
8351616|NCT01254019|20586733|P2|NOT COMPLETED|Overall Study||4
8351617|NCT01254019|20586734|P1|NOT COMPLETED|Overall Study||1
8351618|NCT01254019|20586733|P2|COMPLETED|Overall Study||121
8351619|NCT01254019|20586734|P1|COMPLETED|Overall Study||60
8351620|NCT01254019|20586733|P2|STARTED|Overall Study||125
8351621|NCT01254019|20586734|P1|STARTED|Overall Study||61
8351622|NCT01253980|20586787|P2|NOT COMPLETED|Overall Study||0
8351623|NCT01253980|20586788|P1|NOT COMPLETED|Overall Study||0
8351624|NCT01253980|20586787|P2|COMPLETED|Overall Study||39
8351625|NCT01253980|20586788|P1|COMPLETED|Overall Study||35
8351626|NCT01253980|20586787|P2|STARTED|Overall Study||39
8351627|NCT01253980|20586788|P1|STARTED|Overall Study||35
8351628|NCT01253902|20586797|P3|NOT COMPLETED|Overall Study||4
8351629|NCT01253902|20586798|P2|NOT COMPLETED|Overall Study||2
8351630|NCT01253902|20586799|P1|NOT COMPLETED|Overall Study||5
8351631|NCT01253902|20586797|P3|COMPLETED|Overall Study||51
8351632|NCT01253902|20586798|P2|COMPLETED|Overall Study||51
8351633|NCT01253902|20586799|P1|COMPLETED|Overall Study||51
8351634|NCT01253902|20586797|P3|STARTED|Overall Study||55
8351635|NCT01253902|20586798|P2|STARTED|Overall Study||53
8351636|NCT01253902|20586799|P1|STARTED|Overall Study||56
8351637|NCT01253824|20586815|P2|NOT COMPLETED|Overall Study||0
8351638|NCT01253824|20586816|P1|NOT COMPLETED|Overall Study||0
8351639|NCT01253824|20586815|P2|COMPLETED|Overall Study||7
8351640|NCT01253824|20586816|P1|COMPLETED|Overall Study||7
8351641|NCT01253824|20586815|P2|STARTED|Overall Study||7
8351642|NCT01253824|20586816|P1|STARTED|Overall Study||7
8351643|NCT01253811|20586828|P1|NOT COMPLETED|Overall Study||1
8351644|NCT01253811|20586828|P1|COMPLETED|Overall Study||5
8351645|NCT01253811|20586828|P1|Exposed|Overall Study||6
8351646|NCT01253811|20586828|P1|STARTED|Overall Study||6
8351647|NCT01253642|20586847|P1|NOT COMPLETED|Overall Study||5
8351648|NCT01253642|20586847|P1|COMPLETED|Overall Study||6
8351649|NCT01253642|20586847|P1|STARTED|Overall Study||11
8351650|NCT01253577|20586859|P1|NOT COMPLETED|Overall Study||3
8351651|NCT01253577|20586859|P1|COMPLETED|Overall Study||102
8351652|NCT01253577|20586859|P1|STARTED|Overall Study||105
8351653|NCT01253564|20586867|P1|NOT COMPLETED|Overall Study||24
8351654|NCT01253564|20586867|P1|COMPLETED|Overall Study||0
8351655|NCT01253564|20586867|P1|STARTED|Overall Study||24
8351656|NCT01253525|20586884|P1|NOT COMPLETED|Overall Study||0
8351657|NCT01253525|20586884|P1|COMPLETED|Overall Study||6
8351658|NCT01253525|20586884|P1|Received Any Quantity of Study Drug|Overall Study||6
8351659|NCT01253525|20586884|P1|STARTED|Overall Study||6
8351660|NCT01253460|20586911|P1|NOT COMPLETED|Overall Study||0
8351661|NCT01253460|20586911|P1|COMPLETED|Overall Study||18
8351662|NCT01253460|20586911|P1|STARTED|Overall Study||18
8351663|NCT01253447|20586916|P1|NOT COMPLETED|Overall Study||2
8351664|NCT01253447|20586916|P1|COMPLETED|Overall Study||17
8351665|NCT01253447|20586916|P1|STARTED|Overall Study||19
8351666|NCT01253421|20586926|P5|NOT COMPLETED|Drug+Scanning Visit||1
8351667|NCT01253421|20586927|P4|NOT COMPLETED|Drug+Scanning Visit||0
8351668|NCT01253421|20586928|P3|NOT COMPLETED|Drug+Scanning Visit||0
8351669|NCT01253421|20586929|P2|NOT COMPLETED|Drug+Scanning Visit||0
8351670|NCT01253421|20586930|P1|NOT COMPLETED|Drug+Scanning Visit||0
8351671|NCT01253421|20586926|P5|COMPLETED|Drug+Scanning Visit||14
8351672|NCT01253421|20586927|P4|COMPLETED|Drug+Scanning Visit||16
8351673|NCT01253421|20586928|P3|COMPLETED|Drug+Scanning Visit||14
8351674|NCT01253421|20586929|P2|COMPLETED|Drug+Scanning Visit||15
8351675|NCT01253421|20586930|P1|COMPLETED|Drug+Scanning Visit||0
8351676|NCT01253421|20586926|P5|Received Drug Challenge|Drug+Scanning Visit||15
8351677|NCT01253421|20586927|P4|Received Drug Challenge|Drug+Scanning Visit||16
8351678|NCT01253421|20586928|P3|Received Drug Challenge|Drug+Scanning Visit||14
8351679|NCT01253421|20586929|P2|Received Drug Challenge|Drug+Scanning Visit||15
8351680|NCT01253421|20586930|P1|Received Drug Challenge|Drug+Scanning Visit||0
8351681|NCT01253421|20586926|P5|STARTED|Drug+Scanning Visit||15
8351682|NCT01253421|20586927|P4|STARTED|Drug+Scanning Visit||16
8351683|NCT01253421|20586928|P3|STARTED|Drug+Scanning Visit||14
8351684|NCT01253421|20586929|P2|STARTED|Drug+Scanning Visit||15
8351685|NCT01253421|20586930|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
8351686|NCT01253421|20586926|P5|NOT COMPLETED|Assessment and Scheduling||0
8351687|NCT01253421|20586927|P4|NOT COMPLETED|Assessment and Scheduling||0
8351688|NCT01253421|20586928|P3|NOT COMPLETED|Assessment and Scheduling||0
8351689|NCT01253421|20586929|P2|NOT COMPLETED|Assessment and Scheduling||0
8351690|NCT01253421|20586930|P1|NOT COMPLETED|Assessment and Scheduling||99
8351691|NCT01253421|20586926|P5|COMPLETED|Assessment and Scheduling||0
8351692|NCT01253421|20586927|P4|COMPLETED|Assessment and Scheduling||0
8351693|NCT01253421|20586928|P3|COMPLETED|Assessment and Scheduling||0
8351694|NCT01253421|20586929|P2|COMPLETED|Assessment and Scheduling||0
8351695|NCT01253421|20586930|P1|COMPLETED|Assessment and Scheduling||60
8351696|NCT01253421|20586926|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351697|NCT01253421|20586927|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351698|NCT01253421|20586928|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351699|NCT01253421|20586929|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351700|NCT01253421|20586930|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
8351701|NCT01253421|20586926|P5|Eligible After Screening Visit|Assessment and Scheduling||0
8351702|NCT01253421|20586927|P4|Eligible After Screening Visit|Assessment and Scheduling||0
8351703|NCT01253421|20586928|P3|Eligible After Screening Visit|Assessment and Scheduling||0
8351704|NCT01253421|20586929|P2|Eligible After Screening Visit|Assessment and Scheduling||0
8351705|NCT01253421|20586930|P1|Eligible After Screening Visit|Assessment and Scheduling||85
8351706|NCT01253421|20586926|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351707|NCT01253421|20586927|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351708|NCT01253421|20586928|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351709|NCT01253421|20586929|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351710|NCT01253421|20586930|P1|STARTED|Assessment and Scheduling||159
8351711|NCT01253408|20586979|P3|NOT COMPLETED|Overall Study||0
8351712|NCT01253408|20586980|P2|NOT COMPLETED|Overall Study||1
8351713|NCT01253408|20586981|P1|NOT COMPLETED|Overall Study||0
8351714|NCT01253408|20586979|P3|COMPLETED|Overall Study||13
8351715|NCT01253408|20586980|P2|COMPLETED|Overall Study||12
8351716|NCT01253408|20586981|P1|COMPLETED|Overall Study||10
8351717|NCT01253408|20586979|P3|STARTED|Overall Study||13
8351718|NCT01253408|20586980|P2|STARTED|Overall Study||13
8351719|NCT01253408|20586981|P1|STARTED|Overall Study||10
8351720|NCT01253369|20587004|P1|NOT COMPLETED|Overall Study||33
8351721|NCT01253369|20587004|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8351722|NCT01253369|20587004|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
8351723|NCT01253369|20587004|P1|STARTED|Overall Study||33
8351724|NCT01253343|20587011|P2|NOT COMPLETED|Overall Study||0
8351725|NCT01253343|20587012|P1|NOT COMPLETED|Overall Study||0
8351726|NCT01253343|20587011|P2|COMPLETED|Overall Study||8
8351727|NCT01253343|20587012|P1|COMPLETED|Overall Study||9
8351728|NCT01253343|20587011|P2|STARTED|Overall Study||8
8351729|NCT01253343|20587012|P1|STARTED|Overall Study||9
8351730|NCT01253317|20587034|P1|NOT COMPLETED|Overall Study||2
8351731|NCT01253317|20587034|P1|COMPLETED|Overall Study||10
8351732|NCT01253317|20587034|P1|STARTED|Overall Study||12
8351733|NCT01253304|20587046|P4|NOT COMPLETED|Overall Study||1
8351734|NCT01253304|20587047|P3|NOT COMPLETED|Overall Study||0
8351735|NCT01253304|20587048|P2|NOT COMPLETED|Overall Study||0
8351736|NCT01253304|20587049|P1|NOT COMPLETED|Overall Study||0
8351737|NCT01253304|20587046|P4|COMPLETED|Overall Study||2
8351738|NCT01253304|20587047|P3|COMPLETED|Overall Study||6
8351739|NCT01253304|20587048|P2|COMPLETED|Overall Study||6
8351740|NCT01253304|20587049|P1|COMPLETED|Overall Study||11
8351741|NCT01253304|20587046|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8351742|NCT01253304|20587047|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8351743|NCT01253304|20587048|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8351744|NCT01253304|20587049|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
8351745|NCT01253304|20587046|P4|STARTED|Overall Study||3
8351746|NCT01253304|20587047|P3|STARTED|Overall Study||6
8351747|NCT01253304|20587048|P2|STARTED|Overall Study||6
8351748|NCT01253304|20587049|P1|STARTED|Overall Study||11
8351749|NCT01253291|20587088|P5|NOT COMPLETED|Overall Study||2
8351750|NCT01253291|20587089|P4|NOT COMPLETED|Overall Study||0
8351751|NCT01253291|20587090|P3|NOT COMPLETED|Overall Study||0
8351752|NCT01253291|20587091|P2|NOT COMPLETED|Overall Study||2
8351753|NCT01253291|20587092|P1|NOT COMPLETED|Overall Study||4
8351754|NCT01253291|20587088|P5|COMPLETED|Overall Study||3
8351755|NCT01253291|20587089|P4|COMPLETED|Overall Study||5
8351756|NCT01253291|20587090|P3|COMPLETED|Overall Study||4
8351757|NCT01253291|20587091|P2|COMPLETED|Overall Study||4
8351758|NCT01253291|20587092|P1|COMPLETED|Overall Study||2
8351759|NCT01253291|20587088|P5|Received Study Drug During BCDL|Overall Study||5
8351760|NCT01253291|20587089|P4|Received Study Drug During BCDL|Overall Study||5
8351761|NCT01253291|20587090|P3|Received Study Drug During BCDL|Overall Study||4
8351762|NCT01253291|20587091|P2|Received Study Drug During BCDL|Overall Study||6
8351763|NCT01253291|20587092|P1|Received Study Drug During BCDL|Overall Study||6
8351764|NCT01253291|20587088|P5|STARTED|Overall Study||5
8351765|NCT01253291|20587089|P4|STARTED|Overall Study||5
8351766|NCT01253291|20587090|P3|STARTED|Overall Study||4
8351767|NCT01253291|20587091|P2|STARTED|Overall Study||6
8351768|NCT01253291|20587092|P1|STARTED|Overall Study||6
8351769|NCT01253265|20587116|P5|NOT COMPLETED|Overall Study||1
8351770|NCT01253265|20587117|P4|NOT COMPLETED|Overall Study||0
8351771|NCT01253265|20587118|P3|NOT COMPLETED|Overall Study||0
8351772|NCT01253265|20587119|P2|NOT COMPLETED|Overall Study||0
8351773|NCT01253265|20587120|P1|NOT COMPLETED|Overall Study||1
8351774|NCT01253265|20587116|P5|COMPLETED|Overall Study||7
8351775|NCT01253265|20587117|P4|COMPLETED|Overall Study||6
8351776|NCT01253265|20587118|P3|COMPLETED|Overall Study||6
8351777|NCT01253265|20587119|P2|COMPLETED|Overall Study||6
8351778|NCT01253265|20587120|P1|COMPLETED|Overall Study||5
8351779|NCT01253265|20587116|P5|STARTED|Overall Study||8
8351780|NCT01253265|20587117|P4|STARTED|Overall Study||6
8351781|NCT01253265|20587118|P3|STARTED|Overall Study||6
8351782|NCT01253265|20587119|P2|STARTED|Overall Study||6
8351783|NCT01253265|20587120|P1|STARTED|Overall Study||6
8351784|NCT01253226|20587169|P5|NOT COMPLETED|Overall Study||2
8351785|NCT01253226|20587170|P4|NOT COMPLETED|Overall Study||1
8351786|NCT01253226|20587171|P3|NOT COMPLETED|Overall Study||1
8351787|NCT01253226|20587172|P2|NOT COMPLETED|Overall Study||1
8351788|NCT01253226|20587173|P1|NOT COMPLETED|Overall Study||0
8351789|NCT01253226|20587169|P5|COMPLETED|Overall Study||6
8351790|NCT01253226|20587170|P4|COMPLETED|Overall Study||5
8351791|NCT01253226|20587171|P3|COMPLETED|Overall Study||5
8351792|NCT01253226|20587172|P2|COMPLETED|Overall Study||5
8351793|NCT01253226|20587173|P1|COMPLETED|Overall Study||6
8351794|NCT01253226|20587169|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
8351795|NCT01253226|20587170|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8351796|NCT01253226|20587171|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8351797|NCT01253226|20587172|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8351798|NCT01253226|20587173|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8351799|NCT01253226|20587169|P5|STARTED|Overall Study||8
8351800|NCT01253226|20587170|P4|STARTED|Overall Study||6
8351801|NCT01253226|20587171|P3|STARTED|Overall Study||6
8351802|NCT01253226|20587172|P2|STARTED|Overall Study||6
8351803|NCT01253226|20587173|P1|STARTED|Overall Study||6
8351804|NCT01253200|20587233|P5|NOT COMPLETED|Overall Study||5
8351805|NCT01253200|20587234|P4|NOT COMPLETED|Overall Study||5
8351806|NCT01253200|20587235|P3|NOT COMPLETED|Overall Study||2
8351807|NCT01253200|20587236|P2|NOT COMPLETED|Overall Study||19
8351808|NCT01253200|20587237|P1|NOT COMPLETED|Overall Study||21
8351809|NCT01253200|20587233|P5|COMPLETED|Overall Study||0
8351810|NCT01253200|20587234|P4|COMPLETED|Overall Study||12
8351811|NCT01253200|20587235|P3|COMPLETED|Overall Study||28
8351812|NCT01253200|20587236|P2|COMPLETED|Overall Study||106
8351813|NCT01253200|20587237|P1|COMPLETED|Overall Study||104
8351814|NCT01253200|20587233|P5|3 Month Follow-up|Overall Study||0
8351815|NCT01253200|20587234|P4|3 Month Follow-up|Overall Study||12
8351816|NCT01253200|20587235|P3|3 Month Follow-up|Overall Study||28
8351817|NCT01253200|20587236|P2|3 Month Follow-up|Overall Study||106
8351818|NCT01253200|20587237|P1|3 Month Follow-up|Overall Study||104
8351819|NCT01253200|20587233|P5|10 Day Follow-up|Overall Study||0
8351820|NCT01253200|20587234|P4|10 Day Follow-up|Overall Study||12
8351821|NCT01253200|20587235|P3|10 Day Follow-up|Overall Study||28
8351822|NCT01253200|20587236|P2|10 Day Follow-up|Overall Study||111
8351823|NCT01253200|20587237|P1|10 Day Follow-up|Overall Study||106
8351824|NCT01253200|20587233|P5|Procedure|Overall Study||0
8351825|NCT01253200|20587234|P4|Procedure|Overall Study||12
8351826|NCT01253200|20587235|P3|Procedure|Overall Study||28
8351827|NCT01253200|20587236|P2|Procedure|Overall Study||111
8351828|NCT01253200|20587237|P1|Procedure|Overall Study||109
8351829|NCT01253200|20587233|P5|STARTED|Overall Study||5
8351830|NCT01253200|20587234|P4|STARTED|Overall Study||17
8351831|NCT01253200|20587235|P3|STARTED|Overall Study||30
8351832|NCT01253200|20587236|P2|STARTED|Overall Study||125
8351833|NCT01253200|20587237|P1|STARTED|Overall Study||125
8351834|NCT01253187|20587252|P6|NOT COMPLETED|Period 3||0
8351835|NCT01253187|20587253|P5|NOT COMPLETED|Period 3||1
8351836|NCT01253187|20587254|P4|NOT COMPLETED|Period 3||0
8351837|NCT01253187|20587255|P3|NOT COMPLETED|Period 3||0
8351838|NCT01253187|20587256|P2|NOT COMPLETED|Period 3||1
8351839|NCT01253187|20587257|P1|NOT COMPLETED|Period 3||1
8351840|NCT01253187|20587252|P6|COMPLETED|Period 3||6
8351841|NCT01253187|20587253|P5|COMPLETED|Period 3||7
8351842|NCT01253187|20587254|P4|COMPLETED|Period 3||7
8351843|NCT01253187|20587255|P3|COMPLETED|Period 3||7
8351844|NCT01253187|20587256|P2|COMPLETED|Period 3||7
8351845|NCT01253187|20587257|P1|COMPLETED|Period 3||6
8351846|NCT01253187|20587252|P6|STARTED|Period 3||6
8351847|NCT01253187|20587253|P5|STARTED|Period 3||8
8351848|NCT01253187|20587254|P4|STARTED|Period 3||7
8351849|NCT01253187|20587255|P3|STARTED|Period 3||7
8351850|NCT01253187|20587256|P2|STARTED|Period 3||8
8351851|NCT01253187|20587257|P1|STARTED|Period 3||7
8351852|NCT01253187|20587252|P6|NOT COMPLETED|Period 2||0
8351853|NCT01253187|20587253|P5|NOT COMPLETED|Period 2||1
8351854|NCT01253187|20587254|P4|NOT COMPLETED|Period 2||0
8351855|NCT01253187|20587255|P3|NOT COMPLETED|Period 2||0
8351856|NCT01253187|20587256|P2|NOT COMPLETED|Period 2||0
8351857|NCT01253187|20587257|P1|NOT COMPLETED|Period 2||0
8351858|NCT01253187|20587252|P6|COMPLETED|Period 2||6
8351859|NCT01253187|20587253|P5|COMPLETED|Period 2||8
8351860|NCT01253187|20587254|P4|COMPLETED|Period 2||7
8351861|NCT01253187|20587255|P3|COMPLETED|Period 2||7
8351862|NCT01253187|20587256|P2|COMPLETED|Period 2||8
8351863|NCT01253187|20587257|P1|COMPLETED|Period 2||7
8351864|NCT01253187|20587252|P6|STARTED|Period 2||6
8351865|NCT01253187|20587253|P5|STARTED|Period 2||9
8351866|NCT01253187|20587254|P4|STARTED|Period 2||7
8351867|NCT01253187|20587255|P3|STARTED|Period 2||7
8351868|NCT01253187|20587256|P2|STARTED|Period 2||8
8351869|NCT01253187|20587257|P1|STARTED|Period 2||7
8351870|NCT01253187|20587252|P6|NOT COMPLETED|Period 1||0
8351871|NCT01253187|20587253|P5|NOT COMPLETED|Period 1||0
8351872|NCT01253187|20587254|P4|NOT COMPLETED|Period 1||0
8351873|NCT01253187|20587255|P3|NOT COMPLETED|Period 1||0
8351874|NCT01253187|20587256|P2|NOT COMPLETED|Period 1||0
8351875|NCT01253187|20587257|P1|NOT COMPLETED|Period 1||0
8351876|NCT01253187|20587252|P6|COMPLETED|Period 1||6
8351877|NCT01253187|20587253|P5|COMPLETED|Period 1||9
8351878|NCT01253187|20587254|P4|COMPLETED|Period 1||7
8351879|NCT01253187|20587255|P3|COMPLETED|Period 1||7
8351880|NCT01253187|20587256|P2|COMPLETED|Period 1||8
8351881|NCT01253187|20587257|P1|COMPLETED|Period 1||7
8351882|NCT01253187|20587252|P6|STARTED|Period 1||6
8351883|NCT01253187|20587253|P5|STARTED|Period 1||9
8351884|NCT01253187|20587254|P4|STARTED|Period 1||7
8351885|NCT01253187|20587255|P3|STARTED|Period 1||7
8351886|NCT01253187|20587256|P2|STARTED|Period 1||8
8351887|NCT01253187|20587257|P1|STARTED|Period 1||7
8351888|NCT01253174|20587286|P6|NOT COMPLETED|Period 3||0
8351889|NCT01253174|20587287|P5|NOT COMPLETED|Period 3||1
8351890|NCT01253174|20587288|P4|NOT COMPLETED|Period 3||0
8351891|NCT01253174|20587289|P3|NOT COMPLETED|Period 3||1
8351892|NCT01253174|20587290|P2|NOT COMPLETED|Period 3||1
8351893|NCT01253174|20587291|P1|NOT COMPLETED|Period 3||0
8351894|NCT01253174|20587286|P6|COMPLETED|Period 3||7
8351895|NCT01253174|20587287|P5|COMPLETED|Period 3||7
8351896|NCT01253174|20587288|P4|COMPLETED|Period 3||7
8351897|NCT01253174|20587289|P3|COMPLETED|Period 3||6
8351898|NCT01253174|20587290|P2|COMPLETED|Period 3||8
8351899|NCT01253174|20587291|P1|COMPLETED|Period 3||6
8351900|NCT01253174|20587286|P6|STARTED|Period 3||7
8351901|NCT01253174|20587287|P5|STARTED|Period 3||8
8351902|NCT01253174|20587288|P4|STARTED|Period 3||7
8351903|NCT01253174|20587289|P3|STARTED|Period 3||7
8351904|NCT01253174|20587290|P2|STARTED|Period 3||9
8351905|NCT01253174|20587291|P1|STARTED|Period 3||6
8351906|NCT01253174|20587286|P6|NOT COMPLETED|Period 2||0
8351907|NCT01253174|20587287|P5|NOT COMPLETED|Period 2||0
8351908|NCT01253174|20587288|P4|NOT COMPLETED|Period 2||0
8351909|NCT01253174|20587289|P3|NOT COMPLETED|Period 2||1
8351910|NCT01253174|20587290|P2|NOT COMPLETED|Period 2||0
8351911|NCT01253174|20587291|P1|NOT COMPLETED|Period 2||0
8351912|NCT01253174|20587286|P6|COMPLETED|Period 2||7
8351913|NCT01253174|20587287|P5|COMPLETED|Period 2||8
8351914|NCT01253174|20587288|P4|COMPLETED|Period 2||7
8351915|NCT01253174|20587289|P3|COMPLETED|Period 2||7
8351916|NCT01253174|20587290|P2|COMPLETED|Period 2||9
8351917|NCT01253174|20587291|P1|COMPLETED|Period 2||6
8351918|NCT01253174|20587286|P6|STARTED|Period 2||7
8351919|NCT01253174|20587287|P5|STARTED|Period 2||8
8351920|NCT01253174|20587288|P4|STARTED|Period 2||7
8351921|NCT01253174|20587289|P3|STARTED|Period 2||8
8351922|NCT01253174|20587290|P2|STARTED|Period 2||9
8351923|NCT01253174|20587291|P1|STARTED|Period 2||6
8351924|NCT01253174|20587286|P6|NOT COMPLETED|Period 1||0
8351925|NCT01253174|20587287|P5|NOT COMPLETED|Period 1||1
8351926|NCT01253174|20587288|P4|NOT COMPLETED|Period 1||0
8351927|NCT01253174|20587289|P3|NOT COMPLETED|Period 1||1
8351928|NCT01253174|20587290|P2|NOT COMPLETED|Period 1||1
8351929|NCT01253174|20587291|P1|NOT COMPLETED|Period 1||0
8351930|NCT01253174|20587286|P6|COMPLETED|Period 1||7
8351931|NCT01253174|20587287|P5|COMPLETED|Period 1||8
8351932|NCT01253174|20587288|P4|COMPLETED|Period 1||7
8351933|NCT01253174|20587289|P3|COMPLETED|Period 1||8
8351934|NCT01253174|20587290|P2|COMPLETED|Period 1||9
8351935|NCT01253174|20587291|P1|COMPLETED|Period 1||6
8351936|NCT01253174|20587286|P6|STARTED|Period 1||7
8351937|NCT01253174|20587287|P5|STARTED|Period 1||9
8351938|NCT01253174|20587288|P4|STARTED|Period 1||7
8351939|NCT01253174|20587289|P3|STARTED|Period 1||9
8351940|NCT01253174|20587290|P2|STARTED|Period 1||10
8351941|NCT01253174|20587291|P1|STARTED|Period 1||6
8351942|NCT01253148|20587320|P1|NOT COMPLETED|Overall Study||0
8351943|NCT01253148|20587320|P1|COMPLETED|Overall Study||25
8351944|NCT01253148|20587320|P1|STARTED|Overall Study||25
8351945|NCT01253135|20587326|P1|NOT COMPLETED|Amended Protocol||1
8351946|NCT01253135|20587326|P1|COMPLETED|Amended Protocol||24
8351947|NCT01253135|20587326|P1|STARTED|Amended Protocol||25
8351948|NCT01253135|20587326|P1|NOT COMPLETED|Original Protocol||15
8351949|NCT01253135|20587326|P1|COMPLETED|Original Protocol||0
8351950|NCT01253135|20587326|P1|STARTED|Original Protocol||15
8351951|NCT01253070|20587334|P1|NOT COMPLETED|Overall Study||0
8351952|NCT01253070|20587334|P1|COMPLETED|Overall Study||54
8351953|NCT01253070|20587334|P1|STARTED|Overall Study||54
8351954|NCT01253044|20587345|P2|NOT COMPLETED|Overall Study||29
8351955|NCT01253044|20587346|P1|NOT COMPLETED|Overall Study||38
8351956|NCT01253044|20587345|P2|COMPLETED|Overall Study||51
8351957|NCT01253044|20587346|P1|COMPLETED|Overall Study||42
8351958|NCT01253044|20587345|P2|STARTED|Overall Study||80
8351959|NCT01253044|20587346|P1|STARTED|Overall Study||80
8351960|NCT01253018|20587356|P2|NOT COMPLETED|Overall Study||2
8351961|NCT01253018|20587357|P1|NOT COMPLETED|Overall Study||4
8351962|NCT01253018|20587356|P2|COMPLETED|Overall Study||21
8351963|NCT01253018|20587357|P1|COMPLETED|Overall Study||18
8351964|NCT01253018|20587356|P2|STARTED|Overall Study||23
8351965|NCT01253018|20587357|P1|STARTED|Overall Study||22
8351966|NCT01252966|20587371|P2|NOT COMPLETED|Overall Study||13
8351967|NCT01252966|20587372|P1|NOT COMPLETED|Overall Study||23
8351968|NCT01252966|20587371|P2|COMPLETED|Overall Study||92
8351969|NCT01252966|20587372|P1|COMPLETED|Overall Study||85
8351970|NCT01252966|20587371|P2|STARTED|Overall Study||105
8351971|NCT01252966|20587372|P1|STARTED|Overall Study||108
8351972|NCT01252953|20587388|P2|NOT COMPLETED|Overall Study||38
8351973|NCT01252953|20587389|P1|NOT COMPLETED|Overall Study||38
8351974|NCT01252953|20587388|P2|COMPLETED|Overall Study||15186
8351975|NCT01252953|20587389|P1|COMPLETED|Overall Study||15187
8351976|NCT01252953|20587388|P2|STARTED|Overall Study||15224
8351977|NCT01252953|20587389|P1|STARTED|Overall Study||15225
8351978|NCT01252940|20587403|P2|NOT COMPLETED|Extension Phase||3
8351979|NCT01252940|20587404|P1|NOT COMPLETED|Extension Phase||10
8351980|NCT01252940|20587403|P2|COMPLETED|Extension Phase||46
8351981|NCT01252940|20587404|P1|COMPLETED|Extension Phase||100
8351982|NCT01252940|20587403|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
8351983|NCT01252940|20587404|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
8351984|NCT01252940|20587403|P2|NOT COMPLETED|Main Study Phase||12
8351985|NCT01252940|20587404|P1|NOT COMPLETED|Main Study Phase||26
8352078|NCT01252134|20587705|P4|COMPLETED|Period 3, 8 Hours||5
8351986|NCT01252940|20587403|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
8351987|NCT01252940|20587404|P1|COMPLETED|Main Study Phase||295
8351988|NCT01252940|20587403|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
8351989|NCT01252940|20587404|P1|Completed 24 Weeks|Main Study Phase||0
8351990|NCT01252940|20587403|P2|STARTED|Main Study Phase||161
8351991|NCT01252940|20587404|P1|STARTED|Main Study Phase||321
8351992|NCT01252810|20587435|P2|NOT COMPLETED|Overall Study||3
8351993|NCT01252810|20587436|P1|NOT COMPLETED|Overall Study||14
8351994|NCT01252810|20587435|P2|COMPLETED|Overall Study||139
8351995|NCT01252810|20587436|P1|COMPLETED|Overall Study||128
8351996|NCT01252810|20587435|P2|STARTED|Overall Study||142
8351997|NCT01252810|20587436|P1|STARTED|Overall Study||142
8351998|NCT01252745|20587449|P3|NOT COMPLETED|Overall Study||0
8351999|NCT01252745|20587450|P2|NOT COMPLETED|Overall Study||0
8352000|NCT01252745|20587451|P1|NOT COMPLETED|Overall Study||0
8352001|NCT01252745|20587449|P3|COMPLETED|Overall Study||7
8352002|NCT01252745|20587450|P2|COMPLETED|Overall Study||7
8352003|NCT01252745|20587451|P1|COMPLETED|Overall Study||8
8352004|NCT01252745|20587449|P3|STARTED|Overall Study||7
8352005|NCT01252745|20587450|P2|STARTED|Overall Study||7
8352006|NCT01252745|20587451|P1|STARTED|Overall Study||8
8352007|NCT01252667|20587471|P6|NOT COMPLETED|Overall Study||1
8352008|NCT01252667|20587472|P5|NOT COMPLETED|Overall Study||0
8352009|NCT01252667|20587473|P4|NOT COMPLETED|Overall Study||0
8352010|NCT01252667|20587474|P3|NOT COMPLETED|Overall Study||0
8352011|NCT01252667|20587475|P2|NOT COMPLETED|Overall Study||0
8352012|NCT01252667|20587476|P1|NOT COMPLETED|Overall Study||0
8352013|NCT01252667|20587471|P6|COMPLETED|Overall Study||34
8352014|NCT01252667|20587472|P5|COMPLETED|Overall Study||0
8352015|NCT01252667|20587473|P4|COMPLETED|Overall Study||0
8352016|NCT01252667|20587474|P3|COMPLETED|Overall Study||3
8352017|NCT01252667|20587475|P2|COMPLETED|Overall Study||3
8352018|NCT01252667|20587476|P1|COMPLETED|Overall Study||3
8352019|NCT01252667|20587471|P6|STARTED|Overall Study||35
8352020|NCT01252667|20587472|P5|STARTED|Overall Study||0
8352021|NCT01252667|20587473|P4|STARTED|Overall Study||0
8352022|NCT01252667|20587474|P3|STARTED|Overall Study||3
8352023|NCT01252667|20587475|P2|STARTED|Overall Study||3
8352024|NCT01252667|20587476|P1|STARTED|Overall Study||3
8352025|NCT01252355|20587541|P3|NOT COMPLETED|Overall Study||179
8352026|NCT01252355|20587542|P2|NOT COMPLETED|Overall Study||178
8352027|NCT01252355|20587543|P1|NOT COMPLETED|Overall Study||177
8352028|NCT01252355|20587541|P3|COMPLETED|Overall Study||0
8352029|NCT01252355|20587542|P2|COMPLETED|Overall Study||0
8352030|NCT01252355|20587543|P1|COMPLETED|Overall Study||0
8352031|NCT01252355|20587541|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
8352032|NCT01252355|20587542|P2|Treated|Overall Study||178
8352033|NCT01252355|20587543|P1|Treated|Overall Study||175
8352034|NCT01252355|20587541|P3|STARTED|Overall Study|Randomized.|179
8352035|NCT01252355|20587542|P2|STARTED|Overall Study|Randomized.|178
8352036|NCT01252355|20587543|P1|STARTED|Overall Study|Randomized.|177
8352037|NCT01252290|20587581|P1|NOT COMPLETED|Overall Study||1
8352038|NCT01252290|20587581|P1|COMPLETED|Overall Study||34
8352039|NCT01252290|20587581|P1|STARTED|Overall Study||35
8352040|NCT01252277|20587589|P1|NOT COMPLETED|Overall Study||2
8352041|NCT01252277|20587589|P1|COMPLETED|Overall Study||34
8352042|NCT01252277|20587589|P1|STARTED|Overall Study||36
8352043|NCT01252251|20587597|P1|NOT COMPLETED|Overall Study||1
8352044|NCT01252251|20587597|P1|COMPLETED|Overall Study||13
8352045|NCT01252251|20587597|P1|STARTED|Overall Study||14
8352046|NCT01252238|20587609|P3|NOT COMPLETED|Overall Study||4
8352047|NCT01252238|20587610|P2|NOT COMPLETED|Overall Study||4
8352048|NCT01252238|20587611|P1|NOT COMPLETED|Overall Study||4
8352049|NCT01252238|20587609|P3|COMPLETED|Overall Study|sponsor terminated study|4
8352050|NCT01252238|20587610|P2|COMPLETED|Overall Study|sponsor terminated study|4
8352051|NCT01252238|20587611|P1|COMPLETED|Overall Study|sponsor terminated study|4
8352052|NCT01252238|20587609|P3|STARTED|Overall Study||8
8352053|NCT01252238|20587610|P2|STARTED|Overall Study||8
8352054|NCT01252238|20587611|P1|STARTED|Overall Study||8
8352055|NCT01252186|20587628|P3|NOT COMPLETED|Overall Study||34
8352056|NCT01252186|20587629|P2|NOT COMPLETED|Overall Study||32
8352057|NCT01252186|20587630|P1|NOT COMPLETED|Overall Study||30
8352058|NCT01252186|20587628|P3|COMPLETED|Overall Study||53
8352059|NCT01252186|20587629|P2|COMPLETED|Overall Study||59
8352060|NCT01252186|20587630|P1|COMPLETED|Overall Study||57
8352061|NCT01252186|20587628|P3|Received Study Drug|Overall Study||80
8352062|NCT01252186|20587629|P2|Received Study Drug|Overall Study||89
8352063|NCT01252186|20587630|P1|Received Study Drug|Overall Study||83
8352064|NCT01252186|20587628|P3|STARTED|Overall Study||87
8352065|NCT01252186|20587629|P2|STARTED|Overall Study||91
8352066|NCT01252186|20587630|P1|STARTED|Overall Study||87
8352067|NCT01252147|20587698|P1|NOT COMPLETED|Overall Study||0
8352068|NCT01252147|20587698|P1|COMPLETED|Overall Study||68
8352069|NCT01252147|20587698|P1|STARTED|Overall Study||68
8352070|NCT01252134|20587703|P6|NOT COMPLETED|Period 3, 8 Hours||0
8352071|NCT01252134|20587704|P5|NOT COMPLETED|Period 3, 8 Hours||0
8352072|NCT01252134|20587705|P4|NOT COMPLETED|Period 3, 8 Hours||0
8352073|NCT01252134|20587706|P3|NOT COMPLETED|Period 3, 8 Hours||0
8352074|NCT01252134|20587707|P2|NOT COMPLETED|Period 3, 8 Hours||0
8352075|NCT01252134|20587708|P1|NOT COMPLETED|Period 3, 8 Hours||0
8352076|NCT01252134|20587703|P6|COMPLETED|Period 3, 8 Hours||4
8352077|NCT01252134|20587704|P5|COMPLETED|Period 3, 8 Hours||3
8352079|NCT01252134|20587706|P3|COMPLETED|Period 3, 8 Hours||2
8352080|NCT01252134|20587707|P2|COMPLETED|Period 3, 8 Hours||3
8352081|NCT01252134|20587708|P1|COMPLETED|Period 3, 8 Hours||3
8352082|NCT01252134|20587703|P6|STARTED|Period 3, 8 Hours||4
8352083|NCT01252134|20587704|P5|STARTED|Period 3, 8 Hours||3
8352084|NCT01252134|20587705|P4|STARTED|Period 3, 8 Hours||5
8352085|NCT01252134|20587706|P3|STARTED|Period 3, 8 Hours||2
8352086|NCT01252134|20587707|P2|STARTED|Period 3, 8 Hours||3
8352087|NCT01252134|20587708|P1|STARTED|Period 3, 8 Hours||3
8352088|NCT01252134|20587703|P6|NOT COMPLETED|Period 2, 8 Hours||0
8352089|NCT01252134|20587704|P5|NOT COMPLETED|Period 2, 8 Hours||0
8352090|NCT01252134|20587705|P4|NOT COMPLETED|Period 2, 8 Hours||0
8352091|NCT01252134|20587706|P3|NOT COMPLETED|Period 2, 8 Hours||0
8352092|NCT01252134|20587707|P2|NOT COMPLETED|Period 2, 8 Hours||0
8352093|NCT01252134|20587708|P1|NOT COMPLETED|Period 2, 8 Hours||0
8352094|NCT01252134|20587703|P6|COMPLETED|Period 2, 8 Hours||4
8352095|NCT01252134|20587704|P5|COMPLETED|Period 2, 8 Hours||3
8352096|NCT01252134|20587705|P4|COMPLETED|Period 2, 8 Hours||5
8352097|NCT01252134|20587706|P3|COMPLETED|Period 2, 8 Hours||2
8352098|NCT01252134|20587707|P2|COMPLETED|Period 2, 8 Hours||3
8352099|NCT01252134|20587708|P1|COMPLETED|Period 2, 8 Hours||3
8352100|NCT01252134|20587703|P6|STARTED|Period 2, 8 Hours||4
8352101|NCT01252134|20587704|P5|STARTED|Period 2, 8 Hours||3
8352102|NCT01252134|20587705|P4|STARTED|Period 2, 8 Hours||5
8352103|NCT01252134|20587706|P3|STARTED|Period 2, 8 Hours||2
8352104|NCT01252134|20587707|P2|STARTED|Period 2, 8 Hours||3
8352105|NCT01252134|20587708|P1|STARTED|Period 2, 8 Hours||3
8352106|NCT01252134|20587703|P6|NOT COMPLETED|Period 1, 8 Hours||0
8352107|NCT01252134|20587704|P5|NOT COMPLETED|Period 1, 8 Hours||0
8352108|NCT01252134|20587705|P4|NOT COMPLETED|Period 1, 8 Hours||0
8352109|NCT01252134|20587706|P3|NOT COMPLETED|Period 1, 8 Hours||1
8352110|NCT01252134|20587707|P2|NOT COMPLETED|Period 1, 8 Hours||1
8352111|NCT01252134|20587708|P1|NOT COMPLETED|Period 1, 8 Hours||0
8352112|NCT01252134|20587703|P6|COMPLETED|Period 1, 8 Hours||4
8352113|NCT01252134|20587704|P5|COMPLETED|Period 1, 8 Hours||3
8352114|NCT01252134|20587705|P4|COMPLETED|Period 1, 8 Hours||5
8352115|NCT01252134|20587706|P3|COMPLETED|Period 1, 8 Hours||2
8352116|NCT01252134|20587707|P2|COMPLETED|Period 1, 8 Hours||3
8352117|NCT01252134|20587708|P1|COMPLETED|Period 1, 8 Hours||3
8352118|NCT01252134|20587703|P6|STARTED|Period 1, 8 Hours||4
8352119|NCT01252134|20587704|P5|STARTED|Period 1, 8 Hours||3
8352120|NCT01252134|20587705|P4|STARTED|Period 1, 8 Hours||5
8352121|NCT01252134|20587706|P3|STARTED|Period 1, 8 Hours||3
8352122|NCT01252134|20587707|P2|STARTED|Period 1, 8 Hours||4
8352123|NCT01252134|20587708|P1|STARTED|Period 1, 8 Hours||3
8352124|NCT01252095|20587727|P2|NOT COMPLETED|Overall Study||0
8352125|NCT01252095|20587728|P1|NOT COMPLETED|Overall Study||1
8352126|NCT01252095|20587727|P2|COMPLETED|Overall Study||1
8352127|NCT01252095|20587728|P1|COMPLETED|Overall Study||2
8352128|NCT01252095|20587727|P2|STARTED|Overall Study||1
8352129|NCT01252095|20587728|P1|STARTED|Overall Study||3
8352130|NCT01251978|20587736|P2|NOT COMPLETED|Overall Study||0
8352131|NCT01251978|20587737|P1|NOT COMPLETED|Overall Study||0
8352132|NCT01251978|20587736|P2|COMPLETED|Overall Study||3
8352133|NCT01251978|20587737|P1|COMPLETED|Overall Study||5
8352134|NCT01251978|20587736|P2|STARTED|Overall Study||3
8352135|NCT01251978|20587737|P1|STARTED|Overall Study||5
8352136|NCT01251965|20587749|P3|NOT COMPLETED|Overall Study||11
8352137|NCT01251965|20587750|P2|NOT COMPLETED|Overall Study||2
8352138|NCT01251965|20587751|P1|NOT COMPLETED|Overall Study||1
8352139|NCT01251965|20587749|P3|COMPLETED|Overall Study||7
8352140|NCT01251965|20587750|P2|COMPLETED|Overall Study||3
8352141|NCT01251965|20587751|P1|COMPLETED|Overall Study||3
8352142|NCT01251965|20587749|P3|STARTED|Overall Study||18
8352143|NCT01251965|20587750|P2|STARTED|Overall Study||5
8352144|NCT01251965|20587751|P1|STARTED|Overall Study||4
8352145|NCT01251952|20587763|P1|NOT COMPLETED|Overall Study||1
8352146|NCT01251952|20587763|P1|COMPLETED|Overall Study||1
8352147|NCT01251952|20587763|P1|STARTED|Overall Study||2
8352160|NCT01251770|20587798|P2|NOT COMPLETED|Overall Study||7
8352161|NCT01251770|20587799|P1|NOT COMPLETED|Overall Study||13
8352162|NCT01251770|20587798|P2|COMPLETED|Overall Study||29
8352163|NCT01251770|20587799|P1|COMPLETED|Overall Study||29
8352164|NCT01251770|20587798|P2|STARTED|Overall Study||36
8352165|NCT01251770|20587799|P1|STARTED|Overall Study||42
8352166|NCT01251757|20587810|P3|NOT COMPLETED|Overall Study||0
8352167|NCT01251757|20587811|P2|NOT COMPLETED|Overall Study||0
8352168|NCT01251757|20587812|P1|NOT COMPLETED|Overall Study||0
8352169|NCT01251757|20587810|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
8352170|NCT01251757|20587811|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
8352171|NCT01251757|20587812|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
8352172|NCT01251757|20587810|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
8352173|NCT01251757|20587811|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
8352174|NCT01251757|20587812|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
8352175|NCT01251744|20587843|P2|NOT COMPLETED|Overall Study||0
8352176|NCT01251744|20587844|P1|NOT COMPLETED|Overall Study||1
8352177|NCT01251744|20587843|P2|COMPLETED|Overall Study||78
8352178|NCT01251744|20587844|P1|COMPLETED|Overall Study||76
8352179|NCT01251744|20587843|P2|STARTED|Overall Study||78
8352180|NCT01251744|20587844|P1|STARTED|Overall Study||77
8352181|NCT01251653|20587902|P9|NOT COMPLETED|Overall Study||6
8352182|NCT01251653|20587903|P8|NOT COMPLETED|Overall Study||12
8352183|NCT01251653|20587904|P7|NOT COMPLETED|Overall Study||18
8352184|NCT01251653|20587905|P6|NOT COMPLETED|Overall Study||18
8352185|NCT01251653|20587906|P5|NOT COMPLETED|Overall Study||2
8352186|NCT01251653|20587907|P4|NOT COMPLETED|Overall Study||6
8352187|NCT01251653|20587908|P3|NOT COMPLETED|Overall Study||20
8352188|NCT01251653|20587909|P2|NOT COMPLETED|Overall Study||8
8352189|NCT01251653|20587910|P1|NOT COMPLETED|Overall Study||3
8352190|NCT01251653|20587902|P9|COMPLETED|Overall Study||0
8352191|NCT01251653|20587903|P8|COMPLETED|Overall Study||0
8352192|NCT01251653|20587904|P7|COMPLETED|Overall Study||0
8352193|NCT01251653|20587905|P6|COMPLETED|Overall Study||0
8352194|NCT01251653|20587906|P5|COMPLETED|Overall Study||0
8352195|NCT01251653|20587907|P4|COMPLETED|Overall Study||0
8352196|NCT01251653|20587908|P3|COMPLETED|Overall Study||0
8352197|NCT01251653|20587909|P2|COMPLETED|Overall Study||0
8352198|NCT01251653|20587910|P1|COMPLETED|Overall Study||0
8352199|NCT01251653|20587902|P9|STARTED|Overall Study||6
8352200|NCT01251653|20587903|P8|STARTED|Overall Study||12
8352201|NCT01251653|20587904|P7|STARTED|Overall Study||18
8352202|NCT01251653|20587905|P6|STARTED|Overall Study||18
8352203|NCT01251653|20587906|P5|STARTED|Overall Study||2
8352204|NCT01251653|20587907|P4|STARTED|Overall Study||6
8352205|NCT01251653|20587908|P3|STARTED|Overall Study||20
8352206|NCT01251653|20587909|P2|STARTED|Overall Study||8
8352207|NCT01251653|20587910|P1|STARTED|Overall Study||3
8352208|NCT01251614|20588038|P3|NOT COMPLETED|Overall Study||8
8352209|NCT01251614|20588039|P2|NOT COMPLETED|Overall Study||13
8352210|NCT01251614|20588040|P1|NOT COMPLETED|Overall Study||3
8352211|NCT01251614|20588038|P3|COMPLETED|Overall Study||30
8352212|NCT01251614|20588039|P2|COMPLETED|Overall Study||26
8352213|NCT01251614|20588040|P1|COMPLETED|Overall Study||34
8352214|NCT01251614|20588038|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8352215|NCT01251614|20588039|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8352216|NCT01251614|20588040|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8352217|NCT01251614|20588038|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
8352218|NCT01251614|20588039|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
8352219|NCT01251614|20588040|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
8352220|NCT01251614|20588038|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
8352221|NCT01251614|20588039|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
8352222|NCT01251614|20588040|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
8352223|NCT01251614|20588038|P3|STARTED|Overall Study||38
8352224|NCT01251614|20588039|P2|STARTED|Overall Study||39
8352225|NCT01251614|20588040|P1|STARTED|Overall Study||37
8352226|NCT01251588|20588114|P2|NOT COMPLETED|Overall Study||4
8352227|NCT01251588|20588115|P1|NOT COMPLETED|Overall Study||0
8352228|NCT01251588|20588114|P2|COMPLETED|Overall Study||59
8352229|NCT01251588|20588115|P1|COMPLETED|Overall Study||65
8352230|NCT01251588|20588114|P2|STARTED|Overall Study||63
8352231|NCT01251588|20588115|P1|STARTED|Overall Study||65
8352232|NCT01251575|20588147|P1|NOT COMPLETED|Overall Study||1
8352233|NCT01251575|20588147|P1|COMPLETED|Overall Study||76
8352234|NCT01251575|20588147|P1|STARTED|Overall Study||77
8352235|NCT01251536|20588157|P3|NOT COMPLETED|Overall Study||0
8352236|NCT01251536|20588158|P2|NOT COMPLETED|Overall Study||0
8352237|NCT01251536|20588159|P1|NOT COMPLETED|Overall Study||0
8352238|NCT01251536|20588157|P3|COMPLETED|Overall Study||7
8352239|NCT01251536|20588158|P2|COMPLETED|Overall Study||93
8352240|NCT01251536|20588159|P1|COMPLETED|Overall Study||8
8352241|NCT01251536|20588157|P3|STARTED|Overall Study||7
8352242|NCT01251536|20588158|P2|STARTED|Overall Study||93
8352243|NCT01251536|20588159|P1|STARTED|Overall Study||8
8352244|NCT01251393|20588231|P2|NOT COMPLETED|Overall Study||44
8352245|NCT01251393|20588232|P1|NOT COMPLETED|Overall Study||32
8352246|NCT01251393|20588231|P2|COMPLETED|Overall Study||11
8352247|NCT01251393|20588232|P1|COMPLETED|Overall Study||24
8352248|NCT01251393|20588231|P2|STARTED|Overall Study||55
8352249|NCT01251393|20588232|P1|STARTED|Overall Study||56
8352250|NCT01251380|20588238|P1|NOT COMPLETED|Overall Study||22
8352251|NCT01251380|20588238|P1|COMPLETED|Overall Study||194
8352252|NCT01251380|20588238|P1|Cycle 4|Overall Study||11
8352253|NCT01251380|20588238|P1|Cycle 3|Overall Study||86
8352254|NCT01251380|20588238|P1|Cycle 2|Overall Study||175
8352255|NCT01251380|20588238|P1|Cycle 1|Overall Study||207
8352256|NCT01251380|20588238|P1|STARTED|Overall Study|Safety population.|216
8352257|NCT01251367|20588262|P1|NOT COMPLETED|Overall Study||76
8352258|NCT01251367|20588262|P1|COMPLETED|Overall Study||269
8352259|NCT01251367|20588262|P1|Cycle 4|Overall Study||139
8352260|NCT01251367|20588262|P1|Cycle 3|Overall Study||224
8352261|NCT01251367|20588262|P1|Cycle 2|Overall Study||297
8352262|NCT01251367|20588262|P1|Cycle 1|Overall Study||345
8352263|NCT01251367|20588262|P1|STARTED|Overall Study||345
8352264|NCT01251354|20588297|P1|NOT COMPLETED|Overall Study||6
8352265|NCT01251354|20588297|P1|COMPLETED|Overall Study||0
8352266|NCT01251354|20588297|P1|STARTED|Overall Study||6
8352267|NCT01251315|20588313|P6|NOT COMPLETED|Overall Study||0
8352268|NCT01251315|20588314|P5|NOT COMPLETED|Overall Study||0
8352269|NCT01251315|20588315|P4|NOT COMPLETED|Overall Study||0
8352270|NCT01251315|20588316|P3|NOT COMPLETED|Overall Study||0
8352271|NCT01251315|20588317|P2|NOT COMPLETED|Overall Study||0
8352272|NCT01251315|20588318|P1|NOT COMPLETED|Overall Study||0
8352273|NCT01251315|20588313|P6|COMPLETED|Overall Study||4
8352274|NCT01251315|20588314|P5|COMPLETED|Overall Study||4
8352275|NCT01251315|20588315|P4|COMPLETED|Overall Study||4
8352276|NCT01251315|20588316|P3|COMPLETED|Overall Study||4
8352277|NCT01251315|20588317|P2|COMPLETED|Overall Study||4
8352278|NCT01251315|20588318|P1|COMPLETED|Overall Study||4
8352279|NCT01251315|20588313|P6|STARTED|Overall Study||4
8352280|NCT01251315|20588314|P5|STARTED|Overall Study||4
8352281|NCT01251315|20588315|P4|STARTED|Overall Study||4
8352282|NCT01251315|20588316|P3|STARTED|Overall Study||4
8352283|NCT01251315|20588317|P2|STARTED|Overall Study||4
8352284|NCT01251315|20588318|P1|STARTED|Overall Study||4
8352285|NCT01251276|20588340|P2|NOT COMPLETED|Overall Study||1
8352286|NCT01251276|20588341|P1|NOT COMPLETED|Overall Study||1
8352287|NCT01251276|20588340|P2|COMPLETED|Overall Study||107
8352288|NCT01251276|20588341|P1|COMPLETED|Overall Study||95
8352289|NCT01251276|20588340|P2|Vaccinated|Overall Study||108
8352290|NCT01251276|20588341|P1|Vaccinated|Overall Study||96
8352291|NCT01251276|20588340|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
8352292|NCT01251276|20588341|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
8352293|NCT01251146|20588359|P2|NOT COMPLETED|Overall Study||10
8352294|NCT01251146|20588360|P1|NOT COMPLETED|Overall Study||3
8352295|NCT01251146|20588359|P2|COMPLETED|Overall Study||81
8352296|NCT01251146|20588360|P1|COMPLETED|Overall Study||83
8352297|NCT01251146|20588359|P2|STARTED|Overall Study||91
8352298|NCT01251146|20588360|P1|STARTED|Overall Study||86
8352299|NCT01251120|20588382|P2|NOT COMPLETED|Overall Study||1
8352300|NCT01251120|20588383|P1|NOT COMPLETED|Overall Study||0
8352301|NCT01251120|20588382|P2|COMPLETED|Overall Study||0
8352302|NCT01251120|20588383|P1|COMPLETED|Overall Study||1
8352303|NCT01251120|20588382|P2|STARTED|Overall Study||1
8352304|NCT01251120|20588383|P1|STARTED|Overall Study||1
8352305|NCT01251042|20588405|P2|NOT COMPLETED|Overall Study||0
8352306|NCT01251042|20588406|P1|NOT COMPLETED|Overall Study||0
8352307|NCT01251042|20588405|P2|COMPLETED|Overall Study||23
8352308|NCT01251042|20588406|P1|COMPLETED|Overall Study||26
8352309|NCT01251042|20588405|P2|STARTED|Overall Study||23
8352310|NCT01251042|20588406|P1|STARTED|Overall Study||26
8352311|NCT01250990|20588438|P2|NOT COMPLETED|Overall Study||2
8352312|NCT01250990|20588439|P1|NOT COMPLETED|Overall Study||4
8352313|NCT01250990|20588438|P2|COMPLETED|Overall Study||9
8352314|NCT01250990|20588439|P1|COMPLETED|Overall Study||7
8352315|NCT01250990|20588438|P2|STARTED|Overall Study||11
8352316|NCT01250990|20588439|P1|STARTED|Overall Study||11
8352317|NCT01250977|20588447|P2|NOT COMPLETED|Overall Study||2
8352318|NCT01250977|20588448|P1|NOT COMPLETED|Overall Study||0
8352319|NCT01250977|20588447|P2|COMPLETED|Overall Study||12
8352320|NCT01250977|20588448|P1|COMPLETED|Overall Study||6
8352321|NCT01250977|20588447|P2|STARTED|Overall Study||14
8352322|NCT01250977|20588448|P1|STARTED|Overall Study||6
8352323|NCT01250925|20588463|P3|NOT COMPLETED|Overall Study||2
8352324|NCT01250925|20588464|P2|NOT COMPLETED|Overall Study||3
8352325|NCT01250925|20588465|P1|NOT COMPLETED|Overall Study||5
8352326|NCT01250925|20588463|P3|COMPLETED|Overall Study||30
8352327|NCT01250925|20588464|P2|COMPLETED|Overall Study||28
8352328|NCT01250925|20588465|P1|COMPLETED|Overall Study||26
8352329|NCT01250925|20588463|P3|STARTED|Overall Study||32
8352330|NCT01250925|20588464|P2|STARTED|Overall Study||31
8352331|NCT01250925|20588465|P1|STARTED|Overall Study||31
8352335|NCT01250899|20588512|P2|NOT COMPLETED|Overall Study||0
8352336|NCT01250899|20588513|P1|NOT COMPLETED|Overall Study||0
8352337|NCT01250899|20588512|P2|COMPLETED|Overall Study||82
8352338|NCT01250899|20588513|P1|COMPLETED|Overall Study||40
8352339|NCT01250899|20588512|P2|STARTED|Overall Study||82
8352340|NCT01250899|20588513|P1|STARTED|Overall Study||40
8352341|NCT01250873|20588517|P1|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
8352342|NCT01250873|20588517|P1|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
8352343|NCT01250873|20588517|P1|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
8352344|NCT01250873|20588517|P1|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
8352345|NCT01250873|20588517|P1|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
8352346|NCT01250873|20588517|P1|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
8352347|NCT01250873|20588517|P1|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
8352348|NCT01250873|20588517|P1|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
8352349|NCT01250873|20588517|P1|STARTED|Period 1: LY2216684 (Days 1-3)||20
8352350|NCT01250834|20588528|P1|NOT COMPLETED|Overall Study||0
8352351|NCT01250834|20588528|P1|COMPLETED|Overall Study||27
8352352|NCT01250834|20588528|P1|STARTED|Overall Study||27
8352353|NCT01250769|20588549|P4|NOT COMPLETED|Overall Study||0
8352354|NCT01250769|20588550|P3|NOT COMPLETED|Overall Study||2
8352355|NCT01250769|20588551|P2|NOT COMPLETED|Overall Study||1
8352356|NCT01250769|20588552|P1|NOT COMPLETED|Overall Study||0
8352357|NCT01250769|20588549|P4|COMPLETED|Overall Study||11
8352358|NCT01250769|20588550|P3|COMPLETED|Overall Study||73
8352359|NCT01250769|20588551|P2|COMPLETED|Overall Study||72
8352360|NCT01250769|20588552|P1|COMPLETED|Overall Study||11
8352361|NCT01250769|20588549|P4|Day 14|Overall Study||11
8352362|NCT01250769|20588550|P3|Day 14|Overall Study||74
8352363|NCT01250769|20588551|P2|Day 14|Overall Study||72
8352364|NCT01250769|20588552|P1|Day 14|Overall Study||11
8352365|NCT01250769|20588549|P4|STARTED|Overall Study||11
8352366|NCT01250769|20588550|P3|STARTED|Overall Study||75
8352367|NCT01250769|20588551|P2|STARTED|Overall Study||73
8352368|NCT01250769|20588552|P1|STARTED|Overall Study||11
8352369|NCT01250756|20588584|P2|NOT COMPLETED|After Toddler Dose||1
8352370|NCT01250756|20588585|P1|NOT COMPLETED|After Toddler Dose||0
8352371|NCT01250756|20588584|P2|COMPLETED|After Toddler Dose||147
8352372|NCT01250756|20588585|P1|COMPLETED|After Toddler Dose||0
8352373|NCT01250756|20588584|P2|STARTED|After Toddler Dose||148
8352374|NCT01250756|20588585|P1|STARTED|After Toddler Dose||0
8352375|NCT01250756|20588584|P2|NOT COMPLETED|Toddler Dose||1
8352376|NCT01250756|20588585|P1|NOT COMPLETED|Toddler Dose||0
8352377|NCT01250756|20588584|P2|COMPLETED|Toddler Dose||148
8352378|NCT01250756|20588585|P1|COMPLETED|Toddler Dose||122
8352379|NCT01250756|20588584|P2|STARTED|Toddler Dose||149
8352380|NCT01250756|20588585|P1|STARTED|Toddler Dose||122
8352381|NCT01250756|20588584|P2|NOT COMPLETED|After Infant Series||4
8352382|NCT01250756|20588585|P1|NOT COMPLETED|After Infant Series||11
8352383|NCT01250756|20588584|P2|COMPLETED|After Infant Series||149
8352384|NCT01250756|20588585|P1|COMPLETED|After Infant Series||122
8352385|NCT01250756|20588584|P2|STARTED|After Infant Series||153
8352386|NCT01250756|20588585|P1|STARTED|After Infant Series||133
8352387|NCT01250756|20588584|P2|NOT COMPLETED|Infant Series||7
8352388|NCT01250756|20588585|P1|NOT COMPLETED|Infant Series||28
8352389|NCT01250756|20588584|P2|COMPLETED|Infant Series||153
8352390|NCT01250756|20588585|P1|COMPLETED|Infant Series||133
8352391|NCT01250756|20588584|P2|Vaccinated Dose 3|Infant Series||155
8352392|NCT01250756|20588585|P1|Vaccinated Dose 3|Infant Series||133
8352393|NCT01250756|20588584|P2|Vaccinated Dose 2|Infant Series||157
8352394|NCT01250756|20588585|P1|Vaccinated Dose 2|Infant Series||147
8352395|NCT01250756|20588584|P2|Vaccinated Dose 1|Infant Series||158
8352396|NCT01250756|20588585|P1|Vaccinated Dose 1|Infant Series||159
8352397|NCT01250756|20588584|P2|STARTED|Infant Series||160
8352398|NCT01250756|20588585|P1|STARTED|Infant Series||161
8352399|NCT01250730|20588638|P3|NOT COMPLETED|Overall Study||0
8352400|NCT01250730|20588639|P2|NOT COMPLETED|Overall Study||0
8352401|NCT01250730|20588640|P1|NOT COMPLETED|Overall Study||0
8352402|NCT01250730|20588638|P3|COMPLETED|Overall Study||6
8352403|NCT01250730|20588639|P2|COMPLETED|Overall Study||6
8352404|NCT01250730|20588640|P1|COMPLETED|Overall Study||6
8352405|NCT01250730|20588638|P3|STARTED|Overall Study||6
8352406|NCT01250730|20588639|P2|STARTED|Overall Study||6
8352407|NCT01250730|20588640|P1|STARTED|Overall Study||6
8352408|NCT01250717|20588696|P1|NOT COMPLETED|Overall Study||0
8352409|NCT01250717|20588696|P1|COMPLETED|Overall Study||28
8352410|NCT01250717|20588696|P1|STARTED|Overall Study||28
8352411|NCT01250509|20588702|P2|NOT COMPLETED|Overall Study||2
8352412|NCT01250509|20588703|P1|NOT COMPLETED|Overall Study||5
8352413|NCT01250509|20588702|P2|COMPLETED|Overall Study||21
8352414|NCT01250509|20588703|P1|COMPLETED|Overall Study||19
8352415|NCT01250509|20588702|P2|STARTED|Overall Study||23
8352416|NCT01250509|20588703|P1|STARTED|Overall Study||24
8352417|NCT01250418|20588717|P2|NOT COMPLETED|Overall Study||1
8352418|NCT01250418|20588718|P1|NOT COMPLETED|Overall Study||1
8352419|NCT01250418|20588717|P2|COMPLETED|Overall Study||15
8352420|NCT01250418|20588718|P1|COMPLETED|Overall Study||8
8352421|NCT01250418|20588717|P2|STARTED|Overall Study||16
8352422|NCT01250418|20588718|P1|STARTED|Overall Study||9
8352423|NCT01250379|20588726|P2|NOT COMPLETED|Overall Study||193
8352424|NCT01250379|20588727|P1|NOT COMPLETED|Overall Study||202
8352425|NCT01250379|20588726|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
8352426|NCT01250379|20588727|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
8352427|NCT01250379|20588726|P2|STARTED|Overall Study||247
8352428|NCT01250379|20588727|P1|STARTED|Overall Study||247
8352429|NCT01250210|20588788|P3|NOT COMPLETED|Overall Study||8
8352430|NCT01250210|20588789|P2|NOT COMPLETED|Overall Study||4
8352431|NCT01250210|20588790|P1|NOT COMPLETED|Overall Study||4
8352432|NCT01250210|20588788|P3|COMPLETED|Overall Study||25
8352433|NCT01250210|20588789|P2|COMPLETED|Overall Study||41
8352434|NCT01250210|20588790|P1|COMPLETED|Overall Study||41
8352435|NCT01250210|20588788|P3|STARTED|Overall Study||33
8352436|NCT01250210|20588789|P2|STARTED|Overall Study||45
8352437|NCT01250210|20588790|P1|STARTED|Overall Study||45
8352438|NCT01250184|20588804|P3|NOT COMPLETED|Overall Study||0
8352439|NCT01250184|20588805|P2|NOT COMPLETED|Overall Study||0
8352440|NCT01250184|20588806|P1|NOT COMPLETED|Overall Study||0
8352441|NCT01250184|20588804|P3|COMPLETED|Overall Study||43
8352442|NCT01250184|20588805|P2|COMPLETED|Overall Study||41
8352443|NCT01250184|20588806|P1|COMPLETED|Overall Study||43
8352444|NCT01250184|20588804|P3|STARTED|Overall Study||43
8352445|NCT01250184|20588805|P2|STARTED|Overall Study||41
8352446|NCT01250184|20588806|P1|STARTED|Overall Study||43
8352447|NCT01250171|20588832|P3|NOT COMPLETED|Overall Study||0
8352448|NCT01250171|20588833|P2|NOT COMPLETED|Overall Study||0
8352449|NCT01250171|20588834|P1|NOT COMPLETED|Overall Study||1
8352450|NCT01250171|20588832|P3|COMPLETED|Overall Study||24
8352451|NCT01250171|20588833|P2|COMPLETED|Overall Study||22
8352452|NCT01250171|20588834|P1|COMPLETED|Overall Study||25
8352453|NCT01250171|20588832|P3|STARTED|Overall Study||24
8352454|NCT01250171|20588833|P2|STARTED|Overall Study||22
8352455|NCT01250171|20588834|P1|STARTED|Overall Study||26
8352456|NCT01250145|20588865|P2|NOT COMPLETED|Overall Study||5
8352457|NCT01250145|20588866|P1|NOT COMPLETED|Overall Study||2
8352458|NCT01250145|20588865|P2|COMPLETED|Overall Study||205
8352459|NCT01250145|20588866|P1|COMPLETED|Overall Study||39
8352460|NCT01250145|20588865|P2|STARTED|Overall Study||210
8352461|NCT01250145|20588866|P1|STARTED|Overall Study||41
8352462|NCT01250119|20588886|P2|NOT COMPLETED|Treatment Phase||41
8352463|NCT01250119|20588887|P1|NOT COMPLETED|Treatment Phase||0
8352464|NCT01250119|20588886|P2|COMPLETED|Treatment Phase||0
8352465|NCT01250119|20588887|P1|COMPLETED|Treatment Phase||0
8352466|NCT01250119|20588886|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
8352467|NCT01250119|20588887|P1|STARTED|Treatment Phase||0
8352468|NCT01250119|20588886|P2|NOT COMPLETED|Diagnostic Phase||0
8352469|NCT01250119|20588887|P1|NOT COMPLETED|Diagnostic Phase||113
8352470|NCT01250119|20588886|P2|COMPLETED|Diagnostic Phase||0
8352471|NCT01250119|20588887|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
8352472|NCT01250119|20588886|P2|STARTED|Diagnostic Phase||0
8352473|NCT01250119|20588887|P1|STARTED|Diagnostic Phase||688
8352474|NCT01250054|20588902|P2|NOT COMPLETED|Period 2, One Week of Wear||0
8352475|NCT01250054|20588903|P1|NOT COMPLETED|Period 2, One Week of Wear||1
8352476|NCT01250054|20588902|P2|COMPLETED|Period 2, One Week of Wear||8
8352477|NCT01250054|20588903|P1|COMPLETED|Period 2, One Week of Wear||6
8352478|NCT01250054|20588902|P2|STARTED|Period 2, One Week of Wear||8
8352479|NCT01250054|20588903|P1|STARTED|Period 2, One Week of Wear||7
8352480|NCT01250054|20588902|P2|NOT COMPLETED|Period 1, One Week of Wear||0
8352481|NCT01250054|20588903|P1|NOT COMPLETED|Period 1, One Week of Wear||0
8352482|NCT01250054|20588902|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
8352483|NCT01250054|20588903|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
8352484|NCT01250054|20588902|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
8352485|NCT01250054|20588903|P1|STARTED|Period 1, One Week of Wear||8
8352486|NCT01250002|20588911|P2|NOT COMPLETED|Overall Study||3
8352487|NCT01250002|20588912|P1|NOT COMPLETED|Overall Study||4
8352488|NCT01250002|20588911|P2|COMPLETED|Overall Study||32
8352489|NCT01250002|20588912|P1|COMPLETED|Overall Study||31
8352490|NCT01250002|20588911|P2|STARTED|Overall Study||35
8352491|NCT01250002|20588912|P1|STARTED|Overall Study||35
8352492|NCT01249872|20588926|P6|NOT COMPLETED|Overall Study||0
8352493|NCT01249872|20588927|P5|NOT COMPLETED|Overall Study||0
8352494|NCT01249872|20588928|P4|NOT COMPLETED|Overall Study||0
8352495|NCT01249872|20588929|P3|NOT COMPLETED|Overall Study||0
8352496|NCT01249872|20588930|P2|NOT COMPLETED|Overall Study||0
8352497|NCT01249872|20588931|P1|NOT COMPLETED|Overall Study||0
8352498|NCT01249872|20588926|P6|COMPLETED|Overall Study||16
8352499|NCT01249872|20588927|P5|COMPLETED|Overall Study||16
8352500|NCT01249872|20588928|P4|COMPLETED|Overall Study||16
8352501|NCT01249872|20588929|P3|COMPLETED|Overall Study||16
8352502|NCT01249872|20588930|P2|COMPLETED|Overall Study||16
8352503|NCT01249872|20588931|P1|COMPLETED|Overall Study||16
8352504|NCT01249872|20588926|P6|STARTED|Overall Study||16
8352505|NCT01249872|20588927|P5|STARTED|Overall Study||16
8352506|NCT01249872|20588928|P4|STARTED|Overall Study||16
8352507|NCT01249872|20588929|P3|STARTED|Overall Study||16
8352508|NCT01249872|20588930|P2|STARTED|Overall Study||16
8352509|NCT01249872|20588931|P1|STARTED|Overall Study||16
8352510|NCT01249833|20588977|P2|NOT COMPLETED|Overall Study||1
8352511|NCT01249833|20588978|P1|NOT COMPLETED|Overall Study||0
8352512|NCT01249833|20588977|P2|COMPLETED|Overall Study||62
8352513|NCT01249833|20588978|P1|COMPLETED|Overall Study||59
8352514|NCT01249833|20588977|P2|STARTED|Overall Study||63
8352515|NCT01249833|20588978|P1|STARTED|Overall Study||59
8352516|NCT01249664|20588992|P2|NOT COMPLETED|Overall Study||0
8352517|NCT01249664|20588993|P1|NOT COMPLETED|Overall Study||6
8352518|NCT01249664|20588992|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
8352519|NCT01249664|20588993|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
8352520|NCT01249664|20588992|P2|Completed 48 Weeks Treatment|Overall Study||24
8352521|NCT01249664|20588993|P1|Completed 48 Weeks Treatment|Overall Study||78
8352522|NCT01249664|20588992|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
8352523|NCT01249664|20588993|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
8352524|NCT01249664|20588992|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
8352611|NCT01249131|20589238|P6|NOT COMPLETED|Washout Period of 10 Days||0
8352525|NCT01249664|20588993|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
8352526|NCT01249664|20588992|P2|Participants Received Treatment|Overall Study|Safety population|31
8352527|NCT01249664|20588993|P1|Participants Received Treatment|Overall Study|Safety population|91
8352528|NCT01249664|20588992|P2|STARTED|Overall Study||31
8352529|NCT01249664|20588993|P1|STARTED|Overall Study||91
8352530|NCT01249651|20589043|P1|NOT COMPLETED|Overall Study||7
8352531|NCT01249651|20589043|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
8352532|NCT01249651|20589043|P1|STARTED|Overall Study|Enrolled|101
8352533|NCT01249625|20589052|P2|NOT COMPLETED|Overall Study||0
8352534|NCT01249625|20589053|P1|NOT COMPLETED|Overall Study||0
8352535|NCT01249625|20589052|P2|COMPLETED|Overall Study||1488
8352536|NCT01249625|20589053|P1|COMPLETED|Overall Study||1374
8352537|NCT01249625|20589052|P2|STARTED|Overall Study||1488
8352538|NCT01249625|20589053|P1|STARTED|Overall Study||1374
8352539|NCT01249417|20589072|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
8352540|NCT01249417|20589073|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
8352541|NCT01249417|20589074|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
8352542|NCT01249417|20589072|P3|COMPLETED|Treatment Phase - ITT Population||73
8352543|NCT01249417|20589073|P2|COMPLETED|Treatment Phase - ITT Population||75
8352544|NCT01249417|20589074|P1|COMPLETED|Treatment Phase - ITT Population||78
8352545|NCT01249417|20589072|P3|STARTED|Treatment Phase - ITT Population||77
8352546|NCT01249417|20589073|P2|STARTED|Treatment Phase - ITT Population||79
8352547|NCT01249417|20589074|P1|STARTED|Treatment Phase - ITT Population||79
8352548|NCT01249417|20589072|P3|NOT COMPLETED|Randomised Population||4
8352549|NCT01249417|20589073|P2|NOT COMPLETED|Randomised Population||1
8352550|NCT01249417|20589074|P1|NOT COMPLETED|Randomised Population||1
8352551|NCT01249417|20589072|P3|COMPLETED|Randomised Population||77
8352552|NCT01249417|20589073|P2|COMPLETED|Randomised Population||79
8352553|NCT01249417|20589074|P1|COMPLETED|Randomised Population||79
8352554|NCT01249417|20589072|P3|Treated|Randomised Population||79
8352555|NCT01249417|20589073|P2|Treated|Randomised Population||80
8352556|NCT01249417|20589074|P1|Treated|Randomised Population||80
8352557|NCT01249417|20589072|P3|STARTED|Randomised Population||81
8352558|NCT01249417|20589073|P2|STARTED|Randomised Population||80
8352559|NCT01249417|20589074|P1|STARTED|Randomised Population||80
8352560|NCT01249404|20589091|P3|NOT COMPLETED|Overall Study||7
8352561|NCT01249404|20589092|P2|NOT COMPLETED|Overall Study||8
8352562|NCT01249404|20589093|P1|NOT COMPLETED|Overall Study||7
8352563|NCT01249404|20589091|P3|COMPLETED|Overall Study||125
8352564|NCT01249404|20589092|P2|COMPLETED|Overall Study||121
8352565|NCT01249404|20589093|P1|COMPLETED|Overall Study||120
8352566|NCT01249404|20589091|P3|STARTED|Overall Study||132
8352567|NCT01249404|20589092|P2|STARTED|Overall Study||129
8352568|NCT01249404|20589093|P1|STARTED|Overall Study||127
8352569|NCT01249365|20589170|P1|NOT COMPLETED|Overall Study||1
8352570|NCT01249365|20589170|P1|COMPLETED|Overall Study||198
8352571|NCT01249365|20589170|P1|STARTED|Overall Study||199
8352572|NCT01249274|20589178|P2|NOT COMPLETED|Overall Study||6
8352573|NCT01249274|20589179|P1|NOT COMPLETED|Overall Study||4
8352574|NCT01249274|20589178|P2|COMPLETED|Overall Study||19
8352575|NCT01249274|20589179|P1|COMPLETED|Overall Study||21
8352576|NCT01249274|20589178|P2|Completed Post Trial Visit But Not tx|Overall Study||2
8352577|NCT01249274|20589179|P1|Completed Post Trial Visit But Not tx|Overall Study||1
8352578|NCT01249274|20589178|P2|Completed Treatment & Post Trial Visit|Overall Study||17
8352579|NCT01249274|20589179|P1|Completed Treatment & Post Trial Visit|Overall Study||20
8352580|NCT01249274|20589178|P2|Completed Treatment|Overall Study||19
8352581|NCT01249274|20589179|P1|Completed Treatment|Overall Study||21
8352582|NCT01249274|20589178|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
8352583|NCT01249274|20589179|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
8352584|NCT01249261|20589205|P2|NOT COMPLETED|Overall Study||0
8352585|NCT01249261|20589206|P1|NOT COMPLETED|Overall Study||1
8352586|NCT01249261|20589205|P2|COMPLETED|Overall Study||31
8352587|NCT01249261|20589206|P1|COMPLETED|Overall Study||29
8352588|NCT01249261|20589205|P2|STARTED|Overall Study||31
8352589|NCT01249261|20589206|P1|STARTED|Overall Study||30
8352590|NCT01249157|20589234|P1|NOT COMPLETED|Overall Study||1
8352591|NCT01249157|20589234|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
8352592|NCT01249157|20589234|P1|STARTED|Overall Study||1
8352593|NCT01249131|20589238|P6|NOT COMPLETED|Third Intervention||0
8352594|NCT01249131|20589239|P5|NOT COMPLETED|Third Intervention||0
8352595|NCT01249131|20589240|P4|NOT COMPLETED|Third Intervention||0
8352596|NCT01249131|20589241|P3|NOT COMPLETED|Third Intervention||0
8352597|NCT01249131|20589242|P2|NOT COMPLETED|Third Intervention||0
8352598|NCT01249131|20589243|P1|NOT COMPLETED|Third Intervention||0
8352599|NCT01249131|20589238|P6|COMPLETED|Third Intervention||4
8352600|NCT01249131|20589239|P5|COMPLETED|Third Intervention||2
8352601|NCT01249131|20589240|P4|COMPLETED|Third Intervention||3
8352602|NCT01249131|20589241|P3|COMPLETED|Third Intervention||4
8352603|NCT01249131|20589242|P2|COMPLETED|Third Intervention||3
8352604|NCT01249131|20589243|P1|COMPLETED|Third Intervention||3
8352605|NCT01249131|20589238|P6|STARTED|Third Intervention||4
8352606|NCT01249131|20589239|P5|STARTED|Third Intervention||2
8352607|NCT01249131|20589240|P4|STARTED|Third Intervention||3
8352608|NCT01249131|20589241|P3|STARTED|Third Intervention||4
8352609|NCT01249131|20589242|P2|STARTED|Third Intervention||3
8352610|NCT01249131|20589243|P1|STARTED|Third Intervention||3
8352612|NCT01249131|20589239|P5|NOT COMPLETED|Washout Period of 10 Days||0
8352613|NCT01249131|20589240|P4|NOT COMPLETED|Washout Period of 10 Days||0
8352614|NCT01249131|20589241|P3|NOT COMPLETED|Washout Period of 10 Days||0
8352615|NCT01249131|20589242|P2|NOT COMPLETED|Washout Period of 10 Days||0
8352616|NCT01249131|20589243|P1|NOT COMPLETED|Washout Period of 10 Days||0
8352617|NCT01249131|20589238|P6|COMPLETED|Washout Period of 10 Days||4
8352618|NCT01249131|20589239|P5|COMPLETED|Washout Period of 10 Days||2
8352619|NCT01249131|20589240|P4|COMPLETED|Washout Period of 10 Days||3
8352620|NCT01249131|20589241|P3|COMPLETED|Washout Period of 10 Days||4
8352621|NCT01249131|20589242|P2|COMPLETED|Washout Period of 10 Days||3
8352622|NCT01249131|20589243|P1|COMPLETED|Washout Period of 10 Days||3
8352623|NCT01249131|20589238|P6|STARTED|Washout Period of 10 Days||4
8352624|NCT01249131|20589239|P5|STARTED|Washout Period of 10 Days||2
8352625|NCT01249131|20589240|P4|STARTED|Washout Period of 10 Days||3
8352626|NCT01249131|20589241|P3|STARTED|Washout Period of 10 Days||4
8352627|NCT01249131|20589242|P2|STARTED|Washout Period of 10 Days||3
8352628|NCT01249131|20589243|P1|STARTED|Washout Period of 10 Days||3
8352629|NCT01249131|20589238|P6|NOT COMPLETED|Second Intervention||0
8352630|NCT01249131|20589239|P5|NOT COMPLETED|Second Intervention||0
8352631|NCT01249131|20589240|P4|NOT COMPLETED|Second Intervention||0
8352632|NCT01249131|20589241|P3|NOT COMPLETED|Second Intervention||0
8352633|NCT01249131|20589242|P2|NOT COMPLETED|Second Intervention||0
8352634|NCT01249131|20589243|P1|NOT COMPLETED|Second Intervention||0
8352635|NCT01249131|20589238|P6|COMPLETED|Second Intervention||4
8352636|NCT01249131|20589239|P5|COMPLETED|Second Intervention||2
8352637|NCT01249131|20589240|P4|COMPLETED|Second Intervention||3
8352638|NCT01249131|20589241|P3|COMPLETED|Second Intervention||4
8352639|NCT01249131|20589242|P2|COMPLETED|Second Intervention||3
8352640|NCT01249131|20589243|P1|COMPLETED|Second Intervention||3
8352641|NCT01249131|20589238|P6|STARTED|Second Intervention||4
8352642|NCT01249131|20589239|P5|STARTED|Second Intervention||2
8352643|NCT01249131|20589240|P4|STARTED|Second Intervention||3
8352644|NCT01249131|20589241|P3|STARTED|Second Intervention||4
8352645|NCT01249131|20589242|P2|STARTED|Second Intervention||3
8352646|NCT01249131|20589243|P1|STARTED|Second Intervention||3
8352647|NCT01249131|20589238|P6|NOT COMPLETED|Washout Period of 10 Days||0
8352648|NCT01249131|20589239|P5|NOT COMPLETED|Washout Period of 10 Days||1
8352649|NCT01249131|20589240|P4|NOT COMPLETED|Washout Period of 10 Days||0
8352650|NCT01249131|20589241|P3|NOT COMPLETED|Washout Period of 10 Days||0
8352651|NCT01249131|20589242|P2|NOT COMPLETED|Washout Period of 10 Days||0
8352652|NCT01249131|20589243|P1|NOT COMPLETED|Washout Period of 10 Days||0
8352653|NCT01249131|20589238|P6|COMPLETED|Washout Period of 10 Days||4
8352654|NCT01249131|20589239|P5|COMPLETED|Washout Period of 10 Days||2
8352655|NCT01249131|20589240|P4|COMPLETED|Washout Period of 10 Days||3
8352656|NCT01249131|20589241|P3|COMPLETED|Washout Period of 10 Days||4
8352657|NCT01249131|20589242|P2|COMPLETED|Washout Period of 10 Days||3
8352658|NCT01249131|20589243|P1|COMPLETED|Washout Period of 10 Days||3
8352659|NCT01249131|20589238|P6|STARTED|Washout Period of 10 Days||4
8352660|NCT01249131|20589239|P5|STARTED|Washout Period of 10 Days||3
8352661|NCT01249131|20589240|P4|STARTED|Washout Period of 10 Days||3
8352662|NCT01249131|20589241|P3|STARTED|Washout Period of 10 Days||4
8352663|NCT01249131|20589242|P2|STARTED|Washout Period of 10 Days||3
8352664|NCT01249131|20589243|P1|STARTED|Washout Period of 10 Days||3
8352665|NCT01249131|20589238|P6|NOT COMPLETED|First Intervention||0
8352666|NCT01249131|20589239|P5|NOT COMPLETED|First Intervention||0
8352667|NCT01249131|20589240|P4|NOT COMPLETED|First Intervention||0
8352668|NCT01249131|20589241|P3|NOT COMPLETED|First Intervention||0
8352669|NCT01249131|20589242|P2|NOT COMPLETED|First Intervention||0
8352670|NCT01249131|20589243|P1|NOT COMPLETED|First Intervention||0
8352671|NCT01249131|20589238|P6|COMPLETED|First Intervention||4
8352672|NCT01249131|20589239|P5|COMPLETED|First Intervention||3
8352673|NCT01249131|20589240|P4|COMPLETED|First Intervention||3
8352674|NCT01249131|20589241|P3|COMPLETED|First Intervention||4
8352675|NCT01249131|20589242|P2|COMPLETED|First Intervention||3
8352676|NCT01249131|20589243|P1|COMPLETED|First Intervention||3
8352677|NCT01249131|20589238|P6|STARTED|First Intervention||4
8352678|NCT01249131|20589239|P5|STARTED|First Intervention||3
8352679|NCT01249131|20589240|P4|STARTED|First Intervention||3
8352680|NCT01249131|20589241|P3|STARTED|First Intervention||4
8352681|NCT01249131|20589242|P2|STARTED|First Intervention||3
8352682|NCT01249131|20589243|P1|STARTED|First Intervention||3
8352683|NCT01249118|20589263|P3|NOT COMPLETED|Second Washout Period||0
8352684|NCT01249118|20589264|P2|NOT COMPLETED|Second Washout Period||0
8352685|NCT01249118|20589265|P1|NOT COMPLETED|Second Washout Period||0
8352686|NCT01249118|20589263|P3|COMPLETED|Second Washout Period||5
8352687|NCT01249118|20589264|P2|COMPLETED|Second Washout Period||5
8352688|NCT01249118|20589265|P1|COMPLETED|Second Washout Period||2
8352689|NCT01249118|20589263|P3|STARTED|Second Washout Period||5
8352690|NCT01249118|20589264|P2|STARTED|Second Washout Period||5
8352691|NCT01249118|20589265|P1|STARTED|Second Washout Period||2
8352692|NCT01249118|20589263|P3|NOT COMPLETED|Second Intervention Period||0
8352693|NCT01249118|20589264|P2|NOT COMPLETED|Second Intervention Period||0
8352694|NCT01249118|20589265|P1|NOT COMPLETED|Second Intervention Period||0
8352695|NCT01249118|20589263|P3|COMPLETED|Second Intervention Period||5
8352696|NCT01249118|20589264|P2|COMPLETED|Second Intervention Period||5
8352697|NCT01249118|20589265|P1|COMPLETED|Second Intervention Period||2
8352698|NCT01249118|20589263|P3|STARTED|Second Intervention Period||5
8352699|NCT01249118|20589264|P2|STARTED|Second Intervention Period||5
8352700|NCT01249118|20589265|P1|STARTED|Second Intervention Period||2
8352701|NCT01249118|20589263|P3|NOT COMPLETED|First Washout Period||0
8352702|NCT01249118|20589264|P2|NOT COMPLETED|First Washout Period||1
8352703|NCT01249118|20589265|P1|NOT COMPLETED|First Washout Period||0
8352704|NCT01249118|20589263|P3|COMPLETED|First Washout Period||5
8352705|NCT01249118|20589264|P2|COMPLETED|First Washout Period||5
8352706|NCT01249118|20589265|P1|COMPLETED|First Washout Period||2
8352707|NCT01249118|20589263|P3|STARTED|First Washout Period||5
8352708|NCT01249118|20589264|P2|STARTED|First Washout Period||6
8352709|NCT01249118|20589265|P1|STARTED|First Washout Period||2
8352710|NCT01249118|20589263|P3|NOT COMPLETED|First Intervention Period||0
8352711|NCT01249118|20589264|P2|NOT COMPLETED|First Intervention Period||0
8352712|NCT01249118|20589265|P1|NOT COMPLETED|First Intervention Period||0
8352713|NCT01249118|20589263|P3|COMPLETED|First Intervention Period||5
8352714|NCT01249118|20589264|P2|COMPLETED|First Intervention Period||6
8352715|NCT01249118|20589265|P1|COMPLETED|First Intervention Period||2
8352716|NCT01249118|20589263|P3|STARTED|First Intervention Period||5
8352717|NCT01249118|20589264|P2|STARTED|First Intervention Period||6
8352718|NCT01249118|20589265|P1|STARTED|First Intervention Period||2
8352719|NCT01249092|20589299|P1|NOT COMPLETED|Overall Study||2
8352720|NCT01249092|20589299|P1|COMPLETED|Overall Study||18
8352721|NCT01249092|20589299|P1|STARTED|Overall Study||20
8352722|NCT01249027|20589305|P1|NOT COMPLETED|5 Years Clinical Follow up||68
8352723|NCT01249027|20589305|P1|COMPLETED|5 Years Clinical Follow up||2142
8352724|NCT01249027|20589305|P1|STARTED|5 Years Clinical Follow up||2210
8352725|NCT01249027|20589305|P1|NOT COMPLETED|4 Years Clinical Follow up||13
8352726|NCT01249027|20589305|P1|COMPLETED|4 Years Clinical Follow up||2210
8352727|NCT01249027|20589305|P1|STARTED|4 Years Clinical Follow up||2223
8352728|NCT01249027|20589305|P1|NOT COMPLETED|3 Years Clinical Follow up||31
8352729|NCT01249027|20589305|P1|COMPLETED|3 Years Clinical Follow up||2223
8352730|NCT01249027|20589305|P1|STARTED|3 Years Clinical Follow up||2254
8352731|NCT01249027|20589305|P1|NOT COMPLETED|2 Years Clinical Follow up||137
8352732|NCT01249027|20589305|P1|COMPLETED|2 Years Clinical Follow up||2254
8352733|NCT01249027|20589305|P1|STARTED|2 Years Clinical Follow up||2391
8352734|NCT01249027|20589305|P1|NOT COMPLETED|1 Year Clinical Follow up||91
8352735|NCT01249027|20589305|P1|COMPLETED|1 Year Clinical Follow up||2391
8352736|NCT01249027|20589305|P1|STARTED|1 Year Clinical Follow up||2482
8352737|NCT01248962|20589376|P2|NOT COMPLETED|Overall Study||16
8352738|NCT01248962|20589377|P1|NOT COMPLETED|Overall Study||16
8352739|NCT01248962|20589376|P2|COMPLETED|Overall Study||56
8352740|NCT01248962|20589377|P1|COMPLETED|Overall Study||58
8352741|NCT01248962|20589376|P2|STARTED|Overall Study||72
8352742|NCT01248962|20589377|P1|STARTED|Overall Study||74
8352743|NCT01248949|20589393|P5|NOT COMPLETED|Overall Study||4
8352744|NCT01248949|20589394|P4|NOT COMPLETED|Overall Study||10
8352745|NCT01248949|20589395|P3|NOT COMPLETED|Overall Study||37
8352746|NCT01248949|20589396|P2|NOT COMPLETED|Overall Study||13
8352747|NCT01248949|20589397|P1|NOT COMPLETED|Overall Study||33
8352748|NCT01248949|20589393|P5|COMPLETED|Overall Study||3
8352749|NCT01248949|20589394|P4|COMPLETED|Overall Study||3
8352750|NCT01248949|20589395|P3|COMPLETED|Overall Study||1
8352751|NCT01248949|20589396|P2|COMPLETED|Overall Study||3
8352752|NCT01248949|20589397|P1|COMPLETED|Overall Study||9
8352753|NCT01248949|20589393|P5|STARTED|Overall Study||7
8352754|NCT01248949|20589394|P4|STARTED|Overall Study||13
8352755|NCT01248949|20589395|P3|STARTED|Overall Study||38
8352756|NCT01248949|20589396|P2|STARTED|Overall Study||16
8352757|NCT01248949|20589397|P1|STARTED|Overall Study||42
8352758|NCT01248936|20589509|P1|NOT COMPLETED|Overall Study||374
8352759|NCT01248936|20589509|P1|COMPLETED|Overall Study||0
8352760|NCT01248936|20589509|P1|STARTED|Overall Study||374
8352761|NCT01248884|20589522|P3|NOT COMPLETED|Overall Study||1
8352762|NCT01248884|20589523|P2|NOT COMPLETED|Overall Study||3
8352763|NCT01248884|20589524|P1|NOT COMPLETED|Overall Study||2
8352764|NCT01248884|20589522|P3|COMPLETED|Overall Study||238
8352765|NCT01248884|20589523|P2|COMPLETED|Overall Study||239
8352766|NCT01248884|20589524|P1|COMPLETED|Overall Study||238
8352767|NCT01248884|20589522|P3|STARTED|Overall Study||239
8352768|NCT01248884|20589523|P2|STARTED|Overall Study||242
8352769|NCT01248884|20589524|P1|STARTED|Overall Study||240
8352770|NCT01248793|20589582|P2|NOT COMPLETED|Overall Study||6
8352771|NCT01248793|20589583|P1|NOT COMPLETED|Overall Study||4
8352772|NCT01248793|20589582|P2|COMPLETED|Overall Study||102
8352773|NCT01248793|20589583|P1|COMPLETED|Overall Study||101
8352774|NCT01248793|20589582|P2|STARTED|Overall Study||108
8352775|NCT01248793|20589583|P1|STARTED|Overall Study||105
8352776|NCT01248780|20589597|P2|NOT COMPLETED|Overall Study||15
8352777|NCT01248780|20589598|P1|NOT COMPLETED|Overall Study||9
8352778|NCT01248780|20589597|P2|COMPLETED|Overall Study||117
8352779|NCT01248780|20589598|P1|COMPLETED|Overall Study||123
8352780|NCT01248780|20589597|P2|STARTED|Overall Study||132
8352781|NCT01248780|20589598|P1|STARTED|Overall Study||132
8352782|NCT01248741|20589610|P1|NOT COMPLETED|Overall Study||0
8352783|NCT01248741|20589610|P1|COMPLETED|Overall Study||20
8352784|NCT01248741|20589610|P1|STARTED|Overall Study||20
8352785|NCT01248728|20589616|P2|NOT COMPLETED|Overall Study||2
8352786|NCT01248728|20589617|P1|NOT COMPLETED|Overall Study||4
8352787|NCT01248728|20589616|P2|COMPLETED|Overall Study||17
8352788|NCT01248728|20589617|P1|COMPLETED|Overall Study||15
8352789|NCT01248728|20589616|P2|STARTED|Overall Study||19
8352790|NCT01248728|20589617|P1|STARTED|Overall Study||19
8352791|NCT01248715|20589633|P2|NOT COMPLETED|Overall Study||510
8352792|NCT01248715|20589634|P1|NOT COMPLETED|Overall Study||501
8352793|NCT01248715|20589633|P2|COMPLETED|Overall Study||41
8352794|NCT01248715|20589634|P1|COMPLETED|Overall Study||55
8352795|NCT01248715|20589633|P2|STARTED|Overall Study||551
8352796|NCT01248715|20589634|P1|STARTED|Overall Study||556
8352797|NCT01248585|20589654|P2|NOT COMPLETED|Overall Study||0
8352798|NCT01248585|20589655|P1|NOT COMPLETED|Overall Study||0
8352799|NCT01248585|20589654|P2|COMPLETED|Overall Study||150
8352800|NCT01248585|20589655|P1|COMPLETED|Overall Study||148
8352801|NCT01248585|20589654|P2|STARTED|Overall Study||150
8352802|NCT01248585|20589655|P1|STARTED|Overall Study||148
8352803|NCT01248468|20589672|P3|NOT COMPLETED|Overall Study||4
8352804|NCT01248468|20589673|P2|NOT COMPLETED|Overall Study||14
8352805|NCT01248468|20589674|P1|NOT COMPLETED|Overall Study||15
8352806|NCT01248468|20589672|P3|COMPLETED|Overall Study||145
8352807|NCT01248468|20589673|P2|COMPLETED|Overall Study||290
8352808|NCT01248468|20589674|P1|COMPLETED|Overall Study||284
8352809|NCT01248468|20589672|P3|ITT Population|Overall Study||125
8352810|NCT01248468|20589673|P2|ITT Population|Overall Study||261
8352811|NCT01248468|20589674|P1|ITT Population|Overall Study||256
8352812|NCT01248468|20589672|P3|Safety Population|Overall Study||133
8352813|NCT01248468|20589673|P2|Safety Population|Overall Study||271
8352814|NCT01248468|20589674|P1|Safety Population|Overall Study||266
8352815|NCT01248468|20589672|P3|STARTED|Overall Study||149
8352816|NCT01248468|20589673|P2|STARTED|Overall Study||304
8352817|NCT01248468|20589674|P1|STARTED|Overall Study||299
8352818|NCT01248455|20589691|P1|NOT COMPLETED|Overall Study||1
8352819|NCT01248455|20589691|P1|COMPLETED|Overall Study||8
8352820|NCT01248455|20589691|P1|STARTED|Overall Study||9
8352821|NCT01248416|20589699|P3|NOT COMPLETED|Overall Study||1
8352822|NCT01248416|20589700|P2|NOT COMPLETED|Overall Study||0
8352823|NCT01248416|20589701|P1|NOT COMPLETED|Overall Study||4
8352824|NCT01248416|20589699|P3|COMPLETED|Overall Study||25
8352825|NCT01248416|20589700|P2|COMPLETED|Overall Study||25
8352826|NCT01248416|20589701|P1|COMPLETED|Overall Study||21
8352827|NCT01248416|20589699|P3|STARTED|Overall Study||26
8352828|NCT01248416|20589700|P2|STARTED|Overall Study||25
8352829|NCT01248416|20589701|P1|STARTED|Overall Study||25
8352830|NCT01248364|20589736|P4|NOT COMPLETED|Overall Study||0
8352831|NCT01248364|20589737|P3|NOT COMPLETED|Overall Study||0
8352832|NCT01248364|20589738|P2|NOT COMPLETED|Overall Study||1
8352833|NCT01248364|20589739|P1|NOT COMPLETED|Overall Study||0
8352834|NCT01248364|20589736|P4|COMPLETED|Overall Study||12
8352835|NCT01248364|20589737|P3|COMPLETED|Overall Study||13
8352836|NCT01248364|20589738|P2|COMPLETED|Overall Study||33
8352837|NCT01248364|20589739|P1|COMPLETED|Overall Study||32
8352838|NCT01248364|20589736|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
8352839|NCT01248364|20589737|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
8352840|NCT01248364|20589738|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
8352841|NCT01248364|20589739|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
8352842|NCT01248364|20589736|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
8352843|NCT01248364|20589737|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
8352844|NCT01248364|20589738|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
8352845|NCT01248364|20589739|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
8352846|NCT01248364|20589736|P4|STARTED|Overall Study||12
8352847|NCT01248364|20589737|P3|STARTED|Overall Study||13
8352848|NCT01248364|20589738|P2|STARTED|Overall Study||34
8352849|NCT01248364|20589739|P1|STARTED|Overall Study||32
8352850|NCT01248221|20589787|P2|NOT COMPLETED|Overall Study||0
8352851|NCT01248221|20589788|P1|NOT COMPLETED|Overall Study||0
8352852|NCT01248221|20589787|P2|COMPLETED|Overall Study||15
8352853|NCT01248221|20589788|P1|COMPLETED|Overall Study||15
8352854|NCT01248221|20589787|P2|STARTED|Overall Study||15
8352855|NCT01248221|20589788|P1|STARTED|Overall Study||15
8352856|NCT01248130|20589802|P2|NOT COMPLETED|Overall Study||0
8352857|NCT01248130|20589803|P1|NOT COMPLETED|Overall Study||2
8352858|NCT01248130|20589802|P2|COMPLETED|Overall Study||4
8352859|NCT01248130|20589803|P1|COMPLETED|Overall Study||1
8352860|NCT01248130|20589802|P2|STARTED|Overall Study||4
8352861|NCT01248130|20589803|P1|STARTED|Overall Study||3
8352862|NCT01248104|20589813|P2|NOT COMPLETED|Overall Study||8
8352863|NCT01248104|20589814|P1|NOT COMPLETED|Overall Study||10
8352864|NCT01248104|20589813|P2|COMPLETED|Overall Study||42
8352865|NCT01248104|20589814|P1|COMPLETED|Overall Study||40
8352866|NCT01248104|20589813|P2|STARTED|Overall Study||50
8352867|NCT01248104|20589814|P1|STARTED|Overall Study||50
8352868|NCT01248065|20589822|P2|NOT COMPLETED|Overall Study||22
8352869|NCT01248065|20589823|P1|NOT COMPLETED|Overall Study||26
8352870|NCT01248065|20589822|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
8352871|NCT01248065|20589823|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
8352872|NCT01248065|20589822|P2|STARTED|Overall Study||201
8352873|NCT01248065|20589823|P1|STARTED|Overall Study||207
8352874|NCT01248013|20589833|P1|NOT COMPLETED|Overall Study||14
8352875|NCT01248013|20589833|P1|COMPLETED|Overall Study||75
8352876|NCT01248013|20589833|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
8352877|NCT01248013|20589833|P1|STARTED|Overall Study||89
8352878|NCT01247974|20589839|P2|NOT COMPLETED|Overall Study||19
8352879|NCT01247974|20589840|P1|NOT COMPLETED|Overall Study||26
8352880|NCT01247974|20589839|P2|COMPLETED|Overall Study||203
8352881|NCT01247974|20589840|P1|COMPLETED|Overall Study||191
8352882|NCT01247974|20589839|P2|STARTED|Overall Study||222
8352883|NCT01247974|20589840|P1|STARTED|Overall Study||217
8352884|NCT01247922|20589848|P1|NOT COMPLETED|Overall Study||4
8352885|NCT01247922|20589848|P1|COMPLETED|Overall Study||0
8352886|NCT01247922|20589848|P1|Treated|Overall Study||4
8352887|NCT01247922|20589848|P1|STARTED|Overall Study||4
8352888|NCT01247675|20589858|P4|NOT COMPLETED|Overall Study||0
8352889|NCT01247675|20589859|P3|NOT COMPLETED|Overall Study||0
8352890|NCT01247675|20589860|P2|NOT COMPLETED|Overall Study||2
8352891|NCT01247675|20589861|P1|NOT COMPLETED|Overall Study||2
8352892|NCT01247675|20589858|P4|COMPLETED|Overall Study||8
8352893|NCT01247675|20589859|P3|COMPLETED|Overall Study||9
8352894|NCT01247675|20589860|P2|COMPLETED|Overall Study||8
8352895|NCT01247675|20589861|P1|COMPLETED|Overall Study||8
8352896|NCT01247675|20589858|P4|STARTED|Overall Study||8
8352897|NCT01247675|20589859|P3|STARTED|Overall Study||9
8352898|NCT01247675|20589860|P2|STARTED|Overall Study||10
8352899|NCT01247675|20589861|P1|STARTED|Overall Study||10
8352900|NCT01247571|20589883|P1|NOT COMPLETED|Overall Study||3
8352901|NCT01247571|20589883|P1|COMPLETED|Overall Study||19
8352902|NCT01247571|20589883|P1|STARTED|Overall Study||22
8352903|NCT01247428|20589891|P1|NOT COMPLETED|Overall Study||0
8352904|NCT01247428|20589891|P1|COMPLETED|Overall Study||30
8352905|NCT01247428|20589891|P1|STARTED|Overall Study||30
8352906|NCT01247363|20589912|P1|NOT COMPLETED|Overall Study||0
8352907|NCT01247363|20589912|P1|COMPLETED|Overall Study||20
8352908|NCT01247363|20589912|P1|STARTED|Overall Study||20
8352909|NCT01247350|20589946|P5|NOT COMPLETED|Overall Study||1
8352910|NCT01247350|20589947|P4|NOT COMPLETED|Overall Study||1
8352911|NCT01247350|20589948|P3|NOT COMPLETED|Overall Study||1
8352912|NCT01247350|20589949|P2|NOT COMPLETED|Overall Study||0
8352913|NCT01247350|20589950|P1|NOT COMPLETED|Overall Study||0
8352914|NCT01247350|20589946|P5|COMPLETED|Overall Study||8
8352915|NCT01247350|20589947|P4|COMPLETED|Overall Study||6
8352916|NCT01247350|20589948|P3|COMPLETED|Overall Study||5
8352917|NCT01247350|20589949|P2|COMPLETED|Overall Study||6
8352918|NCT01247350|20589950|P1|COMPLETED|Overall Study||6
8352919|NCT01247350|20589946|P5|Received Multiple Doses of Study Drug|Overall Study||5
8352920|NCT01247350|20589947|P4|Received Multiple Doses of Study Drug|Overall Study||6
8352921|NCT01247350|20589948|P3|Received Multiple Doses of Study Drug|Overall Study||6
8352922|NCT01247350|20589949|P2|Received Multiple Doses of Study Drug|Overall Study||0
8352923|NCT01247350|20589950|P1|Received Multiple Doses of Study Drug|Overall Study||0
8352924|NCT01247350|20589946|P5|STARTED|Overall Study||9
8352925|NCT01247350|20589947|P4|STARTED|Overall Study||7
8352926|NCT01247350|20589948|P3|STARTED|Overall Study||6
8352927|NCT01247350|20589949|P2|STARTED|Overall Study||6
8352928|NCT01247350|20589950|P1|STARTED|Overall Study||6
8352929|NCT01247324|20590008|P2|NOT COMPLETED|Overall Study||44
8352930|NCT01247324|20590009|P1|NOT COMPLETED|Overall Study||71
8352931|NCT01247324|20590008|P2|COMPLETED|Overall Study||366
8352932|NCT01247324|20590009|P1|COMPLETED|Overall Study||340
8352933|NCT01247324|20590008|P2|STARTED|Overall Study||410
8352934|NCT01247324|20590009|P1|STARTED|Overall Study||411
8352935|NCT01247298|20590040|P1|NOT COMPLETED|Overall Study||0
8352936|NCT01247298|20590040|P1|COMPLETED|Overall Study||17
8352937|NCT01247298|20590040|P1|STARTED|Overall Study||17
8352938|NCT01247285|20590050|P2|NOT COMPLETED|Second Intervention||0
8352939|NCT01247285|20590051|P1|NOT COMPLETED|Second Intervention||0
8352940|NCT01247285|20590050|P2|COMPLETED|Second Intervention||13
8352941|NCT01247285|20590051|P1|COMPLETED|Second Intervention||13
8352942|NCT01247285|20590050|P2|STARTED|Second Intervention||13
8352943|NCT01247285|20590051|P1|STARTED|Second Intervention||13
8352944|NCT01247285|20590050|P2|NOT COMPLETED|Washout of 28 Days||0
8352945|NCT01247285|20590051|P1|NOT COMPLETED|Washout of 28 Days||0
8352946|NCT01247285|20590050|P2|COMPLETED|Washout of 28 Days||13
8352947|NCT01247285|20590051|P1|COMPLETED|Washout of 28 Days||13
8352948|NCT01247285|20590050|P2|STARTED|Washout of 28 Days||13
8352949|NCT01247285|20590051|P1|STARTED|Washout of 28 Days||13
8352950|NCT01247285|20590050|P2|NOT COMPLETED|First Intervention||0
8352951|NCT01247285|20590051|P1|NOT COMPLETED|First Intervention||0
8352952|NCT01247285|20590050|P2|COMPLETED|First Intervention||13
8352953|NCT01247285|20590051|P1|COMPLETED|First Intervention||13
8352954|NCT01247285|20590050|P2|STARTED|First Intervention||13
8352955|NCT01247285|20590051|P1|STARTED|First Intervention||13
8352956|NCT01247272|20590069|P2|NOT COMPLETED|Second Intervention||0
8352957|NCT01247272|20590070|P1|NOT COMPLETED|Second Intervention||0
8352958|NCT01247272|20590069|P2|COMPLETED|Second Intervention||13
8352959|NCT01247272|20590070|P1|COMPLETED|Second Intervention||13
8352960|NCT01247272|20590069|P2|STARTED|Second Intervention||13
8352961|NCT01247272|20590070|P1|STARTED|Second Intervention||13
8352962|NCT01247272|20590069|P2|NOT COMPLETED|Washout of 28 Days||0
8352963|NCT01247272|20590070|P1|NOT COMPLETED|Washout of 28 Days||0
8352964|NCT01247272|20590069|P2|COMPLETED|Washout of 28 Days||13
8352965|NCT01247272|20590070|P1|COMPLETED|Washout of 28 Days||13
8352966|NCT01247272|20590069|P2|STARTED|Washout of 28 Days||13
8352967|NCT01247272|20590070|P1|STARTED|Washout of 28 Days||13
8352968|NCT01247272|20590069|P2|NOT COMPLETED|First Intervention||0
8352969|NCT01247272|20590070|P1|NOT COMPLETED|First Intervention||0
8352970|NCT01247272|20590069|P2|COMPLETED|First Intervention||13
8352971|NCT01247272|20590070|P1|COMPLETED|First Intervention||13
8352972|NCT01247272|20590069|P2|STARTED|First Intervention||13
8352973|NCT01247272|20590070|P1|STARTED|First Intervention||13
8352974|NCT01247220|20590088|P2|NOT COMPLETED|Overall Study||0
8352975|NCT01247220|20590089|P1|NOT COMPLETED|Overall Study||0
8352976|NCT01247220|20590088|P2|COMPLETED|Overall Study||6
8352977|NCT01247220|20590089|P1|COMPLETED|Overall Study||6
8352978|NCT01247220|20590088|P2|STARTED|Overall Study||6
8352979|NCT01247220|20590089|P1|STARTED|Overall Study||6
8352980|NCT01247090|20590102|P3|NOT COMPLETED|Overall Study||0
8352981|NCT01247090|20590103|P2|NOT COMPLETED|Overall Study||1
8352982|NCT01247090|20590104|P1|NOT COMPLETED|Overall Study||1
8352983|NCT01247090|20590102|P3|COMPLETED|Overall Study||4
8352984|NCT01247090|20590103|P2|COMPLETED|Overall Study||3
8352985|NCT01247090|20590104|P1|COMPLETED|Overall Study||3
8352986|NCT01247090|20590102|P3|STARTED|Overall Study||4
8352987|NCT01247090|20590103|P2|STARTED|Overall Study||4
8352988|NCT01247090|20590104|P1|STARTED|Overall Study||4
8352989|NCT01247064|20590114|P2|NOT COMPLETED|Overall Study||0
8352990|NCT01247064|20590115|P1|NOT COMPLETED|Overall Study||0
8352991|NCT01247064|20590114|P2|COMPLETED|Overall Study||31
8352992|NCT01247064|20590115|P1|COMPLETED|Overall Study||31
8352993|NCT01247064|20590114|P2|STARTED|Overall Study||31
8352994|NCT01247064|20590115|P1|STARTED|Overall Study||31
8352995|NCT01246999|20590133|P4|NOT COMPLETED|Overall Study||2
8352996|NCT01246999|20590134|P3|NOT COMPLETED|Overall Study||0
8352997|NCT01246999|20590135|P2|NOT COMPLETED|Overall Study||1
8352998|NCT01246999|20590136|P1|NOT COMPLETED|Overall Study||0
8352999|NCT01246999|20590133|P4|COMPLETED|Overall Study||15
8353000|NCT01246999|20590134|P3|COMPLETED|Overall Study||2
8353001|NCT01246999|20590135|P2|COMPLETED|Overall Study||3
8353002|NCT01246999|20590136|P1|COMPLETED|Overall Study||11
8353003|NCT01246999|20590133|P4|STARTED|Overall Study||17
8353004|NCT01246999|20590134|P3|STARTED|Overall Study||2
8353005|NCT01246999|20590135|P2|STARTED|Overall Study||4
8353006|NCT01246999|20590136|P1|STARTED|Overall Study||11
8353007|NCT01246986|20590176|P7|NOT COMPLETED|Overall Study||0
8353008|NCT01246986|20590177|P6|NOT COMPLETED|Overall Study||1
8353009|NCT01246986|20590178|P5|NOT COMPLETED|Overall Study||4
8353010|NCT01246986|20590179|P4|NOT COMPLETED|Overall Study||0
8353011|NCT01246986|20590180|P3|NOT COMPLETED|Overall Study||6
8353012|NCT01246986|20590181|P2|NOT COMPLETED|Overall Study||5
8353013|NCT01246986|20590182|P1|NOT COMPLETED|Overall Study||3
8353014|NCT01246986|20590176|P7|COMPLETED|Overall Study||5
8353015|NCT01246986|20590177|P6|COMPLETED|Overall Study||2
8353016|NCT01246986|20590178|P5|COMPLETED|Overall Study||40
8353017|NCT01246986|20590179|P4|COMPLETED|Overall Study||3
8353018|NCT01246986|20590180|P3|COMPLETED|Overall Study||34
8353019|NCT01246986|20590181|P2|COMPLETED|Overall Study||67
8353020|NCT01246986|20590182|P1|COMPLETED|Overall Study||34
8353021|NCT01246986|20590176|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
8353022|NCT01246986|20590177|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8353023|NCT01246986|20590178|P5|Received at Least 1 Dose of Study Drug|Overall Study||44
8353024|NCT01246986|20590179|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8353025|NCT01246986|20590180|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
8353026|NCT01246986|20590181|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
8353027|NCT01246986|20590182|P1|Received at Least 1 Dose of Study Drug|Overall Study||37
8353028|NCT01246986|20590176|P7|STARTED|Overall Study||5
8353029|NCT01246986|20590177|P6|STARTED|Overall Study||3
8353030|NCT01246986|20590178|P5|STARTED|Overall Study||44
8353031|NCT01246986|20590179|P4|STARTED|Overall Study||3
8353032|NCT01246986|20590180|P3|STARTED|Overall Study||40
8353033|NCT01246986|20590181|P2|STARTED|Overall Study||72
8353034|NCT01246986|20590182|P1|STARTED|Overall Study||37
8353035|NCT01246973|20590242|P2|NOT COMPLETED|Overall Study||47
8353036|NCT01246973|20590243|P1|NOT COMPLETED|Overall Study||61
8353037|NCT01246973|20590242|P2|COMPLETED|Overall Study||295
8353038|NCT01246973|20590243|P1|COMPLETED|Overall Study||283
8353039|NCT01246973|20590242|P2|STARTED|Overall Study||342
8353040|NCT01246973|20590243|P1|STARTED|Overall Study||344
8353041|NCT01246960|20590253|P2|NOT COMPLETED|Overall Study||4
8353042|NCT01246960|20590254|P1|NOT COMPLETED|Overall Study||6
8353043|NCT01246960|20590253|P2|COMPLETED|Overall Study||80
8353044|NCT01246960|20590254|P1|COMPLETED|Overall Study||78
8353045|NCT01246960|20590253|P2|Received Any Quantity of Study Drug|Overall Study||80
8353046|NCT01246960|20590254|P1|Received Any Quantity of Study Drug|Overall Study||82
8353047|NCT01246960|20590253|P2|STARTED|Overall Study||84
8353048|NCT01246960|20590254|P1|STARTED|Overall Study||84
8353049|NCT01246895|20590274|P2|NOT COMPLETED|Overall Study||4
8353050|NCT01246895|20590275|P1|NOT COMPLETED|Overall Study||3
8353051|NCT01246895|20590274|P2|COMPLETED|Overall Study||26
8353052|NCT01246895|20590275|P1|COMPLETED|Overall Study||34
8353053|NCT01246895|20590274|P2|STARTED|Overall Study||30
8353054|NCT01246895|20590275|P1|STARTED|Overall Study||37
8353055|NCT01246791|20590289|P1|NOT COMPLETED|Overall Study||0
8353056|NCT01246791|20590289|P1|COMPLETED|Overall Study||12
8353057|NCT01246791|20590289|P1|STARTED|Overall Study||12
8353058|NCT01246713|20590304|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
8353059|NCT01246713|20590305|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
8353060|NCT01246713|20590304|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
8353061|NCT01246713|20590305|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
8353062|NCT01246713|20590304|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
8353063|NCT01246713|20590305|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
8353064|NCT01246713|20590304|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8353065|NCT01246713|20590305|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8353066|NCT01246713|20590304|P2|COMPLETED|Washout (at Least 14 Days)||9
8353067|NCT01246713|20590305|P1|COMPLETED|Washout (at Least 14 Days)||6
8353068|NCT01246713|20590304|P2|STARTED|Washout (at Least 14 Days)||9
8353069|NCT01246713|20590305|P1|STARTED|Washout (at Least 14 Days)||6
8353070|NCT01246713|20590304|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
8353071|NCT01246713|20590305|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
8353072|NCT01246713|20590304|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
8353073|NCT01246713|20590305|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
8353074|NCT01246713|20590304|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
8353075|NCT01246713|20590305|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
8353076|NCT01246583|20590315|P4|NOT COMPLETED|Overall Study||1
8353077|NCT01246583|20590316|P3|NOT COMPLETED|Overall Study||1
8353078|NCT01246583|20590317|P2|NOT COMPLETED|Overall Study||0
8353079|NCT01246583|20590318|P1|NOT COMPLETED|Overall Study||1
8353080|NCT01246583|20590315|P4|COMPLETED|Overall Study||9
8353081|NCT01246583|20590316|P3|COMPLETED|Overall Study||24
8353082|NCT01246583|20590317|P2|COMPLETED|Overall Study||13
8353083|NCT01246583|20590318|P1|COMPLETED|Overall Study||22
8353084|NCT01246583|20590315|P4|STARTED|Overall Study||10
8353085|NCT01246583|20590316|P3|STARTED|Overall Study||25
8353086|NCT01246583|20590317|P2|STARTED|Overall Study||13
8353087|NCT01246583|20590318|P1|STARTED|Overall Study||23
8353088|NCT01246479|20590402|P1|NOT COMPLETED|Overall Study||5
8353089|NCT01246479|20590402|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
8353090|NCT01246479|20590402|P1|STARTED|Overall Study||23
8353091|NCT01246401|20590412|P2|NOT COMPLETED|Overall Study||0
8353092|NCT01246401|20590413|P1|NOT COMPLETED|Overall Study||0
8353093|NCT01246401|20590412|P2|COMPLETED|Overall Study||27
8353094|NCT01246401|20590413|P1|COMPLETED|Overall Study||66
8353095|NCT01246401|20590412|P2|STARTED|Overall Study||27
8353096|NCT01246401|20590413|P1|STARTED|Overall Study||66
8353097|NCT01246349|20590439|P2|NOT COMPLETED|Overall Study||0
8353098|NCT01246349|20590440|P1|NOT COMPLETED|Overall Study||0
8353099|NCT01246349|20590439|P2|COMPLETED|Overall Study||20
8353100|NCT01246349|20590440|P1|COMPLETED|Overall Study||20
8353101|NCT01246349|20590439|P2|STARTED|Overall Study||20
8353102|NCT01246349|20590440|P1|STARTED|Overall Study||20
8353103|NCT01246258|20590452|P1|NOT COMPLETED|Overall Study||0
8353104|NCT01246258|20590452|P1|COMPLETED|Overall Study||5
8353105|NCT01246258|20590452|P1|STARTED|Overall Study||5
8353106|NCT01246206|20590457|P1|NOT COMPLETED|Overall Study||1
8353107|NCT01246206|20590457|P1|COMPLETED|Overall Study||20
8353108|NCT01246206|20590457|P1|STARTED|Overall Study||21
8353109|NCT01246076|20590468|P1|NOT COMPLETED|Overall Study||0
8353110|NCT01246076|20590468|P1|COMPLETED|Overall Study||24
8353111|NCT01246076|20590468|P1|STARTED|Overall Study||24
8353112|NCT01246063|20590483|P6|NOT COMPLETED|Overall Study||0
8353113|NCT01246063|20590484|P5|NOT COMPLETED|Overall Study||0
8353114|NCT01246063|20590485|P4|NOT COMPLETED|Overall Study||0
8353115|NCT01246063|20590486|P3|NOT COMPLETED|Overall Study||0
8353116|NCT01246063|20590487|P2|NOT COMPLETED|Overall Study||0
8353117|NCT01246063|20590488|P1|NOT COMPLETED|Overall Study||0
8353118|NCT01246063|20590483|P6|COMPLETED|Overall Study||17
8353119|NCT01246063|20590484|P5|COMPLETED|Overall Study||7
8353120|NCT01246063|20590485|P4|COMPLETED|Overall Study||5
8353121|NCT01246063|20590486|P3|COMPLETED|Overall Study||4
8353122|NCT01246063|20590487|P2|COMPLETED|Overall Study||4
8353123|NCT01246063|20590488|P1|COMPLETED|Overall Study||3
8353124|NCT01246063|20590483|P6|STARTED|Overall Study||17
8353125|NCT01246063|20590484|P5|STARTED|Overall Study||7
8353126|NCT01246063|20590485|P4|STARTED|Overall Study||5
8353127|NCT01246063|20590486|P3|STARTED|Overall Study||4
8353128|NCT01246063|20590487|P2|STARTED|Overall Study||4
8353129|NCT01246063|20590488|P1|STARTED|Overall Study||3
8353130|NCT01246050|20590525|P2|NOT COMPLETED|Overall Study||0
8353131|NCT01246050|20590526|P1|NOT COMPLETED|Overall Study||0
8353132|NCT01246050|20590525|P2|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
8353133|NCT01246050|20590526|P1|COMPLETED|Overall Study||6
8353134|NCT01246050|20590525|P2|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
8353135|NCT01246050|20590526|P1|STARTED|Overall Study||6
8353136|NCT01246011|20590535|P3|NOT COMPLETED|Overall Study||4
8353137|NCT01246011|20590536|P2|NOT COMPLETED|Overall Study||0
8353138|NCT01246011|20590537|P1|NOT COMPLETED|Overall Study||0
8353139|NCT01246011|20590535|P3|COMPLETED|Overall Study||5
8353140|NCT01246011|20590536|P2|COMPLETED|Overall Study||0
8353141|NCT01246011|20590537|P1|COMPLETED|Overall Study||0
8353142|NCT01246011|20590535|P3|STARTED|Overall Study||9
8353143|NCT01246011|20590536|P2|STARTED|Overall Study||0
8353144|NCT01246011|20590537|P1|STARTED|Overall Study||0
8353145|NCT01245972|20590551|P3|NOT COMPLETED|Overall Study||0
8353146|NCT01245972|20590552|P2|NOT COMPLETED|Overall Study||0
8353147|NCT01245972|20590553|P1|NOT COMPLETED|Overall Study||0
8353148|NCT01245972|20590551|P3|COMPLETED|Overall Study||8
8353149|NCT01245972|20590552|P2|COMPLETED|Overall Study||8
8353150|NCT01245972|20590553|P1|COMPLETED|Overall Study||7
8353151|NCT01245972|20590551|P3|STARTED|Overall Study||8
8353152|NCT01245972|20590552|P2|STARTED|Overall Study||8
8353153|NCT01245972|20590553|P1|STARTED|Overall Study||7
8353154|NCT01245764|20590565|P4|NOT COMPLETED|Study Phase B||0
8353155|NCT01245764|20590566|P3|NOT COMPLETED|Study Phase B||0
8353156|NCT01245764|20590567|P2|NOT COMPLETED|Study Phase B||0
8353157|NCT01245764|20590568|P1|NOT COMPLETED|Study Phase B||0
8353158|NCT01245764|20590565|P4|COMPLETED|Study Phase B||17
8353159|NCT01245764|20590566|P3|COMPLETED|Study Phase B||0
8353160|NCT01245764|20590567|P2|COMPLETED|Study Phase B||0
8353161|NCT01245764|20590568|P1|COMPLETED|Study Phase B||0
8353162|NCT01245764|20590565|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
8353163|NCT01245764|20590566|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
8353164|NCT01245764|20590567|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
8353165|NCT01245764|20590568|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
8353166|NCT01245764|20590565|P4|STARTED|Study Phase B||17
8353167|NCT01245764|20590566|P3|STARTED|Study Phase B||0
8353168|NCT01245764|20590567|P2|STARTED|Study Phase B||0
8353169|NCT01245764|20590568|P1|STARTED|Study Phase B||0
8353170|NCT01245764|20590565|P4|NOT COMPLETED|Study Phase A||3
8353171|NCT01245764|20590566|P3|NOT COMPLETED|Study Phase A||10
8353172|NCT01245764|20590567|P2|NOT COMPLETED|Study Phase A||5
8353173|NCT01245764|20590568|P1|NOT COMPLETED|Study Phase A||9
8353174|NCT01245764|20590565|P4|COMPLETED|Study Phase A||17
8353175|NCT01245764|20590566|P3|COMPLETED|Study Phase A||110
8353176|NCT01245764|20590567|P2|COMPLETED|Study Phase A||25
8353177|NCT01245764|20590568|P1|COMPLETED|Study Phase A||71
8353178|NCT01245764|20590565|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
8353179|NCT01245764|20590566|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
8353180|NCT01245764|20590567|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
8353181|NCT01245764|20590568|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
8353182|NCT01245764|20590565|P4|STARTED|Study Phase A||20
8353183|NCT01245764|20590566|P3|STARTED|Study Phase A||120
8353184|NCT01245764|20590567|P2|STARTED|Study Phase A||30
8353185|NCT01245764|20590568|P1|STARTED|Study Phase A||80
8353186|NCT01245751|20590606|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353187|NCT01245751|20590607|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353188|NCT01245751|20590608|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353189|NCT01245751|20590609|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353190|NCT01245751|20590606|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353191|NCT01245751|20590607|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353192|NCT01245751|20590608|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
8353193|NCT01245751|20590609|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
8353194|NCT01245751|20590606|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
8353195|NCT01245751|20590607|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
8353196|NCT01245751|20590608|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
8353197|NCT01245751|20590609|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
8353198|NCT01245751|20590606|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
8353199|NCT01245751|20590607|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
8353200|NCT01245751|20590608|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
8353201|NCT01245751|20590609|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
8353202|NCT01245751|20590606|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
8353203|NCT01245751|20590607|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
8353204|NCT01245751|20590608|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
8353205|NCT01245751|20590609|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
8353206|NCT01245751|20590606|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
8353207|NCT01245751|20590607|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
8353208|NCT01245751|20590608|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
8353209|NCT01245751|20590609|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
8353210|NCT01245751|20590606|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
8353211|NCT01245751|20590607|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
8353212|NCT01245751|20590608|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
8353213|NCT01245751|20590609|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
8353214|NCT01245738|20590622|P1|NOT COMPLETED|Overall Study||40
8353215|NCT01245738|20590622|P1|COMPLETED|Overall Study||474
8353216|NCT01245738|20590622|P1|STARTED|Overall Study||514
8353217|NCT01245699|20590641|P2|NOT COMPLETED|Overall Study||5
8353218|NCT01245699|20590642|P1|NOT COMPLETED|Overall Study||9
8353219|NCT01245699|20590641|P2|COMPLETED|Overall Study||49
8353220|NCT01245699|20590642|P1|COMPLETED|Overall Study||52
8353221|NCT01245699|20590641|P2|STARTED|Overall Study||54
8353222|NCT01245699|20590642|P1|STARTED|Overall Study||61
8353223|NCT01245673|20590658|P1|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
8353224|NCT01245673|20590658|P1|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
8353225|NCT01245673|20590658|P1|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
8353226|NCT01245673|20590658|P1|NOT COMPLETED|Start Lenalidomide||0
8353227|NCT01245673|20590658|P1|COMPLETED|Start Lenalidomide||26
8353228|NCT01245673|20590658|P1|STARTED|Start Lenalidomide||26
8353229|NCT01245673|20590658|P1|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
8353230|NCT01245673|20590658|P1|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
8353231|NCT01245673|20590658|P1|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
8353232|NCT01245673|20590658|P1|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
8353233|NCT01245673|20590658|P1|COMPLETED|Activated/Costimulated Autologous T Cell||27
8353234|NCT01245673|20590658|P1|STARTED|Activated/Costimulated Autologous T Cell||27
8353235|NCT01245673|20590658|P1|NOT COMPLETED|Pre Transplant Vaccinations||0
8353236|NCT01245673|20590658|P1|COMPLETED|Pre Transplant Vaccinations||27
8353237|NCT01245673|20590658|P1|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
8353238|NCT01245673|20590658|P1|STARTED|Pre Transplant Vaccinations||27
8353239|NCT01245673|20590658|P1|NOT COMPLETED|Enrollment||1
8353240|NCT01245673|20590658|P1|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
8353241|NCT01245673|20590658|P1|STARTED|Enrollment||28
8353242|NCT01245647|20590664|P2|NOT COMPLETED|Overall Study||4
8353243|NCT01245647|20590665|P1|NOT COMPLETED|Overall Study||0
8353244|NCT01245647|20590664|P2|COMPLETED|Overall Study||8
8353245|NCT01245647|20590665|P1|COMPLETED|Overall Study||7
8353246|NCT01245647|20590664|P2|STARTED|Overall Study||12
8353247|NCT01245647|20590665|P1|STARTED|Overall Study||7
8353248|NCT01245595|20590681|P2|NOT COMPLETED|Overall Study||0
8353249|NCT01245595|20590682|P1|NOT COMPLETED|Overall Study||0
8353250|NCT01245595|20590681|P2|COMPLETED|Overall Study||72
8353251|NCT01245595|20590682|P1|COMPLETED|Overall Study||72
8353252|NCT01245595|20590681|P2|Completed Full Course of Study Drug|Overall Study||61
8353253|NCT01245595|20590682|P1|Completed Full Course of Study Drug|Overall Study||57
8353254|NCT01245595|20590681|P2|STARTED|Overall Study||72
8353255|NCT01245595|20590682|P1|STARTED|Overall Study||72
8353256|NCT01245439|20590688|P1|NOT COMPLETED|Overall Study||0
8353257|NCT01245439|20590688|P1|COMPLETED|Overall Study||65
8353258|NCT01245439|20590688|P1|STARTED|Overall Study||65
8353259|NCT01245413|20590719|P2|NOT COMPLETED|Athena First,||0
8353260|NCT01245413|20590720|P1|NOT COMPLETED|Athena First,||0
8353261|NCT01245413|20590719|P2|COMPLETED|Athena First,||16
8353262|NCT01245413|20590720|P1|COMPLETED|Athena First,||16
8353263|NCT01245413|20590719|P2|STARTED|Athena First,||16
8353264|NCT01245413|20590720|P1|STARTED|Athena First,||16
8353265|NCT01245413|20590719|P2|NOT COMPLETED|Sensura First,||0
8353266|NCT01245413|20590720|P1|NOT COMPLETED|Sensura First,||0
8353267|NCT01245413|20590719|P2|COMPLETED|Sensura First,||16
8353268|NCT01245413|20590720|P1|COMPLETED|Sensura First,||16
8353269|NCT01245413|20590719|P2|STARTED|Sensura First,||16
8353270|NCT01245413|20590720|P1|STARTED|Sensura First,||16
8353271|NCT01245387|20590726|P1|NOT COMPLETED|Overall Study||813
8353272|NCT01245387|20590726|P1|COMPLETED|Overall Study||188
8353273|NCT01245387|20590726|P1|STARTED|Overall Study||1001
8353274|NCT01245374|20590775|P1|NOT COMPLETED|Overall Study||4
8353275|NCT01245374|20590775|P1|COMPLETED|Overall Study||99
8353276|NCT01245374|20590775|P1|STARTED|Overall Study||103
8353277|NCT01245283|20590798|P3|NOT COMPLETED|Overall Study||11
8353278|NCT01245283|20590799|P2|NOT COMPLETED|Overall Study||11
8353279|NCT01245283|20590800|P1|NOT COMPLETED|Overall Study||14
8353280|NCT01245283|20590798|P3|COMPLETED|Overall Study||19
8353281|NCT01245283|20590799|P2|COMPLETED|Overall Study||17
8353282|NCT01245283|20590800|P1|COMPLETED|Overall Study||18
8353283|NCT01245283|20590798|P3|STARTED|Overall Study||30
8353284|NCT01245283|20590799|P2|STARTED|Overall Study||28
8353285|NCT01245283|20590800|P1|STARTED|Overall Study||32
8353286|NCT01245270|20590834|P2|NOT COMPLETED|Overall Study||0
8353287|NCT01245270|20590835|P1|NOT COMPLETED|Overall Study||0
8353288|NCT01245270|20590834|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8353289|NCT01245270|20590835|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8353290|NCT01245270|20590834|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8353291|NCT01245270|20590835|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8353292|NCT01245140|20590845|P2|NOT COMPLETED|Overall Study||10
8353293|NCT01245140|20590846|P1|NOT COMPLETED|Overall Study||3
8353294|NCT01245140|20590845|P2|COMPLETED|Overall Study||14
8353295|NCT01245140|20590846|P1|COMPLETED|Overall Study||6
8353296|NCT01245140|20590845|P2|STARTED|Overall Study||24
8353297|NCT01245140|20590846|P1|STARTED|Overall Study||9
8353298|NCT01245101|20590902|P2|NOT COMPLETED|Period 3 (Treatment)||0
8353299|NCT01245101|20590903|P1|NOT COMPLETED|Period 3 (Treatment)||1
8353300|NCT01245101|20590902|P2|COMPLETED|Period 3 (Treatment)||0
8353301|NCT01245101|20590903|P1|COMPLETED|Period 3 (Treatment)||11
8353302|NCT01245101|20590902|P2|STARTED|Period 3 (Treatment)||0
8353303|NCT01245101|20590903|P1|STARTED|Period 3 (Treatment)||12
8353304|NCT01245101|20590902|P2|NOT COMPLETED|Period 2 (Washout)||0
8353305|NCT01245101|20590903|P1|NOT COMPLETED|Period 2 (Washout)||1
8353306|NCT01245101|20590902|P2|COMPLETED|Period 2 (Washout)||0
8353307|NCT01245101|20590903|P1|COMPLETED|Period 2 (Washout)||12
8353308|NCT01245101|20590902|P2|STARTED|Period 2 (Washout)||0
8353309|NCT01245101|20590903|P1|STARTED|Period 2 (Washout)||13
8353310|NCT01245101|20590902|P2|NOT COMPLETED|Period 1 (Treatment)||0
8353311|NCT01245101|20590903|P1|NOT COMPLETED|Period 1 (Treatment)||2
8353312|NCT01245101|20590902|P2|COMPLETED|Period 1 (Treatment)||0
8353313|NCT01245101|20590903|P1|COMPLETED|Period 1 (Treatment)||13
8353314|NCT01245101|20590902|P2|STARTED|Period 1 (Treatment)||0
8353315|NCT01245101|20590903|P1|STARTED|Period 1 (Treatment)||15
8353316|NCT01245062|20590913|P3|NOT COMPLETED|Cross-over Phase||17
8353317|NCT01245062|20590914|P2|NOT COMPLETED|Cross-over Phase||0
8353318|NCT01245062|20590915|P1|NOT COMPLETED|Cross-over Phase||0
8353319|NCT01245062|20590913|P3|COMPLETED|Cross-over Phase||53
8353320|NCT01245062|20590914|P2|COMPLETED|Cross-over Phase||0
8353321|NCT01245062|20590915|P1|COMPLETED|Cross-over Phase||0
8353322|NCT01245062|20590913|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
8353323|NCT01245062|20590914|P2|STARTED|Cross-over Phase||0
8353324|NCT01245062|20590915|P1|STARTED|Cross-over Phase||0
8353325|NCT01245062|20590913|P3|NOT COMPLETED|Randomization and Crossover Phase||0
8353326|NCT01245062|20590914|P2|NOT COMPLETED|Randomization and Crossover Phase||31
8353327|NCT01245062|20590915|P1|NOT COMPLETED|Randomization and Crossover Phase||41
8353328|NCT01245062|20590913|P3|COMPLETED|Randomization and Crossover Phase||0
8353329|NCT01245062|20590914|P2|COMPLETED|Randomization and Crossover Phase||77
8353330|NCT01245062|20590915|P1|COMPLETED|Randomization and Crossover Phase||173
8353331|NCT01245062|20590913|P3|STARTED|Randomization and Crossover Phase||0
8353332|NCT01245062|20590914|P2|STARTED|Randomization and Crossover Phase||108
8353333|NCT01245062|20590915|P1|STARTED|Randomization and Crossover Phase||214
8353334|NCT01245049|20590953|P2|NOT COMPLETED|Overall Study||4
8353335|NCT01245049|20590954|P1|NOT COMPLETED|Overall Study||1
8353336|NCT01245049|20590953|P2|COMPLETED|Overall Study||126
8353337|NCT01245049|20590954|P1|COMPLETED|Overall Study||254
8353338|NCT01245049|20590953|P2|STARTED|Overall Study||130
8353339|NCT01245049|20590954|P1|STARTED|Overall Study||255
8353340|NCT01244984|20591007|P3|NOT COMPLETED|Overall Study||4
8353341|NCT01244984|20591008|P2|NOT COMPLETED|Overall Study||14
8353342|NCT01244984|20591009|P1|NOT COMPLETED|Overall Study||5
8353343|NCT01244984|20591007|P3|COMPLETED|Overall Study||86
8353344|NCT01244984|20591008|P2|COMPLETED|Overall Study||79
8353345|NCT01244984|20591009|P1|COMPLETED|Overall Study||55
8353346|NCT01244984|20591007|P3|STARTED|Overall Study||90
8353347|NCT01244984|20591008|P2|STARTED|Overall Study||93
8353348|NCT01244984|20591009|P1|STARTED|Overall Study||60
8353349|NCT01244906|20591083|P1|NOT COMPLETED|Overall Study||8
8353350|NCT01244906|20591083|P1|COMPLETED|Overall Study||18
8353351|NCT01244906|20591083|P1|STARTED|Overall Study||26
8353352|NCT01244893|20591092|P2|NOT COMPLETED|Final Visit||0
8353353|NCT01244893|20591093|P1|NOT COMPLETED|Final Visit||0
8353354|NCT01244893|20591092|P2|COMPLETED|Final Visit||21
8353355|NCT01244893|20591093|P1|COMPLETED|Final Visit||21
8353356|NCT01244893|20591092|P2|STARTED|Final Visit||21
8353357|NCT01244893|20591093|P1|STARTED|Final Visit||21
8353358|NCT01244893|20591092|P2|NOT COMPLETED|1-Week Follow Up||0
8353359|NCT01244893|20591093|P1|NOT COMPLETED|1-Week Follow Up||1
8353360|NCT01244893|20591092|P2|COMPLETED|1-Week Follow Up||21
8353361|NCT01244893|20591093|P1|COMPLETED|1-Week Follow Up||21
8353362|NCT01244893|20591092|P2|STARTED|1-Week Follow Up||21
8353363|NCT01244893|20591093|P1|STARTED|1-Week Follow Up||22
8353364|NCT01244893|20591092|P2|NOT COMPLETED|Baseline||1
8353365|NCT01244893|20591093|P1|NOT COMPLETED|Baseline||0
8353366|NCT01244893|20591092|P2|COMPLETED|Baseline||21
8353367|NCT01244893|20591093|P1|COMPLETED|Baseline||22
8353368|NCT01244893|20591092|P2|STARTED|Baseline||22
8353369|NCT01244893|20591093|P1|STARTED|Baseline||22
8353370|NCT01244828|20591105|P1|NOT COMPLETED|Overall Study||78
8353371|NCT01244828|20591105|P1|COMPLETED|Overall Study||79
8353372|NCT01244828|20591105|P1|STARTED|Overall Study|Received study drug|157
8353373|NCT01244815|20591121|P4|NOT COMPLETED|Overall Study||12
8353374|NCT01244815|20591122|P3|NOT COMPLETED|Overall Study||11
8353375|NCT01244815|20591123|P2|NOT COMPLETED|Overall Study||17
8353376|NCT01244815|20591124|P1|NOT COMPLETED|Overall Study||14
8353377|NCT01244815|20591121|P4|COMPLETED|Overall Study||87
8353378|NCT01244815|20591122|P3|COMPLETED|Overall Study||88
8353379|NCT01244815|20591123|P2|COMPLETED|Overall Study||88
8353380|NCT01244815|20591124|P1|COMPLETED|Overall Study||87
8353381|NCT01244815|20591121|P4|Treated|Overall Study||99
8353382|NCT01244815|20591122|P3|Treated|Overall Study||99
8353383|NCT01244815|20591123|P2|Treated|Overall Study||104
8353384|NCT01244815|20591124|P1|Treated|Overall Study||101
8353385|NCT01244815|20591121|P4|STARTED|Overall Study|Randomized|99
8353386|NCT01244815|20591122|P3|STARTED|Overall Study|Randomized|99
8353387|NCT01244815|20591123|P2|STARTED|Overall Study|Randomized|105
8353388|NCT01244815|20591124|P1|STARTED|Overall Study|Randomized|101
8353389|NCT01244724|20591198|P1|NOT COMPLETED|Overall Study||8
8353390|NCT01244724|20591198|P1|COMPLETED|Overall Study||9
8353391|NCT01244724|20591198|P1|Week 2 Visit|Overall Study||15
8353392|NCT01244724|20591198|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
8353393|NCT01244711|20591203|P1|NOT COMPLETED|Overall Study||0
8353394|NCT01244711|20591203|P1|COMPLETED|Overall Study||1
8353395|NCT01244711|20591203|P1|STARTED|Overall Study||1
8353396|NCT01244633|20591207|P1|NOT COMPLETED|Overall Study||3
8353397|NCT01244633|20591207|P1|COMPLETED|Overall Study||15
8353398|NCT01244633|20591207|P1|STARTED|Overall Study||18
8353399|NCT01244620|20591211|P4|NOT COMPLETED|Overall Study||4
8353400|NCT01244620|20591212|P3|NOT COMPLETED|Overall Study||4
8353401|NCT01244620|20591213|P2|NOT COMPLETED|Overall Study||4
8353402|NCT01244620|20591214|P1|NOT COMPLETED|Overall Study||4
8353403|NCT01244620|20591211|P4|COMPLETED|Overall Study||0
8353404|NCT01244620|20591212|P3|COMPLETED|Overall Study||0
8353405|NCT01244620|20591213|P2|COMPLETED|Overall Study||0
8353406|NCT01244620|20591214|P1|COMPLETED|Overall Study||0
8353407|NCT01244620|20591211|P4|STARTED|Overall Study||4
8353408|NCT01244620|20591212|P3|STARTED|Overall Study||4
8353409|NCT01244620|20591213|P2|STARTED|Overall Study||4
8353410|NCT01244620|20591214|P1|STARTED|Overall Study||4
8353411|NCT01244529|20591248|P1|NOT COMPLETED|Overall Study||0
8353412|NCT01244529|20591248|P1|COMPLETED|Overall Study||41
8353413|NCT01244529|20591248|P1|STARTED|Overall Study||41
8353414|NCT01244516|20591273|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
8353415|NCT01244516|20591274|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
8353416|NCT01244516|20591275|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
8353417|NCT01244516|20591273|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
8353418|NCT01244516|20591274|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
8353419|NCT01244516|20591275|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
8353420|NCT01244516|20591273|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
8353421|NCT01244516|20591274|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
8353422|NCT01244516|20591275|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
8353423|NCT01244516|20591273|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
8353424|NCT01244516|20591274|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
8353425|NCT01244516|20591275|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
8353426|NCT01244516|20591273|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
8353427|NCT01244516|20591274|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
8353428|NCT01244516|20591275|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
8353429|NCT01244516|20591273|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
8353430|NCT01244516|20591274|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
8353431|NCT01244516|20591275|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
8353432|NCT01244503|20591288|P1|NOT COMPLETED|Overall Study||0
8353433|NCT01244503|20591288|P1|COMPLETED|Overall Study||61
8353434|NCT01244503|20591288|P1|STARTED|Overall Study||61
8353435|NCT01244490|20591296|P3|NOT COMPLETED|Overall Study||23
8353436|NCT01244490|20591297|P2|NOT COMPLETED|Overall Study||24
8353437|NCT01244490|20591298|P1|NOT COMPLETED|Overall Study||19
8353438|NCT01244490|20591296|P3|COMPLETED|Overall Study||89
8353439|NCT01244490|20591297|P2|COMPLETED|Overall Study||91
8353440|NCT01244490|20591298|P1|COMPLETED|Overall Study||92
8353441|NCT01244490|20591296|P3|STARTED|Overall Study||112
8353442|NCT01244490|20591297|P2|STARTED|Overall Study||115
8353443|NCT01244490|20591298|P1|STARTED|Overall Study||111
8353444|NCT01244477|20591353|P2|NOT COMPLETED|Overall Study||3
8353445|NCT01244477|20591354|P1|NOT COMPLETED|Overall Study||20
8353446|NCT01244477|20591353|P2|COMPLETED|Overall Study||20
8353447|NCT01244477|20591354|P1|COMPLETED|Overall Study||18
8353448|NCT01244477|20591353|P2|STARTED|Overall Study||23
8353449|NCT01244477|20591354|P1|STARTED|Overall Study||38
8353450|NCT01244451|20591366|P1|NOT COMPLETED|Overall Study||13
8353451|NCT01244451|20591366|P1|COMPLETED|Overall Study||36
8353452|NCT01244451|20591366|P1|STARTED|Overall Study||49
8353453|NCT01244425|20591375|P2|NOT COMPLETED|Overall Study||3
8353454|NCT01244425|20591376|P1|NOT COMPLETED|Overall Study||3
8353455|NCT01244425|20591375|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
8353456|NCT01244425|20591376|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
8353457|NCT01244425|20591375|P2|STARTED|Overall Study||35
8353458|NCT01244425|20591376|P1|STARTED|Overall Study||35
8353459|NCT01244412|20591396|P1|NOT COMPLETED|Overall Study||0
8353460|NCT01244412|20591396|P1|COMPLETED|Overall Study||1
8353461|NCT01244412|20591396|P1|STARTED|Overall Study||1
8353462|NCT01244243|20591400|P1|NOT COMPLETED|Overall Study||0
8353463|NCT01244243|20591400|P1|COMPLETED|Overall Study||41
8353464|NCT01244243|20591400|P1|STARTED|Overall Study||41
8353465|NCT01244191|20591407|P2|NOT COMPLETED|Overall Study||498
8353466|NCT01244191|20591408|P1|NOT COMPLETED|Overall Study||480
8353467|NCT01244191|20591407|P2|COMPLETED|Overall Study||24
8353468|NCT01244191|20591408|P1|COMPLETED|Overall Study||46
8353469|NCT01244191|20591407|P2|Did Not Receive Treatment|Overall Study||5
8353470|NCT01244191|20591408|P1|Did Not Receive Treatment|Overall Study||6
8353471|NCT01244191|20591407|P2|STARTED|Overall Study||522
8353472|NCT01244191|20591408|P1|STARTED|Overall Study||526
8353473|NCT01244126|20591431|P3|NOT COMPLETED|Overall Study||9
8353474|NCT01244126|20591432|P2|NOT COMPLETED|Overall Study||3
8353475|NCT01244126|20591433|P1|NOT COMPLETED|Overall Study||3
8353476|NCT01244126|20591431|P3|COMPLETED|Overall Study||48
8353477|NCT01244126|20591432|P2|COMPLETED|Overall Study||52
8353478|NCT01244126|20591433|P1|COMPLETED|Overall Study||56
8353479|NCT01244126|20591431|P3|STARTED|Overall Study||57
8353480|NCT01244126|20591432|P2|STARTED|Overall Study||55
8353481|NCT01244126|20591433|P1|STARTED|Overall Study||59
8353482|NCT01244061|20591446|P2|NOT COMPLETED|Overall Study||103
8353483|NCT01244061|20591447|P1|NOT COMPLETED|Overall Study||82
8353484|NCT01244061|20591446|P2|COMPLETED|Overall Study||144
8353485|NCT01244061|20591447|P1|COMPLETED|Overall Study||169
8353486|NCT01244061|20591446|P2|STARTED|Overall Study||247
8353487|NCT01244061|20591447|P1|STARTED|Overall Study||251
8353488|NCT01244035|20591459|P6|NOT COMPLETED|Part 1: Period 3||1
8353489|NCT01244035|20591460|P5|NOT COMPLETED|Part 1: Period 3||1
8353490|NCT01244035|20591461|P4|NOT COMPLETED|Part 1: Period 3||0
8353491|NCT01244035|20591462|P3|NOT COMPLETED|Part 1: Period 3||0
8353492|NCT01244035|20591463|P2|NOT COMPLETED|Part 1: Period 3||1
8353493|NCT01244035|20591464|P1|NOT COMPLETED|Part 1: Period 3||0
8353494|NCT01244035|20591459|P6|COMPLETED|Part 1: Period 3||2
8353495|NCT01244035|20591460|P5|COMPLETED|Part 1: Period 3||3
8353496|NCT01244035|20591461|P4|COMPLETED|Part 1: Period 3||5
8353497|NCT01244035|20591462|P3|COMPLETED|Part 1: Period 3||3
8353498|NCT01244035|20591463|P2|COMPLETED|Part 1: Period 3||2
8353499|NCT01244035|20591464|P1|COMPLETED|Part 1: Period 3||4
8353500|NCT01244035|20591459|P6|STARTED|Part 1: Period 3||3
8353501|NCT01244035|20591460|P5|STARTED|Part 1: Period 3||4
8353502|NCT01244035|20591461|P4|STARTED|Part 1: Period 3||5
8353503|NCT01244035|20591462|P3|STARTED|Part 1: Period 3||3
8353504|NCT01244035|20591463|P2|STARTED|Part 1: Period 3||3
8353505|NCT01244035|20591464|P1|STARTED|Part 1: Period 3||4
8353506|NCT01244035|20591459|P6|NOT COMPLETED|Part 1: Period 2||0
8353507|NCT01244035|20591460|P5|NOT COMPLETED|Part 1: Period 2||0
8353508|NCT01244035|20591461|P4|NOT COMPLETED|Part 1: Period 2||0
8353509|NCT01244035|20591462|P3|NOT COMPLETED|Part 1: Period 2||1
8353510|NCT01244035|20591463|P2|NOT COMPLETED|Part 1: Period 2||0
8353511|NCT01244035|20591464|P1|NOT COMPLETED|Part 1: Period 2||0
8353512|NCT01244035|20591459|P6|COMPLETED|Part 1: Period 2||3
8353513|NCT01244035|20591460|P5|COMPLETED|Part 1: Period 2||4
8353514|NCT01244035|20591461|P4|COMPLETED|Part 1: Period 2||5
8353515|NCT01244035|20591462|P3|COMPLETED|Part 1: Period 2||3
8353516|NCT01244035|20591463|P2|COMPLETED|Part 1: Period 2||3
8353517|NCT01244035|20591464|P1|COMPLETED|Part 1: Period 2||4
8353518|NCT01244035|20591459|P6|STARTED|Part 1: Period 2||3
8353519|NCT01244035|20591460|P5|STARTED|Part 1: Period 2||4
8353520|NCT01244035|20591461|P4|STARTED|Part 1: Period 2||5
8353521|NCT01244035|20591462|P3|STARTED|Part 1: Period 2||4
8353522|NCT01244035|20591463|P2|STARTED|Part 1: Period 2||3
8353523|NCT01244035|20591464|P1|STARTED|Part 1: Period 2||4
8353524|NCT01244035|20591459|P6|NOT COMPLETED|Part 1: Period 1||2
8353525|NCT01244035|20591460|P5|NOT COMPLETED|Part 1: Period 1||1
8353526|NCT01244035|20591461|P4|NOT COMPLETED|Part 1: Period 1||0
8353527|NCT01244035|20591462|P3|NOT COMPLETED|Part 1: Period 1||2
8353528|NCT01244035|20591463|P2|NOT COMPLETED|Part 1: Period 1||2
8353529|NCT01244035|20591464|P1|NOT COMPLETED|Part 1: Period 1||1
8353530|NCT01244035|20591459|P6|COMPLETED|Part 1: Period 1||3
8353531|NCT01244035|20591460|P5|COMPLETED|Part 1: Period 1||4
8353532|NCT01244035|20591461|P4|COMPLETED|Part 1: Period 1||5
8353533|NCT01244035|20591462|P3|COMPLETED|Part 1: Period 1||4
8353534|NCT01244035|20591463|P2|COMPLETED|Part 1: Period 1||3
8353535|NCT01244035|20591464|P1|COMPLETED|Part 1: Period 1||4
8353536|NCT01244035|20591459|P6|STARTED|Part 1: Period 1||5
8353537|NCT01244035|20591460|P5|STARTED|Part 1: Period 1||5
8353538|NCT01244035|20591461|P4|STARTED|Part 1: Period 1||5
8353539|NCT01244035|20591462|P3|STARTED|Part 1: Period 1||6
8353540|NCT01244035|20591463|P2|STARTED|Part 1: Period 1||5
8353541|NCT01244035|20591464|P1|STARTED|Part 1: Period 1||5
8353542|NCT01243957|20591492|P1|NOT COMPLETED|Overall Study||0
8353543|NCT01243957|20591492|P1|COMPLETED|Overall Study||20
8353544|NCT01243957|20591492|P1|STARTED|Overall Study||20
8353545|NCT01243944|20591505|P2|NOT COMPLETED|Overall Study||51
8353546|NCT01243944|20591506|P1|NOT COMPLETED|Overall Study||45
8353547|NCT01243944|20591505|P2|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
8353548|NCT01243944|20591506|P1|COMPLETED|Overall Study||65
8353549|NCT01243944|20591505|P2|Followed for Survival|Overall Study||21
8353550|NCT01243944|20591506|P1|Followed for Survival|Overall Study||22
8353551|NCT01243944|20591505|P2|Treated|Overall Study||111
8353552|NCT01243944|20591506|P1|Treated|Overall Study||110
8353553|NCT01243944|20591505|P2|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
8353554|NCT01243944|20591506|P1|STARTED|Overall Study||110
8353555|NCT01243892|20591534|P2|NOT COMPLETED|Overall Study||0
8353556|NCT01243892|20591535|P1|NOT COMPLETED|Overall Study||2
8353557|NCT01243892|20591534|P2|COMPLETED|Overall Study||3
8353558|NCT01243892|20591535|P1|COMPLETED|Overall Study||13
8353559|NCT01243892|20591534|P2|STARTED|Overall Study||3
8353560|NCT01243892|20591535|P1|STARTED|Overall Study||15
8353561|NCT01243775|20591545|P1|NOT COMPLETED|Overall Study||2
8353562|NCT01243775|20591545|P1|COMPLETED|Overall Study||31
8353563|NCT01243775|20591545|P1|STARTED|Overall Study||33
8353564|NCT01243762|20591559|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
8353565|NCT01243762|20591560|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353566|NCT01243762|20591561|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
8353567|NCT01243762|20591562|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
8353568|NCT01243762|20591563|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353569|NCT01243762|20591564|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
8353570|NCT01243762|20591565|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
8353571|NCT01243762|20591559|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353572|NCT01243762|20591560|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353573|NCT01243762|20591561|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353574|NCT01243762|20591562|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353575|NCT01243762|20591563|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353576|NCT01243762|20591564|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353577|NCT01243762|20591565|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353578|NCT01243762|20591559|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
8353579|NCT01243762|20591560|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
8353580|NCT01243762|20591561|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
8353581|NCT01243762|20591562|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
8353582|NCT01243762|20591563|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
8353583|NCT01243762|20591564|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
8353584|NCT01243762|20591565|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
8353585|NCT01243762|20591559|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353586|NCT01243762|20591560|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8353587|NCT01243762|20591561|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
8353588|NCT01243762|20591562|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
8353589|NCT01243762|20591563|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8353590|NCT01243762|20591564|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
8353591|NCT01243762|20591565|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8353592|NCT01243762|20591559|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353593|NCT01243762|20591560|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353594|NCT01243762|20591561|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
8353595|NCT01243762|20591562|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
8353596|NCT01243762|20591563|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353597|NCT01243762|20591564|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
8353598|NCT01243762|20591565|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
8353599|NCT01243762|20591559|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
8353600|NCT01243762|20591560|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
8353601|NCT01243762|20591561|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
8353602|NCT01243762|20591562|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
8353603|NCT01243762|20591563|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
8353604|NCT01243762|20591564|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
8353605|NCT01243762|20591565|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
8353606|NCT01243671|20591584|P1|NOT COMPLETED|Overall Study||5
8353607|NCT01243671|20591584|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
8353608|NCT01243671|20591584|P1|Completed 52 Weeks of Treatment|Overall Study||17
8353609|NCT01243671|20591584|P1|Completed 24 Weeks of Treatment|Overall Study||18
8353610|NCT01243671|20591584|P1|STARTED|Overall Study||20
8353611|NCT01243619|20591597|P1|NOT COMPLETED|Overall Study||0
8353612|NCT01243619|20591597|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
8353613|NCT01243619|20591597|P1|STARTED|Overall Study||5
8353614|NCT01243580|20591603|P2|NOT COMPLETED|Overall Study||2
8353615|NCT01243580|20591604|P1|NOT COMPLETED|Overall Study||0
8353616|NCT01243580|20591603|P2|COMPLETED|Overall Study||16
8353617|NCT01243580|20591604|P1|COMPLETED|Overall Study||18
8353618|NCT01243580|20591603|P2|STARTED|Overall Study||18
8353619|NCT01243580|20591604|P1|STARTED|Overall Study||18
8353620|NCT01243567|20591633|P2|NOT COMPLETED|Overall Study||0
8353621|NCT01243567|20591634|P1|NOT COMPLETED|Overall Study||1
8353622|NCT01243567|20591633|P2|COMPLETED|Overall Study||38
8353623|NCT01243567|20591634|P1|COMPLETED|Overall Study||42
8353624|NCT01243567|20591633|P2|STARTED|Overall Study||38
8353625|NCT01243567|20591634|P1|STARTED|Overall Study||43
8353626|NCT01243450|20591651|P3|NOT COMPLETED|Overall Study||67
8353627|NCT01243450|20591652|P2|NOT COMPLETED|Overall Study||25
8353628|NCT01243450|20591653|P1|NOT COMPLETED|Overall Study||83
8353629|NCT01243450|20591651|P3|COMPLETED|Overall Study||337
8353630|NCT01243450|20591652|P2|COMPLETED|Overall Study||110
8353631|NCT01243450|20591653|P1|COMPLETED|Overall Study||318
8353632|NCT01243450|20591651|P3|STARTED|Overall Study||404
8353633|NCT01243450|20591652|P2|STARTED|Overall Study||135
8353634|NCT01243450|20591653|P1|STARTED|Overall Study||401
8353635|NCT01243424|20591663|P2|NOT COMPLETED|Discontinuation From Treatment||1182
8353636|NCT01243424|20591664|P1|NOT COMPLETED|Discontinuation From Treatment||1132
8353637|NCT01243424|20591663|P2|COMPLETED|Discontinuation From Treatment||1832
8353638|NCT01243424|20591664|P1|COMPLETED|Discontinuation From Treatment||1896
8353639|NCT01243424|20591663|P2|Treated|Discontinuation From Treatment||3010
8353640|NCT01243424|20591664|P1|Treated|Discontinuation From Treatment||3023
8353641|NCT01243424|20591663|P2|STARTED|Discontinuation From Treatment||3014
8353642|NCT01243424|20591664|P1|STARTED|Discontinuation From Treatment||3028
8353643|NCT01243424|20591663|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
8353644|NCT01243424|20591664|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
8353645|NCT01243424|20591663|P2|COMPLETED|Discontinuation From Study (Treated Set)||2895
8353646|NCT01243424|20591664|P1|COMPLETED|Discontinuation From Study (Treated Set)||2899
8353647|NCT01243424|20591663|P2|Treated|Discontinuation From Study (Treated Set)||3010
8353648|NCT01243424|20591664|P1|Treated|Discontinuation From Study (Treated Set)||3023
8353649|NCT01243424|20591663|P2|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
8353650|NCT01243424|20591664|P1|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
8353651|NCT01243424|20591663|P2|STARTED|Discontinuation From Study (Treated Set)||3014
8353652|NCT01243424|20591664|P1|STARTED|Discontinuation From Study (Treated Set)||3028
8353653|NCT01243411|20591706|P1|NOT COMPLETED|Overall Study||41
8353654|NCT01243411|20591706|P1|COMPLETED|Overall Study||306
8353655|NCT01243411|20591706|P1|STARTED|Overall Study||347
8353656|NCT01243333|20591718|P1|NOT COMPLETED|Overall Study||8
8353657|NCT01243333|20591718|P1|COMPLETED|Overall Study||18
8353658|NCT01243333|20591718|P1|STARTED|Overall Study||26
8353659|NCT01243320|20591724|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
8353660|NCT01243320|20591724|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
8353661|NCT01243320|20591724|P1|STARTED|32ppm Oral Silver (14 Days)||24
8353662|NCT01243320|20591724|P1|NOT COMPLETED|Washout (3 Days)||0
8353663|NCT01243320|20591724|P1|COMPLETED|Washout (3 Days)||36
8353664|NCT01243320|20591724|P1|STARTED|Washout (3 Days)||36
8353665|NCT01243320|20591724|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
8353666|NCT01243320|20591724|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
8353667|NCT01243320|20591724|P1|STARTED|10ppm Oral Silver (14 Days)||36
8353668|NCT01243320|20591724|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
8353669|NCT01243320|20591724|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
8353670|NCT01243320|20591724|P1|STARTED|10ppm Oral Silver (7 Days)||36
8353671|NCT01243320|20591724|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
8353672|NCT01243320|20591724|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
8353673|NCT01243320|20591724|P1|STARTED|10ppm Oral Silver (3 Days)||36
8353674|NCT01243294|20591800|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
8353675|NCT01243294|20591801|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
8353676|NCT01243294|20591800|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
8353677|NCT01243294|20591801|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
8353678|NCT01243294|20591800|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
8353679|NCT01243294|20591801|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
8353680|NCT01243294|20591800|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
8353681|NCT01243294|20591801|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
8353682|NCT01243294|20591800|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
8353683|NCT01243294|20591801|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
8353684|NCT01243294|20591800|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
8353685|NCT01243294|20591801|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
8353686|NCT01243268|20591817|P1|NOT COMPLETED|Overall Study||64
8353687|NCT01243268|20591817|P1|COMPLETED|Overall Study||610
8353688|NCT01243268|20591817|P1|STARTED|Overall Study||674
8353689|NCT01243242|20591827|P2|NOT COMPLETED|Overall Study||4
8353690|NCT01243242|20591828|P1|NOT COMPLETED|Overall Study||3
8353691|NCT01243242|20591827|P2|COMPLETED|Overall Study||56
8353692|NCT01243242|20591828|P1|COMPLETED|Overall Study||57
8353693|NCT01243242|20591827|P2|STARTED|Overall Study||60
8353694|NCT01243242|20591828|P1|STARTED|Overall Study||60
8353701|NCT01243151|20591864|P5|NOT COMPLETED|Overall Study||0
8353702|NCT01243151|20591865|P4|NOT COMPLETED|Overall Study||2
8353703|NCT01243151|20591866|P3|NOT COMPLETED|Overall Study||1
8353704|NCT01243151|20591867|P2|NOT COMPLETED|Overall Study||1
8353705|NCT01243151|20591868|P1|NOT COMPLETED|Overall Study||0
8353706|NCT01243151|20591864|P5|COMPLETED|Overall Study||14
8353707|NCT01243151|20591865|P4|COMPLETED|Overall Study||12
8353708|NCT01243151|20591866|P3|COMPLETED|Overall Study||13
8353709|NCT01243151|20591867|P2|COMPLETED|Overall Study||13
8353710|NCT01243151|20591868|P1|COMPLETED|Overall Study||12
8353711|NCT01243151|20591864|P5|Treated|Overall Study||14
8353712|NCT01243151|20591865|P4|Treated|Overall Study||13
8353713|NCT01243151|20591866|P3|Treated|Overall Study||14
8353714|NCT01243151|20591867|P2|Treated|Overall Study||14
8353715|NCT01243151|20591868|P1|Treated|Overall Study||12
8353716|NCT01243151|20591864|P5|STARTED|Overall Study||14
8353717|NCT01243151|20591865|P4|STARTED|Overall Study||14
8353718|NCT01243151|20591866|P3|STARTED|Overall Study||14
8353719|NCT01243151|20591867|P2|STARTED|Overall Study||14
8353720|NCT01243151|20591868|P1|STARTED|Overall Study||12
8353721|NCT01243112|20592107|P1|NOT COMPLETED|Overall Study||0
8353722|NCT01243112|20592107|P1|COMPLETED|Overall Study||25
8353723|NCT01243112|20592107|P1|STARTED|Overall Study||25
8353724|NCT01242813|20592112|P1|NOT COMPLETED|Overall Study||2
8353725|NCT01242813|20592112|P1|COMPLETED|Overall Study||18
8353726|NCT01242813|20592112|P1|STARTED|Overall Study||20
8353727|NCT01242748|20592134|P2|NOT COMPLETED|Overall Study||14
8353728|NCT01242748|20592135|P1|NOT COMPLETED|Overall Study||38
8353729|NCT01242748|20592134|P2|COMPLETED|Overall Study||80
8353730|NCT01242748|20592135|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
8353731|NCT01242748|20592134|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
8353732|NCT01242748|20592135|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
8353733|NCT01242748|20592134|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
8353734|NCT01242748|20592135|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
8353735|NCT01242748|20592134|P2|STARTED|Overall Study||94
8353736|NCT01242748|20592135|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
8353737|NCT01242644|20592158|P3|NOT COMPLETED|Overall Study||0
8353738|NCT01242644|20592159|P2|NOT COMPLETED|Overall Study||0
8353739|NCT01242644|20592160|P1|NOT COMPLETED|Overall Study||0
8353740|NCT01242644|20592158|P3|COMPLETED|Overall Study||15
8353741|NCT01242644|20592159|P2|COMPLETED|Overall Study||17
8353742|NCT01242644|20592160|P1|COMPLETED|Overall Study||16
8353743|NCT01242644|20592158|P3|STARTED|Overall Study||15
8353744|NCT01242644|20592159|P2|STARTED|Overall Study||17
8353745|NCT01242644|20592160|P1|STARTED|Overall Study||16
8353746|NCT01242527|20592193|P4|NOT COMPLETED|Overall Study||9
8353747|NCT01242527|20592194|P3|NOT COMPLETED|Overall Study||14
8353748|NCT01242527|20592195|P2|NOT COMPLETED|Overall Study||7
8353749|NCT01242527|20592196|P1|NOT COMPLETED|Overall Study||5
8353750|NCT01242527|20592193|P4|COMPLETED|Overall Study||90
8353751|NCT01242527|20592194|P3|COMPLETED|Overall Study||87
8353752|NCT01242527|20592195|P2|COMPLETED|Overall Study||93
8353753|NCT01242527|20592196|P1|COMPLETED|Overall Study||94
8353754|NCT01242527|20592193|P4|STARTED|Overall Study||99
8353755|NCT01242527|20592194|P3|STARTED|Overall Study||101
8353756|NCT01242527|20592195|P2|STARTED|Overall Study||100
8353757|NCT01242527|20592196|P1|STARTED|Overall Study||99
8353758|NCT01242514|20592209|P3|NOT COMPLETED|Overall Study||212
8353759|NCT01242514|20592210|P2|NOT COMPLETED|Overall Study||357
8353760|NCT01242514|20592211|P1|NOT COMPLETED|Overall Study||1343
8353761|NCT01242514|20592209|P3|COMPLETED|Overall Study|Due to project closure.|0
8353762|NCT01242514|20592210|P2|COMPLETED|Overall Study|Due to project closure.|0
8353763|NCT01242514|20592211|P1|COMPLETED|Overall Study|Due to project closure.|0
8353764|NCT01242514|20592209|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
8353765|NCT01242514|20592210|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
8353766|NCT01242514|20592211|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
8353767|NCT01242514|20592209|P3|STARTED|Overall Study|Patients who received treatment|212
8353768|NCT01242514|20592210|P2|STARTED|Overall Study|Patients who received treatment|357
8353769|NCT01242514|20592211|P1|STARTED|Overall Study|Patients who received treatment|1343
8353770|NCT01242371|20592230|P2|NOT COMPLETED|Overall Study||5
8353771|NCT01242371|20592231|P1|NOT COMPLETED|Overall Study||2
8353772|NCT01242371|20592230|P2|COMPLETED|Overall Study||27
8353773|NCT01242371|20592231|P1|COMPLETED|Overall Study||31
8353774|NCT01242371|20592230|P2|STARTED|Overall Study||32
8353775|NCT01242371|20592231|P1|STARTED|Overall Study||33
8353776|NCT01242241|20592239|P2|NOT COMPLETED|Overall Study||0
8353777|NCT01242241|20592240|P1|NOT COMPLETED|Overall Study||0
8353778|NCT01242241|20592239|P2|COMPLETED|Overall Study||40
8353779|NCT01242241|20592240|P1|COMPLETED|Overall Study||40
8353780|NCT01242241|20592239|P2|STARTED|Overall Study||40
8353781|NCT01242241|20592240|P1|STARTED|Overall Study||40
8353782|NCT01242176|20592248|P2|NOT COMPLETED|Second Intervention||0
8353783|NCT01242176|20592249|P1|NOT COMPLETED|Second Intervention||0
8353784|NCT01242176|20592248|P2|COMPLETED|Second Intervention||10
8353785|NCT01242176|20592249|P1|COMPLETED|Second Intervention||11
8353786|NCT01242176|20592248|P2|STARTED|Second Intervention||10
8353787|NCT01242176|20592249|P1|STARTED|Second Intervention||11
8353788|NCT01242176|20592248|P2|NOT COMPLETED|Washout Period of 7 Days||2
8353789|NCT01242176|20592249|P1|NOT COMPLETED|Washout Period of 7 Days||1
8353790|NCT01242176|20592248|P2|COMPLETED|Washout Period of 7 Days||10
8353791|NCT01242176|20592249|P1|COMPLETED|Washout Period of 7 Days||11
8353792|NCT01242176|20592248|P2|STARTED|Washout Period of 7 Days||12
8353793|NCT01242176|20592249|P1|STARTED|Washout Period of 7 Days||12
8353794|NCT01242176|20592248|P2|NOT COMPLETED|First Intervention||0
8353795|NCT01242176|20592249|P1|NOT COMPLETED|First Intervention||0
8353796|NCT01242176|20592248|P2|COMPLETED|First Intervention||12
8353797|NCT01242176|20592249|P1|COMPLETED|First Intervention||12
8353798|NCT01242176|20592248|P2|STARTED|First Intervention||12
8353799|NCT01242176|20592249|P1|STARTED|First Intervention||12
8353800|NCT01242111|20592259|P1|NOT COMPLETED|Overall Study||3
8353801|NCT01242111|20592259|P1|COMPLETED|Overall Study||17
8353802|NCT01242111|20592259|P1|STARTED|Overall Study||20
8353803|NCT01242085|20592271|P3|NOT COMPLETED|Overall Study||0
8353804|NCT01242085|20592272|P2|NOT COMPLETED|Overall Study||7
8353805|NCT01242085|20592273|P1|NOT COMPLETED|Overall Study||8
8353806|NCT01242085|20592271|P3|COMPLETED|Overall Study||1
8353807|NCT01242085|20592272|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
8353808|NCT01242085|20592273|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
8353809|NCT01242085|20592271|P3|STARTED|Overall Study||1
8353810|NCT01242085|20592272|P2|STARTED|Overall Study||33
8353811|NCT01242085|20592273|P1|STARTED|Overall Study||30
8353812|NCT01242020|20592283|P2|NOT COMPLETED|Overall Study||0
8353813|NCT01242020|20592284|P1|NOT COMPLETED|Overall Study||3
8353814|NCT01242020|20592283|P2|COMPLETED|Overall Study||0
8353815|NCT01242020|20592284|P1|COMPLETED|Overall Study||3
8353816|NCT01242020|20592283|P2|STARTED|Overall Study||0
8353817|NCT01242020|20592284|P1|STARTED|Overall Study||6
8353818|NCT01241916|20592294|P2|NOT COMPLETED|Overall Study||10
8353819|NCT01241916|20592295|P1|NOT COMPLETED|Overall Study||7
8353820|NCT01241916|20592294|P2|COMPLETED|Overall Study||21
8353821|NCT01241916|20592295|P1|COMPLETED|Overall Study||28
8353822|NCT01241916|20592294|P2|STARTED|Overall Study||31
8353823|NCT01241916|20592295|P1|STARTED|Overall Study||35
8353824|NCT01241903|20592305|P2|NOT COMPLETED|Overall Study||0
8353825|NCT01241903|20592306|P1|NOT COMPLETED|Overall Study||1
8353826|NCT01241903|20592305|P2|COMPLETED|Overall Study||27
8353827|NCT01241903|20592306|P1|COMPLETED|Overall Study||26
8353828|NCT01241903|20592305|P2|STARTED|Overall Study||27
8353829|NCT01241903|20592306|P1|STARTED|Overall Study||27
8353830|NCT01241760|20592314|P2|NOT COMPLETED|Overall Study||40
8353831|NCT01241760|20592315|P1|NOT COMPLETED|Overall Study||34
8353832|NCT01241760|20592314|P2|COMPLETED|Overall Study||329
8353833|NCT01241760|20592315|P1|COMPLETED|Overall Study||337
8353834|NCT01241760|20592314|P2|STARTED|Overall Study||369
8353835|NCT01241760|20592315|P1|STARTED|Overall Study||371
8353836|NCT01241604|20592334|P3|NOT COMPLETED|Study Period||0
8353837|NCT01241604|20592335|P2|NOT COMPLETED|Study Period||0
8353838|NCT01241604|20592336|P1|NOT COMPLETED|Study Period||0
8353839|NCT01241604|20592334|P3|COMPLETED|Study Period||3
8353840|NCT01241604|20592335|P2|COMPLETED|Study Period||5
8353841|NCT01241604|20592336|P1|COMPLETED|Study Period||0
8353842|NCT01241604|20592334|P3|STARTED|Study Period||3
8353843|NCT01241604|20592335|P2|STARTED|Study Period||5
8353844|NCT01241604|20592336|P1|STARTED|Study Period||0
8353845|NCT01241604|20592334|P3|NOT COMPLETED|Screening Period||0
8353846|NCT01241604|20592335|P2|NOT COMPLETED|Screening Period||0
8353847|NCT01241604|20592336|P1|NOT COMPLETED|Screening Period||3
8353848|NCT01241604|20592334|P3|COMPLETED|Screening Period||0
8353849|NCT01241604|20592335|P2|COMPLETED|Screening Period||0
8353850|NCT01241604|20592336|P1|COMPLETED|Screening Period||8
8353851|NCT01241604|20592334|P3|STARTED|Screening Period||0
8353852|NCT01241604|20592335|P2|STARTED|Screening Period||0
8353853|NCT01241604|20592336|P1|STARTED|Screening Period||11
8353854|NCT01241591|20592381|P4|NOT COMPLETED|Overall Study||12
8353855|NCT01241591|20592382|P3|NOT COMPLETED|Overall Study||22
8353856|NCT01241591|20592383|P2|NOT COMPLETED|Overall Study||24
8353857|NCT01241591|20592384|P1|NOT COMPLETED|Overall Study||23
8353858|NCT01241591|20592381|P4|COMPLETED|Overall Study||95
8353859|NCT01241591|20592382|P3|COMPLETED|Overall Study||313
8353860|NCT01241591|20592383|P2|COMPLETED|Overall Study||306
8353861|NCT01241591|20592384|P1|COMPLETED|Overall Study||306
8353862|NCT01241591|20592381|P4|STARTED|Overall Study||107
8353863|NCT01241591|20592382|P3|STARTED|Overall Study||335
8353864|NCT01241591|20592383|P2|STARTED|Overall Study||330
8353865|NCT01241591|20592384|P1|STARTED|Overall Study||329
8353866|NCT01241565|20592574|P1|NOT COMPLETED|Overall Study||0
8353867|NCT01241565|20592574|P1|COMPLETED|Overall Study||50
8353868|NCT01241565|20592574|P1|STARTED|Overall Study||50
8353869|NCT01241552|20592587|P4|NOT COMPLETED|Overall Study||64
8353870|NCT01241552|20592588|P3|NOT COMPLETED|Overall Study||60
8353871|NCT01241552|20592589|P2|NOT COMPLETED|Overall Study||63
8353872|NCT01241552|20592590|P1|NOT COMPLETED|Overall Study||41
8353873|NCT01241552|20592587|P4|COMPLETED|Overall Study||340
8353874|NCT01241552|20592588|P3|COMPLETED|Overall Study||343
8353875|NCT01241552|20592589|P2|COMPLETED|Overall Study||340
8353876|NCT01241552|20592590|P1|COMPLETED|Overall Study||201
8353877|NCT01241552|20592587|P4|Treated|Overall Study||397
8353878|NCT01241552|20592588|P3|Treated|Overall Study||388
8353879|NCT01241552|20592589|P2|Treated|Overall Study||392
8353880|NCT01241552|20592590|P1|Treated|Overall Study||235
8353881|NCT01241552|20592587|P4|STARTED|Overall Study||404
8353882|NCT01241552|20592588|P3|STARTED|Overall Study||403
8353883|NCT01241552|20592589|P2|STARTED|Overall Study||403
8353884|NCT01241552|20592590|P1|STARTED|Overall Study||242
8353885|NCT01241539|20592656|P1|NOT COMPLETED|Period 2||0
8353886|NCT01241539|20592656|P1|COMPLETED|Period 2||7
8353887|NCT01241539|20592656|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
8353888|NCT01241539|20592656|P1|NOT COMPLETED|Period 1||0
8353889|NCT01241539|20592656|P1|COMPLETED|Period 1||7
8353890|NCT01241539|20592656|P1|STARTED|Period 1||7
8353891|NCT01241513|20592677|P2|NOT COMPLETED|Overall Study||0
8353892|NCT01241513|20592678|P1|NOT COMPLETED|Overall Study||0
8353893|NCT01241513|20592677|P2|COMPLETED|Overall Study||9
8353894|NCT01241513|20592678|P1|COMPLETED|Overall Study|Study has been completed|10
8353895|NCT01241513|20592677|P2|STARTED|Overall Study||9
8353896|NCT01241513|20592678|P1|STARTED|Overall Study||10
8353897|NCT01241461|20592685|P2|NOT COMPLETED|Overall Study||6
8353898|NCT01241461|20592686|P1|NOT COMPLETED|Overall Study||3
8353899|NCT01241461|20592685|P2|COMPLETED|Overall Study||0
8353900|NCT01241461|20592686|P1|COMPLETED|Overall Study||0
8353901|NCT01241461|20592685|P2|STARTED|Overall Study||6
8353902|NCT01241461|20592686|P1|STARTED|Overall Study||3
8353903|NCT01241448|20592706|P4|NOT COMPLETED|Overall Study||23
8353904|NCT01241448|20592707|P3|NOT COMPLETED|Overall Study||23
8353905|NCT01241448|20592708|P2|NOT COMPLETED|Overall Study||29
8353906|NCT01241448|20592709|P1|NOT COMPLETED|Overall Study||37
8353907|NCT01241448|20592706|P4|COMPLETED|Overall Study||43
8353908|NCT01241448|20592707|P3|COMPLETED|Overall Study||43
8353909|NCT01241448|20592708|P2|COMPLETED|Overall Study||36
8353910|NCT01241448|20592709|P1|COMPLETED|Overall Study||29
8353911|NCT01241448|20592706|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
8353912|NCT01241448|20592707|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
8353913|NCT01241448|20592708|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
8353914|NCT01241448|20592709|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
8353915|NCT01241448|20592706|P4|Intent-to-Treat Population (ITT)|Overall Study||64
8353916|NCT01241448|20592707|P3|Intent-to-Treat Population (ITT)|Overall Study||64
8353917|NCT01241448|20592708|P2|Intent-to-Treat Population (ITT)|Overall Study||63
8353918|NCT01241448|20592709|P1|Intent-to-Treat Population (ITT)|Overall Study||63
8353919|NCT01241448|20592706|P4|STARTED|Overall Study||66
8353920|NCT01241448|20592707|P3|STARTED|Overall Study||66
8353921|NCT01241448|20592708|P2|STARTED|Overall Study||65
8353922|NCT01241448|20592709|P1|STARTED|Overall Study||66
8353923|NCT01241435|20592777|P4|NOT COMPLETED|Overall Study||0
8353924|NCT01241435|20592778|P3|NOT COMPLETED|Overall Study||0
8353925|NCT01241435|20592779|P2|NOT COMPLETED|Overall Study||0
8353926|NCT01241435|20592780|P1|NOT COMPLETED|Overall Study||0
8353927|NCT01241435|20592777|P4|COMPLETED|Overall Study||8
8353928|NCT01241435|20592778|P3|COMPLETED|Overall Study||8
8353929|NCT01241435|20592779|P2|COMPLETED|Overall Study||8
8353930|NCT01241435|20592780|P1|COMPLETED|Overall Study||12
8353931|NCT01241435|20592777|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
8353932|NCT01241435|20592778|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8353933|NCT01241435|20592779|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8353934|NCT01241435|20592780|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8353935|NCT01241435|20592777|P4|STARTED|Overall Study||8
8353936|NCT01241435|20592778|P3|STARTED|Overall Study||8
8353937|NCT01241435|20592779|P2|STARTED|Overall Study||8
8353938|NCT01241435|20592780|P1|STARTED|Overall Study||12
8353939|NCT01241318|20592800|P2|NOT COMPLETED|Overall Study||742
8353940|NCT01241318|20592801|P1|NOT COMPLETED|Overall Study||1179
8353941|NCT01241318|20592800|P2|COMPLETED|Overall Study|Infants|19308
8353942|NCT01241318|20592801|P1|COMPLETED|Overall Study|Infants|18450
8353943|NCT01241318|20592800|P2|Liveborn Infant|Overall Study|Infants|19346
8353944|NCT01241318|20592801|P1|Liveborn Infant|Overall Study|Infants|18510
8353945|NCT01241318|20592800|P2|STARTED|Overall Study|Women enrolled|20050
8353946|NCT01241318|20592801|P1|STARTED|Overall Study|Women enrolled|19629
8353947|NCT01241292|20592818|P2|NOT COMPLETED|Overall Study||3
8353948|NCT01241292|20592819|P1|NOT COMPLETED|Overall Study||3
8353949|NCT01241292|20592818|P2|COMPLETED|Overall Study|completed=treatment on-going|0
8353950|NCT01241292|20592819|P1|COMPLETED|Overall Study|completed=treatment on-going|0
8353951|NCT01241292|20592818|P2|Entered Treatment Period|Overall Study||3
8353952|NCT01241292|20592819|P1|Entered Treatment Period|Overall Study||3
8353953|NCT01241292|20592818|P2|STARTED|Overall Study||3
8353954|NCT01241292|20592819|P1|STARTED|Overall Study||3
8353955|NCT01241279|20592843|P2|NOT COMPLETED|Overall Study||1
8353956|NCT01241279|20592844|P1|NOT COMPLETED|Overall Study||0
8353957|NCT01241279|20592843|P2|COMPLETED|Overall Study||1
8353958|NCT01241279|20592844|P1|COMPLETED|Overall Study||4
8353959|NCT01241279|20592843|P2|STARTED|Overall Study||2
8353960|NCT01241279|20592844|P1|STARTED|Overall Study||4
8353961|NCT01241240|20592854|P2|NOT COMPLETED|Overall Study||9
8353962|NCT01241240|20592855|P1|NOT COMPLETED|Overall Study||8
8353963|NCT01241240|20592854|P2|COMPLETED|Overall Study||89
8353964|NCT01241240|20592855|P1|COMPLETED|Overall Study||86
8353965|NCT01241240|20592854|P2|STARTED|Overall Study||98
8353966|NCT01241240|20592855|P1|STARTED|Overall Study||94
8353967|NCT01240915|20592873|P9|NOT COMPLETED|Overall Study||8
8353968|NCT01240915|20592874|P8|NOT COMPLETED|Overall Study||4
8353969|NCT01240915|20592875|P7|NOT COMPLETED|Overall Study||8
8353970|NCT01240915|20592876|P6|NOT COMPLETED|Overall Study||10
8353971|NCT01240915|20592877|P5|NOT COMPLETED|Overall Study||4
8353972|NCT01240915|20592878|P4|NOT COMPLETED|Overall Study||3
8353973|NCT01240915|20592879|P3|NOT COMPLETED|Overall Study||0
8353974|NCT01240915|20592880|P2|NOT COMPLETED|Overall Study||1
8353975|NCT01240915|20592881|P1|NOT COMPLETED|Overall Study||2
8353976|NCT01240915|20592873|P9|COMPLETED|Overall Study||13
8353977|NCT01240915|20592874|P8|COMPLETED|Overall Study||15
8353978|NCT01240915|20592875|P7|COMPLETED|Overall Study||17
8353979|NCT01240915|20592876|P6|COMPLETED|Overall Study||13
8353980|NCT01240915|20592877|P5|COMPLETED|Overall Study||2
8353981|NCT01240915|20592878|P4|COMPLETED|Overall Study||1
8353982|NCT01240915|20592879|P3|COMPLETED|Overall Study||2
8353983|NCT01240915|20592880|P2|COMPLETED|Overall Study||2
8353984|NCT01240915|20592881|P1|COMPLETED|Overall Study||0
8353985|NCT01240915|20592873|P9|STARTED|Overall Study||21
8353986|NCT01240915|20592874|P8|STARTED|Overall Study||19
8353987|NCT01240915|20592875|P7|STARTED|Overall Study||25
8353988|NCT01240915|20592876|P6|STARTED|Overall Study||23
8353989|NCT01240915|20592877|P5|STARTED|Overall Study||6
8353990|NCT01240915|20592878|P4|STARTED|Overall Study||4
8353991|NCT01240915|20592879|P3|STARTED|Overall Study||2
8353992|NCT01240915|20592880|P2|STARTED|Overall Study||3
8353993|NCT01240915|20592881|P1|STARTED|Overall Study||2
8353994|NCT01240902|20593064|P4|NOT COMPLETED|Overall Study||165
8353995|NCT01240902|20593065|P3|NOT COMPLETED|Overall Study||100
8353996|NCT01240902|20593066|P2|NOT COMPLETED|Overall Study||79
8353997|NCT01240902|20593067|P1|NOT COMPLETED|Overall Study||211
8353998|NCT01240902|20593064|P4|COMPLETED|Overall Study||237
8353999|NCT01240902|20593065|P3|COMPLETED|Overall Study||295
8354000|NCT01240902|20593066|P2|COMPLETED|Overall Study||77
8354001|NCT01240902|20593067|P1|COMPLETED|Overall Study||289
8354002|NCT01240902|20593064|P4|STARTED|Overall Study||402
8354003|NCT01240902|20593065|P3|STARTED|Overall Study||395
8354004|NCT01240902|20593066|P2|STARTED|Overall Study||156
8354005|NCT01240902|20593067|P1|STARTED|Overall Study||500
8354006|NCT01240863|20593155|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
8354007|NCT01240863|20593156|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
8354008|NCT01240863|20593157|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8354009|NCT01240863|20593155|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
8354010|NCT01240863|20593156|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
8354011|NCT01240863|20593157|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8354012|NCT01240863|20593155|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
8354013|NCT01240863|20593156|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
8354014|NCT01240863|20593157|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
8354015|NCT01240863|20593155|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
8354016|NCT01240863|20593156|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
8354017|NCT01240863|20593157|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
8354018|NCT01240863|20593155|P3|NOT COMPLETED|Open-label Titration Period||0
8354019|NCT01240863|20593156|P2|NOT COMPLETED|Open-label Titration Period||0
8354020|NCT01240863|20593157|P1|NOT COMPLETED|Open-label Titration Period||97
8354021|NCT01240863|20593155|P3|COMPLETED|Open-label Titration Period||0
8354022|NCT01240863|20593156|P2|COMPLETED|Open-label Titration Period||0
8354023|NCT01240863|20593157|P1|COMPLETED|Open-label Titration Period||294
8354024|NCT01240863|20593155|P3|Safety Analysis Set|Open-label Titration Period||0
8354025|NCT01240863|20593156|P2|Safety Analysis Set|Open-label Titration Period||0
8354026|NCT01240863|20593157|P1|Safety Analysis Set|Open-label Titration Period||389
8354027|NCT01240863|20593155|P3|STARTED|Open-label Titration Period||0
8354028|NCT01240863|20593156|P2|STARTED|Open-label Titration Period||0
8354029|NCT01240863|20593157|P1|STARTED|Open-label Titration Period||391
8354030|NCT01240811|20593219|P3|NOT COMPLETED|Overall Study||1
8354031|NCT01240811|20593220|P2|NOT COMPLETED|Overall Study||1
8354032|NCT01240811|20593221|P1|NOT COMPLETED|Overall Study||0
8354033|NCT01240811|20593219|P3|COMPLETED|Overall Study||16
8354034|NCT01240811|20593220|P2|COMPLETED|Overall Study||16
8354035|NCT01240811|20593221|P1|COMPLETED|Overall Study||8
8354036|NCT01240811|20593219|P3|STARTED|Overall Study||17
8354037|NCT01240811|20593220|P2|STARTED|Overall Study||17
8354038|NCT01240811|20593221|P1|STARTED|Overall Study||8
8354039|NCT01240785|20593237|P2|NOT COMPLETED|Overall Study||3
8354040|NCT01240785|20593238|P1|NOT COMPLETED|Overall Study||1
8354041|NCT01240785|20593237|P2|COMPLETED|Overall Study||107
8354042|NCT01240785|20593238|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
8354043|NCT01240785|20593237|P2|STARTED|Overall Study||110
8354044|NCT01240785|20593238|P1|STARTED|Overall Study||111
8354045|NCT01240746|20593269|P3|NOT COMPLETED|Overall Study||243
8354046|NCT01240746|20593270|P2|NOT COMPLETED|Overall Study||48
8354047|NCT01240746|20593271|P1|NOT COMPLETED|Overall Study||59
8354048|NCT01240746|20593269|P3|COMPLETED|Overall Study||2659
8354049|NCT01240746|20593270|P2|COMPLETED|Overall Study||677
8354050|NCT01240746|20593271|P1|COMPLETED|Overall Study||677
8354051|NCT01240746|20593269|P3|STARTED|Overall Study||2902
8354052|NCT01240746|20593270|P2|STARTED|Overall Study||725
8354053|NCT01240746|20593271|P1|STARTED|Overall Study||736
8354054|NCT01240590|20593326|P5|NOT COMPLETED|Phase II||1
8354055|NCT01240590|20593327|P4|NOT COMPLETED|Phase II||2
8354056|NCT01240590|20593328|P3|NOT COMPLETED|Phase II||0
8354057|NCT01240590|20593329|P2|NOT COMPLETED|Phase II||0
8354058|NCT01240590|20593330|P1|NOT COMPLETED|Phase II||0
8354059|NCT01240590|20593326|P5|COMPLETED|Phase II||0
8354060|NCT01240590|20593327|P4|COMPLETED|Phase II||15
8354061|NCT01240590|20593328|P3|COMPLETED|Phase II||0
8354062|NCT01240590|20593329|P2|COMPLETED|Phase II||0
8354063|NCT01240590|20593330|P1|COMPLETED|Phase II||0
8354064|NCT01240590|20593326|P5|STARTED|Phase II||1
8354065|NCT01240590|20593327|P4|STARTED|Phase II||17
8354066|NCT01240590|20593328|P3|STARTED|Phase II||0
8354067|NCT01240590|20593329|P2|STARTED|Phase II||0
8354068|NCT01240590|20593330|P1|STARTED|Phase II||0
8354069|NCT01240590|20593326|P5|NOT COMPLETED|Phase I||0
8354070|NCT01240590|20593327|P4|NOT COMPLETED|Phase I||0
8354071|NCT01240590|20593328|P3|NOT COMPLETED|Phase I||3
8354072|NCT01240590|20593329|P2|NOT COMPLETED|Phase I||0
8354073|NCT01240590|20593330|P1|NOT COMPLETED|Phase I||0
8354074|NCT01240590|20593326|P5|COMPLETED|Phase I||0
8354075|NCT01240590|20593327|P4|COMPLETED|Phase I||0
8354076|NCT01240590|20593328|P3|COMPLETED|Phase I||0
8354077|NCT01240590|20593329|P2|COMPLETED|Phase I||6
8354078|NCT01240590|20593330|P1|COMPLETED|Phase I||0
8354079|NCT01240590|20593326|P5|STARTED|Phase I||0
8354080|NCT01240590|20593327|P4|STARTED|Phase I||0
8354081|NCT01240590|20593328|P3|STARTED|Phase I||3
8354082|NCT01240590|20593329|P2|STARTED|Phase I||6
8354083|NCT01240590|20593330|P1|STARTED|Phase I||0
8354084|NCT01240551|20593358|P2|NOT COMPLETED|Overall Study||3
8354085|NCT01240551|20593359|P1|NOT COMPLETED|Overall Study||4
8354086|NCT01240551|20593358|P2|COMPLETED|Overall Study||27
8354087|NCT01240551|20593359|P1|COMPLETED|Overall Study||26
8354088|NCT01240551|20593358|P2|STARTED|Overall Study||30
8354089|NCT01240551|20593359|P1|STARTED|Overall Study||30
8354090|NCT01240382|20593369|P2|NOT COMPLETED|Overall Study||4
8354091|NCT01240382|20593370|P1|NOT COMPLETED|Overall Study||2
8354092|NCT01240382|20593369|P2|COMPLETED|Overall Study||139
8354093|NCT01240382|20593370|P1|COMPLETED|Overall Study||142
8354094|NCT01240382|20593369|P2|STARTED|Overall Study||143
8354095|NCT01240382|20593370|P1|STARTED|Overall Study||144
8354096|NCT01240356|20593380|P2|NOT COMPLETED|Overall Study||0
8354097|NCT01240356|20593381|P1|NOT COMPLETED|Overall Study||3
8354098|NCT01240356|20593380|P2|COMPLETED|Overall Study||20
8354099|NCT01240356|20593381|P1|COMPLETED|Overall Study||15
8354100|NCT01240356|20593380|P2|STARTED|Overall Study||20
8354101|NCT01240356|20593381|P1|STARTED|Overall Study||18
8354102|NCT01240330|20593392|P1|NOT COMPLETED|Overall Study||0
8354103|NCT01240330|20593392|P1|COMPLETED|Overall Study||33
8354104|NCT01240330|20593392|P1|STARTED|Overall Study||33
8354105|NCT01240304|20593398|P1|NOT COMPLETED|Overall Study||10
8354106|NCT01240304|20593398|P1|COMPLETED|Overall Study||0
8354107|NCT01240304|20593398|P1|STARTED|Overall Study||10
8354108|NCT01240200|20593404|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
8354109|NCT01240200|20593405|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
8354110|NCT01240200|20593404|P2|COMPLETED|12-week Crossover Phase - Period 2||23
8354111|NCT01240200|20593405|P1|COMPLETED|12-week Crossover Phase - Period 2||23
8354112|NCT01240200|20593404|P2|STARTED|12-week Crossover Phase - Period 2||23
8354113|NCT01240200|20593405|P1|STARTED|12-week Crossover Phase - Period 2||23
8354114|NCT01240200|20593404|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
8354115|NCT01240200|20593405|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
8354116|NCT01240200|20593404|P2|COMPLETED|12-week Crossover Phase - Period 1||23
8354117|NCT01240200|20593405|P1|COMPLETED|12-week Crossover Phase - Period 1||23
8354118|NCT01240200|20593404|P2|STARTED|12-week Crossover Phase - Period 1||24
8354119|NCT01240200|20593405|P1|STARTED|12-week Crossover Phase - Period 1||25
8354120|NCT01240135|20593423|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
8354121|NCT01240135|20593424|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
8354122|NCT01240135|20593423|P2|COMPLETED|Period Two, 14 Days of Wear||43
8354123|NCT01240135|20593424|P1|COMPLETED|Period Two, 14 Days of Wear||43
8354124|NCT01240135|20593423|P2|STARTED|Period Two, 14 Days of Wear||45
8354125|NCT01240135|20593424|P1|STARTED|Period Two, 14 Days of Wear||44
8354126|NCT01240135|20593423|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
8354127|NCT01240135|20593424|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
8354128|NCT01240135|20593423|P2|COMPLETED|Period One, 14 Days of Wear||45
8354129|NCT01240135|20593424|P1|COMPLETED|Period One, 14 Days of Wear||44
8354130|NCT01240135|20593423|P2|STARTED|Period One, 14 Days of Wear||45
8354131|NCT01240135|20593424|P1|STARTED|Period One, 14 Days of Wear||44
8354132|NCT01240122|20593432|P1|NOT COMPLETED|Overall Study||0
8354133|NCT01240122|20593432|P1|COMPLETED|Overall Study||29
8354134|NCT01240122|20593432|P1|STARTED|Overall Study||29
8354135|NCT01239992|20593441|P1|NOT COMPLETED|Overall Study||2
8354136|NCT01239992|20593441|P1|COMPLETED|Overall Study||10
8354137|NCT01239992|20593441|P1|STARTED|Overall Study||12
8354138|NCT01239797|20593450|P2|NOT COMPLETED|Treated Participants||274
8354139|NCT01239797|20593451|P1|NOT COMPLETED|Treated Participants||235
8354140|NCT01239797|20593450|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
8354141|NCT01239797|20593451|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
8354142|NCT01239797|20593450|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
8354143|NCT01239797|20593451|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
8354144|NCT01239797|20593450|P2|NOT COMPLETED|Randomized Participants||9
8354145|NCT01239797|20593451|P1|NOT COMPLETED|Randomized Participants||2
8354146|NCT01239797|20593450|P2|COMPLETED|Randomized Participants||316
8354147|NCT01239797|20593451|P1|COMPLETED|Randomized Participants||319
8354148|NCT01239797|20593450|P2|STARTED|Randomized Participants||325
8354149|NCT01239797|20593451|P1|STARTED|Randomized Participants||321
8354150|NCT01239745|20593459|P1|NOT COMPLETED|Overall Study||46
8354151|NCT01239745|20593459|P1|COMPLETED|Overall Study||0
8354152|NCT01239745|20593459|P1|STARTED|Overall Study||46
8354153|NCT01239732|20593470|P1|NOT COMPLETED|Overall Study||1021
8354154|NCT01239732|20593470|P1|COMPLETED|Overall Study||0
8354155|NCT01239732|20593470|P1|STARTED|Overall Study||1021
8354156|NCT01239680|20593483|P2|NOT COMPLETED|Overall Study||0
8354157|NCT01239680|20593484|P1|NOT COMPLETED|Overall Study||2
8354158|NCT01239680|20593483|P2|COMPLETED|Overall Study||2
8354159|NCT01239680|20593484|P1|COMPLETED|Overall Study||1
8354160|NCT01239680|20593483|P2|STARTED|Overall Study||2
8354161|NCT01239680|20593484|P1|STARTED|Overall Study||3
8354162|NCT01239511|20593494|P4|NOT COMPLETED|Overall Study||9
8354163|NCT01239511|20593495|P3|NOT COMPLETED|Overall Study||4
8354164|NCT01239511|20593496|P2|NOT COMPLETED|Overall Study||5
8354165|NCT01239511|20593497|P1|NOT COMPLETED|Overall Study||1
8354166|NCT01239511|20593494|P4|COMPLETED|Overall Study||38
8354167|NCT01239511|20593495|P3|COMPLETED|Overall Study||43
8354168|NCT01239511|20593496|P2|COMPLETED|Overall Study||40
8354169|NCT01239511|20593497|P1|COMPLETED|Overall Study||46
8354170|NCT01239511|20593494|P4|STARTED|Overall Study||47
8354171|NCT01239511|20593495|P3|STARTED|Overall Study||47
8354172|NCT01239511|20593496|P2|STARTED|Overall Study||45
8354173|NCT01239511|20593497|P1|STARTED|Overall Study||47
8354174|NCT01239472|20593509|P2|NOT COMPLETED|Overall Study||3
8354175|NCT01239472|20593510|P1|NOT COMPLETED|Overall Study||5
8354176|NCT01239472|20593509|P2|COMPLETED|Overall Study||12
8354177|NCT01239472|20593510|P1|COMPLETED|Overall Study||10
8354178|NCT01239472|20593509|P2|STARTED|Overall Study||15
8354179|NCT01239472|20593510|P1|STARTED|Overall Study||15
8354180|NCT01239394|20593518|P1|NOT COMPLETED|Overall Study||1
8354181|NCT01239394|20593518|P1|COMPLETED|Overall Study||41
8354182|NCT01239394|20593518|P1|STARTED|Overall Study||42
8354183|NCT01239381|20593525|P1|NOT COMPLETED|Overall Study||2
8354184|NCT01239381|20593525|P1|COMPLETED|Overall Study||90
8354185|NCT01239381|20593525|P1|STARTED|Overall Study||92
8354186|NCT01239368|20593545|P10|NOT COMPLETED|Overall Study||4
8354187|NCT01239368|20593546|P9|NOT COMPLETED|Overall Study||0
8354188|NCT01239368|20593547|P8|NOT COMPLETED|Overall Study||0
8354189|NCT01239368|20593548|P7|NOT COMPLETED|Overall Study||6
8354190|NCT01239368|20593549|P6|NOT COMPLETED|Overall Study||4
8354191|NCT01239368|20593550|P5|NOT COMPLETED|Overall Study||5
8354192|NCT01239368|20593551|P4|NOT COMPLETED|Overall Study||1
8354193|NCT01239368|20593552|P3|NOT COMPLETED|Overall Study||1
8354194|NCT01239368|20593553|P2|NOT COMPLETED|Overall Study||1
8354195|NCT01239368|20593554|P1|NOT COMPLETED|Overall Study||2
8354196|NCT01239368|20593545|P10|COMPLETED|Overall Study||1
8354197|NCT01239368|20593546|P9|COMPLETED|Overall Study||1
8354198|NCT01239368|20593547|P8|COMPLETED|Overall Study||0
8354199|NCT01239368|20593548|P7|COMPLETED|Overall Study||1
8354200|NCT01239368|20593549|P6|COMPLETED|Overall Study||1
8354201|NCT01239368|20593550|P5|COMPLETED|Overall Study||2
8354202|NCT01239368|20593551|P4|COMPLETED|Overall Study||1
8354203|NCT01239368|20593552|P3|COMPLETED|Overall Study||0
8354204|NCT01239368|20593553|P2|COMPLETED|Overall Study||0
8354205|NCT01239368|20593554|P1|COMPLETED|Overall Study||0
8354206|NCT01239368|20593545|P10|STARTED|Overall Study||5
8354207|NCT01239368|20593546|P9|STARTED|Overall Study||1
8354208|NCT01239368|20593547|P8|STARTED|Overall Study||0
8354209|NCT01239368|20593548|P7|STARTED|Overall Study||7
8354210|NCT01239368|20593549|P6|STARTED|Overall Study||5
8354211|NCT01239368|20593550|P5|STARTED|Overall Study||7
8354212|NCT01239368|20593551|P4|STARTED|Overall Study||2
8354213|NCT01239368|20593552|P3|STARTED|Overall Study||1
8354214|NCT01239368|20593553|P2|STARTED|Overall Study||1
8354215|NCT01239368|20593554|P1|STARTED|Overall Study||2
8354216|NCT01239355|20593598|P1|NOT COMPLETED|Overall Study||0
8354217|NCT01239355|20593598|P1|COMPLETED|Overall Study||15
8354218|NCT01239355|20593598|P1|STARTED|Overall Study||15
8354219|NCT01239342|20593606|P2|NOT COMPLETED|Overall Study||6
8354220|NCT01239342|20593607|P1|NOT COMPLETED|Overall Study||3
8354221|NCT01239342|20593606|P2|COMPLETED|Overall Study||8
8354222|NCT01239342|20593607|P1|COMPLETED|Overall Study||26
8354223|NCT01239342|20593606|P2|STARTED|Overall Study||14
8354224|NCT01239342|20593607|P1|STARTED|Overall Study||29
8354225|NCT01239316|20593623|P1|NOT COMPLETED|Overall Study||12
8354226|NCT01239316|20593623|P1|COMPLETED|Overall Study||0
8354227|NCT01239316|20593623|P1|STARTED|Overall Study||12
8354228|NCT01239212|20593631|P1|NOT COMPLETED|Overall Study||0
8354229|NCT01239212|20593631|P1|COMPLETED|Overall Study||7
8354230|NCT01239212|20593631|P1|STARTED|Overall Study||7
8354231|NCT01239160|20593637|P3|NOT COMPLETED|Overall Study||10
8354232|NCT01239160|20593638|P2|NOT COMPLETED|Overall Study||19
8354233|NCT01239160|20593639|P1|NOT COMPLETED|Overall Study||25
8354234|NCT01239160|20593637|P3|COMPLETED|Overall Study||0
8354235|NCT01239160|20593638|P2|COMPLETED|Overall Study||95
8354236|NCT01239160|20593639|P1|COMPLETED|Overall Study||89
8354237|NCT01239160|20593637|P3|STARTED|Overall Study||10
8354238|NCT01239160|20593638|P2|STARTED|Overall Study||114
8354239|NCT01239160|20593639|P1|STARTED|Overall Study||114
8354240|NCT01239121|20593652|P3|NOT COMPLETED|Overall Study||0
8354241|NCT01239121|20593653|P2|NOT COMPLETED|Overall Study||4
8354242|NCT01239121|20593654|P1|NOT COMPLETED|Overall Study||2
8354243|NCT01239121|20593652|P3|COMPLETED|Overall Study||15
8354244|NCT01239121|20593653|P2|COMPLETED|Overall Study||195
8354245|NCT01239121|20593654|P1|COMPLETED|Overall Study||186
8354246|NCT01239121|20593652|P3|STARTED|Overall Study||15
8354247|NCT01239121|20593653|P2|STARTED|Overall Study||199
8354248|NCT01239121|20593654|P1|STARTED|Overall Study||188
8354249|NCT01239056|20593668|P1|NOT COMPLETED|Overall Study||0
8354250|NCT01239056|20593668|P1|COMPLETED|Overall Study||20
8354251|NCT01239056|20593668|P1|STARTED|Overall Study||20
8354252|NCT01239043|20593676|P2|NOT COMPLETED|Overall Study||1
8354253|NCT01239043|20593677|P1|NOT COMPLETED|Overall Study||2
8354254|NCT01239043|20593676|P2|COMPLETED|Overall Study||102
8354255|NCT01239043|20593677|P1|COMPLETED|Overall Study||34
8354256|NCT01239043|20593676|P2|STARTED|Overall Study||103
8354257|NCT01239043|20593677|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
8354258|NCT01238991|20593705|P10|NOT COMPLETED|Overall Study||2
8354259|NCT01238991|20593706|P9|NOT COMPLETED|Overall Study||4
8354260|NCT01238991|20593707|P8|NOT COMPLETED|Overall Study||5
8354261|NCT01238991|20593708|P7|NOT COMPLETED|Overall Study||8
8354262|NCT01238991|20593709|P6|NOT COMPLETED|Overall Study||0
8354263|NCT01238991|20593710|P5|NOT COMPLETED|Overall Study||2
8354264|NCT01238991|20593711|P4|NOT COMPLETED|Overall Study||2
8354265|NCT01238991|20593712|P3|NOT COMPLETED|Overall Study||6
8354266|NCT01238991|20593713|P2|NOT COMPLETED|Overall Study||0
8354267|NCT01238991|20593714|P1|NOT COMPLETED|Overall Study||2
8354268|NCT01238991|20593705|P10|COMPLETED|Overall Study||0
8354269|NCT01238991|20593706|P9|COMPLETED|Overall Study||0
8354270|NCT01238991|20593707|P8|COMPLETED|Overall Study||0
8354271|NCT01238991|20593708|P7|COMPLETED|Overall Study||0
8354272|NCT01238991|20593709|P6|COMPLETED|Overall Study||2
8354273|NCT01238991|20593710|P5|COMPLETED|Overall Study||3
8354274|NCT01238991|20593711|P4|COMPLETED|Overall Study||4
8354275|NCT01238991|20593712|P3|COMPLETED|Overall Study||5
8354276|NCT01238991|20593713|P2|COMPLETED|Overall Study||3
8354277|NCT01238991|20593714|P1|COMPLETED|Overall Study||5
8354278|NCT01238991|20593705|P10|Received Treatment|Overall Study||2
8354279|NCT01238991|20593706|P9|Received Treatment|Overall Study||4
8354280|NCT01238991|20593707|P8|Received Treatment|Overall Study||5
8354281|NCT01238991|20593708|P7|Received Treatment|Overall Study||8
8354282|NCT01238991|20593709|P6|Received Treatment|Overall Study||2
8354283|NCT01238991|20593710|P5|Received Treatment|Overall Study||5
8354284|NCT01238991|20593711|P4|Received Treatment|Overall Study||6
8354285|NCT01238991|20593712|P3|Received Treatment|Overall Study||11
8354286|NCT01238991|20593713|P2|Received Treatment|Overall Study||3
8354287|NCT01238991|20593714|P1|Received Treatment|Overall Study||7
8354288|NCT01238991|20593705|P10|STARTED|Overall Study||2
8354289|NCT01238991|20593706|P9|STARTED|Overall Study||4
8354290|NCT01238991|20593707|P8|STARTED|Overall Study||5
8354291|NCT01238991|20593708|P7|STARTED|Overall Study||8
8354292|NCT01238991|20593709|P6|STARTED|Overall Study||2
8354293|NCT01238991|20593710|P5|STARTED|Overall Study||5
8354294|NCT01238991|20593711|P4|STARTED|Overall Study||6
8354295|NCT01238991|20593712|P3|STARTED|Overall Study||11
8354296|NCT01238991|20593713|P2|STARTED|Overall Study||3
8354297|NCT01238991|20593714|P1|STARTED|Overall Study||7
8354298|NCT01238900|20593801|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
8354299|NCT01238900|20593801|P1|COMPLETED|<12 Months Post Stent Removal||18
8354300|NCT01238900|20593801|P1|STARTED|<12 Months Post Stent Removal||23
8354301|NCT01238900|20593801|P1|NOT COMPLETED|6 Months Post Stent Placement||0
8354302|NCT01238900|20593801|P1|COMPLETED|6 Months Post Stent Placement||23
8354303|NCT01238900|20593801|P1|STARTED|6 Months Post Stent Placement||23
8354304|NCT01238861|20593815|P6|NOT COMPLETED|Overall Study||15
8354305|NCT01238861|20593816|P5|NOT COMPLETED|Overall Study||13
8354306|NCT01238861|20593817|P4|NOT COMPLETED|Overall Study||13
8354307|NCT01238861|20593818|P3|NOT COMPLETED|Overall Study||11
8354308|NCT01238861|20593819|P2|NOT COMPLETED|Overall Study||8
8354309|NCT01238861|20593820|P1|NOT COMPLETED|Overall Study||11
8354310|NCT01238861|20593815|P6|COMPLETED|Overall Study||125
8354311|NCT01238861|20593816|P5|COMPLETED|Overall Study||129
8354312|NCT01238861|20593817|P4|COMPLETED|Overall Study||69
8354313|NCT01238861|20593818|P3|COMPLETED|Overall Study||70
8354314|NCT01238861|20593819|P2|COMPLETED|Overall Study||73
8354315|NCT01238861|20593820|P1|COMPLETED|Overall Study||69
8354316|NCT01238861|20593815|P6|STARTED|Overall Study||140
8354317|NCT01238861|20593816|P5|STARTED|Overall Study||142
8354318|NCT01238861|20593817|P4|STARTED|Overall Study||82
8354319|NCT01238861|20593818|P3|STARTED|Overall Study||81
8354320|NCT01238861|20593819|P2|STARTED|Overall Study||81
8354321|NCT01238861|20593820|P1|STARTED|Overall Study||80
8354322|NCT01238848|20593900|P2|NOT COMPLETED|Overall Study||5
8354323|NCT01238848|20593901|P1|NOT COMPLETED|Overall Study||13
8354324|NCT01238848|20593900|P2|COMPLETED|Overall Study||45
8354325|NCT01238848|20593901|P1|COMPLETED|Overall Study||37
8354326|NCT01238848|20593900|P2|STARTED|Overall Study||50
8354327|NCT01238848|20593901|P1|STARTED|Overall Study||50
8354328|NCT01238835|20593909|P1|NOT COMPLETED|Overall Study||136
8354329|NCT01238835|20593909|P1|COMPLETED|Overall Study||82
8354330|NCT01238835|20593909|P1|STARTED|Overall Study||218
8354331|NCT01238822|20593914|P1|NOT COMPLETED|Overall Study||3
8354332|NCT01238822|20593914|P1|COMPLETED|Overall Study||93
8354333|NCT01238822|20593914|P1|Received High Dosage|Overall Study||93
8354334|NCT01238822|20593914|P1|Received Medium Dosage|Overall Study||93
8354335|NCT01238822|20593914|P1|Received Low Dosage|Overall Study||93
8354336|NCT01238822|20593914|P1|Received Placebo|Overall Study||93
8354337|NCT01238822|20593914|P1|STARTED|Overall Study||96
8354338|NCT01238640|20593924|P1|NOT COMPLETED|Overall Study||0
8354339|NCT01238640|20593924|P1|COMPLETED|Overall Study||84
8354340|NCT01238640|20593924|P1|STARTED|Overall Study||84
8354341|NCT01238588|20593941|P1|NOT COMPLETED|Overall Study||3
8354342|NCT01238588|20593941|P1|COMPLETED|Overall Study||9
8354343|NCT01238588|20593941|P1|STARTED|Overall Study||12
8354344|NCT01238575|20593954|P2|NOT COMPLETED|Overall Study||4
8354345|NCT01238575|20593955|P1|NOT COMPLETED|Overall Study||4
8354346|NCT01238575|20593954|P2|COMPLETED|Overall Study||28
8354347|NCT01238575|20593955|P1|COMPLETED|Overall Study||26
8354348|NCT01238575|20593954|P2|STARTED|Overall Study||32
8354349|NCT01238575|20593955|P1|STARTED|Overall Study||30
8354350|NCT01238549|20593991|P1|NOT COMPLETED|Overall Study||36
8354351|NCT01238549|20593991|P1|COMPLETED|Overall Study||248
8354352|NCT01238549|20593991|P1|STARTED|Overall Study||284
8354353|NCT01238536|20594010|P2|NOT COMPLETED|Overall Study||50
8354354|NCT01238536|20594011|P1|NOT COMPLETED|Overall Study||47
8354355|NCT01238536|20594010|P2|COMPLETED|Overall Study||150
8354356|NCT01238536|20594011|P1|COMPLETED|Overall Study||153
8354357|NCT01238536|20594010|P2|STARTED|Overall Study||200
8354358|NCT01238536|20594011|P1|STARTED|Overall Study||200
8354359|NCT01238471|20594025|P2|NOT COMPLETED|Overall Study||0
8354360|NCT01238471|20594026|P1|NOT COMPLETED|Overall Study||0
8354361|NCT01238471|20594025|P2|COMPLETED|Overall Study||10
8354362|NCT01238471|20594026|P1|COMPLETED|Overall Study||10
8354363|NCT01238471|20594025|P2|STARTED|Overall Study||10
8354364|NCT01238471|20594026|P1|STARTED|Overall Study||10
8354365|NCT01238341|20594032|P1|NOT COMPLETED|Overall Study||0
8354366|NCT01238341|20594032|P1|COMPLETED|Overall Study||7
8354367|NCT01238341|20594032|P1|STARTED|Overall Study||7
8354368|NCT01238211|20594039|P1|NOT COMPLETED|Overall Study||58
8354369|NCT01238211|20594039|P1|COMPLETED|Overall Study||3
8354370|NCT01238211|20594039|P1|STARTED|Overall Study||61
8354371|NCT01238172|20594045|P2|NOT COMPLETED|Overall Study||24
8354372|NCT01238172|20594046|P1|NOT COMPLETED|Overall Study||11
8354373|NCT01238172|20594045|P2|COMPLETED|Overall Study||217
8354374|NCT01238172|20594046|P1|COMPLETED|Overall Study||226
8354375|NCT01238172|20594045|P2|STARTED|Overall Study||241
8354376|NCT01238172|20594046|P1|STARTED|Overall Study||237
8354377|NCT01237951|20594058|P1|NOT COMPLETED|Overall Study||1
8354378|NCT01237951|20594058|P1|COMPLETED|Overall Study||74
8354379|NCT01237951|20594058|P1|STARTED|Overall Study||75
8354380|NCT01237899|20594076|P11|NOT COMPLETED|Second Dosing Period||0
8354381|NCT01237899|20594077|P10|NOT COMPLETED|Second Dosing Period||0
8354382|NCT01237899|20594078|P9|NOT COMPLETED|Second Dosing Period||0
8354383|NCT01237899|20594079|P8|NOT COMPLETED|Second Dosing Period||0
8354384|NCT01237899|20594080|P7|NOT COMPLETED|Second Dosing Period||0
8354385|NCT01237899|20594081|P6|NOT COMPLETED|Second Dosing Period||0
8354386|NCT01237899|20594082|P5|NOT COMPLETED|Second Dosing Period||0
8354387|NCT01237899|20594083|P4|NOT COMPLETED|Second Dosing Period||0
8354388|NCT01237899|20594084|P3|NOT COMPLETED|Second Dosing Period||0
8354389|NCT01237899|20594085|P2|NOT COMPLETED|Second Dosing Period||0
8354390|NCT01237899|20594086|P1|NOT COMPLETED|Second Dosing Period||0
8354391|NCT01237899|20594076|P11|COMPLETED|Second Dosing Period||4
8354392|NCT01237899|20594077|P10|COMPLETED|Second Dosing Period||3
8354393|NCT01237899|20594078|P9|COMPLETED|Second Dosing Period||4
8354394|NCT01237899|20594079|P8|COMPLETED|Second Dosing Period||3
8354395|NCT01237899|20594080|P7|COMPLETED|Second Dosing Period||1
8354396|NCT01237899|20594081|P6|COMPLETED|Second Dosing Period||4
8354397|NCT01237899|20594082|P5|COMPLETED|Second Dosing Period||2
8354398|NCT01237899|20594083|P4|COMPLETED|Second Dosing Period||3
8354399|NCT01237899|20594084|P3|COMPLETED|Second Dosing Period||3
8354400|NCT01237899|20594085|P2|COMPLETED|Second Dosing Period||3
8354401|NCT01237899|20594086|P1|COMPLETED|Second Dosing Period||1
8354402|NCT01237899|20594076|P11|STARTED|Second Dosing Period||4
8354403|NCT01237899|20594077|P10|STARTED|Second Dosing Period||3
8354404|NCT01237899|20594078|P9|STARTED|Second Dosing Period||4
8354405|NCT01237899|20594079|P8|STARTED|Second Dosing Period||3
8354406|NCT01237899|20594080|P7|STARTED|Second Dosing Period||1
8354407|NCT01237899|20594081|P6|STARTED|Second Dosing Period||4
8354408|NCT01237899|20594082|P5|STARTED|Second Dosing Period||2
8354409|NCT01237899|20594083|P4|STARTED|Second Dosing Period||3
8354410|NCT01237899|20594084|P3|STARTED|Second Dosing Period||3
8354411|NCT01237899|20594085|P2|STARTED|Second Dosing Period||3
8354412|NCT01237899|20594086|P1|STARTED|Second Dosing Period||1
8354413|NCT01237899|20594076|P11|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354414|NCT01237899|20594077|P10|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354415|NCT01237899|20594078|P9|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354416|NCT01237899|20594079|P8|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354417|NCT01237899|20594080|P7|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354418|NCT01237899|20594081|P6|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354419|NCT01237899|20594082|P5|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354420|NCT01237899|20594083|P4|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354421|NCT01237899|20594084|P3|NOT COMPLETED|Washout Period of at Least 7 Days||1
8354422|NCT01237899|20594085|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354423|NCT01237899|20594086|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354424|NCT01237899|20594076|P11|COMPLETED|Washout Period of at Least 7 Days||4
8354425|NCT01237899|20594077|P10|COMPLETED|Washout Period of at Least 7 Days||3
8354426|NCT01237899|20594078|P9|COMPLETED|Washout Period of at Least 7 Days||4
8354427|NCT01237899|20594079|P8|COMPLETED|Washout Period of at Least 7 Days||3
8354428|NCT01237899|20594080|P7|COMPLETED|Washout Period of at Least 7 Days||1
8354429|NCT01237899|20594081|P6|COMPLETED|Washout Period of at Least 7 Days||4
8354430|NCT01237899|20594082|P5|COMPLETED|Washout Period of at Least 7 Days||2
8354431|NCT01237899|20594083|P4|COMPLETED|Washout Period of at Least 7 Days||3
8354432|NCT01237899|20594084|P3|COMPLETED|Washout Period of at Least 7 Days||3
8354433|NCT01237899|20594085|P2|COMPLETED|Washout Period of at Least 7 Days||3
8354434|NCT01237899|20594086|P1|COMPLETED|Washout Period of at Least 7 Days||1
8354435|NCT01237899|20594076|P11|STARTED|Washout Period of at Least 7 Days||4
8354436|NCT01237899|20594077|P10|STARTED|Washout Period of at Least 7 Days||3
8354437|NCT01237899|20594078|P9|STARTED|Washout Period of at Least 7 Days||4
8354438|NCT01237899|20594079|P8|STARTED|Washout Period of at Least 7 Days||3
8354439|NCT01237899|20594080|P7|STARTED|Washout Period of at Least 7 Days||1
8354440|NCT01237899|20594081|P6|STARTED|Washout Period of at Least 7 Days||4
8354441|NCT01237899|20594082|P5|STARTED|Washout Period of at Least 7 Days||2
8354442|NCT01237899|20594083|P4|STARTED|Washout Period of at Least 7 Days||3
8354443|NCT01237899|20594084|P3|STARTED|Washout Period of at Least 7 Days||4
8354444|NCT01237899|20594085|P2|STARTED|Washout Period of at Least 7 Days||3
8354445|NCT01237899|20594086|P1|STARTED|Washout Period of at Least 7 Days||1
8354446|NCT01237899|20594076|P11|NOT COMPLETED|First Dosing Period||0
8354447|NCT01237899|20594077|P10|NOT COMPLETED|First Dosing Period||0
8354448|NCT01237899|20594078|P9|NOT COMPLETED|First Dosing Period||0
8354449|NCT01237899|20594079|P8|NOT COMPLETED|First Dosing Period||0
8354450|NCT01237899|20594080|P7|NOT COMPLETED|First Dosing Period||0
8354451|NCT01237899|20594081|P6|NOT COMPLETED|First Dosing Period||0
8354452|NCT01237899|20594082|P5|NOT COMPLETED|First Dosing Period||0
8354453|NCT01237899|20594083|P4|NOT COMPLETED|First Dosing Period||0
8354454|NCT01237899|20594084|P3|NOT COMPLETED|First Dosing Period||0
8354455|NCT01237899|20594085|P2|NOT COMPLETED|First Dosing Period||0
8354456|NCT01237899|20594086|P1|NOT COMPLETED|First Dosing Period||0
8354457|NCT01237899|20594076|P11|COMPLETED|First Dosing Period||4
8354458|NCT01237899|20594077|P10|COMPLETED|First Dosing Period||3
8354459|NCT01237899|20594078|P9|COMPLETED|First Dosing Period||4
8354460|NCT01237899|20594079|P8|COMPLETED|First Dosing Period||3
8354461|NCT01237899|20594080|P7|COMPLETED|First Dosing Period||1
8354462|NCT01237899|20594081|P6|COMPLETED|First Dosing Period||4
8354463|NCT01237899|20594082|P5|COMPLETED|First Dosing Period||2
8354464|NCT01237899|20594083|P4|COMPLETED|First Dosing Period||3
8354465|NCT01237899|20594084|P3|COMPLETED|First Dosing Period||4
8354466|NCT01237899|20594085|P2|COMPLETED|First Dosing Period||3
8354467|NCT01237899|20594086|P1|COMPLETED|First Dosing Period||1
8354468|NCT01237899|20594076|P11|STARTED|First Dosing Period||4
8354469|NCT01237899|20594077|P10|STARTED|First Dosing Period||3
8354470|NCT01237899|20594078|P9|STARTED|First Dosing Period||4
8354471|NCT01237899|20594079|P8|STARTED|First Dosing Period||3
8354472|NCT01237899|20594080|P7|STARTED|First Dosing Period||1
8354473|NCT01237899|20594081|P6|STARTED|First Dosing Period||4
8354474|NCT01237899|20594082|P5|STARTED|First Dosing Period||2
8354475|NCT01237899|20594083|P4|STARTED|First Dosing Period||3
8354476|NCT01237899|20594084|P3|STARTED|First Dosing Period||4
8354477|NCT01237899|20594085|P2|STARTED|First Dosing Period||3
8354478|NCT01237899|20594086|P1|STARTED|First Dosing Period||1
8354479|NCT01237821|20594116|P2|NOT COMPLETED|Overall Study||0
8354480|NCT01237821|20594117|P1|NOT COMPLETED|Overall Study||6
8354481|NCT01237821|20594116|P2|COMPLETED|Overall Study||34
8354482|NCT01237821|20594117|P1|COMPLETED|Overall Study||26
8354483|NCT01237821|20594116|P2|STARTED|Overall Study||34
8354484|NCT01237821|20594117|P1|STARTED|Overall Study||32
8354485|NCT01237678|20594166|P3|NOT COMPLETED|Phase II||50
8354486|NCT01237678|20594167|P2|NOT COMPLETED|Phase II||98
8354487|NCT01237678|20594168|P1|NOT COMPLETED|Phase II||0
8354488|NCT01237678|20594166|P3|COMPLETED|Phase II||0
8354489|NCT01237678|20594167|P2|COMPLETED|Phase II||0
8354490|NCT01237678|20594168|P1|COMPLETED|Phase II||0
8354491|NCT01237678|20594166|P3|Received Intervention|Phase II||47
8354492|NCT01237678|20594167|P2|Received Intervention|Phase II||94
8354493|NCT01237678|20594168|P1|Received Intervention|Phase II||0
8354494|NCT01237678|20594166|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
8354495|NCT01237678|20594167|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
8354496|NCT01237678|20594168|P1|STARTED|Phase II||0
8354497|NCT01237678|20594166|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354498|NCT01237678|20594167|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354499|NCT01237678|20594168|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
8354500|NCT01237678|20594166|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354501|NCT01237678|20594167|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354502|NCT01237678|20594168|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354503|NCT01237678|20594166|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
8354504|NCT01237678|20594167|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
8354505|NCT01237678|20594168|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
8354506|NCT01237678|20594166|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354507|NCT01237678|20594167|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354508|NCT01237678|20594168|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
8354509|NCT01237613|20594187|P1|NOT COMPLETED|Overall Study||0
8354510|NCT01237613|20594187|P1|COMPLETED|Overall Study||4
8354511|NCT01237613|20594187|P1|STARTED|Overall Study||4
8354512|NCT01237587|20594213|P2|NOT COMPLETED|Taper Phase||10
8354513|NCT01237587|20594214|P1|NOT COMPLETED|Taper Phase||5
8354514|NCT01237587|20594213|P2|COMPLETED|Taper Phase||34
8354515|NCT01237587|20594214|P1|COMPLETED|Taper Phase||31
8354516|NCT01237587|20594213|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
8354517|NCT01237587|20594214|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
8354518|NCT01237587|20594213|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
8354519|NCT01237587|20594214|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
8354520|NCT01237587|20594213|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
8354521|NCT01237587|20594214|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
8354522|NCT01237587|20594213|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
8354523|NCT01237587|20594214|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
8354524|NCT01237587|20594213|P2|STARTED|Open Label Treatment (Extension Phase)||75
8354525|NCT01237587|20594214|P1|STARTED|Open Label Treatment (Extension Phase)||74
8354526|NCT01237587|20594213|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
8354527|NCT01237587|20594214|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
8354528|NCT01237587|20594213|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
8354529|NCT01237587|20594214|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
8354530|NCT01237587|20594213|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
8354531|NCT01237587|20594214|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
8354532|NCT01237587|20594213|P2|STARTED|Double Blind Treatment (Acute Phase)||93
8354533|NCT01237587|20594214|P1|STARTED|Double Blind Treatment (Acute Phase)||91
8354534|NCT01237353|20594261|P1|NOT COMPLETED|Overall Study||0
8354535|NCT01237353|20594261|P1|COMPLETED|Overall Study||6
8354536|NCT01237353|20594261|P1|STARTED|Overall Study||6
8354537|NCT01237340|20594266|P1|NOT COMPLETED|Overall Study||40
8354538|NCT01237340|20594266|P1|COMPLETED|Overall Study||19
8354539|NCT01237340|20594266|P1|STARTED|Overall Study||59
8354540|NCT01237327|20594280|P2|NOT COMPLETED|Overall Study||40
8354541|NCT01237327|20594281|P1|NOT COMPLETED|Overall Study||42
8354542|NCT01237327|20594280|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
8354543|NCT01237327|20594281|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
8354544|NCT01237327|20594280|P2|Continued Treatment in Extension Study|Overall Study||17
8354545|NCT01237327|20594281|P1|Continued Treatment in Extension Study|Overall Study||21
8354546|NCT01237327|20594280|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
8354547|NCT01237327|20594281|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
8354548|NCT01237327|20594280|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
8354549|NCT01237327|20594281|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
8354550|NCT01237327|20594280|P2|STARTED|Overall Study||41
8354551|NCT01237327|20594281|P1|STARTED|Overall Study||43
8354552|NCT01237301|20594297|P2|NOT COMPLETED|Overall Study||4
8354553|NCT01237301|20594298|P1|NOT COMPLETED|Overall Study||5
8354554|NCT01237301|20594297|P2|COMPLETED|Overall Study||55
8354555|NCT01237301|20594298|P1|COMPLETED|Overall Study||60
8354556|NCT01237301|20594297|P2|STARTED|Overall Study||59
8354557|NCT01237301|20594298|P1|STARTED|Overall Study||65
8354558|NCT01237223|20594316|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
8354559|NCT01237223|20594317|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
8354560|NCT01237223|20594318|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
8354561|NCT01237223|20594319|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
8354562|NCT01237223|20594320|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
8354563|NCT01237223|20594321|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
8354564|NCT01237223|20594316|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
8354565|NCT01237223|20594317|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
8354566|NCT01237223|20594318|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
8354567|NCT01237223|20594319|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
8354568|NCT01237223|20594320|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
8354569|NCT01237223|20594321|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
8354570|NCT01237223|20594316|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
8354571|NCT01237223|20594317|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
8354572|NCT01237223|20594318|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
8354573|NCT01237223|20594319|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
8354574|NCT01237223|20594320|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
8354575|NCT01237223|20594321|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
8354576|NCT01237223|20594316|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354577|NCT01237223|20594317|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354578|NCT01237223|20594318|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354579|NCT01237223|20594319|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354580|NCT01237223|20594320|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354581|NCT01237223|20594321|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
8354582|NCT01237223|20594316|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354583|NCT01237223|20594317|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354584|NCT01237223|20594318|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354585|NCT01237223|20594319|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354586|NCT01237223|20594320|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354587|NCT01237223|20594321|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
8354588|NCT01237223|20594316|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354589|NCT01237223|20594317|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354590|NCT01237223|20594318|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354591|NCT01237223|20594319|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354592|NCT01237223|20594320|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354593|NCT01237223|20594321|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
8354594|NCT01237197|20594362|P2|NOT COMPLETED|Open Label Period||0
8354595|NCT01237197|20594363|P1|NOT COMPLETED|Open Label Period||0
8354596|NCT01237197|20594362|P2|COMPLETED|Open Label Period||10
8354597|NCT01237197|20594363|P1|COMPLETED|Open Label Period||12
8354598|NCT01237197|20594362|P2|STARTED|Open Label Period||10
8354599|NCT01237197|20594363|P1|STARTED|Open Label Period||12
8354600|NCT01237197|20594362|P2|NOT COMPLETED|Randomization Period||3
8354601|NCT01237197|20594363|P1|NOT COMPLETED|Randomization Period||1
8354602|NCT01237197|20594362|P2|COMPLETED|Randomization Period||10
8354603|NCT01237197|20594363|P1|COMPLETED|Randomization Period||12
8354604|NCT01237197|20594362|P2|STARTED|Randomization Period||13
8354605|NCT01237197|20594363|P1|STARTED|Randomization Period||13
8354606|NCT01237080|20594371|P2|NOT COMPLETED|Overall Study||0
8354607|NCT01237080|20594372|P1|NOT COMPLETED|Overall Study||0
8354608|NCT01237080|20594371|P2|COMPLETED|Overall Study||50
8354609|NCT01237080|20594372|P1|COMPLETED|Overall Study||50
8354610|NCT01237080|20594371|P2|STARTED|Overall Study||50
8354611|NCT01237080|20594372|P1|STARTED|Overall Study||50
8354612|NCT01237054|20594380|P1|NOT COMPLETED|Overall Study||1
8354613|NCT01237054|20594380|P1|COMPLETED|Overall Study||30
8354614|NCT01237054|20594380|P1|STARTED|Overall Study||31
8354615|NCT01237041|20594406|P5|NOT COMPLETED|Overall Study||0
8354616|NCT01237041|20594407|P4|NOT COMPLETED|Overall Study||0
8354617|NCT01237041|20594408|P3|NOT COMPLETED|Overall Study||0
8354618|NCT01237041|20594409|P2|NOT COMPLETED|Overall Study||0
8354619|NCT01237041|20594410|P1|NOT COMPLETED|Overall Study||0
8354620|NCT01237041|20594406|P5|COMPLETED|Overall Study||5
8354621|NCT01237041|20594407|P4|COMPLETED|Overall Study||5
8354622|NCT01237041|20594408|P3|COMPLETED|Overall Study||2
8354623|NCT01237041|20594409|P2|COMPLETED|Overall Study||3
8354624|NCT01237041|20594410|P1|COMPLETED|Overall Study||2
8354625|NCT01237041|20594406|P5|STARTED|Overall Study||5
8354626|NCT01237041|20594407|P4|STARTED|Overall Study||5
8354627|NCT01237041|20594408|P3|STARTED|Overall Study||2
8354628|NCT01237041|20594409|P2|STARTED|Overall Study||3
8354629|NCT01237041|20594410|P1|STARTED|Overall Study||2
8354630|NCT01236768|20594434|P2|NOT COMPLETED|Overall Study||61
8354631|NCT01236768|20594435|P1|NOT COMPLETED|Overall Study||89
8354632|NCT01236768|20594434|P2|COMPLETED|Overall Study||145
8354633|NCT01236768|20594435|P1|COMPLETED|Overall Study||112
8354634|NCT01236768|20594434|P2|STARTED|Overall Study||206
8354635|NCT01236768|20594435|P1|STARTED|Overall Study||201
8354636|NCT01236755|20594449|P1|NOT COMPLETED|Orthokeratology Wearing Phase||8
8354637|NCT01236755|20594449|P1|COMPLETED|Orthokeratology Wearing Phase||66
8354638|NCT01236755|20594449|P1|STARTED|Orthokeratology Wearing Phase||74
8354639|NCT01236755|20594449|P1|NOT COMPLETED|Spectacles Wearing Phase||17
8354640|NCT01236755|20594449|P1|COMPLETED|Spectacles Wearing Phase||74
8354641|NCT01236755|20594449|P1|STARTED|Spectacles Wearing Phase||91
8354642|NCT01236742|20594457|P3|NOT COMPLETED|Overall Study||3
8354643|NCT01236742|20594458|P2|NOT COMPLETED|Overall Study||3
8354644|NCT01236742|20594459|P1|NOT COMPLETED|Overall Study||3
8354645|NCT01236742|20594457|P3|COMPLETED|Overall Study||13
8354646|NCT01236742|20594458|P2|COMPLETED|Overall Study||16
8354647|NCT01236742|20594459|P1|COMPLETED|Overall Study||15
8354648|NCT01236742|20594457|P3|STARTED|Overall Study||16
8354649|NCT01236742|20594458|P2|STARTED|Overall Study||19
8354650|NCT01236742|20594459|P1|STARTED|Overall Study||18
8354651|NCT01236534|20594472|P2|NOT COMPLETED|Overall Study||0
8354652|NCT01236534|20594473|P1|NOT COMPLETED|Overall Study||3
8354653|NCT01236534|20594472|P2|COMPLETED|Overall Study||10
8354654|NCT01236534|20594473|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
8354655|NCT01236534|20594472|P2|STARTED|Overall Study||10
8354656|NCT01236534|20594473|P1|STARTED|Overall Study||11
8354657|NCT01236391|20594481|P1|NOT COMPLETED|Overall Study||16
8354658|NCT01236391|20594481|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
8354659|NCT01236391|20594481|P1|STARTED|Overall Study|Participants who received study treatment|111
8354660|NCT01236365|20594491|P2|NOT COMPLETED|Overall Study||2
8354661|NCT01236365|20594492|P1|NOT COMPLETED|Overall Study||2
8354662|NCT01236365|20594491|P2|COMPLETED|Overall Study||19
8354663|NCT01236365|20594492|P1|COMPLETED|Overall Study||19
8354664|NCT01236365|20594491|P2|STARTED|Overall Study||21
8354665|NCT01236365|20594492|P1|STARTED|Overall Study||21
8354666|NCT01236339|20594516|P2|NOT COMPLETED|Overall Study||13
8354667|NCT01236339|20594517|P1|NOT COMPLETED|Overall Study||11
8354668|NCT01236339|20594516|P2|COMPLETED|Overall Study||0
8354669|NCT01236339|20594517|P1|COMPLETED|Overall Study||2
8354670|NCT01236339|20594516|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
8354671|NCT01236339|20594517|P1|LVP Crossover to TIPS|Overall Study||0
8354672|NCT01236339|20594516|P2|STARTED|Overall Study||13
8354673|NCT01236339|20594517|P1|STARTED|Overall Study||13
8354674|NCT01235923|20594537|P2|NOT COMPLETED|Overall Study||0
8354675|NCT01235923|20594538|P1|NOT COMPLETED|Overall Study||0
8354676|NCT01235923|20594537|P2|COMPLETED|Overall Study||10
8354677|NCT01235923|20594538|P1|COMPLETED|Overall Study||10
8354678|NCT01235923|20594537|P2|STARTED|Overall Study||10
8354679|NCT01235923|20594538|P1|STARTED|Overall Study||10
8354680|NCT01235793|20594546|P1|NOT COMPLETED|Overall Study||6
8354681|NCT01235793|20594546|P1|COMPLETED|Overall Study||5
8354682|NCT01235793|20594546|P1|STARTED|Overall Study||11
8354683|NCT01236573|20594562|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
8354684|NCT01236573|20594563|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354685|NCT01236573|20594564|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354686|NCT01236573|20594565|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354687|NCT01236573|20594566|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354688|NCT01236573|20594567|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354689|NCT01236573|20594568|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354690|NCT01236573|20594569|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354691|NCT01236573|20594570|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354692|NCT01236573|20594571|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354693|NCT01236573|20594572|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354694|NCT01236573|20594562|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
8354695|NCT01236573|20594563|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354696|NCT01236573|20594564|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354697|NCT01236573|20594565|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354698|NCT01236573|20594566|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354699|NCT01236573|20594567|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354700|NCT01236573|20594568|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354701|NCT01236573|20594569|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354702|NCT01236573|20594570|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354703|NCT01236573|20594571|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354704|NCT01236573|20594572|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354705|NCT01236573|20594562|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
8354706|NCT01236573|20594563|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354707|NCT01236573|20594564|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354708|NCT01236573|20594565|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354709|NCT01236573|20594566|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354710|NCT01236573|20594567|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354711|NCT01236573|20594568|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354712|NCT01236573|20594569|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354713|NCT01236573|20594570|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354714|NCT01236573|20594571|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354715|NCT01236573|20594572|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354716|NCT01236573|20594562|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354717|NCT01236573|20594563|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354718|NCT01236573|20594564|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8354719|NCT01236573|20594565|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354720|NCT01236573|20594566|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354721|NCT01236573|20594567|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354722|NCT01236573|20594568|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354723|NCT01236573|20594569|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354724|NCT01236573|20594570|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354725|NCT01236573|20594571|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354726|NCT01236573|20594572|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354727|NCT01236573|20594562|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354728|NCT01236573|20594563|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354729|NCT01236573|20594564|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8354730|NCT01236573|20594565|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354731|NCT01236573|20594566|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8354732|NCT01236573|20594567|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354733|NCT01236573|20594568|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354734|NCT01236573|20594569|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354735|NCT01236573|20594570|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354736|NCT01236573|20594571|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354737|NCT01236573|20594572|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354738|NCT01236573|20594562|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354739|NCT01236573|20594563|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354740|NCT01236573|20594564|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354741|NCT01236573|20594565|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354742|NCT01236573|20594566|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354743|NCT01236573|20594567|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354744|NCT01236573|20594568|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354745|NCT01236573|20594569|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354746|NCT01236573|20594570|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354747|NCT01236573|20594571|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354748|NCT01236573|20594572|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354749|NCT01236573|20594562|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354750|NCT01236573|20594563|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354751|NCT01236573|20594564|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354752|NCT01236573|20594565|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354753|NCT01236573|20594566|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354754|NCT01236573|20594567|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354755|NCT01236573|20594568|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354756|NCT01236573|20594569|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354757|NCT01236573|20594570|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354758|NCT01236573|20594571|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354759|NCT01236573|20594572|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354760|NCT01236573|20594562|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354761|NCT01236573|20594563|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354762|NCT01236573|20594564|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354763|NCT01236573|20594565|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354764|NCT01236573|20594566|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354765|NCT01236573|20594567|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354766|NCT01236573|20594568|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354767|NCT01236573|20594569|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354768|NCT01236573|20594570|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
8354769|NCT01236573|20594571|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354770|NCT01236573|20594572|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354771|NCT01236573|20594562|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354772|NCT01236573|20594563|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354773|NCT01236573|20594564|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354774|NCT01236573|20594565|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354775|NCT01236573|20594566|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354776|NCT01236573|20594567|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354777|NCT01236573|20594568|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354778|NCT01236573|20594569|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354779|NCT01236573|20594570|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
8354780|NCT01236573|20594571|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354781|NCT01236573|20594572|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354800|NCT01236521|20594640|P2|NOT COMPLETED|Overall Study||25
8354801|NCT01236521|20594641|P1|NOT COMPLETED|Overall Study||21
8354802|NCT01236521|20594640|P2|COMPLETED|Overall Study||105
8354803|NCT01236521|20594641|P1|COMPLETED|Overall Study||110
8354804|NCT01236521|20594640|P2|12-moth Completed|Overall Study||105
8354805|NCT01236521|20594641|P1|12-moth Completed|Overall Study||110
8354806|NCT01236521|20594640|P2|9-month Completed|Overall Study||101
8354807|NCT01236521|20594641|P1|9-month Completed|Overall Study||115
8354808|NCT01236521|20594640|P2|6-month Completed|Overall Study||116
8354809|NCT01236521|20594641|P1|6-month Completed|Overall Study||122
8354810|NCT01236521|20594640|P2|3-month Completed|Overall Study||119
8354811|NCT01236521|20594641|P1|3-month Completed|Overall Study||122
8354812|NCT01236521|20594640|P2|STARTED|Overall Study||130
8354813|NCT01236521|20594641|P1|STARTED|Overall Study||131
8354814|NCT01236378|20594669|P1|NOT COMPLETED|Overall Study||0
8354815|NCT01236378|20594669|P1|COMPLETED|Overall Study||24
8354816|NCT01236378|20594669|P1|STARTED|Overall Study||24
8354817|NCT01236352|20594692|P11|NOT COMPLETED|Overall Study||20
8354818|NCT01236352|20594693|P10|NOT COMPLETED|Overall Study||22
8354819|NCT01236352|20594694|P9|NOT COMPLETED|Overall Study||3
8354820|NCT01236352|20594695|P8|NOT COMPLETED|Overall Study||7
8354821|NCT01236352|20594696|P7|NOT COMPLETED|Overall Study||8
8354822|NCT01236352|20594697|P6|NOT COMPLETED|Overall Study||4
8354823|NCT01236352|20594698|P5|NOT COMPLETED|Overall Study||4
8354824|NCT01236352|20594699|P4|NOT COMPLETED|Overall Study||3
8354825|NCT01236352|20594700|P3|NOT COMPLETED|Overall Study||4
8354826|NCT01236352|20594701|P2|NOT COMPLETED|Overall Study||4
8354827|NCT01236352|20594702|P1|NOT COMPLETED|Overall Study||4
8354828|NCT01236352|20594692|P11|COMPLETED|Overall Study||0
8354829|NCT01236352|20594693|P10|COMPLETED|Overall Study||0
8354830|NCT01236352|20594694|P9|COMPLETED|Overall Study||0
8354831|NCT01236352|20594695|P8|COMPLETED|Overall Study||0
8354832|NCT01236352|20594696|P7|COMPLETED|Overall Study||0
8354833|NCT01236352|20594697|P6|COMPLETED|Overall Study||0
8354834|NCT01236352|20594698|P5|COMPLETED|Overall Study||0
8354835|NCT01236352|20594699|P4|COMPLETED|Overall Study||1
8354836|NCT01236352|20594700|P3|COMPLETED|Overall Study||0
8354837|NCT01236352|20594701|P2|COMPLETED|Overall Study||0
8354838|NCT01236352|20594702|P1|COMPLETED|Overall Study||0
8354839|NCT01236352|20594692|P11|STARTED|Overall Study||20
8354840|NCT01236352|20594693|P10|STARTED|Overall Study||22
8354841|NCT01236352|20594694|P9|STARTED|Overall Study||3
8354842|NCT01236352|20594695|P8|STARTED|Overall Study||7
8354843|NCT01236352|20594696|P7|STARTED|Overall Study||8
8354844|NCT01236352|20594697|P6|STARTED|Overall Study||4
8354845|NCT01236352|20594698|P5|STARTED|Overall Study||4
8354846|NCT01236352|20594699|P4|STARTED|Overall Study||4
8354847|NCT01236352|20594700|P3|STARTED|Overall Study||4
8354848|NCT01236352|20594701|P2|STARTED|Overall Study||4
8354849|NCT01236352|20594702|P1|STARTED|Overall Study||4
8354850|NCT01236326|20594871|P2|NOT COMPLETED|Overall Study||4
8354851|NCT01236326|20594872|P1|NOT COMPLETED|Overall Study||1
8354852|NCT01236326|20594871|P2|COMPLETED|Overall Study||51
8354853|NCT01236326|20594872|P1|COMPLETED|Overall Study||49
8354854|NCT01236326|20594871|P2|STARTED|Overall Study||55
8354855|NCT01236326|20594872|P1|STARTED|Overall Study||50
8354856|NCT01236300|20594886|P1|NOT COMPLETED|Overall Study||0
8354857|NCT01236300|20594886|P1|COMPLETED|Overall Study||66
8354858|NCT01236300|20594886|P1|STARTED|Overall Study||66
8354859|NCT01236196|20594896|P2|NOT COMPLETED|Overall Study||8
8354860|NCT01236196|20594897|P1|NOT COMPLETED|Overall Study||1
8354861|NCT01236196|20594896|P2|COMPLETED|Overall Study||13
8354862|NCT01236196|20594897|P1|COMPLETED|Overall Study||17
8354863|NCT01236196|20594896|P2|STARTED|Overall Study||21
8354864|NCT01236196|20594897|P1|STARTED|Overall Study||18
8354865|NCT01236170|20594909|P1|NOT COMPLETED|Overall Study||15
8354866|NCT01236170|20594909|P1|COMPLETED|Overall Study||482
8354867|NCT01236170|20594909|P1|STARTED|Overall Study||497
8354868|NCT01236118|20594920|P3|NOT COMPLETED|Overall Study||3
8354869|NCT01236118|20594921|P2|NOT COMPLETED|Overall Study||1
8354870|NCT01236118|20594922|P1|NOT COMPLETED|Overall Study||2
8354871|NCT01236118|20594920|P3|COMPLETED|Overall Study||14
8354872|NCT01236118|20594921|P2|COMPLETED|Overall Study||4
8354873|NCT01236118|20594922|P1|COMPLETED|Overall Study||4
8354874|NCT01236118|20594920|P3|STARTED|Overall Study||17
8354875|NCT01236118|20594921|P2|STARTED|Overall Study||5
8354876|NCT01236118|20594922|P1|STARTED|Overall Study||6
8354877|NCT01236105|20594930|P1|NOT COMPLETED|Overall Study||0
8354878|NCT01236105|20594930|P1|COMPLETED|Overall Study||21
8354879|NCT01236105|20594930|P1|STARTED|Overall Study||21
8354880|NCT01236053|20594966|P22|NOT COMPLETED|Overall Study||0
8354881|NCT01236053|20594967|P21|NOT COMPLETED|Overall Study||0
8354882|NCT01236053|20594968|P20|NOT COMPLETED|Overall Study||0
8354883|NCT01236053|20594969|P19|NOT COMPLETED|Overall Study||0
8354884|NCT01236053|20594970|P18|NOT COMPLETED|Overall Study||0
8354885|NCT01236053|20594971|P17|NOT COMPLETED|Overall Study||0
8354886|NCT01236053|20594972|P16|NOT COMPLETED|Overall Study||0
8354887|NCT01236053|20594973|P15|NOT COMPLETED|Overall Study||0
8354888|NCT01236053|20594974|P14|NOT COMPLETED|Overall Study||0
8354889|NCT01236053|20594975|P13|NOT COMPLETED|Overall Study||0
8354890|NCT01236053|20594976|P12|NOT COMPLETED|Overall Study||0
8354891|NCT01236053|20594977|P11|NOT COMPLETED|Overall Study||0
8354892|NCT01236053|20594978|P10|NOT COMPLETED|Overall Study||0
8354893|NCT01236053|20594979|P9|NOT COMPLETED|Overall Study||0
8354894|NCT01236053|20594980|P8|NOT COMPLETED|Overall Study||0
8354895|NCT01236053|20594981|P7|NOT COMPLETED|Overall Study||0
8354896|NCT01236053|20594982|P6|NOT COMPLETED|Overall Study||0
8354897|NCT01236053|20594983|P5|NOT COMPLETED|Overall Study||0
8354898|NCT01236053|20594984|P4|NOT COMPLETED|Overall Study||0
8354899|NCT01236053|20594985|P3|NOT COMPLETED|Overall Study||0
8354900|NCT01236053|20594986|P2|NOT COMPLETED|Overall Study||0
8354901|NCT01236053|20594987|P1|NOT COMPLETED|Overall Study||0
8354902|NCT01236053|20594966|P22|COMPLETED|Overall Study||12167
8354903|NCT01236053|20594967|P21|COMPLETED|Overall Study||1272
8354904|NCT01236053|20594968|P20|COMPLETED|Overall Study||20382
8354905|NCT01236053|20594969|P19|COMPLETED|Overall Study||2155
8354906|NCT01236053|20594970|P18|COMPLETED|Overall Study||380
8354907|NCT01236053|20594971|P17|COMPLETED|Overall Study||38
8354908|NCT01236053|20594972|P16|COMPLETED|Overall Study||43559
8354909|NCT01236053|20594973|P15|COMPLETED|Overall Study||4600
8354910|NCT01236053|20594974|P14|COMPLETED|Overall Study||1396
8354911|NCT01236053|20594975|P13|COMPLETED|Overall Study||148
8354912|NCT01236053|20594976|P12|COMPLETED|Overall Study||188924
8354913|NCT01236053|20594977|P11|COMPLETED|Overall Study||19564
8354914|NCT01236053|20594978|P10|COMPLETED|Overall Study||2935
8354915|NCT01236053|20594979|P9|COMPLETED|Overall Study||300
8354916|NCT01236053|20594980|P8|COMPLETED|Overall Study||102836
8354917|NCT01236053|20594981|P7|COMPLETED|Overall Study||10855
8354918|NCT01236053|20594982|P6|COMPLETED|Overall Study||2067
8354919|NCT01236053|20594983|P5|COMPLETED|Overall Study||212
8354920|NCT01236053|20594984|P4|COMPLETED|Overall Study||17853
8354921|NCT01236053|20594985|P3|COMPLETED|Overall Study||1877
8354922|NCT01236053|20594986|P2|COMPLETED|Overall Study||1710950
8354923|NCT01236053|20594987|P1|COMPLETED|Overall Study||179138
8354924|NCT01236053|20594966|P22|STARTED|Overall Study||12167
8354925|NCT01236053|20594967|P21|STARTED|Overall Study||1272
8354926|NCT01236053|20594968|P20|STARTED|Overall Study||20382
8354927|NCT01236053|20594969|P19|STARTED|Overall Study||2155
8354928|NCT01236053|20594970|P18|STARTED|Overall Study||380
8354929|NCT01236053|20594971|P17|STARTED|Overall Study||38
8354930|NCT01236053|20594972|P16|STARTED|Overall Study||43559
8354931|NCT01236053|20594973|P15|STARTED|Overall Study||4600
8354932|NCT01236053|20594974|P14|STARTED|Overall Study||1396
8354933|NCT01236053|20594975|P13|STARTED|Overall Study||148
8354934|NCT01236053|20594976|P12|STARTED|Overall Study||188924
8354935|NCT01236053|20594977|P11|STARTED|Overall Study||19564
8354936|NCT01236053|20594978|P10|STARTED|Overall Study||2935
8354937|NCT01236053|20594979|P9|STARTED|Overall Study||300
8354938|NCT01236053|20594980|P8|STARTED|Overall Study||102836
8354939|NCT01236053|20594981|P7|STARTED|Overall Study||10855
8354940|NCT01236053|20594982|P6|STARTED|Overall Study||2067
8354941|NCT01236053|20594983|P5|STARTED|Overall Study||212
8354942|NCT01236053|20594984|P4|STARTED|Overall Study||17853
8354943|NCT01236053|20594985|P3|STARTED|Overall Study||1877
8354944|NCT01236053|20594986|P2|STARTED|Overall Study||1710950
8354945|NCT01236053|20594987|P1|STARTED|Overall Study||179138
8354946|NCT01236001|20595123|P2|NOT COMPLETED|Overall Study||22
8354947|NCT01236001|20595124|P1|NOT COMPLETED|Overall Study||18
8354948|NCT01236001|20595123|P2|COMPLETED|Overall Study||65
8354949|NCT01236001|20595124|P1|COMPLETED|Overall Study||87
8354950|NCT01236001|20595123|P2|STARTED|Overall Study||87
8354951|NCT01236001|20595124|P1|STARTED|Overall Study||105
8354952|NCT01235975|20595156|P2|NOT COMPLETED|Overall Study||7
8354953|NCT01235975|20595157|P1|NOT COMPLETED|Overall Study||17
8354954|NCT01235975|20595156|P2|COMPLETED|Overall Study||88
8354955|NCT01235975|20595157|P1|COMPLETED|Overall Study||257
8354956|NCT01235975|20595156|P2|STARTED|Overall Study||95
8354957|NCT01235975|20595157|P1|STARTED|Overall Study||274
8354958|NCT01235962|20595193|P4|NOT COMPLETED|Overall Study||86
8354959|NCT01235962|20595194|P3|NOT COMPLETED|Overall Study||118
8354960|NCT01235962|20595195|P2|NOT COMPLETED|Overall Study||35
8354961|NCT01235962|20595196|P1|NOT COMPLETED|Overall Study||46
8354962|NCT01235962|20595193|P4|COMPLETED|Overall Study||478
8354963|NCT01235962|20595194|P3|COMPLETED|Overall Study||453
8354964|NCT01235962|20595195|P2|COMPLETED|Overall Study||170
8354965|NCT01235962|20595196|P1|COMPLETED|Overall Study||152
8354966|NCT01235962|20595193|P4|All Deaths|Overall Study||104
8354967|NCT01235962|20595194|P3|All Deaths|Overall Study||102
8354968|NCT01235962|20595195|P2|All Deaths|Overall Study||46
8354969|NCT01235962|20595196|P1|All Deaths|Overall Study||43
8354970|NCT01235962|20595193|P4|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
8354971|NCT01235962|20595194|P3|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
8354972|NCT01235962|20595195|P2|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
8354973|NCT01235962|20595196|P1|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
8354974|NCT01235962|20595193|P4|STARTED|Overall Study||564
8354975|NCT01235962|20595194|P3|STARTED|Overall Study||571
8354976|NCT01235962|20595195|P2|STARTED|Overall Study||205
8354977|NCT01235962|20595196|P1|STARTED|Overall Study||198
8354978|NCT01235949|20595266|P18|NOT COMPLETED|Booster Phase||2
8354979|NCT01235949|20595267|P17|NOT COMPLETED|Booster Phase||0
8354980|NCT01235949|20595268|P16|NOT COMPLETED|Booster Phase||1
8354981|NCT01235949|20595269|P15|NOT COMPLETED|Booster Phase||2
8354982|NCT01235949|20595270|P14|NOT COMPLETED|Booster Phase||0
8354983|NCT01235949|20595271|P13|NOT COMPLETED|Booster Phase||3
8354984|NCT01235949|20595272|P12|NOT COMPLETED|Booster Phase||3
8354985|NCT01235949|20595273|P11|NOT COMPLETED|Booster Phase||2
8354986|NCT01235949|20595274|P10|NOT COMPLETED|Booster Phase||1
8354987|NCT01235949|20595275|P9|NOT COMPLETED|Booster Phase||2
8354988|NCT01235949|20595276|P8|NOT COMPLETED|Booster Phase||1
8354989|NCT01235949|20595277|P7|NOT COMPLETED|Booster Phase||0
8354990|NCT01235949|20595278|P6|NOT COMPLETED|Booster Phase||0
8354991|NCT01235949|20595279|P5|NOT COMPLETED|Booster Phase||0
8354992|NCT01235949|20595280|P4|NOT COMPLETED|Booster Phase||0
8354993|NCT01235949|20595281|P3|NOT COMPLETED|Booster Phase||0
8354994|NCT01235949|20595282|P2|NOT COMPLETED|Booster Phase||0
8354995|NCT01235949|20595283|P1|NOT COMPLETED|Booster Phase||0
8354996|NCT01235949|20595266|P18|COMPLETED|Booster Phase||65
8354997|NCT01235949|20595267|P17|COMPLETED|Booster Phase||68
8354998|NCT01235949|20595268|P16|COMPLETED|Booster Phase||66
8354999|NCT01235949|20595269|P15|COMPLETED|Booster Phase||60
8355000|NCT01235949|20595270|P14|COMPLETED|Booster Phase||65
8355001|NCT01235949|20595271|P13|COMPLETED|Booster Phase||60
8355002|NCT01235949|20595272|P12|COMPLETED|Booster Phase||60
8355003|NCT01235949|20595273|P11|COMPLETED|Booster Phase||61
8355004|NCT01235949|20595274|P10|COMPLETED|Booster Phase||62
8355005|NCT01235949|20595275|P9|COMPLETED|Booster Phase||61
8355006|NCT01235949|20595276|P8|COMPLETED|Booster Phase||59
8355007|NCT01235949|20595277|P7|COMPLETED|Booster Phase||64
8355008|NCT01235949|20595278|P6|COMPLETED|Booster Phase||0
8355009|NCT01235949|20595279|P5|COMPLETED|Booster Phase||0
8355010|NCT01235949|20595280|P4|COMPLETED|Booster Phase||0
8355011|NCT01235949|20595281|P3|COMPLETED|Booster Phase||0
8355012|NCT01235949|20595282|P2|COMPLETED|Booster Phase||0
8355013|NCT01235949|20595283|P1|COMPLETED|Booster Phase||0
8355014|NCT01235949|20595266|P18|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
8355015|NCT01235949|20595267|P17|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
8355016|NCT01235949|20595268|P16|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
8355017|NCT01235949|20595269|P15|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
8355018|NCT01235949|20595270|P14|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
8355019|NCT01235949|20595271|P13|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
8355020|NCT01235949|20595272|P12|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8355021|NCT01235949|20595273|P11|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8355022|NCT01235949|20595274|P10|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8355023|NCT01235949|20595275|P9|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
8355024|NCT01235949|20595276|P8|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
8355025|NCT01235949|20595277|P7|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
8355026|NCT01235949|20595278|P6|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
8355027|NCT01235949|20595279|P5|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
8355028|NCT01235949|20595280|P4|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
8355029|NCT01235949|20595281|P3|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
8355030|NCT01235949|20595282|P2|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
8355031|NCT01235949|20595283|P1|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
8355032|NCT01235949|20595266|P18|NOT COMPLETED|Primary Phase||0
8355033|NCT01235949|20595267|P17|NOT COMPLETED|Primary Phase||0
8355034|NCT01235949|20595268|P16|NOT COMPLETED|Primary Phase||0
8355035|NCT01235949|20595269|P15|NOT COMPLETED|Primary Phase||0
8355036|NCT01235949|20595270|P14|NOT COMPLETED|Primary Phase||0
8355037|NCT01235949|20595271|P13|NOT COMPLETED|Primary Phase||0
8355038|NCT01235949|20595272|P12|NOT COMPLETED|Primary Phase||0
8355039|NCT01235949|20595273|P11|NOT COMPLETED|Primary Phase||0
8355040|NCT01235949|20595274|P10|NOT COMPLETED|Primary Phase||0
8355041|NCT01235949|20595275|P9|NOT COMPLETED|Primary Phase||0
8355042|NCT01235949|20595276|P8|NOT COMPLETED|Primary Phase||0
8355043|NCT01235949|20595277|P7|NOT COMPLETED|Primary Phase||0
8355044|NCT01235949|20595278|P6|NOT COMPLETED|Primary Phase||7
8355045|NCT01235949|20595279|P5|NOT COMPLETED|Primary Phase||1
8355046|NCT01235949|20595280|P4|NOT COMPLETED|Primary Phase||2
8355047|NCT01235949|20595281|P3|NOT COMPLETED|Primary Phase||3
8355048|NCT01235949|20595282|P2|NOT COMPLETED|Primary Phase||3
8355049|NCT01235949|20595283|P1|NOT COMPLETED|Primary Phase||4
8355050|NCT01235949|20595266|P18|COMPLETED|Primary Phase||0
8355051|NCT01235949|20595267|P17|COMPLETED|Primary Phase||0
8355052|NCT01235949|20595268|P16|COMPLETED|Primary Phase||0
8355053|NCT01235949|20595269|P15|COMPLETED|Primary Phase||0
8355054|NCT01235949|20595270|P14|COMPLETED|Primary Phase||0
8355055|NCT01235949|20595271|P13|COMPLETED|Primary Phase||0
8355056|NCT01235949|20595272|P12|COMPLETED|Primary Phase||0
8355057|NCT01235949|20595273|P11|COMPLETED|Primary Phase||0
8355058|NCT01235949|20595274|P10|COMPLETED|Primary Phase||0
8355059|NCT01235949|20595275|P9|COMPLETED|Primary Phase||0
8355060|NCT01235949|20595276|P8|COMPLETED|Primary Phase||0
8355061|NCT01235949|20595277|P7|COMPLETED|Primary Phase||0
8355062|NCT01235949|20595278|P6|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
8355063|NCT01235949|20595279|P5|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
8355064|NCT01235949|20595280|P4|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
8355065|NCT01235949|20595281|P3|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
8355066|NCT01235949|20595282|P2|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
8355067|NCT01235949|20595283|P1|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
8355068|NCT01235949|20595266|P18|STARTED|Primary Phase||0
8355069|NCT01235949|20595267|P17|STARTED|Primary Phase||0
8355070|NCT01235949|20595268|P16|STARTED|Primary Phase||0
8355071|NCT01235949|20595269|P15|STARTED|Primary Phase||0
8355072|NCT01235949|20595270|P14|STARTED|Primary Phase||0
8355073|NCT01235949|20595271|P13|STARTED|Primary Phase||0
8355074|NCT01235949|20595272|P12|STARTED|Primary Phase||0
8355075|NCT01235949|20595273|P11|STARTED|Primary Phase||0
8355076|NCT01235949|20595274|P10|STARTED|Primary Phase||0
8355077|NCT01235949|20595275|P9|STARTED|Primary Phase||0
8355078|NCT01235949|20595276|P8|STARTED|Primary Phase||0
8355079|NCT01235949|20595277|P7|STARTED|Primary Phase||0
8355080|NCT01235949|20595278|P6|STARTED|Primary Phase||74
8355081|NCT01235949|20595279|P5|STARTED|Primary Phase||72
8355082|NCT01235949|20595280|P4|STARTED|Primary Phase||71
8355083|NCT01235949|20595281|P3|STARTED|Primary Phase||199
8355084|NCT01235949|20595282|P2|STARTED|Primary Phase||198
8355085|NCT01235949|20595283|P1|STARTED|Primary Phase||198
8355086|NCT01235910|20595519|P1|NOT COMPLETED|Overall Study||0
8355087|NCT01235910|20595519|P1|COMPLETED|Overall Study||1
8355088|NCT01235910|20595519|P1|STARTED|Overall Study||1
8355089|NCT01235897|20595525|P1|NOT COMPLETED|Overall Study||0
8355090|NCT01235897|20595525|P1|COMPLETED|Overall Study||16
8355091|NCT01235897|20595525|P1|STARTED|Overall Study||16
8355092|NCT01235741|20595533|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
8355093|NCT01235741|20595534|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
8355094|NCT01235741|20595535|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
8355095|NCT01235741|20595533|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
8355096|NCT01235741|20595534|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
8355097|NCT01235741|20595535|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
8355098|NCT01235741|20595533|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
8355099|NCT01235741|20595534|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
8355100|NCT01235741|20595535|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
8355101|NCT01235741|20595533|P3|NOT COMPLETED|Randomized to Treatment||36
8355102|NCT01235741|20595534|P2|NOT COMPLETED|Randomized to Treatment||36
8355103|NCT01235741|20595535|P1|NOT COMPLETED|Randomized to Treatment||0
8355104|NCT01235741|20595533|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
8355105|NCT01235741|20595534|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
8355106|NCT01235741|20595535|P1|COMPLETED|Randomized to Treatment||0
8355107|NCT01235741|20595533|P3|STARTED|Randomized to Treatment||36
8355108|NCT01235741|20595534|P2|STARTED|Randomized to Treatment||36
8355109|NCT01235741|20595535|P1|STARTED|Randomized to Treatment||0
8355110|NCT01235741|20595533|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355111|NCT01235741|20595534|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355112|NCT01235741|20595535|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
8355113|NCT01235741|20595533|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355114|NCT01235741|20595534|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355115|NCT01235741|20595535|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
8355116|NCT01235741|20595533|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
8355117|NCT01235741|20595534|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
8355118|NCT01235741|20595535|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
8355119|NCT01235728|20595562|P8|NOT COMPLETED|Overall Study||0
8355120|NCT01235728|20595563|P7|NOT COMPLETED|Overall Study||0
8355121|NCT01235728|20595564|P6|NOT COMPLETED|Overall Study||0
8355122|NCT01235728|20595565|P5|NOT COMPLETED|Overall Study||0
8355123|NCT01235728|20595566|P4|NOT COMPLETED|Overall Study||1
8355124|NCT01235728|20595567|P3|NOT COMPLETED|Overall Study||0
8355125|NCT01235728|20595568|P2|NOT COMPLETED|Overall Study||0
8355126|NCT01235728|20595569|P1|NOT COMPLETED|Overall Study||0
8355127|NCT01235728|20595562|P8|COMPLETED|Overall Study||3
8355128|NCT01235728|20595563|P7|COMPLETED|Overall Study||3
8355129|NCT01235728|20595564|P6|COMPLETED|Overall Study||3
8355130|NCT01235728|20595565|P5|COMPLETED|Overall Study||3
8355131|NCT01235728|20595566|P4|COMPLETED|Overall Study||2
8355132|NCT01235728|20595567|P3|COMPLETED|Overall Study||3
8355133|NCT01235728|20595568|P2|COMPLETED|Overall Study||3
8355134|NCT01235728|20595569|P1|COMPLETED|Overall Study||3
8355135|NCT01235728|20595562|P8|STARTED|Overall Study||3
8355136|NCT01235728|20595563|P7|STARTED|Overall Study||3
8355137|NCT01235728|20595564|P6|STARTED|Overall Study||3
8355138|NCT01235728|20595565|P5|STARTED|Overall Study||3
8355139|NCT01235728|20595566|P4|STARTED|Overall Study||3
8355140|NCT01235728|20595567|P3|STARTED|Overall Study||3
8355141|NCT01235728|20595568|P2|STARTED|Overall Study||3
8355142|NCT01235728|20595569|P1|STARTED|Overall Study||3
8355143|NCT01235715|20595579|P2|NOT COMPLETED|Overall Study||2
8355144|NCT01235715|20595580|P1|NOT COMPLETED|Overall Study||0
8355145|NCT01235715|20595579|P2|COMPLETED|Overall Study||100
8355146|NCT01235715|20595580|P1|COMPLETED|Overall Study||98
8355147|NCT01235715|20595579|P2|STARTED|Overall Study||102
8355148|NCT01235715|20595580|P1|STARTED|Overall Study||98
8355149|NCT01235689|20595620|P2|NOT COMPLETED|Overall Study||32
8355150|NCT01235689|20595621|P1|NOT COMPLETED|Overall Study||29
8355151|NCT01235689|20595620|P2|COMPLETED|Overall Study||90
8355152|NCT01235689|20595621|P1|COMPLETED|Overall Study||93
8355153|NCT01235689|20595620|P2|Randomized at Week 9|Overall Study||53
8355154|NCT01235689|20595621|P1|Randomized at Week 9|Overall Study||59
8355155|NCT01235689|20595620|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
8355156|NCT01235689|20595621|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
8355157|NCT01235689|20595620|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
8355158|NCT01235689|20595621|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
8355159|NCT01235598|20595693|P2|NOT COMPLETED|Overall Study||4
8355160|NCT01235598|20595694|P1|NOT COMPLETED|Overall Study||1
8355161|NCT01235598|20595693|P2|COMPLETED|Overall Study||24
8355162|NCT01235598|20595694|P1|COMPLETED|Overall Study||12
8355163|NCT01235598|20595693|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
8355164|NCT01235598|20595694|P1|STARTED|Overall Study||13
8355165|NCT01235546|20595739|P2|NOT COMPLETED|Overall Study||1
8355166|NCT01235546|20595740|P1|NOT COMPLETED|Overall Study||2
8355167|NCT01235546|20595739|P2|COMPLETED|Overall Study||1018
8355168|NCT01235546|20595740|P1|COMPLETED|Overall Study||992
8355169|NCT01235546|20595739|P2|STARTED|Overall Study||1019
8355170|NCT01235546|20595740|P1|STARTED|Overall Study||994
8355171|NCT01235507|20595764|P1|NOT COMPLETED|Overall Study||2
8355172|NCT01235507|20595764|P1|COMPLETED|Overall Study||69
8355173|NCT01235507|20595764|P1|STARTED|Overall Study||71
8355174|NCT01235442|20595778|P2|NOT COMPLETED|Overall Study||44
8355175|NCT01235442|20595779|P1|NOT COMPLETED|Overall Study||44
8355176|NCT01235442|20595778|P2|COMPLETED|Overall Study||251
8355177|NCT01235442|20595779|P1|COMPLETED|Overall Study||253
8355178|NCT01235442|20595778|P2|STARTED|Overall Study||295
8355179|NCT01235442|20595779|P1|STARTED|Overall Study||297
8355180|NCT01235403|20595797|P1|NOT COMPLETED|Overall Study||26
8355181|NCT01235403|20595797|P1|COMPLETED|Overall Study||74
8355182|NCT01235403|20595797|P1|STARTED|Overall Study||100
8355183|NCT01235377|20595805|P2|NOT COMPLETED|Overall Study||1
8355184|NCT01235377|20595806|P1|NOT COMPLETED|Overall Study||1
8355185|NCT01235377|20595805|P2|COMPLETED|Overall Study||8
8355186|NCT01235377|20595806|P1|COMPLETED|Overall Study||10
8355187|NCT01235377|20595805|P2|STARTED|Overall Study||9
8355188|NCT01235377|20595806|P1|STARTED|Overall Study||11
8355189|NCT01235351|20595814|P2|NOT COMPLETED|Treatment With Different Dose Sequences||0
8355190|NCT01235351|20595815|P1|NOT COMPLETED|Treatment With Different Dose Sequences||0
8355191|NCT01235351|20595814|P2|COMPLETED|Treatment With Different Dose Sequences||82
8355192|NCT01235351|20595815|P1|COMPLETED|Treatment With Different Dose Sequences||233
8355193|NCT01235351|20595814|P2|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
8355194|NCT01235351|20595815|P1|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
8355195|NCT01235351|20595814|P2|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
8355196|NCT01235351|20595815|P1|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
8355197|NCT01235351|20595814|P2|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
8355198|NCT01235351|20595815|P1|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
8355199|NCT01235351|20595814|P2|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
8355200|NCT01235351|20595815|P1|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
8355201|NCT01235351|20595814|P2|STARTED|Treatment With Different Dose Sequences||82
8355202|NCT01235351|20595815|P1|STARTED|Treatment With Different Dose Sequences||233
8355203|NCT01235351|20595814|P2|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
8355204|NCT01235351|20595815|P1|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
8355205|NCT01235351|20595814|P2|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
8355206|NCT01235351|20595815|P1|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
8355207|NCT01235351|20595814|P2|STARTED|Initial Treatment With 75 mg and 150 mg||86
8355208|NCT01235351|20595815|P1|STARTED|Initial Treatment With 75 mg and 150 mg||247
8355209|NCT01235338|20595827|P2|NOT COMPLETED|Overall Study||5
8355210|NCT01235338|20595828|P1|NOT COMPLETED|Overall Study||11
8355211|NCT01235338|20595827|P2|COMPLETED|Overall Study||33
8355212|NCT01235338|20595828|P1|COMPLETED|Overall Study||31
8355213|NCT01235338|20595827|P2|STARTED|Overall Study||38
8355214|NCT01235338|20595828|P1|STARTED|Overall Study||42
8355215|NCT01235234|20595873|P3|NOT COMPLETED|Overall Study||1
8355216|NCT01235234|20595874|P2|NOT COMPLETED|Overall Study||2
8355217|NCT01235234|20595875|P1|NOT COMPLETED|Overall Study||2
8355218|NCT01235234|20595873|P3|COMPLETED|Overall Study||80
8355219|NCT01235234|20595874|P2|COMPLETED|Overall Study||76
8355220|NCT01235234|20595875|P1|COMPLETED|Overall Study||75
8355221|NCT01235234|20595873|P3|STARTED|Overall Study||81
8355222|NCT01235234|20595874|P2|STARTED|Overall Study||78
8355223|NCT01235234|20595875|P1|STARTED|Overall Study||77
8355224|NCT01235195|20595883|P2|NOT COMPLETED|Second Intervention||0
8355225|NCT01235195|20595884|P1|NOT COMPLETED|Second Intervention||0
8355226|NCT01235195|20595883|P2|COMPLETED|Second Intervention||15
8355227|NCT01235195|20595884|P1|COMPLETED|Second Intervention||15
8355228|NCT01235195|20595883|P2|STARTED|Second Intervention||15
8355229|NCT01235195|20595884|P1|STARTED|Second Intervention||15
8355230|NCT01235195|20595883|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
8355231|NCT01235195|20595884|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
8355232|NCT01235195|20595883|P2|COMPLETED|Washout Period of At Least 8 Days||15
8355233|NCT01235195|20595884|P1|COMPLETED|Washout Period of At Least 8 Days||15
8355234|NCT01235195|20595883|P2|STARTED|Washout Period of At Least 8 Days||15
8355235|NCT01235195|20595884|P1|STARTED|Washout Period of At Least 8 Days||15
8355236|NCT01235195|20595883|P2|NOT COMPLETED|First Intervention||0
8355237|NCT01235195|20595884|P1|NOT COMPLETED|First Intervention||0
8355238|NCT01235195|20595883|P2|COMPLETED|First Intervention||15
8355239|NCT01235195|20595884|P1|COMPLETED|First Intervention||15
8355240|NCT01235195|20595883|P2|STARTED|First Intervention||15
8355241|NCT01235195|20595884|P1|STARTED|First Intervention||15
8355242|NCT01234922|20595904|P4|NOT COMPLETED|Overall Study||0
8355243|NCT01234922|20595905|P3|NOT COMPLETED|Overall Study||0
8355244|NCT01234922|20595906|P2|NOT COMPLETED|Overall Study||0
8355245|NCT01234922|20595907|P1|NOT COMPLETED|Overall Study||0
8355246|NCT01234922|20595904|P4|COMPLETED|Overall Study||2
8355247|NCT01234922|20595905|P3|COMPLETED|Overall Study||2
8355248|NCT01234922|20595906|P2|COMPLETED|Overall Study||1
8355249|NCT01234922|20595907|P1|COMPLETED|Overall Study||1
8355250|NCT01234922|20595904|P4|STARTED|Overall Study||2
8355251|NCT01234922|20595905|P3|STARTED|Overall Study||2
8355252|NCT01234922|20595906|P2|STARTED|Overall Study||1
8355253|NCT01234922|20595907|P1|STARTED|Overall Study||1
8355254|NCT01234883|20595923|P2|NOT COMPLETED|Overall Study||13
8355255|NCT01234883|20595924|P1|NOT COMPLETED|Overall Study||10
8355256|NCT01234883|20595923|P2|COMPLETED|Overall Study||36
8355257|NCT01234883|20595924|P1|COMPLETED|Overall Study||41
8355258|NCT01234883|20595923|P2|STARTED|Overall Study||49
8355259|NCT01234883|20595924|P1|STARTED|Overall Study||51
8355260|NCT01234870|20595930|P1|NOT COMPLETED|Overall Study||0
8355261|NCT01234870|20595930|P1|COMPLETED|Overall Study||40
8355262|NCT01234870|20595930|P1|STARTED|Overall Study||40
8355263|NCT01234831|20595937|P2|NOT COMPLETED|Overall Study||4
8355264|NCT01234831|20595938|P1|NOT COMPLETED|Overall Study||2
8355265|NCT01234831|20595937|P2|COMPLETED|Overall Study||198
8355266|NCT01234831|20595938|P1|COMPLETED|Overall Study||259
8355267|NCT01234831|20595937|P2|STARTED|Overall Study||202
8355268|NCT01234831|20595938|P1|STARTED|Overall Study||261
8355269|NCT01234766|20595950|P1|NOT COMPLETED|Overall Study||4
8355270|NCT01234766|20595950|P1|COMPLETED|Overall Study||35
8355271|NCT01234766|20595950|P1|STARTED|Overall Study||39
8355272|NCT01234714|20595954|P1|NOT COMPLETED|Overall Study||0
8355273|NCT01234714|20595954|P1|COMPLETED|Overall Study||84
8355274|NCT01234714|20595954|P1|STARTED|Overall Study||84
8355275|NCT01234675|20595971|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8355276|NCT01234675|20595972|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
8355277|NCT01234675|20595971|P2|COMPLETED|Second Intervention (6 Weeks)||8
8355278|NCT01234675|20595972|P1|COMPLETED|Second Intervention (6 Weeks)||7
8355279|NCT01234675|20595971|P2|STARTED|Second Intervention (6 Weeks)||8
8355280|NCT01234675|20595972|P1|STARTED|Second Intervention (6 Weeks)||9
8355281|NCT01234675|20595971|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
8355282|NCT01234675|20595972|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
8355283|NCT01234675|20595971|P2|COMPLETED|First Intervention (6 Weeks)||8
8355284|NCT01234675|20595972|P1|COMPLETED|First Intervention (6 Weeks)||9
8355285|NCT01234675|20595971|P2|STARTED|First Intervention (6 Weeks)||9
8355286|NCT01234675|20595972|P1|STARTED|First Intervention (6 Weeks)||10
8355287|NCT01234649|20596004|P2|NOT COMPLETED|Overall Study||38
8355288|NCT01234649|20596005|P1|NOT COMPLETED|Overall Study||43
8355289|NCT01234649|20596004|P2|COMPLETED|Overall Study||37
8355290|NCT01234649|20596005|P1|COMPLETED|Overall Study||35
8355291|NCT01234649|20596004|P2|STARTED|Overall Study||75
8355292|NCT01234649|20596005|P1|STARTED|Overall Study||78
8355293|NCT01234467|20596053|P1|NOT COMPLETED|Overall Study||12
8355294|NCT01234467|20596053|P1|COMPLETED|Overall Study||11
8355295|NCT01234467|20596053|P1|STARTED|Overall Study||23
8355296|NCT01234402|20596065|P3|NOT COMPLETED|Overall Study||8
8355297|NCT01234402|20596066|P2|NOT COMPLETED|Overall Study||6
8355298|NCT01234402|20596067|P1|NOT COMPLETED|Overall Study||1
8355299|NCT01234402|20596065|P3|COMPLETED|Overall Study||42
8355300|NCT01234402|20596066|P2|COMPLETED|Overall Study||45
8355301|NCT01234402|20596067|P1|COMPLETED|Overall Study||51
8355302|NCT01234402|20596065|P3|Capecitabine Crossover to Icrucumab|Overall Study||1
8355303|NCT01234402|20596066|P2|Capecitabine Crossover to Icrucumab|Overall Study||0
8355304|NCT01234402|20596067|P1|Capecitabine Crossover to Icrucumab|Overall Study||0
8355305|NCT01234402|20596065|P3|Capecitabine Crossover to Ramucirumab|Overall Study||29
8355306|NCT01234402|20596066|P2|Capecitabine Crossover to Ramucirumab|Overall Study||0
8355307|NCT01234402|20596067|P1|Capecitabine Crossover to Ramucirumab|Overall Study||0
8355308|NCT01234402|20596065|P3|Received at Least One Dose of Study Drug|Overall Study||49
8355309|NCT01234402|20596066|P2|Received at Least One Dose of Study Drug|Overall Study||49
8355310|NCT01234402|20596067|P1|Received at Least One Dose of Study Drug|Overall Study||52
8355311|NCT01234402|20596065|P3|STARTED|Overall Study||50
8355312|NCT01234402|20596066|P2|STARTED|Overall Study||51
8355313|NCT01234402|20596067|P1|STARTED|Overall Study||52
8355314|NCT01234350|20596108|P2|NOT COMPLETED|Overall Study||267
8355315|NCT01234350|20596109|P1|NOT COMPLETED|Overall Study||687
8355316|NCT01234350|20596108|P2|COMPLETED|Overall Study||226
8355317|NCT01234350|20596109|P1|COMPLETED|Overall Study||313
8355318|NCT01234350|20596108|P2|STARTED|Overall Study||493
8355319|NCT01234350|20596109|P1|STARTED|Overall Study||1000
8355320|NCT01234337|20596135|P2|NOT COMPLETED|Overall Study||271
8355321|NCT01234337|20596136|P1|NOT COMPLETED|Overall Study||266
8355322|NCT01234337|20596135|P2|COMPLETED|Overall Study||0
8355323|NCT01234337|20596136|P1|COMPLETED|Overall Study||0
8355324|NCT01234337|20596135|P2|Participants Received Treatment|Overall Study||267
8355325|NCT01234337|20596136|P1|Participants Received Treatment|Overall Study||260
8355326|NCT01234337|20596135|P2|STARTED|Overall Study||271
8355327|NCT01234337|20596136|P1|STARTED|Overall Study||266
8355328|NCT01234207|20596164|P2|NOT COMPLETED|Second Intervention||0
8355329|NCT01234207|20596165|P1|NOT COMPLETED|Second Intervention||0
8355330|NCT01234207|20596164|P2|COMPLETED|Second Intervention||48
8355331|NCT01234207|20596165|P1|COMPLETED|Second Intervention||47
8355332|NCT01234207|20596164|P2|STARTED|Second Intervention||48
8355333|NCT01234207|20596165|P1|STARTED|Second Intervention||47
8355334|NCT01234207|20596164|P2|NOT COMPLETED|1-Week Washout Period||0
8355335|NCT01234207|20596165|P1|NOT COMPLETED|1-Week Washout Period||0
8355336|NCT01234207|20596164|P2|COMPLETED|1-Week Washout Period||48
8355337|NCT01234207|20596165|P1|COMPLETED|1-Week Washout Period||47
8355338|NCT01234207|20596164|P2|STARTED|1-Week Washout Period||48
8355339|NCT01234207|20596165|P1|STARTED|1-Week Washout Period||47
8355340|NCT01234207|20596164|P2|NOT COMPLETED|First Intervention||0
8355341|NCT01234207|20596165|P1|NOT COMPLETED|First Intervention||0
8355342|NCT01234207|20596164|P2|COMPLETED|First Intervention||48
8355343|NCT01234207|20596165|P1|COMPLETED|First Intervention||47
8355344|NCT01234207|20596164|P2|STARTED|First Intervention||48
8355345|NCT01234207|20596165|P1|STARTED|First Intervention||47
8355346|NCT01234103|20596187|P2|NOT COMPLETED|Overall Study||0
8355347|NCT01234103|20596188|P1|NOT COMPLETED|Overall Study||0
8355348|NCT01234103|20596187|P2|COMPLETED|Overall Study||391
8355349|NCT01234103|20596188|P1|COMPLETED|Overall Study||542
8355350|NCT01234103|20596187|P2|STARTED|Overall Study||391
8355351|NCT01234103|20596188|P1|STARTED|Overall Study||542
8355352|NCT01233999|20596196|P1|NOT COMPLETED|Overall Study||2
8355353|NCT01233999|20596196|P1|COMPLETED|Overall Study||8
8355354|NCT01233999|20596196|P1|STARTED|Overall Study||10
8355355|NCT01233921|20596202|P2|NOT COMPLETED|Overall Study||0
8355356|NCT01233921|20596203|P1|NOT COMPLETED|Overall Study||0
8355357|NCT01233921|20596202|P2|COMPLETED|Overall Study||3
8355358|NCT01233921|20596203|P1|COMPLETED|Overall Study||3
8355359|NCT01233921|20596202|P2|STARTED|Overall Study||3
8355360|NCT01233921|20596203|P1|STARTED|Overall Study||3
8355361|NCT01233869|20596215|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
8355362|NCT01233869|20596216|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
8355363|NCT01233869|20596217|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
8355364|NCT01233869|20596218|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
8355365|NCT01233869|20596215|P4|COMPLETED|Extended Treatment Period (46 Months)||18
8355366|NCT01233869|20596216|P3|COMPLETED|Extended Treatment Period (46 Months)||17
8355367|NCT01233869|20596217|P2|COMPLETED|Extended Treatment Period (46 Months)||0
8355368|NCT01233869|20596218|P1|COMPLETED|Extended Treatment Period (46 Months)||20
8355369|NCT01233869|20596215|P4|STARTED|Extended Treatment Period (46 Months)||34
8355370|NCT01233869|20596216|P3|STARTED|Extended Treatment Period (46 Months)||22
8355371|NCT01233869|20596217|P2|STARTED|Extended Treatment Period (46 Months)||3
8355372|NCT01233869|20596218|P1|STARTED|Extended Treatment Period (46 Months)||34
8355373|NCT01233869|20596215|P4|NOT COMPLETED|Washout Period 30 Days||0
8355374|NCT01233869|20596216|P3|NOT COMPLETED|Washout Period 30 Days||0
8355375|NCT01233869|20596217|P2|NOT COMPLETED|Washout Period 30 Days||0
8355376|NCT01233869|20596218|P1|NOT COMPLETED|Washout Period 30 Days||0
8355377|NCT01233869|20596215|P4|COMPLETED|Washout Period 30 Days||34
8355378|NCT01233869|20596216|P3|COMPLETED|Washout Period 30 Days||22
8355379|NCT01233869|20596217|P2|COMPLETED|Washout Period 30 Days||3
8355380|NCT01233869|20596218|P1|COMPLETED|Washout Period 30 Days||34
8355381|NCT01233869|20596215|P4|STARTED|Washout Period 30 Days||34
8355382|NCT01233869|20596216|P3|STARTED|Washout Period 30 Days||22
8355383|NCT01233869|20596217|P2|STARTED|Washout Period 30 Days||3
8355384|NCT01233869|20596218|P1|STARTED|Washout Period 30 Days||34
8355385|NCT01233869|20596215|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
8355386|NCT01233869|20596216|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
8355387|NCT01233869|20596217|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
8355388|NCT01233869|20596218|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
8355389|NCT01233869|20596215|P4|COMPLETED|Initial Treatment Period (24 Months)||34
8355390|NCT01233869|20596216|P3|COMPLETED|Initial Treatment Period (24 Months)||22
8355391|NCT01233869|20596217|P2|COMPLETED|Initial Treatment Period (24 Months)||3
8355392|NCT01233869|20596218|P1|COMPLETED|Initial Treatment Period (24 Months)||34
8355393|NCT01233869|20596215|P4|STARTED|Initial Treatment Period (24 Months)||56
8355394|NCT01233869|20596216|P3|STARTED|Initial Treatment Period (24 Months)||24
8355395|NCT01233869|20596217|P2|STARTED|Initial Treatment Period (24 Months)||31
8355396|NCT01233869|20596218|P1|STARTED|Initial Treatment Period (24 Months)||58
8355397|NCT01233817|20596304|P1|NOT COMPLETED|Overall Study||3
8355398|NCT01233817|20596304|P1|COMPLETED|Overall Study||9
8355399|NCT01233817|20596304|P1|STARTED|Overall Study||12
8355400|NCT01233726|20596311|P3|NOT COMPLETED|Overall Study||1
8355401|NCT01233726|20596312|P2|NOT COMPLETED|Overall Study||0
8355402|NCT01233726|20596313|P1|NOT COMPLETED|Overall Study||1
8355403|NCT01233726|20596311|P3|COMPLETED|Overall Study||52
8355404|NCT01233726|20596312|P2|COMPLETED|Overall Study||53
8355405|NCT01233726|20596313|P1|COMPLETED|Overall Study||52
8355406|NCT01233726|20596311|P3|STARTED|Overall Study||53
8355407|NCT01233726|20596312|P2|STARTED|Overall Study||53
8355408|NCT01233726|20596313|P1|STARTED|Overall Study||53
8355409|NCT01233687|20596351|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
8355410|NCT01233687|20596351|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
8355411|NCT01233687|20596351|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
8355412|NCT01233687|20596351|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
8355413|NCT01233687|20596351|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
8355414|NCT01233687|20596351|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
8355415|NCT01233687|20596351|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
8355416|NCT01233609|20596361|P2|NOT COMPLETED|Overall Study||2
8355417|NCT01233609|20596362|P1|NOT COMPLETED|Overall Study||9
8355418|NCT01233609|20596361|P2|COMPLETED|Overall Study||42
8355419|NCT01233609|20596362|P1|COMPLETED|Overall Study||37
8355420|NCT01233609|20596361|P2|STARTED|Overall Study||44
8355421|NCT01233609|20596362|P1|STARTED|Overall Study||46
8355425|NCT01233284|20596391|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
8355426|NCT01233284|20596392|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
8355427|NCT01233284|20596393|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
8355428|NCT01233284|20596394|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
8355429|NCT01233284|20596395|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
8355430|NCT01233284|20596391|P5|COMPLETED|Period 4 (4 Weeks)||1
8355431|NCT01233284|20596392|P4|COMPLETED|Period 4 (4 Weeks)||33
8355432|NCT01233284|20596393|P3|COMPLETED|Period 4 (4 Weeks)||35
8355433|NCT01233284|20596394|P2|COMPLETED|Period 4 (4 Weeks)||36
8355434|NCT01233284|20596395|P1|COMPLETED|Period 4 (4 Weeks)||36
8355435|NCT01233284|20596391|P5|STARTED|Period 4 (4 Weeks)||1
8355436|NCT01233284|20596392|P4|STARTED|Period 4 (4 Weeks)||34
8355437|NCT01233284|20596393|P3|STARTED|Period 4 (4 Weeks)||35
8355438|NCT01233284|20596394|P2|STARTED|Period 4 (4 Weeks)||37
8355439|NCT01233284|20596395|P1|STARTED|Period 4 (4 Weeks)||36
8355440|NCT01233284|20596391|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
8355441|NCT01233284|20596392|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
8355442|NCT01233284|20596393|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
8355443|NCT01233284|20596394|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
8355444|NCT01233284|20596395|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
8355445|NCT01233284|20596391|P5|COMPLETED|Period 3 (4 Weeks)||1
8355446|NCT01233284|20596392|P4|COMPLETED|Period 3 (4 Weeks)||34
8355447|NCT01233284|20596393|P3|COMPLETED|Period 3 (4 Weeks)||35
8355448|NCT01233284|20596394|P2|COMPLETED|Period 3 (4 Weeks)||37
8355449|NCT01233284|20596395|P1|COMPLETED|Period 3 (4 Weeks)||36
8355450|NCT01233284|20596391|P5|STARTED|Period 3 (4 Weeks)||1
8355451|NCT01233284|20596392|P4|STARTED|Period 3 (4 Weeks)||35
8355452|NCT01233284|20596393|P3|STARTED|Period 3 (4 Weeks)||36
8355453|NCT01233284|20596394|P2|STARTED|Period 3 (4 Weeks)||37
8355454|NCT01233284|20596395|P1|STARTED|Period 3 (4 Weeks)||36
8355455|NCT01233284|20596391|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
8355456|NCT01233284|20596392|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
8355457|NCT01233284|20596393|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
8355458|NCT01233284|20596394|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8355459|NCT01233284|20596395|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
8355460|NCT01233284|20596391|P5|COMPLETED|Period 2 (4 Weeks)||1
8355461|NCT01233284|20596392|P4|COMPLETED|Period 2 (4 Weeks)||35
8355462|NCT01233284|20596393|P3|COMPLETED|Period 2 (4 Weeks)||36
8355463|NCT01233284|20596394|P2|COMPLETED|Period 2 (4 Weeks)||37
8355464|NCT01233284|20596395|P1|COMPLETED|Period 2 (4 Weeks)||36
8355465|NCT01233284|20596391|P5|STARTED|Period 2 (4 Weeks)||1
8355466|NCT01233284|20596392|P4|STARTED|Period 2 (4 Weeks)||35
8355467|NCT01233284|20596393|P3|STARTED|Period 2 (4 Weeks)||37
8355468|NCT01233284|20596394|P2|STARTED|Period 2 (4 Weeks)||37
8355469|NCT01233284|20596395|P1|STARTED|Period 2 (4 Weeks)||36
8355470|NCT01233284|20596391|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
8355471|NCT01233284|20596392|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8355472|NCT01233284|20596393|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
8355473|NCT01233284|20596394|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
8355474|NCT01233284|20596395|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
8355475|NCT01233284|20596391|P5|COMPLETED|Period 1 (4 Weeks)||1
8355476|NCT01233284|20596392|P4|COMPLETED|Period 1 (4 Weeks)||35
8355477|NCT01233284|20596393|P3|COMPLETED|Period 1 (4 Weeks)||37
8355478|NCT01233284|20596394|P2|COMPLETED|Period 1 (4 Weeks)||37
8355479|NCT01233284|20596395|P1|COMPLETED|Period 1 (4 Weeks)||36
8355480|NCT01233284|20596391|P5|STARTED|Period 1 (4 Weeks)||1
8355481|NCT01233284|20596392|P4|STARTED|Period 1 (4 Weeks)||35
8355482|NCT01233284|20596393|P3|STARTED|Period 1 (4 Weeks)||38
8355483|NCT01233284|20596394|P2|STARTED|Period 1 (4 Weeks)||38
8355484|NCT01233284|20596395|P1|STARTED|Period 1 (4 Weeks)||37
8355485|NCT01233258|20596476|P6|NOT COMPLETED|Second Intervention (6 Months)||0
8355486|NCT01233258|20596477|P5|NOT COMPLETED|Second Intervention (6 Months)||0
8355487|NCT01233258|20596478|P4|NOT COMPLETED|Second Intervention (6 Months)||0
8355488|NCT01233258|20596479|P3|NOT COMPLETED|Second Intervention (6 Months)||0
8355489|NCT01233258|20596480|P2|NOT COMPLETED|Second Intervention (6 Months)||0
8355490|NCT01233258|20596481|P1|NOT COMPLETED|Second Intervention (6 Months)||0
8355491|NCT01233258|20596476|P6|COMPLETED|Second Intervention (6 Months)||15
8355492|NCT01233258|20596477|P5|COMPLETED|Second Intervention (6 Months)||16
8355493|NCT01233258|20596478|P4|COMPLETED|Second Intervention (6 Months)||15
8355494|NCT01233258|20596479|P3|COMPLETED|Second Intervention (6 Months)||13
8355495|NCT01233258|20596480|P2|COMPLETED|Second Intervention (6 Months)||10
8355496|NCT01233258|20596481|P1|COMPLETED|Second Intervention (6 Months)||10
8355497|NCT01233258|20596476|P6|STARTED|Second Intervention (6 Months)||15
8355498|NCT01233258|20596477|P5|STARTED|Second Intervention (6 Months)||16
8355499|NCT01233258|20596478|P4|STARTED|Second Intervention (6 Months)||15
8355500|NCT01233258|20596479|P3|STARTED|Second Intervention (6 Months)||13
8355501|NCT01233258|20596480|P2|STARTED|Second Intervention (6 Months)||10
8355502|NCT01233258|20596481|P1|STARTED|Second Intervention (6 Months)||10
8355503|NCT01233258|20596476|P6|NOT COMPLETED|Washout (2-3 Days)||0
8355504|NCT01233258|20596477|P5|NOT COMPLETED|Washout (2-3 Days)||0
8355505|NCT01233258|20596478|P4|NOT COMPLETED|Washout (2-3 Days)||0
8355506|NCT01233258|20596479|P3|NOT COMPLETED|Washout (2-3 Days)||0
8355507|NCT01233258|20596480|P2|NOT COMPLETED|Washout (2-3 Days)||0
8355508|NCT01233258|20596481|P1|NOT COMPLETED|Washout (2-3 Days)||0
8355509|NCT01233258|20596476|P6|COMPLETED|Washout (2-3 Days)||15
8355510|NCT01233258|20596477|P5|COMPLETED|Washout (2-3 Days)||16
8355511|NCT01233258|20596478|P4|COMPLETED|Washout (2-3 Days)||15
8355512|NCT01233258|20596479|P3|COMPLETED|Washout (2-3 Days)||13
8355513|NCT01233258|20596480|P2|COMPLETED|Washout (2-3 Days)||10
8355514|NCT01233258|20596481|P1|COMPLETED|Washout (2-3 Days)||10
8355515|NCT01233258|20596476|P6|STARTED|Washout (2-3 Days)||15
8355516|NCT01233258|20596477|P5|STARTED|Washout (2-3 Days)||16
8355517|NCT01233258|20596478|P4|STARTED|Washout (2-3 Days)||15
8355518|NCT01233258|20596479|P3|STARTED|Washout (2-3 Days)||13
8355519|NCT01233258|20596480|P2|STARTED|Washout (2-3 Days)||10
8355520|NCT01233258|20596481|P1|STARTED|Washout (2-3 Days)||10
8355521|NCT01233258|20596476|P6|NOT COMPLETED|First Intervention (6 Months)||1
8355522|NCT01233258|20596477|P5|NOT COMPLETED|First Intervention (6 Months)||0
8355523|NCT01233258|20596478|P4|NOT COMPLETED|First Intervention (6 Months)||1
8355524|NCT01233258|20596479|P3|NOT COMPLETED|First Intervention (6 Months)||1
8355525|NCT01233258|20596480|P2|NOT COMPLETED|First Intervention (6 Months)||0
8355526|NCT01233258|20596481|P1|NOT COMPLETED|First Intervention (6 Months)||1
8355527|NCT01233258|20596476|P6|COMPLETED|First Intervention (6 Months)||15
8355528|NCT01233258|20596477|P5|COMPLETED|First Intervention (6 Months)||16
8355529|NCT01233258|20596478|P4|COMPLETED|First Intervention (6 Months)||15
8355530|NCT01233258|20596479|P3|COMPLETED|First Intervention (6 Months)||13
8355531|NCT01233258|20596480|P2|COMPLETED|First Intervention (6 Months)||10
8355532|NCT01233258|20596481|P1|COMPLETED|First Intervention (6 Months)||10
8355533|NCT01233258|20596476|P6|Participants Received Treatment|First Intervention (6 Months)||15
8355534|NCT01233258|20596477|P5|Participants Received Treatment|First Intervention (6 Months)||16
8355535|NCT01233258|20596478|P4|Participants Received Treatment|First Intervention (6 Months)||15
8355536|NCT01233258|20596479|P3|Participants Received Treatment|First Intervention (6 Months)||13
8355537|NCT01233258|20596480|P2|Participants Received Treatment|First Intervention (6 Months)||10
8355538|NCT01233258|20596481|P1|Participants Received Treatment|First Intervention (6 Months)||11
8355539|NCT01233258|20596476|P6|STARTED|First Intervention (6 Months)||16
8355540|NCT01233258|20596477|P5|STARTED|First Intervention (6 Months)||16
8355541|NCT01233258|20596478|P4|STARTED|First Intervention (6 Months)||16
8355542|NCT01233258|20596479|P3|STARTED|First Intervention (6 Months)||14
8355543|NCT01233258|20596480|P2|STARTED|First Intervention (6 Months)||10
8355544|NCT01233258|20596481|P1|STARTED|First Intervention (6 Months)||11
8355545|NCT01233232|20596501|P3|NOT COMPLETED|Overall Study||0
8355546|NCT01233232|20596502|P2|NOT COMPLETED|Overall Study||0
8355547|NCT01233232|20596503|P1|NOT COMPLETED|Overall Study||1
8355548|NCT01233232|20596501|P3|COMPLETED|Overall Study||28
8355549|NCT01233232|20596502|P2|COMPLETED|Overall Study||30
8355550|NCT01233232|20596503|P1|COMPLETED|Overall Study||28
8355551|NCT01233232|20596501|P3|STARTED|Overall Study||28
8355552|NCT01233232|20596502|P2|STARTED|Overall Study||30
8355553|NCT01233232|20596503|P1|STARTED|Overall Study||29
8355554|NCT01233076|20596556|P2|NOT COMPLETED|Period 2, One Week||0
8355555|NCT01233076|20596557|P1|NOT COMPLETED|Period 2, One Week||1
8355556|NCT01233076|20596556|P2|COMPLETED|Period 2, One Week||30
8355557|NCT01233076|20596557|P1|COMPLETED|Period 2, One Week||29
8355558|NCT01233076|20596556|P2|STARTED|Period 2, One Week||30
8355559|NCT01233076|20596557|P1|STARTED|Period 2, One Week||30
8355560|NCT01233076|20596556|P2|NOT COMPLETED|Period 1, One Week||0
8355561|NCT01233076|20596557|P1|NOT COMPLETED|Period 1, One Week||0
8355562|NCT01233076|20596556|P2|COMPLETED|Period 1, One Week||30
8355563|NCT01233076|20596557|P1|COMPLETED|Period 1, One Week||30
8355564|NCT01233076|20596556|P2|STARTED|Period 1, One Week||30
8355565|NCT01233076|20596557|P1|STARTED|Period 1, One Week||30
8355566|NCT01233050|20596565|P2|NOT COMPLETED|Overall Study||6
8355567|NCT01233050|20596566|P1|NOT COMPLETED|Overall Study||8
8355568|NCT01233050|20596565|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
8355569|NCT01233050|20596566|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
8355570|NCT01233050|20596565|P2|STARTED|Overall Study||402
8355571|NCT01233050|20596566|P1|STARTED|Overall Study||400
8355572|NCT01232946|20596585|P3|NOT COMPLETED|Overall Study||2
8355573|NCT01232946|20596586|P2|NOT COMPLETED|Overall Study||1
8355574|NCT01232946|20596587|P1|NOT COMPLETED|Overall Study||0
8355575|NCT01232946|20596585|P3|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
8355576|NCT01232946|20596586|P2|COMPLETED|Overall Study|1 participant died unrelated to study|9
8355577|NCT01232946|20596587|P1|COMPLETED|Overall Study||9
8355578|NCT01232946|20596585|P3|STARTED|Overall Study||11
8355579|NCT01232946|20596586|P2|STARTED|Overall Study||10
8355580|NCT01232946|20596587|P1|STARTED|Overall Study||9
8355581|NCT01232920|20596603|P2|NOT COMPLETED|Overall Study||7
8355582|NCT01232920|20596604|P1|NOT COMPLETED|Overall Study||6
8355583|NCT01232920|20596603|P2|COMPLETED|Overall Study||32
8355584|NCT01232920|20596604|P1|COMPLETED|Overall Study||35
8355585|NCT01232920|20596603|P2|STARTED|Overall Study||39
8355586|NCT01232920|20596604|P1|STARTED|Overall Study||41
8355587|NCT01232894|20596618|P2|NOT COMPLETED|Overall Study||8
8355588|NCT01232894|20596619|P1|NOT COMPLETED|Overall Study||12
8355589|NCT01232894|20596618|P2|COMPLETED|Overall Study||22
8355590|NCT01232894|20596619|P1|COMPLETED|Overall Study||48
8355591|NCT01232894|20596618|P2|Received Study Drug|Overall Study||28
8355592|NCT01232894|20596619|P1|Received Study Drug|Overall Study||59
8355593|NCT01232894|20596618|P2|STARTED|Overall Study||30
8355594|NCT01232894|20596619|P1|STARTED|Overall Study||60
8355595|NCT01232868|20596627|P2|NOT COMPLETED|Overall Study||4
8355596|NCT01232868|20596628|P1|NOT COMPLETED|Overall Study||2
8355597|NCT01232868|20596627|P2|COMPLETED|Overall Study||40
8355598|NCT01232868|20596628|P1|COMPLETED|Overall Study||20
8355599|NCT01232868|20596627|P2|STARTED|Overall Study||44
8355600|NCT01232868|20596628|P1|STARTED|Overall Study||22
8355601|NCT01232829|20596636|P1|NOT COMPLETED|Overall Study||0
8355602|NCT01232829|20596636|P1|COMPLETED|Overall Study||18
8355603|NCT01232829|20596636|P1|STARTED|Overall Study||18
8355604|NCT01232790|20596642|P2|NOT COMPLETED|Second Crossover||2
8355605|NCT01232790|20596643|P1|NOT COMPLETED|Second Crossover||1
8355606|NCT01232790|20596642|P2|COMPLETED|Second Crossover||9
8355607|NCT01232790|20596643|P1|COMPLETED|Second Crossover||10
8355608|NCT01232790|20596642|P2|STARTED|Second Crossover||11
8355609|NCT01232790|20596643|P1|STARTED|Second Crossover||11
8355610|NCT01232790|20596642|P2|NOT COMPLETED|First Crossover||0
8355611|NCT01232790|20596643|P1|NOT COMPLETED|First Crossover||1
8355612|NCT01232790|20596642|P2|COMPLETED|First Crossover||11
8355613|NCT01232790|20596643|P1|COMPLETED|First Crossover||11
8355614|NCT01232790|20596642|P2|STARTED|First Crossover||11
8355615|NCT01232790|20596643|P1|STARTED|First Crossover||12
8355616|NCT01232790|20596642|P2|NOT COMPLETED|Initial Assessment||1
8355617|NCT01232790|20596643|P1|NOT COMPLETED|Initial Assessment||0
8355618|NCT01232790|20596642|P2|COMPLETED|Initial Assessment||11
8355619|NCT01232790|20596643|P1|COMPLETED|Initial Assessment||12
8355620|NCT01232790|20596642|P2|STARTED|Initial Assessment||12
8355621|NCT01232790|20596643|P1|STARTED|Initial Assessment||12
8355622|NCT01232790|20596642|P2|NOT COMPLETED|Randomization||2
8355623|NCT01232790|20596643|P1|NOT COMPLETED|Randomization||2
8355624|NCT01232790|20596642|P2|COMPLETED|Randomization||12
8355625|NCT01232790|20596643|P1|COMPLETED|Randomization||12
8355626|NCT01232790|20596642|P2|STARTED|Randomization||14
8355627|NCT01232790|20596643|P1|STARTED|Randomization||14
8355628|NCT01232738|20596697|P1|NOT COMPLETED|Overall Study||13
8355629|NCT01232738|20596697|P1|COMPLETED|Overall Study||23
8355630|NCT01232738|20596697|P1|STARTED|Overall Study||36
8355631|NCT01232569|20596713|P4|NOT COMPLETED|Open-label Extension Period||27
8355632|NCT01232569|20596714|P3|NOT COMPLETED|Open-label Extension Period||27
8355633|NCT01232569|20596715|P2|NOT COMPLETED|Open-label Extension Period||0
8355634|NCT01232569|20596716|P1|NOT COMPLETED|Open-label Extension Period||0
8355635|NCT01232569|20596713|P4|COMPLETED|Open-label Extension Period||200
8355636|NCT01232569|20596714|P3|COMPLETED|Open-label Extension Period||203
8355637|NCT01232569|20596715|P2|COMPLETED|Open-label Extension Period||0
8355638|NCT01232569|20596716|P1|COMPLETED|Open-label Extension Period||0
8355639|NCT01232569|20596713|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
8355640|NCT01232569|20596714|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
8355641|NCT01232569|20596715|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
8355642|NCT01232569|20596716|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
8355643|NCT01232569|20596713|P4|NOT COMPLETED|Double-blind Treatment Period||0
8355644|NCT01232569|20596714|P3|NOT COMPLETED|Double-blind Treatment Period||0
8355645|NCT01232569|20596715|P2|NOT COMPLETED|Double-blind Treatment Period||9
8355646|NCT01232569|20596716|P1|NOT COMPLETED|Double-blind Treatment Period||28
8355647|NCT01232569|20596713|P4|COMPLETED|Double-blind Treatment Period||0
8355648|NCT01232569|20596714|P3|COMPLETED|Double-blind Treatment Period||0
8355649|NCT01232569|20596715|P2|COMPLETED|Double-blind Treatment Period||209
8355650|NCT01232569|20596716|P1|COMPLETED|Double-blind Treatment Period||410
8355651|NCT01232569|20596713|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
8355652|NCT01232569|20596714|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
8355653|NCT01232569|20596715|P2|STARTED|Double-blind Treatment Period||218
8355654|NCT01232569|20596716|P1|STARTED|Double-blind Treatment Period||438
8355655|NCT01232556|20596759|P2|NOT COMPLETED|Overall Study||171
8355656|NCT01232556|20596760|P1|NOT COMPLETED|Overall Study||159
8355657|NCT01232556|20596759|P2|COMPLETED|Overall Study||1
8355658|NCT01232556|20596760|P1|COMPLETED|Overall Study||7
8355659|NCT01232556|20596759|P2|Treated|Overall Study||167
8355660|NCT01232556|20596760|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
8355661|NCT01232556|20596759|P2|STARTED|Overall Study||172
8355662|NCT01232556|20596760|P1|STARTED|Overall Study||166
8355663|NCT01232504|20596783|P3|NOT COMPLETED|Overall Study||8
8355664|NCT01232504|20596784|P2|NOT COMPLETED|Overall Study||2
8355665|NCT01232504|20596785|P1|NOT COMPLETED|Overall Study||9
8355666|NCT01232504|20596783|P3|COMPLETED|Overall Study||61
8355667|NCT01232504|20596784|P2|COMPLETED|Overall Study||67
8355668|NCT01232504|20596785|P1|COMPLETED|Overall Study||59
8355669|NCT01232504|20596783|P3|STARTED|Overall Study||69
8355670|NCT01232504|20596784|P2|STARTED|Overall Study||69
8355671|NCT01232504|20596785|P1|STARTED|Overall Study||68
8355672|NCT01232491|20596819|P2|NOT COMPLETED|Overall Study||63
8355673|NCT01232491|20596820|P1|NOT COMPLETED|Overall Study||60
8355674|NCT01232491|20596819|P2|COMPLETED|Overall Study||242
8355675|NCT01232491|20596820|P1|COMPLETED|Overall Study||246
8355676|NCT01232491|20596819|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
8355677|NCT01232491|20596820|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
8355678|NCT01232491|20596819|P2|STARTED|Overall Study||305
8355679|NCT01232491|20596820|P1|STARTED|Overall Study||306
8355680|NCT01232465|20596840|P2|NOT COMPLETED|Overall Study||0
8355681|NCT01232465|20596841|P1|NOT COMPLETED|Overall Study||0
8355682|NCT01232465|20596840|P2|COMPLETED|Overall Study||402
8355683|NCT01232465|20596841|P1|COMPLETED|Overall Study||337
8355684|NCT01232465|20596840|P2|STARTED|Overall Study||402
8355685|NCT01232465|20596841|P1|STARTED|Overall Study||337
8355686|NCT01232452|20596849|P2|NOT COMPLETED|Overall Study||39
8355687|NCT01232452|20596850|P1|NOT COMPLETED|Overall Study||39
8355688|NCT01232452|20596849|P2|COMPLETED|Overall Study||46
8355689|NCT01232452|20596850|P1|COMPLETED|Overall Study||48
8355690|NCT01232452|20596849|P2|Received at Least One Dose of Study Drug|Overall Study||81
8355691|NCT01232452|20596850|P1|Received at Least One Dose of Study Drug|Overall Study||85
8355692|NCT01232452|20596849|P2|STARTED|Overall Study||85
8355693|NCT01232452|20596850|P1|STARTED|Overall Study||87
8355694|NCT01232296|20596876|P2|NOT COMPLETED|Overall Study||83
8355695|NCT01232296|20596877|P1|NOT COMPLETED|Overall Study||82
8355696|NCT01232296|20596876|P2|COMPLETED|Overall Study||0
8355697|NCT01232296|20596877|P1|COMPLETED|Overall Study||0
8355698|NCT01232296|20596876|P2|Safety Set|Overall Study||83
8355699|NCT01232296|20596877|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
8355700|NCT01232296|20596876|P2|Full Analysis Set|Overall Study||83
8355701|NCT01232296|20596877|P1|Full Analysis Set|Overall Study||82
8355702|NCT01232296|20596876|P2|STARTED|Overall Study||83
8355703|NCT01232296|20596877|P1|STARTED|Overall Study||82
8355704|NCT01232283|20596894|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
8355705|NCT01232283|20596895|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
8355706|NCT01232283|20596896|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355707|NCT01232283|20596897|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355708|NCT01232283|20596898|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355709|NCT01232283|20596899|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355710|NCT01232283|20596900|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355711|NCT01232283|20596901|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355712|NCT01232283|20596902|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355713|NCT01232283|20596903|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355714|NCT01232283|20596894|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
8355715|NCT01232283|20596895|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
8355716|NCT01232283|20596896|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355717|NCT01232283|20596897|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355718|NCT01232283|20596898|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355719|NCT01232283|20596899|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355720|NCT01232283|20596900|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355721|NCT01232283|20596901|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355722|NCT01232283|20596902|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355723|NCT01232283|20596903|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355724|NCT01232283|20596894|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
8355725|NCT01232283|20596895|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
8355726|NCT01232283|20596896|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355727|NCT01232283|20596897|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355728|NCT01232283|20596898|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355729|NCT01232283|20596899|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355730|NCT01232283|20596900|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355731|NCT01232283|20596901|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355732|NCT01232283|20596902|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355733|NCT01232283|20596903|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355734|NCT01232283|20596894|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355735|NCT01232283|20596895|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355736|NCT01232283|20596896|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
8355737|NCT01232283|20596897|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
8355738|NCT01232283|20596898|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
8355739|NCT01232283|20596899|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
8355740|NCT01232283|20596900|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355741|NCT01232283|20596901|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355742|NCT01232283|20596902|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355743|NCT01232283|20596903|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355744|NCT01232283|20596894|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355745|NCT01232283|20596895|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355746|NCT01232283|20596896|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
8355747|NCT01232283|20596897|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
8355748|NCT01232283|20596898|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
8355749|NCT01232283|20596899|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
8355750|NCT01232283|20596900|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355751|NCT01232283|20596901|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355752|NCT01232283|20596902|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355753|NCT01232283|20596903|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355754|NCT01232283|20596894|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355755|NCT01232283|20596895|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355756|NCT01232283|20596896|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
8355757|NCT01232283|20596897|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
8355758|NCT01232283|20596898|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355759|NCT01232283|20596899|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355760|NCT01232283|20596900|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355761|NCT01232283|20596901|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355762|NCT01232283|20596902|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355763|NCT01232283|20596903|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355764|NCT01232283|20596894|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355765|NCT01232283|20596895|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355766|NCT01232283|20596896|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
8355767|NCT01232283|20596897|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
8355768|NCT01232283|20596898|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
8355769|NCT01232283|20596899|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
8355770|NCT01232283|20596900|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355771|NCT01232283|20596901|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355772|NCT01232283|20596902|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355773|NCT01232283|20596903|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355774|NCT01232283|20596894|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355775|NCT01232283|20596895|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355776|NCT01232283|20596896|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355777|NCT01232283|20596897|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355778|NCT01232283|20596898|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355779|NCT01232283|20596899|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355780|NCT01232283|20596900|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
8355781|NCT01232283|20596901|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
8355782|NCT01232283|20596902|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355783|NCT01232283|20596903|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355784|NCT01232283|20596894|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355785|NCT01232283|20596895|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355786|NCT01232283|20596896|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355787|NCT01232283|20596897|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355788|NCT01232283|20596898|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355789|NCT01232283|20596899|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355790|NCT01232283|20596900|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
8355791|NCT01232283|20596901|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
8355792|NCT01232283|20596902|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355793|NCT01232283|20596903|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355794|NCT01232283|20596894|P10|STARTED|Maintenance Phase (Weeks16-32)||0
8355795|NCT01232283|20596895|P9|STARTED|Maintenance Phase (Weeks16-32)||0
8355796|NCT01232283|20596896|P8|STARTED|Maintenance Phase (Weeks16-32)||0
8355797|NCT01232283|20596897|P7|STARTED|Maintenance Phase (Weeks16-32)||0
8355798|NCT01232283|20596898|P6|STARTED|Maintenance Phase (Weeks16-32)||0
8355799|NCT01232283|20596899|P5|STARTED|Maintenance Phase (Weeks16-32)||0
8355800|NCT01232283|20596900|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
8355801|NCT01232283|20596901|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
8355802|NCT01232283|20596902|P2|STARTED|Maintenance Phase (Weeks16-32)||0
8355803|NCT01232283|20596903|P1|STARTED|Maintenance Phase (Weeks16-32)||0
8355804|NCT01232283|20596894|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355805|NCT01232283|20596895|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355806|NCT01232283|20596896|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355807|NCT01232283|20596897|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355808|NCT01232283|20596898|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355809|NCT01232283|20596899|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355810|NCT01232283|20596900|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355811|NCT01232283|20596901|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355812|NCT01232283|20596902|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
8355813|NCT01232283|20596903|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
8355814|NCT01232283|20596894|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355815|NCT01232283|20596895|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355816|NCT01232283|20596896|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355817|NCT01232283|20596897|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355818|NCT01232283|20596898|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355819|NCT01232283|20596899|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355820|NCT01232283|20596900|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355821|NCT01232283|20596901|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355822|NCT01232283|20596902|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
8355823|NCT01232283|20596903|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
8355824|NCT01232283|20596894|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355825|NCT01232283|20596895|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355826|NCT01232283|20596896|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355827|NCT01232283|20596897|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355828|NCT01232283|20596898|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355829|NCT01232283|20596899|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355830|NCT01232283|20596900|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355831|NCT01232283|20596901|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355832|NCT01232283|20596902|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
8355833|NCT01232283|20596903|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
8355834|NCT01232283|20596894|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355835|NCT01232283|20596895|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355836|NCT01232283|20596896|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355837|NCT01232283|20596897|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355838|NCT01232283|20596898|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355839|NCT01232283|20596899|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355840|NCT01232283|20596900|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355841|NCT01232283|20596901|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355842|NCT01232283|20596902|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
8355843|NCT01232283|20596903|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
8355844|NCT01232205|20596937|P2|NOT COMPLETED|Overall Study||3
8355845|NCT01232205|20596938|P1|NOT COMPLETED|Overall Study||3
8355846|NCT01232205|20596937|P2|COMPLETED|Overall Study||55
8355847|NCT01232205|20596938|P1|COMPLETED|Overall Study||49
8355848|NCT01232205|20596937|P2|STARTED|Overall Study||58
8355849|NCT01232205|20596938|P1|STARTED|Overall Study||52
8355850|NCT01232127|20596944|P3|NOT COMPLETED|Period 3: Days 18-24||0
8355851|NCT01232127|20596945|P2|NOT COMPLETED|Period 3: Days 18-24||0
8355852|NCT01232127|20596946|P1|NOT COMPLETED|Period 3: Days 18-24||0
8355853|NCT01232127|20596944|P3|COMPLETED|Period 3: Days 18-24||24
8355854|NCT01232127|20596945|P2|COMPLETED|Period 3: Days 18-24||0
8355855|NCT01232127|20596946|P1|COMPLETED|Period 3: Days 18-24||0
8355856|NCT01232127|20596944|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
8355857|NCT01232127|20596945|P2|STARTED|Period 3: Days 18-24||0
8355858|NCT01232127|20596946|P1|STARTED|Period 3: Days 18-24||0
8355859|NCT01232127|20596944|P3|NOT COMPLETED|Period 2: Days 11-17||0
8355860|NCT01232127|20596945|P2|NOT COMPLETED|Period 2: Days 11-17||0
8355861|NCT01232127|20596946|P1|NOT COMPLETED|Period 2: Days 11-17||0
8355862|NCT01232127|20596944|P3|COMPLETED|Period 2: Days 11-17||0
8355863|NCT01232127|20596945|P2|COMPLETED|Period 2: Days 11-17||24
8355864|NCT01232127|20596946|P1|COMPLETED|Period 2: Days 11-17||0
8355865|NCT01232127|20596944|P3|STARTED|Period 2: Days 11-17||0
8355866|NCT01232127|20596945|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
8355867|NCT01232127|20596946|P1|STARTED|Period 2: Days 11-17||0
8355868|NCT01232127|20596944|P3|NOT COMPLETED|Period 1: Days 1-10||0
8355869|NCT01232127|20596945|P2|NOT COMPLETED|Period 1: Days 1-10||0
8355870|NCT01232127|20596946|P1|NOT COMPLETED|Period 1: Days 1-10||1
8355871|NCT01232127|20596944|P3|COMPLETED|Period 1: Days 1-10||0
8355872|NCT01232127|20596945|P2|COMPLETED|Period 1: Days 1-10||0
8355873|NCT01232127|20596946|P1|COMPLETED|Period 1: Days 1-10||24
8355874|NCT01232127|20596944|P3|STARTED|Period 1: Days 1-10||0
8355875|NCT01232127|20596945|P2|STARTED|Period 1: Days 1-10||0
8355876|NCT01232127|20596946|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
8355877|NCT01231984|20596970|P4|NOT COMPLETED|Study Period 2||4
8355878|NCT01231984|20596971|P3|NOT COMPLETED|Study Period 2||0
8355879|NCT01231984|20596972|P2|NOT COMPLETED|Study Period 2||2
8355880|NCT01231984|20596973|P1|NOT COMPLETED|Study Period 2||3
8355881|NCT01231984|20596970|P4|COMPLETED|Study Period 2||56
8355882|NCT01231984|20596971|P3|COMPLETED|Study Period 2||59
8355883|NCT01231984|20596972|P2|COMPLETED|Study Period 2||61
8355884|NCT01231984|20596973|P1|COMPLETED|Study Period 2||54
8355885|NCT01231984|20596970|P4|STARTED|Study Period 2||60
8355886|NCT01231984|20596971|P3|STARTED|Study Period 2||59
8355887|NCT01231984|20596972|P2|STARTED|Study Period 2||63
8355888|NCT01231984|20596973|P1|STARTED|Study Period 2||57
8355889|NCT01231984|20596970|P4|NOT COMPLETED|Study Period 1||9
8355890|NCT01231984|20596971|P3|NOT COMPLETED|Study Period 1||7
8355891|NCT01231984|20596972|P2|NOT COMPLETED|Study Period 1||7
8355892|NCT01231984|20596973|P1|NOT COMPLETED|Study Period 1||12
8355893|NCT01231984|20596970|P4|COMPLETED|Study Period 1||60
8355894|NCT01231984|20596971|P3|COMPLETED|Study Period 1||59
8355895|NCT01231984|20596972|P2|COMPLETED|Study Period 1||63
8355896|NCT01231984|20596973|P1|COMPLETED|Study Period 1||57
8355897|NCT01231984|20596970|P4|STARTED|Study Period 1||69
8355898|NCT01231984|20596971|P3|STARTED|Study Period 1||66
8355899|NCT01231984|20596972|P2|STARTED|Study Period 1||70
8355900|NCT01231984|20596973|P1|STARTED|Study Period 1||69
8355901|NCT01231841|20596994|P1|NOT COMPLETED|Overall Study||0
8355902|NCT01231841|20596994|P1|COMPLETED|Overall Study||20
8355903|NCT01231841|20596994|P1|STARTED|Overall Study||20
8355904|NCT01231750|20597000|P2|NOT COMPLETED|Overall Study||0
8355905|NCT01231750|20597001|P1|NOT COMPLETED|Overall Study||0
8355906|NCT01231750|20597000|P2|COMPLETED|Overall Study||4
8355907|NCT01231750|20597001|P1|COMPLETED|Overall Study||3
8355908|NCT01231750|20597000|P2|STARTED|Overall Study||4
8355909|NCT01231750|20597001|P1|STARTED|Overall Study||3
8355910|NCT01231646|20597019|P2|NOT COMPLETED|Overall Study||0
8355911|NCT01231646|20597020|P1|NOT COMPLETED|Overall Study||0
8355912|NCT01231646|20597019|P2|COMPLETED|Overall Study||10
8355913|NCT01231646|20597020|P1|COMPLETED|Overall Study||28
8355914|NCT01231646|20597019|P2|STARTED|Overall Study||10
8355915|NCT01231646|20597020|P1|STARTED|Overall Study||28
8355916|NCT01231633|20597028|P2|NOT COMPLETED|Overall Study||0
8355917|NCT01231633|20597029|P1|NOT COMPLETED|Overall Study||0
8355918|NCT01231633|20597028|P2|COMPLETED|Overall Study||13
8355919|NCT01231633|20597029|P1|COMPLETED|Overall Study||14
8355920|NCT01231633|20597028|P2|STARTED|Overall Study||13
8355921|NCT01231633|20597029|P1|STARTED|Overall Study||14
8355922|NCT01231620|20597042|P3|NOT COMPLETED|Overall Study||39
8355923|NCT01231620|20597043|P2|NOT COMPLETED|Overall Study||31
8355924|NCT01231620|20597044|P1|NOT COMPLETED|Overall Study||26
8355925|NCT01231620|20597042|P3|COMPLETED|Overall Study||166
8355926|NCT01231620|20597043|P2|COMPLETED|Overall Study||178
8355927|NCT01231620|20597044|P1|COMPLETED|Overall Study||175
8355928|NCT01231620|20597042|P3|STARTED|Overall Study||205
8355929|NCT01231620|20597043|P2|STARTED|Overall Study||209
8355930|NCT01231620|20597044|P1|STARTED|Overall Study||201
8355931|NCT01231607|20597150|P5|NOT COMPLETED|Overall Study||24
8355932|NCT01231607|20597151|P4|NOT COMPLETED|Overall Study||38
8355933|NCT01231607|20597152|P3|NOT COMPLETED|Overall Study||31
8355934|NCT01231607|20597153|P2|NOT COMPLETED|Overall Study||34
8355935|NCT01231607|20597154|P1|NOT COMPLETED|Overall Study||29
8355936|NCT01231607|20597150|P5|COMPLETED|Overall Study||157
8355937|NCT01231607|20597151|P4|COMPLETED|Overall Study||141
8355938|NCT01231607|20597152|P3|COMPLETED|Overall Study||153
8355939|NCT01231607|20597153|P2|COMPLETED|Overall Study||154
8355940|NCT01231607|20597154|P1|COMPLETED|Overall Study||156
8355941|NCT01231607|20597150|P5|STARTED|Overall Study||181
8355942|NCT01231607|20597151|P4|STARTED|Overall Study||179
8355943|NCT01231607|20597152|P3|STARTED|Overall Study||184
8355944|NCT01231607|20597153|P2|STARTED|Overall Study||188
8355945|NCT01231607|20597154|P1|STARTED|Overall Study||185
8355946|NCT01231581|20597246|P2|NOT COMPLETED|Overall Study||80
8355947|NCT01231581|20597247|P1|NOT COMPLETED|Overall Study||80
8355948|NCT01231581|20597246|P2|COMPLETED|Overall Study||0
8355949|NCT01231581|20597247|P1|COMPLETED|Overall Study||0
8355950|NCT01231581|20597246|P2|Ongoing|Overall Study||0
8355951|NCT01231581|20597247|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
8355952|NCT01231581|20597246|P2|STARTED|Overall Study||80
8355953|NCT01231581|20597247|P1|STARTED|Overall Study||80
8355954|NCT01231555|20597268|P3|NOT COMPLETED|Overall Study||8
8355955|NCT01231555|20597269|P2|NOT COMPLETED|Overall Study||7
8355956|NCT01231555|20597270|P1|NOT COMPLETED|Overall Study||8
8355957|NCT01231555|20597268|P3|COMPLETED|Overall Study||0
8355958|NCT01231555|20597269|P2|COMPLETED|Overall Study||0
8355959|NCT01231555|20597270|P1|COMPLETED|Overall Study||0
8355960|NCT01231555|20597268|P3|STARTED|Overall Study||8
8355961|NCT01231555|20597269|P2|STARTED|Overall Study||7
8355962|NCT01231555|20597270|P1|STARTED|Overall Study||8
8355977|NCT01231503|20597332|P8|NOT COMPLETED|Overall Study||8
8355978|NCT01231503|20597333|P7|NOT COMPLETED|Overall Study||7
8355979|NCT01231503|20597334|P6|NOT COMPLETED|Overall Study||16
8355980|NCT01231503|20597335|P5|NOT COMPLETED|Overall Study||10
8355981|NCT01231503|20597336|P4|NOT COMPLETED|Overall Study||8
8355982|NCT01231503|20597337|P3|NOT COMPLETED|Overall Study||12
8355983|NCT01231503|20597338|P2|NOT COMPLETED|Overall Study||13
8355984|NCT01231503|20597339|P1|NOT COMPLETED|Overall Study||14
8355985|NCT01231503|20597332|P8|COMPLETED|Overall Study||52
8355986|NCT01231503|20597333|P7|COMPLETED|Overall Study||53
8355987|NCT01231503|20597334|P6|COMPLETED|Overall Study||44
8355988|NCT01231503|20597335|P5|COMPLETED|Overall Study||50
8355989|NCT01231503|20597336|P4|COMPLETED|Overall Study||52
8355990|NCT01231503|20597337|P3|COMPLETED|Overall Study||48
8355991|NCT01231503|20597338|P2|COMPLETED|Overall Study||46
8355992|NCT01231503|20597339|P1|COMPLETED|Overall Study||46
8355993|NCT01231503|20597332|P8|STARTED|Overall Study||60
8355994|NCT01231503|20597333|P7|STARTED|Overall Study||60
8355995|NCT01231503|20597334|P6|STARTED|Overall Study||60
8355996|NCT01231503|20597335|P5|STARTED|Overall Study||60
8355997|NCT01231503|20597336|P4|STARTED|Overall Study||60
8355998|NCT01231503|20597337|P3|STARTED|Overall Study||60
8355999|NCT01231503|20597338|P2|STARTED|Overall Study||59
8356000|NCT01231503|20597339|P1|STARTED|Overall Study||60
8356001|NCT01231464|20597579|P2|NOT COMPLETED|Overall Study||7
8356002|NCT01231464|20597580|P1|NOT COMPLETED|Overall Study||5
8356003|NCT01231464|20597579|P2|COMPLETED|Overall Study||176
8356004|NCT01231464|20597580|P1|COMPLETED|Overall Study||177
8356005|NCT01231464|20597579|P2|STARTED|Overall Study||183
8356006|NCT01231464|20597580|P1|STARTED|Overall Study||182
8356007|NCT01231412|20597593|P3|NOT COMPLETED|Overall Study||0
8356008|NCT01231412|20597594|P2|NOT COMPLETED|Overall Study||1
8356009|NCT01231412|20597595|P1|NOT COMPLETED|Overall Study||0
8356010|NCT01231412|20597593|P3|COMPLETED|Overall Study||6
8356011|NCT01231412|20597594|P2|COMPLETED|Overall Study||90
8356012|NCT01231412|20597595|P1|COMPLETED|Overall Study||77
8356013|NCT01231412|20597593|P3|STARTED|Overall Study||6
8356014|NCT01231412|20597594|P2|STARTED|Overall Study||91
8356015|NCT01231412|20597595|P1|STARTED|Overall Study||77
8356016|NCT01231399|20597618|P1|NOT COMPLETED|Overall Study||0
8356017|NCT01231399|20597618|P1|COMPLETED|Overall Study||6
8356018|NCT01231399|20597618|P1|STARTED|Overall Study||6
8356019|NCT01231373|20597629|P4|NOT COMPLETED|Overall Study||1
8356020|NCT01231373|20597630|P3|NOT COMPLETED|Overall Study||0
8356021|NCT01231373|20597631|P2|NOT COMPLETED|Overall Study||1
8356022|NCT01231373|20597632|P1|NOT COMPLETED|Overall Study||3
8356023|NCT01231373|20597629|P4|COMPLETED|Overall Study||57
8356024|NCT01231373|20597630|P3|COMPLETED|Overall Study||60
8356025|NCT01231373|20597631|P2|COMPLETED|Overall Study||57
8356026|NCT01231373|20597632|P1|COMPLETED|Overall Study||56
8356027|NCT01231373|20597629|P4|Patients Receiving Blinded Treatment|Overall Study||58
8356028|NCT01231373|20597630|P3|Patients Receiving Blinded Treatment|Overall Study||60
8356029|NCT01231373|20597631|P2|Patients Receiving Blinded Treatment|Overall Study||57
8356030|NCT01231373|20597632|P1|Patients Receiving Blinded Treatment|Overall Study||57
8356031|NCT01231373|20597629|P4|STARTED|Overall Study||58
8356032|NCT01231373|20597630|P3|STARTED|Overall Study||60
8356033|NCT01231373|20597631|P2|STARTED|Overall Study||58
8356034|NCT01231373|20597632|P1|STARTED|Overall Study||59
8356035|NCT01231334|20597652|P2|NOT COMPLETED|Overall Study||21
8356036|NCT01231334|20597653|P1|NOT COMPLETED|Overall Study||19
8356037|NCT01231334|20597652|P2|COMPLETED|Overall Study||120
8356038|NCT01231334|20597653|P1|COMPLETED|Overall Study||126
8356039|NCT01231334|20597652|P2|STARTED|Overall Study||141
8356040|NCT01231334|20597653|P1|STARTED|Overall Study||145
8356041|NCT01231321|20597671|P1|NOT COMPLETED|Overall Study||5
8356042|NCT01231321|20597671|P1|COMPLETED|Overall Study||95
8356043|NCT01231321|20597671|P1|STARTED|Overall Study||100
8356044|NCT01231230|20597682|P1|NOT COMPLETED|Overall Study||0
8356045|NCT01231230|20597682|P1|COMPLETED|Overall Study||14
8356046|NCT01231230|20597682|P1|Placebo|Overall Study||14
8356047|NCT01231230|20597682|P1|Fluticasone/Salmeterol|Overall Study||14
8356048|NCT01231230|20597682|P1|Salmeterol|Overall Study||14
8356049|NCT01231230|20597682|P1|Fluticasone|Overall Study||14
8356050|NCT01231230|20597682|P1|STARTED|Overall Study||14
8356051|NCT01230931|20597694|P2|NOT COMPLETED|Overall Study||0
8356052|NCT01230931|20597695|P1|NOT COMPLETED|Overall Study||0
8356053|NCT01230931|20597694|P2|COMPLETED|Overall Study||10
8356054|NCT01230931|20597695|P1|COMPLETED|Overall Study||10
8356055|NCT01230931|20597694|P2|STARTED|Overall Study||10
8356056|NCT01230931|20597695|P1|STARTED|Overall Study||10
8356057|NCT01230892|20597719|P2|NOT COMPLETED|Overall Study||1
8356058|NCT01230892|20597720|P1|NOT COMPLETED|Overall Study||3
8356059|NCT01230892|20597719|P2|COMPLETED|Overall Study||13
8356060|NCT01230892|20597720|P1|COMPLETED|Overall Study||12
8356061|NCT01230892|20597719|P2|STARTED|Overall Study||14
8356062|NCT01230892|20597720|P1|STARTED|Overall Study||15
8356063|NCT01230827|20597730|P4|NOT COMPLETED|Overall Study||78
8356064|NCT01230827|20597731|P3|NOT COMPLETED|Overall Study||65
8356065|NCT01230827|20597732|P2|NOT COMPLETED|Overall Study||11
8356066|NCT01230827|20597733|P1|NOT COMPLETED|Overall Study||19
8356067|NCT01230827|20597730|P4|COMPLETED|Overall Study||0
8356068|NCT01230827|20597731|P3|COMPLETED|Overall Study||0
8356069|NCT01230827|20597732|P2|COMPLETED|Overall Study||0
8356070|NCT01230827|20597733|P1|COMPLETED|Overall Study||0
8356071|NCT01230827|20597730|P4|STARTED|Overall Study||78
8356072|NCT01230827|20597731|P3|STARTED|Overall Study||65
8356073|NCT01230827|20597732|P2|STARTED|Overall Study||11
8356074|NCT01230827|20597733|P1|STARTED|Overall Study||19
8356075|NCT01230814|20597749|P2|NOT COMPLETED|Overall Study||4
8356076|NCT01230814|20597750|P1|NOT COMPLETED|Overall Study||13
8356077|NCT01230814|20597749|P2|COMPLETED|Overall Study||112
8356078|NCT01230814|20597750|P1|COMPLETED|Overall Study||105
8356079|NCT01230814|20597749|P2|STARTED|Overall Study||116
8356080|NCT01230814|20597750|P1|STARTED|Overall Study||118
8356081|NCT01230801|20597765|P3|NOT COMPLETED|Overall Study||1
8356082|NCT01230801|20597766|P2|NOT COMPLETED|Overall Study||0
8356083|NCT01230801|20597767|P1|NOT COMPLETED|Overall Study||0
8356084|NCT01230801|20597765|P3|COMPLETED|Overall Study||15
8356085|NCT01230801|20597766|P2|COMPLETED|Overall Study||3
8356086|NCT01230801|20597767|P1|COMPLETED|Overall Study||3
8356087|NCT01230801|20597765|P3|STARTED|Overall Study||16
8356088|NCT01230801|20597766|P2|STARTED|Overall Study||3
8356089|NCT01230801|20597767|P1|STARTED|Overall Study||3
8356090|NCT01230788|20597800|P1|NOT COMPLETED|Overall Study||1
8356091|NCT01230788|20597800|P1|COMPLETED|Overall Study||0
8356092|NCT01230788|20597800|P1|STARTED|Overall Study||1
8356093|NCT01230749|20597812|P4|NOT COMPLETED|Overall Study||2
8356094|NCT01230749|20597813|P3|NOT COMPLETED|Overall Study||2
8356095|NCT01230749|20597814|P2|NOT COMPLETED|Overall Study||2
8356096|NCT01230749|20597815|P1|NOT COMPLETED|Overall Study||0
8356097|NCT01230749|20597812|P4|COMPLETED|Overall Study||20
8356098|NCT01230749|20597813|P3|COMPLETED|Overall Study||21
8356099|NCT01230749|20597814|P2|COMPLETED|Overall Study||20
8356100|NCT01230749|20597815|P1|COMPLETED|Overall Study||22
8356101|NCT01230749|20597812|P4|STARTED|Overall Study||22
8356102|NCT01230749|20597813|P3|STARTED|Overall Study||23
8356103|NCT01230749|20597814|P2|STARTED|Overall Study||22
8356104|NCT01230749|20597815|P1|STARTED|Overall Study||22
8356105|NCT01230710|20597850|P1|NOT COMPLETED|Overall Study||49
8356106|NCT01230710|20597850|P1|COMPLETED|Overall Study||2
8356107|NCT01230710|20597850|P1|STARTED|Overall Study||51
8356108|NCT01230593|20597861|P3|NOT COMPLETED|Overall Study||12
8356109|NCT01230593|20597862|P2|NOT COMPLETED|Overall Study||18
8356110|NCT01230593|20597863|P1|NOT COMPLETED|Overall Study||15
8356111|NCT01230593|20597861|P3|COMPLETED|Overall Study||38
8356112|NCT01230593|20597862|P2|COMPLETED|Overall Study||32
8356113|NCT01230593|20597863|P1|COMPLETED|Overall Study||35
8356114|NCT01230593|20597861|P3|STARTED|Overall Study||50
8356115|NCT01230593|20597862|P2|STARTED|Overall Study||50
8356116|NCT01230593|20597863|P1|STARTED|Overall Study||50
8356117|NCT01230554|20597874|P1|NOT COMPLETED|Overall Study||3
8356118|NCT01230554|20597874|P1|COMPLETED|Overall Study||209
8356119|NCT01230554|20597874|P1|STARTED|Overall Study||212
8356120|NCT01230502|20597884|P3|NOT COMPLETED|Overall Study||0
8356121|NCT01230502|20597885|P2|NOT COMPLETED|Overall Study||0
8356122|NCT01230502|20597886|P1|NOT COMPLETED|Overall Study||0
8356123|NCT01230502|20597884|P3|COMPLETED|Overall Study||0
8356124|NCT01230502|20597885|P2|COMPLETED|Overall Study||0
8356125|NCT01230502|20597886|P1|COMPLETED|Overall Study||9
8356126|NCT01230502|20597884|P3|STARTED|Overall Study||0
8356127|NCT01230502|20597885|P2|STARTED|Overall Study||0
8356128|NCT01230502|20597886|P1|STARTED|Overall Study||9
8356129|NCT01230489|20597897|P1|NOT COMPLETED|Overall Study||5
8356130|NCT01230489|20597897|P1|COMPLETED|Overall Study||8
8356131|NCT01230489|20597897|P1|STARTED|Overall Study||13
8356132|NCT01230424|20597903|P2|NOT COMPLETED|Overall Study||0
8356133|NCT01230424|20597904|P1|NOT COMPLETED|Overall Study||0
8356134|NCT01230424|20597903|P2|COMPLETED|Overall Study||70
8356135|NCT01230424|20597904|P1|COMPLETED|Overall Study||70
8356136|NCT01230424|20597903|P2|STARTED|Overall Study||70
8356137|NCT01230424|20597904|P1|STARTED|Overall Study||70
8356138|NCT01230307|20597932|P2|NOT COMPLETED|Overall Study||2
8356139|NCT01230307|20597933|P1|NOT COMPLETED|Overall Study||0
8356140|NCT01230307|20597932|P2|COMPLETED|Overall Study||4
8356141|NCT01230307|20597933|P1|COMPLETED|Overall Study||6
8356142|NCT01230307|20597932|P2|STARTED|Overall Study||6
8356143|NCT01230307|20597933|P1|STARTED|Overall Study||6
8356144|NCT01230177|20597945|P1|NOT COMPLETED|Overall Study||0
8356145|NCT01230177|20597945|P1|COMPLETED|Overall Study||3
8356146|NCT01230177|20597945|P1|STARTED|Overall Study||3
8356147|NCT01230125|20597955|P2|NOT COMPLETED|Overall Study||50
8356148|NCT01230125|20597956|P1|NOT COMPLETED|Overall Study||73
8356149|NCT01230125|20597955|P2|COMPLETED|Overall Study||54
8356150|NCT01230125|20597956|P1|COMPLETED|Overall Study||134
8356151|NCT01230125|20597955|P2|STARTED|Overall Study||104
8356152|NCT01230125|20597956|P1|STARTED|Overall Study||207
8356153|NCT01230060|20597966|P1|NOT COMPLETED|Overall Study||1
8356154|NCT01230060|20597966|P1|COMPLETED|Overall Study||121
8356155|NCT01230060|20597966|P1|STARTED|Overall Study||122
8356156|NCT01230021|20597970|P1|NOT COMPLETED|Overall Study||0
8356157|NCT01230021|20597970|P1|COMPLETED|Overall Study||6
8356158|NCT01230021|20597970|P1|STARTED|Overall Study||6
8356165|NCT01229891|20598006|P3|NOT COMPLETED|Overall Study||0
8356166|NCT01229891|20598007|P2|NOT COMPLETED|Overall Study||0
8356167|NCT01229891|20598008|P1|NOT COMPLETED|Overall Study||0
8356168|NCT01229891|20598006|P3|COMPLETED|Overall Study||30
8356169|NCT01229891|20598007|P2|COMPLETED|Overall Study||30
8356170|NCT01229891|20598008|P1|COMPLETED|Overall Study||30
8356171|NCT01229891|20598006|P3|STARTED|Overall Study||30
8356172|NCT01229891|20598007|P2|STARTED|Overall Study||30
8356173|NCT01229891|20598008|P1|STARTED|Overall Study||30
8356174|NCT01229735|20598039|P2|NOT COMPLETED|Overall Study||66
8356175|NCT01229735|20598040|P1|NOT COMPLETED|Overall Study||66
8356176|NCT01229735|20598039|P2|COMPLETED|Overall Study||100
8356177|NCT01229735|20598040|P1|COMPLETED|Overall Study||111
8356178|NCT01229735|20598039|P2|STARTED|Overall Study||166
8356179|NCT01229735|20598040|P1|STARTED|Overall Study||177
8356180|NCT01229722|20598056|P2|NOT COMPLETED|Overall Study||4
8356181|NCT01229722|20598057|P1|NOT COMPLETED|Overall Study||0
8356182|NCT01229722|20598056|P2|COMPLETED|Overall Study||30
8356183|NCT01229722|20598057|P1|COMPLETED|Overall Study||36
8356184|NCT01229722|20598056|P2|STARTED|Overall Study||34
8356185|NCT01229722|20598057|P1|STARTED|Overall Study||36
8356186|NCT01229527|20598070|P3|NOT COMPLETED|Overall Study||0
8356187|NCT01229527|20598071|P2|NOT COMPLETED|Overall Study||0
8356188|NCT01229527|20598072|P1|NOT COMPLETED|Overall Study||0
8356189|NCT01229527|20598070|P3|COMPLETED|Overall Study||30
8356190|NCT01229527|20598071|P2|COMPLETED|Overall Study||30
8356191|NCT01229527|20598072|P1|COMPLETED|Overall Study||30
8356192|NCT01229527|20598070|P3|STARTED|Overall Study||30
8356193|NCT01229527|20598071|P2|STARTED|Overall Study||30
8356194|NCT01229527|20598072|P1|STARTED|Overall Study||30
8356195|NCT01229462|20598085|P2|NOT COMPLETED|Overall Study||9
8356196|NCT01229462|20598086|P1|NOT COMPLETED|Overall Study||5
8356197|NCT01229462|20598085|P2|COMPLETED|Overall Study||109
8356198|NCT01229462|20598086|P1|COMPLETED|Overall Study||115
8356199|NCT01229462|20598085|P2|STARTED|Overall Study||118
8356200|NCT01229462|20598086|P1|STARTED|Overall Study||120
8356201|NCT01229449|20598097|P5|NOT COMPLETED|Overall Study||1
8356202|NCT01229449|20598098|P4|NOT COMPLETED|Overall Study||1
8356203|NCT01229449|20598099|P3|NOT COMPLETED|Overall Study||2
8356204|NCT01229449|20598100|P2|NOT COMPLETED|Overall Study||4
8356205|NCT01229449|20598101|P1|NOT COMPLETED|Overall Study||1
8356206|NCT01229449|20598097|P5|COMPLETED|Overall Study||54
8356207|NCT01229449|20598098|P4|COMPLETED|Overall Study||112
8356208|NCT01229449|20598099|P3|COMPLETED|Overall Study||167
8356209|NCT01229449|20598100|P2|COMPLETED|Overall Study||164
8356210|NCT01229449|20598101|P1|COMPLETED|Overall Study||172
8356211|NCT01229449|20598097|P5|STARTED|Overall Study||55
8356212|NCT01229449|20598098|P4|STARTED|Overall Study||113
8356213|NCT01229449|20598099|P3|STARTED|Overall Study||169
8356214|NCT01229449|20598100|P2|STARTED|Overall Study||168
8356215|NCT01229449|20598101|P1|STARTED|Overall Study||173
8356216|NCT01229436|20598158|P1|NOT COMPLETED|Overall Study||5
8356217|NCT01229436|20598158|P1|COMPLETED|Overall Study||249
8356218|NCT01229436|20598158|P1|STARTED|Overall Study||254
8356219|NCT01229423|20598196|P1|NOT COMPLETED|Overall Study||15
8356220|NCT01229423|20598196|P1|COMPLETED|Overall Study||47
8356221|NCT01229423|20598196|P1|STARTED|Overall Study||62
8356222|NCT01229410|20598207|P2|NOT COMPLETED|Overall Study||3
8356223|NCT01229410|20598208|P1|NOT COMPLETED|Overall Study||5
8356224|NCT01229410|20598207|P2|COMPLETED|Overall Study||9
8356225|NCT01229410|20598208|P1|COMPLETED|Overall Study||7
8356226|NCT01229410|20598207|P2|STARTED|Overall Study||12
8356227|NCT01229410|20598208|P1|STARTED|Overall Study||12
8356228|NCT01229397|20598220|P2|NOT COMPLETED|Overall Study||9
8356229|NCT01229397|20598221|P1|NOT COMPLETED|Overall Study||11
8356230|NCT01229397|20598220|P2|COMPLETED|Overall Study||93
8356231|NCT01229397|20598221|P1|COMPLETED|Overall Study||92
8356232|NCT01229397|20598220|P2|STARTED|Overall Study||102
8356233|NCT01229397|20598221|P1|STARTED|Overall Study||103
8356234|NCT01229371|20598239|P4|NOT COMPLETED|Overall Study||0
8356235|NCT01229371|20598240|P3|NOT COMPLETED|Overall Study||0
8356236|NCT01229371|20598241|P2|NOT COMPLETED|Overall Study||1
8356237|NCT01229371|20598242|P1|NOT COMPLETED|Overall Study||0
8356238|NCT01229371|20598239|P4|COMPLETED|Overall Study||110
8356239|NCT01229371|20598240|P3|COMPLETED|Overall Study||110
8356240|NCT01229371|20598241|P2|COMPLETED|Overall Study||110
8356241|NCT01229371|20598242|P1|COMPLETED|Overall Study||109
8356242|NCT01229371|20598239|P4|STARTED|Overall Study||110
8356243|NCT01229371|20598240|P3|STARTED|Overall Study||110
8356244|NCT01229371|20598241|P2|STARTED|Overall Study||111
8356245|NCT01229371|20598242|P1|STARTED|Overall Study||109
8356246|NCT01229267|20598269|P5|NOT COMPLETED|Overall Study||220
8356247|NCT01229267|20598270|P4|NOT COMPLETED|Overall Study||35
8356248|NCT01229267|20598271|P3|NOT COMPLETED|Overall Study||86
8356249|NCT01229267|20598272|P2|NOT COMPLETED|Overall Study||82
8356250|NCT01229267|20598273|P1|NOT COMPLETED|Overall Study||81
8356251|NCT01229267|20598269|P5|COMPLETED|Overall Study||344
8356252|NCT01229267|20598270|P4|COMPLETED|Overall Study||71
8356253|NCT01229267|20598271|P3|COMPLETED|Overall Study||101
8356254|NCT01229267|20598272|P2|COMPLETED|Overall Study||102
8356255|NCT01229267|20598273|P1|COMPLETED|Overall Study||108
8356256|NCT01229267|20598269|P5|Received Vaccination 4|Overall Study||477
8356257|NCT01229267|20598270|P4|Received Vaccination 4|Overall Study||87
8356258|NCT01229267|20598271|P3|Received Vaccination 4|Overall Study||149
8356259|NCT01229267|20598272|P2|Received Vaccination 4|Overall Study||149
8356260|NCT01229267|20598273|P1|Received Vaccination 4|Overall Study||155
8356261|NCT01229267|20598269|P5|Received Vaccination 3|Overall Study||491
8356262|NCT01229267|20598270|P4|Received Vaccination 3|Overall Study||89
8356263|NCT01229267|20598271|P3|Received Vaccination 3|Overall Study||160
8356264|NCT01229267|20598272|P2|Received Vaccination 3|Overall Study||155
8356265|NCT01229267|20598273|P1|Received Vaccination 3|Overall Study||163
8356266|NCT01229267|20598269|P5|Received Vaccination 2|Overall Study||511
8356267|NCT01229267|20598270|P4|Received Vaccination 2|Overall Study||94
8356268|NCT01229267|20598271|P3|Received Vaccination 2|Overall Study||168
8356269|NCT01229267|20598272|P2|Received Vaccination 2|Overall Study||163
8356270|NCT01229267|20598273|P1|Received Vaccination 2|Overall Study||171
8356271|NCT01229267|20598269|P5|Received Vaccination 1|Overall Study||556
8356272|NCT01229267|20598270|P4|Received Vaccination 1|Overall Study||104
8356273|NCT01229267|20598271|P3|Received Vaccination 1|Overall Study||186
8356274|NCT01229267|20598272|P2|Received Vaccination 1|Overall Study||180
8356275|NCT01229267|20598273|P1|Received Vaccination 1|Overall Study||188
8356276|NCT01229267|20598269|P5|STARTED|Overall Study||564
8356277|NCT01229267|20598270|P4|STARTED|Overall Study||106
8356278|NCT01229267|20598271|P3|STARTED|Overall Study||187
8356279|NCT01229267|20598272|P2|STARTED|Overall Study||184
8356280|NCT01229267|20598273|P1|STARTED|Overall Study||189
8356281|NCT01229254|20598292|P3|NOT COMPLETED|Overall Study||12
8356282|NCT01229254|20598293|P2|NOT COMPLETED|Overall Study||16
8356283|NCT01229254|20598294|P1|NOT COMPLETED|Overall Study||15
8356284|NCT01229254|20598292|P3|COMPLETED|Overall Study||61
8356285|NCT01229254|20598293|P2|COMPLETED|Overall Study||58
8356286|NCT01229254|20598294|P1|COMPLETED|Overall Study||27
8356287|NCT01229254|20598292|P3|STARTED|Overall Study||73
8356288|NCT01229254|20598293|P2|STARTED|Overall Study||74
8356289|NCT01229254|20598294|P1|STARTED|Overall Study||42
8356290|NCT01229228|20598308|P5|NOT COMPLETED|Overall Study||1
8356291|NCT01229228|20598309|P4|NOT COMPLETED|Overall Study||0
8356292|NCT01229228|20598310|P3|NOT COMPLETED|Overall Study||1
8356293|NCT01229228|20598311|P2|NOT COMPLETED|Overall Study||0
8356294|NCT01229228|20598312|P1|NOT COMPLETED|Overall Study||1
8356295|NCT01229228|20598308|P5|COMPLETED|Overall Study||50
8356296|NCT01229228|20598309|P4|COMPLETED|Overall Study||51
8356297|NCT01229228|20598310|P3|COMPLETED|Overall Study||49
8356298|NCT01229228|20598311|P2|COMPLETED|Overall Study||51
8356299|NCT01229228|20598312|P1|COMPLETED|Overall Study||50
8356300|NCT01229228|20598308|P5|STARTED|Overall Study||51
8356301|NCT01229228|20598309|P4|STARTED|Overall Study||51
8356302|NCT01229228|20598310|P3|STARTED|Overall Study||50
8356303|NCT01229228|20598311|P2|STARTED|Overall Study||51
8356304|NCT01229228|20598312|P1|STARTED|Overall Study||51
8356305|NCT01229176|20598332|P8|NOT COMPLETED|Overall Study||3
8356306|NCT01229176|20598333|P7|NOT COMPLETED|Overall Study||0
8356307|NCT01229176|20598334|P6|NOT COMPLETED|Overall Study||2
8356308|NCT01229176|20598335|P5|NOT COMPLETED|Overall Study||2
8356309|NCT01229176|20598336|P4|NOT COMPLETED|Overall Study||1
8356310|NCT01229176|20598337|P3|NOT COMPLETED|Overall Study||0
8356311|NCT01229176|20598338|P2|NOT COMPLETED|Overall Study||3
8356312|NCT01229176|20598339|P1|NOT COMPLETED|Overall Study||0
8356313|NCT01229176|20598332|P8|COMPLETED|Overall Study||17
8356314|NCT01229176|20598333|P7|COMPLETED|Overall Study||20
8356315|NCT01229176|20598334|P6|COMPLETED|Overall Study||18
8356316|NCT01229176|20598335|P5|COMPLETED|Overall Study||18
8356317|NCT01229176|20598336|P4|COMPLETED|Overall Study||19
8356318|NCT01229176|20598337|P3|COMPLETED|Overall Study||20
8356319|NCT01229176|20598338|P2|COMPLETED|Overall Study||37
8356320|NCT01229176|20598339|P1|COMPLETED|Overall Study||40
8356321|NCT01229176|20598332|P8|STARTED|Overall Study||20
8356322|NCT01229176|20598333|P7|STARTED|Overall Study||20
8356323|NCT01229176|20598334|P6|STARTED|Overall Study||20
8356324|NCT01229176|20598335|P5|STARTED|Overall Study||20
8356325|NCT01229176|20598336|P4|STARTED|Overall Study||20
8356326|NCT01229176|20598337|P3|STARTED|Overall Study||20
8356327|NCT01229176|20598338|P2|STARTED|Overall Study||40
8356328|NCT01229176|20598339|P1|STARTED|Overall Study||40
8356329|NCT01229150|20598393|P4|NOT COMPLETED|Overall Study||0
8356330|NCT01229150|20598394|P3|NOT COMPLETED|Overall Study||0
8356331|NCT01229150|20598395|P2|NOT COMPLETED|Overall Study||2
8356332|NCT01229150|20598396|P1|NOT COMPLETED|Overall Study||2
8356333|NCT01229150|20598393|P4|COMPLETED|Overall Study||19
8356334|NCT01229150|20598394|P3|COMPLETED|Overall Study||19
8356335|NCT01229150|20598395|P2|COMPLETED|Overall Study||9
8356336|NCT01229150|20598396|P1|COMPLETED|Overall Study||28
8356337|NCT01229150|20598393|P4|STARTED|Overall Study||19
8356338|NCT01229150|20598394|P3|STARTED|Overall Study||19
8356339|NCT01229150|20598395|P2|STARTED|Overall Study||11
8356340|NCT01229150|20598396|P1|STARTED|Overall Study||30
8356341|NCT01229111|20598453|P1|NOT COMPLETED|Overall Study||1
8356342|NCT01229111|20598453|P1|COMPLETED|Overall Study||13
8356343|NCT01229111|20598453|P1|STARTED|Overall Study||14
8356344|NCT01228968|20598461|P1|NOT COMPLETED|Overall Study||0
8356345|NCT01228968|20598461|P1|COMPLETED|Overall Study||9
8356346|NCT01228968|20598461|P1|STARTED|Overall Study||9
8356347|NCT01228929|20598471|P3|NOT COMPLETED|High Temperature Condition||0
8356348|NCT01228929|20598472|P2|NOT COMPLETED|High Temperature Condition||0
8356349|NCT01228929|20598473|P1|NOT COMPLETED|High Temperature Condition||0
8356350|NCT01228929|20598471|P3|COMPLETED|High Temperature Condition||6
8356351|NCT01228929|20598472|P2|COMPLETED|High Temperature Condition||6
8356352|NCT01228929|20598473|P1|COMPLETED|High Temperature Condition||6
8356353|NCT01228929|20598471|P3|STARTED|High Temperature Condition||6
8356354|NCT01228929|20598472|P2|STARTED|High Temperature Condition||6
8356355|NCT01228929|20598473|P1|STARTED|High Temperature Condition||6
8356356|NCT01228929|20598471|P3|NOT COMPLETED|Low Humidity Condition||0
8356357|NCT01228929|20598472|P2|NOT COMPLETED|Low Humidity Condition||0
8356358|NCT01228929|20598473|P1|NOT COMPLETED|Low Humidity Condition||0
8356359|NCT01228929|20598471|P3|COMPLETED|Low Humidity Condition||6
8356360|NCT01228929|20598472|P2|COMPLETED|Low Humidity Condition||6
8356361|NCT01228929|20598473|P1|COMPLETED|Low Humidity Condition||6
8356362|NCT01228929|20598471|P3|STARTED|Low Humidity Condition||6
8356363|NCT01228929|20598472|P2|STARTED|Low Humidity Condition||6
8356364|NCT01228929|20598473|P1|STARTED|Low Humidity Condition||6
8356365|NCT01228929|20598471|P3|NOT COMPLETED|Nominal Condition||0
8356366|NCT01228929|20598472|P2|NOT COMPLETED|Nominal Condition||0
8356367|NCT01228929|20598473|P1|NOT COMPLETED|Nominal Condition||0
8356368|NCT01228929|20598471|P3|COMPLETED|Nominal Condition||6
8356369|NCT01228929|20598472|P2|COMPLETED|Nominal Condition||6
8356370|NCT01228929|20598473|P1|COMPLETED|Nominal Condition||6
8356371|NCT01228929|20598471|P3|STARTED|Nominal Condition||6
8356372|NCT01228929|20598472|P2|STARTED|Nominal Condition||6
8356373|NCT01228929|20598473|P1|STARTED|Nominal Condition||6
8356374|NCT01228903|20598483|P2|NOT COMPLETED|Overall Study||5
8356375|NCT01228903|20598484|P1|NOT COMPLETED|Overall Study||5
8356376|NCT01228903|20598483|P2|COMPLETED|Overall Study||34
8356377|NCT01228903|20598484|P1|COMPLETED|Overall Study||36
8356378|NCT01228903|20598483|P2|STARTED|Overall Study||39
8356379|NCT01228903|20598484|P1|STARTED|Overall Study||41
8356380|NCT01228747|20598502|P2|NOT COMPLETED|Overall Study||45
8356381|NCT01228747|20598503|P1|NOT COMPLETED|Overall Study||65
8356382|NCT01228747|20598502|P2|COMPLETED|Overall Study||81
8356383|NCT01228747|20598503|P1|COMPLETED|Overall Study||60
8356384|NCT01228747|20598502|P2|STARTED|Overall Study||126
8356385|NCT01228747|20598503|P1|STARTED|Overall Study||125
8356386|NCT01228734|20598519|P2|NOT COMPLETED|Overall Study||4
8356387|NCT01228734|20598520|P1|NOT COMPLETED|Overall Study||0
8356388|NCT01228734|20598519|P2|COMPLETED|Overall Study||200
8356389|NCT01228734|20598520|P1|COMPLETED|Overall Study||193
8356390|NCT01228734|20598519|P2|Modified Safety Population|Overall Study||199
8356391|NCT01228734|20598520|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
8356392|NCT01228734|20598519|P2|Modified Intent-to-treat Population|Overall Study||200
8356393|NCT01228734|20598520|P1|Modified Intent-to-treat Population|Overall Study||193
8356394|NCT01228734|20598519|P2|STARTED|Overall Study||204
8356395|NCT01228734|20598520|P1|STARTED|Overall Study||193
8356396|NCT01228591|20598534|P2|NOT COMPLETED|Final Visit||0
8356397|NCT01228591|20598535|P1|NOT COMPLETED|Final Visit||0
8356398|NCT01228591|20598534|P2|COMPLETED|Final Visit||16
8356399|NCT01228591|20598535|P1|COMPLETED|Final Visit||17
8356400|NCT01228591|20598534|P2|STARTED|Final Visit||16
8356401|NCT01228591|20598535|P1|STARTED|Final Visit||17
8356402|NCT01228591|20598534|P2|NOT COMPLETED|1-Week Follow-Up||0
8356403|NCT01228591|20598535|P1|NOT COMPLETED|1-Week Follow-Up||0
8356404|NCT01228591|20598534|P2|COMPLETED|1-Week Follow-Up||16
8356405|NCT01228591|20598535|P1|COMPLETED|1-Week Follow-Up||17
8356406|NCT01228591|20598534|P2|STARTED|1-Week Follow-Up||16
8356407|NCT01228591|20598535|P1|STARTED|1-Week Follow-Up||17
8356408|NCT01228591|20598534|P2|NOT COMPLETED|Baseline||2
8356409|NCT01228591|20598535|P1|NOT COMPLETED|Baseline||1
8356410|NCT01228591|20598534|P2|COMPLETED|Baseline||16
8356411|NCT01228591|20598535|P1|COMPLETED|Baseline||17
8356412|NCT01228591|20598534|P2|STARTED|Baseline||18
8356413|NCT01228591|20598535|P1|STARTED|Baseline||18
8356414|NCT01228435|20598553|P2|NOT COMPLETED|Overall Study||0
8356415|NCT01228435|20598554|P1|NOT COMPLETED|Overall Study||0
8356416|NCT01228435|20598553|P2|COMPLETED|Overall Study||2
8356417|NCT01228435|20598554|P1|COMPLETED|Overall Study||1
8356418|NCT01228435|20598553|P2|STARTED|Overall Study||2
8356419|NCT01228435|20598554|P1|STARTED|Overall Study||1
8356420|NCT01228318|20598564|P2|NOT COMPLETED|Overall Study||7
8356421|NCT01228318|20598565|P1|NOT COMPLETED|Overall Study||4
8356422|NCT01228318|20598564|P2|COMPLETED|Overall Study||22
8356423|NCT01228318|20598565|P1|COMPLETED|Overall Study||30
8356424|NCT01228318|20598564|P2|STARTED|Overall Study||29
8356425|NCT01228318|20598565|P1|STARTED|Overall Study||34
8356426|NCT01228175|20598581|P2|NOT COMPLETED|Overall Study||53
8356427|NCT01228175|20598582|P1|NOT COMPLETED|Overall Study||66
8356428|NCT01228175|20598581|P2|COMPLETED|Overall Study||46
8356429|NCT01228175|20598582|P1|COMPLETED|Overall Study||53
8356430|NCT01228175|20598581|P2|STARTED|Overall Study||99
8356431|NCT01228175|20598582|P1|STARTED|Overall Study||119
8356432|NCT01228149|20598590|P2|NOT COMPLETED|Overall Study||4
8356433|NCT01228149|20598591|P1|NOT COMPLETED|Overall Study||5
8356434|NCT01228149|20598590|P2|COMPLETED|Overall Study||26
8356435|NCT01228149|20598591|P1|COMPLETED|Overall Study||27
8356436|NCT01228149|20598590|P2|STARTED|Overall Study||30
8356437|NCT01228149|20598591|P1|STARTED|Overall Study||32
8356438|NCT01228084|20598613|P1|NOT COMPLETED|Overall Study||4
8356439|NCT01228084|20598613|P1|COMPLETED|Overall Study||16
8356440|NCT01228084|20598613|P1|STARTED|Overall Study||20
8356441|NCT01228071|20598624|P1|NOT COMPLETED|Overall Study||2
8356442|NCT01228071|20598624|P1|COMPLETED|Overall Study||32
8356443|NCT01228071|20598624|P1|STARTED|Overall Study||34
8356444|NCT01228019|20598630|P1|NOT COMPLETED|Overall Study||304
8356445|NCT01228019|20598630|P1|COMPLETED|Overall Study||862
8356446|NCT01228019|20598630|P1|STARTED|Overall Study||1166
8356447|NCT01227993|20598645|P1|NOT COMPLETED|Overall Study||0
8356448|NCT01227993|20598645|P1|COMPLETED|Overall Study||3
8356449|NCT01227993|20598645|P1|STARTED|Overall Study||3
8356450|NCT01227980|20598657|P2|NOT COMPLETED|Overall Study||5
8356451|NCT01227980|20598658|P1|NOT COMPLETED|Overall Study||2
8356452|NCT01227980|20598657|P2|COMPLETED|Overall Study||25
8356453|NCT01227980|20598658|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
8356454|NCT01227980|20598657|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
8356455|NCT01227980|20598658|P1|Measure Drug Level Concentration|Overall Study||10
8356456|NCT01227980|20598657|P2|Scripts Challenge Sessions|Overall Study||25
8356457|NCT01227980|20598658|P1|Scripts Challenge Sessions|Overall Study||26
8356458|NCT01227980|20598657|P2|STARTED|Overall Study||30
8356459|NCT01227980|20598658|P1|STARTED|Overall Study||40
8356460|NCT01227967|20598696|P2|NOT COMPLETED|Overall Study||13
8356461|NCT01227967|20598697|P1|NOT COMPLETED|Overall Study||16
8356462|NCT01227967|20598696|P2|COMPLETED|Overall Study||303
8356463|NCT01227967|20598697|P1|COMPLETED|Overall Study||298
8356464|NCT01227967|20598696|P2|STARTED|Overall Study||316
8356465|NCT01227967|20598697|P1|STARTED|Overall Study||314
8356466|NCT01227954|20598731|P1|NOT COMPLETED|Overall Study||13
8356467|NCT01227954|20598731|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
8356468|NCT01227954|20598731|P1|STARTED|Overall Study||113
8356469|NCT01227928|20598745|P2|NOT COMPLETED|Overall Study||17
8356470|NCT01227928|20598746|P1|NOT COMPLETED|Overall Study||22
8356471|NCT01227928|20598745|P2|COMPLETED|Overall Study||56
8356472|NCT01227928|20598746|P1|COMPLETED|Overall Study||50
8356473|NCT01227928|20598745|P2|STARTED|Overall Study||73
8356474|NCT01227928|20598746|P1|STARTED|Overall Study||72
8356475|NCT01227902|20598784|P4|NOT COMPLETED|Overall Study||10
8356476|NCT01227902|20598785|P3|NOT COMPLETED|Overall Study||19
8356477|NCT01227902|20598786|P2|NOT COMPLETED|Overall Study||13
8356478|NCT01227902|20598787|P1|NOT COMPLETED|Overall Study||18
8356479|NCT01227902|20598784|P4|COMPLETED|Overall Study||42
8356480|NCT01227902|20598785|P3|COMPLETED|Overall Study||25
8356481|NCT01227902|20598786|P2|COMPLETED|Overall Study||38
8356482|NCT01227902|20598787|P1|COMPLETED|Overall Study||38
8356483|NCT01227902|20598784|P4|STARTED|Overall Study||52
8356484|NCT01227902|20598785|P3|STARTED|Overall Study||44
8356485|NCT01227902|20598786|P2|STARTED|Overall Study||51
8356486|NCT01227902|20598787|P1|STARTED|Overall Study||56
8356487|NCT01227889|20598880|P2|NOT COMPLETED|Crossover Phase||37
8356488|NCT01227889|20598881|P1|NOT COMPLETED|Crossover Phase||0
8356489|NCT01227889|20598880|P2|COMPLETED|Crossover Phase||0
8356490|NCT01227889|20598881|P1|COMPLETED|Crossover Phase||0
8356491|NCT01227889|20598880|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
8356492|NCT01227889|20598881|P1|STARTED|Crossover Phase||0
8356493|NCT01227889|20598880|P2|NOT COMPLETED|Randomized Phase (RP)||63
8356494|NCT01227889|20598881|P1|NOT COMPLETED|Randomized Phase (RP)||187
8356495|NCT01227889|20598880|P2|COMPLETED|Randomized Phase (RP)||0
8356496|NCT01227889|20598881|P1|COMPLETED|Randomized Phase (RP)||0
8356497|NCT01227889|20598880|P2|STARTED|Randomized Phase (RP)||63
8356498|NCT01227889|20598881|P1|STARTED|Randomized Phase (RP)||187
8356499|NCT01227824|20598908|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
8356500|NCT01227824|20598909|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
8356501|NCT01227824|20598910|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
8356502|NCT01227824|20598908|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
8356503|NCT01227824|20598909|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
8356504|NCT01227824|20598910|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
8356505|NCT01227824|20598908|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
8356506|NCT01227824|20598909|P2|STARTED|Open-label Phase: Median of 1267 Days||0
8356507|NCT01227824|20598910|P1|STARTED|Open-label Phase: Median of 1267 Days||0
8356508|NCT01227824|20598908|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
8356509|NCT01227824|20598909|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
8356510|NCT01227824|20598910|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
8356511|NCT01227824|20598908|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
8356512|NCT01227824|20598909|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
8356513|NCT01227824|20598910|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
8356514|NCT01227824|20598908|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
8356515|NCT01227824|20598909|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
8356516|NCT01227824|20598910|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
8356517|NCT01227785|20598939|P1|NOT COMPLETED|Overall Study||12
8356518|NCT01227785|20598939|P1|COMPLETED|Overall Study||108
8356519|NCT01227785|20598939|P1|STARTED|Overall Study||120
8356520|NCT01227707|20599005|P1|NOT COMPLETED|Overall Study||24
8356521|NCT01227707|20599005|P1|COMPLETED|Overall Study||19
8356522|NCT01227707|20599005|P1|STARTED|Overall Study||43
8356523|NCT01227681|20599024|P3|NOT COMPLETED|Overall Study||0
8356524|NCT01227681|20599025|P2|NOT COMPLETED|Overall Study||0
8356525|NCT01227681|20599026|P1|NOT COMPLETED|Overall Study||0
8356526|NCT01227681|20599024|P3|COMPLETED|Overall Study||0
8356527|NCT01227681|20599025|P2|COMPLETED|Overall Study||0
8356528|NCT01227681|20599026|P1|COMPLETED|Overall Study||4
8356529|NCT01227681|20599024|P3|STARTED|Overall Study||0
8356530|NCT01227681|20599025|P2|STARTED|Overall Study||0
8356531|NCT01227681|20599026|P1|STARTED|Overall Study||4
8356532|NCT01227668|20599032|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
8356533|NCT01227668|20599033|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
8356534|NCT01227668|20599032|P2|COMPLETED|Phase 2 (Randomization Phase)||19
8356535|NCT01227668|20599033|P1|COMPLETED|Phase 2 (Randomization Phase)||22
8356536|NCT01227668|20599032|P2|Received Treatment|Phase 2 (Randomization Phase)||43
8356537|NCT01227668|20599033|P1|Received Treatment|Phase 2 (Randomization Phase)||39
8356538|NCT01227668|20599032|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
8356539|NCT01227668|20599033|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
8356540|NCT01227668|20599032|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
8356541|NCT01227668|20599033|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
8356542|NCT01227668|20599032|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
8356543|NCT01227668|20599033|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
8356544|NCT01227668|20599032|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
8356545|NCT01227668|20599033|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
8356546|NCT01227668|20599032|P2|STARTED|Phase 1 (Stabilization Phase)||0
8356547|NCT01227668|20599033|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
8356548|NCT01227655|20599050|P3|NOT COMPLETED|Overall Study||14
8356549|NCT01227655|20599051|P2|NOT COMPLETED|Overall Study||26
8356550|NCT01227655|20599052|P1|NOT COMPLETED|Overall Study||11
8356551|NCT01227655|20599050|P3|COMPLETED|Overall Study||130
8356552|NCT01227655|20599051|P2|COMPLETED|Overall Study||128
8356553|NCT01227655|20599052|P1|COMPLETED|Overall Study||118
8356554|NCT01227655|20599050|P3|Full Analysis Set|Overall Study||135
8356555|NCT01227655|20599051|P2|Full Analysis Set|Overall Study||147
8356556|NCT01227655|20599052|P1|Full Analysis Set|Overall Study||125
8356557|NCT01227655|20599050|P3|Safety Set|Overall Study||136
8356558|NCT01227655|20599051|P2|Safety Set|Overall Study||150
8356559|NCT01227655|20599052|P1|Safety Set|Overall Study||125
8356560|NCT01227655|20599050|P3|STARTED|Overall Study||144
8356561|NCT01227655|20599051|P2|STARTED|Overall Study||154
8356562|NCT01227655|20599052|P1|STARTED|Overall Study||129
8356563|NCT01227629|20599079|P10|NOT COMPLETED|Overall Study||2
8356564|NCT01227629|20599080|P9|NOT COMPLETED|Overall Study||6
8356565|NCT01227629|20599081|P8|NOT COMPLETED|Overall Study||6
8356566|NCT01227629|20599082|P7|NOT COMPLETED|Overall Study||8
8356567|NCT01227629|20599083|P6|NOT COMPLETED|Overall Study||1
8356568|NCT01227629|20599084|P5|NOT COMPLETED|Overall Study||2
8356569|NCT01227629|20599085|P4|NOT COMPLETED|Overall Study||8
8356570|NCT01227629|20599086|P3|NOT COMPLETED|Overall Study||1
8356571|NCT01227629|20599087|P2|NOT COMPLETED|Overall Study||2
8356572|NCT01227629|20599088|P1|NOT COMPLETED|Overall Study||2
8356573|NCT01227629|20599079|P10|COMPLETED|Overall Study||68
8356574|NCT01227629|20599080|P9|COMPLETED|Overall Study||24
8356575|NCT01227629|20599081|P8|COMPLETED|Overall Study||27
8356576|NCT01227629|20599082|P7|COMPLETED|Overall Study||90
8356577|NCT01227629|20599083|P6|COMPLETED|Overall Study||32
8356578|NCT01227629|20599084|P5|COMPLETED|Overall Study||32
8356579|NCT01227629|20599085|P4|COMPLETED|Overall Study||91
8356580|NCT01227629|20599086|P3|COMPLETED|Overall Study||26
8356581|NCT01227629|20599087|P2|COMPLETED|Overall Study||18
8356582|NCT01227629|20599088|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
8356583|NCT01227629|20599079|P10|STARTED|Overall Study||70
8356584|NCT01227629|20599080|P9|STARTED|Overall Study||30
8356585|NCT01227629|20599081|P8|STARTED|Overall Study||33
8356586|NCT01227629|20599082|P7|STARTED|Overall Study||98
8356587|NCT01227629|20599083|P6|STARTED|Overall Study||33
8356588|NCT01227629|20599084|P5|STARTED|Overall Study||34
8356589|NCT01227629|20599085|P4|STARTED|Overall Study||99
8356590|NCT01227629|20599086|P3|STARTED|Overall Study||27
8356591|NCT01227629|20599087|P2|STARTED|Overall Study||20
8356592|NCT01227629|20599088|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
8356593|NCT01227616|20599326|P2|NOT COMPLETED|Overall Study||23
8356594|NCT01227616|20599327|P1|NOT COMPLETED|Overall Study||54
8356595|NCT01227616|20599326|P2|COMPLETED|Overall Study||74
8356596|NCT01227616|20599327|P1|COMPLETED|Overall Study||142
8356597|NCT01227616|20599326|P2|STARTED|Overall Study||97
8356598|NCT01227616|20599327|P1|STARTED|Overall Study||196
8356599|NCT01227577|20599337|P1|NOT COMPLETED|Overall Study||35
8356600|NCT01227577|20599337|P1|COMPLETED|Overall Study||93
8356601|NCT01227577|20599337|P1|STARTED|Overall Study||128
8356602|NCT01227564|20599352|P3|NOT COMPLETED|Overall Study||6
8356603|NCT01227564|20599353|P2|NOT COMPLETED|Overall Study||2
8356604|NCT01227564|20599354|P1|NOT COMPLETED|Overall Study||4
8356605|NCT01227564|20599352|P3|COMPLETED|Overall Study|Completed study|15
8356606|NCT01227564|20599353|P2|COMPLETED|Overall Study|Completed study|18
8356607|NCT01227564|20599354|P1|COMPLETED|Overall Study|Completed study|18
8356608|NCT01227564|20599352|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
8356609|NCT01227564|20599353|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
8356610|NCT01227564|20599354|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
8356611|NCT01227564|20599352|P3|Treated|Overall Study||21
8356612|NCT01227564|20599353|P2|Treated|Overall Study||20
8356613|NCT01227564|20599354|P1|Treated|Overall Study||22
8356614|NCT01227564|20599352|P3|STARTED|Overall Study||21
8356615|NCT01227564|20599353|P2|STARTED|Overall Study||20
8356616|NCT01227564|20599354|P1|STARTED|Overall Study||22
8356617|NCT01227551|20599485|P1|NOT COMPLETED|Overall Study||34
8356618|NCT01227551|20599485|P1|COMPLETED|Overall Study||23
8356619|NCT01227551|20599485|P1|STARTED|Overall Study||57
8356620|NCT01227512|20599492|P2|NOT COMPLETED|Overall Study||10
8356621|NCT01227512|20599493|P1|NOT COMPLETED|Overall Study||13
8356622|NCT01227512|20599492|P2|COMPLETED|Overall Study||48
8356623|NCT01227512|20599493|P1|COMPLETED|Overall Study||53
8356624|NCT01227512|20599492|P2|STARTED|Overall Study||58
8356625|NCT01227512|20599493|P1|STARTED|Overall Study||66
8356626|NCT01227434|20599515|P2|NOT COMPLETED|Overall Study||0
8356627|NCT01227434|20599516|P1|NOT COMPLETED|Overall Study||0
8356628|NCT01227434|20599515|P2|COMPLETED|Overall Study||16
8356629|NCT01227434|20599516|P1|COMPLETED|Overall Study||6
8356630|NCT01227434|20599515|P2|STARTED|Overall Study||16
8356631|NCT01227434|20599516|P1|STARTED|Overall Study||6
8356632|NCT01227421|20599527|P3|NOT COMPLETED|Overall Study||10
8356633|NCT01227421|20599528|P2|NOT COMPLETED|Overall Study||18
8356634|NCT01227421|20599529|P1|NOT COMPLETED|Overall Study||11
8356635|NCT01227421|20599527|P3|COMPLETED|Overall Study||201
8356636|NCT01227421|20599528|P2|COMPLETED|Overall Study||194
8356637|NCT01227421|20599529|P1|COMPLETED|Overall Study||190
8356638|NCT01227421|20599527|P3|STARTED|Overall Study||211
8356639|NCT01227421|20599528|P2|STARTED|Overall Study||212
8356640|NCT01227421|20599529|P1|STARTED|Overall Study||201
8356641|NCT01227395|20599581|P2|NOT COMPLETED|Overall Study||1
8356642|NCT01227395|20599582|P1|NOT COMPLETED|Overall Study||0
8356643|NCT01227395|20599581|P2|COMPLETED|Overall Study||84
8356644|NCT01227395|20599582|P1|COMPLETED|Overall Study||391
8356645|NCT01227395|20599581|P2|STARTED|Overall Study||85
8356646|NCT01227395|20599582|P1|STARTED|Overall Study||391
8356647|NCT01227382|20599610|P1|NOT COMPLETED|Overall Study||0
8356648|NCT01227382|20599610|P1|COMPLETED|Overall Study||26
8356649|NCT01227382|20599610|P1|STARTED|Overall Study||26
8356650|NCT01227278|20599622|P2|NOT COMPLETED|Overall Study||8
8356651|NCT01227278|20599623|P1|NOT COMPLETED|Overall Study||5
8356652|NCT01227278|20599622|P2|COMPLETED|Overall Study||43
8356653|NCT01227278|20599623|P1|COMPLETED|Overall Study||45
8356654|NCT01227278|20599622|P2|STARTED|Overall Study||51
8356655|NCT01227278|20599623|P1|STARTED|Overall Study||50
8356656|NCT01227265|20599650|P3|NOT COMPLETED|Overall Study||14
8356657|NCT01227265|20599651|P2|NOT COMPLETED|Overall Study||20
8356658|NCT01227265|20599652|P1|NOT COMPLETED|Overall Study||19
8356659|NCT01227265|20599650|P3|COMPLETED|Overall Study||145
8356660|NCT01227265|20599651|P2|COMPLETED|Overall Study||139
8356661|NCT01227265|20599652|P1|COMPLETED|Overall Study||139
8356662|NCT01227265|20599650|P3|Treated|Overall Study||159
8356663|NCT01227265|20599651|P2|Treated|Overall Study||157
8356664|NCT01227265|20599652|P1|Treated|Overall Study||157
8356665|NCT01227265|20599650|P3|STARTED|Overall Study||159
8356666|NCT01227265|20599651|P2|STARTED|Overall Study||159
8356667|NCT01227265|20599652|P1|STARTED|Overall Study||158
8356668|NCT01227252|20599682|P4|NOT COMPLETED|Overall Study||0
8356669|NCT01227252|20599683|P3|NOT COMPLETED|Overall Study||0
8356670|NCT01227252|20599684|P2|NOT COMPLETED|Overall Study||3
8356671|NCT01227252|20599685|P1|NOT COMPLETED|Overall Study||0
8356672|NCT01227252|20599682|P4|COMPLETED|Overall Study||10
8356673|NCT01227252|20599683|P3|COMPLETED|Overall Study||10
8356674|NCT01227252|20599684|P2|COMPLETED|Overall Study||7
8356675|NCT01227252|20599685|P1|COMPLETED|Overall Study||12
8356676|NCT01227252|20599682|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
8356677|NCT01227252|20599683|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
8356678|NCT01227252|20599684|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8356679|NCT01227252|20599685|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8356680|NCT01227252|20599682|P4|STARTED|Overall Study||10
8356681|NCT01227252|20599683|P3|STARTED|Overall Study||10
8356682|NCT01227252|20599684|P2|STARTED|Overall Study||10
8356683|NCT01227252|20599685|P1|STARTED|Overall Study||12
8356684|NCT01227057|20599714|P2|NOT COMPLETED|Overall Study||8
8356685|NCT01227057|20599715|P1|NOT COMPLETED|Overall Study||6
8356686|NCT01227057|20599714|P2|COMPLETED|Overall Study||19
8356687|NCT01227057|20599715|P1|COMPLETED|Overall Study||25
8356688|NCT01227057|20599714|P2|STARTED|Overall Study||27
8356689|NCT01227057|20599715|P1|STARTED|Overall Study||31
8356690|NCT01227044|20599727|P2|NOT COMPLETED|Overall Study||9
8356691|NCT01227044|20599728|P1|NOT COMPLETED|Overall Study||6
8356692|NCT01227044|20599727|P2|COMPLETED|Overall Study||17
8356693|NCT01227044|20599728|P1|COMPLETED|Overall Study||19
8356694|NCT01227044|20599727|P2|STARTED|Overall Study||26
8356695|NCT01227044|20599728|P1|STARTED|Overall Study||25
8356696|NCT01227018|20599736|P1|NOT COMPLETED|Overall Study||15
8356697|NCT01227018|20599736|P1|COMPLETED|Overall Study||0
8356698|NCT01227018|20599736|P1|STARTED|Overall Study||15
8356699|NCT01227005|20599746|P2|NOT COMPLETED|Overall Study||1
8356700|NCT01227005|20599747|P1|NOT COMPLETED|Overall Study||5
8356701|NCT01227005|20599746|P2|COMPLETED|Overall Study||51
8356702|NCT01227005|20599747|P1|COMPLETED|Overall Study||50
8356703|NCT01227005|20599746|P2|STARTED|Overall Study||52
8356704|NCT01227005|20599747|P1|STARTED|Overall Study||55
8356705|NCT01226979|20599757|P1|NOT COMPLETED|Overall Study||0
8356706|NCT01226979|20599757|P1|COMPLETED|Overall Study||16
8356707|NCT01226979|20599757|P1|STARTED|Overall Study||16
8356708|NCT01226914|20599768|P2|NOT COMPLETED|Overall Study||0
8356709|NCT01226914|20599769|P1|NOT COMPLETED|Overall Study||0
8356710|NCT01226914|20599768|P2|COMPLETED|Overall Study||27
8356711|NCT01226914|20599769|P1|COMPLETED|Overall Study||28
8356712|NCT01226914|20599768|P2|STARTED|Overall Study||27
8356713|NCT01226914|20599769|P1|STARTED|Overall Study||28
8356714|NCT01226745|20599781|P6|NOT COMPLETED|Overall Study||5
8356715|NCT01226745|20599782|P5|NOT COMPLETED|Overall Study||4
8356716|NCT01226745|20599783|P4|NOT COMPLETED|Overall Study||5
8356717|NCT01226745|20599784|P3|NOT COMPLETED|Overall Study||20
8356718|NCT01226745|20599785|P2|NOT COMPLETED|Overall Study||16
8356719|NCT01226745|20599786|P1|NOT COMPLETED|Overall Study||17
8356720|NCT01226745|20599781|P6|COMPLETED|Overall Study||24
8356721|NCT01226745|20599782|P5|COMPLETED|Overall Study||22
8356722|NCT01226745|20599783|P4|COMPLETED|Overall Study||24
8356723|NCT01226745|20599784|P3|COMPLETED|Overall Study||69
8356724|NCT01226745|20599785|P2|COMPLETED|Overall Study||71
8356725|NCT01226745|20599786|P1|COMPLETED|Overall Study||63
8356726|NCT01226745|20599781|P6|STARTED|Overall Study||29
8356727|NCT01226745|20599782|P5|STARTED|Overall Study||26
8356728|NCT01226745|20599783|P4|STARTED|Overall Study||29
8356729|NCT01226745|20599784|P3|STARTED|Overall Study||89
8356730|NCT01226745|20599785|P2|STARTED|Overall Study||87
8356731|NCT01226745|20599786|P1|STARTED|Overall Study||80
8356732|NCT01226732|20599866|P6|NOT COMPLETED|Overall Study||6
8356733|NCT01226732|20599867|P5|NOT COMPLETED|Overall Study||3
8356734|NCT01226732|20599868|P4|NOT COMPLETED|Overall Study||5
8356735|NCT01226732|20599869|P3|NOT COMPLETED|Overall Study||3
8356736|NCT01226732|20599870|P2|NOT COMPLETED|Overall Study||3
8356737|NCT01226732|20599871|P1|NOT COMPLETED|Overall Study||3
8356738|NCT01226732|20599866|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356739|NCT01226732|20599867|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356740|NCT01226732|20599868|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356741|NCT01226732|20599869|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356742|NCT01226732|20599870|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356743|NCT01226732|20599871|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356744|NCT01226732|20599866|P6|STARTED|Overall Study||6
8356745|NCT01226732|20599867|P5|STARTED|Overall Study||3
8356746|NCT01226732|20599868|P4|STARTED|Overall Study||5
8356747|NCT01226732|20599869|P3|STARTED|Overall Study||3
8356748|NCT01226732|20599870|P2|STARTED|Overall Study||3
8356749|NCT01226732|20599871|P1|STARTED|Overall Study||3
8356750|NCT01226719|20599887|P1|NOT COMPLETED|Overall Study||13
8356751|NCT01226719|20599887|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
8356752|NCT01226719|20599887|P1|STARTED|Overall Study||15
8356753|NCT01226706|20599897|P2|NOT COMPLETED|Overall Study||0
8356754|NCT01226706|20599898|P1|NOT COMPLETED|Overall Study||0
8356755|NCT01226706|20599897|P2|COMPLETED|Overall Study||11
8356756|NCT01226706|20599898|P1|COMPLETED|Overall Study||10
8356757|NCT01226706|20599897|P2|STARTED|Overall Study||11
8356758|NCT01226706|20599898|P1|STARTED|Overall Study||10
8356759|NCT01226511|20599982|P2|NOT COMPLETED|Taper Period||3
8356760|NCT01226511|20599983|P1|NOT COMPLETED|Taper Period||5
8356761|NCT01226511|20599982|P2|COMPLETED|Taper Period||54
8356762|NCT01226511|20599983|P1|COMPLETED|Taper Period||46
8356763|NCT01226511|20599982|P2|STARTED|Taper Period||57
8356764|NCT01226511|20599983|P1|STARTED|Taper Period||51
8356765|NCT01226511|20599982|P2|NOT COMPLETED|Extension Treatment Period||27
8356766|NCT01226511|20599983|P1|NOT COMPLETED|Extension Treatment Period||27
8356767|NCT01226511|20599982|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
8356768|NCT01226511|20599983|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
8356769|NCT01226511|20599982|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
8356770|NCT01226511|20599983|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
8356771|NCT01226511|20599982|P2|NOT COMPLETED|Acute Treatment Period||31
8356772|NCT01226511|20599983|P1|NOT COMPLETED|Acute Treatment Period||32
8356773|NCT01226511|20599982|P2|COMPLETED|Acute Treatment Period||110
8356774|NCT01226511|20599983|P1|COMPLETED|Acute Treatment Period||108
8356775|NCT01226511|20599982|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
8356776|NCT01226511|20599983|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
8356777|NCT01226485|20600026|P7|NOT COMPLETED|Overall Study||0
8356778|NCT01226485|20600027|P6|NOT COMPLETED|Overall Study||0
8356779|NCT01226485|20600028|P5|NOT COMPLETED|Overall Study||0
8356780|NCT01226485|20600029|P4|NOT COMPLETED|Overall Study||0
8356781|NCT01226485|20600030|P3|NOT COMPLETED|Overall Study||0
8356782|NCT01226485|20600031|P2|NOT COMPLETED|Overall Study||0
8356783|NCT01226485|20600032|P1|NOT COMPLETED|Overall Study||0
8356784|NCT01226485|20600026|P7|COMPLETED|Overall Study||40
8356785|NCT01226485|20600027|P6|COMPLETED|Overall Study||19
8356786|NCT01226485|20600028|P5|COMPLETED|Overall Study||7
8356787|NCT01226485|20600029|P4|COMPLETED|Overall Study||6
8356788|NCT01226485|20600030|P3|COMPLETED|Overall Study||3
8356789|NCT01226485|20600031|P2|COMPLETED|Overall Study||6
8356790|NCT01226485|20600032|P1|COMPLETED|Overall Study||3
8356791|NCT01226485|20600026|P7|Received at Least One Dose of Drug|Overall Study||40
8356792|NCT01226485|20600027|P6|Received at Least One Dose of Drug|Overall Study||19
8356793|NCT01226485|20600028|P5|Received at Least One Dose of Drug|Overall Study||7
8356794|NCT01226485|20600029|P4|Received at Least One Dose of Drug|Overall Study||6
8356795|NCT01226485|20600030|P3|Received at Least One Dose of Drug|Overall Study||3
8356796|NCT01226485|20600031|P2|Received at Least One Dose of Drug|Overall Study||6
8356797|NCT01226485|20600032|P1|Received at Least One Dose of Drug|Overall Study||3
8356798|NCT01226485|20600026|P7|STARTED|Overall Study||40
8356799|NCT01226485|20600027|P6|STARTED|Overall Study||19
8356800|NCT01226485|20600028|P5|STARTED|Overall Study||7
8356801|NCT01226485|20600029|P4|STARTED|Overall Study||6
8356802|NCT01226485|20600030|P3|STARTED|Overall Study||3
8356803|NCT01226485|20600031|P2|STARTED|Overall Study||6
8356804|NCT01226485|20600032|P1|STARTED|Overall Study||3
8356805|NCT01226472|20600081|P1|NOT COMPLETED|Overall Study||1
8356806|NCT01226472|20600081|P1|COMPLETED|Overall Study||0
8356807|NCT01226472|20600081|P1|STARTED|Overall Study||1
8356808|NCT01226459|20600088|P2|NOT COMPLETED|Overall Study||32
8356809|NCT01226459|20600089|P1|NOT COMPLETED|Overall Study||21
8356810|NCT01226459|20600088|P2|COMPLETED|Overall Study||171
8356811|NCT01226459|20600089|P1|COMPLETED|Overall Study||180
8356812|NCT01226459|20600088|P2|STARTED|Overall Study||203
8356813|NCT01226459|20600089|P1|STARTED|Overall Study||201
8356814|NCT01226420|20600099|P1|NOT COMPLETED|Overall Study||0
8356815|NCT01226420|20600099|P1|COMPLETED|Overall Study||6
8356816|NCT01226420|20600099|P1|STARTED|Overall Study||6
8356817|NCT01226121|20600107|P3|NOT COMPLETED|Overall Study||1
8356818|NCT01226121|20600108|P2|NOT COMPLETED|Overall Study||0
8356819|NCT01226121|20600109|P1|NOT COMPLETED|Overall Study||2
8356820|NCT01226121|20600107|P3|COMPLETED|Overall Study||12
8356821|NCT01226121|20600108|P2|COMPLETED|Overall Study||11
8356822|NCT01226121|20600109|P1|COMPLETED|Overall Study||11
8356823|NCT01226121|20600107|P3|30 Day Evaluation|Overall Study||13
8356824|NCT01226121|20600108|P2|30 Day Evaluation|Overall Study||11
8356825|NCT01226121|20600109|P1|30 Day Evaluation|Overall Study||12
8356826|NCT01226121|20600107|P3|STARTED|Overall Study||13
8356827|NCT01226121|20600108|P2|STARTED|Overall Study||11
8356828|NCT01226121|20600109|P1|STARTED|Overall Study||13
8356829|NCT01226095|20600120|P1|NOT COMPLETED|Overall Study||1
8356830|NCT01226095|20600120|P1|COMPLETED|Overall Study||518
8356831|NCT01226095|20600120|P1|STARTED|Overall Study||519
8356832|NCT01226043|20600145|P4|NOT COMPLETED|30-week Observational Phase||13
8356833|NCT01226043|20600146|P3|NOT COMPLETED|30-week Observational Phase||6
8356834|NCT01226043|20600147|P2|NOT COMPLETED|30-week Observational Phase||0
8356835|NCT01226043|20600148|P1|NOT COMPLETED|30-week Observational Phase||0
8356836|NCT01226043|20600145|P4|COMPLETED|30-week Observational Phase||140
8356837|NCT01226043|20600146|P3|COMPLETED|30-week Observational Phase||153
8356838|NCT01226043|20600147|P2|COMPLETED|30-week Observational Phase||0
8356839|NCT01226043|20600148|P1|COMPLETED|30-week Observational Phase||0
8356840|NCT01226043|20600145|P4|TREATED|30-week Observational Phase||153
8356841|NCT01226043|20600146|P3|TREATED|30-week Observational Phase||159
8356842|NCT01226043|20600147|P2|TREATED|30-week Observational Phase||0
8356843|NCT01226043|20600148|P1|TREATED|30-week Observational Phase||0
8356844|NCT01226043|20600145|P4|STARTED|30-week Observational Phase||153
8356845|NCT01226043|20600146|P3|STARTED|30-week Observational Phase||159
8356846|NCT01226043|20600147|P2|STARTED|30-week Observational Phase||0
8356847|NCT01226043|20600148|P1|STARTED|30-week Observational Phase||0
8356848|NCT01226043|20600145|P4|NOT COMPLETED|6-week Re-randomization Phase||11
8356849|NCT01226043|20600146|P3|NOT COMPLETED|6-week Re-randomization Phase||7
8356850|NCT01226043|20600147|P2|NOT COMPLETED|6-week Re-randomization Phase||0
8356851|NCT01226043|20600148|P1|NOT COMPLETED|6-week Re-randomization Phase||0
8356852|NCT01226043|20600145|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
8356853|NCT01226043|20600146|P3|COMPLETED|6-week Re-randomization Phase||159
8356854|NCT01226043|20600147|P2|COMPLETED|6-week Re-randomization Phase||0
8356855|NCT01226043|20600148|P1|COMPLETED|6-week Re-randomization Phase||0
8356856|NCT01226043|20600145|P4|TREATED|6-week Re-randomization Phase||165
8356857|NCT01226043|20600146|P3|TREATED|6-week Re-randomization Phase||165
8356858|NCT01226043|20600147|P2|TREATED|6-week Re-randomization Phase||0
8356859|NCT01226043|20600148|P1|TREATED|6-week Re-randomization Phase||0
8356860|NCT01226043|20600145|P4|STARTED|6-week Re-randomization Phase||167
8356861|NCT01226043|20600146|P3|STARTED|6-week Re-randomization Phase||166
8356862|NCT01226043|20600147|P2|STARTED|6-week Re-randomization Phase||0
8356863|NCT01226043|20600148|P1|STARTED|6-week Re-randomization Phase||0
8356864|NCT01226043|20600145|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
8356865|NCT01226043|20600146|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
8356866|NCT01226043|20600147|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
8356867|NCT01226043|20600148|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
8356868|NCT01226043|20600145|P4|COMPLETED|4-week Crossover Phase - Period 2||0
8356869|NCT01226043|20600146|P3|COMPLETED|4-week Crossover Phase - Period 2||0
8356870|NCT01226043|20600147|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
8356871|NCT01226043|20600148|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
8356872|NCT01226043|20600145|P4|TREATED|4-week Crossover Phase - Period 2||0
8356873|NCT01226043|20600146|P3|TREATED|4-week Crossover Phase - Period 2||0
8356874|NCT01226043|20600147|P2|TREATED|4-week Crossover Phase - Period 2||194
8356875|NCT01226043|20600148|P1|TREATED|4-week Crossover Phase - Period 2||199
8356876|NCT01226043|20600145|P4|STARTED|4-week Crossover Phase - Period 2||0
8356877|NCT01226043|20600146|P3|STARTED|4-week Crossover Phase - Period 2||0
8356878|NCT01226043|20600147|P2|STARTED|4-week Crossover Phase - Period 2||194
8356879|NCT01226043|20600148|P1|STARTED|4-week Crossover Phase - Period 2||199
8356880|NCT01226043|20600145|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
8356881|NCT01226043|20600146|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
8356882|NCT01226043|20600147|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
8356883|NCT01226043|20600148|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
8356884|NCT01226043|20600145|P4|COMPLETED|4-week Crossover Phase - Period 1||0
8356885|NCT01226043|20600146|P3|COMPLETED|4-week Crossover Phase - Period 1||0
8356886|NCT01226043|20600147|P2|COMPLETED|4-week Crossover Phase - Period 1||194
8356887|NCT01226043|20600148|P1|COMPLETED|4-week Crossover Phase - Period 1||199
8356888|NCT01226043|20600145|P4|TREATED|4-week Crossover Phase - Period 1||0
8356889|NCT01226043|20600146|P3|TREATED|4-week Crossover Phase - Period 1||0
8356890|NCT01226043|20600147|P2|TREATED|4-week Crossover Phase - Period 1||200
8356891|NCT01226043|20600148|P1|TREATED|4-week Crossover Phase - Period 1||202
8356892|NCT01226043|20600145|P4|STARTED|4-week Crossover Phase - Period 1||0
8356893|NCT01226043|20600146|P3|STARTED|4-week Crossover Phase - Period 1||0
8356894|NCT01226043|20600147|P2|STARTED|4-week Crossover Phase - Period 1||203
8356895|NCT01226043|20600148|P1|STARTED|4-week Crossover Phase - Period 1||202
8356896|NCT01225991|20600186|P1|NOT COMPLETED|Overall Study||6
8356897|NCT01225991|20600186|P1|COMPLETED|Overall Study||12
8356898|NCT01225991|20600186|P1|STARTED|Overall Study||18
8356899|NCT01225952|20600197|P3|NOT COMPLETED|Overall Study||6
8356900|NCT01225952|20600198|P2|NOT COMPLETED|Overall Study||4
8356901|NCT01225952|20600199|P1|NOT COMPLETED|Overall Study||6
8356902|NCT01225952|20600197|P3|COMPLETED|Overall Study||25
8356903|NCT01225952|20600198|P2|COMPLETED|Overall Study||27
8356904|NCT01225952|20600199|P1|COMPLETED|Overall Study||25
8356905|NCT01225952|20600197|P3|STARTED|Overall Study||31
8356906|NCT01225952|20600198|P2|STARTED|Overall Study||31
8356907|NCT01225952|20600199|P1|STARTED|Overall Study||31
8356908|NCT01225926|20600284|P2|NOT COMPLETED|Overall Study||0
8356909|NCT01225926|20600285|P1|NOT COMPLETED|Overall Study||0
8356910|NCT01225926|20600284|P2|COMPLETED|Overall Study||12
8356911|NCT01225926|20600285|P1|COMPLETED|Overall Study||12
8356912|NCT01225926|20600284|P2|STARTED|Overall Study||12
8356913|NCT01225926|20600285|P1|STARTED|Overall Study||12
8356914|NCT01225887|20600291|P1|NOT COMPLETED|Overall Study||5
8356915|NCT01225887|20600291|P1|COMPLETED|Overall Study||32
8356916|NCT01225887|20600291|P1|STARTED|Overall Study||37
8356917|NCT01225835|20600301|P2|NOT COMPLETED|Overall Study||3
8356918|NCT01225835|20600302|P1|NOT COMPLETED|Overall Study||7
8356919|NCT01225835|20600301|P2|COMPLETED|Overall Study|hCG criterion met|59
8356920|NCT01225835|20600302|P1|COMPLETED|Overall Study|hCG criterion met|55
8356921|NCT01225835|20600301|P2|Per Protocol Population|Overall Study||58
8356922|NCT01225835|20600302|P1|Per Protocol Population|Overall Study||48
8356923|NCT01225835|20600301|P2|STARTED|Overall Study||62
8356924|NCT01225835|20600302|P1|STARTED|Overall Study||62
8356925|NCT01225822|20600350|P5|NOT COMPLETED|Overall Study||31
8356926|NCT01225822|20600351|P4|NOT COMPLETED|Overall Study||52
8356927|NCT01225822|20600352|P3|NOT COMPLETED|Overall Study||38
8356928|NCT01225822|20600353|P2|NOT COMPLETED|Overall Study||56
8356929|NCT01225822|20600354|P1|NOT COMPLETED|Overall Study||38
8356930|NCT01225822|20600350|P5|COMPLETED|Overall Study||361
8356931|NCT01225822|20600351|P4|COMPLETED|Overall Study||333
8356932|NCT01225822|20600352|P3|COMPLETED|Overall Study||355
8356933|NCT01225822|20600353|P2|COMPLETED|Overall Study||334
8356934|NCT01225822|20600354|P1|COMPLETED|Overall Study||351
8356935|NCT01225822|20600350|P5|STARTED|Overall Study||392
8356936|NCT01225822|20600351|P4|STARTED|Overall Study||385
8356937|NCT01225822|20600352|P3|STARTED|Overall Study||393
8356938|NCT01225822|20600353|P2|STARTED|Overall Study||390
8356939|NCT01225822|20600354|P1|STARTED|Overall Study||389
8356940|NCT01225731|20600421|P13|NOT COMPLETED|Part 3||7
8356941|NCT01225731|20600422|P12|NOT COMPLETED|Part 3||10
8356942|NCT01225731|20600423|P11|NOT COMPLETED|Part 3||6
8356943|NCT01225731|20600424|P10|NOT COMPLETED|Part 3||0
8356944|NCT01225731|20600425|P9|NOT COMPLETED|Part 3||0
8356945|NCT01225731|20600426|P8|NOT COMPLETED|Part 3||0
8356946|NCT01225731|20600427|P7|NOT COMPLETED|Part 3||0
8356947|NCT01225731|20600428|P6|NOT COMPLETED|Part 3||0
8356948|NCT01225731|20600429|P5|NOT COMPLETED|Part 3||0
8356949|NCT01225731|20600430|P4|NOT COMPLETED|Part 3||0
8356950|NCT01225731|20600431|P3|NOT COMPLETED|Part 3||0
8356951|NCT01225731|20600432|P2|NOT COMPLETED|Part 3||0
8356952|NCT01225731|20600433|P1|NOT COMPLETED|Part 3||0
8356953|NCT01225731|20600421|P13|COMPLETED|Part 3||60
8356954|NCT01225731|20600422|P12|COMPLETED|Part 3||116
8356955|NCT01225731|20600423|P11|COMPLETED|Part 3||80
8356956|NCT01225731|20600424|P10|COMPLETED|Part 3||10
8356957|NCT01225731|20600425|P9|COMPLETED|Part 3||0
8356958|NCT01225731|20600426|P8|COMPLETED|Part 3||0
8356959|NCT01225731|20600427|P7|COMPLETED|Part 3||0
8356960|NCT01225731|20600428|P6|COMPLETED|Part 3||0
8356961|NCT01225731|20600429|P5|COMPLETED|Part 3||0
8356962|NCT01225731|20600430|P4|COMPLETED|Part 3||0
8356963|NCT01225731|20600431|P3|COMPLETED|Part 3||0
8356964|NCT01225731|20600432|P2|COMPLETED|Part 3||0
8356965|NCT01225731|20600433|P1|COMPLETED|Part 3||0
8356966|NCT01225731|20600421|P13|STARTED|Part 3|Not all participants entered follow-up|67
8356967|NCT01225731|20600422|P12|STARTED|Part 3|Not all participants entered follow-up|126
8356968|NCT01225731|20600423|P11|STARTED|Part 3|Not all participants entered follow-up|86
8356969|NCT01225731|20600424|P10|STARTED|Part 3|Not all participants entered follow-up|10
8356970|NCT01225731|20600425|P9|STARTED|Part 3|Participants could enter the follow-up period|0
8356971|NCT01225731|20600426|P8|STARTED|Part 3|Participants could enter the follow-up period|0
8356972|NCT01225731|20600427|P7|STARTED|Part 3|Participants could enter the follow-up period|0
8356973|NCT01225731|20600428|P6|STARTED|Part 3|Participants could enter the follow-up period|0
8356974|NCT01225731|20600429|P5|STARTED|Part 3||0
8356975|NCT01225731|20600430|P4|STARTED|Part 3||0
8356976|NCT01225731|20600431|P3|STARTED|Part 3||0
8356977|NCT01225731|20600432|P2|STARTED|Part 3||0
8356978|NCT01225731|20600433|P1|STARTED|Part 3||0
8356979|NCT01225731|20600421|P13|NOT COMPLETED|Part 2||0
8356980|NCT01225731|20600422|P12|NOT COMPLETED|Part 2||0
8356981|NCT01225731|20600423|P11|NOT COMPLETED|Part 2||0
8356982|NCT01225731|20600424|P10|NOT COMPLETED|Part 2||0
8356983|NCT01225731|20600425|P9|NOT COMPLETED|Part 2||11
8356984|NCT01225731|20600426|P8|NOT COMPLETED|Part 2||25
8356985|NCT01225731|20600427|P7|NOT COMPLETED|Part 2||8
8356986|NCT01225731|20600428|P6|NOT COMPLETED|Part 2||3
8356987|NCT01225731|20600429|P5|NOT COMPLETED|Part 2||0
8356988|NCT01225731|20600430|P4|NOT COMPLETED|Part 2||0
8356989|NCT01225731|20600431|P3|NOT COMPLETED|Part 2||0
8356990|NCT01225731|20600432|P2|NOT COMPLETED|Part 2||0
8356991|NCT01225731|20600433|P1|NOT COMPLETED|Part 2||0
8356992|NCT01225731|20600421|P13|COMPLETED|Part 2||0
8356993|NCT01225731|20600422|P12|COMPLETED|Part 2||0
8356994|NCT01225731|20600423|P11|COMPLETED|Part 2||0
8356995|NCT01225731|20600424|P10|COMPLETED|Part 2||0
8356996|NCT01225731|20600425|P9|COMPLETED|Part 2||68
8356997|NCT01225731|20600426|P8|COMPLETED|Part 2||128
8356998|NCT01225731|20600427|P7|COMPLETED|Part 2||86
8356999|NCT01225731|20600428|P6|COMPLETED|Part 2||10
8357000|NCT01225731|20600429|P5|COMPLETED|Part 2||0
8357001|NCT01225731|20600430|P4|COMPLETED|Part 2||0
8357002|NCT01225731|20600431|P3|COMPLETED|Part 2||0
8357003|NCT01225731|20600432|P2|COMPLETED|Part 2||0
8357004|NCT01225731|20600433|P1|COMPLETED|Part 2||0
8357005|NCT01225731|20600421|P13|STARTED|Part 2||0
8357006|NCT01225731|20600422|P12|STARTED|Part 2||0
8357007|NCT01225731|20600423|P11|STARTED|Part 2||0
8357008|NCT01225731|20600424|P10|STARTED|Part 2||0
8357009|NCT01225731|20600425|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
8357010|NCT01225731|20600426|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
8357011|NCT01225731|20600427|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
8357012|NCT01225731|20600428|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
8357013|NCT01225731|20600429|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
8357014|NCT01225731|20600430|P4|STARTED|Part 2|Participants could progress into Part 2|0
8357015|NCT01225731|20600431|P3|STARTED|Part 2|Participants could progress into Part 2|0
8357016|NCT01225731|20600432|P2|STARTED|Part 2|Participants could progress into Part 2|0
8357017|NCT01225731|20600433|P1|STARTED|Part 2|Participants could progress into Part 2|0
8357018|NCT01225731|20600421|P13|NOT COMPLETED|Part 1||0
8357019|NCT01225731|20600422|P12|NOT COMPLETED|Part 1||0
8357020|NCT01225731|20600423|P11|NOT COMPLETED|Part 1||0
8357021|NCT01225731|20600424|P10|NOT COMPLETED|Part 1||0
8357022|NCT01225731|20600425|P9|NOT COMPLETED|Part 1||0
8357023|NCT01225731|20600426|P8|NOT COMPLETED|Part 1||0
8357024|NCT01225731|20600427|P7|NOT COMPLETED|Part 1||0
8357025|NCT01225731|20600428|P6|NOT COMPLETED|Part 1||0
8357026|NCT01225731|20600429|P5|NOT COMPLETED|Part 1||6
8357027|NCT01225731|20600430|P4|NOT COMPLETED|Part 1||2
8357028|NCT01225731|20600431|P3|NOT COMPLETED|Part 1||1
8357029|NCT01225731|20600432|P2|NOT COMPLETED|Part 1||5
8357030|NCT01225731|20600433|P1|NOT COMPLETED|Part 1||2
8357031|NCT01225731|20600421|P13|COMPLETED|Part 1||0
8357032|NCT01225731|20600422|P12|COMPLETED|Part 1||0
8357033|NCT01225731|20600423|P11|COMPLETED|Part 1||0
8357034|NCT01225731|20600424|P10|COMPLETED|Part 1||0
8357035|NCT01225731|20600425|P9|COMPLETED|Part 1||0
8357036|NCT01225731|20600426|P8|COMPLETED|Part 1||0
8357037|NCT01225731|20600427|P7|COMPLETED|Part 1||0
8357038|NCT01225731|20600428|P6|COMPLETED|Part 1||0
8357039|NCT01225731|20600429|P5|COMPLETED|Part 1||40
8357040|NCT01225731|20600430|P4|COMPLETED|Part 1||84
8357041|NCT01225731|20600431|P3|COMPLETED|Part 1||88
8357042|NCT01225731|20600432|P2|COMPLETED|Part 1||87
8357043|NCT01225731|20600433|P1|COMPLETED|Part 1||40
8357044|NCT01225731|20600421|P13|STARTED|Part 1||0
8357045|NCT01225731|20600422|P12|STARTED|Part 1||0
8357046|NCT01225731|20600423|P11|STARTED|Part 1||0
8357047|NCT01225731|20600424|P10|STARTED|Part 1||0
8357048|NCT01225731|20600425|P9|STARTED|Part 1||0
8357049|NCT01225731|20600426|P8|STARTED|Part 1||0
8357050|NCT01225731|20600427|P7|STARTED|Part 1||0
8357051|NCT01225731|20600428|P6|STARTED|Part 1||0
8357052|NCT01225731|20600429|P5|STARTED|Part 1||46
8357053|NCT01225731|20600430|P4|STARTED|Part 1||86
8357054|NCT01225731|20600431|P3|STARTED|Part 1||89
8357055|NCT01225731|20600432|P2|STARTED|Part 1||92
8357056|NCT01225731|20600433|P1|STARTED|Part 1||42
8357057|NCT01225562|20600528|P3|NOT COMPLETED|Overall Study||53
8357058|NCT01225562|20600529|P2|NOT COMPLETED|Overall Study||56
8357059|NCT01225562|20600530|P1|NOT COMPLETED|Overall Study||55
8357060|NCT01225562|20600528|P3|COMPLETED|Overall Study||7014
8357061|NCT01225562|20600529|P2|COMPLETED|Overall Study||6989
8357062|NCT01225562|20600530|P1|COMPLETED|Overall Study||6995
8357063|NCT01225562|20600528|P3|STARTED|Overall Study||7067
8357064|NCT01225562|20600529|P2|STARTED|Overall Study||7045
8357065|NCT01225562|20600530|P1|STARTED|Overall Study||7050
8357066|NCT01225549|20600547|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357067|NCT01225549|20600548|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357068|NCT01225549|20600549|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357069|NCT01225549|20600550|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357070|NCT01225549|20600551|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357071|NCT01225549|20600552|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357072|NCT01225549|20600553|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357073|NCT01225549|20600554|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357074|NCT01225549|20600555|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357075|NCT01225549|20600556|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357076|NCT01225549|20600547|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
8357077|NCT01225549|20600548|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
8357078|NCT01225549|20600549|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
8357079|NCT01225549|20600550|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
8357080|NCT01225549|20600551|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
8357081|NCT01225549|20600552|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
8357082|NCT01225549|20600553|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
8357083|NCT01225549|20600554|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
8357084|NCT01225549|20600555|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
8357085|NCT01225549|20600556|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
8357086|NCT01225549|20600547|P10|STARTED|Period 7 - Fourth Treatment Period||1
8357087|NCT01225549|20600548|P9|STARTED|Period 7 - Fourth Treatment Period||4
8357088|NCT01225549|20600549|P8|STARTED|Period 7 - Fourth Treatment Period||1
8357089|NCT01225549|20600550|P7|STARTED|Period 7 - Fourth Treatment Period||3
8357090|NCT01225549|20600551|P6|STARTED|Period 7 - Fourth Treatment Period||1
8357091|NCT01225549|20600552|P5|STARTED|Period 7 - Fourth Treatment Period||1
8357092|NCT01225549|20600553|P4|STARTED|Period 7 - Fourth Treatment Period||0
8357093|NCT01225549|20600554|P3|STARTED|Period 7 - Fourth Treatment Period||3
8357094|NCT01225549|20600555|P2|STARTED|Period 7 - Fourth Treatment Period||3
8357095|NCT01225549|20600556|P1|STARTED|Period 7 - Fourth Treatment Period||1
8357096|NCT01225549|20600547|P10|NOT COMPLETED|Period 6 - Washout||0
8357097|NCT01225549|20600548|P9|NOT COMPLETED|Period 6 - Washout||0
8357098|NCT01225549|20600549|P8|NOT COMPLETED|Period 6 - Washout||0
8357099|NCT01225549|20600550|P7|NOT COMPLETED|Period 6 - Washout||0
8357100|NCT01225549|20600551|P6|NOT COMPLETED|Period 6 - Washout||0
8357101|NCT01225549|20600552|P5|NOT COMPLETED|Period 6 - Washout||0
8357102|NCT01225549|20600553|P4|NOT COMPLETED|Period 6 - Washout||1
8357103|NCT01225549|20600554|P3|NOT COMPLETED|Period 6 - Washout||0
8357104|NCT01225549|20600555|P2|NOT COMPLETED|Period 6 - Washout||0
8357105|NCT01225549|20600556|P1|NOT COMPLETED|Period 6 - Washout||0
8357106|NCT01225549|20600547|P10|COMPLETED|Period 6 - Washout||1
8357107|NCT01225549|20600548|P9|COMPLETED|Period 6 - Washout||4
8357108|NCT01225549|20600549|P8|COMPLETED|Period 6 - Washout||1
8357109|NCT01225549|20600550|P7|COMPLETED|Period 6 - Washout||3
8357110|NCT01225549|20600551|P6|COMPLETED|Period 6 - Washout||1
8357111|NCT01225549|20600552|P5|COMPLETED|Period 6 - Washout||1
8357112|NCT01225549|20600553|P4|COMPLETED|Period 6 - Washout||0
8357113|NCT01225549|20600554|P3|COMPLETED|Period 6 - Washout||3
8357114|NCT01225549|20600555|P2|COMPLETED|Period 6 - Washout||3
8357115|NCT01225549|20600556|P1|COMPLETED|Period 6 - Washout||1
8357116|NCT01225549|20600547|P10|STARTED|Period 6 - Washout||1
8357117|NCT01225549|20600548|P9|STARTED|Period 6 - Washout||4
8357118|NCT01225549|20600549|P8|STARTED|Period 6 - Washout||1
8357119|NCT01225549|20600550|P7|STARTED|Period 6 - Washout||3
8357120|NCT01225549|20600551|P6|STARTED|Period 6 - Washout||1
8357121|NCT01225549|20600552|P5|STARTED|Period 6 - Washout||1
8357122|NCT01225549|20600553|P4|STARTED|Period 6 - Washout||1
8357123|NCT01225549|20600554|P3|STARTED|Period 6 - Washout||3
8357124|NCT01225549|20600555|P2|STARTED|Period 6 - Washout||3
8357125|NCT01225549|20600556|P1|STARTED|Period 6 - Washout||1
8357126|NCT01225549|20600547|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357127|NCT01225549|20600548|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357128|NCT01225549|20600549|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357129|NCT01225549|20600550|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357130|NCT01225549|20600551|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357131|NCT01225549|20600552|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357132|NCT01225549|20600553|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357133|NCT01225549|20600554|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357134|NCT01225549|20600555|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357135|NCT01225549|20600556|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357136|NCT01225549|20600547|P10|COMPLETED|Period 5 - Third Treatment Period||1
8357137|NCT01225549|20600548|P9|COMPLETED|Period 5 - Third Treatment Period||4
8357138|NCT01225549|20600549|P8|COMPLETED|Period 5 - Third Treatment Period||1
8357139|NCT01225549|20600550|P7|COMPLETED|Period 5 - Third Treatment Period||3
8357140|NCT01225549|20600551|P6|COMPLETED|Period 5 - Third Treatment Period||1
8357141|NCT01225549|20600552|P5|COMPLETED|Period 5 - Third Treatment Period||1
8357142|NCT01225549|20600553|P4|COMPLETED|Period 5 - Third Treatment Period||1
8357143|NCT01225549|20600554|P3|COMPLETED|Period 5 - Third Treatment Period||3
8357144|NCT01225549|20600555|P2|COMPLETED|Period 5 - Third Treatment Period||3
8357145|NCT01225549|20600556|P1|COMPLETED|Period 5 - Third Treatment Period||1
8357146|NCT01225549|20600547|P10|STARTED|Period 5 - Third Treatment Period||1
8357147|NCT01225549|20600548|P9|STARTED|Period 5 - Third Treatment Period||4
8357148|NCT01225549|20600549|P8|STARTED|Period 5 - Third Treatment Period||1
8357149|NCT01225549|20600550|P7|STARTED|Period 5 - Third Treatment Period||3
8357150|NCT01225549|20600551|P6|STARTED|Period 5 - Third Treatment Period||1
8357151|NCT01225549|20600552|P5|STARTED|Period 5 - Third Treatment Period||1
8357152|NCT01225549|20600553|P4|STARTED|Period 5 - Third Treatment Period||1
8357153|NCT01225549|20600554|P3|STARTED|Period 5 - Third Treatment Period||3
8357154|NCT01225549|20600555|P2|STARTED|Period 5 - Third Treatment Period||3
8357155|NCT01225549|20600556|P1|STARTED|Period 5 - Third Treatment Period||1
8357156|NCT01225549|20600547|P10|NOT COMPLETED|Period 4 - Washout||0
8357157|NCT01225549|20600548|P9|NOT COMPLETED|Period 4 - Washout||0
8357158|NCT01225549|20600549|P8|NOT COMPLETED|Period 4 - Washout||0
8357159|NCT01225549|20600550|P7|NOT COMPLETED|Period 4 - Washout||0
8357160|NCT01225549|20600551|P6|NOT COMPLETED|Period 4 - Washout||0
8357161|NCT01225549|20600552|P5|NOT COMPLETED|Period 4 - Washout||0
8357162|NCT01225549|20600553|P4|NOT COMPLETED|Period 4 - Washout||0
8357163|NCT01225549|20600554|P3|NOT COMPLETED|Period 4 - Washout||0
8357164|NCT01225549|20600555|P2|NOT COMPLETED|Period 4 - Washout||1
8357165|NCT01225549|20600556|P1|NOT COMPLETED|Period 4 - Washout||0
8357166|NCT01225549|20600547|P10|COMPLETED|Period 4 - Washout||1
8357167|NCT01225549|20600548|P9|COMPLETED|Period 4 - Washout||4
8357168|NCT01225549|20600549|P8|COMPLETED|Period 4 - Washout||1
8357169|NCT01225549|20600550|P7|COMPLETED|Period 4 - Washout||3
8357170|NCT01225549|20600551|P6|COMPLETED|Period 4 - Washout||1
8357171|NCT01225549|20600552|P5|COMPLETED|Period 4 - Washout||1
8357172|NCT01225549|20600553|P4|COMPLETED|Period 4 - Washout||1
8357173|NCT01225549|20600554|P3|COMPLETED|Period 4 - Washout||3
8357174|NCT01225549|20600555|P2|COMPLETED|Period 4 - Washout||3
8357175|NCT01225549|20600556|P1|COMPLETED|Period 4 - Washout||1
8357176|NCT01225549|20600547|P10|STARTED|Period 4 - Washout||1
8357177|NCT01225549|20600548|P9|STARTED|Period 4 - Washout||4
8357178|NCT01225549|20600549|P8|STARTED|Period 4 - Washout||1
8357179|NCT01225549|20600550|P7|STARTED|Period 4 - Washout||3
8357180|NCT01225549|20600551|P6|STARTED|Period 4 - Washout||1
8357181|NCT01225549|20600552|P5|STARTED|Period 4 - Washout||1
8357182|NCT01225549|20600553|P4|STARTED|Period 4 - Washout||1
8357183|NCT01225549|20600554|P3|STARTED|Period 4 - Washout||3
8357184|NCT01225549|20600555|P2|STARTED|Period 4 - Washout||4
8357185|NCT01225549|20600556|P1|STARTED|Period 4 - Washout||1
8357186|NCT01225549|20600547|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357187|NCT01225549|20600548|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357188|NCT01225549|20600549|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357189|NCT01225549|20600550|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357190|NCT01225549|20600551|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357191|NCT01225549|20600552|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357192|NCT01225549|20600553|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357193|NCT01225549|20600554|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357194|NCT01225549|20600555|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357195|NCT01225549|20600556|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357196|NCT01225549|20600547|P10|COMPLETED|Period 3 - Second Treatment Period||1
8357197|NCT01225549|20600548|P9|COMPLETED|Period 3 - Second Treatment Period||4
8357198|NCT01225549|20600549|P8|COMPLETED|Period 3 - Second Treatment Period||1
8357199|NCT01225549|20600550|P7|COMPLETED|Period 3 - Second Treatment Period||3
8357200|NCT01225549|20600551|P6|COMPLETED|Period 3 - Second Treatment Period||1
8357201|NCT01225549|20600552|P5|COMPLETED|Period 3 - Second Treatment Period||1
8357202|NCT01225549|20600553|P4|COMPLETED|Period 3 - Second Treatment Period||1
8357203|NCT01225549|20600554|P3|COMPLETED|Period 3 - Second Treatment Period||3
8357204|NCT01225549|20600555|P2|COMPLETED|Period 3 - Second Treatment Period||4
8357205|NCT01225549|20600556|P1|COMPLETED|Period 3 - Second Treatment Period||1
8357206|NCT01225549|20600547|P10|STARTED|Period 3 - Second Treatment Period||1
8357207|NCT01225549|20600548|P9|STARTED|Period 3 - Second Treatment Period||4
8357208|NCT01225549|20600549|P8|STARTED|Period 3 - Second Treatment Period||1
8357209|NCT01225549|20600550|P7|STARTED|Period 3 - Second Treatment Period||3
8357210|NCT01225549|20600551|P6|STARTED|Period 3 - Second Treatment Period||1
8357211|NCT01225549|20600552|P5|STARTED|Period 3 - Second Treatment Period||1
8357212|NCT01225549|20600553|P4|STARTED|Period 3 - Second Treatment Period||1
8357213|NCT01225549|20600554|P3|STARTED|Period 3 - Second Treatment Period||3
8357214|NCT01225549|20600555|P2|STARTED|Period 3 - Second Treatment Period||4
8357215|NCT01225549|20600556|P1|STARTED|Period 3 - Second Treatment Period||1
8357216|NCT01225549|20600547|P10|NOT COMPLETED|Period 2 - Washout||0
8357217|NCT01225549|20600548|P9|NOT COMPLETED|Period 2 - Washout||0
8357218|NCT01225549|20600549|P8|NOT COMPLETED|Period 2 - Washout||0
8357219|NCT01225549|20600550|P7|NOT COMPLETED|Period 2 - Washout||0
8357220|NCT01225549|20600551|P6|NOT COMPLETED|Period 2 - Washout||0
8357221|NCT01225549|20600552|P5|NOT COMPLETED|Period 2 - Washout||0
8357222|NCT01225549|20600553|P4|NOT COMPLETED|Period 2 - Washout||0
8357223|NCT01225549|20600554|P3|NOT COMPLETED|Period 2 - Washout||0
8357224|NCT01225549|20600555|P2|NOT COMPLETED|Period 2 - Washout||0
8357225|NCT01225549|20600556|P1|NOT COMPLETED|Period 2 - Washout||0
8357226|NCT01225549|20600547|P10|COMPLETED|Period 2 - Washout||1
8357227|NCT01225549|20600548|P9|COMPLETED|Period 2 - Washout||4
8357228|NCT01225549|20600549|P8|COMPLETED|Period 2 - Washout||1
8357229|NCT01225549|20600550|P7|COMPLETED|Period 2 - Washout||3
8357230|NCT01225549|20600551|P6|COMPLETED|Period 2 - Washout||1
8357231|NCT01225549|20600552|P5|COMPLETED|Period 2 - Washout||1
8357232|NCT01225549|20600553|P4|COMPLETED|Period 2 - Washout||1
8357233|NCT01225549|20600554|P3|COMPLETED|Period 2 - Washout||3
8357234|NCT01225549|20600555|P2|COMPLETED|Period 2 - Washout||4
8357235|NCT01225549|20600556|P1|COMPLETED|Period 2 - Washout||1
8357236|NCT01225549|20600547|P10|STARTED|Period 2 - Washout||1
8357237|NCT01225549|20600548|P9|STARTED|Period 2 - Washout||4
8357238|NCT01225549|20600549|P8|STARTED|Period 2 - Washout||1
8357239|NCT01225549|20600550|P7|STARTED|Period 2 - Washout||3
8357240|NCT01225549|20600551|P6|STARTED|Period 2 - Washout||1
8357241|NCT01225549|20600552|P5|STARTED|Period 2 - Washout||1
8357242|NCT01225549|20600553|P4|STARTED|Period 2 - Washout||1
8357243|NCT01225549|20600554|P3|STARTED|Period 2 - Washout||3
8357244|NCT01225549|20600555|P2|STARTED|Period 2 - Washout||4
8357245|NCT01225549|20600556|P1|STARTED|Period 2 - Washout||1
8357246|NCT01225549|20600547|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
8357247|NCT01225549|20600548|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
8357248|NCT01225549|20600549|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
8357249|NCT01225549|20600550|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
8357250|NCT01225549|20600551|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
8357251|NCT01225549|20600552|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
8357252|NCT01225549|20600553|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
8357253|NCT01225549|20600554|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
8357254|NCT01225549|20600555|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
8357255|NCT01225549|20600556|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
8357256|NCT01225549|20600547|P10|COMPLETED|Period 1 - First Treatment Period||1
8357257|NCT01225549|20600548|P9|COMPLETED|Period 1 - First Treatment Period||4
8357258|NCT01225549|20600549|P8|COMPLETED|Period 1 - First Treatment Period||1
8357259|NCT01225549|20600550|P7|COMPLETED|Period 1 - First Treatment Period||3
8357260|NCT01225549|20600551|P6|COMPLETED|Period 1 - First Treatment Period||1
8357261|NCT01225549|20600552|P5|COMPLETED|Period 1 - First Treatment Period||1
8357262|NCT01225549|20600553|P4|COMPLETED|Period 1 - First Treatment Period||1
8357263|NCT01225549|20600554|P3|COMPLETED|Period 1 - First Treatment Period||3
8357264|NCT01225549|20600555|P2|COMPLETED|Period 1 - First Treatment Period||4
8357265|NCT01225549|20600556|P1|COMPLETED|Period 1 - First Treatment Period||1
8357266|NCT01225549|20600547|P10|STARTED|Period 1 - First Treatment Period||1
8357267|NCT01225549|20600548|P9|STARTED|Period 1 - First Treatment Period||4
8357268|NCT01225549|20600549|P8|STARTED|Period 1 - First Treatment Period||1
8357269|NCT01225549|20600550|P7|STARTED|Period 1 - First Treatment Period||3
8357270|NCT01225549|20600551|P6|STARTED|Period 1 - First Treatment Period||1
8357271|NCT01225549|20600552|P5|STARTED|Period 1 - First Treatment Period||1
8357272|NCT01225549|20600553|P4|STARTED|Period 1 - First Treatment Period||1
8357273|NCT01225549|20600554|P3|STARTED|Period 1 - First Treatment Period||3
8357274|NCT01225549|20600555|P2|STARTED|Period 1 - First Treatment Period||4
8357275|NCT01225549|20600556|P1|STARTED|Period 1 - First Treatment Period||1
8357276|NCT01225354|20600598|P1|NOT COMPLETED|Overall Study||1
8357277|NCT01225354|20600598|P1|COMPLETED|Overall Study||19
8357278|NCT01225354|20600598|P1|STARTED|Overall Study||20
8357279|NCT01225341|20600609|P2|NOT COMPLETED|Overall Study||0
8357280|NCT01225341|20600610|P1|NOT COMPLETED|Overall Study||0
8357281|NCT01225341|20600609|P2|COMPLETED|Overall Study||0
8357282|NCT01225341|20600610|P1|COMPLETED|Overall Study||0
8357283|NCT01225341|20600609|P2|STARTED|Overall Study||0
8357284|NCT01225341|20600610|P1|STARTED|Overall Study||0
8357285|NCT01225289|20600624|P2|NOT COMPLETED|Overall Study||1
8357286|NCT01225289|20600625|P1|NOT COMPLETED|Overall Study||0
8357287|NCT01225289|20600624|P2|COMPLETED|Overall Study||17
8357288|NCT01225289|20600625|P1|COMPLETED|Overall Study||18
8357289|NCT01225289|20600624|P2|STARTED|Overall Study||18
8357290|NCT01225289|20600625|P1|STARTED|Overall Study||18
8357291|NCT01225263|20600639|P2|NOT COMPLETED|Weeks 13 to 24||1
8357292|NCT01225263|20600640|P1|NOT COMPLETED|Weeks 13 to 24||4
8357293|NCT01225263|20600639|P2|COMPLETED|Weeks 13 to 24||28
8357294|NCT01225263|20600640|P1|COMPLETED|Weeks 13 to 24||24
8357295|NCT01225263|20600639|P2|STARTED|Weeks 13 to 24||29
8357296|NCT01225263|20600640|P1|STARTED|Weeks 13 to 24||28
8357297|NCT01225263|20600639|P2|NOT COMPLETED|Weeks 1 to 12||0
8357298|NCT01225263|20600640|P1|NOT COMPLETED|Weeks 1 to 12||0
8357299|NCT01225263|20600639|P2|COMPLETED|Weeks 1 to 12||29
8357300|NCT01225263|20600640|P1|COMPLETED|Weeks 1 to 12||28
8357301|NCT01225263|20600639|P2|STARTED|Weeks 1 to 12||29
8357302|NCT01225263|20600640|P1|STARTED|Weeks 1 to 12||28
8357303|NCT01225250|20600650|P2|NOT COMPLETED|Overall Study||5
8357304|NCT01225250|20600651|P1|NOT COMPLETED|Overall Study||5
8357305|NCT01225250|20600650|P2|COMPLETED|Overall Study||10
8357306|NCT01225250|20600651|P1|COMPLETED|Overall Study||10
8357307|NCT01225250|20600650|P2|STARTED|Overall Study||15
8357308|NCT01225250|20600651|P1|STARTED|Overall Study||15
8357309|NCT01225211|20600677|P10|NOT COMPLETED|Overall Study||5
8357310|NCT01225211|20600678|P9|NOT COMPLETED|Overall Study||1
8357311|NCT01225211|20600679|P8|NOT COMPLETED|Overall Study||0
8357312|NCT01225211|20600680|P7|NOT COMPLETED|Overall Study||1
8357313|NCT01225211|20600681|P6|NOT COMPLETED|Overall Study||0
8357314|NCT01225211|20600682|P5|NOT COMPLETED|Overall Study||0
8357315|NCT01225211|20600683|P4|NOT COMPLETED|Overall Study||0
8357316|NCT01225211|20600684|P3|NOT COMPLETED|Overall Study||1
8357317|NCT01225211|20600685|P2|NOT COMPLETED|Overall Study||0
8357318|NCT01225211|20600686|P1|NOT COMPLETED|Overall Study||0
8357319|NCT01225211|20600677|P10|COMPLETED|Overall Study||57
8357320|NCT01225211|20600678|P9|COMPLETED|Overall Study||62
8357321|NCT01225211|20600679|P8|COMPLETED|Overall Study||11
8357322|NCT01225211|20600680|P7|COMPLETED|Overall Study||41
8357323|NCT01225211|20600681|P6|COMPLETED|Overall Study||21
8357324|NCT01225211|20600682|P5|COMPLETED|Overall Study||23
8357325|NCT01225211|20600683|P4|COMPLETED|Overall Study||27
8357326|NCT01225211|20600684|P3|COMPLETED|Overall Study||20
8357327|NCT01225211|20600685|P2|COMPLETED|Overall Study||20
8357328|NCT01225211|20600686|P1|COMPLETED|Overall Study||21
8357329|NCT01225211|20600677|P10|STARTED|Overall Study||62
8357330|NCT01225211|20600678|P9|STARTED|Overall Study||63
8357331|NCT01225211|20600679|P8|STARTED|Overall Study||11
8357332|NCT01225211|20600680|P7|STARTED|Overall Study||42
8357333|NCT01225211|20600681|P6|STARTED|Overall Study||21
8357334|NCT01225211|20600682|P5|STARTED|Overall Study||23
8357335|NCT01225211|20600683|P4|STARTED|Overall Study||27
8357336|NCT01225211|20600684|P3|STARTED|Overall Study||21
8357337|NCT01225211|20600685|P2|STARTED|Overall Study||20
8357338|NCT01225211|20600686|P1|STARTED|Overall Study||21
8357339|NCT01225172|20600789|P2|NOT COMPLETED|Overall Study||1
8357340|NCT01225172|20600790|P1|NOT COMPLETED|Overall Study||6
8357341|NCT01225172|20600789|P2|COMPLETED|Overall Study||6
8357342|NCT01225172|20600790|P1|COMPLETED|Overall Study||46
8357343|NCT01225172|20600789|P2|STARTED|Overall Study||7
8357344|NCT01225172|20600790|P1|STARTED|Overall Study||52
8357345|NCT01225159|20600812|P2|NOT COMPLETED|Overall Study||0
8357346|NCT01225159|20600813|P1|NOT COMPLETED|Overall Study||1
8357347|NCT01225159|20600812|P2|COMPLETED|Overall Study||100
8357348|NCT01225159|20600813|P1|COMPLETED|Overall Study||99
8357349|NCT01225159|20600812|P2|STARTED|Overall Study||100
8357350|NCT01225159|20600813|P1|STARTED|Overall Study||100
8357351|NCT01225146|20600823|P2|NOT COMPLETED|Overall Study||2
8357352|NCT01225146|20600824|P1|NOT COMPLETED|Overall Study||0
8357353|NCT01225146|20600823|P2|COMPLETED|Overall Study||0
8357354|NCT01225146|20600824|P1|COMPLETED|Overall Study||6
8357355|NCT01225146|20600823|P2|STARTED|Overall Study||2
8357356|NCT01225146|20600824|P1|STARTED|Overall Study||6
8357357|NCT01225068|20600842|P2|NOT COMPLETED|Overall Study||1
8357358|NCT01225068|20600843|P1|NOT COMPLETED|Overall Study||4
8357359|NCT01225068|20600842|P2|COMPLETED|Overall Study||19
8357360|NCT01225068|20600843|P1|COMPLETED|Overall Study||16
8357361|NCT01225068|20600842|P2|STARTED|Overall Study||20
8357362|NCT01225068|20600843|P1|STARTED|Overall Study||20
8357363|NCT01225055|20600852|P3|NOT COMPLETED|Overall Study||3
8357364|NCT01225055|20600853|P2|NOT COMPLETED|Overall Study||2
8357365|NCT01225055|20600854|P1|NOT COMPLETED|Overall Study||0
8357366|NCT01225055|20600852|P3|COMPLETED|Overall Study||18
8357367|NCT01225055|20600853|P2|COMPLETED|Overall Study||18
8357368|NCT01225055|20600854|P1|COMPLETED|Overall Study||20
8357369|NCT01225055|20600852|P3|STARTED|Overall Study||21
8357370|NCT01225055|20600853|P2|STARTED|Overall Study||20
8357371|NCT01225055|20600854|P1|STARTED|Overall Study||20
8357372|NCT01225029|20600879|P2|NOT COMPLETED|Overall Study||0
8357373|NCT01225029|20600880|P1|NOT COMPLETED|Overall Study||0
8357374|NCT01225029|20600879|P2|COMPLETED|Overall Study||32
8357375|NCT01225029|20600880|P1|COMPLETED|Overall Study||32
8357376|NCT01225029|20600879|P2|STARTED|Overall Study||32
8357377|NCT01225029|20600880|P1|STARTED|Overall Study||32
8357378|NCT01224925|20600892|P2|NOT COMPLETED|Overall Study||2
8357379|NCT01224925|20600893|P1|NOT COMPLETED|Overall Study||3
8357380|NCT01224925|20600892|P2|COMPLETED|Overall Study||31
8357381|NCT01224925|20600893|P1|COMPLETED|Overall Study||34
8357382|NCT01224925|20600892|P2|STARTED|Overall Study||33
8357383|NCT01224925|20600893|P1|STARTED|Overall Study||37
8357384|NCT01224821|20600901|P1|NOT COMPLETED|Long-Term Follow-Up||11
8357385|NCT01224821|20600901|P1|COMPLETED|Long-Term Follow-Up||0
8357386|NCT01224821|20600901|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
8357387|NCT01224821|20600901|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
8357388|NCT01224821|20600901|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
8357389|NCT01224821|20600901|P1|STARTED|Dosimetric and Therapeutic Treatment||47
8357390|NCT01224782|20600920|P1|NOT COMPLETED|Overall Study||264
8357391|NCT01224782|20600920|P1|COMPLETED|Overall Study||730
8357392|NCT01224782|20600920|P1|STARTED|Overall Study||994
8357393|NCT01224678|20600931|P2|NOT COMPLETED|Overall Study||0
8357394|NCT01224678|20600932|P1|NOT COMPLETED|Overall Study||0
8357395|NCT01224678|20600931|P2|COMPLETED|Overall Study||150
8357396|NCT01224678|20600932|P1|COMPLETED|Overall Study||150
8357397|NCT01224678|20600931|P2|STARTED|Overall Study||150
8357398|NCT01224678|20600932|P1|STARTED|Overall Study||150
8357399|NCT01224639|20600946|P8|NOT COMPLETED|Overall Study||2
8357400|NCT01224639|20600947|P7|NOT COMPLETED|Overall Study||1
8357401|NCT01224639|20600948|P6|NOT COMPLETED|Overall Study||0
8357402|NCT01224639|20600949|P5|NOT COMPLETED|Overall Study||2
8357403|NCT01224639|20600950|P4|NOT COMPLETED|Overall Study||0
8357404|NCT01224639|20600951|P3|NOT COMPLETED|Overall Study||0
8357405|NCT01224639|20600952|P2|NOT COMPLETED|Overall Study||0
8357406|NCT01224639|20600953|P1|NOT COMPLETED|Overall Study||0
8357407|NCT01224639|20600946|P8|COMPLETED|Overall Study||3
8357408|NCT01224639|20600947|P7|COMPLETED|Overall Study||17
8357409|NCT01224639|20600948|P6|COMPLETED|Overall Study||4
8357410|NCT01224639|20600949|P5|COMPLETED|Overall Study||19
8357411|NCT01224639|20600950|P4|COMPLETED|Overall Study||3
8357412|NCT01224639|20600951|P3|COMPLETED|Overall Study||21
8357413|NCT01224639|20600952|P2|COMPLETED|Overall Study||5
8357414|NCT01224639|20600953|P1|COMPLETED|Overall Study||19
8357415|NCT01224639|20600946|P8|STARTED|Overall Study||5
8357416|NCT01224639|20600947|P7|STARTED|Overall Study||18
8357417|NCT01224639|20600948|P6|STARTED|Overall Study||4
8357418|NCT01224639|20600949|P5|STARTED|Overall Study||21
8357419|NCT01224639|20600950|P4|STARTED|Overall Study||3
8357420|NCT01224639|20600951|P3|STARTED|Overall Study||21
8357421|NCT01224639|20600952|P2|STARTED|Overall Study||5
8357422|NCT01224639|20600953|P1|STARTED|Overall Study||19
8357423|NCT01224626|20601059|P1|NOT COMPLETED|Overall Study||1
8357424|NCT01224626|20601059|P1|COMPLETED|Overall Study||41
8357425|NCT01224626|20601059|P1|STARTED|Overall Study||42
8357426|NCT01224444|20601065|P1|NOT COMPLETED|Overall Study||0
8357427|NCT01224444|20601065|P1|COMPLETED|Overall Study||269
8357428|NCT01224444|20601065|P1|STARTED|Overall Study||269
8357429|NCT01224431|20601071|P2|NOT COMPLETED|Overall Study||5
8357430|NCT01224431|20601072|P1|NOT COMPLETED|Overall Study||0
8357431|NCT01224431|20601071|P2|COMPLETED|Overall Study||25
8357432|NCT01224431|20601072|P1|COMPLETED|Overall Study||30
8357433|NCT01224431|20601071|P2|STARTED|Overall Study||30
8357434|NCT01224431|20601072|P1|STARTED|Overall Study||30
8357435|NCT01224236|20601082|P2|NOT COMPLETED|Overall Study||1
8357436|NCT01224236|20601083|P1|NOT COMPLETED|Overall Study||1
8357437|NCT01224236|20601082|P2|COMPLETED|Overall Study||73
8357438|NCT01224236|20601083|P1|COMPLETED|Overall Study||75
8357439|NCT01224236|20601082|P2|STARTED|Overall Study||74
8357440|NCT01224236|20601083|P1|STARTED|Overall Study||76
8357441|NCT01224210|20601091|P1|NOT COMPLETED|Overall Study||7
8357442|NCT01224210|20601091|P1|COMPLETED|Overall Study||23
8357443|NCT01224210|20601091|P1|STARTED|Overall Study||30
8357444|NCT01224171|20601098|P2|NOT COMPLETED|Overall Study||13
8357445|NCT01224171|20601099|P1|NOT COMPLETED|Overall Study||15
8357446|NCT01224171|20601098|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
8357447|NCT01224171|20601099|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
8357448|NCT01224171|20601098|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
8357449|NCT01224171|20601099|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
8357450|NCT01224171|20601098|P2|STARTED|Overall Study||209
8357451|NCT01224171|20601099|P1|STARTED|Overall Study||207
8357452|NCT01224158|20601121|P2|NOT COMPLETED|Overall Study||0
8357453|NCT01224158|20601122|P1|NOT COMPLETED|Overall Study||1
8357454|NCT01224158|20601121|P2|COMPLETED|Overall Study||77
8357455|NCT01224158|20601122|P1|COMPLETED|Overall Study||75
8357456|NCT01224158|20601121|P2|STARTED|Overall Study||77
8357457|NCT01224158|20601122|P1|STARTED|Overall Study||76
8357458|NCT01224145|20601138|P1|NOT COMPLETED|Overall Study||0
8357459|NCT01224145|20601138|P1|COMPLETED|Overall Study||10
8357460|NCT01224145|20601138|P1|STARTED|Overall Study||10
8357461|NCT01224015|20601149|P3|NOT COMPLETED|Overall Study||13
8357462|NCT01224015|20601150|P2|NOT COMPLETED|Overall Study||16
8357463|NCT01224015|20601151|P1|NOT COMPLETED|Overall Study||14
8357464|NCT01224015|20601149|P3|COMPLETED|Overall Study||83
8357465|NCT01224015|20601150|P2|COMPLETED|Overall Study||211
8357466|NCT01224015|20601151|P1|COMPLETED|Overall Study||347
8357467|NCT01224015|20601149|P3|STARTED|Overall Study||96
8357468|NCT01224015|20601150|P2|STARTED|Overall Study||227
8357469|NCT01224015|20601151|P1|STARTED|Overall Study||361
8357470|NCT01223963|20601159|P1|NOT COMPLETED|Overall Study||0
8357471|NCT01223963|20601159|P1|COMPLETED|Overall Study||93
8357472|NCT01223963|20601159|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
8357473|NCT01223937|20601166|P2|NOT COMPLETED|Overall Study||18
8357474|NCT01223937|20601167|P1|NOT COMPLETED|Overall Study||17
8357475|NCT01223937|20601166|P2|COMPLETED|Overall Study||119
8357476|NCT01223937|20601167|P1|COMPLETED|Overall Study||114
8357477|NCT01223937|20601166|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
8357478|NCT01223937|20601167|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
8357479|NCT01223937|20601166|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
8357480|NCT01223937|20601167|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
8357481|NCT01223937|20601166|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
8357482|NCT01223937|20601167|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
8357483|NCT01223703|20601191|P2|NOT COMPLETED|Overall Study||0
8357484|NCT01223703|20601192|P1|NOT COMPLETED|Overall Study||0
8357485|NCT01223703|20601191|P2|COMPLETED|Overall Study||66
8357486|NCT01223703|20601192|P1|COMPLETED|Overall Study||67
8357487|NCT01223703|20601191|P2|STARTED|Overall Study||66
8357488|NCT01223703|20601192|P1|STARTED|Overall Study||67
8357489|NCT01223469|20601206|P2|NOT COMPLETED|Overall Study||0
8357490|NCT01223469|20601207|P1|NOT COMPLETED|Overall Study||0
8357491|NCT01223469|20601206|P2|COMPLETED|Overall Study||43
8357492|NCT01223469|20601207|P1|COMPLETED|Overall Study||34
8357493|NCT01223469|20601206|P2|STARTED|Overall Study||43
8357494|NCT01223469|20601207|P1|STARTED|Overall Study||34
8357495|NCT01223404|20601213|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8357496|NCT01223404|20601214|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8357497|NCT01223404|20601215|P4|NOT COMPLETED|Third Intervention (1 Day)||1
8357498|NCT01223404|20601216|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8357499|NCT01223404|20601217|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8357500|NCT01223404|20601218|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8357501|NCT01223404|20601213|P6|COMPLETED|Third Intervention (1 Day)||3
8357502|NCT01223404|20601214|P5|COMPLETED|Third Intervention (1 Day)||2
8357503|NCT01223404|20601215|P4|COMPLETED|Third Intervention (1 Day)||3
8357504|NCT01223404|20601216|P3|COMPLETED|Third Intervention (1 Day)||4
8357505|NCT01223404|20601217|P2|COMPLETED|Third Intervention (1 Day)||3
8357506|NCT01223404|20601218|P1|COMPLETED|Third Intervention (1 Day)||3
8357507|NCT01223404|20601213|P6|STARTED|Third Intervention (1 Day)||3
8357508|NCT01223404|20601214|P5|STARTED|Third Intervention (1 Day)||2
8357509|NCT01223404|20601215|P4|STARTED|Third Intervention (1 Day)||4
8357510|NCT01223404|20601216|P3|STARTED|Third Intervention (1 Day)||4
8357511|NCT01223404|20601217|P2|STARTED|Third Intervention (1 Day)||3
8357512|NCT01223404|20601218|P1|STARTED|Third Intervention (1 Day)||3
8357513|NCT01223404|20601213|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8357514|NCT01223404|20601214|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8357515|NCT01223404|20601215|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8357516|NCT01223404|20601216|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8357517|NCT01223404|20601217|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8357518|NCT01223404|20601218|P1|NOT COMPLETED|Second Intervention (1 Day)||1
8357519|NCT01223404|20601213|P6|COMPLETED|Second Intervention (1 Day)||3
8357520|NCT01223404|20601214|P5|COMPLETED|Second Intervention (1 Day)||2
8357521|NCT01223404|20601215|P4|COMPLETED|Second Intervention (1 Day)||4
8357522|NCT01223404|20601216|P3|COMPLETED|Second Intervention (1 Day)||4
8357523|NCT01223404|20601217|P2|COMPLETED|Second Intervention (1 Day)||3
8357524|NCT01223404|20601218|P1|COMPLETED|Second Intervention (1 Day)||3
8357525|NCT01223404|20601213|P6|STARTED|Second Intervention (1 Day)||3
8357526|NCT01223404|20601214|P5|STARTED|Second Intervention (1 Day)||2
8357527|NCT01223404|20601215|P4|STARTED|Second Intervention (1 Day)||4
8357528|NCT01223404|20601216|P3|STARTED|Second Intervention (1 Day)||4
8357529|NCT01223404|20601217|P2|STARTED|Second Intervention (1 Day)||3
8357530|NCT01223404|20601218|P1|STARTED|Second Intervention (1 Day)||4
8357531|NCT01223404|20601213|P6|NOT COMPLETED|First Intervention (1 Day)||0
8357532|NCT01223404|20601214|P5|NOT COMPLETED|First Intervention (1 Day)||0
8357533|NCT01223404|20601215|P4|NOT COMPLETED|First Intervention (1 Day)||1
8357534|NCT01223404|20601216|P3|NOT COMPLETED|First Intervention (1 Day)||0
8357535|NCT01223404|20601217|P2|NOT COMPLETED|First Intervention (1 Day)||0
8357536|NCT01223404|20601218|P1|NOT COMPLETED|First Intervention (1 Day)||0
8357537|NCT01223404|20601213|P6|COMPLETED|First Intervention (1 Day)||3
8357538|NCT01223404|20601214|P5|COMPLETED|First Intervention (1 Day)||2
8357539|NCT01223404|20601215|P4|COMPLETED|First Intervention (1 Day)||4
8357540|NCT01223404|20601216|P3|COMPLETED|First Intervention (1 Day)||4
8357541|NCT01223404|20601217|P2|COMPLETED|First Intervention (1 Day)||3
8357542|NCT01223404|20601218|P1|COMPLETED|First Intervention (1 Day)||4
8357543|NCT01223404|20601213|P6|STARTED|First Intervention (1 Day)||3
8357544|NCT01223404|20601214|P5|STARTED|First Intervention (1 Day)||2
8357545|NCT01223404|20601215|P4|STARTED|First Intervention (1 Day)||5
8357546|NCT01223404|20601216|P3|STARTED|First Intervention (1 Day)||4
8357547|NCT01223404|20601217|P2|STARTED|First Intervention (1 Day)||3
8357548|NCT01223404|20601218|P1|STARTED|First Intervention (1 Day)||4
8357549|NCT01223378|20601246|P5|NOT COMPLETED|Overall Study||3
8357550|NCT01223378|20601247|P4|NOT COMPLETED|Overall Study||1
8357551|NCT01223378|20601248|P3|NOT COMPLETED|Overall Study||3
8357552|NCT01223378|20601249|P2|NOT COMPLETED|Overall Study||4
8357553|NCT01223378|20601250|P1|NOT COMPLETED|Overall Study||6
8357554|NCT01223378|20601246|P5|COMPLETED|Overall Study||79
8357555|NCT01223378|20601247|P4|COMPLETED|Overall Study||80
8357556|NCT01223378|20601248|P3|COMPLETED|Overall Study||80
8357557|NCT01223378|20601249|P2|COMPLETED|Overall Study||81
8357558|NCT01223378|20601250|P1|COMPLETED|Overall Study||76
8357559|NCT01223378|20601246|P5|STARTED|Overall Study||82
8357560|NCT01223378|20601247|P4|STARTED|Overall Study||81
8357561|NCT01223378|20601248|P3|STARTED|Overall Study||83
8357562|NCT01223378|20601249|P2|STARTED|Overall Study||85
8357563|NCT01223378|20601250|P1|STARTED|Overall Study||82
8357564|NCT01223365|20601282|P1|NOT COMPLETED|Open-label Treatment Period||102
8357565|NCT01223365|20601282|P1|COMPLETED|Open-label Treatment Period||189
8357566|NCT01223365|20601282|P1|STARTED|Open-label Treatment Period||291
8357567|NCT01223365|20601282|P1|NOT COMPLETED|Open-label Titration Period||39
8357568|NCT01223365|20601282|P1|COMPLETED|Open-label Titration Period||291
8357569|NCT01223365|20601282|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
8357570|NCT01223365|20601282|P1|Safety Analysis Set|Open-label Titration Period||329
8357571|NCT01223365|20601282|P1|STARTED|Open-label Titration Period||330
8357572|NCT01223352|20601325|P2|NOT COMPLETED|Overall Study||0
8357573|NCT01223352|20601326|P1|NOT COMPLETED|Overall Study||0
8357574|NCT01223352|20601325|P2|COMPLETED|Overall Study||33
8357575|NCT01223352|20601326|P1|COMPLETED|Overall Study||31
8357576|NCT01223352|20601325|P2|STARTED|Overall Study||33
8357577|NCT01223352|20601326|P1|STARTED|Overall Study||31
8357578|NCT01223235|20601346|P1|NOT COMPLETED|Overall Study||1
8357579|NCT01223235|20601346|P1|COMPLETED|Overall Study||21
8357580|NCT01223235|20601346|P1|STARTED|Overall Study||22
8357581|NCT01223196|20601354|P2|NOT COMPLETED|Overall Study||0
8357582|NCT01223196|20601355|P1|NOT COMPLETED|Overall Study||4
8357583|NCT01223196|20601354|P2|COMPLETED|Overall Study||11
8357584|NCT01223196|20601355|P1|COMPLETED|Overall Study||9
8357585|NCT01223196|20601354|P2|STARTED|Overall Study||11
8357586|NCT01223196|20601355|P1|STARTED|Overall Study||13
8357587|NCT01223183|20601367|P2|NOT COMPLETED|Imaging Day 2||0
8357588|NCT01223183|20601368|P1|NOT COMPLETED|Imaging Day 2||0
8357589|NCT01223183|20601367|P2|COMPLETED|Imaging Day 2||9
8357590|NCT01223183|20601368|P1|COMPLETED|Imaging Day 2||8
8357591|NCT01223183|20601367|P2|STARTED|Imaging Day 2||9
8357592|NCT01223183|20601368|P1|STARTED|Imaging Day 2||8
8357593|NCT01223183|20601367|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
8357594|NCT01223183|20601368|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
8357595|NCT01223183|20601367|P2|COMPLETED|Washout Period (5-24 Days)||9
8357596|NCT01223183|20601368|P1|COMPLETED|Washout Period (5-24 Days)||8
8357597|NCT01223183|20601367|P2|STARTED|Washout Period (5-24 Days)||9
8357598|NCT01223183|20601368|P1|STARTED|Washout Period (5-24 Days)||10
8357599|NCT01223183|20601367|P2|NOT COMPLETED|Imaging Day 1||1
8357600|NCT01223183|20601368|P1|NOT COMPLETED|Imaging Day 1||0
8357601|NCT01223183|20601367|P2|COMPLETED|Imaging Day 1||9
8357602|NCT01223183|20601368|P1|COMPLETED|Imaging Day 1||10
8357603|NCT01223183|20601367|P2|STARTED|Imaging Day 1||10
8357604|NCT01223183|20601368|P1|STARTED|Imaging Day 1||10
8357605|NCT01223027|20601378|P2|NOT COMPLETED|Overall Study||277
8357606|NCT01223027|20601379|P1|NOT COMPLETED|Overall Study||274
8357607|NCT01223027|20601378|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
8357608|NCT01223027|20601379|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
8357609|NCT01223027|20601378|P2|STARTED|Overall Study||286
8357610|NCT01223027|20601379|P1|STARTED|Overall Study||284
8357611|NCT01223001|20601402|P2|NOT COMPLETED|Overall Study||4
8357612|NCT01223001|20601403|P1|NOT COMPLETED|Overall Study||4
8357613|NCT01223001|20601402|P2|COMPLETED|Overall Study||0
8357614|NCT01223001|20601403|P1|COMPLETED|Overall Study||0
8357615|NCT01223001|20601402|P2|STARTED|Overall Study||4
8357616|NCT01223001|20601403|P1|STARTED|Overall Study||4
8357617|NCT01222884|20601411|P2|NOT COMPLETED|Overall Study||4
8357618|NCT01222884|20601412|P1|NOT COMPLETED|Overall Study||24
8357619|NCT01222884|20601411|P2|COMPLETED|Overall Study||113
8357620|NCT01222884|20601412|P1|COMPLETED|Overall Study||210
8357621|NCT01222884|20601411|P2|STARTED|Overall Study||117
8357622|NCT01222884|20601412|P1|STARTED|Overall Study||234
8357623|NCT01222871|20601422|P2|NOT COMPLETED|Overall Study||0
8357624|NCT01222871|20601423|P1|NOT COMPLETED|Overall Study||0
8357625|NCT01222871|20601422|P2|COMPLETED|Overall Study||0
8357626|NCT01222871|20601423|P1|COMPLETED|Overall Study||0
8357627|NCT01222871|20601422|P2|STARTED|Overall Study||0
8357628|NCT01222871|20601423|P1|STARTED|Overall Study||0
8357629|NCT01222832|20601432|P2|NOT COMPLETED|Overall Study||1
8357630|NCT01222832|20601433|P1|NOT COMPLETED|Overall Study||0
8357631|NCT01222832|20601432|P2|COMPLETED|Overall Study||112
8357632|NCT01222832|20601433|P1|COMPLETED|Overall Study||113
8357633|NCT01222832|20601432|P2|STARTED|Overall Study||113
8357634|NCT01222832|20601433|P1|STARTED|Overall Study||113
8357635|NCT01222715|20601441|P2|NOT COMPLETED|Overall Study||27
8357636|NCT01222715|20601442|P1|NOT COMPLETED|Overall Study||36
8357637|NCT01222715|20601441|P2|COMPLETED|Overall Study||16
8357638|NCT01222715|20601442|P1|COMPLETED|Overall Study||8
8357639|NCT01222715|20601441|P2|STARTED|Overall Study||43
8357640|NCT01222715|20601442|P1|STARTED|Overall Study||44
8357641|NCT01222689|20601452|P1|NOT COMPLETED|Overall Study||0
8357642|NCT01222689|20601452|P1|COMPLETED|Overall Study||46
8357643|NCT01222689|20601452|P1|STARTED|Overall Study||46
8357644|NCT01222585|20601465|P1|NOT COMPLETED|Overall Study||0
8357645|NCT01222585|20601465|P1|COMPLETED|Overall Study||24
8357646|NCT01222585|20601465|P1|STARTED|Overall Study||24
8357647|NCT01222572|20601475|P3|NOT COMPLETED|Overall Study||0
8357648|NCT01222572|20601476|P2|NOT COMPLETED|Overall Study||0
8357649|NCT01222572|20601477|P1|NOT COMPLETED|Overall Study||0
8357650|NCT01222572|20601475|P3|COMPLETED|Overall Study||0
8357651|NCT01222572|20601476|P2|COMPLETED|Overall Study||0
8357652|NCT01222572|20601477|P1|COMPLETED|Overall Study||1
8357653|NCT01222572|20601475|P3|STARTED|Overall Study||0
8357654|NCT01222572|20601476|P2|STARTED|Overall Study||0
8357655|NCT01222572|20601477|P1|STARTED|Overall Study||1
8357656|NCT01222533|20601481|P1|NOT COMPLETED|Overall Study||14
8357657|NCT01222533|20601481|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
8357658|NCT01222533|20601481|P1|Received Tio HH18|Overall Study||146
8357659|NCT01222533|20601481|P1|Received Tio R5|Overall Study||150
8357660|NCT01222533|20601481|P1|Received Tio R2.5|Overall Study||145
8357661|NCT01222533|20601481|P1|Received Tio R1.25|Overall Study||147
8357662|NCT01222533|20601481|P1|Received Placebo|Overall Study||147
8357663|NCT01222533|20601481|P1|STARTED|Overall Study|Entered and treated.|154
8357664|NCT01222520|20601620|P2|NOT COMPLETED|Double-blind Period||2
8357665|NCT01222520|20601621|P1|NOT COMPLETED|Double-blind Period||1
8357666|NCT01222520|20601620|P2|COMPLETED|Double-blind Period||85
8357667|NCT01222520|20601621|P1|COMPLETED|Double-blind Period||86
8357668|NCT01222520|20601620|P2|STARTED|Double-blind Period||87
8357669|NCT01222520|20601621|P1|STARTED|Double-blind Period||87
8357670|NCT01222520|20601620|P2|NOT COMPLETED|Open-label run-in Period||23
8357671|NCT01222520|20601621|P1|NOT COMPLETED|Open-label run-in Period||0
8357672|NCT01222520|20601620|P2|COMPLETED|Open-label run-in Period||174
8357673|NCT01222520|20601621|P1|COMPLETED|Open-label run-in Period||0
8357674|NCT01222520|20601620|P2|STARTED|Open-label run-in Period||197
8357675|NCT01222520|20601621|P1|STARTED|Open-label run-in Period||0
8357676|NCT01222507|20601639|P1|NOT COMPLETED|Overall Study||2
8357677|NCT01222507|20601639|P1|COMPLETED|Overall Study||60
8357678|NCT01222507|20601639|P1|STARTED|Overall Study||62
8357679|NCT01222494|20601646|P3|NOT COMPLETED|Overall Study||4
8357680|NCT01222494|20601647|P2|NOT COMPLETED|Overall Study||4
8357681|NCT01222494|20601648|P1|NOT COMPLETED|Overall Study||1
8357682|NCT01222494|20601646|P3|COMPLETED|Overall Study||17
8357683|NCT01222494|20601647|P2|COMPLETED|Overall Study||15
8357684|NCT01222494|20601648|P1|COMPLETED|Overall Study||6
8357685|NCT01222494|20601646|P3|STARTED|Overall Study||21
8357686|NCT01222494|20601647|P2|STARTED|Overall Study||19
8357687|NCT01222494|20601648|P1|STARTED|Overall Study||7
8357688|NCT01222416|20601667|P2|NOT COMPLETED|Overall Study||0
8357689|NCT01222416|20601668|P1|NOT COMPLETED|Overall Study||20
8357690|NCT01222416|20601667|P2|COMPLETED|Overall Study||0
8357691|NCT01222416|20601668|P1|COMPLETED|Overall Study||30
8357692|NCT01222416|20601667|P2|STARTED|Overall Study||0
8357693|NCT01222416|20601668|P1|STARTED|Overall Study||50
8357694|NCT01222403|20601678|P2|NOT COMPLETED|Overall Study||2
8357695|NCT01222403|20601679|P1|NOT COMPLETED|Overall Study||0
8357696|NCT01222403|20601678|P2|COMPLETED|Overall Study||379
8357697|NCT01222403|20601679|P1|COMPLETED|Overall Study||386
8357698|NCT01222403|20601678|P2|STARTED|Overall Study||381
8357699|NCT01222403|20601679|P1|STARTED|Overall Study||386
8357700|NCT01222390|20601689|P1|NOT COMPLETED|Overall Study||0
8357701|NCT01222390|20601689|P1|COMPLETED|Overall Study||12
8357702|NCT01222390|20601689|P1|STARTED|Overall Study||12
8357703|NCT01222299|20601697|P4|NOT COMPLETED|Overall Study||5
8357704|NCT01222299|20601698|P3|NOT COMPLETED|Overall Study||2
8357705|NCT01222299|20601699|P2|NOT COMPLETED|Overall Study||2
8357706|NCT01222299|20601700|P1|NOT COMPLETED|Overall Study||0
8357707|NCT01222299|20601697|P4|COMPLETED|Overall Study||18
8357708|NCT01222299|20601698|P3|COMPLETED|Overall Study||20
8357709|NCT01222299|20601699|P2|COMPLETED|Overall Study||21
8357710|NCT01222299|20601700|P1|COMPLETED|Overall Study||21
8357711|NCT01222299|20601697|P4|STARTED|Overall Study||23
8357712|NCT01222299|20601698|P3|STARTED|Overall Study||22
8357713|NCT01222299|20601699|P2|STARTED|Overall Study||23
8357714|NCT01222299|20601700|P1|STARTED|Overall Study||21
8357715|NCT01222286|20601712|P2|NOT COMPLETED|Overall Study||0
8357716|NCT01222286|20601713|P1|NOT COMPLETED|Overall Study||0
8357717|NCT01222286|20601712|P2|COMPLETED|Overall Study||14
8357718|NCT01222286|20601713|P1|COMPLETED|Overall Study||16
8357719|NCT01222286|20601712|P2|STARTED|Overall Study||14
8357720|NCT01222286|20601713|P1|STARTED|Overall Study||16
8357721|NCT01222273|20601725|P1|NOT COMPLETED|Overall Study||0
8357722|NCT01222273|20601725|P1|COMPLETED|Overall Study||7
8357723|NCT01222273|20601725|P1|STARTED|Overall Study||7
8357724|NCT01222260|20601731|P1|NOT COMPLETED|Overall Study||2
8357725|NCT01222260|20601731|P1|COMPLETED|Overall Study||29
8357726|NCT01222260|20601731|P1|STARTED|Overall Study||31
8357727|NCT01222247|20601740|P2|NOT COMPLETED|Overall Study||2
8357728|NCT01222247|20601741|P1|NOT COMPLETED|Overall Study||2
8357729|NCT01222247|20601740|P2|COMPLETED|Overall Study||1400
8357730|NCT01222247|20601741|P1|COMPLETED|Overall Study||1427
8357731|NCT01222247|20601740|P2|Did Not Receive Assigned Medication|Overall Study||5
8357732|NCT01222247|20601741|P1|Did Not Receive Assigned Medication|Overall Study||1
8357733|NCT01222247|20601740|P2|Received 1 Dose|Overall Study||571
8357734|NCT01222247|20601741|P1|Received 1 Dose|Overall Study||568
8357735|NCT01222247|20601740|P2|Received 2 Doses|Overall Study||826
8357736|NCT01222247|20601741|P1|Received 2 Doses|Overall Study||860
8357737|NCT01222247|20601740|P2|STARTED|Overall Study||1402
8357738|NCT01222247|20601741|P1|STARTED|Overall Study||1429
8357739|NCT01222234|20601806|P3|NOT COMPLETED|Overall Study||2
8357740|NCT01222234|20601807|P2|NOT COMPLETED|Overall Study||2
8357741|NCT01222234|20601808|P1|NOT COMPLETED|Overall Study||0
8357742|NCT01222234|20601806|P3|COMPLETED|Overall Study||22
8357743|NCT01222234|20601807|P2|COMPLETED|Overall Study||15
8357744|NCT01222234|20601808|P1|COMPLETED|Overall Study||15
8357745|NCT01222234|20601806|P3|STARTED|Overall Study||24
8357746|NCT01222234|20601807|P2|STARTED|Overall Study||17
8357747|NCT01222234|20601808|P1|STARTED|Overall Study||15
8357748|NCT01222195|20601817|P1|NOT COMPLETED|Overall Study||0
8357749|NCT01222195|20601817|P1|COMPLETED|Overall Study||1
8357750|NCT01222195|20601817|P1|STARTED|Overall Study||1
8357751|NCT01222117|20601832|P11|NOT COMPLETED|Overall Study||0
8357752|NCT01222117|20601833|P10|NOT COMPLETED|Overall Study||2
8357753|NCT01222117|20601834|P9|NOT COMPLETED|Overall Study||3
8357754|NCT01222117|20601835|P8|NOT COMPLETED|Overall Study||0
8357755|NCT01222117|20601836|P7|NOT COMPLETED|Overall Study||0
8357756|NCT01222117|20601837|P6|NOT COMPLETED|Overall Study||1
8357757|NCT01222117|20601838|P5|NOT COMPLETED|Overall Study||1
8357758|NCT01222117|20601839|P4|NOT COMPLETED|Overall Study||1
8357759|NCT01222117|20601840|P3|NOT COMPLETED|Overall Study||0
8357760|NCT01222117|20601841|P2|NOT COMPLETED|Overall Study||1
8357761|NCT01222117|20601842|P1|NOT COMPLETED|Overall Study||3
8357762|NCT01222117|20601832|P11|COMPLETED|Overall Study||6
8357763|NCT01222117|20601833|P10|COMPLETED|Overall Study||17
8357764|NCT01222117|20601834|P9|COMPLETED|Overall Study||20
8357765|NCT01222117|20601835|P8|COMPLETED|Overall Study||12
8357766|NCT01222117|20601836|P7|COMPLETED|Overall Study||13
8357767|NCT01222117|20601837|P6|COMPLETED|Overall Study||9
8357768|NCT01222117|20601838|P5|COMPLETED|Overall Study||8
8357769|NCT01222117|20601839|P4|COMPLETED|Overall Study||19
8357770|NCT01222117|20601840|P3|COMPLETED|Overall Study||22
8357771|NCT01222117|20601841|P2|COMPLETED|Overall Study||19
8357772|NCT01222117|20601842|P1|COMPLETED|Overall Study||17
8357773|NCT01222117|20601832|P11|STARTED|Overall Study||6
8357774|NCT01222117|20601833|P10|STARTED|Overall Study||19
8357775|NCT01222117|20601834|P9|STARTED|Overall Study||23
8357776|NCT01222117|20601835|P8|STARTED|Overall Study||12
8357777|NCT01222117|20601836|P7|STARTED|Overall Study||13
8357778|NCT01222117|20601837|P6|STARTED|Overall Study||10
8357779|NCT01222117|20601838|P5|STARTED|Overall Study||9
8357780|NCT01222117|20601839|P4|STARTED|Overall Study||20
8357781|NCT01222117|20601840|P3|STARTED|Overall Study||22
8357782|NCT01222117|20601841|P2|STARTED|Overall Study||20
8357783|NCT01222117|20601842|P1|STARTED|Overall Study||20
8357784|NCT01222104|20601877|P1|NOT COMPLETED|Overall Study||47
8357785|NCT01222104|20601877|P1|COMPLETED|Overall Study||587
8357786|NCT01222104|20601877|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
8357787|NCT01222104|20601877|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
8357788|NCT01222104|20601877|P1|Successful Deployment and Hemostasis|Overall Study||524
8357789|NCT01222104|20601877|P1|Successful Deployment|Overall Study||529
8357790|NCT01222104|20601877|P1|Angio-Seal Deployment Attempted|Overall Study||534
8357791|NCT01222104|20601877|P1|STARTED|Overall Study||634
8357792|NCT01222091|20601891|P2|NOT COMPLETED|Overall Study||0
8357793|NCT01222091|20601892|P1|NOT COMPLETED|Overall Study||0
8357794|NCT01222091|20601891|P2|COMPLETED|Overall Study||5
8357795|NCT01222091|20601892|P1|COMPLETED|Overall Study||5
8357796|NCT01222091|20601891|P2|STARTED|Overall Study||5
8357797|NCT01222091|20601892|P1|STARTED|Overall Study||5
8357798|NCT01222078|20601900|P1|NOT COMPLETED|Overall Study||1
8357799|NCT01222078|20601900|P1|COMPLETED|Overall Study||0
8357800|NCT01222078|20601900|P1|STARTED|Overall Study||1
8357801|NCT01221948|20601934|P1|NOT COMPLETED|Overall Study||14
8357802|NCT01221948|20601934|P1|COMPLETED|Overall Study||39
8357803|NCT01221948|20601934|P1|STARTED|Overall Study||53
8357804|NCT01221857|20601945|P1|NOT COMPLETED|Overall Study||0
8357805|NCT01221857|20601945|P1|COMPLETED|Overall Study||12
8357806|NCT01221857|20601945|P1|STARTED|Overall Study||12
8357807|NCT01221753|20601953|P1|NOT COMPLETED|Overall Study||1
8357808|NCT01221753|20601953|P1|COMPLETED|Overall Study||6
8357809|NCT01221753|20601953|P1|STARTED|Overall Study||7
8357810|NCT01221727|20601960|P2|NOT COMPLETED|Overall Study||1
8357811|NCT01221727|20601961|P1|NOT COMPLETED|Overall Study||3
8357812|NCT01221727|20601960|P2|COMPLETED|Overall Study||8
8357813|NCT01221727|20601961|P1|COMPLETED|Overall Study||18
8357814|NCT01221727|20601960|P2|Treated|Overall Study|Number of subjects received investigational product|8
8357815|NCT01221727|20601961|P1|Treated|Overall Study|Number of subjects received investigational product|19
8357816|NCT01221727|20601960|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
8357817|NCT01221727|20601961|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
8357818|NCT01221623|20601982|P2|NOT COMPLETED|Overall Study||14
8357819|NCT01221623|20601983|P1|NOT COMPLETED|Overall Study||38
8357820|NCT01221623|20601982|P2|COMPLETED|Overall Study||127
8357821|NCT01221623|20601983|P1|COMPLETED|Overall Study||236
8357822|NCT01221623|20601982|P2|STARTED|Overall Study||141
8357823|NCT01221623|20601983|P1|STARTED|Overall Study||274
8357824|NCT01221597|20602007|P2|NOT COMPLETED|Overall Study||16
8357825|NCT01221597|20602008|P1|NOT COMPLETED|Overall Study||36
8357826|NCT01221597|20602007|P2|COMPLETED|Overall Study||124
8357827|NCT01221597|20602008|P1|COMPLETED|Overall Study||241
8357828|NCT01221597|20602007|P2|STARTED|Overall Study||140
8357829|NCT01221597|20602008|P1|STARTED|Overall Study||277
8357830|NCT01221441|20602032|P2|NOT COMPLETED|Overall Study||12
8357831|NCT01221441|20602033|P1|NOT COMPLETED|Overall Study||22
8357832|NCT01221441|20602032|P2|COMPLETED|Overall Study||23
8357833|NCT01221441|20602033|P1|COMPLETED|Overall Study||45
8357834|NCT01221441|20602032|P2|STARTED|Overall Study||35
8357835|NCT01221441|20602033|P1|STARTED|Overall Study||67
8357836|NCT01221363|20602065|P2|NOT COMPLETED|Overall Study||5
8357837|NCT01221363|20602066|P1|NOT COMPLETED|Overall Study||12
8357838|NCT01221363|20602065|P2|COMPLETED|Overall Study||68
8357839|NCT01221363|20602066|P1|COMPLETED|Overall Study||81
8357840|NCT01221363|20602065|P2|STARTED|Overall Study||73
8357841|NCT01221363|20602066|P1|STARTED|Overall Study||93
8357842|NCT01221350|20602076|P2|NOT COMPLETED|Overall Study||3
8357843|NCT01221350|20602077|P1|NOT COMPLETED|Overall Study||5
8357844|NCT01221350|20602076|P2|COMPLETED|Overall Study||24
8357845|NCT01221350|20602077|P1|COMPLETED|Overall Study||23
8357846|NCT01221350|20602076|P2|Analysis Population|Overall Study||24
8357847|NCT01221350|20602077|P1|Analysis Population|Overall Study||23
8357848|NCT01221350|20602076|P2|Received Intervention|Overall Study||27
8357849|NCT01221350|20602077|P1|Received Intervention|Overall Study||28
8357850|NCT01221350|20602076|P2|STARTED|Overall Study||27
8357851|NCT01221350|20602077|P1|STARTED|Overall Study||28
8357852|NCT01221311|20602119|P2|NOT COMPLETED|Overall Study||0
8357853|NCT01221311|20602120|P1|NOT COMPLETED|Overall Study||0
8357854|NCT01221311|20602119|P2|COMPLETED|Overall Study||55
8357855|NCT01221311|20602120|P1|COMPLETED|Overall Study||57
8357856|NCT01221311|20602119|P2|STARTED|Overall Study||55
8357857|NCT01221311|20602120|P1|STARTED|Overall Study||57
8357858|NCT01221298|20602126|P1|NOT COMPLETED|Overall Study||0
8357859|NCT01221298|20602126|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
8357860|NCT01221298|20602126|P1|STARTED|Overall Study||11
8357861|NCT01221285|20602136|P1|NOT COMPLETED|Overall Study||1
8357862|NCT01221285|20602136|P1|COMPLETED|Overall Study||10
8357863|NCT01221285|20602136|P1|STARTED|Overall Study||11
8357864|NCT01221272|20602145|P2|NOT COMPLETED|Period 2||2
8357865|NCT01221272|20602146|P1|NOT COMPLETED|Period 2||0
8357866|NCT01221272|20602145|P2|COMPLETED|Period 2||37
8357867|NCT01221272|20602146|P1|COMPLETED|Period 2||39
8357868|NCT01221272|20602145|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
8357869|NCT01221272|20602146|P1|STARTED|Period 2||39
8357870|NCT01221272|20602145|P2|NOT COMPLETED|Period 1||2
8357871|NCT01221272|20602146|P1|NOT COMPLETED|Period 1||2
8357872|NCT01221272|20602145|P2|COMPLETED|Period 1||38
8357873|NCT01221272|20602146|P1|COMPLETED|Period 1||39
8357874|NCT01221272|20602145|P2|STARTED|Period 1||40
8357875|NCT01221272|20602146|P1|STARTED|Period 1||41
8357876|NCT01221233|20602163|P2|NOT COMPLETED|Overall Study||1
8357877|NCT01221233|20602164|P1|NOT COMPLETED|Overall Study||3
8357878|NCT01221233|20602163|P2|COMPLETED|Overall Study||19
8357879|NCT01221233|20602164|P1|COMPLETED|Overall Study||15
8357880|NCT01221233|20602163|P2|STARTED|Overall Study||20
8357881|NCT01221233|20602164|P1|STARTED|Overall Study||18
8357882|NCT01221207|20602173|P3|NOT COMPLETED|Overall Study||21
8357883|NCT01221207|20602174|P2|NOT COMPLETED|Overall Study||9
8357884|NCT01221207|20602175|P1|NOT COMPLETED|Overall Study||32
8357885|NCT01221207|20602173|P3|COMPLETED|Overall Study||54
8357886|NCT01221207|20602174|P2|COMPLETED|Overall Study||66
8357887|NCT01221207|20602175|P1|COMPLETED|Overall Study||43
8357888|NCT01221207|20602173|P3|STARTED|Overall Study||75
8357889|NCT01221207|20602174|P2|STARTED|Overall Study||75
8357890|NCT01221207|20602175|P1|STARTED|Overall Study||75
8357891|NCT01221194|20602185|P2|NOT COMPLETED|Overall Study||0
8357892|NCT01221194|20602186|P1|NOT COMPLETED|Overall Study||0
8357893|NCT01221194|20602185|P2|COMPLETED|Overall Study||186
8357894|NCT01221194|20602186|P1|COMPLETED|Overall Study||195
8357895|NCT01221194|20602185|P2|STARTED|Overall Study||186
8357896|NCT01221194|20602186|P1|STARTED|Overall Study||195
8357897|NCT01221181|20602192|P1|NOT COMPLETED|Overall Study||1
8357898|NCT01221181|20602192|P1|COMPLETED|Overall Study||5
8357899|NCT01221181|20602192|P1|STARTED|Overall Study||6
8357900|NCT01221090|20602200|P4|NOT COMPLETED|Overall Study||22
8357901|NCT01221090|20602201|P3|NOT COMPLETED|Overall Study||42
8357902|NCT01221090|20602202|P2|NOT COMPLETED|Overall Study||34
8357903|NCT01221090|20602203|P1|NOT COMPLETED|Overall Study||15
8357904|NCT01221090|20602200|P4|COMPLETED|Overall Study||73
8357905|NCT01221090|20602201|P3|COMPLETED|Overall Study||57
8357906|NCT01221090|20602202|P2|COMPLETED|Overall Study||47
8357907|NCT01221090|20602203|P1|COMPLETED|Overall Study||86
8357908|NCT01221090|20602200|P4|STARTED|Overall Study||95
8357909|NCT01221090|20602201|P3|STARTED|Overall Study||99
8357910|NCT01221090|20602202|P2|STARTED|Overall Study||81
8357911|NCT01221090|20602203|P1|STARTED|Overall Study||101
8357912|NCT01220999|20602234|P5|NOT COMPLETED|Overall Study||0
8357913|NCT01220999|20602235|P4|NOT COMPLETED|Overall Study||0
8357914|NCT01220999|20602236|P3|NOT COMPLETED|Overall Study||1
8357915|NCT01220999|20602237|P2|NOT COMPLETED|Overall Study||0
8357916|NCT01220999|20602238|P1|NOT COMPLETED|Overall Study||0
8357917|NCT01220999|20602234|P5|COMPLETED|Overall Study||5
8357918|NCT01220999|20602235|P4|COMPLETED|Overall Study||3
8357919|NCT01220999|20602236|P3|COMPLETED|Overall Study||4
8357920|NCT01220999|20602237|P2|COMPLETED|Overall Study||4
8357921|NCT01220999|20602238|P1|COMPLETED|Overall Study||2
8357922|NCT01220999|20602234|P5|STARTED|Overall Study||5
8357923|NCT01220999|20602235|P4|STARTED|Overall Study||3
8357924|NCT01220999|20602236|P3|STARTED|Overall Study||5
8357925|NCT01220999|20602237|P2|STARTED|Overall Study||4
8357926|NCT01220999|20602238|P1|STARTED|Overall Study||2
8357927|NCT01220973|20602315|P1|NOT COMPLETED|Overall Study||4
8357928|NCT01220973|20602315|P1|COMPLETED|Overall Study||23
8357929|NCT01220973|20602315|P1|STARTED|Overall Study||27
8357930|NCT01220869|20602319|P1|NOT COMPLETED|Overall Study||6
8357931|NCT01220869|20602319|P1|COMPLETED|Overall Study||104
8357932|NCT01220869|20602319|P1|STARTED|Overall Study||110
8357933|NCT01220739|20602329|P2|NOT COMPLETED|Overall Study||0
8357934|NCT01220739|20602330|P1|NOT COMPLETED|Overall Study||0
8357935|NCT01220739|20602329|P2|COMPLETED|Overall Study||5
8357936|NCT01220739|20602330|P1|COMPLETED|Overall Study||7
8357937|NCT01220739|20602329|P2|STARTED|Overall Study||5
8357938|NCT01220739|20602330|P1|STARTED|Overall Study||7
8357939|NCT01220726|20602340|P2|NOT COMPLETED|Overall Study||2
8357940|NCT01220726|20602341|P1|NOT COMPLETED|Overall Study||0
8357941|NCT01220726|20602340|P2|COMPLETED|Overall Study||13
8357942|NCT01220726|20602341|P1|COMPLETED|Overall Study||15
8357943|NCT01220726|20602340|P2|STARTED|Overall Study||15
8357944|NCT01220726|20602341|P1|STARTED|Overall Study||15
8357945|NCT01220687|20602361|P2|NOT COMPLETED|Overall Study||1
8357946|NCT01220687|20602362|P1|NOT COMPLETED|Overall Study||2
8357947|NCT01220687|20602361|P2|COMPLETED|Overall Study||14
8357948|NCT01220687|20602362|P1|COMPLETED|Overall Study||14
8357949|NCT01220687|20602361|P2|STARTED|Overall Study||15
8357950|NCT01220687|20602362|P1|STARTED|Overall Study||16
8357951|NCT01220609|20602388|P1|NOT COMPLETED|Overall Study||3
8357952|NCT01220609|20602388|P1|COMPLETED|Overall Study|Eligible and treated patients|23
8357953|NCT01220609|20602388|P1|STARTED|Overall Study||26
8357954|NCT01220557|20602402|P2|NOT COMPLETED|Overall Study||5
8357955|NCT01220557|20602403|P1|NOT COMPLETED|Overall Study||6
8357956|NCT01220557|20602402|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
8357957|NCT01220557|20602403|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
8357958|NCT01220557|20602402|P2|STARTED|Overall Study||79
8357959|NCT01220557|20602403|P1|STARTED|Overall Study||81
8357960|NCT01220466|20602412|P3|NOT COMPLETED|Overall Study||0
8357961|NCT01220466|20602413|P2|NOT COMPLETED|Overall Study||0
8357962|NCT01220466|20602414|P1|NOT COMPLETED|Overall Study||0
8357963|NCT01220466|20602412|P3|COMPLETED|Overall Study|16 eyes|10
8357964|NCT01220466|20602413|P2|COMPLETED|Overall Study|108 eyes|56
8357965|NCT01220466|20602414|P1|COMPLETED|Overall Study|19 eyes|11
8357966|NCT01220466|20602412|P3|STARTED|Overall Study|16 eyes|10
8357967|NCT01220466|20602413|P2|STARTED|Overall Study|108 eyes|56
8357968|NCT01220466|20602414|P1|STARTED|Overall Study|19 eyes|11
8357969|NCT01220414|20602436|P4|NOT COMPLETED|Overall Study||1
8357970|NCT01220414|20602437|P3|NOT COMPLETED|Overall Study||0
8357971|NCT01220414|20602438|P2|NOT COMPLETED|Overall Study||0
8357972|NCT01220414|20602439|P1|NOT COMPLETED|Overall Study||1
8357973|NCT01220414|20602436|P4|COMPLETED|Overall Study||14
8357974|NCT01220414|20602437|P3|COMPLETED|Overall Study||14
8357975|NCT01220414|20602438|P2|COMPLETED|Overall Study||14
8357976|NCT01220414|20602439|P1|COMPLETED|Overall Study||14
8357977|NCT01220414|20602436|P4|STARTED|Overall Study||15
8357978|NCT01220414|20602437|P3|STARTED|Overall Study||14
8357979|NCT01220414|20602438|P2|STARTED|Overall Study||14
8357980|NCT01220414|20602439|P1|STARTED|Overall Study||15
8357981|NCT01220401|20602446|P1|NOT COMPLETED|Overall Study||3
8357982|NCT01220401|20602446|P1|COMPLETED|Overall Study||18
8357983|NCT01220401|20602446|P1|STARTED|Overall Study||21
8357984|NCT01220297|20602455|P1|NOT COMPLETED|Overall Study||3
8357985|NCT01220297|20602455|P1|COMPLETED|Overall Study||0
8357986|NCT01220297|20602455|P1|STARTED|Overall Study||3
8357987|NCT01220180|20602472|P1|NOT COMPLETED|Overall Study||207
8357988|NCT01220180|20602472|P1|COMPLETED|Overall Study||3968
8357989|NCT01220180|20602472|P1|Treated|Overall Study||4174
8357990|NCT01220180|20602472|P1|STARTED|Overall Study||4175
8357991|NCT01220167|20602498|P3|NOT COMPLETED|Period 3||0
8357992|NCT01220167|20602499|P2|NOT COMPLETED|Period 3||1
8357993|NCT01220167|20602500|P1|NOT COMPLETED|Period 3||0
8357994|NCT01220167|20602498|P3|COMPLETED|Period 3||6
8357995|NCT01220167|20602499|P2|COMPLETED|Period 3||5
8357996|NCT01220167|20602500|P1|COMPLETED|Period 3||6
8357997|NCT01220167|20602498|P3|STARTED|Period 3||6
8357998|NCT01220167|20602499|P2|STARTED|Period 3||6
8357999|NCT01220167|20602500|P1|STARTED|Period 3||6
8358000|NCT01220167|20602498|P3|NOT COMPLETED|Period 2||0
8358001|NCT01220167|20602499|P2|NOT COMPLETED|Period 2||0
8358002|NCT01220167|20602500|P1|NOT COMPLETED|Period 2||0
8358003|NCT01220167|20602498|P3|COMPLETED|Period 2||6
8358004|NCT01220167|20602499|P2|COMPLETED|Period 2||6
8358005|NCT01220167|20602500|P1|COMPLETED|Period 2||6
8358006|NCT01220167|20602498|P3|STARTED|Period 2||6
8358007|NCT01220167|20602499|P2|STARTED|Period 2||6
8358008|NCT01220167|20602500|P1|STARTED|Period 2||6
8358009|NCT01220167|20602498|P3|NOT COMPLETED|Period 1||0
8358010|NCT01220167|20602499|P2|NOT COMPLETED|Period 1||0
8358011|NCT01220167|20602500|P1|NOT COMPLETED|Period 1||0
8358012|NCT01220167|20602498|P3|COMPLETED|Period 1||6
8358013|NCT01220167|20602499|P2|COMPLETED|Period 1||6
8358014|NCT01220167|20602500|P1|COMPLETED|Period 1||6
8358015|NCT01220167|20602498|P3|STARTED|Period 1||6
8358016|NCT01220167|20602499|P2|STARTED|Period 1||6
8358017|NCT01220167|20602500|P1|STARTED|Period 1||6
8358018|NCT01220128|20602513|P7|NOT COMPLETED|Overall Study||5
8358019|NCT01220128|20602514|P6|NOT COMPLETED|Overall Study||0
8358020|NCT01220128|20602515|P5|NOT COMPLETED|Overall Study||0
8358021|NCT01220128|20602516|P4|NOT COMPLETED|Overall Study||0
8358022|NCT01220128|20602517|P3|NOT COMPLETED|Overall Study||3
8358023|NCT01220128|20602518|P2|NOT COMPLETED|Overall Study||1
8358024|NCT01220128|20602519|P1|NOT COMPLETED|Overall Study||4
8358025|NCT01220128|20602513|P7|COMPLETED|Overall Study||3
8358026|NCT01220128|20602514|P6|COMPLETED|Overall Study||4
8358027|NCT01220128|20602515|P5|COMPLETED|Overall Study||11
8358028|NCT01220128|20602516|P4|COMPLETED|Overall Study||6
8358029|NCT01220128|20602517|P3|COMPLETED|Overall Study||6
8358030|NCT01220128|20602518|P2|COMPLETED|Overall Study||6
8358031|NCT01220128|20602519|P1|COMPLETED|Overall Study||11
8358032|NCT01220128|20602513|P7|STARTED|Overall Study||8
8358033|NCT01220128|20602514|P6|STARTED|Overall Study||4
8358034|NCT01220128|20602515|P5|STARTED|Overall Study||11
8358035|NCT01220128|20602516|P4|STARTED|Overall Study||6
8358036|NCT01220128|20602517|P3|STARTED|Overall Study||9
8358037|NCT01220128|20602518|P2|STARTED|Overall Study||7
8358038|NCT01220128|20602519|P1|STARTED|Overall Study||15
8358039|NCT01219985|20602724|P1|NOT COMPLETED|Overall Study||20
8358040|NCT01219985|20602724|P1|COMPLETED|Overall Study||30
8358041|NCT01219985|20602724|P1|STARTED|Overall Study||50
8358042|NCT01219959|20602732|P2|NOT COMPLETED|Overall Study||23
8358043|NCT01219959|20602733|P1|NOT COMPLETED|Overall Study||7
8358044|NCT01219959|20602732|P2|COMPLETED|Overall Study||101
8358045|NCT01219959|20602733|P1|COMPLETED|Overall Study||120
8358046|NCT01219959|20602732|P2|STARTED|Overall Study||124
8358047|NCT01219959|20602733|P1|STARTED|Overall Study||127
8358048|NCT01219933|20602781|P1|NOT COMPLETED|Overall Study||38
8358049|NCT01219933|20602781|P1|COMPLETED|Overall Study||30
8358050|NCT01219933|20602781|P1|STARTED|Overall Study||68
8358051|NCT01219881|20602820|P2|NOT COMPLETED|Overall Study||5
8358052|NCT01219881|20602821|P1|NOT COMPLETED|Overall Study||4
8358053|NCT01219881|20602820|P2|COMPLETED|Overall Study||32
8358054|NCT01219881|20602821|P1|COMPLETED|Overall Study||34
8358055|NCT01219881|20602820|P2|STARTED|Overall Study||37
8358056|NCT01219881|20602821|P1|STARTED|Overall Study||38
8358057|NCT01219855|20602838|P5|NOT COMPLETED|Overall Study||1
8358058|NCT01219855|20602839|P4|NOT COMPLETED|Overall Study||1
8358059|NCT01219855|20602840|P3|NOT COMPLETED|Overall Study||1
8358060|NCT01219855|20602841|P2|NOT COMPLETED|Overall Study||5
8358061|NCT01219855|20602842|P1|NOT COMPLETED|Overall Study||1
8358062|NCT01219855|20602838|P5|COMPLETED|Overall Study||13
8358063|NCT01219855|20602839|P4|COMPLETED|Overall Study||12
8358064|NCT01219855|20602840|P3|COMPLETED|Overall Study||16
8358065|NCT01219855|20602841|P2|COMPLETED|Overall Study||12
8358066|NCT01219855|20602842|P1|COMPLETED|Overall Study||16
8358067|NCT01219855|20602838|P5|STARTED|Overall Study||14
8358068|NCT01219855|20602839|P4|STARTED|Overall Study||13
8358069|NCT01219855|20602840|P3|STARTED|Overall Study||17
8358070|NCT01219855|20602841|P2|STARTED|Overall Study||17
8358071|NCT01219855|20602842|P1|STARTED|Overall Study||17
8358072|NCT01219777|20602878|P1|NOT COMPLETED|Overall Study||0
8358073|NCT01219777|20602878|P1|COMPLETED|Overall Study||9
8358074|NCT01219777|20602878|P1|STARTED|Overall Study||9
8358075|NCT01219738|20602883|P1|NOT COMPLETED|Overall Study||0
8358076|NCT01219738|20602883|P1|COMPLETED|Overall Study||20
8358077|NCT01219738|20602883|P1|Budesonide 720- 4 Times|Overall Study||20
8358078|NCT01219738|20602883|P1|Budesonide 1440|Overall Study||20
8358079|NCT01219738|20602883|P1|Budesonide 720|Overall Study||20
8358080|NCT01219738|20602883|P1|Budesonide 360|Overall Study||20
8358081|NCT01219738|20602883|P1|STARTED|Overall Study||20
8358082|NCT01219673|20602904|P8|NOT COMPLETED|Overall Study||0
8358083|NCT01219673|20602905|P7|NOT COMPLETED|Overall Study||0
8358084|NCT01219673|20602906|P6|NOT COMPLETED|Overall Study||0
8358085|NCT01219673|20602907|P5|NOT COMPLETED|Overall Study||0
8358086|NCT01219673|20602908|P4|NOT COMPLETED|Overall Study||0
8358087|NCT01219673|20602909|P3|NOT COMPLETED|Overall Study||0
8358088|NCT01219673|20602910|P2|NOT COMPLETED|Overall Study||0
8358089|NCT01219673|20602911|P1|NOT COMPLETED|Overall Study||0
8358090|NCT01219673|20602904|P8|COMPLETED|Overall Study||0
8358091|NCT01219673|20602905|P7|COMPLETED|Overall Study||0
8358092|NCT01219673|20602906|P6|COMPLETED|Overall Study||0
8358093|NCT01219673|20602907|P5|COMPLETED|Overall Study||0
8358094|NCT01219673|20602908|P4|COMPLETED|Overall Study||0
8358095|NCT01219673|20602909|P3|COMPLETED|Overall Study||1
8358096|NCT01219673|20602910|P2|COMPLETED|Overall Study||0
8358097|NCT01219673|20602911|P1|COMPLETED|Overall Study||0
8358098|NCT01219673|20602904|P8|STARTED|Overall Study||0
8358099|NCT01219673|20602905|P7|STARTED|Overall Study||0
8358100|NCT01219673|20602906|P6|STARTED|Overall Study||0
8358101|NCT01219673|20602907|P5|STARTED|Overall Study||0
8358102|NCT01219673|20602908|P4|STARTED|Overall Study||0
8358103|NCT01219673|20602909|P3|STARTED|Overall Study||1
8358104|NCT01219673|20602910|P2|STARTED|Overall Study||0
8358105|NCT01219673|20602911|P1|STARTED|Overall Study||0
8358106|NCT01218997|20602931|P2|NOT COMPLETED|Overall Study||41
8358107|NCT01218997|20602932|P1|NOT COMPLETED|Overall Study||245
8358108|NCT01218997|20602931|P2|COMPLETED|Overall Study||24
8358109|NCT01218997|20602932|P1|COMPLETED|Overall Study||126
8358110|NCT01218997|20602931|P2|STARTED|Overall Study||65
8358111|NCT01218997|20602932|P1|STARTED|Overall Study||371
8358112|NCT01218984|20602941|P3|NOT COMPLETED|Overall Study||3
8358113|NCT01218984|20602942|P2|NOT COMPLETED|Overall Study||2
8358114|NCT01218984|20602943|P1|NOT COMPLETED|Overall Study||1
8358115|NCT01218984|20602941|P3|COMPLETED|Overall Study||7
8358116|NCT01218984|20602942|P2|COMPLETED|Overall Study||6
8358117|NCT01218984|20602943|P1|COMPLETED|Overall Study||8
8358118|NCT01218984|20602941|P3|STARTED|Overall Study||10
8358119|NCT01218984|20602942|P2|STARTED|Overall Study||8
8358120|NCT01218984|20602943|P1|STARTED|Overall Study||9
8358121|NCT01218971|20602953|P2|NOT COMPLETED|Overall Study||80
8358122|NCT01218971|20602954|P1|NOT COMPLETED|Overall Study||104
8358123|NCT01218971|20602953|P2|COMPLETED|Overall Study||77
8358124|NCT01218971|20602954|P1|COMPLETED|Overall Study||71
8358125|NCT01218971|20602953|P2|STARTED|Overall Study||157
8358126|NCT01218971|20602954|P1|STARTED|Overall Study||175
8358127|NCT01218958|20602967|P3|NOT COMPLETED|Overall Study||81
8358128|NCT01218958|20602968|P2|NOT COMPLETED|Overall Study||81
8358129|NCT01218958|20602969|P1|NOT COMPLETED|Overall Study||84
8358130|NCT01218958|20602967|P3|COMPLETED|Overall Study||128
8358131|NCT01218958|20602968|P2|COMPLETED|Overall Study||124
8358132|NCT01218958|20602969|P1|COMPLETED|Overall Study||126
8358133|NCT01218958|20602967|P3|STARTED|Overall Study||209
8358134|NCT01218958|20602968|P2|STARTED|Overall Study||205
8358135|NCT01218958|20602969|P1|STARTED|Overall Study||210
8358136|NCT01218867|20602991|P11|NOT COMPLETED|Overall Study||0
8358137|NCT01218867|20602992|P10|NOT COMPLETED|Overall Study||0
8358138|NCT01218867|20602993|P9|NOT COMPLETED|Overall Study||0
8358139|NCT01218867|20602994|P8|NOT COMPLETED|Overall Study||0
8358140|NCT01218867|20602995|P7|NOT COMPLETED|Overall Study||1
8358141|NCT01218867|20602996|P6|NOT COMPLETED|Overall Study||0
8358142|NCT01218867|20602997|P5|NOT COMPLETED|Overall Study||0
8358143|NCT01218867|20602998|P4|NOT COMPLETED|Overall Study||0
8358144|NCT01218867|20602999|P3|NOT COMPLETED|Overall Study||0
8358145|NCT01218867|20603000|P2|NOT COMPLETED|Overall Study||0
8358146|NCT01218867|20603001|P1|NOT COMPLETED|Overall Study||0
8358147|NCT01218867|20602991|P11|COMPLETED|Overall Study||2
8358148|NCT01218867|20602992|P10|COMPLETED|Overall Study||4
8358149|NCT01218867|20602993|P9|COMPLETED|Overall Study||3
8358150|NCT01218867|20602994|P8|COMPLETED|Overall Study||3
8358151|NCT01218867|20602995|P7|COMPLETED|Overall Study||3
8358152|NCT01218867|20602996|P6|COMPLETED|Overall Study||1
8358153|NCT01218867|20602997|P5|COMPLETED|Overall Study||1
8358154|NCT01218867|20602998|P4|COMPLETED|Overall Study||1
8358155|NCT01218867|20602999|P3|COMPLETED|Overall Study||3
8358156|NCT01218867|20603000|P2|COMPLETED|Overall Study||1
8358157|NCT01218867|20603001|P1|COMPLETED|Overall Study||1
8358158|NCT01218867|20602991|P11|STARTED|Overall Study||2
8358159|NCT01218867|20602992|P10|STARTED|Overall Study||4
8358160|NCT01218867|20602993|P9|STARTED|Overall Study||3
8358161|NCT01218867|20602994|P8|STARTED|Overall Study||3
8358162|NCT01218867|20602995|P7|STARTED|Overall Study||4
8358163|NCT01218867|20602996|P6|STARTED|Overall Study||1
8358164|NCT01218867|20602997|P5|STARTED|Overall Study||1
8358165|NCT01218867|20602998|P4|STARTED|Overall Study||1
8358166|NCT01218867|20602999|P3|STARTED|Overall Study||3
8358167|NCT01218867|20603000|P2|STARTED|Overall Study||1
8358168|NCT01218867|20603001|P1|STARTED|Overall Study||1
8358169|NCT01218802|20603049|P2|NOT COMPLETED|Overall Study||18
8358170|NCT01218802|20603050|P1|NOT COMPLETED|Overall Study||10
8358171|NCT01218802|20603049|P2|COMPLETED|Overall Study||57
8358172|NCT01218802|20603050|P1|COMPLETED|Overall Study||62
8358173|NCT01218802|20603049|P2|STARTED|Overall Study||75
8358174|NCT01218802|20603050|P1|STARTED|Overall Study||72
8358175|NCT01218672|20603060|P2|NOT COMPLETED|Overall Study||21
8358176|NCT01218672|20603061|P1|NOT COMPLETED|Overall Study||11
8358177|NCT01218672|20603060|P2|COMPLETED|Overall Study||121
8358178|NCT01218672|20603061|P1|COMPLETED|Overall Study||128
8358179|NCT01218672|20603060|P2|Treated|Overall Study||133
8358180|NCT01218672|20603061|P1|Treated|Overall Study||136
8358181|NCT01218672|20603060|P2|STARTED|Overall Study||142
8358182|NCT01218672|20603061|P1|STARTED|Overall Study||139
8358183|NCT01218659|20603087|P3|NOT COMPLETED|12-Month OLE||10
8358184|NCT01218659|20603088|P2|NOT COMPLETED|12-Month OLE||0
8358185|NCT01218659|20603089|P1|NOT COMPLETED|12-Month OLE||0
8358186|NCT01218659|20603087|P3|COMPLETED|12-Month OLE||42
8358187|NCT01218659|20603088|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358188|NCT01218659|20603089|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358189|NCT01218659|20603087|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
8358190|NCT01218659|20603088|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358191|NCT01218659|20603089|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358192|NCT01218659|20603087|P3|Safety Population|12-Month OLE||51
8358193|NCT01218659|20603088|P2|Safety Population|12-Month OLE||0
8358194|NCT01218659|20603089|P1|Safety Population|12-Month OLE||0
8358195|NCT01218659|20603087|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
8358196|NCT01218659|20603088|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358197|NCT01218659|20603089|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358198|NCT01218659|20603087|P3|NOT COMPLETED|18-Month Randomized Period||0
8358199|NCT01218659|20603088|P2|NOT COMPLETED|18-Month Randomized Period||6
8358200|NCT01218659|20603089|P1|NOT COMPLETED|18-Month Randomized Period||2
8358201|NCT01218659|20603087|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8358202|NCT01218659|20603088|P2|COMPLETED|18-Month Randomized Period||18
8358203|NCT01218659|20603089|P1|COMPLETED|18-Month Randomized Period||34
8358204|NCT01218659|20603087|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8358205|NCT01218659|20603088|P2|Safety Population|18-Month Randomized Period||21
8358206|NCT01218659|20603089|P1|Safety Population|18-Month Randomized Period||36
8358207|NCT01218659|20603087|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8358208|NCT01218659|20603088|P2|STARTED|18-Month Randomized Period||24
8358209|NCT01218659|20603089|P1|STARTED|18-Month Randomized Period||36
8358210|NCT01218646|20603104|P4|NOT COMPLETED|Overall Study||1
8358211|NCT01218646|20603105|P3|NOT COMPLETED|Overall Study||2
8358212|NCT01218646|20603106|P2|NOT COMPLETED|Overall Study||0
8358213|NCT01218646|20603107|P1|NOT COMPLETED|Overall Study||1
8358214|NCT01218646|20603104|P4|COMPLETED|Overall Study||63
8358215|NCT01218646|20603105|P3|COMPLETED|Overall Study||223
8358216|NCT01218646|20603106|P2|COMPLETED|Overall Study||225
8358217|NCT01218646|20603107|P1|COMPLETED|Overall Study||224
8358218|NCT01218646|20603104|P4|STARTED|Overall Study||64
8358219|NCT01218646|20603105|P3|STARTED|Overall Study||225
8358220|NCT01218646|20603106|P2|STARTED|Overall Study||225
8358221|NCT01218646|20603107|P1|STARTED|Overall Study||225
8358222|NCT01218594|20603145|P1|NOT COMPLETED|Overall Study||12
8358223|NCT01218594|20603145|P1|COMPLETED|Overall Study||36
8358224|NCT01218594|20603145|P1|STARTED|Overall Study||48
8358225|NCT01218516|20603151|P4|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358226|NCT01218516|20603152|P3|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358227|NCT01218516|20603153|P2|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358228|NCT01218516|20603154|P1|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358229|NCT01218516|20603151|P4|COMPLETED|Monotherapy (up to 23.5 Months)||28
8358230|NCT01218516|20603152|P3|COMPLETED|Monotherapy (up to 23.5 Months)||38
8358231|NCT01218516|20603153|P2|COMPLETED|Monotherapy (up to 23.5 Months)||0
8358232|NCT01218516|20603154|P1|COMPLETED|Monotherapy (up to 23.5 Months)||0
8358233|NCT01218516|20603151|P4|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
8358234|NCT01218516|20603152|P3|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
8358235|NCT01218516|20603153|P2|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
8358236|NCT01218516|20603154|P1|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
8358237|NCT01218516|20603151|P4|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
8358238|NCT01218516|20603152|P3|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
8358239|NCT01218516|20603153|P2|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
8358240|NCT01218516|20603154|P1|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
8358241|NCT01218516|20603151|P4|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358242|NCT01218516|20603152|P3|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358243|NCT01218516|20603153|P2|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
8358244|NCT01218516|20603154|P1|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
8358245|NCT01218516|20603151|P4|COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358246|NCT01218516|20603152|P3|COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358247|NCT01218516|20603153|P2|COMPLETED|Combination Therapy (up to 4.5 Months)||28
8358248|NCT01218516|20603154|P1|COMPLETED|Combination Therapy (up to 4.5 Months)||38
8358249|NCT01218516|20603151|P4|STARTED|Combination Therapy (up to 4.5 Months)||0
8358250|NCT01218516|20603152|P3|STARTED|Combination Therapy (up to 4.5 Months)||0
8358251|NCT01218516|20603153|P2|STARTED|Combination Therapy (up to 4.5 Months)||63
8358252|NCT01218516|20603154|P1|STARTED|Combination Therapy (up to 4.5 Months)||67
8358253|NCT01218477|20603176|P4|NOT COMPLETED|Overall Study||2
8358254|NCT01218477|20603177|P3|NOT COMPLETED|Overall Study||14
8358255|NCT01218477|20603178|P2|NOT COMPLETED|Overall Study||8
8358256|NCT01218477|20603179|P1|NOT COMPLETED|Overall Study||3
8358257|NCT01218477|20603176|P4|COMPLETED|Overall Study|Still receiving study drug|0
8358258|NCT01218477|20603177|P3|COMPLETED|Overall Study|Still receiving study drug|0
8358259|NCT01218477|20603178|P2|COMPLETED|Overall Study|Still receiving study drug|0
8358260|NCT01218477|20603179|P1|COMPLETED|Overall Study|Still receiving study drug|0
8358261|NCT01218477|20603176|P4|STARTED|Overall Study|Participants who received treatment|2
8358262|NCT01218477|20603177|P3|STARTED|Overall Study|Participants who received treatment|14
8358263|NCT01218477|20603178|P2|STARTED|Overall Study|Participants who received treatment|8
8358264|NCT01218477|20603179|P1|STARTED|Overall Study|Participants who received treatment|3
8358265|NCT01218438|20603196|P1|NOT COMPLETED|Epoch 4||3
8358266|NCT01218438|20603196|P1|COMPLETED|Epoch 4||67
8358267|NCT01218438|20603196|P1|STARTED|Epoch 4||70
8358268|NCT01218438|20603196|P1|NOT COMPLETED|Epoch 3||4
8358269|NCT01218438|20603196|P1|COMPLETED|Epoch 3||70
8358270|NCT01218438|20603196|P1|STARTED|Epoch 3||74
8358271|NCT01218438|20603196|P1|NOT COMPLETED|Epoch 2||0
8358272|NCT01218438|20603196|P1|COMPLETED|Epoch 2||45
8358273|NCT01218438|20603196|P1|STARTED|Epoch 2||45
8358274|NCT01218438|20603196|P1|NOT COMPLETED|Epoch 1||3
8358275|NCT01218438|20603196|P1|COMPLETED|Epoch 1||74
8358276|NCT01218438|20603196|P1|STARTED|Epoch 1||77
8358277|NCT01218399|20603351|P2|NOT COMPLETED|Overall Study||0
8358278|NCT01218399|20603352|P1|NOT COMPLETED|Overall Study||0
8358279|NCT01218399|20603351|P2|COMPLETED|Overall Study||5
8358280|NCT01218399|20603352|P1|COMPLETED|Overall Study||5
8358281|NCT01218399|20603351|P2|STARTED|Overall Study||5
8358282|NCT01218399|20603352|P1|STARTED|Overall Study||5
8358283|NCT01218308|20603362|P2|NOT COMPLETED|Overall Study||120
8358284|NCT01218308|20603363|P1|NOT COMPLETED|Overall Study||103
8358285|NCT01218308|20603362|P2|COMPLETED|Overall Study||2464
8358286|NCT01218308|20603363|P1|COMPLETED|Overall Study||2481
8358287|NCT01218308|20603362|P2|STARTED|Overall Study||2584
8358288|NCT01218308|20603363|P1|STARTED|Overall Study||2584
8358289|NCT01218243|20603407|P2|NOT COMPLETED|Overall Study||14
8358290|NCT01218243|20603408|P1|NOT COMPLETED|Overall Study||9
8358291|NCT01218243|20603407|P2|COMPLETED|Overall Study||36
8358292|NCT01218243|20603408|P1|COMPLETED|Overall Study||41
8358293|NCT01218243|20603407|P2|Treatment Completed|Overall Study||42
8358294|NCT01218243|20603408|P1|Treatment Completed|Overall Study||45
8358295|NCT01218243|20603407|P2|STARTED|Overall Study||50
8358296|NCT01218243|20603408|P1|STARTED|Overall Study||50
8358297|NCT01218204|20603424|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
8358298|NCT01218204|20603425|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
8358299|NCT01218204|20603426|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
8358300|NCT01218204|20603427|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
8358301|NCT01218204|20603424|P4|COMPLETED|Part B Pooled Treatment Arm||127
8358302|NCT01218204|20603425|P3|COMPLETED|Part B Pooled Treatment Arm||0
8358303|NCT01218204|20603426|P2|COMPLETED|Part B Pooled Treatment Arm||0
8358304|NCT01218204|20603427|P1|COMPLETED|Part B Pooled Treatment Arm||0
8358305|NCT01218204|20603424|P4|STARTED|Part B Pooled Treatment Arm||130
8358306|NCT01218204|20603425|P3|STARTED|Part B Pooled Treatment Arm||0
8358307|NCT01218204|20603426|P2|STARTED|Part B Pooled Treatment Arm||0
8358308|NCT01218204|20603427|P1|STARTED|Part B Pooled Treatment Arm||0
8358309|NCT01218204|20603424|P4|NOT COMPLETED|Part B Run-in||0
8358310|NCT01218204|20603425|P3|NOT COMPLETED|Part B Run-in||6
8358311|NCT01218204|20603426|P2|NOT COMPLETED|Part B Run-in||0
8358312|NCT01218204|20603427|P1|NOT COMPLETED|Part B Run-in||0
8358313|NCT01218204|20603424|P4|COMPLETED|Part B Run-in||0
8358314|NCT01218204|20603425|P3|COMPLETED|Part B Run-in||83
8358315|NCT01218204|20603426|P2|COMPLETED|Part B Run-in||0
8358316|NCT01218204|20603427|P1|COMPLETED|Part B Run-in||0
8358317|NCT01218204|20603424|P4|STARTED|Part B Run-in||0
8358318|NCT01218204|20603425|P3|STARTED|Part B Run-in||89
8358319|NCT01218204|20603426|P2|STARTED|Part B Run-in||0
8358320|NCT01218204|20603427|P1|STARTED|Part B Run-in||0
8358321|NCT01218204|20603424|P4|NOT COMPLETED|Part B Washout||0
8358322|NCT01218204|20603425|P3|NOT COMPLETED|Part B Washout||0
8358323|NCT01218204|20603426|P2|NOT COMPLETED|Part B Washout||145
8358324|NCT01218204|20603427|P1|NOT COMPLETED|Part B Washout||0
8358325|NCT01218204|20603424|P4|COMPLETED|Part B Washout||0
8358326|NCT01218204|20603425|P3|COMPLETED|Part B Washout||0
8358327|NCT01218204|20603426|P2|COMPLETED|Part B Washout||136
8358328|NCT01218204|20603427|P1|COMPLETED|Part B Washout||0
8358329|NCT01218204|20603424|P4|STARTED|Part B Washout||0
8358330|NCT01218204|20603425|P3|STARTED|Part B Washout||0
8358331|NCT01218204|20603426|P2|STARTED|Part B Washout||281
8358332|NCT01218204|20603427|P1|STARTED|Part B Washout||0
8358333|NCT01218204|20603424|P4|NOT COMPLETED|Part A||0
8358334|NCT01218204|20603425|P3|NOT COMPLETED|Part A||0
8358335|NCT01218204|20603426|P2|NOT COMPLETED|Part A||0
8358336|NCT01218204|20603427|P1|NOT COMPLETED|Part A||0
8358337|NCT01218204|20603424|P4|COMPLETED|Part A||0
8358338|NCT01218204|20603425|P3|COMPLETED|Part A||0
8358339|NCT01218204|20603426|P2|COMPLETED|Part A||0
8358340|NCT01218204|20603427|P1|COMPLETED|Part A||6
8358341|NCT01218204|20603424|P4|STARTED|Part A||0
8358342|NCT01218204|20603425|P3|STARTED|Part A||0
8358343|NCT01218204|20603426|P2|STARTED|Part A||0
8358344|NCT01218204|20603427|P1|STARTED|Part A||6
8358345|NCT01218126|20603691|P4|NOT COMPLETED|Overall Study||35
8358346|NCT01218126|20603692|P3|NOT COMPLETED|Overall Study||24
8358347|NCT01218126|20603693|P2|NOT COMPLETED|Overall Study||22
8358348|NCT01218126|20603694|P1|NOT COMPLETED|Overall Study||24
8358349|NCT01218126|20603691|P4|COMPLETED|Overall Study||114
8358350|NCT01218126|20603692|P3|COMPLETED|Overall Study||127
8358351|NCT01218126|20603693|P2|COMPLETED|Overall Study||127
8358352|NCT01218126|20603694|P1|COMPLETED|Overall Study||129
8358353|NCT01218126|20603691|P4|STARTED|Overall Study||149
8358354|NCT01218126|20603692|P3|STARTED|Overall Study||151
8358355|NCT01218126|20603693|P2|STARTED|Overall Study||149
8358356|NCT01218126|20603694|P1|STARTED|Overall Study||153
8358357|NCT01218113|20603735|P3|NOT COMPLETED|Overall Study||6
8358358|NCT01218113|20603736|P2|NOT COMPLETED|Overall Study||1
8358359|NCT01218113|20603737|P1|NOT COMPLETED|Overall Study||5
8358360|NCT01218113|20603735|P3|COMPLETED|Overall Study||58
8358361|NCT01218113|20603736|P2|COMPLETED|Overall Study||63
8358362|NCT01218113|20603737|P1|COMPLETED|Overall Study||57
8358363|NCT01218113|20603735|P3|STARTED|Overall Study||64
8358364|NCT01218113|20603736|P2|STARTED|Overall Study||64
8358365|NCT01218113|20603737|P1|STARTED|Overall Study||62
8358366|NCT01218100|20603918|P4|NOT COMPLETED|Overall Study||34
8358367|NCT01218100|20603919|P3|NOT COMPLETED|Overall Study||27
8358368|NCT01218100|20603920|P2|NOT COMPLETED|Overall Study||25
8358369|NCT01218100|20603921|P1|NOT COMPLETED|Overall Study||24
8358370|NCT01218100|20603918|P4|COMPLETED|Overall Study||156
8358371|NCT01218100|20603919|P3|COMPLETED|Overall Study||162
8358372|NCT01218100|20603920|P2|COMPLETED|Overall Study||165
8358373|NCT01218100|20603921|P1|COMPLETED|Overall Study||71
8358374|NCT01218100|20603918|P4|STARTED|Overall Study||190
8358375|NCT01218100|20603919|P3|STARTED|Overall Study||189
8358376|NCT01218100|20603920|P2|STARTED|Overall Study||190
8358377|NCT01218100|20603921|P1|STARTED|Overall Study||95
8358378|NCT01218087|20603937|P2|NOT COMPLETED|Overall Study||6
8358379|NCT01218087|20603938|P1|NOT COMPLETED|Overall Study||15
8358380|NCT01218087|20603937|P2|COMPLETED|Overall Study||35
8358381|NCT01218087|20603938|P1|COMPLETED|Overall Study||27
8358382|NCT01218087|20603937|P2|STARTED|Overall Study||41
8358383|NCT01218087|20603938|P1|STARTED|Overall Study||42
8358384|NCT01218048|20603946|P1|NOT COMPLETED|Overall Study||0
8358385|NCT01218048|20603946|P1|COMPLETED|Overall Study||40
8358386|NCT01218048|20603946|P1|STARTED|Overall Study||40
8358387|NCT01218009|20603960|P2|NOT COMPLETED|Overall Study||165
8358388|NCT01218009|20603961|P1|NOT COMPLETED|Overall Study||166
8358389|NCT01218009|20603960|P2|COMPLETED|Overall Study||0
8358390|NCT01218009|20603961|P1|COMPLETED|Overall Study||0
8358391|NCT01218009|20603960|P2|STARTED|Overall Study||165
8358392|NCT01218009|20603961|P1|STARTED|Overall Study||166
8358393|NCT01217957|20603984|P5|NOT COMPLETED|Phase 2||1
8358394|NCT01217957|20603985|P4|NOT COMPLETED|Phase 2||0
8358395|NCT01217957|20603986|P3|NOT COMPLETED|Phase 2||0
8358396|NCT01217957|20603987|P2|NOT COMPLETED|Phase 2||0
8358397|NCT01217957|20603988|P1|NOT COMPLETED|Phase 2||0
8358398|NCT01217957|20603984|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
8358399|NCT01217957|20603985|P4|COMPLETED|Phase 2||0
8358400|NCT01217957|20603986|P3|COMPLETED|Phase 2||0
8358401|NCT01217957|20603987|P2|COMPLETED|Phase 2||0
8358402|NCT01217957|20603988|P1|COMPLETED|Phase 2||0
8358403|NCT01217957|20603984|P5|STARTED|Phase 2||50
8358404|NCT01217957|20603985|P4|STARTED|Phase 2||0
8358405|NCT01217957|20603986|P3|STARTED|Phase 2||0
8358406|NCT01217957|20603987|P2|STARTED|Phase 2||0
8358407|NCT01217957|20603988|P1|STARTED|Phase 2||0
8358408|NCT01217957|20603984|P5|NOT COMPLETED|Phase 1||0
8358409|NCT01217957|20603985|P4|NOT COMPLETED|Phase 1||1
8358410|NCT01217957|20603986|P3|NOT COMPLETED|Phase 1||1
8358411|NCT01217957|20603987|P2|NOT COMPLETED|Phase 1||0
8358412|NCT01217957|20603988|P1|NOT COMPLETED|Phase 1||1
8358413|NCT01217957|20603984|P5|COMPLETED|Phase 1||0
8358414|NCT01217957|20603985|P4|COMPLETED|Phase 1||2
8358415|NCT01217957|20603986|P3|COMPLETED|Phase 1||5
8358416|NCT01217957|20603987|P2|COMPLETED|Phase 1||3
8358417|NCT01217957|20603988|P1|COMPLETED|Phase 1||2
8358418|NCT01217957|20603984|P5|STARTED|Phase 1||0
8358419|NCT01217957|20603985|P4|STARTED|Phase 1||3
8358420|NCT01217957|20603986|P3|STARTED|Phase 1||6
8358421|NCT01217957|20603987|P2|STARTED|Phase 1||3
8358422|NCT01217957|20603988|P1|STARTED|Phase 1||3
8358423|NCT01217944|20604047|P3|NOT COMPLETED|Overall Study||0
8358424|NCT01217944|20604048|P2|NOT COMPLETED|Overall Study||4
8358425|NCT01217944|20604049|P1|NOT COMPLETED|Overall Study||6
8358426|NCT01217944|20604047|P3|COMPLETED|Overall Study||55
8358427|NCT01217944|20604048|P2|COMPLETED|Overall Study||112
8358428|NCT01217944|20604049|P1|COMPLETED|Overall Study||100
8358429|NCT01217944|20604047|P3|Completed 6 Months|Overall Study||55
8358430|NCT01217944|20604048|P2|Completed 6 Months|Overall Study||116
8358431|NCT01217944|20604049|P1|Completed 6 Months|Overall Study||103
8358432|NCT01217944|20604047|P3|Completed 3 Months|Overall Study||55
8358433|NCT01217944|20604048|P2|Completed 3 Months|Overall Study||116
8358434|NCT01217944|20604049|P1|Completed 3 Months|Overall Study||105
8358435|NCT01217944|20604047|P3|STARTED|Overall Study||55
8358436|NCT01217944|20604048|P2|STARTED|Overall Study||116
8358437|NCT01217944|20604049|P1|STARTED|Overall Study||106
8358438|NCT01217892|20604092|P4|NOT COMPLETED|Overall Study||8
8358439|NCT01217892|20604093|P3|NOT COMPLETED|Overall Study||9
8358440|NCT01217892|20604094|P2|NOT COMPLETED|Overall Study||6
8358441|NCT01217892|20604095|P1|NOT COMPLETED|Overall Study||7
8358442|NCT01217892|20604092|P4|COMPLETED|Overall Study||93
8358443|NCT01217892|20604093|P3|COMPLETED|Overall Study||90
8358444|NCT01217892|20604094|P2|COMPLETED|Overall Study||94
8358445|NCT01217892|20604095|P1|COMPLETED|Overall Study||93
8358446|NCT01217892|20604092|P4|STARTED|Overall Study||101
8358447|NCT01217892|20604093|P3|STARTED|Overall Study||99
8358448|NCT01217892|20604094|P2|STARTED|Overall Study||100
8358449|NCT01217892|20604095|P1|STARTED|Overall Study||100
8358450|NCT01217840|20604123|P2|NOT COMPLETED|Overall Study||3
8358451|NCT01217840|20604124|P1|NOT COMPLETED|Overall Study||6
8358452|NCT01217840|20604123|P2|COMPLETED|Overall Study||17
8358453|NCT01217840|20604124|P1|COMPLETED|Overall Study||14
8358454|NCT01217840|20604123|P2|STARTED|Overall Study||20
8358455|NCT01217840|20604124|P1|STARTED|Overall Study||20
8358456|NCT01217827|20604148|P2|NOT COMPLETED|Overall Study||0
8358457|NCT01217827|20604149|P1|NOT COMPLETED|Overall Study||0
8358458|NCT01217827|20604148|P2|COMPLETED|Overall Study||43
8358459|NCT01217827|20604149|P1|COMPLETED|Overall Study||46
8358460|NCT01217827|20604148|P2|STARTED|Overall Study||43
8358461|NCT01217827|20604149|P1|STARTED|Overall Study||46
8358462|NCT01217814|20604158|P3|NOT COMPLETED|Overall Study||1
8358463|NCT01217814|20604159|P2|NOT COMPLETED|Overall Study||1
8358464|NCT01217814|20604160|P1|NOT COMPLETED|Overall Study||1
8358465|NCT01217814|20604158|P3|COMPLETED|Overall Study||6
8358466|NCT01217814|20604159|P2|COMPLETED|Overall Study||4
8358467|NCT01217814|20604160|P1|COMPLETED|Overall Study||3
8358468|NCT01217814|20604158|P3|STARTED|Overall Study||7
8358469|NCT01217814|20604159|P2|STARTED|Overall Study||5
8358470|NCT01217814|20604160|P1|STARTED|Overall Study||4
8358471|NCT01217801|20604186|P2|NOT COMPLETED|Period 2||0
8358472|NCT01217801|20604187|P1|NOT COMPLETED|Period 2||0
8358473|NCT01217801|20604186|P2|COMPLETED|Period 2||22
8358474|NCT01217801|20604187|P1|COMPLETED|Period 2||23
8358475|NCT01217801|20604186|P2|STARTED|Period 2||22
8358476|NCT01217801|20604187|P1|STARTED|Period 2||23
8358477|NCT01217801|20604186|P2|NOT COMPLETED|Period 1||2
8358478|NCT01217801|20604187|P1|NOT COMPLETED|Period 1||1
8358479|NCT01217801|20604186|P2|COMPLETED|Period 1||22
8358480|NCT01217801|20604187|P1|COMPLETED|Period 1||23
8358481|NCT01217801|20604186|P2|STARTED|Period 1||24
8358482|NCT01217801|20604187|P1|STARTED|Period 1||24
8358483|NCT01217749|20604196|P3|NOT COMPLETED|Overall Study||2
8358484|NCT01217749|20604197|P2|NOT COMPLETED|Overall Study||3
8358485|NCT01217749|20604198|P1|NOT COMPLETED|Overall Study||3
8358486|NCT01217749|20604196|P3|COMPLETED|Overall Study||22
8358487|NCT01217749|20604197|P2|COMPLETED|Overall Study||17
8358488|NCT01217749|20604198|P1|COMPLETED|Overall Study||24
8358489|NCT01217749|20604196|P3|STARTED|Overall Study||24
8358490|NCT01217749|20604197|P2|STARTED|Overall Study||20
8358491|NCT01217749|20604198|P1|STARTED|Overall Study||27
8358492|NCT01217606|20604216|P2|NOT COMPLETED|9-Month Masked Extension||11
8358493|NCT01217606|20604217|P1|NOT COMPLETED|9-Month Masked Extension||13
8358494|NCT01217606|20604216|P2|COMPLETED|9-Month Masked Extension||62
8358495|NCT01217606|20604217|P1|COMPLETED|9-Month Masked Extension||54
8358496|NCT01217606|20604216|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
8358497|NCT01217606|20604217|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
8358498|NCT01217606|20604216|P2|STARTED|9-Month Masked Extension||73
8358499|NCT01217606|20604217|P1|STARTED|9-Month Masked Extension||67
8358500|NCT01217606|20604216|P2|NOT COMPLETED|Initial Treatment Phase||12
8358501|NCT01217606|20604217|P1|NOT COMPLETED|Initial Treatment Phase||14
8358502|NCT01217606|20604216|P2|COMPLETED|Initial Treatment Phase||83
8358503|NCT01217606|20604217|P1|COMPLETED|Initial Treatment Phase||76
8358504|NCT01217606|20604216|P2|STARTED|Initial Treatment Phase||95
8358505|NCT01217606|20604217|P1|STARTED|Initial Treatment Phase||90
8358506|NCT01217515|20604230|P3|NOT COMPLETED|Overall Study||10
8358507|NCT01217515|20604231|P2|NOT COMPLETED|Overall Study||8
8358508|NCT01217515|20604232|P1|NOT COMPLETED|Overall Study||7
8358509|NCT01217515|20604230|P3|COMPLETED|Overall Study||145
8358510|NCT01217515|20604231|P2|COMPLETED|Overall Study||148
8358511|NCT01217515|20604232|P1|COMPLETED|Overall Study||147
8358512|NCT01217515|20604230|P3|STARTED|Overall Study||155
8358513|NCT01217515|20604231|P2|STARTED|Overall Study||156
8358514|NCT01217515|20604232|P1|STARTED|Overall Study||154
8358515|NCT01217476|20604248|P2|NOT COMPLETED|Overall Study||7
8358516|NCT01217476|20604249|P1|NOT COMPLETED|Overall Study||12
8358517|NCT01217476|20604248|P2|COMPLETED|Overall Study||95
8358518|NCT01217476|20604249|P1|COMPLETED|Overall Study||93
8358519|NCT01217476|20604248|P2|STARTED|Overall Study||102
8358520|NCT01217476|20604249|P1|STARTED|Overall Study||105
8358521|NCT01217463|20604259|P2|NOT COMPLETED|Overall Study||8
8358522|NCT01217463|20604260|P1|NOT COMPLETED|Overall Study||13
8358523|NCT01217463|20604259|P2|COMPLETED|Overall Study||94
8358524|NCT01217463|20604260|P1|COMPLETED|Overall Study||86
8358525|NCT01217463|20604259|P2|STARTED|Overall Study||102
8358526|NCT01217463|20604260|P1|STARTED|Overall Study||99
8358533|NCT01217411|20604283|P2|NOT COMPLETED|Overall Study||2
8358534|NCT01217411|20604284|P1|NOT COMPLETED|Overall Study||3
8358535|NCT01217411|20604283|P2|COMPLETED|Overall Study||0
8358536|NCT01217411|20604284|P1|COMPLETED|Overall Study||0
8358537|NCT01217411|20604283|P2|20mg|Overall Study||0
8358538|NCT01217411|20604284|P1|20mg|Overall Study||0
8358539|NCT01217411|20604283|P2|10mg|Overall Study||0
8358540|NCT01217411|20604284|P1|10mg|Overall Study||0
8358541|NCT01217411|20604283|P2|5mg|Overall Study||2
8358542|NCT01217411|20604284|P1|5mg|Overall Study||3
8358543|NCT01217411|20604283|P2|STARTED|Overall Study||2
8358544|NCT01217411|20604284|P1|STARTED|Overall Study||3
8358545|NCT01217385|20604292|P1|NOT COMPLETED|Overall Study||26
8358546|NCT01217385|20604292|P1|COMPLETED|Overall Study||34
8358547|NCT01217385|20604292|P1|STARTED|Overall Study||60
8358548|NCT01217307|20604304|P2|NOT COMPLETED|Overall Study||1
8358549|NCT01217307|20604305|P1|NOT COMPLETED|Overall Study||0
8358550|NCT01217307|20604304|P2|COMPLETED|Overall Study||188
8358551|NCT01217307|20604305|P1|COMPLETED|Overall Study||191
8358552|NCT01217307|20604304|P2|STARTED|Overall Study||189
8358553|NCT01217307|20604305|P1|STARTED|Overall Study||191
8358554|NCT01217229|20604311|P1|NOT COMPLETED|Overall Study||20
8358555|NCT01217229|20604311|P1|COMPLETED|Overall Study||0
8358556|NCT01217229|20604311|P1|STARTED|Overall Study||20
8358557|NCT01217190|20604320|P2|NOT COMPLETED|Second Dosing||2
8358558|NCT01217190|20604321|P1|NOT COMPLETED|Second Dosing||0
8358559|NCT01217190|20604320|P2|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
8358560|NCT01217190|20604321|P1|COMPLETED|Second Dosing||24
8358561|NCT01217190|20604320|P2|STARTED|Second Dosing||24
8358562|NCT01217190|20604321|P1|STARTED|Second Dosing||24
8358563|NCT01217190|20604320|P2|NOT COMPLETED|First Dosing||0
8358564|NCT01217190|20604321|P1|NOT COMPLETED|First Dosing||0
8358565|NCT01217190|20604320|P2|COMPLETED|First Dosing||24
8358566|NCT01217190|20604321|P1|COMPLETED|First Dosing||24
8358567|NCT01217190|20604320|P2|STARTED|First Dosing||24
8358568|NCT01217190|20604321|P1|STARTED|First Dosing||24
8358569|NCT01217112|20604336|P5|NOT COMPLETED|Overall Study||1
8358570|NCT01217112|20604337|P4|NOT COMPLETED|Overall Study||2
8358571|NCT01217112|20604338|P3|NOT COMPLETED|Overall Study||1
8358572|NCT01217112|20604339|P2|NOT COMPLETED|Overall Study||2
8358573|NCT01217112|20604340|P1|NOT COMPLETED|Overall Study||0
8358574|NCT01217112|20604336|P5|COMPLETED|Overall Study||13
8358575|NCT01217112|20604337|P4|COMPLETED|Overall Study||10
8358576|NCT01217112|20604338|P3|COMPLETED|Overall Study||12
8358577|NCT01217112|20604339|P2|COMPLETED|Overall Study||10
8358578|NCT01217112|20604340|P1|COMPLETED|Overall Study||11
8358579|NCT01217112|20604336|P5|STARTED|Overall Study||14
8358580|NCT01217112|20604337|P4|STARTED|Overall Study||12
8358581|NCT01217112|20604338|P3|STARTED|Overall Study||13
8358582|NCT01217112|20604339|P2|STARTED|Overall Study||12
8358583|NCT01217112|20604340|P1|STARTED|Overall Study||11
8358584|NCT01217073|20604573|P8|NOT COMPLETED|Extension Period||20
8358585|NCT01217073|20604574|P7|NOT COMPLETED|Extension Period||91
8358586|NCT01217073|20604575|P6|NOT COMPLETED|Extension Period||0
8358587|NCT01217073|20604576|P5|NOT COMPLETED|Extension Period||0
8358588|NCT01217073|20604577|P4|NOT COMPLETED|Extension Period||0
8358589|NCT01217073|20604578|P3|NOT COMPLETED|Extension Period||0
8358590|NCT01217073|20604579|P2|NOT COMPLETED|Extension Period||0
8358591|NCT01217073|20604580|P1|NOT COMPLETED|Extension Period||0
8358592|NCT01217073|20604573|P8|COMPLETED|Extension Period||60
8358593|NCT01217073|20604574|P7|COMPLETED|Extension Period||314
8358594|NCT01217073|20604575|P6|COMPLETED|Extension Period||0
8358595|NCT01217073|20604576|P5|COMPLETED|Extension Period||0
8358596|NCT01217073|20604577|P4|COMPLETED|Extension Period||0
8358597|NCT01217073|20604578|P3|COMPLETED|Extension Period||0
8358598|NCT01217073|20604579|P2|COMPLETED|Extension Period||0
8358599|NCT01217073|20604580|P1|COMPLETED|Extension Period||0
8358600|NCT01217073|20604573|P8|STARTED|Extension Period||80
8358601|NCT01217073|20604574|P7|STARTED|Extension Period||405
8358602|NCT01217073|20604575|P6|STARTED|Extension Period||0
8358603|NCT01217073|20604576|P5|STARTED|Extension Period||0
8358604|NCT01217073|20604577|P4|STARTED|Extension Period||0
8358605|NCT01217073|20604578|P3|STARTED|Extension Period||0
8358606|NCT01217073|20604579|P2|STARTED|Extension Period||0
8358607|NCT01217073|20604580|P1|STARTED|Extension Period||0
8358608|NCT01217073|20604573|P8|NOT COMPLETED|Base Period||0
8358609|NCT01217073|20604574|P7|NOT COMPLETED|Base Period||0
8358610|NCT01217073|20604575|P6|NOT COMPLETED|Base Period||9
8358611|NCT01217073|20604576|P5|NOT COMPLETED|Base Period||15
8358612|NCT01217073|20604577|P4|NOT COMPLETED|Base Period||2
8358613|NCT01217073|20604578|P3|NOT COMPLETED|Base Period||7
8358614|NCT01217073|20604579|P2|NOT COMPLETED|Base Period||5
8358615|NCT01217073|20604580|P1|NOT COMPLETED|Base Period||7
8358616|NCT01217073|20604573|P8|COMPLETED|Base Period||0
8358617|NCT01217073|20604574|P7|COMPLETED|Base Period||0
8358618|NCT01217073|20604575|P6|COMPLETED|Base Period||105
8358619|NCT01217073|20604576|P5|COMPLETED|Base Period||99
8358620|NCT01217073|20604577|P4|COMPLETED|Base Period||113
8358621|NCT01217073|20604578|P3|COMPLETED|Base Period||107
8358622|NCT01217073|20604579|P2|COMPLETED|Base Period||110
8358623|NCT01217073|20604580|P1|COMPLETED|Base Period||106
8358624|NCT01217073|20604573|P8|STARTED|Base Period||0
8358625|NCT01217073|20604574|P7|STARTED|Base Period||0
8358626|NCT01217073|20604575|P6|STARTED|Base Period||114
8358627|NCT01217073|20604576|P5|STARTED|Base Period||114
8358628|NCT01217073|20604577|P4|STARTED|Base Period||115
8358629|NCT01217073|20604578|P3|STARTED|Base Period||114
8358630|NCT01217073|20604579|P2|STARTED|Base Period||115
8358631|NCT01217073|20604580|P1|STARTED|Base Period||113
8358632|NCT01217047|20604652|P3|NOT COMPLETED|Overall Study||0
8358633|NCT01217047|20604653|P2|NOT COMPLETED|Overall Study||1
8358634|NCT01217047|20604654|P1|NOT COMPLETED|Overall Study||0
8358635|NCT01217047|20604652|P3|COMPLETED|Overall Study||3
8358636|NCT01217047|20604653|P2|COMPLETED|Overall Study||3
8358637|NCT01217047|20604654|P1|COMPLETED|Overall Study||3
8358638|NCT01217047|20604652|P3|STARTED|Overall Study||3
8358639|NCT01217047|20604653|P2|STARTED|Overall Study||4
8358640|NCT01217047|20604654|P1|STARTED|Overall Study||3
8358641|NCT01216943|20604695|P1|NOT COMPLETED|Overall Study||13
8358642|NCT01216943|20604695|P1|COMPLETED|Overall Study||113
8358643|NCT01216943|20604695|P1|STARTED|Overall Study||126
8358644|NCT01216761|20604699|P3|NOT COMPLETED|Overall Study||0
8358645|NCT01216761|20604700|P2|NOT COMPLETED|Overall Study||0
8358646|NCT01216761|20604701|P1|NOT COMPLETED|Overall Study||0
8358647|NCT01216761|20604699|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
8358648|NCT01216761|20604700|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
8358649|NCT01216761|20604701|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
8358650|NCT01216761|20604699|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
8358651|NCT01216761|20604700|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
8358652|NCT01216761|20604701|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
8358653|NCT01216748|20604709|P1|NOT COMPLETED|Overall Study||0
8358654|NCT01216748|20604709|P1|COMPLETED|Overall Study||10
8358655|NCT01216748|20604709|P1|Eucapnic Hyperventilation|Overall Study||10
8358656|NCT01216748|20604709|P1|Hypercapnic Hyperventilation|Overall Study||10
8358657|NCT01216748|20604709|P1|Hypocapnic Hyperventilation|Overall Study||10
8358658|NCT01216748|20604709|P1|Quiet Breathing|Overall Study||10
8358659|NCT01216748|20604709|P1|STARTED|Overall Study||10
8358660|NCT01216735|20604716|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8358661|NCT01216735|20604717|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8358662|NCT01216735|20604716|P2|COMPLETED|Second Intervention (3 Weeks)||7
8358663|NCT01216735|20604717|P1|COMPLETED|Second Intervention (3 Weeks)||8
8358664|NCT01216735|20604716|P2|STARTED|Second Intervention (3 Weeks)||7
8358665|NCT01216735|20604717|P1|STARTED|Second Intervention (3 Weeks)||8
8358666|NCT01216735|20604716|P2|NOT COMPLETED|Washout (3 Weeks)||0
8358667|NCT01216735|20604717|P1|NOT COMPLETED|Washout (3 Weeks)||0
8358668|NCT01216735|20604716|P2|COMPLETED|Washout (3 Weeks)||7
8358669|NCT01216735|20604717|P1|COMPLETED|Washout (3 Weeks)||8
8358670|NCT01216735|20604716|P2|STARTED|Washout (3 Weeks)||7
8358671|NCT01216735|20604717|P1|STARTED|Washout (3 Weeks)||8
8358672|NCT01216735|20604716|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8358673|NCT01216735|20604717|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8358674|NCT01216735|20604716|P2|COMPLETED|First Intervention (3 Weeks)||7
8358675|NCT01216735|20604717|P1|COMPLETED|First Intervention (3 Weeks)||8
8358676|NCT01216735|20604716|P2|STARTED|First Intervention (3 Weeks)||7
8358677|NCT01216735|20604717|P1|STARTED|First Intervention (3 Weeks)||8
8358678|NCT01216631|20604728|P3|NOT COMPLETED|Overall Study||0
8358679|NCT01216631|20604729|P2|NOT COMPLETED|Overall Study||0
8358680|NCT01216631|20604730|P1|NOT COMPLETED|Overall Study||0
8358681|NCT01216631|20604728|P3|COMPLETED|Overall Study||1
8358682|NCT01216631|20604729|P2|COMPLETED|Overall Study||0
8358683|NCT01216631|20604730|P1|COMPLETED|Overall Study||0
8358684|NCT01216631|20604728|P3|STARTED|Overall Study||1
8358685|NCT01216631|20604729|P2|STARTED|Overall Study||0
8358686|NCT01216631|20604730|P1|STARTED|Overall Study||0
8358687|NCT01216410|20604741|P3|NOT COMPLETED|Overall Study||3
8358688|NCT01216410|20604742|P2|NOT COMPLETED|Overall Study||1
8358689|NCT01216410|20604743|P1|NOT COMPLETED|Overall Study||2
8358690|NCT01216410|20604741|P3|COMPLETED|Overall Study||100
8358691|NCT01216410|20604742|P2|COMPLETED|Overall Study||99
8358692|NCT01216410|20604743|P1|COMPLETED|Overall Study||101
8358693|NCT01216410|20604741|P3|STARTED|Overall Study||103
8358694|NCT01216410|20604742|P2|STARTED|Overall Study||100
8358695|NCT01216410|20604743|P1|STARTED|Overall Study||103
8358696|NCT01216397|20604763|P2|NOT COMPLETED|Period 2||0
8358697|NCT01216397|20604764|P1|NOT COMPLETED|Period 2||0
8358698|NCT01216397|20604763|P2|COMPLETED|Period 2||20
8358699|NCT01216397|20604764|P1|COMPLETED|Period 2||20
8358700|NCT01216397|20604763|P2|STARTED|Period 2||20
8358701|NCT01216397|20604764|P1|STARTED|Period 2||20
8358702|NCT01216397|20604763|P2|NOT COMPLETED|Washout (35 Days)||0
8358703|NCT01216397|20604764|P1|NOT COMPLETED|Washout (35 Days)||0
8358704|NCT01216397|20604763|P2|COMPLETED|Washout (35 Days)||20
8358705|NCT01216397|20604764|P1|COMPLETED|Washout (35 Days)||20
8358706|NCT01216397|20604763|P2|STARTED|Washout (35 Days)||20
8358707|NCT01216397|20604764|P1|STARTED|Washout (35 Days)||20
8358708|NCT01216397|20604763|P2|NOT COMPLETED|Period 1||0
8358709|NCT01216397|20604764|P1|NOT COMPLETED|Period 1||0
8358710|NCT01216397|20604763|P2|COMPLETED|Period 1||20
8358711|NCT01216397|20604764|P1|COMPLETED|Period 1||20
8358712|NCT01216397|20604763|P2|STARTED|Period 1||20
8358713|NCT01216397|20604764|P1|STARTED|Period 1||20
8358714|NCT01216332|20604818|P2|NOT COMPLETED|Overall Study||0
8358715|NCT01216332|20604819|P1|NOT COMPLETED|Overall Study||4
8358716|NCT01216332|20604818|P2|COMPLETED|Overall Study||16
8358717|NCT01216332|20604819|P1|COMPLETED|Overall Study||30
8358718|NCT01216332|20604818|P2|STARTED|Overall Study||16
8358719|NCT01216332|20604819|P1|STARTED|Overall Study||34
8358720|NCT01216319|20604837|P1|NOT COMPLETED|Overall Study||4
8358721|NCT01216319|20604837|P1|COMPLETED|Overall Study||46
8358722|NCT01216319|20604837|P1|STARTED|Overall Study||50
8358723|NCT01216241|20604844|P2|NOT COMPLETED|Overall Study||0
8358724|NCT01216241|20604845|P1|NOT COMPLETED|Overall Study||0
8358725|NCT01216241|20604844|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
8358726|NCT01216241|20604845|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
8358727|NCT01216241|20604844|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
8358728|NCT01216241|20604845|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
8358729|NCT01216176|20604854|P3|NOT COMPLETED|Overall Study||1
8358730|NCT01216176|20604855|P2|NOT COMPLETED|Overall Study||8
8358731|NCT01216176|20604856|P1|NOT COMPLETED|Overall Study||0
8358732|NCT01216176|20604854|P3|COMPLETED|Overall Study||19
8358733|NCT01216176|20604855|P2|COMPLETED|Overall Study||31
8358734|NCT01216176|20604856|P1|COMPLETED|Overall Study||12
8358735|NCT01216176|20604854|P3|STARTED|Overall Study||20
8358736|NCT01216176|20604855|P2|STARTED|Overall Study||39
8358737|NCT01216176|20604856|P1|STARTED|Overall Study||12
8358738|NCT01216163|20604879|P3|NOT COMPLETED|Overall Study||0
8358739|NCT01216163|20604880|P2|NOT COMPLETED|Overall Study||1
8358740|NCT01216163|20604881|P1|NOT COMPLETED|Overall Study||1
8358741|NCT01216163|20604879|P3|COMPLETED|Overall Study||85
8358742|NCT01216163|20604880|P2|COMPLETED|Overall Study||87
8358743|NCT01216163|20604881|P1|COMPLETED|Overall Study||44
8358744|NCT01216163|20604879|P3|STARTED|Overall Study||85
8358745|NCT01216163|20604880|P2|STARTED|Overall Study||88
8358746|NCT01216163|20604881|P1|STARTED|Overall Study||45
8358747|NCT01216072|20604933|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
8358748|NCT01216072|20604934|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
8358749|NCT01216072|20604933|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
8358750|NCT01216072|20604934|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
8358751|NCT01216072|20604933|P2|Safety Set|Open-Label Extension Period (3 Months)||193
8358752|NCT01216072|20604934|P1|Safety Set|Open-Label Extension Period (3 Months)||0
8358753|NCT01216072|20604933|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
8358754|NCT01216072|20604934|P1|STARTED|Open-Label Extension Period (3 Months)||0
8358755|NCT01216072|20604933|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
8358756|NCT01216072|20604934|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
8358757|NCT01216072|20604933|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
8358758|NCT01216072|20604934|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
8358759|NCT01216072|20604933|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
8358760|NCT01216072|20604934|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
8358761|NCT01216072|20604933|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
8358762|NCT01216072|20604934|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
8358763|NCT01216072|20604933|P2|STARTED|Open-Label Core Period ( 6 Months)||263
8358764|NCT01216072|20604934|P1|STARTED|Open-Label Core Period ( 6 Months)||790
8358765|NCT01215981|20604962|P2|NOT COMPLETED|Overall Study||1
8358766|NCT01215981|20604963|P1|NOT COMPLETED|Overall Study||2
8358767|NCT01215981|20604962|P2|COMPLETED|Overall Study||32
8358768|NCT01215981|20604963|P1|COMPLETED|Overall Study||33
8358769|NCT01215981|20604962|P2|STARTED|Overall Study||33
8358770|NCT01215981|20604963|P1|STARTED|Overall Study||35
8358771|NCT01215968|20604973|P2|NOT COMPLETED|Overall Study||7
8358772|NCT01215968|20604974|P1|NOT COMPLETED|Overall Study||2
8358773|NCT01215968|20604973|P2|COMPLETED|Overall Study||18
8358774|NCT01215968|20604974|P1|COMPLETED|Overall Study||11
8358775|NCT01215968|20604973|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
8358776|NCT01215968|20604974|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
8358777|NCT01215968|20604973|P2|STARTED|Overall Study||25
8358778|NCT01215968|20604974|P1|STARTED|Overall Study||13
8358779|NCT01215955|20604994|P4|NOT COMPLETED|Overall Study||53
8358780|NCT01215955|20604995|P3|NOT COMPLETED|Overall Study||48
8358781|NCT01215955|20604996|P2|NOT COMPLETED|Overall Study||53
8358782|NCT01215955|20604997|P1|NOT COMPLETED|Overall Study||45
8358783|NCT01215955|20604994|P4|COMPLETED|Overall Study||241
8358784|NCT01215955|20604995|P3|COMPLETED|Overall Study||244
8358785|NCT01215955|20604996|P2|COMPLETED|Overall Study||210
8358786|NCT01215955|20604997|P1|COMPLETED|Overall Study||223
8358787|NCT01215955|20604994|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
8358788|NCT01215955|20604995|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
8358789|NCT01215955|20604996|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
8358790|NCT01215955|20604997|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
8358791|NCT01215955|20604994|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
8358792|NCT01215955|20604995|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
8358793|NCT01215955|20604996|P2|STARTED|Overall Study||263
8358794|NCT01215955|20604997|P1|STARTED|Overall Study||268
8358795|NCT01215942|20605065|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
8358796|NCT01215942|20605066|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
8358797|NCT01215942|20605065|P2|COMPLETED|Post-Treatment Follow-Up Period||445
8358798|NCT01215942|20605066|P1|COMPLETED|Post-Treatment Follow-Up Period||283
8358799|NCT01215942|20605065|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
8358800|NCT01215942|20605066|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
8358801|NCT01215942|20605065|P2|NOT COMPLETED|Treatment Period||672
8358802|NCT01215942|20605066|P1|NOT COMPLETED|Treatment Period||414
8358803|NCT01215942|20605065|P2|COMPLETED|Treatment Period||0
8358804|NCT01215942|20605066|P1|COMPLETED|Treatment Period||0
8358805|NCT01215942|20605065|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
8358806|NCT01215942|20605066|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
8358807|NCT01215929|20605183|P2|NOT COMPLETED|Overall Study||5
8358808|NCT01215929|20605184|P1|NOT COMPLETED|Overall Study||6
8358809|NCT01215929|20605183|P2|COMPLETED|Overall Study||12
8358810|NCT01215929|20605184|P1|COMPLETED|Overall Study||12
8358811|NCT01215929|20605183|P2|STARTED|Overall Study||17
8358812|NCT01215929|20605184|P1|STARTED|Overall Study||18
8358813|NCT01215916|20605199|P9|NOT COMPLETED|Overall Study||2
8358814|NCT01215916|20605200|P8|NOT COMPLETED|Overall Study||3
8358815|NCT01215916|20605201|P7|NOT COMPLETED|Overall Study||9
8358816|NCT01215916|20605202|P6|NOT COMPLETED|Overall Study||4
8358817|NCT01215916|20605203|P5|NOT COMPLETED|Overall Study||6
8358818|NCT01215916|20605204|P4|NOT COMPLETED|Overall Study||6
8358819|NCT01215916|20605205|P3|NOT COMPLETED|Overall Study||3
8358820|NCT01215916|20605206|P2|NOT COMPLETED|Overall Study||5
8358821|NCT01215916|20605207|P1|NOT COMPLETED|Overall Study||1
8358822|NCT01215916|20605199|P9|COMPLETED|Overall Study||0
8358823|NCT01215916|20605200|P8|COMPLETED|Overall Study||0
8358824|NCT01215916|20605201|P7|COMPLETED|Overall Study||0
8358825|NCT01215916|20605202|P6|COMPLETED|Overall Study||0
8358826|NCT01215916|20605203|P5|COMPLETED|Overall Study||0
8358827|NCT01215916|20605204|P4|COMPLETED|Overall Study||0
8358828|NCT01215916|20605205|P3|COMPLETED|Overall Study||0
8358829|NCT01215916|20605206|P2|COMPLETED|Overall Study||0
8358830|NCT01215916|20605207|P1|COMPLETED|Overall Study||0
8358831|NCT01215916|20605199|P9|Received at Least 1 Dose of Either Drug|Overall Study||2
8358832|NCT01215916|20605200|P8|Received at Least 1 Dose of Either Drug|Overall Study||3
8358833|NCT01215916|20605201|P7|Received at Least 1 Dose of Either Drug|Overall Study||9
8358834|NCT01215916|20605202|P6|Received at Least 1 Dose of Either Drug|Overall Study||4
8358835|NCT01215916|20605203|P5|Received at Least 1 Dose of Either Drug|Overall Study||6
8358836|NCT01215916|20605204|P4|Received at Least 1 Dose of Either Drug|Overall Study||6
8358837|NCT01215916|20605205|P3|Received at Least 1 Dose of Either Drug|Overall Study||3
8358838|NCT01215916|20605206|P2|Received at Least 1 Dose of Either Drug|Overall Study||5
8358839|NCT01215916|20605207|P1|Received at Least 1 Dose of Either Drug|Overall Study||1
8358840|NCT01215916|20605199|P9|STARTED|Overall Study||2
8358841|NCT01215916|20605200|P8|STARTED|Overall Study||3
8358842|NCT01215916|20605201|P7|STARTED|Overall Study||9
8358843|NCT01215916|20605202|P6|STARTED|Overall Study||4
8358844|NCT01215916|20605203|P5|STARTED|Overall Study||6
8358845|NCT01215916|20605204|P4|STARTED|Overall Study||6
8358846|NCT01215916|20605205|P3|STARTED|Overall Study||3
8358847|NCT01215916|20605206|P2|STARTED|Overall Study||5
8358848|NCT01215916|20605207|P1|STARTED|Overall Study||1
8358849|NCT01215851|20605241|P6|NOT COMPLETED|Follow up Period||1
8358850|NCT01215851|20605242|P5|NOT COMPLETED|Follow up Period||0
8358851|NCT01215851|20605243|P4|NOT COMPLETED|Follow up Period||0
8358852|NCT01215851|20605244|P3|NOT COMPLETED|Follow up Period||0
8358853|NCT01215851|20605245|P2|NOT COMPLETED|Follow up Period||0
8358854|NCT01215851|20605246|P1|NOT COMPLETED|Follow up Period||0
8358855|NCT01215851|20605241|P6|COMPLETED|Follow up Period||13
8358856|NCT01215851|20605242|P5|COMPLETED|Follow up Period||10
8358857|NCT01215851|20605243|P4|COMPLETED|Follow up Period||12
8358858|NCT01215851|20605244|P3|COMPLETED|Follow up Period||14
8358859|NCT01215851|20605245|P2|COMPLETED|Follow up Period||14
8358860|NCT01215851|20605246|P1|COMPLETED|Follow up Period||14
8358861|NCT01215851|20605241|P6|STARTED|Follow up Period||14
8358862|NCT01215851|20605242|P5|STARTED|Follow up Period||10
8358863|NCT01215851|20605243|P4|STARTED|Follow up Period||12
8358864|NCT01215851|20605244|P3|STARTED|Follow up Period||14
8358865|NCT01215851|20605245|P2|STARTED|Follow up Period||14
8358866|NCT01215851|20605246|P1|STARTED|Follow up Period||14
8358867|NCT01215851|20605241|P6|NOT COMPLETED|Treatment Period||1
8358868|NCT01215851|20605242|P5|NOT COMPLETED|Treatment Period||0
8358869|NCT01215851|20605243|P4|NOT COMPLETED|Treatment Period||3
8358870|NCT01215851|20605244|P3|NOT COMPLETED|Treatment Period||1
8358871|NCT01215851|20605245|P2|NOT COMPLETED|Treatment Period||1
8358872|NCT01215851|20605246|P1|NOT COMPLETED|Treatment Period||1
8358873|NCT01215851|20605241|P6|COMPLETED|Treatment Period||14
8358874|NCT01215851|20605242|P5|COMPLETED|Treatment Period||10
8358875|NCT01215851|20605243|P4|COMPLETED|Treatment Period||12
8358876|NCT01215851|20605244|P3|COMPLETED|Treatment Period||14
8358877|NCT01215851|20605245|P2|COMPLETED|Treatment Period||14
8358878|NCT01215851|20605246|P1|COMPLETED|Treatment Period||14
8358879|NCT01215851|20605241|P6|STARTED|Treatment Period||15
8358880|NCT01215851|20605242|P5|STARTED|Treatment Period||10
8358881|NCT01215851|20605243|P4|STARTED|Treatment Period||15
8358882|NCT01215851|20605244|P3|STARTED|Treatment Period||15
8358883|NCT01215851|20605245|P2|STARTED|Treatment Period||15
8358884|NCT01215851|20605246|P1|STARTED|Treatment Period||15
8358885|NCT01215786|20605287|P3|NOT COMPLETED|Overall Study||0
8358886|NCT01215786|20605288|P2|NOT COMPLETED|Overall Study||0
8358887|NCT01215786|20605289|P1|NOT COMPLETED|Overall Study||0
8358888|NCT01215786|20605287|P3|COMPLETED|Overall Study||10
8358889|NCT01215786|20605288|P2|COMPLETED|Overall Study||19
8358890|NCT01215786|20605289|P1|COMPLETED|Overall Study||21
8358891|NCT01215786|20605287|P3|STARTED|Overall Study||10
8358892|NCT01215786|20605288|P2|STARTED|Overall Study||19
8358893|NCT01215786|20605289|P1|STARTED|Overall Study||21
8358894|NCT01215734|20605305|P2|NOT COMPLETED|Overall Study||1
8358895|NCT01215734|20605306|P1|NOT COMPLETED|Overall Study||0
8358896|NCT01215734|20605305|P2|COMPLETED|Overall Study||14
8358897|NCT01215734|20605306|P1|COMPLETED|Overall Study||29
8358898|NCT01215734|20605305|P2|STARTED|Overall Study||15
8358899|NCT01215734|20605306|P1|STARTED|Overall Study||29
8358900|NCT01215721|20605314|P1|NOT COMPLETED|Overall Study||2
8358901|NCT01215721|20605314|P1|COMPLETED|Overall Study||38
8358902|NCT01215721|20605314|P1|STARTED|Overall Study||40
8358903|NCT01215695|20605320|P2|NOT COMPLETED|Overall Study||0
8358904|NCT01215695|20605321|P1|NOT COMPLETED|Overall Study||0
8358905|NCT01215695|20605320|P2|COMPLETED|Overall Study||70
8358906|NCT01215695|20605321|P1|COMPLETED|Overall Study||70
8358907|NCT01215695|20605320|P2|STARTED|Overall Study||70
8358908|NCT01215695|20605321|P1|STARTED|Overall Study||70
8358909|NCT01215643|20605340|P5|NOT COMPLETED|Overall Study||11
8358910|NCT01215643|20605341|P4|NOT COMPLETED|Overall Study||4
8358911|NCT01215643|20605342|P3|NOT COMPLETED|Overall Study||12
8358912|NCT01215643|20605343|P2|NOT COMPLETED|Overall Study||4
8358913|NCT01215643|20605344|P1|NOT COMPLETED|Overall Study||9
8358914|NCT01215643|20605340|P5|COMPLETED|Overall Study||29
8358915|NCT01215643|20605341|P4|COMPLETED|Overall Study||35
8358916|NCT01215643|20605342|P3|COMPLETED|Overall Study||82
8358917|NCT01215643|20605343|P2|COMPLETED|Overall Study||80
8358918|NCT01215643|20605344|P1|COMPLETED|Overall Study||74
8358919|NCT01215643|20605340|P5|STARTED|Overall Study||40
8358920|NCT01215643|20605341|P4|STARTED|Overall Study||39
8358921|NCT01215643|20605342|P3|STARTED|Overall Study||94
8358922|NCT01215643|20605343|P2|STARTED|Overall Study||84
8358923|NCT01215643|20605344|P1|STARTED|Overall Study||83
8358924|NCT01215513|20605446|P1|NOT COMPLETED|Overall Study||45
8358925|NCT01215513|20605446|P1|COMPLETED|Overall Study||112
8358926|NCT01215513|20605446|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
8358927|NCT01215513|20605446|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
8358928|NCT01215513|20605446|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
8358929|NCT01215513|20605446|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
8358930|NCT01215435|20605455|P2|NOT COMPLETED|Overall Study||16
8358931|NCT01215435|20605456|P1|NOT COMPLETED|Overall Study||19
8358932|NCT01215435|20605455|P2|COMPLETED|Overall Study||107
8358933|NCT01215435|20605456|P1|COMPLETED|Overall Study||103
8358934|NCT01215435|20605455|P2|STARTED|Overall Study||123
8358935|NCT01215435|20605456|P1|STARTED|Overall Study||122
8358936|NCT01215422|20605470|P4|NOT COMPLETED|Overall Study||8
8358937|NCT01215422|20605471|P3|NOT COMPLETED|Overall Study||3
8358938|NCT01215422|20605472|P2|NOT COMPLETED|Overall Study||0
8358939|NCT01215422|20605473|P1|NOT COMPLETED|Overall Study||8
8358940|NCT01215422|20605470|P4|COMPLETED|Overall Study||193
8358941|NCT01215422|20605471|P3|COMPLETED|Overall Study||193
8358942|NCT01215422|20605472|P2|COMPLETED|Overall Study||249
8358943|NCT01215422|20605473|P1|COMPLETED|Overall Study||6
8358944|NCT01215422|20605470|P4|STARTED|Overall Study||201
8358945|NCT01215422|20605471|P3|STARTED|Overall Study||196
8358946|NCT01215422|20605472|P2|STARTED|Overall Study||249
8358947|NCT01215422|20605473|P1|STARTED|Overall Study||14
8358948|NCT01215357|20605495|P1|NOT COMPLETED|Overall Study||12
8358949|NCT01215357|20605495|P1|COMPLETED|Overall Study||22
8358950|NCT01215357|20605495|P1|STARTED|Overall Study||34
8358951|NCT01215344|20605501|P2|NOT COMPLETED|Overall Study||0
8358952|NCT01215344|20605502|P1|NOT COMPLETED|Overall Study||10
8358953|NCT01215344|20605501|P2|COMPLETED|Overall Study||3
8358954|NCT01215344|20605502|P1|COMPLETED|Overall Study||23
8358955|NCT01215344|20605501|P2|STARTED|Overall Study||3
8358956|NCT01215344|20605502|P1|STARTED|Overall Study||33
8358957|NCT01215318|20605512|P2|NOT COMPLETED|Overall Study||0
8358958|NCT01215318|20605513|P1|NOT COMPLETED|Overall Study||0
8358959|NCT01215318|20605512|P2|COMPLETED|Overall Study||24
8358960|NCT01215318|20605513|P1|COMPLETED|Overall Study||20
8358961|NCT01215318|20605512|P2|STARTED|Overall Study||24
8358962|NCT01215318|20605513|P1|STARTED|Overall Study||20
8358963|NCT01215292|20605526|P5|NOT COMPLETED|Overall Study||0
8358964|NCT01215292|20605527|P4|NOT COMPLETED|Overall Study||0
8358965|NCT01215292|20605528|P3|NOT COMPLETED|Overall Study||0
8358966|NCT01215292|20605529|P2|NOT COMPLETED|Overall Study||0
8358967|NCT01215292|20605530|P1|NOT COMPLETED|Overall Study||0
8358968|NCT01215292|20605526|P5|COMPLETED|Overall Study||8
8358969|NCT01215292|20605527|P4|COMPLETED|Overall Study||8
8358970|NCT01215292|20605528|P3|COMPLETED|Overall Study||8
8358971|NCT01215292|20605529|P2|COMPLETED|Overall Study||8
8358972|NCT01215292|20605530|P1|COMPLETED|Overall Study||8
8358973|NCT01215292|20605526|P5|STARTED|Overall Study||8
8358974|NCT01215292|20605527|P4|STARTED|Overall Study||8
8358975|NCT01215292|20605528|P3|STARTED|Overall Study||8
8358976|NCT01215292|20605529|P2|STARTED|Overall Study||8
8358977|NCT01215292|20605530|P1|STARTED|Overall Study||8
8358978|NCT01215279|20605554|P2|NOT COMPLETED|Overall Study||0
8358979|NCT01215279|20605555|P1|NOT COMPLETED|Overall Study||0
8358980|NCT01215279|20605554|P2|COMPLETED|Overall Study||32
8358981|NCT01215279|20605555|P1|COMPLETED|Overall Study||31
8358982|NCT01215279|20605554|P2|STARTED|Overall Study||32
8358983|NCT01215279|20605555|P1|STARTED|Overall Study||31
8358984|NCT01215253|20605621|P2|NOT COMPLETED|Overall Study||63
8358985|NCT01215253|20605622|P1|NOT COMPLETED|Overall Study||86
8358986|NCT01215253|20605621|P2|COMPLETED|Overall Study||439
8358987|NCT01215253|20605622|P1|COMPLETED|Overall Study||424
8358988|NCT01215253|20605621|P2|STARTED|Overall Study||502
8358989|NCT01215253|20605622|P1|STARTED|Overall Study||510
8358990|NCT01215240|20605652|P2|NOT COMPLETED|Overall Study||0
8358991|NCT01215240|20605653|P1|NOT COMPLETED|Overall Study||0
8358992|NCT01215240|20605652|P2|COMPLETED|Overall Study||12
8358993|NCT01215240|20605653|P1|COMPLETED|Overall Study||10
8358994|NCT01215240|20605652|P2|STARTED|Overall Study||12
8358995|NCT01215240|20605653|P1|STARTED|Overall Study||10
8358996|NCT01215227|20605675|P6|NOT COMPLETED|Overall Study||58
8358997|NCT01215227|20605676|P5|NOT COMPLETED|Overall Study||48
8358998|NCT01215227|20605677|P4|NOT COMPLETED|Overall Study||49
8358999|NCT01215227|20605678|P3|NOT COMPLETED|Overall Study||57
8359000|NCT01215227|20605679|P2|NOT COMPLETED|Overall Study||119
8359001|NCT01215227|20605680|P1|NOT COMPLETED|Overall Study||121
8359002|NCT01215227|20605675|P6|COMPLETED|Overall Study||51
8359003|NCT01215227|20605676|P5|COMPLETED|Overall Study||45
8359004|NCT01215227|20605677|P4|COMPLETED|Overall Study||48
8359005|NCT01215227|20605678|P3|COMPLETED|Overall Study||50
8359006|NCT01215227|20605679|P2|COMPLETED|Overall Study||96
8359007|NCT01215227|20605680|P1|COMPLETED|Overall Study||97
8359008|NCT01215227|20605675|P6|Treated|Overall Study||108
8359009|NCT01215227|20605676|P5|Treated|Overall Study||93
8359010|NCT01215227|20605677|P4|Treated|Overall Study||96
8359011|NCT01215227|20605678|P3|Treated|Overall Study||106
8359012|NCT01215227|20605679|P2|Treated|Overall Study||215
8359013|NCT01215227|20605680|P1|Treated|Overall Study||218
8359014|NCT01215227|20605675|P6|STARTED|Overall Study||109
8359015|NCT01215227|20605676|P5|STARTED|Overall Study||93
8359016|NCT01215227|20605677|P4|STARTED|Overall Study||97
8359017|NCT01215227|20605678|P3|STARTED|Overall Study||107
8359018|NCT01215227|20605679|P2|STARTED|Overall Study||215
8359019|NCT01215227|20605680|P1|STARTED|Overall Study||218
8359020|NCT01215188|20605727|P3|NOT COMPLETED|Overall Study||52
8359021|NCT01215188|20605728|P2|NOT COMPLETED|Overall Study||59
8359022|NCT01215188|20605729|P1|NOT COMPLETED|Overall Study||58
8359023|NCT01215188|20605727|P3|COMPLETED|Overall Study||326
8359024|NCT01215188|20605728|P2|COMPLETED|Overall Study||327
8359025|NCT01215188|20605729|P1|COMPLETED|Overall Study||320
8359026|NCT01215188|20605727|P3|STARTED|Overall Study||378
8359027|NCT01215188|20605728|P2|STARTED|Overall Study||386
8359028|NCT01215188|20605729|P1|STARTED|Overall Study||378
8359029|NCT01215175|20605781|P5|NOT COMPLETED|Overall Study||0
8359030|NCT01215175|20605782|P4|NOT COMPLETED|Overall Study||1
8359031|NCT01215175|20605783|P3|NOT COMPLETED|Overall Study||0
8359032|NCT01215175|20605784|P2|NOT COMPLETED|Overall Study||1
8359033|NCT01215175|20605785|P1|NOT COMPLETED|Overall Study||0
8359034|NCT01215175|20605781|P5|COMPLETED|Overall Study||28
8359035|NCT01215175|20605782|P4|COMPLETED|Overall Study||28
8359036|NCT01215175|20605783|P3|COMPLETED|Overall Study||33
8359037|NCT01215175|20605784|P2|COMPLETED|Overall Study||29
8359038|NCT01215175|20605785|P1|COMPLETED|Overall Study||30
8359039|NCT01215175|20605781|P5|Treated|Overall Study||28
8359040|NCT01215175|20605782|P4|Treated|Overall Study||29
8359041|NCT01215175|20605783|P3|Treated|Overall Study||33
8359042|NCT01215175|20605784|P2|Treated|Overall Study||30
8359043|NCT01215175|20605785|P1|Treated|Overall Study||30
8359044|NCT01215175|20605781|P5|STARTED|Overall Study||28
8359045|NCT01215175|20605782|P4|STARTED|Overall Study||29
8359046|NCT01215175|20605783|P3|STARTED|Overall Study||33
8359047|NCT01215175|20605784|P2|STARTED|Overall Study||30
8359048|NCT01215175|20605785|P1|STARTED|Overall Study||30
8359049|NCT01215123|20605827|P1|NOT COMPLETED|Overall Study||0
8359050|NCT01215123|20605827|P1|COMPLETED|Overall Study||28
8359051|NCT01215123|20605827|P1|STARTED|Overall Study||28
8359052|NCT01215110|20605837|P5|NOT COMPLETED|Overall Study||0
8359053|NCT01215110|20605838|P4|NOT COMPLETED|Overall Study||1
8359054|NCT01215110|20605839|P3|NOT COMPLETED|Overall Study||2
8359055|NCT01215110|20605840|P2|NOT COMPLETED|Overall Study||0
8359056|NCT01215110|20605841|P1|NOT COMPLETED|Overall Study||0
8359057|NCT01215110|20605837|P5|COMPLETED|Overall Study||8
8359058|NCT01215110|20605838|P4|COMPLETED|Overall Study||14
8359059|NCT01215110|20605839|P3|COMPLETED|Overall Study||13
8359060|NCT01215110|20605840|P2|COMPLETED|Overall Study||15
8359061|NCT01215110|20605841|P1|COMPLETED|Overall Study||15
8359062|NCT01215110|20605837|P5|STARTED|Overall Study||8
8359063|NCT01215110|20605838|P4|STARTED|Overall Study||15
8359064|NCT01215110|20605839|P3|STARTED|Overall Study||15
8359065|NCT01215110|20605840|P2|STARTED|Overall Study||15
8359066|NCT01215110|20605841|P1|STARTED|Overall Study||15
8359067|NCT01215097|20605902|P2|NOT COMPLETED|Overall Study||14
8359068|NCT01215097|20605903|P1|NOT COMPLETED|Overall Study||12
8359069|NCT01215097|20605902|P2|COMPLETED|Overall Study||191
8359070|NCT01215097|20605903|P1|COMPLETED|Overall Study||88
8359071|NCT01215097|20605902|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
8359072|NCT01215097|20605903|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
8359073|NCT01215032|20605935|P1|NOT COMPLETED|Overall Study||20
8359074|NCT01215032|20605935|P1|COMPLETED|Overall Study||1
8359075|NCT01215032|20605935|P1|STARTED|Overall Study||21
8359076|NCT01214980|20605945|P2|NOT COMPLETED|Overall Study||2
8359077|NCT01214980|20605946|P1|NOT COMPLETED|Overall Study||3
8359078|NCT01214980|20605945|P2|COMPLETED|Overall Study||14
8359079|NCT01214980|20605946|P1|COMPLETED|Overall Study||13
8359080|NCT01214980|20605945|P2|STARTED|Overall Study||16
8359081|NCT01214980|20605946|P1|STARTED|Overall Study||16
8359082|NCT01214915|20605960|P1|NOT COMPLETED|Overall Study||11
8359083|NCT01214915|20605960|P1|COMPLETED|Overall Study||42
8359084|NCT01214915|20605960|P1|STARTED|Overall Study||53
8359085|NCT01214850|20605971|P3|NOT COMPLETED|Overall Study||161
8359086|NCT01214850|20605972|P2|NOT COMPLETED|Overall Study||144
8359087|NCT01214850|20605973|P1|NOT COMPLETED|Overall Study||183
8359088|NCT01214850|20605971|P3|COMPLETED|Overall Study||826
8359089|NCT01214850|20605972|P2|COMPLETED|Overall Study||844
8359090|NCT01214850|20605973|P1|COMPLETED|Overall Study||796
8359091|NCT01214850|20605971|P3|STARTED|Overall Study||987
8359092|NCT01214850|20605972|P2|STARTED|Overall Study||988
8359093|NCT01214850|20605973|P1|STARTED|Overall Study||979
8359094|NCT01214837|20606057|P3|NOT COMPLETED|Overall Study||62
8359095|NCT01214837|20606058|P2|NOT COMPLETED|Overall Study||64
8359096|NCT01214837|20606059|P1|NOT COMPLETED|Overall Study||54
8359097|NCT01214837|20606057|P3|COMPLETED|Overall Study||184
8359098|NCT01214837|20606058|P2|COMPLETED|Overall Study||192
8359099|NCT01214837|20606059|P1|COMPLETED|Overall Study||195
8359100|NCT01214837|20606057|P3|STARTED|Overall Study||246
8359101|NCT01214837|20606058|P2|STARTED|Overall Study||256
8359102|NCT01214837|20606059|P1|STARTED|Overall Study||249
8359103|NCT01214824|20606096|P1|NOT COMPLETED|Overall Study||3
8359104|NCT01214824|20606096|P1|COMPLETED|Overall Study||29
8359105|NCT01214824|20606096|P1|STARTED|Overall Study||32
8359106|NCT01214811|20606103|P1|NOT COMPLETED|Overall Study||3
8359107|NCT01214811|20606103|P1|COMPLETED|Overall Study||24
8359108|NCT01214811|20606103|P1|STARTED|Overall Study||27
8359109|NCT01214759|20606107|P1|NOT COMPLETED|Overall Study||48
8359110|NCT01214759|20606107|P1|COMPLETED|Overall Study||55
8359111|NCT01214759|20606107|P1|28 Days nPEP Completion|Overall Study||85
8359112|NCT01214759|20606107|P1|STARTED|Overall Study||103
8359113|NCT01214720|20606115|P2|NOT COMPLETED|Overall Study||68
8359114|NCT01214720|20606116|P1|NOT COMPLETED|Overall Study||85
8359115|NCT01214720|20606115|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
8359116|NCT01214720|20606116|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
8359117|NCT01214720|20606115|P2|STARTED|Overall Study||301
8359118|NCT01214720|20606116|P1|STARTED|Overall Study||306
8359119|NCT01214668|20606139|P6|NOT COMPLETED|Overall Study||6
8359120|NCT01214668|20606140|P5|NOT COMPLETED|Overall Study||6
8359121|NCT01214668|20606141|P4|NOT COMPLETED|Overall Study||6
8359122|NCT01214668|20606142|P3|NOT COMPLETED|Overall Study||6
8359123|NCT01214668|20606143|P2|NOT COMPLETED|Overall Study||3
8359124|NCT01214668|20606144|P1|NOT COMPLETED|Overall Study||4
8359125|NCT01214668|20606139|P6|COMPLETED|Overall Study||0
8359126|NCT01214668|20606140|P5|COMPLETED|Overall Study||0
8359127|NCT01214668|20606141|P4|COMPLETED|Overall Study||0
8359128|NCT01214668|20606142|P3|COMPLETED|Overall Study||0
8359129|NCT01214668|20606143|P2|COMPLETED|Overall Study||0
8359130|NCT01214668|20606144|P1|COMPLETED|Overall Study||0
8359131|NCT01214668|20606139|P6|Received at Least One Dose of Study Drug|Overall Study||6
8359132|NCT01214668|20606140|P5|Received at Least One Dose of Study Drug|Overall Study||6
8359133|NCT01214668|20606141|P4|Received at Least One Dose of Study Drug|Overall Study||6
8359134|NCT01214668|20606142|P3|Received at Least One Dose of Study Drug|Overall Study||6
8359135|NCT01214668|20606143|P2|Received at Least One Dose of Study Drug|Overall Study||3
8359136|NCT01214668|20606144|P1|Received at Least One Dose of Study Drug|Overall Study||4
8359137|NCT01214668|20606139|P6|STARTED|Overall Study||6
8359138|NCT01214668|20606140|P5|STARTED|Overall Study||6
8359139|NCT01214668|20606141|P4|STARTED|Overall Study||6
8359140|NCT01214668|20606142|P3|STARTED|Overall Study||6
8359141|NCT01214668|20606143|P2|STARTED|Overall Study||3
8359142|NCT01214668|20606144|P1|STARTED|Overall Study||4
8359143|NCT01214655|20606181|P3|NOT COMPLETED|Part C||7
8359144|NCT01214655|20606182|P2|NOT COMPLETED|Part C||0
8359145|NCT01214655|20606183|P1|NOT COMPLETED|Part C||0
8359146|NCT01214655|20606181|P3|COMPLETED|Part C||1
8359147|NCT01214655|20606182|P2|COMPLETED|Part C||0
8359148|NCT01214655|20606183|P1|COMPLETED|Part C||0
8359149|NCT01214655|20606181|P3|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
8359150|NCT01214655|20606182|P2|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
8359151|NCT01214655|20606183|P1|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
8359152|NCT01214655|20606181|P3|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
8359153|NCT01214655|20606182|P2|STARTED|Part C||0
8359154|NCT01214655|20606183|P1|STARTED|Part C||0
8359155|NCT01214655|20606181|P3|NOT COMPLETED|Part B||0
8359156|NCT01214655|20606182|P2|NOT COMPLETED|Part B||13
8359157|NCT01214655|20606183|P1|NOT COMPLETED|Part B||0
8359158|NCT01214655|20606181|P3|COMPLETED|Part B||0
8359159|NCT01214655|20606182|P2|COMPLETED|Part B||2
8359160|NCT01214655|20606183|P1|COMPLETED|Part B||0
8359161|NCT01214655|20606181|P3|Joined 14 mg/m²/Day|Part B||0
8359162|NCT01214655|20606182|P2|Joined 14 mg/m²/Day|Part B||3
8359163|NCT01214655|20606183|P1|Joined 14 mg/m²/Day|Part B||0
8359164|NCT01214655|20606181|P3|Escalated From 12 to 14 mg/m²/Day|Part B||0
8359165|NCT01214655|20606182|P2|Escalated From 12 to 14 mg/m²/Day|Part B||1
8359166|NCT01214655|20606183|P1|Escalated From 12 to 14 mg/m²/Day|Part B||0
8359167|NCT01214655|20606181|P3|Joined 12 mg/m²/Day|Part B||0
8359168|NCT01214655|20606182|P2|Joined 12 mg/m²/Day|Part B||5
8359169|NCT01214655|20606183|P1|Joined 12 mg/m²/Day|Part B||0
8359170|NCT01214655|20606181|P3|Escalated to 12 mg/m²/Day|Part B||0
8359171|NCT01214655|20606182|P2|Escalated to 12 mg/m²/Day|Part B||2
8359172|NCT01214655|20606183|P1|Escalated to 12 mg/m²/Day|Part B||0
8359173|NCT01214655|20606181|P3|Joined 10 mg/m²/Day Study D|Part B||0
8359174|NCT01214655|20606182|P2|Joined 10 mg/m²/Day Study D|Part B||3
8359175|NCT01214655|20606183|P1|Joined 10 mg/m²/Day Study D|Part B||0
8359176|NCT01214655|20606181|P3|Escalated From 8 to 10 mg/m²/Day|Part B||0
8359177|NCT01214655|20606182|P2|Escalated From 8 to 10 mg/m²/Day|Part B||2
8359178|NCT01214655|20606183|P1|Escalated From 8 to 10 mg/m²/Day|Part B||0
8359179|NCT01214655|20606181|P3|Recieved 8 mg/m²/Day Study Drug|Part B||0
8359180|NCT01214655|20606182|P2|Recieved 8 mg/m²/Day Study Drug|Part B||4
8359181|NCT01214655|20606183|P1|Recieved 8 mg/m²/Day Study Drug|Part B||0
8359182|NCT01214655|20606181|P3|Received at Least 1 Dose of Study Drug|Part B||0
8359183|NCT01214655|20606182|P2|Received at Least 1 Dose of Study Drug|Part B||15
8359184|NCT01214655|20606183|P1|Received at Least 1 Dose of Study Drug|Part B||0
8359185|NCT01214655|20606181|P3|STARTED|Part B||0
8359186|NCT01214655|20606182|P2|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
8359187|NCT01214655|20606183|P1|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
8359188|NCT01214655|20606181|P3|NOT COMPLETED|Part A||0
8359189|NCT01214655|20606182|P2|NOT COMPLETED|Part A||0
8359190|NCT01214655|20606183|P1|NOT COMPLETED|Part A||8
8359191|NCT01214655|20606181|P3|COMPLETED|Part A||0
8359192|NCT01214655|20606182|P2|COMPLETED|Part A||0
8359193|NCT01214655|20606183|P1|COMPLETED|Part A||2
8359194|NCT01214655|20606181|P3|Received 6 mg Study Drug|Part A||0
8359195|NCT01214655|20606182|P2|Received 6 mg Study Drug|Part A||0
8359196|NCT01214655|20606183|P1|Received 6 mg Study Drug|Part A||5
8359197|NCT01214655|20606181|P3|Joined 6 mg Group|Part A||0
8359198|NCT01214655|20606182|P2|Joined 6 mg Group|Part A||0
8359199|NCT01214655|20606183|P1|Joined 6 mg Group|Part A||4
8359200|NCT01214655|20606181|P3|Escalated From 5 mg Study Drug|Part A||0
8359201|NCT01214655|20606182|P2|Escalated From 5 mg Study Drug|Part A||0
8359202|NCT01214655|20606183|P1|Escalated From 5 mg Study Drug|Part A||1
8359203|NCT01214655|20606181|P3|Joined 5 mg Study Drug|Part A||0
8359204|NCT01214655|20606182|P2|Joined 5 mg Study Drug|Part A||0
8359205|NCT01214655|20606183|P1|Joined 5 mg Study Drug|Part A||2
8359206|NCT01214655|20606181|P3|Escalated From 4 mg Study Drug|Part A||0
8359207|NCT01214655|20606182|P2|Escalated From 4 mg Study Drug|Part A||0
8359208|NCT01214655|20606183|P1|Escalated From 4 mg Study Drug|Part A||0
8359209|NCT01214655|20606181|P3|Joined 4 mg Group|Part A||0
8359210|NCT01214655|20606182|P2|Joined 4 mg Group|Part A||0
8359211|NCT01214655|20606183|P1|Joined 4 mg Group|Part A||1
8359212|NCT01214655|20606181|P3|Escalated From 2 to 4 mg/m²/Day|Part A||0
8359213|NCT01214655|20606182|P2|Escalated From 2 to 4 mg/m²/Day|Part A||0
8359214|NCT01214655|20606183|P1|Escalated From 2 to 4 mg/m²/Day|Part A||3
8359215|NCT01214655|20606181|P3|Received 2 mg Study Drug|Part A||0
8359216|NCT01214655|20606182|P2|Received 2 mg Study Drug|Part A||0
8359217|NCT01214655|20606183|P1|Received 2 mg Study Drug|Part A||3
8359218|NCT01214655|20606181|P3|STARTED|Part A||0
8359219|NCT01214655|20606182|P2|STARTED|Part A||0
8359220|NCT01214655|20606183|P1|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
8359221|NCT01214642|20606256|P12|NOT COMPLETED|Overall Study||6
8359222|NCT01214642|20606257|P11|NOT COMPLETED|Overall Study||4
8359223|NCT01214642|20606258|P10|NOT COMPLETED|Overall Study||4
8359224|NCT01214642|20606259|P9|NOT COMPLETED|Overall Study||13
8359225|NCT01214642|20606260|P8|NOT COMPLETED|Overall Study||3
8359226|NCT01214642|20606261|P7|NOT COMPLETED|Overall Study||6
8359227|NCT01214642|20606262|P6|NOT COMPLETED|Overall Study||3
8359228|NCT01214642|20606263|P5|NOT COMPLETED|Overall Study||6
8359229|NCT01214642|20606264|P4|NOT COMPLETED|Overall Study||6
8359230|NCT01214642|20606265|P3|NOT COMPLETED|Overall Study||6
8359231|NCT01214642|20606266|P2|NOT COMPLETED|Overall Study||3
8359232|NCT01214642|20606267|P1|NOT COMPLETED|Overall Study||3
8359233|NCT01214642|20606256|P12|COMPLETED|Overall Study||0
8359234|NCT01214642|20606257|P11|COMPLETED|Overall Study||0
8359235|NCT01214642|20606258|P10|COMPLETED|Overall Study||0
8359236|NCT01214642|20606259|P9|COMPLETED|Overall Study||0
8359237|NCT01214642|20606260|P8|COMPLETED|Overall Study||0
8359238|NCT01214642|20606261|P7|COMPLETED|Overall Study||0
8359239|NCT01214642|20606262|P6|COMPLETED|Overall Study||0
8359240|NCT01214642|20606263|P5|COMPLETED|Overall Study||0
8359241|NCT01214642|20606264|P4|COMPLETED|Overall Study||0
8359242|NCT01214642|20606265|P3|COMPLETED|Overall Study||0
8359243|NCT01214642|20606266|P2|COMPLETED|Overall Study||0
8359244|NCT01214642|20606267|P1|COMPLETED|Overall Study||0
8359245|NCT01214642|20606256|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
8359246|NCT01214642|20606257|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
8359247|NCT01214642|20606258|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
8359248|NCT01214642|20606259|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
8359249|NCT01214642|20606260|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
8359250|NCT01214642|20606261|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
8359251|NCT01214642|20606262|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
8359252|NCT01214642|20606263|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
8359253|NCT01214642|20606264|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
8359254|NCT01214642|20606265|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
8359255|NCT01214642|20606266|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
8359256|NCT01214642|20606267|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
8359257|NCT01214642|20606256|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
8359258|NCT01214642|20606257|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
8359259|NCT01214642|20606258|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
8359260|NCT01214642|20606259|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
8359261|NCT01214642|20606260|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8359262|NCT01214642|20606261|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8359263|NCT01214642|20606262|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8359264|NCT01214642|20606263|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8359265|NCT01214642|20606264|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8359266|NCT01214642|20606265|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8359267|NCT01214642|20606266|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8359268|NCT01214642|20606267|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8359269|NCT01214642|20606256|P12|STARTED|Overall Study||6
8359270|NCT01214642|20606257|P11|STARTED|Overall Study||4
8359271|NCT01214642|20606258|P10|STARTED|Overall Study||4
8359272|NCT01214642|20606259|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
8359273|NCT01214642|20606260|P8|STARTED|Overall Study||3
8359274|NCT01214642|20606261|P7|STARTED|Overall Study||6
8359275|NCT01214642|20606262|P6|STARTED|Overall Study||3
8359276|NCT01214642|20606263|P5|STARTED|Overall Study||6
8359277|NCT01214642|20606264|P4|STARTED|Overall Study||6
8359278|NCT01214642|20606265|P3|STARTED|Overall Study||6
8359279|NCT01214642|20606266|P2|STARTED|Overall Study||3
8359280|NCT01214642|20606267|P1|STARTED|Overall Study||3
8359281|NCT01214629|20606347|P11|NOT COMPLETED|Overall Study||2
8359282|NCT01214629|20606348|P10|NOT COMPLETED|Overall Study||7
8359283|NCT01214629|20606349|P9|NOT COMPLETED|Overall Study||1
8359284|NCT01214629|20606350|P8|NOT COMPLETED|Overall Study||1
8359285|NCT01214629|20606351|P7|NOT COMPLETED|Overall Study||1
8359286|NCT01214629|20606352|P6|NOT COMPLETED|Overall Study||4
8359287|NCT01214629|20606353|P5|NOT COMPLETED|Overall Study||2
8359288|NCT01214629|20606354|P4|NOT COMPLETED|Overall Study||2
8359289|NCT01214629|20606355|P3|NOT COMPLETED|Overall Study||0
8359290|NCT01214629|20606356|P2|NOT COMPLETED|Overall Study||1
8359291|NCT01214629|20606357|P1|NOT COMPLETED|Overall Study||1
8359292|NCT01214629|20606347|P11|COMPLETED|Overall Study||1
8359293|NCT01214629|20606348|P10|COMPLETED|Overall Study||11
8359294|NCT01214629|20606349|P9|COMPLETED|Overall Study||2
8359295|NCT01214629|20606350|P8|COMPLETED|Overall Study||2
8359296|NCT01214629|20606351|P7|COMPLETED|Overall Study||4
8359297|NCT01214629|20606352|P6|COMPLETED|Overall Study||9
8359298|NCT01214629|20606353|P5|COMPLETED|Overall Study||1
8359299|NCT01214629|20606354|P4|COMPLETED|Overall Study||1
8359300|NCT01214629|20606355|P3|COMPLETED|Overall Study||1
8359301|NCT01214629|20606356|P2|COMPLETED|Overall Study||0
8359302|NCT01214629|20606357|P1|COMPLETED|Overall Study||0
8359303|NCT01214629|20606347|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
8359304|NCT01214629|20606348|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
8359305|NCT01214629|20606349|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
8359306|NCT01214629|20606350|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8359307|NCT01214629|20606351|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
8359308|NCT01214629|20606352|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
8359309|NCT01214629|20606353|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8359310|NCT01214629|20606354|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8359311|NCT01214629|20606355|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
8359312|NCT01214629|20606356|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
8359313|NCT01214629|20606357|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
8359314|NCT01214629|20606347|P11|STARTED|Overall Study||3
8359315|NCT01214629|20606348|P10|STARTED|Overall Study||18
8359316|NCT01214629|20606349|P9|STARTED|Overall Study||3
8359317|NCT01214629|20606350|P8|STARTED|Overall Study||3
8359318|NCT01214629|20606351|P7|STARTED|Overall Study||5
8359319|NCT01214629|20606352|P6|STARTED|Overall Study||13
8359320|NCT01214629|20606353|P5|STARTED|Overall Study||3
8359321|NCT01214629|20606354|P4|STARTED|Overall Study||3
8359322|NCT01214629|20606355|P3|STARTED|Overall Study||1
8359323|NCT01214629|20606356|P2|STARTED|Overall Study||1
8359324|NCT01214629|20606357|P1|STARTED|Overall Study||1
8359325|NCT01214616|20606422|P4|NOT COMPLETED|Overall Study||6
8359326|NCT01214616|20606423|P3|NOT COMPLETED|Overall Study||3
8359327|NCT01214616|20606424|P2|NOT COMPLETED|Overall Study||5
8359328|NCT01214616|20606425|P1|NOT COMPLETED|Overall Study||3
8359329|NCT01214616|20606422|P4|COMPLETED|Overall Study||0
8359330|NCT01214616|20606423|P3|COMPLETED|Overall Study||0
8359331|NCT01214616|20606424|P2|COMPLETED|Overall Study||0
8359332|NCT01214616|20606425|P1|COMPLETED|Overall Study||0
8359333|NCT01214616|20606422|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
8359334|NCT01214616|20606423|P3|STARTED|Overall Study||3
8359335|NCT01214616|20606424|P2|STARTED|Overall Study||5
8359336|NCT01214616|20606425|P1|STARTED|Overall Study||3
8359337|NCT01214603|20606462|P3|NOT COMPLETED|Overall Study||4
8359338|NCT01214603|20606463|P2|NOT COMPLETED|Overall Study||1
8359339|NCT01214603|20606464|P1|NOT COMPLETED|Overall Study||5
8359340|NCT01214603|20606462|P3|COMPLETED|Overall Study||3
8359341|NCT01214603|20606463|P2|COMPLETED|Overall Study||5
8359342|NCT01214603|20606464|P1|COMPLETED|Overall Study||2
8359343|NCT01214603|20606462|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
8359344|NCT01214603|20606463|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
8359345|NCT01214603|20606464|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
8359346|NCT01214603|20606462|P3|STARTED|Overall Study||7
8359347|NCT01214603|20606463|P2|STARTED|Overall Study||6
8359348|NCT01214603|20606464|P1|STARTED|Overall Study||7
8359349|NCT01214434|20606487|P2|NOT COMPLETED|Overall Study||2
8359350|NCT01214434|20606488|P1|NOT COMPLETED|Overall Study||4
8359351|NCT01214434|20606487|P2|COMPLETED|Overall Study||25
8359352|NCT01214434|20606488|P1|COMPLETED|Overall Study||11
8359353|NCT01214434|20606487|P2|STARTED|Overall Study||27
8359354|NCT01214434|20606488|P1|STARTED|Overall Study||15
8359355|NCT01214395|20606504|P1|NOT COMPLETED|Overall Study||5
8359356|NCT01214395|20606504|P1|COMPLETED|Overall Study||0
8359357|NCT01214395|20606504|P1|STARTED|Overall Study||5
8359358|NCT01214356|20606511|P2|NOT COMPLETED|Overall Study||14
8359359|NCT01214356|20606512|P1|NOT COMPLETED|Overall Study||17
8359360|NCT01214356|20606511|P2|COMPLETED|Overall Study||13
8359361|NCT01214356|20606512|P1|COMPLETED|Overall Study||10
8359362|NCT01214356|20606511|P2|STARTED|Overall Study||27
8359363|NCT01214356|20606512|P1|STARTED|Overall Study||27
8359364|NCT01214330|20606518|P1|NOT COMPLETED|Overall Study||48
8359365|NCT01214330|20606518|P1|COMPLETED|Overall Study||102
8359366|NCT01214330|20606518|P1|STARTED|Overall Study||150
8359367|NCT01214317|20606524|P2|NOT COMPLETED|Overall Study||0
8359368|NCT01214317|20606525|P1|NOT COMPLETED|Overall Study||0
8359369|NCT01214317|20606524|P2|COMPLETED|Overall Study||22
8359370|NCT01214317|20606525|P1|COMPLETED|Overall Study||18
8359371|NCT01214317|20606524|P2|STARTED|Overall Study||22
8359372|NCT01214317|20606525|P1|STARTED|Overall Study||18
8359373|NCT01214252|20606533|P1|NOT COMPLETED|Overall Study||82
8359374|NCT01214252|20606533|P1|COMPLETED|Overall Study||343
8359375|NCT01214252|20606533|P1|STARTED|Overall Study||425
8359376|NCT01214239|20606541|P2|NOT COMPLETED|Overall Study||18
8359377|NCT01214239|20606542|P1|NOT COMPLETED|Overall Study||12
8359378|NCT01214239|20606541|P2|COMPLETED|Overall Study||182
8359379|NCT01214239|20606542|P1|COMPLETED|Overall Study||87
8359380|NCT01214239|20606541|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
8359381|NCT01214239|20606542|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
8359382|NCT01214200|20606574|P1|NOT COMPLETED|Overall Study||11
8359383|NCT01214200|20606574|P1|COMPLETED|Overall Study||9
8359384|NCT01214200|20606574|P1|STARTED|Overall Study||20
8359385|NCT01214187|20606588|P2|NOT COMPLETED|Overall Study||6
8359386|NCT01214187|20606589|P1|NOT COMPLETED|Overall Study||7
8359387|NCT01214187|20606588|P2|COMPLETED|Overall Study||23
8359388|NCT01214187|20606589|P1|COMPLETED|Overall Study||22
8359389|NCT01214187|20606588|P2|STARTED|Overall Study||29
8359390|NCT01214187|20606589|P1|STARTED|Overall Study||29
8359391|NCT01214174|20606606|P3|NOT COMPLETED|Overall Study||1
8359392|NCT01214174|20606607|P2|NOT COMPLETED|Overall Study||0
8359393|NCT01214174|20606608|P1|NOT COMPLETED|Overall Study||0
8359394|NCT01214174|20606606|P3|COMPLETED|Overall Study||13
8359395|NCT01214174|20606607|P2|COMPLETED|Overall Study||16
8359396|NCT01214174|20606608|P1|COMPLETED|Overall Study||13
8359397|NCT01214174|20606606|P3|STARTED|Overall Study||14
8359398|NCT01214174|20606607|P2|STARTED|Overall Study||16
8359399|NCT01214174|20606608|P1|STARTED|Overall Study||13
8359400|NCT01214161|20606618|P2|NOT COMPLETED|Overall Study||0
8359401|NCT01214161|20606619|P1|NOT COMPLETED|Overall Study||0
8359402|NCT01214161|20606618|P2|COMPLETED|Overall Study||100
8359403|NCT01214161|20606619|P1|COMPLETED|Overall Study||100
8359404|NCT01214161|20606618|P2|STARTED|Overall Study||100
8359405|NCT01214161|20606619|P1|STARTED|Overall Study||100
8359406|NCT01214109|20606629|P4|NOT COMPLETED|Overall Study||0
8359407|NCT01214109|20606630|P3|NOT COMPLETED|Overall Study||0
8359408|NCT01214109|20606631|P2|NOT COMPLETED|Overall Study||0
8359409|NCT01214109|20606632|P1|NOT COMPLETED|Overall Study||0
8359410|NCT01214109|20606629|P4|COMPLETED|Overall Study||24
8359411|NCT01214109|20606630|P3|COMPLETED|Overall Study||24
8359412|NCT01214109|20606631|P2|COMPLETED|Overall Study||24
8359413|NCT01214109|20606632|P1|COMPLETED|Overall Study||24
8359414|NCT01214109|20606629|P4|STARTED|Overall Study||24
8359415|NCT01214109|20606630|P3|STARTED|Overall Study||24
8359416|NCT01214109|20606631|P2|STARTED|Overall Study||24
8359417|NCT01214109|20606632|P1|STARTED|Overall Study||24
8359418|NCT01214083|20606724|P3|NOT COMPLETED|Overall Study||10
8359419|NCT01214083|20606725|P2|NOT COMPLETED|Overall Study||10
8359420|NCT01214083|20606726|P1|NOT COMPLETED|Overall Study||12
8359421|NCT01214083|20606724|P3|COMPLETED|Overall Study||21
8359422|NCT01214083|20606725|P2|COMPLETED|Overall Study||23
8359423|NCT01214083|20606726|P1|COMPLETED|Overall Study||19
8359424|NCT01214083|20606724|P3|STARTED|Overall Study||31
8359425|NCT01214083|20606725|P2|STARTED|Overall Study||33
8359426|NCT01214083|20606726|P1|STARTED|Overall Study||31
8359427|NCT01214044|20606758|P1|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
8359428|NCT01214044|20606758|P1|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
8359429|NCT01214044|20606758|P1|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
8359430|NCT01214044|20606758|P1|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
8359431|NCT01214044|20606758|P1|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
8359432|NCT01214044|20606758|P1|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
8359433|NCT01214044|20606758|P1|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
8359434|NCT01214044|20606758|P1|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
8359435|NCT01214044|20606758|P1|STARTED|Visit 2: End Washout & Start Placebo||19
8359436|NCT01214044|20606758|P1|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
8359437|NCT01214044|20606758|P1|COMPLETED|Visit 1: Screening and Consent, Washout||19
8359438|NCT01214044|20606758|P1|STARTED|Visit 1: Screening and Consent, Washout||31
8359439|NCT01213966|20606772|P4|NOT COMPLETED|Overall Study||1
8359440|NCT01213966|20606773|P3|NOT COMPLETED|Overall Study||3
8359441|NCT01213966|20606774|P2|NOT COMPLETED|Overall Study||0
8359442|NCT01213966|20606775|P1|NOT COMPLETED|Overall Study||1
8359443|NCT01213966|20606772|P4|COMPLETED|Overall Study||20
8359444|NCT01213966|20606773|P3|COMPLETED|Overall Study||17
8359445|NCT01213966|20606774|P2|COMPLETED|Overall Study||20
8359446|NCT01213966|20606775|P1|COMPLETED|Overall Study||19
8359447|NCT01213966|20606772|P4|STARTED|Overall Study||21
8359448|NCT01213966|20606773|P3|STARTED|Overall Study||20
8359449|NCT01213966|20606774|P2|STARTED|Overall Study||20
8359450|NCT01213966|20606775|P1|STARTED|Overall Study||20
8359451|NCT01213940|20606787|P2|NOT COMPLETED|Overall Study||0
8359452|NCT01213940|20606788|P1|NOT COMPLETED|Overall Study||0
8359453|NCT01213940|20606787|P2|COMPLETED|Overall Study||6
8359454|NCT01213940|20606788|P1|COMPLETED|Overall Study||14
8359455|NCT01213940|20606787|P2|STARTED|Overall Study||6
8359456|NCT01213940|20606788|P1|STARTED|Overall Study||14
8359457|NCT01213836|20606796|P2|NOT COMPLETED|Period 2, Second Intervention||0
8359458|NCT01213836|20606797|P1|NOT COMPLETED|Period 2, Second Intervention||0
8359459|NCT01213836|20606796|P2|COMPLETED|Period 2, Second Intervention||29
8359460|NCT01213836|20606797|P1|COMPLETED|Period 2, Second Intervention||31
8359461|NCT01213836|20606796|P2|STARTED|Period 2, Second Intervention||29
8359462|NCT01213836|20606797|P1|STARTED|Period 2, Second Intervention||31
8359463|NCT01213836|20606796|P2|NOT COMPLETED|Period 1, First Intervention||3
8359464|NCT01213836|20606797|P1|NOT COMPLETED|Period 1, First Intervention||3
8359465|NCT01213836|20606796|P2|COMPLETED|Period 1, First Intervention||29
8359466|NCT01213836|20606797|P1|COMPLETED|Period 1, First Intervention||31
8359467|NCT01213836|20606796|P2|STARTED|Period 1, First Intervention||32
8359468|NCT01213836|20606797|P1|STARTED|Period 1, First Intervention||34
8359469|NCT01213823|20606817|P2|NOT COMPLETED|Overall Study||0
8359470|NCT01213823|20606818|P1|NOT COMPLETED|Overall Study||0
8359471|NCT01213823|20606817|P2|COMPLETED|Overall Study||467
8359472|NCT01213823|20606818|P1|COMPLETED|Overall Study||69
8359473|NCT01213823|20606817|P2|STARTED|Overall Study||467
8359474|NCT01213823|20606818|P1|STARTED|Overall Study||69
8359475|NCT01213706|20606824|P1|NOT COMPLETED|WBPA||0
8359476|NCT01213706|20606824|P1|COMPLETED|WBPA||45
8359477|NCT01213706|20606824|P1|STARTED|WBPA||45
8359478|NCT01213706|20606824|P1|NOT COMPLETED|Washout (1 Hour)||0
8359479|NCT01213706|20606824|P1|COMPLETED|Washout (1 Hour)||45
8359480|NCT01213706|20606824|P1|STARTED|Washout (1 Hour)||45
8359481|NCT01213706|20606824|P1|NOT COMPLETED|Sham WBPA||0
8359482|NCT01213706|20606824|P1|COMPLETED|Sham WBPA||45
8359483|NCT01213706|20606824|P1|STARTED|Sham WBPA||45
8359484|NCT01213589|20606833|P3|NOT COMPLETED|Overall Study||8
8359485|NCT01213589|20606834|P2|NOT COMPLETED|Overall Study||5
8359486|NCT01213589|20606835|P1|NOT COMPLETED|Overall Study||13
8359487|NCT01213589|20606833|P3|COMPLETED|Overall Study||18
8359488|NCT01213589|20606834|P2|COMPLETED|Overall Study||19
8359489|NCT01213589|20606835|P1|COMPLETED|Overall Study||37
8359490|NCT01213589|20606833|P3|STARTED|Overall Study||26
8359491|NCT01213589|20606834|P2|STARTED|Overall Study||24
8359492|NCT01213589|20606835|P1|STARTED|Overall Study||50
8359493|NCT01213576|20606865|P4|NOT COMPLETED|Overall Study||4
8359494|NCT01213576|20606866|P3|NOT COMPLETED|Overall Study||5
8359495|NCT01213576|20606867|P2|NOT COMPLETED|Overall Study||4
8359496|NCT01213576|20606868|P1|NOT COMPLETED|Overall Study||3
8359497|NCT01213576|20606865|P4|COMPLETED|Overall Study||13
8359498|NCT01213576|20606866|P3|COMPLETED|Overall Study||13
8359499|NCT01213576|20606867|P2|COMPLETED|Overall Study||13
8359500|NCT01213576|20606868|P1|COMPLETED|Overall Study||15
8359501|NCT01213576|20606865|P4|STARTED|Overall Study||17
8359502|NCT01213576|20606866|P3|STARTED|Overall Study||18
8359503|NCT01213576|20606867|P2|STARTED|Overall Study||17
8359504|NCT01213576|20606868|P1|STARTED|Overall Study||18
8359505|NCT01213524|20606884|P1|NOT COMPLETED|Session 7||0
8359506|NCT01213524|20606884|P1|COMPLETED|Session 7||56
8359507|NCT01213524|20606884|P1|STARTED|Session 7||56
8359508|NCT01213524|20606884|P1|NOT COMPLETED|Session 6||0
8359509|NCT01213524|20606884|P1|COMPLETED|Session 6|Number who continued in the study to the next session|56
8359510|NCT01213524|20606884|P1|STARTED|Session 6||56
8359511|NCT01213524|20606884|P1|NOT COMPLETED|Session 5||0
8359512|NCT01213524|20606884|P1|COMPLETED|Session 5|Number who continued in the study to the next session|56
8359513|NCT01213524|20606884|P1|STARTED|Session 5||56
8359514|NCT01213524|20606884|P1|NOT COMPLETED|Session 4||3
8359515|NCT01213524|20606884|P1|COMPLETED|Session 4|Number who continued in the study to the next session|56
8359516|NCT01213524|20606884|P1|STARTED|Session 4||59
8359517|NCT01213524|20606884|P1|NOT COMPLETED|Session 3||4
8359518|NCT01213524|20606884|P1|COMPLETED|Session 3|Number who continued in study to next session|59
8359519|NCT01213524|20606884|P1|STARTED|Session 3||63
8359520|NCT01213524|20606884|P1|NOT COMPLETED|Session 2||5
8359521|NCT01213524|20606884|P1|COMPLETED|Session 2|Number who continued in the study to the next session|63
8359522|NCT01213524|20606884|P1|STARTED|Session 2||68
8359523|NCT01213524|20606884|P1|NOT COMPLETED|Baseline||7
8359524|NCT01213524|20606884|P1|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
8359610|NCT01213043|20607047|P2|COMPLETED|Treatment Period 1||15
8359525|NCT01213524|20606884|P1|STARTED|Baseline|Total number who signed informed consent.|75
8359526|NCT01213472|20606898|P1|NOT COMPLETED|Overall Study||27
8359527|NCT01213472|20606898|P1|COMPLETED|Overall Study||6
8359528|NCT01213472|20606898|P1|STARTED|Overall Study||33
8359529|NCT01213329|20606921|P2|NOT COMPLETED|Phase 2||0
8359530|NCT01213329|20606922|P1|NOT COMPLETED|Phase 2||0
8359531|NCT01213329|20606921|P2|COMPLETED|Phase 2||0
8359532|NCT01213329|20606922|P1|COMPLETED|Phase 2||0
8359533|NCT01213329|20606921|P2|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
8359534|NCT01213329|20606922|P1|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
8359535|NCT01213329|20606921|P2|NOT COMPLETED|Screening||0
8359536|NCT01213329|20606922|P1|NOT COMPLETED|Screening||0
8359537|NCT01213329|20606921|P2|COMPLETED|Screening||25
8359538|NCT01213329|20606922|P1|COMPLETED|Screening||25
8359539|NCT01213329|20606921|P2|STARTED|Screening||25
8359540|NCT01213329|20606922|P1|STARTED|Screening||25
8359541|NCT01213316|20606928|P1|NOT COMPLETED|Overall Study||0
8359542|NCT01213316|20606928|P1|COMPLETED|Overall Study||451
8359543|NCT01213316|20606928|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
8359544|NCT01213316|20606928|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
8359545|NCT01213316|20606928|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
8359546|NCT01213316|20606928|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
8359547|NCT01213316|20606928|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
8359548|NCT01213264|20606947|P3|NOT COMPLETED|Overall Study||6
8359549|NCT01213264|20606948|P2|NOT COMPLETED|Overall Study||2
8359550|NCT01213264|20606949|P1|NOT COMPLETED|Overall Study||2
8359551|NCT01213264|20606947|P3|COMPLETED|Overall Study||321
8359552|NCT01213264|20606948|P2|COMPLETED|Overall Study||175
8359553|NCT01213264|20606949|P1|COMPLETED|Overall Study||153
8359554|NCT01213264|20606947|P3|STARTED|Overall Study||327
8359555|NCT01213264|20606948|P2|STARTED|Overall Study||177
8359556|NCT01213264|20606949|P1|STARTED|Overall Study||155
8359557|NCT01213251|20606969|P3|NOT COMPLETED|Overall Study||11
8359558|NCT01213251|20606970|P2|NOT COMPLETED|Overall Study||4
8359559|NCT01213251|20606971|P1|NOT COMPLETED|Overall Study||6
8359560|NCT01213251|20606969|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
8359561|NCT01213251|20606970|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
8359562|NCT01213251|20606971|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
8359563|NCT01213251|20606969|P3|STARTED|Overall Study||45
8359564|NCT01213251|20606970|P2|STARTED|Overall Study||41
8359565|NCT01213251|20606971|P1|STARTED|Overall Study||40
8359569|NCT01213173|20606998|P2|NOT COMPLETED|Overall Study||16
8359570|NCT01213173|20606999|P1|NOT COMPLETED|Overall Study||12
8359571|NCT01213173|20606998|P2|COMPLETED|Overall Study|Patients who completed the study|110
8359572|NCT01213173|20606999|P1|COMPLETED|Overall Study|Patients who completed the study|113
8359573|NCT01213173|20606998|P2|Patients Included in PP Population|Overall Study||89
8359574|NCT01213173|20606999|P1|Patients Included in PP Population|Overall Study||102
8359575|NCT01213173|20606998|P2|Patients Included in ITT Population|Overall Study||115
8359576|NCT01213173|20606999|P1|Patients Included in ITT Population|Overall Study||116
8359577|NCT01213173|20606998|P2|Patients Included in Safety Population|Overall Study||112
8359578|NCT01213173|20606999|P1|Patients Included in Safety Population|Overall Study||139
8359579|NCT01213173|20606998|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
8359580|NCT01213173|20606999|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
8359581|NCT01213082|20607032|P3|NOT COMPLETED|Overall Study||5
8359582|NCT01213082|20607033|P2|NOT COMPLETED|Overall Study||7
8359583|NCT01213082|20607034|P1|NOT COMPLETED|Overall Study||6
8359584|NCT01213082|20607032|P3|COMPLETED|Overall Study||6
8359585|NCT01213082|20607033|P2|COMPLETED|Overall Study||4
8359586|NCT01213082|20607034|P1|COMPLETED|Overall Study||6
8359587|NCT01213082|20607032|P3|STARTED|Overall Study||11
8359588|NCT01213082|20607033|P2|STARTED|Overall Study||11
8359589|NCT01213082|20607034|P1|STARTED|Overall Study||12
8359590|NCT01213043|20607047|P2|NOT COMPLETED|Follow-up||0
8359591|NCT01213043|20607048|P1|NOT COMPLETED|Follow-up||0
8359592|NCT01213043|20607047|P2|COMPLETED|Follow-up||15
8359593|NCT01213043|20607048|P1|COMPLETED|Follow-up||15
8359594|NCT01213043|20607047|P2|STARTED|Follow-up||15
8359595|NCT01213043|20607048|P1|STARTED|Follow-up||15
8359596|NCT01213043|20607047|P2|NOT COMPLETED|Treatment Period 2||0
8359597|NCT01213043|20607048|P1|NOT COMPLETED|Treatment Period 2||0
8359598|NCT01213043|20607047|P2|COMPLETED|Treatment Period 2||15
8359599|NCT01213043|20607048|P1|COMPLETED|Treatment Period 2||15
8359600|NCT01213043|20607047|P2|STARTED|Treatment Period 2||15
8359601|NCT01213043|20607048|P1|STARTED|Treatment Period 2||15
8359602|NCT01213043|20607047|P2|NOT COMPLETED|Washout Period||0
8359603|NCT01213043|20607048|P1|NOT COMPLETED|Washout Period||0
8359604|NCT01213043|20607047|P2|COMPLETED|Washout Period||15
8359605|NCT01213043|20607048|P1|COMPLETED|Washout Period||15
8359606|NCT01213043|20607047|P2|STARTED|Washout Period||15
8359607|NCT01213043|20607048|P1|STARTED|Washout Period||15
8359608|NCT01213043|20607047|P2|NOT COMPLETED|Treatment Period 1||0
8359609|NCT01213043|20607048|P1|NOT COMPLETED|Treatment Period 1||0
8359611|NCT01213043|20607048|P1|COMPLETED|Treatment Period 1||15
8359612|NCT01213043|20607047|P2|STARTED|Treatment Period 1||15
8359613|NCT01213043|20607048|P1|STARTED|Treatment Period 1||15
8359614|NCT01212991|20607076|P3|NOT COMPLETED|Open-label||234
8359615|NCT01212991|20607077|P2|NOT COMPLETED|Open-label||0
8359616|NCT01212991|20607078|P1|NOT COMPLETED|Open-label||0
8359617|NCT01212991|20607076|P3|COMPLETED|Open-label||0
8359618|NCT01212991|20607077|P2|COMPLETED|Open-label||0
8359619|NCT01212991|20607078|P1|COMPLETED|Open-label||0
8359620|NCT01212991|20607076|P3|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
8359621|NCT01212991|20607077|P2|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
8359622|NCT01212991|20607078|P1|STARTED|Open-label||0
8359623|NCT01212991|20607076|P3|NOT COMPLETED|Double-blind||0
8359624|NCT01212991|20607077|P2|NOT COMPLETED|Double-blind||611
8359625|NCT01212991|20607078|P1|NOT COMPLETED|Double-blind||872
8359626|NCT01212991|20607076|P3|COMPLETED|Double-blind||0
8359627|NCT01212991|20607077|P2|COMPLETED|Double-blind||234
8359628|NCT01212991|20607078|P1|COMPLETED|Double-blind||0
8359629|NCT01212991|20607076|P3|Safety Population|Double-blind||0
8359630|NCT01212991|20607077|P2|Safety Population|Double-blind||844
8359631|NCT01212991|20607078|P1|Safety Population|Double-blind||871
8359632|NCT01212991|20607076|P3|STARTED|Double-blind||0
8359633|NCT01212991|20607077|P2|STARTED|Double-blind||845
8359634|NCT01212991|20607078|P1|STARTED|Double-blind||872
8359635|NCT01212952|20607109|P3|NOT COMPLETED|Overall Study||0
8359636|NCT01212952|20607110|P2|NOT COMPLETED|Overall Study||0
8359637|NCT01212952|20607111|P1|NOT COMPLETED|Overall Study||0
8359638|NCT01212952|20607109|P3|COMPLETED|Overall Study||41
8359639|NCT01212952|20607110|P2|COMPLETED|Overall Study||6
8359640|NCT01212952|20607111|P1|COMPLETED|Overall Study||3
8359641|NCT01212952|20607109|P3|STARTED|Overall Study||41
8359642|NCT01212952|20607110|P2|STARTED|Overall Study||6
8359643|NCT01212952|20607111|P1|STARTED|Overall Study||3
8359644|NCT01212900|20607129|P2|NOT COMPLETED|Overall Study||7
8359645|NCT01212900|20607130|P1|NOT COMPLETED|Overall Study||12
8359646|NCT01212900|20607129|P2|COMPLETED|Overall Study||107
8359647|NCT01212900|20607130|P1|COMPLETED|Overall Study||104
8359648|NCT01212900|20607129|P2|STARTED|Overall Study||114
8359649|NCT01212900|20607130|P1|STARTED|Overall Study||116
8359650|NCT01212874|20607138|P2|NOT COMPLETED|Overall Study||23
8359651|NCT01212874|20607139|P1|NOT COMPLETED|Overall Study||22
8359652|NCT01212874|20607138|P2|COMPLETED|Overall Study||12
8359653|NCT01212874|20607139|P1|COMPLETED|Overall Study||13
8359654|NCT01212874|20607138|P2|Received Allocated Intervention|Overall Study||12
8359655|NCT01212874|20607139|P1|Received Allocated Intervention|Overall Study||13
8359656|NCT01212874|20607138|P2|STARTED|Overall Study||35
8359657|NCT01212874|20607139|P1|STARTED|Overall Study||35
8359658|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
8359659|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
8359660|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359661|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359662|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359663|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359664|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
8359665|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
8359666|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359667|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
8359668|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
8359669|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
8359670|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
8359671|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
8359672|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
8359673|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
8359674|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
8359675|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
8359676|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 5)||42
8359677|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 5)||32
8359678|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 5)||0
8359679|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 5)||0
8359680|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 5)||0
8359681|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 5)||0
8359682|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 5)||83
8359683|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
8359684|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 5)||0
8359685|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
8359686|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
8359687|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359688|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359689|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359690|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359691|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
8359692|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
8359693|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359694|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
8359695|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
8359696|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
8359697|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
8359698|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
8359699|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
8359700|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
8359701|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
8359702|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
8359703|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 4)||44
8359704|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 4)||35
8359705|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 4)||0
8359706|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 4)||0
8359707|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 4)||0
8359708|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 4)||0
8359709|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 4)||94
8359710|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
8359711|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 4)||0
8359712|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
8359713|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
8359714|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359715|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359716|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359717|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359718|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8359719|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8359720|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359721|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
8359722|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
8359723|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
8359724|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
8359725|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
8359726|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
8359727|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
8359728|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
8359729|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
8359730|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
8359731|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
8359732|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 3)||0
8359733|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 3)||0
8359734|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 3)||0
8359735|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 3)||0
8359736|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
8359737|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
8359738|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 3)||0
8359739|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
8359740|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
8359741|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359742|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359743|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359744|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359745|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
8359746|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
8359747|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359748|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
8359749|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
8359750|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
8359751|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
8359752|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
8359753|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
8359754|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
8359755|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
8359756|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
8359757|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
8359758|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
8359759|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 2)||0
8359760|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 2)||0
8359761|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 2)||0
8359762|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 2)||0
8359763|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
8359764|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
8359765|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 2)||0
8359766|NCT01212770|20607150|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359767|NCT01212770|20607151|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359768|NCT01212770|20607152|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
8359769|NCT01212770|20607153|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
8359770|NCT01212770|20607154|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
8359771|NCT01212770|20607155|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
8359772|NCT01212770|20607156|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
8359773|NCT01212770|20607157|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
8359774|NCT01212770|20607158|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359775|NCT01212770|20607150|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359776|NCT01212770|20607151|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359777|NCT01212770|20607152|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
8359778|NCT01212770|20607153|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
8359779|NCT01212770|20607154|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
8359780|NCT01212770|20607155|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
8359781|NCT01212770|20607156|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
8359782|NCT01212770|20607157|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
8359783|NCT01212770|20607158|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359784|NCT01212770|20607150|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8359785|NCT01212770|20607151|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8359786|NCT01212770|20607152|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
8359787|NCT01212770|20607153|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
8359788|NCT01212770|20607154|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
8359789|NCT01212770|20607155|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
8359790|NCT01212770|20607156|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
8359791|NCT01212770|20607157|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
8359792|NCT01212770|20607158|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8359793|NCT01212770|20607150|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359794|NCT01212770|20607151|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359795|NCT01212770|20607152|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359796|NCT01212770|20607153|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359797|NCT01212770|20607154|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359798|NCT01212770|20607155|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359799|NCT01212770|20607156|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8359800|NCT01212770|20607157|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8359801|NCT01212770|20607158|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
8359802|NCT01212770|20607150|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359803|NCT01212770|20607151|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359804|NCT01212770|20607152|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359805|NCT01212770|20607153|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359806|NCT01212770|20607154|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359807|NCT01212770|20607155|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359808|NCT01212770|20607156|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
8359809|NCT01212770|20607157|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
8359810|NCT01212770|20607158|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
8359811|NCT01212770|20607150|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359812|NCT01212770|20607151|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359813|NCT01212770|20607152|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359814|NCT01212770|20607153|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359815|NCT01212770|20607154|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359816|NCT01212770|20607155|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359817|NCT01212770|20607156|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
8359818|NCT01212770|20607157|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
8359819|NCT01212770|20607158|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
8359820|NCT01212770|20607150|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359821|NCT01212770|20607151|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359822|NCT01212770|20607152|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359823|NCT01212770|20607153|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359824|NCT01212770|20607154|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359825|NCT01212770|20607155|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359826|NCT01212770|20607156|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
8359827|NCT01212770|20607157|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
8359828|NCT01212770|20607158|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
8359829|NCT01212770|20607150|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359830|NCT01212770|20607151|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359831|NCT01212770|20607152|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359832|NCT01212770|20607153|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359833|NCT01212770|20607154|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359834|NCT01212770|20607155|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359835|NCT01212770|20607156|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
8359836|NCT01212770|20607157|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
8359837|NCT01212770|20607158|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
8359838|NCT01212770|20607150|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359839|NCT01212770|20607151|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359840|NCT01212770|20607152|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359841|NCT01212770|20607153|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359842|NCT01212770|20607154|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359843|NCT01212770|20607155|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359844|NCT01212770|20607156|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
8359845|NCT01212770|20607157|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
8359846|NCT01212770|20607158|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
8359847|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
8359848|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
8359849|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359850|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359851|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359852|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359853|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
8359854|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
8359855|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359856|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
8359857|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
8359858|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359859|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359860|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359861|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359862|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
8359863|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
8359864|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359865|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 5)||39
8359866|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
8359867|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 5)||0
8359868|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 5)||0
8359869|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 5)||0
8359870|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 5)||0
8359871|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 5)||77
8359872|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 5)||80
8359873|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 5)||0
8359874|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
8359875|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
8359876|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359877|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359878|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359879|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359880|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
8359881|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
8359882|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359883|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
8359884|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
8359885|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359886|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359887|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359888|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359889|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
8359890|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
8359891|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359892|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 4)||46
8359893|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
8359894|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 4)||0
8359895|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 4)||0
8359896|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 4)||0
8359897|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 4)||0
8359898|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 4)||84
8359899|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 4)||89
8359900|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 4)||0
8359901|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
8359902|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
8359903|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359904|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359905|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359906|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359907|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
8359908|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
8359909|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359910|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
8359911|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
8359912|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359913|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359914|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359915|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359916|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
8359917|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
8359918|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359919|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 3)||51
8359920|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 3)||48
8359921|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 3)||0
8359922|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 3)||0
8359923|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 3)||0
8359924|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 3)||0
8359925|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 3)||95
8359926|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 3)||107
8359927|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 3)||0
8359928|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
8359929|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
8359930|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359931|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359932|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359933|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359934|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
8359935|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
8359936|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359937|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
8359938|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
8359939|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359940|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359941|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359942|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359943|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
8359944|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
8359945|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359946|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
8359947|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
8359948|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 2)||0
8359949|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 2)||0
8359950|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 2)||0
8359951|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 2)||0
8359952|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
8359953|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
8359954|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 2)||0
8359955|NCT01212757|20607355|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359956|NCT01212757|20607356|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359957|NCT01212757|20607357|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359958|NCT01212757|20607358|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
8359959|NCT01212757|20607359|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
8359960|NCT01212757|20607360|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
8359961|NCT01212757|20607361|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
8359962|NCT01212757|20607362|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
8359963|NCT01212757|20607363|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359964|NCT01212757|20607355|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359965|NCT01212757|20607356|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359966|NCT01212757|20607357|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
8359967|NCT01212757|20607358|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
8359968|NCT01212757|20607359|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
8359969|NCT01212757|20607360|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
8359970|NCT01212757|20607361|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
8359971|NCT01212757|20607362|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
8359972|NCT01212757|20607363|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359973|NCT01212757|20607355|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8359974|NCT01212757|20607356|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8359975|NCT01212757|20607357|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
8359976|NCT01212757|20607358|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
8359977|NCT01212757|20607359|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
8359978|NCT01212757|20607360|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
8359979|NCT01212757|20607361|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
8359980|NCT01212757|20607362|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
8359981|NCT01212757|20607363|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8359982|NCT01212757|20607355|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359983|NCT01212757|20607356|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359984|NCT01212757|20607357|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359985|NCT01212757|20607358|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359986|NCT01212757|20607359|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359987|NCT01212757|20607360|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359988|NCT01212757|20607361|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
8359989|NCT01212757|20607362|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
8359990|NCT01212757|20607363|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
8359991|NCT01212757|20607355|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359992|NCT01212757|20607356|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359993|NCT01212757|20607357|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359994|NCT01212757|20607358|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359995|NCT01212757|20607359|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359996|NCT01212757|20607360|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359997|NCT01212757|20607361|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
8359998|NCT01212757|20607362|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
8359999|NCT01212757|20607363|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
8360000|NCT01212757|20607355|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360001|NCT01212757|20607356|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360002|NCT01212757|20607357|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360003|NCT01212757|20607358|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360004|NCT01212757|20607359|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360005|NCT01212757|20607360|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360006|NCT01212757|20607361|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
8360007|NCT01212757|20607362|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
8360008|NCT01212757|20607363|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
8360009|NCT01212757|20607355|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360010|NCT01212757|20607356|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360011|NCT01212757|20607357|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360012|NCT01212757|20607358|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360013|NCT01212757|20607359|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360014|NCT01212757|20607360|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360015|NCT01212757|20607361|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
8360016|NCT01212757|20607362|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
8360017|NCT01212757|20607363|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
8360018|NCT01212757|20607355|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360019|NCT01212757|20607356|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360020|NCT01212757|20607357|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360021|NCT01212757|20607358|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360022|NCT01212757|20607359|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360023|NCT01212757|20607360|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360024|NCT01212757|20607361|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
8360025|NCT01212757|20607362|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
8360026|NCT01212757|20607363|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
8360027|NCT01212757|20607355|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360028|NCT01212757|20607356|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360029|NCT01212757|20607357|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360030|NCT01212757|20607358|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360031|NCT01212757|20607359|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360032|NCT01212757|20607360|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360033|NCT01212757|20607361|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
8360034|NCT01212757|20607362|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
8360035|NCT01212757|20607363|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
8360036|NCT01212744|20607547|P1|NOT COMPLETED|Overall Study||1
8360037|NCT01212744|20607547|P1|COMPLETED|Overall Study||15
8360038|NCT01212744|20607547|P1|STARTED|Overall Study||16
8360042|NCT01212588|20607566|P2|NOT COMPLETED|Overall Study||2
8360043|NCT01212588|20607567|P1|NOT COMPLETED|Overall Study||1
8360044|NCT01212588|20607566|P2|COMPLETED|Overall Study||10
8360045|NCT01212588|20607567|P1|COMPLETED|Overall Study||9
8360046|NCT01212588|20607566|P2|STARTED|Overall Study||12
8360047|NCT01212588|20607567|P1|STARTED|Overall Study||10
8360048|NCT01212484|20607601|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8360049|NCT01212484|20607602|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8360050|NCT01212484|20607601|P2|COMPLETED|Second Intervention (4 Weeks)||3
8360051|NCT01212484|20607602|P1|COMPLETED|Second Intervention (4 Weeks)||5
8360052|NCT01212484|20607601|P2|STARTED|Second Intervention (4 Weeks)||4
8360053|NCT01212484|20607602|P1|STARTED|Second Intervention (4 Weeks)||5
8360054|NCT01212484|20607601|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
8360055|NCT01212484|20607602|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8360056|NCT01212484|20607601|P2|COMPLETED|First Intervention (4 Weeks)||4
8360057|NCT01212484|20607602|P1|COMPLETED|First Intervention (4 Weeks)||5
8360058|NCT01212484|20607601|P2|STARTED|First Intervention (4 Weeks)||6
8360059|NCT01212484|20607602|P1|STARTED|First Intervention (4 Weeks)||5
8360060|NCT01212484|20607601|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
8360061|NCT01212484|20607602|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
8360062|NCT01212484|20607601|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
8360063|NCT01212484|20607602|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
8360064|NCT01212484|20607601|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
8360065|NCT01212484|20607602|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
8360066|NCT01212471|20607615|P3|NOT COMPLETED|Overall Study||7
8360067|NCT01212471|20607616|P2|NOT COMPLETED|Overall Study||3
8360068|NCT01212471|20607617|P1|NOT COMPLETED|Overall Study||2
8360069|NCT01212471|20607615|P3|COMPLETED|Overall Study||132
8360070|NCT01212471|20607616|P2|COMPLETED|Overall Study||137
8360071|NCT01212471|20607617|P1|COMPLETED|Overall Study||139
8360072|NCT01212471|20607615|P3|STARTED|Overall Study||139
8360073|NCT01212471|20607616|P2|STARTED|Overall Study||140
8360074|NCT01212471|20607617|P1|STARTED|Overall Study||141
8360075|NCT01212445|20607628|P3|NOT COMPLETED|Overall Study||0
8360076|NCT01212445|20607629|P2|NOT COMPLETED|Overall Study||0
8360077|NCT01212445|20607630|P1|NOT COMPLETED|Overall Study||0
8360078|NCT01212445|20607628|P3|COMPLETED|Overall Study||51
8360079|NCT01212445|20607629|P2|COMPLETED|Overall Study||51
8360080|NCT01212445|20607630|P1|COMPLETED|Overall Study||52
8360081|NCT01212445|20607628|P3|STARTED|Overall Study||51
8360082|NCT01212445|20607629|P2|STARTED|Overall Study||51
8360083|NCT01212445|20607630|P1|STARTED|Overall Study||52
8360084|NCT01212302|20607659|P1|NOT COMPLETED|Overall Study||0
8360085|NCT01212302|20607659|P1|COMPLETED|Overall Study||504
8360086|NCT01212302|20607659|P1|STARTED|Overall Study||504
8360087|NCT01212185|20607665|P2|NOT COMPLETED|Overall Study||1
8360088|NCT01212185|20607666|P1|NOT COMPLETED|Overall Study||2
8360089|NCT01212185|20607665|P2|COMPLETED|Overall Study||7
8360090|NCT01212185|20607666|P1|COMPLETED|Overall Study||4
8360091|NCT01212185|20607665|P2|STARTED|Overall Study||8
8360092|NCT01212185|20607666|P1|STARTED|Overall Study||6
8360093|NCT01212172|20607674|P2|NOT COMPLETED|Overall Study||1
8360094|NCT01212172|20607675|P1|NOT COMPLETED|Overall Study||1
8360095|NCT01212172|20607674|P2|COMPLETED|Overall Study||9
8360096|NCT01212172|20607675|P1|COMPLETED|Overall Study||9
8360097|NCT01212172|20607674|P2|STARTED|Overall Study||10
8360098|NCT01212172|20607675|P1|STARTED|Overall Study||10
8360099|NCT01212159|20607685|P2|NOT COMPLETED|Overall Study||12
8360100|NCT01212159|20607686|P1|NOT COMPLETED|Overall Study||12
8360101|NCT01212159|20607685|P2|COMPLETED|Overall Study||32
8360102|NCT01212159|20607686|P1|COMPLETED|Overall Study||14
8360103|NCT01212159|20607685|P2|STARTED|Overall Study||44
8360104|NCT01212159|20607686|P1|STARTED|Overall Study||26
8360105|NCT01212107|20607708|P12|NOT COMPLETED|Overall Study||32
8360106|NCT01212107|20607709|P11|NOT COMPLETED|Overall Study||1
8360107|NCT01212107|20607710|P10|NOT COMPLETED|Overall Study||2
8360108|NCT01212107|20607711|P9|NOT COMPLETED|Overall Study||2
8360109|NCT01212107|20607712|P8|NOT COMPLETED|Overall Study||1
8360110|NCT01212107|20607713|P7|NOT COMPLETED|Overall Study||0
8360111|NCT01212107|20607714|P6|NOT COMPLETED|Overall Study||1
8360112|NCT01212107|20607715|P5|NOT COMPLETED|Overall Study||1
8360113|NCT01212107|20607716|P4|NOT COMPLETED|Overall Study||0
8360114|NCT01212107|20607717|P3|NOT COMPLETED|Overall Study||3
8360115|NCT01212107|20607718|P2|NOT COMPLETED|Overall Study||1
8360116|NCT01212107|20607719|P1|NOT COMPLETED|Overall Study||1
8360117|NCT01212107|20607708|P12|COMPLETED|Overall Study||26
8360118|NCT01212107|20607709|P11|COMPLETED|Overall Study||2
8360119|NCT01212107|20607710|P10|COMPLETED|Overall Study||1
8360120|NCT01212107|20607711|P9|COMPLETED|Overall Study||1
8360121|NCT01212107|20607712|P8|COMPLETED|Overall Study||2
8360122|NCT01212107|20607713|P7|COMPLETED|Overall Study||3
8360123|NCT01212107|20607714|P6|COMPLETED|Overall Study||2
8360124|NCT01212107|20607715|P5|COMPLETED|Overall Study||2
8360125|NCT01212107|20607716|P4|COMPLETED|Overall Study||3
8360126|NCT01212107|20607717|P3|COMPLETED|Overall Study||3
8360127|NCT01212107|20607718|P2|COMPLETED|Overall Study||2
8360128|NCT01212107|20607719|P1|COMPLETED|Overall Study||2
8360129|NCT01212107|20607708|P12|STARTED|Overall Study||58
8360130|NCT01212107|20607709|P11|STARTED|Overall Study||3
8360131|NCT01212107|20607710|P10|STARTED|Overall Study||3
8360132|NCT01212107|20607711|P9|STARTED|Overall Study||3
8360133|NCT01212107|20607712|P8|STARTED|Overall Study||3
8360134|NCT01212107|20607713|P7|STARTED|Overall Study||3
8360135|NCT01212107|20607714|P6|STARTED|Overall Study||3
8360136|NCT01212107|20607715|P5|STARTED|Overall Study||3
8360137|NCT01212107|20607716|P4|STARTED|Overall Study||3
8360138|NCT01212107|20607717|P3|STARTED|Overall Study||6
8360139|NCT01212107|20607718|P2|STARTED|Overall Study||3
8360140|NCT01212107|20607719|P1|STARTED|Overall Study||3
8360141|NCT01212094|20607785|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
8360142|NCT01212094|20607786|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
8360143|NCT01212094|20607787|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
8360144|NCT01212094|20607785|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
8360145|NCT01212094|20607786|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
8360146|NCT01212094|20607787|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
8360147|NCT01212094|20607785|P3|STARTED|Years 2 & 3: Treatment Randomization||18
8360148|NCT01212094|20607786|P2|STARTED|Years 2 & 3: Treatment Randomization||9
8360149|NCT01212094|20607787|P1|STARTED|Years 2 & 3: Treatment Randomization||0
8360150|NCT01212094|20607785|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
8360151|NCT01212094|20607786|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
8360152|NCT01212094|20607787|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
8360153|NCT01212094|20607785|P3|COMPLETED|Year 1: Baseline Monitoring||0
8360154|NCT01212094|20607786|P2|COMPLETED|Year 1: Baseline Monitoring||0
8360155|NCT01212094|20607787|P1|COMPLETED|Year 1: Baseline Monitoring||27
8360156|NCT01212094|20607785|P3|STARTED|Year 1: Baseline Monitoring||0
8360157|NCT01212094|20607786|P2|STARTED|Year 1: Baseline Monitoring||0
8360158|NCT01212094|20607787|P1|STARTED|Year 1: Baseline Monitoring||43
8360159|NCT01211873|20607821|P3|NOT COMPLETED|Overall Study||2
8360160|NCT01211873|20607822|P2|NOT COMPLETED|Overall Study||2
8360161|NCT01211873|20607823|P1|NOT COMPLETED|Overall Study||5
8360162|NCT01211873|20607821|P3|COMPLETED|Overall Study||36
8360163|NCT01211873|20607822|P2|COMPLETED|Overall Study||117
8360164|NCT01211873|20607823|P1|COMPLETED|Overall Study||240
8360165|NCT01211873|20607821|P3|STARTED|Overall Study||38
8360166|NCT01211873|20607822|P2|STARTED|Overall Study||119
8360167|NCT01211873|20607823|P1|STARTED|Overall Study||245
8360168|NCT01211769|20607846|P4|NOT COMPLETED|Overall Study||11
8360169|NCT01211769|20607847|P3|NOT COMPLETED|Overall Study||8
8360170|NCT01211769|20607848|P2|NOT COMPLETED|Overall Study||10
8360171|NCT01211769|20607849|P1|NOT COMPLETED|Overall Study||9
8360172|NCT01211769|20607846|P4|COMPLETED|Overall Study||9
8360173|NCT01211769|20607847|P3|COMPLETED|Overall Study||12
8360174|NCT01211769|20607848|P2|COMPLETED|Overall Study||10
8360175|NCT01211769|20607849|P1|COMPLETED|Overall Study||11
8360176|NCT01211769|20607846|P4|Participants/Group|Overall Study||20
8360177|NCT01211769|20607847|P3|Participants/Group|Overall Study||20
8360178|NCT01211769|20607848|P2|Participants/Group|Overall Study||20
8360179|NCT01211769|20607849|P1|Participants/Group|Overall Study||20
8360180|NCT01211769|20607846|P4|STARTED|Overall Study||20
8360181|NCT01211769|20607847|P3|STARTED|Overall Study||20
8360182|NCT01211769|20607848|P2|STARTED|Overall Study||20
8360183|NCT01211769|20607849|P1|STARTED|Overall Study||20
8360184|NCT01211756|20607867|P1|NOT COMPLETED|Overall Study||0
8360185|NCT01211756|20607867|P1|COMPLETED|Overall Study||1
8360186|NCT01211756|20607867|P1|STARTED|Overall Study||1
8360187|NCT01211730|20607885|P2|NOT COMPLETED|Overall Study||0
8360188|NCT01211730|20607886|P1|NOT COMPLETED|Overall Study||0
8360189|NCT01211730|20607885|P2|COMPLETED|Overall Study||82
8360190|NCT01211730|20607886|P1|COMPLETED|Overall Study||82
8360191|NCT01211730|20607885|P2|STARTED|Overall Study||82
8360192|NCT01211730|20607886|P1|STARTED|Overall Study||82
8360193|NCT01211665|20607904|P2|NOT COMPLETED|Overall Study||0
8360194|NCT01211665|20607905|P1|NOT COMPLETED|Overall Study||2
8360195|NCT01211665|20607904|P2|COMPLETED|Overall Study|completed treatment with study drug|1
8360196|NCT01211665|20607905|P1|COMPLETED|Overall Study||0
8360197|NCT01211665|20607904|P2|STARTED|Overall Study||1
8360198|NCT01211665|20607905|P1|STARTED|Overall Study||2
8360199|NCT01211613|20607932|P3|NOT COMPLETED|Overall Study||2
8360200|NCT01211613|20607933|P2|NOT COMPLETED|Overall Study||2
8360201|NCT01211613|20607934|P1|NOT COMPLETED|Overall Study||3
8360202|NCT01211613|20607932|P3|COMPLETED|Overall Study||33
8360203|NCT01211613|20607933|P2|COMPLETED|Overall Study||33
8360204|NCT01211613|20607934|P1|COMPLETED|Overall Study||34
8360205|NCT01211613|20607932|P3|STARTED|Overall Study||35
8360206|NCT01211613|20607933|P2|STARTED|Overall Study||35
8360207|NCT01211613|20607934|P1|STARTED|Overall Study||37
8360208|NCT01211600|20607947|P2|NOT COMPLETED|Overall Study||0
8360209|NCT01211600|20607948|P1|NOT COMPLETED|Overall Study||0
8360210|NCT01211600|20607947|P2|COMPLETED|Overall Study||376
8360211|NCT01211600|20607948|P1|COMPLETED|Overall Study||370
8360212|NCT01211600|20607947|P2|STARTED|Overall Study||376
8360213|NCT01211600|20607948|P1|STARTED|Overall Study||370
8360214|NCT01211535|20607980|P2|NOT COMPLETED|Overall Study||1
8360215|NCT01211535|20607981|P1|NOT COMPLETED|Overall Study||0
8360216|NCT01211535|20607980|P2|COMPLETED|Overall Study||51
8360217|NCT01211535|20607981|P1|COMPLETED|Overall Study||52
8360218|NCT01211535|20607980|P2|STARTED|Overall Study||52
8360219|NCT01211535|20607981|P1|STARTED|Overall Study||52
8360220|NCT01211522|20607990|P3|NOT COMPLETED|Overall Study||5
8360221|NCT01211522|20607991|P2|NOT COMPLETED|Overall Study||7
8360222|NCT01211522|20607992|P1|NOT COMPLETED|Overall Study||3
8360223|NCT01211522|20607990|P3|COMPLETED|Overall Study||179
8360224|NCT01211522|20607991|P2|COMPLETED|Overall Study||183
8360225|NCT01211522|20607992|P1|COMPLETED|Overall Study||189
8360226|NCT01211522|20607990|P3|STARTED|Overall Study||184
8360227|NCT01211522|20607991|P2|STARTED|Overall Study||190
8360228|NCT01211522|20607992|P1|STARTED|Overall Study||192
8360235|NCT01211288|20608042|P2|NOT COMPLETED|Overall Study||1
8360236|NCT01211288|20608043|P1|NOT COMPLETED|Overall Study||1
8360237|NCT01211288|20608042|P2|COMPLETED|Overall Study||19
8360238|NCT01211288|20608043|P1|COMPLETED|Overall Study||20
8360239|NCT01211288|20608042|P2|STARTED|Overall Study||20
8360240|NCT01211288|20608043|P1|STARTED|Overall Study||21
8360241|NCT01211262|20608061|P2|NOT COMPLETED|Overall Study||10
8360242|NCT01211262|20608062|P1|NOT COMPLETED|Overall Study||23
8360243|NCT01211262|20608061|P2|COMPLETED|Overall Study||8
8360244|NCT01211262|20608062|P1|COMPLETED|Overall Study||43
8360245|NCT01211262|20608061|P2|STARTED|Overall Study||18
8360246|NCT01211262|20608062|P1|STARTED|Overall Study||66
8360247|NCT01211197|20608102|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360248|NCT01211197|20608103|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360249|NCT01211197|20608104|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360250|NCT01211197|20608105|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360251|NCT01211197|20608106|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360252|NCT01211197|20608107|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360253|NCT01211197|20608102|P6|COMPLETED|Treatment Period 3 (1 Day)||2
8360254|NCT01211197|20608103|P5|COMPLETED|Treatment Period 3 (1 Day)||2
8360255|NCT01211197|20608104|P4|COMPLETED|Treatment Period 3 (1 Day)||3
8360256|NCT01211197|20608105|P3|COMPLETED|Treatment Period 3 (1 Day)||2
8360257|NCT01211197|20608106|P2|COMPLETED|Treatment Period 3 (1 Day)||3
8360258|NCT01211197|20608107|P1|COMPLETED|Treatment Period 3 (1 Day)||2
8360259|NCT01211197|20608102|P6|STARTED|Treatment Period 3 (1 Day)||2
8360260|NCT01211197|20608103|P5|STARTED|Treatment Period 3 (1 Day)||2
8360261|NCT01211197|20608104|P4|STARTED|Treatment Period 3 (1 Day)||3
8360262|NCT01211197|20608105|P3|STARTED|Treatment Period 3 (1 Day)||2
8360263|NCT01211197|20608106|P2|STARTED|Treatment Period 3 (1 Day)||3
8360264|NCT01211197|20608107|P1|STARTED|Treatment Period 3 (1 Day)||2
8360265|NCT01211197|20608102|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360266|NCT01211197|20608103|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360267|NCT01211197|20608104|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360268|NCT01211197|20608105|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360269|NCT01211197|20608106|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360270|NCT01211197|20608107|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
8360271|NCT01211197|20608102|P6|COMPLETED|Washout Period 2 (7 Days)||2
8360272|NCT01211197|20608103|P5|COMPLETED|Washout Period 2 (7 Days)||2
8360273|NCT01211197|20608104|P4|COMPLETED|Washout Period 2 (7 Days)||3
8360274|NCT01211197|20608105|P3|COMPLETED|Washout Period 2 (7 Days)||2
8360275|NCT01211197|20608106|P2|COMPLETED|Washout Period 2 (7 Days)||3
8360276|NCT01211197|20608107|P1|COMPLETED|Washout Period 2 (7 Days)||2
8360277|NCT01211197|20608102|P6|STARTED|Washout Period 2 (7 Days)||2
8360278|NCT01211197|20608103|P5|STARTED|Washout Period 2 (7 Days)||2
8360279|NCT01211197|20608104|P4|STARTED|Washout Period 2 (7 Days)||3
8360280|NCT01211197|20608105|P3|STARTED|Washout Period 2 (7 Days)||2
8360281|NCT01211197|20608106|P2|STARTED|Washout Period 2 (7 Days)||3
8360282|NCT01211197|20608107|P1|STARTED|Washout Period 2 (7 Days)||3
8360283|NCT01211197|20608102|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360284|NCT01211197|20608103|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360285|NCT01211197|20608104|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360286|NCT01211197|20608105|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360287|NCT01211197|20608106|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360288|NCT01211197|20608107|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360289|NCT01211197|20608102|P6|COMPLETED|Treatment Period 2 (1 Day)||2
8360290|NCT01211197|20608103|P5|COMPLETED|Treatment Period 2 (1 Day)||2
8360291|NCT01211197|20608104|P4|COMPLETED|Treatment Period 2 (1 Day)||3
8360292|NCT01211197|20608105|P3|COMPLETED|Treatment Period 2 (1 Day)||2
8360293|NCT01211197|20608106|P2|COMPLETED|Treatment Period 2 (1 Day)||3
8360294|NCT01211197|20608107|P1|COMPLETED|Treatment Period 2 (1 Day)||3
8360295|NCT01211197|20608102|P6|STARTED|Treatment Period 2 (1 Day)||2
8360296|NCT01211197|20608103|P5|STARTED|Treatment Period 2 (1 Day)||2
8360297|NCT01211197|20608104|P4|STARTED|Treatment Period 2 (1 Day)||3
8360298|NCT01211197|20608105|P3|STARTED|Treatment Period 2 (1 Day)||2
8360299|NCT01211197|20608106|P2|STARTED|Treatment Period 2 (1 Day)||3
8360300|NCT01211197|20608107|P1|STARTED|Treatment Period 2 (1 Day)||3
8360301|NCT01211197|20608102|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360302|NCT01211197|20608103|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360303|NCT01211197|20608104|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360304|NCT01211197|20608105|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
8360305|NCT01211197|20608106|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360306|NCT01211197|20608107|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360307|NCT01211197|20608102|P6|COMPLETED|Washout Period 1 (7 Days)||2
8360308|NCT01211197|20608103|P5|COMPLETED|Washout Period 1 (7 Days)||2
8360309|NCT01211197|20608104|P4|COMPLETED|Washout Period 1 (7 Days)||3
8360310|NCT01211197|20608105|P3|COMPLETED|Washout Period 1 (7 Days)||2
8360311|NCT01211197|20608106|P2|COMPLETED|Washout Period 1 (7 Days)||3
8360312|NCT01211197|20608107|P1|COMPLETED|Washout Period 1 (7 Days)||3
8360313|NCT01211197|20608102|P6|STARTED|Washout Period 1 (7 Days)||2
8360314|NCT01211197|20608103|P5|STARTED|Washout Period 1 (7 Days)||2
8360315|NCT01211197|20608104|P4|STARTED|Washout Period 1 (7 Days)||3
8360316|NCT01211197|20608105|P3|STARTED|Washout Period 1 (7 Days)||3
8360317|NCT01211197|20608106|P2|STARTED|Washout Period 1 (7 Days)||3
8360318|NCT01211197|20608107|P1|STARTED|Washout Period 1 (7 Days)||3
8360319|NCT01211197|20608102|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360320|NCT01211197|20608103|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360321|NCT01211197|20608104|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360322|NCT01211197|20608105|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360323|NCT01211197|20608106|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360324|NCT01211197|20608107|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360325|NCT01211197|20608102|P6|COMPLETED|Treatment Period 1 (1 Day)||2
8360326|NCT01211197|20608103|P5|COMPLETED|Treatment Period 1 (1 Day)||2
8360327|NCT01211197|20608104|P4|COMPLETED|Treatment Period 1 (1 Day)||3
8360328|NCT01211197|20608105|P3|COMPLETED|Treatment Period 1 (1 Day)||3
8360329|NCT01211197|20608106|P2|COMPLETED|Treatment Period 1 (1 Day)||3
8360330|NCT01211197|20608107|P1|COMPLETED|Treatment Period 1 (1 Day)||3
8360331|NCT01211197|20608102|P6|STARTED|Treatment Period 1 (1 Day)||2
8360332|NCT01211197|20608103|P5|STARTED|Treatment Period 1 (1 Day)||2
8360333|NCT01211197|20608104|P4|STARTED|Treatment Period 1 (1 Day)||3
8360334|NCT01211197|20608105|P3|STARTED|Treatment Period 1 (1 Day)||3
8360335|NCT01211197|20608106|P2|STARTED|Treatment Period 1 (1 Day)||3
8360336|NCT01211197|20608107|P1|STARTED|Treatment Period 1 (1 Day)||3
8360337|NCT01211184|20608154|P3|NOT COMPLETED|Overall Study||1
8360338|NCT01211184|20608155|P2|NOT COMPLETED|Overall Study||2
8360339|NCT01211184|20608156|P1|NOT COMPLETED|Overall Study||0
8360340|NCT01211184|20608154|P3|COMPLETED|Overall Study||19
8360341|NCT01211184|20608155|P2|COMPLETED|Overall Study||18
8360342|NCT01211184|20608156|P1|COMPLETED|Overall Study||20
8360343|NCT01211184|20608154|P3|STARTED|Overall Study||20
8360344|NCT01211184|20608155|P2|STARTED|Overall Study||20
8360345|NCT01211184|20608156|P1|STARTED|Overall Study||20
8360346|NCT01211145|20608171|P4|NOT COMPLETED|Overall Study||20
8360347|NCT01211145|20608172|P3|NOT COMPLETED|Overall Study||13
8360348|NCT01211145|20608173|P2|NOT COMPLETED|Overall Study||17
8360349|NCT01211145|20608174|P1|NOT COMPLETED|Overall Study||26
8360350|NCT01211145|20608171|P4|COMPLETED|Overall Study||268
8360351|NCT01211145|20608172|P3|COMPLETED|Overall Study||86
8360352|NCT01211145|20608173|P2|COMPLETED|Overall Study||98
8360353|NCT01211145|20608174|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
8360354|NCT01211145|20608171|P4|STARTED|Overall Study||288
8360355|NCT01211145|20608172|P3|STARTED|Overall Study||99
8360356|NCT01211145|20608173|P2|STARTED|Overall Study||115
8360357|NCT01211145|20608174|P1|STARTED|Overall Study||296
8360358|NCT01211106|20608206|P2|NOT COMPLETED|Overall Study||11
8360359|NCT01211106|20608207|P1|NOT COMPLETED|Overall Study||13
8360360|NCT01211106|20608206|P2|COMPLETED|Overall Study||77
8360361|NCT01211106|20608207|P1|COMPLETED|Overall Study||82
8360362|NCT01211106|20608206|P2|STARTED|Overall Study||88
8360363|NCT01211106|20608207|P1|STARTED|Overall Study||95
8360364|NCT01210820|20608217|P2|NOT COMPLETED|Overall Study||0
8360365|NCT01210820|20608218|P1|NOT COMPLETED|Overall Study||0
8360366|NCT01210820|20608217|P2|COMPLETED|Overall Study||4
8360367|NCT01210820|20608218|P1|COMPLETED|Overall Study||17
8360368|NCT01210820|20608217|P2|STARTED|Overall Study||4
8360369|NCT01210820|20608218|P1|STARTED|Overall Study||17
8360370|NCT01210807|20608228|P2|NOT COMPLETED|Overall Study||3
8360371|NCT01210807|20608229|P1|NOT COMPLETED|Overall Study||3
8360372|NCT01210807|20608228|P2|COMPLETED|Overall Study||31
8360373|NCT01210807|20608229|P1|COMPLETED|Overall Study||33
8360374|NCT01210807|20608228|P2|STARTED|Overall Study||34
8360375|NCT01210807|20608229|P1|STARTED|Overall Study||36
8360376|NCT01210716|20608237|P2|NOT COMPLETED|Second TPE Procedure||0
8360377|NCT01210716|20608238|P1|NOT COMPLETED|Second TPE Procedure||3
8360378|NCT01210716|20608237|P2|COMPLETED|Second TPE Procedure||15
8360379|NCT01210716|20608238|P1|COMPLETED|Second TPE Procedure||15
8360380|NCT01210716|20608237|P2|STARTED|Second TPE Procedure||15
8360381|NCT01210716|20608238|P1|STARTED|Second TPE Procedure||18
8360382|NCT01210716|20608237|P2|NOT COMPLETED|First TPE Procedure||2
8360383|NCT01210716|20608238|P1|NOT COMPLETED|First TPE Procedure||2
8360384|NCT01210716|20608237|P2|COMPLETED|First TPE Procedure||15
8360385|NCT01210716|20608238|P1|COMPLETED|First TPE Procedure||18
8360386|NCT01210716|20608237|P2|STARTED|First TPE Procedure||17
8360387|NCT01210716|20608238|P1|STARTED|First TPE Procedure||20
8360388|NCT01210690|20608244|P1|NOT COMPLETED|Overall Study||26
8360389|NCT01210690|20608244|P1|COMPLETED|Overall Study||75
8360390|NCT01210690|20608244|P1|STARTED|Overall Study||101
8360391|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
8360392|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360393|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360394|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360395|NCT01210664|20608257|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
8360396|NCT01210664|20608258|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360397|NCT01210664|20608259|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360398|NCT01210664|20608260|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360399|NCT01210664|20608257|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
8360400|NCT01210664|20608258|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360401|NCT01210664|20608259|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360402|NCT01210664|20608260|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360403|NCT01210664|20608257|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
8360404|NCT01210664|20608258|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360405|NCT01210664|20608259|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360406|NCT01210664|20608260|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360407|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360408|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
8360409|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360410|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360411|NCT01210664|20608257|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360412|NCT01210664|20608258|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
8360413|NCT01210664|20608259|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360414|NCT01210664|20608260|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360415|NCT01210664|20608257|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360416|NCT01210664|20608258|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
8360417|NCT01210664|20608259|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360418|NCT01210664|20608260|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360419|NCT01210664|20608257|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360420|NCT01210664|20608258|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
8360421|NCT01210664|20608259|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360422|NCT01210664|20608260|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360423|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360424|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360425|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360426|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360427|NCT01210664|20608257|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360428|NCT01210664|20608258|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360429|NCT01210664|20608259|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8360430|NCT01210664|20608260|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360431|NCT01210664|20608257|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360432|NCT01210664|20608258|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360433|NCT01210664|20608259|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8360434|NCT01210664|20608260|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360435|NCT01210664|20608257|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360436|NCT01210664|20608258|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360437|NCT01210664|20608259|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8360438|NCT01210664|20608260|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360439|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360440|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360441|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360442|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360443|NCT01210664|20608257|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360444|NCT01210664|20608258|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360445|NCT01210664|20608259|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360446|NCT01210664|20608260|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8360447|NCT01210664|20608257|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360448|NCT01210664|20608258|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360449|NCT01210664|20608259|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360450|NCT01210664|20608260|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8360451|NCT01210664|20608257|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360452|NCT01210664|20608258|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360453|NCT01210664|20608259|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360454|NCT01210664|20608260|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8360455|NCT01210651|20608288|P2|NOT COMPLETED|Overall Study||8
8360456|NCT01210651|20608289|P1|NOT COMPLETED|Overall Study||5
8360457|NCT01210651|20608288|P2|COMPLETED|Overall Study||10
8360458|NCT01210651|20608289|P1|COMPLETED|Overall Study||15
8360459|NCT01210651|20608288|P2|Number Attending 1st Assigned Session|Overall Study||12
8360460|NCT01210651|20608289|P1|Number Attending 1st Assigned Session|Overall Study||18
8360461|NCT01210651|20608288|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
8360462|NCT01210651|20608289|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
8360463|NCT01210560|20608305|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
8360464|NCT01210560|20608306|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
8360465|NCT01210560|20608307|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
8360466|NCT01210560|20608308|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
8360467|NCT01210560|20608309|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
8360468|NCT01210560|20608310|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
8360469|NCT01210560|20608311|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
8360470|NCT01210560|20608312|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
8360471|NCT01210560|20608313|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
8360472|NCT01210560|20608305|P9|COMPLETED|Intervention 3 (7 Days)||5
8360473|NCT01210560|20608306|P8|COMPLETED|Intervention 3 (7 Days)||4
8360474|NCT01210560|20608307|P7|COMPLETED|Intervention 3 (7 Days)||4
8360475|NCT01210560|20608308|P6|COMPLETED|Intervention 3 (7 Days)||2
8360476|NCT01210560|20608309|P5|COMPLETED|Intervention 3 (7 Days)||2
8360477|NCT01210560|20608310|P4|COMPLETED|Intervention 3 (7 Days)||2
8360478|NCT01210560|20608311|P3|COMPLETED|Intervention 3 (7 Days)||2
8360479|NCT01210560|20608312|P2|COMPLETED|Intervention 3 (7 Days)||2
8360480|NCT01210560|20608313|P1|COMPLETED|Intervention 3 (7 Days)||2
8360481|NCT01210560|20608305|P9|STARTED|Intervention 3 (7 Days)||5
8360482|NCT01210560|20608306|P8|STARTED|Intervention 3 (7 Days)||4
8360483|NCT01210560|20608307|P7|STARTED|Intervention 3 (7 Days)||4
8360484|NCT01210560|20608308|P6|STARTED|Intervention 3 (7 Days)||2
8360485|NCT01210560|20608309|P5|STARTED|Intervention 3 (7 Days)||2
8360486|NCT01210560|20608310|P4|STARTED|Intervention 3 (7 Days)||2
8360487|NCT01210560|20608311|P3|STARTED|Intervention 3 (7 Days)||2
8360488|NCT01210560|20608312|P2|STARTED|Intervention 3 (7 Days)||2
8360489|NCT01210560|20608313|P1|STARTED|Intervention 3 (7 Days)||2
8360490|NCT01210560|20608305|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
8360491|NCT01210560|20608306|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
8360492|NCT01210560|20608307|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
8360493|NCT01210560|20608308|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
8360494|NCT01210560|20608309|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
8360495|NCT01210560|20608310|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
8360496|NCT01210560|20608311|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
8360497|NCT01210560|20608312|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
8360498|NCT01210560|20608313|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
8360499|NCT01210560|20608305|P9|COMPLETED|Intervention 2 (7 Days)||5
8360500|NCT01210560|20608306|P8|COMPLETED|Intervention 2 (7 Days)||4
8360501|NCT01210560|20608307|P7|COMPLETED|Intervention 2 (7 Days)||4
8360502|NCT01210560|20608308|P6|COMPLETED|Intervention 2 (7 Days)||2
8360503|NCT01210560|20608309|P5|COMPLETED|Intervention 2 (7 Days)||2
8360504|NCT01210560|20608310|P4|COMPLETED|Intervention 2 (7 Days)||2
8360505|NCT01210560|20608311|P3|COMPLETED|Intervention 2 (7 Days)||2
8360506|NCT01210560|20608312|P2|COMPLETED|Intervention 2 (7 Days)||2
8360507|NCT01210560|20608313|P1|COMPLETED|Intervention 2 (7 Days)||2
8360508|NCT01210560|20608305|P9|STARTED|Intervention 2 (7 Days)||5
8360509|NCT01210560|20608306|P8|STARTED|Intervention 2 (7 Days)||4
8360510|NCT01210560|20608307|P7|STARTED|Intervention 2 (7 Days)||4
8360511|NCT01210560|20608308|P6|STARTED|Intervention 2 (7 Days)||2
8360512|NCT01210560|20608309|P5|STARTED|Intervention 2 (7 Days)||2
8360513|NCT01210560|20608310|P4|STARTED|Intervention 2 (7 Days)||2
8360514|NCT01210560|20608311|P3|STARTED|Intervention 2 (7 Days)||2
8360515|NCT01210560|20608312|P2|STARTED|Intervention 2 (7 Days)||2
8360516|NCT01210560|20608313|P1|STARTED|Intervention 2 (7 Days)||2
8360517|NCT01210560|20608305|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
8360518|NCT01210560|20608306|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
8360519|NCT01210560|20608307|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
8360520|NCT01210560|20608308|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
8360521|NCT01210560|20608309|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
8360522|NCT01210560|20608310|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
8360523|NCT01210560|20608311|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
8360524|NCT01210560|20608312|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
8360525|NCT01210560|20608313|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
8360526|NCT01210560|20608305|P9|COMPLETED|Intervention 1 (7 Days)||5
8360527|NCT01210560|20608306|P8|COMPLETED|Intervention 1 (7 Days)||4
8360528|NCT01210560|20608307|P7|COMPLETED|Intervention 1 (7 Days)||4
8360529|NCT01210560|20608308|P6|COMPLETED|Intervention 1 (7 Days)||2
8360530|NCT01210560|20608309|P5|COMPLETED|Intervention 1 (7 Days)||2
8360531|NCT01210560|20608310|P4|COMPLETED|Intervention 1 (7 Days)||2
8360532|NCT01210560|20608311|P3|COMPLETED|Intervention 1 (7 Days)||2
8360533|NCT01210560|20608312|P2|COMPLETED|Intervention 1 (7 Days)||2
8360534|NCT01210560|20608313|P1|COMPLETED|Intervention 1 (7 Days)||2
8360535|NCT01210560|20608305|P9|STARTED|Intervention 1 (7 Days)||5
8360536|NCT01210560|20608306|P8|STARTED|Intervention 1 (7 Days)||4
8360537|NCT01210560|20608307|P7|STARTED|Intervention 1 (7 Days)||4
8360538|NCT01210560|20608308|P6|STARTED|Intervention 1 (7 Days)||2
8360539|NCT01210560|20608309|P5|STARTED|Intervention 1 (7 Days)||2
8360540|NCT01210560|20608310|P4|STARTED|Intervention 1 (7 Days)||2
8360541|NCT01210560|20608311|P3|STARTED|Intervention 1 (7 Days)||2
8360542|NCT01210560|20608312|P2|STARTED|Intervention 1 (7 Days)||2
8360543|NCT01210560|20608313|P1|STARTED|Intervention 1 (7 Days)||2
8360544|NCT01210495|20608409|P4|NOT COMPLETED|Overall Study||68
8360545|NCT01210495|20608410|P3|NOT COMPLETED|Overall Study||134
8360546|NCT01210495|20608411|P2|NOT COMPLETED|Overall Study||7
8360547|NCT01210495|20608412|P1|NOT COMPLETED|Overall Study||15
8360548|NCT01210495|20608409|P4|COMPLETED|Overall Study||0
8360549|NCT01210495|20608410|P3|COMPLETED|Overall Study||0
8360550|NCT01210495|20608411|P2|COMPLETED|Overall Study||0
8360551|NCT01210495|20608412|P1|COMPLETED|Overall Study||0
8360552|NCT01210495|20608409|P4|STARTED|Overall Study||68
8360553|NCT01210495|20608410|P3|STARTED|Overall Study||134
8360554|NCT01210495|20608411|P2|STARTED|Overall Study||7
8360555|NCT01210495|20608412|P1|STARTED|Overall Study||15
8360556|NCT01210443|20608474|P1|NOT COMPLETED|Overall Study||2
8360557|NCT01210443|20608474|P1|COMPLETED|Overall Study||0
8360558|NCT01210443|20608474|P1|STARTED|Overall Study||2
8360559|NCT01210352|20608491|P9|NOT COMPLETED|Overall Study||4
8360560|NCT01210352|20608492|P8|NOT COMPLETED|Overall Study||3
8360561|NCT01210352|20608493|P7|NOT COMPLETED|Overall Study||2
8360562|NCT01210352|20608494|P6|NOT COMPLETED|Overall Study||0
8360563|NCT01210352|20608495|P5|NOT COMPLETED|Overall Study||0
8360564|NCT01210352|20608496|P4|NOT COMPLETED|Overall Study||0
8360565|NCT01210352|20608497|P3|NOT COMPLETED|Overall Study||2
8360566|NCT01210352|20608498|P2|NOT COMPLETED|Overall Study||0
8360567|NCT01210352|20608499|P1|NOT COMPLETED|Overall Study||0
8360568|NCT01210352|20608491|P9|COMPLETED|Overall Study||2
8360569|NCT01210352|20608492|P8|COMPLETED|Overall Study||7
8360570|NCT01210352|20608493|P7|COMPLETED|Overall Study||5
8360571|NCT01210352|20608494|P6|COMPLETED|Overall Study||6
8360572|NCT01210352|20608495|P5|COMPLETED|Overall Study||6
8360573|NCT01210352|20608496|P4|COMPLETED|Overall Study||7
8360574|NCT01210352|20608497|P3|COMPLETED|Overall Study||5
8360575|NCT01210352|20608498|P2|COMPLETED|Overall Study||6
8360576|NCT01210352|20608499|P1|COMPLETED|Overall Study||6
8360577|NCT01210352|20608491|P9|STARTED|Overall Study||6
8360578|NCT01210352|20608492|P8|STARTED|Overall Study||10
8360579|NCT01210352|20608493|P7|STARTED|Overall Study||7
8360580|NCT01210352|20608494|P6|STARTED|Overall Study||6
8360581|NCT01210352|20608495|P5|STARTED|Overall Study||6
8360582|NCT01210352|20608496|P4|STARTED|Overall Study||7
8360583|NCT01210352|20608497|P3|STARTED|Overall Study||7
8360584|NCT01210352|20608498|P2|STARTED|Overall Study||6
8360585|NCT01210352|20608499|P1|STARTED|Overall Study||6
8360586|NCT01210222|20608690|P1|NOT COMPLETED|Overall Study||3
8360587|NCT01210222|20608690|P1|COMPLETED|Overall Study||32
8360588|NCT01210222|20608690|P1|STARTED|Overall Study||35
8360589|NCT01210170|20608703|P1|NOT COMPLETED|Overall Study||7
8360590|NCT01210170|20608703|P1|COMPLETED|Overall Study||15
8360591|NCT01210170|20608703|P1|STARTED|Overall Study||22
8360592|NCT01210144|20608726|P2|NOT COMPLETED|Overall Study||0
8360593|NCT01210144|20608727|P1|NOT COMPLETED|Overall Study||3
8360594|NCT01210144|20608726|P2|COMPLETED|Overall Study||11
8360595|NCT01210144|20608727|P1|COMPLETED|Overall Study||10
8360596|NCT01210144|20608726|P2|STARTED|Overall Study||11
8360597|NCT01210144|20608727|P1|STARTED|Overall Study||13
8360598|NCT01210118|20608749|P2|NOT COMPLETED|Overall Study||5
8360599|NCT01210118|20608750|P1|NOT COMPLETED|Overall Study||3
8360600|NCT01210118|20608749|P2|COMPLETED|Overall Study||42
8360601|NCT01210118|20608750|P1|COMPLETED|Overall Study||42
8360602|NCT01210118|20608749|P2|STARTED|Overall Study||47
8360603|NCT01210118|20608750|P1|STARTED|Overall Study||45
8360604|NCT01210079|20608764|P2|NOT COMPLETED|Overall Study||0
8360605|NCT01210079|20608765|P1|NOT COMPLETED|Overall Study||0
8360606|NCT01210079|20608764|P2|COMPLETED|Overall Study||16
8360607|NCT01210079|20608765|P1|COMPLETED|Overall Study||10
8360608|NCT01210079|20608764|P2|STARTED|Overall Study||16
8360609|NCT01210079|20608765|P1|STARTED|Overall Study||10
8360610|NCT01210001|20608774|P3|NOT COMPLETED|Overall Study||12
8360611|NCT01210001|20608775|P2|NOT COMPLETED|Overall Study||11
8360612|NCT01210001|20608776|P1|NOT COMPLETED|Overall Study||19
8360613|NCT01210001|20608774|P3|COMPLETED|Overall Study||156
8360614|NCT01210001|20608775|P2|COMPLETED|Overall Study||154
8360615|NCT01210001|20608776|P1|COMPLETED|Overall Study||147
8360616|NCT01210001|20608774|P3|STARTED|Overall Study||168
8360617|NCT01210001|20608775|P2|STARTED|Overall Study||165
8360618|NCT01210001|20608776|P1|STARTED|Overall Study||166
8360619|NCT01209949|20608796|P1|NOT COMPLETED|Overall Study||3
8360620|NCT01209949|20608796|P1|COMPLETED|Overall Study||27
8360621|NCT01209949|20608796|P1|STARTED|Overall Study||30
8360622|NCT01209832|20608802|P1|NOT COMPLETED|Maintenance Period 2 (M1)||0
8360623|NCT01209832|20608802|P1|COMPLETED|Maintenance Period 2 (M1)||3
8360624|NCT01209832|20608802|P1|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
8360625|NCT01209832|20608802|P1|NOT COMPLETED|Maintenance Period 1 (M1)||0
8360626|NCT01209832|20608802|P1|COMPLETED|Maintenance Period 1 (M1)||4
8360627|NCT01209832|20608802|P1|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
8360628|NCT01209832|20608802|P1|NOT COMPLETED|Period 2||1
8360629|NCT01209832|20608802|P1|COMPLETED|Period 2||9
8360630|NCT01209832|20608802|P1|STARTED|Period 2||10
8360631|NCT01209832|20608802|P1|NOT COMPLETED|Period 1||1
8360632|NCT01209832|20608802|P1|COMPLETED|Period 1||10
8360633|NCT01209832|20608802|P1|Received At Least 1 Dose of Study Drug|Period 1||10
8360634|NCT01209832|20608802|P1|STARTED|Period 1||11
8360635|NCT01209780|20608821|P5|NOT COMPLETED|Overall Study||5
8360636|NCT01209780|20608822|P4|NOT COMPLETED|Overall Study||10
8360637|NCT01209780|20608823|P3|NOT COMPLETED|Overall Study||4
8360638|NCT01209780|20608824|P2|NOT COMPLETED|Overall Study||18
8360639|NCT01209780|20608825|P1|NOT COMPLETED|Overall Study||26
8360640|NCT01209780|20608821|P5|COMPLETED|Overall Study||407
8360641|NCT01209780|20608822|P4|COMPLETED|Overall Study||807
8360642|NCT01209780|20608823|P3|COMPLETED|Overall Study||44
8360643|NCT01209780|20608824|P2|COMPLETED|Overall Study||467
8360644|NCT01209780|20608825|P1|COMPLETED|Overall Study||1016
8360645|NCT01209780|20608821|P5|STARTED|Overall Study||412
8360646|NCT01209780|20608822|P4|STARTED|Overall Study||817
8360647|NCT01209780|20608823|P3|STARTED|Overall Study||48
8360648|NCT01209780|20608824|P2|STARTED|Overall Study||485
8360649|NCT01209780|20608825|P1|STARTED|Overall Study||1042
8360650|NCT01209767|20608851|P1|NOT COMPLETED|Overall Study||4
8360651|NCT01209767|20608851|P1|COMPLETED|Overall Study||18
8360652|NCT01209767|20608851|P1|STARTED|Overall Study||22
8360653|NCT01209702|20608861|P4|NOT COMPLETED|Overall Study||153
8360654|NCT01209702|20608862|P3|NOT COMPLETED|Overall Study||51
8360655|NCT01209702|20608863|P2|NOT COMPLETED|Overall Study||51
8360656|NCT01209702|20608864|P1|NOT COMPLETED|Overall Study||51
8360657|NCT01209702|20608861|P4|COMPLETED|Overall Study||0
8360658|NCT01209702|20608862|P3|COMPLETED|Overall Study||0
8360659|NCT01209702|20608863|P2|COMPLETED|Overall Study||0
8360660|NCT01209702|20608864|P1|COMPLETED|Overall Study||0
8360661|NCT01209702|20608861|P4|Completed 24 Weeks Treatment|Overall Study||10
8360662|NCT01209702|20608862|P3|Completed 24 Weeks Treatment|Overall Study||3
8360663|NCT01209702|20608863|P2|Completed 24 Weeks Treatment|Overall Study||28
8360664|NCT01209702|20608864|P1|Completed 24 Weeks Treatment|Overall Study||19
8360665|NCT01209702|20608861|P4|Completed 12 Weeks Treatment|Overall Study||59
8360666|NCT01209702|20608862|P3|Completed 12 Weeks Treatment|Overall Study||12
8360667|NCT01209702|20608863|P2|Completed 12 Weeks Treatment|Overall Study||48
8360668|NCT01209702|20608864|P1|Completed 12 Weeks Treatment|Overall Study||50
8360669|NCT01209702|20608861|P4|Escape or Switched to Tocilizumab|Overall Study||0
8360670|NCT01209702|20608862|P3|Escape or Switched to Tocilizumab|Overall Study||6
8360671|NCT01209702|20608863|P2|Escape or Switched to Tocilizumab|Overall Study||0
8360672|NCT01209702|20608864|P1|Escape or Switched to Tocilizumab|Overall Study||51
8360673|NCT01209702|20608861|P4|Treated|Overall Study||152
8360674|NCT01209702|20608862|P3|Treated|Overall Study||51
8360675|NCT01209702|20608863|P2|Treated|Overall Study||51
8360676|NCT01209702|20608864|P1|Treated|Overall Study||51
8360677|NCT01209702|20608861|P4|STARTED|Overall Study||153
8360678|NCT01209702|20608862|P3|STARTED|Overall Study||51
8360679|NCT01209702|20608863|P2|STARTED|Overall Study||51
8360680|NCT01209702|20608864|P1|STARTED|Overall Study||51
8360681|NCT01209689|20608920|P2|NOT COMPLETED|Overall Study||22
8360682|NCT01209689|20608921|P1|NOT COMPLETED|Overall Study||91
8360683|NCT01209689|20608920|P2|COMPLETED|Overall Study||0
8360684|NCT01209689|20608921|P1|COMPLETED|Overall Study||0
8360685|NCT01209689|20608920|P2|STARTED|Overall Study||22
8360686|NCT01209689|20608921|P1|STARTED|Overall Study||91
8360691|NCT01209598|20608960|P2|NOT COMPLETED|Overall Study||0
8360692|NCT01209598|20608961|P1|NOT COMPLETED|Overall Study||1
8360693|NCT01209598|20608960|P2|COMPLETED|Overall Study||60
8360694|NCT01209598|20608961|P1|COMPLETED|Overall Study||29
8360695|NCT01209598|20608960|P2|STARTED|Overall Study||60
8360696|NCT01209598|20608961|P1|STARTED|Overall Study||30
8360697|NCT01209520|20608969|P1|NOT COMPLETED|Overall Study||3
8360698|NCT01209520|20608969|P1|COMPLETED|Overall Study||3
8360699|NCT01209520|20608969|P1|STARTED|Overall Study||6
8360700|NCT01209442|20608974|P1|NOT COMPLETED|Overall Study||0
8360701|NCT01209442|20608974|P1|COMPLETED|Overall Study||30
8360702|NCT01209442|20608974|P1|STARTED|Overall Study||30
8360703|NCT01209325|20608979|P1|NOT COMPLETED|Overall Study||43
8360704|NCT01209325|20608979|P1|COMPLETED|Overall Study||106
8360705|NCT01209325|20608979|P1|Returned After Week 28|Overall Study||124
8360706|NCT01209325|20608979|P1|Received Third Vaccine Infjection|Overall Study||138
8360707|NCT01209325|20608979|P1|Received Second Vaccine Injection|Overall Study||141
8360708|NCT01209325|20608979|P1|Received First Vaccine Injection|Overall Study||144
8360709|NCT01209325|20608979|P1|Eligible|Overall Study||145
8360710|NCT01209325|20608979|P1|STARTED|Overall Study||149
8360711|NCT01209286|20609034|P3|NOT COMPLETED|Overall Study||3
8360712|NCT01209286|20609035|P2|NOT COMPLETED|Overall Study||10
8360713|NCT01209286|20609036|P1|NOT COMPLETED|Overall Study||5
8360714|NCT01209286|20609034|P3|COMPLETED|Overall Study||3
8360715|NCT01209286|20609035|P2|COMPLETED|Overall Study||13
8360716|NCT01209286|20609036|P1|COMPLETED|Overall Study||2
8360717|NCT01209286|20609034|P3|STARTED|Overall Study||6
8360718|NCT01209286|20609035|P2|STARTED|Overall Study||23
8360719|NCT01209286|20609036|P1|STARTED|Overall Study||7
8360720|NCT01209260|20609089|P2|NOT COMPLETED|Overall Study||0
8360721|NCT01209260|20609090|P1|NOT COMPLETED|Overall Study||0
8360722|NCT01209260|20609089|P2|COMPLETED|Overall Study||36
8360723|NCT01209260|20609090|P1|COMPLETED|Overall Study||36
8360724|NCT01209260|20609089|P2|STARTED|Overall Study||36
8360725|NCT01209260|20609090|P1|STARTED|Overall Study||36
8360726|NCT01209234|20609104|P2|NOT COMPLETED|Overall Study||7
8360727|NCT01209234|20609105|P1|NOT COMPLETED|Overall Study||12
8360728|NCT01209234|20609104|P2|COMPLETED|Overall Study||1063
8360729|NCT01209234|20609105|P1|COMPLETED|Overall Study||1058
8360730|NCT01209234|20609104|P2|STARTED|Overall Study||1070
8360731|NCT01209234|20609105|P1|STARTED|Overall Study||1070
8360732|NCT01209195|20609115|P6|NOT COMPLETED|Overall Study||0
8360733|NCT01209195|20609116|P5|NOT COMPLETED|Overall Study||0
8360734|NCT01209195|20609117|P4|NOT COMPLETED|Overall Study||0
8360735|NCT01209195|20609118|P3|NOT COMPLETED|Overall Study||0
8360736|NCT01209195|20609119|P2|NOT COMPLETED|Overall Study||0
8360737|NCT01209195|20609120|P1|NOT COMPLETED|Overall Study||0
8360738|NCT01209195|20609115|P6|COMPLETED|Overall Study||13
8360739|NCT01209195|20609116|P5|COMPLETED|Overall Study||6
8360740|NCT01209195|20609117|P4|COMPLETED|Overall Study||6
8360741|NCT01209195|20609118|P3|COMPLETED|Overall Study||6
8360742|NCT01209195|20609119|P2|COMPLETED|Overall Study||3
8360743|NCT01209195|20609120|P1|COMPLETED|Overall Study||7
8360744|NCT01209195|20609115|P6|STARTED|Overall Study||13
8360745|NCT01209195|20609116|P5|STARTED|Overall Study||6
8360746|NCT01209195|20609117|P4|STARTED|Overall Study||6
8360747|NCT01209195|20609118|P3|STARTED|Overall Study||6
8360748|NCT01209195|20609119|P2|STARTED|Overall Study||3
8360749|NCT01209195|20609120|P1|STARTED|Overall Study||7
8360750|NCT01209143|20609156|P2|NOT COMPLETED|Overall Study||20
8360751|NCT01209143|20609157|P1|NOT COMPLETED|Overall Study||19
8360752|NCT01209143|20609156|P2|COMPLETED|Overall Study||8
8360753|NCT01209143|20609157|P1|COMPLETED|Overall Study||5
8360754|NCT01209143|20609156|P2|STARTED|Overall Study||28
8360755|NCT01209143|20609157|P1|STARTED|Overall Study||24
8360756|NCT01209078|20609167|P2|NOT COMPLETED|Overall Study||3
8360757|NCT01209078|20609168|P1|NOT COMPLETED|Overall Study||16
8360758|NCT01209078|20609167|P2|COMPLETED|Overall Study||24
8360759|NCT01209078|20609168|P1|COMPLETED|Overall Study||41
8360760|NCT01209078|20609167|P2|STARTED|Overall Study||27
8360761|NCT01209078|20609168|P1|STARTED|Overall Study||57
8360762|NCT01208961|20609243|P2|NOT COMPLETED|High-Fat Period IV||0
8360763|NCT01208961|20609244|P1|NOT COMPLETED|High-Fat Period IV||0
8360764|NCT01208961|20609243|P2|COMPLETED|High-Fat Period IV||26
8360765|NCT01208961|20609244|P1|COMPLETED|High-Fat Period IV||25
8360766|NCT01208961|20609243|P2|STARTED|High-Fat Period IV||26
8360767|NCT01208961|20609244|P1|STARTED|High-Fat Period IV||25
8360768|NCT01208961|20609243|P2|NOT COMPLETED|High-Fat Period III||0
8360769|NCT01208961|20609244|P1|NOT COMPLETED|High-Fat Period III||1
8360770|NCT01208961|20609243|P2|COMPLETED|High-Fat Period III||26
8360771|NCT01208961|20609244|P1|COMPLETED|High-Fat Period III||25
8360772|NCT01208961|20609243|P2|STARTED|High-Fat Period III||26
8360773|NCT01208961|20609244|P1|STARTED|High-Fat Period III||26
8360774|NCT01208961|20609243|P2|NOT COMPLETED|Low-Fat Period II||0
8360775|NCT01208961|20609244|P1|NOT COMPLETED|Low-Fat Period II||0
8360776|NCT01208961|20609243|P2|COMPLETED|Low-Fat Period II||27
8360777|NCT01208961|20609244|P1|COMPLETED|Low-Fat Period II||26
8360778|NCT01208961|20609243|P2|STARTED|Low-Fat Period II||27
8360779|NCT01208961|20609244|P1|STARTED|Low-Fat Period II||26
8360780|NCT01208961|20609243|P2|NOT COMPLETED|Low-Fat Period I||0
8360781|NCT01208961|20609244|P1|NOT COMPLETED|Low-Fat Period I||0
8360782|NCT01208961|20609243|P2|COMPLETED|Low-Fat Period I||27
8360783|NCT01208961|20609244|P1|COMPLETED|Low-Fat Period I||27
8360784|NCT01208961|20609243|P2|STARTED|Low-Fat Period I||27
8360785|NCT01208961|20609244|P1|STARTED|Low-Fat Period I||27
8360786|NCT01208922|20609255|P2|NOT COMPLETED|Overall Study||10
8360787|NCT01208922|20609256|P1|NOT COMPLETED|Overall Study||11
8360788|NCT01208922|20609255|P2|COMPLETED|Overall Study||405
8360789|NCT01208922|20609256|P1|COMPLETED|Overall Study||409
8360790|NCT01208922|20609255|P2|STARTED|Overall Study||415
8360791|NCT01208922|20609256|P1|STARTED|Overall Study||420
8360792|NCT01208870|20609266|P2|NOT COMPLETED|Overall Study||8
8360793|NCT01208870|20609267|P1|NOT COMPLETED|Overall Study||2
8360794|NCT01208870|20609266|P2|COMPLETED|Overall Study||36
8360795|NCT01208870|20609267|P1|COMPLETED|Overall Study||44
8360796|NCT01208870|20609266|P2|Pilot 2|Overall Study||22
8360797|NCT01208870|20609267|P1|Pilot 2|Overall Study||26
8360798|NCT01208870|20609266|P2|Pilot 1|Overall Study||22
8360799|NCT01208870|20609267|P1|Pilot 1|Overall Study||20
8360800|NCT01208870|20609266|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
8360801|NCT01208870|20609267|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
8360802|NCT01208415|20609283|P1|NOT COMPLETED|Overall Study||40
8360803|NCT01208415|20609283|P1|COMPLETED|Overall Study||0
8360804|NCT01208415|20609283|P1|6 Months|Overall Study||37
8360805|NCT01208415|20609283|P1|STARTED|Overall Study||40
8360806|NCT01208402|20609289|P2|NOT COMPLETED|Overall Study||0
8360807|NCT01208402|20609290|P1|NOT COMPLETED|Overall Study||1
8360808|NCT01208402|20609289|P2|COMPLETED|Overall Study||28
8360809|NCT01208402|20609290|P1|COMPLETED|Overall Study||30
8360810|NCT01208402|20609289|P2|STARTED|Overall Study||28
8360811|NCT01208402|20609290|P1|STARTED|Overall Study||31
8360812|NCT01208337|20609306|P1|NOT COMPLETED|Overall Study||3
8360813|NCT01208337|20609306|P1|COMPLETED|Overall Study||20
8360814|NCT01208337|20609306|P1|Five-year Follow-up|Overall Study||20
8360815|NCT01208337|20609306|P1|One-year Follow-up|Overall Study||23
8360816|NCT01208337|20609306|P1|STARTED|Overall Study||23
8360817|NCT01208233|20609320|P6|NOT COMPLETED|Overall Study||21
8360818|NCT01208233|20609321|P5|NOT COMPLETED|Overall Study||24
8360819|NCT01208233|20609322|P4|NOT COMPLETED|Overall Study||1
8360820|NCT01208233|20609323|P3|NOT COMPLETED|Overall Study||4
8360821|NCT01208233|20609324|P2|NOT COMPLETED|Overall Study||3
8360822|NCT01208233|20609325|P1|NOT COMPLETED|Overall Study||5
8360823|NCT01208233|20609320|P6|COMPLETED|Overall Study||46
8360824|NCT01208233|20609321|P5|COMPLETED|Overall Study||46
8360825|NCT01208233|20609322|P4|COMPLETED|Overall Study||9
8360826|NCT01208233|20609323|P3|COMPLETED|Overall Study||7
8360827|NCT01208233|20609324|P2|COMPLETED|Overall Study||6
8360828|NCT01208233|20609325|P1|COMPLETED|Overall Study||6
8360829|NCT01208233|20609320|P6|STARTED|Overall Study||67
8360830|NCT01208233|20609321|P5|STARTED|Overall Study||70
8360831|NCT01208233|20609322|P4|STARTED|Overall Study||10
8360832|NCT01208233|20609323|P3|STARTED|Overall Study||11
8360833|NCT01208233|20609324|P2|STARTED|Overall Study||9
8360834|NCT01208233|20609325|P1|STARTED|Overall Study||11
8360835|NCT01208220|20609438|P2|NOT COMPLETED|Overall Study||0
8360836|NCT01208220|20609439|P1|NOT COMPLETED|Overall Study||0
8360837|NCT01208220|20609438|P2|COMPLETED|Overall Study||1
8360838|NCT01208220|20609439|P1|COMPLETED|Overall Study||1
8360839|NCT01208220|20609438|P2|STARTED|Overall Study||1
8360840|NCT01208220|20609439|P1|STARTED|Overall Study||1
8360841|NCT01208207|20609450|P7|NOT COMPLETED|Part II||11
8360842|NCT01208207|20609451|P6|NOT COMPLETED|Part II||16
8360843|NCT01208207|20609452|P5|NOT COMPLETED|Part II||23
8360844|NCT01208207|20609453|P4|NOT COMPLETED|Part II||32
8360845|NCT01208207|20609454|P3|NOT COMPLETED|Part II||0
8360846|NCT01208207|20609455|P2|NOT COMPLETED|Part II||0
8360847|NCT01208207|20609456|P1|NOT COMPLETED|Part II||0
8360848|NCT01208207|20609450|P7|COMPLETED|Part II||131
8360849|NCT01208207|20609451|P6|COMPLETED|Part II||129
8360850|NCT01208207|20609452|P5|COMPLETED|Part II||295
8360851|NCT01208207|20609453|P4|COMPLETED|Part II||282
8360852|NCT01208207|20609454|P3|COMPLETED|Part II||0
8360853|NCT01208207|20609455|P2|COMPLETED|Part II||0
8360854|NCT01208207|20609456|P1|COMPLETED|Part II||0
8360855|NCT01208207|20609450|P7|STARTED|Part II||142
8360856|NCT01208207|20609451|P6|STARTED|Part II||145
8360857|NCT01208207|20609452|P5|STARTED|Part II||318
8360858|NCT01208207|20609453|P4|STARTED|Part II||314
8360859|NCT01208207|20609454|P3|STARTED|Part II||0
8360860|NCT01208207|20609455|P2|STARTED|Part II||0
8360861|NCT01208207|20609456|P1|STARTED|Part II||0
8360862|NCT01208207|20609450|P7|NOT COMPLETED|Part I||0
8360863|NCT01208207|20609451|P6|NOT COMPLETED|Part I||0
8360864|NCT01208207|20609452|P5|NOT COMPLETED|Part I||0
8360865|NCT01208207|20609453|P4|NOT COMPLETED|Part I||0
8360866|NCT01208207|20609454|P3|NOT COMPLETED|Part I||15
8360867|NCT01208207|20609455|P2|NOT COMPLETED|Part I||11
8360868|NCT01208207|20609456|P1|NOT COMPLETED|Part I||70
8360869|NCT01208207|20609450|P7|COMPLETED|Part I||0
8360870|NCT01208207|20609451|P6|COMPLETED|Part I||0
8360871|NCT01208207|20609452|P5|COMPLETED|Part I||0
8360872|NCT01208207|20609453|P4|COMPLETED|Part I||0
8360873|NCT01208207|20609454|P3|COMPLETED|Part I||142
8360874|NCT01208207|20609455|P2|COMPLETED|Part I||145
8360875|NCT01208207|20609456|P1|COMPLETED|Part I||632
8360876|NCT01208207|20609450|P7|STARTED|Part I||0
8360877|NCT01208207|20609451|P6|STARTED|Part I||0
8360878|NCT01208207|20609452|P5|STARTED|Part I||0
8360879|NCT01208207|20609453|P4|STARTED|Part I||0
8360880|NCT01208207|20609454|P3|STARTED|Part I||157
8360881|NCT01208207|20609455|P2|STARTED|Part I||156
8360882|NCT01208207|20609456|P1|STARTED|Part I||702
8360883|NCT01208181|20609483|P5|NOT COMPLETED|Part 2||0
8360884|NCT01208181|20609484|P4|NOT COMPLETED|Part 2||20
8360885|NCT01208181|20609485|P3|NOT COMPLETED|Part 2||16
8360886|NCT01208181|20609486|P2|NOT COMPLETED|Part 2||0
8360887|NCT01208181|20609487|P1|NOT COMPLETED|Part 2||0
8360888|NCT01208181|20609483|P5|COMPLETED|Part 2||0
8360889|NCT01208181|20609484|P4|COMPLETED|Part 2||343
8360890|NCT01208181|20609485|P3|COMPLETED|Part 2||334
8360891|NCT01208181|20609486|P2|COMPLETED|Part 2||0
8360892|NCT01208181|20609487|P1|COMPLETED|Part 2||0
8360893|NCT01208181|20609483|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
8360894|NCT01208181|20609484|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
8360895|NCT01208181|20609485|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
8360896|NCT01208181|20609486|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
8360897|NCT01208181|20609487|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
8360898|NCT01208181|20609483|P5|NOT COMPLETED|Part 1||22
8360899|NCT01208181|20609484|P4|NOT COMPLETED|Part 1||0
8360900|NCT01208181|20609485|P3|NOT COMPLETED|Part 1||0
8360901|NCT01208181|20609486|P2|NOT COMPLETED|Part 1||55
8360902|NCT01208181|20609487|P1|NOT COMPLETED|Part 1||99
8360903|NCT01208181|20609483|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
8360904|NCT01208181|20609484|P4|COMPLETED|Part 1||0
8360905|NCT01208181|20609485|P3|COMPLETED|Part 1||0
8360906|NCT01208181|20609486|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
8360907|NCT01208181|20609487|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
8360908|NCT01208181|20609483|P5|STARTED|Part 1||118
8360909|NCT01208181|20609484|P4|STARTED|Part 1||0
8360910|NCT01208181|20609485|P3|STARTED|Part 1||0
8360911|NCT01208181|20609486|P2|STARTED|Part 1||468
8360912|NCT01208181|20609487|P1|STARTED|Part 1||818
8360913|NCT01208103|20609516|P1|NOT COMPLETED|Overall Study||2
8360914|NCT01208103|20609516|P1|COMPLETED|Overall Study||28
8360915|NCT01208103|20609516|P1|STARTED|Overall Study||30
8360916|NCT01208038|20609524|P1|NOT COMPLETED|Overall Study||1
8360917|NCT01208038|20609524|P1|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
8360918|NCT01208038|20609524|P1|STARTED|Overall Study||22
8360919|NCT01207934|20609534|P3|NOT COMPLETED|Overall Study||0
8360920|NCT01207934|20609535|P2|NOT COMPLETED|Overall Study||0
8360921|NCT01207934|20609536|P1|NOT COMPLETED|Overall Study||0
8360922|NCT01207934|20609534|P3|COMPLETED|Overall Study||6
8360923|NCT01207934|20609535|P2|COMPLETED|Overall Study||6
8360924|NCT01207934|20609536|P1|COMPLETED|Overall Study||6
8360925|NCT01207934|20609534|P3|STARTED|Overall Study||6
8360926|NCT01207934|20609535|P2|STARTED|Overall Study||6
8360927|NCT01207934|20609536|P1|STARTED|Overall Study||6
8360928|NCT01207908|20609555|P2|NOT COMPLETED|Overall Study||1
8360929|NCT01207908|20609556|P1|NOT COMPLETED|Overall Study||5
8360930|NCT01207908|20609555|P2|COMPLETED|Overall Study||21
8360931|NCT01207908|20609556|P1|COMPLETED|Overall Study||17
8360932|NCT01207908|20609555|P2|STARTED|Overall Study||22
8360933|NCT01207908|20609556|P1|STARTED|Overall Study||22
8360934|NCT01207765|20609566|P1|NOT COMPLETED|Overall Study||0
8360935|NCT01207765|20609566|P1|COMPLETED|Overall Study||8
8360936|NCT01207765|20609566|P1|STARTED|Overall Study||8
8360937|NCT01207726|20609574|P2|NOT COMPLETED|Overall Study||0
8360938|NCT01207726|20609575|P1|NOT COMPLETED|Overall Study||0
8360939|NCT01207726|20609574|P2|COMPLETED|Overall Study||6
8360940|NCT01207726|20609575|P1|COMPLETED|Overall Study||7
8360941|NCT01207726|20609574|P2|STARTED|Overall Study||6
8360942|NCT01207726|20609575|P1|STARTED|Overall Study||7
8360943|NCT01207687|20609593|P1|NOT COMPLETED|Overall Study||2
8360944|NCT01207687|20609593|P1|COMPLETED|Overall Study||12
8360945|NCT01207687|20609593|P1|STARTED|Overall Study||14
8360946|NCT01207648|20609623|P1|NOT COMPLETED|Overall Study||0
8360947|NCT01207648|20609623|P1|COMPLETED|Overall Study||307
8360948|NCT01207648|20609623|P1|STARTED|Overall Study||307
8360949|NCT01207596|20609631|P1|NOT COMPLETED|Overall Study||9
8360950|NCT01207596|20609631|P1|COMPLETED|Overall Study||21
8360951|NCT01207596|20609631|P1|STARTED|Overall Study||30
8360952|NCT01207583|20609644|P3|NOT COMPLETED|Overall Study||1
8360953|NCT01207583|20609645|P2|NOT COMPLETED|Overall Study||5
8360954|NCT01207583|20609646|P1|NOT COMPLETED|Overall Study||1
8360955|NCT01207583|20609644|P3|COMPLETED|Overall Study||54
8360956|NCT01207583|20609645|P2|COMPLETED|Overall Study||26
8360957|NCT01207583|20609646|P1|COMPLETED|Overall Study||13
8360958|NCT01207583|20609644|P3|Dose 4|Overall Study||0
8360959|NCT01207583|20609645|P2|Dose 4|Overall Study||0
8360960|NCT01207583|20609646|P1|Dose 4|Overall Study||7
8360961|NCT01207583|20609644|P3|Dose 3|Overall Study||0
8360962|NCT01207583|20609645|P2|Dose 3|Overall Study||27
8360963|NCT01207583|20609646|P1|Dose 3|Overall Study||13
8360964|NCT01207583|20609644|P3|Dose 2|Overall Study||54
8360965|NCT01207583|20609645|P2|Dose 2|Overall Study||29
8360966|NCT01207583|20609646|P1|Dose 2|Overall Study||13
8360967|NCT01207583|20609644|P3|Dose 1|Overall Study||55
8360968|NCT01207583|20609645|P2|Dose 1|Overall Study||31
8360969|NCT01207583|20609646|P1|Dose 1|Overall Study||14
8360970|NCT01207583|20609644|P3|STARTED|Overall Study||55
8360971|NCT01207583|20609645|P2|STARTED|Overall Study||31
8360972|NCT01207583|20609646|P1|STARTED|Overall Study||14
8360973|NCT01207570|20609686|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
8360974|NCT01207570|20609687|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
8360975|NCT01207570|20609686|P2|COMPLETED|The Second Stage (After Crossover)||23
8360976|NCT01207570|20609687|P1|COMPLETED|The Second Stage (After Crossover)||31
8360977|NCT01207570|20609686|P2|STARTED|The Second Stage (After Crossover)||23
8360978|NCT01207570|20609687|P1|STARTED|The Second Stage (After Crossover)||31
8360979|NCT01207570|20609686|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
8360980|NCT01207570|20609687|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
8360981|NCT01207570|20609686|P2|COMPLETED|The First Stage (Before Crossover)||31
8360982|NCT01207570|20609687|P1|COMPLETED|The First Stage (Before Crossover)||23
8360983|NCT01207570|20609686|P2|STARTED|The First Stage (Before Crossover)||31
8360984|NCT01207570|20609687|P1|STARTED|The First Stage (Before Crossover)||23
8360985|NCT01207492|20609699|P1|NOT COMPLETED|Overall Study||15
8360986|NCT01207492|20609699|P1|COMPLETED|Overall Study||2
8360987|NCT01207492|20609699|P1|STARTED|Overall Study||17
8360988|NCT01207466|20609705|P2|NOT COMPLETED|Period 2, One Week of Wear||0
8360989|NCT01207466|20609706|P1|NOT COMPLETED|Period 2, One Week of Wear||0
8360990|NCT01207466|20609705|P2|COMPLETED|Period 2, One Week of Wear||48
8360991|NCT01207466|20609706|P1|COMPLETED|Period 2, One Week of Wear||45
8360992|NCT01207466|20609705|P2|STARTED|Period 2, One Week of Wear||48
8360993|NCT01207466|20609706|P1|STARTED|Period 2, One Week of Wear||45
8360994|NCT01207466|20609705|P2|NOT COMPLETED|Period 1, One Week of Wear||0
8360995|NCT01207466|20609706|P1|NOT COMPLETED|Period 1, One Week of Wear||0
8360996|NCT01207466|20609705|P2|COMPLETED|Period 1, One Week of Wear||48
8360997|NCT01207466|20609706|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
8360998|NCT01207466|20609705|P2|STARTED|Period 1, One Week of Wear||48
8360999|NCT01207466|20609706|P1|STARTED|Period 1, One Week of Wear||46
8361000|NCT01207453|20609714|P2|NOT COMPLETED|2nd Intervention||2
8361001|NCT01207453|20609715|P1|NOT COMPLETED|2nd Intervention||2
8361002|NCT01207453|20609714|P2|COMPLETED|2nd Intervention||15
8361003|NCT01207453|20609715|P1|COMPLETED|2nd Intervention||17
8361004|NCT01207453|20609714|P2|STARTED|2nd Intervention||17
8361005|NCT01207453|20609715|P1|STARTED|2nd Intervention||19
8361006|NCT01207453|20609714|P2|NOT COMPLETED|Washout||0
8361007|NCT01207453|20609715|P1|NOT COMPLETED|Washout||2
8361008|NCT01207453|20609714|P2|COMPLETED|Washout||17
8361009|NCT01207453|20609715|P1|COMPLETED|Washout||19
8361010|NCT01207453|20609714|P2|STARTED|Washout||17
8361011|NCT01207453|20609715|P1|STARTED|Washout||21
8361012|NCT01207453|20609714|P2|NOT COMPLETED|First Intervention||1
8361013|NCT01207453|20609715|P1|NOT COMPLETED|First Intervention||2
8361014|NCT01207453|20609714|P2|COMPLETED|First Intervention||17
8361015|NCT01207453|20609715|P1|COMPLETED|First Intervention||21
8361016|NCT01207453|20609714|P2|STARTED|First Intervention||18
8361017|NCT01207453|20609715|P1|STARTED|First Intervention||23
8361039|NCT01207427|20609814|P3|NOT COMPLETED|Run-out Placebo Period||0
8361040|NCT01207427|20609815|P2|NOT COMPLETED|Run-out Placebo Period||0
8361041|NCT01207427|20609816|P1|NOT COMPLETED|Run-out Placebo Period||0
8361042|NCT01207427|20609814|P3|COMPLETED|Run-out Placebo Period||41
8361043|NCT01207427|20609815|P2|COMPLETED|Run-out Placebo Period||43
8361044|NCT01207427|20609816|P1|COMPLETED|Run-out Placebo Period||40
8361045|NCT01207427|20609814|P3|STARTED|Run-out Placebo Period||41
8361046|NCT01207427|20609815|P2|STARTED|Run-out Placebo Period||43
8361047|NCT01207427|20609816|P1|STARTED|Run-out Placebo Period||40
8361048|NCT01207427|20609814|P3|NOT COMPLETED|Double-blind Treatment Period||2
8361049|NCT01207427|20609815|P2|NOT COMPLETED|Double-blind Treatment Period||2
8361050|NCT01207427|20609816|P1|NOT COMPLETED|Double-blind Treatment Period||3
8361051|NCT01207427|20609814|P3|COMPLETED|Double-blind Treatment Period||41
8361052|NCT01207427|20609815|P2|COMPLETED|Double-blind Treatment Period||43
8361053|NCT01207427|20609816|P1|COMPLETED|Double-blind Treatment Period||40
8361054|NCT01207427|20609814|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
8361055|NCT01207427|20609815|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
8361056|NCT01207427|20609816|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
8361057|NCT01207427|20609814|P3|STARTED|Double-blind Treatment Period||43
8361058|NCT01207427|20609815|P2|STARTED|Double-blind Treatment Period||45
8361059|NCT01207427|20609816|P1|STARTED|Double-blind Treatment Period||43
8361060|NCT01207427|20609814|P3|NOT COMPLETED|Run-in Placebo Period||0
8361061|NCT01207427|20609815|P2|NOT COMPLETED|Run-in Placebo Period||0
8361062|NCT01207427|20609816|P1|NOT COMPLETED|Run-in Placebo Period||0
8361063|NCT01207427|20609814|P3|COMPLETED|Run-in Placebo Period||43
8361064|NCT01207427|20609815|P2|COMPLETED|Run-in Placebo Period||45
8361065|NCT01207427|20609816|P1|COMPLETED|Run-in Placebo Period||43
8361066|NCT01207427|20609814|P3|STARTED|Run-in Placebo Period||43
8361067|NCT01207427|20609815|P2|STARTED|Run-in Placebo Period||45
8361068|NCT01207427|20609816|P1|STARTED|Run-in Placebo Period||43
8361069|NCT01207414|20609826|P2|NOT COMPLETED|Overall Study||82
8361070|NCT01207414|20609827|P1|NOT COMPLETED|Overall Study||73
8361071|NCT01207414|20609826|P2|COMPLETED|Overall Study||178
8361072|NCT01207414|20609827|P1|COMPLETED|Overall Study||168
8361073|NCT01207414|20609826|P2|Safety Population: Received Study Drug|Overall Study||260
8361074|NCT01207414|20609827|P1|Safety Population: Received Study Drug|Overall Study||240
8361075|NCT01207414|20609826|P2|STARTED|Overall Study||260
8361076|NCT01207414|20609827|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
8361077|NCT01207401|20609845|P2|NOT COMPLETED|Overall Study||0
8361078|NCT01207401|20609846|P1|NOT COMPLETED|Overall Study||0
8361079|NCT01207401|20609845|P2|COMPLETED|Overall Study||24
8361080|NCT01207401|20609846|P1|COMPLETED|Overall Study||26
8361081|NCT01207401|20609845|P2|STARTED|Overall Study||24
8361082|NCT01207401|20609846|P1|STARTED|Overall Study||26
8361083|NCT01207388|20609852|P1|NOT COMPLETED|Overall Study||68
8361084|NCT01207388|20609852|P1|COMPLETED|Overall Study||48
8361085|NCT01207388|20609852|P1|STARTED|Overall Study||116
8361086|NCT01207219|20609877|P3|NOT COMPLETED|Overall Study||7
8361087|NCT01207219|20609878|P2|NOT COMPLETED|Overall Study||11
8361088|NCT01207219|20609879|P1|NOT COMPLETED|Overall Study||11
8361089|NCT01207219|20609877|P3|COMPLETED|Overall Study||32
8361090|NCT01207219|20609878|P2|COMPLETED|Overall Study||29
8361091|NCT01207219|20609879|P1|COMPLETED|Overall Study||34
8361092|NCT01207219|20609877|P3|Included in ITT Analysis|Overall Study||38
8361093|NCT01207219|20609878|P2|Included in ITT Analysis|Overall Study||37
8361094|NCT01207219|20609879|P1|Included in ITT Analysis|Overall Study||40
8361095|NCT01207219|20609877|P3|STARTED|Overall Study||39
8361096|NCT01207219|20609878|P2|STARTED|Overall Study||40
8361097|NCT01207219|20609879|P1|STARTED|Overall Study||45
8361098|NCT01207102|20609899|P1|NOT COMPLETED|Overall Study||10
8361099|NCT01207102|20609899|P1|COMPLETED|Overall Study||0
8361100|NCT01207102|20609899|P1|STARTED|Overall Study||10
8361101|NCT01206816|20609911|P7|NOT COMPLETED|Overall Study||6
8361102|NCT01206816|20609912|P6|NOT COMPLETED|Overall Study||19
8361103|NCT01206816|20609913|P5|NOT COMPLETED|Overall Study||3
8361104|NCT01206816|20609914|P4|NOT COMPLETED|Overall Study||3
8361105|NCT01206816|20609915|P3|NOT COMPLETED|Overall Study||20
8361106|NCT01206816|20609916|P2|NOT COMPLETED|Overall Study||3
8361107|NCT01206816|20609917|P1|NOT COMPLETED|Overall Study||3
8361108|NCT01206816|20609911|P7|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
8361109|NCT01206816|20609912|P6|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
8361110|NCT01206816|20609913|P5|COMPLETED|Overall Study||0
8361111|NCT01206816|20609914|P4|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
8361112|NCT01206816|20609915|P3|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
8361113|NCT01206816|20609916|P2|COMPLETED|Overall Study||0
8361114|NCT01206816|20609917|P1|COMPLETED|Overall Study||0
8361115|NCT01206816|20609911|P7|STARTED|Overall Study|Started=Treated|6
8361116|NCT01206816|20609912|P6|STARTED|Overall Study|Started=Treated|19
8361117|NCT01206816|20609913|P5|STARTED|Overall Study|Started=Treated|3
8361118|NCT01206816|20609914|P4|STARTED|Overall Study|Started=Treated|3
8361119|NCT01206816|20609915|P3|STARTED|Overall Study|Started=Treated|20
8361120|NCT01206816|20609916|P2|STARTED|Overall Study|Started=Treated|3
8361121|NCT01206816|20609917|P1|STARTED|Overall Study|Started=Treated|3
8361122|NCT01206777|20609963|P1|NOT COMPLETED|Overall Study||2
8361123|NCT01206777|20609963|P1|COMPLETED|Overall Study||50
8361220|NCT01206322|20610168|P4|COMPLETED|Overall Study||5
8361124|NCT01206777|20609963|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
8361125|NCT01206777|20609963|P1|STARTED|Overall Study||52
8361126|NCT01206764|20609969|P1|NOT COMPLETED|Overall Study||138
8361127|NCT01206764|20609969|P1|COMPLETED|Overall Study||4
8361128|NCT01206764|20609969|P1|STARTED|Overall Study||142
8361129|NCT01206738|20609980|P3|NOT COMPLETED|Overall Study||19
8361130|NCT01206738|20609981|P2|NOT COMPLETED|Overall Study||25
8361131|NCT01206738|20609982|P1|NOT COMPLETED|Overall Study||23
8361132|NCT01206738|20609980|P3|COMPLETED|Overall Study||42
8361133|NCT01206738|20609981|P2|COMPLETED|Overall Study||49
8361134|NCT01206738|20609982|P1|COMPLETED|Overall Study||40
8361135|NCT01206738|20609980|P3|STARTED|Overall Study||61
8361136|NCT01206738|20609981|P2|STARTED|Overall Study||74
8361137|NCT01206738|20609982|P1|STARTED|Overall Study||63
8361138|NCT01206660|20609994|P2|NOT COMPLETED|Overall Study||0
8361139|NCT01206660|20609995|P1|NOT COMPLETED|Overall Study||0
8361140|NCT01206660|20609994|P2|COMPLETED|Overall Study||60
8361141|NCT01206660|20609995|P1|COMPLETED|Overall Study||60
8361142|NCT01206660|20609994|P2|STARTED|Overall Study||60
8361143|NCT01206660|20609995|P1|STARTED|Overall Study||60
8361144|NCT01206608|20610007|P2|NOT COMPLETED|Overall Study||0
8361145|NCT01206608|20610008|P1|NOT COMPLETED|Overall Study||0
8361146|NCT01206608|20610007|P2|COMPLETED|Overall Study||20
8361147|NCT01206608|20610008|P1|COMPLETED|Overall Study||20
8361148|NCT01206608|20610007|P2|STARTED|Overall Study||20
8361149|NCT01206608|20610008|P1|STARTED|Overall Study||20
8361150|NCT01206595|20610016|P2|NOT COMPLETED|Overall Study||0
8361151|NCT01206595|20610017|P1|NOT COMPLETED|Overall Study||0
8361152|NCT01206595|20610016|P2|COMPLETED|Overall Study||20
8361153|NCT01206595|20610017|P1|COMPLETED|Overall Study||38
8361154|NCT01206595|20610016|P2|STARTED|Overall Study||20
8361155|NCT01206595|20610017|P1|STARTED|Overall Study||38
8361156|NCT01206582|20610027|P2|NOT COMPLETED|Overall Study||2
8361157|NCT01206582|20610028|P1|NOT COMPLETED|Overall Study||2
8361158|NCT01206582|20610027|P2|COMPLETED|Overall Study||7
8361159|NCT01206582|20610028|P1|COMPLETED|Overall Study||9
8361160|NCT01206582|20610027|P2|STARTED|Overall Study||9
8361161|NCT01206582|20610028|P1|STARTED|Overall Study||11
8361162|NCT01206517|20610060|P6|NOT COMPLETED|Overall Study||0
8361163|NCT01206517|20610061|P5|NOT COMPLETED|Overall Study||1
8361164|NCT01206517|20610062|P4|NOT COMPLETED|Overall Study||0
8361165|NCT01206517|20610063|P3|NOT COMPLETED|Overall Study||2
8361166|NCT01206517|20610064|P2|NOT COMPLETED|Overall Study||0
8361167|NCT01206517|20610065|P1|NOT COMPLETED|Overall Study||0
8361168|NCT01206517|20610060|P6|COMPLETED|Overall Study||4
8361169|NCT01206517|20610061|P5|COMPLETED|Overall Study||3
8361170|NCT01206517|20610062|P4|COMPLETED|Overall Study||4
8361171|NCT01206517|20610063|P3|COMPLETED|Overall Study||4
8361172|NCT01206517|20610064|P2|COMPLETED|Overall Study||6
8361173|NCT01206517|20610065|P1|COMPLETED|Overall Study||6
8361174|NCT01206517|20610060|P6|STARTED|Overall Study||4
8361175|NCT01206517|20610061|P5|STARTED|Overall Study||4
8361176|NCT01206517|20610062|P4|STARTED|Overall Study||4
8361177|NCT01206517|20610063|P3|STARTED|Overall Study||6
8361178|NCT01206517|20610064|P2|STARTED|Overall Study||6
8361179|NCT01206517|20610065|P1|STARTED|Overall Study||6
8361180|NCT01206478|20610096|P2|NOT COMPLETED|Overall Study||5
8361181|NCT01206478|20610097|P1|NOT COMPLETED|Overall Study||2
8361182|NCT01206478|20610096|P2|COMPLETED|Overall Study||7
8361183|NCT01206478|20610097|P1|COMPLETED|Overall Study||7
8361184|NCT01206478|20610096|P2|STARTED|Overall Study||12
8361185|NCT01206478|20610097|P1|STARTED|Overall Study||9
8361186|NCT01206465|20610105|P5|NOT COMPLETED|Overall Study||0
8361187|NCT01206465|20610106|P4|NOT COMPLETED|Overall Study||0
8361188|NCT01206465|20610107|P3|NOT COMPLETED|Overall Study||0
8361189|NCT01206465|20610108|P2|NOT COMPLETED|Overall Study||0
8361190|NCT01206465|20610109|P1|NOT COMPLETED|Overall Study||0
8361191|NCT01206465|20610105|P5|COMPLETED|Overall Study||6
8361192|NCT01206465|20610106|P4|COMPLETED|Overall Study||6
8361193|NCT01206465|20610107|P3|COMPLETED|Overall Study||6
8361194|NCT01206465|20610108|P2|COMPLETED|Overall Study||6
8361195|NCT01206465|20610109|P1|COMPLETED|Overall Study||3
8361196|NCT01206465|20610105|P5|STARTED|Overall Study||6
8361197|NCT01206465|20610106|P4|STARTED|Overall Study||6
8361198|NCT01206465|20610107|P3|STARTED|Overall Study||6
8361199|NCT01206465|20610108|P2|STARTED|Overall Study||6
8361200|NCT01206465|20610109|P1|STARTED|Overall Study||3
8361201|NCT01206452|20610130|P2|NOT COMPLETED|Overall Study||0
8361202|NCT01206452|20610131|P1|NOT COMPLETED|Overall Study||0
8361203|NCT01206452|20610130|P2|COMPLETED|Overall Study||30
8361204|NCT01206452|20610131|P1|COMPLETED|Overall Study||30
8361205|NCT01206452|20610130|P2|STARTED|Overall Study||30
8361206|NCT01206452|20610131|P1|STARTED|Overall Study||30
8361207|NCT01206439|20610145|P1|NOT COMPLETED|Overall Study||1
8361208|NCT01206439|20610145|P1|COMPLETED|Overall Study||1
8361209|NCT01206439|20610145|P1|STARTED|Overall Study||2
8361210|NCT01206387|20610151|P2|NOT COMPLETED|Overall Study||0
8361211|NCT01206387|20610152|P1|NOT COMPLETED|Overall Study||1
8361212|NCT01206387|20610151|P2|COMPLETED|Overall Study||60
8361213|NCT01206387|20610152|P1|COMPLETED|Overall Study||59
8361214|NCT01206387|20610151|P2|STARTED|Overall Study||60
8361215|NCT01206387|20610152|P1|STARTED|Overall Study||60
8361216|NCT01206322|20610168|P4|NOT COMPLETED|Overall Study||1
8361217|NCT01206322|20610169|P3|NOT COMPLETED|Overall Study||0
8361218|NCT01206322|20610170|P2|NOT COMPLETED|Overall Study||0
8361219|NCT01206322|20610171|P1|NOT COMPLETED|Overall Study||0
8361221|NCT01206322|20610169|P3|COMPLETED|Overall Study||9
8361222|NCT01206322|20610170|P2|COMPLETED|Overall Study||11
8361223|NCT01206322|20610171|P1|COMPLETED|Overall Study||4
8361224|NCT01206322|20610168|P4|STARTED|Overall Study||6
8361225|NCT01206322|20610169|P3|STARTED|Overall Study||9
8361226|NCT01206322|20610170|P2|STARTED|Overall Study||11
8361227|NCT01206322|20610171|P1|STARTED|Overall Study||4
8361228|NCT01206140|20610187|P2|NOT COMPLETED|Overall Study||0
8361229|NCT01206140|20610188|P1|NOT COMPLETED|Overall Study||1
8361230|NCT01206140|20610187|P2|COMPLETED|Overall Study||35
8361231|NCT01206140|20610188|P1|COMPLETED|Overall Study||34
8361232|NCT01206140|20610187|P2|STARTED|Overall Study||35
8361233|NCT01206140|20610188|P1|STARTED|Overall Study||35
8361234|NCT01206101|20610200|P2|NOT COMPLETED|Overall Study||1
8361235|NCT01206101|20610201|P1|NOT COMPLETED|Overall Study||2
8361236|NCT01206101|20610200|P2|COMPLETED|Overall Study||0
8361237|NCT01206101|20610201|P1|COMPLETED|Overall Study||0
8361238|NCT01206101|20610200|P2|STARTED|Overall Study||1
8361239|NCT01206101|20610201|P1|STARTED|Overall Study||2
8361240|NCT01206062|20610219|P2|NOT COMPLETED|Overall Study||0
8361241|NCT01206062|20610220|P1|NOT COMPLETED|Overall Study||0
8361242|NCT01206062|20610219|P2|COMPLETED|Overall Study||4683
8361243|NCT01206062|20610220|P1|COMPLETED|Overall Study||4678
8361244|NCT01206062|20610219|P2|STARTED|Overall Study||4683
8361245|NCT01206062|20610220|P1|STARTED|Overall Study||4678
8361246|NCT01205828|20610236|P1|NOT COMPLETED|Overall Study||0
8361247|NCT01205828|20610236|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
8361248|NCT01205828|20610236|P1|STARTED|Overall Study||16
8361249|NCT01205776|20610246|P2|NOT COMPLETED|Overall Study||95
8361250|NCT01205776|20610247|P1|NOT COMPLETED|Overall Study||64
8361251|NCT01205776|20610246|P2|COMPLETED|Overall Study||862
8361252|NCT01205776|20610247|P1|COMPLETED|Overall Study||884
8361253|NCT01205776|20610246|P2|STARTED|Overall Study||957
8361254|NCT01205776|20610247|P1|STARTED|Overall Study||948
8361255|NCT01205685|20610435|P1|NOT COMPLETED|Overall Study||11
8361256|NCT01205685|20610435|P1|COMPLETED|Overall Study||0
8361257|NCT01205685|20610435|P1|STARTED|Overall Study||11
8361258|NCT01205646|20610442|P1|NOT COMPLETED|Overall Study||0
8361259|NCT01205646|20610442|P1|COMPLETED|Overall Study||11
8361260|NCT01205646|20610442|P1|STARTED|Overall Study||11
8361261|NCT01205581|20610455|P6|NOT COMPLETED|Overall Study||0
8361262|NCT01205581|20610456|P5|NOT COMPLETED|Overall Study||0
8361263|NCT01205581|20610457|P4|NOT COMPLETED|Overall Study||0
8361264|NCT01205581|20610458|P3|NOT COMPLETED|Overall Study||0
8361265|NCT01205581|20610459|P2|NOT COMPLETED|Overall Study||0
8361266|NCT01205581|20610460|P1|NOT COMPLETED|Overall Study||1
8361267|NCT01205581|20610455|P6|COMPLETED|Overall Study||20
8361268|NCT01205581|20610456|P5|COMPLETED|Overall Study||20
8361269|NCT01205581|20610457|P4|COMPLETED|Overall Study||9
8361270|NCT01205581|20610458|P3|COMPLETED|Overall Study||8
8361271|NCT01205581|20610459|P2|COMPLETED|Overall Study||13
8361272|NCT01205581|20610460|P1|COMPLETED|Overall Study||13
8361273|NCT01205581|20610455|P6|STARTED|Overall Study||20
8361274|NCT01205581|20610456|P5|STARTED|Overall Study||20
8361275|NCT01205581|20610457|P4|STARTED|Overall Study||9
8361276|NCT01205581|20610458|P3|STARTED|Overall Study||8
8361277|NCT01205581|20610459|P2|STARTED|Overall Study||13
8361278|NCT01205581|20610460|P1|STARTED|Overall Study||14
8361279|NCT01205568|20610524|P2|NOT COMPLETED|Overall Study||0
8361280|NCT01205568|20610525|P1|NOT COMPLETED|Overall Study||0
8361281|NCT01205568|20610524|P2|COMPLETED|Overall Study||47
8361282|NCT01205568|20610525|P1|COMPLETED|Overall Study||65
8361283|NCT01205568|20610524|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
8361284|NCT01205568|20610525|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
8361285|NCT01205529|20610530|P1|NOT COMPLETED|Overall Study||55
8361286|NCT01205529|20610530|P1|COMPLETED|Overall Study||106
8361287|NCT01205529|20610530|P1|STARTED|Overall Study||161
8361288|NCT01205503|20610536|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
8361289|NCT01205503|20610537|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
8361290|NCT01205503|20610536|P2|COMPLETED|Second Intervention (2nd Cycle)||16
8361291|NCT01205503|20610537|P1|COMPLETED|Second Intervention (2nd Cycle)||16
8361292|NCT01205503|20610536|P2|STARTED|Second Intervention (2nd Cycle)||16
8361293|NCT01205503|20610537|P1|STARTED|Second Intervention (2nd Cycle)||16
8361294|NCT01205503|20610536|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
8361295|NCT01205503|20610537|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
8361296|NCT01205503|20610536|P2|COMPLETED|First Intervention (1st Cycle)||16
8361297|NCT01205503|20610537|P1|COMPLETED|First Intervention (1st Cycle)||16
8361298|NCT01205503|20610536|P2|STARTED|First Intervention (1st Cycle)||16
8361299|NCT01205503|20610537|P1|STARTED|First Intervention (1st Cycle)||16
8361300|NCT01205451|20610553|P2|NOT COMPLETED|Overall Study||10
8361301|NCT01205451|20610554|P1|NOT COMPLETED|Overall Study||6
8361302|NCT01205451|20610553|P2|COMPLETED|Overall Study||46
8361303|NCT01205451|20610554|P1|COMPLETED|Overall Study||47
8361304|NCT01205451|20610553|P2|STARTED|Overall Study||56
8361305|NCT01205451|20610554|P1|STARTED|Overall Study||53
8361306|NCT01205438|20610599|P3|NOT COMPLETED|Overall Study||88
8361307|NCT01205438|20610600|P2|NOT COMPLETED|Overall Study||87
8361308|NCT01205438|20610601|P1|NOT COMPLETED|Overall Study||77
8361309|NCT01205438|20610599|P3|COMPLETED|Overall Study||288
8361310|NCT01205438|20610600|P2|COMPLETED|Overall Study||289
8361311|NCT01205438|20610601|P1|COMPLETED|Overall Study||295
8361312|NCT01205438|20610599|P3|Participated in Follow Up|Overall Study||66
8361313|NCT01205438|20610600|P2|Participated in Follow Up|Overall Study||78
8361314|NCT01205438|20610601|P1|Participated in Follow Up|Overall Study||72
8361315|NCT01205438|20610599|P3|Received At Least One Dose of Study Drug|Overall Study||376
8361316|NCT01205438|20610600|P2|Received At Least One Dose of Study Drug|Overall Study||374
8361317|NCT01205438|20610601|P1|Received At Least One Dose of Study Drug|Overall Study||371
8361318|NCT01205438|20610599|P3|STARTED|Overall Study||376
8361319|NCT01205438|20610600|P2|STARTED|Overall Study||376
8361320|NCT01205438|20610601|P1|STARTED|Overall Study||372
8361321|NCT01205399|20610651|P1|NOT COMPLETED|Overall Study||0
8361322|NCT01205399|20610651|P1|COMPLETED|Overall Study||78
8361323|NCT01205399|20610651|P1|STARTED|Overall Study||78
8361324|NCT01205269|20610657|P6|NOT COMPLETED|Period 5 - Third Intervention||0
8361325|NCT01205269|20610658|P5|NOT COMPLETED|Period 5 - Third Intervention||0
8361326|NCT01205269|20610659|P4|NOT COMPLETED|Period 5 - Third Intervention||0
8361327|NCT01205269|20610660|P3|NOT COMPLETED|Period 5 - Third Intervention||0
8361328|NCT01205269|20610661|P2|NOT COMPLETED|Period 5 - Third Intervention||0
8361329|NCT01205269|20610662|P1|NOT COMPLETED|Period 5 - Third Intervention||0
8361330|NCT01205269|20610657|P6|COMPLETED|Period 5 - Third Intervention||5
8361331|NCT01205269|20610658|P5|COMPLETED|Period 5 - Third Intervention||5
8361332|NCT01205269|20610659|P4|COMPLETED|Period 5 - Third Intervention||5
8361333|NCT01205269|20610660|P3|COMPLETED|Period 5 - Third Intervention||4
8361334|NCT01205269|20610661|P2|COMPLETED|Period 5 - Third Intervention||4
8361335|NCT01205269|20610662|P1|COMPLETED|Period 5 - Third Intervention||4
8361336|NCT01205269|20610657|P6|STARTED|Period 5 - Third Intervention||5
8361337|NCT01205269|20610658|P5|STARTED|Period 5 - Third Intervention||5
8361338|NCT01205269|20610659|P4|STARTED|Period 5 - Third Intervention||5
8361339|NCT01205269|20610660|P3|STARTED|Period 5 - Third Intervention||4
8361340|NCT01205269|20610661|P2|STARTED|Period 5 - Third Intervention||4
8361341|NCT01205269|20610662|P1|STARTED|Period 5 - Third Intervention||4
8361342|NCT01205269|20610657|P6|NOT COMPLETED|Period 4 - Washout||0
8361343|NCT01205269|20610658|P5|NOT COMPLETED|Period 4 - Washout||0
8361344|NCT01205269|20610659|P4|NOT COMPLETED|Period 4 - Washout||1
8361345|NCT01205269|20610660|P3|NOT COMPLETED|Period 4 - Washout||0
8361346|NCT01205269|20610661|P2|NOT COMPLETED|Period 4 - Washout||0
8361347|NCT01205269|20610662|P1|NOT COMPLETED|Period 4 - Washout||0
8361348|NCT01205269|20610657|P6|COMPLETED|Period 4 - Washout||5
8361349|NCT01205269|20610658|P5|COMPLETED|Period 4 - Washout||5
8361350|NCT01205269|20610659|P4|COMPLETED|Period 4 - Washout||5
8361351|NCT01205269|20610660|P3|COMPLETED|Period 4 - Washout||4
8361352|NCT01205269|20610661|P2|COMPLETED|Period 4 - Washout||4
8361353|NCT01205269|20610662|P1|COMPLETED|Period 4 - Washout||4
8361354|NCT01205269|20610657|P6|STARTED|Period 4 - Washout||5
8361355|NCT01205269|20610658|P5|STARTED|Period 4 - Washout||5
8361356|NCT01205269|20610659|P4|STARTED|Period 4 - Washout||6
8361357|NCT01205269|20610660|P3|STARTED|Period 4 - Washout||4
8361358|NCT01205269|20610661|P2|STARTED|Period 4 - Washout||4
8361359|NCT01205269|20610662|P1|STARTED|Period 4 - Washout||4
8361360|NCT01205269|20610657|P6|NOT COMPLETED|Period 3 - Second Intervention||0
8361361|NCT01205269|20610658|P5|NOT COMPLETED|Period 3 - Second Intervention||0
8361362|NCT01205269|20610659|P4|NOT COMPLETED|Period 3 - Second Intervention||0
8361363|NCT01205269|20610660|P3|NOT COMPLETED|Period 3 - Second Intervention||0
8361364|NCT01205269|20610661|P2|NOT COMPLETED|Period 3 - Second Intervention||0
8361365|NCT01205269|20610662|P1|NOT COMPLETED|Period 3 - Second Intervention||0
8361366|NCT01205269|20610657|P6|COMPLETED|Period 3 - Second Intervention||5
8361367|NCT01205269|20610658|P5|COMPLETED|Period 3 - Second Intervention||5
8361368|NCT01205269|20610659|P4|COMPLETED|Period 3 - Second Intervention||6
8361369|NCT01205269|20610660|P3|COMPLETED|Period 3 - Second Intervention||4
8361370|NCT01205269|20610661|P2|COMPLETED|Period 3 - Second Intervention||4
8361371|NCT01205269|20610662|P1|COMPLETED|Period 3 - Second Intervention||4
8361372|NCT01205269|20610657|P6|STARTED|Period 3 - Second Intervention||5
8361373|NCT01205269|20610658|P5|STARTED|Period 3 - Second Intervention||5
8361374|NCT01205269|20610659|P4|STARTED|Period 3 - Second Intervention||6
8361375|NCT01205269|20610660|P3|STARTED|Period 3 - Second Intervention||4
8361376|NCT01205269|20610661|P2|STARTED|Period 3 - Second Intervention||4
8361377|NCT01205269|20610662|P1|STARTED|Period 3 - Second Intervention||4
8361378|NCT01205269|20610657|P6|NOT COMPLETED|Period 2 - Washout||0
8361379|NCT01205269|20610658|P5|NOT COMPLETED|Period 2 - Washout||0
8361380|NCT01205269|20610659|P4|NOT COMPLETED|Period 2 - Washout||0
8361381|NCT01205269|20610660|P3|NOT COMPLETED|Period 2 - Washout||0
8361382|NCT01205269|20610661|P2|NOT COMPLETED|Period 2 - Washout||0
8361383|NCT01205269|20610662|P1|NOT COMPLETED|Period 2 - Washout||0
8361384|NCT01205269|20610657|P6|COMPLETED|Period 2 - Washout||5
8361385|NCT01205269|20610658|P5|COMPLETED|Period 2 - Washout||5
8361386|NCT01205269|20610659|P4|COMPLETED|Period 2 - Washout||6
8361387|NCT01205269|20610660|P3|COMPLETED|Period 2 - Washout||4
8361388|NCT01205269|20610661|P2|COMPLETED|Period 2 - Washout||4
8361389|NCT01205269|20610662|P1|COMPLETED|Period 2 - Washout||4
8361390|NCT01205269|20610657|P6|STARTED|Period 2 - Washout||5
8361391|NCT01205269|20610658|P5|STARTED|Period 2 - Washout||5
8361392|NCT01205269|20610659|P4|STARTED|Period 2 - Washout||6
8361393|NCT01205269|20610660|P3|STARTED|Period 2 - Washout||4
8361394|NCT01205269|20610661|P2|STARTED|Period 2 - Washout||4
8361395|NCT01205269|20610662|P1|STARTED|Period 2 - Washout||4
8361396|NCT01205269|20610657|P6|NOT COMPLETED|Period 1 - First Intervention||0
8361397|NCT01205269|20610658|P5|NOT COMPLETED|Period 1 - First Intervention||0
8361398|NCT01205269|20610659|P4|NOT COMPLETED|Period 1 - First Intervention||0
8361399|NCT01205269|20610660|P3|NOT COMPLETED|Period 1 - First Intervention||0
8361400|NCT01205269|20610661|P2|NOT COMPLETED|Period 1 - First Intervention||0
8361401|NCT01205269|20610662|P1|NOT COMPLETED|Period 1 - First Intervention||0
8361402|NCT01205269|20610657|P6|COMPLETED|Period 1 - First Intervention||5
8361403|NCT01205269|20610658|P5|COMPLETED|Period 1 - First Intervention||5
8361404|NCT01205269|20610659|P4|COMPLETED|Period 1 - First Intervention||6
8361405|NCT01205269|20610660|P3|COMPLETED|Period 1 - First Intervention||4
8361406|NCT01205269|20610661|P2|COMPLETED|Period 1 - First Intervention||4
8361407|NCT01205269|20610662|P1|COMPLETED|Period 1 - First Intervention||4
8361408|NCT01205269|20610657|P6|STARTED|Period 1 - First Intervention||5
8361409|NCT01205269|20610658|P5|STARTED|Period 1 - First Intervention||5
8361410|NCT01205269|20610659|P4|STARTED|Period 1 - First Intervention||6
8361411|NCT01205269|20610660|P3|STARTED|Period 1 - First Intervention||4
8361412|NCT01205269|20610661|P2|STARTED|Period 1 - First Intervention||4
8361413|NCT01205269|20610662|P1|STARTED|Period 1 - First Intervention||4
8361414|NCT01205230|20610702|P2|NOT COMPLETED|Overall Study||0
8361415|NCT01205230|20610703|P1|NOT COMPLETED|Overall Study||5
8361416|NCT01205230|20610702|P2|COMPLETED|Overall Study||13
8361417|NCT01205230|20610703|P1|COMPLETED|Overall Study||16
8361418|NCT01205230|20610702|P2|Combination Therapy|Overall Study||13
8361419|NCT01205230|20610703|P1|Combination Therapy|Overall Study||21
8361420|NCT01205230|20610702|P2|STARTED|Overall Study||13
8361421|NCT01205230|20610703|P1|STARTED|Overall Study||21
8361422|NCT01205165|20610746|P1|NOT COMPLETED|Overall Study||2
8361423|NCT01205165|20610746|P1|COMPLETED|Overall Study||102
8361424|NCT01205165|20610746|P1|STARTED|Overall Study||104
8361425|NCT01205152|20610759|P1|NOT COMPLETED|Overall Study||1
8361426|NCT01205152|20610759|P1|COMPLETED|Overall Study||9
8361427|NCT01205152|20610759|P1|STARTED|Overall Study||10
8361428|NCT01205126|20610772|P2|NOT COMPLETED|Maintenance Phase||40
8361429|NCT01205126|20610773|P1|NOT COMPLETED|Maintenance Phase||37
8361430|NCT01205126|20610772|P2|COMPLETED|Maintenance Phase||67
8361431|NCT01205126|20610773|P1|COMPLETED|Maintenance Phase||70
8361432|NCT01205126|20610772|P2|STARTED|Maintenance Phase||107
8361433|NCT01205126|20610773|P1|STARTED|Maintenance Phase||107
8361434|NCT01205126|20610772|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
8361435|NCT01205126|20610773|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
8361436|NCT01205126|20610772|P2|COMPLETED|Between Titration & Maintenance Phase||107
8361437|NCT01205126|20610773|P1|COMPLETED|Between Titration & Maintenance Phase||107
8361438|NCT01205126|20610772|P2|STARTED|Between Titration & Maintenance Phase||111
8361439|NCT01205126|20610773|P1|STARTED|Between Titration & Maintenance Phase||107
8361440|NCT01205126|20610772|P2|NOT COMPLETED|Titration Phase||19
8361441|NCT01205126|20610773|P1|NOT COMPLETED|Titration Phase||23
8361442|NCT01205126|20610772|P2|COMPLETED|Titration Phase||111
8361443|NCT01205126|20610773|P1|COMPLETED|Titration Phase||107
8361444|NCT01205126|20610772|P2|STARTED|Titration Phase||130
8361445|NCT01205126|20610773|P1|STARTED|Titration Phase||130
8361446|NCT01205035|20610791|P2|NOT COMPLETED|Overall Study||0
8361447|NCT01205035|20610792|P1|NOT COMPLETED|Overall Study||2
8361448|NCT01205035|20610791|P2|COMPLETED|Overall Study||3
8361449|NCT01205035|20610792|P1|COMPLETED|Overall Study||1
8361450|NCT01205035|20610791|P2|STARTED|Overall Study||3
8361451|NCT01205035|20610792|P1|STARTED|Overall Study||3
8361452|NCT01204918|20610809|P3|NOT COMPLETED|Overall Study||5
8361453|NCT01204918|20610810|P2|NOT COMPLETED|Overall Study||10
8361454|NCT01204918|20610811|P1|NOT COMPLETED|Overall Study||4
8361455|NCT01204918|20610809|P3|COMPLETED|Overall Study||35
8361456|NCT01204918|20610810|P2|COMPLETED|Overall Study||29
8361457|NCT01204918|20610811|P1|COMPLETED|Overall Study||21
8361458|NCT01204918|20610809|P3|Stage 2 End|Overall Study||35
8361459|NCT01204918|20610810|P2|Stage 2 End|Overall Study||29
8361460|NCT01204918|20610811|P1|Stage 2 End|Overall Study||21
8361461|NCT01204918|20610809|P3|Stage 2 Begin|Overall Study||36
8361462|NCT01204918|20610810|P2|Stage 2 Begin|Overall Study||35
8361463|NCT01204918|20610811|P1|Stage 2 Begin|Overall Study||22
8361464|NCT01204918|20610809|P3|Stage 1 End|Overall Study||36
8361465|NCT01204918|20610810|P2|Stage 1 End|Overall Study||35
8361466|NCT01204918|20610811|P1|Stage 1 End|Overall Study||22
8361467|NCT01204918|20610809|P3|Stage 1 Begin|Overall Study||40
8361468|NCT01204918|20610810|P2|Stage 1 Begin|Overall Study||39
8361469|NCT01204918|20610811|P1|Stage 1 Begin|Overall Study||25
8361470|NCT01204918|20610809|P3|STARTED|Overall Study||40
8361471|NCT01204918|20610810|P2|STARTED|Overall Study||39
8361472|NCT01204918|20610811|P1|STARTED|Overall Study||25
8361473|NCT01204905|20610828|P1|NOT COMPLETED|Overall Study||2
8361474|NCT01204905|20610828|P1|COMPLETED|Overall Study||5
8361475|NCT01204905|20610828|P1|STARTED|Overall Study||7
8361476|NCT01204853|20610833|P1|NOT COMPLETED|Overall Study||0
8361477|NCT01204853|20610833|P1|COMPLETED|Overall Study||2
8361478|NCT01204853|20610833|P1|STARTED|Overall Study||2
8361479|NCT01204788|20610845|P2|NOT COMPLETED|Overall Study||3
8361480|NCT01204788|20610846|P1|NOT COMPLETED|Overall Study||1
8361481|NCT01204788|20610845|P2|COMPLETED|Overall Study||0
8361482|NCT01204788|20610846|P1|COMPLETED|Overall Study||0
8361483|NCT01204788|20610845|P2|STARTED|Overall Study||3
8361484|NCT01204788|20610846|P1|STARTED|Overall Study||1
8361485|NCT01204775|20610854|P2|NOT COMPLETED|Overall Study||1
8361486|NCT01204775|20610855|P1|NOT COMPLETED|Overall Study||1
8361487|NCT01204775|20610854|P2|COMPLETED|Overall Study||3
8361488|NCT01204775|20610855|P1|COMPLETED|Overall Study||3
8361489|NCT01204775|20610854|P2|Double-blind Treatment Period|Overall Study||4
8361490|NCT01204775|20610855|P1|Double-blind Treatment Period|Overall Study||4
8361491|NCT01204775|20610854|P2|STARTED|Overall Study||4
8361492|NCT01204775|20610855|P1|STARTED|Overall Study||4
8361493|NCT01204736|20610865|P4|NOT COMPLETED|Overall Study||0
8361494|NCT01204736|20610866|P3|NOT COMPLETED|Overall Study||0
8361495|NCT01204736|20610867|P2|NOT COMPLETED|Overall Study||0
8361496|NCT01204736|20610868|P1|NOT COMPLETED|Overall Study||0
8361497|NCT01204736|20610865|P4|COMPLETED|Overall Study||2
8361498|NCT01204736|20610866|P3|COMPLETED|Overall Study||3
8361499|NCT01204736|20610867|P2|COMPLETED|Overall Study||5
8361500|NCT01204736|20610868|P1|COMPLETED|Overall Study||4
8361501|NCT01204736|20610865|P4|STARTED|Overall Study||2
8361502|NCT01204736|20610866|P3|STARTED|Overall Study||3
8361503|NCT01204736|20610867|P2|STARTED|Overall Study||5
8361504|NCT01204736|20610868|P1|STARTED|Overall Study||4
8361505|NCT01204710|20610880|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
8361506|NCT01204710|20610881|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
8361507|NCT01204710|20610880|P2|COMPLETED|Optional Olaratumab Monotherapy||16
8361508|NCT01204710|20610881|P1|COMPLETED|Optional Olaratumab Monotherapy||0
8361509|NCT01204710|20610880|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
8361510|NCT01204710|20610881|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
8361511|NCT01204710|20610880|P2|NOT COMPLETED|Randomization Treatment||13
8361512|NCT01204710|20610881|P1|NOT COMPLETED|Randomization Treatment||14
8361513|NCT01204710|20610880|P2|COMPLETED|Randomization Treatment||47
8361514|NCT01204710|20610881|P1|COMPLETED|Randomization Treatment||49
8361515|NCT01204710|20610880|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
8361516|NCT01204710|20610881|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
8361517|NCT01204710|20610880|P2|STARTED|Randomization Treatment||60
8361518|NCT01204710|20610881|P1|STARTED|Randomization Treatment||63
8361519|NCT01204697|20610917|P2|NOT COMPLETED|Overall Study||36
8361520|NCT01204697|20610918|P1|NOT COMPLETED|Overall Study||31
8361521|NCT01204697|20610917|P2|COMPLETED|Overall Study||2
8361522|NCT01204697|20610918|P1|COMPLETED|Overall Study||5
8361523|NCT01204697|20610917|P2|Treated|Overall Study||37
8361524|NCT01204697|20610918|P1|Treated|Overall Study||36
8361525|NCT01204697|20610917|P2|STARTED|Overall Study||38
8361526|NCT01204697|20610918|P1|STARTED|Overall Study||36
8361527|NCT01204671|20610939|P5|NOT COMPLETED|Overall Study||4
8361528|NCT01204671|20610940|P4|NOT COMPLETED|Overall Study||13
8361529|NCT01204671|20610941|P3|NOT COMPLETED|Overall Study||13
8361530|NCT01204671|20610942|P2|NOT COMPLETED|Overall Study||15
8361531|NCT01204671|20610943|P1|NOT COMPLETED|Overall Study||14
8361532|NCT01204671|20610939|P5|COMPLETED|Overall Study||606
8361533|NCT01204671|20610940|P4|COMPLETED|Overall Study||997
8361534|NCT01204671|20610941|P3|COMPLETED|Overall Study||998
8361535|NCT01204671|20610942|P2|COMPLETED|Overall Study||998
8361536|NCT01204671|20610943|P1|COMPLETED|Overall Study||998
8361537|NCT01204671|20610939|P5|STARTED|Overall Study||610
8361538|NCT01204671|20610940|P4|STARTED|Overall Study||1010
8361539|NCT01204671|20610941|P3|STARTED|Overall Study||1011
8361540|NCT01204671|20610942|P2|STARTED|Overall Study||1013
8361541|NCT01204671|20610943|P1|STARTED|Overall Study||1012
8361542|NCT01204658|20611005|P4|NOT COMPLETED|Booster Phase||0
8361543|NCT01204658|20611006|P3|NOT COMPLETED|Booster Phase||0
8361544|NCT01204658|20611007|P2|NOT COMPLETED|Booster Phase||0
8361545|NCT01204658|20611008|P1|NOT COMPLETED|Booster Phase||0
8361546|NCT01204658|20611005|P4|COMPLETED|Booster Phase||140
8361547|NCT01204658|20611006|P3|COMPLETED|Booster Phase||140
8361548|NCT01204658|20611007|P2|COMPLETED|Booster Phase||140
8361549|NCT01204658|20611008|P1|COMPLETED|Booster Phase||144
8361550|NCT01204658|20611005|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8361551|NCT01204658|20611006|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8361552|NCT01204658|20611007|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8361553|NCT01204658|20611008|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
8361554|NCT01204658|20611005|P4|NOT COMPLETED|Primary Phase||0
8361555|NCT01204658|20611006|P3|NOT COMPLETED|Primary Phase||1
8361556|NCT01204658|20611007|P2|NOT COMPLETED|Primary Phase||0
8361557|NCT01204658|20611008|P1|NOT COMPLETED|Primary Phase||0
8361558|NCT01204658|20611005|P4|COMPLETED|Primary Phase||142
8361559|NCT01204658|20611006|P3|COMPLETED|Primary Phase||144
8361560|NCT01204658|20611007|P2|COMPLETED|Primary Phase||142
8361561|NCT01204658|20611008|P1|COMPLETED|Primary Phase||146
8361562|NCT01204658|20611005|P4|STARTED|Primary Phase||142
8361563|NCT01204658|20611006|P3|STARTED|Primary Phase||145
8361564|NCT01204658|20611007|P2|STARTED|Primary Phase||142
8361565|NCT01204658|20611008|P1|STARTED|Primary Phase||146
8361566|NCT01204398|20611126|P1|NOT COMPLETED|Overall Study||1
8361567|NCT01204398|20611126|P1|COMPLETED|Overall Study|Completed trial medication.|26
8361568|NCT01204398|20611126|P1|STARTED|Overall Study|Entered and treated.|27
8361569|NCT01204294|20611143|P7|NOT COMPLETED|Overall Study||2
8361570|NCT01204294|20611144|P6|NOT COMPLETED|Overall Study||5
8361571|NCT01204294|20611145|P5|NOT COMPLETED|Overall Study||2
8361572|NCT01204294|20611146|P4|NOT COMPLETED|Overall Study||11
8361573|NCT01204294|20611147|P3|NOT COMPLETED|Overall Study||5
8361574|NCT01204294|20611148|P2|NOT COMPLETED|Overall Study||8
8361575|NCT01204294|20611149|P1|NOT COMPLETED|Overall Study||3
8361576|NCT01204294|20611143|P7|COMPLETED|Overall Study||59
8361577|NCT01204294|20611144|P6|COMPLETED|Overall Study||58
8361578|NCT01204294|20611145|P5|COMPLETED|Overall Study||83
8361579|NCT01204294|20611146|P4|COMPLETED|Overall Study||132
8361580|NCT01204294|20611147|P3|COMPLETED|Overall Study||69
8361581|NCT01204294|20611148|P2|COMPLETED|Overall Study||58
8361582|NCT01204294|20611149|P1|COMPLETED|Overall Study||79
8361583|NCT01204294|20611143|P7|STARTED|Overall Study||61
8361584|NCT01204294|20611144|P6|STARTED|Overall Study||63
8361585|NCT01204294|20611145|P5|STARTED|Overall Study||85
8361586|NCT01204294|20611146|P4|STARTED|Overall Study||143
8361587|NCT01204294|20611147|P3|STARTED|Overall Study||74
8361588|NCT01204294|20611148|P2|STARTED|Overall Study||66
8361589|NCT01204294|20611149|P1|STARTED|Overall Study||82
8361590|NCT01204255|20611172|P1|NOT COMPLETED|Overall Study||1
8361591|NCT01204255|20611172|P1|COMPLETED|Overall Study||10
8361592|NCT01204255|20611172|P1|STARTED|Overall Study||11
8361593|NCT01204203|20611177|P1|NOT COMPLETED|Overall Study||0
8361594|NCT01204203|20611177|P1|COMPLETED|Overall Study||8
8361595|NCT01204203|20611177|P1|STARTED|Overall Study||8
8361596|NCT01203956|20611183|P2|NOT COMPLETED|Second Two-week Period||6
8361597|NCT01203956|20611184|P1|NOT COMPLETED|Second Two-week Period||5
8361598|NCT01203956|20611183|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
8361599|NCT01203956|20611184|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
8361600|NCT01203956|20611183|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
8361601|NCT01203956|20611184|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
8361602|NCT01203956|20611183|P2|STARTED|Second Two-week Period||13
8361603|NCT01203956|20611184|P1|STARTED|Second Two-week Period||15
8361604|NCT01203956|20611183|P2|NOT COMPLETED|First Two-week Period||0
8361605|NCT01203956|20611184|P1|NOT COMPLETED|First Two-week Period||0
8361606|NCT01203956|20611183|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
8361607|NCT01203956|20611184|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
8361608|NCT01203956|20611183|P2|STARTED|First Two-week Period||13
8361609|NCT01203956|20611184|P1|STARTED|First Two-week Period||15
8361610|NCT01203930|20611193|P2|NOT COMPLETED|Overall Study||41
8361611|NCT01203930|20611194|P1|NOT COMPLETED|Overall Study||21
8361612|NCT01203930|20611193|P2|COMPLETED|Overall Study||0
8361613|NCT01203930|20611194|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
8361614|NCT01203930|20611193|P2|STARTED|Overall Study||41
8361615|NCT01203930|20611194|P1|STARTED|Overall Study||64
8361616|NCT01203917|20611216|P1|NOT COMPLETED|Overall Study||36
8361617|NCT01203917|20611216|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
8361618|NCT01203917|20611216|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
8361619|NCT01203878|20611229|P3|NOT COMPLETED|Overall Study||3
8361620|NCT01203878|20611230|P2|NOT COMPLETED|Overall Study||0
8361621|NCT01203878|20611231|P1|NOT COMPLETED|Overall Study||0
8361622|NCT01203878|20611229|P3|COMPLETED|Overall Study||0
8361623|NCT01203878|20611230|P2|COMPLETED|Overall Study||9
8361624|NCT01203878|20611231|P1|COMPLETED|Overall Study||9
8361625|NCT01203878|20611229|P3|STARTED|Overall Study||3
8361626|NCT01203878|20611230|P2|STARTED|Overall Study||9
8361627|NCT01203878|20611231|P1|STARTED|Overall Study||9
8361628|NCT01203852|20611242|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
8361629|NCT01203852|20611242|P1|COMPLETED|Chlorthalidone 8 Weeks||328
8361630|NCT01203852|20611242|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
8361631|NCT01203852|20611242|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
8361632|NCT01203852|20611242|P1|NOT COMPLETED|Washout 2 Weeks||46
8361633|NCT01203852|20611242|P1|COMPLETED|Washout 2 Weeks||282
8361634|NCT01203852|20611242|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
8361635|NCT01203852|20611242|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
8361636|NCT01203852|20611242|P1|COMPLETED|Metoprolol 8 Weeks||369
8361637|NCT01203852|20611242|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
8361638|NCT01203826|20611251|P2|NOT COMPLETED|Overall Study||0
8361639|NCT01203826|20611252|P1|NOT COMPLETED|Overall Study||0
8361640|NCT01203826|20611251|P2|COMPLETED|Overall Study||6
8361641|NCT01203826|20611252|P1|COMPLETED|Overall Study||6
8361642|NCT01203826|20611251|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
8361643|NCT01203826|20611252|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
8361644|NCT01203787|20611260|P2|NOT COMPLETED|Overall Study||27
8361645|NCT01203787|20611261|P1|NOT COMPLETED|Overall Study||31
8361646|NCT01203787|20611260|P2|COMPLETED|Overall Study||30
8361647|NCT01203787|20611261|P1|COMPLETED|Overall Study||32
8361648|NCT01203787|20611260|P2|STARTED|Overall Study||57
8361649|NCT01203787|20611261|P1|STARTED|Overall Study||63
8361650|NCT01203644|20611281|P2|NOT COMPLETED|Overall Study||0
8361651|NCT01203644|20611282|P1|NOT COMPLETED|Overall Study||0
8361652|NCT01203644|20611281|P2|COMPLETED|Overall Study||50
8361653|NCT01203644|20611282|P1|COMPLETED|Overall Study||26
8361654|NCT01203644|20611281|P2|STARTED|Overall Study||50
8361655|NCT01203644|20611282|P1|STARTED|Overall Study||26
8361656|NCT01203319|20611294|P3|NOT COMPLETED|Overall Study||5
8361657|NCT01203319|20611295|P2|NOT COMPLETED|Overall Study||9
8361658|NCT01203319|20611296|P1|NOT COMPLETED|Overall Study||6
8361659|NCT01203319|20611294|P3|COMPLETED|Overall Study||217
8361660|NCT01203319|20611295|P2|COMPLETED|Overall Study||426
8361661|NCT01203319|20611296|P1|COMPLETED|Overall Study||428
8361662|NCT01203319|20611294|P3|STARTED|Overall Study||222
8361663|NCT01203319|20611295|P2|STARTED|Overall Study||435
8361664|NCT01203319|20611296|P1|STARTED|Overall Study||434
8361665|NCT01203189|20611313|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361666|NCT01203189|20611314|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361667|NCT01203189|20611315|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361668|NCT01203189|20611313|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
8361669|NCT01203189|20611314|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361670|NCT01203189|20611315|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361671|NCT01203189|20611313|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
8361672|NCT01203189|20611314|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
8361673|NCT01203189|20611315|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
8361674|NCT01203189|20611313|P3|NOT COMPLETED|First 4 Weeks Treatment||0
8361675|NCT01203189|20611314|P2|NOT COMPLETED|First 4 Weeks Treatment||2
8361676|NCT01203189|20611315|P1|NOT COMPLETED|First 4 Weeks Treatment||2
8361677|NCT01203189|20611313|P3|COMPLETED|First 4 Weeks Treatment||3
8361678|NCT01203189|20611314|P2|COMPLETED|First 4 Weeks Treatment||8
8361679|NCT01203189|20611315|P1|COMPLETED|First 4 Weeks Treatment||8
8361680|NCT01203189|20611313|P3|STARTED|First 4 Weeks Treatment||3
8361681|NCT01203189|20611314|P2|STARTED|First 4 Weeks Treatment||10
8361682|NCT01203189|20611315|P1|STARTED|First 4 Weeks Treatment||10
8361683|NCT01203098|20611332|P3|NOT COMPLETED|Overall Study||11
8361684|NCT01203098|20611333|P2|NOT COMPLETED|Overall Study||4
8361685|NCT01203098|20611334|P1|NOT COMPLETED|Overall Study||6
8361686|NCT01203098|20611332|P3|COMPLETED|Overall Study||78
8361687|NCT01203098|20611333|P2|COMPLETED|Overall Study||82
8361688|NCT01203098|20611334|P1|COMPLETED|Overall Study||83
8361689|NCT01203098|20611332|P3|Safety Analysis Dataset|Overall Study||87
8361690|NCT01203098|20611333|P2|Safety Analysis Dataset|Overall Study||85
8361691|NCT01203098|20611334|P1|Safety Analysis Dataset|Overall Study||89
8361692|NCT01203098|20611332|P3|STARTED|Overall Study||89
8361693|NCT01203098|20611333|P2|STARTED|Overall Study||86
8361694|NCT01203098|20611334|P1|STARTED|Overall Study||89
8361695|NCT01203072|20611350|P5|NOT COMPLETED|Overall Study||6
8361696|NCT01203072|20611351|P4|NOT COMPLETED|Overall Study||6
8361697|NCT01203072|20611352|P3|NOT COMPLETED|Overall Study||3
8361698|NCT01203072|20611353|P2|NOT COMPLETED|Overall Study||6
8361699|NCT01203072|20611354|P1|NOT COMPLETED|Overall Study||10
8361700|NCT01203072|20611350|P5|COMPLETED|Overall Study||96
8361701|NCT01203072|20611351|P4|COMPLETED|Overall Study||100
8361702|NCT01203072|20611352|P3|COMPLETED|Overall Study||101
8361703|NCT01203072|20611353|P2|COMPLETED|Overall Study||100
8361704|NCT01203072|20611354|P1|COMPLETED|Overall Study||95
8361705|NCT01203072|20611350|P5|STARTED|Overall Study||102
8361706|NCT01203072|20611351|P4|STARTED|Overall Study||106
8361707|NCT01203072|20611352|P3|STARTED|Overall Study||104
8361708|NCT01203072|20611353|P2|STARTED|Overall Study||106
8361709|NCT01203072|20611354|P1|STARTED|Overall Study||105
8361710|NCT01203046|20611373|P2|NOT COMPLETED|Overall Study||0
8361711|NCT01203046|20611374|P1|NOT COMPLETED|Overall Study||0
8361712|NCT01203046|20611373|P2|COMPLETED|Overall Study||28
8361713|NCT01203046|20611374|P1|COMPLETED|Overall Study||28
8361714|NCT01203046|20611373|P2|STARTED|Overall Study||28
8361715|NCT01203046|20611374|P1|STARTED|Overall Study||28
8361716|NCT01202994|20611382|P1|NOT COMPLETED|Overall Study||0
8361717|NCT01202994|20611382|P1|COMPLETED|Overall Study||27
8361718|NCT01202994|20611382|P1|STARTED|Overall Study||27
8361719|NCT01202955|20611389|P2|NOT COMPLETED|Period 3: 10 Days||0
8361720|NCT01202955|20611390|P1|NOT COMPLETED|Period 3: 10 Days||0
8361721|NCT01202955|20611389|P2|COMPLETED|Period 3: 10 Days||8
8361722|NCT01202955|20611390|P1|COMPLETED|Period 3: 10 Days||9
8361723|NCT01202955|20611389|P2|STARTED|Period 3: 10 Days||8
8361724|NCT01202955|20611390|P1|STARTED|Period 3: 10 Days||9
8361725|NCT01202955|20611389|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
8361726|NCT01202955|20611390|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
8361727|NCT01202955|20611389|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
8361728|NCT01202955|20611390|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
8361729|NCT01202955|20611389|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
8361730|NCT01202955|20611390|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
8361731|NCT01202955|20611389|P2|NOT COMPLETED|Period 1: 10 Days||2
8361732|NCT01202955|20611390|P1|NOT COMPLETED|Period 1: 10 Days||0
8361733|NCT01202955|20611389|P2|COMPLETED|Period 1: 10 Days||8
8361734|NCT01202955|20611390|P1|COMPLETED|Period 1: 10 Days||9
8361735|NCT01202955|20611389|P2|STARTED|Period 1: 10 Days||10
8361736|NCT01202955|20611390|P1|STARTED|Period 1: 10 Days||9
8361737|NCT01202903|20611402|P2|NOT COMPLETED|Overall Study||16
8361738|NCT01202903|20611403|P1|NOT COMPLETED|Overall Study||11
8361739|NCT01202903|20611402|P2|COMPLETED|Overall Study||292
8361740|NCT01202903|20611403|P1|COMPLETED|Overall Study||297
8361741|NCT01202903|20611402|P2|Safety Set*|Overall Study||299
8361742|NCT01202903|20611403|P1|Safety Set*|Overall Study||310
8361743|NCT01202903|20611402|P2|Full Analysis Set|Overall Study||302
8361744|NCT01202903|20611403|P1|Full Analysis Set|Overall Study||306
8361745|NCT01202903|20611402|P2|STARTED|Overall Study||308
8361746|NCT01202903|20611403|P1|STARTED|Overall Study||308
8361747|NCT01202877|20611430|P3|NOT COMPLETED|Overall Study||6
8361748|NCT01202877|20611431|P2|NOT COMPLETED|Overall Study||1
8361749|NCT01202877|20611432|P1|NOT COMPLETED|Overall Study||0
8361750|NCT01202877|20611430|P3|COMPLETED|Overall Study||34
8361751|NCT01202877|20611431|P2|COMPLETED|Overall Study||7
8361752|NCT01202877|20611432|P1|COMPLETED|Overall Study||6
8361753|NCT01202877|20611430|P3|STARTED|Overall Study||40
8361754|NCT01202877|20611431|P2|STARTED|Overall Study||8
8361755|NCT01202877|20611432|P1|STARTED|Overall Study||6
8361756|NCT01202773|20611446|P3|NOT COMPLETED|Overall Study||55
8361757|NCT01202773|20611447|P2|NOT COMPLETED|Overall Study||43
8361758|NCT01202773|20611448|P1|NOT COMPLETED|Overall Study||57
8361759|NCT01202773|20611446|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
8361760|NCT01202773|20611447|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
8361761|NCT01202773|20611448|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
8361762|NCT01202773|20611446|P3|Post-Treatment Follow-Up Population|Overall Study||51
8361763|NCT01202773|20611447|P2|Post-Treatment Follow-Up Population|Overall Study||36
8361764|NCT01202773|20611448|P1|Post-Treatment Follow-Up Population|Overall Study||46
8361765|NCT01202773|20611446|P3|Week 16 NR|Overall Study||37
8361766|NCT01202773|20611447|P2|Week 16 NR|Overall Study||33
8361767|NCT01202773|20611448|P1|Week 16 NR|Overall Study||23
8361768|NCT01202773|20611446|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
8361769|NCT01202773|20611447|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
8361770|NCT01202773|20611448|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
8361771|NCT01202773|20611446|P3|STARTED|Overall Study||155
8361772|NCT01202773|20611447|P2|STARTED|Overall Study||148
8361773|NCT01202773|20611448|P1|STARTED|Overall Study||153
8361774|NCT01202760|20611525|P3|NOT COMPLETED|Overall Study||35
8361775|NCT01202760|20611526|P2|NOT COMPLETED|Overall Study||52
8361776|NCT01202760|20611527|P1|NOT COMPLETED|Overall Study||47
8361777|NCT01202760|20611525|P3|COMPLETED|Overall Study||216
8361778|NCT01202760|20611526|P2|COMPLETED|Overall Study||322
8361779|NCT01202760|20611527|P1|COMPLETED|Overall Study||332
8361780|NCT01202760|20611525|P3|Received at Least One Dose of Study Drug|Overall Study||250
8361781|NCT01202760|20611526|P2|Received at Least One Dose of Study Drug|Overall Study||371
8361782|NCT01202760|20611527|P1|Received at Least One Dose of Study Drug|Overall Study||379
8361783|NCT01202760|20611525|P3|STARTED|Overall Study||251
8361784|NCT01202760|20611526|P2|STARTED|Overall Study||374
8361785|NCT01202760|20611527|P1|STARTED|Overall Study||379
8361786|NCT01202747|20611595|P1|NOT COMPLETED|Overall Study||1
8361787|NCT01202747|20611595|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
8361788|NCT01202747|20611595|P1|STARTED|Overall Study||50
8361789|NCT01202721|20611603|P4|NOT COMPLETED|Overall Study||0
8361790|NCT01202721|20611604|P3|NOT COMPLETED|Overall Study||0
8361791|NCT01202721|20611605|P2|NOT COMPLETED|Overall Study||0
8361792|NCT01202721|20611606|P1|NOT COMPLETED|Overall Study||0
8361793|NCT01202721|20611603|P4|COMPLETED|Overall Study||27
8361794|NCT01202721|20611604|P3|COMPLETED|Overall Study||14
8361795|NCT01202721|20611605|P2|COMPLETED|Overall Study||26
8361796|NCT01202721|20611606|P1|COMPLETED|Overall Study||18
8361797|NCT01202721|20611603|P4|STARTED|Overall Study||27
8361798|NCT01202721|20611604|P3|STARTED|Overall Study||14
8361799|NCT01202721|20611605|P2|STARTED|Overall Study||26
8361800|NCT01202721|20611606|P1|STARTED|Overall Study||18
8361801|NCT01202656|20611622|P2|NOT COMPLETED|CrossoverCycle||0
8361802|NCT01202656|20611623|P1|NOT COMPLETED|CrossoverCycle||0
8361803|NCT01202656|20611622|P2|COMPLETED|CrossoverCycle||14
8361804|NCT01202656|20611623|P1|COMPLETED|CrossoverCycle||18
8361805|NCT01202656|20611622|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
8361806|NCT01202656|20611623|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
8361807|NCT01202656|20611622|P2|NOT COMPLETED|Cycle 1||0
8361808|NCT01202656|20611623|P1|NOT COMPLETED|Cycle 1||0
8361809|NCT01202656|20611622|P2|COMPLETED|Cycle 1||62
8361810|NCT01202656|20611623|P1|COMPLETED|Cycle 1||67
8361811|NCT01202656|20611622|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
8361812|NCT01202656|20611623|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
8361813|NCT01202643|20611633|P2|NOT COMPLETED|Crossover Cycle||0
8361814|NCT01202643|20611634|P1|NOT COMPLETED|Crossover Cycle||0
8361815|NCT01202643|20611633|P2|COMPLETED|Crossover Cycle||2
8361816|NCT01202643|20611634|P1|COMPLETED|Crossover Cycle||1
8361817|NCT01202643|20611633|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
8361818|NCT01202643|20611634|P1|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
8361819|NCT01202643|20611633|P2|NOT COMPLETED|Period 1||0
8361820|NCT01202643|20611634|P1|NOT COMPLETED|Period 1||0
8361821|NCT01202643|20611633|P2|COMPLETED|Period 1||6
8361822|NCT01202643|20611634|P1|COMPLETED|Period 1||6
8361823|NCT01202643|20611633|P2|STARTED|Period 1||6
8361824|NCT01202643|20611634|P1|STARTED|Period 1||6
8361825|NCT01202591|20611648|P6|NOT COMPLETED|Overall Study||4
8361826|NCT01202591|20611649|P5|NOT COMPLETED|Overall Study||5
8361827|NCT01202591|20611650|P4|NOT COMPLETED|Overall Study||7
8361828|NCT01202591|20611651|P3|NOT COMPLETED|Overall Study||11
8361829|NCT01202591|20611652|P2|NOT COMPLETED|Overall Study||5
8361830|NCT01202591|20611653|P1|NOT COMPLETED|Overall Study||5
8361831|NCT01202591|20611648|P6|COMPLETED|Overall Study||0
8361832|NCT01202591|20611649|P5|COMPLETED|Overall Study||0
8361833|NCT01202591|20611650|P4|COMPLETED|Overall Study||2
8361834|NCT01202591|20611651|P3|COMPLETED|Overall Study||1
8361835|NCT01202591|20611652|P2|COMPLETED|Overall Study||0
8361836|NCT01202591|20611653|P1|COMPLETED|Overall Study||0
8361837|NCT01202591|20611648|P6|STARTED|Overall Study||4
8361838|NCT01202591|20611649|P5|STARTED|Overall Study||5
8361839|NCT01202591|20611650|P4|STARTED|Overall Study||9
8361840|NCT01202591|20611651|P3|STARTED|Overall Study||12
8361841|NCT01202591|20611652|P2|STARTED|Overall Study||5
8361842|NCT01202591|20611653|P1|STARTED|Overall Study||5
8361843|NCT01202578|20611667|P1|NOT COMPLETED|Overall Study||0
8361844|NCT01202578|20611667|P1|COMPLETED|Overall Study||53
8361845|NCT01202578|20611667|P1|STARTED|Overall Study||53
8361846|NCT01202565|20611674|P1|NOT COMPLETED|Overall Study||67
8361847|NCT01202565|20611674|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
8361848|NCT01202565|20611674|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
8361849|NCT01202565|20611674|P1|STARTED|Overall Study||506
8361850|NCT01202409|20611697|P1|NOT COMPLETED|Overall Study||8
8361851|NCT01202409|20611697|P1|COMPLETED|Overall Study||11
8361852|NCT01202409|20611697|P1|STARTED|Overall Study||19
8361853|NCT01202279|20611704|P2|NOT COMPLETED|Overall Study||27
8361854|NCT01202279|20611705|P1|NOT COMPLETED|Overall Study||37
8361855|NCT01202279|20611704|P2|COMPLETED|Overall Study||561
8361856|NCT01202279|20611705|P1|COMPLETED|Overall Study||554
8361857|NCT01202279|20611704|P2|STARTED|Overall Study||588
8361858|NCT01202279|20611705|P1|STARTED|Overall Study||591
8361859|NCT01202253|20611713|P1|NOT COMPLETED|Overall Study||0
8361860|NCT01202253|20611713|P1|COMPLETED|Overall Study||50
8361861|NCT01202253|20611713|P1|STARTED|Overall Study||50
8361862|NCT01202188|20611762|P5|NOT COMPLETED|Overall Study||45
8361863|NCT01202188|20611763|P4|NOT COMPLETED|Overall Study||42
8361864|NCT01202188|20611764|P3|NOT COMPLETED|Overall Study||53
8361865|NCT01202188|20611765|P2|NOT COMPLETED|Overall Study||56
8361866|NCT01202188|20611766|P1|NOT COMPLETED|Overall Study||38
8361867|NCT01202188|20611762|P5|COMPLETED|Overall Study||189
8361868|NCT01202188|20611763|P4|COMPLETED|Overall Study||441
8361869|NCT01202188|20611764|P3|COMPLETED|Overall Study||422
8361870|NCT01202188|20611765|P2|COMPLETED|Overall Study||421
8361871|NCT01202188|20611766|P1|COMPLETED|Overall Study||437
8361872|NCT01202188|20611762|P5|Safety Set; Received Study Drug|Overall Study||232
8361873|NCT01202188|20611763|P4|Safety Set; Received Study Drug|Overall Study||480
8361874|NCT01202188|20611764|P3|Safety Set; Received Study Drug|Overall Study||473
8361875|NCT01202188|20611765|P2|Safety Set; Received Study Drug|Overall Study||476
8361876|NCT01202188|20611766|P1|Safety Set; Received Study Drug|Overall Study||474
8361877|NCT01202188|20611762|P5|STARTED|Overall Study||234
8361878|NCT01202188|20611763|P4|STARTED|Overall Study||483
8361879|NCT01202188|20611764|P3|STARTED|Overall Study||475
8361880|NCT01202188|20611765|P2|STARTED|Overall Study||477
8361881|NCT01202188|20611766|P1|STARTED|Overall Study||475
8361882|NCT01202175|20611874|P1|NOT COMPLETED|Overall Study||5
8361883|NCT01202175|20611874|P1|COMPLETED|Overall Study||45
8361884|NCT01202175|20611874|P1|Pacebo|Overall Study||25
8361885|NCT01202175|20611874|P1|Nebivolol|Overall Study||25
8361886|NCT01202175|20611874|P1|STARTED|Overall Study||50
8361887|NCT01202162|20611903|P2|NOT COMPLETED|Overall Study||2
8361888|NCT01202162|20611904|P1|NOT COMPLETED|Overall Study||3
8361889|NCT01202162|20611903|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
8361890|NCT01202162|20611904|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
8361891|NCT01202162|20611903|P2|STARTED|Overall Study||42
8361892|NCT01202162|20611904|P1|STARTED|Overall Study||43
8361893|NCT01202110|20611914|P2|NOT COMPLETED|Overall Study||0
8361894|NCT01202110|20611915|P1|NOT COMPLETED|Overall Study||0
8361895|NCT01202110|20611914|P2|COMPLETED|Overall Study||0
8361896|NCT01202110|20611915|P1|COMPLETED|Overall Study||10
8361897|NCT01202110|20611914|P2|STARTED|Overall Study||0
8361898|NCT01202110|20611915|P1|STARTED|Overall Study||10
8361899|NCT01202071|20611919|P4|NOT COMPLETED|Overall Study||0
8361900|NCT01202071|20611920|P3|NOT COMPLETED|Overall Study||0
8361901|NCT01202071|20611921|P2|NOT COMPLETED|Overall Study||0
8361902|NCT01202071|20611922|P1|NOT COMPLETED|Overall Study||0
8361903|NCT01202071|20611919|P4|COMPLETED|Overall Study||6
8361904|NCT01202071|20611920|P3|COMPLETED|Overall Study||6
8361905|NCT01202071|20611921|P2|COMPLETED|Overall Study||6
8361906|NCT01202071|20611922|P1|COMPLETED|Overall Study||6
8361907|NCT01202071|20611919|P4|STARTED|Overall Study||6
8361908|NCT01202071|20611920|P3|STARTED|Overall Study||6
8361909|NCT01202071|20611921|P2|STARTED|Overall Study||6
8361910|NCT01202071|20611922|P1|STARTED|Overall Study||6
8361911|NCT01201967|20611942|P2|NOT COMPLETED|Overall Study||5
8361912|NCT01201967|20611943|P1|NOT COMPLETED|Overall Study||6
8361913|NCT01201967|20611942|P2|COMPLETED|Overall Study||86
8361914|NCT01201967|20611943|P1|COMPLETED|Overall Study||86
8361915|NCT01201967|20611942|P2|STARTED|Overall Study||91
8361916|NCT01201967|20611943|P1|STARTED|Overall Study||92
8361917|NCT01201915|20611968|P3|NOT COMPLETED|Overall Study||6
8361918|NCT01201915|20611969|P2|NOT COMPLETED|Overall Study||11
8361919|NCT01201915|20611970|P1|NOT COMPLETED|Overall Study||8
8361920|NCT01201915|20611968|P3|COMPLETED|Overall Study||19
8361921|NCT01201915|20611969|P2|COMPLETED|Overall Study||14
8361922|NCT01201915|20611970|P1|COMPLETED|Overall Study||16
8361923|NCT01201915|20611968|P3|STARTED|Overall Study||25
8361924|NCT01201915|20611969|P2|STARTED|Overall Study||25
8361925|NCT01201915|20611970|P1|STARTED|Overall Study||24
8361926|NCT01201811|20611981|P1|NOT COMPLETED|Overall Study||19
8361927|NCT01201811|20611981|P1|COMPLETED|Overall Study||25
8361928|NCT01201811|20611981|P1|STARTED|Overall Study||44
8361929|NCT01201798|20612003|P2|NOT COMPLETED|Overall Study||15
8361930|NCT01201798|20612004|P1|NOT COMPLETED|Overall Study||9
8361931|NCT01201798|20612003|P2|COMPLETED|Overall Study||39
8361932|NCT01201798|20612004|P1|COMPLETED|Overall Study||47
8361933|NCT01201798|20612003|P2|STARTED|Overall Study||54
8361934|NCT01201798|20612004|P1|STARTED|Overall Study||56
8361935|NCT01201785|20612028|P1|NOT COMPLETED|Overall Study||16
8361936|NCT01201785|20612028|P1|COMPLETED|Overall Study||20
8361937|NCT01201785|20612028|P1|STARTED|Overall Study||36
8361938|NCT01201772|20612035|P3|NOT COMPLETED|Overall Study||0
8361939|NCT01201772|20612036|P2|NOT COMPLETED|Overall Study||0
8361940|NCT01201772|20612037|P1|NOT COMPLETED|Overall Study||1
8361941|NCT01201772|20612035|P3|COMPLETED|Overall Study||21
8361942|NCT01201772|20612036|P2|COMPLETED|Overall Study||21
8361943|NCT01201772|20612037|P1|COMPLETED|Overall Study||22
8361944|NCT01201772|20612035|P3|STARTED|Overall Study||21
8361945|NCT01201772|20612036|P2|STARTED|Overall Study||21
8361946|NCT01201772|20612037|P1|STARTED|Overall Study||23
8361947|NCT01201759|20612045|P2|NOT COMPLETED|Visit 5||0
8361948|NCT01201759|20612046|P1|NOT COMPLETED|Visit 5||0
8361949|NCT01201759|20612045|P2|COMPLETED|Visit 5||3
8361950|NCT01201759|20612046|P1|COMPLETED|Visit 5||7
8361951|NCT01201759|20612045|P2|STARTED|Visit 5||3
8361952|NCT01201759|20612046|P1|STARTED|Visit 5||7
8361953|NCT01201759|20612045|P2|NOT COMPLETED|Visit 4 Crossover||1
8361954|NCT01201759|20612046|P1|NOT COMPLETED|Visit 4 Crossover||0
8361955|NCT01201759|20612045|P2|COMPLETED|Visit 4 Crossover||3
8361956|NCT01201759|20612046|P1|COMPLETED|Visit 4 Crossover||7
8361957|NCT01201759|20612045|P2|STARTED|Visit 4 Crossover||4
8361958|NCT01201759|20612046|P1|STARTED|Visit 4 Crossover||7
8361959|NCT01201759|20612045|P2|NOT COMPLETED|Visit 3 - Washout||3
8361960|NCT01201759|20612046|P1|NOT COMPLETED|Visit 3 - Washout||1
8361961|NCT01201759|20612045|P2|COMPLETED|Visit 3 - Washout||4
8361962|NCT01201759|20612046|P1|COMPLETED|Visit 3 - Washout||7
8361963|NCT01201759|20612045|P2|STARTED|Visit 3 - Washout||7
8361964|NCT01201759|20612046|P1|STARTED|Visit 3 - Washout||8
8361965|NCT01201759|20612045|P2|NOT COMPLETED|Visit 2||0
8361966|NCT01201759|20612046|P1|NOT COMPLETED|Visit 2||0
8361967|NCT01201759|20612045|P2|COMPLETED|Visit 2||7
8361968|NCT01201759|20612046|P1|COMPLETED|Visit 2||8
8361969|NCT01201759|20612045|P2|STARTED|Visit 2||7
8361970|NCT01201759|20612046|P1|STARTED|Visit 2||8
8361971|NCT01201759|20612045|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
8361972|NCT01201759|20612046|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
8361973|NCT01201759|20612045|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
8361974|NCT01201759|20612046|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
8361975|NCT01201759|20612045|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
8361976|NCT01201759|20612046|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
8361977|NCT01201629|20612060|P2|NOT COMPLETED|Overall Study||0
8361978|NCT01201629|20612061|P1|NOT COMPLETED|Overall Study||0
8361979|NCT01201629|20612060|P2|COMPLETED|Overall Study||8
8361980|NCT01201629|20612061|P1|COMPLETED|Overall Study||8
8361981|NCT01201629|20612060|P2|STARTED|Overall Study||8
8361982|NCT01201629|20612061|P1|STARTED|Overall Study||8
8361983|NCT01201486|20612071|P1|NOT COMPLETED|Overall Study||0
8361984|NCT01201486|20612071|P1|COMPLETED|Overall Study||6781
8361985|NCT01201486|20612071|P1|STARTED|Overall Study||6781
8361986|NCT01201356|20612075|P1|NOT COMPLETED|Overall Study||644
8361987|NCT01201356|20612075|P1|COMPLETED|Overall Study||3481
8361988|NCT01201356|20612075|P1|Fingolimod Full Analysis Set|Overall Study||4046
8361989|NCT01201356|20612075|P1|Safety Set|Overall Study||4083
8361990|NCT01201356|20612075|P1|STARTED|Overall Study||4125
8361991|NCT01201343|20612089|P1|NOT COMPLETED|Overall Study||19
8361992|NCT01201343|20612089|P1|COMPLETED|Overall Study||60
8361993|NCT01201343|20612089|P1|Treated|Overall Study||76
8361994|NCT01201343|20612089|P1|STARTED|Overall Study||79
8361995|NCT01201317|20612103|P3|NOT COMPLETED|Overall Study||8
8361996|NCT01201317|20612104|P2|NOT COMPLETED|Overall Study||7
8361997|NCT01201317|20612105|P1|NOT COMPLETED|Overall Study||9
8361998|NCT01201317|20612103|P3|COMPLETED|Overall Study||33
8361999|NCT01201317|20612104|P2|COMPLETED|Overall Study||38
8362000|NCT01201317|20612105|P1|COMPLETED|Overall Study||39
8362001|NCT01201317|20612103|P3|STARTED|Overall Study||41
8362002|NCT01201317|20612104|P2|STARTED|Overall Study||45
8362003|NCT01201317|20612105|P1|STARTED|Overall Study||48
8362004|NCT01201265|20612125|P1|NOT COMPLETED|Overall Study||38
8362005|NCT01201265|20612125|P1|COMPLETED|Overall Study||2
8362006|NCT01201265|20612125|P1|STARTED|Overall Study||40
8362007|NCT01201057|20612141|P4|NOT COMPLETED|Overall Study||4
8362008|NCT01201057|20612142|P3|NOT COMPLETED|Overall Study||5
8362009|NCT01201057|20612143|P2|NOT COMPLETED|Overall Study||4
8362010|NCT01201057|20612144|P1|NOT COMPLETED|Overall Study||2
8362011|NCT01201057|20612141|P4|COMPLETED|Overall Study||29
8362012|NCT01201057|20612142|P3|COMPLETED|Overall Study||27
8362013|NCT01201057|20612143|P2|COMPLETED|Overall Study||29
8362014|NCT01201057|20612144|P1|COMPLETED|Overall Study||32
8362015|NCT01201057|20612141|P4|STARTED|Overall Study||33
8362016|NCT01201057|20612142|P3|STARTED|Overall Study||32
8362017|NCT01201057|20612143|P2|STARTED|Overall Study||33
8362018|NCT01201057|20612144|P1|STARTED|Overall Study||34
8362019|NCT01200992|20612172|P2|NOT COMPLETED|Overall Study||41
8362020|NCT01200992|20612173|P1|NOT COMPLETED|Overall Study||37
8362021|NCT01200992|20612172|P2|COMPLETED|Overall Study||4
8362022|NCT01200992|20612173|P1|COMPLETED|Overall Study||2
8362023|NCT01200992|20612172|P2|STARTED|Overall Study||45
8362024|NCT01200992|20612173|P1|STARTED|Overall Study||39
8362025|NCT01200875|20612181|P1|NOT COMPLETED|Overall Study||0
8362026|NCT01200875|20612181|P1|COMPLETED|Overall Study||25
8362027|NCT01200875|20612181|P1|STARTED|Overall Study||25
8362028|NCT01200862|20612188|P3|NOT COMPLETED|Part 2||0
8362029|NCT01200862|20612189|P2|NOT COMPLETED|Part 2||1
8362030|NCT01200862|20612190|P1|NOT COMPLETED|Part 2||0
8362031|NCT01200862|20612188|P3|COMPLETED|Part 2||8
8362032|NCT01200862|20612189|P2|COMPLETED|Part 2||6
8362033|NCT01200862|20612190|P1|COMPLETED|Part 2||0
8362034|NCT01200862|20612188|P3|STARTED|Part 2||8
8362035|NCT01200862|20612189|P2|STARTED|Part 2||7
8362036|NCT01200862|20612190|P1|STARTED|Part 2||0
8362037|NCT01200862|20612188|P3|NOT COMPLETED|Part 1||0
8362038|NCT01200862|20612189|P2|NOT COMPLETED|Part 1||0
8362039|NCT01200862|20612190|P1|NOT COMPLETED|Part 1||1
8362040|NCT01200862|20612188|P3|COMPLETED|Part 1||0
8362041|NCT01200862|20612189|P2|COMPLETED|Part 1||0
8362042|NCT01200862|20612190|P1|COMPLETED|Part 1||13
8362043|NCT01200862|20612188|P3|STARTED|Part 1||0
8362044|NCT01200862|20612189|P2|STARTED|Part 1||0
8362045|NCT01200862|20612190|P1|STARTED|Part 1||14
8362046|NCT01200810|20612204|P2|NOT COMPLETED|Overall Study||5
8362047|NCT01200810|20612205|P1|NOT COMPLETED|Overall Study||5
8362048|NCT01200810|20612204|P2|COMPLETED|Overall Study||0
8362049|NCT01200810|20612205|P1|COMPLETED|Overall Study||0
8362050|NCT01200810|20612204|P2|STARTED|Overall Study||5
8362051|NCT01200810|20612205|P1|STARTED|Overall Study||5
8362052|NCT01200797|20612225|P1|NOT COMPLETED|Overall Study||19
8362053|NCT01200797|20612225|P1|COMPLETED|Overall Study||0
8362054|NCT01200797|20612225|P1|STARTED|Overall Study||19
8362055|NCT01200758|20612235|P4|NOT COMPLETED|Stage 2||50
8362056|NCT01200758|20612236|P3|NOT COMPLETED|Stage 2||41
8362057|NCT01200758|20612237|P2|NOT COMPLETED|Stage 2||0
8362058|NCT01200758|20612238|P1|NOT COMPLETED|Stage 2||0
8362059|NCT01200758|20612235|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
8362060|NCT01200758|20612236|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
8362061|NCT01200758|20612237|P2|COMPLETED|Stage 2||0
8362062|NCT01200758|20612238|P1|COMPLETED|Stage 2||0
8362063|NCT01200758|20612235|P4|STARTED|Stage 2||142
8362064|NCT01200758|20612236|P3|STARTED|Stage 2||141
8362065|NCT01200758|20612237|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
8362066|NCT01200758|20612238|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
8362067|NCT01200758|20612235|P4|NOT COMPLETED|Stage I||0
8362068|NCT01200758|20612236|P3|NOT COMPLETED|Stage I||0
8362069|NCT01200758|20612237|P2|NOT COMPLETED|Stage I||17
8362070|NCT01200758|20612238|P1|NOT COMPLETED|Stage I||18
8362071|NCT01200758|20612235|P4|COMPLETED|Stage I||0
8362072|NCT01200758|20612236|P3|COMPLETED|Stage I||0
8362073|NCT01200758|20612237|P2|COMPLETED|Stage I|Participants completed treatment period.|46
8362074|NCT01200758|20612238|P1|COMPLETED|Stage I|Participants completed treatment period.|46
8362075|NCT01200758|20612235|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
8362076|NCT01200758|20612236|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
8362077|NCT01200758|20612237|P2|STARTED|Stage I||63
8362078|NCT01200758|20612238|P1|STARTED|Stage I||64
8362079|NCT01200602|20612294|P2|NOT COMPLETED|Overall Study||0
8362080|NCT01200602|20612295|P1|NOT COMPLETED|Overall Study||0
8362081|NCT01200602|20612294|P2|COMPLETED|Overall Study||0
8362082|NCT01200602|20612295|P1|COMPLETED|Overall Study||0
8362083|NCT01200602|20612294|P2|STARTED|Overall Study||0
8362084|NCT01200602|20612295|P1|STARTED|Overall Study||0
8362085|NCT01200589|20612311|P2|NOT COMPLETED|Overall Study||189
8362086|NCT01200589|20612312|P1|NOT COMPLETED|Overall Study||190
8362087|NCT01200589|20612311|P2|COMPLETED|Overall Study||30
8362088|NCT01200589|20612312|P1|COMPLETED|Overall Study||29
8362089|NCT01200589|20612311|P2|Safety Set|Overall Study||218
8362090|NCT01200589|20612312|P1|Safety Set|Overall Study||217
8362091|NCT01200589|20612311|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
8362092|NCT01200589|20612312|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
8362093|NCT01200589|20612311|P2|STARTED|Overall Study||219
8362094|NCT01200589|20612312|P1|STARTED|Overall Study||219
8362095|NCT01200524|20612339|P3|NOT COMPLETED|Overall Study||4
8362096|NCT01200524|20612340|P2|NOT COMPLETED|Overall Study||1
8362097|NCT01200524|20612341|P1|NOT COMPLETED|Overall Study||2
8362098|NCT01200524|20612339|P3|COMPLETED|Overall Study||40
8362099|NCT01200524|20612340|P2|COMPLETED|Overall Study||47
8362100|NCT01200524|20612341|P1|COMPLETED|Overall Study||39
8362101|NCT01200524|20612339|P3|STARTED|Overall Study||44
8362102|NCT01200524|20612340|P2|STARTED|Overall Study||48
8362103|NCT01200524|20612341|P1|STARTED|Overall Study||41
8362104|NCT01200511|20612361|P1|NOT COMPLETED|Overall Study||5
8362105|NCT01200511|20612361|P1|COMPLETED|Overall Study||44
8362106|NCT01200511|20612361|P1|STARTED|Overall Study||49
8362107|NCT01200498|20612369|P1|NOT COMPLETED|Overall Study||0
8362108|NCT01200498|20612369|P1|COMPLETED|Overall Study||22
8362109|NCT01200498|20612369|P1|STARTED|Overall Study||22
8362110|NCT01200485|20612373|P3|NOT COMPLETED|Cycle 2: Randomization||0
8362111|NCT01200485|20612374|P2|NOT COMPLETED|Cycle 2: Randomization||0
8362112|NCT01200485|20612375|P1|NOT COMPLETED|Cycle 2: Randomization||0
8362113|NCT01200485|20612373|P3|COMPLETED|Cycle 2: Randomization||25
8362114|NCT01200485|20612374|P2|COMPLETED|Cycle 2: Randomization||21
8362115|NCT01200485|20612375|P1|COMPLETED|Cycle 2: Randomization||0
8362116|NCT01200485|20612373|P3|STARTED|Cycle 2: Randomization||25
8362117|NCT01200485|20612374|P2|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
8362118|NCT01200485|20612375|P1|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
8362119|NCT01200485|20612373|P3|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362120|NCT01200485|20612374|P2|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362121|NCT01200485|20612375|P1|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
8362122|NCT01200485|20612373|P3|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362123|NCT01200485|20612374|P2|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362124|NCT01200485|20612375|P1|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
8362125|NCT01200485|20612373|P3|STARTED|Cycle 1: Rasburicase Alone Delivery||0
8362126|NCT01200485|20612374|P2|STARTED|Cycle 1: Rasburicase Alone Delivery||0
8362127|NCT01200485|20612375|P1|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
8362128|NCT01200433|20612386|P2|NOT COMPLETED|Overall Study||0
8362129|NCT01200433|20612387|P1|NOT COMPLETED|Overall Study||0
8362130|NCT01200433|20612386|P2|COMPLETED|Overall Study||23
8362131|NCT01200433|20612387|P1|COMPLETED|Overall Study||21
8362132|NCT01200433|20612386|P2|STARTED|Overall Study||23
8362133|NCT01200433|20612387|P1|STARTED|Overall Study||21
8362134|NCT01200394|20612409|P2|NOT COMPLETED|Overall Study||28
8362135|NCT01200394|20612410|P1|NOT COMPLETED|Overall Study||2
8362136|NCT01200394|20612409|P2|COMPLETED|Overall Study||164
8362137|NCT01200394|20612410|P1|COMPLETED|Overall Study||62
8362138|NCT01200394|20612409|P2|STARTED|Overall Study||192
8362139|NCT01200394|20612410|P1|STARTED|Overall Study||64
8362140|NCT01200368|20612448|P3|NOT COMPLETED|Toddler Dose||1
8362141|NCT01200368|20612449|P2|NOT COMPLETED|Toddler Dose||3
8362142|NCT01200368|20612450|P1|NOT COMPLETED|Toddler Dose||0
8362143|NCT01200368|20612448|P3|COMPLETED|Toddler Dose||168
8362144|NCT01200368|20612449|P2|COMPLETED|Toddler Dose||159
8362145|NCT01200368|20612450|P1|COMPLETED|Toddler Dose||162
8362146|NCT01200368|20612448|P3|STARTED|Toddler Dose||169
8362147|NCT01200368|20612449|P2|STARTED|Toddler Dose||162
8362148|NCT01200368|20612450|P1|STARTED|Toddler Dose||162
8362149|NCT01200368|20612448|P3|NOT COMPLETED|After Infant Series||9
8362150|NCT01200368|20612449|P2|NOT COMPLETED|After Infant Series||16
8362151|NCT01200368|20612450|P1|NOT COMPLETED|After Infant Series||18
8362152|NCT01200368|20612448|P3|COMPLETED|After Infant Series||169
8362153|NCT01200368|20612449|P2|COMPLETED|After Infant Series||162
8362154|NCT01200368|20612450|P1|COMPLETED|After Infant Series||162
8362155|NCT01200368|20612448|P3|STARTED|After Infant Series||178
8362156|NCT01200368|20612449|P2|STARTED|After Infant Series||178
8362157|NCT01200368|20612450|P1|STARTED|After Infant Series||180
8362158|NCT01200368|20612448|P3|NOT COMPLETED|Infant Series||6
8362159|NCT01200368|20612449|P2|NOT COMPLETED|Infant Series||6
8362160|NCT01200368|20612450|P1|NOT COMPLETED|Infant Series||3
8362161|NCT01200368|20612448|P3|COMPLETED|Infant Series||178
8362162|NCT01200368|20612449|P2|COMPLETED|Infant Series||178
8362163|NCT01200368|20612450|P1|COMPLETED|Infant Series||180
8362164|NCT01200368|20612448|P3|Vaccinated Dose 3|Infant Series||182
8362165|NCT01200368|20612449|P2|Vaccinated Dose 3|Infant Series||178
8362166|NCT01200368|20612450|P1|Vaccinated Dose 3|Infant Series||181
8362167|NCT01200368|20612448|P3|Vaccinated Dose 2|Infant Series||183
8362168|NCT01200368|20612449|P2|Vaccinated Dose 2|Infant Series||182
8362169|NCT01200368|20612450|P1|Vaccinated Dose 2|Infant Series||183
8362170|NCT01200368|20612448|P3|Vaccinated Dose 1|Infant Series||183
8362171|NCT01200368|20612449|P2|Vaccinated Dose 1|Infant Series||183
8362172|NCT01200368|20612450|P1|Vaccinated Dose 1|Infant Series||183
8362173|NCT01200368|20612448|P3|STARTED|Infant Series||184
8362174|NCT01200368|20612449|P2|STARTED|Infant Series||184
8362175|NCT01200368|20612450|P1|STARTED|Infant Series||183
8362176|NCT01200355|20612516|P2|NOT COMPLETED|Overall Study||2
8362177|NCT01200355|20612517|P1|NOT COMPLETED|Overall Study||7
8362178|NCT01200355|20612516|P2|COMPLETED|Overall Study||53
8362179|NCT01200355|20612517|P1|COMPLETED|Overall Study||51
8362180|NCT01200355|20612516|P2|STARTED|Overall Study||55
8362181|NCT01200355|20612517|P1|STARTED|Overall Study||58
8362182|NCT01200342|20612531|P1|NOT COMPLETED|Overall Study||1
8362183|NCT01200342|20612531|P1|COMPLETED|Overall Study||6
8362184|NCT01200342|20612531|P1|STARTED|Overall Study||7
8362185|NCT01200329|20612536|P1|NOT COMPLETED|Overall Study||3
8362186|NCT01200329|20612536|P1|COMPLETED|Overall Study||78
8362187|NCT01200329|20612536|P1|STARTED|Overall Study||81
8362188|NCT01200290|20612541|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
8362189|NCT01200290|20612541|P1|COMPLETED|Post-Treatment Follow-Up Period||16
8362190|NCT01200290|20612541|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
8362191|NCT01200290|20612541|P1|NOT COMPLETED|Treatment Period||1
8362192|NCT01200290|20612541|P1|COMPLETED|Treatment Period||17
8362193|NCT01200290|20612541|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
8362194|NCT01200290|20612541|P1|STARTED|Treatment Period||18
8362195|NCT01200238|20612554|P2|NOT COMPLETED|Overall Study||10
8362196|NCT01200238|20612555|P1|NOT COMPLETED|Overall Study||7
8362197|NCT01200238|20612554|P2|COMPLETED|Overall Study||0
8362198|NCT01200238|20612555|P1|COMPLETED|Overall Study||0
8362199|NCT01200238|20612554|P2|STARTED|Overall Study||10
8362200|NCT01200238|20612555|P1|STARTED|Overall Study||7
8362201|NCT01200160|20612573|P1|NOT COMPLETED|Overall Study||62
8362202|NCT01200160|20612573|P1|COMPLETED|Overall Study||66
8362203|NCT01200160|20612573|P1|STARTED|Overall Study||128
8362204|NCT01200069|20612579|P2|NOT COMPLETED|Overall Study||1
8362205|NCT01200069|20612580|P1|NOT COMPLETED|Overall Study||0
8362206|NCT01200069|20612579|P2|COMPLETED|Overall Study||5
8362207|NCT01200069|20612580|P1|COMPLETED|Overall Study||8
8362208|NCT01200069|20612579|P2|STARTED|Overall Study||6
8362209|NCT01200069|20612580|P1|STARTED|Overall Study||8
8362210|NCT01200030|20612635|P3|NOT COMPLETED|Overall Study||0
8362211|NCT01200030|20612636|P2|NOT COMPLETED|Overall Study||0
8362212|NCT01200030|20612637|P1|NOT COMPLETED|Overall Study||0
8362213|NCT01200030|20612635|P3|COMPLETED|Overall Study||12
8362214|NCT01200030|20612636|P2|COMPLETED|Overall Study||13
8362215|NCT01200030|20612637|P1|COMPLETED|Overall Study||12
8362216|NCT01200030|20612635|P3|STARTED|Overall Study||12
8362217|NCT01200030|20612636|P2|STARTED|Overall Study||13
8362218|NCT01200030|20612637|P1|STARTED|Overall Study||12
8362219|NCT01199965|20612650|P2|NOT COMPLETED|Overall Study||0
8362220|NCT01199965|20612651|P1|NOT COMPLETED|Overall Study||1
8362221|NCT01199965|20612650|P2|COMPLETED|Overall Study||24
8362222|NCT01199965|20612651|P1|COMPLETED|Overall Study||22
8362223|NCT01199965|20612650|P2|STARTED|Overall Study||24
8362224|NCT01199965|20612651|P1|STARTED|Overall Study||23
8362225|NCT01199952|20612667|P2|NOT COMPLETED|Overall Study||45
8362226|NCT01199952|20612668|P1|NOT COMPLETED|Overall Study||52
8362227|NCT01199952|20612667|P2|COMPLETED|Overall Study||59
8362228|NCT01199952|20612668|P1|COMPLETED|Overall Study||51
8362229|NCT01199952|20612667|P2|STARTED|Overall Study||104
8362230|NCT01199952|20612668|P1|STARTED|Overall Study||103
8362231|NCT01199939|20612676|P1|NOT COMPLETED|Overall Study||13
8362232|NCT01199939|20612676|P1|COMPLETED|Overall Study||41
8362233|NCT01199939|20612676|P1|STARTED|Overall Study|Number of enrolled participants|54
8362234|NCT01199926|20612695|P2|NOT COMPLETED|Overall Study||4
8362235|NCT01199926|20612696|P1|NOT COMPLETED|Overall Study||7
8362236|NCT01199926|20612695|P2|COMPLETED|Overall Study||13
8362237|NCT01199926|20612696|P1|COMPLETED|Overall Study||10
8362238|NCT01199926|20612695|P2|STARTED|Overall Study||17
8362239|NCT01199926|20612696|P1|STARTED|Overall Study||17
8362240|NCT01199861|20612708|P2|NOT COMPLETED|Overall Study||0
8362241|NCT01199861|20612709|P1|NOT COMPLETED|Overall Study||2
8362242|NCT01199861|20612708|P2|COMPLETED|Overall Study||43
8362243|NCT01199861|20612709|P1|COMPLETED|Overall Study||93
8362244|NCT01199861|20612708|P2|STARTED|Overall Study||43
8362245|NCT01199861|20612709|P1|STARTED|Overall Study||95
8362246|NCT01199822|20612730|P3|NOT COMPLETED|Overall Study||0
8362247|NCT01199822|20612731|P2|NOT COMPLETED|Overall Study||1
8362248|NCT01199822|20612732|P1|NOT COMPLETED|Overall Study||0
8362249|NCT01199822|20612730|P3|COMPLETED|Overall Study||6
8362250|NCT01199822|20612731|P2|COMPLETED|Overall Study||6
8362251|NCT01199822|20612732|P1|COMPLETED|Overall Study||3
8362252|NCT01199822|20612730|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8362253|NCT01199822|20612731|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
8362254|NCT01199822|20612732|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8362255|NCT01199822|20612730|P3|STARTED|Overall Study||6
8362256|NCT01199822|20612731|P2|STARTED|Overall Study||7
8362257|NCT01199822|20612732|P1|STARTED|Overall Study||3
8362258|NCT01199744|20612765|P1|NOT COMPLETED|Overall Study||0
8362259|NCT01199744|20612765|P1|COMPLETED|Overall Study||1575
8362260|NCT01199744|20612765|P1|STARTED|Overall Study||1575
8362261|NCT01199731|20612781|P3|NOT COMPLETED|Overall Study||10
8362262|NCT01199731|20612782|P2|NOT COMPLETED|Overall Study||11
8362263|NCT01199731|20612783|P1|NOT COMPLETED|Overall Study||9
8362264|NCT01199731|20612781|P3|COMPLETED|Overall Study||0
8362265|NCT01199731|20612782|P2|COMPLETED|Overall Study||0
8362266|NCT01199731|20612783|P1|COMPLETED|Overall Study||0
8362267|NCT01199731|20612781|P3|STARTED|Overall Study||10
8362268|NCT01199731|20612782|P2|STARTED|Overall Study||11
8362269|NCT01199731|20612783|P1|STARTED|Overall Study||9
8362270|NCT01199705|20612821|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
8362271|NCT01199705|20612821|P1|COMPLETED|SCIG Treatment (Efficacy)||24
8362272|NCT01199705|20612821|P1|STARTED|SCIG Treatment (Efficacy)||24
8362273|NCT01199705|20612821|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
8362274|NCT01199705|20612821|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
8362275|NCT01199705|20612821|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
8362276|NCT01199705|20612821|P1|NOT COMPLETED|IVIG Treatment||0
8362277|NCT01199705|20612821|P1|COMPLETED|IVIG Treatment||25
8362278|NCT01199705|20612821|P1|STARTED|IVIG Treatment||25
8362279|NCT01199601|20612853|P2|NOT COMPLETED|Overall Study||78
8362280|NCT01199601|20612854|P1|NOT COMPLETED|Overall Study||69
8362281|NCT01199601|20612853|P2|COMPLETED|Overall Study||344
8362282|NCT01199601|20612854|P1|COMPLETED|Overall Study||353
8362283|NCT01199601|20612853|P2|STARTED|Overall Study|Intervention Group|422
8362284|NCT01199601|20612854|P1|STARTED|Overall Study|Control Group|422
8362285|NCT01199575|20612864|P1|NOT COMPLETED|Overall Study||5
8362286|NCT01199575|20612864|P1|COMPLETED|Overall Study||25
8362287|NCT01199575|20612864|P1|STARTED|Overall Study||30
8362288|NCT01199471|20612869|P1|NOT COMPLETED|Overall Study||6
8362289|NCT01199471|20612869|P1|COMPLETED|Overall Study||3994
8362290|NCT01199471|20612869|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
8362291|NCT01199380|20612880|P2|NOT COMPLETED|Overall Study||15
8362292|NCT01199380|20612881|P1|NOT COMPLETED|Overall Study||10
8362293|NCT01199380|20612880|P2|COMPLETED|Overall Study||81
8362294|NCT01199380|20612881|P1|COMPLETED|Overall Study||78
8362295|NCT01199380|20612880|P2|STARTED|Overall Study||96
8362296|NCT01199380|20612881|P1|STARTED|Overall Study||88
8362297|NCT01199263|20612889|P2|NOT COMPLETED|Overall Study||2
8362298|NCT01199263|20612890|P1|NOT COMPLETED|Overall Study||6
8362299|NCT01199263|20612889|P2|COMPLETED|Overall Study||52
8362300|NCT01199263|20612890|P1|COMPLETED|Overall Study||48
8362301|NCT01199263|20612889|P2|STARTED|Overall Study||54
8362302|NCT01199263|20612890|P1|STARTED|Overall Study||54
8362303|NCT01199237|20612906|P2|NOT COMPLETED|Overall Study||0
8362304|NCT01199237|20612907|P1|NOT COMPLETED|Overall Study||0
8362305|NCT01199237|20612906|P2|COMPLETED|Overall Study||40
8362306|NCT01199237|20612907|P1|COMPLETED|Overall Study||41
8362307|NCT01199237|20612906|P2|STARTED|Overall Study||40
8362308|NCT01199237|20612907|P1|STARTED|Overall Study||41
8362309|NCT01199198|20612923|P2|NOT COMPLETED|Overall Study||11
8362310|NCT01199198|20612924|P1|NOT COMPLETED|Overall Study||7
8362311|NCT01199198|20612923|P2|COMPLETED|Overall Study||13
8362312|NCT01199198|20612924|P1|COMPLETED|Overall Study||17
8362313|NCT01199198|20612923|P2|STARTED|Overall Study||24
8362314|NCT01199198|20612924|P1|STARTED|Overall Study||24
8362315|NCT01199146|20612932|P1|NOT COMPLETED|Overall Study||3
8362316|NCT01199146|20612932|P1|COMPLETED|Overall Study||39
8362317|NCT01199146|20612932|P1|STARTED|Overall Study||42
8362318|NCT01199068|20612941|P3|NOT COMPLETED|Overall Study||9
8362319|NCT01199068|20612942|P2|NOT COMPLETED|Overall Study||3
8362320|NCT01199068|20612943|P1|NOT COMPLETED|Overall Study||3
8362321|NCT01199068|20612941|P3|COMPLETED|Overall Study||0
8362322|NCT01199068|20612942|P2|COMPLETED|Overall Study||0
8362323|NCT01199068|20612943|P1|COMPLETED|Overall Study||0
8362324|NCT01199068|20612941|P3|Received Treatment|Overall Study||8
8362325|NCT01199068|20612942|P2|Received Treatment|Overall Study||3
8362326|NCT01199068|20612943|P1|Received Treatment|Overall Study||3
8362327|NCT01199068|20612941|P3|STARTED|Overall Study||9
8362328|NCT01199068|20612942|P2|STARTED|Overall Study||3
8362329|NCT01199068|20612943|P1|STARTED|Overall Study||3
8362330|NCT01199055|20612977|P3|NOT COMPLETED|Overall Study||4
8362331|NCT01199055|20612978|P2|NOT COMPLETED|Overall Study||3
8362332|NCT01199055|20612979|P1|NOT COMPLETED|Overall Study||2
8362333|NCT01199055|20612977|P3|COMPLETED|Overall Study||5
8362334|NCT01199055|20612978|P2|COMPLETED|Overall Study||1
8362335|NCT01199055|20612979|P1|COMPLETED|Overall Study||1
8362336|NCT01199055|20612977|P3|STARTED|Overall Study||9
8362337|NCT01199055|20612978|P2|STARTED|Overall Study||4
8362338|NCT01199055|20612979|P1|STARTED|Overall Study||3
8362339|NCT01199042|20613004|P1|NOT COMPLETED|At Home (3 Months)||1
8362340|NCT01199042|20613004|P1|COMPLETED|At Home (3 Months)||26
8362341|NCT01199042|20613004|P1|STARTED|At Home (3 Months)||27
8362342|NCT01199042|20613004|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
8362343|NCT01199042|20613004|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
8362344|NCT01199042|20613004|P1|STARTED|Sleep Laboratory (3 Nights)||29
8362345|NCT01199016|20613013|P1|NOT COMPLETED|Overall Study||77
8362346|NCT01199016|20613013|P1|COMPLETED|Overall Study||162
8362347|NCT01199016|20613013|P1|Treated|Overall Study||236
8362348|NCT01199016|20613013|P1|STARTED|Overall Study||239
8362349|NCT01198977|20613022|P2|NOT COMPLETED|Overall Study||0
8362350|NCT01198977|20613023|P1|NOT COMPLETED|Overall Study||1
8362351|NCT01198977|20613022|P2|COMPLETED|Overall Study||33
8362352|NCT01198977|20613023|P1|COMPLETED|Overall Study||30
8362353|NCT01198977|20613022|P2|STARTED|Overall Study||33
8362354|NCT01198977|20613023|P1|STARTED|Overall Study||31
8362355|NCT01198873|20613035|P2|NOT COMPLETED|Overall Study||32
8362356|NCT01198873|20613036|P1|NOT COMPLETED|Overall Study||37
8362357|NCT01198873|20613035|P2|COMPLETED|Overall Study||3
8362358|NCT01198873|20613036|P1|COMPLETED|Overall Study||4
8362359|NCT01198873|20613035|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
8362360|NCT01198873|20613036|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
8362361|NCT01198873|20613035|P2|Treated|Overall Study||35
8362362|NCT01198873|20613036|P1|Treated|Overall Study||41
8362363|NCT01198873|20613035|P2|STARTED|Overall Study||35
8362364|NCT01198873|20613036|P1|STARTED|Overall Study||41
8362365|NCT01198795|20613050|P1|NOT COMPLETED|Overall Study||82
8362366|NCT01198795|20613050|P1|COMPLETED|Overall Study||80
8362367|NCT01198795|20613050|P1|STARTED|Overall Study||162
8362368|NCT01198769|20613054|P1|NOT COMPLETED|Overall Study||0
8362369|NCT01198769|20613054|P1|COMPLETED|Overall Study||15
8362370|NCT01198769|20613054|P1|STARTED|Overall Study||15
8362371|NCT01198756|20613067|P4|NOT COMPLETED|Overall Study||26
8362372|NCT01198756|20613068|P3|NOT COMPLETED|Overall Study||30
8362373|NCT01198756|20613069|P2|NOT COMPLETED|Overall Study||40
8362374|NCT01198756|20613070|P1|NOT COMPLETED|Overall Study||38
8362375|NCT01198756|20613067|P4|COMPLETED|Overall Study||275
8362376|NCT01198756|20613068|P3|COMPLETED|Overall Study||902
8362377|NCT01198756|20613069|P2|COMPLETED|Overall Study||889
8362378|NCT01198756|20613070|P1|COMPLETED|Overall Study||894
8362379|NCT01198756|20613067|P4|STARTED|Overall Study||301
8362380|NCT01198756|20613068|P3|STARTED|Overall Study||932
8362381|NCT01198756|20613069|P2|STARTED|Overall Study||929
8362382|NCT01198756|20613070|P1|STARTED|Overall Study||932
8362383|NCT01198691|20613168|P2|NOT COMPLETED|6 Week Post-partum Survey||24
8362384|NCT01198691|20613169|P1|NOT COMPLETED|6 Week Post-partum Survey||29
8362385|NCT01198691|20613168|P2|COMPLETED|6 Week Post-partum Survey||26
8362386|NCT01198691|20613169|P1|COMPLETED|6 Week Post-partum Survey||21
8362387|NCT01198691|20613168|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
8362388|NCT01198691|20613169|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
8362389|NCT01198691|20613168|P2|NOT COMPLETED|Survey Prior to Discharge||33
8362390|NCT01198691|20613169|P1|NOT COMPLETED|Survey Prior to Discharge||32
8362391|NCT01198691|20613168|P2|COMPLETED|Survey Prior to Discharge||17
8362392|NCT01198691|20613169|P1|COMPLETED|Survey Prior to Discharge||18
8362393|NCT01198691|20613168|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
8362394|NCT01198691|20613169|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
8362395|NCT01198691|20613168|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
8362396|NCT01198691|20613169|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
8362397|NCT01198691|20613168|P2|COMPLETED|Completed VAS Score at Discharge||44
8362398|NCT01198691|20613169|P1|COMPLETED|Completed VAS Score at Discharge||45
8362399|NCT01198691|20613168|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
8362400|NCT01198691|20613169|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
8362401|NCT01198691|20613168|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
8362402|NCT01198691|20613169|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
8362403|NCT01198691|20613168|P2|COMPLETED|Completed VAS Score Postop Day 1||46
8362404|NCT01198691|20613169|P1|COMPLETED|Completed VAS Score Postop Day 1||47
8362405|NCT01198691|20613168|P2|STARTED|Completed VAS Score Postop Day 1||50
8362406|NCT01198691|20613169|P1|STARTED|Completed VAS Score Postop Day 1||50
8362407|NCT01198691|20613168|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
8362408|NCT01198691|20613169|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
8362409|NCT01198691|20613168|P2|COMPLETED|Completed Surgery -Received Intervention||50
8362410|NCT01198691|20613169|P1|COMPLETED|Completed Surgery -Received Intervention||50
8362411|NCT01198691|20613168|P2|STARTED|Completed Surgery -Received Intervention||50
8362412|NCT01198691|20613169|P1|STARTED|Completed Surgery -Received Intervention||50
8362413|NCT01198600|20613181|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362414|NCT01198600|20613182|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362415|NCT01198600|20613183|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362416|NCT01198600|20613184|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362417|NCT01198600|20613181|P4|COMPLETED|Phase 3: 43 Days of Wear||38
8362418|NCT01198600|20613182|P3|COMPLETED|Phase 3: 43 Days of Wear||0
8362419|NCT01198600|20613183|P2|COMPLETED|Phase 3: 43 Days of Wear||0
8362420|NCT01198600|20613184|P1|COMPLETED|Phase 3: 43 Days of Wear||0
8362421|NCT01198600|20613181|P4|STARTED|Phase 3: 43 Days of Wear||38
8362422|NCT01198600|20613182|P3|STARTED|Phase 3: 43 Days of Wear||0
8362423|NCT01198600|20613183|P2|STARTED|Phase 3: 43 Days of Wear||0
8362424|NCT01198600|20613184|P1|STARTED|Phase 3: 43 Days of Wear||0
8362425|NCT01198600|20613181|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8362426|NCT01198600|20613182|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
8362427|NCT01198600|20613183|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8362428|NCT01198600|20613184|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8362429|NCT01198600|20613181|P4|COMPLETED|Phase 2: 56 Days of Wear||0
8362430|NCT01198600|20613182|P3|COMPLETED|Phase 2: 56 Days of Wear||62
8362431|NCT01198600|20613183|P2|COMPLETED|Phase 2: 56 Days of Wear||0
8362432|NCT01198600|20613184|P1|COMPLETED|Phase 2: 56 Days of Wear||0
8362433|NCT01198600|20613181|P4|STARTED|Phase 2: 56 Days of Wear||0
8362434|NCT01198600|20613182|P3|STARTED|Phase 2: 56 Days of Wear||67
8362435|NCT01198600|20613183|P2|STARTED|Phase 2: 56 Days of Wear||0
8362436|NCT01198600|20613184|P1|STARTED|Phase 2: 56 Days of Wear||0
8362437|NCT01198600|20613181|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362438|NCT01198600|20613182|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362439|NCT01198600|20613183|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
8362440|NCT01198600|20613184|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362441|NCT01198600|20613181|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362442|NCT01198600|20613182|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362443|NCT01198600|20613183|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
8362444|NCT01198600|20613184|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
8362445|NCT01198600|20613181|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
8362446|NCT01198600|20613182|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
8362447|NCT01198600|20613183|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
8362448|NCT01198600|20613184|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
8362449|NCT01198600|20613181|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362450|NCT01198600|20613182|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362451|NCT01198600|20613183|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
8362452|NCT01198600|20613184|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
8362453|NCT01198600|20613181|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362454|NCT01198600|20613182|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362455|NCT01198600|20613183|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
8362456|NCT01198600|20613184|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
8362457|NCT01198600|20613181|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
8362458|NCT01198600|20613182|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
8362459|NCT01198600|20613183|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
8362460|NCT01198600|20613184|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
8362461|NCT01198587|20613210|P4|NOT COMPLETED|Overall Study||0
8362462|NCT01198587|20613211|P3|NOT COMPLETED|Overall Study||9
8362463|NCT01198587|20613212|P2|NOT COMPLETED|Overall Study||0
8362464|NCT01198587|20613213|P1|NOT COMPLETED|Overall Study||8
8362465|NCT01198587|20613210|P4|COMPLETED|Overall Study||5
8362466|NCT01198587|20613211|P3|COMPLETED|Overall Study||21
8362467|NCT01198587|20613212|P2|COMPLETED|Overall Study||5
8362468|NCT01198587|20613213|P1|COMPLETED|Overall Study||23
8362469|NCT01198587|20613210|P4|STARTED|Overall Study||5
8362470|NCT01198587|20613211|P3|STARTED|Overall Study||30
8362471|NCT01198587|20613212|P2|STARTED|Overall Study||5
8362472|NCT01198587|20613213|P1|STARTED|Overall Study||31
8362473|NCT01198574|20613235|P4|NOT COMPLETED|Overall Study||4
8362474|NCT01198574|20613236|P3|NOT COMPLETED|Overall Study||1
8362475|NCT01198574|20613237|P2|NOT COMPLETED|Overall Study||1
8362476|NCT01198574|20613238|P1|NOT COMPLETED|Overall Study||4
8362477|NCT01198574|20613235|P4|COMPLETED|Overall Study||98
8362478|NCT01198574|20613236|P3|COMPLETED|Overall Study||99
8362479|NCT01198574|20613237|P2|COMPLETED|Overall Study||101
8362480|NCT01198574|20613238|P1|COMPLETED|Overall Study||94
8362481|NCT01198574|20613235|P4|STARTED|Overall Study||102
8362482|NCT01198574|20613236|P3|STARTED|Overall Study||100
8362483|NCT01198574|20613237|P2|STARTED|Overall Study||102
8362484|NCT01198574|20613238|P1|STARTED|Overall Study||98
8362485|NCT01198548|20613256|P1|NOT COMPLETED|Overall Study||10
8362486|NCT01198548|20613256|P1|COMPLETED|Overall Study||0
8362487|NCT01198548|20613256|P1|STARTED|Overall Study||10
8362488|NCT01198509|20613271|P6|NOT COMPLETED|Overall Study||0
8362489|NCT01198509|20613272|P5|NOT COMPLETED|Overall Study||0
8362490|NCT01198509|20613273|P4|NOT COMPLETED|Overall Study||0
8362491|NCT01198509|20613274|P3|NOT COMPLETED|Overall Study||0
8362492|NCT01198509|20613275|P2|NOT COMPLETED|Overall Study||0
8362493|NCT01198509|20613276|P1|NOT COMPLETED|Overall Study||1
8362494|NCT01198509|20613271|P6|COMPLETED|Overall Study||58
8362495|NCT01198509|20613272|P5|COMPLETED|Overall Study||20
8362496|NCT01198509|20613273|P4|COMPLETED|Overall Study||66
8362497|NCT01198509|20613274|P3|COMPLETED|Overall Study||19
8362498|NCT01198509|20613275|P2|COMPLETED|Overall Study||10
8362499|NCT01198509|20613276|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
8362500|NCT01198509|20613271|P6|STARTED|Overall Study||58
8362501|NCT01198509|20613272|P5|STARTED|Overall Study||20
8362502|NCT01198509|20613273|P4|STARTED|Overall Study||66
8362503|NCT01198509|20613274|P3|STARTED|Overall Study||19
8362504|NCT01198509|20613275|P2|STARTED|Overall Study||10
8362505|NCT01198509|20613276|P1|STARTED|Overall Study||5
8362506|NCT01198470|20613293|P1|NOT COMPLETED|Overall Study||2
8362507|NCT01198470|20613293|P1|COMPLETED|Overall Study||18
8362508|NCT01198470|20613293|P1|STARTED|Overall Study||20
8362509|NCT01198366|20613306|P6|NOT COMPLETED|Overall Study||13
8362510|NCT01198366|20613307|P5|NOT COMPLETED|Overall Study||15
8362511|NCT01198366|20613308|P4|NOT COMPLETED|Overall Study||5
8362512|NCT01198366|20613309|P3|NOT COMPLETED|Overall Study||8
8362513|NCT01198366|20613310|P2|NOT COMPLETED|Overall Study||7
8362514|NCT01198366|20613311|P1|NOT COMPLETED|Overall Study||12
8362515|NCT01198366|20613306|P6|COMPLETED|Overall Study||128
8362516|NCT01198366|20613307|P5|COMPLETED|Overall Study||125
8362517|NCT01198366|20613308|P4|COMPLETED|Overall Study||47
8362518|NCT01198366|20613309|P3|COMPLETED|Overall Study||43
8362519|NCT01198366|20613310|P2|COMPLETED|Overall Study||44
8362520|NCT01198366|20613311|P1|COMPLETED|Overall Study||40
8362521|NCT01198366|20613306|P6|STARTED|Overall Study||141
8362522|NCT01198366|20613307|P5|STARTED|Overall Study||140
8362523|NCT01198366|20613308|P4|STARTED|Overall Study||52
8362524|NCT01198366|20613309|P3|STARTED|Overall Study||51
8362525|NCT01198366|20613310|P2|STARTED|Overall Study||51
8362526|NCT01198366|20613311|P1|STARTED|Overall Study||52
8362527|NCT01198327|20613349|P1|NOT COMPLETED|Overall Study||10
8362528|NCT01198327|20613349|P1|COMPLETED|Overall Study||56
8362529|NCT01198327|20613349|P1|STARTED|Overall Study||66
8362530|NCT01198275|20613359|P2|NOT COMPLETED|Overall Study||5
8362531|NCT01198275|20613360|P1|NOT COMPLETED|Overall Study||6
8362532|NCT01198275|20613359|P2|COMPLETED|Overall Study||94
8362533|NCT01198275|20613360|P1|COMPLETED|Overall Study||94
8362534|NCT01198275|20613359|P2|STARTED|Overall Study||99
8362535|NCT01198275|20613360|P1|STARTED|Overall Study||100
8362536|NCT01198158|20613368|P2|NOT COMPLETED|Overall Study||0
8362537|NCT01198158|20613369|P1|NOT COMPLETED|Overall Study||0
8362538|NCT01198158|20613368|P2|COMPLETED|Overall Study||36
8362539|NCT01198158|20613369|P1|COMPLETED|Overall Study||41
8362540|NCT01198158|20613368|P2|STARTED|Overall Study||36
8362541|NCT01198158|20613369|P1|STARTED|Overall Study||41
8362542|NCT01198145|20613383|P2|NOT COMPLETED|Overall Study||1
8362543|NCT01198145|20613384|P1|NOT COMPLETED|Overall Study||1
8362544|NCT01198145|20613383|P2|COMPLETED|Overall Study||42
8362545|NCT01198145|20613384|P1|COMPLETED|Overall Study||43
8362546|NCT01198145|20613383|P2|STARTED|Overall Study||43
8362547|NCT01198145|20613384|P1|STARTED|Overall Study||44
8362548|NCT01198132|20613406|P2|NOT COMPLETED|Overall Study||21
8362549|NCT01198132|20613407|P1|NOT COMPLETED|Overall Study||18
8362550|NCT01198132|20613406|P2|COMPLETED|Overall Study||45
8362551|NCT01198132|20613407|P1|COMPLETED|Overall Study||45
8362552|NCT01198132|20613406|P2|STARTED|Overall Study||66
8362553|NCT01198132|20613407|P1|STARTED|Overall Study||63
8362554|NCT01198028|20613431|P1|NOT COMPLETED|Overall Study||10
8362555|NCT01198028|20613431|P1|COMPLETED|Overall Study||29
8362556|NCT01198028|20613431|P1|STARTED|Overall Study||39
8362557|NCT01198002|20613443|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
8362558|NCT01198002|20613444|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
8362559|NCT01198002|20613445|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
8362560|NCT01198002|20613443|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
8362561|NCT01198002|20613444|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
8362562|NCT01198002|20613445|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
8362563|NCT01198002|20613443|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
8362564|NCT01198002|20613444|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
8362565|NCT01198002|20613445|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
8362566|NCT01198002|20613443|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
8362567|NCT01198002|20613444|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
8362568|NCT01198002|20613445|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
8362569|NCT01198002|20613443|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
8362570|NCT01198002|20613444|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
8362571|NCT01198002|20613445|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
8362572|NCT01198002|20613443|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
8362573|NCT01198002|20613444|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
8362574|NCT01198002|20613445|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
8362575|NCT01198002|20613443|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
8362576|NCT01198002|20613444|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
8362577|NCT01198002|20613445|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
8362578|NCT01198002|20613443|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
8362579|NCT01198002|20613444|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
8362580|NCT01198002|20613445|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
8362581|NCT01198002|20613443|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
8362582|NCT01198002|20613444|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
8362583|NCT01198002|20613445|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
8362584|NCT01197911|20613560|P3|NOT COMPLETED|Overall Study||1
8362585|NCT01197911|20613561|P2|NOT COMPLETED|Overall Study||0
8362586|NCT01197911|20613562|P1|NOT COMPLETED|Overall Study||0
8362587|NCT01197911|20613560|P3|COMPLETED|Overall Study||9
8362588|NCT01197911|20613561|P2|COMPLETED|Overall Study||10
8362589|NCT01197911|20613562|P1|COMPLETED|Overall Study||18
8362590|NCT01197911|20613560|P3|STARTED|Overall Study||10
8362591|NCT01197911|20613561|P2|STARTED|Overall Study||10
8362592|NCT01197911|20613562|P1|STARTED|Overall Study||18
8362593|NCT01197898|20613647|P2|NOT COMPLETED|Overall Study||0
8362594|NCT01197898|20613648|P1|NOT COMPLETED|Overall Study||0
8362595|NCT01197898|20613647|P2|COMPLETED|Overall Study||5
8362596|NCT01197898|20613648|P1|COMPLETED|Overall Study||5
8362597|NCT01197898|20613647|P2|STARTED|Overall Study||5
8362598|NCT01197898|20613648|P1|STARTED|Overall Study||5
8362599|NCT01197833|20613657|P3|NOT COMPLETED|Overall Study||0
8362600|NCT01197833|20613658|P2|NOT COMPLETED|Overall Study||0
8362601|NCT01197833|20613659|P1|NOT COMPLETED|Overall Study||0
8362602|NCT01197833|20613657|P3|COMPLETED|Overall Study||40
8362603|NCT01197833|20613658|P2|COMPLETED|Overall Study||39
8362604|NCT01197833|20613659|P1|COMPLETED|Overall Study||38
8362605|NCT01197833|20613657|P3|STARTED|Overall Study||40
8362606|NCT01197833|20613658|P2|STARTED|Overall Study||39
8362607|NCT01197833|20613659|P1|STARTED|Overall Study||38
8362608|NCT01197794|20613677|P7|NOT COMPLETED|Overall Study||21
8362609|NCT01197794|20613678|P6|NOT COMPLETED|Overall Study||19
8362610|NCT01197794|20613679|P5|NOT COMPLETED|Overall Study||14
8362611|NCT01197794|20613680|P4|NOT COMPLETED|Overall Study||12
8362612|NCT01197794|20613681|P3|NOT COMPLETED|Overall Study||13
8362613|NCT01197794|20613682|P2|NOT COMPLETED|Overall Study||15
8362614|NCT01197794|20613683|P1|NOT COMPLETED|Overall Study||16
8362615|NCT01197794|20613677|P7|COMPLETED|Overall Study||142
8362616|NCT01197794|20613678|P6|COMPLETED|Overall Study||144
8362617|NCT01197794|20613679|P5|COMPLETED|Overall Study||149
8362618|NCT01197794|20613680|P4|COMPLETED|Overall Study||152
8362619|NCT01197794|20613681|P3|COMPLETED|Overall Study||153
8362620|NCT01197794|20613682|P2|COMPLETED|Overall Study||146
8362621|NCT01197794|20613683|P1|COMPLETED|Overall Study||148
8362622|NCT01197794|20613677|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
8362623|NCT01197794|20613678|P6|STARTED|Overall Study||163
8362624|NCT01197794|20613679|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
8362625|NCT01197794|20613680|P4|STARTED|Overall Study||164
8362626|NCT01197794|20613681|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
8362627|NCT01197794|20613682|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
8362628|NCT01197794|20613683|P1|STARTED|Overall Study||164
8362629|NCT01197755|20613765|P3|NOT COMPLETED|Overall Study||54
8362630|NCT01197755|20613766|P2|NOT COMPLETED|Overall Study||43
8362631|NCT01197755|20613767|P1|NOT COMPLETED|Overall Study||38
8362632|NCT01197755|20613765|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
8362633|NCT01197755|20613766|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
8362634|NCT01197755|20613767|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
8362635|NCT01197755|20613765|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
8362636|NCT01197755|20613766|P2|Randomised But Did Not Receive Treatment|Overall Study||0
8362637|NCT01197755|20613767|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8362638|NCT01197755|20613765|P3|STARTED|Overall Study|Patients who received treatment|109
8362639|NCT01197755|20613766|P2|STARTED|Overall Study|Patients who received treatment|108
8362640|NCT01197755|20613767|P1|STARTED|Overall Study|Patients who received treatment|105
8362641|NCT01197612|20613807|P1|NOT COMPLETED|Overall Study||12
8362642|NCT01197612|20613807|P1|COMPLETED|Overall Study||6
8362643|NCT01197612|20613807|P1|Returned for Week 24|Overall Study||6
8362644|NCT01197612|20613807|P1|Week 3|Overall Study||16
8362645|NCT01197612|20613807|P1|STARTED|Overall Study||18
8362646|NCT01197573|20613822|P4|NOT COMPLETED|Overall Study||0
8362647|NCT01197573|20613823|P3|NOT COMPLETED|Overall Study||0
8362648|NCT01197573|20613824|P2|NOT COMPLETED|Overall Study||0
8362649|NCT01197573|20613825|P1|NOT COMPLETED|Overall Study||0
8362650|NCT01197573|20613822|P4|COMPLETED|Overall Study||12
8362651|NCT01197573|20613823|P3|COMPLETED|Overall Study||12
8362652|NCT01197573|20613824|P2|COMPLETED|Overall Study||46
8362653|NCT01197573|20613825|P1|COMPLETED|Overall Study||33
8362654|NCT01197573|20613822|P4|STARTED|Overall Study||12
8362655|NCT01197573|20613823|P3|STARTED|Overall Study||12
8362656|NCT01197573|20613824|P2|STARTED|Overall Study||46
8362657|NCT01197573|20613825|P1|STARTED|Overall Study||33
8362658|NCT01197560|20613839|P2|NOT COMPLETED|Overall Study||53
8362659|NCT01197560|20613840|P1|NOT COMPLETED|Overall Study||54
8362660|NCT01197560|20613839|P2|COMPLETED|Overall Study||4
8362661|NCT01197560|20613840|P1|COMPLETED|Overall Study||0
8362662|NCT01197560|20613839|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
8362663|NCT01197560|20613840|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
8362664|NCT01197560|20613839|P2|Lenalidomide Crossover|Overall Study||29
8362665|NCT01197560|20613840|P1|Lenalidomide Crossover|Overall Study||0
8362666|NCT01197560|20613839|P2|Received ≥ One Dose Study Drug|Overall Study||55
8362667|NCT01197560|20613840|P1|Received ≥ One Dose Study Drug|Overall Study||54
8362668|NCT01197560|20613839|P2|STARTED|Overall Study|This is the intent to treat population|57
8362669|NCT01197560|20613840|P1|STARTED|Overall Study|This is the intent to treat population|54
8362670|NCT01197547|20613878|P1|NOT COMPLETED|Overall Study||22
8362671|NCT01197547|20613878|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
8362672|NCT01197547|20613878|P1|STARTED|Overall Study||1014
8362673|NCT01197534|20613887|P3|NOT COMPLETED|Overall Study||173
8362674|NCT01197534|20613888|P2|NOT COMPLETED|Overall Study||130
8362675|NCT01197534|20613889|P1|NOT COMPLETED|Overall Study||134
8362676|NCT01197534|20613887|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
8362677|NCT01197534|20613888|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
8362678|NCT01197534|20613889|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
8362679|NCT01197534|20613887|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
8362680|NCT01197534|20613888|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
8362681|NCT01197534|20613889|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8362682|NCT01197534|20613887|P3|STARTED|Overall Study|Patients who received treatment|302
8362683|NCT01197534|20613888|P2|STARTED|Overall Study|Patients who received treatment|298
8362684|NCT01197534|20613889|P1|STARTED|Overall Study|Patients who received treatment|308
8362685|NCT01197521|20613933|P3|NOT COMPLETED|Overall Study||143
8362686|NCT01197521|20613934|P2|NOT COMPLETED|Overall Study||113
8362687|NCT01197521|20613935|P1|NOT COMPLETED|Overall Study||103
8362688|NCT01197521|20613933|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
8362689|NCT01197521|20613934|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
8362690|NCT01197521|20613935|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
8362691|NCT01197521|20613933|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
8362692|NCT01197521|20613934|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
8362693|NCT01197521|20613935|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
8362694|NCT01197521|20613933|P3|STARTED|Overall Study|Patients who received treatment|304
8362695|NCT01197521|20613934|P2|STARTED|Overall Study|Patients who received treatment|304
8362696|NCT01197521|20613935|P1|STARTED|Overall Study|Patients who received treatment|310
8362697|NCT01197508|20613980|P4|NOT COMPLETED|Overall Study||16
8362698|NCT01197508|20613981|P3|NOT COMPLETED|Overall Study||49
8362699|NCT01197508|20613982|P2|NOT COMPLETED|Overall Study||30
8362700|NCT01197508|20613983|P1|NOT COMPLETED|Overall Study||23
8362701|NCT01197508|20613980|P4|COMPLETED|Overall Study||158
8362702|NCT01197508|20613981|P3|COMPLETED|Overall Study||125
8362703|NCT01197508|20613982|P2|COMPLETED|Overall Study||144
8362704|NCT01197508|20613983|P1|COMPLETED|Overall Study||151
8362705|NCT01197508|20613980|P4|Received Treatment|Overall Study||174
8362706|NCT01197508|20613981|P3|Received Treatment|Overall Study||171
8362707|NCT01197508|20613982|P2|Received Treatment|Overall Study||174
8362708|NCT01197508|20613983|P1|Received Treatment|Overall Study||174
8362709|NCT01197508|20613980|P4|STARTED|Overall Study||174
8362710|NCT01197508|20613981|P3|STARTED|Overall Study||174
8362711|NCT01197508|20613982|P2|STARTED|Overall Study||174
8362712|NCT01197508|20613983|P1|STARTED|Overall Study||174
8362713|NCT01197495|20614079|P2|NOT COMPLETED|Overall Study||7
8362714|NCT01197495|20614080|P1|NOT COMPLETED|Overall Study||13
8362715|NCT01197495|20614079|P2|COMPLETED|Overall Study||49
8362716|NCT01197495|20614080|P1|COMPLETED|Overall Study||144
8362717|NCT01197495|20614079|P2|STARTED|Overall Study||56
8362718|NCT01197495|20614080|P1|STARTED|Overall Study||157
8362719|NCT01197456|20614093|P2|NOT COMPLETED|Overall Study||0
8362720|NCT01197456|20614094|P1|NOT COMPLETED|Overall Study||0
8362721|NCT01197456|20614093|P2|COMPLETED|Overall Study||61
8362722|NCT01197456|20614094|P1|COMPLETED|Overall Study||171
8362723|NCT01197456|20614093|P2|STARTED|Overall Study||61
8362724|NCT01197456|20614094|P1|STARTED|Overall Study||171
8362725|NCT01197417|20614104|P2|NOT COMPLETED|Overall Study||18
8362726|NCT01197417|20614105|P1|NOT COMPLETED|Overall Study||8
8362727|NCT01197417|20614104|P2|COMPLETED|Overall Study||86
8362728|NCT01197417|20614105|P1|COMPLETED|Overall Study||96
8362729|NCT01197417|20614104|P2|Received Study Drug|Overall Study||103
8362730|NCT01197417|20614105|P1|Received Study Drug|Overall Study||101
8362731|NCT01197417|20614104|P2|STARTED|Overall Study||104
8362732|NCT01197417|20614105|P1|STARTED|Overall Study||104
8362733|NCT01197378|20614123|P1|NOT COMPLETED|Overall Study||7
8362734|NCT01197378|20614123|P1|COMPLETED|Overall Study||53
8362735|NCT01197378|20614123|P1|Received Treatment|Overall Study||59
8362736|NCT01197378|20614123|P1|STARTED|Overall Study||60
8362737|NCT01197326|20614131|P2|NOT COMPLETED|Overall Study||0
8362738|NCT01197326|20614132|P1|NOT COMPLETED|Overall Study||0
8362739|NCT01197326|20614131|P2|COMPLETED|Overall Study||209
8362740|NCT01197326|20614132|P1|COMPLETED|Overall Study||205
8362741|NCT01197326|20614131|P2|STARTED|Overall Study||209
8362742|NCT01197326|20614132|P1|STARTED|Overall Study||205
8362743|NCT01197300|20614142|P2|NOT COMPLETED|Overall Study||2
8362744|NCT01197300|20614143|P1|NOT COMPLETED|Overall Study||0
8362745|NCT01197300|20614142|P2|COMPLETED|Overall Study||13
8362746|NCT01197300|20614143|P1|COMPLETED|Overall Study||10
8362747|NCT01197300|20614142|P2|STARTED|Overall Study||15
8362748|NCT01197300|20614143|P1|STARTED|Overall Study||10
8362749|NCT01196988|20614175|P4|NOT COMPLETED|Overall Study||1
8362750|NCT01196988|20614176|P3|NOT COMPLETED|Overall Study||25
8362751|NCT01196988|20614177|P2|NOT COMPLETED|Overall Study||32
8362752|NCT01196988|20614178|P1|NOT COMPLETED|Overall Study||24
8362753|NCT01196988|20614175|P4|COMPLETED|Overall Study||276
8362754|NCT01196988|20614176|P3|COMPLETED|Overall Study||886
8362755|NCT01196988|20614177|P2|COMPLETED|Overall Study||880
8362756|NCT01196988|20614178|P1|COMPLETED|Overall Study||891
8362757|NCT01196988|20614175|P4|STARTED|Overall Study||277
8362758|NCT01196988|20614176|P3|STARTED|Overall Study||911
8362759|NCT01196988|20614177|P2|STARTED|Overall Study||912
8362760|NCT01196988|20614178|P1|STARTED|Overall Study||915
8362761|NCT01196975|20614272|P5|NOT COMPLETED|Overall Study||13
8362762|NCT01196975|20614273|P4|NOT COMPLETED|Overall Study||6
8362763|NCT01196975|20614274|P3|NOT COMPLETED|Overall Study||5
8362764|NCT01196975|20614275|P2|NOT COMPLETED|Overall Study||9
8362765|NCT01196975|20614276|P1|NOT COMPLETED|Overall Study||15
8362766|NCT01196975|20614272|P5|COMPLETED|Overall Study||205
8362767|NCT01196975|20614273|P4|COMPLETED|Overall Study||207
8362768|NCT01196975|20614274|P3|COMPLETED|Overall Study||420
8362769|NCT01196975|20614275|P2|COMPLETED|Overall Study||415
8362770|NCT01196975|20614276|P1|COMPLETED|Overall Study||408
8362771|NCT01196975|20614272|P5|STARTED|Overall Study||218
8362772|NCT01196975|20614273|P4|STARTED|Overall Study||213
8362773|NCT01196975|20614274|P3|STARTED|Overall Study||425
8362774|NCT01196975|20614275|P2|STARTED|Overall Study||424
8362775|NCT01196975|20614276|P1|STARTED|Overall Study||423
8362776|NCT01196936|20614410|P2|NOT COMPLETED|Overall Study||17
8362777|NCT01196936|20614411|P1|NOT COMPLETED|Overall Study||11
8362778|NCT01196936|20614410|P2|COMPLETED|Overall Study||21
8362779|NCT01196936|20614411|P1|COMPLETED|Overall Study||23
8362780|NCT01196936|20614410|P2|Year One Post Treatment|Overall Study||28
8362781|NCT01196936|20614411|P1|Year One Post Treatment|Overall Study||27
8362782|NCT01196936|20614410|P2|STARTED|Overall Study||38
8362783|NCT01196936|20614411|P1|STARTED|Overall Study||34
8362784|NCT01196923|20614433|P1|NOT COMPLETED|Overall Study||0
8362785|NCT01196923|20614433|P1|COMPLETED|Overall Study||20
8362786|NCT01196923|20614433|P1|STARTED|Overall Study||20
8362787|NCT01196871|20614443|P6|NOT COMPLETED|Stage 2: Period 2||0
8362788|NCT01196871|20614444|P5|NOT COMPLETED|Stage 2: Period 2||0
8362789|NCT01196871|20614445|P4|NOT COMPLETED|Stage 2: Period 2||0
8362790|NCT01196871|20614446|P3|NOT COMPLETED|Stage 2: Period 2||0
8362791|NCT01196871|20614447|P2|NOT COMPLETED|Stage 2: Period 2||0
8362792|NCT01196871|20614448|P1|NOT COMPLETED|Stage 2: Period 2||0
8362793|NCT01196871|20614443|P6|COMPLETED|Stage 2: Period 2||4
8362794|NCT01196871|20614444|P5|COMPLETED|Stage 2: Period 2||6
8362795|NCT01196871|20614445|P4|COMPLETED|Stage 2: Period 2||1
8362796|NCT01196871|20614446|P3|COMPLETED|Stage 2: Period 2||0
8362797|NCT01196871|20614447|P2|COMPLETED|Stage 2: Period 2||0
8362798|NCT01196871|20614448|P1|COMPLETED|Stage 2: Period 2||0
8362799|NCT01196871|20614443|P6|PK Population|Stage 2: Period 2||4
8362800|NCT01196871|20614444|P5|PK Population|Stage 2: Period 2||6
8362801|NCT01196871|20614445|P4|PK Population|Stage 2: Period 2||1
8362802|NCT01196871|20614446|P3|PK Population|Stage 2: Period 2||0
8362803|NCT01196871|20614447|P2|PK Population|Stage 2: Period 2||0
8362804|NCT01196871|20614448|P1|PK Population|Stage 2: Period 2||0
8362805|NCT01196871|20614443|P6|STARTED|Stage 2: Period 2||4
8362884|NCT01196871|20614444|P5|NOT COMPLETED|Stage 1: Period 1||0
8362806|NCT01196871|20614444|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
8362807|NCT01196871|20614445|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
8362808|NCT01196871|20614446|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8362809|NCT01196871|20614447|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8362810|NCT01196871|20614448|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8362811|NCT01196871|20614443|P6|NOT COMPLETED|Stage 2: Period 1||0
8362812|NCT01196871|20614444|P5|NOT COMPLETED|Stage 2: Period 1||0
8362813|NCT01196871|20614445|P4|NOT COMPLETED|Stage 2: Period 1||0
8362814|NCT01196871|20614446|P3|NOT COMPLETED|Stage 2: Period 1||0
8362815|NCT01196871|20614447|P2|NOT COMPLETED|Stage 2: Period 1||0
8362816|NCT01196871|20614448|P1|NOT COMPLETED|Stage 2: Period 1||0
8362817|NCT01196871|20614443|P6|COMPLETED|Stage 2: Period 1||4
8362818|NCT01196871|20614444|P5|COMPLETED|Stage 2: Period 1||5
8362819|NCT01196871|20614445|P4|COMPLETED|Stage 2: Period 1||2
8362820|NCT01196871|20614446|P3|COMPLETED|Stage 2: Period 1||0
8362821|NCT01196871|20614447|P2|COMPLETED|Stage 2: Period 1||0
8362822|NCT01196871|20614448|P1|COMPLETED|Stage 2: Period 1||0
8362823|NCT01196871|20614443|P6|PK Population|Stage 2: Period 1||4
8362824|NCT01196871|20614444|P5|PK Population|Stage 2: Period 1||5
8362825|NCT01196871|20614445|P4|PK Population|Stage 2: Period 1||1
8362826|NCT01196871|20614446|P3|PK Population|Stage 2: Period 1||0
8362827|NCT01196871|20614447|P2|PK Population|Stage 2: Period 1||0
8362828|NCT01196871|20614448|P1|PK Population|Stage 2: Period 1||0
8362829|NCT01196871|20614443|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
8362830|NCT01196871|20614444|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
8362831|NCT01196871|20614445|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
8362832|NCT01196871|20614446|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8362833|NCT01196871|20614447|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8362834|NCT01196871|20614448|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8362835|NCT01196871|20614443|P6|STARTED|Stage 2: Period 1||4
8362836|NCT01196871|20614444|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
8362837|NCT01196871|20614445|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
8362838|NCT01196871|20614446|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8362839|NCT01196871|20614447|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8362840|NCT01196871|20614448|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8362841|NCT01196871|20614443|P6|NOT COMPLETED|Stage 1: Period 3||0
8362842|NCT01196871|20614444|P5|NOT COMPLETED|Stage 1: Period 3||0
8362843|NCT01196871|20614445|P4|NOT COMPLETED|Stage 1: Period 3||0
8362844|NCT01196871|20614446|P3|NOT COMPLETED|Stage 1: Period 3||0
8362845|NCT01196871|20614447|P2|NOT COMPLETED|Stage 1: Period 3||0
8362846|NCT01196871|20614448|P1|NOT COMPLETED|Stage 1: Period 3||0
8362847|NCT01196871|20614443|P6|COMPLETED|Stage 1: Period 3||0
8362848|NCT01196871|20614444|P5|COMPLETED|Stage 1: Period 3||0
8362849|NCT01196871|20614445|P4|COMPLETED|Stage 1: Period 3||0
8362850|NCT01196871|20614446|P3|COMPLETED|Stage 1: Period 3||4
8362851|NCT01196871|20614447|P2|COMPLETED|Stage 1: Period 3||3
8362852|NCT01196871|20614448|P1|COMPLETED|Stage 1: Period 3||5
8362853|NCT01196871|20614443|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8362854|NCT01196871|20614444|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8362855|NCT01196871|20614445|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8362856|NCT01196871|20614446|P3|STARTED|Stage 1: Period 3||4
8362857|NCT01196871|20614447|P2|STARTED|Stage 1: Period 3||3
8362858|NCT01196871|20614448|P1|STARTED|Stage 1: Period 3||5
8362859|NCT01196871|20614443|P6|NOT COMPLETED|Stage 1: Period 2||0
8362860|NCT01196871|20614444|P5|NOT COMPLETED|Stage 1: Period 2||0
8362861|NCT01196871|20614445|P4|NOT COMPLETED|Stage 1: Period 2||0
8362862|NCT01196871|20614446|P3|NOT COMPLETED|Stage 1: Period 2||0
8362863|NCT01196871|20614447|P2|NOT COMPLETED|Stage 1: Period 2||0
8362864|NCT01196871|20614448|P1|NOT COMPLETED|Stage 1: Period 2||0
8362865|NCT01196871|20614443|P6|COMPLETED|Stage 1: Period 2||0
8362866|NCT01196871|20614444|P5|COMPLETED|Stage 1: Period 2||0
8362867|NCT01196871|20614445|P4|COMPLETED|Stage 1: Period 2||0
8362868|NCT01196871|20614446|P3|COMPLETED|Stage 1: Period 2||4
8362869|NCT01196871|20614447|P2|COMPLETED|Stage 1: Period 2||3
8362870|NCT01196871|20614448|P1|COMPLETED|Stage 1: Period 2||5
8362871|NCT01196871|20614443|P6|PK Population|Stage 1: Period 2||0
8362872|NCT01196871|20614444|P5|PK Population|Stage 1: Period 2||0
8362873|NCT01196871|20614445|P4|PK Population|Stage 1: Period 2||0
8362874|NCT01196871|20614446|P3|PK Population|Stage 1: Period 2||4
8362875|NCT01196871|20614447|P2|PK Population|Stage 1: Period 2||3
8362876|NCT01196871|20614448|P1|PK Population|Stage 1: Period 2||5
8362877|NCT01196871|20614443|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8362878|NCT01196871|20614444|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8362879|NCT01196871|20614445|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8362880|NCT01196871|20614446|P3|STARTED|Stage 1: Period 2||4
8362881|NCT01196871|20614447|P2|STARTED|Stage 1: Period 2||3
8362882|NCT01196871|20614448|P1|STARTED|Stage 1: Period 2||5
8362883|NCT01196871|20614443|P6|NOT COMPLETED|Stage 1: Period 1||0
8362885|NCT01196871|20614445|P4|NOT COMPLETED|Stage 1: Period 1||0
8362886|NCT01196871|20614446|P3|NOT COMPLETED|Stage 1: Period 1||0
8362887|NCT01196871|20614447|P2|NOT COMPLETED|Stage 1: Period 1||0
8362888|NCT01196871|20614448|P1|NOT COMPLETED|Stage 1: Period 1||0
8362889|NCT01196871|20614443|P6|COMPLETED|Stage 1: Period 1||0
8362890|NCT01196871|20614444|P5|COMPLETED|Stage 1: Period 1||0
8362891|NCT01196871|20614445|P4|COMPLETED|Stage 1: Period 1||0
8362892|NCT01196871|20614446|P3|COMPLETED|Stage 1: Period 1||4
8362893|NCT01196871|20614447|P2|COMPLETED|Stage 1: Period 1||3
8362894|NCT01196871|20614448|P1|COMPLETED|Stage 1: Period 1||5
8362895|NCT01196871|20614443|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8362896|NCT01196871|20614444|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8362897|NCT01196871|20614445|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8362898|NCT01196871|20614446|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
8362899|NCT01196871|20614447|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
8362900|NCT01196871|20614448|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
8362901|NCT01196871|20614443|P6|PK Population|Stage 1: Period 1||0
8362902|NCT01196871|20614444|P5|PK Population|Stage 1: Period 1||0
8362903|NCT01196871|20614445|P4|PK Population|Stage 1: Period 1||0
8362904|NCT01196871|20614446|P3|PK Population|Stage 1: Period 1||4
8362905|NCT01196871|20614447|P2|PK Population|Stage 1: Period 1||3
8362906|NCT01196871|20614448|P1|PK Population|Stage 1: Period 1||5
8362907|NCT01196871|20614443|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8362908|NCT01196871|20614444|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8362909|NCT01196871|20614445|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8362910|NCT01196871|20614446|P3|STARTED|Stage 1: Period 1||4
8362911|NCT01196871|20614447|P2|STARTED|Stage 1: Period 1||3
8362912|NCT01196871|20614448|P1|STARTED|Stage 1: Period 1||5
8362913|NCT01196819|20614533|P2|NOT COMPLETED|Overall Study||0
8362914|NCT01196819|20614534|P1|NOT COMPLETED|Overall Study||6
8362915|NCT01196819|20614533|P2|COMPLETED|Overall Study||227
8362916|NCT01196819|20614534|P1|COMPLETED|Overall Study||225
8362917|NCT01196819|20614533|P2|STARTED|Overall Study||227
8362918|NCT01196819|20614534|P1|STARTED|Overall Study||231
8362919|NCT01196793|20614554|P1|NOT COMPLETED|Overall Study||0
8362920|NCT01196793|20614554|P1|COMPLETED|Overall Study||108
8362921|NCT01196793|20614554|P1|STARTED|Overall Study||108
8362922|NCT01196741|20614560|P2|NOT COMPLETED|Overall Study||28
8362923|NCT01196741|20614561|P1|NOT COMPLETED|Overall Study||60
8362924|NCT01196741|20614560|P2|COMPLETED|Overall Study||8
8362925|NCT01196741|20614561|P1|COMPLETED|Overall Study||11
8362926|NCT01196741|20614560|P2|STARTED|Overall Study||36
8362927|NCT01196741|20614561|P1|STARTED|Overall Study||71
8362928|NCT01196533|20614575|P1|NOT COMPLETED|Overall Study||0
8362929|NCT01196533|20614575|P1|COMPLETED|Overall Study||94
8362930|NCT01196533|20614575|P1|STARTED|Overall Study||94
8362931|NCT01196442|20614579|P1|NOT COMPLETED|Overall Study||0
8362932|NCT01196442|20614579|P1|COMPLETED|Overall Study||39
8362933|NCT01196442|20614579|P1|STARTED|Overall Study||39
8362934|NCT01196429|20614591|P2|NOT COMPLETED|Overall Study||0
8362935|NCT01196429|20614592|P1|NOT COMPLETED|Overall Study||3
8362936|NCT01196429|20614591|P2|COMPLETED|Overall Study||45
8362937|NCT01196429|20614592|P1|COMPLETED|Overall Study||42
8362938|NCT01196429|20614591|P2|STARTED|Overall Study||45
8362939|NCT01196429|20614592|P1|STARTED|Overall Study||45
8362940|NCT01196416|20614608|P1|NOT COMPLETED|Overall Study||2
8362941|NCT01196416|20614608|P1|COMPLETED|Overall Study||12
8362942|NCT01196416|20614608|P1|STARTED|Overall Study||14
8362943|NCT01196377|20614626|P4|NOT COMPLETED|Overall Study||0
8362944|NCT01196377|20614627|P3|NOT COMPLETED|Overall Study||0
8362945|NCT01196377|20614628|P2|NOT COMPLETED|Overall Study||0
8362946|NCT01196377|20614629|P1|NOT COMPLETED|Overall Study||0
8362947|NCT01196377|20614626|P4|COMPLETED|Overall Study||4
8362948|NCT01196377|20614627|P3|COMPLETED|Overall Study||4
8362949|NCT01196377|20614628|P2|COMPLETED|Overall Study||4
8362950|NCT01196377|20614629|P1|COMPLETED|Overall Study||4
8362951|NCT01196377|20614626|P4|STARTED|Overall Study||4
8362952|NCT01196377|20614627|P3|STARTED|Overall Study||4
8362953|NCT01196377|20614628|P2|STARTED|Overall Study||4
8362954|NCT01196377|20614629|P1|STARTED|Overall Study||4
8362955|NCT01196117|20614639|P2|NOT COMPLETED|CPAP||0
8362956|NCT01196117|20614640|P1|NOT COMPLETED|CPAP||0
8362957|NCT01196117|20614639|P2|COMPLETED|CPAP||18
8362958|NCT01196117|20614640|P1|COMPLETED|CPAP||0
8362959|NCT01196117|20614639|P2|STARTED|CPAP||18
8362960|NCT01196117|20614640|P1|STARTED|CPAP||0
8362961|NCT01196117|20614639|P2|NOT COMPLETED|Placebo, Then CPAP||0
8362962|NCT01196117|20614640|P1|NOT COMPLETED|Placebo, Then CPAP||0
8362963|NCT01196117|20614639|P2|COMPLETED|Placebo, Then CPAP||0
8362964|NCT01196117|20614640|P1|COMPLETED|Placebo, Then CPAP||18
8362965|NCT01196117|20614639|P2|STARTED|Placebo, Then CPAP||0
8362966|NCT01196117|20614640|P1|STARTED|Placebo, Then CPAP||18
8362967|NCT01196104|20614666|P2|NOT COMPLETED|Overall Study||5
8362968|NCT01196104|20614667|P1|NOT COMPLETED|Overall Study||4
8362969|NCT01196104|20614666|P2|COMPLETED|Overall Study||15
8362970|NCT01196104|20614667|P1|COMPLETED|Overall Study||15
8362971|NCT01196104|20614666|P2|STARTED|Overall Study||20
8362972|NCT01196104|20614667|P1|STARTED|Overall Study||19
8362973|NCT01196091|20614710|P3|NOT COMPLETED|Overall Study||104
8362974|NCT01196091|20614711|P2|NOT COMPLETED|Overall Study||98
8362975|NCT01196091|20614712|P1|NOT COMPLETED|Overall Study||88
8362976|NCT01196091|20614710|P3|COMPLETED|Overall Study||284
8362977|NCT01196091|20614711|P2|COMPLETED|Overall Study||291
8362978|NCT01196091|20614712|P1|COMPLETED|Overall Study||299
8362979|NCT01196091|20614710|P3|Follow-Up|Overall Study||128
8362980|NCT01196091|20614711|P2|Follow-Up|Overall Study||105
8362981|NCT01196091|20614712|P1|Follow-Up|Overall Study||103
8362982|NCT01196091|20614710|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
8362983|NCT01196091|20614711|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
8362984|NCT01196091|20614712|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
8362985|NCT01196091|20614710|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
8362986|NCT01196091|20614711|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
8362987|NCT01196091|20614712|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
8362988|NCT01196091|20614710|P3|STARTED|Overall Study||388
8362989|NCT01196091|20614711|P2|STARTED|Overall Study||389
8362990|NCT01196091|20614712|P1|STARTED|Overall Study||387
8362991|NCT01196078|20614764|P2|NOT COMPLETED|Overall Study||37
8362992|NCT01196078|20614765|P1|NOT COMPLETED|Overall Study||33
8362993|NCT01196078|20614764|P2|COMPLETED|Overall Study||20
8362994|NCT01196078|20614765|P1|COMPLETED|Overall Study||24
8362995|NCT01196078|20614764|P2|STARTED|Overall Study||57
8362996|NCT01196078|20614765|P1|STARTED|Overall Study||57
8362997|NCT01196052|20614793|P1|NOT COMPLETED|Overall Study||23
8362998|NCT01196052|20614793|P1|COMPLETED|Overall Study||130
8362999|NCT01196052|20614793|P1|Received Trastuzumab Emtansine|Overall Study||148
8363000|NCT01196052|20614793|P1|STARTED|Overall Study||153
8363001|NCT01196026|20614810|P6|NOT COMPLETED|Overall Study||0
8363002|NCT01196026|20614811|P5|NOT COMPLETED|Overall Study||1
8363003|NCT01196026|20614812|P4|NOT COMPLETED|Overall Study||0
8363004|NCT01196026|20614813|P3|NOT COMPLETED|Overall Study||0
8363005|NCT01196026|20614814|P2|NOT COMPLETED|Overall Study||8
8363006|NCT01196026|20614815|P1|NOT COMPLETED|Overall Study||1
8363007|NCT01196026|20614810|P6|COMPLETED|Overall Study||24
8363008|NCT01196026|20614811|P5|COMPLETED|Overall Study||42
8363009|NCT01196026|20614812|P4|COMPLETED|Overall Study||10
8363010|NCT01196026|20614813|P3|COMPLETED|Overall Study||23
8363011|NCT01196026|20614814|P2|COMPLETED|Overall Study||36
8363012|NCT01196026|20614815|P1|COMPLETED|Overall Study||9
8363013|NCT01196026|20614810|P6|Completed at Day 28|Overall Study||24
8363014|NCT01196026|20614811|P5|Completed at Day 28|Overall Study||42
8363015|NCT01196026|20614812|P4|Completed at Day 28|Overall Study||10
8363016|NCT01196026|20614813|P3|Completed at Day 28|Overall Study||23
8363017|NCT01196026|20614814|P2|Completed at Day 28|Overall Study||41
8363018|NCT01196026|20614815|P1|Completed at Day 28|Overall Study||9
8363019|NCT01196026|20614810|P6|STARTED|Overall Study||24
8363020|NCT01196026|20614811|P5|STARTED|Overall Study||43
8363021|NCT01196026|20614812|P4|STARTED|Overall Study||10
8363022|NCT01196026|20614813|P3|STARTED|Overall Study||23
8363023|NCT01196026|20614814|P2|STARTED|Overall Study||44
8363024|NCT01196026|20614815|P1|STARTED|Overall Study||10
8363025|NCT01195948|20615049|P3|NOT COMPLETED|Overall Study||2
8363026|NCT01195948|20615050|P2|NOT COMPLETED|Overall Study||1
8363027|NCT01195948|20615051|P1|NOT COMPLETED|Overall Study||0
8363028|NCT01195948|20615049|P3|COMPLETED|Overall Study||9
8363029|NCT01195948|20615050|P2|COMPLETED|Overall Study||9
8363030|NCT01195948|20615051|P1|COMPLETED|Overall Study||10
8363031|NCT01195948|20615049|P3|Week 24|Overall Study||10
8363032|NCT01195948|20615050|P2|Week 24|Overall Study||10
8363033|NCT01195948|20615051|P1|Week 24|Overall Study||10
8363034|NCT01195948|20615049|P3|STARTED|Overall Study||11
8363035|NCT01195948|20615050|P2|STARTED|Overall Study||10
8363036|NCT01195948|20615051|P1|STARTED|Overall Study||10
8363037|NCT01195922|20615083|P1|NOT COMPLETED|Overall Study||0
8363038|NCT01195922|20615083|P1|COMPLETED|Overall Study||16
8363039|NCT01195922|20615083|P1|STARTED|Overall Study||16
8363040|NCT01195883|20615091|P2|NOT COMPLETED|Overall Study||26
8363041|NCT01195883|20615092|P1|NOT COMPLETED|Overall Study||19
8363042|NCT01195883|20615091|P2|COMPLETED|Overall Study||523
8363043|NCT01195883|20615092|P1|COMPLETED|Overall Study||534
8363044|NCT01195883|20615091|P2|STARTED|Overall Study||549
8363045|NCT01195883|20615092|P1|STARTED|Overall Study||553
8363046|NCT01195844|20615104|P1|NOT COMPLETED|Overall Study||40
8363047|NCT01195844|20615104|P1|COMPLETED|Overall Study||190
8363048|NCT01195844|20615104|P1|STARTED|Overall Study||230
8363049|NCT01195831|20615121|P2|NOT COMPLETED|Overall Study||10
8363050|NCT01195831|20615122|P1|NOT COMPLETED|Overall Study||8
8363051|NCT01195831|20615121|P2|COMPLETED|Overall Study||114
8363052|NCT01195831|20615122|P1|COMPLETED|Overall Study||112
8363053|NCT01195831|20615121|P2|STARTED|Overall Study||124
8363054|NCT01195831|20615122|P1|STARTED|Overall Study||120
8363055|NCT01195779|20615150|P14|NOT COMPLETED|Overall Study||0
8363056|NCT01195779|20615151|P13|NOT COMPLETED|Overall Study||0
8363057|NCT01195779|20615152|P12|NOT COMPLETED|Overall Study||0
8363058|NCT01195779|20615153|P11|NOT COMPLETED|Overall Study||0
8363059|NCT01195779|20615154|P10|NOT COMPLETED|Overall Study||0
8363060|NCT01195779|20615155|P9|NOT COMPLETED|Overall Study||0
8363061|NCT01195779|20615156|P8|NOT COMPLETED|Overall Study||0
8363062|NCT01195779|20615157|P7|NOT COMPLETED|Overall Study||0
8363063|NCT01195779|20615158|P6|NOT COMPLETED|Overall Study||0
8363064|NCT01195779|20615159|P5|NOT COMPLETED|Overall Study||0
8363065|NCT01195779|20615160|P4|NOT COMPLETED|Overall Study||0
8363066|NCT01195779|20615161|P3|NOT COMPLETED|Overall Study||0
8363067|NCT01195779|20615162|P2|NOT COMPLETED|Overall Study||0
8363068|NCT01195779|20615163|P1|NOT COMPLETED|Overall Study||0
8363069|NCT01195779|20615150|P14|COMPLETED|Overall Study||1
8363070|NCT01195779|20615151|P13|COMPLETED|Overall Study||0
8363071|NCT01195779|20615152|P12|COMPLETED|Overall Study||1
8363072|NCT01195779|20615153|P11|COMPLETED|Overall Study||0
8363073|NCT01195779|20615154|P10|COMPLETED|Overall Study||0
8363074|NCT01195779|20615155|P9|COMPLETED|Overall Study||0
8363075|NCT01195779|20615156|P8|COMPLETED|Overall Study||1
8363076|NCT01195779|20615157|P7|COMPLETED|Overall Study||0
8363077|NCT01195779|20615158|P6|COMPLETED|Overall Study||0
8363078|NCT01195779|20615159|P5|COMPLETED|Overall Study||1
8363079|NCT01195779|20615160|P4|COMPLETED|Overall Study||0
8363080|NCT01195779|20615161|P3|COMPLETED|Overall Study||0
8363081|NCT01195779|20615162|P2|COMPLETED|Overall Study||0
8363082|NCT01195779|20615163|P1|COMPLETED|Overall Study||0
8363083|NCT01195779|20615150|P14|STARTED|Overall Study||1
8363084|NCT01195779|20615151|P13|STARTED|Overall Study||0
8363085|NCT01195779|20615152|P12|STARTED|Overall Study||1
8363086|NCT01195779|20615153|P11|STARTED|Overall Study||0
8363087|NCT01195779|20615154|P10|STARTED|Overall Study||0
8363088|NCT01195779|20615155|P9|STARTED|Overall Study||0
8363089|NCT01195779|20615156|P8|STARTED|Overall Study||1
8363090|NCT01195779|20615157|P7|STARTED|Overall Study||0
8363091|NCT01195779|20615158|P6|STARTED|Overall Study||0
8363092|NCT01195779|20615159|P5|STARTED|Overall Study||1
8363093|NCT01195779|20615160|P4|STARTED|Overall Study||0
8363094|NCT01195779|20615161|P3|STARTED|Overall Study||0
8363095|NCT01195779|20615162|P2|STARTED|Overall Study||0
8363096|NCT01195779|20615163|P1|STARTED|Overall Study||0
8363097|NCT01195701|20615335|P2|NOT COMPLETED|Overall Study||5
8363098|NCT01195701|20615336|P1|NOT COMPLETED|Overall Study||0
8363099|NCT01195701|20615335|P2|COMPLETED|Overall Study||20
8363100|NCT01195701|20615336|P1|COMPLETED|Overall Study||10
8363101|NCT01195701|20615335|P2|STARTED|Overall Study||25
8363102|NCT01195701|20615336|P1|STARTED|Overall Study||10
8363103|NCT01195675|20615362|P1|NOT COMPLETED|Overall Study||3
8363104|NCT01195675|20615362|P1|COMPLETED|Overall Study||27
8363105|NCT01195675|20615362|P1|Received Placebo 2|Overall Study||28
8363106|NCT01195675|20615362|P1|Received Placebo 1|Overall Study||29
8363107|NCT01195675|20615362|P1|Received Moxifloxacin|Overall Study||29
8363108|NCT01195675|20615362|P1|Received Empa 200mg|Overall Study||30
8363109|NCT01195675|20615362|P1|Received Empa 25mg|Overall Study||28
8363110|NCT01195675|20615362|P1|STARTED|Overall Study||30
8363111|NCT01195662|20615395|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
8363112|NCT01195662|20615396|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
8363113|NCT01195662|20615397|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
8363114|NCT01195662|20615395|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
8363115|NCT01195662|20615396|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
8363116|NCT01195662|20615397|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
8363117|NCT01195662|20615395|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
8363118|NCT01195662|20615396|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
8363119|NCT01195662|20615397|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
8363120|NCT01195662|20615395|P3|NOT COMPLETED|Double Blind Treatment Period||14
8363121|NCT01195662|20615396|P2|NOT COMPLETED|Double Blind Treatment Period||14
8363122|NCT01195662|20615397|P1|NOT COMPLETED|Double Blind Treatment Period||22
8363123|NCT01195662|20615395|P3|COMPLETED|Double Blind Treatment Period||119
8363124|NCT01195662|20615396|P2|COMPLETED|Double Blind Treatment Period||211
8363125|NCT01195662|20615397|P1|COMPLETED|Double Blind Treatment Period||202
8363126|NCT01195662|20615395|P3|STARTED|Double Blind Treatment Period||133
8363127|NCT01195662|20615396|P2|STARTED|Double Blind Treatment Period||225
8363128|NCT01195662|20615397|P1|STARTED|Double Blind Treatment Period||224
8363129|NCT01195636|20615427|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
8363130|NCT01195636|20615428|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
8363131|NCT01195636|20615427|P2|COMPLETED|Second Intervention (3 Weeks)||27
8363132|NCT01195636|20615428|P1|COMPLETED|Second Intervention (3 Weeks)||27
8363133|NCT01195636|20615427|P2|STARTED|Second Intervention (3 Weeks)||29
8363134|NCT01195636|20615428|P1|STARTED|Second Intervention (3 Weeks)||28
8363135|NCT01195636|20615427|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
8363136|NCT01195636|20615428|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
8363137|NCT01195636|20615427|P2|COMPLETED|Washout Period (2 Weeks)||29
8363138|NCT01195636|20615428|P1|COMPLETED|Washout Period (2 Weeks)||28
8363139|NCT01195636|20615427|P2|STARTED|Washout Period (2 Weeks)||32
8363140|NCT01195636|20615428|P1|STARTED|Washout Period (2 Weeks)||30
8363141|NCT01195636|20615427|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
8363142|NCT01195636|20615428|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
8363143|NCT01195636|20615427|P2|COMPLETED|First Intervention (3 Weeks)||32
8363144|NCT01195636|20615428|P1|COMPLETED|First Intervention (3 Weeks)||30
8363145|NCT01195636|20615427|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
8363146|NCT01195636|20615428|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
8363147|NCT01195636|20615427|P2|STARTED|First Intervention (3 Weeks)||35
8363148|NCT01195636|20615428|P1|STARTED|First Intervention (3 Weeks)||35
8363149|NCT01195623|20615454|P2|NOT COMPLETED|Overall Study||37
8363150|NCT01195623|20615455|P1|NOT COMPLETED|Overall Study||35
8363151|NCT01195623|20615454|P2|COMPLETED|Overall Study|129 legs|108
8363152|NCT01195623|20615455|P1|COMPLETED|Overall Study|127 legs|113
8363153|NCT01195623|20615454|P2|STARTED|Overall Study|177 legs total operated|145
8363154|NCT01195623|20615455|P1|STARTED|Overall Study|166 legs total operated|148
8363155|NCT01195597|20615463|P1|NOT COMPLETED|Overall Study||13
8363156|NCT01195597|20615463|P1|COMPLETED|Overall Study||27
8363157|NCT01195597|20615463|P1|STARTED|Overall Study||40
8363158|NCT01195584|20615471|P3|NOT COMPLETED|Overall Study||0
8363159|NCT01195584|20615472|P2|NOT COMPLETED|Overall Study||0
8363160|NCT01195584|20615473|P1|NOT COMPLETED|Overall Study||0
8363161|NCT01195584|20615471|P3|COMPLETED|Overall Study||27
8363162|NCT01195584|20615472|P2|COMPLETED|Overall Study||25
8363163|NCT01195584|20615473|P1|COMPLETED|Overall Study||20
8363164|NCT01195584|20615471|P3|STARTED|Overall Study||27
8363165|NCT01195584|20615472|P2|STARTED|Overall Study||25
8363166|NCT01195584|20615473|P1|STARTED|Overall Study||20
8363167|NCT01195545|20615484|P1|NOT COMPLETED|Overall Study||4
8363168|NCT01195545|20615484|P1|COMPLETED|Overall Study||16
8363169|NCT01195545|20615484|P1|STARTED|Overall Study||20
8363170|NCT01195467|20615491|P1|NOT COMPLETED|Overall Study||10
8363171|NCT01195467|20615491|P1|COMPLETED|Overall Study||30
8363172|NCT01195467|20615491|P1|STARTED|Overall Study||40
8363173|NCT01195415|20615496|P1|NOT COMPLETED|Overall Study||2
8363174|NCT01195415|20615496|P1|COMPLETED|Overall Study||23
8363175|NCT01195415|20615496|P1|STARTED|Overall Study||25
8363176|NCT01195363|20615505|P2|NOT COMPLETED|Overall Study||9
8363177|NCT01195363|20615506|P1|NOT COMPLETED|Overall Study||11
8363178|NCT01195363|20615505|P2|COMPLETED|Overall Study||4
8363179|NCT01195363|20615506|P1|COMPLETED|Overall Study||4
8363180|NCT01195363|20615505|P2|STARTED|Overall Study||13
8363181|NCT01195363|20615506|P1|STARTED|Overall Study||15
8363182|NCT01195272|20615512|P1|NOT COMPLETED|Overall Study||4
8363183|NCT01195272|20615512|P1|COMPLETED|Overall Study||17
8363184|NCT01195272|20615512|P1|STARTED|Overall Study||21
8363185|NCT01195116|20615531|P2|NOT COMPLETED|Overall Study||0
8363186|NCT01195116|20615532|P1|NOT COMPLETED|Overall Study||0
8363187|NCT01195116|20615531|P2|COMPLETED|Overall Study||20
8363188|NCT01195116|20615532|P1|COMPLETED|Overall Study||21
8363189|NCT01195116|20615531|P2|STARTED|Overall Study||20
8363190|NCT01195116|20615532|P1|STARTED|Overall Study||21
8363191|NCT01195103|20615541|P3|NOT COMPLETED|Overall Study||0
8363192|NCT01195103|20615542|P2|NOT COMPLETED|Overall Study||0
8363193|NCT01195103|20615543|P1|NOT COMPLETED|Overall Study||1
8363194|NCT01195103|20615541|P3|COMPLETED|Overall Study||5
8363195|NCT01195103|20615542|P2|COMPLETED|Overall Study||2
8363196|NCT01195103|20615543|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
8363197|NCT01195103|20615541|P3|STARTED|Overall Study||5
8363198|NCT01195103|20615542|P2|STARTED|Overall Study||2
8363199|NCT01195103|20615543|P1|STARTED|Overall Study||6
8363200|NCT01195090|20615553|P2|NOT COMPLETED|Overall Study||8
8363201|NCT01195090|20615554|P1|NOT COMPLETED|Overall Study||6
8363202|NCT01195090|20615553|P2|COMPLETED|Overall Study||52
8363203|NCT01195090|20615554|P1|COMPLETED|Overall Study||54
8363204|NCT01195090|20615553|P2|STARTED|Overall Study||60
8363205|NCT01195090|20615554|P1|STARTED|Overall Study||60
8363206|NCT01195025|20615612|P5|NOT COMPLETED|Third Intervention C||0
8363207|NCT01195025|20615613|P4|NOT COMPLETED|Third Intervention C||0
8363208|NCT01195025|20615614|P3|NOT COMPLETED|Third Intervention C||0
8363209|NCT01195025|20615615|P2|NOT COMPLETED|Third Intervention C||0
8363210|NCT01195025|20615616|P1|NOT COMPLETED|Third Intervention C||0
8363211|NCT01195025|20615612|P5|COMPLETED|Third Intervention C||1
8363212|NCT01195025|20615613|P4|COMPLETED|Third Intervention C||2
8363213|NCT01195025|20615614|P3|COMPLETED|Third Intervention C||2
8363214|NCT01195025|20615615|P2|COMPLETED|Third Intervention C||3
8363215|NCT01195025|20615616|P1|COMPLETED|Third Intervention C||2
8363216|NCT01195025|20615612|P5|STARTED|Third Intervention C||1
8363217|NCT01195025|20615613|P4|STARTED|Third Intervention C||2
8363218|NCT01195025|20615614|P3|STARTED|Third Intervention C||2
8363219|NCT01195025|20615615|P2|STARTED|Third Intervention C||3
8363220|NCT01195025|20615616|P1|STARTED|Third Intervention C||2
8363221|NCT01195025|20615612|P5|NOT COMPLETED|Second Intervention B||0
8363222|NCT01195025|20615613|P4|NOT COMPLETED|Second Intervention B||0
8363223|NCT01195025|20615614|P3|NOT COMPLETED|Second Intervention B||0
8363224|NCT01195025|20615615|P2|NOT COMPLETED|Second Intervention B||0
8363225|NCT01195025|20615616|P1|NOT COMPLETED|Second Intervention B||0
8363226|NCT01195025|20615612|P5|COMPLETED|Second Intervention B||1
8363227|NCT01195025|20615613|P4|COMPLETED|Second Intervention B||2
8363228|NCT01195025|20615614|P3|COMPLETED|Second Intervention B||2
8363229|NCT01195025|20615615|P2|COMPLETED|Second Intervention B||3
8363230|NCT01195025|20615616|P1|COMPLETED|Second Intervention B||2
8363231|NCT01195025|20615612|P5|STARTED|Second Intervention B||1
8363232|NCT01195025|20615613|P4|STARTED|Second Intervention B||2
8363233|NCT01195025|20615614|P3|STARTED|Second Intervention B||2
8363234|NCT01195025|20615615|P2|STARTED|Second Intervention B||3
8363235|NCT01195025|20615616|P1|STARTED|Second Intervention B||2
8363236|NCT01195025|20615612|P5|NOT COMPLETED|First Intervention A||0
8363237|NCT01195025|20615613|P4|NOT COMPLETED|First Intervention A||0
8363238|NCT01195025|20615614|P3|NOT COMPLETED|First Intervention A||0
8363239|NCT01195025|20615615|P2|NOT COMPLETED|First Intervention A||0
8363240|NCT01195025|20615616|P1|NOT COMPLETED|First Intervention A||0
8363241|NCT01195025|20615612|P5|COMPLETED|First Intervention A||1
8363242|NCT01195025|20615613|P4|COMPLETED|First Intervention A||2
8363243|NCT01195025|20615614|P3|COMPLETED|First Intervention A||2
8363244|NCT01195025|20615615|P2|COMPLETED|First Intervention A||3
8363245|NCT01195025|20615616|P1|COMPLETED|First Intervention A||2
8363246|NCT01195025|20615612|P5|STARTED|First Intervention A||1
8363247|NCT01195025|20615613|P4|STARTED|First Intervention A||2
8363248|NCT01195025|20615614|P3|STARTED|First Intervention A||2
8363249|NCT01195025|20615615|P2|STARTED|First Intervention A||3
8363250|NCT01195025|20615616|P1|STARTED|First Intervention A||2
8363251|NCT01194999|20615623|P1|NOT COMPLETED|Overall Study||17
8363252|NCT01194999|20615623|P1|COMPLETED|Overall Study||115
8363253|NCT01194999|20615623|P1|STARTED|Overall Study||132
8363254|NCT01194973|20615627|P1|NOT COMPLETED|26 Week Treatment Period||3
8363255|NCT01194973|20615627|P1|COMPLETED|26 Week Treatment Period||38
8363256|NCT01194973|20615627|P1|STARTED|26 Week Treatment Period||41
8363257|NCT01194973|20615627|P1|NOT COMPLETED|Screening Period||3
8363258|NCT01194973|20615627|P1|COMPLETED|Screening Period||41
8363259|NCT01194973|20615627|P1|STARTED|Screening Period||44
8363260|NCT01194908|20615642|P1|NOT COMPLETED|Overall Study||0
8363261|NCT01194908|20615642|P1|COMPLETED|Overall Study||5
8363262|NCT01194908|20615642|P1|STARTED|Overall Study||5
8363263|NCT01194869|20615647|P1|NOT COMPLETED|Overall Study||4
8363264|NCT01194869|20615647|P1|COMPLETED|Overall Study||21
8363265|NCT01194869|20615647|P1|STARTED|Overall Study||25
8363266|NCT01194856|20615655|P2|NOT COMPLETED|Overall Study||0
8363267|NCT01194856|20615656|P1|NOT COMPLETED|Overall Study||1
8363268|NCT01194856|20615655|P2|COMPLETED|Overall Study||0
8363269|NCT01194856|20615656|P1|COMPLETED|Overall Study||0
8363270|NCT01194856|20615655|P2|STARTED|Overall Study||0
8363271|NCT01194856|20615656|P1|STARTED|Overall Study||1
8363272|NCT01194830|20615678|P2|NOT COMPLETED|Overall Study||27
8363273|NCT01194830|20615679|P1|NOT COMPLETED|Overall Study||36
8363274|NCT01194830|20615678|P2|COMPLETED|Overall Study||83
8363275|NCT01194830|20615679|P1|COMPLETED|Overall Study||88
8363276|NCT01194830|20615678|P2|STARTED|Overall Study||110
8363277|NCT01194830|20615679|P1|STARTED|Overall Study||124
8363278|NCT01194804|20615701|P1|NOT COMPLETED|Overall Study||1
8363279|NCT01194804|20615701|P1|COMPLETED|Overall Study||26
8363280|NCT01194804|20615701|P1|STARTED|Overall Study||27
8363281|NCT01194674|20615709|P1|NOT COMPLETED|Overall Study||0
8363282|NCT01194674|20615709|P1|COMPLETED|Overall Study||2
8363283|NCT01194674|20615709|P1|STARTED|Overall Study||2
8363284|NCT01194570|20615723|P2|NOT COMPLETED|Overall Study||488
8363285|NCT01194570|20615724|P1|NOT COMPLETED|Overall Study||244
8363286|NCT01194570|20615723|P2|COMPLETED|Overall Study||0
8363287|NCT01194570|20615724|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
8363288|NCT01194570|20615723|P2|STARTED|Overall Study||488
8363289|NCT01194570|20615724|P1|STARTED|Overall Study||244
8363290|NCT01194531|20615744|P2|NOT COMPLETED|Overall Study||3
8363291|NCT01194531|20615745|P1|NOT COMPLETED|Overall Study||5
8363292|NCT01194531|20615744|P2|COMPLETED|Overall Study||27
8363293|NCT01194531|20615745|P1|COMPLETED|Overall Study||24
8363294|NCT01194531|20615744|P2|STARTED|Overall Study||30
8363295|NCT01194531|20615745|P1|STARTED|Overall Study||29
8363296|NCT01194479|20615753|P4|NOT COMPLETED|Overall Study||0
8363297|NCT01194479|20615754|P3|NOT COMPLETED|Overall Study||0
8363298|NCT01194479|20615755|P2|NOT COMPLETED|Overall Study||0
8363299|NCT01194479|20615756|P1|NOT COMPLETED|Overall Study||0
8363300|NCT01194479|20615753|P4|COMPLETED|Overall Study||5
8363301|NCT01194479|20615754|P3|COMPLETED|Overall Study||2
8363302|NCT01194479|20615755|P2|COMPLETED|Overall Study||4
8363303|NCT01194479|20615756|P1|COMPLETED|Overall Study||3
8363304|NCT01194479|20615753|P4|Cross-over at Second Visit|Overall Study||5
8363305|NCT01194479|20615754|P3|Cross-over at Second Visit|Overall Study||2
8363306|NCT01194479|20615755|P2|Cross-over at Second Visit|Overall Study||4
8363307|NCT01194479|20615756|P1|Cross-over at Second Visit|Overall Study||3
8363308|NCT01194479|20615753|P4|STARTED|Overall Study||5
8363309|NCT01194479|20615754|P3|STARTED|Overall Study||2
8363310|NCT01194479|20615755|P2|STARTED|Overall Study||4
8363311|NCT01194479|20615756|P1|STARTED|Overall Study||3
8363312|NCT01194466|20615778|P3|NOT COMPLETED|Overall Study||0
8363313|NCT01194466|20615779|P2|NOT COMPLETED|Overall Study||0
8363314|NCT01194466|20615780|P1|NOT COMPLETED|Overall Study||0
8363315|NCT01194466|20615778|P3|COMPLETED|Overall Study||13
8363316|NCT01194466|20615779|P2|COMPLETED|Overall Study||14
8363317|NCT01194466|20615780|P1|COMPLETED|Overall Study||14
8363318|NCT01194466|20615778|P3|STARTED|Overall Study||13
8363319|NCT01194466|20615779|P2|STARTED|Overall Study||14
8363320|NCT01194466|20615780|P1|STARTED|Overall Study||14
8363321|NCT01194453|20615790|P2|NOT COMPLETED|Overall Study||17
8363322|NCT01194453|20615791|P1|NOT COMPLETED|Overall Study||17
8363323|NCT01194453|20615790|P2|COMPLETED|Overall Study||127
8363324|NCT01194453|20615791|P1|COMPLETED|Overall Study||127
8363325|NCT01194453|20615790|P2|STARTED|Overall Study||144
8363326|NCT01194453|20615791|P1|STARTED|Overall Study||144
8363327|NCT01194440|20615799|P1|NOT COMPLETED|6-months (2nd Dose)||4
8363328|NCT01194440|20615799|P1|COMPLETED|6-months (2nd Dose)||48
8363329|NCT01194440|20615799|P1|STARTED|6-months (2nd Dose)||52
8363330|NCT01194440|20615799|P1|NOT COMPLETED|Baseline (First Dose)||7
8363331|NCT01194440|20615799|P1|COMPLETED|Baseline (First Dose)||52
8363332|NCT01194440|20615799|P1|STARTED|Baseline (First Dose)||59
8363333|NCT01194427|20615806|P1|NOT COMPLETED|Overall Study||0
8363334|NCT01194427|20615806|P1|COMPLETED|Overall Study||2
8363335|NCT01194427|20615806|P1|STARTED|Overall Study||2
8363336|NCT01194414|20615812|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
8363337|NCT01194414|20615813|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
8363338|NCT01194414|20615814|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
8363339|NCT01194414|20615815|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
8363340|NCT01194414|20615812|P4|COMPLETED|72 Weeks Open Label Extension||160
8363341|NCT01194414|20615813|P3|COMPLETED|72 Weeks Open Label Extension||40
8363342|NCT01194414|20615814|P2|COMPLETED|72 Weeks Open Label Extension||311
8363343|NCT01194414|20615815|P1|COMPLETED|72 Weeks Open Label Extension||445
8363344|NCT01194414|20615812|P4|STARTED|72 Weeks Open Label Extension||186
8363345|NCT01194414|20615813|P3|STARTED|72 Weeks Open Label Extension||48
8363346|NCT01194414|20615814|P2|STARTED|72 Weeks Open Label Extension||377
8363347|NCT01194414|20615815|P1|STARTED|72 Weeks Open Label Extension||524
8363348|NCT01194414|20615812|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
8363349|NCT01194414|20615813|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
8363350|NCT01194414|20615814|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
8363351|NCT01194414|20615815|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
8363352|NCT01194414|20615812|P4|COMPLETED|24 Weeks Double Blind Period||0
8363353|NCT01194414|20615813|P3|COMPLETED|24 Weeks Double Blind Period||0
8363354|NCT01194414|20615814|P2|COMPLETED|24 Weeks Double Blind Period||564
8363355|NCT01194414|20615815|P1|COMPLETED|24 Weeks Double Blind Period||572
8363356|NCT01194414|20615812|P4|Per Protocol Population|24 Weeks Double Blind Period||0
8363357|NCT01194414|20615813|P3|Per Protocol Population|24 Weeks Double Blind Period||0
8363358|NCT01194414|20615814|P2|Per Protocol Population|24 Weeks Double Blind Period||537
8363359|NCT01194414|20615815|P1|Per Protocol Population|24 Weeks Double Blind Period||558
8363360|NCT01194414|20615812|P4|STARTED|24 Weeks Double Blind Period||0
8363361|NCT01194414|20615813|P3|STARTED|24 Weeks Double Blind Period||0
8363362|NCT01194414|20615814|P2|STARTED|24 Weeks Double Blind Period||631
8363363|NCT01194414|20615815|P1|STARTED|24 Weeks Double Blind Period||631
8363364|NCT01194297|20615877|P2|NOT COMPLETED|Overall Study||0
8363365|NCT01194297|20615878|P1|NOT COMPLETED|Overall Study||0
8363366|NCT01194297|20615877|P2|COMPLETED|Overall Study||1
8363367|NCT01194297|20615878|P1|COMPLETED|Overall Study||2
8363368|NCT01194297|20615877|P2|STARTED|Overall Study||1
8363369|NCT01194297|20615878|P1|STARTED|Overall Study||2
8363370|NCT01194271|20615886|P1|NOT COMPLETED|Overall Study||3
8363371|NCT01194271|20615886|P1|COMPLETED|Overall Study||16
8363372|NCT01194271|20615886|P1|STARTED|Overall Study||19
8363373|NCT01194258|20615890|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
8363374|NCT01194258|20615891|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
8363375|NCT01194258|20615892|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
8363376|NCT01194258|20615893|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
8363377|NCT01194258|20615894|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
8363378|NCT01194258|20615890|P5|COMPLETED|Period 2 (12 Weeks)||30
8363379|NCT01194258|20615891|P4|COMPLETED|Period 2 (12 Weeks)||29
8363380|NCT01194258|20615892|P3|COMPLETED|Period 2 (12 Weeks)||29
8363381|NCT01194258|20615893|P2|COMPLETED|Period 2 (12 Weeks)||27
8363382|NCT01194258|20615894|P1|COMPLETED|Period 2 (12 Weeks)||0
8363383|NCT01194258|20615890|P5|STARTED|Period 2 (12 Weeks)||32
8363384|NCT01194258|20615891|P4|STARTED|Period 2 (12 Weeks)||29
8363385|NCT01194258|20615892|P3|STARTED|Period 2 (12 Weeks)||30
8363386|NCT01194258|20615893|P2|STARTED|Period 2 (12 Weeks)||29
8363387|NCT01194258|20615894|P1|STARTED|Period 2 (12 Weeks)||0
8363388|NCT01194258|20615890|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
8363389|NCT01194258|20615891|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
8363390|NCT01194258|20615892|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
8363391|NCT01194258|20615893|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
8363392|NCT01194258|20615894|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
8363393|NCT01194258|20615890|P5|COMPLETED|Period 1 (12 Weeks)||32
8363394|NCT01194258|20615891|P4|COMPLETED|Period 1 (12 Weeks)||29
8363395|NCT01194258|20615892|P3|COMPLETED|Period 1 (12 Weeks)||30
8363396|NCT01194258|20615893|P2|COMPLETED|Period 1 (12 Weeks)||29
8363397|NCT01194258|20615894|P1|COMPLETED|Period 1 (12 Weeks)||0
8363398|NCT01194258|20615890|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
8363399|NCT01194258|20615891|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
8363400|NCT01194258|20615892|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
8363401|NCT01194258|20615893|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
8363402|NCT01194258|20615894|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
8363403|NCT01194258|20615890|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
8363404|NCT01194258|20615891|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
8363405|NCT01194258|20615892|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
8363406|NCT01194258|20615893|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
8363407|NCT01194258|20615894|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
8363408|NCT01194258|20615890|P5|NOT COMPLETED|Titration Period||0
8363409|NCT01194258|20615891|P4|NOT COMPLETED|Titration Period||0
8363410|NCT01194258|20615892|P3|NOT COMPLETED|Titration Period||0
8363411|NCT01194258|20615893|P2|NOT COMPLETED|Titration Period||0
8363412|NCT01194258|20615894|P1|NOT COMPLETED|Titration Period||11
8363413|NCT01194258|20615890|P5|COMPLETED|Titration Period||0
8363414|NCT01194258|20615891|P4|COMPLETED|Titration Period||0
8363415|NCT01194258|20615892|P3|COMPLETED|Titration Period||0
8363416|NCT01194258|20615893|P2|COMPLETED|Titration Period||0
8363417|NCT01194258|20615894|P1|COMPLETED|Titration Period||121
8363418|NCT01194258|20615890|P5|STARTED|Titration Period||0
8363419|NCT01194258|20615891|P4|STARTED|Titration Period||0
8363420|NCT01194258|20615892|P3|STARTED|Titration Period||0
8363421|NCT01194258|20615893|P2|STARTED|Titration Period||0
8363422|NCT01194258|20615894|P1|STARTED|Titration Period||132
8363423|NCT01194245|20615918|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363424|NCT01194245|20615919|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363425|NCT01194245|20615920|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363426|NCT01194245|20615921|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363427|NCT01194245|20615922|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363428|NCT01194245|20615918|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
8363429|NCT01194245|20615919|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
8363430|NCT01194245|20615920|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
8363431|NCT01194245|20615921|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
8363432|NCT01194245|20615922|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363433|NCT01194245|20615918|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
8363434|NCT01194245|20615919|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
8363435|NCT01194245|20615920|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
8363436|NCT01194245|20615921|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
8363437|NCT01194245|20615922|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
8363438|NCT01194245|20615918|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
8363439|NCT01194245|20615919|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
8363440|NCT01194245|20615920|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
8363441|NCT01194245|20615921|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8363442|NCT01194245|20615922|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8363443|NCT01194245|20615918|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
8363444|NCT01194245|20615919|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
8363445|NCT01194245|20615920|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
8363446|NCT01194245|20615921|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
8363447|NCT01194245|20615922|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8363448|NCT01194245|20615918|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
8363449|NCT01194245|20615919|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
8363450|NCT01194245|20615920|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
8363451|NCT01194245|20615921|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
8363452|NCT01194245|20615922|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
8363453|NCT01194245|20615918|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
8363454|NCT01194245|20615919|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
8363455|NCT01194245|20615920|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
8363456|NCT01194245|20615921|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
8363457|NCT01194245|20615922|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
8363458|NCT01194245|20615918|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363459|NCT01194245|20615919|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363460|NCT01194245|20615920|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363461|NCT01194245|20615921|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363462|NCT01194245|20615922|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
8363463|NCT01194245|20615918|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363464|NCT01194245|20615919|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363465|NCT01194245|20615920|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363466|NCT01194245|20615921|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363467|NCT01194245|20615922|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
8363468|NCT01194245|20615918|P5|STARTED|Titration Period (4 to 6 Weeks)||0
8363469|NCT01194245|20615919|P4|STARTED|Titration Period (4 to 6 Weeks)||0
8363470|NCT01194245|20615920|P3|STARTED|Titration Period (4 to 6 Weeks)||0
8363471|NCT01194245|20615921|P2|STARTED|Titration Period (4 to 6 Weeks)||0
8363472|NCT01194245|20615922|P1|STARTED|Titration Period (4 to 6 Weeks)||135
8363473|NCT01194219|20615943|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
8363474|NCT01194219|20615944|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
8363475|NCT01194219|20615945|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363476|NCT01194219|20615946|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363477|NCT01194219|20615947|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363478|NCT01194219|20615948|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363479|NCT01194219|20615949|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363480|NCT01194219|20615950|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363481|NCT01194219|20615951|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363482|NCT01194219|20615952|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363483|NCT01194219|20615943|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
8363484|NCT01194219|20615944|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
8363485|NCT01194219|20615945|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363486|NCT01194219|20615946|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363487|NCT01194219|20615947|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363488|NCT01194219|20615948|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363489|NCT01194219|20615949|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363490|NCT01194219|20615950|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363491|NCT01194219|20615951|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363492|NCT01194219|20615952|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363493|NCT01194219|20615943|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
8363561|NCT01194219|20615951|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363494|NCT01194219|20615944|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
8363495|NCT01194219|20615945|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363496|NCT01194219|20615946|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363497|NCT01194219|20615947|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363498|NCT01194219|20615948|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363499|NCT01194219|20615949|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363500|NCT01194219|20615950|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363501|NCT01194219|20615951|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363502|NCT01194219|20615952|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363503|NCT01194219|20615943|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
8363504|NCT01194219|20615944|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
8363505|NCT01194219|20615945|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
8363506|NCT01194219|20615946|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
8363507|NCT01194219|20615947|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
8363508|NCT01194219|20615948|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
8363509|NCT01194219|20615949|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
8363510|NCT01194219|20615950|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
8363511|NCT01194219|20615951|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
8363512|NCT01194219|20615952|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
8363513|NCT01194219|20615943|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363514|NCT01194219|20615944|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363515|NCT01194219|20615945|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
8363516|NCT01194219|20615946|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
8363517|NCT01194219|20615947|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
8363518|NCT01194219|20615948|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
8363519|NCT01194219|20615949|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363520|NCT01194219|20615950|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363521|NCT01194219|20615951|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363522|NCT01194219|20615952|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363523|NCT01194219|20615943|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363524|NCT01194219|20615944|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363525|NCT01194219|20615945|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
8363526|NCT01194219|20615946|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
8363527|NCT01194219|20615947|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
8363528|NCT01194219|20615948|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
8363529|NCT01194219|20615949|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363530|NCT01194219|20615950|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363531|NCT01194219|20615951|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363532|NCT01194219|20615952|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363533|NCT01194219|20615943|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363534|NCT01194219|20615944|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363535|NCT01194219|20615945|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
8363536|NCT01194219|20615946|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
8363537|NCT01194219|20615947|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363538|NCT01194219|20615948|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363539|NCT01194219|20615949|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363540|NCT01194219|20615950|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363541|NCT01194219|20615951|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363542|NCT01194219|20615952|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363543|NCT01194219|20615943|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363544|NCT01194219|20615944|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363545|NCT01194219|20615945|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
8363546|NCT01194219|20615946|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
8363547|NCT01194219|20615947|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
8363548|NCT01194219|20615948|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
8363549|NCT01194219|20615949|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363550|NCT01194219|20615950|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363551|NCT01194219|20615951|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363552|NCT01194219|20615952|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363553|NCT01194219|20615943|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363554|NCT01194219|20615944|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363555|NCT01194219|20615945|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363556|NCT01194219|20615946|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363557|NCT01194219|20615947|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363558|NCT01194219|20615948|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363559|NCT01194219|20615949|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
8363560|NCT01194219|20615950|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
8363562|NCT01194219|20615952|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363563|NCT01194219|20615943|P10|COMPLETED|Maintenance Phase Weeks16-32||0
8363564|NCT01194219|20615944|P9|COMPLETED|Maintenance Phase Weeks16-32||0
8363565|NCT01194219|20615945|P8|COMPLETED|Maintenance Phase Weeks16-32||0
8363566|NCT01194219|20615946|P7|COMPLETED|Maintenance Phase Weeks16-32||0
8363567|NCT01194219|20615947|P6|COMPLETED|Maintenance Phase Weeks16-32||0
8363568|NCT01194219|20615948|P5|COMPLETED|Maintenance Phase Weeks16-32||0
8363569|NCT01194219|20615949|P4|COMPLETED|Maintenance Phase Weeks16-32||215
8363570|NCT01194219|20615950|P3|COMPLETED|Maintenance Phase Weeks16-32||424
8363571|NCT01194219|20615951|P2|COMPLETED|Maintenance Phase Weeks16-32||0
8363572|NCT01194219|20615952|P1|COMPLETED|Maintenance Phase Weeks16-32||0
8363573|NCT01194219|20615943|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
8363574|NCT01194219|20615944|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
8363575|NCT01194219|20615945|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
8363576|NCT01194219|20615946|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
8363577|NCT01194219|20615947|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
8363578|NCT01194219|20615948|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
8363579|NCT01194219|20615949|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
8363580|NCT01194219|20615950|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
8363581|NCT01194219|20615951|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
8363582|NCT01194219|20615952|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
8363583|NCT01194219|20615943|P10|STARTED|Maintenance Phase Weeks16-32||0
8363584|NCT01194219|20615944|P9|STARTED|Maintenance Phase Weeks16-32||0
8363585|NCT01194219|20615945|P8|STARTED|Maintenance Phase Weeks16-32||0
8363586|NCT01194219|20615946|P7|STARTED|Maintenance Phase Weeks16-32||0
8363587|NCT01194219|20615947|P6|STARTED|Maintenance Phase Weeks16-32||0
8363588|NCT01194219|20615948|P5|STARTED|Maintenance Phase Weeks16-32||0
8363589|NCT01194219|20615949|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
8363590|NCT01194219|20615950|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
8363591|NCT01194219|20615951|P2|STARTED|Maintenance Phase Weeks16-32||0
8363592|NCT01194219|20615952|P1|STARTED|Maintenance Phase Weeks16-32||0
8363593|NCT01194219|20615943|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363594|NCT01194219|20615944|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363595|NCT01194219|20615945|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363596|NCT01194219|20615946|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363597|NCT01194219|20615947|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363598|NCT01194219|20615948|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363599|NCT01194219|20615949|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363600|NCT01194219|20615950|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363601|NCT01194219|20615951|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
8363602|NCT01194219|20615952|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
8363603|NCT01194219|20615943|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363604|NCT01194219|20615944|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363605|NCT01194219|20615945|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363606|NCT01194219|20615946|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363607|NCT01194219|20615947|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363608|NCT01194219|20615948|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363609|NCT01194219|20615949|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363610|NCT01194219|20615950|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363611|NCT01194219|20615951|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
8363612|NCT01194219|20615952|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
8363613|NCT01194219|20615943|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363614|NCT01194219|20615944|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363615|NCT01194219|20615945|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363616|NCT01194219|20615946|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363617|NCT01194219|20615947|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363618|NCT01194219|20615948|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363619|NCT01194219|20615949|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363620|NCT01194219|20615950|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363621|NCT01194219|20615951|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
8363622|NCT01194219|20615952|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
8363623|NCT01194219|20615943|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363624|NCT01194219|20615944|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363625|NCT01194219|20615945|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363626|NCT01194219|20615946|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363627|NCT01194219|20615947|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363628|NCT01194219|20615948|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363629|NCT01194219|20615949|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363630|NCT01194219|20615950|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363631|NCT01194219|20615951|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
8363632|NCT01194219|20615952|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
8363633|NCT01194154|20615986|P2|NOT COMPLETED|Overall Study||33
8363634|NCT01194154|20615987|P1|NOT COMPLETED|Overall Study||49
8363635|NCT01194154|20615986|P2|COMPLETED|Overall Study||91
8363636|NCT01194154|20615987|P1|COMPLETED|Overall Study||68
8363637|NCT01194154|20615986|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
8363638|NCT01194154|20615987|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
8363639|NCT01194154|20615986|P2|Full Analysis Set|Overall Study||120
8363640|NCT01194154|20615987|P1|Full Analysis Set|Overall Study||115
8363641|NCT01194154|20615986|P2|STARTED|Overall Study||124
8363642|NCT01194154|20615987|P1|STARTED|Overall Study||117
8363643|NCT01194089|20616007|P2|NOT COMPLETED|Overall Study||0
8363644|NCT01194089|20616008|P1|NOT COMPLETED|Overall Study||0
8363645|NCT01194089|20616007|P2|COMPLETED|Overall Study||47
8363646|NCT01194089|20616008|P1|COMPLETED|Overall Study||42
8363647|NCT01194089|20616007|P2|STARTED|Overall Study||47
8363648|NCT01194089|20616008|P1|STARTED|Overall Study||42
8363649|NCT01193920|20616028|P10|NOT COMPLETED|Overall Study||7
8363650|NCT01193920|20616029|P9|NOT COMPLETED|Overall Study||5
8363651|NCT01193920|20616030|P8|NOT COMPLETED|Overall Study||4
8363652|NCT01193920|20616031|P7|NOT COMPLETED|Overall Study||6
8363653|NCT01193920|20616032|P6|NOT COMPLETED|Overall Study||4
8363654|NCT01193920|20616033|P5|NOT COMPLETED|Overall Study||6
8363655|NCT01193920|20616034|P4|NOT COMPLETED|Overall Study||4
8363656|NCT01193920|20616035|P3|NOT COMPLETED|Overall Study||6
8363657|NCT01193920|20616036|P2|NOT COMPLETED|Overall Study||0
8363658|NCT01193920|20616037|P1|NOT COMPLETED|Overall Study||3
8363659|NCT01193920|20616028|P10|COMPLETED|Overall Study||74
8363660|NCT01193920|20616029|P9|COMPLETED|Overall Study||71
8363661|NCT01193920|20616030|P8|COMPLETED|Overall Study||76
8363662|NCT01193920|20616031|P7|COMPLETED|Overall Study||74
8363663|NCT01193920|20616032|P6|COMPLETED|Overall Study||76
8363664|NCT01193920|20616033|P5|COMPLETED|Overall Study||74
8363665|NCT01193920|20616034|P4|COMPLETED|Overall Study||76
8363666|NCT01193920|20616035|P3|COMPLETED|Overall Study||74
8363667|NCT01193920|20616036|P2|COMPLETED|Overall Study||20
8363668|NCT01193920|20616037|P1|COMPLETED|Overall Study||37
8363669|NCT01193920|20616028|P10|STARTED|Overall Study||81
8363670|NCT01193920|20616029|P9|STARTED|Overall Study||76
8363671|NCT01193920|20616030|P8|STARTED|Overall Study||80
8363672|NCT01193920|20616031|P7|STARTED|Overall Study||80
8363673|NCT01193920|20616032|P6|STARTED|Overall Study||80
8363674|NCT01193920|20616033|P5|STARTED|Overall Study||80
8363675|NCT01193920|20616034|P4|STARTED|Overall Study||80
8363676|NCT01193920|20616035|P3|STARTED|Overall Study||80
8363677|NCT01193920|20616036|P2|STARTED|Overall Study||20
8363678|NCT01193920|20616037|P1|STARTED|Overall Study||40
8363679|NCT01193907|20616091|P4|NOT COMPLETED|Overall Study||1
8363680|NCT01193907|20616092|P3|NOT COMPLETED|Overall Study||0
8363681|NCT01193907|20616093|P2|NOT COMPLETED|Overall Study||0
8363682|NCT01193907|20616094|P1|NOT COMPLETED|Overall Study||1
8363683|NCT01193907|20616091|P4|COMPLETED|Overall Study||21
8363684|NCT01193907|20616092|P3|COMPLETED|Overall Study||22
8363685|NCT01193907|20616093|P2|COMPLETED|Overall Study||22
8363686|NCT01193907|20616094|P1|COMPLETED|Overall Study||21
8363687|NCT01193907|20616091|P4|STARTED|Overall Study||22
8363688|NCT01193907|20616092|P3|STARTED|Overall Study||22
8363689|NCT01193907|20616093|P2|STARTED|Overall Study||22
8363690|NCT01193907|20616094|P1|STARTED|Overall Study||22
8363691|NCT01193868|20616116|P1|NOT COMPLETED|Overall Study||0
8363692|NCT01193868|20616116|P1|COMPLETED|Overall Study||6
8363693|NCT01193868|20616116|P1|STARTED|Overall Study||6
8363694|NCT01193842|20616133|P5|NOT COMPLETED|Phase II: Randomized Groups||10
8363695|NCT01193842|20616134|P4|NOT COMPLETED|Phase II: Randomized Groups||12
8363696|NCT01193842|20616135|P3|NOT COMPLETED|Phase II: Randomized Groups||0
8363697|NCT01193842|20616136|P2|NOT COMPLETED|Phase II: Randomized Groups||0
8363698|NCT01193842|20616137|P1|NOT COMPLETED|Phase II: Randomized Groups||0
8363699|NCT01193842|20616133|P5|COMPLETED|Phase II: Randomized Groups||36
8363700|NCT01193842|20616134|P4|COMPLETED|Phase II: Randomized Groups||33
8363701|NCT01193842|20616135|P3|COMPLETED|Phase II: Randomized Groups||0
8363702|NCT01193842|20616136|P2|COMPLETED|Phase II: Randomized Groups||0
8363703|NCT01193842|20616137|P1|COMPLETED|Phase II: Randomized Groups||0
8363704|NCT01193842|20616133|P5|STARTED|Phase II: Randomized Groups||46
8363705|NCT01193842|20616134|P4|STARTED|Phase II: Randomized Groups||45
8363706|NCT01193842|20616135|P3|STARTED|Phase II: Randomized Groups||0
8363707|NCT01193842|20616136|P2|STARTED|Phase II: Randomized Groups||0
8363708|NCT01193842|20616137|P1|STARTED|Phase II: Randomized Groups||0
8363709|NCT01193842|20616133|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8363710|NCT01193842|20616134|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8363711|NCT01193842|20616135|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
8363712|NCT01193842|20616136|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8363713|NCT01193842|20616137|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8363714|NCT01193842|20616133|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
8363715|NCT01193842|20616134|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
8363716|NCT01193842|20616135|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
8363717|NCT01193842|20616136|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
8363718|NCT01193842|20616137|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
8363719|NCT01193842|20616133|P5|STARTED|Phase I: VR-CHOP, DL 1||0
8363720|NCT01193842|20616134|P4|STARTED|Phase I: VR-CHOP, DL 1||0
8363721|NCT01193842|20616135|P3|STARTED|Phase I: VR-CHOP, DL 1||2
8363722|NCT01193842|20616136|P2|STARTED|Phase I: VR-CHOP, DL 1||0
8363723|NCT01193842|20616137|P1|STARTED|Phase I: VR-CHOP, DL 1||0
8363724|NCT01193842|20616133|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363725|NCT01193842|20616134|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363726|NCT01193842|20616135|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363727|NCT01193842|20616136|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363728|NCT01193842|20616137|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
8363729|NCT01193842|20616133|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363730|NCT01193842|20616134|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363731|NCT01193842|20616135|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363732|NCT01193842|20616136|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363733|NCT01193842|20616137|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
8363734|NCT01193842|20616133|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363735|NCT01193842|20616134|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363736|NCT01193842|20616135|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363737|NCT01193842|20616136|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8363738|NCT01193842|20616137|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
8363739|NCT01193842|20616133|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363740|NCT01193842|20616134|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363741|NCT01193842|20616135|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363742|NCT01193842|20616136|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
8363743|NCT01193842|20616137|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363744|NCT01193842|20616133|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363745|NCT01193842|20616134|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363746|NCT01193842|20616135|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363747|NCT01193842|20616136|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
8363748|NCT01193842|20616137|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8363749|NCT01193842|20616133|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8363750|NCT01193842|20616134|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8363751|NCT01193842|20616135|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8363752|NCT01193842|20616136|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
8363753|NCT01193842|20616137|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8363754|NCT01193842|20616133|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363755|NCT01193842|20616134|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363756|NCT01193842|20616135|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363757|NCT01193842|20616136|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363758|NCT01193842|20616137|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363759|NCT01193842|20616133|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363760|NCT01193842|20616134|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363761|NCT01193842|20616135|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363762|NCT01193842|20616136|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363763|NCT01193842|20616137|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
8363764|NCT01193842|20616133|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363765|NCT01193842|20616134|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363766|NCT01193842|20616135|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363767|NCT01193842|20616136|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8363768|NCT01193842|20616137|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
8363769|NCT01193686|20616172|P2|NOT COMPLETED|Overall Study||1
8363770|NCT01193686|20616173|P1|NOT COMPLETED|Overall Study||7
8363771|NCT01193686|20616172|P2|COMPLETED|Overall Study||8
8363772|NCT01193686|20616173|P1|COMPLETED|Overall Study||8
8363773|NCT01193686|20616172|P2|Completed Visits and Final Assessment|Overall Study||8
8363774|NCT01193686|20616173|P1|Completed Visits and Final Assessment|Overall Study||8
8363775|NCT01193686|20616172|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
8363776|NCT01193686|20616173|P1|Completed Mentor Training|Overall Study||9
8363777|NCT01193686|20616172|P2|Completed Baseline Assessment|Overall Study||9
8363778|NCT01193686|20616173|P1|Completed Baseline Assessment|Overall Study||15
8363779|NCT01193686|20616172|P2|STARTED|Overall Study||9
8363780|NCT01193686|20616173|P1|STARTED|Overall Study||15
8363781|NCT01193660|20616190|P3|NOT COMPLETED|Overall Study||2
8363782|NCT01193660|20616191|P2|NOT COMPLETED|Overall Study||3
8363783|NCT01193660|20616192|P1|NOT COMPLETED|Overall Study||4
8363784|NCT01193660|20616190|P3|COMPLETED|Overall Study||32
8363785|NCT01193660|20616191|P2|COMPLETED|Overall Study||33
8363786|NCT01193660|20616192|P1|COMPLETED|Overall Study||31
8363787|NCT01193660|20616190|P3|STARTED|Overall Study||34
8363788|NCT01193660|20616191|P2|STARTED|Overall Study||36
8363789|NCT01193660|20616192|P1|STARTED|Overall Study||35
8363790|NCT01193608|20616236|P6|NOT COMPLETED|Overall Study||2
8363791|NCT01193608|20616237|P5|NOT COMPLETED|Overall Study||5
8363792|NCT01193608|20616238|P4|NOT COMPLETED|Overall Study||3
8363793|NCT01193608|20616239|P3|NOT COMPLETED|Overall Study||2
8363794|NCT01193608|20616240|P2|NOT COMPLETED|Overall Study||2
8363795|NCT01193608|20616241|P1|NOT COMPLETED|Overall Study||0
8363796|NCT01193608|20616236|P6|COMPLETED|Overall Study||17
8363797|NCT01193608|20616237|P5|COMPLETED|Overall Study||19
8363798|NCT01193608|20616238|P4|COMPLETED|Overall Study||14
8363799|NCT01193608|20616239|P3|COMPLETED|Overall Study||14
8363800|NCT01193608|20616240|P2|COMPLETED|Overall Study||4
8363801|NCT01193608|20616241|P1|COMPLETED|Overall Study||6
8363802|NCT01193608|20616236|P6|STARTED|Overall Study||19
8363803|NCT01193608|20616237|P5|STARTED|Overall Study||24
8363804|NCT01193608|20616238|P4|STARTED|Overall Study||17
8363805|NCT01193608|20616239|P3|STARTED|Overall Study||16
8363806|NCT01193608|20616240|P2|STARTED|Overall Study||6
8363807|NCT01193608|20616241|P1|STARTED|Overall Study||6
8363808|NCT01193582|20616478|P4|NOT COMPLETED|12 Month Follow-up||11
8363809|NCT01193582|20616479|P3|NOT COMPLETED|12 Month Follow-up||4
8363810|NCT01193582|20616480|P2|NOT COMPLETED|12 Month Follow-up||0
8363811|NCT01193582|20616481|P1|NOT COMPLETED|12 Month Follow-up||6
8363812|NCT01193582|20616478|P4|COMPLETED|12 Month Follow-up||166
8363813|NCT01193582|20616479|P3|COMPLETED|12 Month Follow-up||113
8363814|NCT01193582|20616480|P2|COMPLETED|12 Month Follow-up||88
8363815|NCT01193582|20616481|P1|COMPLETED|12 Month Follow-up||83
8363816|NCT01193582|20616478|P4|STARTED|12 Month Follow-up||177
8363817|NCT01193582|20616479|P3|STARTED|12 Month Follow-up||117
8363818|NCT01193582|20616480|P2|STARTED|12 Month Follow-up||88
8363819|NCT01193582|20616481|P1|STARTED|12 Month Follow-up||89
8363820|NCT01193582|20616478|P4|NOT COMPLETED|Vaccination Series||3
8363821|NCT01193582|20616479|P3|NOT COMPLETED|Vaccination Series||8
8363822|NCT01193582|20616480|P2|NOT COMPLETED|Vaccination Series||13
8363823|NCT01193582|20616481|P1|NOT COMPLETED|Vaccination Series||11
8363824|NCT01193582|20616478|P4|COMPLETED|Vaccination Series||177
8363825|NCT01193582|20616479|P3|COMPLETED|Vaccination Series||117
8363826|NCT01193582|20616480|P2|COMPLETED|Vaccination Series||88
8363827|NCT01193582|20616481|P1|COMPLETED|Vaccination Series||89
8363828|NCT01193582|20616478|P4|Vaccinated Dose 4|Vaccination Series||0
8363829|NCT01193582|20616479|P3|Vaccinated Dose 4|Vaccination Series||0
8363830|NCT01193582|20616480|P2|Vaccinated Dose 4|Vaccination Series||0
8363831|NCT01193582|20616481|P1|Vaccinated Dose 4|Vaccination Series||90
8363832|NCT01193582|20616478|P4|Vaccinated Dose 3|Vaccination Series||0
8363833|NCT01193582|20616479|P3|Vaccinated Dose 3|Vaccination Series||0
8363834|NCT01193582|20616480|P2|Vaccinated Dose 3|Vaccination Series||89
8363835|NCT01193582|20616481|P1|Vaccinated Dose 3|Vaccination Series||90
8363836|NCT01193582|20616478|P4|Vaccinated Dose 2|Vaccination Series||0
8363837|NCT01193582|20616479|P3|Vaccinated Dose 2|Vaccination Series||118
8363838|NCT01193582|20616480|P2|Vaccinated Dose 2|Vaccination Series||91
8363839|NCT01193582|20616481|P1|Vaccinated Dose 2|Vaccination Series||92
8363840|NCT01193582|20616478|P4|Vaccinated Dose 1|Vaccination Series||180
8363841|NCT01193582|20616479|P3|Vaccinated Dose 1|Vaccination Series||125
8363842|NCT01193582|20616480|P2|Vaccinated Dose 1|Vaccination Series||100
8363843|NCT01193582|20616481|P1|Vaccinated Dose 1|Vaccination Series||100
8363844|NCT01193582|20616478|P4|STARTED|Vaccination Series||180
8363845|NCT01193582|20616479|P3|STARTED|Vaccination Series||125
8363846|NCT01193582|20616480|P2|STARTED|Vaccination Series||101
8363847|NCT01193582|20616481|P1|STARTED|Vaccination Series||100
8363848|NCT01193556|20616511|P2|NOT COMPLETED|Overall Study||25
8363849|NCT01193556|20616512|P1|NOT COMPLETED|Overall Study||26
8363850|NCT01193556|20616511|P2|COMPLETED|Overall Study||0
8363851|NCT01193556|20616512|P1|COMPLETED|Overall Study||0
8363852|NCT01193556|20616511|P2|STARTED|Overall Study||25
8363853|NCT01193556|20616512|P1|STARTED|Overall Study||26
8363854|NCT01193530|20616522|P2|NOT COMPLETED|Overall Study||5
8363855|NCT01193530|20616523|P1|NOT COMPLETED|Overall Study||3
8363856|NCT01193530|20616522|P2|COMPLETED|Overall Study||3
8363857|NCT01193530|20616523|P1|COMPLETED|Overall Study||1
8363858|NCT01193530|20616522|P2|STARTED|Overall Study||8
8363859|NCT01193530|20616523|P1|STARTED|Overall Study||4
8363860|NCT01193517|20616532|P3|NOT COMPLETED|Overall Study||0
8363861|NCT01193517|20616533|P2|NOT COMPLETED|Overall Study||0
8363862|NCT01193517|20616534|P1|NOT COMPLETED|Overall Study||1
8363863|NCT01193517|20616532|P3|COMPLETED|Overall Study||11
8363864|NCT01193517|20616533|P2|COMPLETED|Overall Study||12
8363865|NCT01193517|20616534|P1|COMPLETED|Overall Study||2
8363866|NCT01193517|20616532|P3|STARTED|Overall Study||11
8363867|NCT01193517|20616533|P2|STARTED|Overall Study||12
8363868|NCT01193517|20616534|P1|STARTED|Overall Study||3
8363869|NCT01193348|20616543|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
8363870|NCT01193348|20616543|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
8363871|NCT01193348|20616543|P1|STARTED|Post Treatment Period (Patients Who Disc||10
8363872|NCT01193348|20616543|P1|NOT COMPLETED|Extension Treatment Period||1
8363873|NCT01193348|20616543|P1|COMPLETED|Extension Treatment Period||16
8363874|NCT01193348|20616543|P1|STARTED|Extension Treatment Period||17
8363875|NCT01193348|20616543|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
8363876|NCT01193348|20616543|P1|COMPLETED|Treatment Period (26 Weeks)||19
8363877|NCT01193348|20616543|P1|STARTED|Treatment Period (26 Weeks)||22
8363878|NCT01193348|20616543|P1|NOT COMPLETED|Screening Period||5
8363879|NCT01193348|20616543|P1|COMPLETED|Screening Period||22
8363880|NCT01193348|20616543|P1|STARTED|Screening Period||27
8363881|NCT01193335|20616563|P2|NOT COMPLETED|2-Year Follow-up||8
8363882|NCT01193335|20616564|P1|NOT COMPLETED|2-Year Follow-up||7
8363883|NCT01193335|20616563|P2|COMPLETED|2-Year Follow-up||80
8363884|NCT01193335|20616564|P1|COMPLETED|2-Year Follow-up||81
8363885|NCT01193335|20616563|P2|STARTED|2-Year Follow-up||88
8363886|NCT01193335|20616564|P1|STARTED|2-Year Follow-up||88
8363887|NCT01193335|20616563|P2|NOT COMPLETED|1-Year Follow-up||9
8363888|NCT01193335|20616564|P1|NOT COMPLETED|1-Year Follow-up||11
8363889|NCT01193335|20616563|P2|COMPLETED|1-Year Follow-up||88
8363890|NCT01193335|20616564|P1|COMPLETED|1-Year Follow-up||88
8363891|NCT01193335|20616563|P2|STARTED|1-Year Follow-up||97
8363892|NCT01193335|20616564|P1|STARTED|1-Year Follow-up||99
8363893|NCT01193335|20616563|P2|NOT COMPLETED|Toddler Dose||0
8363894|NCT01193335|20616564|P1|NOT COMPLETED|Toddler Dose||0
8363895|NCT01193335|20616563|P2|COMPLETED|Toddler Dose||97
8363896|NCT01193335|20616564|P1|COMPLETED|Toddler Dose||99
8363897|NCT01193335|20616563|P2|STARTED|Toddler Dose||97
8363898|NCT01193335|20616564|P1|STARTED|Toddler Dose||99
8363899|NCT01193335|20616563|P2|NOT COMPLETED|After Infant Series||3
8363900|NCT01193335|20616564|P1|NOT COMPLETED|After Infant Series||1
8363901|NCT01193335|20616563|P2|COMPLETED|After Infant Series||97
8363902|NCT01193335|20616564|P1|COMPLETED|After Infant Series||99
8363903|NCT01193335|20616563|P2|STARTED|After Infant Series||100
8363904|NCT01193335|20616564|P1|STARTED|After Infant Series||100
8363905|NCT01193335|20616563|P2|NOT COMPLETED|Infant Series||0
8363906|NCT01193335|20616564|P1|NOT COMPLETED|Infant Series||0
8363907|NCT01193335|20616563|P2|COMPLETED|Infant Series||100
8363908|NCT01193335|20616564|P1|COMPLETED|Infant Series||100
8363909|NCT01193335|20616563|P2|STARTED|Infant Series||100
8363910|NCT01193335|20616564|P1|STARTED|Infant Series||100
8363911|NCT01193283|20616659|P1|NOT COMPLETED|Overall Study||1
8363912|NCT01193283|20616659|P1|COMPLETED|Overall Study||21
8363913|NCT01193283|20616659|P1|STARTED|Overall Study||22
8363914|NCT01193257|20616665|P2|NOT COMPLETED|Overall Study||734
8363915|NCT01193257|20616666|P1|NOT COMPLETED|Overall Study||365
8363916|NCT01193257|20616665|P2|COMPLETED|Overall Study||0
8363917|NCT01193257|20616666|P1|COMPLETED|Overall Study||0
8363918|NCT01193257|20616665|P2|Treated|Overall Study||732
8363919|NCT01193257|20616666|P1|Treated|Overall Study||363
8363920|NCT01193257|20616665|P2|STARTED|Overall Study||734
8363921|NCT01193257|20616666|P1|STARTED|Overall Study||365
8363922|NCT01193244|20616716|P2|NOT COMPLETED|Overall Study||390
8363923|NCT01193244|20616717|P1|NOT COMPLETED|Overall Study||388
8363924|NCT01193244|20616716|P2|COMPLETED|Overall Study||391
8363925|NCT01193244|20616717|P1|COMPLETED|Overall Study||391
8363926|NCT01193244|20616716|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
8363927|NCT01193244|20616717|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
8363928|NCT01193244|20616716|P2|STARTED|Overall Study||781
8363929|NCT01193244|20616717|P1|STARTED|Overall Study||779
8363930|NCT01193218|20616772|P8|NOT COMPLETED|12-52 Weeks||4
8363931|NCT01193218|20616773|P7|NOT COMPLETED|12-52 Weeks||3
8363932|NCT01193218|20616774|P6|NOT COMPLETED|12-52 Weeks||5
8363933|NCT01193218|20616775|P5|NOT COMPLETED|12-52 Weeks||4
8363934|NCT01193218|20616776|P4|NOT COMPLETED|12-52 Weeks||3
8363935|NCT01193218|20616777|P3|NOT COMPLETED|12-52 Weeks||4
8363936|NCT01193218|20616778|P2|NOT COMPLETED|12-52 Weeks||0
8363937|NCT01193218|20616779|P1|NOT COMPLETED|12-52 Weeks||5
8363938|NCT01193218|20616772|P8|COMPLETED|12-52 Weeks||49
8363939|NCT01193218|20616773|P7|COMPLETED|12-52 Weeks||51
8363940|NCT01193218|20616774|P6|COMPLETED|12-52 Weeks||101
8363941|NCT01193218|20616775|P5|COMPLETED|12-52 Weeks||104
8363942|NCT01193218|20616776|P4|COMPLETED|12-52 Weeks||50
8363943|NCT01193218|20616777|P3|COMPLETED|12-52 Weeks||50
8363944|NCT01193218|20616778|P2|COMPLETED|12-52 Weeks||50
8363945|NCT01193218|20616779|P1|COMPLETED|12-52 Weeks||45
8363946|NCT01193218|20616772|P8|STARTED|12-52 Weeks||53
8363947|NCT01193218|20616773|P7|STARTED|12-52 Weeks||54
8363948|NCT01193218|20616774|P6|STARTED|12-52 Weeks||106
8363949|NCT01193218|20616775|P5|STARTED|12-52 Weeks||108
8363950|NCT01193218|20616776|P4|STARTED|12-52 Weeks||53
8363951|NCT01193218|20616777|P3|STARTED|12-52 Weeks||54
8363952|NCT01193218|20616778|P2|STARTED|12-52 Weeks||50
8363953|NCT01193218|20616779|P1|STARTED|12-52 Weeks||50
8363954|NCT01193218|20616772|P8|NOT COMPLETED|0-12 Weeks||0
8363955|NCT01193218|20616773|P7|NOT COMPLETED|0-12 Weeks||3
8363956|NCT01193218|20616774|P6|NOT COMPLETED|0-12 Weeks||3
8363957|NCT01193218|20616775|P5|NOT COMPLETED|0-12 Weeks||1
8363958|NCT01193218|20616776|P4|NOT COMPLETED|0-12 Weeks||0
8363959|NCT01193218|20616777|P3|NOT COMPLETED|0-12 Weeks||3
8363960|NCT01193218|20616778|P2|NOT COMPLETED|0-12 Weeks||0
8363961|NCT01193218|20616779|P1|NOT COMPLETED|0-12 Weeks||9
8363962|NCT01193218|20616772|P8|COMPLETED|0-12 Weeks||0
8363963|NCT01193218|20616773|P7|COMPLETED|0-12 Weeks||107
8363964|NCT01193218|20616774|P6|COMPLETED|0-12 Weeks||106
8363965|NCT01193218|20616775|P5|COMPLETED|0-12 Weeks||108
8363966|NCT01193218|20616776|P4|COMPLETED|0-12 Weeks||0
8363967|NCT01193218|20616777|P3|COMPLETED|0-12 Weeks||107
8363968|NCT01193218|20616778|P2|COMPLETED|0-12 Weeks||0
8363969|NCT01193218|20616779|P1|COMPLETED|0-12 Weeks||100
8363970|NCT01193218|20616772|P8|STARTED|0-12 Weeks|It is actually N/A|0
8363971|NCT01193218|20616773|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
8363972|NCT01193218|20616774|P6|STARTED|0-12 Weeks||109
8363973|NCT01193218|20616775|P5|STARTED|0-12 Weeks||109
8363974|NCT01193218|20616776|P4|STARTED|0-12 Weeks|It is actually N/A|0
8363975|NCT01193218|20616777|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
8363976|NCT01193218|20616778|P2|STARTED|0-12 Weeks|It is actually N/A|0
8363977|NCT01193218|20616779|P1|STARTED|0-12 Weeks|It is actually placebo group|109
8363978|NCT01193153|20616810|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
8363979|NCT01193153|20616811|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
8363980|NCT01193153|20616810|P2|COMPLETED|Double Blind Relapse Prevention Period||65
8363981|NCT01193153|20616811|P1|COMPLETED|Double Blind Relapse Prevention Period||100
8363982|NCT01193153|20616810|P2|STARTED|Double Blind Relapse Prevention Period||170
8363983|NCT01193153|20616811|P1|STARTED|Double Blind Relapse Prevention Period||164
8363984|NCT01193153|20616810|P2|NOT COMPLETED|Open-label Stabilization Period||0
8363985|NCT01193153|20616811|P1|NOT COMPLETED|Open-label Stabilization Period||98
8363986|NCT01193153|20616810|P2|COMPLETED|Open-label Stabilization Period||0
8363987|NCT01193153|20616811|P1|COMPLETED|Open-label Stabilization Period||334
8363988|NCT01193153|20616810|P2|STARTED|Open-label Stabilization Period||0
8363989|NCT01193153|20616811|P1|STARTED|Open-label Stabilization Period||432
8363990|NCT01193153|20616810|P2|NOT COMPLETED|Open-label Lead in Period||0
8363991|NCT01193153|20616811|P1|NOT COMPLETED|Open-label Lead in Period||235
8363992|NCT01193153|20616810|P2|COMPLETED|Open-label Lead in Period||0
8363993|NCT01193153|20616811|P1|COMPLETED|Open-label Lead in Period||432
8363994|NCT01193153|20616810|P2|STARTED|Open-label Lead in Period||0
8363995|NCT01193153|20616811|P1|STARTED|Open-label Lead in Period||667
8363996|NCT01193127|20616846|P4|NOT COMPLETED|Treated||1
8363997|NCT01193127|20616847|P3|NOT COMPLETED|Treated||0
8363998|NCT01193127|20616848|P2|NOT COMPLETED|Treated||0
8363999|NCT01193127|20616849|P1|NOT COMPLETED|Treated||0
8364000|NCT01193127|20616846|P4|COMPLETED|Treated||55
8364001|NCT01193127|20616847|P3|COMPLETED|Treated||55
8364002|NCT01193127|20616848|P2|COMPLETED|Treated||54
8364003|NCT01193127|20616849|P1|COMPLETED|Treated||57
8364004|NCT01193127|20616846|P4|STARTED|Treated||56
8364005|NCT01193127|20616847|P3|STARTED|Treated||55
8364006|NCT01193127|20616848|P2|STARTED|Treated||54
8364007|NCT01193127|20616849|P1|STARTED|Treated||57
8364008|NCT01193127|20616846|P4|NOT COMPLETED|Randomized||1
8364009|NCT01193127|20616847|P3|NOT COMPLETED|Randomized||0
8364010|NCT01193127|20616848|P2|NOT COMPLETED|Randomized||0
8364011|NCT01193127|20616849|P1|NOT COMPLETED|Randomized||0
8364012|NCT01193127|20616846|P4|COMPLETED|Randomized||56
8364013|NCT01193127|20616847|P3|COMPLETED|Randomized||55
8364014|NCT01193127|20616848|P2|COMPLETED|Randomized||54
8364015|NCT01193127|20616849|P1|COMPLETED|Randomized||57
8364016|NCT01193127|20616846|P4|STARTED|Randomized||57
8364017|NCT01193127|20616847|P3|STARTED|Randomized||55
8364018|NCT01193127|20616848|P2|STARTED|Randomized||54
8364019|NCT01193127|20616849|P1|STARTED|Randomized||57
8364020|NCT01193114|20617153|P2|NOT COMPLETED|Overall Study||0
8364021|NCT01193114|20617154|P1|NOT COMPLETED|Overall Study||0
8364022|NCT01193114|20617153|P2|COMPLETED|Overall Study||30
8364023|NCT01193114|20617154|P1|COMPLETED|Overall Study||30
8364024|NCT01193114|20617153|P2|STARTED|Overall Study||30
8364025|NCT01193114|20617154|P1|STARTED|Overall Study||30
8364026|NCT01193101|20617174|P4|NOT COMPLETED|Overall Study||12
8364027|NCT01193101|20617175|P3|NOT COMPLETED|Overall Study||3
8364028|NCT01193101|20617176|P2|NOT COMPLETED|Overall Study||7
8364029|NCT01193101|20617177|P1|NOT COMPLETED|Overall Study||5
8364030|NCT01193101|20617174|P4|COMPLETED|Overall Study||80
8364031|NCT01193101|20617175|P3|COMPLETED|Overall Study||93
8364032|NCT01193101|20617176|P2|COMPLETED|Overall Study||94
8364033|NCT01193101|20617177|P1|COMPLETED|Overall Study||95
8364034|NCT01193101|20617174|P4|Placebo Withdrawal Set|Overall Study||80
8364035|NCT01193101|20617175|P3|Placebo Withdrawal Set|Overall Study||93
8364036|NCT01193101|20617176|P2|Placebo Withdrawal Set|Overall Study||94
8364037|NCT01193101|20617177|P1|Placebo Withdrawal Set|Overall Study||95
8364038|NCT01193101|20617174|P4|Full Analysis Set|Overall Study||92
8364039|NCT01193101|20617175|P3|Full Analysis Set|Overall Study||96
8364040|NCT01193101|20617176|P2|Full Analysis Set|Overall Study||101
8364041|NCT01193101|20617177|P1|Full Analysis Set|Overall Study||100
8364042|NCT01193101|20617174|P4|STARTED|Overall Study||92
8364043|NCT01193101|20617175|P3|STARTED|Overall Study||96
8364044|NCT01193101|20617176|P2|STARTED|Overall Study||101
8364045|NCT01193101|20617177|P1|STARTED|Overall Study||100
8364046|NCT01193049|20617233|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
8364047|NCT01193049|20617234|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
8364048|NCT01193049|20617233|P2|COMPLETED|Period 3 : Double Blind Crossover||6
8364049|NCT01193049|20617234|P1|COMPLETED|Period 3 : Double Blind Crossover||5
8364050|NCT01193049|20617233|P2|STARTED|Period 3 : Double Blind Crossover||6
8364051|NCT01193049|20617234|P1|STARTED|Period 3 : Double Blind Crossover||5
8364052|NCT01193049|20617233|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
8364053|NCT01193049|20617234|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
8364054|NCT01193049|20617233|P2|COMPLETED|Washout 2 : 21 Day Washout||6
8364055|NCT01193049|20617234|P1|COMPLETED|Washout 2 : 21 Day Washout||5
8364056|NCT01193049|20617233|P2|STARTED|Washout 2 : 21 Day Washout||6
8364057|NCT01193049|20617234|P1|STARTED|Washout 2 : 21 Day Washout||5
8364058|NCT01193049|20617233|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
8364059|NCT01193049|20617234|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
8364060|NCT01193049|20617233|P2|COMPLETED|Period 2 : Double Blind Crossover||6
8364061|NCT01193049|20617234|P1|COMPLETED|Period 2 : Double Blind Crossover||5
8364062|NCT01193049|20617233|P2|STARTED|Period 2 : Double Blind Crossover||6
8364063|NCT01193049|20617234|P1|STARTED|Period 2 : Double Blind Crossover||5
8364064|NCT01193049|20617233|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
8364065|NCT01193049|20617234|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
8364066|NCT01193049|20617233|P2|COMPLETED|Washout 1 : 21 Day Washout||6
8364067|NCT01193049|20617234|P1|COMPLETED|Washout 1 : 21 Day Washout||5
8364068|NCT01193049|20617233|P2|STARTED|Washout 1 : 21 Day Washout||6
8364069|NCT01193049|20617234|P1|STARTED|Washout 1 : 21 Day Washout||5
8364070|NCT01193049|20617233|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
8364071|NCT01193049|20617234|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
8364072|NCT01193049|20617233|P2|COMPLETED|Period 1: Placebo Run-In||6
8364073|NCT01193049|20617234|P1|COMPLETED|Period 1: Placebo Run-In||5
8364074|NCT01193049|20617233|P2|STARTED|Period 1: Placebo Run-In||6
8364075|NCT01193049|20617234|P1|STARTED|Period 1: Placebo Run-In||5
8364076|NCT01193010|20617266|P2|NOT COMPLETED|Overall Study||0
8364077|NCT01193010|20617267|P1|NOT COMPLETED|Overall Study||3
8364078|NCT01193010|20617266|P2|COMPLETED|Overall Study||20
8364079|NCT01193010|20617267|P1|COMPLETED|Overall Study||17
8364080|NCT01193010|20617266|P2|STARTED|Overall Study||20
8364081|NCT01193010|20617267|P1|STARTED|Overall Study||20
8364082|NCT01192828|20617279|P1|NOT COMPLETED|Overall Study||0
8364083|NCT01192828|20617279|P1|COMPLETED|Overall Study||14
8364084|NCT01192828|20617279|P1|STARTED|Overall Study||14
8364085|NCT01192815|20617294|P1|NOT COMPLETED|Overall Study||2
8364086|NCT01192815|20617294|P1|COMPLETED|Overall Study||0
8364087|NCT01192815|20617294|P1|STARTED|Overall Study||2
8364088|NCT01192776|20617309|P4|NOT COMPLETED|Overall Study||20
8364089|NCT01192776|20617310|P3|NOT COMPLETED|Overall Study||21
8364090|NCT01192776|20617311|P2|NOT COMPLETED|Overall Study||21
8364091|NCT01192776|20617312|P1|NOT COMPLETED|Overall Study||11
8364092|NCT01192776|20617309|P4|COMPLETED|Overall Study||63
8364093|NCT01192776|20617310|P3|COMPLETED|Overall Study||75
8364094|NCT01192776|20617311|P2|COMPLETED|Overall Study||69
8364095|NCT01192776|20617312|P1|COMPLETED|Overall Study||84
8364096|NCT01192776|20617309|P4|Died After Discharge|Overall Study||1
8364097|NCT01192776|20617310|P3|Died After Discharge|Overall Study||3
8364098|NCT01192776|20617311|P2|Died After Discharge|Overall Study||2
8364099|NCT01192776|20617312|P1|Died After Discharge|Overall Study||1
8364100|NCT01192776|20617309|P4|Died Prior to Discharge|Overall Study||14
8364101|NCT01192776|20617310|P3|Died Prior to Discharge|Overall Study||15
8364102|NCT01192776|20617311|P2|Died Prior to Discharge|Overall Study||13
8364103|NCT01192776|20617312|P1|Died Prior to Discharge|Overall Study||7
8364104|NCT01192776|20617309|P4|STARTED|Overall Study||83
8364105|NCT01192776|20617310|P3|STARTED|Overall Study||96
8364106|NCT01192776|20617311|P2|STARTED|Overall Study||90
8364107|NCT01192776|20617312|P1|STARTED|Overall Study||95
8364108|NCT01192698|20617368|P2|NOT COMPLETED|Overall Study||0
8364109|NCT01192698|20617369|P1|NOT COMPLETED|Overall Study||0
8364110|NCT01192698|20617368|P2|COMPLETED|Overall Study||5
8364111|NCT01192698|20617369|P1|COMPLETED|Overall Study||10
8364112|NCT01192698|20617368|P2|STARTED|Overall Study||5
8364113|NCT01192698|20617369|P1|STARTED|Overall Study||10
8364114|NCT01192542|20617375|P2|NOT COMPLETED|Period 2||0
8364115|NCT01192542|20617376|P1|NOT COMPLETED|Period 2||0
8364116|NCT01192542|20617375|P2|COMPLETED|Period 2||20
8364117|NCT01192542|20617376|P1|COMPLETED|Period 2||18
8364118|NCT01192542|20617375|P2|STARTED|Period 2||20
8364119|NCT01192542|20617376|P1|STARTED|Period 2||18
8364120|NCT01192542|20617375|P2|NOT COMPLETED|Period 1||0
8364121|NCT01192542|20617376|P1|NOT COMPLETED|Period 1||0
8364122|NCT01192542|20617375|P2|COMPLETED|Period 1||20
8364123|NCT01192542|20617376|P1|COMPLETED|Period 1||18
8364124|NCT01192542|20617375|P2|STARTED|Period 1||20
8364125|NCT01192542|20617376|P1|STARTED|Period 1||18
8364126|NCT01192516|20617390|P3|NOT COMPLETED|Overall Study||8
8364127|NCT01192516|20617391|P2|NOT COMPLETED|Overall Study||17
8364128|NCT01192516|20617392|P1|NOT COMPLETED|Overall Study||20
8364129|NCT01192516|20617390|P3|COMPLETED|Overall Study||55
8364130|NCT01192516|20617391|P2|COMPLETED|Overall Study||49
8364131|NCT01192516|20617392|P1|COMPLETED|Overall Study||46
8364132|NCT01192516|20617390|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
8364133|NCT01192516|20617391|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
8364134|NCT01192516|20617392|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
8364135|NCT01192412|20617426|P2|NOT COMPLETED|Overall Study||2
8364136|NCT01192412|20617427|P1|NOT COMPLETED|Overall Study||4
8364137|NCT01192412|20617426|P2|COMPLETED|Overall Study||488
8364138|NCT01192412|20617427|P1|COMPLETED|Overall Study||493
8364139|NCT01192412|20617426|P2|STARTED|Overall Study||490
8364140|NCT01192412|20617427|P1|STARTED|Overall Study||497
8364141|NCT01192399|20617435|P1|NOT COMPLETED|Overall Study||2
8364142|NCT01192399|20617435|P1|COMPLETED|Overall Study||27
8364143|NCT01192399|20617435|P1|STARTED|Overall Study||29
8364144|NCT01192347|20617445|P1|NOT COMPLETED|Overall Study||12
8364145|NCT01192347|20617445|P1|COMPLETED|Overall Study||163
8364146|NCT01192347|20617445|P1|STARTED|Overall Study||175
8364147|NCT01192295|20617468|P2|NOT COMPLETED|Overall Study||23
8364148|NCT01192295|20617469|P1|NOT COMPLETED|Overall Study||10
8364149|NCT01192295|20617468|P2|COMPLETED|Overall Study||105
8364150|NCT01192295|20617469|P1|COMPLETED|Overall Study||17
8364151|NCT01192295|20617468|P2|STARTED|Overall Study||128
8364152|NCT01192295|20617469|P1|STARTED|Overall Study||27
8364153|NCT01192282|20617490|P1|NOT COMPLETED|Overall Study||0
8364154|NCT01192282|20617490|P1|COMPLETED|Overall Study||156
8364155|NCT01192282|20617490|P1|STARTED|Overall Study||156
8364156|NCT01192204|20617507|P2|NOT COMPLETED|Overall Study||0
8364157|NCT01192204|20617508|P1|NOT COMPLETED|Overall Study||1
8364158|NCT01192204|20617507|P2|COMPLETED|Overall Study||18
8364159|NCT01192204|20617508|P1|COMPLETED|Overall Study||22
8364160|NCT01192204|20617507|P2|STARTED|Overall Study||18
8364161|NCT01192204|20617508|P1|STARTED|Overall Study||23
8364162|NCT01192191|20617520|P2|NOT COMPLETED|Overall Study||21
8364163|NCT01192191|20617521|P1|NOT COMPLETED|Overall Study||11
8364164|NCT01192191|20617520|P2|COMPLETED|Overall Study||106
8364165|NCT01192191|20617521|P1|COMPLETED|Overall Study||49
8364166|NCT01192191|20617520|P2|STARTED|Overall Study||127
8364167|NCT01192191|20617521|P1|STARTED|Overall Study||60
8364168|NCT01192178|20617547|P2|NOT COMPLETED|Overall Study||23
8364169|NCT01192178|20617548|P1|NOT COMPLETED|Overall Study||24
8364170|NCT01192178|20617547|P2|COMPLETED|Overall Study||145
8364171|NCT01192178|20617548|P1|COMPLETED|Overall Study||147
8364172|NCT01192178|20617547|P2|STARTED|Overall Study||168
8364173|NCT01192178|20617548|P1|STARTED|Overall Study||171
8364174|NCT01192152|20617568|P2|NOT COMPLETED|Period 3||0
8364175|NCT01192152|20617569|P1|NOT COMPLETED|Period 3||1
8364176|NCT01192152|20617568|P2|COMPLETED|Period 3||0
8364177|NCT01192152|20617569|P1|COMPLETED|Period 3||14
8364178|NCT01192152|20617568|P2|STARTED|Period 3||0
8364179|NCT01192152|20617569|P1|STARTED|Period 3||15
8364180|NCT01192152|20617568|P2|NOT COMPLETED|Period 2||0
8364181|NCT01192152|20617569|P1|NOT COMPLETED|Period 2||0
8364182|NCT01192152|20617568|P2|COMPLETED|Period 2||14
8364183|NCT01192152|20617569|P1|COMPLETED|Period 2||15
8364184|NCT01192152|20617568|P2|STARTED|Period 2||14
8364185|NCT01192152|20617569|P1|STARTED|Period 2||15
8364186|NCT01192152|20617568|P2|NOT COMPLETED|Period 1||1
8364187|NCT01192152|20617569|P1|NOT COMPLETED|Period 1||0
8364188|NCT01192152|20617568|P2|COMPLETED|Period 1||14
8364189|NCT01192152|20617569|P1|COMPLETED|Period 1||15
8364190|NCT01192152|20617568|P2|STARTED|Period 1||15
8364191|NCT01192152|20617569|P1|STARTED|Period 1||15
8364192|NCT01192139|20617670|P6|NOT COMPLETED|Period 3||0
8364193|NCT01192139|20617671|P5|NOT COMPLETED|Period 3||0
8364194|NCT01192139|20617672|P4|NOT COMPLETED|Period 3||0
8364195|NCT01192139|20617673|P3|NOT COMPLETED|Period 3||0
8364196|NCT01192139|20617674|P2|NOT COMPLETED|Period 3||0
8364197|NCT01192139|20617675|P1|NOT COMPLETED|Period 3||0
8364198|NCT01192139|20617670|P6|COMPLETED|Period 3||5
8364199|NCT01192139|20617671|P5|COMPLETED|Period 3||5
8364200|NCT01192139|20617672|P4|COMPLETED|Period 3||5
8364201|NCT01192139|20617673|P3|COMPLETED|Period 3||5
8364202|NCT01192139|20617674|P2|COMPLETED|Period 3||5
8364203|NCT01192139|20617675|P1|COMPLETED|Period 3||5
8364204|NCT01192139|20617670|P6|STARTED|Period 3||5
8364205|NCT01192139|20617671|P5|STARTED|Period 3||5
8364206|NCT01192139|20617672|P4|STARTED|Period 3||5
8364207|NCT01192139|20617673|P3|STARTED|Period 3||5
8364208|NCT01192139|20617674|P2|STARTED|Period 3||5
8364209|NCT01192139|20617675|P1|STARTED|Period 3||5
8364210|NCT01192139|20617670|P6|NOT COMPLETED|Period 2||0
8364211|NCT01192139|20617671|P5|NOT COMPLETED|Period 2||0
8364212|NCT01192139|20617672|P4|NOT COMPLETED|Period 2||0
8364213|NCT01192139|20617673|P3|NOT COMPLETED|Period 2||0
8364214|NCT01192139|20617674|P2|NOT COMPLETED|Period 2||0
8364215|NCT01192139|20617675|P1|NOT COMPLETED|Period 2||0
8364216|NCT01192139|20617670|P6|COMPLETED|Period 2||5
8364217|NCT01192139|20617671|P5|COMPLETED|Period 2||5
8364218|NCT01192139|20617672|P4|COMPLETED|Period 2||5
8364219|NCT01192139|20617673|P3|COMPLETED|Period 2||5
8364220|NCT01192139|20617674|P2|COMPLETED|Period 2||5
8364221|NCT01192139|20617675|P1|COMPLETED|Period 2||5
8364222|NCT01192139|20617670|P6|STARTED|Period 2||5
8364223|NCT01192139|20617671|P5|STARTED|Period 2||5
8364224|NCT01192139|20617672|P4|STARTED|Period 2||5
8364225|NCT01192139|20617673|P3|STARTED|Period 2||5
8364226|NCT01192139|20617674|P2|STARTED|Period 2||5
8364227|NCT01192139|20617675|P1|STARTED|Period 2||5
8364228|NCT01192139|20617670|P6|NOT COMPLETED|Period 1||0
8364229|NCT01192139|20617671|P5|NOT COMPLETED|Period 1||0
8364230|NCT01192139|20617672|P4|NOT COMPLETED|Period 1||0
8364231|NCT01192139|20617673|P3|NOT COMPLETED|Period 1||0
8364232|NCT01192139|20617674|P2|NOT COMPLETED|Period 1||0
8364233|NCT01192139|20617675|P1|NOT COMPLETED|Period 1||0
8364234|NCT01192139|20617670|P6|COMPLETED|Period 1||5
8364235|NCT01192139|20617671|P5|COMPLETED|Period 1||5
8364236|NCT01192139|20617672|P4|COMPLETED|Period 1||5
8364237|NCT01192139|20617673|P3|COMPLETED|Period 1||5
8364238|NCT01192139|20617674|P2|COMPLETED|Period 1||5
8364239|NCT01192139|20617675|P1|COMPLETED|Period 1||5
8364240|NCT01192139|20617670|P6|STARTED|Period 1||5
8364241|NCT01192139|20617671|P5|STARTED|Period 1||5
8364242|NCT01192139|20617672|P4|STARTED|Period 1||5
8364243|NCT01192139|20617673|P3|STARTED|Period 1||5
8364244|NCT01192139|20617674|P2|STARTED|Period 1||5
8364245|NCT01192139|20617675|P1|STARTED|Period 1||5
8364246|NCT01192126|20617740|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8364247|NCT01192126|20617741|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8364248|NCT01192126|20617740|P2|COMPLETED|Second Intervention (1 Week)||50
8364249|NCT01192126|20617741|P1|COMPLETED|Second Intervention (1 Week)||49
8364250|NCT01192126|20617740|P2|STARTED|Second Intervention (1 Week)||50
8364251|NCT01192126|20617741|P1|STARTED|Second Intervention (1 Week)||49
8364252|NCT01192126|20617740|P2|NOT COMPLETED|First Intervention (1 Week)||1
8364253|NCT01192126|20617741|P1|NOT COMPLETED|First Intervention (1 Week)||2
8364254|NCT01192126|20617740|P2|COMPLETED|First Intervention (1 Week)||50
8364255|NCT01192126|20617741|P1|COMPLETED|First Intervention (1 Week)||49
8364256|NCT01192126|20617740|P2|STARTED|First Intervention (1 Week)||51
8364257|NCT01192126|20617741|P1|STARTED|First Intervention (1 Week)||51
8364258|NCT01192100|20617749|P6|NOT COMPLETED|Overall Study||0
8364259|NCT01192100|20617750|P5|NOT COMPLETED|Overall Study||1
8364260|NCT01192100|20617751|P4|NOT COMPLETED|Overall Study||1
8364261|NCT01192100|20617752|P3|NOT COMPLETED|Overall Study||0
8364262|NCT01192100|20617753|P2|NOT COMPLETED|Overall Study||0
8364263|NCT01192100|20617754|P1|NOT COMPLETED|Overall Study||0
8364264|NCT01192100|20617749|P6|COMPLETED|Overall Study||2
8364265|NCT01192100|20617750|P5|COMPLETED|Overall Study||2
8364266|NCT01192100|20617751|P4|COMPLETED|Overall Study||3
8364267|NCT01192100|20617752|P3|COMPLETED|Overall Study||3
8364268|NCT01192100|20617753|P2|COMPLETED|Overall Study||4
8364269|NCT01192100|20617754|P1|COMPLETED|Overall Study||6
8364270|NCT01192100|20617749|P6|Began 3rd Intervention Week|Overall Study||2
8364271|NCT01192100|20617750|P5|Began 3rd Intervention Week|Overall Study||2
8364272|NCT01192100|20617751|P4|Began 3rd Intervention Week|Overall Study||3
8364273|NCT01192100|20617752|P3|Began 3rd Intervention Week|Overall Study||3
8364274|NCT01192100|20617753|P2|Began 3rd Intervention Week|Overall Study||4
8364275|NCT01192100|20617754|P1|Began 3rd Intervention Week|Overall Study||6
8364276|NCT01192100|20617749|P6|Began 2nd Intervention Week|Overall Study||2
8364277|NCT01192100|20617750|P5|Began 2nd Intervention Week|Overall Study||2
8364278|NCT01192100|20617751|P4|Began 2nd Intervention Week|Overall Study||3
8364279|NCT01192100|20617752|P3|Began 2nd Intervention Week|Overall Study||3
8364280|NCT01192100|20617753|P2|Began 2nd Intervention Week|Overall Study||4
8364281|NCT01192100|20617754|P1|Began 2nd Intervention Week|Overall Study||6
8364282|NCT01192100|20617749|P6|Began 1st Intervention Week|Overall Study||2
8364283|NCT01192100|20617750|P5|Began 1st Intervention Week|Overall Study||3
8364284|NCT01192100|20617751|P4|Began 1st Intervention Week|Overall Study||4
8364285|NCT01192100|20617752|P3|Began 1st Intervention Week|Overall Study||3
8364286|NCT01192100|20617753|P2|Began 1st Intervention Week|Overall Study||4
8364287|NCT01192100|20617754|P1|Began 1st Intervention Week|Overall Study||6
8364288|NCT01192100|20617749|P6|STARTED|Overall Study||2
8364289|NCT01192100|20617750|P5|STARTED|Overall Study||3
8364290|NCT01192100|20617751|P4|STARTED|Overall Study||4
8364291|NCT01192100|20617752|P3|STARTED|Overall Study||3
8364292|NCT01192100|20617753|P2|STARTED|Overall Study||4
8364293|NCT01192100|20617754|P1|STARTED|Overall Study||6
8364294|NCT01192022|20617774|P5|NOT COMPLETED|Overall Study||1
8364295|NCT01192022|20617775|P4|NOT COMPLETED|Overall Study||2
8364296|NCT01192022|20617776|P3|NOT COMPLETED|Overall Study||1
8364297|NCT01192022|20617777|P2|NOT COMPLETED|Overall Study||11
8364298|NCT01192022|20617778|P1|NOT COMPLETED|Overall Study||13
8364299|NCT01192022|20617774|P5|COMPLETED|Overall Study||11
8364300|NCT01192022|20617775|P4|COMPLETED|Overall Study||7
8364301|NCT01192022|20617776|P3|COMPLETED|Overall Study||7
8364302|NCT01192022|20617777|P2|COMPLETED|Overall Study||99
8364303|NCT01192022|20617778|P1|COMPLETED|Overall Study||101
8364304|NCT01192022|20617774|P5|Safety Population-Received Treatment|Overall Study||12
8364305|NCT01192022|20617775|P4|Safety Population-Received Treatment|Overall Study||9
8364306|NCT01192022|20617776|P3|Safety Population-Received Treatment|Overall Study||8
8364307|NCT01192022|20617777|P2|Safety Population-Received Treatment|Overall Study||109
8364308|NCT01192022|20617778|P1|Safety Population-Received Treatment|Overall Study||114
8364309|NCT01192022|20617774|P5|STARTED|Overall Study||12
8364310|NCT01192022|20617775|P4|STARTED|Overall Study||9
8364311|NCT01192022|20617776|P3|STARTED|Overall Study||8
8364312|NCT01192022|20617777|P2|STARTED|Overall Study||110
8364313|NCT01192022|20617778|P1|STARTED|Overall Study||114
8364314|NCT01191944|20617801|P2|NOT COMPLETED|Overall Study||19
8364315|NCT01191944|20617802|P1|NOT COMPLETED|Overall Study||17
8364316|NCT01191944|20617801|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
8364317|NCT01191944|20617802|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
8364318|NCT01191944|20617801|P2|STARTED|Overall Study|Treated titration/maintenance|239
8364319|NCT01191944|20617802|P1|STARTED|Overall Study|Treated titration/maintenance|234
8364320|NCT01191840|20617848|P2|NOT COMPLETED|Overall Study||15
8364321|NCT01191840|20617849|P1|NOT COMPLETED|Overall Study||14
8364322|NCT01191840|20617848|P2|COMPLETED|Overall Study||240
8364323|NCT01191840|20617849|P1|COMPLETED|Overall Study||240
8364324|NCT01191840|20617848|P2|STARTED|Overall Study||255
8364325|NCT01191840|20617849|P1|STARTED|Overall Study||254
8364326|NCT01191827|20617865|P2|NOT COMPLETED|Overall Study||0
8364327|NCT01191827|20617866|P1|NOT COMPLETED|Overall Study||0
8364328|NCT01191827|20617865|P2|COMPLETED|Overall Study||20
8364329|NCT01191827|20617866|P1|COMPLETED|Overall Study||20
8364330|NCT01191827|20617865|P2|STARTED|Overall Study||20
8364331|NCT01191827|20617866|P1|STARTED|Overall Study||20
8364332|NCT01191801|20617874|P2|NOT COMPLETED|Overall Study||337
8364333|NCT01191801|20617875|P1|NOT COMPLETED|Overall Study||316
8364334|NCT01191801|20617874|P2|COMPLETED|Overall Study||18
8364335|NCT01191801|20617875|P1|COMPLETED|Overall Study||40
8364336|NCT01191801|20617874|P2|STARTED|Overall Study||355
8364337|NCT01191801|20617875|P1|STARTED|Overall Study||356
8364338|NCT01191788|20617895|P2|NOT COMPLETED|Overall Study||22
8364339|NCT01191788|20617896|P1|NOT COMPLETED|Overall Study||21
8364340|NCT01191788|20617895|P2|COMPLETED|Overall Study|Completed 3-month followup|137
8364341|NCT01191788|20617896|P1|COMPLETED|Overall Study|Completed 3-month followup|119
8364342|NCT01191788|20617895|P2|STARTED|Overall Study||159
8364343|NCT01191788|20617896|P1|STARTED|Overall Study||140
8364344|NCT01191762|20617906|P2|NOT COMPLETED|Overall Study||0
8364345|NCT01191762|20617907|P1|NOT COMPLETED|Overall Study||1
8364346|NCT01191762|20617906|P2|COMPLETED|Overall Study||15
8364347|NCT01191762|20617907|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
8364348|NCT01191762|20617906|P2|STARTED|Overall Study||15
8364349|NCT01191762|20617907|P1|STARTED|Overall Study||15
8364350|NCT01191749|20617913|P1|NOT COMPLETED|Overall Study||0
8364351|NCT01191749|20617913|P1|COMPLETED|Overall Study||7
8364352|NCT01191749|20617913|P1|STARTED|Overall Study||7
8364353|NCT01191736|20617924|P7|NOT COMPLETED|Overall Study||0
8364354|NCT01191736|20617925|P6|NOT COMPLETED|Overall Study||0
8364355|NCT01191736|20617926|P5|NOT COMPLETED|Overall Study||0
8364356|NCT01191736|20617927|P4|NOT COMPLETED|Overall Study||0
8364357|NCT01191736|20617928|P3|NOT COMPLETED|Overall Study||0
8364358|NCT01191736|20617929|P2|NOT COMPLETED|Overall Study||0
8364359|NCT01191736|20617930|P1|NOT COMPLETED|Overall Study||0
8364360|NCT01191736|20617924|P7|COMPLETED|Overall Study||45
8364361|NCT01191736|20617925|P6|COMPLETED|Overall Study||50
8364362|NCT01191736|20617926|P5|COMPLETED|Overall Study||48
8364363|NCT01191736|20617927|P4|COMPLETED|Overall Study||46
8364364|NCT01191736|20617928|P3|COMPLETED|Overall Study||49
8364365|NCT01191736|20617929|P2|COMPLETED|Overall Study||47
8364366|NCT01191736|20617930|P1|COMPLETED|Overall Study||51
8364367|NCT01191736|20617924|P7|STARTED|Overall Study||45
8364368|NCT01191736|20617925|P6|STARTED|Overall Study||50
8364369|NCT01191736|20617926|P5|STARTED|Overall Study||48
8364370|NCT01191736|20617927|P4|STARTED|Overall Study||46
8364371|NCT01191736|20617928|P3|STARTED|Overall Study||49
8364372|NCT01191736|20617929|P2|STARTED|Overall Study||47
8364373|NCT01191736|20617930|P1|STARTED|Overall Study||51
8364374|NCT01191723|20617953|P6|NOT COMPLETED|Overall Study||0
8364375|NCT01191723|20617954|P5|NOT COMPLETED|Overall Study||0
8364376|NCT01191723|20617955|P4|NOT COMPLETED|Overall Study||0
8364377|NCT01191723|20617956|P3|NOT COMPLETED|Overall Study||0
8364378|NCT01191723|20617957|P2|NOT COMPLETED|Overall Study||0
8364379|NCT01191723|20617958|P1|NOT COMPLETED|Overall Study||0
8364380|NCT01191723|20617953|P6|COMPLETED|Overall Study||9
8364381|NCT01191723|20617954|P5|COMPLETED|Overall Study||9
8364382|NCT01191723|20617955|P4|COMPLETED|Overall Study||9
8364383|NCT01191723|20617956|P3|COMPLETED|Overall Study||9
8364384|NCT01191723|20617957|P2|COMPLETED|Overall Study||9
8364385|NCT01191723|20617958|P1|COMPLETED|Overall Study||9
8364386|NCT01191723|20617953|P6|STARTED|Overall Study||9
8364387|NCT01191723|20617954|P5|STARTED|Overall Study||9
8364388|NCT01191723|20617955|P4|STARTED|Overall Study||9
8364389|NCT01191723|20617956|P3|STARTED|Overall Study||9
8364390|NCT01191723|20617957|P2|STARTED|Overall Study||9
8364391|NCT01191723|20617958|P1|STARTED|Overall Study||9
8364392|NCT01191476|20617979|P3|NOT COMPLETED|Overall Study||0
8364393|NCT01191476|20617980|P2|NOT COMPLETED|Overall Study||4
8364394|NCT01191476|20617981|P1|NOT COMPLETED|Overall Study||3
8364395|NCT01191476|20617979|P3|COMPLETED|Overall Study||111
8364396|NCT01191476|20617980|P2|COMPLETED|Overall Study||107
8364397|NCT01191476|20617981|P1|COMPLETED|Overall Study||109
8364398|NCT01191476|20617979|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
8364399|NCT01191476|20617980|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
8364400|NCT01191476|20617981|P1|STARTED|Overall Study||112
8364401|NCT01191411|20618004|P3|NOT COMPLETED|Overall Study||3427
8364402|NCT01191411|20618005|P2|NOT COMPLETED|Overall Study||361
8364403|NCT01191411|20618006|P1|NOT COMPLETED|Overall Study||945
8364404|NCT01191411|20618004|P3|COMPLETED|Overall Study||471
8364405|NCT01191411|20618005|P2|COMPLETED|Overall Study||118
8364406|NCT01191411|20618006|P1|COMPLETED|Overall Study||648
8364407|NCT01191411|20618004|P3|STARTED|Overall Study||3898
8364408|NCT01191411|20618005|P2|STARTED|Overall Study||479
8364409|NCT01191411|20618006|P1|STARTED|Overall Study||1593
8364410|NCT01191398|20618017|P3|NOT COMPLETED|Overall Study||0
8364411|NCT01191398|20618018|P2|NOT COMPLETED|Overall Study||0
8364412|NCT01191398|20618019|P1|NOT COMPLETED|Overall Study||0
8364413|NCT01191398|20618017|P3|COMPLETED|Overall Study||18
8364414|NCT01191398|20618018|P2|COMPLETED|Overall Study||17
8364415|NCT01191398|20618019|P1|COMPLETED|Overall Study||17
8364416|NCT01191398|20618017|P3|STARTED|Overall Study||18
8364417|NCT01191398|20618018|P2|STARTED|Overall Study||17
8364418|NCT01191398|20618019|P1|STARTED|Overall Study||17
8364419|NCT01191333|20618032|P2|NOT COMPLETED|Overall Study||18
8364420|NCT01191333|20618033|P1|NOT COMPLETED|Overall Study||21
8364421|NCT01191333|20618032|P2|COMPLETED|Overall Study||65
8364422|NCT01191333|20618033|P1|COMPLETED|Overall Study||60
8364423|NCT01191333|20618032|P2|STARTED|Overall Study||83
8364424|NCT01191333|20618033|P1|STARTED|Overall Study||81
8364425|NCT01191320|20618052|P3|NOT COMPLETED|Overall Study||7
8364426|NCT01191320|20618053|P2|NOT COMPLETED|Overall Study||6
8364427|NCT01191320|20618054|P1|NOT COMPLETED|Overall Study||7
8364428|NCT01191320|20618052|P3|COMPLETED|Overall Study||31
8364429|NCT01191320|20618053|P2|COMPLETED|Overall Study||32
8364430|NCT01191320|20618054|P1|COMPLETED|Overall Study||36
8364431|NCT01191320|20618052|P3|STARTED|Overall Study||38
8364432|NCT01191320|20618053|P2|STARTED|Overall Study||38
8364433|NCT01191320|20618054|P1|STARTED|Overall Study||43
8364434|NCT01191268|20618065|P3|NOT COMPLETED|Overall Study||52
8364435|NCT01191268|20618066|P2|NOT COMPLETED|Overall Study||55
8364436|NCT01191268|20618067|P1|NOT COMPLETED|Overall Study||58
8364437|NCT01191268|20618065|P3|COMPLETED|Overall Study||244
8364438|NCT01191268|20618066|P2|COMPLETED|Overall Study||238
8364439|NCT01191268|20618067|P1|COMPLETED|Overall Study||237
8364440|NCT01191268|20618065|P3|Received at Least One Dose of Study Drug|Overall Study||296
8364441|NCT01191268|20618066|P2|Received at Least One Dose of Study Drug|Overall Study||293
8364442|NCT01191268|20618067|P1|Received at Least One Dose of Study Drug|Overall Study||295
8364443|NCT01191268|20618065|P3|STARTED|Overall Study||296
8364444|NCT01191268|20618066|P2|STARTED|Overall Study||293
8364445|NCT01191268|20618067|P1|STARTED|Overall Study||295
8364446|NCT01191255|20618164|P4|NOT COMPLETED|Efficacy Assessment Period||6
8364447|NCT01191255|20618165|P3|NOT COMPLETED|Efficacy Assessment Period||26
8364448|NCT01191255|20618166|P2|NOT COMPLETED|Efficacy Assessment Period||0
8364449|NCT01191255|20618167|P1|NOT COMPLETED|Efficacy Assessment Period||0
8364450|NCT01191255|20618164|P4|COMPLETED|Efficacy Assessment Period||90
8364451|NCT01191255|20618165|P3|COMPLETED|Efficacy Assessment Period||70
8364452|NCT01191255|20618166|P2|COMPLETED|Efficacy Assessment Period||0
8364453|NCT01191255|20618167|P1|COMPLETED|Efficacy Assessment Period||0
8364454|NCT01191255|20618164|P4|STARTED|Efficacy Assessment Period||96
8364455|NCT01191255|20618165|P3|STARTED|Efficacy Assessment Period||96
8364456|NCT01191255|20618166|P2|STARTED|Efficacy Assessment Period||0
8364457|NCT01191255|20618167|P1|STARTED|Efficacy Assessment Period||0
8364458|NCT01191255|20618164|P4|NOT COMPLETED|Safety Assessment Period||0
8364459|NCT01191255|20618165|P3|NOT COMPLETED|Safety Assessment Period||0
8364460|NCT01191255|20618166|P2|NOT COMPLETED|Safety Assessment Period||99
8364461|NCT01191255|20618167|P1|NOT COMPLETED|Safety Assessment Period||38
8364462|NCT01191255|20618164|P4|COMPLETED|Safety Assessment Period||0
8364463|NCT01191255|20618165|P3|COMPLETED|Safety Assessment Period||0
8364464|NCT01191255|20618166|P2|COMPLETED|Safety Assessment Period||193
8364465|NCT01191255|20618167|P1|COMPLETED|Safety Assessment Period||111
8364466|NCT01191255|20618164|P4|Safety Population|Safety Assessment Period||0
8364467|NCT01191255|20618165|P3|Safety Population|Safety Assessment Period||0
8364468|NCT01191255|20618166|P2|Safety Population|Safety Assessment Period||289
8364469|NCT01191255|20618167|P1|Safety Population|Safety Assessment Period||149
8364470|NCT01191255|20618164|P4|STARTED|Safety Assessment Period||0
8364471|NCT01191255|20618165|P3|STARTED|Safety Assessment Period||0
8364472|NCT01191255|20618166|P2|STARTED|Safety Assessment Period||292
8364473|NCT01191255|20618167|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
8364474|NCT01191242|20618193|P1|NOT COMPLETED|Overall Study||0
8364475|NCT01191242|20618193|P1|COMPLETED|Overall Study||31
8364476|NCT01191242|20618193|P1|STARTED|Overall Study||31
8364477|NCT01191190|20618208|P1|NOT COMPLETED|Overall Study||1
8364478|NCT01191190|20618208|P1|COMPLETED|Overall Study||20
8364479|NCT01191190|20618208|P1|STARTED|Overall Study||21
8364480|NCT01191086|20618221|P1|NOT COMPLETED|Overall Study||62
8364481|NCT01191086|20618221|P1|COMPLETED|Overall Study||148
8364482|NCT01191086|20618221|P1|STARTED|Overall Study||210
8364486|NCT01190930|20618233|P10|NOT COMPLETED|Maintenance||37
8364487|NCT01190930|20618234|P9|NOT COMPLETED|Maintenance||46
8364488|NCT01190930|20618235|P8|NOT COMPLETED|Maintenance||46
8364489|NCT01190930|20618236|P7|NOT COMPLETED|Maintenance||26
8364490|NCT01190930|20618237|P6|NOT COMPLETED|Maintenance||12
8364491|NCT01190930|20618238|P5|NOT COMPLETED|Maintenance||9
8364492|NCT01190930|20618239|P4|NOT COMPLETED|Maintenance||40
8364493|NCT01190930|20618240|P3|NOT COMPLETED|Maintenance||0
8364494|NCT01190930|20618241|P2|NOT COMPLETED|Maintenance||10
8364495|NCT01190930|20618242|P1|NOT COMPLETED|Maintenance||0
8364496|NCT01190930|20618233|P10|COMPLETED|Maintenance||555
8364497|NCT01190930|20618234|P9|COMPLETED|Maintenance||540
8364498|NCT01190930|20618235|P8|COMPLETED|Maintenance||540
8364499|NCT01190930|20618236|P7|COMPLETED|Maintenance||574
8364500|NCT01190930|20618237|P6|COMPLETED|Maintenance||284
8364501|NCT01190930|20618238|P5|COMPLETED|Maintenance||287
8364502|NCT01190930|20618239|P4|COMPLETED|Maintenance||167
8364503|NCT01190930|20618240|P3|COMPLETED|Maintenance||0
8364504|NCT01190930|20618241|P2|COMPLETED|Maintenance||27
8364505|NCT01190930|20618242|P1|COMPLETED|Maintenance||0
8364506|NCT01190930|20618233|P10|STARTED|Maintenance||592
8364507|NCT01190930|20618234|P9|STARTED|Maintenance||586
8364508|NCT01190930|20618235|P8|STARTED|Maintenance||586
8364509|NCT01190930|20618236|P7|STARTED|Maintenance||600
8364510|NCT01190930|20618237|P6|STARTED|Maintenance||296
8364511|NCT01190930|20618238|P5|STARTED|Maintenance||296
8364512|NCT01190930|20618239|P4|STARTED|Maintenance||207
8364513|NCT01190930|20618240|P3|STARTED|Maintenance||0
8364514|NCT01190930|20618241|P2|STARTED|Maintenance||37
8364515|NCT01190930|20618242|P1|STARTED|Maintenance||0
8364516|NCT01190930|20618233|P10|NOT COMPLETED|Post Induction Pre-Maintenance||0
8364517|NCT01190930|20618234|P9|NOT COMPLETED|Post Induction Pre-Maintenance||0
8364518|NCT01190930|20618235|P8|NOT COMPLETED|Post Induction Pre-Maintenance||0
8364519|NCT01190930|20618236|P7|NOT COMPLETED|Post Induction Pre-Maintenance||0
8364520|NCT01190930|20618237|P6|NOT COMPLETED|Post Induction Pre-Maintenance||6
8364521|NCT01190930|20618238|P5|NOT COMPLETED|Post Induction Pre-Maintenance||5
8364522|NCT01190930|20618239|P4|NOT COMPLETED|Post Induction Pre-Maintenance||17
8364523|NCT01190930|20618240|P3|NOT COMPLETED|Post Induction Pre-Maintenance||758
8364524|NCT01190930|20618241|P2|NOT COMPLETED|Post Induction Pre-Maintenance||6
8364525|NCT01190930|20618242|P1|NOT COMPLETED|Post Induction Pre-Maintenance||0
8364526|NCT01190930|20618233|P10|COMPLETED|Post Induction Pre-Maintenance||0
8364527|NCT01190930|20618234|P9|COMPLETED|Post Induction Pre-Maintenance||0
8364528|NCT01190930|20618235|P8|COMPLETED|Post Induction Pre-Maintenance||0
8364529|NCT01190930|20618236|P7|COMPLETED|Post Induction Pre-Maintenance||0
8364530|NCT01190930|20618237|P6|COMPLETED|Post Induction Pre-Maintenance||296
8364531|NCT01190930|20618238|P5|COMPLETED|Post Induction Pre-Maintenance||296
8364532|NCT01190930|20618239|P4|COMPLETED|Post Induction Pre-Maintenance||207
8364533|NCT01190930|20618240|P3|COMPLETED|Post Induction Pre-Maintenance||2364
8364534|NCT01190930|20618241|P2|COMPLETED|Post Induction Pre-Maintenance||37
8364535|NCT01190930|20618242|P1|COMPLETED|Post Induction Pre-Maintenance||0
8364536|NCT01190930|20618233|P10|STARTED|Post Induction Pre-Maintenance||0
8364537|NCT01190930|20618234|P9|STARTED|Post Induction Pre-Maintenance||0
8364538|NCT01190930|20618235|P8|STARTED|Post Induction Pre-Maintenance||0
8364539|NCT01190930|20618236|P7|STARTED|Post Induction Pre-Maintenance||0
8364540|NCT01190930|20618237|P6|STARTED|Post Induction Pre-Maintenance||302
8364541|NCT01190930|20618238|P5|STARTED|Post Induction Pre-Maintenance||301
8364542|NCT01190930|20618239|P4|STARTED|Post Induction Pre-Maintenance||224
8364543|NCT01190930|20618240|P3|STARTED|Post Induction Pre-Maintenance||3122
8364544|NCT01190930|20618241|P2|STARTED|Post Induction Pre-Maintenance||43
8364545|NCT01190930|20618242|P1|STARTED|Post Induction Pre-Maintenance||0
8364546|NCT01190930|20618233|P10|NOT COMPLETED|Induction||0
8364547|NCT01190930|20618234|P9|NOT COMPLETED|Induction||0
8364548|NCT01190930|20618235|P8|NOT COMPLETED|Induction||0
8364549|NCT01190930|20618236|P7|NOT COMPLETED|Induction||0
8364550|NCT01190930|20618237|P6|NOT COMPLETED|Induction||0
8364551|NCT01190930|20618238|P5|NOT COMPLETED|Induction||0
8364552|NCT01190930|20618239|P4|NOT COMPLETED|Induction||0
8364553|NCT01190930|20618240|P3|NOT COMPLETED|Induction||0
8364554|NCT01190930|20618241|P2|NOT COMPLETED|Induction||9
8364555|NCT01190930|20618242|P1|NOT COMPLETED|Induction||5349
8364556|NCT01190930|20618233|P10|COMPLETED|Induction||0
8364557|NCT01190930|20618234|P9|COMPLETED|Induction||0
8364558|NCT01190930|20618235|P8|COMPLETED|Induction||0
8364559|NCT01190930|20618236|P7|COMPLETED|Induction||0
8364560|NCT01190930|20618237|P6|COMPLETED|Induction||0
8364561|NCT01190930|20618238|P5|COMPLETED|Induction||0
8364562|NCT01190930|20618239|P4|COMPLETED|Induction||0
8364563|NCT01190930|20618240|P3|COMPLETED|Induction||0
8364564|NCT01190930|20618241|P2|COMPLETED|Induction||43
8364565|NCT01190930|20618242|P1|COMPLETED|Induction||3949
8364566|NCT01190930|20618233|P10|STARTED|Induction||0
8364567|NCT01190930|20618234|P9|STARTED|Induction||0
8364568|NCT01190930|20618235|P8|STARTED|Induction||0
8364569|NCT01190930|20618236|P7|STARTED|Induction||0
8364570|NCT01190930|20618237|P6|STARTED|Induction||0
8364571|NCT01190930|20618238|P5|STARTED|Induction||0
8364572|NCT01190930|20618239|P4|STARTED|Induction||0
8364573|NCT01190930|20618240|P3|STARTED|Induction||0
8364574|NCT01190930|20618241|P2|STARTED|Induction||52
8364575|NCT01190930|20618242|P1|STARTED|Induction||9298
8364576|NCT01190891|20618266|P2|NOT COMPLETED|Overall Study||0
8364577|NCT01190891|20618267|P1|NOT COMPLETED|Overall Study||6
8364578|NCT01190891|20618266|P2|COMPLETED|Overall Study||52
8364579|NCT01190891|20618267|P1|COMPLETED|Overall Study||46
8364580|NCT01190891|20618266|P2|STARTED|Overall Study||52
8364581|NCT01190891|20618267|P1|STARTED|Overall Study||52
8364582|NCT01190878|20618279|P4|NOT COMPLETED|Overall Study||20
8364583|NCT01190878|20618280|P3|NOT COMPLETED|Overall Study||5
8364584|NCT01190878|20618281|P2|NOT COMPLETED|Overall Study||3
8364585|NCT01190878|20618282|P1|NOT COMPLETED|Overall Study||3
8364586|NCT01190878|20618279|P4|COMPLETED|Overall Study||22
8364587|NCT01190878|20618280|P3|COMPLETED|Overall Study||37
8364588|NCT01190878|20618281|P2|COMPLETED|Overall Study||42
8364589|NCT01190878|20618282|P1|COMPLETED|Overall Study||37
8364590|NCT01190878|20618279|P4|STARTED|Overall Study||42
8364591|NCT01190878|20618280|P3|STARTED|Overall Study||42
8364592|NCT01190878|20618281|P2|STARTED|Overall Study||45
8364593|NCT01190878|20618282|P1|STARTED|Overall Study||40
8364594|NCT01190865|20618292|P1|NOT COMPLETED|Overall Study||3
8364595|NCT01190865|20618292|P1|COMPLETED|Overall Study||25
8364596|NCT01190865|20618292|P1|STARTED|Overall Study||28
8364597|NCT01190839|20618299|P2|NOT COMPLETED|Overall Study||147
8364598|NCT01190839|20618300|P1|NOT COMPLETED|Overall Study||150
8364599|NCT01190839|20618299|P2|COMPLETED|Overall Study||0
8364600|NCT01190839|20618300|P1|COMPLETED|Overall Study||0
8364601|NCT01190839|20618299|P2|Treated|Overall Study||143
8364602|NCT01190839|20618300|P1|Treated|Overall Study||148
8364603|NCT01190839|20618299|P2|STARTED|Overall Study||147
8364604|NCT01190839|20618300|P1|STARTED|Overall Study||150
8364605|NCT01190813|20618314|P2|NOT COMPLETED|Overall Study||4
8364606|NCT01190813|20618315|P1|NOT COMPLETED|Overall Study||4
8364607|NCT01190813|20618314|P2|COMPLETED|Overall Study||45
8364608|NCT01190813|20618315|P1|COMPLETED|Overall Study||86
8364609|NCT01190813|20618314|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
8364610|NCT01190813|20618315|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
8364611|NCT01190813|20618314|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
8364612|NCT01190813|20618315|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
8364613|NCT01190813|20618314|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
8364614|NCT01190813|20618315|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
8364615|NCT01190813|20618314|P2|16-week Visit|Overall Study|2 dropped|46
8364616|NCT01190813|20618315|P1|16-week Visit|Overall Study|1 dropped|87
8364617|NCT01190813|20618314|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
8364618|NCT01190813|20618315|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
8364619|NCT01190813|20618314|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
8364620|NCT01190813|20618315|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
8364621|NCT01190813|20618314|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
8364622|NCT01190813|20618315|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
8364623|NCT01190813|20618314|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
8364624|NCT01190813|20618315|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
8364625|NCT01190813|20618314|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
8364626|NCT01190813|20618315|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
8364627|NCT01190813|20618314|P2|STARTED|Overall Study||49
8364628|NCT01190813|20618315|P1|STARTED|Overall Study||90
8364629|NCT01190566|20618407|P2|NOT COMPLETED|Overall Study||0
8364630|NCT01190566|20618408|P1|NOT COMPLETED|Overall Study||0
8364631|NCT01190566|20618407|P2|COMPLETED|Overall Study||42
8364632|NCT01190566|20618408|P1|COMPLETED|Overall Study||6
8364633|NCT01190566|20618407|P2|STARTED|Overall Study||42
8364634|NCT01190566|20618408|P1|STARTED|Overall Study||6
8364635|NCT01190527|20618429|P1|NOT COMPLETED|Overall Study||0
8364636|NCT01190527|20618429|P1|COMPLETED|Overall Study||42
8364637|NCT01190527|20618429|P1|STARTED|Overall Study||42
8364638|NCT01190514|20618436|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364639|NCT01190514|20618437|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364640|NCT01190514|20618438|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364641|NCT01190514|20618439|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364642|NCT01190514|20618436|P4|COMPLETED|Fourth Intervention (Period 4)||10
8364643|NCT01190514|20618437|P3|COMPLETED|Fourth Intervention (Period 4)||10
8364644|NCT01190514|20618438|P2|COMPLETED|Fourth Intervention (Period 4)||10
8364645|NCT01190514|20618439|P1|COMPLETED|Fourth Intervention (Period 4)||9
8364646|NCT01190514|20618436|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
8364647|NCT01190514|20618437|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
8364648|NCT01190514|20618438|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
8364649|NCT01190514|20618439|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
8364650|NCT01190514|20618436|P4|NOT COMPLETED|Third Intervention (Period 3)||0
8364651|NCT01190514|20618437|P3|NOT COMPLETED|Third Intervention (Period 3)||0
8364652|NCT01190514|20618438|P2|NOT COMPLETED|Third Intervention (Period 3)||0
8364653|NCT01190514|20618439|P1|NOT COMPLETED|Third Intervention (Period 3)||1
8364654|NCT01190514|20618436|P4|COMPLETED|Third Intervention (Period 3)||10
8364655|NCT01190514|20618437|P3|COMPLETED|Third Intervention (Period 3)||10
8364656|NCT01190514|20618438|P2|COMPLETED|Third Intervention (Period 3)||10
8364657|NCT01190514|20618439|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
8364658|NCT01190514|20618436|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
8364659|NCT01190514|20618437|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
8364660|NCT01190514|20618438|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
8364661|NCT01190514|20618439|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
8364662|NCT01190514|20618436|P4|NOT COMPLETED|Second Intervention (Period 2)||0
8364663|NCT01190514|20618437|P3|NOT COMPLETED|Second Intervention (Period 2)||0
8364664|NCT01190514|20618438|P2|NOT COMPLETED|Second Intervention (Period 2)||0
8364665|NCT01190514|20618439|P1|NOT COMPLETED|Second Intervention (Period 2)||0
8364666|NCT01190514|20618436|P4|COMPLETED|Second Intervention (Period 2)||10
8364667|NCT01190514|20618437|P3|COMPLETED|Second Intervention (Period 2)||10
8364668|NCT01190514|20618438|P2|COMPLETED|Second Intervention (Period 2)||10
8364669|NCT01190514|20618439|P1|COMPLETED|Second Intervention (Period 2)||10
8364670|NCT01190514|20618436|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
8364671|NCT01190514|20618437|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
8364672|NCT01190514|20618438|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
8364673|NCT01190514|20618439|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
8364674|NCT01190514|20618436|P4|NOT COMPLETED|First Intervention (Period 1)||0
8364675|NCT01190514|20618437|P3|NOT COMPLETED|First Intervention (Period 1)||0
8364676|NCT01190514|20618438|P2|NOT COMPLETED|First Intervention (Period 1)||0
8364677|NCT01190514|20618439|P1|NOT COMPLETED|First Intervention (Period 1)||1
8364678|NCT01190514|20618436|P4|COMPLETED|First Intervention (Period 1)||10
8364679|NCT01190514|20618437|P3|COMPLETED|First Intervention (Period 1)||10
8364680|NCT01190514|20618438|P2|COMPLETED|First Intervention (Period 1)||10
8364681|NCT01190514|20618439|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
8364682|NCT01190514|20618436|P4|STARTED|First Intervention (Period 1)||10
8364683|NCT01190514|20618437|P3|STARTED|First Intervention (Period 1)||10
8364684|NCT01190514|20618438|P2|STARTED|First Intervention (Period 1)||10
8364685|NCT01190514|20618439|P1|STARTED|First Intervention (Period 1)||11
8364686|NCT01190475|20618472|P3|NOT COMPLETED|Overall Study||1
8364687|NCT01190475|20618473|P2|NOT COMPLETED|Overall Study||0
8364688|NCT01190475|20618474|P1|NOT COMPLETED|Overall Study||0
8364689|NCT01190475|20618472|P3|COMPLETED|Overall Study||1
8364690|NCT01190475|20618473|P2|COMPLETED|Overall Study||2
8364691|NCT01190475|20618474|P1|COMPLETED|Overall Study||2
8364692|NCT01190475|20618472|P3|STARTED|Overall Study||2
8364693|NCT01190475|20618473|P2|STARTED|Overall Study||2
8364694|NCT01190475|20618474|P1|STARTED|Overall Study||2
8364695|NCT01190449|20618490|P2|NOT COMPLETED|Overall Study||4
8364696|NCT01190449|20618491|P1|NOT COMPLETED|Overall Study||0
8364697|NCT01190449|20618490|P2|COMPLETED|Overall Study||32
8364698|NCT01190449|20618491|P1|COMPLETED|Overall Study||15
8364699|NCT01190449|20618490|P2|STARTED|Overall Study||36
8364700|NCT01190449|20618491|P1|STARTED|Overall Study||15
8364701|NCT01190436|20618499|P1|NOT COMPLETED|Overall Study||39
8364702|NCT01190436|20618499|P1|COMPLETED|Overall Study||86
8364703|NCT01190436|20618499|P1|STARTED|Overall Study||125
8364704|NCT01190410|20618515|P2|NOT COMPLETED|Overall Study||9
8364705|NCT01190410|20618516|P1|NOT COMPLETED|Overall Study||1
8364706|NCT01190410|20618515|P2|COMPLETED|Overall Study||3
8364707|NCT01190410|20618516|P1|COMPLETED|Overall Study||3
8364708|NCT01190410|20618515|P2|Re-Induction|Overall Study||2
8364709|NCT01190410|20618516|P1|Re-Induction|Overall Study||0
8364710|NCT01190410|20618515|P2|STARTED|Overall Study||12
8364711|NCT01190410|20618516|P1|STARTED|Overall Study||4
8364712|NCT01190306|20618535|P2|NOT COMPLETED|Overall Study||0
8364713|NCT01190306|20618536|P1|NOT COMPLETED|Overall Study||0
8364714|NCT01190306|20618535|P2|COMPLETED|Overall Study||66
8364715|NCT01190306|20618536|P1|COMPLETED|Overall Study||61
8364716|NCT01190306|20618535|P2|STARTED|Overall Study||66
8364717|NCT01190306|20618536|P1|STARTED|Overall Study||61
8364724|NCT01190254|20618556|P3|NOT COMPLETED|Overall Study||22
8364725|NCT01190254|20618557|P2|NOT COMPLETED|Overall Study||17
8364726|NCT01190254|20618558|P1|NOT COMPLETED|Overall Study||21
8364727|NCT01190254|20618556|P3|COMPLETED|Overall Study||84
8364728|NCT01190254|20618557|P2|COMPLETED|Overall Study||81
8364729|NCT01190254|20618558|P1|COMPLETED|Overall Study||81
8364730|NCT01190254|20618556|P3|Treated|Overall Study||106
8364731|NCT01190254|20618557|P2|Treated|Overall Study||98
8364732|NCT01190254|20618558|P1|Treated|Overall Study||102
8364733|NCT01190254|20618556|P3|STARTED|Overall Study||106
8364734|NCT01190254|20618557|P2|STARTED|Overall Study||98
8364735|NCT01190254|20618558|P1|STARTED|Overall Study||102
8364736|NCT01190228|20618623|P3|NOT COMPLETED|Overall Study||0
8364737|NCT01190228|20618624|P2|NOT COMPLETED|Overall Study||0
8364738|NCT01190228|20618625|P1|NOT COMPLETED|Overall Study||5
8364739|NCT01190228|20618623|P3|COMPLETED|Overall Study||59
8364740|NCT01190228|20618624|P2|COMPLETED|Overall Study||46
8364741|NCT01190228|20618625|P1|COMPLETED|Overall Study||344
8364742|NCT01190228|20618623|P3|STARTED|Overall Study||59
8364743|NCT01190228|20618624|P2|STARTED|Overall Study||46
8364744|NCT01190228|20618625|P1|STARTED|Overall Study||349
8364745|NCT01190215|20618648|P2|NOT COMPLETED|Up to Month 6||0
8364746|NCT01190215|20618649|P1|NOT COMPLETED|Up to Month 6||2
8364747|NCT01190215|20618648|P2|COMPLETED|Up to Month 6||39
8364748|NCT01190215|20618649|P1|COMPLETED|Up to Month 6||36
8364749|NCT01190215|20618648|P2|STARTED|Up to Month 6||39
8364750|NCT01190215|20618649|P1|STARTED|Up to Month 6||38
8364751|NCT01190215|20618648|P2|NOT COMPLETED|Up to Day 28||0
8364752|NCT01190215|20618649|P1|NOT COMPLETED|Up to Day 28||0
8364753|NCT01190215|20618648|P2|COMPLETED|Up to Day 28||39
8364754|NCT01190215|20618649|P1|COMPLETED|Up to Day 28||38
8364755|NCT01190215|20618648|P2|STARTED|Up to Day 28||39
8364756|NCT01190215|20618649|P1|STARTED|Up to Day 28||38
8364757|NCT01190202|20618721|P4|NOT COMPLETED|Overall Study||0
8364758|NCT01190202|20618722|P3|NOT COMPLETED|Overall Study||0
8364759|NCT01190202|20618723|P2|NOT COMPLETED|Overall Study||0
8364760|NCT01190202|20618724|P1|NOT COMPLETED|Overall Study||0
8364761|NCT01190202|20618721|P4|COMPLETED|Overall Study||2400
8364762|NCT01190202|20618722|P3|COMPLETED|Overall Study||6400
8364763|NCT01190202|20618723|P2|COMPLETED|Overall Study||6414
8364764|NCT01190202|20618724|P1|COMPLETED|Overall Study||6404
8364765|NCT01190202|20618721|P4|STARTED|Overall Study||2400
8364766|NCT01190202|20618722|P3|STARTED|Overall Study||6400
8364767|NCT01190202|20618723|P2|STARTED|Overall Study||6414
8364768|NCT01190202|20618724|P1|STARTED|Overall Study||6404
8364769|NCT01190189|20618982|P1|NOT COMPLETED|Overall Study||6
8364770|NCT01190189|20618982|P1|COMPLETED|Overall Study||131
8364771|NCT01190189|20618982|P1|STARTED|Overall Study||137
8364772|NCT01190176|20618989|P1|NOT COMPLETED|Overall Study||2
8364773|NCT01190176|20618989|P1|COMPLETED|Overall Study||30
8364774|NCT01190176|20618989|P1|STARTED|Overall Study||32
8364775|NCT01190150|20619010|P2|NOT COMPLETED|Second Treatment||0
8364776|NCT01190150|20619011|P1|NOT COMPLETED|Second Treatment||0
8364777|NCT01190150|20619010|P2|COMPLETED|Second Treatment||7
8364778|NCT01190150|20619011|P1|COMPLETED|Second Treatment||10
8364779|NCT01190150|20619010|P2|STARTED|Second Treatment||7
8364780|NCT01190150|20619011|P1|STARTED|Second Treatment||10
8364781|NCT01190150|20619010|P2|NOT COMPLETED|Washout||2
8364782|NCT01190150|20619011|P1|NOT COMPLETED|Washout||0
8364783|NCT01190150|20619010|P2|COMPLETED|Washout||7
8364784|NCT01190150|20619011|P1|COMPLETED|Washout||10
8364785|NCT01190150|20619010|P2|STARTED|Washout||9
8364786|NCT01190150|20619011|P1|STARTED|Washout||10
8364787|NCT01190150|20619010|P2|NOT COMPLETED|First Treatment||0
8364788|NCT01190150|20619011|P1|NOT COMPLETED|First Treatment||1
8364789|NCT01190150|20619010|P2|COMPLETED|First Treatment||9
8364790|NCT01190150|20619011|P1|COMPLETED|First Treatment||10
8364791|NCT01190150|20619010|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
8364792|NCT01190150|20619011|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
8364793|NCT01190124|20619038|P3|NOT COMPLETED|Overall Study||1
8364794|NCT01190124|20619039|P2|NOT COMPLETED|Overall Study||0
8364795|NCT01190124|20619040|P1|NOT COMPLETED|Overall Study||17
8364796|NCT01190124|20619038|P3|COMPLETED|Overall Study||19
8364797|NCT01190124|20619039|P2|COMPLETED|Overall Study||24
8364798|NCT01190124|20619040|P1|COMPLETED|Overall Study||90
8364799|NCT01190124|20619038|P3|STARTED|Overall Study||20
8364800|NCT01190124|20619039|P2|STARTED|Overall Study||24
8364801|NCT01190124|20619040|P1|STARTED|Overall Study||107
8364802|NCT01190098|20619078|P2|NOT COMPLETED|Overall Study||2
8364803|NCT01190098|20619079|P1|NOT COMPLETED|Overall Study||3
8364804|NCT01190098|20619078|P2|COMPLETED|Overall Study||8
8364805|NCT01190098|20619079|P1|COMPLETED|Overall Study||39
8364806|NCT01190098|20619078|P2|STARTED|Overall Study||10
8364807|NCT01190098|20619079|P1|STARTED|Overall Study||42
8364808|NCT01190085|20619102|P3|NOT COMPLETED|Overall Study||0
8364809|NCT01190085|20619103|P2|NOT COMPLETED|Overall Study||0
8364810|NCT01190085|20619104|P1|NOT COMPLETED|Overall Study||0
8364811|NCT01190085|20619102|P3|COMPLETED|Overall Study||18
8364812|NCT01190085|20619103|P2|COMPLETED|Overall Study||14
8364813|NCT01190085|20619104|P1|COMPLETED|Overall Study||13
8364814|NCT01190085|20619102|P3|STARTED|Overall Study||18
8364815|NCT01190085|20619103|P2|STARTED|Overall Study||14
8364816|NCT01190085|20619104|P1|STARTED|Overall Study||13
8364817|NCT01190020|20619120|P2|NOT COMPLETED|Overall Study||0
8364818|NCT01190020|20619121|P1|NOT COMPLETED|Overall Study||7
8364819|NCT01190020|20619120|P2|COMPLETED|Overall Study||12
8364820|NCT01190020|20619121|P1|COMPLETED|Overall Study||22
8364821|NCT01190020|20619120|P2|STARTED|Overall Study||12
8364822|NCT01190020|20619121|P1|STARTED|Overall Study||29
8364823|NCT01189890|20619135|P2|NOT COMPLETED|Overall Study||39
8364824|NCT01189890|20619136|P1|NOT COMPLETED|Overall Study||37
8364825|NCT01189890|20619135|P2|COMPLETED|Overall Study||200
8364826|NCT01189890|20619136|P1|COMPLETED|Overall Study||204
8364827|NCT01189890|20619135|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
8364828|NCT01189890|20619136|P1|STARTED|Overall Study||241
8364829|NCT01189812|20619158|P2|NOT COMPLETED|Overall Study||8
8364830|NCT01189812|20619159|P1|NOT COMPLETED|Overall Study||8
8364831|NCT01189812|20619158|P2|COMPLETED|Overall Study||32
8364832|NCT01189812|20619159|P1|COMPLETED|Overall Study||32
8364833|NCT01189812|20619158|P2|STARTED|Overall Study||40
8364834|NCT01189812|20619159|P1|STARTED|Overall Study||40
8364835|NCT01189760|20619168|P3|NOT COMPLETED|Overall Study||51
8364836|NCT01189760|20619169|P2|NOT COMPLETED|Overall Study||23
8364837|NCT01189760|20619170|P1|NOT COMPLETED|Overall Study||14
8364838|NCT01189760|20619168|P3|COMPLETED|Overall Study||255
8364839|NCT01189760|20619169|P2|COMPLETED|Overall Study||283
8364840|NCT01189760|20619170|P1|COMPLETED|Overall Study||291
8364841|NCT01189760|20619168|P3|STARTED|Overall Study||306
8364842|NCT01189760|20619169|P2|STARTED|Overall Study||306
8364843|NCT01189760|20619170|P1|STARTED|Overall Study||305
8364844|NCT01189747|20619204|P2|NOT COMPLETED|Overall Study||18
8364845|NCT01189747|20619205|P1|NOT COMPLETED|Overall Study||12
8364846|NCT01189747|20619204|P2|COMPLETED|Overall Study||206
8364847|NCT01189747|20619205|P1|COMPLETED|Overall Study||210
8364848|NCT01189747|20619204|P2|STARTED|Overall Study||224
8364849|NCT01189747|20619205|P1|STARTED|Overall Study||222
8364850|NCT01189617|20619229|P2|NOT COMPLETED|Overall Study||0
8364851|NCT01189617|20619230|P1|NOT COMPLETED|Overall Study||0
8364852|NCT01189617|20619229|P2|COMPLETED|Overall Study||35
8364853|NCT01189617|20619230|P1|COMPLETED|Overall Study||35
8364854|NCT01189617|20619229|P2|STARTED|Overall Study||35
8364855|NCT01189617|20619230|P1|STARTED|Overall Study||35
8364856|NCT01189604|20619243|P7|NOT COMPLETED|Overall Study||1
8364857|NCT01189604|20619244|P6|NOT COMPLETED|Overall Study||1
8364858|NCT01189604|20619245|P5|NOT COMPLETED|Overall Study||2
8364859|NCT01189604|20619246|P4|NOT COMPLETED|Overall Study||0
8364860|NCT01189604|20619247|P3|NOT COMPLETED|Overall Study||0
8364861|NCT01189604|20619248|P2|NOT COMPLETED|Overall Study||1
8364862|NCT01189604|20619249|P1|NOT COMPLETED|Overall Study||1
8364863|NCT01189604|20619243|P7|COMPLETED|Overall Study||9
8364864|NCT01189604|20619244|P6|COMPLETED|Overall Study||10
8364865|NCT01189604|20619245|P5|COMPLETED|Overall Study||18
8364866|NCT01189604|20619246|P4|COMPLETED|Overall Study||20
8364867|NCT01189604|20619247|P3|COMPLETED|Overall Study||20
8364868|NCT01189604|20619248|P2|COMPLETED|Overall Study||20
8364869|NCT01189604|20619249|P1|COMPLETED|Overall Study||20
8364870|NCT01189604|20619243|P7|Administered Study Drug|Overall Study||10
8364871|NCT01189604|20619244|P6|Administered Study Drug|Overall Study||10
8364872|NCT01189604|20619245|P5|Administered Study Drug|Overall Study||20
8364873|NCT01189604|20619246|P4|Administered Study Drug|Overall Study||20
8364874|NCT01189604|20619247|P3|Administered Study Drug|Overall Study||20
8364875|NCT01189604|20619248|P2|Administered Study Drug|Overall Study||20
8364876|NCT01189604|20619249|P1|Administered Study Drug|Overall Study||20
8364877|NCT01189604|20619243|P7|STARTED|Overall Study||10
8364878|NCT01189604|20619244|P6|STARTED|Overall Study||11
8364879|NCT01189604|20619245|P5|STARTED|Overall Study||20
8364880|NCT01189604|20619246|P4|STARTED|Overall Study||20
8364881|NCT01189604|20619247|P3|STARTED|Overall Study||20
8364882|NCT01189604|20619248|P2|STARTED|Overall Study||21
8364883|NCT01189604|20619249|P1|STARTED|Overall Study||21
8364884|NCT01189500|20619293|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
8364885|NCT01189500|20619293|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
8364886|NCT01189500|20619293|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
8364887|NCT01189500|20619293|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
8364888|NCT01189500|20619293|P1|COMPLETED|Period 1: TAMOX Alone||29
8364889|NCT01189500|20619293|P1|STARTED|Period 1: TAMOX Alone||30
8364890|NCT01189487|20619354|P1|NOT COMPLETED|Overall Study||3
8364891|NCT01189487|20619354|P1|COMPLETED|Overall Study||44
8364892|NCT01189487|20619354|P1|STARTED|Overall Study|Treated participants|47
8364893|NCT01189461|20619362|P1|NOT COMPLETED|Overall Study||34
8364894|NCT01189461|20619362|P1|COMPLETED|Overall Study||12
8364895|NCT01189461|20619362|P1|STARTED|Overall Study||46
8364896|NCT01189435|20619369|P1|NOT COMPLETED|Overall Study||2
8364897|NCT01189435|20619369|P1|COMPLETED|Overall Study||0
8364898|NCT01189435|20619369|P1|STARTED|Overall Study||2
8364899|NCT01189409|20619375|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
8364900|NCT01189409|20619376|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
8364901|NCT01189409|20619375|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
8364902|NCT01189409|20619376|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
8364903|NCT01189409|20619375|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
8364904|NCT01189409|20619376|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
8364905|NCT01189409|20619375|P2|NOT COMPLETED|First 3 Weeks||10
8364906|NCT01189409|20619376|P1|NOT COMPLETED|First 3 Weeks||18
8364907|NCT01189409|20619375|P2|COMPLETED|First 3 Weeks||23
8364908|NCT01189409|20619376|P1|COMPLETED|First 3 Weeks||19
8364909|NCT01189409|20619375|P2|STARTED|First 3 Weeks||33
8364910|NCT01189409|20619376|P1|STARTED|First 3 Weeks||37
8364911|NCT01189370|20619391|P3|NOT COMPLETED|Dose Level 3||6
8364912|NCT01189370|20619392|P2|NOT COMPLETED|Dose Level 3||0
8364913|NCT01189370|20619393|P1|NOT COMPLETED|Dose Level 3||0
8364914|NCT01189370|20619391|P3|COMPLETED|Dose Level 3||6
8364915|NCT01189370|20619392|P2|COMPLETED|Dose Level 3||0
8364916|NCT01189370|20619393|P1|COMPLETED|Dose Level 3||0
8364917|NCT01189370|20619391|P3|STARTED|Dose Level 3||12
8364918|NCT01189370|20619392|P2|STARTED|Dose Level 3||0
8364919|NCT01189370|20619393|P1|STARTED|Dose Level 3||0
8364920|NCT01189370|20619391|P3|NOT COMPLETED|Dose Level 2||0
8364921|NCT01189370|20619392|P2|NOT COMPLETED|Dose Level 2||4
8364922|NCT01189370|20619393|P1|NOT COMPLETED|Dose Level 2||0
8364923|NCT01189370|20619391|P3|COMPLETED|Dose Level 2||0
8364924|NCT01189370|20619392|P2|COMPLETED|Dose Level 2||12
8364925|NCT01189370|20619393|P1|COMPLETED|Dose Level 2||0
8364926|NCT01189370|20619391|P3|STARTED|Dose Level 2||0
8364927|NCT01189370|20619392|P2|STARTED|Dose Level 2||16
8364928|NCT01189370|20619393|P1|STARTED|Dose Level 2||0
8364929|NCT01189370|20619391|P3|NOT COMPLETED|Dose Level 1||0
8364930|NCT01189370|20619392|P2|NOT COMPLETED|Dose Level 1||0
8364931|NCT01189370|20619393|P1|NOT COMPLETED|Dose Level 1||9
8364932|NCT01189370|20619391|P3|COMPLETED|Dose Level 1||0
8364933|NCT01189370|20619392|P2|COMPLETED|Dose Level 1||0
8364934|NCT01189370|20619393|P1|COMPLETED|Dose Level 1||16
8364935|NCT01189370|20619391|P3|STARTED|Dose Level 1||0
8364936|NCT01189370|20619392|P2|STARTED|Dose Level 1||0
8364937|NCT01189370|20619393|P1|STARTED|Dose Level 1||25
8364938|NCT01189292|20619402|P2|NOT COMPLETED|Per Protocol Analysis||16
8364939|NCT01189292|20619403|P1|NOT COMPLETED|Per Protocol Analysis||11
8364940|NCT01189292|20619402|P2|COMPLETED|Per Protocol Analysis||60
8364941|NCT01189292|20619403|P1|COMPLETED|Per Protocol Analysis||65
8364942|NCT01189292|20619402|P2|STARTED|Per Protocol Analysis||76
8364943|NCT01189292|20619403|P1|STARTED|Per Protocol Analysis||76
8364944|NCT01189292|20619402|P2|NOT COMPLETED|Intention to Treat Analysis||0
8364945|NCT01189292|20619403|P1|NOT COMPLETED|Intention to Treat Analysis||0
8364946|NCT01189292|20619402|P2|COMPLETED|Intention to Treat Analysis||76
8364947|NCT01189292|20619403|P1|COMPLETED|Intention to Treat Analysis||76
8364948|NCT01189292|20619402|P2|STARTED|Intention to Treat Analysis||76
8364949|NCT01189292|20619403|P1|STARTED|Intention to Treat Analysis||76
8364950|NCT01189279|20619424|P3|NOT COMPLETED|Overall Study||1
8364951|NCT01189279|20619425|P2|NOT COMPLETED|Overall Study||0
8364952|NCT01189279|20619426|P1|NOT COMPLETED|Overall Study||1
8364953|NCT01189279|20619424|P3|COMPLETED|Overall Study||13
8364954|NCT01189279|20619425|P2|COMPLETED|Overall Study||14
8364955|NCT01189279|20619426|P1|COMPLETED|Overall Study||13
8364956|NCT01189279|20619424|P3|STARTED|Overall Study||14
8364957|NCT01189279|20619425|P2|STARTED|Overall Study||14
8364958|NCT01189279|20619426|P1|STARTED|Overall Study||14
8364959|NCT01189266|20619449|P3|NOT COMPLETED|Overall Study||65
8364960|NCT01189266|20619450|P2|NOT COMPLETED|Overall Study||6
8364961|NCT01189266|20619451|P1|NOT COMPLETED|Overall Study||6
8364962|NCT01189266|20619449|P3|COMPLETED|Overall Study||2
8364963|NCT01189266|20619450|P2|COMPLETED|Overall Study||0
8364964|NCT01189266|20619451|P1|COMPLETED|Overall Study||0
8364965|NCT01189266|20619449|P3|STARTED|Overall Study||67
8364966|NCT01189266|20619450|P2|STARTED|Overall Study||6
8364967|NCT01189266|20619451|P1|STARTED|Overall Study||6
8364968|NCT01189240|20619478|P3|NOT COMPLETED|Overall Study||0
8364969|NCT01189240|20619479|P2|NOT COMPLETED|Overall Study||0
8364970|NCT01189240|20619480|P1|NOT COMPLETED|Overall Study||0
8364971|NCT01189240|20619478|P3|COMPLETED|Overall Study||3
8364972|NCT01189240|20619479|P2|COMPLETED|Overall Study||6
8364973|NCT01189240|20619480|P1|COMPLETED|Overall Study||4
8364974|NCT01189240|20619478|P3|STARTED|Overall Study||3
8364975|NCT01189240|20619479|P2|STARTED|Overall Study||6
8364976|NCT01189240|20619480|P1|STARTED|Overall Study||4
8364977|NCT01189227|20619501|P2|NOT COMPLETED|Overall Study||3
8364978|NCT01189227|20619502|P1|NOT COMPLETED|Overall Study||6
8364979|NCT01189227|20619501|P2|COMPLETED|Overall Study||0
8364980|NCT01189227|20619502|P1|COMPLETED|Overall Study||0
8364981|NCT01189227|20619501|P2|STARTED|Overall Study||3
8364982|NCT01189227|20619502|P1|STARTED|Overall Study||6
8364983|NCT01189201|20619508|P1|NOT COMPLETED|Overall Study||1
8364984|NCT01189201|20619508|P1|COMPLETED|Overall Study||41
8364985|NCT01189201|20619508|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
8364986|NCT01189201|20619508|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
8364987|NCT01189201|20619508|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
8364988|NCT01189201|20619508|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
8364989|NCT01189201|20619508|P1|STARTED|Overall Study||42
8364990|NCT01189136|20619564|P2|NOT COMPLETED|Overall Study||0
8364991|NCT01189136|20619565|P1|NOT COMPLETED|Overall Study||0
8364992|NCT01189136|20619564|P2|COMPLETED|Overall Study||42
8364993|NCT01189136|20619565|P1|COMPLETED|Overall Study||42
8364994|NCT01189136|20619564|P2|STARTED|Overall Study||42
8364995|NCT01189136|20619565|P1|STARTED|Overall Study||42
8364996|NCT01189123|20619579|P2|NOT COMPLETED|Overall Study||6
8364997|NCT01189123|20619580|P1|NOT COMPLETED|Overall Study||2
8364998|NCT01189123|20619579|P2|COMPLETED|Overall Study||47
8364999|NCT01189123|20619580|P1|COMPLETED|Overall Study||50
8365000|NCT01189123|20619579|P2|STARTED|Overall Study||53
8365001|NCT01189123|20619580|P1|STARTED|Overall Study||52
8365002|NCT01189110|20619590|P2|NOT COMPLETED|Overall Study||0
8365003|NCT01189110|20619591|P1|NOT COMPLETED|Overall Study||0
8365004|NCT01189110|20619590|P2|COMPLETED|Overall Study||61
8365005|NCT01189110|20619591|P1|COMPLETED|Overall Study|February, 2011|64
8365006|NCT01189110|20619590|P2|STARTED|Overall Study||61
8365007|NCT01189110|20619591|P1|STARTED|Overall Study|September, 2010|64
8365008|NCT01189071|20619599|P2|NOT COMPLETED|Overall Study||0
8365009|NCT01189071|20619600|P1|NOT COMPLETED|Overall Study||0
8365010|NCT01189071|20619599|P2|COMPLETED|Overall Study||0
8365011|NCT01189071|20619600|P1|COMPLETED|Overall Study||0
8365012|NCT01189071|20619599|P2|STARTED|Overall Study||0
8365013|NCT01189071|20619600|P1|STARTED|Overall Study||0
8365014|NCT01189032|20619611|P3|NOT COMPLETED|Overall Study||6
8365015|NCT01189032|20619612|P2|NOT COMPLETED|Overall Study||7
8365016|NCT01189032|20619613|P1|NOT COMPLETED|Overall Study||5
8365017|NCT01189032|20619611|P3|COMPLETED|Overall Study||90
8365018|NCT01189032|20619612|P2|COMPLETED|Overall Study||89
8365019|NCT01189032|20619613|P1|COMPLETED|Overall Study||89
8365020|NCT01189032|20619611|P3|STARTED|Overall Study||96
8365021|NCT01189032|20619612|P2|STARTED|Overall Study||96
8365022|NCT01189032|20619613|P1|STARTED|Overall Study||94
8365023|NCT01188967|20619623|P2|NOT COMPLETED|Overall Study||4
8365024|NCT01188967|20619624|P1|NOT COMPLETED|Overall Study||5
8365025|NCT01188967|20619623|P2|COMPLETED|Overall Study||4
8365026|NCT01188967|20619624|P1|COMPLETED|Overall Study||5
8365027|NCT01188967|20619623|P2|STARTED|Overall Study||8
8365028|NCT01188967|20619624|P1|STARTED|Overall Study||10
8365029|NCT01188928|20619640|P4|NOT COMPLETED|Overall Study||18
8365030|NCT01188928|20619641|P3|NOT COMPLETED|Overall Study||14
8365031|NCT01188928|20619642|P2|NOT COMPLETED|Overall Study||62
8365032|NCT01188928|20619643|P1|NOT COMPLETED|Overall Study||38
8365033|NCT01188928|20619640|P4|COMPLETED|Overall Study||77
8365034|NCT01188928|20619641|P3|COMPLETED|Overall Study||82
8365035|NCT01188928|20619642|P2|COMPLETED|Overall Study||417
8365036|NCT01188928|20619643|P1|COMPLETED|Overall Study||444
8365037|NCT01188928|20619640|P4|STARTED|Overall Study||95
8365038|NCT01188928|20619641|P3|STARTED|Overall Study||96
8365039|NCT01188928|20619642|P2|STARTED|Overall Study||479
8365040|NCT01188928|20619643|P1|STARTED|Overall Study||482
8365041|NCT01188876|20619665|P1|NOT COMPLETED|Overall Study||0
8365042|NCT01188876|20619665|P1|COMPLETED|Overall Study||50
8365043|NCT01188876|20619665|P1|STARTED|Overall Study||50
8365044|NCT01188811|20619677|P2|NOT COMPLETED|Overall Study||2
8365045|NCT01188811|20619678|P1|NOT COMPLETED|Overall Study||6
8365046|NCT01188811|20619677|P2|COMPLETED|Overall Study||24
8365047|NCT01188811|20619678|P1|COMPLETED|Overall Study||22
8365048|NCT01188811|20619677|P2|STARTED|Overall Study||26
8365049|NCT01188811|20619678|P1|STARTED|Overall Study||28
8365050|NCT01188798|20619690|P2|NOT COMPLETED|Overall Study||3
8365051|NCT01188798|20619691|P1|NOT COMPLETED|Overall Study||2
8365052|NCT01188798|20619690|P2|COMPLETED|Overall Study||1
8365053|NCT01188798|20619691|P1|COMPLETED|Overall Study||0
8365054|NCT01188798|20619690|P2|STARTED|Overall Study||4
8365055|NCT01188798|20619691|P1|STARTED|Overall Study||2
8365056|NCT01188772|20619703|P4|NOT COMPLETED|Overall Study||1
8365057|NCT01188772|20619704|P3|NOT COMPLETED|Overall Study||11
8365058|NCT01188772|20619705|P2|NOT COMPLETED|Overall Study||3
8365059|NCT01188772|20619706|P1|NOT COMPLETED|Overall Study||5
8365060|NCT01188772|20619703|P4|COMPLETED|Overall Study||24
8365061|NCT01188772|20619704|P3|COMPLETED|Overall Study||15
8365062|NCT01188772|20619705|P2|COMPLETED|Overall Study||45
8365063|NCT01188772|20619706|P1|COMPLETED|Overall Study||43
8365064|NCT01188772|20619703|P4|Randomized and Treated|Overall Study||25
8365065|NCT01188772|20619704|P3|Randomized and Treated|Overall Study||26
8365066|NCT01188772|20619705|P2|Randomized and Treated|Overall Study||47
8365067|NCT01188772|20619706|P1|Randomized and Treated|Overall Study||48
8365068|NCT01188772|20619703|P4|STARTED|Overall Study||25
8365069|NCT01188772|20619704|P3|STARTED|Overall Study||26
8365070|NCT01188772|20619705|P2|STARTED|Overall Study||48
8365071|NCT01188772|20619706|P1|STARTED|Overall Study||48
8365072|NCT01188694|20619764|P3|NOT COMPLETED|Overall Study||1
8365073|NCT01188694|20619765|P2|NOT COMPLETED|Overall Study||1
8365074|NCT01188694|20619766|P1|NOT COMPLETED|Overall Study||5
8365075|NCT01188694|20619764|P3|COMPLETED|Overall Study||10
8365076|NCT01188694|20619765|P2|COMPLETED|Overall Study||15
8365077|NCT01188694|20619766|P1|COMPLETED|Overall Study||10
8365078|NCT01188694|20619764|P3|STARTED|Overall Study||11
8365079|NCT01188694|20619765|P2|STARTED|Overall Study||16
8365080|NCT01188694|20619766|P1|STARTED|Overall Study||15
8365081|NCT01188681|20619778|P4|NOT COMPLETED|Overall Study||1
8365082|NCT01188681|20619779|P3|NOT COMPLETED|Overall Study||1
8365083|NCT01188681|20619780|P2|NOT COMPLETED|Overall Study||0
8365084|NCT01188681|20619781|P1|NOT COMPLETED|Overall Study||0
8365085|NCT01188681|20619778|P4|COMPLETED|Overall Study||33
8365086|NCT01188681|20619779|P3|COMPLETED|Overall Study||32
8365087|NCT01188681|20619780|P2|COMPLETED|Overall Study||6
8365088|NCT01188681|20619781|P1|COMPLETED|Overall Study||6
8365089|NCT01188681|20619778|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
8365090|NCT01188681|20619779|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
8365091|NCT01188681|20619780|P2|STARTED|Overall Study||6
8365092|NCT01188681|20619781|P1|STARTED|Overall Study||6
8365093|NCT01188668|20619795|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
8365094|NCT01188668|20619795|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
8365095|NCT01188668|20619795|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
8365096|NCT01188668|20619795|P1|NOT COMPLETED|Period 1: ARIP Alone||2
8365097|NCT01188668|20619795|P1|COMPLETED|Period 1: ARIP Alone||36
8365098|NCT01188668|20619795|P1|STARTED|Period 1: ARIP Alone||38
8365099|NCT01188655|20619828|P1|NOT COMPLETED|Overall Study||13
8365100|NCT01188655|20619828|P1|COMPLETED|Overall Study||76
8365101|NCT01188655|20619828|P1|STARTED|Overall Study||89
8365102|NCT01188603|20619843|P1|NOT COMPLETED|Overall Study||0
8365103|NCT01188603|20619843|P1|COMPLETED|Overall Study||24
8365104|NCT01188603|20619843|P1|STARTED|Overall Study||24
8365105|NCT01188577|20619853|P2|NOT COMPLETED|Visit 2||0
8365106|NCT01188577|20619854|P1|NOT COMPLETED|Visit 2||0
8365107|NCT01188577|20619853|P2|COMPLETED|Visit 2||12
8365108|NCT01188577|20619854|P1|COMPLETED|Visit 2||11
8365109|NCT01188577|20619853|P2|STARTED|Visit 2||12
8365110|NCT01188577|20619854|P1|STARTED|Visit 2||11
8365111|NCT01188577|20619853|P2|NOT COMPLETED|3-14 Day Washout||0
8365112|NCT01188577|20619854|P1|NOT COMPLETED|3-14 Day Washout||0
8365113|NCT01188577|20619853|P2|COMPLETED|3-14 Day Washout||12
8365114|NCT01188577|20619854|P1|COMPLETED|3-14 Day Washout||11
8365115|NCT01188577|20619853|P2|STARTED|3-14 Day Washout||12
8365116|NCT01188577|20619854|P1|STARTED|3-14 Day Washout||11
8365117|NCT01188577|20619853|P2|NOT COMPLETED|Visit 1||0
8365118|NCT01188577|20619854|P1|NOT COMPLETED|Visit 1||0
8365119|NCT01188577|20619853|P2|COMPLETED|Visit 1||12
8365120|NCT01188577|20619854|P1|COMPLETED|Visit 1||11
8365121|NCT01188577|20619853|P2|STARTED|Visit 1||12
8365122|NCT01188577|20619854|P1|STARTED|Visit 1||11
8365123|NCT01188564|20619872|P2|NOT COMPLETED|Open Label Phase||0
8365124|NCT01188564|20619873|P1|NOT COMPLETED|Open Label Phase||0
8365125|NCT01188564|20619872|P2|COMPLETED|Open Label Phase||20
8365126|NCT01188564|20619873|P1|COMPLETED|Open Label Phase||24
8365127|NCT01188564|20619872|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
8365128|NCT01188564|20619873|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
8365129|NCT01188564|20619872|P2|NOT COMPLETED|Double-blind Phase||0
8365130|NCT01188564|20619873|P1|NOT COMPLETED|Double-blind Phase||1
8365131|NCT01188564|20619872|P2|COMPLETED|Double-blind Phase||31
8365132|NCT01188564|20619873|P1|COMPLETED|Double-blind Phase||43
8365133|NCT01188564|20619872|P2|STARTED|Double-blind Phase||31
8365134|NCT01188564|20619873|P1|STARTED|Double-blind Phase||44
8365135|NCT01188551|20619885|P4|NOT COMPLETED|Overall Study||0
8365136|NCT01188551|20619886|P3|NOT COMPLETED|Overall Study||0
8365137|NCT01188551|20619887|P2|NOT COMPLETED|Overall Study||0
8365138|NCT01188551|20619888|P1|NOT COMPLETED|Overall Study||1
8365139|NCT01188551|20619885|P4|COMPLETED|Overall Study||25
8365140|NCT01188551|20619886|P3|COMPLETED|Overall Study||25
8365141|NCT01188551|20619887|P2|COMPLETED|Overall Study||25
8365142|NCT01188551|20619888|P1|COMPLETED|Overall Study||24
8365143|NCT01188551|20619885|P4|STARTED|Overall Study||25
8365144|NCT01188551|20619886|P3|STARTED|Overall Study||25
8365145|NCT01188551|20619887|P2|STARTED|Overall Study||25
8365146|NCT01188551|20619888|P1|STARTED|Overall Study||25
8365153|NCT01188499|20619918|P5|NOT COMPLETED|Overall Study||0
8365154|NCT01188499|20619919|P4|NOT COMPLETED|Overall Study||0
8365155|NCT01188499|20619920|P3|NOT COMPLETED|Overall Study||0
8365156|NCT01188499|20619921|P2|NOT COMPLETED|Overall Study||0
8365157|NCT01188499|20619922|P1|NOT COMPLETED|Overall Study||0
8365158|NCT01188499|20619918|P5|COMPLETED|Overall Study||18
8365159|NCT01188499|20619919|P4|COMPLETED|Overall Study||18
8365160|NCT01188499|20619920|P3|COMPLETED|Overall Study||33
8365161|NCT01188499|20619921|P2|COMPLETED|Overall Study||83
8365162|NCT01188499|20619922|P1|COMPLETED|Overall Study||24
8365163|NCT01188499|20619918|P5|STARTED|Overall Study||18
8365164|NCT01188499|20619919|P4|STARTED|Overall Study||18
8365165|NCT01188499|20619920|P3|STARTED|Overall Study||33
8365166|NCT01188499|20619921|P2|STARTED|Overall Study||83
8365167|NCT01188499|20619922|P1|STARTED|Overall Study||24
8365168|NCT01188460|20619941|P2|NOT COMPLETED|Overall Study||0
8365169|NCT01188460|20619942|P1|NOT COMPLETED|Overall Study||0
8365170|NCT01188460|20619941|P2|COMPLETED|Overall Study||23
8365171|NCT01188460|20619942|P1|COMPLETED|Overall Study||25
8365172|NCT01188460|20619941|P2|STARTED|Overall Study||23
8365173|NCT01188460|20619942|P1|STARTED|Overall Study||25
8365174|NCT01188447|20619968|P1|NOT COMPLETED|Overall Study||0
8365175|NCT01188447|20619968|P1|COMPLETED|Overall Study||4034
8365176|NCT01188447|20619968|P1|STARTED|Overall Study||4034
8365177|NCT01188421|20619979|P3|NOT COMPLETED|Overall Study||14
8365178|NCT01188421|20619980|P2|NOT COMPLETED|Overall Study||10
8365179|NCT01188421|20619981|P1|NOT COMPLETED|Overall Study||3
8365180|NCT01188421|20619979|P3|COMPLETED|Overall Study||22
8365181|NCT01188421|20619980|P2|COMPLETED|Overall Study||26
8365182|NCT01188421|20619981|P1|COMPLETED|Overall Study||28
8365183|NCT01188421|20619979|P3|STARTED|Overall Study||36
8365184|NCT01188421|20619980|P2|STARTED|Overall Study||36
8365185|NCT01188421|20619981|P1|STARTED|Overall Study||31
8365186|NCT01188369|20619991|P2|NOT COMPLETED|Overall Study||0
8365187|NCT01188369|20619992|P1|NOT COMPLETED|Overall Study||0
8365188|NCT01188369|20619991|P2|COMPLETED|Overall Study||10
8365189|NCT01188369|20619992|P1|COMPLETED|Overall Study||10
8365190|NCT01188369|20619991|P2|STARTED|Overall Study||10
8365191|NCT01188369|20619992|P1|STARTED|Overall Study||10
8365192|NCT01188343|20620001|P3|NOT COMPLETED|Overall Study||1
8365193|NCT01188343|20620002|P2|NOT COMPLETED|Overall Study||26
8365194|NCT01188343|20620003|P1|NOT COMPLETED|Overall Study||1
8365195|NCT01188343|20620001|P3|COMPLETED|Overall Study||220
8365196|NCT01188343|20620002|P2|COMPLETED|Overall Study||193
8365197|NCT01188343|20620003|P1|COMPLETED|Overall Study||101
8365198|NCT01188343|20620001|P3|STARTED|Overall Study||221
8365199|NCT01188343|20620002|P2|STARTED|Overall Study||219
8365200|NCT01188343|20620003|P1|STARTED|Overall Study||102
8365201|NCT01188226|20620029|P1|NOT COMPLETED|Overall Study||4
8365202|NCT01188226|20620029|P1|COMPLETED|Overall Study||6
8365203|NCT01188226|20620029|P1|STARTED|Overall Study||10
8365204|NCT01188109|20620068|P1|NOT COMPLETED|Overall Study||0
8365205|NCT01188109|20620068|P1|COMPLETED|Overall Study||22
8365206|NCT01188109|20620068|P1|STARTED|Overall Study||22
8365207|NCT01187953|20620075|P2|NOT COMPLETED|Overall Study||21
8365208|NCT01187953|20620076|P1|NOT COMPLETED|Overall Study||15
8365209|NCT01187953|20620075|P2|COMPLETED|Overall Study||254
8365210|NCT01187953|20620076|P1|COMPLETED|Overall Study||253
8365211|NCT01187953|20620075|P2|Dosed|Overall Study||271
8365212|NCT01187953|20620076|P1|Dosed|Overall Study||266
8365213|NCT01187953|20620075|P2|STARTED|Overall Study||275
8365214|NCT01187953|20620076|P1|STARTED|Overall Study||268
8365215|NCT01187914|20620084|P1|NOT COMPLETED|Overall Study||0
8365216|NCT01187914|20620084|P1|COMPLETED|Overall Study||40
8365217|NCT01187914|20620084|P1|STARTED|Overall Study||40
8365218|NCT01187901|20620090|P2|NOT COMPLETED|Overall Study||10
8365219|NCT01187901|20620091|P1|NOT COMPLETED|Overall Study||9
8365220|NCT01187901|20620090|P2|COMPLETED|Overall Study||36
8365221|NCT01187901|20620091|P1|COMPLETED|Overall Study||37
8365222|NCT01187901|20620090|P2|STARTED|Overall Study||46
8365223|NCT01187901|20620091|P1|STARTED|Overall Study||46
8365224|NCT01187771|20620109|P2|NOT COMPLETED|Overall Study||3
8365225|NCT01187771|20620110|P1|NOT COMPLETED|Overall Study||3
8365226|NCT01187771|20620109|P2|COMPLETED|Overall Study||18
8365227|NCT01187771|20620110|P1|COMPLETED|Overall Study||25
8365228|NCT01187771|20620109|P2|STARTED|Overall Study||21
8365229|NCT01187771|20620110|P1|STARTED|Overall Study||28
8365230|NCT01187550|20620132|P2|NOT COMPLETED|Overall Study||1
8365231|NCT01187550|20620133|P1|NOT COMPLETED|Overall Study||14
8365232|NCT01187550|20620132|P2|COMPLETED|Overall Study||29
8365233|NCT01187550|20620133|P1|COMPLETED|Overall Study||169
8365234|NCT01187550|20620132|P2|Treated|Overall Study||30
8365235|NCT01187550|20620133|P1|Treated|Overall Study||175
8365236|NCT01187550|20620132|P2|STARTED|Overall Study||30
8365237|NCT01187550|20620133|P1|STARTED|Overall Study||183
8365238|NCT01187511|20620151|P2|NOT COMPLETED|Overall Study||1
8365239|NCT01187511|20620152|P1|NOT COMPLETED|Overall Study||8
8365240|NCT01187511|20620151|P2|COMPLETED|Overall Study||21
8365241|NCT01187511|20620152|P1|COMPLETED|Overall Study||14
8365242|NCT01187511|20620151|P2|STARTED|Overall Study||22
8365243|NCT01187511|20620152|P1|STARTED|Overall Study||22
8365244|NCT01187498|20620260|P2|NOT COMPLETED|Overall Study||10
8365245|NCT01187498|20620261|P1|NOT COMPLETED|Overall Study||9
8365246|NCT01187498|20620260|P2|COMPLETED|Overall Study||60
8365247|NCT01187498|20620261|P1|COMPLETED|Overall Study||64
8365248|NCT01187498|20620260|P2|STARTED|Overall Study||70
8365249|NCT01187498|20620261|P1|STARTED|Overall Study||73
8365250|NCT01187446|20620289|P2|NOT COMPLETED|Overall Study||1
8365251|NCT01187446|20620290|P1|NOT COMPLETED|Overall Study||0
8365252|NCT01187446|20620289|P2|COMPLETED|Overall Study||13
8365253|NCT01187446|20620290|P1|COMPLETED|Overall Study||14
8365254|NCT01187446|20620289|P2|STARTED|Overall Study||14
8365255|NCT01187446|20620290|P1|STARTED|Overall Study||14
8365256|NCT01187433|20620306|P2|NOT COMPLETED|Overall Study||4
8365257|NCT01187433|20620307|P1|NOT COMPLETED|Overall Study||11
8365258|NCT01187433|20620306|P2|COMPLETED|Overall Study||46
8365259|NCT01187433|20620307|P1|COMPLETED|Overall Study||89
8365260|NCT01187433|20620306|P2|STARTED|Overall Study||50
8365261|NCT01187433|20620307|P1|STARTED|Overall Study||100
8365262|NCT01187407|20620337|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
8365263|NCT01187407|20620338|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
8365264|NCT01187407|20620339|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8365265|NCT01187407|20620340|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
8365266|NCT01187407|20620341|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365267|NCT01187407|20620337|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
8365268|NCT01187407|20620338|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
8365269|NCT01187407|20620339|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
8365270|NCT01187407|20620340|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
8365271|NCT01187407|20620341|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365272|NCT01187407|20620337|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
8365273|NCT01187407|20620338|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
8365274|NCT01187407|20620339|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
8365275|NCT01187407|20620340|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
8365276|NCT01187407|20620341|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365277|NCT01187407|20620337|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
8365278|NCT01187407|20620338|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
8365279|NCT01187407|20620339|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
8365280|NCT01187407|20620340|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
8365281|NCT01187407|20620341|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365282|NCT01187407|20620337|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365283|NCT01187407|20620338|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365284|NCT01187407|20620339|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365285|NCT01187407|20620340|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365286|NCT01187407|20620341|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
8365287|NCT01187407|20620337|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365288|NCT01187407|20620338|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365289|NCT01187407|20620339|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365290|NCT01187407|20620340|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365291|NCT01187407|20620341|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
8365292|NCT01187407|20620337|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365293|NCT01187407|20620338|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365294|NCT01187407|20620339|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365295|NCT01187407|20620340|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365296|NCT01187407|20620341|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
8365297|NCT01187407|20620337|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365298|NCT01187407|20620338|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365299|NCT01187407|20620339|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365300|NCT01187407|20620340|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365301|NCT01187407|20620341|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
8365302|NCT01187381|20620411|P1|NOT COMPLETED|Overall Study||0
8365303|NCT01187381|20620411|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
8365304|NCT01187381|20620411|P1|STARTED|Overall Study||250
8365305|NCT01187355|20620423|P2|NOT COMPLETED|Overall Study||20
8365306|NCT01187355|20620424|P1|NOT COMPLETED|Overall Study||18
8365307|NCT01187355|20620423|P2|COMPLETED|Overall Study||277
8365308|NCT01187355|20620424|P1|COMPLETED|Overall Study||276
8365309|NCT01187355|20620423|P2|STARTED|Overall Study||297
8365310|NCT01187355|20620424|P1|STARTED|Overall Study||294
8365311|NCT01187329|20620436|P2|NOT COMPLETED|Overall Study||2
8365312|NCT01187329|20620437|P1|NOT COMPLETED|Overall Study||1
8365313|NCT01187329|20620436|P2|COMPLETED|Overall Study||48
8365314|NCT01187329|20620437|P1|COMPLETED|Overall Study||49
8365315|NCT01187329|20620436|P2|STARTED|Overall Study||50
8365316|NCT01187329|20620437|P1|STARTED|Overall Study||50
8365317|NCT01187043|20620454|P5|NOT COMPLETED|Overall Study||2
8365318|NCT01187043|20620455|P4|NOT COMPLETED|Overall Study||0
8365319|NCT01187043|20620456|P3|NOT COMPLETED|Overall Study||4
8365320|NCT01187043|20620457|P2|NOT COMPLETED|Overall Study||0
8365321|NCT01187043|20620458|P1|NOT COMPLETED|Overall Study||1
8365322|NCT01187043|20620454|P5|COMPLETED|Overall Study||10
8365323|NCT01187043|20620455|P4|COMPLETED|Overall Study||12
8365324|NCT01187043|20620456|P3|COMPLETED|Overall Study||8
8365325|NCT01187043|20620457|P2|COMPLETED|Overall Study||10
8365326|NCT01187043|20620458|P1|COMPLETED|Overall Study||11
8365327|NCT01187043|20620454|P5|STARTED|Overall Study||12
8365328|NCT01187043|20620455|P4|STARTED|Overall Study||12
8365329|NCT01187043|20620456|P3|STARTED|Overall Study||12
8365330|NCT01187043|20620457|P2|STARTED|Overall Study||10
8365331|NCT01187043|20620458|P1|STARTED|Overall Study||12
8365332|NCT01187017|20620470|P1|NOT COMPLETED|Overall Study||0
8365333|NCT01187017|20620470|P1|COMPLETED|Overall Study||1
8365334|NCT01187017|20620470|P1|STARTED|Overall Study||1
8365335|NCT01187004|20620476|P2|NOT COMPLETED|Overall Study||0
8365336|NCT01187004|20620477|P1|NOT COMPLETED|Overall Study||0
8365337|NCT01187004|20620476|P2|COMPLETED|Overall Study||144
8365338|NCT01187004|20620477|P1|COMPLETED|Overall Study||20
8365339|NCT01187004|20620476|P2|STARTED|Overall Study||144
8365340|NCT01187004|20620477|P1|STARTED|Overall Study||20
8365341|NCT01186978|20620484|P1|NOT COMPLETED|Overall Study||1
8365342|NCT01186978|20620484|P1|COMPLETED|Overall Study||62
8365343|NCT01186978|20620484|P1|STARTED|Overall Study||63
8365344|NCT01186939|20620491|P1|NOT COMPLETED|Overall Study||40
8365345|NCT01186939|20620491|P1|COMPLETED|Overall Study||0
8365346|NCT01186939|20620491|P1|STARTED|Overall Study||40
8365347|NCT01186848|20620495|P1|NOT COMPLETED|Overall Study||8
8365348|NCT01186848|20620495|P1|COMPLETED|Overall Study||22
8365349|NCT01186848|20620495|P1|STARTED|Overall Study||30
8365350|NCT01186809|20620501|P1|NOT COMPLETED|Overall Study||30
8365351|NCT01186809|20620501|P1|COMPLETED|Overall Study||43
8365352|NCT01186809|20620501|P1|STARTED|Overall Study||73
8365353|NCT01186796|20620507|P2|NOT COMPLETED|Overall Study||2
8365354|NCT01186796|20620508|P1|NOT COMPLETED|Overall Study||4
8365355|NCT01186796|20620507|P2|COMPLETED|Overall Study||14
8365356|NCT01186796|20620508|P1|COMPLETED|Overall Study||10
8365357|NCT01186796|20620507|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
8365358|NCT01186796|20620508|P1|STARTED|Overall Study||14
8365359|NCT01186770|20620526|P4|NOT COMPLETED|Overall Study||58
8365360|NCT01186770|20620527|P3|NOT COMPLETED|Overall Study||52
8365361|NCT01186770|20620528|P2|NOT COMPLETED|Overall Study||46
8365362|NCT01186770|20620529|P1|NOT COMPLETED|Overall Study||41
8365363|NCT01186770|20620526|P4|COMPLETED|Overall Study||143
8365364|NCT01186770|20620527|P3|COMPLETED|Overall Study||148
8365365|NCT01186770|20620528|P2|COMPLETED|Overall Study||156
8365366|NCT01186770|20620529|P1|COMPLETED|Overall Study||160
8365367|NCT01186770|20620526|P4|Intent-to-treat (ITT Population)|Overall Study||201
8365368|NCT01186770|20620527|P3|Intent-to-treat (ITT Population)|Overall Study||200
8365369|NCT01186770|20620528|P2|Intent-to-treat (ITT Population)|Overall Study||201
8365370|NCT01186770|20620529|P1|Intent-to-treat (ITT Population)|Overall Study||201
8365371|NCT01186770|20620526|P4|STARTED|Overall Study||201
8365372|NCT01186770|20620527|P3|STARTED|Overall Study||200
8365373|NCT01186770|20620528|P2|STARTED|Overall Study||202
8365374|NCT01186770|20620529|P1|STARTED|Overall Study||201
8365375|NCT01186744|20620553|P6|NOT COMPLETED|Overall Study||26
8365376|NCT01186744|20620554|P5|NOT COMPLETED|Overall Study||6
8365377|NCT01186744|20620555|P4|NOT COMPLETED|Overall Study||12
8365378|NCT01186744|20620556|P3|NOT COMPLETED|Overall Study||6
8365379|NCT01186744|20620557|P2|NOT COMPLETED|Overall Study||152
8365380|NCT01186744|20620558|P1|NOT COMPLETED|Overall Study||208
8365381|NCT01186744|20620553|P6|COMPLETED|Overall Study||107
8365382|NCT01186744|20620554|P5|COMPLETED|Overall Study||39
8365383|NCT01186744|20620555|P4|COMPLETED|Overall Study||70
8365384|NCT01186744|20620556|P3|COMPLETED|Overall Study||25
8365385|NCT01186744|20620557|P2|COMPLETED|Overall Study||5
8365386|NCT01186744|20620558|P1|COMPLETED|Overall Study||10
8365387|NCT01186744|20620553|P6|STARTED|Overall Study||133
8365388|NCT01186744|20620554|P5|STARTED|Overall Study||45
8365389|NCT01186744|20620555|P4|STARTED|Overall Study||82
8365390|NCT01186744|20620556|P3|STARTED|Overall Study||31
8365391|NCT01186744|20620557|P2|STARTED|Overall Study||157
8365392|NCT01186744|20620558|P1|STARTED|Overall Study||218
8365393|NCT01186705|20620974|P1|NOT COMPLETED|Overall Study||0
8365394|NCT01186705|20620974|P1|COMPLETED|Overall Study||1
8365395|NCT01186705|20620974|P1|STARTED|Overall Study||1
8365396|NCT01186692|20620978|P1|NOT COMPLETED|Overall Study||32
8365397|NCT01186692|20620978|P1|COMPLETED|Overall Study||99
8365398|NCT01186692|20620978|P1|STARTED|Overall Study||131
8365399|NCT01186562|20620988|P2|NOT COMPLETED|Overall Study||2
8365400|NCT01186562|20620989|P1|NOT COMPLETED|Overall Study||4
8365401|NCT01186562|20620988|P2|COMPLETED|Overall Study||27
8365402|NCT01186562|20620989|P1|COMPLETED|Overall Study||50
8365403|NCT01186562|20620988|P2|STARTED|Overall Study||29
8365404|NCT01186562|20620989|P1|STARTED|Overall Study||54
8365405|NCT01186458|20621005|P1|NOT COMPLETED|Overall Study||1
8365406|NCT01186458|20621005|P1|COMPLETED|Overall Study||3
8365407|NCT01186458|20621005|P1|STARTED|Overall Study||4
8365408|NCT01186419|20621014|P2|NOT COMPLETED|Overall Study||9
8365409|NCT01186419|20621015|P1|NOT COMPLETED|Overall Study||7
8365410|NCT01186419|20621014|P2|COMPLETED|Overall Study||18
8365411|NCT01186419|20621015|P1|COMPLETED|Overall Study||17
8365412|NCT01186419|20621014|P2|STARTED|Overall Study||27
8365413|NCT01186419|20621015|P1|STARTED|Overall Study||24
8365414|NCT01186406|20621022|P1|NOT COMPLETED|Overall Study||0
8365415|NCT01186406|20621022|P1|COMPLETED|Overall Study||41
8365416|NCT01186406|20621022|P1|STARTED|Overall Study||41
8365417|NCT01186328|20621029|P3|NOT COMPLETED|Overall Study||0
8365418|NCT01186328|20621030|P2|NOT COMPLETED|Overall Study||0
8365419|NCT01186328|20621031|P1|NOT COMPLETED|Overall Study||1
8365420|NCT01186328|20621029|P3|COMPLETED|Overall Study||0
8365421|NCT01186328|20621030|P2|COMPLETED|Overall Study||0
8365422|NCT01186328|20621031|P1|COMPLETED|Overall Study||5
8365423|NCT01186328|20621029|P3|STARTED|Overall Study||0
8365424|NCT01186328|20621030|P2|STARTED|Overall Study||0
8365425|NCT01186328|20621031|P1|STARTED|Overall Study||6
8365426|NCT01186250|20621039|P2|NOT COMPLETED|Overall Study||0
8365427|NCT01186250|20621040|P1|NOT COMPLETED|Overall Study||1
8365428|NCT01186250|20621039|P2|COMPLETED|Overall Study||9
8365429|NCT01186250|20621040|P1|COMPLETED|Overall Study||8
8365430|NCT01186250|20621039|P2|STARTED|Overall Study||9
8365431|NCT01186250|20621040|P1|STARTED|Overall Study||9
8365432|NCT01185964|20621061|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
8365433|NCT01185964|20621062|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365434|NCT01185964|20621063|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365435|NCT01185964|20621064|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365436|NCT01185964|20621061|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
8365437|NCT01185964|20621062|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365438|NCT01185964|20621063|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365439|NCT01185964|20621064|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365440|NCT01185964|20621061|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
8365441|NCT01185964|20621062|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
8365442|NCT01185964|20621063|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
8365443|NCT01185964|20621064|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
8365444|NCT01185964|20621061|P4|NOT COMPLETED|Phase 1b and Phase 2||0
8365445|NCT01185964|20621062|P3|NOT COMPLETED|Phase 1b and Phase 2||9
8365446|NCT01185964|20621063|P2|NOT COMPLETED|Phase 1b and Phase 2||10
8365447|NCT01185964|20621064|P1|NOT COMPLETED|Phase 1b and Phase 2||2
8365448|NCT01185964|20621061|P4|COMPLETED|Phase 1b and Phase 2||0
8365449|NCT01185964|20621062|P3|COMPLETED|Phase 1b and Phase 2||58
8365450|NCT01185964|20621063|P2|COMPLETED|Phase 1b and Phase 2||56
8365451|NCT01185964|20621064|P1|COMPLETED|Phase 1b and Phase 2||13
8365452|NCT01185964|20621061|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
8365453|NCT01185964|20621062|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
8365454|NCT01185964|20621063|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
8365455|NCT01185964|20621064|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
8365456|NCT01185964|20621061|P4|STARTED|Phase 1b and Phase 2||0
8365457|NCT01185964|20621062|P3|STARTED|Phase 1b and Phase 2||67
8365458|NCT01185964|20621063|P2|STARTED|Phase 1b and Phase 2||66
8365459|NCT01185964|20621064|P1|STARTED|Phase 1b and Phase 2||15
8365460|NCT01185834|20621090|P1|NOT COMPLETED|Overall Study||14
8365461|NCT01185834|20621090|P1|COMPLETED|Overall Study||104
8365462|NCT01185834|20621090|P1|STARTED|Overall Study||118
8365463|NCT01185821|20621100|P5|NOT COMPLETED|Overall Study||24
8365464|NCT01185821|20621101|P4|NOT COMPLETED|Overall Study||6
8365465|NCT01185821|20621102|P3|NOT COMPLETED|Overall Study||10
8365466|NCT01185821|20621103|P2|NOT COMPLETED|Overall Study||9
8365467|NCT01185821|20621104|P1|NOT COMPLETED|Overall Study||7
8365468|NCT01185821|20621100|P5|COMPLETED|Overall Study||26
8365469|NCT01185821|20621101|P4|COMPLETED|Overall Study||23
8365470|NCT01185821|20621102|P3|COMPLETED|Overall Study||33
8365471|NCT01185821|20621103|P2|COMPLETED|Overall Study||20
8365472|NCT01185821|20621104|P1|COMPLETED|Overall Study||26
8365473|NCT01185821|20621100|P5|Patients on Placebo in Core|Overall Study||2
8365474|NCT01185821|20621101|P4|Patients on Placebo in Core|Overall Study||8
8365475|NCT01185821|20621102|P3|Patients on Placebo in Core|Overall Study||9
8365476|NCT01185821|20621103|P2|Patients on Placebo in Core|Overall Study||7
8365477|NCT01185821|20621104|P1|Patients on Placebo in Core|Overall Study||8
8365478|NCT01185821|20621100|P5|Patients Without Washout|Overall Study||17
8365479|NCT01185821|20621101|P4|Patients Without Washout|Overall Study||0
8365480|NCT01185821|20621102|P3|Patients Without Washout|Overall Study||4
8365481|NCT01185821|20621103|P2|Patients Without Washout|Overall Study||0
8365482|NCT01185821|20621104|P1|Patients Without Washout|Overall Study||0
8365483|NCT01185821|20621100|P5|Patients With Washout|Overall Study||33
8365484|NCT01185821|20621101|P4|Patients With Washout|Overall Study||29
8365485|NCT01185821|20621102|P3|Patients With Washout|Overall Study||39
8365486|NCT01185821|20621103|P2|Patients With Washout|Overall Study||29
8365487|NCT01185821|20621104|P1|Patients With Washout|Overall Study||33
8365488|NCT01185821|20621100|P5|STARTED|Overall Study||50
8365489|NCT01185821|20621101|P4|STARTED|Overall Study||29
8365490|NCT01185821|20621102|P3|STARTED|Overall Study||43
8365491|NCT01185821|20621103|P2|STARTED|Overall Study||29
8365492|NCT01185821|20621104|P1|STARTED|Overall Study||33
8365493|NCT01185782|20621155|P2|NOT COMPLETED|Overall Study||11
8365494|NCT01185782|20621156|P1|NOT COMPLETED|Overall Study||6
8365495|NCT01185782|20621155|P2|COMPLETED|Overall Study||125
8365496|NCT01185782|20621156|P1|COMPLETED|Overall Study||123
8365497|NCT01185782|20621155|P2|Treated|Overall Study||132
8365498|NCT01185782|20621156|P1|Treated|Overall Study||129
8365499|NCT01185782|20621155|P2|STARTED|Overall Study||136
8365500|NCT01185782|20621156|P1|STARTED|Overall Study||129
8365501|NCT01185704|20621184|P2|NOT COMPLETED|Overall Study||8
8365502|NCT01185704|20621185|P1|NOT COMPLETED|Overall Study||13
8365503|NCT01185704|20621184|P2|COMPLETED|Overall Study||60
8365504|NCT01185704|20621185|P1|COMPLETED|Overall Study||55
8365505|NCT01185704|20621184|P2|Treated|Overall Study||65
8365506|NCT01185704|20621185|P1|Treated|Overall Study||65
8365507|NCT01185704|20621184|P2|STARTED|Overall Study||68
8365508|NCT01185704|20621185|P1|STARTED|Overall Study||68
8365509|NCT01185639|20621219|P1|NOT COMPLETED|Overall Study||2
8365510|NCT01185639|20621219|P1|COMPLETED|Overall Study||27
8365511|NCT01185639|20621219|P1|STARTED|Overall Study||29
8365512|NCT01185600|20621229|P2|NOT COMPLETED|Overall Study||45
8365513|NCT01185600|20621230|P1|NOT COMPLETED|Overall Study||32
8365514|NCT01185600|20621229|P2|COMPLETED|Overall Study||59
8365515|NCT01185600|20621230|P1|COMPLETED|Overall Study||41
8365516|NCT01185600|20621229|P2|STARTED|Overall Study||104
8365517|NCT01185600|20621230|P1|STARTED|Overall Study||73
8365518|NCT01185561|20621252|P2|NOT COMPLETED|Overall Study||12
8365519|NCT01185561|20621253|P1|NOT COMPLETED|Overall Study||2
8365520|NCT01185561|20621252|P2|COMPLETED|Overall Study||26
8365521|NCT01185561|20621253|P1|COMPLETED|Overall Study||34
8365522|NCT01185561|20621252|P2|STARTED|Overall Study||38
8365523|NCT01185561|20621253|P1|STARTED|Overall Study||36
8365524|NCT01185548|20621265|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
8365525|NCT01185548|20621265|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
8365526|NCT01185548|20621265|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
8365527|NCT01185548|20621265|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
8365528|NCT01185548|20621265|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
8365529|NCT01185548|20621265|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
8365530|NCT01185548|20621265|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
8365531|NCT01185548|20621265|P1|COMPLETED|Period 1 : Tolbutamide||4
8365532|NCT01185548|20621265|P1|STARTED|Period 1 : Tolbutamide||4
8365533|NCT01185522|20621278|P1|NOT COMPLETED|Overall Study||108
8365534|NCT01185522|20621278|P1|COMPLETED|Overall Study||585
8365535|NCT01185522|20621278|P1|STARTED|Overall Study||693
8365536|NCT01185509|20621304|P2|NOT COMPLETED|Overall Study||20
8365537|NCT01185509|20621305|P1|NOT COMPLETED|Overall Study||11
8365538|NCT01185509|20621304|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8365539|NCT01185509|20621305|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8365540|NCT01185509|20621304|P2|STARTED|Overall Study||20
8365541|NCT01185509|20621305|P1|STARTED|Overall Study||11
8365542|NCT01185353|20621321|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
8365543|NCT01185353|20621322|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
8365544|NCT01185353|20621323|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
8365545|NCT01185353|20621324|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365546|NCT01185353|20621325|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365547|NCT01185353|20621326|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365548|NCT01185353|20621327|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365549|NCT01185353|20621328|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365550|NCT01185353|20621329|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365551|NCT01185353|20621330|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365552|NCT01185353|20621321|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
8365553|NCT01185353|20621322|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
8365554|NCT01185353|20621323|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
8365555|NCT01185353|20621324|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
8365556|NCT01185353|20621325|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
8365557|NCT01185353|20621326|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
8365558|NCT01185353|20621327|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
8365559|NCT01185353|20621328|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
8365560|NCT01185353|20621329|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
8365561|NCT01185353|20621330|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
8365562|NCT01185353|20621321|P10|STARTED|Part D (Weeks 76 Through 128)||18
8365563|NCT01185353|20621322|P9|STARTED|Part D (Weeks 76 Through 128)||47
8365564|NCT01185353|20621323|P8|STARTED|Part D (Weeks 76 Through 128)||79
8365565|NCT01185353|20621324|P7|STARTED|Part D (Weeks 76 Through 128)||0
8365566|NCT01185353|20621325|P6|STARTED|Part D (Weeks 76 Through 128)||0
8365567|NCT01185353|20621326|P5|STARTED|Part D (Weeks 76 Through 128)||0
8365568|NCT01185353|20621327|P4|STARTED|Part D (Weeks 76 Through 128)||0
8365569|NCT01185353|20621328|P3|STARTED|Part D (Weeks 76 Through 128)||0
8365570|NCT01185353|20621329|P2|STARTED|Part D (Weeks 76 Through 128)||0
8365571|NCT01185353|20621330|P1|STARTED|Part D (Weeks 76 Through 128)||0
8365572|NCT01185353|20621321|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
8365573|NCT01185353|20621322|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
8365574|NCT01185353|20621323|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
8365575|NCT01185353|20621324|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365576|NCT01185353|20621325|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365577|NCT01185353|20621326|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365578|NCT01185353|20621327|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365579|NCT01185353|20621328|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365580|NCT01185353|20621329|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365581|NCT01185353|20621330|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365582|NCT01185353|20621321|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
8365583|NCT01185353|20621322|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
8365584|NCT01185353|20621323|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
8365585|NCT01185353|20621324|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
8365586|NCT01185353|20621325|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
8365587|NCT01185353|20621326|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
8365588|NCT01185353|20621327|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
8365589|NCT01185353|20621328|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
8365590|NCT01185353|20621329|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
8365591|NCT01185353|20621330|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
8365592|NCT01185353|20621321|P10|STARTED|Part C (Weeks 24 Through 76)||32
8365593|NCT01185353|20621322|P9|STARTED|Part C (Weeks 24 Through 76)||61
8365594|NCT01185353|20621323|P8|STARTED|Part C (Weeks 24 Through 76)||108
8365595|NCT01185353|20621324|P7|STARTED|Part C (Weeks 24 Through 76)||0
8365596|NCT01185353|20621325|P6|STARTED|Part C (Weeks 24 Through 76)||0
8365597|NCT01185353|20621326|P5|STARTED|Part C (Weeks 24 Through 76)||0
8365598|NCT01185353|20621327|P4|STARTED|Part C (Weeks 24 Through 76)||0
8365599|NCT01185353|20621328|P3|STARTED|Part C (Weeks 24 Through 76)||0
8365600|NCT01185353|20621329|P2|STARTED|Part C (Weeks 24 Through 76)||0
8365601|NCT01185353|20621330|P1|STARTED|Part C (Weeks 24 Through 76)||0
8365602|NCT01185353|20621321|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365603|NCT01185353|20621322|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365604|NCT01185353|20621323|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365605|NCT01185353|20621324|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
8365606|NCT01185353|20621325|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
8365607|NCT01185353|20621326|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365608|NCT01185353|20621327|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
8365609|NCT01185353|20621328|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
8365610|NCT01185353|20621329|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
8365611|NCT01185353|20621330|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365612|NCT01185353|20621321|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
8365613|NCT01185353|20621322|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
8365614|NCT01185353|20621323|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
8365615|NCT01185353|20621324|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
8365616|NCT01185353|20621325|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
8365617|NCT01185353|20621326|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
8365618|NCT01185353|20621327|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
8365619|NCT01185353|20621328|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
8365620|NCT01185353|20621329|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
8365621|NCT01185353|20621330|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
8365622|NCT01185353|20621321|P10|STARTED|Part B (Weeks 12 Through 24)||0
8365623|NCT01185353|20621322|P9|STARTED|Part B (Weeks 12 Through 24)||0
8365624|NCT01185353|20621323|P8|STARTED|Part B (Weeks 12 Through 24)||0
8365625|NCT01185353|20621324|P7|STARTED|Part B (Weeks 12 Through 24)||63
8365626|NCT01185353|20621325|P6|STARTED|Part B (Weeks 12 Through 24)||63
8365627|NCT01185353|20621326|P5|STARTED|Part B (Weeks 12 Through 24)||0
8365628|NCT01185353|20621327|P4|STARTED|Part B (Weeks 12 Through 24)||49
8365629|NCT01185353|20621328|P3|STARTED|Part B (Weeks 12 Through 24)||50
8365630|NCT01185353|20621329|P2|STARTED|Part B (Weeks 12 Through 24)||51
8365631|NCT01185353|20621330|P1|STARTED|Part B (Weeks 12 Through 24)||0
8365632|NCT01185353|20621321|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365633|NCT01185353|20621322|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365634|NCT01185353|20621323|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365635|NCT01185353|20621324|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365636|NCT01185353|20621325|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365637|NCT01185353|20621326|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
8365638|NCT01185353|20621327|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
8365639|NCT01185353|20621328|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
8365640|NCT01185353|20621329|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
8365641|NCT01185353|20621330|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
8365642|NCT01185353|20621321|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
8365643|NCT01185353|20621322|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
8365644|NCT01185353|20621323|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
8365645|NCT01185353|20621324|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
8365646|NCT01185353|20621325|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
8365647|NCT01185353|20621326|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
8365648|NCT01185353|20621327|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
8365649|NCT01185353|20621328|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
8365650|NCT01185353|20621329|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
8365651|NCT01185353|20621330|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
8365652|NCT01185353|20621321|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365653|NCT01185353|20621322|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365654|NCT01185353|20621323|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365655|NCT01185353|20621324|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365656|NCT01185353|20621325|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365657|NCT01185353|20621326|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
8365658|NCT01185353|20621327|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
8365659|NCT01185353|20621328|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
8365660|NCT01185353|20621329|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
8365661|NCT01185353|20621330|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
8365662|NCT01185353|20621321|P10|STARTED|Part A (Weeks 0 Through 12)||0
8365663|NCT01185353|20621322|P9|STARTED|Part A (Weeks 0 Through 12)||0
8365664|NCT01185353|20621323|P8|STARTED|Part A (Weeks 0 Through 12)||0
8365665|NCT01185353|20621324|P7|STARTED|Part A (Weeks 0 Through 12)||0
8365666|NCT01185353|20621325|P6|STARTED|Part A (Weeks 0 Through 12)||0
8365667|NCT01185353|20621326|P5|STARTED|Part A (Weeks 0 Through 12)||98
8365668|NCT01185353|20621327|P4|STARTED|Part A (Weeks 0 Through 12)||50
8365669|NCT01185353|20621328|P3|STARTED|Part A (Weeks 0 Through 12)||52
8365670|NCT01185353|20621329|P2|STARTED|Part A (Weeks 0 Through 12)||52
8365671|NCT01185353|20621330|P1|STARTED|Part A (Weeks 0 Through 12)||49
8365672|NCT01185340|20621491|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
8365673|NCT01185340|20621492|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
8365674|NCT01185340|20621493|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8365675|NCT01185340|20621494|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365676|NCT01185340|20621491|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
8365677|NCT01185340|20621492|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
8365678|NCT01185340|20621493|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
8365679|NCT01185340|20621494|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365680|NCT01185340|20621491|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
8365681|NCT01185340|20621492|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
8365682|NCT01185340|20621493|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
8365683|NCT01185340|20621494|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365684|NCT01185340|20621491|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
8365685|NCT01185340|20621492|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
8365686|NCT01185340|20621493|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
8365687|NCT01185340|20621494|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365688|NCT01185340|20621491|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365689|NCT01185340|20621492|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365690|NCT01185340|20621493|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365691|NCT01185340|20621494|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
8365692|NCT01185340|20621491|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365693|NCT01185340|20621492|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365694|NCT01185340|20621493|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365695|NCT01185340|20621494|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
8365696|NCT01185340|20621491|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365697|NCT01185340|20621492|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365698|NCT01185340|20621493|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365699|NCT01185340|20621494|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
8365700|NCT01185340|20621491|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365701|NCT01185340|20621492|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365702|NCT01185340|20621493|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365703|NCT01185340|20621494|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
8365704|NCT01185301|20621546|P4|NOT COMPLETED|Overall Study||9
8365705|NCT01185301|20621547|P3|NOT COMPLETED|Overall Study||6
8365706|NCT01185301|20621548|P2|NOT COMPLETED|Overall Study||7
8365707|NCT01185301|20621549|P1|NOT COMPLETED|Overall Study||15
8365708|NCT01185301|20621546|P4|COMPLETED|Overall Study||89
8365709|NCT01185301|20621547|P3|COMPLETED|Overall Study||93
8365710|NCT01185301|20621548|P2|COMPLETED|Overall Study||93
8365711|NCT01185301|20621549|P1|COMPLETED|Overall Study||83
8365712|NCT01185301|20621546|P4|STARTED|Overall Study||98
8365713|NCT01185301|20621547|P3|STARTED|Overall Study||99
8365714|NCT01185301|20621548|P2|STARTED|Overall Study||100
8365715|NCT01185301|20621549|P1|STARTED|Overall Study||98
8365716|NCT01185288|20621609|P2|NOT COMPLETED|Overall Study||16
8365717|NCT01185288|20621610|P1|NOT COMPLETED|Overall Study||19
8365718|NCT01185288|20621609|P2|COMPLETED|Overall Study||139
8365719|NCT01185288|20621610|P1|COMPLETED|Overall Study||135
8365720|NCT01185288|20621609|P2|STARTED|Overall Study||155
8365721|NCT01185288|20621610|P1|STARTED|Overall Study||154
8365722|NCT01185249|20621628|P1|NOT COMPLETED|Overall Study||42
8365723|NCT01185249|20621628|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
8365724|NCT01185249|20621628|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
8365725|NCT01185171|20621633|P1|NOT COMPLETED|Maintenance||12
8365726|NCT01185171|20621633|P1|COMPLETED|Maintenance||48
8365727|NCT01185171|20621633|P1|STARTED|Maintenance||60
8365728|NCT01185171|20621633|P1|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
8365729|NCT01185171|20621633|P1|COMPLETED|Concurrent Chemo and Radiation Treatment||66
8365730|NCT01185171|20621633|P1|STARTED|Concurrent Chemo and Radiation Treatment||69
8365731|NCT01185171|20621633|P1|NOT COMPLETED|Induction Chemotherapy||2
8365732|NCT01185171|20621633|P1|COMPLETED|Induction Chemotherapy||57
8365733|NCT01185171|20621633|P1|STARTED|Induction Chemotherapy||59
8365734|NCT01185080|20621643|P3|NOT COMPLETED|Overall Study||1
8365735|NCT01185080|20621644|P2|NOT COMPLETED|Overall Study||1
8365736|NCT01185080|20621645|P1|NOT COMPLETED|Overall Study||1
8365737|NCT01185080|20621643|P3|COMPLETED|Overall Study||16
8365738|NCT01185080|20621644|P2|COMPLETED|Overall Study||15
8365739|NCT01185080|20621645|P1|COMPLETED|Overall Study||49
8365740|NCT01185080|20621643|P3|STARTED|Overall Study||17
8365741|NCT01185080|20621644|P2|STARTED|Overall Study||16
8365742|NCT01185080|20621645|P1|STARTED|Overall Study||50
8365743|NCT01185028|20621692|P1|NOT COMPLETED|Overall Study||4
8365744|NCT01185028|20621692|P1|COMPLETED|Overall Study||4
8365745|NCT01185028|20621692|P1|STARTED|Overall Study||8
8365746|NCT01184989|20621697|P1|NOT COMPLETED|Overall Study||12
8365747|NCT01184989|20621697|P1|COMPLETED|Overall Study||100
8365748|NCT01184989|20621697|P1|STARTED|Overall Study|Treated Patients|112
8365749|NCT01184898|20621703|P1|NOT COMPLETED|Overall Study||0
8365750|NCT01184898|20621703|P1|COMPLETED|Overall Study||36
8365751|NCT01184898|20621703|P1|STARTED|Overall Study||36
8365752|NCT01184885|20621710|P1|NOT COMPLETED|Overall Study||0
8365753|NCT01184885|20621710|P1|COMPLETED|Overall Study||7
8365754|NCT01184885|20621710|P1|STARTED|Overall Study||7
8365755|NCT01184872|20621717|P2|NOT COMPLETED|Overall Study||8
8365756|NCT01184872|20621718|P1|NOT COMPLETED|Overall Study||10
8365757|NCT01184872|20621717|P2|COMPLETED|Overall Study||31
8365758|NCT01184872|20621718|P1|COMPLETED|Overall Study||71
8365759|NCT01184872|20621717|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
8365760|NCT01184872|20621718|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
8365761|NCT01184872|20621717|P2|Clinical Evaluable Set (CES)|Overall Study||30
8365762|NCT01184872|20621718|P1|Clinical Evaluable Set (CES)|Overall Study||73
8365763|NCT01184872|20621717|P2|Safety Set|Overall Study||40
8365764|NCT01184872|20621718|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
8365765|NCT01184872|20621717|P2|STARTED|Overall Study||39
8365766|NCT01184872|20621718|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
8365767|NCT01184859|20621737|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
8365768|NCT01184859|20621738|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8365769|NCT01184859|20621739|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8365770|NCT01184859|20621740|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8365771|NCT01184859|20621741|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
8365772|NCT01184859|20621737|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365773|NCT01184859|20621738|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365774|NCT01184859|20621739|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365775|NCT01184859|20621740|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
8365776|NCT01184859|20621741|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365777|NCT01184859|20621737|P5|STARTED|Period 2: Daily Dose for 28 Days||23
8365778|NCT01184859|20621738|P4|STARTED|Period 2: Daily Dose for 28 Days||22
8365779|NCT01184859|20621739|P3|STARTED|Period 2: Daily Dose for 28 Days||22
8365780|NCT01184859|20621740|P2|STARTED|Period 2: Daily Dose for 28 Days||23
8365781|NCT01184859|20621741|P1|STARTED|Period 2: Daily Dose for 28 Days||23
8365782|NCT01184859|20621737|P5|NOT COMPLETED|Washout Period||0
8365783|NCT01184859|20621738|P4|NOT COMPLETED|Washout Period||0
8365784|NCT01184859|20621739|P3|NOT COMPLETED|Washout Period||0
8365785|NCT01184859|20621740|P2|NOT COMPLETED|Washout Period||0
8365786|NCT01184859|20621741|P1|NOT COMPLETED|Washout Period||0
8365787|NCT01184859|20621737|P5|COMPLETED|Washout Period||23
8365788|NCT01184859|20621738|P4|COMPLETED|Washout Period||22
8365789|NCT01184859|20621739|P3|COMPLETED|Washout Period||22
8365790|NCT01184859|20621740|P2|COMPLETED|Washout Period||23
8365791|NCT01184859|20621741|P1|COMPLETED|Washout Period||23
8365792|NCT01184859|20621737|P5|STARTED|Washout Period||23
8365793|NCT01184859|20621738|P4|STARTED|Washout Period||22
8365794|NCT01184859|20621739|P3|STARTED|Washout Period||22
8365795|NCT01184859|20621740|P2|STARTED|Washout Period||23
8365796|NCT01184859|20621741|P1|STARTED|Washout Period||23
8365797|NCT01184859|20621737|P5|NOT COMPLETED|Period 1: Single Dose||1
8365798|NCT01184859|20621738|P4|NOT COMPLETED|Period 1: Single Dose||0
8365799|NCT01184859|20621739|P3|NOT COMPLETED|Period 1: Single Dose||0
8365800|NCT01184859|20621740|P2|NOT COMPLETED|Period 1: Single Dose||2
8365801|NCT01184859|20621741|P1|NOT COMPLETED|Period 1: Single Dose||0
8365802|NCT01184859|20621737|P5|COMPLETED|Period 1: Single Dose||23
8365803|NCT01184859|20621738|P4|COMPLETED|Period 1: Single Dose||22
8365804|NCT01184859|20621739|P3|COMPLETED|Period 1: Single Dose||22
8365805|NCT01184859|20621740|P2|COMPLETED|Period 1: Single Dose||23
8365806|NCT01184859|20621741|P1|COMPLETED|Period 1: Single Dose||23
8365807|NCT01184859|20621737|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
8365808|NCT01184859|20621738|P4|Per Protocol (PP)|Period 1: Single Dose||21
8365809|NCT01184859|20621739|P3|Per Protocol (PP)|Period 1: Single Dose||22
8365810|NCT01184859|20621740|P2|Per Protocol (PP)|Period 1: Single Dose||23
8365811|NCT01184859|20621741|P1|Per Protocol (PP)|Period 1: Single Dose||23
8365812|NCT01184859|20621737|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
8365813|NCT01184859|20621738|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
8365814|NCT01184859|20621739|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
8365815|NCT01184859|20621740|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
8365816|NCT01184859|20621741|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
8365817|NCT01184859|20621737|P5|STARTED|Period 1: Single Dose||24
8365818|NCT01184859|20621738|P4|STARTED|Period 1: Single Dose||22
8365819|NCT01184859|20621739|P3|STARTED|Period 1: Single Dose||22
8365820|NCT01184859|20621740|P2|STARTED|Period 1: Single Dose||25
8365821|NCT01184859|20621741|P1|STARTED|Period 1: Single Dose||23
8365822|NCT01184846|20621833|P1|NOT COMPLETED|Overall Study||3
8365823|NCT01184846|20621833|P1|COMPLETED|Overall Study||25
8365824|NCT01184846|20621833|P1|STARTED|Overall Study||28
8365825|NCT01184755|20621854|P3|NOT COMPLETED|Overall Study||6
8365826|NCT01184755|20621855|P2|NOT COMPLETED|Overall Study||11
8365827|NCT01184755|20621856|P1|NOT COMPLETED|Overall Study||25
8365828|NCT01184755|20621854|P3|COMPLETED|Overall Study||56
8365829|NCT01184755|20621855|P2|COMPLETED|Overall Study||54
8365830|NCT01184755|20621856|P1|COMPLETED|Overall Study||101
8365831|NCT01184755|20621854|P3|STARTED|Overall Study||62
8365832|NCT01184755|20621855|P2|STARTED|Overall Study||65
8365833|NCT01184755|20621856|P1|STARTED|Overall Study||126
8365834|NCT01184508|20621866|P2|NOT COMPLETED|Overall Study||15
8365835|NCT01184508|20621867|P1|NOT COMPLETED|Overall Study||16
8365836|NCT01184508|20621866|P2|COMPLETED|Overall Study||27
8365837|NCT01184508|20621867|P1|COMPLETED|Overall Study||29
8365838|NCT01184508|20621866|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
8365839|NCT01184508|20621867|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
8365840|NCT01184508|20621866|P2|STARTED|Overall Study||42
8365841|NCT01184508|20621867|P1|STARTED|Overall Study||45
8365842|NCT01184456|20621894|P2|NOT COMPLETED|Overall Study||0
8365843|NCT01184456|20621895|P1|NOT COMPLETED|Overall Study||0
8365844|NCT01184456|20621894|P2|COMPLETED|Overall Study||0
8365845|NCT01184456|20621895|P1|COMPLETED|Overall Study||0
8365846|NCT01184456|20621894|P2|STARTED|Overall Study||0
8365847|NCT01184456|20621895|P1|STARTED|Overall Study||0
8365848|NCT01184417|20621903|P2|NOT COMPLETED|Overall Study||0
8365849|NCT01184417|20621904|P1|NOT COMPLETED|Overall Study||0
8365850|NCT01184417|20621903|P2|COMPLETED|Overall Study||51
8365851|NCT01184417|20621904|P1|COMPLETED|Overall Study||51
8365852|NCT01184417|20621903|P2|STARTED|Overall Study||51
8365853|NCT01184417|20621904|P1|STARTED|Overall Study||51
8365854|NCT01184326|20621927|P3|NOT COMPLETED|Overall Study||14
8365855|NCT01184326|20621928|P2|NOT COMPLETED|Overall Study||6
8365856|NCT01184326|20621929|P1|NOT COMPLETED|Overall Study||3
8365857|NCT01184326|20621927|P3|COMPLETED|Overall Study||0
8365858|NCT01184326|20621928|P2|COMPLETED|Overall Study||0
8365859|NCT01184326|20621929|P1|COMPLETED|Overall Study||0
8365860|NCT01184326|20621927|P3|STARTED|Overall Study||14
8365861|NCT01184326|20621928|P2|STARTED|Overall Study||6
8365862|NCT01184326|20621929|P1|STARTED|Overall Study||3
8365863|NCT01184118|20621943|P1|NOT COMPLETED|Overall Study||18
8365864|NCT01184118|20621943|P1|COMPLETED|Overall Study||18
8365865|NCT01184118|20621943|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
8365866|NCT01184118|20621943|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
8365867|NCT01184118|20621943|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
8365868|NCT01184118|20621943|P1|STARTED|Overall Study||36
8365869|NCT01184079|20621951|P2|NOT COMPLETED|Overall Study||2
8365870|NCT01184079|20621952|P1|NOT COMPLETED|Overall Study||14
8365871|NCT01184079|20621951|P2|COMPLETED|Overall Study||107
8365872|NCT01184079|20621952|P1|COMPLETED|Overall Study||97
8365873|NCT01184079|20621951|P2|Final Blood Draw|Overall Study||107
8365874|NCT01184079|20621952|P1|Final Blood Draw|Overall Study||97
8365875|NCT01184079|20621951|P2|Dose 3|Overall Study||107
8365876|NCT01184079|20621952|P1|Dose 3|Overall Study||101
8365877|NCT01184079|20621951|P2|Dose 2|Overall Study||108
8365878|NCT01184079|20621952|P1|Dose 2|Overall Study||110
8365879|NCT01184079|20621951|P2|STARTED|Overall Study||109
8365880|NCT01184079|20621952|P1|STARTED|Overall Study||111
8365881|NCT01184053|20621962|P1|NOT COMPLETED|Overall Study||3
8365882|NCT01184053|20621962|P1|COMPLETED|Overall Study||0
8365883|NCT01184053|20621962|P1|STARTED|Overall Study||3
8365884|NCT01184014|20621971|P2|NOT COMPLETED|Overall Study||6
8365885|NCT01184014|20621972|P1|NOT COMPLETED|Overall Study||5
8365886|NCT01184014|20621971|P2|COMPLETED|Overall Study||31
8365887|NCT01184014|20621972|P1|COMPLETED|Overall Study||30
8365888|NCT01184014|20621971|P2|STARTED|Overall Study||37
8365889|NCT01184014|20621972|P1|STARTED|Overall Study||35
8365890|NCT01183975|20621978|P1|NOT COMPLETED|Overall Study||73
8365891|NCT01183975|20621978|P1|COMPLETED|Overall Study||444
8365892|NCT01183975|20621978|P1|STARTED|Overall Study||517
8365893|NCT01183923|20621983|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
8365894|NCT01183923|20621984|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
8365895|NCT01183923|20621983|P2|COMPLETED|Intervention 2 (7 Days)||0
8365896|NCT01183923|20621984|P1|COMPLETED|Intervention 2 (7 Days)||1
8365897|NCT01183923|20621983|P2|STARTED|Intervention 2 (7 Days)||0
8365898|NCT01183923|20621984|P1|STARTED|Intervention 2 (7 Days)||1
8365899|NCT01183923|20621983|P2|NOT COMPLETED|Washout (14 Days)||0
8365900|NCT01183923|20621984|P1|NOT COMPLETED|Washout (14 Days)||0
8365901|NCT01183923|20621983|P2|COMPLETED|Washout (14 Days)||0
8365902|NCT01183923|20621984|P1|COMPLETED|Washout (14 Days)||1
8365903|NCT01183923|20621983|P2|STARTED|Washout (14 Days)||0
8365904|NCT01183923|20621984|P1|STARTED|Washout (14 Days)||1
8365905|NCT01183923|20621983|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
8365906|NCT01183923|20621984|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
8365907|NCT01183923|20621983|P2|COMPLETED|Intervention 1 (7 Days)||0
8365908|NCT01183923|20621984|P1|COMPLETED|Intervention 1 (7 Days)||1
8365909|NCT01183923|20621983|P2|STARTED|Intervention 1 (7 Days)||0
8365910|NCT01183923|20621984|P1|STARTED|Intervention 1 (7 Days)||1
8365911|NCT01183897|20621989|P1|NOT COMPLETED|Overall Study||0
8365912|NCT01183897|20621989|P1|COMPLETED|Overall Study||31
8365913|NCT01183897|20621989|P1|STARTED|Overall Study||31
8365914|NCT01183884|20621995|P1|NOT COMPLETED|Overall Study||38
8365915|NCT01183884|20621995|P1|COMPLETED|Overall Study||8
8365916|NCT01183884|20621995|P1|STARTED|Overall Study||46
8365917|NCT01183858|20622003|P2|NOT COMPLETED|Overall Study||156
8365918|NCT01183858|20622004|P1|NOT COMPLETED|Overall Study||153
8365919|NCT01183858|20622003|P2|COMPLETED|Overall Study||3
8365920|NCT01183858|20622004|P1|COMPLETED|Overall Study||1
8365921|NCT01183858|20622003|P2|Safety Population|Overall Study||158
8365922|NCT01183858|20622004|P1|Safety Population|Overall Study||154
8365923|NCT01183858|20622003|P2|STARTED|Overall Study||159
8365924|NCT01183858|20622004|P1|STARTED|Overall Study||154
8365925|NCT01183780|20622026|P2|NOT COMPLETED|Overall Study||25
8365926|NCT01183780|20622027|P1|NOT COMPLETED|Overall Study||31
8365927|NCT01183780|20622026|P2|COMPLETED|Overall Study||511
8365928|NCT01183780|20622027|P1|COMPLETED|Overall Study||505
8365929|NCT01183780|20622026|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
8365930|NCT01183780|20622027|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
8365931|NCT01183780|20622026|P2|STARTED|Overall Study||536
8365932|NCT01183780|20622027|P1|STARTED|Overall Study||536
8365933|NCT01183728|20622044|P1|NOT COMPLETED|Overall Study||0
8365934|NCT01183728|20622044|P1|COMPLETED|Overall Study||12
8365935|NCT01183728|20622044|P1|STARTED|Overall Study||12
8365936|NCT01183689|20622052|P3|NOT COMPLETED|Overall Study||0
8365937|NCT01183689|20622053|P2|NOT COMPLETED|Overall Study||0
8365938|NCT01183689|20622054|P1|NOT COMPLETED|Overall Study||0
8365939|NCT01183689|20622052|P3|COMPLETED|Overall Study||197
8365940|NCT01183689|20622053|P2|COMPLETED|Overall Study||200
8365941|NCT01183689|20622054|P1|COMPLETED|Overall Study||202
8365942|NCT01183689|20622052|P3|Year 4 Visit|Overall Study||30
8365943|NCT01183689|20622053|P2|Year 4 Visit|Overall Study||33
8365944|NCT01183689|20622054|P1|Year 4 Visit|Overall Study||38
8365945|NCT01183689|20622052|P3|Year 3 Visit|Overall Study||126
8365946|NCT01183689|20622053|P2|Year 3 Visit|Overall Study||125
8365947|NCT01183689|20622054|P1|Year 3 Visit|Overall Study||139
8365948|NCT01183689|20622052|P3|Year 2 Visit|Overall Study||174
8365949|NCT01183689|20622053|P2|Year 2 Visit|Overall Study||172
8365950|NCT01183689|20622054|P1|Year 2 Visit|Overall Study||178
8365951|NCT01183689|20622052|P3|Year 1 Visit|Overall Study||183
8365952|NCT01183689|20622053|P2|Year 1 Visit|Overall Study||172
8365953|NCT01183689|20622054|P1|Year 1 Visit|Overall Study||187
8365954|NCT01183689|20622052|P3|Month 4 Visit|Overall Study||187
8365955|NCT01183689|20622053|P2|Month 4 Visit|Overall Study||192
8365956|NCT01183689|20622054|P1|Month 4 Visit|Overall Study||197
8365957|NCT01183689|20622052|P3|STARTED|Overall Study||197
8365958|NCT01183689|20622053|P2|STARTED|Overall Study||200
8365959|NCT01183689|20622054|P1|STARTED|Overall Study||202
8365960|NCT01183650|20622124|P2|NOT COMPLETED|Overall Study||0
8365961|NCT01183650|20622125|P1|NOT COMPLETED|Overall Study||0
8365962|NCT01183650|20622124|P2|COMPLETED|Overall Study||12
8365963|NCT01183650|20622125|P1|COMPLETED|Overall Study||12
8365964|NCT01183650|20622124|P2|STARTED|Overall Study||12
8365965|NCT01183650|20622125|P1|STARTED|Overall Study||12
8365966|NCT01183559|20622135|P1|NOT COMPLETED|Overall Study||0
8365967|NCT01183559|20622135|P1|COMPLETED|Overall Study||9
8365968|NCT01183559|20622135|P1|STARTED|Overall Study||9
8365969|NCT01183546|20622140|P1|NOT COMPLETED|Overall Study||0
8365970|NCT01183546|20622140|P1|COMPLETED|Overall Study||53
8365971|NCT01183546|20622140|P1|STARTED|Overall Study||53
8365972|NCT01183533|20622147|P1|NOT COMPLETED|Overall Study||0
8365973|NCT01183533|20622147|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
8365974|NCT01183533|20622147|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
8365975|NCT01183481|20622153|P1|NOT COMPLETED|Overall Study||0
8365976|NCT01183481|20622153|P1|COMPLETED|Overall Study||19
8365977|NCT01183481|20622153|P1|STARTED|Overall Study||19
8365978|NCT01183468|20622165|P4|NOT COMPLETED|Overall Study||0
8365979|NCT01183468|20622166|P3|NOT COMPLETED|Overall Study||0
8365980|NCT01183468|20622167|P2|NOT COMPLETED|Overall Study||2
8365981|NCT01183468|20622168|P1|NOT COMPLETED|Overall Study||3
8365982|NCT01183468|20622165|P4|COMPLETED|Overall Study||0
8365983|NCT01183468|20622166|P3|COMPLETED|Overall Study||0
8365984|NCT01183468|20622167|P2|COMPLETED|Overall Study||7
8365985|NCT01183468|20622168|P1|COMPLETED|Overall Study||5
8365986|NCT01183468|20622165|P4|STARTED|Overall Study||0
8365987|NCT01183468|20622166|P3|STARTED|Overall Study||0
8365988|NCT01183468|20622167|P2|STARTED|Overall Study||9
8365989|NCT01183468|20622168|P1|STARTED|Overall Study||8
8365990|NCT01183429|20622176|P1|NOT COMPLETED|Overall Study||0
8365991|NCT01183429|20622176|P1|COMPLETED|Overall Study||39
8365992|NCT01183429|20622176|P1|STARTED|Overall Study||39
8365993|NCT01183416|20622182|P1|NOT COMPLETED|Overall Study||0
8365994|NCT01183416|20622182|P1|COMPLETED|Overall Study||4
8365995|NCT01183416|20622182|P1|STARTED|Overall Study||4
8365996|NCT01183390|20622190|P2|NOT COMPLETED|Second Intervention||0
8365997|NCT01183390|20622191|P1|NOT COMPLETED|Second Intervention||0
8365998|NCT01183390|20622190|P2|COMPLETED|Second Intervention||10
8365999|NCT01183390|20622191|P1|COMPLETED|Second Intervention||11
8366000|NCT01183390|20622190|P2|STARTED|Second Intervention||10
8366001|NCT01183390|20622191|P1|STARTED|Second Intervention||11
8366002|NCT01183390|20622190|P2|NOT COMPLETED|Washout of 21 Days||0
8366003|NCT01183390|20622191|P1|NOT COMPLETED|Washout of 21 Days||0
8366004|NCT01183390|20622190|P2|COMPLETED|Washout of 21 Days||10
8366005|NCT01183390|20622191|P1|COMPLETED|Washout of 21 Days||11
8366006|NCT01183390|20622190|P2|STARTED|Washout of 21 Days||10
8366007|NCT01183390|20622191|P1|STARTED|Washout of 21 Days||11
8366008|NCT01183390|20622190|P2|NOT COMPLETED|First Intervention||1
8366009|NCT01183390|20622191|P1|NOT COMPLETED|First Intervention||0
8366010|NCT01183390|20622190|P2|COMPLETED|First Intervention||10
8366011|NCT01183390|20622191|P1|COMPLETED|First Intervention||11
8366012|NCT01183390|20622190|P2|STARTED|First Intervention||11
8366013|NCT01183390|20622191|P1|STARTED|First Intervention||11
8366014|NCT01183312|20622201|P2|NOT COMPLETED|Second Intervention Day||0
8366015|NCT01183312|20622202|P1|NOT COMPLETED|Second Intervention Day||0
8366016|NCT01183312|20622201|P2|COMPLETED|Second Intervention Day||5
8366017|NCT01183312|20622202|P1|COMPLETED|Second Intervention Day||5
8366018|NCT01183312|20622201|P2|STARTED|Second Intervention Day||5
8366019|NCT01183312|20622202|P1|STARTED|Second Intervention Day||5
8366020|NCT01183312|20622201|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
8366021|NCT01183312|20622202|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
8366022|NCT01183312|20622201|P2|COMPLETED|Washout Period of at Least 1 Week||5
8366023|NCT01183312|20622202|P1|COMPLETED|Washout Period of at Least 1 Week||5
8366024|NCT01183312|20622201|P2|STARTED|Washout Period of at Least 1 Week||5
8366025|NCT01183312|20622202|P1|STARTED|Washout Period of at Least 1 Week||5
8366026|NCT01183312|20622201|P2|NOT COMPLETED|First Intervention Day||0
8366027|NCT01183312|20622202|P1|NOT COMPLETED|First Intervention Day||0
8366028|NCT01183312|20622201|P2|COMPLETED|First Intervention Day||5
8366029|NCT01183312|20622202|P1|COMPLETED|First Intervention Day||5
8366030|NCT01183312|20622201|P2|STARTED|First Intervention Day||5
8366031|NCT01183312|20622202|P1|STARTED|First Intervention Day||5
8366032|NCT01183260|20622224|P2|NOT COMPLETED|Overall Study||2
8366033|NCT01183260|20622225|P1|NOT COMPLETED|Overall Study||4
8366034|NCT01183260|20622224|P2|COMPLETED|Overall Study||9
8366035|NCT01183260|20622225|P1|COMPLETED|Overall Study||10
8366036|NCT01183260|20622224|P2|STARTED|Overall Study||11
8366037|NCT01183260|20622225|P1|STARTED|Overall Study||14
8366038|NCT01183234|20622235|P2|NOT COMPLETED|Second Intervention||0
8366039|NCT01183234|20622236|P1|NOT COMPLETED|Second Intervention||0
8366040|NCT01183234|20622235|P2|COMPLETED|Second Intervention||14
8366041|NCT01183234|20622236|P1|COMPLETED|Second Intervention||13
8366042|NCT01183234|20622235|P2|STARTED|Second Intervention||14
8366043|NCT01183234|20622236|P1|STARTED|Second Intervention||13
8366044|NCT01183234|20622235|P2|NOT COMPLETED|Washout||0
8366045|NCT01183234|20622236|P1|NOT COMPLETED|Washout||0
8366046|NCT01183234|20622235|P2|COMPLETED|Washout||14
8366047|NCT01183234|20622236|P1|COMPLETED|Washout||13
8366048|NCT01183234|20622235|P2|STARTED|Washout||14
8366049|NCT01183234|20622236|P1|STARTED|Washout||13
8366050|NCT01183234|20622235|P2|NOT COMPLETED|First Intervention||0
8366051|NCT01183234|20622236|P1|NOT COMPLETED|First Intervention||1
8366052|NCT01183234|20622235|P2|COMPLETED|First Intervention||14
8366053|NCT01183234|20622236|P1|COMPLETED|First Intervention||13
8366054|NCT01183234|20622235|P2|STARTED|First Intervention||14
8366055|NCT01183234|20622236|P1|STARTED|First Intervention||14
8366056|NCT01183169|20622250|P7|NOT COMPLETED|Post-switch Phase||9
8366057|NCT01183169|20622251|P6|NOT COMPLETED|Post-switch Phase||14
8366058|NCT01183169|20622252|P5|NOT COMPLETED|Post-switch Phase||0
8366059|NCT01183169|20622253|P4|NOT COMPLETED|Post-switch Phase||0
8366060|NCT01183169|20622254|P3|NOT COMPLETED|Post-switch Phase||0
8366061|NCT01183169|20622255|P2|NOT COMPLETED|Post-switch Phase||0
8366062|NCT01183169|20622256|P1|NOT COMPLETED|Post-switch Phase||0
8366063|NCT01183169|20622250|P7|COMPLETED|Post-switch Phase||21
8366064|NCT01183169|20622251|P6|COMPLETED|Post-switch Phase||21
8366065|NCT01183169|20622252|P5|COMPLETED|Post-switch Phase||0
8366066|NCT01183169|20622253|P4|COMPLETED|Post-switch Phase||0
8366067|NCT01183169|20622254|P3|COMPLETED|Post-switch Phase||0
8366068|NCT01183169|20622255|P2|COMPLETED|Post-switch Phase||0
8366069|NCT01183169|20622256|P1|COMPLETED|Post-switch Phase||0
8366070|NCT01183169|20622250|P7|Completed Treatment|Post-switch Phase||13
8366071|NCT01183169|20622251|P6|Completed Treatment|Post-switch Phase||12
8366072|NCT01183169|20622252|P5|Completed Treatment|Post-switch Phase||0
8366073|NCT01183169|20622253|P4|Completed Treatment|Post-switch Phase||0
8366074|NCT01183169|20622254|P3|Completed Treatment|Post-switch Phase||0
8366075|NCT01183169|20622255|P2|Completed Treatment|Post-switch Phase||0
8366076|NCT01183169|20622256|P1|Completed Treatment|Post-switch Phase||0
8366077|NCT01183169|20622250|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
8366078|NCT01183169|20622251|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
8366079|NCT01183169|20622252|P5|STARTED|Post-switch Phase|Not a post-switch group|0
8366080|NCT01183169|20622253|P4|STARTED|Post-switch Phase|Not a post-switch group|0
8366081|NCT01183169|20622254|P3|STARTED|Post-switch Phase|Not a post-switch group|0
8366082|NCT01183169|20622255|P2|STARTED|Post-switch Phase|Not a post-switch group|0
8366083|NCT01183169|20622256|P1|STARTED|Post-switch Phase|Not a post-switch group|0
8366084|NCT01183169|20622250|P7|NOT COMPLETED|Main Phase||0
8366085|NCT01183169|20622251|P6|NOT COMPLETED|Main Phase||0
8366086|NCT01183169|20622252|P5|NOT COMPLETED|Main Phase||26
8366087|NCT01183169|20622253|P4|NOT COMPLETED|Main Phase||37
8366088|NCT01183169|20622254|P3|NOT COMPLETED|Main Phase||41
8366089|NCT01183169|20622255|P2|NOT COMPLETED|Main Phase||22
8366090|NCT01183169|20622256|P1|NOT COMPLETED|Main Phase||27
8366091|NCT01183169|20622250|P7|COMPLETED|Main Phase||0
8366092|NCT01183169|20622251|P6|COMPLETED|Main Phase||0
8366093|NCT01183169|20622252|P5|COMPLETED|Main Phase||83
8366094|NCT01183169|20622253|P4|COMPLETED|Main Phase||18
8366095|NCT01183169|20622254|P3|COMPLETED|Main Phase||18
8366096|NCT01183169|20622255|P2|COMPLETED|Main Phase||93
8366097|NCT01183169|20622256|P1|COMPLETED|Main Phase||94
8366098|NCT01183169|20622250|P7|Switched to ALV|Main Phase||0
8366099|NCT01183169|20622251|P6|Switched to ALV|Main Phase||0
8366100|NCT01183169|20622252|P5|Switched to ALV|Main Phase||0
8366101|NCT01183169|20622253|P4|Switched to ALV|Main Phase||30
8366102|NCT01183169|20622254|P3|Switched to ALV|Main Phase||35
8366103|NCT01183169|20622255|P2|Switched to ALV|Main Phase||0
8366104|NCT01183169|20622256|P1|Switched to ALV|Main Phase||0
8366105|NCT01183169|20622250|P7|Completed Treatment|Main Phase||0
8366106|NCT01183169|20622251|P6|Completed Treatment|Main Phase||0
8366107|NCT01183169|20622252|P5|Completed Treatment|Main Phase||77
8366108|NCT01183169|20622253|P4|Completed Treatment|Main Phase||17
8366109|NCT01183169|20622254|P3|Completed Treatment|Main Phase||17
8366110|NCT01183169|20622255|P2|Completed Treatment|Main Phase||78
8366111|NCT01183169|20622256|P1|Completed Treatment|Main Phase||72
8366112|NCT01183169|20622250|P7|STARTED|Main Phase||0
8366113|NCT01183169|20622251|P6|STARTED|Main Phase||0
8366114|NCT01183169|20622252|P5|STARTED|Main Phase||109
8366115|NCT01183169|20622253|P4|STARTED|Main Phase||55
8366116|NCT01183169|20622254|P3|STARTED|Main Phase||59
8366117|NCT01183169|20622255|P2|STARTED|Main Phase||115
8366118|NCT01183169|20622256|P1|STARTED|Main Phase||121
8366119|NCT01183143|20622328|P1|NOT COMPLETED|Overall Study||150
8366120|NCT01183143|20622328|P1|COMPLETED|Overall Study||65
8366121|NCT01183143|20622328|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
8366122|NCT01183143|20622328|P1|STARTED|Overall Study||215
8366123|NCT01183104|20622344|P2|NOT COMPLETED|Overall Study||92
8366124|NCT01183104|20622345|P1|NOT COMPLETED|Overall Study||77
8366125|NCT01183104|20622344|P2|COMPLETED|Overall Study||60
8366126|NCT01183104|20622345|P1|COMPLETED|Overall Study||76
8366127|NCT01183104|20622344|P2|Enrolled in Extension Study|Overall Study||61
8366128|NCT01183104|20622345|P1|Enrolled in Extension Study|Overall Study||80
8366129|NCT01183104|20622344|P2|Completed 52-week Treatment|Overall Study||111
8366130|NCT01183104|20622345|P1|Completed 52-week Treatment|Overall Study||119
8366131|NCT01183104|20622344|P2|Continued Treatment for 12 Weeks|Overall Study||129
8366132|NCT01183104|20622345|P1|Continued Treatment for 12 Weeks|Overall Study||143
8366133|NCT01183104|20622344|P2|Received Study Drug|Overall Study||143
8366134|NCT01183104|20622345|P1|Received Study Drug|Overall Study||148
8366135|NCT01183104|20622344|P2|STARTED|Overall Study||152
8366136|NCT01183104|20622345|P1|STARTED|Overall Study||153
8366137|NCT01183065|20622361|P1|NOT COMPLETED|Overall Study||1
8366138|NCT01183065|20622361|P1|COMPLETED|Overall Study||12
8366139|NCT01183065|20622361|P1|STARTED|Overall Study||13
8366140|NCT01183013|20622372|P7|NOT COMPLETED|Overall Study||37
8366141|NCT01183013|20622373|P6|NOT COMPLETED|Overall Study||45
8366142|NCT01183013|20622374|P5|NOT COMPLETED|Overall Study||36
8366143|NCT01183013|20622375|P4|NOT COMPLETED|Overall Study||30
8366144|NCT01183013|20622376|P3|NOT COMPLETED|Overall Study||41
8366145|NCT01183013|20622377|P2|NOT COMPLETED|Overall Study||39
8366146|NCT01183013|20622378|P1|NOT COMPLETED|Overall Study||45
8366147|NCT01183013|20622372|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
8366148|NCT01183013|20622373|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
8366149|NCT01183013|20622374|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
8366150|NCT01183013|20622375|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
8366151|NCT01183013|20622376|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
8366152|NCT01183013|20622377|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
8366153|NCT01183013|20622378|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
8366154|NCT01183013|20622372|P7|STARTED|Overall Study||133
8366155|NCT01183013|20622373|P6|STARTED|Overall Study||133
8366156|NCT01183013|20622374|P5|STARTED|Overall Study||126
8366157|NCT01183013|20622375|P4|STARTED|Overall Study||135
8366158|NCT01183013|20622376|P3|STARTED|Overall Study||138
8366159|NCT01183013|20622377|P2|STARTED|Overall Study||140
8366160|NCT01183013|20622378|P1|STARTED|Overall Study||131
8366161|NCT01182844|20622459|P2|NOT COMPLETED|Overall Study||2
8366162|NCT01182844|20622460|P1|NOT COMPLETED|Overall Study||0
8366163|NCT01182844|20622459|P2|COMPLETED|Overall Study||13
8366164|NCT01182844|20622460|P1|COMPLETED|Overall Study||15
8366165|NCT01182844|20622459|P2|STARTED|Overall Study||15
8366166|NCT01182844|20622460|P1|STARTED|Overall Study||15
8366167|NCT01182805|20622478|P1|NOT COMPLETED|Overall Study||0
8366168|NCT01182805|20622478|P1|COMPLETED|Overall Study||50
8366169|NCT01182805|20622478|P1|STARTED|Overall Study||50
8366170|NCT01182727|20622487|P1|NOT COMPLETED|Overall Study||0
8366171|NCT01182727|20622487|P1|COMPLETED|Overall Study||10
8366172|NCT01182727|20622487|P1|STARTED|Overall Study||10
8366173|NCT01182675|20622493|P2|NOT COMPLETED|Overall Study||0
8366174|NCT01182675|20622494|P1|NOT COMPLETED|Overall Study||0
8366175|NCT01182675|20622493|P2|COMPLETED|Overall Study||0
8366176|NCT01182675|20622494|P1|COMPLETED|Overall Study||7
8366177|NCT01182675|20622493|P2|STARTED|Overall Study||0
8366178|NCT01182675|20622494|P1|STARTED|Overall Study||7
8366179|NCT01182610|20622510|P1|NOT COMPLETED|Overall Study||0
8366180|NCT01182610|20622510|P1|COMPLETED|Overall Study||1
8366181|NCT01182610|20622510|P1|STARTED|Overall Study||1
8366182|NCT01182493|20622520|P2|NOT COMPLETED|Overall Study||7
8366183|NCT01182493|20622521|P1|NOT COMPLETED|Overall Study||16
8366184|NCT01182493|20622520|P2|COMPLETED|Overall Study||156
8366185|NCT01182493|20622521|P1|COMPLETED|Overall Study||152
8366186|NCT01182493|20622520|P2|STARTED|Overall Study||163
8366187|NCT01182493|20622521|P1|STARTED|Overall Study||168
8366188|NCT01182480|20622539|P1|NOT COMPLETED|Overall Study||0
8366189|NCT01182480|20622539|P1|COMPLETED|Overall Study||47
8366190|NCT01182480|20622539|P1|STARTED|Overall Study||47
8366191|NCT01182441|20622545|P2|NOT COMPLETED|Overall Study||119
8366192|NCT01182441|20622546|P1|NOT COMPLETED|Overall Study||220
8366193|NCT01182441|20622545|P2|COMPLETED|Overall Study||19
8366194|NCT01182441|20622546|P1|COMPLETED|Overall Study||49
8366195|NCT01182441|20622545|P2|STARTED|Overall Study||138
8366196|NCT01182441|20622546|P1|STARTED|Overall Study||269
8366197|NCT01182428|20622557|P2|NOT COMPLETED|Overall Study||1
8366198|NCT01182428|20622558|P1|NOT COMPLETED|Overall Study||11
8366199|NCT01182428|20622557|P2|COMPLETED|Overall Study||150
8366200|NCT01182428|20622558|P1|COMPLETED|Overall Study||293
8366201|NCT01182428|20622557|P2|STARTED|Overall Study||151
8366202|NCT01182428|20622558|P1|STARTED|Overall Study||304
8366203|NCT01182415|20622622|P1|NOT COMPLETED|Overall Study||1
8366204|NCT01182415|20622622|P1|COMPLETED|Overall Study||29
8366205|NCT01182415|20622622|P1|STARTED|Overall Study||30
8366206|NCT01182376|20622631|P2|NOT COMPLETED|Overall Study||5
8366207|NCT01182376|20622632|P1|NOT COMPLETED|Overall Study||11
8366208|NCT01182376|20622631|P2|COMPLETED|Overall Study||13
8366209|NCT01182376|20622632|P1|COMPLETED|Overall Study||4
8366210|NCT01182376|20622631|P2|STARTED|Overall Study||18
8366211|NCT01182376|20622632|P1|STARTED|Overall Study||15
8366212|NCT01182350|20622638|P5|NOT COMPLETED|Overall Study||3
8366213|NCT01182350|20622639|P4|NOT COMPLETED|Overall Study||3
8366214|NCT01182350|20622640|P3|NOT COMPLETED|Overall Study||3
8366215|NCT01182350|20622641|P2|NOT COMPLETED|Overall Study||14
8366216|NCT01182350|20622642|P1|NOT COMPLETED|Overall Study||27
8366217|NCT01182350|20622638|P5|COMPLETED|Overall Study||0
8366218|NCT01182350|20622639|P4|COMPLETED|Overall Study||0
8366219|NCT01182350|20622640|P3|COMPLETED|Overall Study||0
8366220|NCT01182350|20622641|P2|COMPLETED|Overall Study||0
8366221|NCT01182350|20622642|P1|COMPLETED|Overall Study||3
8366222|NCT01182350|20622638|P5|Started Assigned Chemoradiation|Overall Study||0
8366223|NCT01182350|20622639|P4|Started Assigned Chemoradiation|Overall Study||2
8366224|NCT01182350|20622640|P3|Started Assigned Chemoradiation|Overall Study||2
8366225|NCT01182350|20622641|P2|Started Assigned Chemoradiation|Overall Study||14
8366226|NCT01182350|20622642|P1|Started Assigned Chemoradiation|Overall Study||27
8366227|NCT01182350|20622638|P5|Underwent Stereotactic Biopsy|Overall Study||0
8366228|NCT01182350|20622639|P4|Underwent Stereotactic Biopsy|Overall Study||3
8366229|NCT01182350|20622640|P3|Underwent Stereotactic Biopsy|Overall Study||3
8366230|NCT01182350|20622641|P2|Underwent Stereotactic Biopsy|Overall Study||14
8366231|NCT01182350|20622642|P1|Underwent Stereotactic Biopsy|Overall Study||30
8366232|NCT01182350|20622638|P5|STARTED|Overall Study||3
8366233|NCT01182350|20622639|P4|STARTED|Overall Study||3
8366234|NCT01182350|20622640|P3|STARTED|Overall Study||3
8366235|NCT01182350|20622641|P2|STARTED|Overall Study||14
8366236|NCT01182350|20622642|P1|STARTED|Overall Study||30
8366237|NCT01182337|20622664|P2|NOT COMPLETED|Overall Study||2
8366238|NCT01182337|20622665|P1|NOT COMPLETED|Overall Study||3
8366239|NCT01182337|20622664|P2|COMPLETED|Overall Study||7
8366240|NCT01182337|20622665|P1|COMPLETED|Overall Study||19
8366241|NCT01182337|20622664|P2|STARTED|Overall Study||9
8366242|NCT01182337|20622665|P1|STARTED|Overall Study||22
8366243|NCT01182298|20622683|P1|NOT COMPLETED|Overall Study||6
8366244|NCT01182298|20622683|P1|COMPLETED|Overall Study||4
8366245|NCT01182298|20622683|P1|STARTED|Overall Study||10
8366246|NCT01182285|20622687|P3|NOT COMPLETED|Third Intervention Week 11-52||8
8366247|NCT01182285|20622688|P2|NOT COMPLETED|Third Intervention Week 11-52||0
8366248|NCT01182285|20622689|P1|NOT COMPLETED|Third Intervention Week 11-52||0
8366249|NCT01182285|20622687|P3|COMPLETED|Third Intervention Week 11-52||0
8366250|NCT01182285|20622688|P2|COMPLETED|Third Intervention Week 11-52||0
8366251|NCT01182285|20622689|P1|COMPLETED|Third Intervention Week 11-52||0
8366252|NCT01182285|20622687|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
8366253|NCT01182285|20622688|P2|STARTED|Third Intervention Week 11-52||0
8366254|NCT01182285|20622689|P1|STARTED|Third Intervention Week 11-52||0
8366255|NCT01182285|20622687|P3|NOT COMPLETED|Second Intervention Week 11-17||0
8366256|NCT01182285|20622688|P2|NOT COMPLETED|Second Intervention Week 11-17||0
8366257|NCT01182285|20622689|P1|NOT COMPLETED|Second Intervention Week 11-17||0
8366258|NCT01182285|20622687|P3|COMPLETED|Second Intervention Week 11-17||0
8366259|NCT01182285|20622688|P2|COMPLETED|Second Intervention Week 11-17||0
8366260|NCT01182285|20622689|P1|COMPLETED|Second Intervention Week 11-17||0
8366261|NCT01182285|20622687|P3|STARTED|Second Intervention Week 11-17||0
8366262|NCT01182285|20622688|P2|STARTED|Second Intervention Week 11-17||0
8366263|NCT01182285|20622689|P1|STARTED|Second Intervention Week 11-17||0
8366264|NCT01182285|20622687|P3|NOT COMPLETED|First Intervention Week 1-10||0
8366265|NCT01182285|20622688|P2|NOT COMPLETED|First Intervention Week 1-10||0
8366266|NCT01182285|20622689|P1|NOT COMPLETED|First Intervention Week 1-10||3
8366267|NCT01182285|20622687|P3|COMPLETED|First Intervention Week 1-10||0
8366268|NCT01182285|20622688|P2|COMPLETED|First Intervention Week 1-10||0
8366269|NCT01182285|20622689|P1|COMPLETED|First Intervention Week 1-10||10
8366270|NCT01182285|20622687|P3|STARTED|First Intervention Week 1-10||0
8366271|NCT01182285|20622688|P2|STARTED|First Intervention Week 1-10||0
8366272|NCT01182285|20622689|P1|STARTED|First Intervention Week 1-10||13
8366273|NCT01182207|20622699|P2|NOT COMPLETED|Second Intervention||0
8366274|NCT01182207|20622700|P1|NOT COMPLETED|Second Intervention||1
8366275|NCT01182207|20622699|P2|COMPLETED|Second Intervention||14
8366276|NCT01182207|20622700|P1|COMPLETED|Second Intervention||17
8366277|NCT01182207|20622699|P2|STARTED|Second Intervention||14
8366278|NCT01182207|20622700|P1|STARTED|Second Intervention||18
8366279|NCT01182207|20622699|P2|NOT COMPLETED|Washout of 28 Days||0
8366280|NCT01182207|20622700|P1|NOT COMPLETED|Washout of 28 Days||0
8366281|NCT01182207|20622699|P2|COMPLETED|Washout of 28 Days||14
8366282|NCT01182207|20622700|P1|COMPLETED|Washout of 28 Days||18
8366283|NCT01182207|20622699|P2|STARTED|Washout of 28 Days||14
8366284|NCT01182207|20622700|P1|STARTED|Washout of 28 Days||18
8366285|NCT01182207|20622699|P2|NOT COMPLETED|First Intervention||1
8366286|NCT01182207|20622700|P1|NOT COMPLETED|First Intervention||0
8366287|NCT01182207|20622699|P2|COMPLETED|First Intervention||14
8366288|NCT01182207|20622700|P1|COMPLETED|First Intervention||18
8366289|NCT01182207|20622699|P2|STARTED|First Intervention||15
8366290|NCT01182207|20622700|P1|STARTED|First Intervention||18
8366291|NCT01182194|20622718|P2|NOT COMPLETED|Second Intervention||0
8366292|NCT01182194|20622719|P1|NOT COMPLETED|Second Intervention||0
8366293|NCT01182194|20622718|P2|COMPLETED|Second Intervention||16
8366294|NCT01182194|20622719|P1|COMPLETED|Second Intervention||15
8366295|NCT01182194|20622718|P2|STARTED|Second Intervention||16
8366296|NCT01182194|20622719|P1|STARTED|Second Intervention||15
8366297|NCT01182194|20622718|P2|NOT COMPLETED|Washout of 28 Days||0
8366298|NCT01182194|20622719|P1|NOT COMPLETED|Washout of 28 Days||1
8366299|NCT01182194|20622718|P2|COMPLETED|Washout of 28 Days||16
8366300|NCT01182194|20622719|P1|COMPLETED|Washout of 28 Days||15
8366301|NCT01182194|20622718|P2|STARTED|Washout of 28 Days||16
8366302|NCT01182194|20622719|P1|STARTED|Washout of 28 Days||16
8366303|NCT01182194|20622718|P2|NOT COMPLETED|First Intervention||0
8366304|NCT01182194|20622719|P1|NOT COMPLETED|First Intervention||0
8366305|NCT01182194|20622718|P2|COMPLETED|First Intervention||16
8366306|NCT01182194|20622719|P1|COMPLETED|First Intervention||16
8366307|NCT01182194|20622718|P2|STARTED|First Intervention||16
8366308|NCT01182194|20622719|P1|STARTED|First Intervention||16
8366309|NCT01182181|20622737|P2|NOT COMPLETED|Second Intervention||0
8366310|NCT01182181|20622738|P1|NOT COMPLETED|Second Intervention||0
8366311|NCT01182181|20622737|P2|COMPLETED|Second Intervention||10
8366312|NCT01182181|20622738|P1|COMPLETED|Second Intervention||10
8366313|NCT01182181|20622737|P2|STARTED|Second Intervention||10
8366314|NCT01182181|20622738|P1|STARTED|Second Intervention||10
8366315|NCT01182181|20622737|P2|NOT COMPLETED|Washout of 21 Days||1
8366316|NCT01182181|20622738|P1|NOT COMPLETED|Washout of 21 Days||0
8366317|NCT01182181|20622737|P2|COMPLETED|Washout of 21 Days||10
8366318|NCT01182181|20622738|P1|COMPLETED|Washout of 21 Days||10
8366319|NCT01182181|20622737|P2|STARTED|Washout of 21 Days||11
8366320|NCT01182181|20622738|P1|STARTED|Washout of 21 Days||10
8366321|NCT01182181|20622737|P2|NOT COMPLETED|First Intervention||0
8366322|NCT01182181|20622738|P1|NOT COMPLETED|First Intervention||1
8366323|NCT01182181|20622737|P2|COMPLETED|First Intervention||11
8366324|NCT01182181|20622738|P1|COMPLETED|First Intervention||10
8366325|NCT01182181|20622737|P2|STARTED|First Intervention||11
8366326|NCT01182181|20622738|P1|STARTED|First Intervention||11
8366327|NCT01182103|20622748|P2|NOT COMPLETED|Overall Study||0
8366328|NCT01182103|20622749|P1|NOT COMPLETED|Overall Study||0
8366329|NCT01182103|20622748|P2|COMPLETED|Overall Study||62
8366330|NCT01182103|20622749|P1|COMPLETED|Overall Study||48
8366331|NCT01182103|20622748|P2|STARTED|Overall Study||62
8366332|NCT01182103|20622749|P1|STARTED|Overall Study||48
8366333|NCT01181986|20622763|P3|NOT COMPLETED|Phase 2||0
8366334|NCT01181986|20622764|P2|NOT COMPLETED|Phase 2||4
8366335|NCT01181986|20622765|P1|NOT COMPLETED|Phase 2||0
8366336|NCT01181986|20622763|P3|COMPLETED|Phase 2||0
8366337|NCT01181986|20622764|P2|COMPLETED|Phase 2||18
8366338|NCT01181986|20622765|P1|COMPLETED|Phase 2||18
8366339|NCT01181986|20622763|P3|STARTED|Phase 2|N/A for Sub-study 2|0
8366340|NCT01181986|20622764|P2|STARTED|Phase 2||22
8366341|NCT01181986|20622765|P1|STARTED|Phase 2||18
8366342|NCT01181986|20622763|P3|NOT COMPLETED|Phase 1||2
8366343|NCT01181986|20622764|P2|NOT COMPLETED|Phase 1||1
8366344|NCT01181986|20622765|P1|NOT COMPLETED|Phase 1||1
8366345|NCT01181986|20622763|P3|COMPLETED|Phase 1||32
8366346|NCT01181986|20622764|P2|COMPLETED|Phase 1||22
8366347|NCT01181986|20622765|P1|COMPLETED|Phase 1||18
8366348|NCT01181986|20622763|P3|Exendin-9+Exenatide|Phase 1||33
8366349|NCT01181986|20622764|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
8366350|NCT01181986|20622765|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
8366351|NCT01181986|20622763|P3|Saline+Placebo|Phase 1||33
8366352|NCT01181986|20622764|P2|Saline+Placebo|Phase 1|N/A for this arm|0
8366353|NCT01181986|20622765|P1|Saline+Placebo|Phase 1|N/A for this arm|0
8366354|NCT01181986|20622763|P3|Saline+Exenatide|Phase 1||32
8366355|NCT01181986|20622764|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
8366356|NCT01181986|20622765|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
8366357|NCT01181986|20622763|P3|STARTED|Phase 1||34
8366358|NCT01181986|20622764|P2|STARTED|Phase 1||23
8366359|NCT01181986|20622765|P1|STARTED|Phase 1||19
8366360|NCT01181947|20622781|P1|NOT COMPLETED|Overall Study||0
8366361|NCT01181947|20622781|P1|COMPLETED|Overall Study||100
8366362|NCT01181947|20622781|P1|STARTED|Overall Study||100
8366363|NCT01181921|20622786|P1|NOT COMPLETED|Overall Study||1
8366364|NCT01181921|20622786|P1|COMPLETED|Overall Study||0
8366365|NCT01181921|20622786|P1|STARTED|Overall Study||1
8366366|NCT01181895|20622793|P3|NOT COMPLETED|Overall Study||18
8366367|NCT01181895|20622794|P2|NOT COMPLETED|Overall Study||14
8366368|NCT01181895|20622795|P1|NOT COMPLETED|Overall Study||17
8366369|NCT01181895|20622793|P3|COMPLETED|Overall Study||98
8366370|NCT01181895|20622794|P2|COMPLETED|Overall Study||101
8366371|NCT01181895|20622795|P1|COMPLETED|Overall Study||99
8366372|NCT01181895|20622793|P3|STARTED|Overall Study||116
8366373|NCT01181895|20622794|P2|STARTED|Overall Study||115
8366374|NCT01181895|20622795|P1|STARTED|Overall Study||116
8366375|NCT01181804|20622828|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8366376|NCT01181804|20622829|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
8366377|NCT01181804|20622830|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8366378|NCT01181804|20622831|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8366379|NCT01181804|20622828|P4|COMPLETED|Period 4, Fasted (Part 2)||58
8366380|NCT01181804|20622829|P3|COMPLETED|Period 4, Fasted (Part 2)||58
8366381|NCT01181804|20622830|P2|COMPLETED|Period 4, Fasted (Part 2)||0
8366382|NCT01181804|20622831|P1|COMPLETED|Period 4, Fasted (Part 2)||0
8366383|NCT01181804|20622828|P4|STARTED|Period 4, Fasted (Part 2)||58
8366384|NCT01181804|20622829|P3|STARTED|Period 4, Fasted (Part 2)||59
8366385|NCT01181804|20622830|P2|STARTED|Period 4, Fasted (Part 2)||0
8366386|NCT01181804|20622831|P1|STARTED|Period 4, Fasted (Part 2)||0
8366387|NCT01181804|20622828|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366388|NCT01181804|20622829|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366389|NCT01181804|20622830|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366390|NCT01181804|20622831|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366391|NCT01181804|20622828|P4|COMPLETED|Period 3, Fasted (Part 2)||58
8366392|NCT01181804|20622829|P3|COMPLETED|Period 3, Fasted (Part 2)||59
8366393|NCT01181804|20622830|P2|COMPLETED|Period 3, Fasted (Part 2)||0
8366394|NCT01181804|20622831|P1|COMPLETED|Period 3, Fasted (Part 2)||0
8366395|NCT01181804|20622828|P4|STARTED|Period 3, Fasted (Part 2)||58
8366396|NCT01181804|20622829|P3|STARTED|Period 3, Fasted (Part 2)||59
8366397|NCT01181804|20622830|P2|STARTED|Period 3, Fasted (Part 2)||0
8366398|NCT01181804|20622831|P1|STARTED|Period 3, Fasted (Part 2)||0
8366399|NCT01181804|20622828|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366400|NCT01181804|20622829|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366401|NCT01181804|20622830|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366402|NCT01181804|20622831|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366403|NCT01181804|20622828|P4|COMPLETED|Period 2, Fed (Part 1)||0
8366404|NCT01181804|20622829|P3|COMPLETED|Period 2, Fed (Part 1)||0
8366405|NCT01181804|20622830|P2|COMPLETED|Period 2, Fed (Part 1)||30
8366406|NCT01181804|20622831|P1|COMPLETED|Period 2, Fed (Part 1)||30
8366407|NCT01181804|20622828|P4|STARTED|Period 2, Fed (Part 1)||0
8366408|NCT01181804|20622829|P3|STARTED|Period 2, Fed (Part 1)||0
8366409|NCT01181804|20622830|P2|STARTED|Period 2, Fed (Part 1)||30
8366410|NCT01181804|20622831|P1|STARTED|Period 2, Fed (Part 1)||30
8366411|NCT01181804|20622828|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366412|NCT01181804|20622829|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366413|NCT01181804|20622830|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366414|NCT01181804|20622831|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366415|NCT01181804|20622828|P4|COMPLETED|Period 1, Fed (Part 1)||0
8366416|NCT01181804|20622829|P3|COMPLETED|Period 1, Fed (Part 1)||0
8366417|NCT01181804|20622830|P2|COMPLETED|Period 1, Fed (Part 1)||30
8366418|NCT01181804|20622831|P1|COMPLETED|Period 1, Fed (Part 1)||30
8366419|NCT01181804|20622828|P4|STARTED|Period 1, Fed (Part 1)||0
8366420|NCT01181804|20622829|P3|STARTED|Period 1, Fed (Part 1)||0
8366421|NCT01181804|20622830|P2|STARTED|Period 1, Fed (Part 1)||30
8366422|NCT01181804|20622831|P1|STARTED|Period 1, Fed (Part 1)||30
8366423|NCT01181778|20622853|P1|NOT COMPLETED|Overall Study||48
8366424|NCT01181778|20622853|P1|COMPLETED|Overall Study||1871
8366425|NCT01181778|20622853|P1|STARTED|Overall Study||1919
8366426|NCT01181726|20622861|P2|NOT COMPLETED|Second Intervention||0
8366427|NCT01181726|20622862|P1|NOT COMPLETED|Second Intervention||0
8366428|NCT01181726|20622861|P2|COMPLETED|Second Intervention||20
8366429|NCT01181726|20622862|P1|COMPLETED|Second Intervention||19
8366430|NCT01181726|20622861|P2|STARTED|Second Intervention||20
8366431|NCT01181726|20622862|P1|STARTED|Second Intervention||19
8366432|NCT01181726|20622861|P2|NOT COMPLETED|Washout of 28 Days||0
8366433|NCT01181726|20622862|P1|NOT COMPLETED|Washout of 28 Days||0
8366434|NCT01181726|20622861|P2|COMPLETED|Washout of 28 Days||20
8366435|NCT01181726|20622862|P1|COMPLETED|Washout of 28 Days||19
8366436|NCT01181726|20622861|P2|STARTED|Washout of 28 Days||20
8366437|NCT01181726|20622862|P1|STARTED|Washout of 28 Days||19
8366438|NCT01181726|20622861|P2|NOT COMPLETED|First Intervention||0
8366439|NCT01181726|20622862|P1|NOT COMPLETED|First Intervention||1
8366440|NCT01181726|20622861|P2|COMPLETED|First Intervention||20
8366441|NCT01181726|20622862|P1|COMPLETED|First Intervention||19
8366442|NCT01181726|20622861|P2|STARTED|First Intervention||20
8366443|NCT01181726|20622862|P1|STARTED|First Intervention||20
8366444|NCT01181674|20622911|P3|NOT COMPLETED|Overall Study||2
8366445|NCT01181674|20622912|P2|NOT COMPLETED|Overall Study||0
8366446|NCT01181674|20622913|P1|NOT COMPLETED|Overall Study||0
8366447|NCT01181674|20622911|P3|COMPLETED|Overall Study|28 included in analyses|26
8366448|NCT01181674|20622912|P2|COMPLETED|Overall Study||27
8366449|NCT01181674|20622913|P1|COMPLETED|Overall Study||28
8366450|NCT01181674|20622911|P3|STARTED|Overall Study||28
8366451|NCT01181674|20622912|P2|STARTED|Overall Study||27
8366452|NCT01181674|20622913|P1|STARTED|Overall Study||28
8366453|NCT01181609|20622942|P1|NOT COMPLETED|Overall Study||53
8366454|NCT01181609|20622942|P1|COMPLETED|Overall Study||1
8366455|NCT01181609|20622942|P1|STARTED|Overall Study||54
8366456|NCT01181596|20622953|P1|NOT COMPLETED|Overall Study||0
8366457|NCT01181596|20622953|P1|COMPLETED|Overall Study||31
8366458|NCT01181596|20622953|P1|STARTED|Overall Study||31
8366459|NCT01181531|20622960|P2|NOT COMPLETED|Overall Study||53
8366460|NCT01181531|20622961|P1|NOT COMPLETED|Overall Study||61
8366461|NCT01181531|20622960|P2|COMPLETED|Overall Study||102
8366462|NCT01181531|20622961|P1|COMPLETED|Overall Study||96
8366463|NCT01181531|20622960|P2|Received Investigational Product|Overall Study||153
8366464|NCT01181531|20622961|P1|Received Investigational Product|Overall Study||155
8366465|NCT01181531|20622960|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
8366466|NCT01181531|20622961|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
8366467|NCT01181492|20622974|P3|NOT COMPLETED|Overall Study||0
8366468|NCT01181492|20622975|P2|NOT COMPLETED|Overall Study||0
8366469|NCT01181492|20622976|P1|NOT COMPLETED|Overall Study||0
8366470|NCT01181492|20622974|P3|COMPLETED|Overall Study||7
8366471|NCT01181492|20622975|P2|COMPLETED|Overall Study||66
8366472|NCT01181492|20622976|P1|COMPLETED|Overall Study||103
8366473|NCT01181492|20622974|P3|STARTED|Overall Study||7
8366474|NCT01181492|20622975|P2|STARTED|Overall Study||66
8366475|NCT01181492|20622976|P1|STARTED|Overall Study||103
8366476|NCT01181479|20622992|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
8366477|NCT01181479|20622993|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
8366478|NCT01181479|20622994|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
8366479|NCT01181479|20622992|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
8366480|NCT01181479|20622993|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
8366481|NCT01181479|20622994|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
8366482|NCT01181479|20622992|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
8366483|NCT01181479|20622993|P2|STARTED|Crossover Subjects Recieve AG200-15||0
8366484|NCT01181479|20622994|P1|STARTED|Crossover Subjects Recieve AG200-15||0
8366485|NCT01181479|20622992|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
8366486|NCT01181479|20622993|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
8366487|NCT01181479|20622994|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
8366488|NCT01181479|20622992|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
8366489|NCT01181479|20622993|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
8366490|NCT01181479|20622994|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
8366491|NCT01181479|20622992|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
8366492|NCT01181479|20622993|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
8366493|NCT01181479|20622994|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
8366494|NCT01181349|20623009|P1|NOT COMPLETED|Overall Study||0
8366495|NCT01181349|20623009|P1|COMPLETED|Overall Study||350
8366496|NCT01181349|20623009|P1|STARTED|Overall Study||350
8366497|NCT01181323|20623025|P4|NOT COMPLETED|Overall Study||3
8366498|NCT01181323|20623026|P3|NOT COMPLETED|Overall Study||1
8366499|NCT01181323|20623027|P2|NOT COMPLETED|Overall Study||3
8366500|NCT01181323|20623028|P1|NOT COMPLETED|Overall Study||1
8366501|NCT01181323|20623025|P4|COMPLETED|Overall Study||122
8366502|NCT01181323|20623026|P3|COMPLETED|Overall Study||123
8366503|NCT01181323|20623027|P2|COMPLETED|Overall Study||121
8366504|NCT01181323|20623028|P1|COMPLETED|Overall Study||123
8366505|NCT01181323|20623025|P4|STARTED|Overall Study||125
8366506|NCT01181323|20623026|P3|STARTED|Overall Study||124
8366507|NCT01181323|20623027|P2|STARTED|Overall Study||124
8366508|NCT01181323|20623028|P1|STARTED|Overall Study||124
8366509|NCT01181271|20623103|P1|NOT COMPLETED|Allogeneic Transplant||0
8366510|NCT01181271|20623103|P1|COMPLETED|Allogeneic Transplant||29
8366511|NCT01181271|20623103|P1|STARTED|Allogeneic Transplant||29
8366512|NCT01181271|20623103|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
8366513|NCT01181271|20623103|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
8366514|NCT01181271|20623103|P1|STARTED|Evaluation for Allogeneic Transplant||42
8366515|NCT01181271|20623103|P1|NOT COMPLETED|Autologous Transplant||0
8366516|NCT01181271|20623103|P1|COMPLETED|Autologous Transplant||42
8366517|NCT01181271|20623103|P1|STARTED|Autologous Transplant||42
8366518|NCT01181258|20623118|P1|NOT COMPLETED|Overall Study||0
8366519|NCT01181258|20623118|P1|COMPLETED|Overall Study||16
8366520|NCT01181258|20623118|P1|STARTED|Overall Study||16
8366521|NCT01181167|20623127|P2|NOT COMPLETED|Overall Study||32
8366522|NCT01181167|20623128|P1|NOT COMPLETED|Overall Study||23
8366523|NCT01181167|20623127|P2|COMPLETED|Overall Study||271
8366524|NCT01181167|20623128|P1|COMPLETED|Overall Study||284
8366525|NCT01181167|20623127|P2|Efficacy Analysis Population|Overall Study||248
8366526|NCT01181167|20623128|P1|Efficacy Analysis Population|Overall Study||255
8366527|NCT01181167|20623127|P2|STARTED|Overall Study||303
8366528|NCT01181167|20623128|P1|STARTED|Overall Study||307
8366529|NCT01181141|20623138|P2|NOT COMPLETED|Overall Study||4
8366530|NCT01181141|20623139|P1|NOT COMPLETED|Overall Study||12
8366531|NCT01181141|20623138|P2|COMPLETED|Overall Study||26
8366532|NCT01181141|20623139|P1|COMPLETED|Overall Study||50
8366533|NCT01181141|20623138|P2|Safety Analysis Population|Overall Study||29
8366534|NCT01181141|20623139|P1|Safety Analysis Population|Overall Study||59
8366535|NCT01181141|20623138|P2|STARTED|Overall Study||30
8366536|NCT01181141|20623139|P1|STARTED|Overall Study||62
8366537|NCT01181128|20623148|P3|NOT COMPLETED|Overall Study||1
8366538|NCT01181128|20623149|P2|NOT COMPLETED|Overall Study||5
8366539|NCT01181128|20623150|P1|NOT COMPLETED|Overall Study||6
8366540|NCT01181128|20623148|P3|COMPLETED|Overall Study||22
8366541|NCT01181128|20623149|P2|COMPLETED|Overall Study||19
8366542|NCT01181128|20623150|P1|COMPLETED|Overall Study||112
8366543|NCT01181128|20623148|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
8366544|NCT01181128|20623149|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
8366545|NCT01181128|20623150|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
8366546|NCT01181128|20623148|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
8366547|NCT01181128|20623149|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
8366548|NCT01181128|20623150|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
8366549|NCT01181128|20623148|P3|STARTED|Overall Study||23
8366550|NCT01181128|20623149|P2|STARTED|Overall Study||24
8366551|NCT01181128|20623150|P1|STARTED|Overall Study||118
8366552|NCT01181102|20623238|P2|NOT COMPLETED|Overall Study||46
8366553|NCT01181102|20623239|P1|NOT COMPLETED|Overall Study||51
8366554|NCT01181102|20623238|P2|COMPLETED|Overall Study||310
8366555|NCT01181102|20623239|P1|COMPLETED|Overall Study||309
8366556|NCT01181102|20623238|P2|Efficacy Analysis Population|Overall Study||295
8366557|NCT01181102|20623239|P1|Efficacy Analysis Population|Overall Study||299
8366558|NCT01181102|20623238|P2|Safety Analysis Set|Overall Study||349
8366559|NCT01181102|20623239|P1|Safety Analysis Set|Overall Study||354
8366560|NCT01181102|20623238|P2|STARTED|Overall Study||356
8366561|NCT01181102|20623239|P1|STARTED|Overall Study||360
8366562|NCT01181076|20623249|P2|NOT COMPLETED|Overall Study||12
8366563|NCT01181076|20623250|P1|NOT COMPLETED|Overall Study||19
8366564|NCT01181076|20623249|P2|COMPLETED|Overall Study|As determined|48
8366565|NCT01181076|20623250|P1|COMPLETED|Overall Study||40
8366566|NCT01181076|20623249|P2|STARTED|Overall Study||60
8366567|NCT01181076|20623250|P1|STARTED|Overall Study||59
8366568|NCT01181050|20623272|P2|NOT COMPLETED|Overall Study||0
8366569|NCT01181050|20623273|P1|NOT COMPLETED|Overall Study||0
8366570|NCT01181050|20623272|P2|COMPLETED|Overall Study||22
8366571|NCT01181050|20623273|P1|COMPLETED|Overall Study||41
8366572|NCT01181050|20623272|P2|STARTED|Overall Study||22
8366573|NCT01181050|20623273|P1|STARTED|Overall Study||41
8366574|NCT01181011|20623283|P1|NOT COMPLETED|Overall Study||3
8366575|NCT01181011|20623283|P1|COMPLETED|Overall Study||25
8366576|NCT01181011|20623283|P1|Received Amlodipine 5mg|Overall Study||26
8366577|NCT01181011|20623283|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
8366578|NCT01181011|20623283|P1|Received Telmisartan 80mg|Overall Study||27
8366579|NCT01181011|20623283|P1|STARTED|Overall Study||28
8366580|NCT01180998|20623333|P3|NOT COMPLETED|Overall Study||10
8366581|NCT01180998|20623334|P2|NOT COMPLETED|Overall Study||4
8366582|NCT01180998|20623335|P1|NOT COMPLETED|Overall Study||4
8366583|NCT01180998|20623333|P3|COMPLETED|Overall Study||51
8366584|NCT01180998|20623334|P2|COMPLETED|Overall Study||68
8366585|NCT01180998|20623335|P1|COMPLETED|Overall Study||63
8366586|NCT01180998|20623333|P3|STARTED|Overall Study||61
8366587|NCT01180998|20623334|P2|STARTED|Overall Study||72
8366588|NCT01180998|20623335|P1|STARTED|Overall Study||67
8366589|NCT01180985|20623349|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
8366590|NCT01180985|20623350|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
8366591|NCT01180985|20623349|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
8366592|NCT01180985|20623350|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
8366593|NCT01180985|20623349|P2|STARTED|Period 2 (7 +/- 1 Days)||26
8366594|NCT01180985|20623350|P1|STARTED|Period 2 (7 +/- 1 Days)||27
8366595|NCT01180985|20623349|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
8366596|NCT01180985|20623350|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
8366597|NCT01180985|20623349|P2|COMPLETED|Period 1 (7 +/- Days)||26
8366598|NCT01180985|20623350|P1|COMPLETED|Period 1 (7 +/- Days)||27
8366599|NCT01180985|20623349|P2|STARTED|Period 1 (7 +/- Days)||26
8366600|NCT01180985|20623350|P1|STARTED|Period 1 (7 +/- Days)||27
8366601|NCT01180894|20623369|P2|NOT COMPLETED|Overall Study||0
8366602|NCT01180894|20623370|P1|NOT COMPLETED|Overall Study||0
8366603|NCT01180894|20623369|P2|COMPLETED|Overall Study||75
8366604|NCT01180894|20623370|P1|COMPLETED|Overall Study||75
8366605|NCT01180894|20623369|P2|STARTED|Overall Study||75
8366606|NCT01180894|20623370|P1|STARTED|Overall Study||75
8366607|NCT01180790|20623389|P7|NOT COMPLETED|Overall Study||1
8366608|NCT01180790|20623390|P6|NOT COMPLETED|Overall Study||7
8366609|NCT01180790|20623391|P5|NOT COMPLETED|Overall Study||5
8366610|NCT01180790|20623392|P4|NOT COMPLETED|Overall Study||9
8366611|NCT01180790|20623393|P3|NOT COMPLETED|Overall Study||13
8366612|NCT01180790|20623394|P2|NOT COMPLETED|Overall Study||5
8366613|NCT01180790|20623395|P1|NOT COMPLETED|Overall Study||9
8366614|NCT01180790|20623389|P7|COMPLETED|Overall Study||18
8366615|NCT01180790|20623390|P6|COMPLETED|Overall Study||13
8366616|NCT01180790|20623391|P5|COMPLETED|Overall Study||14
8366617|NCT01180790|20623392|P4|COMPLETED|Overall Study||6
8366618|NCT01180790|20623393|P3|COMPLETED|Overall Study||4
8366619|NCT01180790|20623394|P2|COMPLETED|Overall Study||11
8366620|NCT01180790|20623395|P1|COMPLETED|Overall Study||7
8366621|NCT01180790|20623389|P7|STARTED|Overall Study||19
8366622|NCT01180790|20623390|P6|STARTED|Overall Study||20
8366623|NCT01180790|20623391|P5|STARTED|Overall Study||19
8366624|NCT01180790|20623392|P4|STARTED|Overall Study||15
8366625|NCT01180790|20623393|P3|STARTED|Overall Study||17
8366626|NCT01180790|20623394|P2|STARTED|Overall Study||16
8366627|NCT01180790|20623395|P1|STARTED|Overall Study||16
8366628|NCT01180777|20623460|P1|NOT COMPLETED|Overall Study||12
8366629|NCT01180777|20623460|P1|COMPLETED|Overall Study||80
8366630|NCT01180777|20623460|P1|STARTED|Overall Study||92
8366631|NCT01180660|20623474|P2|NOT COMPLETED|Overall Study||0
8366632|NCT01180660|20623475|P1|NOT COMPLETED|Overall Study||1
8366633|NCT01180660|20623474|P2|COMPLETED|Overall Study||26
8366634|NCT01180660|20623475|P1|COMPLETED|Overall Study||24
8366635|NCT01180660|20623474|P2|STARTED|Overall Study||26
8366636|NCT01180660|20623475|P1|STARTED|Overall Study||25
8366637|NCT01180647|20623485|P2|NOT COMPLETED|Overall Study||6
8366638|NCT01180647|20623486|P1|NOT COMPLETED|Overall Study||5
8366639|NCT01180647|20623485|P2|COMPLETED|Overall Study||11
8366640|NCT01180647|20623486|P1|COMPLETED|Overall Study||12
8366641|NCT01180647|20623485|P2|STARTED|Overall Study||17
8366642|NCT01180647|20623486|P1|STARTED|Overall Study||17
8366643|NCT01180478|20623504|P2|NOT COMPLETED|Overall Study||188
8366644|NCT01180478|20623505|P1|NOT COMPLETED|Overall Study||181
8366645|NCT01180478|20623504|P2|COMPLETED|Overall Study||293
8366646|NCT01180478|20623505|P1|COMPLETED|Overall Study||303
8366647|NCT01180478|20623504|P2|STARTED|Overall Study||481
8366648|NCT01180478|20623505|P1|STARTED|Overall Study||484
8366649|NCT01180400|20623521|P2|NOT COMPLETED|Overall Study||27
8366650|NCT01180400|20623522|P1|NOT COMPLETED|Overall Study||25
8366651|NCT01180400|20623521|P2|COMPLETED|Overall Study||121
8366652|NCT01180400|20623522|P1|COMPLETED|Overall Study||122
8366653|NCT01180400|20623521|P2|Received Treatment|Overall Study||146
8366654|NCT01180400|20623522|P1|Received Treatment|Overall Study||147
8366655|NCT01180400|20623521|P2|STARTED|Overall Study||148
8366656|NCT01180400|20623522|P1|STARTED|Overall Study||147
8366657|NCT01180296|20623570|P2|NOT COMPLETED|Overall Study||2
8366658|NCT01180296|20623571|P1|NOT COMPLETED|Overall Study||1
8366659|NCT01180296|20623570|P2|COMPLETED|Overall Study||14
8366660|NCT01180296|20623571|P1|COMPLETED|Overall Study||19
8366661|NCT01180296|20623570|P2|STARTED|Overall Study||16
8366662|NCT01180296|20623571|P1|STARTED|Overall Study||20
8366663|NCT01180244|20623581|P2|NOT COMPLETED|Overall Study||8
8366664|NCT01180244|20623582|P1|NOT COMPLETED|Overall Study||6
8366665|NCT01180244|20623581|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
8366666|NCT01180244|20623582|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
8366667|NCT01180244|20623581|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
8366668|NCT01180244|20623582|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
8366758|NCT01179568|20623722|P1|Completed Week 12 Assessment|Overall Study||69
8366669|NCT01180244|20623581|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
8366670|NCT01180244|20623582|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
8366671|NCT01180127|20623600|P4|NOT COMPLETED|Overall Study||1
8366672|NCT01180127|20623601|P3|NOT COMPLETED|Overall Study||1
8366673|NCT01180127|20623602|P2|NOT COMPLETED|Overall Study||0
8366674|NCT01180127|20623603|P1|NOT COMPLETED|Overall Study||2
8366675|NCT01180127|20623600|P4|COMPLETED|Overall Study||9
8366676|NCT01180127|20623601|P3|COMPLETED|Overall Study||9
8366677|NCT01180127|20623602|P2|COMPLETED|Overall Study||11
8366678|NCT01180127|20623603|P1|COMPLETED|Overall Study||8
8366679|NCT01180127|20623600|P4|STARTED|Overall Study||10
8366680|NCT01180127|20623601|P3|STARTED|Overall Study||10
8366681|NCT01180127|20623602|P2|STARTED|Overall Study||11
8366682|NCT01180127|20623603|P1|STARTED|Overall Study||10
8366683|NCT01180049|20623627|P2|NOT COMPLETED|Overall Study||48
8366684|NCT01180049|20623628|P1|NOT COMPLETED|Overall Study||53
8366685|NCT01180049|20623627|P2|COMPLETED|Overall Study||0
8366686|NCT01180049|20623628|P1|COMPLETED|Overall Study||0
8366687|NCT01180049|20623627|P2|STARTED|Overall Study||48
8366688|NCT01180049|20623628|P1|STARTED|Overall Study||53
8366689|NCT01180036|20623650|P2|NOT COMPLETED|Overall Study||0
8366690|NCT01180036|20623651|P1|NOT COMPLETED|Overall Study||0
8366691|NCT01180036|20623650|P2|COMPLETED|Overall Study||65
8366692|NCT01180036|20623651|P1|COMPLETED|Overall Study||65
8366693|NCT01180036|20623650|P2|STARTED|Overall Study||65
8366694|NCT01180036|20623651|P1|STARTED|Overall Study||65
8366695|NCT01179984|20623659|P1|NOT COMPLETED|Overall Study||18
8366696|NCT01179984|20623659|P1|COMPLETED|Overall Study||58
8366697|NCT01179984|20623659|P1|STARTED|Overall Study||76
8366698|NCT01179919|20623665|P1|NOT COMPLETED|Overall Study||2
8366699|NCT01179919|20623665|P1|COMPLETED|Overall Study||19
8366700|NCT01179919|20623665|P1|STARTED|Overall Study||21
8366701|NCT01179737|20623674|P4|NOT COMPLETED|Extension||0
8366702|NCT01179737|20623675|P3|NOT COMPLETED|Extension||0
8366703|NCT01179737|20623676|P2|NOT COMPLETED|Extension||0
8366704|NCT01179737|20623677|P1|NOT COMPLETED|Extension||3
8366705|NCT01179737|20623674|P4|COMPLETED|Extension||0
8366706|NCT01179737|20623675|P3|COMPLETED|Extension||0
8366707|NCT01179737|20623676|P2|COMPLETED|Extension||0
8366708|NCT01179737|20623677|P1|COMPLETED|Extension||0
8366709|NCT01179737|20623674|P4|STARTED|Extension||0
8366710|NCT01179737|20623675|P3|STARTED|Extension||0
8366711|NCT01179737|20623676|P2|STARTED|Extension|One patient did not enrol in the extension|0
8366712|NCT01179737|20623677|P1|STARTED|Extension|Two patients did not enrol in the extension|3
8366713|NCT01179737|20623674|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366714|NCT01179737|20623675|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366715|NCT01179737|20623676|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366716|NCT01179737|20623677|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
8366717|NCT01179737|20623674|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366718|NCT01179737|20623675|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366719|NCT01179737|20623676|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
8366720|NCT01179737|20623677|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
8366721|NCT01179737|20623674|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
8366722|NCT01179737|20623675|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
8366723|NCT01179737|20623676|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
8366724|NCT01179737|20623677|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
8366725|NCT01179737|20623674|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
8366726|NCT01179737|20623675|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
8366727|NCT01179737|20623676|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
8366728|NCT01179737|20623677|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
8366729|NCT01179737|20623674|P4|COMPLETED|Cohort 1 & Cohort 2||0
8366730|NCT01179737|20623675|P3|COMPLETED|Cohort 1 & Cohort 2||0
8366731|NCT01179737|20623676|P2|COMPLETED|Cohort 1 & Cohort 2||1
8366732|NCT01179737|20623677|P1|COMPLETED|Cohort 1 & Cohort 2||7
8366733|NCT01179737|20623674|P4|STARTED|Cohort 1 & Cohort 2||4
8366734|NCT01179737|20623675|P3|STARTED|Cohort 1 & Cohort 2||4
8366735|NCT01179737|20623676|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
8366736|NCT01179737|20623677|P1|STARTED|Cohort 1 & Cohort 2||12
8366737|NCT01179672|20623688|P2|NOT COMPLETED|Overall Study||26
8366738|NCT01179672|20623689|P1|NOT COMPLETED|Overall Study||30
8366739|NCT01179672|20623688|P2|COMPLETED|Overall Study||176
8366740|NCT01179672|20623689|P1|COMPLETED|Overall Study||173
8366741|NCT01179672|20623688|P2|Entered Taper|Overall Study||177
8366742|NCT01179672|20623689|P1|Entered Taper|Overall Study||181
8366743|NCT01179672|20623688|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
8366744|NCT01179672|20623689|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
8366745|NCT01179672|20623688|P2|STARTED|Overall Study||202
8366746|NCT01179672|20623689|P1|STARTED|Overall Study||203
8366747|NCT01179568|20623719|P4|NOT COMPLETED|Overall Study||20
8366748|NCT01179568|20623720|P3|NOT COMPLETED|Overall Study||23
8366749|NCT01179568|20623721|P2|NOT COMPLETED|Overall Study||38
8366750|NCT01179568|20623722|P1|NOT COMPLETED|Overall Study||28
8366751|NCT01179568|20623719|P4|COMPLETED|Overall Study||76
8366752|NCT01179568|20623720|P3|COMPLETED|Overall Study||76
8366753|NCT01179568|20623721|P2|COMPLETED|Overall Study||61
8366754|NCT01179568|20623722|P1|COMPLETED|Overall Study||73
8366755|NCT01179568|20623719|P4|Completed Week 12 Assessment|Overall Study||75
8366756|NCT01179568|20623720|P3|Completed Week 12 Assessment|Overall Study||76
8366757|NCT01179568|20623721|P2|Completed Week 12 Assessment|Overall Study||69
8366759|NCT01179568|20623719|P4|STARTED|Overall Study||96
8366760|NCT01179568|20623720|P3|STARTED|Overall Study||99
8366761|NCT01179568|20623721|P2|STARTED|Overall Study||99
8366762|NCT01179568|20623722|P1|STARTED|Overall Study||101
8366763|NCT01179516|20623745|P3|NOT COMPLETED|Overall Study||31
8366764|NCT01179516|20623746|P2|NOT COMPLETED|Overall Study||26
8366765|NCT01179516|20623747|P1|NOT COMPLETED|Overall Study||27
8366766|NCT01179516|20623745|P3|COMPLETED|Overall Study||121
8366767|NCT01179516|20623746|P2|COMPLETED|Overall Study||131
8366768|NCT01179516|20623747|P1|COMPLETED|Overall Study||133
8366769|NCT01179516|20623745|P3|Treated|Overall Study||151
8366770|NCT01179516|20623746|P2|Treated|Overall Study||154
8366771|NCT01179516|20623747|P1|Treated|Overall Study||160
8366772|NCT01179516|20623745|P3|STARTED|Overall Study||152
8366773|NCT01179516|20623746|P2|STARTED|Overall Study||157
8366774|NCT01179516|20623747|P1|STARTED|Overall Study||160
8366775|NCT01179490|20623770|P1|NOT COMPLETED|Overall Study||0
8366776|NCT01179490|20623770|P1|COMPLETED|Overall Study||5
8366777|NCT01179490|20623770|P1|STARTED|Overall Study||5
8366778|NCT01179477|20623791|P1|NOT COMPLETED|Overall Study||1087
8366779|NCT01179477|20623791|P1|COMPLETED|Overall Study||843
8366780|NCT01179477|20623791|P1|STARTED|Overall Study||1930
8366781|NCT01179399|20623796|P1|NOT COMPLETED|Overall Study||32
8366782|NCT01179399|20623796|P1|COMPLETED|Overall Study||0
8366783|NCT01179399|20623796|P1|STARTED|Overall Study||32
8366784|NCT01179347|20623802|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
8366785|NCT01179347|20623803|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
8366786|NCT01179347|20623802|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
8366787|NCT01179347|20623803|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
8366788|NCT01179347|20623802|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
8366789|NCT01179347|20623803|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
8366790|NCT01179347|20623802|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
8366791|NCT01179347|20623803|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
8366792|NCT01179347|20623802|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
8366793|NCT01179347|20623803|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
8366794|NCT01179347|20623802|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
8366795|NCT01179347|20623803|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
8366796|NCT01179334|20623825|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
8366797|NCT01179334|20623826|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
8366798|NCT01179334|20623825|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
8366799|NCT01179334|20623826|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
8366800|NCT01179334|20623825|P2|STARTED|Long-term Extension (LTE) Period||6
8366801|NCT01179334|20623826|P1|STARTED|Long-term Extension (LTE) Period||11
8366802|NCT01179334|20623825|P2|NOT COMPLETED|Treatment Period||0
8366803|NCT01179334|20623826|P1|NOT COMPLETED|Treatment Period||1
8366804|NCT01179334|20623825|P2|COMPLETED|Treatment Period||6
8366805|NCT01179334|20623826|P1|COMPLETED|Treatment Period||11
8366806|NCT01179334|20623825|P2|Participants Received Treatment|Treatment Period||6
8366807|NCT01179334|20623826|P1|Participants Received Treatment|Treatment Period||12
8366808|NCT01179334|20623825|P2|STARTED|Treatment Period||6
8366809|NCT01179334|20623826|P1|STARTED|Treatment Period||12
8366810|NCT01179217|20623856|P2|NOT COMPLETED|Overall Study||19
8366811|NCT01179217|20623857|P1|NOT COMPLETED|Overall Study||55
8366812|NCT01179217|20623856|P2|COMPLETED|Overall Study||59
8366813|NCT01179217|20623857|P1|COMPLETED|Overall Study||97
8366814|NCT01179217|20623856|P2|STARTED|Overall Study||78
8366815|NCT01179217|20623857|P1|STARTED|Overall Study||152
8366816|NCT01179191|20623881|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
8366817|NCT01179191|20623881|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
8366818|NCT01179191|20623881|P1|STARTED|Maintenance Phase (8 Weeks)||351
8366819|NCT01179191|20623881|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
8366820|NCT01179191|20623881|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
8366821|NCT01179191|20623881|P1|STARTED|Titration Phase (up to 6 Weeks)||684
8366822|NCT01179113|20623900|P2|NOT COMPLETED|Overall Study||0
8366823|NCT01179113|20623901|P1|NOT COMPLETED|Overall Study||0
8366824|NCT01179113|20623900|P2|COMPLETED|Overall Study||16
8366825|NCT01179113|20623901|P1|COMPLETED|Overall Study||17
8366826|NCT01179113|20623900|P2|STARTED|Overall Study||16
8366827|NCT01179113|20623901|P1|STARTED|Overall Study||17
8366828|NCT01179048|20623913|P2|NOT COMPLETED|Overall Study||159
8366829|NCT01179048|20623914|P1|NOT COMPLETED|Overall Study||139
8366830|NCT01179048|20623913|P2|COMPLETED|Overall Study||4513
8366831|NCT01179048|20623914|P1|COMPLETED|Overall Study||4529
8366832|NCT01179048|20623913|P2|STARTED|Overall Study||4672
8366833|NCT01179048|20623914|P1|STARTED|Overall Study||4668
8366834|NCT01178944|20623930|P1|NOT COMPLETED|Overall Study||0
8366835|NCT01178944|20623930|P1|COMPLETED|Overall Study||35
8366836|NCT01178944|20623930|P1|STARTED|Overall Study||35
8366837|NCT01178853|20623941|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
8366838|NCT01178853|20623942|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
8366839|NCT01178853|20623941|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
8366840|NCT01178853|20623942|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
8366841|NCT01178853|20623941|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
8366842|NCT01178853|20623942|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
8366843|NCT01178853|20623941|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
8366844|NCT01178853|20623942|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
8366845|NCT01178853|20623941|P2|COMPLETED|Period 3 (Warfarin Titration)||22
8366846|NCT01178853|20623942|P1|COMPLETED|Period 3 (Warfarin Titration)||21
8366847|NCT01178853|20623941|P2|STARTED|Period 3 (Warfarin Titration)||22
8366848|NCT01178853|20623942|P1|STARTED|Period 3 (Warfarin Titration)||22
8366849|NCT01178853|20623941|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
8366850|NCT01178853|20623942|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
8366851|NCT01178853|20623941|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
8366852|NCT01178853|20623942|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
8366853|NCT01178853|20623941|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
8366854|NCT01178853|20623942|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
8366855|NCT01178853|20623941|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
8366856|NCT01178853|20623942|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
8366857|NCT01178853|20623941|P2|COMPLETED|Period 1 (Warfarin Titration)||22
8366858|NCT01178853|20623942|P1|COMPLETED|Period 1 (Warfarin Titration)||23
8366859|NCT01178853|20623941|P2|STARTED|Period 1 (Warfarin Titration)||24
8366860|NCT01178853|20623942|P1|STARTED|Period 1 (Warfarin Titration)||24
8366861|NCT01178827|20623951|P3|NOT COMPLETED|Overall Study||0
8366862|NCT01178827|20623952|P2|NOT COMPLETED|Overall Study||0
8366863|NCT01178827|20623953|P1|NOT COMPLETED|Overall Study||0
8366864|NCT01178827|20623951|P3|COMPLETED|Overall Study||4
8366865|NCT01178827|20623952|P2|COMPLETED|Overall Study||10
8366866|NCT01178827|20623953|P1|COMPLETED|Overall Study||6
8366867|NCT01178827|20623951|P3|STARTED|Overall Study||4
8366868|NCT01178827|20623952|P2|STARTED|Overall Study||10
8366869|NCT01178827|20623953|P1|STARTED|Overall Study||6
8366870|NCT01178762|20623982|P1|NOT COMPLETED|Overall Study||15
8366871|NCT01178762|20623982|P1|COMPLETED|Overall Study||27
8366872|NCT01178762|20623982|P1|STARTED|Overall Study||42
8366873|NCT01178671|20623988|P2|NOT COMPLETED|Overall Study||15
8366874|NCT01178671|20623989|P1|NOT COMPLETED|Overall Study||12
8366875|NCT01178671|20623988|P2|COMPLETED|Overall Study||3
8366876|NCT01178671|20623989|P1|COMPLETED|Overall Study||6
8366877|NCT01178671|20623988|P2|STARTED|Overall Study||18
8366878|NCT01178671|20623989|P1|STARTED|Overall Study||18
8366879|NCT01178528|20624016|P3|NOT COMPLETED|Overall Study||0
8366880|NCT01178528|20624017|P2|NOT COMPLETED|Overall Study||0
8366881|NCT01178528|20624018|P1|NOT COMPLETED|Overall Study||0
8366882|NCT01178528|20624016|P3|COMPLETED|Overall Study||42
8366883|NCT01178528|20624017|P2|COMPLETED|Overall Study||38
8366884|NCT01178528|20624018|P1|COMPLETED|Overall Study||41
8366885|NCT01178528|20624016|P3|STARTED|Overall Study||42
8366886|NCT01178528|20624017|P2|STARTED|Overall Study||38
8366887|NCT01178528|20624018|P1|STARTED|Overall Study||41
8366888|NCT01178385|20624037|P2|NOT COMPLETED|Overall Study||0
8366889|NCT01178385|20624038|P1|NOT COMPLETED|Overall Study||2
8366890|NCT01178385|20624037|P2|COMPLETED|Overall Study||21
8366891|NCT01178385|20624038|P1|COMPLETED|Overall Study||22
8366892|NCT01178385|20624037|P2|STARTED|Overall Study||21
8366893|NCT01178385|20624038|P1|STARTED|Overall Study||24
8366894|NCT01178333|20624051|P3|NOT COMPLETED|Overall Study||0
8366895|NCT01178333|20624052|P2|NOT COMPLETED|Overall Study||0
8366896|NCT01178333|20624053|P1|NOT COMPLETED|Overall Study||0
8366897|NCT01178333|20624051|P3|COMPLETED|Overall Study||87
8366898|NCT01178333|20624052|P2|COMPLETED|Overall Study||284
8366899|NCT01178333|20624053|P1|COMPLETED|Overall Study||71
8366900|NCT01178333|20624051|P3|STARTED|Overall Study||87
8366901|NCT01178333|20624052|P2|STARTED|Overall Study||284
8366902|NCT01178333|20624053|P1|STARTED|Overall Study||71
8366903|NCT01178294|20624107|P1|NOT COMPLETED|Overall Study||11
8366904|NCT01178294|20624107|P1|COMPLETED|Overall Study||18
8366905|NCT01178294|20624107|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
8366906|NCT01178281|20624131|P3|NOT COMPLETED|Overall Study||0
8366907|NCT01178281|20624132|P2|NOT COMPLETED|Overall Study||0
8366908|NCT01178281|20624133|P1|NOT COMPLETED|Overall Study||0
8366909|NCT01178281|20624131|P3|COMPLETED|Overall Study||15
8366910|NCT01178281|20624132|P2|COMPLETED|Overall Study||84
8366911|NCT01178281|20624133|P1|COMPLETED|Overall Study||168
8366912|NCT01178281|20624131|P3|Received Study Drug|Overall Study||15
8366913|NCT01178281|20624132|P2|Received Study Drug|Overall Study||83
8366914|NCT01178281|20624133|P1|Received Study Drug|Overall Study||167
8366915|NCT01178281|20624131|P3|STARTED|Overall Study||15
8366916|NCT01178281|20624132|P2|STARTED|Overall Study||84
8366917|NCT01178281|20624133|P1|STARTED|Overall Study||168
8366918|NCT01178268|20624160|P2|NOT COMPLETED|Overall Study||1
8366919|NCT01178268|20624161|P1|NOT COMPLETED|Overall Study||7
8366920|NCT01178268|20624160|P2|COMPLETED|Overall Study||120
8366921|NCT01178268|20624161|P1|COMPLETED|Overall Study||360
8366922|NCT01178268|20624160|P2|STARTED|Overall Study||121
8366923|NCT01178268|20624161|P1|STARTED|Overall Study||367
8366924|NCT01178216|20624378|P1|NOT COMPLETED|Overall Study||2
8366925|NCT01178216|20624378|P1|COMPLETED|Overall Study||39
8366926|NCT01178216|20624378|P1|STARTED|Overall Study||41
8366927|NCT01178138|20624387|P1|NOT COMPLETED|Overall Study||23
8366928|NCT01178138|20624387|P1|COMPLETED|Overall Study||1
8366929|NCT01178138|20624387|P1|Completed 3 Sessions|Overall Study||1
8366930|NCT01178138|20624387|P1|Completed 5 Sessions|Overall Study||1
8366931|NCT01178138|20624387|P1|Completed 6 Sessions|Overall Study||1
8366932|NCT01178138|20624387|P1|STARTED|Overall Study||24
8366933|NCT01178125|20624408|P1|NOT COMPLETED|Overall Study||1178
8366934|NCT01178125|20624408|P1|COMPLETED|Overall Study||1680
8366935|NCT01178125|20624408|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
8366936|NCT01178125|20624408|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
8366937|NCT01178125|20624408|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
8366938|NCT01178125|20624408|P1|STARTED|Overall Study|Number enrolled.|2858
8366939|NCT01178099|20624439|P2|NOT COMPLETED|Overall Study||1
8366940|NCT01178099|20624440|P1|NOT COMPLETED|Overall Study||0
8366941|NCT01178099|20624439|P2|COMPLETED|Overall Study||12
8366942|NCT01178099|20624440|P1|COMPLETED|Overall Study||13
8366943|NCT01178099|20624439|P2|STARTED|Overall Study||13
8366944|NCT01178099|20624440|P1|STARTED|Overall Study||13
8366945|NCT01178086|20624480|P1|NOT COMPLETED|Overall Study||332
8366946|NCT01178086|20624480|P1|COMPLETED|Overall Study||349
8366947|NCT01178086|20624480|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
8366948|NCT01178086|20624480|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
8366949|NCT01178073|20624507|P3|NOT COMPLETED|Overall Study||46
8366950|NCT01178073|20624508|P2|NOT COMPLETED|Overall Study||44
8366951|NCT01178073|20624509|P1|NOT COMPLETED|Overall Study||62
8366952|NCT01178073|20624507|P3|COMPLETED|Overall Study||105
8366953|NCT01178073|20624508|P2|COMPLETED|Overall Study||108
8366954|NCT01178073|20624509|P1|COMPLETED|Overall Study||240
8366955|NCT01178073|20624507|P3|STARTED|Overall Study||151
8366956|NCT01178073|20624508|P2|STARTED|Overall Study||152
8366957|NCT01178073|20624509|P1|STARTED|Overall Study||302
8366958|NCT01177969|20624540|P2|NOT COMPLETED|Overall Study||3
8366959|NCT01177969|20624541|P1|NOT COMPLETED|Overall Study||3
8366960|NCT01177969|20624540|P2|COMPLETED|Overall Study||11
8366961|NCT01177969|20624541|P1|COMPLETED|Overall Study||16
8366962|NCT01177969|20624540|P2|STARTED|Overall Study||14
8366963|NCT01177969|20624541|P1|STARTED|Overall Study||19
8366964|NCT01177956|20624549|P1|NOT COMPLETED|Overall Study||0
8366965|NCT01177956|20624549|P1|COMPLETED|Overall Study||68
8366966|NCT01177956|20624549|P1|STARTED|Overall Study||68
8366967|NCT01177943|20624564|P2|NOT COMPLETED|Second Intervention||0
8366968|NCT01177943|20624565|P1|NOT COMPLETED|Second Intervention||0
8366969|NCT01177943|20624564|P2|COMPLETED|Second Intervention||21
8366970|NCT01177943|20624565|P1|COMPLETED|Second Intervention||19
8366971|NCT01177943|20624564|P2|STARTED|Second Intervention||21
8366972|NCT01177943|20624565|P1|STARTED|Second Intervention||19
8366973|NCT01177943|20624564|P2|NOT COMPLETED|First Intervention||0
8366974|NCT01177943|20624565|P1|NOT COMPLETED|First Intervention||2
8366975|NCT01177943|20624564|P2|COMPLETED|First Intervention||21
8366976|NCT01177943|20624565|P1|COMPLETED|First Intervention||19
8366977|NCT01177943|20624564|P2|STARTED|First Intervention||21
8366978|NCT01177943|20624565|P1|STARTED|First Intervention||21
8366979|NCT01177813|20624578|P5|NOT COMPLETED|Overall Study||9
8366980|NCT01177813|20624579|P4|NOT COMPLETED|Overall Study||17
8366981|NCT01177813|20624580|P3|NOT COMPLETED|Overall Study||20
8366982|NCT01177813|20624581|P2|NOT COMPLETED|Overall Study||18
8366983|NCT01177813|20624582|P1|NOT COMPLETED|Overall Study||41
8366984|NCT01177813|20624578|P5|COMPLETED|Overall Study||78
8366985|NCT01177813|20624579|P4|COMPLETED|Overall Study||206
8366986|NCT01177813|20624580|P3|COMPLETED|Overall Study||204
8366987|NCT01177813|20624581|P2|COMPLETED|Overall Study||206
8366988|NCT01177813|20624582|P1|COMPLETED|Overall Study||187
8366989|NCT01177813|20624578|P5|STARTED|Overall Study||87
8366990|NCT01177813|20624579|P4|STARTED|Overall Study||223
8366991|NCT01177813|20624580|P3|STARTED|Overall Study||224
8366992|NCT01177813|20624581|P2|STARTED|Overall Study||224
8366993|NCT01177813|20624582|P1|STARTED|Overall Study||228
8366994|NCT01177800|20624611|P2|NOT COMPLETED|Overall Study||5
8366995|NCT01177800|20624612|P1|NOT COMPLETED|Overall Study||10
8366996|NCT01177800|20624611|P2|COMPLETED|Overall Study||40
8366997|NCT01177800|20624612|P1|COMPLETED|Overall Study||74
8366998|NCT01177800|20624611|P2|STARTED|Overall Study||45
8366999|NCT01177800|20624612|P1|STARTED|Overall Study||84
8367000|NCT01177735|20624626|P1|NOT COMPLETED|Overall Study||71
8367001|NCT01177735|20624626|P1|COMPLETED|Overall Study||0
8367002|NCT01177735|20624626|P1|STARTED|Overall Study||71
8367003|NCT01177722|20624634|P4|NOT COMPLETED|Overall Study||7
8367004|NCT01177722|20624635|P3|NOT COMPLETED|Overall Study||9
8367005|NCT01177722|20624636|P2|NOT COMPLETED|Overall Study||10
8367006|NCT01177722|20624637|P1|NOT COMPLETED|Overall Study||13
8367007|NCT01177722|20624634|P4|COMPLETED|Overall Study||338
8367008|NCT01177722|20624635|P3|COMPLETED|Overall Study||333
8367009|NCT01177722|20624636|P2|COMPLETED|Overall Study||334
8367010|NCT01177722|20624637|P1|COMPLETED|Overall Study||331
8367011|NCT01177722|20624634|P4|STARTED|Overall Study||345
8367012|NCT01177722|20624635|P3|STARTED|Overall Study||342
8367013|NCT01177722|20624636|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
8367014|NCT01177722|20624637|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
8367015|NCT01177709|20624663|P1|NOT COMPLETED|Overall Study||0
8367016|NCT01177709|20624663|P1|COMPLETED|Overall Study||12
8367017|NCT01177709|20624663|P1|STARTED|Overall Study||12
8367018|NCT01177670|20624669|P1|NOT COMPLETED|Overall Study||169
8367019|NCT01177670|20624669|P1|COMPLETED|Overall Study||0
8367020|NCT01177670|20624669|P1|STARTED|Overall Study||169
8367021|NCT01177553|20624676|P2|NOT COMPLETED|Overall Study||0
8367022|NCT01177553|20624677|P1|NOT COMPLETED|Overall Study||1
8367023|NCT01177553|20624676|P2|COMPLETED|Overall Study|data as of March 2009|2
8367024|NCT01177553|20624677|P1|COMPLETED|Overall Study|data as of March 2009|2
8367025|NCT01177553|20624676|P2|STARTED|Overall Study||2
8367026|NCT01177553|20624677|P1|STARTED|Overall Study||3
8367027|NCT01177410|20624686|P3|NOT COMPLETED|Overall Study||5
8367028|NCT01177410|20624687|P2|NOT COMPLETED|Overall Study||7
8367029|NCT01177410|20624688|P1|NOT COMPLETED|Overall Study||1
8367030|NCT01177410|20624686|P3|COMPLETED|Overall Study||45
8367031|NCT01177410|20624687|P2|COMPLETED|Overall Study||40
8367032|NCT01177410|20624688|P1|COMPLETED|Overall Study||50
8367033|NCT01177410|20624686|P3|STARTED|Overall Study||50
8367034|NCT01177410|20624687|P2|STARTED|Overall Study||47
8367035|NCT01177410|20624688|P1|STARTED|Overall Study||51
8367036|NCT01177384|20624701|P2|NOT COMPLETED|Overall Study||26
8367037|NCT01177384|20624702|P1|NOT COMPLETED|Overall Study||14
8367038|NCT01177384|20624701|P2|COMPLETED|Overall Study||164
8367039|NCT01177384|20624702|P1|COMPLETED|Overall Study||177
8367040|NCT01177384|20624701|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
8367041|NCT01177384|20624702|P1|STARTED|Overall Study||191
8367042|NCT01177228|20624718|P4|NOT COMPLETED|Overall Study||0
8367043|NCT01177228|20624719|P3|NOT COMPLETED|Overall Study||0
8367044|NCT01177228|20624720|P2|NOT COMPLETED|Overall Study||2
8367045|NCT01177228|20624721|P1|NOT COMPLETED|Overall Study||1
8367046|NCT01177228|20624718|P4|COMPLETED|Overall Study||11
8367047|NCT01177228|20624719|P3|COMPLETED|Overall Study||14
8367048|NCT01177228|20624720|P2|COMPLETED|Overall Study||11
8367049|NCT01177228|20624721|P1|COMPLETED|Overall Study||8
8367050|NCT01177228|20624718|P4|Received Treatment|Overall Study||11
8367051|NCT01177228|20624719|P3|Received Treatment|Overall Study||14
8367052|NCT01177228|20624720|P2|Received Treatment|Overall Study||12
8367053|NCT01177228|20624721|P1|Received Treatment|Overall Study||9
8367054|NCT01177228|20624718|P4|STARTED|Overall Study||11
8367055|NCT01177228|20624719|P3|STARTED|Overall Study||14
8367056|NCT01177228|20624720|P2|STARTED|Overall Study||13
8367057|NCT01177228|20624721|P1|STARTED|Overall Study||9
8367058|NCT01177189|20624761|P2|NOT COMPLETED|Overall Study||0
8367059|NCT01177189|20624762|P1|NOT COMPLETED|Overall Study||0
8367060|NCT01177189|20624761|P2|COMPLETED|Overall Study||45
8367061|NCT01177189|20624762|P1|COMPLETED|Overall Study||42
8367062|NCT01177189|20624761|P2|STARTED|Overall Study||45
8367063|NCT01177189|20624762|P1|STARTED|Overall Study||42
8367064|NCT01177137|20624775|P3|NOT COMPLETED|Overall Study||2
8367065|NCT01177137|20624776|P2|NOT COMPLETED|Overall Study||10
8367066|NCT01177137|20624777|P1|NOT COMPLETED|Overall Study||10
8367067|NCT01177137|20624775|P3|COMPLETED|Overall Study||47
8367068|NCT01177137|20624776|P2|COMPLETED|Overall Study||41
8367069|NCT01177137|20624777|P1|COMPLETED|Overall Study||41
8367070|NCT01177137|20624775|P3|STARTED|Overall Study||49
8367071|NCT01177137|20624776|P2|STARTED|Overall Study||51
8367072|NCT01177137|20624777|P1|STARTED|Overall Study||51
8367073|NCT01177098|20624844|P2|NOT COMPLETED|Overall Study||12
8367074|NCT01177098|20624845|P1|NOT COMPLETED|Overall Study||9
8367075|NCT01177098|20624844|P2|COMPLETED|Overall Study||271
8367076|NCT01177098|20624845|P1|COMPLETED|Overall Study||269
8367077|NCT01177098|20624844|P2|STARTED|Overall Study||283
8367078|NCT01177098|20624845|P1|STARTED|Overall Study||278
8367079|NCT01177059|20624861|P1|NOT COMPLETED|Overall Study||50
8367080|NCT01177059|20624861|P1|COMPLETED|Overall Study||18
8367081|NCT01177059|20624861|P1|STARTED|Overall Study||68
8367082|NCT01177007|20624867|P1|NOT COMPLETED|Overall Study||38
8367083|NCT01177007|20624867|P1|COMPLETED|Overall Study||12
8367084|NCT01177007|20624867|P1|Completed First Clinical and Imaging|Overall Study||43
8367085|NCT01177007|20624867|P1|Completed First Y90 Treatment|Overall Study||50
8367086|NCT01177007|20624867|P1|STARTED|Overall Study||50
8367087|NCT01176968|20624881|P2|NOT COMPLETED|Overall Study||82
8367088|NCT01176968|20624882|P1|NOT COMPLETED|Overall Study||84
8367089|NCT01176968|20624881|P2|COMPLETED|Overall Study||424
8367090|NCT01176968|20624882|P1|COMPLETED|Overall Study||422
8367091|NCT01176968|20624881|P2|Treated|Overall Study||505
8367092|NCT01176968|20624882|P1|Treated|Overall Study||505
8367093|NCT01176968|20624881|P2|STARTED|Overall Study||506
8367094|NCT01176968|20624882|P1|STARTED|Overall Study||506
8367095|NCT01176955|20624916|P2|NOT COMPLETED|Overall Study||2
8367096|NCT01176955|20624917|P1|NOT COMPLETED|Overall Study||3
8367097|NCT01176955|20624916|P2|COMPLETED|Overall Study||8
8367098|NCT01176955|20624917|P1|COMPLETED|Overall Study||7
8367099|NCT01176955|20624916|P2|STARTED|Overall Study||10
8367100|NCT01176955|20624917|P1|STARTED|Overall Study||10
8367101|NCT01176916|20624928|P1|NOT COMPLETED|Overall Study||167
8367102|NCT01176916|20624928|P1|COMPLETED|Overall Study||397
8367103|NCT01176916|20624928|P1|Assigne But Not Treated|Overall Study||6
8367104|NCT01176916|20624928|P1|Treated|Overall Study||558
8367105|NCT01176916|20624928|P1|STARTED|Overall Study||564
8367106|NCT01176877|20624938|P1|NOT COMPLETED|Overall Study||9
8367107|NCT01176877|20624938|P1|COMPLETED|Overall Study||31
8367108|NCT01176877|20624938|P1|STARTED|Overall Study||40
8367109|NCT01176773|20624943|P1|NOT COMPLETED|Overall Study||3
8367110|NCT01176773|20624943|P1|COMPLETED|Overall Study||59
8367111|NCT01176773|20624943|P1|STARTED|Overall Study||62
8367112|NCT01176617|20624954|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
8367113|NCT01176617|20624955|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
8367114|NCT01176617|20624956|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
8367115|NCT01176617|20624954|P3|COMPLETED|6 - 12 Months (Randomized)||0
8367116|NCT01176617|20624955|P2|COMPLETED|6 - 12 Months (Randomized)||20
8367117|NCT01176617|20624956|P1|COMPLETED|6 - 12 Months (Randomized)||13
8367118|NCT01176617|20624954|P3|STARTED|6 - 12 Months (Randomized)||0
8367119|NCT01176617|20624955|P2|STARTED|6 - 12 Months (Randomized)||20
8367120|NCT01176617|20624956|P1|STARTED|6 - 12 Months (Randomized)||18
8367121|NCT01176617|20624954|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8367122|NCT01176617|20624955|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8367123|NCT01176617|20624956|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8367124|NCT01176617|20624954|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
8367125|NCT01176617|20624955|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
8367126|NCT01176617|20624956|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
8367127|NCT01176617|20624954|P3|STARTED|1 - 6 Months (Ron-randomized)||38
8367128|NCT01176617|20624955|P2|STARTED|1 - 6 Months (Ron-randomized)||0
8367129|NCT01176617|20624956|P1|STARTED|1 - 6 Months (Ron-randomized)||0
8367130|NCT01176591|20624967|P2|NOT COMPLETED|Session 2||0
8367131|NCT01176591|20624968|P1|NOT COMPLETED|Session 2||0
8367132|NCT01176591|20624967|P2|COMPLETED|Session 2||3
8367133|NCT01176591|20624968|P1|COMPLETED|Session 2||10
8367134|NCT01176591|20624967|P2|STARTED|Session 2||3
8367135|NCT01176591|20624968|P1|STARTED|Session 2||10
8367136|NCT01176591|20624967|P2|NOT COMPLETED|Session 1||0
8367137|NCT01176591|20624968|P1|NOT COMPLETED|Session 1||0
8367138|NCT01176591|20624967|P2|COMPLETED|Session 1||3
8367139|NCT01176591|20624968|P1|COMPLETED|Session 1||10
8367140|NCT01176591|20624967|P2|STARTED|Session 1||3
8367141|NCT01176591|20624968|P1|STARTED|Session 1||10
8367142|NCT01176565|20624986|P2|NOT COMPLETED|Overall Study||19
8367143|NCT01176565|20624987|P1|NOT COMPLETED|Overall Study||20
8367144|NCT01176565|20624986|P2|COMPLETED|Overall Study||481
8367145|NCT01176565|20624987|P1|COMPLETED|Overall Study||480
8367146|NCT01176565|20624986|P2|STARTED|Overall Study||500
8367147|NCT01176565|20624987|P1|STARTED|Overall Study||500
8367148|NCT01176513|20625005|P1|NOT COMPLETED|Overall Study||3
8367149|NCT01176513|20625005|P1|COMPLETED|Overall Study||22
8367150|NCT01176513|20625005|P1|STARTED|Overall Study||25
8367151|NCT01176448|20625010|P1|NOT COMPLETED|Overall Study||0
8367152|NCT01176448|20625010|P1|COMPLETED|Overall Study||6
8367153|NCT01176448|20625010|P1|STARTED|Overall Study||6
8367154|NCT01176435|20625021|P3|NOT COMPLETED|Overall Study||0
8367155|NCT01176435|20625022|P2|NOT COMPLETED|Overall Study||0
8367156|NCT01176435|20625023|P1|NOT COMPLETED|Overall Study||0
8367157|NCT01176435|20625021|P3|COMPLETED|Overall Study||15
8367158|NCT01176435|20625022|P2|COMPLETED|Overall Study||15
8367159|NCT01176435|20625023|P1|COMPLETED|Overall Study||15
8367160|NCT01176435|20625021|P3|STARTED|Overall Study||15
8367161|NCT01176435|20625022|P2|STARTED|Overall Study||15
8367162|NCT01176435|20625023|P1|STARTED|Overall Study||15
8367163|NCT01176292|20625033|P2|NOT COMPLETED|Overall Study||9
8367164|NCT01176292|20625034|P1|NOT COMPLETED|Overall Study||5
8367165|NCT01176292|20625033|P2|COMPLETED|Overall Study||62
8367166|NCT01176292|20625034|P1|COMPLETED|Overall Study||66
8367167|NCT01176292|20625033|P2|STARTED|Overall Study||71
8367168|NCT01176292|20625034|P1|STARTED|Overall Study||71
8367169|NCT01176266|20625052|P1|NOT COMPLETED|Overall Study||9
8367170|NCT01176266|20625052|P1|COMPLETED|Overall Study||60
8367171|NCT01176266|20625052|P1|STARTED|Overall Study||69
8367172|NCT01176240|20625076|P2|NOT COMPLETED|Study 306B||17
8367173|NCT01176240|20625077|P1|NOT COMPLETED|Study 306B||26
8367174|NCT01176240|20625076|P2|COMPLETED|Study 306B||68
8367175|NCT01176240|20625077|P1|COMPLETED|Study 306B||63
8367176|NCT01176240|20625076|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
8367177|NCT01176240|20625077|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
8367178|NCT01176240|20625076|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
8367179|NCT01176240|20625077|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
8367180|NCT01176240|20625076|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
8367181|NCT01176240|20625077|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
8367182|NCT01176240|20625076|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
8367183|NCT01176240|20625077|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
8367184|NCT01176240|20625076|P2|STARTED|Study 306B||85
8367185|NCT01176240|20625077|P1|STARTED|Study 306B||89
8367186|NCT01176240|20625076|P2|NOT COMPLETED|Study 306A||3
8367187|NCT01176240|20625077|P1|NOT COMPLETED|Study 306A||3
8367188|NCT01176240|20625076|P2|COMPLETED|Study 306A||24
8367189|NCT01176240|20625077|P1|COMPLETED|Study 306A||21
8367190|NCT01176240|20625076|P2|STARTED|Study 306A||27
8367191|NCT01176240|20625077|P1|STARTED|Study 306A||24
8367192|NCT01176058|20625103|P2|NOT COMPLETED|Overall Study||3
8367193|NCT01176058|20625104|P1|NOT COMPLETED|Overall Study||4
8367194|NCT01176058|20625103|P2|COMPLETED|Overall Study||5
8367195|NCT01176058|20625104|P1|COMPLETED|Overall Study||5
8367196|NCT01176058|20625103|P2|STARTED|Overall Study||8
8367197|NCT01176058|20625104|P1|STARTED|Overall Study||9
8367198|NCT01176032|20625128|P2|NOT COMPLETED|Overall Study||1
8367199|NCT01176032|20625129|P1|NOT COMPLETED|Overall Study||6
8367200|NCT01176032|20625128|P2|COMPLETED|Overall Study||36
8367201|NCT01176032|20625129|P1|COMPLETED|Overall Study||31
8367202|NCT01176032|20625128|P2|Intention-to-treat (ITT) Population|Overall Study||37
8367203|NCT01176032|20625129|P1|Intention-to-treat (ITT) Population|Overall Study||32
8367204|NCT01176032|20625128|P2|STARTED|Overall Study||37
8367205|NCT01176032|20625129|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
8367206|NCT01175980|20625187|P1|NOT COMPLETED|Overall Study||0
8367207|NCT01175980|20625187|P1|COMPLETED|Overall Study||30
8367208|NCT01175980|20625187|P1|STARTED|Overall Study||30
8367209|NCT01175902|20625206|P2|NOT COMPLETED|Overall Study||0
8367210|NCT01175902|20625207|P1|NOT COMPLETED|Overall Study||0
8367211|NCT01175902|20625206|P2|COMPLETED|Overall Study||22
8367212|NCT01175902|20625207|P1|COMPLETED|Overall Study||22
8367213|NCT01175902|20625206|P2|STARTED|Overall Study||22
8367214|NCT01175902|20625207|P1|STARTED|Overall Study||22
8367215|NCT01175850|20625225|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
8367216|NCT01175850|20625226|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
8367217|NCT01175850|20625225|P2|COMPLETED|IN.PACT SFA II Phase||55
8367218|NCT01175850|20625226|P1|COMPLETED|IN.PACT SFA II Phase||109
8367219|NCT01175850|20625225|P2|STARTED|IN.PACT SFA II Phase||60
8367220|NCT01175850|20625226|P1|STARTED|IN.PACT SFA II Phase||121
8367221|NCT01175850|20625225|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
8367222|NCT01175850|20625226|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
8367223|NCT01175850|20625225|P2|COMPLETED|IN.PACT SFA I Phase||49
8367224|NCT01175850|20625226|P1|COMPLETED|IN.PACT SFA I Phase||88
8367225|NCT01175850|20625225|P2|STARTED|IN.PACT SFA I Phase||51
8367226|NCT01175850|20625226|P1|STARTED|IN.PACT SFA I Phase||99
8367227|NCT01175824|20625270|P2|NOT COMPLETED|Overall Study||22
8367228|NCT01175824|20625271|P1|NOT COMPLETED|Overall Study||16
8367229|NCT01175824|20625270|P2|COMPLETED|Overall Study||220
8367230|NCT01175824|20625271|P1|COMPLETED|Overall Study||220
8367231|NCT01175824|20625270|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
8367232|NCT01175824|20625271|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
8367233|NCT01175824|20625270|P2|STARTED|Overall Study||242
8367234|NCT01175824|20625271|P1|STARTED|Overall Study||236
8367235|NCT01175811|20625305|P2|NOT COMPLETED|Overall Study||14
8367236|NCT01175811|20625306|P1|NOT COMPLETED|Overall Study||16
8367237|NCT01175811|20625305|P2|COMPLETED|Overall Study||189
8367238|NCT01175811|20625306|P1|COMPLETED|Overall Study||183
8367239|NCT01175811|20625305|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
8367240|NCT01175811|20625306|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
8367241|NCT01175811|20625305|P2|STARTED|Overall Study||203
8367242|NCT01175811|20625306|P1|STARTED|Overall Study||199
8367243|NCT01175798|20625332|P2|NOT COMPLETED|Overall Study||21
8367244|NCT01175798|20625333|P1|NOT COMPLETED|Overall Study||7
8367245|NCT01175798|20625332|P2|COMPLETED|Overall Study||41
8367246|NCT01175798|20625333|P1|COMPLETED|Overall Study||27
8367247|NCT01175798|20625332|P2|STARTED|Overall Study||62
8367248|NCT01175798|20625333|P1|STARTED|Overall Study||34
8367249|NCT01175707|20625341|P2|NOT COMPLETED|Overall Study||6
8367250|NCT01175707|20625342|P1|NOT COMPLETED|Overall Study||4
8367251|NCT01175707|20625341|P2|COMPLETED|Overall Study||34
8367252|NCT01175707|20625342|P1|COMPLETED|Overall Study||36
8367253|NCT01175707|20625341|P2|STARTED|Overall Study||40
8367254|NCT01175707|20625342|P1|STARTED|Overall Study||40
8367255|NCT01175668|20625378|P2|NOT COMPLETED|Overall Study||0
8367256|NCT01175668|20625379|P1|NOT COMPLETED|Overall Study||2
8367257|NCT01175668|20625378|P2|COMPLETED|Overall Study||34
8367258|NCT01175668|20625379|P1|COMPLETED|Overall Study||32
8367259|NCT01175668|20625378|P2|STARTED|Overall Study||34
8367260|NCT01175668|20625379|P1|STARTED|Overall Study||34
8367261|NCT01175590|20625389|P2|NOT COMPLETED|Overall Study||10
8367262|NCT01175590|20625390|P1|NOT COMPLETED|Overall Study||12
8367263|NCT01175590|20625389|P2|COMPLETED|Overall Study||161
8367264|NCT01175590|20625390|P1|COMPLETED|Overall Study||335
8367265|NCT01175590|20625389|P2|Safety Population|Overall Study||170
8367266|NCT01175590|20625390|P1|Safety Population|Overall Study||344
8367267|NCT01175590|20625389|P2|Modified Intent to Treat Population|Overall Study||87
8367268|NCT01175590|20625390|P1|Modified Intent to Treat Population|Overall Study||212
8367269|NCT01175590|20625389|P2|STARTED|Overall Study||171
8367270|NCT01175590|20625390|P1|STARTED|Overall Study||347
8367271|NCT01175473|20625424|P2|NOT COMPLETED|Overall Study||2
8367272|NCT01175473|20625425|P1|NOT COMPLETED|Overall Study||2
8367273|NCT01175473|20625424|P2|COMPLETED|Overall Study||69
8367274|NCT01175473|20625425|P1|COMPLETED|Overall Study||75
8367275|NCT01175473|20625424|P2|Pharmacodynamic (PD) Population|Overall Study||68
8367276|NCT01175473|20625425|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
8367277|NCT01175473|20625424|P2|Safety Population|Overall Study||71
8367278|NCT01175473|20625425|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
8367279|NCT01175473|20625424|P2|STARTED|Overall Study||71
8367280|NCT01175473|20625425|P1|STARTED|Overall Study|Randomized and treated.|77
8367281|NCT01175434|20625451|P2|NOT COMPLETED|Overall Study||0
8367282|NCT01175434|20625452|P1|NOT COMPLETED|Overall Study||0
8367283|NCT01175434|20625451|P2|COMPLETED|Overall Study||51
8367284|NCT01175434|20625452|P1|COMPLETED|Overall Study||48
8367285|NCT01175434|20625451|P2|STARTED|Overall Study||51
8367286|NCT01175434|20625452|P1|STARTED|Overall Study||48
8367287|NCT01175395|20625458|P1|NOT COMPLETED|Overall Study||0
8367288|NCT01175395|20625458|P1|COMPLETED|Overall Study||10
8367289|NCT01175395|20625458|P1|STARTED|Overall Study||10
8367290|NCT01175382|20625466|P3|NOT COMPLETED|Overall Study||6
8367291|NCT01175382|20625467|P2|NOT COMPLETED|Overall Study||7
8367292|NCT01175382|20625468|P1|NOT COMPLETED|Overall Study||8
8367293|NCT01175382|20625466|P3|COMPLETED|Overall Study||59
8367294|NCT01175382|20625467|P2|COMPLETED|Overall Study||61
8367295|NCT01175382|20625468|P1|COMPLETED|Overall Study||63
8367296|NCT01175382|20625466|P3|STARTED|Overall Study||65
8367297|NCT01175382|20625467|P2|STARTED|Overall Study||68
8367298|NCT01175382|20625468|P1|STARTED|Overall Study||71
8367299|NCT01175369|20625547|P2|NOT COMPLETED|Overall Study||5
8367300|NCT01175369|20625548|P1|NOT COMPLETED|Overall Study||2
8367301|NCT01175369|20625547|P2|COMPLETED|Overall Study||260
8367302|NCT01175369|20625548|P1|COMPLETED|Overall Study||263
8367303|NCT01175369|20625547|P2|STARTED|Overall Study||265
8367304|NCT01175369|20625548|P1|STARTED|Overall Study||265
8367305|NCT01175356|20625554|P1|NOT COMPLETED|Overall Study||81
8367306|NCT01175356|20625554|P1|COMPLETED|Overall Study||18
8367307|NCT01175356|20625554|P1|STARTED|Overall Study||99
8367308|NCT01175343|20625560|P1|NOT COMPLETED|Overall Study||0
8367309|NCT01175343|20625560|P1|COMPLETED|Overall Study||44
8367310|NCT01175343|20625560|P1|STARTED|Overall Study||44
8367311|NCT01175317|20625572|P2|NOT COMPLETED|Overall Study||0
8367312|NCT01175317|20625573|P1|NOT COMPLETED|Overall Study||0
8367313|NCT01175317|20625572|P2|COMPLETED|Overall Study||31
8367314|NCT01175317|20625573|P1|COMPLETED|Overall Study||27
8367315|NCT01175317|20625572|P2|STARTED|Overall Study||31
8367316|NCT01175317|20625573|P1|STARTED|Overall Study||27
8367317|NCT01175226|20625583|P2|NOT COMPLETED|Overall Study||5
8367318|NCT01175226|20625584|P1|NOT COMPLETED|Overall Study||11
8367319|NCT01175226|20625583|P2|COMPLETED|Overall Study||140
8367320|NCT01175226|20625584|P1|COMPLETED|Overall Study||144
8367321|NCT01175226|20625583|P2|STARTED|Overall Study||145
8367322|NCT01175226|20625584|P1|STARTED|Overall Study||155
8367323|NCT01175213|20625594|P2|NOT COMPLETED|Safety Follow-up||0
8367324|NCT01175213|20625595|P1|NOT COMPLETED|Safety Follow-up||1
8367325|NCT01175213|20625594|P2|COMPLETED|Safety Follow-up||3
8367326|NCT01175213|20625595|P1|COMPLETED|Safety Follow-up||47
8367327|NCT01175213|20625594|P2|STARTED|Safety Follow-up||3
8367328|NCT01175213|20625595|P1|STARTED|Safety Follow-up||48
8367329|NCT01175213|20625594|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
8367330|NCT01175213|20625595|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
8367331|NCT01175213|20625594|P2|COMPLETED|IGSC, 10%/rHuPH20||3
8367332|NCT01175213|20625595|P1|COMPLETED|IGSC, 10%/rHuPH20||48
8367333|NCT01175213|20625594|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
8367334|NCT01175213|20625595|P1|STARTED|IGSC, 10%/rHuPH20||63
8367335|NCT01175148|20625642|P2|NOT COMPLETED|Overall Study||0
8367336|NCT01175148|20625643|P1|NOT COMPLETED|Overall Study||0
8367337|NCT01175148|20625642|P2|COMPLETED|Overall Study||30
8367338|NCT01175148|20625643|P1|COMPLETED|Overall Study||30
8367339|NCT01175148|20625642|P2|STARTED|Overall Study||30
8367340|NCT01175148|20625643|P1|STARTED|Overall Study||30
8367341|NCT01175135|20625652|P4|NOT COMPLETED|Overall Study||14
8367342|NCT01175135|20625653|P3|NOT COMPLETED|Overall Study||12
8367343|NCT01175135|20625654|P2|NOT COMPLETED|Overall Study||22
8367344|NCT01175135|20625655|P1|NOT COMPLETED|Overall Study||16
8367345|NCT01175135|20625652|P4|COMPLETED|Overall Study||60
8367346|NCT01175135|20625653|P3|COMPLETED|Overall Study||25
8367347|NCT01175135|20625654|P2|COMPLETED|Overall Study||52
8367348|NCT01175135|20625655|P1|COMPLETED|Overall Study||58
8367349|NCT01175135|20625652|P4|Analyzed for Efficacy|Overall Study||73
8367350|NCT01175135|20625653|P3|Analyzed for Efficacy|Overall Study||34
8367351|NCT01175135|20625654|P2|Analyzed for Efficacy|Overall Study||73
8367352|NCT01175135|20625655|P1|Analyzed for Efficacy|Overall Study||74
8367353|NCT01175135|20625652|P4|Treated|Overall Study||74
8367354|NCT01175135|20625653|P3|Treated|Overall Study||36
8367355|NCT01175135|20625654|P2|Treated|Overall Study||74
8367356|NCT01175135|20625655|P1|Treated|Overall Study||74
8367357|NCT01175135|20625652|P4|STARTED|Overall Study||74
8367358|NCT01175135|20625653|P3|STARTED|Overall Study||37
8367359|NCT01175135|20625654|P2|STARTED|Overall Study||74
8367360|NCT01175135|20625655|P1|STARTED|Overall Study||74
8367361|NCT01175083|20625743|P6|NOT COMPLETED|Booster Epoch||0
8367362|NCT01175083|20625744|P5|NOT COMPLETED|Booster Epoch||0
8367363|NCT01175083|20625745|P4|NOT COMPLETED|Booster Epoch||1
8367364|NCT01175083|20625746|P3|NOT COMPLETED|Booster Epoch||1
8367365|NCT01175083|20625747|P2|NOT COMPLETED|Booster Epoch||0
8367366|NCT01175083|20625748|P1|NOT COMPLETED|Booster Epoch||0
8367367|NCT01175083|20625743|P6|COMPLETED|Booster Epoch||0
8367368|NCT01175083|20625744|P5|COMPLETED|Booster Epoch||0
8367369|NCT01175083|20625745|P4|COMPLETED|Booster Epoch||49
8367370|NCT01175083|20625746|P3|COMPLETED|Booster Epoch||49
8367371|NCT01175083|20625747|P2|COMPLETED|Booster Epoch||49
8367372|NCT01175083|20625748|P1|COMPLETED|Booster Epoch||49
8367373|NCT01175083|20625743|P6|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
8367374|NCT01175083|20625744|P5|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
8367375|NCT01175083|20625745|P4|STARTED|Booster Epoch||50
8367376|NCT01175083|20625746|P3|STARTED|Booster Epoch||50
8367377|NCT01175083|20625747|P2|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
8367378|NCT01175083|20625748|P1|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
8367379|NCT01175083|20625743|P6|NOT COMPLETED|Primary Epoch||3
8367380|NCT01175083|20625744|P5|NOT COMPLETED|Primary Epoch||0
8367381|NCT01175083|20625745|P4|NOT COMPLETED|Primary Epoch||0
8367382|NCT01175083|20625746|P3|NOT COMPLETED|Primary Epoch||0
8367383|NCT01175083|20625747|P2|NOT COMPLETED|Primary Epoch||0
8367384|NCT01175083|20625748|P1|NOT COMPLETED|Primary Epoch||0
8367385|NCT01175083|20625743|P6|COMPLETED|Primary Epoch||47
8367386|NCT01175083|20625744|P5|COMPLETED|Primary Epoch||50
8367387|NCT01175083|20625745|P4|COMPLETED|Primary Epoch||50
8367388|NCT01175083|20625746|P3|COMPLETED|Primary Epoch||50
8367389|NCT01175083|20625747|P2|COMPLETED|Primary Epoch||50
8367390|NCT01175083|20625748|P1|COMPLETED|Primary Epoch||50
8367391|NCT01175083|20625743|P6|STARTED|Primary Epoch||50
8367392|NCT01175083|20625744|P5|STARTED|Primary Epoch||50
8367393|NCT01175083|20625745|P4|STARTED|Primary Epoch||50
8367394|NCT01175083|20625746|P3|STARTED|Primary Epoch||50
8367395|NCT01175083|20625747|P2|STARTED|Primary Epoch||50
8367396|NCT01175083|20625748|P1|STARTED|Primary Epoch||50
8367397|NCT01175031|20625830|P1|NOT COMPLETED|Overall Study||0
8367398|NCT01175031|20625830|P1|COMPLETED|Overall Study||45
8367399|NCT01175031|20625830|P1|STARTED|Overall Study||45
8367400|NCT01175018|20625840|P2|NOT COMPLETED|Overall Study||1
8367401|NCT01175018|20625841|P1|NOT COMPLETED|Overall Study||3
8367402|NCT01175018|20625840|P2|COMPLETED|Overall Study||14
8367403|NCT01175018|20625841|P1|COMPLETED|Overall Study||12
8367404|NCT01175018|20625840|P2|STARTED|Overall Study||15
8367405|NCT01175018|20625841|P1|STARTED|Overall Study||15
8367406|NCT01175005|20625877|P1|NOT COMPLETED|Overall Study||0
8367407|NCT01175005|20625877|P1|COMPLETED|Overall Study||62
8367408|NCT01175005|20625877|P1|STARTED|Overall Study||62
8367409|NCT01174823|20625884|P2|NOT COMPLETED|Overall Study||4
8367410|NCT01174823|20625885|P1|NOT COMPLETED|Overall Study||7
8367411|NCT01174823|20625884|P2|COMPLETED|Overall Study||119
8367412|NCT01174823|20625885|P1|COMPLETED|Overall Study||115
8367413|NCT01174823|20625884|P2|STARTED|Overall Study||123
8367414|NCT01174823|20625885|P1|STARTED|Overall Study||122
8367415|NCT01174784|20625903|P1|NOT COMPLETED|Overall Study||4
8367416|NCT01174784|20625903|P1|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
8367417|NCT01174784|20625903|P1|STARTED|Overall Study||88
8367418|NCT01174576|20625908|P1|NOT COMPLETED|Overall Study||0
8367419|NCT01174576|20625908|P1|COMPLETED|Overall Study||16
8367420|NCT01174576|20625908|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
8367421|NCT01174563|20625949|P1|NOT COMPLETED|Overall Study||60
8367422|NCT01174563|20625949|P1|COMPLETED|Overall Study||0
8367423|NCT01174563|20625949|P1|Safety Set|Overall Study||59
8367424|NCT01174563|20625949|P1|Efficacy Set|Overall Study||59
8367425|NCT01174563|20625949|P1|STARTED|Overall Study||60
8367426|NCT01174550|20625957|P2|NOT COMPLETED|Overall Study||873
8367427|NCT01174550|20625958|P1|NOT COMPLETED|Overall Study||1270
8367428|NCT01174550|20625957|P2|COMPLETED|Overall Study||4123
8367429|NCT01174550|20625958|P1|COMPLETED|Overall Study||3737
8367430|NCT01174550|20625957|P2|STARTED|Overall Study||4996
8367431|NCT01174550|20625958|P1|STARTED|Overall Study||5007
8367432|NCT01174459|20625986|P1|NOT COMPLETED|Overall Study||5
8367433|NCT01174459|20625986|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
8367434|NCT01174459|20625986|P1|STARTED|Overall Study|Registered patients|571
8367435|NCT01174446|20625991|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8367436|NCT01174446|20625992|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8367437|NCT01174446|20625993|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
8367438|NCT01174446|20625994|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
8367439|NCT01174446|20625991|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8367440|NCT01174446|20625992|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8367441|NCT01174446|20625993|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
8367442|NCT01174446|20625994|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
8367443|NCT01174446|20625991|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
8367444|NCT01174446|20625992|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
8367445|NCT01174446|20625993|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
8367446|NCT01174446|20625994|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
8367447|NCT01174446|20625991|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8367448|NCT01174446|20625992|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
8367449|NCT01174446|20625993|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8367450|NCT01174446|20625994|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8367451|NCT01174446|20625991|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8367452|NCT01174446|20625992|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
8367453|NCT01174446|20625993|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8367454|NCT01174446|20625994|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8367455|NCT01174446|20625991|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
8367456|NCT01174446|20625992|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
8367457|NCT01174446|20625993|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
8367458|NCT01174446|20625994|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
8367459|NCT01174446|20625991|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8367460|NCT01174446|20625992|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8367461|NCT01174446|20625993|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8367462|NCT01174446|20625994|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8367463|NCT01174446|20625991|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8367464|NCT01174446|20625992|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8367465|NCT01174446|20625993|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
8367466|NCT01174446|20625994|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
8367467|NCT01174446|20625991|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
8367468|NCT01174446|20625992|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
8367469|NCT01174446|20625993|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
8367470|NCT01174446|20625994|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
8367471|NCT01174368|20626181|P1|NOT COMPLETED|Overall Study||1
8367472|NCT01174368|20626181|P1|COMPLETED|Overall Study||0
8367473|NCT01174368|20626181|P1|STARTED|Overall Study||1
8367474|NCT01174342|20626187|P1|NOT COMPLETED|Overall Study||4
8367475|NCT01174342|20626187|P1|COMPLETED|Overall Study||26
8367476|NCT01174342|20626187|P1|STARTED|Overall Study||30
8367477|NCT01174264|20626194|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
8367478|NCT01174264|20626195|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
8367479|NCT01174264|20626196|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
8367480|NCT01174264|20626194|P3|COMPLETED|Steady-state Pharmacokinetics||27
8367481|NCT01174264|20626195|P2|COMPLETED|Steady-state Pharmacokinetics||0
8367482|NCT01174264|20626196|P1|COMPLETED|Steady-state Pharmacokinetics||25
8367483|NCT01174264|20626194|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
8367484|NCT01174264|20626195|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
8367485|NCT01174264|20626196|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
8367486|NCT01174264|20626194|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
8367487|NCT01174264|20626195|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
8367488|NCT01174264|20626196|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
8367489|NCT01174264|20626194|P3|COMPLETED|Single Dose Pharmacokinetics||18
8367490|NCT01174264|20626195|P2|COMPLETED|Single Dose Pharmacokinetics||20
8367491|NCT01174264|20626196|P1|COMPLETED|Single Dose Pharmacokinetics||22
8367492|NCT01174264|20626194|P3|STARTED|Single Dose Pharmacokinetics||20
8367493|NCT01174264|20626195|P2|STARTED|Single Dose Pharmacokinetics||20
8367494|NCT01174264|20626196|P1|STARTED|Single Dose Pharmacokinetics||23
8367495|NCT01174238|20626228|P1|NOT COMPLETED|Overall Study||2
8367496|NCT01174238|20626228|P1|COMPLETED|Overall Study||36
8367497|NCT01174238|20626228|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
8367498|NCT01174238|20626228|P1|STARTED|Overall Study||38
8367499|NCT01174186|20626239|P2|NOT COMPLETED|Overall Study||3
8367500|NCT01174186|20626240|P1|NOT COMPLETED|Overall Study||0
8367501|NCT01174186|20626239|P2|COMPLETED|Overall Study||12
8367502|NCT01174186|20626240|P1|COMPLETED|Overall Study||15
8367503|NCT01174186|20626239|P2|STARTED|Overall Study||15
8367504|NCT01174186|20626240|P1|STARTED|Overall Study|Patients were included over three years|15
8367505|NCT01174173|20626247|P1|NOT COMPLETED|Overall Study||1
8367506|NCT01174173|20626247|P1|COMPLETED|Overall Study||10
8367507|NCT01174173|20626247|P1|STARTED|Overall Study||11
8367508|NCT01174160|20626258|P2|NOT COMPLETED|Overall Study||6
8367509|NCT01174160|20626259|P1|NOT COMPLETED|Overall Study||8
8367510|NCT01174160|20626258|P2|COMPLETED|Overall Study||56
8367511|NCT01174160|20626259|P1|COMPLETED|Overall Study||53
8367512|NCT01174160|20626258|P2|Discontinued Post Dose|Overall Study||0
8367513|NCT01174160|20626259|P1|Discontinued Post Dose|Overall Study||2
8367514|NCT01174160|20626258|P2|Dosed|Overall Study||56
8367515|NCT01174160|20626259|P1|Dosed|Overall Study||55
8367516|NCT01174160|20626258|P2|Discontinued Pre Dose|Overall Study||6
8367517|NCT01174160|20626259|P1|Discontinued Pre Dose|Overall Study||6
8367518|NCT01174160|20626258|P2|STARTED|Overall Study||62
8367519|NCT01174160|20626259|P1|STARTED|Overall Study||61
8367520|NCT01174082|20626267|P2|NOT COMPLETED|Overall Study||0
8367521|NCT01174082|20626268|P1|NOT COMPLETED|Overall Study||0
8367522|NCT01174082|20626267|P2|COMPLETED|Overall Study||1
8367523|NCT01174082|20626268|P1|COMPLETED|Overall Study||1
8367524|NCT01174082|20626267|P2|STARTED|Overall Study||1
8367525|NCT01174082|20626268|P1|STARTED|Overall Study||1
8367526|NCT01174043|20626274|P1|NOT COMPLETED|Overall Study||11
8367527|NCT01174043|20626274|P1|COMPLETED|Overall Study||0
8367528|NCT01174043|20626274|P1|STARTED|Overall Study||11
8367544|NCT01174004|20626313|P2|NOT COMPLETED|Overall Study||16
8367545|NCT01174004|20626314|P1|NOT COMPLETED|Overall Study||7
8367546|NCT01174004|20626313|P2|COMPLETED|Overall Study||89
8367547|NCT01174004|20626314|P1|COMPLETED|Overall Study||87
8367548|NCT01174004|20626313|P2|STARTED|Overall Study||105
8367549|NCT01174004|20626314|P1|STARTED|Overall Study||94
8367550|NCT01173874|20626324|P2|NOT COMPLETED|Overall Study||23
8367551|NCT01173874|20626325|P1|NOT COMPLETED|Overall Study||23
8367552|NCT01173874|20626324|P2|COMPLETED|Overall Study||41
8367553|NCT01173874|20626325|P1|COMPLETED|Overall Study||33
8367554|NCT01173874|20626324|P2|STARTED|Overall Study||64
8367555|NCT01173874|20626325|P1|STARTED|Overall Study||56
8367556|NCT01173848|20626339|P2|NOT COMPLETED|Overall Study||8
8367557|NCT01173848|20626340|P1|NOT COMPLETED|Overall Study||4
8367558|NCT01173848|20626339|P2|COMPLETED|Overall Study||3
8367559|NCT01173848|20626340|P1|COMPLETED|Overall Study||4
8367560|NCT01173848|20626339|P2|STARTED|Overall Study||11
8367561|NCT01173848|20626340|P1|STARTED|Overall Study||8
8367562|NCT01173718|20626345|P1|NOT COMPLETED|Overall Study||44
8367563|NCT01173718|20626345|P1|COMPLETED|Overall Study||94
8367564|NCT01173718|20626345|P1|STARTED|Overall Study||138
8367565|NCT01173679|20626354|P1|NOT COMPLETED|Overall Study||1
8367566|NCT01173679|20626354|P1|COMPLETED|Overall Study||9
8367567|NCT01173679|20626354|P1|STARTED|Overall Study||10
8367568|NCT01173653|20626362|P2|NOT COMPLETED|Overall Study||41
8367569|NCT01173653|20626363|P1|NOT COMPLETED|Overall Study||53
8367570|NCT01173653|20626362|P2|COMPLETED|Overall Study||49
8367571|NCT01173653|20626363|P1|COMPLETED|Overall Study||56
8367572|NCT01173653|20626362|P2|STARTED|Overall Study||90
8367573|NCT01173653|20626363|P1|STARTED|Overall Study||109
8367574|NCT01173601|20626373|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
8367575|NCT01173601|20626374|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
8367576|NCT01173601|20626375|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
8367577|NCT01173601|20626376|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8367578|NCT01173601|20626377|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367579|NCT01173601|20626373|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
8367580|NCT01173601|20626374|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
8367581|NCT01173601|20626375|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
8367582|NCT01173601|20626376|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
8367583|NCT01173601|20626377|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367584|NCT01173601|20626373|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
8367585|NCT01173601|20626374|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
8367586|NCT01173601|20626375|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
8367587|NCT01173601|20626376|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
8367588|NCT01173601|20626377|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367589|NCT01173601|20626373|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367590|NCT01173601|20626374|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367591|NCT01173601|20626375|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
8367592|NCT01173601|20626376|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
8367593|NCT01173601|20626377|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367594|NCT01173601|20626373|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
8367595|NCT01173601|20626374|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
8367596|NCT01173601|20626375|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
8367597|NCT01173601|20626376|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
8367598|NCT01173601|20626377|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367599|NCT01173601|20626373|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367600|NCT01173601|20626374|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367601|NCT01173601|20626375|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367602|NCT01173601|20626376|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367603|NCT01173601|20626377|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
8367604|NCT01173601|20626373|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367605|NCT01173601|20626374|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367606|NCT01173601|20626375|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367607|NCT01173601|20626376|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367608|NCT01173601|20626377|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
8367609|NCT01173601|20626373|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367610|NCT01173601|20626374|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367611|NCT01173601|20626375|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367612|NCT01173601|20626376|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367613|NCT01173601|20626377|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
8367614|NCT01173601|20626373|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367615|NCT01173601|20626374|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367616|NCT01173601|20626375|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367617|NCT01173601|20626376|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367618|NCT01173601|20626377|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
8367619|NCT01173523|20626454|P2|NOT COMPLETED|Overall Study||12
8367620|NCT01173523|20626455|P1|NOT COMPLETED|Overall Study||13
8367621|NCT01173523|20626454|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8367622|NCT01173523|20626455|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8367623|NCT01173523|20626454|P2|STARTED|Overall Study||12
8367624|NCT01173523|20626455|P1|STARTED|Overall Study||13
8367625|NCT01173471|20626471|P4|NOT COMPLETED|Overall Study||1
8367626|NCT01173471|20626472|P3|NOT COMPLETED|Overall Study||3
8367627|NCT01173471|20626473|P2|NOT COMPLETED|Overall Study||0
8367628|NCT01173471|20626474|P1|NOT COMPLETED|Overall Study||2
8367629|NCT01173471|20626471|P4|COMPLETED|Overall Study|Completed study|18
8367630|NCT01173471|20626472|P3|COMPLETED|Overall Study|Completed study|15
8367631|NCT01173471|20626473|P2|COMPLETED|Overall Study|Completed study|7
8367632|NCT01173471|20626474|P1|COMPLETED|Overall Study|Completed study|4
8367633|NCT01173471|20626471|P4|Completed Treatment|Overall Study||18
8367634|NCT01173471|20626472|P3|Completed Treatment|Overall Study||15
8367635|NCT01173471|20626473|P2|Completed Treatment|Overall Study||7
8367636|NCT01173471|20626474|P1|Completed Treatment|Overall Study||4
8367637|NCT01173471|20626471|P4|Received Treatment|Overall Study||19
8367638|NCT01173471|20626472|P3|Received Treatment|Overall Study||18
8367639|NCT01173471|20626473|P2|Received Treatment|Overall Study||7
8367640|NCT01173471|20626474|P1|Received Treatment|Overall Study||6
8367641|NCT01173471|20626471|P4|STARTED|Overall Study|Randomized|19
8367642|NCT01173471|20626472|P3|STARTED|Overall Study|Randomized|18
8367643|NCT01173471|20626473|P2|STARTED|Overall Study|Randomized|7
8367644|NCT01173471|20626474|P1|STARTED|Overall Study|Randomized|6
8367645|NCT01173211|20626498|P6|NOT COMPLETED|Overall Study||0
8367646|NCT01173211|20626499|P5|NOT COMPLETED|Overall Study||0
8367647|NCT01173211|20626500|P4|NOT COMPLETED|Overall Study||0
8367648|NCT01173211|20626501|P3|NOT COMPLETED|Overall Study||2
8367649|NCT01173211|20626502|P2|NOT COMPLETED|Overall Study||1
8367650|NCT01173211|20626503|P1|NOT COMPLETED|Overall Study||2
8367651|NCT01173211|20626498|P6|COMPLETED|Overall Study||13
8367652|NCT01173211|20626499|P5|COMPLETED|Overall Study||16
8367653|NCT01173211|20626500|P4|COMPLETED|Overall Study||15
8367654|NCT01173211|20626501|P3|COMPLETED|Overall Study||44
8367655|NCT01173211|20626502|P2|COMPLETED|Overall Study||44
8367656|NCT01173211|20626503|P1|COMPLETED|Overall Study||46
8367657|NCT01173211|20626498|P6|STARTED|Overall Study||13
8367658|NCT01173211|20626499|P5|STARTED|Overall Study||16
8367659|NCT01173211|20626500|P4|STARTED|Overall Study||15
8367660|NCT01173211|20626501|P3|STARTED|Overall Study||46
8367661|NCT01173211|20626502|P2|STARTED|Overall Study||45
8367662|NCT01173211|20626503|P1|STARTED|Overall Study||48
8367663|NCT01173159|20626604|P1|NOT COMPLETED|Overall Study||0
8367664|NCT01173159|20626604|P1|COMPLETED|Overall Study||10
8367665|NCT01173159|20626604|P1|STARTED|Overall Study||10
8367666|NCT01173120|20626614|P1|NOT COMPLETED|Overall Study||62
8367667|NCT01173120|20626614|P1|COMPLETED|Overall Study||0
8367668|NCT01173120|20626614|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
8367669|NCT01173120|20626614|P1|Switched Back to Main Study|Overall Study||57
8367670|NCT01173120|20626614|P1|STARTED|Overall Study||62
8367671|NCT01173055|20626632|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
8367672|NCT01173055|20626633|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
8367673|NCT01173055|20626632|P2|COMPLETED|Period 2 - Day 64 to 112||9
8367674|NCT01173055|20626633|P1|COMPLETED|Period 2 - Day 64 to 112||8
8367675|NCT01173055|20626632|P2|STARTED|Period 2 - Day 64 to 112||10
8367676|NCT01173055|20626633|P1|STARTED|Period 2 - Day 64 to 112||8
8367677|NCT01173055|20626632|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
8367678|NCT01173055|20626633|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
8367679|NCT01173055|20626632|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
8367680|NCT01173055|20626633|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
8367681|NCT01173055|20626632|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
8367682|NCT01173055|20626633|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
8367683|NCT01173055|20626632|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
8367684|NCT01173055|20626633|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
8367685|NCT01173055|20626632|P2|COMPLETED|Period 1 - Day 1 to 49||10
8367686|NCT01173055|20626633|P1|COMPLETED|Period 1 - Day 1 to 49||8
8367687|NCT01173055|20626632|P2|STARTED|Period 1 - Day 1 to 49||12
8367688|NCT01173055|20626633|P1|STARTED|Period 1 - Day 1 to 49||10
8367689|NCT01173029|20626651|P2|NOT COMPLETED|Overall Study||0
8367690|NCT01173029|20626652|P1|NOT COMPLETED|Overall Study||0
8367691|NCT01173029|20626651|P2|COMPLETED|Overall Study||31
8367692|NCT01173029|20626652|P1|COMPLETED|Overall Study||61
8367693|NCT01173029|20626651|P2|STARTED|Overall Study||31
8367694|NCT01173029|20626652|P1|STARTED|Overall Study||61
8367695|NCT01173016|20626669|P1|NOT COMPLETED|Overall Study||1
8367696|NCT01173016|20626669|P1|COMPLETED|Overall Study||10
8367697|NCT01173016|20626669|P1|STARTED|Overall Study||11
8367698|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
8367699|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
8367700|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367701|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367702|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367703|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367704|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
8367705|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
8367706|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367707|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
8367708|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
8367709|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367710|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367711|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367712|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367713|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
8367714|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
8367715|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367716|NCT01172938|20626684|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367717|NCT01172938|20626685|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
8367718|NCT01172938|20626686|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367719|NCT01172938|20626687|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367720|NCT01172938|20626688|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367721|NCT01172938|20626689|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367722|NCT01172938|20626690|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367723|NCT01172938|20626691|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367724|NCT01172938|20626692|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367725|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
8367726|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
8367727|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367728|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367729|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367730|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367731|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
8367732|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
8367733|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367734|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
8367735|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
8367736|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367737|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367738|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367739|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367740|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
8367741|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
8367742|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367743|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
8367744|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
8367745|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367746|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367747|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367748|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367749|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
8367750|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
8367751|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367752|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
8367753|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
8367754|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367755|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367756|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367757|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367758|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
8367759|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
8367760|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367761|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
8367762|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
8367763|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367764|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367765|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367766|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367767|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
8367768|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
8367769|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367770|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
8367771|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
8367772|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367773|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367774|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367775|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367776|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
8367777|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
8367778|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367779|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
8367780|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
8367781|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367782|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367783|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367784|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367785|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
8367786|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
8367787|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367788|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
8367789|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
8367790|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367791|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367792|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367793|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367794|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
8367795|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
8367796|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367797|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
8367798|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
8367799|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367800|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367801|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367802|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367803|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
8367804|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
8367805|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367806|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
8367807|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
8367808|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367809|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367810|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367811|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367812|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
8367813|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
8367814|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367815|NCT01172938|20626684|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367816|NCT01172938|20626685|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367817|NCT01172938|20626686|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
8367818|NCT01172938|20626687|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
8367819|NCT01172938|20626688|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
8367820|NCT01172938|20626689|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
8367821|NCT01172938|20626690|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
8367822|NCT01172938|20626691|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
8367823|NCT01172938|20626692|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367824|NCT01172938|20626684|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367825|NCT01172938|20626685|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367826|NCT01172938|20626686|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
8367827|NCT01172938|20626687|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
8367828|NCT01172938|20626688|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
8367829|NCT01172938|20626689|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
8367830|NCT01172938|20626690|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
8367831|NCT01172938|20626691|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
8367832|NCT01172938|20626692|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367833|NCT01172938|20626684|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
8367834|NCT01172938|20626685|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
8367835|NCT01172938|20626686|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
8367836|NCT01172938|20626687|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
8367837|NCT01172938|20626688|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
8367838|NCT01172938|20626689|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
8367839|NCT01172938|20626690|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
8367840|NCT01172938|20626691|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
8367841|NCT01172938|20626692|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
8367842|NCT01172938|20626684|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367843|NCT01172938|20626685|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367844|NCT01172938|20626686|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367845|NCT01172938|20626687|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367846|NCT01172938|20626688|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367847|NCT01172938|20626689|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367848|NCT01172938|20626690|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
8367849|NCT01172938|20626691|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
8367850|NCT01172938|20626692|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
8367851|NCT01172938|20626684|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367852|NCT01172938|20626685|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367853|NCT01172938|20626686|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367854|NCT01172938|20626687|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367855|NCT01172938|20626688|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367856|NCT01172938|20626689|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367857|NCT01172938|20626690|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
8367858|NCT01172938|20626691|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
8367859|NCT01172938|20626692|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
8367860|NCT01172938|20626684|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367861|NCT01172938|20626685|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367862|NCT01172938|20626686|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367863|NCT01172938|20626687|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367864|NCT01172938|20626688|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367865|NCT01172938|20626689|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367866|NCT01172938|20626690|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
8367867|NCT01172938|20626691|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
8367868|NCT01172938|20626692|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
8367869|NCT01172938|20626684|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367870|NCT01172938|20626685|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367871|NCT01172938|20626686|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367872|NCT01172938|20626687|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367873|NCT01172938|20626688|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367874|NCT01172938|20626689|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367875|NCT01172938|20626690|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
8367876|NCT01172938|20626691|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
8367877|NCT01172938|20626692|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
8367878|NCT01172938|20626684|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367879|NCT01172938|20626685|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367880|NCT01172938|20626686|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367881|NCT01172938|20626687|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367882|NCT01172938|20626688|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367883|NCT01172938|20626689|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367884|NCT01172938|20626690|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8367885|NCT01172938|20626691|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8367886|NCT01172938|20626692|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8367887|NCT01172938|20626684|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367888|NCT01172938|20626685|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367889|NCT01172938|20626686|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367890|NCT01172938|20626687|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367891|NCT01172938|20626688|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367892|NCT01172938|20626689|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367893|NCT01172938|20626690|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
8367894|NCT01172938|20626691|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
8367895|NCT01172938|20626692|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
8367896|NCT01172873|20626878|P2|NOT COMPLETED|Overall Study||2
8367897|NCT01172873|20626879|P1|NOT COMPLETED|Overall Study||3
8367898|NCT01172873|20626878|P2|COMPLETED|Overall Study||3
8367899|NCT01172873|20626879|P1|COMPLETED|Overall Study||8
8367900|NCT01172873|20626878|P2|STARTED|Overall Study||5
8367901|NCT01172873|20626879|P1|STARTED|Overall Study||11
8367902|NCT01172847|20626889|P1|NOT COMPLETED|Overall Study||3
8367903|NCT01172847|20626889|P1|COMPLETED|Overall Study||21
8367904|NCT01172847|20626889|P1|Oseltamivir + Rimantadine|Overall Study||21
8367905|NCT01172847|20626889|P1|Rimantadine|Overall Study||22
8367906|NCT01172847|20626889|P1|Oseltamivir|Overall Study||24
8367907|NCT01172847|20626889|P1|STARTED|Overall Study||24
8367908|NCT01172821|20626918|P4|NOT COMPLETED|Overall Study||17
8367909|NCT01172821|20626919|P3|NOT COMPLETED|Overall Study||13
8367910|NCT01172821|20626920|P2|NOT COMPLETED|Overall Study||12
8367911|NCT01172821|20626921|P1|NOT COMPLETED|Overall Study||14
8367912|NCT01172821|20626918|P4|COMPLETED|Overall Study||249
8367913|NCT01172821|20626919|P3|COMPLETED|Overall Study||240
8367914|NCT01172821|20626920|P2|COMPLETED|Overall Study||245
8367915|NCT01172821|20626921|P1|COMPLETED|Overall Study||240
8367916|NCT01172821|20626918|P4|STARTED|Overall Study|Entered and Treated|266
8367917|NCT01172821|20626919|P3|STARTED|Overall Study|Entered and Treated|253
8367918|NCT01172821|20626920|P2|STARTED|Overall Study|Entered and Treated|257
8367919|NCT01172821|20626921|P1|STARTED|Overall Study|Entered and Treated|254
8367920|NCT01172808|20627011|P4|NOT COMPLETED|Overall Study||15
8367921|NCT01172808|20627012|P3|NOT COMPLETED|Overall Study||23
8367922|NCT01172808|20627013|P2|NOT COMPLETED|Overall Study||13
8367923|NCT01172808|20627014|P1|NOT COMPLETED|Overall Study||21
8367924|NCT01172808|20627011|P4|COMPLETED|Overall Study||260
8367925|NCT01172808|20627012|P3|COMPLETED|Overall Study||241
8367926|NCT01172808|20627013|P2|COMPLETED|Overall Study||249
8367927|NCT01172808|20627014|P1|COMPLETED|Overall Study||248
8367928|NCT01172808|20627011|P4|STARTED|Overall Study|Entered and Treated|275
8367929|NCT01172808|20627012|P3|STARTED|Overall Study|Entered and Treated|264
8367930|NCT01172808|20627013|P2|STARTED|Overall Study|Entered and Treated|262
8367931|NCT01172808|20627014|P1|STARTED|Overall Study|Entered and Treated|269
8367932|NCT01172639|20627105|P5|NOT COMPLETED|Overall Study||6
8367933|NCT01172639|20627106|P4|NOT COMPLETED|Overall Study||11
8367934|NCT01172639|20627107|P3|NOT COMPLETED|Overall Study||16
8367935|NCT01172639|20627108|P2|NOT COMPLETED|Overall Study||11
8367936|NCT01172639|20627109|P1|NOT COMPLETED|Overall Study||13
8367937|NCT01172639|20627105|P5|COMPLETED|Overall Study||41
8367938|NCT01172639|20627106|P4|COMPLETED|Overall Study||32
8367939|NCT01172639|20627107|P3|COMPLETED|Overall Study||77
8367940|NCT01172639|20627108|P2|COMPLETED|Overall Study||87
8367941|NCT01172639|20627109|P1|COMPLETED|Overall Study||85
8367942|NCT01172639|20627105|P5|Week 52|Overall Study||45
8367943|NCT01172639|20627106|P4|Week 52|Overall Study||38
8367944|NCT01172639|20627107|P3|Week 52|Overall Study||88
8367945|NCT01172639|20627108|P2|Week 52|Overall Study||89
8367946|NCT01172639|20627109|P1|Week 52|Overall Study||89
8367947|NCT01172639|20627105|P5|Week 16|Overall Study||47
8367948|NCT01172639|20627106|P4|Week 16|Overall Study||39
8367949|NCT01172639|20627107|P3|Week 16|Overall Study||91
8367950|NCT01172639|20627108|P2|Week 16|Overall Study||96
8367951|NCT01172639|20627109|P1|Week 16|Overall Study||94
8367952|NCT01172639|20627105|P5|STARTED|Overall Study||47
8367953|NCT01172639|20627106|P4|STARTED|Overall Study||43
8367954|NCT01172639|20627107|P3|STARTED|Overall Study||93
8367955|NCT01172639|20627108|P2|STARTED|Overall Study||98
8367956|NCT01172639|20627109|P1|STARTED|Overall Study||98
8367957|NCT01172600|20627153|P2|NOT COMPLETED|Overall Study||0
8367958|NCT01172600|20627154|P1|NOT COMPLETED|Overall Study||0
8367959|NCT01172600|20627153|P2|COMPLETED|Overall Study||39
8367960|NCT01172600|20627154|P1|COMPLETED|Overall Study||39
8367961|NCT01172600|20627153|P2|STARTED|Overall Study||39
8367962|NCT01172600|20627154|P1|STARTED|Overall Study||39
8367963|NCT01172535|20627184|P1|NOT COMPLETED|Overall Study||8
8367964|NCT01172535|20627184|P1|COMPLETED|Overall Study||89
8367965|NCT01172535|20627184|P1|STARTED|Overall Study||97
8367966|NCT01172522|20627201|P2|NOT COMPLETED|Overall Study||0
8367967|NCT01172522|20627202|P1|NOT COMPLETED|Overall Study||0
8367968|NCT01172522|20627201|P2|COMPLETED|Overall Study||15
8367969|NCT01172522|20627202|P1|COMPLETED|Overall Study||15
8367970|NCT01172522|20627201|P2|STARTED|Overall Study||15
8367971|NCT01172522|20627202|P1|STARTED|Overall Study||15
8367972|NCT01172418|20627209|P2|NOT COMPLETED|Overall Study||0
8367973|NCT01172418|20627210|P1|NOT COMPLETED|Overall Study||0
8367974|NCT01172418|20627209|P2|COMPLETED|Overall Study||100
8367975|NCT01172418|20627210|P1|COMPLETED|Overall Study||100
8367976|NCT01172418|20627209|P2|STARTED|Overall Study||100
8367977|NCT01172418|20627210|P1|STARTED|Overall Study||100
8367978|NCT01172353|20627226|P2|NOT COMPLETED|Overall Study||0
8367979|NCT01172353|20627227|P1|NOT COMPLETED|Overall Study||0
8367980|NCT01172353|20627226|P2|COMPLETED|Overall Study||151
8367981|NCT01172353|20627227|P1|COMPLETED|Overall Study||150
8367982|NCT01172353|20627226|P2|STARTED|Overall Study||151
8367983|NCT01172353|20627227|P1|STARTED|Overall Study||150
8367984|NCT01172288|20627237|P2|NOT COMPLETED|Overall Study||1
8367985|NCT01172288|20627238|P1|NOT COMPLETED|Overall Study||1
8367986|NCT01172288|20627237|P2|COMPLETED|Overall Study||13
8367987|NCT01172288|20627238|P1|COMPLETED|Overall Study||16
8367988|NCT01172288|20627237|P2|STARTED|Overall Study||14
8367989|NCT01172288|20627238|P1|STARTED|Overall Study||17
8367990|NCT01172275|20627254|P2|NOT COMPLETED|Overall Study||0
8367991|NCT01172275|20627255|P1|NOT COMPLETED|Overall Study||2
8367992|NCT01172275|20627254|P2|COMPLETED|Overall Study||6
8367993|NCT01172275|20627255|P1|COMPLETED|Overall Study||3
8367994|NCT01172275|20627254|P2|STARTED|Overall Study||6
8367995|NCT01172275|20627255|P1|STARTED|Overall Study||5
8367996|NCT01172197|20627265|P2|NOT COMPLETED|Overall Study||0
8367997|NCT01172197|20627266|P1|NOT COMPLETED|Overall Study||0
8367998|NCT01172197|20627265|P2|COMPLETED|Overall Study||7
8367999|NCT01172197|20627266|P1|COMPLETED|Overall Study||7
8368000|NCT01172197|20627265|P2|STARTED|Overall Study||7
8368001|NCT01172197|20627266|P1|STARTED|Overall Study||7
8368002|NCT01172184|20627272|P1|NOT COMPLETED|Overall Study||0
8368003|NCT01172184|20627272|P1|COMPLETED|Overall Study||111
8368004|NCT01172184|20627272|P1|STARTED|Overall Study||111
8368005|NCT01172145|20627280|P2|NOT COMPLETED|Overall Study||0
8368006|NCT01172145|20627281|P1|NOT COMPLETED|Overall Study||0
8368007|NCT01172145|20627280|P2|COMPLETED|Overall Study||11
8368008|NCT01172145|20627281|P1|COMPLETED|Overall Study||11
8368009|NCT01172145|20627280|P2|STARTED|Overall Study||11
8368010|NCT01172145|20627281|P1|STARTED|Overall Study||11
8368011|NCT01172067|20627303|P2|NOT COMPLETED|Overall Study||37
8368012|NCT01172067|20627304|P1|NOT COMPLETED|Overall Study||47
8368013|NCT01172067|20627303|P2|COMPLETED|Overall Study||163
8368014|NCT01172067|20627304|P1|COMPLETED|Overall Study||153
8368015|NCT01172067|20627303|P2|STARTED|Overall Study||200
8368016|NCT01172067|20627304|P1|STARTED|Overall Study||200
8368017|NCT01171989|20627313|P3|NOT COMPLETED|Overall Study||1
8368018|NCT01171989|20627314|P2|NOT COMPLETED|Overall Study||0
8368019|NCT01171989|20627315|P1|NOT COMPLETED|Overall Study||0
8368020|NCT01171989|20627313|P3|COMPLETED|Overall Study||120
8368021|NCT01171989|20627314|P2|COMPLETED|Overall Study||133
8368022|NCT01171989|20627315|P1|COMPLETED|Overall Study||137
8368023|NCT01171989|20627313|P3|STARTED|Overall Study||121
8368024|NCT01171989|20627314|P2|STARTED|Overall Study||133
8368025|NCT01171989|20627315|P1|STARTED|Overall Study||137
8368026|NCT01171976|20627389|P3|NOT COMPLETED|Overall Study||15
8368027|NCT01171976|20627390|P2|NOT COMPLETED|Overall Study||11
8368028|NCT01171976|20627391|P1|NOT COMPLETED|Overall Study||14
8368029|NCT01171976|20627389|P3|COMPLETED|Overall Study||108
8368030|NCT01171976|20627390|P2|COMPLETED|Overall Study||117
8368031|NCT01171976|20627391|P1|COMPLETED|Overall Study||107
8368032|NCT01171976|20627389|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
8368033|NCT01171976|20627390|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
8368034|NCT01171976|20627391|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
8368035|NCT01171976|20627389|P3|STARTED|Overall Study||123
8368036|NCT01171976|20627390|P2|STARTED|Overall Study||128
8368037|NCT01171976|20627391|P1|STARTED|Overall Study||121
8368038|NCT01171963|20627428|P2|NOT COMPLETED|Overall Study||168
8368039|NCT01171963|20627429|P1|NOT COMPLETED|Overall Study||148
8368040|NCT01171963|20627428|P2|COMPLETED|Overall Study||1499
8368041|NCT01171963|20627429|P1|COMPLETED|Overall Study||1518
8368042|NCT01171963|20627428|P2|STARTED|Overall Study||1667
8368043|NCT01171963|20627429|P1|STARTED|Overall Study||1666
8368044|NCT01171924|20627487|P2|NOT COMPLETED|Overall Study||23
8368045|NCT01171924|20627488|P1|NOT COMPLETED|Overall Study||23
8368046|NCT01171924|20627487|P2|COMPLETED|Overall Study||0
8368047|NCT01171924|20627488|P1|COMPLETED|Overall Study||0
8368048|NCT01171924|20627487|P2|STARTED|Overall Study||23
8368049|NCT01171924|20627488|P1|STARTED|Overall Study||23
8368050|NCT01171898|20627498|P4|NOT COMPLETED|Overall Study||6
8368051|NCT01171898|20627499|P3|NOT COMPLETED|Overall Study||12
8368052|NCT01171898|20627500|P2|NOT COMPLETED|Overall Study||19
8368053|NCT01171898|20627501|P1|NOT COMPLETED|Overall Study||4
8368054|NCT01171898|20627498|P4|COMPLETED|Overall Study||15
8368055|NCT01171898|20627499|P3|COMPLETED|Overall Study||13
8368056|NCT01171898|20627500|P2|COMPLETED|Overall Study||32
8368057|NCT01171898|20627501|P1|COMPLETED|Overall Study||26
8368058|NCT01171898|20627498|P4|STARTED|Overall Study||21
8368059|NCT01171898|20627499|P3|STARTED|Overall Study||25
8368060|NCT01171898|20627500|P2|STARTED|Overall Study||51
8368061|NCT01171898|20627501|P1|STARTED|Overall Study||30
8368062|NCT01171820|20627525|P2|NOT COMPLETED|Overall Study||6
8368063|NCT01171820|20627526|P1|NOT COMPLETED|Overall Study||6
8368064|NCT01171820|20627525|P2|COMPLETED|Overall Study||212
8368065|NCT01171820|20627526|P1|COMPLETED|Overall Study||100
8368066|NCT01171820|20627525|P2|STARTED|Overall Study||218
8368067|NCT01171820|20627526|P1|STARTED|Overall Study||106
8368068|NCT01171794|20627582|P2|NOT COMPLETED|Overall Study||0
8368069|NCT01171794|20627583|P1|NOT COMPLETED|Overall Study||3
8368070|NCT01171794|20627582|P2|COMPLETED|Overall Study||42
8368071|NCT01171794|20627583|P1|COMPLETED|Overall Study||44
8368072|NCT01171794|20627582|P2|STARTED|Overall Study||42
8368073|NCT01171794|20627583|P1|STARTED|Overall Study||47
8368074|NCT01171690|20627593|P2|NOT COMPLETED|Overall Study||0
8368075|NCT01171690|20627594|P1|NOT COMPLETED|Overall Study||0
8368076|NCT01171690|20627593|P2|COMPLETED|Overall Study||5
8368077|NCT01171690|20627594|P1|COMPLETED|Overall Study||5
8368078|NCT01171690|20627593|P2|STARTED|Overall Study||5
8368079|NCT01171690|20627594|P1|STARTED|Overall Study||5
8368080|NCT01171677|20627604|P2|NOT COMPLETED|Overall Study||3
8368081|NCT01171677|20627605|P1|NOT COMPLETED|Overall Study||6
8368082|NCT01171677|20627604|P2|COMPLETED|Overall Study||12
8368083|NCT01171677|20627605|P1|COMPLETED|Overall Study||11
8368084|NCT01171677|20627604|P2|STARTED|Overall Study||15
8368085|NCT01171677|20627605|P1|STARTED|Overall Study||17
8368086|NCT01171625|20627637|P1|NOT COMPLETED|Overall Study||180
8368087|NCT01171625|20627637|P1|COMPLETED|Overall Study||103
8368088|NCT01171625|20627637|P1|Subjects Implanted With Device|Overall Study||258
8368089|NCT01171625|20627637|P1|STARTED|Overall Study||283
8368090|NCT01171612|20627670|P1|NOT COMPLETED|Overall Study||51
8368091|NCT01171612|20627670|P1|COMPLETED|Overall Study||432
8368092|NCT01171612|20627670|P1|STARTED|Overall Study||483
8368093|NCT01171534|20627680|P2|NOT COMPLETED|Overall Study||3
8368094|NCT01171534|20627681|P1|NOT COMPLETED|Overall Study||0
8368095|NCT01171534|20627680|P2|COMPLETED|Overall Study||4
8368096|NCT01171534|20627681|P1|COMPLETED|Overall Study||0
8368097|NCT01171534|20627680|P2|STARTED|Overall Study||7
8368098|NCT01171534|20627681|P1|STARTED|Overall Study|retrospective arm never performed on study|0
8368099|NCT01171521|20627693|P1|NOT COMPLETED|Overall Study||6
8368100|NCT01171521|20627693|P1|COMPLETED|Overall Study||0
8368101|NCT01171521|20627693|P1|STARTED|Overall Study||6
8368102|NCT01171183|20627700|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
8368103|NCT01171183|20627701|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
8368104|NCT01171183|20627700|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
8368105|NCT01171183|20627701|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
8368106|NCT01171183|20627700|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
8368107|NCT01171183|20627701|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
8368108|NCT01171183|20627700|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
8368109|NCT01171183|20627701|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
8368110|NCT01171183|20627700|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
8368111|NCT01171183|20627701|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
8368112|NCT01171183|20627700|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
8368113|NCT01171183|20627701|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
8368114|NCT01171118|20627709|P1|NOT COMPLETED|Overall Study||0
8368115|NCT01171118|20627709|P1|COMPLETED|Overall Study||10
8368116|NCT01171118|20627709|P1|STARTED|Overall Study||10
8368117|NCT01170962|20627722|P3|NOT COMPLETED|Follow up Period||6
8368118|NCT01170962|20627723|P2|NOT COMPLETED|Follow up Period||27
8368119|NCT01170962|20627724|P1|NOT COMPLETED|Follow up Period||39
8368120|NCT01170962|20627722|P3|COMPLETED|Follow up Period||9
8368121|NCT01170962|20627723|P2|COMPLETED|Follow up Period||165
8368122|NCT01170962|20627724|P1|COMPLETED|Follow up Period||159
8368123|NCT01170962|20627722|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
8368124|NCT01170962|20627723|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
8368125|NCT01170962|20627724|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
8368126|NCT01170962|20627722|P3|NOT COMPLETED|Treatment Period||12
8368127|NCT01170962|20627723|P2|NOT COMPLETED|Treatment Period||111
8368128|NCT01170962|20627724|P1|NOT COMPLETED|Treatment Period||127
8368129|NCT01170962|20627722|P3|COMPLETED|Treatment Period||5
8368130|NCT01170962|20627723|P2|COMPLETED|Treatment Period||88
8368131|NCT01170962|20627724|P1|COMPLETED|Treatment Period||76
8368132|NCT01170962|20627722|P3|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
8368133|NCT01170962|20627723|P2|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
8368134|NCT01170962|20627724|P1|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
8368135|NCT01170962|20627722|P3|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
8368136|NCT01170962|20627723|P2|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
8368137|NCT01170962|20627724|P1|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
8368138|NCT01170962|20627722|P3|No PDR|Treatment Period||17
8368139|NCT01170962|20627723|P2|No PDR|Treatment Period||127
8368140|NCT01170962|20627724|P1|No PDR|Treatment Period||145
8368141|NCT01170962|20627722|P3|STARTED|Treatment Period||17
8368142|NCT01170962|20627723|P2|STARTED|Treatment Period||199
8368143|NCT01170962|20627724|P1|STARTED|Treatment Period||203
8368144|NCT01170949|20627770|P2|NOT COMPLETED|Overall Study||4
8368145|NCT01170949|20627771|P1|NOT COMPLETED|Overall Study||7
8368146|NCT01170949|20627770|P2|COMPLETED|Overall Study||22
8368147|NCT01170949|20627771|P1|COMPLETED|Overall Study||43
8368148|NCT01170949|20627770|P2|STARTED|Overall Study||26
8368149|NCT01170949|20627771|P1|STARTED|Overall Study||50
8368150|NCT01170884|20627779|P2|NOT COMPLETED|Overall Study||2
8368151|NCT01170884|20627780|P1|NOT COMPLETED|Overall Study||5
8368152|NCT01170884|20627779|P2|COMPLETED|Overall Study||60
8368153|NCT01170884|20627780|P1|COMPLETED|Overall Study||54
8368154|NCT01170884|20627779|P2|STARTED|Overall Study||62
8368155|NCT01170884|20627780|P1|STARTED|Overall Study||59
8368156|NCT01170754|20627788|P2|NOT COMPLETED|Overall Study||0
8368157|NCT01170754|20627789|P1|NOT COMPLETED|Overall Study||0
8368158|NCT01170754|20627788|P2|COMPLETED|Overall Study||70
8368159|NCT01170754|20627789|P1|COMPLETED|Overall Study||66
8368160|NCT01170754|20627788|P2|STARTED|Overall Study||70
8368161|NCT01170754|20627789|P1|STARTED|Overall Study||66
8368162|NCT01170663|20627819|P2|NOT COMPLETED|Overall Study||20
8368163|NCT01170663|20627820|P1|NOT COMPLETED|Overall Study||14
8368164|NCT01170663|20627819|P2|COMPLETED|Overall Study||315
8368165|NCT01170663|20627820|P1|COMPLETED|Overall Study||316
8368166|NCT01170663|20627819|P2|Received Any Treatment (Safety Pop)|Overall Study||329
8368167|NCT01170663|20627820|P1|Received Any Treatment (Safety Pop)|Overall Study||327
8368168|NCT01170663|20627819|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
8368169|NCT01170663|20627820|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
8368170|NCT01170598|20627848|P1|NOT COMPLETED|Overall Study||6
8368171|NCT01170598|20627848|P1|COMPLETED|Overall Study||29
8368172|NCT01170598|20627848|P1|STARTED|Overall Study||35
8368173|NCT01170546|20627867|P4|NOT COMPLETED|Overall Study||0
8368174|NCT01170546|20627868|P3|NOT COMPLETED|Overall Study||0
8368175|NCT01170546|20627869|P2|NOT COMPLETED|Overall Study||0
8368176|NCT01170546|20627870|P1|NOT COMPLETED|Overall Study||0
8368177|NCT01170546|20627867|P4|COMPLETED|Overall Study||8
8368178|NCT01170546|20627868|P3|COMPLETED|Overall Study||6
8368179|NCT01170546|20627869|P2|COMPLETED|Overall Study||7
8368180|NCT01170546|20627870|P1|COMPLETED|Overall Study||7
8368181|NCT01170546|20627867|P4|STARTED|Overall Study||8
8368182|NCT01170546|20627868|P3|STARTED|Overall Study||6
8368183|NCT01170546|20627869|P2|STARTED|Overall Study||7
8368184|NCT01170546|20627870|P1|STARTED|Overall Study||7
8368185|NCT01170533|20627880|P2|NOT COMPLETED|Pantoprazole Cross-over||0
8368186|NCT01170533|20627881|P1|NOT COMPLETED|Pantoprazole Cross-over||0
8368187|NCT01170533|20627880|P2|COMPLETED|Pantoprazole Cross-over||20
8368188|NCT01170533|20627881|P1|COMPLETED|Pantoprazole Cross-over||0
8368189|NCT01170533|20627880|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
8368190|NCT01170533|20627881|P1|STARTED|Pantoprazole Cross-over||0
8368191|NCT01170533|20627880|P2|NOT COMPLETED|Omeprazole Cross-over||0
8368192|NCT01170533|20627881|P1|NOT COMPLETED|Omeprazole Cross-over||0
8368193|NCT01170533|20627880|P2|COMPLETED|Omeprazole Cross-over||0
8368194|NCT01170533|20627881|P1|COMPLETED|Omeprazole Cross-over||20
8368195|NCT01170533|20627880|P2|STARTED|Omeprazole Cross-over||0
8368196|NCT01170533|20627881|P1|STARTED|Omeprazole Cross-over||20
8368197|NCT01170390|20627893|P3|NOT COMPLETED|Randomized Treatment||0
8368198|NCT01170390|20627894|P2|NOT COMPLETED|Randomized Treatment||1
8368199|NCT01170390|20627895|P1|NOT COMPLETED|Randomized Treatment||0
8368200|NCT01170390|20627893|P3|COMPLETED|Randomized Treatment||15
8368201|NCT01170390|20627894|P2|COMPLETED|Randomized Treatment||16
8368202|NCT01170390|20627895|P1|COMPLETED|Randomized Treatment||0
8368203|NCT01170390|20627893|P3|STARTED|Randomized Treatment||15
8368204|NCT01170390|20627894|P2|STARTED|Randomized Treatment||17
8368205|NCT01170390|20627895|P1|STARTED|Randomized Treatment||0
8368206|NCT01170390|20627893|P3|NOT COMPLETED|Oral Contraceptives||0
8368207|NCT01170390|20627894|P2|NOT COMPLETED|Oral Contraceptives||0
8368208|NCT01170390|20627895|P1|NOT COMPLETED|Oral Contraceptives||1
8368209|NCT01170390|20627893|P3|COMPLETED|Oral Contraceptives||0
8368210|NCT01170390|20627894|P2|COMPLETED|Oral Contraceptives||0
8368211|NCT01170390|20627895|P1|COMPLETED|Oral Contraceptives||31
8368212|NCT01170390|20627893|P3|STARTED|Oral Contraceptives||0
8368213|NCT01170390|20627894|P2|STARTED|Oral Contraceptives||0
8368214|NCT01170390|20627895|P1|STARTED|Oral Contraceptives||32
8368215|NCT01170364|20627911|P2|NOT COMPLETED|Overall Study||1
8368216|NCT01170364|20627912|P1|NOT COMPLETED|Overall Study||4
8368217|NCT01170364|20627911|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
8368218|NCT01170364|20627912|P1|COMPLETED|Overall Study||4
8368219|NCT01170364|20627911|P2|STARTED|Overall Study||6
8368220|NCT01170364|20627912|P1|STARTED|Overall Study||8
8368221|NCT01170273|20627920|P2|NOT COMPLETED|Overall Study||9
8368222|NCT01170273|20627921|P1|NOT COMPLETED|Overall Study||8
8368223|NCT01170273|20627920|P2|COMPLETED|Overall Study||57
8368224|NCT01170273|20627921|P1|COMPLETED|Overall Study||56
8368225|NCT01170273|20627920|P2|STARTED|Overall Study||66
8368226|NCT01170273|20627921|P1|STARTED|Overall Study||64
8368227|NCT01170247|20627929|P2|NOT COMPLETED|Overall Study||0
8368228|NCT01170247|20627930|P1|NOT COMPLETED|Overall Study||0
8368229|NCT01170247|20627929|P2|COMPLETED|Overall Study||1
8368230|NCT01170247|20627930|P1|COMPLETED|Overall Study||2
8368231|NCT01170247|20627929|P2|STARTED|Overall Study||1
8368232|NCT01170247|20627930|P1|STARTED|Overall Study||2
8368233|NCT01170221|20627938|P2|NOT COMPLETED|Overall Study||28
8368234|NCT01170221|20627939|P1|NOT COMPLETED|Overall Study||33
8368235|NCT01170221|20627938|P2|COMPLETED|Overall Study||307
8368236|NCT01170221|20627939|P1|COMPLETED|Overall Study||299
8368237|NCT01170221|20627938|P2|STARTED|Overall Study||335
8368238|NCT01170221|20627939|P1|STARTED|Overall Study||332
8368239|NCT01170208|20627962|P3|NOT COMPLETED|Overall Study||2
8368240|NCT01170208|20627963|P2|NOT COMPLETED|Overall Study||0
8368241|NCT01170208|20627964|P1|NOT COMPLETED|Overall Study||6
8368242|NCT01170208|20627962|P3|COMPLETED|Overall Study||4
8368243|NCT01170208|20627963|P2|COMPLETED|Overall Study||20
8368244|NCT01170208|20627964|P1|COMPLETED|Overall Study||14
8368245|NCT01170208|20627962|P3|STARTED|Overall Study||6
8368246|NCT01170208|20627963|P2|STARTED|Overall Study||20
8368247|NCT01170208|20627964|P1|STARTED|Overall Study||20
8368248|NCT01170117|20627983|P2|NOT COMPLETED|Overall Study||20
8368249|NCT01170117|20627984|P1|NOT COMPLETED|Overall Study||30
8368250|NCT01170117|20627983|P2|COMPLETED|Overall Study||55
8368251|NCT01170117|20627984|P1|COMPLETED|Overall Study||47
8368252|NCT01170117|20627983|P2|STARTED|Overall Study||75
8368253|NCT01170117|20627984|P1|STARTED|Overall Study||77
8368254|NCT01170091|20627992|P1|NOT COMPLETED|Overall Study||24
8368255|NCT01170091|20627992|P1|COMPLETED|Overall Study||627
8368256|NCT01170091|20627992|P1|STARTED|Overall Study||651
8368257|NCT01170065|20628002|P3|NOT COMPLETED|Overall Study||26
8368258|NCT01170065|20628003|P2|NOT COMPLETED|Overall Study||92
8368259|NCT01170065|20628004|P1|NOT COMPLETED|Overall Study||28
8368260|NCT01170065|20628002|P3|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
8368261|NCT01170065|20628003|P2|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
8368262|NCT01170065|20628004|P1|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
8368263|NCT01170065|20628002|P3|STARTED|Overall Study||35
8368264|NCT01170065|20628003|P2|STARTED|Overall Study||126
8368265|NCT01170065|20628004|P1|STARTED|Overall Study||37
8368266|NCT01170039|20628035|P2|NOT COMPLETED|Overall Study||6
8368267|NCT01170039|20628036|P1|NOT COMPLETED|Overall Study||8
8368268|NCT01170039|20628035|P2|COMPLETED|Overall Study||33
8368269|NCT01170039|20628036|P1|COMPLETED|Overall Study||29
8368270|NCT01170039|20628035|P2|STARTED|Overall Study||39
8368271|NCT01170039|20628036|P1|STARTED|Overall Study||37
8368272|NCT01169987|20628048|P1|NOT COMPLETED|Overall Study||31
8368273|NCT01169987|20628048|P1|COMPLETED|Overall Study||160
8368274|NCT01169987|20628048|P1|STARTED|Overall Study||191
8368275|NCT01169779|20628114|P2|NOT COMPLETED|Overall Study||17
8368276|NCT01169779|20628115|P1|NOT COMPLETED|Overall Study||11
8368277|NCT01169779|20628114|P2|COMPLETED|Overall Study||179
8368278|NCT01169779|20628115|P1|COMPLETED|Overall Study||184
8368279|NCT01169779|20628114|P2|Subgroup for Standardized Meal Test|Overall Study||121
8368280|NCT01169779|20628115|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
8368281|NCT01169779|20628114|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
8368282|NCT01169779|20628115|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
8368283|NCT01169779|20628114|P2|Treated/Safety Population|Overall Study||196
8368284|NCT01169779|20628115|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
8368285|NCT01169779|20628114|P2|STARTED|Overall Study||196
8368286|NCT01169779|20628115|P1|STARTED|Overall Study|Randomized.|195
8368287|NCT01169753|20628141|P2|NOT COMPLETED|Overall Study||1
8368288|NCT01169753|20628142|P1|NOT COMPLETED|Overall Study||0
8368289|NCT01169753|20628141|P2|COMPLETED|Overall Study||0
8368290|NCT01169753|20628142|P1|COMPLETED|Overall Study||0
8368291|NCT01169753|20628141|P2|STARTED|Overall Study||1
8368292|NCT01169753|20628142|P1|STARTED|Overall Study||0
8368293|NCT01169701|20628150|P2|NOT COMPLETED|Overall Study||10
8368294|NCT01169701|20628151|P1|NOT COMPLETED|Overall Study||5
8368295|NCT01169701|20628150|P2|COMPLETED|Overall Study||25
8368296|NCT01169701|20628151|P1|COMPLETED|Overall Study||31
8368297|NCT01169701|20628150|P2|Intent to Treat (ITT) Set|Overall Study||28
8368298|NCT01169701|20628151|P1|Intent to Treat (ITT) Set|Overall Study||32
8368299|NCT01169701|20628150|P2|Safety Set|Overall Study||35
8368300|NCT01169701|20628151|P1|Safety Set|Overall Study||36
8368301|NCT01169701|20628150|P2|STARTED|Overall Study||35
8368302|NCT01169701|20628151|P1|STARTED|Overall Study||36
8368303|NCT01169675|20628188|P5|NOT COMPLETED|Overall Study||6
8368304|NCT01169675|20628189|P4|NOT COMPLETED|Overall Study||17
8368305|NCT01169675|20628190|P3|NOT COMPLETED|Overall Study||7
8368306|NCT01169675|20628191|P2|NOT COMPLETED|Overall Study||3
8368307|NCT01169675|20628192|P1|NOT COMPLETED|Overall Study||20
8368308|NCT01169675|20628188|P5|COMPLETED|Overall Study||0
8368309|NCT01169675|20628189|P4|COMPLETED|Overall Study||0
8368310|NCT01169675|20628190|P3|COMPLETED|Overall Study||0
8368311|NCT01169675|20628191|P2|COMPLETED|Overall Study||0
8368312|NCT01169675|20628192|P1|COMPLETED|Overall Study||0
8368313|NCT01169675|20628188|P5|STARTED|Overall Study||6
8368314|NCT01169675|20628189|P4|STARTED|Overall Study||17
8368315|NCT01169675|20628190|P3|STARTED|Overall Study||7
8368316|NCT01169675|20628191|P2|STARTED|Overall Study||3
8368317|NCT01169675|20628192|P1|STARTED|Overall Study||20
8368318|NCT01169649|20628229|P1|NOT COMPLETED|Overall Study||3
8368319|NCT01169649|20628229|P1|COMPLETED|Overall Study||8
8368320|NCT01169649|20628229|P1|STARTED|Overall Study||11
8368321|NCT01169636|20628238|P5|NOT COMPLETED|Overall Study||3
8368322|NCT01169636|20628239|P4|NOT COMPLETED|Overall Study||1
8368323|NCT01169636|20628240|P3|NOT COMPLETED|Overall Study||3
8368324|NCT01169636|20628241|P2|NOT COMPLETED|Overall Study||0
8368325|NCT01169636|20628242|P1|NOT COMPLETED|Overall Study||0
8368326|NCT01169636|20628238|P5|COMPLETED|Overall Study||11
8368327|NCT01169636|20628239|P4|COMPLETED|Overall Study||12
8368328|NCT01169636|20628240|P3|COMPLETED|Overall Study||17
8368329|NCT01169636|20628241|P2|COMPLETED|Overall Study||6
8368330|NCT01169636|20628242|P1|COMPLETED|Overall Study||3
8368331|NCT01169636|20628238|P5|STARTED|Overall Study||14
8368332|NCT01169636|20628239|P4|STARTED|Overall Study||13
8368333|NCT01169636|20628240|P3|STARTED|Overall Study||20
8368334|NCT01169636|20628241|P2|STARTED|Overall Study||6
8368335|NCT01169636|20628242|P1|STARTED|Overall Study||3
8368336|NCT01169610|20628256|P1|NOT COMPLETED|Overall Study||0
8368337|NCT01169610|20628256|P1|COMPLETED|Overall Study||1
8368338|NCT01169610|20628256|P1|STARTED|Overall Study||1
8368339|NCT01169558|20628264|P1|NOT COMPLETED|Overall Study||156
8368340|NCT01169558|20628264|P1|COMPLETED|Overall Study||6
8368341|NCT01169558|20628264|P1|STARTED|Overall Study||162
8368342|NCT01169519|20628271|P1|NOT COMPLETED|Overall Study||0
8368343|NCT01169519|20628271|P1|COMPLETED|Overall Study||21
8368344|NCT01169519|20628271|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
8368345|NCT01169493|20628289|P6|NOT COMPLETED|Period 3 (6 Months)||0
8368346|NCT01169493|20628290|P5|NOT COMPLETED|Period 3 (6 Months)||0
8368347|NCT01169493|20628291|P4|NOT COMPLETED|Period 3 (6 Months)||0
8368348|NCT01169493|20628292|P3|NOT COMPLETED|Period 3 (6 Months)||1
8368349|NCT01169493|20628293|P2|NOT COMPLETED|Period 3 (6 Months)||2
8368350|NCT01169493|20628294|P1|NOT COMPLETED|Period 3 (6 Months)||0
8368351|NCT01169493|20628289|P6|COMPLETED|Period 3 (6 Months)||2
8368352|NCT01169493|20628290|P5|COMPLETED|Period 3 (6 Months)||0
8368353|NCT01169493|20628291|P4|COMPLETED|Period 3 (6 Months)||0
8368354|NCT01169493|20628292|P3|COMPLETED|Period 3 (6 Months)||2
8368355|NCT01169493|20628293|P2|COMPLETED|Period 3 (6 Months)||1
8368356|NCT01169493|20628294|P1|COMPLETED|Period 3 (6 Months)||2
8368357|NCT01169493|20628289|P6|STARTED|Period 3 (6 Months)||2
8368358|NCT01169493|20628290|P5|STARTED|Period 3 (6 Months)||0
8368359|NCT01169493|20628291|P4|STARTED|Period 3 (6 Months)||0
8368360|NCT01169493|20628292|P3|STARTED|Period 3 (6 Months)||3
8368361|NCT01169493|20628293|P2|STARTED|Period 3 (6 Months)||3
8368362|NCT01169493|20628294|P1|STARTED|Period 3 (6 Months)||2
8368363|NCT01169493|20628289|P6|NOT COMPLETED|Period 2 (6 Months)||0
8368364|NCT01169493|20628290|P5|NOT COMPLETED|Period 2 (6 Months)||0
8368365|NCT01169493|20628291|P4|NOT COMPLETED|Period 2 (6 Months)||0
8368366|NCT01169493|20628292|P3|NOT COMPLETED|Period 2 (6 Months)||0
8368367|NCT01169493|20628293|P2|NOT COMPLETED|Period 2 (6 Months)||0
8368368|NCT01169493|20628294|P1|NOT COMPLETED|Period 2 (6 Months)||0
8368369|NCT01169493|20628289|P6|COMPLETED|Period 2 (6 Months)||2
8368370|NCT01169493|20628290|P5|COMPLETED|Period 2 (6 Months)||0
8368371|NCT01169493|20628291|P4|COMPLETED|Period 2 (6 Months)||0
8368372|NCT01169493|20628292|P3|COMPLETED|Period 2 (6 Months)||3
8368373|NCT01169493|20628293|P2|COMPLETED|Period 2 (6 Months)||3
8368374|NCT01169493|20628294|P1|COMPLETED|Period 2 (6 Months)||2
8368375|NCT01169493|20628289|P6|STARTED|Period 2 (6 Months)||2
8368376|NCT01169493|20628290|P5|STARTED|Period 2 (6 Months)||0
8368377|NCT01169493|20628291|P4|STARTED|Period 2 (6 Months)||0
8368378|NCT01169493|20628292|P3|STARTED|Period 2 (6 Months)||3
8368379|NCT01169493|20628293|P2|STARTED|Period 2 (6 Months)||3
8368380|NCT01169493|20628294|P1|STARTED|Period 2 (6 Months)||2
8368381|NCT01169493|20628289|P6|NOT COMPLETED|Period 1 (6 Months)||3
8368382|NCT01169493|20628290|P5|NOT COMPLETED|Period 1 (6 Months)||0
8368383|NCT01169493|20628291|P4|NOT COMPLETED|Period 1 (6 Months)||0
8368384|NCT01169493|20628292|P3|NOT COMPLETED|Period 1 (6 Months)||2
8368385|NCT01169493|20628293|P2|NOT COMPLETED|Period 1 (6 Months)||1
8368386|NCT01169493|20628294|P1|NOT COMPLETED|Period 1 (6 Months)||0
8368387|NCT01169493|20628289|P6|COMPLETED|Period 1 (6 Months)||2
8368388|NCT01169493|20628290|P5|COMPLETED|Period 1 (6 Months)||0
8368389|NCT01169493|20628291|P4|COMPLETED|Period 1 (6 Months)||0
8368390|NCT01169493|20628292|P3|COMPLETED|Period 1 (6 Months)||3
8368391|NCT01169493|20628293|P2|COMPLETED|Period 1 (6 Months)||3
8368392|NCT01169493|20628294|P1|COMPLETED|Period 1 (6 Months)||2
8368393|NCT01169493|20628289|P6|STARTED|Period 1 (6 Months)||5
8368394|NCT01169493|20628290|P5|STARTED|Period 1 (6 Months)||0
8368395|NCT01169493|20628291|P4|STARTED|Period 1 (6 Months)||0
8368396|NCT01169493|20628292|P3|STARTED|Period 1 (6 Months)||5
8368397|NCT01169493|20628293|P2|STARTED|Period 1 (6 Months)||4
8368398|NCT01169493|20628294|P1|STARTED|Period 1 (6 Months)||2
8368399|NCT01169467|20628325|P2|NOT COMPLETED|Overall Study||4
8368400|NCT01169467|20628326|P1|NOT COMPLETED|Overall Study||7
8368401|NCT01169467|20628325|P2|COMPLETED|Overall Study||36
8368402|NCT01169467|20628326|P1|COMPLETED|Overall Study||37
8368403|NCT01169467|20628325|P2|STARTED|Overall Study||40
8368404|NCT01169467|20628326|P1|STARTED|Overall Study||44
8368405|NCT01169350|20628340|P1|NOT COMPLETED|Overall Study||5
8368406|NCT01169350|20628340|P1|COMPLETED|Overall Study||3
8368407|NCT01169350|20628340|P1|STARTED|Overall Study||8
8368408|NCT01169311|20628347|P1|NOT COMPLETED|Overall Study||0
8368409|NCT01169311|20628347|P1|COMPLETED|Overall Study||27
8368410|NCT01169311|20628347|P1|STARTED|Overall Study||27
8368423|NCT01169103|20628478|P2|NOT COMPLETED|Overall Study||4
8368424|NCT01169103|20628479|P1|NOT COMPLETED|Overall Study||6
8368425|NCT01169103|20628478|P2|COMPLETED|Overall Study||7
8368426|NCT01169103|20628479|P1|COMPLETED|Overall Study||5
8368427|NCT01169103|20628478|P2|STARTED|Overall Study||11
8368428|NCT01169103|20628479|P1|STARTED|Overall Study||11
8368429|NCT01169064|20628495|P2|NOT COMPLETED|Overall Study||0
8368430|NCT01169064|20628496|P1|NOT COMPLETED|Overall Study||0
8368431|NCT01169064|20628495|P2|COMPLETED|Overall Study||236
8368432|NCT01169064|20628496|P1|COMPLETED|Overall Study||239
8368433|NCT01169064|20628495|P2|STARTED|Overall Study||236
8368434|NCT01169064|20628496|P1|STARTED|Overall Study||239
8368435|NCT01169038|20628506|P1|NOT COMPLETED|Overall Study||7
8368436|NCT01169038|20628506|P1|COMPLETED|Overall Study||8
8368437|NCT01169038|20628506|P1|STARTED|Overall Study||15
8368438|NCT01168999|20628514|P4|NOT COMPLETED|Overall Study||0
8368439|NCT01168999|20628515|P3|NOT COMPLETED|Overall Study||0
8368440|NCT01168999|20628516|P2|NOT COMPLETED|Overall Study||1
8368441|NCT01168999|20628517|P1|NOT COMPLETED|Overall Study||2
8368442|NCT01168999|20628514|P4|COMPLETED|Overall Study||28
8368443|NCT01168999|20628515|P3|COMPLETED|Overall Study||27
8368444|NCT01168999|20628516|P2|COMPLETED|Overall Study||26
8368445|NCT01168999|20628517|P1|COMPLETED|Overall Study||26
8368446|NCT01168999|20628514|P4|STARTED|Overall Study||28
8368447|NCT01168999|20628515|P3|STARTED|Overall Study||27
8368448|NCT01168999|20628516|P2|STARTED|Overall Study||27
8368449|NCT01168999|20628517|P1|STARTED|Overall Study||28
8368450|NCT01168986|20628562|P3|NOT COMPLETED|Overall Study||0
8368451|NCT01168986|20628563|P2|NOT COMPLETED|Overall Study||1
8368452|NCT01168986|20628564|P1|NOT COMPLETED|Overall Study||2
8368453|NCT01168986|20628562|P3|COMPLETED|Overall Study||21
8368454|NCT01168986|20628563|P2|COMPLETED|Overall Study||20
8368455|NCT01168986|20628564|P1|COMPLETED|Overall Study||18
8368456|NCT01168986|20628562|P3|STARTED|Overall Study||21
8368457|NCT01168986|20628563|P2|STARTED|Overall Study||21
8368458|NCT01168986|20628564|P1|STARTED|Overall Study||20
8368459|NCT01168973|20628583|P2|NOT COMPLETED|Overall Study||611
8368460|NCT01168973|20628584|P1|NOT COMPLETED|Overall Study||613
8368461|NCT01168973|20628583|P2|COMPLETED|Overall Study||14
8368462|NCT01168973|20628584|P1|COMPLETED|Overall Study||15
8368463|NCT01168973|20628583|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
8368464|NCT01168973|20628584|P1|Received Any Quantity of Any Study Drug|Overall Study||624
8368465|NCT01168973|20628583|P2|STARTED|Overall Study||625
8368466|NCT01168973|20628584|P1|STARTED|Overall Study||628
8368467|NCT01168934|20628605|P2|NOT COMPLETED|Second Intervention Period||0
8368468|NCT01168934|20628606|P1|NOT COMPLETED|Second Intervention Period||0
8368469|NCT01168934|20628605|P2|COMPLETED|Second Intervention Period||7
8368470|NCT01168934|20628606|P1|COMPLETED|Second Intervention Period||7
8368471|NCT01168934|20628605|P2|STARTED|Second Intervention Period||7
8368472|NCT01168934|20628606|P1|STARTED|Second Intervention Period||7
8368473|NCT01168934|20628605|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8368474|NCT01168934|20628606|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8368475|NCT01168934|20628605|P2|COMPLETED|Washout Period (at Least 14 Days)||7
8368476|NCT01168934|20628606|P1|COMPLETED|Washout Period (at Least 14 Days)||7
8368477|NCT01168934|20628605|P2|STARTED|Washout Period (at Least 14 Days)||7
8368478|NCT01168934|20628606|P1|STARTED|Washout Period (at Least 14 Days)||7
8368479|NCT01168934|20628605|P2|NOT COMPLETED|First Intervention Period||0
8368480|NCT01168934|20628606|P1|NOT COMPLETED|First Intervention Period||0
8368481|NCT01168934|20628605|P2|COMPLETED|First Intervention Period||7
8368482|NCT01168934|20628606|P1|COMPLETED|First Intervention Period||7
8368483|NCT01168934|20628605|P2|STARTED|First Intervention Period||7
8368484|NCT01168934|20628606|P1|STARTED|First Intervention Period||7
8368485|NCT01168908|20628640|P2|NOT COMPLETED|Open Label||1
8368486|NCT01168908|20628641|P1|NOT COMPLETED|Open Label||1
8368487|NCT01168908|20628640|P2|COMPLETED|Open Label||7
8368488|NCT01168908|20628641|P1|COMPLETED|Open Label||6
8368489|NCT01168908|20628640|P2|STARTED|Open Label||8
8368490|NCT01168908|20628641|P1|STARTED|Open Label||7
8368491|NCT01168908|20628640|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
8368492|NCT01168908|20628641|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
8368493|NCT01168908|20628640|P2|COMPLETED|Double Blind, Placebo Controlled||8
8368494|NCT01168908|20628641|P1|COMPLETED|Double Blind, Placebo Controlled||7
8368495|NCT01168908|20628640|P2|STARTED|Double Blind, Placebo Controlled||10
8368496|NCT01168908|20628641|P1|STARTED|Double Blind, Placebo Controlled||10
8368497|NCT01168856|20628659|P2|NOT COMPLETED|Overall Study||343
8368498|NCT01168856|20628660|P1|NOT COMPLETED|Overall Study||18
8368499|NCT01168856|20628659|P2|COMPLETED|Overall Study||215
8368500|NCT01168856|20628660|P1|COMPLETED|Overall Study||158
8368501|NCT01168856|20628659|P2|STARTED|Overall Study||558
8368502|NCT01168856|20628660|P1|STARTED|Overall Study||176
8368503|NCT01168726|20628720|P3|NOT COMPLETED|Overall Study||5
8368504|NCT01168726|20628721|P2|NOT COMPLETED|Overall Study||9
8368505|NCT01168726|20628722|P1|NOT COMPLETED|Overall Study||8
8368506|NCT01168726|20628720|P3|COMPLETED|Overall Study||128
8368507|NCT01168726|20628721|P2|COMPLETED|Overall Study||112
8368508|NCT01168726|20628722|P1|COMPLETED|Overall Study||103
8368509|NCT01168726|20628720|P3|STARTED|Overall Study||133
8368510|NCT01168726|20628721|P2|STARTED|Overall Study||121
8368511|NCT01168726|20628722|P1|STARTED|Overall Study||111
8368512|NCT01168687|20628741|P2|NOT COMPLETED|Overall Study||0
8368513|NCT01168687|20628742|P1|NOT COMPLETED|Overall Study||0
8368514|NCT01168687|20628741|P2|COMPLETED|Overall Study||23
8368515|NCT01168687|20628742|P1|COMPLETED|Overall Study||23
8368516|NCT01168687|20628741|P2|STARTED|Overall Study||23
8368517|NCT01168687|20628742|P1|STARTED|Overall Study||23
8368518|NCT01168674|20628748|P2|NOT COMPLETED|Overall Study||0
8368519|NCT01168674|20628749|P1|NOT COMPLETED|Overall Study||0
8368520|NCT01168674|20628748|P2|COMPLETED|Overall Study||24
8368521|NCT01168674|20628749|P1|COMPLETED|Overall Study||25
8368522|NCT01168674|20628748|P2|STARTED|Overall Study||24
8368523|NCT01168674|20628749|P1|STARTED|Overall Study||25
8368524|NCT01168596|20628758|P2|NOT COMPLETED|Overall Study||1
8368525|NCT01168596|20628759|P1|NOT COMPLETED|Overall Study||3
8368526|NCT01168596|20628758|P2|COMPLETED|Overall Study||13
8368527|NCT01168596|20628759|P1|COMPLETED|Overall Study||13
8368528|NCT01168596|20628758|P2|STARTED|Overall Study||14
8368529|NCT01168596|20628759|P1|STARTED|Overall Study||16
8368530|NCT01168427|20628803|P1|NOT COMPLETED|Overall Study||1
8368531|NCT01168427|20628803|P1|COMPLETED|Overall Study||65
8368532|NCT01168427|20628803|P1|STARTED|Overall Study||66
8368533|NCT01168401|20628819|P11|NOT COMPLETED|Overall Study||0
8368534|NCT01168401|20628820|P10|NOT COMPLETED|Overall Study||0
8368535|NCT01168401|20628821|P9|NOT COMPLETED|Overall Study||0
8368536|NCT01168401|20628822|P8|NOT COMPLETED|Overall Study||0
8368537|NCT01168401|20628823|P7|NOT COMPLETED|Overall Study||0
8368538|NCT01168401|20628824|P6|NOT COMPLETED|Overall Study||0
8368539|NCT01168401|20628825|P5|NOT COMPLETED|Overall Study||0
8368540|NCT01168401|20628826|P4|NOT COMPLETED|Overall Study||2
8368541|NCT01168401|20628827|P3|NOT COMPLETED|Overall Study||2
8368542|NCT01168401|20628828|P2|NOT COMPLETED|Overall Study||1
8368543|NCT01168401|20628829|P1|NOT COMPLETED|Overall Study||1
8368544|NCT01168401|20628819|P11|COMPLETED|Overall Study||8
8368545|NCT01168401|20628820|P10|COMPLETED|Overall Study||8
8368546|NCT01168401|20628821|P9|COMPLETED|Overall Study||9
8368547|NCT01168401|20628822|P8|COMPLETED|Overall Study||10
8368548|NCT01168401|20628823|P7|COMPLETED|Overall Study||10
8368549|NCT01168401|20628824|P6|COMPLETED|Overall Study||9
8368550|NCT01168401|20628825|P5|COMPLETED|Overall Study||9
8368551|NCT01168401|20628826|P4|COMPLETED|Overall Study||7
8368552|NCT01168401|20628827|P3|COMPLETED|Overall Study||8
8368553|NCT01168401|20628828|P2|COMPLETED|Overall Study||9
8368554|NCT01168401|20628829|P1|COMPLETED|Overall Study||9
8368555|NCT01168401|20628819|P11|STARTED|Overall Study||8
8368556|NCT01168401|20628820|P10|STARTED|Overall Study||8
8368557|NCT01168401|20628821|P9|STARTED|Overall Study||9
8368558|NCT01168401|20628822|P8|STARTED|Overall Study||10
8368559|NCT01168401|20628823|P7|STARTED|Overall Study||10
8368560|NCT01168401|20628824|P6|STARTED|Overall Study||9
8368561|NCT01168401|20628825|P5|STARTED|Overall Study||9
8368562|NCT01168401|20628826|P4|STARTED|Overall Study||9
8368563|NCT01168401|20628827|P3|STARTED|Overall Study||10
8368564|NCT01168401|20628828|P2|STARTED|Overall Study||10
8368565|NCT01168401|20628829|P1|STARTED|Overall Study||10
8368566|NCT01168349|20629062|P1|NOT COMPLETED|Overall Study||301
8368567|NCT01168349|20629062|P1|COMPLETED|Overall Study||754
8368568|NCT01168349|20629062|P1|STARTED|Overall Study||1055
8368569|NCT01168232|20629168|P1|NOT COMPLETED|Overall Study||8
8368570|NCT01168232|20629168|P1|COMPLETED|Overall Study|Eligible and treated patients|34
8368571|NCT01168232|20629168|P1|STARTED|Overall Study||42
8368572|NCT01168219|20629175|P1|NOT COMPLETED|Overall Study||5
8368573|NCT01168219|20629175|P1|COMPLETED|Overall Study||63
8368574|NCT01168219|20629175|P1|STARTED|Overall Study||68
8368575|NCT01168024|20629183|P2|NOT COMPLETED|Overall Study||0
8368576|NCT01168024|20629184|P1|NOT COMPLETED|Overall Study||0
8368577|NCT01168024|20629183|P2|COMPLETED|Overall Study||3
8368578|NCT01168024|20629184|P1|COMPLETED|Overall Study||13
8368579|NCT01168024|20629183|P2|STARTED|Overall Study||3
8368580|NCT01168024|20629184|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
8368581|NCT01167907|20629198|P2|NOT COMPLETED|Overall Study||1
8368582|NCT01167907|20629199|P1|NOT COMPLETED|Overall Study||2
8368583|NCT01167907|20629198|P2|COMPLETED|Overall Study||14
8368584|NCT01167907|20629199|P1|COMPLETED|Overall Study||15
8368585|NCT01167907|20629198|P2|STARTED|Overall Study||15
8368586|NCT01167907|20629199|P1|STARTED|Overall Study||17
8368587|NCT01167881|20629217|P2|NOT COMPLETED|Overall Study||191
8368588|NCT01167881|20629218|P1|NOT COMPLETED|Overall Study||159
8368589|NCT01167881|20629217|P2|COMPLETED|Overall Study||589
8368590|NCT01167881|20629218|P1|COMPLETED|Overall Study||610
8368591|NCT01167881|20629217|P2|Completed After 4 Years Treatment|Overall Study||462
8368592|NCT01167881|20629218|P1|Completed After 4 Years Treatment|Overall Study||515
8368593|NCT01167881|20629217|P2|Completed After 2 Years Treatment|Overall Study||127
8368594|NCT01167881|20629218|P1|Completed After 2 Years Treatment|Overall Study||95
8368595|NCT01167881|20629217|P2|STARTED|Overall Study||780
8368596|NCT01167881|20629218|P1|STARTED|Overall Study||769
8368597|NCT01167829|20629242|P1|NOT COMPLETED|Overall Study||0
8368598|NCT01167829|20629242|P1|COMPLETED|Overall Study||12
8368599|NCT01167829|20629242|P1|STARTED|Overall Study||12
8368606|NCT01167634|20629272|P4|NOT COMPLETED|Overall Study||4
8368607|NCT01167634|20629273|P3|NOT COMPLETED|Overall Study||3
8368608|NCT01167634|20629274|P2|NOT COMPLETED|Overall Study||4
8368609|NCT01167634|20629275|P1|NOT COMPLETED|Overall Study||2
8368610|NCT01167634|20629272|P4|COMPLETED|Overall Study||29
8368611|NCT01167634|20629273|P3|COMPLETED|Overall Study||30
8368612|NCT01167634|20629274|P2|COMPLETED|Overall Study||29
8368613|NCT01167634|20629275|P1|COMPLETED|Overall Study||31
8368614|NCT01167634|20629272|P4|STARTED|Overall Study||33
8368615|NCT01167634|20629273|P3|STARTED|Overall Study||33
8368616|NCT01167634|20629274|P2|STARTED|Overall Study||33
8368617|NCT01167634|20629275|P1|STARTED|Overall Study||33
8368618|NCT01167608|20629285|P1|NOT COMPLETED|Overall Study||114
8368619|NCT01167608|20629285|P1|COMPLETED|Overall Study||769
8368620|NCT01167608|20629285|P1|STARTED|Overall Study||883
8368621|NCT01167582|20629296|P2|NOT COMPLETED|Overall Study||1
8368622|NCT01167582|20629297|P1|NOT COMPLETED|Overall Study||0
8368623|NCT01167582|20629296|P2|COMPLETED|Overall Study||54
8368624|NCT01167582|20629297|P1|COMPLETED|Overall Study||55
8368625|NCT01167582|20629296|P2|STARTED|Overall Study||55
8368626|NCT01167582|20629297|P1|STARTED|Overall Study||55
8368627|NCT01167569|20629329|P2|NOT COMPLETED|Overall Study||2
8368628|NCT01167569|20629330|P1|NOT COMPLETED|Overall Study||1
8368629|NCT01167569|20629329|P2|COMPLETED|Overall Study||27
8368630|NCT01167569|20629330|P1|COMPLETED|Overall Study||27
8368631|NCT01167569|20629329|P2|STARTED|Overall Study||29
8368632|NCT01167569|20629330|P1|STARTED|Overall Study||28
8368633|NCT01167504|20629338|P1|NOT COMPLETED|Overall Study||3
8368634|NCT01167504|20629338|P1|COMPLETED|Overall Study||12
8368635|NCT01167504|20629338|P1|STARTED|Overall Study||15
8368636|NCT01167452|20629343|P1|NOT COMPLETED|Overall Study||0
8368637|NCT01167452|20629343|P1|COMPLETED|Overall Study||36
8368638|NCT01167452|20629343|P1|STARTED|Overall Study||36
8368639|NCT01167426|20629348|P1|NOT COMPLETED|Overall Study||10
8368640|NCT01167426|20629348|P1|COMPLETED|Overall Study||138
8368641|NCT01167426|20629348|P1|STARTED|Overall Study||148
8368642|NCT01167257|20629356|P2|NOT COMPLETED|Overall Study||3
8368643|NCT01167257|20629357|P1|NOT COMPLETED|Overall Study||3
8368644|NCT01167257|20629356|P2|COMPLETED|Overall Study||28
8368645|NCT01167257|20629357|P1|COMPLETED|Overall Study||28
8368646|NCT01167257|20629356|P2|STARTED|Overall Study||31
8368647|NCT01167257|20629357|P1|STARTED|Overall Study||31
8368648|NCT01167192|20629379|P1|NOT COMPLETED|Overall Study||4
8368649|NCT01167192|20629379|P1|COMPLETED|Overall Study||6
8368650|NCT01167192|20629379|P1|STARTED|Overall Study||10
8368651|NCT01167179|20629396|P2|NOT COMPLETED|Overall Study||21
8368652|NCT01167179|20629397|P1|NOT COMPLETED|Overall Study||15
8368653|NCT01167179|20629396|P2|COMPLETED|Overall Study||59
8368654|NCT01167179|20629397|P1|COMPLETED|Overall Study||65
8368655|NCT01167179|20629396|P2|STARTED|Overall Study||80
8368656|NCT01167179|20629397|P1|STARTED|Overall Study||80
8368657|NCT01167153|20629407|P2|NOT COMPLETED|Overall Study||33
8368658|NCT01167153|20629408|P1|NOT COMPLETED|Overall Study||18
8368659|NCT01167153|20629407|P2|COMPLETED|Overall Study||249
8368660|NCT01167153|20629408|P1|COMPLETED|Overall Study||264
8368661|NCT01167153|20629407|P2|Intention to Treat (ITT)|Overall Study||268
8368662|NCT01167153|20629408|P1|Intention to Treat (ITT)|Overall Study||272
8368663|NCT01167153|20629407|P2|STARTED|Overall Study||282
8368664|NCT01167153|20629408|P1|STARTED|Overall Study||282
8368665|NCT01167140|20629426|P1|NOT COMPLETED|Overall Study||1
8368666|NCT01167140|20629426|P1|COMPLETED|Overall Study||41
8368667|NCT01167140|20629426|P1|STARTED|Overall Study||42
8368668|NCT01167023|20629434|P3|NOT COMPLETED|Overall Study||2
8368669|NCT01167023|20629435|P2|NOT COMPLETED|Overall Study||3
8368670|NCT01167023|20629436|P1|NOT COMPLETED|Overall Study||0
8368671|NCT01167023|20629434|P3|COMPLETED|Overall Study||39
8368672|NCT01167023|20629435|P2|COMPLETED|Overall Study||18
8368673|NCT01167023|20629436|P1|COMPLETED|Overall Study||0
8368674|NCT01167023|20629434|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
8368675|NCT01167023|20629435|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
8368676|NCT01167023|20629436|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
8368677|NCT01167023|20629434|P3|STARTED|Overall Study||41
8368678|NCT01167023|20629435|P2|STARTED|Overall Study||21
8368679|NCT01167023|20629436|P1|STARTED|Overall Study||0
8368680|NCT01166997|20629456|P2|NOT COMPLETED|Overall Study||0
8368681|NCT01166997|20629457|P1|NOT COMPLETED|Overall Study||2
8368682|NCT01166997|20629456|P2|COMPLETED|Overall Study||30
8368683|NCT01166997|20629457|P1|COMPLETED|Overall Study||27
8368684|NCT01166997|20629456|P2|STARTED|Overall Study||30
8368685|NCT01166997|20629457|P1|STARTED|Overall Study||29
8368686|NCT01166971|20629467|P2|NOT COMPLETED|Overall Study||1
8368687|NCT01166971|20629468|P1|NOT COMPLETED|Overall Study||1
8368688|NCT01166971|20629467|P2|COMPLETED|Overall Study||30
8368689|NCT01166971|20629468|P1|COMPLETED|Overall Study||32
8368690|NCT01166971|20629467|P2|STARTED|Overall Study||31
8368691|NCT01166971|20629468|P1|STARTED|Overall Study||33
8368692|NCT01166958|20629476|P2|NOT COMPLETED|Overall Study||0
8368693|NCT01166958|20629477|P1|NOT COMPLETED|Overall Study||1
8368694|NCT01166958|20629476|P2|COMPLETED|Overall Study||13
8368695|NCT01166958|20629477|P1|COMPLETED|Overall Study||12
8368696|NCT01166958|20629476|P2|STARTED|Overall Study||13
8368697|NCT01166958|20629477|P1|STARTED|Overall Study||13
8368698|NCT01166945|20629493|P2|NOT COMPLETED|Day 30||3
8368699|NCT01166945|20629494|P1|NOT COMPLETED|Day 30||4
8368700|NCT01166945|20629493|P2|COMPLETED|Day 30||37
8368701|NCT01166945|20629494|P1|COMPLETED|Day 30||38
8368702|NCT01166945|20629493|P2|STARTED|Day 30||40
8368703|NCT01166945|20629494|P1|STARTED|Day 30||42
8368704|NCT01166945|20629493|P2|NOT COMPLETED|Day 20||0
8368705|NCT01166945|20629494|P1|NOT COMPLETED|Day 20||0
8368706|NCT01166945|20629493|P2|COMPLETED|Day 20||40
8368707|NCT01166945|20629494|P1|COMPLETED|Day 20||42
8368708|NCT01166945|20629493|P2|STARTED|Day 20||40
8368709|NCT01166945|20629494|P1|STARTED|Day 20||42
8368710|NCT01166945|20629493|P2|NOT COMPLETED|Day 15||1
8368711|NCT01166945|20629494|P1|NOT COMPLETED|Day 15||2
8368712|NCT01166945|20629493|P2|COMPLETED|Day 15||40
8368713|NCT01166945|20629494|P1|COMPLETED|Day 15||42
8368714|NCT01166945|20629493|P2|STARTED|Day 15||41
8368715|NCT01166945|20629494|P1|STARTED|Day 15||44
8368716|NCT01166945|20629493|P2|NOT COMPLETED|Day 10||2
8368717|NCT01166945|20629494|P1|NOT COMPLETED|Day 10||3
8368718|NCT01166945|20629493|P2|COMPLETED|Day 10||41
8368719|NCT01166945|20629494|P1|COMPLETED|Day 10||44
8368720|NCT01166945|20629493|P2|STARTED|Day 10||43
8368721|NCT01166945|20629494|P1|STARTED|Day 10||47
8368722|NCT01166945|20629493|P2|NOT COMPLETED|Day 5||0
8368723|NCT01166945|20629494|P1|NOT COMPLETED|Day 5||0
8368724|NCT01166945|20629493|P2|COMPLETED|Day 5||43
8368725|NCT01166945|20629494|P1|COMPLETED|Day 5||47
8368726|NCT01166945|20629493|P2|STARTED|Day 5||43
8368727|NCT01166945|20629494|P1|STARTED|Day 5||47
8368728|NCT01166945|20629493|P2|NOT COMPLETED|Randomized||4
8368729|NCT01166945|20629494|P1|NOT COMPLETED|Randomized||4
8368730|NCT01166945|20629493|P2|COMPLETED|Randomized||43
8368731|NCT01166945|20629494|P1|COMPLETED|Randomized||47
8368732|NCT01166945|20629493|P2|STARTED|Randomized||47
8368733|NCT01166945|20629494|P1|STARTED|Randomized||51
8368734|NCT01166763|20629502|P1|NOT COMPLETED|Overall Study||3
8368735|NCT01166763|20629502|P1|COMPLETED|Overall Study||27
8368736|NCT01166763|20629502|P1|STARTED|Overall Study||30
8368737|NCT01166750|20629510|P2|NOT COMPLETED|Overall Study||0
8368738|NCT01166750|20629511|P1|NOT COMPLETED|Overall Study||1
8368739|NCT01166750|20629510|P2|COMPLETED|Overall Study||13
8368740|NCT01166750|20629511|P1|COMPLETED|Overall Study||9
8368741|NCT01166750|20629510|P2|STARTED|Overall Study||13
8368742|NCT01166750|20629511|P1|STARTED|Overall Study||10
8368743|NCT01166724|20629519|P2|NOT COMPLETED|Overall Study||5
8368744|NCT01166724|20629520|P1|NOT COMPLETED|Overall Study||7
8368745|NCT01166724|20629519|P2|COMPLETED|Overall Study||0
8368746|NCT01166724|20629520|P1|COMPLETED|Overall Study||0
8368747|NCT01166724|20629519|P2|STARTED|Overall Study||5
8368748|NCT01166724|20629520|P1|STARTED|Overall Study||7
8368749|NCT01166659|20629528|P1|NOT COMPLETED|Overall Study||13
8368750|NCT01166659|20629528|P1|COMPLETED|Overall Study||35
8368751|NCT01166659|20629528|P1|STARTED|Overall Study||48
8368752|NCT01166646|20629537|P2|NOT COMPLETED|Overall Study||1
8368753|NCT01166646|20629538|P1|NOT COMPLETED|Overall Study||1
8368754|NCT01166646|20629537|P2|COMPLETED|Overall Study||21
8368755|NCT01166646|20629538|P1|COMPLETED|Overall Study||20
8368756|NCT01166646|20629537|P2|STARTED|Overall Study||22
8368757|NCT01166646|20629538|P1|STARTED|Overall Study||21
8368758|NCT01166568|20629557|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8368759|NCT01166568|20629558|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8368760|NCT01166568|20629559|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
8368761|NCT01166568|20629557|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
8368762|NCT01166568|20629558|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
8368763|NCT01166568|20629559|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
8368764|NCT01166568|20629557|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
8368765|NCT01166568|20629558|P2|STARTED|Implantation- Nonrandomized & Randomized||33
8368766|NCT01166568|20629559|P1|STARTED|Implantation- Nonrandomized & Randomized||288
8368767|NCT01166568|20629557|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
8368768|NCT01166568|20629558|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
8368769|NCT01166568|20629559|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
8368770|NCT01166568|20629557|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
8368771|NCT01166568|20629558|P2|COMPLETED|Deferred Implantation- Randomized||0
8368772|NCT01166568|20629559|P1|COMPLETED|Deferred Implantation- Randomized||0
8368773|NCT01166568|20629557|P3|STARTED|Deferred Implantation- Randomized||16
8368774|NCT01166568|20629558|P2|STARTED|Deferred Implantation- Randomized||0
8368775|NCT01166568|20629559|P1|STARTED|Deferred Implantation- Randomized||0
8368776|NCT01166438|20629572|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
8368777|NCT01166438|20629573|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
8368778|NCT01166438|20629572|P2|COMPLETED|Off Treatment Follow-up Phase||33
8368779|NCT01166438|20629573|P1|COMPLETED|Off Treatment Follow-up Phase||51
8368780|NCT01166438|20629572|P2|STARTED|Off Treatment Follow-up Phase||89
8368781|NCT01166438|20629573|P1|STARTED|Off Treatment Follow-up Phase||85
8368782|NCT01166438|20629572|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
8368783|NCT01166438|20629573|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
8368784|NCT01166438|20629572|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
8368785|NCT01166438|20629573|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
8368786|NCT01166438|20629572|P2|Treated|Double-blind Phase: 1st 6 Months||126
8368787|NCT01166438|20629573|P1|Treated|Double-blind Phase: 1st 6 Months||121
8368788|NCT01166438|20629572|P2|STARTED|Double-blind Phase: 1st 6 Months||127
8368789|NCT01166438|20629573|P1|STARTED|Double-blind Phase: 1st 6 Months||122
8368790|NCT01166373|20629591|P4|NOT COMPLETED|Overall Study||5
8368791|NCT01166373|20629592|P3|NOT COMPLETED|Overall Study||4
8368792|NCT01166373|20629593|P2|NOT COMPLETED|Overall Study||4
8368793|NCT01166373|20629594|P1|NOT COMPLETED|Overall Study||5
8368794|NCT01166373|20629591|P4|COMPLETED|Overall Study||92
8368795|NCT01166373|20629592|P3|COMPLETED|Overall Study||87
8368796|NCT01166373|20629593|P2|COMPLETED|Overall Study||87
8368797|NCT01166373|20629594|P1|COMPLETED|Overall Study||90
8368798|NCT01166373|20629591|P4|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
8368799|NCT01166373|20629592|P3|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
8368800|NCT01166373|20629593|P2|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
8368801|NCT01166373|20629594|P1|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
8368802|NCT01166373|20629591|P4|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
8368803|NCT01166373|20629592|P3|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
8368804|NCT01166373|20629593|P2|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
8368805|NCT01166373|20629594|P1|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
8368806|NCT01166373|20629591|P4|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
8368807|NCT01166373|20629592|P3|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
8368808|NCT01166373|20629593|P2|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
8368809|NCT01166373|20629594|P1|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
8368810|NCT01166373|20629591|P4|Consented to Participate E-OPTIMAL|Overall Study||78
8368811|NCT01166373|20629592|P3|Consented to Participate E-OPTIMAL|Overall Study||69
8368812|NCT01166373|20629593|P2|Consented to Participate E-OPTIMAL|Overall Study||66
8368813|NCT01166373|20629594|P1|Consented to Participate E-OPTIMAL|Overall Study||72
8368814|NCT01166373|20629591|P4|Randomized to No Video|Overall Study||42
8368815|NCT01166373|20629592|P3|Randomized to No Video|Overall Study||34
8368816|NCT01166373|20629593|P2|Randomized to No Video|Overall Study||30
8368817|NCT01166373|20629594|P1|Randomized to No Video|Overall Study||45
8368818|NCT01166373|20629591|P4|Randomized to Video|Overall Study||40
8368819|NCT01166373|20629592|P3|Randomized to Video|Overall Study||38
8368820|NCT01166373|20629593|P2|Randomized to Video|Overall Study||43
8368821|NCT01166373|20629594|P1|Randomized to Video|Overall Study||32
8368822|NCT01166373|20629591|P4|Completed OPTIMAL Year 2 Visit|Overall Study||87
8368823|NCT01166373|20629592|P3|Completed OPTIMAL Year 2 Visit|Overall Study||79
8368824|NCT01166373|20629593|P2|Completed OPTIMAL Year 2 Visit|Overall Study||80
8368825|NCT01166373|20629594|P1|Completed OPTIMAL Year 2 Visit|Overall Study||81
8368826|NCT01166373|20629591|P4|STARTED|Overall Study||97
8368827|NCT01166373|20629592|P3|STARTED|Overall Study||91
8368828|NCT01166373|20629593|P2|STARTED|Overall Study||91
8368829|NCT01166373|20629594|P1|STARTED|Overall Study||95
8368830|NCT01166347|20629694|P2|NOT COMPLETED|Overall Study||1
8368831|NCT01166347|20629695|P1|NOT COMPLETED|Overall Study||2
8368832|NCT01166347|20629694|P2|COMPLETED|Overall Study||148
8368833|NCT01166347|20629695|P1|COMPLETED|Overall Study||295
8368834|NCT01166347|20629694|P2|STARTED|Overall Study||149
8368835|NCT01166347|20629695|P1|STARTED|Overall Study||297
8368836|NCT01166282|20629727|P3|NOT COMPLETED|Open-label Period||17
8368837|NCT01166282|20629728|P2|NOT COMPLETED|Open-label Period||0
8368838|NCT01166282|20629729|P1|NOT COMPLETED|Open-label Period||0
8368839|NCT01166282|20629727|P3|COMPLETED|Open-label Period||29
8368840|NCT01166282|20629728|P2|COMPLETED|Open-label Period||0
8368841|NCT01166282|20629729|P1|COMPLETED|Open-label Period||0
8368842|NCT01166282|20629727|P3|STARTED|Open-label Period||46
8368843|NCT01166282|20629728|P2|STARTED|Open-label Period||0
8368844|NCT01166282|20629729|P1|STARTED|Open-label Period||0
8368845|NCT01166282|20629727|P3|NOT COMPLETED|Double-blind Period||0
8368846|NCT01166282|20629728|P2|NOT COMPLETED|Double-blind Period||0
8368847|NCT01166282|20629729|P1|NOT COMPLETED|Double-blind Period||0
8368848|NCT01166282|20629727|P3|COMPLETED|Double-blind Period||0
8368849|NCT01166282|20629728|P2|COMPLETED|Double-blind Period||31
8368850|NCT01166282|20629729|P1|COMPLETED|Double-blind Period||15
8368851|NCT01166282|20629727|P3|STARTED|Double-blind Period||0
8368852|NCT01166282|20629728|P2|STARTED|Double-blind Period||31
8368853|NCT01166282|20629729|P1|STARTED|Double-blind Period||15
8368854|NCT01166230|20629753|P2|NOT COMPLETED|Overall Study||16
8368855|NCT01166230|20629754|P1|NOT COMPLETED|Overall Study||19
8368856|NCT01166230|20629753|P2|COMPLETED|Overall Study||255
8368857|NCT01166230|20629754|P1|COMPLETED|Overall Study||261
8368858|NCT01166230|20629753|P2|STARTED|Overall Study||271
8368859|NCT01166230|20629754|P1|STARTED|Overall Study||280
8368860|NCT01166178|20629768|P2|NOT COMPLETED|Overall Study||8
8368861|NCT01166178|20629769|P1|NOT COMPLETED|Overall Study||21
8368862|NCT01166178|20629768|P2|COMPLETED|Overall Study||0
8368863|NCT01166178|20629769|P1|COMPLETED|Overall Study||0
8368864|NCT01166178|20629768|P2|STARTED|Overall Study||8
8368865|NCT01166178|20629769|P1|STARTED|Overall Study||21
8368866|NCT01166139|20629795|P1|NOT COMPLETED|Overall Study||3
8368867|NCT01166139|20629795|P1|COMPLETED|Overall Study||7
8368868|NCT01166139|20629795|P1|STARTED|Overall Study||10
8368869|NCT01166126|20629801|P1|NOT COMPLETED|Overall Study||0
8368870|NCT01166126|20629801|P1|COMPLETED|Overall Study||4
8368871|NCT01166126|20629801|P1|STARTED|Overall Study||4
8368872|NCT01165996|20629808|P1|NOT COMPLETED|Overall Study||2
8368873|NCT01165996|20629808|P1|COMPLETED|Overall Study||23
8368874|NCT01165996|20629808|P1|Maintenance Phase|Overall Study||23
8368875|NCT01165996|20629808|P1|Induction Phase|Overall Study||25
8368876|NCT01165996|20629808|P1|STARTED|Overall Study||25
8368877|NCT01165983|20629820|P2|NOT COMPLETED|Overall Study||7
8368878|NCT01165983|20629821|P1|NOT COMPLETED|Overall Study||5
8368879|NCT01165983|20629820|P2|COMPLETED|Overall Study||42
8368880|NCT01165983|20629821|P1|COMPLETED|Overall Study||46
8368881|NCT01165983|20629820|P2|STARTED|Overall Study||49
8368882|NCT01165983|20629821|P1|STARTED|Overall Study||51
8368883|NCT01165840|20629865|P1|NOT COMPLETED|Overall Study||0
8368884|NCT01165840|20629865|P1|COMPLETED|Overall Study||36
8368885|NCT01165840|20629865|P1|STARTED|Overall Study||36
8368886|NCT01165775|20629869|P1|NOT COMPLETED|Overall Study||2
8368887|NCT01165775|20629869|P1|COMPLETED|Overall Study||15
8368888|NCT01165775|20629869|P1|STARTED|Overall Study||17
8368889|NCT01165684|20629879|P2|NOT COMPLETED|Overall Study||52
8368890|NCT01165684|20629880|P1|NOT COMPLETED|Overall Study||28
8368891|NCT01165684|20629879|P2|COMPLETED|Overall Study||148
8368892|NCT01165684|20629880|P1|COMPLETED|Overall Study||173
8368893|NCT01165684|20629879|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
8368894|NCT01165684|20629880|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
8368895|NCT01165684|20629879|P2|STARTED|Overall Study||200
8368896|NCT01165684|20629880|P1|STARTED|Overall Study||201
8368897|NCT01165554|20629914|P1|NOT COMPLETED|Overall Study||23
8368898|NCT01165554|20629914|P1|COMPLETED|Overall Study||180
8368899|NCT01165554|20629914|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
8368900|NCT01165541|20629921|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
8368901|NCT01165541|20629921|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
8368902|NCT01165541|20629921|P1|STARTED|Quetiapine XR and Mirtazepine||16
8368903|NCT01165541|20629921|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
8368904|NCT01165541|20629921|P1|COMPLETED|Quetiapine XR Monotherapy||16
8368905|NCT01165541|20629921|P1|STARTED|Quetiapine XR Monotherapy||20
8368906|NCT01165450|20629927|P1|NOT COMPLETED|Overall Study||0
8368907|NCT01165450|20629927|P1|COMPLETED|Overall Study||2
8368908|NCT01165450|20629927|P1|STARTED|Overall Study||2
8368909|NCT01165424|20629937|P1|NOT COMPLETED|Overall Study||4
8368910|NCT01165424|20629937|P1|COMPLETED|Overall Study||76
8368911|NCT01165424|20629937|P1|STARTED|Overall Study||80
8368912|NCT01165320|20629944|P3|NOT COMPLETED|Overall Study||0
8368913|NCT01165320|20629945|P2|NOT COMPLETED|Overall Study||4
8368914|NCT01165320|20629946|P1|NOT COMPLETED|Overall Study||3
8368915|NCT01165320|20629944|P3|COMPLETED|Overall Study||0
8368916|NCT01165320|20629945|P2|COMPLETED|Overall Study||4
8368917|NCT01165320|20629946|P1|COMPLETED|Overall Study||9
8368918|NCT01165320|20629944|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
8368919|NCT01165320|20629945|P2|STARTED|Overall Study||8
8368920|NCT01165320|20629946|P1|STARTED|Overall Study||12
8368921|NCT01165307|20629956|P2|NOT COMPLETED|Overall Study||3
8368922|NCT01165307|20629957|P1|NOT COMPLETED|Overall Study||14
8368923|NCT01165307|20629956|P2|COMPLETED|Overall Study||31
8368924|NCT01165307|20629957|P1|COMPLETED|Overall Study||19
8368925|NCT01165307|20629956|P2|STARTED|Overall Study||34
8368926|NCT01165307|20629957|P1|STARTED|Overall Study||33
8368927|NCT01165281|20629987|P2|NOT COMPLETED|Overall Study||51
8368928|NCT01165281|20629988|P1|NOT COMPLETED|Overall Study||58
8368929|NCT01165281|20629987|P2|COMPLETED|Overall Study||121
8368930|NCT01165281|20629988|P1|COMPLETED|Overall Study||110
8368931|NCT01165281|20629987|P2|STARTED|Overall Study||172
8368932|NCT01165281|20629988|P1|STARTED|Overall Study||168
8368933|NCT01165242|20630009|P3|NOT COMPLETED|Overall Study||14
8368934|NCT01165242|20630010|P2|NOT COMPLETED|Overall Study||10
8368935|NCT01165242|20630011|P1|NOT COMPLETED|Overall Study||10
8368936|NCT01165242|20630009|P3|COMPLETED|Overall Study||324
8368937|NCT01165242|20630010|P2|COMPLETED|Overall Study||326
8368938|NCT01165242|20630011|P1|COMPLETED|Overall Study||327
8368939|NCT01165242|20630009|P3|STARTED|Overall Study||338
8368940|NCT01165242|20630010|P2|STARTED|Overall Study||336
8368941|NCT01165242|20630011|P1|STARTED|Overall Study||337
8368942|NCT01165229|20630045|P2|NOT COMPLETED|Overall Study||1190
8368943|NCT01165229|20630046|P1|NOT COMPLETED|Overall Study||1180
8368944|NCT01165229|20630045|P2|COMPLETED|Overall Study||5760
8368945|NCT01165229|20630046|P1|COMPLETED|Overall Study||5770
8368946|NCT01165229|20630045|P2|STARTED|Overall Study||6950
8368947|NCT01165229|20630046|P1|STARTED|Overall Study||6950
8368948|NCT01165216|20630180|P2|NOT COMPLETED|Overall Study||7
8368949|NCT01165216|20630181|P1|NOT COMPLETED|Overall Study||8
8368950|NCT01165216|20630180|P2|COMPLETED|Overall Study|Completed=still on study drug|0
8368951|NCT01165216|20630181|P1|COMPLETED|Overall Study|Completed=still on study drug|0
8368952|NCT01165216|20630180|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
8368953|NCT01165216|20630181|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
8368954|NCT01165216|20630180|P2|STARTED|Overall Study|Participants who received any study drug|7
8368955|NCT01165216|20630181|P1|STARTED|Overall Study|Participants who received any study drug|8
8368956|NCT01165203|20630203|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
8368957|NCT01165203|20630204|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
8368958|NCT01165203|20630203|P2|COMPLETED|Extended Safety Follow-up Phase||45
8368959|NCT01165203|20630204|P1|COMPLETED|Extended Safety Follow-up Phase||67
8368960|NCT01165203|20630203|P2|STARTED|Extended Safety Follow-up Phase||49
8368961|NCT01165203|20630204|P1|STARTED|Extended Safety Follow-up Phase||74
8368962|NCT01165203|20630203|P2|NOT COMPLETED|Active Phase||2
8368963|NCT01165203|20630204|P1|NOT COMPLETED|Active Phase||5
8368964|NCT01165203|20630203|P2|COMPLETED|Active Phase||47
8368965|NCT01165203|20630204|P1|COMPLETED|Active Phase||69
8368966|NCT01165203|20630203|P2|STARTED|Active Phase||49
8368967|NCT01165203|20630204|P1|STARTED|Active Phase||74
8368974|NCT01165138|20630424|P4|NOT COMPLETED|Overall Study||22
8368975|NCT01165138|20630425|P3|NOT COMPLETED|Overall Study||20
8368976|NCT01165138|20630426|P2|NOT COMPLETED|Overall Study||52
8368977|NCT01165138|20630427|P1|NOT COMPLETED|Overall Study||0
8368978|NCT01165138|20630424|P4|COMPLETED|Overall Study||179
8368979|NCT01165138|20630425|P3|COMPLETED|Overall Study||185
8368980|NCT01165138|20630426|P2|COMPLETED|Overall Study||151
8368981|NCT01165138|20630427|P1|COMPLETED|Overall Study||0
8368982|NCT01165138|20630424|P4|STARTED|Overall Study||201
8368983|NCT01165138|20630425|P3|STARTED|Overall Study||205
8368984|NCT01165138|20630426|P2|STARTED|Overall Study||203
8368985|NCT01165138|20630427|P1|STARTED|Overall Study||0
8368986|NCT01165112|20630486|P1|NOT COMPLETED|Overall Study||0
8368987|NCT01165112|20630486|P1|COMPLETED|Overall Study||48
8368988|NCT01165112|20630486|P1|STARTED|Overall Study||48
8368989|NCT01165047|20630493|P1|NOT COMPLETED|Overall Study||0
8368990|NCT01165047|20630493|P1|COMPLETED|Overall Study||10
8368991|NCT01165047|20630493|P1|STARTED|Overall Study||10
8368992|NCT01165021|20630497|P1|NOT COMPLETED|Overall Study||1
8368993|NCT01165021|20630497|P1|COMPLETED|Overall Study||18
8368994|NCT01165021|20630497|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
8368995|NCT01165021|20630497|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
8368996|NCT01165021|20630497|P1|≥1 Dose Chemo|Overall Study||19
8368997|NCT01165021|20630497|P1|STARTED|Overall Study||19
8368998|NCT01164956|20630505|P3|NOT COMPLETED|Overall Study||1
8368999|NCT01164956|20630506|P2|NOT COMPLETED|Overall Study||0
8369000|NCT01164956|20630507|P1|NOT COMPLETED|Overall Study||1
8369001|NCT01164956|20630505|P3|COMPLETED|Overall Study||0
8369002|NCT01164956|20630506|P2|COMPLETED|Overall Study||1
8369003|NCT01164956|20630507|P1|COMPLETED|Overall Study||0
8369004|NCT01164956|20630505|P3|Evaluable for pedsFACIT-F Score Change|Overall Study||0
8369005|NCT01164956|20630506|P2|Evaluable for pedsFACIT-F Score Change|Overall Study||1
8369006|NCT01164956|20630507|P1|Evaluable for pedsFACIT-F Score Change|Overall Study||0
8369007|NCT01164956|20630505|P3|STARTED|Overall Study||1
8369008|NCT01164956|20630506|P2|STARTED|Overall Study||1
8369009|NCT01164956|20630507|P1|STARTED|Overall Study||1
8369010|NCT01164891|20630515|P1|NOT COMPLETED|Overall Study||6
8369011|NCT01164891|20630515|P1|COMPLETED|Overall Study||1
8369012|NCT01164891|20630515|P1|STARTED|Overall Study||7
8369013|NCT01164865|20630535|P2|NOT COMPLETED|Overall Study||1
8369014|NCT01164865|20630536|P1|NOT COMPLETED|Overall Study||2
8369015|NCT01164865|20630535|P2|COMPLETED|Overall Study||38
8369016|NCT01164865|20630536|P1|COMPLETED|Overall Study||37
8369017|NCT01164865|20630535|P2|STARTED|Overall Study||39
8369018|NCT01164865|20630536|P1|STARTED|Overall Study||39
8369019|NCT01164722|20630546|P2|NOT COMPLETED|Overall Study||15
8369020|NCT01164722|20630547|P1|NOT COMPLETED|Overall Study||18
8369021|NCT01164722|20630546|P2|COMPLETED|Overall Study||45
8369022|NCT01164722|20630547|P1|COMPLETED|Overall Study||42
8369023|NCT01164722|20630546|P2|STARTED|Overall Study||60
8369024|NCT01164722|20630547|P1|STARTED|Overall Study||60
8369025|NCT01164644|20630563|P2|NOT COMPLETED|Overall Study||1
8369026|NCT01164644|20630564|P1|NOT COMPLETED|Overall Study||3
8369027|NCT01164644|20630563|P2|COMPLETED|Overall Study||13
8369028|NCT01164644|20630564|P1|COMPLETED|Overall Study||9
8369029|NCT01164644|20630563|P2|STARTED|Overall Study||14
8369030|NCT01164644|20630564|P1|STARTED|Overall Study||12
8369031|NCT01164579|20630577|P3|NOT COMPLETED|Overall Study||16
8369032|NCT01164579|20630578|P2|NOT COMPLETED|Overall Study||9
8369033|NCT01164579|20630579|P1|NOT COMPLETED|Overall Study||8
8369034|NCT01164579|20630577|P3|COMPLETED|Overall Study||21
8369035|NCT01164579|20630578|P2|COMPLETED|Overall Study||27
8369036|NCT01164579|20630579|P1|COMPLETED|Overall Study||28
8369037|NCT01164579|20630577|P3|STARTED|Overall Study||37
8369038|NCT01164579|20630578|P2|STARTED|Overall Study||36
8369039|NCT01164579|20630579|P1|STARTED|Overall Study||36
8369040|NCT01164501|20630659|P3|NOT COMPLETED|Overall Study||42
8369041|NCT01164501|20630660|P2|NOT COMPLETED|Overall Study||10
8369042|NCT01164501|20630661|P1|NOT COMPLETED|Overall Study||43
8369043|NCT01164501|20630659|P3|COMPLETED|Overall Study||280
8369044|NCT01164501|20630660|P2|COMPLETED|Overall Study||88
8369045|NCT01164501|20630661|P1|COMPLETED|Overall Study||278
8369046|NCT01164501|20630659|P3|STARTED|Overall Study||322
8369047|NCT01164501|20630660|P2|STARTED|Overall Study||98
8369048|NCT01164501|20630661|P1|STARTED|Overall Study||321
8369049|NCT01164475|20630678|P2|NOT COMPLETED|Overall Study||2
8369050|NCT01164475|20630679|P1|NOT COMPLETED|Overall Study||2
8369051|NCT01164475|20630678|P2|COMPLETED|Overall Study||29
8369052|NCT01164475|20630679|P1|COMPLETED|Overall Study||28
8369053|NCT01164475|20630678|P2|STARTED|Overall Study||31
8369054|NCT01164475|20630679|P1|STARTED|Overall Study||30
8369055|NCT01164137|20630705|P2|NOT COMPLETED|Overall Study||0
8369056|NCT01164137|20630706|P1|NOT COMPLETED|Overall Study||3
8369057|NCT01164137|20630705|P2|COMPLETED|Overall Study||76
8369058|NCT01164137|20630706|P1|COMPLETED|Overall Study||77
8369059|NCT01164137|20630705|P2|STARTED|Overall Study||76
8369060|NCT01164137|20630706|P1|STARTED|Overall Study||80
8369061|NCT01164098|20630722|P2|NOT COMPLETED|Overall Study||0
8369062|NCT01164098|20630723|P1|NOT COMPLETED|Overall Study||0
8369063|NCT01164098|20630722|P2|COMPLETED|Overall Study||15
8369064|NCT01164098|20630723|P1|COMPLETED|Overall Study||15
8369065|NCT01164098|20630722|P2|STARTED|Overall Study||15
8369066|NCT01164098|20630723|P1|STARTED|Overall Study||15
8369067|NCT01164007|20630733|P1|NOT COMPLETED|Overall Study||40
8369068|NCT01164007|20630733|P1|COMPLETED|Overall Study||0
8369069|NCT01164007|20630733|P1|Treated|Overall Study||37
8369070|NCT01164007|20630733|P1|STARTED|Overall Study||40
8369071|NCT01163955|20630749|P2|NOT COMPLETED|Overall Study||4
8369072|NCT01163955|20630750|P1|NOT COMPLETED|Overall Study||0
8369073|NCT01163955|20630749|P2|COMPLETED|Overall Study||26
8369074|NCT01163955|20630750|P1|COMPLETED|Overall Study||26
8369075|NCT01163955|20630749|P2|STARTED|Overall Study||30
8369076|NCT01163955|20630750|P1|STARTED|Overall Study||26
8369077|NCT01163916|20630759|P3|NOT COMPLETED|Overall Study||20
8369078|NCT01163916|20630760|P2|NOT COMPLETED|Overall Study||4
8369079|NCT01163916|20630761|P1|NOT COMPLETED|Overall Study||30
8369080|NCT01163916|20630759|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
8369081|NCT01163916|20630760|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
8369082|NCT01163916|20630761|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
8369083|NCT01163916|20630759|P3|Safety Population|Overall Study||91
8369084|NCT01163916|20630760|P2|Safety Population|Overall Study||35
8369085|NCT01163916|20630761|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
8369086|NCT01163916|20630759|P3|STARTED|Overall Study||91
8369087|NCT01163916|20630760|P2|STARTED|Overall Study||35
8369088|NCT01163916|20630761|P1|STARTED|Overall Study||126
8369089|NCT01163851|20630799|P2|NOT COMPLETED|Overall Study||1
8369090|NCT01163851|20630800|P1|NOT COMPLETED|Overall Study||1
8369091|NCT01163851|20630799|P2|COMPLETED|Overall Study||11
8369092|NCT01163851|20630800|P1|COMPLETED|Overall Study||12
8369093|NCT01163851|20630799|P2|Treated|Overall Study||12
8369094|NCT01163851|20630800|P1|Treated|Overall Study||12
8369095|NCT01163851|20630799|P2|STARTED|Overall Study||12
8369096|NCT01163851|20630800|P1|STARTED|Overall Study||13
8369097|NCT01163786|20630878|P1|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
8369098|NCT01163786|20630878|P1|COMPLETED|Completed Follow up (Visit 9 and 10)||13
8369099|NCT01163786|20630878|P1|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
8369100|NCT01163786|20630878|P1|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
8369101|NCT01163786|20630878|P1|STARTED|Completed Follow up (Visit 9 and 10)||14
8369102|NCT01163786|20630878|P1|NOT COMPLETED|Treatment With Bortezomib||3
8369103|NCT01163786|20630878|P1|COMPLETED|Treatment With Bortezomib||14
8369104|NCT01163786|20630878|P1|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
8369105|NCT01163786|20630878|P1|Completed 1st Cycle|Treatment With Bortezomib||17
8369106|NCT01163786|20630878|P1|STARTED|Treatment With Bortezomib||17
8369107|NCT01163760|20630884|P4|NOT COMPLETED|Period 4 (Follow-up)||0
8369108|NCT01163760|20630885|P3|NOT COMPLETED|Period 4 (Follow-up)||0
8369109|NCT01163760|20630886|P2|NOT COMPLETED|Period 4 (Follow-up)||0
8369110|NCT01163760|20630887|P1|NOT COMPLETED|Period 4 (Follow-up)||0
8369111|NCT01163760|20630884|P4|COMPLETED|Period 4 (Follow-up)||12
8369112|NCT01163760|20630885|P3|COMPLETED|Period 4 (Follow-up)||13
8369113|NCT01163760|20630886|P2|COMPLETED|Period 4 (Follow-up)||13
8369114|NCT01163760|20630887|P1|COMPLETED|Period 4 (Follow-up)||12
8369115|NCT01163760|20630884|P4|STARTED|Period 4 (Follow-up)||12
8369116|NCT01163760|20630885|P3|STARTED|Period 4 (Follow-up)||13
8369117|NCT01163760|20630886|P2|STARTED|Period 4 (Follow-up)||13
8369118|NCT01163760|20630887|P1|STARTED|Period 4 (Follow-up)||12
8369119|NCT01163760|20630884|P4|NOT COMPLETED|Period 3 (Fit)||0
8369120|NCT01163760|20630885|P3|NOT COMPLETED|Period 3 (Fit)||0
8369121|NCT01163760|20630886|P2|NOT COMPLETED|Period 3 (Fit)||0
8369122|NCT01163760|20630887|P1|NOT COMPLETED|Period 3 (Fit)||0
8369123|NCT01163760|20630884|P4|COMPLETED|Period 3 (Fit)||12
8369124|NCT01163760|20630885|P3|COMPLETED|Period 3 (Fit)||13
8369125|NCT01163760|20630886|P2|COMPLETED|Period 3 (Fit)||13
8369126|NCT01163760|20630887|P1|COMPLETED|Period 3 (Fit)||12
8369127|NCT01163760|20630884|P4|STARTED|Period 3 (Fit)||12
8369128|NCT01163760|20630885|P3|STARTED|Period 3 (Fit)||13
8369129|NCT01163760|20630886|P2|STARTED|Period 3 (Fit)||13
8369130|NCT01163760|20630887|P1|STARTED|Period 3 (Fit)||12
8369131|NCT01163760|20630884|P4|NOT COMPLETED|Period 2 (Follow-up)||0
8369132|NCT01163760|20630885|P3|NOT COMPLETED|Period 2 (Follow-up)||0
8369133|NCT01163760|20630886|P2|NOT COMPLETED|Period 2 (Follow-up)||0
8369134|NCT01163760|20630887|P1|NOT COMPLETED|Period 2 (Follow-up)||0
8369135|NCT01163760|20630884|P4|COMPLETED|Period 2 (Follow-up)||12
8369136|NCT01163760|20630885|P3|COMPLETED|Period 2 (Follow-up)||13
8369137|NCT01163760|20630886|P2|COMPLETED|Period 2 (Follow-up)||13
8369138|NCT01163760|20630887|P1|COMPLETED|Period 2 (Follow-up)||12
8369139|NCT01163760|20630884|P4|STARTED|Period 2 (Follow-up)||12
8369140|NCT01163760|20630885|P3|STARTED|Period 2 (Follow-up)||13
8369141|NCT01163760|20630886|P2|STARTED|Period 2 (Follow-up)||13
8369142|NCT01163760|20630887|P1|STARTED|Period 2 (Follow-up)||12
8369143|NCT01163760|20630884|P4|NOT COMPLETED|Period 1 (Fit)||0
8369144|NCT01163760|20630885|P3|NOT COMPLETED|Period 1 (Fit)||0
8369145|NCT01163760|20630886|P2|NOT COMPLETED|Period 1 (Fit)||0
8369146|NCT01163760|20630887|P1|NOT COMPLETED|Period 1 (Fit)||0
8369147|NCT01163760|20630884|P4|COMPLETED|Period 1 (Fit)||12
8369148|NCT01163760|20630885|P3|COMPLETED|Period 1 (Fit)||13
8369149|NCT01163760|20630886|P2|COMPLETED|Period 1 (Fit)||13
8369150|NCT01163760|20630887|P1|COMPLETED|Period 1 (Fit)||12
8369151|NCT01163760|20630884|P4|STARTED|Period 1 (Fit)||12
8369152|NCT01163760|20630885|P3|STARTED|Period 1 (Fit)||13
8369153|NCT01163760|20630886|P2|STARTED|Period 1 (Fit)||13
8369154|NCT01163760|20630887|P1|STARTED|Period 1 (Fit)||12
8369155|NCT01163747|20630901|P2|NOT COMPLETED|Overall Study||11
8369156|NCT01163747|20630902|P1|NOT COMPLETED|Overall Study||6
8369157|NCT01163747|20630901|P2|COMPLETED|Overall Study||49
8369158|NCT01163747|20630902|P1|COMPLETED|Overall Study||25
8369159|NCT01163747|20630901|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
8369160|NCT01163747|20630902|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
8369161|NCT01163747|20630901|P2|STARTED|Overall Study||60
8369162|NCT01163747|20630902|P1|STARTED|Overall Study||31
8369163|NCT01163721|20630922|P2|NOT COMPLETED|Overall Study||12
8369164|NCT01163721|20630923|P1|NOT COMPLETED|Overall Study||8
8369165|NCT01163721|20630922|P2|COMPLETED|Overall Study||29
8369166|NCT01163721|20630923|P1|COMPLETED|Overall Study||31
8369167|NCT01163721|20630922|P2|STARTED|Overall Study||41
8369168|NCT01163721|20630923|P1|STARTED|Overall Study||39
8369169|NCT01163656|20630935|P2|NOT COMPLETED|Overall Study||3
8369170|NCT01163656|20630936|P1|NOT COMPLETED|Overall Study||3
8369171|NCT01163656|20630935|P2|COMPLETED|Overall Study||30
8369172|NCT01163656|20630936|P1|COMPLETED|Overall Study||30
8369173|NCT01163656|20630935|P2|STARTED|Overall Study||33
8369174|NCT01163656|20630936|P1|STARTED|Overall Study||33
8369175|NCT01163643|20630948|P6|NOT COMPLETED|Overall Study||7
8369176|NCT01163643|20630949|P5|NOT COMPLETED|Overall Study||8
8369177|NCT01163643|20630950|P4|NOT COMPLETED|Overall Study||5
8369178|NCT01163643|20630951|P3|NOT COMPLETED|Overall Study||2
8369179|NCT01163643|20630952|P2|NOT COMPLETED|Overall Study||2
8369180|NCT01163643|20630953|P1|NOT COMPLETED|Overall Study||6
8369181|NCT01163643|20630948|P6|COMPLETED|Overall Study||66
8369182|NCT01163643|20630949|P5|COMPLETED|Overall Study||61
8369183|NCT01163643|20630950|P4|COMPLETED|Overall Study||69
8369184|NCT01163643|20630951|P3|COMPLETED|Overall Study||33
8369185|NCT01163643|20630952|P2|COMPLETED|Overall Study||35
8369186|NCT01163643|20630953|P1|COMPLETED|Overall Study||62
8369187|NCT01163643|20630948|P6|STARTED|Overall Study||73
8369188|NCT01163643|20630949|P5|STARTED|Overall Study||69
8369189|NCT01163643|20630950|P4|STARTED|Overall Study||74
8369190|NCT01163643|20630951|P3|STARTED|Overall Study||35
8369191|NCT01163643|20630952|P2|STARTED|Overall Study||37
8369192|NCT01163643|20630953|P1|STARTED|Overall Study||68
8369193|NCT01163617|20630973|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369194|NCT01163617|20630974|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369195|NCT01163617|20630975|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369196|NCT01163617|20630976|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369197|NCT01163617|20630977|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369198|NCT01163617|20630978|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369199|NCT01163617|20630979|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369200|NCT01163617|20630980|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369201|NCT01163617|20630973|P8|COMPLETED|Phase B (Injection Time), Week 4||20
8369202|NCT01163617|20630974|P7|COMPLETED|Phase B (Injection Time), Week 4||16
8369203|NCT01163617|20630975|P6|COMPLETED|Phase B (Injection Time), Week 4||27
8369204|NCT01163617|20630976|P5|COMPLETED|Phase B (Injection Time), Week 4||18
8369205|NCT01163617|20630977|P4|COMPLETED|Phase B (Injection Time), Week 4||0
8369206|NCT01163617|20630978|P3|COMPLETED|Phase B (Injection Time), Week 4||0
8369207|NCT01163617|20630979|P2|COMPLETED|Phase B (Injection Time), Week 4||0
8369208|NCT01163617|20630980|P1|COMPLETED|Phase B (Injection Time), Week 4||0
8369209|NCT01163617|20630973|P8|STARTED|Phase B (Injection Time), Week 4||20
8369210|NCT01163617|20630974|P7|STARTED|Phase B (Injection Time), Week 4||16
8369211|NCT01163617|20630975|P6|STARTED|Phase B (Injection Time), Week 4||27
8369212|NCT01163617|20630976|P5|STARTED|Phase B (Injection Time), Week 4||18
8369213|NCT01163617|20630977|P4|STARTED|Phase B (Injection Time), Week 4||0
8369214|NCT01163617|20630978|P3|STARTED|Phase B (Injection Time), Week 4||0
8369215|NCT01163617|20630979|P2|STARTED|Phase B (Injection Time), Week 4||0
8369216|NCT01163617|20630980|P1|STARTED|Phase B (Injection Time), Week 4||0
8369217|NCT01163617|20630973|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369218|NCT01163617|20630974|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369219|NCT01163617|20630975|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369220|NCT01163617|20630976|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369221|NCT01163617|20630977|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369222|NCT01163617|20630978|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
8369223|NCT01163617|20630979|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
8369224|NCT01163617|20630980|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369225|NCT01163617|20630973|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369226|NCT01163617|20630974|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369227|NCT01163617|20630975|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369228|NCT01163617|20630976|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369229|NCT01163617|20630977|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
8369230|NCT01163617|20630978|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
8369231|NCT01163617|20630979|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
8369232|NCT01163617|20630980|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
8369233|NCT01163617|20630973|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369234|NCT01163617|20630974|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369235|NCT01163617|20630975|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369236|NCT01163617|20630976|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369237|NCT01163617|20630977|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
8369238|NCT01163617|20630978|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
8369239|NCT01163617|20630979|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
8369240|NCT01163617|20630980|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
8369241|NCT01163604|20631002|P2|NOT COMPLETED|Overall Study||0
8369242|NCT01163604|20631003|P1|NOT COMPLETED|Overall Study||0
8369243|NCT01163604|20631002|P2|COMPLETED|Overall Study|August 2011|56
8369244|NCT01163604|20631003|P1|COMPLETED|Overall Study|August 2011|58
8369245|NCT01163604|20631002|P2|STARTED|Overall Study|August 2010|56
8369246|NCT01163604|20631003|P1|STARTED|Overall Study|August 2010|58
8369247|NCT01163474|20631009|P1|NOT COMPLETED|Overall Study||16
8369248|NCT01163474|20631009|P1|COMPLETED|Overall Study||24
8369249|NCT01163474|20631009|P1|STARTED|Overall Study||40
8369250|NCT01163461|20631016|P2|NOT COMPLETED|Overall Study||0
8369251|NCT01163461|20631017|P1|NOT COMPLETED|Overall Study||0
8369252|NCT01163461|20631016|P2|COMPLETED|Overall Study||14
8369253|NCT01163461|20631017|P1|COMPLETED|Overall Study||14
8369254|NCT01163461|20631016|P2|STARTED|Overall Study||14
8369255|NCT01163461|20631017|P1|STARTED|Overall Study||14
8369256|NCT01163318|20631021|P1|NOT COMPLETED|Overall Study||268
8369257|NCT01163318|20631021|P1|COMPLETED|Overall Study||284
8369258|NCT01163318|20631021|P1|STARTED|Overall Study||552
8369259|NCT01163292|20631030|P2|NOT COMPLETED|Overall Study||22
8369260|NCT01163292|20631031|P1|NOT COMPLETED|Overall Study||41
8369261|NCT01163292|20631030|P2|COMPLETED|Overall Study||92
8369262|NCT01163292|20631031|P1|COMPLETED|Overall Study||65
8369263|NCT01163292|20631030|P2|STARTED|Overall Study||114
8369264|NCT01163292|20631031|P1|STARTED|Overall Study||106
8369265|NCT01163279|20631047|P2|NOT COMPLETED|Overall Study||0
8369266|NCT01163279|20631048|P1|NOT COMPLETED|Overall Study||2
8369267|NCT01163279|20631047|P2|COMPLETED|Overall Study||9
8369268|NCT01163279|20631048|P1|COMPLETED|Overall Study||8
8369269|NCT01163279|20631047|P2|STARTED|Overall Study||9
8369270|NCT01163279|20631048|P1|STARTED|Overall Study||10
8369271|NCT01163266|20631077|P3|NOT COMPLETED|Overall Study||28
8369272|NCT01163266|20631078|P2|NOT COMPLETED|Overall Study||31
8369273|NCT01163266|20631079|P1|NOT COMPLETED|Overall Study||18
8369274|NCT01163266|20631077|P3|COMPLETED|Overall Study||122
8369275|NCT01163266|20631078|P2|COMPLETED|Overall Study||124
8369276|NCT01163266|20631079|P1|COMPLETED|Overall Study||139
8369277|NCT01163266|20631077|P3|Treated|Overall Study||150
8369278|NCT01163266|20631078|P2|Treated|Overall Study||155
8369279|NCT01163266|20631079|P1|Treated|Overall Study||157
8369280|NCT01163266|20631077|P3|STARTED|Overall Study||150
8369281|NCT01163266|20631078|P2|STARTED|Overall Study||155
8369282|NCT01163266|20631079|P1|STARTED|Overall Study||157
8369283|NCT01163253|20631104|P2|NOT COMPLETED|Overall Study||586
8369284|NCT01163253|20631105|P1|NOT COMPLETED|Overall Study||2281
8369285|NCT01163253|20631104|P2|COMPLETED|Overall Study||0
8369286|NCT01163253|20631105|P1|COMPLETED|Overall Study||0
8369287|NCT01163253|20631104|P2|STARTED|Overall Study||586
8369288|NCT01163253|20631105|P1|STARTED|Overall Study||2281
8369289|NCT01163214|20631267|P2|NOT COMPLETED|Overall Study||0
8369290|NCT01163214|20631268|P1|NOT COMPLETED|Overall Study||0
8369291|NCT01163214|20631267|P2|COMPLETED|Overall Study||81
8369292|NCT01163214|20631268|P1|COMPLETED|Overall Study||79
8369293|NCT01163214|20631267|P2|STARTED|Overall Study||81
8369294|NCT01163214|20631268|P1|STARTED|Overall Study||79
8369295|NCT01163162|20631284|P1|NOT COMPLETED|Overall Study||0
8369296|NCT01163162|20631284|P1|COMPLETED|Overall Study||16
8369297|NCT01163162|20631284|P1|STARTED|Overall Study||16
8369298|NCT01163149|20631293|P3|NOT COMPLETED|Extension Treatment Period||2
8369299|NCT01163149|20631294|P2|NOT COMPLETED|Extension Treatment Period||1
8369300|NCT01163149|20631295|P1|NOT COMPLETED|Extension Treatment Period||2
8369301|NCT01163149|20631293|P3|COMPLETED|Extension Treatment Period||4
8369302|NCT01163149|20631294|P2|COMPLETED|Extension Treatment Period||5
8369303|NCT01163149|20631295|P1|COMPLETED|Extension Treatment Period||5
8369304|NCT01163149|20631293|P3|STARTED|Extension Treatment Period||6
8369305|NCT01163149|20631294|P2|STARTED|Extension Treatment Period||6
8369306|NCT01163149|20631295|P1|STARTED|Extension Treatment Period||7
8369307|NCT01163149|20631293|P3|NOT COMPLETED|Primary Treatment Period||0
8369308|NCT01163149|20631294|P2|NOT COMPLETED|Primary Treatment Period||0
8369309|NCT01163149|20631295|P1|NOT COMPLETED|Primary Treatment Period||0
8369310|NCT01163149|20631293|P3|COMPLETED|Primary Treatment Period||6
8369311|NCT01163149|20631294|P2|COMPLETED|Primary Treatment Period||6
8369312|NCT01163149|20631295|P1|COMPLETED|Primary Treatment Period||7
8369313|NCT01163149|20631293|P3|STARTED|Primary Treatment Period||6
8369314|NCT01163149|20631294|P2|STARTED|Primary Treatment Period||6
8369315|NCT01163149|20631295|P1|STARTED|Primary Treatment Period||7
8369316|NCT01163097|20631340|P3|NOT COMPLETED|Overall Study||0
8369317|NCT01163097|20631341|P2|NOT COMPLETED|Overall Study||0
8369318|NCT01163097|20631342|P1|NOT COMPLETED|Overall Study||6
8369319|NCT01163097|20631340|P3|COMPLETED|Overall Study||8
8369320|NCT01163097|20631341|P2|COMPLETED|Overall Study||16
8369321|NCT01163097|20631342|P1|COMPLETED|Overall Study||14
8369322|NCT01163097|20631340|P3|STARTED|Overall Study||8
8369323|NCT01163097|20631341|P2|STARTED|Overall Study||16
8369324|NCT01163097|20631342|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
8369325|NCT01163084|20631394|P2|NOT COMPLETED|Overall Study||0
8369326|NCT01163084|20631395|P1|NOT COMPLETED|Overall Study||0
8369327|NCT01163084|20631394|P2|COMPLETED|Overall Study||5
8369328|NCT01163084|20631395|P1|COMPLETED|Overall Study||4
8369329|NCT01163084|20631394|P2|STARTED|Overall Study||5
8369330|NCT01163084|20631395|P1|STARTED|Overall Study||4
8369331|NCT01163032|20631404|P3|NOT COMPLETED|Open Label Extension Phase||16
8369332|NCT01163032|20631405|P2|NOT COMPLETED|Open Label Extension Phase||0
8369333|NCT01163032|20631406|P1|NOT COMPLETED|Open Label Extension Phase||0
8369334|NCT01163032|20631404|P3|COMPLETED|Open Label Extension Phase||39
8369335|NCT01163032|20631405|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369336|NCT01163032|20631406|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369337|NCT01163032|20631404|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
8369338|NCT01163032|20631405|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369339|NCT01163032|20631406|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369340|NCT01163032|20631404|P3|NOT COMPLETED|Randomization Phase||0
8369341|NCT01163032|20631405|P2|NOT COMPLETED|Randomization Phase||12
8369342|NCT01163032|20631406|P1|NOT COMPLETED|Randomization Phase||10
8369343|NCT01163032|20631404|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
8369344|NCT01163032|20631405|P2|COMPLETED|Randomization Phase||30
8369345|NCT01163032|20631406|P1|COMPLETED|Randomization Phase||32
8369346|NCT01163032|20631404|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
8369347|NCT01163032|20631405|P2|STARTED|Randomization Phase||42
8369348|NCT01163032|20631406|P1|STARTED|Randomization Phase||42
8369349|NCT01162863|20631439|P3|NOT COMPLETED|Overall Study||0
8369350|NCT01162863|20631440|P2|NOT COMPLETED|Overall Study||1
8369351|NCT01162863|20631441|P1|NOT COMPLETED|Overall Study||1
8369352|NCT01162863|20631439|P3|COMPLETED|Overall Study||17
8369353|NCT01162863|20631440|P2|COMPLETED|Overall Study||16
8369354|NCT01162863|20631441|P1|COMPLETED|Overall Study||17
8369355|NCT01162863|20631439|P3|STARTED|Overall Study||17
8369356|NCT01162863|20631440|P2|STARTED|Overall Study||17
8369357|NCT01162863|20631441|P1|STARTED|Overall Study||18
8369358|NCT01162733|20631457|P2|NOT COMPLETED|Overall Study||25
8369359|NCT01162733|20631458|P1|NOT COMPLETED|Overall Study||27
8369360|NCT01162733|20631457|P2|COMPLETED|Overall Study||25
8369361|NCT01162733|20631458|P1|COMPLETED|Overall Study||22
8369362|NCT01162733|20631457|P2|STARTED|Overall Study||50
8369363|NCT01162733|20631458|P1|STARTED|Overall Study||49
8369364|NCT01162551|20631466|P1|NOT COMPLETED|Overall Study||0
8369365|NCT01162551|20631466|P1|COMPLETED|Overall Study||3
8369366|NCT01162551|20631466|P1|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
8369367|NCT01162499|20631471|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
8369368|NCT01162499|20631472|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
8369369|NCT01162499|20631471|P2|COMPLETED|Intervention 2 (4 Hours)||3
8369370|NCT01162499|20631472|P1|COMPLETED|Intervention 2 (4 Hours)||3
8369371|NCT01162499|20631471|P2|STARTED|Intervention 2 (4 Hours)||3
8369372|NCT01162499|20631472|P1|STARTED|Intervention 2 (4 Hours)||3
8369373|NCT01162499|20631471|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
8369374|NCT01162499|20631472|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
8369375|NCT01162499|20631471|P2|COMPLETED|Intervention 1 (4 Hours)||3
8369376|NCT01162499|20631472|P1|COMPLETED|Intervention 1 (4 Hours)||3
8369377|NCT01162499|20631471|P2|Received Intervention|Intervention 1 (4 Hours)||3
8369378|NCT01162499|20631472|P1|Received Intervention|Intervention 1 (4 Hours)||3
8369379|NCT01162499|20631471|P2|STARTED|Intervention 1 (4 Hours)||4
8369380|NCT01162499|20631472|P1|STARTED|Intervention 1 (4 Hours)||3
8369381|NCT01162486|20631497|P5|NOT COMPLETED|Overall Study||0
8369382|NCT01162486|20631498|P4|NOT COMPLETED|Overall Study||1
8369383|NCT01162486|20631499|P3|NOT COMPLETED|Overall Study||1
8369384|NCT01162486|20631500|P2|NOT COMPLETED|Overall Study||0
8369385|NCT01162486|20631501|P1|NOT COMPLETED|Overall Study||2
8369386|NCT01162486|20631497|P5|COMPLETED|Overall Study||6
8369387|NCT01162486|20631498|P4|COMPLETED|Overall Study||6
8369388|NCT01162486|20631499|P3|COMPLETED|Overall Study||5
8369389|NCT01162486|20631500|P2|COMPLETED|Overall Study||6
8369390|NCT01162486|20631501|P1|COMPLETED|Overall Study||6
8369391|NCT01162486|20631497|P5|Took at Least One Dose Study Drug|Overall Study||6
8369392|NCT01162486|20631498|P4|Took at Least One Dose Study Drug|Overall Study||7
8369393|NCT01162486|20631499|P3|Took at Least One Dose Study Drug|Overall Study||6
8369394|NCT01162486|20631500|P2|Took at Least One Dose Study Drug|Overall Study||6
8369395|NCT01162486|20631501|P1|Took at Least One Dose Study Drug|Overall Study||8
8369396|NCT01162486|20631497|P5|STARTED|Overall Study||6
8369397|NCT01162486|20631498|P4|STARTED|Overall Study||7
8369398|NCT01162486|20631499|P3|STARTED|Overall Study||6
8369399|NCT01162486|20631500|P2|STARTED|Overall Study||6
8369400|NCT01162486|20631501|P1|STARTED|Overall Study||8
8369401|NCT01162473|20631534|P2|NOT COMPLETED|Overall Study||5
8369402|NCT01162473|20631535|P1|NOT COMPLETED|Overall Study||2
8369403|NCT01162473|20631534|P2|COMPLETED|Overall Study||12
8369404|NCT01162473|20631535|P1|COMPLETED|Overall Study||6
8369405|NCT01162473|20631534|P2|STARTED|Overall Study||17
8369406|NCT01162473|20631535|P1|STARTED|Overall Study||8
8369407|NCT01162421|20631543|P2|NOT COMPLETED|Overall Study||13
8369408|NCT01162421|20631544|P1|NOT COMPLETED|Overall Study||8
8369409|NCT01162421|20631543|P2|COMPLETED|Overall Study||27
8369410|NCT01162421|20631544|P1|COMPLETED|Overall Study||29
8369411|NCT01162421|20631543|P2|STARTED|Overall Study||40
8369412|NCT01162421|20631544|P1|STARTED|Overall Study||37
8369413|NCT01162382|20631622|P1|NOT COMPLETED|Overall Study||0
8369414|NCT01162382|20631622|P1|COMPLETED|Overall Study||0
8369415|NCT01162382|20631622|P1|STARTED|Overall Study||0
8369416|NCT01162343|20631627|P1|NOT COMPLETED|Overall Study||92
8369417|NCT01162343|20631627|P1|COMPLETED|Overall Study||406
8369418|NCT01162343|20631627|P1|STARTED|Overall Study||498
8369419|NCT01162317|20631633|P2|NOT COMPLETED|Overall Study||2
8369420|NCT01162317|20631634|P1|NOT COMPLETED|Overall Study||3
8369421|NCT01162317|20631633|P2|COMPLETED|Overall Study||28
8369422|NCT01162317|20631634|P1|COMPLETED|Overall Study||27
8369423|NCT01162317|20631633|P2|STARTED|Overall Study||30
8369424|NCT01162317|20631634|P1|STARTED|Overall Study||30
8369425|NCT01162304|20631642|P1|NOT COMPLETED|Overall Study||11
8369426|NCT01162304|20631642|P1|COMPLETED|Overall Study||7
8369427|NCT01162304|20631642|P1|STARTED|Overall Study||18
8369428|NCT01162239|20631660|P4|NOT COMPLETED|Extended Follow-up||6
8369429|NCT01162239|20631661|P3|NOT COMPLETED|Extended Follow-up||8
8369430|NCT01162239|20631662|P2|NOT COMPLETED|Extended Follow-up||13
8369431|NCT01162239|20631663|P1|NOT COMPLETED|Extended Follow-up||8
8369432|NCT01162239|20631660|P4|COMPLETED|Extended Follow-up||41
8369433|NCT01162239|20631661|P3|COMPLETED|Extended Follow-up||37
8369434|NCT01162239|20631662|P2|COMPLETED|Extended Follow-up||32
8369435|NCT01162239|20631663|P1|COMPLETED|Extended Follow-up||39
8369436|NCT01162239|20631660|P4|STARTED|Extended Follow-up||47
8369437|NCT01162239|20631661|P3|STARTED|Extended Follow-up||45
8369438|NCT01162239|20631662|P2|STARTED|Extended Follow-up||45
8369439|NCT01162239|20631663|P1|STARTED|Extended Follow-up||47
8369440|NCT01162239|20631660|P4|NOT COMPLETED|Treatment Phase||5
8369441|NCT01162239|20631661|P3|NOT COMPLETED|Treatment Phase||4
8369442|NCT01162239|20631662|P2|NOT COMPLETED|Treatment Phase||7
8369443|NCT01162239|20631663|P1|NOT COMPLETED|Treatment Phase||6
8369444|NCT01162239|20631660|P4|COMPLETED|Treatment Phase||50
8369445|NCT01162239|20631661|P3|COMPLETED|Treatment Phase||48
8369446|NCT01162239|20631662|P2|COMPLETED|Treatment Phase||47
8369447|NCT01162239|20631663|P1|COMPLETED|Treatment Phase||49
8369448|NCT01162239|20631660|P4|Week 52|Treatment Phase||50
8369449|NCT01162239|20631661|P3|Week 52|Treatment Phase||48
8369450|NCT01162239|20631662|P2|Week 52|Treatment Phase||47
8369451|NCT01162239|20631663|P1|Week 52|Treatment Phase||49
8369452|NCT01162239|20631660|P4|Week 24|Treatment Phase||50
8369453|NCT01162239|20631661|P3|Week 24|Treatment Phase||48
8369454|NCT01162239|20631662|P2|Week 24|Treatment Phase||48
8369455|NCT01162239|20631663|P1|Week 24|Treatment Phase||51
8369456|NCT01162239|20631660|P4|Week 12|Treatment Phase||53
8369457|NCT01162239|20631661|P3|Week 12|Treatment Phase||49
8369458|NCT01162239|20631662|P2|Week 12|Treatment Phase||51
8369459|NCT01162239|20631663|P1|Week 12|Treatment Phase||50
8369460|NCT01162239|20631660|P4|STARTED|Treatment Phase||55
8369461|NCT01162239|20631661|P3|STARTED|Treatment Phase||52
8369462|NCT01162239|20631662|P2|STARTED|Treatment Phase||54
8369463|NCT01162239|20631663|P1|STARTED|Treatment Phase||55
8369464|NCT01162135|20631693|P1|NOT COMPLETED|Overall Study||3
8369465|NCT01162135|20631693|P1|COMPLETED|Overall Study||13
8369466|NCT01162135|20631693|P1|STARTED|Overall Study||16
8369467|NCT01162122|20631699|P2|NOT COMPLETED|Overall Study||196
8369468|NCT01162122|20631700|P1|NOT COMPLETED|Overall Study||191
8369469|NCT01162122|20631699|P2|COMPLETED|Overall Study||3356
8369470|NCT01162122|20631700|P1|COMPLETED|Overall Study||3361
8369471|NCT01162122|20631699|P2|Vaccinated|Overall Study||3541
8369472|NCT01162122|20631700|P1|Vaccinated|Overall Study||3541
8369473|NCT01162122|20631699|P2|STARTED|Overall Study||3552
8369474|NCT01162122|20631700|P1|STARTED|Overall Study||3552
8369475|NCT01162096|20631757|P1|NOT COMPLETED|Overall Study||0
8369476|NCT01162096|20631757|P1|COMPLETED|Overall Study||34
8369477|NCT01162096|20631757|P1|STARTED|Overall Study||34
8369478|NCT01162005|20631765|P2|NOT COMPLETED|Overall Study||0
8369479|NCT01162005|20631766|P1|NOT COMPLETED|Overall Study||0
8369480|NCT01162005|20631765|P2|COMPLETED|Overall Study||33
8369481|NCT01162005|20631766|P1|COMPLETED|Overall Study||44
8369482|NCT01162005|20631765|P2|STARTED|Overall Study||33
8369483|NCT01162005|20631766|P1|STARTED|Overall Study||44
8369484|NCT01161862|20631776|P2|NOT COMPLETED|Overall Study||0
8369485|NCT01161862|20631777|P1|NOT COMPLETED|Overall Study||0
8369486|NCT01161862|20631776|P2|COMPLETED|Overall Study||12
8369487|NCT01161862|20631777|P1|COMPLETED|Overall Study||12
8369488|NCT01161862|20631776|P2|STARTED|Overall Study||12
8369489|NCT01161862|20631777|P1|STARTED|Overall Study||12
8369490|NCT01161771|20631797|P1|NOT COMPLETED|Overall Study||0
8369491|NCT01161771|20631797|P1|COMPLETED|Overall Study||32
8369492|NCT01161771|20631797|P1|STARTED|Overall Study||32
8369493|NCT01161628|20631806|P1|NOT COMPLETED|Overall Study||8
8369494|NCT01161628|20631806|P1|COMPLETED|Overall Study||17
8369495|NCT01161628|20631806|P1|STARTED|Overall Study||25
8369496|NCT01161563|20631820|P2|NOT COMPLETED|Overall Study||6
8369497|NCT01161563|20631821|P1|NOT COMPLETED|Overall Study||5
8369498|NCT01161563|20631820|P2|COMPLETED|Overall Study||49
8369499|NCT01161563|20631821|P1|COMPLETED|Overall Study||58
8369500|NCT01161563|20631820|P2|STARTED|Overall Study||55
8369501|NCT01161563|20631821|P1|STARTED|Overall Study||63
8369502|NCT01161537|20631829|P1|NOT COMPLETED|Part B||2
8369503|NCT01161537|20631829|P1|COMPLETED|Part B||7
8369504|NCT01161537|20631829|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
8369505|NCT01161537|20631829|P1|NOT COMPLETED|Part A||0
8369506|NCT01161537|20631829|P1|COMPLETED|Part A||8
8369507|NCT01161537|20631829|P1|STARTED|Part A||8
8369508|NCT01161524|20631847|P3|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
8369509|NCT01161524|20631848|P2|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369510|NCT01161524|20631849|P1|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369511|NCT01161524|20631847|P3|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
8369512|NCT01161524|20631848|P2|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369513|NCT01161524|20631849|P1|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369514|NCT01161524|20631847|P3|STARTED|Extension Phase (Approximately 83 Weeks)||114
8369515|NCT01161524|20631848|P2|STARTED|Extension Phase (Approximately 83 Weeks)||0
8369516|NCT01161524|20631849|P1|STARTED|Extension Phase (Approximately 83 Weeks)||0
8369517|NCT01161524|20631847|P3|NOT COMPLETED|Core Study (23 Weeks)||0
8369518|NCT01161524|20631848|P2|NOT COMPLETED|Core Study (23 Weeks)||5
8369519|NCT01161524|20631849|P1|NOT COMPLETED|Core Study (23 Weeks)||9
8369520|NCT01161524|20631847|P3|COMPLETED|Core Study (23 Weeks)||0
8369521|NCT01161524|20631848|P2|COMPLETED|Core Study (23 Weeks)||43
8369522|NCT01161524|20631849|P1|COMPLETED|Core Study (23 Weeks)||76
8369523|NCT01161524|20631847|P3|STARTED|Core Study (23 Weeks)||0
8369524|NCT01161524|20631848|P2|STARTED|Core Study (23 Weeks)||48
8369525|NCT01161524|20631849|P1|STARTED|Core Study (23 Weeks)||85
8369526|NCT01161498|20631888|P2|NOT COMPLETED|Overall Study||1
8369527|NCT01161498|20631889|P1|NOT COMPLETED|Overall Study||0
8369528|NCT01161498|20631888|P2|COMPLETED|Overall Study||1
8369529|NCT01161498|20631889|P1|COMPLETED|Overall Study||3
8369530|NCT01161498|20631888|P2|STARTED|Overall Study||2
8369531|NCT01161498|20631889|P1|STARTED|Overall Study||3
8369532|NCT01161472|20631913|P4|NOT COMPLETED|Fourth Intervention Period||0
8369533|NCT01161472|20631914|P3|NOT COMPLETED|Fourth Intervention Period||0
8369534|NCT01161472|20631915|P2|NOT COMPLETED|Fourth Intervention Period||0
8369535|NCT01161472|20631916|P1|NOT COMPLETED|Fourth Intervention Period||0
8369536|NCT01161472|20631913|P4|COMPLETED|Fourth Intervention Period||5
8369537|NCT01161472|20631914|P3|COMPLETED|Fourth Intervention Period||5
8369538|NCT01161472|20631915|P2|COMPLETED|Fourth Intervention Period||5
8369539|NCT01161472|20631916|P1|COMPLETED|Fourth Intervention Period||4
8369540|NCT01161472|20631913|P4|STARTED|Fourth Intervention Period||5
8369541|NCT01161472|20631914|P3|STARTED|Fourth Intervention Period||5
8369542|NCT01161472|20631915|P2|STARTED|Fourth Intervention Period||5
8369543|NCT01161472|20631916|P1|STARTED|Fourth Intervention Period||4
8369544|NCT01161472|20631913|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369545|NCT01161472|20631914|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369546|NCT01161472|20631915|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369547|NCT01161472|20631916|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369548|NCT01161472|20631913|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369549|NCT01161472|20631914|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369550|NCT01161472|20631915|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369551|NCT01161472|20631916|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
8369552|NCT01161472|20631913|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369553|NCT01161472|20631914|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369554|NCT01161472|20631915|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369555|NCT01161472|20631916|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
8369556|NCT01161472|20631913|P4|NOT COMPLETED|Third Intervention Period||0
8369557|NCT01161472|20631914|P3|NOT COMPLETED|Third Intervention Period||0
8369558|NCT01161472|20631915|P2|NOT COMPLETED|Third Intervention Period||0
8369559|NCT01161472|20631916|P1|NOT COMPLETED|Third Intervention Period||0
8369560|NCT01161472|20631913|P4|COMPLETED|Third Intervention Period||5
8369561|NCT01161472|20631914|P3|COMPLETED|Third Intervention Period||5
8369562|NCT01161472|20631915|P2|COMPLETED|Third Intervention Period||5
8369563|NCT01161472|20631916|P1|COMPLETED|Third Intervention Period||4
8369564|NCT01161472|20631913|P4|STARTED|Third Intervention Period||5
8369565|NCT01161472|20631914|P3|STARTED|Third Intervention Period||5
8369566|NCT01161472|20631915|P2|STARTED|Third Intervention Period||5
8369567|NCT01161472|20631916|P1|STARTED|Third Intervention Period||4
8369568|NCT01161472|20631913|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369569|NCT01161472|20631914|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369570|NCT01161472|20631915|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369571|NCT01161472|20631916|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
8369572|NCT01161472|20631913|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369573|NCT01161472|20631914|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369574|NCT01161472|20631915|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369575|NCT01161472|20631916|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
8369576|NCT01161472|20631913|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369577|NCT01161472|20631914|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369578|NCT01161472|20631915|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369579|NCT01161472|20631916|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369580|NCT01161472|20631913|P4|NOT COMPLETED|Second Intervention Period||0
8369581|NCT01161472|20631914|P3|NOT COMPLETED|Second Intervention Period||0
8369582|NCT01161472|20631915|P2|NOT COMPLETED|Second Intervention Period||0
8369583|NCT01161472|20631916|P1|NOT COMPLETED|Second Intervention Period||0
8369584|NCT01161472|20631913|P4|COMPLETED|Second Intervention Period||5
8369585|NCT01161472|20631914|P3|COMPLETED|Second Intervention Period||5
8369586|NCT01161472|20631915|P2|COMPLETED|Second Intervention Period||5
8369587|NCT01161472|20631916|P1|COMPLETED|Second Intervention Period||5
8369588|NCT01161472|20631913|P4|STARTED|Second Intervention Period||5
8369589|NCT01161472|20631914|P3|STARTED|Second Intervention Period||5
8369590|NCT01161472|20631915|P2|STARTED|Second Intervention Period||5
8369591|NCT01161472|20631916|P1|STARTED|Second Intervention Period||5
8369592|NCT01161472|20631913|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369593|NCT01161472|20631914|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369594|NCT01161472|20631915|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369595|NCT01161472|20631916|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369596|NCT01161472|20631913|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369597|NCT01161472|20631914|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369598|NCT01161472|20631915|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369599|NCT01161472|20631916|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369600|NCT01161472|20631913|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369601|NCT01161472|20631914|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369602|NCT01161472|20631915|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369603|NCT01161472|20631916|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369604|NCT01161472|20631913|P4|NOT COMPLETED|First Intervention Period||0
8369605|NCT01161472|20631914|P3|NOT COMPLETED|First Intervention Period||0
8369606|NCT01161472|20631915|P2|NOT COMPLETED|First Intervention Period||0
8369607|NCT01161472|20631916|P1|NOT COMPLETED|First Intervention Period||0
8369608|NCT01161472|20631913|P4|COMPLETED|First Intervention Period||5
8369609|NCT01161472|20631914|P3|COMPLETED|First Intervention Period||5
8369610|NCT01161472|20631915|P2|COMPLETED|First Intervention Period||5
8369611|NCT01161472|20631916|P1|COMPLETED|First Intervention Period||5
8369612|NCT01161472|20631913|P4|Treated|First Intervention Period||5
8369613|NCT01161472|20631914|P3|Treated|First Intervention Period||5
8369614|NCT01161472|20631915|P2|Treated|First Intervention Period||5
8369615|NCT01161472|20631916|P1|Treated|First Intervention Period||5
8369616|NCT01161472|20631913|P4|STARTED|First Intervention Period||5
8369617|NCT01161472|20631914|P3|STARTED|First Intervention Period||5
8369618|NCT01161472|20631915|P2|STARTED|First Intervention Period||5
8369619|NCT01161472|20631916|P1|STARTED|First Intervention Period||5
8369620|NCT01161446|20631972|P2|NOT COMPLETED|Overall Study||15
8369621|NCT01161446|20631973|P1|NOT COMPLETED|Overall Study||18
8369622|NCT01161446|20631972|P2|COMPLETED|Overall Study||99
8369623|NCT01161446|20631973|P1|COMPLETED|Overall Study||98
8369624|NCT01161446|20631972|P2|STARTED|Overall Study||114
8369625|NCT01161446|20631973|P1|STARTED|Overall Study||116
8369626|NCT01161420|20631985|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
8369627|NCT01161420|20631985|P1|COMPLETED|Withdrawal Study - Withdrawal||23
8369628|NCT01161420|20631985|P1|STARTED|Withdrawal Study - Withdrawal||23
8369629|NCT01161420|20631985|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
8369630|NCT01161420|20631985|P1|COMPLETED|Withdrawal Study - Maintenance||23
8369631|NCT01161420|20631985|P1|STARTED|Withdrawal Study - Maintenance||23
8369632|NCT01161420|20631985|P1|NOT COMPLETED|Inspire Therapy||2
8369633|NCT01161420|20631985|P1|COMPLETED|Inspire Therapy||124
8369634|NCT01161420|20631985|P1|STARTED|Inspire Therapy||126
8369635|NCT01161407|20631999|P2|NOT COMPLETED|Overall Study||1
8369636|NCT01161407|20632000|P1|NOT COMPLETED|Overall Study||3
8369637|NCT01161407|20631999|P2|COMPLETED|Overall Study||5
8369638|NCT01161407|20632000|P1|COMPLETED|Overall Study||3
8369639|NCT01161407|20631999|P2|STARTED|Overall Study||6
8369640|NCT01161407|20632000|P1|STARTED|Overall Study||6
8369641|NCT01161329|20632012|P2|NOT COMPLETED|Overall Study||10
8369642|NCT01161329|20632013|P1|NOT COMPLETED|Overall Study||4
8369643|NCT01161329|20632012|P2|COMPLETED|Overall Study||24
8369644|NCT01161329|20632013|P1|COMPLETED|Overall Study||29
8369645|NCT01161329|20632012|P2|STARTED|Overall Study||34
8369646|NCT01161329|20632013|P1|STARTED|Overall Study||33
8369647|NCT01161225|20632024|P3|NOT COMPLETED|Overall Study||2
8369648|NCT01161225|20632025|P2|NOT COMPLETED|Overall Study||9
8369649|NCT01161225|20632026|P1|NOT COMPLETED|Overall Study||14
8369650|NCT01161225|20632024|P3|COMPLETED|Overall Study||12
8369651|NCT01161225|20632025|P2|COMPLETED|Overall Study||44
8369652|NCT01161225|20632026|P1|COMPLETED|Overall Study||45
8369653|NCT01161225|20632024|P3|STARTED|Overall Study||14
8369654|NCT01161225|20632025|P2|STARTED|Overall Study||53
8369655|NCT01161225|20632026|P1|STARTED|Overall Study||59
8369656|NCT01161173|20632055|P1|NOT COMPLETED|Overall Study||347
8369657|NCT01161173|20632055|P1|COMPLETED|Overall Study||0
8369658|NCT01161173|20632055|P1|STARTED|Overall Study||347
8369659|NCT01161160|20632067|P3|NOT COMPLETED|Overall Study||0
8369660|NCT01161160|20632068|P2|NOT COMPLETED|Overall Study||0
8369661|NCT01161160|20632069|P1|NOT COMPLETED|Overall Study||0
8369662|NCT01161160|20632067|P3|COMPLETED|Overall Study||58
8369663|NCT01161160|20632068|P2|COMPLETED|Overall Study||75
8369664|NCT01161160|20632069|P1|COMPLETED|Overall Study||76
8369665|NCT01161160|20632067|P3|STARTED|Overall Study||58
8369666|NCT01161160|20632068|P2|STARTED|Overall Study||75
8369667|NCT01161160|20632069|P1|STARTED|Overall Study||76
8369668|NCT01161121|20632140|P1|NOT COMPLETED|Overall Study||0
8369669|NCT01161121|20632140|P1|COMPLETED|Overall Study||46
8369670|NCT01161121|20632140|P1|STARTED|Overall Study||46
8369671|NCT01161043|20632150|P1|NOT COMPLETED|Overall Study||3
8369672|NCT01161043|20632150|P1|COMPLETED|Overall Study||80
8369673|NCT01161043|20632150|P1|STARTED|Overall Study||83
8369674|NCT01160848|20632157|P2|NOT COMPLETED|Overall Study||0
8369675|NCT01160848|20632158|P1|NOT COMPLETED|Overall Study||0
8369676|NCT01160848|20632157|P2|COMPLETED|Overall Study||8
8369677|NCT01160848|20632158|P1|COMPLETED|Overall Study||12
8369678|NCT01160848|20632157|P2|STARTED|Overall Study||8
8369679|NCT01160848|20632158|P1|STARTED|Overall Study||12
8369680|NCT01160822|20632187|P7|NOT COMPLETED|Overall Study||9
8369681|NCT01160822|20632188|P6|NOT COMPLETED|Overall Study||7
8369682|NCT01160822|20632189|P5|NOT COMPLETED|Overall Study||9
8369683|NCT01160822|20632190|P4|NOT COMPLETED|Overall Study||0
8369684|NCT01160822|20632191|P3|NOT COMPLETED|Overall Study||0
8369685|NCT01160822|20632192|P2|NOT COMPLETED|Overall Study||0
8369686|NCT01160822|20632193|P1|NOT COMPLETED|Overall Study||0
8369687|NCT01160822|20632187|P7|COMPLETED|Overall Study||44
8369688|NCT01160822|20632188|P6|COMPLETED|Overall Study||40
8369689|NCT01160822|20632189|P5|COMPLETED|Overall Study||36
8369690|NCT01160822|20632190|P4|COMPLETED|Overall Study||5
8369691|NCT01160822|20632191|P3|COMPLETED|Overall Study||6
8369692|NCT01160822|20632192|P2|COMPLETED|Overall Study||7
8369693|NCT01160822|20632193|P1|COMPLETED|Overall Study||6
8369694|NCT01160822|20632187|P7|STARTED|Overall Study||53
8369695|NCT01160822|20632188|P6|STARTED|Overall Study||47
8369696|NCT01160822|20632189|P5|STARTED|Overall Study||45
8369697|NCT01160822|20632190|P4|STARTED|Overall Study||5
8369698|NCT01160822|20632191|P3|STARTED|Overall Study||6
8369699|NCT01160822|20632192|P2|STARTED|Overall Study||7
8369700|NCT01160822|20632193|P1|STARTED|Overall Study||6
8369701|NCT01160770|20632282|P1|NOT COMPLETED|Overall Study||79
8369702|NCT01160770|20632282|P1|COMPLETED|Overall Study||188
8369703|NCT01160770|20632282|P1|STARTED|Overall Study||267
8369704|NCT01160744|20632295|P4|NOT COMPLETED|Overall Study||4
8369705|NCT01160744|20632296|P3|NOT COMPLETED|Overall Study||7
8369706|NCT01160744|20632297|P2|NOT COMPLETED|Overall Study||5
8369707|NCT01160744|20632298|P1|NOT COMPLETED|Overall Study||11
8369708|NCT01160744|20632295|P4|COMPLETED|Overall Study||67
8369709|NCT01160744|20632296|P3|COMPLETED|Overall Study||62
8369710|NCT01160744|20632297|P2|COMPLETED|Overall Study||64
8369711|NCT01160744|20632298|P1|COMPLETED|Overall Study||60
8369712|NCT01160744|20632295|P4|Received Study Drug|Overall Study||71
8369713|NCT01160744|20632296|P3|Received Study Drug|Overall Study||63
8369714|NCT01160744|20632297|P2|Received Study Drug|Overall Study||67
8369715|NCT01160744|20632298|P1|Received Study Drug|Overall Study||69
8369716|NCT01160744|20632295|P4|STARTED|Overall Study||71
8369717|NCT01160744|20632296|P3|STARTED|Overall Study||69
8369718|NCT01160744|20632297|P2|STARTED|Overall Study||69
8369719|NCT01160744|20632298|P1|STARTED|Overall Study||71
8369720|NCT01160640|20632334|P2|NOT COMPLETED|Overall Study||6
8369721|NCT01160640|20632335|P1|NOT COMPLETED|Overall Study||4
8369722|NCT01160640|20632334|P2|COMPLETED|Overall Study||110
8369723|NCT01160640|20632335|P1|COMPLETED|Overall Study||113
8369724|NCT01160640|20632334|P2|STARTED|Overall Study||116
8369725|NCT01160640|20632335|P1|STARTED|Overall Study||117
8369726|NCT01160614|20632351|P2|NOT COMPLETED|Overall Study||2
8369727|NCT01160614|20632352|P1|NOT COMPLETED|Overall Study||0
8369728|NCT01160614|20632351|P2|COMPLETED|Overall Study||23
8369729|NCT01160614|20632352|P1|COMPLETED|Overall Study||5
8369730|NCT01160614|20632351|P2|STARTED|Overall Study||25
8369731|NCT01160614|20632352|P1|STARTED|Overall Study||5
8369732|NCT01160484|20632400|P1|NOT COMPLETED|Overall Study||18
8369733|NCT01160484|20632400|P1|COMPLETED|Overall Study||22
8369734|NCT01160484|20632400|P1|STARTED|Overall Study||40
8369735|NCT01160458|20632410|P1|NOT COMPLETED|Overall Study||0
8369736|NCT01160458|20632410|P1|COMPLETED|Overall Study||20
8369737|NCT01160458|20632410|P1|STARTED|Overall Study||20
8369738|NCT01160445|20632420|P2|NOT COMPLETED|Overall Study||0
8369739|NCT01160445|20632421|P1|NOT COMPLETED|Overall Study||0
8369740|NCT01160445|20632420|P2|COMPLETED|Overall Study||2
8369741|NCT01160445|20632421|P1|COMPLETED|Overall Study||7
8369742|NCT01160445|20632420|P2|STARTED|Overall Study||2
8369743|NCT01160445|20632421|P1|STARTED|Overall Study||7
8369744|NCT01160380|20632431|P2|NOT COMPLETED|Overall Study||5
8369745|NCT01160380|20632432|P1|NOT COMPLETED|Overall Study||8
8369746|NCT01160380|20632431|P2|COMPLETED|Overall Study||20
8369747|NCT01160380|20632432|P1|COMPLETED|Overall Study||17
8369748|NCT01160380|20632431|P2|STARTED|Overall Study||25
8369749|NCT01160380|20632432|P1|STARTED|Overall Study||25
8369750|NCT01160354|20632453|P3|NOT COMPLETED|Overall Study||1
8369751|NCT01160354|20632454|P2|NOT COMPLETED|Overall Study||1
8369752|NCT01160354|20632455|P1|NOT COMPLETED|Overall Study||0
8369753|NCT01160354|20632453|P3|COMPLETED|Overall Study||14
8369754|NCT01160354|20632454|P2|COMPLETED|Overall Study||3
8369755|NCT01160354|20632455|P1|COMPLETED|Overall Study||3
8369756|NCT01160354|20632453|P3|STARTED|Overall Study||15
8369757|NCT01160354|20632454|P2|STARTED|Overall Study||4
8369758|NCT01160354|20632455|P1|STARTED|Overall Study||3
8369759|NCT01160289|20632474|P6|NOT COMPLETED|Post-Randomization Period||14
8369760|NCT01160289|20632475|P5|NOT COMPLETED|Post-Randomization Period||9
8369761|NCT01160289|20632476|P4|NOT COMPLETED|Post-Randomization Period||21
8369762|NCT01160289|20632477|P3|NOT COMPLETED|Post-Randomization Period||24
8369763|NCT01160289|20632478|P2|NOT COMPLETED|Post-Randomization Period||20
8369764|NCT01160289|20632479|P1|NOT COMPLETED|Post-Randomization Period||0
8369765|NCT01160289|20632474|P6|COMPLETED|Post-Randomization Period||73
8369766|NCT01160289|20632475|P5|COMPLETED|Post-Randomization Period||80
8369767|NCT01160289|20632476|P4|COMPLETED|Post-Randomization Period||31
8369768|NCT01160289|20632477|P3|COMPLETED|Post-Randomization Period||73
8369769|NCT01160289|20632478|P2|COMPLETED|Post-Randomization Period||65
8369770|NCT01160289|20632479|P1|COMPLETED|Post-Randomization Period||0
8369771|NCT01160289|20632474|P6|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
8369772|NCT01160289|20632475|P5|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
8369773|NCT01160289|20632476|P4|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
8369774|NCT01160289|20632477|P3|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
8369775|NCT01160289|20632478|P2|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
8369776|NCT01160289|20632479|P1|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
8369777|NCT01160289|20632474|P6|STARTED|Post-Randomization Period||87
8369778|NCT01160289|20632475|P5|STARTED|Post-Randomization Period||89
8369779|NCT01160289|20632476|P4|STARTED|Post-Randomization Period||52
8369780|NCT01160289|20632477|P3|STARTED|Post-Randomization Period||97
8369781|NCT01160289|20632478|P2|STARTED|Post-Randomization Period||85
8369782|NCT01160289|20632479|P1|STARTED|Post-Randomization Period||0
8369783|NCT01160289|20632474|P6|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369784|NCT01160289|20632475|P5|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369785|NCT01160289|20632476|P4|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369786|NCT01160289|20632477|P3|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369787|NCT01160289|20632478|P2|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369788|NCT01160289|20632479|P1|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
8369789|NCT01160289|20632474|P6|COMPLETED|Screening, Washout, and Lead-In Period||0
8369790|NCT01160289|20632475|P5|COMPLETED|Screening, Washout, and Lead-In Period||0
8369791|NCT01160289|20632476|P4|COMPLETED|Screening, Washout, and Lead-In Period||0
8369792|NCT01160289|20632477|P3|COMPLETED|Screening, Washout, and Lead-In Period||0
8369793|NCT01160289|20632478|P2|COMPLETED|Screening, Washout, and Lead-In Period||0
8369794|NCT01160289|20632479|P1|COMPLETED|Screening, Washout, and Lead-In Period||410
8369795|NCT01160289|20632474|P6|STARTED|Screening, Washout, and Lead-In Period||0
8369796|NCT01160289|20632475|P5|STARTED|Screening, Washout, and Lead-In Period||0
8369797|NCT01160289|20632476|P4|STARTED|Screening, Washout, and Lead-In Period||0
8369798|NCT01160289|20632477|P3|STARTED|Screening, Washout, and Lead-In Period||0
8369799|NCT01160289|20632478|P2|STARTED|Screening, Washout, and Lead-In Period||0
8369800|NCT01160289|20632479|P1|STARTED|Screening, Washout, and Lead-In Period||894
8369801|NCT01160237|20632540|P3|NOT COMPLETED|Overall Study||0
8369802|NCT01160237|20632541|P2|NOT COMPLETED|Overall Study||0
8369803|NCT01160237|20632542|P1|NOT COMPLETED|Overall Study||0
8369804|NCT01160237|20632540|P3|COMPLETED|Overall Study||0
8369805|NCT01160237|20632541|P2|COMPLETED|Overall Study||3
8369806|NCT01160237|20632542|P1|COMPLETED|Overall Study||4
8369807|NCT01160237|20632540|P3|STARTED|Overall Study||0
8369808|NCT01160237|20632541|P2|STARTED|Overall Study||3
8369809|NCT01160237|20632542|P1|STARTED|Overall Study||4
8369810|NCT01160211|20632568|P3|NOT COMPLETED|Overall Study||87
8369811|NCT01160211|20632569|P2|NOT COMPLETED|Overall Study||87
8369812|NCT01160211|20632570|P1|NOT COMPLETED|Overall Study||99
8369813|NCT01160211|20632568|P3|COMPLETED|Overall Study||30
8369814|NCT01160211|20632569|P2|COMPLETED|Overall Study||31
8369815|NCT01160211|20632570|P1|COMPLETED|Overall Study||21
8369816|NCT01160211|20632568|P3|Ongoing|Overall Study||79
8369817|NCT01160211|20632569|P2|Ongoing|Overall Study||75
8369818|NCT01160211|20632570|P1|Ongoing|Overall Study||90
8369819|NCT01160211|20632568|P3|STARTED|Overall Study||117
8369820|NCT01160211|20632569|P2|STARTED|Overall Study||118
8369821|NCT01160211|20632570|P1|STARTED|Overall Study||120
8369822|NCT01160198|20632603|P3|NOT COMPLETED|Overall Study||1
8369823|NCT01160198|20632604|P2|NOT COMPLETED|Overall Study||3
8369824|NCT01160198|20632605|P1|NOT COMPLETED|Overall Study||2
8369825|NCT01160198|20632603|P3|COMPLETED|Overall Study||89
8369826|NCT01160198|20632604|P2|COMPLETED|Overall Study||88
8369827|NCT01160198|20632605|P1|COMPLETED|Overall Study||87
8369828|NCT01160198|20632603|P3|STARTED|Overall Study||90
8369829|NCT01160198|20632604|P2|STARTED|Overall Study||91
8369830|NCT01160198|20632605|P1|STARTED|Overall Study||89
8369831|NCT01159938|20632627|P5|NOT COMPLETED|Second Study Period||0
8369832|NCT01159938|20632628|P4|NOT COMPLETED|Second Study Period||0
8369833|NCT01159938|20632629|P3|NOT COMPLETED|Second Study Period||0
8369834|NCT01159938|20632630|P2|NOT COMPLETED|Second Study Period||0
8369835|NCT01159938|20632631|P1|NOT COMPLETED|Second Study Period||0
8369836|NCT01159938|20632627|P5|COMPLETED|Second Study Period||12
8369837|NCT01159938|20632628|P4|COMPLETED|Second Study Period||12
8369838|NCT01159938|20632629|P3|COMPLETED|Second Study Period||10
8369839|NCT01159938|20632630|P2|COMPLETED|Second Study Period||11
8369840|NCT01159938|20632631|P1|COMPLETED|Second Study Period||0
8369841|NCT01159938|20632627|P5|STARTED|Second Study Period||12
8369842|NCT01159938|20632628|P4|STARTED|Second Study Period||12
8369843|NCT01159938|20632629|P3|STARTED|Second Study Period||10
8369844|NCT01159938|20632630|P2|STARTED|Second Study Period||11
8369845|NCT01159938|20632631|P1|STARTED|Second Study Period||0
8369846|NCT01159938|20632627|P5|NOT COMPLETED|First Study Period||0
8369847|NCT01159938|20632628|P4|NOT COMPLETED|First Study Period||0
8369848|NCT01159938|20632629|P3|NOT COMPLETED|First Study Period||1
8369849|NCT01159938|20632630|P2|NOT COMPLETED|First Study Period||0
8369850|NCT01159938|20632631|P1|NOT COMPLETED|First Study Period||0
8369851|NCT01159938|20632627|P5|COMPLETED|First Study Period||12
8369852|NCT01159938|20632628|P4|COMPLETED|First Study Period||12
8369853|NCT01159938|20632629|P3|COMPLETED|First Study Period||10
8369854|NCT01159938|20632630|P2|COMPLETED|First Study Period||11
8369855|NCT01159938|20632631|P1|COMPLETED|First Study Period||26
8369856|NCT01159938|20632627|P5|Safety and Efficacy Analysis Population|First Study Period||12
8369857|NCT01159938|20632628|P4|Safety and Efficacy Analysis Population|First Study Period||12
8369858|NCT01159938|20632629|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
8369859|NCT01159938|20632630|P2|Safety and Efficacy Analysis Population|First Study Period||11
8369860|NCT01159938|20632631|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
8369861|NCT01159938|20632627|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
8369862|NCT01159938|20632628|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
8369863|NCT01159938|20632629|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
8369864|NCT01159938|20632630|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
8369865|NCT01159938|20632631|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
8369866|NCT01159938|20632627|P5|STARTED|First Study Period||12
8369867|NCT01159938|20632628|P4|STARTED|First Study Period||12
8369868|NCT01159938|20632629|P3|STARTED|First Study Period||11
8369869|NCT01159938|20632630|P2|STARTED|First Study Period||11
8369870|NCT01159938|20632631|P1|STARTED|First Study Period||26
8369871|NCT01159912|20632694|P3|NOT COMPLETED|Overall Study||26
8369872|NCT01159912|20632695|P2|NOT COMPLETED|Overall Study||22
8369873|NCT01159912|20632696|P1|NOT COMPLETED|Overall Study||40
8369874|NCT01159912|20632694|P3|COMPLETED|Overall Study||88
8369875|NCT01159912|20632695|P2|COMPLETED|Overall Study||92
8369876|NCT01159912|20632696|P1|COMPLETED|Overall Study||75
8369877|NCT01159912|20632694|P3|STARTED|Overall Study||114
8369878|NCT01159912|20632695|P2|STARTED|Overall Study||114
8369879|NCT01159912|20632696|P1|STARTED|Overall Study||115
8369880|NCT01159769|20632719|P1|NOT COMPLETED|Overall Study||1
8369881|NCT01159769|20632719|P1|COMPLETED|Overall Study||214
8369882|NCT01159769|20632719|P1|STARTED|Overall Study||215
8369883|NCT01159743|20632726|P2|NOT COMPLETED|Overall Study||0
8369884|NCT01159743|20632727|P1|NOT COMPLETED|Overall Study||0
8369885|NCT01159743|20632726|P2|COMPLETED|Overall Study||109
8369886|NCT01159743|20632727|P1|COMPLETED|Overall Study||237
8369887|NCT01159743|20632726|P2|STARTED|Overall Study||109
8369888|NCT01159743|20632727|P1|STARTED|Overall Study||237
8369889|NCT01159691|20632739|P1|NOT COMPLETED|Overall Study||22
8369890|NCT01159691|20632739|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
8369891|NCT01159691|20632739|P1|STARTED|Overall Study||76
8369892|NCT01159665|20632752|P6|NOT COMPLETED|Overall Study||0
8369893|NCT01159665|20632753|P5|NOT COMPLETED|Overall Study||0
8369894|NCT01159665|20632754|P4|NOT COMPLETED|Overall Study||0
8369895|NCT01159665|20632755|P3|NOT COMPLETED|Overall Study||0
8369896|NCT01159665|20632756|P2|NOT COMPLETED|Overall Study||1
8369897|NCT01159665|20632757|P1|NOT COMPLETED|Overall Study||0
8369898|NCT01159665|20632752|P6|COMPLETED|Overall Study||4
8369899|NCT01159665|20632753|P5|COMPLETED|Overall Study||4
8369900|NCT01159665|20632754|P4|COMPLETED|Overall Study||4
8369901|NCT01159665|20632755|P3|COMPLETED|Overall Study||8
8369902|NCT01159665|20632756|P2|COMPLETED|Overall Study||8
8369903|NCT01159665|20632757|P1|COMPLETED|Overall Study||9
8369904|NCT01159665|20632752|P6|STARTED|Overall Study||4
8369905|NCT01159665|20632753|P5|STARTED|Overall Study||4
8369906|NCT01159665|20632754|P4|STARTED|Overall Study||4
8369907|NCT01159665|20632755|P3|STARTED|Overall Study||8
8369908|NCT01159665|20632756|P2|STARTED|Overall Study||9
8369909|NCT01159665|20632757|P1|STARTED|Overall Study||9
8369910|NCT01159600|20632785|P8|NOT COMPLETED|Overall Study||18
8369911|NCT01159600|20632786|P7|NOT COMPLETED|Overall Study||19
8369912|NCT01159600|20632787|P6|NOT COMPLETED|Overall Study||18
8369913|NCT01159600|20632788|P5|NOT COMPLETED|Overall Study||24
8369914|NCT01159600|20632789|P4|NOT COMPLETED|Overall Study||11
8369915|NCT01159600|20632790|P3|NOT COMPLETED|Overall Study||18
8369916|NCT01159600|20632791|P2|NOT COMPLETED|Overall Study||8
8369917|NCT01159600|20632792|P1|NOT COMPLETED|Overall Study||21
8369918|NCT01159600|20632785|P8|COMPLETED|Overall Study||85
8369919|NCT01159600|20632786|P7|COMPLETED|Overall Study||199
8369920|NCT01159600|20632787|P6|COMPLETED|Overall Study||208
8369921|NCT01159600|20632788|P5|COMPLETED|Overall Study||201
8369922|NCT01159600|20632789|P4|COMPLETED|Overall Study||58
8369923|NCT01159600|20632790|P3|COMPLETED|Overall Study||196
8369924|NCT01159600|20632791|P2|COMPLETED|Overall Study||209
8369925|NCT01159600|20632792|P1|COMPLETED|Overall Study||186
8369926|NCT01159600|20632785|P8|STARTED|Overall Study||103
8369927|NCT01159600|20632786|P7|STARTED|Overall Study||218
8369928|NCT01159600|20632787|P6|STARTED|Overall Study||226
8369929|NCT01159600|20632788|P5|STARTED|Overall Study||225
8369930|NCT01159600|20632789|P4|STARTED|Overall Study||69
8369931|NCT01159600|20632790|P3|STARTED|Overall Study||214
8369932|NCT01159600|20632791|P2|STARTED|Overall Study||217
8369933|NCT01159600|20632792|P1|STARTED|Overall Study||207
8369934|NCT01159574|20632834|P1|NOT COMPLETED|Follow Up Phase||20
8369935|NCT01159574|20632834|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
8369936|NCT01159574|20632834|P1|STARTED|Follow Up Phase||112
8369937|NCT01159574|20632834|P1|NOT COMPLETED|Treatment Phase||21
8369938|NCT01159574|20632834|P1|COMPLETED|Treatment Phase||100
8369939|NCT01159574|20632834|P1|STARTED|Treatment Phase||121
8369940|NCT01159535|20632843|P3|NOT COMPLETED|Overall Study||31
8369941|NCT01159535|20632844|P2|NOT COMPLETED|Overall Study||24
8369942|NCT01159535|20632845|P1|NOT COMPLETED|Overall Study||24
8369943|NCT01159535|20632843|P3|COMPLETED|Overall Study||64
8369944|NCT01159535|20632844|P2|COMPLETED|Overall Study||64
8369945|NCT01159535|20632845|P1|COMPLETED|Overall Study||79
8369946|NCT01159535|20632843|P3|STARTED|Overall Study||95
8369947|NCT01159535|20632844|P2|STARTED|Overall Study||88
8369948|NCT01159535|20632845|P1|STARTED|Overall Study||103
8369949|NCT01159431|20632855|P2|NOT COMPLETED|Overall Study||6
8369950|NCT01159431|20632856|P1|NOT COMPLETED|Overall Study||2
8369951|NCT01159431|20632855|P2|COMPLETED|Overall Study||19
8369952|NCT01159431|20632856|P1|COMPLETED|Overall Study||23
8369953|NCT01159431|20632855|P2|STARTED|Overall Study||25
8369954|NCT01159431|20632856|P1|STARTED|Overall Study||25
8369955|NCT01159262|20632875|P3|NOT COMPLETED|Overall Study||0
8369956|NCT01159262|20632876|P2|NOT COMPLETED|Overall Study||0
8369957|NCT01159262|20632877|P1|NOT COMPLETED|Overall Study||0
8369958|NCT01159262|20632875|P3|COMPLETED|Overall Study||8
8369959|NCT01159262|20632876|P2|COMPLETED|Overall Study||14
8369960|NCT01159262|20632877|P1|COMPLETED|Overall Study||14
8369961|NCT01159262|20632875|P3|STARTED|Overall Study||8
8369962|NCT01159262|20632876|P2|STARTED|Overall Study||14
8369963|NCT01159262|20632877|P1|STARTED|Overall Study||14
8369964|NCT01159171|20632909|P1|NOT COMPLETED|Overall Study||50
8369965|NCT01159171|20632909|P1|COMPLETED|Overall Study||0
8369966|NCT01159171|20632909|P1|STARTED|Overall Study||50
8369967|NCT01159067|20632924|P1|NOT COMPLETED|Overall Study||0
8369968|NCT01159067|20632924|P1|COMPLETED|Overall Study||1
8369969|NCT01159067|20632924|P1|STARTED|Overall Study||1
8369970|NCT01159054|20632931|P1|NOT COMPLETED|Overall Study||20
8369971|NCT01159054|20632931|P1|COMPLETED|Overall Study||2
8369972|NCT01159054|20632931|P1|STARTED|Overall Study||22
8369973|NCT01159015|20632945|P2|NOT COMPLETED|Overall Study||7
8369974|NCT01159015|20632946|P1|NOT COMPLETED|Overall Study||18
8369975|NCT01159015|20632945|P2|COMPLETED|Overall Study||170
8369976|NCT01159015|20632946|P1|COMPLETED|Overall Study||339
8369977|NCT01159015|20632945|P2|STARTED|Overall Study||177
8369978|NCT01159015|20632946|P1|STARTED|Overall Study||357
8369979|NCT01158976|20632954|P2|NOT COMPLETED|Overall Study||4
8369980|NCT01158976|20632955|P1|NOT COMPLETED|Overall Study||9
8369981|NCT01158976|20632954|P2|COMPLETED|Overall Study||17
8369982|NCT01158976|20632955|P1|COMPLETED|Overall Study||34
8369983|NCT01158976|20632954|P2|STARTED|Overall Study||21
8369984|NCT01158976|20632955|P1|STARTED|Overall Study||43
8369985|NCT01158950|20632997|P2|NOT COMPLETED|2nd Intervention (1 Day)||0
8369986|NCT01158950|20632998|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
8369987|NCT01158950|20632997|P2|COMPLETED|2nd Intervention (1 Day)||11
8369988|NCT01158950|20632998|P1|COMPLETED|2nd Intervention (1 Day)||12
8369989|NCT01158950|20632997|P2|STARTED|2nd Intervention (1 Day)||11
8369990|NCT01158950|20632998|P1|STARTED|2nd Intervention (1 Day)||12
8369991|NCT01158950|20632997|P2|NOT COMPLETED|Washout (1 Week)||0
8369992|NCT01158950|20632998|P1|NOT COMPLETED|Washout (1 Week)||0
8369993|NCT01158950|20632997|P2|COMPLETED|Washout (1 Week)||11
8369994|NCT01158950|20632998|P1|COMPLETED|Washout (1 Week)||12
8369995|NCT01158950|20632997|P2|STARTED|Washout (1 Week)||11
8369996|NCT01158950|20632998|P1|STARTED|Washout (1 Week)||12
8369997|NCT01158950|20632997|P2|NOT COMPLETED|1st Intervention (1 Day)||2
8369998|NCT01158950|20632998|P1|NOT COMPLETED|1st Intervention (1 Day)||1
8369999|NCT01158950|20632997|P2|COMPLETED|1st Intervention (1 Day)||11
8370000|NCT01158950|20632998|P1|COMPLETED|1st Intervention (1 Day)||12
8370001|NCT01158950|20632997|P2|Data Collected|1st Intervention (1 Day)||11
8370002|NCT01158950|20632998|P1|Data Collected|1st Intervention (1 Day)||12
8370003|NCT01158950|20632997|P2|STARTED|1st Intervention (1 Day)||13
8370004|NCT01158950|20632998|P1|STARTED|1st Intervention (1 Day)||13
8370005|NCT01158924|20633006|P2|NOT COMPLETED|Overall Study||3
8370006|NCT01158924|20633007|P1|NOT COMPLETED|Overall Study||1
8370007|NCT01158924|20633006|P2|COMPLETED|Overall Study||23
8370008|NCT01158924|20633007|P1|COMPLETED|Overall Study||13
8370009|NCT01158924|20633006|P2|STARTED|Overall Study||26
8370010|NCT01158924|20633007|P1|STARTED|Overall Study||14
8370011|NCT01158885|20633021|P1|NOT COMPLETED|Treatment Course 2||0
8370012|NCT01158885|20633021|P1|COMPLETED|Treatment Course 2||0
8370013|NCT01158885|20633021|P1|STARTED|Treatment Course 2||0
8370014|NCT01158885|20633021|P1|NOT COMPLETED|Treatment Course 1||0
8370015|NCT01158885|20633021|P1|COMPLETED|Treatment Course 1||2
8370016|NCT01158885|20633021|P1|STARTED|Treatment Course 1||2
8370017|NCT01158820|20633029|P2|NOT COMPLETED|Overall Study||0
8370018|NCT01158820|20633030|P1|NOT COMPLETED|Overall Study||0
8370019|NCT01158820|20633029|P2|COMPLETED|Overall Study||25
8370020|NCT01158820|20633030|P1|COMPLETED|Overall Study||25
8370021|NCT01158820|20633029|P2|STARTED|Overall Study||25
8370022|NCT01158820|20633030|P1|STARTED|Overall Study||25
8370023|NCT01158716|20633052|P2|NOT COMPLETED|Overall Study||1
8370024|NCT01158716|20633053|P1|NOT COMPLETED|Overall Study||1
8370025|NCT01158716|20633052|P2|COMPLETED|Overall Study||47
8370026|NCT01158716|20633053|P1|COMPLETED|Overall Study||47
8370027|NCT01158716|20633052|P2|STARTED|Overall Study||48
8370028|NCT01158716|20633053|P1|STARTED|Overall Study||48
8370029|NCT01158703|20633061|P2|NOT COMPLETED|Overall Study||0
8370030|NCT01158703|20633062|P1|NOT COMPLETED|Overall Study||0
8370031|NCT01158703|20633061|P2|COMPLETED|Overall Study||8
8370032|NCT01158703|20633062|P1|COMPLETED|Overall Study||12
8370033|NCT01158703|20633061|P2|STARTED|Overall Study||8
8370034|NCT01158703|20633062|P1|STARTED|Overall Study||12
8370035|NCT01158651|20633078|P1|NOT COMPLETED|Overall Study||1
8370036|NCT01158651|20633078|P1|COMPLETED|Overall Study||22
8370037|NCT01158651|20633078|P1|STARTED|Overall Study||23
8370038|NCT01158573|20633087|P4|NOT COMPLETED|Overall Study||0
8370039|NCT01158573|20633088|P3|NOT COMPLETED|Overall Study||0
8370040|NCT01158573|20633089|P2|NOT COMPLETED|Overall Study||0
8370041|NCT01158573|20633090|P1|NOT COMPLETED|Overall Study||0
8370042|NCT01158573|20633087|P4|COMPLETED|Overall Study||28
8370043|NCT01158573|20633088|P3|COMPLETED|Overall Study||29
8370044|NCT01158573|20633089|P2|COMPLETED|Overall Study||30
8370045|NCT01158573|20633090|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
8370046|NCT01158573|20633087|P4|STARTED|Overall Study||28
8370047|NCT01158573|20633088|P3|STARTED|Overall Study||29
8370048|NCT01158573|20633089|P2|STARTED|Overall Study||30
8370049|NCT01158573|20633090|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
8370050|NCT01158534|20633112|P1|NOT COMPLETED|Overall Study||3
8370051|NCT01158534|20633112|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
8370052|NCT01158534|20633112|P1|STARTED|Overall Study||17
8370053|NCT01158521|20633120|P1|NOT COMPLETED|Overall Study||0
8370054|NCT01158521|20633120|P1|COMPLETED|Overall Study||25
8370055|NCT01158521|20633120|P1|STARTED|Overall Study||25
8370056|NCT01158404|20633137|P8|NOT COMPLETED|Overall Study||2
8370057|NCT01158404|20633138|P7|NOT COMPLETED|Overall Study||1
8370058|NCT01158404|20633139|P6|NOT COMPLETED|Overall Study||1
8370059|NCT01158404|20633140|P5|NOT COMPLETED|Overall Study||3
8370060|NCT01158404|20633141|P4|NOT COMPLETED|Overall Study||0
8370061|NCT01158404|20633142|P3|NOT COMPLETED|Overall Study||0
8370062|NCT01158404|20633143|P2|NOT COMPLETED|Overall Study||1
8370063|NCT01158404|20633144|P1|NOT COMPLETED|Overall Study||0
8370064|NCT01158404|20633137|P8|COMPLETED|Overall Study||6
8370065|NCT01158404|20633138|P7|COMPLETED|Overall Study||2
8370066|NCT01158404|20633139|P6|COMPLETED|Overall Study||4
8370067|NCT01158404|20633140|P5|COMPLETED|Overall Study||3
8370068|NCT01158404|20633141|P4|COMPLETED|Overall Study||3
8370069|NCT01158404|20633142|P3|COMPLETED|Overall Study||3
8370070|NCT01158404|20633143|P2|COMPLETED|Overall Study||3
8370071|NCT01158404|20633144|P1|COMPLETED|Overall Study||3
8370072|NCT01158404|20633137|P8|Received at Least 1 Dose of Study Drug|Overall Study||8
8370073|NCT01158404|20633138|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
8370074|NCT01158404|20633139|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
8370075|NCT01158404|20633140|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8370076|NCT01158404|20633141|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8370077|NCT01158404|20633142|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8370078|NCT01158404|20633143|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8370079|NCT01158404|20633144|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8370080|NCT01158404|20633137|P8|STARTED|Overall Study||8
8370081|NCT01158404|20633138|P7|STARTED|Overall Study||3
8370082|NCT01158404|20633139|P6|STARTED|Overall Study||5
8370083|NCT01158404|20633140|P5|STARTED|Overall Study||6
8370084|NCT01158404|20633141|P4|STARTED|Overall Study||3
8370085|NCT01158404|20633142|P3|STARTED|Overall Study||3
8370086|NCT01158404|20633143|P2|STARTED|Overall Study||4
8370087|NCT01158404|20633144|P1|STARTED|Overall Study||3
8370088|NCT01158378|20633186|P2|NOT COMPLETED|Overall Study||9
8370089|NCT01158378|20633187|P1|NOT COMPLETED|Overall Study||10
8370090|NCT01158378|20633186|P2|COMPLETED|Overall Study||117
8370091|NCT01158378|20633187|P1|COMPLETED|Overall Study||114
8370092|NCT01158378|20633186|P2|STARTED|Overall Study||126
8370093|NCT01158378|20633187|P1|STARTED|Overall Study||124
8370094|NCT01158261|20633199|P1|NOT COMPLETED|Overall Study||17
8370095|NCT01158261|20633199|P1|COMPLETED|Overall Study||283
8370096|NCT01158261|20633199|P1|STARTED|Overall Study||300
8370097|NCT01158222|20633203|P1|NOT COMPLETED|Overall Study||17
8370098|NCT01158222|20633203|P1|COMPLETED|Overall Study||20
8370099|NCT01158222|20633203|P1|STARTED|Overall Study||37
8370100|NCT01158157|20633209|P1|NOT COMPLETED|Overall Study||0
8370101|NCT01158157|20633209|P1|COMPLETED|Overall Study||25
8370102|NCT01158157|20633209|P1|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
8370103|NCT01158118|20633215|P2|NOT COMPLETED|Overall Study||3
8370104|NCT01158118|20633216|P1|NOT COMPLETED|Overall Study||1
8370105|NCT01158118|20633215|P2|COMPLETED|Overall Study||21
8370106|NCT01158118|20633216|P1|COMPLETED|Overall Study||23
8370107|NCT01158118|20633215|P2|STARTED|Overall Study||24
8370108|NCT01158118|20633216|P1|STARTED|Overall Study||24
8370109|NCT01157897|20633236|P4|NOT COMPLETED|Overall Study||1
8370110|NCT01157897|20633237|P3|NOT COMPLETED|Overall Study||0
8370111|NCT01157897|20633238|P2|NOT COMPLETED|Overall Study||2
8370112|NCT01157897|20633239|P1|NOT COMPLETED|Overall Study||2
8370113|NCT01157897|20633236|P4|COMPLETED|Overall Study||5
8370114|NCT01157897|20633237|P3|COMPLETED|Overall Study||10
8370115|NCT01157897|20633238|P2|COMPLETED|Overall Study||8
8370116|NCT01157897|20633239|P1|COMPLETED|Overall Study||8
8370117|NCT01157897|20633236|P4|STARTED|Overall Study||6
8370118|NCT01157897|20633237|P3|STARTED|Overall Study||10
8370119|NCT01157897|20633238|P2|STARTED|Overall Study||10
8370120|NCT01157897|20633239|P1|STARTED|Overall Study||10
8370121|NCT01157845|20633264|P1|NOT COMPLETED|Overall Study||35
8370122|NCT01157845|20633264|P1|COMPLETED|Overall Study||130
8370123|NCT01157845|20633264|P1|STARTED|Overall Study||165
8370124|NCT01157676|20633271|P2|NOT COMPLETED|Surgery||9
8370125|NCT01157676|20633272|P1|NOT COMPLETED|Surgery||1
8370126|NCT01157676|20633271|P2|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
8370127|NCT01157676|20633272|P1|COMPLETED|Surgery||152
8370128|NCT01157676|20633271|P2|STARTED|Surgery||159
8370129|NCT01157676|20633272|P1|STARTED|Surgery||153
8370130|NCT01157676|20633271|P2|NOT COMPLETED|Randomization||17
8370131|NCT01157676|20633272|P1|NOT COMPLETED|Randomization||21
8370132|NCT01157676|20633271|P2|COMPLETED|Randomization||159
8370133|NCT01157676|20633272|P1|COMPLETED|Randomization||153
8370134|NCT01157676|20633271|P2|STARTED|Randomization||176
8370135|NCT01157676|20633272|P1|STARTED|Randomization||174
8370136|NCT01157676|20633271|P2|NOT COMPLETED|Enrollment||0
8370137|NCT01157676|20633272|P1|NOT COMPLETED|Enrollment||0
8370138|NCT01157676|20633271|P2|COMPLETED|Enrollment||176
8370139|NCT01157676|20633272|P1|COMPLETED|Enrollment||174
8370140|NCT01157676|20633271|P2|STARTED|Enrollment||176
8370141|NCT01157676|20633272|P1|STARTED|Enrollment||174
8370142|NCT01157533|20633318|P1|NOT COMPLETED|Overall Study||0
8370143|NCT01157533|20633318|P1|COMPLETED|Overall Study||1
8370144|NCT01157533|20633318|P1|STARTED|Overall Study||1
8370145|NCT01157429|20633324|P2|NOT COMPLETED|Overall Study||4
8370146|NCT01157429|20633325|P1|NOT COMPLETED|Overall Study||4
8370147|NCT01157429|20633324|P2|COMPLETED|Overall Study||8
8370148|NCT01157429|20633325|P1|COMPLETED|Overall Study||8
8370149|NCT01157429|20633324|P2|STARTED|Overall Study||12
8370150|NCT01157429|20633325|P1|STARTED|Overall Study||12
8370151|NCT01157416|20633333|P2|NOT COMPLETED|Overall Study||0
8370152|NCT01157416|20633334|P1|NOT COMPLETED|Overall Study||2
8370153|NCT01157416|20633333|P2|COMPLETED|Overall Study||16
8370154|NCT01157416|20633334|P1|COMPLETED|Overall Study||15
8370155|NCT01157416|20633333|P2|STARTED|Overall Study||16
8370156|NCT01157416|20633334|P1|STARTED|Overall Study||17
8370157|NCT01157377|20633347|P7|NOT COMPLETED|Overall Study||2
8370158|NCT01157377|20633348|P6|NOT COMPLETED|Overall Study||3
8370159|NCT01157377|20633349|P5|NOT COMPLETED|Overall Study||2
8370160|NCT01157377|20633350|P4|NOT COMPLETED|Overall Study||1
8370161|NCT01157377|20633351|P3|NOT COMPLETED|Overall Study||1
8370162|NCT01157377|20633352|P2|NOT COMPLETED|Overall Study||3
8370163|NCT01157377|20633353|P1|NOT COMPLETED|Overall Study||2
8370164|NCT01157377|20633347|P7|COMPLETED|Overall Study||27
8370165|NCT01157377|20633348|P6|COMPLETED|Overall Study||16
8370166|NCT01157377|20633349|P5|COMPLETED|Overall Study||18
8370167|NCT01157377|20633350|P4|COMPLETED|Overall Study||14
8370168|NCT01157377|20633351|P3|COMPLETED|Overall Study||26
8370169|NCT01157377|20633352|P2|COMPLETED|Overall Study||20
8370170|NCT01157377|20633353|P1|COMPLETED|Overall Study||21
8370171|NCT01157377|20633347|P7|STARTED|Overall Study||29
8370172|NCT01157377|20633348|P6|STARTED|Overall Study||19
8370173|NCT01157377|20633349|P5|STARTED|Overall Study||20
8370174|NCT01157377|20633350|P4|STARTED|Overall Study||15
8370175|NCT01157377|20633351|P3|STARTED|Overall Study||27
8370176|NCT01157377|20633352|P2|STARTED|Overall Study||23
8370177|NCT01157377|20633353|P1|STARTED|Overall Study||23
8370178|NCT01157364|20633375|P6|NOT COMPLETED|Overall Study||1
8370179|NCT01157364|20633376|P5|NOT COMPLETED|Overall Study||2
8370180|NCT01157364|20633377|P4|NOT COMPLETED|Overall Study||2
8370181|NCT01157364|20633378|P3|NOT COMPLETED|Overall Study||4
8370182|NCT01157364|20633379|P2|NOT COMPLETED|Overall Study||4
8370183|NCT01157364|20633380|P1|NOT COMPLETED|Overall Study||2
8370184|NCT01157364|20633375|P6|COMPLETED|Overall Study||22
8370185|NCT01157364|20633376|P5|COMPLETED|Overall Study||9
8370186|NCT01157364|20633377|P4|COMPLETED|Overall Study||16
8370187|NCT01157364|20633378|P3|COMPLETED|Overall Study||17
8370188|NCT01157364|20633379|P2|COMPLETED|Overall Study||17
8370189|NCT01157364|20633380|P1|COMPLETED|Overall Study||13
8370190|NCT01157364|20633375|P6|STARTED|Overall Study||23
8370191|NCT01157364|20633376|P5|STARTED|Overall Study||11
8370192|NCT01157364|20633377|P4|STARTED|Overall Study||18
8370193|NCT01157364|20633378|P3|STARTED|Overall Study||21
8370194|NCT01157364|20633379|P2|STARTED|Overall Study||21
8370195|NCT01157364|20633380|P1|STARTED|Overall Study||15
8370196|NCT01157351|20633414|P2|NOT COMPLETED|Overall Study||132
8370197|NCT01157351|20633415|P1|NOT COMPLETED|Overall Study||137
8370198|NCT01157351|20633414|P2|COMPLETED|Overall Study||88
8370199|NCT01157351|20633415|P1|COMPLETED|Overall Study||93
8370200|NCT01157351|20633414|P2|Treated|Overall Study||218
8370201|NCT01157351|20633415|P1|Treated|Overall Study||226
8370202|NCT01157351|20633414|P2|STARTED|Overall Study||220
8370203|NCT01157351|20633415|P1|STARTED|Overall Study||230
8370204|NCT01157234|20633433|P2|NOT COMPLETED|Overall Study||0
8370205|NCT01157234|20633434|P1|NOT COMPLETED|Overall Study||1
8370206|NCT01157234|20633433|P2|COMPLETED|Overall Study||15
8370207|NCT01157234|20633434|P1|COMPLETED|Overall Study||14
8370208|NCT01157234|20633433|P2|STARTED|Overall Study||15
8370209|NCT01157234|20633434|P1|STARTED|Overall Study||15
8370210|NCT01157182|20633466|P2|NOT COMPLETED|Second Intervention||0
8370211|NCT01157182|20633467|P1|NOT COMPLETED|Second Intervention||0
8370212|NCT01157182|20633466|P2|COMPLETED|Second Intervention||18
8370213|NCT01157182|20633467|P1|COMPLETED|Second Intervention||16
8370214|NCT01157182|20633466|P2|STARTED|Second Intervention||18
8370215|NCT01157182|20633467|P1|STARTED|Second Intervention||16
8370216|NCT01157182|20633466|P2|NOT COMPLETED|Washout of 28 Days||0
8370217|NCT01157182|20633467|P1|NOT COMPLETED|Washout of 28 Days||2
8370218|NCT01157182|20633466|P2|COMPLETED|Washout of 28 Days||18
8370219|NCT01157182|20633467|P1|COMPLETED|Washout of 28 Days||16
8370220|NCT01157182|20633466|P2|STARTED|Washout of 28 Days||18
8370221|NCT01157182|20633467|P1|STARTED|Washout of 28 Days||18
8370222|NCT01157182|20633466|P2|NOT COMPLETED|First Intervention||0
8370223|NCT01157182|20633467|P1|NOT COMPLETED|First Intervention||0
8370224|NCT01157182|20633466|P2|COMPLETED|First Intervention||18
8370225|NCT01157182|20633467|P1|COMPLETED|First Intervention||18
8370226|NCT01157182|20633466|P2|STARTED|First Intervention||18
8370227|NCT01157182|20633467|P1|STARTED|First Intervention||18
8370228|NCT01157169|20633515|P2|NOT COMPLETED|Second Intervention||1
8370229|NCT01157169|20633516|P1|NOT COMPLETED|Second Intervention||0
8370230|NCT01157169|20633515|P2|COMPLETED|Second Intervention||17
8370231|NCT01157169|20633516|P1|COMPLETED|Second Intervention||16
8370232|NCT01157169|20633515|P2|STARTED|Second Intervention||18
8370233|NCT01157169|20633516|P1|STARTED|Second Intervention||16
8370234|NCT01157169|20633515|P2|NOT COMPLETED|Washout of 10 Days||0
8370235|NCT01157169|20633516|P1|NOT COMPLETED|Washout of 10 Days||0
8370236|NCT01157169|20633515|P2|COMPLETED|Washout of 10 Days||18
8370237|NCT01157169|20633516|P1|COMPLETED|Washout of 10 Days||16
8370238|NCT01157169|20633515|P2|STARTED|Washout of 10 Days||18
8370239|NCT01157169|20633516|P1|STARTED|Washout of 10 Days||16
8370240|NCT01157169|20633515|P2|NOT COMPLETED|First Intervention||2
8370241|NCT01157169|20633516|P1|NOT COMPLETED|First Intervention||4
8370242|NCT01157169|20633515|P2|COMPLETED|First Intervention||18
8370243|NCT01157169|20633516|P1|COMPLETED|First Intervention||16
8370244|NCT01157169|20633515|P2|STARTED|First Intervention||20
8370245|NCT01157169|20633516|P1|STARTED|First Intervention||20
8370246|NCT01157117|20633535|P3|NOT COMPLETED|Overall Study||15
8370247|NCT01157117|20633536|P2|NOT COMPLETED|Overall Study||11
8370248|NCT01157117|20633537|P1|NOT COMPLETED|Overall Study||9
8370249|NCT01157117|20633535|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
8370250|NCT01157117|20633536|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
8370251|NCT01157117|20633537|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
8370252|NCT01157117|20633535|P3|Completed Final Month 38 Study Visit|Overall Study||3
8370253|NCT01157117|20633536|P2|Completed Final Month 38 Study Visit|Overall Study||18
8370254|NCT01157117|20633537|P1|Completed Final Month 38 Study Visit|Overall Study||19
8370255|NCT01157117|20633535|P3|Completed Month 32 Tolerance OFC|Overall Study||0
8370256|NCT01157117|20633536|P2|Completed Month 32 Tolerance OFC|Overall Study||20
8370257|NCT01157117|20633537|P1|Completed Month 32 Tolerance OFC|Overall Study||24
8370258|NCT01157117|20633535|P3|Discontinued Milk OIT at Month 30|Overall Study||0
8370259|NCT01157117|20633536|P2|Discontinued Milk OIT at Month 30|Overall Study||20
8370260|NCT01157117|20633537|P1|Discontinued Milk OIT at Month 30|Overall Study||24
8370261|NCT01157117|20633535|P3|Completed Month 28 Desensitization OFC|Overall Study||0
8370262|NCT01157117|20633536|P2|Completed Month 28 Desensitization OFC|Overall Study||24
8370263|NCT01157117|20633537|P1|Completed Month 28 Desensitization OFC|Overall Study||26
8370264|NCT01157117|20633535|P3|Unblinded at Month 16|Overall Study||0
8370265|NCT01157117|20633536|P2|Unblinded at Month 16|Overall Study||26
8370266|NCT01157117|20633537|P1|Unblinded at Month 16|Overall Study||26
8370267|NCT01157117|20633535|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
8370268|NCT01157117|20633536|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
8370269|NCT01157117|20633537|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
8370270|NCT01157117|20633535|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
8370271|NCT01157117|20633536|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
8370272|NCT01157117|20633537|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
8370273|NCT01157117|20633535|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
8370274|NCT01157117|20633536|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
8370275|NCT01157117|20633537|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
8370276|NCT01157117|20633535|P3|STARTED|Overall Study||20
8370277|NCT01157117|20633536|P2|STARTED|Overall Study||29
8370278|NCT01157117|20633537|P1|STARTED|Overall Study||28
8370279|NCT01157078|20633578|P2|NOT COMPLETED|Overall Study||36
8370280|NCT01157078|20633579|P1|NOT COMPLETED|Overall Study||35
8370281|NCT01157078|20633578|P2|COMPLETED|Overall Study||124
8370282|NCT01157078|20633579|P1|COMPLETED|Overall Study||124
8370283|NCT01157078|20633578|P2|Received Treatment|Overall Study||159
8370284|NCT01157078|20633579|P1|Received Treatment|Overall Study||157
8370285|NCT01157078|20633578|P2|STARTED|Overall Study||160
8370286|NCT01157078|20633579|P1|STARTED|Overall Study||159
8370287|NCT01157065|20633629|P2|NOT COMPLETED|Overall Study||1
8370288|NCT01157065|20633630|P1|NOT COMPLETED|Overall Study||0
8370289|NCT01157065|20633629|P2|COMPLETED|Overall Study||10
8370290|NCT01157065|20633630|P1|COMPLETED|Overall Study||38
8370291|NCT01157065|20633629|P2|STARTED|Overall Study||11
8370292|NCT01157065|20633630|P1|STARTED|Overall Study||38
8370293|NCT01156987|20633640|P2|NOT COMPLETED|Overall Study||11
8370294|NCT01156987|20633641|P1|NOT COMPLETED|Overall Study||0
8370295|NCT01156987|20633640|P2|COMPLETED|Overall Study||12
8370296|NCT01156987|20633641|P1|COMPLETED|Overall Study||8
8370297|NCT01156987|20633640|P2|STARTED|Overall Study||23
8370298|NCT01156987|20633641|P1|STARTED|Overall Study||8
8370299|NCT01156844|20633651|P4|NOT COMPLETED|Overall Study||6
8370300|NCT01156844|20633652|P3|NOT COMPLETED|Overall Study||6
8370301|NCT01156844|20633653|P2|NOT COMPLETED|Overall Study||2
8370302|NCT01156844|20633654|P1|NOT COMPLETED|Overall Study||2
8370303|NCT01156844|20633651|P4|COMPLETED|Overall Study||41
8370304|NCT01156844|20633652|P3|COMPLETED|Overall Study||42
8370305|NCT01156844|20633653|P2|COMPLETED|Overall Study||46
8370306|NCT01156844|20633654|P1|COMPLETED|Overall Study||46
8370307|NCT01156844|20633651|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
8370308|NCT01156844|20633652|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
8370309|NCT01156844|20633653|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
8370310|NCT01156844|20633654|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
8370311|NCT01156844|20633651|P4|STARTED|Overall Study||47
8370312|NCT01156844|20633652|P3|STARTED|Overall Study||48
8370313|NCT01156844|20633653|P2|STARTED|Overall Study||48
8370314|NCT01156844|20633654|P1|STARTED|Overall Study|Randomized participants.|48
8370315|NCT01156805|20633675|P2|NOT COMPLETED|Overall Study||56
8370316|NCT01156805|20633676|P1|NOT COMPLETED|Overall Study||56
8370317|NCT01156805|20633675|P2|COMPLETED|Overall Study||216
8370318|NCT01156805|20633676|P1|COMPLETED|Overall Study||181
8370319|NCT01156805|20633675|P2|STARTED|Overall Study||272
8370320|NCT01156805|20633676|P1|STARTED|Overall Study||237
8370321|NCT01156792|20633688|P1|NOT COMPLETED|Overall Study||69
8370322|NCT01156792|20633688|P1|COMPLETED|Overall Study||93
8370323|NCT01156792|20633688|P1|STARTED|Overall Study||162
8370324|NCT01156714|20633756|P3|NOT COMPLETED|Overall Study||3
8370325|NCT01156714|20633757|P2|NOT COMPLETED|Overall Study||4
8370326|NCT01156714|20633758|P1|NOT COMPLETED|Overall Study||9
8370327|NCT01156714|20633756|P3|COMPLETED|Overall Study||17
8370328|NCT01156714|20633757|P2|COMPLETED|Overall Study||15
8370329|NCT01156714|20633758|P1|COMPLETED|Overall Study||11
8370330|NCT01156714|20633756|P3|STARTED|Overall Study||20
8370331|NCT01156714|20633757|P2|STARTED|Overall Study||19
8370332|NCT01156714|20633758|P1|STARTED|Overall Study||20
8370333|NCT01156701|20633781|P4|NOT COMPLETED|Overall Study||0
8370334|NCT01156701|20633782|P3|NOT COMPLETED|Overall Study||0
8370335|NCT01156701|20633783|P2|NOT COMPLETED|Overall Study||0
8370336|NCT01156701|20633784|P1|NOT COMPLETED|Overall Study||0
8370337|NCT01156701|20633781|P4|COMPLETED|Overall Study||6725
8370338|NCT01156701|20633782|P3|COMPLETED|Overall Study||163716
8370339|NCT01156701|20633783|P2|COMPLETED|Overall Study||1007
8370340|NCT01156701|20633784|P1|COMPLETED|Overall Study||257
8370341|NCT01156701|20633781|P4|STARTED|Overall Study||6725
8370342|NCT01156701|20633782|P3|STARTED|Overall Study||163716
8370343|NCT01156701|20633783|P2|STARTED|Overall Study||1007
8370344|NCT01156701|20633784|P1|STARTED|Overall Study||257
8370345|NCT01156675|20633821|P3|NOT COMPLETED|Overall Study||2
8370346|NCT01156675|20633822|P2|NOT COMPLETED|Overall Study||25
8370347|NCT01156675|20633823|P1|NOT COMPLETED|Overall Study||34
8370348|NCT01156675|20633821|P3|COMPLETED|Overall Study||0
8370349|NCT01156675|20633822|P2|COMPLETED|Overall Study||81
8370350|NCT01156675|20633823|P1|COMPLETED|Overall Study||73
8370351|NCT01156675|20633821|P3|STARTED|Overall Study||2
8370352|NCT01156675|20633822|P2|STARTED|Overall Study||106
8370353|NCT01156675|20633823|P1|STARTED|Overall Study||107
8370354|NCT01156597|20633857|P2|NOT COMPLETED|Overall Study||1
8370355|NCT01156597|20633858|P1|NOT COMPLETED|Overall Study||3
8370356|NCT01156597|20633857|P2|COMPLETED|Overall Study||13
8370357|NCT01156597|20633858|P1|COMPLETED|Overall Study||13
8370358|NCT01156597|20633857|P2|STARTED|Overall Study||14
8370359|NCT01156597|20633858|P1|STARTED|Overall Study||16
8370360|NCT01156571|20633870|P2|NOT COMPLETED|Overall Study||19
8370361|NCT01156571|20633871|P1|NOT COMPLETED|Overall Study||17
8370449|NCT01155869|20634262|P2|STARTED|Overall Study||4
8370362|NCT01156571|20633870|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
8370363|NCT01156571|20633871|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
8370364|NCT01156571|20633870|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
8370365|NCT01156571|20633871|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
8370366|NCT01156532|20633881|P1|NOT COMPLETED|Overall Study||2
8370367|NCT01156532|20633881|P1|COMPLETED|Overall Study||28
8370368|NCT01156532|20633881|P1|STARTED|Overall Study||30
8370369|NCT01156480|20633893|P2|NOT COMPLETED|Overall Study||1
8370370|NCT01156480|20633894|P1|NOT COMPLETED|Overall Study||0
8370371|NCT01156480|20633893|P2|COMPLETED|Overall Study||1
8370372|NCT01156480|20633894|P1|COMPLETED|Overall Study||0
8370373|NCT01156480|20633893|P2|STARTED|Overall Study||2
8370374|NCT01156480|20633894|P1|STARTED|Overall Study||0
8370375|NCT01156376|20633923|P3|NOT COMPLETED|Overall Study||4
8370376|NCT01156376|20633924|P2|NOT COMPLETED|Overall Study||0
8370377|NCT01156376|20633925|P1|NOT COMPLETED|Overall Study||1
8370378|NCT01156376|20633923|P3|COMPLETED|Overall Study||23
8370379|NCT01156376|20633924|P2|COMPLETED|Overall Study||26
8370380|NCT01156376|20633925|P1|COMPLETED|Overall Study||26
8370381|NCT01156376|20633923|P3|STARTED|Overall Study||27
8370382|NCT01156376|20633924|P2|STARTED|Overall Study||26
8370383|NCT01156376|20633925|P1|STARTED|Overall Study||27
8370384|NCT01156363|20634146|P1|NOT COMPLETED|Overall Study||22
8370385|NCT01156363|20634146|P1|COMPLETED|Overall Study||64
8370386|NCT01156363|20634146|P1|STARTED|Overall Study||86
8370387|NCT01156311|20634168|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
8370388|NCT01156311|20634169|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
8370389|NCT01156311|20634170|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
8370390|NCT01156311|20634171|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
8370391|NCT01156311|20634168|P4|COMPLETED|6-month Add-on Therapy Period||37
8370392|NCT01156311|20634169|P3|COMPLETED|6-month Add-on Therapy Period||45
8370393|NCT01156311|20634170|P2|COMPLETED|6-month Add-on Therapy Period||0
8370394|NCT01156311|20634171|P1|COMPLETED|6-month Add-on Therapy Period||0
8370395|NCT01156311|20634168|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
8370396|NCT01156311|20634169|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
8370397|NCT01156311|20634170|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
8370398|NCT01156311|20634171|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
8370399|NCT01156311|20634168|P4|STARTED|6-month Add-on Therapy Period||47
8370400|NCT01156311|20634169|P3|STARTED|6-month Add-on Therapy Period||57
8370401|NCT01156311|20634170|P2|STARTED|6-month Add-on Therapy Period||0
8370402|NCT01156311|20634171|P1|STARTED|6-month Add-on Therapy Period||0
8370403|NCT01156311|20634168|P4|NOT COMPLETED|2-Month Monotherapy Period||0
8370404|NCT01156311|20634169|P3|NOT COMPLETED|2-Month Monotherapy Period||0
8370405|NCT01156311|20634170|P2|NOT COMPLETED|2-Month Monotherapy Period||2
8370406|NCT01156311|20634171|P1|NOT COMPLETED|2-Month Monotherapy Period||2
8370407|NCT01156311|20634168|P4|COMPLETED|2-Month Monotherapy Period||0
8370408|NCT01156311|20634169|P3|COMPLETED|2-Month Monotherapy Period||0
8370409|NCT01156311|20634170|P2|COMPLETED|2-Month Monotherapy Period||47
8370410|NCT01156311|20634171|P1|COMPLETED|2-Month Monotherapy Period||57
8370411|NCT01156311|20634168|P4|STARTED|2-Month Monotherapy Period||0
8370412|NCT01156311|20634169|P3|STARTED|2-Month Monotherapy Period||0
8370413|NCT01156311|20634170|P2|STARTED|2-Month Monotherapy Period||49
8370414|NCT01156311|20634171|P1|STARTED|2-Month Monotherapy Period||59
8370415|NCT01156142|20634195|P2|NOT COMPLETED|Overall Study||7
8370416|NCT01156142|20634196|P1|NOT COMPLETED|Overall Study||8
8370417|NCT01156142|20634195|P2|COMPLETED|Overall Study||71
8370418|NCT01156142|20634196|P1|COMPLETED|Overall Study||69
8370419|NCT01156142|20634195|P2|STARTED|Overall Study||78
8370420|NCT01156142|20634196|P1|STARTED|Overall Study||77
8370421|NCT01156116|20634214|P2|NOT COMPLETED|Overall Study||1
8370422|NCT01156116|20634215|P1|NOT COMPLETED|Overall Study||5
8370423|NCT01156116|20634214|P2|COMPLETED|Overall Study||12
8370424|NCT01156116|20634215|P1|COMPLETED|Overall Study||21
8370425|NCT01156116|20634214|P2|STARTED|Overall Study||13
8370426|NCT01156116|20634215|P1|STARTED|Overall Study||26
8370427|NCT01156051|20634229|P2|NOT COMPLETED|Overall Study||1
8370428|NCT01156051|20634230|P1|NOT COMPLETED|Overall Study||1
8370429|NCT01156051|20634229|P2|COMPLETED|Overall Study||16
8370430|NCT01156051|20634230|P1|COMPLETED|Overall Study||11
8370431|NCT01156051|20634229|P2|STARTED|Overall Study||17
8370432|NCT01156051|20634230|P1|STARTED|Overall Study||12
8370433|NCT01156012|20634244|P2|NOT COMPLETED|Overall Study||3
8370434|NCT01156012|20634245|P1|NOT COMPLETED|Overall Study||7
8370435|NCT01156012|20634244|P2|COMPLETED|Overall Study||186
8370436|NCT01156012|20634245|P1|COMPLETED|Overall Study||206
8370437|NCT01156012|20634244|P2|STARTED|Overall Study||189
8370438|NCT01156012|20634245|P1|STARTED|Overall Study||213
8370439|NCT01155999|20634253|P2|NOT COMPLETED|Overall Study||4
8370440|NCT01155999|20634254|P1|NOT COMPLETED|Overall Study||7
8370441|NCT01155999|20634253|P2|COMPLETED|Overall Study||136
8370442|NCT01155999|20634254|P1|COMPLETED|Overall Study||139
8370443|NCT01155999|20634253|P2|STARTED|Overall Study||140
8370444|NCT01155999|20634254|P1|STARTED|Overall Study||146
8370445|NCT01155869|20634262|P2|NOT COMPLETED|Overall Study||1
8370446|NCT01155869|20634263|P1|NOT COMPLETED|Overall Study||3
8370447|NCT01155869|20634262|P2|COMPLETED|Overall Study||3
8370448|NCT01155869|20634263|P1|COMPLETED|Overall Study||0
8370450|NCT01155869|20634263|P1|STARTED|Overall Study||3
8370451|NCT01155830|20634274|P3|NOT COMPLETED|Overall Study||0
8370452|NCT01155830|20634275|P2|NOT COMPLETED|Overall Study||0
8370453|NCT01155830|20634276|P1|NOT COMPLETED|Overall Study||0
8370454|NCT01155830|20634274|P3|COMPLETED|Overall Study||21
8370455|NCT01155830|20634275|P2|COMPLETED|Overall Study||0
8370456|NCT01155830|20634276|P1|COMPLETED|Overall Study||0
8370457|NCT01155830|20634274|P3|STARTED|Overall Study||21
8370458|NCT01155830|20634275|P2|STARTED|Overall Study||0
8370459|NCT01155830|20634276|P1|STARTED|Overall Study||0
8370460|NCT01155778|20634290|P3|NOT COMPLETED|Overall Study||0
8370461|NCT01155778|20634291|P2|NOT COMPLETED|Overall Study||0
8370462|NCT01155778|20634292|P1|NOT COMPLETED|Overall Study||0
8370463|NCT01155778|20634290|P3|COMPLETED|Overall Study||4
8370464|NCT01155778|20634291|P2|COMPLETED|Overall Study||4
8370465|NCT01155778|20634292|P1|COMPLETED|Overall Study||4
8370466|NCT01155778|20634290|P3|STARTED|Overall Study||4
8370467|NCT01155778|20634291|P2|STARTED|Overall Study||4
8370468|NCT01155778|20634292|P1|STARTED|Overall Study||4
8370469|NCT01155726|20634372|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370470|NCT01155726|20634373|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370471|NCT01155726|20634374|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370472|NCT01155726|20634375|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370473|NCT01155726|20634372|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
8370474|NCT01155726|20634373|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
8370475|NCT01155726|20634374|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
8370476|NCT01155726|20634375|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
8370477|NCT01155726|20634372|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
8370478|NCT01155726|20634373|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
8370479|NCT01155726|20634374|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
8370480|NCT01155726|20634375|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
8370481|NCT01155726|20634372|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
8370482|NCT01155726|20634373|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
8370483|NCT01155726|20634374|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
8370484|NCT01155726|20634375|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
8370485|NCT01155726|20634372|P4|COMPLETED|Period 1, 3 Days (Masked)||25
8370486|NCT01155726|20634373|P3|COMPLETED|Period 1, 3 Days (Masked)||28
8370487|NCT01155726|20634374|P2|COMPLETED|Period 1, 3 Days (Masked)||20
8370488|NCT01155726|20634375|P1|COMPLETED|Period 1, 3 Days (Masked)||23
8370489|NCT01155726|20634372|P4|STARTED|Period 1, 3 Days (Masked)||25
8370490|NCT01155726|20634373|P3|STARTED|Period 1, 3 Days (Masked)||30
8370491|NCT01155726|20634374|P2|STARTED|Period 1, 3 Days (Masked)||20
8370492|NCT01155726|20634375|P1|STARTED|Period 1, 3 Days (Masked)||24
8370493|NCT01155661|20634397|P1|NOT COMPLETED|Overall Study||280
8370494|NCT01155661|20634397|P1|COMPLETED|Overall Study||328
8370495|NCT01155661|20634397|P1|STARTED|Overall Study||608
8370496|NCT01155583|20634432|P9|NOT COMPLETED|Phase II - Expansion Phase||0
8370497|NCT01155583|20634433|P8|NOT COMPLETED|Phase II - Expansion Phase||0
8370498|NCT01155583|20634434|P7|NOT COMPLETED|Phase II - Expansion Phase||0
8370499|NCT01155583|20634435|P6|NOT COMPLETED|Phase II - Expansion Phase||0
8370500|NCT01155583|20634436|P5|NOT COMPLETED|Phase II - Expansion Phase||0
8370501|NCT01155583|20634437|P4|NOT COMPLETED|Phase II - Expansion Phase||0
8370502|NCT01155583|20634438|P3|NOT COMPLETED|Phase II - Expansion Phase||0
8370503|NCT01155583|20634439|P2|NOT COMPLETED|Phase II - Expansion Phase||0
8370504|NCT01155583|20634440|P1|NOT COMPLETED|Phase II - Expansion Phase||0
8370505|NCT01155583|20634432|P9|COMPLETED|Phase II - Expansion Phase||11
8370506|NCT01155583|20634433|P8|COMPLETED|Phase II - Expansion Phase||0
8370507|NCT01155583|20634434|P7|COMPLETED|Phase II - Expansion Phase||0
8370508|NCT01155583|20634435|P6|COMPLETED|Phase II - Expansion Phase||0
8370509|NCT01155583|20634436|P5|COMPLETED|Phase II - Expansion Phase||0
8370510|NCT01155583|20634437|P4|COMPLETED|Phase II - Expansion Phase||0
8370511|NCT01155583|20634438|P3|COMPLETED|Phase II - Expansion Phase||0
8370512|NCT01155583|20634439|P2|COMPLETED|Phase II - Expansion Phase||0
8370513|NCT01155583|20634440|P1|COMPLETED|Phase II - Expansion Phase||0
8370514|NCT01155583|20634432|P9|STARTED|Phase II - Expansion Phase||11
8370515|NCT01155583|20634433|P8|STARTED|Phase II - Expansion Phase||0
8370516|NCT01155583|20634434|P7|STARTED|Phase II - Expansion Phase||0
8370517|NCT01155583|20634435|P6|STARTED|Phase II - Expansion Phase||0
8370518|NCT01155583|20634436|P5|STARTED|Phase II - Expansion Phase||0
8370519|NCT01155583|20634437|P4|STARTED|Phase II - Expansion Phase||0
8370520|NCT01155583|20634438|P3|STARTED|Phase II - Expansion Phase||0
8370521|NCT01155583|20634439|P2|STARTED|Phase II - Expansion Phase||0
8370522|NCT01155583|20634440|P1|STARTED|Phase II - Expansion Phase||0
8370523|NCT01155583|20634432|P9|NOT COMPLETED|Phase I||0
8370524|NCT01155583|20634433|P8|NOT COMPLETED|Phase I||3
8370525|NCT01155583|20634434|P7|NOT COMPLETED|Phase I||0
8370526|NCT01155583|20634435|P6|NOT COMPLETED|Phase I||0
8370527|NCT01155583|20634436|P5|NOT COMPLETED|Phase I||1
8370528|NCT01155583|20634437|P4|NOT COMPLETED|Phase I||0
8370529|NCT01155583|20634438|P3|NOT COMPLETED|Phase I||0
8370530|NCT01155583|20634439|P2|NOT COMPLETED|Phase I||0
8370531|NCT01155583|20634440|P1|NOT COMPLETED|Phase I||0
8370532|NCT01155583|20634432|P9|COMPLETED|Phase I||0
8370533|NCT01155583|20634433|P8|COMPLETED|Phase I||5
8370534|NCT01155583|20634434|P7|COMPLETED|Phase I||3
8370535|NCT01155583|20634435|P6|COMPLETED|Phase I||0
8370536|NCT01155583|20634436|P5|COMPLETED|Phase I||6
8370537|NCT01155583|20634437|P4|COMPLETED|Phase I||6
8370538|NCT01155583|20634438|P3|COMPLETED|Phase I||4
8370539|NCT01155583|20634439|P2|COMPLETED|Phase I||3
8370540|NCT01155583|20634440|P1|COMPLETED|Phase I||3
8370541|NCT01155583|20634432|P9|STARTED|Phase I||0
8370542|NCT01155583|20634433|P8|STARTED|Phase I||8
8370543|NCT01155583|20634434|P7|STARTED|Phase I||3
8370544|NCT01155583|20634435|P6|STARTED|Phase I||0
8370545|NCT01155583|20634436|P5|STARTED|Phase I||7
8370546|NCT01155583|20634437|P4|STARTED|Phase I||6
8370547|NCT01155583|20634438|P3|STARTED|Phase I||4
8370548|NCT01155583|20634439|P2|STARTED|Phase I||3
8370549|NCT01155583|20634440|P1|STARTED|Phase I||3
8370550|NCT01155570|20634459|P1|NOT COMPLETED|Overall Study||142
8370551|NCT01155570|20634459|P1|COMPLETED|Overall Study||592
8370552|NCT01155570|20634459|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
8370553|NCT01155570|20634459|P1|STARTED|Overall Study|Safety Analysis Population|734
8370554|NCT01155531|20634493|P4|NOT COMPLETED|Overall Study||1
8370555|NCT01155531|20634494|P3|NOT COMPLETED|Overall Study||2
8370556|NCT01155531|20634495|P2|NOT COMPLETED|Overall Study||0
8370557|NCT01155531|20634496|P1|NOT COMPLETED|Overall Study||1
8370558|NCT01155531|20634493|P4|COMPLETED|Overall Study||9
8370559|NCT01155531|20634494|P3|COMPLETED|Overall Study||8
8370560|NCT01155531|20634495|P2|COMPLETED|Overall Study||10
8370561|NCT01155531|20634496|P1|COMPLETED|Overall Study||9
8370562|NCT01155531|20634493|P4|STARTED|Overall Study||10
8370563|NCT01155531|20634494|P3|STARTED|Overall Study||10
8370564|NCT01155531|20634495|P2|STARTED|Overall Study||10
8370565|NCT01155531|20634496|P1|STARTED|Overall Study||10
8370566|NCT01155518|20634520|P6|NOT COMPLETED|Overall Study||0
8370567|NCT01155518|20634521|P5|NOT COMPLETED|Overall Study||0
8370568|NCT01155518|20634522|P4|NOT COMPLETED|Overall Study||0
8370569|NCT01155518|20634523|P3|NOT COMPLETED|Overall Study||0
8370570|NCT01155518|20634524|P2|NOT COMPLETED|Overall Study||1
8370571|NCT01155518|20634525|P1|NOT COMPLETED|Overall Study||0
8370572|NCT01155518|20634520|P6|COMPLETED|Overall Study||2
8370573|NCT01155518|20634521|P5|COMPLETED|Overall Study||1
8370574|NCT01155518|20634522|P4|COMPLETED|Overall Study||0
8370575|NCT01155518|20634523|P3|COMPLETED|Overall Study||0
8370576|NCT01155518|20634524|P2|COMPLETED|Overall Study|never started the study|0
8370577|NCT01155518|20634525|P1|COMPLETED|Overall Study||1
8370578|NCT01155518|20634520|P6|STARTED|Overall Study||2
8370579|NCT01155518|20634521|P5|STARTED|Overall Study||1
8370580|NCT01155518|20634522|P4|STARTED|Overall Study||0
8370581|NCT01155518|20634523|P3|STARTED|Overall Study||0
8370582|NCT01155518|20634524|P2|STARTED|Overall Study||1
8370583|NCT01155518|20634525|P1|STARTED|Overall Study||1
8370584|NCT01155479|20634544|P5|NOT COMPLETED|Part II||55
8370585|NCT01155479|20634545|P4|NOT COMPLETED|Part II||50
8370586|NCT01155479|20634546|P3|NOT COMPLETED|Part II||58
8370587|NCT01155479|20634547|P2|NOT COMPLETED|Part II||61
8370588|NCT01155479|20634548|P1|NOT COMPLETED|Part II||59
8370589|NCT01155479|20634544|P5|COMPLETED|Part II||126
8370590|NCT01155479|20634545|P4|COMPLETED|Part II||127
8370591|NCT01155479|20634546|P3|COMPLETED|Part II||109
8370592|NCT01155479|20634547|P2|COMPLETED|Part II||116
8370593|NCT01155479|20634548|P1|COMPLETED|Part II||107
8370594|NCT01155479|20634544|P5|STARTED|Part II||181
8370595|NCT01155479|20634545|P4|STARTED|Part II||177
8370596|NCT01155479|20634546|P3|STARTED|Part II||167
8370597|NCT01155479|20634547|P2|STARTED|Part II||177
8370598|NCT01155479|20634548|P1|STARTED|Part II||166
8370599|NCT01155479|20634544|P5|NOT COMPLETED|Part I||23
8370600|NCT01155479|20634545|P4|NOT COMPLETED|Part I||27
8370601|NCT01155479|20634546|P3|NOT COMPLETED|Part I||39
8370602|NCT01155479|20634547|P2|NOT COMPLETED|Part I||27
8370603|NCT01155479|20634548|P1|NOT COMPLETED|Part I||38
8370604|NCT01155479|20634544|P5|COMPLETED|Part I||181
8370605|NCT01155479|20634545|P4|COMPLETED|Part I||177
8370606|NCT01155479|20634546|P3|COMPLETED|Part I||167
8370607|NCT01155479|20634547|P2|COMPLETED|Part I||177
8370608|NCT01155479|20634548|P1|COMPLETED|Part I||166
8370609|NCT01155479|20634544|P5|Treated|Part I||203
8370610|NCT01155479|20634545|P4|Treated|Part I||198
8370611|NCT01155479|20634546|P3|Treated|Part I||204
8370612|NCT01155479|20634547|P2|Treated|Part I||202
8370613|NCT01155479|20634548|P1|Treated|Part I||200
8370614|NCT01155479|20634544|P5|STARTED|Part I||204
8370615|NCT01155479|20634545|P4|STARTED|Part I||204
8370616|NCT01155479|20634546|P3|STARTED|Part I||206
8370617|NCT01155479|20634547|P2|STARTED|Part I||204
8370618|NCT01155479|20634548|P1|STARTED|Part I||204
8370619|NCT01155466|20634600|P5|NOT COMPLETED|Overall Study||27
8370620|NCT01155466|20634601|P4|NOT COMPLETED|Overall Study||21
8370621|NCT01155466|20634602|P3|NOT COMPLETED|Overall Study||20
8370622|NCT01155466|20634603|P2|NOT COMPLETED|Overall Study||25
8370623|NCT01155466|20634604|P1|NOT COMPLETED|Overall Study||22
8370624|NCT01155466|20634600|P5|COMPLETED|Overall Study|Completed treatment phase|129
8370625|NCT01155466|20634601|P4|COMPLETED|Overall Study|Completed treatment phase|134
8370626|NCT01155466|20634602|P3|COMPLETED|Overall Study|Completed treatment phase|136
8370627|NCT01155466|20634603|P2|COMPLETED|Overall Study|Completed treatment phase|130
8370628|NCT01155466|20634604|P1|COMPLETED|Overall Study|Completed treatment phase|134
8370629|NCT01155466|20634600|P5|Treated|Overall Study||154
8370630|NCT01155466|20634601|P4|Treated|Overall Study||155
8370631|NCT01155466|20634602|P3|Treated|Overall Study||153
8370632|NCT01155466|20634603|P2|Treated|Overall Study||153
8370633|NCT01155466|20634604|P1|Treated|Overall Study||154
8370634|NCT01155466|20634600|P5|STARTED|Overall Study||156
8370635|NCT01155466|20634601|P4|STARTED|Overall Study||155
8370636|NCT01155466|20634602|P3|STARTED|Overall Study||156
8370637|NCT01155466|20634603|P2|STARTED|Overall Study||155
8370638|NCT01155466|20634604|P1|STARTED|Overall Study||156
8370639|NCT01155388|20634658|P2|NOT COMPLETED|Overall Study||0
8370640|NCT01155388|20634659|P1|NOT COMPLETED|Overall Study||1
8370641|NCT01155388|20634658|P2|COMPLETED|Overall Study||6
8370642|NCT01155388|20634659|P1|COMPLETED|Overall Study||7
8370643|NCT01155388|20634658|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8370644|NCT01155388|20634659|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8370645|NCT01155388|20634658|P2|STARTED|Overall Study||6
8370646|NCT01155388|20634659|P1|STARTED|Overall Study||8
8370647|NCT01155375|20634669|P2|NOT COMPLETED|Overall Study||0
8370648|NCT01155375|20634670|P1|NOT COMPLETED|Overall Study||1
8370649|NCT01155375|20634669|P2|COMPLETED|Overall Study||6
8370650|NCT01155375|20634670|P1|COMPLETED|Overall Study||7
8370651|NCT01155375|20634669|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8370652|NCT01155375|20634670|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8370653|NCT01155375|20634669|P2|STARTED|Overall Study||6
8370654|NCT01155375|20634670|P1|STARTED|Overall Study||8
8370655|NCT01155336|20634680|P2|NOT COMPLETED|Overall Study||0
8370656|NCT01155336|20634681|P1|NOT COMPLETED|Overall Study||0
8370657|NCT01155336|20634680|P2|COMPLETED|Overall Study|We did not complete the study.|4
8370658|NCT01155336|20634681|P1|COMPLETED|Overall Study|We did not complete the study.|0
8370659|NCT01155336|20634680|P2|STARTED|Overall Study|We did not complete the study.|4
8370660|NCT01155336|20634681|P1|STARTED|Overall Study|We did not complete the study.|0
8370661|NCT01155323|20634689|P2|NOT COMPLETED|Second Intervention||1
8370662|NCT01155323|20634690|P1|NOT COMPLETED|Second Intervention||1
8370663|NCT01155323|20634689|P2|COMPLETED|Second Intervention||56
8370664|NCT01155323|20634690|P1|COMPLETED|Second Intervention||58
8370665|NCT01155323|20634689|P2|STARTED|Second Intervention||57
8370666|NCT01155323|20634690|P1|STARTED|Second Intervention||59
8370667|NCT01155323|20634689|P2|NOT COMPLETED|First Intervention||1
8370668|NCT01155323|20634690|P1|NOT COMPLETED|First Intervention||1
8370669|NCT01155323|20634689|P2|COMPLETED|First Intervention||57
8370670|NCT01155323|20634690|P1|COMPLETED|First Intervention||59
8370671|NCT01155323|20634689|P2|STARTED|First Intervention||58
8370672|NCT01155323|20634690|P1|STARTED|First Intervention||60
8370673|NCT01155284|20634708|P2|NOT COMPLETED|Overall Study||5
8370674|NCT01155284|20634709|P1|NOT COMPLETED|Overall Study||7
8370675|NCT01155284|20634708|P2|COMPLETED|Overall Study||18
8370676|NCT01155284|20634709|P1|COMPLETED|Overall Study||40
8370677|NCT01155284|20634708|P2|STARTED|Overall Study||23
8370678|NCT01155284|20634709|P1|STARTED|Overall Study||47
8370679|NCT01155219|20634719|P2|NOT COMPLETED|Overall Study||3
8370680|NCT01155219|20634720|P1|NOT COMPLETED|Overall Study||4
8370681|NCT01155219|20634719|P2|COMPLETED|Overall Study||70
8370682|NCT01155219|20634720|P1|COMPLETED|Overall Study||73
8370683|NCT01155219|20634719|P2|STARTED|Overall Study||73
8370684|NCT01155219|20634720|P1|STARTED|Overall Study||77
8370685|NCT01155193|20634730|P4|NOT COMPLETED|Overall Study||91
8370686|NCT01155193|20634731|P3|NOT COMPLETED|Overall Study||12
8370687|NCT01155193|20634732|P2|NOT COMPLETED|Overall Study||13
8370688|NCT01155193|20634733|P1|NOT COMPLETED|Overall Study||238
8370689|NCT01155193|20634730|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
8370690|NCT01155193|20634731|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
8370691|NCT01155193|20634732|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
8370692|NCT01155193|20634733|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
8370693|NCT01155193|20634730|P4|STARTED|Overall Study||13802
8370694|NCT01155193|20634731|P3|STARTED|Overall Study||2260
8370695|NCT01155193|20634732|P2|STARTED|Overall Study||3818
8370696|NCT01155193|20634733|P1|STARTED|Overall Study||10924
8370697|NCT01155180|20634760|P2|NOT COMPLETED|Overall Study||0
8370698|NCT01155180|20634761|P1|NOT COMPLETED|Overall Study||0
8370699|NCT01155180|20634760|P2|COMPLETED|Overall Study||6
8370700|NCT01155180|20634761|P1|COMPLETED|Overall Study||18
8370701|NCT01155180|20634760|P2|STARTED|Overall Study||6
8370702|NCT01155180|20634761|P1|STARTED|Overall Study||18
8370703|NCT01155167|20634769|P2|NOT COMPLETED|Overall Study||0
8370704|NCT01155167|20634770|P1|NOT COMPLETED|Overall Study||3
8370705|NCT01155167|20634769|P2|COMPLETED|Overall Study||43
8370706|NCT01155167|20634770|P1|COMPLETED|Overall Study||40
8370707|NCT01155167|20634769|P2|STARTED|Overall Study||43
8370708|NCT01155167|20634770|P1|STARTED|Overall Study||43
8370709|NCT01155154|20634783|P3|NOT COMPLETED|Overall Study||0
8370710|NCT01155154|20634784|P2|NOT COMPLETED|Overall Study||0
8370711|NCT01155154|20634785|P1|NOT COMPLETED|Overall Study||0
8370712|NCT01155154|20634783|P3|COMPLETED|Overall Study||24
8370713|NCT01155154|20634784|P2|COMPLETED|Overall Study||24
8370714|NCT01155154|20634785|P1|COMPLETED|Overall Study||25
8370715|NCT01155154|20634783|P3|STARTED|Overall Study||24
8370716|NCT01155154|20634784|P2|STARTED|Overall Study||24
8370717|NCT01155154|20634785|P1|STARTED|Overall Study||25
8370718|NCT01155141|20634793|P1|NOT COMPLETED|Overall Study||2
8370719|NCT01155141|20634793|P1|COMPLETED|Overall Study||14
8370720|NCT01155141|20634793|P1|STARTED|Overall Study||16
8370721|NCT01155063|20634805|P1|NOT COMPLETED|Overall Study||89
8370722|NCT01155063|20634805|P1|COMPLETED|Overall Study||0
8370723|NCT01155063|20634805|P1|STARTED|Overall Study||89
8370724|NCT01155050|20634819|P4|NOT COMPLETED|Overall Study||22
8370725|NCT01155050|20634820|P3|NOT COMPLETED|Overall Study||19
8370726|NCT01155050|20634821|P2|NOT COMPLETED|Overall Study||20
8370727|NCT01155050|20634822|P1|NOT COMPLETED|Overall Study||15
8370728|NCT01155050|20634819|P4|COMPLETED|Overall Study||27
8370729|NCT01155050|20634820|P3|COMPLETED|Overall Study||33
8370730|NCT01155050|20634821|P2|COMPLETED|Overall Study||31
8370731|NCT01155050|20634822|P1|COMPLETED|Overall Study||35
8370732|NCT01155050|20634819|P4|STARTED|Overall Study||49
8370733|NCT01155050|20634820|P3|STARTED|Overall Study||52
8370734|NCT01155050|20634821|P2|STARTED|Overall Study||51
8370735|NCT01155050|20634822|P1|STARTED|Overall Study||50
8370736|NCT01155024|20634860|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
8370737|NCT01155024|20634861|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
8370738|NCT01155024|20634860|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
8370739|NCT01155024|20634861|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
8370740|NCT01155024|20634860|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
8370741|NCT01155024|20634861|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
8370742|NCT01155024|20634860|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
8370743|NCT01155024|20634861|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
8370744|NCT01155024|20634860|P2|COMPLETED|Second Socket Intervention Fitting||5
8370745|NCT01155024|20634861|P1|COMPLETED|Second Socket Intervention Fitting||5
8370746|NCT01155024|20634860|P2|STARTED|Second Socket Intervention Fitting||5
8370747|NCT01155024|20634861|P1|STARTED|Second Socket Intervention Fitting||5
8370748|NCT01155024|20634860|P2|NOT COMPLETED|First Socket Intervention Fitting||0
8370749|NCT01155024|20634861|P1|NOT COMPLETED|First Socket Intervention Fitting||0
8370750|NCT01155024|20634860|P2|COMPLETED|First Socket Intervention Fitting||5
8370751|NCT01155024|20634861|P1|COMPLETED|First Socket Intervention Fitting||5
8370752|NCT01155024|20634860|P2|STARTED|First Socket Intervention Fitting||5
8370753|NCT01155024|20634861|P1|STARTED|First Socket Intervention Fitting||5
8370754|NCT01155011|20634871|P2|NOT COMPLETED|6 to 12 Months||10
8370755|NCT01155011|20634872|P1|NOT COMPLETED|6 to 12 Months||9
8370756|NCT01155011|20634871|P2|COMPLETED|6 to 12 Months||121
8370757|NCT01155011|20634872|P1|COMPLETED|6 to 12 Months||120
8370758|NCT01155011|20634871|P2|STARTED|6 to 12 Months||131
8370759|NCT01155011|20634872|P1|STARTED|6 to 12 Months||129
8370760|NCT01155011|20634871|P2|NOT COMPLETED|Baseline to 6 Months||25
8370761|NCT01155011|20634872|P1|NOT COMPLETED|Baseline to 6 Months||22
8370762|NCT01155011|20634871|P2|COMPLETED|Baseline to 6 Months||131
8370763|NCT01155011|20634872|P1|COMPLETED|Baseline to 6 Months||129
8370764|NCT01155011|20634871|P2|STARTED|Baseline to 6 Months||156
8370765|NCT01155011|20634872|P1|STARTED|Baseline to 6 Months||151
8370766|NCT01154985|20634885|P3|NOT COMPLETED|Overall Study||18
8370767|NCT01154985|20634886|P2|NOT COMPLETED|Overall Study||27
8370768|NCT01154985|20634887|P1|NOT COMPLETED|Overall Study||17
8370769|NCT01154985|20634885|P3|COMPLETED|Overall Study||68
8370770|NCT01154985|20634886|P2|COMPLETED|Overall Study||55
8370771|NCT01154985|20634887|P1|COMPLETED|Overall Study||58
8370772|NCT01154985|20634885|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
8370773|NCT01154985|20634886|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
8370774|NCT01154985|20634887|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
8370775|NCT01154985|20634885|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
8370776|NCT01154985|20634886|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
8370777|NCT01154985|20634887|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
8370778|NCT01154985|20634885|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
8370779|NCT01154985|20634886|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
8370780|NCT01154985|20634887|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
8370781|NCT01154985|20634885|P3|STARTED|Overall Study|Randomized|86
8370782|NCT01154985|20634886|P2|STARTED|Overall Study|Randomized|82
8370783|NCT01154985|20634887|P1|STARTED|Overall Study|Randomized|75
8370784|NCT01154816|20634913|P12|NOT COMPLETED|Overall Study||4
8370785|NCT01154816|20634914|P11|NOT COMPLETED|Overall Study||11
8370786|NCT01154816|20634915|P10|NOT COMPLETED|Overall Study||10
8370787|NCT01154816|20634916|P9|NOT COMPLETED|Overall Study||9
8370788|NCT01154816|20634917|P8|NOT COMPLETED|Overall Study||7
8370789|NCT01154816|20634918|P7|NOT COMPLETED|Overall Study||6
8370790|NCT01154816|20634919|P6|NOT COMPLETED|Overall Study||8
8370791|NCT01154816|20634920|P5|NOT COMPLETED|Overall Study||10
8370792|NCT01154816|20634921|P4|NOT COMPLETED|Overall Study||10
8370793|NCT01154816|20634922|P3|NOT COMPLETED|Overall Study||10
8370794|NCT01154816|20634923|P2|NOT COMPLETED|Overall Study||10
8370795|NCT01154816|20634924|P1|NOT COMPLETED|Overall Study||20
8370796|NCT01154816|20634913|P12|COMPLETED|Overall Study||0
8370797|NCT01154816|20634914|P11|COMPLETED|Overall Study||0
8370798|NCT01154816|20634915|P10|COMPLETED|Overall Study||0
8370799|NCT01154816|20634916|P9|COMPLETED|Overall Study||1
8370800|NCT01154816|20634917|P8|COMPLETED|Overall Study||0
8370801|NCT01154816|20634918|P7|COMPLETED|Overall Study||0
8370802|NCT01154816|20634919|P6|COMPLETED|Overall Study||0
8370803|NCT01154816|20634920|P5|COMPLETED|Overall Study||0
8370804|NCT01154816|20634921|P4|COMPLETED|Overall Study||0
8370805|NCT01154816|20634922|P3|COMPLETED|Overall Study||0
8370806|NCT01154816|20634923|P2|COMPLETED|Overall Study||2
8370807|NCT01154816|20634924|P1|COMPLETED|Overall Study||0
8370808|NCT01154816|20634913|P12|STARTED|Overall Study||4
8370809|NCT01154816|20634914|P11|STARTED|Overall Study||11
8370810|NCT01154816|20634915|P10|STARTED|Overall Study||10
8370811|NCT01154816|20634916|P9|STARTED|Overall Study||10
8370812|NCT01154816|20634917|P8|STARTED|Overall Study||7
8370813|NCT01154816|20634918|P7|STARTED|Overall Study||6
8370814|NCT01154816|20634919|P6|STARTED|Overall Study||8
8370815|NCT01154816|20634920|P5|STARTED|Overall Study||10
8370816|NCT01154816|20634921|P4|STARTED|Overall Study||10
8370817|NCT01154816|20634922|P3|STARTED|Overall Study||10
8370818|NCT01154816|20634923|P2|STARTED|Overall Study||12
8370819|NCT01154816|20634924|P1|STARTED|Overall Study||20
8370820|NCT01154751|20634957|P1|NOT COMPLETED|3-year Follow-up||49
8370821|NCT01154751|20634957|P1|COMPLETED|3-year Follow-up||34
8370822|NCT01154751|20634957|P1|STARTED|3-year Follow-up||83
8370823|NCT01154751|20634957|P1|NOT COMPLETED|2-year Follow-up||10
8370824|NCT01154751|20634957|P1|COMPLETED|2-year Follow-up||83
8370825|NCT01154751|20634957|P1|STARTED|2-year Follow-up||93
8370826|NCT01154751|20634957|P1|NOT COMPLETED|1-year Follow-up||5
8370827|NCT01154751|20634957|P1|COMPLETED|1-year Follow-up||93
8370828|NCT01154751|20634957|P1|STARTED|1-year Follow-up||98
8370829|NCT01154751|20634957|P1|NOT COMPLETED|6-month Follow-up||11
8370830|NCT01154751|20634957|P1|COMPLETED|6-month Follow-up||98
8370831|NCT01154751|20634957|P1|STARTED|6-month Follow-up||109
8370832|NCT01154699|20634982|P2|NOT COMPLETED|Second Intervention||0
8370833|NCT01154699|20634983|P1|NOT COMPLETED|Second Intervention||0
8370834|NCT01154699|20634982|P2|COMPLETED|Second Intervention||8
8370835|NCT01154699|20634983|P1|COMPLETED|Second Intervention||13
8370836|NCT01154699|20634982|P2|Subjects With Asthma + OSA|Second Intervention||2
8370837|NCT01154699|20634983|P1|Subjects With Asthma + OSA|Second Intervention||6
8370838|NCT01154699|20634982|P2|Subjects With Asthma Only|Second Intervention||6
8370839|NCT01154699|20634983|P1|Subjects With Asthma Only|Second Intervention||7
8370840|NCT01154699|20634982|P2|STARTED|Second Intervention||8
8370841|NCT01154699|20634983|P1|STARTED|Second Intervention||13
8370842|NCT01154699|20634982|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
8370843|NCT01154699|20634983|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
8370844|NCT01154699|20634982|P2|COMPLETED|Washout Period (4 Weeks)||8
8370845|NCT01154699|20634983|P1|COMPLETED|Washout Period (4 Weeks)||13
8370846|NCT01154699|20634982|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
8370847|NCT01154699|20634983|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
8370848|NCT01154699|20634982|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
8370849|NCT01154699|20634983|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
8370850|NCT01154699|20634982|P2|STARTED|Washout Period (4 Weeks)||8
8370851|NCT01154699|20634983|P1|STARTED|Washout Period (4 Weeks)||13
8370852|NCT01154699|20634982|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8370853|NCT01154699|20634983|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8370854|NCT01154699|20634982|P2|COMPLETED|First Intervention (4 Weeks)||8
8370855|NCT01154699|20634983|P1|COMPLETED|First Intervention (4 Weeks)||13
8370856|NCT01154699|20634982|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
8370857|NCT01154699|20634983|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
8370858|NCT01154699|20634982|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
8370859|NCT01154699|20634983|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
8370860|NCT01154699|20634982|P2|STARTED|First Intervention (4 Weeks)||8
8370861|NCT01154699|20634983|P1|STARTED|First Intervention (4 Weeks)||13
8370862|NCT01154673|20635001|P2|NOT COMPLETED|Overall Study||0
8370863|NCT01154673|20635002|P1|NOT COMPLETED|Overall Study||2
8370864|NCT01154673|20635001|P2|COMPLETED|Overall Study||16
8370865|NCT01154673|20635002|P1|COMPLETED|Overall Study||14
8370866|NCT01154673|20635001|P2|STARTED|Overall Study||16
8370867|NCT01154673|20635002|P1|STARTED|Overall Study||16
8370868|NCT01154634|20635012|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370869|NCT01154634|20635013|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370870|NCT01154634|20635014|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370871|NCT01154634|20635015|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370872|NCT01154634|20635012|P4|COMPLETED|Period 7 - Fourth Intervention||5
8370873|NCT01154634|20635013|P3|COMPLETED|Period 7 - Fourth Intervention||4
8370874|NCT01154634|20635014|P2|COMPLETED|Period 7 - Fourth Intervention||7
8370875|NCT01154634|20635015|P1|COMPLETED|Period 7 - Fourth Intervention||4
8370876|NCT01154634|20635012|P4|STARTED|Period 7 - Fourth Intervention||5
8370877|NCT01154634|20635013|P3|STARTED|Period 7 - Fourth Intervention||4
8370878|NCT01154634|20635014|P2|STARTED|Period 7 - Fourth Intervention||7
8370879|NCT01154634|20635015|P1|STARTED|Period 7 - Fourth Intervention||4
8370880|NCT01154634|20635012|P4|NOT COMPLETED|Period 6 - Washout||0
8370881|NCT01154634|20635013|P3|NOT COMPLETED|Period 6 - Washout||0
8370882|NCT01154634|20635014|P2|NOT COMPLETED|Period 6 - Washout||0
8370883|NCT01154634|20635015|P1|NOT COMPLETED|Period 6 - Washout||0
8370884|NCT01154634|20635012|P4|COMPLETED|Period 6 - Washout||5
8370885|NCT01154634|20635013|P3|COMPLETED|Period 6 - Washout||4
8370886|NCT01154634|20635014|P2|COMPLETED|Period 6 - Washout||7
8370887|NCT01154634|20635015|P1|COMPLETED|Period 6 - Washout||4
8370888|NCT01154634|20635012|P4|STARTED|Period 6 - Washout||5
8370889|NCT01154634|20635013|P3|STARTED|Period 6 - Washout||4
8370890|NCT01154634|20635014|P2|STARTED|Period 6 - Washout||7
8370891|NCT01154634|20635015|P1|STARTED|Period 6 - Washout||4
8370892|NCT01154634|20635012|P4|NOT COMPLETED|Period 5 - Third Intervention||0
8370893|NCT01154634|20635013|P3|NOT COMPLETED|Period 5 - Third Intervention||0
8370894|NCT01154634|20635014|P2|NOT COMPLETED|Period 5 - Third Intervention||0
8370895|NCT01154634|20635015|P1|NOT COMPLETED|Period 5 - Third Intervention||0
8370896|NCT01154634|20635012|P4|COMPLETED|Period 5 - Third Intervention||5
8370897|NCT01154634|20635013|P3|COMPLETED|Period 5 - Third Intervention||4
8370898|NCT01154634|20635014|P2|COMPLETED|Period 5 - Third Intervention||7
8370899|NCT01154634|20635015|P1|COMPLETED|Period 5 - Third Intervention||4
8370900|NCT01154634|20635012|P4|STARTED|Period 5 - Third Intervention||5
8370901|NCT01154634|20635013|P3|STARTED|Period 5 - Third Intervention||4
8370902|NCT01154634|20635014|P2|STARTED|Period 5 - Third Intervention||7
8370903|NCT01154634|20635015|P1|STARTED|Period 5 - Third Intervention||4
8370904|NCT01154634|20635012|P4|NOT COMPLETED|Period 4 - Washout||0
8370905|NCT01154634|20635013|P3|NOT COMPLETED|Period 4 - Washout||0
8370906|NCT01154634|20635014|P2|NOT COMPLETED|Period 4 - Washout||0
8370907|NCT01154634|20635015|P1|NOT COMPLETED|Period 4 - Washout||0
8370908|NCT01154634|20635012|P4|COMPLETED|Period 4 - Washout||5
8370909|NCT01154634|20635013|P3|COMPLETED|Period 4 - Washout||4
8370910|NCT01154634|20635014|P2|COMPLETED|Period 4 - Washout||7
8370911|NCT01154634|20635015|P1|COMPLETED|Period 4 - Washout||4
8370912|NCT01154634|20635012|P4|STARTED|Period 4 - Washout||5
8370913|NCT01154634|20635013|P3|STARTED|Period 4 - Washout||4
8370914|NCT01154634|20635014|P2|STARTED|Period 4 - Washout||7
8370915|NCT01154634|20635015|P1|STARTED|Period 4 - Washout||4
8370916|NCT01154634|20635012|P4|NOT COMPLETED|Period 3- Second Intervention||0
8370917|NCT01154634|20635013|P3|NOT COMPLETED|Period 3- Second Intervention||0
8370918|NCT01154634|20635014|P2|NOT COMPLETED|Period 3- Second Intervention||0
8370919|NCT01154634|20635015|P1|NOT COMPLETED|Period 3- Second Intervention||0
8370920|NCT01154634|20635012|P4|COMPLETED|Period 3- Second Intervention||5
8370921|NCT01154634|20635013|P3|COMPLETED|Period 3- Second Intervention||4
8370922|NCT01154634|20635014|P2|COMPLETED|Period 3- Second Intervention||7
8370923|NCT01154634|20635015|P1|COMPLETED|Period 3- Second Intervention||4
8370924|NCT01154634|20635012|P4|STARTED|Period 3- Second Intervention||5
8370925|NCT01154634|20635013|P3|STARTED|Period 3- Second Intervention||4
8370926|NCT01154634|20635014|P2|STARTED|Period 3- Second Intervention||7
8370927|NCT01154634|20635015|P1|STARTED|Period 3- Second Intervention||4
8370928|NCT01154634|20635012|P4|NOT COMPLETED|Period 2 - Washout||0
8370929|NCT01154634|20635013|P3|NOT COMPLETED|Period 2 - Washout||0
8370930|NCT01154634|20635014|P2|NOT COMPLETED|Period 2 - Washout||0
8370931|NCT01154634|20635015|P1|NOT COMPLETED|Period 2 - Washout||0
8370932|NCT01154634|20635012|P4|COMPLETED|Period 2 - Washout||5
8370933|NCT01154634|20635013|P3|COMPLETED|Period 2 - Washout||4
8370934|NCT01154634|20635014|P2|COMPLETED|Period 2 - Washout||7
8370935|NCT01154634|20635015|P1|COMPLETED|Period 2 - Washout||4
8370936|NCT01154634|20635012|P4|STARTED|Period 2 - Washout||5
8370937|NCT01154634|20635013|P3|STARTED|Period 2 - Washout||4
8370938|NCT01154634|20635014|P2|STARTED|Period 2 - Washout||7
8370939|NCT01154634|20635015|P1|STARTED|Period 2 - Washout||4
8370940|NCT01154634|20635012|P4|NOT COMPLETED|Period 1 - First Intervention||0
8370941|NCT01154634|20635013|P3|NOT COMPLETED|Period 1 - First Intervention||0
8370942|NCT01154634|20635014|P2|NOT COMPLETED|Period 1 - First Intervention||0
8370943|NCT01154634|20635015|P1|NOT COMPLETED|Period 1 - First Intervention||0
8370944|NCT01154634|20635012|P4|COMPLETED|Period 1 - First Intervention||5
8370945|NCT01154634|20635013|P3|COMPLETED|Period 1 - First Intervention||4
8370946|NCT01154634|20635014|P2|COMPLETED|Period 1 - First Intervention||7
8370947|NCT01154634|20635015|P1|COMPLETED|Period 1 - First Intervention||4
8370948|NCT01154634|20635012|P4|STARTED|Period 1 - First Intervention||5
8370949|NCT01154634|20635013|P3|STARTED|Period 1 - First Intervention||4
8370950|NCT01154634|20635014|P2|STARTED|Period 1 - First Intervention||7
8370951|NCT01154634|20635015|P1|STARTED|Period 1 - First Intervention||4
8370952|NCT01154452|20635057|P4|NOT COMPLETED|Phase II||6
8370953|NCT01154452|20635058|P3|NOT COMPLETED|Phase II||5
8370954|NCT01154452|20635059|P2|NOT COMPLETED|Phase II||0
8370955|NCT01154452|20635060|P1|NOT COMPLETED|Phase II||0
8370956|NCT01154452|20635057|P4|COMPLETED|Phase II||27
8370957|NCT01154452|20635058|P3|COMPLETED|Phase II||30
8370958|NCT01154452|20635059|P2|COMPLETED|Phase II||0
8370959|NCT01154452|20635060|P1|COMPLETED|Phase II||0
8370960|NCT01154452|20635057|P4|STARTED|Phase II||33
8370961|NCT01154452|20635058|P3|STARTED|Phase II||35
8370962|NCT01154452|20635059|P2|STARTED|Phase II||0
8370963|NCT01154452|20635060|P1|STARTED|Phase II||0
8370964|NCT01154452|20635057|P4|NOT COMPLETED|Phase Ib||0
8370965|NCT01154452|20635058|P3|NOT COMPLETED|Phase Ib||0
8370966|NCT01154452|20635059|P2|NOT COMPLETED|Phase Ib||1
8370967|NCT01154452|20635060|P1|NOT COMPLETED|Phase Ib||3
8370968|NCT01154452|20635057|P4|COMPLETED|Phase Ib||0
8370969|NCT01154452|20635058|P3|COMPLETED|Phase Ib||0
8370970|NCT01154452|20635059|P2|COMPLETED|Phase Ib||3
8370971|NCT01154452|20635060|P1|COMPLETED|Phase Ib||3
8370972|NCT01154452|20635057|P4|STARTED|Phase Ib||0
8370973|NCT01154452|20635058|P3|STARTED|Phase Ib||0
8370974|NCT01154452|20635059|P2|STARTED|Phase Ib||4
8370975|NCT01154452|20635060|P1|STARTED|Phase Ib||6
8370976|NCT01154335|20635076|P3|NOT COMPLETED|Overall Study||5
8370977|NCT01154335|20635077|P2|NOT COMPLETED|Overall Study||6
8370978|NCT01154335|20635078|P1|NOT COMPLETED|Overall Study||7
8370979|NCT01154335|20635076|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8370980|NCT01154335|20635077|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8371066|NCT01154218|20635133|P1|NOT COMPLETED|Second Intervention Period||0
8370981|NCT01154335|20635078|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8370982|NCT01154335|20635076|P3|STARTED|Overall Study||5
8370983|NCT01154335|20635077|P2|STARTED|Overall Study||6
8370984|NCT01154335|20635078|P1|STARTED|Overall Study||7
8370985|NCT01154322|20635085|P1|NOT COMPLETED|Overall Study||2
8370986|NCT01154322|20635085|P1|COMPLETED|Overall Study||14
8370987|NCT01154322|20635085|P1|STARTED|Overall Study||16
8370988|NCT01154296|20635092|P2|NOT COMPLETED|6-month Follow-up||328
8370989|NCT01154296|20635093|P1|NOT COMPLETED|6-month Follow-up||328
8370990|NCT01154296|20635092|P2|COMPLETED|6-month Follow-up||2179
8370991|NCT01154296|20635093|P1|COMPLETED|6-month Follow-up||2177
8370992|NCT01154296|20635092|P2|STARTED|6-month Follow-up||2507
8370993|NCT01154296|20635093|P1|STARTED|6-month Follow-up||2505
8370994|NCT01154296|20635092|P2|NOT COMPLETED|Randomization and Intervention||2
8370995|NCT01154296|20635093|P1|NOT COMPLETED|Randomization and Intervention||5
8370996|NCT01154296|20635092|P2|COMPLETED|Randomization and Intervention||2505
8370997|NCT01154296|20635093|P1|COMPLETED|Randomization and Intervention||2500
8370998|NCT01154296|20635092|P2|STARTED|Randomization and Intervention||2507
8370999|NCT01154296|20635093|P1|STARTED|Randomization and Intervention||2505
8371000|NCT01154283|20635111|P2|NOT COMPLETED|7-12 Weeks||1
8371001|NCT01154283|20635112|P1|NOT COMPLETED|7-12 Weeks||1
8371002|NCT01154283|20635111|P2|COMPLETED|7-12 Weeks||10
8371003|NCT01154283|20635112|P1|COMPLETED|7-12 Weeks||6
8371004|NCT01154283|20635111|P2|STARTED|7-12 Weeks||11
8371005|NCT01154283|20635112|P1|STARTED|7-12 Weeks||7
8371006|NCT01154283|20635111|P2|NOT COMPLETED|0-6 Weeks||3
8371007|NCT01154283|20635112|P1|NOT COMPLETED|0-6 Weeks||7
8371008|NCT01154283|20635111|P2|COMPLETED|0-6 Weeks||11
8371009|NCT01154283|20635112|P1|COMPLETED|0-6 Weeks||7
8371010|NCT01154283|20635111|P2|STARTED|0-6 Weeks||14
8371011|NCT01154283|20635112|P1|STARTED|0-6 Weeks||14
8371012|NCT01154231|20635124|P1|NOT COMPLETED|Overall Study||2
8371013|NCT01154231|20635124|P1|COMPLETED|Overall Study||312
8371014|NCT01154231|20635124|P1|STARTED|Overall Study||314
8371015|NCT01154218|20635130|P4|NOT COMPLETED|Fourth Intervention Period||0
8371016|NCT01154218|20635131|P3|NOT COMPLETED|Fourth Intervention Period||0
8371017|NCT01154218|20635132|P2|NOT COMPLETED|Fourth Intervention Period||0
8371018|NCT01154218|20635133|P1|NOT COMPLETED|Fourth Intervention Period||1
8371019|NCT01154218|20635130|P4|COMPLETED|Fourth Intervention Period||8
8371020|NCT01154218|20635131|P3|COMPLETED|Fourth Intervention Period||9
8371021|NCT01154218|20635132|P2|COMPLETED|Fourth Intervention Period||8
8371022|NCT01154218|20635133|P1|COMPLETED|Fourth Intervention Period||8
8371023|NCT01154218|20635130|P4|STARTED|Fourth Intervention Period||8
8371024|NCT01154218|20635131|P3|STARTED|Fourth Intervention Period||9
8371025|NCT01154218|20635132|P2|STARTED|Fourth Intervention Period||8
8371026|NCT01154218|20635133|P1|STARTED|Fourth Intervention Period||9
8371027|NCT01154218|20635130|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8371028|NCT01154218|20635131|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371029|NCT01154218|20635132|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371030|NCT01154218|20635133|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371031|NCT01154218|20635130|P4|COMPLETED|Washout Period (at Least 14 Days)||8
8371032|NCT01154218|20635131|P3|COMPLETED|Washout Period (at Least 14 Days)||9
8371033|NCT01154218|20635132|P2|COMPLETED|Washout Period (at Least 14 Days)||8
8371034|NCT01154218|20635133|P1|COMPLETED|Washout Period (at Least 14 Days)||9
8371035|NCT01154218|20635130|P4|STARTED|Washout Period (at Least 14 Days)||9
8371036|NCT01154218|20635131|P3|STARTED|Washout Period (at Least 14 Days)||9
8371037|NCT01154218|20635132|P2|STARTED|Washout Period (at Least 14 Days)||8
8371038|NCT01154218|20635133|P1|STARTED|Washout Period (at Least 14 Days)||9
8371039|NCT01154218|20635130|P4|NOT COMPLETED|Third Intervention Period||0
8371040|NCT01154218|20635131|P3|NOT COMPLETED|Third Intervention Period||0
8371041|NCT01154218|20635132|P2|NOT COMPLETED|Third Intervention Period||1
8371042|NCT01154218|20635133|P1|NOT COMPLETED|Third Intervention Period||0
8371043|NCT01154218|20635130|P4|COMPLETED|Third Intervention Period||9
8371044|NCT01154218|20635131|P3|COMPLETED|Third Intervention Period||9
8371045|NCT01154218|20635132|P2|COMPLETED|Third Intervention Period||8
8371046|NCT01154218|20635133|P1|COMPLETED|Third Intervention Period||9
8371047|NCT01154218|20635130|P4|STARTED|Third Intervention Period||9
8371048|NCT01154218|20635131|P3|STARTED|Third Intervention Period||9
8371049|NCT01154218|20635132|P2|STARTED|Third Intervention Period||9
8371050|NCT01154218|20635133|P1|STARTED|Third Intervention Period||9
8371051|NCT01154218|20635130|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371052|NCT01154218|20635131|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371053|NCT01154218|20635132|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371054|NCT01154218|20635133|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371055|NCT01154218|20635130|P4|COMPLETED|Washout Period (at Least 14 Days)||9
8371056|NCT01154218|20635131|P3|COMPLETED|Washout Period (at Least 14 Days)||9
8371057|NCT01154218|20635132|P2|COMPLETED|Washout Period (at Least 14 Days)||9
8371058|NCT01154218|20635133|P1|COMPLETED|Washout Period (at Least 14 Days)||9
8371059|NCT01154218|20635130|P4|STARTED|Washout Period (at Least 14 Days)||9
8371060|NCT01154218|20635131|P3|STARTED|Washout Period (at Least 14 Days)||9
8371061|NCT01154218|20635132|P2|STARTED|Washout Period (at Least 14 Days)||9
8371062|NCT01154218|20635133|P1|STARTED|Washout Period (at Least 14 Days)||9
8371063|NCT01154218|20635130|P4|NOT COMPLETED|Second Intervention Period||0
8371064|NCT01154218|20635131|P3|NOT COMPLETED|Second Intervention Period||0
8371065|NCT01154218|20635132|P2|NOT COMPLETED|Second Intervention Period||0
8371067|NCT01154218|20635130|P4|COMPLETED|Second Intervention Period||9
8371068|NCT01154218|20635131|P3|COMPLETED|Second Intervention Period||9
8371069|NCT01154218|20635132|P2|COMPLETED|Second Intervention Period||9
8371070|NCT01154218|20635133|P1|COMPLETED|Second Intervention Period||9
8371071|NCT01154218|20635130|P4|STARTED|Second Intervention Period||9
8371072|NCT01154218|20635131|P3|STARTED|Second Intervention Period||9
8371073|NCT01154218|20635132|P2|STARTED|Second Intervention Period||9
8371074|NCT01154218|20635133|P1|STARTED|Second Intervention Period||9
8371075|NCT01154218|20635130|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371076|NCT01154218|20635131|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371077|NCT01154218|20635132|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371078|NCT01154218|20635133|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371079|NCT01154218|20635130|P4|COMPLETED|Washout Period (at Least 14 Days)||9
8371080|NCT01154218|20635131|P3|COMPLETED|Washout Period (at Least 14 Days)||9
8371081|NCT01154218|20635132|P2|COMPLETED|Washout Period (at Least 14 Days)||9
8371082|NCT01154218|20635133|P1|COMPLETED|Washout Period (at Least 14 Days)||9
8371083|NCT01154218|20635130|P4|STARTED|Washout Period (at Least 14 Days)||9
8371084|NCT01154218|20635131|P3|STARTED|Washout Period (at Least 14 Days)||9
8371085|NCT01154218|20635132|P2|STARTED|Washout Period (at Least 14 Days)||9
8371086|NCT01154218|20635133|P1|STARTED|Washout Period (at Least 14 Days)||9
8371087|NCT01154218|20635130|P4|NOT COMPLETED|First Intervention Period||0
8371088|NCT01154218|20635131|P3|NOT COMPLETED|First Intervention Period||0
8371089|NCT01154218|20635132|P2|NOT COMPLETED|First Intervention Period||0
8371090|NCT01154218|20635133|P1|NOT COMPLETED|First Intervention Period||0
8371091|NCT01154218|20635130|P4|COMPLETED|First Intervention Period||9
8371092|NCT01154218|20635131|P3|COMPLETED|First Intervention Period||9
8371093|NCT01154218|20635132|P2|COMPLETED|First Intervention Period||9
8371094|NCT01154218|20635133|P1|COMPLETED|First Intervention Period||9
8371095|NCT01154218|20635130|P4|STARTED|First Intervention Period||9
8371096|NCT01154218|20635131|P3|STARTED|First Intervention Period||9
8371097|NCT01154218|20635132|P2|STARTED|First Intervention Period||9
8371098|NCT01154218|20635133|P1|STARTED|First Intervention Period||9
8371099|NCT01154192|20635186|P3|NOT COMPLETED|Overall Study||0
8371100|NCT01154192|20635187|P2|NOT COMPLETED|Overall Study||0
8371101|NCT01154192|20635188|P1|NOT COMPLETED|Overall Study||0
8371102|NCT01154192|20635186|P3|COMPLETED|Overall Study||0
8371103|NCT01154192|20635187|P2|COMPLETED|Overall Study||10
8371104|NCT01154192|20635188|P1|COMPLETED|Overall Study||14
8371105|NCT01154192|20635186|P3|STARTED|Overall Study||0
8371106|NCT01154192|20635187|P2|STARTED|Overall Study||10
8371107|NCT01154192|20635188|P1|STARTED|Overall Study||14
8371108|NCT01154166|20635207|P2|NOT COMPLETED|Overall Study||12
8371109|NCT01154166|20635208|P1|NOT COMPLETED|Overall Study||34
8371110|NCT01154166|20635207|P2|COMPLETED|Overall Study||163
8371111|NCT01154166|20635208|P1|COMPLETED|Overall Study||135
8371112|NCT01154166|20635207|P2|STARTED|Overall Study||175
8371113|NCT01154166|20635208|P1|STARTED|Overall Study||169
8371114|NCT01154153|20635240|P2|NOT COMPLETED|Overall Study||3
8371115|NCT01154153|20635241|P1|NOT COMPLETED|Overall Study||5
8371116|NCT01154153|20635240|P2|COMPLETED|Overall Study||66
8371117|NCT01154153|20635241|P1|COMPLETED|Overall Study||66
8371118|NCT01154153|20635240|P2|STARTED|Overall Study||69
8371119|NCT01154153|20635241|P1|STARTED|Overall Study||71
8371120|NCT01154140|20635259|P2|NOT COMPLETED|Overall Study||102
8371121|NCT01154140|20635260|P1|NOT COMPLETED|Overall Study||91
8371122|NCT01154140|20635259|P2|COMPLETED|Overall Study||69
8371123|NCT01154140|20635260|P1|COMPLETED|Overall Study||81
8371124|NCT01154140|20635259|P2|Treated|Overall Study||169
8371125|NCT01154140|20635260|P1|Treated|Overall Study||171
8371126|NCT01154140|20635259|P2|STARTED|Overall Study||171
8371127|NCT01154140|20635260|P1|STARTED|Overall Study||172
8371128|NCT01154127|20635313|P2|NOT COMPLETED|Period 2 (21 Days)||1
8371129|NCT01154127|20635314|P1|NOT COMPLETED|Period 2 (21 Days)||0
8371130|NCT01154127|20635313|P2|COMPLETED|Period 2 (21 Days)||46
8371131|NCT01154127|20635314|P1|COMPLETED|Period 2 (21 Days)||49
8371132|NCT01154127|20635313|P2|STARTED|Period 2 (21 Days)||47
8371133|NCT01154127|20635314|P1|STARTED|Period 2 (21 Days)||49
8371134|NCT01154127|20635313|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
8371135|NCT01154127|20635314|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
8371136|NCT01154127|20635313|P2|COMPLETED|Washout (14 - 28 Days)||47
8371137|NCT01154127|20635314|P1|COMPLETED|Washout (14 - 28 Days)||49
8371138|NCT01154127|20635313|P2|STARTED|Washout (14 - 28 Days)||47
8371139|NCT01154127|20635314|P1|STARTED|Washout (14 - 28 Days)||52
8371140|NCT01154127|20635313|P2|NOT COMPLETED|Period 1 (21 Days)||6
8371141|NCT01154127|20635314|P1|NOT COMPLETED|Period 1 (21 Days)||3
8371142|NCT01154127|20635313|P2|COMPLETED|Period 1 (21 Days)||47
8371143|NCT01154127|20635314|P1|COMPLETED|Period 1 (21 Days)||52
8371144|NCT01154127|20635313|P2|STARTED|Period 1 (21 Days)||53
8371145|NCT01154127|20635314|P1|STARTED|Period 1 (21 Days)||55
8371146|NCT01154101|20635341|P5|NOT COMPLETED|Overall Study||1
8371147|NCT01154101|20635342|P4|NOT COMPLETED|Overall Study||2
8371148|NCT01154101|20635343|P3|NOT COMPLETED|Overall Study||3
8371149|NCT01154101|20635344|P2|NOT COMPLETED|Overall Study||4
8371150|NCT01154101|20635345|P1|NOT COMPLETED|Overall Study||0
8371151|NCT01154101|20635341|P5|COMPLETED|Overall Study||0
8371152|NCT01154101|20635342|P4|COMPLETED|Overall Study||9
8371153|NCT01154101|20635343|P3|COMPLETED|Overall Study||9
8371154|NCT01154101|20635344|P2|COMPLETED|Overall Study||5
8371155|NCT01154101|20635345|P1|COMPLETED|Overall Study||7
8371156|NCT01154101|20635341|P5|STARTED|Overall Study||1
8371157|NCT01154101|20635342|P4|STARTED|Overall Study||11
8371158|NCT01154101|20635343|P3|STARTED|Overall Study||12
8371159|NCT01154101|20635344|P2|STARTED|Overall Study||9
8371160|NCT01154101|20635345|P1|STARTED|Overall Study||7
8371161|NCT01154088|20635400|P3|NOT COMPLETED|Overall Study||7
8371162|NCT01154088|20635401|P2|NOT COMPLETED|Overall Study||6
8371163|NCT01154088|20635402|P1|NOT COMPLETED|Overall Study||4
8371164|NCT01154088|20635400|P3|COMPLETED|Overall Study||383
8371165|NCT01154088|20635401|P2|COMPLETED|Overall Study||384
8371166|NCT01154088|20635402|P1|COMPLETED|Overall Study||386
8371167|NCT01154088|20635400|P3|STARTED|Overall Study||390
8371168|NCT01154088|20635401|P2|STARTED|Overall Study||390
8371169|NCT01154088|20635402|P1|STARTED|Overall Study||390
8371170|NCT01154036|20635442|P8|NOT COMPLETED|Phase II||6
8371171|NCT01154036|20635443|P7|NOT COMPLETED|Phase II||9
8371172|NCT01154036|20635444|P6|NOT COMPLETED|Phase II||5
8371173|NCT01154036|20635445|P5|NOT COMPLETED|Phase II||8
8371174|NCT01154036|20635446|P4|NOT COMPLETED|Phase II||1
8371175|NCT01154036|20635447|P3|NOT COMPLETED|Phase II||0
8371176|NCT01154036|20635448|P2|NOT COMPLETED|Phase II||0
8371177|NCT01154036|20635449|P1|NOT COMPLETED|Phase II||0
8371178|NCT01154036|20635442|P8|COMPLETED|Phase II||200
8371179|NCT01154036|20635443|P7|COMPLETED|Phase II||225
8371180|NCT01154036|20635444|P6|COMPLETED|Phase II||121
8371181|NCT01154036|20635445|P5|COMPLETED|Phase II||116
8371182|NCT01154036|20635446|P4|COMPLETED|Phase II||27
8371183|NCT01154036|20635447|P3|COMPLETED|Phase II||0
8371184|NCT01154036|20635448|P2|COMPLETED|Phase II||0
8371185|NCT01154036|20635449|P1|COMPLETED|Phase II||0
8371186|NCT01154036|20635442|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
8371187|NCT01154036|20635443|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
8371188|NCT01154036|20635444|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
8371189|NCT01154036|20635445|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
8371190|NCT01154036|20635446|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
8371191|NCT01154036|20635447|P3|STARTED|Phase II||0
8371192|NCT01154036|20635448|P2|STARTED|Phase II||0
8371193|NCT01154036|20635449|P1|STARTED|Phase II||0
8371194|NCT01154036|20635442|P8|NOT COMPLETED|Phase I||0
8371195|NCT01154036|20635443|P7|NOT COMPLETED|Phase I||0
8371196|NCT01154036|20635444|P6|NOT COMPLETED|Phase I||0
8371197|NCT01154036|20635445|P5|NOT COMPLETED|Phase I||0
8371198|NCT01154036|20635446|P4|NOT COMPLETED|Phase I||0
8371199|NCT01154036|20635447|P3|NOT COMPLETED|Phase I||56
8371200|NCT01154036|20635448|P2|NOT COMPLETED|Phase I||28
8371201|NCT01154036|20635449|P1|NOT COMPLETED|Phase I||3
8371202|NCT01154036|20635442|P8|COMPLETED|Phase I||0
8371203|NCT01154036|20635443|P7|COMPLETED|Phase I||0
8371204|NCT01154036|20635444|P6|COMPLETED|Phase I||0
8371205|NCT01154036|20635445|P5|COMPLETED|Phase I||0
8371206|NCT01154036|20635446|P4|COMPLETED|Phase I||0
8371207|NCT01154036|20635447|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
8371208|NCT01154036|20635448|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
8371209|NCT01154036|20635449|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
8371210|NCT01154036|20635442|P8|STARTED|Phase I||0
8371211|NCT01154036|20635443|P7|STARTED|Phase I||0
8371212|NCT01154036|20635444|P6|STARTED|Phase I||0
8371213|NCT01154036|20635445|P5|STARTED|Phase I||0
8371214|NCT01154036|20635446|P4|STARTED|Phase I||0
8371215|NCT01154036|20635447|P3|STARTED|Phase I||944
8371216|NCT01154036|20635448|P2|STARTED|Phase I||483
8371217|NCT01154036|20635449|P1|STARTED|Phase I||120
8371218|NCT01154010|20635573|P2|NOT COMPLETED|Overall Study||1
8371219|NCT01154010|20635574|P1|NOT COMPLETED|Overall Study||0
8371220|NCT01154010|20635573|P2|COMPLETED|Overall Study||8
8371221|NCT01154010|20635574|P1|COMPLETED|Overall Study||9
8371222|NCT01154010|20635573|P2|STARTED|Overall Study||9
8371223|NCT01154010|20635574|P1|STARTED|Overall Study||9
8371224|NCT01153984|20635580|P1|NOT COMPLETED|Overall Study||2
8371225|NCT01153984|20635580|P1|COMPLETED|Overall Study||21
8371226|NCT01153984|20635580|P1|STARTED|Overall Study||23
8371227|NCT01153971|20635591|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
8371228|NCT01153971|20635591|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
8371229|NCT01153971|20635591|P1|STARTED|Follow-up (Months 17-40 of Study)||41
8371230|NCT01153971|20635591|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
8371231|NCT01153971|20635591|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
8371232|NCT01153971|20635591|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
8371233|NCT01153971|20635591|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
8371234|NCT01153971|20635591|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
8371235|NCT01153971|20635591|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
8371236|NCT01153958|20635614|P2|NOT COMPLETED|Overall Study||32
8371237|NCT01153958|20635615|P1|NOT COMPLETED|Overall Study||36
8371238|NCT01153958|20635614|P2|COMPLETED|Overall Study||35
8371239|NCT01153958|20635615|P1|COMPLETED|Overall Study||30
8371240|NCT01153958|20635614|P2|STARTED|Overall Study||67
8371241|NCT01153958|20635615|P1|STARTED|Overall Study||66
8371242|NCT01153893|20635633|P2|NOT COMPLETED|Overall Study||0
8371243|NCT01153893|20635634|P1|NOT COMPLETED|Overall Study||1
8371244|NCT01153893|20635633|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
8371338|NCT01153321|20635987|P2|COMPLETED|Overall Study||19
8371245|NCT01153893|20635634|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
8371246|NCT01153893|20635633|P2|STARTED|Overall Study||36
8371247|NCT01153893|20635634|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
8371248|NCT01153841|20635660|P2|NOT COMPLETED|Overall Study||0
8371249|NCT01153841|20635661|P1|NOT COMPLETED|Overall Study||6
8371250|NCT01153841|20635660|P2|COMPLETED|Overall Study||99
8371251|NCT01153841|20635661|P1|COMPLETED|Overall Study||193
8371252|NCT01153841|20635660|P2|STARTED|Overall Study||99
8371253|NCT01153841|20635661|P1|STARTED|Overall Study||199
8371254|NCT01153815|20635677|P2|NOT COMPLETED|Overall Study||5
8371255|NCT01153815|20635678|P1|NOT COMPLETED|Overall Study||9
8371256|NCT01153815|20635677|P2|COMPLETED|Overall Study||82
8371257|NCT01153815|20635678|P1|COMPLETED|Overall Study||74
8371258|NCT01153815|20635677|P2|STARTED|Overall Study||87
8371259|NCT01153815|20635678|P1|STARTED|Overall Study||83
8371260|NCT01153763|20635700|P1|NOT COMPLETED|Overall Study||21
8371261|NCT01153763|20635700|P1|COMPLETED|Overall Study||71
8371262|NCT01153763|20635700|P1|STARTED|Overall Study||92
8371263|NCT01153724|20635716|P1|NOT COMPLETED|Treatment Period 2||2
8371264|NCT01153724|20635716|P1|COMPLETED|Treatment Period 2||32
8371265|NCT01153724|20635716|P1|STARTED|Treatment Period 2||34
8371266|NCT01153724|20635716|P1|NOT COMPLETED|Treatment Period 1||1
8371267|NCT01153724|20635716|P1|COMPLETED|Treatment Period 1||34
8371268|NCT01153724|20635716|P1|STARTED|Treatment Period 1||35
8371269|NCT01153711|20635736|P1|NOT COMPLETED|Overall Study||0
8371270|NCT01153711|20635736|P1|COMPLETED|Overall Study||32
8371271|NCT01153711|20635736|P1|STARTED|Overall Study||32
8371272|NCT01153698|20635756|P1|NOT COMPLETED|Overall Study||29
8371273|NCT01153698|20635756|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
8371274|NCT01153698|20635756|P1|STARTED|Overall Study|Entered and treated.|168
8371275|NCT01153685|20635772|P2|NOT COMPLETED|Overall Study||0
8371276|NCT01153685|20635773|P1|NOT COMPLETED|Overall Study||0
8371277|NCT01153685|20635772|P2|COMPLETED|Overall Study||70
8371278|NCT01153685|20635773|P1|COMPLETED|Overall Study||50
8371279|NCT01153685|20635772|P2|STARTED|Overall Study||70
8371280|NCT01153685|20635773|P1|STARTED|Overall Study||50
8371281|NCT01153672|20635797|P1|NOT COMPLETED|Overall Study||2
8371282|NCT01153672|20635797|P1|COMPLETED|Overall Study||6
8371283|NCT01153672|20635797|P1|STARTED|Overall Study||8
8371284|NCT01153633|20635807|P2|NOT COMPLETED|Overall Study||4
8371285|NCT01153633|20635808|P1|NOT COMPLETED|Overall Study||4
8371286|NCT01153633|20635807|P2|COMPLETED|Overall Study||13
8371287|NCT01153633|20635808|P1|COMPLETED|Overall Study||13
8371288|NCT01153633|20635807|P2|STARTED|Overall Study||17
8371289|NCT01153633|20635808|P1|STARTED|Overall Study||17
8371290|NCT01153620|20635826|P2|NOT COMPLETED|Overall Study||0
8371291|NCT01153620|20635827|P1|NOT COMPLETED|Overall Study||0
8371292|NCT01153620|20635826|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
8371293|NCT01153620|20635827|P1|COMPLETED|Overall Study||30
8371294|NCT01153620|20635826|P2|STARTED|Overall Study|30 patients (31 wounds)|30
8371295|NCT01153620|20635827|P1|STARTED|Overall Study||30
8371296|NCT01153581|20635833|P1|NOT COMPLETED|Overall Study||0
8371297|NCT01153581|20635833|P1|COMPLETED|Overall Study||109
8371298|NCT01153581|20635833|P1|STARTED|Overall Study||109
8371299|NCT01153516|20635845|P2|NOT COMPLETED|Overall Study||0
8371300|NCT01153516|20635846|P1|NOT COMPLETED|Overall Study||2
8371301|NCT01153516|20635845|P2|COMPLETED|Overall Study||10
8371302|NCT01153516|20635846|P1|COMPLETED|Overall Study||10
8371303|NCT01153516|20635845|P2|STARTED|Overall Study||10
8371304|NCT01153516|20635846|P1|STARTED|Overall Study||12
8371305|NCT01153503|20635859|P3|NOT COMPLETED|Overall Study||0
8371306|NCT01153503|20635860|P2|NOT COMPLETED|Overall Study||1
8371307|NCT01153503|20635861|P1|NOT COMPLETED|Overall Study||0
8371308|NCT01153503|20635859|P3|COMPLETED|Overall Study||25
8371309|NCT01153503|20635860|P2|COMPLETED|Overall Study||24
8371310|NCT01153503|20635861|P1|COMPLETED|Overall Study||25
8371311|NCT01153503|20635859|P3|STARTED|Overall Study||25
8371312|NCT01153503|20635860|P2|STARTED|Overall Study||25
8371313|NCT01153503|20635861|P1|STARTED|Overall Study||25
8371314|NCT01153425|20635871|P2|NOT COMPLETED|Overall Study||3
8371315|NCT01153425|20635872|P1|NOT COMPLETED|Overall Study||3
8371316|NCT01153425|20635871|P2|COMPLETED|Overall Study||14
8371317|NCT01153425|20635872|P1|COMPLETED|Overall Study||13
8371318|NCT01153425|20635871|P2|STARTED|Overall Study||17
8371319|NCT01153425|20635872|P1|STARTED|Overall Study||16
8371320|NCT01153347|20635884|P4|NOT COMPLETED|Overall Study||32
8371321|NCT01153347|20635885|P3|NOT COMPLETED|Overall Study||50
8371322|NCT01153347|20635886|P2|NOT COMPLETED|Overall Study||44
8371323|NCT01153347|20635887|P1|NOT COMPLETED|Overall Study||33
8371324|NCT01153347|20635884|P4|COMPLETED|Overall Study||129
8371325|NCT01153347|20635885|P3|COMPLETED|Overall Study||110
8371326|NCT01153347|20635886|P2|COMPLETED|Overall Study||116
8371327|NCT01153347|20635887|P1|COMPLETED|Overall Study||127
8371328|NCT01153347|20635884|P4|Received Treatment|Overall Study||160
8371329|NCT01153347|20635885|P3|Received Treatment|Overall Study||158
8371330|NCT01153347|20635886|P2|Received Treatment|Overall Study||158
8371331|NCT01153347|20635887|P1|Received Treatment|Overall Study||160
8371332|NCT01153347|20635884|P4|STARTED|Overall Study||161
8371333|NCT01153347|20635885|P3|STARTED|Overall Study||160
8371334|NCT01153347|20635886|P2|STARTED|Overall Study||160
8371335|NCT01153347|20635887|P1|STARTED|Overall Study||160
8371336|NCT01153321|20635987|P2|NOT COMPLETED|Overall Study||3
8371337|NCT01153321|20635988|P1|NOT COMPLETED|Overall Study||1
8371339|NCT01153321|20635988|P1|COMPLETED|Overall Study||21
8371340|NCT01153321|20635987|P2|STARTED|Overall Study||22
8371341|NCT01153321|20635988|P1|STARTED|Overall Study||22
8371342|NCT01153269|20636100|P1|NOT COMPLETED|Overall Study||2
8371343|NCT01153269|20636100|P1|COMPLETED|Overall Study||31
8371344|NCT01153269|20636100|P1|Participants Analyzed|Overall Study||33
8371345|NCT01153269|20636100|P1|STARTED|Overall Study||33
8371346|NCT01153009|20636163|P4|NOT COMPLETED|Overall Study||37
8371347|NCT01153009|20636164|P3|NOT COMPLETED|Overall Study||41
8371348|NCT01153009|20636165|P2|NOT COMPLETED|Overall Study||34
8371349|NCT01153009|20636166|P1|NOT COMPLETED|Overall Study||32
8371350|NCT01153009|20636163|P4|COMPLETED|Overall Study||115
8371351|NCT01153009|20636164|P3|COMPLETED|Overall Study||113
8371352|NCT01153009|20636165|P2|COMPLETED|Overall Study||113
8371353|NCT01153009|20636166|P1|COMPLETED|Overall Study||129
8371354|NCT01153009|20636163|P4|Treated|Overall Study||150
8371355|NCT01153009|20636164|P3|Treated|Overall Study||154
8371356|NCT01153009|20636165|P2|Treated|Overall Study||147
8371357|NCT01153009|20636166|P1|Treated|Overall Study||159
8371358|NCT01153009|20636163|P4|STARTED|Overall Study||152
8371359|NCT01153009|20636164|P3|STARTED|Overall Study||154
8371360|NCT01153009|20636165|P2|STARTED|Overall Study||147
8371361|NCT01153009|20636166|P1|STARTED|Overall Study||161
8371362|NCT01152996|20636196|P1|NOT COMPLETED|Overall Study||537
8371363|NCT01152996|20636196|P1|COMPLETED|Overall Study||538
8371364|NCT01152996|20636196|P1|Treated|Overall Study||1073
8371365|NCT01152996|20636196|P1|STARTED|Overall Study||1075
8371366|NCT01152814|20636209|P1|NOT COMPLETED|Overall Study||2
8371367|NCT01152814|20636209|P1|COMPLETED|Overall Study||62
8371368|NCT01152814|20636209|P1|STARTED|Overall Study||64
8371369|NCT01152788|20636218|P2|NOT COMPLETED|Overall Study||4
8371370|NCT01152788|20636219|P1|NOT COMPLETED|Overall Study||0
8371371|NCT01152788|20636218|P2|COMPLETED|Overall Study||28
8371372|NCT01152788|20636219|P1|COMPLETED|Overall Study||32
8371373|NCT01152788|20636218|P2|STARTED|Overall Study||32
8371374|NCT01152788|20636219|P1|STARTED|Overall Study||32
8371375|NCT01152697|20636231|P1|NOT COMPLETED|Overall Study||19
8371376|NCT01152697|20636231|P1|COMPLETED|Overall Study||11
8371377|NCT01152697|20636231|P1|STARTED|Overall Study||30
8371378|NCT01152580|20636256|P2|NOT COMPLETED|Overall Study||1
8371379|NCT01152580|20636257|P1|NOT COMPLETED|Overall Study||0
8371380|NCT01152580|20636256|P2|COMPLETED|Overall Study||13
8371381|NCT01152580|20636257|P1|COMPLETED|Overall Study||5
8371382|NCT01152580|20636256|P2|STARTED|Overall Study||14
8371383|NCT01152580|20636257|P1|STARTED|Overall Study||5
8371384|NCT01152554|20636279|P2|NOT COMPLETED|Overall Study||111
8371385|NCT01152554|20636280|P1|NOT COMPLETED|Overall Study||334
8371386|NCT01152554|20636279|P2|COMPLETED|Overall Study||92
8371387|NCT01152554|20636280|P1|COMPLETED|Overall Study||276
8371388|NCT01152554|20636279|P2|Received Treatment|Overall Study||201
8371389|NCT01152554|20636280|P1|Received Treatment|Overall Study||607
8371390|NCT01152554|20636279|P2|STARTED|Overall Study||203
8371391|NCT01152554|20636280|P1|STARTED|Overall Study||610
8371392|NCT01152515|20636304|P2|NOT COMPLETED|Overall Study||0
8371393|NCT01152515|20636305|P1|NOT COMPLETED|Overall Study||0
8371394|NCT01152515|20636304|P2|COMPLETED|Overall Study||25
8371395|NCT01152515|20636305|P1|COMPLETED|Overall Study||25
8371396|NCT01152515|20636304|P2|STARTED|Overall Study||25
8371397|NCT01152515|20636305|P1|STARTED|Overall Study||25
8371398|NCT01152450|20636319|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
8371399|NCT01152450|20636320|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
8371400|NCT01152450|20636321|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
8371401|NCT01152450|20636322|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
8371402|NCT01152450|20636323|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
8371403|NCT01152450|20636324|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
8371404|NCT01152450|20636319|P6|COMPLETED|Period 3 (4 Weeks)||12
8371405|NCT01152450|20636320|P5|COMPLETED|Period 3 (4 Weeks)||16
8371406|NCT01152450|20636321|P4|COMPLETED|Period 3 (4 Weeks)||15
8371407|NCT01152450|20636322|P3|COMPLETED|Period 3 (4 Weeks)||16
8371408|NCT01152450|20636323|P2|COMPLETED|Period 3 (4 Weeks)||15
8371409|NCT01152450|20636324|P1|COMPLETED|Period 3 (4 Weeks)||15
8371410|NCT01152450|20636319|P6|STARTED|Period 3 (4 Weeks)||12
8371411|NCT01152450|20636320|P5|STARTED|Period 3 (4 Weeks)||16
8371412|NCT01152450|20636321|P4|STARTED|Period 3 (4 Weeks)||15
8371413|NCT01152450|20636322|P3|STARTED|Period 3 (4 Weeks)||16
8371414|NCT01152450|20636323|P2|STARTED|Period 3 (4 Weeks)||15
8371415|NCT01152450|20636324|P1|STARTED|Period 3 (4 Weeks)||15
8371416|NCT01152450|20636319|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
8371417|NCT01152450|20636320|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
8371418|NCT01152450|20636321|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
8371419|NCT01152450|20636322|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
8371420|NCT01152450|20636323|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8371421|NCT01152450|20636324|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
8371422|NCT01152450|20636319|P6|COMPLETED|Period 2 (4 Weeks)||12
8371423|NCT01152450|20636320|P5|COMPLETED|Period 2 (4 Weeks)||16
8371424|NCT01152450|20636321|P4|COMPLETED|Period 2 (4 Weeks)||15
8371425|NCT01152450|20636322|P3|COMPLETED|Period 2 (4 Weeks)||16
8371426|NCT01152450|20636323|P2|COMPLETED|Period 2 (4 Weeks)||15
8371427|NCT01152450|20636324|P1|COMPLETED|Period 2 (4 Weeks)||15
8371428|NCT01152450|20636319|P6|STARTED|Period 2 (4 Weeks)||12
8371429|NCT01152450|20636320|P5|STARTED|Period 2 (4 Weeks)||16
8371430|NCT01152450|20636321|P4|STARTED|Period 2 (4 Weeks)||15
8371431|NCT01152450|20636322|P3|STARTED|Period 2 (4 Weeks)||16
8371432|NCT01152450|20636323|P2|STARTED|Period 2 (4 Weeks)||15
8371433|NCT01152450|20636324|P1|STARTED|Period 2 (4 Weeks)||15
8371434|NCT01152450|20636319|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
8371435|NCT01152450|20636320|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
8371436|NCT01152450|20636321|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8371437|NCT01152450|20636322|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
8371438|NCT01152450|20636323|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
8371439|NCT01152450|20636324|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
8371440|NCT01152450|20636319|P6|COMPLETED|Period 1 (4 Weeks)||12
8371441|NCT01152450|20636320|P5|COMPLETED|Period 1 (4 Weeks)||16
8371442|NCT01152450|20636321|P4|COMPLETED|Period 1 (4 Weeks)||15
8371443|NCT01152450|20636322|P3|COMPLETED|Period 1 (4 Weeks)||16
8371444|NCT01152450|20636323|P2|COMPLETED|Period 1 (4 Weeks)||15
8371445|NCT01152450|20636324|P1|COMPLETED|Period 1 (4 Weeks)||15
8371446|NCT01152450|20636319|P6|STARTED|Period 1 (4 Weeks)||13
8371447|NCT01152450|20636320|P5|STARTED|Period 1 (4 Weeks)||18
8371448|NCT01152450|20636321|P4|STARTED|Period 1 (4 Weeks)||15
8371449|NCT01152450|20636322|P3|STARTED|Period 1 (4 Weeks)||17
8371450|NCT01152450|20636323|P2|STARTED|Period 1 (4 Weeks)||16
8371451|NCT01152450|20636324|P1|STARTED|Period 1 (4 Weeks)||15
8371452|NCT01152437|20636395|P3|NOT COMPLETED|Overall Study||43
8371453|NCT01152437|20636396|P2|NOT COMPLETED|Overall Study||15
8371454|NCT01152437|20636397|P1|NOT COMPLETED|Overall Study||36
8371455|NCT01152437|20636395|P3|COMPLETED|Overall Study||0
8371456|NCT01152437|20636396|P2|COMPLETED|Overall Study||0
8371457|NCT01152437|20636397|P1|COMPLETED|Overall Study||0
8371458|NCT01152437|20636395|P3|STARTED|Overall Study|entered|43
8371459|NCT01152437|20636396|P2|STARTED|Overall Study|randomised|15
8371460|NCT01152437|20636397|P1|STARTED|Overall Study|randomised|36
8371461|NCT01152385|20636417|P4|NOT COMPLETED|Overall Study||5
8371462|NCT01152385|20636418|P3|NOT COMPLETED|Overall Study||5
8371463|NCT01152385|20636419|P2|NOT COMPLETED|Overall Study||6
8371464|NCT01152385|20636420|P1|NOT COMPLETED|Overall Study||9
8371465|NCT01152385|20636417|P4|COMPLETED|Overall Study||50
8371466|NCT01152385|20636418|P3|COMPLETED|Overall Study||51
8371467|NCT01152385|20636419|P2|COMPLETED|Overall Study||52
8371468|NCT01152385|20636420|P1|COMPLETED|Overall Study||46
8371469|NCT01152385|20636417|P4|STARTED|Overall Study||55
8371470|NCT01152385|20636418|P3|STARTED|Overall Study||56
8371471|NCT01152385|20636419|P2|STARTED|Overall Study||58
8371472|NCT01152385|20636420|P1|STARTED|Overall Study||55
8371473|NCT01152359|20636460|P2|NOT COMPLETED|Overall Study||22
8371474|NCT01152359|20636461|P1|NOT COMPLETED|Overall Study||24
8371475|NCT01152359|20636460|P2|COMPLETED|Overall Study||80
8371476|NCT01152359|20636461|P1|COMPLETED|Overall Study||81
8371477|NCT01152359|20636460|P2|STARTED|Overall Study||102
8371478|NCT01152359|20636461|P1|STARTED|Overall Study||105
8371479|NCT01152307|20636473|P2|NOT COMPLETED|Overall Study||0
8371480|NCT01152307|20636474|P1|NOT COMPLETED|Overall Study||0
8371481|NCT01152307|20636473|P2|COMPLETED|Overall Study||214
8371482|NCT01152307|20636474|P1|COMPLETED|Overall Study||191
8371483|NCT01152307|20636473|P2|STARTED|Overall Study||214
8371484|NCT01152307|20636474|P1|STARTED|Overall Study||191
8371485|NCT01152294|20636482|P2|NOT COMPLETED|Overall Study||0
8371486|NCT01152294|20636483|P1|NOT COMPLETED|Overall Study||0
8371487|NCT01152294|20636482|P2|COMPLETED|Overall Study||188
8371488|NCT01152294|20636483|P1|COMPLETED|Overall Study||213
8371489|NCT01152294|20636482|P2|STARTED|Overall Study||188
8371490|NCT01152294|20636483|P1|STARTED|Overall Study||213
8371491|NCT01152190|20636491|P2|NOT COMPLETED|Overall Study||8
8371492|NCT01152190|20636492|P1|NOT COMPLETED|Overall Study||5
8371493|NCT01152190|20636491|P2|COMPLETED|Overall Study||39
8371494|NCT01152190|20636492|P1|COMPLETED|Overall Study||45
8371495|NCT01152190|20636491|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
8371496|NCT01152190|20636492|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
8371497|NCT01152190|20636491|P2|STARTED|Overall Study||47
8371498|NCT01152190|20636492|P1|STARTED|Overall Study||50
8371499|NCT01152112|20636506|P2|NOT COMPLETED|Overall Study||0
8371500|NCT01152112|20636507|P1|NOT COMPLETED|Overall Study||0
8371501|NCT01152112|20636506|P2|COMPLETED|Overall Study||32
8371502|NCT01152112|20636507|P1|COMPLETED|Overall Study||42
8371503|NCT01152112|20636506|P2|STARTED|Overall Study||32
8371504|NCT01152112|20636507|P1|STARTED|Overall Study||42
8371505|NCT01152021|20636515|P2|NOT COMPLETED|Overall Study||6
8371506|NCT01152021|20636516|P1|NOT COMPLETED|Overall Study||6
8371507|NCT01152021|20636515|P2|COMPLETED|Overall Study||1
8371508|NCT01152021|20636516|P1|COMPLETED|Overall Study||2
8371509|NCT01152021|20636515|P2|STARTED|Overall Study||7
8371510|NCT01152021|20636516|P1|STARTED|Overall Study||8
8371511|NCT01151904|20636524|P1|NOT COMPLETED|Overall Study||0
8371512|NCT01151904|20636524|P1|COMPLETED|Overall Study||17
8371513|NCT01151904|20636524|P1|STARTED|Overall Study||17
8371514|NCT01151852|20636532|P2|NOT COMPLETED|Overall Study||0
8371515|NCT01151852|20636533|P1|NOT COMPLETED|Overall Study||0
8371516|NCT01151852|20636532|P2|COMPLETED|Overall Study||40
8371517|NCT01151852|20636533|P1|COMPLETED|Overall Study||41
8371518|NCT01151852|20636532|P2|STARTED|Overall Study||40
8371519|NCT01151852|20636533|P1|STARTED|Overall Study||41
8371520|NCT01151813|20636549|P2|NOT COMPLETED|Period 2||0
8371521|NCT01151813|20636550|P1|NOT COMPLETED|Period 2||0
8371522|NCT01151813|20636549|P2|COMPLETED|Period 2||7
8371523|NCT01151813|20636550|P1|COMPLETED|Period 2||8
8371524|NCT01151813|20636549|P2|STARTED|Period 2||7
8371525|NCT01151813|20636550|P1|STARTED|Period 2||8
8371526|NCT01151813|20636549|P2|NOT COMPLETED|Period 1||0
8371527|NCT01151813|20636550|P1|NOT COMPLETED|Period 1||0
8371528|NCT01151813|20636549|P2|COMPLETED|Period 1||7
8371529|NCT01151813|20636550|P1|COMPLETED|Period 1||8
8371530|NCT01151813|20636549|P2|STARTED|Period 1||7
8371531|NCT01151813|20636550|P1|STARTED|Period 1||8
8371532|NCT01151761|20636562|P1|NOT COMPLETED|Overall Study||0
8371533|NCT01151761|20636562|P1|COMPLETED|Overall Study||2
8371534|NCT01151761|20636562|P1|STARTED|Overall Study||2
8371535|NCT01151618|20636573|P1|NOT COMPLETED|Overall Study||9
8371536|NCT01151618|20636573|P1|COMPLETED|Overall Study||13
8371537|NCT01151618|20636573|P1|STARTED|Overall Study||22
8371538|NCT01151579|20636581|P2|NOT COMPLETED|Overall Study||7
8371539|NCT01151579|20636582|P1|NOT COMPLETED|Overall Study||12
8371540|NCT01151579|20636581|P2|COMPLETED|Overall Study||24
8371541|NCT01151579|20636582|P1|COMPLETED|Overall Study||46
8371542|NCT01151579|20636581|P2|STARTED|Overall Study||31
8371543|NCT01151579|20636582|P1|STARTED|Overall Study||58
8371544|NCT01151553|20636592|P1|NOT COMPLETED|Overall Study||0
8371545|NCT01151553|20636592|P1|COMPLETED|Overall Study||5
8371546|NCT01151553|20636592|P1|STARTED|Overall Study||5
8371547|NCT01151540|20636596|P1|NOT COMPLETED|Overall Study||13
8371548|NCT01151540|20636596|P1|COMPLETED|Overall Study||41
8371549|NCT01151540|20636596|P1|STARTED|Overall Study||54
8371550|NCT01151449|20636605|P1|NOT COMPLETED|Overall Study||0
8371551|NCT01151449|20636605|P1|COMPLETED|Overall Study||6
8371552|NCT01151449|20636605|P1|STARTED|Overall Study||6
8371553|NCT01151436|20636613|P1|NOT COMPLETED|Overall Study||1
8371554|NCT01151436|20636613|P1|COMPLETED|Overall Study||76
8371555|NCT01151436|20636613|P1|STARTED|Overall Study||77
8371556|NCT01151423|20636645|P2|NOT COMPLETED|Overall Study||18
8371557|NCT01151423|20636646|P1|NOT COMPLETED|Overall Study||16
8371558|NCT01151423|20636645|P2|COMPLETED|Overall Study||21
8371559|NCT01151423|20636646|P1|COMPLETED|Overall Study||20
8371560|NCT01151423|20636645|P2|Received Study Drug|Overall Study||37
8371561|NCT01151423|20636646|P1|Received Study Drug|Overall Study||35
8371562|NCT01151423|20636645|P2|STARTED|Overall Study||39
8371563|NCT01151423|20636646|P1|STARTED|Overall Study||36
8371564|NCT01151410|20636694|P2|NOT COMPLETED|Overall Study||15
8371565|NCT01151410|20636695|P1|NOT COMPLETED|Overall Study||11
8371566|NCT01151410|20636694|P2|COMPLETED|Overall Study||89
8371567|NCT01151410|20636695|P1|COMPLETED|Overall Study||93
8371568|NCT01151410|20636694|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
8371569|NCT01151410|20636695|P1|Safety Set (SAF)|Overall Study||105
8371570|NCT01151410|20636694|P2|STARTED|Overall Study||104
8371571|NCT01151410|20636695|P1|STARTED|Overall Study||104
8371572|NCT01151371|20636708|P3|NOT COMPLETED|Overall Study||7
8371573|NCT01151371|20636709|P2|NOT COMPLETED|Overall Study||1
8371574|NCT01151371|20636710|P1|NOT COMPLETED|Overall Study||5
8371575|NCT01151371|20636708|P3|COMPLETED|Overall Study||146
8371576|NCT01151371|20636709|P2|COMPLETED|Overall Study||149
8371577|NCT01151371|20636710|P1|COMPLETED|Overall Study||144
8371578|NCT01151371|20636708|P3|STARTED|Overall Study||153
8371579|NCT01151371|20636709|P2|STARTED|Overall Study||150
8371580|NCT01151371|20636710|P1|STARTED|Overall Study||149
8371581|NCT01151345|20636739|P2|NOT COMPLETED|Second Intervention Period||0
8371582|NCT01151345|20636740|P1|NOT COMPLETED|Second Intervention Period||0
8371583|NCT01151345|20636739|P2|COMPLETED|Second Intervention Period||12
8371584|NCT01151345|20636740|P1|COMPLETED|Second Intervention Period||13
8371585|NCT01151345|20636739|P2|STARTED|Second Intervention Period||12
8371586|NCT01151345|20636740|P1|STARTED|Second Intervention Period||13
8371587|NCT01151345|20636739|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
8371588|NCT01151345|20636740|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
8371589|NCT01151345|20636739|P2|COMPLETED|Wash-out Period (7 Days)||12
8371590|NCT01151345|20636740|P1|COMPLETED|Wash-out Period (7 Days)||13
8371591|NCT01151345|20636739|P2|STARTED|Wash-out Period (7 Days)||12
8371592|NCT01151345|20636740|P1|STARTED|Wash-out Period (7 Days)||13
8371593|NCT01151345|20636739|P2|NOT COMPLETED|First Intervention Period||1
8371594|NCT01151345|20636740|P1|NOT COMPLETED|First Intervention Period||0
8371595|NCT01151345|20636739|P2|COMPLETED|First Intervention Period||12
8371596|NCT01151345|20636740|P1|COMPLETED|First Intervention Period||13
8371597|NCT01151345|20636739|P2|Treated|First Intervention Period||12
8371598|NCT01151345|20636740|P1|Treated|First Intervention Period||13
8371599|NCT01151345|20636739|P2|STARTED|First Intervention Period||13
8371600|NCT01151345|20636740|P1|STARTED|First Intervention Period||13
8371601|NCT01151280|20636754|P1|NOT COMPLETED|Overall Study||4
8371602|NCT01151280|20636754|P1|COMPLETED|Overall Study||6
8371603|NCT01151280|20636754|P1|STARTED|Overall Study||10
8371604|NCT01151215|20636767|P3|NOT COMPLETED|Overall Study||19
8371605|NCT01151215|20636768|P2|NOT COMPLETED|Overall Study||23
8371606|NCT01151215|20636769|P1|NOT COMPLETED|Overall Study||20
8371607|NCT01151215|20636767|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
8371608|NCT01151215|20636768|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
8371609|NCT01151215|20636769|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
8371610|NCT01151215|20636767|P3|STARTED|Overall Study||121
8371611|NCT01151215|20636768|P2|STARTED|Overall Study||118
8371612|NCT01151215|20636769|P1|STARTED|Overall Study||120
8371613|NCT01151189|20636782|P2|NOT COMPLETED|Overall Study||10
8371614|NCT01151189|20636783|P1|NOT COMPLETED|Overall Study||15
8371615|NCT01151189|20636782|P2|COMPLETED|Overall Study||314
8371616|NCT01151189|20636783|P1|COMPLETED|Overall Study||311
8371617|NCT01151189|20636782|P2|Received Vaccine|Overall Study||324
8371618|NCT01151189|20636783|P1|Received Vaccine|Overall Study||325
8371619|NCT01151189|20636782|P2|STARTED|Overall Study||324
8371620|NCT01151189|20636783|P1|STARTED|Overall Study||326
8371621|NCT01151137|20636807|P2|NOT COMPLETED|Overall Study||28
8371622|NCT01151137|20636808|P1|NOT COMPLETED|Overall Study||16
8371623|NCT01151137|20636807|P2|COMPLETED|Overall Study||1591
8371624|NCT01151137|20636808|P1|COMPLETED|Overall Study||1601
8371625|NCT01151137|20636807|P2|Discontinued Treatment|Overall Study||342
8371626|NCT01151137|20636808|P1|Discontinued Treatment|Overall Study||171
8371627|NCT01151137|20636807|P2|Treated|Overall Study||1613
8371628|NCT01151137|20636808|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
8371629|NCT01151137|20636807|P2|STARTED|Overall Study||1619
8371630|NCT01151137|20636808|P1|STARTED|Overall Study||1617
8371631|NCT01151098|20636826|P1|NOT COMPLETED|Overall Study||117
8371632|NCT01151098|20636826|P1|COMPLETED|Overall Study||72
8371633|NCT01151098|20636826|P1|STARTED|Overall Study|Extension Safety Population|189
8371634|NCT01151085|20636830|P1|NOT COMPLETED|Overall Study||56
8371635|NCT01151085|20636830|P1|COMPLETED|Overall Study||946
8371636|NCT01151085|20636830|P1|STARTED|Overall Study||1002
8371637|NCT01151046|20636848|P2|NOT COMPLETED|Overall Study||0
8371638|NCT01151046|20636849|P1|NOT COMPLETED|Overall Study||3
8371639|NCT01151046|20636848|P2|COMPLETED|Overall Study||59
8371640|NCT01151046|20636849|P1|COMPLETED|Overall Study||56
8371641|NCT01151046|20636848|P2|STARTED|Overall Study||59
8371642|NCT01151046|20636849|P1|STARTED|Overall Study||59
8371643|NCT01151020|20636861|P1|NOT COMPLETED|Overall Study||54
8371644|NCT01151020|20636861|P1|COMPLETED|Overall Study||56
8371645|NCT01151020|20636861|P1|30-day|Overall Study||110
8371646|NCT01151020|20636861|P1|STARTED|Overall Study||110
8371647|NCT01150981|20636868|P2|NOT COMPLETED|Overall Study||2
8371648|NCT01150981|20636869|P1|NOT COMPLETED|Overall Study||4
8371649|NCT01150981|20636868|P2|COMPLETED|Overall Study||13
8371650|NCT01150981|20636869|P1|COMPLETED|Overall Study||16
8371651|NCT01150981|20636868|P2|STARTED|Overall Study||15
8371652|NCT01150981|20636869|P1|STARTED|Overall Study||20
8371653|NCT01150903|20636879|P2|NOT COMPLETED|Overall Study||0
8371654|NCT01150903|20636880|P1|NOT COMPLETED|Overall Study||0
8371655|NCT01150903|20636879|P2|COMPLETED|Overall Study||74124
8371656|NCT01150903|20636880|P1|COMPLETED|Overall Study||24708
8371657|NCT01150903|20636879|P2|STARTED|Overall Study||74124
8371658|NCT01150903|20636880|P1|STARTED|Overall Study||24708
8371659|NCT01150760|20636896|P2|NOT COMPLETED|Overall Study||0
8371660|NCT01150760|20636897|P1|NOT COMPLETED|Overall Study||0
8371661|NCT01150760|20636896|P2|COMPLETED|Overall Study||3525
8371662|NCT01150760|20636897|P1|COMPLETED|Overall Study||3525
8371663|NCT01150760|20636896|P2|STARTED|Overall Study||3525
8371664|NCT01150760|20636897|P1|STARTED|Overall Study||3525
8371665|NCT01150500|20636929|P1|NOT COMPLETED|Overall Study||65
8371666|NCT01150500|20636929|P1|COMPLETED|Overall Study||0
8371667|NCT01150500|20636929|P1|STARTED|Overall Study||65
8371668|NCT01150474|20636940|P2|NOT COMPLETED|Overall Study||3
8371669|NCT01150474|20636941|P1|NOT COMPLETED|Overall Study||10
8371670|NCT01150474|20636940|P2|COMPLETED|Overall Study||49
8371671|NCT01150474|20636941|P1|COMPLETED|Overall Study||41
8371672|NCT01150474|20636940|P2|STARTED|Overall Study||52
8371673|NCT01150474|20636941|P1|STARTED|Overall Study||51
8371674|NCT01150461|20636965|P2|NOT COMPLETED|Overall Study||0
8371675|NCT01150461|20636966|P1|NOT COMPLETED|Overall Study||0
8371676|NCT01150461|20636965|P2|COMPLETED|Overall Study||9
8371677|NCT01150461|20636966|P1|COMPLETED|Overall Study||11
8371678|NCT01150461|20636965|P2|STARTED|Overall Study||9
8371679|NCT01150461|20636966|P1|STARTED|Overall Study||11
8371680|NCT01150409|20636976|P2|NOT COMPLETED|Overall Study||0
8371681|NCT01150409|20636977|P1|NOT COMPLETED|Overall Study||0
8371682|NCT01150409|20636976|P2|COMPLETED|Overall Study||0
8371683|NCT01150409|20636977|P1|COMPLETED|Overall Study||11
8371684|NCT01150409|20636976|P2|STARTED|Overall Study||0
8371685|NCT01150409|20636977|P1|STARTED|Overall Study||11
8371686|NCT01150357|20636986|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
8371687|NCT01150357|20636987|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
8371688|NCT01150357|20636988|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
8371689|NCT01150357|20636986|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
8371690|NCT01150357|20636987|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
8371691|NCT01150357|20636988|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
8371692|NCT01150357|20636986|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
8371693|NCT01150357|20636987|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
8371694|NCT01150357|20636988|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
8371695|NCT01150357|20636986|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
8371696|NCT01150357|20636987|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
8371697|NCT01150357|20636988|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
8371698|NCT01150357|20636986|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
8371699|NCT01150357|20636987|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
8371700|NCT01150357|20636988|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8371701|NCT01150357|20636986|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8371702|NCT01150357|20636987|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
8371703|NCT01150357|20636988|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8371704|NCT01150357|20636986|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
8371705|NCT01150357|20636987|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
8371706|NCT01150357|20636988|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
8371707|NCT01150357|20636986|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
8371708|NCT01150357|20636987|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
8371709|NCT01150357|20636988|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
8371710|NCT01150357|20636986|P3|COMPLETED|Dose Response Phase (Phase 1)||102
8371711|NCT01150357|20636987|P2|COMPLETED|Dose Response Phase (Phase 1)||51
8371712|NCT01150357|20636988|P1|COMPLETED|Dose Response Phase (Phase 1)||107
8371713|NCT01150357|20636986|P3|STARTED|Dose Response Phase (Phase 1)||105
8371714|NCT01150357|20636987|P2|STARTED|Dose Response Phase (Phase 1)||54
8371715|NCT01150357|20636988|P1|STARTED|Dose Response Phase (Phase 1)||108
8371716|NCT01150123|20637068|P18|NOT COMPLETED|Overall Study||1
8371717|NCT01150123|20637069|P17|NOT COMPLETED|Overall Study||0
8371718|NCT01150123|20637070|P16|NOT COMPLETED|Overall Study||1
8371719|NCT01150123|20637071|P15|NOT COMPLETED|Overall Study||0
8371720|NCT01150123|20637072|P14|NOT COMPLETED|Overall Study||0
8371721|NCT01150123|20637073|P13|NOT COMPLETED|Overall Study||3
8371722|NCT01150123|20637074|P12|NOT COMPLETED|Overall Study||1
8371723|NCT01150123|20637075|P11|NOT COMPLETED|Overall Study||2
8371724|NCT01150123|20637076|P10|NOT COMPLETED|Overall Study||1
8371725|NCT01150123|20637077|P9|NOT COMPLETED|Overall Study||5
8371726|NCT01150123|20637078|P8|NOT COMPLETED|Overall Study||3
8371727|NCT01150123|20637079|P7|NOT COMPLETED|Overall Study||0
8371728|NCT01150123|20637080|P6|NOT COMPLETED|Overall Study||6
8371729|NCT01150123|20637081|P5|NOT COMPLETED|Overall Study||3
8371730|NCT01150123|20637082|P4|NOT COMPLETED|Overall Study||3
8371731|NCT01150123|20637083|P3|NOT COMPLETED|Overall Study||4
8371732|NCT01150123|20637084|P2|NOT COMPLETED|Overall Study||2
8371733|NCT01150123|20637085|P1|NOT COMPLETED|Overall Study||3
8371734|NCT01150123|20637068|P18|COMPLETED|Overall Study||19
8371735|NCT01150123|20637069|P17|COMPLETED|Overall Study||40
8371736|NCT01150123|20637070|P16|COMPLETED|Overall Study||39
8371737|NCT01150123|20637071|P15|COMPLETED|Overall Study||40
8371738|NCT01150123|20637072|P14|COMPLETED|Overall Study||40
8371739|NCT01150123|20637073|P13|COMPLETED|Overall Study||37
8371740|NCT01150123|20637074|P12|COMPLETED|Overall Study||39
8371741|NCT01150123|20637075|P11|COMPLETED|Overall Study||38
8371742|NCT01150123|20637076|P10|COMPLETED|Overall Study||39
8371743|NCT01150123|20637077|P9|COMPLETED|Overall Study||15
8371744|NCT01150123|20637078|P8|COMPLETED|Overall Study||37
8371745|NCT01150123|20637079|P7|COMPLETED|Overall Study||39
8371746|NCT01150123|20637080|P6|COMPLETED|Overall Study||34
8371747|NCT01150123|20637081|P5|COMPLETED|Overall Study||37
8371748|NCT01150123|20637082|P4|COMPLETED|Overall Study||37
8371749|NCT01150123|20637083|P3|COMPLETED|Overall Study||35
8371750|NCT01150123|20637084|P2|COMPLETED|Overall Study||38
8371751|NCT01150123|20637085|P1|COMPLETED|Overall Study||37
8371752|NCT01150123|20637068|P18|STARTED|Overall Study||20
8371753|NCT01150123|20637069|P17|STARTED|Overall Study||40
8371754|NCT01150123|20637070|P16|STARTED|Overall Study||40
8371755|NCT01150123|20637071|P15|STARTED|Overall Study||40
8371756|NCT01150123|20637072|P14|STARTED|Overall Study||40
8371757|NCT01150123|20637073|P13|STARTED|Overall Study||40
8371758|NCT01150123|20637074|P12|STARTED|Overall Study||40
8371759|NCT01150123|20637075|P11|STARTED|Overall Study||40
8371760|NCT01150123|20637076|P10|STARTED|Overall Study||40
8371761|NCT01150123|20637077|P9|STARTED|Overall Study||20
8371762|NCT01150123|20637078|P8|STARTED|Overall Study||40
8371763|NCT01150123|20637079|P7|STARTED|Overall Study||39
8371764|NCT01150123|20637080|P6|STARTED|Overall Study||40
8371765|NCT01150123|20637081|P5|STARTED|Overall Study||40
8371766|NCT01150123|20637082|P4|STARTED|Overall Study||40
8371767|NCT01150123|20637083|P3|STARTED|Overall Study||39
8371768|NCT01150123|20637084|P2|STARTED|Overall Study||40
8371769|NCT01150123|20637085|P1|STARTED|Overall Study||40
8371770|NCT01150097|20637261|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
8371771|NCT01150097|20637262|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
8371772|NCT01150097|20637263|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
8371773|NCT01150097|20637261|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
8371774|NCT01150097|20637262|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
8371775|NCT01150097|20637263|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
8371776|NCT01150097|20637261|P3|STARTED|Months 24 to 48 Post-transplantation||0
8371777|NCT01150097|20637262|P2|STARTED|Months 24 to 48 Post-transplantation||51
8371778|NCT01150097|20637263|P1|STARTED|Months 24 to 48 Post-transplantation||106
8371779|NCT01150097|20637261|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
8371780|NCT01150097|20637262|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
8371781|NCT01150097|20637263|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
8371782|NCT01150097|20637261|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
8371783|NCT01150097|20637262|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
8371784|NCT01150097|20637263|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
8371785|NCT01150097|20637261|P3|STARTED|Months 24 to 36 Post-transplantation||125
8371786|NCT01150097|20637262|P2|STARTED|Months 24 to 36 Post-transplantation||51
8371787|NCT01150097|20637263|P1|STARTED|Months 24 to 36 Post-transplantation||106
8371788|NCT01149876|20637290|P4|NOT COMPLETED|Overall Study||0
8371789|NCT01149876|20637291|P3|NOT COMPLETED|Overall Study||1
8371790|NCT01149876|20637292|P2|NOT COMPLETED|Overall Study||0
8371791|NCT01149876|20637293|P1|NOT COMPLETED|Overall Study||1
8371792|NCT01149876|20637290|P4|COMPLETED|Overall Study||18
8371793|NCT01149876|20637291|P3|COMPLETED|Overall Study||20
8371794|NCT01149876|20637292|P2|COMPLETED|Overall Study||20
8371795|NCT01149876|20637293|P1|COMPLETED|Overall Study||20
8371796|NCT01149876|20637290|P4|STARTED|Overall Study||18
8371797|NCT01149876|20637291|P3|STARTED|Overall Study||21
8371798|NCT01149876|20637292|P2|STARTED|Overall Study||20
8371799|NCT01149876|20637293|P1|STARTED|Overall Study||21
8371800|NCT01149863|20637307|P1|NOT COMPLETED|Overall Study||3
8371801|NCT01149863|20637307|P1|COMPLETED|Overall Study||31
8371802|NCT01149863|20637307|P1|STARTED|Overall Study||34
8371803|NCT01149785|20637312|P2|NOT COMPLETED|Second Intervention||0
8371804|NCT01149785|20637313|P1|NOT COMPLETED|Second Intervention||0
8371805|NCT01149785|20637312|P2|COMPLETED|Second Intervention||15
8371806|NCT01149785|20637313|P1|COMPLETED|Second Intervention||0
8371807|NCT01149785|20637312|P2|STARTED|Second Intervention||15
8371808|NCT01149785|20637313|P1|STARTED|Second Intervention||0
8371809|NCT01149785|20637312|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
8371810|NCT01149785|20637313|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
8371811|NCT01149785|20637312|P2|COMPLETED|Washout Period of at Least 14 Days||0
8371812|NCT01149785|20637313|P1|COMPLETED|Washout Period of at Least 14 Days||15
8371813|NCT01149785|20637312|P2|STARTED|Washout Period of at Least 14 Days||0
8371814|NCT01149785|20637313|P1|STARTED|Washout Period of at Least 14 Days||15
8371815|NCT01149785|20637312|P2|NOT COMPLETED|First Intervention||0
8371816|NCT01149785|20637313|P1|NOT COMPLETED|First Intervention||0
8371817|NCT01149785|20637312|P2|COMPLETED|First Intervention||0
8371818|NCT01149785|20637313|P1|COMPLETED|First Intervention||15
8371819|NCT01149785|20637312|P2|STARTED|First Intervention||0
8371820|NCT01149785|20637313|P1|STARTED|First Intervention||15
8371821|NCT01149772|20637347|P2|NOT COMPLETED|Overall Study||21
8371822|NCT01149772|20637348|P1|NOT COMPLETED|Overall Study||48
8371823|NCT01149772|20637347|P2|COMPLETED|Overall Study||101
8371824|NCT01149772|20637348|P1|COMPLETED|Overall Study||132
8371825|NCT01149772|20637347|P2|STARTED|Overall Study||122
8371826|NCT01149772|20637348|P1|STARTED|Overall Study||180
8371827|NCT01149759|20637364|P1|NOT COMPLETED|Overall Study||0
8371828|NCT01149759|20637364|P1|COMPLETED|Overall Study||9
8371829|NCT01149759|20637364|P1|STARTED|Overall Study||9
8371830|NCT01149733|20637371|P2|NOT COMPLETED|Overall Study||0
8371831|NCT01149733|20637372|P1|NOT COMPLETED|Overall Study||0
8371832|NCT01149733|20637371|P2|COMPLETED|Overall Study||16
8371833|NCT01149733|20637372|P1|COMPLETED|Overall Study||16
8371834|NCT01149733|20637371|P2|STARTED|Overall Study||16
8371835|NCT01149733|20637372|P1|STARTED|Overall Study||16
8371836|NCT01149681|20637382|P1|NOT COMPLETED|Overall Study||12
8371837|NCT01149681|20637382|P1|COMPLETED|Overall Study||0
8371838|NCT01149681|20637382|P1|STARTED|Overall Study||12
8371839|NCT01149655|20637390|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
8371840|NCT01149655|20637391|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
8371841|NCT01149655|20637392|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
8371842|NCT01149655|20637393|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
8371843|NCT01149655|20637390|P4|COMPLETED|Period 3-DB Maintenance Phase||6
8371844|NCT01149655|20637391|P3|COMPLETED|Period 3-DB Maintenance Phase||15
8371845|NCT01149655|20637392|P2|COMPLETED|Period 3-DB Maintenance Phase||0
8371846|NCT01149655|20637393|P1|COMPLETED|Period 3-DB Maintenance Phase||0
8371847|NCT01149655|20637390|P4|STARTED|Period 3-DB Maintenance Phase||48
8371848|NCT01149655|20637391|P3|STARTED|Period 3-DB Maintenance Phase||98
8371849|NCT01149655|20637392|P2|STARTED|Period 3-DB Maintenance Phase||0
8371850|NCT01149655|20637393|P1|STARTED|Period 3-DB Maintenance Phase||0
8371851|NCT01149655|20637390|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
8371852|NCT01149655|20637391|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
8371853|NCT01149655|20637392|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
8371854|NCT01149655|20637393|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
8371855|NCT01149655|20637390|P4|COMPLETED|Period 2-Stabilization Phase||0
8371856|NCT01149655|20637391|P3|COMPLETED|Period 2-Stabilization Phase||0
8371857|NCT01149655|20637392|P2|COMPLETED|Period 2-Stabilization Phase||146
8371858|NCT01149655|20637393|P1|COMPLETED|Period 2-Stabilization Phase||0
8371859|NCT01149655|20637390|P4|STARTED|Period 2-Stabilization Phase||0
8371860|NCT01149655|20637391|P3|STARTED|Period 2-Stabilization Phase||0
8371861|NCT01149655|20637392|P2|STARTED|Period 2-Stabilization Phase||183
8371862|NCT01149655|20637393|P1|STARTED|Period 2-Stabilization Phase||0
8371863|NCT01149655|20637390|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
8371864|NCT01149655|20637391|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
8371865|NCT01149655|20637392|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
8371866|NCT01149655|20637393|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
8371867|NCT01149655|20637390|P4|COMPLETED|Period 1 - Conversion Phase||0
8371868|NCT01149655|20637391|P3|COMPLETED|Period 1 - Conversion Phase||0
8371869|NCT01149655|20637392|P2|COMPLETED|Period 1 - Conversion Phase||0
8371870|NCT01149655|20637393|P1|COMPLETED|Period 1 - Conversion Phase||168
8371871|NCT01149655|20637390|P4|STARTED|Period 1 - Conversion Phase||0
8371872|NCT01149655|20637391|P3|STARTED|Period 1 - Conversion Phase||0
8371873|NCT01149655|20637392|P2|STARTED|Period 1 - Conversion Phase||0
8371874|NCT01149655|20637393|P1|STARTED|Period 1 - Conversion Phase||186
8371875|NCT01149616|20637423|P2|NOT COMPLETED|Overall Study||0
8371876|NCT01149616|20637424|P1|NOT COMPLETED|Overall Study||0
8371877|NCT01149616|20637423|P2|COMPLETED|Overall Study||41
8371878|NCT01149616|20637424|P1|COMPLETED|Overall Study||41
8371879|NCT01149616|20637423|P2|STARTED|Overall Study||41
8371880|NCT01149616|20637424|P1|STARTED|Overall Study||41
8371881|NCT01149538|20637436|P2|NOT COMPLETED|Overall Study||4
8371882|NCT01149538|20637437|P1|NOT COMPLETED|Overall Study||5
8371883|NCT01149538|20637436|P2|COMPLETED|Overall Study||25
8371884|NCT01149538|20637437|P1|COMPLETED|Overall Study||26
8371885|NCT01149538|20637436|P2|STARTED|Overall Study||29
8371886|NCT01149538|20637437|P1|STARTED|Overall Study||31
8371887|NCT01149512|20637451|P1|NOT COMPLETED|Overall Study||0
8371888|NCT01149512|20637451|P1|COMPLETED|Overall Study||178
8371889|NCT01149512|20637451|P1|STARTED|Overall Study||178
8371890|NCT01149486|20637458|P2|NOT COMPLETED|Second Intervention||0
8371891|NCT01149486|20637459|P1|NOT COMPLETED|Second Intervention||0
8371892|NCT01149486|20637458|P2|COMPLETED|Second Intervention||9
8371893|NCT01149486|20637459|P1|COMPLETED|Second Intervention||10
8371894|NCT01149486|20637458|P2|STARTED|Second Intervention||9
8371895|NCT01149486|20637459|P1|STARTED|Second Intervention||10
8371896|NCT01149486|20637458|P2|NOT COMPLETED|Washout of 7 Days||0
8371897|NCT01149486|20637459|P1|NOT COMPLETED|Washout of 7 Days||0
8371898|NCT01149486|20637458|P2|COMPLETED|Washout of 7 Days||9
8371899|NCT01149486|20637459|P1|COMPLETED|Washout of 7 Days||10
8371900|NCT01149486|20637458|P2|STARTED|Washout of 7 Days||9
8371901|NCT01149486|20637459|P1|STARTED|Washout of 7 Days||10
8371902|NCT01149486|20637458|P2|NOT COMPLETED|First Intervention||1
8371903|NCT01149486|20637459|P1|NOT COMPLETED|First Intervention||0
8371904|NCT01149486|20637458|P2|COMPLETED|First Intervention||9
8371905|NCT01149486|20637459|P1|COMPLETED|First Intervention||10
8371906|NCT01149486|20637458|P2|STARTED|First Intervention||10
8371907|NCT01149486|20637459|P1|STARTED|First Intervention||10
8371908|NCT01149473|20637483|P2|NOT COMPLETED|Second Intervention||0
8371909|NCT01149473|20637484|P1|NOT COMPLETED|Second Intervention||0
8371910|NCT01149473|20637483|P2|COMPLETED|Second Intervention||38
8371911|NCT01149473|20637484|P1|COMPLETED|Second Intervention||38
8371912|NCT01149473|20637483|P2|STARTED|Second Intervention||38
8371913|NCT01149473|20637484|P1|STARTED|Second Intervention||38
8371914|NCT01149473|20637483|P2|NOT COMPLETED|Washout of 7 Days||1
8371915|NCT01149473|20637484|P1|NOT COMPLETED|Washout of 7 Days||1
8371916|NCT01149473|20637483|P2|COMPLETED|Washout of 7 Days||38
8371917|NCT01149473|20637484|P1|COMPLETED|Washout of 7 Days||38
8371918|NCT01149473|20637483|P2|STARTED|Washout of 7 Days||39
8371919|NCT01149473|20637484|P1|STARTED|Washout of 7 Days||39
8371920|NCT01149473|20637483|P2|NOT COMPLETED|First Intervention||1
8371921|NCT01149473|20637484|P1|NOT COMPLETED|First Intervention||1
8371922|NCT01149473|20637483|P2|COMPLETED|First Intervention||39
8371923|NCT01149473|20637484|P1|COMPLETED|First Intervention||39
8371924|NCT01149473|20637483|P2|STARTED|First Intervention||40
8371925|NCT01149473|20637484|P1|STARTED|First Intervention||40
8371926|NCT01149460|20637502|P2|NOT COMPLETED|Overall Study||2
8371927|NCT01149460|20637503|P1|NOT COMPLETED|Overall Study||0
8371928|NCT01149460|20637502|P2|COMPLETED|Overall Study||16
8371929|NCT01149460|20637503|P1|COMPLETED|Overall Study||18
8371930|NCT01149460|20637502|P2|STARTED|Overall Study||18
8371931|NCT01149460|20637503|P1|STARTED|Overall Study||18
8371932|NCT01149434|20637521|P2|NOT COMPLETED|Overall Study||5
8371933|NCT01149434|20637522|P1|NOT COMPLETED|Overall Study||0
8371934|NCT01149434|20637521|P2|COMPLETED|Overall Study||10
8371935|NCT01149434|20637522|P1|COMPLETED|Overall Study||4
8371936|NCT01149434|20637521|P2|STARTED|Overall Study||15
8371937|NCT01149434|20637522|P1|STARTED|Overall Study||4
8371938|NCT01149421|20637536|P3|NOT COMPLETED|Overall Study||44
8371939|NCT01149421|20637537|P2|NOT COMPLETED|Overall Study||29
8371940|NCT01149421|20637538|P1|NOT COMPLETED|Overall Study||52
8371941|NCT01149421|20637536|P3|COMPLETED|Overall Study||206
8371942|NCT01149421|20637537|P2|COMPLETED|Overall Study||225
8371943|NCT01149421|20637538|P1|COMPLETED|Overall Study||199
8371944|NCT01149421|20637536|P3|Received at Least One Dose of Study Drug|Overall Study||250
8371945|NCT01149421|20637537|P2|Received at Least One Dose of Study Drug|Overall Study||254
8371946|NCT01149421|20637538|P1|Received at Least One Dose of Study Drug|Overall Study||251
8371947|NCT01149421|20637536|P3|STARTED|Overall Study||250
8371948|NCT01149421|20637537|P2|STARTED|Overall Study||254
8371949|NCT01149421|20637538|P1|STARTED|Overall Study||251
8371950|NCT01149369|20637619|P2|NOT COMPLETED|Overall Study||3
8371951|NCT01149369|20637620|P1|NOT COMPLETED|Overall Study||6
8371952|NCT01149369|20637619|P2|COMPLETED|Overall Study||60
8371953|NCT01149369|20637620|P1|COMPLETED|Overall Study||57
8371954|NCT01149369|20637619|P2|STARTED|Overall Study||63
8371955|NCT01149369|20637620|P1|STARTED|Overall Study||63
8371956|NCT01149343|20637788|P4|NOT COMPLETED|Overall Study||40
8371957|NCT01149343|20637789|P3|NOT COMPLETED|Overall Study||22
8371958|NCT01149343|20637790|P2|NOT COMPLETED|Overall Study||24
8371959|NCT01149343|20637791|P1|NOT COMPLETED|Overall Study||20
8371960|NCT01149343|20637788|P4|COMPLETED|Overall Study||0
8371961|NCT01149343|20637789|P3|COMPLETED|Overall Study||0
8371962|NCT01149343|20637790|P2|COMPLETED|Overall Study||0
8371963|NCT01149343|20637791|P1|COMPLETED|Overall Study||0
8371964|NCT01149343|20637788|P4|STARTED|Overall Study||40
8371965|NCT01149343|20637789|P3|STARTED|Overall Study||22
8371966|NCT01149343|20637790|P2|STARTED|Overall Study||24
8371967|NCT01149343|20637791|P1|STARTED|Overall Study||20
8371968|NCT01149148|20637876|P2|NOT COMPLETED|Overall Study||2
8371969|NCT01149148|20637877|P1|NOT COMPLETED|Overall Study||2
8371970|NCT01149148|20637876|P2|COMPLETED|Overall Study||11
8371971|NCT01149148|20637877|P1|COMPLETED|Overall Study||10
8371972|NCT01149148|20637876|P2|STARTED|Overall Study||13
8371973|NCT01149148|20637877|P1|STARTED|Overall Study||12
8371974|NCT01149096|20637887|P2|NOT COMPLETED|Overall Study||1
8371975|NCT01149096|20637888|P1|NOT COMPLETED|Overall Study||0
8371976|NCT01149096|20637887|P2|COMPLETED|Overall Study||6
8371977|NCT01149096|20637888|P1|COMPLETED|Overall Study||6
8371978|NCT01149096|20637887|P2|STARTED|Overall Study||7
8371979|NCT01149096|20637888|P1|STARTED|Overall Study||6
8371980|NCT01149057|20637912|P1|NOT COMPLETED|Overall Study||57
8371981|NCT01149057|20637912|P1|COMPLETED|Overall Study||88
8371982|NCT01149057|20637912|P1|STARTED|Overall Study||145
8371983|NCT01148979|20637939|P2|NOT COMPLETED|Overall Study||1
8371984|NCT01148979|20637940|P1|NOT COMPLETED|Overall Study||0
8371985|NCT01148979|20637939|P2|COMPLETED|Overall Study||15
8371986|NCT01148979|20637940|P1|COMPLETED|Overall Study||13
8371987|NCT01148979|20637939|P2|STARTED|Overall Study||16
8371988|NCT01148979|20637940|P1|STARTED|Overall Study||13
8371989|NCT01148940|20637948|P3|NOT COMPLETED|Overall Study||0
8371990|NCT01148940|20637949|P2|NOT COMPLETED|Overall Study||0
8371991|NCT01148940|20637950|P1|NOT COMPLETED|Overall Study||0
8371992|NCT01148940|20637948|P3|COMPLETED|Overall Study||0
8371993|NCT01148940|20637949|P2|COMPLETED|Overall Study||27
8371994|NCT01148940|20637950|P1|COMPLETED|Overall Study||7
8371995|NCT01148940|20637948|P3|STARTED|Overall Study||0
8371996|NCT01148940|20637949|P2|STARTED|Overall Study||27
8371997|NCT01148940|20637950|P1|STARTED|Overall Study||7
8371998|NCT01148862|20637958|P2|NOT COMPLETED|Second Intervention||2
8371999|NCT01148862|20637959|P1|NOT COMPLETED|Second Intervention||0
8372000|NCT01148862|20637958|P2|COMPLETED|Second Intervention||23
8372001|NCT01148862|20637959|P1|COMPLETED|Second Intervention||25
8372002|NCT01148862|20637958|P2|STARTED|Second Intervention||25
8372003|NCT01148862|20637959|P1|STARTED|Second Intervention||25
8372004|NCT01148862|20637958|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8372005|NCT01148862|20637959|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8372006|NCT01148862|20637958|P2|COMPLETED|Washout Period of 2 Weeks||25
8372007|NCT01148862|20637959|P1|COMPLETED|Washout Period of 2 Weeks||25
8372008|NCT01148862|20637958|P2|STARTED|Washout Period of 2 Weeks||25
8372009|NCT01148862|20637959|P1|STARTED|Washout Period of 2 Weeks||25
8372010|NCT01148862|20637958|P2|NOT COMPLETED|First Intervention||0
8372011|NCT01148862|20637959|P1|NOT COMPLETED|First Intervention||0
8372012|NCT01148862|20637958|P2|COMPLETED|First Intervention||25
8372013|NCT01148862|20637959|P1|COMPLETED|First Intervention||25
8372014|NCT01148862|20637958|P2|STARTED|First Intervention||25
8372015|NCT01148862|20637959|P1|STARTED|First Intervention||25
8372016|NCT01148836|20637969|P2|NOT COMPLETED|Overall Study||2
8372017|NCT01148836|20637970|P1|NOT COMPLETED|Overall Study||1
8372018|NCT01148836|20637969|P2|COMPLETED|Overall Study||8
8372019|NCT01148836|20637970|P1|COMPLETED|Overall Study|Enrollment completed|7
8372020|NCT01148836|20637969|P2|STARTED|Overall Study||10
8372021|NCT01148836|20637970|P1|STARTED|Overall Study|Enrollment completed|8
8372022|NCT01148810|20637991|P2|NOT COMPLETED|Overall Study||5
8372023|NCT01148810|20637992|P1|NOT COMPLETED|Overall Study||1
8372024|NCT01148810|20637991|P2|COMPLETED|Overall Study||5
8372025|NCT01148810|20637992|P1|COMPLETED|Overall Study||7
8372026|NCT01148810|20637991|P2|STARTED|Overall Study||10
8372027|NCT01148810|20637992|P1|STARTED|Overall Study||8
8372028|NCT01148771|20638019|P2|NOT COMPLETED|Second Intervention||0
8372029|NCT01148771|20638020|P1|NOT COMPLETED|Second Intervention||0
8372030|NCT01148771|20638019|P2|COMPLETED|Second Intervention||5
8372031|NCT01148771|20638020|P1|COMPLETED|Second Intervention||6
8372032|NCT01148771|20638019|P2|STARTED|Second Intervention||5
8372033|NCT01148771|20638020|P1|STARTED|Second Intervention||6
8372034|NCT01148771|20638019|P2|NOT COMPLETED|Washout Period||1
8372035|NCT01148771|20638020|P1|NOT COMPLETED|Washout Period||0
8372036|NCT01148771|20638019|P2|COMPLETED|Washout Period||5
8372037|NCT01148771|20638020|P1|COMPLETED|Washout Period||6
8372038|NCT01148771|20638019|P2|STARTED|Washout Period||6
8372039|NCT01148771|20638020|P1|STARTED|Washout Period||6
8372040|NCT01148771|20638019|P2|NOT COMPLETED|First Intervention||0
8372041|NCT01148771|20638020|P1|NOT COMPLETED|First Intervention||0
8372042|NCT01148771|20638019|P2|COMPLETED|First Intervention||6
8372043|NCT01148771|20638020|P1|COMPLETED|First Intervention||6
8372044|NCT01148771|20638019|P2|STARTED|First Intervention||6
8372045|NCT01148771|20638020|P1|STARTED|First Intervention||6
8372046|NCT01148745|20638032|P1|NOT COMPLETED|Overall Study||0
8372047|NCT01148745|20638032|P1|COMPLETED|Overall Study||15
8372048|NCT01148745|20638032|P1|STARTED|Overall Study||15
8372049|NCT01148693|20638040|P2|NOT COMPLETED|Overall Study||10
8372050|NCT01148693|20638041|P1|NOT COMPLETED|Overall Study||13
8372051|NCT01148693|20638040|P2|COMPLETED|Overall Study||57
8372052|NCT01148693|20638041|P1|COMPLETED|Overall Study||57
8372053|NCT01148693|20638040|P2|STARTED|Overall Study||67
8372054|NCT01148693|20638041|P1|STARTED|Overall Study||70
8372055|NCT01148563|20638049|P2|NOT COMPLETED|Overall Study||30
8372056|NCT01148563|20638050|P1|NOT COMPLETED|Overall Study||29
8372057|NCT01148563|20638049|P2|COMPLETED|Overall Study||37
8372058|NCT01148563|20638050|P1|COMPLETED|Overall Study||40
8372059|NCT01148563|20638049|P2|STARTED|Overall Study||67
8372060|NCT01148563|20638050|P1|STARTED|Overall Study||69
8372061|NCT01148537|20638061|P3|NOT COMPLETED|Overall Study||3
8372062|NCT01148537|20638062|P2|NOT COMPLETED|Overall Study||0
8372063|NCT01148537|20638063|P1|NOT COMPLETED|Overall Study||3
8372064|NCT01148537|20638061|P3|COMPLETED|Overall Study||41
8372065|NCT01148537|20638062|P2|COMPLETED|Overall Study||44
8372066|NCT01148537|20638063|P1|COMPLETED|Overall Study||41
8372067|NCT01148537|20638061|P3|STARTED|Overall Study||44
8372068|NCT01148537|20638062|P2|STARTED|Overall Study||44
8372069|NCT01148537|20638063|P1|STARTED|Overall Study||44
8372070|NCT01148524|20638093|P9|NOT COMPLETED|Overall Study||0
8372071|NCT01148524|20638094|P8|NOT COMPLETED|Overall Study||0
8372072|NCT01148524|20638095|P7|NOT COMPLETED|Overall Study||0
8372073|NCT01148524|20638096|P6|NOT COMPLETED|Overall Study||0
8372074|NCT01148524|20638097|P5|NOT COMPLETED|Overall Study||0
8372075|NCT01148524|20638098|P4|NOT COMPLETED|Overall Study||0
8372076|NCT01148524|20638099|P3|NOT COMPLETED|Overall Study||0
8372077|NCT01148524|20638100|P2|NOT COMPLETED|Overall Study||0
8372078|NCT01148524|20638101|P1|NOT COMPLETED|Overall Study||0
8372079|NCT01148524|20638093|P9|COMPLETED|Overall Study||151
8372080|NCT01148524|20638094|P8|COMPLETED|Overall Study||51
8372081|NCT01148524|20638095|P7|COMPLETED|Overall Study||153
8372082|NCT01148524|20638096|P6|COMPLETED|Overall Study||106
8372083|NCT01148524|20638097|P5|COMPLETED|Overall Study||57
8372084|NCT01148524|20638098|P4|COMPLETED|Overall Study||102
8372085|NCT01148524|20638099|P3|COMPLETED|Overall Study||53
8372086|NCT01148524|20638100|P2|COMPLETED|Overall Study||95
8372087|NCT01148524|20638101|P1|COMPLETED|Overall Study||49
8372088|NCT01148524|20638093|P9|STARTED|Overall Study||151
8372089|NCT01148524|20638094|P8|STARTED|Overall Study||51
8372090|NCT01148524|20638095|P7|STARTED|Overall Study||153
8372091|NCT01148524|20638096|P6|STARTED|Overall Study||106
8372092|NCT01148524|20638097|P5|STARTED|Overall Study||57
8372093|NCT01148524|20638098|P4|STARTED|Overall Study||102
8372094|NCT01148524|20638099|P3|STARTED|Overall Study||53
8372095|NCT01148524|20638100|P2|STARTED|Overall Study||95
8372096|NCT01148524|20638101|P1|STARTED|Overall Study||49
8372097|NCT01148511|20638149|P3|NOT COMPLETED|Randomized||6
8372098|NCT01148511|20638150|P2|NOT COMPLETED|Randomized||10
8372099|NCT01148511|20638151|P1|NOT COMPLETED|Randomized||0
8372100|NCT01148511|20638149|P3|COMPLETED|Randomized||39
8372101|NCT01148511|20638150|P2|COMPLETED|Randomized||38
8372102|NCT01148511|20638151|P1|COMPLETED|Randomized||0
8372103|NCT01148511|20638149|P3|STARTED|Randomized||45
8372104|NCT01148511|20638150|P2|STARTED|Randomized||48
8372105|NCT01148511|20638151|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
8372106|NCT01148511|20638149|P3|NOT COMPLETED|Exposed to Study Drug||0
8372107|NCT01148511|20638150|P2|NOT COMPLETED|Exposed to Study Drug||0
8372108|NCT01148511|20638151|P1|NOT COMPLETED|Exposed to Study Drug||6
8372109|NCT01148511|20638149|P3|COMPLETED|Exposed to Study Drug||0
8372110|NCT01148511|20638150|P2|COMPLETED|Exposed to Study Drug||0
8372111|NCT01148511|20638151|P1|COMPLETED|Exposed to Study Drug||93
8372112|NCT01148511|20638149|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
8372113|NCT01148511|20638150|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
8372114|NCT01148511|20638151|P1|STARTED|Exposed to Study Drug||99
8372115|NCT01148459|20638172|P2|NOT COMPLETED|Overall Study||11
8372116|NCT01148459|20638173|P1|NOT COMPLETED|Overall Study||12
8372117|NCT01148459|20638172|P2|COMPLETED|Overall Study||90
8372118|NCT01148459|20638173|P1|COMPLETED|Overall Study||87
8372119|NCT01148459|20638172|P2|STARTED|Overall Study||101
8372120|NCT01148459|20638173|P1|STARTED|Overall Study||99
8372121|NCT01148420|20638215|P1|NOT COMPLETED|Overall Study||0
8372122|NCT01148420|20638215|P1|COMPLETED|Overall Study||48
8372123|NCT01148420|20638215|P1|STARTED|Overall Study||48
8372124|NCT01148225|20638221|P1|NOT COMPLETED|Overall Study||185
8372125|NCT01148225|20638221|P1|COMPLETED|Overall Study||239
8372126|NCT01148225|20638221|P1|STARTED|Overall Study||424
8372127|NCT01148056|20638259|P1|NOT COMPLETED|Overall Study||0
8372128|NCT01148056|20638259|P1|COMPLETED|Overall Study||2
8372129|NCT01148056|20638259|P1|STARTED|Overall Study||2
8372130|NCT01148017|20638272|P4|NOT COMPLETED|Overall Study||0
8372131|NCT01148017|20638273|P3|NOT COMPLETED|Overall Study||0
8372132|NCT01148017|20638274|P2|NOT COMPLETED|Overall Study||34
8372133|NCT01148017|20638275|P1|NOT COMPLETED|Overall Study||80
8372134|NCT01148017|20638272|P4|COMPLETED|Overall Study||45
8372135|NCT01148017|20638273|P3|COMPLETED|Overall Study||53
8372136|NCT01148017|20638274|P2|COMPLETED|Overall Study||87
8372137|NCT01148017|20638275|P1|COMPLETED|Overall Study||134
8372138|NCT01148017|20638272|P4|STARTED|Overall Study||45
8372139|NCT01148017|20638273|P3|STARTED|Overall Study||53
8372140|NCT01148017|20638274|P2|STARTED|Overall Study||121
8372141|NCT01148017|20638275|P1|STARTED|Overall Study||214
8372142|NCT01147926|20638314|P2|NOT COMPLETED|Overall Study||29
8372143|NCT01147926|20638315|P1|NOT COMPLETED|Overall Study||27
8372144|NCT01147926|20638314|P2|COMPLETED|Overall Study||158
8372145|NCT01147926|20638315|P1|COMPLETED|Overall Study||160
8372146|NCT01147926|20638314|P2|STARTED|Overall Study||187
8372147|NCT01147926|20638315|P1|STARTED|Overall Study||187
8372148|NCT01147900|20638350|P3|NOT COMPLETED|At Year 10||0
8372149|NCT01147900|20638351|P2|NOT COMPLETED|At Year 10||1
8372150|NCT01147900|20638352|P1|NOT COMPLETED|At Year 10||0
8372151|NCT01147900|20638350|P3|COMPLETED|At Year 10||62
8372152|NCT01147900|20638351|P2|COMPLETED|At Year 10||59
8372153|NCT01147900|20638352|P1|COMPLETED|At Year 10||55
8372154|NCT01147900|20638350|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
8372155|NCT01147900|20638351|P2|STARTED|At Year 10||60
8372156|NCT01147900|20638352|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
8372157|NCT01147900|20638350|P3|NOT COMPLETED|At Year 8.5||0
8372158|NCT01147900|20638351|P2|NOT COMPLETED|At Year 8.5||0
8372159|NCT01147900|20638352|P1|NOT COMPLETED|At Year 8.5||0
8372160|NCT01147900|20638350|P3|COMPLETED|At Year 8.5||66
8372161|NCT01147900|20638351|P2|COMPLETED|At Year 8.5||60
8372162|NCT01147900|20638352|P1|COMPLETED|At Year 8.5||54
8372163|NCT01147900|20638350|P3|STARTED|At Year 8.5||66
8372164|NCT01147900|20638351|P2|STARTED|At Year 8.5||60
8372165|NCT01147900|20638352|P1|STARTED|At Year 8.5||54
8372166|NCT01147874|20638411|P1|NOT COMPLETED|Overall Study||67
8372167|NCT01147874|20638411|P1|COMPLETED|Overall Study||946
8372168|NCT01147874|20638411|P1|STARTED|Overall Study||1013
8372169|NCT01147848|20638419|P3|NOT COMPLETED|Randomized Phase||46
8372170|NCT01147848|20638420|P2|NOT COMPLETED|Randomized Phase||45
8372171|NCT01147848|20638421|P1|NOT COMPLETED|Randomized Phase||0
8372172|NCT01147848|20638419|P3|COMPLETED|Randomized Phase||357
8372173|NCT01147848|20638420|P2|COMPLETED|Randomized Phase||358
8372174|NCT01147848|20638421|P1|COMPLETED|Randomized Phase||0
8372175|NCT01147848|20638419|P3|STARTED|Randomized Phase||403
8372176|NCT01147848|20638420|P2|STARTED|Randomized Phase||403
8372177|NCT01147848|20638421|P1|STARTED|Randomized Phase||0
8372178|NCT01147848|20638419|P3|NOT COMPLETED|Run-in Period||0
8372179|NCT01147848|20638420|P2|NOT COMPLETED|Run-in Period||0
8372180|NCT01147848|20638421|P1|NOT COMPLETED|Run-in Period||758
8372181|NCT01147848|20638419|P3|COMPLETED|Run-in Period||0
8372182|NCT01147848|20638420|P2|COMPLETED|Run-in Period||0
8372183|NCT01147848|20638421|P1|COMPLETED|Run-in Period||806
8372184|NCT01147848|20638419|P3|STARTED|Run-in Period||0
8372185|NCT01147848|20638420|P2|STARTED|Run-in Period||0
8372186|NCT01147848|20638421|P1|STARTED|Run-in Period||1564
8372187|NCT01147822|20638453|P2|NOT COMPLETED|Overall Study||179
8372188|NCT01147822|20638454|P1|NOT COMPLETED|Overall Study||188
8372189|NCT01147822|20638453|P2|COMPLETED|Overall Study||0
8372190|NCT01147822|20638454|P1|COMPLETED|Overall Study||0
8372191|NCT01147822|20638453|P2|Not Completed/Ongoing|Overall Study||102
8372192|NCT01147822|20638454|P1|Not Completed/Ongoing|Overall Study||111
8372193|NCT01147822|20638453|P2|STARTED|Overall Study||179
8372194|NCT01147822|20638454|P1|STARTED|Overall Study||188
8372195|NCT01147809|20638474|P6|NOT COMPLETED|Phase II (168 Days)||33
8372196|NCT01147809|20638475|P5|NOT COMPLETED|Phase II (168 Days)||16
8372197|NCT01147809|20638476|P4|NOT COMPLETED|Phase II (168 Days)||0
8372198|NCT01147809|20638477|P3|NOT COMPLETED|Phase II (168 Days)||0
8372199|NCT01147809|20638478|P2|NOT COMPLETED|Phase II (168 Days)||0
8372200|NCT01147809|20638479|P1|NOT COMPLETED|Phase II (168 Days)||0
8372201|NCT01147809|20638474|P6|COMPLETED|Phase II (168 Days)||19
8372202|NCT01147809|20638475|P5|COMPLETED|Phase II (168 Days)||7
8372203|NCT01147809|20638476|P4|COMPLETED|Phase II (168 Days)||0
8372204|NCT01147809|20638477|P3|COMPLETED|Phase II (168 Days)||0
8372205|NCT01147809|20638478|P2|COMPLETED|Phase II (168 Days)||0
8372206|NCT01147809|20638479|P1|COMPLETED|Phase II (168 Days)||0
8372207|NCT01147809|20638474|P6|Ongoing|Phase II (168 Days)||0
8372208|NCT01147809|20638475|P5|Ongoing|Phase II (168 Days)||1
8372209|NCT01147809|20638476|P4|Ongoing|Phase II (168 Days)||0
8372210|NCT01147809|20638477|P3|Ongoing|Phase II (168 Days)||0
8372211|NCT01147809|20638478|P2|Ongoing|Phase II (168 Days)||0
8372212|NCT01147809|20638479|P1|Ongoing|Phase II (168 Days)||0
8372213|NCT01147809|20638474|P6|STARTED|Phase II (168 Days)||52
8372214|NCT01147809|20638475|P5|STARTED|Phase II (168 Days)||23
8372215|NCT01147809|20638476|P4|STARTED|Phase II (168 Days)||0
8372216|NCT01147809|20638477|P3|STARTED|Phase II (168 Days)||0
8372217|NCT01147809|20638478|P2|STARTED|Phase II (168 Days)||0
8372218|NCT01147809|20638479|P1|STARTED|Phase II (168 Days)||0
8372219|NCT01147809|20638474|P6|NOT COMPLETED|Phase I (168 Days)||0
8372220|NCT01147809|20638475|P5|NOT COMPLETED|Phase I (168 Days)||0
8372221|NCT01147809|20638476|P4|NOT COMPLETED|Phase I (168 Days)||5
8372222|NCT01147809|20638477|P3|NOT COMPLETED|Phase I (168 Days)||2
8372223|NCT01147809|20638478|P2|NOT COMPLETED|Phase I (168 Days)||1
8372224|NCT01147809|20638479|P1|NOT COMPLETED|Phase I (168 Days)||1
8372225|NCT01147809|20638474|P6|COMPLETED|Phase I (168 Days)||0
8372226|NCT01147809|20638475|P5|COMPLETED|Phase I (168 Days)||0
8372227|NCT01147809|20638476|P4|COMPLETED|Phase I (168 Days)||5
8372228|NCT01147809|20638477|P3|COMPLETED|Phase I (168 Days)||2
8372229|NCT01147809|20638478|P2|COMPLETED|Phase I (168 Days)||8
8372230|NCT01147809|20638479|P1|COMPLETED|Phase I (168 Days)||2
8372231|NCT01147809|20638474|P6|STARTED|Phase I (168 Days)||0
8372232|NCT01147809|20638475|P5|STARTED|Phase I (168 Days)||0
8372233|NCT01147809|20638476|P4|STARTED|Phase I (168 Days)||10
8372234|NCT01147809|20638477|P3|STARTED|Phase I (168 Days)||4
8372235|NCT01147809|20638478|P2|STARTED|Phase I (168 Days)||9
8372236|NCT01147809|20638479|P1|STARTED|Phase I (168 Days)||3
8372237|NCT01147744|20638600|P7|NOT COMPLETED|Overall Study||19
8372238|NCT01147744|20638601|P6|NOT COMPLETED|Overall Study||20
8372239|NCT01147744|20638602|P5|NOT COMPLETED|Overall Study||25
8372240|NCT01147744|20638603|P4|NOT COMPLETED|Overall Study||18
8372241|NCT01147744|20638604|P3|NOT COMPLETED|Overall Study||18
8372242|NCT01147744|20638605|P2|NOT COMPLETED|Overall Study||23
8372243|NCT01147744|20638606|P1|NOT COMPLETED|Overall Study||29
8372244|NCT01147744|20638600|P7|COMPLETED|Overall Study||78
8372245|NCT01147744|20638601|P6|COMPLETED|Overall Study||83
8372246|NCT01147744|20638602|P5|COMPLETED|Overall Study||76
8372247|NCT01147744|20638603|P4|COMPLETED|Overall Study||82
8372248|NCT01147744|20638604|P3|COMPLETED|Overall Study||82
8372249|NCT01147744|20638605|P2|COMPLETED|Overall Study||76
8372250|NCT01147744|20638606|P1|COMPLETED|Overall Study||71
8372251|NCT01147744|20638600|P7|STARTED|Overall Study||97
8372252|NCT01147744|20638601|P6|STARTED|Overall Study||103
8372253|NCT01147744|20638602|P5|STARTED|Overall Study||101
8372254|NCT01147744|20638603|P4|STARTED|Overall Study||100
8372255|NCT01147744|20638604|P3|STARTED|Overall Study||100
8372256|NCT01147744|20638605|P2|STARTED|Overall Study||99
8372257|NCT01147744|20638606|P1|STARTED|Overall Study||100
8372258|NCT01147653|20638701|P2|NOT COMPLETED|Year 2||3
8372259|NCT01147653|20638702|P1|NOT COMPLETED|Year 2||2
8372260|NCT01147653|20638701|P2|COMPLETED|Year 2||28
8372261|NCT01147653|20638702|P1|COMPLETED|Year 2||30
8372262|NCT01147653|20638701|P2|STARTED|Year 2||31
8372263|NCT01147653|20638702|P1|STARTED|Year 2||32
8372264|NCT01147653|20638701|P2|NOT COMPLETED|Year 1||0
8372265|NCT01147653|20638702|P1|NOT COMPLETED|Year 1||0
8372266|NCT01147653|20638701|P2|COMPLETED|Year 1||31
8372267|NCT01147653|20638702|P1|COMPLETED|Year 1||32
8372268|NCT01147653|20638701|P2|STARTED|Year 1||31
8372269|NCT01147653|20638702|P1|STARTED|Year 1||32
8372270|NCT01147640|20638763|P2|NOT COMPLETED|Overall Study||1
8372271|NCT01147640|20638764|P1|NOT COMPLETED|Overall Study||5
8372272|NCT01147640|20638763|P2|COMPLETED|Overall Study||38
8372273|NCT01147640|20638764|P1|COMPLETED|Overall Study||78
8372274|NCT01147640|20638763|P2|STARTED|Overall Study||39
8372275|NCT01147640|20638764|P1|STARTED|Overall Study||83
8372276|NCT01147627|20638775|P3|NOT COMPLETED|Overall Study||18
8372277|NCT01147627|20638776|P2|NOT COMPLETED|Overall Study||24
8372278|NCT01147627|20638777|P1|NOT COMPLETED|Overall Study||32
8372279|NCT01147627|20638775|P3|COMPLETED|Overall Study||118
8372280|NCT01147627|20638776|P2|COMPLETED|Overall Study||114
8372281|NCT01147627|20638777|P1|COMPLETED|Overall Study||110
8372282|NCT01147627|20638775|P3|STARTED|Overall Study||136
8372283|NCT01147627|20638776|P2|STARTED|Overall Study||138
8372284|NCT01147627|20638777|P1|STARTED|Overall Study||142
8372285|NCT01147601|20638787|P2|NOT COMPLETED|Overall Study||0
8372286|NCT01147601|20638788|P1|NOT COMPLETED|Overall Study||3
8372287|NCT01147601|20638787|P2|COMPLETED|Overall Study||1
8372288|NCT01147601|20638788|P1|COMPLETED|Overall Study||2
8372289|NCT01147601|20638787|P2|STARTED|Overall Study||1
8372290|NCT01147601|20638788|P1|STARTED|Overall Study||5
8372291|NCT01147497|20638796|P2|NOT COMPLETED|Overall Study||0
8372292|NCT01147497|20638797|P1|NOT COMPLETED|Overall Study||2
8372293|NCT01147497|20638796|P2|COMPLETED|Overall Study||36
8372294|NCT01147497|20638797|P1|COMPLETED|Overall Study||35
8372295|NCT01147497|20638796|P2|STARTED|Overall Study||36
8372296|NCT01147497|20638797|P1|STARTED|Overall Study||37
8372297|NCT01147471|20638817|P2|NOT COMPLETED|6 Month Follow Up||2
8372298|NCT01147471|20638818|P1|NOT COMPLETED|6 Month Follow Up||4
8372299|NCT01147471|20638817|P2|COMPLETED|6 Month Follow Up||4
8372300|NCT01147471|20638818|P1|COMPLETED|6 Month Follow Up||8
8372301|NCT01147471|20638817|P2|STARTED|6 Month Follow Up||6
8372302|NCT01147471|20638818|P1|STARTED|6 Month Follow Up||12
8372303|NCT01147471|20638817|P2|NOT COMPLETED|3 Month Follow Up||2
8372304|NCT01147471|20638818|P1|NOT COMPLETED|3 Month Follow Up||1
8372305|NCT01147471|20638817|P2|COMPLETED|3 Month Follow Up||6
8372306|NCT01147471|20638818|P1|COMPLETED|3 Month Follow Up||12
8372307|NCT01147471|20638817|P2|STARTED|3 Month Follow Up||8
8372308|NCT01147471|20638818|P1|STARTED|3 Month Follow Up||13
8372309|NCT01147471|20638817|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
8372310|NCT01147471|20638818|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
8372311|NCT01147471|20638817|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
8372312|NCT01147471|20638818|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
8372313|NCT01147471|20638817|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
8372314|NCT01147471|20638818|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
8372315|NCT01147471|20638817|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
8372316|NCT01147471|20638818|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
8372317|NCT01147471|20638817|P2|COMPLETED|Through Initial Hospital Discharge||11
8372318|NCT01147471|20638818|P1|COMPLETED|Through Initial Hospital Discharge||13
8372319|NCT01147471|20638817|P2|STARTED|Through Initial Hospital Discharge||11
8372320|NCT01147471|20638818|P1|STARTED|Through Initial Hospital Discharge||13
8372321|NCT01147458|20638832|P4|NOT COMPLETED|Second Intervention||4
8372322|NCT01147458|20638833|P3|NOT COMPLETED|Second Intervention||8
8372323|NCT01147458|20638834|P2|NOT COMPLETED|Second Intervention||7
8372324|NCT01147458|20638835|P1|NOT COMPLETED|Second Intervention||9
8372325|NCT01147458|20638832|P4|COMPLETED|Second Intervention||30
8372326|NCT01147458|20638833|P3|COMPLETED|Second Intervention||27
8372327|NCT01147458|20638834|P2|COMPLETED|Second Intervention||24
8372328|NCT01147458|20638835|P1|COMPLETED|Second Intervention||25
8372329|NCT01147458|20638832|P4|STARTED|Second Intervention||34
8372330|NCT01147458|20638833|P3|STARTED|Second Intervention||35
8372331|NCT01147458|20638834|P2|STARTED|Second Intervention||31
8372332|NCT01147458|20638835|P1|STARTED|Second Intervention||34
8372333|NCT01147458|20638832|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8372334|NCT01147458|20638833|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8372335|NCT01147458|20638834|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8372336|NCT01147458|20638835|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8372337|NCT01147458|20638832|P4|COMPLETED|Washout Period of 2 Weeks||34
8372338|NCT01147458|20638833|P3|COMPLETED|Washout Period of 2 Weeks||35
8372339|NCT01147458|20638834|P2|COMPLETED|Washout Period of 2 Weeks||31
8372340|NCT01147458|20638835|P1|COMPLETED|Washout Period of 2 Weeks||34
8372341|NCT01147458|20638832|P4|STARTED|Washout Period of 2 Weeks||34
8372342|NCT01147458|20638833|P3|STARTED|Washout Period of 2 Weeks||35
8372343|NCT01147458|20638834|P2|STARTED|Washout Period of 2 Weeks||31
8372344|NCT01147458|20638835|P1|STARTED|Washout Period of 2 Weeks||34
8372345|NCT01147458|20638832|P4|NOT COMPLETED|First Intervention||14
8372346|NCT01147458|20638833|P3|NOT COMPLETED|First Intervention||12
8372347|NCT01147458|20638834|P2|NOT COMPLETED|First Intervention||16
8372348|NCT01147458|20638835|P1|NOT COMPLETED|First Intervention||14
8372349|NCT01147458|20638832|P4|COMPLETED|First Intervention||34
8372350|NCT01147458|20638833|P3|COMPLETED|First Intervention||35
8372351|NCT01147458|20638834|P2|COMPLETED|First Intervention||31
8372352|NCT01147458|20638835|P1|COMPLETED|First Intervention||34
8372353|NCT01147458|20638832|P4|STARTED|First Intervention||48
8372354|NCT01147458|20638833|P3|STARTED|First Intervention||47
8372355|NCT01147458|20638834|P2|STARTED|First Intervention||47
8372356|NCT01147458|20638835|P1|STARTED|First Intervention||48
8372357|NCT01147406|20638889|P6|NOT COMPLETED|Overall Study||0
8372358|NCT01147406|20638890|P5|NOT COMPLETED|Overall Study||0
8372359|NCT01147406|20638891|P4|NOT COMPLETED|Overall Study||0
8372360|NCT01147406|20638892|P3|NOT COMPLETED|Overall Study||0
8372361|NCT01147406|20638893|P2|NOT COMPLETED|Overall Study||0
8372362|NCT01147406|20638894|P1|NOT COMPLETED|Overall Study||0
8372363|NCT01147406|20638889|P6|COMPLETED|Overall Study||10
8372364|NCT01147406|20638890|P5|COMPLETED|Overall Study||6
8372365|NCT01147406|20638891|P4|COMPLETED|Overall Study||6
8372366|NCT01147406|20638892|P3|COMPLETED|Overall Study||1
8372367|NCT01147406|20638893|P2|COMPLETED|Overall Study||12
8372368|NCT01147406|20638894|P1|COMPLETED|Overall Study||6
8372369|NCT01147406|20638889|P6|STARTED|Overall Study||10
8372370|NCT01147406|20638890|P5|STARTED|Overall Study||6
8372371|NCT01147406|20638891|P4|STARTED|Overall Study||6
8372372|NCT01147406|20638892|P3|STARTED|Overall Study||1
8372373|NCT01147406|20638893|P2|STARTED|Overall Study||12
8372374|NCT01147406|20638894|P1|STARTED|Overall Study||6
8372375|NCT01147393|20638914|P1|NOT COMPLETED|Dose Level -1||1
8372376|NCT01147393|20638914|P1|COMPLETED|Dose Level -1||0
8372377|NCT01147393|20638914|P1|STARTED|Dose Level -1||1
8372378|NCT01147393|20638914|P1|NOT COMPLETED|Dose Level 1||2
8372379|NCT01147393|20638914|P1|COMPLETED|Dose Level 1||1
8372380|NCT01147393|20638914|P1|STARTED|Dose Level 1||3
8372381|NCT01147380|20638924|P2|NOT COMPLETED|Overall Study||0
8372382|NCT01147380|20638925|P1|NOT COMPLETED|Overall Study||0
8372383|NCT01147380|20638924|P2|COMPLETED|Overall Study||12
8372384|NCT01147380|20638925|P1|COMPLETED|Overall Study||6
8372385|NCT01147380|20638924|P2|STARTED|Overall Study||12
8372386|NCT01147380|20638925|P1|STARTED|Overall Study||6
8372387|NCT01147341|20638935|P2|NOT COMPLETED|Open Label Period||0
8372388|NCT01147341|20638936|P1|NOT COMPLETED|Open Label Period||4
8372389|NCT01147341|20638935|P2|COMPLETED|Open Label Period||8
8372390|NCT01147341|20638936|P1|COMPLETED|Open Label Period||22
8372391|NCT01147341|20638935|P2|STARTED|Open Label Period||8
8372392|NCT01147341|20638936|P1|STARTED|Open Label Period||26
8372393|NCT01147341|20638935|P2|NOT COMPLETED|Double Blind Period||2
8372394|NCT01147341|20638936|P1|NOT COMPLETED|Double Blind Period||1
8372395|NCT01147341|20638935|P2|COMPLETED|Double Blind Period||8
8372396|NCT01147341|20638936|P1|COMPLETED|Double Blind Period||26
8372397|NCT01147341|20638935|P2|STARTED|Double Blind Period||10
8372398|NCT01147341|20638936|P1|STARTED|Double Blind Period||27
8372399|NCT01147302|20638966|P2|NOT COMPLETED|Overall Study||0
8372400|NCT01147302|20638967|P1|NOT COMPLETED|Overall Study||0
8372401|NCT01147302|20638966|P2|COMPLETED|Overall Study||9
8372402|NCT01147302|20638967|P1|COMPLETED|Overall Study||9
8372403|NCT01147302|20638966|P2|STARTED|Overall Study||9
8372404|NCT01147302|20638967|P1|STARTED|Overall Study||9
8372405|NCT01147250|20638999|P2|NOT COMPLETED|Overall Study||105
8372406|NCT01147250|20639000|P1|NOT COMPLETED|Overall Study||110
8372407|NCT01147250|20638999|P2|COMPLETED|Overall Study||2929
8372408|NCT01147250|20639000|P1|COMPLETED|Overall Study||2924
8372409|NCT01147250|20638999|P2|Treated|Overall Study||3031
8372410|NCT01147250|20639000|P1|Treated|Overall Study||3032
8372411|NCT01147250|20638999|P2|STARTED|Overall Study||3034
8372412|NCT01147250|20639000|P1|STARTED|Overall Study||3034
8372413|NCT01147172|20639012|P1|NOT COMPLETED|Overall Study||4
8372414|NCT01147172|20639012|P1|COMPLETED|Overall Study||96
8372415|NCT01147172|20639012|P1|STARTED|Overall Study||100
8372416|NCT01147068|20639030|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372417|NCT01147068|20639031|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372418|NCT01147068|20639032|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
8372419|NCT01147068|20639033|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
8372420|NCT01147068|20639034|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
8372421|NCT01147068|20639035|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372422|NCT01147068|20639036|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372423|NCT01147068|20639030|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
8372424|NCT01147068|20639031|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
8372425|NCT01147068|20639032|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
8372426|NCT01147068|20639033|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
8372427|NCT01147068|20639034|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
8372428|NCT01147068|20639035|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
8372429|NCT01147068|20639036|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
8372430|NCT01147068|20639030|P7|STARTED|Subjects That Completed Safety Follow-up||55
8372431|NCT01147068|20639031|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
8372432|NCT01147068|20639032|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
8372433|NCT01147068|20639033|P4|STARTED|Subjects That Completed Safety Follow-up||56
8372434|NCT01147068|20639034|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
8372435|NCT01147068|20639035|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
8372436|NCT01147068|20639036|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
8372437|NCT01147068|20639030|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
8372438|NCT01147068|20639031|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
8372439|NCT01147068|20639032|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
8372440|NCT01147068|20639033|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
8372441|NCT01147068|20639034|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
8372442|NCT01147068|20639035|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
8372443|NCT01147068|20639036|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
8372444|NCT01147068|20639030|P7|COMPLETED|Subjects That Received 2nd Dose||55
8372445|NCT01147068|20639031|P6|COMPLETED|Subjects That Received 2nd Dose||51
8372446|NCT01147068|20639032|P5|COMPLETED|Subjects That Received 2nd Dose||55
8372447|NCT01147068|20639033|P4|COMPLETED|Subjects That Received 2nd Dose||56
8372448|NCT01147068|20639034|P3|COMPLETED|Subjects That Received 2nd Dose||52
8372449|NCT01147068|20639035|P2|COMPLETED|Subjects That Received 2nd Dose||52
8372450|NCT01147068|20639036|P1|COMPLETED|Subjects That Received 2nd Dose||59
8372451|NCT01147068|20639030|P7|STARTED|Subjects That Received 2nd Dose||55
8372452|NCT01147068|20639031|P6|STARTED|Subjects That Received 2nd Dose||53
8372453|NCT01147068|20639032|P5|STARTED|Subjects That Received 2nd Dose||56
8372454|NCT01147068|20639033|P4|STARTED|Subjects That Received 2nd Dose||56
8372455|NCT01147068|20639034|P3|STARTED|Subjects That Received 2nd Dose||55
8372456|NCT01147068|20639035|P2|STARTED|Subjects That Received 2nd Dose||57
8372457|NCT01147068|20639036|P1|STARTED|Subjects That Received 2nd Dose||60
8372458|NCT01147068|20639030|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
8372459|NCT01147068|20639031|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
8372460|NCT01147068|20639032|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
8372461|NCT01147068|20639033|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
8372462|NCT01147068|20639034|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
8372463|NCT01147068|20639035|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
8372464|NCT01147068|20639036|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
8372465|NCT01147068|20639030|P7|COMPLETED|Subjects That Received 1st Dose||55
8372466|NCT01147068|20639031|P6|COMPLETED|Subjects That Received 1st Dose||53
8372467|NCT01147068|20639032|P5|COMPLETED|Subjects That Received 1st Dose||56
8372468|NCT01147068|20639033|P4|COMPLETED|Subjects That Received 1st Dose||56
8372469|NCT01147068|20639034|P3|COMPLETED|Subjects That Received 1st Dose||55
8372470|NCT01147068|20639035|P2|COMPLETED|Subjects That Received 1st Dose||57
8372471|NCT01147068|20639036|P1|COMPLETED|Subjects That Received 1st Dose||60
8372472|NCT01147068|20639030|P7|STARTED|Subjects That Received 1st Dose||55
8372473|NCT01147068|20639031|P6|STARTED|Subjects That Received 1st Dose||53
8372474|NCT01147068|20639032|P5|STARTED|Subjects That Received 1st Dose||56
8372475|NCT01147068|20639033|P4|STARTED|Subjects That Received 1st Dose||56
8372476|NCT01147068|20639034|P3|STARTED|Subjects That Received 1st Dose||55
8372477|NCT01147068|20639035|P2|STARTED|Subjects That Received 1st Dose||57
8372478|NCT01147068|20639036|P1|STARTED|Subjects That Received 1st Dose||60
8372479|NCT01147055|20639066|P2|NOT COMPLETED|Second Intervention Period||0
8372480|NCT01147055|20639067|P1|NOT COMPLETED|Second Intervention Period||0
8372481|NCT01147055|20639066|P2|COMPLETED|Second Intervention Period||14
8372482|NCT01147055|20639067|P1|COMPLETED|Second Intervention Period||0
8372483|NCT01147055|20639066|P2|STARTED|Second Intervention Period||14
8372484|NCT01147055|20639067|P1|STARTED|Second Intervention Period||0
8372485|NCT01147055|20639066|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8372486|NCT01147055|20639067|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8372487|NCT01147055|20639066|P2|COMPLETED|Washout Period (at Least 14 Days)||0
8372488|NCT01147055|20639067|P1|COMPLETED|Washout Period (at Least 14 Days)||14
8372489|NCT01147055|20639066|P2|STARTED|Washout Period (at Least 14 Days)||0
8372490|NCT01147055|20639067|P1|STARTED|Washout Period (at Least 14 Days)||14
8372491|NCT01147055|20639066|P2|NOT COMPLETED|First Intervention Period||0
8372492|NCT01147055|20639067|P1|NOT COMPLETED|First Intervention Period||1
8372493|NCT01147055|20639066|P2|COMPLETED|First Intervention Period||0
8372494|NCT01147055|20639067|P1|COMPLETED|First Intervention Period||14
8372495|NCT01147055|20639066|P2|STARTED|First Intervention Period||0
8372496|NCT01147055|20639067|P1|STARTED|First Intervention Period||15
8372497|NCT01147042|20639101|P2|NOT COMPLETED|Overall Study||0
8372498|NCT01147042|20639102|P1|NOT COMPLETED|Overall Study||0
8372499|NCT01147042|20639101|P2|COMPLETED|Overall Study||0
8372500|NCT01147042|20639102|P1|COMPLETED|Overall Study||2
8372501|NCT01147042|20639101|P2|STARTED|Overall Study||0
8372502|NCT01147042|20639102|P1|STARTED|Overall Study||2
8372503|NCT01146951|20639109|P2|NOT COMPLETED|Overall Study||1
8372504|NCT01146951|20639110|P1|NOT COMPLETED|Overall Study||4
8372505|NCT01146951|20639109|P2|COMPLETED|Overall Study||29
8372506|NCT01146951|20639110|P1|COMPLETED|Overall Study||25
8372507|NCT01146951|20639109|P2|STARTED|Overall Study||30
8372508|NCT01146951|20639110|P1|STARTED|Overall Study||29
8372509|NCT01146912|20639131|P8|NOT COMPLETED|Overall Study||0
8372510|NCT01146912|20639132|P7|NOT COMPLETED|Overall Study||56
8372511|NCT01146912|20639133|P6|NOT COMPLETED|Overall Study||61
8372512|NCT01146912|20639134|P5|NOT COMPLETED|Overall Study||41
8372513|NCT01146912|20639135|P4|NOT COMPLETED|Overall Study||17
8372514|NCT01146912|20639136|P3|NOT COMPLETED|Overall Study||17
8372515|NCT01146912|20639137|P2|NOT COMPLETED|Overall Study||822
8372516|NCT01146912|20639138|P1|NOT COMPLETED|Overall Study||817
8372517|NCT01146912|20639131|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
8372518|NCT01146912|20639132|P7|COMPLETED|Overall Study||1764
8372519|NCT01146912|20639133|P6|COMPLETED|Overall Study||1760
8372520|NCT01146912|20639134|P5|COMPLETED|Overall Study||1780
8372521|NCT01146912|20639135|P4|COMPLETED|Overall Study||577
8372522|NCT01146912|20639136|P3|COMPLETED|Overall Study||576
8372523|NCT01146912|20639137|P2|COMPLETED|Overall Study||3784
8372524|NCT01146912|20639138|P1|COMPLETED|Overall Study||3790
8372525|NCT01146912|20639131|P8|STARTED|Overall Study||14675
8372526|NCT01146912|20639132|P7|STARTED|Overall Study||1820
8372527|NCT01146912|20639133|P6|STARTED|Overall Study||1821
8372528|NCT01146912|20639134|P5|STARTED|Overall Study||1821
8372529|NCT01146912|20639135|P4|STARTED|Overall Study||594
8372530|NCT01146912|20639136|P3|STARTED|Overall Study||593
8372531|NCT01146912|20639137|P2|STARTED|Overall Study||4606
8372532|NCT01146912|20639138|P1|STARTED|Overall Study||4607
8372533|NCT01146873|20639160|P2|NOT COMPLETED|Overall Study||6
8372534|NCT01146873|20639161|P1|NOT COMPLETED|Overall Study||0
8372535|NCT01146873|20639160|P2|COMPLETED|Overall Study||144
8372536|NCT01146873|20639161|P1|COMPLETED|Overall Study||148
8372537|NCT01146873|20639160|P2|STARTED|Overall Study||150
8372538|NCT01146873|20639161|P1|STARTED|Overall Study||148
8372539|NCT01146860|20639177|P2|NOT COMPLETED|Overall Study||1
8372540|NCT01146860|20639178|P1|NOT COMPLETED|Overall Study||0
8372541|NCT01146860|20639177|P2|COMPLETED|Overall Study||191
8372542|NCT01146860|20639178|P1|COMPLETED|Overall Study||194
8372543|NCT01146860|20639177|P2|STARTED|Overall Study||192
8372544|NCT01146860|20639178|P1|STARTED|Overall Study||194
8372545|NCT01146834|20639197|P5|NOT COMPLETED|Overall Study||0
8372546|NCT01146834|20639198|P4|NOT COMPLETED|Overall Study||0
8372547|NCT01146834|20639199|P3|NOT COMPLETED|Overall Study||2
8372548|NCT01146834|20639200|P2|NOT COMPLETED|Overall Study||0
8372549|NCT01146834|20639201|P1|NOT COMPLETED|Overall Study||3
8372550|NCT01146834|20639197|P5|COMPLETED|Overall Study||0
8372551|NCT01146834|20639198|P4|COMPLETED|Overall Study||0
8372552|NCT01146834|20639199|P3|COMPLETED|Overall Study||21
8372553|NCT01146834|20639200|P2|COMPLETED|Overall Study||4
8372554|NCT01146834|20639201|P1|COMPLETED|Overall Study||17
8372555|NCT01146834|20639197|P5|STARTED|Overall Study||0
8372556|NCT01146834|20639198|P4|STARTED|Overall Study||0
8372557|NCT01146834|20639199|P3|STARTED|Overall Study||23
8372558|NCT01146834|20639200|P2|STARTED|Overall Study||4
8372559|NCT01146834|20639201|P1|STARTED|Overall Study||20
8372560|NCT01146808|20639223|P1|NOT COMPLETED|Overall Study||0
8372561|NCT01146808|20639223|P1|COMPLETED|Overall Study||16
8372562|NCT01146808|20639223|P1|STARTED|Overall Study||16
8372563|NCT01146782|20639229|P1|NOT COMPLETED|Primary Endpoint Cohort||6
8372564|NCT01146782|20639229|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
8372565|NCT01146782|20639229|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
8372566|NCT01146782|20639229|P1|NOT COMPLETED|Safety Cohort||83
8372567|NCT01146782|20639229|P1|COMPLETED|Safety Cohort||63
8372568|NCT01146782|20639229|P1|STARTED|Safety Cohort||146
8372569|NCT01146782|20639229|P1|NOT COMPLETED|Screening Cohort||221
8372570|NCT01146782|20639229|P1|COMPLETED|Screening Cohort||146
8372571|NCT01146782|20639229|P1|STARTED|Screening Cohort||367
8372578|NCT01146665|20639247|P2|NOT COMPLETED|Overall Study||16
8372579|NCT01146665|20639248|P1|NOT COMPLETED|Overall Study||10
8372580|NCT01146665|20639247|P2|COMPLETED|Overall Study||10
8372581|NCT01146665|20639248|P1|COMPLETED|Overall Study||8
8372582|NCT01146665|20639247|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
8372583|NCT01146665|20639248|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
8372584|NCT01146665|20639247|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
8372585|NCT01146665|20639248|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
8372586|NCT01146665|20639247|P2|STARTED|Overall Study||26
8372587|NCT01146665|20639248|P1|STARTED|Overall Study||18
8372588|NCT01146613|20639280|P2|NOT COMPLETED|Overall Study||12
8372589|NCT01146613|20639281|P1|NOT COMPLETED|Overall Study||7
8372590|NCT01146613|20639280|P2|COMPLETED|Overall Study||89
8372591|NCT01146613|20639281|P1|COMPLETED|Overall Study||92
8372592|NCT01146613|20639280|P2|STARTED|Overall Study||101
8372593|NCT01146613|20639281|P1|STARTED|Overall Study||99
8372594|NCT01146600|20639289|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
8372595|NCT01146600|20639290|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
8372596|NCT01146600|20639289|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
8372597|NCT01146600|20639290|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
8372598|NCT01146600|20639289|P2|STARTED|Period 2 (Weeks 4 & 5)||10
8372599|NCT01146600|20639290|P1|STARTED|Period 2 (Weeks 4 & 5)||10
8372600|NCT01146600|20639289|P2|NOT COMPLETED|Washout (Week 3)||0
8372601|NCT01146600|20639290|P1|NOT COMPLETED|Washout (Week 3)||0
8372602|NCT01146600|20639289|P2|COMPLETED|Washout (Week 3)||10
8372603|NCT01146600|20639290|P1|COMPLETED|Washout (Week 3)||10
8372604|NCT01146600|20639289|P2|STARTED|Washout (Week 3)||10
8372605|NCT01146600|20639290|P1|STARTED|Washout (Week 3)||10
8372606|NCT01146600|20639289|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
8372607|NCT01146600|20639290|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
8372608|NCT01146600|20639289|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
8372609|NCT01146600|20639290|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
8372610|NCT01146600|20639289|P2|STARTED|Period 1 (Weeks 1 & 2)||10
8372611|NCT01146600|20639290|P1|STARTED|Period 1 (Weeks 1 & 2)||13
8372612|NCT01146496|20639317|P2|NOT COMPLETED|Overall Study||0
8372613|NCT01146496|20639318|P1|NOT COMPLETED|Overall Study||0
8372614|NCT01146496|20639317|P2|COMPLETED|Overall Study||109693
8372615|NCT01146496|20639318|P1|COMPLETED|Overall Study||114168
8372616|NCT01146496|20639317|P2|STARTED|Overall Study||109693
8372617|NCT01146496|20639318|P1|STARTED|Overall Study||114168
8372618|NCT01146457|20639339|P5|NOT COMPLETED|Overall Study||0
8372619|NCT01146457|20639340|P4|NOT COMPLETED|Overall Study||0
8372620|NCT01146457|20639341|P3|NOT COMPLETED|Overall Study||1
8372621|NCT01146457|20639342|P2|NOT COMPLETED|Overall Study||0
8372622|NCT01146457|20639343|P1|NOT COMPLETED|Overall Study||0
8372623|NCT01146457|20639339|P5|COMPLETED|Overall Study||13
8372624|NCT01146457|20639340|P4|COMPLETED|Overall Study||13
8372625|NCT01146457|20639341|P3|COMPLETED|Overall Study||20
8372626|NCT01146457|20639342|P2|COMPLETED|Overall Study||17
8372627|NCT01146457|20639343|P1|COMPLETED|Overall Study||19
8372628|NCT01146457|20639339|P5|STARTED|Overall Study||13
8372629|NCT01146457|20639340|P4|STARTED|Overall Study||13
8372630|NCT01146457|20639341|P3|STARTED|Overall Study||21
8372631|NCT01146457|20639342|P2|STARTED|Overall Study||17
8372632|NCT01146457|20639343|P1|STARTED|Overall Study||19
8372633|NCT01146418|20639357|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
8372634|NCT01146418|20639358|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
8372635|NCT01146418|20639359|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
8372636|NCT01146418|20639360|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
8372637|NCT01146418|20639357|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
8372638|NCT01146418|20639358|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
8372639|NCT01146418|20639359|P2|COMPLETED|Live-Born Infant Follow Up||0
8372640|NCT01146418|20639360|P1|COMPLETED|Live-Born Infant Follow Up||0
8372641|NCT01146418|20639357|P4|STARTED|Live-Born Infant Follow Up||56
8372642|NCT01146418|20639358|P3|STARTED|Live-Born Infant Follow Up||61
8372643|NCT01146418|20639359|P2|STARTED|Live-Born Infant Follow Up||0
8372644|NCT01146418|20639360|P1|STARTED|Live-Born Infant Follow Up||0
8372645|NCT01146418|20639357|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
8372646|NCT01146418|20639358|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
8372647|NCT01146418|20639359|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
8372648|NCT01146418|20639360|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
8372649|NCT01146418|20639357|P4|COMPLETED|Women/Expectant Mother Follow Up||0
8372650|NCT01146418|20639358|P3|COMPLETED|Women/Expectant Mother Follow Up||0
8372651|NCT01146418|20639359|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
8372652|NCT01146418|20639360|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
8372653|NCT01146418|20639357|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
8372654|NCT01146418|20639358|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
8372655|NCT01146418|20639359|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
8372656|NCT01146418|20639360|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
8372657|NCT01146418|20639357|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
8372658|NCT01146418|20639358|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
8372659|NCT01146418|20639359|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
8372660|NCT01146418|20639360|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
8372661|NCT01146418|20639357|P4|STARTED|Women/Expectant Mother Follow Up||0
8372662|NCT01146418|20639358|P3|STARTED|Women/Expectant Mother Follow Up||0
8372663|NCT01146418|20639359|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
8372664|NCT01146418|20639360|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
8372665|NCT01146418|20639357|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
8372666|NCT01146418|20639358|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
8372667|NCT01146418|20639359|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
8372668|NCT01146418|20639360|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
8372669|NCT01146418|20639357|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
8372670|NCT01146418|20639358|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
8372671|NCT01146418|20639359|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
8372672|NCT01146418|20639360|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
8372673|NCT01146418|20639357|P4|STARTED|Base Study P06029 (NCT01144416)||0
8372674|NCT01146418|20639358|P3|STARTED|Base Study P06029 (NCT01144416)||0
8372675|NCT01146418|20639359|P2|STARTED|Base Study P06029 (NCT01144416)||696
8372676|NCT01146418|20639360|P1|STARTED|Base Study P06029 (NCT01144416)||694
8372677|NCT01146379|20639376|P4|NOT COMPLETED|Overall Study||1
8372678|NCT01146379|20639377|P3|NOT COMPLETED|Overall Study||0
8372679|NCT01146379|20639378|P2|NOT COMPLETED|Overall Study||1
8372680|NCT01146379|20639379|P1|NOT COMPLETED|Overall Study||1
8372681|NCT01146379|20639376|P4|COMPLETED|Overall Study||20
8372682|NCT01146379|20639377|P3|COMPLETED|Overall Study||21
8372683|NCT01146379|20639378|P2|COMPLETED|Overall Study||21
8372684|NCT01146379|20639379|P1|COMPLETED|Overall Study||20
8372685|NCT01146379|20639376|P4|STARTED|Overall Study||21
8372686|NCT01146379|20639377|P3|STARTED|Overall Study||21
8372687|NCT01146379|20639378|P2|STARTED|Overall Study||22
8372688|NCT01146379|20639379|P1|STARTED|Overall Study||21
8372689|NCT01146288|20639391|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8372690|NCT01146288|20639392|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8372691|NCT01146288|20639391|P2|COMPLETED|Second Intervention (1 Day)||5
8372692|NCT01146288|20639392|P1|COMPLETED|Second Intervention (1 Day)||7
8372693|NCT01146288|20639391|P2|STARTED|Second Intervention (1 Day)||5
8372694|NCT01146288|20639392|P1|STARTED|Second Intervention (1 Day)||7
8372695|NCT01146288|20639391|P2|NOT COMPLETED|First Intervention(1 Day)||1
8372696|NCT01146288|20639392|P1|NOT COMPLETED|First Intervention(1 Day)||0
8372697|NCT01146288|20639391|P2|COMPLETED|First Intervention(1 Day)||5
8372698|NCT01146288|20639392|P1|COMPLETED|First Intervention(1 Day)||7
8372699|NCT01146288|20639391|P2|STARTED|First Intervention(1 Day)||6
8372700|NCT01146288|20639392|P1|STARTED|First Intervention(1 Day)||7
8372701|NCT01146275|20639401|P1|NOT COMPLETED|Overall Study||0
8372702|NCT01146275|20639401|P1|COMPLETED|Overall Study||6
8372703|NCT01146275|20639401|P1|STARTED|Overall Study||6
8372704|NCT01146054|20639406|P1|NOT COMPLETED|Overall Study||10
8372705|NCT01146054|20639406|P1|COMPLETED|Overall Study||49
8372706|NCT01146054|20639406|P1|STARTED|Overall Study||59
8372707|NCT01145898|20639416|P2|NOT COMPLETED|3-year Treatment||16
8372708|NCT01145898|20639417|P1|NOT COMPLETED|3-year Treatment||3
8372709|NCT01145898|20639416|P2|COMPLETED|3-year Treatment||28
8372710|NCT01145898|20639417|P1|COMPLETED|3-year Treatment||9
8372711|NCT01145898|20639416|P2|STARTED|3-year Treatment||44
8372712|NCT01145898|20639417|P1|STARTED|3-year Treatment||12
8372713|NCT01145898|20639416|P2|NOT COMPLETED|6-month Treatment||0
8372714|NCT01145898|20639417|P1|NOT COMPLETED|6-month Treatment||0
8372715|NCT01145898|20639416|P2|COMPLETED|6-month Treatment||44
8372716|NCT01145898|20639417|P1|COMPLETED|6-month Treatment||12
8372717|NCT01145898|20639416|P2|STARTED|6-month Treatment||44
8372718|NCT01145898|20639417|P1|STARTED|6-month Treatment||12
8372719|NCT01145885|20639448|P1|NOT COMPLETED|Overall Study||7
8372720|NCT01145885|20639448|P1|COMPLETED|Overall Study||0
8372721|NCT01145885|20639448|P1|STARTED|Overall Study||7
8372722|NCT01145833|20639482|P2|NOT COMPLETED|Overall Study||0
8372723|NCT01145833|20639483|P1|NOT COMPLETED|Overall Study||3
8372724|NCT01145833|20639482|P2|COMPLETED|Overall Study||25
8372725|NCT01145833|20639483|P1|COMPLETED|Overall Study||22
8372726|NCT01145833|20639482|P2|STARTED|Overall Study||25
8372727|NCT01145833|20639483|P1|STARTED|Overall Study||25
8372728|NCT01145755|20639494|P3|NOT COMPLETED|Overall Study||25
8372729|NCT01145755|20639495|P2|NOT COMPLETED|Overall Study||28
8372730|NCT01145755|20639496|P1|NOT COMPLETED|Overall Study||20
8372731|NCT01145755|20639494|P3|COMPLETED|Overall Study||19
8372732|NCT01145755|20639495|P2|COMPLETED|Overall Study||19
8372733|NCT01145755|20639496|P1|COMPLETED|Overall Study||20
8372734|NCT01145755|20639494|P3|STARTED|Overall Study||44
8372735|NCT01145755|20639495|P2|STARTED|Overall Study||47
8372736|NCT01145755|20639496|P1|STARTED|Overall Study||40
8372737|NCT01145638|20639512|P2|NOT COMPLETED|Overall Study||57
8372738|NCT01145638|20639513|P1|NOT COMPLETED|Overall Study||90
8372739|NCT01145638|20639512|P2|COMPLETED|Overall Study||62
8372740|NCT01145638|20639513|P1|COMPLETED|Overall Study||141
8372741|NCT01145638|20639512|P2|STARTED|Overall Study||119
8372742|NCT01145638|20639513|P1|STARTED|Overall Study||231
8372743|NCT01145625|20639523|P2|NOT COMPLETED|Overall Study||31
8372744|NCT01145625|20639524|P1|NOT COMPLETED|Overall Study||24
8372745|NCT01145625|20639523|P2|COMPLETED|Overall Study||130
8372746|NCT01145625|20639524|P1|COMPLETED|Overall Study||137
8372747|NCT01145625|20639523|P2|STARTED|Overall Study||161
8372748|NCT01145625|20639524|P1|STARTED|Overall Study||161
8372749|NCT01145560|20639537|P3|NOT COMPLETED|Overall Study||2
8372750|NCT01145560|20639538|P2|NOT COMPLETED|Overall Study||4
8372751|NCT01145560|20639539|P1|NOT COMPLETED|Overall Study||4
8372752|NCT01145560|20639537|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
8372753|NCT01145560|20639538|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
8372754|NCT01145560|20639539|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
8372755|NCT01145560|20639537|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
8372756|NCT01145560|20639538|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
8372757|NCT01145560|20639539|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
8372758|NCT01145560|20639537|P3|Received Treatment|Overall Study||99
8372759|NCT01145560|20639538|P2|Received Treatment|Overall Study||98
8372760|NCT01145560|20639539|P1|Received Treatment|Overall Study||99
8372761|NCT01145560|20639537|P3|STARTED|Overall Study||100
8372762|NCT01145560|20639538|P2|STARTED|Overall Study||100
8372763|NCT01145560|20639539|P1|STARTED|Overall Study||100
8372764|NCT01145547|20639556|P2|NOT COMPLETED|Overall Study||0
8372765|NCT01145547|20639557|P1|NOT COMPLETED|Overall Study||0
8372766|NCT01145547|20639556|P2|COMPLETED|Overall Study||3
8372767|NCT01145547|20639557|P1|COMPLETED|Overall Study||4
8372768|NCT01145547|20639556|P2|STARTED|Overall Study||3
8372769|NCT01145547|20639557|P1|STARTED|Overall Study||4
8372770|NCT01145508|20639565|P2|NOT COMPLETED|Overall Study||2
8372771|NCT01145508|20639566|P1|NOT COMPLETED|Overall Study||5
8372772|NCT01145508|20639565|P2|COMPLETED|Overall Study||1
8372773|NCT01145508|20639566|P1|COMPLETED|Overall Study||2
8372774|NCT01145508|20639565|P2|Treated|Overall Study||2
8372775|NCT01145508|20639566|P1|Treated|Overall Study||6
8372776|NCT01145508|20639565|P2|STARTED|Overall Study||3
8372777|NCT01145508|20639566|P1|STARTED|Overall Study||7
8372778|NCT01145495|20639572|P1|NOT COMPLETED|Overall Study||12
8372779|NCT01145495|20639572|P1|COMPLETED|Overall Study||51
8372780|NCT01145495|20639572|P1|STARTED|Overall Study||63
8372781|NCT01145482|20639578|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8372782|NCT01145482|20639579|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8372783|NCT01145482|20639578|P2|COMPLETED|Second Intervention (1 Day)||6
8372784|NCT01145482|20639579|P1|COMPLETED|Second Intervention (1 Day)||5
8372785|NCT01145482|20639578|P2|STARTED|Second Intervention (1 Day)||6
8372786|NCT01145482|20639579|P1|STARTED|Second Intervention (1 Day)||5
8372787|NCT01145482|20639578|P2|NOT COMPLETED|First Intervention (1 Day)||1
8372788|NCT01145482|20639579|P1|NOT COMPLETED|First Intervention (1 Day)||0
8372789|NCT01145482|20639578|P2|COMPLETED|First Intervention (1 Day)||5
8372790|NCT01145482|20639579|P1|COMPLETED|First Intervention (1 Day)||6
8372791|NCT01145482|20639578|P2|STARTED|First Intervention (1 Day)||6
8372792|NCT01145482|20639579|P1|STARTED|First Intervention (1 Day)||6
8372793|NCT01145391|20639589|P2|NOT COMPLETED|Overall Study||0
8372794|NCT01145391|20639590|P1|NOT COMPLETED|Overall Study||0
8372795|NCT01145391|20639589|P2|COMPLETED|Overall Study||298
8372796|NCT01145391|20639590|P1|COMPLETED|Overall Study||293
8372797|NCT01145391|20639589|P2|9 Months Post-randomization|Overall Study||298
8372798|NCT01145391|20639590|P1|9 Months Post-randomization|Overall Study||293
8372799|NCT01145391|20639589|P2|STARTED|Overall Study||298
8372800|NCT01145391|20639590|P1|STARTED|Overall Study||293
8372801|NCT01145352|20639598|P1|NOT COMPLETED|Overall Study||11
8372802|NCT01145352|20639598|P1|COMPLETED|Overall Study||102
8372803|NCT01145352|20639598|P1|STARTED|Overall Study||113
8372804|NCT01145222|20639610|P4|NOT COMPLETED|Overall Study||1
8372805|NCT01145222|20639611|P3|NOT COMPLETED|Overall Study||1
8372806|NCT01145222|20639612|P2|NOT COMPLETED|Overall Study||0
8372807|NCT01145222|20639613|P1|NOT COMPLETED|Overall Study||0
8372808|NCT01145222|20639610|P4|COMPLETED|Overall Study||40
8372809|NCT01145222|20639611|P3|COMPLETED|Overall Study||40
8372810|NCT01145222|20639612|P2|COMPLETED|Overall Study||40
8372811|NCT01145222|20639613|P1|COMPLETED|Overall Study||40
8372812|NCT01145222|20639610|P4|Intention to Treat (ITT) Population|Overall Study||40
8372813|NCT01145222|20639611|P3|Intention to Treat (ITT) Population|Overall Study||40
8372814|NCT01145222|20639612|P2|Intention to Treat (ITT) Population|Overall Study||40
8372815|NCT01145222|20639613|P1|Intention to Treat (ITT) Population|Overall Study||40
8372816|NCT01145222|20639610|P4|Safety Population|Overall Study||41
8372817|NCT01145222|20639611|P3|Safety Population|Overall Study||40
8372818|NCT01145222|20639612|P2|Safety Population|Overall Study||40
8372819|NCT01145222|20639613|P1|Safety Population|Overall Study||40
8372820|NCT01145222|20639610|P4|STARTED|Overall Study||41
8372821|NCT01145222|20639611|P3|STARTED|Overall Study||41
8372822|NCT01145222|20639612|P2|STARTED|Overall Study||40
8372823|NCT01145222|20639613|P1|STARTED|Overall Study||40
8372824|NCT01145209|20639633|P2|NOT COMPLETED|Overall Study||1
8372825|NCT01145209|20639634|P1|NOT COMPLETED|Overall Study||3
8372826|NCT01145209|20639633|P2|COMPLETED|Overall Study||18
8372827|NCT01145209|20639634|P1|COMPLETED|Overall Study||10
8372828|NCT01145209|20639633|P2|STARTED|Overall Study||19
8372829|NCT01145209|20639634|P1|STARTED|Overall Study||13
8372830|NCT01145183|20639644|P4|NOT COMPLETED|Overall Study||0
8372831|NCT01145183|20639645|P3|NOT COMPLETED|Overall Study||0
8372832|NCT01145183|20639646|P2|NOT COMPLETED|Overall Study||0
8372833|NCT01145183|20639647|P1|NOT COMPLETED|Overall Study||0
8372834|NCT01145183|20639644|P4|COMPLETED|Overall Study||10
8372835|NCT01145183|20639645|P3|COMPLETED|Overall Study||19
8372836|NCT01145183|20639646|P2|COMPLETED|Overall Study||26
8372837|NCT01145183|20639647|P1|COMPLETED|Overall Study||21
8372838|NCT01145183|20639644|P4|STARTED|Overall Study||10
8372839|NCT01145183|20639645|P3|STARTED|Overall Study||19
8372840|NCT01145183|20639646|P2|STARTED|Overall Study||26
8372841|NCT01145183|20639647|P1|STARTED|Overall Study||21
8372842|NCT01145066|20639660|P3|NOT COMPLETED|Overall Study||4
8372843|NCT01145066|20639661|P2|NOT COMPLETED|Overall Study||4
8372844|NCT01145066|20639662|P1|NOT COMPLETED|Overall Study||4
8372845|NCT01145066|20639660|P3|COMPLETED|Overall Study||21
8372846|NCT01145066|20639661|P2|COMPLETED|Overall Study||16
8372847|NCT01145066|20639662|P1|COMPLETED|Overall Study||22
8372848|NCT01145066|20639660|P3|STARTED|Overall Study||25
8372849|NCT01145066|20639661|P2|STARTED|Overall Study||20
8372850|NCT01145066|20639662|P1|STARTED|Overall Study||26
8372851|NCT01145053|20639730|P1|NOT COMPLETED|Overall Study||93
8372852|NCT01145053|20639730|P1|COMPLETED|Overall Study||248
8372853|NCT01145053|20639730|P1|STARTED|Overall Study||341
8372854|NCT01145001|20639744|P4|NOT COMPLETED|Overall Study||6
8372855|NCT01145001|20639745|P3|NOT COMPLETED|Overall Study||5
8372856|NCT01145001|20639746|P2|NOT COMPLETED|Overall Study||6
8372857|NCT01145001|20639747|P1|NOT COMPLETED|Overall Study||8
8372858|NCT01145001|20639744|P4|COMPLETED|Overall Study||31
8372859|NCT01145001|20639745|P3|COMPLETED|Overall Study||39
8372860|NCT01145001|20639746|P2|COMPLETED|Overall Study||31
8372861|NCT01145001|20639747|P1|COMPLETED|Overall Study||28
8372862|NCT01145001|20639744|P4|STARTED|Overall Study||37
8372863|NCT01145001|20639745|P3|STARTED|Overall Study||44
8372864|NCT01145001|20639746|P2|STARTED|Overall Study||37
8372865|NCT01145001|20639747|P1|STARTED|Overall Study||36
8372866|NCT01144949|20639763|P2|NOT COMPLETED|Overall Study||14
8372867|NCT01144949|20639764|P1|NOT COMPLETED|Overall Study||11
8372868|NCT01144949|20639763|P2|COMPLETED|Overall Study||106
8372869|NCT01144949|20639764|P1|COMPLETED|Overall Study||108
8372870|NCT01144949|20639763|P2|STARTED|Overall Study||120
8372871|NCT01144949|20639764|P1|STARTED|Overall Study||119
8372872|NCT01144715|20639782|P2|NOT COMPLETED|Overall Study||3
8372873|NCT01144715|20639783|P1|NOT COMPLETED|Overall Study||4
8372874|NCT01144715|20639782|P2|COMPLETED|Overall Study||45
8372875|NCT01144715|20639783|P1|COMPLETED|Overall Study||47
8372876|NCT01144715|20639782|P2|STARTED|Overall Study||48
8372877|NCT01144715|20639783|P1|STARTED|Overall Study||51
8372878|NCT01144663|20639799|P4|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
8372879|NCT01144663|20639800|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
8372880|NCT01144663|20639801|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
8372881|NCT01144663|20639802|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
8372882|NCT01144663|20639799|P4|COMPLETED|Extended Safety Follow-Up (ESFU)||505
8372883|NCT01144663|20639800|P3|COMPLETED|Extended Safety Follow-Up (ESFU)||496
8372884|NCT01144663|20639801|P2|COMPLETED|Extended Safety Follow-Up (ESFU)||502
8372885|NCT01144663|20639802|P1|COMPLETED|Extended Safety Follow-Up (ESFU)||492
8372886|NCT01144663|20639799|P4|STARTED|Extended Safety Follow-Up (ESFU)||506
8372887|NCT01144663|20639800|P3|STARTED|Extended Safety Follow-Up (ESFU)||503
8372888|NCT01144663|20639801|P2|STARTED|Extended Safety Follow-Up (ESFU)||511
8372889|NCT01144663|20639802|P1|STARTED|Extended Safety Follow-Up (ESFU)||497
8372890|NCT01144663|20639799|P4|NOT COMPLETED|Booster Vaccination Phase||1
8372891|NCT01144663|20639800|P3|NOT COMPLETED|Booster Vaccination Phase||5
8372892|NCT01144663|20639801|P2|NOT COMPLETED|Booster Vaccination Phase||2
8372893|NCT01144663|20639802|P1|NOT COMPLETED|Booster Vaccination Phase||3
8372894|NCT01144663|20639799|P4|COMPLETED|Booster Vaccination Phase||505
8372895|NCT01144663|20639800|P3|COMPLETED|Booster Vaccination Phase||498
8372896|NCT01144663|20639801|P2|COMPLETED|Booster Vaccination Phase||509
8372897|NCT01144663|20639802|P1|COMPLETED|Booster Vaccination Phase||494
8372898|NCT01144663|20639799|P4|STARTED|Booster Vaccination Phase||506
8372899|NCT01144663|20639800|P3|STARTED|Booster Vaccination Phase||503
8372900|NCT01144663|20639801|P2|STARTED|Booster Vaccination Phase||511
8372901|NCT01144663|20639802|P1|STARTED|Booster Vaccination Phase||497
8372902|NCT01144663|20639799|P4|NOT COMPLETED|Primary Vaccination Phase||18
8372903|NCT01144663|20639800|P3|NOT COMPLETED|Primary Vaccination Phase||8
8372904|NCT01144663|20639801|P2|NOT COMPLETED|Primary Vaccination Phase||7
8372905|NCT01144663|20639802|P1|NOT COMPLETED|Primary Vaccination Phase||20
8372906|NCT01144663|20639799|P4|COMPLETED|Primary Vaccination Phase||509
8372907|NCT01144663|20639800|P3|COMPLETED|Primary Vaccination Phase||508
8372908|NCT01144663|20639801|P2|COMPLETED|Primary Vaccination Phase||517
8372909|NCT01144663|20639802|P1|COMPLETED|Primary Vaccination Phase||508
8372910|NCT01144663|20639799|P4|STARTED|Primary Vaccination Phase||527
8372911|NCT01144663|20639800|P3|STARTED|Primary Vaccination Phase||516
8372912|NCT01144663|20639801|P2|STARTED|Primary Vaccination Phase||524
8372913|NCT01144663|20639802|P1|STARTED|Primary Vaccination Phase||528
8372914|NCT01144637|20640006|P4|NOT COMPLETED|Overall Study||56
8372915|NCT01144637|20640007|P3|NOT COMPLETED|Overall Study||60
8372916|NCT01144637|20640008|P2|NOT COMPLETED|Overall Study||76
8372917|NCT01144637|20640009|P1|NOT COMPLETED|Overall Study||74
8372918|NCT01144637|20640006|P4|COMPLETED|Overall Study||946
8372919|NCT01144637|20640007|P3|COMPLETED|Overall Study||939
8372920|NCT01144637|20640008|P2|COMPLETED|Overall Study||929
8372921|NCT01144637|20640009|P1|COMPLETED|Overall Study||925
8372922|NCT01144637|20640006|P4|STARTED|Overall Study||1002
8372923|NCT01144637|20640007|P3|STARTED|Overall Study||999
8372924|NCT01144637|20640008|P2|STARTED|Overall Study||1005
8372925|NCT01144637|20640009|P1|STARTED|Overall Study||999
8372926|NCT01144624|20640066|P3|NOT COMPLETED|Overall Study||0
8372927|NCT01144624|20640067|P2|NOT COMPLETED|Overall Study||0
8372928|NCT01144624|20640068|P1|NOT COMPLETED|Overall Study||0
8372929|NCT01144624|20640066|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
8372930|NCT01144624|20640067|P2|COMPLETED|Overall Study||7
8372931|NCT01144624|20640068|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
8372932|NCT01144624|20640066|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
8372933|NCT01144624|20640067|P2|Completed Treatment|Overall Study||7
8372934|NCT01144624|20640068|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
8372935|NCT01144624|20640066|P3|Received Treatment|Overall Study||6
8372936|NCT01144624|20640067|P2|Received Treatment|Overall Study||7
8372937|NCT01144624|20640068|P1|Received Treatment|Overall Study||7
8372938|NCT01144624|20640066|P3|STARTED|Overall Study||6
8372939|NCT01144624|20640067|P2|STARTED|Overall Study||7
8372940|NCT01144624|20640068|P1|STARTED|Overall Study||7
8372941|NCT01144598|20640082|P1|NOT COMPLETED|Overall Study||0
8372942|NCT01144598|20640082|P1|COMPLETED|Overall Study||356
8372943|NCT01144598|20640082|P1|Analysis Population|Overall Study||356
8372944|NCT01144598|20640082|P1|STARTED|Overall Study||356
8372945|NCT01144494|20640100|P2|NOT COMPLETED|Overall Study||4
8372946|NCT01144494|20640101|P1|NOT COMPLETED|Overall Study||0
8372947|NCT01144494|20640100|P2|COMPLETED|Overall Study||14
8372948|NCT01144494|20640101|P1|COMPLETED|Overall Study||15
8372949|NCT01144494|20640100|P2|STARTED|Overall Study||18
8372950|NCT01144494|20640101|P1|STARTED|Overall Study||15
8372951|NCT01144455|20640120|P3|NOT COMPLETED|Overall Study||36
8372952|NCT01144455|20640121|P2|NOT COMPLETED|Overall Study||42
8372953|NCT01144455|20640122|P1|NOT COMPLETED|Overall Study||50
8372954|NCT01144455|20640120|P3|COMPLETED|Overall Study||38
8372955|NCT01144455|20640121|P2|COMPLETED|Overall Study||29
8372956|NCT01144455|20640122|P1|COMPLETED|Overall Study||19
8372957|NCT01144455|20640120|P3|STARTED|Overall Study||74
8372958|NCT01144455|20640121|P2|STARTED|Overall Study||71
8372959|NCT01144455|20640122|P1|STARTED|Overall Study||69
8372960|NCT01144442|20640130|P1|NOT COMPLETED|Overall Study||0
8372961|NCT01144442|20640130|P1|COMPLETED|Overall Study||10
8372962|NCT01144442|20640130|P1|STARTED|Overall Study||10
8372963|NCT01144416|20640140|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
8372964|NCT01144416|20640141|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
8372965|NCT01144416|20640140|P2|COMPLETED|Pregnancy Follow-up Period||157
8372966|NCT01144416|20640141|P1|COMPLETED|Pregnancy Follow-up Period||146
8372967|NCT01144416|20640140|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
8372968|NCT01144416|20640141|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
8372969|NCT01144416|20640140|P2|NOT COMPLETED|Intervention Period||49
8372970|NCT01144416|20640141|P1|NOT COMPLETED|Intervention Period||62
8372971|NCT01144416|20640140|P2|COMPLETED|Intervention Period||647
8372972|NCT01144416|20640141|P1|COMPLETED|Intervention Period||632
8372973|NCT01144416|20640140|P2|STARTED|Intervention Period||696
8372974|NCT01144416|20640141|P1|STARTED|Intervention Period||694
8372975|NCT01144403|20640157|P1|NOT COMPLETED|Overall Study||5
8372976|NCT01144403|20640157|P1|COMPLETED|Overall Study||3
8372977|NCT01144403|20640157|P1|STARTED|Overall Study||8
8372978|NCT01144377|20640169|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
8372979|NCT01144377|20640170|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
8372980|NCT01144377|20640171|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
8372981|NCT01144377|20640172|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
8372982|NCT01144377|20640173|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
8372983|NCT01144377|20640169|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
8372984|NCT01144377|20640170|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
8372985|NCT01144377|20640171|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
8372986|NCT01144377|20640172|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
8372987|NCT01144377|20640173|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
8372988|NCT01144377|20640169|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
8372989|NCT01144377|20640170|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
8372990|NCT01144377|20640171|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
8372991|NCT01144377|20640172|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
8372992|NCT01144377|20640173|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
8372993|NCT01144377|20640169|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372994|NCT01144377|20640170|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372995|NCT01144377|20640171|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372996|NCT01144377|20640172|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372997|NCT01144377|20640173|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372998|NCT01144377|20640169|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
8372999|NCT01144377|20640170|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
8373000|NCT01144377|20640171|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
8373001|NCT01144377|20640172|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
8373002|NCT01144377|20640173|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
8373003|NCT01144377|20640169|P5|STARTED|12 Week Safety Follow-up Period||34
8373004|NCT01144377|20640170|P4|STARTED|12 Week Safety Follow-up Period||22
8373005|NCT01144377|20640171|P3|STARTED|12 Week Safety Follow-up Period||25
8373006|NCT01144377|20640172|P2|STARTED|12 Week Safety Follow-up Period||29
8373007|NCT01144377|20640173|P1|STARTED|12 Week Safety Follow-up Period||26
8373008|NCT01144377|20640169|P5|NOT COMPLETED|52 Week Treatment Period||3
8373009|NCT01144377|20640170|P4|NOT COMPLETED|52 Week Treatment Period||4
8373010|NCT01144377|20640171|P3|NOT COMPLETED|52 Week Treatment Period||5
8373011|NCT01144377|20640172|P2|NOT COMPLETED|52 Week Treatment Period||1
8373012|NCT01144377|20640173|P1|NOT COMPLETED|52 Week Treatment Period||5
8373013|NCT01144377|20640169|P5|COMPLETED|52 Week Treatment Period||34
8373014|NCT01144377|20640170|P4|COMPLETED|52 Week Treatment Period||22
8373015|NCT01144377|20640171|P3|COMPLETED|52 Week Treatment Period||25
8373016|NCT01144377|20640172|P2|COMPLETED|52 Week Treatment Period||29
8373017|NCT01144377|20640173|P1|COMPLETED|52 Week Treatment Period||26
8373018|NCT01144377|20640169|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
8373019|NCT01144377|20640170|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
8373020|NCT01144377|20640171|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
8373021|NCT01144377|20640172|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
8373022|NCT01144377|20640173|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
8373023|NCT01144377|20640169|P5|STARTED|52 Week Treatment Period||37
8373024|NCT01144377|20640170|P4|STARTED|52 Week Treatment Period||26
8373025|NCT01144377|20640171|P3|STARTED|52 Week Treatment Period||30
8373026|NCT01144377|20640172|P2|STARTED|52 Week Treatment Period||30
8373027|NCT01144377|20640173|P1|STARTED|52 Week Treatment Period||31
8373028|NCT01144364|20640222|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
8373029|NCT01144364|20640223|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
8373030|NCT01144364|20640224|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
8373031|NCT01144364|20640222|P3|COMPLETED|Follow-Up/Maintenance Phase||60
8373032|NCT01144364|20640223|P2|COMPLETED|Follow-Up/Maintenance Phase||66
8373033|NCT01144364|20640224|P1|COMPLETED|Follow-Up/Maintenance Phase||0
8373034|NCT01144364|20640222|P3|STARTED|Follow-Up/Maintenance Phase||101
8373035|NCT01144364|20640223|P2|STARTED|Follow-Up/Maintenance Phase||101
8373036|NCT01144364|20640224|P1|STARTED|Follow-Up/Maintenance Phase||0
8373037|NCT01144364|20640222|P3|NOT COMPLETED|Induction Phase||0
8373038|NCT01144364|20640223|P2|NOT COMPLETED|Induction Phase||0
8373039|NCT01144364|20640224|P1|NOT COMPLETED|Induction Phase||32
8373040|NCT01144364|20640222|P3|COMPLETED|Induction Phase||0
8373041|NCT01144364|20640223|P2|COMPLETED|Induction Phase||0
8373042|NCT01144364|20640224|P1|COMPLETED|Induction Phase||202
8373043|NCT01144364|20640222|P3|STARTED|Induction Phase||0
8373044|NCT01144364|20640223|P2|STARTED|Induction Phase||0
8373045|NCT01144364|20640224|P1|STARTED|Induction Phase||234
8373046|NCT01144338|20640250|P2|NOT COMPLETED|Overall Study||262
8373047|NCT01144338|20640251|P1|NOT COMPLETED|Overall Study||303
8373048|NCT01144338|20640250|P2|COMPLETED|Overall Study||7094
8373049|NCT01144338|20640251|P1|COMPLETED|Overall Study||7093
8373050|NCT01144338|20640250|P2|STARTED|Overall Study||7356
8373051|NCT01144338|20640251|P1|STARTED|Overall Study||7396
8373052|NCT01144299|20640273|P2|NOT COMPLETED|Overall Study||0
8373053|NCT01144299|20640274|P1|NOT COMPLETED|Overall Study||2
8373054|NCT01144299|20640273|P2|COMPLETED|Overall Study||54
8373055|NCT01144299|20640274|P1|COMPLETED|Overall Study||58
8373056|NCT01144299|20640273|P2|STARTED|Overall Study||54
8373057|NCT01144299|20640274|P1|STARTED|Overall Study||60
8373058|NCT01144286|20640300|P4|NOT COMPLETED|Overall Study||0
8373059|NCT01144286|20640301|P3|NOT COMPLETED|Overall Study||0
8373060|NCT01144286|20640302|P2|NOT COMPLETED|Overall Study||0
8373061|NCT01144286|20640303|P1|NOT COMPLETED|Overall Study||0
8373062|NCT01144286|20640300|P4|COMPLETED|Overall Study||56
8373063|NCT01144286|20640301|P3|COMPLETED|Overall Study||58
8373064|NCT01144286|20640302|P2|COMPLETED|Overall Study||58
8373065|NCT01144286|20640303|P1|COMPLETED|Overall Study||57
8373066|NCT01144286|20640300|P4|STARTED|Overall Study||56
8373067|NCT01144286|20640301|P3|STARTED|Overall Study||58
8373068|NCT01144286|20640302|P2|STARTED|Overall Study||58
8373069|NCT01144286|20640303|P1|STARTED|Overall Study||57
8373070|NCT01144182|20640319|P2|NOT COMPLETED|Overall Study||21
8373071|NCT01144182|20640320|P1|NOT COMPLETED|Overall Study||17
8373072|NCT01144182|20640319|P2|COMPLETED|Overall Study||47
8373073|NCT01144182|20640320|P1|COMPLETED|Overall Study||51
8373074|NCT01144182|20640319|P2|STARTED|Overall Study||68
8373075|NCT01144182|20640320|P1|STARTED|Overall Study||68
8373076|NCT01144143|20640353|P3|NOT COMPLETED|Overall Study||0
8373077|NCT01144143|20640354|P2|NOT COMPLETED|Overall Study||0
8373078|NCT01144143|20640355|P1|NOT COMPLETED|Overall Study||0
8373079|NCT01144143|20640353|P3|COMPLETED|Overall Study||4
8373080|NCT01144143|20640354|P2|COMPLETED|Overall Study||4
8373081|NCT01144143|20640355|P1|COMPLETED|Overall Study||8
8373082|NCT01144143|20640353|P3|STARTED|Overall Study||4
8373083|NCT01144143|20640354|P2|STARTED|Overall Study||4
8373084|NCT01144143|20640355|P1|STARTED|Overall Study||8
8373085|NCT01144052|20640380|P2|NOT COMPLETED|Overall Study||1
8373086|NCT01144052|20640381|P1|NOT COMPLETED|Overall Study||1
8373087|NCT01144052|20640380|P2|COMPLETED|Overall Study||8
8373088|NCT01144052|20640381|P1|COMPLETED|Overall Study||9
8373089|NCT01144052|20640380|P2|STARTED|Overall Study||9
8373090|NCT01144052|20640381|P1|STARTED|Overall Study||10
8373091|NCT01144026|20640403|P2|NOT COMPLETED|Overall Study||0
8373092|NCT01144026|20640404|P1|NOT COMPLETED|Overall Study||0
8373093|NCT01144026|20640403|P2|COMPLETED|Overall Study||5
8373094|NCT01144026|20640404|P1|COMPLETED|Overall Study||10
8373095|NCT01144026|20640403|P2|STARTED|Overall Study||5
8373096|NCT01144026|20640404|P1|STARTED|Overall Study||10
8373097|NCT01143896|20640412|P2|NOT COMPLETED|Overall Study||25
8373098|NCT01143896|20640413|P1|NOT COMPLETED|Overall Study||42
8373099|NCT01143896|20640412|P2|COMPLETED|Overall Study||128
8373100|NCT01143896|20640413|P1|COMPLETED|Overall Study||114
8373101|NCT01143896|20640412|P2|STARTED|Overall Study||153
8373102|NCT01143896|20640413|P1|STARTED|Overall Study||156
8373103|NCT01143883|20640431|P2|NOT COMPLETED|Overall Study||0
8373104|NCT01143883|20640432|P1|NOT COMPLETED|Overall Study||0
8373105|NCT01143883|20640431|P2|COMPLETED|Overall Study||55
8373106|NCT01143883|20640432|P1|COMPLETED|Overall Study||55
8373107|NCT01143883|20640431|P2|STARTED|Overall Study||55
8373108|NCT01143883|20640432|P1|STARTED|Overall Study||55
8373109|NCT01143870|20640441|P3|NOT COMPLETED|Overall Study||0
8373110|NCT01143870|20640442|P2|NOT COMPLETED|Overall Study||0
8373111|NCT01143870|20640443|P1|NOT COMPLETED|Overall Study||0
8373112|NCT01143870|20640441|P3|COMPLETED|Overall Study||61
8373113|NCT01143870|20640442|P2|COMPLETED|Overall Study||58
8373114|NCT01143870|20640443|P1|COMPLETED|Overall Study||58
8373115|NCT01143870|20640441|P3|A1C Imputed|Overall Study||30
8373116|NCT01143870|20640442|P2|A1C Imputed|Overall Study||29
8373117|NCT01143870|20640443|P1|A1C Imputed|Overall Study||31
8373118|NCT01143870|20640441|P3|Had Available 6-month A1C|Overall Study||31
8373119|NCT01143870|20640442|P2|Had Available 6-month A1C|Overall Study||29
8373120|NCT01143870|20640443|P1|Had Available 6-month A1C|Overall Study||27
8373121|NCT01143870|20640441|P3|Post-intervention Survey|Overall Study||61
8373122|NCT01143870|20640442|P2|Post-intervention Survey|Overall Study||50
8373123|NCT01143870|20640443|P1|Post-intervention Survey|Overall Study||53
8373124|NCT01143870|20640441|P3|STARTED|Overall Study||61
8373125|NCT01143870|20640442|P2|STARTED|Overall Study||58
8373126|NCT01143870|20640443|P1|STARTED|Overall Study||58
8373127|NCT01143818|20640451|P1|NOT COMPLETED|Overall Study||250
8373128|NCT01143818|20640451|P1|COMPLETED|Overall Study||799
8373129|NCT01143818|20640451|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
8373130|NCT01143792|20640461|P3|NOT COMPLETED|Overall Study||0
8373131|NCT01143792|20640462|P2|NOT COMPLETED|Overall Study||0
8373132|NCT01143792|20640463|P1|NOT COMPLETED|Overall Study||0
8373133|NCT01143792|20640461|P3|COMPLETED|Overall Study||91
8373134|NCT01143792|20640462|P2|COMPLETED|Overall Study||86
8373135|NCT01143792|20640463|P1|COMPLETED|Overall Study||93
8373136|NCT01143792|20640461|P3|STARTED|Overall Study||91
8373137|NCT01143792|20640462|P2|STARTED|Overall Study||86
8373138|NCT01143792|20640463|P1|STARTED|Overall Study||93
8373139|NCT01143766|20640497|P2|NOT COMPLETED|Overall Study||0
8373140|NCT01143766|20640498|P1|NOT COMPLETED|Overall Study||0
8373141|NCT01143766|20640497|P2|COMPLETED|Overall Study||31
8373142|NCT01143766|20640498|P1|COMPLETED|Overall Study||25
8373143|NCT01143766|20640497|P2|STARTED|Overall Study||31
8373144|NCT01143766|20640498|P1|STARTED|Overall Study||25
8373145|NCT01143727|20640514|P2|NOT COMPLETED|Overall Study||0
8373146|NCT01143727|20640515|P1|NOT COMPLETED|Overall Study||0
8373147|NCT01143727|20640514|P2|COMPLETED|Overall Study||8
8373148|NCT01143727|20640515|P1|COMPLETED|Overall Study||9
8373149|NCT01143727|20640514|P2|STARTED|Overall Study||8
8373150|NCT01143727|20640515|P1|STARTED|Overall Study||9
8373151|NCT01143714|20640525|P2|NOT COMPLETED|Overall Study||3
8373152|NCT01143714|20640526|P1|NOT COMPLETED|Overall Study||7
8373153|NCT01143714|20640525|P2|COMPLETED|Overall Study||25
8373154|NCT01143714|20640526|P1|COMPLETED|Overall Study||22
8373155|NCT01143714|20640525|P2|STARTED|Overall Study||28
8373156|NCT01143714|20640526|P1|STARTED|Overall Study||29
8373157|NCT01143701|20640536|P2|NOT COMPLETED|Overall Study||32
8373158|NCT01143701|20640537|P1|NOT COMPLETED|Overall Study||23
8373159|NCT01143701|20640536|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
8373160|NCT01143701|20640537|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
8373161|NCT01143701|20640536|P2|STARTED|Overall Study||319
8373162|NCT01143701|20640537|P1|STARTED|Overall Study||258
8373163|NCT01143688|20640545|P1|NOT COMPLETED|Overall Study||0
8373164|NCT01143688|20640545|P1|COMPLETED|Overall Study||39
8373165|NCT01143688|20640545|P1|STARTED|Overall Study||39
8373166|NCT01143649|20640564|P6|NOT COMPLETED|Overall Study||2
8373167|NCT01143649|20640565|P5|NOT COMPLETED|Overall Study||1
8373168|NCT01143649|20640566|P4|NOT COMPLETED|Overall Study||0
8373169|NCT01143649|20640567|P3|NOT COMPLETED|Overall Study||0
8373170|NCT01143649|20640568|P2|NOT COMPLETED|Overall Study||0
8373171|NCT01143649|20640569|P1|NOT COMPLETED|Overall Study||0
8373172|NCT01143649|20640564|P6|COMPLETED|Overall Study||3
8373173|NCT01143649|20640565|P5|COMPLETED|Overall Study||4
8373174|NCT01143649|20640566|P4|COMPLETED|Overall Study||10
8373175|NCT01143649|20640567|P3|COMPLETED|Overall Study||10
8373176|NCT01143649|20640568|P2|COMPLETED|Overall Study||7
8373177|NCT01143649|20640569|P1|COMPLETED|Overall Study||7
8373178|NCT01143649|20640564|P6|STARTED|Overall Study||5
8373179|NCT01143649|20640565|P5|STARTED|Overall Study||5
8373180|NCT01143649|20640566|P4|STARTED|Overall Study||10
8373181|NCT01143649|20640567|P3|STARTED|Overall Study||10
8373182|NCT01143649|20640568|P2|STARTED|Overall Study||7
8373183|NCT01143649|20640569|P1|STARTED|Overall Study||7
8373184|NCT01143636|20640586|P4|NOT COMPLETED|Overall Study||0
8373185|NCT01143636|20640587|P3|NOT COMPLETED|Overall Study||0
8373186|NCT01143636|20640588|P2|NOT COMPLETED|Overall Study||1
8373187|NCT01143636|20640589|P1|NOT COMPLETED|Overall Study||1
8373188|NCT01143636|20640586|P4|COMPLETED|Overall Study||7
8373189|NCT01143636|20640587|P3|COMPLETED|Overall Study||8
8373190|NCT01143636|20640588|P2|COMPLETED|Overall Study||4
8373191|NCT01143636|20640589|P1|COMPLETED|Overall Study||5
8373192|NCT01143636|20640586|P4|STARTED|Overall Study||7
8373193|NCT01143636|20640587|P3|STARTED|Overall Study||8
8373194|NCT01143636|20640588|P2|STARTED|Overall Study||5
8373195|NCT01143636|20640589|P1|STARTED|Overall Study||6
8373196|NCT01143610|20640619|P2|NOT COMPLETED|Overall Study||0
8373197|NCT01143610|20640620|P1|NOT COMPLETED|Overall Study||0
8373198|NCT01143610|20640619|P2|COMPLETED|Overall Study||8
8373199|NCT01143610|20640620|P1|COMPLETED|Overall Study||7
8373200|NCT01143610|20640619|P2|STARTED|Overall Study||8
8373201|NCT01143610|20640620|P1|STARTED|Overall Study||7
8373202|NCT01143402|20640631|P3|NOT COMPLETED|Overall Study||1
8373203|NCT01143402|20640632|P2|NOT COMPLETED|Overall Study||1
8373204|NCT01143402|20640633|P1|NOT COMPLETED|Overall Study||1
8373205|NCT01143402|20640631|P3|COMPLETED|Overall Study||18
8373206|NCT01143402|20640632|P2|COMPLETED|Overall Study||49
8373207|NCT01143402|20640633|P1|COMPLETED|Overall Study||50
8373208|NCT01143402|20640631|P3|STARTED|Overall Study||19
8373209|NCT01143402|20640632|P2|STARTED|Overall Study||50
8373210|NCT01143402|20640633|P1|STARTED|Overall Study||51
8373211|NCT01143389|20640644|P2|NOT COMPLETED|Overall Study||25
8373212|NCT01143389|20640645|P1|NOT COMPLETED|Overall Study||26
8373213|NCT01143389|20640644|P2|COMPLETED|Overall Study||232
8373214|NCT01143389|20640645|P1|COMPLETED|Overall Study||227
8373215|NCT01143389|20640644|P2|STARTED|Overall Study||257
8373216|NCT01143389|20640645|P1|STARTED|Overall Study||253
8373217|NCT01143337|20640659|P3|NOT COMPLETED|Overall Study||12
8373218|NCT01143337|20640660|P2|NOT COMPLETED|Overall Study||11
8373219|NCT01143337|20640661|P1|NOT COMPLETED|Overall Study||10
8373220|NCT01143337|20640659|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
8373221|NCT01143337|20640660|P2|COMPLETED|Overall Study||39
8373222|NCT01143337|20640661|P1|COMPLETED|Overall Study||39
8373223|NCT01143337|20640659|P3|STARTED|Overall Study||13
8373224|NCT01143337|20640660|P2|STARTED|Overall Study||50
8373225|NCT01143337|20640661|P1|STARTED|Overall Study||49
8373226|NCT01143324|20640675|P1|NOT COMPLETED|Overall Study||19
8373227|NCT01143324|20640675|P1|COMPLETED|Overall Study||233
8373228|NCT01143324|20640675|P1|STARTED|Overall Study||252
8373229|NCT01143272|20640693|P2|NOT COMPLETED|Overall Study||0
8373230|NCT01143272|20640694|P1|NOT COMPLETED|Overall Study||0
8373231|NCT01143272|20640693|P2|COMPLETED|Overall Study||231
8373232|NCT01143272|20640694|P1|COMPLETED|Overall Study||246
8373233|NCT01143272|20640693|P2|STARTED|Overall Study||231
8373234|NCT01143272|20640694|P1|STARTED|Overall Study||246
8373235|NCT01143259|20640714|P2|NOT COMPLETED|Overall Study||20
8373236|NCT01143259|20640715|P1|NOT COMPLETED|Overall Study||23
8373237|NCT01143259|20640714|P2|COMPLETED|Overall Study||118
8373238|NCT01143259|20640715|P1|COMPLETED|Overall Study||113
8373239|NCT01143259|20640714|P2|STARTED|Overall Study||138
8373240|NCT01143259|20640715|P1|STARTED|Overall Study||136
8373241|NCT01143207|20640723|P1|NOT COMPLETED|Overall Study||2
8373242|NCT01143207|20640723|P1|COMPLETED|Overall Study||24
8373243|NCT01143207|20640723|P1|STARTED|Overall Study||26
8373244|NCT01143142|20640734|P2|NOT COMPLETED|Overall Study||0
8373245|NCT01143142|20640735|P1|NOT COMPLETED|Overall Study||0
8373246|NCT01143142|20640734|P2|COMPLETED|Overall Study||34
8373247|NCT01143142|20640735|P1|COMPLETED|Overall Study||36
8373248|NCT01143142|20640734|P2|STARTED|Overall Study||34
8373249|NCT01143142|20640735|P1|STARTED|Overall Study||36
8373250|NCT01143090|20640743|P1|NOT COMPLETED|Overall Study||51
8373251|NCT01143090|20640743|P1|COMPLETED|Overall Study||98
8373252|NCT01143090|20640743|P1|STARTED|Overall Study||149
8373253|NCT01143077|20640750|P3|NOT COMPLETED|Overall Study||15
8373254|NCT01143077|20640751|P2|NOT COMPLETED|Overall Study||15
8373255|NCT01143077|20640752|P1|NOT COMPLETED|Overall Study||16
8373256|NCT01143077|20640750|P3|COMPLETED|Overall Study||67
8373257|NCT01143077|20640751|P2|COMPLETED|Overall Study||73
8373258|NCT01143077|20640752|P1|COMPLETED|Overall Study||58
8373259|NCT01143077|20640750|P3|STARTED|Overall Study||82
8373260|NCT01143077|20640751|P2|STARTED|Overall Study||88
8373261|NCT01143077|20640752|P1|STARTED|Overall Study||74
8373262|NCT01143051|20640769|P6|NOT COMPLETED|Visit 3||0
8373263|NCT01143051|20640770|P5|NOT COMPLETED|Visit 3||0
8373264|NCT01143051|20640771|P4|NOT COMPLETED|Visit 3||0
8373265|NCT01143051|20640772|P3|NOT COMPLETED|Visit 3||0
8373266|NCT01143051|20640773|P2|NOT COMPLETED|Visit 3||0
8373267|NCT01143051|20640774|P1|NOT COMPLETED|Visit 3||0
8373268|NCT01143051|20640769|P6|COMPLETED|Visit 3||3
8373269|NCT01143051|20640770|P5|COMPLETED|Visit 3||4
8373270|NCT01143051|20640771|P4|COMPLETED|Visit 3||4
8373271|NCT01143051|20640772|P3|COMPLETED|Visit 3||3
8373272|NCT01143051|20640773|P2|COMPLETED|Visit 3||4
8373273|NCT01143051|20640774|P1|COMPLETED|Visit 3||4
8373274|NCT01143051|20640769|P6|STARTED|Visit 3||3
8373275|NCT01143051|20640770|P5|STARTED|Visit 3||4
8373276|NCT01143051|20640771|P4|STARTED|Visit 3||4
8373277|NCT01143051|20640772|P3|STARTED|Visit 3||3
8373278|NCT01143051|20640773|P2|STARTED|Visit 3||4
8373279|NCT01143051|20640774|P1|STARTED|Visit 3||4
8373280|NCT01143051|20640769|P6|NOT COMPLETED|3-14 Day Washout||1
8373281|NCT01143051|20640770|P5|NOT COMPLETED|3-14 Day Washout||0
8373282|NCT01143051|20640771|P4|NOT COMPLETED|3-14 Day Washout||0
8373283|NCT01143051|20640772|P3|NOT COMPLETED|3-14 Day Washout||0
8373284|NCT01143051|20640773|P2|NOT COMPLETED|3-14 Day Washout||0
8373285|NCT01143051|20640774|P1|NOT COMPLETED|3-14 Day Washout||0
8373286|NCT01143051|20640769|P6|COMPLETED|3-14 Day Washout||3
8373287|NCT01143051|20640770|P5|COMPLETED|3-14 Day Washout||4
8373288|NCT01143051|20640771|P4|COMPLETED|3-14 Day Washout||4
8373289|NCT01143051|20640772|P3|COMPLETED|3-14 Day Washout||3
8373290|NCT01143051|20640773|P2|COMPLETED|3-14 Day Washout||4
8373291|NCT01143051|20640774|P1|COMPLETED|3-14 Day Washout||4
8373292|NCT01143051|20640769|P6|STARTED|3-14 Day Washout||4
8373293|NCT01143051|20640770|P5|STARTED|3-14 Day Washout||4
8373294|NCT01143051|20640771|P4|STARTED|3-14 Day Washout||4
8373295|NCT01143051|20640772|P3|STARTED|3-14 Day Washout||3
8373296|NCT01143051|20640773|P2|STARTED|3-14 Day Washout||4
8373297|NCT01143051|20640774|P1|STARTED|3-14 Day Washout||4
8373298|NCT01143051|20640769|P6|NOT COMPLETED|Visit 2||0
8373299|NCT01143051|20640770|P5|NOT COMPLETED|Visit 2||0
8373300|NCT01143051|20640771|P4|NOT COMPLETED|Visit 2||0
8373301|NCT01143051|20640772|P3|NOT COMPLETED|Visit 2||0
8373302|NCT01143051|20640773|P2|NOT COMPLETED|Visit 2||0
8373303|NCT01143051|20640774|P1|NOT COMPLETED|Visit 2||0
8373304|NCT01143051|20640769|P6|COMPLETED|Visit 2||4
8373305|NCT01143051|20640770|P5|COMPLETED|Visit 2||4
8373306|NCT01143051|20640771|P4|COMPLETED|Visit 2||4
8373307|NCT01143051|20640772|P3|COMPLETED|Visit 2||3
8373308|NCT01143051|20640773|P2|COMPLETED|Visit 2||4
8373309|NCT01143051|20640774|P1|COMPLETED|Visit 2||4
8373310|NCT01143051|20640769|P6|STARTED|Visit 2||4
8373311|NCT01143051|20640770|P5|STARTED|Visit 2||4
8373312|NCT01143051|20640771|P4|STARTED|Visit 2||4
8373313|NCT01143051|20640772|P3|STARTED|Visit 2||3
8373314|NCT01143051|20640773|P2|STARTED|Visit 2||4
8373315|NCT01143051|20640774|P1|STARTED|Visit 2||4
8373316|NCT01143051|20640769|P6|NOT COMPLETED|3-14 Day Washout||0
8373317|NCT01143051|20640770|P5|NOT COMPLETED|3-14 Day Washout||0
8373318|NCT01143051|20640771|P4|NOT COMPLETED|3-14 Day Washout||0
8373319|NCT01143051|20640772|P3|NOT COMPLETED|3-14 Day Washout||1
8373320|NCT01143051|20640773|P2|NOT COMPLETED|3-14 Day Washout||0
8373321|NCT01143051|20640774|P1|NOT COMPLETED|3-14 Day Washout||0
8373322|NCT01143051|20640769|P6|COMPLETED|3-14 Day Washout||4
8373323|NCT01143051|20640770|P5|COMPLETED|3-14 Day Washout||4
8373324|NCT01143051|20640771|P4|COMPLETED|3-14 Day Washout||4
8373325|NCT01143051|20640772|P3|COMPLETED|3-14 Day Washout||3
8373326|NCT01143051|20640773|P2|COMPLETED|3-14 Day Washout||4
8373327|NCT01143051|20640774|P1|COMPLETED|3-14 Day Washout||4
8373328|NCT01143051|20640769|P6|STARTED|3-14 Day Washout||4
8373329|NCT01143051|20640770|P5|STARTED|3-14 Day Washout||4
8373330|NCT01143051|20640771|P4|STARTED|3-14 Day Washout||4
8373331|NCT01143051|20640772|P3|STARTED|3-14 Day Washout||4
8373332|NCT01143051|20640773|P2|STARTED|3-14 Day Washout||4
8373333|NCT01143051|20640774|P1|STARTED|3-14 Day Washout||4
8373334|NCT01143051|20640769|P6|NOT COMPLETED|Visit 1||0
8373335|NCT01143051|20640770|P5|NOT COMPLETED|Visit 1||0
8373336|NCT01143051|20640771|P4|NOT COMPLETED|Visit 1||0
8373337|NCT01143051|20640772|P3|NOT COMPLETED|Visit 1||0
8373338|NCT01143051|20640773|P2|NOT COMPLETED|Visit 1||0
8373339|NCT01143051|20640774|P1|NOT COMPLETED|Visit 1||0
8373340|NCT01143051|20640769|P6|COMPLETED|Visit 1||4
8373341|NCT01143051|20640770|P5|COMPLETED|Visit 1||4
8373342|NCT01143051|20640771|P4|COMPLETED|Visit 1||4
8373343|NCT01143051|20640772|P3|COMPLETED|Visit 1||4
8373344|NCT01143051|20640773|P2|COMPLETED|Visit 1||4
8373345|NCT01143051|20640774|P1|COMPLETED|Visit 1||4
8373346|NCT01143051|20640769|P6|STARTED|Visit 1||4
8373347|NCT01143051|20640770|P5|STARTED|Visit 1||4
8373348|NCT01143051|20640771|P4|STARTED|Visit 1||4
8373349|NCT01143051|20640772|P3|STARTED|Visit 1||4
8373350|NCT01143051|20640773|P2|STARTED|Visit 1||4
8373351|NCT01143051|20640774|P1|STARTED|Visit 1||4
8373352|NCT01143038|20640823|P1|NOT COMPLETED|Overall Study||16
8373353|NCT01143038|20640823|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
8373354|NCT01143038|20640823|P1|STARTED|Overall Study||75
8373355|NCT01142947|20640831|P1|NOT COMPLETED|Overall Study||118
8373356|NCT01142947|20640831|P1|COMPLETED|Overall Study||244
8373357|NCT01142947|20640831|P1|STARTED|Overall Study||362
8373358|NCT01142908|20640837|P2|NOT COMPLETED|Overall Study||22
8373359|NCT01142908|20640838|P1|NOT COMPLETED|Overall Study||32
8373360|NCT01142908|20640837|P2|COMPLETED|Overall Study||191
8373361|NCT01142908|20640838|P1|COMPLETED|Overall Study||183
8373362|NCT01142908|20640837|P2|6 Month f/u|Overall Study||196
8373363|NCT01142908|20640838|P1|6 Month f/u|Overall Study||188
8373364|NCT01142908|20640837|P2|STARTED|Overall Study||213
8373365|NCT01142908|20640838|P1|STARTED|Overall Study||215
8373366|NCT01142791|20640884|P2|NOT COMPLETED|Overall Study||6
8373367|NCT01142791|20640885|P1|NOT COMPLETED|Overall Study||7
8373368|NCT01142791|20640884|P2|COMPLETED|Overall Study||0
8373369|NCT01142791|20640885|P1|COMPLETED|Overall Study||108
8373370|NCT01142791|20640884|P2|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
8373371|NCT01142791|20640885|P1|Safety|Overall Study||115
8373372|NCT01142791|20640884|P2|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
8373373|NCT01142791|20640885|P1|STARTED|Overall Study||115
8373374|NCT01142726|20640892|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
8373375|NCT01142726|20640893|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
8373376|NCT01142726|20640894|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
8373377|NCT01142726|20640892|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
8373378|NCT01142726|20640893|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
8373379|NCT01142726|20640894|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
8373380|NCT01142726|20640892|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
8373381|NCT01142726|20640893|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
8373382|NCT01142726|20640894|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
8373383|NCT01142726|20640892|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
8373384|NCT01142726|20640893|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
8373385|NCT01142726|20640894|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
8373386|NCT01142726|20640892|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
8373387|NCT01142726|20640893|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
8373388|NCT01142726|20640894|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
8373389|NCT01142726|20640892|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
8373390|NCT01142726|20640893|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
8373391|NCT01142726|20640894|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
8373392|NCT01142726|20640892|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
8373393|NCT01142726|20640893|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
8373394|NCT01142726|20640894|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
8373395|NCT01142726|20640892|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
8373396|NCT01142726|20640893|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
8373397|NCT01142726|20640894|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
8373398|NCT01142726|20640892|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
8373399|NCT01142726|20640893|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
8373400|NCT01142726|20640894|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
8373401|NCT01142661|20640957|P1|NOT COMPLETED|Overall Study||4
8373402|NCT01142661|20640957|P1|COMPLETED|Overall Study||5
8373403|NCT01142661|20640957|P1|STARTED|Overall Study||9
8373404|NCT01142596|20640964|P2|NOT COMPLETED|Overall Study||86
8373405|NCT01142596|20640965|P1|NOT COMPLETED|Overall Study||29
8373406|NCT01142596|20640964|P2|COMPLETED|Overall Study||71
8373407|NCT01142596|20640965|P1|COMPLETED|Overall Study||15
8373408|NCT01142596|20640964|P2|STARTED|Overall Study||157
8373409|NCT01142596|20640965|P1|STARTED|Overall Study||44
8373410|NCT01142466|20641017|P2|NOT COMPLETED|Overall Study||2
8373411|NCT01142466|20641018|P1|NOT COMPLETED|Overall Study||3
8373412|NCT01142466|20641017|P2|COMPLETED|Overall Study||13
8373413|NCT01142466|20641018|P1|COMPLETED|Overall Study||12
8373414|NCT01142466|20641017|P2|STARTED|Overall Study||15
8373415|NCT01142466|20641018|P1|STARTED|Overall Study||15
8373426|NCT01142336|20641051|P2|NOT COMPLETED|Overall Study||2
8373427|NCT01142336|20641052|P1|NOT COMPLETED|Overall Study||1
8373428|NCT01142336|20641051|P2|COMPLETED|Overall Study||21
8373429|NCT01142336|20641052|P1|COMPLETED|Overall Study||25
8373430|NCT01142336|20641051|P2|STARTED|Overall Study||23
8373431|NCT01142336|20641052|P1|STARTED|Overall Study||26
8373432|NCT01142323|20641062|P1|NOT COMPLETED|Overall Study||0
8373433|NCT01142323|20641062|P1|COMPLETED|Overall Study||8
8373434|NCT01142323|20641062|P1|STARTED|Overall Study||8
8373435|NCT01142310|20641070|P2|NOT COMPLETED|Overall Study||12
8373436|NCT01142310|20641071|P1|NOT COMPLETED|Overall Study||9
8373437|NCT01142310|20641070|P2|COMPLETED|Overall Study||16
8373438|NCT01142310|20641071|P1|COMPLETED|Overall Study||17
8373439|NCT01142310|20641070|P2|STARTED|Overall Study||28
8373440|NCT01142310|20641071|P1|STARTED|Overall Study||26
8373441|NCT01142297|20641077|P1|NOT COMPLETED|Overall Study||6
8373442|NCT01142297|20641077|P1|COMPLETED|Overall Study||18
8373443|NCT01142297|20641077|P1|STARTED|Overall Study||24
8373444|NCT01142232|20641089|P5|NOT COMPLETED|Overall Study||34
8373445|NCT01142232|20641090|P4|NOT COMPLETED|Overall Study||5
8373446|NCT01142232|20641091|P3|NOT COMPLETED|Overall Study||3
8373447|NCT01142232|20641092|P2|NOT COMPLETED|Overall Study||4
8373448|NCT01142232|20641093|P1|NOT COMPLETED|Overall Study||3
8373449|NCT01142232|20641089|P5|COMPLETED|Overall Study||10
8373450|NCT01142232|20641090|P4|COMPLETED|Overall Study||1
8373451|NCT01142232|20641091|P3|COMPLETED|Overall Study||0
8373452|NCT01142232|20641092|P2|COMPLETED|Overall Study||0
8373453|NCT01142232|20641093|P1|COMPLETED|Overall Study||0
8373454|NCT01142232|20641089|P5|STARTED|Overall Study||44
8373455|NCT01142232|20641090|P4|STARTED|Overall Study||6
8373456|NCT01142232|20641091|P3|STARTED|Overall Study||3
8373457|NCT01142232|20641092|P2|STARTED|Overall Study||4
8373458|NCT01142232|20641093|P1|STARTED|Overall Study||3
8373459|NCT01142193|20641108|P2|NOT COMPLETED|Overall Study||11
8373460|NCT01142193|20641109|P1|NOT COMPLETED|Overall Study||21
8373461|NCT01142193|20641108|P2|COMPLETED|Overall Study||114
8373462|NCT01142193|20641109|P1|COMPLETED|Overall Study||103
8373463|NCT01142193|20641108|P2|STARTED|Overall Study||125
8373464|NCT01142193|20641109|P1|STARTED|Overall Study||124
8373465|NCT01142128|20641137|P1|NOT COMPLETED|Overall Study||4
8373466|NCT01142128|20641137|P1|COMPLETED|Overall Study||4
8373467|NCT01142128|20641137|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
8373468|NCT01142128|20641137|P1|Viokase 16 Plus Nexium|Overall Study||2
8373469|NCT01142128|20641137|P1|Placebo to Nexium, Alone|Overall Study||3
8373470|NCT01142128|20641137|P1|Nexium Alone|Overall Study||3
8373471|NCT01142128|20641137|P1|STARTED|Overall Study||8
8373472|NCT01142115|20641147|P2|NOT COMPLETED|Second Intervention||0
8373473|NCT01142115|20641148|P1|NOT COMPLETED|Second Intervention||0
8373474|NCT01142115|20641147|P2|COMPLETED|Second Intervention||19
8373475|NCT01142115|20641148|P1|COMPLETED|Second Intervention||19
8373476|NCT01142115|20641147|P2|STARTED|Second Intervention||19
8373477|NCT01142115|20641148|P1|STARTED|Second Intervention||19
8373478|NCT01142115|20641147|P2|NOT COMPLETED|First Intervention||1
8373479|NCT01142115|20641148|P1|NOT COMPLETED|First Intervention||2
8373480|NCT01142115|20641147|P2|COMPLETED|First Intervention||19
8373481|NCT01142115|20641148|P1|COMPLETED|First Intervention||19
8373482|NCT01142115|20641147|P2|STARTED|First Intervention||20
8373483|NCT01142115|20641148|P1|STARTED|First Intervention||21
8373484|NCT01142089|20641165|P2|NOT COMPLETED|Overall Study||21
8373485|NCT01142089|20641166|P1|NOT COMPLETED|Overall Study||12
8373486|NCT01142089|20641165|P2|COMPLETED|Overall Study||178
8373487|NCT01142089|20641166|P1|COMPLETED|Overall Study||53
8373488|NCT01142089|20641165|P2|STARTED|Overall Study||199
8373489|NCT01142089|20641166|P1|STARTED|Overall Study||65
8373490|NCT01141907|20641176|P2|NOT COMPLETED|Overall Study||0
8373491|NCT01141907|20641177|P1|NOT COMPLETED|Overall Study||0
8373492|NCT01141907|20641176|P2|COMPLETED|Overall Study||5
8373493|NCT01141907|20641177|P1|COMPLETED|Overall Study||6
8373494|NCT01141907|20641176|P2|STARTED|Overall Study||5
8373495|NCT01141907|20641177|P1|STARTED|Overall Study||6
8373496|NCT01141725|20641183|P3|NOT COMPLETED|Overall Study||0
8373497|NCT01141725|20641184|P2|NOT COMPLETED|Overall Study||0
8373498|NCT01141725|20641185|P1|NOT COMPLETED|Overall Study||0
8373499|NCT01141725|20641183|P3|COMPLETED|Overall Study||3
8373500|NCT01141725|20641184|P2|COMPLETED|Overall Study||33
8373501|NCT01141725|20641185|P1|COMPLETED|Overall Study||3
8373502|NCT01141725|20641183|P3|STARTED|Overall Study||3
8373503|NCT01141725|20641184|P2|STARTED|Overall Study||33
8373504|NCT01141725|20641185|P1|STARTED|Overall Study||3
8373505|NCT01141712|20641197|P1|NOT COMPLETED|Overall Study||3
8373506|NCT01141712|20641197|P1|COMPLETED|Overall Study||40
8373507|NCT01141712|20641197|P1|STARTED|Overall Study||43
8373508|NCT01141660|20641218|P2|NOT COMPLETED|Overall Study||12
8373509|NCT01141660|20641219|P1|NOT COMPLETED|Overall Study||0
8373510|NCT01141660|20641218|P2|COMPLETED|Overall Study||48
8373511|NCT01141660|20641219|P1|COMPLETED|Overall Study||71
8373512|NCT01141660|20641218|P2|STARTED|Overall Study||60
8373513|NCT01141660|20641219|P1|STARTED|Overall Study||71
8373514|NCT01141647|20641227|P1|NOT COMPLETED|Overall Study||46
8373515|NCT01141647|20641227|P1|COMPLETED|Overall Study||167
8373516|NCT01141647|20641227|P1|STARTED|Overall Study||213
8373517|NCT01141608|20641242|P2|NOT COMPLETED|Overall Study||0
8373518|NCT01141608|20641243|P1|NOT COMPLETED|Overall Study||0
8373519|NCT01141608|20641242|P2|COMPLETED|Overall Study||150
8373520|NCT01141608|20641243|P1|COMPLETED|Overall Study||152
8373521|NCT01141608|20641242|P2|STARTED|Overall Study||150
8373522|NCT01141608|20641243|P1|STARTED|Overall Study||152
8373523|NCT01141595|20641249|P1|NOT COMPLETED|Overall Study||2
8373524|NCT01141595|20641249|P1|COMPLETED|Overall Study||8
8373525|NCT01141595|20641249|P1|STARTED|Overall Study||10
8373526|NCT01141569|20641253|P1|NOT COMPLETED|Overall Study||0
8373527|NCT01141569|20641253|P1|COMPLETED|Overall Study||12
8373528|NCT01141569|20641253|P1|STARTED|Overall Study||12
8373529|NCT01141491|20641264|P2|NOT COMPLETED|Overall Study||47
8373530|NCT01141491|20641265|P1|NOT COMPLETED|Overall Study||48
8373531|NCT01141491|20641264|P2|COMPLETED|Overall Study||21
8373532|NCT01141491|20641265|P1|COMPLETED|Overall Study||20
8373533|NCT01141491|20641264|P2|STARTED|Overall Study||68
8373534|NCT01141491|20641265|P1|STARTED|Overall Study||68
8373535|NCT01141374|20641274|P3|NOT COMPLETED|Overall Study||0
8373536|NCT01141374|20641275|P2|NOT COMPLETED|Overall Study||0
8373537|NCT01141374|20641276|P1|NOT COMPLETED|Overall Study||0
8373538|NCT01141374|20641274|P3|COMPLETED|Overall Study||22
8373539|NCT01141374|20641275|P2|COMPLETED|Overall Study||27
8373540|NCT01141374|20641276|P1|COMPLETED|Overall Study||26
8373541|NCT01141374|20641274|P3|STARTED|Overall Study||22
8373542|NCT01141374|20641275|P2|STARTED|Overall Study||27
8373543|NCT01141374|20641276|P1|STARTED|Overall Study||26
8373544|NCT01141283|20641287|P1|NOT COMPLETED|Overall Study||88
8373545|NCT01141283|20641287|P1|COMPLETED|Overall Study||202
8373546|NCT01141283|20641287|P1|STARTED|Overall Study||290
8373547|NCT01141205|20641293|P2|NOT COMPLETED|Overall Study||2
8373548|NCT01141205|20641294|P1|NOT COMPLETED|Overall Study||3
8373549|NCT01141205|20641293|P2|COMPLETED|Overall Study||3
8373550|NCT01141205|20641294|P1|COMPLETED|Overall Study||15
8373551|NCT01141205|20641293|P2|STARTED|Overall Study||5
8373552|NCT01141205|20641294|P1|STARTED|Overall Study||18
8373553|NCT01141075|20641306|P1|NOT COMPLETED|Cycle 2||0
8373554|NCT01141075|20641306|P1|COMPLETED|Cycle 2||11
8373555|NCT01141075|20641306|P1|Received at Least 1 Dose of Study Drug|Cycle 2||11
8373556|NCT01141075|20641306|P1|STARTED|Cycle 2||11
8373557|NCT01141075|20641306|P1|NOT COMPLETED|Cycle 1||0
8373558|NCT01141075|20641306|P1|COMPLETED|Cycle 1||11
8373559|NCT01141075|20641306|P1|Received at Least 1 Dose of Study Drug|Cycle 1||11
8373560|NCT01141075|20641306|P1|STARTED|Cycle 1||11
8373561|NCT01141049|20641320|P2|NOT COMPLETED|Overall Study||8
8373562|NCT01141049|20641321|P1|NOT COMPLETED|Overall Study||5
8373563|NCT01141049|20641320|P2|COMPLETED|Overall Study||13
8373564|NCT01141049|20641321|P1|COMPLETED|Overall Study||14
8373565|NCT01141049|20641320|P2|STARTED|Overall Study||21
8373566|NCT01141049|20641321|P1|STARTED|Overall Study||19
8373567|NCT01140906|20641333|P4|NOT COMPLETED|Overall Study||16
8373568|NCT01140906|20641334|P3|NOT COMPLETED|Overall Study||26
8373569|NCT01140906|20641335|P2|NOT COMPLETED|Overall Study||34
8373570|NCT01140906|20641336|P1|NOT COMPLETED|Overall Study||25
8373571|NCT01140906|20641333|P4|COMPLETED|Overall Study||131
8373572|NCT01140906|20641334|P3|COMPLETED|Overall Study||125
8373573|NCT01140906|20641335|P2|COMPLETED|Overall Study||117
8373574|NCT01140906|20641336|P1|COMPLETED|Overall Study||133
8373575|NCT01140906|20641333|P4|STARTED|Overall Study||147
8373576|NCT01140906|20641334|P3|STARTED|Overall Study||151
8373577|NCT01140906|20641335|P2|STARTED|Overall Study||151
8373578|NCT01140906|20641336|P1|STARTED|Overall Study||158
8373579|NCT01140880|20641376|P2|NOT COMPLETED|Overall Study||44
8373580|NCT01140880|20641377|P1|NOT COMPLETED|Overall Study||14
8373581|NCT01140880|20641376|P2|COMPLETED|Overall Study||56
8373582|NCT01140880|20641377|P1|COMPLETED|Overall Study||56
8373583|NCT01140880|20641376|P2|STARTED|Overall Study||100
8373584|NCT01140880|20641377|P1|STARTED|Overall Study||70
8373585|NCT01140867|20641389|P1|NOT COMPLETED|Overall Study||33
8373586|NCT01140867|20641389|P1|COMPLETED|Overall Study||88
8373587|NCT01140867|20641389|P1|STARTED|Overall Study||121
8373588|NCT01140815|20641398|P2|NOT COMPLETED|Overall Study||0
8373589|NCT01140815|20641399|P1|NOT COMPLETED|Overall Study||0
8373590|NCT01140815|20641398|P2|COMPLETED|Overall Study||25
8373591|NCT01140815|20641399|P1|COMPLETED|Overall Study||25
8373592|NCT01140815|20641398|P2|STARTED|Overall Study||25
8373593|NCT01140815|20641399|P1|STARTED|Overall Study||25
8373594|NCT01140646|20641429|P1|NOT COMPLETED|Overall Study||9
8373595|NCT01140646|20641429|P1|COMPLETED|Overall Study||34
8373596|NCT01140646|20641429|P1|STARTED|Overall Study||43
8373597|NCT01140568|20641437|P1|NOT COMPLETED|Overall Study||36
8373598|NCT01140568|20641437|P1|COMPLETED|Overall Study||2
8373599|NCT01140568|20641437|P1|Treated With Study Drug|Overall Study||34
8373600|NCT01140568|20641437|P1|Screen Fail|Overall Study||4
8373601|NCT01140568|20641437|P1|STARTED|Overall Study||38
8373602|NCT01140503|20641442|P1|NOT COMPLETED|Overall Study||1
8373603|NCT01140503|20641442|P1|COMPLETED|Overall Study||4
8373604|NCT01140503|20641442|P1|STARTED|Overall Study||5
8373605|NCT01140477|20641450|P2|NOT COMPLETED|Overall Study||6
8373606|NCT01140477|20641451|P1|NOT COMPLETED|Overall Study||8
8373607|NCT01140477|20641450|P2|COMPLETED|Overall Study||70
8373608|NCT01140477|20641451|P1|COMPLETED|Overall Study||145
8373609|NCT01140477|20641450|P2|STARTED|Overall Study||76
8373610|NCT01140477|20641451|P1|STARTED|Overall Study||153
8373611|NCT01140451|20641462|P2|NOT COMPLETED|Overall Study||42
8373612|NCT01140451|20641463|P1|NOT COMPLETED|Overall Study||38
8373613|NCT01140451|20641462|P2|COMPLETED|Overall Study||54
8373614|NCT01140451|20641463|P1|COMPLETED|Overall Study||57
8373615|NCT01140451|20641462|P2|144-Week Completer Population|Overall Study||54
8373616|NCT01140451|20641463|P1|144-Week Completer Population|Overall Study||57
8373617|NCT01140451|20641462|P2|96-Week Completer Population|Overall Study||70
8373618|NCT01140451|20641463|P1|96-Week Completer Population|Overall Study||78
8373619|NCT01140451|20641462|P2|As-Treated Population|Overall Study||96
8373620|NCT01140451|20641463|P1|As-Treated Population|Overall Study||95
8373621|NCT01140451|20641462|P2|Completed 96 Weeks|Overall Study||54
8373622|NCT01140451|20641463|P1|Completed 96 Weeks|Overall Study||57
8373623|NCT01140451|20641462|P2|Completed 72 Weeks|Overall Study||62
8373624|NCT01140451|20641463|P1|Completed 72 Weeks|Overall Study||63
8373625|NCT01140451|20641462|P2|Completed 48 Weeks|Overall Study||70
8373626|NCT01140451|20641463|P1|Completed 48 Weeks|Overall Study||78
8373627|NCT01140451|20641462|P2|Completed 24 Weeks|Overall Study||86
8373628|NCT01140451|20641463|P1|Completed 24 Weeks|Overall Study||89
8373629|NCT01140451|20641462|P2|STARTED|Overall Study||96
8373630|NCT01140451|20641463|P1|STARTED|Overall Study||95
8373631|NCT01140360|20641522|P1|NOT COMPLETED|Overall Study||6
8373632|NCT01140360|20641522|P1|COMPLETED|Overall Study||15
8373633|NCT01140360|20641522|P1|STARTED|Overall Study||21
8373634|NCT01140347|20641528|P2|NOT COMPLETED|Overall Study||14
8373635|NCT01140347|20641529|P1|NOT COMPLETED|Overall Study||18
8373636|NCT01140347|20641528|P2|COMPLETED|Overall Study||268
8373637|NCT01140347|20641529|P1|COMPLETED|Overall Study||265
8373638|NCT01140347|20641528|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
8373639|NCT01140347|20641529|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
8373640|NCT01140347|20641528|P2|STARTED|Overall Study||282
8373641|NCT01140347|20641529|P1|STARTED|Overall Study||283
8373642|NCT01140295|20641554|P2|NOT COMPLETED|Overall Study||2
8373643|NCT01140295|20641555|P1|NOT COMPLETED|Overall Study||1
8373644|NCT01140295|20641554|P2|COMPLETED|Overall Study||14
8373645|NCT01140295|20641555|P1|COMPLETED|Overall Study||16
8373646|NCT01140295|20641554|P2|STARTED|Overall Study||16
8373647|NCT01140295|20641555|P1|STARTED|Overall Study||17
8373648|NCT01140191|20641563|P1|NOT COMPLETED|Overall Study||0
8373649|NCT01140191|20641563|P1|COMPLETED|Overall Study||1
8373650|NCT01140191|20641563|P1|STARTED|Overall Study||1
8373651|NCT01140061|20641582|P10|NOT COMPLETED|Extension||1
8373652|NCT01140061|20641583|P9|NOT COMPLETED|Extension||0
8373653|NCT01140061|20641584|P8|NOT COMPLETED|Extension||0
8373654|NCT01140061|20641585|P7|NOT COMPLETED|Extension||0
8373655|NCT01140061|20641586|P6|NOT COMPLETED|Extension||0
8373656|NCT01140061|20641587|P5|NOT COMPLETED|Extension||0
8373657|NCT01140061|20641588|P4|NOT COMPLETED|Extension||0
8373658|NCT01140061|20641589|P3|NOT COMPLETED|Extension||0
8373659|NCT01140061|20641590|P2|NOT COMPLETED|Extension||0
8373660|NCT01140061|20641591|P1|NOT COMPLETED|Extension||0
8373661|NCT01140061|20641582|P10|COMPLETED|Extension||1
8373662|NCT01140061|20641583|P9|COMPLETED|Extension||7
8373663|NCT01140061|20641584|P8|COMPLETED|Extension||0
8373664|NCT01140061|20641585|P7|COMPLETED|Extension||0
8373665|NCT01140061|20641586|P6|COMPLETED|Extension||0
8373666|NCT01140061|20641587|P5|COMPLETED|Extension||0
8373667|NCT01140061|20641588|P4|COMPLETED|Extension||0
8373668|NCT01140061|20641589|P3|COMPLETED|Extension||0
8373669|NCT01140061|20641590|P2|COMPLETED|Extension||0
8373670|NCT01140061|20641591|P1|COMPLETED|Extension||0
8373671|NCT01140061|20641582|P10|STARTED|Extension||2
8373672|NCT01140061|20641583|P9|STARTED|Extension||7
8373673|NCT01140061|20641584|P8|STARTED|Extension||0
8373674|NCT01140061|20641585|P7|STARTED|Extension||0
8373675|NCT01140061|20641586|P6|STARTED|Extension||0
8373676|NCT01140061|20641587|P5|STARTED|Extension||0
8373677|NCT01140061|20641588|P4|STARTED|Extension||0
8373678|NCT01140061|20641589|P3|STARTED|Extension||0
8373679|NCT01140061|20641590|P2|STARTED|Extension||0
8373680|NCT01140061|20641591|P1|STARTED|Extension||0
8373681|NCT01140061|20641582|P10|NOT COMPLETED|Part III||0
8373682|NCT01140061|20641583|P9|NOT COMPLETED|Part III||0
8373683|NCT01140061|20641584|P8|NOT COMPLETED|Part III||0
8373684|NCT01140061|20641585|P7|NOT COMPLETED|Part III||0
8373685|NCT01140061|20641586|P6|NOT COMPLETED|Part III||0
8373686|NCT01140061|20641587|P5|NOT COMPLETED|Part III||0
8373687|NCT01140061|20641588|P4|NOT COMPLETED|Part III||0
8373688|NCT01140061|20641589|P3|NOT COMPLETED|Part III||0
8373689|NCT01140061|20641590|P2|NOT COMPLETED|Part III||0
8373690|NCT01140061|20641591|P1|NOT COMPLETED|Part III||0
8373691|NCT01140061|20641582|P10|COMPLETED|Part III||2
8373692|NCT01140061|20641583|P9|COMPLETED|Part III||7
8373693|NCT01140061|20641584|P8|COMPLETED|Part III||0
8373694|NCT01140061|20641585|P7|COMPLETED|Part III||0
8373695|NCT01140061|20641586|P6|COMPLETED|Part III||0
8373696|NCT01140061|20641587|P5|COMPLETED|Part III||0
8373697|NCT01140061|20641588|P4|COMPLETED|Part III||0
8373698|NCT01140061|20641589|P3|COMPLETED|Part III||0
8373699|NCT01140061|20641590|P2|COMPLETED|Part III||0
8373700|NCT01140061|20641591|P1|COMPLETED|Part III||0
8373701|NCT01140061|20641582|P10|STARTED|Part III|Includes 1 replacement participant|2
8373702|NCT01140061|20641583|P9|STARTED|Part III||7
8373703|NCT01140061|20641584|P8|STARTED|Part III||0
8373704|NCT01140061|20641585|P7|STARTED|Part III||0
8373705|NCT01140061|20641586|P6|STARTED|Part III||0
8373706|NCT01140061|20641587|P5|STARTED|Part III||0
8373707|NCT01140061|20641588|P4|STARTED|Part III||0
8373708|NCT01140061|20641589|P3|STARTED|Part III||0
8373709|NCT01140061|20641590|P2|STARTED|Part III||0
8373710|NCT01140061|20641591|P1|STARTED|Part III||0
8373711|NCT01140061|20641582|P10|NOT COMPLETED|Part II||0
8373712|NCT01140061|20641583|P9|NOT COMPLETED|Part II||0
8373713|NCT01140061|20641584|P8|NOT COMPLETED|Part II||0
8373714|NCT01140061|20641585|P7|NOT COMPLETED|Part II||0
8373715|NCT01140061|20641586|P6|NOT COMPLETED|Part II||0
8373716|NCT01140061|20641587|P5|NOT COMPLETED|Part II||0
8373717|NCT01140061|20641588|P4|NOT COMPLETED|Part II||0
8373718|NCT01140061|20641589|P3|NOT COMPLETED|Part II||0
8373719|NCT01140061|20641590|P2|NOT COMPLETED|Part II||0
8373720|NCT01140061|20641591|P1|NOT COMPLETED|Part II||0
8373721|NCT01140061|20641582|P10|COMPLETED|Part II||0
8373722|NCT01140061|20641583|P9|COMPLETED|Part II||0
8373723|NCT01140061|20641584|P8|COMPLETED|Part II||2
8373724|NCT01140061|20641585|P7|COMPLETED|Part II||6
8373725|NCT01140061|20641586|P6|COMPLETED|Part II||2
8373726|NCT01140061|20641587|P5|COMPLETED|Part II||6
8373727|NCT01140061|20641588|P4|COMPLETED|Part II||2
8373728|NCT01140061|20641589|P3|COMPLETED|Part II||6
8373729|NCT01140061|20641590|P2|COMPLETED|Part II||0
8373730|NCT01140061|20641591|P1|COMPLETED|Part II||0
8373731|NCT01140061|20641582|P10|STARTED|Part II||0
8373732|NCT01140061|20641583|P9|STARTED|Part II||0
8373733|NCT01140061|20641584|P8|STARTED|Part II||2
8373734|NCT01140061|20641585|P7|STARTED|Part II||6
8373735|NCT01140061|20641586|P6|STARTED|Part II||2
8373736|NCT01140061|20641587|P5|STARTED|Part II||6
8373737|NCT01140061|20641588|P4|STARTED|Part II||2
8373738|NCT01140061|20641589|P3|STARTED|Part II||6
8373739|NCT01140061|20641590|P2|STARTED|Part II||0
8373740|NCT01140061|20641591|P1|STARTED|Part II||0
8373741|NCT01140061|20641582|P10|NOT COMPLETED|Part I||0
8373742|NCT01140061|20641583|P9|NOT COMPLETED|Part I||0
8373743|NCT01140061|20641584|P8|NOT COMPLETED|Part I||0
8373744|NCT01140061|20641585|P7|NOT COMPLETED|Part I||0
8373745|NCT01140061|20641586|P6|NOT COMPLETED|Part I||0
8373746|NCT01140061|20641587|P5|NOT COMPLETED|Part I||0
8373747|NCT01140061|20641588|P4|NOT COMPLETED|Part I||0
8373748|NCT01140061|20641589|P3|NOT COMPLETED|Part I||0
8373749|NCT01140061|20641590|P2|NOT COMPLETED|Part I||0
8373750|NCT01140061|20641591|P1|NOT COMPLETED|Part I||1
8373751|NCT01140061|20641582|P10|COMPLETED|Part I||0
8373752|NCT01140061|20641583|P9|COMPLETED|Part I||0
8373753|NCT01140061|20641584|P8|COMPLETED|Part I||0
8373754|NCT01140061|20641585|P7|COMPLETED|Part I||0
8373755|NCT01140061|20641586|P6|COMPLETED|Part I||0
8373756|NCT01140061|20641587|P5|COMPLETED|Part I||0
8373757|NCT01140061|20641588|P4|COMPLETED|Part I||0
8373758|NCT01140061|20641589|P3|COMPLETED|Part I||0
8373759|NCT01140061|20641590|P2|COMPLETED|Part I||2
8373760|NCT01140061|20641591|P1|COMPLETED|Part I||6
8373761|NCT01140061|20641582|P10|STARTED|Part I||0
8373762|NCT01140061|20641583|P9|STARTED|Part I||0
8373763|NCT01140061|20641584|P8|STARTED|Part I||0
8373764|NCT01140061|20641585|P7|STARTED|Part I||0
8373765|NCT01140061|20641586|P6|STARTED|Part I||0
8373766|NCT01140061|20641587|P5|STARTED|Part I||0
8373767|NCT01140061|20641588|P4|STARTED|Part I||0
8373768|NCT01140061|20641589|P3|STARTED|Part I||0
8373769|NCT01140061|20641590|P2|STARTED|Part I||2
8373770|NCT01140061|20641591|P1|STARTED|Part I|Includes 1 replacement participant|7
8373771|NCT01140048|20641618|P1|NOT COMPLETED|Overall Study||45
8373772|NCT01140048|20641618|P1|COMPLETED|Overall Study||298
8373773|NCT01140048|20641618|P1|STARTED|Overall Study||343
8373774|NCT01139996|20641626|P2|NOT COMPLETED|Overall Study||0
8373775|NCT01139996|20641627|P1|NOT COMPLETED|Overall Study||0
8373776|NCT01139996|20641626|P2|COMPLETED|Overall Study||11
8373777|NCT01139996|20641627|P1|COMPLETED|Overall Study||11
8373778|NCT01139996|20641626|P2|STARTED|Overall Study||11
8373779|NCT01139996|20641627|P1|STARTED|Overall Study||11
8373780|NCT01139879|20641633|P1|NOT COMPLETED|Overall Study||0
8373781|NCT01139879|20641633|P1|COMPLETED|Overall Study||10
8373782|NCT01139879|20641633|P1|STARTED|Overall Study||10
8373783|NCT01139814|20641639|P1|NOT COMPLETED|Overall Study||0
8373784|NCT01139814|20641639|P1|COMPLETED|Overall Study||181
8373785|NCT01139814|20641639|P1|STARTED|Overall Study||181
8373786|NCT01139801|20641646|P2|NOT COMPLETED|Overall Study||0
8373787|NCT01139801|20641647|P1|NOT COMPLETED|Overall Study||0
8373788|NCT01139801|20641646|P2|COMPLETED|Overall Study||25
8373789|NCT01139801|20641647|P1|COMPLETED|Overall Study||25
8373790|NCT01139801|20641646|P2|STARTED|Overall Study||25
8373791|NCT01139801|20641647|P1|STARTED|Overall Study||25
8373792|NCT01139775|20641658|P3|NOT COMPLETED|Overall Study||6
8373793|NCT01139775|20641659|P2|NOT COMPLETED|Overall Study||13
8373794|NCT01139775|20641660|P1|NOT COMPLETED|Overall Study||1
8373795|NCT01139775|20641658|P3|COMPLETED|Overall Study||17
8373796|NCT01139775|20641659|P2|COMPLETED|Overall Study||26
8373797|NCT01139775|20641660|P1|COMPLETED|Overall Study||13
8373798|NCT01139775|20641658|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
8373799|NCT01139775|20641659|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
8373800|NCT01139775|20641660|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
8373801|NCT01139775|20641658|P3|STARTED|Overall Study||23
8373802|NCT01139775|20641659|P2|STARTED|Overall Study||39
8373803|NCT01139775|20641660|P1|STARTED|Overall Study||14
8373804|NCT01139762|20641692|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
8373805|NCT01139762|20641693|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
8373806|NCT01139762|20641694|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
8373807|NCT01139762|20641692|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
8373808|NCT01139762|20641693|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
8373809|NCT01139762|20641694|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
8373810|NCT01139762|20641692|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
8373811|NCT01139762|20641693|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
8373812|NCT01139762|20641694|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
8373813|NCT01139762|20641692|P3|STARTED|Double-Blind Randomized Active Treatment||350
8373814|NCT01139762|20641693|P2|STARTED|Double-Blind Randomized Active Treatment||346
8373815|NCT01139762|20641694|P1|STARTED|Double-Blind Randomized Active Treatment||0
8373816|NCT01139762|20641692|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
8373817|NCT01139762|20641693|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
8373818|NCT01139762|20641694|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
8373819|NCT01139762|20641692|P3|COMPLETED|Washout and Placebo Lead-In Period||0
8373820|NCT01139762|20641693|P2|COMPLETED|Washout and Placebo Lead-In Period||0
8373821|NCT01139762|20641694|P1|COMPLETED|Washout and Placebo Lead-In Period||696
8373822|NCT01139762|20641692|P3|STARTED|Washout and Placebo Lead-In Period||0
8373823|NCT01139762|20641693|P2|STARTED|Washout and Placebo Lead-In Period||0
8373824|NCT01139762|20641694|P1|STARTED|Washout and Placebo Lead-In Period||1070
8373825|NCT01139658|20641729|P2|NOT COMPLETED|Overall Study||113
8373826|NCT01139658|20641730|P1|NOT COMPLETED|Overall Study||56
8373827|NCT01139658|20641729|P2|COMPLETED|Overall Study||816
8373828|NCT01139658|20641730|P1|COMPLETED|Overall Study||691
8373829|NCT01139658|20641729|P2|STARTED|Overall Study||929
8373830|NCT01139658|20641730|P1|STARTED|Overall Study||747
8373831|NCT01139580|20641768|P2|NOT COMPLETED|Overall Study||18
8373832|NCT01139580|20641769|P1|NOT COMPLETED|Overall Study||23
8373833|NCT01139580|20641768|P2|COMPLETED|Overall Study||164
8373834|NCT01139580|20641769|P1|COMPLETED|Overall Study||158
8373835|NCT01139580|20641768|P2|STARTED|Overall Study||182
8373836|NCT01139580|20641769|P1|STARTED|Overall Study||181
8373837|NCT01139450|20641788|P3|NOT COMPLETED|Overall Study||38
8373838|NCT01139450|20641789|P2|NOT COMPLETED|Overall Study||25
8373839|NCT01139450|20641790|P1|NOT COMPLETED|Overall Study||27
8373840|NCT01139450|20641788|P3|COMPLETED|Overall Study||262
8373841|NCT01139450|20641789|P2|COMPLETED|Overall Study||272
8373842|NCT01139450|20641790|P1|COMPLETED|Overall Study||275
8373843|NCT01139450|20641788|P3|STARTED|Overall Study||300
8373844|NCT01139450|20641789|P2|STARTED|Overall Study||297
8373845|NCT01139450|20641790|P1|STARTED|Overall Study||302
8373846|NCT01139411|20641800|P2|NOT COMPLETED|Overall Study||4
8373847|NCT01139411|20641801|P1|NOT COMPLETED|Overall Study||2
8373848|NCT01139411|20641800|P2|COMPLETED|Overall Study||19
8373849|NCT01139411|20641801|P1|COMPLETED|Overall Study||24
8373850|NCT01139411|20641800|P2|STARTED|Overall Study||23
8373851|NCT01139411|20641801|P1|STARTED|Overall Study||26
8373852|NCT01139294|20641821|P2|NOT COMPLETED|Overall Study||0
8373853|NCT01139294|20641822|P1|NOT COMPLETED|Overall Study||0
8373854|NCT01139294|20641821|P2|COMPLETED|Overall Study||0
8373855|NCT01139294|20641822|P1|COMPLETED|Overall Study||0
8373856|NCT01139294|20641821|P2|STARTED|Overall Study||0
8373857|NCT01139294|20641822|P1|STARTED|Overall Study||0
8373858|NCT01139190|20641832|P2|NOT COMPLETED|Overall Study||1
8373859|NCT01139190|20641833|P1|NOT COMPLETED|Overall Study||0
8373860|NCT01139190|20641832|P2|COMPLETED|Overall Study||38
8373861|NCT01139190|20641833|P1|COMPLETED|Overall Study||38
8373862|NCT01139190|20641832|P2|STARTED|Overall Study||39
8373863|NCT01139190|20641833|P1|STARTED|Overall Study||38
8373864|NCT01139164|20641842|P3|NOT COMPLETED|Overall Study||0
8373865|NCT01139164|20641843|P2|NOT COMPLETED|Overall Study||2
8373866|NCT01139164|20641844|P1|NOT COMPLETED|Overall Study||0
8373867|NCT01139164|20641842|P3|COMPLETED|Overall Study||7
8373868|NCT01139164|20641843|P2|COMPLETED|Overall Study||65
8373869|NCT01139164|20641844|P1|COMPLETED|Overall Study||4
8373870|NCT01139164|20641842|P3|STARTED|Overall Study||7
8373871|NCT01139164|20641843|P2|STARTED|Overall Study||67
8373872|NCT01139164|20641844|P1|STARTED|Overall Study||4
8373873|NCT01139125|20641858|P1|NOT COMPLETED|Overall Study||1
8373874|NCT01139125|20641858|P1|COMPLETED|Overall Study||2
8373875|NCT01139125|20641858|P1|STARTED|Overall Study||3
8373876|NCT01139047|20641862|P1|NOT COMPLETED|Overall Study||1
8373877|NCT01139047|20641862|P1|COMPLETED|Overall Study||76
8373878|NCT01139047|20641862|P1|STARTED|Overall Study||77
8373879|NCT01139021|20641877|P6|NOT COMPLETED|Overall Study||0
8373880|NCT01139021|20641878|P5|NOT COMPLETED|Overall Study||9
8373881|NCT01139021|20641879|P4|NOT COMPLETED|Overall Study||1
8373882|NCT01139021|20641880|P3|NOT COMPLETED|Overall Study||0
8373883|NCT01139021|20641881|P2|NOT COMPLETED|Overall Study||0
8373884|NCT01139021|20641882|P1|NOT COMPLETED|Overall Study||1
8373885|NCT01139021|20641877|P6|COMPLETED|Overall Study||1
8373886|NCT01139021|20641878|P5|COMPLETED|Overall Study||107
8373887|NCT01139021|20641879|P4|COMPLETED|Overall Study||18
8373888|NCT01139021|20641880|P3|COMPLETED|Overall Study||67
8373889|NCT01139021|20641881|P2|COMPLETED|Overall Study||153
8373890|NCT01139021|20641882|P1|COMPLETED|Overall Study||151
8373891|NCT01139021|20641877|P6|STARTED|Overall Study||1
8373892|NCT01139021|20641878|P5|STARTED|Overall Study||116
8373893|NCT01139021|20641879|P4|STARTED|Overall Study||19
8373894|NCT01139021|20641880|P3|STARTED|Overall Study||67
8373895|NCT01139021|20641881|P2|STARTED|Overall Study||153
8373896|NCT01139021|20641882|P1|STARTED|Overall Study||152
8373897|NCT01139008|20641918|P1|NOT COMPLETED|Overall Study||6
8373898|NCT01139008|20641918|P1|COMPLETED|Overall Study||74
8373899|NCT01139008|20641918|P1|STARTED|Overall Study||80
8373900|NCT01138995|20641929|P2|NOT COMPLETED|Overall Study||25
8373901|NCT01138995|20641930|P1|NOT COMPLETED|Overall Study||10
8373902|NCT01138995|20641929|P2|COMPLETED|Overall Study||74
8373903|NCT01138995|20641930|P1|COMPLETED|Overall Study||88
8373904|NCT01138995|20641929|P2|STARTED|Overall Study||99
8373905|NCT01138995|20641930|P1|STARTED|Overall Study||98
8373906|NCT01138969|20641942|P2|NOT COMPLETED|Overall Study||0
8373907|NCT01138969|20641943|P1|NOT COMPLETED|Overall Study||0
8373908|NCT01138969|20641942|P2|COMPLETED|Overall Study||82
8373909|NCT01138969|20641943|P1|COMPLETED|Overall Study||83
8373910|NCT01138969|20641942|P2|STARTED|Overall Study||82
8373911|NCT01138969|20641943|P1|STARTED|Overall Study||83
8373912|NCT01138917|20641951|P1|NOT COMPLETED|Overall Study||24
8373913|NCT01138917|20641951|P1|COMPLETED|Overall Study||77
8373914|NCT01138917|20641951|P1|STARTED|Overall Study||101
8373921|NCT01138657|20641982|P2|NOT COMPLETED|Overall Study||18
8373922|NCT01138657|20641983|P1|NOT COMPLETED|Overall Study||8
8373923|NCT01138657|20641982|P2|COMPLETED|Overall Study||101
8373924|NCT01138657|20641983|P1|COMPLETED|Overall Study||112
8373925|NCT01138657|20641982|P2|Enrolled in Japan Sub-study|Overall Study||8
8373926|NCT01138657|20641983|P1|Enrolled in Japan Sub-study|Overall Study||8
8373927|NCT01138657|20641982|P2|Enrolled in Main Study|Overall Study||111
8373928|NCT01138657|20641983|P1|Enrolled in Main Study|Overall Study||112
8373929|NCT01138657|20641982|P2|STARTED|Overall Study||119
8373930|NCT01138657|20641983|P1|STARTED|Overall Study||120
8373931|NCT01138514|20642030|P3|NOT COMPLETED|Overall Study||93
8373932|NCT01138514|20642031|P2|NOT COMPLETED|Overall Study||53
8373933|NCT01138514|20642032|P1|NOT COMPLETED|Overall Study||48
8373934|NCT01138514|20642030|P3|COMPLETED|Overall Study||424
8373935|NCT01138514|20642031|P2|COMPLETED|Overall Study||463
8373936|NCT01138514|20642032|P1|COMPLETED|Overall Study||474
8373937|NCT01138514|20642030|P3|STARTED|Overall Study||517
8373938|NCT01138514|20642031|P2|STARTED|Overall Study||516
8373939|NCT01138514|20642032|P1|STARTED|Overall Study||522
8373940|NCT01138501|20642046|P1|NOT COMPLETED|Overall Study||5
8373941|NCT01138501|20642046|P1|COMPLETED|Overall Study||60
8373942|NCT01138501|20642046|P1|Exposed|Overall Study||63
8373943|NCT01138501|20642046|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
8373944|NCT01138475|20642054|P3|NOT COMPLETED|Overall Study||0
8373945|NCT01138475|20642055|P2|NOT COMPLETED|Overall Study||0
8373946|NCT01138475|20642056|P1|NOT COMPLETED|Overall Study||0
8373947|NCT01138475|20642054|P3|COMPLETED|Overall Study||17
8373948|NCT01138475|20642055|P2|COMPLETED|Overall Study||16
8373949|NCT01138475|20642056|P1|COMPLETED|Overall Study||16
8373950|NCT01138475|20642054|P3|STARTED|Overall Study||17
8373951|NCT01138475|20642055|P2|STARTED|Overall Study||16
8373952|NCT01138475|20642056|P1|STARTED|Overall Study||16
8373953|NCT01138150|20642090|P2|NOT COMPLETED|Overall Study||1
8373954|NCT01138150|20642091|P1|NOT COMPLETED|Overall Study||1
8373955|NCT01138150|20642090|P2|COMPLETED|Overall Study||17
8373956|NCT01138150|20642091|P1|COMPLETED|Overall Study||17
8373957|NCT01138150|20642090|P2|STARTED|Overall Study||18
8373958|NCT01138150|20642091|P1|STARTED|Overall Study||18
8373959|NCT01138124|20642147|P4|NOT COMPLETED|Overall Study||0
8373960|NCT01138124|20642148|P3|NOT COMPLETED|Overall Study||0
8373961|NCT01138124|20642149|P2|NOT COMPLETED|Overall Study||0
8373962|NCT01138124|20642150|P1|NOT COMPLETED|Overall Study||0
8373963|NCT01138124|20642147|P4|COMPLETED|Overall Study||19046
8373964|NCT01138124|20642148|P3|COMPLETED|Overall Study||1981
8373965|NCT01138124|20642149|P2|COMPLETED|Overall Study||30026
8373966|NCT01138124|20642150|P1|COMPLETED|Overall Study||3149
8373967|NCT01138124|20642147|P4|STARTED|Overall Study||19046
8373968|NCT01138124|20642148|P3|STARTED|Overall Study||1981
8373969|NCT01138124|20642149|P2|STARTED|Overall Study||30026
8373970|NCT01138124|20642150|P1|STARTED|Overall Study||3149
8373971|NCT01138111|20642172|P1|NOT COMPLETED|Overall Study||9
8373972|NCT01138111|20642172|P1|COMPLETED|Overall Study||36
8373973|NCT01138111|20642172|P1|STARTED|Overall Study||45
8373974|NCT01138098|20642203|P2|NOT COMPLETED|Overall Study||0
8373975|NCT01138098|20642204|P1|NOT COMPLETED|Overall Study||0
8373976|NCT01138098|20642203|P2|COMPLETED|Overall Study||90
8373977|NCT01138098|20642204|P1|COMPLETED|Overall Study||95
8373978|NCT01138098|20642203|P2|STARTED|Overall Study||90
8373979|NCT01138098|20642204|P1|STARTED|Overall Study||95
8373980|NCT01138046|20642226|P1|NOT COMPLETED|Overall Study||6
8373981|NCT01138046|20642226|P1|COMPLETED|Overall Study||6
8373982|NCT01138046|20642226|P1|STARTED|Overall Study||12
8373983|NCT01138007|20642246|P3|NOT COMPLETED|Overall Study||48
8373984|NCT01138007|20642247|P2|NOT COMPLETED|Overall Study||30
8373985|NCT01138007|20642248|P1|NOT COMPLETED|Overall Study||22
8373986|NCT01138007|20642246|P3|COMPLETED|Overall Study||144
8373987|NCT01138007|20642247|P2|COMPLETED|Overall Study||160
8373988|NCT01138007|20642248|P1|COMPLETED|Overall Study||165
8373989|NCT01138007|20642246|P3|STARTED|Overall Study||192
8373990|NCT01138007|20642247|P2|STARTED|Overall Study||190
8373991|NCT01138007|20642248|P1|STARTED|Overall Study||187
8373992|NCT01137890|20642282|P2|NOT COMPLETED|Overall Study||3
8373993|NCT01137890|20642283|P1|NOT COMPLETED|Overall Study||6
8373994|NCT01137890|20642282|P2|COMPLETED|Overall Study||2
8373995|NCT01137890|20642283|P1|COMPLETED|Overall Study||8
8373996|NCT01137890|20642282|P2|STARTED|Overall Study||5
8373997|NCT01137890|20642283|P1|STARTED|Overall Study||14
8373998|NCT01137812|20642355|P2|NOT COMPLETED|Overall Study||168
8373999|NCT01137812|20642356|P1|NOT COMPLETED|Overall Study||123
8374000|NCT01137812|20642355|P2|COMPLETED|Overall Study||210
8374001|NCT01137812|20642356|P1|COMPLETED|Overall Study||254
8374002|NCT01137812|20642355|P2|STARTED|Overall Study||378
8374003|NCT01137812|20642356|P1|STARTED|Overall Study||377
8374004|NCT01137786|20642376|P2|NOT COMPLETED|Overall Study||3
8374005|NCT01137786|20642377|P1|NOT COMPLETED|Overall Study||1
8374006|NCT01137786|20642376|P2|COMPLETED|Overall Study||21
8374007|NCT01137786|20642377|P1|COMPLETED|Overall Study||24
8374008|NCT01137786|20642376|P2|STARTED|Overall Study||24
8374009|NCT01137786|20642377|P1|STARTED|Overall Study||25
8374010|NCT01137773|20642387|P2|NOT COMPLETED|Overall Study||3
8374011|NCT01137773|20642388|P1|NOT COMPLETED|Overall Study||9
8374012|NCT01137773|20642387|P2|COMPLETED|Overall Study||20
8374013|NCT01137773|20642388|P1|COMPLETED|Overall Study||24
8374014|NCT01137773|20642387|P2|STARTED|Overall Study||23
8374015|NCT01137773|20642388|P1|STARTED|Overall Study||33
8374016|NCT01137682|20642399|P3|NOT COMPLETED|Overall Study||34
8374017|NCT01137682|20642400|P2|NOT COMPLETED|Overall Study||40
8374018|NCT01137682|20642401|P1|NOT COMPLETED|Overall Study||37
8374019|NCT01137682|20642399|P3|COMPLETED|Overall Study||34
8374020|NCT01137682|20642400|P2|COMPLETED|Overall Study||25
8374021|NCT01137682|20642401|P1|COMPLETED|Overall Study||28
8374022|NCT01137682|20642399|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
8374023|NCT01137682|20642400|P2|Safety Set - Extension|Overall Study||54
8374024|NCT01137682|20642401|P1|Safety Set - Extension|Overall Study||57
8374025|NCT01137682|20642399|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
8374026|NCT01137682|20642400|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
8374027|NCT01137682|20642401|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
8374028|NCT01137682|20642399|P3|Continuing Into Extension|Overall Study||63
8374029|NCT01137682|20642400|P2|Continuing Into Extension|Overall Study||54
8374030|NCT01137682|20642401|P1|Continuing Into Extension|Overall Study||57
8374031|NCT01137682|20642399|P3|Not Continuing Into Extension|Overall Study||2
8374032|NCT01137682|20642400|P2|Not Continuing Into Extension|Overall Study||3
8374033|NCT01137682|20642401|P1|Not Continuing Into Extension|Overall Study||2
8374034|NCT01137682|20642399|P3|Completed 24-Week Core Phase|Overall Study||65
8374035|NCT01137682|20642400|P2|Completed 24-Week Core Phase|Overall Study||57
8374036|NCT01137682|20642401|P1|Completed 24-Week Core Phase|Overall Study||59
8374037|NCT01137682|20642399|P3|Treated|Overall Study||67
8374038|NCT01137682|20642400|P2|Treated|Overall Study||63
8374039|NCT01137682|20642401|P1|Treated|Overall Study||63
8374040|NCT01137682|20642399|P3|Not Treated|Overall Study||1
8374041|NCT01137682|20642400|P2|Not Treated|Overall Study||2
8374042|NCT01137682|20642401|P1|Not Treated|Overall Study||2
8374043|NCT01137682|20642399|P3|STARTED|Overall Study||68
8374044|NCT01137682|20642400|P2|STARTED|Overall Study||65
8374045|NCT01137682|20642401|P1|STARTED|Overall Study||65
8374046|NCT01137604|20642451|P4|NOT COMPLETED|Overall Study||11
8374047|NCT01137604|20642452|P3|NOT COMPLETED|Overall Study||13
8374048|NCT01137604|20642453|P2|NOT COMPLETED|Overall Study||10
8374049|NCT01137604|20642454|P1|NOT COMPLETED|Overall Study||2
8374050|NCT01137604|20642451|P4|COMPLETED|Overall Study||21
8374051|NCT01137604|20642452|P3|COMPLETED|Overall Study||26
8374052|NCT01137604|20642453|P2|COMPLETED|Overall Study||32
8374053|NCT01137604|20642454|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
8374054|NCT01137604|20642451|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
8374055|NCT01137604|20642452|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
8374056|NCT01137604|20642453|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
8374057|NCT01137604|20642454|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
8374058|NCT01137604|20642451|P4|Disease Progression|Overall Study||21
8374059|NCT01137604|20642452|P3|Disease Progression|Overall Study||25
8374060|NCT01137604|20642453|P2|Disease Progression|Overall Study||29
8374061|NCT01137604|20642454|P1|Disease Progression|Overall Study||34
8374062|NCT01137604|20642451|P4|STARTED|Overall Study||32
8374063|NCT01137604|20642452|P3|STARTED|Overall Study||39
8374064|NCT01137604|20642453|P2|STARTED|Overall Study||42
8374065|NCT01137604|20642454|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
8374066|NCT01137578|20642488|P3|NOT COMPLETED|Overall Study||6
8374067|NCT01137578|20642489|P2|NOT COMPLETED|Overall Study||2
8374068|NCT01137578|20642490|P1|NOT COMPLETED|Overall Study||16
8374069|NCT01137578|20642488|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
8374070|NCT01137578|20642489|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
8374071|NCT01137578|20642490|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
8374072|NCT01137578|20642488|P3|STARTED|Overall Study||43
8374073|NCT01137578|20642489|P2|STARTED|Overall Study||14
8374074|NCT01137578|20642490|P1|STARTED|Overall Study||77
8374075|NCT01137539|20642530|P1|NOT COMPLETED|Overall Study||0
8374076|NCT01137539|20642530|P1|COMPLETED|Overall Study||50
8374077|NCT01137539|20642530|P1|STARTED|Overall Study||50
8374078|NCT01137474|20642539|P4|NOT COMPLETED|Overall Study||21
8374079|NCT01137474|20642540|P3|NOT COMPLETED|Overall Study||7
8374080|NCT01137474|20642541|P2|NOT COMPLETED|Overall Study||12
8374081|NCT01137474|20642542|P1|NOT COMPLETED|Overall Study||24
8374082|NCT01137474|20642539|P4|COMPLETED|Overall Study||281
8374083|NCT01137474|20642540|P3|COMPLETED|Overall Study||158
8374084|NCT01137474|20642541|P2|COMPLETED|Overall Study||154
8374085|NCT01137474|20642542|P1|COMPLETED|Overall Study||287
8374086|NCT01137474|20642539|P4|Received Treatment|Overall Study||302
8374087|NCT01137474|20642540|P3|Received Treatment|Overall Study||165
8374088|NCT01137474|20642541|P2|Received Treatment|Overall Study||166
8374089|NCT01137474|20642542|P1|Received Treatment|Overall Study||311
8374090|NCT01137474|20642539|P4|STARTED|Overall Study||302
8374091|NCT01137474|20642540|P3|STARTED|Overall Study||165
8374092|NCT01137474|20642541|P2|STARTED|Overall Study||166
8374093|NCT01137474|20642542|P1|STARTED|Overall Study||311
8374094|NCT01137435|20642560|P1|NOT COMPLETED|Overall Study||28
8374095|NCT01137435|20642560|P1|COMPLETED|Overall Study||659
8374096|NCT01137435|20642560|P1|STARTED|Overall Study||687
8374097|NCT01137396|20642569|P2|NOT COMPLETED|Overall Study||2
8374098|NCT01137396|20642570|P1|NOT COMPLETED|Overall Study||8
8374099|NCT01137396|20642569|P2|COMPLETED|Overall Study||25
8374100|NCT01137396|20642570|P1|COMPLETED|Overall Study||22
8374101|NCT01137396|20642569|P2|STARTED|Overall Study||27
8374102|NCT01137396|20642570|P1|STARTED|Overall Study||30
8374103|NCT01137370|20642580|P2|NOT COMPLETED|Overall Study||0
8374104|NCT01137370|20642581|P1|NOT COMPLETED|Overall Study||0
8374105|NCT01137370|20642580|P2|COMPLETED|Overall Study||87
8374106|NCT01137370|20642581|P1|COMPLETED|Overall Study||116
8374107|NCT01137370|20642580|P2|STARTED|Overall Study||87
8374108|NCT01137370|20642581|P1|STARTED|Overall Study||116
8374109|NCT01137292|20642587|P1|NOT COMPLETED|Overall Study||54
8374110|NCT01137292|20642587|P1|COMPLETED|Overall Study||123
8374111|NCT01137292|20642587|P1|STARTED|Overall Study||177
8374112|NCT01137110|20642596|P2|NOT COMPLETED|Overall Study||0
8374113|NCT01137110|20642597|P1|NOT COMPLETED|Overall Study||1
8374114|NCT01137110|20642596|P2|COMPLETED|Overall Study||49
8374115|NCT01137110|20642597|P1|COMPLETED|Overall Study||34
8374116|NCT01137110|20642596|P2|STARTED|Overall Study||49
8374117|NCT01137110|20642597|P1|STARTED|Overall Study||35
8374118|NCT01137071|20642603|P1|NOT COMPLETED|Overall Study||14
8374119|NCT01137071|20642603|P1|COMPLETED|Overall Study|Of the eligible patients|15
8374120|NCT01137071|20642603|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
8374121|NCT01137032|20642664|P1|NOT COMPLETED|Overall Study||0
8374122|NCT01137032|20642664|P1|COMPLETED|Overall Study||19
8374123|NCT01137032|20642664|P1|STARTED|Overall Study||19
8374124|NCT01137006|20642677|P7|NOT COMPLETED|Overall Study||0
8374125|NCT01137006|20642678|P6|NOT COMPLETED|Overall Study||0
8374126|NCT01137006|20642679|P5|NOT COMPLETED|Overall Study||0
8374127|NCT01137006|20642680|P4|NOT COMPLETED|Overall Study||0
8374128|NCT01137006|20642681|P3|NOT COMPLETED|Overall Study||0
8374129|NCT01137006|20642682|P2|NOT COMPLETED|Overall Study||0
8374130|NCT01137006|20642683|P1|NOT COMPLETED|Overall Study||0
8374131|NCT01137006|20642677|P7|COMPLETED|Overall Study||3
8374132|NCT01137006|20642678|P6|COMPLETED|Overall Study||4
8374133|NCT01137006|20642679|P5|COMPLETED|Overall Study||3
8374134|NCT01137006|20642680|P4|COMPLETED|Overall Study||3
8374135|NCT01137006|20642681|P3|COMPLETED|Overall Study||8
8374136|NCT01137006|20642682|P2|COMPLETED|Overall Study||3
8374137|NCT01137006|20642683|P1|COMPLETED|Overall Study||3
8374138|NCT01137006|20642677|P7|Completed at Least 1 Treatment Cycle|Overall Study||3
8374139|NCT01137006|20642678|P6|Completed at Least 1 Treatment Cycle|Overall Study||4
8374140|NCT01137006|20642679|P5|Completed at Least 1 Treatment Cycle|Overall Study||3
8374141|NCT01137006|20642680|P4|Completed at Least 1 Treatment Cycle|Overall Study||3
8374142|NCT01137006|20642681|P3|Completed at Least 1 Treatment Cycle|Overall Study||8
8374143|NCT01137006|20642682|P2|Completed at Least 1 Treatment Cycle|Overall Study||3
8374144|NCT01137006|20642683|P1|Completed at Least 1 Treatment Cycle|Overall Study||3
8374145|NCT01137006|20642677|P7|STARTED|Overall Study||3
8374146|NCT01137006|20642678|P6|STARTED|Overall Study||4
8374147|NCT01137006|20642679|P5|STARTED|Overall Study||3
8374148|NCT01137006|20642680|P4|STARTED|Overall Study||3
8374149|NCT01137006|20642681|P3|STARTED|Overall Study||8
8374150|NCT01137006|20642682|P2|STARTED|Overall Study||3
8374151|NCT01137006|20642683|P1|STARTED|Overall Study||3
8374152|NCT01136967|20642759|P2|NOT COMPLETED|Overall Study||27
8374153|NCT01136967|20642760|P1|NOT COMPLETED|Overall Study||24
8374154|NCT01136967|20642759|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
8374155|NCT01136967|20642760|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
8374156|NCT01136967|20642759|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
8374157|NCT01136967|20642760|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
8374158|NCT01136967|20642759|P2|Disease Progression|Overall Study||56
8374159|NCT01136967|20642760|P1|Disease Progression|Overall Study||55
8374160|NCT01136967|20642759|P2|STARTED|Overall Study||89
8374161|NCT01136967|20642760|P1|STARTED|Overall Study||93
8374162|NCT01136954|20642782|P2|NOT COMPLETED|Overall Study||21
8374163|NCT01136954|20642783|P1|NOT COMPLETED|Overall Study||24
8374164|NCT01136954|20642782|P2|COMPLETED|Overall Study||51
8374165|NCT01136954|20642783|P1|COMPLETED|Overall Study||48
8374166|NCT01136954|20642782|P2|STARTED|Overall Study||72
8374167|NCT01136954|20642783|P1|STARTED|Overall Study||72
8374168|NCT01136915|20642797|P2|NOT COMPLETED|Overall Study||1
8374169|NCT01136915|20642798|P1|NOT COMPLETED|Overall Study||2
8374170|NCT01136915|20642797|P2|COMPLETED|Overall Study||6
8374171|NCT01136915|20642798|P1|COMPLETED|Overall Study||6
8374172|NCT01136915|20642797|P2|STARTED|Overall Study||7
8374173|NCT01136915|20642798|P1|STARTED|Overall Study||8
8374174|NCT01136876|20642808|P2|NOT COMPLETED|Overall Study||11
8374175|NCT01136876|20642809|P1|NOT COMPLETED|Overall Study||5
8374176|NCT01136876|20642808|P2|COMPLETED|Overall Study||18
8374177|NCT01136876|20642809|P1|COMPLETED|Overall Study||23
8374178|NCT01136876|20642808|P2|STARTED|Overall Study||29
8374179|NCT01136876|20642809|P1|STARTED|Overall Study||28
8374180|NCT01136798|20642819|P2|NOT COMPLETED|Overall Study||0
8374181|NCT01136798|20642820|P1|NOT COMPLETED|Overall Study||0
8374182|NCT01136798|20642819|P2|COMPLETED|Overall Study||8
8374183|NCT01136798|20642820|P1|COMPLETED|Overall Study||10
8374184|NCT01136798|20642819|P2|STARTED|Overall Study||8
8374185|NCT01136798|20642820|P1|STARTED|Overall Study||10
8374186|NCT01136785|20642838|P2|NOT COMPLETED|Overall Study||1
8374187|NCT01136785|20642839|P1|NOT COMPLETED|Overall Study||2
8374188|NCT01136785|20642838|P2|COMPLETED|Overall Study||6
8374189|NCT01136785|20642839|P1|COMPLETED|Overall Study||13
8374190|NCT01136785|20642838|P2|STARTED|Overall Study||7
8374191|NCT01136785|20642839|P1|STARTED|Overall Study||15
8374192|NCT01136772|20642854|P2|NOT COMPLETED|Overall Study||110
8374193|NCT01136772|20642855|P1|NOT COMPLETED|Overall Study||116
8374194|NCT01136772|20642854|P2|COMPLETED|Overall Study||44
8374195|NCT01136772|20642855|P1|COMPLETED|Overall Study||41
8374196|NCT01136772|20642854|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
8374197|NCT01136772|20642855|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
8374198|NCT01136772|20642854|P2|STARTED|Overall Study||154
8374199|NCT01136772|20642855|P1|STARTED|Overall Study||157
8374200|NCT01136746|20642865|P2|NOT COMPLETED|Overall Study||3
8374201|NCT01136746|20642866|P1|NOT COMPLETED|Overall Study||3
8374202|NCT01136746|20642865|P2|COMPLETED|Overall Study||4
8374203|NCT01136746|20642866|P1|COMPLETED|Overall Study||6
8374204|NCT01136746|20642865|P2|STARTED|Overall Study||7
8374205|NCT01136746|20642866|P1|STARTED|Overall Study||9
8374206|NCT01136733|20642933|P7|NOT COMPLETED|Phase 2||50
8374207|NCT01136733|20642934|P6|NOT COMPLETED|Phase 2||52
8374208|NCT01136733|20642935|P5|NOT COMPLETED|Phase 2||51
8374209|NCT01136733|20642936|P4|NOT COMPLETED|Phase 2||0
8374210|NCT01136733|20642937|P3|NOT COMPLETED|Phase 2||0
8374211|NCT01136733|20642938|P2|NOT COMPLETED|Phase 2||0
8374212|NCT01136733|20642939|P1|NOT COMPLETED|Phase 2||0
8374213|NCT01136733|20642933|P7|COMPLETED|Phase 2||0
8374214|NCT01136733|20642934|P6|COMPLETED|Phase 2||0
8374215|NCT01136733|20642935|P5|COMPLETED|Phase 2||0
8374216|NCT01136733|20642936|P4|COMPLETED|Phase 2||0
8374217|NCT01136733|20642937|P3|COMPLETED|Phase 2||0
8374218|NCT01136733|20642938|P2|COMPLETED|Phase 2||0
8374219|NCT01136733|20642939|P1|COMPLETED|Phase 2||0
8374220|NCT01136733|20642933|P7|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
8374221|NCT01136733|20642934|P6|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
8374222|NCT01136733|20642935|P5|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
8374223|NCT01136733|20642936|P4|STARTED|Phase 2||0
8374224|NCT01136733|20642937|P3|STARTED|Phase 2||0
8374225|NCT01136733|20642938|P2|STARTED|Phase 2||0
8374226|NCT01136733|20642939|P1|STARTED|Phase 2||0
8374227|NCT01136733|20642933|P7|NOT COMPLETED|Phase 1b||0
8374228|NCT01136733|20642934|P6|NOT COMPLETED|Phase 1b||0
8374229|NCT01136733|20642935|P5|NOT COMPLETED|Phase 1b||0
8374230|NCT01136733|20642936|P4|NOT COMPLETED|Phase 1b||0
8374231|NCT01136733|20642937|P3|NOT COMPLETED|Phase 1b||2
8374232|NCT01136733|20642938|P2|NOT COMPLETED|Phase 1b||5
8374233|NCT01136733|20642939|P1|NOT COMPLETED|Phase 1b||1
8374234|NCT01136733|20642933|P7|COMPLETED|Phase 1b||0
8374235|NCT01136733|20642934|P6|COMPLETED|Phase 1b||0
8374236|NCT01136733|20642935|P5|COMPLETED|Phase 1b||0
8374237|NCT01136733|20642936|P4|COMPLETED|Phase 1b||0
8374238|NCT01136733|20642937|P3|COMPLETED|Phase 1b||0
8374239|NCT01136733|20642938|P2|COMPLETED|Phase 1b||6
8374240|NCT01136733|20642939|P1|COMPLETED|Phase 1b||6
8374241|NCT01136733|20642933|P7|STARTED|Phase 1b||0
8374242|NCT01136733|20642934|P6|STARTED|Phase 1b||0
8374243|NCT01136733|20642935|P5|STARTED|Phase 1b||0
8374244|NCT01136733|20642936|P4|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
8374245|NCT01136733|20642937|P3|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
8374246|NCT01136733|20642938|P2|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
8374247|NCT01136733|20642939|P1|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
8374248|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
8374249|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
8374250|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
8374251|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
8374252|NCT01136655|20643022|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
8374253|NCT01136655|20643022|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
8374254|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
8374255|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
8374256|NCT01136655|20643022|P1|STARTED|Washout After BUD 160 (7 Days)||51
8374257|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
8374258|NCT01136655|20643022|P1|COMPLETED|BUD 160 (1 Dose)||51
8374259|NCT01136655|20643022|P1|STARTED|BUD 160 (1 Dose)||51
8374260|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
8374261|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
8374262|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
8374263|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
8374264|NCT01136655|20643022|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
8374265|NCT01136655|20643022|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
8374266|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
8374267|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
8374268|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
8374269|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
8374270|NCT01136655|20643022|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
8374271|NCT01136655|20643022|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
8374272|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
8374273|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
8374274|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
8374275|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
8374276|NCT01136655|20643022|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
8374277|NCT01136655|20643022|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
8374278|NCT01136486|20643048|P1|NOT COMPLETED|Overall Study||0
8374279|NCT01136486|20643048|P1|COMPLETED|Overall Study||56
8374280|NCT01136486|20643048|P1|STARTED|Overall Study||56
8374281|NCT01136408|20643055|P3|NOT COMPLETED|Overall Study||5
8374282|NCT01136408|20643056|P2|NOT COMPLETED|Overall Study||9
8374283|NCT01136408|20643057|P1|NOT COMPLETED|Overall Study||5
8374284|NCT01136408|20643055|P3|COMPLETED|Overall Study||57
8374285|NCT01136408|20643056|P2|COMPLETED|Overall Study||49
8374286|NCT01136408|20643057|P1|COMPLETED|Overall Study||41
8374287|NCT01136408|20643055|P3|STARTED|Overall Study||62
8374288|NCT01136408|20643056|P2|STARTED|Overall Study||58
8374289|NCT01136408|20643057|P1|STARTED|Overall Study||46
8374290|NCT01136382|20643114|P2|NOT COMPLETED|Overall Study||31
8374291|NCT01136382|20643115|P1|NOT COMPLETED|Overall Study||60
8374292|NCT01136382|20643114|P2|COMPLETED|Overall Study||121
8374293|NCT01136382|20643115|P1|COMPLETED|Overall Study||92
8374294|NCT01136382|20643114|P2|STARTED|Overall Study||152
8374295|NCT01136382|20643115|P1|STARTED|Overall Study||152
8374296|NCT01136356|20643141|P2|NOT COMPLETED|Second 18-day Withdrawal||1
8374297|NCT01136356|20643142|P1|NOT COMPLETED|Second 18-day Withdrawal||0
8374298|NCT01136356|20643141|P2|COMPLETED|Second 18-day Withdrawal||5
8374299|NCT01136356|20643142|P1|COMPLETED|Second 18-day Withdrawal||2
8374300|NCT01136356|20643141|P2|STARTED|Second 18-day Withdrawal||6
8374301|NCT01136356|20643142|P1|STARTED|Second 18-day Withdrawal||2
8374302|NCT01136356|20643141|P2|NOT COMPLETED|Second Intervention||0
8374303|NCT01136356|20643142|P1|NOT COMPLETED|Second Intervention||0
8374304|NCT01136356|20643141|P2|COMPLETED|Second Intervention||6
8374305|NCT01136356|20643142|P1|COMPLETED|Second Intervention||2
8374306|NCT01136356|20643141|P2|STARTED|Second Intervention||6
8374307|NCT01136356|20643142|P1|STARTED|Second Intervention||2
8374308|NCT01136356|20643141|P2|NOT COMPLETED|First 18-day Withdrawal||0
8374309|NCT01136356|20643142|P1|NOT COMPLETED|First 18-day Withdrawal||4
8374310|NCT01136356|20643141|P2|COMPLETED|First 18-day Withdrawal||6
8374311|NCT01136356|20643142|P1|COMPLETED|First 18-day Withdrawal||2
8374312|NCT01136356|20643141|P2|STARTED|First 18-day Withdrawal||6
8374313|NCT01136356|20643142|P1|STARTED|First 18-day Withdrawal||6
8374314|NCT01136356|20643141|P2|NOT COMPLETED|First Intervention||0
8374315|NCT01136356|20643142|P1|NOT COMPLETED|First Intervention||0
8374316|NCT01136356|20643141|P2|COMPLETED|First Intervention||6
8374317|NCT01136356|20643142|P1|COMPLETED|First Intervention||6
8374318|NCT01136356|20643141|P2|STARTED|First Intervention||6
8374319|NCT01136356|20643142|P1|STARTED|First Intervention||6
8374320|NCT01136291|20643153|P2|NOT COMPLETED|Overall Study||1
8374321|NCT01136291|20643154|P1|NOT COMPLETED|Overall Study||1
8374322|NCT01136291|20643153|P2|COMPLETED|Overall Study||41
8374323|NCT01136291|20643154|P1|COMPLETED|Overall Study||39
8374324|NCT01136291|20643153|P2|Follow|Overall Study||42
8374325|NCT01136291|20643154|P1|Follow|Overall Study||40
8374326|NCT01136291|20643153|P2|STARTED|Overall Study||42
8374327|NCT01136291|20643154|P1|STARTED|Overall Study||40
8374328|NCT01136226|20643164|P1|NOT COMPLETED|Overall Study||13
8374329|NCT01136226|20643164|P1|COMPLETED|Overall Study||29
8374330|NCT01136226|20643164|P1|STARTED|Overall Study||42
8374331|NCT01136174|20643173|P4|NOT COMPLETED|Overall Study||4
8374332|NCT01136174|20643174|P3|NOT COMPLETED|Overall Study||0
8374333|NCT01136174|20643175|P2|NOT COMPLETED|Overall Study||0
8374334|NCT01136174|20643176|P1|NOT COMPLETED|Overall Study||0
8374335|NCT01136174|20643173|P4|COMPLETED|Overall Study||20
8374336|NCT01136174|20643174|P3|COMPLETED|Overall Study||8
8374337|NCT01136174|20643175|P2|COMPLETED|Overall Study||6
8374338|NCT01136174|20643176|P1|COMPLETED|Overall Study||12
8374339|NCT01136174|20643173|P4|STARTED|Overall Study||24
8374340|NCT01136174|20643174|P3|STARTED|Overall Study||8
8374341|NCT01136174|20643175|P2|STARTED|Overall Study||6
8374342|NCT01136174|20643176|P1|STARTED|Overall Study||12
8374343|NCT01135992|20643256|P1|NOT COMPLETED|Overall Study||21
8374344|NCT01135992|20643256|P1|COMPLETED|Overall Study||122
8374345|NCT01135992|20643256|P1|Full Analysis Set|Overall Study||129
8374346|NCT01135992|20643256|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
8374347|NCT01135992|20643256|P1|STARTED|Overall Study||143
8374348|NCT01135914|20643268|P3|NOT COMPLETED|Overall Study||22
8374349|NCT01135914|20643269|P2|NOT COMPLETED|Overall Study||5
8374350|NCT01135914|20643270|P1|NOT COMPLETED|Overall Study||4
8374351|NCT01135914|20643268|P3|COMPLETED|Overall Study||59
8374352|NCT01135914|20643269|P2|COMPLETED|Overall Study||75
8374353|NCT01135914|20643270|P1|COMPLETED|Overall Study||74
8374354|NCT01135914|20643268|P3|Safety Population|Overall Study||74
8374355|NCT01135914|20643269|P2|Safety Population|Overall Study||75
8374356|NCT01135914|20643270|P1|Safety Population|Overall Study||73
8374357|NCT01135914|20643268|P3|Intent to Treat (ITT) Population|Overall Study||72
8374358|NCT01135914|20643269|P2|Intent to Treat (ITT) Population|Overall Study||75
8374359|NCT01135914|20643270|P1|Intent to Treat (ITT) Population|Overall Study||73
8374360|NCT01135914|20643268|P3|STARTED|Overall Study||81
8374361|NCT01135914|20643269|P2|STARTED|Overall Study||80
8374362|NCT01135914|20643270|P1|STARTED|Overall Study||78
8374363|NCT01135537|20643299|P1|NOT COMPLETED|Overall Study||13
8374364|NCT01135537|20643299|P1|COMPLETED|Overall Study||17
8374365|NCT01135537|20643299|P1|STARTED|Overall Study||30
8374366|NCT01135524|20643303|P1|NOT COMPLETED|Overall Study||196
8374367|NCT01135524|20643303|P1|COMPLETED|Overall Study||0
8374368|NCT01135524|20643303|P1|STARTED|Overall Study||196
8374369|NCT01135511|20643316|P9|NOT COMPLETED|Overall Study||1
8374370|NCT01135511|20643317|P8|NOT COMPLETED|Overall Study||1
8374371|NCT01135511|20643318|P7|NOT COMPLETED|Overall Study||1
8374372|NCT01135511|20643319|P6|NOT COMPLETED|Overall Study||1
8374373|NCT01135511|20643320|P5|NOT COMPLETED|Overall Study||1
8374374|NCT01135511|20643321|P4|NOT COMPLETED|Overall Study||3
8374375|NCT01135511|20643322|P3|NOT COMPLETED|Overall Study||8
8374376|NCT01135511|20643323|P2|NOT COMPLETED|Overall Study||3
8374377|NCT01135511|20643324|P1|NOT COMPLETED|Overall Study||0
8374378|NCT01135511|20643316|P9|COMPLETED|Overall Study||20
8374379|NCT01135511|20643317|P8|COMPLETED|Overall Study||20
8374380|NCT01135511|20643318|P7|COMPLETED|Overall Study||18
8374381|NCT01135511|20643319|P6|COMPLETED|Overall Study||20
8374382|NCT01135511|20643320|P5|COMPLETED|Overall Study||38
8374383|NCT01135511|20643321|P4|COMPLETED|Overall Study||37
8374384|NCT01135511|20643322|P3|COMPLETED|Overall Study||33
8374385|NCT01135511|20643323|P2|COMPLETED|Overall Study||39
8374386|NCT01135511|20643324|P1|COMPLETED|Overall Study||41
8374387|NCT01135511|20643316|P9|STARTED|Overall Study||21
8374388|NCT01135511|20643317|P8|STARTED|Overall Study||21
8374389|NCT01135511|20643318|P7|STARTED|Overall Study||19
8374390|NCT01135511|20643319|P6|STARTED|Overall Study||21
8374391|NCT01135511|20643320|P5|STARTED|Overall Study||39
8374392|NCT01135511|20643321|P4|STARTED|Overall Study||40
8374393|NCT01135511|20643322|P3|STARTED|Overall Study||41
8374394|NCT01135511|20643323|P2|STARTED|Overall Study||42
8374395|NCT01135511|20643324|P1|STARTED|Overall Study||41
8374396|NCT01135498|20643606|P1|NOT COMPLETED|Overall Study||90
8374397|NCT01135498|20643606|P1|COMPLETED|Overall Study||0
8374398|NCT01135498|20643606|P1|STARTED|Overall Study||90
8374399|NCT01135420|20643617|P2|NOT COMPLETED|Overall Study||32
8374400|NCT01135420|20643618|P1|NOT COMPLETED|Overall Study||44
8374401|NCT01135420|20643617|P2|COMPLETED|Overall Study||175
8374402|NCT01135420|20643618|P1|COMPLETED|Overall Study||155
8374403|NCT01135420|20643617|P2|STARTED|Overall Study||207
8374404|NCT01135420|20643618|P1|STARTED|Overall Study||199
8374405|NCT01135381|20643628|P4|NOT COMPLETED|Overall Study||1
8374406|NCT01135381|20643629|P3|NOT COMPLETED|Overall Study||4
8374407|NCT01135381|20643630|P2|NOT COMPLETED|Overall Study||7
8374408|NCT01135381|20643631|P1|NOT COMPLETED|Overall Study||21
8374409|NCT01135381|20643628|P4|COMPLETED|Overall Study||67
8374410|NCT01135381|20643629|P3|COMPLETED|Overall Study||65
8374411|NCT01135381|20643630|P2|COMPLETED|Overall Study||178
8374412|NCT01135381|20643631|P1|COMPLETED|Overall Study||168
8374413|NCT01135381|20643628|P4|STARTED|Overall Study||68
8374414|NCT01135381|20643629|P3|STARTED|Overall Study||69
8374415|NCT01135381|20643630|P2|STARTED|Overall Study||185
8374416|NCT01135381|20643631|P1|STARTED|Overall Study||189
8374417|NCT01135368|20643649|P1|NOT COMPLETED|Overall Study||251
8374418|NCT01135368|20643649|P1|COMPLETED|Overall Study||255
8374419|NCT01135368|20643649|P1|STARTED|Overall Study||506
8374420|NCT01135329|20643765|P1|NOT COMPLETED|Overall Study||0
8374421|NCT01135329|20643765|P1|COMPLETED|Overall Study||15
8374422|NCT01135329|20643765|P1|STARTED|Overall Study||15
8374423|NCT01135186|20643776|P1|NOT COMPLETED|Overall Study||0
8374424|NCT01135186|20643776|P1|COMPLETED|Overall Study||9
8374425|NCT01135186|20643776|P1|STARTED|Overall Study||9
8374426|NCT01135134|20643785|P2|NOT COMPLETED|Overall Study||1
8374427|NCT01135134|20643786|P1|NOT COMPLETED|Overall Study||2
8374428|NCT01135134|20643785|P2|COMPLETED|Overall Study||112
8374429|NCT01135134|20643786|P1|COMPLETED|Overall Study||218
8374430|NCT01135134|20643785|P2|STARTED|Overall Study||113
8374431|NCT01135134|20643786|P1|STARTED|Overall Study||220
8374432|NCT01135095|20643794|P1|NOT COMPLETED|Overall Study||0
8374433|NCT01135095|20643794|P1|COMPLETED|Overall Study||101
8374434|NCT01135095|20643794|P1|STARTED|Overall Study||101
8374435|NCT01135069|20643801|P3|NOT COMPLETED|Overall Study||10
8374436|NCT01135069|20643802|P2|NOT COMPLETED|Overall Study||32
8374437|NCT01135069|20643803|P1|NOT COMPLETED|Overall Study||36
8374438|NCT01135069|20643801|P3|COMPLETED|Overall Study||56
8374439|NCT01135069|20643802|P2|COMPLETED|Overall Study||177
8374440|NCT01135069|20643803|P1|COMPLETED|Overall Study||169
8374441|NCT01135069|20643801|P3|STARTED|Overall Study||66
8374442|NCT01135069|20643802|P2|STARTED|Overall Study||209
8374443|NCT01135069|20643803|P1|STARTED|Overall Study||205
8374444|NCT01135017|20643813|P2|NOT COMPLETED|Overall Study||12
8374445|NCT01135017|20643814|P1|NOT COMPLETED|Overall Study||6
8374446|NCT01135017|20643813|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
8374447|NCT01135017|20643814|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
8374448|NCT01135017|20643813|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
8374449|NCT01135017|20643814|P1|Evaluable for Efficacy|Overall Study||55
8374450|NCT01135017|20643813|P2|Treated|Overall Study||57
8374451|NCT01135017|20643814|P1|Treated|Overall Study||55
8374452|NCT01135017|20643813|P2|STARTED|Overall Study||57
8374453|NCT01135017|20643814|P1|STARTED|Overall Study||55
8374454|NCT01134952|20643830|P1|NOT COMPLETED|Overall Study||0
8374455|NCT01134952|20643830|P1|COMPLETED|Overall Study||11
8374456|NCT01134952|20643830|P1|STARTED|Overall Study||11
8374457|NCT01134939|20643852|P8|NOT COMPLETED|Overall Study||0
8374458|NCT01134939|20643853|P7|NOT COMPLETED|Overall Study||9
8374459|NCT01134939|20643854|P6|NOT COMPLETED|Overall Study||9
8374460|NCT01134939|20643855|P5|NOT COMPLETED|Overall Study||10
8374461|NCT01134939|20643856|P4|NOT COMPLETED|Overall Study||14
8374462|NCT01134939|20643857|P3|NOT COMPLETED|Overall Study||10
8374463|NCT01134939|20643858|P2|NOT COMPLETED|Overall Study||18
8374464|NCT01134939|20643859|P1|NOT COMPLETED|Overall Study||17
8374465|NCT01134939|20643852|P8|COMPLETED|Overall Study||1
8374466|NCT01134939|20643853|P7|COMPLETED|Overall Study||10
8374467|NCT01134939|20643854|P6|COMPLETED|Overall Study||5
8374468|NCT01134939|20643855|P5|COMPLETED|Overall Study||23
8374469|NCT01134939|20643856|P4|COMPLETED|Overall Study||32
8374470|NCT01134939|20643857|P3|COMPLETED|Overall Study||41
8374471|NCT01134939|20643858|P2|COMPLETED|Overall Study||24
8374472|NCT01134939|20643859|P1|COMPLETED|Overall Study||42
8374473|NCT01134939|20643852|P8|STARTED|Overall Study||1
8374474|NCT01134939|20643853|P7|STARTED|Overall Study||19
8374475|NCT01134939|20643854|P6|STARTED|Overall Study||14
8374476|NCT01134939|20643855|P5|STARTED|Overall Study||33
8374477|NCT01134939|20643856|P4|STARTED|Overall Study||46
8374478|NCT01134939|20643857|P3|STARTED|Overall Study||51
8374479|NCT01134939|20643858|P2|STARTED|Overall Study||42
8374480|NCT01134939|20643859|P1|STARTED|Overall Study||59
8374481|NCT01134900|20643971|P2|NOT COMPLETED|Overall Study||0
8374482|NCT01134900|20643972|P1|NOT COMPLETED|Overall Study||0
8374483|NCT01134900|20643971|P2|COMPLETED|Overall Study||196
8374484|NCT01134900|20643972|P1|COMPLETED|Overall Study||200
8374485|NCT01134900|20643971|P2|STARTED|Overall Study||196
8374486|NCT01134900|20643972|P1|STARTED|Overall Study||200
8374487|NCT01134887|20643984|P4|NOT COMPLETED|Overall Study||0
8374488|NCT01134887|20643985|P3|NOT COMPLETED|Overall Study||0
8374489|NCT01134887|20643986|P2|NOT COMPLETED|Overall Study||4
8374490|NCT01134887|20643987|P1|NOT COMPLETED|Overall Study||0
8374491|NCT01134887|20643984|P4|COMPLETED|Overall Study||5
8374492|NCT01134887|20643985|P3|COMPLETED|Overall Study||5
8374493|NCT01134887|20643986|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
8374494|NCT01134887|20643987|P1|COMPLETED|Overall Study||9
8374495|NCT01134887|20643984|P4|STARTED|Overall Study||5
8374496|NCT01134887|20643985|P3|STARTED|Overall Study||5
8374497|NCT01134887|20643986|P2|STARTED|Overall Study||11
8374498|NCT01134887|20643987|P1|STARTED|Overall Study||9
8374499|NCT01134783|20643997|P2|NOT COMPLETED|Overall Study||37
8374500|NCT01134783|20643998|P1|NOT COMPLETED|Overall Study||36
8374501|NCT01134783|20643997|P2|COMPLETED|Overall Study||180
8374502|NCT01134783|20643998|P1|COMPLETED|Overall Study||188
8374503|NCT01134783|20643997|P2|STARTED|Overall Study||217
8374504|NCT01134783|20643998|P1|STARTED|Overall Study||224
8374505|NCT01134731|20644017|P3|NOT COMPLETED|Overall Study||8
8374506|NCT01134731|20644018|P2|NOT COMPLETED|Overall Study||11
8374507|NCT01134731|20644019|P1|NOT COMPLETED|Overall Study||13
8374508|NCT01134731|20644017|P3|COMPLETED|Overall Study||2
8374509|NCT01134731|20644018|P2|COMPLETED|Overall Study||10
8374510|NCT01134731|20644019|P1|COMPLETED|Overall Study||10
8374511|NCT01134731|20644017|P3|STARTED|Overall Study||10
8374512|NCT01134731|20644018|P2|STARTED|Overall Study||21
8374513|NCT01134731|20644019|P1|STARTED|Overall Study||23
8374514|NCT01134705|20644032|P2|NOT COMPLETED|Overall Study||22
8374515|NCT01134705|20644033|P1|NOT COMPLETED|Overall Study||15
8374516|NCT01134705|20644032|P2|COMPLETED|Overall Study||216
8374517|NCT01134705|20644033|P1|COMPLETED|Overall Study||221
8374518|NCT01134705|20644032|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
8374519|NCT01134705|20644033|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
8374520|NCT01134705|20644032|P2|STARTED|Overall Study||238
8374521|NCT01134705|20644033|P1|STARTED|Overall Study||236
8374522|NCT01134627|20644045|P2|NOT COMPLETED|Overall Study||67
8374523|NCT01134627|20644046|P1|NOT COMPLETED|Overall Study||69
8374524|NCT01134627|20644045|P2|COMPLETED|Overall Study||88
8374525|NCT01134627|20644046|P1|COMPLETED|Overall Study||80
8374526|NCT01134627|20644045|P2|STARTED|Overall Study|Number of participants treated.|155
8374527|NCT01134627|20644046|P1|STARTED|Overall Study|Number of participants treated.|149
8374538|NCT01134575|20644090|P3|NOT COMPLETED|Overall Study||0
8374539|NCT01134575|20644091|P2|NOT COMPLETED|Overall Study||0
8374540|NCT01134575|20644092|P1|NOT COMPLETED|Overall Study||0
8374541|NCT01134575|20644090|P3|COMPLETED|Overall Study||42
8374542|NCT01134575|20644091|P2|COMPLETED|Overall Study||45
8374543|NCT01134575|20644092|P1|COMPLETED|Overall Study||3
8374544|NCT01134575|20644090|P3|STARTED|Overall Study||42
8374545|NCT01134575|20644091|P2|STARTED|Overall Study||45
8374546|NCT01134575|20644092|P1|STARTED|Overall Study||3
8374547|NCT01134562|20644105|P5|NOT COMPLETED|Overall Study||0
8374548|NCT01134562|20644106|P4|NOT COMPLETED|Overall Study||0
8374549|NCT01134562|20644107|P3|NOT COMPLETED|Overall Study||0
8374550|NCT01134562|20644108|P2|NOT COMPLETED|Overall Study||1
8374551|NCT01134562|20644109|P1|NOT COMPLETED|Overall Study||0
8374552|NCT01134562|20644105|P5|COMPLETED|Overall Study||8
8374553|NCT01134562|20644106|P4|COMPLETED|Overall Study||8
8374554|NCT01134562|20644107|P3|COMPLETED|Overall Study||4
8374555|NCT01134562|20644108|P2|COMPLETED|Overall Study||3
8374556|NCT01134562|20644109|P1|COMPLETED|Overall Study||4
8374557|NCT01134562|20644105|P5|STARTED|Overall Study||8
8374558|NCT01134562|20644106|P4|STARTED|Overall Study||8
8374559|NCT01134562|20644107|P3|STARTED|Overall Study||4
8374560|NCT01134562|20644108|P2|STARTED|Overall Study||4
8374561|NCT01134562|20644109|P1|STARTED|Overall Study||4
8374562|NCT01134549|20644178|P5|NOT COMPLETED|Overall Study||0
8374563|NCT01134549|20644179|P4|NOT COMPLETED|Overall Study||0
8374564|NCT01134549|20644180|P3|NOT COMPLETED|Overall Study||0
8374565|NCT01134549|20644181|P2|NOT COMPLETED|Overall Study||0
8374566|NCT01134549|20644182|P1|NOT COMPLETED|Overall Study||0
8374567|NCT01134549|20644178|P5|COMPLETED|Overall Study||6
8374568|NCT01134549|20644179|P4|COMPLETED|Overall Study||6
8374569|NCT01134549|20644180|P3|COMPLETED|Overall Study||6
8374570|NCT01134549|20644181|P2|COMPLETED|Overall Study||6
8374571|NCT01134549|20644182|P1|COMPLETED|Overall Study||8
8374572|NCT01134549|20644178|P5|STARTED|Overall Study||6
8374573|NCT01134549|20644179|P4|STARTED|Overall Study||6
8374574|NCT01134549|20644180|P3|STARTED|Overall Study||6
8374575|NCT01134549|20644181|P2|STARTED|Overall Study||6
8374576|NCT01134549|20644182|P1|STARTED|Overall Study||8
8374577|NCT01134510|20644268|P2|NOT COMPLETED|Overall Study||1
8374578|NCT01134510|20644269|P1|NOT COMPLETED|Overall Study||0
8374579|NCT01134510|20644268|P2|COMPLETED|Overall Study||9
8374580|NCT01134510|20644269|P1|COMPLETED|Overall Study||10
8374581|NCT01134510|20644268|P2|Month 3|Overall Study||9
8374582|NCT01134510|20644269|P1|Month 3|Overall Study||10
8374583|NCT01134510|20644268|P2|Month 1|Overall Study||10
8374584|NCT01134510|20644269|P1|Month 1|Overall Study||10
8374585|NCT01134510|20644268|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
8374586|NCT01134510|20644269|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
8374587|NCT01134510|20644268|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
8374588|NCT01134510|20644269|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
8374589|NCT01134510|20644268|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
8374590|NCT01134510|20644269|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
8374591|NCT01134510|20644268|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
8374592|NCT01134510|20644269|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
8374593|NCT01134510|20644268|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
8374594|NCT01134510|20644269|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
8374595|NCT01134510|20644268|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
8374772|NCT01133756|20644831|P1|COMPLETED|Overall Study||0
8374596|NCT01134510|20644269|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
8374597|NCT01134510|20644268|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
8374598|NCT01134510|20644269|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
8374599|NCT01134510|20644268|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
8374600|NCT01134510|20644269|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
8374601|NCT01134393|20644281|P1|NOT COMPLETED|Overall Study||52
8374602|NCT01134393|20644281|P1|COMPLETED|Overall Study|Completed trial medication.|449
8374603|NCT01134393|20644281|P1|STARTED|Overall Study|Entered and treated.|501
8374604|NCT01134328|20644299|P4|NOT COMPLETED|Overall Study||4
8374605|NCT01134328|20644300|P3|NOT COMPLETED|Overall Study||3
8374606|NCT01134328|20644301|P2|NOT COMPLETED|Overall Study||3
8374607|NCT01134328|20644302|P1|NOT COMPLETED|Overall Study||2
8374608|NCT01134328|20644299|P4|COMPLETED|Overall Study||17
8374609|NCT01134328|20644300|P3|COMPLETED|Overall Study||17
8374610|NCT01134328|20644301|P2|COMPLETED|Overall Study||18
8374611|NCT01134328|20644302|P1|COMPLETED|Overall Study||19
8374612|NCT01134328|20644299|P4|STARTED|Overall Study||21
8374613|NCT01134328|20644300|P3|STARTED|Overall Study||20
8374614|NCT01134328|20644301|P2|STARTED|Overall Study||21
8374615|NCT01134328|20644302|P1|STARTED|Overall Study||21
8374616|NCT01134315|20644402|P2|NOT COMPLETED|Overall Study||19
8374617|NCT01134315|20644403|P1|NOT COMPLETED|Overall Study||9
8374618|NCT01134315|20644402|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
8374619|NCT01134315|20644403|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
8374620|NCT01134315|20644402|P2|STARTED|Overall Study||40
8374621|NCT01134315|20644403|P1|STARTED|Overall Study||21
8374622|NCT01134276|20644425|P2|NOT COMPLETED|Overall Study||0
8374623|NCT01134276|20644426|P1|NOT COMPLETED|Overall Study||0
8374624|NCT01134276|20644425|P2|COMPLETED|Overall Study||107
8374625|NCT01134276|20644426|P1|COMPLETED|Overall Study||104
8374626|NCT01134276|20644425|P2|STARTED|Overall Study||107
8374627|NCT01134276|20644426|P1|STARTED|Overall Study||104
8374628|NCT01134263|20644441|P5|NOT COMPLETED|Overall Study||9
8374629|NCT01134263|20644442|P4|NOT COMPLETED|Overall Study||19
8374630|NCT01134263|20644443|P3|NOT COMPLETED|Overall Study||29
8374631|NCT01134263|20644444|P2|NOT COMPLETED|Overall Study||20
8374632|NCT01134263|20644445|P1|NOT COMPLETED|Overall Study||24
8374633|NCT01134263|20644441|P5|COMPLETED|Overall Study||48
8374634|NCT01134263|20644442|P4|COMPLETED|Overall Study||149
8374635|NCT01134263|20644443|P3|COMPLETED|Overall Study||134
8374636|NCT01134263|20644444|P2|COMPLETED|Overall Study||143
8374637|NCT01134263|20644445|P1|COMPLETED|Overall Study||140
8374638|NCT01134263|20644441|P5|Safety Population|Overall Study||57
8374639|NCT01134263|20644442|P4|Safety Population|Overall Study||167
8374640|NCT01134263|20644443|P3|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
8374641|NCT01134263|20644444|P2|Safety Population|Overall Study||161
8374642|NCT01134263|20644445|P1|Safety Population|Overall Study||163
8374643|NCT01134263|20644441|P5|Received Vaccination 3|Overall Study||49
8374644|NCT01134263|20644442|P4|Received Vaccination 3|Overall Study||151
8374645|NCT01134263|20644443|P3|Received Vaccination 3|Overall Study||134
8374646|NCT01134263|20644444|P2|Received Vaccination 3|Overall Study||145
8374647|NCT01134263|20644445|P1|Received Vaccination 3|Overall Study||140
8374648|NCT01134263|20644441|P5|Received Vaccination 2|Overall Study||53
8374649|NCT01134263|20644442|P4|Received Vaccination 2|Overall Study||154
8374650|NCT01134263|20644443|P3|Received Vaccination 2|Overall Study||139
8374651|NCT01134263|20644444|P2|Received Vaccination 2|Overall Study||152
8374652|NCT01134263|20644445|P1|Received Vaccination 2|Overall Study||151
8374653|NCT01134263|20644441|P5|Received Vaccination 1|Overall Study||57
8374654|NCT01134263|20644442|P4|Received Vaccination 1|Overall Study||167
8374655|NCT01134263|20644443|P3|Received Vaccination 1|Overall Study||163
8374656|NCT01134263|20644444|P2|Received Vaccination 1|Overall Study||162
8374657|NCT01134263|20644445|P1|Received Vaccination 1|Overall Study||163
8374658|NCT01134263|20644441|P5|STARTED|Overall Study||57
8374659|NCT01134263|20644442|P4|STARTED|Overall Study||168
8374660|NCT01134263|20644443|P3|STARTED|Overall Study||163
8374661|NCT01134263|20644444|P2|STARTED|Overall Study||163
8374662|NCT01134263|20644445|P1|STARTED|Overall Study||164
8374663|NCT01134198|20644469|P2|NOT COMPLETED|Phase 2||4
8374664|NCT01134198|20644470|P1|NOT COMPLETED|Phase 2||0
8374665|NCT01134198|20644469|P2|COMPLETED|Phase 2||7
8374666|NCT01134198|20644470|P1|COMPLETED|Phase 2||9
8374667|NCT01134198|20644469|P2|STARTED|Phase 2||11
8374668|NCT01134198|20644470|P1|STARTED|Phase 2||9
8374669|NCT01134198|20644469|P2|NOT COMPLETED|Phase 1||2
8374670|NCT01134198|20644470|P1|NOT COMPLETED|Phase 1||7
8374671|NCT01134198|20644469|P2|COMPLETED|Phase 1||11
8374672|NCT01134198|20644470|P1|COMPLETED|Phase 1||9
8374673|NCT01134198|20644469|P2|STARTED|Phase 1||13
8374674|NCT01134198|20644470|P1|STARTED|Phase 1||16
8374675|NCT01134107|20644478|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
8374676|NCT01134107|20644479|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
8374677|NCT01134107|20644478|P2|COMPLETED|Period 2-Second Treatment Intervention||61
8374678|NCT01134107|20644479|P1|COMPLETED|Period 2-Second Treatment Intervention||57
8374679|NCT01134107|20644478|P2|STARTED|Period 2-Second Treatment Intervention||61
8374680|NCT01134107|20644479|P1|STARTED|Period 2-Second Treatment Intervention||61
8374773|NCT01133756|20644829|P3|Completed 6 Cycles|Overall Study||0
8374681|NCT01134107|20644478|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
8374682|NCT01134107|20644479|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
8374683|NCT01134107|20644478|P2|COMPLETED|Period 1-First Treatment Intervention||61
8374684|NCT01134107|20644479|P1|COMPLETED|Period 1-First Treatment Intervention||61
8374685|NCT01134107|20644478|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
8374686|NCT01134107|20644479|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
8374687|NCT01134107|20644478|P2|STARTED|Period 1-First Treatment Intervention||66
8374688|NCT01134107|20644479|P1|STARTED|Period 1-First Treatment Intervention||67
8374689|NCT01134081|20644511|P1|NOT COMPLETED|Overall Study||0
8374690|NCT01134081|20644511|P1|COMPLETED|Overall Study||44
8374691|NCT01134081|20644511|P1|STARTED|Overall Study||44
8374692|NCT01134055|20644526|P7|NOT COMPLETED|Overall Study||11
8374693|NCT01134055|20644527|P6|NOT COMPLETED|Overall Study||7
8374694|NCT01134055|20644528|P5|NOT COMPLETED|Overall Study||6
8374695|NCT01134055|20644529|P4|NOT COMPLETED|Overall Study||6
8374696|NCT01134055|20644530|P3|NOT COMPLETED|Overall Study||3
8374697|NCT01134055|20644531|P2|NOT COMPLETED|Overall Study||6
8374698|NCT01134055|20644532|P1|NOT COMPLETED|Overall Study||8
8374699|NCT01134055|20644526|P7|COMPLETED|Overall Study||62
8374700|NCT01134055|20644527|P6|COMPLETED|Overall Study||65
8374701|NCT01134055|20644528|P5|COMPLETED|Overall Study||67
8374702|NCT01134055|20644529|P4|COMPLETED|Overall Study||67
8374703|NCT01134055|20644530|P3|COMPLETED|Overall Study||71
8374704|NCT01134055|20644531|P2|COMPLETED|Overall Study||66
8374705|NCT01134055|20644532|P1|COMPLETED|Overall Study||65
8374706|NCT01134055|20644526|P7|STARTED|Overall Study||73
8374707|NCT01134055|20644527|P6|STARTED|Overall Study||72
8374708|NCT01134055|20644528|P5|STARTED|Overall Study||73
8374709|NCT01134055|20644529|P4|STARTED|Overall Study||73
8374710|NCT01134055|20644530|P3|STARTED|Overall Study||74
8374711|NCT01134055|20644531|P2|STARTED|Overall Study||72
8374712|NCT01134055|20644532|P1|STARTED|Overall Study||73
8374713|NCT01134042|20644666|P3|NOT COMPLETED|Overall Study||34
8374714|NCT01134042|20644667|P2|NOT COMPLETED|Overall Study||28
8374715|NCT01134042|20644668|P1|NOT COMPLETED|Overall Study||48
8374716|NCT01134042|20644666|P3|COMPLETED|Overall Study||161
8374717|NCT01134042|20644667|P2|COMPLETED|Overall Study||169
8374718|NCT01134042|20644668|P1|COMPLETED|Overall Study||146
8374719|NCT01134042|20644666|P3|STARTED|Overall Study||195
8374720|NCT01134042|20644667|P2|STARTED|Overall Study||197
8374721|NCT01134042|20644668|P1|STARTED|Overall Study||194
8374722|NCT01134016|20644706|P1|NOT COMPLETED|Overall Study||3
8374723|NCT01134016|20644706|P1|COMPLETED|Overall Study||10
8374724|NCT01134016|20644706|P1|STARTED|Overall Study||13
8374725|NCT01133977|20644744|P5|NOT COMPLETED|Overall Study||38
8374726|NCT01133977|20644745|P4|NOT COMPLETED|Overall Study||39
8374727|NCT01133977|20644746|P3|NOT COMPLETED|Overall Study||6
8374728|NCT01133977|20644747|P2|NOT COMPLETED|Overall Study||7
8374729|NCT01133977|20644748|P1|NOT COMPLETED|Overall Study||3
8374730|NCT01133977|20644744|P5|COMPLETED|Overall Study||1
8374731|NCT01133977|20644745|P4|COMPLETED|Overall Study||3
8374732|NCT01133977|20644746|P3|COMPLETED|Overall Study||0
8374733|NCT01133977|20644747|P2|COMPLETED|Overall Study||0
8374734|NCT01133977|20644748|P1|COMPLETED|Overall Study||0
8374735|NCT01133977|20644744|P5|STARTED|Overall Study|Treated|39
8374736|NCT01133977|20644745|P4|STARTED|Overall Study|Treated|42
8374737|NCT01133977|20644746|P3|STARTED|Overall Study|Treated|6
8374738|NCT01133977|20644747|P2|STARTED|Overall Study|Treated|7
8374739|NCT01133977|20644748|P1|STARTED|Overall Study|Treated|3
8374740|NCT01133860|20644765|P1|NOT COMPLETED|Overall Study||0
8374741|NCT01133860|20644765|P1|COMPLETED|Overall Study||12
8374742|NCT01133860|20644765|P1|STARTED|Overall Study||12
8374743|NCT01133847|20644775|P3|NOT COMPLETED|Follow-Up Phase||7
8374744|NCT01133847|20644776|P2|NOT COMPLETED|Follow-Up Phase||3
8374745|NCT01133847|20644777|P1|NOT COMPLETED|Follow-Up Phase||1
8374746|NCT01133847|20644775|P3|COMPLETED|Follow-Up Phase||60
8374747|NCT01133847|20644776|P2|COMPLETED|Follow-Up Phase||70
8374748|NCT01133847|20644777|P1|COMPLETED|Follow-Up Phase||72
8374749|NCT01133847|20644775|P3|STARTED|Follow-Up Phase||67
8374750|NCT01133847|20644776|P2|STARTED|Follow-Up Phase||73
8374751|NCT01133847|20644777|P1|STARTED|Follow-Up Phase||73
8374752|NCT01133847|20644775|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
8374753|NCT01133847|20644776|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
8374754|NCT01133847|20644777|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
8374755|NCT01133847|20644775|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
8374756|NCT01133847|20644776|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
8374757|NCT01133847|20644777|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
8374758|NCT01133847|20644775|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
8374759|NCT01133847|20644776|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
8374760|NCT01133847|20644777|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
8374761|NCT01133821|20644817|P2|NOT COMPLETED|Overall Study||19
8374762|NCT01133821|20644818|P1|NOT COMPLETED|Overall Study||18
8374763|NCT01133821|20644817|P2|COMPLETED|Overall Study||28
8374764|NCT01133821|20644818|P1|COMPLETED|Overall Study||27
8374765|NCT01133821|20644817|P2|STARTED|Overall Study||47
8374766|NCT01133821|20644818|P1|STARTED|Overall Study||45
8374767|NCT01133756|20644829|P3|NOT COMPLETED|Overall Study||2
8374768|NCT01133756|20644830|P2|NOT COMPLETED|Overall Study||3
8374769|NCT01133756|20644831|P1|NOT COMPLETED|Overall Study||2
8374770|NCT01133756|20644829|P3|COMPLETED|Overall Study||0
8374771|NCT01133756|20644830|P2|COMPLETED|Overall Study||0
8374774|NCT01133756|20644830|P2|Completed 6 Cycles|Overall Study||0
8374775|NCT01133756|20644831|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
8374776|NCT01133756|20644829|P3|STARTED|Overall Study||2
8374777|NCT01133756|20644830|P2|STARTED|Overall Study||3
8374778|NCT01133756|20644831|P1|STARTED|Overall Study||2
8374779|NCT01133704|20644847|P2|NOT COMPLETED|Overall Study||26
8374780|NCT01133704|20644848|P1|NOT COMPLETED|Overall Study||49
8374781|NCT01133704|20644847|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
8374782|NCT01133704|20644848|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
8374783|NCT01133704|20644847|P2|STARTED|Overall Study||33
8374784|NCT01133704|20644848|P1|STARTED|Overall Study||65
8374785|NCT01133678|20644858|P2|NOT COMPLETED|Overall Study||1
8374786|NCT01133678|20644859|P1|NOT COMPLETED|Overall Study||1
8374787|NCT01133678|20644858|P2|COMPLETED|Overall Study||24
8374788|NCT01133678|20644859|P1|COMPLETED|Overall Study||24
8374789|NCT01133678|20644858|P2|STARTED|Overall Study||25
8374790|NCT01133678|20644859|P1|STARTED|Overall Study||25
8374791|NCT01133665|20644865|P1|NOT COMPLETED|Overall Study||2
8374792|NCT01133665|20644865|P1|COMPLETED|Overall Study||40
8374793|NCT01133665|20644865|P1|STARTED|Overall Study||42
8374794|NCT01133639|20644908|P2|NOT COMPLETED|Overall Study||0
8374795|NCT01133639|20644909|P1|NOT COMPLETED|Overall Study||0
8374796|NCT01133639|20644908|P2|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
8374797|NCT01133639|20644909|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
8374798|NCT01133639|20644908|P2|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
8374799|NCT01133639|20644909|P1|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
8374800|NCT01133626|20644925|P3|NOT COMPLETED|Overall Study||2
8374801|NCT01133626|20644926|P2|NOT COMPLETED|Overall Study||5
8374802|NCT01133626|20644927|P1|NOT COMPLETED|Overall Study||1
8374803|NCT01133626|20644925|P3|COMPLETED|Overall Study||9
8374804|NCT01133626|20644926|P2|COMPLETED|Overall Study||41
8374805|NCT01133626|20644927|P1|COMPLETED|Overall Study||49
8374806|NCT01133626|20644925|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
8374807|NCT01133626|20644926|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
8374808|NCT01133626|20644927|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
8374809|NCT01133626|20644925|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
8374810|NCT01133626|20644926|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
8374811|NCT01133626|20644927|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
8374812|NCT01133626|20644925|P3|STARTED|Overall Study||11
8374813|NCT01133626|20644926|P2|STARTED|Overall Study||46
8374814|NCT01133626|20644927|P1|STARTED|Overall Study||50
8374815|NCT01133522|20644945|P10|NOT COMPLETED|Overall Study||0
8374816|NCT01133522|20644946|P9|NOT COMPLETED|Overall Study||0
8374817|NCT01133522|20644947|P8|NOT COMPLETED|Overall Study||0
8374818|NCT01133522|20644948|P7|NOT COMPLETED|Overall Study||0
8374819|NCT01133522|20644949|P6|NOT COMPLETED|Overall Study||0
8374820|NCT01133522|20644950|P5|NOT COMPLETED|Overall Study||1
8374821|NCT01133522|20644951|P4|NOT COMPLETED|Overall Study||1
8374822|NCT01133522|20644952|P3|NOT COMPLETED|Overall Study||0
8374823|NCT01133522|20644953|P2|NOT COMPLETED|Overall Study||1
8374824|NCT01133522|20644954|P1|NOT COMPLETED|Overall Study||0
8374825|NCT01133522|20644945|P10|COMPLETED|Overall Study||4
8374826|NCT01133522|20644946|P9|COMPLETED|Overall Study||2
8374827|NCT01133522|20644947|P8|COMPLETED|Overall Study||9
8374828|NCT01133522|20644948|P7|COMPLETED|Overall Study||2
8374829|NCT01133522|20644949|P6|COMPLETED|Overall Study||6
8374830|NCT01133522|20644950|P5|COMPLETED|Overall Study||6
8374831|NCT01133522|20644951|P4|COMPLETED|Overall Study||6
8374832|NCT01133522|20644952|P3|COMPLETED|Overall Study||6
8374833|NCT01133522|20644953|P2|COMPLETED|Overall Study||6
8374834|NCT01133522|20644954|P1|COMPLETED|Overall Study||10
8374835|NCT01133522|20644945|P10|Received Treatment|Overall Study||4
8374836|NCT01133522|20644946|P9|Received Treatment|Overall Study||2
8374837|NCT01133522|20644947|P8|Received Treatment|Overall Study||9
8374838|NCT01133522|20644948|P7|Received Treatment|Overall Study||2
8374839|NCT01133522|20644949|P6|Received Treatment|Overall Study||6
8374840|NCT01133522|20644950|P5|Received Treatment|Overall Study||6
8374841|NCT01133522|20644951|P4|Received Treatment|Overall Study||6
8374842|NCT01133522|20644952|P3|Received Treatment|Overall Study||6
8374843|NCT01133522|20644953|P2|Received Treatment|Overall Study||6
8374844|NCT01133522|20644954|P1|Received Treatment|Overall Study||10
8374845|NCT01133522|20644945|P10|STARTED|Overall Study||4
8374846|NCT01133522|20644946|P9|STARTED|Overall Study||2
8374847|NCT01133522|20644947|P8|STARTED|Overall Study||9
8374848|NCT01133522|20644948|P7|STARTED|Overall Study||2
8374849|NCT01133522|20644949|P6|STARTED|Overall Study||6
8374850|NCT01133522|20644950|P5|STARTED|Overall Study||7
8374851|NCT01133522|20644951|P4|STARTED|Overall Study||7
8374852|NCT01133522|20644952|P3|STARTED|Overall Study||6
8374853|NCT01133522|20644953|P2|STARTED|Overall Study||7
8374854|NCT01133522|20644954|P1|STARTED|Overall Study||10
8374855|NCT01133418|20645022|P2|NOT COMPLETED|Overall Study||6
8374856|NCT01133418|20645023|P1|NOT COMPLETED|Overall Study||5
8374857|NCT01133418|20645022|P2|COMPLETED|Overall Study||32
8374858|NCT01133418|20645023|P1|COMPLETED|Overall Study||29
8374859|NCT01133418|20645022|P2|STARTED|Overall Study||38
8374860|NCT01133418|20645023|P1|STARTED|Overall Study||34
8374861|NCT01133405|20645045|P10|NOT COMPLETED|Period 3||0
8374862|NCT01133405|20645046|P9|NOT COMPLETED|Period 3||0
8374863|NCT01133405|20645047|P8|NOT COMPLETED|Period 3||0
8374864|NCT01133405|20645048|P7|NOT COMPLETED|Period 3||0
8374865|NCT01133405|20645049|P6|NOT COMPLETED|Period 3||0
8374866|NCT01133405|20645050|P5|NOT COMPLETED|Period 3||0
8374867|NCT01133405|20645051|P4|NOT COMPLETED|Period 3||0
8374868|NCT01133405|20645052|P3|NOT COMPLETED|Period 3||0
8374869|NCT01133405|20645053|P2|NOT COMPLETED|Period 3||0
8374870|NCT01133405|20645054|P1|NOT COMPLETED|Period 3||0
8374871|NCT01133405|20645045|P10|COMPLETED|Period 3||0
8374872|NCT01133405|20645046|P9|COMPLETED|Period 3||0
8374873|NCT01133405|20645047|P8|COMPLETED|Period 3||0
8374874|NCT01133405|20645048|P7|COMPLETED|Period 3||0
8374875|NCT01133405|20645049|P6|COMPLETED|Period 3||2
8374876|NCT01133405|20645050|P5|COMPLETED|Period 3||3
8374877|NCT01133405|20645051|P4|COMPLETED|Period 3||2
8374878|NCT01133405|20645052|P3|COMPLETED|Period 3||4
8374879|NCT01133405|20645053|P2|COMPLETED|Period 3||4
8374880|NCT01133405|20645054|P1|COMPLETED|Period 3||2
8374881|NCT01133405|20645045|P10|Received at Least 1 Dose of Study Drug|Period 3||0
8374882|NCT01133405|20645046|P9|Received at Least 1 Dose of Study Drug|Period 3||0
8374883|NCT01133405|20645047|P8|Received at Least 1 Dose of Study Drug|Period 3||0
8374884|NCT01133405|20645048|P7|Received at Least 1 Dose of Study Drug|Period 3||0
8374885|NCT01133405|20645049|P6|Received at Least 1 Dose of Study Drug|Period 3||2
8374886|NCT01133405|20645050|P5|Received at Least 1 Dose of Study Drug|Period 3||3
8374887|NCT01133405|20645051|P4|Received at Least 1 Dose of Study Drug|Period 3||2
8374888|NCT01133405|20645052|P3|Received at Least 1 Dose of Study Drug|Period 3||4
8374889|NCT01133405|20645053|P2|Received at Least 1 Dose of Study Drug|Period 3||4
8374890|NCT01133405|20645054|P1|Received at Least 1 Dose of Study Drug|Period 3||2
8374891|NCT01133405|20645045|P10|STARTED|Period 3||0
8374892|NCT01133405|20645046|P9|STARTED|Period 3||0
8374893|NCT01133405|20645047|P8|STARTED|Period 3||0
8374894|NCT01133405|20645048|P7|STARTED|Period 3||0
8374895|NCT01133405|20645049|P6|STARTED|Period 3||2
8374896|NCT01133405|20645050|P5|STARTED|Period 3||3
8374897|NCT01133405|20645051|P4|STARTED|Period 3||2
8374898|NCT01133405|20645052|P3|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
8374899|NCT01133405|20645053|P2|STARTED|Period 3|One participant started and received placebo only in period 3.|4
8374900|NCT01133405|20645054|P1|STARTED|Period 3||2
8374901|NCT01133405|20645045|P10|NOT COMPLETED|Period 2||0
8374902|NCT01133405|20645046|P9|NOT COMPLETED|Period 2||0
8374903|NCT01133405|20645047|P8|NOT COMPLETED|Period 2||0
8374904|NCT01133405|20645048|P7|NOT COMPLETED|Period 2||0
8374905|NCT01133405|20645049|P6|NOT COMPLETED|Period 2||2
8374906|NCT01133405|20645050|P5|NOT COMPLETED|Period 2||0
8374907|NCT01133405|20645051|P4|NOT COMPLETED|Period 2||1
8374908|NCT01133405|20645052|P3|NOT COMPLETED|Period 2||1
8374909|NCT01133405|20645053|P2|NOT COMPLETED|Period 2||1
8374910|NCT01133405|20645054|P1|NOT COMPLETED|Period 2||0
8374911|NCT01133405|20645045|P10|COMPLETED|Period 2||0
8374912|NCT01133405|20645046|P9|COMPLETED|Period 2||0
8374913|NCT01133405|20645047|P8|COMPLETED|Period 2||0
8374914|NCT01133405|20645048|P7|COMPLETED|Period 2||0
8374915|NCT01133405|20645049|P6|COMPLETED|Period 2||2
8374916|NCT01133405|20645050|P5|COMPLETED|Period 2||3
8374917|NCT01133405|20645051|P4|COMPLETED|Period 2||2
8374918|NCT01133405|20645052|P3|COMPLETED|Period 2||3
8374919|NCT01133405|20645053|P2|COMPLETED|Period 2||3
8374920|NCT01133405|20645054|P1|COMPLETED|Period 2||2
8374921|NCT01133405|20645045|P10|Received at Least 1 Dose of Study Drug|Period 2||0
8374922|NCT01133405|20645046|P9|Received at Least 1 Dose of Study Drug|Period 2||0
8374923|NCT01133405|20645047|P8|Received at Least 1 Dose of Study Drug|Period 2||0
8374924|NCT01133405|20645048|P7|Received at Least 1 Dose of Study Drug|Period 2||0
8374925|NCT01133405|20645049|P6|Received at Least 1 Dose of Study Drug|Period 2||4
8374926|NCT01133405|20645050|P5|Received at Least 1 Dose of Study Drug|Period 2||3
8374927|NCT01133405|20645051|P4|Received at Least 1 Dose of Study Drug|Period 2||3
8374928|NCT01133405|20645052|P3|Received at Least 1 Dose of Study Drug|Period 2||4
8374929|NCT01133405|20645053|P2|Received at Least 1 Dose of Study Drug|Period 2||4
8374930|NCT01133405|20645054|P1|Received at Least 1 Dose of Study Drug|Period 2||2
8374931|NCT01133405|20645045|P10|STARTED|Period 2|Cohort D was planned only for single period.|0
8374932|NCT01133405|20645046|P9|STARTED|Period 2|Cohort D was planned only for single period.|0
8374933|NCT01133405|20645047|P8|STARTED|Period 2|Cohort C was planned only for single period.|0
8374934|NCT01133405|20645048|P7|STARTED|Period 2|Cohort C was planned only for single period.|0
8374935|NCT01133405|20645049|P6|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
8374936|NCT01133405|20645050|P5|STARTED|Period 2||3
8374937|NCT01133405|20645051|P4|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
8374938|NCT01133405|20645052|P3|STARTED|Period 2||4
8374939|NCT01133405|20645053|P2|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
8374940|NCT01133405|20645054|P1|STARTED|Period 2||2
8374941|NCT01133405|20645045|P10|NOT COMPLETED|Period 1||0
8374942|NCT01133405|20645046|P9|NOT COMPLETED|Period 1||0
8374943|NCT01133405|20645047|P8|NOT COMPLETED|Period 1||0
8374944|NCT01133405|20645048|P7|NOT COMPLETED|Period 1||1
8374945|NCT01133405|20645049|P6|NOT COMPLETED|Period 1||2
8374946|NCT01133405|20645050|P5|NOT COMPLETED|Period 1||0
8374947|NCT01133405|20645051|P4|NOT COMPLETED|Period 1||4
8374948|NCT01133405|20645052|P3|NOT COMPLETED|Period 1||1
8374949|NCT01133405|20645053|P2|NOT COMPLETED|Period 1||3
8374950|NCT01133405|20645054|P1|NOT COMPLETED|Period 1||1
8374951|NCT01133405|20645045|P10|COMPLETED|Period 1||2
8374952|NCT01133405|20645046|P9|COMPLETED|Period 1||4
8374953|NCT01133405|20645047|P8|COMPLETED|Period 1||2
8374954|NCT01133405|20645048|P7|COMPLETED|Period 1||4
8374955|NCT01133405|20645049|P6|COMPLETED|Period 1||3
8374956|NCT01133405|20645050|P5|COMPLETED|Period 1||3
8374957|NCT01133405|20645051|P4|COMPLETED|Period 1||1
8374958|NCT01133405|20645052|P3|COMPLETED|Period 1||4
8374959|NCT01133405|20645053|P2|COMPLETED|Period 1||3
8374960|NCT01133405|20645054|P1|COMPLETED|Period 1||2
8374961|NCT01133405|20645045|P10|Received at Least 1 Dose of Drug|Period 1||2
8374962|NCT01133405|20645046|P9|Received at Least 1 Dose of Drug|Period 1||4
8374963|NCT01133405|20645047|P8|Received at Least 1 Dose of Drug|Period 1||2
8374964|NCT01133405|20645048|P7|Received at Least 1 Dose of Drug|Period 1||4
8374965|NCT01133405|20645049|P6|Received at Least 1 Dose of Drug|Period 1||4
8374966|NCT01133405|20645050|P5|Received at Least 1 Dose of Drug|Period 1||3
8374967|NCT01133405|20645051|P4|Received at Least 1 Dose of Drug|Period 1||3
8374968|NCT01133405|20645052|P3|Received at Least 1 Dose of Drug|Period 1||4
8374969|NCT01133405|20645053|P2|Received at Least 1 Dose of Drug|Period 1||4
8374970|NCT01133405|20645054|P1|Received at Least 1 Dose of Drug|Period 1||2
8374971|NCT01133405|20645045|P10|Safety Analysis Population|Period 1||2
8374972|NCT01133405|20645046|P9|Safety Analysis Population|Period 1||4
8374973|NCT01133405|20645047|P8|Safety Analysis Population|Period 1||2
8374974|NCT01133405|20645048|P7|Safety Analysis Population|Period 1||5
8374975|NCT01133405|20645049|P6|Safety Analysis Population|Period 1||5
8374976|NCT01133405|20645050|P5|Safety Analysis Population|Period 1||3
8374977|NCT01133405|20645051|P4|Safety Analysis Population|Period 1||5
8374978|NCT01133405|20645052|P3|Safety Analysis Population|Period 1||5
8374979|NCT01133405|20645053|P2|Safety Analysis Population|Period 1||6
8374980|NCT01133405|20645054|P1|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
8374981|NCT01133405|20645045|P10|STARTED|Period 1||2
8374982|NCT01133405|20645046|P9|STARTED|Period 1||4
8374983|NCT01133405|20645047|P8|STARTED|Period 1||2
8374984|NCT01133405|20645048|P7|STARTED|Period 1||5
8374985|NCT01133405|20645049|P6|STARTED|Period 1||5
8374986|NCT01133405|20645050|P5|STARTED|Period 1||3
8374987|NCT01133405|20645051|P4|STARTED|Period 1||5
8374988|NCT01133405|20645052|P3|STARTED|Period 1||5
8374989|NCT01133405|20645053|P2|STARTED|Period 1||6
8374990|NCT01133405|20645054|P1|STARTED|Period 1||3
8374991|NCT01133392|20645105|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8374992|NCT01133392|20645106|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8374993|NCT01133392|20645105|P2|COMPLETED|Fourth Intervention (1 Day)||16
8374994|NCT01133392|20645106|P1|COMPLETED|Fourth Intervention (1 Day)||20
8374995|NCT01133392|20645105|P2|STARTED|Fourth Intervention (1 Day)||16
8374996|NCT01133392|20645106|P1|STARTED|Fourth Intervention (1 Day)||20
8374997|NCT01133392|20645105|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
8374998|NCT01133392|20645106|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8374999|NCT01133392|20645105|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
8375000|NCT01133392|20645106|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
8375001|NCT01133392|20645105|P2|STARTED|Interval Between Dosing (4-7 Days)||17
8375002|NCT01133392|20645106|P1|STARTED|Interval Between Dosing (4-7 Days)||20
8375003|NCT01133392|20645105|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8375004|NCT01133392|20645106|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8375005|NCT01133392|20645105|P2|COMPLETED|Third Intervention (1 Day)||17
8375006|NCT01133392|20645106|P1|COMPLETED|Third Intervention (1 Day)||20
8375007|NCT01133392|20645105|P2|STARTED|Third Intervention (1 Day)||17
8375008|NCT01133392|20645106|P1|STARTED|Third Intervention (1 Day)||20
8375009|NCT01133392|20645105|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8375010|NCT01133392|20645106|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8375011|NCT01133392|20645105|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
8375012|NCT01133392|20645106|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
8375013|NCT01133392|20645105|P2|STARTED|Interval Between Dosing (4-7 Days)||17
8375014|NCT01133392|20645106|P1|STARTED|Interval Between Dosing (4-7 Days)||20
8375015|NCT01133392|20645105|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8375016|NCT01133392|20645106|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8375017|NCT01133392|20645105|P2|COMPLETED|Second Intervention (1 Day)||17
8375018|NCT01133392|20645106|P1|COMPLETED|Second Intervention (1 Day)||20
8375019|NCT01133392|20645105|P2|STARTED|Second Intervention (1 Day)||17
8375020|NCT01133392|20645106|P1|STARTED|Second Intervention (1 Day)||20
8375021|NCT01133392|20645105|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
8375022|NCT01133392|20645106|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8375023|NCT01133392|20645105|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
8375024|NCT01133392|20645106|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
8375025|NCT01133392|20645105|P2|STARTED|Interval Between Dosing (4-7 Days)||18
8375026|NCT01133392|20645106|P1|STARTED|Interval Between Dosing (4-7 Days)||20
8375027|NCT01133392|20645105|P2|NOT COMPLETED|First Intervention (1 Day )||0
8375028|NCT01133392|20645106|P1|NOT COMPLETED|First Intervention (1 Day )||0
8375029|NCT01133392|20645105|P2|COMPLETED|First Intervention (1 Day )||18
8375030|NCT01133392|20645106|P1|COMPLETED|First Intervention (1 Day )||20
8375031|NCT01133392|20645105|P2|STARTED|First Intervention (1 Day )||18
8375032|NCT01133392|20645106|P1|STARTED|First Intervention (1 Day )||20
8375033|NCT01133379|20645123|P3|NOT COMPLETED|Overall Study||2
8375034|NCT01133379|20645124|P2|NOT COMPLETED|Overall Study||2
8375035|NCT01133379|20645125|P1|NOT COMPLETED|Overall Study||1
8375036|NCT01133379|20645123|P3|COMPLETED|Overall Study||56
8375037|NCT01133379|20645124|P2|COMPLETED|Overall Study||56
8375038|NCT01133379|20645125|P1|COMPLETED|Overall Study||57
8375039|NCT01133379|20645123|P3|STARTED|Overall Study||58
8375040|NCT01133379|20645124|P2|STARTED|Overall Study||58
8375041|NCT01133379|20645125|P1|STARTED|Overall Study||58
8375042|NCT01133288|20645178|P1|NOT COMPLETED|Intervention Allocation||2
8375043|NCT01133288|20645178|P1|COMPLETED|Intervention Allocation||0
8375044|NCT01133288|20645178|P1|STARTED|Intervention Allocation||2
8375045|NCT01133288|20645178|P1|NOT COMPLETED|Eligibility Assessment||5
8375046|NCT01133288|20645178|P1|COMPLETED|Eligibility Assessment||2
8375047|NCT01133288|20645178|P1|STARTED|Eligibility Assessment||7
8375048|NCT01133275|20645183|P1|NOT COMPLETED|Overall Study||2
8375049|NCT01133275|20645183|P1|COMPLETED|Overall Study||26
8375050|NCT01133275|20645183|P1|STARTED|Overall Study||28
8375051|NCT01133171|20645191|P3|NOT COMPLETED|Overall Study||0
8375052|NCT01133171|20645192|P2|NOT COMPLETED|Overall Study||2
8375053|NCT01133171|20645193|P1|NOT COMPLETED|Overall Study||1
8375054|NCT01133171|20645191|P3|COMPLETED|Overall Study||25
8375055|NCT01133171|20645192|P2|COMPLETED|Overall Study||25
8375056|NCT01133171|20645193|P1|COMPLETED|Overall Study||24
8375057|NCT01133171|20645191|P3|STARTED|Overall Study||25
8375058|NCT01133171|20645192|P2|STARTED|Overall Study||27
8375059|NCT01133171|20645193|P1|STARTED|Overall Study||25
8375060|NCT01133158|20645203|P1|NOT COMPLETED|Overall Study||17
8375061|NCT01133158|20645203|P1|COMPLETED|Overall Study||43
8375062|NCT01133158|20645203|P1|STARTED|Overall Study||60
8375063|NCT01133067|20645209|P1|NOT COMPLETED|Overall Study||139
8375064|NCT01133067|20645209|P1|COMPLETED|Overall Study||61
8375065|NCT01133067|20645209|P1|STARTED|Overall Study||200
8375066|NCT01132846|20645217|P3|NOT COMPLETED|Overall Study||11
8375067|NCT01132846|20645218|P2|NOT COMPLETED|Overall Study||18
8375068|NCT01132846|20645219|P1|NOT COMPLETED|Overall Study||16
8375069|NCT01132846|20645217|P3|COMPLETED|Overall Study||108
8375070|NCT01132846|20645218|P2|COMPLETED|Overall Study||101
8375071|NCT01132846|20645219|P1|COMPLETED|Overall Study||106
8375072|NCT01132846|20645217|P3|STARTED|Overall Study||119
8375073|NCT01132846|20645218|P2|STARTED|Overall Study||119
8375074|NCT01132846|20645219|P1|STARTED|Overall Study||122
8375075|NCT01132820|20645269|P1|NOT COMPLETED|Overall Study||5
8375076|NCT01132820|20645269|P1|COMPLETED|Overall Study||48
8375077|NCT01132820|20645269|P1|STARTED|Overall Study||53
8375078|NCT01132755|20645278|P1|NOT COMPLETED|Overall Study||42
8375079|NCT01132755|20645278|P1|COMPLETED|Overall Study||70
8375080|NCT01132755|20645278|P1|STARTED|Overall Study||112
8375081|NCT01132690|20645285|P2|NOT COMPLETED|Overall Study||0
8375082|NCT01132690|20645286|P1|NOT COMPLETED|Overall Study||0
8375083|NCT01132690|20645285|P2|COMPLETED|Overall Study||5
8375084|NCT01132690|20645286|P1|COMPLETED|Overall Study||6
8375085|NCT01132690|20645285|P2|STARTED|Overall Study||5
8375086|NCT01132690|20645286|P1|STARTED|Overall Study||6
8375087|NCT01132664|20645307|P5|NOT COMPLETED|BM Cohort||6
8375088|NCT01132664|20645308|P4|NOT COMPLETED|BM Cohort||3
8375089|NCT01132664|20645309|P3|NOT COMPLETED|BM Cohort||0
8375090|NCT01132664|20645310|P2|NOT COMPLETED|BM Cohort||0
8375091|NCT01132664|20645311|P1|NOT COMPLETED|BM Cohort||0
8375092|NCT01132664|20645307|P5|COMPLETED|BM Cohort||0
8375093|NCT01132664|20645308|P4|COMPLETED|BM Cohort||0
8375094|NCT01132664|20645309|P3|COMPLETED|BM Cohort||0
8375095|NCT01132664|20645310|P2|COMPLETED|BM Cohort||0
8375096|NCT01132664|20645311|P1|COMPLETED|BM Cohort||0
8375097|NCT01132664|20645307|P5|STARTED|BM Cohort||6
8375098|NCT01132664|20645308|P4|STARTED|BM Cohort||3
8375099|NCT01132664|20645309|P3|STARTED|BM Cohort||0
8375100|NCT01132664|20645310|P2|STARTED|BM Cohort||0
8375101|NCT01132664|20645311|P1|STARTED|BM Cohort||0
8375102|NCT01132664|20645307|P5|NOT COMPLETED|Phase ll||0
8375103|NCT01132664|20645308|P4|NOT COMPLETED|Phase ll||0
8375104|NCT01132664|20645309|P3|NOT COMPLETED|Phase ll||50
8375105|NCT01132664|20645310|P2|NOT COMPLETED|Phase ll||0
8375106|NCT01132664|20645311|P1|NOT COMPLETED|Phase ll||0
8375107|NCT01132664|20645307|P5|COMPLETED|Phase ll||0
8375108|NCT01132664|20645308|P4|COMPLETED|Phase ll||0
8375109|NCT01132664|20645309|P3|COMPLETED|Phase ll||0
8375110|NCT01132664|20645310|P2|COMPLETED|Phase ll||0
8375111|NCT01132664|20645311|P1|COMPLETED|Phase ll||0
8375112|NCT01132664|20645307|P5|STARTED|Phase ll||0
8375113|NCT01132664|20645308|P4|STARTED|Phase ll||0
8375114|NCT01132664|20645309|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
8375115|NCT01132664|20645310|P2|STARTED|Phase ll||0
8375116|NCT01132664|20645311|P1|STARTED|Phase ll||0
8375117|NCT01132664|20645307|P5|NOT COMPLETED|Phase lb||0
8375118|NCT01132664|20645308|P4|NOT COMPLETED|Phase lb||0
8375119|NCT01132664|20645309|P3|NOT COMPLETED|Phase lb||0
8375120|NCT01132664|20645310|P2|NOT COMPLETED|Phase lb||12
8375121|NCT01132664|20645311|P1|NOT COMPLETED|Phase lb||5
8375122|NCT01132664|20645307|P5|COMPLETED|Phase lb||0
8375123|NCT01132664|20645308|P4|COMPLETED|Phase lb||0
8375124|NCT01132664|20645309|P3|COMPLETED|Phase lb||0
8375125|NCT01132664|20645310|P2|COMPLETED|Phase lb||0
8375126|NCT01132664|20645311|P1|COMPLETED|Phase lb||0
8375127|NCT01132664|20645307|P5|STARTED|Phase lb||0
8375128|NCT01132664|20645308|P4|STARTED|Phase lb||0
8375129|NCT01132664|20645309|P3|STARTED|Phase lb||0
8375130|NCT01132664|20645310|P2|STARTED|Phase lb||12
8375131|NCT01132664|20645311|P1|STARTED|Phase lb||5
8375132|NCT01132651|20645345|P2|NOT COMPLETED|Overall Study||1
8375133|NCT01132651|20645346|P1|NOT COMPLETED|Overall Study||1
8375134|NCT01132651|20645345|P2|COMPLETED|Overall Study||4
8375135|NCT01132651|20645346|P1|COMPLETED|Overall Study||3
8375136|NCT01132651|20645345|P2|STARTED|Overall Study||5
8375137|NCT01132651|20645346|P1|STARTED|Overall Study||4
8375138|NCT01132612|20645357|P3|NOT COMPLETED|Overall Study||170
8375139|NCT01132612|20645358|P2|NOT COMPLETED|Overall Study||35
8375140|NCT01132612|20645359|P1|NOT COMPLETED|Overall Study||40
8375141|NCT01132612|20645357|P3|COMPLETED|Overall Study||17
8375142|NCT01132612|20645358|P2|COMPLETED|Overall Study||7
8375143|NCT01132612|20645359|P1|COMPLETED|Overall Study||6
8375144|NCT01132612|20645357|P3|STARTED|Overall Study||187
8375145|NCT01132612|20645358|P2|STARTED|Overall Study||42
8375146|NCT01132612|20645359|P1|STARTED|Overall Study||46
8375147|NCT01132547|20645375|P2|NOT COMPLETED|Overall Study||1
8375148|NCT01132547|20645376|P1|NOT COMPLETED|Overall Study||4
8375149|NCT01132547|20645375|P2|COMPLETED|Overall Study||12
8375150|NCT01132547|20645376|P1|COMPLETED|Overall Study||5
8375151|NCT01132547|20645375|P2|STARTED|Overall Study||13
8375152|NCT01132547|20645376|P1|STARTED|Overall Study||9
8375153|NCT01132508|20645386|P1|NOT COMPLETED|Overall Study||9
8375154|NCT01132508|20645386|P1|COMPLETED|Overall Study||24
8375155|NCT01132508|20645386|P1|104 Weeks|Overall Study||27
8375156|NCT01132508|20645386|P1|78 Weeks|Overall Study||28
8375157|NCT01132508|20645386|P1|52 Weeks|Overall Study||30
8375158|NCT01132508|20645386|P1|26 Weeks|Overall Study||33
8375159|NCT01132508|20645386|P1|12 Weeks|Overall Study||33
8375160|NCT01132508|20645386|P1|6 Weeks|Overall Study||33
8375161|NCT01132508|20645386|P1|Treated at Baseline|Overall Study||33
8375162|NCT01132508|20645386|P1|STARTED|Overall Study||33
8375163|NCT01132495|20645446|P4|NOT COMPLETED|Overall Study||12
8375164|NCT01132495|20645447|P3|NOT COMPLETED|Overall Study||20
8375165|NCT01132495|20645448|P2|NOT COMPLETED|Overall Study||38
8375166|NCT01132495|20645449|P1|NOT COMPLETED|Overall Study||40
8375167|NCT01132495|20645446|P4|COMPLETED|Overall Study||104
8375168|NCT01132495|20645447|P3|COMPLETED|Overall Study||146
8375169|NCT01132495|20645448|P2|COMPLETED|Overall Study||403
8375170|NCT01132495|20645449|P1|COMPLETED|Overall Study||407
8375171|NCT01132495|20645446|P4|STARTED|Overall Study||116
8375172|NCT01132495|20645447|P3|STARTED|Overall Study||166
8375173|NCT01132495|20645448|P2|STARTED|Overall Study||441
8375174|NCT01132495|20645449|P1|STARTED|Overall Study||447
8375175|NCT01132482|20645462|P2|NOT COMPLETED|Overall Study||0
8375176|NCT01132482|20645463|P1|NOT COMPLETED|Overall Study||1
8375177|NCT01132482|20645462|P2|COMPLETED|Overall Study||6
8375178|NCT01132482|20645463|P1|COMPLETED|Overall Study||12
8375179|NCT01132482|20645462|P2|STARTED|Overall Study||6
8375180|NCT01132482|20645463|P1|STARTED|Overall Study||13
8375181|NCT01132378|20645481|P1|NOT COMPLETED|Overall Study||0
8375182|NCT01132378|20645481|P1|COMPLETED|Overall Study||40
8375183|NCT01132378|20645481|P1|STARTED|Overall Study||40
8375184|NCT01132326|20645486|P1|NOT COMPLETED|Overall Study||218
8375185|NCT01132326|20645486|P1|COMPLETED|Overall Study||132
8375186|NCT01132326|20645486|P1|STARTED|Overall Study||350
8375187|NCT01132313|20645502|P12|NOT COMPLETED|Overall Study||0
8375188|NCT01132313|20645503|P11|NOT COMPLETED|Overall Study||1
8375189|NCT01132313|20645504|P10|NOT COMPLETED|Overall Study||20
8375190|NCT01132313|20645505|P9|NOT COMPLETED|Overall Study||21
8375191|NCT01132313|20645506|P8|NOT COMPLETED|Overall Study||8
8375192|NCT01132313|20645507|P7|NOT COMPLETED|Overall Study||30
8375193|NCT01132313|20645508|P6|NOT COMPLETED|Overall Study||25
8375194|NCT01132313|20645509|P5|NOT COMPLETED|Overall Study||45
8375195|NCT01132313|20645510|P4|NOT COMPLETED|Overall Study||32
8375196|NCT01132313|20645511|P3|NOT COMPLETED|Overall Study||20
8375197|NCT01132313|20645512|P2|NOT COMPLETED|Overall Study||0
8375198|NCT01132313|20645513|P1|NOT COMPLETED|Overall Study||3
8375199|NCT01132313|20645502|P12|COMPLETED|Overall Study||2
8375200|NCT01132313|20645503|P11|COMPLETED|Overall Study||0
8375201|NCT01132313|20645504|P10|COMPLETED|Overall Study||5
8375202|NCT01132313|20645505|P9|COMPLETED|Overall Study||5
8375203|NCT01132313|20645506|P8|COMPLETED|Overall Study||24
8375204|NCT01132313|20645507|P7|COMPLETED|Overall Study||19
8375205|NCT01132313|20645508|P6|COMPLETED|Overall Study||54
8375206|NCT01132313|20645509|P5|COMPLETED|Overall Study||34
8375207|NCT01132313|20645510|P4|COMPLETED|Overall Study||48
8375208|NCT01132313|20645511|P3|COMPLETED|Overall Study||61
8375209|NCT01132313|20645512|P2|COMPLETED|Overall Study||17
8375210|NCT01132313|20645513|P1|COMPLETED|Overall Study||14
8375211|NCT01132313|20645502|P12|STARTED|Overall Study||2
8375212|NCT01132313|20645503|P11|STARTED|Overall Study||1
8375213|NCT01132313|20645504|P10|STARTED|Overall Study||25
8375214|NCT01132313|20645505|P9|STARTED|Overall Study||26
8375215|NCT01132313|20645506|P8|STARTED|Overall Study||32
8375216|NCT01132313|20645507|P7|STARTED|Overall Study||49
8375217|NCT01132313|20645508|P6|STARTED|Overall Study||79
8375218|NCT01132313|20645509|P5|STARTED|Overall Study||79
8375219|NCT01132313|20645510|P4|STARTED|Overall Study||80
8375220|NCT01132313|20645511|P3|STARTED|Overall Study||81
8375221|NCT01132313|20645512|P2|STARTED|Overall Study||17
8375222|NCT01132313|20645513|P1|STARTED|Overall Study||17
8375223|NCT01132144|20645570|P2|NOT COMPLETED|Overall Study||0
8375224|NCT01132144|20645571|P1|NOT COMPLETED|Overall Study||0
8375225|NCT01132144|20645570|P2|COMPLETED|Overall Study||79
8375226|NCT01132144|20645571|P1|COMPLETED|Overall Study||79
8375227|NCT01132144|20645570|P2|STARTED|Overall Study||79
8375228|NCT01132144|20645571|P1|STARTED|Overall Study||79
8375229|NCT01132118|20645593|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
8375230|NCT01132118|20645594|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8375231|NCT01132118|20645593|P2|COMPLETED|Second Intervention (8 Weeks)||11
8375232|NCT01132118|20645594|P1|COMPLETED|Second Intervention (8 Weeks)||12
8375233|NCT01132118|20645593|P2|STARTED|Second Intervention (8 Weeks)||12
8375234|NCT01132118|20645594|P1|STARTED|Second Intervention (8 Weeks)||12
8375235|NCT01132118|20645593|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
8375236|NCT01132118|20645594|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
8375237|NCT01132118|20645593|P2|COMPLETED|First Intervention (8 Weeks)||12
8375238|NCT01132118|20645594|P1|COMPLETED|First Intervention (8 Weeks)||12
8375239|NCT01132118|20645593|P2|STARTED|First Intervention (8 Weeks)||15
8375240|NCT01132118|20645594|P1|STARTED|First Intervention (8 Weeks)||15
8375241|NCT01131884|20645614|P2|NOT COMPLETED|Overall Study||0
8375242|NCT01131884|20645615|P1|NOT COMPLETED|Overall Study||0
8375243|NCT01131884|20645614|P2|COMPLETED|Overall Study||0
8375244|NCT01131884|20645615|P1|COMPLETED|Overall Study||1
8375245|NCT01131884|20645614|P2|STARTED|Overall Study||0
8375246|NCT01131884|20645615|P1|STARTED|Overall Study||1
8375247|NCT01131676|20645624|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
8375248|NCT01131676|20645625|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
8375249|NCT01131676|20645626|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
8375250|NCT01131676|20645624|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
8375251|NCT01131676|20645625|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
8375252|NCT01131676|20645626|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
8375253|NCT01131676|20645624|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
8375254|NCT01131676|20645625|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
8375255|NCT01131676|20645626|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
8375256|NCT01131676|20645624|P3|STARTED|Discontinuation From Study (Treated Set)||2342
8375257|NCT01131676|20645625|P2|STARTED|Discontinuation From Study (Treated Set)||2345
8375258|NCT01131676|20645626|P1|STARTED|Discontinuation From Study (Treated Set)||2333
8375259|NCT01131676|20645624|P3|NOT COMPLETED|Discontinuation From Treatment||544
8375260|NCT01131676|20645625|P2|NOT COMPLETED|Discontinuation From Treatment||557
8375261|NCT01131676|20645626|P1|NOT COMPLETED|Discontinuation From Treatment||687
8375262|NCT01131676|20645624|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
8375263|NCT01131676|20645625|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
8375264|NCT01131676|20645626|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
8375265|NCT01131676|20645624|P3|STARTED|Discontinuation From Treatment|Randomised|2344
8375266|NCT01131676|20645625|P2|STARTED|Discontinuation From Treatment|Randomised|2347
8375267|NCT01131676|20645626|P1|STARTED|Discontinuation From Treatment|Randomised|2337
8375268|NCT01131585|20645661|P2|NOT COMPLETED|Overall Study||43
8375269|NCT01131585|20645662|P1|NOT COMPLETED|Overall Study||85
8375270|NCT01131585|20645661|P2|COMPLETED|Overall Study||0
8375271|NCT01131585|20645662|P1|COMPLETED|Overall Study||0
8375272|NCT01131585|20645661|P2|STARTED|Overall Study||43
8375273|NCT01131585|20645662|P1|STARTED|Overall Study||85
8375274|NCT01131520|20645670|P2|NOT COMPLETED|Overall Study||4
8375275|NCT01131520|20645671|P1|NOT COMPLETED|Overall Study||1
8375276|NCT01131520|20645670|P2|COMPLETED|Overall Study||176
8375277|NCT01131520|20645671|P1|COMPLETED|Overall Study||179
8375278|NCT01131520|20645670|P2|STARTED|Overall Study||180
8375279|NCT01131520|20645671|P1|STARTED|Overall Study||180
8375280|NCT01131507|20645693|P1|NOT COMPLETED|Overall Study||3
8375281|NCT01131507|20645693|P1|COMPLETED|Overall Study||12
8375282|NCT01131507|20645693|P1|STARTED|Overall Study||15
8375283|NCT01131494|20645698|P1|NOT COMPLETED|Overall Study||2
8375284|NCT01131494|20645698|P1|COMPLETED|Overall Study||15
8375285|NCT01131494|20645698|P1|STARTED|Overall Study||17
8375286|NCT01131455|20645708|P3|NOT COMPLETED|Overall Study||0
8375287|NCT01131455|20645709|P2|NOT COMPLETED|Overall Study||4
8375288|NCT01131455|20645710|P1|NOT COMPLETED|Overall Study||6
8375289|NCT01131455|20645708|P3|COMPLETED|Overall Study||0
8375290|NCT01131455|20645709|P2|COMPLETED|Overall Study||0
8375291|NCT01131455|20645710|P1|COMPLETED|Overall Study||0
8375292|NCT01131455|20645708|P3|STARTED|Overall Study||0
8375293|NCT01131455|20645709|P2|STARTED|Overall Study||4
8375294|NCT01131455|20645710|P1|STARTED|Overall Study||6
8375295|NCT01131312|20645721|P3|NOT COMPLETED|Overall Study||351
8375296|NCT01131312|20645722|P2|NOT COMPLETED|Overall Study||229
8375297|NCT01131312|20645723|P1|NOT COMPLETED|Overall Study||425
8375298|NCT01131312|20645721|P3|COMPLETED|Overall Study||1485
8375299|NCT01131312|20645722|P2|COMPLETED|Overall Study||1156
8375300|NCT01131312|20645723|P1|COMPLETED|Overall Study||1414
8375301|NCT01131312|20645721|P3|STARTED|Overall Study||1836
8375302|NCT01131312|20645722|P2|STARTED|Overall Study||1385
8375303|NCT01131312|20645723|P1|STARTED|Overall Study||1839
8375304|NCT01131299|20645734|P2|NOT COMPLETED|Overall Study||7
8375305|NCT01131299|20645735|P1|NOT COMPLETED|Overall Study||4
8375306|NCT01131299|20645734|P2|COMPLETED|Overall Study||37
8375307|NCT01131299|20645735|P1|COMPLETED|Overall Study||38
8375308|NCT01131299|20645734|P2|STARTED|Overall Study||44
8375309|NCT01131299|20645735|P1|STARTED|Overall Study||42
8375310|NCT01131260|20645748|P2|NOT COMPLETED|Overall Study||47
8375311|NCT01131260|20645749|P1|NOT COMPLETED|Overall Study||44
8375312|NCT01131260|20645748|P2|COMPLETED|Overall Study||5529
8375313|NCT01131260|20645749|P1|COMPLETED|Overall Study||5488
8375314|NCT01131260|20645748|P2|STARTED|Overall Study||5576
8375315|NCT01131260|20645749|P1|STARTED|Overall Study||5532
8375316|NCT01131182|20645797|P2|NOT COMPLETED|Overall Study||16
8375317|NCT01131182|20645798|P1|NOT COMPLETED|Overall Study||16
8375318|NCT01131182|20645797|P2|COMPLETED|Overall Study||521
8375319|NCT01131182|20645798|P1|COMPLETED|Overall Study||513
8375320|NCT01131182|20645797|P2|STARTED|Overall Study||537
8375321|NCT01131182|20645798|P1|STARTED|Overall Study||529
8375322|NCT01131130|20645806|P1|NOT COMPLETED|Period 3- Crossover||1
8375323|NCT01131130|20645806|P1|COMPLETED|Period 3- Crossover||116
8375324|NCT01131130|20645806|P1|STARTED|Period 3- Crossover||117
8375325|NCT01131130|20645806|P1|NOT COMPLETED|Period 2 - Crossover||0
8375326|NCT01131130|20645806|P1|COMPLETED|Period 2 - Crossover||117
8375327|NCT01131130|20645806|P1|STARTED|Period 2 - Crossover||117
8375328|NCT01131130|20645806|P1|NOT COMPLETED|Period 1 - Baseline||1
8375329|NCT01131130|20645806|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
8375330|NCT01131130|20645806|P1|STARTED|Period 1 - Baseline||118
8375331|NCT01131104|20645819|P1|NOT COMPLETED|Overall Study||13
8375332|NCT01131104|20645819|P1|COMPLETED|Overall Study||332
8375333|NCT01131104|20645819|P1|12-Month Analysis Set|Overall Study||26
8375334|NCT01131104|20645819|P1|42-Day Analysis Set|Overall Study||28
8375335|NCT01131104|20645819|P1|30-Day Analysis Set|Overall Study||24
8375336|NCT01131104|20645819|P1|Adjudication-Confirmed NAION Set|Overall Study||279
8375337|NCT01131104|20645819|P1|Study Set|Overall Study||344
8375338|NCT01131104|20645819|P1|STARTED|Overall Study||345
8375339|NCT01131078|20645826|P3|NOT COMPLETED|Overall Study||102
8375340|NCT01131078|20645827|P2|NOT COMPLETED|Overall Study||101
8375341|NCT01131078|20645828|P1|NOT COMPLETED|Overall Study||101
8375342|NCT01131078|20645826|P3|COMPLETED|Overall Study||1
8375343|NCT01131078|20645827|P2|COMPLETED|Overall Study||1
8375344|NCT01131078|20645828|P1|COMPLETED|Overall Study||0
8375345|NCT01131078|20645826|P3|STARTED|Overall Study||103
8375346|NCT01131078|20645827|P2|STARTED|Overall Study||102
8375347|NCT01131078|20645828|P1|STARTED|Overall Study||101
8375348|NCT01131065|20645884|P1|NOT COMPLETED|Overall Study||0
8375349|NCT01131065|20645884|P1|COMPLETED|Overall Study||15
8375350|NCT01131065|20645884|P1|STARTED|Overall Study||15
8375351|NCT01131052|20645892|P2|NOT COMPLETED|Overall Study||0
8375352|NCT01131052|20645893|P1|NOT COMPLETED|Overall Study||0
8375353|NCT01131052|20645892|P2|COMPLETED|Overall Study||75
8375354|NCT01131052|20645893|P1|COMPLETED|Overall Study||75
8375355|NCT01131052|20645892|P2|STARTED|Overall Study||75
8375356|NCT01131052|20645893|P1|STARTED|Overall Study||75
8375357|NCT01130974|20645915|P2|NOT COMPLETED|Overall Study||13
8375358|NCT01130974|20645916|P1|NOT COMPLETED|Overall Study||15
8375359|NCT01130974|20645915|P2|COMPLETED|Overall Study||87
8375360|NCT01130974|20645916|P1|COMPLETED|Overall Study||85
8375361|NCT01130974|20645915|P2|STARTED|Overall Study||100
8375362|NCT01130974|20645916|P1|STARTED|Overall Study||100
8375363|NCT01130896|20645936|P1|NOT COMPLETED|Overall Study||0
8375364|NCT01130896|20645936|P1|COMPLETED|Overall Study||1509
8375365|NCT01130896|20645936|P1|STARTED|Overall Study||1509
8375366|NCT01130883|20645942|P1|NOT COMPLETED|Overall Study||10
8375367|NCT01130883|20645942|P1|COMPLETED|Overall Study||3120
8375368|NCT01130883|20645942|P1|Participants Analyzed|Overall Study||3128
8375369|NCT01130883|20645942|P1|STARTED|Overall Study||3130
8375370|NCT01130844|20645959|P3|NOT COMPLETED|Overall Study||0
8375371|NCT01130844|20645960|P2|NOT COMPLETED|Overall Study||0
8375372|NCT01130844|20645961|P1|NOT COMPLETED|Overall Study||0
8375373|NCT01130844|20645959|P3|COMPLETED|Overall Study||9
8375374|NCT01130844|20645960|P2|COMPLETED|Overall Study||22
8375375|NCT01130844|20645961|P1|COMPLETED|Overall Study||21
8375376|NCT01130844|20645959|P3|STARTED|Overall Study||9
8375377|NCT01130844|20645960|P2|STARTED|Overall Study||22
8375378|NCT01130844|20645961|P1|STARTED|Overall Study||21
8375379|NCT01130831|20645999|P1|NOT COMPLETED|Overall Study||14
8375380|NCT01130831|20645999|P1|COMPLETED|Overall Study||52
8375381|NCT01130831|20645999|P1|STARTED|Overall Study||66
8375382|NCT01130740|20646027|P2|NOT COMPLETED|Overall Study||15
8375383|NCT01130740|20646028|P1|NOT COMPLETED|Overall Study||12
8375384|NCT01130740|20646027|P2|COMPLETED|Overall Study||136
8375385|NCT01130740|20646028|P1|COMPLETED|Overall Study||137
8375386|NCT01130740|20646027|P2|STARTED|Overall Study||151
8375387|NCT01130740|20646028|P1|STARTED|Overall Study||149
8375388|NCT01130597|20646038|P1|NOT COMPLETED|Overall Study||7
8375389|NCT01130597|20646038|P1|COMPLETED|Overall Study||56
8375390|NCT01130597|20646038|P1|STARTED|Overall Study||63
8375391|NCT01130532|20646063|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
8375392|NCT01130532|20646064|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
8375393|NCT01130532|20646065|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
8375394|NCT01130532|20646066|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
8375395|NCT01130532|20646063|P4|COMPLETED|Period IV (Weeks 13-16)||552
8375396|NCT01130532|20646064|P3|COMPLETED|Period IV (Weeks 13-16)||0
8375397|NCT01130532|20646065|P2|COMPLETED|Period IV (Weeks 13-16)||0
8375398|NCT01130532|20646066|P1|COMPLETED|Period IV (Weeks 13-16)||0
8375399|NCT01130532|20646063|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
8375400|NCT01130532|20646064|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8375401|NCT01130532|20646065|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8375402|NCT01130532|20646066|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8375403|NCT01130532|20646063|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
8375404|NCT01130532|20646064|P3|STARTED|Period IV (Weeks 13-16)||0
8375405|NCT01130532|20646065|P2|STARTED|Period IV (Weeks 13-16)||0
8375406|NCT01130532|20646066|P1|STARTED|Period IV (Weeks 13-16)||0
8375407|NCT01130532|20646063|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
8375408|NCT01130532|20646064|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
8375409|NCT01130532|20646065|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
8375410|NCT01130532|20646066|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
8375411|NCT01130532|20646063|P4|COMPLETED|Period III (Weeks 0-12)||0
8375412|NCT01130532|20646064|P3|COMPLETED|Period III (Weeks 0-12)||190
8375413|NCT01130532|20646065|P2|COMPLETED|Period III (Weeks 0-12)||189
8375414|NCT01130532|20646066|P1|COMPLETED|Period III (Weeks 0-12)||186
8375415|NCT01130532|20646063|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
8375416|NCT01130532|20646064|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
8375417|NCT01130532|20646065|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
8375418|NCT01130532|20646066|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
8375419|NCT01130532|20646063|P4|STARTED|Period III (Weeks 0-12)||0
8375420|NCT01130532|20646064|P3|STARTED|Period III (Weeks 0-12)||209
8375421|NCT01130532|20646065|P2|STARTED|Period III (Weeks 0-12)||207
8375422|NCT01130532|20646066|P1|STARTED|Period III (Weeks 0-12)||207
8375423|NCT01130493|20646111|P3|NOT COMPLETED|Part 2: OLE||5
8375424|NCT01130493|20646112|P2|NOT COMPLETED|Part 2: OLE||3
8375425|NCT01130493|20646113|P1|NOT COMPLETED|Part 2: OLE||0
8375426|NCT01130493|20646111|P3|COMPLETED|Part 2: OLE||30
8375427|NCT01130493|20646112|P2|COMPLETED|Part 2: OLE||36
8375428|NCT01130493|20646113|P1|COMPLETED|Part 2: OLE||0
8375429|NCT01130493|20646111|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
8375430|NCT01130493|20646112|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
8375431|NCT01130493|20646113|P1|STARTED|Part 2: OLE||0
8375432|NCT01130493|20646111|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
8375433|NCT01130493|20646112|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
8375434|NCT01130493|20646113|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
8375435|NCT01130493|20646111|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
8375436|NCT01130493|20646112|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
8375437|NCT01130493|20646113|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
8375438|NCT01130493|20646111|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
8375439|NCT01130493|20646112|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
8375440|NCT01130493|20646113|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
8375441|NCT01130493|20646111|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
8375442|NCT01130493|20646112|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
8375443|NCT01130493|20646113|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
8375444|NCT01130493|20646111|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
8375445|NCT01130493|20646112|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
8375446|NCT01130493|20646113|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
8375447|NCT01130493|20646111|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
8375448|NCT01130493|20646112|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
8375449|NCT01130493|20646113|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
8375450|NCT01130493|20646111|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
8375451|NCT01130493|20646112|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
8375452|NCT01130493|20646113|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
8375453|NCT01130493|20646111|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
8375454|NCT01130493|20646112|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
8375455|NCT01130493|20646113|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
8375456|NCT01130493|20646111|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
8375457|NCT01130493|20646112|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
8375458|NCT01130493|20646113|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
8375459|NCT01130493|20646111|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
8375460|NCT01130493|20646112|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
8375461|NCT01130493|20646113|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
8375462|NCT01130493|20646111|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
8375463|NCT01130493|20646112|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
8375464|NCT01130493|20646113|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
8375465|NCT01130493|20646111|P3|STARTED|Open-label Dose Conversion to IPX066||0
8375466|NCT01130493|20646112|P2|STARTED|Open-label Dose Conversion to IPX066||0
8375467|NCT01130493|20646113|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
8375468|NCT01130337|20646130|P1|NOT COMPLETED|Overall Study||14
8375469|NCT01130337|20646130|P1|COMPLETED|Overall Study||22
8375470|NCT01130337|20646130|P1|STARTED|Overall Study||36
8375471|NCT01130272|20646142|P5|NOT COMPLETED|Overall Study||52
8375472|NCT01130272|20646143|P4|NOT COMPLETED|Overall Study||68
8375473|NCT01130272|20646144|P3|NOT COMPLETED|Overall Study||48
8375474|NCT01130272|20646145|P2|NOT COMPLETED|Overall Study||42
8375475|NCT01130272|20646146|P1|NOT COMPLETED|Overall Study||59
8375476|NCT01130272|20646142|P5|COMPLETED|Overall Study||117
8375477|NCT01130272|20646143|P4|COMPLETED|Overall Study||103
8375478|NCT01130272|20646144|P3|COMPLETED|Overall Study||121
8375479|NCT01130272|20646145|P2|COMPLETED|Overall Study||131
8375480|NCT01130272|20646146|P1|COMPLETED|Overall Study||48
8375481|NCT01130272|20646142|P5|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
8375482|NCT01130272|20646143|P4|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
8375483|NCT01130272|20646144|P3|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
8375484|NCT01130272|20646145|P2|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
8375485|NCT01130272|20646146|P1|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
8375486|NCT01130272|20646142|P5|Safety Analysis Set: as Randomized|Overall Study||162
8375487|NCT01130272|20646143|P4|Safety Analysis Set: as Randomized|Overall Study||167
8375488|NCT01130272|20646144|P3|Safety Analysis Set: as Randomized|Overall Study||166
8375489|NCT01130272|20646145|P2|Safety Analysis Set: as Randomized|Overall Study||171
8375490|NCT01130272|20646146|P1|Safety Analysis Set: as Randomized|Overall Study||105
8375491|NCT01130272|20646142|P5|STARTED|Overall Study||169
8375492|NCT01130272|20646143|P4|STARTED|Overall Study||171
8375493|NCT01130272|20646144|P3|STARTED|Overall Study||169
8375494|NCT01130272|20646145|P2|STARTED|Overall Study||173
8375495|NCT01130272|20646146|P1|STARTED|Overall Study||107
8375496|NCT01130168|20646183|P6|NOT COMPLETED|Period 3||0
8375497|NCT01130168|20646184|P5|NOT COMPLETED|Period 3||0
8375498|NCT01130168|20646185|P4|NOT COMPLETED|Period 3||0
8375499|NCT01130168|20646186|P3|NOT COMPLETED|Period 3||0
8375500|NCT01130168|20646187|P2|NOT COMPLETED|Period 3||0
8375501|NCT01130168|20646188|P1|NOT COMPLETED|Period 3||0
8375502|NCT01130168|20646183|P6|COMPLETED|Period 3||6
8375503|NCT01130168|20646184|P5|COMPLETED|Period 3||5
8375504|NCT01130168|20646185|P4|COMPLETED|Period 3||5
8375505|NCT01130168|20646186|P3|COMPLETED|Period 3||5
8375506|NCT01130168|20646187|P2|COMPLETED|Period 3||6
8375507|NCT01130168|20646188|P1|COMPLETED|Period 3||6
8375508|NCT01130168|20646183|P6|STARTED|Period 3||6
8375509|NCT01130168|20646184|P5|STARTED|Period 3||5
8375510|NCT01130168|20646185|P4|STARTED|Period 3||5
8375511|NCT01130168|20646186|P3|STARTED|Period 3||5
8375512|NCT01130168|20646187|P2|STARTED|Period 3||6
8375513|NCT01130168|20646188|P1|STARTED|Period 3||6
8375514|NCT01130168|20646183|P6|NOT COMPLETED|Period 2||0
8375515|NCT01130168|20646184|P5|NOT COMPLETED|Period 2||0
8375516|NCT01130168|20646185|P4|NOT COMPLETED|Period 2||0
8375517|NCT01130168|20646186|P3|NOT COMPLETED|Period 2||0
8375518|NCT01130168|20646187|P2|NOT COMPLETED|Period 2||0
8375519|NCT01130168|20646188|P1|NOT COMPLETED|Period 2||0
8375520|NCT01130168|20646183|P6|COMPLETED|Period 2||6
8375521|NCT01130168|20646184|P5|COMPLETED|Period 2||5
8375522|NCT01130168|20646185|P4|COMPLETED|Period 2||5
8375523|NCT01130168|20646186|P3|COMPLETED|Period 2||5
8375524|NCT01130168|20646187|P2|COMPLETED|Period 2||6
8375525|NCT01130168|20646188|P1|COMPLETED|Period 2||6
8375526|NCT01130168|20646183|P6|STARTED|Period 2||6
8375527|NCT01130168|20646184|P5|STARTED|Period 2||5
8375528|NCT01130168|20646185|P4|STARTED|Period 2||5
8375529|NCT01130168|20646186|P3|STARTED|Period 2||5
8375530|NCT01130168|20646187|P2|STARTED|Period 2||6
8375531|NCT01130168|20646188|P1|STARTED|Period 2||6
8375532|NCT01130168|20646183|P6|NOT COMPLETED|Period 1||0
8375533|NCT01130168|20646184|P5|NOT COMPLETED|Period 1||0
8375534|NCT01130168|20646185|P4|NOT COMPLETED|Period 1||3
8375535|NCT01130168|20646186|P3|NOT COMPLETED|Period 1||1
8375536|NCT01130168|20646187|P2|NOT COMPLETED|Period 1||1
8375537|NCT01130168|20646188|P1|NOT COMPLETED|Period 1||0
8375538|NCT01130168|20646183|P6|COMPLETED|Period 1||6
8375539|NCT01130168|20646184|P5|COMPLETED|Period 1||5
8375540|NCT01130168|20646185|P4|COMPLETED|Period 1||5
8375541|NCT01130168|20646186|P3|COMPLETED|Period 1||5
8375542|NCT01130168|20646187|P2|COMPLETED|Period 1||6
8375543|NCT01130168|20646188|P1|COMPLETED|Period 1||6
8375544|NCT01130168|20646183|P6|STARTED|Period 1||6
8375545|NCT01130168|20646184|P5|STARTED|Period 1||5
8375546|NCT01130168|20646185|P4|STARTED|Period 1||8
8375547|NCT01130168|20646186|P3|STARTED|Period 1||6
8375548|NCT01130168|20646187|P2|STARTED|Period 1||7
8375549|NCT01130168|20646188|P1|STARTED|Period 1||6
8375550|NCT01130103|20646225|P2|NOT COMPLETED|Maintenance Treatment||2
8375551|NCT01130103|20646226|P1|NOT COMPLETED|Maintenance Treatment||2
8375552|NCT01130103|20646225|P2|COMPLETED|Maintenance Treatment||11
8375553|NCT01130103|20646226|P1|COMPLETED|Maintenance Treatment||11
8375554|NCT01130103|20646225|P2|STARTED|Maintenance Treatment||13
8375555|NCT01130103|20646226|P1|STARTED|Maintenance Treatment||13
8375556|NCT01130103|20646225|P2|NOT COMPLETED|Randomized Treatment||5
8375557|NCT01130103|20646226|P1|NOT COMPLETED|Randomized Treatment||6
8375558|NCT01130103|20646225|P2|COMPLETED|Randomized Treatment||13
8375559|NCT01130103|20646226|P1|COMPLETED|Randomized Treatment||13
8375560|NCT01130103|20646225|P2|STARTED|Randomized Treatment||18
8375561|NCT01130103|20646226|P1|STARTED|Randomized Treatment||19
8375562|NCT01130051|20646240|P2|NOT COMPLETED|Period 2||0
8375563|NCT01130051|20646241|P1|NOT COMPLETED|Period 2||0
8375564|NCT01130051|20646240|P2|COMPLETED|Period 2||6
8375565|NCT01130051|20646241|P1|COMPLETED|Period 2||7
8375566|NCT01130051|20646240|P2|STARTED|Period 2||6
8375567|NCT01130051|20646241|P1|STARTED|Period 2||7
8375568|NCT01130051|20646240|P2|NOT COMPLETED|Washout Period of 14 Days||2
8375569|NCT01130051|20646241|P1|NOT COMPLETED|Washout Period of 14 Days||1
8375570|NCT01130051|20646240|P2|COMPLETED|Washout Period of 14 Days||6
8375571|NCT01130051|20646241|P1|COMPLETED|Washout Period of 14 Days||7
8375572|NCT01130051|20646240|P2|STARTED|Washout Period of 14 Days||8
8375573|NCT01130051|20646241|P1|STARTED|Washout Period of 14 Days||8
8375574|NCT01130051|20646240|P2|NOT COMPLETED|Period 1||0
8375575|NCT01130051|20646241|P1|NOT COMPLETED|Period 1||0
8375576|NCT01130051|20646240|P2|COMPLETED|Period 1||8
8375577|NCT01130051|20646241|P1|COMPLETED|Period 1||8
8375578|NCT01130051|20646240|P2|STARTED|Period 1||8
8375579|NCT01130051|20646241|P1|STARTED|Period 1||8
8375580|NCT01129960|20646255|P4|NOT COMPLETED|Overall Study||13
8375581|NCT01129960|20646256|P3|NOT COMPLETED|Overall Study||26
8375582|NCT01129960|20646257|P2|NOT COMPLETED|Overall Study||22
8375583|NCT01129960|20646258|P1|NOT COMPLETED|Overall Study||30
8375584|NCT01129960|20646255|P4|COMPLETED|Overall Study||70
8375585|NCT01129960|20646256|P3|COMPLETED|Overall Study||56
8375586|NCT01129960|20646257|P2|COMPLETED|Overall Study||61
8375587|NCT01129960|20646258|P1|COMPLETED|Overall Study||54
8375588|NCT01129960|20646255|P4|Full Analysis Set (FAS|Overall Study||71
8375589|NCT01129960|20646256|P3|Full Analysis Set (FAS|Overall Study||68
8375590|NCT01129960|20646257|P2|Full Analysis Set (FAS|Overall Study||67
8375591|NCT01129960|20646258|P1|Full Analysis Set (FAS|Overall Study||71
8375592|NCT01129960|20646255|P4|Per-Protocol|Overall Study||55
8375593|NCT01129960|20646256|P3|Per-Protocol|Overall Study||49
8375594|NCT01129960|20646257|P2|Per-Protocol|Overall Study||52
8375595|NCT01129960|20646258|P1|Per-Protocol|Overall Study||34
8375596|NCT01129960|20646255|P4|Intent-to-Treat|Overall Study||83
8375597|NCT01129960|20646256|P3|Intent-to-Treat|Overall Study||82
8375598|NCT01129960|20646257|P2|Intent-to-Treat|Overall Study||83
8375599|NCT01129960|20646258|P1|Intent-to-Treat|Overall Study||84
8375600|NCT01129960|20646255|P4|Safety|Overall Study||82
8375601|NCT01129960|20646256|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
8375602|NCT01129960|20646257|P2|Safety|Overall Study||83
8375603|NCT01129960|20646258|P1|Safety|Overall Study||84
8375604|NCT01129960|20646255|P4|STARTED|Overall Study||83
8375605|NCT01129960|20646256|P3|STARTED|Overall Study||82
8375606|NCT01129960|20646257|P2|STARTED|Overall Study||83
8375607|NCT01129960|20646258|P1|STARTED|Overall Study||84
8375608|NCT01129921|20646270|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
8375609|NCT01129921|20646271|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
8375610|NCT01129921|20646270|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
8375611|NCT01129921|20646271|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
8375612|NCT01129921|20646270|P2|STARTED|After Sham Cross-over to Mild, One Year||20
8375613|NCT01129921|20646271|P1|STARTED|After Sham Cross-over to Mild, One Year||20
8375614|NCT01129921|20646270|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
8375615|NCT01129921|20646271|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
8375616|NCT01129921|20646270|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
8375617|NCT01129921|20646271|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
8375618|NCT01129921|20646270|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
8375619|NCT01129921|20646271|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
8375620|NCT01129882|20646281|P1|NOT COMPLETED|Overall Study||278
8375621|NCT01129882|20646281|P1|COMPLETED|Overall Study||431
8375622|NCT01129882|20646281|P1|Received at Least 1 Dose of Study Drug|Overall Study||709
8375623|NCT01129882|20646281|P1|STARTED|Overall Study||709
8375624|NCT01129778|20646286|P1|NOT COMPLETED|Overall Study||7
8375625|NCT01129778|20646286|P1|COMPLETED|Overall Study||15
8375626|NCT01129778|20646286|P1|STARTED|Overall Study||22
8375627|NCT01129765|20646291|P1|NOT COMPLETED|Overall Study||0
8375628|NCT01129765|20646291|P1|COMPLETED|Overall Study||30
8375629|NCT01129765|20646291|P1|STARTED|Overall Study||30
8375630|NCT01129622|20646300|P1|NOT COMPLETED|Overall Study||2
8375631|NCT01129622|20646300|P1|COMPLETED|Overall Study||14
8375632|NCT01129622|20646300|P1|STARTED|Overall Study||16
8375633|NCT01129609|20646305|P1|NOT COMPLETED|Overall Study||2
8375634|NCT01129609|20646305|P1|COMPLETED|Overall Study||18
8375635|NCT01129609|20646305|P1|STARTED|Overall Study||20
8375636|NCT01129583|20646311|P2|NOT COMPLETED|Overall Study||2
8375637|NCT01129583|20646312|P1|NOT COMPLETED|Overall Study||3
8375638|NCT01129583|20646311|P2|COMPLETED|Overall Study||7
8375639|NCT01129583|20646312|P1|COMPLETED|Overall Study||6
8375640|NCT01129583|20646311|P2|STARTED|Overall Study||9
8375641|NCT01129583|20646312|P1|STARTED|Overall Study||9
8375642|NCT01129557|20646325|P3|NOT COMPLETED|Overall Study||4
8375643|NCT01129557|20646326|P2|NOT COMPLETED|Overall Study||5
8375644|NCT01129557|20646327|P1|NOT COMPLETED|Overall Study||4
8375645|NCT01129557|20646325|P3|COMPLETED|Overall Study||10
8375646|NCT01129557|20646326|P2|COMPLETED|Overall Study||12
8375647|NCT01129557|20646327|P1|COMPLETED|Overall Study||11
8375648|NCT01129557|20646325|P3|STARTED|Overall Study||14
8375649|NCT01129557|20646326|P2|STARTED|Overall Study||17
8375650|NCT01129557|20646327|P1|STARTED|Overall Study||15
8375651|NCT01129531|20646398|P3|NOT COMPLETED|Treatment Cycle 2||5
8375652|NCT01129531|20646399|P2|NOT COMPLETED|Treatment Cycle 2||3
8375653|NCT01129531|20646400|P1|NOT COMPLETED|Treatment Cycle 2||6
8375654|NCT01129531|20646398|P3|COMPLETED|Treatment Cycle 2||74
8375655|NCT01129531|20646399|P2|COMPLETED|Treatment Cycle 2||92
8375656|NCT01129531|20646400|P1|COMPLETED|Treatment Cycle 2||88
8375657|NCT01129531|20646398|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
8375658|NCT01129531|20646399|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
8375659|NCT01129531|20646400|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
8375660|NCT01129531|20646398|P3|NOT COMPLETED|Treatment Cycle 1||16
8375661|NCT01129531|20646399|P2|NOT COMPLETED|Treatment Cycle 1||6
8375662|NCT01129531|20646400|P1|NOT COMPLETED|Treatment Cycle 1||4
8375663|NCT01129531|20646398|P3|COMPLETED|Treatment Cycle 1||110
8375664|NCT01129531|20646399|P2|COMPLETED|Treatment Cycle 1||78
8375665|NCT01129531|20646400|P1|COMPLETED|Treatment Cycle 1||80
8375666|NCT01129531|20646398|P3|STARTED|Treatment Cycle 1||126
8375667|NCT01129531|20646399|P2|STARTED|Treatment Cycle 1||84
8375668|NCT01129531|20646400|P1|STARTED|Treatment Cycle 1||84
8375669|NCT01129440|20646422|P2|NOT COMPLETED|Overall Study||42
8375670|NCT01129440|20646423|P1|NOT COMPLETED|Overall Study||51
8375671|NCT01129440|20646422|P2|COMPLETED|Overall Study||258
8375672|NCT01129440|20646423|P1|COMPLETED|Overall Study||246
8375673|NCT01129440|20646422|P2|24 Month Follow-up|Overall Study||258
8375674|NCT01129440|20646423|P1|24 Month Follow-up|Overall Study||239
8375675|NCT01129440|20646422|P2|12 Month Follow-up|Overall Study||256
8375676|NCT01129440|20646423|P1|12 Month Follow-up|Overall Study||249
8375677|NCT01129440|20646422|P2|STARTED|Overall Study||300
8375678|NCT01129440|20646423|P1|STARTED|Overall Study||297
8375679|NCT01129336|20646440|P2|NOT COMPLETED|Overall Study||16
8375680|NCT01129336|20646441|P1|NOT COMPLETED|Overall Study||12
8375681|NCT01129336|20646440|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
8375682|NCT01129336|20646441|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
8375683|NCT01129336|20646440|P2|Completed Treatment|Overall Study||3
8375684|NCT01129336|20646441|P1|Completed Treatment|Overall Study||1
8375685|NCT01129336|20646440|P2|STARTED|Overall Study||29
8375686|NCT01129336|20646441|P1|STARTED|Overall Study||15
8375687|NCT01129284|20646456|P3|NOT COMPLETED|Overall Study||1
8375688|NCT01129284|20646457|P2|NOT COMPLETED|Overall Study||0
8375689|NCT01129284|20646458|P1|NOT COMPLETED|Overall Study||2
8375690|NCT01129284|20646456|P3|COMPLETED|Overall Study||4
8375691|NCT01129284|20646457|P2|COMPLETED|Overall Study||5
8375692|NCT01129284|20646458|P1|COMPLETED|Overall Study||3
8375693|NCT01129284|20646456|P3|STARTED|Overall Study||5
8375694|NCT01129284|20646457|P2|STARTED|Overall Study||5
8375695|NCT01129284|20646458|P1|STARTED|Overall Study||5
8375696|NCT01129245|20646471|P2|NOT COMPLETED|Treatment Cycle 2||0
8375697|NCT01129245|20646472|P1|NOT COMPLETED|Treatment Cycle 2||0
8375698|NCT01129245|20646471|P2|COMPLETED|Treatment Cycle 2||10
8375699|NCT01129245|20646472|P1|COMPLETED|Treatment Cycle 2||10
8375700|NCT01129245|20646471|P2|STARTED|Treatment Cycle 2||10
8375701|NCT01129245|20646472|P1|STARTED|Treatment Cycle 2||10
8375702|NCT01129245|20646471|P2|NOT COMPLETED|Washout Cycle||0
8375703|NCT01129245|20646472|P1|NOT COMPLETED|Washout Cycle||0
8375704|NCT01129245|20646471|P2|COMPLETED|Washout Cycle||10
8375705|NCT01129245|20646472|P1|COMPLETED|Washout Cycle||10
8375706|NCT01129245|20646471|P2|STARTED|Washout Cycle||10
8375707|NCT01129245|20646472|P1|STARTED|Washout Cycle||10
8375708|NCT01129245|20646471|P2|NOT COMPLETED|Treatment Cycle 1||0
8375709|NCT01129245|20646472|P1|NOT COMPLETED|Treatment Cycle 1||0
8375710|NCT01129245|20646471|P2|COMPLETED|Treatment Cycle 1||10
8375711|NCT01129245|20646472|P1|COMPLETED|Treatment Cycle 1||10
8375712|NCT01129245|20646471|P2|STARTED|Treatment Cycle 1||10
8375713|NCT01129245|20646472|P1|STARTED|Treatment Cycle 1||10
8375714|NCT01129245|20646471|P2|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
8375715|NCT01129245|20646472|P1|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
8375716|NCT01129245|20646471|P2|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
8375717|NCT01129245|20646472|P1|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
8375718|NCT01129245|20646471|P2|STARTED|Control Cycle (no Celecoxib or Placebo)||10
8375719|NCT01129245|20646472|P1|STARTED|Control Cycle (no Celecoxib or Placebo)||10
8375720|NCT01129206|20646486|P1|NOT COMPLETED|Overall Study||0
8375721|NCT01129206|20646486|P1|COMPLETED|Overall Study||6
8375722|NCT01129206|20646486|P1|STARTED|Overall Study||6
8375723|NCT01129141|20646496|P2|NOT COMPLETED|Overall Study||13
8375724|NCT01129141|20646497|P1|NOT COMPLETED|Overall Study||15
8375725|NCT01129141|20646496|P2|COMPLETED|Overall Study||91
8375726|NCT01129141|20646497|P1|COMPLETED|Overall Study||86
8375727|NCT01129141|20646496|P2|STARTED|Overall Study||104
8375728|NCT01129141|20646497|P1|STARTED|Overall Study||101
8375729|NCT01129128|20646506|P3|NOT COMPLETED|Overall Study||4
8375730|NCT01129128|20646507|P2|NOT COMPLETED|Overall Study||4
8375731|NCT01129128|20646508|P1|NOT COMPLETED|Overall Study||3
8375732|NCT01129128|20646506|P3|COMPLETED|Overall Study||19
8375733|NCT01129128|20646507|P2|COMPLETED|Overall Study||18
8375734|NCT01129128|20646508|P1|COMPLETED|Overall Study||19
8375735|NCT01129128|20646506|P3|STARTED|Overall Study||23
8375736|NCT01129128|20646507|P2|STARTED|Overall Study||22
8375737|NCT01129128|20646508|P1|STARTED|Overall Study||22
8375738|NCT01129115|20646532|P4|NOT COMPLETED|Overall Study||9
8375739|NCT01129115|20646533|P3|NOT COMPLETED|Overall Study||6
8375740|NCT01129115|20646534|P2|NOT COMPLETED|Overall Study||7
8375741|NCT01129115|20646535|P1|NOT COMPLETED|Overall Study||2
8375742|NCT01129115|20646532|P4|COMPLETED|Overall Study||15
8375743|NCT01129115|20646533|P3|COMPLETED|Overall Study||21
8375744|NCT01129115|20646534|P2|COMPLETED|Overall Study||18
8375745|NCT01129115|20646535|P1|COMPLETED|Overall Study||23
8375746|NCT01129115|20646532|P4|STARTED|Overall Study||24
8375747|NCT01129115|20646533|P3|STARTED|Overall Study||27
8375748|NCT01129115|20646534|P2|STARTED|Overall Study||25
8375749|NCT01129115|20646535|P1|STARTED|Overall Study||25
8375750|NCT01129102|20646572|P3|NOT COMPLETED|Overall Study||7
8375751|NCT01129102|20646573|P2|NOT COMPLETED|Overall Study||6
8375752|NCT01129102|20646574|P1|NOT COMPLETED|Overall Study||8
8375753|NCT01129102|20646572|P3|COMPLETED|Overall Study||48
8375754|NCT01129102|20646573|P2|COMPLETED|Overall Study||44
8375755|NCT01129102|20646574|P1|COMPLETED|Overall Study||102
8375756|NCT01129102|20646572|P3|STARTED|Overall Study||55
8375757|NCT01129102|20646573|P2|STARTED|Overall Study||50
8375758|NCT01129102|20646574|P1|STARTED|Overall Study||110
8375759|NCT01129011|20646585|P2|NOT COMPLETED|Overall Study||57
8375760|NCT01129011|20646586|P1|NOT COMPLETED|Overall Study||59
8375761|NCT01129011|20646585|P2|COMPLETED|Overall Study||153
8375762|NCT01129011|20646586|P1|COMPLETED|Overall Study||151
8375763|NCT01129011|20646585|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
8375764|NCT01129011|20646586|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
8375765|NCT01128972|20646608|P5|NOT COMPLETED|Period V||0
8375766|NCT01128972|20646609|P4|NOT COMPLETED|Period V||0
8375767|NCT01128972|20646610|P3|NOT COMPLETED|Period V||0
8375768|NCT01128972|20646611|P2|NOT COMPLETED|Period V||0
8375769|NCT01128972|20646612|P1|NOT COMPLETED|Period V||0
8375770|NCT01128972|20646608|P5|COMPLETED|Period V||7
8375771|NCT01128972|20646609|P4|COMPLETED|Period V||7
8375772|NCT01128972|20646610|P3|COMPLETED|Period V||7
8375773|NCT01128972|20646611|P2|COMPLETED|Period V||7
8375774|NCT01128972|20646612|P1|COMPLETED|Period V||8
8375775|NCT01128972|20646608|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375776|NCT01128972|20646609|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375777|NCT01128972|20646610|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375778|NCT01128972|20646611|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375779|NCT01128972|20646612|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
8375780|NCT01128972|20646608|P5|NOT COMPLETED|Period IV||0
8375781|NCT01128972|20646609|P4|NOT COMPLETED|Period IV||0
8375782|NCT01128972|20646610|P3|NOT COMPLETED|Period IV||0
8375783|NCT01128972|20646611|P2|NOT COMPLETED|Period IV||0
8375784|NCT01128972|20646612|P1|NOT COMPLETED|Period IV||0
8375785|NCT01128972|20646608|P5|COMPLETED|Period IV||7
8375786|NCT01128972|20646609|P4|COMPLETED|Period IV||7
8375787|NCT01128972|20646610|P3|COMPLETED|Period IV||7
8375788|NCT01128972|20646611|P2|COMPLETED|Period IV||8
8375789|NCT01128972|20646612|P1|COMPLETED|Period IV||7
8375790|NCT01128972|20646608|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375791|NCT01128972|20646609|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375792|NCT01128972|20646610|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375793|NCT01128972|20646611|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
8375794|NCT01128972|20646612|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375795|NCT01128972|20646608|P5|NOT COMPLETED|Period III||0
8375796|NCT01128972|20646609|P4|NOT COMPLETED|Period III||0
8375797|NCT01128972|20646610|P3|NOT COMPLETED|Period III||0
8375798|NCT01128972|20646611|P2|NOT COMPLETED|Period III||0
8375799|NCT01128972|20646612|P1|NOT COMPLETED|Period III||0
8375800|NCT01128972|20646608|P5|COMPLETED|Period III||7
8375801|NCT01128972|20646609|P4|COMPLETED|Period III||7
8375802|NCT01128972|20646610|P3|COMPLETED|Period III||8
8375803|NCT01128972|20646611|P2|COMPLETED|Period III||7
8375804|NCT01128972|20646612|P1|COMPLETED|Period III||7
8375805|NCT01128972|20646608|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375806|NCT01128972|20646609|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375807|NCT01128972|20646610|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
8375808|NCT01128972|20646611|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375809|NCT01128972|20646612|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375810|NCT01128972|20646608|P5|NOT COMPLETED|Period II||0
8375811|NCT01128972|20646609|P4|NOT COMPLETED|Period II||0
8375812|NCT01128972|20646610|P3|NOT COMPLETED|Period II||0
8375813|NCT01128972|20646611|P2|NOT COMPLETED|Period II||0
8375814|NCT01128972|20646612|P1|NOT COMPLETED|Period II||0
8375815|NCT01128972|20646608|P5|COMPLETED|Period II||7
8375816|NCT01128972|20646609|P4|COMPLETED|Period II||8
8375817|NCT01128972|20646610|P3|COMPLETED|Period II||7
8375818|NCT01128972|20646611|P2|COMPLETED|Period II||7
8375819|NCT01128972|20646612|P1|COMPLETED|Period II||7
8375820|NCT01128972|20646608|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375821|NCT01128972|20646609|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
8375822|NCT01128972|20646610|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375823|NCT01128972|20646611|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375824|NCT01128972|20646612|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375825|NCT01128972|20646608|P5|NOT COMPLETED|Period I||0
8375826|NCT01128972|20646609|P4|NOT COMPLETED|Period I||0
8375827|NCT01128972|20646610|P3|NOT COMPLETED|Period I||0
8375828|NCT01128972|20646611|P2|NOT COMPLETED|Period I||0
8375829|NCT01128972|20646612|P1|NOT COMPLETED|Period I||0
8375830|NCT01128972|20646608|P5|COMPLETED|Period I||8
8375831|NCT01128972|20646609|P4|COMPLETED|Period I||7
8375832|NCT01128972|20646610|P3|COMPLETED|Period I||7
8375833|NCT01128972|20646611|P2|COMPLETED|Period I||7
8375834|NCT01128972|20646612|P1|COMPLETED|Period I||7
8375835|NCT01128972|20646608|P5|STARTED|Period I||8
8375836|NCT01128972|20646609|P4|STARTED|Period I||7
8375837|NCT01128972|20646610|P3|STARTED|Period I||7
8375838|NCT01128972|20646611|P2|STARTED|Period I||7
8375839|NCT01128972|20646612|P1|STARTED|Period I||7
8375840|NCT01128959|20646641|P1|NOT COMPLETED|Treatment Period||4
8375841|NCT01128959|20646641|P1|COMPLETED|Treatment Period||101
8375842|NCT01128959|20646641|P1|STARTED|Treatment Period||105
8375843|NCT01128959|20646641|P1|NOT COMPLETED|Lead in Period||3
8375844|NCT01128959|20646641|P1|COMPLETED|Lead in Period||105
8375845|NCT01128959|20646641|P1|STARTED|Lead in Period||108
8375846|NCT01128946|20646647|P4|NOT COMPLETED|Period IV||0
8375847|NCT01128946|20646648|P3|NOT COMPLETED|Period IV||0
8375848|NCT01128946|20646649|P2|NOT COMPLETED|Period IV||0
8375849|NCT01128946|20646650|P1|NOT COMPLETED|Period IV||0
8375850|NCT01128946|20646647|P4|COMPLETED|Period IV||19
8375851|NCT01128946|20646648|P3|COMPLETED|Period IV||19
8375852|NCT01128946|20646649|P2|COMPLETED|Period IV||20
8375853|NCT01128946|20646650|P1|COMPLETED|Period IV||19
8375854|NCT01128946|20646647|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8375855|NCT01128946|20646648|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8375856|NCT01128946|20646649|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
8375857|NCT01128946|20646650|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8375858|NCT01128946|20646647|P4|NOT COMPLETED|Period III||0
8375859|NCT01128946|20646648|P3|NOT COMPLETED|Period III||0
8375860|NCT01128946|20646649|P2|NOT COMPLETED|Period III||0
8375861|NCT01128946|20646650|P1|NOT COMPLETED|Period III||1
8375862|NCT01128946|20646647|P4|COMPLETED|Period III||19
8375863|NCT01128946|20646648|P3|COMPLETED|Period III||20
8375864|NCT01128946|20646649|P2|COMPLETED|Period III||19
8375865|NCT01128946|20646650|P1|COMPLETED|Period III||19
8375866|NCT01128946|20646647|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
8375867|NCT01128946|20646648|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
8375868|NCT01128946|20646649|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
8375869|NCT01128946|20646650|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
8375870|NCT01128946|20646647|P4|NOT COMPLETED|Period II||1
8375871|NCT01128946|20646648|P3|NOT COMPLETED|Period II||0
8375872|NCT01128946|20646649|P2|NOT COMPLETED|Period II||1
8375873|NCT01128946|20646650|P1|NOT COMPLETED|Period II||0
8375874|NCT01128946|20646647|P4|COMPLETED|Period II||19
8375875|NCT01128946|20646648|P3|COMPLETED|Period II||20
8375876|NCT01128946|20646649|P2|COMPLETED|Period II||19
8375877|NCT01128946|20646650|P1|COMPLETED|Period II||20
8375878|NCT01128946|20646647|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375879|NCT01128946|20646648|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375880|NCT01128946|20646649|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375881|NCT01128946|20646650|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375882|NCT01128946|20646647|P4|NOT COMPLETED|Period I||1
8375883|NCT01128946|20646648|P3|NOT COMPLETED|Period I||1
8375884|NCT01128946|20646649|P2|NOT COMPLETED|Period I||1
8375885|NCT01128946|20646650|P1|NOT COMPLETED|Period I||0
8375886|NCT01128946|20646647|P4|COMPLETED|Period I||20
8375887|NCT01128946|20646648|P3|COMPLETED|Period I||20
8375888|NCT01128946|20646649|P2|COMPLETED|Period I||20
8375889|NCT01128946|20646650|P1|COMPLETED|Period I||20
8375890|NCT01128946|20646647|P4|STARTED|Period I||21
8375891|NCT01128946|20646648|P3|STARTED|Period I||21
8375892|NCT01128946|20646649|P2|STARTED|Period I||21
8375893|NCT01128946|20646650|P1|STARTED|Period I||20
8375894|NCT01128894|20646668|P2|NOT COMPLETED|Overall Study||68
8375895|NCT01128894|20646669|P1|NOT COMPLETED|Overall Study||58
8375896|NCT01128894|20646668|P2|COMPLETED|Overall Study||340
8375897|NCT01128894|20646669|P1|COMPLETED|Overall Study||346
8375898|NCT01128894|20646668|P2|STARTED|Overall Study||408
8375899|NCT01128894|20646669|P1|STARTED|Overall Study||404
8375900|NCT01128842|20646687|P1|NOT COMPLETED|Overall Study||7
8375901|NCT01128842|20646687|P1|COMPLETED|Overall Study||0
8375902|NCT01128842|20646687|P1|STARTED|Overall Study||7
8375903|NCT01128829|20646697|P2|NOT COMPLETED|Overall Study||0
8375904|NCT01128829|20646698|P1|NOT COMPLETED|Overall Study||0
8375905|NCT01128829|20646697|P2|COMPLETED|Overall Study||11
8375906|NCT01128829|20646698|P1|COMPLETED|Overall Study||6
8375907|NCT01128829|20646697|P2|STARTED|Overall Study||11
8375908|NCT01128829|20646698|P1|STARTED|Overall Study||6
8375909|NCT01128738|20646704|P2|NOT COMPLETED|Second TP||3
8375910|NCT01128738|20646705|P1|NOT COMPLETED|Second TP||0
8375911|NCT01128738|20646704|P2|COMPLETED|Second TP||63
8375912|NCT01128738|20646705|P1|COMPLETED|Second TP||34
8375913|NCT01128738|20646704|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
8375914|NCT01128738|20646705|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
8375915|NCT01128738|20646704|P2|NOT COMPLETED|First Treatment Phase (TP)||1
8375916|NCT01128738|20646705|P1|NOT COMPLETED|First Treatment Phase (TP)||4
8375917|NCT01128738|20646704|P2|COMPLETED|First Treatment Phase (TP)||73
8375918|NCT01128738|20646705|P1|COMPLETED|First Treatment Phase (TP)||74
8375919|NCT01128738|20646704|P2|STARTED|First Treatment Phase (TP)||74
8375920|NCT01128738|20646705|P1|STARTED|First Treatment Phase (TP)||78
8375921|NCT01128621|20646830|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
8375922|NCT01128621|20646831|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8375923|NCT01128621|20646830|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
8375924|NCT01128621|20646831|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8375925|NCT01128621|20646830|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
8375926|NCT01128621|20646831|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8375927|NCT01128621|20646830|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
8375928|NCT01128621|20646831|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
8375929|NCT01128621|20646830|P2|COMPLETED|Part A: GSK1292263 300 mg||0
8375930|NCT01128621|20646831|P1|COMPLETED|Part A: GSK1292263 300 mg||6
8375931|NCT01128621|20646830|P2|STARTED|Part A: GSK1292263 300 mg||0
8375932|NCT01128621|20646831|P1|STARTED|Part A: GSK1292263 300 mg||6
8375933|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 4||0
8375934|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 4||0
8375935|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 4||0
8375936|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 4||0
8375937|NCT01128595|20646952|P4|COMPLETED|Treatment Period 4||7
8375938|NCT01128595|20646953|P3|COMPLETED|Treatment Period 4||7
8375939|NCT01128595|20646954|P2|COMPLETED|Treatment Period 4||5
8375940|NCT01128595|20646955|P1|COMPLETED|Treatment Period 4||7
8375941|NCT01128595|20646952|P4|STARTED|Treatment Period 4||7
8375942|NCT01128595|20646953|P3|STARTED|Treatment Period 4||7
8375943|NCT01128595|20646954|P2|STARTED|Treatment Period 4||5
8375944|NCT01128595|20646955|P1|STARTED|Treatment Period 4||7
8375945|NCT01128595|20646952|P4|NOT COMPLETED|Washout Period 3||0
8375946|NCT01128595|20646953|P3|NOT COMPLETED|Washout Period 3||0
8375947|NCT01128595|20646954|P2|NOT COMPLETED|Washout Period 3||0
8375948|NCT01128595|20646955|P1|NOT COMPLETED|Washout Period 3||0
8375949|NCT01128595|20646952|P4|COMPLETED|Washout Period 3||7
8375950|NCT01128595|20646953|P3|COMPLETED|Washout Period 3||7
8375951|NCT01128595|20646954|P2|COMPLETED|Washout Period 3||5
8375952|NCT01128595|20646955|P1|COMPLETED|Washout Period 3||7
8375953|NCT01128595|20646952|P4|STARTED|Washout Period 3||7
8375954|NCT01128595|20646953|P3|STARTED|Washout Period 3||7
8375955|NCT01128595|20646954|P2|STARTED|Washout Period 3||5
8375956|NCT01128595|20646955|P1|STARTED|Washout Period 3||7
8375957|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 3||0
8375958|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 3||0
8375959|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 3||1
8375960|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 3||0
8375961|NCT01128595|20646952|P4|COMPLETED|Treatment Period 3||7
8375962|NCT01128595|20646953|P3|COMPLETED|Treatment Period 3||7
8375963|NCT01128595|20646954|P2|COMPLETED|Treatment Period 3||5
8375964|NCT01128595|20646955|P1|COMPLETED|Treatment Period 3||7
8375965|NCT01128595|20646952|P4|STARTED|Treatment Period 3||7
8375966|NCT01128595|20646953|P3|STARTED|Treatment Period 3||7
8375967|NCT01128595|20646954|P2|STARTED|Treatment Period 3||6
8375968|NCT01128595|20646955|P1|STARTED|Treatment Period 3||7
8375969|NCT01128595|20646952|P4|NOT COMPLETED|Washout Period 2||0
8375970|NCT01128595|20646953|P3|NOT COMPLETED|Washout Period 2||0
8375971|NCT01128595|20646954|P2|NOT COMPLETED|Washout Period 2||0
8375972|NCT01128595|20646955|P1|NOT COMPLETED|Washout Period 2||0
8375973|NCT01128595|20646952|P4|COMPLETED|Washout Period 2||7
8375974|NCT01128595|20646953|P3|COMPLETED|Washout Period 2||7
8375975|NCT01128595|20646954|P2|COMPLETED|Washout Period 2||6
8375976|NCT01128595|20646955|P1|COMPLETED|Washout Period 2||7
8375977|NCT01128595|20646952|P4|STARTED|Washout Period 2||7
8375978|NCT01128595|20646953|P3|STARTED|Washout Period 2||7
8375979|NCT01128595|20646954|P2|STARTED|Washout Period 2||6
8375980|NCT01128595|20646955|P1|STARTED|Washout Period 2||7
8375981|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 2||0
8375982|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 2||0
8375983|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 2||0
8375984|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 2||0
8375985|NCT01128595|20646952|P4|COMPLETED|Treatment Period 2||7
8375986|NCT01128595|20646953|P3|COMPLETED|Treatment Period 2||7
8375987|NCT01128595|20646954|P2|COMPLETED|Treatment Period 2||6
8375988|NCT01128595|20646955|P1|COMPLETED|Treatment Period 2||7
8375989|NCT01128595|20646952|P4|STARTED|Treatment Period 2||7
8375990|NCT01128595|20646953|P3|STARTED|Treatment Period 2||7
8375991|NCT01128595|20646954|P2|STARTED|Treatment Period 2||6
8375992|NCT01128595|20646955|P1|STARTED|Treatment Period 2||7
8375993|NCT01128595|20646952|P4|NOT COMPLETED|Washout Period 1||0
8375994|NCT01128595|20646953|P3|NOT COMPLETED|Washout Period 1||0
8375995|NCT01128595|20646954|P2|NOT COMPLETED|Washout Period 1||0
8375996|NCT01128595|20646955|P1|NOT COMPLETED|Washout Period 1||0
8375997|NCT01128595|20646952|P4|COMPLETED|Washout Period 1||7
8375998|NCT01128595|20646953|P3|COMPLETED|Washout Period 1||7
8375999|NCT01128595|20646954|P2|COMPLETED|Washout Period 1||6
8376000|NCT01128595|20646955|P1|COMPLETED|Washout Period 1||7
8376001|NCT01128595|20646952|P4|STARTED|Washout Period 1||7
8376002|NCT01128595|20646953|P3|STARTED|Washout Period 1||7
8376003|NCT01128595|20646954|P2|STARTED|Washout Period 1||6
8376004|NCT01128595|20646955|P1|STARTED|Washout Period 1||7
8376005|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 1||0
8376006|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 1||0
8376007|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 1||0
8376008|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 1||0
8376009|NCT01128595|20646952|P4|COMPLETED|Treatment Period 1||7
8376010|NCT01128595|20646953|P3|COMPLETED|Treatment Period 1||7
8376011|NCT01128595|20646954|P2|COMPLETED|Treatment Period 1||6
8376012|NCT01128595|20646955|P1|COMPLETED|Treatment Period 1||7
8376013|NCT01128595|20646952|P4|STARTED|Treatment Period 1||7
8376014|NCT01128595|20646953|P3|STARTED|Treatment Period 1||7
8376015|NCT01128595|20646954|P2|STARTED|Treatment Period 1||6
8376016|NCT01128595|20646955|P1|STARTED|Treatment Period 1||7
8376017|NCT01128569|20646985|P6|NOT COMPLETED|Treatment Period 3||0
8376018|NCT01128569|20646986|P5|NOT COMPLETED|Treatment Period 3||0
8376019|NCT01128569|20646987|P4|NOT COMPLETED|Treatment Period 3||0
8376020|NCT01128569|20646988|P3|NOT COMPLETED|Treatment Period 3||0
8376021|NCT01128569|20646989|P2|NOT COMPLETED|Treatment Period 3||0
8376022|NCT01128569|20646990|P1|NOT COMPLETED|Treatment Period 3||0
8376023|NCT01128569|20646985|P6|COMPLETED|Treatment Period 3||9
8376024|NCT01128569|20646986|P5|COMPLETED|Treatment Period 3||9
8376025|NCT01128569|20646987|P4|COMPLETED|Treatment Period 3||8
8376026|NCT01128569|20646988|P3|COMPLETED|Treatment Period 3||8
8376027|NCT01128569|20646989|P2|COMPLETED|Treatment Period 3||7
8376028|NCT01128569|20646990|P1|COMPLETED|Treatment Period 3||9
8376029|NCT01128569|20646985|P6|STARTED|Treatment Period 3||9
8376030|NCT01128569|20646986|P5|STARTED|Treatment Period 3||9
8376031|NCT01128569|20646987|P4|STARTED|Treatment Period 3||8
8376032|NCT01128569|20646988|P3|STARTED|Treatment Period 3||8
8376033|NCT01128569|20646989|P2|STARTED|Treatment Period 3||7
8376034|NCT01128569|20646990|P1|STARTED|Treatment Period 3||9
8376035|NCT01128569|20646985|P6|NOT COMPLETED|Washout Period 2||0
8376036|NCT01128569|20646986|P5|NOT COMPLETED|Washout Period 2||0
8376037|NCT01128569|20646987|P4|NOT COMPLETED|Washout Period 2||0
8376038|NCT01128569|20646988|P3|NOT COMPLETED|Washout Period 2||0
8376039|NCT01128569|20646989|P2|NOT COMPLETED|Washout Period 2||0
8376040|NCT01128569|20646990|P1|NOT COMPLETED|Washout Period 2||0
8376041|NCT01128569|20646985|P6|COMPLETED|Washout Period 2||9
8376042|NCT01128569|20646986|P5|COMPLETED|Washout Period 2||9
8376043|NCT01128569|20646987|P4|COMPLETED|Washout Period 2||8
8376044|NCT01128569|20646988|P3|COMPLETED|Washout Period 2||8
8376045|NCT01128569|20646989|P2|COMPLETED|Washout Period 2||7
8376046|NCT01128569|20646990|P1|COMPLETED|Washout Period 2||9
8376047|NCT01128569|20646985|P6|STARTED|Washout Period 2||9
8376048|NCT01128569|20646986|P5|STARTED|Washout Period 2||9
8376049|NCT01128569|20646987|P4|STARTED|Washout Period 2||8
8376050|NCT01128569|20646988|P3|STARTED|Washout Period 2||8
8376051|NCT01128569|20646989|P2|STARTED|Washout Period 2||7
8376052|NCT01128569|20646990|P1|STARTED|Washout Period 2||9
8376053|NCT01128569|20646985|P6|NOT COMPLETED|Treatment Period 2||0
8376054|NCT01128569|20646986|P5|NOT COMPLETED|Treatment Period 2||0
8376055|NCT01128569|20646987|P4|NOT COMPLETED|Treatment Period 2||0
8376056|NCT01128569|20646988|P3|NOT COMPLETED|Treatment Period 2||0
8376057|NCT01128569|20646989|P2|NOT COMPLETED|Treatment Period 2||1
8376058|NCT01128569|20646990|P1|NOT COMPLETED|Treatment Period 2||0
8376059|NCT01128569|20646985|P6|COMPLETED|Treatment Period 2||9
8376060|NCT01128569|20646986|P5|COMPLETED|Treatment Period 2||9
8376061|NCT01128569|20646987|P4|COMPLETED|Treatment Period 2||8
8376062|NCT01128569|20646988|P3|COMPLETED|Treatment Period 2||8
8376063|NCT01128569|20646989|P2|COMPLETED|Treatment Period 2||7
8376064|NCT01128569|20646990|P1|COMPLETED|Treatment Period 2||9
8376065|NCT01128569|20646985|P6|STARTED|Treatment Period 2||9
8376066|NCT01128569|20646986|P5|STARTED|Treatment Period 2||9
8376067|NCT01128569|20646987|P4|STARTED|Treatment Period 2||8
8376068|NCT01128569|20646988|P3|STARTED|Treatment Period 2||8
8376069|NCT01128569|20646989|P2|STARTED|Treatment Period 2||8
8376070|NCT01128569|20646990|P1|STARTED|Treatment Period 2||9
8376071|NCT01128569|20646985|P6|NOT COMPLETED|Washout Period 1||0
8376072|NCT01128569|20646986|P5|NOT COMPLETED|Washout Period 1||0
8376073|NCT01128569|20646987|P4|NOT COMPLETED|Washout Period 1||0
8376074|NCT01128569|20646988|P3|NOT COMPLETED|Washout Period 1||1
8376075|NCT01128569|20646989|P2|NOT COMPLETED|Washout Period 1||0
8376076|NCT01128569|20646990|P1|NOT COMPLETED|Washout Period 1||0
8376077|NCT01128569|20646985|P6|COMPLETED|Washout Period 1||9
8376078|NCT01128569|20646986|P5|COMPLETED|Washout Period 1||9
8376079|NCT01128569|20646987|P4|COMPLETED|Washout Period 1||8
8376080|NCT01128569|20646988|P3|COMPLETED|Washout Period 1||8
8376081|NCT01128569|20646989|P2|COMPLETED|Washout Period 1||8
8376082|NCT01128569|20646990|P1|COMPLETED|Washout Period 1||9
8376083|NCT01128569|20646985|P6|STARTED|Washout Period 1||9
8376084|NCT01128569|20646986|P5|STARTED|Washout Period 1||9
8376085|NCT01128569|20646987|P4|STARTED|Washout Period 1||8
8376086|NCT01128569|20646988|P3|STARTED|Washout Period 1||9
8376087|NCT01128569|20646989|P2|STARTED|Washout Period 1||8
8376088|NCT01128569|20646990|P1|STARTED|Washout Period 1||9
8376089|NCT01128569|20646985|P6|NOT COMPLETED|Treatment Period 1||0
8376090|NCT01128569|20646986|P5|NOT COMPLETED|Treatment Period 1||0
8376091|NCT01128569|20646987|P4|NOT COMPLETED|Treatment Period 1||0
8376092|NCT01128569|20646988|P3|NOT COMPLETED|Treatment Period 1||0
8376093|NCT01128569|20646989|P2|NOT COMPLETED|Treatment Period 1||0
8376094|NCT01128569|20646990|P1|NOT COMPLETED|Treatment Period 1||0
8376095|NCT01128569|20646985|P6|COMPLETED|Treatment Period 1||9
8376096|NCT01128569|20646986|P5|COMPLETED|Treatment Period 1||9
8376097|NCT01128569|20646987|P4|COMPLETED|Treatment Period 1||8
8376098|NCT01128569|20646988|P3|COMPLETED|Treatment Period 1||9
8376099|NCT01128569|20646989|P2|COMPLETED|Treatment Period 1||8
8376100|NCT01128569|20646990|P1|COMPLETED|Treatment Period 1||9
8376101|NCT01128569|20646985|P6|STARTED|Treatment Period 1||9
8376102|NCT01128569|20646986|P5|STARTED|Treatment Period 1||9
8376103|NCT01128569|20646987|P4|STARTED|Treatment Period 1||8
8376104|NCT01128569|20646988|P3|STARTED|Treatment Period 1||9
8376105|NCT01128569|20646989|P2|STARTED|Treatment Period 1||8
8376106|NCT01128569|20646990|P1|STARTED|Treatment Period 1||9
8376107|NCT01128543|20647007|P1|NOT COMPLETED|Overall Study||4
8376108|NCT01128543|20647007|P1|COMPLETED|Overall Study||25
8376109|NCT01128543|20647007|P1|STARTED|Overall Study||29
8376110|NCT01128426|20647013|P1|NOT COMPLETED|Overall Study||0
8376111|NCT01128426|20647013|P1|COMPLETED|Overall Study||53902
8376112|NCT01128426|20647013|P1|STARTED|Overall Study||53902
8376113|NCT01128413|20647033|P2|NOT COMPLETED|Overall Study||1
8376114|NCT01128413|20647034|P1|NOT COMPLETED|Overall Study||4
8376115|NCT01128413|20647033|P2|COMPLETED|Overall Study||10
8376116|NCT01128413|20647034|P1|COMPLETED|Overall Study||7
8376117|NCT01128413|20647033|P2|STARTED|Overall Study||11
8376118|NCT01128413|20647034|P1|STARTED|Overall Study||11
8376119|NCT01128400|20647043|P3|NOT COMPLETED|Overall Study||16
8376120|NCT01128400|20647044|P2|NOT COMPLETED|Overall Study||1
8376121|NCT01128400|20647045|P1|NOT COMPLETED|Overall Study||2
8376122|NCT01128400|20647043|P3|COMPLETED|Overall Study||7
8376123|NCT01128400|20647044|P2|COMPLETED|Overall Study||8
8376124|NCT01128400|20647045|P1|COMPLETED|Overall Study||6
8376125|NCT01128400|20647043|P3|STARTED|Overall Study||23
8376126|NCT01128400|20647044|P2|STARTED|Overall Study||9
8376127|NCT01128400|20647045|P1|STARTED|Overall Study||8
8376128|NCT01128387|20647058|P2|NOT COMPLETED|Overall Study||1
8376129|NCT01128387|20647059|P1|NOT COMPLETED|Overall Study||0
8376130|NCT01128387|20647058|P2|COMPLETED|Overall Study||5
8376131|NCT01128387|20647059|P1|COMPLETED|Overall Study||5
8376132|NCT01128387|20647058|P2|STARTED|Overall Study||6
8376133|NCT01128387|20647059|P1|STARTED|Overall Study||5
8376134|NCT01128361|20647069|P2|NOT COMPLETED|Overall Study||3
8376135|NCT01128361|20647070|P1|NOT COMPLETED|Overall Study||5
8376136|NCT01128361|20647069|P2|COMPLETED|Overall Study||34
8376137|NCT01128361|20647070|P1|COMPLETED|Overall Study||34
8376138|NCT01128361|20647069|P2|STARTED|Overall Study||37
8376139|NCT01128361|20647070|P1|STARTED|Overall Study||39
8376140|NCT01128296|20647082|P6|NOT COMPLETED|Overall Study||5
8376141|NCT01128296|20647083|P5|NOT COMPLETED|Overall Study||0
8376142|NCT01128296|20647084|P4|NOT COMPLETED|Overall Study||0
8376143|NCT01128296|20647085|P3|NOT COMPLETED|Overall Study||0
8376144|NCT01128296|20647086|P2|NOT COMPLETED|Overall Study||0
8376145|NCT01128296|20647087|P1|NOT COMPLETED|Overall Study||0
8376146|NCT01128296|20647082|P6|COMPLETED|Overall Study||21
8376147|NCT01128296|20647083|P5|COMPLETED|Overall Study||1
8376148|NCT01128296|20647084|P4|COMPLETED|Overall Study||1
8376149|NCT01128296|20647085|P3|COMPLETED|Overall Study||1
8376150|NCT01128296|20647086|P2|COMPLETED|Overall Study||1
8376151|NCT01128296|20647087|P1|COMPLETED|Overall Study||1
8376152|NCT01128296|20647082|P6|STARTED|Overall Study||26
8376153|NCT01128296|20647083|P5|STARTED|Overall Study||1
8376154|NCT01128296|20647084|P4|STARTED|Overall Study||1
8376155|NCT01128296|20647085|P3|STARTED|Overall Study||1
8376156|NCT01128296|20647086|P2|STARTED|Overall Study||1
8376157|NCT01128296|20647087|P1|STARTED|Overall Study||1
8376158|NCT01128270|20647105|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
8376159|NCT01128270|20647105|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
8376160|NCT01128270|20647105|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
8376161|NCT01128270|20647105|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
8376162|NCT01128270|20647105|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
8376163|NCT01128270|20647105|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
8376164|NCT01128270|20647105|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
8376165|NCT01128270|20647105|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
8376166|NCT01128270|20647105|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
8376167|NCT01128270|20647105|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
8376168|NCT01128270|20647105|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
8376169|NCT01128270|20647105|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
8376170|NCT01128244|20647118|P1|NOT COMPLETED|Overall Study||3
8376171|NCT01128244|20647118|P1|COMPLETED|Overall Study||10
8376172|NCT01128244|20647118|P1|STARTED|Overall Study||13
8376173|NCT01128192|20647128|P3|NOT COMPLETED|Overall Study||0
8376174|NCT01128192|20647129|P2|NOT COMPLETED|Overall Study||0
8376175|NCT01128192|20647130|P1|NOT COMPLETED|Overall Study||0
8376176|NCT01128192|20647128|P3|COMPLETED|Overall Study||7
8376177|NCT01128192|20647129|P2|COMPLETED|Overall Study||19
8376178|NCT01128192|20647130|P1|COMPLETED|Overall Study||19
8376179|NCT01128192|20647128|P3|STARTED|Overall Study||7
8376180|NCT01128192|20647129|P2|STARTED|Overall Study||19
8376181|NCT01128192|20647130|P1|STARTED|Overall Study||19
8376182|NCT01128179|20647159|P2|NOT COMPLETED|Overall Study||0
8376183|NCT01128179|20647160|P1|NOT COMPLETED|Overall Study||2
8376184|NCT01128179|20647159|P2|COMPLETED|Overall Study||12
8376185|NCT01128179|20647160|P1|COMPLETED|Overall Study||21
8376186|NCT01128179|20647159|P2|STARTED|Overall Study||12
8376187|NCT01128179|20647160|P1|STARTED|Overall Study||23
8376188|NCT01128153|20647180|P2|NOT COMPLETED|Overall Study||15
8376189|NCT01128153|20647181|P1|NOT COMPLETED|Overall Study||16
8376190|NCT01128153|20647180|P2|COMPLETED|Overall Study|Completed 24 weeks|113
8376191|NCT01128153|20647181|P1|COMPLETED|Overall Study|Completed 24 weeks|113
8376192|NCT01128153|20647180|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
8376193|NCT01128153|20647181|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
8376194|NCT01128153|20647180|P2|STARTED|Overall Study|Randomised|128
8376195|NCT01128153|20647181|P1|STARTED|Overall Study|Randomised|129
8376196|NCT01128114|20647197|P1|NOT COMPLETED|Overall Study||8
8376197|NCT01128114|20647197|P1|COMPLETED|Overall Study||24
8376198|NCT01128114|20647197|P1|STARTED|Overall Study||32
8376199|NCT01128049|20647204|P3|NOT COMPLETED|Overall Study||0
8376200|NCT01128049|20647205|P2|NOT COMPLETED|Overall Study||0
8376201|NCT01128049|20647206|P1|NOT COMPLETED|Overall Study||0
8376202|NCT01128049|20647204|P3|COMPLETED|Overall Study||5
8376203|NCT01128049|20647205|P2|COMPLETED|Overall Study||5
8376204|NCT01128049|20647206|P1|COMPLETED|Overall Study||5
8376205|NCT01128049|20647204|P3|STARTED|Overall Study||5
8376206|NCT01128049|20647205|P2|STARTED|Overall Study||5
8376207|NCT01128049|20647206|P1|STARTED|Overall Study||5
8376208|NCT01127763|20647214|P1|NOT COMPLETED|Overall Study||5
8376209|NCT01127763|20647214|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
8376210|NCT01127763|20647214|P1|STARTED|Overall Study||25
8376211|NCT01127737|20647225|P2|NOT COMPLETED|Overall Study||0
8376212|NCT01127737|20647226|P1|NOT COMPLETED|Overall Study||0
8376213|NCT01127737|20647225|P2|COMPLETED|Overall Study||38
8376214|NCT01127737|20647226|P1|COMPLETED|Overall Study||37
8376215|NCT01127737|20647225|P2|STARTED|Overall Study||38
8376216|NCT01127737|20647226|P1|STARTED|Overall Study||37
8376217|NCT01127659|20647238|P6|NOT COMPLETED|Overall Study||0
8376218|NCT01127659|20647239|P5|NOT COMPLETED|Overall Study||0
8376219|NCT01127659|20647240|P4|NOT COMPLETED|Overall Study||4
8376220|NCT01127659|20647241|P3|NOT COMPLETED|Overall Study||2
8376221|NCT01127659|20647242|P2|NOT COMPLETED|Overall Study||8
8376222|NCT01127659|20647243|P1|NOT COMPLETED|Overall Study||2
8376223|NCT01127659|20647238|P6|COMPLETED|Overall Study||21
8376224|NCT01127659|20647239|P5|COMPLETED|Overall Study||50
8376225|NCT01127659|20647240|P4|COMPLETED|Overall Study||6
8376226|NCT01127659|20647241|P3|COMPLETED|Overall Study||10
8376227|NCT01127659|20647242|P2|COMPLETED|Overall Study||14
8376228|NCT01127659|20647243|P1|COMPLETED|Overall Study||20
8376229|NCT01127659|20647238|P6|STARTED|Overall Study||21
8376230|NCT01127659|20647239|P5|STARTED|Overall Study||50
8376231|NCT01127659|20647240|P4|STARTED|Overall Study||10
8376232|NCT01127659|20647241|P3|STARTED|Overall Study||12
8376233|NCT01127659|20647242|P2|STARTED|Overall Study||22
8376234|NCT01127659|20647243|P1|STARTED|Overall Study||22
8376235|NCT01127646|20647259|P2|NOT COMPLETED|Overall Study||1
8376236|NCT01127646|20647260|P1|NOT COMPLETED|Overall Study||1
8376237|NCT01127646|20647259|P2|COMPLETED|Overall Study||7
8376238|NCT01127646|20647260|P1|COMPLETED|Overall Study||14
8376239|NCT01127646|20647259|P2|STARTED|Overall Study||8
8376240|NCT01127646|20647260|P1|STARTED|Overall Study||15
8376241|NCT01127633|20647294|P2|NOT COMPLETED|Overall Study||673
8376242|NCT01127633|20647295|P1|NOT COMPLETED|Overall Study||653
8376243|NCT01127633|20647294|P2|COMPLETED|Overall Study||61
8376244|NCT01127633|20647295|P1|COMPLETED|Overall Study||70
8376245|NCT01127633|20647294|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
8376246|NCT01127633|20647295|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
8376247|NCT01127633|20647294|P2|STARTED|Overall Study||734
8376248|NCT01127633|20647295|P1|STARTED|Overall Study||723
8376249|NCT01127607|20647327|P2|NOT COMPLETED|Phase II (Between Subjects)||2
8376250|NCT01127607|20647328|P1|NOT COMPLETED|Phase II (Between Subjects)||1
8376251|NCT01127607|20647327|P2|COMPLETED|Phase II (Between Subjects)||11
8376252|NCT01127607|20647328|P1|COMPLETED|Phase II (Between Subjects)||13
8376253|NCT01127607|20647327|P2|STARTED|Phase II (Between Subjects)||13
8376254|NCT01127607|20647328|P1|STARTED|Phase II (Between Subjects)||14
8376255|NCT01127607|20647327|P2|NOT COMPLETED|Phase I (Within Subjects)||0
8376256|NCT01127607|20647328|P1|NOT COMPLETED|Phase I (Within Subjects)||0
8376257|NCT01127607|20647327|P2|COMPLETED|Phase I (Within Subjects)||13
8376258|NCT01127607|20647328|P1|COMPLETED|Phase I (Within Subjects)||14
8376259|NCT01127607|20647327|P2|STARTED|Phase I (Within Subjects)||13
8376260|NCT01127607|20647328|P1|STARTED|Phase I (Within Subjects)||14
8376261|NCT01127581|20647401|P2|NOT COMPLETED|Overall Study||0
8376262|NCT01127581|20647402|P1|NOT COMPLETED|Overall Study||0
8376263|NCT01127581|20647401|P2|COMPLETED|Overall Study||680
8376264|NCT01127581|20647402|P1|COMPLETED|Overall Study||678
8376265|NCT01127581|20647401|P2|STARTED|Overall Study||680
8376266|NCT01127581|20647402|P1|STARTED|Overall Study||678
8376267|NCT01127503|20647430|P2|NOT COMPLETED|Overall Study||0
8376268|NCT01127503|20647431|P1|NOT COMPLETED|Overall Study||0
8376269|NCT01127503|20647430|P2|COMPLETED|Overall Study||1
8376270|NCT01127503|20647431|P1|COMPLETED|Overall Study||1
8376271|NCT01127503|20647430|P2|STARTED|Overall Study||1
8376272|NCT01127503|20647431|P1|STARTED|Overall Study||1
8376273|NCT01127438|20647445|P6|NOT COMPLETED|Overall Study||0
8376274|NCT01127438|20647446|P5|NOT COMPLETED|Overall Study||0
8376275|NCT01127438|20647447|P4|NOT COMPLETED|Overall Study||0
8376276|NCT01127438|20647448|P3|NOT COMPLETED|Overall Study||0
8376277|NCT01127438|20647449|P2|NOT COMPLETED|Overall Study||0
8376278|NCT01127438|20647450|P1|NOT COMPLETED|Overall Study||0
8376279|NCT01127438|20647445|P6|COMPLETED|Overall Study||25
8376280|NCT01127438|20647446|P5|COMPLETED|Overall Study||28
8376281|NCT01127438|20647447|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
8376282|NCT01127438|20647448|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
8376283|NCT01127438|20647449|P2|COMPLETED|Overall Study||25
8376284|NCT01127438|20647450|P1|COMPLETED|Overall Study||25
8376285|NCT01127438|20647445|P6|STARTED|Overall Study||25
8376286|NCT01127438|20647446|P5|STARTED|Overall Study||28
8376287|NCT01127438|20647447|P4|STARTED|Overall Study||24
8376288|NCT01127438|20647448|P3|STARTED|Overall Study||26
8376289|NCT01127438|20647449|P2|STARTED|Overall Study||25
8376290|NCT01127438|20647450|P1|STARTED|Overall Study||25
8376291|NCT01127321|20647477|P5|NOT COMPLETED|Overall Study||0
8376292|NCT01127321|20647478|P4|NOT COMPLETED|Overall Study||0
8376293|NCT01127321|20647479|P3|NOT COMPLETED|Overall Study||0
8376294|NCT01127321|20647480|P2|NOT COMPLETED|Overall Study||0
8376295|NCT01127321|20647481|P1|NOT COMPLETED|Overall Study||0
8376296|NCT01127321|20647477|P5|COMPLETED|Overall Study||5
8376297|NCT01127321|20647478|P4|COMPLETED|Overall Study||7
8376298|NCT01127321|20647479|P3|COMPLETED|Overall Study||1
8376299|NCT01127321|20647480|P2|COMPLETED|Overall Study||1
8376300|NCT01127321|20647481|P1|COMPLETED|Overall Study||3
8376301|NCT01127321|20647477|P5|STARTED|Overall Study||5
8376302|NCT01127321|20647478|P4|STARTED|Overall Study||7
8376303|NCT01127321|20647479|P3|STARTED|Overall Study||1
8376304|NCT01127321|20647480|P2|STARTED|Overall Study||1
8376305|NCT01127321|20647481|P1|STARTED|Overall Study||3
8376306|NCT01127256|20647505|P2|NOT COMPLETED|Overall Study||39
8376307|NCT01127256|20647506|P1|NOT COMPLETED|Overall Study||39
8376308|NCT01127256|20647505|P2|COMPLETED|Overall Study||65
8376309|NCT01127256|20647506|P1|COMPLETED|Overall Study||57
8376310|NCT01127256|20647505|P2|STARTED|Overall Study||104
8376311|NCT01127256|20647506|P1|STARTED|Overall Study||96
8376312|NCT01127165|20647518|P2|NOT COMPLETED|Overall Study||19
8376313|NCT01127165|20647519|P1|NOT COMPLETED|Overall Study||16
8376314|NCT01127165|20647518|P2|COMPLETED|Overall Study||41
8376315|NCT01127165|20647519|P1|COMPLETED|Overall Study||49
8376316|NCT01127165|20647518|P2|STARTED|Overall Study||60
8376317|NCT01127165|20647519|P1|STARTED|Overall Study||65
8376318|NCT01127139|20647531|P1|NOT COMPLETED|Overall Study||57
8376319|NCT01127139|20647531|P1|COMPLETED|Overall Study||3771
8376320|NCT01127139|20647531|P1|Number of Participants Analyzed|Overall Study||3828
8376321|NCT01127139|20647531|P1|STARTED|Overall Study||3828
8376322|NCT01127087|20647548|P2|NOT COMPLETED|Overall Study||0
8376323|NCT01127087|20647549|P1|NOT COMPLETED|Overall Study||0
8376324|NCT01127087|20647548|P2|COMPLETED|Overall Study||2
8376325|NCT01127087|20647549|P1|COMPLETED|Overall Study||8
8376326|NCT01127087|20647548|P2|STARTED|Overall Study||2
8376327|NCT01127087|20647549|P1|STARTED|Overall Study||8
8376328|NCT01127061|20647559|P2|NOT COMPLETED|Overall Study||13
8376329|NCT01127061|20647560|P1|NOT COMPLETED|Overall Study||10
8376330|NCT01127061|20647559|P2|COMPLETED|Overall Study||56
8376331|NCT01127061|20647560|P1|COMPLETED|Overall Study||57
8376332|NCT01127061|20647559|P2|STARTED|Overall Study||69
8376333|NCT01127061|20647560|P1|STARTED|Overall Study||67
8376334|NCT01126957|20647590|P1|NOT COMPLETED|Overall Study||0
8376335|NCT01126957|20647590|P1|COMPLETED|Overall Study||103
8376336|NCT01126957|20647590|P1|STARTED|Overall Study||103
8376337|NCT01126879|20647597|P2|NOT COMPLETED|Overall Study||2
8376338|NCT01126879|20647598|P1|NOT COMPLETED|Overall Study||5
8376339|NCT01126879|20647597|P2|COMPLETED|Overall Study||2
8376340|NCT01126879|20647598|P1|COMPLETED|Overall Study||3
8376341|NCT01126879|20647597|P2|Completed 3 Months Genistein/Placebo|Overall Study||2
8376342|NCT01126879|20647598|P1|Completed 3 Months Genistein/Placebo|Overall Study||4
8376343|NCT01126879|20647597|P2|Prostatectomy or Radiation|Overall Study||4
8376344|NCT01126879|20647598|P1|Prostatectomy or Radiation|Overall Study||8
8376345|NCT01126879|20647597|P2|Started 3 Months of Genistein/Placebo|Overall Study||4
8376346|NCT01126879|20647598|P1|Started 3 Months of Genistein/Placebo|Overall Study||8
8376347|NCT01126879|20647597|P2|STARTED|Overall Study||4
8376348|NCT01126879|20647598|P1|STARTED|Overall Study||8
8376349|NCT01126801|20647612|P2|NOT COMPLETED|Overall Study||0
8376350|NCT01126801|20647613|P1|NOT COMPLETED|Overall Study||0
8376351|NCT01126801|20647612|P2|COMPLETED|Overall Study||1
8376352|NCT01126801|20647613|P1|COMPLETED|Overall Study||1
8376353|NCT01126801|20647612|P2|STARTED|Overall Study||1
8376354|NCT01126801|20647613|P1|STARTED|Overall Study||1
8376355|NCT01126723|20647623|P2|NOT COMPLETED|Overall Study||3
8376356|NCT01126723|20647624|P1|NOT COMPLETED|Overall Study||6
8376357|NCT01126723|20647623|P2|COMPLETED|Overall Study||28
8376358|NCT01126723|20647624|P1|COMPLETED|Overall Study||29
8376359|NCT01126723|20647623|P2|STARTED|Overall Study||31
8376360|NCT01126723|20647624|P1|STARTED|Overall Study||35
8376361|NCT01126671|20647632|P2|NOT COMPLETED|Overall Study||1
8376362|NCT01126671|20647633|P1|NOT COMPLETED|Overall Study||2
8376363|NCT01126671|20647632|P2|COMPLETED|Overall Study||29
8376364|NCT01126671|20647633|P1|COMPLETED|Overall Study||24
8376365|NCT01126671|20647632|P2|STARTED|Overall Study||30
8376366|NCT01126671|20647633|P1|STARTED|Overall Study||26
8376367|NCT01126619|20647645|P1|NOT COMPLETED|Overall Study||17
8376368|NCT01126619|20647645|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
8376369|NCT01126619|20647645|P1|STARTED|Overall Study||103
8376370|NCT01126593|20647660|P3|NOT COMPLETED|Overall Study||2
8376371|NCT01126593|20647661|P2|NOT COMPLETED|Overall Study||2
8376372|NCT01126593|20647662|P1|NOT COMPLETED|Overall Study||4
8376373|NCT01126593|20647660|P3|COMPLETED|Overall Study||32
8376374|NCT01126593|20647661|P2|COMPLETED|Overall Study||27
8376375|NCT01126593|20647662|P1|COMPLETED|Overall Study||29
8376376|NCT01126593|20647660|P3|STARTED|Overall Study||34
8376377|NCT01126593|20647661|P2|STARTED|Overall Study||29
8376378|NCT01126593|20647662|P1|STARTED|Overall Study||33
8376379|NCT01126580|20647673|P3|NOT COMPLETED|Overall Study||55
8376380|NCT01126580|20647674|P2|NOT COMPLETED|Overall Study||52
8376381|NCT01126580|20647675|P1|NOT COMPLETED|Overall Study||49
8376382|NCT01126580|20647673|P3|COMPLETED|Overall Study||213
8376383|NCT01126580|20647674|P2|COMPLETED|Overall Study||218
8376384|NCT01126580|20647675|P1|COMPLETED|Overall Study||220
8376385|NCT01126580|20647673|P3|Completed 26 Weeks|Overall Study||226
8376386|NCT01126580|20647674|P2|Completed 26 Weeks|Overall Study||242
8376387|NCT01126580|20647675|P1|Completed 26 Weeks|Overall Study||233
8376388|NCT01126580|20647673|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
8376389|NCT01126580|20647674|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
8376390|NCT01126580|20647675|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
8376391|NCT01126580|20647673|P3|STARTED|Overall Study||268
8376392|NCT01126580|20647674|P2|STARTED|Overall Study||270
8376393|NCT01126580|20647675|P1|STARTED|Overall Study||269
8376394|NCT01126541|20647770|P3|NOT COMPLETED|Overall Study||26
8376395|NCT01126541|20647771|P2|NOT COMPLETED|Overall Study||12
8376396|NCT01126541|20647772|P1|NOT COMPLETED|Overall Study||10
8376397|NCT01126541|20647770|P3|COMPLETED|Overall Study||55
8376398|NCT01126541|20647771|P2|COMPLETED|Overall Study||61
8376399|NCT01126541|20647772|P1|COMPLETED|Overall Study||60
8376400|NCT01126541|20647770|P3|STARTED|Overall Study||81
8376401|NCT01126541|20647771|P2|STARTED|Overall Study||73
8376402|NCT01126541|20647772|P1|STARTED|Overall Study||70
8376403|NCT01126437|20647856|P3|NOT COMPLETED|Overall Study||1313
8376404|NCT01126437|20647857|P2|NOT COMPLETED|Overall Study||1330
8376405|NCT01126437|20647858|P1|NOT COMPLETED|Overall Study||1341
8376406|NCT01126437|20647856|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
8376407|NCT01126437|20647857|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
8376408|NCT01126437|20647858|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
8376409|NCT01126437|20647856|P3|STARTED|Overall Study||5713
8376410|NCT01126437|20647857|P2|STARTED|Overall Study||5729
8376411|NCT01126437|20647858|P1|STARTED|Overall Study||5741
8376412|NCT01126424|20647896|P6|NOT COMPLETED|Overall Study||0
8376413|NCT01126424|20647897|P5|NOT COMPLETED|Overall Study||2
8376414|NCT01126424|20647898|P4|NOT COMPLETED|Overall Study||3
8376415|NCT01126424|20647899|P3|NOT COMPLETED|Overall Study||1
8376416|NCT01126424|20647900|P2|NOT COMPLETED|Overall Study||0
8376417|NCT01126424|20647901|P1|NOT COMPLETED|Overall Study||0
8376418|NCT01126424|20647896|P6|COMPLETED|Overall Study||4
8376419|NCT01126424|20647897|P5|COMPLETED|Overall Study||2
8376420|NCT01126424|20647898|P4|COMPLETED|Overall Study||3
8376421|NCT01126424|20647899|P3|COMPLETED|Overall Study||4
8376422|NCT01126424|20647900|P2|COMPLETED|Overall Study||4
8376423|NCT01126424|20647901|P1|COMPLETED|Overall Study||3
8376424|NCT01126424|20647896|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376425|NCT01126424|20647897|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376426|NCT01126424|20647898|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376427|NCT01126424|20647899|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376428|NCT01126424|20647900|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376429|NCT01126424|20647901|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
8376430|NCT01126424|20647896|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8376431|NCT01126424|20647897|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8376432|NCT01126424|20647898|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
8376433|NCT01126424|20647899|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
8376434|NCT01126424|20647900|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8376435|NCT01126424|20647901|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
8376436|NCT01126359|20647924|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
8376437|NCT01126359|20647925|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
8376438|NCT01126359|20647924|P2|COMPLETED|Second Intervention (20-minutes)||5
8376439|NCT01126359|20647925|P1|COMPLETED|Second Intervention (20-minutes)||5
8376440|NCT01126359|20647924|P2|STARTED|Second Intervention (20-minutes)||5
8376441|NCT01126359|20647925|P1|STARTED|Second Intervention (20-minutes)||5
8376442|NCT01126359|20647924|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
8376443|NCT01126359|20647925|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
8376444|NCT01126359|20647924|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
8376445|NCT01126359|20647925|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
8376446|NCT01126359|20647924|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
8376447|NCT01126359|20647925|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
8376448|NCT01126359|20647924|P2|NOT COMPLETED|First Intervention (20-minutes)||1
8376449|NCT01126359|20647925|P1|NOT COMPLETED|First Intervention (20-minutes)||0
8376450|NCT01126359|20647924|P2|COMPLETED|First Intervention (20-minutes)||5
8376451|NCT01126359|20647925|P1|COMPLETED|First Intervention (20-minutes)||5
8376452|NCT01126359|20647924|P2|STARTED|First Intervention (20-minutes)||6
8376453|NCT01126359|20647925|P1|STARTED|First Intervention (20-minutes)||5
8376454|NCT01126268|20647937|P1|NOT COMPLETED|Overall Study||1
8376455|NCT01126268|20647937|P1|COMPLETED|Overall Study||37
8376456|NCT01126268|20647937|P1|STARTED|Overall Study||38
8376457|NCT01126099|20647961|P2|NOT COMPLETED|Open-label Extension||1
8376458|NCT01126099|20647962|P1|NOT COMPLETED|Open-label Extension||1
8376459|NCT01126099|20647961|P2|COMPLETED|Open-label Extension||6
8376460|NCT01126099|20647962|P1|COMPLETED|Open-label Extension||4
8376461|NCT01126099|20647961|P2|STARTED|Open-label Extension||7
8376462|NCT01126099|20647962|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
8376463|NCT01126099|20647961|P2|NOT COMPLETED|Double Blind Phase||2
8376464|NCT01126099|20647962|P1|NOT COMPLETED|Double Blind Phase||4
8376465|NCT01126099|20647961|P2|COMPLETED|Double Blind Phase||7
8376466|NCT01126099|20647962|P1|COMPLETED|Double Blind Phase||7
8376467|NCT01126099|20647961|P2|STARTED|Double Blind Phase||9
8376468|NCT01126099|20647962|P1|STARTED|Double Blind Phase||11
8376469|NCT01126060|20647976|P2|NOT COMPLETED|Overall Study||2
8376470|NCT01126060|20647977|P1|NOT COMPLETED|Overall Study||0
8376471|NCT01126060|20647976|P2|COMPLETED|Overall Study||38
8376472|NCT01126060|20647977|P1|COMPLETED|Overall Study||40
8376473|NCT01126060|20647976|P2|STARTED|Overall Study||40
8376474|NCT01126060|20647977|P1|STARTED|Overall Study||40
8376475|NCT01125930|20647985|P2|NOT COMPLETED|Overall Study||10
8376476|NCT01125930|20647986|P1|NOT COMPLETED|Overall Study||1
8376477|NCT01125930|20647985|P2|COMPLETED|Overall Study||36
8376478|NCT01125930|20647986|P1|COMPLETED|Overall Study||21
8376479|NCT01125930|20647985|P2|STARTED|Overall Study||46
8376480|NCT01125930|20647986|P1|STARTED|Overall Study||22
8376481|NCT01125917|20648140|P1|NOT COMPLETED|Overall Study||339
8376482|NCT01125917|20648140|P1|COMPLETED|Overall Study||15
8376483|NCT01125917|20648140|P1|STARTED|Overall Study||354
8376484|NCT01125813|20648144|P1|NOT COMPLETED|Overall Study||6
8376485|NCT01125813|20648144|P1|COMPLETED|Overall Study||30
8376486|NCT01125813|20648144|P1|STARTED|Overall Study||36
8376487|NCT01125800|20648154|P5|NOT COMPLETED|Phase II||11
8376488|NCT01125800|20648155|P4|NOT COMPLETED|Phase II||1
8376489|NCT01125800|20648156|P3|NOT COMPLETED|Phase II||0
8376490|NCT01125800|20648157|P2|NOT COMPLETED|Phase II||0
8376491|NCT01125800|20648158|P1|NOT COMPLETED|Phase II||0
8376492|NCT01125800|20648154|P5|COMPLETED|Phase II||5
8376493|NCT01125800|20648155|P4|COMPLETED|Phase II||0
8376494|NCT01125800|20648156|P3|COMPLETED|Phase II||0
8376495|NCT01125800|20648157|P2|COMPLETED|Phase II||0
8376496|NCT01125800|20648158|P1|COMPLETED|Phase II||0
8376497|NCT01125800|20648154|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
8376498|NCT01125800|20648155|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
8376499|NCT01125800|20648156|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8376500|NCT01125800|20648157|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8376501|NCT01125800|20648158|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8376502|NCT01125800|20648154|P5|NOT COMPLETED|Phase I||0
8376503|NCT01125800|20648155|P4|NOT COMPLETED|Phase I||11
8376504|NCT01125800|20648156|P3|NOT COMPLETED|Phase I||4
8376505|NCT01125800|20648157|P2|NOT COMPLETED|Phase I||9
8376506|NCT01125800|20648158|P1|NOT COMPLETED|Phase I||8
8376507|NCT01125800|20648154|P5|COMPLETED|Phase I||0
8376508|NCT01125800|20648155|P4|COMPLETED|Phase I||10
8376509|NCT01125800|20648156|P3|COMPLETED|Phase I||7
8376510|NCT01125800|20648157|P2|COMPLETED|Phase I||7
8376511|NCT01125800|20648158|P1|COMPLETED|Phase I||3
8376512|NCT01125800|20648154|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
8376513|NCT01125800|20648155|P4|STARTED|Phase I||21
8376514|NCT01125800|20648156|P3|STARTED|Phase I||11
8376515|NCT01125800|20648157|P2|STARTED|Phase I||16
8376516|NCT01125800|20648158|P1|STARTED|Phase I||11
8376517|NCT01125774|20648197|P4|NOT COMPLETED|Overall Study||3
8376518|NCT01125774|20648198|P3|NOT COMPLETED|Overall Study||9
8376519|NCT01125774|20648199|P2|NOT COMPLETED|Overall Study||554
8376520|NCT01125774|20648200|P1|NOT COMPLETED|Overall Study||1125
8376521|NCT01125774|20648197|P4|COMPLETED|Overall Study|Completed study at least once|3
8376522|NCT01125774|20648198|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
8376523|NCT01125774|20648199|P2|COMPLETED|Overall Study||948
8376524|NCT01125774|20648200|P1|COMPLETED|Overall Study||1893
8376525|NCT01125774|20648197|P4|Treated|Overall Study||5
8376526|NCT01125774|20648198|P3|Treated|Overall Study|Received telcagepant|21
8376527|NCT01125774|20648199|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
8376528|NCT01125774|20648200|P1|Treated|Overall Study||2638
8376529|NCT01125774|20648197|P4|STARTED|Overall Study|Unique participants randomized|6
8376530|NCT01125774|20648198|P3|STARTED|Overall Study|Unique participants randomized|22
8376531|NCT01125774|20648199|P2|STARTED|Overall Study|Randomized|1502
8376532|NCT01125774|20648200|P1|STARTED|Overall Study|Randomized|3018
8376533|NCT01125748|20648224|P2|NOT COMPLETED|Overall Study||14
8376534|NCT01125748|20648225|P1|NOT COMPLETED|Overall Study||10
8376535|NCT01125748|20648224|P2|COMPLETED|Overall Study||74
8376536|NCT01125748|20648225|P1|COMPLETED|Overall Study||78
8376537|NCT01125748|20648224|P2|STARTED|Overall Study||88
8376538|NCT01125748|20648225|P1|STARTED|Overall Study||88
8376539|NCT01125722|20648235|P2|NOT COMPLETED|Overall Study||1
8376540|NCT01125722|20648236|P1|NOT COMPLETED|Overall Study||3
8376541|NCT01125722|20648235|P2|COMPLETED|Overall Study||36
8376542|NCT01125722|20648236|P1|COMPLETED|Overall Study||34
8376543|NCT01125722|20648235|P2|STARTED|Overall Study||37
8376544|NCT01125722|20648236|P1|STARTED|Overall Study||37
8376545|NCT01125605|20648250|P1|NOT COMPLETED|Overall Study||0
8376546|NCT01125605|20648250|P1|COMPLETED|Overall Study||325
8376547|NCT01125605|20648250|P1|Safety|Overall Study|1 patient was only analysed for safety|326
8376548|NCT01125605|20648250|P1|STARTED|Overall Study|started = had baseline values|325
8376549|NCT01125566|20648283|P3|NOT COMPLETED|Patients Who Switched From AV to TV||73
8376550|NCT01125566|20648284|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
8376551|NCT01125566|20648285|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
8376552|NCT01125566|20648283|P3|COMPLETED|Patients Who Switched From AV to TV||2
8376553|NCT01125566|20648284|P2|COMPLETED|Patients Who Switched From AV to TV||0
8376554|NCT01125566|20648285|P1|COMPLETED|Patients Who Switched From AV to TV||0
8376555|NCT01125566|20648283|P3|STARTED|Patients Who Switched From AV to TV||75
8376556|NCT01125566|20648284|P2|STARTED|Patients Who Switched From AV to TV||0
8376557|NCT01125566|20648285|P1|STARTED|Patients Who Switched From AV to TV||0
8376558|NCT01125566|20648283|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
8376559|NCT01125566|20648284|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
8376560|NCT01125566|20648285|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
8376561|NCT01125566|20648283|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
8376562|NCT01125566|20648284|P2|COMPLETED|Patients Before the Switch (26Apr2013)||0
8376563|NCT01125566|20648285|P1|COMPLETED|Patients Before the Switch (26Apr2013)||74
8376564|NCT01125566|20648283|P3|Treated|Patients Before the Switch (26Apr2013)||0
8376565|NCT01125566|20648284|P2|Treated|Patients Before the Switch (26Apr2013)||169
8376566|NCT01125566|20648285|P1|Treated|Patients Before the Switch (26Apr2013)||337
8376567|NCT01125566|20648283|P3|STARTED|Patients Before the Switch (26Apr2013)||0
8376568|NCT01125566|20648284|P2|STARTED|Patients Before the Switch (26Apr2013)||169
8376569|NCT01125566|20648285|P1|STARTED|Patients Before the Switch (26Apr2013)||339
8376570|NCT01125514|20648298|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
8376571|NCT01125514|20648298|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
8376572|NCT01125514|20648298|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
8376573|NCT01125514|20648298|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
8376574|NCT01125514|20648298|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
8376575|NCT01125514|20648298|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
8376576|NCT01125514|20648298|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
8376577|NCT01125514|20648298|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
8376578|NCT01125514|20648298|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
8376579|NCT01125514|20648298|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
8376580|NCT01125514|20648298|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
8376581|NCT01125202|20648372|P2|NOT COMPLETED|Overall Study||7
8376582|NCT01125202|20648373|P1|NOT COMPLETED|Overall Study||12
8376583|NCT01125202|20648372|P2|COMPLETED|Overall Study||79
8376584|NCT01125202|20648373|P1|COMPLETED|Overall Study||81
8376585|NCT01125202|20648372|P2|STARTED|Overall Study||86
8376586|NCT01125202|20648373|P1|STARTED|Overall Study||93
8376587|NCT01125189|20648398|P3|NOT COMPLETED|Follow up Period||16
8376588|NCT01125189|20648399|P2|NOT COMPLETED|Follow up Period||15
8376589|NCT01125189|20648400|P1|NOT COMPLETED|Follow up Period||20
8376590|NCT01125189|20648398|P3|COMPLETED|Follow up Period||58
8376591|NCT01125189|20648399|P2|COMPLETED|Follow up Period||138
8376592|NCT01125189|20648400|P1|COMPLETED|Follow up Period||132
8376593|NCT01125189|20648398|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
8376594|NCT01125189|20648399|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
8376595|NCT01125189|20648400|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
8376596|NCT01125189|20648398|P3|NOT COMPLETED|Treatment Period||41
8376597|NCT01125189|20648399|P2|NOT COMPLETED|Treatment Period||35
8376598|NCT01125189|20648400|P1|NOT COMPLETED|Treatment Period||31
8376599|NCT01125189|20648398|P3|COMPLETED|Treatment Period||37
8376600|NCT01125189|20648399|P2|COMPLETED|Treatment Period||123
8376601|NCT01125189|20648400|P1|COMPLETED|Treatment Period||128
8376602|NCT01125189|20648398|P3|STARTED|Treatment Period||78
8376603|NCT01125189|20648399|P2|STARTED|Treatment Period||158
8376604|NCT01125189|20648400|P1|STARTED|Treatment Period||159
8376605|NCT01125176|20648426|P1|NOT COMPLETED|Post-treatment Follow-up Phase||11
8376606|NCT01125176|20648426|P1|COMPLETED|Post-treatment Follow-up Phase||2
8376607|NCT01125176|20648426|P1|STARTED|Post-treatment Follow-up Phase||13
8376608|NCT01125176|20648426|P1|NOT COMPLETED|Treatment Phase||1
8376609|NCT01125176|20648426|P1|COMPLETED|Treatment Phase||13
8376610|NCT01125176|20648426|P1|STARTED|Treatment Phase||14
8376611|NCT01125163|20648432|P2|NOT COMPLETED|Overall Study||0
8376612|NCT01125163|20648433|P1|NOT COMPLETED|Overall Study||0
8376613|NCT01125163|20648432|P2|COMPLETED|Overall Study||74
8376614|NCT01125163|20648433|P1|COMPLETED|Overall Study||76
8376615|NCT01125163|20648432|P2|STARTED|Overall Study||74
8376616|NCT01125163|20648433|P1|STARTED|Overall Study||76
8376617|NCT01125098|20648443|P2|NOT COMPLETED|Overall Study||0
8376618|NCT01125098|20648444|P1|NOT COMPLETED|Overall Study||3
8376619|NCT01125098|20648443|P2|COMPLETED|Overall Study||90
8376620|NCT01125098|20648444|P1|COMPLETED|Overall Study||88
8376621|NCT01125098|20648443|P2|STARTED|Overall Study||90
8376622|NCT01125098|20648444|P1|STARTED|Overall Study||91
8376623|NCT01125046|20648450|P1|NOT COMPLETED|Follow-up/Data Cut Off Point||33
8376624|NCT01125046|20648450|P1|COMPLETED|Follow-up/Data Cut Off Point||16
8376625|NCT01125046|20648450|P1|STARTED|Follow-up/Data Cut Off Point||49
8376626|NCT01125046|20648450|P1|NOT COMPLETED|Continued Treatment After 6 Months||3
8376627|NCT01125046|20648450|P1|COMPLETED|Continued Treatment After 6 Months||33
8376628|NCT01125046|20648450|P1|STARTED|Continued Treatment After 6 Months||36
8376629|NCT01125046|20648450|P1|NOT COMPLETED|First 6 Months of Treatment||14
8376630|NCT01125046|20648450|P1|COMPLETED|First 6 Months of Treatment||36
8376631|NCT01125046|20648450|P1|STARTED|First 6 Months of Treatment||50
8376632|NCT01124955|20648460|P2|NOT COMPLETED|Overall Study||0
8376633|NCT01124955|20648461|P1|NOT COMPLETED|Overall Study||0
8376634|NCT01124955|20648460|P2|COMPLETED|Overall Study||40
8376635|NCT01124955|20648461|P1|COMPLETED|Overall Study||40
8376636|NCT01124955|20648460|P2|STARTED|Overall Study||40
8376637|NCT01124955|20648461|P1|STARTED|Overall Study||40
8376638|NCT01124916|20648477|P2|NOT COMPLETED|Overall Study||2
8376639|NCT01124916|20648478|P1|NOT COMPLETED|Overall Study||3
8376640|NCT01124916|20648477|P2|COMPLETED|Overall Study||38
8376641|NCT01124916|20648478|P1|COMPLETED|Overall Study||35
8376642|NCT01124916|20648477|P2|STARTED|Overall Study||40
8376643|NCT01124916|20648478|P1|STARTED|Overall Study||38
8376644|NCT01124864|20648492|P6|NOT COMPLETED|Overall Study||3
8376645|NCT01124864|20648493|P5|NOT COMPLETED|Overall Study||30
8376646|NCT01124864|20648494|P4|NOT COMPLETED|Overall Study||21
8376647|NCT01124864|20648495|P3|NOT COMPLETED|Overall Study||34
8376648|NCT01124864|20648496|P2|NOT COMPLETED|Overall Study||35
8376649|NCT01124864|20648497|P1|NOT COMPLETED|Overall Study||28
8376650|NCT01124864|20648492|P6|COMPLETED|Overall Study||0
8376651|NCT01124864|20648493|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
8376652|NCT01124864|20648494|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
8376653|NCT01124864|20648495|P3|COMPLETED|Overall Study||0
8376654|NCT01124864|20648496|P2|COMPLETED|Overall Study||0
8376655|NCT01124864|20648497|P1|COMPLETED|Overall Study||0
8376656|NCT01124864|20648492|P6|STARTED|Overall Study||3
8376657|NCT01124864|20648493|P5|STARTED|Overall Study||31
8376658|NCT01124864|20648494|P4|STARTED|Overall Study||22
8376659|NCT01124864|20648495|P3|STARTED|Overall Study||34
8376660|NCT01124864|20648496|P2|STARTED|Overall Study||35
8376661|NCT01124864|20648497|P1|STARTED|Overall Study||28
8376662|NCT01124838|20648531|P2|NOT COMPLETED|Overall Study||15
8376663|NCT01124838|20648532|P1|NOT COMPLETED|Overall Study||18
8376664|NCT01124838|20648531|P2|COMPLETED|Overall Study||116
8376665|NCT01124838|20648532|P1|COMPLETED|Overall Study||112
8376666|NCT01124838|20648531|P2|Enrolled in Japan Sub-study|Overall Study||16
8376667|NCT01124838|20648532|P1|Enrolled in Japan Sub-study|Overall Study||16
8376668|NCT01124838|20648531|P2|Enrolled in Main Study|Overall Study||115
8376669|NCT01124838|20648532|P1|Enrolled in Main Study|Overall Study||114
8376670|NCT01124838|20648531|P2|STARTED|Overall Study||131
8376671|NCT01124838|20648532|P1|STARTED|Overall Study||130
8376672|NCT01124786|20648578|P2|NOT COMPLETED|Overall Study||5
8376673|NCT01124786|20648579|P1|NOT COMPLETED|Overall Study||4
8376674|NCT01124786|20648578|P2|COMPLETED|Overall Study||180
8376675|NCT01124786|20648579|P1|COMPLETED|Overall Study||178
8376676|NCT01124786|20648578|P2|Tumor Evaluable Population|Overall Study||180
8376677|NCT01124786|20648579|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
8376678|NCT01124786|20648578|P2|Safety Population|Overall Study||181
8376679|NCT01124786|20648579|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
8376680|NCT01124786|20648578|P2|Intent-to-Treat (ITT) Population|Overall Study||185
8376681|NCT01124786|20648579|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
8376682|NCT01124786|20648578|P2|STARTED|Overall Study||185
8376683|NCT01124786|20648579|P1|STARTED|Overall Study||182
8376684|NCT01124734|20648599|P1|NOT COMPLETED|Overall Study||17
8376685|NCT01124734|20648599|P1|COMPLETED|Overall Study|Closed to accrual|0
8376686|NCT01124734|20648599|P1|Initiation of Course 1 Cycle 2|Overall Study||17
8376687|NCT01124734|20648599|P1|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
8376688|NCT01124734|20648599|P1|STARTED|Overall Study||17
8376689|NCT01124643|20648610|P1|NOT COMPLETED|Overall Study||1
8376690|NCT01124643|20648610|P1|COMPLETED|Overall Study||34
8376691|NCT01124643|20648610|P1|STARTED|Overall Study||35
8376692|NCT01124617|20648624|P2|NOT COMPLETED|Overall Study||6
8376693|NCT01124617|20648625|P1|NOT COMPLETED|Overall Study||19
8376694|NCT01124617|20648624|P2|COMPLETED|Overall Study||25
8376695|NCT01124617|20648625|P1|COMPLETED|Overall Study||41
8376696|NCT01124617|20648624|P2|STARTED|Overall Study||31
8376697|NCT01124617|20648625|P1|STARTED|Overall Study||60
8376698|NCT01124604|20648657|P2|NOT COMPLETED|Overall Study||2
8376699|NCT01124604|20648658|P1|NOT COMPLETED|Overall Study||15
8376700|NCT01124604|20648657|P2|COMPLETED|Overall Study||29
8376701|NCT01124604|20648658|P1|COMPLETED|Overall Study||45
8376702|NCT01124604|20648657|P2|STARTED|Overall Study||31
8376703|NCT01124604|20648658|P1|STARTED|Overall Study||60
8376704|NCT01124448|20648697|P2|NOT COMPLETED|Overall Study||3
8376705|NCT01124448|20648698|P1|NOT COMPLETED|Overall Study||2
8376706|NCT01124448|20648697|P2|COMPLETED|Overall Study||12
8376707|NCT01124448|20648698|P1|COMPLETED|Overall Study||23
8376708|NCT01124448|20648697|P2|STARTED|Overall Study||15
8376709|NCT01124448|20648698|P1|STARTED|Overall Study||25
8376710|NCT01124422|20648706|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
8376711|NCT01124422|20648707|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
8376712|NCT01124422|20648708|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
8376713|NCT01124422|20648706|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
8376714|NCT01124422|20648707|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
8376715|NCT01124422|20648708|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
8376716|NCT01124422|20648706|P3|STARTED|4-Week Double-blind Treatment Phase||124
8376717|NCT01124422|20648707|P2|STARTED|4-Week Double-blind Treatment Phase||131
8376718|NCT01124422|20648708|P1|STARTED|4-Week Double-blind Treatment Phase||0
8376719|NCT01124422|20648706|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
8376720|NCT01124422|20648707|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
8376721|NCT01124422|20648708|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
8376722|NCT01124422|20648706|P3|COMPLETED|4-Week Open-label Run-in Phase||0
8376723|NCT01124422|20648707|P2|COMPLETED|4-Week Open-label Run-in Phase||0
8376724|NCT01124422|20648708|P1|COMPLETED|4-Week Open-label Run-in Phase||255
8376725|NCT01124422|20648706|P3|STARTED|4-Week Open-label Run-in Phase||0
8376726|NCT01124422|20648707|P2|STARTED|4-Week Open-label Run-in Phase||0
8376727|NCT01124422|20648708|P1|STARTED|4-Week Open-label Run-in Phase||338
8376728|NCT01124370|20648750|P1|NOT COMPLETED|Overall Study||20
8376729|NCT01124370|20648750|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
8376730|NCT01124370|20648750|P1|3 Month Visit|Overall Study|Defines evaluable population|47
8376731|NCT01124370|20648750|P1|Therapy Initiated|Overall Study||48
8376732|NCT01124370|20648750|P1|Successfully Implanted|Overall Study||50
8376733|NCT01124370|20648750|P1|STARTED|Overall Study|Underwent implant attempt|57
8376734|NCT01124305|20648762|P2|NOT COMPLETED|Overall Study||10
8376735|NCT01124305|20648763|P1|NOT COMPLETED|Overall Study||8
8376736|NCT01124305|20648762|P2|COMPLETED|Overall Study||26
8376737|NCT01124305|20648763|P1|COMPLETED|Overall Study||26
8376738|NCT01124305|20648762|P2|STARTED|Overall Study||36
8376739|NCT01124305|20648763|P1|STARTED|Overall Study||34
8376740|NCT01124292|20648778|P3|NOT COMPLETED|Overall Study||10
8376741|NCT01124292|20648779|P2|NOT COMPLETED|Overall Study||15
8376742|NCT01124292|20648780|P1|NOT COMPLETED|Overall Study||2
8376743|NCT01124292|20648778|P3|COMPLETED|Overall Study||11
8376744|NCT01124292|20648779|P2|COMPLETED|Overall Study||9
8376745|NCT01124292|20648780|P1|COMPLETED|Overall Study||14
8376746|NCT01124292|20648778|P3|STARTED|Overall Study||21
8376747|NCT01124292|20648779|P2|STARTED|Overall Study||24
8376748|NCT01124292|20648780|P1|STARTED|Overall Study||16
8376749|NCT01124188|20648838|P2|NOT COMPLETED|Overall Study||6
8376750|NCT01124188|20648839|P1|NOT COMPLETED|Overall Study||8
8376751|NCT01124188|20648838|P2|COMPLETED|Overall Study||65
8376752|NCT01124188|20648839|P1|COMPLETED|Overall Study||60
8376753|NCT01124188|20648838|P2|STARTED|Overall Study||71
8376754|NCT01124188|20648839|P1|STARTED|Overall Study||68
8376755|NCT01124175|20648851|P2|NOT COMPLETED|Second Intervention||0
8376756|NCT01124175|20648852|P1|NOT COMPLETED|Second Intervention||0
8376757|NCT01124175|20648851|P2|COMPLETED|Second Intervention||38
8376758|NCT01124175|20648852|P1|COMPLETED|Second Intervention||40
8376759|NCT01124175|20648851|P2|STARTED|Second Intervention||38
8376760|NCT01124175|20648852|P1|STARTED|Second Intervention||40
8376761|NCT01124175|20648851|P2|NOT COMPLETED|Washout of 7 Days||2
8376762|NCT01124175|20648852|P1|NOT COMPLETED|Washout of 7 Days||0
8376763|NCT01124175|20648851|P2|COMPLETED|Washout of 7 Days||38
8376764|NCT01124175|20648852|P1|COMPLETED|Washout of 7 Days||40
8376765|NCT01124175|20648851|P2|STARTED|Washout of 7 Days||40
8376766|NCT01124175|20648852|P1|STARTED|Washout of 7 Days||40
8376767|NCT01124175|20648851|P2|NOT COMPLETED|First Intervention||0
8376768|NCT01124175|20648852|P1|NOT COMPLETED|First Intervention||0
8376769|NCT01124175|20648851|P2|COMPLETED|First Intervention||40
8376770|NCT01124175|20648852|P1|COMPLETED|First Intervention||40
8376771|NCT01124175|20648851|P2|STARTED|First Intervention||40
8376772|NCT01124175|20648852|P1|STARTED|First Intervention||40
8376773|NCT01124162|20648870|P2|NOT COMPLETED|Second Intervention||0
8376774|NCT01124162|20648871|P1|NOT COMPLETED|Second Intervention||0
8376775|NCT01124162|20648870|P2|COMPLETED|Second Intervention||40
8376776|NCT01124162|20648871|P1|COMPLETED|Second Intervention||37
8376777|NCT01124162|20648870|P2|STARTED|Second Intervention||40
8376778|NCT01124162|20648871|P1|STARTED|Second Intervention||37
8376779|NCT01124162|20648870|P2|NOT COMPLETED|Washout of 7 Days||0
8376780|NCT01124162|20648871|P1|NOT COMPLETED|Washout of 7 Days||1
8376781|NCT01124162|20648870|P2|COMPLETED|Washout of 7 Days||40
8376782|NCT01124162|20648871|P1|COMPLETED|Washout of 7 Days||37
8376783|NCT01124162|20648870|P2|STARTED|Washout of 7 Days||40
8376784|NCT01124162|20648871|P1|STARTED|Washout of 7 Days||38
8376785|NCT01124162|20648870|P2|NOT COMPLETED|First Intervention||0
8376786|NCT01124162|20648871|P1|NOT COMPLETED|First Intervention||2
8376787|NCT01124162|20648870|P2|COMPLETED|First Intervention||40
8376788|NCT01124162|20648871|P1|COMPLETED|First Intervention||38
8376789|NCT01124162|20648870|P2|STARTED|First Intervention||40
8376790|NCT01124162|20648871|P1|STARTED|First Intervention||40
8376791|NCT01124149|20648887|P1|NOT COMPLETED|Maintenance Phase||96
8376792|NCT01124149|20648887|P1|COMPLETED|Maintenance Phase||373
8376793|NCT01124149|20648887|P1|STARTED|Maintenance Phase||469
8376794|NCT01124149|20648887|P1|NOT COMPLETED|Acute Phase||83
8376795|NCT01124149|20648887|P1|COMPLETED|Acute Phase||639
8376796|NCT01124149|20648887|P1|STARTED|Acute Phase||722
8376797|NCT01124097|20648907|P4|NOT COMPLETED|Overall Study||14
8376798|NCT01124097|20648908|P3|NOT COMPLETED|Overall Study||20
8376799|NCT01124097|20648909|P2|NOT COMPLETED|Overall Study||22
8376800|NCT01124097|20648910|P1|NOT COMPLETED|Overall Study||34
8376801|NCT01124097|20648907|P4|COMPLETED|Overall Study||46
8376802|NCT01124097|20648908|P3|COMPLETED|Overall Study||40
8376803|NCT01124097|20648909|P2|COMPLETED|Overall Study||38
8376804|NCT01124097|20648910|P1|COMPLETED|Overall Study||26
8376805|NCT01124097|20648907|P4|Efficacy Population|Overall Study||51
8376806|NCT01124097|20648908|P3|Efficacy Population|Overall Study||53
8376807|NCT01124097|20648909|P2|Efficacy Population|Overall Study||53
8376808|NCT01124097|20648910|P1|Efficacy Population|Overall Study||52
8376809|NCT01124097|20648907|P4|Safety Population|Overall Study||60
8376810|NCT01124097|20648908|P3|Safety Population|Overall Study||60
8376811|NCT01124097|20648909|P2|Safety Population|Overall Study||60
8376812|NCT01124097|20648910|P1|Safety Population|Overall Study||60
8376813|NCT01124097|20648907|P4|STARTED|Overall Study||60
8376814|NCT01124097|20648908|P3|STARTED|Overall Study||60
8376815|NCT01124097|20648909|P2|STARTED|Overall Study||60
8376816|NCT01124097|20648910|P1|STARTED|Overall Study||60
8376817|NCT01124045|20648922|P2|NOT COMPLETED|Overall Study||3
8376818|NCT01124045|20648923|P1|NOT COMPLETED|Overall Study||0
8376819|NCT01124045|20648922|P2|COMPLETED|Overall Study||37
8376820|NCT01124045|20648923|P1|COMPLETED|Overall Study||39
8376821|NCT01124045|20648922|P2|STARTED|Overall Study||40
8376822|NCT01124045|20648923|P1|STARTED|Overall Study||39
8376823|NCT01124006|20648956|P3|NOT COMPLETED|Overall Study||2
8376824|NCT01124006|20648957|P2|NOT COMPLETED|Overall Study||2
8376825|NCT01124006|20648958|P1|NOT COMPLETED|Overall Study||3
8376826|NCT01124006|20648956|P3|COMPLETED|Overall Study||2
8376827|NCT01124006|20648957|P2|COMPLETED|Overall Study||8
8376828|NCT01124006|20648958|P1|COMPLETED|Overall Study||7
8376829|NCT01124006|20648956|P3|STARTED|Overall Study||4
8376830|NCT01124006|20648957|P2|STARTED|Overall Study||10
8376831|NCT01124006|20648958|P1|STARTED|Overall Study||10
8376832|NCT01123980|20648986|P2|NOT COMPLETED|Overall Study||24
8376833|NCT01123980|20648987|P1|NOT COMPLETED|Overall Study||19
8376834|NCT01123980|20648986|P2|COMPLETED|Overall Study||236
8376835|NCT01123980|20648987|P1|COMPLETED|Overall Study||242
8376836|NCT01123980|20648986|P2|STARTED|Overall Study||260
8376837|NCT01123980|20648987|P1|STARTED|Overall Study||261
8376838|NCT01123941|20649007|P2|NOT COMPLETED|Overall Study||1
8376839|NCT01123941|20649008|P1|NOT COMPLETED|Overall Study||2
8376840|NCT01123941|20649007|P2|COMPLETED|Overall Study||24
8376841|NCT01123941|20649008|P1|COMPLETED|Overall Study||23
8376842|NCT01123941|20649007|P2|STARTED|Overall Study||25
8376843|NCT01123941|20649008|P1|STARTED|Overall Study||25
8376844|NCT01123928|20649022|P2|NOT COMPLETED|Overall Study||0
8376845|NCT01123928|20649023|P1|NOT COMPLETED|Overall Study||0
8376846|NCT01123928|20649022|P2|COMPLETED|Overall Study||222
8376847|NCT01123928|20649023|P1|COMPLETED|Overall Study||212
8376848|NCT01123928|20649022|P2|STARTED|Overall Study||222
8376849|NCT01123928|20649023|P1|STARTED|Overall Study||212
8376850|NCT01123889|20649043|P2|NOT COMPLETED|Overall Study||1
8376851|NCT01123889|20649044|P1|NOT COMPLETED|Overall Study||3
8376852|NCT01123889|20649043|P2|COMPLETED|Overall Study||6
8376853|NCT01123889|20649044|P1|COMPLETED|Overall Study||2
8376854|NCT01123889|20649043|P2|STARTED|Overall Study||7
8376855|NCT01123889|20649044|P1|STARTED|Overall Study||5
8376856|NCT01123850|20649054|P1|NOT COMPLETED|Overall Study||45
8376857|NCT01123850|20649054|P1|COMPLETED|Overall Study||0
8376858|NCT01123850|20649054|P1|STARTED|Overall Study||45
8376859|NCT01123655|20649061|P3|NOT COMPLETED|Overall Study||1
8376860|NCT01123655|20649062|P2|NOT COMPLETED|Overall Study||1
8376861|NCT01123655|20649063|P1|NOT COMPLETED|Overall Study||1
8376862|NCT01123655|20649061|P3|COMPLETED|Overall Study||7
8376863|NCT01123655|20649062|P2|COMPLETED|Overall Study||3
8376864|NCT01123655|20649063|P1|COMPLETED|Overall Study||9
8376865|NCT01123655|20649061|P3|STARTED|Overall Study||8
8376866|NCT01123655|20649062|P2|STARTED|Overall Study||4
8376867|NCT01123655|20649063|P1|STARTED|Overall Study||10
8376868|NCT01123642|20649135|P1|NOT COMPLETED|Overall Study||68
8376869|NCT01123642|20649135|P1|COMPLETED|Overall Study||277
8376870|NCT01123642|20649135|P1|STARTED|Overall Study||345
8376871|NCT01123512|20649144|P2|NOT COMPLETED|Overall Study||21
8376872|NCT01123512|20649145|P1|NOT COMPLETED|Overall Study||26
8376873|NCT01123512|20649144|P2|COMPLETED|Overall Study||126
8376874|NCT01123512|20649145|P1|COMPLETED|Overall Study||127
8376875|NCT01123512|20649144|P2|STARTED|Overall Study||147
8376876|NCT01123512|20649145|P1|STARTED|Overall Study||153
8376877|NCT01123395|20649151|P2|NOT COMPLETED|Period 2||0
8376878|NCT01123395|20649152|P1|NOT COMPLETED|Period 2||0
8376879|NCT01123395|20649151|P2|COMPLETED|Period 2||7
8376880|NCT01123395|20649152|P1|COMPLETED|Period 2||8
8376881|NCT01123395|20649151|P2|STARTED|Period 2||7
8376882|NCT01123395|20649152|P1|STARTED|Period 2||8
8376883|NCT01123395|20649151|P2|NOT COMPLETED|Washout Period of 14 Days||1
8376884|NCT01123395|20649152|P1|NOT COMPLETED|Washout Period of 14 Days||0
8376885|NCT01123395|20649151|P2|COMPLETED|Washout Period of 14 Days||7
8376886|NCT01123395|20649152|P1|COMPLETED|Washout Period of 14 Days||8
8376887|NCT01123395|20649151|P2|STARTED|Washout Period of 14 Days||8
8376888|NCT01123395|20649152|P1|STARTED|Washout Period of 14 Days||8
8376889|NCT01123395|20649151|P2|NOT COMPLETED|Period 1||0
8376890|NCT01123395|20649152|P1|NOT COMPLETED|Period 1||0
8376891|NCT01123395|20649151|P2|COMPLETED|Period 1||8
8376892|NCT01123395|20649152|P1|COMPLETED|Period 1||8
8376893|NCT01123395|20649151|P2|STARTED|Period 1||8
8376894|NCT01123395|20649152|P1|STARTED|Period 1||8
8376895|NCT01123382|20649164|P2|NOT COMPLETED|Overall Study||6
8376896|NCT01123382|20649165|P1|NOT COMPLETED|Overall Study||2
8376897|NCT01123382|20649164|P2|COMPLETED|Overall Study||6
8376898|NCT01123382|20649165|P1|COMPLETED|Overall Study||11
8376899|NCT01123382|20649164|P2|Received Intervention|Overall Study||10
8376900|NCT01123382|20649165|P1|Received Intervention|Overall Study||12
8376901|NCT01123382|20649164|P2|STARTED|Overall Study||12
8376902|NCT01123382|20649165|P1|STARTED|Overall Study||13
8376903|NCT01123356|20649187|P1|NOT COMPLETED|Overall Study||7
8376904|NCT01123356|20649187|P1|COMPLETED|Overall Study||14
8376905|NCT01123356|20649187|P1|STARTED|Overall Study||21
8376906|NCT01123200|20649195|P1|NOT COMPLETED|Overall Study||1
8376907|NCT01123200|20649195|P1|COMPLETED|Overall Study||0
8376908|NCT01123200|20649195|P1|STARTED|Overall Study||1
8376909|NCT01123161|20649202|P2|NOT COMPLETED|Overall Study||0
8376910|NCT01123161|20649203|P1|NOT COMPLETED|Overall Study||2
8376911|NCT01123161|20649202|P2|COMPLETED|Overall Study||63
8376912|NCT01123161|20649203|P1|COMPLETED|Overall Study||55
8376913|NCT01123161|20649202|P2|STARTED|Overall Study||63
8376914|NCT01123161|20649203|P1|STARTED|Overall Study||57
8376915|NCT01123148|20649221|P1|NOT COMPLETED|Overall Study||2
8376916|NCT01123148|20649221|P1|COMPLETED|Overall Study||12
8376917|NCT01123148|20649221|P1|BCI Calibration >50% Accuracy|Overall Study||13
8376918|NCT01123148|20649221|P1|STARTED|Overall Study||14
8376919|NCT01123083|20649227|P2|NOT COMPLETED|Overall Study||15
8376920|NCT01123083|20649228|P1|NOT COMPLETED|Overall Study||11
8376921|NCT01123083|20649227|P2|COMPLETED|Overall Study||103
8376922|NCT01123083|20649228|P1|COMPLETED|Overall Study||50
8376923|NCT01123083|20649227|P2|STARTED|Overall Study||118
8376924|NCT01123083|20649228|P1|STARTED|Overall Study||61
8376925|NCT01122927|20649252|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
8376926|NCT01122927|20649253|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
8376927|NCT01122927|20649252|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
8376928|NCT01122927|20649253|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
8376929|NCT01122927|20649252|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
8376930|NCT01122927|20649253|P1|STARTED|Period 2- Open-label Treatment Phase||0
8376931|NCT01122927|20649252|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
8376932|NCT01122927|20649253|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
8376933|NCT01122927|20649252|P2|COMPLETED|Period 1 - Conversion Phase||0
8376934|NCT01122927|20649253|P1|COMPLETED|Period 1 - Conversion Phase||283
8376935|NCT01122927|20649252|P2|STARTED|Period 1 - Conversion Phase||0
8376936|NCT01122927|20649253|P1|STARTED|Period 1 - Conversion Phase||297
8376937|NCT01122901|20649286|P2|NOT COMPLETED|Overall Study||0
8376938|NCT01122901|20649287|P1|NOT COMPLETED|Overall Study||0
8376939|NCT01122901|20649286|P2|COMPLETED|Overall Study||7
8376940|NCT01122901|20649287|P1|COMPLETED|Overall Study||40
8376941|NCT01122901|20649286|P2|STARTED|Overall Study||7
8376942|NCT01122901|20649287|P1|STARTED|Overall Study||40
8376943|NCT01122862|20649305|P3|NOT COMPLETED|Period 3||0
8376944|NCT01122862|20649306|P2|NOT COMPLETED|Period 3||0
8376945|NCT01122862|20649307|P1|NOT COMPLETED|Period 3||0
8376946|NCT01122862|20649305|P3|COMPLETED|Period 3||8
8376947|NCT01122862|20649306|P2|COMPLETED|Period 3||7
8376948|NCT01122862|20649307|P1|COMPLETED|Period 3||6
8376949|NCT01122862|20649305|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
8376950|NCT01122862|20649306|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
8376951|NCT01122862|20649307|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
8376952|NCT01122862|20649305|P3|NOT COMPLETED|Period 2||1
8376953|NCT01122862|20649306|P2|NOT COMPLETED|Period 2||0
8376954|NCT01122862|20649307|P1|NOT COMPLETED|Period 2||0
8376955|NCT01122862|20649305|P3|COMPLETED|Period 2||6
8376956|NCT01122862|20649306|P2|COMPLETED|Period 2||7
8376957|NCT01122862|20649307|P1|COMPLETED|Period 2||8
8376958|NCT01122862|20649305|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
8376959|NCT01122862|20649306|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
8376960|NCT01122862|20649307|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
8376961|NCT01122862|20649305|P3|NOT COMPLETED|Period 1||0
8376962|NCT01122862|20649306|P2|NOT COMPLETED|Period 1||1
8376963|NCT01122862|20649307|P1|NOT COMPLETED|Period 1||0
8376964|NCT01122862|20649305|P3|COMPLETED|Period 1||7
8376965|NCT01122862|20649306|P2|COMPLETED|Period 1||7
8376966|NCT01122862|20649307|P1|COMPLETED|Period 1||8
8376967|NCT01122862|20649305|P3|STARTED|Period 1||7
8376968|NCT01122862|20649306|P2|STARTED|Period 1||8
8376969|NCT01122862|20649307|P1|STARTED|Period 1||8
8376970|NCT01122849|20649328|P3|NOT COMPLETED|Overall Study||0
8376971|NCT01122849|20649329|P2|NOT COMPLETED|Overall Study||0
8376972|NCT01122849|20649330|P1|NOT COMPLETED|Overall Study||0
8376973|NCT01122849|20649328|P3|COMPLETED|Overall Study||20
8376974|NCT01122849|20649329|P2|COMPLETED|Overall Study||21
8376975|NCT01122849|20649330|P1|COMPLETED|Overall Study||20
8376976|NCT01122849|20649328|P3|STARTED|Overall Study||20
8376977|NCT01122849|20649329|P2|STARTED|Overall Study||21
8376978|NCT01122849|20649330|P1|STARTED|Overall Study||20
8376979|NCT01122680|20649413|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
8376980|NCT01122680|20649414|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
8376981|NCT01122680|20649415|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
8376982|NCT01122680|20649416|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
8376983|NCT01122680|20649413|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
8376984|NCT01122680|20649414|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
8376985|NCT01122680|20649415|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
8376986|NCT01122680|20649416|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
8376987|NCT01122680|20649413|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
8376988|NCT01122680|20649414|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
8376989|NCT01122680|20649415|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
8376990|NCT01122680|20649416|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
8376991|NCT01122680|20649413|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
8376992|NCT01122680|20649414|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
8376993|NCT01122680|20649415|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8376994|NCT01122680|20649416|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
8376995|NCT01122680|20649413|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
8376996|NCT01122680|20649414|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
8376997|NCT01122680|20649415|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
8376998|NCT01122680|20649416|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
8376999|NCT01122680|20649413|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
8377000|NCT01122680|20649414|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
8377001|NCT01122680|20649415|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
8377002|NCT01122680|20649416|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
8377003|NCT01122680|20649413|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8377004|NCT01122680|20649414|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
8377005|NCT01122680|20649415|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
8377006|NCT01122680|20649416|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
8377007|NCT01122680|20649413|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
8377008|NCT01122680|20649414|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
8377009|NCT01122680|20649415|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
8377010|NCT01122680|20649416|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
8377011|NCT01122680|20649413|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
8377012|NCT01122680|20649414|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
8377013|NCT01122680|20649415|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
8377014|NCT01122680|20649416|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
8377015|NCT01122576|20649481|P3|NOT COMPLETED|Post-Cataract Surgery||2
8377016|NCT01122576|20649482|P2|NOT COMPLETED|Post-Cataract Surgery||0
8377017|NCT01122576|20649483|P1|NOT COMPLETED|Post-Cataract Surgery||0
8377018|NCT01122576|20649481|P3|COMPLETED|Post-Cataract Surgery||22
8377019|NCT01122576|20649482|P2|COMPLETED|Post-Cataract Surgery||25
8377020|NCT01122576|20649483|P1|COMPLETED|Post-Cataract Surgery||26
8377021|NCT01122576|20649481|P3|STARTED|Post-Cataract Surgery||24
8377022|NCT01122576|20649482|P2|STARTED|Post-Cataract Surgery||25
8377023|NCT01122576|20649483|P1|STARTED|Post-Cataract Surgery||26
8377024|NCT01122576|20649481|P3|NOT COMPLETED|Pre-Cataract Surgery||2
8377025|NCT01122576|20649482|P2|NOT COMPLETED|Pre-Cataract Surgery||1
8377026|NCT01122576|20649483|P1|NOT COMPLETED|Pre-Cataract Surgery||0
8377027|NCT01122576|20649481|P3|COMPLETED|Pre-Cataract Surgery||24
8377028|NCT01122576|20649482|P2|COMPLETED|Pre-Cataract Surgery||25
8377029|NCT01122576|20649483|P1|COMPLETED|Pre-Cataract Surgery||26
8377030|NCT01122576|20649481|P3|STARTED|Pre-Cataract Surgery||26
8377031|NCT01122576|20649482|P2|STARTED|Pre-Cataract Surgery||26
8377032|NCT01122576|20649483|P1|STARTED|Pre-Cataract Surgery||26
8377033|NCT01122511|20649622|P2|NOT COMPLETED|Overall Study||2
8377034|NCT01122511|20649623|P1|NOT COMPLETED|Overall Study||2
8377035|NCT01122511|20649622|P2|COMPLETED|Overall Study||0
8377036|NCT01122511|20649623|P1|COMPLETED|Overall Study||0
8377037|NCT01122511|20649622|P2|STARTED|Overall Study||2
8377038|NCT01122511|20649623|P1|STARTED|Overall Study||2
8377039|NCT01122446|20649637|P2|NOT COMPLETED|Overall Study||0
8377040|NCT01122446|20649638|P1|NOT COMPLETED|Overall Study||0
8377041|NCT01122446|20649637|P2|COMPLETED|Overall Study||25
8377042|NCT01122446|20649638|P1|COMPLETED|Overall Study||25
8377043|NCT01122446|20649637|P2|STARTED|Overall Study||25
8377044|NCT01122446|20649638|P1|STARTED|Overall Study||25
8377045|NCT01122394|20649664|P2|NOT COMPLETED|Overall Study||4
8377046|NCT01122394|20649665|P1|NOT COMPLETED|Overall Study||3
8377047|NCT01122394|20649664|P2|COMPLETED|Overall Study||70
8377048|NCT01122394|20649665|P1|COMPLETED|Overall Study||63
8377049|NCT01122394|20649664|P2|STARTED|Overall Study||74
8377050|NCT01122394|20649665|P1|STARTED|Overall Study||66
8377051|NCT01122381|20649681|P2|NOT COMPLETED|Overall Study||1
8377052|NCT01122381|20649682|P1|NOT COMPLETED|Overall Study||0
8377053|NCT01122381|20649681|P2|COMPLETED|Overall Study||0
8377054|NCT01122381|20649682|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
8377055|NCT01122381|20649681|P2|STARTED|Overall Study||1
8377056|NCT01122381|20649682|P1|STARTED|Overall Study||1
8377057|NCT01122316|20649688|P1|NOT COMPLETED|Overall Study||2
8377058|NCT01122316|20649688|P1|COMPLETED|Overall Study||8
8377059|NCT01122316|20649688|P1|STARTED|Overall Study||10
8377060|NCT01122264|20649698|P3|NOT COMPLETED|Overall Study||47
8377061|NCT01122264|20649699|P2|NOT COMPLETED|Overall Study||29
8377062|NCT01122264|20649700|P1|NOT COMPLETED|Overall Study||32
8377063|NCT01122264|20649698|P3|COMPLETED|Overall Study||214
8377064|NCT01122264|20649699|P2|COMPLETED|Overall Study||228
8377065|NCT01122264|20649700|P1|COMPLETED|Overall Study||220
8377066|NCT01122264|20649698|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
8377067|NCT01122264|20649699|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
8377068|NCT01122264|20649700|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
8377069|NCT01122264|20649698|P3|STARTED|Overall Study||261
8377070|NCT01122264|20649699|P2|STARTED|Overall Study||257
8377071|NCT01122264|20649700|P1|STARTED|Overall Study||252
8377072|NCT01122238|20649773|P16|NOT COMPLETED|Overall Study||0
8377073|NCT01122238|20649774|P15|NOT COMPLETED|Overall Study||0
8377074|NCT01122238|20649775|P14|NOT COMPLETED|Overall Study||1
8377075|NCT01122238|20649776|P13|NOT COMPLETED|Overall Study||2
8377076|NCT01122238|20649777|P12|NOT COMPLETED|Overall Study||2
8377077|NCT01122238|20649778|P11|NOT COMPLETED|Overall Study||0
8377078|NCT01122238|20649779|P10|NOT COMPLETED|Overall Study||1
8377079|NCT01122238|20649780|P9|NOT COMPLETED|Overall Study||1
8377080|NCT01122238|20649781|P8|NOT COMPLETED|Overall Study||0
8377081|NCT01122238|20649782|P7|NOT COMPLETED|Overall Study||1
8377082|NCT01122238|20649783|P6|NOT COMPLETED|Overall Study||1
8377083|NCT01122238|20649784|P5|NOT COMPLETED|Overall Study||0
8377084|NCT01122238|20649785|P4|NOT COMPLETED|Overall Study||0
8377085|NCT01122238|20649786|P3|NOT COMPLETED|Overall Study||5
8377086|NCT01122238|20649787|P2|NOT COMPLETED|Overall Study||1
8377087|NCT01122238|20649788|P1|NOT COMPLETED|Overall Study||2
8377088|NCT01122238|20649773|P16|COMPLETED|Overall Study||31
8377089|NCT01122238|20649774|P15|COMPLETED|Overall Study||28
8377090|NCT01122238|20649775|P14|COMPLETED|Overall Study||31
8377091|NCT01122238|20649776|P13|COMPLETED|Overall Study||28
8377092|NCT01122238|20649777|P12|COMPLETED|Overall Study||31
8377093|NCT01122238|20649778|P11|COMPLETED|Overall Study||32
8377094|NCT01122238|20649779|P10|COMPLETED|Overall Study||33
8377095|NCT01122238|20649780|P9|COMPLETED|Overall Study||31
8377096|NCT01122238|20649781|P8|COMPLETED|Overall Study||32
8377097|NCT01122238|20649782|P7|COMPLETED|Overall Study||34
8377098|NCT01122238|20649783|P6|COMPLETED|Overall Study||31
8377099|NCT01122238|20649784|P5|COMPLETED|Overall Study||33
8377100|NCT01122238|20649785|P4|COMPLETED|Overall Study||33
8377101|NCT01122238|20649786|P3|COMPLETED|Overall Study||28
8377102|NCT01122238|20649787|P2|COMPLETED|Overall Study||36
8377103|NCT01122238|20649788|P1|COMPLETED|Overall Study||28
8377104|NCT01122238|20649773|P16|STARTED|Overall Study||31
8377105|NCT01122238|20649774|P15|STARTED|Overall Study||28
8377106|NCT01122238|20649775|P14|STARTED|Overall Study||32
8377107|NCT01122238|20649776|P13|STARTED|Overall Study||30
8377108|NCT01122238|20649777|P12|STARTED|Overall Study||33
8377109|NCT01122238|20649778|P11|STARTED|Overall Study||32
8377110|NCT01122238|20649779|P10|STARTED|Overall Study||34
8377111|NCT01122238|20649780|P9|STARTED|Overall Study||32
8377112|NCT01122238|20649781|P8|STARTED|Overall Study||32
8377113|NCT01122238|20649782|P7|STARTED|Overall Study||35
8377114|NCT01122238|20649783|P6|STARTED|Overall Study||32
8377115|NCT01122238|20649784|P5|STARTED|Overall Study||33
8377116|NCT01122238|20649785|P4|STARTED|Overall Study||33
8377117|NCT01122238|20649786|P3|STARTED|Overall Study||33
8377118|NCT01122238|20649787|P2|STARTED|Overall Study||37
8377119|NCT01122238|20649788|P1|STARTED|Overall Study||30
8377120|NCT01122173|20649810|P1|NOT COMPLETED|Overall Study||9
8377121|NCT01122173|20649810|P1|COMPLETED|Overall Study||141
8377122|NCT01122173|20649810|P1|STARTED|Overall Study||150
8377123|NCT01122160|20649817|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8377124|NCT01122160|20649818|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8377125|NCT01122160|20649817|P2|COMPLETED|Second Intervention (7 Days)||5
8377126|NCT01122160|20649818|P1|COMPLETED|Second Intervention (7 Days)||6
8377127|NCT01122160|20649817|P2|STARTED|Second Intervention (7 Days)||5
8377128|NCT01122160|20649818|P1|STARTED|Second Intervention (7 Days)||6
8377129|NCT01122160|20649817|P2|NOT COMPLETED|Washout (7-14 Days)||0
8377130|NCT01122160|20649818|P1|NOT COMPLETED|Washout (7-14 Days)||0
8377131|NCT01122160|20649817|P2|COMPLETED|Washout (7-14 Days)||5
8377132|NCT01122160|20649818|P1|COMPLETED|Washout (7-14 Days)||6
8377133|NCT01122160|20649817|P2|STARTED|Washout (7-14 Days)||5
8377134|NCT01122160|20649818|P1|STARTED|Washout (7-14 Days)||6
8377135|NCT01122160|20649817|P2|NOT COMPLETED|First Intervention (7 Days)||0
8377136|NCT01122160|20649818|P1|NOT COMPLETED|First Intervention (7 Days)||0
8377137|NCT01122160|20649817|P2|COMPLETED|First Intervention (7 Days)||5
8377138|NCT01122160|20649818|P1|COMPLETED|First Intervention (7 Days)||6
8377139|NCT01122160|20649817|P2|STARTED|First Intervention (7 Days)||5
8377140|NCT01122160|20649818|P1|STARTED|First Intervention (7 Days)||6
8377141|NCT01122108|20649824|P2|NOT COMPLETED|Overall Study||0
8377142|NCT01122108|20649825|P1|NOT COMPLETED|Overall Study||0
8377143|NCT01122108|20649824|P2|COMPLETED|Overall Study||21
8377144|NCT01122108|20649825|P1|COMPLETED|Overall Study||21
8377145|NCT01122108|20649824|P2|STARTED|Overall Study||21
8377146|NCT01122108|20649825|P1|STARTED|Overall Study||21
8377147|NCT01122030|20649841|P7|NOT COMPLETED|Overall Study||0
8377148|NCT01122030|20649842|P6|NOT COMPLETED|Overall Study||0
8377149|NCT01122030|20649843|P5|NOT COMPLETED|Overall Study||0
8377150|NCT01122030|20649844|P4|NOT COMPLETED|Overall Study||0
8377151|NCT01122030|20649845|P3|NOT COMPLETED|Overall Study||0
8377152|NCT01122030|20649846|P2|NOT COMPLETED|Overall Study||0
8377153|NCT01122030|20649847|P1|NOT COMPLETED|Overall Study||0
8377154|NCT01122030|20649841|P7|COMPLETED|Overall Study||9
8377155|NCT01122030|20649842|P6|COMPLETED|Overall Study||9
8377156|NCT01122030|20649843|P5|COMPLETED|Overall Study||9
8377157|NCT01122030|20649844|P4|COMPLETED|Overall Study||9
8377158|NCT01122030|20649845|P3|COMPLETED|Overall Study||9
8377159|NCT01122030|20649846|P2|COMPLETED|Overall Study||9
8377160|NCT01122030|20649847|P1|COMPLETED|Overall Study||18
8377161|NCT01122030|20649841|P7|Received Treatment|Overall Study||9
8377162|NCT01122030|20649842|P6|Received Treatment|Overall Study||9
8377163|NCT01122030|20649843|P5|Received Treatment|Overall Study||9
8377164|NCT01122030|20649844|P4|Received Treatment|Overall Study||9
8377165|NCT01122030|20649845|P3|Received Treatment|Overall Study||9
8377166|NCT01122030|20649846|P2|Received Treatment|Overall Study||9
8377167|NCT01122030|20649847|P1|Received Treatment|Overall Study||18
8377168|NCT01122030|20649841|P7|STARTED|Overall Study||9
8377169|NCT01122030|20649842|P6|STARTED|Overall Study||9
8377170|NCT01122030|20649843|P5|STARTED|Overall Study||9
8377171|NCT01122030|20649844|P4|STARTED|Overall Study||9
8377172|NCT01122030|20649845|P3|STARTED|Overall Study||9
8377173|NCT01122030|20649846|P2|STARTED|Overall Study||9
8377174|NCT01122030|20649847|P1|STARTED|Overall Study||18
8377175|NCT01121991|20650033|P1|NOT COMPLETED|Overall Study||6
8377176|NCT01121991|20650033|P1|COMPLETED|Overall Study||46
8377177|NCT01121991|20650033|P1|STARTED|Overall Study|Number of participants treated|52
8377178|NCT01121939|20650044|P1|NOT COMPLETED|Overall Study||43
8377179|NCT01121939|20650044|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
8377180|NCT01121939|20650044|P1|STARTED|Overall Study||43
8377181|NCT01121926|20650058|P2|NOT COMPLETED|Second Intervention Period||0
8377182|NCT01121926|20650059|P1|NOT COMPLETED|Second Intervention Period||0
8377183|NCT01121926|20650058|P2|COMPLETED|Second Intervention Period||13
8377184|NCT01121926|20650059|P1|COMPLETED|Second Intervention Period||14
8377185|NCT01121926|20650058|P2|STARTED|Second Intervention Period||13
8377186|NCT01121926|20650059|P1|STARTED|Second Intervention Period||14
8377187|NCT01121926|20650058|P2|NOT COMPLETED|Washout Period||2
8377188|NCT01121926|20650059|P1|NOT COMPLETED|Washout Period||0
8377189|NCT01121926|20650058|P2|COMPLETED|Washout Period||13
8377190|NCT01121926|20650059|P1|COMPLETED|Washout Period||14
8377191|NCT01121926|20650058|P2|STARTED|Washout Period||15
8377192|NCT01121926|20650059|P1|STARTED|Washout Period||14
8377193|NCT01121926|20650058|P2|NOT COMPLETED|First Intervention Period||0
8377194|NCT01121926|20650059|P1|NOT COMPLETED|First Intervention Period||1
8377195|NCT01121926|20650058|P2|COMPLETED|First Intervention Period||15
8377196|NCT01121926|20650059|P1|COMPLETED|First Intervention Period||14
8377197|NCT01121926|20650058|P2|STARTED|First Intervention Period||15
8377198|NCT01121926|20650059|P1|STARTED|First Intervention Period||15
8377199|NCT01121913|20650077|P4|NOT COMPLETED|Fourth Intervention Period||0
8377200|NCT01121913|20650078|P3|NOT COMPLETED|Fourth Intervention Period||0
8377201|NCT01121913|20650079|P2|NOT COMPLETED|Fourth Intervention Period||0
8377202|NCT01121913|20650080|P1|NOT COMPLETED|Fourth Intervention Period||0
8377203|NCT01121913|20650077|P4|COMPLETED|Fourth Intervention Period||6
8377204|NCT01121913|20650078|P3|COMPLETED|Fourth Intervention Period||3
8377205|NCT01121913|20650079|P2|COMPLETED|Fourth Intervention Period||6
8377206|NCT01121913|20650080|P1|COMPLETED|Fourth Intervention Period||4
8377207|NCT01121913|20650077|P4|STARTED|Fourth Intervention Period||6
8377208|NCT01121913|20650078|P3|STARTED|Fourth Intervention Period||3
8377209|NCT01121913|20650079|P2|STARTED|Fourth Intervention Period||6
8377210|NCT01121913|20650080|P1|STARTED|Fourth Intervention Period||4
8377211|NCT01121913|20650077|P4|NOT COMPLETED|Third Washout Period||0
8377212|NCT01121913|20650078|P3|NOT COMPLETED|Third Washout Period||0
8377213|NCT01121913|20650079|P2|NOT COMPLETED|Third Washout Period||0
8377214|NCT01121913|20650080|P1|NOT COMPLETED|Third Washout Period||1
8377215|NCT01121913|20650077|P4|COMPLETED|Third Washout Period||6
8377216|NCT01121913|20650078|P3|COMPLETED|Third Washout Period||3
8377217|NCT01121913|20650079|P2|COMPLETED|Third Washout Period||6
8377218|NCT01121913|20650080|P1|COMPLETED|Third Washout Period||4
8377219|NCT01121913|20650077|P4|STARTED|Third Washout Period||6
8377220|NCT01121913|20650078|P3|STARTED|Third Washout Period||3
8377221|NCT01121913|20650079|P2|STARTED|Third Washout Period||6
8377222|NCT01121913|20650080|P1|STARTED|Third Washout Period||5
8377223|NCT01121913|20650077|P4|NOT COMPLETED|Third Intervention Period||0
8377224|NCT01121913|20650078|P3|NOT COMPLETED|Third Intervention Period||0
8377225|NCT01121913|20650079|P2|NOT COMPLETED|Third Intervention Period||0
8377226|NCT01121913|20650080|P1|NOT COMPLETED|Third Intervention Period||0
8377227|NCT01121913|20650077|P4|COMPLETED|Third Intervention Period||6
8377228|NCT01121913|20650078|P3|COMPLETED|Third Intervention Period||3
8377229|NCT01121913|20650079|P2|COMPLETED|Third Intervention Period||6
8377230|NCT01121913|20650080|P1|COMPLETED|Third Intervention Period||5
8377231|NCT01121913|20650077|P4|STARTED|Third Intervention Period||6
8377232|NCT01121913|20650078|P3|STARTED|Third Intervention Period||3
8377233|NCT01121913|20650079|P2|STARTED|Third Intervention Period||6
8377234|NCT01121913|20650080|P1|STARTED|Third Intervention Period||5
8377235|NCT01121913|20650077|P4|NOT COMPLETED|Second Washout Period||0
8377236|NCT01121913|20650078|P3|NOT COMPLETED|Second Washout Period||1
8377237|NCT01121913|20650079|P2|NOT COMPLETED|Second Washout Period||0
8377238|NCT01121913|20650080|P1|NOT COMPLETED|Second Washout Period||0
8377239|NCT01121913|20650077|P4|COMPLETED|Second Washout Period||6
8377240|NCT01121913|20650078|P3|COMPLETED|Second Washout Period||3
8377241|NCT01121913|20650079|P2|COMPLETED|Second Washout Period||6
8377242|NCT01121913|20650080|P1|COMPLETED|Second Washout Period||5
8377243|NCT01121913|20650077|P4|STARTED|Second Washout Period||6
8377244|NCT01121913|20650078|P3|STARTED|Second Washout Period||4
8377245|NCT01121913|20650079|P2|STARTED|Second Washout Period||6
8377246|NCT01121913|20650080|P1|STARTED|Second Washout Period||5
8377247|NCT01121913|20650077|P4|NOT COMPLETED|Second Intervention Period||0
8377248|NCT01121913|20650078|P3|NOT COMPLETED|Second Intervention Period||1
8377249|NCT01121913|20650079|P2|NOT COMPLETED|Second Intervention Period||0
8377250|NCT01121913|20650080|P1|NOT COMPLETED|Second Intervention Period||0
8377251|NCT01121913|20650077|P4|COMPLETED|Second Intervention Period||6
8377252|NCT01121913|20650078|P3|COMPLETED|Second Intervention Period||4
8377253|NCT01121913|20650079|P2|COMPLETED|Second Intervention Period||6
8377254|NCT01121913|20650080|P1|COMPLETED|Second Intervention Period||5
8377255|NCT01121913|20650077|P4|STARTED|Second Intervention Period||6
8377256|NCT01121913|20650078|P3|STARTED|Second Intervention Period||5
8377257|NCT01121913|20650079|P2|STARTED|Second Intervention Period||6
8377258|NCT01121913|20650080|P1|STARTED|Second Intervention Period||5
8377259|NCT01121913|20650077|P4|NOT COMPLETED|First Washout Period||0
8377260|NCT01121913|20650078|P3|NOT COMPLETED|First Washout Period||0
8377261|NCT01121913|20650079|P2|NOT COMPLETED|First Washout Period||0
8377262|NCT01121913|20650080|P1|NOT COMPLETED|First Washout Period||1
8377263|NCT01121913|20650077|P4|COMPLETED|First Washout Period||6
8377264|NCT01121913|20650078|P3|COMPLETED|First Washout Period||5
8377265|NCT01121913|20650079|P2|COMPLETED|First Washout Period||6
8377266|NCT01121913|20650080|P1|COMPLETED|First Washout Period||5
8377267|NCT01121913|20650077|P4|STARTED|First Washout Period||6
8377268|NCT01121913|20650078|P3|STARTED|First Washout Period||5
8377269|NCT01121913|20650079|P2|STARTED|First Washout Period||6
8377270|NCT01121913|20650080|P1|STARTED|First Washout Period||6
8377271|NCT01121913|20650077|P4|NOT COMPLETED|First Intervention Period||0
8377272|NCT01121913|20650078|P3|NOT COMPLETED|First Intervention Period||1
8377273|NCT01121913|20650079|P2|NOT COMPLETED|First Intervention Period||0
8377274|NCT01121913|20650080|P1|NOT COMPLETED|First Intervention Period||0
8377275|NCT01121913|20650077|P4|COMPLETED|First Intervention Period||6
8377276|NCT01121913|20650078|P3|COMPLETED|First Intervention Period||5
8377277|NCT01121913|20650079|P2|COMPLETED|First Intervention Period||6
8377278|NCT01121913|20650080|P1|COMPLETED|First Intervention Period||6
8377279|NCT01121913|20650077|P4|STARTED|First Intervention Period||6
8377280|NCT01121913|20650078|P3|STARTED|First Intervention Period||6
8377281|NCT01121913|20650079|P2|STARTED|First Intervention Period||6
8377282|NCT01121913|20650080|P1|STARTED|First Intervention Period||6
8377283|NCT01121900|20650110|P2|NOT COMPLETED|Second Intervention Period||0
8377284|NCT01121900|20650111|P1|NOT COMPLETED|Second Intervention Period||0
8377285|NCT01121900|20650110|P2|COMPLETED|Second Intervention Period||11
8377286|NCT01121900|20650111|P1|COMPLETED|Second Intervention Period||12
8377287|NCT01121900|20650110|P2|STARTED|Second Intervention Period||11
8377288|NCT01121900|20650111|P1|STARTED|Second Intervention Period||12
8377289|NCT01121900|20650110|P2|NOT COMPLETED|Washout Period of 7 Days||1
8377290|NCT01121900|20650111|P1|NOT COMPLETED|Washout Period of 7 Days||0
8377291|NCT01121900|20650110|P2|COMPLETED|Washout Period of 7 Days||11
8377292|NCT01121900|20650111|P1|COMPLETED|Washout Period of 7 Days||12
8377293|NCT01121900|20650110|P2|STARTED|Washout Period of 7 Days||12
8377294|NCT01121900|20650111|P1|STARTED|Washout Period of 7 Days||12
8377295|NCT01121900|20650110|P2|NOT COMPLETED|First Intervention Period||1
8377296|NCT01121900|20650111|P1|NOT COMPLETED|First Intervention Period||1
8377297|NCT01121900|20650110|P2|COMPLETED|First Intervention Period||12
8377298|NCT01121900|20650111|P1|COMPLETED|First Intervention Period||12
8377299|NCT01121900|20650110|P2|STARTED|First Intervention Period||13
8377300|NCT01121900|20650111|P1|STARTED|First Intervention Period||13
8377301|NCT01121757|20650131|P2|NOT COMPLETED|Combination||1
8377302|NCT01121757|20650132|P1|NOT COMPLETED|Combination||2
8377303|NCT01121757|20650131|P2|COMPLETED|Combination||0
8377304|NCT01121757|20650132|P1|COMPLETED|Combination||0
8377305|NCT01121757|20650131|P2|STARTED|Combination||1
8377306|NCT01121757|20650132|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
8377307|NCT01121757|20650131|P2|NOT COMPLETED|Second Drug||0
8377308|NCT01121757|20650132|P1|NOT COMPLETED|Second Drug||0
8377309|NCT01121757|20650131|P2|COMPLETED|Second Drug||1
8377310|NCT01121757|20650132|P1|COMPLETED|Second Drug||4
8377311|NCT01121757|20650131|P2|STARTED|Second Drug||1
8377312|NCT01121757|20650132|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
8377313|NCT01121757|20650131|P2|NOT COMPLETED|First Drug||2
8377314|NCT01121757|20650132|P1|NOT COMPLETED|First Drug||1
8377315|NCT01121757|20650131|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
8377316|NCT01121757|20650132|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
8377317|NCT01121757|20650131|P2|STARTED|First Drug||3
8377318|NCT01121757|20650132|P1|STARTED|First Drug||6
8377319|NCT01121666|20650148|P2|NOT COMPLETED|Overall Study||10
8377320|NCT01121666|20650149|P1|NOT COMPLETED|Overall Study||29
8377321|NCT01121666|20650148|P2|COMPLETED|Overall Study||113
8377322|NCT01121666|20650149|P1|COMPLETED|Overall Study||220
8377323|NCT01121666|20650148|P2|STARTED|Overall Study||123
8377324|NCT01121666|20650149|P1|STARTED|Overall Study||249
8377325|NCT01121575|20650205|P6|NOT COMPLETED|Overall Study||12
8377326|NCT01121575|20650206|P5|NOT COMPLETED|Overall Study||25
8377327|NCT01121575|20650207|P4|NOT COMPLETED|Overall Study||6
8377328|NCT01121575|20650208|P3|NOT COMPLETED|Overall Study||7
8377329|NCT01121575|20650209|P2|NOT COMPLETED|Overall Study||6
8377330|NCT01121575|20650210|P1|NOT COMPLETED|Overall Study||14
8377331|NCT01121575|20650205|P6|COMPLETED|Overall Study||0
8377332|NCT01121575|20650206|P5|COMPLETED|Overall Study||0
8377333|NCT01121575|20650207|P4|COMPLETED|Overall Study||0
8377334|NCT01121575|20650208|P3|COMPLETED|Overall Study||0
8377335|NCT01121575|20650209|P2|COMPLETED|Overall Study||0
8377336|NCT01121575|20650210|P1|COMPLETED|Overall Study||0
8377337|NCT01121575|20650205|P6|Treated|Overall Study||12
8377338|NCT01121575|20650206|P5|Treated|Overall Study||25
8377339|NCT01121575|20650207|P4|Treated|Overall Study||6
8377340|NCT01121575|20650208|P3|Treated|Overall Study||7
8377341|NCT01121575|20650209|P2|Treated|Overall Study||6
8377342|NCT01121575|20650210|P1|Treated|Overall Study||14
8377343|NCT01121575|20650205|P6|STARTED|Overall Study||12
8377344|NCT01121575|20650206|P5|STARTED|Overall Study||25
8377345|NCT01121575|20650207|P4|STARTED|Overall Study||6
8377346|NCT01121575|20650208|P3|STARTED|Overall Study||7
8377347|NCT01121575|20650209|P2|STARTED|Overall Study||6
8377348|NCT01121575|20650210|P1|STARTED|Overall Study||14
8377349|NCT01121562|20650334|P1|NOT COMPLETED|Overall Study||12
8377350|NCT01121562|20650334|P1|COMPLETED|Overall Study||0
8377351|NCT01121562|20650334|P1|STARTED|Overall Study||12
8377352|NCT01121549|20650343|P1|NOT COMPLETED|Overall Study||347
8377353|NCT01121549|20650343|P1|COMPLETED|Overall Study||31
8377354|NCT01121549|20650343|P1|STARTED|Overall Study||378
8377355|NCT01121536|20650354|P1|NOT COMPLETED|Overall Study||361
8377356|NCT01121536|20650354|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
8377357|NCT01121536|20650354|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
8377358|NCT01121536|20650354|P1|Safety Population|Overall Study|Participants treated|863
8377359|NCT01121536|20650354|P1|STARTED|Overall Study||867
8377360|NCT01121484|20650375|P2|NOT COMPLETED|Overall Study||43
8377361|NCT01121484|20650376|P1|NOT COMPLETED|Overall Study||33
8377362|NCT01121484|20650375|P2|COMPLETED|Overall Study||178
8377363|NCT01121484|20650376|P1|COMPLETED|Overall Study||185
8377364|NCT01121484|20650375|P2|Treated|Overall Study||217
8377365|NCT01121484|20650376|P1|Treated|Overall Study||217
8377366|NCT01121484|20650375|P2|STARTED|Overall Study||221
8377367|NCT01121484|20650376|P1|STARTED|Overall Study||218
8377368|NCT01121406|20650394|P2|NOT COMPLETED|Overall Study||55
8377369|NCT01121406|20650395|P1|NOT COMPLETED|Overall Study||55
8377370|NCT01121406|20650394|P2|COMPLETED|Overall Study||0
8377371|NCT01121406|20650395|P1|COMPLETED|Overall Study||0
8377372|NCT01121406|20650394|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
8377373|NCT01121406|20650395|P1|STARTED|Overall Study||55
8377374|NCT01121393|20650445|P2|NOT COMPLETED|Overall Study||84
8377375|NCT01121393|20650446|P1|NOT COMPLETED|Overall Study||242
8377376|NCT01121393|20650445|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
8377377|NCT01121393|20650446|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
8377378|NCT01121393|20650445|P2|Treated|Overall Study|Treated|113
8377379|NCT01121393|20650446|P1|Treated|Overall Study|Treated|239
8377380|NCT01121393|20650445|P2|STARTED|Overall Study|Randomised|122
8377381|NCT01121393|20650446|P1|STARTED|Overall Study|Randomised|242
8377382|NCT01121263|20650491|P2|NOT COMPLETED|Overall Study||15
8377383|NCT01121263|20650492|P1|NOT COMPLETED|Overall Study||25
8377384|NCT01121263|20650491|P2|COMPLETED|Overall Study||83
8377385|NCT01121263|20650492|P1|COMPLETED|Overall Study||175
8377386|NCT01121263|20650491|P2|STARTED|Overall Study||98
8377387|NCT01121263|20650492|P1|STARTED|Overall Study||200
8377388|NCT01121250|20650503|P3|NOT COMPLETED|Overall Study||1
8377389|NCT01121250|20650504|P2|NOT COMPLETED|Overall Study||0
8377390|NCT01121250|20650505|P1|NOT COMPLETED|Overall Study||0
8377391|NCT01121250|20650503|P3|COMPLETED|Overall Study||75
8377392|NCT01121250|20650504|P2|COMPLETED|Overall Study||76
8377393|NCT01121250|20650505|P1|COMPLETED|Overall Study||76
8377394|NCT01121250|20650503|P3|STARTED|Overall Study||76
8377395|NCT01121250|20650504|P2|STARTED|Overall Study||76
8377396|NCT01121250|20650505|P1|STARTED|Overall Study||76
8377397|NCT01121224|20650521|P2|NOT COMPLETED|Overall Study||17
8377398|NCT01121224|20650522|P1|NOT COMPLETED|Overall Study||25
8377399|NCT01121224|20650521|P2|COMPLETED|Overall Study||275
8377400|NCT01121224|20650522|P1|COMPLETED|Overall Study||280
8377401|NCT01121224|20650521|P2|STARTED|Overall Study||292
8377402|NCT01121224|20650522|P1|STARTED|Overall Study||305
8377403|NCT01121211|20650572|P2|NOT COMPLETED|Overall Study||12
8377404|NCT01121211|20650573|P1|NOT COMPLETED|Overall Study||11
8377405|NCT01121211|20650572|P2|COMPLETED|Overall Study||35
8377406|NCT01121211|20650573|P1|COMPLETED|Overall Study||32
8377407|NCT01121211|20650572|P2|STARTED|Overall Study||47
8377408|NCT01121211|20650573|P1|STARTED|Overall Study||43
8377409|NCT01121185|20650583|P2|NOT COMPLETED|Overall Study||1
8377410|NCT01121185|20650584|P1|NOT COMPLETED|Overall Study||1
8377411|NCT01121185|20650583|P2|COMPLETED|Overall Study||5
8377412|NCT01121185|20650584|P1|COMPLETED|Overall Study||6
8377413|NCT01121185|20650583|P2|Transplanted|Overall Study||5
8377414|NCT01121185|20650584|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
8377415|NCT01121185|20650583|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
8377416|NCT01121185|20650584|P1|Infused|Overall Study||7
8377417|NCT01121185|20650583|P2|STARTED|Overall Study||6
8377418|NCT01121185|20650584|P1|STARTED|Overall Study||7
8377419|NCT01121172|20650608|P2|NOT COMPLETED|Overall Study||0
8377420|NCT01121172|20650609|P1|NOT COMPLETED|Overall Study||0
8377421|NCT01121172|20650608|P2|COMPLETED|Overall Study||90
8377422|NCT01121172|20650609|P1|COMPLETED|Overall Study||90
8377423|NCT01121172|20650608|P2|STARTED|Overall Study||90
8377424|NCT01121172|20650609|P1|STARTED|Overall Study||90
8377425|NCT01121146|20650618|P2|NOT COMPLETED|Overall Study||42
8377426|NCT01121146|20650619|P1|NOT COMPLETED|Overall Study||26
8377427|NCT01121146|20650618|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
8377428|NCT01121146|20650619|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
8377429|NCT01121146|20650618|P2|STARTED|Overall Study||114
8377430|NCT01121146|20650619|P1|STARTED|Overall Study||116
8377431|NCT01120990|20650633|P1|NOT COMPLETED|Overall Study||0
8377432|NCT01120990|20650633|P1|COMPLETED|Overall Study||51
8377433|NCT01120990|20650633|P1|STARTED|Overall Study||51
8377434|NCT01120899|20650640|P1|NOT COMPLETED|Overall Study||3
8377435|NCT01120899|20650640|P1|COMPLETED|Overall Study||3
8377436|NCT01120899|20650640|P1|Month 18|Overall Study||3
8377437|NCT01120899|20650640|P1|Month 12|Overall Study||3
8377438|NCT01120899|20650640|P1|Month 6|Overall Study||5
8377439|NCT01120899|20650640|P1|STARTED|Overall Study||6
8377440|NCT01120834|20650660|P1|NOT COMPLETED|Overall Study||0
8377441|NCT01120834|20650660|P1|COMPLETED|Overall Study||18
8377442|NCT01120834|20650660|P1|STARTED|Overall Study||18
8377443|NCT01120808|20650664|P1|NOT COMPLETED|Overall Study||46
8377444|NCT01120808|20650664|P1|COMPLETED|Overall Study||90
8377445|NCT01120808|20650664|P1|STARTED|Overall Study||136
8377446|NCT01120782|20650668|P1|NOT COMPLETED|Overall Study||11
8377447|NCT01120782|20650668|P1|COMPLETED|Overall Study||34
8377448|NCT01120782|20650668|P1|STARTED|Overall Study||45
8377449|NCT01120756|20650674|P2|NOT COMPLETED|Overall Study||1
8377450|NCT01120756|20650675|P1|NOT COMPLETED|Overall Study||1
8377451|NCT01120756|20650674|P2|COMPLETED|Overall Study||13
8377452|NCT01120756|20650675|P1|COMPLETED|Overall Study||20
8377453|NCT01120756|20650674|P2|STARTED|Overall Study||14
8377454|NCT01120756|20650675|P1|STARTED|Overall Study||21
8377455|NCT01120717|20650685|P2|NOT COMPLETED|Overall Study||24
8377456|NCT01120717|20650686|P1|NOT COMPLETED|Overall Study||32
8377457|NCT01120717|20650685|P2|COMPLETED|Overall Study||89
8377458|NCT01120717|20650686|P1|COMPLETED|Overall Study||194
8377459|NCT01120717|20650685|P2|Safety Population: Received Study Drug|Overall Study||113
8377460|NCT01120717|20650686|P1|Safety Population: Received Study Drug|Overall Study||225
8377461|NCT01120717|20650685|P2|STARTED|Overall Study||113
8377462|NCT01120717|20650686|P1|STARTED|Overall Study||226
8377463|NCT01120704|20650734|P32|NOT COMPLETED|Overall Study||1
8377464|NCT01120704|20650735|P31|NOT COMPLETED|Overall Study||2
8377465|NCT01120704|20650736|P30|NOT COMPLETED|Overall Study||3
8377466|NCT01120704|20650737|P29|NOT COMPLETED|Overall Study||5
8377467|NCT01120704|20650738|P28|NOT COMPLETED|Overall Study||2
8377468|NCT01120704|20650739|P27|NOT COMPLETED|Overall Study||3
8377469|NCT01120704|20650740|P26|NOT COMPLETED|Overall Study||0
8377470|NCT01120704|20650741|P25|NOT COMPLETED|Overall Study||2
8377471|NCT01120704|20650742|P24|NOT COMPLETED|Overall Study||3
8377472|NCT01120704|20650743|P23|NOT COMPLETED|Overall Study||4
8377473|NCT01120704|20650744|P22|NOT COMPLETED|Overall Study||0
8377474|NCT01120704|20650745|P21|NOT COMPLETED|Overall Study||3
8377475|NCT01120704|20650746|P20|NOT COMPLETED|Overall Study||3
8377476|NCT01120704|20650747|P19|NOT COMPLETED|Overall Study||2
8377477|NCT01120704|20650748|P18|NOT COMPLETED|Overall Study||0
8377478|NCT01120704|20650749|P17|NOT COMPLETED|Overall Study||1
8377479|NCT01120704|20650750|P16|NOT COMPLETED|Overall Study||2
8377480|NCT01120704|20650751|P15|NOT COMPLETED|Overall Study||1
8377481|NCT01120704|20650752|P14|NOT COMPLETED|Overall Study||4
8377482|NCT01120704|20650753|P13|NOT COMPLETED|Overall Study||3
8377483|NCT01120704|20650754|P12|NOT COMPLETED|Overall Study||2
8377484|NCT01120704|20650755|P11|NOT COMPLETED|Overall Study||1
8377485|NCT01120704|20650756|P10|NOT COMPLETED|Overall Study||1
8377486|NCT01120704|20650757|P9|NOT COMPLETED|Overall Study||3
8377487|NCT01120704|20650758|P8|NOT COMPLETED|Overall Study||2
8377488|NCT01120704|20650759|P7|NOT COMPLETED|Overall Study||3
8377489|NCT01120704|20650760|P6|NOT COMPLETED|Overall Study||1
8377490|NCT01120704|20650761|P5|NOT COMPLETED|Overall Study||2
8377491|NCT01120704|20650762|P4|NOT COMPLETED|Overall Study||4
8377492|NCT01120704|20650763|P3|NOT COMPLETED|Overall Study||1
8377493|NCT01120704|20650764|P2|NOT COMPLETED|Overall Study||4
8377494|NCT01120704|20650765|P1|NOT COMPLETED|Overall Study||3
8377495|NCT01120704|20650734|P32|COMPLETED|Overall Study||17
8377496|NCT01120704|20650735|P31|COMPLETED|Overall Study||12
8377497|NCT01120704|20650736|P30|COMPLETED|Overall Study||12
8377498|NCT01120704|20650737|P29|COMPLETED|Overall Study||14
8377499|NCT01120704|20650738|P28|COMPLETED|Overall Study||16
8377500|NCT01120704|20650739|P27|COMPLETED|Overall Study||15
8377501|NCT01120704|20650740|P26|COMPLETED|Overall Study||14
8377502|NCT01120704|20650741|P25|COMPLETED|Overall Study||16
8377503|NCT01120704|20650742|P24|COMPLETED|Overall Study||13
8377504|NCT01120704|20650743|P23|COMPLETED|Overall Study||17
8377505|NCT01120704|20650744|P22|COMPLETED|Overall Study||16
8377506|NCT01120704|20650745|P21|COMPLETED|Overall Study||14
8377507|NCT01120704|20650746|P20|COMPLETED|Overall Study||15
8377508|NCT01120704|20650747|P19|COMPLETED|Overall Study||15
8377509|NCT01120704|20650748|P18|COMPLETED|Overall Study||16
8377510|NCT01120704|20650749|P17|COMPLETED|Overall Study||13
8377511|NCT01120704|20650750|P16|COMPLETED|Overall Study||16
8377512|NCT01120704|20650751|P15|COMPLETED|Overall Study||17
8377513|NCT01120704|20650752|P14|COMPLETED|Overall Study||15
8377514|NCT01120704|20650753|P13|COMPLETED|Overall Study||14
8377515|NCT01120704|20650754|P12|COMPLETED|Overall Study||14
8377516|NCT01120704|20650755|P11|COMPLETED|Overall Study||16
8377517|NCT01120704|20650756|P10|COMPLETED|Overall Study||19
8377518|NCT01120704|20650757|P9|COMPLETED|Overall Study||19
8377519|NCT01120704|20650758|P8|COMPLETED|Overall Study||13
8377520|NCT01120704|20650759|P7|COMPLETED|Overall Study||12
8377521|NCT01120704|20650760|P6|COMPLETED|Overall Study||18
8377522|NCT01120704|20650761|P5|COMPLETED|Overall Study||14
8377523|NCT01120704|20650762|P4|COMPLETED|Overall Study||15
8377524|NCT01120704|20650763|P3|COMPLETED|Overall Study||13
8377525|NCT01120704|20650764|P2|COMPLETED|Overall Study||13
8377526|NCT01120704|20650765|P1|COMPLETED|Overall Study||10
8377527|NCT01120704|20650734|P32|STARTED|Overall Study||18
8377528|NCT01120704|20650735|P31|STARTED|Overall Study||14
8377529|NCT01120704|20650736|P30|STARTED|Overall Study||15
8377530|NCT01120704|20650737|P29|STARTED|Overall Study||19
8377531|NCT01120704|20650738|P28|STARTED|Overall Study||18
8377532|NCT01120704|20650739|P27|STARTED|Overall Study||18
8377533|NCT01120704|20650740|P26|STARTED|Overall Study||14
8377534|NCT01120704|20650741|P25|STARTED|Overall Study||18
8377535|NCT01120704|20650742|P24|STARTED|Overall Study||16
8377536|NCT01120704|20650743|P23|STARTED|Overall Study||21
8377537|NCT01120704|20650744|P22|STARTED|Overall Study||16
8377538|NCT01120704|20650745|P21|STARTED|Overall Study||17
8377539|NCT01120704|20650746|P20|STARTED|Overall Study||18
8377540|NCT01120704|20650747|P19|STARTED|Overall Study||17
8377541|NCT01120704|20650748|P18|STARTED|Overall Study||16
8377542|NCT01120704|20650749|P17|STARTED|Overall Study||14
8377543|NCT01120704|20650750|P16|STARTED|Overall Study||18
8377544|NCT01120704|20650751|P15|STARTED|Overall Study||18
8377545|NCT01120704|20650752|P14|STARTED|Overall Study||19
8377546|NCT01120704|20650753|P13|STARTED|Overall Study||17
8377547|NCT01120704|20650754|P12|STARTED|Overall Study||16
8377548|NCT01120704|20650755|P11|STARTED|Overall Study||17
8377549|NCT01120704|20650756|P10|STARTED|Overall Study||20
8377550|NCT01120704|20650757|P9|STARTED|Overall Study||22
8377551|NCT01120704|20650758|P8|STARTED|Overall Study||15
8377552|NCT01120704|20650759|P7|STARTED|Overall Study||15
8377553|NCT01120704|20650760|P6|STARTED|Overall Study||19
8377554|NCT01120704|20650761|P5|STARTED|Overall Study||16
8377555|NCT01120704|20650762|P4|STARTED|Overall Study||19
8377556|NCT01120704|20650763|P3|STARTED|Overall Study||14
8377557|NCT01120704|20650764|P2|STARTED|Overall Study||17
8377558|NCT01120704|20650765|P1|STARTED|Overall Study||13
8377559|NCT01120691|20650792|P3|NOT COMPLETED|Overall Study||183
8377560|NCT01120691|20650793|P2|NOT COMPLETED|Overall Study||203
8377561|NCT01120691|20650794|P1|NOT COMPLETED|Overall Study||171
8377562|NCT01120691|20650792|P3|COMPLETED|Overall Study||559
8377563|NCT01120691|20650793|P2|COMPLETED|Overall Study||538
8377564|NCT01120691|20650794|P1|COMPLETED|Overall Study||570
8377565|NCT01120691|20650792|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
8377566|NCT01120691|20650793|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
8377567|NCT01120691|20650794|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
8377568|NCT01120691|20650792|P3|Modified Safety Set (mSAF)|Overall Study||737
8377569|NCT01120691|20650793|P2|Modified Safety Set (mSAF)|Overall Study||740
8377570|NCT01120691|20650794|P1|Modified Safety Set (mSAF)|Overall Study||729
8377571|NCT01120691|20650792|P3|Safety Set (SAF)|Overall Study||739
8377572|NCT01120691|20650793|P2|Safety Set (SAF)|Overall Study||740
8377573|NCT01120691|20650794|P1|Safety Set (SAF)|Overall Study||736
8377574|NCT01120691|20650792|P3|Full Analysis Set (FAS)|Overall Study||739
8377575|NCT01120691|20650793|P2|Full Analysis Set (FAS)|Overall Study||739
8377576|NCT01120691|20650794|P1|Full Analysis Set (FAS)|Overall Study||736
8377577|NCT01120691|20650792|P3|STARTED|Overall Study||742
8377578|NCT01120691|20650793|P2|STARTED|Overall Study||741
8377579|NCT01120691|20650794|P1|STARTED|Overall Study||741
8377580|NCT01120639|20650840|P4|NOT COMPLETED|Overall Study||0
8377581|NCT01120639|20650841|P3|NOT COMPLETED|Overall Study||0
8377582|NCT01120639|20650842|P2|NOT COMPLETED|Overall Study||0
8377583|NCT01120639|20650843|P1|NOT COMPLETED|Overall Study||0
8377584|NCT01120639|20650840|P4|COMPLETED|Overall Study||12
8377585|NCT01120639|20650841|P3|COMPLETED|Overall Study||6
8377586|NCT01120639|20650842|P2|COMPLETED|Overall Study||6
8377587|NCT01120639|20650843|P1|COMPLETED|Overall Study||6
8377588|NCT01120639|20650840|P4|STARTED|Overall Study||12
8377589|NCT01120639|20650841|P3|STARTED|Overall Study||6
8377590|NCT01120639|20650842|P2|STARTED|Overall Study||6
8377591|NCT01120639|20650843|P1|STARTED|Overall Study||6
8377592|NCT01120626|20650891|P2|NOT COMPLETED|Overall Study||0
8377593|NCT01120626|20650892|P1|NOT COMPLETED|Overall Study||1
8377594|NCT01120626|20650891|P2|COMPLETED|Overall Study||22
8377595|NCT01120626|20650892|P1|COMPLETED|Overall Study||19
8377596|NCT01120626|20650891|P2|STARTED|Overall Study||22
8377597|NCT01120626|20650892|P1|STARTED|Overall Study||20
8377598|NCT01120600|20650902|P2|NOT COMPLETED|Overall Study||32
8377599|NCT01120600|20650903|P1|NOT COMPLETED|Overall Study||19
8377600|NCT01120600|20650902|P2|COMPLETED|Overall Study||115
8377601|NCT01120600|20650903|P1|COMPLETED|Overall Study||128
8377602|NCT01120600|20650902|P2|Treated|Overall Study||146
8377603|NCT01120600|20650903|P1|Treated|Overall Study||146
8377604|NCT01120600|20650902|P2|STARTED|Overall Study||147
8377605|NCT01120600|20650903|P1|STARTED|Overall Study||147
8377606|NCT01120405|20650929|P2|NOT COMPLETED|Overall Study||33
8377607|NCT01120405|20650930|P1|NOT COMPLETED|Overall Study||27
8377608|NCT01120405|20650929|P2|COMPLETED|Overall Study||269
8377609|NCT01120405|20650930|P1|COMPLETED|Overall Study||271
8377610|NCT01120405|20650929|P2|STARTED|Overall Study||302
8377611|NCT01120405|20650930|P1|STARTED|Overall Study||298
8377612|NCT01120379|20650958|P1|NOT COMPLETED|Four Year Timepoint||368
8377613|NCT01120379|20650958|P1|COMPLETED|Four Year Timepoint||3923
8377614|NCT01120379|20650958|P1|STARTED|Four Year Timepoint||4291
8377615|NCT01120379|20650958|P1|NOT COMPLETED|Three Year Timepoint||214
8377616|NCT01120379|20650958|P1|COMPLETED|Three Year Timepoint||4291
8377617|NCT01120379|20650958|P1|STARTED|Three Year Timepoint||4505
8377618|NCT01120379|20650958|P1|NOT COMPLETED|Two Year Timepoint||237
8377619|NCT01120379|20650958|P1|COMPLETED|Two Year Timepoint||4505
8377620|NCT01120379|20650958|P1|STARTED|Two Year Timepoint||4742
8377621|NCT01120379|20650958|P1|NOT COMPLETED|One Year Timepoint||278
8377622|NCT01120379|20650958|P1|COMPLETED|One Year Timepoint||4742
8377623|NCT01120379|20650958|P1|STARTED|One Year Timepoint||5020
8377624|NCT01120275|20650994|P1|NOT COMPLETED|Overall Study||36
8377625|NCT01120275|20650994|P1|COMPLETED|Overall Study||0
8377626|NCT01120275|20650994|P1|Eligible and Treated|Overall Study||32
8377627|NCT01120275|20650994|P1|STARTED|Overall Study||36
8377628|NCT01120236|20651003|P2|NOT COMPLETED|Overall Study||1
8377629|NCT01120236|20651004|P1|NOT COMPLETED|Overall Study||0
8377630|NCT01120236|20651003|P2|COMPLETED|Overall Study||105
8377631|NCT01120236|20651004|P1|COMPLETED|Overall Study||105
8377632|NCT01120236|20651003|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
8377633|NCT01120236|20651004|P1|Ineligble|Overall Study||0
8377634|NCT01120236|20651003|P2|STARTED|Overall Study||106
8377635|NCT01120236|20651004|P1|STARTED|Overall Study||105
8377636|NCT01120223|20651031|P1|NOT COMPLETED|Overall Study||4
8377637|NCT01120223|20651031|P1|COMPLETED|Overall Study||74
8377638|NCT01120223|20651031|P1|STARTED|Overall Study||78
8377639|NCT01120210|20651061|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
8377640|NCT01120210|20651062|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
8377641|NCT01120210|20651061|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
8377642|NCT01120210|20651062|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
8377643|NCT01120210|20651061|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
8377644|NCT01120210|20651062|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
8377645|NCT01120210|20651061|P2|NOT COMPLETED|MAIN INFUSION||1
8377646|NCT01120210|20651062|P1|NOT COMPLETED|MAIN INFUSION||1
8377647|NCT01120210|20651061|P2|COMPLETED|MAIN INFUSION||45
8377648|NCT01120210|20651062|P1|COMPLETED|MAIN INFUSION||15
8377649|NCT01120210|20651061|P2|STARTED|MAIN INFUSION||46
8377650|NCT01120210|20651062|P1|STARTED|MAIN INFUSION||16
8377651|NCT01120197|20651094|P2|NOT COMPLETED|Overall Study||10
8377652|NCT01120197|20651095|P1|NOT COMPLETED|Overall Study||9
8377653|NCT01120197|20651094|P2|COMPLETED|Overall Study||32
8377654|NCT01120197|20651095|P1|COMPLETED|Overall Study||38
8377655|NCT01120197|20651094|P2|STARTED|Overall Study||42
8377656|NCT01120197|20651095|P1|STARTED|Overall Study||47
8377657|NCT01120184|20651112|P3|NOT COMPLETED|Overall Study||363
8377658|NCT01120184|20651113|P2|NOT COMPLETED|Overall Study||367
8377659|NCT01120184|20651114|P1|NOT COMPLETED|Overall Study||365
8377660|NCT01120184|20651112|P3|COMPLETED|Overall Study||0
8377661|NCT01120184|20651113|P2|COMPLETED|Overall Study||0
8377662|NCT01120184|20651114|P1|COMPLETED|Overall Study||0
8377663|NCT01120184|20651112|P3|Treated|Overall Study||360
8377664|NCT01120184|20651113|P2|Treated|Overall Study||365
8377665|NCT01120184|20651114|P1|Treated|Overall Study||355
8377666|NCT01120184|20651112|P3|STARTED|Overall Study||363
8377667|NCT01120184|20651113|P2|STARTED|Overall Study||367
8377668|NCT01120184|20651114|P1|STARTED|Overall Study||365
8377669|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 5||0
8377670|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 5||1
8377671|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 5||0
8377672|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 5||1
8377673|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 5||0
8377674|NCT01120093|20651236|P5|COMPLETED|Treatment Period 5||13
8377675|NCT01120093|20651237|P4|COMPLETED|Treatment Period 5||11
8377676|NCT01120093|20651238|P3|COMPLETED|Treatment Period 5||15
8377677|NCT01120093|20651239|P2|COMPLETED|Treatment Period 5||12
8377678|NCT01120093|20651240|P1|COMPLETED|Treatment Period 5||17
8377679|NCT01120093|20651236|P5|STARTED|Treatment Period 5||13
8377680|NCT01120093|20651237|P4|STARTED|Treatment Period 5||12
8377681|NCT01120093|20651238|P3|STARTED|Treatment Period 5||15
8377682|NCT01120093|20651239|P2|STARTED|Treatment Period 5||13
8377683|NCT01120093|20651240|P1|STARTED|Treatment Period 5||17
8377684|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 4||0
8377685|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 4||0
8377686|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 4||0
8377687|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 4||0
8377688|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 4||1
8377689|NCT01120093|20651236|P5|COMPLETED|Treatment Period 4||13
8377690|NCT01120093|20651237|P4|COMPLETED|Treatment Period 4||12
8377691|NCT01120093|20651238|P3|COMPLETED|Treatment Period 4||15
8377692|NCT01120093|20651239|P2|COMPLETED|Treatment Period 4||13
8377693|NCT01120093|20651240|P1|COMPLETED|Treatment Period 4||17
8377694|NCT01120093|20651236|P5|STARTED|Treatment Period 4||13
8377695|NCT01120093|20651237|P4|STARTED|Treatment Period 4||12
8377696|NCT01120093|20651238|P3|STARTED|Treatment Period 4||15
8377697|NCT01120093|20651239|P2|STARTED|Treatment Period 4||13
8377698|NCT01120093|20651240|P1|STARTED|Treatment Period 4||18
8377699|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 3||1
8377700|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 3||1
8377701|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 3||1
8377702|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 3||0
8377703|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 3||0
8377704|NCT01120093|20651236|P5|COMPLETED|Treatment Period 3||13
8377705|NCT01120093|20651237|P4|COMPLETED|Treatment Period 3||12
8377706|NCT01120093|20651238|P3|COMPLETED|Treatment Period 3||15
8377707|NCT01120093|20651239|P2|COMPLETED|Treatment Period 3||13
8377708|NCT01120093|20651240|P1|COMPLETED|Treatment Period 3||18
8377709|NCT01120093|20651236|P5|STARTED|Treatment Period 3||14
8377710|NCT01120093|20651237|P4|STARTED|Treatment Period 3||13
8377711|NCT01120093|20651238|P3|STARTED|Treatment Period 3||16
8377712|NCT01120093|20651239|P2|STARTED|Treatment Period 3||13
8377713|NCT01120093|20651240|P1|STARTED|Treatment Period 3||18
8377714|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 2||1
8377715|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 2||1
8377716|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 2||0
8377717|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 2||0
8377718|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 2||0
8377719|NCT01120093|20651236|P5|COMPLETED|Treatment Period 2||14
8377720|NCT01120093|20651237|P4|COMPLETED|Treatment Period 2||13
8377721|NCT01120093|20651238|P3|COMPLETED|Treatment Period 2||16
8377722|NCT01120093|20651239|P2|COMPLETED|Treatment Period 2||13
8377723|NCT01120093|20651240|P1|COMPLETED|Treatment Period 2||18
8377724|NCT01120093|20651236|P5|STARTED|Treatment Period 2||15
8377725|NCT01120093|20651237|P4|STARTED|Treatment Period 2||14
8377726|NCT01120093|20651238|P3|STARTED|Treatment Period 2||16
8377727|NCT01120093|20651239|P2|STARTED|Treatment Period 2||13
8377728|NCT01120093|20651240|P1|STARTED|Treatment Period 2||18
8377729|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 1||1
8377730|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 1||0
8377731|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 1||1
8377732|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 1||1
8377733|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 1||0
8377734|NCT01120093|20651236|P5|COMPLETED|Treatment Period 1||15
8377735|NCT01120093|20651237|P4|COMPLETED|Treatment Period 1||14
8377736|NCT01120093|20651238|P3|COMPLETED|Treatment Period 1||16
8377737|NCT01120093|20651239|P2|COMPLETED|Treatment Period 1||13
8377738|NCT01120093|20651240|P1|COMPLETED|Treatment Period 1||18
8377739|NCT01120093|20651236|P5|STARTED|Treatment Period 1||16
8377740|NCT01120093|20651237|P4|STARTED|Treatment Period 1||14
8377741|NCT01120093|20651238|P3|STARTED|Treatment Period 1||17
8377742|NCT01120093|20651239|P2|STARTED|Treatment Period 1||14
8377743|NCT01120093|20651240|P1|STARTED|Treatment Period 1||18
8377744|NCT01120067|20651269|P2|NOT COMPLETED|Overall Study||1
8377745|NCT01120067|20651270|P1|NOT COMPLETED|Overall Study||5
8377746|NCT01120067|20651269|P2|COMPLETED|Overall Study||10
8377747|NCT01120067|20651270|P1|COMPLETED|Overall Study||7
8377748|NCT01120067|20651269|P2|STARTED|Overall Study||11
8377749|NCT01120067|20651270|P1|STARTED|Overall Study||12
8377750|NCT01120028|20651280|P4|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377751|NCT01120028|20651281|P3|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377752|NCT01120028|20651282|P2|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377753|NCT01120028|20651283|P1|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377754|NCT01120028|20651280|P4|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
8377755|NCT01120028|20651281|P3|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
8377756|NCT01120028|20651282|P2|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377757|NCT01120028|20651283|P1|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377758|NCT01120028|20651280|P4|STARTED|Period 2: Tacrolimus or Sirolimus||197
8377759|NCT01120028|20651281|P3|STARTED|Period 2: Tacrolimus or Sirolimus||197
8377760|NCT01120028|20651282|P2|STARTED|Period 2: Tacrolimus or Sirolimus||0
8377761|NCT01120028|20651283|P1|STARTED|Period 2: Tacrolimus or Sirolimus||0
8377762|NCT01120028|20651280|P4|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377763|NCT01120028|20651281|P3|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377764|NCT01120028|20651282|P2|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
8377765|NCT01120028|20651283|P1|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
8377766|NCT01120028|20651280|P4|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377767|NCT01120028|20651281|P3|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377768|NCT01120028|20651282|P2|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
8377769|NCT01120028|20651283|P1|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
8377770|NCT01120028|20651280|P4|STARTED|Period 1: Alemtuzumab or Basiliximab||0
8377771|NCT01120028|20651281|P3|STARTED|Period 1: Alemtuzumab or Basiliximab||0
8377772|NCT01120028|20651282|P2|STARTED|Period 1: Alemtuzumab or Basiliximab||426
8377773|NCT01120028|20651283|P1|STARTED|Period 1: Alemtuzumab or Basiliximab||426
8377774|NCT01119963|20651307|P2|NOT COMPLETED|Overall Study||1
8377775|NCT01119963|20651308|P1|NOT COMPLETED|Overall Study||1
8377776|NCT01119963|20651307|P2|COMPLETED|Overall Study||77
8377777|NCT01119963|20651308|P1|COMPLETED|Overall Study||73
8377778|NCT01119963|20651307|P2|STARTED|Overall Study||78
8377779|NCT01119963|20651308|P1|STARTED|Overall Study||74
8377780|NCT01119950|20651318|P1|NOT COMPLETED|Overall Study||47
8377781|NCT01119950|20651318|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
8377782|NCT01119950|20651318|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
8377783|NCT01119950|20651318|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
8377784|NCT01119950|20651318|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
8377785|NCT01119950|20651318|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
8377786|NCT01119950|20651318|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
8377787|NCT01119950|20651318|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
8377788|NCT01119950|20651318|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
8377789|NCT01119950|20651318|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
8377790|NCT01119950|20651318|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
8377791|NCT01119937|20651565|P2|NOT COMPLETED|Overall Study||7
8377792|NCT01119937|20651566|P1|NOT COMPLETED|Overall Study||19
8377793|NCT01119937|20651565|P2|COMPLETED|Overall Study||33
8377794|NCT01119937|20651566|P1|COMPLETED|Overall Study||104
8377795|NCT01119937|20651565|P2|STARTED|Overall Study||40
8377796|NCT01119937|20651566|P1|STARTED|Overall Study||123
8377797|NCT01119898|20651594|P2|NOT COMPLETED|Overall Study||12
8377798|NCT01119898|20651595|P1|NOT COMPLETED|Overall Study||8
8377799|NCT01119898|20651594|P2|COMPLETED|Overall Study||117
8377800|NCT01119898|20651595|P1|COMPLETED|Overall Study||123
8377801|NCT01119898|20651594|P2|Received Study Drug (mITT)|Overall Study||129
8377802|NCT01119898|20651595|P1|Received Study Drug (mITT)|Overall Study||130
8377803|NCT01119898|20651594|P2|STARTED|Overall Study||129
8377804|NCT01119898|20651595|P1|STARTED|Overall Study||131
8377805|NCT01119859|20651621|P2|NOT COMPLETED|Overall Study||30
8377806|NCT01119859|20651622|P1|NOT COMPLETED|Overall Study||24
8377807|NCT01119859|20651621|P2|COMPLETED|Overall Study||133
8377808|NCT01119859|20651622|P1|COMPLETED|Overall Study||139
8377809|NCT01119859|20651621|P2|STARTED|Overall Study||163
8377810|NCT01119859|20651622|P1|STARTED|Overall Study||163
8377811|NCT01119846|20651641|P3|NOT COMPLETED|Overall Study||11
8377812|NCT01119846|20651642|P2|NOT COMPLETED|Overall Study||0
8377813|NCT01119846|20651643|P1|NOT COMPLETED|Overall Study||2
8377814|NCT01119846|20651641|P3|COMPLETED|Overall Study||72
8377815|NCT01119846|20651642|P2|COMPLETED|Overall Study||4
8377816|NCT01119846|20651643|P1|COMPLETED|Overall Study||11
8377817|NCT01119846|20651641|P3|STARTED|Overall Study||83
8377818|NCT01119846|20651642|P2|STARTED|Overall Study||4
8377819|NCT01119846|20651643|P1|STARTED|Overall Study||13
8377820|NCT01119794|20651851|P1|NOT COMPLETED|Overall Study||0
8377821|NCT01119794|20651851|P1|COMPLETED|Overall Study||10
8377822|NCT01119794|20651851|P1|STARTED|Overall Study||10
8377823|NCT01119768|20651857|P2|NOT COMPLETED|Follow-up||2
8377824|NCT01119768|20651858|P1|NOT COMPLETED|Follow-up||1
8377825|NCT01119768|20651857|P2|COMPLETED|Follow-up||122
8377826|NCT01119768|20651858|P1|COMPLETED|Follow-up||135
8377827|NCT01119768|20651857|P2|STARTED|Follow-up||124
8377828|NCT01119768|20651858|P1|STARTED|Follow-up||136
8377829|NCT01119768|20651857|P2|NOT COMPLETED|Treatment Period||25
8377830|NCT01119768|20651858|P1|NOT COMPLETED|Treatment Period||18
8377831|NCT01119768|20651857|P2|COMPLETED|Treatment Period||126
8377832|NCT01119768|20651858|P1|COMPLETED|Treatment Period||136
8377833|NCT01119768|20651857|P2|STARTED|Treatment Period||151
8377834|NCT01119768|20651858|P1|STARTED|Treatment Period||154
8377835|NCT01119755|20651880|P1|NOT COMPLETED|Overall Study||0
8377836|NCT01119755|20651880|P1|COMPLETED|Overall Study||80
8377837|NCT01119755|20651880|P1|STARTED|Overall Study||80
8377838|NCT01119716|20651891|P1|NOT COMPLETED|Overall Study||0
8377839|NCT01119716|20651891|P1|COMPLETED|Overall Study||4658
8377840|NCT01119716|20651891|P1|STARTED|Overall Study||4658
8377841|NCT01119703|20651914|P2|NOT COMPLETED|Overall Study||1
8377842|NCT01119703|20651915|P1|NOT COMPLETED|Overall Study||0
8377843|NCT01119703|20651914|P2|COMPLETED|Overall Study||143
8377844|NCT01119703|20651915|P1|COMPLETED|Overall Study||30
8377845|NCT01119703|20651914|P2|STARTED|Overall Study||144
8377846|NCT01119703|20651915|P1|STARTED|Overall Study||30
8377847|NCT01119625|20651929|P2|NOT COMPLETED|Overall Study||4
8377848|NCT01119625|20651930|P1|NOT COMPLETED|Overall Study||3
8377849|NCT01119625|20651929|P2|COMPLETED|Overall Study||116
8377850|NCT01119625|20651930|P1|COMPLETED|Overall Study||115
8377851|NCT01119625|20651929|P2|STARTED|Overall Study||120
8377852|NCT01119625|20651930|P1|STARTED|Overall Study||118
8377853|NCT01119508|20651970|P1|NOT COMPLETED|Overall Study||59
8377854|NCT01119508|20651970|P1|COMPLETED|Overall Study||5
8377855|NCT01119508|20651970|P1|Received Fifth Consolidation Dose week12|Overall Study||32
8377856|NCT01119508|20651970|P1|Received Four Induction Doses|Overall Study||45
8377857|NCT01119508|20651970|P1|STARTED|Overall Study||64
8377858|NCT01119456|20651982|P8|NOT COMPLETED|Overall Study||0
8377859|NCT01119456|20651983|P7|NOT COMPLETED|Overall Study||0
8377860|NCT01119456|20651984|P6|NOT COMPLETED|Overall Study||0
8377861|NCT01119456|20651985|P5|NOT COMPLETED|Overall Study||0
8377862|NCT01119456|20651986|P4|NOT COMPLETED|Overall Study||0
8377863|NCT01119456|20651987|P3|NOT COMPLETED|Overall Study||0
8377864|NCT01119456|20651988|P2|NOT COMPLETED|Overall Study||0
8377865|NCT01119456|20651989|P1|NOT COMPLETED|Overall Study||0
8377866|NCT01119456|20651982|P8|COMPLETED|Overall Study||3
8377867|NCT01119456|20651983|P7|COMPLETED|Overall Study||3
8377868|NCT01119456|20651984|P6|COMPLETED|Overall Study||3
8377869|NCT01119456|20651985|P5|COMPLETED|Overall Study||4
8377870|NCT01119456|20651986|P4|COMPLETED|Overall Study||13
8377871|NCT01119456|20651987|P3|COMPLETED|Overall Study||3
8377872|NCT01119456|20651988|P2|COMPLETED|Overall Study||3
8377873|NCT01119456|20651989|P1|COMPLETED|Overall Study||7
8377874|NCT01119456|20651982|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8377875|NCT01119456|20651983|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
8377876|NCT01119456|20651984|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8377877|NCT01119456|20651985|P5|Received at Least 1 Dose of Study Drug|Overall Study||4
8377878|NCT01119456|20651986|P4|Received at Least 1 Dose of Study Drug|Overall Study||13
8377879|NCT01119456|20651987|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8377880|NCT01119456|20651988|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8377881|NCT01119456|20651989|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8377882|NCT01119456|20651982|P8|STARTED|Overall Study||3
8377883|NCT01119456|20651983|P7|STARTED|Overall Study||3
8377884|NCT01119456|20651984|P6|STARTED|Overall Study||3
8377885|NCT01119456|20651985|P5|STARTED|Overall Study||4
8377886|NCT01119456|20651986|P4|STARTED|Overall Study||13
8377887|NCT01119456|20651987|P3|STARTED|Overall Study||3
8377888|NCT01119456|20651988|P2|STARTED|Overall Study||3
8377889|NCT01119456|20651989|P1|STARTED|Overall Study||7
8377890|NCT01119443|20652050|P2|NOT COMPLETED|End of Study (All Patients)||0
8377891|NCT01119443|20652051|P1|NOT COMPLETED|End of Study (All Patients)||0
8377892|NCT01119443|20652050|P2|COMPLETED|End of Study (All Patients)||14
8377893|NCT01119443|20652051|P1|COMPLETED|End of Study (All Patients)||14
8377894|NCT01119443|20652050|P2|STARTED|End of Study (All Patients)||14
8377895|NCT01119443|20652051|P1|STARTED|End of Study (All Patients)||14
8377896|NCT01119443|20652050|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
8377897|NCT01119443|20652051|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
8377898|NCT01119443|20652050|P2|COMPLETED|Down-titration Period (1 Day)||13
8377899|NCT01119443|20652051|P1|COMPLETED|Down-titration Period (1 Day)||14
8377900|NCT01119443|20652050|P2|STARTED|Down-titration Period (1 Day)||13
8377901|NCT01119443|20652051|P1|STARTED|Down-titration Period (1 Day)||14
8377902|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
8377903|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
8377904|NCT01119443|20652050|P2|COMPLETED|Crossover Period 4 (5 Days)||13
8377905|NCT01119443|20652051|P1|COMPLETED|Crossover Period 4 (5 Days)||14
8377906|NCT01119443|20652050|P2|STARTED|Crossover Period 4 (5 Days)||13
8377907|NCT01119443|20652051|P1|STARTED|Crossover Period 4 (5 Days)||14
8377908|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
8377909|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
8377910|NCT01119443|20652050|P2|COMPLETED|Crossover Period 3 (5 Days)||13
8377911|NCT01119443|20652051|P1|COMPLETED|Crossover Period 3 (5 Days)||14
8377912|NCT01119443|20652050|P2|STARTED|Crossover Period 3 (5 Days)||13
8377913|NCT01119443|20652051|P1|STARTED|Crossover Period 3 (5 Days)||14
8377914|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
8377915|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
8377916|NCT01119443|20652050|P2|COMPLETED|Crossover Period 2 (5 Days)||13
8377917|NCT01119443|20652051|P1|COMPLETED|Crossover Period 2 (5 Days)||14
8377918|NCT01119443|20652050|P2|STARTED|Crossover Period 2 (5 Days)||13
8377919|NCT01119443|20652051|P1|STARTED|Crossover Period 2 (5 Days)||14
8377920|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
8377921|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
8377922|NCT01119443|20652050|P2|COMPLETED|Crossover Period 1 (5 Days)||13
8377923|NCT01119443|20652051|P1|COMPLETED|Crossover Period 1 (5 Days)||14
8377924|NCT01119443|20652050|P2|STARTED|Crossover Period 1 (5 Days)||14
8377925|NCT01119443|20652051|P1|STARTED|Crossover Period 1 (5 Days)||14
8377926|NCT01119443|20652050|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
8377927|NCT01119443|20652051|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
8377928|NCT01119443|20652050|P2|COMPLETED|Up-titration Period (10 Days)||14
8377929|NCT01119443|20652051|P1|COMPLETED|Up-titration Period (10 Days)||14
8377930|NCT01119443|20652050|P2|STARTED|Up-titration Period (10 Days)||14
8377931|NCT01119443|20652051|P1|STARTED|Up-titration Period (10 Days)||14
8377932|NCT01119287|20652094|P6|NOT COMPLETED|Overall Study||0
8377933|NCT01119287|20652095|P5|NOT COMPLETED|Overall Study||1
8377934|NCT01119287|20652096|P4|NOT COMPLETED|Overall Study||2
8377935|NCT01119287|20652097|P3|NOT COMPLETED|Overall Study||2
8377936|NCT01119287|20652098|P2|NOT COMPLETED|Overall Study||0
8377937|NCT01119287|20652099|P1|NOT COMPLETED|Overall Study||0
8377938|NCT01119287|20652094|P6|COMPLETED|Overall Study||32
8377939|NCT01119287|20652095|P5|COMPLETED|Overall Study||30
8377940|NCT01119287|20652096|P4|COMPLETED|Overall Study||29
8377941|NCT01119287|20652097|P3|COMPLETED|Overall Study||24
8377942|NCT01119287|20652098|P2|COMPLETED|Overall Study||24
8377943|NCT01119287|20652099|P1|COMPLETED|Overall Study||26
8377944|NCT01119287|20652094|P6|STARTED|Overall Study||32
8377945|NCT01119287|20652095|P5|STARTED|Overall Study||31
8377946|NCT01119287|20652096|P4|STARTED|Overall Study||31
8377947|NCT01119287|20652097|P3|STARTED|Overall Study||26
8377948|NCT01119287|20652098|P2|STARTED|Overall Study||24
8377949|NCT01119287|20652099|P1|STARTED|Overall Study||26
8377950|NCT01119248|20652112|P1|NOT COMPLETED|Overall Study||5
8377951|NCT01119248|20652112|P1|COMPLETED|Overall Study||115
8377952|NCT01119248|20652112|P1|STARTED|Overall Study||120
8377953|NCT01119222|20652118|P4|NOT COMPLETED|Overall Study||0
8377954|NCT01119222|20652119|P3|NOT COMPLETED|Overall Study||0
8377955|NCT01119222|20652120|P2|NOT COMPLETED|Overall Study||0
8377956|NCT01119222|20652121|P1|NOT COMPLETED|Overall Study||0
8377957|NCT01119222|20652118|P4|COMPLETED|Overall Study||4
8377958|NCT01119222|20652119|P3|COMPLETED|Overall Study||5
8377959|NCT01119222|20652120|P2|COMPLETED|Overall Study||5
8377960|NCT01119222|20652121|P1|COMPLETED|Overall Study||5
8377961|NCT01119222|20652118|P4|STARTED|Overall Study||4
8377962|NCT01119222|20652119|P3|STARTED|Overall Study||5
8377963|NCT01119222|20652120|P2|STARTED|Overall Study||5
8377964|NCT01119222|20652121|P1|STARTED|Overall Study||5
8377965|NCT01119131|20652162|P3|NOT COMPLETED|Overall Study||6
8377966|NCT01119131|20652163|P2|NOT COMPLETED|Overall Study||1
8377967|NCT01119131|20652164|P1|NOT COMPLETED|Overall Study||2
8377968|NCT01119131|20652162|P3|COMPLETED|Overall Study||24
8377969|NCT01119131|20652163|P2|COMPLETED|Overall Study||27
8377970|NCT01119131|20652164|P1|COMPLETED|Overall Study||8
8377971|NCT01119131|20652162|P3|STARTED|Overall Study||30
8377972|NCT01119131|20652163|P2|STARTED|Overall Study||28
8377973|NCT01119131|20652164|P1|STARTED|Overall Study||10
8377974|NCT01119118|20652193|P1|NOT COMPLETED|Overall Study||1
8377975|NCT01119118|20652193|P1|COMPLETED|Overall Study||5
8377976|NCT01119118|20652193|P1|STARTED|Overall Study||6
8377977|NCT01119105|20652204|P3|NOT COMPLETED|Overall Study||8
8377978|NCT01119105|20652205|P2|NOT COMPLETED|Overall Study||6
8377979|NCT01119105|20652206|P1|NOT COMPLETED|Overall Study||4
8377980|NCT01119105|20652204|P3|COMPLETED|Overall Study||60
8377981|NCT01119105|20652205|P2|COMPLETED|Overall Study||66
8377982|NCT01119105|20652206|P1|COMPLETED|Overall Study||66
8377983|NCT01119105|20652204|P3|STARTED|Overall Study||68
8377984|NCT01119105|20652205|P2|STARTED|Overall Study||72
8377985|NCT01119105|20652206|P1|STARTED|Overall Study||70
8377986|NCT01119040|20652217|P1|NOT COMPLETED|Overall Study||1
8377987|NCT01119040|20652217|P1|COMPLETED|Overall Study||0
8377988|NCT01119040|20652217|P1|STARTED|Overall Study||1
8377989|NCT01119001|20652221|P1|NOT COMPLETED|Overall Study||2
8377990|NCT01119001|20652221|P1|COMPLETED|Overall Study||11
8377991|NCT01119001|20652221|P1|STARTED|Overall Study||13
8377992|NCT01118988|20652230|P3|NOT COMPLETED|Overall Study||4
8377993|NCT01118988|20652231|P2|NOT COMPLETED|Overall Study||1
8377994|NCT01118988|20652232|P1|NOT COMPLETED|Overall Study||5
8377995|NCT01118988|20652230|P3|COMPLETED|Overall Study||3
8377996|NCT01118988|20652231|P2|COMPLETED|Overall Study||3
8377997|NCT01118988|20652232|P1|COMPLETED|Overall Study||11
8377998|NCT01118988|20652230|P3|STARTED|Overall Study||7
8377999|NCT01118988|20652231|P2|STARTED|Overall Study||4
8378000|NCT01118988|20652232|P1|STARTED|Overall Study||16
8378001|NCT01118975|20652265|P2|NOT COMPLETED|Overall Study||1
8378002|NCT01118975|20652266|P1|NOT COMPLETED|Overall Study||0
8378003|NCT01118975|20652265|P2|COMPLETED|Overall Study||2
8378004|NCT01118975|20652266|P1|COMPLETED|Overall Study||9
8378005|NCT01118975|20652265|P2|STARTED|Overall Study||3
8378006|NCT01118975|20652266|P1|STARTED|Overall Study||9
8378007|NCT01118962|20652272|P1|NOT COMPLETED|Overall Study||10
8378008|NCT01118962|20652272|P1|COMPLETED|Overall Study||29
8378009|NCT01118962|20652272|P1|STARTED|Overall Study||39
8378010|NCT01118949|20652277|P1|NOT COMPLETED|Overall Study||9
8378011|NCT01118949|20652277|P1|COMPLETED|Overall Study||40
8378012|NCT01118949|20652277|P1|STARTED|Overall Study||49
8378013|NCT01118845|20652286|P1|NOT COMPLETED|Overall Study||42
8378014|NCT01118845|20652286|P1|COMPLETED|Overall Study||17
8378015|NCT01118845|20652286|P1|STARTED|Overall Study||59
8378016|NCT01118780|20652307|P2|NOT COMPLETED|Overall Study||35
8378017|NCT01118780|20652308|P1|NOT COMPLETED|Overall Study||36
8378018|NCT01118780|20652307|P2|COMPLETED|Overall Study||105
8378019|NCT01118780|20652308|P1|COMPLETED|Overall Study||115
8378020|NCT01118780|20652307|P2|STARTED|Overall Study||140
8378021|NCT01118780|20652308|P1|STARTED|Overall Study||151
8378022|NCT01118741|20652357|P2|NOT COMPLETED|Overall Study||0
8378023|NCT01118741|20652358|P1|NOT COMPLETED|Overall Study||0
8378024|NCT01118741|20652357|P2|COMPLETED|Overall Study||10
8378025|NCT01118741|20652358|P1|COMPLETED|Overall Study||9
8378026|NCT01118741|20652357|P2|STARTED|Overall Study||10
8378027|NCT01118741|20652358|P1|STARTED|Overall Study||9
8378028|NCT01118728|20652366|P1|NOT COMPLETED|Overall Study||223
8378029|NCT01118728|20652366|P1|COMPLETED|Overall Study||0
8378030|NCT01118728|20652366|P1|STARTED|Overall Study||223
8378031|NCT01118715|20652373|P2|NOT COMPLETED|Overall Study||0
8378032|NCT01118715|20652374|P1|NOT COMPLETED|Overall Study||0
8378033|NCT01118715|20652373|P2|COMPLETED|Overall Study||60
8378034|NCT01118715|20652374|P1|COMPLETED|Overall Study||68
8378035|NCT01118715|20652373|P2|STARTED|Overall Study||60
8378036|NCT01118715|20652374|P1|STARTED|Overall Study||68
8378037|NCT01118663|20652403|P2|NOT COMPLETED|Overall Study||2
8378038|NCT01118663|20652404|P1|NOT COMPLETED|Overall Study||2
8378039|NCT01118663|20652403|P2|COMPLETED|Overall Study||8
8378040|NCT01118663|20652404|P1|COMPLETED|Overall Study||5
8378041|NCT01118663|20652403|P2|STARTED|Overall Study||10
8378042|NCT01118663|20652404|P1|STARTED|Overall Study||7
8378043|NCT01118624|20652418|P1|NOT COMPLETED|Overall Study||22
8378044|NCT01118624|20652418|P1|COMPLETED|Overall Study||0
8378045|NCT01118624|20652418|P1|STARTED|Overall Study||22
8378046|NCT01118520|20652428|P3|NOT COMPLETED|Overall Study||20
8378047|NCT01118520|20652429|P2|NOT COMPLETED|Overall Study||23
8378048|NCT01118520|20652430|P1|NOT COMPLETED|Overall Study||20
8378049|NCT01118520|20652428|P3|COMPLETED|Overall Study||59
8378050|NCT01118520|20652429|P2|COMPLETED|Overall Study||49
8378051|NCT01118520|20652430|P1|COMPLETED|Overall Study||53
8378052|NCT01118520|20652428|P3|STARTED|Overall Study||79
8378053|NCT01118520|20652429|P2|STARTED|Overall Study||72
8378054|NCT01118520|20652430|P1|STARTED|Overall Study||73
8378055|NCT01118455|20652443|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
8378056|NCT01118455|20652444|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
8378057|NCT01118455|20652443|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
8378058|NCT01118455|20652444|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
8378059|NCT01118455|20652443|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
8378060|NCT01118455|20652444|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
8378061|NCT01118455|20652443|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
8378062|NCT01118455|20652444|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
8378063|NCT01118455|20652443|P2|COMPLETED|Baseline [Visits 1 & 2]||69
8378064|NCT01118455|20652444|P1|COMPLETED|Baseline [Visits 1 & 2]||65
8378065|NCT01118455|20652443|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
8378066|NCT01118455|20652444|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
8378067|NCT01118455|20652443|P2|STARTED|Baseline [Visits 1 & 2]||69
8378068|NCT01118455|20652444|P1|STARTED|Baseline [Visits 1 & 2]||66
8378069|NCT01118377|20652472|P1|NOT COMPLETED|Overall Study||42
8378070|NCT01118377|20652472|P1|COMPLETED|Overall Study||3
8378071|NCT01118377|20652472|P1|STARTED|Overall Study||45
8378072|NCT01118351|20652478|P1|NOT COMPLETED|Overall Study||4
8378073|NCT01118351|20652478|P1|COMPLETED|Overall Study||15
8378074|NCT01118351|20652478|P1|STARTED|Overall Study||19
8378075|NCT01118338|20652488|P2|NOT COMPLETED|Overall Study||9
8378076|NCT01118338|20652489|P1|NOT COMPLETED|Overall Study||3
8378077|NCT01118338|20652488|P2|COMPLETED|Overall Study||174
8378078|NCT01118338|20652489|P1|COMPLETED|Overall Study||182
8378079|NCT01118338|20652488|P2|STARTED|Overall Study||183
8378080|NCT01118338|20652489|P1|STARTED|Overall Study||185
8378081|NCT01118325|20652502|P3|NOT COMPLETED|Overall Study||1
8378082|NCT01118325|20652503|P2|NOT COMPLETED|Overall Study||0
8378083|NCT01118325|20652504|P1|NOT COMPLETED|Overall Study||1
8378084|NCT01118325|20652502|P3|COMPLETED|Overall Study||45
8378085|NCT01118325|20652503|P2|COMPLETED|Overall Study||43
8378086|NCT01118325|20652504|P1|COMPLETED|Overall Study||49
8378087|NCT01118325|20652502|P3|STARTED|Overall Study||46
8378088|NCT01118325|20652503|P2|STARTED|Overall Study||43
8378089|NCT01118325|20652504|P1|STARTED|Overall Study||50
8378090|NCT01118312|20652550|P2|NOT COMPLETED|Overall Study||35
8378091|NCT01118312|20652551|P1|NOT COMPLETED|Overall Study||34
8378092|NCT01118312|20652550|P2|COMPLETED|Overall Study||164
8378093|NCT01118312|20652551|P1|COMPLETED|Overall Study||155
8378094|NCT01118312|20652550|P2|STARTED|Overall Study||199
8378095|NCT01118312|20652551|P1|STARTED|Overall Study||189
8378096|NCT01118299|20652561|P2|NOT COMPLETED|Overall Study||29
8378097|NCT01118299|20652562|P1|NOT COMPLETED|Overall Study||23
8378098|NCT01118299|20652561|P2|COMPLETED|Overall Study||0
8378099|NCT01118299|20652562|P1|COMPLETED|Overall Study||45
8378100|NCT01118299|20652561|P2|STARTED|Overall Study||29
8378101|NCT01118299|20652562|P1|STARTED|Overall Study||68
8378102|NCT01118273|20652575|P6|NOT COMPLETED|Overall Study||0
8378103|NCT01118273|20652576|P5|NOT COMPLETED|Overall Study||0
8378104|NCT01118273|20652577|P4|NOT COMPLETED|Overall Study||0
8378105|NCT01118273|20652578|P3|NOT COMPLETED|Overall Study||0
8378106|NCT01118273|20652579|P2|NOT COMPLETED|Overall Study||0
8378107|NCT01118273|20652580|P1|NOT COMPLETED|Overall Study||0
8378108|NCT01118273|20652575|P6|COMPLETED|Overall Study||27
8378109|NCT01118273|20652576|P5|COMPLETED|Overall Study||27
8378110|NCT01118273|20652577|P4|COMPLETED|Overall Study||27
8378111|NCT01118273|20652578|P3|COMPLETED|Overall Study||27
8378112|NCT01118273|20652579|P2|COMPLETED|Overall Study||27
8378113|NCT01118273|20652580|P1|COMPLETED|Overall Study||27
8378114|NCT01118273|20652575|P6|STARTED|Overall Study||27
8378115|NCT01118273|20652576|P5|STARTED|Overall Study||27
8378116|NCT01118273|20652577|P4|STARTED|Overall Study||27
8378117|NCT01118273|20652578|P3|STARTED|Overall Study||27
8378118|NCT01118273|20652579|P2|STARTED|Overall Study||27
8378119|NCT01118273|20652580|P1|STARTED|Overall Study||27
8378120|NCT01118221|20652746|P2|NOT COMPLETED|Overall Study||1
8378121|NCT01118221|20652747|P1|NOT COMPLETED|Overall Study||3
8378122|NCT01118221|20652746|P2|COMPLETED|Overall Study||10
8378123|NCT01118221|20652747|P1|COMPLETED|Overall Study||11
8378124|NCT01118221|20652746|P2|STARTED|Overall Study||11
8378125|NCT01118221|20652747|P1|STARTED|Overall Study||14
8378126|NCT01118143|20652759|P2|NOT COMPLETED|Overall Study||5
8378127|NCT01118143|20652760|P1|NOT COMPLETED|Overall Study||2
8378128|NCT01118143|20652759|P2|COMPLETED|Overall Study||64
8378129|NCT01118143|20652760|P1|COMPLETED|Overall Study||62
8378130|NCT01118143|20652759|P2|STARTED|Overall Study||69
8378131|NCT01118143|20652760|P1|STARTED|Overall Study||64
8378132|NCT01118117|20652770|P2|NOT COMPLETED|Overall Study||0
8378133|NCT01118117|20652771|P1|NOT COMPLETED|Overall Study||21
8378134|NCT01118117|20652770|P2|COMPLETED|Overall Study||15
8378135|NCT01118117|20652771|P1|COMPLETED|Overall Study||240
8378136|NCT01118117|20652770|P2|STARTED|Overall Study||15
8378137|NCT01118117|20652771|P1|STARTED|Overall Study||261
8378138|NCT01118091|20652792|P2|NOT COMPLETED|Overall Study||0
8378139|NCT01118091|20652793|P1|NOT COMPLETED|Overall Study||0
8378140|NCT01118091|20652792|P2|COMPLETED|Overall Study||5
8378141|NCT01118091|20652793|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
8378142|NCT01118091|20652792|P2|STARTED|Overall Study||5
8378143|NCT01118091|20652793|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
8378144|NCT01118052|20652803|P1|NOT COMPLETED|Overall Study||2
8378145|NCT01118052|20652803|P1|COMPLETED|Overall Study||20
8378146|NCT01118052|20652803|P1|STARTED|Overall Study||22
8378147|NCT01118013|20652816|P1|NOT COMPLETED|Overall Study||0
8378148|NCT01118013|20652816|P1|COMPLETED|Overall Study||6
8378149|NCT01118013|20652816|P1|STARTED|Overall Study||6
8378150|NCT01117987|20652826|P2|NOT COMPLETED|Overall Study||74
8378151|NCT01117987|20652827|P1|NOT COMPLETED|Overall Study||61
8378152|NCT01117987|20652826|P2|COMPLETED|Overall Study||4
8378153|NCT01117987|20652827|P1|COMPLETED|Overall Study||5
8378154|NCT01117987|20652826|P2|STARTED|Overall Study||78
8378155|NCT01117987|20652827|P1|STARTED|Overall Study||66
8378156|NCT01117948|20652839|P2|NOT COMPLETED|Open Label||47
8378157|NCT01117948|20652840|P1|NOT COMPLETED|Open Label||52
8378158|NCT01117948|20652839|P2|COMPLETED|Open Label||51
8378159|NCT01117948|20652840|P1|COMPLETED|Open Label||41
8378160|NCT01117948|20652839|P2|STARTED|Open Label||98
8378161|NCT01117948|20652840|P1|STARTED|Open Label||93
8378162|NCT01117948|20652839|P2|NOT COMPLETED|Double Blind||10
8378163|NCT01117948|20652840|P1|NOT COMPLETED|Double Blind||18
8378164|NCT01117948|20652839|P2|COMPLETED|Double Blind||98
8378165|NCT01117948|20652840|P1|COMPLETED|Double Blind||93
8378166|NCT01117948|20652839|P2|STARTED|Double Blind||108
8378167|NCT01117948|20652840|P1|STARTED|Double Blind||111
8378168|NCT01117870|20652848|P2|NOT COMPLETED|Overall Study||0
8378169|NCT01117870|20652849|P1|NOT COMPLETED|Overall Study||1
8378170|NCT01117870|20652848|P2|COMPLETED|Overall Study||16
8378171|NCT01117870|20652849|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
8378172|NCT01117870|20652848|P2|STARTED|Overall Study||16
8378173|NCT01117870|20652849|P1|STARTED|Overall Study||15
8378174|NCT01117857|20652863|P1|NOT COMPLETED|Overall Study||9
8378175|NCT01117857|20652863|P1|COMPLETED|Overall Study||13
8378176|NCT01117857|20652863|P1|STARTED|Overall Study||22
8378177|NCT01117766|20652871|P2|NOT COMPLETED|Second Intervention||5
8378178|NCT01117766|20652872|P1|NOT COMPLETED|Second Intervention||2
8378179|NCT01117766|20652871|P2|COMPLETED|Second Intervention||9
8378180|NCT01117766|20652872|P1|COMPLETED|Second Intervention||11
8378181|NCT01117766|20652871|P2|STARTED|Second Intervention||14
8378182|NCT01117766|20652872|P1|STARTED|Second Intervention||13
8378183|NCT01117766|20652871|P2|NOT COMPLETED|Washout Period||2
8378184|NCT01117766|20652872|P1|NOT COMPLETED|Washout Period||0
8378185|NCT01117766|20652871|P2|COMPLETED|Washout Period||14
8378186|NCT01117766|20652872|P1|COMPLETED|Washout Period||13
8378187|NCT01117766|20652871|P2|STARTED|Washout Period||16
8378188|NCT01117766|20652872|P1|STARTED|Washout Period||13
8378189|NCT01117766|20652871|P2|NOT COMPLETED|First Intervention||1
8378190|NCT01117766|20652872|P1|NOT COMPLETED|First Intervention||1
8378191|NCT01117766|20652871|P2|COMPLETED|First Intervention||16
8378192|NCT01117766|20652872|P1|COMPLETED|First Intervention||13
8378193|NCT01117766|20652871|P2|Received Treatment|First Intervention||17
8378194|NCT01117766|20652872|P1|Received Treatment|First Intervention||14
8378195|NCT01117766|20652871|P2|STARTED|First Intervention||17
8378196|NCT01117766|20652872|P1|STARTED|First Intervention||14
8378197|NCT01117727|20652896|P1|NOT COMPLETED|Overall Study||0
8378198|NCT01117727|20652896|P1|COMPLETED|Overall Study||1
8378199|NCT01117727|20652896|P1|STARTED|Overall Study||1
8378200|NCT01117623|20652909|P8|NOT COMPLETED|Overall Study||26
8378201|NCT01117623|20652910|P7|NOT COMPLETED|Overall Study||6
8378202|NCT01117623|20652911|P6|NOT COMPLETED|Overall Study||16
8378203|NCT01117623|20652912|P5|NOT COMPLETED|Overall Study||10
8378204|NCT01117623|20652913|P4|NOT COMPLETED|Overall Study||6
8378205|NCT01117623|20652914|P3|NOT COMPLETED|Overall Study||11
8378206|NCT01117623|20652915|P2|NOT COMPLETED|Overall Study||8
8378207|NCT01117623|20652916|P1|NOT COMPLETED|Overall Study||3
8378208|NCT01117623|20652909|P8|COMPLETED|Overall Study||0
8378209|NCT01117623|20652910|P7|COMPLETED|Overall Study||0
8378210|NCT01117623|20652911|P6|COMPLETED|Overall Study||0
8378211|NCT01117623|20652912|P5|COMPLETED|Overall Study||0
8378212|NCT01117623|20652913|P4|COMPLETED|Overall Study||0
8378213|NCT01117623|20652914|P3|COMPLETED|Overall Study||0
8378214|NCT01117623|20652915|P2|COMPLETED|Overall Study||0
8378215|NCT01117623|20652916|P1|COMPLETED|Overall Study||0
8378216|NCT01117623|20652909|P8|PK Population|Overall Study||24
8378217|NCT01117623|20652910|P7|PK Population|Overall Study||6
8378218|NCT01117623|20652911|P6|PK Population|Overall Study||14
8378219|NCT01117623|20652912|P5|PK Population|Overall Study||10
8378220|NCT01117623|20652913|P4|PK Population|Overall Study||6
8378221|NCT01117623|20652914|P3|PK Population|Overall Study||10
8378222|NCT01117623|20652915|P2|PK Population|Overall Study||8
8378223|NCT01117623|20652916|P1|PK Population|Overall Study||3
8378224|NCT01117623|20652909|P8|ITT Efficacy Analysis Population|Overall Study||22
8378225|NCT01117623|20652910|P7|ITT Efficacy Analysis Population|Overall Study||6
8378226|NCT01117623|20652911|P6|ITT Efficacy Analysis Population|Overall Study||16
8378227|NCT01117623|20652912|P5|ITT Efficacy Analysis Population|Overall Study||10
8378228|NCT01117623|20652913|P4|ITT Efficacy Analysis Population|Overall Study||5
8378229|NCT01117623|20652914|P3|ITT Efficacy Analysis Population|Overall Study||11
8378230|NCT01117623|20652915|P2|ITT Efficacy Analysis Population|Overall Study||8
8378231|NCT01117623|20652916|P1|ITT Efficacy Analysis Population|Overall Study||3
8378232|NCT01117623|20652909|P8|STARTED|Overall Study||26
8378233|NCT01117623|20652910|P7|STARTED|Overall Study||6
8378234|NCT01117623|20652911|P6|STARTED|Overall Study||16
8378235|NCT01117623|20652912|P5|STARTED|Overall Study||10
8378236|NCT01117623|20652913|P4|STARTED|Overall Study||6
8378237|NCT01117623|20652914|P3|STARTED|Overall Study||11
8378238|NCT01117623|20652915|P2|STARTED|Overall Study||8
8378239|NCT01117623|20652916|P1|STARTED|Overall Study||3
8378240|NCT01117480|20653068|P1|NOT COMPLETED|Overall Study||28
8378241|NCT01117480|20653068|P1|COMPLETED|Overall Study||985
8378242|NCT01117480|20653068|P1|STARTED|Overall Study||1013
8378243|NCT01117454|20653076|P2|NOT COMPLETED|Overall Study||1
8378244|NCT01117454|20653077|P1|NOT COMPLETED|Overall Study||0
8378245|NCT01117454|20653076|P2|COMPLETED|Overall Study||7
8378246|NCT01117454|20653077|P1|COMPLETED|Overall Study||6
8378247|NCT01117454|20653076|P2|STARTED|Overall Study||8
8378248|NCT01117454|20653077|P1|STARTED|Overall Study||6
8378249|NCT01117428|20653089|P6|NOT COMPLETED|Overall Study||20
8378250|NCT01117428|20653090|P5|NOT COMPLETED|Overall Study||17
8378251|NCT01117428|20653091|P4|NOT COMPLETED|Overall Study||12
8378252|NCT01117428|20653092|P3|NOT COMPLETED|Overall Study||13
8378253|NCT01117428|20653093|P2|NOT COMPLETED|Overall Study||29
8378254|NCT01117428|20653094|P1|NOT COMPLETED|Overall Study||20
8378255|NCT01117428|20653089|P6|COMPLETED|Overall Study||0
8378256|NCT01117428|20653090|P5|COMPLETED|Overall Study||0
8378257|NCT01117428|20653091|P4|COMPLETED|Overall Study||0
8378258|NCT01117428|20653092|P3|COMPLETED|Overall Study||0
8378259|NCT01117428|20653093|P2|COMPLETED|Overall Study||0
8378260|NCT01117428|20653094|P1|COMPLETED|Overall Study||0
8378261|NCT01117428|20653089|P6|STARTED|Overall Study||20
8378262|NCT01117428|20653090|P5|STARTED|Overall Study||17
8378263|NCT01117428|20653091|P4|STARTED|Overall Study||12
8378264|NCT01117428|20653092|P3|STARTED|Overall Study||13
8378265|NCT01117428|20653093|P2|STARTED|Overall Study||29
8378266|NCT01117428|20653094|P1|STARTED|Overall Study|"0.4 mg/kg=1
~0.75 mg/kg=1
~1.5 mg/kg=3
~3 mg/kg=3
~6 mg/kg=3
~9 mg/kg=6
~12 mg/kg=3"|20
8378267|NCT01117350|20653128|P2|NOT COMPLETED|Extension Period||63
8378268|NCT01117350|20653129|P1|NOT COMPLETED|Extension Period||0
8378269|NCT01117350|20653128|P2|COMPLETED|Extension Period||147
8378270|NCT01117350|20653129|P1|COMPLETED|Extension Period||0
8378271|NCT01117350|20653128|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
8378272|NCT01117350|20653129|P1|mITT Population (Extension)|Extension Period||0
8378273|NCT01117350|20653128|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
8378274|NCT01117350|20653129|P1|TREATED = Safety Population (Extension)|Extension Period||0
8378275|NCT01117350|20653128|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
8378276|NCT01117350|20653129|P1|STARTED|Extension Period||0
8378277|NCT01117350|20653128|P2|NOT COMPLETED|Comparative Period||75
8378278|NCT01117350|20653129|P1|NOT COMPLETED|Comparative Period||42
8378279|NCT01117350|20653128|P2|COMPLETED|Comparative Period||414
8378280|NCT01117350|20653129|P1|COMPLETED|Comparative Period||447
8378281|NCT01117350|20653128|P2|mITT Population|Comparative Period||470
8378282|NCT01117350|20653129|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
8378283|NCT01117350|20653128|P2|TREATED = Safety Population|Comparative Period||481
8378284|NCT01117350|20653129|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
8378285|NCT01117350|20653128|P2|STARTED|Comparative Period||489
8378286|NCT01117350|20653129|P1|STARTED|Comparative Period|STARTED: randomized|489
8378287|NCT01117337|20653161|P2|NOT COMPLETED|Overall Study||0
8378288|NCT01117337|20653162|P1|NOT COMPLETED|Overall Study||4
8378289|NCT01117337|20653161|P2|COMPLETED|Overall Study||52
8378290|NCT01117337|20653162|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
8378291|NCT01117337|20653161|P2|Underwent Surgery|Overall Study||52
8378292|NCT01117337|20653162|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
8378293|NCT01117337|20653161|P2|STARTED|Overall Study||52
8378294|NCT01117337|20653162|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
8378295|NCT01117311|20653172|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
8378296|NCT01117311|20653173|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
8378297|NCT01117311|20653172|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
8378298|NCT01117311|20653173|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
8378299|NCT01117311|20653172|P2|STARTED|Second Intervention - Mixed Meal 3||4
8378300|NCT01117311|20653173|P1|STARTED|Second Intervention - Mixed Meal 3||3
8378301|NCT01117311|20653172|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
8378302|NCT01117311|20653173|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
8378303|NCT01117311|20653172|P2|COMPLETED|First Intervention - Mixed Meal 2||4
8378304|NCT01117311|20653173|P1|COMPLETED|First Intervention - Mixed Meal 2||3
8378305|NCT01117311|20653172|P2|STARTED|First Intervention - Mixed Meal 2||4
8378306|NCT01117311|20653173|P1|STARTED|First Intervention - Mixed Meal 2||3
8378307|NCT01117311|20653172|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
8378308|NCT01117311|20653173|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
8378309|NCT01117311|20653172|P2|COMPLETED|Lead-in Mixed Meal 1||4
8378310|NCT01117311|20653173|P1|COMPLETED|Lead-in Mixed Meal 1||3
8378311|NCT01117311|20653172|P2|STARTED|Lead-in Mixed Meal 1||4
8378312|NCT01117311|20653173|P1|STARTED|Lead-in Mixed Meal 1||3
8378313|NCT01117181|20653183|P2|NOT COMPLETED|Overall Study||2
8378314|NCT01117181|20653184|P1|NOT COMPLETED|Overall Study||1
8378315|NCT01117181|20653183|P2|COMPLETED|Overall Study||29
8378316|NCT01117181|20653184|P1|COMPLETED|Overall Study||28
8378317|NCT01117181|20653183|P2|STARTED|Overall Study||31
8378318|NCT01117181|20653184|P1|STARTED|Overall Study||29
8378319|NCT01117090|20653204|P1|NOT COMPLETED|Overall Study||0
8378320|NCT01117090|20653204|P1|COMPLETED|Overall Study||47
8378321|NCT01117090|20653204|P1|STARTED|Overall Study||47
8378322|NCT01117051|20653217|P2|NOT COMPLETED|Overall Study||11
8378323|NCT01117051|20653218|P1|NOT COMPLETED|Overall Study||13
8378324|NCT01117051|20653217|P2|COMPLETED|Overall Study||77
8378325|NCT01117051|20653218|P1|COMPLETED|Overall Study||73
8378326|NCT01117051|20653217|P2|STARTED|Overall Study||88
8378327|NCT01117051|20653218|P1|STARTED|Overall Study||86
8378328|NCT01117012|20653228|P2|NOT COMPLETED|Overall Study||5
8378329|NCT01117012|20653229|P1|NOT COMPLETED|Overall Study||8
8378330|NCT01117012|20653228|P2|COMPLETED|Overall Study||98
8378331|NCT01117012|20653229|P1|COMPLETED|Overall Study||81
8378332|NCT01117012|20653228|P2|STARTED|Overall Study||103
8378333|NCT01117012|20653229|P1|STARTED|Overall Study||89
8378334|NCT01116986|20653277|P32|NOT COMPLETED|Overall Study||3
8378335|NCT01116986|20653278|P31|NOT COMPLETED|Overall Study||1
8378336|NCT01116986|20653279|P30|NOT COMPLETED|Overall Study||0
8378337|NCT01116986|20653280|P29|NOT COMPLETED|Overall Study||0
8378338|NCT01116986|20653281|P28|NOT COMPLETED|Overall Study||1
8378339|NCT01116986|20653282|P27|NOT COMPLETED|Overall Study||4
8378340|NCT01116986|20653283|P26|NOT COMPLETED|Overall Study||0
8378341|NCT01116986|20653284|P25|NOT COMPLETED|Overall Study||3
8378342|NCT01116986|20653285|P24|NOT COMPLETED|Overall Study||2
8378343|NCT01116986|20653286|P23|NOT COMPLETED|Overall Study||4
8378344|NCT01116986|20653287|P22|NOT COMPLETED|Overall Study||2
8378345|NCT01116986|20653288|P21|NOT COMPLETED|Overall Study||2
8378346|NCT01116986|20653289|P20|NOT COMPLETED|Overall Study||2
8378347|NCT01116986|20653290|P19|NOT COMPLETED|Overall Study||3
8378348|NCT01116986|20653291|P18|NOT COMPLETED|Overall Study||5
8378349|NCT01116986|20653292|P17|NOT COMPLETED|Overall Study||3
8378350|NCT01116986|20653293|P16|NOT COMPLETED|Overall Study||6
8378351|NCT01116986|20653294|P15|NOT COMPLETED|Overall Study||0
8378352|NCT01116986|20653295|P14|NOT COMPLETED|Overall Study||3
8378353|NCT01116986|20653296|P13|NOT COMPLETED|Overall Study||1
8378354|NCT01116986|20653297|P12|NOT COMPLETED|Overall Study||0
8378355|NCT01116986|20653298|P11|NOT COMPLETED|Overall Study||1
8378356|NCT01116986|20653299|P10|NOT COMPLETED|Overall Study||4
8378357|NCT01116986|20653300|P9|NOT COMPLETED|Overall Study||1
8378358|NCT01116986|20653301|P8|NOT COMPLETED|Overall Study||2
8378359|NCT01116986|20653302|P7|NOT COMPLETED|Overall Study||2
8378360|NCT01116986|20653303|P6|NOT COMPLETED|Overall Study||2
8378361|NCT01116986|20653304|P5|NOT COMPLETED|Overall Study||4
8378362|NCT01116986|20653305|P4|NOT COMPLETED|Overall Study||2
8378363|NCT01116986|20653306|P3|NOT COMPLETED|Overall Study||2
8378364|NCT01116986|20653307|P2|NOT COMPLETED|Overall Study||3
8378365|NCT01116986|20653308|P1|NOT COMPLETED|Overall Study||2
8378366|NCT01116986|20653277|P32|COMPLETED|Overall Study||14
8378367|NCT01116986|20653278|P31|COMPLETED|Overall Study||16
8378368|NCT01116986|20653279|P30|COMPLETED|Overall Study||17
8378369|NCT01116986|20653280|P29|COMPLETED|Overall Study||17
8378370|NCT01116986|20653281|P28|COMPLETED|Overall Study||18
8378371|NCT01116986|20653282|P27|COMPLETED|Overall Study||14
8378372|NCT01116986|20653283|P26|COMPLETED|Overall Study||19
8378373|NCT01116986|20653284|P25|COMPLETED|Overall Study||15
8378374|NCT01116986|20653285|P24|COMPLETED|Overall Study||19
8378375|NCT01116986|20653286|P23|COMPLETED|Overall Study||19
8378376|NCT01116986|20653287|P22|COMPLETED|Overall Study||18
8378377|NCT01116986|20653288|P21|COMPLETED|Overall Study||22
8378378|NCT01116986|20653289|P20|COMPLETED|Overall Study||13
8378379|NCT01116986|20653290|P19|COMPLETED|Overall Study||20
8378380|NCT01116986|20653291|P18|COMPLETED|Overall Study||19
8378381|NCT01116986|20653292|P17|COMPLETED|Overall Study||13
8378382|NCT01116986|20653293|P16|COMPLETED|Overall Study||15
8378383|NCT01116986|20653294|P15|COMPLETED|Overall Study||17
8378384|NCT01116986|20653295|P14|COMPLETED|Overall Study||16
8378385|NCT01116986|20653296|P13|COMPLETED|Overall Study||16
8378386|NCT01116986|20653297|P12|COMPLETED|Overall Study||20
8378387|NCT01116986|20653298|P11|COMPLETED|Overall Study||18
8378388|NCT01116986|20653299|P10|COMPLETED|Overall Study||19
8378389|NCT01116986|20653300|P9|COMPLETED|Overall Study||19
8378390|NCT01116986|20653301|P8|COMPLETED|Overall Study||20
8378391|NCT01116986|20653302|P7|COMPLETED|Overall Study||20
8378392|NCT01116986|20653303|P6|COMPLETED|Overall Study||20
8378393|NCT01116986|20653304|P5|COMPLETED|Overall Study||20
8378394|NCT01116986|20653305|P4|COMPLETED|Overall Study||20
8378395|NCT01116986|20653306|P3|COMPLETED|Overall Study||16
8378396|NCT01116986|20653307|P2|COMPLETED|Overall Study||16
8378397|NCT01116986|20653308|P1|COMPLETED|Overall Study||22
8378398|NCT01116986|20653277|P32|STARTED|Overall Study||17
8378399|NCT01116986|20653278|P31|STARTED|Overall Study||17
8378400|NCT01116986|20653279|P30|STARTED|Overall Study||17
8378401|NCT01116986|20653280|P29|STARTED|Overall Study||17
8378402|NCT01116986|20653281|P28|STARTED|Overall Study||19
8378403|NCT01116986|20653282|P27|STARTED|Overall Study||18
8378404|NCT01116986|20653283|P26|STARTED|Overall Study||19
8378405|NCT01116986|20653284|P25|STARTED|Overall Study||18
8378406|NCT01116986|20653285|P24|STARTED|Overall Study||21
8378407|NCT01116986|20653286|P23|STARTED|Overall Study||23
8378408|NCT01116986|20653287|P22|STARTED|Overall Study||20
8378409|NCT01116986|20653288|P21|STARTED|Overall Study||24
8378410|NCT01116986|20653289|P20|STARTED|Overall Study||15
8378411|NCT01116986|20653290|P19|STARTED|Overall Study||23
8378412|NCT01116986|20653291|P18|STARTED|Overall Study||24
8378413|NCT01116986|20653292|P17|STARTED|Overall Study||16
8378414|NCT01116986|20653293|P16|STARTED|Overall Study||21
8378415|NCT01116986|20653294|P15|STARTED|Overall Study||17
8378416|NCT01116986|20653295|P14|STARTED|Overall Study||19
8378417|NCT01116986|20653296|P13|STARTED|Overall Study||17
8378418|NCT01116986|20653297|P12|STARTED|Overall Study||20
8378419|NCT01116986|20653298|P11|STARTED|Overall Study||19
8378420|NCT01116986|20653299|P10|STARTED|Overall Study||23
8378421|NCT01116986|20653300|P9|STARTED|Overall Study||20
8378422|NCT01116986|20653301|P8|STARTED|Overall Study||22
8378423|NCT01116986|20653302|P7|STARTED|Overall Study||22
8378424|NCT01116986|20653303|P6|STARTED|Overall Study||22
8378425|NCT01116986|20653304|P5|STARTED|Overall Study||24
8378426|NCT01116986|20653305|P4|STARTED|Overall Study||22
8378427|NCT01116986|20653306|P3|STARTED|Overall Study||18
8378428|NCT01116986|20653307|P2|STARTED|Overall Study||19
8378429|NCT01116986|20653308|P1|STARTED|Overall Study||24
8378430|NCT01116934|20653342|P2|NOT COMPLETED|Overall Study||0
8378431|NCT01116934|20653343|P1|NOT COMPLETED|Overall Study||0
8378432|NCT01116934|20653342|P2|COMPLETED|Overall Study||9
8378433|NCT01116934|20653343|P1|COMPLETED|Overall Study||8
8378434|NCT01116934|20653342|P2|STARTED|Overall Study||9
8378435|NCT01116934|20653343|P1|STARTED|Overall Study||8
8378436|NCT01116921|20653351|P2|NOT COMPLETED|Overall Study||0
8378437|NCT01116921|20653352|P1|NOT COMPLETED|Overall Study||0
8378438|NCT01116921|20653351|P2|COMPLETED|Overall Study||50
8378439|NCT01116921|20653352|P1|COMPLETED|Overall Study||53
8378440|NCT01116921|20653351|P2|STARTED|Overall Study||50
8378441|NCT01116921|20653352|P1|STARTED|Overall Study||53
8378442|NCT01116895|20653372|P4|NOT COMPLETED|Overall Study||3
8378443|NCT01116895|20653373|P3|NOT COMPLETED|Overall Study||4
8378444|NCT01116895|20653374|P2|NOT COMPLETED|Overall Study||7
8378445|NCT01116895|20653375|P1|NOT COMPLETED|Overall Study||4
8378446|NCT01116895|20653372|P4|COMPLETED|Overall Study||11
8378447|NCT01116895|20653373|P3|COMPLETED|Overall Study||14
8378448|NCT01116895|20653374|P2|COMPLETED|Overall Study||8
8378449|NCT01116895|20653375|P1|COMPLETED|Overall Study||12
8378450|NCT01116895|20653372|P4|STARTED|Overall Study||14
8378451|NCT01116895|20653373|P3|STARTED|Overall Study||18
8378452|NCT01116895|20653374|P2|STARTED|Overall Study||15
8378453|NCT01116895|20653375|P1|STARTED|Overall Study||16
8378454|NCT01116882|20653403|P2|NOT COMPLETED|12-month||99
8378455|NCT01116882|20653404|P1|NOT COMPLETED|12-month||267
8378456|NCT01116882|20653403|P2|COMPLETED|12-month||787
8378457|NCT01116882|20653404|P1|COMPLETED|12-month||2439
8378458|NCT01116882|20653403|P2|STARTED|12-month||886
8378459|NCT01116882|20653404|P1|STARTED|12-month||2706
8378460|NCT01116882|20653403|P2|NOT COMPLETED|30-day||31
8378461|NCT01116882|20653404|P1|NOT COMPLETED|30-day||68
8378462|NCT01116882|20653403|P2|COMPLETED|30-day||886
8378463|NCT01116882|20653404|P1|COMPLETED|30-day||2706
8378464|NCT01116882|20653403|P2|STARTED|30-day||917
8378465|NCT01116882|20653404|P1|STARTED|30-day||2774
8378466|NCT01116687|20653442|P1|NOT COMPLETED|Overall Study||4
8378467|NCT01116687|20653442|P1|COMPLETED|Overall Study||33
8378468|NCT01116687|20653442|P1|STARTED|Overall Study||37
8378469|NCT01116661|20653449|P1|NOT COMPLETED|Overall Study||2
8378470|NCT01116661|20653449|P1|COMPLETED|Overall Study||197
8378471|NCT01116661|20653449|P1|STARTED|Overall Study||199
8379102|NCT01116544|20653510|P2|NOT COMPLETED|Overall Study||1
8379103|NCT01116544|20653511|P1|NOT COMPLETED|Overall Study||2
8379104|NCT01116544|20653510|P2|COMPLETED|Overall Study||22
8379105|NCT01116544|20653511|P1|COMPLETED|Overall Study||21
8379106|NCT01116544|20653510|P2|STARTED|Overall Study||23
8379107|NCT01116544|20653511|P1|STARTED|Overall Study||23
8379108|NCT01116466|20653527|P1|NOT COMPLETED|Overall Study||0
8379109|NCT01116466|20653527|P1|COMPLETED|Overall Study||5
8379110|NCT01116466|20653527|P1|STARTED|Overall Study||5
8379111|NCT01116440|20653537|P2|NOT COMPLETED|Follow-up||2
8379112|NCT01116440|20653538|P1|NOT COMPLETED|Follow-up||0
8379113|NCT01116440|20653537|P2|COMPLETED|Follow-up||5
8379114|NCT01116440|20653538|P1|COMPLETED|Follow-up||8
8379115|NCT01116440|20653537|P2|STARTED|Follow-up||7
8379116|NCT01116440|20653538|P1|STARTED|Follow-up||8
8379117|NCT01116440|20653537|P2|NOT COMPLETED|Withdrawal||2
8379118|NCT01116440|20653538|P1|NOT COMPLETED|Withdrawal||0
8379119|NCT01116440|20653537|P2|COMPLETED|Withdrawal||7
8379120|NCT01116440|20653538|P1|COMPLETED|Withdrawal||8
8379121|NCT01116440|20653537|P2|STARTED|Withdrawal||9
8379122|NCT01116440|20653538|P1|STARTED|Withdrawal||8
8379123|NCT01116440|20653537|P2|NOT COMPLETED|Treatment||7
8379124|NCT01116440|20653538|P1|NOT COMPLETED|Treatment||3
8379125|NCT01116440|20653537|P2|COMPLETED|Treatment||9
8379126|NCT01116440|20653538|P1|COMPLETED|Treatment||8
8379127|NCT01116440|20653537|P2|STARTED|Treatment||16
8379128|NCT01116440|20653538|P1|STARTED|Treatment||11
8379129|NCT01116427|20653554|P2|NOT COMPLETED|Extension Phase||2
8379130|NCT01116427|20653555|P1|NOT COMPLETED|Extension Phase||9
8379131|NCT01116427|20653554|P2|COMPLETED|Extension Phase||18
8379132|NCT01116427|20653555|P1|COMPLETED|Extension Phase||29
8379133|NCT01116427|20653554|P2|STARTED|Extension Phase||20
8379134|NCT01116427|20653555|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
8379135|NCT01116427|20653554|P2|NOT COMPLETED|Core Phase||1
8379136|NCT01116427|20653555|P1|NOT COMPLETED|Core Phase||5
8379137|NCT01116427|20653554|P2|COMPLETED|Core Phase||20
8379138|NCT01116427|20653555|P1|COMPLETED|Core Phase||39
8379139|NCT01116427|20653554|P2|STARTED|Core Phase||21
8379140|NCT01116427|20653555|P1|STARTED|Core Phase||44
8379141|NCT01116401|20653591|P1|NOT COMPLETED|Overall Study||0
8379142|NCT01116401|20653591|P1|COMPLETED|Overall Study||29
8379143|NCT01116401|20653591|P1|STARTED|Overall Study||29
8379144|NCT01116232|20653596|P1|NOT COMPLETED|Overall Study||4
8379145|NCT01116232|20653596|P1|COMPLETED|Overall Study||0
8379146|NCT01116232|20653596|P1|STARTED|Overall Study||4
8379147|NCT01116102|20653615|P8|NOT COMPLETED|Overall Study||0
8379148|NCT01116102|20653616|P7|NOT COMPLETED|Overall Study||0
8379149|NCT01116102|20653617|P6|NOT COMPLETED|Overall Study||0
8379150|NCT01116102|20653618|P5|NOT COMPLETED|Overall Study||0
8379151|NCT01116102|20653619|P4|NOT COMPLETED|Overall Study||0
8379152|NCT01116102|20653620|P3|NOT COMPLETED|Overall Study||0
8379153|NCT01116102|20653621|P2|NOT COMPLETED|Overall Study||0
8379154|NCT01116102|20653622|P1|NOT COMPLETED|Overall Study||0
8379155|NCT01116102|20653615|P8|COMPLETED|Overall Study||3
8379156|NCT01116102|20653616|P7|COMPLETED|Overall Study||2
8379157|NCT01116102|20653617|P6|COMPLETED|Overall Study||2
8379158|NCT01116102|20653618|P5|COMPLETED|Overall Study||2
8379159|NCT01116102|20653619|P4|COMPLETED|Overall Study||3
8379160|NCT01116102|20653620|P3|COMPLETED|Overall Study||3
8379161|NCT01116102|20653621|P2|COMPLETED|Overall Study||3
8379162|NCT01116102|20653622|P1|COMPLETED|Overall Study||2
8379163|NCT01116102|20653615|P8|STARTED|Overall Study||3
8379164|NCT01116102|20653616|P7|STARTED|Overall Study||2
8379165|NCT01116102|20653617|P6|STARTED|Overall Study||2
8379166|NCT01116102|20653618|P5|STARTED|Overall Study||2
8379167|NCT01116102|20653619|P4|STARTED|Overall Study||3
8379168|NCT01116102|20653620|P3|STARTED|Overall Study||3
8379169|NCT01116102|20653621|P2|STARTED|Overall Study||3
8379170|NCT01116102|20653622|P1|STARTED|Overall Study||2
8379171|NCT01116037|20653664|P1|NOT COMPLETED|Overall Study||25
8379172|NCT01116037|20653664|P1|COMPLETED|Overall Study||1
8379173|NCT01116037|20653664|P1|STARTED|Overall Study||26
8379174|NCT01116024|20653669|P1|NOT COMPLETED|Overall Study||52
8379175|NCT01116024|20653669|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
8379176|NCT01116024|20653669|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
8379177|NCT01115998|20653710|P2|NOT COMPLETED|Overall Study||6
8379178|NCT01115998|20653711|P1|NOT COMPLETED|Overall Study||6
8379179|NCT01115998|20653710|P2|COMPLETED|Overall Study||11
8379180|NCT01115998|20653711|P1|COMPLETED|Overall Study||11
8379181|NCT01115998|20653710|P2|STARTED|Overall Study||17
8379182|NCT01115998|20653711|P1|STARTED|Overall Study||17
8379183|NCT01115933|20653721|P1|NOT COMPLETED|Overall Study||1
8379184|NCT01115933|20653721|P1|COMPLETED|Overall Study||64
8379185|NCT01115933|20653721|P1|STARTED|Overall Study||65
8379186|NCT01115855|20653818|P2|NOT COMPLETED|Overall Study||36
8379187|NCT01115855|20653819|P1|NOT COMPLETED|Overall Study||36
8379188|NCT01115855|20653818|P2|COMPLETED|Overall Study||74
8379189|NCT01115855|20653819|P1|COMPLETED|Overall Study||75
8379190|NCT01115855|20653818|P2|STARTED|Overall Study||110
8379191|NCT01115855|20653819|P1|STARTED|Overall Study||111
8379192|NCT01115803|20653874|P7|NOT COMPLETED|Overall Study||2
8379193|NCT01115803|20653875|P6|NOT COMPLETED|Overall Study||0
8379194|NCT01115803|20653876|P5|NOT COMPLETED|Overall Study||0
8379195|NCT01115803|20653877|P4|NOT COMPLETED|Overall Study||0
8379196|NCT01115803|20653878|P3|NOT COMPLETED|Overall Study||1
8379197|NCT01115803|20653879|P2|NOT COMPLETED|Overall Study||0
8379198|NCT01115803|20653880|P1|NOT COMPLETED|Overall Study||0
8379199|NCT01115803|20653874|P7|COMPLETED|Overall Study||4
8379200|NCT01115803|20653875|P6|COMPLETED|Overall Study||3
8379201|NCT01115803|20653876|P5|COMPLETED|Overall Study||3
8379202|NCT01115803|20653877|P4|COMPLETED|Overall Study||5
8379203|NCT01115803|20653878|P3|COMPLETED|Overall Study||2
8379204|NCT01115803|20653879|P2|COMPLETED|Overall Study||5
8379205|NCT01115803|20653880|P1|COMPLETED|Overall Study||4
8379206|NCT01115803|20653874|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8379207|NCT01115803|20653875|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8379208|NCT01115803|20653876|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8379209|NCT01115803|20653877|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8379210|NCT01115803|20653878|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8379211|NCT01115803|20653879|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
8379212|NCT01115803|20653880|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8379213|NCT01115803|20653874|P7|STARTED|Overall Study||6
8379214|NCT01115803|20653875|P6|STARTED|Overall Study||3
8379215|NCT01115803|20653876|P5|STARTED|Overall Study||3
8379216|NCT01115803|20653877|P4|STARTED|Overall Study||5
8379217|NCT01115803|20653878|P3|STARTED|Overall Study||3
8379218|NCT01115803|20653879|P2|STARTED|Overall Study||5
8379219|NCT01115803|20653880|P1|STARTED|Overall Study||4
8379220|NCT01115738|20653943|P3|NOT COMPLETED|Overall Study||27
8379221|NCT01115738|20653944|P2|NOT COMPLETED|Overall Study||21
8379222|NCT01115738|20653945|P1|NOT COMPLETED|Overall Study||25
8379223|NCT01115738|20653943|P3|COMPLETED|Overall Study||62
8379224|NCT01115738|20653944|P2|COMPLETED|Overall Study||62
8379225|NCT01115738|20653945|P1|COMPLETED|Overall Study||85
8379226|NCT01115738|20653943|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
8379227|NCT01115738|20653944|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
8379228|NCT01115738|20653945|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
8379229|NCT01115738|20653943|P3|Received Any Treatment|Overall Study||88
8379230|NCT01115738|20653944|P2|Received Any Treatment|Overall Study||79
8379231|NCT01115738|20653945|P1|Received Any Treatment|Overall Study||109
8379232|NCT01115738|20653943|P3|STARTED|Overall Study||89
8379233|NCT01115738|20653944|P2|STARTED|Overall Study||83
8379234|NCT01115738|20653945|P1|STARTED|Overall Study||110
8379235|NCT01115699|20653979|P1|NOT COMPLETED|Overall Study||0
8379236|NCT01115699|20653979|P1|COMPLETED|Overall Study||2
8379237|NCT01115699|20653979|P1|STARTED|Overall Study||2
8379238|NCT01115673|20653987|P3|NOT COMPLETED|Overall Study||0
8379239|NCT01115673|20653988|P2|NOT COMPLETED|Overall Study||0
8379240|NCT01115673|20653989|P1|NOT COMPLETED|Overall Study||0
8379241|NCT01115673|20653987|P3|COMPLETED|Overall Study||60
8379242|NCT01115673|20653988|P2|COMPLETED|Overall Study||241
8379243|NCT01115673|20653989|P1|COMPLETED|Overall Study||239
8379244|NCT01115673|20653987|P3|STARTED|Overall Study||60
8379245|NCT01115673|20653988|P2|STARTED|Overall Study||241
8379246|NCT01115673|20653989|P1|STARTED|Overall Study||239
8379247|NCT01115660|20654125|P2|NOT COMPLETED|Overall Study||0
8379248|NCT01115660|20654126|P1|NOT COMPLETED|Overall Study||1
8379249|NCT01115660|20654125|P2|COMPLETED|Overall Study||10
8379250|NCT01115660|20654126|P1|COMPLETED|Overall Study||19
8379251|NCT01115660|20654125|P2|STARTED|Overall Study||10
8379252|NCT01115660|20654126|P1|STARTED|Overall Study||20
8379253|NCT01115582|20654134|P1|NOT COMPLETED|Overall Study||0
8379254|NCT01115582|20654134|P1|COMPLETED|Overall Study||16
8379255|NCT01115582|20654134|P1|STARTED|Overall Study||16
8379256|NCT01115569|20654143|P2|NOT COMPLETED|Maintenance Phase||139
8379257|NCT01115569|20654144|P1|NOT COMPLETED|Maintenance Phase||0
8379258|NCT01115569|20654143|P2|COMPLETED|Maintenance Phase||285
8379259|NCT01115569|20654144|P1|COMPLETED|Maintenance Phase||0
8379260|NCT01115569|20654143|P2|STARTED|Maintenance Phase||424
8379261|NCT01115569|20654144|P1|STARTED|Maintenance Phase||0
8379262|NCT01115569|20654143|P2|NOT COMPLETED|Conversion/Titration Phase||0
8379263|NCT01115569|20654144|P1|NOT COMPLETED|Conversion/Titration Phase||214
8379264|NCT01115569|20654143|P2|COMPLETED|Conversion/Titration Phase||0
8379265|NCT01115569|20654144|P1|COMPLETED|Conversion/Titration Phase||424
8379266|NCT01115569|20654143|P2|STARTED|Conversion/Titration Phase||0
8379267|NCT01115569|20654144|P1|STARTED|Conversion/Titration Phase||638
8379268|NCT01115556|20654151|P2|NOT COMPLETED|Overall Study||0
8379269|NCT01115556|20654152|P1|NOT COMPLETED|Overall Study||0
8379270|NCT01115556|20654151|P2|COMPLETED|Overall Study||2
8379271|NCT01115556|20654152|P1|COMPLETED|Overall Study||7
8379272|NCT01115556|20654151|P2|STARTED|Overall Study||2
8379273|NCT01115556|20654152|P1|STARTED|Overall Study||7
8379274|NCT01115517|20654162|P2|NOT COMPLETED|Overall Study||5
8379275|NCT01115517|20654163|P1|NOT COMPLETED|Overall Study||4
8379276|NCT01115517|20654162|P2|COMPLETED|Overall Study||16
8379277|NCT01115517|20654163|P1|COMPLETED|Overall Study||14
8379278|NCT01115517|20654162|P2|STARTED|Overall Study||21
8379279|NCT01115517|20654163|P1|STARTED|Overall Study||18
8379280|NCT01115491|20654173|P1|NOT COMPLETED|Overall Study||30
8379281|NCT01115491|20654173|P1|COMPLETED|Overall Study||2
8379282|NCT01115491|20654173|P1|STARTED|Overall Study||32
8379283|NCT01115452|20654182|P1|NOT COMPLETED|Overall Study||0
8379284|NCT01115452|20654182|P1|COMPLETED|Overall Study||32
8379285|NCT01115452|20654182|P1|STARTED|Overall Study||32
8379286|NCT01115309|20654232|P1|NOT COMPLETED|Long-term Follow-up||6
8379287|NCT01115309|20654232|P1|COMPLETED|Long-term Follow-up||44
8379288|NCT01115309|20654232|P1|12-Month Follow-up|Long-term Follow-up||44
8379289|NCT01115309|20654232|P1|6-Month Follow-up|Long-term Follow-up||46
8379290|NCT01115309|20654232|P1|STARTED|Long-term Follow-up||50
8379291|NCT01115309|20654232|P1|NOT COMPLETED|Procedure Safety (1-Month)||3
8379292|NCT01115309|20654232|P1|COMPLETED|Procedure Safety (1-Month)||172
8379293|NCT01115309|20654232|P1|STARTED|Procedure Safety (1-Month)||175
8379294|NCT01115244|20654242|P2|NOT COMPLETED|Overall Study||0
8379295|NCT01115244|20654243|P1|NOT COMPLETED|Overall Study||0
8379296|NCT01115244|20654242|P2|COMPLETED|Overall Study||0
8379297|NCT01115244|20654243|P1|COMPLETED|Overall Study||0
8379298|NCT01115244|20654242|P2|STARTED|Overall Study||0
8379299|NCT01115244|20654243|P1|STARTED|Overall Study||0
8379300|NCT01115231|20654255|P2|NOT COMPLETED|Overall Study||0
8379301|NCT01115231|20654256|P1|NOT COMPLETED|Overall Study||0
8379302|NCT01115231|20654255|P2|COMPLETED|Overall Study||90
8379303|NCT01115231|20654256|P1|COMPLETED|Overall Study||133
8379304|NCT01115231|20654255|P2|STARTED|Overall Study||90
8379305|NCT01115231|20654256|P1|STARTED|Overall Study||133
8379306|NCT01115166|20654268|P1|NOT COMPLETED|Overall Study||0
8379307|NCT01115166|20654268|P1|COMPLETED|Overall Study||10
8379308|NCT01115166|20654268|P1|STARTED|Overall Study||10
8379309|NCT01115101|20654276|P2|NOT COMPLETED|Overall Study||0
8379310|NCT01115101|20654277|P1|NOT COMPLETED|Overall Study||0
8379311|NCT01115101|20654276|P2|COMPLETED|Overall Study||126
8379312|NCT01115101|20654277|P1|COMPLETED|Overall Study||113
8379313|NCT01115101|20654276|P2|STARTED|Overall Study||126
8379314|NCT01115101|20654277|P1|STARTED|Overall Study||113
8379315|NCT01114997|20654286|P3|NOT COMPLETED|Overall Study||0
8379316|NCT01114997|20654287|P2|NOT COMPLETED|Overall Study||0
8379317|NCT01114997|20654288|P1|NOT COMPLETED|Overall Study||0
8379318|NCT01114997|20654286|P3|COMPLETED|Overall Study||11
8379319|NCT01114997|20654287|P2|COMPLETED|Overall Study||10
8379320|NCT01114997|20654288|P1|COMPLETED|Overall Study||11
8379321|NCT01114997|20654286|P3|STARTED|Overall Study||11
8379322|NCT01114997|20654287|P2|STARTED|Overall Study||10
8379323|NCT01114997|20654288|P1|STARTED|Overall Study||11
8379324|NCT01114971|20654317|P3|NOT COMPLETED|Overall Study||0
8379325|NCT01114971|20654318|P2|NOT COMPLETED|Overall Study||0
8379326|NCT01114971|20654319|P1|NOT COMPLETED|Overall Study||0
8379327|NCT01114971|20654317|P3|COMPLETED|Overall Study||25
8379328|NCT01114971|20654318|P2|COMPLETED|Overall Study||25
8379329|NCT01114971|20654319|P1|COMPLETED|Overall Study||25
8379330|NCT01114971|20654317|P3|STARTED|Overall Study||25
8379331|NCT01114971|20654318|P2|STARTED|Overall Study||25
8379332|NCT01114971|20654319|P1|STARTED|Overall Study||25
8379333|NCT01114945|20654346|P4|NOT COMPLETED|Overall Study||0
8379334|NCT01114945|20654347|P3|NOT COMPLETED|Overall Study||0
8379335|NCT01114945|20654348|P2|NOT COMPLETED|Overall Study||0
8379336|NCT01114945|20654349|P1|NOT COMPLETED|Overall Study||0
8379337|NCT01114945|20654346|P4|COMPLETED|Overall Study||31
8379338|NCT01114945|20654347|P3|COMPLETED|Overall Study||30
8379339|NCT01114945|20654348|P2|COMPLETED|Overall Study||30
8379340|NCT01114945|20654349|P1|COMPLETED|Overall Study||30
8379341|NCT01114945|20654346|P4|STARTED|Overall Study||31
8379342|NCT01114945|20654347|P3|STARTED|Overall Study||30
8379343|NCT01114945|20654348|P2|STARTED|Overall Study||30
8379344|NCT01114945|20654349|P1|STARTED|Overall Study||30
8379345|NCT01114893|20654376|P5|NOT COMPLETED|Overall Study||0
8379346|NCT01114893|20654377|P4|NOT COMPLETED|Overall Study||0
8379347|NCT01114893|20654378|P3|NOT COMPLETED|Overall Study||0
8379348|NCT01114893|20654379|P2|NOT COMPLETED|Overall Study||0
8379349|NCT01114893|20654380|P1|NOT COMPLETED|Overall Study||0
8379350|NCT01114893|20654376|P5|COMPLETED|Overall Study||12
8379351|NCT01114893|20654377|P4|COMPLETED|Overall Study||13
8379352|NCT01114893|20654378|P3|COMPLETED|Overall Study||14
8379353|NCT01114893|20654379|P2|COMPLETED|Overall Study||14
8379354|NCT01114893|20654380|P1|COMPLETED|Overall Study||14
8379355|NCT01114893|20654376|P5|STARTED|Overall Study||12
8379356|NCT01114893|20654377|P4|STARTED|Overall Study||13
8379357|NCT01114893|20654378|P3|STARTED|Overall Study||14
8379358|NCT01114893|20654379|P2|STARTED|Overall Study||14
8379359|NCT01114893|20654380|P1|STARTED|Overall Study||14
8379360|NCT01114880|20654399|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
8379361|NCT01114880|20654400|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
8379362|NCT01114880|20654399|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
8379363|NCT01114880|20654400|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
8379364|NCT01114880|20654399|P2|STARTED|Period 2 (Week 12 to Week 24)||113
8379365|NCT01114880|20654400|P1|STARTED|Period 2 (Week 12 to Week 24)||224
8379366|NCT01114880|20654399|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
8379367|NCT01114880|20654400|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
8379368|NCT01114880|20654399|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
8379369|NCT01114880|20654400|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
8379370|NCT01114880|20654399|P2|STARTED|Period 1 (Week 0 to Week 12)||115
8379371|NCT01114880|20654400|P1|STARTED|Period 1 (Week 0 to Week 12)||229
8379372|NCT01114828|20654452|P2|NOT COMPLETED|Overall Study||4
8379373|NCT01114828|20654453|P1|NOT COMPLETED|Overall Study||3
8379374|NCT01114828|20654452|P2|COMPLETED|Overall Study||17
8379375|NCT01114828|20654453|P1|COMPLETED|Overall Study||16
8379376|NCT01114828|20654452|P2|STARTED|Overall Study||21
8379377|NCT01114828|20654453|P1|STARTED|Overall Study||19
8379378|NCT01114737|20654463|P2|NOT COMPLETED|Open-Label Treatment Period||2
8379379|NCT01114737|20654464|P1|NOT COMPLETED|Open-Label Treatment Period||5
8379380|NCT01114737|20654463|P2|COMPLETED|Open-Label Treatment Period||95
8379381|NCT01114737|20654464|P1|COMPLETED|Open-Label Treatment Period||100
8379382|NCT01114737|20654463|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
8379383|NCT01114737|20654464|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
8379384|NCT01114737|20654463|P2|NOT COMPLETED|Randomized Treatment Period||1
8379385|NCT01114737|20654464|P1|NOT COMPLETED|Randomized Treatment Period||3
8379386|NCT01114737|20654463|P2|COMPLETED|Randomized Treatment Period||97
8379387|NCT01114737|20654464|P1|COMPLETED|Randomized Treatment Period||105
8379388|NCT01114737|20654463|P2|STARTED|Randomized Treatment Period||98
8379389|NCT01114737|20654464|P1|STARTED|Randomized Treatment Period||108
8379390|NCT01114724|20654512|P1|NOT COMPLETED|Overall Study||10
8379391|NCT01114724|20654512|P1|COMPLETED|Overall Study||40
8379392|NCT01114724|20654512|P1|STARTED|Overall Study||50
8379393|NCT01114672|20654532|P2|NOT COMPLETED|Overall Study||2
8379394|NCT01114672|20654533|P1|NOT COMPLETED|Overall Study||4
8379395|NCT01114672|20654532|P2|COMPLETED|Overall Study||23
8379396|NCT01114672|20654533|P1|COMPLETED|Overall Study||21
8379397|NCT01114672|20654532|P2|STARTED|Overall Study||25
8379398|NCT01114672|20654533|P1|STARTED|Overall Study||25
8379399|NCT01114646|20654541|P2|NOT COMPLETED|Overall Study||2
8379400|NCT01114646|20654542|P1|NOT COMPLETED|Overall Study||3
8379401|NCT01114646|20654541|P2|COMPLETED|Overall Study||62
8379402|NCT01114646|20654542|P1|COMPLETED|Overall Study||63
8379403|NCT01114646|20654541|P2|STARTED|Overall Study||64
8379404|NCT01114646|20654542|P1|STARTED|Overall Study||66
8379405|NCT01114620|20654548|P1|NOT COMPLETED|Overall Study||0
8379406|NCT01114620|20654548|P1|COMPLETED|Overall Study||50
8379407|NCT01114620|20654548|P1|STARTED|Overall Study||50
8379408|NCT01114581|20654581|P2|NOT COMPLETED|Overall Study||0
8379409|NCT01114581|20654582|P1|NOT COMPLETED|Overall Study||0
8379410|NCT01114581|20654581|P2|COMPLETED|Overall Study||19
8379411|NCT01114581|20654582|P1|COMPLETED|Overall Study||19
8379412|NCT01114581|20654581|P2|STARTED|Overall Study||19
8379413|NCT01114581|20654582|P1|STARTED|Overall Study||19
8379414|NCT01114555|20654592|P1|NOT COMPLETED|Overall Study||0
8379415|NCT01114555|20654592|P1|COMPLETED|Overall Study||34
8379416|NCT01114555|20654592|P1|STARTED|Overall Study||34
8379417|NCT01114529|20654602|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
8379418|NCT01114529|20654603|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
8379419|NCT01114529|20654604|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
8379420|NCT01114529|20654602|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
8379421|NCT01114529|20654603|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
8379422|NCT01114529|20654604|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
8379423|NCT01114529|20654602|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
8379424|NCT01114529|20654603|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
8379425|NCT01114529|20654604|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
8379426|NCT01114529|20654602|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
8379427|NCT01114529|20654603|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
8379428|NCT01114529|20654604|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
8379429|NCT01114529|20654602|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
8379430|NCT01114529|20654603|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
8379431|NCT01114529|20654604|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
8379432|NCT01114529|20654602|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
8379433|NCT01114529|20654603|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
8379434|NCT01114529|20654604|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
8379435|NCT01114516|20654623|P2|NOT COMPLETED|Overall Study||1
8379436|NCT01114516|20654624|P1|NOT COMPLETED|Overall Study||2
8379437|NCT01114516|20654623|P2|COMPLETED|Overall Study||26
8379438|NCT01114516|20654624|P1|COMPLETED|Overall Study||24
8379439|NCT01114516|20654623|P2|STARTED|Overall Study||27
8379440|NCT01114516|20654624|P1|STARTED|Overall Study||26
8379441|NCT01114503|20654638|P1|NOT COMPLETED|Overall Study||0
8379442|NCT01114503|20654638|P1|COMPLETED|Overall Study||2
8379443|NCT01114503|20654638|P1|STARTED|Overall Study||2
8379444|NCT01114438|20654659|P1|NOT COMPLETED|Overall Study||14
8379445|NCT01114438|20654659|P1|COMPLETED|Overall Study||31
8379446|NCT01114438|20654659|P1|STARTED|Overall Study||45
8379447|NCT01114373|20654669|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
8379448|NCT01114373|20654670|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8379449|NCT01114373|20654669|P2|COMPLETED|Intervention 2 (4 Weeks)||18
8379450|NCT01114373|20654670|P1|COMPLETED|Intervention 2 (4 Weeks)||18
8379451|NCT01114373|20654669|P2|STARTED|Intervention 2 (4 Weeks)||19
8379452|NCT01114373|20654670|P1|STARTED|Intervention 2 (4 Weeks)||18
8379453|NCT01114373|20654669|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
8379454|NCT01114373|20654670|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
8379455|NCT01114373|20654669|P2|COMPLETED|Intervention 1 (4 Weeks)||19
8379456|NCT01114373|20654670|P1|COMPLETED|Intervention 1 (4 Weeks)||18
8379457|NCT01114373|20654669|P2|STARTED|Intervention 1 (4 Weeks)||19
8379458|NCT01114373|20654670|P1|STARTED|Intervention 1 (4 Weeks)||21
8379459|NCT01114360|20654702|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8379460|NCT01114360|20654703|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8379461|NCT01114360|20654702|P2|COMPLETED|Intervention 2 (4 Weeks)||18
8379462|NCT01114360|20654703|P1|COMPLETED|Intervention 2 (4 Weeks)||18
8379463|NCT01114360|20654702|P2|STARTED|Intervention 2 (4 Weeks)||18
8379464|NCT01114360|20654703|P1|STARTED|Intervention 2 (4 Weeks)||18
8379465|NCT01114360|20654702|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
8379466|NCT01114360|20654703|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
8379467|NCT01114360|20654702|P2|COMPLETED|Intervention 1 (4 Weeks)||18
8379468|NCT01114360|20654703|P1|COMPLETED|Intervention 1 (4 Weeks)||18
8379469|NCT01114360|20654702|P2|STARTED|Intervention 1 (4 Weeks)||19
8379470|NCT01114360|20654703|P1|STARTED|Intervention 1 (4 Weeks)||18
8379471|NCT01114334|20654741|P2|NOT COMPLETED|Overall Study||22
8379472|NCT01114334|20654742|P1|NOT COMPLETED|Overall Study||21
8379473|NCT01114334|20654741|P2|COMPLETED|Overall Study||58
8379474|NCT01114334|20654742|P1|COMPLETED|Overall Study||67
8379475|NCT01114334|20654741|P2|STARTED|Overall Study||80
8379476|NCT01114334|20654742|P1|STARTED|Overall Study||88
8379477|NCT01114217|20654754|P2|NOT COMPLETED|Overall Study||98
8379478|NCT01114217|20654755|P1|NOT COMPLETED|Overall Study||75
8379479|NCT01114217|20654754|P2|COMPLETED|Overall Study||199
8379480|NCT01114217|20654755|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
8379481|NCT01114217|20654754|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
8379482|NCT01114217|20654755|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
8379483|NCT01114217|20654754|P2|STARTED|Overall Study||297
8379484|NCT01114217|20654755|P1|STARTED|Overall Study||337
8379485|NCT01114204|20654767|P2|NOT COMPLETED|Overall Study||8
8379486|NCT01114204|20654768|P1|NOT COMPLETED|Overall Study||21
8379487|NCT01114204|20654767|P2|COMPLETED|Overall Study||191
8379488|NCT01114204|20654768|P1|COMPLETED|Overall Study||385
8379489|NCT01114204|20654767|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
8379490|NCT01114204|20654768|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
8379491|NCT01114204|20654767|P2|STARTED|Overall Study||199
8379492|NCT01114204|20654768|P1|STARTED|Overall Study||406
8379493|NCT01114139|20654786|P2|NOT COMPLETED|Overall Study||16
8379494|NCT01114139|20654787|P1|NOT COMPLETED|Overall Study||40
8379495|NCT01114139|20654786|P2|COMPLETED|Overall Study||187
8379496|NCT01114139|20654787|P1|COMPLETED|Overall Study||569
8379497|NCT01114139|20654786|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
8379498|NCT01114139|20654787|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
8379499|NCT01114139|20654786|P2|STARTED|Overall Study||203
8379500|NCT01114139|20654787|P1|STARTED|Overall Study||609
8379501|NCT01113983|20654805|P2|NOT COMPLETED|Overall Study||17
8379502|NCT01113983|20654806|P1|NOT COMPLETED|Overall Study||25
8379503|NCT01113983|20654805|P2|COMPLETED|Overall Study||10
8379504|NCT01113983|20654806|P1|COMPLETED|Overall Study||12
8379505|NCT01113983|20654805|P2|STARTED|Overall Study||27
8379506|NCT01113983|20654806|P1|STARTED|Overall Study||37
8379507|NCT01113931|20654816|P2|NOT COMPLETED|Overall Study||17
8379508|NCT01113931|20654817|P1|NOT COMPLETED|Overall Study||19
8379509|NCT01113931|20654816|P2|COMPLETED|Overall Study||231
8379510|NCT01113931|20654817|P1|COMPLETED|Overall Study||228
8379511|NCT01113931|20654816|P2|mITT Population|Overall Study||190
8379512|NCT01113931|20654817|P1|mITT Population|Overall Study||188
8379513|NCT01113931|20654816|P2|Safety Population|Overall Study||248
8379514|NCT01113931|20654817|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
8379515|NCT01113931|20654816|P2|STARTED|Overall Study||248
8379516|NCT01113931|20654817|P1|STARTED|Overall Study||247
8379517|NCT01113892|20654831|P2|NOT COMPLETED|Overall Study||16
8379518|NCT01113892|20654832|P1|NOT COMPLETED|Overall Study||14
8379519|NCT01113892|20654831|P2|COMPLETED|Overall Study||90
8379520|NCT01113892|20654832|P1|COMPLETED|Overall Study||87
8379521|NCT01113892|20654831|P2|STARTED|Overall Study||106
8379522|NCT01113892|20654832|P1|STARTED|Overall Study||101
8379523|NCT01113879|20654860|P2|NOT COMPLETED|Period 2: Block 2||0
8379524|NCT01113879|20654861|P1|NOT COMPLETED|Period 2: Block 2||0
8379525|NCT01113879|20654860|P2|COMPLETED|Period 2: Block 2||2
8379526|NCT01113879|20654861|P1|COMPLETED|Period 2: Block 2||5
8379527|NCT01113879|20654860|P2|STARTED|Period 2: Block 2||2
8379528|NCT01113879|20654861|P1|STARTED|Period 2: Block 2||5
8379529|NCT01113879|20654860|P2|NOT COMPLETED|Period 1: Block 1||0
8379530|NCT01113879|20654861|P1|NOT COMPLETED|Period 1: Block 1||2
8379531|NCT01113879|20654860|P2|COMPLETED|Period 1: Block 1||2
8379532|NCT01113879|20654861|P1|COMPLETED|Period 1: Block 1||5
8379533|NCT01113879|20654860|P2|STARTED|Period 1: Block 1||2
8379534|NCT01113879|20654861|P1|STARTED|Period 1: Block 1||7
8379535|NCT01113801|20654873|P4|NOT COMPLETED|Overall Study||41
8379536|NCT01113801|20654874|P3|NOT COMPLETED|Overall Study||37
8379537|NCT01113801|20654875|P2|NOT COMPLETED|Overall Study||40
8379538|NCT01113801|20654876|P1|NOT COMPLETED|Overall Study||41
8379539|NCT01113801|20654873|P4|COMPLETED|Overall Study||65
8379540|NCT01113801|20654874|P3|COMPLETED|Overall Study||66
8379541|NCT01113801|20654875|P2|COMPLETED|Overall Study||65
8379542|NCT01113801|20654876|P1|COMPLETED|Overall Study||62
8379543|NCT01113801|20654873|P4|Received at Least One Dose of Drug|Overall Study||105
8379544|NCT01113801|20654874|P3|Received at Least One Dose of Drug|Overall Study||103
8379545|NCT01113801|20654875|P2|Received at Least One Dose of Drug|Overall Study||105
8379546|NCT01113801|20654876|P1|Received at Least One Dose of Drug|Overall Study||103
8379547|NCT01113801|20654873|P4|STARTED|Overall Study||106
8379548|NCT01113801|20654874|P3|STARTED|Overall Study||103
8379549|NCT01113801|20654875|P2|STARTED|Overall Study||105
8379550|NCT01113801|20654876|P1|STARTED|Overall Study||103
8379551|NCT01113749|20654904|P2|NOT COMPLETED|Overall Study||2
8379552|NCT01113749|20654905|P1|NOT COMPLETED|Overall Study||1
8379553|NCT01113749|20654904|P2|COMPLETED|Overall Study||127
8379554|NCT01113749|20654905|P1|COMPLETED|Overall Study||126
8379555|NCT01113749|20654904|P2|STARTED|Overall Study||129
8379556|NCT01113749|20654905|P1|STARTED|Overall Study||127
8379557|NCT01113723|20654917|P2|NOT COMPLETED|Overall Study||0
8379558|NCT01113723|20654918|P1|NOT COMPLETED|Overall Study||0
8379559|NCT01113723|20654917|P2|COMPLETED|Overall Study||70
8379560|NCT01113723|20654918|P1|COMPLETED|Overall Study||70
8379561|NCT01113723|20654917|P2|STARTED|Overall Study||70
8379562|NCT01113723|20654918|P1|STARTED|Overall Study||70
8379563|NCT01113710|20654928|P1|NOT COMPLETED|Overall Study||269
8379564|NCT01113710|20654928|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
8379565|NCT01113710|20654928|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
8379566|NCT01113632|20654939|P2|NOT COMPLETED|Overall Study||25
8379567|NCT01113632|20654940|P1|NOT COMPLETED|Overall Study||31
8379568|NCT01113632|20654939|P2|COMPLETED|Overall Study||19
8379569|NCT01113632|20654940|P1|COMPLETED|Overall Study||2
8379570|NCT01113632|20654939|P2|STARTED|Overall Study||44
8379571|NCT01113632|20654940|P1|STARTED|Overall Study||33
8379572|NCT01113580|20654956|P2|NOT COMPLETED|Overall Study||0
8379573|NCT01113580|20654957|P1|NOT COMPLETED|Overall Study||1
8379574|NCT01113580|20654956|P2|COMPLETED|Overall Study||60
8379575|NCT01113580|20654957|P1|COMPLETED|Overall Study||59
8379576|NCT01113580|20654956|P2|STARTED|Overall Study||60
8379577|NCT01113580|20654957|P1|STARTED|Overall Study||60
8379578|NCT01113541|20654971|P1|NOT COMPLETED|Overall Study||13
8379579|NCT01113541|20654971|P1|COMPLETED|Overall Study||0
8379580|NCT01113541|20654971|P1|STARTED|Overall Study||13
8379581|NCT01113463|20655004|P1|NOT COMPLETED|Overall Study||5
8379582|NCT01113463|20655004|P1|COMPLETED|Overall Study||12
8379583|NCT01113463|20655004|P1|STARTED|Overall Study||17
8379584|NCT01113398|20655009|P1|NOT COMPLETED|Overall Study||0
8379585|NCT01113398|20655009|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
8379586|NCT01113398|20655009|P1|STARTED|Overall Study||36
8379587|NCT01113385|20655016|P1|NOT COMPLETED|Overall Study||0
8379588|NCT01113385|20655016|P1|COMPLETED|Overall Study||7
8379589|NCT01113385|20655016|P1|STARTED|Overall Study||7
8379590|NCT01113008|20655023|P2|NOT COMPLETED|Overall Study||0
8379591|NCT01113008|20655024|P1|NOT COMPLETED|Overall Study||0
8379592|NCT01113008|20655023|P2|COMPLETED|Overall Study||133
8379593|NCT01113008|20655024|P1|COMPLETED|Overall Study||133
8379594|NCT01113008|20655023|P2|STARTED|Overall Study||133
8379595|NCT01113008|20655024|P1|STARTED|Overall Study||133
8379596|NCT01112982|20655034|P1|NOT COMPLETED|Overall Study||2
8379597|NCT01112982|20655034|P1|COMPLETED|Overall Study||72
8379598|NCT01112982|20655034|P1|STARTED|Overall Study||74
8379599|NCT01112917|20655046|P2|NOT COMPLETED|Overall Study||15
8379600|NCT01112917|20655047|P1|NOT COMPLETED|Overall Study||7
8379601|NCT01112917|20655046|P2|COMPLETED|Overall Study||38
8379602|NCT01112917|20655047|P1|COMPLETED|Overall Study||89
8379603|NCT01112917|20655046|P2|STARTED|Overall Study||53
8379604|NCT01112917|20655047|P1|STARTED|Overall Study||96
8379605|NCT01112865|20655052|P2|NOT COMPLETED|Second Intervention||0
8379606|NCT01112865|20655053|P1|NOT COMPLETED|Second Intervention||0
8379607|NCT01112865|20655052|P2|COMPLETED|Second Intervention||61
8379608|NCT01112865|20655053|P1|COMPLETED|Second Intervention||59
8379609|NCT01112865|20655052|P2|STARTED|Second Intervention||61
8379610|NCT01112865|20655053|P1|STARTED|Second Intervention||59
8379611|NCT01112865|20655052|P2|NOT COMPLETED|First Intervention||0
8379612|NCT01112865|20655053|P1|NOT COMPLETED|First Intervention||0
8379613|NCT01112865|20655052|P2|COMPLETED|First Intervention||61
8379614|NCT01112865|20655053|P1|COMPLETED|First Intervention||59
8379615|NCT01112865|20655052|P2|STARTED|First Intervention||61
8379616|NCT01112865|20655053|P1|STARTED|First Intervention||59
8379617|NCT01112735|20655065|P2|NOT COMPLETED|Overall Study||0
8379618|NCT01112735|20655066|P1|NOT COMPLETED|Overall Study||0
8379619|NCT01112735|20655065|P2|COMPLETED|Overall Study||20
8379620|NCT01112735|20655066|P1|COMPLETED|Overall Study||20
8379621|NCT01112735|20655065|P2|STARTED|Overall Study||20
8379622|NCT01112735|20655066|P1|STARTED|Overall Study||20
8379623|NCT01112696|20655090|P1|NOT COMPLETED|Overall Study||2
8379624|NCT01112696|20655090|P1|COMPLETED|Overall Study||98
8379625|NCT01112696|20655090|P1|STARTED|Overall Study||100
8379626|NCT01112683|20655097|P2|NOT COMPLETED|Overall Study||1
8379627|NCT01112683|20655098|P1|NOT COMPLETED|Overall Study||1
8379628|NCT01112683|20655097|P2|COMPLETED|Overall Study||19
8379629|NCT01112683|20655098|P1|COMPLETED|Overall Study||18
8379630|NCT01112683|20655097|P2|STARTED|Overall Study||20
8379631|NCT01112683|20655098|P1|STARTED|Overall Study||19
8379632|NCT01112670|20655108|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379633|NCT01112670|20655109|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379634|NCT01112670|20655110|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379635|NCT01112670|20655111|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379636|NCT01112670|20655112|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379637|NCT01112670|20655113|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379638|NCT01112670|20655108|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
8379639|NCT01112670|20655109|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379640|NCT01112670|20655110|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
8379641|NCT01112670|20655111|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379642|NCT01112670|20655112|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
8379643|NCT01112670|20655113|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379644|NCT01112670|20655108|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
8379645|NCT01112670|20655109|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379646|NCT01112670|20655110|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
8379647|NCT01112670|20655111|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379648|NCT01112670|20655112|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
8379649|NCT01112670|20655113|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379650|NCT01112670|20655108|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379651|NCT01112670|20655109|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8379652|NCT01112670|20655110|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379653|NCT01112670|20655111|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8379654|NCT01112670|20655112|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379655|NCT01112670|20655113|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8379656|NCT01112670|20655108|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379657|NCT01112670|20655109|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
8379658|NCT01112670|20655110|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379659|NCT01112670|20655111|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
8379660|NCT01112670|20655112|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379661|NCT01112670|20655113|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
8379662|NCT01112670|20655108|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379663|NCT01112670|20655109|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
8379664|NCT01112670|20655110|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379665|NCT01112670|20655111|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
8379666|NCT01112670|20655112|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379667|NCT01112670|20655113|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
8379668|NCT01112579|20655151|P2|NOT COMPLETED|Overall Study||3
8379669|NCT01112579|20655152|P1|NOT COMPLETED|Overall Study||1
8379670|NCT01112579|20655151|P2|COMPLETED|Overall Study||21
8379671|NCT01112579|20655152|P1|COMPLETED|Overall Study||41
8379672|NCT01112579|20655151|P2|STARTED|Overall Study||24
8379673|NCT01112579|20655152|P1|STARTED|Overall Study||42
8379674|NCT01112514|20655162|P1|NOT COMPLETED|Overall Study||1
8379675|NCT01112514|20655162|P1|COMPLETED|Overall Study||3
8379676|NCT01112514|20655162|P1|STARTED|Overall Study||4
8379677|NCT01112358|20655168|P2|NOT COMPLETED|Overall Study||0
8379678|NCT01112358|20655169|P1|NOT COMPLETED|Overall Study||0
8379679|NCT01112358|20655168|P2|COMPLETED|Overall Study||33
8379680|NCT01112358|20655169|P1|COMPLETED|Overall Study||25
8379681|NCT01112358|20655168|P2|STARTED|Overall Study||33
8379682|NCT01112358|20655169|P1|STARTED|Overall Study||25
8379683|NCT01112293|20655205|P1|NOT COMPLETED|Overall Study||0
8379684|NCT01112293|20655205|P1|COMPLETED|Overall Study||14
8379685|NCT01112293|20655205|P1|STARTED|Overall Study||14
8379686|NCT01112267|20655218|P2|NOT COMPLETED|Overall Study||18
8379687|NCT01112267|20655219|P1|NOT COMPLETED|Overall Study||34
8379688|NCT01112267|20655218|P2|COMPLETED|Overall Study||104
8379689|NCT01112267|20655219|P1|COMPLETED|Overall Study||92
8379690|NCT01112267|20655218|P2|Treated|Overall Study||120
8379691|NCT01112267|20655219|P1|Treated|Overall Study||125
8379692|NCT01112267|20655218|P2|STARTED|Overall Study||122
8379693|NCT01112267|20655219|P1|STARTED|Overall Study||126
8379694|NCT01112241|20655237|P1|NOT COMPLETED|Overall Study||0
8379695|NCT01112241|20655237|P1|COMPLETED|Overall Study||17
8379696|NCT01112241|20655237|P1|STARTED|Overall Study||17
8379697|NCT01112228|20655250|P1|NOT COMPLETED|Overall Study||0
8379698|NCT01112228|20655250|P1|COMPLETED|Overall Study||600
8379699|NCT01112228|20655250|P1|STARTED|Overall Study||600
8379700|NCT01112059|20655258|P2|NOT COMPLETED|Overall Study||0
8379701|NCT01112059|20655259|P1|NOT COMPLETED|Overall Study||1
8379702|NCT01112059|20655258|P2|COMPLETED|Overall Study||20
8379703|NCT01112059|20655259|P1|COMPLETED|Overall Study||19
8379704|NCT01112059|20655258|P2|STARTED|Overall Study||20
8379705|NCT01112059|20655259|P1|STARTED|Overall Study||20
8379706|NCT01111851|20655273|P2|NOT COMPLETED|Overall Study||0
8379707|NCT01111851|20655274|P1|NOT COMPLETED|Overall Study||2
8379708|NCT01111851|20655273|P2|COMPLETED|Overall Study||8
8379709|NCT01111851|20655274|P1|COMPLETED|Overall Study||6
8379710|NCT01111851|20655273|P2|STARTED|Overall Study||8
8379711|NCT01111851|20655274|P1|STARTED|Overall Study||8
8379712|NCT01111838|20655286|P1|NOT COMPLETED|Overall Study||7
8379713|NCT01111838|20655286|P1|COMPLETED|Overall Study||15
8379714|NCT01111838|20655286|P1|STARTED|Overall Study||22
8379715|NCT01111825|20655294|P4|NOT COMPLETED|Overall Study||21
8379716|NCT01111825|20655295|P3|NOT COMPLETED|Overall Study||8
8379717|NCT01111825|20655296|P2|NOT COMPLETED|Overall Study||1
8379718|NCT01111825|20655297|P1|NOT COMPLETED|Overall Study||3
8379719|NCT01111825|20655294|P4|COMPLETED|Overall Study||27
8379720|NCT01111825|20655295|P3|COMPLETED|Overall Study||29
8379721|NCT01111825|20655296|P2|COMPLETED|Overall Study||5
8379722|NCT01111825|20655297|P1|COMPLETED|Overall Study||5
8379723|NCT01111825|20655294|P4|STARTED|Overall Study||48
8379724|NCT01111825|20655295|P3|STARTED|Overall Study||37
8379725|NCT01111825|20655296|P2|STARTED|Overall Study||6
8379726|NCT01111825|20655297|P1|STARTED|Overall Study||8
8379727|NCT01111604|20655319|P3|NOT COMPLETED|Overall Study||3
8379728|NCT01111604|20655320|P2|NOT COMPLETED|Overall Study||0
8379729|NCT01111604|20655321|P1|NOT COMPLETED|Overall Study||8
8379730|NCT01111604|20655319|P3|COMPLETED|Overall Study||49
8379731|NCT01111604|20655320|P2|COMPLETED|Overall Study||52
8379732|NCT01111604|20655321|P1|COMPLETED|Overall Study||46
8379733|NCT01111604|20655319|P3|Received at Least One Dose of Study Drug|Overall Study||52
8379734|NCT01111604|20655320|P2|Received at Least One Dose of Study Drug|Overall Study||52
8379735|NCT01111604|20655321|P1|Received at Least One Dose of Study Drug|Overall Study||49
8379736|NCT01111604|20655319|P3|STARTED|Overall Study||52
8379737|NCT01111604|20655320|P2|STARTED|Overall Study||52
8379738|NCT01111604|20655321|P1|STARTED|Overall Study||54
8379739|NCT01111526|20655359|P3|NOT COMPLETED|Overall Study||2
8379740|NCT01111526|20655360|P2|NOT COMPLETED|Overall Study||1
8379741|NCT01111526|20655361|P1|NOT COMPLETED|Overall Study||0
8379742|NCT01111526|20655359|P3|COMPLETED|Overall Study||8
8379743|NCT01111526|20655360|P2|COMPLETED|Overall Study||7
8379744|NCT01111526|20655361|P1|COMPLETED|Overall Study||4
8379745|NCT01111526|20655359|P3|STARTED|Overall Study||10
8379746|NCT01111526|20655360|P2|STARTED|Overall Study||8
8379747|NCT01111526|20655361|P1|STARTED|Overall Study||4
8379748|NCT01111474|20655373|P1|NOT COMPLETED|Overall Study||12
8379749|NCT01111474|20655373|P1|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
8379750|NCT01111474|20655373|P1|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
8379751|NCT01111461|20655381|P1|NOT COMPLETED|Overall Study||51
8379752|NCT01111461|20655381|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
8379753|NCT01111461|20655381|P1|STARTED|Overall Study||133
8379754|NCT01111370|20655394|P1|NOT COMPLETED|Overall Study||2
8379755|NCT01111370|20655394|P1|COMPLETED|Overall Study||58
8379756|NCT01111370|20655394|P1|STARTED|Overall Study||60
8379757|NCT01111331|20655398|P2|NOT COMPLETED|Overall Study||0
8379758|NCT01111331|20655399|P1|NOT COMPLETED|Overall Study||0
8379759|NCT01111331|20655398|P2|COMPLETED|Overall Study||9
8379760|NCT01111331|20655399|P1|COMPLETED|Overall Study||9
8379761|NCT01111331|20655398|P2|STARTED|Overall Study||9
8379762|NCT01111331|20655399|P1|STARTED|Overall Study||9
8379763|NCT01111318|20655481|P4|NOT COMPLETED|Overall Study||0
8379764|NCT01111318|20655482|P3|NOT COMPLETED|Overall Study||0
8379765|NCT01111318|20655483|P2|NOT COMPLETED|Overall Study||0
8379766|NCT01111318|20655484|P1|NOT COMPLETED|Overall Study||0
8379767|NCT01111318|20655481|P4|COMPLETED|Overall Study||8
8379768|NCT01111318|20655482|P3|COMPLETED|Overall Study||8
8379769|NCT01111318|20655483|P2|COMPLETED|Overall Study||8
8379770|NCT01111318|20655484|P1|COMPLETED|Overall Study||12
8379771|NCT01111318|20655481|P4|STARTED|Overall Study||8
8379772|NCT01111318|20655482|P3|STARTED|Overall Study||8
8379773|NCT01111318|20655483|P2|STARTED|Overall Study||8
8379774|NCT01111318|20655484|P1|STARTED|Overall Study||12
8379775|NCT01111305|20655548|P2|NOT COMPLETED|Overall Study||0
8379776|NCT01111305|20655549|P1|NOT COMPLETED|Overall Study||0
8379777|NCT01111305|20655548|P2|COMPLETED|Overall Study||4
8379778|NCT01111305|20655549|P1|COMPLETED|Overall Study||4
8379779|NCT01111305|20655548|P2|STARTED|Overall Study||4
8379780|NCT01111305|20655549|P1|STARTED|Overall Study||4
8379781|NCT01111292|20655561|P2|NOT COMPLETED|Follow-Up||0
8379782|NCT01111292|20655562|P1|NOT COMPLETED|Follow-Up||0
8379783|NCT01111292|20655561|P2|COMPLETED|Follow-Up||1
8379784|NCT01111292|20655562|P1|COMPLETED|Follow-Up||2
8379785|NCT01111292|20655561|P2|STARTED|Follow-Up||1
8379786|NCT01111292|20655562|P1|STARTED|Follow-Up||2
8379787|NCT01111292|20655561|P2|NOT COMPLETED|Post Treatment Biopsy||0
8379788|NCT01111292|20655562|P1|NOT COMPLETED|Post Treatment Biopsy||0
8379789|NCT01111292|20655561|P2|COMPLETED|Post Treatment Biopsy||1
8379790|NCT01111292|20655562|P1|COMPLETED|Post Treatment Biopsy||2
8379791|NCT01111292|20655561|P2|STARTED|Post Treatment Biopsy||1
8379792|NCT01111292|20655562|P1|STARTED|Post Treatment Biopsy||2
8379793|NCT01111292|20655561|P2|NOT COMPLETED|Treatment||1
8379794|NCT01111292|20655562|P1|NOT COMPLETED|Treatment||1
8379795|NCT01111292|20655561|P2|COMPLETED|Treatment||1
8379796|NCT01111292|20655562|P1|COMPLETED|Treatment||2
8379797|NCT01111292|20655561|P2|STARTED|Treatment||2
8379798|NCT01111292|20655562|P1|STARTED|Treatment||3
8379799|NCT01111292|20655561|P2|NOT COMPLETED|Randomization||0
8379800|NCT01111292|20655562|P1|NOT COMPLETED|Randomization||0
8379801|NCT01111292|20655561|P2|COMPLETED|Randomization||2
8379802|NCT01111292|20655562|P1|COMPLETED|Randomization||3
8379803|NCT01111292|20655561|P2|STARTED|Randomization||2
8379804|NCT01111292|20655562|P1|STARTED|Randomization||3
8379805|NCT01111240|20655568|P1|NOT COMPLETED|Overall Study||1066
8379806|NCT01111240|20655568|P1|COMPLETED|Overall Study||3569
8379807|NCT01111240|20655568|P1|STARTED|Overall Study||4635
8379808|NCT01111162|20655590|P1|NOT COMPLETED|Overall Study||0
8379809|NCT01111162|20655590|P1|COMPLETED|Overall Study||120
8379810|NCT01111162|20655590|P1|STARTED|Overall Study||120
8379811|NCT01111149|20655598|P3|NOT COMPLETED|Overall Study||4
8379812|NCT01111149|20655599|P2|NOT COMPLETED|Overall Study||1
8379813|NCT01111149|20655600|P1|NOT COMPLETED|Overall Study||2
8379814|NCT01111149|20655598|P3|COMPLETED|Overall Study||5
8379815|NCT01111149|20655599|P2|COMPLETED|Overall Study||5
8379816|NCT01111149|20655600|P1|COMPLETED|Overall Study||7
8379817|NCT01111149|20655598|P3|STARTED|Overall Study||9
8379818|NCT01111149|20655599|P2|STARTED|Overall Study||6
8379819|NCT01111149|20655600|P1|STARTED|Overall Study||9
8379820|NCT01111123|20655676|P2|NOT COMPLETED|Maintenance Phase||2
8379821|NCT01111123|20655677|P1|NOT COMPLETED|Maintenance Phase||0
8379822|NCT01111123|20655676|P2|COMPLETED|Maintenance Phase||18
8379823|NCT01111123|20655677|P1|COMPLETED|Maintenance Phase||21
8379824|NCT01111123|20655676|P2|STARTED|Maintenance Phase||20
8379825|NCT01111123|20655677|P1|STARTED|Maintenance Phase||21
8379826|NCT01111123|20655676|P2|NOT COMPLETED|Open- Label Phase||0
8379827|NCT01111123|20655677|P1|NOT COMPLETED|Open- Label Phase||14
8379828|NCT01111123|20655676|P2|COMPLETED|Open- Label Phase||0
8379829|NCT01111123|20655677|P1|COMPLETED|Open- Label Phase||41
8379830|NCT01111123|20655676|P2|STARTED|Open- Label Phase||0
8379831|NCT01111123|20655677|P1|STARTED|Open- Label Phase||55
8379832|NCT01111110|20655687|P2|NOT COMPLETED|Overall Study||0
8379833|NCT01111110|20655688|P1|NOT COMPLETED|Overall Study||0
8379834|NCT01111110|20655687|P2|COMPLETED|Overall Study||4
8379835|NCT01111110|20655688|P1|COMPLETED|Overall Study||3
8379836|NCT01111110|20655687|P2|STARTED|Overall Study||4
8379837|NCT01111110|20655688|P1|STARTED|Overall Study||3
8379838|NCT01111058|20655700|P2|NOT COMPLETED|Overall Study||0
8379839|NCT01111058|20655701|P1|NOT COMPLETED|Overall Study||0
8379840|NCT01111058|20655700|P2|COMPLETED|Overall Study||24
8379841|NCT01111058|20655701|P1|COMPLETED|Overall Study||28
8379842|NCT01111058|20655700|P2|STARTED|Overall Study||24
8379843|NCT01111058|20655701|P1|STARTED|Overall Study||28
8379844|NCT01111019|20655723|P1|NOT COMPLETED|Overall Study||3
8379845|NCT01111019|20655723|P1|COMPLETED|Overall Study||16
8379846|NCT01111019|20655723|P1|STARTED|Overall Study||19
8379847|NCT01110967|20655742|P1|NOT COMPLETED|Overall Study||9
8379848|NCT01110967|20655742|P1|COMPLETED|Overall Study||31
8379849|NCT01110967|20655742|P1|12 Months Follow up|Overall Study||31
8379850|NCT01110967|20655742|P1|6 Months Follow up|Overall Study||24
8379851|NCT01110967|20655742|P1|3 Months Follow up|Overall Study||28
8379852|NCT01110967|20655742|P1|1 Month Follow up|Overall Study||26
8379853|NCT01110967|20655742|P1|Surgery|Overall Study||40
8379854|NCT01110967|20655742|P1|STARTED|Overall Study||40
8379855|NCT01110915|20655755|P2|NOT COMPLETED|Overall Study||2
8379856|NCT01110915|20655756|P1|NOT COMPLETED|Overall Study||10
8379857|NCT01110915|20655755|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
8379858|NCT01110915|20655756|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
8379859|NCT01110915|20655755|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
8379860|NCT01110915|20655756|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
8379861|NCT01110707|20655773|P2|NOT COMPLETED|Overall Study||3
8379862|NCT01110707|20655774|P1|NOT COMPLETED|Overall Study||0
8379863|NCT01110707|20655773|P2|COMPLETED|Overall Study||65
8379864|NCT01110707|20655774|P1|COMPLETED|Overall Study||63
8379865|NCT01110707|20655773|P2|STARTED|Overall Study||68
8379866|NCT01110707|20655774|P1|STARTED|Overall Study||63
8379867|NCT01110681|20655796|P1|NOT COMPLETED|Overall Study||32
8379868|NCT01110681|20655796|P1|COMPLETED|Overall Study||83
8379869|NCT01110681|20655796|P1|STARTED|Overall Study||115
8379870|NCT01110499|20655812|P8|NOT COMPLETED|Overall Study||0
8379871|NCT01110499|20655813|P7|NOT COMPLETED|Overall Study||0
8379872|NCT01110499|20655814|P6|NOT COMPLETED|Overall Study||0
8379873|NCT01110499|20655815|P5|NOT COMPLETED|Overall Study||0
8379874|NCT01110499|20655816|P4|NOT COMPLETED|Overall Study||0
8379875|NCT01110499|20655817|P3|NOT COMPLETED|Overall Study||0
8379876|NCT01110499|20655818|P2|NOT COMPLETED|Overall Study||0
8379877|NCT01110499|20655819|P1|NOT COMPLETED|Overall Study||0
8379878|NCT01110499|20655812|P8|COMPLETED|Overall Study||40
8379879|NCT01110499|20655813|P7|COMPLETED|Overall Study||39
8379880|NCT01110499|20655814|P6|COMPLETED|Overall Study||14
8379881|NCT01110499|20655815|P5|COMPLETED|Overall Study||14
8379882|NCT01110499|20655816|P4|COMPLETED|Overall Study||14
8379883|NCT01110499|20655817|P3|COMPLETED|Overall Study||14
8379884|NCT01110499|20655818|P2|COMPLETED|Overall Study||14
8379885|NCT01110499|20655819|P1|COMPLETED|Overall Study||14
8379886|NCT01110499|20655812|P8|STARTED|Overall Study||40
8379887|NCT01110499|20655813|P7|STARTED|Overall Study||39
8379888|NCT01110499|20655814|P6|STARTED|Overall Study||14
8379889|NCT01110499|20655815|P5|STARTED|Overall Study||14
8379890|NCT01110499|20655816|P4|STARTED|Overall Study||14
8379891|NCT01110499|20655817|P3|STARTED|Overall Study||14
8379892|NCT01110499|20655818|P2|STARTED|Overall Study||14
8379893|NCT01110499|20655819|P1|STARTED|Overall Study||14
8379894|NCT01110434|20655841|P2|NOT COMPLETED|Overall Study||6
8379895|NCT01110434|20655842|P1|NOT COMPLETED|Overall Study||11
8379896|NCT01110434|20655841|P2|COMPLETED|Overall Study||20
8379897|NCT01110434|20655842|P1|COMPLETED|Overall Study||29
8379898|NCT01110434|20655841|P2|STARTED|Overall Study||26
8379899|NCT01110434|20655842|P1|STARTED|Overall Study||40
8379900|NCT01110421|20655854|P2|NOT COMPLETED|Overall Study||0
8379901|NCT01110421|20655855|P1|NOT COMPLETED|Overall Study||0
8379902|NCT01110421|20655854|P2|COMPLETED|Overall Study||2
8379903|NCT01110421|20655855|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
8379904|NCT01110421|20655854|P2|STARTED|Overall Study||2
8379905|NCT01110421|20655855|P1|STARTED|Overall Study||5
8379906|NCT01110408|20655875|P2|NOT COMPLETED|Overall Study||0
8379907|NCT01110408|20655876|P1|NOT COMPLETED|Overall Study||1
8379908|NCT01110408|20655875|P2|COMPLETED|Overall Study||10
8379909|NCT01110408|20655876|P1|COMPLETED|Overall Study||30
8379910|NCT01110408|20655875|P2|STARTED|Overall Study||10
8379911|NCT01110408|20655876|P1|STARTED|Overall Study||31
8379912|NCT01110395|20655894|P1|NOT COMPLETED|Overall Study||0
8379913|NCT01110395|20655894|P1|COMPLETED|Overall Study||15
8379914|NCT01110395|20655894|P1|STARTED|Overall Study||15
8379915|NCT01110382|20655900|P2|NOT COMPLETED|Overall Study||2
8379916|NCT01110382|20655901|P1|NOT COMPLETED|Overall Study||0
8379917|NCT01110382|20655900|P2|COMPLETED|Overall Study||8
8379918|NCT01110382|20655901|P1|COMPLETED|Overall Study||31
8379919|NCT01110382|20655900|P2|STARTED|Overall Study||10
8379920|NCT01110382|20655901|P1|STARTED|Overall Study||31
8379921|NCT01110330|20655922|P3|NOT COMPLETED|Overall Study||26
8379922|NCT01110330|20655923|P2|NOT COMPLETED|Overall Study||23
8379923|NCT01110330|20655924|P1|NOT COMPLETED|Overall Study||15
8379924|NCT01110330|20655922|P3|COMPLETED|Overall Study||208
8379925|NCT01110330|20655923|P2|COMPLETED|Overall Study||207
8379926|NCT01110330|20655924|P1|COMPLETED|Overall Study||104
8379927|NCT01110330|20655922|P3|Positive Baseline Culture Set|Overall Study||114
8379928|NCT01110330|20655923|P2|Positive Baseline Culture Set|Overall Study||111
8379929|NCT01110330|20655924|P1|Positive Baseline Culture Set|Overall Study||56
8379930|NCT01110330|20655922|P3|STARTED|Overall Study||234
8379931|NCT01110330|20655923|P2|STARTED|Overall Study||230
8379932|NCT01110330|20655924|P1|STARTED|Overall Study||119
8379933|NCT01110252|20655935|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
8379934|NCT01110252|20655935|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
8379935|NCT01110252|20655935|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
8379936|NCT01110252|20655935|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
8379937|NCT01110252|20655935|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
8379938|NCT01110252|20655935|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
8379939|NCT01110239|20655952|P4|NOT COMPLETED|10 Min Ischemia||0
8379940|NCT01110239|20655953|P3|NOT COMPLETED|10 Min Ischemia||0
8379941|NCT01110239|20655954|P2|NOT COMPLETED|10 Min Ischemia||0
8379942|NCT01110239|20655955|P1|NOT COMPLETED|10 Min Ischemia||0
8379943|NCT01110239|20655952|P4|COMPLETED|10 Min Ischemia||6
8379944|NCT01110239|20655953|P3|COMPLETED|10 Min Ischemia||0
8379945|NCT01110239|20655954|P2|COMPLETED|10 Min Ischemia||0
8379946|NCT01110239|20655955|P1|COMPLETED|10 Min Ischemia||0
8379947|NCT01110239|20655952|P4|STARTED|10 Min Ischemia||6
8379948|NCT01110239|20655953|P3|STARTED|10 Min Ischemia||0
8379949|NCT01110239|20655954|P2|STARTED|10 Min Ischemia||0
8379950|NCT01110239|20655955|P1|STARTED|10 Min Ischemia||0
8379951|NCT01110239|20655952|P4|NOT COMPLETED|7.5 Min Ischemia||0
8379952|NCT01110239|20655953|P3|NOT COMPLETED|7.5 Min Ischemia||1
8379953|NCT01110239|20655954|P2|NOT COMPLETED|7.5 Min Ischemia||0
8379954|NCT01110239|20655955|P1|NOT COMPLETED|7.5 Min Ischemia||0
8379955|NCT01110239|20655952|P4|COMPLETED|7.5 Min Ischemia||0
8379956|NCT01110239|20655953|P3|COMPLETED|7.5 Min Ischemia||6
8379957|NCT01110239|20655954|P2|COMPLETED|7.5 Min Ischemia||0
8379958|NCT01110239|20655955|P1|COMPLETED|7.5 Min Ischemia||0
8379959|NCT01110239|20655952|P4|STARTED|7.5 Min Ischemia||0
8379960|NCT01110239|20655953|P3|STARTED|7.5 Min Ischemia||7
8379961|NCT01110239|20655954|P2|STARTED|7.5 Min Ischemia||0
8379962|NCT01110239|20655955|P1|STARTED|7.5 Min Ischemia||0
8379963|NCT01110239|20655952|P4|NOT COMPLETED|5 Min Ischemia||0
8379964|NCT01110239|20655953|P3|NOT COMPLETED|5 Min Ischemia||0
8379965|NCT01110239|20655954|P2|NOT COMPLETED|5 Min Ischemia||14
8379966|NCT01110239|20655955|P1|NOT COMPLETED|5 Min Ischemia||0
8379967|NCT01110239|20655952|P4|COMPLETED|5 Min Ischemia||0
8379968|NCT01110239|20655953|P3|COMPLETED|5 Min Ischemia||0
8379969|NCT01110239|20655954|P2|COMPLETED|5 Min Ischemia||0
8379970|NCT01110239|20655955|P1|COMPLETED|5 Min Ischemia||0
8379971|NCT01110239|20655952|P4|STARTED|5 Min Ischemia||0
8379972|NCT01110239|20655953|P3|STARTED|5 Min Ischemia||0
8379973|NCT01110239|20655954|P2|STARTED|5 Min Ischemia||14
8379974|NCT01110239|20655955|P1|STARTED|5 Min Ischemia||0
8379975|NCT01110239|20655952|P4|NOT COMPLETED|Sham Preconditioning||0
8379976|NCT01110239|20655953|P3|NOT COMPLETED|Sham Preconditioning||1
8379977|NCT01110239|20655954|P2|NOT COMPLETED|Sham Preconditioning||0
8379978|NCT01110239|20655955|P1|NOT COMPLETED|Sham Preconditioning||0
8379979|NCT01110239|20655952|P4|COMPLETED|Sham Preconditioning||6
8379980|NCT01110239|20655953|P3|COMPLETED|Sham Preconditioning||6
8379981|NCT01110239|20655954|P2|COMPLETED|Sham Preconditioning||14
8379982|NCT01110239|20655955|P1|COMPLETED|Sham Preconditioning||7
8379983|NCT01110239|20655952|P4|STARTED|Sham Preconditioning||6
8379984|NCT01110239|20655953|P3|STARTED|Sham Preconditioning||7
8379985|NCT01110239|20655954|P2|STARTED|Sham Preconditioning||14
8379986|NCT01110239|20655955|P1|STARTED|Sham Preconditioning||7
8379987|NCT01110200|20655971|P2|NOT COMPLETED|Overall Study||121
8379988|NCT01110200|20655972|P1|NOT COMPLETED|Overall Study||106
8379989|NCT01110200|20655971|P2|COMPLETED|Overall Study||204
8379990|NCT01110200|20655972|P1|COMPLETED|Overall Study||208
8379991|NCT01110200|20655971|P2|STARTED|Overall Study||325
8379992|NCT01110200|20655972|P1|STARTED|Overall Study||314
8379993|NCT01110187|20655988|P2|NOT COMPLETED|Overall Study||0
8379994|NCT01110187|20655989|P1|NOT COMPLETED|Overall Study||0
8379995|NCT01110187|20655988|P2|COMPLETED|Overall Study|completed 7 day treatment|4
8379996|NCT01110187|20655989|P1|COMPLETED|Overall Study|completed 7 day treatment|7
8379997|NCT01110187|20655988|P2|STARTED|Overall Study||4
8379998|NCT01110187|20655989|P1|STARTED|Overall Study||7
8379999|NCT01110174|20655997|P1|NOT COMPLETED|Overall Study||0
8380000|NCT01110174|20655997|P1|COMPLETED|Overall Study||8
8380001|NCT01110174|20655997|P1|STARTED|Overall Study||8
8380002|NCT01110135|20656002|P1|NOT COMPLETED|Overall Study||9
8380003|NCT01110135|20656002|P1|COMPLETED|Overall Study||34
8380004|NCT01110135|20656002|P1|STARTED|Overall Study||43
8380005|NCT01110005|20656008|P2|NOT COMPLETED|Overall Study||5
8380006|NCT01110005|20656009|P1|NOT COMPLETED|Overall Study||4
8380007|NCT01110005|20656008|P2|COMPLETED|Overall Study||156
8380008|NCT01110005|20656009|P1|COMPLETED|Overall Study||153
8380009|NCT01110005|20656008|P2|STARTED|Overall Study||161
8380010|NCT01110005|20656009|P1|STARTED|Overall Study||157
8380011|NCT01109992|20656021|P2|NOT COMPLETED|Overall Study||2
8380012|NCT01109992|20656022|P1|NOT COMPLETED|Overall Study||0
8380013|NCT01109992|20656021|P2|COMPLETED|Overall Study||30
8380014|NCT01109992|20656022|P1|COMPLETED|Overall Study||11
8380015|NCT01109992|20656021|P2|Subjects Enrolled|Overall Study||32
8380016|NCT01109992|20656022|P1|Subjects Enrolled|Overall Study||11
8380017|NCT01109992|20656021|P2|STARTED|Overall Study||32
8380018|NCT01109992|20656022|P1|STARTED|Overall Study||11
8380019|NCT01109979|20656036|P2|NOT COMPLETED|Overall Study||1
8380020|NCT01109979|20656037|P1|NOT COMPLETED|Overall Study||2
8380021|NCT01109979|20656036|P2|COMPLETED|Overall Study||11
8380022|NCT01109979|20656037|P1|COMPLETED|Overall Study||10
8380023|NCT01109979|20656036|P2|STARTED|Overall Study||12
8380024|NCT01109979|20656037|P1|STARTED|Overall Study||12
8380025|NCT01109849|20656045|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
8380026|NCT01109849|20656046|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
8380027|NCT01109849|20656047|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
8380028|NCT01109849|20656048|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
8380029|NCT01109849|20656049|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
8380030|NCT01109849|20656045|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
8380031|NCT01109849|20656046|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
8380032|NCT01109849|20656047|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
8380033|NCT01109849|20656048|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
8380034|NCT01109849|20656049|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
8380035|NCT01109849|20656045|P5|STARTED|Adaptive Randomization: Weight Recovery||25
8380036|NCT01109849|20656046|P4|STARTED|Adaptive Randomization: Weight Recovery||23
8380037|NCT01109849|20656047|P3|STARTED|Adaptive Randomization: Weight Recovery||24
8380038|NCT01109849|20656048|P2|STARTED|Adaptive Randomization: Weight Recovery||0
8380039|NCT01109849|20656049|P1|STARTED|Adaptive Randomization: Weight Recovery||0
8380040|NCT01109849|20656045|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8380041|NCT01109849|20656046|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8380042|NCT01109849|20656047|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8380043|NCT01109849|20656048|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
8380044|NCT01109849|20656049|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
8380045|NCT01109849|20656045|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
8380046|NCT01109849|20656046|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
8380047|NCT01109849|20656047|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
8380048|NCT01109849|20656048|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
8380049|NCT01109849|20656049|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
8380050|NCT01109849|20656045|P5|STARTED|Initial Randomization: ADHD Treatment||0
8380051|NCT01109849|20656046|P4|STARTED|Initial Randomization: ADHD Treatment||0
8380052|NCT01109849|20656047|P3|STARTED|Initial Randomization: ADHD Treatment||0
8380053|NCT01109849|20656048|P2|STARTED|Initial Randomization: ADHD Treatment||180
8380054|NCT01109849|20656049|P1|STARTED|Initial Randomization: ADHD Treatment||50
8380055|NCT01109602|20656101|P3|NOT COMPLETED|Overall Study||1
8380056|NCT01109602|20656102|P2|NOT COMPLETED|Overall Study||2
8380057|NCT01109602|20656103|P1|NOT COMPLETED|Overall Study||1
8380058|NCT01109602|20656101|P3|COMPLETED|Overall Study||9
8380059|NCT01109602|20656102|P2|COMPLETED|Overall Study||21
8380060|NCT01109602|20656103|P1|COMPLETED|Overall Study||13
8380061|NCT01109602|20656101|P3|STARTED|Overall Study||10
8380062|NCT01109602|20656102|P2|STARTED|Overall Study||23
8380063|NCT01109602|20656103|P1|STARTED|Overall Study||14
8380064|NCT01109576|20656114|P1|NOT COMPLETED|Overall Study||1
8380065|NCT01109576|20656114|P1|COMPLETED|Overall Study||12
8380066|NCT01109576|20656114|P1|STARTED|Overall Study||13
8380067|NCT01109524|20656118|P1|NOT COMPLETED|Overall Study||57
8380068|NCT01109524|20656118|P1|COMPLETED|Overall Study||3
8380069|NCT01109524|20656118|P1|STARTED|Overall Study||60
8380070|NCT01109381|20656128|P1|NOT COMPLETED|Overall Study||2
8380071|NCT01109381|20656128|P1|COMPLETED|Overall Study||31
8380072|NCT01109381|20656128|P1|STARTED|Overall Study||33
8380073|NCT01109316|20656140|P6|NOT COMPLETED|Study Period 3||0
8380074|NCT01109316|20656141|P5|NOT COMPLETED|Study Period 3||2
8380075|NCT01109316|20656142|P4|NOT COMPLETED|Study Period 3||0
8380076|NCT01109316|20656143|P3|NOT COMPLETED|Study Period 3||0
8380077|NCT01109316|20656144|P2|NOT COMPLETED|Study Period 3||0
8380078|NCT01109316|20656145|P1|NOT COMPLETED|Study Period 3||1
8380079|NCT01109316|20656140|P6|COMPLETED|Study Period 3||19
8380080|NCT01109316|20656141|P5|COMPLETED|Study Period 3||18
8380081|NCT01109316|20656142|P4|COMPLETED|Study Period 3||20
8380082|NCT01109316|20656143|P3|COMPLETED|Study Period 3||18
8380083|NCT01109316|20656144|P2|COMPLETED|Study Period 3||21
8380084|NCT01109316|20656145|P1|COMPLETED|Study Period 3||20
8380085|NCT01109316|20656140|P6|STARTED|Study Period 3||19
8380086|NCT01109316|20656141|P5|STARTED|Study Period 3||20
8380087|NCT01109316|20656142|P4|STARTED|Study Period 3||20
8380088|NCT01109316|20656143|P3|STARTED|Study Period 3||18
8380089|NCT01109316|20656144|P2|STARTED|Study Period 3||21
8380090|NCT01109316|20656145|P1|STARTED|Study Period 3||21
8380091|NCT01109316|20656140|P6|NOT COMPLETED|Study Period 2||1
8380092|NCT01109316|20656141|P5|NOT COMPLETED|Study Period 2||0
8380093|NCT01109316|20656142|P4|NOT COMPLETED|Study Period 2||1
8380094|NCT01109316|20656143|P3|NOT COMPLETED|Study Period 2||1
8380095|NCT01109316|20656144|P2|NOT COMPLETED|Study Period 2||1
8380096|NCT01109316|20656145|P1|NOT COMPLETED|Study Period 2||1
8380097|NCT01109316|20656140|P6|COMPLETED|Study Period 2||19
8380098|NCT01109316|20656141|P5|COMPLETED|Study Period 2||20
8380099|NCT01109316|20656142|P4|COMPLETED|Study Period 2||20
8380100|NCT01109316|20656143|P3|COMPLETED|Study Period 2||18
8380101|NCT01109316|20656144|P2|COMPLETED|Study Period 2||21
8380102|NCT01109316|20656145|P1|COMPLETED|Study Period 2||21
8380103|NCT01109316|20656140|P6|STARTED|Study Period 2||20
8380104|NCT01109316|20656141|P5|STARTED|Study Period 2||20
8380105|NCT01109316|20656142|P4|STARTED|Study Period 2||21
8380106|NCT01109316|20656143|P3|STARTED|Study Period 2||19
8380107|NCT01109316|20656144|P2|STARTED|Study Period 2||22
8380108|NCT01109316|20656145|P1|STARTED|Study Period 2||22
8380109|NCT01109316|20656140|P6|NOT COMPLETED|Study Period 1||2
8380110|NCT01109316|20656141|P5|NOT COMPLETED|Study Period 1||2
8380111|NCT01109316|20656142|P4|NOT COMPLETED|Study Period 1||1
8380112|NCT01109316|20656143|P3|NOT COMPLETED|Study Period 1||3
8380113|NCT01109316|20656144|P2|NOT COMPLETED|Study Period 1||0
8380114|NCT01109316|20656145|P1|NOT COMPLETED|Study Period 1||0
8380115|NCT01109316|20656140|P6|COMPLETED|Study Period 1||20
8380116|NCT01109316|20656141|P5|COMPLETED|Study Period 1||20
8380117|NCT01109316|20656142|P4|COMPLETED|Study Period 1||21
8380118|NCT01109316|20656143|P3|COMPLETED|Study Period 1||19
8380119|NCT01109316|20656144|P2|COMPLETED|Study Period 1||22
8380120|NCT01109316|20656145|P1|COMPLETED|Study Period 1||22
8380121|NCT01109316|20656140|P6|Received at Least One Dose of Study Drug|Study Period 1||20
8380122|NCT01109316|20656141|P5|Received at Least One Dose of Study Drug|Study Period 1||22
8380123|NCT01109316|20656142|P4|Received at Least One Dose of Study Drug|Study Period 1||22
8380124|NCT01109316|20656143|P3|Received at Least One Dose of Study Drug|Study Period 1||22
8380125|NCT01109316|20656144|P2|Received at Least One Dose of Study Drug|Study Period 1||22
8380126|NCT01109316|20656145|P1|Received at Least One Dose of Study Drug|Study Period 1||22
8380127|NCT01109316|20656140|P6|STARTED|Study Period 1||22
8380128|NCT01109316|20656141|P5|STARTED|Study Period 1||22
8380129|NCT01109316|20656142|P4|STARTED|Study Period 1||22
8380130|NCT01109316|20656143|P3|STARTED|Study Period 1||22
8380131|NCT01109316|20656144|P2|STARTED|Study Period 1||22
8380132|NCT01109316|20656145|P1|STARTED|Study Period 1||22
8380133|NCT01109173|20656193|P4|NOT COMPLETED|Overall Study||93
8380134|NCT01109173|20656194|P3|NOT COMPLETED|Overall Study||101
8380135|NCT01109173|20656195|P2|NOT COMPLETED|Overall Study||86
8380136|NCT01109173|20656196|P1|NOT COMPLETED|Overall Study||88
8380137|NCT01109173|20656193|P4|COMPLETED|Overall Study||120
8380138|NCT01109173|20656194|P3|COMPLETED|Overall Study||110
8380139|NCT01109173|20656195|P2|COMPLETED|Overall Study||759
8380140|NCT01109173|20656196|P1|COMPLETED|Overall Study||763
8380141|NCT01109173|20656193|P4|STARTED|Overall Study||213
8380142|NCT01109173|20656194|P3|STARTED|Overall Study||211
8380143|NCT01109173|20656195|P2|STARTED|Overall Study||845
8380144|NCT01109173|20656196|P1|STARTED|Overall Study||851
8380145|NCT01109147|20656213|P3|NOT COMPLETED|Overall Study||10
8380146|NCT01109147|20656214|P2|NOT COMPLETED|Overall Study||3
8380147|NCT01109147|20656215|P1|NOT COMPLETED|Overall Study||2
8380148|NCT01109147|20656213|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
8380149|NCT01109147|20656214|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
8380150|NCT01109147|20656215|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
8380151|NCT01109147|20656213|P3|STARTED|Overall Study||36
8380152|NCT01109147|20656214|P2|STARTED|Overall Study||14
8380153|NCT01109147|20656215|P1|STARTED|Overall Study||17
8380154|NCT01109108|20656225|P2|NOT COMPLETED|Overall Study||0
8380155|NCT01109108|20656226|P1|NOT COMPLETED|Overall Study||0
8380156|NCT01109108|20656225|P2|COMPLETED|Overall Study||4755
8380157|NCT01109108|20656226|P1|COMPLETED|Overall Study||4035
8380158|NCT01109108|20656225|P2|STARTED|Overall Study||4755
8380159|NCT01109108|20656226|P1|STARTED|Overall Study||4035
8380160|NCT01109069|20656232|P1|NOT COMPLETED|Overall Study||93
8380161|NCT01109069|20656232|P1|COMPLETED|Overall Study||106
8380162|NCT01109069|20656232|P1|STARTED|Overall Study||199
8380163|NCT01109056|20656241|P2|NOT COMPLETED|Overall Study||5
8380164|NCT01109056|20656242|P1|NOT COMPLETED|Overall Study||7
8380165|NCT01109056|20656241|P2|COMPLETED|Overall Study||53
8380166|NCT01109056|20656242|P1|COMPLETED|Overall Study||50
8380167|NCT01109056|20656241|P2|STARTED|Overall Study||58
8380168|NCT01109056|20656242|P1|STARTED|Overall Study||57
8380169|NCT01109004|20656255|P3|NOT COMPLETED|Overall Study||0
8380170|NCT01109004|20656256|P2|NOT COMPLETED|Overall Study||0
8380171|NCT01109004|20656257|P1|NOT COMPLETED|Overall Study||0
8380172|NCT01109004|20656255|P3|COMPLETED|Overall Study||257
8380173|NCT01109004|20656256|P2|COMPLETED|Overall Study||254
8380174|NCT01109004|20656257|P1|COMPLETED|Overall Study||247
8380175|NCT01109004|20656255|P3|STARTED|Overall Study||257
8380176|NCT01109004|20656256|P2|STARTED|Overall Study||254
8380177|NCT01109004|20656257|P1|STARTED|Overall Study||247
8380178|NCT01108835|20656294|P2|NOT COMPLETED|Overall Study||21
8380179|NCT01108835|20656295|P1|NOT COMPLETED|Overall Study||17
8380180|NCT01108835|20656294|P2|COMPLETED|Overall Study||69
8380181|NCT01108835|20656295|P1|COMPLETED|Overall Study||73
8380182|NCT01108835|20656294|P2|STARTED|Overall Study||90
8380183|NCT01108835|20656295|P1|STARTED|Overall Study||90
8380184|NCT01108809|20656309|P1|NOT COMPLETED|Overall Study||4
8380185|NCT01108809|20656309|P1|COMPLETED|Overall Study||291
8380186|NCT01108809|20656309|P1|STARTED|Overall Study||295
8380187|NCT01108796|20656326|P2|NOT COMPLETED|Overall Study||7
8380188|NCT01108796|20656327|P1|NOT COMPLETED|Overall Study||7
8380189|NCT01108796|20656326|P2|COMPLETED|Overall Study||1060
8380190|NCT01108796|20656327|P1|COMPLETED|Overall Study||767
8380191|NCT01108796|20656326|P2|STARTED|Overall Study||1067
8380192|NCT01108796|20656327|P1|STARTED|Overall Study||774
8380193|NCT01108757|20656361|P2|NOT COMPLETED|Overall Study||0
8380194|NCT01108757|20656362|P1|NOT COMPLETED|Overall Study||0
8380195|NCT01108757|20656361|P2|COMPLETED|Overall Study||26
8380196|NCT01108757|20656362|P1|COMPLETED|Overall Study||26
8380197|NCT01108757|20656361|P2|STARTED|Overall Study||26
8380198|NCT01108757|20656362|P1|STARTED|Overall Study||26
8380199|NCT01108731|20656370|P2|NOT COMPLETED|Overall Study||4
8380200|NCT01108731|20656371|P1|NOT COMPLETED|Overall Study||4
8380201|NCT01108731|20656370|P2|COMPLETED|Overall Study||13
8380202|NCT01108731|20656371|P1|COMPLETED|Overall Study||13
8380203|NCT01108731|20656370|P2|STARTED|Overall Study||17
8380204|NCT01108731|20656371|P1|STARTED|Overall Study||17
8380205|NCT01108718|20656383|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
8380206|NCT01108718|20656384|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
8380207|NCT01108718|20656383|P2|COMPLETED|Received Second Intervention (2 Months)||7
8380208|NCT01108718|20656384|P1|COMPLETED|Received Second Intervention (2 Months)||4
8380209|NCT01108718|20656383|P2|STARTED|Received Second Intervention (2 Months)||7
8380210|NCT01108718|20656384|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
8380211|NCT01108718|20656383|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
8380212|NCT01108718|20656384|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
8380213|NCT01108718|20656383|P2|COMPLETED|Received First Intervention (2 Months)||7
8380214|NCT01108718|20656384|P1|COMPLETED|Received First Intervention (2 Months)||5
8380215|NCT01108718|20656383|P2|STARTED|Received First Intervention (2 Months)||7
8380216|NCT01108718|20656384|P1|STARTED|Received First Intervention (2 Months)||5
8380217|NCT01108666|20656389|P1|NOT COMPLETED|Overall Study||0
8380218|NCT01108666|20656389|P1|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
8380219|NCT01108666|20656389|P1|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, no data are available to be reported|0
8380220|NCT01108523|20656396|P1|NOT COMPLETED|Overall Study||4
8380221|NCT01108523|20656396|P1|COMPLETED|Overall Study||3
8380222|NCT01108523|20656396|P1|STARTED|Overall Study||7
8380223|NCT01108510|20656403|P2|NOT COMPLETED|Overall Study||268
8380224|NCT01108510|20656404|P1|NOT COMPLETED|Overall Study||279
8380225|NCT01108510|20656403|P2|COMPLETED|Overall Study||81
8380226|NCT01108510|20656404|P1|COMPLETED|Overall Study||70
8380227|NCT01108510|20656403|P2|STARTED|Overall Study||349
8380228|NCT01108510|20656404|P1|STARTED|Overall Study||349
8380229|NCT01108458|20656424|P1|NOT COMPLETED|Overall Study||1
8380230|NCT01108458|20656424|P1|COMPLETED|Overall Study||0
8380231|NCT01108458|20656424|P1|STARTED|Overall Study||1
8380232|NCT01108445|20656435|P2|NOT COMPLETED|Overall Study||49
8380233|NCT01108445|20656436|P1|NOT COMPLETED|Overall Study||56
8380234|NCT01108445|20656435|P2|COMPLETED|Overall Study||2
8380235|NCT01108445|20656436|P1|COMPLETED|Overall Study||1
8380236|NCT01108445|20656435|P2|STARTED|Overall Study||51
8380237|NCT01108445|20656436|P1|STARTED|Overall Study||57
8380238|NCT01108406|20656470|P1|NOT COMPLETED|Overall Study||0
8380239|NCT01108406|20656470|P1|COMPLETED|Overall Study||22
8380240|NCT01108406|20656470|P1|STARTED|Overall Study||22
8380241|NCT01108341|20656476|P1|NOT COMPLETED|Overall Study||5
8380242|NCT01108341|20656476|P1|COMPLETED|Overall Study||45
8380243|NCT01108341|20656476|P1|Safety Set (Enrolled and Treated)|Overall Study||49
8380244|NCT01108341|20656476|P1|STARTED|Overall Study||50
8380245|NCT01108263|20656483|P2|NOT COMPLETED|Overall Study||1
8380246|NCT01108263|20656484|P1|NOT COMPLETED|Overall Study||0
8380247|NCT01108263|20656483|P2|COMPLETED|Overall Study||2
8380248|NCT01108263|20656484|P1|COMPLETED|Overall Study||2
8380249|NCT01108263|20656483|P2|STARTED|Overall Study||3
8380250|NCT01108263|20656484|P1|STARTED|Overall Study||2
8380251|NCT01108237|20656494|P2|NOT COMPLETED|Overall Study||17
8380252|NCT01108237|20656495|P1|NOT COMPLETED|Overall Study||9
8380253|NCT01108237|20656494|P2|COMPLETED|Overall Study||84
8380254|NCT01108237|20656495|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
8380255|NCT01108237|20656494|P2|STARTED|Overall Study||101
8380256|NCT01108237|20656495|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
8380257|NCT01108185|20656501|P1|NOT COMPLETED|Overall Study||27
8380258|NCT01108185|20656501|P1|COMPLETED|Overall Study||3154
8380259|NCT01108185|20656501|P1|Per Protocol Population|Overall Study||3181
8380260|NCT01108185|20656501|P1|STARTED|Overall Study||3181
8380261|NCT01108094|20656518|P4|NOT COMPLETED|Overall Study||0
8380262|NCT01108094|20656519|P3|NOT COMPLETED|Overall Study||0
8380263|NCT01108094|20656520|P2|NOT COMPLETED|Overall Study||0
8380264|NCT01108094|20656521|P1|NOT COMPLETED|Overall Study||3
8380265|NCT01108094|20656518|P4|COMPLETED|Overall Study||10
8380266|NCT01108094|20656519|P3|COMPLETED|Overall Study||4
8380267|NCT01108094|20656520|P2|COMPLETED|Overall Study||3
8380268|NCT01108094|20656521|P1|COMPLETED|Overall Study||9
8380269|NCT01108094|20656518|P4|STARTED|Overall Study||10
8380270|NCT01108094|20656519|P3|STARTED|Overall Study||4
8380271|NCT01108094|20656520|P2|STARTED|Overall Study||3
8380272|NCT01108094|20656521|P1|STARTED|Overall Study||12
8380273|NCT01108081|20656546|P4|NOT COMPLETED|Overall Study||4
8380274|NCT01108081|20656547|P3|NOT COMPLETED|Overall Study||0
8380275|NCT01108081|20656548|P2|NOT COMPLETED|Overall Study||2
8380276|NCT01108081|20656549|P1|NOT COMPLETED|Overall Study||2
8380277|NCT01108081|20656546|P4|COMPLETED|Overall Study||39
8380278|NCT01108081|20656547|P3|COMPLETED|Overall Study||38
8380279|NCT01108081|20656548|P2|COMPLETED|Overall Study||40
8380280|NCT01108081|20656549|P1|COMPLETED|Overall Study||44
8380281|NCT01108081|20656546|P4|STARTED|Overall Study||43
8380282|NCT01108081|20656547|P3|STARTED|Overall Study||38
8380283|NCT01108081|20656548|P2|STARTED|Overall Study||42
8380284|NCT01108081|20656549|P1|STARTED|Overall Study||46
8380285|NCT01108068|20656565|P2|NOT COMPLETED|Overall Study||0
8380286|NCT01108068|20656566|P1|NOT COMPLETED|Overall Study||6
8380287|NCT01108068|20656565|P2|COMPLETED|Overall Study||16
8380288|NCT01108068|20656566|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
8380289|NCT01108068|20656565|P2|STARTED|Overall Study||16
8380290|NCT01108068|20656566|P1|STARTED|Overall Study||10
8380291|NCT01108055|20656573|P1|NOT COMPLETED|Overall Study||15
8380292|NCT01108055|20656573|P1|COMPLETED|Overall Study||28
8380293|NCT01108055|20656573|P1|Eligible and Started Treatment|Overall Study||32
8380294|NCT01108055|20656573|P1|STARTED|Overall Study||43
8380295|NCT01108003|20656583|P2|NOT COMPLETED|Overall Study||0
8380296|NCT01108003|20656584|P1|NOT COMPLETED|Overall Study||0
8380297|NCT01108003|20656583|P2|COMPLETED|Overall Study||3
8380298|NCT01108003|20656584|P1|COMPLETED|Overall Study||4
8380299|NCT01108003|20656583|P2|STARTED|Overall Study||3
8380300|NCT01108003|20656584|P1|STARTED|Overall Study||4
8380301|NCT01107964|20656594|P2|NOT COMPLETED|Overall Study||1
8380302|NCT01107964|20656595|P1|NOT COMPLETED|Overall Study||1
8380303|NCT01107964|20656594|P2|COMPLETED|Overall Study||13
8380304|NCT01107964|20656595|P1|COMPLETED|Overall Study||12
8380305|NCT01107964|20656594|P2|STARTED|Overall Study||14
8380306|NCT01107964|20656595|P1|STARTED|Overall Study||13
8380307|NCT01107925|20656611|P6|NOT COMPLETED|Period 3||0
8380308|NCT01107925|20656612|P5|NOT COMPLETED|Period 3||0
8380309|NCT01107925|20656613|P4|NOT COMPLETED|Period 3||0
8380310|NCT01107925|20656614|P3|NOT COMPLETED|Period 3||0
8380311|NCT01107925|20656615|P2|NOT COMPLETED|Period 3||0
8380312|NCT01107925|20656616|P1|NOT COMPLETED|Period 3||0
8380313|NCT01107925|20656611|P6|COMPLETED|Period 3||20
8380314|NCT01107925|20656612|P5|COMPLETED|Period 3||0
8380315|NCT01107925|20656613|P4|COMPLETED|Period 3||16
8380316|NCT01107925|20656614|P3|COMPLETED|Period 3||15
8380317|NCT01107925|20656615|P2|COMPLETED|Period 3||17
8380318|NCT01107925|20656616|P1|COMPLETED|Period 3||0
8380319|NCT01107925|20656611|P6|Took at Least 1 Dose of Study Drug|Period 3||20
8380320|NCT01107925|20656612|P5|Took at Least 1 Dose of Study Drug|Period 3||0
8380321|NCT01107925|20656613|P4|Took at Least 1 Dose of Study Drug|Period 3||16
8380322|NCT01107925|20656614|P3|Took at Least 1 Dose of Study Drug|Period 3||15
8380323|NCT01107925|20656615|P2|Took at Least 1 Dose of Study Drug|Period 3||17
8380324|NCT01107925|20656616|P1|Took at Least 1 Dose of Study Drug|Period 3||0
8380325|NCT01107925|20656611|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
8380326|NCT01107925|20656612|P5|STARTED|Period 3||0
8380327|NCT01107925|20656613|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
8380328|NCT01107925|20656614|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
8380329|NCT01107925|20656615|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
8380330|NCT01107925|20656616|P1|STARTED|Period 3||0
8380331|NCT01107925|20656611|P6|NOT COMPLETED|Period 2||1
8380332|NCT01107925|20656612|P5|NOT COMPLETED|Period 2||0
8380333|NCT01107925|20656613|P4|NOT COMPLETED|Period 2||0
8380334|NCT01107925|20656614|P3|NOT COMPLETED|Period 2||0
8380335|NCT01107925|20656615|P2|NOT COMPLETED|Period 2||1
8380336|NCT01107925|20656616|P1|NOT COMPLETED|Period 2||0
8380337|NCT01107925|20656611|P6|COMPLETED|Period 2||16
8380338|NCT01107925|20656612|P5|COMPLETED|Period 2||0
8380339|NCT01107925|20656613|P4|COMPLETED|Period 2||20
8380340|NCT01107925|20656614|P3|COMPLETED|Period 2||17
8380341|NCT01107925|20656615|P2|COMPLETED|Period 2||15
8380342|NCT01107925|20656616|P1|COMPLETED|Period 2||0
8380343|NCT01107925|20656611|P6|Took at Least 1 Dose of Study Drug|Period 2||17
8380344|NCT01107925|20656612|P5|Took at Least 1 Dose of Study Drug|Period 2||0
8380345|NCT01107925|20656613|P4|Took at Least 1 Dose of Study Drug|Period 2||20
8380346|NCT01107925|20656614|P3|Took at Least 1 Dose of Study Drug|Period 2||17
8380347|NCT01107925|20656615|P2|Took at Least 1 Dose of Study Drug|Period 2||16
8380348|NCT01107925|20656616|P1|Took at Least 1 Dose of Study Drug|Period 2||0
8380349|NCT01107925|20656611|P6|STARTED|Period 2||17
8380350|NCT01107925|20656612|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
8380351|NCT01107925|20656613|P4|STARTED|Period 2||20
8380352|NCT01107925|20656614|P3|STARTED|Period 2||17
8380353|NCT01107925|20656615|P2|STARTED|Period 2||16
8380354|NCT01107925|20656616|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
8380355|NCT01107925|20656611|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380356|NCT01107925|20656612|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
8380357|NCT01107925|20656613|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380358|NCT01107925|20656614|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380359|NCT01107925|20656615|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380360|NCT01107925|20656616|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
8380361|NCT01107925|20656611|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
8380362|NCT01107925|20656612|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
8380363|NCT01107925|20656613|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
8380364|NCT01107925|20656614|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
8380365|NCT01107925|20656615|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
8380366|NCT01107925|20656616|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
8380367|NCT01107925|20656611|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380368|NCT01107925|20656612|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
8380369|NCT01107925|20656613|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380370|NCT01107925|20656614|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380371|NCT01107925|20656615|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380372|NCT01107925|20656616|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
8380373|NCT01107925|20656611|P6|STARTED|Period 1-Randomization up Through Day 12||0
8380374|NCT01107925|20656612|P5|STARTED|Period 1-Randomization up Through Day 12||38
8380375|NCT01107925|20656613|P4|STARTED|Period 1-Randomization up Through Day 12||0
8380376|NCT01107925|20656614|P3|STARTED|Period 1-Randomization up Through Day 12||0
8380377|NCT01107925|20656615|P2|STARTED|Period 1-Randomization up Through Day 12||0
8380378|NCT01107925|20656616|P1|STARTED|Period 1-Randomization up Through Day 12||34
8380379|NCT01107912|20656654|P6|NOT COMPLETED|Period 3||0
8380380|NCT01107912|20656655|P5|NOT COMPLETED|Period 3||0
8380381|NCT01107912|20656656|P4|NOT COMPLETED|Period 3||1
8380382|NCT01107912|20656657|P3|NOT COMPLETED|Period 3||1
8380383|NCT01107912|20656658|P2|NOT COMPLETED|Period 3||1
8380384|NCT01107912|20656659|P1|NOT COMPLETED|Period 3||0
8380385|NCT01107912|20656654|P6|COMPLETED|Period 3||41
8380386|NCT01107912|20656655|P5|COMPLETED|Period 3||0
8380387|NCT01107912|20656656|P4|COMPLETED|Period 3||37
8380388|NCT01107912|20656657|P3|COMPLETED|Period 3||35
8380389|NCT01107912|20656658|P2|COMPLETED|Period 3||34
8380390|NCT01107912|20656659|P1|COMPLETED|Period 3||0
8380391|NCT01107912|20656654|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
8380392|NCT01107912|20656655|P5|STARTED|Period 3||0
8380393|NCT01107912|20656656|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
8380394|NCT01107912|20656657|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
8380395|NCT01107912|20656658|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
8380396|NCT01107912|20656659|P1|STARTED|Period 3||0
8380397|NCT01107912|20656654|P6|NOT COMPLETED|Period 2||0
8380398|NCT01107912|20656655|P5|NOT COMPLETED|Period 2||0
8380399|NCT01107912|20656656|P4|NOT COMPLETED|Period 2||0
8380400|NCT01107912|20656657|P3|NOT COMPLETED|Period 2||1
8380401|NCT01107912|20656658|P2|NOT COMPLETED|Period 2||0
8380402|NCT01107912|20656659|P1|NOT COMPLETED|Period 2||0
8380403|NCT01107912|20656654|P6|COMPLETED|Period 2||38
8380404|NCT01107912|20656655|P5|COMPLETED|Period 2||0
8380405|NCT01107912|20656656|P4|COMPLETED|Period 2||41
8380406|NCT01107912|20656657|P3|COMPLETED|Period 2||35
8380407|NCT01107912|20656658|P2|COMPLETED|Period 2||36
8380408|NCT01107912|20656659|P1|COMPLETED|Period 2||0
8380409|NCT01107912|20656654|P6|STARTED|Period 2||38
8380410|NCT01107912|20656655|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
8380411|NCT01107912|20656656|P4|STARTED|Period 2||41
8380412|NCT01107912|20656657|P3|STARTED|Period 2||36
8380413|NCT01107912|20656658|P2|STARTED|Period 2||36
8380414|NCT01107912|20656659|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
8380415|NCT01107912|20656654|P6|NOT COMPLETED|Period 1||0
8380416|NCT01107912|20656655|P5|NOT COMPLETED|Period 1||3
8380417|NCT01107912|20656656|P4|NOT COMPLETED|Period 1||0
8380418|NCT01107912|20656657|P3|NOT COMPLETED|Period 1||0
8380419|NCT01107912|20656658|P2|NOT COMPLETED|Period 1||0
8380420|NCT01107912|20656659|P1|NOT COMPLETED|Period 1||1
8380421|NCT01107912|20656654|P6|COMPLETED|Period 1||0
8380422|NCT01107912|20656655|P5|COMPLETED|Period 1||79
8380423|NCT01107912|20656656|P4|COMPLETED|Period 1||0
8380424|NCT01107912|20656657|P3|COMPLETED|Period 1||0
8380425|NCT01107912|20656658|P2|COMPLETED|Period 1||0
8380426|NCT01107912|20656659|P1|COMPLETED|Period 1||72
8380427|NCT01107912|20656654|P6|Received at Least 1 Dose of Study Drug|Period 1||0
8380428|NCT01107912|20656655|P5|Received at Least 1 Dose of Study Drug|Period 1||82
8380429|NCT01107912|20656656|P4|Received at Least 1 Dose of Study Drug|Period 1||0
8380430|NCT01107912|20656657|P3|Received at Least 1 Dose of Study Drug|Period 1||0
8380431|NCT01107912|20656658|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8380432|NCT01107912|20656659|P1|Received at Least 1 Dose of Study Drug|Period 1||73
8380433|NCT01107912|20656654|P6|STARTED|Period 1||0
8380434|NCT01107912|20656655|P5|STARTED|Period 1||82
8380435|NCT01107912|20656656|P4|STARTED|Period 1||0
8380436|NCT01107912|20656657|P3|STARTED|Period 1||0
8380437|NCT01107912|20656658|P2|STARTED|Period 1||0
8380438|NCT01107912|20656659|P1|STARTED|Period 1||73
8380439|NCT01107899|20656696|P3|NOT COMPLETED|Overall Study||4
8380440|NCT01107899|20656697|P2|NOT COMPLETED|Overall Study||0
8380441|NCT01107899|20656698|P1|NOT COMPLETED|Overall Study||5
8380442|NCT01107899|20656696|P3|COMPLETED|Overall Study||5
8380443|NCT01107899|20656697|P2|COMPLETED|Overall Study||10
8380444|NCT01107899|20656698|P1|COMPLETED|Overall Study||5
8380445|NCT01107899|20656696|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
8380446|NCT01107899|20656697|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
8380447|NCT01107899|20656698|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
8380448|NCT01107899|20656696|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
8380449|NCT01107899|20656697|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
8380450|NCT01107899|20656698|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
8380451|NCT01107899|20656696|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
8380452|NCT01107899|20656697|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
8380453|NCT01107899|20656698|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
8380454|NCT01107899|20656696|P3|Received at Least One Dose of Study Drug|Overall Study||8
8380455|NCT01107899|20656697|P2|Received at Least One Dose of Study Drug|Overall Study||10
8380456|NCT01107899|20656698|P1|Received at Least One Dose of Study Drug|Overall Study||10
8380457|NCT01107899|20656696|P3|STARTED|Overall Study||9
8380458|NCT01107899|20656697|P2|STARTED|Overall Study||10
8380459|NCT01107899|20656698|P1|STARTED|Overall Study||10
8380460|NCT01107886|20656744|P2|NOT COMPLETED|Overall Study||214
8380461|NCT01107886|20656745|P1|NOT COMPLETED|Overall Study||202
8380462|NCT01107886|20656744|P2|COMPLETED|Overall Study|Completed subjects|7998
8380463|NCT01107886|20656745|P1|COMPLETED|Overall Study|Completed subjects|8078
8380464|NCT01107886|20656744|P2|STARTED|Overall Study|Randomized subjects|8212
8380465|NCT01107886|20656745|P1|STARTED|Overall Study|Randomized subjects|8280
8380466|NCT01107834|20656757|P2|NOT COMPLETED|Overall Study||0
8380467|NCT01107834|20656758|P1|NOT COMPLETED|Overall Study||0
8380468|NCT01107834|20656757|P2|COMPLETED|Overall Study||30
8380469|NCT01107834|20656758|P1|COMPLETED|Overall Study||30
8380470|NCT01107834|20656757|P2|STARTED|Overall Study||30
8380471|NCT01107834|20656758|P1|STARTED|Overall Study||30
8380472|NCT01107795|20656774|P1|NOT COMPLETED|Overall Study||0
8380473|NCT01107795|20656774|P1|COMPLETED|Overall Study||41
8380474|NCT01107795|20656774|P1|STARTED|Overall Study||41
8380475|NCT01107730|20656781|P3|NOT COMPLETED|Overall Study||0
8380476|NCT01107730|20656782|P2|NOT COMPLETED|Overall Study||0
8380477|NCT01107730|20656783|P1|NOT COMPLETED|Overall Study||0
8380478|NCT01107730|20656781|P3|COMPLETED|Overall Study||11
8380479|NCT01107730|20656782|P2|COMPLETED|Overall Study||11
8380480|NCT01107730|20656783|P1|COMPLETED|Overall Study||11
8380481|NCT01107730|20656781|P3|STARTED|Overall Study||11
8380482|NCT01107730|20656782|P2|STARTED|Overall Study||11
8380483|NCT01107730|20656783|P1|STARTED|Overall Study||11
8380484|NCT01107665|20656791|P1|NOT COMPLETED|Overall Study||49
8380485|NCT01107665|20656791|P1|COMPLETED|Overall Study||11
8380486|NCT01107665|20656791|P1|STARTED|Overall Study||60
8380487|NCT01107535|20656806|P1|NOT COMPLETED|Overall Study||5
8380488|NCT01107535|20656806|P1|COMPLETED|Overall Study||77
8380489|NCT01107535|20656806|P1|Number of Participants Analyzed|Overall Study||82
8380490|NCT01107535|20656806|P1|STARTED|Overall Study||82
8380491|NCT01107457|20656819|P6|NOT COMPLETED|Part B and C||120
8380492|NCT01107457|20656820|P5|NOT COMPLETED|Part B and C||0
8380493|NCT01107457|20656821|P4|NOT COMPLETED|Part B and C||0
8380494|NCT01107457|20656822|P3|NOT COMPLETED|Part B and C||0
8380495|NCT01107457|20656823|P2|NOT COMPLETED|Part B and C||0
8380496|NCT01107457|20656824|P1|NOT COMPLETED|Part B and C||0
8380497|NCT01107457|20656819|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
8380498|NCT01107457|20656820|P5|COMPLETED|Part B and C||0
8380499|NCT01107457|20656821|P4|COMPLETED|Part B and C||0
8380500|NCT01107457|20656822|P3|COMPLETED|Part B and C||0
8380501|NCT01107457|20656823|P2|COMPLETED|Part B and C||0
8380502|NCT01107457|20656824|P1|COMPLETED|Part B and C||0
8380503|NCT01107457|20656819|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
8380504|NCT01107457|20656820|P5|Post Treatment Safety Visits|Part B and C||0
8380505|NCT01107457|20656821|P4|Post Treatment Safety Visits|Part B and C||0
8380506|NCT01107457|20656822|P3|Post Treatment Safety Visits|Part B and C||0
8380507|NCT01107457|20656823|P2|Post Treatment Safety Visits|Part B and C||0
8380508|NCT01107457|20656824|P1|Post Treatment Safety Visits|Part B and C||0
8380509|NCT01107457|20656819|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
8380510|NCT01107457|20656820|P5|Completed Part C|Part B and C||0
8380511|NCT01107457|20656821|P4|Completed Part C|Part B and C||0
8380512|NCT01107457|20656822|P3|Completed Part C|Part B and C||0
8380513|NCT01107457|20656823|P2|Completed Part C|Part B and C||0
8380514|NCT01107457|20656824|P1|Completed Part C|Part B and C||0
8380515|NCT01107457|20656819|P6|Completed Part B (Week 240)|Part B and C||74
8380516|NCT01107457|20656820|P5|Completed Part B (Week 240)|Part B and C||0
8380517|NCT01107457|20656821|P4|Completed Part B (Week 240)|Part B and C||0
8380518|NCT01107457|20656822|P3|Completed Part B (Week 240)|Part B and C||0
8380519|NCT01107457|20656823|P2|Completed Part B (Week 240)|Part B and C||0
8380520|NCT01107457|20656824|P1|Completed Part B (Week 240)|Part B and C||0
8380521|NCT01107457|20656819|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
8380522|NCT01107457|20656820|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380523|NCT01107457|20656821|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380524|NCT01107457|20656822|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380525|NCT01107457|20656823|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380526|NCT01107457|20656824|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380527|NCT01107457|20656819|P6|NOT COMPLETED|Part A||0
8380528|NCT01107457|20656820|P5|NOT COMPLETED|Part A||1
8380529|NCT01107457|20656821|P4|NOT COMPLETED|Part A||3
8380530|NCT01107457|20656822|P3|NOT COMPLETED|Part A||1
8380531|NCT01107457|20656823|P2|NOT COMPLETED|Part A||7
8380532|NCT01107457|20656824|P1|NOT COMPLETED|Part A||5
8380533|NCT01107457|20656819|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8380534|NCT01107457|20656820|P5|COMPLETED|Part A||27
8380535|NCT01107457|20656821|P4|COMPLETED|Part A||26
8380536|NCT01107457|20656822|P3|COMPLETED|Part A||29
8380537|NCT01107457|20656823|P2|COMPLETED|Part A||21
8380538|NCT01107457|20656824|P1|COMPLETED|Part A||22
8380539|NCT01107457|20656819|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8380540|NCT01107457|20656820|P5|Received at Least 1 Dose of Study Drug|Part A||28
8380541|NCT01107457|20656821|P4|Received at Least 1 Dose of Study Drug|Part A||29
8380542|NCT01107457|20656822|P3|Received at Least 1 Dose of Study Drug|Part A||30
8380543|NCT01107457|20656823|P2|Received at Least 1 Dose of Study Drug|Part A||28
8380544|NCT01107457|20656824|P1|Received at Least 1 Dose of Study Drug|Part A||27
8380545|NCT01107457|20656819|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8380546|NCT01107457|20656820|P5|STARTED|Part A||28
8380547|NCT01107457|20656821|P4|STARTED|Part A||29
8380548|NCT01107457|20656822|P3|STARTED|Part A||30
8380549|NCT01107457|20656823|P2|STARTED|Part A||28
8380550|NCT01107457|20656824|P1|STARTED|Part A||27
8380551|NCT01107444|20656952|P2|NOT COMPLETED|Overall Study||13
8380552|NCT01107444|20656953|P1|NOT COMPLETED|Overall Study||8
8380553|NCT01107444|20656952|P2|COMPLETED|Overall Study||47
8380554|NCT01107444|20656953|P1|COMPLETED|Overall Study||112
8380555|NCT01107444|20656952|P2|Received At Least 1 Dose of Study Drug|Overall Study||48
8380556|NCT01107444|20656953|P1|Received At Least 1 Dose of Study Drug|Overall Study||114
8380557|NCT01107444|20656952|P2|STARTED|Overall Study||60
8380558|NCT01107444|20656953|P1|STARTED|Overall Study||120
8380559|NCT01107418|20656987|P1|NOT COMPLETED|Overall Study||52
8380560|NCT01107418|20656987|P1|COMPLETED|Overall Study||0
8380561|NCT01107418|20656987|P1|STARTED|Overall Study||52
8380562|NCT01107405|20657060|P5|NOT COMPLETED|Overall Study||3
8380563|NCT01107405|20657061|P4|NOT COMPLETED|Overall Study||3
8380564|NCT01107405|20657062|P3|NOT COMPLETED|Overall Study||2
8380565|NCT01107405|20657063|P2|NOT COMPLETED|Overall Study||1
8380566|NCT01107405|20657064|P1|NOT COMPLETED|Overall Study||2
8380567|NCT01107405|20657060|P5|COMPLETED|Overall Study||17
8380568|NCT01107405|20657061|P4|COMPLETED|Overall Study||17
8380569|NCT01107405|20657062|P3|COMPLETED|Overall Study||18
8380570|NCT01107405|20657063|P2|COMPLETED|Overall Study||19
8380571|NCT01107405|20657064|P1|COMPLETED|Overall Study||19
8380572|NCT01107405|20657060|P5|STARTED|Overall Study||20
8380573|NCT01107405|20657061|P4|STARTED|Overall Study||20
8380574|NCT01107405|20657062|P3|STARTED|Overall Study||20
8380575|NCT01107405|20657063|P2|STARTED|Overall Study||20
8380576|NCT01107405|20657064|P1|STARTED|Overall Study||21
8380577|NCT01107392|20657103|P2|NOT COMPLETED|Overall Study||3
8380578|NCT01107392|20657104|P1|NOT COMPLETED|Overall Study||5
8380579|NCT01107392|20657103|P2|COMPLETED|Overall Study||154
8380580|NCT01107392|20657104|P1|COMPLETED|Overall Study||153
8380581|NCT01107392|20657103|P2|STARTED|Overall Study||157
8380582|NCT01107392|20657104|P1|STARTED|Overall Study||158
8380583|NCT01107379|20657116|P1|NOT COMPLETED|Overall Study||21
8380584|NCT01107379|20657116|P1|COMPLETED|Overall Study||182
8380585|NCT01107379|20657116|P1|STARTED|Overall Study||203
8380586|NCT01107353|20657127|P2|NOT COMPLETED|Overall Study||0
8380587|NCT01107353|20657128|P1|NOT COMPLETED|Overall Study||1
8380588|NCT01107353|20657127|P2|COMPLETED|Overall Study||20
8380589|NCT01107353|20657128|P1|COMPLETED|Overall Study||19
8380590|NCT01107353|20657127|P2|STARTED|Overall Study||20
8380591|NCT01107353|20657128|P1|STARTED|Overall Study||20
8380592|NCT01107197|20657136|P2|NOT COMPLETED|Overall Study||23
8380593|NCT01107197|20657137|P1|NOT COMPLETED|Overall Study||20
8380594|NCT01107197|20657136|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
8380595|NCT01107197|20657137|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
8380596|NCT01107197|20657136|P2|STARTED|Overall Study||101
8380597|NCT01107197|20657137|P1|STARTED|Overall Study||99
8380598|NCT01107015|20657159|P4|NOT COMPLETED|Overall Study||18
8380599|NCT01107015|20657160|P3|NOT COMPLETED|Overall Study||11
8380600|NCT01107015|20657161|P2|NOT COMPLETED|Overall Study||15
8380601|NCT01107015|20657162|P1|NOT COMPLETED|Overall Study||6
8380602|NCT01107015|20657159|P4|COMPLETED|Overall Study||62
8380603|NCT01107015|20657160|P3|COMPLETED|Overall Study||22
8380604|NCT01107015|20657161|P2|COMPLETED|Overall Study||23
8380605|NCT01107015|20657162|P1|COMPLETED|Overall Study||56
8380606|NCT01107015|20657159|P4|STARTED|Overall Study||80
8380607|NCT01107015|20657160|P3|STARTED|Overall Study||33
8380608|NCT01107015|20657161|P2|STARTED|Overall Study||38
8380609|NCT01107015|20657162|P1|STARTED|Overall Study||62
8380610|NCT01106976|20657172|P1|NOT COMPLETED|Overall Study||8
8380611|NCT01106976|20657172|P1|COMPLETED|Overall Study||59
8380612|NCT01106976|20657172|P1|STARTED|Overall Study||67
8380613|NCT01106950|20657176|P1|NOT COMPLETED|Overall Study||0
8380614|NCT01106950|20657176|P1|COMPLETED|Overall Study||15
8380615|NCT01106950|20657176|P1|STARTED|Overall Study||15
8380616|NCT01106911|20657186|P1|NOT COMPLETED|Overall Study||5
8380617|NCT01106911|20657186|P1|COMPLETED|Overall Study||1080
8380618|NCT01106911|20657186|P1|STARTED|Overall Study||1085
8380619|NCT01106898|20657190|P1|NOT COMPLETED|Overall Study||6
8380620|NCT01106898|20657190|P1|COMPLETED|Overall Study||94
8380621|NCT01106898|20657190|P1|STARTED|Overall Study||100
8380622|NCT01106859|20657194|P1|NOT COMPLETED|Overall Study||0
8380623|NCT01106859|20657194|P1|COMPLETED|Overall Study||40
8380624|NCT01106859|20657194|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
8380625|NCT01106846|20657235|P2|NOT COMPLETED|Overall Study||1
8380626|NCT01106846|20657236|P1|NOT COMPLETED|Overall Study||0
8380627|NCT01106846|20657235|P2|COMPLETED|Overall Study||9
8380628|NCT01106846|20657236|P1|COMPLETED|Overall Study||12
8380629|NCT01106846|20657235|P2|STARTED|Overall Study||10
8380630|NCT01106846|20657236|P1|STARTED|Overall Study||12
8380631|NCT01106833|20657244|P2|NOT COMPLETED|Overall Study||0
8380632|NCT01106833|20657245|P1|NOT COMPLETED|Overall Study||0
8380633|NCT01106833|20657244|P2|COMPLETED|Overall Study||77
8380634|NCT01106833|20657245|P1|COMPLETED|Overall Study||74
8380635|NCT01106833|20657244|P2|STARTED|Overall Study||77
8380636|NCT01106833|20657245|P1|STARTED|Overall Study||74
8380637|NCT01106690|20657286|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
8380638|NCT01106690|20657287|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
8380639|NCT01106690|20657288|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
8380640|NCT01106690|20657286|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
8380641|NCT01106690|20657287|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
8380642|NCT01106690|20657288|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
8380643|NCT01106690|20657286|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
8380644|NCT01106690|20657287|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
8380645|NCT01106690|20657288|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
8380646|NCT01106690|20657286|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
8380647|NCT01106690|20657287|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
8380648|NCT01106690|20657288|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
8380649|NCT01106690|20657286|P3|COMPLETED|Core Period: Baseline to Week 26||101
8380650|NCT01106690|20657287|P2|COMPLETED|Core Period: Baseline to Week 26||104
8380651|NCT01106690|20657288|P1|COMPLETED|Core Period: Baseline to Week 26||91
8380652|NCT01106690|20657286|P3|STARTED|Core Period: Baseline to Week 26||114
8380653|NCT01106690|20657287|P2|STARTED|Core Period: Baseline to Week 26||113
8380654|NCT01106690|20657288|P1|STARTED|Core Period: Baseline to Week 26||115
8380655|NCT01106677|20657324|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
8380656|NCT01106677|20657325|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
8380657|NCT01106677|20657326|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8380658|NCT01106677|20657327|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
8380659|NCT01106677|20657324|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
8380660|NCT01106677|20657325|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
8380661|NCT01106677|20657326|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
8380662|NCT01106677|20657327|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
8380663|NCT01106677|20657324|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
8380664|NCT01106677|20657325|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
8380665|NCT01106677|20657326|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
8380666|NCT01106677|20657327|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
8380667|NCT01106677|20657324|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
8380668|NCT01106677|20657325|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
8380669|NCT01106677|20657326|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
8380670|NCT01106677|20657327|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
8380671|NCT01106677|20657324|P4|COMPLETED|Core Period: Baseline to Week 26||319
8380672|NCT01106677|20657325|P3|COMPLETED|Core Period: Baseline to Week 26||323
8380673|NCT01106677|20657326|P2|COMPLETED|Core Period: Baseline to Week 26||322
8380674|NCT01106677|20657327|P1|COMPLETED|Core Period: Baseline to Week 26||155
8380675|NCT01106677|20657324|P4|STARTED|Core Period: Baseline to Week 26||366
8380676|NCT01106677|20657325|P3|STARTED|Core Period: Baseline to Week 26||367
8380677|NCT01106677|20657326|P2|STARTED|Core Period: Baseline to Week 26||368
8380678|NCT01106677|20657327|P1|STARTED|Core Period: Baseline to Week 26||183
8380679|NCT01106651|20657390|P3|NOT COMPLETED|Overall Study||58
8380680|NCT01106651|20657391|P2|NOT COMPLETED|Overall Study||57
8380681|NCT01106651|20657392|P1|NOT COMPLETED|Overall Study||79
8380682|NCT01106651|20657390|P3|COMPLETED|Overall Study||178
8380683|NCT01106651|20657391|P2|COMPLETED|Overall Study||184
8380684|NCT01106651|20657392|P1|COMPLETED|Overall Study||158
8380685|NCT01106651|20657390|P3|STARTED|Overall Study||236
8380686|NCT01106651|20657391|P2|STARTED|Overall Study||241
8380687|NCT01106651|20657392|P1|STARTED|Overall Study||237
8380688|NCT01106625|20657445|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
8380689|NCT01106625|20657446|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8380690|NCT01106625|20657447|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
8380691|NCT01106625|20657445|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
8380692|NCT01106625|20657446|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
8380693|NCT01106625|20657447|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
8380694|NCT01106625|20657445|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
8380695|NCT01106625|20657446|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
8380696|NCT01106625|20657447|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
8380697|NCT01106625|20657445|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
8380698|NCT01106625|20657446|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
8380699|NCT01106625|20657447|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
8380700|NCT01106625|20657445|P3|COMPLETED|Core Period: Baseline to Week 26||129
8380701|NCT01106625|20657446|P2|COMPLETED|Core Period: Baseline to Week 26||129
8380702|NCT01106625|20657447|P1|COMPLETED|Core Period: Baseline to Week 26||123
8380703|NCT01106625|20657445|P3|STARTED|Core Period: Baseline to Week 26||156
8380704|NCT01106625|20657446|P2|STARTED|Core Period: Baseline to Week 26||157
8380705|NCT01106625|20657447|P1|STARTED|Core Period: Baseline to Week 26||156
8380706|NCT01106586|20657478|P2|NOT COMPLETED|Overall Study||285
8380707|NCT01106586|20657479|P1|NOT COMPLETED|Overall Study||285
8380708|NCT01106586|20657478|P2|COMPLETED|Overall Study||70
8380709|NCT01106586|20657479|P1|COMPLETED|Overall Study||68
8380710|NCT01106586|20657478|P2|STARTED|Overall Study||355
8380711|NCT01106586|20657479|P1|STARTED|Overall Study||353
8380712|NCT01106534|20657497|P1|NOT COMPLETED|Overall Study||37
8380713|NCT01106534|20657497|P1|COMPLETED|Overall Study||2960
8380714|NCT01106534|20657497|P1|STARTED|Overall Study||2997
8380715|NCT01106456|20657520|P2|NOT COMPLETED|Overall Study||124
8380716|NCT01106456|20657521|P1|NOT COMPLETED|Overall Study||103
8380717|NCT01106456|20657520|P2|COMPLETED|Overall Study||96
8380718|NCT01106456|20657521|P1|COMPLETED|Overall Study||140
8380719|NCT01106456|20657520|P2|STARTED|Overall Study||220
8380720|NCT01106456|20657521|P1|STARTED|Overall Study||243
8380721|NCT01106430|20657529|P2|NOT COMPLETED|Overall Study||33
8380722|NCT01106430|20657530|P1|NOT COMPLETED|Overall Study||33
8380723|NCT01106430|20657529|P2|COMPLETED|Overall Study||101
8380724|NCT01106430|20657530|P1|COMPLETED|Overall Study||100
8380725|NCT01106430|20657529|P2|STARTED|Overall Study||134
8380726|NCT01106430|20657530|P1|STARTED|Overall Study||133
8380727|NCT01106404|20657552|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
8380728|NCT01106404|20657553|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
8380729|NCT01106404|20657552|P2|COMPLETED|Period II (Second 6 Weeks)||38
8380730|NCT01106404|20657553|P1|COMPLETED|Period II (Second 6 Weeks)||33
8380731|NCT01106404|20657552|P2|STARTED|Period II (Second 6 Weeks)||38
8380732|NCT01106404|20657553|P1|STARTED|Period II (Second 6 Weeks)||33
8380733|NCT01106404|20657552|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
8380734|NCT01106404|20657553|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
8380735|NCT01106404|20657552|P2|COMPLETED|Period I (First 6 Weeks)||38
8380736|NCT01106404|20657553|P1|COMPLETED|Period I (First 6 Weeks)||33
8380737|NCT01106404|20657552|P2|STARTED|Period I (First 6 Weeks)||40
8380738|NCT01106404|20657553|P1|STARTED|Period I (First 6 Weeks)||36
8380739|NCT01106391|20657566|P1|NOT COMPLETED|Overall Study||0
8380740|NCT01106391|20657566|P1|COMPLETED|Overall Study||60
8380741|NCT01106391|20657566|P1|STARTED|Overall Study||60
8380742|NCT01106352|20657576|P5|NOT COMPLETED|Overall Study||8
8380743|NCT01106352|20657577|P4|NOT COMPLETED|Overall Study||13
8380744|NCT01106352|20657578|P3|NOT COMPLETED|Overall Study||2
8380745|NCT01106352|20657579|P2|NOT COMPLETED|Overall Study||0
8380746|NCT01106352|20657580|P1|NOT COMPLETED|Overall Study||1
8380747|NCT01106352|20657576|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
8380748|NCT01106352|20657577|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
8380749|NCT01106352|20657578|P3|COMPLETED|Overall Study||5
8380750|NCT01106352|20657579|P2|COMPLETED|Overall Study||3
8380751|NCT01106352|20657580|P1|COMPLETED|Overall Study||6
8380752|NCT01106352|20657576|P5|Completed Safety Cohort|Overall Study||9
8380753|NCT01106352|20657577|P4|Completed Safety Cohort|Overall Study||23
8380754|NCT01106352|20657578|P3|Completed Safety Cohort|Overall Study||0
8380755|NCT01106352|20657579|P2|Completed Safety Cohort|Overall Study||0
8380756|NCT01106352|20657580|P1|Completed Safety Cohort|Overall Study||0
8380757|NCT01106352|20657576|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
8380758|NCT01106352|20657577|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
8380759|NCT01106352|20657578|P3|Treated Safety Cohort|Overall Study||0
8380760|NCT01106352|20657579|P2|Treated Safety Cohort|Overall Study||0
8380761|NCT01106352|20657580|P1|Treated Safety Cohort|Overall Study||0
8380762|NCT01106352|20657576|P5|Started Safety Cohort|Overall Study||17
8380763|NCT01106352|20657577|P4|Started Safety Cohort|Overall Study||36
8380764|NCT01106352|20657578|P3|Started Safety Cohort|Overall Study||0
8380765|NCT01106352|20657579|P2|Started Safety Cohort|Overall Study||0
8380766|NCT01106352|20657580|P1|Started Safety Cohort|Overall Study||0
8380767|NCT01106352|20657576|P5|Completed Dose Escalation|Overall Study||0
8380768|NCT01106352|20657577|P4|Completed Dose Escalation|Overall Study||0
8380769|NCT01106352|20657578|P3|Completed Dose Escalation|Overall Study||5
8380770|NCT01106352|20657579|P2|Completed Dose Escalation|Overall Study||3
8380771|NCT01106352|20657580|P1|Completed Dose Escalation|Overall Study||6
8380772|NCT01106352|20657576|P5|Started Dose Escalation|Overall Study||0
8380773|NCT01106352|20657577|P4|Started Dose Escalation|Overall Study||0
8380774|NCT01106352|20657578|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
8380775|NCT01106352|20657579|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
8380776|NCT01106352|20657580|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
8380777|NCT01106352|20657576|P5|STARTED|Overall Study||17
8380778|NCT01106352|20657577|P4|STARTED|Overall Study||36
8380779|NCT01106352|20657578|P3|STARTED|Overall Study||7
8380780|NCT01106352|20657579|P2|STARTED|Overall Study||3
8380781|NCT01106352|20657580|P1|STARTED|Overall Study||7
8380782|NCT01106326|20657666|P1|NOT COMPLETED|Overall Study||2
8380783|NCT01106326|20657666|P1|COMPLETED|Overall Study||28
8380784|NCT01106326|20657666|P1|STARTED|Overall Study||30
8380785|NCT01106287|20657676|P4|NOT COMPLETED|Overall Study||0
8380786|NCT01106287|20657677|P3|NOT COMPLETED|Overall Study||0
8380787|NCT01106287|20657678|P2|NOT COMPLETED|Overall Study||0
8380788|NCT01106287|20657679|P1|NOT COMPLETED|Overall Study||1
8380789|NCT01106287|20657676|P4|COMPLETED|Overall Study||3
8380790|NCT01106287|20657677|P3|COMPLETED|Overall Study||3
8380791|NCT01106287|20657678|P2|COMPLETED|Overall Study||3
8380792|NCT01106287|20657679|P1|COMPLETED|Overall Study||3
8380793|NCT01106287|20657676|P4|STARTED|Overall Study||3
8380794|NCT01106287|20657677|P3|STARTED|Overall Study||3
8380795|NCT01106287|20657678|P2|STARTED|Overall Study||3
8380796|NCT01106287|20657679|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
8380797|NCT01106248|20657699|P1|NOT COMPLETED|Overall Study||3
8380798|NCT01106248|20657699|P1|COMPLETED|Overall Study||23
8380799|NCT01106248|20657699|P1|STARTED|Overall Study||26
8380800|NCT01106157|20657707|P2|NOT COMPLETED|Overall Study||0
8380801|NCT01106157|20657708|P1|NOT COMPLETED|Overall Study||1
8380802|NCT01106157|20657707|P2|COMPLETED|Overall Study||8
8380803|NCT01106157|20657708|P1|COMPLETED|Overall Study||16
8380804|NCT01106157|20657707|P2|STARTED|Overall Study||8
8380805|NCT01106157|20657708|P1|STARTED|Overall Study||17
8380806|NCT01106092|20657736|P4|NOT COMPLETED|Overall Study||1
8380807|NCT01106092|20657737|P3|NOT COMPLETED|Overall Study||0
8380808|NCT01106092|20657738|P2|NOT COMPLETED|Overall Study||0
8380809|NCT01106092|20657739|P1|NOT COMPLETED|Overall Study||0
8380810|NCT01106092|20657736|P4|COMPLETED|Overall Study||77
8380811|NCT01106092|20657737|P3|COMPLETED|Overall Study||78
8380812|NCT01106092|20657738|P2|COMPLETED|Overall Study||78
8380813|NCT01106092|20657739|P1|COMPLETED|Overall Study||78
8380814|NCT01106092|20657736|P4|STARTED|Overall Study||78
8380815|NCT01106092|20657737|P3|STARTED|Overall Study||78
8380816|NCT01106092|20657738|P2|STARTED|Overall Study||78
8380817|NCT01106092|20657739|P1|STARTED|Overall Study||78
8380818|NCT01106040|20657817|P1|NOT COMPLETED|Overall Study||11
8380819|NCT01106040|20657817|P1|COMPLETED|Overall Study||152
8380820|NCT01106040|20657817|P1|STARTED|Overall Study||163
8380821|NCT01106027|20657822|P1|NOT COMPLETED|Overall Study||1
8380822|NCT01106027|20657822|P1|COMPLETED|Overall Study||1
8380823|NCT01106027|20657822|P1|STARTED|Overall Study||2
8380824|NCT01106014|20657828|P2|NOT COMPLETED|Overall Study||330
8380825|NCT01106014|20657829|P1|NOT COMPLETED|Overall Study||285
8380826|NCT01106014|20657828|P2|COMPLETED|Overall Study||252
8380827|NCT01106014|20657829|P1|COMPLETED|Overall Study||289
8380828|NCT01106014|20657828|P2|STARTED|Overall Study||582
8380829|NCT01106014|20657829|P1|STARTED|Overall Study||574
8380830|NCT01105975|20657849|P10|NOT COMPLETED|Overall Study||9
8380831|NCT01105975|20657850|P9|NOT COMPLETED|Overall Study||6
8380832|NCT01105975|20657851|P8|NOT COMPLETED|Overall Study||7
8380833|NCT01105975|20657852|P7|NOT COMPLETED|Overall Study||8
8380834|NCT01105975|20657853|P6|NOT COMPLETED|Overall Study||5
8380835|NCT01105975|20657854|P5|NOT COMPLETED|Overall Study||6
8380836|NCT01105975|20657855|P4|NOT COMPLETED|Overall Study||2
8380837|NCT01105975|20657856|P3|NOT COMPLETED|Overall Study||10
8380838|NCT01105975|20657857|P2|NOT COMPLETED|Overall Study||5
8380839|NCT01105975|20657858|P1|NOT COMPLETED|Overall Study||5
8380840|NCT01105975|20657849|P10|COMPLETED|Overall Study||32
8380841|NCT01105975|20657850|P9|COMPLETED|Overall Study||34
8380842|NCT01105975|20657851|P8|COMPLETED|Overall Study||33
8380843|NCT01105975|20657852|P7|COMPLETED|Overall Study||34
8380844|NCT01105975|20657853|P6|COMPLETED|Overall Study||30
8380845|NCT01105975|20657854|P5|COMPLETED|Overall Study||35
8380846|NCT01105975|20657855|P4|COMPLETED|Overall Study||36
8380847|NCT01105975|20657856|P3|COMPLETED|Overall Study||32
8380848|NCT01105975|20657857|P2|COMPLETED|Overall Study||34
8380849|NCT01105975|20657858|P1|COMPLETED|Overall Study||35
8380850|NCT01105975|20657849|P10|Took at Least One Dose of Study Drug|Overall Study||41
8380851|NCT01105975|20657850|P9|Took at Least One Dose of Study Drug|Overall Study||39
8380852|NCT01105975|20657851|P8|Took at Least One Dose of Study Drug|Overall Study||40
8380853|NCT01105975|20657852|P7|Took at Least One Dose of Study Drug|Overall Study||41
8380854|NCT01105975|20657853|P6|Took at Least One Dose of Study Drug|Overall Study||35
8380855|NCT01105975|20657854|P5|Took at Least One Dose of Study Drug|Overall Study||41
8380856|NCT01105975|20657855|P4|Took at Least One Dose of Study Drug|Overall Study||38
8380857|NCT01105975|20657856|P3|Took at Least One Dose of Study Drug|Overall Study||40
8380858|NCT01105975|20657857|P2|Took at Least One Dose of Study Drug|Overall Study||38
8380859|NCT01105975|20657858|P1|Took at Least One Dose of Study Drug|Overall Study||40
8380860|NCT01105975|20657849|P10|STARTED|Overall Study||41
8380861|NCT01105975|20657850|P9|STARTED|Overall Study||40
8380862|NCT01105975|20657851|P8|STARTED|Overall Study||40
8380863|NCT01105975|20657852|P7|STARTED|Overall Study||42
8380864|NCT01105975|20657853|P6|STARTED|Overall Study||35
8380865|NCT01105975|20657854|P5|STARTED|Overall Study||41
8380866|NCT01105975|20657855|P4|STARTED|Overall Study||38
8380867|NCT01105975|20657856|P3|STARTED|Overall Study||42
8380868|NCT01105975|20657857|P2|STARTED|Overall Study||39
8380869|NCT01105975|20657858|P1|STARTED|Overall Study||40
8380870|NCT01105936|20658006|P4|NOT COMPLETED|Period 3||0
8380871|NCT01105936|20658007|P3|NOT COMPLETED|Period 3||0
8380872|NCT01105936|20658008|P2|NOT COMPLETED|Period 3||2
8380873|NCT01105936|20658009|P1|NOT COMPLETED|Period 3||0
8380874|NCT01105936|20658006|P4|COMPLETED|Period 3||7
8380875|NCT01105936|20658007|P3|COMPLETED|Period 3||7
8380876|NCT01105936|20658008|P2|COMPLETED|Period 3||6
8380877|NCT01105936|20658009|P1|COMPLETED|Period 3||7
8380878|NCT01105936|20658006|P4|STARTED|Period 3||7
8380879|NCT01105936|20658007|P3|STARTED|Period 3||7
8380880|NCT01105936|20658008|P2|STARTED|Period 3||8
8380881|NCT01105936|20658009|P1|STARTED|Period 3||7
8380882|NCT01105936|20658006|P4|NOT COMPLETED|Wash-out Period 2||0
8380883|NCT01105936|20658007|P3|NOT COMPLETED|Wash-out Period 2||0
8380884|NCT01105936|20658008|P2|NOT COMPLETED|Wash-out Period 2||0
8380885|NCT01105936|20658009|P1|NOT COMPLETED|Wash-out Period 2||0
8380886|NCT01105936|20658006|P4|COMPLETED|Wash-out Period 2||7
8380887|NCT01105936|20658007|P3|COMPLETED|Wash-out Period 2||7
8380888|NCT01105936|20658008|P2|COMPLETED|Wash-out Period 2||8
8380889|NCT01105936|20658009|P1|COMPLETED|Wash-out Period 2||7
8380890|NCT01105936|20658006|P4|STARTED|Wash-out Period 2||7
8380891|NCT01105936|20658007|P3|STARTED|Wash-out Period 2||7
8380892|NCT01105936|20658008|P2|STARTED|Wash-out Period 2||8
8380893|NCT01105936|20658009|P1|STARTED|Wash-out Period 2||7
8380894|NCT01105936|20658006|P4|NOT COMPLETED|Period 2||0
8380895|NCT01105936|20658007|P3|NOT COMPLETED|Period 2||0
8380896|NCT01105936|20658008|P2|NOT COMPLETED|Period 2||0
8380897|NCT01105936|20658009|P1|NOT COMPLETED|Period 2||1
8380898|NCT01105936|20658006|P4|COMPLETED|Period 2||7
8380899|NCT01105936|20658007|P3|COMPLETED|Period 2||7
8380900|NCT01105936|20658008|P2|COMPLETED|Period 2||8
8380901|NCT01105936|20658009|P1|COMPLETED|Period 2||7
8380902|NCT01105936|20658006|P4|STARTED|Period 2||7
8380903|NCT01105936|20658007|P3|STARTED|Period 2||7
8380904|NCT01105936|20658008|P2|STARTED|Period 2||8
8380905|NCT01105936|20658009|P1|STARTED|Period 2||8
8380906|NCT01105936|20658006|P4|NOT COMPLETED|Wash-out Period 1||0
8380907|NCT01105936|20658007|P3|NOT COMPLETED|Wash-out Period 1||0
8380908|NCT01105936|20658008|P2|NOT COMPLETED|Wash-out Period 1||0
8380909|NCT01105936|20658009|P1|NOT COMPLETED|Wash-out Period 1||0
8380910|NCT01105936|20658006|P4|COMPLETED|Wash-out Period 1||7
8380911|NCT01105936|20658007|P3|COMPLETED|Wash-out Period 1||7
8380912|NCT01105936|20658008|P2|COMPLETED|Wash-out Period 1||8
8380913|NCT01105936|20658009|P1|COMPLETED|Wash-out Period 1||8
8380914|NCT01105936|20658006|P4|STARTED|Wash-out Period 1||7
8380915|NCT01105936|20658007|P3|STARTED|Wash-out Period 1||7
8380916|NCT01105936|20658008|P2|STARTED|Wash-out Period 1||8
8380917|NCT01105936|20658009|P1|STARTED|Wash-out Period 1||8
8380918|NCT01105936|20658006|P4|NOT COMPLETED|Period 1||1
8380919|NCT01105936|20658007|P3|NOT COMPLETED|Period 1||0
8380920|NCT01105936|20658008|P2|NOT COMPLETED|Period 1||0
8380921|NCT01105936|20658009|P1|NOT COMPLETED|Period 1||0
8380922|NCT01105936|20658006|P4|COMPLETED|Period 1||7
8380923|NCT01105936|20658007|P3|COMPLETED|Period 1||7
8380924|NCT01105936|20658008|P2|COMPLETED|Period 1||8
8380925|NCT01105936|20658009|P1|COMPLETED|Period 1||8
8380926|NCT01105936|20658006|P4|STARTED|Period 1||8
8380927|NCT01105936|20658007|P3|STARTED|Period 1||7
8380928|NCT01105936|20658008|P2|STARTED|Period 1||8
8380929|NCT01105936|20658009|P1|STARTED|Period 1||8
8380930|NCT01105767|20658038|P3|NOT COMPLETED|Overall Study||1184
8380931|NCT01105767|20658039|P2|NOT COMPLETED|Overall Study||1614
8380932|NCT01105767|20658040|P1|NOT COMPLETED|Overall Study||1160
8380933|NCT01105767|20658038|P3|COMPLETED|Overall Study||8846
8380934|NCT01105767|20658039|P2|COMPLETED|Overall Study||9250
8380935|NCT01105767|20658040|P1|COMPLETED|Overall Study||8155
8380936|NCT01105767|20658038|P3|STARTED|Overall Study||10030
8380937|NCT01105767|20658039|P2|STARTED|Overall Study||10864
8380938|NCT01105767|20658040|P1|STARTED|Overall Study||9315
8380939|NCT01105754|20658053|P2|NOT COMPLETED|Overall Study||12
8380940|NCT01105754|20658054|P1|NOT COMPLETED|Overall Study||15
8380941|NCT01105754|20658053|P2|COMPLETED|Overall Study||307
8380942|NCT01105754|20658054|P1|COMPLETED|Overall Study||304
8380943|NCT01105754|20658053|P2|STARTED|Overall Study||319
8380944|NCT01105754|20658054|P1|STARTED|Overall Study||319
8380945|NCT01105702|20658062|P1|NOT COMPLETED|Overall Study||18
8380946|NCT01105702|20658062|P1|COMPLETED|Overall Study||10
8380947|NCT01105702|20658062|P1|STARTED|Overall Study||28
8380948|NCT01105650|20658072|P4|NOT COMPLETED|Overall Study||0
8380949|NCT01105650|20658073|P3|NOT COMPLETED|Overall Study||0
8380950|NCT01105650|20658074|P2|NOT COMPLETED|Overall Study||0
8380951|NCT01105650|20658075|P1|NOT COMPLETED|Overall Study||0
8380952|NCT01105650|20658072|P4|COMPLETED|Overall Study||0
8380953|NCT01105650|20658073|P3|COMPLETED|Overall Study||7
8380954|NCT01105650|20658074|P2|COMPLETED|Overall Study||3
8380955|NCT01105650|20658075|P1|COMPLETED|Overall Study||3
8380956|NCT01105650|20658072|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
8380957|NCT01105650|20658073|P3|STARTED|Overall Study||7
8380958|NCT01105650|20658074|P2|STARTED|Overall Study||3
8380959|NCT01105650|20658075|P1|STARTED|Overall Study||3
8380960|NCT01105533|20658092|P9|NOT COMPLETED|Overall Study||12
8380961|NCT01105533|20658093|P8|NOT COMPLETED|Overall Study||4
8380962|NCT01105533|20658094|P7|NOT COMPLETED|Overall Study||8
8380963|NCT01105533|20658095|P6|NOT COMPLETED|Overall Study||7
8380964|NCT01105533|20658096|P5|NOT COMPLETED|Overall Study||7
8380965|NCT01105533|20658097|P4|NOT COMPLETED|Overall Study||3
8380966|NCT01105533|20658098|P3|NOT COMPLETED|Overall Study||3
8380967|NCT01105533|20658099|P2|NOT COMPLETED|Overall Study||1
8380968|NCT01105533|20658100|P1|NOT COMPLETED|Overall Study||1
8380969|NCT01105533|20658092|P9|COMPLETED|Overall Study||0
8380970|NCT01105533|20658093|P8|COMPLETED|Overall Study||0
8380971|NCT01105533|20658094|P7|COMPLETED|Overall Study||0
8380972|NCT01105533|20658095|P6|COMPLETED|Overall Study||0
8380973|NCT01105533|20658096|P5|COMPLETED|Overall Study||0
8380974|NCT01105533|20658097|P4|COMPLETED|Overall Study||0
8380975|NCT01105533|20658098|P3|COMPLETED|Overall Study||0
8380976|NCT01105533|20658099|P2|COMPLETED|Overall Study||0
8380977|NCT01105533|20658100|P1|COMPLETED|Overall Study||0
8380978|NCT01105533|20658092|P9|STARTED|Overall Study||12
8380979|NCT01105533|20658093|P8|STARTED|Overall Study||4
8380980|NCT01105533|20658094|P7|STARTED|Overall Study||8
8380981|NCT01105533|20658095|P6|STARTED|Overall Study||7
8380982|NCT01105533|20658096|P5|STARTED|Overall Study||7
8380983|NCT01105533|20658097|P4|STARTED|Overall Study||3
8380984|NCT01105533|20658098|P3|STARTED|Overall Study||3
8380985|NCT01105533|20658099|P2|STARTED|Overall Study||1
8380986|NCT01105533|20658100|P1|STARTED|Overall Study||1
8380987|NCT01105377|20658190|P2|NOT COMPLETED|Overall Study||1
8380988|NCT01105377|20658191|P1|NOT COMPLETED|Overall Study||0
8380989|NCT01105377|20658190|P2|COMPLETED|Overall Study||22
8380990|NCT01105377|20658191|P1|COMPLETED|Overall Study||24
8380991|NCT01105377|20658190|P2|STARTED|Overall Study||23
8380992|NCT01105377|20658191|P1|STARTED|Overall Study||24
8380993|NCT01105312|20658202|P3|NOT COMPLETED|Overall Study||0
8380994|NCT01105312|20658203|P2|NOT COMPLETED|Overall Study||0
8380995|NCT01105312|20658204|P1|NOT COMPLETED|Overall Study||3
8380996|NCT01105312|20658202|P3|COMPLETED|Overall Study||6
8380997|NCT01105312|20658203|P2|COMPLETED|Overall Study||6
8380998|NCT01105312|20658204|P1|COMPLETED|Overall Study||13
8380999|NCT01105312|20658202|P3|STARTED|Overall Study||6
8381000|NCT01105312|20658203|P2|STARTED|Overall Study||6
8381001|NCT01105312|20658204|P1|STARTED|Overall Study||16
8381002|NCT01105247|20658222|P2|NOT COMPLETED|Overall Study||0
8381003|NCT01105247|20658223|P1|NOT COMPLETED|Overall Study||37
8381004|NCT01105247|20658222|P2|COMPLETED|Overall Study||16
8381005|NCT01105247|20658223|P1|COMPLETED|Overall Study||79
8381006|NCT01105247|20658222|P2|STARTED|Overall Study||16
8381007|NCT01105247|20658223|P1|STARTED|Overall Study||116
8381008|NCT01105130|20658239|P3|NOT COMPLETED|Overall Study||10
8381009|NCT01105130|20658240|P2|NOT COMPLETED|Overall Study||11
8381010|NCT01105130|20658241|P1|NOT COMPLETED|Overall Study||10
8381011|NCT01105130|20658239|P3|COMPLETED|Overall Study||37
8381012|NCT01105130|20658240|P2|COMPLETED|Overall Study||34
8381013|NCT01105130|20658241|P1|COMPLETED|Overall Study||38
8381014|NCT01105130|20658239|P3|STARTED|Overall Study||47
8381015|NCT01105130|20658240|P2|STARTED|Overall Study||45
8381016|NCT01105130|20658241|P1|STARTED|Overall Study||48
8381017|NCT01105117|20658260|P2|NOT COMPLETED|Overall Study||0
8381018|NCT01105117|20658261|P1|NOT COMPLETED|Overall Study||0
8381019|NCT01105117|20658260|P2|COMPLETED|Overall Study||1
8381020|NCT01105117|20658261|P1|COMPLETED|Overall Study||1
8381021|NCT01105117|20658260|P2|STARTED|Overall Study||1
8381022|NCT01105117|20658261|P1|STARTED|Overall Study||1
8381023|NCT01105091|20658271|P2|NOT COMPLETED|Overall Study||0
8381024|NCT01105091|20658272|P1|NOT COMPLETED|Overall Study||2
8381025|NCT01105091|20658271|P2|COMPLETED|Overall Study||10
8381026|NCT01105091|20658272|P1|COMPLETED|Overall Study||18
8381027|NCT01105091|20658271|P2|STARTED|Overall Study||10
8381028|NCT01105091|20658272|P1|STARTED|Overall Study||20
8381029|NCT01105065|20658296|P1|NOT COMPLETED|Overall Study||6
8381030|NCT01105065|20658296|P1|COMPLETED|Overall Study||17
8381031|NCT01105065|20658296|P1|STARTED|Overall Study||23
8381032|NCT01104870|20658305|P3|NOT COMPLETED|Overall Study||2
8381033|NCT01104870|20658306|P2|NOT COMPLETED|Overall Study||1
8381034|NCT01104870|20658307|P1|NOT COMPLETED|Overall Study||1
8381035|NCT01104870|20658305|P3|COMPLETED|Overall Study||18
8381036|NCT01104870|20658306|P2|COMPLETED|Overall Study||18
8381037|NCT01104870|20658307|P1|COMPLETED|Overall Study||10
8381038|NCT01104870|20658305|P3|STARTED|Overall Study||20
8381039|NCT01104870|20658306|P2|STARTED|Overall Study||19
8381040|NCT01104870|20658307|P1|STARTED|Overall Study||11
8381041|NCT01104792|20658336|P1|NOT COMPLETED|Overall Study||526
8381042|NCT01104792|20658336|P1|COMPLETED|Overall Study||226
8381043|NCT01104792|20658336|P1|STARTED|Overall Study||752
8381044|NCT01104779|20658344|P3|NOT COMPLETED|Overall Study||62
8381045|NCT01104779|20658345|P2|NOT COMPLETED|Overall Study||55
8381046|NCT01104779|20658346|P1|NOT COMPLETED|Overall Study||59
8381047|NCT01104779|20658344|P3|COMPLETED|Overall Study||86
8381048|NCT01104779|20658345|P2|COMPLETED|Overall Study||96
8381049|NCT01104779|20658346|P1|COMPLETED|Overall Study||88
8381050|NCT01104779|20658344|P3|STARTED|Overall Study||148
8381051|NCT01104779|20658345|P2|STARTED|Overall Study||151
8381052|NCT01104779|20658346|P1|STARTED|Overall Study||147
8381053|NCT01104766|20658361|P4|NOT COMPLETED|Overall Study||38
8381054|NCT01104766|20658362|P3|NOT COMPLETED|Overall Study||60
8381055|NCT01104766|20658363|P2|NOT COMPLETED|Overall Study||51
8381056|NCT01104766|20658364|P1|NOT COMPLETED|Overall Study||58
8381057|NCT01104766|20658361|P4|COMPLETED|Overall Study||114
8381058|NCT01104766|20658362|P3|COMPLETED|Overall Study||97
8381059|NCT01104766|20658363|P2|COMPLETED|Overall Study||104
8381060|NCT01104766|20658364|P1|COMPLETED|Overall Study||95
8381061|NCT01104766|20658361|P4|STARTED|Overall Study||152
8381062|NCT01104766|20658362|P3|STARTED|Overall Study||157
8381063|NCT01104766|20658363|P2|STARTED|Overall Study||155
8381064|NCT01104766|20658364|P1|STARTED|Overall Study||153
8381065|NCT01104701|20658382|P4|NOT COMPLETED|Overall Study||2
8381066|NCT01104701|20658383|P3|NOT COMPLETED|Overall Study||2
8381067|NCT01104701|20658384|P2|NOT COMPLETED|Overall Study||3
8381068|NCT01104701|20658385|P1|NOT COMPLETED|Overall Study||0
8381069|NCT01104701|20658382|P4|COMPLETED|Overall Study||28
8381070|NCT01104701|20658383|P3|COMPLETED|Overall Study||29
8381071|NCT01104701|20658384|P2|COMPLETED|Overall Study||27
8381072|NCT01104701|20658385|P1|COMPLETED|Overall Study||30
8381073|NCT01104701|20658382|P4|STARTED|Overall Study||30
8381074|NCT01104701|20658383|P3|STARTED|Overall Study||31
8381075|NCT01104701|20658384|P2|STARTED|Overall Study||30
8381076|NCT01104701|20658385|P1|STARTED|Overall Study||30
8381077|NCT01104662|20658447|P8|NOT COMPLETED|Overall Study||0
8381078|NCT01104662|20658448|P7|NOT COMPLETED|Overall Study||0
8381079|NCT01104662|20658449|P6|NOT COMPLETED|Overall Study||4
8381080|NCT01104662|20658450|P5|NOT COMPLETED|Overall Study||1
8381081|NCT01104662|20658451|P4|NOT COMPLETED|Overall Study||1
8381082|NCT01104662|20658452|P3|NOT COMPLETED|Overall Study||1
8381083|NCT01104662|20658453|P2|NOT COMPLETED|Overall Study||10
8381084|NCT01104662|20658454|P1|NOT COMPLETED|Overall Study||10
8381085|NCT01104662|20658447|P8|COMPLETED|Overall Study||6
8381086|NCT01104662|20658448|P7|COMPLETED|Overall Study||5
8381087|NCT01104662|20658449|P6|COMPLETED|Overall Study||12
8381088|NCT01104662|20658450|P5|COMPLETED|Overall Study||14
8381089|NCT01104662|20658451|P4|COMPLETED|Overall Study||3
8381090|NCT01104662|20658452|P3|COMPLETED|Overall Study||4
8381091|NCT01104662|20658453|P2|COMPLETED|Overall Study||11
8381092|NCT01104662|20658454|P1|COMPLETED|Overall Study||10
8381093|NCT01104662|20658447|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
8381094|NCT01104662|20658448|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
8381095|NCT01104662|20658449|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
8381096|NCT01104662|20658450|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
8381097|NCT01104662|20658451|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8381098|NCT01104662|20658452|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
8381099|NCT01104662|20658453|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
8381100|NCT01104662|20658454|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
8381101|NCT01104662|20658447|P8|STARTED|Overall Study||6
8381102|NCT01104662|20658448|P7|STARTED|Overall Study||5
8381103|NCT01104662|20658449|P6|STARTED|Overall Study||16
8381104|NCT01104662|20658450|P5|STARTED|Overall Study||15
8381105|NCT01104662|20658451|P4|STARTED|Overall Study||4
8381106|NCT01104662|20658452|P3|STARTED|Overall Study||5
8381107|NCT01104662|20658453|P2|STARTED|Overall Study||21
8381108|NCT01104662|20658454|P1|STARTED|Overall Study||20
8381109|NCT01104636|20658480|P1|NOT COMPLETED|Overall Study||178
8381110|NCT01104636|20658480|P1|COMPLETED|Overall Study||999
8381111|NCT01104636|20658480|P1|STARTED|Overall Study||1177
8381112|NCT01104584|20658485|P1|NOT COMPLETED|Overall Study||23
8381113|NCT01104584|20658485|P1|COMPLETED|Overall Study|study course completed|437
8381114|NCT01104584|20658485|P1|Fulfilled Requirements of FAS Population|Overall Study||397
8381115|NCT01104584|20658485|P1|Received Treatment|Overall Study|treatment started|439
8381116|NCT01104584|20658485|P1|STARTED|Overall Study|screened and enrolled|460
8381117|NCT01104558|20658555|P1|NOT COMPLETED|Overall Study||17
8381118|NCT01104558|20658555|P1|COMPLETED|Overall Study||83
8381119|NCT01104558|20658555|P1|STARTED|Overall Study||100
8381120|NCT01104545|20658599|P3|NOT COMPLETED|Overall Study||2
8381121|NCT01104545|20658600|P2|NOT COMPLETED|Overall Study||1
8381122|NCT01104545|20658601|P1|NOT COMPLETED|Overall Study||0
8381123|NCT01104545|20658599|P3|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
8381124|NCT01104545|20658600|P2|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
8381125|NCT01104545|20658601|P1|COMPLETED|Overall Study||8
8381126|NCT01104545|20658599|P3|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
8381127|NCT01104545|20658600|P2|STARTED|Overall Study||8
8381128|NCT01104545|20658601|P1|STARTED|Overall Study||8
8381129|NCT01104493|20658758|P2|NOT COMPLETED|Overall Study||2
8381130|NCT01104493|20658759|P1|NOT COMPLETED|Overall Study||0
8381131|NCT01104493|20658758|P2|COMPLETED|Overall Study||58
8381132|NCT01104493|20658759|P1|COMPLETED|Overall Study||240
8381133|NCT01104493|20658758|P2|STARTED|Overall Study||60
8381134|NCT01104493|20658759|P1|STARTED|Overall Study||240
8381135|NCT01104415|20658777|P2|NOT COMPLETED|Extension Period||11
8381136|NCT01104415|20658778|P1|NOT COMPLETED|Extension Period||0
8381137|NCT01104415|20658777|P2|COMPLETED|Extension Period||0
8381138|NCT01104415|20658778|P1|COMPLETED|Extension Period||0
8381139|NCT01104415|20658777|P2|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
8381140|NCT01104415|20658778|P1|STARTED|Extension Period||0
8381141|NCT01104415|20658777|P2|NOT COMPLETED|Core Phase||0
8381142|NCT01104415|20658778|P1|NOT COMPLETED|Core Phase||1
8381143|NCT01104415|20658777|P2|COMPLETED|Core Phase||0
8381144|NCT01104415|20658778|P1|COMPLETED|Core Phase||14
8381145|NCT01104415|20658777|P2|STARTED|Core Phase||0
8381146|NCT01104415|20658778|P1|STARTED|Core Phase||15
8381147|NCT01104402|20658803|P2|NOT COMPLETED|Overall Study||33
8381148|NCT01104402|20658804|P1|NOT COMPLETED|Overall Study||21
8381149|NCT01104402|20658803|P2|COMPLETED|Overall Study||102
8381150|NCT01104402|20658804|P1|COMPLETED|Overall Study||111
8381151|NCT01104402|20658803|P2|STARTED|Overall Study||135
8381152|NCT01104402|20658804|P1|STARTED|Overall Study||132
8381153|NCT01104376|20658822|P1|NOT COMPLETED|Overall Study||28
8381154|NCT01104376|20658822|P1|COMPLETED|Overall Study||61
8381155|NCT01104376|20658822|P1|STARTED|Overall Study||89
8381156|NCT01104311|20658828|P2|NOT COMPLETED|Overall Study||12
8381157|NCT01104311|20658829|P1|NOT COMPLETED|Overall Study||10
8381158|NCT01104311|20658828|P2|COMPLETED|Overall Study||54
8381159|NCT01104311|20658829|P1|COMPLETED|Overall Study||56
8381160|NCT01104311|20658828|P2|STARTED|Overall Study||66
8381161|NCT01104311|20658829|P1|STARTED|Overall Study||66
8381162|NCT01104285|20658849|P2|NOT COMPLETED|Overall Study||0
8381163|NCT01104285|20658850|P1|NOT COMPLETED|Overall Study||0
8381164|NCT01104285|20658849|P2|COMPLETED|Overall Study||86
8381165|NCT01104285|20658850|P1|COMPLETED|Overall Study||112
8381166|NCT01104285|20658849|P2|STARTED|Overall Study||86
8381167|NCT01104285|20658850|P1|STARTED|Overall Study||112
8381168|NCT01104246|20658856|P1|NOT COMPLETED|Overall Study||5
8381169|NCT01104246|20658856|P1|COMPLETED|Overall Study||35
8381170|NCT01104246|20658856|P1|Baseline Characteristics Measured|Overall Study||35
8381171|NCT01104246|20658856|P1|STARTED|Overall Study||40
8381172|NCT01104207|20658862|P2|NOT COMPLETED|Overall Study||3
8381173|NCT01104207|20658863|P1|NOT COMPLETED|Overall Study||3
8381174|NCT01104207|20658862|P2|COMPLETED|Overall Study||32
8381175|NCT01104207|20658863|P1|COMPLETED|Overall Study||32
8381176|NCT01104207|20658862|P2|STARTED|Overall Study||35
8381177|NCT01104207|20658863|P1|STARTED|Overall Study||35
8381178|NCT01104155|20658871|P2|NOT COMPLETED|Overall Study||18
8381179|NCT01104155|20658872|P1|NOT COMPLETED|Overall Study||25
8381180|NCT01104155|20658871|P2|COMPLETED|Overall Study||42
8381181|NCT01104155|20658872|P1|COMPLETED|Overall Study||38
8381182|NCT01104155|20658871|P2|STARTED|Overall Study||60
8381183|NCT01104155|20658872|P1|STARTED|Overall Study||63
8381184|NCT01104116|20658886|P1|NOT COMPLETED|Overall Study||0
8381185|NCT01104116|20658886|P1|COMPLETED|Overall Study||1
8381186|NCT01104116|20658886|P1|STARTED|Overall Study||1
8381187|NCT01104103|20658893|P2|NOT COMPLETED|Overall Study||0
8381188|NCT01104103|20658894|P1|NOT COMPLETED|Overall Study||0
8381189|NCT01104103|20658893|P2|COMPLETED|Overall Study||224
8381190|NCT01104103|20658894|P1|COMPLETED|Overall Study||243
8381191|NCT01104103|20658893|P2|STARTED|Overall Study||224
8381192|NCT01104103|20658894|P1|STARTED|Overall Study||243
8381193|NCT01104025|20658902|P1|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
8381194|NCT01104025|20658902|P1|COMPLETED|Follow up Until Day 100 Post BMT||9
8381195|NCT01104025|20658902|P1|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
8381196|NCT01104025|20658902|P1|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
8381197|NCT01104025|20658902|P1|COMPLETED|Follow up Until BMT OR 6 Months||22
8381198|NCT01104025|20658902|P1|STARTED|Follow up Until BMT OR 6 Months||25
8381199|NCT01104025|20658902|P1|NOT COMPLETED|Treatment Period||6
8381200|NCT01104025|20658902|P1|COMPLETED|Treatment Period||25
8381201|NCT01104025|20658902|P1|STARTED|Treatment Period||31
8381202|NCT01103973|20658913|P2|NOT COMPLETED|Overall Study||0
8381203|NCT01103973|20658914|P1|NOT COMPLETED|Overall Study||0
8381204|NCT01103973|20658913|P2|COMPLETED|Overall Study||46
8381205|NCT01103973|20658914|P1|COMPLETED|Overall Study||51
8381206|NCT01103973|20658913|P2|STARTED|Overall Study||46
8381207|NCT01103973|20658914|P1|STARTED|Overall Study||51
8381208|NCT01103960|20658924|P2|NOT COMPLETED|Overall Study||2
8381209|NCT01103960|20658925|P1|NOT COMPLETED|Overall Study||5
8381210|NCT01103960|20658924|P2|COMPLETED|Overall Study|Completed study medication.|158
8381211|NCT01103960|20658925|P1|COMPLETED|Overall Study|Completed study medication.|159
8381212|NCT01103960|20658924|P2|STARTED|Overall Study|Randomised and treated.|160
8381213|NCT01103960|20658925|P1|STARTED|Overall Study|Randomised and treated.|164
8381214|NCT01103934|20658951|P2|NOT COMPLETED|Overall Study||0
8381215|NCT01103934|20658952|P1|NOT COMPLETED|Overall Study||0
8381216|NCT01103934|20658951|P2|COMPLETED|Overall Study||18
8381217|NCT01103934|20658952|P1|COMPLETED|Overall Study||17
8381218|NCT01103934|20658951|P2|STARTED|Overall Study||18
8381219|NCT01103934|20658952|P1|STARTED|Overall Study||17
8381220|NCT01103778|20658960|P1|NOT COMPLETED|Overall Study||3
8381221|NCT01103778|20658960|P1|COMPLETED|Overall Study||8
8381222|NCT01103778|20658960|P1|STARTED|Overall Study||11
8381223|NCT01103713|20658967|P1|NOT COMPLETED|Overall Study||13
8381224|NCT01103713|20658967|P1|COMPLETED|Overall Study||155
8381225|NCT01103713|20658967|P1|STARTED|Overall Study||168
8381226|NCT01103505|20658995|P2|NOT COMPLETED|Overall Study||20
8381227|NCT01103505|20658996|P1|NOT COMPLETED|Overall Study||24
8381228|NCT01103505|20658995|P2|COMPLETED|Overall Study||737
8381229|NCT01103505|20658996|P1|COMPLETED|Overall Study||739
8381230|NCT01103505|20658995|P2|STARTED|Overall Study||757
8381231|NCT01103505|20658996|P1|STARTED|Overall Study||763
8381232|NCT01103492|20659010|P1|NOT COMPLETED|Overall Study||0
8381233|NCT01103492|20659010|P1|COMPLETED|Overall Study||1
8381234|NCT01103492|20659010|P1|STARTED|Overall Study||1
8381235|NCT01103479|20659017|P3|NOT COMPLETED|Overall Study||14
8381236|NCT01103479|20659018|P2|NOT COMPLETED|Overall Study||9
8381237|NCT01103479|20659019|P1|NOT COMPLETED|Overall Study||5
8381238|NCT01103479|20659017|P3|COMPLETED|Overall Study||174
8381239|NCT01103479|20659018|P2|COMPLETED|Overall Study||201
8381240|NCT01103479|20659019|P1|COMPLETED|Overall Study||163
8381241|NCT01103479|20659017|P3|STARTED|Overall Study||188
8381242|NCT01103479|20659018|P2|STARTED|Overall Study||210
8381243|NCT01103479|20659019|P1|STARTED|Overall Study||168
8381244|NCT01103466|20659032|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
8381245|NCT01103466|20659033|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
8381246|NCT01103466|20659034|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
8381247|NCT01103466|20659032|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
8381248|NCT01103466|20659033|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
8381249|NCT01103466|20659034|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
8381250|NCT01103466|20659032|P3|STARTED|Third Period (14 +/- 3 Days)||14
8381251|NCT01103466|20659033|P2|STARTED|Third Period (14 +/- 3 Days)||8
8381252|NCT01103466|20659034|P1|STARTED|Third Period (14 +/- 3 Days)||8
8381253|NCT01103466|20659032|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
8381254|NCT01103466|20659033|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
8381255|NCT01103466|20659034|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
8381256|NCT01103466|20659032|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
8381257|NCT01103466|20659033|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
8381258|NCT01103466|20659034|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
8381259|NCT01103466|20659032|P3|STARTED|Second Period (14 +/- 3 Days)||7
8381260|NCT01103466|20659033|P2|STARTED|Second Period (14 +/- 3 Days)||13
8381261|NCT01103466|20659034|P1|STARTED|Second Period (14 +/- 3 Days)||15
8381262|NCT01103466|20659032|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
8381263|NCT01103466|20659033|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
8381264|NCT01103466|20659034|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
8381265|NCT01103466|20659032|P3|COMPLETED|First Period (14 +/- 3 Days)||13
8381266|NCT01103466|20659033|P2|COMPLETED|First Period (14 +/- 3 Days)||12
8381267|NCT01103466|20659034|P1|COMPLETED|First Period (14 +/- 3 Days)||10
8381268|NCT01103466|20659032|P3|STARTED|First Period (14 +/- 3 Days)||13
8381269|NCT01103466|20659033|P2|STARTED|First Period (14 +/- 3 Days)||12
8381270|NCT01103466|20659034|P1|STARTED|First Period (14 +/- 3 Days)||12
8381271|NCT01103440|20659044|P2|NOT COMPLETED|Overall Study||0
8381272|NCT01103440|20659045|P1|NOT COMPLETED|Overall Study||0
8381273|NCT01103440|20659044|P2|COMPLETED|Overall Study||18
8381274|NCT01103440|20659045|P1|COMPLETED|Overall Study||18
8381275|NCT01103440|20659044|P2|STARTED|Overall Study||18
8381276|NCT01103440|20659045|P1|STARTED|Overall Study||18
8381277|NCT01103414|20659058|P5|NOT COMPLETED|Overall Study||15
8381278|NCT01103414|20659059|P4|NOT COMPLETED|Overall Study||7
8381279|NCT01103414|20659060|P3|NOT COMPLETED|Overall Study||15
8381280|NCT01103414|20659061|P2|NOT COMPLETED|Overall Study||9
8381281|NCT01103414|20659062|P1|NOT COMPLETED|Overall Study||13
8381282|NCT01103414|20659058|P5|COMPLETED|Overall Study||56
8381283|NCT01103414|20659059|P4|COMPLETED|Overall Study||64
8381284|NCT01103414|20659060|P3|COMPLETED|Overall Study||56
8381285|NCT01103414|20659061|P2|COMPLETED|Overall Study||62
8381286|NCT01103414|20659062|P1|COMPLETED|Overall Study||59
8381287|NCT01103414|20659058|P5|STARTED|Overall Study||71
8381288|NCT01103414|20659059|P4|STARTED|Overall Study||71
8381289|NCT01103414|20659060|P3|STARTED|Overall Study||71
8381290|NCT01103414|20659061|P2|STARTED|Overall Study||71
8381291|NCT01103414|20659062|P1|STARTED|Overall Study||72
8381292|NCT01103362|20659124|P1|NOT COMPLETED|Overall Study||596
8381293|NCT01103362|20659124|P1|COMPLETED|Overall Study||0
8381294|NCT01103362|20659124|P1|STARTED|Overall Study||596
8381295|NCT01103323|20659130|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
8381296|NCT01103323|20659131|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
8381297|NCT01103323|20659130|P2|COMPLETED|Switched From Placebo to Regorafenib||3
8381298|NCT01103323|20659131|P1|COMPLETED|Switched From Placebo to Regorafenib||0
8381299|NCT01103323|20659130|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
8381300|NCT01103323|20659131|P1|STARTED|Switched From Placebo to Regorafenib||0
8381301|NCT01103323|20659130|P2|NOT COMPLETED|Without/Before Drug Switch||18
8381302|NCT01103323|20659131|P1|NOT COMPLETED|Without/Before Drug Switch||76
8381303|NCT01103323|20659130|P2|COMPLETED|Without/Before Drug Switch||237
8381304|NCT01103323|20659131|P1|COMPLETED|Without/Before Drug Switch||429
8381305|NCT01103323|20659130|P2|Participants Received Treatment|Without/Before Drug Switch||253
8381306|NCT01103323|20659131|P1|Participants Received Treatment|Without/Before Drug Switch||500
8381307|NCT01103323|20659130|P2|STARTED|Without/Before Drug Switch||255
8381308|NCT01103323|20659131|P1|STARTED|Without/Before Drug Switch||505
8381309|NCT01103284|20659148|P2|NOT COMPLETED|Overall Study||44
8381310|NCT01103284|20659149|P1|NOT COMPLETED|Overall Study||42
8381311|NCT01103284|20659148|P2|COMPLETED|Overall Study||195
8381312|NCT01103284|20659149|P1|COMPLETED|Overall Study||194
8381313|NCT01103284|20659148|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
8381404|NCT01102491|20659435|P1|STARTED|Overall Study||71
8381314|NCT01103284|20659149|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
8381315|NCT01103284|20659148|P2|Treated|Overall Study||238
8381316|NCT01103284|20659149|P1|Treated|Overall Study||236
8381317|NCT01103284|20659148|P2|STARTED|Overall Study||239
8381318|NCT01103284|20659149|P1|STARTED|Overall Study||236
8381319|NCT01103271|20659165|P2|NOT COMPLETED|Overall Study||4
8381320|NCT01103271|20659166|P1|NOT COMPLETED|Overall Study||1
8381321|NCT01103271|20659165|P2|COMPLETED|Overall Study||5
8381322|NCT01103271|20659166|P1|COMPLETED|Overall Study||10
8381323|NCT01103271|20659165|P2|STARTED|Overall Study||9
8381324|NCT01103271|20659166|P1|STARTED|Overall Study||11
8381325|NCT01103245|20659177|P4|NOT COMPLETED|Overall Study||0
8381326|NCT01103245|20659178|P3|NOT COMPLETED|Overall Study||4
8381327|NCT01103245|20659179|P2|NOT COMPLETED|Overall Study||2
8381328|NCT01103245|20659180|P1|NOT COMPLETED|Overall Study||3
8381329|NCT01103245|20659177|P4|COMPLETED|Overall Study||6
8381330|NCT01103245|20659178|P3|COMPLETED|Overall Study||8
8381331|NCT01103245|20659179|P2|COMPLETED|Overall Study||5
8381332|NCT01103245|20659180|P1|COMPLETED|Overall Study||10
8381333|NCT01103245|20659177|P4|STARTED|Overall Study||6
8381334|NCT01103245|20659178|P3|STARTED|Overall Study||12
8381335|NCT01103245|20659179|P2|STARTED|Overall Study||7
8381336|NCT01103245|20659180|P1|STARTED|Overall Study||13
8381337|NCT01103232|20659196|P2|NOT COMPLETED|Overall Study||2
8381338|NCT01103232|20659197|P1|NOT COMPLETED|Overall Study||1
8381339|NCT01103232|20659196|P2|COMPLETED|Overall Study||11
8381340|NCT01103232|20659197|P1|COMPLETED|Overall Study||12
8381341|NCT01103232|20659196|P2|STARTED|Overall Study||13
8381342|NCT01103232|20659197|P1|STARTED|Overall Study||13
8381343|NCT01103180|20659205|P2|NOT COMPLETED|Overall Study||21
8381344|NCT01103180|20659206|P1|NOT COMPLETED|Overall Study||22
8381345|NCT01103180|20659205|P2|COMPLETED|Overall Study||14
8381346|NCT01103180|20659206|P1|COMPLETED|Overall Study||13
8381347|NCT01103180|20659205|P2|STARTED|Overall Study||35
8381348|NCT01103180|20659206|P1|STARTED|Overall Study||35
8381349|NCT01103141|20659216|P2|NOT COMPLETED|Overall Study||2
8381350|NCT01103141|20659217|P1|NOT COMPLETED|Overall Study||2
8381351|NCT01103141|20659216|P2|COMPLETED|Overall Study||74
8381352|NCT01103141|20659217|P1|COMPLETED|Overall Study||65
8381353|NCT01103141|20659216|P2|STARTED|Overall Study||76
8381354|NCT01103141|20659217|P1|STARTED|Overall Study||67
8381355|NCT01103063|20659225|P2|NOT COMPLETED|Overall Study||421
8381356|NCT01103063|20659226|P1|NOT COMPLETED|Overall Study||477
8381357|NCT01103063|20659225|P2|COMPLETED|Overall Study||1024
8381358|NCT01103063|20659226|P1|COMPLETED|Overall Study||969
8381359|NCT01103063|20659225|P2|STARTED|Overall Study||1445
8381360|NCT01103063|20659226|P1|STARTED|Overall Study||1446
8381361|NCT01102972|20659294|P2|NOT COMPLETED|Overall Study||14
8381362|NCT01102972|20659295|P1|NOT COMPLETED|Overall Study||29
8381363|NCT01102972|20659294|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
8381364|NCT01102972|20659295|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
8381365|NCT01102972|20659294|P2|Completed Week 24|Overall Study||88
8381366|NCT01102972|20659295|P1|Completed Week 24|Overall Study||180
8381367|NCT01102972|20659294|P2|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
8381368|NCT01102972|20659295|P1|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
8381369|NCT01102894|20659347|P1|NOT COMPLETED|Overall Study||0
8381370|NCT01102894|20659347|P1|COMPLETED|Overall Study||10
8381371|NCT01102894|20659347|P1|STARTED|Overall Study||10
8381372|NCT01102803|20659359|P2|NOT COMPLETED|Post to Follow-Up||3
8381373|NCT01102803|20659360|P1|NOT COMPLETED|Post to Follow-Up||1
8381374|NCT01102803|20659359|P2|COMPLETED|Post to Follow-Up||12
8381375|NCT01102803|20659360|P1|COMPLETED|Post to Follow-Up||10
8381376|NCT01102803|20659359|P2|STARTED|Post to Follow-Up||15
8381377|NCT01102803|20659360|P1|STARTED|Post to Follow-Up||11
8381378|NCT01102803|20659359|P2|NOT COMPLETED|Baseline to Post-Treatment||0
8381379|NCT01102803|20659360|P1|NOT COMPLETED|Baseline to Post-Treatment||3
8381380|NCT01102803|20659359|P2|COMPLETED|Baseline to Post-Treatment||15
8381381|NCT01102803|20659360|P1|COMPLETED|Baseline to Post-Treatment||11
8381382|NCT01102803|20659359|P2|STARTED|Baseline to Post-Treatment||15
8381383|NCT01102803|20659360|P1|STARTED|Baseline to Post-Treatment||14
8381384|NCT01102777|20659374|P2|NOT COMPLETED|Overall Study||16
8381385|NCT01102777|20659375|P1|NOT COMPLETED|Overall Study||9
8381386|NCT01102777|20659374|P2|COMPLETED|Overall Study||139
8381387|NCT01102777|20659375|P1|COMPLETED|Overall Study||75
8381388|NCT01102777|20659374|P2|STARTED|Overall Study||155
8381389|NCT01102777|20659375|P1|STARTED|Overall Study||84
8381390|NCT01102764|20659401|P2|NOT COMPLETED|Overall Study||13
8381391|NCT01102764|20659402|P1|NOT COMPLETED|Overall Study||21
8381392|NCT01102764|20659401|P2|COMPLETED|Overall Study||55
8381393|NCT01102764|20659402|P1|COMPLETED|Overall Study||43
8381394|NCT01102764|20659401|P2|STARTED|Overall Study||68
8381395|NCT01102764|20659402|P1|STARTED|Overall Study||64
8381396|NCT01102738|20659428|P1|NOT COMPLETED|Overall Study||0
8381397|NCT01102738|20659428|P1|COMPLETED|Overall Study||369
8381398|NCT01102738|20659428|P1|STARTED|Overall Study||369
8381399|NCT01102491|20659434|P2|NOT COMPLETED|Overall Study||12
8381400|NCT01102491|20659435|P1|NOT COMPLETED|Overall Study||11
8381401|NCT01102491|20659434|P2|COMPLETED|Overall Study|12 patients were excluded|59
8381402|NCT01102491|20659435|P1|COMPLETED|Overall Study|11 patient excluded|60
8381403|NCT01102491|20659434|P2|STARTED|Overall Study||71
8381405|NCT01102426|20659443|P2|NOT COMPLETED|Overall Study||81
8381406|NCT01102426|20659444|P1|NOT COMPLETED|Overall Study||165
8381407|NCT01102426|20659443|P2|COMPLETED|Overall Study||3
8381408|NCT01102426|20659444|P1|COMPLETED|Overall Study||6
8381409|NCT01102426|20659443|P2|STARTED|Overall Study||84
8381410|NCT01102426|20659444|P1|STARTED|Overall Study||171
8381411|NCT01102413|20659484|P2|NOT COMPLETED|Overall Study||12
8381412|NCT01102413|20659485|P1|NOT COMPLETED|Overall Study||25
8381413|NCT01102413|20659484|P2|COMPLETED|Overall Study||106
8381414|NCT01102413|20659485|P1|COMPLETED|Overall Study||208
8381415|NCT01102413|20659484|P2|STARTED|Overall Study||118
8381416|NCT01102413|20659485|P1|STARTED|Overall Study||233
8381417|NCT01102374|20659495|P2|NOT COMPLETED|Overall Study||19
8381418|NCT01102374|20659496|P1|NOT COMPLETED|Overall Study||16
8381419|NCT01102374|20659495|P2|COMPLETED|Overall Study||33
8381420|NCT01102374|20659496|P1|COMPLETED|Overall Study||39
8381421|NCT01102374|20659495|P2|STARTED|Overall Study||52
8381422|NCT01102374|20659496|P1|STARTED|Overall Study||55
8381423|NCT01102270|20659530|P2|NOT COMPLETED|Overall Study||0
8381424|NCT01102270|20659531|P1|NOT COMPLETED|Overall Study||0
8381425|NCT01102270|20659530|P2|COMPLETED|Overall Study||9
8381426|NCT01102270|20659531|P1|COMPLETED|Overall Study||8
8381427|NCT01102270|20659530|P2|STARTED|Overall Study||9
8381428|NCT01102270|20659531|P1|STARTED|Overall Study||8
8381429|NCT01102257|20659545|P2|NOT COMPLETED|Overall Study||0
8381430|NCT01102257|20659546|P1|NOT COMPLETED|Overall Study||2
8381431|NCT01102257|20659545|P2|COMPLETED|Overall Study||9
8381432|NCT01102257|20659546|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
8381433|NCT01102257|20659545|P2|STARTED|Overall Study||9
8381434|NCT01102257|20659546|P1|STARTED|Overall Study||9
8381435|NCT01102218|20659554|P2|NOT COMPLETED|Overall Study||10
8381436|NCT01102218|20659555|P1|NOT COMPLETED|Overall Study||11
8381437|NCT01102218|20659554|P2|COMPLETED|Overall Study||14
8381438|NCT01102218|20659555|P1|COMPLETED|Overall Study||13
8381439|NCT01102218|20659554|P2|STARTED|Overall Study||24
8381440|NCT01102218|20659555|P1|STARTED|Overall Study||24
8381441|NCT01102140|20659563|P2|NOT COMPLETED|Overall Study||2
8381442|NCT01102140|20659564|P1|NOT COMPLETED|Overall Study||3
8381443|NCT01102140|20659563|P2|COMPLETED|Overall Study||5
8381444|NCT01102140|20659564|P1|COMPLETED|Overall Study||10
8381445|NCT01102140|20659563|P2|STARTED|Overall Study||7
8381446|NCT01102140|20659564|P1|STARTED|Overall Study||13
8381447|NCT01101997|20659576|P1|NOT COMPLETED|Overall Study||2
8381448|NCT01101997|20659576|P1|COMPLETED|Overall Study||58
8381449|NCT01101997|20659576|P1|STARTED|Overall Study||60
8381450|NCT01101971|20659582|P1|NOT COMPLETED|Overall Study||0
8381451|NCT01101971|20659582|P1|COMPLETED|Overall Study||45
8381452|NCT01101971|20659582|P1|STARTED|Overall Study||45
8381453|NCT01101958|20659588|P2|NOT COMPLETED|Overall Study||5
8381454|NCT01101958|20659589|P1|NOT COMPLETED|Overall Study||11
8381455|NCT01101958|20659588|P2|COMPLETED|Overall Study||29
8381456|NCT01101958|20659589|P1|COMPLETED|Overall Study||51
8381457|NCT01101958|20659588|P2|STARTED|Overall Study||34
8381458|NCT01101958|20659589|P1|STARTED|Overall Study||62
8381459|NCT01101880|20659595|P1|NOT COMPLETED|Overall Study||0
8381460|NCT01101880|20659595|P1|COMPLETED|Overall Study||50
8381461|NCT01101880|20659595|P1|STARTED|Overall Study||50
8381462|NCT01101867|20659606|P2|NOT COMPLETED|Overall Study||4
8381463|NCT01101867|20659607|P1|NOT COMPLETED|Overall Study||1
8381464|NCT01101867|20659606|P2|COMPLETED|Overall Study||59
8381465|NCT01101867|20659607|P1|COMPLETED|Overall Study||62
8381466|NCT01101867|20659606|P2|STARTED|Overall Study||63
8381467|NCT01101867|20659607|P1|STARTED|Overall Study||63
8381468|NCT01101841|20659625|P2|NOT COMPLETED|Overall Study||67
8381469|NCT01101841|20659626|P1|NOT COMPLETED|Overall Study||50
8381470|NCT01101841|20659625|P2|COMPLETED|Overall Study||218
8381471|NCT01101841|20659626|P1|COMPLETED|Overall Study||235
8381472|NCT01101841|20659625|P2|STARTED|Overall Study||285
8381473|NCT01101841|20659626|P1|STARTED|Overall Study||285
8381474|NCT01101750|20659664|P1|NOT COMPLETED|Overall Study||16
8381475|NCT01101750|20659664|P1|COMPLETED|Overall Study||9
8381476|NCT01101750|20659664|P1|STARTED|Overall Study||25
8381477|NCT01101542|20659668|P1|NOT COMPLETED|Year 6 Surveillance Period||991
8381478|NCT01101542|20659668|P1|COMPLETED|Year 6 Surveillance Period||2100
8381479|NCT01101542|20659668|P1|STARTED|Year 6 Surveillance Period||3091
8381480|NCT01101542|20659668|P1|NOT COMPLETED|Year 5 Surveillance Period||141
8381481|NCT01101542|20659668|P1|COMPLETED|Year 5 Surveillance Period||668
8381482|NCT01101542|20659668|P1|STARTED|Year 5 Surveillance Period||809
8381483|NCT01101542|20659668|P1|NOT COMPLETED|Year 4 Surveillance Period||287
8381484|NCT01101542|20659668|P1|COMPLETED|Year 4 Surveillance Period||282
8381485|NCT01101542|20659668|P1|STARTED|Year 4 Surveillance Period||569
8381486|NCT01101542|20659668|P1|NOT COMPLETED|Year 3 Surveillance Period||11
8381487|NCT01101542|20659668|P1|COMPLETED|Year 3 Surveillance Period||94
8381488|NCT01101542|20659668|P1|STARTED|Year 3 Surveillance Period||105
8381489|NCT01101477|20659684|P3|NOT COMPLETED|Overall Study||1
8381490|NCT01101477|20659685|P2|NOT COMPLETED|Overall Study||3
8381491|NCT01101477|20659686|P1|NOT COMPLETED|Overall Study||5
8381492|NCT01101477|20659684|P3|COMPLETED|Overall Study||45
8381493|NCT01101477|20659685|P2|COMPLETED|Overall Study||46
8381494|NCT01101477|20659686|P1|COMPLETED|Overall Study||44
8381495|NCT01101477|20659684|P3|STARTED|Overall Study||46
8381496|NCT01101477|20659685|P2|STARTED|Overall Study||49
8381497|NCT01101477|20659686|P1|STARTED|Overall Study||49
8381595|NCT01101061|20659793|P4|Received Study Drug|Overall Study||6
8381498|NCT01101464|20659696|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
8381499|NCT01101464|20659697|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
8381500|NCT01101464|20659696|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
8381501|NCT01101464|20659697|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
8381502|NCT01101464|20659696|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
8381503|NCT01101464|20659697|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
8381504|NCT01101464|20659696|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
8381505|NCT01101464|20659697|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
8381506|NCT01101464|20659696|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
8381507|NCT01101464|20659697|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
8381508|NCT01101464|20659696|P2|STARTED|Day 1 Through AM Dose of Day 5||4
8381509|NCT01101464|20659697|P1|STARTED|Day 1 Through AM Dose of Day 5||4
8381510|NCT01101334|20659709|P2|NOT COMPLETED|Overall Study||45
8381511|NCT01101334|20659710|P1|NOT COMPLETED|Overall Study||45
8381512|NCT01101334|20659709|P2|COMPLETED|Overall Study||0
8381513|NCT01101334|20659710|P1|COMPLETED|Overall Study||0
8381514|NCT01101334|20659709|P2|Received Study Treatment|Overall Study||45
8381515|NCT01101334|20659710|P1|Received Study Treatment|Overall Study||44
8381516|NCT01101334|20659709|P2|STARTED|Overall Study||45
8381517|NCT01101334|20659710|P1|STARTED|Overall Study||45
8381518|NCT01101321|20659722|P2|NOT COMPLETED|Period 2||0
8381519|NCT01101321|20659723|P1|NOT COMPLETED|Period 2||0
8381520|NCT01101321|20659722|P2|COMPLETED|Period 2||24
8381521|NCT01101321|20659723|P1|COMPLETED|Period 2||26
8381522|NCT01101321|20659722|P2|STARTED|Period 2||24
8381523|NCT01101321|20659723|P1|STARTED|Period 2||26
8381524|NCT01101321|20659722|P2|NOT COMPLETED|Period 1||4
8381525|NCT01101321|20659723|P1|NOT COMPLETED|Period 1||4
8381526|NCT01101321|20659722|P2|COMPLETED|Period 1||24
8381527|NCT01101321|20659723|P1|COMPLETED|Period 1||26
8381528|NCT01101321|20659722|P2|STARTED|Period 1||28
8381529|NCT01101321|20659723|P1|STARTED|Period 1||30
8381530|NCT01101308|20659733|P2|NOT COMPLETED|Period 2||0
8381531|NCT01101308|20659734|P1|NOT COMPLETED|Period 2||0
8381532|NCT01101308|20659733|P2|COMPLETED|Period 2||27
8381533|NCT01101308|20659734|P1|COMPLETED|Period 2||24
8381534|NCT01101308|20659733|P2|STARTED|Period 2||27
8381535|NCT01101308|20659734|P1|STARTED|Period 2||24
8381536|NCT01101308|20659733|P2|NOT COMPLETED|Period 1||1
8381537|NCT01101308|20659734|P1|NOT COMPLETED|Period 1||3
8381538|NCT01101308|20659733|P2|COMPLETED|Period 1||27
8381539|NCT01101308|20659734|P1|COMPLETED|Period 1||24
8381540|NCT01101308|20659733|P2|STARTED|Period 1||28
8381541|NCT01101308|20659734|P1|STARTED|Period 1||27
8381542|NCT01101191|20659745|P2|NOT COMPLETED|Period 2||0
8381543|NCT01101191|20659746|P1|NOT COMPLETED|Period 2||0
8381544|NCT01101191|20659745|P2|COMPLETED|Period 2||40
8381545|NCT01101191|20659746|P1|COMPLETED|Period 2||40
8381546|NCT01101191|20659745|P2|STARTED|Period 2||40
8381547|NCT01101191|20659746|P1|STARTED|Period 2||40
8381548|NCT01101191|20659745|P2|NOT COMPLETED|Period 1||2
8381549|NCT01101191|20659746|P1|NOT COMPLETED|Period 1||2
8381550|NCT01101191|20659745|P2|COMPLETED|Period 1||40
8381551|NCT01101191|20659746|P1|COMPLETED|Period 1||40
8381552|NCT01101191|20659745|P2|STARTED|Period 1||42
8381553|NCT01101191|20659746|P1|STARTED|Period 1||42
8381554|NCT01101178|20659757|P2|NOT COMPLETED|Period 2||1
8381555|NCT01101178|20659758|P1|NOT COMPLETED|Period 2||0
8381556|NCT01101178|20659757|P2|COMPLETED|Period 2||34
8381557|NCT01101178|20659758|P1|COMPLETED|Period 2||36
8381558|NCT01101178|20659757|P2|STARTED|Period 2||35
8381559|NCT01101178|20659758|P1|STARTED|Period 2||36
8381560|NCT01101178|20659757|P2|NOT COMPLETED|Period 1||4
8381561|NCT01101178|20659758|P1|NOT COMPLETED|Period 1||4
8381562|NCT01101178|20659757|P2|COMPLETED|Period 1||35
8381563|NCT01101178|20659758|P1|COMPLETED|Period 1||36
8381564|NCT01101178|20659757|P2|STARTED|Period 1||39
8381565|NCT01101178|20659758|P1|STARTED|Period 1||40
8381566|NCT01101165|20659769|P2|NOT COMPLETED|Period 2||1
8381567|NCT01101165|20659770|P1|NOT COMPLETED|Period 2||4
8381568|NCT01101165|20659769|P2|COMPLETED|Period 2||39
8381569|NCT01101165|20659770|P1|COMPLETED|Period 2||41
8381570|NCT01101165|20659769|P2|STARTED|Period 2||40
8381571|NCT01101165|20659770|P1|STARTED|Period 2||45
8381572|NCT01101165|20659769|P2|NOT COMPLETED|Period 1||5
8381573|NCT01101165|20659770|P1|NOT COMPLETED|Period 1||2
8381574|NCT01101165|20659769|P2|COMPLETED|Period 1||40
8381575|NCT01101165|20659770|P1|COMPLETED|Period 1||45
8381576|NCT01101165|20659769|P2|STARTED|Period 1||45
8381577|NCT01101165|20659770|P1|STARTED|Period 1||47
8381578|NCT01101100|20659780|P1|NOT COMPLETED|Overall Study||55
8381579|NCT01101100|20659780|P1|COMPLETED|Overall Study||126
8381580|NCT01101100|20659780|P1|STARTED|Overall Study||181
8381581|NCT01101061|20659791|P6|NOT COMPLETED|Overall Study||0
8381582|NCT01101061|20659792|P5|NOT COMPLETED|Overall Study||0
8381583|NCT01101061|20659793|P4|NOT COMPLETED|Overall Study||0
8381584|NCT01101061|20659794|P3|NOT COMPLETED|Overall Study||1
8381585|NCT01101061|20659795|P2|NOT COMPLETED|Overall Study||0
8381586|NCT01101061|20659796|P1|NOT COMPLETED|Overall Study||0
8381587|NCT01101061|20659791|P6|COMPLETED|Overall Study||4
8381588|NCT01101061|20659792|P5|COMPLETED|Overall Study||2
8381589|NCT01101061|20659793|P4|COMPLETED|Overall Study||6
8381590|NCT01101061|20659794|P3|COMPLETED|Overall Study||6
8381591|NCT01101061|20659795|P2|COMPLETED|Overall Study||6
8381592|NCT01101061|20659796|P1|COMPLETED|Overall Study||6
8381593|NCT01101061|20659791|P6|Received Study Drug|Overall Study||4
8381594|NCT01101061|20659792|P5|Received Study Drug|Overall Study||2
8381596|NCT01101061|20659794|P3|Received Study Drug|Overall Study||6
8381597|NCT01101061|20659795|P2|Received Study Drug|Overall Study||6
8381598|NCT01101061|20659796|P1|Received Study Drug|Overall Study||6
8381599|NCT01101061|20659791|P6|STARTED|Overall Study||4
8381600|NCT01101061|20659792|P5|STARTED|Overall Study||2
8381601|NCT01101061|20659793|P4|STARTED|Overall Study||6
8381602|NCT01101061|20659794|P3|STARTED|Overall Study||7
8381603|NCT01101061|20659795|P2|STARTED|Overall Study||6
8381604|NCT01101061|20659796|P1|STARTED|Overall Study||6
8381605|NCT01101035|20659876|P2|NOT COMPLETED|Overall Study||1391
8381606|NCT01101035|20659877|P1|NOT COMPLETED|Overall Study||1397
8381607|NCT01101035|20659876|P2|COMPLETED|Overall Study||1706
8381608|NCT01101035|20659877|P1|COMPLETED|Overall Study||1704
8381609|NCT01101035|20659876|P2|STARTED|Overall Study||3097
8381610|NCT01101035|20659877|P1|STARTED|Overall Study||3101
8381611|NCT01101022|20659897|P2|NOT COMPLETED|Overall Study||27
8381612|NCT01101022|20659898|P1|NOT COMPLETED|Overall Study||17
8381613|NCT01101022|20659897|P2|COMPLETED|Overall Study||53
8381614|NCT01101022|20659898|P1|COMPLETED|Overall Study||62
8381615|NCT01101022|20659897|P2|STARTED|Overall Study||80
8381616|NCT01101022|20659898|P1|STARTED|Overall Study||79
8381617|NCT01100944|20659932|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
8381618|NCT01100944|20659933|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
8381619|NCT01100944|20659934|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
8381620|NCT01100944|20659932|P3|COMPLETED|Expansion Phase - Phase 2||18
8381621|NCT01100944|20659933|P2|COMPLETED|Expansion Phase - Phase 2||0
8381622|NCT01100944|20659934|P1|COMPLETED|Expansion Phase - Phase 2||0
8381623|NCT01100944|20659932|P3|STARTED|Expansion Phase - Phase 2||18
8381624|NCT01100944|20659933|P2|STARTED|Expansion Phase - Phase 2||0
8381625|NCT01100944|20659934|P1|STARTED|Expansion Phase - Phase 2||0
8381626|NCT01100944|20659932|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381627|NCT01100944|20659933|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
8381628|NCT01100944|20659934|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381629|NCT01100944|20659932|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381630|NCT01100944|20659933|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381631|NCT01100944|20659934|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381632|NCT01100944|20659932|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
8381633|NCT01100944|20659933|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
8381634|NCT01100944|20659934|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
8381635|NCT01100944|20659932|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381636|NCT01100944|20659933|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381637|NCT01100944|20659934|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
8381638|NCT01100944|20659932|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381639|NCT01100944|20659933|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381640|NCT01100944|20659934|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
8381641|NCT01100944|20659932|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
8381642|NCT01100944|20659933|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
8381643|NCT01100944|20659934|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
8381644|NCT01100931|20659981|P2|NOT COMPLETED|Phase II||0
8381645|NCT01100931|20659982|P1|NOT COMPLETED|Phase II||0
8381646|NCT01100931|20659981|P2|COMPLETED|Phase II||19
8381647|NCT01100931|20659982|P1|COMPLETED|Phase II||0
8381648|NCT01100931|20659981|P2|STARTED|Phase II||19
8381649|NCT01100931|20659982|P1|STARTED|Phase II||0
8381650|NCT01100931|20659981|P2|NOT COMPLETED|Phase I||0
8381651|NCT01100931|20659982|P1|NOT COMPLETED|Phase I||0
8381652|NCT01100931|20659981|P2|COMPLETED|Phase I||0
8381653|NCT01100931|20659982|P1|COMPLETED|Phase I||22
8381654|NCT01100931|20659981|P2|STARTED|Phase I||0
8381655|NCT01100931|20659982|P1|STARTED|Phase I||22
8381656|NCT01100853|20659992|P2|NOT COMPLETED|Overall Study||23
8381657|NCT01100853|20659993|P1|NOT COMPLETED|Overall Study||27
8381658|NCT01100853|20659992|P2|COMPLETED|Overall Study||26
8381659|NCT01100853|20659993|P1|COMPLETED|Overall Study||24
8381660|NCT01100853|20659992|P2|STARTED|Overall Study||49
8381661|NCT01100853|20659993|P1|STARTED|Overall Study||51
8381662|NCT01100762|20660009|P1|NOT COMPLETED|Overall Study||0
8381663|NCT01100762|20660009|P1|COMPLETED|Overall Study||10
8381664|NCT01100762|20660009|P1|STARTED|Overall Study||10
8381665|NCT01100723|20660030|P1|NOT COMPLETED|Overall Study||14
8381666|NCT01100723|20660030|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
8381667|NCT01100723|20660030|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
8381668|NCT01100723|20660030|P1|STARTED|Overall Study||92
8381669|NCT01100658|20660039|P1|NOT COMPLETED|Overall Study||1
8381670|NCT01100658|20660039|P1|COMPLETED|Overall Study||0
8381671|NCT01100658|20660039|P1|STARTED|Overall Study||1
8381672|NCT01100606|20660044|P2|NOT COMPLETED|Second Treatment Period||0
8381673|NCT01100606|20660045|P1|NOT COMPLETED|Second Treatment Period||0
8381674|NCT01100606|20660044|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
8381675|NCT01100606|20660045|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
8381676|NCT01100606|20660044|P2|STARTED|Second Treatment Period||7
8381677|NCT01100606|20660045|P1|STARTED|Second Treatment Period||8
8381678|NCT01100606|20660044|P2|NOT COMPLETED|First Treatment Period||0
8381679|NCT01100606|20660045|P1|NOT COMPLETED|First Treatment Period||0
8381680|NCT01100606|20660044|P2|COMPLETED|First Treatment Period||7
8381681|NCT01100606|20660045|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
8381682|NCT01100606|20660044|P2|STARTED|First Treatment Period||7
8381683|NCT01100606|20660045|P1|STARTED|First Treatment Period||8
8381684|NCT01100567|20660071|P2|NOT COMPLETED|Overall Study||16
8381685|NCT01100567|20660072|P1|NOT COMPLETED|Overall Study||12
8381686|NCT01100567|20660071|P2|COMPLETED|Overall Study||35
8381687|NCT01100567|20660072|P1|COMPLETED|Overall Study||38
8381688|NCT01100567|20660071|P2|STARTED|Overall Study||51
8381689|NCT01100567|20660072|P1|STARTED|Overall Study||50
8381690|NCT01100528|20660080|P1|NOT COMPLETED|Overall Study||3
8381691|NCT01100528|20660080|P1|COMPLETED|Overall Study||35
8381692|NCT01100528|20660080|P1|STARTED|Overall Study||38
8381693|NCT01100502|20660088|P2|NOT COMPLETED|Long-Term Follow-up||139
8381694|NCT01100502|20660089|P1|NOT COMPLETED|Long-Term Follow-up||137
8381695|NCT01100502|20660088|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
8381696|NCT01100502|20660089|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
8381697|NCT01100502|20660088|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
8381698|NCT01100502|20660089|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
8381699|NCT01100502|20660088|P2|NOT COMPLETED|Treatment Period||83
8381700|NCT01100502|20660089|P1|NOT COMPLETED|Treatment Period||87
8381701|NCT01100502|20660088|P2|COMPLETED|Treatment Period||81
8381702|NCT01100502|20660089|P1|COMPLETED|Treatment Period||78
8381703|NCT01100502|20660088|P2|STARTED|Treatment Period||164
8381704|NCT01100502|20660089|P1|STARTED|Treatment Period||165
8381705|NCT01100437|20660099|P3|NOT COMPLETED|Treatment 2||0
8381706|NCT01100437|20660100|P2|NOT COMPLETED|Treatment 2||0
8381707|NCT01100437|20660101|P1|NOT COMPLETED|Treatment 2||0
8381708|NCT01100437|20660099|P3|COMPLETED|Treatment 2||0
8381709|NCT01100437|20660100|P2|COMPLETED|Treatment 2||2
8381710|NCT01100437|20660101|P1|COMPLETED|Treatment 2||4
8381711|NCT01100437|20660099|P3|STARTED|Treatment 2||0
8381712|NCT01100437|20660100|P2|STARTED|Treatment 2||2
8381713|NCT01100437|20660101|P1|STARTED|Treatment 2||4
8381714|NCT01100437|20660099|P3|NOT COMPLETED|Washout (4 Days)||0
8381715|NCT01100437|20660100|P2|NOT COMPLETED|Washout (4 Days)||0
8381716|NCT01100437|20660101|P1|NOT COMPLETED|Washout (4 Days)||0
8381717|NCT01100437|20660099|P3|COMPLETED|Washout (4 Days)||0
8381718|NCT01100437|20660100|P2|COMPLETED|Washout (4 Days)||2
8381719|NCT01100437|20660101|P1|COMPLETED|Washout (4 Days)||4
8381720|NCT01100437|20660099|P3|STARTED|Washout (4 Days)||0
8381721|NCT01100437|20660100|P2|STARTED|Washout (4 Days)||2
8381722|NCT01100437|20660101|P1|STARTED|Washout (4 Days)||4
8381723|NCT01100437|20660099|P3|NOT COMPLETED|Treatment 1||0
8381724|NCT01100437|20660100|P2|NOT COMPLETED|Treatment 1||0
8381725|NCT01100437|20660101|P1|NOT COMPLETED|Treatment 1||0
8381726|NCT01100437|20660099|P3|COMPLETED|Treatment 1||0
8381727|NCT01100437|20660100|P2|COMPLETED|Treatment 1||2
8381728|NCT01100437|20660101|P1|COMPLETED|Treatment 1||4
8381729|NCT01100437|20660099|P3|STARTED|Treatment 1||0
8381730|NCT01100437|20660100|P2|STARTED|Treatment 1||2
8381731|NCT01100437|20660101|P1|STARTED|Treatment 1||4
8381732|NCT01100437|20660099|P3|NOT COMPLETED|Maintenance||2
8381733|NCT01100437|20660100|P2|NOT COMPLETED|Maintenance||0
8381734|NCT01100437|20660101|P1|NOT COMPLETED|Maintenance||0
8381735|NCT01100437|20660099|P3|COMPLETED|Maintenance||0
8381736|NCT01100437|20660100|P2|COMPLETED|Maintenance||2
8381737|NCT01100437|20660101|P1|COMPLETED|Maintenance||4
8381738|NCT01100437|20660099|P3|STARTED|Maintenance||2
8381739|NCT01100437|20660100|P2|STARTED|Maintenance||2
8381740|NCT01100437|20660101|P1|STARTED|Maintenance||4
8381741|NCT01100437|20660099|P3|NOT COMPLETED|Titration/Stabilization||6
8381742|NCT01100437|20660100|P2|NOT COMPLETED|Titration/Stabilization||0
8381743|NCT01100437|20660101|P1|NOT COMPLETED|Titration/Stabilization||0
8381744|NCT01100437|20660099|P3|COMPLETED|Titration/Stabilization||2
8381745|NCT01100437|20660100|P2|COMPLETED|Titration/Stabilization||2
8381746|NCT01100437|20660101|P1|COMPLETED|Titration/Stabilization||4
8381747|NCT01100437|20660099|P3|STARTED|Titration/Stabilization||8
8381748|NCT01100437|20660100|P2|STARTED|Titration/Stabilization||2
8381749|NCT01100437|20660101|P1|STARTED|Titration/Stabilization||4
8381750|NCT01100437|20660099|P3|NOT COMPLETED|Screening||0
8381751|NCT01100437|20660100|P2|NOT COMPLETED|Screening||0
8381752|NCT01100437|20660101|P1|NOT COMPLETED|Screening||0
8381753|NCT01100437|20660099|P3|COMPLETED|Screening||8
8381754|NCT01100437|20660100|P2|COMPLETED|Screening||2
8381755|NCT01100437|20660101|P1|COMPLETED|Screening||4
8381756|NCT01100437|20660099|P3|STARTED|Screening||8
8381757|NCT01100437|20660100|P2|STARTED|Screening||2
8381758|NCT01100437|20660101|P1|STARTED|Screening||4
8381759|NCT01100320|20660138|P2|NOT COMPLETED|Period 2||1
8381760|NCT01100320|20660139|P1|NOT COMPLETED|Period 2||1
8381761|NCT01100320|20660138|P2|COMPLETED|Period 2||37
8381762|NCT01100320|20660139|P1|COMPLETED|Period 2||37
8381763|NCT01100320|20660138|P2|STARTED|Period 2||38
8381764|NCT01100320|20660139|P1|STARTED|Period 2||38
8381765|NCT01100320|20660138|P2|NOT COMPLETED|Period 1||7
8381766|NCT01100320|20660139|P1|NOT COMPLETED|Period 1||5
8381767|NCT01100320|20660138|P2|COMPLETED|Period 1||38
8381768|NCT01100320|20660139|P1|COMPLETED|Period 1||38
8381769|NCT01100320|20660138|P2|STARTED|Period 1||45
8381770|NCT01100320|20660139|P1|STARTED|Period 1||43
8381771|NCT01100307|20660151|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
8381772|NCT01100307|20660152|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
8381865|NCT01099631|20660368|P2|NOT COMPLETED|Overall Study||0
8381773|NCT01100307|20660151|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
8381774|NCT01100307|20660152|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
8381775|NCT01100307|20660151|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
8381776|NCT01100307|20660152|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
8381777|NCT01100307|20660151|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
8381778|NCT01100307|20660152|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
8381779|NCT01100307|20660151|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
8381780|NCT01100307|20660152|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
8381781|NCT01100307|20660151|P2|STARTED|Double Masked Phase (Up to Week 24)||120
8381782|NCT01100307|20660152|P1|STARTED|Double Masked Phase (Up to Week 24)||123
8381783|NCT01100268|20660194|P1|NOT COMPLETED|Overall Study||0
8381784|NCT01100268|20660194|P1|COMPLETED|Overall Study||4
8381785|NCT01100268|20660194|P1|STARTED|Overall Study||4
8381786|NCT01100255|20660201|P2|NOT COMPLETED|Overall Study||0
8381787|NCT01100255|20660202|P1|NOT COMPLETED|Overall Study||0
8381788|NCT01100255|20660201|P2|COMPLETED|Overall Study||7
8381789|NCT01100255|20660202|P1|COMPLETED|Overall Study||8
8381790|NCT01100255|20660201|P2|STARTED|Overall Study||7
8381791|NCT01100255|20660202|P1|STARTED|Overall Study||8
8381792|NCT01100242|20660208|P1|NOT COMPLETED|Overall Study||0
8381793|NCT01100242|20660208|P1|COMPLETED|Overall Study||17
8381794|NCT01100242|20660208|P1|STARTED|Overall Study||17
8381795|NCT01100112|20660214|P1|NOT COMPLETED|Overall Study||8
8381796|NCT01100112|20660214|P1|COMPLETED|Overall Study||52
8381797|NCT01100112|20660214|P1|STARTED|Overall Study||60
8381798|NCT01100086|20660221|P2|NOT COMPLETED|Period 2||0
8381799|NCT01100086|20660222|P1|NOT COMPLETED|Period 2||0
8381800|NCT01100086|20660221|P2|COMPLETED|Period 2||41
8381801|NCT01100086|20660222|P1|COMPLETED|Period 2||42
8381802|NCT01100086|20660221|P2|STARTED|Period 2||41
8381803|NCT01100086|20660222|P1|STARTED|Period 2||42
8381804|NCT01100086|20660221|P2|NOT COMPLETED|Period 1||0
8381805|NCT01100086|20660222|P1|NOT COMPLETED|Period 1||1
8381806|NCT01100086|20660221|P2|COMPLETED|Period 1||41
8381807|NCT01100086|20660222|P1|COMPLETED|Period 1||42
8381808|NCT01100086|20660221|P2|STARTED|Period 1||41
8381809|NCT01100086|20660222|P1|STARTED|Period 1||43
8381810|NCT01100073|20660232|P1|NOT COMPLETED|Overall Study||100
8381811|NCT01100073|20660232|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
8381812|NCT01100073|20660232|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
8381813|NCT01100034|20660247|P1|NOT COMPLETED|Overall Study||43
8381814|NCT01100034|20660247|P1|COMPLETED|Overall Study||29
8381815|NCT01100034|20660247|P1|STARTED|Overall Study||72
8381816|NCT01099969|20660260|P4|NOT COMPLETED|Overall Study||0
8381817|NCT01099969|20660261|P3|NOT COMPLETED|Overall Study||0
8381818|NCT01099969|20660262|P2|NOT COMPLETED|Overall Study||0
8381819|NCT01099969|20660263|P1|NOT COMPLETED|Overall Study||0
8381820|NCT01099969|20660260|P4|COMPLETED|Overall Study||15
8381821|NCT01099969|20660261|P3|COMPLETED|Overall Study||15
8381822|NCT01099969|20660262|P2|COMPLETED|Overall Study||15
8381823|NCT01099969|20660263|P1|COMPLETED|Overall Study||15
8381824|NCT01099969|20660260|P4|STARTED|Overall Study||15
8381825|NCT01099969|20660261|P3|STARTED|Overall Study||15
8381826|NCT01099969|20660262|P2|STARTED|Overall Study||15
8381827|NCT01099969|20660263|P1|STARTED|Overall Study||15
8381828|NCT01099917|20660285|P1|NOT COMPLETED|Overall Study||27
8381829|NCT01099917|20660285|P1|COMPLETED|Overall Study||18
8381830|NCT01099917|20660285|P1|STARTED|Overall Study||45
8381831|NCT01099774|20660291|P2|NOT COMPLETED|Overall Study||6
8381832|NCT01099774|20660292|P1|NOT COMPLETED|Overall Study||6
8381833|NCT01099774|20660291|P2|COMPLETED|Overall Study||289
8381834|NCT01099774|20660292|P1|COMPLETED|Overall Study||296
8381835|NCT01099774|20660291|P2|STARTED|Overall Study||295
8381836|NCT01099774|20660292|P1|STARTED|Overall Study||302
8381837|NCT01099761|20660308|P4|NOT COMPLETED|Overall Study||0
8381838|NCT01099761|20660309|P3|NOT COMPLETED|Overall Study||0
8381839|NCT01099761|20660310|P2|NOT COMPLETED|Overall Study||0
8381840|NCT01099761|20660311|P1|NOT COMPLETED|Overall Study||0
8381841|NCT01099761|20660308|P4|COMPLETED|Overall Study||6
8381842|NCT01099761|20660309|P3|COMPLETED|Overall Study||0
8381843|NCT01099761|20660310|P2|COMPLETED|Overall Study||9
8381844|NCT01099761|20660311|P1|COMPLETED|Overall Study||9
8381845|NCT01099761|20660308|P4|STARTED|Overall Study||6
8381846|NCT01099761|20660309|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
8381847|NCT01099761|20660310|P2|STARTED|Overall Study||9
8381848|NCT01099761|20660311|P1|STARTED|Overall Study||9
8381849|NCT01099709|20660347|P2|NOT COMPLETED|Period 2||0
8381850|NCT01099709|20660348|P1|NOT COMPLETED|Period 2||0
8381851|NCT01099709|20660347|P2|COMPLETED|Period 2||41
8381852|NCT01099709|20660348|P1|COMPLETED|Period 2||41
8381853|NCT01099709|20660347|P2|STARTED|Period 2||41
8381854|NCT01099709|20660348|P1|STARTED|Period 2||41
8381855|NCT01099709|20660347|P2|NOT COMPLETED|Period 1||2
8381856|NCT01099709|20660348|P1|NOT COMPLETED|Period 1||1
8381857|NCT01099709|20660347|P2|COMPLETED|Period 1||41
8381858|NCT01099709|20660348|P1|COMPLETED|Period 1||41
8381859|NCT01099709|20660347|P2|STARTED|Period 1||43
8381860|NCT01099709|20660348|P1|STARTED|Period 1||42
8381861|NCT01099631|20660364|P6|NOT COMPLETED|Overall Study||0
8381862|NCT01099631|20660365|P5|NOT COMPLETED|Overall Study||0
8381863|NCT01099631|20660366|P4|NOT COMPLETED|Overall Study||0
8381864|NCT01099631|20660367|P3|NOT COMPLETED|Overall Study||0
8381866|NCT01099631|20660369|P1|NOT COMPLETED|Overall Study||0
8381867|NCT01099631|20660364|P6|COMPLETED|Overall Study||4
8381868|NCT01099631|20660365|P5|COMPLETED|Overall Study||3
8381869|NCT01099631|20660366|P4|COMPLETED|Overall Study||3
8381870|NCT01099631|20660367|P3|COMPLETED|Overall Study||3
8381871|NCT01099631|20660368|P2|COMPLETED|Overall Study||3
8381872|NCT01099631|20660369|P1|COMPLETED|Overall Study||6
8381873|NCT01099631|20660364|P6|STARTED|Overall Study||4
8381874|NCT01099631|20660365|P5|STARTED|Overall Study||3
8381875|NCT01099631|20660366|P4|STARTED|Overall Study||3
8381876|NCT01099631|20660367|P3|STARTED|Overall Study||3
8381877|NCT01099631|20660368|P2|STARTED|Overall Study||3
8381878|NCT01099631|20660369|P1|STARTED|Overall Study||6
8381879|NCT01099618|20660404|P3|NOT COMPLETED|Overall Study||0
8381880|NCT01099618|20660405|P2|NOT COMPLETED|Overall Study||0
8381881|NCT01099618|20660406|P1|NOT COMPLETED|Overall Study||0
8381882|NCT01099618|20660404|P3|COMPLETED|Overall Study||15
8381883|NCT01099618|20660405|P2|COMPLETED|Overall Study||16
8381884|NCT01099618|20660406|P1|COMPLETED|Overall Study||17
8381885|NCT01099618|20660404|P3|STARTED|Overall Study||15
8381886|NCT01099618|20660405|P2|STARTED|Overall Study||16
8381887|NCT01099618|20660406|P1|STARTED|Overall Study||17
8381888|NCT01099579|20660417|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
8381889|NCT01099579|20660418|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
8381890|NCT01099579|20660419|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
8381891|NCT01099579|20660417|P3|COMPLETED|Stage 2 (ATV Capsule)||9
8381892|NCT01099579|20660418|P2|COMPLETED|Stage 2 (ATV Capsule)||9
8381893|NCT01099579|20660419|P1|COMPLETED|Stage 2 (ATV Capsule)||10
8381894|NCT01099579|20660417|P3|STARTED|Stage 2 (ATV Capsule)||15
8381895|NCT01099579|20660418|P2|STARTED|Stage 2 (ATV Capsule)||14
8381896|NCT01099579|20660419|P1|STARTED|Stage 2 (ATV Capsule)||16
8381897|NCT01099579|20660417|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
8381898|NCT01099579|20660418|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
8381899|NCT01099579|20660419|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
8381900|NCT01099579|20660417|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
8381901|NCT01099579|20660418|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
8381902|NCT01099579|20660419|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
8381903|NCT01099579|20660417|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
8381904|NCT01099579|20660418|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
8381905|NCT01099579|20660419|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
8381906|NCT01099475|20660475|P2|NOT COMPLETED|Overall Study||0
8381907|NCT01099475|20660476|P1|NOT COMPLETED|Overall Study||0
8381908|NCT01099475|20660475|P2|COMPLETED|Overall Study||10
8381909|NCT01099475|20660476|P1|COMPLETED|Overall Study||10
8381910|NCT01099475|20660475|P2|STARTED|Overall Study||10
8381911|NCT01099475|20660476|P1|STARTED|Overall Study||10
8381912|NCT01099449|20660491|P3|NOT COMPLETED|Overall Study||0
8381913|NCT01099449|20660492|P2|NOT COMPLETED|Overall Study||0
8381914|NCT01099449|20660493|P1|NOT COMPLETED|Overall Study||0
8381915|NCT01099449|20660491|P3|COMPLETED|Overall Study||116
8381916|NCT01099449|20660492|P2|COMPLETED|Overall Study||119
8381917|NCT01099449|20660493|P1|COMPLETED|Overall Study||118
8381918|NCT01099449|20660491|P3|STARTED|Overall Study||116
8381919|NCT01099449|20660492|P2|STARTED|Overall Study||119
8381920|NCT01099449|20660493|P1|STARTED|Overall Study||118
8381921|NCT01099397|20660528|P1|NOT COMPLETED|Overall Study||13
8381922|NCT01099397|20660528|P1|COMPLETED|Overall Study||26
8381923|NCT01099397|20660528|P1|STARTED|Overall Study||39
8381924|NCT01099358|20660533|P4|NOT COMPLETED|Overall Study||4
8381925|NCT01099358|20660534|P3|NOT COMPLETED|Overall Study||8
8381926|NCT01099358|20660535|P2|NOT COMPLETED|Overall Study||1
8381927|NCT01099358|20660536|P1|NOT COMPLETED|Overall Study||3
8381928|NCT01099358|20660533|P4|COMPLETED|Overall Study||12
8381929|NCT01099358|20660534|P3|COMPLETED|Overall Study||13
8381930|NCT01099358|20660535|P2|COMPLETED|Overall Study||5
8381931|NCT01099358|20660536|P1|COMPLETED|Overall Study||1
8381932|NCT01099358|20660533|P4|Received at Least One Dose of Study Drug|Overall Study||15
8381933|NCT01099358|20660534|P3|Received at Least One Dose of Study Drug|Overall Study||20
8381934|NCT01099358|20660535|P2|Received at Least One Dose of Study Drug|Overall Study||6
8381935|NCT01099358|20660536|P1|Received at Least One Dose of Study Drug|Overall Study||3
8381936|NCT01099358|20660533|P4|STARTED|Overall Study||16
8381937|NCT01099358|20660534|P3|STARTED|Overall Study||21
8381938|NCT01099358|20660535|P2|STARTED|Overall Study||6
8381939|NCT01099358|20660536|P1|STARTED|Overall Study||4
8381940|NCT01099267|20660555|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
8381941|NCT01099267|20660555|P1|COMPLETED|MDS-009 Extension Follow-up||54
8381942|NCT01099267|20660555|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
8381943|NCT01099267|20660555|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
8381944|NCT01099267|20660555|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
8381945|NCT01099267|20660555|P1|NOT COMPLETED|MDS-003 Study||124
8381946|NCT01099267|20660555|P1|COMPLETED|MDS-003 Study||24
8381947|NCT01099267|20660555|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
8381948|NCT01099215|20660565|P2|NOT COMPLETED|Overall Study||1
8381949|NCT01099215|20660566|P1|NOT COMPLETED|Overall Study||1
8381950|NCT01099215|20660565|P2|COMPLETED|Overall Study||9
8381951|NCT01099215|20660566|P1|COMPLETED|Overall Study||10
8381952|NCT01099215|20660565|P2|STARTED|Overall Study||10
8381953|NCT01099215|20660566|P1|STARTED|Overall Study||11
8381954|NCT01099202|20660604|P2|NOT COMPLETED|Overall Study||0
8381955|NCT01099202|20660605|P1|NOT COMPLETED|Overall Study||0
8381956|NCT01099202|20660604|P2|COMPLETED|Overall Study||54
8381957|NCT01099202|20660605|P1|COMPLETED|Overall Study||55
8381958|NCT01099202|20660604|P2|STARTED|Overall Study||54
8381959|NCT01099202|20660605|P1|STARTED|Overall Study||55
8381960|NCT01099111|20660618|P5|NOT COMPLETED|Overall Study||0
8381961|NCT01099111|20660619|P4|NOT COMPLETED|Overall Study||0
8381962|NCT01099111|20660620|P3|NOT COMPLETED|Overall Study||0
8381963|NCT01099111|20660621|P2|NOT COMPLETED|Overall Study||0
8381964|NCT01099111|20660622|P1|NOT COMPLETED|Overall Study||0
8381965|NCT01099111|20660618|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8381966|NCT01099111|20660619|P4|COMPLETED|Overall Study||29
8381967|NCT01099111|20660620|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
8381968|NCT01099111|20660621|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8381969|NCT01099111|20660622|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8381970|NCT01099111|20660618|P5|STARTED|Overall Study||50
8381971|NCT01099111|20660619|P4|STARTED|Overall Study||29
8381972|NCT01099111|20660620|P3|STARTED|Overall Study||46
8381973|NCT01099111|20660621|P2|STARTED|Overall Study||50
8381974|NCT01099111|20660622|P1|STARTED|Overall Study||50
8381975|NCT01098851|20660636|P2|NOT COMPLETED|Overall Study||0
8381976|NCT01098851|20660637|P1|NOT COMPLETED|Overall Study||1
8381977|NCT01098851|20660636|P2|COMPLETED|Overall Study||10
8381978|NCT01098851|20660637|P1|COMPLETED|Overall Study||10
8381979|NCT01098851|20660636|P2|STARTED|Overall Study||10
8381980|NCT01098851|20660637|P1|STARTED|Overall Study||11
8381981|NCT01098812|20660648|P3|NOT COMPLETED|Overall Study||1
8381982|NCT01098812|20660649|P2|NOT COMPLETED|Overall Study||1
8381983|NCT01098812|20660650|P1|NOT COMPLETED|Overall Study||2
8381984|NCT01098812|20660648|P3|COMPLETED|Overall Study||71
8381985|NCT01098812|20660649|P2|COMPLETED|Overall Study||101
8381986|NCT01098812|20660650|P1|COMPLETED|Overall Study||93
8381987|NCT01098812|20660648|P3|STARTED|Overall Study||72
8381988|NCT01098812|20660649|P2|STARTED|Overall Study||102
8381989|NCT01098812|20660650|P1|STARTED|Overall Study||95
8381990|NCT01098747|20660664|P4|NOT COMPLETED|Overall Study||0
8381991|NCT01098747|20660665|P3|NOT COMPLETED|Overall Study||0
8381992|NCT01098747|20660666|P2|NOT COMPLETED|Overall Study||0
8381993|NCT01098747|20660667|P1|NOT COMPLETED|Overall Study||0
8381994|NCT01098747|20660664|P4|COMPLETED|Overall Study||87
8381995|NCT01098747|20660665|P3|COMPLETED|Overall Study||86
8381996|NCT01098747|20660666|P2|COMPLETED|Overall Study||95
8381997|NCT01098747|20660667|P1|COMPLETED|Overall Study||48
8381998|NCT01098747|20660664|P4|STARTED|Overall Study||87
8381999|NCT01098747|20660665|P3|STARTED|Overall Study||86
8382000|NCT01098747|20660666|P2|STARTED|Overall Study||95
8382001|NCT01098747|20660667|P1|STARTED|Overall Study||48
8382002|NCT01098578|20660717|P1|NOT COMPLETED|Overall Study||0
8382003|NCT01098578|20660717|P1|COMPLETED|Overall Study||20
8382004|NCT01098578|20660717|P1|STARTED|Overall Study||20
8382005|NCT01098539|20660726|P2|NOT COMPLETED|Overall Study||68
8382006|NCT01098539|20660727|P1|NOT COMPLETED|Overall Study||51
8382007|NCT01098539|20660726|P2|COMPLETED|Overall Study||178
8382008|NCT01098539|20660727|P1|COMPLETED|Overall Study||198
8382009|NCT01098539|20660726|P2|STARTED|Overall Study||246
8382010|NCT01098539|20660727|P1|STARTED|Overall Study||249
8382011|NCT01098500|20660763|P1|NOT COMPLETED|Overall Study||0
8382012|NCT01098500|20660763|P1|COMPLETED|Overall Study||3800
8382013|NCT01098500|20660763|P1|STARTED|Overall Study||3800
8382014|NCT01098487|20660778|P1|NOT COMPLETED|Overall Study||44
8382015|NCT01098487|20660778|P1|COMPLETED|Overall Study||118
8382016|NCT01098487|20660778|P1|STARTED|Overall Study||162
8382017|NCT01098474|20660796|P6|NOT COMPLETED|Follow Up Phase||5
8382018|NCT01098474|20660797|P5|NOT COMPLETED|Follow Up Phase||2
8382019|NCT01098474|20660798|P4|NOT COMPLETED|Follow Up Phase||2
8382020|NCT01098474|20660799|P3|NOT COMPLETED|Follow Up Phase||0
8382021|NCT01098474|20660800|P2|NOT COMPLETED|Follow Up Phase||0
8382022|NCT01098474|20660801|P1|NOT COMPLETED|Follow Up Phase||0
8382023|NCT01098474|20660796|P6|COMPLETED|Follow Up Phase||44
8382024|NCT01098474|20660797|P5|COMPLETED|Follow Up Phase||50
8382025|NCT01098474|20660798|P4|COMPLETED|Follow Up Phase||47
8382026|NCT01098474|20660799|P3|COMPLETED|Follow Up Phase||45
8382027|NCT01098474|20660800|P2|COMPLETED|Follow Up Phase||49
8382028|NCT01098474|20660801|P1|COMPLETED|Follow Up Phase||48
8382029|NCT01098474|20660796|P6|STARTED|Follow Up Phase||49
8382030|NCT01098474|20660797|P5|STARTED|Follow Up Phase||52
8382031|NCT01098474|20660798|P4|STARTED|Follow Up Phase||49
8382032|NCT01098474|20660799|P3|STARTED|Follow Up Phase||45
8382033|NCT01098474|20660800|P2|STARTED|Follow Up Phase||49
8382034|NCT01098474|20660801|P1|STARTED|Follow Up Phase||48
8382035|NCT01098474|20660796|P6|NOT COMPLETED|Active Phase||0
8382036|NCT01098474|20660797|P5|NOT COMPLETED|Active Phase||0
8382037|NCT01098474|20660798|P4|NOT COMPLETED|Active Phase||0
8382038|NCT01098474|20660799|P3|NOT COMPLETED|Active Phase||5
8382039|NCT01098474|20660800|P2|NOT COMPLETED|Active Phase||1
8382040|NCT01098474|20660801|P1|NOT COMPLETED|Active Phase||2
8382041|NCT01098474|20660796|P6|COMPLETED|Active Phase||49
8382042|NCT01098474|20660797|P5|COMPLETED|Active Phase||52
8382043|NCT01098474|20660798|P4|COMPLETED|Active Phase||49
8382044|NCT01098474|20660799|P3|COMPLETED|Active Phase||45
8382045|NCT01098474|20660800|P2|COMPLETED|Active Phase||49
8382046|NCT01098474|20660801|P1|COMPLETED|Active Phase||48
8382047|NCT01098474|20660796|P6|STARTED|Active Phase||49
8382048|NCT01098474|20660797|P5|STARTED|Active Phase||52
8382049|NCT01098474|20660798|P4|STARTED|Active Phase||49
8382050|NCT01098474|20660799|P3|STARTED|Active Phase||50
8382051|NCT01098474|20660800|P2|STARTED|Active Phase||50
8382052|NCT01098474|20660801|P1|STARTED|Active Phase||50
8382053|NCT01098461|20661035|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
8382054|NCT01098461|20661036|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
8382055|NCT01098461|20661037|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
8382056|NCT01098461|20661038|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
8382057|NCT01098461|20661035|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8382058|NCT01098461|20661036|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8382059|NCT01098461|20661037|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
8382060|NCT01098461|20661038|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8382061|NCT01098461|20661035|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
8382062|NCT01098461|20661036|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
8382063|NCT01098461|20661037|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
8382064|NCT01098461|20661038|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
8382065|NCT01098461|20661035|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
8382066|NCT01098461|20661036|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
8382067|NCT01098461|20661037|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
8382068|NCT01098461|20661038|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
8382069|NCT01098461|20661035|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
8382070|NCT01098461|20661036|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
8382071|NCT01098461|20661037|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
8382072|NCT01098461|20661038|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
8382073|NCT01098461|20661035|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
8382074|NCT01098461|20661036|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
8382075|NCT01098461|20661037|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
8382076|NCT01098461|20661038|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
8382077|NCT01098318|20661071|P3|NOT COMPLETED|Overall Study||3
8382078|NCT01098318|20661072|P2|NOT COMPLETED|Overall Study||7
8382079|NCT01098318|20661073|P1|NOT COMPLETED|Overall Study||3
8382080|NCT01098318|20661071|P3|COMPLETED|Overall Study||15
8382081|NCT01098318|20661072|P2|COMPLETED|Overall Study||12
8382082|NCT01098318|20661073|P1|COMPLETED|Overall Study||17
8382083|NCT01098318|20661071|P3|STARTED|Overall Study||18
8382084|NCT01098318|20661072|P2|STARTED|Overall Study||19
8382085|NCT01098318|20661073|P1|STARTED|Overall Study||20
8382086|NCT01098305|20661098|P2|NOT COMPLETED|Overall Study||33
8382087|NCT01098305|20661099|P1|NOT COMPLETED|Overall Study||31
8382088|NCT01098305|20661098|P2|COMPLETED|Overall Study||85
8382089|NCT01098305|20661099|P1|COMPLETED|Overall Study||88
8382090|NCT01098305|20661098|P2|STARTED|Overall Study||118
8382091|NCT01098305|20661099|P1|STARTED|Overall Study||119
8382092|NCT01098266|20661109|P2|NOT COMPLETED|Overall Study||7
8382093|NCT01098266|20661110|P1|NOT COMPLETED|Overall Study||7
8382094|NCT01098266|20661109|P2|COMPLETED|Overall Study||193
8382095|NCT01098266|20661110|P1|COMPLETED|Overall Study||193
8382096|NCT01098266|20661109|P2|STARTED|Overall Study||200
8382097|NCT01098266|20661110|P1|STARTED|Overall Study||200
8382098|NCT01098253|20661130|P2|NOT COMPLETED|Overall Study||0
8382099|NCT01098253|20661131|P1|NOT COMPLETED|Overall Study||2
8382100|NCT01098253|20661130|P2|COMPLETED|Overall Study||88
8382101|NCT01098253|20661131|P1|COMPLETED|Overall Study||92
8382102|NCT01098253|20661130|P2|STARTED|Overall Study||88
8382103|NCT01098253|20661131|P1|STARTED|Overall Study||94
8382104|NCT01098240|20661139|P3|NOT COMPLETED|Double-Blind Phase||22
8382105|NCT01098240|20661140|P2|NOT COMPLETED|Double-Blind Phase||17
8382106|NCT01098240|20661141|P1|NOT COMPLETED|Double-Blind Phase||0
8382107|NCT01098240|20661139|P3|COMPLETED|Double-Blind Phase||63
8382108|NCT01098240|20661140|P2|COMPLETED|Double-Blind Phase||60
8382109|NCT01098240|20661141|P1|COMPLETED|Double-Blind Phase||0
8382110|NCT01098240|20661139|P3|STARTED|Double-Blind Phase||85
8382111|NCT01098240|20661140|P2|STARTED|Double-Blind Phase||77
8382112|NCT01098240|20661141|P1|STARTED|Double-Blind Phase||0
8382113|NCT01098240|20661139|P3|NOT COMPLETED|Open-Label Phase||0
8382114|NCT01098240|20661140|P2|NOT COMPLETED|Open-Label Phase||0
8382115|NCT01098240|20661141|P1|NOT COMPLETED|Open-Label Phase||135
8382116|NCT01098240|20661139|P3|COMPLETED|Open-Label Phase||0
8382117|NCT01098240|20661140|P2|COMPLETED|Open-Label Phase||0
8382118|NCT01098240|20661141|P1|COMPLETED|Open-Label Phase||162
8382119|NCT01098240|20661139|P3|STARTED|Open-Label Phase||0
8382120|NCT01098240|20661140|P2|STARTED|Open-Label Phase||0
8382121|NCT01098240|20661141|P1|STARTED|Open-Label Phase||297
8382122|NCT01098162|20661171|P1|NOT COMPLETED|Overall Study||112
8382123|NCT01098162|20661171|P1|COMPLETED|Overall Study||461
8382124|NCT01098162|20661171|P1|STARTED|Overall Study||573
8382125|NCT01098110|20661183|P3|NOT COMPLETED|Overall Study||94
8382126|NCT01098110|20661184|P2|NOT COMPLETED|Overall Study||73
8382127|NCT01098110|20661185|P1|NOT COMPLETED|Overall Study||62
8382128|NCT01098110|20661183|P3|COMPLETED|Overall Study||80
8382129|NCT01098110|20661184|P2|COMPLETED|Overall Study||109
8382130|NCT01098110|20661185|P1|COMPLETED|Overall Study||114
8382131|NCT01098110|20661183|P3|Treated|Overall Study|Received at least one dose of trial medication|174
8382132|NCT01098110|20661184|P2|Treated|Overall Study|Received at least one dose of trial medication|181
8382133|NCT01098110|20661185|P1|Treated|Overall Study|Received at least one dose of trial medication|175
8382134|NCT01098110|20661183|P3|STARTED|Overall Study|Randomized participants|174
8382135|NCT01098110|20661184|P2|STARTED|Overall Study|Randomized participants|182
8382136|NCT01098110|20661185|P1|STARTED|Overall Study|Randomized participants|176
8382137|NCT01098097|20661226|P1|NOT COMPLETED|Overall Study||82
8382138|NCT01098097|20661226|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
8382139|NCT01098097|20661226|P1|STARTED|Overall Study||963
8382140|NCT01098071|20661235|P1|NOT COMPLETED|Overall Study||15
8382141|NCT01098071|20661235|P1|COMPLETED|Overall Study||19
8382142|NCT01098071|20661235|P1|STARTED|Overall Study||34
8382143|NCT01098032|20661248|P2|NOT COMPLETED|Overall Study||1
8382144|NCT01098032|20661249|P1|NOT COMPLETED|Overall Study||1
8382145|NCT01098032|20661248|P2|COMPLETED|Overall Study||146
8382146|NCT01098032|20661249|P1|COMPLETED|Overall Study||146
8382147|NCT01098032|20661248|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
8382148|NCT01098032|20661249|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
8382149|NCT01098006|20661259|P4|NOT COMPLETED|Overall Study||0
8382150|NCT01098006|20661260|P3|NOT COMPLETED|Overall Study||0
8382151|NCT01098006|20661261|P2|NOT COMPLETED|Overall Study||0
8382152|NCT01098006|20661262|P1|NOT COMPLETED|Overall Study||0
8382153|NCT01098006|20661259|P4|COMPLETED|Overall Study||21
8382154|NCT01098006|20661260|P3|COMPLETED|Overall Study||60
8382155|NCT01098006|20661261|P2|COMPLETED|Overall Study||11
8382156|NCT01098006|20661262|P1|COMPLETED|Overall Study||7
8382157|NCT01098006|20661259|P4|STARTED|Overall Study||21
8382158|NCT01098006|20661260|P3|STARTED|Overall Study||60
8382159|NCT01098006|20661261|P2|STARTED|Overall Study||11
8382160|NCT01098006|20661262|P1|STARTED|Overall Study||7
8382161|NCT01097915|20661339|P3|NOT COMPLETED|Overall Study||30
8382162|NCT01097915|20661340|P2|NOT COMPLETED|Overall Study||42
8382163|NCT01097915|20661341|P1|NOT COMPLETED|Overall Study||23
8382164|NCT01097915|20661339|P3|COMPLETED|Overall Study||20
8382165|NCT01097915|20661340|P2|COMPLETED|Overall Study||28
8382166|NCT01097915|20661341|P1|COMPLETED|Overall Study||27
8382167|NCT01097915|20661339|P3|STARTED|Overall Study||50
8382168|NCT01097915|20661340|P2|STARTED|Overall Study||70
8382169|NCT01097915|20661341|P1|STARTED|Overall Study||50
8382170|NCT01097863|20661366|P3|NOT COMPLETED|Overall Study||2
8382171|NCT01097863|20661367|P2|NOT COMPLETED|Overall Study||0
8382172|NCT01097863|20661368|P1|NOT COMPLETED|Overall Study||1
8382173|NCT01097863|20661366|P3|COMPLETED|Overall Study||89
8382174|NCT01097863|20661367|P2|COMPLETED|Overall Study||98
8382175|NCT01097863|20661368|P1|COMPLETED|Overall Study||89
8382176|NCT01097863|20661366|P3|STARTED|Overall Study||91
8382177|NCT01097863|20661367|P2|STARTED|Overall Study||98
8382178|NCT01097863|20661368|P1|STARTED|Overall Study||90
8382179|NCT01097785|20661378|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
8382180|NCT01097785|20661379|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
8382181|NCT01097785|20661378|P2|COMPLETED|Cycle 3 (30 Days)||6
8382182|NCT01097785|20661379|P1|COMPLETED|Cycle 3 (30 Days)||6
8382183|NCT01097785|20661378|P2|STARTED|Cycle 3 (30 Days)||6
8382184|NCT01097785|20661379|P1|STARTED|Cycle 3 (30 Days)||6
8382185|NCT01097785|20661378|P2|NOT COMPLETED|Washout (2 Weeks)||0
8382186|NCT01097785|20661379|P1|NOT COMPLETED|Washout (2 Weeks)||0
8382187|NCT01097785|20661378|P2|COMPLETED|Washout (2 Weeks)||6
8382188|NCT01097785|20661379|P1|COMPLETED|Washout (2 Weeks)||6
8382189|NCT01097785|20661378|P2|STARTED|Washout (2 Weeks)||6
8382190|NCT01097785|20661379|P1|STARTED|Washout (2 Weeks)||6
8382191|NCT01097785|20661378|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
8382192|NCT01097785|20661379|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
8382193|NCT01097785|20661378|P2|COMPLETED|Cycle 1 (30 Days)||6
8382194|NCT01097785|20661379|P1|COMPLETED|Cycle 1 (30 Days)||6
8382195|NCT01097785|20661378|P2|STARTED|Cycle 1 (30 Days)||6
8382196|NCT01097785|20661379|P1|STARTED|Cycle 1 (30 Days)||6
8382197|NCT01097707|20661392|P5|NOT COMPLETED|Overall Study||50
8382198|NCT01097707|20661393|P4|NOT COMPLETED|Overall Study||44
8382199|NCT01097707|20661394|P3|NOT COMPLETED|Overall Study||45
8382200|NCT01097707|20661395|P2|NOT COMPLETED|Overall Study||43
8382201|NCT01097707|20661396|P1|NOT COMPLETED|Overall Study||44
8382202|NCT01097707|20661392|P5|COMPLETED|Overall Study||35
8382203|NCT01097707|20661393|P4|COMPLETED|Overall Study||40
8382204|NCT01097707|20661394|P3|COMPLETED|Overall Study||37
8382205|NCT01097707|20661395|P2|COMPLETED|Overall Study||37
8382206|NCT01097707|20661396|P1|COMPLETED|Overall Study||39
8382207|NCT01097707|20661392|P5|STARTED|Overall Study||85
8382208|NCT01097707|20661393|P4|STARTED|Overall Study||84
8382209|NCT01097707|20661394|P3|STARTED|Overall Study||82
8382210|NCT01097707|20661395|P2|STARTED|Overall Study||80
8382211|NCT01097707|20661396|P1|STARTED|Overall Study||83
8382212|NCT01097694|20661445|P2|NOT COMPLETED|Overall Study||4
8382213|NCT01097694|20661446|P1|NOT COMPLETED|Overall Study||8
8382214|NCT01097694|20661445|P2|COMPLETED|Overall Study||26
8382215|NCT01097694|20661446|P1|COMPLETED|Overall Study||24
8382216|NCT01097694|20661445|P2|STARTED|Overall Study||30
8382217|NCT01097694|20661446|P1|STARTED|Overall Study||32
8382218|NCT01097668|20661508|P2|NOT COMPLETED|Overall Study||2
8382219|NCT01097668|20661509|P1|NOT COMPLETED|Overall Study||2
8382220|NCT01097668|20661508|P2|COMPLETED|Overall Study||20
8382221|NCT01097668|20661509|P1|COMPLETED|Overall Study||19
8382222|NCT01097668|20661508|P2|Week 48|Overall Study||20
8382223|NCT01097668|20661509|P1|Week 48|Overall Study||19
8382224|NCT01097668|20661508|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
8382225|NCT01097668|20661509|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
8382226|NCT01097668|20661508|P2|STARTED|Overall Study||22
8382227|NCT01097668|20661509|P1|STARTED|Overall Study||21
8382228|NCT01097655|20661519|P1|NOT COMPLETED|Overall Study||10
8382229|NCT01097655|20661519|P1|COMPLETED|Overall Study|participants included for analysis|3039
8382230|NCT01097655|20661519|P1|STARTED|Overall Study||3049
8382231|NCT01097629|20661529|P8|NOT COMPLETED|DB RO Phase||1
8382232|NCT01097629|20661530|P7|NOT COMPLETED|DB RO Phase||3
8382233|NCT01097629|20661531|P6|NOT COMPLETED|DB RO Phase||1
8382234|NCT01097629|20661532|P5|NOT COMPLETED|DB RO Phase||0
8382235|NCT01097629|20661533|P4|NOT COMPLETED|DB RO Phase||1
8382236|NCT01097629|20661534|P3|NOT COMPLETED|DB RO Phase||0
8382237|NCT01097629|20661535|P2|NOT COMPLETED|DB RO Phase||0
8382238|NCT01097629|20661536|P1|NOT COMPLETED|DB RO Phase||0
8382239|NCT01097629|20661529|P8|COMPLETED|DB RO Phase||326
8382240|NCT01097629|20661530|P7|COMPLETED|DB RO Phase||168
8382241|NCT01097629|20661531|P6|COMPLETED|DB RO Phase||172
8382242|NCT01097629|20661532|P5|COMPLETED|DB RO Phase||108
8382243|NCT01097629|20661533|P4|COMPLETED|DB RO Phase||96
8382244|NCT01097629|20661534|P3|COMPLETED|DB RO Phase||0
8382245|NCT01097629|20661535|P2|COMPLETED|DB RO Phase||0
8382246|NCT01097629|20661536|P1|COMPLETED|DB RO Phase||0
8382247|NCT01097629|20661529|P8|STARTED|DB RO Phase||327
8382248|NCT01097629|20661530|P7|STARTED|DB RO Phase||171
8382249|NCT01097629|20661531|P6|STARTED|DB RO Phase||173
8382250|NCT01097629|20661532|P5|STARTED|DB RO Phase||108
8382251|NCT01097629|20661533|P4|STARTED|DB RO Phase||97
8382252|NCT01097629|20661534|P3|STARTED|DB RO Phase||0
8382253|NCT01097629|20661535|P2|STARTED|DB RO Phase||0
8382254|NCT01097629|20661536|P1|STARTED|DB RO Phase||0
8382255|NCT01097629|20661529|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382256|NCT01097629|20661530|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382257|NCT01097629|20661531|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382258|NCT01097629|20661532|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382259|NCT01097629|20661533|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382260|NCT01097629|20661534|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
8382261|NCT01097629|20661535|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
8382262|NCT01097629|20661536|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
8382263|NCT01097629|20661529|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382264|NCT01097629|20661530|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382265|NCT01097629|20661531|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382266|NCT01097629|20661532|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382267|NCT01097629|20661533|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382268|NCT01097629|20661534|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
8382269|NCT01097629|20661535|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
8382270|NCT01097629|20661536|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
8382271|NCT01097629|20661529|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382272|NCT01097629|20661530|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382273|NCT01097629|20661531|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382274|NCT01097629|20661532|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382275|NCT01097629|20661533|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382276|NCT01097629|20661534|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
8382277|NCT01097629|20661535|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
8382278|NCT01097629|20661536|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
8382279|NCT01097629|20661529|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382280|NCT01097629|20661530|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382281|NCT01097629|20661531|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382282|NCT01097629|20661532|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382283|NCT01097629|20661533|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382284|NCT01097629|20661534|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
8382285|NCT01097629|20661535|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
8382286|NCT01097629|20661536|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
8382287|NCT01097616|20661587|P8|NOT COMPLETED|DB RO Phase||1
8382288|NCT01097616|20661588|P7|NOT COMPLETED|DB RO Phase||1
8382289|NCT01097616|20661589|P6|NOT COMPLETED|DB RO Phase||2
8382290|NCT01097616|20661590|P5|NOT COMPLETED|DB RO Phase||1
8382291|NCT01097616|20661591|P4|NOT COMPLETED|DB RO Phase||1
8382292|NCT01097616|20661592|P3|NOT COMPLETED|DB RO Phase||0
8382293|NCT01097616|20661593|P2|NOT COMPLETED|DB RO Phase||0
8382294|NCT01097616|20661594|P1|NOT COMPLETED|DB RO Phase||0
8382295|NCT01097616|20661587|P8|COMPLETED|DB RO Phase||326
8382296|NCT01097616|20661588|P7|COMPLETED|DB RO Phase||161
8382297|NCT01097616|20661589|P6|COMPLETED|DB RO Phase||159
8382298|NCT01097616|20661590|P5|COMPLETED|DB RO Phase||111
8382299|NCT01097616|20661591|P4|COMPLETED|DB RO Phase||100
8382300|NCT01097616|20661592|P3|COMPLETED|DB RO Phase||0
8382301|NCT01097616|20661593|P2|COMPLETED|DB RO Phase||0
8382302|NCT01097616|20661594|P1|COMPLETED|DB RO Phase||0
8382303|NCT01097616|20661587|P8|STARTED|DB RO Phase||327
8382304|NCT01097616|20661588|P7|STARTED|DB RO Phase||162
8382305|NCT01097616|20661589|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
8382306|NCT01097616|20661590|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
8382307|NCT01097616|20661591|P4|STARTED|DB RO Phase||101
8382308|NCT01097616|20661592|P3|STARTED|DB RO Phase||0
8382309|NCT01097616|20661593|P2|STARTED|DB RO Phase||0
8382310|NCT01097616|20661594|P1|STARTED|DB RO Phase||0
8382311|NCT01097616|20661587|P8|NOT COMPLETED|Optional DB EXT Phase||0
8382312|NCT01097616|20661588|P7|NOT COMPLETED|Optional DB EXT Phase||0
8382313|NCT01097616|20661589|P6|NOT COMPLETED|Optional DB EXT Phase||0
8382314|NCT01097616|20661590|P5|NOT COMPLETED|Optional DB EXT Phase||0
8382315|NCT01097616|20661591|P4|NOT COMPLETED|Optional DB EXT Phase||0
8382316|NCT01097616|20661592|P3|NOT COMPLETED|Optional DB EXT Phase||10
8382317|NCT01097616|20661593|P2|NOT COMPLETED|Optional DB EXT Phase||21
8382318|NCT01097616|20661594|P1|NOT COMPLETED|Optional DB EXT Phase||15
8382319|NCT01097616|20661587|P8|COMPLETED|Optional DB EXT Phase||0
8382320|NCT01097616|20661588|P7|COMPLETED|Optional DB EXT Phase||0
8382321|NCT01097616|20661589|P6|COMPLETED|Optional DB EXT Phase||0
8382322|NCT01097616|20661590|P5|COMPLETED|Optional DB EXT Phase||0
8382323|NCT01097616|20661591|P4|COMPLETED|Optional DB EXT Phase||0
8382324|NCT01097616|20661592|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
8382325|NCT01097616|20661593|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
8382326|NCT01097616|20661594|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
8382327|NCT01097616|20661587|P8|STARTED|Optional DB EXT Phase||0
8382328|NCT01097616|20661588|P7|STARTED|Optional DB EXT Phase||0
8382329|NCT01097616|20661589|P6|STARTED|Optional DB EXT Phase||0
8382330|NCT01097616|20661590|P5|STARTED|Optional DB EXT Phase||0
8382331|NCT01097616|20661591|P4|STARTED|Optional DB EXT Phase||0
8382332|NCT01097616|20661592|P3|STARTED|Optional DB EXT Phase||151
8382333|NCT01097616|20661593|P2|STARTED|Optional DB EXT Phase||172
8382334|NCT01097616|20661594|P1|STARTED|Optional DB EXT Phase||100
8382335|NCT01097616|20661587|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382336|NCT01097616|20661588|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382337|NCT01097616|20661589|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382338|NCT01097616|20661590|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382339|NCT01097616|20661591|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382340|NCT01097616|20661592|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
8382341|NCT01097616|20661593|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
8382342|NCT01097616|20661594|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
8382343|NCT01097616|20661587|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382344|NCT01097616|20661588|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382345|NCT01097616|20661589|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382346|NCT01097616|20661590|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382347|NCT01097616|20661591|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382348|NCT01097616|20661592|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
8382349|NCT01097616|20661593|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
8382350|NCT01097616|20661594|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
8382351|NCT01097616|20661587|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382352|NCT01097616|20661588|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382353|NCT01097616|20661589|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382354|NCT01097616|20661590|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382355|NCT01097616|20661591|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382356|NCT01097616|20661592|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
8382357|NCT01097616|20661593|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
8382358|NCT01097616|20661594|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
8382359|NCT01097616|20661587|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382360|NCT01097616|20661588|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382361|NCT01097616|20661589|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382362|NCT01097616|20661590|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382363|NCT01097616|20661591|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382364|NCT01097616|20661592|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
8382365|NCT01097616|20661593|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
8382366|NCT01097616|20661594|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
8382367|NCT01097577|20661667|P2|NOT COMPLETED|Overall Study||1
8382368|NCT01097577|20661668|P1|NOT COMPLETED|Overall Study||0
8382369|NCT01097577|20661667|P2|COMPLETED|Overall Study||62
8382370|NCT01097577|20661668|P1|COMPLETED|Overall Study||67
8382371|NCT01097577|20661667|P2|STARTED|Overall Study||63
8382372|NCT01097577|20661668|P1|STARTED|Overall Study||67
8382373|NCT01097460|20661684|P1|NOT COMPLETED|Overall Study||0
8382374|NCT01097460|20661684|P1|COMPLETED|Overall Study||16
8382375|NCT01097460|20661684|P1|STARTED|Overall Study||16
8382376|NCT01097421|20661688|P1|NOT COMPLETED|Overall Study||14
8382377|NCT01097421|20661688|P1|COMPLETED|Overall Study||314
8382378|NCT01097421|20661688|P1|STARTED|Overall Study||328
8382379|NCT01097343|20661698|P2|NOT COMPLETED|Second Intervention- 30 Days||0
8382380|NCT01097343|20661699|P1|NOT COMPLETED|Second Intervention- 30 Days||0
8382381|NCT01097343|20661698|P2|COMPLETED|Second Intervention- 30 Days||25
8382382|NCT01097343|20661699|P1|COMPLETED|Second Intervention- 30 Days||25
8382383|NCT01097343|20661698|P2|STARTED|Second Intervention- 30 Days||25
8382384|NCT01097343|20661699|P1|STARTED|Second Intervention- 30 Days||25
8382385|NCT01097343|20661698|P2|NOT COMPLETED|First Intervention- 30 Days||0
8382386|NCT01097343|20661699|P1|NOT COMPLETED|First Intervention- 30 Days||0
8382387|NCT01097343|20661698|P2|COMPLETED|First Intervention- 30 Days||25
8382388|NCT01097343|20661699|P1|COMPLETED|First Intervention- 30 Days||25
8382389|NCT01097343|20661698|P2|STARTED|First Intervention- 30 Days||25
8382390|NCT01097343|20661699|P1|STARTED|First Intervention- 30 Days||25
8382391|NCT01097330|20661707|P2|NOT COMPLETED|Overall Study||5
8382392|NCT01097330|20661708|P1|NOT COMPLETED|Overall Study||7
8382393|NCT01097330|20661707|P2|COMPLETED|Overall Study||0
8382394|NCT01097330|20661708|P1|COMPLETED|Overall Study||0
8382395|NCT01097330|20661707|P2|STARTED|Overall Study||5
8382396|NCT01097330|20661708|P1|STARTED|Overall Study||7
8382397|NCT01097304|20661718|P1|NOT COMPLETED|Overall Study||7
8382398|NCT01097304|20661718|P1|COMPLETED|Overall Study||29
8382399|NCT01097304|20661718|P1|STARTED|Overall Study||36
8382400|NCT01097057|20661725|P1|NOT COMPLETED|Overall Study||3
8382401|NCT01097057|20661725|P1|COMPLETED|Overall Study||17
8382402|NCT01097057|20661725|P1|STARTED|Overall Study||20
8382403|NCT01097044|20661734|P2|NOT COMPLETED|Overall Study||5
8382404|NCT01097044|20661735|P1|NOT COMPLETED|Overall Study||5
8382405|NCT01097044|20661734|P2|COMPLETED|Overall Study||33
8382406|NCT01097044|20661735|P1|COMPLETED|Overall Study||34
8382407|NCT01097044|20661734|P2|STARTED|Overall Study||38
8382408|NCT01097044|20661735|P1|STARTED|Overall Study||39
8382409|NCT01097005|20661753|P1|NOT COMPLETED|Overall Study||365
8382410|NCT01097005|20661753|P1|COMPLETED|Overall Study||101
8382411|NCT01097005|20661753|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
8382412|NCT01097005|20661753|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
8382413|NCT01097005|20661753|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
8382414|NCT01097005|20661753|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
8382415|NCT01097005|20661753|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
8382416|NCT01096992|20661764|P5|NOT COMPLETED|Overall Study||0
8382417|NCT01096992|20661765|P4|NOT COMPLETED|Overall Study||0
8382418|NCT01096992|20661766|P3|NOT COMPLETED|Overall Study||0
8382419|NCT01096992|20661767|P2|NOT COMPLETED|Overall Study||0
8382420|NCT01096992|20661768|P1|NOT COMPLETED|Overall Study||0
8382421|NCT01096992|20661764|P5|COMPLETED|Overall Study||30
8382422|NCT01096992|20661765|P4|COMPLETED|Overall Study||6
8382423|NCT01096992|20661766|P3|COMPLETED|Overall Study||6
8382424|NCT01096992|20661767|P2|COMPLETED|Overall Study||3
8382425|NCT01096992|20661768|P1|COMPLETED|Overall Study||6
8382426|NCT01096992|20661764|P5|STARTED|Overall Study||30
8382427|NCT01096992|20661765|P4|STARTED|Overall Study||6
8382428|NCT01096992|20661766|P3|STARTED|Overall Study||6
8382429|NCT01096992|20661767|P2|STARTED|Overall Study||3
8382430|NCT01096992|20661768|P1|STARTED|Overall Study||6
8382431|NCT01096875|20661783|P2|NOT COMPLETED|Overall Study||1
8382432|NCT01096875|20661784|P1|NOT COMPLETED|Overall Study||0
8382433|NCT01096875|20661783|P2|COMPLETED|Overall Study||29
8382434|NCT01096875|20661784|P1|COMPLETED|Overall Study||30
8382435|NCT01096875|20661783|P2|STARTED|Overall Study||30
8382436|NCT01096875|20661784|P1|STARTED|Overall Study||30
8382437|NCT01096849|20661799|P3|NOT COMPLETED|Overall Study||6
8382438|NCT01096849|20661800|P2|NOT COMPLETED|Overall Study||12
8382439|NCT01096849|20661801|P1|NOT COMPLETED|Overall Study||2
8382440|NCT01096849|20661799|P3|COMPLETED|Overall Study||41
8382441|NCT01096849|20661800|P2|COMPLETED|Overall Study||64
8382442|NCT01096849|20661801|P1|COMPLETED|Overall Study||20
8382443|NCT01096849|20661799|P3|STARTED|Overall Study||47
8382444|NCT01096849|20661800|P2|STARTED|Overall Study||76
8382445|NCT01096849|20661801|P1|STARTED|Overall Study||22
8382446|NCT01096823|20661856|P2|NOT COMPLETED|Overall Study||1
8382447|NCT01096823|20661857|P1|NOT COMPLETED|Overall Study||3
8382448|NCT01096823|20661856|P2|COMPLETED|Overall Study||15
8382449|NCT01096823|20661857|P1|COMPLETED|Overall Study||11
8382450|NCT01096823|20661856|P2|STARTED|Overall Study||16
8382451|NCT01096823|20661857|P1|STARTED|Overall Study||14
8382452|NCT01096810|20661869|P1|NOT COMPLETED|Overall Study||0
8382453|NCT01096810|20661869|P1|COMPLETED|Overall Study||20
8382454|NCT01096810|20661869|P1|STARTED|Overall Study||20
8382455|NCT01096784|20661877|P2|NOT COMPLETED|Overall Study||14
8382456|NCT01096784|20661878|P1|NOT COMPLETED|Overall Study||15
8382457|NCT01096784|20661877|P2|COMPLETED|Overall Study||46
8382458|NCT01096784|20661878|P1|COMPLETED|Overall Study||46
8382459|NCT01096784|20661877|P2|STARTED|Overall Study||60
8382460|NCT01096784|20661878|P1|STARTED|Overall Study||61
8382461|NCT01096771|20661912|P2|NOT COMPLETED|Overall Study||0
8382462|NCT01096771|20661913|P1|NOT COMPLETED|Overall Study||0
8382463|NCT01096771|20661912|P2|COMPLETED|Overall Study||7
8382464|NCT01096771|20661913|P1|COMPLETED|Overall Study||7
8382465|NCT01096771|20661912|P2|STARTED|Overall Study||7
8382466|NCT01096771|20661913|P1|STARTED|Overall Study||7
8382467|NCT01096680|20661942|P5|NOT COMPLETED|Overall Study||0
8382468|NCT01096680|20661943|P4|NOT COMPLETED|Overall Study||0
8382469|NCT01096680|20661944|P3|NOT COMPLETED|Overall Study||0
8382470|NCT01096680|20661945|P2|NOT COMPLETED|Overall Study||0
8382471|NCT01096680|20661946|P1|NOT COMPLETED|Overall Study||0
8382472|NCT01096680|20661942|P5|COMPLETED|Overall Study||27
8382473|NCT01096680|20661943|P4|COMPLETED|Overall Study||27
8382474|NCT01096680|20661944|P3|COMPLETED|Overall Study||27
8382475|NCT01096680|20661945|P2|COMPLETED|Overall Study||27
8382476|NCT01096680|20661946|P1|COMPLETED|Overall Study||27
8382477|NCT01096680|20661942|P5|STARTED|Overall Study||27
8382478|NCT01096680|20661943|P4|STARTED|Overall Study||27
8382479|NCT01096680|20661944|P3|STARTED|Overall Study||27
8382480|NCT01096680|20661945|P2|STARTED|Overall Study||27
8382481|NCT01096680|20661946|P1|STARTED|Overall Study||27
8382482|NCT01096667|20661983|P5|NOT COMPLETED|Overall Study||0
8382483|NCT01096667|20661984|P4|NOT COMPLETED|Overall Study||3
8382484|NCT01096667|20661985|P3|NOT COMPLETED|Overall Study||2
8382485|NCT01096667|20661986|P2|NOT COMPLETED|Overall Study||2
8382486|NCT01096667|20661987|P1|NOT COMPLETED|Overall Study||3
8382487|NCT01096667|20661983|P5|COMPLETED|Overall Study||39
8382488|NCT01096667|20661984|P4|COMPLETED|Overall Study||36
8382489|NCT01096667|20661985|P3|COMPLETED|Overall Study||36
8382490|NCT01096667|20661986|P2|COMPLETED|Overall Study||37
8382491|NCT01096667|20661987|P1|COMPLETED|Overall Study||36
8382492|NCT01096667|20661983|P5|Treated|Overall Study||39
8382493|NCT01096667|20661984|P4|Treated|Overall Study||39
8382494|NCT01096667|20661985|P3|Treated|Overall Study||38
8382495|NCT01096667|20661986|P2|Treated|Overall Study||39
8382496|NCT01096667|20661987|P1|Treated|Overall Study||38
8382497|NCT01096667|20661983|P5|STARTED|Overall Study||39
8382498|NCT01096667|20661984|P4|STARTED|Overall Study||39
8382499|NCT01096667|20661985|P3|STARTED|Overall Study||38
8382500|NCT01096667|20661986|P2|STARTED|Overall Study||39
8382501|NCT01096667|20661987|P1|STARTED|Overall Study||39
8382502|NCT01096589|20662129|P4|NOT COMPLETED|Overall Study||3
8382503|NCT01096589|20662130|P3|NOT COMPLETED|Overall Study||4
8382504|NCT01096589|20662131|P2|NOT COMPLETED|Overall Study||2
8382505|NCT01096589|20662132|P1|NOT COMPLETED|Overall Study||4
8382506|NCT01096589|20662129|P4|COMPLETED|Overall Study||15
8382507|NCT01096589|20662130|P3|COMPLETED|Overall Study||18
8382508|NCT01096589|20662131|P2|COMPLETED|Overall Study||18
8382509|NCT01096589|20662132|P1|COMPLETED|Overall Study||18
8382510|NCT01096589|20662129|P4|STARTED|Overall Study||18
8382511|NCT01096589|20662130|P3|STARTED|Overall Study||22
8382512|NCT01096589|20662131|P2|STARTED|Overall Study||20
8382513|NCT01096589|20662132|P1|STARTED|Overall Study||22
8382514|NCT01096550|20662148|P2|NOT COMPLETED|Overall Study||29
8382515|NCT01096550|20662149|P1|NOT COMPLETED|Overall Study||37
8382516|NCT01096550|20662148|P2|COMPLETED|Overall Study||146
8382517|NCT01096550|20662149|P1|COMPLETED|Overall Study||133
8382518|NCT01096550|20662148|P2|STARTED|Overall Study||175
8382519|NCT01096550|20662149|P1|STARTED|Overall Study||170
8382520|NCT01096446|20662157|P2|NOT COMPLETED|Overall Study||0
8382521|NCT01096446|20662158|P1|NOT COMPLETED|Overall Study||3
8382522|NCT01096446|20662157|P2|COMPLETED|Overall Study||10
8382523|NCT01096446|20662158|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
8382524|NCT01096446|20662157|P2|STARTED|Overall Study||10
8382525|NCT01096446|20662158|P1|STARTED|Overall Study||12
8382526|NCT01096342|20662163|P1|NOT COMPLETED|Overall Study||1
8382527|NCT01096342|20662163|P1|COMPLETED|Overall Study||15
8382528|NCT01096342|20662163|P1|STARTED|Overall Study||16
8382529|NCT01096316|20662171|P2|NOT COMPLETED|Overall Study||9
8382530|NCT01096316|20662172|P1|NOT COMPLETED|Overall Study||15
8382531|NCT01096316|20662171|P2|COMPLETED|Overall Study||94
8382532|NCT01096316|20662172|P1|COMPLETED|Overall Study||87
8382533|NCT01096316|20662171|P2|STARTED|Overall Study||103
8382534|NCT01096316|20662172|P1|STARTED|Overall Study||102
8382535|NCT01096290|20662184|P2|NOT COMPLETED|Overall Study||0
8382536|NCT01096290|20662185|P1|NOT COMPLETED|Overall Study||0
8382537|NCT01096290|20662184|P2|COMPLETED|Overall Study||14
8382538|NCT01096290|20662185|P1|COMPLETED|Overall Study||9
8382539|NCT01096290|20662184|P2|STARTED|Overall Study||14
8382540|NCT01096290|20662185|P1|STARTED|Overall Study||9
8382541|NCT01096186|20662193|P1|NOT COMPLETED|Overall Study||50
8382542|NCT01096186|20662193|P1|COMPLETED|Overall Study||567
8382543|NCT01096186|20662193|P1|STARTED|Overall Study||617
8382544|NCT01096160|20662209|P10|NOT COMPLETED|Overall Study||1
8382545|NCT01096160|20662210|P9|NOT COMPLETED|Overall Study||2
8382546|NCT01096160|20662211|P8|NOT COMPLETED|Overall Study||0
8382547|NCT01096160|20662212|P7|NOT COMPLETED|Overall Study||2
8382548|NCT01096160|20662213|P6|NOT COMPLETED|Overall Study||0
8382549|NCT01096160|20662214|P5|NOT COMPLETED|Overall Study||1
8382550|NCT01096160|20662215|P4|NOT COMPLETED|Overall Study||0
8382551|NCT01096160|20662216|P3|NOT COMPLETED|Overall Study||1
8382552|NCT01096160|20662217|P2|NOT COMPLETED|Overall Study||0
8382553|NCT01096160|20662218|P1|NOT COMPLETED|Overall Study||0
8382554|NCT01096160|20662209|P10|COMPLETED|Overall Study||1
8382555|NCT01096160|20662210|P9|COMPLETED|Overall Study||4
8382556|NCT01096160|20662211|P8|COMPLETED|Overall Study||2
8382557|NCT01096160|20662212|P7|COMPLETED|Overall Study||4
8382558|NCT01096160|20662213|P6|COMPLETED|Overall Study||2
8382559|NCT01096160|20662214|P5|COMPLETED|Overall Study||5
8382560|NCT01096160|20662215|P4|COMPLETED|Overall Study||2
8382561|NCT01096160|20662216|P3|COMPLETED|Overall Study||5
8382562|NCT01096160|20662217|P2|COMPLETED|Overall Study||2
8382563|NCT01096160|20662218|P1|COMPLETED|Overall Study||6
8382564|NCT01096160|20662209|P10|STARTED|Overall Study||2
8382565|NCT01096160|20662210|P9|STARTED|Overall Study||6
8382566|NCT01096160|20662211|P8|STARTED|Overall Study||2
8382567|NCT01096160|20662212|P7|STARTED|Overall Study||6
8382568|NCT01096160|20662213|P6|STARTED|Overall Study||2
8382569|NCT01096160|20662214|P5|STARTED|Overall Study||6
8382570|NCT01096160|20662215|P4|STARTED|Overall Study||2
8382571|NCT01096160|20662216|P3|STARTED|Overall Study||6
8382572|NCT01096160|20662217|P2|STARTED|Overall Study||2
8382573|NCT01096160|20662218|P1|STARTED|Overall Study||6
8382574|NCT01096056|20662276|P2|NOT COMPLETED|Overall Study||1
8382575|NCT01096056|20662277|P1|NOT COMPLETED|Overall Study||0
8382576|NCT01096056|20662276|P2|COMPLETED|Overall Study||19
8382577|NCT01096056|20662277|P1|COMPLETED|Overall Study||20
8382578|NCT01096056|20662276|P2|Completed at Day 42|Overall Study||20
8382579|NCT01096056|20662277|P1|Completed at Day 42|Overall Study||20
8382580|NCT01096056|20662276|P2|STARTED|Overall Study||20
8382581|NCT01096056|20662277|P1|STARTED|Overall Study||20
8382582|NCT01096017|20662309|P2|NOT COMPLETED|Treatment Period 2||1
8382583|NCT01096017|20662310|P1|NOT COMPLETED|Treatment Period 2||1
8382584|NCT01096017|20662309|P2|COMPLETED|Treatment Period 2||11
8382585|NCT01096017|20662310|P1|COMPLETED|Treatment Period 2||11
8382586|NCT01096017|20662309|P2|STARTED|Treatment Period 2||12
8382587|NCT01096017|20662310|P1|STARTED|Treatment Period 2||12
8382588|NCT01096017|20662309|P2|NOT COMPLETED|Washout 1 - 14 Days||0
8382589|NCT01096017|20662310|P1|NOT COMPLETED|Washout 1 - 14 Days||0
8382590|NCT01096017|20662309|P2|COMPLETED|Washout 1 - 14 Days||12
8382591|NCT01096017|20662310|P1|COMPLETED|Washout 1 - 14 Days||12
8382592|NCT01096017|20662309|P2|STARTED|Washout 1 - 14 Days||12
8382593|NCT01096017|20662310|P1|STARTED|Washout 1 - 14 Days||12
8382594|NCT01096017|20662309|P2|NOT COMPLETED|Treatment Period 1||0
8382595|NCT01096017|20662310|P1|NOT COMPLETED|Treatment Period 1||0
8382596|NCT01096017|20662309|P2|COMPLETED|Treatment Period 1||12
8382597|NCT01096017|20662310|P1|COMPLETED|Treatment Period 1||12
8382598|NCT01096017|20662309|P2|STARTED|Treatment Period 1||12
8382599|NCT01096017|20662310|P1|STARTED|Treatment Period 1||12
8382600|NCT01095978|20662338|P1|NOT COMPLETED|Overall Study||3
8382601|NCT01095978|20662338|P1|COMPLETED|Overall Study||2819
8382602|NCT01095978|20662338|P1|STARTED|Overall Study||2822
8382603|NCT01095887|20662365|P1|NOT COMPLETED|Overall Study||0
8382604|NCT01095887|20662365|P1|COMPLETED|Overall Study||6
8382605|NCT01095887|20662365|P1|STARTED|Overall Study||6
8382606|NCT01095835|20662372|P3|NOT COMPLETED|Overall Study||8
8382607|NCT01095835|20662373|P2|NOT COMPLETED|Overall Study||12
8382608|NCT01095835|20662374|P1|NOT COMPLETED|Overall Study||10
8382609|NCT01095835|20662372|P3|COMPLETED|Overall Study||17
8382610|NCT01095835|20662373|P2|COMPLETED|Overall Study||40
8382611|NCT01095835|20662374|P1|COMPLETED|Overall Study||41
8382612|NCT01095835|20662372|P3|STARTED|Overall Study||25
8382613|NCT01095835|20662373|P2|STARTED|Overall Study||52
8382614|NCT01095835|20662374|P1|STARTED|Overall Study||51
8382615|NCT01095796|20662412|P2|NOT COMPLETED|Overall Study||289
8382616|NCT01095796|20662413|P1|NOT COMPLETED|Overall Study||295
8382617|NCT01095796|20662412|P2|COMPLETED|Overall Study||65
8382618|NCT01095796|20662413|P1|COMPLETED|Overall Study||58
8382619|NCT01095796|20662412|P2|STARTED|Overall Study||354
8382620|NCT01095796|20662413|P1|STARTED|Overall Study||353
8382621|NCT01095757|20662431|P1|NOT COMPLETED|Overall Study||0
8382622|NCT01095757|20662431|P1|COMPLETED|Overall Study||45
8382623|NCT01095757|20662431|P1|STARTED|Overall Study||45
8382624|NCT01095666|20662443|P3|NOT COMPLETED|Overall Study||7
8382625|NCT01095666|20662444|P2|NOT COMPLETED|Overall Study||11
8382626|NCT01095666|20662445|P1|NOT COMPLETED|Overall Study||17
8382627|NCT01095666|20662443|P3|COMPLETED|Overall Study||145
8382628|NCT01095666|20662444|P2|COMPLETED|Overall Study||136
8382629|NCT01095666|20662445|P1|COMPLETED|Overall Study||128
8382630|NCT01095666|20662443|P3|STARTED|Overall Study||152
8382631|NCT01095666|20662444|P2|STARTED|Overall Study||147
8382632|NCT01095666|20662445|P1|STARTED|Overall Study||145
8382633|NCT01095653|20662468|P3|NOT COMPLETED|Overall Study||16
8382634|NCT01095653|20662469|P2|NOT COMPLETED|Overall Study||15
8382635|NCT01095653|20662470|P1|NOT COMPLETED|Overall Study||19
8382636|NCT01095653|20662468|P3|COMPLETED|Overall Study||117
8382637|NCT01095653|20662469|P2|COMPLETED|Overall Study||113
8382638|NCT01095653|20662470|P1|COMPLETED|Overall Study||113
8382639|NCT01095653|20662468|P3|STARTED|Overall Study||133
8382640|NCT01095653|20662469|P2|STARTED|Overall Study||128
8382641|NCT01095653|20662470|P1|STARTED|Overall Study||132
8382642|NCT01095510|20662493|P4|NOT COMPLETED|Overall Study||0
8382643|NCT01095510|20662494|P3|NOT COMPLETED|Overall Study||0
8382644|NCT01095510|20662495|P2|NOT COMPLETED|Overall Study||0
8382645|NCT01095510|20662496|P1|NOT COMPLETED|Overall Study||0
8382646|NCT01095510|20662493|P4|COMPLETED|Overall Study||3
8382647|NCT01095510|20662494|P3|COMPLETED|Overall Study||3
8382648|NCT01095510|20662495|P2|COMPLETED|Overall Study||0
8382649|NCT01095510|20662496|P1|COMPLETED|Overall Study||3
8382650|NCT01095510|20662493|P4|STARTED|Overall Study||3
8382651|NCT01095510|20662494|P3|STARTED|Overall Study||3
8382652|NCT01095510|20662495|P2|STARTED|Overall Study||0
8382653|NCT01095510|20662496|P1|STARTED|Overall Study||3
8382654|NCT01095497|20662515|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
8382655|NCT01095497|20662516|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
8382656|NCT01095497|20662515|P2|COMPLETED|Subcutaneous CINRYZE||12
8382657|NCT01095497|20662516|P1|COMPLETED|Subcutaneous CINRYZE||12
8382658|NCT01095497|20662515|P2|STARTED|Subcutaneous CINRYZE||12
8382659|NCT01095497|20662516|P1|STARTED|Subcutaneous CINRYZE||13
8382660|NCT01095497|20662515|P2|NOT COMPLETED|Intravenous CINRYZE||0
8382661|NCT01095497|20662516|P1|NOT COMPLETED|Intravenous CINRYZE||1
8382662|NCT01095497|20662515|P2|COMPLETED|Intravenous CINRYZE||12
8382663|NCT01095497|20662516|P1|COMPLETED|Intravenous CINRYZE||13
8382664|NCT01095497|20662515|P2|STARTED|Intravenous CINRYZE||12
8382665|NCT01095497|20662516|P1|STARTED|Intravenous CINRYZE||14
8382666|NCT01095250|20662528|P4|NOT COMPLETED|Overall Study||5
8382667|NCT01095250|20662529|P3|NOT COMPLETED|Overall Study||8
8382668|NCT01095250|20662530|P2|NOT COMPLETED|Overall Study||10
8382669|NCT01095250|20662531|P1|NOT COMPLETED|Overall Study||8
8382670|NCT01095250|20662528|P4|COMPLETED|Overall Study||0
8382671|NCT01095250|20662529|P3|COMPLETED|Overall Study||0
8382672|NCT01095250|20662530|P2|COMPLETED|Overall Study||0
8382673|NCT01095250|20662531|P1|COMPLETED|Overall Study||0
8382674|NCT01095250|20662528|P4|STARTED|Overall Study||5
8382675|NCT01095250|20662529|P3|STARTED|Overall Study||8
8382676|NCT01095250|20662530|P2|STARTED|Overall Study||10
8382677|NCT01095250|20662531|P1|STARTED|Overall Study||8
8382678|NCT01095094|20662561|P1|NOT COMPLETED|Overall Study||3
8382679|NCT01095094|20662561|P1|COMPLETED|Overall Study||16
8382680|NCT01095094|20662561|P1|STARTED|Overall Study||19
8382681|NCT01095003|20662568|P2|NOT COMPLETED|Overall Study||386
8382682|NCT01095003|20662569|P1|NOT COMPLETED|Overall Study||384
8382683|NCT01095003|20662568|P2|COMPLETED|Overall Study||0
8382684|NCT01095003|20662569|P1|COMPLETED|Overall Study||0
8382685|NCT01095003|20662568|P2|STARTED|Overall Study||386
8382686|NCT01095003|20662569|P1|STARTED|Overall Study||384
8382687|NCT01094886|20662583|P1|NOT COMPLETED|Overall Study||7
8382688|NCT01094886|20662583|P1|COMPLETED|Overall Study||46
8382689|NCT01094886|20662583|P1|STARTED|Overall Study||53
8382690|NCT01094808|20662593|P3|NOT COMPLETED|Overall Study||0
8382691|NCT01094808|20662594|P2|NOT COMPLETED|Overall Study||1
8382692|NCT01094808|20662595|P1|NOT COMPLETED|Overall Study||1
8382693|NCT01094808|20662593|P3|COMPLETED|Overall Study||21
8382694|NCT01094808|20662594|P2|COMPLETED|Overall Study||19
8382695|NCT01094808|20662595|P1|COMPLETED|Overall Study||20
8382696|NCT01094808|20662593|P3|STARTED|Overall Study||21
8382697|NCT01094808|20662594|P2|STARTED|Overall Study||20
8382698|NCT01094808|20662595|P1|STARTED|Overall Study||21
8382699|NCT01094782|20662636|P6|NOT COMPLETED|Overall Study||8
8382700|NCT01094782|20662637|P5|NOT COMPLETED|Overall Study||11
8382701|NCT01094782|20662638|P4|NOT COMPLETED|Overall Study||11
8382702|NCT01094782|20662639|P3|NOT COMPLETED|Overall Study||3
8382703|NCT01094782|20662640|P2|NOT COMPLETED|Overall Study||10
8382704|NCT01094782|20662641|P1|NOT COMPLETED|Overall Study||8
8382705|NCT01094782|20662636|P6|COMPLETED|Overall Study||30
8382706|NCT01094782|20662637|P5|COMPLETED|Overall Study||31
8382707|NCT01094782|20662638|P4|COMPLETED|Overall Study||45
8382708|NCT01094782|20662639|P3|COMPLETED|Overall Study||31
8382709|NCT01094782|20662640|P2|COMPLETED|Overall Study||29
8382710|NCT01094782|20662641|P1|COMPLETED|Overall Study||31
8382711|NCT01094782|20662636|P6|STARTED|Overall Study||38
8382712|NCT01094782|20662637|P5|STARTED|Overall Study||42
8382713|NCT01094782|20662638|P4|STARTED|Overall Study||56
8382714|NCT01094782|20662639|P3|STARTED|Overall Study||34
8382715|NCT01094782|20662640|P2|STARTED|Overall Study||39
8382716|NCT01094782|20662641|P1|STARTED|Overall Study||39
8382717|NCT01094743|20662685|P1|NOT COMPLETED|Period 2||0
8382718|NCT01094743|20662685|P1|COMPLETED|Period 2||50
8382719|NCT01094743|20662685|P1|STARTED|Period 2||50
8382720|NCT01094743|20662685|P1|NOT COMPLETED|Period 1||2
8382721|NCT01094743|20662685|P1|COMPLETED|Period 1||50
8382722|NCT01094743|20662685|P1|STARTED|Period 1||52
8382723|NCT01094730|20662702|P2|NOT COMPLETED|Period 2 (14 Days)||2
8382724|NCT01094730|20662703|P1|NOT COMPLETED|Period 2 (14 Days)||3
8382725|NCT01094730|20662702|P2|COMPLETED|Period 2 (14 Days)||84
8382726|NCT01094730|20662703|P1|COMPLETED|Period 2 (14 Days)||87
8382727|NCT01094730|20662702|P2|STARTED|Period 2 (14 Days)||86
8382728|NCT01094730|20662703|P1|STARTED|Period 2 (14 Days)||90
8382729|NCT01094730|20662702|P2|NOT COMPLETED|Period 1 (14 Days)||2
8382730|NCT01094730|20662703|P1|NOT COMPLETED|Period 1 (14 Days)||2
8382731|NCT01094730|20662702|P2|COMPLETED|Period 1 (14 Days)||86
8382732|NCT01094730|20662703|P1|COMPLETED|Period 1 (14 Days)||90
8382733|NCT01094730|20662702|P2|STARTED|Period 1 (14 Days)||88
8382734|NCT01094730|20662703|P1|STARTED|Period 1 (14 Days)||92
8382735|NCT01094717|20662716|P2|NOT COMPLETED|Overall Study||0
8382736|NCT01094717|20662717|P1|NOT COMPLETED|Overall Study||0
8382737|NCT01094717|20662716|P2|COMPLETED|Overall Study||10
8382738|NCT01094717|20662717|P1|COMPLETED|Overall Study||3
8382739|NCT01094717|20662716|P2|STARTED|Overall Study||10
8382740|NCT01094717|20662717|P1|STARTED|Overall Study||3
8382741|NCT01094704|20662735|P2|NOT COMPLETED|Overall Study||0
8382742|NCT01094704|20662736|P1|NOT COMPLETED|Overall Study||0
8382743|NCT01094704|20662735|P2|COMPLETED|Overall Study||8
8382744|NCT01094704|20662736|P1|COMPLETED|Overall Study||8
8382745|NCT01094704|20662735|P2|STARTED|Overall Study||8
8382746|NCT01094704|20662736|P1|STARTED|Overall Study||8
8382747|NCT01094574|20662748|P6|NOT COMPLETED|Overall Study||0
8382748|NCT01094574|20662749|P5|NOT COMPLETED|Overall Study||0
8382749|NCT01094574|20662750|P4|NOT COMPLETED|Overall Study||0
8382750|NCT01094574|20662751|P3|NOT COMPLETED|Overall Study||0
8382751|NCT01094574|20662752|P2|NOT COMPLETED|Overall Study||0
8382752|NCT01094574|20662753|P1|NOT COMPLETED|Overall Study||0
8382753|NCT01094574|20662748|P6|COMPLETED|Overall Study||2
8382754|NCT01094574|20662749|P5|COMPLETED|Overall Study||2
8382755|NCT01094574|20662750|P4|COMPLETED|Overall Study||2
8382756|NCT01094574|20662751|P3|COMPLETED|Overall Study||2
8382757|NCT01094574|20662752|P2|COMPLETED|Overall Study||1
8382758|NCT01094574|20662753|P1|COMPLETED|Overall Study||1
8382759|NCT01094574|20662748|P6|STARTED|Overall Study||2
8382760|NCT01094574|20662749|P5|STARTED|Overall Study||2
8382761|NCT01094574|20662750|P4|STARTED|Overall Study||2
8382762|NCT01094574|20662751|P3|STARTED|Overall Study||2
8382763|NCT01094574|20662752|P2|STARTED|Overall Study||1
8382764|NCT01094574|20662753|P1|STARTED|Overall Study||1
8382765|NCT01094561|20662800|P1|NOT COMPLETED|Overall Study||6
8382766|NCT01094561|20662800|P1|COMPLETED|Overall Study||17
8382767|NCT01094561|20662800|P1|STARTED|Overall Study||23
8382768|NCT01094548|20662807|P2|NOT COMPLETED|Overall Study||0
8382769|NCT01094548|20662808|P1|NOT COMPLETED|Overall Study||0
8382770|NCT01094548|20662807|P2|COMPLETED|Overall Study||17
8382771|NCT01094548|20662808|P1|COMPLETED|Overall Study||17
8382772|NCT01094548|20662807|P2|STARTED|Overall Study||17
8382773|NCT01094548|20662808|P1|STARTED|Overall Study||17
8382774|NCT01094522|20662828|P2|NOT COMPLETED|Overall Study||0
8382775|NCT01094522|20662829|P1|NOT COMPLETED|Overall Study||0
8382776|NCT01094522|20662828|P2|COMPLETED|Overall Study||20
8382777|NCT01094522|20662829|P1|COMPLETED|Overall Study||20
8382778|NCT01094522|20662828|P2|STARTED|Overall Study||20
8382779|NCT01094522|20662829|P1|STARTED|Overall Study||20
8382780|NCT01094301|20662839|P1|NOT COMPLETED|Implant Stage||8
8382781|NCT01094301|20662839|P1|COMPLETED|Implant Stage||5
8382782|NCT01094301|20662839|P1|Subjects Who Received SPR IPG|Implant Stage||5
8382783|NCT01094301|20662839|P1|Met Criteria for Implant Stage|Implant Stage||7
8382784|NCT01094301|20662839|P1|STARTED|Implant Stage||13
8382785|NCT01094301|20662839|P1|NOT COMPLETED|Trial Stage||1
8382786|NCT01094301|20662839|P1|COMPLETED|Trial Stage||27
8382787|NCT01094301|20662839|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
8382788|NCT01094301|20662839|P1|STARTED|Trial Stage||28
8382789|NCT01094288|20662869|P8|NOT COMPLETED|Overall Study||2
8382790|NCT01094288|20662870|P7|NOT COMPLETED|Overall Study||0
8382791|NCT01094288|20662871|P6|NOT COMPLETED|Overall Study||0
8382792|NCT01094288|20662872|P5|NOT COMPLETED|Overall Study||0
8382793|NCT01094288|20662873|P4|NOT COMPLETED|Overall Study||2
8382794|NCT01094288|20662874|P3|NOT COMPLETED|Overall Study||4
8382795|NCT01094288|20662875|P2|NOT COMPLETED|Overall Study||10
8382796|NCT01094288|20662876|P1|NOT COMPLETED|Overall Study||2
8382797|NCT01094288|20662869|P8|COMPLETED|Overall Study||2
8382798|NCT01094288|20662870|P7|COMPLETED|Overall Study||2
8382799|NCT01094288|20662871|P6|COMPLETED|Overall Study||4
8382800|NCT01094288|20662872|P5|COMPLETED|Overall Study||2
8382801|NCT01094288|20662873|P4|COMPLETED|Overall Study||1
8382802|NCT01094288|20662874|P3|COMPLETED|Overall Study||1
8382803|NCT01094288|20662875|P2|COMPLETED|Overall Study||5
8382804|NCT01094288|20662876|P1|COMPLETED|Overall Study|Completed=Completed Treatment|4
8382805|NCT01094288|20662869|P8|STARTED|Overall Study||4
8382806|NCT01094288|20662870|P7|STARTED|Overall Study||2
8382807|NCT01094288|20662871|P6|STARTED|Overall Study||4
8382808|NCT01094288|20662872|P5|STARTED|Overall Study||2
8382809|NCT01094288|20662873|P4|STARTED|Overall Study||3
8382810|NCT01094288|20662874|P3|STARTED|Overall Study||5
8382811|NCT01094288|20662875|P2|STARTED|Overall Study||15
8382812|NCT01094288|20662876|P1|STARTED|Overall Study||6
8382813|NCT01094184|20662988|P2|NOT COMPLETED|Overall Study||11
8382814|NCT01094184|20662989|P1|NOT COMPLETED|Overall Study||35
8382815|NCT01094184|20662988|P2|COMPLETED|Overall Study||2
8382816|NCT01094184|20662989|P1|COMPLETED|Overall Study||1
8382817|NCT01094184|20662988|P2|STARTED|Overall Study||13
8382818|NCT01094184|20662989|P1|STARTED|Overall Study||36
8382819|NCT01094171|20663223|P1|NOT COMPLETED|Overall Study||10
8382820|NCT01094171|20663223|P1|COMPLETED|Overall Study||390
8382821|NCT01094171|20663223|P1|STARTED|Overall Study||400
8382822|NCT01094119|20663232|P2|NOT COMPLETED|Overall Study||4
8382823|NCT01094119|20663233|P1|NOT COMPLETED|Overall Study||2
8382824|NCT01094119|20663232|P2|COMPLETED|Overall Study||32
8382825|NCT01094119|20663233|P1|COMPLETED|Overall Study||32
8382826|NCT01094119|20663232|P2|STARTED|Overall Study||36
8382827|NCT01094119|20663233|P1|STARTED|Overall Study||34
8382828|NCT01094106|20663243|P2|NOT COMPLETED|Overall Study||0
8382829|NCT01094106|20663244|P1|NOT COMPLETED|Overall Study||0
8382830|NCT01094106|20663243|P2|COMPLETED|Overall Study||34
8382831|NCT01094106|20663244|P1|COMPLETED|Overall Study||33
8382832|NCT01094106|20663243|P2|STARTED|Overall Study||34
8382833|NCT01094106|20663244|P1|STARTED|Overall Study||33
8382834|NCT01093976|20663254|P1|NOT COMPLETED|Overall Study||0
8382835|NCT01093976|20663254|P1|COMPLETED|Overall Study||14
8382836|NCT01093976|20663254|P1|STARTED|Overall Study||14
8382837|NCT01093885|20663258|P1|NOT COMPLETED|Overall Study||5
8382838|NCT01093885|20663258|P1|COMPLETED|Overall Study||10
8382839|NCT01093885|20663258|P1|STARTED|Overall Study||15
8382840|NCT01093846|20663266|P3|NOT COMPLETED|Overall Study||21
8382841|NCT01093846|20663267|P2|NOT COMPLETED|Overall Study||18
8382842|NCT01093846|20663268|P1|NOT COMPLETED|Overall Study||19
8382843|NCT01093846|20663266|P3|COMPLETED|Overall Study||1
8382844|NCT01093846|20663267|P2|COMPLETED|Overall Study||0
8382845|NCT01093846|20663268|P1|COMPLETED|Overall Study||0
8382846|NCT01093846|20663266|P3|STARTED|Overall Study||22
8382847|NCT01093846|20663267|P2|STARTED|Overall Study||18
8382848|NCT01093846|20663268|P1|STARTED|Overall Study||19
8382849|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 4||0
8382850|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 4||0
8382851|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 4||0
8382852|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 4||0
8382853|NCT01093794|20663274|P4|COMPLETED|Treatment Period 4||7
8382854|NCT01093794|20663275|P3|COMPLETED|Treatment Period 4||6
8382855|NCT01093794|20663276|P2|COMPLETED|Treatment Period 4||7
8382856|NCT01093794|20663277|P1|COMPLETED|Treatment Period 4||7
8382857|NCT01093794|20663274|P4|STARTED|Treatment Period 4||7
8382858|NCT01093794|20663275|P3|STARTED|Treatment Period 4||6
8382859|NCT01093794|20663276|P2|STARTED|Treatment Period 4||7
8382860|NCT01093794|20663277|P1|STARTED|Treatment Period 4||7
8382861|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 3||0
8382862|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 3||0
8382863|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 3||0
8382864|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 3||0
8382865|NCT01093794|20663274|P4|COMPLETED|Treatment Period 3||7
8382866|NCT01093794|20663275|P3|COMPLETED|Treatment Period 3||6
8382867|NCT01093794|20663276|P2|COMPLETED|Treatment Period 3||7
8382868|NCT01093794|20663277|P1|COMPLETED|Treatment Period 3||7
8382869|NCT01093794|20663274|P4|STARTED|Treatment Period 3||7
8382870|NCT01093794|20663275|P3|STARTED|Treatment Period 3||6
8382871|NCT01093794|20663276|P2|STARTED|Treatment Period 3||7
8382872|NCT01093794|20663277|P1|STARTED|Treatment Period 3||7
8382873|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 2||0
8382874|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 2||0
8382875|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 2||0
8382876|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 2||0
8382877|NCT01093794|20663274|P4|COMPLETED|Treatment Period 2||7
8382878|NCT01093794|20663275|P3|COMPLETED|Treatment Period 2||6
8382879|NCT01093794|20663276|P2|COMPLETED|Treatment Period 2||7
8382880|NCT01093794|20663277|P1|COMPLETED|Treatment Period 2||7
8382881|NCT01093794|20663274|P4|STARTED|Treatment Period 2||7
8382882|NCT01093794|20663275|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
8382883|NCT01093794|20663276|P2|STARTED|Treatment Period 2||7
8382884|NCT01093794|20663277|P1|STARTED|Treatment Period 2||7
8382885|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 1||0
8382886|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 1||0
8382887|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 1||0
8382888|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 1||0
8382889|NCT01093794|20663274|P4|COMPLETED|Treatment Period 1||7
8382890|NCT01093794|20663275|P3|COMPLETED|Treatment Period 1||7
8382891|NCT01093794|20663276|P2|COMPLETED|Treatment Period 1||7
8382892|NCT01093794|20663277|P1|COMPLETED|Treatment Period 1||7
8382893|NCT01093794|20663274|P4|STARTED|Treatment Period 1||7
8382894|NCT01093794|20663275|P3|STARTED|Treatment Period 1||7
8382895|NCT01093794|20663276|P2|STARTED|Treatment Period 1||7
8382896|NCT01093794|20663277|P1|STARTED|Treatment Period 1||7
8382897|NCT01093755|20663293|P2|NOT COMPLETED|Overall Study||4
8382898|NCT01093755|20663294|P1|NOT COMPLETED|Overall Study||3
8382899|NCT01093755|20663293|P2|COMPLETED|Overall Study||10
8382900|NCT01093755|20663294|P1|COMPLETED|Overall Study||13
8382901|NCT01093755|20663293|P2|STARTED|Overall Study||14
8382902|NCT01093755|20663294|P1|STARTED|Overall Study||16
8382903|NCT01093690|20663304|P2|NOT COMPLETED|Overall Study||0
8382904|NCT01093690|20663305|P1|NOT COMPLETED|Overall Study||0
8382905|NCT01093690|20663304|P2|COMPLETED|Overall Study||79
8382906|NCT01093690|20663305|P1|COMPLETED|Overall Study||83
8382907|NCT01093690|20663304|P2|STARTED|Overall Study||79
8382908|NCT01093690|20663305|P1|STARTED|Overall Study||83
8382909|NCT01093651|20663313|P2|NOT COMPLETED|Overall Study||0
8382910|NCT01093651|20663314|P1|NOT COMPLETED|Overall Study||0
8382911|NCT01093651|20663313|P2|COMPLETED|Overall Study||10
8382912|NCT01093651|20663314|P1|COMPLETED|Overall Study||10
8382913|NCT01093651|20663313|P2|STARTED|Overall Study||10
8382914|NCT01093651|20663314|P1|STARTED|Overall Study||10
8382915|NCT01093625|20663334|P2|NOT COMPLETED|1-Year Visit||3
8382916|NCT01093625|20663335|P1|NOT COMPLETED|1-Year Visit||5
8382917|NCT01093625|20663334|P2|COMPLETED|1-Year Visit||37
8382918|NCT01093625|20663335|P1|COMPLETED|1-Year Visit||29
8382919|NCT01093625|20663334|P2|STARTED|1-Year Visit||40
8382920|NCT01093625|20663335|P1|STARTED|1-Year Visit||34
8382921|NCT01093625|20663334|P2|NOT COMPLETED|6-Month Visit||9
8382922|NCT01093625|20663335|P1|NOT COMPLETED|6-Month Visit||8
8382923|NCT01093625|20663334|P2|COMPLETED|6-Month Visit||40
8382924|NCT01093625|20663335|P1|COMPLETED|6-Month Visit||34
8382925|NCT01093625|20663334|P2|STARTED|6-Month Visit||49
8382926|NCT01093625|20663335|P1|STARTED|6-Month Visit||42
8382927|NCT01093625|20663334|P2|NOT COMPLETED|3-Month Visit||0
8382928|NCT01093625|20663335|P1|NOT COMPLETED|3-Month Visit||2
8382929|NCT01093625|20663334|P2|COMPLETED|3-Month Visit||49
8382930|NCT01093625|20663335|P1|COMPLETED|3-Month Visit||42
8382931|NCT01093625|20663334|P2|STARTED|3-Month Visit||49
8382932|NCT01093625|20663335|P1|STARTED|3-Month Visit||44
8382933|NCT01093625|20663334|P2|NOT COMPLETED|1-Month Visit||0
8382934|NCT01093625|20663335|P1|NOT COMPLETED|1-Month Visit||2
8382935|NCT01093625|20663334|P2|COMPLETED|1-Month Visit||49
8382936|NCT01093625|20663335|P1|COMPLETED|1-Month Visit||44
8382937|NCT01093625|20663334|P2|STARTED|1-Month Visit||49
8382938|NCT01093625|20663335|P1|STARTED|1-Month Visit||46
8382939|NCT01093625|20663334|P2|NOT COMPLETED|2-Week Visit||0
8382940|NCT01093625|20663335|P1|NOT COMPLETED|2-Week Visit||1
8382941|NCT01093625|20663334|P2|COMPLETED|2-Week Visit||49
8382942|NCT01093625|20663335|P1|COMPLETED|2-Week Visit||46
8382943|NCT01093625|20663334|P2|STARTED|2-Week Visit||49
8382944|NCT01093625|20663335|P1|STARTED|2-Week Visit||47
8382945|NCT01093625|20663334|P2|NOT COMPLETED|Baseline and Dispensed||0
8382946|NCT01093625|20663335|P1|NOT COMPLETED|Baseline and Dispensed||2
8382947|NCT01093625|20663334|P2|COMPLETED|Baseline and Dispensed||49
8382948|NCT01093625|20663335|P1|COMPLETED|Baseline and Dispensed||47
8382949|NCT01093625|20663334|P2|STARTED|Baseline and Dispensed||49
8382950|NCT01093625|20663335|P1|STARTED|Baseline and Dispensed||49
8382951|NCT01093599|20663355|P2|NOT COMPLETED|Overall Study||46
8382952|NCT01093599|20663356|P1|NOT COMPLETED|Overall Study||32
8382953|NCT01093599|20663355|P2|COMPLETED|Overall Study||59
8382954|NCT01093599|20663356|P1|COMPLETED|Overall Study||59
8382955|NCT01093599|20663355|P2|STARTED|Overall Study||105
8382956|NCT01093599|20663356|P1|STARTED|Overall Study||91
8382957|NCT01093586|20663362|P1|NOT COMPLETED|Overall Study||3
8382958|NCT01093586|20663362|P1|COMPLETED|Overall Study||11
8382959|NCT01093586|20663362|P1|STARTED|Overall Study||14
8382960|NCT01093573|20663383|P3|NOT COMPLETED|Overall Study||2
8382961|NCT01093573|20663384|P2|NOT COMPLETED|Overall Study||0
8382962|NCT01093573|20663385|P1|NOT COMPLETED|Overall Study||0
8382963|NCT01093573|20663383|P3|COMPLETED|Overall Study||26
8382964|NCT01093573|20663384|P2|COMPLETED|Overall Study||3
8382965|NCT01093573|20663385|P1|COMPLETED|Overall Study||3
8382966|NCT01093573|20663383|P3|STARTED|Overall Study||28
8382967|NCT01093573|20663384|P2|STARTED|Overall Study||3
8382968|NCT01093573|20663385|P1|STARTED|Overall Study||3
8382969|NCT01093534|20663402|P3|NOT COMPLETED|Overall Study||9
8382970|NCT01093534|20663403|P2|NOT COMPLETED|Overall Study||16
8382971|NCT01093534|20663404|P1|NOT COMPLETED|Overall Study||10
8382972|NCT01093534|20663402|P3|COMPLETED|Overall Study||169
8382973|NCT01093534|20663403|P2|COMPLETED|Overall Study||167
8382974|NCT01093534|20663404|P1|COMPLETED|Overall Study||176
8382975|NCT01093534|20663402|P3|Received Study Treatment|Overall Study||175
8382976|NCT01093534|20663403|P2|Received Study Treatment|Overall Study||182
8382977|NCT01093534|20663404|P1|Received Study Treatment|Overall Study||186
8382978|NCT01093534|20663402|P3|STARTED|Overall Study||178
8382979|NCT01093534|20663403|P2|STARTED|Overall Study||183
8382980|NCT01093534|20663404|P1|STARTED|Overall Study||186
8382981|NCT01093521|20663509|P1|NOT COMPLETED|Overall Study||0
8382982|NCT01093521|20663509|P1|COMPLETED|Overall Study||20
8382983|NCT01093521|20663509|P1|STARTED|Overall Study||20
8382984|NCT01093482|20663524|P1|NOT COMPLETED|Overall Study||0
8382985|NCT01093482|20663524|P1|COMPLETED|Overall Study||8151
8382986|NCT01093482|20663524|P1|STARTED|Overall Study||8151
8382987|NCT01093469|20663531|P3|NOT COMPLETED|Overall Study||1
8382988|NCT01093469|20663532|P2|NOT COMPLETED|Overall Study||0
8382989|NCT01093469|20663533|P1|NOT COMPLETED|Overall Study||0
8382990|NCT01093469|20663531|P3|COMPLETED|Overall Study||12
8382991|NCT01093469|20663532|P2|COMPLETED|Overall Study||13
8382992|NCT01093469|20663533|P1|COMPLETED|Overall Study||13
8382993|NCT01093469|20663531|P3|STARTED|Overall Study||13
8382994|NCT01093469|20663532|P2|STARTED|Overall Study||13
8382995|NCT01093469|20663533|P1|STARTED|Overall Study||13
8382996|NCT01093417|20663543|P2|NOT COMPLETED|Overall Study||1
8382997|NCT01093417|20663544|P1|NOT COMPLETED|Overall Study||0
8382998|NCT01093417|20663543|P2|COMPLETED|Overall Study||29
8382999|NCT01093417|20663544|P1|COMPLETED|Overall Study||15
8383000|NCT01093417|20663543|P2|STARTED|Overall Study||30
8383001|NCT01093417|20663544|P1|STARTED|Overall Study||15
8383002|NCT01093222|20663552|P1|NOT COMPLETED|Overall Study||40
8383003|NCT01093222|20663552|P1|COMPLETED|Overall Study||0
8383004|NCT01093222|20663552|P1|Eligible and Began Protocol Therapy|Overall Study||34
8383005|NCT01093222|20663552|P1|STARTED|Overall Study||40
8383006|NCT01093183|20663559|P2|NOT COMPLETED|Overall Study||2
8383007|NCT01093183|20663560|P1|NOT COMPLETED|Overall Study||1
8383008|NCT01093183|20663559|P2|COMPLETED|Overall Study||4
8383009|NCT01093183|20663560|P1|COMPLETED|Overall Study||18
8383010|NCT01093183|20663559|P2|STARTED|Overall Study||6
8383011|NCT01093183|20663560|P1|STARTED|Overall Study||19
8383012|NCT01093027|20663570|P2|NOT COMPLETED|Visit 2||0
8383013|NCT01093027|20663571|P1|NOT COMPLETED|Visit 2||0
8383014|NCT01093027|20663570|P2|COMPLETED|Visit 2||10
8383015|NCT01093027|20663571|P1|COMPLETED|Visit 2||10
8383016|NCT01093027|20663570|P2|STARTED|Visit 2||10
8383017|NCT01093027|20663571|P1|STARTED|Visit 2||10
8383018|NCT01093027|20663570|P2|NOT COMPLETED|Visit 1||0
8383019|NCT01093027|20663571|P1|NOT COMPLETED|Visit 1||0
8383020|NCT01093027|20663570|P2|COMPLETED|Visit 1||10
8383021|NCT01093027|20663571|P1|COMPLETED|Visit 1||10
8383022|NCT01093027|20663570|P2|STARTED|Visit 1||10
8383023|NCT01093027|20663571|P1|STARTED|Visit 1||10
8383024|NCT01093014|20663582|P3|NOT COMPLETED|Overall Study||0
8383025|NCT01093014|20663583|P2|NOT COMPLETED|Overall Study||0
8383026|NCT01093014|20663584|P1|NOT COMPLETED|Overall Study||0
8383027|NCT01093014|20663582|P3|COMPLETED|Overall Study||12
8383028|NCT01093014|20663583|P2|COMPLETED|Overall Study||9
8383029|NCT01093014|20663584|P1|COMPLETED|Overall Study||12
8383030|NCT01093014|20663582|P3|STARTED|Overall Study||12
8383031|NCT01093014|20663583|P2|STARTED|Overall Study||9
8383032|NCT01093014|20663584|P1|STARTED|Overall Study||12
8383033|NCT01092923|20663603|P2|NOT COMPLETED|Overall Study||0
8383034|NCT01092923|20663604|P1|NOT COMPLETED|Overall Study||0
8383035|NCT01092923|20663603|P2|COMPLETED|Overall Study||10
8383036|NCT01092923|20663604|P1|COMPLETED|Overall Study||10
8383037|NCT01092923|20663603|P2|STARTED|Overall Study||10
8383038|NCT01092923|20663604|P1|STARTED|Overall Study||10
8383039|NCT01092910|20663613|P1|NOT COMPLETED|Overall Study||5
8383040|NCT01092910|20663613|P1|COMPLETED|Overall Study||52
8383041|NCT01092910|20663613|P1|10 Month Follow-up|Overall Study||52
8383042|NCT01092910|20663613|P1|4 Month Follow-up|Overall Study||54
8383043|NCT01092910|20663613|P1|STARTED|Overall Study||57
8383044|NCT01092832|20663628|P2|NOT COMPLETED|Overall Study||0
8383045|NCT01092832|20663629|P1|NOT COMPLETED|Overall Study||1
8383046|NCT01092832|20663628|P2|COMPLETED|Overall Study||8
8383047|NCT01092832|20663629|P1|COMPLETED|Overall Study||13
8383048|NCT01092832|20663628|P2|STARTED|Overall Study||8
8383049|NCT01092832|20663629|P1|STARTED|Overall Study||14
8383050|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 4||0
8383051|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 4||0
8383052|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 4||0
8383053|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 4||0
8383054|NCT01092780|20663641|P4|COMPLETED|Treatment Period 4||13
8383055|NCT01092780|20663642|P3|COMPLETED|Treatment Period 4||13
8383056|NCT01092780|20663643|P2|COMPLETED|Treatment Period 4||13
8383057|NCT01092780|20663644|P1|COMPLETED|Treatment Period 4||13
8383058|NCT01092780|20663641|P4|STARTED|Treatment Period 4||13
8383059|NCT01092780|20663642|P3|STARTED|Treatment Period 4||13
8383060|NCT01092780|20663643|P2|STARTED|Treatment Period 4||13
8383061|NCT01092780|20663644|P1|STARTED|Treatment Period 4||13
8383062|NCT01092780|20663641|P4|NOT COMPLETED|Washout Period 3||0
8383063|NCT01092780|20663642|P3|NOT COMPLETED|Washout Period 3||0
8383064|NCT01092780|20663643|P2|NOT COMPLETED|Washout Period 3||0
8383065|NCT01092780|20663644|P1|NOT COMPLETED|Washout Period 3||0
8383066|NCT01092780|20663641|P4|COMPLETED|Washout Period 3||13
8383067|NCT01092780|20663642|P3|COMPLETED|Washout Period 3||13
8383068|NCT01092780|20663643|P2|COMPLETED|Washout Period 3||13
8383069|NCT01092780|20663644|P1|COMPLETED|Washout Period 3||13
8383070|NCT01092780|20663641|P4|STARTED|Washout Period 3||13
8383071|NCT01092780|20663642|P3|STARTED|Washout Period 3||13
8383072|NCT01092780|20663643|P2|STARTED|Washout Period 3||13
8383073|NCT01092780|20663644|P1|STARTED|Washout Period 3||13
8383074|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 3||0
8383075|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 3||0
8383076|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 3||0
8383077|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 3||0
8383078|NCT01092780|20663641|P4|COMPLETED|Treatment Period 3||13
8383079|NCT01092780|20663642|P3|COMPLETED|Treatment Period 3||13
8383080|NCT01092780|20663643|P2|COMPLETED|Treatment Period 3||13
8383081|NCT01092780|20663644|P1|COMPLETED|Treatment Period 3||13
8383082|NCT01092780|20663641|P4|STARTED|Treatment Period 3||13
8383083|NCT01092780|20663642|P3|STARTED|Treatment Period 3||13
8383084|NCT01092780|20663643|P2|STARTED|Treatment Period 3||13
8383085|NCT01092780|20663644|P1|STARTED|Treatment Period 3||13
8383086|NCT01092780|20663641|P4|NOT COMPLETED|Washout Period 2||0
8383087|NCT01092780|20663642|P3|NOT COMPLETED|Washout Period 2||1
8383088|NCT01092780|20663643|P2|NOT COMPLETED|Washout Period 2||1
8383089|NCT01092780|20663644|P1|NOT COMPLETED|Washout Period 2||0
8383090|NCT01092780|20663641|P4|COMPLETED|Washout Period 2||13
8383091|NCT01092780|20663642|P3|COMPLETED|Washout Period 2||13
8383092|NCT01092780|20663643|P2|COMPLETED|Washout Period 2||13
8383093|NCT01092780|20663644|P1|COMPLETED|Washout Period 2||13
8383094|NCT01092780|20663641|P4|STARTED|Washout Period 2||13
8383095|NCT01092780|20663642|P3|STARTED|Washout Period 2||14
8383096|NCT01092780|20663643|P2|STARTED|Washout Period 2||14
8383097|NCT01092780|20663644|P1|STARTED|Washout Period 2||13
8383098|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 2||0
8383099|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 2||0
8383100|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 2||0
8383101|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 2||0
8383102|NCT01092780|20663641|P4|COMPLETED|Treatment Period 2||13
8383103|NCT01092780|20663642|P3|COMPLETED|Treatment Period 2||14
8383104|NCT01092780|20663643|P2|COMPLETED|Treatment Period 2||14
8383105|NCT01092780|20663644|P1|COMPLETED|Treatment Period 2||13
8383106|NCT01092780|20663641|P4|STARTED|Treatment Period 2||13
8383107|NCT01092780|20663642|P3|STARTED|Treatment Period 2||14
8383108|NCT01092780|20663643|P2|STARTED|Treatment Period 2||14
8383109|NCT01092780|20663644|P1|STARTED|Treatment Period 2||13
8383110|NCT01092780|20663641|P4|NOT COMPLETED|Washout Period 1||0
8383111|NCT01092780|20663642|P3|NOT COMPLETED|Washout Period 1||0
8383112|NCT01092780|20663643|P2|NOT COMPLETED|Washout Period 1||1
8383113|NCT01092780|20663644|P1|NOT COMPLETED|Washout Period 1||1
8383114|NCT01092780|20663641|P4|COMPLETED|Washout Period 1||13
8383115|NCT01092780|20663642|P3|COMPLETED|Washout Period 1||14
8383116|NCT01092780|20663643|P2|COMPLETED|Washout Period 1||14
8383117|NCT01092780|20663644|P1|COMPLETED|Washout Period 1||13
8383118|NCT01092780|20663641|P4|STARTED|Washout Period 1||13
8383119|NCT01092780|20663642|P3|STARTED|Washout Period 1||14
8383120|NCT01092780|20663643|P2|STARTED|Washout Period 1||15
8383121|NCT01092780|20663644|P1|STARTED|Washout Period 1||14
8383122|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 1||0
8383123|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 1||0
8383124|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 1||0
8383125|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 1||0
8383126|NCT01092780|20663641|P4|COMPLETED|Treatment Period 1||13
8383127|NCT01092780|20663642|P3|COMPLETED|Treatment Period 1||14
8383128|NCT01092780|20663643|P2|COMPLETED|Treatment Period 1||15
8383129|NCT01092780|20663644|P1|COMPLETED|Treatment Period 1||14
8383130|NCT01092780|20663641|P4|STARTED|Treatment Period 1||13
8383131|NCT01092780|20663642|P3|STARTED|Treatment Period 1||14
8383132|NCT01092780|20663643|P2|STARTED|Treatment Period 1||15
8383133|NCT01092780|20663644|P1|STARTED|Treatment Period 1||14
8383134|NCT01092767|20663674|P1|NOT COMPLETED|Overall Study||5
8383135|NCT01092767|20663674|P1|COMPLETED|Overall Study||45
8383136|NCT01092767|20663674|P1|STARTED|Overall Study||50
8383137|NCT01092728|20663680|P2|NOT COMPLETED|Overall Study||14
8383138|NCT01092728|20663681|P1|NOT COMPLETED|Overall Study||4
8383139|NCT01092728|20663680|P2|COMPLETED|Overall Study||0
8383140|NCT01092728|20663681|P1|COMPLETED|Overall Study||0
8383141|NCT01092728|20663680|P2|STARTED|Overall Study||14
8383142|NCT01092728|20663681|P1|STARTED|Overall Study||4
8383143|NCT01092702|20663689|P1|NOT COMPLETED|Overall Study||9
8383144|NCT01092702|20663689|P1|COMPLETED|Overall Study||23
8383145|NCT01092702|20663689|P1|STARTED|Overall Study||32
8383146|NCT01092676|20663695|P2|NOT COMPLETED|Overall Study||0
8383147|NCT01092676|20663696|P1|NOT COMPLETED|Overall Study||0
8383148|NCT01092676|20663695|P2|COMPLETED|Overall Study||49
8383149|NCT01092676|20663696|P1|COMPLETED|Overall Study||50
8383150|NCT01092676|20663695|P2|STARTED|Overall Study||49
8383151|NCT01092676|20663696|P1|STARTED|Overall Study||50
8383152|NCT01092663|20663706|P2|NOT COMPLETED|Overall Study||4
8383153|NCT01092663|20663707|P1|NOT COMPLETED|Overall Study||7
8383154|NCT01092663|20663706|P2|COMPLETED|Overall Study||26
8383155|NCT01092663|20663707|P1|COMPLETED|Overall Study||24
8383156|NCT01092663|20663706|P2|STARTED|Overall Study||30
8383157|NCT01092663|20663707|P1|STARTED|Overall Study||31
8383158|NCT01092637|20663755|P2|NOT COMPLETED|Overall Study||49
8383159|NCT01092637|20663756|P1|NOT COMPLETED|Overall Study||47
8383160|NCT01092637|20663755|P2|COMPLETED|Overall Study||86
8383161|NCT01092637|20663756|P1|COMPLETED|Overall Study||98
8383162|NCT01092637|20663755|P2|STARTED|Overall Study||135
8383163|NCT01092637|20663756|P1|STARTED|Overall Study||145
8383164|NCT01092559|20663766|P1|NOT COMPLETED|Overall Study||0
8383165|NCT01092559|20663766|P1|COMPLETED|Overall Study||10
8383166|NCT01092559|20663766|P1|STARTED|Overall Study||10
8383167|NCT01092546|20663771|P1|NOT COMPLETED|Overall Study||4
8383168|NCT01092546|20663771|P1|COMPLETED|Overall Study||12
8383169|NCT01092546|20663771|P1|STARTED|Overall Study||16
8383170|NCT01092507|20663778|P2|NOT COMPLETED|Overall Study||0
8383171|NCT01092507|20663779|P1|NOT COMPLETED|Overall Study||2
8383172|NCT01092507|20663778|P2|COMPLETED|Overall Study||150
8383173|NCT01092507|20663779|P1|COMPLETED|Overall Study||147
8383174|NCT01092507|20663778|P2|STARTED|Overall Study||150
8383175|NCT01092507|20663779|P1|STARTED|Overall Study||149
8383176|NCT01092442|20663799|P2|NOT COMPLETED|Overall Study||0
8383177|NCT01092442|20663800|P1|NOT COMPLETED|Overall Study||0
8383178|NCT01092442|20663799|P2|COMPLETED|Overall Study||60
8383179|NCT01092442|20663800|P1|COMPLETED|Overall Study||80
8383180|NCT01092442|20663799|P2|STARTED|Overall Study||60
8383181|NCT01092442|20663800|P1|STARTED|Overall Study||80
8383182|NCT01092416|20663814|P1|NOT COMPLETED|12-Month Follow-up||25
8383183|NCT01092416|20663814|P1|COMPLETED|12-Month Follow-up||413
8383184|NCT01092416|20663814|P1|STARTED|12-Month Follow-up||438
8383185|NCT01092416|20663814|P1|NOT COMPLETED|30-Day Follow-up||10
8383186|NCT01092416|20663814|P1|COMPLETED|30-Day Follow-up||430
8383187|NCT01092416|20663814|P1|STARTED|30-Day Follow-up||440
8383188|NCT01092416|20663814|P1|NOT COMPLETED|Enrollment||3
8383189|NCT01092416|20663814|P1|COMPLETED|Enrollment||440
8383190|NCT01092416|20663814|P1|STARTED|Enrollment||443
8383191|NCT01092364|20663826|P3|NOT COMPLETED|Overall Study||18
8383192|NCT01092364|20663827|P2|NOT COMPLETED|Overall Study||16
8383193|NCT01092364|20663828|P1|NOT COMPLETED|Overall Study||18
8383194|NCT01092364|20663826|P3|COMPLETED|Overall Study||105
8383195|NCT01092364|20663827|P2|COMPLETED|Overall Study||104
8383196|NCT01092364|20663828|P1|COMPLETED|Overall Study||104
8383197|NCT01092364|20663826|P3|STARTED|Overall Study||123
8383198|NCT01092364|20663827|P2|STARTED|Overall Study||120
8383199|NCT01092364|20663828|P1|STARTED|Overall Study||122
8383200|NCT01092338|20663838|P2|NOT COMPLETED|Overall Study||1
8383201|NCT01092338|20663839|P1|NOT COMPLETED|Overall Study||1
8383202|NCT01092338|20663838|P2|COMPLETED|Overall Study||21
8383203|NCT01092338|20663839|P1|COMPLETED|Overall Study||21
8383204|NCT01092338|20663838|P2|STARTED|Overall Study||22
8383205|NCT01092338|20663839|P1|STARTED|Overall Study||22
8383206|NCT01092195|20663850|P3|NOT COMPLETED|Overall Study||0
8383207|NCT01092195|20663851|P2|NOT COMPLETED|Overall Study||0
8383208|NCT01092195|20663852|P1|NOT COMPLETED|Overall Study||0
8383209|NCT01092195|20663850|P3|COMPLETED|Overall Study||20
8383210|NCT01092195|20663851|P2|COMPLETED|Overall Study||21
8383211|NCT01092195|20663852|P1|COMPLETED|Overall Study||23
8383212|NCT01092195|20663850|P3|STARTED|Overall Study||20
8383213|NCT01092195|20663851|P2|STARTED|Overall Study||21
8383214|NCT01092195|20663852|P1|STARTED|Overall Study||23
8383215|NCT01091974|20663864|P4|NOT COMPLETED|Overall Study||7
8383216|NCT01091974|20663865|P3|NOT COMPLETED|Overall Study||6
8383217|NCT01091974|20663866|P2|NOT COMPLETED|Overall Study||5
8383218|NCT01091974|20663867|P1|NOT COMPLETED|Overall Study||5
8383219|NCT01091974|20663864|P4|COMPLETED|Overall Study||17
8383220|NCT01091974|20663865|P3|COMPLETED|Overall Study||19
8383221|NCT01091974|20663866|P2|COMPLETED|Overall Study||18
8383222|NCT01091974|20663867|P1|COMPLETED|Overall Study||19
8383223|NCT01091974|20663864|P4|STARTED|Overall Study||24
8383224|NCT01091974|20663865|P3|STARTED|Overall Study||25
8383225|NCT01091974|20663866|P2|STARTED|Overall Study||23
8383226|NCT01091974|20663867|P1|STARTED|Overall Study||24
8383227|NCT01091948|20663883|P2|NOT COMPLETED|Overall Study||0
8383228|NCT01091948|20663884|P1|NOT COMPLETED|Overall Study||0
8383229|NCT01091948|20663883|P2|COMPLETED|Overall Study||38
8383230|NCT01091948|20663884|P1|COMPLETED|Overall Study||37
8383231|NCT01091948|20663883|P2|STARTED|Overall Study||38
8383232|NCT01091948|20663884|P1|STARTED|Overall Study||37
8383233|NCT01091675|20663902|P1|NOT COMPLETED|Overall Study||34
8383234|NCT01091675|20663902|P1|COMPLETED|Overall Study||23
8383235|NCT01091675|20663902|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
8383236|NCT01091662|20663908|P2|NOT COMPLETED|Overall Study||34
8383237|NCT01091662|20663909|P1|NOT COMPLETED|Overall Study||17
8383238|NCT01091662|20663908|P2|COMPLETED|Overall Study||80
8383239|NCT01091662|20663909|P1|COMPLETED|Overall Study||41
8383240|NCT01091662|20663908|P2|STARTED|Overall Study||114
8383241|NCT01091662|20663909|P1|STARTED|Overall Study||58
8383242|NCT01091519|20663947|P2|NOT COMPLETED|Overall Study||73
8383243|NCT01091519|20663948|P1|NOT COMPLETED|Overall Study||55
8383244|NCT01091519|20663947|P2|COMPLETED|Overall Study||362
8383245|NCT01091519|20663948|P1|COMPLETED|Overall Study||291
8383246|NCT01091519|20663947|P2|Treated|Overall Study||431
8383247|NCT01091519|20663948|P1|Treated|Overall Study||342
8383248|NCT01091519|20663947|P2|STARTED|Overall Study||435
8383249|NCT01091519|20663948|P1|STARTED|Overall Study||346
8383250|NCT01091454|20663960|P1|NOT COMPLETED|Overall Study||1
8383251|NCT01091454|20663960|P1|COMPLETED|Overall Study||47
8383252|NCT01091454|20663960|P1|STARTED|Overall Study||48
8383253|NCT01091428|20663973|P4|NOT COMPLETED|Phase 2||69
8383254|NCT01091428|20663974|P3|NOT COMPLETED|Phase 2||73
8383255|NCT01091428|20663975|P2|NOT COMPLETED|Phase 2||0
8383256|NCT01091428|20663976|P1|NOT COMPLETED|Phase 2||0
8383257|NCT01091428|20663973|P4|COMPLETED|Phase 2||0
8383258|NCT01091428|20663974|P3|COMPLETED|Phase 2||0
8383259|NCT01091428|20663975|P2|COMPLETED|Phase 2||0
8383260|NCT01091428|20663976|P1|COMPLETED|Phase 2||0
8383261|NCT01091428|20663973|P4|STARTED|Phase 2||69
8383262|NCT01091428|20663974|P3|STARTED|Phase 2||73
8383263|NCT01091428|20663975|P2|STARTED|Phase 2||0
8383264|NCT01091428|20663976|P1|STARTED|Phase 2||0
8383265|NCT01091428|20663973|P4|NOT COMPLETED|Phase 1||0
8383266|NCT01091428|20663974|P3|NOT COMPLETED|Phase 1||0
8383267|NCT01091428|20663975|P2|NOT COMPLETED|Phase 1||11
8383268|NCT01091428|20663976|P1|NOT COMPLETED|Phase 1||38
8383269|NCT01091428|20663973|P4|COMPLETED|Phase 1||0
8383270|NCT01091428|20663974|P3|COMPLETED|Phase 1||0
8383271|NCT01091428|20663975|P2|COMPLETED|Phase 1||0
8383272|NCT01091428|20663976|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
8383273|NCT01091428|20663973|P4|STARTED|Phase 1||0
8383274|NCT01091428|20663974|P3|STARTED|Phase 1||0
8383275|NCT01091428|20663975|P2|STARTED|Phase 1||11
8383276|NCT01091428|20663976|P1|STARTED|Phase 1||38
8383277|NCT01091363|20664079|P2|NOT COMPLETED|Overall Study||17
8383278|NCT01091363|20664080|P1|NOT COMPLETED|Overall Study||13
8383279|NCT01091363|20664079|P2|COMPLETED|Overall Study||37
8383280|NCT01091363|20664080|P1|COMPLETED|Overall Study||42
8383281|NCT01091363|20664079|P2|STARTED|Overall Study||54
8383282|NCT01091363|20664080|P1|STARTED|Overall Study||55
8383283|NCT01091259|20664090|P1|NOT COMPLETED|Overall Study||5
8383284|NCT01091259|20664090|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
8383285|NCT01091259|20664090|P1|STARTED|Overall Study||29
8383286|NCT01091246|20664101|P3|NOT COMPLETED|Overall Study||13
8383287|NCT01091246|20664102|P2|NOT COMPLETED|Overall Study||16
8383288|NCT01091246|20664103|P1|NOT COMPLETED|Overall Study||35
8383289|NCT01091246|20664101|P3|COMPLETED|Overall Study||450
8383290|NCT01091246|20664102|P2|COMPLETED|Overall Study||448
8383291|NCT01091246|20664103|P1|COMPLETED|Overall Study||1350
8383292|NCT01091246|20664101|P3|STARTED|Overall Study||463
8383293|NCT01091246|20664102|P2|STARTED|Overall Study||464
8383294|NCT01091246|20664103|P1|STARTED|Overall Study||1385
8383295|NCT01091168|20664179|P2|NOT COMPLETED|Overall Study||296
8383296|NCT01091168|20664180|P1|NOT COMPLETED|Overall Study||298
8383297|NCT01091168|20664179|P2|COMPLETED|Overall Study||0
8383298|NCT01091168|20664180|P1|COMPLETED|Overall Study||0
8383299|NCT01091168|20664179|P2|STARTED|Overall Study||296
8383300|NCT01091168|20664180|P1|STARTED|Overall Study||298
8383301|NCT01091155|20664190|P1|NOT COMPLETED|Overall Study||9
8383302|NCT01091155|20664190|P1|COMPLETED|Overall Study||279
8383303|NCT01091155|20664190|P1|STARTED|Overall Study||288
8383304|NCT01091116|20664199|P5|NOT COMPLETED|Overall Study||11
8383305|NCT01091116|20664200|P4|NOT COMPLETED|Overall Study||4
8383306|NCT01091116|20664201|P3|NOT COMPLETED|Overall Study||11
8383307|NCT01091116|20664202|P2|NOT COMPLETED|Overall Study||8
8383308|NCT01091116|20664203|P1|NOT COMPLETED|Overall Study||6
8383309|NCT01091116|20664199|P5|COMPLETED|Overall Study||73
8383310|NCT01091116|20664200|P4|COMPLETED|Overall Study||80
8383311|NCT01091116|20664201|P3|COMPLETED|Overall Study||73
8383312|NCT01091116|20664202|P2|COMPLETED|Overall Study||80
8383313|NCT01091116|20664203|P1|COMPLETED|Overall Study||77
8383314|NCT01091116|20664199|P5|STARTED|Overall Study||84
8383315|NCT01091116|20664200|P4|STARTED|Overall Study||84
8383316|NCT01091116|20664201|P3|STARTED|Overall Study||84
8383317|NCT01091116|20664202|P2|STARTED|Overall Study||88
8383318|NCT01091116|20664203|P1|STARTED|Overall Study||83
8383319|NCT01091103|20664255|P1|NOT COMPLETED|Overall Study||4
8383320|NCT01091103|20664255|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
8383321|NCT01091103|20664255|P1|STARTED|Overall Study||60
8383322|NCT01090973|20664275|P1|NOT COMPLETED|Overall Study||1
8383323|NCT01090973|20664275|P1|COMPLETED|Overall Study||0
8383324|NCT01090973|20664275|P1|STARTED|Overall Study||1
8383325|NCT01090921|20664285|P1|NOT COMPLETED|Overall Study||27
8383326|NCT01090921|20664285|P1|COMPLETED|Overall Study||23
8383327|NCT01090921|20664285|P1|STARTED|Overall Study||50
8383328|NCT01090765|20664296|P6|NOT COMPLETED|Overall Study||1
8383329|NCT01090765|20664297|P5|NOT COMPLETED|Overall Study||2
8383330|NCT01090765|20664298|P4|NOT COMPLETED|Overall Study||1
8383331|NCT01090765|20664299|P3|NOT COMPLETED|Overall Study||0
8383332|NCT01090765|20664300|P2|NOT COMPLETED|Overall Study||0
8383333|NCT01090765|20664301|P1|NOT COMPLETED|Overall Study||0
8383334|NCT01090765|20664296|P6|COMPLETED|Overall Study||3
8383335|NCT01090765|20664297|P5|COMPLETED|Overall Study||4
8383336|NCT01090765|20664298|P4|COMPLETED|Overall Study||1
8383337|NCT01090765|20664299|P3|COMPLETED|Overall Study||3
8383338|NCT01090765|20664300|P2|COMPLETED|Overall Study||3
8383339|NCT01090765|20664301|P1|COMPLETED|Overall Study||3
8383340|NCT01090765|20664296|P6|STARTED|Overall Study||4
8383341|NCT01090765|20664297|P5|STARTED|Overall Study||6
8383342|NCT01090765|20664298|P4|STARTED|Overall Study||2
8383343|NCT01090765|20664299|P3|STARTED|Overall Study||3
8383344|NCT01090765|20664300|P2|STARTED|Overall Study||3
8383345|NCT01090765|20664301|P1|STARTED|Overall Study||3
8383346|NCT01090752|20664336|P2|NOT COMPLETED|Overall Study||0
8383347|NCT01090752|20664337|P1|NOT COMPLETED|Overall Study||0
8383348|NCT01090752|20664336|P2|COMPLETED|Overall Study||8
8383349|NCT01090752|20664337|P1|COMPLETED|Overall Study||8
8383350|NCT01090752|20664336|P2|STARTED|Overall Study||8
8383351|NCT01090752|20664337|P1|STARTED|Overall Study||8
8383352|NCT01090739|20664347|P1|NOT COMPLETED|36 Month Follow-up||23
8383353|NCT01090739|20664347|P1|COMPLETED|36 Month Follow-up||115
8383354|NCT01090739|20664347|P1|STARTED|36 Month Follow-up||138
8383355|NCT01090739|20664347|P1|NOT COMPLETED|24 Month Follow-up||9
8383356|NCT01090739|20664347|P1|COMPLETED|24 Month Follow-up||138
8383357|NCT01090739|20664347|P1|STARTED|24 Month Follow-up||147
8383358|NCT01090739|20664347|P1|NOT COMPLETED|12 Month Follow-up||5
8383359|NCT01090739|20664347|P1|COMPLETED|12 Month Follow-up||147
8383360|NCT01090739|20664347|P1|STARTED|12 Month Follow-up||152
8383361|NCT01090739|20664347|P1|NOT COMPLETED|Enrollment||55
8383362|NCT01090739|20664347|P1|COMPLETED|Enrollment||152
8383363|NCT01090739|20664347|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
8383364|NCT01090492|20664372|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383365|NCT01090492|20664373|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
8383366|NCT01090492|20664374|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8383367|NCT01090492|20664375|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383368|NCT01090492|20664376|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
8383369|NCT01090492|20664377|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383370|NCT01090492|20664378|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383371|NCT01090492|20664379|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8383372|NCT01090492|20664372|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
8383373|NCT01090492|20664373|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
8383374|NCT01090492|20664374|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
8383375|NCT01090492|20664375|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
8383376|NCT01090492|20664376|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
8383377|NCT01090492|20664377|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
8383378|NCT01090492|20664378|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
8383379|NCT01090492|20664379|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
8383380|NCT01090492|20664372|P8|STARTED|Second Intervention Period (4 Weeks)||27
8383381|NCT01090492|20664373|P7|STARTED|Second Intervention Period (4 Weeks)||31
8383382|NCT01090492|20664374|P6|STARTED|Second Intervention Period (4 Weeks)||30
8383383|NCT01090492|20664375|P5|STARTED|Second Intervention Period (4 Weeks)||29
8383384|NCT01090492|20664376|P4|STARTED|Second Intervention Period (4 Weeks)||22
8383385|NCT01090492|20664377|P3|STARTED|Second Intervention Period (4 Weeks)||26
8383386|NCT01090492|20664378|P2|STARTED|Second Intervention Period (4 Weeks)||24
8383387|NCT01090492|20664379|P1|STARTED|Second Intervention Period (4 Weeks)||26
8383388|NCT01090492|20664372|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383389|NCT01090492|20664373|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383390|NCT01090492|20664374|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383391|NCT01090492|20664375|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383392|NCT01090492|20664376|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383393|NCT01090492|20664377|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383394|NCT01090492|20664378|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383395|NCT01090492|20664379|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383396|NCT01090492|20664372|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
8383397|NCT01090492|20664373|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
8383398|NCT01090492|20664374|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
8383399|NCT01090492|20664375|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
8383400|NCT01090492|20664376|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
8383401|NCT01090492|20664377|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
8383402|NCT01090492|20664378|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
8383403|NCT01090492|20664379|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
8383404|NCT01090492|20664372|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
8383405|NCT01090492|20664373|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
8383406|NCT01090492|20664374|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
8383407|NCT01090492|20664375|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
8383408|NCT01090492|20664376|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
8383409|NCT01090492|20664377|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
8383410|NCT01090492|20664378|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
8383411|NCT01090492|20664379|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
8383412|NCT01090492|20664372|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
8383413|NCT01090492|20664373|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
8383414|NCT01090492|20664374|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
8383415|NCT01090492|20664375|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
8383416|NCT01090492|20664376|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
8383417|NCT01090492|20664377|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
8383418|NCT01090492|20664378|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
8383419|NCT01090492|20664379|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
8383420|NCT01090492|20664372|P8|COMPLETED|First Intervention Period (4 Weeks)||27
8383421|NCT01090492|20664373|P7|COMPLETED|First Intervention Period (4 Weeks)||31
8383422|NCT01090492|20664374|P6|COMPLETED|First Intervention Period (4 Weeks)||30
8383423|NCT01090492|20664375|P5|COMPLETED|First Intervention Period (4 Weeks)||29
8383424|NCT01090492|20664376|P4|COMPLETED|First Intervention Period (4 Weeks)||22
8383425|NCT01090492|20664377|P3|COMPLETED|First Intervention Period (4 Weeks)||26
8383426|NCT01090492|20664378|P2|COMPLETED|First Intervention Period (4 Weeks)||24
8383427|NCT01090492|20664379|P1|COMPLETED|First Intervention Period (4 Weeks)||26
8383428|NCT01090492|20664372|P8|STARTED|First Intervention Period (4 Weeks)||33
8383429|NCT01090492|20664373|P7|STARTED|First Intervention Period (4 Weeks)||32
8383430|NCT01090492|20664374|P6|STARTED|First Intervention Period (4 Weeks)||32
8383431|NCT01090492|20664375|P5|STARTED|First Intervention Period (4 Weeks)||33
8383432|NCT01090492|20664376|P4|STARTED|First Intervention Period (4 Weeks)||28
8383433|NCT01090492|20664377|P3|STARTED|First Intervention Period (4 Weeks)||29
8383434|NCT01090492|20664378|P2|STARTED|First Intervention Period (4 Weeks)||29
8383435|NCT01090492|20664379|P1|STARTED|First Intervention Period (4 Weeks)||27
8383436|NCT01090479|20664438|P2|NOT COMPLETED|Overall Study||0
8383437|NCT01090479|20664439|P1|NOT COMPLETED|Overall Study||0
8383438|NCT01090479|20664438|P2|COMPLETED|Overall Study||50
8383439|NCT01090479|20664439|P1|COMPLETED|Overall Study||50
8383440|NCT01090479|20664438|P2|STARTED|Overall Study||50
8383441|NCT01090479|20664439|P1|STARTED|Overall Study||50
8383442|NCT01090453|20664447|P2|NOT COMPLETED|Overall Study||14
8383443|NCT01090453|20664448|P1|NOT COMPLETED|Overall Study||13
8383444|NCT01090453|20664447|P2|COMPLETED|Overall Study||228
8383445|NCT01090453|20664448|P1|COMPLETED|Overall Study||225
8383446|NCT01090453|20664447|P2|STARTED|Overall Study||242
8383447|NCT01090453|20664448|P1|STARTED|Overall Study||238
8383448|NCT01090427|20664499|P7|NOT COMPLETED|After Controlled Period||2
8383449|NCT01090427|20664500|P6|NOT COMPLETED|After Controlled Period||5
8383450|NCT01090427|20664501|P5|NOT COMPLETED|After Controlled Period||0
8383451|NCT01090427|20664502|P4|NOT COMPLETED|After Controlled Period||2
8383452|NCT01090427|20664503|P3|NOT COMPLETED|After Controlled Period||0
8383453|NCT01090427|20664504|P2|NOT COMPLETED|After Controlled Period||0
8383454|NCT01090427|20664505|P1|NOT COMPLETED|After Controlled Period||0
8383455|NCT01090427|20664499|P7|COMPLETED|After Controlled Period||34
8383456|NCT01090427|20664500|P6|COMPLETED|After Controlled Period||32
8383457|NCT01090427|20664501|P5|COMPLETED|After Controlled Period||18
8383458|NCT01090427|20664502|P4|COMPLETED|After Controlled Period||17
8383459|NCT01090427|20664503|P3|COMPLETED|After Controlled Period||0
8383460|NCT01090427|20664504|P2|COMPLETED|After Controlled Period||0
8383461|NCT01090427|20664505|P1|COMPLETED|After Controlled Period||0
8383462|NCT01090427|20664499|P7|STARTED|After Controlled Period||36
8383463|NCT01090427|20664500|P6|STARTED|After Controlled Period||37
8383464|NCT01090427|20664501|P5|STARTED|After Controlled Period||18
8383465|NCT01090427|20664502|P4|STARTED|After Controlled Period||19
8383466|NCT01090427|20664503|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8383467|NCT01090427|20664504|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8383468|NCT01090427|20664505|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8383469|NCT01090427|20664499|P7|NOT COMPLETED|Controlled Period||0
8383470|NCT01090427|20664500|P6|NOT COMPLETED|Controlled Period||0
8383471|NCT01090427|20664501|P5|NOT COMPLETED|Controlled Period||0
8383472|NCT01090427|20664502|P4|NOT COMPLETED|Controlled Period||0
8383473|NCT01090427|20664503|P3|NOT COMPLETED|Controlled Period||0
8383474|NCT01090427|20664504|P2|NOT COMPLETED|Controlled Period||0
8383475|NCT01090427|20664505|P1|NOT COMPLETED|Controlled Period||0
8383476|NCT01090427|20664499|P7|COMPLETED|Controlled Period||0
8383477|NCT01090427|20664500|P6|COMPLETED|Controlled Period||0
8383478|NCT01090427|20664501|P5|COMPLETED|Controlled Period||0
8383479|NCT01090427|20664502|P4|COMPLETED|Controlled Period||0
8383480|NCT01090427|20664503|P3|COMPLETED|Controlled Period||36
8383481|NCT01090427|20664504|P2|COMPLETED|Controlled Period||37
8383482|NCT01090427|20664505|P1|COMPLETED|Controlled Period||37
8383483|NCT01090427|20664499|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383484|NCT01090427|20664500|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383485|NCT01090427|20664501|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383486|NCT01090427|20664502|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383487|NCT01090427|20664503|P3|STARTED|Controlled Period||36
8383488|NCT01090427|20664504|P2|STARTED|Controlled Period||37
8383489|NCT01090427|20664505|P1|STARTED|Controlled Period||37
8383490|NCT01090414|20664542|P4|NOT COMPLETED|Study 101-99||5
8383491|NCT01090414|20664543|P3|NOT COMPLETED|Study 101-99||41
8383492|NCT01090414|20664544|P2|NOT COMPLETED|Study 101-99||108
8383493|NCT01090414|20664545|P1|NOT COMPLETED|Study 101-99||48
8383494|NCT01090414|20664542|P4|COMPLETED|Study 101-99||0
8383495|NCT01090414|20664543|P3|COMPLETED|Study 101-99||0
8383496|NCT01090414|20664544|P2|COMPLETED|Study 101-99||0
8383497|NCT01090414|20664545|P1|COMPLETED|Study 101-99||0
8383498|NCT01090414|20664542|P4|STARTED|Study 101-99||5
8383499|NCT01090414|20664543|P3|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
8383500|NCT01090414|20664544|P2|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
8383501|NCT01090414|20664545|P1|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
8383502|NCT01090414|20664542|P4|NOT COMPLETED|Parent Studies||13
8383503|NCT01090414|20664543|P3|NOT COMPLETED|Parent Studies||21
8383504|NCT01090414|20664544|P2|NOT COMPLETED|Parent Studies||127
8383505|NCT01090414|20664545|P1|NOT COMPLETED|Parent Studies||141
8383506|NCT01090414|20664542|P4|COMPLETED|Parent Studies||5
8383507|NCT01090414|20664543|P3|COMPLETED|Parent Studies||43
8383508|NCT01090414|20664544|P2|COMPLETED|Parent Studies||114
8383509|NCT01090414|20664545|P1|COMPLETED|Parent Studies||50
8383510|NCT01090414|20664542|P4|STARTED|Parent Studies||18
8383511|NCT01090414|20664543|P3|STARTED|Parent Studies||64
8383512|NCT01090414|20664544|P2|STARTED|Parent Studies||241
8383513|NCT01090414|20664545|P1|STARTED|Parent Studies||191
8383514|NCT01090323|20664612|P2|NOT COMPLETED|Overall Study||34
8383515|NCT01090323|20664613|P1|NOT COMPLETED|Overall Study||89
8383516|NCT01090323|20664612|P2|COMPLETED|Overall Study||19
8383517|NCT01090323|20664613|P1|COMPLETED|Overall Study||43
8383518|NCT01090323|20664612|P2|STARTED|Overall Study||53
8383519|NCT01090323|20664613|P1|STARTED|Overall Study||132
8383520|NCT01090310|20664625|P4|NOT COMPLETED|Extension Study||20
8383521|NCT01090310|20664626|P3|NOT COMPLETED|Extension Study||15
8383522|NCT01090310|20664627|P2|NOT COMPLETED|Extension Study||16
8383523|NCT01090310|20664628|P1|NOT COMPLETED|Extension Study||14
8383524|NCT01090310|20664625|P4|COMPLETED|Extension Study||1
8383525|NCT01090310|20664626|P3|COMPLETED|Extension Study||1
8383526|NCT01090310|20664627|P2|COMPLETED|Extension Study||0
8383527|NCT01090310|20664628|P1|COMPLETED|Extension Study||3
8383528|NCT01090310|20664625|P4|STARTED|Extension Study||21
8383529|NCT01090310|20664626|P3|STARTED|Extension Study||16
8383530|NCT01090310|20664627|P2|STARTED|Extension Study||16
8383531|NCT01090310|20664628|P1|STARTED|Extension Study||17
8383532|NCT01090310|20664625|P4|NOT COMPLETED|Core Study||7
8383533|NCT01090310|20664626|P3|NOT COMPLETED|Core Study||7
8383534|NCT01090310|20664627|P2|NOT COMPLETED|Core Study||11
8383535|NCT01090310|20664628|P1|NOT COMPLETED|Core Study||8
8383536|NCT01090310|20664625|P4|COMPLETED|Core Study||27
8383537|NCT01090310|20664626|P3|COMPLETED|Core Study||24
8383538|NCT01090310|20664627|P2|COMPLETED|Core Study||20
8383539|NCT01090310|20664628|P1|COMPLETED|Core Study||21
8383540|NCT01090310|20664625|P4|STARTED|Core Study||34
8383541|NCT01090310|20664626|P3|STARTED|Core Study||31
8383542|NCT01090310|20664627|P2|STARTED|Core Study||31
8383543|NCT01090310|20664628|P1|STARTED|Core Study||29
8383544|NCT01090180|20664656|P2|NOT COMPLETED|Overall Study||8
8383545|NCT01090180|20664657|P1|NOT COMPLETED|Overall Study||11
8383546|NCT01090180|20664656|P2|COMPLETED|Overall Study||21
8383547|NCT01090180|20664657|P1|COMPLETED|Overall Study||22
8383548|NCT01090180|20664656|P2|STARTED|Overall Study||29
8383549|NCT01090180|20664657|P1|STARTED|Overall Study||33
8383550|NCT01090141|20664667|P2|NOT COMPLETED|Overall Study||0
8383551|NCT01090141|20664668|P1|NOT COMPLETED|Overall Study||0
8383552|NCT01090141|20664667|P2|COMPLETED|Overall Study||0
8383553|NCT01090141|20664668|P1|COMPLETED|Overall Study||0
8383554|NCT01090141|20664667|P2|STARTED|Overall Study||0
8383555|NCT01090141|20664668|P1|STARTED|Overall Study||0
8383556|NCT01090102|20664676|P2|NOT COMPLETED|Second 12 Weeks||1
8383557|NCT01090102|20664677|P1|NOT COMPLETED|Second 12 Weeks||0
8383558|NCT01090102|20664676|P2|COMPLETED|Second 12 Weeks||15
8383559|NCT01090102|20664677|P1|COMPLETED|Second 12 Weeks||11
8383560|NCT01090102|20664676|P2|STARTED|Second 12 Weeks||16
8383561|NCT01090102|20664677|P1|STARTED|Second 12 Weeks||11
8383562|NCT01090102|20664676|P2|NOT COMPLETED|First 12 Weeks||2
8383563|NCT01090102|20664677|P1|NOT COMPLETED|First 12 Weeks||4
8383564|NCT01090102|20664676|P2|COMPLETED|First 12 Weeks||16
8383565|NCT01090102|20664677|P1|COMPLETED|First 12 Weeks||11
8383566|NCT01090102|20664676|P2|STARTED|First 12 Weeks||18
8383567|NCT01090102|20664677|P1|STARTED|First 12 Weeks||15
8383568|NCT01090076|20664687|P2|NOT COMPLETED|Overall Study||2
8383569|NCT01090076|20664688|P1|NOT COMPLETED|Overall Study||1
8383570|NCT01090076|20664687|P2|COMPLETED|Overall Study||12
8383571|NCT01090076|20664688|P1|COMPLETED|Overall Study||11
8383572|NCT01090076|20664687|P2|STARTED|Overall Study||14
8383573|NCT01090076|20664688|P1|STARTED|Overall Study||12
8383574|NCT01090063|20664698|P1|NOT COMPLETED|Treatment||4
8383575|NCT01090063|20664698|P1|COMPLETED|Treatment||20
8383576|NCT01090063|20664698|P1|STARTED|Treatment||24
8383577|NCT01090063|20664698|P1|NOT COMPLETED|Screen||4
8383578|NCT01090063|20664698|P1|COMPLETED|Screen||24
8383579|NCT01090063|20664698|P1|STARTED|Screen||28
8383580|NCT01090050|20664714|P2|NOT COMPLETED|Overall Study||7
8383581|NCT01090050|20664715|P1|NOT COMPLETED|Overall Study||1
8383582|NCT01090050|20664714|P2|COMPLETED|Overall Study||5
8383583|NCT01090050|20664715|P1|COMPLETED|Overall Study||15
8383584|NCT01090050|20664714|P2|STARTED|Overall Study||12
8383585|NCT01090050|20664715|P1|STARTED|Overall Study||16
8383586|NCT01090011|20664735|P1|NOT COMPLETED|Overall Study||171
8383587|NCT01090011|20664735|P1|COMPLETED|Overall Study||0
8383588|NCT01090011|20664735|P1|STARTED|Overall Study||171
8383589|NCT01089751|20664805|P2|NOT COMPLETED|Overall Study||27
8383590|NCT01089751|20664806|P1|NOT COMPLETED|Overall Study||34
8383591|NCT01089751|20664805|P2|COMPLETED|Overall Study||132
8383592|NCT01089751|20664806|P1|COMPLETED|Overall Study||129
8383593|NCT01089751|20664805|P2|STARTED|Overall Study||159
8383594|NCT01089751|20664806|P1|STARTED|Overall Study||163
8383595|NCT01089647|20664828|P2|NOT COMPLETED|Overall Study||4
8383596|NCT01089647|20664829|P1|NOT COMPLETED|Overall Study||4
8383597|NCT01089647|20664828|P2|COMPLETED|Overall Study||13
8383598|NCT01089647|20664829|P1|COMPLETED|Overall Study||13
8383599|NCT01089647|20664828|P2|STARTED|Overall Study||17
8383600|NCT01089647|20664829|P1|STARTED|Overall Study||17
8383601|NCT01089608|20664837|P2|NOT COMPLETED|Overall Study||6
8383602|NCT01089608|20664838|P1|NOT COMPLETED|Overall Study||0
8383603|NCT01089608|20664837|P2|COMPLETED|Overall Study||44
8383604|NCT01089608|20664838|P1|COMPLETED|Overall Study||43
8383605|NCT01089608|20664837|P2|STARTED|Overall Study||50
8383606|NCT01089608|20664838|P1|STARTED|Overall Study||43
8383607|NCT01089595|20664846|P2|NOT COMPLETED|Overall Study||0
8383608|NCT01089595|20664847|P1|NOT COMPLETED|Overall Study||0
8383609|NCT01089595|20664846|P2|COMPLETED|Overall Study||3
8383610|NCT01089595|20664847|P1|COMPLETED|Overall Study||2
8383611|NCT01089595|20664846|P2|STARTED|Overall Study||3
8383612|NCT01089595|20664847|P1|STARTED|Overall Study||2
8383613|NCT01089582|20664855|P1|NOT COMPLETED|Overall Study||30
8383614|NCT01089582|20664855|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
8383615|NCT01089582|20664855|P1|STARTED|Overall Study||603
8383616|NCT01089569|20664868|P3|NOT COMPLETED|Overall Study||4
8383617|NCT01089569|20664869|P2|NOT COMPLETED|Overall Study||3
8383618|NCT01089569|20664870|P1|NOT COMPLETED|Overall Study||4
8383619|NCT01089569|20664868|P3|COMPLETED|Overall Study||16
8383620|NCT01089569|20664869|P2|COMPLETED|Overall Study||17
8383621|NCT01089569|20664870|P1|COMPLETED|Overall Study||16
8383622|NCT01089569|20664868|P3|STARTED|Overall Study||20
8383623|NCT01089569|20664869|P2|STARTED|Overall Study||20
8383624|NCT01089569|20664870|P1|STARTED|Overall Study||20
8383625|NCT01089556|20664898|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
8383626|NCT01089556|20664899|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
8383627|NCT01089556|20664900|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
8383628|NCT01089556|20664901|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
8383629|NCT01089556|20664902|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
8383630|NCT01089556|20664903|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
8383631|NCT01089556|20664898|P6|COMPLETED|Study Period III (Weeks 9-16)||92
8383632|NCT01089556|20664899|P5|COMPLETED|Study Period III (Weeks 9-16)||83
8383633|NCT01089556|20664900|P4|COMPLETED|Study Period III (Weeks 9-16)||66
8383634|NCT01089556|20664901|P3|COMPLETED|Study Period III (Weeks 9-16)||60
8383635|NCT01089556|20664902|P2|COMPLETED|Study Period III (Weeks 9-16)||0
8383636|NCT01089556|20664903|P1|COMPLETED|Study Period III (Weeks 9-16)||0
8383637|NCT01089556|20664898|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
8383638|NCT01089556|20664899|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
8383639|NCT01089556|20664900|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
8383640|NCT01089556|20664901|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
8383641|NCT01089556|20664902|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
8383642|NCT01089556|20664903|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
8383643|NCT01089556|20664898|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
8383644|NCT01089556|20664899|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
8383645|NCT01089556|20664900|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
8383646|NCT01089556|20664901|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
8383647|NCT01089556|20664902|P2|STARTED|Study Period III (Weeks 9-16)||0
8383648|NCT01089556|20664903|P1|STARTED|Study Period III (Weeks 9-16)||0
8383649|NCT01089556|20664898|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383650|NCT01089556|20664899|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383651|NCT01089556|20664900|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383652|NCT01089556|20664901|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383653|NCT01089556|20664902|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
8383654|NCT01089556|20664903|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
8383655|NCT01089556|20664898|P6|COMPLETED|Study Period II (Weeks 1-8)||0
8383656|NCT01089556|20664899|P5|COMPLETED|Study Period II (Weeks 1-8)||0
8383657|NCT01089556|20664900|P4|COMPLETED|Study Period II (Weeks 1-8)||0
8383658|NCT01089556|20664901|P3|COMPLETED|Study Period II (Weeks 1-8)||0
8383659|NCT01089556|20664902|P2|COMPLETED|Study Period II (Weeks 1-8)||333
8383660|NCT01089556|20664903|P1|COMPLETED|Study Period II (Weeks 1-8)||333
8383661|NCT01089556|20664898|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383662|NCT01089556|20664899|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383663|NCT01089556|20664900|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383664|NCT01089556|20664901|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383665|NCT01089556|20664902|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
8383752|NCT01089062|20665129|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383666|NCT01089556|20664903|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
8383667|NCT01089556|20664898|P6|Safety Population|Study Period II (Weeks 1-8)||0
8383668|NCT01089556|20664899|P5|Safety Population|Study Period II (Weeks 1-8)||0
8383669|NCT01089556|20664900|P4|Safety Population|Study Period II (Weeks 1-8)||0
8383670|NCT01089556|20664901|P3|Safety Population|Study Period II (Weeks 1-8)||0
8383671|NCT01089556|20664902|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
8383672|NCT01089556|20664903|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
8383673|NCT01089556|20664898|P6|STARTED|Study Period II (Weeks 1-8)||0
8383674|NCT01089556|20664899|P5|STARTED|Study Period II (Weeks 1-8)||0
8383675|NCT01089556|20664900|P4|STARTED|Study Period II (Weeks 1-8)||0
8383676|NCT01089556|20664901|P3|STARTED|Study Period II (Weeks 1-8)||0
8383677|NCT01089556|20664902|P2|STARTED|Study Period II (Weeks 1-8)||407
8383678|NCT01089556|20664903|P1|STARTED|Study Period II (Weeks 1-8)||404
8383679|NCT01089543|20664977|P4|NOT COMPLETED|Overall Study||2
8383680|NCT01089543|20664978|P3|NOT COMPLETED|Overall Study||3
8383681|NCT01089543|20664979|P2|NOT COMPLETED|Overall Study||4
8383682|NCT01089543|20664980|P1|NOT COMPLETED|Overall Study||3
8383683|NCT01089543|20664977|P4|COMPLETED|Overall Study||83
8383684|NCT01089543|20664978|P3|COMPLETED|Overall Study||81
8383685|NCT01089543|20664979|P2|COMPLETED|Overall Study||81
8383686|NCT01089543|20664980|P1|COMPLETED|Overall Study||81
8383687|NCT01089543|20664977|P4|STARTED|Overall Study||85
8383688|NCT01089543|20664978|P3|STARTED|Overall Study||84
8383689|NCT01089543|20664979|P2|STARTED|Overall Study||85
8383690|NCT01089543|20664980|P1|STARTED|Overall Study||84
8383691|NCT01089517|20664997|P3|NOT COMPLETED|Overall Study||5
8383692|NCT01089517|20664998|P2|NOT COMPLETED|Overall Study||5
8383693|NCT01089517|20664999|P1|NOT COMPLETED|Overall Study||4
8383694|NCT01089517|20664997|P3|COMPLETED|Overall Study||147
8383695|NCT01089517|20664998|P2|COMPLETED|Overall Study||144
8383696|NCT01089517|20664999|P1|COMPLETED|Overall Study||144
8383697|NCT01089517|20664997|P3|STARTED|Overall Study||152
8383698|NCT01089517|20664998|P2|STARTED|Overall Study||149
8383699|NCT01089517|20664999|P1|STARTED|Overall Study||148
8383700|NCT01089504|20665015|P2|NOT COMPLETED|Overall Study||1
8383701|NCT01089504|20665016|P1|NOT COMPLETED|Overall Study||3
8383702|NCT01089504|20665015|P2|COMPLETED|Overall Study||4
8383703|NCT01089504|20665016|P1|COMPLETED|Overall Study||5
8383704|NCT01089504|20665015|P2|STARTED|Overall Study||5
8383705|NCT01089504|20665016|P1|STARTED|Overall Study||8
8383706|NCT01089413|20665029|P1|NOT COMPLETED|Overall Study||201
8383707|NCT01089413|20665029|P1|COMPLETED|Overall Study||0
8383708|NCT01089413|20665029|P1|Received Bevacizumab in First Line|Overall Study||199
8383709|NCT01089413|20665029|P1|STARTED|Overall Study||201
8383710|NCT01089361|20665048|P2|NOT COMPLETED|Overall Study||0
8383711|NCT01089361|20665049|P1|NOT COMPLETED|Overall Study||1
8383712|NCT01089361|20665048|P2|COMPLETED|Overall Study||10
8383713|NCT01089361|20665049|P1|COMPLETED|Overall Study||8
8383714|NCT01089361|20665048|P2|STARTED|Overall Study||10
8383715|NCT01089361|20665049|P1|STARTED|Overall Study||9
8383716|NCT01089231|20665071|P4|NOT COMPLETED|Overall Study||1
8383717|NCT01089231|20665072|P3|NOT COMPLETED|Overall Study||2
8383718|NCT01089231|20665073|P2|NOT COMPLETED|Overall Study||2
8383719|NCT01089231|20665074|P1|NOT COMPLETED|Overall Study||4
8383720|NCT01089231|20665071|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
8383721|NCT01089231|20665072|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
8383722|NCT01089231|20665073|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
8383723|NCT01089231|20665074|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
8383724|NCT01089231|20665071|P4|STARTED|Overall Study||10
8383725|NCT01089231|20665072|P3|STARTED|Overall Study||10
8383726|NCT01089231|20665073|P2|STARTED|Overall Study||10
8383727|NCT01089231|20665074|P1|STARTED|Overall Study||10
8383728|NCT01089127|20665098|P6|NOT COMPLETED|Overall Study||3
8383729|NCT01089127|20665099|P5|NOT COMPLETED|Overall Study||2
8383730|NCT01089127|20665100|P4|NOT COMPLETED|Overall Study||1
8383731|NCT01089127|20665101|P3|NOT COMPLETED|Overall Study||2
8383732|NCT01089127|20665102|P2|NOT COMPLETED|Overall Study||5
8383733|NCT01089127|20665103|P1|NOT COMPLETED|Overall Study||8
8383734|NCT01089127|20665098|P6|COMPLETED|Overall Study||88
8383735|NCT01089127|20665099|P5|COMPLETED|Overall Study||90
8383736|NCT01089127|20665100|P4|COMPLETED|Overall Study||91
8383737|NCT01089127|20665101|P3|COMPLETED|Overall Study||92
8383738|NCT01089127|20665102|P2|COMPLETED|Overall Study||86
8383739|NCT01089127|20665103|P1|COMPLETED|Overall Study||84
8383740|NCT01089127|20665098|P6|Exposed to Study Drug|Overall Study||91
8383741|NCT01089127|20665099|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
8383742|NCT01089127|20665100|P4|Exposed to Study Drug|Overall Study||92
8383743|NCT01089127|20665101|P3|Exposed to Study Drug|Overall Study||94
8383744|NCT01089127|20665102|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
8383745|NCT01089127|20665103|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
8383746|NCT01089127|20665098|P6|STARTED|Overall Study||91
8383747|NCT01089127|20665099|P5|STARTED|Overall Study||92
8383748|NCT01089127|20665100|P4|STARTED|Overall Study||92
8383749|NCT01089127|20665101|P3|STARTED|Overall Study||94
8383750|NCT01089127|20665102|P2|STARTED|Overall Study||91
8383751|NCT01089127|20665103|P1|STARTED|Overall Study||92
8383753|NCT01089062|20665130|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383754|NCT01089062|20665131|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383755|NCT01089062|20665132|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383756|NCT01089062|20665133|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383757|NCT01089062|20665134|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383758|NCT01089062|20665129|P6|COMPLETED|Follow-up Visit (Final Visit)||3
8383759|NCT01089062|20665130|P5|COMPLETED|Follow-up Visit (Final Visit)||3
8383760|NCT01089062|20665131|P4|COMPLETED|Follow-up Visit (Final Visit)||3
8383761|NCT01089062|20665132|P3|COMPLETED|Follow-up Visit (Final Visit)||3
8383762|NCT01089062|20665133|P2|COMPLETED|Follow-up Visit (Final Visit)||3
8383763|NCT01089062|20665134|P1|COMPLETED|Follow-up Visit (Final Visit)||3
8383764|NCT01089062|20665129|P6|STARTED|Follow-up Visit (Final Visit)||3
8383765|NCT01089062|20665130|P5|STARTED|Follow-up Visit (Final Visit)||3
8383766|NCT01089062|20665131|P4|STARTED|Follow-up Visit (Final Visit)||3
8383767|NCT01089062|20665132|P3|STARTED|Follow-up Visit (Final Visit)||3
8383768|NCT01089062|20665133|P2|STARTED|Follow-up Visit (Final Visit)||3
8383769|NCT01089062|20665134|P1|STARTED|Follow-up Visit (Final Visit)||3
8383770|NCT01089062|20665129|P6|NOT COMPLETED|Visit 4||0
8383771|NCT01089062|20665130|P5|NOT COMPLETED|Visit 4||0
8383772|NCT01089062|20665131|P4|NOT COMPLETED|Visit 4||0
8383773|NCT01089062|20665132|P3|NOT COMPLETED|Visit 4||0
8383774|NCT01089062|20665133|P2|NOT COMPLETED|Visit 4||0
8383775|NCT01089062|20665134|P1|NOT COMPLETED|Visit 4||0
8383776|NCT01089062|20665129|P6|COMPLETED|Visit 4||3
8383777|NCT01089062|20665130|P5|COMPLETED|Visit 4||3
8383778|NCT01089062|20665131|P4|COMPLETED|Visit 4||3
8383779|NCT01089062|20665132|P3|COMPLETED|Visit 4||3
8383780|NCT01089062|20665133|P2|COMPLETED|Visit 4||3
8383781|NCT01089062|20665134|P1|COMPLETED|Visit 4||3
8383782|NCT01089062|20665129|P6|STARTED|Visit 4||3
8383783|NCT01089062|20665130|P5|STARTED|Visit 4||3
8383784|NCT01089062|20665131|P4|STARTED|Visit 4||3
8383785|NCT01089062|20665132|P3|STARTED|Visit 4||3
8383786|NCT01089062|20665133|P2|STARTED|Visit 4||3
8383787|NCT01089062|20665134|P1|STARTED|Visit 4||3
8383788|NCT01089062|20665129|P6|NOT COMPLETED|Visit 3||0
8383789|NCT01089062|20665130|P5|NOT COMPLETED|Visit 3||0
8383790|NCT01089062|20665131|P4|NOT COMPLETED|Visit 3||1
8383791|NCT01089062|20665132|P3|NOT COMPLETED|Visit 3||0
8383792|NCT01089062|20665133|P2|NOT COMPLETED|Visit 3||0
8383793|NCT01089062|20665134|P1|NOT COMPLETED|Visit 3||0
8383794|NCT01089062|20665129|P6|COMPLETED|Visit 3||3
8383795|NCT01089062|20665130|P5|COMPLETED|Visit 3||3
8383796|NCT01089062|20665131|P4|COMPLETED|Visit 3||3
8383797|NCT01089062|20665132|P3|COMPLETED|Visit 3||3
8383798|NCT01089062|20665133|P2|COMPLETED|Visit 3||3
8383799|NCT01089062|20665134|P1|COMPLETED|Visit 3||3
8383800|NCT01089062|20665129|P6|STARTED|Visit 3||3
8383801|NCT01089062|20665130|P5|STARTED|Visit 3||3
8383802|NCT01089062|20665131|P4|STARTED|Visit 3||4
8383803|NCT01089062|20665132|P3|STARTED|Visit 3||3
8383804|NCT01089062|20665133|P2|STARTED|Visit 3||3
8383805|NCT01089062|20665134|P1|STARTED|Visit 3||3
8383806|NCT01089062|20665129|P6|NOT COMPLETED|Visit 2 (Randomization)||1
8383807|NCT01089062|20665130|P5|NOT COMPLETED|Visit 2 (Randomization)||1
8383808|NCT01089062|20665131|P4|NOT COMPLETED|Visit 2 (Randomization)||0
8383809|NCT01089062|20665132|P3|NOT COMPLETED|Visit 2 (Randomization)||1
8383810|NCT01089062|20665133|P2|NOT COMPLETED|Visit 2 (Randomization)||1
8383811|NCT01089062|20665134|P1|NOT COMPLETED|Visit 2 (Randomization)||1
8383812|NCT01089062|20665129|P6|COMPLETED|Visit 2 (Randomization)||3
8383813|NCT01089062|20665130|P5|COMPLETED|Visit 2 (Randomization)||3
8383814|NCT01089062|20665131|P4|COMPLETED|Visit 2 (Randomization)||4
8383815|NCT01089062|20665132|P3|COMPLETED|Visit 2 (Randomization)||3
8383816|NCT01089062|20665133|P2|COMPLETED|Visit 2 (Randomization)||3
8383817|NCT01089062|20665134|P1|COMPLETED|Visit 2 (Randomization)||3
8383818|NCT01089062|20665129|P6|STARTED|Visit 2 (Randomization)||4
8383819|NCT01089062|20665130|P5|STARTED|Visit 2 (Randomization)||4
8383820|NCT01089062|20665131|P4|STARTED|Visit 2 (Randomization)||4
8383821|NCT01089062|20665132|P3|STARTED|Visit 2 (Randomization)||4
8383822|NCT01089062|20665133|P2|STARTED|Visit 2 (Randomization)||4
8383823|NCT01089062|20665134|P1|STARTED|Visit 2 (Randomization)||4
8383824|NCT01089023|20665157|P1|NOT COMPLETED|Overall Study||7
8383825|NCT01089023|20665157|P1|COMPLETED|Overall Study||88
8383826|NCT01089023|20665157|P1|STARTED|Overall Study||95
8383827|NCT01088997|20665171|P2|NOT COMPLETED|Overall Study||3
8383828|NCT01088997|20665172|P1|NOT COMPLETED|Overall Study||3
8383829|NCT01088997|20665171|P2|COMPLETED|Overall Study||2
8383830|NCT01088997|20665172|P1|COMPLETED|Overall Study||4
8383831|NCT01088997|20665171|P2|STARTED|Overall Study||5
8383832|NCT01088997|20665172|P1|STARTED|Overall Study||7
8383833|NCT01088984|20665183|P2|NOT COMPLETED|Phase 2||32
8383834|NCT01088984|20665184|P1|NOT COMPLETED|Phase 2||0
8383835|NCT01088984|20665183|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
8383836|NCT01088984|20665184|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
8383837|NCT01088984|20665183|P2|STARTED|Phase 2||32
8383838|NCT01088984|20665184|P1|STARTED|Phase 2||0
8383839|NCT01088984|20665183|P2|NOT COMPLETED|Phase 1||6
8383840|NCT01088984|20665184|P1|NOT COMPLETED|Phase 1||5
8383841|NCT01088984|20665183|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
8383842|NCT01088984|20665184|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
8383843|NCT01088984|20665183|P2|STARTED|Phase 1||6
8383844|NCT01088984|20665184|P1|STARTED|Phase 1||5
8383845|NCT01088815|20665202|P1|NOT COMPLETED|Overall Study||0
8383846|NCT01088815|20665202|P1|COMPLETED|Overall Study||72
8383847|NCT01088815|20665202|P1|STARTED|Overall Study||72
8383848|NCT01088711|20665215|P4|NOT COMPLETED|Overall Study||0
8383849|NCT01088711|20665216|P3|NOT COMPLETED|Overall Study||0
8383850|NCT01088711|20665217|P2|NOT COMPLETED|Overall Study||0
8383851|NCT01088711|20665218|P1|NOT COMPLETED|Overall Study||0
8383852|NCT01088711|20665215|P4|COMPLETED|Overall Study||2
8383853|NCT01088711|20665216|P3|COMPLETED|Overall Study||6
8383854|NCT01088711|20665217|P2|COMPLETED|Overall Study||6
8383855|NCT01088711|20665218|P1|COMPLETED|Overall Study||18
8383856|NCT01088711|20665215|P4|STARTED|Overall Study||2
8383857|NCT01088711|20665216|P3|STARTED|Overall Study||6
8383858|NCT01088711|20665217|P2|STARTED|Overall Study||6
8383859|NCT01088711|20665218|P1|STARTED|Overall Study||18
8383860|NCT01088672|20665242|P1|NOT COMPLETED|Overall Study||0
8383861|NCT01088672|20665242|P1|COMPLETED|Overall Study||60
8383862|NCT01088672|20665242|P1|STARTED|Overall Study||60
8383863|NCT01088646|20665248|P1|NOT COMPLETED|Overall Study||0
8383864|NCT01088646|20665248|P1|COMPLETED|Overall Study||25
8383865|NCT01088646|20665248|P1|STARTED|Overall Study||25
8383866|NCT01088529|20665255|P2|NOT COMPLETED|Overall Study||1
8383867|NCT01088529|20665256|P1|NOT COMPLETED|Overall Study||0
8383868|NCT01088529|20665255|P2|COMPLETED|Overall Study||21
8383869|NCT01088529|20665256|P1|COMPLETED|Overall Study||44
8383870|NCT01088529|20665255|P2|Received Treatment|Overall Study||21
8383871|NCT01088529|20665256|P1|Received Treatment|Overall Study||44
8383872|NCT01088529|20665255|P2|STARTED|Overall Study||22
8383873|NCT01088529|20665256|P1|STARTED|Overall Study||44
8383874|NCT01088503|20665269|P3|NOT COMPLETED|Overall Study||17
8383875|NCT01088503|20665270|P2|NOT COMPLETED|Overall Study||685
8383876|NCT01088503|20665271|P1|NOT COMPLETED|Overall Study||182
8383877|NCT01088503|20665269|P3|COMPLETED|Overall Study||241
8383878|NCT01088503|20665270|P2|COMPLETED|Overall Study||8161
8383879|NCT01088503|20665271|P1|COMPLETED|Overall Study||2941
8383880|NCT01088503|20665269|P3|STARTED|Overall Study||258
8383881|NCT01088503|20665270|P2|STARTED|Overall Study||8846
8383882|NCT01088503|20665271|P1|STARTED|Overall Study||3123
8383883|NCT01088464|20665295|P3|NOT COMPLETED|Overall Study||0
8383884|NCT01088464|20665296|P2|NOT COMPLETED|Overall Study||0
8383885|NCT01088464|20665297|P1|NOT COMPLETED|Overall Study||0
8383886|NCT01088464|20665295|P3|COMPLETED|Overall Study||6
8383887|NCT01088464|20665296|P2|COMPLETED|Overall Study||6
8383888|NCT01088464|20665297|P1|COMPLETED|Overall Study||3
8383889|NCT01088464|20665295|P3|Received Any Quantity of Study Drug|Overall Study||6
8383890|NCT01088464|20665296|P2|Received Any Quantity of Study Drug|Overall Study||6
8383891|NCT01088464|20665297|P1|Received Any Quantity of Study Drug|Overall Study||3
8383892|NCT01088464|20665295|P3|STARTED|Overall Study||6
8383893|NCT01088464|20665296|P2|STARTED|Overall Study||6
8383894|NCT01088464|20665297|P1|STARTED|Overall Study||3
8383895|NCT01088438|20665349|P2|NOT COMPLETED|Overall Study||36
8383896|NCT01088438|20665350|P1|NOT COMPLETED|Overall Study||29
8383897|NCT01088438|20665349|P2|COMPLETED|Overall Study||59
8383898|NCT01088438|20665350|P1|COMPLETED|Overall Study||65
8383899|NCT01088438|20665349|P2|STARTED|Overall Study||95
8383900|NCT01088438|20665350|P1|STARTED|Overall Study||94
8383901|NCT01088412|20665363|P3|NOT COMPLETED|Overall Study||72
8383902|NCT01088412|20665364|P2|NOT COMPLETED|Overall Study||436
8383903|NCT01088412|20665365|P1|NOT COMPLETED|Overall Study||18017
8383904|NCT01088412|20665363|P3|COMPLETED|Overall Study||5
8383905|NCT01088412|20665364|P2|COMPLETED|Overall Study||21
8383906|NCT01088412|20665365|P1|COMPLETED|Overall Study||4294
8383907|NCT01088412|20665363|P3|SME+ >= 1 FU and Previous Cancer|Overall Study||0
8383908|NCT01088412|20665364|P2|SME+ >= 1 FU and Previous Cancer|Overall Study||114
8383909|NCT01088412|20665365|P1|SME+ >= 1 FU and Previous Cancer|Overall Study||622
8383910|NCT01088412|20665363|P3|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
8383911|NCT01088412|20665364|P2|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
8383912|NCT01088412|20665365|P1|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
8383913|NCT01088412|20665363|P3|SME+ >= 1 FU and Unknown Arm|Overall Study||40
8383914|NCT01088412|20665364|P2|SME+ >= 1 FU and Unknown Arm|Overall Study||306
8383915|NCT01088412|20665365|P1|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
8383916|NCT01088412|20665363|P3|SME With at Least 1 Follow Up (FU)|Overall Study||0
8383917|NCT01088412|20665364|P2|SME With at Least 1 Follow Up (FU)|Overall Study||306
8383918|NCT01088412|20665365|P1|SME With at Least 1 Follow Up (FU)|Overall Study||21178
8383919|NCT01088412|20665363|P3|Safety Modified Evaluable (SME)|Overall Study||0
8383920|NCT01088412|20665364|P2|Safety Modified Evaluable (SME)|Overall Study||456
8383921|NCT01088412|20665365|P1|Safety Modified Evaluable (SME)|Overall Study||22294
8383922|NCT01088412|20665363|P3|STARTED|Overall Study||77
8383923|NCT01088412|20665364|P2|STARTED|Overall Study||457
8383924|NCT01088412|20665365|P1|STARTED|Overall Study||22311
8383925|NCT01088399|20665384|P3|NOT COMPLETED|Overall Study||281
8383926|NCT01088399|20665385|P2|NOT COMPLETED|Overall Study||1347
8383927|NCT01088399|20665386|P1|NOT COMPLETED|Overall Study||7121
8383928|NCT01088399|20665384|P3|COMPLETED|Overall Study||21
8383929|NCT01088399|20665385|P2|COMPLETED|Overall Study||308
8383930|NCT01088399|20665386|P1|COMPLETED|Overall Study||1595
8383931|NCT01088399|20665384|P3|STARTED|Overall Study||302
8383932|NCT01088399|20665385|P2|STARTED|Overall Study||1655
8383933|NCT01088399|20665386|P1|STARTED|Overall Study||8716
8383934|NCT01088295|20665409|P1|NOT COMPLETED|Overall Study||1
8383935|NCT01088295|20665409|P1|COMPLETED|Overall Study||35
8383936|NCT01088295|20665409|P1|STARTED|Overall Study||36
8383937|NCT01088243|20665415|P2|NOT COMPLETED|Overall Study||0
8383938|NCT01088243|20665416|P1|NOT COMPLETED|Overall Study||1
8383939|NCT01088243|20665415|P2|COMPLETED|Overall Study||5
8383940|NCT01088243|20665416|P1|COMPLETED|Overall Study||12
8383941|NCT01088243|20665415|P2|STARTED|Overall Study||5
8383942|NCT01088243|20665416|P1|STARTED|Overall Study||13
8383943|NCT01087996|20665434|P2|NOT COMPLETED|Overall Study||0
8383944|NCT01087996|20665435|P1|NOT COMPLETED|Overall Study||0
8383945|NCT01087996|20665434|P2|COMPLETED|Overall Study||15
8383946|NCT01087996|20665435|P1|COMPLETED|Overall Study||15
8383947|NCT01087996|20665434|P2|STARTED|Overall Study||15
8383948|NCT01087996|20665435|P1|STARTED|Overall Study||15
8383949|NCT01087970|20665457|P1|NOT COMPLETED|Overall Study||2
8383950|NCT01087970|20665457|P1|COMPLETED|Overall Study||67
8383951|NCT01087970|20665457|P1|Received Carboplatin|Overall Study||63
8383952|NCT01087970|20665457|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
8383953|NCT01087970|20665457|P1|Completed 6 Cycles|Overall Study||69
8383954|NCT01087970|20665457|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
8383955|NCT01087970|20665457|P1|STARTED|Overall Study||69
8383956|NCT01087957|20665469|P2|NOT COMPLETED|Overall Study||55
8383957|NCT01087957|20665470|P1|NOT COMPLETED|Overall Study||41
8383958|NCT01087957|20665469|P2|COMPLETED|Overall Study||187
8383959|NCT01087957|20665470|P1|COMPLETED|Overall Study||212
8383960|NCT01087957|20665469|P2|STARTED|Overall Study||242
8383961|NCT01087957|20665470|P1|STARTED|Overall Study||253
8383962|NCT01087944|20665496|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
8383963|NCT01087944|20665497|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
8383964|NCT01087944|20665496|P2|COMPLETED|Period 2 (Week 4-6)||28
8383965|NCT01087944|20665497|P1|COMPLETED|Period 2 (Week 4-6)||29
8383966|NCT01087944|20665496|P2|STARTED|Period 2 (Week 4-6)||30
8383967|NCT01087944|20665497|P1|STARTED|Period 2 (Week 4-6)||29
8383968|NCT01087944|20665496|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
8383969|NCT01087944|20665497|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
8383970|NCT01087944|20665496|P2|COMPLETED|Period 1 (Week 1-3)||30
8383971|NCT01087944|20665497|P1|COMPLETED|Period 1 (Week 1-3)||29
8383972|NCT01087944|20665496|P2|STARTED|Period 1 (Week 1-3)||30
8383973|NCT01087944|20665497|P1|STARTED|Period 1 (Week 1-3)||30
8383974|NCT01087931|20665527|P2|NOT COMPLETED|Overall Study||0
8383975|NCT01087931|20665528|P1|NOT COMPLETED|Overall Study||0
8383976|NCT01087931|20665527|P2|COMPLETED|Overall Study||20
8383977|NCT01087931|20665528|P1|COMPLETED|Overall Study||20
8383978|NCT01087931|20665527|P2|Final Follow up|Overall Study||17
8383979|NCT01087931|20665528|P1|Final Follow up|Overall Study||19
8383980|NCT01087931|20665527|P2|1st Follow up|Overall Study||19
8383981|NCT01087931|20665528|P1|1st Follow up|Overall Study||20
8383982|NCT01087931|20665527|P2|STARTED|Overall Study||20
8383983|NCT01087931|20665528|P1|STARTED|Overall Study||20
8383984|NCT01087918|20665542|P2|NOT COMPLETED|Overall Study||0
8383985|NCT01087918|20665543|P1|NOT COMPLETED|Overall Study||0
8383986|NCT01087918|20665542|P2|COMPLETED|Overall Study||4
8383987|NCT01087918|20665543|P1|COMPLETED|Overall Study||5
8383988|NCT01087918|20665542|P2|STARTED|Overall Study||4
8383989|NCT01087918|20665543|P1|STARTED|Overall Study||5
8383990|NCT01087905|20665577|P8|NOT COMPLETED|Overall Study||29
8383991|NCT01087905|20665578|P7|NOT COMPLETED|Overall Study||23
8383992|NCT01087905|20665579|P6|NOT COMPLETED|Overall Study||28
8383993|NCT01087905|20665580|P5|NOT COMPLETED|Overall Study||31
8383994|NCT01087905|20665581|P4|NOT COMPLETED|Overall Study||36
8383995|NCT01087905|20665582|P3|NOT COMPLETED|Overall Study||22
8383996|NCT01087905|20665583|P2|NOT COMPLETED|Overall Study||32
8383997|NCT01087905|20665584|P1|NOT COMPLETED|Overall Study||29
8383998|NCT01087905|20665577|P8|COMPLETED|Overall Study||98
8383999|NCT01087905|20665578|P7|COMPLETED|Overall Study||98
8384000|NCT01087905|20665579|P6|COMPLETED|Overall Study||99
8384001|NCT01087905|20665580|P5|COMPLETED|Overall Study||91
8384002|NCT01087905|20665581|P4|COMPLETED|Overall Study||86
8384003|NCT01087905|20665582|P3|COMPLETED|Overall Study||101
8384004|NCT01087905|20665583|P2|COMPLETED|Overall Study||94
8384005|NCT01087905|20665584|P1|COMPLETED|Overall Study||90
8384006|NCT01087905|20665577|P8|STARTED|Overall Study||127
8384007|NCT01087905|20665578|P7|STARTED|Overall Study||121
8384008|NCT01087905|20665579|P6|STARTED|Overall Study||127
8384009|NCT01087905|20665580|P5|STARTED|Overall Study||122
8384010|NCT01087905|20665581|P4|STARTED|Overall Study||122
8384011|NCT01087905|20665582|P3|STARTED|Overall Study||123
8384012|NCT01087905|20665583|P2|STARTED|Overall Study||126
8384013|NCT01087905|20665584|P1|STARTED|Overall Study||119
8384014|NCT01087814|20665606|P2|NOT COMPLETED|Second Intervention (5 Days)||0
8384015|NCT01087814|20665607|P1|NOT COMPLETED|Second Intervention (5 Days)||1
8384016|NCT01087814|20665606|P2|COMPLETED|Second Intervention (5 Days)||6
8384017|NCT01087814|20665607|P1|COMPLETED|Second Intervention (5 Days)||4
8384018|NCT01087814|20665606|P2|STARTED|Second Intervention (5 Days)||6
8384019|NCT01087814|20665607|P1|STARTED|Second Intervention (5 Days)||5
8384020|NCT01087814|20665606|P2|NOT COMPLETED|First Intervention (5 Days)||1
8384021|NCT01087814|20665607|P1|NOT COMPLETED|First Intervention (5 Days)||3
8384022|NCT01087814|20665606|P2|COMPLETED|First Intervention (5 Days)||6
8384023|NCT01087814|20665607|P1|COMPLETED|First Intervention (5 Days)||5
8384024|NCT01087814|20665606|P2|STARTED|First Intervention (5 Days)||7
8384025|NCT01087814|20665607|P1|STARTED|First Intervention (5 Days)||8
8384026|NCT01087801|20665615|P2|NOT COMPLETED|Overall Study||5
8384027|NCT01087801|20665616|P1|NOT COMPLETED|Overall Study||4
8384028|NCT01087801|20665615|P2|COMPLETED|Overall Study||29
8384029|NCT01087801|20665616|P1|COMPLETED|Overall Study||26
8384030|NCT01087801|20665615|P2|STARTED|Overall Study||34
8384031|NCT01087801|20665616|P1|STARTED|Overall Study||30
8384032|NCT01087788|20665625|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
8384033|NCT01087788|20665626|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
8384034|NCT01087788|20665627|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
8384035|NCT01087788|20665625|P3|COMPLETED|Open-Label Period (OL-P)||86
8384036|NCT01087788|20665626|P2|COMPLETED|Open-Label Period (OL-P)||97
8384037|NCT01087788|20665627|P1|COMPLETED|Open-Label Period (OL-P)||81
8384038|NCT01087788|20665625|P3|STARTED|Open-Label Period (OL-P)||114
8384039|NCT01087788|20665626|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
8384040|NCT01087788|20665627|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
8384041|NCT01087788|20665625|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
8384042|NCT01087788|20665626|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
8384043|NCT01087788|20665627|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
8384044|NCT01087788|20665625|P3|COMPLETED|24-weeks Dose-blind Period||114
8384045|NCT01087788|20665626|P2|COMPLETED|24-weeks Dose-blind Period||123
8384046|NCT01087788|20665627|P1|COMPLETED|24-weeks Dose-blind Period||113
8384047|NCT01087788|20665625|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384048|NCT01087788|20665626|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384049|NCT01087788|20665627|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
8384050|NCT01087788|20665625|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384051|NCT01087788|20665626|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384052|NCT01087788|20665627|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
8384053|NCT01087788|20665625|P3|STARTED|24-weeks Dose-blind Period||120
8384054|NCT01087788|20665626|P2|STARTED|24-weeks Dose-blind Period||128
8384055|NCT01087788|20665627|P1|STARTED|24-weeks Dose-blind Period||120
8384056|NCT01087788|20665625|P3|NOT COMPLETED|24-weeks Double-blind Period||15
8384057|NCT01087788|20665626|P2|NOT COMPLETED|24-weeks Double-blind Period||10
8384058|NCT01087788|20665627|P1|NOT COMPLETED|24-weeks Double-blind Period||16
8384059|NCT01087788|20665625|P3|COMPLETED|24-weeks Double-blind Period||120
8384060|NCT01087788|20665626|P2|COMPLETED|24-weeks Double-blind Period||128
8384061|NCT01087788|20665627|P1|COMPLETED|24-weeks Double-blind Period||120
8384062|NCT01087788|20665625|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384063|NCT01087788|20665626|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384064|NCT01087788|20665627|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
8384065|NCT01087788|20665625|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384066|NCT01087788|20665626|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384067|NCT01087788|20665627|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
8384068|NCT01087788|20665625|P3|STARTED|24-weeks Double-blind Period||135
8384069|NCT01087788|20665626|P2|STARTED|24-weeks Double-blind Period||138
8384070|NCT01087788|20665627|P1|STARTED|24-weeks Double-blind Period||136
8384071|NCT01087775|20665654|P1|NOT COMPLETED|Overall Study||2
8384072|NCT01087775|20665654|P1|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
8384073|NCT01087775|20665654|P1|STARTED|Overall Study||25
8384074|NCT01087762|20665662|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
8384075|NCT01087762|20665663|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
8384076|NCT01087762|20665664|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8384077|NCT01087762|20665665|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8384078|NCT01087762|20665666|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8384079|NCT01087762|20665662|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
8384080|NCT01087762|20665663|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
8384081|NCT01087762|20665664|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
8384082|NCT01087762|20665665|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
8384083|NCT01087762|20665666|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
8384084|NCT01087762|20665662|P5|STARTED|Open-Label Period (Weeks 48-204)||157
8384085|NCT01087762|20665663|P4|STARTED|Open-Label Period (Weeks 48-204)||158
8384086|NCT01087762|20665664|P3|STARTED|Open-Label Period (Weeks 48-204)||0
8384087|NCT01087762|20665665|P2|STARTED|Open-Label Period (Weeks 48-204)||0
8384088|NCT01087762|20665666|P1|STARTED|Open-Label Period (Weeks 48-204)||0
8384089|NCT01087762|20665662|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
8384090|NCT01087762|20665663|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
8384091|NCT01087762|20665664|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
8384092|NCT01087762|20665665|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
8384093|NCT01087762|20665666|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
8384094|NCT01087762|20665662|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
8384095|NCT01087762|20665663|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
8384096|NCT01087762|20665664|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
8384097|NCT01087762|20665665|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
8384098|NCT01087762|20665666|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
8384099|NCT01087762|20665662|P5|STARTED|Double Blind Period (Weeks 0-24)||0
8384100|NCT01087762|20665663|P4|STARTED|Double Blind Period (Weeks 0-24)||0
8384101|NCT01087762|20665664|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
8384102|NCT01087762|20665665|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
8384103|NCT01087762|20665666|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
8384104|NCT01087736|20665714|P2|NOT COMPLETED|Overall Study||2
8384105|NCT01087736|20665715|P1|NOT COMPLETED|Overall Study||1
8384106|NCT01087736|20665714|P2|COMPLETED|Overall Study||14
8384107|NCT01087736|20665715|P1|COMPLETED|Overall Study||13
8384108|NCT01087736|20665714|P2|STARTED|Overall Study||16
8384109|NCT01087736|20665715|P1|STARTED|Overall Study||14
8384110|NCT01087723|20665725|P2|NOT COMPLETED|Overall Study||20
8384111|NCT01087723|20665726|P1|NOT COMPLETED|Overall Study||14
8384112|NCT01087723|20665725|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
8384113|NCT01087723|20665726|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
8384114|NCT01087723|20665725|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
8384115|NCT01087723|20665726|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
8384116|NCT01087723|20665725|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
8384117|NCT01087723|20665726|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
8384118|NCT01087541|20665750|P2|NOT COMPLETED|Overall Study||0
8384119|NCT01087541|20665751|P1|NOT COMPLETED|Overall Study||0
8384120|NCT01087541|20665750|P2|COMPLETED|Overall Study||3523
8384121|NCT01087541|20665751|P1|COMPLETED|Overall Study||3307
8384122|NCT01087541|20665750|P2|STARTED|Overall Study||3523
8384123|NCT01087541|20665751|P1|STARTED|Overall Study||3307
8384124|NCT01087528|20665767|P1|NOT COMPLETED|Overall Study||7
8384125|NCT01087528|20665767|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
8384126|NCT01087528|20665767|P1|STARTED|Overall Study||51
8384127|NCT01087502|20665779|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
8384128|NCT01087502|20665780|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
8384129|NCT01087502|20665779|P2|COMPLETED|Up to Final Analysis (Week 52)||95
8384130|NCT01087502|20665780|P1|COMPLETED|Up to Final Analysis (Week 52)||90
8384131|NCT01087502|20665779|P2|STARTED|Up to Final Analysis (Week 52)||118
8384132|NCT01087502|20665780|P1|STARTED|Up to Final Analysis (Week 52)||123
8384133|NCT01087502|20665779|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
8384134|NCT01087502|20665780|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
8384135|NCT01087502|20665779|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
8384136|NCT01087502|20665780|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
8384137|NCT01087502|20665779|P2|STARTED|Up to Interim Analysis (Week 12)||118
8384138|NCT01087502|20665780|P1|STARTED|Up to Interim Analysis (Week 12)||123
8384139|NCT01087489|20665799|P2|NOT COMPLETED|Overall Study||3
8384140|NCT01087489|20665800|P1|NOT COMPLETED|Overall Study||0
8384141|NCT01087489|20665799|P2|COMPLETED|Overall Study||31
8384142|NCT01087489|20665800|P1|COMPLETED|Overall Study||19
8384143|NCT01087489|20665799|P2|STARTED|Overall Study||34
8384144|NCT01087489|20665800|P1|STARTED|Overall Study||19
8384145|NCT01086969|20665813|P3|NOT COMPLETED|Overall Study||0
8384146|NCT01086969|20665814|P2|NOT COMPLETED|Overall Study||2
8384147|NCT01086969|20665815|P1|NOT COMPLETED|Overall Study||1
8384148|NCT01086969|20665813|P3|COMPLETED|Overall Study||100
8384149|NCT01086969|20665814|P2|COMPLETED|Overall Study||98
8384150|NCT01086969|20665815|P1|COMPLETED|Overall Study||99
8384151|NCT01086969|20665813|P3|STARTED|Overall Study||100
8384152|NCT01086969|20665814|P2|STARTED|Overall Study||100
8384153|NCT01086969|20665815|P1|STARTED|Overall Study||100
8384154|NCT01086852|20665832|P1|NOT COMPLETED|Overall Study||0
8384155|NCT01086852|20665832|P1|COMPLETED|Overall Study||4
8384156|NCT01086852|20665832|P1|STARTED|Overall Study||4
8384157|NCT01086761|20665848|P6|NOT COMPLETED|Overall Study||0
8384158|NCT01086761|20665849|P5|NOT COMPLETED|Overall Study||0
8384159|NCT01086761|20665850|P4|NOT COMPLETED|Overall Study||0
8384160|NCT01086761|20665851|P3|NOT COMPLETED|Overall Study||0
8384161|NCT01086761|20665852|P2|NOT COMPLETED|Overall Study||0
8384162|NCT01086761|20665853|P1|NOT COMPLETED|Overall Study||0
8384163|NCT01086761|20665848|P6|COMPLETED|Overall Study||0
8384164|NCT01086761|20665849|P5|COMPLETED|Overall Study||4
8384165|NCT01086761|20665850|P4|COMPLETED|Overall Study||6
8384166|NCT01086761|20665851|P3|COMPLETED|Overall Study||6
8384167|NCT01086761|20665852|P2|COMPLETED|Overall Study||7
8384168|NCT01086761|20665853|P1|COMPLETED|Overall Study||9
8384169|NCT01086761|20665848|P6|STARTED|Overall Study||0
8384170|NCT01086761|20665849|P5|STARTED|Overall Study||4
8384171|NCT01086761|20665850|P4|STARTED|Overall Study||6
8384172|NCT01086761|20665851|P3|STARTED|Overall Study||6
8384173|NCT01086761|20665852|P2|STARTED|Overall Study||7
8384174|NCT01086761|20665853|P1|STARTED|Overall Study||9
8384175|NCT01086605|20665893|P2|NOT COMPLETED|Overall Study||0
8384176|NCT01086605|20665894|P1|NOT COMPLETED|Overall Study||0
8384177|NCT01086605|20665893|P2|COMPLETED|Overall Study||22
8384178|NCT01086605|20665894|P1|COMPLETED|Overall Study||24
8384179|NCT01086605|20665893|P2|STARTED|Overall Study||22
8384180|NCT01086605|20665894|P1|STARTED|Overall Study||24
8384181|NCT01086540|20665911|P2|NOT COMPLETED|Overall Study||2
8384182|NCT01086540|20665912|P1|NOT COMPLETED|Overall Study||6
8384183|NCT01086540|20665911|P2|COMPLETED|Overall Study||26
8384184|NCT01086540|20665912|P1|COMPLETED|Overall Study||23
8384185|NCT01086540|20665911|P2|STARTED|Overall Study||28
8384186|NCT01086540|20665912|P1|STARTED|Overall Study||29
8384187|NCT01086475|20665956|P2|NOT COMPLETED|Overall Study||0
8384188|NCT01086475|20665957|P1|NOT COMPLETED|Overall Study||0
8384189|NCT01086475|20665956|P2|COMPLETED|Overall Study||33
8384190|NCT01086475|20665957|P1|COMPLETED|Overall Study||34
8384191|NCT01086475|20665956|P2|STARTED|Overall Study||33
8384192|NCT01086475|20665957|P1|STARTED|Overall Study||34
8384193|NCT01086423|20665970|P3|NOT COMPLETED|Overall Study||9
8384194|NCT01086423|20665971|P2|NOT COMPLETED|Overall Study||3
8384195|NCT01086423|20665972|P1|NOT COMPLETED|Overall Study||10
8384196|NCT01086423|20665970|P3|COMPLETED|Overall Study||321
8384197|NCT01086423|20665971|P2|COMPLETED|Overall Study||321
8384198|NCT01086423|20665972|P1|COMPLETED|Overall Study||320
8384199|NCT01086423|20665970|P3|STARTED|Overall Study||330
8384200|NCT01086423|20665971|P2|STARTED|Overall Study||324
8384201|NCT01086423|20665972|P1|STARTED|Overall Study||330
8384202|NCT01086410|20666017|P4|NOT COMPLETED|Overall Study||2
8384203|NCT01086410|20666018|P3|NOT COMPLETED|Overall Study||1
8384204|NCT01086410|20666019|P2|NOT COMPLETED|Overall Study||2
8384205|NCT01086410|20666020|P1|NOT COMPLETED|Overall Study||3
8384206|NCT01086410|20666017|P4|COMPLETED|Overall Study||13
8384207|NCT01086410|20666018|P3|COMPLETED|Overall Study||55
8384208|NCT01086410|20666019|P2|COMPLETED|Overall Study||54
8384209|NCT01086410|20666020|P1|COMPLETED|Overall Study||55
8384210|NCT01086410|20666017|P4|STARTED|Overall Study||15
8384211|NCT01086410|20666018|P3|STARTED|Overall Study||56
8384212|NCT01086410|20666019|P2|STARTED|Overall Study||56
8384213|NCT01086410|20666020|P1|STARTED|Overall Study||58
8384214|NCT01086384|20666116|P3|NOT COMPLETED|Treatment Period||124
8384215|NCT01086384|20666117|P2|NOT COMPLETED|Treatment Period||148
8384216|NCT01086384|20666118|P1|NOT COMPLETED|Treatment Period||0
8384217|NCT01086384|20666116|P3|COMPLETED|Treatment Period||885
8384218|NCT01086384|20666117|P2|COMPLETED|Treatment Period||863
8384219|NCT01086384|20666118|P1|COMPLETED|Treatment Period||0
8384220|NCT01086384|20666116|P3|STARTED|Treatment Period||1009
8384221|NCT01086384|20666117|P2|STARTED|Treatment Period||1011
8384222|NCT01086384|20666118|P1|STARTED|Treatment Period||0
8384223|NCT01086384|20666116|P3|NOT COMPLETED|2-week Run-in Period||0
8384224|NCT01086384|20666117|P2|NOT COMPLETED|2-week Run-in Period||0
8384225|NCT01086384|20666118|P1|NOT COMPLETED|2-week Run-in Period||163
8384226|NCT01086384|20666116|P3|COMPLETED|2-week Run-in Period||0
8384227|NCT01086384|20666117|P2|COMPLETED|2-week Run-in Period||0
8384228|NCT01086384|20666118|P1|COMPLETED|2-week Run-in Period||2020
8384229|NCT01086384|20666116|P3|STARTED|2-week Run-in Period||0
8384230|NCT01086384|20666117|P2|STARTED|2-week Run-in Period||0
8384231|NCT01086384|20666118|P1|STARTED|2-week Run-in Period||2183
8384232|NCT01086358|20666128|P2|NOT COMPLETED|Second Intervention||4
8384233|NCT01086358|20666129|P1|NOT COMPLETED|Second Intervention||4
8384234|NCT01086358|20666128|P2|COMPLETED|Second Intervention||20
8384235|NCT01086358|20666129|P1|COMPLETED|Second Intervention||17
8384236|NCT01086358|20666128|P2|STARTED|Second Intervention||24
8384237|NCT01086358|20666129|P1|STARTED|Second Intervention||21
8384238|NCT01086358|20666128|P2|NOT COMPLETED|First Intervention||5
8384239|NCT01086358|20666129|P1|NOT COMPLETED|First Intervention||9
8384240|NCT01086358|20666128|P2|COMPLETED|First Intervention||24
8384241|NCT01086358|20666129|P1|COMPLETED|First Intervention||21
8384242|NCT01086358|20666128|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
8384243|NCT01086358|20666129|P1|STARTED|First Intervention|30 subjects enrolled.|30
8384244|NCT01086228|20666141|P1|NOT COMPLETED|5-year Follow-up||652
8384245|NCT01086228|20666141|P1|COMPLETED|5-year Follow-up||1012
8384246|NCT01086228|20666141|P1|STARTED|5-year Follow-up||1664
8384247|NCT01086228|20666141|P1|NOT COMPLETED|4-year Follow-up||103
8384248|NCT01086228|20666141|P1|COMPLETED|4-year Follow-up||1664
8384249|NCT01086228|20666141|P1|STARTED|4-year Follow-up||1767
8384250|NCT01086228|20666141|P1|NOT COMPLETED|3-year Follow-up||67
8384251|NCT01086228|20666141|P1|COMPLETED|3-year Follow-up||1767
8384252|NCT01086228|20666141|P1|STARTED|3-year Follow-up||1834
8384253|NCT01086228|20666141|P1|NOT COMPLETED|2-year Follow-up||60
8384254|NCT01086228|20666141|P1|COMPLETED|2-year Follow-up||1834
8384255|NCT01086228|20666141|P1|STARTED|2-year Follow-up||1894
8384256|NCT01086228|20666141|P1|NOT COMPLETED|1-year Follow-up||44
8384257|NCT01086228|20666141|P1|COMPLETED|1-year Follow-up||1894
8384258|NCT01086228|20666141|P1|STARTED|1-year Follow-up||1938
8384259|NCT01086228|20666141|P1|NOT COMPLETED|8 Month Follow-up||71
8384260|NCT01086228|20666141|P1|COMPLETED|8 Month Follow-up||1938
8384261|NCT01086228|20666141|P1|STARTED|8 Month Follow-up|Analysis population|2009
8384262|NCT01086215|20666199|P4|NOT COMPLETED|Overall Study||3
8384263|NCT01086215|20666200|P3|NOT COMPLETED|Overall Study||26
8384264|NCT01086215|20666201|P2|NOT COMPLETED|Overall Study||47
8384265|NCT01086215|20666202|P1|NOT COMPLETED|Overall Study||36
8384266|NCT01086215|20666199|P4|COMPLETED|Overall Study||11
8384267|NCT01086215|20666200|P3|COMPLETED|Overall Study||47
8384268|NCT01086215|20666201|P2|COMPLETED|Overall Study||154
8384269|NCT01086215|20666202|P1|COMPLETED|Overall Study||176
8384270|NCT01086215|20666199|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
8384271|NCT01086215|20666200|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
8384272|NCT01086215|20666201|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
8384273|NCT01086215|20666202|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
8384274|NCT01086215|20666199|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
8384275|NCT01086215|20666200|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
8384276|NCT01086215|20666201|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
8384277|NCT01086215|20666202|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
8384278|NCT01086215|20666199|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
8384279|NCT01086215|20666200|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
8384280|NCT01086215|20666201|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
8384281|NCT01086215|20666202|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
8384282|NCT01086215|20666199|P4|STARTED|Overall Study||14
8384283|NCT01086215|20666200|P3|STARTED|Overall Study||73
8384284|NCT01086215|20666201|P2|STARTED|Overall Study||201
8384285|NCT01086215|20666202|P1|STARTED|Overall Study||212
8384286|NCT01086150|20666223|P3|NOT COMPLETED|Overall Study||1
8384287|NCT01086150|20666224|P2|NOT COMPLETED|Overall Study||6
8384288|NCT01086150|20666225|P1|NOT COMPLETED|Overall Study||0
8384289|NCT01086150|20666223|P3|COMPLETED|Overall Study||12
8384290|NCT01086150|20666224|P2|COMPLETED|Overall Study||21
8384291|NCT01086150|20666225|P1|COMPLETED|Overall Study||11
8384292|NCT01086150|20666223|P3|STARTED|Overall Study||13
8384293|NCT01086150|20666224|P2|STARTED|Overall Study||27
8384294|NCT01086150|20666225|P1|STARTED|Overall Study||11
8384295|NCT01086033|20666236|P1|NOT COMPLETED|Overall Study||304
8384296|NCT01086033|20666236|P1|COMPLETED|Overall Study||262
8384297|NCT01086033|20666236|P1|STARTED|Overall Study||566
8384298|NCT01085968|20666250|P2|NOT COMPLETED|Overall Study||4
8384299|NCT01085968|20666251|P1|NOT COMPLETED|Overall Study||10
8384300|NCT01085968|20666250|P2|COMPLETED|Overall Study||21
8384301|NCT01085968|20666251|P1|COMPLETED|Overall Study||19
8384302|NCT01085968|20666250|P2|STARTED|Overall Study||25
8384303|NCT01085968|20666251|P1|STARTED|Overall Study||29
8384304|NCT01085903|20666267|P3|NOT COMPLETED|Overall Study||0
8384305|NCT01085903|20666268|P2|NOT COMPLETED|Overall Study||0
8384306|NCT01085903|20666269|P1|NOT COMPLETED|Overall Study||0
8384307|NCT01085903|20666267|P3|COMPLETED|Overall Study||3
8384308|NCT01085903|20666268|P2|COMPLETED|Overall Study||4
8384309|NCT01085903|20666269|P1|COMPLETED|Overall Study||21
8384310|NCT01085903|20666267|P3|STARTED|Overall Study||3
8384311|NCT01085903|20666268|P2|STARTED|Overall Study||4
8384312|NCT01085903|20666269|P1|STARTED|Overall Study||21
8384313|NCT01085825|20666295|P2|NOT COMPLETED|Overall Study||1
8384314|NCT01085825|20666296|P1|NOT COMPLETED|Overall Study||1
8384315|NCT01085825|20666295|P2|COMPLETED|Overall Study||247
8384316|NCT01085825|20666296|P1|COMPLETED|Overall Study||251
8384317|NCT01085825|20666295|P2|STARTED|Overall Study||248
8384318|NCT01085825|20666296|P1|STARTED|Overall Study|1st participant enrolled|252
8384319|NCT01085812|20666302|P2|NOT COMPLETED|Double-blind Intent-to-treat Population||56
8384320|NCT01085812|20666303|P1|NOT COMPLETED|Double-blind Intent-to-treat Population||20
8384321|NCT01085812|20666302|P2|COMPLETED|Double-blind Intent-to-treat Population||174
8384322|NCT01085812|20666303|P1|COMPLETED|Double-blind Intent-to-treat Population||92
8384323|NCT01085812|20666302|P2|STARTED|Double-blind Intent-to-treat Population||230
8384324|NCT01085812|20666303|P1|STARTED|Double-blind Intent-to-treat Population||112
8384325|NCT01085812|20666302|P2|NOT COMPLETED|Double-Blind Period||58
8384326|NCT01085812|20666303|P1|NOT COMPLETED|Double-Blind Period||21
8384327|NCT01085812|20666302|P2|COMPLETED|Double-Blind Period||177
8384328|NCT01085812|20666303|P1|COMPLETED|Double-Blind Period||92
8384329|NCT01085812|20666302|P2|STARTED|Double-Blind Period||235
8384330|NCT01085812|20666303|P1|STARTED|Double-Blind Period||113
8384331|NCT01085812|20666302|P2|NOT COMPLETED|Open-Label Period||240
8384332|NCT01085812|20666303|P1|NOT COMPLETED|Open-Label Period||0
8384333|NCT01085812|20666302|P2|COMPLETED|Open-Label Period||494
8384334|NCT01085812|20666303|P1|COMPLETED|Open-Label Period||0
8384335|NCT01085812|20666302|P2|STARTED|Open-Label Period||734
8384336|NCT01085812|20666303|P1|STARTED|Open-Label Period||0
8384337|NCT01085786|20666312|P2|NOT COMPLETED|Overall Study||0
8384338|NCT01085786|20666313|P1|NOT COMPLETED|Overall Study||0
8384339|NCT01085786|20666312|P2|COMPLETED|Overall Study||117
8384340|NCT01085786|20666313|P1|COMPLETED|Overall Study||123
8384341|NCT01085786|20666312|P2|STARTED|Overall Study||117
8384342|NCT01085786|20666313|P1|STARTED|Overall Study||123
8384343|NCT01085760|20666323|P4|NOT COMPLETED|Overall Study||3
8384344|NCT01085760|20666324|P3|NOT COMPLETED|Overall Study||2
8384345|NCT01085760|20666325|P2|NOT COMPLETED|Overall Study||1
8384346|NCT01085760|20666326|P1|NOT COMPLETED|Overall Study||1
8384347|NCT01085760|20666323|P4|COMPLETED|Overall Study||6
8384348|NCT01085760|20666324|P3|COMPLETED|Overall Study||7
8384349|NCT01085760|20666325|P2|COMPLETED|Overall Study||8
8384350|NCT01085760|20666326|P1|COMPLETED|Overall Study||7
8384351|NCT01085760|20666323|P4|STARTED|Overall Study||9
8384352|NCT01085760|20666324|P3|STARTED|Overall Study||9
8384353|NCT01085760|20666325|P2|STARTED|Overall Study||9
8384354|NCT01085760|20666326|P1|STARTED|Overall Study||8
8384355|NCT01085734|20666350|P2|NOT COMPLETED|Overall Study||4
8384356|NCT01085734|20666351|P1|NOT COMPLETED|Overall Study||1
8384357|NCT01085734|20666350|P2|COMPLETED|Overall Study||11
8384358|NCT01085734|20666351|P1|COMPLETED|Overall Study||14
8384359|NCT01085734|20666350|P2|STARTED|Overall Study||15
8384360|NCT01085734|20666351|P1|STARTED|Overall Study||15
8384361|NCT01085682|20666363|P2|NOT COMPLETED|Overall Study||25
8384362|NCT01085682|20666364|P1|NOT COMPLETED|Overall Study||25
8384363|NCT01085682|20666363|P2|COMPLETED|Overall Study||3
8384364|NCT01085682|20666364|P1|COMPLETED|Overall Study||6
8384365|NCT01085682|20666363|P2|STARTED|Overall Study||28
8384366|NCT01085682|20666364|P1|STARTED|Overall Study||31
8384367|NCT01085643|20666370|P1|NOT COMPLETED|Overall Study||0
8384368|NCT01085643|20666370|P1|COMPLETED|Overall Study||4
8384369|NCT01085643|20666370|P1|STARTED|Overall Study||4
8384370|NCT01085630|20666381|P2|NOT COMPLETED|Overall Study||0
8384371|NCT01085630|20666382|P1|NOT COMPLETED|Overall Study||4
8384372|NCT01085630|20666381|P2|COMPLETED|Overall Study||27
8384373|NCT01085630|20666382|P1|COMPLETED|Overall Study||22
8384374|NCT01085630|20666381|P2|STARTED|Overall Study||27
8384375|NCT01085630|20666382|P1|STARTED|Overall Study||26
8384376|NCT01085591|20666395|P3|NOT COMPLETED|Overall Study||7
8384377|NCT01085591|20666396|P2|NOT COMPLETED|Overall Study||6
8384378|NCT01085591|20666397|P1|NOT COMPLETED|Overall Study||3
8384379|NCT01085591|20666395|P3|COMPLETED|Overall Study||63
8384380|NCT01085591|20666396|P2|COMPLETED|Overall Study||65
8384381|NCT01085591|20666397|P1|COMPLETED|Overall Study||66
8384382|NCT01085591|20666395|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
8384383|NCT01085591|20666396|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
8384384|NCT01085591|20666397|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
8384385|NCT01085591|20666395|P3|STARTED|Overall Study||70
8384386|NCT01085591|20666396|P2|STARTED|Overall Study||71
8384387|NCT01085591|20666397|P1|STARTED|Overall Study||69
8384388|NCT01085539|20666420|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
8384389|NCT01085539|20666420|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
8384390|NCT01085539|20666420|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
8384391|NCT01085539|20666420|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
8384392|NCT01085539|20666420|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
8384393|NCT01085539|20666420|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
8384394|NCT01085539|20666420|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
8384395|NCT01085539|20666420|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
8384396|NCT01085539|20666420|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
8384397|NCT01085539|20666420|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
8384398|NCT01085539|20666420|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
8384399|NCT01085539|20666420|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
8384400|NCT01085539|20666420|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
8384401|NCT01085539|20666420|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
8384402|NCT01085539|20666420|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
8384403|NCT01085513|20666426|P2|NOT COMPLETED|Phase II - Validation Phase||0
8384404|NCT01085513|20666427|P1|NOT COMPLETED|Phase II - Validation Phase||0
8384405|NCT01085513|20666426|P2|COMPLETED|Phase II - Validation Phase||16
8384406|NCT01085513|20666427|P1|COMPLETED|Phase II - Validation Phase||21
8384407|NCT01085513|20666426|P2|STARTED|Phase II - Validation Phase||16
8384408|NCT01085513|20666427|P1|STARTED|Phase II - Validation Phase||21
8384409|NCT01085513|20666426|P2|NOT COMPLETED|Phase I - Development Phase||0
8384410|NCT01085513|20666427|P1|NOT COMPLETED|Phase I - Development Phase||0
8384411|NCT01085513|20666426|P2|COMPLETED|Phase I - Development Phase||52
8384412|NCT01085513|20666427|P1|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
8384413|NCT01085513|20666426|P2|STARTED|Phase I - Development Phase||52
8384414|NCT01085513|20666427|P1|STARTED|Phase I - Development Phase||54
8384415|NCT01085500|20666437|P2|NOT COMPLETED|Overall Study||0
8384416|NCT01085500|20666438|P1|NOT COMPLETED|Overall Study||0
8384417|NCT01085500|20666437|P2|COMPLETED|Overall Study||24
8384418|NCT01085500|20666438|P1|COMPLETED|Overall Study||26
8384419|NCT01085500|20666437|P2|STARTED|Overall Study||24
8384420|NCT01085500|20666438|P1|STARTED|Overall Study||26
8384421|NCT01085357|20666450|P2|NOT COMPLETED|Overall Study||6
8384422|NCT01085357|20666451|P1|NOT COMPLETED|Overall Study||19
8384423|NCT01085357|20666450|P2|COMPLETED|Overall Study||125
8384424|NCT01085357|20666451|P1|COMPLETED|Overall Study||355
8384425|NCT01085357|20666450|P2|STARTED|Overall Study||131
8384426|NCT01085357|20666451|P1|STARTED|Overall Study||374
8384427|NCT01085344|20666461|P1|NOT COMPLETED|Overall Study||6
8384428|NCT01085344|20666461|P1|COMPLETED|Overall Study||50
8384429|NCT01085344|20666461|P1|STARTED|Overall Study||56
8384430|NCT01085331|20666473|P2|NOT COMPLETED|Overall Study||0
8384431|NCT01085331|20666474|P1|NOT COMPLETED|Overall Study||0
8384432|NCT01085331|20666473|P2|COMPLETED|Overall Study||6
8384433|NCT01085331|20666474|P1|COMPLETED|Overall Study||10
8384434|NCT01085331|20666473|P2|STARTED|Overall Study||6
8384435|NCT01085331|20666474|P1|STARTED|Overall Study||10
8384436|NCT01085318|20666513|P2|NOT COMPLETED|Overall Study||0
8384437|NCT01085318|20666514|P1|NOT COMPLETED|Overall Study||2
8384438|NCT01085318|20666513|P2|COMPLETED|Overall Study||15
8384439|NCT01085318|20666514|P1|COMPLETED|Overall Study||21
8384440|NCT01085318|20666513|P2|STARTED|Overall Study||15
8384441|NCT01085318|20666514|P1|STARTED|Overall Study||23
8384442|NCT01085214|20666524|P1|NOT COMPLETED|Overall Study||1
8384443|NCT01085214|20666524|P1|COMPLETED|Overall Study||36
8384444|NCT01085214|20666524|P1|STARTED|Overall Study||37
8384445|NCT01085201|20666536|P5|NOT COMPLETED|Overall Study||0
8384446|NCT01085201|20666537|P4|NOT COMPLETED|Overall Study||0
8384447|NCT01085201|20666538|P3|NOT COMPLETED|Overall Study||2
8384448|NCT01085201|20666539|P2|NOT COMPLETED|Overall Study||1
8384449|NCT01085201|20666540|P1|NOT COMPLETED|Overall Study||3
8384450|NCT01085201|20666536|P5|COMPLETED|Overall Study||3
8384451|NCT01085201|20666537|P4|COMPLETED|Overall Study||6
8384452|NCT01085201|20666538|P3|COMPLETED|Overall Study||3
8384453|NCT01085201|20666539|P2|COMPLETED|Overall Study||6
8384454|NCT01085201|20666540|P1|COMPLETED|Overall Study||15
8384455|NCT01085201|20666536|P5|STARTED|Overall Study||3
8384456|NCT01085201|20666537|P4|STARTED|Overall Study||6
8384457|NCT01085201|20666538|P3|STARTED|Overall Study||5
8384458|NCT01085201|20666539|P2|STARTED|Overall Study||7
8384459|NCT01085201|20666540|P1|STARTED|Overall Study||18
8384460|NCT01085136|20666562|P3|NOT COMPLETED|Part B||26
8384461|NCT01085136|20666563|P2|NOT COMPLETED|Part B||51
8384462|NCT01085136|20666564|P1|NOT COMPLETED|Part B||0
8384463|NCT01085136|20666562|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
8384464|NCT01085136|20666563|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
8384465|NCT01085136|20666564|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
8384466|NCT01085136|20666562|P3|STARTED|Part B||68
8384467|NCT01085136|20666563|P2|STARTED|Part B||138
8384468|NCT01085136|20666564|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
8384469|NCT01085136|20666562|P3|NOT COMPLETED|Part A||0
8384470|NCT01085136|20666563|P2|NOT COMPLETED|Part A||0
8384471|NCT01085136|20666564|P1|NOT COMPLETED|Part A||323
8384472|NCT01085136|20666562|P3|COMPLETED|Part A||0
8384473|NCT01085136|20666563|P2|COMPLETED|Part A||0
8384474|NCT01085136|20666564|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
8384475|NCT01085136|20666562|P3|Randomized to Part B|Part A||0
8384476|NCT01085136|20666563|P2|Randomized to Part B|Part A||0
8384477|NCT01085136|20666564|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
8384478|NCT01085136|20666562|P3|STARTED|Part A||0
8384479|NCT01085136|20666563|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
8384480|NCT01085136|20666564|P1|STARTED|Part A||1154
8384481|NCT01085045|20666580|P1|NOT COMPLETED|Part B||15
8384482|NCT01085045|20666580|P1|COMPLETED|Part B||89
8384483|NCT01085045|20666580|P1|GP MDI 36 µg (PT001)|Part B||0
8384484|NCT01085045|20666580|P1|Foradil 12 µg|Part B||41
8384485|NCT01085045|20666580|P1|Placebo MDI|Part B||47
8384486|NCT01085045|20666580|P1|FF MDI 7.2 µg (PT005)|Part B||43
8384487|NCT01085045|20666580|P1|FF MDI 9.6 µg (PT005)|Part B||43
8384488|NCT01085045|20666580|P1|Spiriva 18 µg|Part B||0
8384489|NCT01085045|20666580|P1|GFF MDI 36/9.6 µg|Part B||0
8384490|NCT01085045|20666580|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
8384491|NCT01085045|20666580|P1|STARTED|Part B||104
8384492|NCT01085045|20666580|P1|NOT COMPLETED|Part A||18
8384493|NCT01085045|20666580|P1|COMPLETED|Part A||104
8384494|NCT01085045|20666580|P1|Foradil 12 µg|Part A||14
8384495|NCT01085045|20666580|P1|Placebo MDI|Part A||5
8384496|NCT01085045|20666580|P1|FF MDI 7.2 µg (PT005)|Part A||21
8384497|NCT01085045|20666580|P1|FF MDI 9.6 µg (PT005)|Part A||20
8384498|NCT01085045|20666580|P1|Spiriva 18 µg|Part A||58
8384499|NCT01085045|20666580|P1|GP MDI 36 µg (PT001)|Part A||40
8384500|NCT01085045|20666580|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
8384501|NCT01085045|20666580|P1|GFF MDI 72/9.6mcg|Part A||40
8384502|NCT01085045|20666580|P1|STARTED|Part A||122
8384503|NCT01085006|20666682|P2|NOT COMPLETED|Overall Study||0
8384504|NCT01085006|20666683|P1|NOT COMPLETED|Overall Study||0
8384505|NCT01085006|20666682|P2|COMPLETED|Overall Study||50
8384506|NCT01085006|20666683|P1|COMPLETED|Overall Study||50
8384507|NCT01085006|20666682|P2|STARTED|Overall Study||50
8384508|NCT01085006|20666683|P1|STARTED|Overall Study||50
8384509|NCT01084772|20666691|P2|NOT COMPLETED|2 Years||4
8384510|NCT01084772|20666692|P1|NOT COMPLETED|2 Years||9
8384511|NCT01084772|20666691|P2|COMPLETED|2 Years||46
8384512|NCT01084772|20666692|P1|COMPLETED|2 Years||46
8384513|NCT01084772|20666691|P2|STARTED|2 Years||50
8384514|NCT01084772|20666692|P1|STARTED|2 Years||55
8384515|NCT01084772|20666691|P2|NOT COMPLETED|1 Year||8
8384516|NCT01084772|20666692|P1|NOT COMPLETED|1 Year||3
8384517|NCT01084772|20666691|P2|COMPLETED|1 Year||50
8384518|NCT01084772|20666692|P1|COMPLETED|1 Year||55
8384519|NCT01084772|20666691|P2|STARTED|1 Year||58
8384520|NCT01084772|20666692|P1|STARTED|1 Year||58
8384521|NCT01084772|20666691|P2|NOT COMPLETED|3 Months||2
8384522|NCT01084772|20666692|P1|NOT COMPLETED|3 Months||3
8384523|NCT01084772|20666691|P2|COMPLETED|3 Months||58
8384524|NCT01084772|20666692|P1|COMPLETED|3 Months||58
8384525|NCT01084772|20666691|P2|STARTED|3 Months||60
8384526|NCT01084772|20666692|P1|STARTED|3 Months||61
8384527|NCT01084772|20666691|P2|NOT COMPLETED|Baseline||6
8384528|NCT01084772|20666692|P1|NOT COMPLETED|Baseline||7
8384529|NCT01084772|20666691|P2|COMPLETED|Baseline||60
8384530|NCT01084772|20666692|P1|COMPLETED|Baseline||61
8384531|NCT01084772|20666691|P2|STARTED|Baseline||66
8384532|NCT01084772|20666692|P1|STARTED|Baseline||68
8384533|NCT01084759|20666722|P1|NOT COMPLETED|Overall Study||2
8384534|NCT01084759|20666722|P1|COMPLETED|Overall Study||14
8384535|NCT01084759|20666722|P1|STARTED|Overall Study||16
8384536|NCT01084707|20666728|P1|NOT COMPLETED|Overall Study||6
8384537|NCT01084707|20666728|P1|COMPLETED|Overall Study||34
8384538|NCT01084707|20666728|P1|STARTED|Overall Study||40
8384539|NCT01084694|20666764|P2|NOT COMPLETED|Overall Study||20
8384540|NCT01084694|20666765|P1|NOT COMPLETED|Overall Study||6
8384541|NCT01084694|20666764|P2|COMPLETED|Overall Study||30
8384542|NCT01084694|20666765|P1|COMPLETED|Overall Study||44
8384543|NCT01084694|20666764|P2|STARTED|Overall Study||50
8384544|NCT01084694|20666765|P1|STARTED|Overall Study||50
8384545|NCT01084668|20666781|P1|NOT COMPLETED|Overall Study||9
8384546|NCT01084668|20666781|P1|COMPLETED|Overall Study||33
8384547|NCT01084668|20666781|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
8384548|NCT01084655|20666793|P3|NOT COMPLETED|Overall Study||19
8384549|NCT01084655|20666794|P2|NOT COMPLETED|Overall Study||6
8384550|NCT01084655|20666795|P1|NOT COMPLETED|Overall Study||6
8384551|NCT01084655|20666793|P3|COMPLETED|Overall Study||5
8384552|NCT01084655|20666794|P2|COMPLETED|Overall Study||2
8384553|NCT01084655|20666795|P1|COMPLETED|Overall Study||0
8384554|NCT01084655|20666793|P3|Treated|Overall Study||23
8384555|NCT01084655|20666794|P2|Treated|Overall Study||8
8384556|NCT01084655|20666795|P1|Treated|Overall Study||6
8384557|NCT01084655|20666793|P3|STARTED|Overall Study||24
8384558|NCT01084655|20666794|P2|STARTED|Overall Study||8
8384559|NCT01084655|20666795|P1|STARTED|Overall Study||6
8384560|NCT01084603|20666830|P1|NOT COMPLETED|Oral Nicotine 4||0
8384561|NCT01084603|20666830|P1|COMPLETED|Oral Nicotine 4||39
8384562|NCT01084603|20666830|P1|STARTED|Oral Nicotine 4||39
8384563|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 4||1
8384564|NCT01084603|20666830|P1|COMPLETED|Washout Period 4||39
8384565|NCT01084603|20666830|P1|STARTED|Washout Period 4||40
8384566|NCT01084603|20666830|P1|NOT COMPLETED|Oral Nicotine 2||0
8384567|NCT01084603|20666830|P1|COMPLETED|Oral Nicotine 2||40
8384568|NCT01084603|20666830|P1|STARTED|Oral Nicotine 2||40
8384569|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 3||0
8384570|NCT01084603|20666830|P1|COMPLETED|Washout Period 3||40
8384571|NCT01084603|20666830|P1|STARTED|Washout Period 3||40
8384572|NCT01084603|20666830|P1|NOT COMPLETED|Oral Nicotine 1||1
8384573|NCT01084603|20666830|P1|COMPLETED|Oral Nicotine 1||40
8384574|NCT01084603|20666830|P1|STARTED|Oral Nicotine 1||41
8384575|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 2||0
8384576|NCT01084603|20666830|P1|COMPLETED|Washout Period 2||41
8384577|NCT01084603|20666830|P1|STARTED|Washout Period 2||41
8384578|NCT01084603|20666830|P1|NOT COMPLETED|Nicorette® Gum||1
8384579|NCT01084603|20666830|P1|COMPLETED|Nicorette® Gum||41
8384580|NCT01084603|20666830|P1|STARTED|Nicorette® Gum||42
8384581|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 1||0
8384582|NCT01084603|20666830|P1|COMPLETED|Washout Period 1||42
8384583|NCT01084603|20666830|P1|STARTED|Washout Period 1||42
8384584|NCT01084603|20666830|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
8384585|NCT01084603|20666830|P1|COMPLETED|NiQuitinTM Lozenge||42
8384586|NCT01084603|20666830|P1|STARTED|NiQuitinTM Lozenge||43
8384587|NCT01084603|20666830|P1|NOT COMPLETED|Baseline||2
8384588|NCT01084603|20666830|P1|COMPLETED|Baseline||43
8384589|NCT01084603|20666830|P1|STARTED|Baseline||45
8384590|NCT01084551|20666866|P3|NOT COMPLETED|Overall Study||8
8384591|NCT01084551|20666867|P2|NOT COMPLETED|Overall Study||14
8384592|NCT01084551|20666868|P1|NOT COMPLETED|Overall Study||9
8384593|NCT01084551|20666866|P3|COMPLETED|Overall Study||86
8384594|NCT01084551|20666867|P2|COMPLETED|Overall Study||81
8384595|NCT01084551|20666868|P1|COMPLETED|Overall Study||86
8384596|NCT01084551|20666866|P3|STARTED|Overall Study||94
8384597|NCT01084551|20666867|P2|STARTED|Overall Study||95
8384598|NCT01084551|20666868|P1|STARTED|Overall Study||95
8384599|NCT01084538|20666906|P1|NOT COMPLETED|Overall Study||68
8384600|NCT01084538|20666906|P1|COMPLETED|Overall Study||113
8384601|NCT01084538|20666906|P1|STARTED|Overall Study||181
8384602|NCT01084499|20666915|P2|NOT COMPLETED|Overall Study||0
8384603|NCT01084499|20666916|P1|NOT COMPLETED|Overall Study||0
8384604|NCT01084499|20666915|P2|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
8384605|NCT01084499|20666916|P1|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
8384606|NCT01084499|20666915|P2|Washout (5 Weeks)|Overall Study||13
8384607|NCT01084499|20666916|P1|Washout (5 Weeks)|Overall Study||13
8384608|NCT01084499|20666915|P2|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
8384609|NCT01084499|20666916|P1|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
8384610|NCT01084278|20666929|P5|NOT COMPLETED|Overall Study||0
8384611|NCT01084278|20666930|P4|NOT COMPLETED|Overall Study||0
8384612|NCT01084278|20666931|P3|NOT COMPLETED|Overall Study||0
8384613|NCT01084278|20666932|P2|NOT COMPLETED|Overall Study||0
8384614|NCT01084278|20666933|P1|NOT COMPLETED|Overall Study||0
8384615|NCT01084278|20666929|P5|COMPLETED|Overall Study||8
8384616|NCT01084278|20666930|P4|COMPLETED|Overall Study||8
8384617|NCT01084278|20666931|P3|COMPLETED|Overall Study||8
8384618|NCT01084278|20666932|P2|COMPLETED|Overall Study||8
8384619|NCT01084278|20666933|P1|COMPLETED|Overall Study||8
8384620|NCT01084278|20666929|P5|STARTED|Overall Study||8
8384621|NCT01084278|20666930|P4|STARTED|Overall Study||8
8384622|NCT01084278|20666931|P3|STARTED|Overall Study||8
8384623|NCT01084278|20666932|P2|STARTED|Overall Study||8
8384624|NCT01084278|20666933|P1|STARTED|Overall Study||8
8384625|NCT01084265|20667014|P1|NOT COMPLETED|Overall Study||0
8384626|NCT01084265|20667014|P1|COMPLETED|Overall Study||31
8384627|NCT01084265|20667014|P1|STARTED|Overall Study||31
8384628|NCT01084252|20667040|P14|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
8384629|NCT01084252|20667041|P13|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
8384630|NCT01084252|20667042|P12|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384631|NCT01084252|20667043|P11|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384632|NCT01084252|20667044|P10|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384633|NCT01084252|20667045|P9|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384634|NCT01084252|20667046|P8|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384635|NCT01084252|20667047|P7|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384636|NCT01084252|20667048|P6|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384637|NCT01084252|20667049|P5|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384638|NCT01084252|20667050|P4|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384639|NCT01084252|20667051|P3|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384640|NCT01084252|20667052|P2|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384641|NCT01084252|20667053|P1|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384642|NCT01084252|20667040|P14|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384643|NCT01084252|20667041|P13|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384644|NCT01084252|20667042|P12|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384645|NCT01084252|20667043|P11|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384646|NCT01084252|20667044|P10|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384647|NCT01084252|20667045|P9|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384648|NCT01084252|20667046|P8|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384649|NCT01084252|20667047|P7|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384650|NCT01084252|20667048|P6|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384651|NCT01084252|20667049|P5|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384652|NCT01084252|20667050|P4|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384653|NCT01084252|20667051|P3|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384654|NCT01084252|20667052|P2|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384655|NCT01084252|20667053|P1|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8384656|NCT01084252|20667040|P14|AT Population|Phase 2 Stage 2 (97 Weeks)||55
8384657|NCT01084252|20667041|P13|AT Population|Phase 2 Stage 2 (97 Weeks)||109
8384658|NCT01084252|20667042|P12|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384659|NCT01084252|20667043|P11|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384660|NCT01084252|20667044|P10|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384661|NCT01084252|20667045|P9|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384662|NCT01084252|20667046|P8|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384663|NCT01084252|20667047|P7|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384664|NCT01084252|20667048|P6|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384665|NCT01084252|20667049|P5|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384666|NCT01084252|20667050|P4|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384667|NCT01084252|20667051|P3|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384668|NCT01084252|20667052|P2|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384669|NCT01084252|20667053|P1|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8384670|NCT01084252|20667040|P14|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
8384671|NCT01084252|20667041|P13|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
8384672|NCT01084252|20667042|P12|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384673|NCT01084252|20667043|P11|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384674|NCT01084252|20667044|P10|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384675|NCT01084252|20667045|P9|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384676|NCT01084252|20667046|P8|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384677|NCT01084252|20667047|P7|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384678|NCT01084252|20667048|P6|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384679|NCT01084252|20667049|P5|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384680|NCT01084252|20667050|P4|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384681|NCT01084252|20667051|P3|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384682|NCT01084252|20667052|P2|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384683|NCT01084252|20667053|P1|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8384684|NCT01084252|20667040|P14|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384685|NCT01084252|20667041|P13|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384686|NCT01084252|20667042|P12|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8384687|NCT01084252|20667043|P11|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8384688|NCT01084252|20667044|P10|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
8384689|NCT01084252|20667045|P9|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
8384690|NCT01084252|20667046|P8|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384691|NCT01084252|20667047|P7|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384692|NCT01084252|20667048|P6|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384693|NCT01084252|20667049|P5|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384694|NCT01084252|20667050|P4|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384695|NCT01084252|20667051|P3|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384696|NCT01084252|20667052|P2|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384697|NCT01084252|20667053|P1|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384698|NCT01084252|20667040|P14|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384699|NCT01084252|20667041|P13|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384700|NCT01084252|20667042|P12|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384701|NCT01084252|20667043|P11|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384702|NCT01084252|20667044|P10|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384703|NCT01084252|20667045|P9|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384704|NCT01084252|20667046|P8|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384705|NCT01084252|20667047|P7|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384706|NCT01084252|20667048|P6|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384707|NCT01084252|20667049|P5|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384708|NCT01084252|20667050|P4|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384709|NCT01084252|20667051|P3|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384710|NCT01084252|20667052|P2|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384711|NCT01084252|20667053|P1|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384712|NCT01084252|20667040|P14|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384713|NCT01084252|20667041|P13|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384714|NCT01084252|20667042|P12|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8384715|NCT01084252|20667043|P11|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8384716|NCT01084252|20667044|P10|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
8384717|NCT01084252|20667045|P9|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
8384718|NCT01084252|20667046|P8|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384719|NCT01084252|20667047|P7|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384720|NCT01084252|20667048|P6|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384721|NCT01084252|20667049|P5|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384722|NCT01084252|20667050|P4|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384723|NCT01084252|20667051|P3|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384724|NCT01084252|20667052|P2|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384725|NCT01084252|20667053|P1|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384726|NCT01084252|20667040|P14|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384727|NCT01084252|20667041|P13|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384728|NCT01084252|20667042|P12|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
8384729|NCT01084252|20667043|P11|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
8384730|NCT01084252|20667044|P10|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
8384731|NCT01084252|20667045|P9|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
8384732|NCT01084252|20667046|P8|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384733|NCT01084252|20667047|P7|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384734|NCT01084252|20667048|P6|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384735|NCT01084252|20667049|P5|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384736|NCT01084252|20667050|P4|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384737|NCT01084252|20667051|P3|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384738|NCT01084252|20667052|P2|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384739|NCT01084252|20667053|P1|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8384740|NCT01084252|20667040|P14|NOT COMPLETED|Phase 1 (120 Weeks)||0
8384741|NCT01084252|20667041|P13|NOT COMPLETED|Phase 1 (120 Weeks)||0
8384742|NCT01084252|20667042|P12|NOT COMPLETED|Phase 1 (120 Weeks)||0
8384743|NCT01084252|20667043|P11|NOT COMPLETED|Phase 1 (120 Weeks)||0
8384744|NCT01084252|20667044|P10|NOT COMPLETED|Phase 1 (120 Weeks)||0
8384745|NCT01084252|20667045|P9|NOT COMPLETED|Phase 1 (120 Weeks)||0
8384746|NCT01084252|20667046|P8|NOT COMPLETED|Phase 1 (120 Weeks)||7
8384747|NCT01084252|20667047|P7|NOT COMPLETED|Phase 1 (120 Weeks)||7
8384748|NCT01084252|20667048|P6|NOT COMPLETED|Phase 1 (120 Weeks)||6
8384749|NCT01084252|20667049|P5|NOT COMPLETED|Phase 1 (120 Weeks)||18
8384750|NCT01084252|20667050|P4|NOT COMPLETED|Phase 1 (120 Weeks)||26
8384751|NCT01084252|20667051|P3|NOT COMPLETED|Phase 1 (120 Weeks)||3
8384752|NCT01084252|20667052|P2|NOT COMPLETED|Phase 1 (120 Weeks)||6
8384753|NCT01084252|20667053|P1|NOT COMPLETED|Phase 1 (120 Weeks)||16
8384754|NCT01084252|20667040|P14|COMPLETED|Phase 1 (120 Weeks)||0
8384755|NCT01084252|20667041|P13|COMPLETED|Phase 1 (120 Weeks)||0
8384756|NCT01084252|20667042|P12|COMPLETED|Phase 1 (120 Weeks)||0
8384757|NCT01084252|20667043|P11|COMPLETED|Phase 1 (120 Weeks)||0
8384758|NCT01084252|20667044|P10|COMPLETED|Phase 1 (120 Weeks)||0
8384759|NCT01084252|20667045|P9|COMPLETED|Phase 1 (120 Weeks)||0
8384760|NCT01084252|20667046|P8|COMPLETED|Phase 1 (120 Weeks)||0
8384761|NCT01084252|20667047|P7|COMPLETED|Phase 1 (120 Weeks)||0
8384762|NCT01084252|20667048|P6|COMPLETED|Phase 1 (120 Weeks)||0
8384763|NCT01084252|20667049|P5|COMPLETED|Phase 1 (120 Weeks)||0
8384764|NCT01084252|20667050|P4|COMPLETED|Phase 1 (120 Weeks)||0
8384765|NCT01084252|20667051|P3|COMPLETED|Phase 1 (120 Weeks)||0
8384766|NCT01084252|20667052|P2|COMPLETED|Phase 1 (120 Weeks)||0
8384767|NCT01084252|20667053|P1|COMPLETED|Phase 1 (120 Weeks)||0
8384768|NCT01084252|20667040|P14|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8384769|NCT01084252|20667041|P13|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8384770|NCT01084252|20667042|P12|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8384771|NCT01084252|20667043|P11|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8384772|NCT01084252|20667044|P10|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8384773|NCT01084252|20667045|P9|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8384774|NCT01084252|20667046|P8|All Treated (AT) Population|Phase 1 (120 Weeks)||7
8384775|NCT01084252|20667047|P7|All Treated (AT) Population|Phase 1 (120 Weeks)||7
8384776|NCT01084252|20667048|P6|All Treated (AT) Population|Phase 1 (120 Weeks)||6
8384777|NCT01084252|20667049|P5|All Treated (AT) Population|Phase 1 (120 Weeks)||18
8384778|NCT01084252|20667050|P4|All Treated (AT) Population|Phase 1 (120 Weeks)||26
8384779|NCT01084252|20667051|P3|All Treated (AT) Population|Phase 1 (120 Weeks)||3
8384780|NCT01084252|20667052|P2|All Treated (AT) Population|Phase 1 (120 Weeks)||6
8384781|NCT01084252|20667053|P1|All Treated (AT) Population|Phase 1 (120 Weeks)||16
8384782|NCT01084252|20667040|P14|STARTED|Phase 1 (120 Weeks)||0
8384783|NCT01084252|20667041|P13|STARTED|Phase 1 (120 Weeks)||0
8384784|NCT01084252|20667042|P12|STARTED|Phase 1 (120 Weeks)||0
8384785|NCT01084252|20667043|P11|STARTED|Phase 1 (120 Weeks)||0
8384786|NCT01084252|20667044|P10|STARTED|Phase 1 (120 Weeks)||0
8384787|NCT01084252|20667045|P9|STARTED|Phase 1 (120 Weeks)||0
8384788|NCT01084252|20667046|P8|STARTED|Phase 1 (120 Weeks)||7
8384789|NCT01084252|20667047|P7|STARTED|Phase 1 (120 Weeks)||7
8384790|NCT01084252|20667048|P6|STARTED|Phase 1 (120 Weeks)||6
8384791|NCT01084252|20667049|P5|STARTED|Phase 1 (120 Weeks)||18
8384792|NCT01084252|20667050|P4|STARTED|Phase 1 (120 Weeks)||26
8384793|NCT01084252|20667051|P3|STARTED|Phase 1 (120 Weeks)||3
8384794|NCT01084252|20667052|P2|STARTED|Phase 1 (120 Weeks)||6
8384795|NCT01084252|20667053|P1|STARTED|Phase 1 (120 Weeks)||16
8384796|NCT01084239|20667237|P2|NOT COMPLETED|28-Day Follow-up||9
8384797|NCT01084239|20667238|P1|NOT COMPLETED|28-Day Follow-up||4
8384798|NCT01084239|20667237|P2|COMPLETED|28-Day Follow-up||490
8384799|NCT01084239|20667238|P1|COMPLETED|28-Day Follow-up||497
8384800|NCT01084239|20667237|P2|STARTED|28-Day Follow-up||499
8384801|NCT01084239|20667238|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
8384802|NCT01084239|20667237|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
8384803|NCT01084239|20667238|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
8384804|NCT01084239|20667237|P2|COMPLETED|Randomization - Index Hospitalization||499
8384805|NCT01084239|20667238|P1|COMPLETED|Randomization - Index Hospitalization||501
8384806|NCT01084239|20667237|P2|STARTED|Randomization - Index Hospitalization||499
8384807|NCT01084239|20667238|P1|STARTED|Randomization - Index Hospitalization||501
8384808|NCT01084174|20667256|P2|NOT COMPLETED|Overall Study||4
8384809|NCT01084174|20667257|P1|NOT COMPLETED|Overall Study||1
8384810|NCT01084174|20667256|P2|COMPLETED|Overall Study||7
8384811|NCT01084174|20667257|P1|COMPLETED|Overall Study||9
8384812|NCT01084174|20667256|P2|STARTED|Overall Study||11
8384813|NCT01084174|20667257|P1|STARTED|Overall Study||10
8384814|NCT01084148|20667277|P2|NOT COMPLETED|Overall Study||16
8384815|NCT01084148|20667278|P1|NOT COMPLETED|Overall Study||30
8384816|NCT01084148|20667277|P2|COMPLETED|Overall Study||102
8384817|NCT01084148|20667278|P1|COMPLETED|Overall Study||88
8384818|NCT01084148|20667277|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
8384819|NCT01084148|20667278|P1|Treated Patients|Overall Study||118
8384820|NCT01084148|20667277|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
8384821|NCT01084148|20667278|P1|STARTED|Overall Study||118
8384822|NCT01084135|20667290|P2|NOT COMPLETED|20 Week||1
8384823|NCT01084135|20667291|P1|NOT COMPLETED|20 Week||0
8384824|NCT01084135|20667290|P2|COMPLETED|20 Week||10
8384825|NCT01084135|20667291|P1|COMPLETED|20 Week||12
8384826|NCT01084135|20667290|P2|STARTED|20 Week||11
8384827|NCT01084135|20667291|P1|STARTED|20 Week||12
8384828|NCT01084135|20667290|P2|NOT COMPLETED|12 Week||0
8384829|NCT01084135|20667291|P1|NOT COMPLETED|12 Week||0
8384830|NCT01084135|20667290|P2|COMPLETED|12 Week||4
8384831|NCT01084135|20667291|P1|COMPLETED|12 Week||4
8384832|NCT01084135|20667290|P2|STARTED|12 Week||4
8384833|NCT01084135|20667291|P1|STARTED|12 Week||4
8384834|NCT01084083|20667301|P1|NOT COMPLETED|Overall Study||12
8384835|NCT01084083|20667301|P1|COMPLETED|Overall Study||78
8384836|NCT01084083|20667301|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
8384837|NCT01084083|20667301|P1|CR to Induction Therapy|Overall Study||56
8384838|NCT01084083|20667301|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
8384839|NCT01084083|20667301|P1|Eligible|Overall Study||81
8384840|NCT01084083|20667301|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
8384841|NCT01084083|20667301|P1|STARTED|Overall Study||90
8384842|NCT01084005|20667309|P2|NOT COMPLETED|Overall Study||16
8384843|NCT01084005|20667310|P1|NOT COMPLETED|Overall Study||5
8384844|NCT01084005|20667309|P2|COMPLETED|Overall Study||146
8384845|NCT01084005|20667310|P1|COMPLETED|Overall Study||74
8384846|NCT01084005|20667309|P2|STARTED|Overall Study||162
8384847|NCT01084005|20667310|P1|STARTED|Overall Study||79
8384848|NCT01083979|20667338|P1|NOT COMPLETED|Overall Study||0
8384849|NCT01083979|20667338|P1|COMPLETED|Overall Study||1
8384850|NCT01083979|20667338|P1|STARTED|Overall Study||1
8384851|NCT01083901|20667346|P3|NOT COMPLETED|Overall Study||2
8384852|NCT01083901|20667347|P2|NOT COMPLETED|Overall Study||2
8384853|NCT01083901|20667348|P1|NOT COMPLETED|Overall Study||1
8384854|NCT01083901|20667346|P3|COMPLETED|Overall Study||11
8384855|NCT01083901|20667347|P2|COMPLETED|Overall Study||6
8384856|NCT01083901|20667348|P1|COMPLETED|Overall Study||12
8384857|NCT01083901|20667346|P3|STARTED|Overall Study||13
8384858|NCT01083901|20667347|P2|STARTED|Overall Study||8
8384859|NCT01083901|20667348|P1|STARTED|Overall Study||13
8384860|NCT01083849|20667367|P2|NOT COMPLETED|Overall Study||111
8384861|NCT01083849|20667368|P1|NOT COMPLETED|Overall Study||60
8384862|NCT01083849|20667367|P2|COMPLETED|Overall Study||527
8384863|NCT01083849|20667368|P1|COMPLETED|Overall Study||61
8384864|NCT01083849|20667367|P2|STARTED|Overall Study||638
8384865|NCT01083849|20667368|P1|STARTED|Overall Study||121
8384866|NCT01083810|20667391|P3|NOT COMPLETED|Overall Study||20
8384867|NCT01083810|20667392|P2|NOT COMPLETED|Overall Study||45
8384868|NCT01083810|20667393|P1|NOT COMPLETED|Overall Study||65
8384869|NCT01083810|20667391|P3|COMPLETED|Overall Study||35
8384870|NCT01083810|20667392|P2|COMPLETED|Overall Study||47
8384871|NCT01083810|20667393|P1|COMPLETED|Overall Study||72
8384872|NCT01083810|20667391|P3|STARTED|Overall Study||55
8384873|NCT01083810|20667392|P2|STARTED|Overall Study||92
8384874|NCT01083810|20667393|P1|STARTED|Overall Study||137
8384875|NCT01083771|20667414|P1|NOT COMPLETED|Overall Study||5
8384876|NCT01083771|20667414|P1|COMPLETED|Overall Study||16
8384877|NCT01083771|20667414|P1|STARTED|Overall Study||21
8384878|NCT01083758|20667419|P1|NOT COMPLETED|Overall Study||2
8384879|NCT01083758|20667419|P1|COMPLETED|Overall Study||29
8384880|NCT01083758|20667419|P1|STARTED|Overall Study||31
8384881|NCT01083732|20667453|P3|NOT COMPLETED|Overall Study||0
8384882|NCT01083732|20667454|P2|NOT COMPLETED|Overall Study||0
8384883|NCT01083732|20667455|P1|NOT COMPLETED|Overall Study||0
8384884|NCT01083732|20667453|P3|COMPLETED|Overall Study||3
8384885|NCT01083732|20667454|P2|COMPLETED|Overall Study||9
8384886|NCT01083732|20667455|P1|COMPLETED|Overall Study||6
8384887|NCT01083732|20667453|P3|STARTED|Overall Study||3
8384888|NCT01083732|20667454|P2|STARTED|Overall Study||9
8384889|NCT01083732|20667455|P1|STARTED|Overall Study||6
8384890|NCT01083706|20667506|P1|NOT COMPLETED|Overall Study||0
8384891|NCT01083706|20667506|P1|COMPLETED|Overall Study||39
8384892|NCT01083706|20667506|P1|STARTED|Overall Study||39
8384893|NCT01083693|20667515|P3|NOT COMPLETED|Overall Study||7
8384894|NCT01083693|20667516|P2|NOT COMPLETED|Overall Study||6
8384895|NCT01083693|20667517|P1|NOT COMPLETED|Overall Study||20
8384896|NCT01083693|20667515|P3|COMPLETED|Overall Study||33
8384897|NCT01083693|20667516|P2|COMPLETED|Overall Study||22
8384898|NCT01083693|20667517|P1|COMPLETED|Overall Study||73
8384899|NCT01083693|20667515|P3|STARTED|Overall Study||40
8384900|NCT01083693|20667516|P2|STARTED|Overall Study||28
8384901|NCT01083693|20667517|P1|STARTED|Overall Study||93
8384902|NCT01083680|20667552|P1|NOT COMPLETED|Overall Study||3844
8384903|NCT01083680|20667552|P1|COMPLETED|Overall Study||263
8384904|NCT01083680|20667552|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
8384905|NCT01083680|20667552|P1|STARTED|Overall Study||4107
8384906|NCT01083667|20667561|P1|NOT COMPLETED|Overall Study||10
8384907|NCT01083667|20667561|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
8384908|NCT01083667|20667561|P1|STARTED|Overall Study|enrolled|32
8384909|NCT01083654|20667568|P2|NOT COMPLETED|Overall Study||0
8384910|NCT01083654|20667569|P1|NOT COMPLETED|Overall Study||0
8384911|NCT01083654|20667568|P2|COMPLETED|Overall Study||50
8384912|NCT01083654|20667569|P1|COMPLETED|Overall Study||53
8384913|NCT01083654|20667568|P2|STARTED|Overall Study||50
8384914|NCT01083654|20667569|P1|STARTED|Overall Study||53
8384915|NCT01083641|20667575|P1|NOT COMPLETED|Overall Study||2
8384916|NCT01083641|20667575|P1|COMPLETED|Overall Study||15
8384917|NCT01083641|20667575|P1|STARTED|Overall Study||17
8384918|NCT01083628|20667584|P2|NOT COMPLETED|Overall Study||0
8384919|NCT01083628|20667585|P1|NOT COMPLETED|Overall Study||0
8384920|NCT01083628|20667584|P2|COMPLETED|Overall Study||40
8384921|NCT01083628|20667585|P1|COMPLETED|Overall Study||45
8384922|NCT01083628|20667584|P2|STARTED|Overall Study||40
8384923|NCT01083628|20667585|P1|STARTED|Overall Study||45
8384924|NCT01083602|20667595|P1|NOT COMPLETED|Overall Study||55
8384925|NCT01083602|20667595|P1|COMPLETED|Overall Study||0
8384926|NCT01083602|20667595|P1|STARTED|Overall Study||55
8384927|NCT01083576|20667606|P2|NOT COMPLETED|Overall Study||1
8384928|NCT01083576|20667607|P1|NOT COMPLETED|Overall Study||6
8384929|NCT01083576|20667606|P2|COMPLETED|Overall Study||14
8384930|NCT01083576|20667607|P1|COMPLETED|Overall Study||9
8384931|NCT01083576|20667606|P2|STARTED|Overall Study||15
8384932|NCT01083576|20667607|P1|STARTED|Overall Study||15
8384933|NCT01083485|20667637|P2|NOT COMPLETED|Overall Study||3
8384934|NCT01083485|20667638|P1|NOT COMPLETED|Overall Study||7
8384935|NCT01083485|20667637|P2|COMPLETED|Overall Study||64
8384936|NCT01083485|20667638|P1|COMPLETED|Overall Study||63
8384937|NCT01083485|20667637|P2|STARTED|Overall Study||67
8384938|NCT01083485|20667638|P1|STARTED|Overall Study||70
8384939|NCT01083472|20667648|P2|NOT COMPLETED|Overall Study||0
8384940|NCT01083472|20667649|P1|NOT COMPLETED|Overall Study||0
8384941|NCT01083472|20667648|P2|COMPLETED|Overall Study||19
8384942|NCT01083472|20667649|P1|COMPLETED|Overall Study||18
8384943|NCT01083472|20667648|P2|STARTED|Overall Study||19
8384944|NCT01083472|20667649|P1|STARTED|Overall Study||18
8384945|NCT01083368|20667657|P4|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384946|NCT01083368|20667658|P3|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384947|NCT01083368|20667659|P2|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384948|NCT01083368|20667660|P1|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384949|NCT01083368|20667657|P4|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
8384950|NCT01083368|20667658|P3|COMPLETED|Phase II - Efficacy/Safety||0
8384951|NCT01083368|20667659|P2|COMPLETED|Phase II - Efficacy/Safety||0
8384952|NCT01083368|20667660|P1|COMPLETED|Phase II - Efficacy/Safety||0
8384953|NCT01083368|20667657|P4|STARTED|Phase II - Efficacy/Safety||20
8384954|NCT01083368|20667658|P3|STARTED|Phase II - Efficacy/Safety||0
8384955|NCT01083368|20667659|P2|STARTED|Phase II - Efficacy/Safety||0
8384956|NCT01083368|20667660|P1|STARTED|Phase II - Efficacy/Safety||0
8384957|NCT01083368|20667657|P4|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384958|NCT01083368|20667658|P3|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384959|NCT01083368|20667659|P2|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384960|NCT01083368|20667660|P1|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384961|NCT01083368|20667657|P4|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
8384962|NCT01083368|20667658|P3|COMPLETED|Dose Escalation Weeks 5-9||1
8384963|NCT01083368|20667659|P2|COMPLETED|Dose Escalation Weeks 5-9||0
8384964|NCT01083368|20667660|P1|COMPLETED|Dose Escalation Weeks 5-9||0
8384965|NCT01083368|20667657|P4|STARTED|Dose Escalation Weeks 5-9||6
8384966|NCT01083368|20667658|P3|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
8384967|NCT01083368|20667659|P2|STARTED|Dose Escalation Weeks 5-9||0
8384968|NCT01083368|20667660|P1|STARTED|Dose Escalation Weeks 5-9||0
8384969|NCT01083368|20667657|P4|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384970|NCT01083368|20667658|P3|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384971|NCT01083368|20667659|P2|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384972|NCT01083368|20667660|P1|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384973|NCT01083368|20667657|P4|COMPLETED|Dose Escalation Weeks 1-4||0
8384974|NCT01083368|20667658|P3|COMPLETED|Dose Escalation Weeks 1-4||4
8384975|NCT01083368|20667659|P2|COMPLETED|Dose Escalation Weeks 1-4||0
8384976|NCT01083368|20667660|P1|COMPLETED|Dose Escalation Weeks 1-4||0
8384977|NCT01083368|20667657|P4|Disease Progression|Dose Escalation Weeks 1-4||0
8384978|NCT01083368|20667658|P3|Disease Progression|Dose Escalation Weeks 1-4||1
8384979|NCT01083368|20667659|P2|Disease Progression|Dose Escalation Weeks 1-4||0
8384980|NCT01083368|20667660|P1|Disease Progression|Dose Escalation Weeks 1-4||0
8384981|NCT01083368|20667657|P4|STARTED|Dose Escalation Weeks 1-4||0
8384982|NCT01083368|20667658|P3|STARTED|Dose Escalation Weeks 1-4||4
8384983|NCT01083368|20667659|P2|STARTED|Dose Escalation Weeks 1-4||0
8384984|NCT01083368|20667660|P1|STARTED|Dose Escalation Weeks 1-4||0
8384985|NCT01083316|20667670|P1|NOT COMPLETED|Overall Study||3
8384986|NCT01083316|20667670|P1|COMPLETED|Overall Study||32
8384987|NCT01083316|20667670|P1|STARTED|Overall Study||35
8384988|NCT01083199|20667677|P1|NOT COMPLETED|Overall Study||0
8384989|NCT01083199|20667677|P1|COMPLETED|Overall Study||10
8384990|NCT01083199|20667677|P1|STARTED|Overall Study||10
8384991|NCT01083186|20667682|P1|NOT COMPLETED|Overall Study||94
8384992|NCT01083186|20667682|P1|COMPLETED|Overall Study||406
8384993|NCT01083186|20667682|P1|STARTED|Overall Study||500
8384994|NCT01083173|20667723|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
8384995|NCT01083173|20667724|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
8384996|NCT01083173|20667723|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
8384997|NCT01083173|20667724|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
8384998|NCT01083173|20667723|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
8384999|NCT01083173|20667724|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
8385000|NCT01083173|20667723|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
8385001|NCT01083173|20667724|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
8385002|NCT01083173|20667723|P2|COMPLETED|Long-term Surveillance: Safety Group||479
8385003|NCT01083173|20667724|P1|COMPLETED|Long-term Surveillance: Safety Group||0
8385004|NCT01083173|20667723|P2|STARTED|Long-term Surveillance: Safety Group||595
8385005|NCT01083173|20667724|P1|STARTED|Long-term Surveillance: Safety Group||0
8385006|NCT01083173|20667723|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
8385007|NCT01083173|20667724|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
8385008|NCT01083173|20667723|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
8385009|NCT01083173|20667724|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
8385010|NCT01083173|20667723|P2|STARTED|Main Surveillance: Effectiveness Group||0
8385011|NCT01083173|20667724|P1|STARTED|Main Surveillance: Effectiveness Group||580
8385012|NCT01083173|20667723|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
8385013|NCT01083173|20667724|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
8385014|NCT01083173|20667723|P2|COMPLETED|Main Surveillance: Safety Group||0
8385015|NCT01083173|20667724|P1|COMPLETED|Main Surveillance: Safety Group||580
8385016|NCT01083173|20667723|P2|STARTED|Main Surveillance: Safety Group||0
8385017|NCT01083173|20667724|P1|STARTED|Main Surveillance: Safety Group||595
8385018|NCT01083160|20667742|P1|NOT COMPLETED|Overall Study||1
8385019|NCT01083160|20667742|P1|COMPLETED|Overall Study||81
8385020|NCT01083160|20667742|P1|Evaluable Population|Overall Study||71
8385021|NCT01083160|20667742|P1|STARTED|Overall Study||82
8385022|NCT01083121|20667749|P1|NOT COMPLETED|Overall Study||81
8385023|NCT01083121|20667749|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
8385024|NCT01083121|20667749|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
8385025|NCT01082965|20667759|P2|NOT COMPLETED|Overall Study||2
8385026|NCT01082965|20667760|P1|NOT COMPLETED|Overall Study||1
8385027|NCT01082965|20667759|P2|COMPLETED|Overall Study||6
8385028|NCT01082965|20667760|P1|COMPLETED|Overall Study||9
8385029|NCT01082965|20667759|P2|STARTED|Overall Study||8
8385030|NCT01082965|20667760|P1|STARTED|Overall Study||10
8385031|NCT01082952|20667780|P2|NOT COMPLETED|Overall Study||0
8385032|NCT01082952|20667781|P1|NOT COMPLETED|Overall Study||0
8385033|NCT01082952|20667780|P2|COMPLETED|Overall Study||6
8385034|NCT01082952|20667781|P1|COMPLETED|Overall Study||6
8385035|NCT01082952|20667780|P2|STARTED|Overall Study||6
8385036|NCT01082952|20667781|P1|STARTED|Overall Study||6
8385037|NCT01082939|20667789|P1|NOT COMPLETED|Overall Study||0
8385038|NCT01082939|20667789|P1|COMPLETED|Overall Study||80
8385039|NCT01082939|20667789|P1|STARTED|Overall Study||80
8385040|NCT01082874|20667797|P4|NOT COMPLETED|Overall Study||13
8385041|NCT01082874|20667798|P3|NOT COMPLETED|Overall Study||11
8385042|NCT01082874|20667799|P2|NOT COMPLETED|Overall Study||12
8385043|NCT01082874|20667800|P1|NOT COMPLETED|Overall Study||11
8385044|NCT01082874|20667797|P4|COMPLETED|Overall Study||2489
8385045|NCT01082874|20667798|P3|COMPLETED|Overall Study||2488
8385046|NCT01082874|20667799|P2|COMPLETED|Overall Study||2498
8385047|NCT01082874|20667800|P1|COMPLETED|Overall Study||2488
8385048|NCT01082874|20667797|P4|STARTED|Overall Study||2502
8385049|NCT01082874|20667798|P3|STARTED|Overall Study||2499
8385050|NCT01082874|20667799|P2|STARTED|Overall Study||2510
8385051|NCT01082874|20667800|P1|STARTED|Overall Study||2499
8385052|NCT01082640|20667813|P3|NOT COMPLETED|Overall Study||8
8385053|NCT01082640|20667814|P2|NOT COMPLETED|Overall Study||15
8385054|NCT01082640|20667815|P1|NOT COMPLETED|Overall Study||17
8385055|NCT01082640|20667813|P3|COMPLETED|Overall Study||24
8385056|NCT01082640|20667814|P2|COMPLETED|Overall Study||17
8385057|NCT01082640|20667815|P1|COMPLETED|Overall Study||15
8385058|NCT01082640|20667813|P3|STARTED|Overall Study||32
8385059|NCT01082640|20667814|P2|STARTED|Overall Study||32
8385060|NCT01082640|20667815|P1|STARTED|Overall Study||32
8385061|NCT01082614|20667837|P2|NOT COMPLETED|Overall Study||5
8385062|NCT01082614|20667838|P1|NOT COMPLETED|Overall Study||3
8385063|NCT01082614|20667837|P2|COMPLETED|Overall Study||18
8385064|NCT01082614|20667838|P1|COMPLETED|Overall Study||20
8385065|NCT01082614|20667837|P2|STARTED|Overall Study||23
8385066|NCT01082614|20667838|P1|STARTED|Overall Study||23
8385067|NCT01082588|20667850|P2|NOT COMPLETED|Overall Study||5
8385068|NCT01082588|20667851|P1|NOT COMPLETED|Overall Study||6
8385069|NCT01082588|20667850|P2|COMPLETED|Overall Study||25
8385070|NCT01082588|20667851|P1|COMPLETED|Overall Study||24
8385071|NCT01082588|20667850|P2|STARTED|Overall Study||30
8385072|NCT01082588|20667851|P1|STARTED|Overall Study||30
8385073|NCT01082575|20667869|P1|NOT COMPLETED|Overall Study||0
8385074|NCT01082575|20667869|P1|COMPLETED|Overall Study||100
8385075|NCT01082575|20667869|P1|STARTED|Overall Study||100
8385076|NCT01082380|20667874|P1|NOT COMPLETED|Overall Study||0
8385077|NCT01082380|20667874|P1|COMPLETED|Overall Study||6
8385078|NCT01082380|20667874|P1|STARTED|Overall Study||6
8385079|NCT01082367|20667909|P2|NOT COMPLETED|Follow-up (F-U) Period||1
8385080|NCT01082367|20667910|P1|NOT COMPLETED|Follow-up (F-U) Period||2
8385081|NCT01082367|20667909|P2|COMPLETED|Follow-up (F-U) Period||9
8385082|NCT01082367|20667910|P1|COMPLETED|Follow-up (F-U) Period||17
8385083|NCT01082367|20667909|P2|Treated in F-U|Follow-up (F-U) Period||5
8385084|NCT01082367|20667910|P1|Treated in F-U|Follow-up (F-U) Period||5
8385085|NCT01082367|20667909|P2|STARTED|Follow-up (F-U) Period||10
8385086|NCT01082367|20667910|P1|STARTED|Follow-up (F-U) Period||19
8385087|NCT01082367|20667909|P2|NOT COMPLETED|Double-blind Period||13
8385088|NCT01082367|20667910|P1|NOT COMPLETED|Double-blind Period||5
8385089|NCT01082367|20667909|P2|COMPLETED|Double-blind Period||12
8385090|NCT01082367|20667910|P1|COMPLETED|Double-blind Period||21
8385091|NCT01082367|20667909|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
8385092|NCT01082367|20667910|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
8385093|NCT01082367|20667909|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
8385094|NCT01082367|20667910|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
8385095|NCT01082367|20667909|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
8385096|NCT01082367|20667910|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
8385097|NCT01082367|20667909|P2|Entered OL TOBI|Double-blind Period||18
8385098|NCT01082367|20667910|P1|Entered OL TOBI|Double-blind Period||4
8385099|NCT01082367|20667909|P2|Stage 2:no tx|Double-blind Period||0
8385100|NCT01082367|20667910|P1|Stage 2:no tx|Double-blind Period||0
8385101|NCT01082367|20667909|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
8385102|NCT01082367|20667910|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
8385103|NCT01082367|20667909|P2|STARTED|Double-blind Period||25
8385104|NCT01082367|20667910|P1|STARTED|Double-blind Period||26
8385105|NCT01082328|20667924|P1|NOT COMPLETED|Overall Study||1
8385106|NCT01082328|20667924|P1|COMPLETED|Overall Study||58
8385107|NCT01082328|20667924|P1|STARTED|Overall Study||59
8385108|NCT01082211|20667933|P1|NOT COMPLETED|Overall Study||7
8385109|NCT01082211|20667933|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
8385110|NCT01082211|20667933|P1|All Eligible Patients|Overall Study||58
8385111|NCT01082211|20667933|P1|Has Baseline/36-Month MD QOL Data|Overall Study||27
8385112|NCT01082211|20667933|P1|Has Baseline/36-month PT QOL Data|Overall Study||32
8385113|NCT01082211|20667933|P1|Has Baseline/12-Month MD QOL Data|Overall Study||35
8385114|NCT01082211|20667933|P1|Has Baseline/12-month PT QOL Data|Overall Study||36
8385115|NCT01082211|20667933|P1|Has Baseline MD QOL Data|Overall Study||44
8385116|NCT01082211|20667933|P1|Has Baseline PT QOL Data|Overall Study||46
8385117|NCT01082211|20667933|P1|STARTED|Overall Study||65
8385118|NCT01082159|20667951|P1|NOT COMPLETED|Overall Study||9
8385119|NCT01082159|20667951|P1|COMPLETED|Overall Study||46
8385120|NCT01082159|20667951|P1|STARTED|Overall Study||55
8385121|NCT01082081|20667960|P3|NOT COMPLETED|Overall Study||2
8385122|NCT01082081|20667961|P2|NOT COMPLETED|Overall Study||1
8385123|NCT01082081|20667962|P1|NOT COMPLETED|Overall Study||0
8385124|NCT01082081|20667960|P3|COMPLETED|Overall Study||58
8385125|NCT01082081|20667961|P2|COMPLETED|Overall Study||118
8385126|NCT01082081|20667962|P1|COMPLETED|Overall Study||121
8385127|NCT01082081|20667960|P3|STARTED|Overall Study||60
8385128|NCT01082081|20667961|P2|STARTED|Overall Study||119
8385129|NCT01082081|20667962|P1|STARTED|Overall Study||121
8385130|NCT01081951|20668014|P2|NOT COMPLETED|Overall Study||55
8385131|NCT01081951|20668015|P1|NOT COMPLETED|Overall Study||56
8385132|NCT01081951|20668014|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
8385133|NCT01081951|20668015|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
8385134|NCT01081951|20668014|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
8385135|NCT01081951|20668015|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
8385136|NCT01081951|20668014|P2|Entered Maintenance Phase|Overall Study||55
8385137|NCT01081951|20668015|P1|Entered Maintenance Phase|Overall Study||66
8385138|NCT01081951|20668014|P2|Received Study Treatment|Overall Study||75
8385139|NCT01081951|20668015|P1|Received Study Treatment|Overall Study||81
8385140|NCT01081951|20668014|P2|STARTED|Overall Study||81
8385141|NCT01081951|20668015|P1|STARTED|Overall Study||81
8385142|NCT01081912|20668025|P3|NOT COMPLETED|Maintenance Treatment||92
8385143|NCT01081912|20668026|P2|NOT COMPLETED|Maintenance Treatment||27
8385144|NCT01081912|20668027|P1|NOT COMPLETED|Maintenance Treatment||0
8385145|NCT01081912|20668025|P3|COMPLETED|Maintenance Treatment||59
8385146|NCT01081912|20668026|P2|COMPLETED|Maintenance Treatment||124
8385147|NCT01081912|20668027|P1|COMPLETED|Maintenance Treatment||0
8385148|NCT01081912|20668025|P3|STARTED|Maintenance Treatment||151
8385149|NCT01081912|20668026|P2|STARTED|Maintenance Treatment||151
8385150|NCT01081912|20668027|P1|STARTED|Maintenance Treatment||0
8385151|NCT01081912|20668025|P3|NOT COMPLETED|Conversion/Titration||0
8385152|NCT01081912|20668026|P2|NOT COMPLETED|Conversion/Titration||0
8385153|NCT01081912|20668027|P1|NOT COMPLETED|Conversion/Titration||208
8385154|NCT01081912|20668025|P3|COMPLETED|Conversion/Titration||0
8385155|NCT01081912|20668026|P2|COMPLETED|Conversion/Titration||0
8385156|NCT01081912|20668027|P1|COMPLETED|Conversion/Titration||302
8385157|NCT01081912|20668025|P3|STARTED|Conversion/Titration||0
8385158|NCT01081912|20668026|P2|STARTED|Conversion/Titration||0
8385159|NCT01081912|20668027|P1|STARTED|Conversion/Titration||510
8385160|NCT01081886|20668036|P2|NOT COMPLETED|Overall Study||13
8385161|NCT01081886|20668037|P1|NOT COMPLETED|Overall Study||11
8385162|NCT01081886|20668036|P2|COMPLETED|Overall Study||0
8385163|NCT01081886|20668037|P1|COMPLETED|Overall Study||0
8385164|NCT01081886|20668036|P2|STARTED|Overall Study||13
8385165|NCT01081886|20668037|P1|STARTED|Overall Study||11
8385166|NCT01081873|20668045|P1|NOT COMPLETED|Overall Study||298
8385167|NCT01081873|20668045|P1|COMPLETED|Overall Study||2416
8385168|NCT01081873|20668045|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
8385169|NCT01081834|20668117|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
8385170|NCT01081834|20668118|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
8385171|NCT01081834|20668119|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8385172|NCT01081834|20668120|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8385173|NCT01081834|20668121|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
8385174|NCT01081834|20668117|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
8385175|NCT01081834|20668118|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
8385176|NCT01081834|20668119|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
8385177|NCT01081834|20668120|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
8385178|NCT01081834|20668121|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
8385179|NCT01081834|20668117|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
8385180|NCT01081834|20668118|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
8385181|NCT01081834|20668119|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
8385182|NCT01081834|20668120|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
8385183|NCT01081834|20668121|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
8385184|NCT01081834|20668117|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
8385185|NCT01081834|20668118|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
8385186|NCT01081834|20668119|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
8385187|NCT01081834|20668120|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
8385188|NCT01081834|20668121|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
8385189|NCT01081834|20668117|P5|COMPLETED|Core Period: Baseline to Week 26||40
8385190|NCT01081834|20668118|P4|COMPLETED|Core Period: Baseline to Week 26||40
8385191|NCT01081834|20668119|P3|COMPLETED|Core Period: Baseline to Week 26||175
8385192|NCT01081834|20668120|P2|COMPLETED|Core Period: Baseline to Week 26||172
8385193|NCT01081834|20668121|P1|COMPLETED|Core Period: Baseline to Week 26||160
8385194|NCT01081834|20668117|P5|STARTED|Core Period: Baseline to Week 26||44
8385195|NCT01081834|20668118|P4|STARTED|Core Period: Baseline to Week 26||47
8385196|NCT01081834|20668119|P3|STARTED|Core Period: Baseline to Week 26||197
8385197|NCT01081834|20668120|P2|STARTED|Core Period: Baseline to Week 26||195
8385198|NCT01081834|20668121|P1|STARTED|Core Period: Baseline to Week 26||192
8385199|NCT01081795|20668182|P3|NOT COMPLETED|Overall Study||30
8385200|NCT01081795|20668183|P2|NOT COMPLETED|Overall Study||35
8385201|NCT01081795|20668184|P1|NOT COMPLETED|Overall Study||33
8385202|NCT01081795|20668182|P3|COMPLETED|Overall Study||97
8385203|NCT01081795|20668183|P2|COMPLETED|Overall Study||95
8385204|NCT01081795|20668184|P1|COMPLETED|Overall Study||97
8385205|NCT01081795|20668182|P3|STARTED|Overall Study||127
8385206|NCT01081795|20668183|P2|STARTED|Overall Study||130
8385207|NCT01081795|20668184|P1|STARTED|Overall Study||130
8385208|NCT01081769|20668221|P2|NOT COMPLETED|CORE Intent-To-Treat||97
8385209|NCT01081769|20668222|P1|NOT COMPLETED|CORE Intent-To-Treat||80
8385210|NCT01081769|20668221|P2|COMPLETED|CORE Intent-To-Treat||266
8385211|NCT01081769|20668222|P1|COMPLETED|CORE Intent-To-Treat||272
8385212|NCT01081769|20668221|P2|STARTED|CORE Intent-To-Treat||363
8385213|NCT01081769|20668222|P1|STARTED|CORE Intent-To-Treat||352
8385214|NCT01081769|20668221|P2|NOT COMPLETED|Whole Intent-to-Treat||25
8385215|NCT01081769|20668222|P1|NOT COMPLETED|Whole Intent-to-Treat||24
8385216|NCT01081769|20668221|P2|COMPLETED|Whole Intent-to-Treat||363
8385217|NCT01081769|20668222|P1|COMPLETED|Whole Intent-to-Treat||352
8385218|NCT01081769|20668221|P2|STARTED|Whole Intent-to-Treat||388
8385219|NCT01081769|20668222|P1|STARTED|Whole Intent-to-Treat||376
8385220|NCT01081678|20668260|P4|NOT COMPLETED|Overall Study||29
8385221|NCT01081678|20668261|P3|NOT COMPLETED|Overall Study||31
8385222|NCT01081678|20668262|P2|NOT COMPLETED|Overall Study||16
8385223|NCT01081678|20668263|P1|NOT COMPLETED|Overall Study||27
8385224|NCT01081678|20668260|P4|COMPLETED|Overall Study||61
8385225|NCT01081678|20668261|P3|COMPLETED|Overall Study||62
8385226|NCT01081678|20668262|P2|COMPLETED|Overall Study||44
8385227|NCT01081678|20668263|P1|COMPLETED|Overall Study||62
8385228|NCT01081678|20668260|P4|Completed 24 Weeks of Study|Overall Study||68
8385229|NCT01081678|20668261|P3|Completed 24 Weeks of Study|Overall Study||72
8385230|NCT01081678|20668262|P2|Completed 24 Weeks of Study|Overall Study||50
8385231|NCT01081678|20668263|P1|Completed 24 Weeks of Study|Overall Study||73
8385232|NCT01081678|20668260|P4|Received Study Drug|Overall Study||89
8385233|NCT01081678|20668261|P3|Received Study Drug|Overall Study||89
8385234|NCT01081678|20668262|P2|Received Study Drug|Overall Study||60
8385235|NCT01081678|20668263|P1|Received Study Drug|Overall Study||87
8385236|NCT01081678|20668260|P4|STARTED|Overall Study||90
8385237|NCT01081678|20668261|P3|STARTED|Overall Study||93
8385238|NCT01081678|20668262|P2|STARTED|Overall Study||60
8385239|NCT01081678|20668263|P1|STARTED|Overall Study||89
8385240|NCT01081665|20668293|P1|NOT COMPLETED|Overall Study||95
8385241|NCT01081665|20668293|P1|COMPLETED|Overall Study||142
8385242|NCT01081665|20668293|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
8385243|NCT01081665|20668293|P1|Full Analysis Set|Overall Study||237
8385244|NCT01081665|20668293|P1|STARTED|Overall Study||237
8385245|NCT01081626|20668305|P2|NOT COMPLETED|Overall Study||61
8385246|NCT01081626|20668306|P1|NOT COMPLETED|Overall Study||60
8385247|NCT01081626|20668305|P2|COMPLETED|Overall Study||94
8385248|NCT01081626|20668306|P1|COMPLETED|Overall Study||95
8385249|NCT01081626|20668305|P2|Assessed for Efficacy|Overall Study||125
8385250|NCT01081626|20668306|P1|Assessed for Efficacy|Overall Study||122
8385251|NCT01081626|20668305|P2|STARTED|Overall Study||155
8385252|NCT01081626|20668306|P1|STARTED|Overall Study||155
8385253|NCT01081301|20668332|P1|NOT COMPLETED|Overall Study||14
8385254|NCT01081301|20668332|P1|COMPLETED|Overall Study||22
8385255|NCT01081301|20668332|P1|STARTED|Overall Study||36
8385268|NCT01081249|20668407|P2|NOT COMPLETED|Overall Study||1
8385269|NCT01081249|20668408|P1|NOT COMPLETED|Overall Study||0
8385270|NCT01081249|20668407|P2|COMPLETED|Overall Study||6
8385271|NCT01081249|20668408|P1|COMPLETED|Overall Study||11
8385272|NCT01081249|20668407|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
8385273|NCT01081249|20668408|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
8385274|NCT01081249|20668407|P2|Washout (5-10 Days)|Overall Study||6
8385275|NCT01081249|20668408|P1|Washout (5-10 Days)|Overall Study||11
8385276|NCT01081249|20668407|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
8385277|NCT01081249|20668408|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
8385278|NCT01081249|20668407|P2|STARTED|Overall Study||7
8385279|NCT01081249|20668408|P1|STARTED|Overall Study||11
8385280|NCT01081145|20668414|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
8385281|NCT01081145|20668415|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
8385282|NCT01081145|20668414|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
8385283|NCT01081145|20668415|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
8385284|NCT01081145|20668414|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
8385285|NCT01081145|20668415|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
8385286|NCT01081145|20668414|P2|NOT COMPLETED|Open-Label Phase||0
8385287|NCT01081145|20668415|P1|NOT COMPLETED|Open-Label Phase||212
8385288|NCT01081145|20668414|P2|COMPLETED|Open-Label Phase||0
8385289|NCT01081145|20668415|P1|COMPLETED|Open-Label Phase||316
8385290|NCT01081145|20668414|P2|STARTED|Open-Label Phase||0
8385291|NCT01081145|20668415|P1|STARTED|Open-Label Phase||528
8385292|NCT01081132|20668443|P2|NOT COMPLETED|Overall Study||52
8385293|NCT01081132|20668444|P1|NOT COMPLETED|Overall Study||55
8385294|NCT01081132|20668443|P2|COMPLETED|Overall Study||105
8385295|NCT01081132|20668444|P1|COMPLETED|Overall Study||102
8385296|NCT01081132|20668443|P2|STARTED|Overall Study||157
8385297|NCT01081132|20668444|P1|STARTED|Overall Study||157
8385298|NCT01081041|20668485|P3|NOT COMPLETED|Overall Study||2
8385299|NCT01081041|20668486|P2|NOT COMPLETED|Overall Study||4
8385300|NCT01081041|20668487|P1|NOT COMPLETED|Overall Study||0
8385301|NCT01081041|20668485|P3|COMPLETED|Overall Study||71
8385302|NCT01081041|20668486|P2|COMPLETED|Overall Study||77
8385303|NCT01081041|20668487|P1|COMPLETED|Overall Study||33
8385304|NCT01081041|20668485|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
8385305|NCT01081041|20668486|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
8385306|NCT01081041|20668487|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
8385307|NCT01081041|20668485|P3|STARTED|Overall Study||73
8385308|NCT01081041|20668486|P2|STARTED|Overall Study||81
8385309|NCT01081041|20668487|P1|STARTED|Overall Study||33
8385310|NCT01080976|20668517|P2|NOT COMPLETED|Overall Study||0
8385311|NCT01080976|20668518|P1|NOT COMPLETED|Overall Study||0
8385312|NCT01080976|20668517|P2|COMPLETED|Overall Study||5
8385313|NCT01080976|20668518|P1|COMPLETED|Overall Study||5
8385314|NCT01080976|20668517|P2|STARTED|Overall Study||5
8385315|NCT01080976|20668518|P1|STARTED|Overall Study||5
8385316|NCT01080807|20668528|P2|NOT COMPLETED|Overall Study||23
8385317|NCT01080807|20668529|P1|NOT COMPLETED|Overall Study||35
8385318|NCT01080807|20668528|P2|COMPLETED|Overall Study||167
8385319|NCT01080807|20668529|P1|COMPLETED|Overall Study||158
8385320|NCT01080807|20668528|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
8385321|NCT01080807|20668529|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
8385322|NCT01080794|20668587|P4|NOT COMPLETED|Overall Study||2
8385323|NCT01080794|20668588|P3|NOT COMPLETED|Overall Study||2
8385324|NCT01080794|20668589|P2|NOT COMPLETED|Overall Study||2
8385325|NCT01080794|20668590|P1|NOT COMPLETED|Overall Study||5
8385326|NCT01080794|20668587|P4|COMPLETED|Overall Study||13
8385327|NCT01080794|20668588|P3|COMPLETED|Overall Study||10
8385328|NCT01080794|20668589|P2|COMPLETED|Overall Study||12
8385329|NCT01080794|20668590|P1|COMPLETED|Overall Study||15
8385330|NCT01080794|20668587|P4|STARTED|Overall Study||15
8385331|NCT01080794|20668588|P3|STARTED|Overall Study||12
8385332|NCT01080794|20668589|P2|STARTED|Overall Study||14
8385333|NCT01080794|20668590|P1|STARTED|Overall Study||20
8385334|NCT01080768|20668638|P2|NOT COMPLETED|Overall Study||1
8385335|NCT01080768|20668639|P1|NOT COMPLETED|Overall Study||2
8385336|NCT01080768|20668638|P2|COMPLETED|Overall Study||16
8385337|NCT01080768|20668639|P1|COMPLETED|Overall Study||12
8385338|NCT01080768|20668638|P2|STARTED|Overall Study||17
8385339|NCT01080768|20668639|P1|STARTED|Overall Study||14
8385340|NCT01080716|20668649|P4|NOT COMPLETED|Part 2||0
8385341|NCT01080716|20668650|P3|NOT COMPLETED|Part 2||0
8385342|NCT01080716|20668651|P2|NOT COMPLETED|Part 2||0
8385343|NCT01080716|20668652|P1|NOT COMPLETED|Part 2||0
8385344|NCT01080716|20668649|P4|COMPLETED|Part 2||10
8385345|NCT01080716|20668650|P3|COMPLETED|Part 2||10
8385346|NCT01080716|20668651|P2|COMPLETED|Part 2||0
8385347|NCT01080716|20668652|P1|COMPLETED|Part 2||0
8385348|NCT01080716|20668649|P4|STARTED|Part 2||10
8385349|NCT01080716|20668650|P3|STARTED|Part 2||10
8385350|NCT01080716|20668651|P2|STARTED|Part 2||0
8385351|NCT01080716|20668652|P1|STARTED|Part 2||0
8385352|NCT01080716|20668649|P4|NOT COMPLETED|Part 1||0
8385353|NCT01080716|20668650|P3|NOT COMPLETED|Part 1||0
8385354|NCT01080716|20668651|P2|NOT COMPLETED|Part 1||0
8385355|NCT01080716|20668652|P1|NOT COMPLETED|Part 1||1
8385356|NCT01080716|20668649|P4|COMPLETED|Part 1||0
8385357|NCT01080716|20668650|P3|COMPLETED|Part 1||0
8385358|NCT01080716|20668651|P2|COMPLETED|Part 1||6
8385359|NCT01080716|20668652|P1|COMPLETED|Part 1||13
8385360|NCT01080716|20668649|P4|STARTED|Part 1||0
8385361|NCT01080716|20668650|P3|STARTED|Part 1||0
8385362|NCT01080716|20668651|P2|STARTED|Part 1||6
8385363|NCT01080716|20668652|P1|STARTED|Part 1||14
8385364|NCT01080677|20668669|P3|NOT COMPLETED|Overall Study||0
8385365|NCT01080677|20668670|P2|NOT COMPLETED|Overall Study||0
8385366|NCT01080677|20668671|P1|NOT COMPLETED|Overall Study||0
8385367|NCT01080677|20668669|P3|COMPLETED|Overall Study||20
8385368|NCT01080677|20668670|P2|COMPLETED|Overall Study||20
8385369|NCT01080677|20668671|P1|COMPLETED|Overall Study||20
8385370|NCT01080677|20668669|P3|STARTED|Overall Study||20
8385371|NCT01080677|20668670|P2|STARTED|Overall Study||20
8385372|NCT01080677|20668671|P1|STARTED|Overall Study||20
8385373|NCT01080625|20668691|P3|NOT COMPLETED|Overall Study||1
8385374|NCT01080625|20668692|P2|NOT COMPLETED|Overall Study||2
8385375|NCT01080625|20668693|P1|NOT COMPLETED|Overall Study||0
8385376|NCT01080625|20668691|P3|COMPLETED|Overall Study||31
8385377|NCT01080625|20668692|P2|COMPLETED|Overall Study||31
8385378|NCT01080625|20668693|P1|COMPLETED|Overall Study||31
8385379|NCT01080625|20668691|P3|STARTED|Overall Study||32
8385380|NCT01080625|20668692|P2|STARTED|Overall Study||33
8385381|NCT01080625|20668693|P1|STARTED|Overall Study||31
8385382|NCT01080391|20668703|P2|NOT COMPLETED|Overall Study||4
8385383|NCT01080391|20668704|P1|NOT COMPLETED|Overall Study||7
8385384|NCT01080391|20668703|P2|COMPLETED|Overall Study||392
8385385|NCT01080391|20668704|P1|COMPLETED|Overall Study||389
8385386|NCT01080391|20668703|P2|Treated|Overall Study||392
8385387|NCT01080391|20668704|P1|Treated|Overall Study||389
8385388|NCT01080391|20668703|P2|STARTED|Overall Study||396
8385389|NCT01080391|20668704|P1|STARTED|Overall Study||396
8385390|NCT01080326|20668722|P1|NOT COMPLETED|Overall Study||4
8385391|NCT01080326|20668722|P1|COMPLETED|Overall Study||3
8385392|NCT01080326|20668722|P1|STARTED|Overall Study||7
8385393|NCT01080300|20668728|P2|NOT COMPLETED|Overall Study||104
8385394|NCT01080300|20668729|P1|NOT COMPLETED|Overall Study||94
8385395|NCT01080300|20668728|P2|COMPLETED|Overall Study||191
8385396|NCT01080300|20668729|P1|COMPLETED|Overall Study||206
8385397|NCT01080300|20668728|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
8385398|NCT01080300|20668729|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
8385399|NCT01080261|20668757|P1|NOT COMPLETED|Overall Study||0
8385400|NCT01080261|20668757|P1|COMPLETED|Overall Study||60
8385401|NCT01080261|20668757|P1|STARTED|Overall Study||60
8385402|NCT01080248|20668772|P1|NOT COMPLETED|Overall Study||0
8385403|NCT01080248|20668772|P1|COMPLETED|Overall Study||2
8385404|NCT01080248|20668772|P1|STARTED|Overall Study||2
8385405|NCT01080209|20668786|P7|NOT COMPLETED|Overall Study||7
8385406|NCT01080209|20668787|P6|NOT COMPLETED|Overall Study||0
8385407|NCT01080209|20668788|P5|NOT COMPLETED|Overall Study||0
8385408|NCT01080209|20668789|P4|NOT COMPLETED|Overall Study||5
8385409|NCT01080209|20668790|P3|NOT COMPLETED|Overall Study||5
8385410|NCT01080209|20668791|P2|NOT COMPLETED|Overall Study||11
8385411|NCT01080209|20668792|P1|NOT COMPLETED|Overall Study||6
8385412|NCT01080209|20668786|P7|COMPLETED|Overall Study||44
8385413|NCT01080209|20668787|P6|COMPLETED|Overall Study||2
8385414|NCT01080209|20668788|P5|COMPLETED|Overall Study||6
8385415|NCT01080209|20668789|P4|COMPLETED|Overall Study||37
8385416|NCT01080209|20668790|P3|COMPLETED|Overall Study||28
8385417|NCT01080209|20668791|P2|COMPLETED|Overall Study||42
8385418|NCT01080209|20668792|P1|COMPLETED|Overall Study||22
8385419|NCT01080209|20668786|P7|STARTED|Overall Study||51
8385420|NCT01080209|20668787|P6|STARTED|Overall Study||2
8385421|NCT01080209|20668788|P5|STARTED|Overall Study||6
8385422|NCT01080209|20668789|P4|STARTED|Overall Study||42
8385423|NCT01080209|20668790|P3|STARTED|Overall Study||33
8385424|NCT01080209|20668791|P2|STARTED|Overall Study||53
8385425|NCT01080209|20668792|P1|STARTED|Overall Study||28
8385426|NCT01080196|20668817|P2|NOT COMPLETED|Overall Study||0
8385427|NCT01080196|20668818|P1|NOT COMPLETED|Overall Study||0
8385428|NCT01080196|20668817|P2|COMPLETED|Overall Study||66
8385429|NCT01080196|20668818|P1|COMPLETED|Overall Study||68
8385430|NCT01080196|20668817|P2|STARTED|Overall Study||66
8385431|NCT01080196|20668818|P1|STARTED|Overall Study||68
8385432|NCT01080131|20668834|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
8385433|NCT01080131|20668835|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
8385434|NCT01080131|20668834|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
8385435|NCT01080131|20668835|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
8385436|NCT01080131|20668834|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
8385437|NCT01080131|20668835|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
8385438|NCT01080131|20668834|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
8385439|NCT01080131|20668835|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
8385440|NCT01080131|20668834|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
8385441|NCT01080131|20668835|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
8385442|NCT01080131|20668834|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
8385443|NCT01080131|20668835|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
8385444|NCT01080131|20668834|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
8385445|NCT01080131|20668835|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
8385446|NCT01080131|20668834|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
8385447|NCT01080131|20668835|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
8385448|NCT01080131|20668834|P2|COMPLETED|Core Study (0- 12 Weeks)||103
8385449|NCT01080131|20668835|P1|COMPLETED|Core Study (0- 12 Weeks)||99
8385450|NCT01080131|20668834|P2|STARTED|Core Study (0- 12 Weeks)||114
8385451|NCT01080131|20668835|P1|STARTED|Core Study (0- 12 Weeks)||112
8385452|NCT01080118|20668914|P4|NOT COMPLETED|Overall Study||0
8385453|NCT01080118|20668915|P3|NOT COMPLETED|Overall Study||0
8385454|NCT01080118|20668916|P2|NOT COMPLETED|Overall Study||0
8385455|NCT01080118|20668917|P1|NOT COMPLETED|Overall Study||0
8385456|NCT01080118|20668914|P4|COMPLETED|Overall Study||30
8385457|NCT01080118|20668915|P3|COMPLETED|Overall Study||30
8385458|NCT01080118|20668916|P2|COMPLETED|Overall Study||15
8385459|NCT01080118|20668917|P1|COMPLETED|Overall Study||15
8385460|NCT01080118|20668914|P4|STARTED|Overall Study||30
8385461|NCT01080118|20668915|P3|STARTED|Overall Study||30
8385462|NCT01080118|20668916|P2|STARTED|Overall Study||15
8385463|NCT01080118|20668917|P1|STARTED|Overall Study||15
8385464|NCT01079988|20668930|P5|NOT COMPLETED|Overall Study||1
8385465|NCT01079988|20668931|P4|NOT COMPLETED|Overall Study||3
8385466|NCT01079988|20668932|P3|NOT COMPLETED|Overall Study||0
8385467|NCT01079988|20668933|P2|NOT COMPLETED|Overall Study||0
8385468|NCT01079988|20668934|P1|NOT COMPLETED|Overall Study||1
8385469|NCT01079988|20668930|P5|COMPLETED|Overall Study||1
8385470|NCT01079988|20668931|P4|COMPLETED|Overall Study||17
8385471|NCT01079988|20668932|P3|COMPLETED|Overall Study||8
8385472|NCT01079988|20668933|P2|COMPLETED|Overall Study||1
8385473|NCT01079988|20668934|P1|COMPLETED|Overall Study||9
8385474|NCT01079988|20668930|P5|STARTED|Overall Study||2
8385475|NCT01079988|20668931|P4|STARTED|Overall Study||20
8385476|NCT01079988|20668932|P3|STARTED|Overall Study||8
8385477|NCT01079988|20668933|P2|STARTED|Overall Study||1
8385478|NCT01079988|20668934|P1|STARTED|Overall Study||10
8385479|NCT01079962|20668953|P2|NOT COMPLETED|Overall Study||15
8385480|NCT01079962|20668954|P1|NOT COMPLETED|Overall Study||15
8385481|NCT01079962|20668953|P2|COMPLETED|Overall Study||89
8385482|NCT01079962|20668954|P1|COMPLETED|Overall Study||90
8385483|NCT01079962|20668953|P2|STARTED|Overall Study||104
8385484|NCT01079962|20668954|P1|STARTED|Overall Study||105
8385485|NCT01079949|20668982|P2|NOT COMPLETED|Overall Study||13
8385486|NCT01079949|20668983|P1|NOT COMPLETED|Overall Study||15
8385487|NCT01079949|20668982|P2|COMPLETED|Overall Study||34
8385488|NCT01079949|20668983|P1|COMPLETED|Overall Study||31
8385489|NCT01079949|20668982|P2|STARTED|Overall Study||47
8385490|NCT01079949|20668983|P1|STARTED|Overall Study||46
8385491|NCT01079936|20669029|P5|NOT COMPLETED|Phase II||1
8385492|NCT01079936|20669030|P4|NOT COMPLETED|Phase II||0
8385493|NCT01079936|20669031|P3|NOT COMPLETED|Phase II||1
8385494|NCT01079936|20669032|P2|NOT COMPLETED|Phase II||0
8385495|NCT01079936|20669033|P1|NOT COMPLETED|Phase II||0
8385496|NCT01079936|20669029|P5|COMPLETED|Phase II||25
8385497|NCT01079936|20669030|P4|COMPLETED|Phase II||24
8385498|NCT01079936|20669031|P3|COMPLETED|Phase II||5
8385499|NCT01079936|20669032|P2|COMPLETED|Phase II||3
8385500|NCT01079936|20669033|P1|COMPLETED|Phase II||0
8385501|NCT01079936|20669029|P5|STARTED|Phase II||26
8385502|NCT01079936|20669030|P4|STARTED|Phase II||24
8385503|NCT01079936|20669031|P3|STARTED|Phase II||6
8385504|NCT01079936|20669032|P2|STARTED|Phase II||3
8385505|NCT01079936|20669033|P1|STARTED|Phase II||0
8385506|NCT01079936|20669029|P5|NOT COMPLETED|Phase I: MTD||0
8385507|NCT01079936|20669030|P4|NOT COMPLETED|Phase I: MTD||0
8385508|NCT01079936|20669031|P3|NOT COMPLETED|Phase I: MTD||0
8385509|NCT01079936|20669032|P2|NOT COMPLETED|Phase I: MTD||0
8385510|NCT01079936|20669033|P1|NOT COMPLETED|Phase I: MTD||4
8385511|NCT01079936|20669029|P5|COMPLETED|Phase I: MTD||0
8385512|NCT01079936|20669030|P4|COMPLETED|Phase I: MTD||0
8385513|NCT01079936|20669031|P3|COMPLETED|Phase I: MTD||0
8385514|NCT01079936|20669032|P2|COMPLETED|Phase I: MTD||0
8385515|NCT01079936|20669033|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
8385516|NCT01079936|20669029|P5|STARTED|Phase I: MTD||0
8385517|NCT01079936|20669030|P4|STARTED|Phase I: MTD||0
8385518|NCT01079936|20669031|P3|STARTED|Phase I: MTD||0
8385519|NCT01079936|20669032|P2|STARTED|Phase I: MTD||0
8385520|NCT01079936|20669033|P1|STARTED|Phase I: MTD||16
8385521|NCT01079832|20669052|P1|NOT COMPLETED|Overall Study||1
8385522|NCT01079832|20669052|P1|COMPLETED|Overall Study||49
8385523|NCT01079832|20669052|P1|STARTED|Overall Study||50
8385524|NCT01079806|20669062|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
8385525|NCT01079806|20669063|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
8385526|NCT01079806|20669062|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
8385527|NCT01079806|20669063|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
8385528|NCT01079806|20669062|P2|STARTED|Long-term Follow-up: Day 1-End of Study||58
8385529|NCT01079806|20669063|P1|STARTED|Long-term Follow-up: Day 1-End of Study||111
8385530|NCT01079806|20669062|P2|NOT COMPLETED|Day 1 to Week 96||7
8385531|NCT01079806|20669063|P1|NOT COMPLETED|Day 1 to Week 96||7
8385532|NCT01079806|20669062|P2|COMPLETED|Day 1 to Week 96||53
8385533|NCT01079806|20669063|P1|COMPLETED|Day 1 to Week 96||113
8385534|NCT01079806|20669062|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
8385535|NCT01079806|20669063|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
8385536|NCT01079806|20669062|P2|Received Treatment|Day 1 to Week 96||60
8385537|NCT01079806|20669063|P1|Received Treatment|Day 1 to Week 96||120
8385538|NCT01079806|20669062|P2|STARTED|Day 1 to Week 96||60
8385539|NCT01079806|20669063|P1|STARTED|Day 1 to Week 96||120
8385540|NCT01079741|20669098|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
8385541|NCT01079741|20669099|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385542|NCT01079741|20669100|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385543|NCT01079741|20669101|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385544|NCT01079741|20669102|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385545|NCT01079741|20669098|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
8385546|NCT01079741|20669099|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
8385547|NCT01079741|20669100|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
8385548|NCT01079741|20669101|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
8385549|NCT01079741|20669102|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
8385550|NCT01079741|20669098|P5|STARTED|Phase 2 (Weeks 37-48)||12
8385551|NCT01079741|20669099|P4|STARTED|Phase 2 (Weeks 37-48)||12
8385552|NCT01079741|20669100|P3|STARTED|Phase 2 (Weeks 37-48)||0
8385553|NCT01079741|20669101|P2|STARTED|Phase 2 (Weeks 37-48)||0
8385554|NCT01079741|20669102|P1|STARTED|Phase 2 (Weeks 37-48)||0
8385555|NCT01079741|20669098|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385556|NCT01079741|20669099|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385557|NCT01079741|20669100|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
8385558|NCT01079741|20669101|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385559|NCT01079741|20669102|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385560|NCT01079741|20669098|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385561|NCT01079741|20669099|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385562|NCT01079741|20669100|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385563|NCT01079741|20669101|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385564|NCT01079741|20669102|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385565|NCT01079741|20669098|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385566|NCT01079741|20669099|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385567|NCT01079741|20669100|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
8385568|NCT01079741|20669101|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385569|NCT01079741|20669102|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385570|NCT01079741|20669098|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385571|NCT01079741|20669099|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385572|NCT01079741|20669100|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385573|NCT01079741|20669101|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
8385574|NCT01079741|20669102|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385575|NCT01079741|20669098|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385576|NCT01079741|20669099|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385577|NCT01079741|20669100|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385578|NCT01079741|20669101|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
8385579|NCT01079741|20669102|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385580|NCT01079741|20669098|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385581|NCT01079741|20669099|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385582|NCT01079741|20669100|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385583|NCT01079741|20669101|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
8385584|NCT01079741|20669102|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385585|NCT01079741|20669098|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385586|NCT01079741|20669099|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385587|NCT01079741|20669100|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385588|NCT01079741|20669101|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385589|NCT01079741|20669102|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385590|NCT01079741|20669098|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385591|NCT01079741|20669099|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385592|NCT01079741|20669100|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385593|NCT01079741|20669101|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385594|NCT01079741|20669102|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
8385595|NCT01079741|20669098|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385596|NCT01079741|20669099|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385597|NCT01079741|20669100|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385598|NCT01079741|20669101|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385599|NCT01079741|20669102|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
8385600|NCT01079598|20669116|P1|NOT COMPLETED|Overall Study||0
8385601|NCT01079598|20669116|P1|COMPLETED|Overall Study||8
8385602|NCT01079598|20669116|P1|STARTED|Overall Study||8
8385603|NCT01079390|20669126|P3|NOT COMPLETED|Overall Study||4
8385604|NCT01079390|20669127|P2|NOT COMPLETED|Overall Study||5
8385605|NCT01079390|20669128|P1|NOT COMPLETED|Overall Study||5
8385606|NCT01079390|20669126|P3|COMPLETED|Overall Study||10
8385607|NCT01079390|20669127|P2|COMPLETED|Overall Study||10
8385608|NCT01079390|20669128|P1|COMPLETED|Overall Study||10
8385609|NCT01079390|20669126|P3|STARTED|Overall Study||14
8385610|NCT01079390|20669127|P2|STARTED|Overall Study||15
8385611|NCT01079390|20669128|P1|STARTED|Overall Study||15
8385612|NCT01079299|20669140|P2|NOT COMPLETED|Overall Study||0
8385613|NCT01079299|20669141|P1|NOT COMPLETED|Overall Study||0
8385614|NCT01079299|20669140|P2|COMPLETED|Overall Study||25
8385615|NCT01079299|20669141|P1|COMPLETED|Overall Study||27
8385616|NCT01079299|20669140|P2|STARTED|Overall Study||25
8385617|NCT01079299|20669141|P1|STARTED|Overall Study||27
8385618|NCT01079234|20669150|P4|NOT COMPLETED|Extension: Week 27 to 52||16
8385619|NCT01079234|20669151|P3|NOT COMPLETED|Extension: Week 27 to 52||11
8385620|NCT01079234|20669152|P2|NOT COMPLETED|Extension: Week 27 to 52||0
8385621|NCT01079234|20669153|P1|NOT COMPLETED|Extension: Week 27 to 52||0
8385622|NCT01079234|20669150|P4|COMPLETED|Extension: Week 27 to 52||223
8385623|NCT01079234|20669151|P3|COMPLETED|Extension: Week 27 to 52||122
8385624|NCT01079234|20669152|P2|COMPLETED|Extension: Week 27 to 52||0
8385625|NCT01079234|20669153|P1|COMPLETED|Extension: Week 27 to 52||0
8385626|NCT01079234|20669150|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
8385627|NCT01079234|20669151|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
8385628|NCT01079234|20669152|P2|STARTED|Extension: Week 27 to 52||0
8385629|NCT01079234|20669153|P1|STARTED|Extension: Week 27 to 52||0
8385630|NCT01079234|20669150|P4|NOT COMPLETED|Main: Week 0 to 26||0
8385631|NCT01079234|20669151|P3|NOT COMPLETED|Main: Week 0 to 26||12
8385632|NCT01079234|20669152|P2|NOT COMPLETED|Main: Week 0 to 26||26
8385633|NCT01079234|20669153|P1|NOT COMPLETED|Main: Week 0 to 26||26
8385634|NCT01079234|20669150|P4|COMPLETED|Main: Week 0 to 26||0
8385635|NCT01079234|20669151|P3|COMPLETED|Main: Week 0 to 26||152
8385636|NCT01079234|20669152|P2|COMPLETED|Main: Week 0 to 26||139
8385637|NCT01079234|20669153|P1|COMPLETED|Main: Week 0 to 26||138
8385638|NCT01079234|20669150|P4|Exposed|Main: Week 0 to 26||0
8385639|NCT01079234|20669151|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
8385640|NCT01079234|20669152|P2|Exposed|Main: Week 0 to 26||165
8385641|NCT01079234|20669153|P1|Exposed|Main: Week 0 to 26||164
8385642|NCT01079234|20669150|P4|STARTED|Main: Week 0 to 26||0
8385643|NCT01079234|20669151|P3|STARTED|Main: Week 0 to 26||164
8385644|NCT01079234|20669152|P2|STARTED|Main: Week 0 to 26||165
8385645|NCT01079234|20669153|P1|STARTED|Main: Week 0 to 26||164
8385646|NCT01079195|20669171|P1|NOT COMPLETED|Overall Study||1431
8385647|NCT01079195|20669171|P1|COMPLETED|Overall Study||14442
8385648|NCT01079195|20669171|P1|STARTED|Overall Study||15873
8385649|NCT01079182|20669177|P1|NOT COMPLETED|Overall Study||2719
8385650|NCT01079182|20669177|P1|COMPLETED|Overall Study||1962
8385651|NCT01079182|20669177|P1|STARTED|Overall Study||4681
8385652|NCT01079143|20669208|P4|NOT COMPLETED|Overall Study||5
8385653|NCT01079143|20669209|P3|NOT COMPLETED|Overall Study||5
8385654|NCT01079143|20669210|P2|NOT COMPLETED|Overall Study||17
8385655|NCT01079143|20669211|P1|NOT COMPLETED|Overall Study||9
8385656|NCT01079143|20669208|P4|COMPLETED|Overall Study||54
8385657|NCT01079143|20669209|P3|COMPLETED|Overall Study||34
8385658|NCT01079143|20669210|P2|COMPLETED|Overall Study||43
8385659|NCT01079143|20669211|P1|COMPLETED|Overall Study||27
8385660|NCT01079143|20669208|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
8385661|NCT01079143|20669209|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
8385662|NCT01079143|20669210|P2|M3 and M12 Biopsies|Overall Study||43
8385663|NCT01079143|20669211|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
8385664|NCT01079143|20669208|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
8385665|NCT01079143|20669209|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
8385666|NCT01079143|20669210|P2|Month 12 (M12) Biopsies|Overall Study||43
8385667|NCT01079143|20669211|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
8385668|NCT01079143|20669208|P4|Month 3 (M3) Biopsies|Overall Study||59
8385669|NCT01079143|20669209|P3|Month 3 (M3) Biopsies|Overall Study||39
8385670|NCT01079143|20669210|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
8385671|NCT01079143|20669211|P1|Month 3 (M3) Biopsies|Overall Study||36
8385672|NCT01079143|20669208|P4|Exposed|Overall Study||59
8385673|NCT01079143|20669209|P3|Exposed|Overall Study||39
8385674|NCT01079143|20669210|P2|Exposed|Overall Study||60
8385675|NCT01079143|20669211|P1|Exposed|Overall Study||36
8385676|NCT01079143|20669208|P4|STARTED|Overall Study||59
8385677|NCT01079143|20669209|P3|STARTED|Overall Study||39
8385678|NCT01079143|20669210|P2|STARTED|Overall Study||60
8385679|NCT01079143|20669211|P1|STARTED|Overall Study||36
8385680|NCT01079130|20669285|P6|NOT COMPLETED|Overall Study||5
8385681|NCT01079130|20669286|P5|NOT COMPLETED|Overall Study||8
8385682|NCT01079130|20669287|P4|NOT COMPLETED|Overall Study||5
8385683|NCT01079130|20669288|P3|NOT COMPLETED|Overall Study||1
8385684|NCT01079130|20669289|P2|NOT COMPLETED|Overall Study||7
8385685|NCT01079130|20669290|P1|NOT COMPLETED|Overall Study||2
8385686|NCT01079130|20669285|P6|COMPLETED|Overall Study||80
8385687|NCT01079130|20669286|P5|COMPLETED|Overall Study||78
8385688|NCT01079130|20669287|P4|COMPLETED|Overall Study||81
8385689|NCT01079130|20669288|P3|COMPLETED|Overall Study||83
8385690|NCT01079130|20669289|P2|COMPLETED|Overall Study||78
8385691|NCT01079130|20669290|P1|COMPLETED|Overall Study||83
8385692|NCT01079130|20669285|P6|Full Analysis Set (FAS)|Overall Study||84
8385693|NCT01079130|20669286|P5|Full Analysis Set (FAS)|Overall Study||84
8385694|NCT01079130|20669287|P4|Full Analysis Set (FAS)|Overall Study||85
8385695|NCT01079130|20669288|P3|Full Analysis Set (FAS)|Overall Study||83
8385696|NCT01079130|20669289|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
8385697|NCT01079130|20669290|P1|Full Analysis Set (FAS)|Overall Study||84
8385698|NCT01079130|20669285|P6|Safety Set: Received Study Drug|Overall Study||84
8385699|NCT01079130|20669286|P5|Safety Set: Received Study Drug|Overall Study||84
8385700|NCT01079130|20669287|P4|Safety Set: Received Study Drug|Overall Study||85
8385701|NCT01079130|20669288|P3|Safety Set: Received Study Drug|Overall Study||84
8385702|NCT01079130|20669289|P2|Safety Set: Received Study Drug|Overall Study||81
8385703|NCT01079130|20669290|P1|Safety Set: Received Study Drug|Overall Study||84
8385704|NCT01079130|20669285|P6|STARTED|Overall Study||85
8385705|NCT01079130|20669286|P5|STARTED|Overall Study||86
8385706|NCT01079130|20669287|P4|STARTED|Overall Study||86
8385707|NCT01079130|20669288|P3|STARTED|Overall Study||84
8385708|NCT01079130|20669289|P2|STARTED|Overall Study||85
8385709|NCT01079130|20669290|P1|STARTED|Overall Study||85
8385710|NCT01078974|20669310|P1|NOT COMPLETED|Overall Study||3
8385711|NCT01078974|20669310|P1|COMPLETED|Overall Study||4
8385712|NCT01078974|20669310|P1|STARTED|Overall Study||7
8385713|NCT01078922|20669315|P1|NOT COMPLETED|Overall Study||1
8385714|NCT01078922|20669315|P1|COMPLETED|Overall Study||10
8385715|NCT01078922|20669315|P1|STARTED|Overall Study||11
8385716|NCT01078909|20669325|P5|NOT COMPLETED|Overall Study||2
8385717|NCT01078909|20669326|P4|NOT COMPLETED|Overall Study||1
8385718|NCT01078909|20669327|P3|NOT COMPLETED|Overall Study||1
8385719|NCT01078909|20669328|P2|NOT COMPLETED|Overall Study||4
8385720|NCT01078909|20669329|P1|NOT COMPLETED|Overall Study||2
8385721|NCT01078909|20669325|P5|COMPLETED|Overall Study||23
8385722|NCT01078909|20669326|P4|COMPLETED|Overall Study||24
8385723|NCT01078909|20669327|P3|COMPLETED|Overall Study||24
8385724|NCT01078909|20669328|P2|COMPLETED|Overall Study||21
8385725|NCT01078909|20669329|P1|COMPLETED|Overall Study||23
8385726|NCT01078909|20669325|P5|STARTED|Overall Study||25
8385727|NCT01078909|20669326|P4|STARTED|Overall Study||25
8385728|NCT01078909|20669327|P3|STARTED|Overall Study||25
8385729|NCT01078909|20669328|P2|STARTED|Overall Study||25
8385730|NCT01078909|20669329|P1|STARTED|Overall Study||25
8385731|NCT01078844|20669351|P1|NOT COMPLETED|Overall Study||4
8385732|NCT01078844|20669351|P1|COMPLETED|Overall Study||0
8385733|NCT01078844|20669351|P1|STARTED|Overall Study||4
8385734|NCT01078805|20669356|P1|NOT COMPLETED|Overall Study||2050
8385735|NCT01078805|20669356|P1|COMPLETED|Overall Study||2117
8385736|NCT01078805|20669356|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
8385737|NCT01078805|20669356|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
8385738|NCT01078805|20669356|P1|STARTED|Overall Study||4167
8385739|NCT01078753|20669370|P2|NOT COMPLETED|Treatment Period II||0
8385740|NCT01078753|20669371|P1|NOT COMPLETED|Treatment Period II||0
8385741|NCT01078753|20669370|P2|COMPLETED|Treatment Period II||44
8385742|NCT01078753|20669371|P1|COMPLETED|Treatment Period II||45
8385743|NCT01078753|20669370|P2|Full Analysis Set|Treatment Period II||44
8385744|NCT01078753|20669371|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
8385745|NCT01078753|20669370|P2|STARTED|Treatment Period II||44
8385746|NCT01078753|20669371|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
8385747|NCT01078753|20669370|P2|NOT COMPLETED|Treatment Period I||0
8385748|NCT01078753|20669371|P1|NOT COMPLETED|Treatment Period I||0
8385749|NCT01078753|20669370|P2|COMPLETED|Treatment Period I||44
8385750|NCT01078753|20669371|P1|COMPLETED|Treatment Period I||45
8385751|NCT01078753|20669370|P2|Full Analysis Set|Treatment Period I||44
8385752|NCT01078753|20669371|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
8385753|NCT01078753|20669370|P2|STARTED|Treatment Period I||44
8385754|NCT01078753|20669371|P1|STARTED|Treatment Period I||45
8385755|NCT01078675|20669383|P2|NOT COMPLETED|Overall Study||6
8385756|NCT01078675|20669384|P1|NOT COMPLETED|Overall Study||68
8385757|NCT01078675|20669383|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
8385758|NCT01078675|20669384|P1|COMPLETED|Overall Study||182
8385759|NCT01078675|20669383|P2|Patients Treated|Overall Study||0
8385760|NCT01078675|20669384|P1|Patients Treated|Overall Study||198
8385761|NCT01078675|20669383|P2|STARTED|Overall Study||65
8385762|NCT01078675|20669384|P1|STARTED|Overall Study||250
8385763|NCT01078662|20669406|P5|NOT COMPLETED|Overall Study||11
8385764|NCT01078662|20669407|P4|NOT COMPLETED|Overall Study||7
8385765|NCT01078662|20669408|P3|NOT COMPLETED|Overall Study||21
8385766|NCT01078662|20669409|P2|NOT COMPLETED|Overall Study||168
8385767|NCT01078662|20669410|P1|NOT COMPLETED|Overall Study||58
8385768|NCT01078662|20669406|P5|COMPLETED|Overall Study||1
8385769|NCT01078662|20669407|P4|COMPLETED|Overall Study||1
8385770|NCT01078662|20669408|P3|COMPLETED|Overall Study||2
8385771|NCT01078662|20669409|P2|COMPLETED|Overall Study||25
8385772|NCT01078662|20669410|P1|COMPLETED|Overall Study||4
8385773|NCT01078662|20669406|P5|STARTED|Overall Study||12
8385774|NCT01078662|20669407|P4|STARTED|Overall Study||8
8385775|NCT01078662|20669408|P3|STARTED|Overall Study||23
8385776|NCT01078662|20669409|P2|STARTED|Overall Study||193
8385777|NCT01078662|20669410|P1|STARTED|Overall Study||62
8385778|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 4||0
8385779|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 4||0
8385780|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 4||0
8385781|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 4||0
8385782|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 4||1
8385783|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 4||0
8385784|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 4||0
8385785|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 4||0
8385786|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 4||0
8385787|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 4||0
8385788|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 4||0
8385789|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 4||0
8385790|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 4||0
8385791|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 4||0
8385792|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 4||0
8385793|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 4||0
8385794|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 4||0
8385795|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 4||1
8385796|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 4||0
8385797|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 4||0
8385798|NCT01078623|20669449|P20|COMPLETED|Treatment Period 4||7
8385799|NCT01078623|20669450|P19|COMPLETED|Treatment Period 4||6
8385800|NCT01078623|20669451|P18|COMPLETED|Treatment Period 4||7
8385801|NCT01078623|20669452|P17|COMPLETED|Treatment Period 4||7
8385802|NCT01078623|20669453|P16|COMPLETED|Treatment Period 4||6
8385803|NCT01078623|20669454|P15|COMPLETED|Treatment Period 4||7
8385804|NCT01078623|20669455|P14|COMPLETED|Treatment Period 4||6
8385805|NCT01078623|20669456|P13|COMPLETED|Treatment Period 4||7
8385806|NCT01078623|20669457|P12|COMPLETED|Treatment Period 4||7
8385807|NCT01078623|20669458|P11|COMPLETED|Treatment Period 4||6
8385808|NCT01078623|20669459|P10|COMPLETED|Treatment Period 4||6
8385809|NCT01078623|20669460|P9|COMPLETED|Treatment Period 4||5
8385810|NCT01078623|20669461|P8|COMPLETED|Treatment Period 4||6
8385811|NCT01078623|20669462|P7|COMPLETED|Treatment Period 4||5
8385812|NCT01078623|20669463|P6|COMPLETED|Treatment Period 4||4
8385813|NCT01078623|20669464|P5|COMPLETED|Treatment Period 4||6
8385814|NCT01078623|20669465|P4|COMPLETED|Treatment Period 4||6
8385815|NCT01078623|20669466|P3|COMPLETED|Treatment Period 4||5
8385816|NCT01078623|20669467|P2|COMPLETED|Treatment Period 4||5
8385817|NCT01078623|20669468|P1|COMPLETED|Treatment Period 4||5
8385818|NCT01078623|20669449|P20|STARTED|Treatment Period 4||7
8385819|NCT01078623|20669450|P19|STARTED|Treatment Period 4||6
8385820|NCT01078623|20669451|P18|STARTED|Treatment Period 4||7
8385821|NCT01078623|20669452|P17|STARTED|Treatment Period 4||7
8385822|NCT01078623|20669453|P16|STARTED|Treatment Period 4||7
8385823|NCT01078623|20669454|P15|STARTED|Treatment Period 4||7
8385824|NCT01078623|20669455|P14|STARTED|Treatment Period 4||6
8385825|NCT01078623|20669456|P13|STARTED|Treatment Period 4||7
8385826|NCT01078623|20669457|P12|STARTED|Treatment Period 4||7
8385827|NCT01078623|20669458|P11|STARTED|Treatment Period 4||6
8385828|NCT01078623|20669459|P10|STARTED|Treatment Period 4||6
8385829|NCT01078623|20669460|P9|STARTED|Treatment Period 4||5
8385830|NCT01078623|20669461|P8|STARTED|Treatment Period 4||6
8385831|NCT01078623|20669462|P7|STARTED|Treatment Period 4||5
8385832|NCT01078623|20669463|P6|STARTED|Treatment Period 4||4
8385833|NCT01078623|20669464|P5|STARTED|Treatment Period 4||6
8385834|NCT01078623|20669465|P4|STARTED|Treatment Period 4||6
8385835|NCT01078623|20669466|P3|STARTED|Treatment Period 4||6
8385836|NCT01078623|20669467|P2|STARTED|Treatment Period 4||5
8385837|NCT01078623|20669468|P1|STARTED|Treatment Period 4||5
8385838|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 3||0
8385839|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 3||0
8385840|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 3||0
8385841|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 3||0
8385842|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 3||0
8385843|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 3||0
8385844|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 3||1
8385845|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 3||0
8385846|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 3||0
8385847|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 3||0
8385848|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 3||0
8385849|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 3||0
8385850|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 3||0
8385851|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 3||0
8385852|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 3||0
8385853|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 3||1
8385854|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 3||0
8385855|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 3||0
8385856|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 3||0
8385857|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 3||0
8385858|NCT01078623|20669449|P20|COMPLETED|Treatment Period 3||7
8385859|NCT01078623|20669450|P19|COMPLETED|Treatment Period 3||6
8385860|NCT01078623|20669451|P18|COMPLETED|Treatment Period 3||7
8385861|NCT01078623|20669452|P17|COMPLETED|Treatment Period 3||7
8385862|NCT01078623|20669453|P16|COMPLETED|Treatment Period 3||7
8385863|NCT01078623|20669454|P15|COMPLETED|Treatment Period 3||7
8385864|NCT01078623|20669455|P14|COMPLETED|Treatment Period 3||6
8385865|NCT01078623|20669456|P13|COMPLETED|Treatment Period 3||7
8385866|NCT01078623|20669457|P12|COMPLETED|Treatment Period 3||7
8385867|NCT01078623|20669458|P11|COMPLETED|Treatment Period 3||6
8385868|NCT01078623|20669459|P10|COMPLETED|Treatment Period 3||6
8385869|NCT01078623|20669460|P9|COMPLETED|Treatment Period 3||5
8385870|NCT01078623|20669461|P8|COMPLETED|Treatment Period 3||6
8385871|NCT01078623|20669462|P7|COMPLETED|Treatment Period 3||5
8385872|NCT01078623|20669463|P6|COMPLETED|Treatment Period 3||4
8385873|NCT01078623|20669464|P5|COMPLETED|Treatment Period 3||6
8385874|NCT01078623|20669465|P4|COMPLETED|Treatment Period 3||6
8385875|NCT01078623|20669466|P3|COMPLETED|Treatment Period 3||6
8385876|NCT01078623|20669467|P2|COMPLETED|Treatment Period 3||5
8385877|NCT01078623|20669468|P1|COMPLETED|Treatment Period 3||5
8385878|NCT01078623|20669449|P20|STARTED|Treatment Period 3||7
8385879|NCT01078623|20669450|P19|STARTED|Treatment Period 3||6
8385880|NCT01078623|20669451|P18|STARTED|Treatment Period 3||7
8385881|NCT01078623|20669452|P17|STARTED|Treatment Period 3||7
8385882|NCT01078623|20669453|P16|STARTED|Treatment Period 3||7
8385883|NCT01078623|20669454|P15|STARTED|Treatment Period 3||7
8385884|NCT01078623|20669455|P14|STARTED|Treatment Period 3||7
8385885|NCT01078623|20669456|P13|STARTED|Treatment Period 3||7
8385886|NCT01078623|20669457|P12|STARTED|Treatment Period 3||7
8385887|NCT01078623|20669458|P11|STARTED|Treatment Period 3||6
8385888|NCT01078623|20669459|P10|STARTED|Treatment Period 3||6
8385889|NCT01078623|20669460|P9|STARTED|Treatment Period 3||5
8385890|NCT01078623|20669461|P8|STARTED|Treatment Period 3||6
8385891|NCT01078623|20669462|P7|STARTED|Treatment Period 3||5
8385892|NCT01078623|20669463|P6|STARTED|Treatment Period 3||4
8385893|NCT01078623|20669464|P5|STARTED|Treatment Period 3||7
8385894|NCT01078623|20669465|P4|STARTED|Treatment Period 3||6
8385895|NCT01078623|20669466|P3|STARTED|Treatment Period 3||6
8385896|NCT01078623|20669467|P2|STARTED|Treatment Period 3||5
8385897|NCT01078623|20669468|P1|STARTED|Treatment Period 3||5
8385898|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 2||0
8385899|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 2||1
8385900|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 2||0
8385901|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 2||0
8385902|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 2||0
8385903|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 2||0
8385904|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 2||0
8385905|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 2||0
8385906|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 2||0
8385907|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 2||0
8385908|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 2||0
8385909|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 2||0
8385910|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 2||0
8385911|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 2||1
8385912|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 2||1
8385913|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 2||0
8385914|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 2||0
8385915|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 2||0
8385916|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 2||0
8385917|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 2||0
8385918|NCT01078623|20669449|P20|COMPLETED|Treatment Period 2||7
8385919|NCT01078623|20669450|P19|COMPLETED|Treatment Period 2||6
8385920|NCT01078623|20669451|P18|COMPLETED|Treatment Period 2||7
8385921|NCT01078623|20669452|P17|COMPLETED|Treatment Period 2||7
8385922|NCT01078623|20669453|P16|COMPLETED|Treatment Period 2||7
8385923|NCT01078623|20669454|P15|COMPLETED|Treatment Period 2||7
8385924|NCT01078623|20669455|P14|COMPLETED|Treatment Period 2||7
8385925|NCT01078623|20669456|P13|COMPLETED|Treatment Period 2||7
8385926|NCT01078623|20669457|P12|COMPLETED|Treatment Period 2||7
8385927|NCT01078623|20669458|P11|COMPLETED|Treatment Period 2||6
8385928|NCT01078623|20669459|P10|COMPLETED|Treatment Period 2||6
8385929|NCT01078623|20669460|P9|COMPLETED|Treatment Period 2||5
8385930|NCT01078623|20669461|P8|COMPLETED|Treatment Period 2||6
8385931|NCT01078623|20669462|P7|COMPLETED|Treatment Period 2||5
8385932|NCT01078623|20669463|P6|COMPLETED|Treatment Period 2||4
8385933|NCT01078623|20669464|P5|COMPLETED|Treatment Period 2||7
8385934|NCT01078623|20669465|P4|COMPLETED|Treatment Period 2||6
8385935|NCT01078623|20669466|P3|COMPLETED|Treatment Period 2||6
8385936|NCT01078623|20669467|P2|COMPLETED|Treatment Period 2||5
8385937|NCT01078623|20669468|P1|COMPLETED|Treatment Period 2||5
8385938|NCT01078623|20669449|P20|STARTED|Treatment Period 2||7
8385939|NCT01078623|20669450|P19|STARTED|Treatment Period 2||7
8385940|NCT01078623|20669451|P18|STARTED|Treatment Period 2||7
8385941|NCT01078623|20669452|P17|STARTED|Treatment Period 2||7
8385942|NCT01078623|20669453|P16|STARTED|Treatment Period 2||7
8385943|NCT01078623|20669454|P15|STARTED|Treatment Period 2||7
8385944|NCT01078623|20669455|P14|STARTED|Treatment Period 2||7
8385945|NCT01078623|20669456|P13|STARTED|Treatment Period 2||7
8385946|NCT01078623|20669457|P12|STARTED|Treatment Period 2||7
8385947|NCT01078623|20669458|P11|STARTED|Treatment Period 2||6
8385948|NCT01078623|20669459|P10|STARTED|Treatment Period 2||6
8385949|NCT01078623|20669460|P9|STARTED|Treatment Period 2||5
8385950|NCT01078623|20669461|P8|STARTED|Treatment Period 2||6
8385951|NCT01078623|20669462|P7|STARTED|Treatment Period 2||6
8385952|NCT01078623|20669463|P6|STARTED|Treatment Period 2||5
8385953|NCT01078623|20669464|P5|STARTED|Treatment Period 2||7
8385954|NCT01078623|20669465|P4|STARTED|Treatment Period 2||6
8385955|NCT01078623|20669466|P3|STARTED|Treatment Period 2||6
8385956|NCT01078623|20669467|P2|STARTED|Treatment Period 2||5
8385957|NCT01078623|20669468|P1|STARTED|Treatment Period 2||5
8385958|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 1||0
8385959|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 1||0
8385960|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 1||0
8385961|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 1||0
8385962|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 1||0
8385963|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 1||0
8385964|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 1||0
8385965|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 1||0
8385966|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 1||0
8385967|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 1||1
8385968|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 1||1
8385969|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 1||1
8385970|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 1||1
8385971|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 1||1
8385972|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 1||1
8385973|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 1||0
8385974|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 1||0
8385975|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 1||1
8385976|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 1||1
8385977|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 1||1
8385978|NCT01078623|20669449|P20|COMPLETED|Treatment Period 1||7
8385979|NCT01078623|20669450|P19|COMPLETED|Treatment Period 1||7
8385980|NCT01078623|20669451|P18|COMPLETED|Treatment Period 1||7
8385981|NCT01078623|20669452|P17|COMPLETED|Treatment Period 1||7
8385982|NCT01078623|20669453|P16|COMPLETED|Treatment Period 1||7
8385983|NCT01078623|20669454|P15|COMPLETED|Treatment Period 1||7
8385984|NCT01078623|20669455|P14|COMPLETED|Treatment Period 1||7
8385985|NCT01078623|20669456|P13|COMPLETED|Treatment Period 1||7
8385986|NCT01078623|20669457|P12|COMPLETED|Treatment Period 1||7
8385987|NCT01078623|20669458|P11|COMPLETED|Treatment Period 1||6
8385988|NCT01078623|20669459|P10|COMPLETED|Treatment Period 1||6
8385989|NCT01078623|20669460|P9|COMPLETED|Treatment Period 1||5
8385990|NCT01078623|20669461|P8|COMPLETED|Treatment Period 1||6
8385991|NCT01078623|20669462|P7|COMPLETED|Treatment Period 1||6
8385992|NCT01078623|20669463|P6|COMPLETED|Treatment Period 1||5
8385993|NCT01078623|20669464|P5|COMPLETED|Treatment Period 1||7
8385994|NCT01078623|20669465|P4|COMPLETED|Treatment Period 1||6
8385995|NCT01078623|20669466|P3|COMPLETED|Treatment Period 1||6
8385996|NCT01078623|20669467|P2|COMPLETED|Treatment Period 1||5
8385997|NCT01078623|20669468|P1|COMPLETED|Treatment Period 1||5
8385998|NCT01078623|20669449|P20|STARTED|Treatment Period 1||7
8385999|NCT01078623|20669450|P19|STARTED|Treatment Period 1||7
8386000|NCT01078623|20669451|P18|STARTED|Treatment Period 1||7
8386001|NCT01078623|20669452|P17|STARTED|Treatment Period 1||7
8386002|NCT01078623|20669453|P16|STARTED|Treatment Period 1||7
8386003|NCT01078623|20669454|P15|STARTED|Treatment Period 1||7
8386004|NCT01078623|20669455|P14|STARTED|Treatment Period 1||7
8386005|NCT01078623|20669456|P13|STARTED|Treatment Period 1||7
8386006|NCT01078623|20669457|P12|STARTED|Treatment Period 1||7
8386007|NCT01078623|20669458|P11|STARTED|Treatment Period 1||7
8386008|NCT01078623|20669459|P10|STARTED|Treatment Period 1||7
8386009|NCT01078623|20669460|P9|STARTED|Treatment Period 1||6
8386010|NCT01078623|20669461|P8|STARTED|Treatment Period 1||7
8386011|NCT01078623|20669462|P7|STARTED|Treatment Period 1||7
8386012|NCT01078623|20669463|P6|STARTED|Treatment Period 1||6
8386013|NCT01078623|20669464|P5|STARTED|Treatment Period 1||7
8386014|NCT01078623|20669465|P4|STARTED|Treatment Period 1||6
8386015|NCT01078623|20669466|P3|STARTED|Treatment Period 1||7
8386016|NCT01078623|20669467|P2|STARTED|Treatment Period 1||6
8386017|NCT01078623|20669468|P1|STARTED|Treatment Period 1||6
8386018|NCT01078584|20669490|P1|NOT COMPLETED|Overall Study||3010
8386019|NCT01078584|20669490|P1|COMPLETED|Overall Study||4983
8386020|NCT01078584|20669490|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
8386021|NCT01078584|20669490|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
8386022|NCT01078584|20669490|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
8386023|NCT01078584|20669490|P1|STARTED|Overall Study||7993
8386024|NCT01078571|20669571|P1|NOT COMPLETED|Overall Study||115
8386025|NCT01078571|20669571|P1|COMPLETED|Overall Study||590
8386026|NCT01078571|20669571|P1|Intent-to-treat (ITT) Population|Overall Study||591
8386027|NCT01078571|20669571|P1|Safety Population|Overall Study||675
8386028|NCT01078571|20669571|P1|STARTED|Overall Study||705
8386029|NCT01078558|20669590|P3|NOT COMPLETED|Overall Study||1361
8386030|NCT01078558|20669591|P2|NOT COMPLETED|Overall Study||755
8386031|NCT01078558|20669592|P1|NOT COMPLETED|Overall Study||2018
8386032|NCT01078558|20669590|P3|COMPLETED|Overall Study||596
8386033|NCT01078558|20669591|P2|COMPLETED|Overall Study||372
8386034|NCT01078558|20669592|P1|COMPLETED|Overall Study||818
8386035|NCT01078558|20669590|P3|Oligoarticular PsA|Overall Study||0
8386036|NCT01078558|20669591|P2|Oligoarticular PsA|Overall Study||197
8386037|NCT01078558|20669592|P1|Oligoarticular PsA|Overall Study||0
8386038|NCT01078558|20669590|P3|STARTED|Overall Study||1957
8386039|NCT01078558|20669591|P2|STARTED|Overall Study||1127
8386040|NCT01078558|20669592|P1|STARTED|Overall Study||2836
8386041|NCT01078545|20669622|P1|NOT COMPLETED|Overall Study||26
8386042|NCT01078545|20669622|P1|COMPLETED|Overall Study||703
8386043|NCT01078545|20669622|P1|Per Protocol Population|Overall Study||661
8386044|NCT01078545|20669622|P1|Intent-to-treat Population|Overall Study||729
8386045|NCT01078545|20669622|P1|STARTED|Overall Study||729
8386046|NCT01078454|20669632|P2|NOT COMPLETED|Overall Study||2
8386047|NCT01078454|20669633|P1|NOT COMPLETED|Overall Study||1
8386048|NCT01078454|20669632|P2|COMPLETED|Overall Study||3
8386049|NCT01078454|20669633|P1|COMPLETED|Overall Study||5
8386050|NCT01078454|20669632|P2|STARTED|Overall Study||5
8386051|NCT01078454|20669633|P1|STARTED|Overall Study||6
8386052|NCT01078441|20669639|P1|NOT COMPLETED|Overall Study||1
8386053|NCT01078441|20669639|P1|COMPLETED|Overall Study||1
8386054|NCT01078441|20669639|P1|STARTED|Overall Study||2
8386055|NCT01078402|20669646|P3|NOT COMPLETED|Overall Study||68
8386056|NCT01078402|20669647|P2|NOT COMPLETED|Overall Study||29
8386057|NCT01078402|20669648|P1|NOT COMPLETED|Overall Study||107
8386058|NCT01078402|20669646|P3|COMPLETED|Overall Study||166
8386059|NCT01078402|20669647|P2|COMPLETED|Overall Study||95
8386060|NCT01078402|20669648|P1|COMPLETED|Overall Study||324
8386061|NCT01078402|20669646|P3|STARTED|Overall Study||234
8386062|NCT01078402|20669647|P2|STARTED|Overall Study||124
8386063|NCT01078402|20669648|P1|STARTED|Overall Study||431
8386064|NCT01078389|20669679|P2|NOT COMPLETED|Overall Study||67
8386065|NCT01078389|20669680|P1|NOT COMPLETED|Overall Study||64
8386066|NCT01078389|20669679|P2|COMPLETED|Overall Study||90
8386067|NCT01078389|20669680|P1|COMPLETED|Overall Study||93
8386068|NCT01078389|20669679|P2|STARTED|Overall Study||157
8386069|NCT01078389|20669680|P1|STARTED|Overall Study||157
8386070|NCT01078376|20669698|P4|NOT COMPLETED|Overall Study||0
8386071|NCT01078376|20669699|P3|NOT COMPLETED|Overall Study||0
8386072|NCT01078376|20669700|P2|NOT COMPLETED|Overall Study||0
8386073|NCT01078376|20669701|P1|NOT COMPLETED|Overall Study||0
8386074|NCT01078376|20669698|P4|COMPLETED|Overall Study||3
8386075|NCT01078376|20669699|P3|COMPLETED|Overall Study||8
8386076|NCT01078376|20669700|P2|COMPLETED|Overall Study||9
8386077|NCT01078376|20669701|P1|COMPLETED|Overall Study||9
8386078|NCT01078376|20669698|P4|STARTED|Overall Study||3
8386079|NCT01078376|20669699|P3|STARTED|Overall Study||8
8386080|NCT01078376|20669700|P2|STARTED|Overall Study||9
8386081|NCT01078376|20669701|P1|STARTED|Overall Study||9
8386082|NCT01078363|20669822|P2|NOT COMPLETED|Overall Study||0
8386083|NCT01078363|20669823|P1|NOT COMPLETED|Overall Study||0
8386084|NCT01078363|20669822|P2|COMPLETED|Overall Study||49
8386085|NCT01078363|20669823|P1|COMPLETED|Overall Study||47
8386086|NCT01078363|20669822|P2|STARTED|Overall Study||49
8386087|NCT01078363|20669823|P1|STARTED|Overall Study||47
8386088|NCT01078298|20669841|P2|NOT COMPLETED|Overall Study||90
8386089|NCT01078298|20669842|P1|NOT COMPLETED|Overall Study||81
8386090|NCT01078298|20669841|P2|COMPLETED|Overall Study||179
8386091|NCT01078298|20669842|P1|COMPLETED|Overall Study||175
8386092|NCT01078298|20669841|P2|STARTED|Overall Study||269
8386093|NCT01078298|20669842|P1|STARTED|Overall Study||256
8386094|NCT01078246|20669875|P7|NOT COMPLETED|Overall Study||0
8386095|NCT01078246|20669876|P6|NOT COMPLETED|Overall Study||0
8386096|NCT01078246|20669877|P5|NOT COMPLETED|Overall Study||0
8386097|NCT01078246|20669878|P4|NOT COMPLETED|Overall Study||0
8386098|NCT01078246|20669879|P3|NOT COMPLETED|Overall Study||0
8386099|NCT01078246|20669880|P2|NOT COMPLETED|Overall Study||0
8386100|NCT01078246|20669881|P1|NOT COMPLETED|Overall Study||0
8386101|NCT01078246|20669875|P7|COMPLETED|Overall Study||22
8386102|NCT01078246|20669876|P6|COMPLETED|Overall Study||231
8386103|NCT01078246|20669877|P5|COMPLETED|Overall Study||3310
8386104|NCT01078246|20669878|P4|COMPLETED|Overall Study||152
8386105|NCT01078246|20669879|P3|COMPLETED|Overall Study||1963
8386106|NCT01078246|20669880|P2|COMPLETED|Overall Study||405
8386107|NCT01078246|20669881|P1|COMPLETED|Overall Study||1041
8386108|NCT01078246|20669875|P7|STARTED|Overall Study||22
8386109|NCT01078246|20669876|P6|STARTED|Overall Study||231
8386110|NCT01078246|20669877|P5|STARTED|Overall Study||3310
8386111|NCT01078246|20669878|P4|STARTED|Overall Study||152
8386112|NCT01078246|20669879|P3|STARTED|Overall Study||1963
8386113|NCT01078246|20669880|P2|STARTED|Overall Study||405
8386114|NCT01078246|20669881|P1|STARTED|Overall Study||1041
8386115|NCT01078233|20669913|P6|NOT COMPLETED|Overall Study||0
8386116|NCT01078233|20669914|P5|NOT COMPLETED|Overall Study||0
8386117|NCT01078233|20669915|P4|NOT COMPLETED|Overall Study||0
8386118|NCT01078233|20669916|P3|NOT COMPLETED|Overall Study||0
8386119|NCT01078233|20669917|P2|NOT COMPLETED|Overall Study||0
8386120|NCT01078233|20669918|P1|NOT COMPLETED|Overall Study||0
8386121|NCT01078233|20669913|P6|COMPLETED|Overall Study||154
8386122|NCT01078233|20669914|P5|COMPLETED|Overall Study||3199
8386123|NCT01078233|20669915|P4|COMPLETED|Overall Study||631
8386124|NCT01078233|20669916|P3|COMPLETED|Overall Study||1681
8386125|NCT01078233|20669917|P2|COMPLETED|Overall Study||296
8386126|NCT01078233|20669918|P1|COMPLETED|Overall Study||656
8386127|NCT01078233|20669913|P6|STARTED|Overall Study||154
8386128|NCT01078233|20669914|P5|STARTED|Overall Study||3199
8386129|NCT01078233|20669915|P4|STARTED|Overall Study||631
8386130|NCT01078233|20669916|P3|STARTED|Overall Study||1681
8386131|NCT01078233|20669917|P2|STARTED|Overall Study||296
8386132|NCT01078233|20669918|P1|STARTED|Overall Study||656
8386133|NCT01078220|20669935|P1|NOT COMPLETED|Overall Study||0
8386134|NCT01078220|20669935|P1|COMPLETED|Overall Study||189629
8386135|NCT01078220|20669935|P1|STARTED|Overall Study||189629
8386136|NCT01078207|20669945|P1|NOT COMPLETED|Overall Study||0
8386137|NCT01078207|20669945|P1|COMPLETED|Overall Study||100
8386138|NCT01078207|20669945|P1|STARTED|Overall Study||100
8386139|NCT01078168|20669952|P2|NOT COMPLETED|Overall Study||1
8386140|NCT01078168|20669953|P1|NOT COMPLETED|Overall Study||0
8386141|NCT01078168|20669952|P2|COMPLETED|Overall Study||10
8386142|NCT01078168|20669953|P1|COMPLETED|Overall Study||11
8386143|NCT01078168|20669952|P2|STARTED|Overall Study||11
8386144|NCT01078168|20669953|P1|STARTED|Overall Study||11
8386145|NCT01078155|20669959|P1|NOT COMPLETED|Overall Study||44
8386146|NCT01078155|20669959|P1|COMPLETED|Overall Study||87
8386147|NCT01078155|20669959|P1|STARTED|Overall Study||131
8386148|NCT01078116|20669975|P1|NOT COMPLETED|Overall Study||48
8386149|NCT01078116|20669975|P1|COMPLETED|Overall Study||76
8386150|NCT01078116|20669975|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
8386151|NCT01078090|20669983|P1|NOT COMPLETED|Overall Study||4593
8386152|NCT01078090|20669983|P1|COMPLETED|Overall Study||1152
8386153|NCT01078090|20669983|P1|STARTED|Overall Study||5745
8386154|NCT01077973|20670027|P3|NOT COMPLETED|Overall Study||0
8386155|NCT01077973|20670028|P2|NOT COMPLETED|Overall Study||0
8386156|NCT01077973|20670029|P1|NOT COMPLETED|Overall Study||0
8386157|NCT01077973|20670027|P3|COMPLETED|Overall Study||80
8386158|NCT01077973|20670028|P2|COMPLETED|Overall Study||79
8386159|NCT01077973|20670029|P1|COMPLETED|Overall Study||41
8386160|NCT01077973|20670027|P3|STARTED|Overall Study||80
8386161|NCT01077973|20670028|P2|STARTED|Overall Study||79
8386162|NCT01077973|20670029|P1|STARTED|Overall Study||41
8386163|NCT01077960|20670077|P1|NOT COMPLETED|Overall Study||16
8386164|NCT01077960|20670077|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
8386165|NCT01077960|20670077|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
8386166|NCT01077921|20670088|P2|NOT COMPLETED|Second Intervention||1
8386167|NCT01077921|20670089|P1|NOT COMPLETED|Second Intervention||0
8386168|NCT01077921|20670088|P2|COMPLETED|Second Intervention||9
8386169|NCT01077921|20670089|P1|COMPLETED|Second Intervention||13
8386170|NCT01077921|20670088|P2|STARTED|Second Intervention||10
8386171|NCT01077921|20670089|P1|STARTED|Second Intervention||13
8386172|NCT01077921|20670088|P2|NOT COMPLETED|Washout||2
8386173|NCT01077921|20670089|P1|NOT COMPLETED|Washout||0
8386174|NCT01077921|20670088|P2|COMPLETED|Washout||10
8386175|NCT01077921|20670089|P1|COMPLETED|Washout||13
8386176|NCT01077921|20670088|P2|STARTED|Washout||12
8386177|NCT01077921|20670089|P1|STARTED|Washout||13
8386178|NCT01077921|20670088|P2|NOT COMPLETED|First Intervention||1
8386179|NCT01077921|20670089|P1|NOT COMPLETED|First Intervention||1
8386180|NCT01077921|20670088|P2|COMPLETED|First Intervention||12
8386181|NCT01077921|20670089|P1|COMPLETED|First Intervention||13
8386182|NCT01077921|20670088|P2|STARTED|First Intervention||13
8386183|NCT01077921|20670089|P1|STARTED|First Intervention||14
8386184|NCT01077856|20670122|P3|NOT COMPLETED|Overall Study||0
8386185|NCT01077856|20670123|P2|NOT COMPLETED|Overall Study||0
8386186|NCT01077856|20670124|P1|NOT COMPLETED|Overall Study||0
8386187|NCT01077856|20670122|P3|COMPLETED|Overall Study||15713
8386188|NCT01077856|20670123|P2|COMPLETED|Overall Study||16604
8386189|NCT01077856|20670124|P1|COMPLETED|Overall Study||22199
8386190|NCT01077856|20670122|P3|STARTED|Overall Study||15713
8386191|NCT01077856|20670123|P2|STARTED|Overall Study||16604
8386192|NCT01077856|20670124|P1|STARTED|Overall Study||22199
8386193|NCT01077830|20670305|P2|NOT COMPLETED|Overall Study||0
8386194|NCT01077830|20670306|P1|NOT COMPLETED|Overall Study||0
8386195|NCT01077830|20670305|P2|COMPLETED|Overall Study||682
8386196|NCT01077830|20670306|P1|COMPLETED|Overall Study||677
8386197|NCT01077830|20670305|P2|STARTED|Overall Study||682
8386198|NCT01077830|20670306|P1|STARTED|Overall Study||677
8386199|NCT01077817|20670316|P1|NOT COMPLETED|Overall Study||0
8386200|NCT01077817|20670316|P1|COMPLETED|Overall Study||684815
8386201|NCT01077817|20670316|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
8386202|NCT01077804|20670327|P1|NOT COMPLETED|Overall Study||199
8386203|NCT01077804|20670327|P1|COMPLETED|Overall Study||7386
8386204|NCT01077804|20670327|P1|STARTED|Overall Study||7585
8386205|NCT01077739|20670336|P2|NOT COMPLETED|Overall Study||10
8386206|NCT01077739|20670337|P1|NOT COMPLETED|Overall Study||5
8386207|NCT01077739|20670336|P2|COMPLETED|Overall Study||40
8386208|NCT01077739|20670337|P1|COMPLETED|Overall Study||20
8386209|NCT01077739|20670336|P2|STARTED|Overall Study||50
8386210|NCT01077739|20670337|P1|STARTED|Overall Study||25
8386211|NCT01077713|20670351|P2|NOT COMPLETED|Overall Study||36
8386212|NCT01077713|20670352|P1|NOT COMPLETED|Overall Study||36
8386213|NCT01077713|20670351|P2|COMPLETED|Overall Study||6
8386214|NCT01077713|20670352|P1|COMPLETED|Overall Study||8
8386215|NCT01077713|20670351|P2|STARTED|Overall Study||42
8386216|NCT01077713|20670352|P1|STARTED|Overall Study||44
8386217|NCT01077622|20670376|P1|NOT COMPLETED|Overall Study||3
8386218|NCT01077622|20670376|P1|COMPLETED|Overall Study||7
8386219|NCT01077622|20670376|P1|STARTED|Overall Study||10
8386220|NCT01077596|20670434|P12|NOT COMPLETED|Overall Study||0
8386221|NCT01077596|20670435|P11|NOT COMPLETED|Overall Study||0
8386222|NCT01077596|20670436|P10|NOT COMPLETED|Overall Study||0
8386223|NCT01077596|20670437|P9|NOT COMPLETED|Overall Study||0
8386224|NCT01077596|20670438|P8|NOT COMPLETED|Overall Study||0
8386225|NCT01077596|20670439|P7|NOT COMPLETED|Overall Study||0
8386226|NCT01077596|20670440|P6|NOT COMPLETED|Overall Study||0
8386227|NCT01077596|20670441|P5|NOT COMPLETED|Overall Study||0
8386228|NCT01077596|20670442|P4|NOT COMPLETED|Overall Study||0
8386229|NCT01077596|20670443|P3|NOT COMPLETED|Overall Study||0
8386230|NCT01077596|20670444|P2|NOT COMPLETED|Overall Study||0
8386231|NCT01077596|20670445|P1|NOT COMPLETED|Overall Study||0
8386232|NCT01077596|20670434|P12|COMPLETED|Overall Study||22150
8386233|NCT01077596|20670435|P11|COMPLETED|Overall Study||2215
8386234|NCT01077596|20670436|P10|COMPLETED|Overall Study||28420
8386235|NCT01077596|20670437|P9|COMPLETED|Overall Study||2842
8386236|NCT01077596|20670438|P8|COMPLETED|Overall Study||837
8386237|NCT01077596|20670439|P7|COMPLETED|Overall Study||308
8386238|NCT01077596|20670440|P6|COMPLETED|Overall Study||882
8386239|NCT01077596|20670441|P5|COMPLETED|Overall Study||294
8386240|NCT01077596|20670442|P4|COMPLETED|Overall Study||1370
8386241|NCT01077596|20670443|P3|COMPLETED|Overall Study||457
8386242|NCT01077596|20670444|P2|COMPLETED|Overall Study||1050
8386243|NCT01077596|20670445|P1|COMPLETED|Overall Study||350
8386244|NCT01077596|20670434|P12|STARTED|Overall Study||22150
8386245|NCT01077596|20670435|P11|STARTED|Overall Study||2215
8386246|NCT01077596|20670436|P10|STARTED|Overall Study||28420
8386247|NCT01077596|20670437|P9|STARTED|Overall Study||2842
8386248|NCT01077596|20670438|P8|STARTED|Overall Study||837
8386249|NCT01077596|20670439|P7|STARTED|Overall Study||308
8386250|NCT01077596|20670440|P6|STARTED|Overall Study||882
8386251|NCT01077596|20670441|P5|STARTED|Overall Study||294
8386252|NCT01077596|20670442|P4|STARTED|Overall Study||1370
8386253|NCT01077596|20670443|P3|STARTED|Overall Study||457
8386254|NCT01077596|20670444|P2|STARTED|Overall Study||1050
8386255|NCT01077596|20670445|P1|STARTED|Overall Study||350
8386256|NCT01077544|20670496|P2|NOT COMPLETED|Overall Study||5
8386257|NCT01077544|20670497|P1|NOT COMPLETED|Overall Study||3
8386258|NCT01077544|20670496|P2|COMPLETED|Overall Study||2
8386259|NCT01077544|20670497|P1|COMPLETED|Overall Study||5
8386260|NCT01077544|20670496|P2|STARTED|Overall Study||7
8386261|NCT01077544|20670497|P1|STARTED|Overall Study||8
8386262|NCT01077518|20670525|P3|NOT COMPLETED|Optional Ofa Phase||16
8386263|NCT01077518|20670526|P2|NOT COMPLETED|Optional Ofa Phase||0
8386264|NCT01077518|20670527|P1|NOT COMPLETED|Optional Ofa Phase||0
8386265|NCT01077518|20670525|P3|COMPLETED|Optional Ofa Phase||16
8386266|NCT01077518|20670526|P2|COMPLETED|Optional Ofa Phase||0
8386267|NCT01077518|20670527|P1|COMPLETED|Optional Ofa Phase||0
8386268|NCT01077518|20670525|P3|Completed 5-year Follow-up|Optional Ofa Phase||12
8386269|NCT01077518|20670526|P2|Completed 5-year Follow-up|Optional Ofa Phase||0
8386270|NCT01077518|20670527|P1|Completed 5-year Follow-up|Optional Ofa Phase||0
8386271|NCT01077518|20670525|P3|STARTED|Optional Ofa Phase||32
8386272|NCT01077518|20670526|P2|STARTED|Optional Ofa Phase||0
8386273|NCT01077518|20670527|P1|STARTED|Optional Ofa Phase||0
8386274|NCT01077518|20670525|P3|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
8386275|NCT01077518|20670526|P2|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
8386276|NCT01077518|20670527|P1|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
8386277|NCT01077518|20670525|P3|COMPLETED|Treatment Phase - no Optional Ofa||0
8386278|NCT01077518|20670526|P2|COMPLETED|Treatment Phase - no Optional Ofa||108
8386279|NCT01077518|20670527|P1|COMPLETED|Treatment Phase - no Optional Ofa||95
8386280|NCT01077518|20670525|P3|Safety Population|Treatment Phase - no Optional Ofa||0
8386281|NCT01077518|20670526|P2|Safety Population|Treatment Phase - no Optional Ofa||170
8386282|NCT01077518|20670527|P1|Safety Population|Treatment Phase - no Optional Ofa||172
8386283|NCT01077518|20670525|P3|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
8386284|NCT01077518|20670526|P2|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
8386285|NCT01077518|20670527|P1|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
8386286|NCT01077518|20670525|P3|STARTED|Treatment Phase - no Optional Ofa||0
8386287|NCT01077518|20670526|P2|STARTED|Treatment Phase - no Optional Ofa||173
8386288|NCT01077518|20670527|P1|STARTED|Treatment Phase - no Optional Ofa||173
8386289|NCT01077401|20670587|P2|NOT COMPLETED|Overall Study||21
8386290|NCT01077401|20670588|P1|NOT COMPLETED|Overall Study||18
8386291|NCT01077401|20670587|P2|COMPLETED|Overall Study||54
8386292|NCT01077401|20670588|P1|COMPLETED|Overall Study||59
8386293|NCT01077401|20670587|P2|STARTED|Overall Study||75
8386294|NCT01077401|20670588|P1|STARTED|Overall Study||77
8386295|NCT01077375|20670600|P2|NOT COMPLETED|Overall Study||35
8386296|NCT01077375|20670601|P1|NOT COMPLETED|Overall Study||10
8386297|NCT01077375|20670600|P2|COMPLETED|Overall Study||51
8386298|NCT01077375|20670601|P1|COMPLETED|Overall Study||11
8386299|NCT01077375|20670600|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
8386300|NCT01077375|20670601|P1|STARTED|Overall Study||21
8386301|NCT01077362|20670612|P3|NOT COMPLETED|Overall Study||24
8386302|NCT01077362|20670613|P2|NOT COMPLETED|Overall Study||19
8386303|NCT01077362|20670614|P1|NOT COMPLETED|Overall Study||31
8386304|NCT01077362|20670612|P3|COMPLETED|Overall Study||81
8386305|NCT01077362|20670613|P2|COMPLETED|Overall Study||84
8386306|NCT01077362|20670614|P1|COMPLETED|Overall Study||73
8386307|NCT01077362|20670612|P3|STARTED|Overall Study||105
8386308|NCT01077362|20670613|P2|STARTED|Overall Study||103
8386309|NCT01077362|20670614|P1|STARTED|Overall Study||104
8386310|NCT01077323|20670650|P3|NOT COMPLETED|Overall Study||11912089
8386311|NCT01077323|20670651|P2|NOT COMPLETED|Overall Study||386263
8386312|NCT01077323|20670652|P1|NOT COMPLETED|Overall Study||11378
8386313|NCT01077323|20670650|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
8386314|NCT01077323|20670651|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
8386315|NCT01077323|20670652|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
8386316|NCT01077323|20670650|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
8386317|NCT01077323|20670651|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
8386318|NCT01077323|20670652|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
8386319|NCT01077310|20670671|P2|NOT COMPLETED|Overall Study||0
8386320|NCT01077310|20670672|P1|NOT COMPLETED|Overall Study||0
8386321|NCT01077310|20670671|P2|COMPLETED|Overall Study||33
8386322|NCT01077310|20670672|P1|COMPLETED|Overall Study||67
8386323|NCT01077310|20670671|P2|STARTED|Overall Study||33
8386324|NCT01077310|20670672|P1|STARTED|Overall Study||67
8386325|NCT01077284|20670695|P3|NOT COMPLETED|Overall Study||3
8386326|NCT01077284|20670696|P2|NOT COMPLETED|Overall Study||5
8386327|NCT01077284|20670697|P1|NOT COMPLETED|Overall Study||5
8386328|NCT01077284|20670695|P3|COMPLETED|Overall Study||30
8386329|NCT01077284|20670696|P2|COMPLETED|Overall Study||28
8386330|NCT01077284|20670697|P1|COMPLETED|Overall Study||28
8386331|NCT01077284|20670695|P3|STARTED|Overall Study||33
8386332|NCT01077284|20670696|P2|STARTED|Overall Study||33
8386333|NCT01077284|20670697|P1|STARTED|Overall Study||33
8386334|NCT01077271|20670718|P1|NOT COMPLETED|Overall Study||22
8386335|NCT01077271|20670718|P1|COMPLETED|Overall Study||102
8386336|NCT01077271|20670718|P1|Number of Participants Analyzed|Overall Study||120
8386337|NCT01077271|20670718|P1|Participants Treated With Palivizumab|Overall Study||120
8386338|NCT01077271|20670718|P1|STARTED|Overall Study||124
8386339|NCT01077258|20670756|P1|NOT COMPLETED|Overall Study||2568
8386340|NCT01077258|20670756|P1|COMPLETED|Overall Study||1640
8386341|NCT01077258|20670756|P1|STARTED|Overall Study||4208
8386342|NCT01077193|20670792|P1|NOT COMPLETED|Overall Study||44
8386343|NCT01077193|20670792|P1|COMPLETED|Overall Study||0
8386344|NCT01077193|20670792|P1|STARTED|Overall Study||44
8386345|NCT01077154|20670798|P2|NOT COMPLETED|Overall Study||2228
8386346|NCT01077154|20670799|P1|NOT COMPLETED|Overall Study||2226
8386347|NCT01077154|20670798|P2|COMPLETED|Overall Study||28
8386348|NCT01077154|20670799|P1|COMPLETED|Overall Study||27
8386349|NCT01077154|20670798|P2|Received Study Drug|Overall Study||2230
8386350|NCT01077154|20670799|P1|Received Study Drug|Overall Study||2229
8386351|NCT01077154|20670798|P2|STARTED|Overall Study||2256
8386352|NCT01077154|20670799|P1|STARTED|Overall Study||2253
8386353|NCT01077128|20670813|P1|NOT COMPLETED|Overall Study||67
8386354|NCT01077128|20670813|P1|COMPLETED|Overall Study||433
8386355|NCT01077128|20670813|P1|STARTED|Overall Study||500
8386356|NCT01077076|20670871|P6|NOT COMPLETED|Third Intervention||1
8386357|NCT01077076|20670872|P5|NOT COMPLETED|Third Intervention||0
8386358|NCT01077076|20670873|P4|NOT COMPLETED|Third Intervention||0
8386359|NCT01077076|20670874|P3|NOT COMPLETED|Third Intervention||0
8386360|NCT01077076|20670875|P2|NOT COMPLETED|Third Intervention||0
8386361|NCT01077076|20670876|P1|NOT COMPLETED|Third Intervention||0
8386362|NCT01077076|20670871|P6|COMPLETED|Third Intervention||4
8386363|NCT01077076|20670872|P5|COMPLETED|Third Intervention||5
8386364|NCT01077076|20670873|P4|COMPLETED|Third Intervention||5
8386365|NCT01077076|20670874|P3|COMPLETED|Third Intervention||5
8386366|NCT01077076|20670875|P2|COMPLETED|Third Intervention||5
8386367|NCT01077076|20670876|P1|COMPLETED|Third Intervention||4
8386368|NCT01077076|20670871|P6|STARTED|Third Intervention||5
8386369|NCT01077076|20670872|P5|STARTED|Third Intervention||5
8386370|NCT01077076|20670873|P4|STARTED|Third Intervention||5
8386371|NCT01077076|20670874|P3|STARTED|Third Intervention||5
8386372|NCT01077076|20670875|P2|STARTED|Third Intervention||5
8386373|NCT01077076|20670876|P1|STARTED|Third Intervention||4
8386374|NCT01077076|20670871|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
8386375|NCT01077076|20670872|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
8386376|NCT01077076|20670873|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8386377|NCT01077076|20670874|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8386378|NCT01077076|20670875|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8386379|NCT01077076|20670876|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8386380|NCT01077076|20670871|P6|COMPLETED|Washout Period of 2 Weeks||5
8386381|NCT01077076|20670872|P5|COMPLETED|Washout Period of 2 Weeks||5
8386382|NCT01077076|20670873|P4|COMPLETED|Washout Period of 2 Weeks||5
8386383|NCT01077076|20670874|P3|COMPLETED|Washout Period of 2 Weeks||5
8386384|NCT01077076|20670875|P2|COMPLETED|Washout Period of 2 Weeks||5
8386385|NCT01077076|20670876|P1|COMPLETED|Washout Period of 2 Weeks||4
8386386|NCT01077076|20670871|P6|STARTED|Washout Period of 2 Weeks||5
8386387|NCT01077076|20670872|P5|STARTED|Washout Period of 2 Weeks||5
8386388|NCT01077076|20670873|P4|STARTED|Washout Period of 2 Weeks||5
8386389|NCT01077076|20670874|P3|STARTED|Washout Period of 2 Weeks||5
8386390|NCT01077076|20670875|P2|STARTED|Washout Period of 2 Weeks||5
8386391|NCT01077076|20670876|P1|STARTED|Washout Period of 2 Weeks||4
8386392|NCT01077076|20670871|P6|NOT COMPLETED|Second Intervention||0
8386393|NCT01077076|20670872|P5|NOT COMPLETED|Second Intervention||0
8386394|NCT01077076|20670873|P4|NOT COMPLETED|Second Intervention||0
8386395|NCT01077076|20670874|P3|NOT COMPLETED|Second Intervention||0
8386396|NCT01077076|20670875|P2|NOT COMPLETED|Second Intervention||0
8386397|NCT01077076|20670876|P1|NOT COMPLETED|Second Intervention||0
8386398|NCT01077076|20670871|P6|COMPLETED|Second Intervention||5
8386399|NCT01077076|20670872|P5|COMPLETED|Second Intervention||5
8386400|NCT01077076|20670873|P4|COMPLETED|Second Intervention||5
8386401|NCT01077076|20670874|P3|COMPLETED|Second Intervention||5
8386402|NCT01077076|20670875|P2|COMPLETED|Second Intervention||5
8386403|NCT01077076|20670876|P1|COMPLETED|Second Intervention||4
8386404|NCT01077076|20670871|P6|STARTED|Second Intervention||5
8386405|NCT01077076|20670872|P5|STARTED|Second Intervention||5
8386406|NCT01077076|20670873|P4|STARTED|Second Intervention||5
8386407|NCT01077076|20670874|P3|STARTED|Second Intervention||5
8386408|NCT01077076|20670875|P2|STARTED|Second Intervention||5
8386409|NCT01077076|20670876|P1|STARTED|Second Intervention||4
8386410|NCT01077076|20670871|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
8386411|NCT01077076|20670872|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
8386412|NCT01077076|20670873|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8386413|NCT01077076|20670874|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8386414|NCT01077076|20670875|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8386415|NCT01077076|20670876|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8386416|NCT01077076|20670871|P6|COMPLETED|Washout Period of 2 Weeks||5
8386417|NCT01077076|20670872|P5|COMPLETED|Washout Period of 2 Weeks||5
8386418|NCT01077076|20670873|P4|COMPLETED|Washout Period of 2 Weeks||5
8386419|NCT01077076|20670874|P3|COMPLETED|Washout Period of 2 Weeks||5
8386420|NCT01077076|20670875|P2|COMPLETED|Washout Period of 2 Weeks||5
8386421|NCT01077076|20670876|P1|COMPLETED|Washout Period of 2 Weeks||4
8386422|NCT01077076|20670871|P6|STARTED|Washout Period of 2 Weeks||5
8386423|NCT01077076|20670872|P5|STARTED|Washout Period of 2 Weeks||5
8386424|NCT01077076|20670873|P4|STARTED|Washout Period of 2 Weeks||5
8386425|NCT01077076|20670874|P3|STARTED|Washout Period of 2 Weeks||5
8386426|NCT01077076|20670875|P2|STARTED|Washout Period of 2 Weeks||5
8386427|NCT01077076|20670876|P1|STARTED|Washout Period of 2 Weeks||4
8386428|NCT01077076|20670871|P6|NOT COMPLETED|First Intervention||0
8386429|NCT01077076|20670872|P5|NOT COMPLETED|First Intervention||0
8386430|NCT01077076|20670873|P4|NOT COMPLETED|First Intervention||0
8386431|NCT01077076|20670874|P3|NOT COMPLETED|First Intervention||0
8386432|NCT01077076|20670875|P2|NOT COMPLETED|First Intervention||0
8386433|NCT01077076|20670876|P1|NOT COMPLETED|First Intervention||1
8386434|NCT01077076|20670871|P6|COMPLETED|First Intervention||5
8386435|NCT01077076|20670872|P5|COMPLETED|First Intervention||5
8386436|NCT01077076|20670873|P4|COMPLETED|First Intervention||5
8386437|NCT01077076|20670874|P3|COMPLETED|First Intervention||5
8386438|NCT01077076|20670875|P2|COMPLETED|First Intervention||5
8386439|NCT01077076|20670876|P1|COMPLETED|First Intervention||4
8386440|NCT01077076|20670871|P6|STARTED|First Intervention||5
8386441|NCT01077076|20670872|P5|STARTED|First Intervention||5
8386442|NCT01077076|20670873|P4|STARTED|First Intervention||5
8386443|NCT01077076|20670874|P3|STARTED|First Intervention||5
8386444|NCT01077076|20670875|P2|STARTED|First Intervention||5
8386445|NCT01077076|20670876|P1|STARTED|First Intervention||5
8386446|NCT01077063|20670886|P2|NOT COMPLETED|Overall Study||3
8386447|NCT01077063|20670887|P1|NOT COMPLETED|Overall Study||4
8386448|NCT01077063|20670886|P2|COMPLETED|Overall Study||0
8386449|NCT01077063|20670887|P1|COMPLETED|Overall Study||0
8386450|NCT01077063|20670886|P2|STARTED|Overall Study||3
8386451|NCT01077063|20670887|P1|STARTED|Overall Study||4
8386452|NCT01077050|20670893|P1|NOT COMPLETED|Overall Study||9
8386453|NCT01077050|20670893|P1|COMPLETED|Overall Study||1942
8386454|NCT01077050|20670893|P1|STARTED|Overall Study||1951
8386455|NCT01077024|20670899|P2|NOT COMPLETED|Overall Study||28
8386456|NCT01077024|20670900|P1|NOT COMPLETED|Overall Study||31
8386457|NCT01077024|20670899|P2|COMPLETED|Overall Study||243
8386458|NCT01077024|20670900|P1|COMPLETED|Overall Study||236
8386459|NCT01077024|20670899|P2|STARTED|Overall Study||271
8386460|NCT01077024|20670900|P1|STARTED|Overall Study||267
8386461|NCT01076985|20670918|P1|NOT COMPLETED|Overall Study||0
8386462|NCT01076985|20670918|P1|COMPLETED|Overall Study||24
8386463|NCT01076985|20670918|P1|STARTED|Overall Study||24
8386464|NCT01076972|20670924|P1|NOT COMPLETED|Overall Study||0
8386465|NCT01076972|20670924|P1|COMPLETED|Overall Study||1184
8386466|NCT01076972|20670924|P1|STARTED|Overall Study||1184
8386467|NCT01076959|20670939|P1|NOT COMPLETED|Overall Study||2250
8386468|NCT01076959|20670939|P1|COMPLETED|Overall Study||5490
8386469|NCT01076959|20670939|P1|STARTED|Overall Study||7740
8386470|NCT01076686|20670960|P4|NOT COMPLETED|Overall Study||0
8386471|NCT01076686|20670961|P3|NOT COMPLETED|Overall Study||0
8386472|NCT01076686|20670962|P2|NOT COMPLETED|Overall Study||0
8386473|NCT01076686|20670963|P1|NOT COMPLETED|Overall Study||0
8386474|NCT01076686|20670960|P4|COMPLETED|Overall Study||31
8386475|NCT01076686|20670961|P3|COMPLETED|Overall Study||32
8386476|NCT01076686|20670962|P2|COMPLETED|Overall Study||14
8386477|NCT01076686|20670963|P1|COMPLETED|Overall Study||17
8386478|NCT01076686|20670960|P4|STARTED|Overall Study||31
8386479|NCT01076686|20670961|P3|STARTED|Overall Study||32
8386480|NCT01076686|20670962|P2|STARTED|Overall Study||14
8386481|NCT01076686|20670963|P1|STARTED|Overall Study||17
8386482|NCT01076647|20670975|P2|NOT COMPLETED|Overall Study||25
8386483|NCT01076647|20670976|P1|NOT COMPLETED|Overall Study||25
8386484|NCT01076647|20670975|P2|COMPLETED|Overall Study||209
8386485|NCT01076647|20670976|P1|COMPLETED|Overall Study||208
8386486|NCT01076647|20670975|P2|STARTED|Overall Study||234
8386487|NCT01076647|20670976|P1|STARTED|Overall Study||233
8386488|NCT01076543|20670990|P6|NOT COMPLETED|Overall Study||0
8386489|NCT01076543|20670991|P5|NOT COMPLETED|Overall Study||0
8386490|NCT01076543|20670992|P4|NOT COMPLETED|Overall Study||0
8386491|NCT01076543|20670993|P3|NOT COMPLETED|Overall Study||0
8386492|NCT01076543|20670994|P2|NOT COMPLETED|Overall Study||0
8386493|NCT01076543|20670995|P1|NOT COMPLETED|Overall Study||2
8386494|NCT01076543|20670990|P6|COMPLETED|Overall Study||39
8386495|NCT01076543|20670991|P5|COMPLETED|Overall Study||15
8386496|NCT01076543|20670992|P4|COMPLETED|Overall Study||39
8386497|NCT01076543|20670993|P3|COMPLETED|Overall Study||6
8386498|NCT01076543|20670994|P2|COMPLETED|Overall Study||3
8386499|NCT01076543|20670995|P1|COMPLETED|Overall Study||6
8386500|NCT01076543|20670990|P6|STARTED|Overall Study||39
8386501|NCT01076543|20670991|P5|STARTED|Overall Study||15
8386502|NCT01076543|20670992|P4|STARTED|Overall Study||39
8386503|NCT01076543|20670993|P3|STARTED|Overall Study||6
8386504|NCT01076543|20670994|P2|STARTED|Overall Study||3
8386505|NCT01076543|20670995|P1|STARTED|Overall Study||8
8386506|NCT01076504|20671033|P1|NOT COMPLETED|Overall Study||80
8386507|NCT01076504|20671033|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
8386508|NCT01076504|20671033|P1|STARTED|Overall Study||80
8386509|NCT01076452|20671043|P2|NOT COMPLETED|Overall Study||14
8386510|NCT01076452|20671044|P1|NOT COMPLETED|Overall Study||24
8386511|NCT01076452|20671043|P2|COMPLETED|Overall Study||138
8386512|NCT01076452|20671044|P1|COMPLETED|Overall Study||123
8386513|NCT01076452|20671043|P2|STARTED|Overall Study||152
8386514|NCT01076452|20671044|P1|STARTED|Overall Study||147
8386515|NCT01076400|20671056|P3|NOT COMPLETED|Overall Study||0
8386516|NCT01076400|20671057|P2|NOT COMPLETED|Overall Study||0
8386517|NCT01076400|20671058|P1|NOT COMPLETED|Overall Study||7
8386518|NCT01076400|20671056|P3|COMPLETED|Overall Study||0
8386519|NCT01076400|20671057|P2|COMPLETED|Overall Study||0
8386520|NCT01076400|20671058|P1|COMPLETED|Overall Study||0
8386521|NCT01076400|20671056|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
8386522|NCT01076400|20671057|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
8386523|NCT01076400|20671058|P1|STARTED|Overall Study||7
8386524|NCT01076361|20671064|P1|NOT COMPLETED|Overall Study||21
8386525|NCT01076361|20671064|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
8386526|NCT01076361|20671064|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
8386527|NCT01076348|20671068|P1|NOT COMPLETED|Overall Study||22
8386528|NCT01076348|20671068|P1|COMPLETED|Overall Study||51
8386529|NCT01076348|20671068|P1|STARTED|Overall Study||73
8386530|NCT01076335|20671072|P1|NOT COMPLETED|Overall Study||4
8386531|NCT01076335|20671072|P1|COMPLETED|Overall Study||36
8386532|NCT01076335|20671072|P1|STARTED|Overall Study||40
8386533|NCT01076296|20671076|P8|NOT COMPLETED|Overall Study||0
8386534|NCT01076296|20671077|P7|NOT COMPLETED|Overall Study||0
8386535|NCT01076296|20671078|P6|NOT COMPLETED|Overall Study||0
8386536|NCT01076296|20671079|P5|NOT COMPLETED|Overall Study||0
8386537|NCT01076296|20671080|P4|NOT COMPLETED|Overall Study||0
8386538|NCT01076296|20671081|P3|NOT COMPLETED|Overall Study||0
8386539|NCT01076296|20671082|P2|NOT COMPLETED|Overall Study||0
8386540|NCT01076296|20671083|P1|NOT COMPLETED|Overall Study||0
8386541|NCT01076296|20671076|P8|COMPLETED|Overall Study||199
8386542|NCT01076296|20671077|P7|COMPLETED|Overall Study||51
8386543|NCT01076296|20671078|P6|COMPLETED|Overall Study||191
8386544|NCT01076296|20671079|P5|COMPLETED|Overall Study||59
8386545|NCT01076296|20671080|P4|COMPLETED|Overall Study||199
8386546|NCT01076296|20671081|P3|COMPLETED|Overall Study||51
8386547|NCT01076296|20671082|P2|COMPLETED|Overall Study||196
8386548|NCT01076296|20671083|P1|COMPLETED|Overall Study||54
8386549|NCT01076296|20671076|P8|STARTED|Overall Study||199
8386550|NCT01076296|20671077|P7|STARTED|Overall Study||51
8386551|NCT01076296|20671078|P6|STARTED|Overall Study||191
8386552|NCT01076296|20671079|P5|STARTED|Overall Study||59
8386553|NCT01076296|20671080|P4|STARTED|Overall Study||199
8386554|NCT01076296|20671081|P3|STARTED|Overall Study||51
8386555|NCT01076296|20671082|P2|STARTED|Overall Study||196
8386556|NCT01076296|20671083|P1|STARTED|Overall Study||54
8386557|NCT01076283|20671103|P2|NOT COMPLETED|Overall Study||0
8386558|NCT01076283|20671104|P1|NOT COMPLETED|Overall Study||1
8386559|NCT01076283|20671103|P2|COMPLETED|Overall Study||7
8386560|NCT01076283|20671104|P1|COMPLETED|Overall Study||6
8386561|NCT01076283|20671103|P2|STARTED|Overall Study||7
8386562|NCT01076283|20671104|P1|STARTED|Overall Study||7
8386563|NCT01076270|20671112|P1|NOT COMPLETED|Overall Study||0
8386564|NCT01076270|20671112|P1|COMPLETED|Overall Study||1
8386565|NCT01076270|20671112|P1|STARTED|Overall Study||1
8386566|NCT01076244|20671117|P1|NOT COMPLETED|Overall Study||4
8386567|NCT01076244|20671117|P1|COMPLETED|Overall Study||42
8386568|NCT01076244|20671117|P1|STARTED|Overall Study||46
8386569|NCT01076205|20671124|P1|NOT COMPLETED|Overall Study||6019
8386570|NCT01076205|20671124|P1|COMPLETED|Overall Study||1210
8386571|NCT01076205|20671124|P1|STARTED|Overall Study||7229
8386572|NCT01076192|20671177|P1|NOT COMPLETED|Overall Study||197
8386573|NCT01076192|20671177|P1|COMPLETED|Overall Study||350
8386574|NCT01076192|20671177|P1|STARTED|Overall Study||547
8386575|NCT01076179|20671192|P1|NOT COMPLETED|Overall Study||1
8386576|NCT01076179|20671192|P1|COMPLETED|Overall Study||501
8386577|NCT01076179|20671192|P1|STARTED|Overall Study||502
8386578|NCT01076166|20671215|P1|NOT COMPLETED|Overall Study||9
8386579|NCT01076166|20671215|P1|COMPLETED|Overall Study||328
8386580|NCT01076166|20671215|P1|STARTED|Overall Study||337
8386581|NCT01076153|20671222|P1|NOT COMPLETED|Overall Study||11
8386582|NCT01076153|20671222|P1|COMPLETED|Overall Study||749
8386583|NCT01076153|20671222|P1|STARTED|Overall Study||760
8386584|NCT01076088|20671236|P6|NOT COMPLETED|Overall Study||23
8386585|NCT01076088|20671237|P5|NOT COMPLETED|Overall Study||16
8386586|NCT01076088|20671238|P4|NOT COMPLETED|Overall Study||15
8386587|NCT01076088|20671239|P3|NOT COMPLETED|Overall Study||17
8386588|NCT01076088|20671240|P2|NOT COMPLETED|Overall Study||18
8386589|NCT01076088|20671241|P1|NOT COMPLETED|Overall Study||11
8386590|NCT01076088|20671236|P6|COMPLETED|Overall Study||104
8386591|NCT01076088|20671237|P5|COMPLETED|Overall Study||104
8386592|NCT01076088|20671238|P4|COMPLETED|Overall Study||109
8386593|NCT01076088|20671239|P3|COMPLETED|Overall Study||109
8386594|NCT01076088|20671240|P2|COMPLETED|Overall Study||107
8386595|NCT01076088|20671241|P1|COMPLETED|Overall Study||111
8386596|NCT01076088|20671236|P6|STARTED|Overall Study||127
8386597|NCT01076088|20671237|P5|STARTED|Overall Study||120
8386598|NCT01076088|20671238|P4|STARTED|Overall Study||124
8386599|NCT01076088|20671239|P3|STARTED|Overall Study||126
8386600|NCT01076088|20671240|P2|STARTED|Overall Study||125
8386601|NCT01076088|20671241|P1|STARTED|Overall Study||122
8386602|NCT01076075|20671269|P2|NOT COMPLETED|Overall Study||47
8386603|NCT01076075|20671270|P1|NOT COMPLETED|Overall Study||41
8386604|NCT01076075|20671269|P2|COMPLETED|Overall Study||167
8386605|NCT01076075|20671270|P1|COMPLETED|Overall Study||172
8386606|NCT01076075|20671269|P2|Completed Phase A|Overall Study||189
8386607|NCT01076075|20671270|P1|Completed Phase A|Overall Study||199
8386608|NCT01076075|20671269|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
8386609|NCT01076075|20671270|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
8386610|NCT01076036|20671284|P1|NOT COMPLETED|Overall Study||2
8386611|NCT01076036|20671284|P1|COMPLETED|Overall Study||8
8386612|NCT01076036|20671284|P1|Complete CorPath Procedures|Overall Study||8
8386613|NCT01076036|20671284|P1|# of Procedures|Overall Study||8
8386614|NCT01076036|20671284|P1|STARTED|Overall Study||10
8386615|NCT01076010|20671292|P3|NOT COMPLETED|Overall Study||2
8386616|NCT01076010|20671293|P2|NOT COMPLETED|Overall Study||39
8386617|NCT01076010|20671294|P1|NOT COMPLETED|Overall Study||125
8386618|NCT01076010|20671292|P3|COMPLETED|Overall Study||26
8386619|NCT01076010|20671293|P2|COMPLETED|Overall Study||49
8386620|NCT01076010|20671294|P1|COMPLETED|Overall Study||36
8386621|NCT01076010|20671292|P3|STARTED|Overall Study||28
8386622|NCT01076010|20671293|P2|STARTED|Overall Study||88
8386623|NCT01076010|20671294|P1|STARTED|Overall Study||161
8386624|NCT01075984|20671334|P5|NOT COMPLETED|Follow-up Phase||47
8386625|NCT01075984|20671335|P4|NOT COMPLETED|Follow-up Phase||2
8386626|NCT01075984|20671336|P3|NOT COMPLETED|Follow-up Phase||1
8386627|NCT01075984|20671337|P2|NOT COMPLETED|Follow-up Phase||0
8386628|NCT01075984|20671338|P1|NOT COMPLETED|Follow-up Phase||0
8386629|NCT01075984|20671334|P5|COMPLETED|Follow-up Phase||165
8386630|NCT01075984|20671335|P4|COMPLETED|Follow-up Phase||19
8386631|NCT01075984|20671336|P3|COMPLETED|Follow-up Phase||19
8386632|NCT01075984|20671337|P2|COMPLETED|Follow-up Phase||10
8386633|NCT01075984|20671338|P1|COMPLETED|Follow-up Phase||10
8386634|NCT01075984|20671334|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
8386635|NCT01075984|20671335|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
8386636|NCT01075984|20671336|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
8386637|NCT01075984|20671337|P2|STARTED|Follow-up Phase||10
8386638|NCT01075984|20671338|P1|STARTED|Follow-up Phase||10
8386639|NCT01075984|20671334|P5|NOT COMPLETED|Treatment Phase||60
8386640|NCT01075984|20671335|P4|NOT COMPLETED|Treatment Phase||7
8386641|NCT01075984|20671336|P3|NOT COMPLETED|Treatment Phase||7
8386642|NCT01075984|20671337|P2|NOT COMPLETED|Treatment Phase||1
8386643|NCT01075984|20671338|P1|NOT COMPLETED|Treatment Phase||0
8386644|NCT01075984|20671334|P5|COMPLETED|Treatment Phase||153
8386645|NCT01075984|20671335|P4|COMPLETED|Treatment Phase||17
8386646|NCT01075984|20671336|P3|COMPLETED|Treatment Phase||14
8386647|NCT01075984|20671337|P2|COMPLETED|Treatment Phase||10
8386648|NCT01075984|20671338|P1|COMPLETED|Treatment Phase||10
8386649|NCT01075984|20671334|P5|STARTED|Treatment Phase||213
8386650|NCT01075984|20671335|P4|STARTED|Treatment Phase||24
8386651|NCT01075984|20671336|P3|STARTED|Treatment Phase||21
8386652|NCT01075984|20671337|P2|STARTED|Treatment Phase||11
8386653|NCT01075984|20671338|P1|STARTED|Treatment Phase||10
8386654|NCT01075971|20671392|P1|NOT COMPLETED|Overall Study||0
8386655|NCT01075971|20671392|P1|COMPLETED|Overall Study||52
8386656|NCT01075971|20671392|P1|STARTED|Overall Study||52
8386657|NCT01075958|20671396|P1|NOT COMPLETED|Overall Study||44
8386658|NCT01075958|20671396|P1|COMPLETED|Overall Study||239
8386659|NCT01075958|20671396|P1|STARTED|Overall Study||283
8386660|NCT01075815|20671412|P2|NOT COMPLETED|Overall Study||4
8386661|NCT01075815|20671413|P1|NOT COMPLETED|Overall Study||10
8386662|NCT01075815|20671412|P2|COMPLETED|Overall Study||31
8386663|NCT01075815|20671413|P1|COMPLETED|Overall Study||30
8386664|NCT01075815|20671412|P2|STARTED|Overall Study|Number of participants treated.|35
8386665|NCT01075815|20671413|P1|STARTED|Overall Study|Number of participants treated.|40
8386666|NCT01075763|20671451|P2|NOT COMPLETED|Overall Study||4
8386667|NCT01075763|20671452|P1|NOT COMPLETED|Overall Study||4
8386668|NCT01075763|20671451|P2|COMPLETED|Overall Study||15
8386669|NCT01075763|20671452|P1|COMPLETED|Overall Study||19
8386670|NCT01075763|20671451|P2|STARTED|Overall Study||19
8386671|NCT01075763|20671452|P1|STARTED|Overall Study||23
8386672|NCT01075685|20671476|P2|NOT COMPLETED|Overall Study||226
8386673|NCT01075685|20671477|P1|NOT COMPLETED|Overall Study||592
8386674|NCT01075685|20671476|P2|COMPLETED|Overall Study||188
8386675|NCT01075685|20671477|P1|COMPLETED|Overall Study||151
8386676|NCT01075685|20671476|P2|Completed Baseline Measures|Overall Study||263
8386677|NCT01075685|20671477|P1|Completed Baseline Measures|Overall Study||225
8386678|NCT01075685|20671476|P2|Met Inclusion Criteria|Overall Study||413
8386679|NCT01075685|20671477|P1|Met Inclusion Criteria|Overall Study||734
8386680|NCT01075685|20671476|P2|STARTED|Overall Study||414
8386681|NCT01075685|20671477|P1|STARTED|Overall Study||743
8386682|NCT01075646|20671493|P4|NOT COMPLETED|Overall Study||2
8386683|NCT01075646|20671494|P3|NOT COMPLETED|Overall Study||1
8386684|NCT01075646|20671495|P2|NOT COMPLETED|Overall Study||3
8386685|NCT01075646|20671496|P1|NOT COMPLETED|Overall Study||4
8386686|NCT01075646|20671493|P4|COMPLETED|Overall Study||44
8386687|NCT01075646|20671494|P3|COMPLETED|Overall Study||52
8386688|NCT01075646|20671495|P2|COMPLETED|Overall Study||31
8386689|NCT01075646|20671496|P1|COMPLETED|Overall Study||29
8386690|NCT01075646|20671493|P4|STARTED|Overall Study||46
8386691|NCT01075646|20671494|P3|STARTED|Overall Study||53
8386692|NCT01075646|20671495|P2|STARTED|Overall Study||34
8386693|NCT01075646|20671496|P1|STARTED|Overall Study||33
8386694|NCT01075412|20671528|P2|NOT COMPLETED|Overall Study||1
8386695|NCT01075412|20671529|P1|NOT COMPLETED|Overall Study||0
8386696|NCT01075412|20671528|P2|COMPLETED|Overall Study||1
8386697|NCT01075412|20671529|P1|COMPLETED|Overall Study||4
8386698|NCT01075412|20671528|P2|STARTED|Overall Study||2
8386699|NCT01075412|20671529|P1|STARTED|Overall Study||4
8386700|NCT01075399|20671539|P1|NOT COMPLETED|Overall Study||8
8386701|NCT01075399|20671539|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
8386702|NCT01075399|20671539|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
8386703|NCT01075347|20671545|P2|NOT COMPLETED|Overall Study||0
8386704|NCT01075347|20671546|P1|NOT COMPLETED|Overall Study||0
8386705|NCT01075347|20671545|P2|COMPLETED|Overall Study||83
8386706|NCT01075347|20671546|P1|COMPLETED|Overall Study||82
8386707|NCT01075347|20671545|P2|STARTED|Overall Study||83
8386708|NCT01075347|20671546|P1|STARTED|Overall Study||82
8386709|NCT01075321|20671554|P4|NOT COMPLETED|Overall Study||2
8386710|NCT01075321|20671555|P3|NOT COMPLETED|Overall Study||2
8386711|NCT01075321|20671556|P2|NOT COMPLETED|Overall Study||0
8386712|NCT01075321|20671557|P1|NOT COMPLETED|Overall Study||1
8386713|NCT01075321|20671554|P4|COMPLETED|Overall Study||31
8386714|NCT01075321|20671555|P3|COMPLETED|Overall Study||7
8386715|NCT01075321|20671556|P2|COMPLETED|Overall Study||9
8386716|NCT01075321|20671557|P1|COMPLETED|Overall Study||6
8386717|NCT01075321|20671554|P4|STARTED|Overall Study||33
8386718|NCT01075321|20671555|P3|STARTED|Overall Study||9
8386719|NCT01075321|20671556|P2|STARTED|Overall Study||9
8386720|NCT01075321|20671557|P1|STARTED|Overall Study||7
8386721|NCT01075282|20671575|P3|NOT COMPLETED|Overall Study||27
8386722|NCT01075282|20671576|P2|NOT COMPLETED|Overall Study||29
8386723|NCT01075282|20671577|P1|NOT COMPLETED|Overall Study||31
8386724|NCT01075282|20671575|P3|COMPLETED|Overall Study||238
8386725|NCT01075282|20671576|P2|COMPLETED|Overall Study||243
8386726|NCT01075282|20671577|P1|COMPLETED|Overall Study||242
8386727|NCT01075282|20671575|P3|Received at Least One Dose of Study Drug|Overall Study||262
8386728|NCT01075282|20671576|P2|Received at Least One Dose of Study Drug|Overall Study||272
8386729|NCT01075282|20671577|P1|Received at Least One Dose of Study Drug|Overall Study||273
8386730|NCT01075282|20671575|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
8386731|NCT01075282|20671576|P2|STARTED|Overall Study||272
8386732|NCT01075282|20671577|P1|STARTED|Overall Study||273
8386733|NCT01075256|20671660|P3|NOT COMPLETED|Overall Study||0
8386734|NCT01075256|20671661|P2|NOT COMPLETED|Overall Study||0
8386735|NCT01075256|20671662|P1|NOT COMPLETED|Overall Study||1
8386736|NCT01075256|20671660|P3|COMPLETED|Overall Study||65
8386737|NCT01075256|20671661|P2|COMPLETED|Overall Study||66
8386738|NCT01075256|20671662|P1|COMPLETED|Overall Study||63
8386739|NCT01075256|20671660|P3|STARTED|Overall Study||65
8386740|NCT01075256|20671661|P2|STARTED|Overall Study||66
8386741|NCT01075256|20671662|P1|STARTED|Overall Study||64
8386742|NCT01075243|20671694|P3|NOT COMPLETED|Overall Study||0
8386743|NCT01075243|20671695|P2|NOT COMPLETED|Overall Study||3
8386744|NCT01075243|20671696|P1|NOT COMPLETED|Overall Study||6
8386745|NCT01075243|20671694|P3|COMPLETED|Overall Study||80
8386746|NCT01075243|20671695|P2|COMPLETED|Overall Study||155
8386747|NCT01075243|20671696|P1|COMPLETED|Overall Study||157
8386748|NCT01075243|20671694|P3|STARTED|Overall Study||80
8386749|NCT01075243|20671695|P2|STARTED|Overall Study||158
8386750|NCT01075243|20671696|P1|STARTED|Overall Study||163
8386751|NCT01075217|20671748|P2|NOT COMPLETED|Overall Study||1
8386752|NCT01075217|20671749|P1|NOT COMPLETED|Overall Study||2
8386753|NCT01075217|20671748|P2|COMPLETED|Overall Study||84
8386754|NCT01075217|20671749|P1|COMPLETED|Overall Study||82
8386755|NCT01075217|20671748|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
8386756|NCT01075217|20671749|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
8386757|NCT01075204|20671765|P1|NOT COMPLETED|Overall Study||0
8386758|NCT01075204|20671765|P1|COMPLETED|Overall Study||335
8386759|NCT01075204|20671765|P1|STARTED|Overall Study||335
8386760|NCT01075191|20671782|P1|NOT COMPLETED|Overall Study||18
8386761|NCT01075191|20671782|P1|COMPLETED|Overall Study||42
8386762|NCT01075191|20671782|P1|Discontinued Year 3|Overall Study||5
8386763|NCT01075191|20671782|P1|Discontinued Year 2|Overall Study||6
8386764|NCT01075191|20671782|P1|Discontinued Year 1|Overall Study||7
8386765|NCT01075191|20671782|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
8386766|NCT01075178|20671793|P2|NOT COMPLETED|Subject Chart Review||9
8386767|NCT01075178|20671794|P1|NOT COMPLETED|Subject Chart Review||9
8386768|NCT01075178|20671793|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
8386769|NCT01075178|20671794|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
8386770|NCT01075178|20671793|P2|STARTED|Subject Chart Review|subjects matched|1018
8386771|NCT01075178|20671794|P1|STARTED|Subject Chart Review|subjects matched|1018
8386772|NCT01075178|20671793|P2|NOT COMPLETED|Subject Matching||403
8386773|NCT01075178|20671794|P1|NOT COMPLETED|Subject Matching||130
8386774|NCT01075178|20671793|P2|COMPLETED|Subject Matching|subjects matched|1018
8386775|NCT01075178|20671794|P1|COMPLETED|Subject Matching|subjects matched|1018
8386776|NCT01075178|20671793|P2|STARTED|Subject Matching|eligible for matching|1421
8386777|NCT01075178|20671794|P1|STARTED|Subject Matching|eligible for matching|1148
8386778|NCT01075152|20671808|P2|NOT COMPLETED|Overall Study||0
8386779|NCT01075152|20671809|P1|NOT COMPLETED|Overall Study||1
8386780|NCT01075152|20671808|P2|COMPLETED|Overall Study||89
8386781|NCT01075152|20671809|P1|COMPLETED|Overall Study||87
8386782|NCT01075152|20671808|P2|STARTED|Overall Study|randomized|89
8386783|NCT01075152|20671809|P1|STARTED|Overall Study|randomized|88
8386784|NCT01075100|20671835|P2|NOT COMPLETED|Overall Study||53
8386785|NCT01075100|20671836|P1|NOT COMPLETED|Overall Study||49
8386786|NCT01075100|20671835|P2|COMPLETED|Overall Study||1
8386787|NCT01075100|20671836|P1|COMPLETED|Overall Study||0
8386788|NCT01075100|20671835|P2|STARTED|Overall Study||54
8386789|NCT01075100|20671836|P1|STARTED|Overall Study||49
8386790|NCT01075087|20671854|P2|NOT COMPLETED|Overall Study||0
8386791|NCT01075087|20671855|P1|NOT COMPLETED|Overall Study||0
8386792|NCT01075087|20671854|P2|COMPLETED|Overall Study||10
8386793|NCT01075087|20671855|P1|COMPLETED|Overall Study||9
8386794|NCT01075087|20671854|P2|STARTED|Overall Study||10
8386795|NCT01075087|20671855|P1|STARTED|Overall Study||9
8386796|NCT01075074|20671866|P3|NOT COMPLETED|Overall Study||2
8386797|NCT01075074|20671867|P2|NOT COMPLETED|Overall Study||2
8386798|NCT01075074|20671868|P1|NOT COMPLETED|Overall Study||1
8386799|NCT01075074|20671866|P3|COMPLETED|Overall Study||23
8386800|NCT01075074|20671867|P2|COMPLETED|Overall Study||23
8386801|NCT01075074|20671868|P1|COMPLETED|Overall Study||24
8386802|NCT01075074|20671866|P3|STARTED|Overall Study||25
8386803|NCT01075074|20671867|P2|STARTED|Overall Study||25
8386804|NCT01075074|20671868|P1|STARTED|Overall Study||25
8386805|NCT01075048|20671888|P3|NOT COMPLETED|Overall Study||62
8386806|NCT01075048|20671889|P2|NOT COMPLETED|Overall Study||60
8386807|NCT01075048|20671890|P1|NOT COMPLETED|Overall Study||9
8386808|NCT01075048|20671888|P3|COMPLETED|Overall Study||0
8386809|NCT01075048|20671889|P2|COMPLETED|Overall Study||0
8386810|NCT01075048|20671890|P1|COMPLETED|Overall Study||0
8386811|NCT01075048|20671888|P3|Did Not Receive Treatment|Overall Study||0
8386812|NCT01075048|20671889|P2|Did Not Receive Treatment|Overall Study||1
8386813|NCT01075048|20671890|P1|Did Not Receive Treatment|Overall Study||0
8386814|NCT01075048|20671888|P3|STARTED|Overall Study||62
8386815|NCT01075048|20671889|P2|STARTED|Overall Study||60
8386816|NCT01075048|20671890|P1|STARTED|Overall Study||9
8386817|NCT01074944|20671913|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
8386818|NCT01074944|20671914|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386819|NCT01074944|20671915|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386820|NCT01074944|20671916|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386821|NCT01074944|20671917|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386822|NCT01074944|20671913|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
8386823|NCT01074944|20671914|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
8386824|NCT01074944|20671915|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
8386825|NCT01074944|20671916|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
8386826|NCT01074944|20671917|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
8386827|NCT01074944|20671913|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
8386828|NCT01074944|20671914|P4|STARTED|Extended Treatment (up to 42 Months)||0
8386829|NCT01074944|20671915|P3|STARTED|Extended Treatment (up to 42 Months)||0
8386830|NCT01074944|20671916|P2|STARTED|Extended Treatment (up to 42 Months)||0
8386831|NCT01074944|20671917|P1|STARTED|Extended Treatment (up to 42 Months)||0
8386832|NCT01074944|20671913|P5|NOT COMPLETED|Long Term Treatment||0
8386833|NCT01074944|20671914|P4|NOT COMPLETED|Long Term Treatment||26
8386834|NCT01074944|20671915|P3|NOT COMPLETED|Long Term Treatment||0
8386835|NCT01074944|20671916|P2|NOT COMPLETED|Long Term Treatment||0
8386836|NCT01074944|20671917|P1|NOT COMPLETED|Long Term Treatment||0
8386837|NCT01074944|20671913|P5|COMPLETED|Long Term Treatment||0
8386838|NCT01074944|20671914|P4|COMPLETED|Long Term Treatment||95
8386839|NCT01074944|20671915|P3|COMPLETED|Long Term Treatment||0
8386840|NCT01074944|20671916|P2|COMPLETED|Long Term Treatment||0
8386841|NCT01074944|20671917|P1|COMPLETED|Long Term Treatment||0
8386842|NCT01074944|20671913|P5|STARTED|Long Term Treatment||0
8386843|NCT01074944|20671914|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
8386844|NCT01074944|20671915|P3|STARTED|Long Term Treatment||0
8386845|NCT01074944|20671916|P2|STARTED|Long Term Treatment||0
8386846|NCT01074944|20671917|P1|STARTED|Long Term Treatment||0
8386847|NCT01074944|20671913|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386848|NCT01074944|20671914|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386849|NCT01074944|20671915|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
8386850|NCT01074944|20671916|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
8386851|NCT01074944|20671917|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386852|NCT01074944|20671913|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386853|NCT01074944|20671914|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386854|NCT01074944|20671915|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
8386855|NCT01074944|20671916|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
8386856|NCT01074944|20671917|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386857|NCT01074944|20671913|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8386858|NCT01074944|20671914|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8386859|NCT01074944|20671915|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
8386860|NCT01074944|20671916|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
8386861|NCT01074944|20671917|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8386862|NCT01074944|20671913|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386863|NCT01074944|20671914|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386864|NCT01074944|20671915|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386865|NCT01074944|20671916|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386866|NCT01074944|20671917|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
8386867|NCT01074944|20671913|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386868|NCT01074944|20671914|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386869|NCT01074944|20671915|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386870|NCT01074944|20671916|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386871|NCT01074944|20671917|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
8386872|NCT01074944|20671913|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
8386873|NCT01074944|20671914|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
8386874|NCT01074944|20671915|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
8386875|NCT01074944|20671916|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
8386876|NCT01074944|20671917|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
8386877|NCT01074931|20671971|P1|NOT COMPLETED|Overall Study||6
8386878|NCT01074931|20671971|P1|COMPLETED|Overall Study||92
8386879|NCT01074931|20671971|P1|STARTED|Overall Study||98
8386880|NCT01074658|20671983|P1|NOT COMPLETED|Overall Study||19
8386881|NCT01074658|20671983|P1|COMPLETED|Overall Study||996
8386882|NCT01074658|20671983|P1|Attempted Implant|Overall Study||996
8386883|NCT01074658|20671983|P1|STARTED|Overall Study||1015
8386884|NCT01074554|20671991|P2|NOT COMPLETED|Overall Study||4
8386885|NCT01074554|20671992|P1|NOT COMPLETED|Overall Study||3
8386886|NCT01074554|20671991|P2|COMPLETED|Overall Study||11
8386887|NCT01074554|20671992|P1|COMPLETED|Overall Study||11
8386888|NCT01074554|20671991|P2|STARTED|Overall Study||15
8386889|NCT01074554|20671992|P1|STARTED|Overall Study||14
8386890|NCT01074502|20672002|P1|NOT COMPLETED|Overall Study||1
8386891|NCT01074502|20672002|P1|COMPLETED|Overall Study||2
8386892|NCT01074502|20672002|P1|STARTED|Overall Study||3
8386893|NCT01074463|20672013|P2|NOT COMPLETED|Second Intervention||0
8386894|NCT01074463|20672014|P1|NOT COMPLETED|Second Intervention||0
8386895|NCT01074463|20672013|P2|COMPLETED|Second Intervention||12
8386896|NCT01074463|20672014|P1|COMPLETED|Second Intervention||12
8386897|NCT01074463|20672013|P2|STARTED|Second Intervention||12
8386898|NCT01074463|20672014|P1|STARTED|Second Intervention||12
8386899|NCT01074463|20672013|P2|NOT COMPLETED|Washout of 7 Days||0
8386900|NCT01074463|20672014|P1|NOT COMPLETED|Washout of 7 Days||0
8386901|NCT01074463|20672013|P2|COMPLETED|Washout of 7 Days||12
8386902|NCT01074463|20672014|P1|COMPLETED|Washout of 7 Days||12
8386903|NCT01074463|20672013|P2|STARTED|Washout of 7 Days||12
8386904|NCT01074463|20672014|P1|STARTED|Washout of 7 Days||12
8386905|NCT01074463|20672013|P2|NOT COMPLETED|First Intervention||0
8386906|NCT01074463|20672014|P1|NOT COMPLETED|First Intervention||0
8386907|NCT01074463|20672013|P2|COMPLETED|First Intervention||12
8386908|NCT01074463|20672014|P1|COMPLETED|First Intervention||12
8386909|NCT01074463|20672013|P2|STARTED|First Intervention||12
8386910|NCT01074463|20672014|P1|STARTED|First Intervention||12
8386911|NCT01074450|20672026|P2|NOT COMPLETED|Second Intervention||1
8386912|NCT01074450|20672027|P1|NOT COMPLETED|Second Intervention||1
8386913|NCT01074450|20672026|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
8386914|NCT01074450|20672027|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
8386915|NCT01074450|20672026|P2|STARTED|Second Intervention||10
8386916|NCT01074450|20672027|P1|STARTED|Second Intervention||12
8386917|NCT01074450|20672026|P2|NOT COMPLETED|Washout of 7 Days||0
8386918|NCT01074450|20672027|P1|NOT COMPLETED|Washout of 7 Days||0
8386919|NCT01074450|20672026|P2|COMPLETED|Washout of 7 Days||10
8386920|NCT01074450|20672027|P1|COMPLETED|Washout of 7 Days||12
8386921|NCT01074450|20672026|P2|STARTED|Washout of 7 Days||10
8386922|NCT01074450|20672027|P1|STARTED|Washout of 7 Days||12
8386923|NCT01074450|20672026|P2|NOT COMPLETED|First Intervention||2
8386924|NCT01074450|20672027|P1|NOT COMPLETED|First Intervention||0
8386925|NCT01074450|20672026|P2|COMPLETED|First Intervention||10
8386926|NCT01074450|20672027|P1|COMPLETED|First Intervention||12
8386927|NCT01074450|20672026|P2|STARTED|First Intervention||12
8386928|NCT01074450|20672027|P1|STARTED|First Intervention||12
8386929|NCT01074437|20672039|P2|NOT COMPLETED|Overall Study||0
8386930|NCT01074437|20672040|P1|NOT COMPLETED|Overall Study||0
8386931|NCT01074437|20672039|P2|COMPLETED|Overall Study||5
8386932|NCT01074437|20672040|P1|COMPLETED|Overall Study||4
8386933|NCT01074437|20672039|P2|STARTED|Overall Study||5
8386934|NCT01074437|20672040|P1|STARTED|Overall Study||4
8386935|NCT01074307|20672056|P2|NOT COMPLETED|Overall Study||12
8386936|NCT01074307|20672057|P1|NOT COMPLETED|Overall Study||22
8386937|NCT01074307|20672056|P2|COMPLETED|Overall Study||102
8386938|NCT01074307|20672057|P1|COMPLETED|Overall Study||44
8386939|NCT01074307|20672056|P2|STARTED|Overall Study||114
8386940|NCT01074307|20672057|P1|STARTED|Overall Study||66
8386941|NCT01074268|20672079|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
8386942|NCT01074268|20672080|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
8386943|NCT01074268|20672079|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
8386944|NCT01074268|20672080|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
8386945|NCT01074268|20672079|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
8386946|NCT01074268|20672080|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
8386947|NCT01074268|20672079|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
8386948|NCT01074268|20672080|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
8386949|NCT01074268|20672079|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
8386950|NCT01074268|20672080|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
8386951|NCT01074268|20672079|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
8386952|NCT01074268|20672080|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
8386953|NCT01074268|20672079|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
8386954|NCT01074268|20672080|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
8386955|NCT01074268|20672079|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
8386956|NCT01074268|20672080|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
8386957|NCT01074255|20672106|P1|NOT COMPLETED|Overall Study||2
8386958|NCT01074255|20672106|P1|COMPLETED|Overall Study||3139
8386959|NCT01074255|20672106|P1|Treated|Overall Study||3139
8386960|NCT01074255|20672106|P1|STARTED|Overall Study||3141
8386961|NCT01074242|20672110|P1|NOT COMPLETED|Overall Study||403
8386962|NCT01074242|20672110|P1|COMPLETED|Overall Study||3395
8386963|NCT01074242|20672110|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
8386964|NCT01074242|20672110|P1|STARTED|Overall Study||3798
8386965|NCT01074229|20672118|P3|NOT COMPLETED|Overall Study||4
8386966|NCT01074229|20672119|P2|NOT COMPLETED|Overall Study||3
8386967|NCT01074229|20672120|P1|NOT COMPLETED|Overall Study||2
8386968|NCT01074229|20672118|P3|COMPLETED|Overall Study||21
8386969|NCT01074229|20672119|P2|COMPLETED|Overall Study||22
8386970|NCT01074229|20672120|P1|COMPLETED|Overall Study||23
8386971|NCT01074229|20672118|P3|STARTED|Overall Study||25
8386972|NCT01074229|20672119|P2|STARTED|Overall Study||25
8386973|NCT01074229|20672120|P1|STARTED|Overall Study||25
8386974|NCT01074216|20672131|P1|NOT COMPLETED|Overall Study||13
8386975|NCT01074216|20672131|P1|COMPLETED|Overall Study||41
8386976|NCT01074216|20672131|P1|STARTED|Overall Study||54
8386977|NCT01074177|20672135|P1|NOT COMPLETED|Overall Study||0
8386978|NCT01074177|20672135|P1|COMPLETED|Overall Study||24
8386979|NCT01074177|20672135|P1|STARTED|Overall Study||24
8386980|NCT01074164|20672144|P2|NOT COMPLETED|Overall Study||1
8386981|NCT01074164|20672145|P1|NOT COMPLETED|Overall Study||3
8386982|NCT01074164|20672144|P2|COMPLETED|Overall Study||7
8386983|NCT01074164|20672145|P1|COMPLETED|Overall Study||4
8386984|NCT01074164|20672144|P2|STARTED|Overall Study||8
8386985|NCT01074164|20672145|P1|STARTED|Overall Study||7
8386986|NCT01074125|20672166|P3|NOT COMPLETED|Overall Study||12
8386987|NCT01074125|20672167|P2|NOT COMPLETED|Overall Study||5
8386988|NCT01074125|20672168|P1|NOT COMPLETED|Overall Study||12
8386989|NCT01074125|20672166|P3|COMPLETED|Overall Study||36
8386990|NCT01074125|20672167|P2|COMPLETED|Overall Study||47
8386991|NCT01074125|20672168|P1|COMPLETED|Overall Study||39
8386992|NCT01074125|20672166|P3|STARTED|Overall Study||48
8386993|NCT01074125|20672167|P2|STARTED|Overall Study||52
8386994|NCT01074125|20672168|P1|STARTED|Overall Study||51
8386995|NCT01074099|20672184|P2|NOT COMPLETED|Overall Study||0
8386996|NCT01074099|20672185|P1|NOT COMPLETED|Overall Study||0
8386997|NCT01074099|20672184|P2|COMPLETED|Overall Study||3
8386998|NCT01074099|20672185|P1|COMPLETED|Overall Study||2
8386999|NCT01074099|20672184|P2|STARTED|Overall Study||3
8387000|NCT01074099|20672185|P1|STARTED|Overall Study||2
8387001|NCT01074047|20672195|P2|NOT COMPLETED|Extension Phase||0
8387002|NCT01074047|20672196|P1|NOT COMPLETED|Extension Phase||22
8387003|NCT01074047|20672195|P2|COMPLETED|Extension Phase||0
8387004|NCT01074047|20672196|P1|COMPLETED|Extension Phase||0
8387005|NCT01074047|20672195|P2|Safety Population|Extension Phase||0
8387006|NCT01074047|20672196|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
8387007|NCT01074047|20672195|P2|STARTED|Extension Phase||0
8387008|NCT01074047|20672196|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
8387009|NCT01074047|20672195|P2|NOT COMPLETED|Survival Follow-Up Phase||136
8387010|NCT01074047|20672196|P1|NOT COMPLETED|Survival Follow-Up Phase||124
8387011|NCT01074047|20672195|P2|COMPLETED|Survival Follow-Up Phase||27
8387012|NCT01074047|20672196|P1|COMPLETED|Survival Follow-Up Phase||16
8387013|NCT01074047|20672195|P2|STARTED|Survival Follow-Up Phase||163
8387014|NCT01074047|20672196|P1|STARTED|Survival Follow-Up Phase||140
8387015|NCT01074047|20672195|P2|NOT COMPLETED|Treatment Phase||234
8387016|NCT01074047|20672196|P1|NOT COMPLETED|Treatment Phase||217
8387017|NCT01074047|20672195|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
8387018|NCT01074047|20672196|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
8387019|NCT01074047|20672195|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
8387020|NCT01074047|20672196|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
8387021|NCT01074047|20672195|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
8387022|NCT01074047|20672196|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
8387023|NCT01074047|20672195|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
8387024|NCT01074047|20672196|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
8387025|NCT01074047|20672195|P2|STARTED|Treatment Phase||247
8387026|NCT01074047|20672196|P1|STARTED|Treatment Phase||241
8387027|NCT01074034|20672270|P1|NOT COMPLETED|Overall Study||6
8387028|NCT01074034|20672270|P1|COMPLETED|Overall Study||205
8387029|NCT01074034|20672270|P1|STARTED|Overall Study||211
8387030|NCT01074008|20672284|P9|NOT COMPLETED|Overall Study||4
8387031|NCT01074008|20672285|P8|NOT COMPLETED|Overall Study||0
8387032|NCT01074008|20672286|P7|NOT COMPLETED|Overall Study||1
8387033|NCT01074008|20672287|P6|NOT COMPLETED|Overall Study||0
8387034|NCT01074008|20672288|P5|NOT COMPLETED|Overall Study||2
8387035|NCT01074008|20672289|P4|NOT COMPLETED|Overall Study||1
8387036|NCT01074008|20672290|P3|NOT COMPLETED|Overall Study||2
8387037|NCT01074008|20672291|P2|NOT COMPLETED|Overall Study||3
8387038|NCT01074008|20672292|P1|NOT COMPLETED|Overall Study||1
8387039|NCT01074008|20672284|P9|COMPLETED|Overall Study||7
8387040|NCT01074008|20672285|P8|COMPLETED|Overall Study||8
8387041|NCT01074008|20672286|P7|COMPLETED|Overall Study||7
8387042|NCT01074008|20672287|P6|COMPLETED|Overall Study||7
8387043|NCT01074008|20672288|P5|COMPLETED|Overall Study||6
8387044|NCT01074008|20672289|P4|COMPLETED|Overall Study||7
8387045|NCT01074008|20672290|P3|COMPLETED|Overall Study||6
8387046|NCT01074008|20672291|P2|COMPLETED|Overall Study||5
8387047|NCT01074008|20672292|P1|COMPLETED|Overall Study||7
8387048|NCT01074008|20672284|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
8387049|NCT01074008|20672285|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
8387050|NCT01074008|20672286|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
8387051|NCT01074008|20672287|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
8387052|NCT01074008|20672288|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
8387053|NCT01074008|20672289|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
8387054|NCT01074008|20672290|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
8387055|NCT01074008|20672291|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
8387056|NCT01074008|20672292|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
8387057|NCT01074008|20672284|P9|STARTED|Overall Study||11
8387058|NCT01074008|20672285|P8|STARTED|Overall Study||8
8387059|NCT01074008|20672286|P7|STARTED|Overall Study||8
8387060|NCT01074008|20672287|P6|STARTED|Overall Study||7
8387061|NCT01074008|20672288|P5|STARTED|Overall Study||8
8387062|NCT01074008|20672289|P4|STARTED|Overall Study||8
8387063|NCT01074008|20672290|P3|STARTED|Overall Study||8
8387064|NCT01074008|20672291|P2|STARTED|Overall Study||8
8387065|NCT01074008|20672292|P1|STARTED|Overall Study||8
8387066|NCT01073943|20672402|P2|NOT COMPLETED|Overall Study||8
8387067|NCT01073943|20672403|P1|NOT COMPLETED|Overall Study||13
8387068|NCT01073943|20672402|P2|COMPLETED|Overall Study||295
8387069|NCT01073943|20672403|P1|COMPLETED|Overall Study||287
8387070|NCT01073943|20672402|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
8387071|NCT01073943|20672403|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
8387072|NCT01073943|20672402|P2|Safety Population (Treated)|Overall Study||302
8387073|NCT01073943|20672403|P1|Safety Population (Treated)|Overall Study||296
8387074|NCT01073943|20672402|P2|STARTED|Overall Study||303
8387075|NCT01073943|20672403|P1|STARTED|Overall Study||300
8387076|NCT01073930|20672429|P2|NOT COMPLETED|Overall Study||6
8387077|NCT01073930|20672430|P1|NOT COMPLETED|Overall Study||3
8387078|NCT01073930|20672429|P2|COMPLETED|Overall Study||295
8387079|NCT01073930|20672430|P1|COMPLETED|Overall Study||304
8387080|NCT01073930|20672429|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
8387081|NCT01073930|20672430|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
8387082|NCT01073930|20672429|P2|Safety Population (Treated)|Overall Study||298
8387083|NCT01073930|20672430|P1|Safety Population (Treated)|Overall Study||305
8387084|NCT01073930|20672429|P2|STARTED|Overall Study||301
8387085|NCT01073930|20672430|P1|STARTED|Overall Study||307
8387086|NCT01073865|20672454|P2|NOT COMPLETED|Overall Study||39
8387087|NCT01073865|20672455|P1|NOT COMPLETED|Overall Study||28
8387088|NCT01073865|20672454|P2|COMPLETED|Overall Study|Number of patients completed the study|74
8387089|NCT01073865|20672455|P1|COMPLETED|Overall Study|Number of patients completed the study|81
8387090|NCT01073865|20672454|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
8387091|NCT01073865|20672455|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
8387092|NCT01073865|20672454|P2|STARTED|Overall Study|Number of patients randomised|113
8387093|NCT01073865|20672455|P1|STARTED|Overall Study|Number of patients randomised|109
8387094|NCT01073657|20672467|P2|NOT COMPLETED|Overall Study||0
8387095|NCT01073657|20672468|P1|NOT COMPLETED|Overall Study||0
8387096|NCT01073657|20672467|P2|COMPLETED|Overall Study||16
8387097|NCT01073657|20672468|P1|COMPLETED|Overall Study||17
8387098|NCT01073657|20672467|P2|STARTED|Overall Study||16
8387099|NCT01073657|20672468|P1|STARTED|Overall Study||17
8387100|NCT01073631|20672474|P1|NOT COMPLETED|Overall Study||169
8387101|NCT01073631|20672474|P1|COMPLETED|Overall Study||374
8387102|NCT01073631|20672474|P1|STARTED|Overall Study||543
8387103|NCT01073618|20672479|P1|NOT COMPLETED|Overall Study||307
8387104|NCT01073618|20672479|P1|COMPLETED|Overall Study||385
8387105|NCT01073618|20672479|P1|STARTED|Overall Study||692
8387106|NCT01073605|20672487|P3|NOT COMPLETED|Overall Study||61
8387107|NCT01073605|20672488|P2|NOT COMPLETED|Overall Study||67
8387108|NCT01073605|20672489|P1|NOT COMPLETED|Overall Study||62
8387109|NCT01073605|20672487|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
8387110|NCT01073605|20672488|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
8387111|NCT01073605|20672489|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
8387112|NCT01073605|20672487|P3|Received Treatment|Overall Study||68
8387113|NCT01073605|20672488|P2|Received Treatment|Overall Study||70
8387114|NCT01073605|20672489|P1|Received Treatment|Overall Study||68
8387115|NCT01073605|20672487|P3|STARTED|Overall Study||69
8387116|NCT01073605|20672488|P2|STARTED|Overall Study||71
8387117|NCT01073605|20672489|P1|STARTED|Overall Study||68
8387118|NCT01073566|20672535|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
8387119|NCT01073566|20672536|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
8387120|NCT01073566|20672535|P2|COMPLETED|Period 2 (6 Weeks)||19
8387121|NCT01073566|20672536|P1|COMPLETED|Period 2 (6 Weeks)||18
8387122|NCT01073566|20672535|P2|STARTED|Period 2 (6 Weeks)||19
8387123|NCT01073566|20672536|P1|STARTED|Period 2 (6 Weeks)||19
8387124|NCT01073566|20672535|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
8387125|NCT01073566|20672536|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
8387126|NCT01073566|20672535|P2|COMPLETED|Period 1 (6 Weeks)||19
8387127|NCT01073566|20672536|P1|COMPLETED|Period 1 (6 Weeks)||19
8387128|NCT01073566|20672535|P2|STARTED|Period 1 (6 Weeks)||19
8387129|NCT01073566|20672536|P1|STARTED|Period 1 (6 Weeks)||19
8387130|NCT01073462|20672548|P1|NOT COMPLETED|Overall Study||41
8387131|NCT01073462|20672548|P1|COMPLETED|Overall Study||26
8387132|NCT01073462|20672548|P1|STARTED|Overall Study||67
8387133|NCT01073449|20672559|P1|NOT COMPLETED|Overall Study||0
8387134|NCT01073449|20672559|P1|COMPLETED|Overall Study||3362
8387135|NCT01073449|20672559|P1|STARTED|Overall Study||3362
8387136|NCT01073293|20672567|P2|NOT COMPLETED|Overall Study||11
8387137|NCT01073293|20672568|P1|NOT COMPLETED|Overall Study||5
8387138|NCT01073293|20672567|P2|COMPLETED|Overall Study||517
8387139|NCT01073293|20672568|P1|COMPLETED|Overall Study||521
8387140|NCT01073293|20672567|P2|STARTED|Overall Study||528
8387141|NCT01073293|20672568|P1|STARTED|Overall Study||526
8387142|NCT01073267|20672590|P1|NOT COMPLETED|Overall Study||3
8387143|NCT01073267|20672590|P1|COMPLETED|Overall Study||1
8387144|NCT01073267|20672590|P1|STARTED|Overall Study||4
8387145|NCT01073163|20672594|P1|NOT COMPLETED|Overall Study||3
8387146|NCT01073163|20672594|P1|COMPLETED|Overall Study|Patients completed study|51
8387147|NCT01073163|20672594|P1|Treated With >=6 Cycles|Overall Study||49
8387148|NCT01073163|20672594|P1|Treated With <6 Cycles|Overall Study||4
8387149|NCT01073163|20672594|P1|Enrolled But Not Treated|Overall Study||1
8387150|NCT01073163|20672594|P1|STARTED|Overall Study||54
8387151|NCT01072929|20672617|P3|NOT COMPLETED|Overall Study||9
8387152|NCT01072929|20672618|P2|NOT COMPLETED|Overall Study||51
8387153|NCT01072929|20672619|P1|NOT COMPLETED|Overall Study||44
8387154|NCT01072929|20672617|P3|COMPLETED|Overall Study||24
8387155|NCT01072929|20672618|P2|COMPLETED|Overall Study||150
8387156|NCT01072929|20672619|P1|COMPLETED|Overall Study||155
8387157|NCT01072929|20672617|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
8387158|NCT01072929|20672618|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
8387159|NCT01072929|20672619|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
8387160|NCT01072929|20672617|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
8387161|NCT01072929|20672618|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
8387162|NCT01072929|20672619|P1|Safety Population|Overall Study|Treated participants|199
8387163|NCT01072929|20672617|P3|STARTED|Overall Study||33
8387164|NCT01072929|20672618|P2|STARTED|Overall Study||201
8387165|NCT01072929|20672619|P1|STARTED|Overall Study||199
8387166|NCT01072877|20672698|P5|NOT COMPLETED|Overall Study||0
8387167|NCT01072877|20672699|P4|NOT COMPLETED|Overall Study||2
8387168|NCT01072877|20672700|P3|NOT COMPLETED|Overall Study||0
8387169|NCT01072877|20672701|P2|NOT COMPLETED|Overall Study||1
8387170|NCT01072877|20672702|P1|NOT COMPLETED|Overall Study||1
8387171|NCT01072877|20672698|P5|COMPLETED|Overall Study||63
8387172|NCT01072877|20672699|P4|COMPLETED|Overall Study||50
8387173|NCT01072877|20672700|P3|COMPLETED|Overall Study||51
8387174|NCT01072877|20672701|P2|COMPLETED|Overall Study||56
8387175|NCT01072877|20672702|P1|COMPLETED|Overall Study||55
8387176|NCT01072877|20672698|P5|STARTED|Overall Study||63
8387177|NCT01072877|20672699|P4|STARTED|Overall Study||52
8387178|NCT01072877|20672700|P3|STARTED|Overall Study||51
8387179|NCT01072877|20672701|P2|STARTED|Overall Study||57
8387180|NCT01072877|20672702|P1|STARTED|Overall Study||56
8387181|NCT01072773|20672724|P1|NOT COMPLETED|Overall Study||0
8387182|NCT01072773|20672724|P1|COMPLETED|Overall Study||2
8387183|NCT01072773|20672724|P1|STARTED|Overall Study||2
8387184|NCT01072669|20672735|P2|NOT COMPLETED|Overall Study||0
8387185|NCT01072669|20672736|P1|NOT COMPLETED|Overall Study||0
8387186|NCT01072669|20672735|P2|COMPLETED|Overall Study||5
8387187|NCT01072669|20672736|P1|COMPLETED|Overall Study||15
8387188|NCT01072669|20672735|P2|STARTED|Overall Study||5
8387189|NCT01072669|20672736|P1|STARTED|Overall Study||15
8387190|NCT01072656|20672744|P2|NOT COMPLETED|Second Intervention||0
8387191|NCT01072656|20672745|P1|NOT COMPLETED|Second Intervention||0
8387192|NCT01072656|20672744|P2|COMPLETED|Second Intervention||4
8387193|NCT01072656|20672745|P1|COMPLETED|Second Intervention||5
8387194|NCT01072656|20672744|P2|STARTED|Second Intervention||4
8387195|NCT01072656|20672745|P1|STARTED|Second Intervention||5
8387196|NCT01072656|20672744|P2|NOT COMPLETED|First Intervention||0
8387197|NCT01072656|20672745|P1|NOT COMPLETED|First Intervention||0
8387198|NCT01072656|20672744|P2|COMPLETED|First Intervention||4
8387199|NCT01072656|20672745|P1|COMPLETED|First Intervention||5
8387200|NCT01072656|20672744|P2|STARTED|First Intervention||4
8387201|NCT01072656|20672745|P1|STARTED|First Intervention||5
8387202|NCT01072643|20672755|P1|NOT COMPLETED|Overall Study||0
8387203|NCT01072643|20672755|P1|COMPLETED|Overall Study||4
8387204|NCT01072643|20672755|P1|STARTED|Overall Study||4
8387205|NCT01072630|20672781|P3|NOT COMPLETED|Overall Study||13
8387206|NCT01072630|20672782|P2|NOT COMPLETED|Overall Study||60
8387207|NCT01072630|20672783|P1|NOT COMPLETED|Overall Study||55
8387208|NCT01072630|20672781|P3|COMPLETED|Overall Study||17
8387209|NCT01072630|20672782|P2|COMPLETED|Overall Study||172
8387210|NCT01072630|20672783|P1|COMPLETED|Overall Study||175
8387211|NCT01072630|20672781|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
8387212|NCT01072630|20672782|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
8387213|NCT01072630|20672783|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
8387214|NCT01072630|20672781|P3|Safety Population|Overall Study|Treated participants.|30
8387215|NCT01072630|20672782|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
8387216|NCT01072630|20672783|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
8387217|NCT01072630|20672781|P3|STARTED|Overall Study||30
8387218|NCT01072630|20672782|P2|STARTED|Overall Study||232
8387219|NCT01072630|20672783|P1|STARTED|Overall Study||230
8387220|NCT01072617|20672857|P1|NOT COMPLETED|Overall Study||0
8387221|NCT01072617|20672857|P1|COMPLETED|Overall Study||8
8387222|NCT01072617|20672857|P1|STARTED|Overall Study||8
8387223|NCT01072539|20672864|P1|NOT COMPLETED|Overall Study||3
8387224|NCT01072539|20672864|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
8387225|NCT01072539|20672864|P1|STARTED|Overall Study||3172
8387226|NCT01072526|20672872|P2|NOT COMPLETED|Overall Study||0
8387227|NCT01072526|20672873|P1|NOT COMPLETED|Overall Study||0
8387228|NCT01072526|20672872|P2|COMPLETED|Overall Study||0
8387229|NCT01072526|20672873|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
8387230|NCT01072526|20672872|P2|STARTED|Overall Study||0
8387231|NCT01072526|20672873|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
8387232|NCT01072500|20672888|P2|NOT COMPLETED|Overall Study||14
8387233|NCT01072500|20672889|P1|NOT COMPLETED|Overall Study||24
8387234|NCT01072500|20672888|P2|COMPLETED|Overall Study||803
8387235|NCT01072500|20672889|P1|COMPLETED|Overall Study||794
8387236|NCT01072500|20672888|P2|STARTED|Overall Study||817
8387237|NCT01072500|20672889|P1|STARTED|Overall Study||818
8387238|NCT01072448|20672899|P2|NOT COMPLETED|Overall Study||30
8387239|NCT01072448|20672900|P1|NOT COMPLETED|Overall Study||19
8387240|NCT01072448|20672899|P2|COMPLETED|Overall Study||130
8387241|NCT01072448|20672900|P1|COMPLETED|Overall Study||144
8387242|NCT01072448|20672899|P2|STARTED|Overall Study||160
8387243|NCT01072448|20672900|P1|STARTED|Overall Study||163
8387244|NCT01072409|20672908|P1|NOT COMPLETED|Overall Study||7
8387245|NCT01072409|20672908|P1|COMPLETED|Overall Study||38
8387246|NCT01072409|20672908|P1|STARTED|Overall Study||45
8387247|NCT01072396|20672914|P2|NOT COMPLETED|Period Two||3
8387248|NCT01072396|20672915|P1|NOT COMPLETED|Period Two||1
8387249|NCT01072396|20672914|P2|COMPLETED|Period Two||57
8387250|NCT01072396|20672915|P1|COMPLETED|Period Two||57
8387251|NCT01072396|20672914|P2|STARTED|Period Two||60
8387252|NCT01072396|20672915|P1|STARTED|Period Two||58
8387253|NCT01072396|20672914|P2|NOT COMPLETED|Washout Period||1
8387254|NCT01072396|20672915|P1|NOT COMPLETED|Washout Period||0
8387255|NCT01072396|20672914|P2|COMPLETED|Washout Period||60
8387256|NCT01072396|20672915|P1|COMPLETED|Washout Period||58
8387257|NCT01072396|20672914|P2|STARTED|Washout Period||61
8387258|NCT01072396|20672915|P1|STARTED|Washout Period||58
8387259|NCT01072396|20672914|P2|NOT COMPLETED|Period One||2
8387260|NCT01072396|20672915|P1|NOT COMPLETED|Period One||5
8387261|NCT01072396|20672914|P2|COMPLETED|Period One||61
8387262|NCT01072396|20672915|P1|COMPLETED|Period One||58
8387263|NCT01072396|20672914|P2|STARTED|Period One||63
8387264|NCT01072396|20672915|P1|STARTED|Period One||63
8387265|NCT01072357|20672927|P2|NOT COMPLETED|Overall Study||1
8387266|NCT01072357|20672928|P1|NOT COMPLETED|Overall Study||0
8387267|NCT01072357|20672927|P2|COMPLETED|Overall Study||14
8387268|NCT01072357|20672928|P1|COMPLETED|Overall Study||15
8387269|NCT01072357|20672927|P2|STARTED|Overall Study||15
8387270|NCT01072357|20672928|P1|STARTED|Overall Study||15
8387271|NCT01072344|20672938|P2|NOT COMPLETED|Overall Study||18
8387272|NCT01072344|20672939|P1|NOT COMPLETED|Overall Study||11
8387273|NCT01072344|20672938|P2|COMPLETED|Overall Study||29
8387274|NCT01072344|20672939|P1|COMPLETED|Overall Study||35
8387275|NCT01072344|20672938|P2|STARTED|Overall Study||47
8387276|NCT01072344|20672939|P1|STARTED|Overall Study||46
8387277|NCT01072331|20672956|P3|NOT COMPLETED|Overall Study||0
8387278|NCT01072331|20672957|P2|NOT COMPLETED|Overall Study||0
8387279|NCT01072331|20672958|P1|NOT COMPLETED|Overall Study||0
8387280|NCT01072331|20672956|P3|COMPLETED|Overall Study||32
8387281|NCT01072331|20672957|P2|COMPLETED|Overall Study||33
8387282|NCT01072331|20672958|P1|COMPLETED|Overall Study||34
8387283|NCT01072331|20672956|P3|STARTED|Overall Study||32
8387284|NCT01072331|20672957|P2|STARTED|Overall Study||33
8387285|NCT01072331|20672958|P1|STARTED|Overall Study||34
8387286|NCT01072201|20672977|P2|NOT COMPLETED|Overall Study||1
8387287|NCT01072201|20672978|P1|NOT COMPLETED|Overall Study||0
8387288|NCT01072201|20672977|P2|COMPLETED|Overall Study||29
8387289|NCT01072201|20672978|P1|COMPLETED|Overall Study||30
8387290|NCT01072201|20672977|P2|STARTED|Overall Study||30
8387291|NCT01072201|20672978|P1|STARTED|Overall Study||30
8387292|NCT01072188|20672990|P2|NOT COMPLETED|Overall Study||0
8387293|NCT01072188|20672991|P1|NOT COMPLETED|Overall Study||0
8387294|NCT01072188|20672990|P2|COMPLETED|Overall Study||23
8387295|NCT01072188|20672991|P1|COMPLETED|Overall Study||22
8387296|NCT01072188|20672990|P2|STARTED|Overall Study||23
8387297|NCT01072188|20672991|P1|STARTED|Overall Study||22
8387298|NCT01072175|20673011|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
8387299|NCT01072175|20673012|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
8387300|NCT01072175|20673013|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
8387301|NCT01072175|20673014|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
8387302|NCT01072175|20673015|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
8387303|NCT01072175|20673016|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
8387304|NCT01072175|20673017|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
8387305|NCT01072175|20673018|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
8387306|NCT01072175|20673019|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
8387307|NCT01072175|20673020|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
8387308|NCT01072175|20673021|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
8387309|NCT01072175|20673022|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
8387310|NCT01072175|20673023|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
8387311|NCT01072175|20673011|P13|COMPLETED|Part D (HPMC Capsules)||0
8387312|NCT01072175|20673012|P12|COMPLETED|Part D (HPMC Capsules)||0
8387313|NCT01072175|20673013|P11|COMPLETED|Part D (HPMC Capsules)||0
8387314|NCT01072175|20673014|P10|COMPLETED|Part D (HPMC Capsules)||0
8387315|NCT01072175|20673015|P9|COMPLETED|Part D (HPMC Capsules)||0
8387316|NCT01072175|20673016|P8|COMPLETED|Part D (HPMC Capsules)||0
8387317|NCT01072175|20673017|P7|COMPLETED|Part D (HPMC Capsules)||0
8387318|NCT01072175|20673018|P6|COMPLETED|Part D (HPMC Capsules)||0
8387319|NCT01072175|20673019|P5|COMPLETED|Part D (HPMC Capsules)||0
8387320|NCT01072175|20673020|P4|COMPLETED|Part D (HPMC Capsules)||0
8387321|NCT01072175|20673021|P3|COMPLETED|Part D (HPMC Capsules)||0
8387322|NCT01072175|20673022|P2|COMPLETED|Part D (HPMC Capsules)||0
8387323|NCT01072175|20673023|P1|COMPLETED|Part D (HPMC Capsules)||0
8387324|NCT01072175|20673011|P13|STARTED|Part D (HPMC Capsules)||39
8387325|NCT01072175|20673012|P12|STARTED|Part D (HPMC Capsules)||43
8387326|NCT01072175|20673013|P11|STARTED|Part D (HPMC Capsules)||16
8387327|NCT01072175|20673014|P10|STARTED|Part D (HPMC Capsules)||12
8387328|NCT01072175|20673015|P9|STARTED|Part D (HPMC Capsules)||0
8387329|NCT01072175|20673016|P8|STARTED|Part D (HPMC Capsules)||0
8387330|NCT01072175|20673017|P7|STARTED|Part D (HPMC Capsules)||0
8387331|NCT01072175|20673018|P6|STARTED|Part D (HPMC Capsules)||0
8387332|NCT01072175|20673019|P5|STARTED|Part D (HPMC Capsules)||0
8387333|NCT01072175|20673020|P4|STARTED|Part D (HPMC Capsules)||0
8387334|NCT01072175|20673021|P3|STARTED|Part D (HPMC Capsules)||0
8387335|NCT01072175|20673022|P2|STARTED|Part D (HPMC Capsules)||0
8387336|NCT01072175|20673023|P1|STARTED|Part D (HPMC Capsules)||0
8387337|NCT01072175|20673011|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387338|NCT01072175|20673012|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387339|NCT01072175|20673013|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387340|NCT01072175|20673014|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387341|NCT01072175|20673015|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
8387342|NCT01072175|20673016|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387343|NCT01072175|20673017|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387344|NCT01072175|20673018|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387345|NCT01072175|20673019|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387346|NCT01072175|20673020|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387347|NCT01072175|20673021|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387500|NCT01072149|20673239|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387348|NCT01072175|20673022|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387349|NCT01072175|20673023|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387350|NCT01072175|20673011|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387351|NCT01072175|20673012|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387352|NCT01072175|20673013|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387353|NCT01072175|20673014|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387354|NCT01072175|20673015|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387355|NCT01072175|20673016|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387356|NCT01072175|20673017|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387357|NCT01072175|20673018|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387358|NCT01072175|20673019|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387359|NCT01072175|20673020|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387360|NCT01072175|20673021|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387361|NCT01072175|20673022|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387362|NCT01072175|20673023|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387363|NCT01072175|20673011|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387364|NCT01072175|20673012|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387365|NCT01072175|20673013|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387366|NCT01072175|20673014|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387367|NCT01072175|20673015|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||45
8387368|NCT01072175|20673016|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387369|NCT01072175|20673017|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387370|NCT01072175|20673018|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387371|NCT01072175|20673019|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387372|NCT01072175|20673020|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387373|NCT01072175|20673021|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387374|NCT01072175|20673022|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387375|NCT01072175|20673023|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387376|NCT01072175|20673011|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387377|NCT01072175|20673012|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387378|NCT01072175|20673013|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387379|NCT01072175|20673014|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387380|NCT01072175|20673015|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387381|NCT01072175|20673016|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
8387382|NCT01072175|20673017|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
8387383|NCT01072175|20673018|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
8387384|NCT01072175|20673019|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387385|NCT01072175|20673020|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387386|NCT01072175|20673021|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387387|NCT01072175|20673022|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387388|NCT01072175|20673023|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387389|NCT01072175|20673011|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387390|NCT01072175|20673012|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387391|NCT01072175|20673013|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387392|NCT01072175|20673014|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387393|NCT01072175|20673015|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387394|NCT01072175|20673016|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387395|NCT01072175|20673017|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387396|NCT01072175|20673018|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387397|NCT01072175|20673019|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387398|NCT01072175|20673020|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387399|NCT01072175|20673021|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387400|NCT01072175|20673022|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387401|NCT01072175|20673023|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387402|NCT01072175|20673011|P13|STARTED|Part C (Phase II: Randomized Phase)||0
8387403|NCT01072175|20673012|P12|STARTED|Part C (Phase II: Randomized Phase)||0
8387404|NCT01072175|20673013|P11|STARTED|Part C (Phase II: Randomized Phase)||0
8387405|NCT01072175|20673014|P10|STARTED|Part C (Phase II: Randomized Phase)||0
8387406|NCT01072175|20673015|P9|STARTED|Part C (Phase II: Randomized Phase)||0
8387407|NCT01072175|20673016|P8|STARTED|Part C (Phase II: Randomized Phase)||54
8387408|NCT01072175|20673017|P7|STARTED|Part C (Phase II: Randomized Phase)||54
8387409|NCT01072175|20673018|P6|STARTED|Part C (Phase II: Randomized Phase)||54
8387410|NCT01072175|20673019|P5|STARTED|Part C (Phase II: Randomized Phase)||0
8387411|NCT01072175|20673020|P4|STARTED|Part C (Phase II: Randomized Phase)||0
8387412|NCT01072175|20673021|P3|STARTED|Part C (Phase II: Randomized Phase)||0
8387413|NCT01072175|20673022|P2|STARTED|Part C (Phase II: Randomized Phase)||0
8387414|NCT01072175|20673023|P1|STARTED|Part C (Phase II: Randomized Phase)||0
8387415|NCT01072175|20673011|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387416|NCT01072175|20673012|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387417|NCT01072175|20673013|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387418|NCT01072175|20673014|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387419|NCT01072175|20673015|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387420|NCT01072175|20673016|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387421|NCT01072175|20673017|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387422|NCT01072175|20673018|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387423|NCT01072175|20673019|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
8387424|NCT01072175|20673020|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
8387425|NCT01072175|20673021|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
8387426|NCT01072175|20673022|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
8387427|NCT01072175|20673023|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387428|NCT01072175|20673011|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387429|NCT01072175|20673012|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387430|NCT01072175|20673013|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387431|NCT01072175|20673014|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387432|NCT01072175|20673015|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387433|NCT01072175|20673016|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387434|NCT01072175|20673017|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387435|NCT01072175|20673018|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387436|NCT01072175|20673019|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387437|NCT01072175|20673020|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387438|NCT01072175|20673021|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387439|NCT01072175|20673022|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387440|NCT01072175|20673023|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387441|NCT01072175|20673011|P13|STARTED|Part B (Dose Escalation and Expansion)||0
8387442|NCT01072175|20673012|P12|STARTED|Part B (Dose Escalation and Expansion)||0
8387443|NCT01072175|20673013|P11|STARTED|Part B (Dose Escalation and Expansion)||0
8387444|NCT01072175|20673014|P10|STARTED|Part B (Dose Escalation and Expansion)||0
8387445|NCT01072175|20673015|P9|STARTED|Part B (Dose Escalation and Expansion)||0
8387446|NCT01072175|20673016|P8|STARTED|Part B (Dose Escalation and Expansion)||0
8387447|NCT01072175|20673017|P7|STARTED|Part B (Dose Escalation and Expansion)||0
8387448|NCT01072175|20673018|P6|STARTED|Part B (Dose Escalation and Expansion)||0
8387449|NCT01072175|20673019|P5|STARTED|Part B (Dose Escalation and Expansion)||94
8387450|NCT01072175|20673020|P4|STARTED|Part B (Dose Escalation and Expansion)||27
8387451|NCT01072175|20673021|P3|STARTED|Part B (Dose Escalation and Expansion)||23
8387452|NCT01072175|20673022|P2|STARTED|Part B (Dose Escalation and Expansion)||6
8387453|NCT01072175|20673023|P1|STARTED|Part B (Dose Escalation and Expansion)||0
8387454|NCT01072175|20673011|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387455|NCT01072175|20673012|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387456|NCT01072175|20673013|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387457|NCT01072175|20673014|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387458|NCT01072175|20673015|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387459|NCT01072175|20673016|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387460|NCT01072175|20673017|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387461|NCT01072175|20673018|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387462|NCT01072175|20673019|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387463|NCT01072175|20673020|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387464|NCT01072175|20673021|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387465|NCT01072175|20673022|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387466|NCT01072175|20673023|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
8387467|NCT01072175|20673011|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
8387468|NCT01072175|20673012|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
8387469|NCT01072175|20673013|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
8387470|NCT01072175|20673014|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
8387471|NCT01072175|20673015|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
8387472|NCT01072175|20673016|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
8387473|NCT01072175|20673017|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
8387474|NCT01072175|20673018|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
8387475|NCT01072175|20673019|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
8387476|NCT01072175|20673020|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
8387477|NCT01072175|20673021|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
8387478|NCT01072175|20673022|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
8387479|NCT01072175|20673023|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
8387480|NCT01072175|20673011|P13|STARTED|Part A (Drug-Drug Interaction)||0
8387481|NCT01072175|20673012|P12|STARTED|Part A (Drug-Drug Interaction)||0
8387482|NCT01072175|20673013|P11|STARTED|Part A (Drug-Drug Interaction)||0
8387483|NCT01072175|20673014|P10|STARTED|Part A (Drug-Drug Interaction)||0
8387484|NCT01072175|20673015|P9|STARTED|Part A (Drug-Drug Interaction)||0
8387485|NCT01072175|20673016|P8|STARTED|Part A (Drug-Drug Interaction)||0
8387486|NCT01072175|20673017|P7|STARTED|Part A (Drug-Drug Interaction)||0
8387487|NCT01072175|20673018|P6|STARTED|Part A (Drug-Drug Interaction)||0
8387488|NCT01072175|20673019|P5|STARTED|Part A (Drug-Drug Interaction)||0
8387489|NCT01072175|20673020|P4|STARTED|Part A (Drug-Drug Interaction)||0
8387490|NCT01072175|20673021|P3|STARTED|Part A (Drug-Drug Interaction)||0
8387491|NCT01072175|20673022|P2|STARTED|Part A (Drug-Drug Interaction)||0
8387492|NCT01072175|20673023|P1|STARTED|Part A (Drug-Drug Interaction)||8
8387493|NCT01072149|20673232|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387494|NCT01072149|20673233|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387495|NCT01072149|20673234|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387496|NCT01072149|20673235|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387497|NCT01072149|20673236|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8387498|NCT01072149|20673237|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387499|NCT01072149|20673238|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387501|NCT01072149|20673240|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387502|NCT01072149|20673241|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387503|NCT01072149|20673242|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387504|NCT01072149|20673243|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387505|NCT01072149|20673244|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387506|NCT01072149|20673245|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387507|NCT01072149|20673246|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387508|NCT01072149|20673247|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8387509|NCT01072149|20673248|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387510|NCT01072149|20673249|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387511|NCT01072149|20673232|P18|COMPLETED|Treatment Period 3 (28 Days)||2
8387512|NCT01072149|20673233|P17|COMPLETED|Treatment Period 3 (28 Days)||3
8387513|NCT01072149|20673234|P16|COMPLETED|Treatment Period 3 (28 Days)||1
8387514|NCT01072149|20673235|P15|COMPLETED|Treatment Period 3 (28 Days)||3
8387515|NCT01072149|20673236|P14|COMPLETED|Treatment Period 3 (28 Days)||2
8387516|NCT01072149|20673237|P13|COMPLETED|Treatment Period 3 (28 Days)||2
8387517|NCT01072149|20673238|P12|COMPLETED|Treatment Period 3 (28 Days)||3
8387518|NCT01072149|20673239|P11|COMPLETED|Treatment Period 3 (28 Days)||2
8387519|NCT01072149|20673240|P10|COMPLETED|Treatment Period 3 (28 Days)||3
8387520|NCT01072149|20673241|P9|COMPLETED|Treatment Period 3 (28 Days)||3
8387521|NCT01072149|20673242|P8|COMPLETED|Treatment Period 3 (28 Days)||2
8387522|NCT01072149|20673243|P7|COMPLETED|Treatment Period 3 (28 Days)||3
8387523|NCT01072149|20673244|P6|COMPLETED|Treatment Period 3 (28 Days)||3
8387524|NCT01072149|20673245|P5|COMPLETED|Treatment Period 3 (28 Days)||3
8387525|NCT01072149|20673246|P4|COMPLETED|Treatment Period 3 (28 Days)||3
8387526|NCT01072149|20673247|P3|COMPLETED|Treatment Period 3 (28 Days)||0
8387527|NCT01072149|20673248|P2|COMPLETED|Treatment Period 3 (28 Days)||2
8387528|NCT01072149|20673249|P1|COMPLETED|Treatment Period 3 (28 Days)||2
8387529|NCT01072149|20673232|P18|STARTED|Treatment Period 3 (28 Days)||2
8387530|NCT01072149|20673233|P17|STARTED|Treatment Period 3 (28 Days)||3
8387531|NCT01072149|20673234|P16|STARTED|Treatment Period 3 (28 Days)||1
8387532|NCT01072149|20673235|P15|STARTED|Treatment Period 3 (28 Days)||3
8387533|NCT01072149|20673236|P14|STARTED|Treatment Period 3 (28 Days)||3
8387534|NCT01072149|20673237|P13|STARTED|Treatment Period 3 (28 Days)||2
8387535|NCT01072149|20673238|P12|STARTED|Treatment Period 3 (28 Days)||3
8387536|NCT01072149|20673239|P11|STARTED|Treatment Period 3 (28 Days)||2
8387537|NCT01072149|20673240|P10|STARTED|Treatment Period 3 (28 Days)||3
8387538|NCT01072149|20673241|P9|STARTED|Treatment Period 3 (28 Days)||3
8387539|NCT01072149|20673242|P8|STARTED|Treatment Period 3 (28 Days)||2
8387540|NCT01072149|20673243|P7|STARTED|Treatment Period 3 (28 Days)||3
8387541|NCT01072149|20673244|P6|STARTED|Treatment Period 3 (28 Days)||3
8387542|NCT01072149|20673245|P5|STARTED|Treatment Period 3 (28 Days)||3
8387543|NCT01072149|20673246|P4|STARTED|Treatment Period 3 (28 Days)||3
8387544|NCT01072149|20673247|P3|STARTED|Treatment Period 3 (28 Days)||1
8387545|NCT01072149|20673248|P2|STARTED|Treatment Period 3 (28 Days)||2
8387546|NCT01072149|20673249|P1|STARTED|Treatment Period 3 (28 Days)||2
8387547|NCT01072149|20673232|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387548|NCT01072149|20673233|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387549|NCT01072149|20673234|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
8387550|NCT01072149|20673235|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387551|NCT01072149|20673236|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387552|NCT01072149|20673237|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
8387553|NCT01072149|20673238|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387554|NCT01072149|20673239|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387555|NCT01072149|20673240|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387556|NCT01072149|20673241|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387557|NCT01072149|20673242|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387558|NCT01072149|20673243|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387559|NCT01072149|20673244|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387560|NCT01072149|20673245|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387561|NCT01072149|20673246|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387562|NCT01072149|20673247|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387563|NCT01072149|20673248|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387564|NCT01072149|20673249|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
8387565|NCT01072149|20673232|P18|COMPLETED|Washout Period 2 (14 Days)||2
8387566|NCT01072149|20673233|P17|COMPLETED|Washout Period 2 (14 Days)||3
8387567|NCT01072149|20673234|P16|COMPLETED|Washout Period 2 (14 Days)||1
8387568|NCT01072149|20673235|P15|COMPLETED|Washout Period 2 (14 Days)||3
8387569|NCT01072149|20673236|P14|COMPLETED|Washout Period 2 (14 Days)||3
8387570|NCT01072149|20673237|P13|COMPLETED|Washout Period 2 (14 Days)||2
8387571|NCT01072149|20673238|P12|COMPLETED|Washout Period 2 (14 Days)||3
8387572|NCT01072149|20673239|P11|COMPLETED|Washout Period 2 (14 Days)||2
8387573|NCT01072149|20673240|P10|COMPLETED|Washout Period 2 (14 Days)||3
8387574|NCT01072149|20673241|P9|COMPLETED|Washout Period 2 (14 Days)||3
8387575|NCT01072149|20673242|P8|COMPLETED|Washout Period 2 (14 Days)||2
8387576|NCT01072149|20673243|P7|COMPLETED|Washout Period 2 (14 Days)||3
8387577|NCT01072149|20673244|P6|COMPLETED|Washout Period 2 (14 Days)||3
8387578|NCT01072149|20673245|P5|COMPLETED|Washout Period 2 (14 Days)||3
8387579|NCT01072149|20673246|P4|COMPLETED|Washout Period 2 (14 Days)||3
8387580|NCT01072149|20673247|P3|COMPLETED|Washout Period 2 (14 Days)||1
8387581|NCT01072149|20673248|P2|COMPLETED|Washout Period 2 (14 Days)||2
8387582|NCT01072149|20673249|P1|COMPLETED|Washout Period 2 (14 Days)||2
8387583|NCT01072149|20673232|P18|STARTED|Washout Period 2 (14 Days)||2
8387584|NCT01072149|20673233|P17|STARTED|Washout Period 2 (14 Days)||3
8387585|NCT01072149|20673234|P16|STARTED|Washout Period 2 (14 Days)||3
8387586|NCT01072149|20673235|P15|STARTED|Washout Period 2 (14 Days)||3
8387587|NCT01072149|20673236|P14|STARTED|Washout Period 2 (14 Days)||3
8387588|NCT01072149|20673237|P13|STARTED|Washout Period 2 (14 Days)||3
8387589|NCT01072149|20673238|P12|STARTED|Washout Period 2 (14 Days)||3
8387590|NCT01072149|20673239|P11|STARTED|Washout Period 2 (14 Days)||2
8387591|NCT01072149|20673240|P10|STARTED|Washout Period 2 (14 Days)||3
8387592|NCT01072149|20673241|P9|STARTED|Washout Period 2 (14 Days)||3
8387593|NCT01072149|20673242|P8|STARTED|Washout Period 2 (14 Days)||2
8387594|NCT01072149|20673243|P7|STARTED|Washout Period 2 (14 Days)||3
8387595|NCT01072149|20673244|P6|STARTED|Washout Period 2 (14 Days)||3
8387596|NCT01072149|20673245|P5|STARTED|Washout Period 2 (14 Days)||3
8387597|NCT01072149|20673246|P4|STARTED|Washout Period 2 (14 Days)||3
8387598|NCT01072149|20673247|P3|STARTED|Washout Period 2 (14 Days)||1
8387599|NCT01072149|20673248|P2|STARTED|Washout Period 2 (14 Days)||2
8387600|NCT01072149|20673249|P1|STARTED|Washout Period 2 (14 Days)||3
8387601|NCT01072149|20673232|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387602|NCT01072149|20673233|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387603|NCT01072149|20673234|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387604|NCT01072149|20673235|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387605|NCT01072149|20673236|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387606|NCT01072149|20673237|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387607|NCT01072149|20673238|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387608|NCT01072149|20673239|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387609|NCT01072149|20673240|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387610|NCT01072149|20673241|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387611|NCT01072149|20673242|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8387612|NCT01072149|20673243|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387613|NCT01072149|20673244|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387614|NCT01072149|20673245|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387615|NCT01072149|20673246|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387616|NCT01072149|20673247|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8387617|NCT01072149|20673248|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8387618|NCT01072149|20673249|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387619|NCT01072149|20673232|P18|COMPLETED|Treatment Period 2 (28 Days)||2
8387620|NCT01072149|20673233|P17|COMPLETED|Treatment Period 2 (28 Days)||3
8387621|NCT01072149|20673234|P16|COMPLETED|Treatment Period 2 (28 Days)||3
8387622|NCT01072149|20673235|P15|COMPLETED|Treatment Period 2 (28 Days)||3
8387623|NCT01072149|20673236|P14|COMPLETED|Treatment Period 2 (28 Days)||3
8387624|NCT01072149|20673237|P13|COMPLETED|Treatment Period 2 (28 Days)||3
8387625|NCT01072149|20673238|P12|COMPLETED|Treatment Period 2 (28 Days)||3
8387626|NCT01072149|20673239|P11|COMPLETED|Treatment Period 2 (28 Days)||2
8387627|NCT01072149|20673240|P10|COMPLETED|Treatment Period 2 (28 Days)||3
8387628|NCT01072149|20673241|P9|COMPLETED|Treatment Period 2 (28 Days)||3
8387629|NCT01072149|20673242|P8|COMPLETED|Treatment Period 2 (28 Days)||2
8387630|NCT01072149|20673243|P7|COMPLETED|Treatment Period 2 (28 Days)||3
8387631|NCT01072149|20673244|P6|COMPLETED|Treatment Period 2 (28 Days)||3
8387632|NCT01072149|20673245|P5|COMPLETED|Treatment Period 2 (28 Days)||3
8387633|NCT01072149|20673246|P4|COMPLETED|Treatment Period 2 (28 Days)||3
8387634|NCT01072149|20673247|P3|COMPLETED|Treatment Period 2 (28 Days)||1
8387635|NCT01072149|20673248|P2|COMPLETED|Treatment Period 2 (28 Days)||2
8387636|NCT01072149|20673249|P1|COMPLETED|Treatment Period 2 (28 Days)||3
8387637|NCT01072149|20673232|P18|STARTED|Treatment Period 2 (28 Days)||2
8387638|NCT01072149|20673233|P17|STARTED|Treatment Period 2 (28 Days)||3
8387639|NCT01072149|20673234|P16|STARTED|Treatment Period 2 (28 Days)||3
8387640|NCT01072149|20673235|P15|STARTED|Treatment Period 2 (28 Days)||3
8387641|NCT01072149|20673236|P14|STARTED|Treatment Period 2 (28 Days)||3
8387642|NCT01072149|20673237|P13|STARTED|Treatment Period 2 (28 Days)||3
8387643|NCT01072149|20673238|P12|STARTED|Treatment Period 2 (28 Days)||3
8387644|NCT01072149|20673239|P11|STARTED|Treatment Period 2 (28 Days)||2
8387645|NCT01072149|20673240|P10|STARTED|Treatment Period 2 (28 Days)||3
8387646|NCT01072149|20673241|P9|STARTED|Treatment Period 2 (28 Days)||3
8387647|NCT01072149|20673242|P8|STARTED|Treatment Period 2 (28 Days)||3
8387648|NCT01072149|20673243|P7|STARTED|Treatment Period 2 (28 Days)||3
8387649|NCT01072149|20673244|P6|STARTED|Treatment Period 2 (28 Days)||3
8387650|NCT01072149|20673245|P5|STARTED|Treatment Period 2 (28 Days)||3
8387651|NCT01072149|20673246|P4|STARTED|Treatment Period 2 (28 Days)||3
8387652|NCT01072149|20673247|P3|STARTED|Treatment Period 2 (28 Days)||2
8387653|NCT01072149|20673248|P2|STARTED|Treatment Period 2 (28 Days)||3
8387654|NCT01072149|20673249|P1|STARTED|Treatment Period 2 (28 Days)||3
8387655|NCT01072149|20673232|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387656|NCT01072149|20673233|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387657|NCT01072149|20673234|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387658|NCT01072149|20673235|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387659|NCT01072149|20673236|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387660|NCT01072149|20673237|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387661|NCT01072149|20673238|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387662|NCT01072149|20673239|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387663|NCT01072149|20673240|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387664|NCT01072149|20673241|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387665|NCT01072149|20673242|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387666|NCT01072149|20673243|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387667|NCT01072149|20673244|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387668|NCT01072149|20673245|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387669|NCT01072149|20673246|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387670|NCT01072149|20673247|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387671|NCT01072149|20673248|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387672|NCT01072149|20673249|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387673|NCT01072149|20673232|P18|COMPLETED|Washout Period 1 (14 Days)||2
8387674|NCT01072149|20673233|P17|COMPLETED|Washout Period 1 (14 Days)||3
8387675|NCT01072149|20673234|P16|COMPLETED|Washout Period 1 (14 Days)||3
8387676|NCT01072149|20673235|P15|COMPLETED|Washout Period 1 (14 Days)||3
8387677|NCT01072149|20673236|P14|COMPLETED|Washout Period 1 (14 Days)||3
8387678|NCT01072149|20673237|P13|COMPLETED|Washout Period 1 (14 Days)||3
8387679|NCT01072149|20673238|P12|COMPLETED|Washout Period 1 (14 Days)||3
8387680|NCT01072149|20673239|P11|COMPLETED|Washout Period 1 (14 Days)||2
8387681|NCT01072149|20673240|P10|COMPLETED|Washout Period 1 (14 Days)||3
8387682|NCT01072149|20673241|P9|COMPLETED|Washout Period 1 (14 Days)||3
8387683|NCT01072149|20673242|P8|COMPLETED|Washout Period 1 (14 Days)||3
8387684|NCT01072149|20673243|P7|COMPLETED|Washout Period 1 (14 Days)||3
8387685|NCT01072149|20673244|P6|COMPLETED|Washout Period 1 (14 Days)||3
8387686|NCT01072149|20673245|P5|COMPLETED|Washout Period 1 (14 Days)||3
8387687|NCT01072149|20673246|P4|COMPLETED|Washout Period 1 (14 Days)||3
8387688|NCT01072149|20673247|P3|COMPLETED|Washout Period 1 (14 Days)||2
8387689|NCT01072149|20673248|P2|COMPLETED|Washout Period 1 (14 Days)||3
8387690|NCT01072149|20673249|P1|COMPLETED|Washout Period 1 (14 Days)||3
8387691|NCT01072149|20673232|P18|STARTED|Washout Period 1 (14 Days)||2
8387692|NCT01072149|20673233|P17|STARTED|Washout Period 1 (14 Days)||3
8387693|NCT01072149|20673234|P16|STARTED|Washout Period 1 (14 Days)||3
8387694|NCT01072149|20673235|P15|STARTED|Washout Period 1 (14 Days)||3
8387695|NCT01072149|20673236|P14|STARTED|Washout Period 1 (14 Days)||3
8387696|NCT01072149|20673237|P13|STARTED|Washout Period 1 (14 Days)||3
8387697|NCT01072149|20673238|P12|STARTED|Washout Period 1 (14 Days)||3
8387698|NCT01072149|20673239|P11|STARTED|Washout Period 1 (14 Days)||2
8387699|NCT01072149|20673240|P10|STARTED|Washout Period 1 (14 Days)||3
8387700|NCT01072149|20673241|P9|STARTED|Washout Period 1 (14 Days)||3
8387701|NCT01072149|20673242|P8|STARTED|Washout Period 1 (14 Days)||3
8387702|NCT01072149|20673243|P7|STARTED|Washout Period 1 (14 Days)||3
8387703|NCT01072149|20673244|P6|STARTED|Washout Period 1 (14 Days)||3
8387704|NCT01072149|20673245|P5|STARTED|Washout Period 1 (14 Days)||3
8387705|NCT01072149|20673246|P4|STARTED|Washout Period 1 (14 Days)||3
8387706|NCT01072149|20673247|P3|STARTED|Washout Period 1 (14 Days)||2
8387707|NCT01072149|20673248|P2|STARTED|Washout Period 1 (14 Days)||3
8387708|NCT01072149|20673249|P1|STARTED|Washout Period 1 (14 Days)||3
8387709|NCT01072149|20673232|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8387710|NCT01072149|20673233|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387711|NCT01072149|20673234|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387712|NCT01072149|20673235|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387713|NCT01072149|20673236|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387714|NCT01072149|20673237|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387715|NCT01072149|20673238|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387716|NCT01072149|20673239|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8387717|NCT01072149|20673240|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387718|NCT01072149|20673241|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387719|NCT01072149|20673242|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387720|NCT01072149|20673243|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387721|NCT01072149|20673244|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387722|NCT01072149|20673245|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387723|NCT01072149|20673246|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387724|NCT01072149|20673247|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8387725|NCT01072149|20673248|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387726|NCT01072149|20673249|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387727|NCT01072149|20673232|P18|COMPLETED|Treatment Period 1 (28 Days)||2
8387728|NCT01072149|20673233|P17|COMPLETED|Treatment Period 1 (28 Days)||3
8387729|NCT01072149|20673234|P16|COMPLETED|Treatment Period 1 (28 Days)||3
8387730|NCT01072149|20673235|P15|COMPLETED|Treatment Period 1 (28 Days)||3
8387731|NCT01072149|20673236|P14|COMPLETED|Treatment Period 1 (28 Days)||3
8387732|NCT01072149|20673237|P13|COMPLETED|Treatment Period 1 (28 Days)||3
8387733|NCT01072149|20673238|P12|COMPLETED|Treatment Period 1 (28 Days)||3
8387734|NCT01072149|20673239|P11|COMPLETED|Treatment Period 1 (28 Days)||2
8387735|NCT01072149|20673240|P10|COMPLETED|Treatment Period 1 (28 Days)||3
8387736|NCT01072149|20673241|P9|COMPLETED|Treatment Period 1 (28 Days)||3
8387737|NCT01072149|20673242|P8|COMPLETED|Treatment Period 1 (28 Days)||3
8387738|NCT01072149|20673243|P7|COMPLETED|Treatment Period 1 (28 Days)||3
8387739|NCT01072149|20673244|P6|COMPLETED|Treatment Period 1 (28 Days)||3
8387740|NCT01072149|20673245|P5|COMPLETED|Treatment Period 1 (28 Days)||3
8387741|NCT01072149|20673246|P4|COMPLETED|Treatment Period 1 (28 Days)||3
8387742|NCT01072149|20673247|P3|COMPLETED|Treatment Period 1 (28 Days)||2
8387743|NCT01072149|20673248|P2|COMPLETED|Treatment Period 1 (28 Days)||3
8387744|NCT01072149|20673249|P1|COMPLETED|Treatment Period 1 (28 Days)||3
8387745|NCT01072149|20673232|P18|STARTED|Treatment Period 1 (28 Days)||3
8387746|NCT01072149|20673233|P17|STARTED|Treatment Period 1 (28 Days)||3
8387747|NCT01072149|20673234|P16|STARTED|Treatment Period 1 (28 Days)||3
8387748|NCT01072149|20673235|P15|STARTED|Treatment Period 1 (28 Days)||3
8387749|NCT01072149|20673236|P14|STARTED|Treatment Period 1 (28 Days)||3
8387750|NCT01072149|20673237|P13|STARTED|Treatment Period 1 (28 Days)||3
8387751|NCT01072149|20673238|P12|STARTED|Treatment Period 1 (28 Days)||3
8387752|NCT01072149|20673239|P11|STARTED|Treatment Period 1 (28 Days)||3
8387753|NCT01072149|20673240|P10|STARTED|Treatment Period 1 (28 Days)||3
8387754|NCT01072149|20673241|P9|STARTED|Treatment Period 1 (28 Days)||3
8387755|NCT01072149|20673242|P8|STARTED|Treatment Period 1 (28 Days)||3
8387756|NCT01072149|20673243|P7|STARTED|Treatment Period 1 (28 Days)||3
8387757|NCT01072149|20673244|P6|STARTED|Treatment Period 1 (28 Days)||3
8387758|NCT01072149|20673245|P5|STARTED|Treatment Period 1 (28 Days)||3
8387759|NCT01072149|20673246|P4|STARTED|Treatment Period 1 (28 Days)||3
8387760|NCT01072149|20673247|P3|STARTED|Treatment Period 1 (28 Days)||3
8387761|NCT01072149|20673248|P2|STARTED|Treatment Period 1 (28 Days)||3
8387762|NCT01072149|20673249|P1|STARTED|Treatment Period 1 (28 Days)||3
8387763|NCT01072136|20673269|P2|NOT COMPLETED|Overall Study||31
8387764|NCT01072136|20673270|P1|NOT COMPLETED|Overall Study||23
8387765|NCT01072136|20673269|P2|COMPLETED|Overall Study||12
8387766|NCT01072136|20673270|P1|COMPLETED|Overall Study||21
8387767|NCT01072136|20673269|P2|Met All Enrollment Criteria|Overall Study||25
8387768|NCT01072136|20673270|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
8387769|NCT01072136|20673269|P2|STARTED|Overall Study||43
8387770|NCT01072136|20673270|P1|STARTED|Overall Study||44
8387771|NCT01072032|20673294|P2|NOT COMPLETED|Overall Study||9
8387772|NCT01072032|20673295|P1|NOT COMPLETED|Overall Study||8
8387773|NCT01072032|20673294|P2|COMPLETED|Overall Study||5
8387774|NCT01072032|20673295|P1|COMPLETED|Overall Study||5
8387775|NCT01072032|20673294|P2|STARTED|Overall Study||14
8387776|NCT01072032|20673295|P1|STARTED|Overall Study||13
8387777|NCT01072006|20673309|P4|NOT COMPLETED|Overall Study||0
8387778|NCT01072006|20673310|P3|NOT COMPLETED|Overall Study||0
8387779|NCT01072006|20673311|P2|NOT COMPLETED|Overall Study||0
8387780|NCT01072006|20673312|P1|NOT COMPLETED|Overall Study||0
8387781|NCT01072006|20673309|P4|COMPLETED|Overall Study||11
8387782|NCT01072006|20673310|P3|COMPLETED|Overall Study||0
8387783|NCT01072006|20673311|P2|COMPLETED|Overall Study||5
8387784|NCT01072006|20673312|P1|COMPLETED|Overall Study||14
8387785|NCT01072006|20673309|P4|STARTED|Overall Study||11
8387786|NCT01072006|20673310|P3|STARTED|Overall Study||0
8387787|NCT01072006|20673311|P2|STARTED|Overall Study||5
8387788|NCT01072006|20673312|P1|STARTED|Overall Study||14
8387789|NCT01071993|20673331|P2|NOT COMPLETED|Overall Study||0
8387790|NCT01071993|20673332|P1|NOT COMPLETED|Overall Study||0
8387791|NCT01071993|20673331|P2|COMPLETED|Overall Study||0
8387792|NCT01071993|20673332|P1|COMPLETED|Overall Study||0
8387793|NCT01071993|20673331|P2|STARTED|Overall Study||0
8387794|NCT01071993|20673332|P1|STARTED|Overall Study||0
8387795|NCT01071954|20673338|P1|NOT COMPLETED|Overall Study||27
8387796|NCT01071954|20673338|P1|COMPLETED|Overall Study||39
8387797|NCT01071954|20673338|P1|Received Treatment|Overall Study||65
8387798|NCT01071954|20673338|P1|STARTED|Overall Study||66
8387799|NCT01071915|20673347|P1|NOT COMPLETED|Overall Study||9
8387800|NCT01071915|20673347|P1|COMPLETED|Overall Study||148
8387801|NCT01071915|20673347|P1|Safety Analysis Set|Overall Study||156
8387802|NCT01071915|20673347|P1|Full Analysis Set (FAS)|Overall Study||155
8387803|NCT01071915|20673347|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
8387804|NCT01071798|20673357|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
8387805|NCT01071798|20673357|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
8387806|NCT01071798|20673357|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
8387807|NCT01071798|20673357|P1|STARTED|Subpopulation Who Received Two Cycles||820
8387808|NCT01071798|20673357|P1|NOT COMPLETED|Participants Who Received One Cycle||65
8387809|NCT01071798|20673357|P1|COMPLETED|Participants Who Received One Cycle||1588
8387810|NCT01071798|20673357|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
8387811|NCT01071798|20673357|P1|STARTED|Participants Who Received One Cycle||1653
8387812|NCT01071538|20673377|P1|NOT COMPLETED|Overall Study||2
8387813|NCT01071538|20673377|P1|COMPLETED|Overall Study||13
8387814|NCT01071538|20673377|P1|STARTED|Overall Study||15
8387815|NCT01071512|20673387|P1|NOT COMPLETED|Overall Study||5
8387816|NCT01071512|20673387|P1|COMPLETED|Overall Study||15
8387817|NCT01071512|20673387|P1|STARTED|Overall Study||20
8387818|NCT01071395|20673397|P2|NOT COMPLETED|Overall Study||2
8387819|NCT01071395|20673398|P1|NOT COMPLETED|Overall Study||5
8387820|NCT01071395|20673397|P2|COMPLETED|Overall Study||30
8387821|NCT01071395|20673398|P1|COMPLETED|Overall Study||31
8387822|NCT01071395|20673397|P2|STARTED|Overall Study||32
8387823|NCT01071395|20673398|P1|STARTED|Overall Study||36
8387824|NCT01071356|20673406|P2|NOT COMPLETED|Overall Study||9
8387825|NCT01071356|20673407|P1|NOT COMPLETED|Overall Study||7
8387826|NCT01071356|20673406|P2|COMPLETED|Overall Study||97
8387827|NCT01071356|20673407|P1|COMPLETED|Overall Study||104
8387828|NCT01071356|20673406|P2|STARTED|Overall Study||106
8387829|NCT01071356|20673407|P1|STARTED|Overall Study||111
8387830|NCT01071317|20673417|P2|NOT COMPLETED|Overall Study||2
8387831|NCT01071317|20673418|P1|NOT COMPLETED|Overall Study||2
8387832|NCT01071317|20673417|P2|COMPLETED|Overall Study||23
8387833|NCT01071317|20673418|P1|COMPLETED|Overall Study||23
8387834|NCT01071317|20673417|P2|STARTED|Overall Study||25
8387835|NCT01071317|20673418|P1|STARTED|Overall Study||25
8387836|NCT01071278|20673430|P1|NOT COMPLETED|Overall Study||713
8387837|NCT01071278|20673430|P1|COMPLETED|Overall Study||1677
8387838|NCT01071278|20673430|P1|STARTED|Overall Study||2390
8387839|NCT01071252|20673441|P5|NOT COMPLETED|Overall Study||11
8387840|NCT01071252|20673442|P4|NOT COMPLETED|Overall Study||7
8387841|NCT01071252|20673443|P3|NOT COMPLETED|Overall Study||4
8387842|NCT01071252|20673444|P2|NOT COMPLETED|Overall Study||10
8387843|NCT01071252|20673445|P1|NOT COMPLETED|Overall Study||15
8387844|NCT01071252|20673441|P5|COMPLETED|Overall Study||11
8387845|NCT01071252|20673442|P4|COMPLETED|Overall Study||20
8387846|NCT01071252|20673443|P3|COMPLETED|Overall Study||17
8387847|NCT01071252|20673444|P2|COMPLETED|Overall Study||16
8387848|NCT01071252|20673445|P1|COMPLETED|Overall Study||14
8387849|NCT01071252|20673441|P5|STARTED|Overall Study||22
8387850|NCT01071252|20673442|P4|STARTED|Overall Study||27
8387851|NCT01071252|20673443|P3|STARTED|Overall Study||21
8387852|NCT01071252|20673444|P2|STARTED|Overall Study||26
8387853|NCT01071252|20673445|P1|STARTED|Overall Study||29
8387854|NCT01071200|20673473|P2|NOT COMPLETED|Overall Study||3
8387855|NCT01071200|20673474|P1|NOT COMPLETED|Overall Study||7
8387856|NCT01071200|20673473|P2|COMPLETED|Overall Study||63
8387857|NCT01071200|20673474|P1|COMPLETED|Overall Study||60
8387858|NCT01071200|20673473|P2|STARTED|Overall Study||66
8387859|NCT01071200|20673474|P1|STARTED|Overall Study||67
8387860|NCT01071096|20673506|P2|NOT COMPLETED|Second Intervention (90 Days)||0
8387861|NCT01071096|20673507|P1|NOT COMPLETED|Second Intervention (90 Days)||0
8387862|NCT01071096|20673506|P2|COMPLETED|Second Intervention (90 Days)||10
8387863|NCT01071096|20673507|P1|COMPLETED|Second Intervention (90 Days)||9
8387864|NCT01071096|20673506|P2|STARTED|Second Intervention (90 Days)||10
8387865|NCT01071096|20673507|P1|STARTED|Second Intervention (90 Days)||9
8387866|NCT01071096|20673506|P2|NOT COMPLETED|Washout Period (30 Days)||0
8387867|NCT01071096|20673507|P1|NOT COMPLETED|Washout Period (30 Days)||0
8387868|NCT01071096|20673506|P2|COMPLETED|Washout Period (30 Days)||10
8387869|NCT01071096|20673507|P1|COMPLETED|Washout Period (30 Days)||9
8387870|NCT01071096|20673506|P2|STARTED|Washout Period (30 Days)||10
8387871|NCT01071096|20673507|P1|STARTED|Washout Period (30 Days)||9
8387872|NCT01071096|20673506|P2|NOT COMPLETED|First Intervention (90 Days)||0
8387873|NCT01071096|20673507|P1|NOT COMPLETED|First Intervention (90 Days)||1
8387874|NCT01071096|20673506|P2|COMPLETED|First Intervention (90 Days)||10
8387875|NCT01071096|20673507|P1|COMPLETED|First Intervention (90 Days)||9
8387876|NCT01071096|20673506|P2|STARTED|First Intervention (90 Days)||10
8387877|NCT01071096|20673507|P1|STARTED|First Intervention (90 Days)||10
8387878|NCT01071083|20673531|P5|NOT COMPLETED|Overall Study||8
8387879|NCT01071083|20673532|P4|NOT COMPLETED|Overall Study||2
8387880|NCT01071083|20673533|P3|NOT COMPLETED|Overall Study||5
8387881|NCT01071083|20673534|P2|NOT COMPLETED|Overall Study||2
8387882|NCT01071083|20673535|P1|NOT COMPLETED|Overall Study||7
8387883|NCT01071083|20673531|P5|COMPLETED|Overall Study||46
8387884|NCT01071083|20673532|P4|COMPLETED|Overall Study||15
8387885|NCT01071083|20673533|P3|COMPLETED|Overall Study||12
8387886|NCT01071083|20673534|P2|COMPLETED|Overall Study||43
8387887|NCT01071083|20673535|P1|COMPLETED|Overall Study||35
8387888|NCT01071083|20673531|P5|STARTED|Overall Study||54
8387889|NCT01071083|20673532|P4|STARTED|Overall Study||17
8387890|NCT01071083|20673533|P3|STARTED|Overall Study||17
8387891|NCT01071083|20673534|P2|STARTED|Overall Study||45
8387892|NCT01071083|20673535|P1|STARTED|Overall Study||42
8387893|NCT01071070|20673554|P2|NOT COMPLETED|Overall Study||3
8387894|NCT01071070|20673555|P1|NOT COMPLETED|Overall Study||4
8387895|NCT01071070|20673554|P2|COMPLETED|Overall Study||105
8387896|NCT01071070|20673555|P1|COMPLETED|Overall Study||104
8387897|NCT01071070|20673554|P2|STARTED|Overall Study||108
8387898|NCT01071070|20673555|P1|STARTED|Overall Study||108
8387899|NCT01071044|20673579|P2|NOT COMPLETED|Overall Study||0
8387900|NCT01071044|20673580|P1|NOT COMPLETED|Overall Study||2
8387901|NCT01071044|20673579|P2|COMPLETED|Overall Study||11
8387902|NCT01071044|20673580|P1|COMPLETED|Overall Study||13
8387903|NCT01071044|20673579|P2|STARTED|Overall Study||11
8387904|NCT01071044|20673580|P1|STARTED|Overall Study||15
8387905|NCT01070979|20673601|P3|NOT COMPLETED|Overall Study||13
8387906|NCT01070979|20673602|P2|NOT COMPLETED|Overall Study||12
8387907|NCT01070979|20673603|P1|NOT COMPLETED|Overall Study||11
8387908|NCT01070979|20673601|P3|COMPLETED|Overall Study||72
8387909|NCT01070979|20673602|P2|COMPLETED|Overall Study||73
8387910|NCT01070979|20673603|P1|COMPLETED|Overall Study||68
8387911|NCT01070979|20673601|P3|STARTED|Overall Study||85
8387912|NCT01070979|20673602|P2|STARTED|Overall Study||85
8387913|NCT01070979|20673603|P1|STARTED|Overall Study||79
8387914|NCT01070966|20673629|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
8387915|NCT01070966|20673629|P1|COMPLETED|Participants for Efficacy Evaluation||1929
8387916|NCT01070966|20673629|P1|STARTED|Participants for Efficacy Evaluation||2011
8387917|NCT01070966|20673629|P1|NOT COMPLETED|Participants for Safety Evaluation||78
8387918|NCT01070966|20673629|P1|COMPLETED|Participants for Safety Evaluation||2011
8387919|NCT01070966|20673629|P1|STARTED|Participants for Safety Evaluation||2089
8387920|NCT01070953|20673640|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
8387921|NCT01070953|20673640|P1|COMPLETED|Participants for Efficacy Evaluation||3309
8387922|NCT01070953|20673640|P1|STARTED|Participants for Efficacy Evaluation||3536
8387923|NCT01070953|20673640|P1|NOT COMPLETED|Participants for Safety Evaluation||931
8387924|NCT01070953|20673640|P1|COMPLETED|Participants for Safety Evaluation||3536
8387925|NCT01070953|20673640|P1|STARTED|Participants for Safety Evaluation||4467
8387926|NCT01070888|20673653|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8387927|NCT01070888|20673654|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8387928|NCT01070888|20673653|P2|COMPLETED|Second Intervention (14 Days)||2
8387929|NCT01070888|20673654|P1|COMPLETED|Second Intervention (14 Days)||1
8387930|NCT01070888|20673653|P2|STARTED|Second Intervention (14 Days)||2
8387931|NCT01070888|20673654|P1|STARTED|Second Intervention (14 Days)||1
8387932|NCT01070888|20673653|P2|NOT COMPLETED|Washout (14 Days)||0
8387933|NCT01070888|20673654|P1|NOT COMPLETED|Washout (14 Days)||1
8387934|NCT01070888|20673653|P2|COMPLETED|Washout (14 Days)||2
8387935|NCT01070888|20673654|P1|COMPLETED|Washout (14 Days)||1
8387936|NCT01070888|20673653|P2|STARTED|Washout (14 Days)||2
8387937|NCT01070888|20673654|P1|STARTED|Washout (14 Days)||2
8387938|NCT01070888|20673653|P2|NOT COMPLETED|First Intervention (14 Days)||2
8387939|NCT01070888|20673654|P1|NOT COMPLETED|First Intervention (14 Days)||0
8387940|NCT01070888|20673653|P2|COMPLETED|First Intervention (14 Days)||2
8387941|NCT01070888|20673654|P1|COMPLETED|First Intervention (14 Days)||2
8387942|NCT01070888|20673653|P2|STARTED|First Intervention (14 Days)||4
8387943|NCT01070888|20673654|P1|STARTED|First Intervention (14 Days)||2
8387944|NCT01070810|20673662|P2|NOT COMPLETED|Overall Study||0
8387945|NCT01070810|20673663|P1|NOT COMPLETED|Overall Study||0
8387946|NCT01070810|20673662|P2|COMPLETED|Overall Study||43
8387947|NCT01070810|20673663|P1|COMPLETED|Overall Study||45
8387948|NCT01070810|20673662|P2|STARTED|Overall Study||43
8387949|NCT01070810|20673663|P1|STARTED|Overall Study||45
8387950|NCT01070784|20673679|P2|NOT COMPLETED|Overall Study||18
8387951|NCT01070784|20673680|P1|NOT COMPLETED|Overall Study||20
8387952|NCT01070784|20673679|P2|COMPLETED|Overall Study||112
8387953|NCT01070784|20673680|P1|COMPLETED|Overall Study||110
8387954|NCT01070784|20673679|P2|STARTED|Overall Study||130
8387955|NCT01070784|20673680|P1|STARTED|Overall Study||130
8387956|NCT01070771|20673768|P1|NOT COMPLETED|Overall Study||3
8387957|NCT01070771|20673768|P1|COMPLETED|Overall Study|August 2012|200
8387958|NCT01070771|20673768|P1|STARTED|Overall Study|September 2008|203
8387959|NCT01070693|20673775|P2|NOT COMPLETED|Overall Study||39
8387960|NCT01070693|20673776|P1|NOT COMPLETED|Overall Study||28
8387961|NCT01070693|20673775|P2|COMPLETED|Overall Study||110
8387962|NCT01070693|20673776|P1|COMPLETED|Overall Study||122
8387963|NCT01070693|20673775|P2|STARTED|Overall Study||149
8387964|NCT01070693|20673776|P1|STARTED|Overall Study||150
8387965|NCT01070550|20673788|P6|NOT COMPLETED|Overall Study||7
8387966|NCT01070550|20673789|P5|NOT COMPLETED|Overall Study||1
8387967|NCT01070550|20673790|P4|NOT COMPLETED|Overall Study||77
8387968|NCT01070550|20673791|P3|NOT COMPLETED|Overall Study||216
8387969|NCT01070550|20673792|P2|NOT COMPLETED|Overall Study||62
8387970|NCT01070550|20673793|P1|NOT COMPLETED|Overall Study||1285
8387971|NCT01070550|20673788|P6|COMPLETED|Overall Study||35
8387972|NCT01070550|20673789|P5|COMPLETED|Overall Study||20
8387973|NCT01070550|20673790|P4|COMPLETED|Overall Study||124
8387974|NCT01070550|20673791|P3|COMPLETED|Overall Study||528
8387975|NCT01070550|20673792|P2|COMPLETED|Overall Study||254
8387976|NCT01070550|20673793|P1|COMPLETED|Overall Study||2071
8387977|NCT01070550|20673788|P6|STARTED|Overall Study||42
8387978|NCT01070550|20673789|P5|STARTED|Overall Study||21
8387979|NCT01070550|20673790|P4|STARTED|Overall Study||201
8387980|NCT01070550|20673791|P3|STARTED|Overall Study||744
8387981|NCT01070550|20673792|P2|STARTED|Overall Study||316
8387982|NCT01070550|20673793|P1|STARTED|Overall Study||3356
8387983|NCT01070394|20673933|P1|NOT COMPLETED|Overall Study||7
8387984|NCT01070394|20673933|P1|COMPLETED|Overall Study||33
8387985|NCT01070394|20673933|P1|STARTED|Overall Study||40
8387986|NCT01070381|20673944|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
8387987|NCT01070381|20673945|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
8387988|NCT01070381|20673944|P2|COMPLETED|Period 2, 1 Week of Wear||106
8387989|NCT01070381|20673945|P1|COMPLETED|Period 2, 1 Week of Wear||108
8387990|NCT01070381|20673944|P2|STARTED|Period 2, 1 Week of Wear||107
8387991|NCT01070381|20673945|P1|STARTED|Period 2, 1 Week of Wear||109
8387992|NCT01070381|20673944|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
8387993|NCT01070381|20673945|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
8387994|NCT01070381|20673944|P2|COMPLETED|Period 1, 1 Week of Wear||107
8387995|NCT01070381|20673945|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
8387996|NCT01070381|20673944|P2|STARTED|Period 1, 1 Week of Wear||107
8387997|NCT01070381|20673945|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
8387998|NCT01070329|20673953|P2|NOT COMPLETED|Overall Study||49
8387999|NCT01070329|20673954|P1|NOT COMPLETED|Overall Study||52
8388000|NCT01070329|20673953|P2|COMPLETED|Overall Study||217
8388001|NCT01070329|20673954|P1|COMPLETED|Overall Study||209
8388002|NCT01070329|20673953|P2|STARTED|Overall Study||266
8388003|NCT01070329|20673954|P1|STARTED|Overall Study||261
8388004|NCT01070316|20673986|P1|NOT COMPLETED|Extension Phase||4
8388005|NCT01070316|20673986|P1|COMPLETED|Extension Phase||14
8388006|NCT01070316|20673986|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
8388007|NCT01070316|20673986|P1|NOT COMPLETED|Main Phase||0
8388008|NCT01070316|20673986|P1|COMPLETED|Main Phase||20
8388009|NCT01070316|20673986|P1|STARTED|Main Phase||20
8388010|NCT01070303|20673993|P1|NOT COMPLETED|Overall Study||89
8388011|NCT01070303|20673993|P1|COMPLETED|Overall Study||88
8388012|NCT01070303|20673993|P1|STARTED|Overall Study||177
8388013|NCT01070173|20674052|P3|NOT COMPLETED|Overall Study||0
8388014|NCT01070173|20674053|P2|NOT COMPLETED|Overall Study||0
8388015|NCT01070173|20674054|P1|NOT COMPLETED|Overall Study||0
8388016|NCT01070173|20674052|P3|COMPLETED|Overall Study||11
8388017|NCT01070173|20674053|P2|COMPLETED|Overall Study||8
8388018|NCT01070173|20674054|P1|COMPLETED|Overall Study||33
8388019|NCT01070173|20674052|P3|STARTED|Overall Study||11
8388020|NCT01070173|20674053|P2|STARTED|Overall Study||8
8388021|NCT01070173|20674054|P1|STARTED|Overall Study||33
8388022|NCT01070095|20674065|P2|NOT COMPLETED|Intervention Period||0
8388023|NCT01070095|20674066|P1|NOT COMPLETED|Intervention Period||0
8388024|NCT01070095|20674065|P2|COMPLETED|Intervention Period||890
8388025|NCT01070095|20674066|P1|COMPLETED|Intervention Period||18
8388026|NCT01070095|20674065|P2|STARTED|Intervention Period||890
8388027|NCT01070095|20674066|P1|STARTED|Intervention Period||18
8388028|NCT01070095|20674065|P2|NOT COMPLETED|Baseline Period||0
8388029|NCT01070095|20674066|P1|NOT COMPLETED|Baseline Period||1
8388030|NCT01070095|20674065|P2|COMPLETED|Baseline Period||830
8388031|NCT01070095|20674066|P1|COMPLETED|Baseline Period||18
8388032|NCT01070095|20674065|P2|STARTED|Baseline Period||830
8388033|NCT01070095|20674066|P1|STARTED|Baseline Period||19
8388034|NCT01070043|20674088|P3|NOT COMPLETED|Double-Blind Treatment||2
8388035|NCT01070043|20674089|P2|NOT COMPLETED|Double-Blind Treatment||0
8388036|NCT01070043|20674090|P1|NOT COMPLETED|Double-Blind Treatment||0
8388037|NCT01070043|20674088|P3|COMPLETED|Double-Blind Treatment||19
8388038|NCT01070043|20674089|P2|COMPLETED|Double-Blind Treatment||21
8388039|NCT01070043|20674090|P1|COMPLETED|Double-Blind Treatment||0
8388040|NCT01070043|20674088|P3|STARTED|Double-Blind Treatment||21
8388041|NCT01070043|20674089|P2|STARTED|Double-Blind Treatment||21
8388042|NCT01070043|20674090|P1|STARTED|Double-Blind Treatment||0
8388043|NCT01070043|20674088|P3|NOT COMPLETED|Run-In Phase||0
8388044|NCT01070043|20674089|P2|NOT COMPLETED|Run-In Phase||0
8388045|NCT01070043|20674090|P1|NOT COMPLETED|Run-In Phase||18
8388046|NCT01070043|20674088|P3|COMPLETED|Run-In Phase||0
8388047|NCT01070043|20674089|P2|COMPLETED|Run-In Phase||0
8388048|NCT01070043|20674090|P1|COMPLETED|Run-In Phase||42
8388049|NCT01070043|20674088|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
8388050|NCT01070043|20674089|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
8388051|NCT01070043|20674090|P1|STARTED|Run-In Phase||60
8388052|NCT01069939|20674106|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
8388053|NCT01069939|20674107|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
8388054|NCT01069939|20674106|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
8388055|NCT01069939|20674107|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
8388056|NCT01069939|20674106|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
8388057|NCT01069939|20674107|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
8388058|NCT01069939|20674106|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
8388059|NCT01069939|20674107|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
8388060|NCT01069939|20674106|P2|COMPLETED|Randomised and Included in the Analyses||137
8388061|NCT01069939|20674107|P1|COMPLETED|Randomised and Included in the Analyses||164
8388062|NCT01069939|20674106|P2|STARTED|Randomised and Included in the Analyses||214
8388063|NCT01069939|20674107|P1|STARTED|Randomised and Included in the Analyses||213
8388064|NCT01069900|20674133|P2|NOT COMPLETED|Overall Study||4
8388065|NCT01069900|20674134|P1|NOT COMPLETED|Overall Study||18
8388066|NCT01069900|20674133|P2|COMPLETED|Overall Study||149
8388067|NCT01069900|20674134|P1|COMPLETED|Overall Study||287
8388068|NCT01069900|20674133|P2|Treated|Overall Study||150
8388069|NCT01069900|20674134|P1|Treated|Overall Study||301
8388070|NCT01069900|20674133|P2|STARTED|Overall Study||153
8388071|NCT01069900|20674134|P1|STARTED|Overall Study||305
8388075|NCT01069627|20674191|P1|NOT COMPLETED|Overall Study||20
8388076|NCT01069627|20674191|P1|COMPLETED|Overall Study||0
8388077|NCT01069627|20674191|P1|STARTED|Overall Study||20
8388078|NCT01069562|20674214|P2|NOT COMPLETED|Overall Study||0
8388079|NCT01069562|20674215|P1|NOT COMPLETED|Overall Study||0
8388080|NCT01069562|20674214|P2|COMPLETED|Overall Study||20
8388081|NCT01069562|20674215|P1|COMPLETED|Overall Study||20
8388082|NCT01069562|20674214|P2|STARTED|Overall Study||20
8388083|NCT01069562|20674215|P1|STARTED|Overall Study||20
8388084|NCT01069523|20674241|P2|NOT COMPLETED|Overall Study||7
8388085|NCT01069523|20674242|P1|NOT COMPLETED|Overall Study||4
8388086|NCT01069523|20674241|P2|COMPLETED|Overall Study||9
8388087|NCT01069523|20674242|P1|COMPLETED|Overall Study||9
8388088|NCT01069523|20674241|P2|STARTED|Overall Study||16
8388089|NCT01069523|20674242|P1|STARTED|Overall Study||13
8388090|NCT01069510|20674252|P2|NOT COMPLETED|Overall Study||0
8388091|NCT01069510|20674253|P1|NOT COMPLETED|Overall Study||0
8388092|NCT01069510|20674252|P2|COMPLETED|Overall Study||7
8388093|NCT01069510|20674253|P1|COMPLETED|Overall Study||8
8388094|NCT01069510|20674252|P2|STARTED|Overall Study||7
8388095|NCT01069510|20674253|P1|STARTED|Overall Study||8
8388096|NCT01069484|20674265|P2|NOT COMPLETED|Overall Study||3
8388097|NCT01069484|20674266|P1|NOT COMPLETED|Overall Study||12
8388098|NCT01069484|20674265|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
8388099|NCT01069484|20674266|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
8388100|NCT01069484|20674265|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
8388101|NCT01069484|20674266|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
8388102|NCT01069419|20674274|P1|NOT COMPLETED|Overall Study||715
8388103|NCT01069419|20674274|P1|COMPLETED|Overall Study||402
8388104|NCT01069419|20674274|P1|Full Analysis Set|Overall Study||851
8388105|NCT01069419|20674274|P1|Safety Set|Overall Study||1111
8388106|NCT01069419|20674274|P1|STARTED|Overall Study||1117
8388107|NCT01069354|20674281|P1|NOT COMPLETED|Overall Study||1
8388108|NCT01069354|20674281|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
8388109|NCT01069354|20674281|P1|STARTED|Overall Study||102
8388110|NCT01069341|20674303|P1|NOT COMPLETED|Overall Study||1
8388111|NCT01069341|20674303|P1|COMPLETED|Overall Study||3
8388112|NCT01069341|20674303|P1|STARTED|Overall Study||4
8388113|NCT01069315|20674318|P4|NOT COMPLETED|Overall Study||7
8388114|NCT01069315|20674319|P3|NOT COMPLETED|Overall Study||5
8388115|NCT01069315|20674320|P2|NOT COMPLETED|Overall Study||6
8388116|NCT01069315|20674321|P1|NOT COMPLETED|Overall Study||4
8388117|NCT01069315|20674318|P4|COMPLETED|Overall Study||19
8388118|NCT01069315|20674319|P3|COMPLETED|Overall Study||23
8388119|NCT01069315|20674320|P2|COMPLETED|Overall Study||24
8388120|NCT01069315|20674321|P1|COMPLETED|Overall Study||23
8388121|NCT01069315|20674318|P4|STARTED|Overall Study||26
8388122|NCT01069315|20674319|P3|STARTED|Overall Study||28
8388123|NCT01069315|20674320|P2|STARTED|Overall Study||30
8388124|NCT01069315|20674321|P1|STARTED|Overall Study||27
8388125|NCT01069289|20674345|P2|NOT COMPLETED|Overall Study||56
8388126|NCT01069289|20674346|P1|NOT COMPLETED|Overall Study||42
8388127|NCT01069289|20674345|P2|COMPLETED|Overall Study||601
8388128|NCT01069289|20674346|P1|COMPLETED|Overall Study||594
8388129|NCT01069289|20674345|P2|STARTED|Overall Study||657
8388130|NCT01069289|20674346|P1|STARTED|Overall Study||636
8388131|NCT01069185|20674386|P2|NOT COMPLETED|Overall Study||0
8388132|NCT01069185|20674387|P1|NOT COMPLETED|Overall Study||0
8388133|NCT01069185|20674386|P2|COMPLETED|Overall Study||45
8388134|NCT01069185|20674387|P1|COMPLETED|Overall Study||47
8388135|NCT01069185|20674386|P2|STARTED|Overall Study||45
8388136|NCT01069185|20674387|P1|STARTED|Overall Study||47
8388137|NCT01069172|20674395|P2|NOT COMPLETED|Overall Study||0
8388138|NCT01069172|20674396|P1|NOT COMPLETED|Overall Study||1
8388139|NCT01069172|20674395|P2|COMPLETED|Overall Study|30 eyes|30
8388140|NCT01069172|20674396|P1|COMPLETED|Overall Study|29 eyes|29
8388141|NCT01069172|20674395|P2|STARTED|Overall Study|30 eyes|30
8388142|NCT01069172|20674396|P1|STARTED|Overall Study|30 eyes|30
8388143|NCT01069120|20674406|P1|NOT COMPLETED|Overall Study||27
8388144|NCT01069120|20674406|P1|COMPLETED|Overall Study||0
8388145|NCT01069120|20674406|P1|STARTED|Overall Study||27
8388146|NCT01069003|20674415|P3|NOT COMPLETED|Overall Study||475
8388147|NCT01069003|20674416|P2|NOT COMPLETED|Overall Study||54
8388148|NCT01069003|20674417|P1|NOT COMPLETED|Overall Study||46
8388149|NCT01069003|20674415|P3|COMPLETED|Overall Study||976
8388150|NCT01069003|20674416|P2|COMPLETED|Overall Study||358
8388151|NCT01069003|20674417|P1|COMPLETED|Overall Study||353
8388152|NCT01069003|20674415|P3|STARTED|Overall Study||1451
8388153|NCT01069003|20674416|P2|STARTED|Overall Study||412
8388154|NCT01069003|20674417|P1|STARTED|Overall Study||399
8388155|NCT01068964|20674433|P2|NOT COMPLETED|Overall Study||10
8388156|NCT01068964|20674434|P1|NOT COMPLETED|Overall Study||8
8388157|NCT01068964|20674433|P2|COMPLETED|Overall Study||104
8388158|NCT01068964|20674434|P1|COMPLETED|Overall Study||113
8388159|NCT01068964|20674433|P2|STARTED|Overall Study||114
8388160|NCT01068964|20674434|P1|STARTED|Overall Study||121
8388161|NCT01068912|20674443|P3|NOT COMPLETED|Overall Study||15
8388162|NCT01068912|20674444|P2|NOT COMPLETED|Overall Study||22
8388163|NCT01068912|20674445|P1|NOT COMPLETED|Overall Study||11
8388164|NCT01068912|20674443|P3|COMPLETED|Overall Study||186
8388165|NCT01068912|20674444|P2|COMPLETED|Overall Study||173
8388166|NCT01068912|20674445|P1|COMPLETED|Overall Study||123
8388167|NCT01068912|20674443|P3|STARTED|Overall Study||201
8388168|NCT01068912|20674444|P2|STARTED|Overall Study||195
8388169|NCT01068912|20674445|P1|STARTED|Overall Study||134
8388170|NCT01068873|20674453|P1|NOT COMPLETED|Overall Study||0
8388171|NCT01068873|20674453|P1|COMPLETED|Overall Study||1
8388172|NCT01068873|20674453|P1|STARTED|Overall Study||1
8388173|NCT01068860|20674473|P10|NOT COMPLETED|Overall Study||4
8388174|NCT01068860|20674474|P9|NOT COMPLETED|Overall Study||0
8388175|NCT01068860|20674475|P8|NOT COMPLETED|Overall Study||0
8388176|NCT01068860|20674476|P7|NOT COMPLETED|Overall Study||0
8388177|NCT01068860|20674477|P6|NOT COMPLETED|Overall Study||2
8388178|NCT01068860|20674478|P5|NOT COMPLETED|Overall Study||0
8388179|NCT01068860|20674479|P4|NOT COMPLETED|Overall Study||1
8388180|NCT01068860|20674480|P3|NOT COMPLETED|Overall Study||0
8388181|NCT01068860|20674481|P2|NOT COMPLETED|Overall Study||1
8388182|NCT01068860|20674482|P1|NOT COMPLETED|Overall Study||0
8388183|NCT01068860|20674473|P10|COMPLETED|Overall Study||23
8388184|NCT01068860|20674474|P9|COMPLETED|Overall Study||28
8388185|NCT01068860|20674475|P8|COMPLETED|Overall Study||15
8388186|NCT01068860|20674476|P7|COMPLETED|Overall Study||28
8388187|NCT01068860|20674477|P6|COMPLETED|Overall Study||14
8388188|NCT01068860|20674478|P5|COMPLETED|Overall Study||32
8388189|NCT01068860|20674479|P4|COMPLETED|Overall Study||16
8388190|NCT01068860|20674480|P3|COMPLETED|Overall Study||33
8388191|NCT01068860|20674481|P2|COMPLETED|Overall Study||16
8388192|NCT01068860|20674482|P1|COMPLETED|Overall Study||33
8388193|NCT01068860|20674473|P10|STARTED|Overall Study||27
8388194|NCT01068860|20674474|P9|STARTED|Overall Study||28
8388195|NCT01068860|20674475|P8|STARTED|Overall Study||15
8388196|NCT01068860|20674476|P7|STARTED|Overall Study||28
8388197|NCT01068860|20674477|P6|STARTED|Overall Study||16
8388198|NCT01068860|20674478|P5|STARTED|Overall Study||32
8388199|NCT01068860|20674479|P4|STARTED|Overall Study||17
8388200|NCT01068860|20674480|P3|STARTED|Overall Study||33
8388201|NCT01068860|20674481|P2|STARTED|Overall Study||17
8388202|NCT01068860|20674482|P1|STARTED|Overall Study||33
8388203|NCT01068821|20674656|P2|NOT COMPLETED|Overall Study||0
8388204|NCT01068821|20674657|P1|NOT COMPLETED|Overall Study||1
8388205|NCT01068821|20674656|P2|COMPLETED|Overall Study||29
8388206|NCT01068821|20674657|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
8388207|NCT01068821|20674656|P2|STARTED|Overall Study||29
8388208|NCT01068821|20674657|P1|STARTED|Overall Study||31
8388209|NCT01068769|20674665|P1|NOT COMPLETED|Overall Study||1
8388210|NCT01068769|20674665|P1|COMPLETED|Overall Study||33
8388211|NCT01068769|20674665|P1|STARTED|Overall Study||34
8388212|NCT01068743|20674670|P4|NOT COMPLETED|Period 4||0
8388213|NCT01068743|20674671|P3|NOT COMPLETED|Period 4||0
8388214|NCT01068743|20674672|P2|NOT COMPLETED|Period 4||0
8388215|NCT01068743|20674673|P1|NOT COMPLETED|Period 4||0
8388216|NCT01068743|20674670|P4|COMPLETED|Period 4||6
8388217|NCT01068743|20674671|P3|COMPLETED|Period 4||6
8388218|NCT01068743|20674672|P2|COMPLETED|Period 4||5
8388219|NCT01068743|20674673|P1|COMPLETED|Period 4||6
8388220|NCT01068743|20674670|P4|STARTED|Period 4||6
8388221|NCT01068743|20674671|P3|STARTED|Period 4||6
8388222|NCT01068743|20674672|P2|STARTED|Period 4||5
8388223|NCT01068743|20674673|P1|STARTED|Period 4||6
8388224|NCT01068743|20674670|P4|NOT COMPLETED|Period 3||0
8388225|NCT01068743|20674671|P3|NOT COMPLETED|Period 3||0
8388226|NCT01068743|20674672|P2|NOT COMPLETED|Period 3||1
8388227|NCT01068743|20674673|P1|NOT COMPLETED|Period 3||0
8388228|NCT01068743|20674670|P4|COMPLETED|Period 3||6
8388229|NCT01068743|20674671|P3|COMPLETED|Period 3||6
8388230|NCT01068743|20674672|P2|COMPLETED|Period 3||5
8388231|NCT01068743|20674673|P1|COMPLETED|Period 3||6
8388232|NCT01068743|20674670|P4|STARTED|Period 3||6
8388233|NCT01068743|20674671|P3|STARTED|Period 3||6
8388234|NCT01068743|20674672|P2|STARTED|Period 3||6
8388235|NCT01068743|20674673|P1|STARTED|Period 3||6
8388236|NCT01068743|20674670|P4|NOT COMPLETED|Period 2||0
8388237|NCT01068743|20674671|P3|NOT COMPLETED|Period 2||0
8388238|NCT01068743|20674672|P2|NOT COMPLETED|Period 2||0
8388239|NCT01068743|20674673|P1|NOT COMPLETED|Period 2||0
8388240|NCT01068743|20674670|P4|COMPLETED|Period 2||6
8388241|NCT01068743|20674671|P3|COMPLETED|Period 2||6
8388242|NCT01068743|20674672|P2|COMPLETED|Period 2||6
8388243|NCT01068743|20674673|P1|COMPLETED|Period 2||6
8388244|NCT01068743|20674670|P4|STARTED|Period 2||6
8388245|NCT01068743|20674671|P3|STARTED|Period 2||6
8388246|NCT01068743|20674672|P2|STARTED|Period 2||6
8388247|NCT01068743|20674673|P1|STARTED|Period 2||6
8388248|NCT01068743|20674670|P4|NOT COMPLETED|Period 1||0
8388249|NCT01068743|20674671|P3|NOT COMPLETED|Period 1||0
8388250|NCT01068743|20674672|P2|NOT COMPLETED|Period 1||0
8388251|NCT01068743|20674673|P1|NOT COMPLETED|Period 1||0
8388252|NCT01068743|20674670|P4|COMPLETED|Period 1||6
8388253|NCT01068743|20674671|P3|COMPLETED|Period 1||6
8388254|NCT01068743|20674672|P2|COMPLETED|Period 1||6
8388255|NCT01068743|20674673|P1|COMPLETED|Period 1||6
8388256|NCT01068743|20674670|P4|STARTED|Period 1||6
8388257|NCT01068743|20674671|P3|STARTED|Period 1||6
8388258|NCT01068743|20674672|P2|STARTED|Period 1||6
8388259|NCT01068743|20674673|P1|STARTED|Period 1||6
8388260|NCT01068730|20674747|P4|NOT COMPLETED|Period 4||0
8388261|NCT01068730|20674748|P3|NOT COMPLETED|Period 4||0
8388262|NCT01068730|20674749|P2|NOT COMPLETED|Period 4||1
8388263|NCT01068730|20674750|P1|NOT COMPLETED|Period 4||0
8388264|NCT01068730|20674747|P4|COMPLETED|Period 4||7
8388265|NCT01068730|20674748|P3|COMPLETED|Period 4||7
8388266|NCT01068730|20674749|P2|COMPLETED|Period 4||6
8388267|NCT01068730|20674750|P1|COMPLETED|Period 4||6
8388268|NCT01068730|20674747|P4|STARTED|Period 4||7
8388269|NCT01068730|20674748|P3|STARTED|Period 4||7
8388270|NCT01068730|20674749|P2|STARTED|Period 4||7
8388271|NCT01068730|20674750|P1|STARTED|Period 4||6
8388272|NCT01068730|20674747|P4|NOT COMPLETED|Period 3||0
8388273|NCT01068730|20674748|P3|NOT COMPLETED|Period 3||0
8388274|NCT01068730|20674749|P2|NOT COMPLETED|Period 3||0
8388275|NCT01068730|20674750|P1|NOT COMPLETED|Period 3||1
8388276|NCT01068730|20674747|P4|COMPLETED|Period 3||7
8388277|NCT01068730|20674748|P3|COMPLETED|Period 3||7
8388278|NCT01068730|20674749|P2|COMPLETED|Period 3||7
8388279|NCT01068730|20674750|P1|COMPLETED|Period 3||6
8388280|NCT01068730|20674747|P4|STARTED|Period 3||7
8388281|NCT01068730|20674748|P3|STARTED|Period 3||7
8388282|NCT01068730|20674749|P2|STARTED|Period 3||7
8388283|NCT01068730|20674750|P1|STARTED|Period 3||7
8388284|NCT01068730|20674747|P4|NOT COMPLETED|Period 2||0
8388285|NCT01068730|20674748|P3|NOT COMPLETED|Period 2||0
8388286|NCT01068730|20674749|P2|NOT COMPLETED|Period 2||0
8388287|NCT01068730|20674750|P1|NOT COMPLETED|Period 2||0
8388288|NCT01068730|20674747|P4|COMPLETED|Period 2||7
8388289|NCT01068730|20674748|P3|COMPLETED|Period 2||7
8388290|NCT01068730|20674749|P2|COMPLETED|Period 2||7
8388291|NCT01068730|20674750|P1|COMPLETED|Period 2||7
8388292|NCT01068730|20674747|P4|STARTED|Period 2||7
8388293|NCT01068730|20674748|P3|STARTED|Period 2||7
8388294|NCT01068730|20674749|P2|STARTED|Period 2||7
8388295|NCT01068730|20674750|P1|STARTED|Period 2||7
8388296|NCT01068730|20674747|P4|NOT COMPLETED|Period 1||0
8388297|NCT01068730|20674748|P3|NOT COMPLETED|Period 1||0
8388298|NCT01068730|20674749|P2|NOT COMPLETED|Period 1||0
8388299|NCT01068730|20674750|P1|NOT COMPLETED|Period 1||0
8388300|NCT01068730|20674747|P4|COMPLETED|Period 1||7
8388301|NCT01068730|20674748|P3|COMPLETED|Period 1||7
8388302|NCT01068730|20674749|P2|COMPLETED|Period 1||7
8388303|NCT01068730|20674750|P1|COMPLETED|Period 1||7
8388304|NCT01068730|20674747|P4|STARTED|Period 1||7
8388305|NCT01068730|20674748|P3|STARTED|Period 1||7
8388306|NCT01068730|20674749|P2|STARTED|Period 1||7
8388307|NCT01068730|20674750|P1|STARTED|Period 1||7
8388308|NCT01068717|20674804|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388309|NCT01068717|20674805|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388310|NCT01068717|20674806|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388311|NCT01068717|20674807|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388312|NCT01068717|20674804|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8388313|NCT01068717|20674805|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8388314|NCT01068717|20674806|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
8388315|NCT01068717|20674807|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8388316|NCT01068717|20674804|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
8388317|NCT01068717|20674805|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
8388318|NCT01068717|20674806|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
8388319|NCT01068717|20674807|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
8388320|NCT01068717|20674804|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388321|NCT01068717|20674805|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388322|NCT01068717|20674806|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388323|NCT01068717|20674807|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388324|NCT01068717|20674804|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8388325|NCT01068717|20674805|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8388326|NCT01068717|20674806|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
8388327|NCT01068717|20674807|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8388328|NCT01068717|20674804|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
8388329|NCT01068717|20674805|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
8388330|NCT01068717|20674806|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
8388331|NCT01068717|20674807|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
8388332|NCT01068717|20674804|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388333|NCT01068717|20674805|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388334|NCT01068717|20674806|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388335|NCT01068717|20674807|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388336|NCT01068717|20674804|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
8388337|NCT01068717|20674805|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
8388338|NCT01068717|20674806|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
8388339|NCT01068717|20674807|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
8388340|NCT01068717|20674804|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
8388341|NCT01068717|20674805|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
8388342|NCT01068717|20674806|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
8388343|NCT01068717|20674807|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
8388344|NCT01068717|20674804|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8388345|NCT01068717|20674805|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8388346|NCT01068717|20674806|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8388347|NCT01068717|20674807|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
8388348|NCT01068717|20674804|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
8388349|NCT01068717|20674805|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
8388350|NCT01068717|20674806|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
8388351|NCT01068717|20674807|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
8388352|NCT01068717|20674804|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
8388353|NCT01068717|20674805|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
8388354|NCT01068717|20674806|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
8388355|NCT01068717|20674807|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
8388356|NCT01068678|20674863|P2|NOT COMPLETED|Overall Study||24
8388357|NCT01068678|20674864|P1|NOT COMPLETED|Overall Study||38
8388358|NCT01068678|20674863|P2|COMPLETED|Overall Study||206
8388359|NCT01068678|20674864|P1|COMPLETED|Overall Study||192
8388360|NCT01068678|20674863|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
8388361|NCT01068678|20674864|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
8388362|NCT01068678|20674863|P2|STARTED|Overall Study||230
8388363|NCT01068678|20674864|P1|STARTED|Overall Study||230
8388364|NCT01068665|20674874|P2|NOT COMPLETED|Overall Study||29
8388365|NCT01068665|20674875|P1|NOT COMPLETED|Overall Study||30
8388366|NCT01068665|20674874|P2|COMPLETED|Overall Study||201
8388367|NCT01068665|20674875|P1|COMPLETED|Overall Study||200
8388368|NCT01068665|20674874|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
8388369|NCT01068665|20674875|P1|Exposed|Overall Study||228
8388370|NCT01068665|20674874|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
8388371|NCT01068665|20674875|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
8388372|NCT01068665|20674874|P2|STARTED|Overall Study||230
8388373|NCT01068665|20674875|P1|STARTED|Overall Study||230
8388374|NCT01068652|20674885|P2|NOT COMPLETED|Overall Study||15
8388375|NCT01068652|20674886|P1|NOT COMPLETED|Overall Study||18
8388376|NCT01068652|20674885|P2|COMPLETED|Overall Study||188
8388377|NCT01068652|20674886|P1|COMPLETED|Overall Study||182
8388378|NCT01068652|20674885|P2|STARTED|Overall Study||203
8388379|NCT01068652|20674886|P1|STARTED|Overall Study||200
8388380|NCT01068626|20674926|P2|NOT COMPLETED|Overall Study||2
8388381|NCT01068626|20674927|P1|NOT COMPLETED|Overall Study||3
8388382|NCT01068626|20674926|P2|COMPLETED|Overall Study||27
8388383|NCT01068626|20674927|P1|COMPLETED|Overall Study||27
8388384|NCT01068626|20674926|P2|STARTED|Overall Study||29
8388385|NCT01068626|20674927|P1|STARTED|Overall Study||30
8388386|NCT01068600|20674945|P2|NOT COMPLETED|Overall Study||17
8388387|NCT01068600|20674946|P1|NOT COMPLETED|Overall Study||11
8388388|NCT01068600|20674945|P2|COMPLETED|Overall Study||142
8388389|NCT01068600|20674946|P1|COMPLETED|Overall Study||148
8388390|NCT01068600|20674945|P2|STARTED|Overall Study||159
8388391|NCT01068600|20674946|P1|STARTED|Overall Study||159
8388392|NCT01068548|20674956|P2|NOT COMPLETED|Overall Study||0
8388393|NCT01068548|20674957|P1|NOT COMPLETED|Overall Study||0
8388394|NCT01068548|20674956|P2|COMPLETED|Overall Study||63
8388395|NCT01068548|20674957|P1|COMPLETED|Overall Study||66
8388396|NCT01068548|20674956|P2|STARTED|Overall Study||63
8388397|NCT01068548|20674957|P1|STARTED|Overall Study||66
8388398|NCT01068509|20674968|P3|NOT COMPLETED|Overall Study||21
8388399|NCT01068509|20674969|P2|NOT COMPLETED|Overall Study||22
8388400|NCT01068509|20674970|P1|NOT COMPLETED|Overall Study||6
8388401|NCT01068509|20674968|P3|COMPLETED|Overall Study||6
8388402|NCT01068509|20674969|P2|COMPLETED|Overall Study||7
8388403|NCT01068509|20674970|P1|COMPLETED|Overall Study||1
8388404|NCT01068509|20674968|P3|STARTED|Overall Study||27
8388405|NCT01068509|20674969|P2|STARTED|Overall Study||29
8388406|NCT01068509|20674970|P1|STARTED|Overall Study||7
8388407|NCT01068418|20674983|P1|NOT COMPLETED|Overall Study||12
8388408|NCT01068418|20674983|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
8388409|NCT01068418|20674983|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
8388410|NCT01068418|20674983|P1|STARTED|Overall Study|26 participants found to be eligible|26
8388411|NCT01068262|20674992|P4|NOT COMPLETED|Overall Study||0
8388412|NCT01068262|20674993|P3|NOT COMPLETED|Overall Study||1
8388413|NCT01068262|20674994|P2|NOT COMPLETED|Overall Study||1
8388414|NCT01068262|20674995|P1|NOT COMPLETED|Overall Study||3
8388415|NCT01068262|20674992|P4|COMPLETED|Overall Study||2
8388416|NCT01068262|20674993|P3|COMPLETED|Overall Study||9
8388417|NCT01068262|20674994|P2|COMPLETED|Overall Study||8
8388418|NCT01068262|20674995|P1|COMPLETED|Overall Study||20
8388419|NCT01068262|20674992|P4|STARTED|Overall Study||2
8388420|NCT01068262|20674993|P3|STARTED|Overall Study||10
8388421|NCT01068262|20674994|P2|STARTED|Overall Study||9
8388422|NCT01068262|20674995|P1|STARTED|Overall Study||23
8388423|NCT01068158|20675025|P2|NOT COMPLETED|Overall Study||4
8388424|NCT01068158|20675026|P1|NOT COMPLETED|Overall Study||8
8388425|NCT01068158|20675025|P2|COMPLETED|Overall Study||198
8388426|NCT01068158|20675026|P1|COMPLETED|Overall Study||161
8388427|NCT01068158|20675025|P2|STARTED|Overall Study||202
8388428|NCT01068158|20675026|P1|STARTED|Overall Study||169
8388429|NCT01067976|20675038|P1|NOT COMPLETED|Overall Study||22
8388430|NCT01067976|20675038|P1|COMPLETED|Overall Study|study course completed|424
8388431|NCT01067976|20675038|P1|Fulfilled Requirements of FAS Population|Overall Study||390
8388432|NCT01067976|20675038|P1|Received Treatment|Overall Study|treatment started|426
8388433|NCT01067976|20675038|P1|STARTED|Overall Study|screened and enrolled|446
8388434|NCT01067846|20675099|P2|NOT COMPLETED|Overall Study||19
8388435|NCT01067846|20675100|P1|NOT COMPLETED|Overall Study||19
8388436|NCT01067846|20675099|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
8388437|NCT01067846|20675100|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
8388438|NCT01067846|20675099|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
8388439|NCT01067846|20675100|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
8388440|NCT01067846|20675099|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
8388441|NCT01067846|20675100|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
8388442|NCT01067781|20675112|P4|NOT COMPLETED|180 to Day 720||89
8388443|NCT01067781|20675113|P3|NOT COMPLETED|180 to Day 720||89
8388444|NCT01067781|20675114|P2|NOT COMPLETED|180 to Day 720||164
8388445|NCT01067781|20675115|P1|NOT COMPLETED|180 to Day 720||170
8388446|NCT01067781|20675112|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
8388447|NCT01067781|20675113|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
8388448|NCT01067781|20675114|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
8388449|NCT01067781|20675115|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
8388450|NCT01067781|20675112|P4|STARTED|180 to Day 720||89
8388451|NCT01067781|20675113|P3|STARTED|180 to Day 720||89
8388452|NCT01067781|20675114|P2|STARTED|180 to Day 720||168
8388453|NCT01067781|20675115|P1|STARTED|180 to Day 720||173
8388454|NCT01067781|20675112|P4|NOT COMPLETED|Up to Day 180||12
8388455|NCT01067781|20675113|P3|NOT COMPLETED|Up to Day 180||8
8388456|NCT01067781|20675114|P2|NOT COMPLETED|Up to Day 180||31
8388457|NCT01067781|20675115|P1|NOT COMPLETED|Up to Day 180||30
8388458|NCT01067781|20675112|P4|COMPLETED|Up to Day 180||89
8388459|NCT01067781|20675113|P3|COMPLETED|Up to Day 180||89
8388460|NCT01067781|20675114|P2|COMPLETED|Up to Day 180||168
8388461|NCT01067781|20675115|P1|COMPLETED|Up to Day 180||173
8388462|NCT01067781|20675112|P4|STARTED|Up to Day 180||101
8388463|NCT01067781|20675113|P3|STARTED|Up to Day 180||97
8388464|NCT01067781|20675114|P2|STARTED|Up to Day 180||199
8388465|NCT01067781|20675115|P1|STARTED|Up to Day 180||203
8388466|NCT01067768|20675137|P2|NOT COMPLETED|Overall Study||0
8388467|NCT01067768|20675138|P1|NOT COMPLETED|Overall Study||0
8388468|NCT01067768|20675137|P2|COMPLETED|Overall Study||605
8388469|NCT01067768|20675138|P1|COMPLETED|Overall Study||604
8388470|NCT01067768|20675137|P2|STARTED|Overall Study||605
8388471|NCT01067768|20675138|P1|STARTED|Overall Study||604
8388472|NCT01067716|20675149|P3|NOT COMPLETED|Overall Study||0
8388473|NCT01067716|20675150|P2|NOT COMPLETED|Overall Study||0
8388474|NCT01067716|20675151|P1|NOT COMPLETED|Overall Study||0
8388475|NCT01067716|20675149|P3|COMPLETED|Overall Study|15 eyes|9
8388476|NCT01067716|20675150|P2|COMPLETED|Overall Study|25 eyes|13
8388477|NCT01067716|20675151|P1|COMPLETED|Overall Study|110 eyes|57
8388478|NCT01067716|20675149|P3|STARTED|Overall Study|15 eyes|9
8388479|NCT01067716|20675150|P2|STARTED|Overall Study|25 eyes|13
8388480|NCT01067716|20675151|P1|STARTED|Overall Study|110 eyes|57
8388481|NCT01067521|20675170|P2|NOT COMPLETED|Open-Label Period||158
8388482|NCT01067521|20675171|P1|NOT COMPLETED|Open-Label Period||254
8388483|NCT01067521|20675170|P2|COMPLETED|Open-Label Period||261
8388484|NCT01067521|20675171|P1|COMPLETED|Open-Label Period||580
8388485|NCT01067521|20675170|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
8388486|NCT01067521|20675171|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
8388487|NCT01067521|20675170|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
8388488|NCT01067521|20675171|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
8388489|NCT01067521|20675170|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
8388490|NCT01067521|20675171|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
8388491|NCT01067521|20675170|P2|STARTED|Double-Blind Placebo-Controlled Period||461
8388492|NCT01067521|20675171|P1|STARTED|Double-Blind Placebo-Controlled Period||943
8388493|NCT01067508|20675197|P2|NOT COMPLETED|Overall Study||2
8388494|NCT01067508|20675198|P1|NOT COMPLETED|Overall Study||0
8388495|NCT01067508|20675197|P2|COMPLETED|Overall Study||7
8388496|NCT01067508|20675198|P1|COMPLETED|Overall Study||10
8388497|NCT01067508|20675197|P2|STARTED|Overall Study||9
8388498|NCT01067508|20675198|P1|STARTED|Overall Study||10
8388499|NCT01067469|20675206|P2|NOT COMPLETED|Overall Study||2
8388500|NCT01067469|20675207|P1|NOT COMPLETED|Overall Study||0
8388501|NCT01067469|20675206|P2|COMPLETED|Overall Study||33
8388502|NCT01067469|20675207|P1|COMPLETED|Overall Study||36
8388503|NCT01067469|20675206|P2|75 mg/m^2|Overall Study||21
8388504|NCT01067469|20675207|P1|75 mg/m^2|Overall Study||0
8388505|NCT01067469|20675206|P2|90 mg/m^2|Overall Study||12
8388506|NCT01067469|20675207|P1|90 mg/m^2|Overall Study||0
8388507|NCT01067469|20675206|P2|STARTED|Overall Study||35
8388508|NCT01067469|20675207|P1|STARTED|Overall Study||36
8388509|NCT01067456|20675225|P2|NOT COMPLETED|Overall Study||0
8388510|NCT01067456|20675226|P1|NOT COMPLETED|Overall Study||0
8388511|NCT01067456|20675225|P2|COMPLETED|Overall Study||29
8388512|NCT01067456|20675226|P1|COMPLETED|Overall Study||30
8388513|NCT01067456|20675225|P2|STARTED|Overall Study||29
8388514|NCT01067456|20675226|P1|STARTED|Overall Study||30
8388515|NCT01067352|20675239|P3|NOT COMPLETED|Overall Study||1
8388516|NCT01067352|20675240|P2|NOT COMPLETED|Overall Study||3
8388517|NCT01067352|20675241|P1|NOT COMPLETED|Overall Study||1
8388518|NCT01067352|20675239|P3|COMPLETED|Overall Study||9
8388519|NCT01067352|20675240|P2|COMPLETED|Overall Study||3
8388520|NCT01067352|20675241|P1|COMPLETED|Overall Study||8
8388521|NCT01067352|20675239|P3|STARTED|Overall Study||10
8388522|NCT01067352|20675240|P2|STARTED|Overall Study||6
8388523|NCT01067352|20675241|P1|STARTED|Overall Study||9
8388524|NCT01067339|20675257|P2|NOT COMPLETED|Overall Study||5
8388525|NCT01067339|20675258|P1|NOT COMPLETED|Overall Study||6
8388526|NCT01067339|20675257|P2|COMPLETED|Overall Study||29
8388527|NCT01067339|20675258|P1|COMPLETED|Overall Study||25
8388528|NCT01067339|20675257|P2|STARTED|Overall Study||34
8388529|NCT01067339|20675258|P1|STARTED|Overall Study||31
8388530|NCT01067326|20675268|P2|NOT COMPLETED|Overall Study||3
8388531|NCT01067326|20675269|P1|NOT COMPLETED|Overall Study||2
8388532|NCT01067326|20675268|P2|COMPLETED|Overall Study||5
8388533|NCT01067326|20675269|P1|COMPLETED|Overall Study||12
8388534|NCT01067326|20675268|P2|STARTED|Overall Study||8
8388535|NCT01067326|20675269|P1|STARTED|Overall Study||14
8388536|NCT01067144|20675283|P2|NOT COMPLETED|Follow-up||56
8388537|NCT01067144|20675284|P1|NOT COMPLETED|Follow-up||59
8388538|NCT01067144|20675283|P2|COMPLETED|Follow-up||152
8388539|NCT01067144|20675284|P1|COMPLETED|Follow-up||144
8388540|NCT01067144|20675283|P2|Intention-to-Treat Analysis Set|Follow-up||208
8388541|NCT01067144|20675284|P1|Intention-to-Treat Analysis Set|Follow-up||202
8388542|NCT01067144|20675283|P2|STARTED|Follow-up||208
8388543|NCT01067144|20675284|P1|STARTED|Follow-up||203
8388544|NCT01067144|20675283|P2|NOT COMPLETED|Treatment||7
8388545|NCT01067144|20675284|P1|NOT COMPLETED|Treatment||4
8388546|NCT01067144|20675283|P2|COMPLETED|Treatment||208
8388547|NCT01067144|20675284|P1|COMPLETED|Treatment||203
8388548|NCT01067144|20675283|P2|STARTED|Treatment||215
8388549|NCT01067144|20675284|P1|STARTED|Treatment||207
8388550|NCT01067105|20675300|P1|NOT COMPLETED|Overall Study||141
8388551|NCT01067105|20675300|P1|COMPLETED|Overall Study||683
8388552|NCT01067105|20675300|P1|STARTED|Overall Study||824
8388553|NCT01066936|20675317|P1|NOT COMPLETED|Overall Study||10
8388554|NCT01066936|20675317|P1|COMPLETED|Overall Study||10
8388555|NCT01066936|20675317|P1|STARTED|Overall Study||20
8388556|NCT01066923|20675353|P4|NOT COMPLETED|Overall Study||8
8388557|NCT01066923|20675354|P3|NOT COMPLETED|Overall Study||8
8388558|NCT01066923|20675355|P2|NOT COMPLETED|Overall Study||3
8388559|NCT01066923|20675356|P1|NOT COMPLETED|Overall Study||3
8388560|NCT01066923|20675353|P4|COMPLETED|Overall Study||23
8388561|NCT01066923|20675354|P3|COMPLETED|Overall Study||25
8388562|NCT01066923|20675355|P2|COMPLETED|Overall Study||29
8388563|NCT01066923|20675356|P1|COMPLETED|Overall Study||25
8388564|NCT01066923|20675353|P4|Retinal Imaging|Overall Study||0
8388565|NCT01066923|20675354|P3|Retinal Imaging|Overall Study||0
8388566|NCT01066923|20675355|P2|Retinal Imaging|Overall Study||0
8388567|NCT01066923|20675356|P1|Retinal Imaging|Overall Study||0
8388568|NCT01066923|20675353|P4|Activation of Coagulation|Overall Study||0
8388569|NCT01066923|20675354|P3|Activation of Coagulation|Overall Study||0
8388570|NCT01066923|20675355|P2|Activation of Coagulation|Overall Study||0
8388571|NCT01066923|20675356|P1|Activation of Coagulation|Overall Study||0
8388572|NCT01066923|20675353|P4|Vascular Function|Overall Study||13
8388573|NCT01066923|20675354|P3|Vascular Function|Overall Study||12
8388574|NCT01066923|20675355|P2|Vascular Function|Overall Study||14
8388575|NCT01066923|20675356|P1|Vascular Function|Overall Study||13
8388576|NCT01066923|20675353|P4|Platelet Closure Time|Overall Study||23
8388577|NCT01066923|20675354|P3|Platelet Closure Time|Overall Study||25
8388578|NCT01066923|20675355|P2|Platelet Closure Time|Overall Study||29
8388579|NCT01066923|20675356|P1|Platelet Closure Time|Overall Study||25
8388580|NCT01066923|20675353|P4|STARTED|Overall Study||31
8388581|NCT01066923|20675354|P3|STARTED|Overall Study||33
8388582|NCT01066923|20675355|P2|STARTED|Overall Study||32
8388583|NCT01066923|20675356|P1|STARTED|Overall Study||28
8388584|NCT01066897|20675380|P2|NOT COMPLETED|Overall Study||0
8388585|NCT01066897|20675381|P1|NOT COMPLETED|Overall Study||2
8388586|NCT01066897|20675380|P2|COMPLETED|Overall Study||9
8388587|NCT01066897|20675381|P1|COMPLETED|Overall Study||5
8388588|NCT01066897|20675380|P2|STARTED|Overall Study||9
8388589|NCT01066897|20675381|P1|STARTED|Overall Study||7
8388590|NCT01066871|20675395|P4|NOT COMPLETED|Overall Study||5
8388591|NCT01066871|20675396|P3|NOT COMPLETED|Overall Study||6
8388592|NCT01066871|20675397|P2|NOT COMPLETED|Overall Study||5
8388593|NCT01066871|20675398|P1|NOT COMPLETED|Overall Study||4
8388594|NCT01066871|20675395|P4|COMPLETED|Overall Study||13
8388595|NCT01066871|20675396|P3|COMPLETED|Overall Study||12
8388596|NCT01066871|20675397|P2|COMPLETED|Overall Study||13
8388597|NCT01066871|20675398|P1|COMPLETED|Overall Study||16
8388598|NCT01066871|20675395|P4|STARTED|Overall Study||18
8388599|NCT01066871|20675396|P3|STARTED|Overall Study||18
8388600|NCT01066871|20675397|P2|STARTED|Overall Study||18
8388601|NCT01066871|20675398|P1|STARTED|Overall Study||20
8388602|NCT01066819|20675462|P6|NOT COMPLETED|Overall Study||6
8388603|NCT01066819|20675463|P5|NOT COMPLETED|Overall Study||4
8388604|NCT01066819|20675464|P4|NOT COMPLETED|Overall Study||17
8388605|NCT01066819|20675465|P3|NOT COMPLETED|Overall Study||146
8388606|NCT01066819|20675466|P2|NOT COMPLETED|Overall Study||171
8388607|NCT01066819|20675467|P1|NOT COMPLETED|Overall Study||689
8388608|NCT01066819|20675462|P6|COMPLETED|Overall Study||7
8388609|NCT01066819|20675463|P5|COMPLETED|Overall Study||3
8388610|NCT01066819|20675464|P4|COMPLETED|Overall Study||8
8388611|NCT01066819|20675465|P3|COMPLETED|Overall Study||111
8388612|NCT01066819|20675466|P2|COMPLETED|Overall Study||177
8388613|NCT01066819|20675467|P1|COMPLETED|Overall Study||317
8388614|NCT01066819|20675462|P6|STARTED|Overall Study||13
8388615|NCT01066819|20675463|P5|STARTED|Overall Study||7
8388616|NCT01066819|20675464|P4|STARTED|Overall Study||25
8388617|NCT01066819|20675465|P3|STARTED|Overall Study||257
8388618|NCT01066819|20675466|P2|STARTED|Overall Study||348
8388619|NCT01066819|20675467|P1|STARTED|Overall Study||1006
8388620|NCT01066793|20675608|P6|NOT COMPLETED|Overall Study||1
8388621|NCT01066793|20675609|P5|NOT COMPLETED|Overall Study||0
8388622|NCT01066793|20675610|P4|NOT COMPLETED|Overall Study||49
8388623|NCT01066793|20675611|P3|NOT COMPLETED|Overall Study||115
8388624|NCT01066793|20675612|P2|NOT COMPLETED|Overall Study||77
8388625|NCT01066793|20675613|P1|NOT COMPLETED|Overall Study||374
8388626|NCT01066793|20675608|P6|COMPLETED|Overall Study||4
8388627|NCT01066793|20675609|P5|COMPLETED|Overall Study||11
8388628|NCT01066793|20675610|P4|COMPLETED|Overall Study||94
8388629|NCT01066793|20675611|P3|COMPLETED|Overall Study||369
8388630|NCT01066793|20675612|P2|COMPLETED|Overall Study||495
8388631|NCT01066793|20675613|P1|COMPLETED|Overall Study||754
8388632|NCT01066793|20675608|P6|STARTED|Overall Study||5
8388633|NCT01066793|20675609|P5|STARTED|Overall Study||11
8388634|NCT01066793|20675610|P4|STARTED|Overall Study||143
8388635|NCT01066793|20675611|P3|STARTED|Overall Study||484
8388636|NCT01066793|20675612|P2|STARTED|Overall Study||572
8388637|NCT01066793|20675613|P1|STARTED|Overall Study||1128
8388638|NCT01066780|20675753|P2|NOT COMPLETED|Overall Study||1
8388639|NCT01066780|20675754|P1|NOT COMPLETED|Overall Study||1
8388640|NCT01066780|20675753|P2|COMPLETED|Overall Study||23
8388641|NCT01066780|20675754|P1|COMPLETED|Overall Study||23
8388642|NCT01066780|20675753|P2|STARTED|Overall Study||24
8388643|NCT01066780|20675754|P1|STARTED|Overall Study||24
8388644|NCT01066637|20675760|P2|NOT COMPLETED|Overall Study||0
8388645|NCT01066637|20675761|P1|NOT COMPLETED|Overall Study||0
8388646|NCT01066637|20675760|P2|COMPLETED|Overall Study||10
8388647|NCT01066637|20675761|P1|COMPLETED|Overall Study||16
8388648|NCT01066637|20675760|P2|STARTED|Overall Study||10
8388649|NCT01066637|20675761|P1|STARTED|Overall Study||16
8388650|NCT01066624|20675772|P3|NOT COMPLETED|Overall Study||0
8388651|NCT01066624|20675773|P2|NOT COMPLETED|Overall Study||0
8388652|NCT01066624|20675774|P1|NOT COMPLETED|Overall Study||0
8388653|NCT01066624|20675772|P3|COMPLETED|Overall Study||39
8388654|NCT01066624|20675773|P2|COMPLETED|Overall Study||40
8388655|NCT01066624|20675774|P1|COMPLETED|Overall Study||38
8388656|NCT01066624|20675772|P3|STARTED|Overall Study||39
8388657|NCT01066624|20675773|P2|STARTED|Overall Study||40
8388658|NCT01066624|20675774|P1|STARTED|Overall Study||38
8388659|NCT01066585|20675784|P2|NOT COMPLETED|Overall Study||3
8388660|NCT01066585|20675785|P1|NOT COMPLETED|Overall Study||1
8388661|NCT01066585|20675784|P2|COMPLETED|Overall Study||196
8388662|NCT01066585|20675785|P1|COMPLETED|Overall Study||210
8388663|NCT01066585|20675784|P2|STARTED|Overall Study||199
8388664|NCT01066585|20675785|P1|STARTED|Overall Study||211
8388665|NCT01066546|20675797|P1|NOT COMPLETED|Overall Study||5
8388666|NCT01066546|20675797|P1|COMPLETED|Overall Study||0
8388667|NCT01066546|20675797|P1|STARTED|Overall Study||5
8388668|NCT01066520|20675811|P3|NOT COMPLETED|Overall Study||0
8388669|NCT01066520|20675812|P2|NOT COMPLETED|Overall Study||0
8388670|NCT01066520|20675813|P1|NOT COMPLETED|Overall Study||0
8388671|NCT01066520|20675811|P3|COMPLETED|Overall Study||137
8388672|NCT01066520|20675812|P2|COMPLETED|Overall Study||140
8388673|NCT01066520|20675813|P1|COMPLETED|Overall Study||143
8388674|NCT01066520|20675811|P3|STARTED|Overall Study||137
8388675|NCT01066520|20675812|P2|STARTED|Overall Study||140
8388676|NCT01066520|20675813|P1|STARTED|Overall Study||143
8388677|NCT01066364|20675829|P2|NOT COMPLETED|Overall Study||2
8388678|NCT01066364|20675830|P1|NOT COMPLETED|Overall Study||3
8388679|NCT01066364|20675829|P2|COMPLETED|Overall Study||23
8388680|NCT01066364|20675830|P1|COMPLETED|Overall Study||22
8388681|NCT01066364|20675829|P2|STARTED|Overall Study||25
8388682|NCT01066364|20675830|P1|STARTED|Overall Study||25
8388683|NCT01066156|20675842|P1|NOT COMPLETED|Overall Study||10
8388684|NCT01066156|20675842|P1|COMPLETED|Overall Study||24
8388685|NCT01066156|20675842|P1|STARTED|Overall Study||34
8388686|NCT01066143|20675846|P1|NOT COMPLETED|Overall Study||8
8388687|NCT01066143|20675846|P1|COMPLETED|Overall Study||0
8388688|NCT01066143|20675846|P1|STARTED|Overall Study||8
8388689|NCT01066104|20675852|P2|NOT COMPLETED|Overall Study||1
8388690|NCT01066104|20675853|P1|NOT COMPLETED|Overall Study||2
8388691|NCT01066104|20675852|P2|COMPLETED|Overall Study||12
8388692|NCT01066104|20675853|P1|COMPLETED|Overall Study||12
8388693|NCT01066104|20675852|P2|STARTED|Overall Study||13
8388694|NCT01066104|20675853|P1|STARTED|Overall Study||14
8388695|NCT01066052|20675863|P2|NOT COMPLETED|Overall Study||0
8388696|NCT01066052|20675864|P1|NOT COMPLETED|Overall Study||3
8388697|NCT01066052|20675863|P2|COMPLETED|Overall Study||51
8388698|NCT01066052|20675864|P1|COMPLETED|Overall Study||61
8388699|NCT01066052|20675863|P2|Treated|Overall Study||0
8388700|NCT01066052|20675864|P1|Treated|Overall Study||61
8388701|NCT01066052|20675863|P2|STARTED|Overall Study||51
8388702|NCT01066052|20675864|P1|STARTED|Overall Study||64
8388703|NCT01066039|20675875|P1|NOT COMPLETED|Overall Study||44
8388704|NCT01066039|20675875|P1|COMPLETED|Overall Study||158
8388705|NCT01066039|20675875|P1|Treated|Overall Study||200
8388706|NCT01066039|20675875|P1|STARTED|Overall Study||202
8388707|NCT01066026|20675888|P1|NOT COMPLETED|Overall Study||2
8388708|NCT01066026|20675888|P1|COMPLETED|Overall Study||23
8388709|NCT01066026|20675888|P1|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
8388710|NCT01066000|20675900|P1|NOT COMPLETED|Overall Study||9
8388711|NCT01066000|20675900|P1|COMPLETED|Overall Study||24
8388712|NCT01066000|20675900|P1|STARTED|Overall Study||33
8388713|NCT01065844|20675911|P1|NOT COMPLETED|Overall Study||5
8388714|NCT01065844|20675911|P1|COMPLETED|Overall Study||10
8388715|NCT01065844|20675911|P1|STARTED|Overall Study||15
8388716|NCT01065818|20675915|P1|NOT COMPLETED|Overall Study||2
8388717|NCT01065818|20675915|P1|COMPLETED|Overall Study||4
8388718|NCT01065818|20675915|P1|STARTED|Overall Study||6
8388719|NCT01065779|20675919|P1|NOT COMPLETED|Overall Study||82
8388720|NCT01065779|20675919|P1|COMPLETED|Overall Study||798
8388721|NCT01065779|20675919|P1|STARTED|Overall Study||880
8388722|NCT01065766|20675930|P1|NOT COMPLETED|Overall Study||32
8388723|NCT01065766|20675930|P1|COMPLETED|Overall Study||4033
8388724|NCT01065766|20675930|P1|STARTED|Overall Study||4065
8388725|NCT01065714|20675942|P1|NOT COMPLETED|Overall Study||0
8388726|NCT01065714|20675942|P1|COMPLETED|Overall Study||20
8388727|NCT01065714|20675942|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
8388728|NCT01065597|20675949|P1|NOT COMPLETED|Overall Study||1
8388729|NCT01065597|20675949|P1|COMPLETED|Overall Study||12
8388730|NCT01065597|20675949|P1|STARTED|Overall Study||13
8388731|NCT01065571|20675958|P2|NOT COMPLETED|Overall Study||0
8388732|NCT01065571|20675959|P1|NOT COMPLETED|Overall Study||3
8388733|NCT01065571|20675958|P2|COMPLETED|Overall Study||5
8388734|NCT01065571|20675959|P1|COMPLETED|Overall Study||7
8388735|NCT01065571|20675958|P2|STARTED|Overall Study||5
8388736|NCT01065571|20675959|P1|STARTED|Overall Study||10
8388737|NCT01065558|20675969|P1|NOT COMPLETED|Overall Study||0
8388738|NCT01065558|20675969|P1|COMPLETED|Overall Study||5
8388739|NCT01065558|20675969|P1|STARTED|Overall Study||5
8388740|NCT01065506|20675976|P2|NOT COMPLETED|Overall Study||38
8388741|NCT01065506|20675977|P1|NOT COMPLETED|Overall Study||32
8388742|NCT01065506|20675976|P2|COMPLETED|Overall Study||34
8388743|NCT01065506|20675977|P1|COMPLETED|Overall Study||32
8388744|NCT01065506|20675976|P2|4-Month Follow-Up|Overall Study||34
8388745|NCT01065506|20675977|P1|4-Month Follow-Up|Overall Study||35
8388746|NCT01065506|20675976|P2|End of Treatment|Overall Study||37
8388747|NCT01065506|20675977|P1|End of Treatment|Overall Study||44
8388748|NCT01065506|20675976|P2|STARTED|Overall Study||72
8388749|NCT01065506|20675977|P1|STARTED|Overall Study||64
8388750|NCT01065480|20675985|P2|NOT COMPLETED|Overall Study||0
8388751|NCT01065480|20675986|P1|NOT COMPLETED|Overall Study||0
8388752|NCT01065480|20675985|P2|COMPLETED|Overall Study||43
8388753|NCT01065480|20675986|P1|COMPLETED|Overall Study||48
8388754|NCT01065480|20675985|P2|STARTED|Overall Study||43
8388755|NCT01065480|20675986|P1|STARTED|Overall Study||48
8388784|NCT01065428|20676111|P2|NOT COMPLETED|Overall Study||0
8388785|NCT01065428|20676112|P1|NOT COMPLETED|Overall Study||0
8388786|NCT01065428|20676111|P2|COMPLETED|Overall Study||35
8388787|NCT01065428|20676112|P1|COMPLETED|Overall Study||17
8388788|NCT01065428|20676111|P2|STARTED|Overall Study||35
8388789|NCT01065428|20676112|P1|STARTED|Overall Study||17
8388790|NCT01065350|20676122|P2|NOT COMPLETED|Overall Study||1
8388791|NCT01065350|20676123|P1|NOT COMPLETED|Overall Study||0
8388792|NCT01065350|20676122|P2|COMPLETED|Overall Study||41
8388793|NCT01065350|20676123|P1|COMPLETED|Overall Study||43
8388794|NCT01065350|20676122|P2|STARTED|Overall Study||42
8388795|NCT01065350|20676123|P1|STARTED|Overall Study||43
8388796|NCT01065051|20676157|P2|NOT COMPLETED|Overall Study||0
8388797|NCT01065051|20676158|P1|NOT COMPLETED|Overall Study||0
8388798|NCT01065051|20676157|P2|COMPLETED|Overall Study||0
8388799|NCT01065051|20676158|P1|COMPLETED|Overall Study||1
8388800|NCT01065051|20676157|P2|STARTED|Overall Study||0
8388801|NCT01065051|20676158|P1|STARTED|Overall Study||1
8388802|NCT01064947|20676184|P1|NOT COMPLETED|Overall Study||41
8388803|NCT01064947|20676184|P1|COMPLETED|Overall Study||29
8388804|NCT01064947|20676184|P1|STARTED|Overall Study||70
8388805|NCT01064882|20676195|P3|NOT COMPLETED|Overall Study||2
8388806|NCT01064882|20676196|P2|NOT COMPLETED|Overall Study||2
8388807|NCT01064882|20676197|P1|NOT COMPLETED|Overall Study||2
8388808|NCT01064882|20676195|P3|COMPLETED|Overall Study||32
8388809|NCT01064882|20676196|P2|COMPLETED|Overall Study||32
8388810|NCT01064882|20676197|P1|COMPLETED|Overall Study||34
8388811|NCT01064882|20676195|P3|STARTED|Overall Study||34
8388812|NCT01064882|20676196|P2|STARTED|Overall Study||34
8388813|NCT01064882|20676197|P1|STARTED|Overall Study||36
8388814|NCT01064856|20676225|P4|NOT COMPLETED|Open-label (OL) Period||20
8388815|NCT01064856|20676226|P3|NOT COMPLETED|Open-label (OL) Period||26
8388816|NCT01064856|20676227|P2|NOT COMPLETED|Open-label (OL) Period||0
8388817|NCT01064856|20676228|P1|NOT COMPLETED|Open-label (OL) Period||0
8388818|NCT01064856|20676225|P4|COMPLETED|Open-label (OL) Period||61
8388819|NCT01064856|20676226|P3|COMPLETED|Open-label (OL) Period||56
8388820|NCT01064856|20676227|P2|COMPLETED|Open-label (OL) Period||0
8388821|NCT01064856|20676228|P1|COMPLETED|Open-label (OL) Period||0
8388822|NCT01064856|20676225|P4|STARTED|Open-label (OL) Period||81
8388823|NCT01064856|20676226|P3|STARTED|Open-label (OL) Period||82
8388824|NCT01064856|20676227|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
8388825|NCT01064856|20676228|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
8388826|NCT01064856|20676225|P4|NOT COMPLETED|Double-blind (DB) Period||0
8388827|NCT01064856|20676226|P3|NOT COMPLETED|Double-blind (DB) Period||0
8388828|NCT01064856|20676227|P2|NOT COMPLETED|Double-blind (DB) Period||0
8388829|NCT01064856|20676228|P1|NOT COMPLETED|Double-blind (DB) Period||2
8388830|NCT01064856|20676225|P4|COMPLETED|Double-blind (DB) Period||0
8388831|NCT01064856|20676226|P3|COMPLETED|Double-blind (DB) Period||0
8388832|NCT01064856|20676227|P2|COMPLETED|Double-blind (DB) Period||81
8388833|NCT01064856|20676228|P1|COMPLETED|Double-blind (DB) Period||82
8388834|NCT01064856|20676225|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
8388835|NCT01064856|20676226|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
8388836|NCT01064856|20676227|P2|STARTED|Double-blind (DB) Period||81
8388837|NCT01064856|20676228|P1|STARTED|Double-blind (DB) Period||84
8388838|NCT01064830|20676261|P2|NOT COMPLETED|Overall Study||4
8388839|NCT01064830|20676262|P1|NOT COMPLETED|Overall Study||2
8388840|NCT01064830|20676261|P2|COMPLETED|Overall Study||7
8388841|NCT01064830|20676262|P1|COMPLETED|Overall Study||8
8388842|NCT01064830|20676261|P2|STARTED|Overall Study||11
8388843|NCT01064830|20676262|P1|STARTED|Overall Study||10
8388844|NCT01064817|20676272|P2|NOT COMPLETED|Study Completion||0
8388845|NCT01064817|20676273|P1|NOT COMPLETED|Study Completion||2
8388846|NCT01064817|20676272|P2|COMPLETED|Study Completion||62
8388847|NCT01064817|20676273|P1|COMPLETED|Study Completion||60
8388848|NCT01064817|20676272|P2|STARTED|Study Completion||62
8388849|NCT01064817|20676273|P1|STARTED|Study Completion||62
8388850|NCT01064817|20676272|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
8388851|NCT01064817|20676273|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
8388852|NCT01064817|20676272|P2|COMPLETED|All Study Treatment Days 1-9||62
8388853|NCT01064817|20676273|P1|COMPLETED|All Study Treatment Days 1-9||62
8388854|NCT01064817|20676272|P2|STARTED|All Study Treatment Days 1-9||62
8388855|NCT01064817|20676273|P1|STARTED|All Study Treatment Days 1-9||62
8388856|NCT01064739|20676285|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
8388857|NCT01064739|20676285|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
8388858|NCT01064739|20676285|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
8388859|NCT01064739|20676285|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
8388860|NCT01064739|20676285|P1|COMPLETED|Fixed Sodium Study Diet||14
8388861|NCT01064739|20676285|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
8388862|NCT01064713|20676343|P2|NOT COMPLETED|Overall Study||0
8388863|NCT01064713|20676344|P1|NOT COMPLETED|Overall Study||0
8388864|NCT01064713|20676343|P2|COMPLETED|Overall Study||4
8388865|NCT01064713|20676344|P1|COMPLETED|Overall Study||13
8388866|NCT01064713|20676343|P2|STARTED|Overall Study||4
8388867|NCT01064713|20676344|P1|STARTED|Overall Study||13
8388868|NCT01064687|20676356|P4|NOT COMPLETED|Overall Study||17
8388869|NCT01064687|20676357|P3|NOT COMPLETED|Overall Study||41
8388870|NCT01064687|20676358|P2|NOT COMPLETED|Overall Study||26
8388871|NCT01064687|20676359|P1|NOT COMPLETED|Overall Study||34
8388872|NCT01064687|20676356|P4|COMPLETED|Overall Study||124
8388873|NCT01064687|20676357|P3|COMPLETED|Overall Study||237
8388874|NCT01064687|20676358|P2|COMPLETED|Overall Study||254
8388875|NCT01064687|20676359|P1|COMPLETED|Overall Study||245
8388876|NCT01064687|20676356|P4|Completed 26 Weeks|Overall Study||124
8388877|NCT01064687|20676357|P3|Completed 26 Weeks|Overall Study||252
8388878|NCT01064687|20676358|P2|Completed 26 Weeks|Overall Study||263
8388879|NCT01064687|20676359|P1|Completed 26 Weeks|Overall Study||260
8388880|NCT01064687|20676356|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
8388881|NCT01064687|20676357|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
8388882|NCT01064687|20676358|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
8388883|NCT01064687|20676359|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
8388884|NCT01064687|20676356|P4|STARTED|Overall Study||141
8388885|NCT01064687|20676357|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
8388886|NCT01064687|20676358|P2|STARTED|Overall Study||280
8388887|NCT01064687|20676359|P1|STARTED|Overall Study||279
8388924|NCT01064622|20676568|P2|NOT COMPLETED|Crossover of Arm I||0
8388925|NCT01064622|20676569|P1|NOT COMPLETED|Crossover of Arm I||0
8388926|NCT01064622|20676568|P2|COMPLETED|Crossover of Arm I||0
8388927|NCT01064622|20676569|P1|COMPLETED|Crossover of Arm I||22
8388928|NCT01064622|20676568|P2|STARTED|Crossover of Arm I||0
8388929|NCT01064622|20676569|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
8388930|NCT01064622|20676568|P2|NOT COMPLETED|Randomized Phase II||3
8388931|NCT01064622|20676569|P1|NOT COMPLETED|Randomized Phase II||2
8388932|NCT01064622|20676568|P2|COMPLETED|Randomized Phase II||53
8388933|NCT01064622|20676569|P1|COMPLETED|Randomized Phase II||53
8388934|NCT01064622|20676568|P2|STARTED|Randomized Phase II||56
8388935|NCT01064622|20676569|P1|STARTED|Randomized Phase II||55
8388936|NCT01064622|20676568|P2|NOT COMPLETED|Lead-in Phase I||0
8388937|NCT01064622|20676569|P1|NOT COMPLETED|Lead-in Phase I||0
8388938|NCT01064622|20676568|P2|COMPLETED|Lead-in Phase I||7
8388939|NCT01064622|20676569|P1|COMPLETED|Lead-in Phase I||0
8388940|NCT01064622|20676568|P2|STARTED|Lead-in Phase I||7
8388941|NCT01064622|20676569|P1|STARTED|Lead-in Phase I||0
8388942|NCT01064531|20676592|P2|NOT COMPLETED|Overall Study||7
8388943|NCT01064531|20676593|P1|NOT COMPLETED|Overall Study||3
8388944|NCT01064531|20676592|P2|COMPLETED|Overall Study||13
8388945|NCT01064531|20676593|P1|COMPLETED|Overall Study||18
8388946|NCT01064531|20676592|P2|STARTED|Overall Study||20
8388947|NCT01064531|20676593|P1|STARTED|Overall Study||21
8388948|NCT01064414|20676640|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8388949|NCT01064414|20676641|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8388950|NCT01064414|20676642|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
8388951|NCT01064414|20676640|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
8388952|NCT01064414|20676641|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
8388953|NCT01064414|20676642|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
8388954|NCT01064414|20676640|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
8388955|NCT01064414|20676641|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
8388956|NCT01064414|20676642|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
8388957|NCT01064414|20676640|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
8388958|NCT01064414|20676641|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
8388959|NCT01064414|20676642|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
8388960|NCT01064414|20676640|P3|COMPLETED|Core Period: Baseline to Week 26||82
8388961|NCT01064414|20676641|P2|COMPLETED|Core Period: Baseline to Week 26||75
8388962|NCT01064414|20676642|P1|COMPLETED|Core Period: Baseline to Week 26||77
8388963|NCT01064414|20676640|P3|STARTED|Core Period: Baseline to Week 26||89
8388964|NCT01064414|20676641|P2|STARTED|Core Period: Baseline to Week 26||90
8388965|NCT01064414|20676642|P1|STARTED|Core Period: Baseline to Week 26||90
8388966|NCT01064401|20676661|P2|NOT COMPLETED|Overall Study||195
8388967|NCT01064401|20676662|P1|NOT COMPLETED|Overall Study||228
8388968|NCT01064401|20676661|P2|COMPLETED|Overall Study||724
8388969|NCT01064401|20676662|P1|COMPLETED|Overall Study||694
8388970|NCT01064401|20676661|P2|STARTED|Overall Study||919
8388971|NCT01064401|20676662|P1|STARTED|Overall Study||922
8388972|NCT01064362|20676678|P2|NOT COMPLETED|Overall Study||0
8388973|NCT01064362|20676679|P1|NOT COMPLETED|Overall Study||0
8388974|NCT01064362|20676678|P2|COMPLETED|Overall Study||11883
8388975|NCT01064362|20676679|P1|COMPLETED|Overall Study||1559
8388976|NCT01064362|20676678|P2|STARTED|Overall Study||11883
8388977|NCT01064362|20676679|P1|STARTED|Overall Study||1559
8388978|NCT01064323|20676687|P1|NOT COMPLETED|Overall Study||0
8388979|NCT01064323|20676687|P1|COMPLETED|Overall Study||10
8388980|NCT01064323|20676687|P1|STARTED|Overall Study||10
8388981|NCT01064310|20676711|P3|NOT COMPLETED|Open Label Pazopinib||84
8388982|NCT01064310|20676712|P2|NOT COMPLETED|Open Label Pazopinib||0
8388983|NCT01064310|20676713|P1|NOT COMPLETED|Open Label Pazopinib||0
8388984|NCT01064310|20676711|P3|COMPLETED|Open Label Pazopinib||0
8388985|NCT01064310|20676712|P2|COMPLETED|Open Label Pazopinib||0
8388986|NCT01064310|20676713|P1|COMPLETED|Open Label Pazopinib||0
8388987|NCT01064310|20676711|P3|STARTED|Open Label Pazopinib||84
8388988|NCT01064310|20676712|P2|STARTED|Open Label Pazopinib||0
8388989|NCT01064310|20676713|P1|STARTED|Open Label Pazopinib||0
8388990|NCT01064310|20676711|P3|NOT COMPLETED|Period 2||0
8388991|NCT01064310|20676712|P2|NOT COMPLETED|Period 2||6
8388992|NCT01064310|20676713|P1|NOT COMPLETED|Period 2||4
8388993|NCT01064310|20676711|P3|COMPLETED|Period 2||0
8388994|NCT01064310|20676712|P2|COMPLETED|Period 2||62
8388995|NCT01064310|20676713|P1|COMPLETED|Period 2||64
8388996|NCT01064310|20676711|P3|STARTED|Period 2||0
8388997|NCT01064310|20676712|P2|STARTED|Period 2||68
8388998|NCT01064310|20676713|P1|STARTED|Period 2||68
8388999|NCT01064310|20676711|P3|NOT COMPLETED|Period 1||0
8389000|NCT01064310|20676712|P2|NOT COMPLETED|Period 1||18
8389001|NCT01064310|20676713|P1|NOT COMPLETED|Period 1||14
8389002|NCT01064310|20676711|P3|COMPLETED|Period 1||0
8389003|NCT01064310|20676712|P2|COMPLETED|Period 1||68
8389004|NCT01064310|20676713|P1|COMPLETED|Period 1||68
8389005|NCT01064310|20676711|P3|STARTED|Period 1||0
8389006|NCT01064310|20676712|P2|STARTED|Period 1||86
8389007|NCT01064310|20676713|P1|STARTED|Period 1||82
8389008|NCT01064297|20676743|P3|NOT COMPLETED|Overall Study||133
8389009|NCT01064297|20676744|P2|NOT COMPLETED|Overall Study||48
8389010|NCT01064297|20676745|P1|NOT COMPLETED|Overall Study||791
8389011|NCT01064297|20676743|P3|COMPLETED|Overall Study||497
8389012|NCT01064297|20676744|P2|COMPLETED|Overall Study||171
8389013|NCT01064297|20676745|P1|COMPLETED|Overall Study||1776
8389014|NCT01064297|20676743|P3|STARTED|Overall Study||630
8389015|NCT01064297|20676744|P2|STARTED|Overall Study||219
8389016|NCT01064297|20676745|P1|STARTED|Overall Study||2567
8389017|NCT01064284|20676791|P2|NOT COMPLETED|Overall Study||17
8389018|NCT01064284|20676792|P1|NOT COMPLETED|Overall Study||18
8389019|NCT01064284|20676791|P2|COMPLETED|Overall Study||109
8389020|NCT01064284|20676792|P1|COMPLETED|Overall Study||107
8389021|NCT01064284|20676791|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
8389022|NCT01064284|20676792|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
8389023|NCT01064167|20676814|P2|NOT COMPLETED|Overall Study||15
8389024|NCT01064167|20676815|P1|NOT COMPLETED|Overall Study||14
8389025|NCT01064167|20676814|P2|COMPLETED|Overall Study||115
8389026|NCT01064167|20676815|P1|COMPLETED|Overall Study||116
8389027|NCT01064167|20676814|P2|STARTED|Overall Study||130
8389028|NCT01064167|20676815|P1|STARTED|Overall Study||130
8389029|NCT01064076|20676823|P1|NOT COMPLETED|Overall Study||18
8389030|NCT01064076|20676823|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
8389031|NCT01064076|20676823|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
8389032|NCT01063972|20676830|P2|NOT COMPLETED|Overall Study||12
8389033|NCT01063972|20676831|P1|NOT COMPLETED|Overall Study||14
8389034|NCT01063972|20676830|P2|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
8389035|NCT01063972|20676831|P1|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
8389036|NCT01063972|20676830|P2|STARTED|Overall Study||296
8389037|NCT01063972|20676831|P1|STARTED|Overall Study||310
8389038|NCT01063907|20676847|P2|NOT COMPLETED|Overall Study||0
8389039|NCT01063907|20676848|P1|NOT COMPLETED|Overall Study||0
8389040|NCT01063907|20676847|P2|COMPLETED|Overall Study||80
8389041|NCT01063907|20676848|P1|COMPLETED|Overall Study||15
8389042|NCT01063907|20676847|P2|STARTED|Overall Study||80
8389043|NCT01063907|20676848|P1|STARTED|Overall Study||15
8389044|NCT01063881|20676881|P3|NOT COMPLETED|Overall Study||1
8389045|NCT01063881|20676882|P2|NOT COMPLETED|Overall Study||11
8389046|NCT01063881|20676883|P1|NOT COMPLETED|Overall Study||55
8389047|NCT01063881|20676881|P3|COMPLETED|Overall Study||12
8389048|NCT01063881|20676882|P2|COMPLETED|Overall Study||114
8389049|NCT01063881|20676883|P1|COMPLETED|Overall Study||92
8389050|NCT01063881|20676881|P3|STARTED|Overall Study||13
8389051|NCT01063881|20676882|P2|STARTED|Overall Study||125
8389052|NCT01063881|20676883|P1|STARTED|Overall Study||147
8389053|NCT01063868|20676907|P2|NOT COMPLETED|Overall Study||12
8389054|NCT01063868|20676908|P1|NOT COMPLETED|Overall Study||35
8389055|NCT01063868|20676907|P2|COMPLETED|Overall Study||0
8389056|NCT01063868|20676908|P1|COMPLETED|Overall Study||0
8389057|NCT01063868|20676907|P2|STARTED|Overall Study||12
8389058|NCT01063868|20676908|P1|STARTED|Overall Study||35
8389059|NCT01063855|20676916|P2|NOT COMPLETED|Overall Study||29
8389060|NCT01063855|20676917|P1|NOT COMPLETED|Overall Study||37
8389061|NCT01063855|20676916|P2|COMPLETED|Overall Study||221
8389062|NCT01063855|20676917|P1|COMPLETED|Overall Study||208
8389063|NCT01063855|20676916|P2|STARTED|Overall Study||250
8389064|NCT01063855|20676917|P1|STARTED|Overall Study||245
8389065|NCT01063829|20676943|P4|NOT COMPLETED|Overall Study||21
8389066|NCT01063829|20676944|P3|NOT COMPLETED|Overall Study||10
8389067|NCT01063829|20676945|P2|NOT COMPLETED|Overall Study||10
8389068|NCT01063829|20676946|P1|NOT COMPLETED|Overall Study||16
8389069|NCT01063829|20676943|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
8389070|NCT01063829|20676944|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
8389071|NCT01063829|20676945|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
8389072|NCT01063829|20676946|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
8389073|NCT01063829|20676943|P4|STARTED|Overall Study||33
8389074|NCT01063829|20676944|P3|STARTED|Overall Study||34
8389075|NCT01063829|20676945|P2|STARTED|Overall Study||31
8389076|NCT01063829|20676946|P1|STARTED|Overall Study||33
8389077|NCT01063764|20676964|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
8389078|NCT01063764|20676964|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
8389079|NCT01063764|20676964|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
8389080|NCT01063764|20676964|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
8389081|NCT01063764|20676964|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
8389082|NCT01063764|20676964|P1|STARTED|1st Period (From Week 8 to Week 22)||73
8389083|NCT01063712|20676978|P1|NOT COMPLETED|Overall Study||0
8389084|NCT01063712|20676978|P1|COMPLETED|Overall Study||29
8389085|NCT01063712|20676978|P1|STARTED|Overall Study||29
8389086|NCT01063595|20676983|P2|NOT COMPLETED|Second Intervention||0
8389087|NCT01063595|20676984|P1|NOT COMPLETED|Second Intervention||0
8389088|NCT01063595|20676983|P2|COMPLETED|Second Intervention||24
8389089|NCT01063595|20676984|P1|COMPLETED|Second Intervention||29
8389090|NCT01063595|20676983|P2|STARTED|Second Intervention||24
8389091|NCT01063595|20676984|P1|STARTED|Second Intervention||29
8389092|NCT01063595|20676983|P2|NOT COMPLETED|First Intervention||5
8389093|NCT01063595|20676984|P1|NOT COMPLETED|First Intervention||2
8389094|NCT01063595|20676983|P2|COMPLETED|First Intervention||24
8389095|NCT01063595|20676984|P1|COMPLETED|First Intervention||29
8389096|NCT01063595|20676983|P2|STARTED|First Intervention||29
8389097|NCT01063595|20676984|P1|STARTED|First Intervention||31
8389098|NCT01063595|20676983|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
8389099|NCT01063595|20676984|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
8389100|NCT01063595|20676983|P2|COMPLETED|Enrolled in Study and Randomized||29
8389101|NCT01063595|20676984|P1|COMPLETED|Enrolled in Study and Randomized||31
8389102|NCT01063595|20676983|P2|Received Treatment|Enrolled in Study and Randomized||29
8389103|NCT01063595|20676984|P1|Received Treatment|Enrolled in Study and Randomized||31
8389104|NCT01063595|20676983|P2|STARTED|Enrolled in Study and Randomized||31
8389105|NCT01063595|20676984|P1|STARTED|Enrolled in Study and Randomized||32
8389106|NCT01063517|20676996|P2|NOT COMPLETED|Overall Study||60
8389107|NCT01063517|20676997|P1|NOT COMPLETED|Overall Study||58
8389108|NCT01063517|20676996|P2|COMPLETED|Overall Study||2
8389109|NCT01063517|20676997|P1|COMPLETED|Overall Study||4
8389110|NCT01063517|20676996|P2|Received Randomised Treatment|Overall Study||62
8389111|NCT01063517|20676997|P1|Received Randomised Treatment|Overall Study||61
8389112|NCT01063517|20676996|P2|STARTED|Overall Study||62
8389113|NCT01063517|20676997|P1|STARTED|Overall Study||62
8389114|NCT01063348|20677037|P2|NOT COMPLETED|Overall Study||10
8389115|NCT01063348|20677038|P1|NOT COMPLETED|Overall Study||3
8389116|NCT01063348|20677037|P2|COMPLETED|Overall Study||21
8389117|NCT01063348|20677038|P1|COMPLETED|Overall Study||32
8389118|NCT01063348|20677037|P2|STARTED|Overall Study||31
8389119|NCT01063348|20677038|P1|STARTED|Overall Study||35
8389120|NCT01063283|20677048|P3|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389121|NCT01063283|20677049|P2|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389122|NCT01063283|20677050|P1|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389123|NCT01063283|20677048|P3|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
8389124|NCT01063283|20677049|P2|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
8389125|NCT01063283|20677050|P1|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389126|NCT01063283|20677048|P3|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
8389127|NCT01063283|20677049|P2|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
8389128|NCT01063283|20677050|P1|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
8389129|NCT01063283|20677048|P3|NOT COMPLETED|Cycle 1||0
8389130|NCT01063283|20677049|P2|NOT COMPLETED|Cycle 1||0
8389131|NCT01063283|20677050|P1|NOT COMPLETED|Cycle 1||3
8389132|NCT01063283|20677048|P3|COMPLETED|Cycle 1||0
8389133|NCT01063283|20677049|P2|COMPLETED|Cycle 1||0
8389134|NCT01063283|20677050|P1|COMPLETED|Cycle 1||17
8389135|NCT01063283|20677048|P3|STARTED|Cycle 1||0
8389136|NCT01063283|20677049|P2|STARTED|Cycle 1||0
8389137|NCT01063283|20677050|P1|STARTED|Cycle 1||20
8389138|NCT01063153|20677064|P2|NOT COMPLETED|Overall Study||12
8389139|NCT01063153|20677065|P1|NOT COMPLETED|Overall Study||2
8389140|NCT01063153|20677064|P2|COMPLETED|Overall Study||26
8389141|NCT01063153|20677065|P1|COMPLETED|Overall Study||31
8389142|NCT01063153|20677064|P2|STARTED|Overall Study||38
8389143|NCT01063153|20677065|P1|STARTED|Overall Study||33
8389144|NCT01063075|20677075|P4|NOT COMPLETED|Overall Study||1
8389145|NCT01063075|20677076|P3|NOT COMPLETED|Overall Study||5
8389146|NCT01063075|20677077|P2|NOT COMPLETED|Overall Study||2
8389147|NCT01063075|20677078|P1|NOT COMPLETED|Overall Study||1
8389148|NCT01063075|20677075|P4|COMPLETED|Overall Study||14
8389149|NCT01063075|20677076|P3|COMPLETED|Overall Study||9
8389150|NCT01063075|20677077|P2|COMPLETED|Overall Study||1
8389151|NCT01063075|20677078|P1|COMPLETED|Overall Study||1
8389152|NCT01063075|20677075|P4|STARTED|Overall Study||15
8389153|NCT01063075|20677076|P3|STARTED|Overall Study||14
8389154|NCT01063075|20677077|P2|STARTED|Overall Study||3
8389155|NCT01063075|20677078|P1|STARTED|Overall Study||2
8389156|NCT01063062|20677096|P2|NOT COMPLETED|Overall Study||12
8389157|NCT01063062|20677097|P1|NOT COMPLETED|Overall Study||8
8389158|NCT01063062|20677096|P2|COMPLETED|Overall Study||65
8389159|NCT01063062|20677097|P1|COMPLETED|Overall Study||22
8389160|NCT01063062|20677096|P2|Received Study Drug|Overall Study||76
8389161|NCT01063062|20677097|P1|Received Study Drug|Overall Study||29
8389162|NCT01063062|20677096|P2|STARTED|Overall Study||77
8389163|NCT01063062|20677097|P1|STARTED|Overall Study||30
8389164|NCT01063049|20677138|P3|NOT COMPLETED|Overall Study||0
8389165|NCT01063049|20677139|P2|NOT COMPLETED|Overall Study||0
8389166|NCT01063049|20677140|P1|NOT COMPLETED|Overall Study||0
8389167|NCT01063049|20677138|P3|COMPLETED|Overall Study||200
8389168|NCT01063049|20677139|P2|COMPLETED|Overall Study||200
8389169|NCT01063049|20677140|P1|COMPLETED|Overall Study||200
8389170|NCT01063049|20677138|P3|STARTED|Overall Study||200
8389171|NCT01063049|20677139|P2|STARTED|Overall Study||200
8389172|NCT01063049|20677140|P1|STARTED|Overall Study||200
8389173|NCT01063036|20677151|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
8389174|NCT01063036|20677151|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
8389175|NCT01063036|20677151|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
8389176|NCT01063036|20677151|P1|NOT COMPLETED|Participants Treated With Study Drug||6
8389177|NCT01063036|20677151|P1|COMPLETED|Participants Treated With Study Drug||86
8389178|NCT01063036|20677151|P1|STARTED|Participants Treated With Study Drug||92
8389179|NCT01062971|20677167|P2|NOT COMPLETED|Overall Study||7
8389180|NCT01062971|20677168|P1|NOT COMPLETED|Overall Study||4
8389181|NCT01062971|20677167|P2|COMPLETED|Overall Study||56
8389182|NCT01062971|20677168|P1|COMPLETED|Overall Study||56
8389183|NCT01062971|20677167|P2|STARTED|Overall Study||63
8389184|NCT01062971|20677168|P1|STARTED|Overall Study||60
8389185|NCT01062893|20677178|P2|NOT COMPLETED|Overall Study||13
8389186|NCT01062893|20677179|P1|NOT COMPLETED|Overall Study||14
8389187|NCT01062893|20677178|P2|COMPLETED|Overall Study||28
8389188|NCT01062893|20677179|P1|COMPLETED|Overall Study||27
8389189|NCT01062893|20677178|P2|STARTED|Overall Study||41
8389190|NCT01062893|20677179|P1|STARTED|Overall Study||41
8389191|NCT01062841|20677207|P2|NOT COMPLETED|Overall Study||53
8389192|NCT01062841|20677208|P1|NOT COMPLETED|Overall Study||49
8389193|NCT01062841|20677207|P2|COMPLETED|Overall Study||162
8389194|NCT01062841|20677208|P1|COMPLETED|Overall Study||154
8389195|NCT01062841|20677207|P2|STARTED|Overall Study||215
8389196|NCT01062841|20677208|P1|STARTED|Overall Study||203
8389197|NCT01062763|20677238|P2|NOT COMPLETED|Overall Study||4
8389198|NCT01062763|20677239|P1|NOT COMPLETED|Overall Study||3
8389199|NCT01062763|20677238|P2|COMPLETED|Overall Study||57
8389200|NCT01062763|20677239|P1|COMPLETED|Overall Study||55
8389201|NCT01062763|20677238|P2|STARTED|Overall Study||61
8389202|NCT01062763|20677239|P1|STARTED|Overall Study|119 randomized.|58
8389203|NCT01062568|20677251|P2|NOT COMPLETED|Overall Study||0
8389204|NCT01062568|20677252|P1|NOT COMPLETED|Overall Study||0
8389205|NCT01062568|20677251|P2|COMPLETED|Overall Study||40
8389206|NCT01062568|20677252|P1|COMPLETED|Overall Study||10
8389207|NCT01062568|20677251|P2|STARTED|Overall Study||40
8389208|NCT01062568|20677252|P1|STARTED|Overall Study||10
8389209|NCT01062555|20677265|P4|NOT COMPLETED|Phase 2||34
8389210|NCT01062555|20677266|P3|NOT COMPLETED|Phase 2||15
8389211|NCT01062555|20677267|P2|NOT COMPLETED|Phase 2||0
8389212|NCT01062555|20677268|P1|NOT COMPLETED|Phase 2||0
8389213|NCT01062555|20677265|P4|COMPLETED|Phase 2||53
8389214|NCT01062555|20677266|P3|COMPLETED|Phase 2||71
8389215|NCT01062555|20677267|P2|COMPLETED|Phase 2||0
8389216|NCT01062555|20677268|P1|COMPLETED|Phase 2||0
8389217|NCT01062555|20677265|P4|STARTED|Phase 2||87
8389218|NCT01062555|20677266|P3|STARTED|Phase 2||86
8389219|NCT01062555|20677267|P2|STARTED|Phase 2||0
8389220|NCT01062555|20677268|P1|STARTED|Phase 2||0
8389221|NCT01062555|20677265|P4|NOT COMPLETED|Phase 1||0
8389222|NCT01062555|20677266|P3|NOT COMPLETED|Phase 1||0
8389223|NCT01062555|20677267|P2|NOT COMPLETED|Phase 1||26
8389224|NCT01062555|20677268|P1|NOT COMPLETED|Phase 1||23
8389225|NCT01062555|20677265|P4|COMPLETED|Phase 1||0
8389226|NCT01062555|20677266|P3|COMPLETED|Phase 1||0
8389227|NCT01062555|20677267|P2|COMPLETED|Phase 1||235
8389228|NCT01062555|20677268|P1|COMPLETED|Phase 1||243
8389229|NCT01062555|20677265|P4|STARTED|Phase 1||0
8389230|NCT01062555|20677266|P3|STARTED|Phase 1||0
8389231|NCT01062555|20677267|P2|STARTED|Phase 1||261
8389232|NCT01062555|20677268|P1|STARTED|Phase 1||266
8389233|NCT01062425|20677288|P2|NOT COMPLETED|Overall Study||6
8389234|NCT01062425|20677289|P1|NOT COMPLETED|Overall Study||3
8389235|NCT01062425|20677288|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
8389236|NCT01062425|20677289|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
8389237|NCT01062425|20677288|P2|STARTED|Overall Study||103
8389238|NCT01062425|20677289|P1|STARTED|Overall Study||55
8389239|NCT01062399|20677306|P5|NOT COMPLETED|Overall Study||4
8389240|NCT01062399|20677307|P4|NOT COMPLETED|Overall Study||6
8389241|NCT01062399|20677308|P3|NOT COMPLETED|Overall Study||0
8389242|NCT01062399|20677309|P2|NOT COMPLETED|Overall Study||1
8389243|NCT01062399|20677310|P1|NOT COMPLETED|Overall Study||0
8389244|NCT01062399|20677306|P5|COMPLETED|Overall Study||88
8389245|NCT01062399|20677307|P4|COMPLETED|Overall Study||83
8389246|NCT01062399|20677308|P3|COMPLETED|Overall Study||8
8389247|NCT01062399|20677309|P2|COMPLETED|Overall Study||9
8389248|NCT01062399|20677310|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
8389249|NCT01062399|20677306|P5|STARTED|Overall Study||92
8389250|NCT01062399|20677307|P4|STARTED|Overall Study||89
8389251|NCT01062399|20677308|P3|STARTED|Overall Study||8
8389252|NCT01062399|20677309|P2|STARTED|Overall Study||10
8389253|NCT01062399|20677310|P1|STARTED|Overall Study||8
8389254|NCT01062308|20677331|P2|NOT COMPLETED|Overall Study||10
8389255|NCT01062308|20677332|P1|NOT COMPLETED|Overall Study||16
8389256|NCT01062308|20677331|P2|COMPLETED|Overall Study||72
8389257|NCT01062308|20677332|P1|COMPLETED|Overall Study||64
8389258|NCT01062308|20677331|P2|STARTED|Overall Study||82
8389259|NCT01062308|20677332|P1|STARTED|Overall Study||80
8389260|NCT01062269|20677340|P1|NOT COMPLETED|Overall Study||0
8389261|NCT01062269|20677340|P1|COMPLETED|Overall Study||42
8389262|NCT01062269|20677340|P1|STARTED|Overall Study||42
8389263|NCT01062256|20677354|P3|NOT COMPLETED|Overall Study||4
8389264|NCT01062256|20677355|P2|NOT COMPLETED|Overall Study||7
8389265|NCT01062256|20677356|P1|NOT COMPLETED|Overall Study||3
8389266|NCT01062256|20677354|P3|COMPLETED|Overall Study||103
8389267|NCT01062256|20677355|P2|COMPLETED|Overall Study||96
8389268|NCT01062256|20677356|P1|COMPLETED|Overall Study||52
8389269|NCT01062256|20677354|P3|STARTED|Overall Study||107
8389270|NCT01062256|20677355|P2|STARTED|Overall Study||103
8389271|NCT01062256|20677356|P1|STARTED|Overall Study||55
8389272|NCT01062230|20677379|P1|NOT COMPLETED|Overall Study||0
8389273|NCT01062230|20677379|P1|COMPLETED|Overall Study||6
8389274|NCT01062230|20677379|P1|STARTED|Overall Study||6
8389275|NCT01062165|20677383|P1|NOT COMPLETED|Overall Study||0
8389276|NCT01062165|20677383|P1|COMPLETED|Overall Study||18
8389277|NCT01062165|20677383|P1|STARTED|Overall Study||18
8389278|NCT01062126|20677387|P1|NOT COMPLETED|Overall Study||533
8389279|NCT01062126|20677387|P1|COMPLETED|Overall Study||2856
8389280|NCT01062126|20677387|P1|STARTED|Overall Study||3389
8389290|NCT01062074|20677409|P1|NOT COMPLETED|Overall Study||0
8389291|NCT01062074|20677409|P1|COMPLETED|Overall Study||3605
8389292|NCT01062074|20677409|P1|STARTED|Overall Study||3605
8389293|NCT01062061|20677414|P1|NOT COMPLETED|Overall Study||27
8389294|NCT01062061|20677414|P1|COMPLETED|Overall Study||727
8389295|NCT01062061|20677414|P1|STARTED|Overall Study||754
8389296|NCT01062009|20677432|P4|NOT COMPLETED|Overall Study||0
8389297|NCT01062009|20677433|P3|NOT COMPLETED|Overall Study||0
8389298|NCT01062009|20677434|P2|NOT COMPLETED|Overall Study||0
8389299|NCT01062009|20677435|P1|NOT COMPLETED|Overall Study||1
8389300|NCT01062009|20677432|P4|COMPLETED|Overall Study||6
8389301|NCT01062009|20677433|P3|COMPLETED|Overall Study||6
8389302|NCT01062009|20677434|P2|COMPLETED|Overall Study||6
8389303|NCT01062009|20677435|P1|COMPLETED|Overall Study||6
8389304|NCT01062009|20677432|P4|STARTED|Overall Study||6
8389305|NCT01062009|20677433|P3|STARTED|Overall Study||6
8389306|NCT01062009|20677434|P2|STARTED|Overall Study||6
8389307|NCT01062009|20677435|P1|STARTED|Overall Study||7
8389308|NCT01061866|20677453|P1|NOT COMPLETED|Overall Study||2
8389309|NCT01061866|20677453|P1|COMPLETED|Overall Study||5
8389310|NCT01061866|20677453|P1|STARTED|Overall Study||7
8389311|NCT01061775|20677457|P1|NOT COMPLETED|Overall Study||3
8389312|NCT01061775|20677457|P1|COMPLETED|Overall Study||16
8389313|NCT01061775|20677457|P1|STARTED|Overall Study||19
8389314|NCT01061736|20677474|P10|NOT COMPLETED|Overall Study||74
8389315|NCT01061736|20677475|P9|NOT COMPLETED|Overall Study||97
8389316|NCT01061736|20677476|P8|NOT COMPLETED|Overall Study||94
8389317|NCT01061736|20677477|P7|NOT COMPLETED|Overall Study||84
8389318|NCT01061736|20677478|P6|NOT COMPLETED|Overall Study||3
8389319|NCT01061736|20677479|P5|NOT COMPLETED|Overall Study||7
8389320|NCT01061736|20677480|P4|NOT COMPLETED|Overall Study||3
8389321|NCT01061736|20677481|P3|NOT COMPLETED|Overall Study||6
8389322|NCT01061736|20677482|P2|NOT COMPLETED|Overall Study||4
8389323|NCT01061736|20677483|P1|NOT COMPLETED|Overall Study||13
8389324|NCT01061736|20677474|P10|COMPLETED|Overall Study||354
8389325|NCT01061736|20677475|P9|COMPLETED|Overall Study||330
8389326|NCT01061736|20677476|P8|COMPLETED|Overall Study||336
8389327|NCT01061736|20677477|P7|COMPLETED|Overall Study||0
8389328|NCT01061736|20677478|P6|COMPLETED|Overall Study||49
8389329|NCT01061736|20677479|P5|COMPLETED|Overall Study||45
8389330|NCT01061736|20677480|P4|COMPLETED|Overall Study||48
8389331|NCT01061736|20677481|P3|COMPLETED|Overall Study||45
8389332|NCT01061736|20677482|P2|COMPLETED|Overall Study||46
8389333|NCT01061736|20677483|P1|COMPLETED|Overall Study||37
8389334|NCT01061736|20677474|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
8389335|NCT01061736|20677475|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
8389336|NCT01061736|20677476|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
8389337|NCT01061736|20677477|P7|Rescued|Overall Study||0
8389338|NCT01061736|20677478|P6|Rescued|Overall Study||0
8389339|NCT01061736|20677479|P5|Rescued|Overall Study||0
8389340|NCT01061736|20677480|P4|Rescued|Overall Study||0
8389341|NCT01061736|20677481|P3|Rescued|Overall Study||0
8389342|NCT01061736|20677482|P2|Rescued|Overall Study||0
8389343|NCT01061736|20677483|P1|Rescued|Overall Study||0
8389344|NCT01061736|20677474|P10|Treated|Overall Study||428
8389345|NCT01061736|20677475|P9|Treated|Overall Study||426
8389346|NCT01061736|20677476|P8|Treated|Overall Study||428
8389347|NCT01061736|20677477|P7|Treated|Overall Study||84
8389348|NCT01061736|20677478|P6|Treated|Overall Study||52
8389349|NCT01061736|20677479|P5|Treated|Overall Study||51
8389350|NCT01061736|20677480|P4|Treated|Overall Study||51
8389351|NCT01061736|20677481|P3|Treated|Overall Study||51
8389352|NCT01061736|20677482|P2|Treated|Overall Study||50
8389353|NCT01061736|20677483|P1|Treated|Overall Study||50
8389354|NCT01061736|20677474|P10|STARTED|Overall Study||428
8389355|NCT01061736|20677475|P9|STARTED|Overall Study||427
8389356|NCT01061736|20677476|P8|STARTED|Overall Study||430
8389357|NCT01061736|20677477|P7|STARTED|Overall Study||84
8389358|NCT01061736|20677478|P6|STARTED|Overall Study||52
8389359|NCT01061736|20677479|P5|STARTED|Overall Study||52
8389360|NCT01061736|20677480|P4|STARTED|Overall Study||51
8389361|NCT01061736|20677481|P3|STARTED|Overall Study||51
8389362|NCT01061736|20677482|P2|STARTED|Overall Study||50
8389363|NCT01061736|20677483|P1|STARTED|Overall Study||50
8389364|NCT01061723|20677522|P6|NOT COMPLETED|Overall Study||9
8389365|NCT01061723|20677523|P5|NOT COMPLETED|Overall Study||3
8389366|NCT01061723|20677524|P4|NOT COMPLETED|Overall Study||8
8389367|NCT01061723|20677525|P3|NOT COMPLETED|Overall Study||10
8389368|NCT01061723|20677526|P2|NOT COMPLETED|Overall Study||6
8389369|NCT01061723|20677527|P1|NOT COMPLETED|Overall Study||4
8389370|NCT01061723|20677522|P6|COMPLETED|Overall Study||41
8389371|NCT01061723|20677523|P5|COMPLETED|Overall Study||47
8389372|NCT01061723|20677524|P4|COMPLETED|Overall Study||44
8389373|NCT01061723|20677525|P3|COMPLETED|Overall Study||40
8389374|NCT01061723|20677526|P2|COMPLETED|Overall Study||43
8389375|NCT01061723|20677527|P1|COMPLETED|Overall Study||46
8389376|NCT01061723|20677522|P6|Treated|Overall Study||49
8389377|NCT01061723|20677523|P5|Treated|Overall Study||50
8389378|NCT01061723|20677524|P4|Treated|Overall Study||52
8389379|NCT01061723|20677525|P3|Treated|Overall Study||50
8389380|NCT01061723|20677526|P2|Treated|Overall Study||49
8389381|NCT01061723|20677527|P1|Treated|Overall Study||50
8389382|NCT01061723|20677522|P6|STARTED|Overall Study||50
8389383|NCT01061723|20677523|P5|STARTED|Overall Study||50
8389384|NCT01061723|20677524|P4|STARTED|Overall Study||52
8389385|NCT01061723|20677525|P3|STARTED|Overall Study||50
8389386|NCT01061723|20677526|P2|STARTED|Overall Study||49
8389387|NCT01061723|20677527|P1|STARTED|Overall Study||50
8389388|NCT01061710|20677607|P1|NOT COMPLETED|Overall Study||14
8389389|NCT01061710|20677607|P1|COMPLETED|Overall Study||6
8389390|NCT01061710|20677607|P1|STARTED|Overall Study||20
8389391|NCT01061671|20677617|P2|NOT COMPLETED|Overall Study||55
8389392|NCT01061671|20677618|P1|NOT COMPLETED|Overall Study||47
8389393|NCT01061671|20677617|P2|COMPLETED|Overall Study||397
8389394|NCT01061671|20677618|P1|COMPLETED|Overall Study||386
8389395|NCT01061671|20677617|P2|STARTED|Overall Study||452
8389396|NCT01061671|20677618|P1|STARTED|Overall Study||433
8389397|NCT01061606|20677630|P1|NOT COMPLETED|Overall Study||8
8389398|NCT01061606|20677630|P1|COMPLETED|Overall Study||0
8389399|NCT01061606|20677630|P1|STARTED|Overall Study||8
8389400|NCT01061567|20677639|P1|NOT COMPLETED|Overall Study||76
8389401|NCT01061567|20677639|P1|COMPLETED|Overall Study||1738
8389402|NCT01061567|20677639|P1|STARTED|Overall Study||1814
8389403|NCT01061528|20677650|P2|NOT COMPLETED|Overall Study||2
8389404|NCT01061528|20677651|P1|NOT COMPLETED|Overall Study||3
8389405|NCT01061528|20677650|P2|COMPLETED|Overall Study||52
8389406|NCT01061528|20677651|P1|COMPLETED|Overall Study||59
8389407|NCT01061528|20677650|P2|STARTED|Overall Study||54
8389408|NCT01061528|20677651|P1|STARTED|Overall Study||62
8389409|NCT01061476|20677657|P1|NOT COMPLETED|Overall Study||0
8389410|NCT01061476|20677657|P1|COMPLETED|Overall Study||12
8389411|NCT01061476|20677657|P1|STARTED|Overall Study||12
8389412|NCT01061385|20677663|P2|NOT COMPLETED|Overall Study||1
8389413|NCT01061385|20677664|P1|NOT COMPLETED|Overall Study||1
8389414|NCT01061385|20677663|P2|COMPLETED|Overall Study||8
8389415|NCT01061385|20677664|P1|COMPLETED|Overall Study||20
8389416|NCT01061385|20677663|P2|STARTED|Overall Study||9
8389417|NCT01061385|20677664|P1|STARTED|Overall Study||21
8389418|NCT01061359|20677672|P1|NOT COMPLETED|Overall Study||1302
8389419|NCT01061359|20677672|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
8389420|NCT01061359|20677672|P1|STARTED|Overall Study||1972
8389421|NCT01061333|20677678|P2|NOT COMPLETED|Period 7: Mometasone||0
8389422|NCT01061333|20677679|P1|NOT COMPLETED|Period 7: Mometasone||0
8389423|NCT01061333|20677678|P2|COMPLETED|Period 7: Mometasone||7
8389424|NCT01061333|20677679|P1|COMPLETED|Period 7: Mometasone||8
8389425|NCT01061333|20677678|P2|STARTED|Period 7: Mometasone||7
8389426|NCT01061333|20677679|P1|STARTED|Period 7: Mometasone||8
8389427|NCT01061333|20677678|P2|NOT COMPLETED|Period 6: 20-day Washout||0
8389428|NCT01061333|20677679|P1|NOT COMPLETED|Period 6: 20-day Washout||0
8389429|NCT01061333|20677678|P2|COMPLETED|Period 6: 20-day Washout||7
8389430|NCT01061333|20677679|P1|COMPLETED|Period 6: 20-day Washout||8
8389431|NCT01061333|20677678|P2|STARTED|Period 6: 20-day Washout||7
8389432|NCT01061333|20677679|P1|STARTED|Period 6: 20-day Washout||8
8389433|NCT01061333|20677678|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
8389434|NCT01061333|20677679|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
8389435|NCT01061333|20677678|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
8389436|NCT01061333|20677679|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
8389437|NCT01061333|20677678|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
8389438|NCT01061333|20677679|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
8389439|NCT01061333|20677678|P2|NOT COMPLETED|Period 4: 20-day Washout||1
8389440|NCT01061333|20677679|P1|NOT COMPLETED|Period 4: 20-day Washout||0
8389441|NCT01061333|20677678|P2|COMPLETED|Period 4: 20-day Washout||7
8389442|NCT01061333|20677679|P1|COMPLETED|Period 4: 20-day Washout||8
8389443|NCT01061333|20677678|P2|STARTED|Period 4: 20-day Washout||8
8389444|NCT01061333|20677679|P1|STARTED|Period 4: 20-day Washout||8
8389445|NCT01061333|20677678|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
8389446|NCT01061333|20677679|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
8389447|NCT01061333|20677678|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
8389448|NCT01061333|20677679|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
8389449|NCT01061333|20677678|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
8389450|NCT01061333|20677679|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
8389451|NCT01061333|20677678|P2|NOT COMPLETED|Period 2: 20-day Washout||0
8389452|NCT01061333|20677679|P1|NOT COMPLETED|Period 2: 20-day Washout||0
8389453|NCT01061333|20677678|P2|COMPLETED|Period 2: 20-day Washout||8
8389454|NCT01061333|20677679|P1|COMPLETED|Period 2: 20-day Washout||8
8389455|NCT01061333|20677678|P2|STARTED|Period 2: 20-day Washout||8
8389456|NCT01061333|20677679|P1|STARTED|Period 2: 20-day Washout||8
8389457|NCT01061333|20677678|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
8389458|NCT01061333|20677679|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
8389459|NCT01061333|20677678|P2|COMPLETED|Period 1: Placebo Run-in||8
8389460|NCT01061333|20677679|P1|COMPLETED|Period 1: Placebo Run-in||8
8389461|NCT01061333|20677678|P2|STARTED|Period 1: Placebo Run-in||8
8389462|NCT01061333|20677679|P1|STARTED|Period 1: Placebo Run-in||8
8389463|NCT01061177|20677717|P1|NOT COMPLETED|Overall Study||208
8389464|NCT01061177|20677717|P1|COMPLETED|Overall Study||881
8389465|NCT01061177|20677717|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
8389466|NCT01061177|20677717|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
8389467|NCT01061177|20677717|P1|STARTED|Overall Study||1089
8389468|NCT01061151|20677740|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
8389469|NCT01061151|20677741|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
8389470|NCT01061151|20677742|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
8389471|NCT01061151|20677743|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
8389472|NCT01061151|20677740|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
8389473|NCT01061151|20677741|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
8389474|NCT01061151|20677742|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
8389475|NCT01061151|20677743|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
8389476|NCT01061151|20677740|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
8389477|NCT01061151|20677741|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
8389478|NCT01061151|20677742|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
8389479|NCT01061151|20677743|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
8389480|NCT01061151|20677740|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
8389481|NCT01061151|20677741|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
8389482|NCT01061151|20677742|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
8389483|NCT01061151|20677743|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
8389484|NCT01061151|20677740|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
8389485|NCT01061151|20677741|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
8389486|NCT01061151|20677742|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
8389487|NCT01061151|20677743|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
8389488|NCT01061151|20677740|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
8389489|NCT01061151|20677741|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
8389490|NCT01061151|20677742|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
8389491|NCT01061151|20677743|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
8389492|NCT01061151|20677740|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
8389493|NCT01061151|20677741|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
8389494|NCT01061151|20677742|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
8389495|NCT01061151|20677743|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
8389496|NCT01061151|20677740|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
8389497|NCT01061151|20677741|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
8389498|NCT01061151|20677742|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
8389499|NCT01061151|20677743|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
8389500|NCT01061034|20677795|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
8389501|NCT01061034|20677795|P1|COMPLETED|Aspirin Plus Omeprazole||9
8389502|NCT01061034|20677795|P1|STARTED|Aspirin Plus Omeprazole||9
8389503|NCT01061034|20677795|P1|NOT COMPLETED|Aspirin||0
8389504|NCT01061034|20677795|P1|COMPLETED|Aspirin||9
8389505|NCT01061034|20677795|P1|STARTED|Aspirin||9
8389506|NCT01061008|20677802|P2|NOT COMPLETED|Overall Study||6
8389507|NCT01061008|20677803|P1|NOT COMPLETED|Overall Study||6
8389508|NCT01061008|20677802|P2|COMPLETED|Overall Study||9
8389509|NCT01061008|20677803|P1|COMPLETED|Overall Study||10
8389510|NCT01061008|20677802|P2|STARTED|Overall Study||15
8389511|NCT01061008|20677803|P1|STARTED|Overall Study||16
8389512|NCT01060670|20677811|P2|NOT COMPLETED|Follow up Phase||35
8389513|NCT01060670|20677812|P1|NOT COMPLETED|Follow up Phase||22
8389514|NCT01060670|20677811|P2|COMPLETED|Follow up Phase||82
8389515|NCT01060670|20677812|P1|COMPLETED|Follow up Phase||106
8389516|NCT01060670|20677811|P2|Withdrew From Follow up Phase|Follow up Phase||35
8389517|NCT01060670|20677812|P1|Withdrew From Follow up Phase|Follow up Phase||22
8389518|NCT01060670|20677811|P2|Recurrence|Follow up Phase||9
8389519|NCT01060670|20677812|P1|Recurrence|Follow up Phase||14
8389520|NCT01060670|20677811|P2|STARTED|Follow up Phase||117
8389521|NCT01060670|20677812|P1|STARTED|Follow up Phase||128
8389522|NCT01060670|20677811|P2|NOT COMPLETED|Treatment Phase||36
8389523|NCT01060670|20677812|P1|NOT COMPLETED|Treatment Phase||26
8389524|NCT01060670|20677811|P2|COMPLETED|Treatment Phase||117
8389525|NCT01060670|20677812|P1|COMPLETED|Treatment Phase||128
8389526|NCT01060670|20677811|P2|Withdrew From Treatment|Treatment Phase||36
8389527|NCT01060670|20677812|P1|Withdrew From Treatment|Treatment Phase||26
8389528|NCT01060670|20677811|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
8389529|NCT01060670|20677812|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
8389530|NCT01060670|20677811|P2|Healed at End of Treatment Phase|Treatment Phase||49
8389531|NCT01060670|20677812|P1|Healed at End of Treatment Phase|Treatment Phase||79
8389532|NCT01060670|20677811|P2|STARTED|Treatment Phase||153
8389533|NCT01060670|20677812|P1|STARTED|Treatment Phase||154
8389534|NCT01060670|20677811|P2|NOT COMPLETED|Run In||238
8389535|NCT01060670|20677812|P1|NOT COMPLETED|Run In||0
8389536|NCT01060670|20677811|P2|COMPLETED|Run In||307
8389537|NCT01060670|20677812|P1|COMPLETED|Run In||0
8389538|NCT01060670|20677811|P2|STARTED|Run In||545
8389539|NCT01060670|20677812|P1|STARTED|Run In||0
8389540|NCT01060592|20677832|P2|NOT COMPLETED|12m||18
8389541|NCT01060592|20677833|P1|NOT COMPLETED|12m||0
8389542|NCT01060592|20677832|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
8389543|NCT01060592|20677833|P1|COMPLETED|12m||35
8389544|NCT01060592|20677832|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
8389545|NCT01060592|20677833|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
8389546|NCT01060592|20677832|P2|NOT COMPLETED|4-6w||10
8389547|NCT01060592|20677833|P1|NOT COMPLETED|4-6w||12
8389548|NCT01060592|20677832|P2|COMPLETED|4-6w||39
8389549|NCT01060592|20677833|P1|COMPLETED|4-6w||23
8389550|NCT01060592|20677832|P2|STARTED|4-6w||49
8389551|NCT01060592|20677833|P1|STARTED|4-6w||35
8389552|NCT01060553|20677847|P2|NOT COMPLETED|Overall Study||10
8389553|NCT01060553|20677848|P1|NOT COMPLETED|Overall Study||9
8389554|NCT01060553|20677847|P2|COMPLETED|Overall Study||5
8389555|NCT01060553|20677848|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
8389556|NCT01060553|20677847|P2|STARTED|Overall Study||15
8389557|NCT01060553|20677848|P1|STARTED|Overall Study||15
8389558|NCT01060540|20677855|P2|NOT COMPLETED|Overall Study||65
8389559|NCT01060540|20677856|P1|NOT COMPLETED|Overall Study||64
8389560|NCT01060540|20677855|P2|COMPLETED|Overall Study||233
8389561|NCT01060540|20677856|P1|COMPLETED|Overall Study||239
8389562|NCT01060540|20677855|P2|STARTED|Overall Study||298
8389563|NCT01060540|20677856|P1|STARTED|Overall Study||303
8389564|NCT01060384|20677870|P5|NOT COMPLETED|Overall Study||2
8389565|NCT01060384|20677871|P4|NOT COMPLETED|Overall Study||0
8389566|NCT01060384|20677872|P3|NOT COMPLETED|Overall Study||0
8389567|NCT01060384|20677873|P2|NOT COMPLETED|Overall Study||1
8389568|NCT01060384|20677874|P1|NOT COMPLETED|Overall Study||0
8389569|NCT01060384|20677870|P5|COMPLETED|Overall Study||34
8389570|NCT01060384|20677871|P4|COMPLETED|Overall Study||0
8389571|NCT01060384|20677872|P3|COMPLETED|Overall Study||0
8389572|NCT01060384|20677873|P2|COMPLETED|Overall Study||3
8389573|NCT01060384|20677874|P1|COMPLETED|Overall Study||6
8389574|NCT01060384|20677870|P5|STARTED|Overall Study||36
8389575|NCT01060384|20677871|P4|STARTED|Overall Study||0
8389576|NCT01060384|20677872|P3|STARTED|Overall Study||0
8389577|NCT01060384|20677873|P2|STARTED|Overall Study||4
8389578|NCT01060384|20677874|P1|STARTED|Overall Study||6
8389579|NCT01060345|20677883|P1|NOT COMPLETED|Overall Study||0
8389580|NCT01060345|20677883|P1|COMPLETED|Overall Study||20
8389581|NCT01060345|20677883|P1|STARTED|Overall Study||20
8389582|NCT01060150|20677893|P1|NOT COMPLETED|Overall Study||23
8389583|NCT01060150|20677893|P1|COMPLETED|Overall Study||92
8389584|NCT01060150|20677893|P1|Treated|Overall Study||113
8389585|NCT01060150|20677893|P1|STARTED|Overall Study||115
8389586|NCT01060124|20677908|P1|NOT COMPLETED|Overall Study||37
8389587|NCT01060124|20677908|P1|COMPLETED|Overall Study||66
8389588|NCT01060124|20677908|P1|STARTED|Overall Study||103
8389589|NCT01060111|20677919|P3|NOT COMPLETED|Overall Study||35
8389590|NCT01060111|20677920|P2|NOT COMPLETED|Overall Study||23
8389591|NCT01060111|20677921|P1|NOT COMPLETED|Overall Study||27
8389592|NCT01060111|20677919|P3|COMPLETED|Overall Study||45
8389593|NCT01060111|20677920|P2|COMPLETED|Overall Study||61
8389594|NCT01060111|20677921|P1|COMPLETED|Overall Study||54
8389595|NCT01060111|20677919|P3|Treated|Overall Study||79
8389596|NCT01060111|20677920|P2|Treated|Overall Study||83
8389597|NCT01060111|20677921|P1|Treated|Overall Study||81
8389598|NCT01060111|20677919|P3|STARTED|Overall Study||80
8389599|NCT01060111|20677920|P2|STARTED|Overall Study||84
8389600|NCT01060111|20677921|P1|STARTED|Overall Study||81
8389601|NCT01060098|20677941|P3|NOT COMPLETED|Overall Study||0
8389602|NCT01060098|20677942|P2|NOT COMPLETED|Overall Study||0
8389603|NCT01060098|20677943|P1|NOT COMPLETED|Overall Study||0
8389604|NCT01060098|20677941|P3|COMPLETED|Overall Study||8
8389605|NCT01060098|20677942|P2|COMPLETED|Overall Study||15
8389606|NCT01060098|20677943|P1|COMPLETED|Overall Study||25
8389607|NCT01060098|20677941|P3|STARTED|Overall Study||8
8389608|NCT01060098|20677942|P2|STARTED|Overall Study||15
8389609|NCT01060098|20677943|P1|STARTED|Overall Study||25
8389610|NCT01060072|20677953|P2|NOT COMPLETED|Overall Study||5
8389611|NCT01060072|20677954|P1|NOT COMPLETED|Overall Study||2
8389612|NCT01060072|20677953|P2|COMPLETED|Overall Study||196
8389613|NCT01060072|20677954|P1|COMPLETED|Overall Study||204
8389614|NCT01060072|20677953|P2|STARTED|Overall Study||201
8389615|NCT01060072|20677954|P1|STARTED|Overall Study||206
8389616|NCT01060059|20677970|P2|NOT COMPLETED|Overall Study||67
8389617|NCT01060059|20677971|P1|NOT COMPLETED|Overall Study||67
8389618|NCT01060059|20677970|P2|COMPLETED|Overall Study||371
8389619|NCT01060059|20677971|P1|COMPLETED|Overall Study||377
8389620|NCT01060059|20677970|P2|STARTED|Overall Study||438
8389621|NCT01060059|20677971|P1|STARTED|Overall Study||444
8389622|NCT01060020|20678021|P1|NOT COMPLETED|Overall Study||0
8389623|NCT01060020|20678021|P1|COMPLETED|Overall Study||20
8389624|NCT01060020|20678021|P1|STARTED|Overall Study||20
8389625|NCT01060007|20678029|P1|NOT COMPLETED|Overall Study||4
8389626|NCT01060007|20678029|P1|COMPLETED|Overall Study||76
8389627|NCT01060007|20678029|P1|STARTED|Overall Study||80
8389628|NCT01059994|20678047|P4|NOT COMPLETED|Overall Study||1
8389629|NCT01059994|20678048|P3|NOT COMPLETED|Overall Study||0
8389630|NCT01059994|20678049|P2|NOT COMPLETED|Overall Study||0
8389631|NCT01059994|20678050|P1|NOT COMPLETED|Overall Study||0
8389632|NCT01059994|20678047|P4|COMPLETED|Overall Study||3
8389633|NCT01059994|20678048|P3|COMPLETED|Overall Study||3
8389634|NCT01059994|20678049|P2|COMPLETED|Overall Study||2
8389635|NCT01059994|20678050|P1|COMPLETED|Overall Study||3
8389636|NCT01059994|20678047|P4|STARTED|Overall Study||4
8389637|NCT01059994|20678048|P3|STARTED|Overall Study||3
8389638|NCT01059994|20678049|P2|STARTED|Overall Study||2
8389639|NCT01059994|20678050|P1|STARTED|Overall Study||3
8389640|NCT01059929|20678066|P2|NOT COMPLETED|Overall Study||0
8389641|NCT01059929|20678067|P1|NOT COMPLETED|Overall Study||0
8389642|NCT01059929|20678066|P2|COMPLETED|Overall Study||21
8389643|NCT01059929|20678067|P1|COMPLETED|Overall Study||20
8389644|NCT01059929|20678066|P2|STARTED|Overall Study||21
8389645|NCT01059929|20678067|P1|STARTED|Overall Study||20
8389646|NCT01059903|20678097|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
8389647|NCT01059903|20678098|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
8389648|NCT01059903|20678097|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
8389649|NCT01059903|20678098|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
8389650|NCT01059903|20678097|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
8389651|NCT01059903|20678098|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
8389652|NCT01059903|20678097|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
8389653|NCT01059903|20678098|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
8389654|NCT01059903|20678097|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
8389655|NCT01059903|20678098|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
8389656|NCT01059903|20678097|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
8389657|NCT01059903|20678098|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
8389658|NCT01059903|20678097|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
8389659|NCT01059903|20678098|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
8389660|NCT01059903|20678097|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
8389661|NCT01059903|20678098|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
8389662|NCT01059903|20678097|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
8389663|NCT01059903|20678098|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
8389664|NCT01059903|20678097|P2|STARTED|Period 1: First Intervention- 24 Hours||25
8389665|NCT01059903|20678098|P1|STARTED|Period 1: First Intervention- 24 Hours||25
8389666|NCT01059877|20678134|P2|NOT COMPLETED|Overall Study||2
8389667|NCT01059877|20678135|P1|NOT COMPLETED|Overall Study||0
8389668|NCT01059877|20678134|P2|COMPLETED|Overall Study||3
8389669|NCT01059877|20678135|P1|COMPLETED|Overall Study||6
8389670|NCT01059877|20678134|P2|STARTED|Overall Study||5
8389671|NCT01059877|20678135|P1|STARTED|Overall Study||6
8389672|NCT01059864|20678141|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
8389673|NCT01059864|20678142|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
8389674|NCT01059864|20678143|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
8389675|NCT01059864|20678141|P3|COMPLETED|Double-Blind Treatment Phase||45
8389676|NCT01059864|20678142|P2|COMPLETED|Double-Blind Treatment Phase||47
8389677|NCT01059864|20678143|P1|COMPLETED|Double-Blind Treatment Phase||0
8389678|NCT01059864|20678141|P3|Treated|Double-Blind Treatment Phase||47
8389679|NCT01059864|20678142|P2|Treated|Double-Blind Treatment Phase||50
8389680|NCT01059864|20678143|P1|Treated|Double-Blind Treatment Phase||0
8389681|NCT01059864|20678141|P3|STARTED|Double-Blind Treatment Phase||48
8389682|NCT01059864|20678142|P2|STARTED|Double-Blind Treatment Phase||50
8389683|NCT01059864|20678143|P1|STARTED|Double-Blind Treatment Phase||0
8389684|NCT01059864|20678141|P3|NOT COMPLETED|Open-Label Run-In Phase||0
8389685|NCT01059864|20678142|P2|NOT COMPLETED|Open-Label Run-In Phase||0
8389686|NCT01059864|20678143|P1|NOT COMPLETED|Open-Label Run-In Phase||13
8389687|NCT01059864|20678141|P3|COMPLETED|Open-Label Run-In Phase||0
8389688|NCT01059864|20678142|P2|COMPLETED|Open-Label Run-In Phase||0
8389689|NCT01059864|20678143|P1|COMPLETED|Open-Label Run-In Phase||98
8389690|NCT01059864|20678141|P3|STARTED|Open-Label Run-In Phase||0
8389691|NCT01059864|20678142|P2|STARTED|Open-Label Run-In Phase||0
8389692|NCT01059864|20678143|P1|STARTED|Open-Label Run-In Phase||111
8389693|NCT01059851|20678192|P6|NOT COMPLETED|Overall Study||0
8389694|NCT01059851|20678193|P5|NOT COMPLETED|Overall Study||0
8389695|NCT01059851|20678194|P4|NOT COMPLETED|Overall Study||0
8389696|NCT01059851|20678195|P3|NOT COMPLETED|Overall Study||0
8389697|NCT01059851|20678196|P2|NOT COMPLETED|Overall Study||0
8389698|NCT01059851|20678197|P1|NOT COMPLETED|Overall Study||0
8389699|NCT01059851|20678192|P6|COMPLETED|Overall Study||0
8389700|NCT01059851|20678193|P5|COMPLETED|Overall Study||0
8389701|NCT01059851|20678194|P4|COMPLETED|Overall Study||0
8389702|NCT01059851|20678195|P3|COMPLETED|Overall Study||0
8389703|NCT01059851|20678196|P2|COMPLETED|Overall Study||8
8389704|NCT01059851|20678197|P1|COMPLETED|Overall Study||8
8389705|NCT01059851|20678192|P6|STARTED|Overall Study||0
8389706|NCT01059851|20678193|P5|STARTED|Overall Study||0
8389707|NCT01059851|20678194|P4|STARTED|Overall Study||0
8389708|NCT01059851|20678195|P3|STARTED|Overall Study||0
8389709|NCT01059851|20678196|P2|STARTED|Overall Study||8
8389710|NCT01059851|20678197|P1|STARTED|Overall Study||8
8389711|NCT01059825|20678217|P7|NOT COMPLETED|Treatment Period||0
8389712|NCT01059825|20678218|P6|NOT COMPLETED|Treatment Period||3
8389713|NCT01059825|20678219|P5|NOT COMPLETED|Treatment Period||8
8389714|NCT01059825|20678220|P4|NOT COMPLETED|Treatment Period||11
8389715|NCT01059825|20678221|P3|NOT COMPLETED|Treatment Period||6
8389716|NCT01059825|20678222|P2|NOT COMPLETED|Treatment Period||4
8389717|NCT01059825|20678223|P1|NOT COMPLETED|Treatment Period||10
8389718|NCT01059825|20678217|P7|COMPLETED|Treatment Period||0
8389719|NCT01059825|20678218|P6|COMPLETED|Treatment Period||52
8389720|NCT01059825|20678219|P5|COMPLETED|Treatment Period||47
8389721|NCT01059825|20678220|P4|COMPLETED|Treatment Period||44
8389722|NCT01059825|20678221|P3|COMPLETED|Treatment Period||49
8389723|NCT01059825|20678222|P2|COMPLETED|Treatment Period||50
8389724|NCT01059825|20678223|P1|COMPLETED|Treatment Period||44
8389725|NCT01059825|20678217|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
8389726|NCT01059825|20678218|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389727|NCT01059825|20678219|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389728|NCT01059825|20678220|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389729|NCT01059825|20678221|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389730|NCT01059825|20678222|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
8389731|NCT01059825|20678223|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
8389732|NCT01059825|20678217|P7|NOT COMPLETED|Enrolled, Run-in Period||47
8389733|NCT01059825|20678218|P6|NOT COMPLETED|Enrolled, Run-in Period||0
8389734|NCT01059825|20678219|P5|NOT COMPLETED|Enrolled, Run-in Period||0
8389735|NCT01059825|20678220|P4|NOT COMPLETED|Enrolled, Run-in Period||0
8389736|NCT01059825|20678221|P3|NOT COMPLETED|Enrolled, Run-in Period||0
8389737|NCT01059825|20678222|P2|NOT COMPLETED|Enrolled, Run-in Period||0
8389738|NCT01059825|20678223|P1|NOT COMPLETED|Enrolled, Run-in Period||0
8389739|NCT01059825|20678217|P7|COMPLETED|Enrolled, Run-in Period||328
8389740|NCT01059825|20678218|P6|COMPLETED|Enrolled, Run-in Period||0
8389741|NCT01059825|20678219|P5|COMPLETED|Enrolled, Run-in Period||0
8389742|NCT01059825|20678220|P4|COMPLETED|Enrolled, Run-in Period||0
8389743|NCT01059825|20678221|P3|COMPLETED|Enrolled, Run-in Period||0
8389744|NCT01059825|20678222|P2|COMPLETED|Enrolled, Run-in Period||0
8389745|NCT01059825|20678223|P1|COMPLETED|Enrolled, Run-in Period||0
8389746|NCT01059825|20678217|P7|STARTED|Enrolled, Run-in Period||375
8389747|NCT01059825|20678218|P6|STARTED|Enrolled, Run-in Period||0
8389748|NCT01059825|20678219|P5|STARTED|Enrolled, Run-in Period||0
8389749|NCT01059825|20678220|P4|STARTED|Enrolled, Run-in Period||0
8389750|NCT01059825|20678221|P3|STARTED|Enrolled, Run-in Period||0
8389751|NCT01059825|20678222|P2|STARTED|Enrolled, Run-in Period||0
8389752|NCT01059825|20678223|P1|STARTED|Enrolled, Run-in Period||0
8389753|NCT01059812|20678410|P2|NOT COMPLETED|Overall Study||16
8389754|NCT01059812|20678411|P1|NOT COMPLETED|Overall Study||37
8389755|NCT01059812|20678410|P2|COMPLETED|Overall Study||126
8389756|NCT01059812|20678411|P1|COMPLETED|Overall Study||245
8389757|NCT01059812|20678410|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
8389758|NCT01059812|20678411|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
8389759|NCT01059812|20678410|P2|STARTED|Overall Study||142
8389760|NCT01059812|20678411|P1|STARTED|Overall Study||282
8389761|NCT01059799|20678427|P2|NOT COMPLETED|Overall Study||10
8389762|NCT01059799|20678428|P1|NOT COMPLETED|Overall Study||31
8389763|NCT01059799|20678427|P2|COMPLETED|Overall Study||136
8389764|NCT01059799|20678428|P1|COMPLETED|Overall Study||258
8389765|NCT01059799|20678427|P2|Exposed|Overall Study||146
8389766|NCT01059799|20678428|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
8389767|NCT01059799|20678427|P2|STARTED|Overall Study||146
8389768|NCT01059799|20678428|P1|STARTED|Overall Study||289
8389769|NCT01059773|20678442|P2|NOT COMPLETED|Overall Study||24
8389770|NCT01059773|20678443|P1|NOT COMPLETED|Overall Study||20
8389771|NCT01059773|20678442|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
8389772|NCT01059773|20678443|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
8389773|NCT01059773|20678442|P2|STARTED|Overall Study||245
8389774|NCT01059773|20678443|P1|STARTED|Overall Study||244
8389775|NCT01059760|20678475|P2|NOT COMPLETED|Overall Study||0
8389776|NCT01059760|20678476|P1|NOT COMPLETED|Overall Study||0
8389777|NCT01059760|20678475|P2|COMPLETED|Overall Study||14
8389778|NCT01059760|20678476|P1|COMPLETED|Overall Study||16
8389779|NCT01059760|20678475|P2|STARTED|Overall Study||14
8389780|NCT01059760|20678476|P1|STARTED|Overall Study||16
8389781|NCT01059682|20678584|P2|NOT COMPLETED|Overall Study||18
8389782|NCT01059682|20678585|P1|NOT COMPLETED|Overall Study||10
8389783|NCT01059682|20678584|P2|COMPLETED|Overall Study||444
8389784|NCT01059682|20678585|P1|COMPLETED|Overall Study||464
8389785|NCT01059682|20678584|P2|STARTED|Overall Study||462
8389786|NCT01059682|20678585|P1|STARTED|Overall Study||474
8389787|NCT01059643|20678599|P1|NOT COMPLETED|Overall Study||6
8389788|NCT01059643|20678599|P1|COMPLETED|Overall Study||97
8389789|NCT01059643|20678599|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
8389790|NCT01059643|20678599|P1|STARTED|Overall Study||103
8389791|NCT01059630|20678614|P2|NOT COMPLETED|Overall Study||103
8389792|NCT01059630|20678615|P1|NOT COMPLETED|Overall Study||127
8389793|NCT01059630|20678614|P2|COMPLETED|Overall Study||101
8389794|NCT01059630|20678615|P1|COMPLETED|Overall Study||82
8389795|NCT01059630|20678614|P2|STARTED|Overall Study||204
8389796|NCT01059630|20678615|P1|STARTED|Overall Study||209
8389797|NCT01059617|20678689|P4|NOT COMPLETED|Overall Study||6
8389798|NCT01059617|20678690|P3|NOT COMPLETED|Overall Study||8
8389799|NCT01059617|20678691|P2|NOT COMPLETED|Overall Study||1
8389800|NCT01059617|20678692|P1|NOT COMPLETED|Overall Study||7
8389801|NCT01059617|20678689|P4|COMPLETED|Overall Study||27
8389802|NCT01059617|20678690|P3|COMPLETED|Overall Study||25
8389803|NCT01059617|20678691|P2|COMPLETED|Overall Study||33
8389804|NCT01059617|20678692|P1|COMPLETED|Overall Study||26
8389805|NCT01059617|20678689|P4|STARTED|Overall Study||33
8389806|NCT01059617|20678690|P3|STARTED|Overall Study||33
8389807|NCT01059617|20678691|P2|STARTED|Overall Study||34
8389808|NCT01059617|20678692|P1|STARTED|Overall Study||33
8389809|NCT01059565|20678862|P2|NOT COMPLETED|24-Week Open-Label Phase||3
8389810|NCT01059565|20678863|P1|NOT COMPLETED|24-Week Open-Label Phase||5
8389811|NCT01059565|20678862|P2|COMPLETED|24-Week Open-Label Phase||42
8389812|NCT01059565|20678863|P1|COMPLETED|24-Week Open-Label Phase||34
8389813|NCT01059565|20678862|P2|STARTED|24-Week Open-Label Phase||45
8389814|NCT01059565|20678863|P1|STARTED|24-Week Open-Label Phase||39
8389815|NCT01059565|20678862|P2|NOT COMPLETED|24-Week Randomized Phase||7
8389816|NCT01059565|20678863|P1|NOT COMPLETED|24-Week Randomized Phase||10
8389817|NCT01059565|20678862|P2|COMPLETED|24-Week Randomized Phase||45
8389818|NCT01059565|20678863|P1|COMPLETED|24-Week Randomized Phase||39
8389819|NCT01059565|20678862|P2|Randomized and Treated|24-Week Randomized Phase||52
8389820|NCT01059565|20678863|P1|Randomized and Treated|24-Week Randomized Phase||48
8389821|NCT01059565|20678862|P2|STARTED|24-Week Randomized Phase||52
8389822|NCT01059565|20678863|P1|STARTED|24-Week Randomized Phase||49
8389823|NCT01059539|20678897|P1|NOT COMPLETED|Overall Study||271
8389824|NCT01059539|20678897|P1|COMPLETED|Overall Study||132
8389825|NCT01059539|20678897|P1|STARTED|Overall Study||403
8389826|NCT01059526|20678904|P2|NOT COMPLETED|Overall Study||22
8389827|NCT01059526|20678905|P1|NOT COMPLETED|Overall Study||30
8389828|NCT01059526|20678904|P2|COMPLETED|Overall Study||18
8389829|NCT01059526|20678905|P1|COMPLETED|Overall Study||11
8389830|NCT01059526|20678904|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
8389831|NCT01059526|20678905|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
8389832|NCT01059526|20678904|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
8389833|NCT01059526|20678905|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
8389834|NCT01059435|20678923|P10|NOT COMPLETED|Overall Study||0
8389835|NCT01059435|20678924|P9|NOT COMPLETED|Overall Study||0
8389836|NCT01059435|20678925|P8|NOT COMPLETED|Overall Study||0
8389837|NCT01059435|20678926|P7|NOT COMPLETED|Overall Study||0
8389838|NCT01059435|20678927|P6|NOT COMPLETED|Overall Study||0
8389839|NCT01059435|20678928|P5|NOT COMPLETED|Overall Study||0
8389840|NCT01059435|20678929|P4|NOT COMPLETED|Overall Study||0
8389841|NCT01059435|20678930|P3|NOT COMPLETED|Overall Study||2
8389842|NCT01059435|20678931|P2|NOT COMPLETED|Overall Study||0
8389843|NCT01059435|20678932|P1|NOT COMPLETED|Overall Study||0
8389844|NCT01059435|20678923|P10|COMPLETED|Overall Study||6
8389845|NCT01059435|20678924|P9|COMPLETED|Overall Study||6
8389846|NCT01059435|20678925|P8|COMPLETED|Overall Study||4
8389847|NCT01059435|20678926|P7|COMPLETED|Overall Study||6
8389848|NCT01059435|20678927|P6|COMPLETED|Overall Study||9
8389849|NCT01059435|20678928|P5|COMPLETED|Overall Study||6
8389850|NCT01059435|20678929|P4|COMPLETED|Overall Study||9
8389851|NCT01059435|20678930|P3|COMPLETED|Overall Study||6
8389852|NCT01059435|20678931|P2|COMPLETED|Overall Study||6
8389853|NCT01059435|20678932|P1|COMPLETED|Overall Study||14
8389854|NCT01059435|20678923|P10|Received Study Drug|Overall Study||6
8389855|NCT01059435|20678924|P9|Received Study Drug|Overall Study||6
8389856|NCT01059435|20678925|P8|Received Study Drug|Overall Study||4
8389857|NCT01059435|20678926|P7|Received Study Drug|Overall Study||6
8389858|NCT01059435|20678927|P6|Received Study Drug|Overall Study||9
8389859|NCT01059435|20678928|P5|Received Study Drug|Overall Study||6
8389860|NCT01059435|20678929|P4|Received Study Drug|Overall Study||9
8389861|NCT01059435|20678930|P3|Received Study Drug|Overall Study||6
8389862|NCT01059435|20678931|P2|Received Study Drug|Overall Study||6
8389863|NCT01059435|20678932|P1|Received Study Drug|Overall Study||14
8389864|NCT01059435|20678923|P10|STARTED|Overall Study||6
8389865|NCT01059435|20678924|P9|STARTED|Overall Study||6
8389866|NCT01059435|20678925|P8|STARTED|Overall Study||4
8389867|NCT01059435|20678926|P7|STARTED|Overall Study||6
8389868|NCT01059435|20678927|P6|STARTED|Overall Study||9
8389869|NCT01059435|20678928|P5|STARTED|Overall Study||6
8389870|NCT01059435|20678929|P4|STARTED|Overall Study||9
8389871|NCT01059435|20678930|P3|STARTED|Overall Study||8
8389872|NCT01059435|20678931|P2|STARTED|Overall Study||6
8389873|NCT01059435|20678932|P1|STARTED|Overall Study||14
8389874|NCT01059357|20679240|P1|NOT COMPLETED|Overall Study||4
8389875|NCT01059357|20679240|P1|COMPLETED|Overall Study||54
8389876|NCT01059357|20679240|P1|STARTED|Overall Study||58
8389877|NCT01059344|20679251|P2|NOT COMPLETED|Overall Study||46
8389878|NCT01059344|20679252|P1|NOT COMPLETED|Overall Study||22
8389879|NCT01059344|20679251|P2|COMPLETED|Overall Study||95
8389880|NCT01059344|20679252|P1|COMPLETED|Overall Study||118
8389881|NCT01059344|20679251|P2|STARTED|Overall Study||141
8389882|NCT01059344|20679252|P1|STARTED|Overall Study||140
8389883|NCT01059318|20679270|P1|NOT COMPLETED|Extension (36 Week)||3
8389884|NCT01059318|20679270|P1|COMPLETED|Extension (36 Week)||17
8389885|NCT01059318|20679270|P1|STARTED|Extension (36 Week)||20
8389886|NCT01059318|20679270|P1|NOT COMPLETED|Core Study (26 Week)||4
8389887|NCT01059318|20679270|P1|COMPLETED|Core Study (26 Week)||20
8389888|NCT01059318|20679270|P1|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
8389889|NCT01059318|20679270|P1|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
8389890|NCT01059318|20679270|P1|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
8389891|NCT01059318|20679270|P1|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
8389892|NCT01059318|20679270|P1|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
8389893|NCT01059305|20679285|P1|NOT COMPLETED|Overall Study||0
8389894|NCT01059305|20679285|P1|COMPLETED|Overall Study||10
8389895|NCT01059305|20679285|P1|STARTED|Overall Study||10
8389896|NCT01059175|20679291|P2|NOT COMPLETED|Overall Study||20
8389897|NCT01059175|20679292|P1|NOT COMPLETED|Overall Study||21
8389898|NCT01059175|20679291|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
8389899|NCT01059175|20679292|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
8389900|NCT01059175|20679291|P2|STARTED|Overall Study||41
8389901|NCT01059175|20679292|P1|STARTED|Overall Study||43
8389902|NCT01059071|20679314|P4|NOT COMPLETED|Overall Study||6
8389903|NCT01059071|20679315|P3|NOT COMPLETED|Overall Study||2
8389904|NCT01059071|20679316|P2|NOT COMPLETED|Overall Study||4
8389905|NCT01059071|20679317|P1|NOT COMPLETED|Overall Study||2
8389906|NCT01059071|20679314|P4|COMPLETED|Overall Study||3
8389907|NCT01059071|20679315|P3|COMPLETED|Overall Study||1
8389908|NCT01059071|20679316|P2|COMPLETED|Overall Study||1
8389909|NCT01059071|20679317|P1|COMPLETED|Overall Study||2
8389910|NCT01059071|20679314|P4|STARTED|Overall Study||9
8389911|NCT01059071|20679315|P3|STARTED|Overall Study||3
8389912|NCT01059071|20679316|P2|STARTED|Overall Study||5
8389913|NCT01059071|20679317|P1|STARTED|Overall Study||4
8389914|NCT01058993|20679329|P1|NOT COMPLETED|Overall Study||0
8389915|NCT01058993|20679329|P1|COMPLETED|Overall Study||6
8389916|NCT01058993|20679329|P1|STARTED|Overall Study||6
8389917|NCT01058941|20679335|P2|NOT COMPLETED|Overall Study||11
8389918|NCT01058941|20679336|P1|NOT COMPLETED|Overall Study||9
8389919|NCT01058941|20679335|P2|COMPLETED|Overall Study||22
8389920|NCT01058941|20679336|P1|COMPLETED|Overall Study||25
8389921|NCT01058941|20679335|P2|STARTED|Overall Study||33
8389922|NCT01058941|20679336|P1|STARTED|Overall Study||34
8389923|NCT01058863|20679344|P1|NOT COMPLETED|Overall Study||4
8389924|NCT01058863|20679344|P1|COMPLETED|Overall Study||68
8389925|NCT01058863|20679344|P1|Treated With Placebo Inhaler|Overall Study||69
8389926|NCT01058863|20679344|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
8389927|NCT01058863|20679344|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
8389928|NCT01058863|20679344|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
8389929|NCT01058863|20679344|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
8389930|NCT01058863|20679344|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
8389931|NCT01058863|20679344|P1|STARTED|Overall Study||72
8389932|NCT01058707|20679369|P7|NOT COMPLETED|Overall Study||26
8389933|NCT01058707|20679370|P6|NOT COMPLETED|Overall Study||17
8389934|NCT01058707|20679371|P5|NOT COMPLETED|Overall Study||39
8389935|NCT01058707|20679372|P4|NOT COMPLETED|Overall Study||22
8389936|NCT01058707|20679373|P3|NOT COMPLETED|Overall Study||33
8389937|NCT01058707|20679374|P2|NOT COMPLETED|Overall Study||30
8389938|NCT01058707|20679375|P1|NOT COMPLETED|Overall Study||31
8389939|NCT01058707|20679369|P7|COMPLETED|Overall Study||0
8389940|NCT01058707|20679370|P6|COMPLETED|Overall Study||0
8389941|NCT01058707|20679371|P5|COMPLETED|Overall Study||0
8389942|NCT01058707|20679372|P4|COMPLETED|Overall Study||0
8389943|NCT01058707|20679373|P3|COMPLETED|Overall Study||0
8389944|NCT01058707|20679374|P2|COMPLETED|Overall Study||0
8389945|NCT01058707|20679375|P1|COMPLETED|Overall Study||0
8389946|NCT01058707|20679369|P7|STARTED|Overall Study||26
8389947|NCT01058707|20679370|P6|STARTED|Overall Study||17
8389948|NCT01058707|20679371|P5|STARTED|Overall Study||39
8389949|NCT01058707|20679372|P4|STARTED|Overall Study||22
8389950|NCT01058707|20679373|P3|STARTED|Overall Study||33
8389951|NCT01058707|20679374|P2|STARTED|Overall Study||30
8389952|NCT01058707|20679375|P1|STARTED|Overall Study||31
8389953|NCT01058668|20679541|P3|NOT COMPLETED|Safety Follow-up||7
8389954|NCT01058668|20679542|P2|NOT COMPLETED|Safety Follow-up||0
8389955|NCT01058668|20679543|P1|NOT COMPLETED|Safety Follow-up||5
8389956|NCT01058668|20679541|P3|COMPLETED|Safety Follow-up||141
8389957|NCT01058668|20679542|P2|COMPLETED|Safety Follow-up||146
8389958|NCT01058668|20679543|P1|COMPLETED|Safety Follow-up||139
8389959|NCT01058668|20679541|P3|STARTED|Safety Follow-up||148
8389960|NCT01058668|20679542|P2|STARTED|Safety Follow-up||146
8389961|NCT01058668|20679543|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
8389962|NCT01058668|20679541|P3|NOT COMPLETED|Double-blind Treatment Phase||50
8389963|NCT01058668|20679542|P2|NOT COMPLETED|Double-blind Treatment Phase||38
8389964|NCT01058668|20679543|P1|NOT COMPLETED|Double-blind Treatment Phase||39
8389965|NCT01058668|20679541|P3|COMPLETED|Double-blind Treatment Phase||119
8389966|NCT01058668|20679542|P2|COMPLETED|Double-blind Treatment Phase||129
8389967|NCT01058668|20679543|P1|COMPLETED|Double-blind Treatment Phase||122
8389968|NCT01058668|20679541|P3|STARTED|Double-blind Treatment Phase||169
8389969|NCT01058668|20679542|P2|STARTED|Double-blind Treatment Phase||167
8389970|NCT01058668|20679543|P1|STARTED|Double-blind Treatment Phase||161
8389971|NCT01058655|20679558|P4|NOT COMPLETED|Overall Study||42
8389972|NCT01058655|20679559|P3|NOT COMPLETED|Overall Study||8
8389973|NCT01058655|20679560|P2|NOT COMPLETED|Overall Study||3
8389974|NCT01058655|20679561|P1|NOT COMPLETED|Overall Study||3
8389975|NCT01058655|20679558|P4|COMPLETED|Overall Study||0
8389976|NCT01058655|20679559|P3|COMPLETED|Overall Study||0
8389977|NCT01058655|20679560|P2|COMPLETED|Overall Study||0
8389978|NCT01058655|20679561|P1|COMPLETED|Overall Study||0
8389979|NCT01058655|20679558|P4|Evaluable|Overall Study||40
8389980|NCT01058655|20679559|P3|Evaluable|Overall Study||6
8389981|NCT01058655|20679560|P2|Evaluable|Overall Study||3
8389982|NCT01058655|20679561|P1|Evaluable|Overall Study||3
8389983|NCT01058655|20679558|P4|STARTED|Overall Study||42
8389984|NCT01058655|20679559|P3|STARTED|Overall Study||8
8389985|NCT01058655|20679560|P2|STARTED|Overall Study||3
8389986|NCT01058655|20679561|P1|STARTED|Overall Study||3
8389987|NCT01058642|20679579|P4|NOT COMPLETED|Treatment Period 2||0
8389988|NCT01058642|20679580|P3|NOT COMPLETED|Treatment Period 2||0
8389989|NCT01058642|20679581|P2|NOT COMPLETED|Treatment Period 2||0
8389990|NCT01058642|20679582|P1|NOT COMPLETED|Treatment Period 2||0
8389991|NCT01058642|20679579|P4|COMPLETED|Treatment Period 2||7
8389992|NCT01058642|20679580|P3|COMPLETED|Treatment Period 2||9
8389993|NCT01058642|20679581|P2|COMPLETED|Treatment Period 2||11
8389994|NCT01058642|20679582|P1|COMPLETED|Treatment Period 2||7
8389995|NCT01058642|20679579|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
8389996|NCT01058642|20679580|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
8389997|NCT01058642|20679581|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
8389998|NCT01058642|20679582|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
8389999|NCT01058642|20679579|P4|STARTED|Treatment Period 2||7
8390000|NCT01058642|20679580|P3|STARTED|Treatment Period 2||9
8390001|NCT01058642|20679581|P2|STARTED|Treatment Period 2||11
8390002|NCT01058642|20679582|P1|STARTED|Treatment Period 2||7
8390003|NCT01058642|20679579|P4|NOT COMPLETED|Washout Period||0
8390004|NCT01058642|20679580|P3|NOT COMPLETED|Washout Period||0
8390005|NCT01058642|20679581|P2|NOT COMPLETED|Washout Period||0
8390006|NCT01058642|20679582|P1|NOT COMPLETED|Washout Period||0
8390007|NCT01058642|20679579|P4|COMPLETED|Washout Period||7
8390008|NCT01058642|20679580|P3|COMPLETED|Washout Period||9
8390009|NCT01058642|20679581|P2|COMPLETED|Washout Period||11
8390010|NCT01058642|20679582|P1|COMPLETED|Washout Period||7
8390011|NCT01058642|20679579|P4|STARTED|Washout Period||7
8390012|NCT01058642|20679580|P3|STARTED|Washout Period||9
8390013|NCT01058642|20679581|P2|STARTED|Washout Period||11
8390014|NCT01058642|20679582|P1|STARTED|Washout Period||7
8390015|NCT01058642|20679579|P4|NOT COMPLETED|Treatment Period 1||2
8390016|NCT01058642|20679580|P3|NOT COMPLETED|Treatment Period 1||2
8390017|NCT01058642|20679581|P2|NOT COMPLETED|Treatment Period 1||1
8390018|NCT01058642|20679582|P1|NOT COMPLETED|Treatment Period 1||2
8390019|NCT01058642|20679579|P4|COMPLETED|Treatment Period 1||7
8390020|NCT01058642|20679580|P3|COMPLETED|Treatment Period 1||9
8390021|NCT01058642|20679581|P2|COMPLETED|Treatment Period 1||11
8390022|NCT01058642|20679582|P1|COMPLETED|Treatment Period 1||7
8390023|NCT01058642|20679579|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
8390024|NCT01058642|20679580|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
8390025|NCT01058642|20679581|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
8390026|NCT01058642|20679582|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
8390027|NCT01058642|20679579|P4|STARTED|Treatment Period 1||9
8390028|NCT01058642|20679580|P3|STARTED|Treatment Period 1||11
8390029|NCT01058642|20679581|P2|STARTED|Treatment Period 1||12
8390030|NCT01058642|20679582|P1|STARTED|Treatment Period 1||9
8390031|NCT01058421|20679592|P2|NOT COMPLETED|6 Month Outcomes||26
8390032|NCT01058421|20679593|P1|NOT COMPLETED|6 Month Outcomes||19
8390033|NCT01058421|20679592|P2|COMPLETED|6 Month Outcomes||24
8390034|NCT01058421|20679593|P1|COMPLETED|6 Month Outcomes||27
8390035|NCT01058421|20679592|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
8390036|NCT01058421|20679593|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
8390037|NCT01058421|20679592|P2|NOT COMPLETED|3 Month Outcomes||26
8390038|NCT01058421|20679593|P1|NOT COMPLETED|3 Month Outcomes||20
8390039|NCT01058421|20679592|P2|COMPLETED|3 Month Outcomes||29
8390040|NCT01058421|20679593|P1|COMPLETED|3 Month Outcomes||29
8390041|NCT01058421|20679592|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
8390042|NCT01058421|20679593|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
8390043|NCT01058421|20679592|P2|NOT COMPLETED|1 Month Outcomes||42
8390044|NCT01058421|20679593|P1|NOT COMPLETED|1 Month Outcomes||39
8390045|NCT01058421|20679592|P2|COMPLETED|1 Month Outcomes||19
8390046|NCT01058421|20679593|P1|COMPLETED|1 Month Outcomes||20
8390047|NCT01058421|20679592|P2|STARTED|1 Month Outcomes||61
8390048|NCT01058421|20679593|P1|STARTED|1 Month Outcomes||59
8390049|NCT01058395|20679617|P2|NOT COMPLETED|Overall Study||1
8390050|NCT01058395|20679618|P1|NOT COMPLETED|Overall Study||3
8390051|NCT01058395|20679617|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
8390052|NCT01058395|20679618|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
8390053|NCT01058395|20679617|P2|STARTED|Overall Study||8
8390054|NCT01058395|20679618|P1|STARTED|Overall Study||7
8390055|NCT01058369|20679627|P1|NOT COMPLETED|Overall Study||2
8390056|NCT01058369|20679627|P1|COMPLETED|Overall Study||0
8390057|NCT01058369|20679627|P1|STARTED|Overall Study||2
8390058|NCT01058356|20679631|P1|NOT COMPLETED|Overall Study||42
8390059|NCT01058356|20679631|P1|COMPLETED|Overall Study||172
8390060|NCT01058356|20679631|P1|STARTED|Overall Study||214
8390061|NCT01058304|20679638|P2|NOT COMPLETED|Overall Study||33
8390062|NCT01058304|20679639|P1|NOT COMPLETED|Overall Study||27
8390063|NCT01058304|20679638|P2|COMPLETED|Overall Study||128
8390064|NCT01058304|20679639|P1|COMPLETED|Overall Study||132
8390065|NCT01058304|20679638|P2|STARTED|Overall Study||161
8390066|NCT01058304|20679639|P1|STARTED|Overall Study||159
8390067|NCT01058265|20679649|P2|NOT COMPLETED|Overall Study||12
8390068|NCT01058265|20679650|P1|NOT COMPLETED|Overall Study||11
8390069|NCT01058265|20679649|P2|COMPLETED|Overall Study||13
8390070|NCT01058265|20679650|P1|COMPLETED|Overall Study||11
8390071|NCT01058265|20679649|P2|STARTED|Overall Study||25
8390072|NCT01058265|20679650|P1|STARTED|Overall Study||22
8390073|NCT01058239|20679658|P1|NOT COMPLETED|Overall Study||0
8390074|NCT01058239|20679658|P1|COMPLETED|Overall Study||7
8390075|NCT01058239|20679658|P1|STARTED|Overall Study||7
8390076|NCT01058096|20679669|P2|NOT COMPLETED|Safety Follow-up||4
8390077|NCT01058096|20679670|P1|NOT COMPLETED|Safety Follow-up||4
8390078|NCT01058096|20679669|P2|COMPLETED|Safety Follow-up||130
8390079|NCT01058096|20679670|P1|COMPLETED|Safety Follow-up||129
8390080|NCT01058096|20679669|P2|STARTED|Safety Follow-up||134
8390081|NCT01058096|20679670|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
8390082|NCT01058096|20679669|P2|NOT COMPLETED|Double-blind Treatment Phase||50
8390083|NCT01058096|20679670|P1|NOT COMPLETED|Double-blind Treatment Phase||48
8390084|NCT01058096|20679669|P2|COMPLETED|Double-blind Treatment Phase||108
8390085|NCT01058096|20679670|P1|COMPLETED|Double-blind Treatment Phase||106
8390086|NCT01058096|20679669|P2|STARTED|Double-blind Treatment Phase||158
8390087|NCT01058096|20679670|P1|STARTED|Double-blind Treatment Phase||154
8390091|NCT01058005|20679686|P3|NOT COMPLETED|Overall Study||20
8390092|NCT01058005|20679687|P2|NOT COMPLETED|Overall Study||25
8390093|NCT01058005|20679688|P1|NOT COMPLETED|Overall Study||38
8390094|NCT01058005|20679686|P3|COMPLETED|Overall Study||1
8390095|NCT01058005|20679687|P2|COMPLETED|Overall Study||0
8390096|NCT01058005|20679688|P1|COMPLETED|Overall Study||0
8390097|NCT01058005|20679686|P3|Dosed With Study Treatment|Overall Study||17
8390098|NCT01058005|20679687|P2|Dosed With Study Treatment|Overall Study||22
8390099|NCT01058005|20679688|P1|Dosed With Study Treatment|Overall Study||36
8390100|NCT01058005|20679686|P3|STARTED|Overall Study||21
8390101|NCT01058005|20679687|P2|STARTED|Overall Study||25
8390102|NCT01058005|20679688|P1|STARTED|Overall Study||38
8390103|NCT01057901|20679698|P2|NOT COMPLETED|Overall Study||246
8390104|NCT01057901|20679699|P1|NOT COMPLETED|Overall Study||260
8390105|NCT01057901|20679698|P2|COMPLETED|Overall Study||126
8390106|NCT01057901|20679699|P1|COMPLETED|Overall Study||116
8390107|NCT01057901|20679698|P2|STARTED|Overall Study||372
8390108|NCT01057901|20679699|P1|STARTED|Overall Study||376
8390109|NCT01057888|20679710|P3|NOT COMPLETED|Overall Study||0
8390110|NCT01057888|20679711|P2|NOT COMPLETED|Overall Study||0
8390111|NCT01057888|20679712|P1|NOT COMPLETED|Overall Study||0
8390112|NCT01057888|20679710|P3|COMPLETED|Overall Study||2494
8390113|NCT01057888|20679711|P2|COMPLETED|Overall Study||2406
8390114|NCT01057888|20679712|P1|COMPLETED|Overall Study||2504
8390115|NCT01057888|20679710|P3|STARTED|Overall Study||2494
8390116|NCT01057888|20679711|P2|STARTED|Overall Study||2406
8390117|NCT01057888|20679712|P1|STARTED|Overall Study||2504
8390118|NCT01057862|20679723|P2|NOT COMPLETED|Overall Study||2
8390119|NCT01057862|20679724|P1|NOT COMPLETED|Overall Study||1
8390120|NCT01057862|20679723|P2|COMPLETED|Overall Study||2
8390121|NCT01057862|20679724|P1|COMPLETED|Overall Study||4
8390122|NCT01057862|20679723|P2|STARTED|Overall Study||4
8390123|NCT01057862|20679724|P1|STARTED|Overall Study||5
8390124|NCT01057810|20679734|P2|NOT COMPLETED|Overall Study||398
8390125|NCT01057810|20679735|P1|NOT COMPLETED|Overall Study||198
8390126|NCT01057810|20679734|P2|COMPLETED|Overall Study||1
8390127|NCT01057810|20679735|P1|COMPLETED|Overall Study||1
8390128|NCT01057810|20679734|P2|STARTED|Overall Study||399
8390129|NCT01057810|20679735|P1|STARTED|Overall Study||199
8390130|NCT01057693|20679751|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
8390131|NCT01057693|20679752|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
8390132|NCT01057693|20679753|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
8390133|NCT01057693|20679751|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
8390134|NCT01057693|20679752|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
8390135|NCT01057693|20679753|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
8390136|NCT01057693|20679751|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
8390137|NCT01057693|20679752|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
8390138|NCT01057693|20679753|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
8390139|NCT01057693|20679751|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
8390140|NCT01057693|20679752|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
8390141|NCT01057693|20679753|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
8390142|NCT01057693|20679751|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
8390143|NCT01057693|20679752|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
8390144|NCT01057693|20679753|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
8390145|NCT01057693|20679751|P3|COMPLETED|Between Single-Blind and Double-Blind||0
8390146|NCT01057693|20679752|P2|COMPLETED|Between Single-Blind and Double-Blind||0
8390147|NCT01057693|20679753|P1|COMPLETED|Between Single-Blind and Double-Blind||296
8390148|NCT01057693|20679751|P3|STARTED|Between Single-Blind and Double-Blind||0
8390149|NCT01057693|20679752|P2|STARTED|Between Single-Blind and Double-Blind||0
8390150|NCT01057693|20679753|P1|STARTED|Between Single-Blind and Double-Blind||566
8390151|NCT01057693|20679751|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390152|NCT01057693|20679752|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390153|NCT01057693|20679753|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
8390154|NCT01057693|20679751|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390155|NCT01057693|20679752|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390156|NCT01057693|20679753|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
8390157|NCT01057693|20679751|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
8390158|NCT01057693|20679752|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
8390159|NCT01057693|20679753|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
8390160|NCT01057589|20679799|P1|NOT COMPLETED|Overall Study||66
8390161|NCT01057589|20679799|P1|COMPLETED|Overall Study||0
8390162|NCT01057589|20679799|P1|STARTED|Overall Study||66
8390163|NCT01057433|20679808|P1|NOT COMPLETED|Overall Study||1
8390164|NCT01057433|20679808|P1|COMPLETED|Overall Study||23
8390165|NCT01057433|20679808|P1|STARTED|Overall Study||24
8390166|NCT01057394|20679812|P2|NOT COMPLETED|Overall Study||2
8390167|NCT01057394|20679813|P1|NOT COMPLETED|Overall Study||0
8390168|NCT01057394|20679812|P2|COMPLETED|Overall Study|19 treated participants|19
8390169|NCT01057394|20679813|P1|COMPLETED|Overall Study||0
8390170|NCT01057394|20679812|P2|STARTED|Overall Study|21 enrolled participants|21
8390171|NCT01057394|20679813|P1|STARTED|Overall Study||0
8390172|NCT01057277|20679817|P1|NOT COMPLETED|Overall Study||0
8390173|NCT01057277|20679817|P1|COMPLETED|Overall Study||3
8390174|NCT01057277|20679817|P1|STARTED|Overall Study||3
8390175|NCT01057251|20679823|P2|NOT COMPLETED|Overall Study||29
8390176|NCT01057251|20679824|P1|NOT COMPLETED|Overall Study||28
8390177|NCT01057251|20679823|P2|COMPLETED|Overall Study||114
8390178|NCT01057251|20679824|P1|COMPLETED|Overall Study||262
8390179|NCT01057251|20679823|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
8390180|NCT01057251|20679824|P1|STARTED|Overall Study||290
8390181|NCT01057225|20679832|P6|NOT COMPLETED|Overall Study||0
8390182|NCT01057225|20679833|P5|NOT COMPLETED|Overall Study||0
8390183|NCT01057225|20679834|P4|NOT COMPLETED|Overall Study||0
8390184|NCT01057225|20679835|P3|NOT COMPLETED|Overall Study||0
8390185|NCT01057225|20679836|P2|NOT COMPLETED|Overall Study||0
8390186|NCT01057225|20679837|P1|NOT COMPLETED|Overall Study||0
8390187|NCT01057225|20679832|P6|COMPLETED|Overall Study||23
8390188|NCT01057225|20679833|P5|COMPLETED|Overall Study||22
8390189|NCT01057225|20679834|P4|COMPLETED|Overall Study||7
8390190|NCT01057225|20679835|P3|COMPLETED|Overall Study||6
8390191|NCT01057225|20679836|P2|COMPLETED|Overall Study||3
8390192|NCT01057225|20679837|P1|COMPLETED|Overall Study||3
8390193|NCT01057225|20679832|P6|STARTED|Overall Study||23
8390194|NCT01057225|20679833|P5|STARTED|Overall Study||22
8390195|NCT01057225|20679834|P4|STARTED|Overall Study||7
8390196|NCT01057225|20679835|P3|STARTED|Overall Study||6
8390197|NCT01057225|20679836|P2|STARTED|Overall Study||3
8390198|NCT01057225|20679837|P1|STARTED|Overall Study||3
8390199|NCT01057121|20679859|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390200|NCT01057121|20679860|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390201|NCT01057121|20679861|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390202|NCT01057121|20679862|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390203|NCT01057121|20679863|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390204|NCT01057121|20679859|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
8390205|NCT01057121|20679860|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390206|NCT01057121|20679861|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390207|NCT01057121|20679862|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390208|NCT01057121|20679863|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390209|NCT01057121|20679859|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
8390210|NCT01057121|20679860|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390211|NCT01057121|20679861|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390212|NCT01057121|20679862|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390213|NCT01057121|20679863|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390214|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390215|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390216|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390217|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390218|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390219|NCT01057121|20679859|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390220|NCT01057121|20679860|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
8390221|NCT01057121|20679861|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390222|NCT01057121|20679862|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390223|NCT01057121|20679863|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390224|NCT01057121|20679859|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390225|NCT01057121|20679860|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
8390226|NCT01057121|20679861|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390227|NCT01057121|20679862|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390228|NCT01057121|20679863|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390229|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390230|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390231|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390232|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390233|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390234|NCT01057121|20679859|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390235|NCT01057121|20679860|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390236|NCT01057121|20679861|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
8390237|NCT01057121|20679862|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390238|NCT01057121|20679863|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390239|NCT01057121|20679859|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390240|NCT01057121|20679860|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390241|NCT01057121|20679861|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
8390242|NCT01057121|20679862|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390243|NCT01057121|20679863|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390244|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390245|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390246|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390247|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390248|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390249|NCT01057121|20679859|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390250|NCT01057121|20679860|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390251|NCT01057121|20679861|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390252|NCT01057121|20679862|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
8390253|NCT01057121|20679863|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390254|NCT01057121|20679859|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390255|NCT01057121|20679860|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390256|NCT01057121|20679861|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390257|NCT01057121|20679862|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
8390258|NCT01057121|20679863|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390259|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390260|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390261|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390262|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390263|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390264|NCT01057121|20679859|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390265|NCT01057121|20679860|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390266|NCT01057121|20679861|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390267|NCT01057121|20679862|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390268|NCT01057121|20679863|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
8390269|NCT01057121|20679859|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390270|NCT01057121|20679860|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390271|NCT01057121|20679861|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390272|NCT01057121|20679862|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390273|NCT01057121|20679863|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
8390274|NCT01057017|20679892|P1|NOT COMPLETED|Overall Study||0
8390275|NCT01057017|20679892|P1|COMPLETED|Overall Study||5
8390276|NCT01057017|20679892|P1|STARTED|Overall Study||5
8390277|NCT01056913|20679896|P1|NOT COMPLETED|Overall Study||0
8390278|NCT01056913|20679896|P1|COMPLETED|Overall Study||62
8390279|NCT01056913|20679896|P1|STARTED|Overall Study||62
8390280|NCT01056822|20679902|P2|NOT COMPLETED|Overall Study||7
8390281|NCT01056822|20679903|P1|NOT COMPLETED|Overall Study||8
8390282|NCT01056822|20679902|P2|COMPLETED|Overall Study||35
8390283|NCT01056822|20679903|P1|COMPLETED|Overall Study||39
8390284|NCT01056822|20679902|P2|Safety (SAF) Population: NO|Overall Study||2
8390285|NCT01056822|20679903|P1|Safety (SAF) Population: NO|Overall Study||1
8390286|NCT01056822|20679902|P2|Safety (SAF) Population: YES|Overall Study||40
8390287|NCT01056822|20679903|P1|Safety (SAF) Population: YES|Overall Study||46
8390288|NCT01056822|20679902|P2|Per-protocol (PP) Population: NO|Overall Study||17
8390289|NCT01056822|20679903|P1|Per-protocol (PP) Population: NO|Overall Study||18
8390290|NCT01056822|20679902|P2|Per-protocol (PP) Population: YES|Overall Study||25
8390291|NCT01056822|20679903|P1|Per-protocol (PP) Population: YES|Overall Study||29
8390292|NCT01056822|20679902|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
8390293|NCT01056822|20679903|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
8390294|NCT01056822|20679902|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
8390295|NCT01056822|20679903|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
8390296|NCT01056822|20679902|P2|STARTED|Overall Study||42
8390297|NCT01056822|20679903|P1|STARTED|Overall Study||47
8390298|NCT01056718|20679952|P1|NOT COMPLETED|Overall Study||3
8390299|NCT01056718|20679952|P1|COMPLETED|Overall Study||50
8390300|NCT01056718|20679952|P1|STARTED|Overall Study||53
8390301|NCT01056653|20679985|P3|NOT COMPLETED|Overall Study||2
8390302|NCT01056653|20679986|P2|NOT COMPLETED|Overall Study||0
8390303|NCT01056653|20679987|P1|NOT COMPLETED|Overall Study||0
8390304|NCT01056653|20679985|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
8390305|NCT01056653|20679986|P2|COMPLETED|Overall Study||23
8390306|NCT01056653|20679987|P1|COMPLETED|Overall Study||46
8390307|NCT01056653|20679985|P3|STARTED|Overall Study||44
8390308|NCT01056653|20679986|P2|STARTED|Overall Study||23
8390309|NCT01056653|20679987|P1|STARTED|Overall Study||46
8390310|NCT01056640|20680003|P2|NOT COMPLETED|Overall Study||12
8390311|NCT01056640|20680004|P1|NOT COMPLETED|Overall Study||26
8390312|NCT01056640|20680003|P2|COMPLETED|Overall Study||91
8390313|NCT01056640|20680004|P1|COMPLETED|Overall Study||76
8390314|NCT01056640|20680003|P2|STARTED|Overall Study||103
8390315|NCT01056640|20680004|P1|STARTED|Overall Study||102
8390316|NCT01056601|20680010|P1|NOT COMPLETED|Overall Study||0
8390317|NCT01056601|20680010|P1|COMPLETED|Overall Study||7
8390318|NCT01056601|20680010|P1|STARTED|Overall Study||7
8390319|NCT01056536|20680019|P3|NOT COMPLETED|Overall Study||248
8390320|NCT01056536|20680020|P2|NOT COMPLETED|Overall Study||116
8390321|NCT01056536|20680021|P1|NOT COMPLETED|Overall Study||202
8390322|NCT01056536|20680019|P3|COMPLETED|Overall Study||481
8390323|NCT01056536|20680020|P2|COMPLETED|Overall Study||240
8390324|NCT01056536|20680021|P1|COMPLETED|Overall Study||394
8390325|NCT01056536|20680019|P3|STARTED|Overall Study||729
8390326|NCT01056536|20680020|P2|STARTED|Overall Study||356
8390327|NCT01056536|20680021|P1|STARTED|Overall Study||596
8390328|NCT01056523|20680032|P7|NOT COMPLETED|Overall Study||1
8390329|NCT01056523|20680033|P6|NOT COMPLETED|Overall Study||0
8390330|NCT01056523|20680034|P5|NOT COMPLETED|Overall Study||0
8390331|NCT01056523|20680035|P4|NOT COMPLETED|Overall Study||3
8390332|NCT01056523|20680036|P3|NOT COMPLETED|Overall Study||2
8390333|NCT01056523|20680037|P2|NOT COMPLETED|Overall Study||0
8390334|NCT01056523|20680038|P1|NOT COMPLETED|Overall Study||1
8390335|NCT01056523|20680032|P7|COMPLETED|Overall Study||4
8390336|NCT01056523|20680033|P6|COMPLETED|Overall Study||3
8390337|NCT01056523|20680034|P5|COMPLETED|Overall Study||3
8390338|NCT01056523|20680035|P4|COMPLETED|Overall Study||3
8390339|NCT01056523|20680036|P3|COMPLETED|Overall Study||3
8390340|NCT01056523|20680037|P2|COMPLETED|Overall Study||3
8390341|NCT01056523|20680038|P1|COMPLETED|Overall Study||3
8390342|NCT01056523|20680032|P7|STARTED|Overall Study||5
8390343|NCT01056523|20680033|P6|STARTED|Overall Study||3
8390344|NCT01056523|20680034|P5|STARTED|Overall Study||3
8390345|NCT01056523|20680035|P4|STARTED|Overall Study||6
8390346|NCT01056523|20680036|P3|STARTED|Overall Study||5
8390347|NCT01056523|20680037|P2|STARTED|Overall Study||3
8390348|NCT01056523|20680038|P1|STARTED|Overall Study||4
8390349|NCT01056510|20680048|P2|NOT COMPLETED|Overall Study||64
8390350|NCT01056510|20680049|P1|NOT COMPLETED|Overall Study||54
8390351|NCT01056510|20680048|P2|COMPLETED|Overall Study||115
8390352|NCT01056510|20680049|P1|COMPLETED|Overall Study||124
8390353|NCT01056510|20680048|P2|STARTED|Overall Study||179
8390354|NCT01056510|20680049|P1|STARTED|Overall Study||178
8390355|NCT01056484|20680095|P2|NOT COMPLETED|Follow up - Non-randomized||2
8390356|NCT01056484|20680096|P1|NOT COMPLETED|Follow up - Non-randomized||0
8390357|NCT01056484|20680095|P2|COMPLETED|Follow up - Non-randomized||56
8390358|NCT01056484|20680096|P1|COMPLETED|Follow up - Non-randomized||57
8390359|NCT01056484|20680095|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
8390360|NCT01056484|20680096|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
8390361|NCT01056484|20680095|P2|NOT COMPLETED|Randomized Controlled Trial||1
8390362|NCT01056484|20680096|P1|NOT COMPLETED|Randomized Controlled Trial||7
8390363|NCT01056484|20680095|P2|COMPLETED|Randomized Controlled Trial||58
8390364|NCT01056484|20680096|P1|COMPLETED|Randomized Controlled Trial||57
8390365|NCT01056484|20680095|P2|STARTED|Randomized Controlled Trial||59
8390366|NCT01056484|20680096|P1|STARTED|Randomized Controlled Trial||64
8390367|NCT01056380|20680112|P2|NOT COMPLETED|Overall Study||3
8390368|NCT01056380|20680113|P1|NOT COMPLETED|Overall Study||2
8390369|NCT01056380|20680112|P2|COMPLETED|Overall Study||39
8390370|NCT01056380|20680113|P1|COMPLETED|Overall Study||35
8390371|NCT01056380|20680112|P2|STARTED|Overall Study||42
8390372|NCT01056380|20680113|P1|STARTED|Overall Study||37
8390373|NCT01056341|20680140|P5|NOT COMPLETED|Overall Study||14
8390374|NCT01056341|20680141|P4|NOT COMPLETED|Overall Study||36
8390375|NCT01056341|20680142|P3|NOT COMPLETED|Overall Study||15
8390376|NCT01056341|20680143|P2|NOT COMPLETED|Overall Study||36
8390377|NCT01056341|20680144|P1|NOT COMPLETED|Overall Study||36
8390378|NCT01056341|20680140|P5|COMPLETED|Overall Study||88
8390379|NCT01056341|20680141|P4|COMPLETED|Overall Study||65
8390380|NCT01056341|20680142|P3|COMPLETED|Overall Study||88
8390381|NCT01056341|20680143|P2|COMPLETED|Overall Study||63
8390382|NCT01056341|20680144|P1|COMPLETED|Overall Study||19
8390383|NCT01056341|20680140|P5|Interim Analysis|Overall Study||43
8390384|NCT01056341|20680141|P4|Interim Analysis|Overall Study||40
8390385|NCT01056341|20680142|P3|Interim Analysis|Overall Study||41
8390386|NCT01056341|20680143|P2|Interim Analysis|Overall Study||41
8390387|NCT01056341|20680144|P1|Interim Analysis|Overall Study||25
8390388|NCT01056341|20680140|P5|STARTED|Overall Study||102
8390389|NCT01056341|20680141|P4|STARTED|Overall Study||101
8390390|NCT01056341|20680142|P3|STARTED|Overall Study||103
8390391|NCT01056341|20680143|P2|STARTED|Overall Study||99
8390392|NCT01056341|20680144|P1|STARTED|Overall Study||55
8390393|NCT01056328|20680165|P2|NOT COMPLETED|Overall Study||16
8390394|NCT01056328|20680166|P1|NOT COMPLETED|Overall Study||17
8390395|NCT01056328|20680165|P2|COMPLETED|Overall Study||144
8390396|NCT01056328|20680166|P1|COMPLETED|Overall Study||147
8390397|NCT01056328|20680165|P2|STARTED|Overall Study||160
8390398|NCT01056328|20680166|P1|STARTED|Overall Study||164
8390399|NCT01056315|20680182|P2|NOT COMPLETED|Overall Study||11
8390400|NCT01056315|20680183|P1|NOT COMPLETED|Overall Study||14
8390401|NCT01056315|20680182|P2|COMPLETED|Overall Study||12
8390402|NCT01056315|20680183|P1|COMPLETED|Overall Study||13
8390403|NCT01056315|20680182|P2|STARTED|Overall Study||23
8390404|NCT01056315|20680183|P1|STARTED|Overall Study||27
8390405|NCT01056302|20680217|P1|NOT COMPLETED|Overall Study||0
8390406|NCT01056302|20680217|P1|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
8390407|NCT01056302|20680217|P1|STARTED|Overall Study||3
8390408|NCT01056289|20680223|P4|NOT COMPLETED|Double-blind Phase||10
8390409|NCT01056289|20680224|P3|NOT COMPLETED|Double-blind Phase||13
8390410|NCT01056289|20680225|P2|NOT COMPLETED|Double-blind Phase||4
8390411|NCT01056289|20680226|P1|NOT COMPLETED|Double-blind Phase||0
8390412|NCT01056289|20680223|P4|COMPLETED|Double-blind Phase||138
8390413|NCT01056289|20680224|P3|COMPLETED|Double-blind Phase||127
8390414|NCT01056289|20680225|P2|COMPLETED|Double-blind Phase||69
8390415|NCT01056289|20680226|P1|COMPLETED|Double-blind Phase||0
8390416|NCT01056289|20680223|P4|STARTED|Double-blind Phase||148
8390417|NCT01056289|20680224|P3|STARTED|Double-blind Phase||140
8390418|NCT01056289|20680225|P2|STARTED|Double-blind Phase||73
8390419|NCT01056289|20680226|P1|STARTED|Double-blind Phase||0
8390420|NCT01056289|20680223|P4|NOT COMPLETED|Open-label Phase||0
8390421|NCT01056289|20680224|P3|NOT COMPLETED|Open-label Phase||0
8390422|NCT01056289|20680225|P2|NOT COMPLETED|Open-label Phase||0
8390423|NCT01056289|20680226|P1|NOT COMPLETED|Open-label Phase||119
8390424|NCT01056289|20680223|P4|COMPLETED|Open-label Phase||0
8390425|NCT01056289|20680224|P3|COMPLETED|Open-label Phase||0
8390426|NCT01056289|20680225|P2|COMPLETED|Open-label Phase||0
8390427|NCT01056289|20680226|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
8390428|NCT01056289|20680223|P4|STARTED|Open-label Phase||0
8390429|NCT01056289|20680224|P3|STARTED|Open-label Phase||0
8390430|NCT01056289|20680225|P2|STARTED|Open-label Phase||0
8390431|NCT01056289|20680226|P1|STARTED|Open-label Phase||480
8390432|NCT01056276|20680243|P2|NOT COMPLETED|Maintenance Therapy||28
8390433|NCT01056276|20680244|P1|NOT COMPLETED|Maintenance Therapy||0
8390434|NCT01056276|20680243|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
8390435|NCT01056276|20680244|P1|COMPLETED|Maintenance Therapy||0
8390436|NCT01056276|20680243|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
8390437|NCT01056276|20680244|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
8390438|NCT01056276|20680243|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
8390439|NCT01056276|20680244|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
8390440|NCT01056276|20680243|P2|COMPLETED|Treatment Period-Cycles 1-8||33
8390441|NCT01056276|20680244|P1|COMPLETED|Treatment Period-Cycles 1-8||5
8390442|NCT01056276|20680243|P2|STARTED|Treatment Period-Cycles 1-8||41
8390443|NCT01056276|20680244|P1|STARTED|Treatment Period-Cycles 1-8||18
8390444|NCT01056263|20680258|P1|NOT COMPLETED|Overall Study||52
8390445|NCT01056263|20680258|P1|COMPLETED|Overall Study||0
8390446|NCT01056263|20680258|P1|STARTED|Overall Study||52
8390447|NCT01056198|20680264|P2|NOT COMPLETED|Overall Study||0
8390448|NCT01056198|20680265|P1|NOT COMPLETED|Overall Study||0
8390449|NCT01056198|20680264|P2|COMPLETED|Overall Study||24
8390450|NCT01056198|20680265|P1|COMPLETED|Overall Study||24
8390451|NCT01056198|20680264|P2|STARTED|Overall Study||24
8390452|NCT01056198|20680265|P1|STARTED|Overall Study||24
8390453|NCT01056107|20680281|P4|NOT COMPLETED|Overall Study||0
8390454|NCT01056107|20680282|P3|NOT COMPLETED|Overall Study||3
8390455|NCT01056107|20680283|P2|NOT COMPLETED|Overall Study||1
8390456|NCT01056107|20680284|P1|NOT COMPLETED|Overall Study||0
8390457|NCT01056107|20680281|P4|COMPLETED|Overall Study||12
8390458|NCT01056107|20680282|P3|COMPLETED|Overall Study||9
8390459|NCT01056107|20680283|P2|COMPLETED|Overall Study||10
8390460|NCT01056107|20680284|P1|COMPLETED|Overall Study||11
8390461|NCT01056107|20680281|P4|STARTED|Overall Study||12
8390462|NCT01056107|20680282|P3|STARTED|Overall Study||12
8390463|NCT01056107|20680283|P2|STARTED|Overall Study||11
8390464|NCT01056107|20680284|P1|STARTED|Overall Study||11
8390465|NCT01056016|20680332|P2|NOT COMPLETED|Overall Study||1
8390466|NCT01056016|20680333|P1|NOT COMPLETED|Overall Study||2
8390467|NCT01056016|20680332|P2|COMPLETED|Overall Study||26
8390468|NCT01056016|20680333|P1|COMPLETED|Overall Study||20
8390469|NCT01056016|20680332|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
8390470|NCT01056016|20680333|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
8390471|NCT01055886|20680341|P2|NOT COMPLETED|Overall Study||11
8390472|NCT01055886|20680342|P1|NOT COMPLETED|Overall Study||5
8390473|NCT01055886|20680341|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
8390474|NCT01055886|20680342|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
8390475|NCT01055886|20680341|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
8390476|NCT01055886|20680342|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
8390477|NCT01055886|20680341|P2|STARTED|Overall Study||32
8390478|NCT01055886|20680342|P1|STARTED|Overall Study||33
8390479|NCT01055834|20680354|P2|NOT COMPLETED|Treatment Period III||0
8390480|NCT01055834|20680355|P1|NOT COMPLETED|Treatment Period III||0
8390481|NCT01055834|20680354|P2|COMPLETED|Treatment Period III||14
8390482|NCT01055834|20680355|P1|COMPLETED|Treatment Period III||0
8390483|NCT01055834|20680354|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
8390484|NCT01055834|20680355|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
8390485|NCT01055834|20680354|P2|NOT COMPLETED|Treatment Period II||0
8390486|NCT01055834|20680355|P1|NOT COMPLETED|Treatment Period II||0
8390487|NCT01055834|20680354|P2|COMPLETED|Treatment Period II||21
8390488|NCT01055834|20680355|P1|COMPLETED|Treatment Period II||20
8390489|NCT01055834|20680354|P2|STARTED|Treatment Period II||21
8390490|NCT01055834|20680355|P1|STARTED|Treatment Period II||20
8390491|NCT01055834|20680354|P2|NOT COMPLETED|Treatment Period I||0
8390492|NCT01055834|20680355|P1|NOT COMPLETED|Treatment Period I||1
8390493|NCT01055834|20680354|P2|COMPLETED|Treatment Period I||21
8390494|NCT01055834|20680355|P1|COMPLETED|Treatment Period I||20
8390495|NCT01055834|20680354|P2|STARTED|Treatment Period I||21
8390496|NCT01055834|20680355|P1|STARTED|Treatment Period I||21
8390497|NCT01055782|20680369|P2|NOT COMPLETED|Overall Study||0
8390498|NCT01055782|20680370|P1|NOT COMPLETED|Overall Study||0
8390499|NCT01055782|20680369|P2|COMPLETED|Overall Study||449
8390500|NCT01055782|20680370|P1|COMPLETED|Overall Study||555
8390501|NCT01055782|20680369|P2|STARTED|Overall Study||449
8390502|NCT01055782|20680370|P1|STARTED|Overall Study||555
8390503|NCT01055769|20680378|P2|NOT COMPLETED|Second Intervention||0
8390504|NCT01055769|20680379|P1|NOT COMPLETED|Second Intervention||0
8390505|NCT01055769|20680378|P2|COMPLETED|Second Intervention||10
8390506|NCT01055769|20680379|P1|COMPLETED|Second Intervention||10
8390507|NCT01055769|20680378|P2|STARTED|Second Intervention||10
8390508|NCT01055769|20680379|P1|STARTED|Second Intervention||10
8390509|NCT01055769|20680378|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
8390510|NCT01055769|20680379|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
8390511|NCT01055769|20680378|P2|COMPLETED|Washout Period of Atleast 4 Days||10
8390512|NCT01055769|20680379|P1|COMPLETED|Washout Period of Atleast 4 Days||10
8390513|NCT01055769|20680378|P2|STARTED|Washout Period of Atleast 4 Days||10
8390514|NCT01055769|20680379|P1|STARTED|Washout Period of Atleast 4 Days||10
8390515|NCT01055769|20680378|P2|NOT COMPLETED|First Intervention||0
8390516|NCT01055769|20680379|P1|NOT COMPLETED|First Intervention||0
8390517|NCT01055769|20680378|P2|COMPLETED|First Intervention||10
8390518|NCT01055769|20680379|P1|COMPLETED|First Intervention||10
8390519|NCT01055769|20680378|P2|STARTED|First Intervention||10
8390520|NCT01055769|20680379|P1|STARTED|First Intervention||10
8390521|NCT01055704|20680397|P4|NOT COMPLETED|Overall Study||0
8390522|NCT01055704|20680398|P3|NOT COMPLETED|Overall Study||0
8390523|NCT01055704|20680399|P2|NOT COMPLETED|Overall Study||0
8390524|NCT01055704|20680400|P1|NOT COMPLETED|Overall Study||0
8390525|NCT01055704|20680397|P4|COMPLETED|Overall Study||8
8390526|NCT01055704|20680398|P3|COMPLETED|Overall Study||16
8390527|NCT01055704|20680399|P2|COMPLETED|Overall Study||8
8390528|NCT01055704|20680400|P1|COMPLETED|Overall Study||16
8390529|NCT01055704|20680397|P4|STARTED|Overall Study||8
8390530|NCT01055704|20680398|P3|STARTED|Overall Study||16
8390531|NCT01055704|20680399|P2|STARTED|Overall Study||8
8390532|NCT01055704|20680400|P1|STARTED|Overall Study||16
8390533|NCT01055639|20680440|P2|NOT COMPLETED|Overall Study||29
8390534|NCT01055639|20680441|P1|NOT COMPLETED|Overall Study||21
8390535|NCT01055639|20680440|P2|COMPLETED|Overall Study||31
8390536|NCT01055639|20680441|P1|COMPLETED|Overall Study||45
8390537|NCT01055639|20680440|P2|STARTED|Overall Study||60
8390538|NCT01055639|20680441|P1|STARTED|Overall Study||66
8390539|NCT01055613|20680465|P2|NOT COMPLETED|Overall Study||4
8390540|NCT01055613|20680466|P1|NOT COMPLETED|Overall Study||9
8390541|NCT01055613|20680465|P2|COMPLETED|Overall Study||96
8390542|NCT01055613|20680466|P1|COMPLETED|Overall Study||191
8390543|NCT01055613|20680465|P2|STARTED|Overall Study||100
8390544|NCT01055613|20680466|P1|STARTED|Overall Study||200
8390545|NCT01055496|20680476|P2|NOT COMPLETED|Overall Study||30
8390546|NCT01055496|20680477|P1|NOT COMPLETED|Overall Study||15
8390547|NCT01055496|20680476|P2|COMPLETED|Overall Study||25
8390548|NCT01055496|20680477|P1|COMPLETED|Overall Study||33
8390549|NCT01055496|20680476|P2|STARTED|Overall Study||55
8390550|NCT01055496|20680477|P1|STARTED|Overall Study||48
8390551|NCT01055457|20680534|P10|NOT COMPLETED|Overall Study||1
8390552|NCT01055457|20680535|P9|NOT COMPLETED|Overall Study||0
8390553|NCT01055457|20680536|P8|NOT COMPLETED|Overall Study||1
8390554|NCT01055457|20680537|P7|NOT COMPLETED|Overall Study||1
8390555|NCT01055457|20680538|P6|NOT COMPLETED|Overall Study||3
8390556|NCT01055457|20680539|P5|NOT COMPLETED|Overall Study||3
8390557|NCT01055457|20680540|P4|NOT COMPLETED|Overall Study||3
8390558|NCT01055457|20680541|P3|NOT COMPLETED|Overall Study||2
8390559|NCT01055457|20680542|P2|NOT COMPLETED|Overall Study||1
8390560|NCT01055457|20680543|P1|NOT COMPLETED|Overall Study||1
8390561|NCT01055457|20680534|P10|COMPLETED|Overall Study||19
8390562|NCT01055457|20680535|P9|COMPLETED|Overall Study||20
8390563|NCT01055457|20680536|P8|COMPLETED|Overall Study||18
8390564|NCT01055457|20680537|P7|COMPLETED|Overall Study||18
8390565|NCT01055457|20680538|P6|COMPLETED|Overall Study||15
8390566|NCT01055457|20680539|P5|COMPLETED|Overall Study||38
8390567|NCT01055457|20680540|P4|COMPLETED|Overall Study||37
8390568|NCT01055457|20680541|P3|COMPLETED|Overall Study||36
8390569|NCT01055457|20680542|P2|COMPLETED|Overall Study||39
8390570|NCT01055457|20680543|P1|COMPLETED|Overall Study||39
8390571|NCT01055457|20680534|P10|STARTED|Overall Study||20
8390572|NCT01055457|20680535|P9|STARTED|Overall Study||20
8390573|NCT01055457|20680536|P8|STARTED|Overall Study||19
8390574|NCT01055457|20680537|P7|STARTED|Overall Study||19
8390575|NCT01055457|20680538|P6|STARTED|Overall Study||18
8390576|NCT01055457|20680539|P5|STARTED|Overall Study||41
8390577|NCT01055457|20680540|P4|STARTED|Overall Study||40
8390578|NCT01055457|20680541|P3|STARTED|Overall Study||38
8390579|NCT01055457|20680542|P2|STARTED|Overall Study||40
8390580|NCT01055457|20680543|P1|STARTED|Overall Study||40
8390581|NCT01055314|20680577|P2|NOT COMPLETED|Overall Study||38
8390582|NCT01055314|20680578|P1|NOT COMPLETED|Overall Study||45
8390583|NCT01055314|20680577|P2|COMPLETED|Overall Study||37
8390584|NCT01055314|20680578|P1|COMPLETED|Overall Study||55
8390585|NCT01055314|20680577|P2|STARTED|Overall Study||75
8390586|NCT01055314|20680578|P1|STARTED|Overall Study||100
8390587|NCT01055262|20680590|P1|NOT COMPLETED|Overall Study||9
8390588|NCT01055262|20680590|P1|COMPLETED|Overall Study||160
8390589|NCT01055262|20680590|P1|STARTED|Overall Study||169
8390590|NCT01055223|20680601|P1|NOT COMPLETED|Overall Study||0
8390591|NCT01055223|20680601|P1|COMPLETED|Overall Study||98483
8390592|NCT01055223|20680601|P1|STARTED|Overall Study||98483
8390593|NCT01055197|20680631|P2|NOT COMPLETED|Overall Study||2
8390594|NCT01055197|20680632|P1|NOT COMPLETED|Overall Study||9
8390595|NCT01055197|20680631|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
8390596|NCT01055197|20680632|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
8390597|NCT01055197|20680631|P2|STARTED|Overall Study||46
8390598|NCT01055197|20680632|P1|STARTED|Overall Study||51
8390599|NCT01055184|20680646|P1|NOT COMPLETED|Overall Study||0
8390600|NCT01055184|20680646|P1|COMPLETED|Overall Study||34
8390601|NCT01055184|20680646|P1|STARTED|Overall Study||34
8390602|NCT01055171|20680652|P2|NOT COMPLETED|Overall Study||7
8390603|NCT01055171|20680653|P1|NOT COMPLETED|Overall Study||11
8390604|NCT01055171|20680652|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
8390605|NCT01055171|20680653|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
8390606|NCT01055171|20680652|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
8390607|NCT01055171|20680653|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
8390608|NCT01055171|20680652|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
8390609|NCT01055171|20680653|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
8390610|NCT01055171|20680652|P2|STARTED|Overall Study|Randomized to receive placebo.|28
8390611|NCT01055171|20680653|P1|STARTED|Overall Study|Randomized to receive medication.|29
8390612|NCT01055132|20680667|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
8390613|NCT01055132|20680668|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
8390614|NCT01055132|20680667|P2|COMPLETED|Period 2 (5-9 Days)||32
8390615|NCT01055132|20680668|P1|COMPLETED|Period 2 (5-9 Days)||35
8390616|NCT01055132|20680667|P2|STARTED|Period 2 (5-9 Days)||33
8390617|NCT01055132|20680668|P1|STARTED|Period 2 (5-9 Days)||35
8390618|NCT01055132|20680667|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
8390619|NCT01055132|20680668|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
8390620|NCT01055132|20680667|P2|COMPLETED|Period 1 (5-9 Days)||33
8390621|NCT01055132|20680668|P1|COMPLETED|Period 1 (5-9 Days)||35
8390622|NCT01055132|20680667|P2|STARTED|Period 1 (5-9 Days)||33
8390623|NCT01055132|20680668|P1|STARTED|Period 1 (5-9 Days)||36
8390624|NCT01055067|20680679|P1|NOT COMPLETED|Overall Study||0
8390625|NCT01055067|20680679|P1|COMPLETED|Overall Study||27
8390626|NCT01055067|20680679|P1|STARTED|Overall Study||27
8390627|NCT01055028|20680693|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
8390628|NCT01055028|20680694|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
8390629|NCT01055028|20680693|P2|COMPLETED|Treatment Cycles 4 to 6||2
8390630|NCT01055028|20680694|P1|COMPLETED|Treatment Cycles 4 to 6||6
8390631|NCT01055028|20680693|P2|STARTED|Treatment Cycles 4 to 6||2
8390632|NCT01055028|20680694|P1|STARTED|Treatment Cycles 4 to 6||6
8390633|NCT01055028|20680693|P2|NOT COMPLETED|Inter-treatment Period||3
8390634|NCT01055028|20680694|P1|NOT COMPLETED|Inter-treatment Period||0
8390635|NCT01055028|20680693|P2|COMPLETED|Inter-treatment Period||2
8390636|NCT01055028|20680694|P1|COMPLETED|Inter-treatment Period||6
8390637|NCT01055028|20680693|P2|STARTED|Inter-treatment Period||5
8390638|NCT01055028|20680694|P1|STARTED|Inter-treatment Period||6
8390639|NCT01055028|20680693|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
8390640|NCT01055028|20680694|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
8390641|NCT01055028|20680693|P2|COMPLETED|Treatment Cycles 1 to 3||5
8390642|NCT01055028|20680694|P1|COMPLETED|Treatment Cycles 1 to 3||6
8390643|NCT01055028|20680693|P2|STARTED|Treatment Cycles 1 to 3||8
8390644|NCT01055028|20680694|P1|STARTED|Treatment Cycles 1 to 3||8
8390645|NCT01055028|20680693|P2|NOT COMPLETED|Screening||1
8390646|NCT01055028|20680694|P1|NOT COMPLETED|Screening||1
8390647|NCT01055028|20680693|P2|COMPLETED|Screening||8
8390648|NCT01055028|20680694|P1|COMPLETED|Screening||8
8390649|NCT01055028|20680693|P2|STARTED|Screening||9
8390650|NCT01055028|20680694|P1|STARTED|Screening||9
8390651|NCT01054976|20680708|P1|NOT COMPLETED|Overall Study||35
8390652|NCT01054976|20680708|P1|COMPLETED|Overall Study||57
8390653|NCT01054976|20680708|P1|STARTED|Overall Study||92
8390654|NCT01054911|20680716|P1|NOT COMPLETED|Overall Study||0
8390655|NCT01054911|20680716|P1|COMPLETED|Overall Study||5
8390656|NCT01054911|20680716|P1|STARTED|Overall Study||5
8390657|NCT01054885|20680729|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
8390658|NCT01054885|20680730|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
8390659|NCT01054885|20680731|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
8390660|NCT01054885|20680732|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
8390661|NCT01054885|20680733|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
8390662|NCT01054885|20680734|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
8390663|NCT01054885|20680735|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8390664|NCT01054885|20680729|P7|COMPLETED|24-week, Double-blind Treatment Period||158
8390665|NCT01054885|20680730|P6|COMPLETED|24-week, Double-blind Treatment Period||144
8390666|NCT01054885|20680731|P5|COMPLETED|24-week, Double-blind Treatment Period||161
8390667|NCT01054885|20680732|P4|COMPLETED|24-week, Double-blind Treatment Period||160
8390668|NCT01054885|20680733|P3|COMPLETED|24-week, Double-blind Treatment Period||155
8390669|NCT01054885|20680734|P2|COMPLETED|24-week, Double-blind Treatment Period||146
8390670|NCT01054885|20680735|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8390671|NCT01054885|20680729|P7|STARTED|24-week, Double-blind Treatment Period||205
8390672|NCT01054885|20680730|P6|STARTED|24-week, Double-blind Treatment Period||204
8390673|NCT01054885|20680731|P5|STARTED|24-week, Double-blind Treatment Period||203
8390674|NCT01054885|20680732|P4|STARTED|24-week, Double-blind Treatment Period||203
8390675|NCT01054885|20680733|P3|STARTED|24-week, Double-blind Treatment Period||204
8390676|NCT01054885|20680734|P2|STARTED|24-week, Double-blind Treatment Period||205
8390677|NCT01054885|20680735|P1|STARTED|24-week, Double-blind Treatment Period||0
8390678|NCT01054885|20680729|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390679|NCT01054885|20680730|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390680|NCT01054885|20680731|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390681|NCT01054885|20680732|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390682|NCT01054885|20680733|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390683|NCT01054885|20680734|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390684|NCT01054885|20680735|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
8390685|NCT01054885|20680729|P7|COMPLETED|2-week, Single-blind Run-In Period||0
8390686|NCT01054885|20680730|P6|COMPLETED|2-week, Single-blind Run-In Period||0
8390687|NCT01054885|20680731|P5|COMPLETED|2-week, Single-blind Run-In Period||0
8390688|NCT01054885|20680732|P4|COMPLETED|2-week, Single-blind Run-In Period||0
8390689|NCT01054885|20680733|P3|COMPLETED|2-week, Single-blind Run-In Period||0
8390690|NCT01054885|20680734|P2|COMPLETED|2-week, Single-blind Run-In Period||0
8390691|NCT01054885|20680735|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
8390692|NCT01054885|20680729|P7|STARTED|2-week, Single-blind Run-In Period||0
8390693|NCT01054885|20680730|P6|STARTED|2-week, Single-blind Run-In Period||0
8390694|NCT01054885|20680731|P5|STARTED|2-week, Single-blind Run-In Period||0
8390695|NCT01054885|20680732|P4|STARTED|2-week, Single-blind Run-In Period||0
8390696|NCT01054885|20680733|P3|STARTED|2-week, Single-blind Run-In Period||0
8390697|NCT01054885|20680734|P2|STARTED|2-week, Single-blind Run-In Period||0
8390698|NCT01054885|20680735|P1|STARTED|2-week, Single-blind Run-In Period||1577
8390699|NCT01054846|20680775|P2|NOT COMPLETED|Overall Study||17
8390700|NCT01054846|20680776|P1|NOT COMPLETED|Overall Study||76
8390701|NCT01054846|20680775|P2|COMPLETED|Overall Study||51
8390702|NCT01054846|20680776|P1|COMPLETED|Overall Study||246
8390703|NCT01054846|20680775|P2|STARTED|Overall Study||68
8390704|NCT01054846|20680776|P1|STARTED|Overall Study||322
8390705|NCT01054820|20680783|P1|NOT COMPLETED|Overall Study||2
8390706|NCT01054820|20680783|P1|COMPLETED|Overall Study||121
8390707|NCT01054820|20680783|P1|STARTED|Overall Study||123
8390708|NCT01054742|20680797|P1|NOT COMPLETED|Overall Study||0
8390709|NCT01054742|20680797|P1|COMPLETED|Overall Study||2
8390710|NCT01054742|20680797|P1|STARTED|Overall Study||2
8390711|NCT01054729|20680805|P4|NOT COMPLETED|Overall Study||3
8390712|NCT01054729|20680806|P3|NOT COMPLETED|Overall Study||6
8390713|NCT01054729|20680807|P2|NOT COMPLETED|Overall Study||5
8390714|NCT01054729|20680808|P1|NOT COMPLETED|Overall Study||4
8390715|NCT01054729|20680805|P4|COMPLETED|Overall Study||11
8390716|NCT01054729|20680806|P3|COMPLETED|Overall Study||9
8390717|NCT01054729|20680807|P2|COMPLETED|Overall Study||14
8390718|NCT01054729|20680808|P1|COMPLETED|Overall Study||12
8390719|NCT01054729|20680805|P4|Randomized and Treated|Overall Study||14
8390720|NCT01054729|20680806|P3|Randomized and Treated|Overall Study||15
8390721|NCT01054729|20680807|P2|Randomized and Treated|Overall Study||18
8390722|NCT01054729|20680808|P1|Randomized and Treated|Overall Study||16
8390723|NCT01054729|20680805|P4|STARTED|Overall Study||14
8390724|NCT01054729|20680806|P3|STARTED|Overall Study||15
8390725|NCT01054729|20680807|P2|STARTED|Overall Study||19
8390726|NCT01054729|20680808|P1|STARTED|Overall Study||16
8390727|NCT01054703|20680869|P1|NOT COMPLETED|Overall Study||0
8390728|NCT01054703|20680869|P1|COMPLETED|Overall Study||14
8390729|NCT01054703|20680869|P1|STARTED|Overall Study||14
8390730|NCT01054625|20680876|P3|NOT COMPLETED|Overall Study||1
8390731|NCT01054625|20680877|P2|NOT COMPLETED|Overall Study||3
8390732|NCT01054625|20680878|P1|NOT COMPLETED|Overall Study||2
8390733|NCT01054625|20680876|P3|COMPLETED|Overall Study||9
8390734|NCT01054625|20680877|P2|COMPLETED|Overall Study||9
8390735|NCT01054625|20680878|P1|COMPLETED|Overall Study||6
8390736|NCT01054625|20680876|P3|STARTED|Overall Study||10
8390737|NCT01054625|20680877|P2|STARTED|Overall Study||12
8390738|NCT01054625|20680878|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
8390739|NCT01054599|20680906|P2|NOT COMPLETED|Overall Study||7
8390740|NCT01054599|20680907|P1|NOT COMPLETED|Overall Study||4
8390741|NCT01054599|20680906|P2|COMPLETED|Overall Study||9
8390742|NCT01054599|20680907|P1|COMPLETED|Overall Study||9
8390743|NCT01054599|20680906|P2|STARTED|Overall Study||16
8390744|NCT01054599|20680907|P1|STARTED|Overall Study||13
8390745|NCT01054586|20680919|P4|NOT COMPLETED|Overall Study||0
8390746|NCT01054586|20680920|P3|NOT COMPLETED|Overall Study||0
8390747|NCT01054586|20680921|P2|NOT COMPLETED|Overall Study||0
8390748|NCT01054586|20680922|P1|NOT COMPLETED|Overall Study||0
8390749|NCT01054586|20680919|P4|COMPLETED|Overall Study||101
8390750|NCT01054586|20680920|P3|COMPLETED|Overall Study||8
8390751|NCT01054586|20680921|P2|COMPLETED|Overall Study||15
8390752|NCT01054586|20680922|P1|COMPLETED|Overall Study||43
8390753|NCT01054586|20680919|P4|STARTED|Overall Study||101
8390754|NCT01054586|20680920|P3|STARTED|Overall Study||8
8390755|NCT01054586|20680921|P2|STARTED|Overall Study||15
8390756|NCT01054586|20680922|P1|STARTED|Overall Study||43
8390757|NCT01054573|20681014|P4|NOT COMPLETED|Overall Study||2
8390758|NCT01054573|20681015|P3|NOT COMPLETED|Overall Study||3
8390759|NCT01054573|20681016|P2|NOT COMPLETED|Overall Study||4
8390760|NCT01054573|20681017|P1|NOT COMPLETED|Overall Study||1
8390761|NCT01054573|20681014|P4|COMPLETED|Overall Study||25
8390762|NCT01054573|20681015|P3|COMPLETED|Overall Study||19
8390763|NCT01054573|20681016|P2|COMPLETED|Overall Study||28
8390764|NCT01054573|20681017|P1|COMPLETED|Overall Study||8
8390765|NCT01054573|20681014|P4|STARTED|Overall Study||27
8390766|NCT01054573|20681015|P3|STARTED|Overall Study||22
8390767|NCT01054573|20681016|P2|STARTED|Overall Study||32
8390768|NCT01054573|20681017|P1|STARTED|Overall Study||9
8390769|NCT01054560|20681063|P2|NOT COMPLETED|Overall Study||28
8390770|NCT01054560|20681064|P1|NOT COMPLETED|Overall Study||13
8390771|NCT01054560|20681063|P2|COMPLETED|Overall Study||27
8390772|NCT01054560|20681064|P1|COMPLETED|Overall Study||45
8390773|NCT01054560|20681063|P2|STARTED|Overall Study||55
8390774|NCT01054560|20681064|P1|STARTED|Overall Study||58
8390775|NCT01054456|20681086|P1|NOT COMPLETED|Overall Study||1
8390776|NCT01054456|20681086|P1|COMPLETED|Overall Study||35
8390777|NCT01054456|20681086|P1|STARTED|Overall Study||36
8390778|NCT01054404|20681106|P2|NOT COMPLETED|Overall Study||0
8390779|NCT01054404|20681107|P1|NOT COMPLETED|Overall Study||0
8390780|NCT01054404|20681106|P2|COMPLETED|Overall Study||13
8390781|NCT01054404|20681107|P1|COMPLETED|Overall Study||10
8390782|NCT01054404|20681106|P2|STARTED|Overall Study||13
8390783|NCT01054404|20681107|P1|STARTED|Overall Study||10
8390784|NCT01054339|20681116|P3|NOT COMPLETED|Overall Study||0
8390785|NCT01054339|20681117|P2|NOT COMPLETED|Overall Study||0
8390786|NCT01054339|20681118|P1|NOT COMPLETED|Overall Study||0
8390787|NCT01054339|20681116|P3|COMPLETED|Overall Study||3
8390788|NCT01054339|20681117|P2|COMPLETED|Overall Study||3
8390789|NCT01054339|20681118|P1|COMPLETED|Overall Study||3
8390790|NCT01054339|20681116|P3|STARTED|Overall Study||3
8390791|NCT01054339|20681117|P2|STARTED|Overall Study||3
8390792|NCT01054339|20681118|P1|STARTED|Overall Study||3
8390793|NCT01054300|20681134|P4|NOT COMPLETED|Period 2||0
8390794|NCT01054300|20681135|P3|NOT COMPLETED|Period 2||1
8390795|NCT01054300|20681136|P2|NOT COMPLETED|Period 2||0
8390796|NCT01054300|20681137|P1|NOT COMPLETED|Period 2||0
8390797|NCT01054300|20681134|P4|COMPLETED|Period 2||13
8390798|NCT01054300|20681135|P3|COMPLETED|Period 2||12
8390799|NCT01054300|20681136|P2|COMPLETED|Period 2||13
8390800|NCT01054300|20681137|P1|COMPLETED|Period 2||12
8390801|NCT01054300|20681134|P4|STARTED|Period 2||13
8390802|NCT01054300|20681135|P3|STARTED|Period 2||13
8390803|NCT01054300|20681136|P2|STARTED|Period 2||13
8390804|NCT01054300|20681137|P1|STARTED|Period 2||12
8390805|NCT01054300|20681134|P4|NOT COMPLETED|Period 1||0
8390806|NCT01054300|20681135|P3|NOT COMPLETED|Period 1||0
8390807|NCT01054300|20681136|P2|NOT COMPLETED|Period 1||0
8390808|NCT01054300|20681137|P1|NOT COMPLETED|Period 1||1
8390809|NCT01054300|20681134|P4|COMPLETED|Period 1||13
8390810|NCT01054300|20681135|P3|COMPLETED|Period 1||13
8390811|NCT01054300|20681136|P2|COMPLETED|Period 1||13
8390812|NCT01054300|20681137|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
8390813|NCT01054300|20681134|P4|STARTED|Period 1||13
8390814|NCT01054300|20681135|P3|STARTED|Period 1||13
8390815|NCT01054300|20681136|P2|STARTED|Period 1||13
8390816|NCT01054300|20681137|P1|STARTED|Period 1||13
8390817|NCT01054222|20681187|P1|NOT COMPLETED|Overall Study||11
8390818|NCT01054222|20681187|P1|COMPLETED|Overall Study||20
8390819|NCT01054222|20681187|P1|STARTED|Overall Study||31
8390820|NCT01054209|20681208|P2|NOT COMPLETED|Overall Study||0
8390821|NCT01054209|20681209|P1|NOT COMPLETED|Overall Study||0
8390822|NCT01054209|20681208|P2|COMPLETED|Overall Study||58
8390823|NCT01054209|20681209|P1|COMPLETED|Overall Study||58
8390824|NCT01054209|20681208|P2|STARTED|Overall Study||58
8390825|NCT01054209|20681209|P1|STARTED|Overall Study||58
8390826|NCT01054183|20681217|P2|NOT COMPLETED|Overall Study||0
8390827|NCT01054183|20681218|P1|NOT COMPLETED|Overall Study||0
8390828|NCT01054183|20681217|P2|COMPLETED|Overall Study||12
8390829|NCT01054183|20681218|P1|COMPLETED|Overall Study||10
8390830|NCT01054183|20681217|P2|STARTED|Overall Study||12
8390831|NCT01054183|20681218|P1|STARTED|Overall Study||10
8390832|NCT01054170|20681228|P2|NOT COMPLETED|Overall Study||6
8390833|NCT01054170|20681229|P1|NOT COMPLETED|Overall Study||4
8390834|NCT01054170|20681228|P2|COMPLETED|Overall Study||21
8390835|NCT01054170|20681229|P1|COMPLETED|Overall Study||21
8390836|NCT01054170|20681228|P2|STARTED|Overall Study||27
8390837|NCT01054170|20681229|P1|STARTED|Overall Study||25
8390838|NCT01054079|20681281|P1|NOT COMPLETED|Overall Study||0
8390839|NCT01054079|20681281|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
8390840|NCT01054079|20681281|P1|# Recieved Proper PSA Testing|Overall Study||10
8390841|NCT01054079|20681281|P1|STARTED|Overall Study||20
8390842|NCT01053988|20681294|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
8390843|NCT01053988|20681295|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
8390844|NCT01053988|20681296|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
8390845|NCT01053988|20681297|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
8390846|NCT01053988|20681298|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
8390847|NCT01053988|20681299|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8390848|NCT01053988|20681294|P6|COMPLETED|24-week, Double-blind Treatment Period||151
8390849|NCT01053988|20681295|P5|COMPLETED|24-week, Double-blind Treatment Period||147
8390850|NCT01053988|20681296|P4|COMPLETED|24-week, Double-blind Treatment Period||142
8390851|NCT01053988|20681297|P3|COMPLETED|24-week, Double-blind Treatment Period||145
8390852|NCT01053988|20681298|P2|COMPLETED|24-week, Double-blind Treatment Period||138
8390853|NCT01053988|20681299|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8390854|NCT01053988|20681294|P6|STARTED|24-week, Double-blind Treatment Period||206
8390855|NCT01053988|20681295|P5|STARTED|24-week, Double-blind Treatment Period||206
8390856|NCT01053988|20681296|P4|STARTED|24-week, Double-blind Treatment Period||205
8390857|NCT01053988|20681297|P3|STARTED|24-week, Double-blind Treatment Period||206
8390858|NCT01053988|20681298|P2|STARTED|24-week, Double-blind Treatment Period||207
8390859|NCT01053988|20681299|P1|STARTED|24-week, Double-blind Treatment Period||0
8390860|NCT01053988|20681294|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390861|NCT01053988|20681295|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390862|NCT01053988|20681296|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390863|NCT01053988|20681297|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390864|NCT01053988|20681298|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390865|NCT01053988|20681299|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
8390866|NCT01053988|20681294|P6|COMPLETED|2-week, Single-blind Run-In Period||0
8390867|NCT01053988|20681295|P5|COMPLETED|2-week, Single-blind Run-In Period||0
8390868|NCT01053988|20681296|P4|COMPLETED|2-week, Single-blind Run-In Period||0
8390869|NCT01053988|20681297|P3|COMPLETED|2-week, Single-blind Run-In Period||0
8390870|NCT01053988|20681298|P2|COMPLETED|2-week, Single-blind Run-In Period||0
8390871|NCT01053988|20681299|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
8390872|NCT01053988|20681294|P6|STARTED|2-week, Single-blind Run-In Period||0
8390873|NCT01053988|20681295|P5|STARTED|2-week, Single-blind Run-In Period||0
8390874|NCT01053988|20681296|P4|STARTED|2-week, Single-blind Run-In Period||0
8390875|NCT01053988|20681297|P3|STARTED|2-week, Single-blind Run-In Period||0
8390876|NCT01053988|20681298|P2|STARTED|2-week, Single-blind Run-In Period||0
8390877|NCT01053988|20681299|P1|STARTED|2-week, Single-blind Run-In Period||1390
8390878|NCT01053962|20681336|P5|NOT COMPLETED|Follow-up Period||0
8390879|NCT01053962|20681337|P4|NOT COMPLETED|Follow-up Period||0
8390880|NCT01053962|20681338|P3|NOT COMPLETED|Follow-up Period||0
8390881|NCT01053962|20681339|P2|NOT COMPLETED|Follow-up Period||0
8390882|NCT01053962|20681340|P1|NOT COMPLETED|Follow-up Period||0
8390883|NCT01053962|20681336|P5|COMPLETED|Follow-up Period||17
8390884|NCT01053962|20681337|P4|COMPLETED|Follow-up Period||15
8390885|NCT01053962|20681338|P3|COMPLETED|Follow-up Period||15
8390886|NCT01053962|20681339|P2|COMPLETED|Follow-up Period||14
8390887|NCT01053962|20681340|P1|COMPLETED|Follow-up Period||13
8390888|NCT01053962|20681336|P5|STARTED|Follow-up Period||17
8390889|NCT01053962|20681337|P4|STARTED|Follow-up Period||15
8390890|NCT01053962|20681338|P3|STARTED|Follow-up Period||15
8390891|NCT01053962|20681339|P2|STARTED|Follow-up Period||14
8390892|NCT01053962|20681340|P1|STARTED|Follow-up Period||13
8390893|NCT01053962|20681336|P5|NOT COMPLETED|Treatment Period||3
8390894|NCT01053962|20681337|P4|NOT COMPLETED|Treatment Period||0
8390895|NCT01053962|20681338|P3|NOT COMPLETED|Treatment Period||0
8390896|NCT01053962|20681339|P2|NOT COMPLETED|Treatment Period||0
8390897|NCT01053962|20681340|P1|NOT COMPLETED|Treatment Period||1
8390898|NCT01053962|20681336|P5|COMPLETED|Treatment Period||17
8390899|NCT01053962|20681337|P4|COMPLETED|Treatment Period||15
8390900|NCT01053962|20681338|P3|COMPLETED|Treatment Period||15
8390901|NCT01053962|20681339|P2|COMPLETED|Treatment Period||14
8390902|NCT01053962|20681340|P1|COMPLETED|Treatment Period||13
8390903|NCT01053962|20681336|P5|STARTED|Treatment Period||20
8390904|NCT01053962|20681337|P4|STARTED|Treatment Period||15
8390905|NCT01053962|20681338|P3|STARTED|Treatment Period||15
8390906|NCT01053962|20681339|P2|STARTED|Treatment Period||14
8390907|NCT01053962|20681340|P1|STARTED|Treatment Period||14
8390908|NCT01053962|20681336|P5|NOT COMPLETED|Pretreatment Period||2
8390909|NCT01053962|20681337|P4|NOT COMPLETED|Pretreatment Period||2
8390910|NCT01053962|20681338|P3|NOT COMPLETED|Pretreatment Period||1
8390911|NCT01053962|20681339|P2|NOT COMPLETED|Pretreatment Period||1
8390912|NCT01053962|20681340|P1|NOT COMPLETED|Pretreatment Period||0
8390913|NCT01053962|20681336|P5|COMPLETED|Pretreatment Period||20
8390914|NCT01053962|20681337|P4|COMPLETED|Pretreatment Period||15
8390915|NCT01053962|20681338|P3|COMPLETED|Pretreatment Period||15
8390916|NCT01053962|20681339|P2|COMPLETED|Pretreatment Period||14
8390917|NCT01053962|20681340|P1|COMPLETED|Pretreatment Period||14
8390918|NCT01053962|20681336|P5|STARTED|Pretreatment Period||22
8390919|NCT01053962|20681337|P4|STARTED|Pretreatment Period||17
8390920|NCT01053962|20681338|P3|STARTED|Pretreatment Period||16
8390921|NCT01053962|20681339|P2|STARTED|Pretreatment Period||15
8390922|NCT01053962|20681340|P1|STARTED|Pretreatment Period||14
8390923|NCT01053897|20681372|P1|NOT COMPLETED|Overall Study||0
8390924|NCT01053897|20681372|P1|COMPLETED|Overall Study||5
8390925|NCT01053897|20681372|P1|STARTED|Overall Study||5
8390926|NCT01053819|20681384|P1|NOT COMPLETED|Overall Study||0
8390927|NCT01053819|20681384|P1|COMPLETED|Overall Study||6
8390928|NCT01053819|20681384|P1|STARTED|Overall Study||6
8390929|NCT01053741|20681391|P2|NOT COMPLETED|2nd Study Intervention||1
8390930|NCT01053741|20681392|P1|NOT COMPLETED|2nd Study Intervention||0
8390931|NCT01053741|20681391|P2|COMPLETED|2nd Study Intervention||5
8390932|NCT01053741|20681392|P1|COMPLETED|2nd Study Intervention||5
8390933|NCT01053741|20681391|P2|STARTED|2nd Study Intervention||6
8390934|NCT01053741|20681392|P1|STARTED|2nd Study Intervention||5
8390935|NCT01053741|20681391|P2|NOT COMPLETED|14 Day Washout||0
8390936|NCT01053741|20681392|P1|NOT COMPLETED|14 Day Washout||0
8390937|NCT01053741|20681391|P2|COMPLETED|14 Day Washout||6
8390938|NCT01053741|20681392|P1|COMPLETED|14 Day Washout||5
8390939|NCT01053741|20681391|P2|STARTED|14 Day Washout||6
8390940|NCT01053741|20681392|P1|STARTED|14 Day Washout||5
8390941|NCT01053741|20681391|P2|NOT COMPLETED|1st Intervention||0
8390942|NCT01053741|20681392|P1|NOT COMPLETED|1st Intervention||0
8390943|NCT01053741|20681391|P2|COMPLETED|1st Intervention||6
8390944|NCT01053741|20681392|P1|COMPLETED|1st Intervention||5
8390945|NCT01053741|20681391|P2|STARTED|1st Intervention||6
8390946|NCT01053741|20681392|P1|STARTED|1st Intervention||5
8390947|NCT01053663|20681401|P1|NOT COMPLETED|Overall Study||6
8390948|NCT01053663|20681401|P1|COMPLETED|Overall Study||3
8390949|NCT01053663|20681401|P1|STARTED|Overall Study||9
8390950|NCT01053507|20681444|P2|NOT COMPLETED|Overall Study||1
8390951|NCT01053507|20681445|P1|NOT COMPLETED|Overall Study||3
8390952|NCT01053507|20681444|P2|COMPLETED|Overall Study||11
8390953|NCT01053507|20681445|P1|COMPLETED|Overall Study||8
8390954|NCT01053507|20681444|P2|STARTED|Overall Study||12
8390955|NCT01053507|20681445|P1|STARTED|Overall Study||11
8390956|NCT01053429|20681459|P1|NOT COMPLETED|Overall Study||373
8390957|NCT01053429|20681459|P1|COMPLETED|Overall Study||3018
8390958|NCT01053429|20681459|P1|STARTED|Overall Study||3391
8390959|NCT01053312|20681468|P1|NOT COMPLETED|Overall Study||0
8390960|NCT01053312|20681468|P1|COMPLETED|Overall Study||7
8390961|NCT01053312|20681468|P1|STARTED|Overall Study||7
8390962|NCT01053247|20681489|P3|NOT COMPLETED|Overall Study||28
8390963|NCT01053247|20681490|P2|NOT COMPLETED|Overall Study||19
8390964|NCT01053247|20681491|P1|NOT COMPLETED|Overall Study||20
8390965|NCT01053247|20681489|P3|COMPLETED|Overall Study||236
8390966|NCT01053247|20681490|P2|COMPLETED|Overall Study||241
8390967|NCT01053247|20681491|P1|COMPLETED|Overall Study||249
8390968|NCT01053247|20681489|P3|STARTED|Overall Study||264
8390969|NCT01053247|20681490|P2|STARTED|Overall Study||260
8390970|NCT01053247|20681491|P1|STARTED|Overall Study||269
8390971|NCT01053221|20681501|P2|NOT COMPLETED|Overall Study||9
8390972|NCT01053221|20681502|P1|NOT COMPLETED|Overall Study||5
8390973|NCT01053221|20681501|P2|COMPLETED|Overall Study||0
8390974|NCT01053221|20681502|P1|COMPLETED|Overall Study||0
8390975|NCT01053221|20681501|P2|STARTED|Overall Study||9
8390976|NCT01053221|20681502|P1|STARTED|Overall Study||5
8390977|NCT01053156|20681518|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
8390978|NCT01053156|20681519|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
8390979|NCT01053156|20681518|P2|COMPLETED|Second Intervention (Week 13-24)||22
8390980|NCT01053156|20681519|P1|COMPLETED|Second Intervention (Week 13-24)||26
8390981|NCT01053156|20681518|P2|STARTED|Second Intervention (Week 13-24)||27
8390982|NCT01053156|20681519|P1|STARTED|Second Intervention (Week 13-24)||28
8390983|NCT01053156|20681518|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
8390984|NCT01053156|20681519|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
8390985|NCT01053156|20681518|P2|COMPLETED|First Intervention (Week 1-12)||27
8390986|NCT01053156|20681519|P1|COMPLETED|First Intervention (Week 1-12)||28
8390987|NCT01053156|20681518|P2|STARTED|First Intervention (Week 1-12)||33
8390988|NCT01053156|20681519|P1|STARTED|First Intervention (Week 1-12)||33
8390989|NCT01053078|20681557|P2|NOT COMPLETED|Overall Study||3
8390990|NCT01053078|20681558|P1|NOT COMPLETED|Overall Study||4
8390991|NCT01053078|20681557|P2|COMPLETED|Overall Study||12
8390992|NCT01053078|20681558|P1|COMPLETED|Overall Study||10
8390993|NCT01053078|20681557|P2|STARTED|Overall Study||15
8390994|NCT01053078|20681558|P1|STARTED|Overall Study||14
8390995|NCT01053000|20681566|P2|NOT COMPLETED|Overall Study||0
8390996|NCT01053000|20681567|P1|NOT COMPLETED|Overall Study||0
8390997|NCT01053000|20681566|P2|COMPLETED|Overall Study||5
8390998|NCT01053000|20681567|P1|COMPLETED|Overall Study||5
8390999|NCT01053000|20681566|P2|STARTED|Overall Study||5
8391000|NCT01053000|20681567|P1|STARTED|Overall Study||5
8391001|NCT01052948|20681577|P4|NOT COMPLETED|Overall Study||0
8391002|NCT01052948|20681578|P3|NOT COMPLETED|Overall Study||0
8391003|NCT01052948|20681579|P2|NOT COMPLETED|Overall Study||0
8391004|NCT01052948|20681580|P1|NOT COMPLETED|Overall Study||0
8391005|NCT01052948|20681577|P4|COMPLETED|Overall Study||29311
8391006|NCT01052948|20681578|P3|COMPLETED|Overall Study||15147
8391007|NCT01052948|20681579|P2|COMPLETED|Overall Study||14669
8391008|NCT01052948|20681580|P1|COMPLETED|Overall Study||27812
8391009|NCT01052948|20681577|P4|STARTED|Overall Study||29311
8391010|NCT01052948|20681578|P3|STARTED|Overall Study||15147
8391011|NCT01052948|20681579|P2|STARTED|Overall Study||14669
8391012|NCT01052948|20681580|P1|STARTED|Overall Study||27812
8391013|NCT01052844|20681604|P2|NOT COMPLETED|Overall Study||1
8391014|NCT01052844|20681605|P1|NOT COMPLETED|Overall Study||0
8391015|NCT01052844|20681604|P2|COMPLETED|Overall Study||39
8391016|NCT01052844|20681605|P1|COMPLETED|Overall Study||40
8391017|NCT01052844|20681604|P2|STARTED|Overall Study||40
8391018|NCT01052844|20681605|P1|STARTED|Overall Study||40
8391019|NCT01052831|20681615|P2|NOT COMPLETED|Overall Study||1
8391020|NCT01052831|20681616|P1|NOT COMPLETED|Overall Study||4
8391021|NCT01052831|20681615|P2|COMPLETED|Overall Study||23
8391022|NCT01052831|20681616|P1|COMPLETED|Overall Study||22
8391023|NCT01052831|20681615|P2|STARTED|Overall Study||24
8391024|NCT01052831|20681616|P1|STARTED|Overall Study||26
8391025|NCT01052779|20681626|P2|NOT COMPLETED|Overall Study||9
8391026|NCT01052779|20681627|P1|NOT COMPLETED|Overall Study||5
8391027|NCT01052779|20681626|P2|COMPLETED|Overall Study||73
8391028|NCT01052779|20681627|P1|COMPLETED|Overall Study||75
8391029|NCT01052779|20681626|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
8391030|NCT01052779|20681627|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
8391031|NCT01052779|20681626|P2|STARTED|Overall Study||82
8391032|NCT01052779|20681627|P1|STARTED|Overall Study||80
8391033|NCT01052714|20681637|P3|NOT COMPLETED|Overall Study||2
8391034|NCT01052714|20681638|P2|NOT COMPLETED|Overall Study||29
8391035|NCT01052714|20681639|P1|NOT COMPLETED|Overall Study||25
8391036|NCT01052714|20681637|P3|COMPLETED|Overall Study||15
8391037|NCT01052714|20681638|P2|COMPLETED|Overall Study||33
8391038|NCT01052714|20681639|P1|COMPLETED|Overall Study||17
8391039|NCT01052714|20681637|P3|STARTED|Overall Study||17
8391040|NCT01052714|20681638|P2|STARTED|Overall Study||62
8391041|NCT01052714|20681639|P1|STARTED|Overall Study||42
8391042|NCT01052701|20681681|P2|NOT COMPLETED|Overall Study||0
8391043|NCT01052701|20681682|P1|NOT COMPLETED|Overall Study||0
8391044|NCT01052701|20681681|P2|COMPLETED|Overall Study||12
8391045|NCT01052701|20681682|P1|COMPLETED|Overall Study||14
8391046|NCT01052701|20681681|P2|STARTED|Overall Study||12
8391047|NCT01052701|20681682|P1|STARTED|Overall Study||14
8391048|NCT01052662|20681693|P3|NOT COMPLETED|Overall Study||22
8391049|NCT01052662|20681694|P2|NOT COMPLETED|Overall Study||22
8391050|NCT01052662|20681695|P1|NOT COMPLETED|Overall Study||22
8391051|NCT01052662|20681693|P3|COMPLETED|Overall Study||10
8391052|NCT01052662|20681694|P2|COMPLETED|Overall Study||5
8391053|NCT01052662|20681695|P1|COMPLETED|Overall Study||6
8391054|NCT01052662|20681693|P3|Discontinuation Phase|Overall Study||10
8391055|NCT01052662|20681694|P2|Discontinuation Phase|Overall Study||5
8391056|NCT01052662|20681695|P1|Discontinuation Phase|Overall Study||6
8391057|NCT01052662|20681693|P3|Stabilization Phase|Overall Study||26
8391058|NCT01052662|20681694|P2|Stabilization Phase|Overall Study||21
8391059|NCT01052662|20681695|P1|Stabilization Phase|Overall Study||21
8391060|NCT01052662|20681693|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
8391061|NCT01052662|20681694|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
8391062|NCT01052662|20681695|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
8391063|NCT01052545|20681711|P2|NOT COMPLETED|Overall Study||0
8391064|NCT01052545|20681712|P1|NOT COMPLETED|Overall Study||0
8391065|NCT01052545|20681711|P2|COMPLETED|Overall Study||731
8391066|NCT01052545|20681712|P1|COMPLETED|Overall Study||867
8391067|NCT01052545|20681711|P2|STARTED|Overall Study||731
8391068|NCT01052545|20681712|P1|STARTED|Overall Study||867
8391069|NCT01052480|20681736|P2|NOT COMPLETED|Overall Study||17
8391070|NCT01052480|20681737|P1|NOT COMPLETED|Overall Study||8
8391071|NCT01052480|20681736|P2|COMPLETED|Overall Study||32
8391072|NCT01052480|20681737|P1|COMPLETED|Overall Study||41
8391073|NCT01052480|20681736|P2|STARTED|Overall Study||49
8391074|NCT01052480|20681737|P1|STARTED|Overall Study||49
8391075|NCT01052428|20681787|P2|NOT COMPLETED|Overall Study||1
8391076|NCT01052428|20681788|P1|NOT COMPLETED|Overall Study||1
8391077|NCT01052428|20681787|P2|COMPLETED|Overall Study||18
8391078|NCT01052428|20681788|P1|COMPLETED|Overall Study||18
8391079|NCT01052428|20681787|P2|STARTED|Overall Study||19
8391080|NCT01052428|20681788|P1|STARTED|Overall Study||19
8391081|NCT01052272|20681810|P4|NOT COMPLETED|Overall Study||7
8391082|NCT01052272|20681811|P3|NOT COMPLETED|Overall Study||8
8391083|NCT01052272|20681812|P2|NOT COMPLETED|Overall Study||7
8391084|NCT01052272|20681813|P1|NOT COMPLETED|Overall Study||5
8391085|NCT01052272|20681810|P4|COMPLETED|Overall Study||11
8391086|NCT01052272|20681811|P3|COMPLETED|Overall Study||10
8391087|NCT01052272|20681812|P2|COMPLETED|Overall Study||11
8391088|NCT01052272|20681813|P1|COMPLETED|Overall Study||13
8391089|NCT01052272|20681810|P4|STARTED|Overall Study||18
8391090|NCT01052272|20681811|P3|STARTED|Overall Study||18
8391091|NCT01052272|20681812|P2|STARTED|Overall Study||18
8391092|NCT01052272|20681813|P1|STARTED|Overall Study||18
8391093|NCT01052207|20681849|P2|NOT COMPLETED|Overall Study||0
8391094|NCT01052207|20681850|P1|NOT COMPLETED|Overall Study||0
8391095|NCT01052207|20681849|P2|COMPLETED|Overall Study||42
8391096|NCT01052207|20681850|P1|COMPLETED|Overall Study||60
8391097|NCT01052207|20681849|P2|STARTED|Overall Study||42
8391098|NCT01052207|20681850|P1|STARTED|Overall Study||60
8391099|NCT01052116|20681858|P2|NOT COMPLETED|Overall Study||27
8391100|NCT01052116|20681859|P1|NOT COMPLETED|Overall Study||14
8391101|NCT01052116|20681858|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
8391102|NCT01052116|20681859|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
8391103|NCT01052116|20681858|P2|STARTED|Overall Study||193
8391104|NCT01052116|20681859|P1|STARTED|Overall Study||193
8391105|NCT01052077|20681867|P4|NOT COMPLETED|Phase A+||21
8391106|NCT01052077|20681868|P3|NOT COMPLETED|Phase A+||0
8391107|NCT01052077|20681869|P2|NOT COMPLETED|Phase A+||0
8391108|NCT01052077|20681870|P1|NOT COMPLETED|Phase A+||0
8391109|NCT01052077|20681867|P4|COMPLETED|Phase A+||230
8391110|NCT01052077|20681868|P3|COMPLETED|Phase A+||0
8391111|NCT01052077|20681869|P2|COMPLETED|Phase A+||0
8391112|NCT01052077|20681870|P1|COMPLETED|Phase A+||0
8391113|NCT01052077|20681867|P4|STARTED|Phase A+||251
8391114|NCT01052077|20681868|P3|STARTED|Phase A+||0
8391115|NCT01052077|20681869|P2|STARTED|Phase A+||0
8391116|NCT01052077|20681870|P1|STARTED|Phase A+||0
8391117|NCT01052077|20681867|P4|NOT COMPLETED|Phase B||0
8391118|NCT01052077|20681868|P3|NOT COMPLETED|Phase B||16
8391119|NCT01052077|20681869|P2|NOT COMPLETED|Phase B||18
8391120|NCT01052077|20681870|P1|NOT COMPLETED|Phase B||0
8391121|NCT01052077|20681867|P4|COMPLETED|Phase B||0
8391122|NCT01052077|20681868|P3|COMPLETED|Phase B||171
8391123|NCT01052077|20681869|P2|COMPLETED|Phase B||167
8391124|NCT01052077|20681870|P1|COMPLETED|Phase B||0
8391125|NCT01052077|20681867|P4|STARTED|Phase B||0
8391126|NCT01052077|20681868|P3|STARTED|Phase B||187
8391127|NCT01052077|20681869|P2|STARTED|Phase B||185
8391128|NCT01052077|20681870|P1|STARTED|Phase B||0
8391129|NCT01052077|20681867|P4|NOT COMPLETED|Phase A||0
8391130|NCT01052077|20681868|P3|NOT COMPLETED|Phase A||0
8391131|NCT01052077|20681869|P2|NOT COMPLETED|Phase A||0
8391132|NCT01052077|20681870|P1|NOT COMPLETED|Phase A||146
8391133|NCT01052077|20681867|P4|COMPLETED|Phase A||0
8391134|NCT01052077|20681868|P3|COMPLETED|Phase A||0
8391135|NCT01052077|20681869|P2|COMPLETED|Phase A||0
8391136|NCT01052077|20681870|P1|COMPLETED|Phase A||623
8391137|NCT01052077|20681867|P4|STARTED|Phase A||0
8391138|NCT01052077|20681868|P3|STARTED|Phase A||0
8391139|NCT01052077|20681869|P2|STARTED|Phase A||0
8391140|NCT01052077|20681870|P1|STARTED|Phase A||769
8391141|NCT01052038|20681897|P3|NOT COMPLETED|Overall Study||4
8391142|NCT01052038|20681898|P2|NOT COMPLETED|Overall Study||6
8391143|NCT01052038|20681899|P1|NOT COMPLETED|Overall Study||4
8391144|NCT01052038|20681897|P3|COMPLETED|Overall Study||36
8391145|NCT01052038|20681898|P2|COMPLETED|Overall Study||34
8391146|NCT01052038|20681899|P1|COMPLETED|Overall Study||36
8391147|NCT01052038|20681897|P3|STARTED|Overall Study||40
8391148|NCT01052038|20681898|P2|STARTED|Overall Study||40
8391149|NCT01052038|20681899|P1|STARTED|Overall Study||40
8391150|NCT01051986|20681921|P2|NOT COMPLETED|Overall Study||4
8391151|NCT01051986|20681922|P1|NOT COMPLETED|Overall Study||5
8391152|NCT01051986|20681921|P2|COMPLETED|Overall Study||108
8391153|NCT01051986|20681922|P1|COMPLETED|Overall Study||107
8391154|NCT01051986|20681921|P2|STARTED|Overall Study||112
8391155|NCT01051986|20681922|P1|STARTED|Overall Study||112
8391156|NCT01051960|20681936|P1|NOT COMPLETED|Overall Study||1
8391157|NCT01051960|20681936|P1|COMPLETED|Overall Study||11
8391158|NCT01051960|20681936|P1|STARTED|Overall Study||12
8391159|NCT01051921|20681944|P1|NOT COMPLETED|Overall Study||30
8391160|NCT01051921|20681944|P1|COMPLETED|Overall Study||37
8391161|NCT01051921|20681944|P1|STARTED|Overall Study||67
8391162|NCT01051856|20681951|P2|NOT COMPLETED|Overall Study||0
8391163|NCT01051856|20681952|P1|NOT COMPLETED|Overall Study||1
8391164|NCT01051856|20681951|P2|COMPLETED|Overall Study||35
8391165|NCT01051856|20681952|P1|COMPLETED|Overall Study||32
8391166|NCT01051856|20681951|P2|STARTED|Overall Study||35
8391167|NCT01051856|20681952|P1|STARTED|Overall Study||33
8391168|NCT01051817|20681962|P2|NOT COMPLETED|Overall Study||9
8391169|NCT01051817|20681963|P1|NOT COMPLETED|Overall Study||3
8391170|NCT01051817|20681962|P2|COMPLETED|Overall Study||26
8391171|NCT01051817|20681963|P1|COMPLETED|Overall Study||35
8391172|NCT01051817|20681962|P2|STARTED|Overall Study||35
8391173|NCT01051817|20681963|P1|STARTED|Overall Study||38
8391174|NCT01051791|20681973|P1|NOT COMPLETED|Overall Study||4
8391175|NCT01051791|20681973|P1|COMPLETED|Overall Study||9
8391176|NCT01051791|20681973|P1|STARTED|Overall Study||13
8391177|NCT01051778|20681982|P2|NOT COMPLETED|Overall Study||0
8391178|NCT01051778|20681983|P1|NOT COMPLETED|Overall Study||0
8391179|NCT01051778|20681982|P2|COMPLETED|Overall Study|November 2009|30
8391180|NCT01051778|20681983|P1|COMPLETED|Overall Study|November 2009|30
8391181|NCT01051778|20681982|P2|STARTED|Overall Study|June 2006|30
8391182|NCT01051778|20681983|P1|STARTED|Overall Study|June 2006|30
8391183|NCT01051739|20681991|P2|NOT COMPLETED|Overall Study||13
8391184|NCT01051739|20681992|P1|NOT COMPLETED|Overall Study||28
8391185|NCT01051739|20681991|P2|COMPLETED|Overall Study||47
8391186|NCT01051739|20681992|P1|COMPLETED|Overall Study||92
8391187|NCT01051739|20681991|P2|STARTED|Overall Study||60
8391188|NCT01051739|20681992|P1|STARTED|Overall Study||120
8391207|NCT01051596|20682188|P1|NOT COMPLETED|Overall Study||0
8391208|NCT01051596|20682188|P1|COMPLETED|Overall Study||75
8391209|NCT01051596|20682188|P1|STARTED|Overall Study||75
8391210|NCT01051570|20682195|P1|NOT COMPLETED|Overall Study||0
8391211|NCT01051570|20682195|P1|COMPLETED|Overall Study||26
8391212|NCT01051570|20682195|P1|STARTED|Overall Study||26
8391213|NCT01051557|20682211|P7|NOT COMPLETED|Overall Study||6
8391214|NCT01051557|20682212|P6|NOT COMPLETED|Overall Study||6
8391215|NCT01051557|20682213|P5|NOT COMPLETED|Overall Study||7
8391216|NCT01051557|20682214|P4|NOT COMPLETED|Overall Study||3
8391217|NCT01051557|20682215|P3|NOT COMPLETED|Overall Study||6
8391218|NCT01051557|20682216|P2|NOT COMPLETED|Overall Study||3
8391219|NCT01051557|20682217|P1|NOT COMPLETED|Overall Study||4
8391220|NCT01051557|20682211|P7|COMPLETED|Overall Study||0
8391221|NCT01051557|20682212|P6|COMPLETED|Overall Study||0
8391222|NCT01051557|20682213|P5|COMPLETED|Overall Study||1
8391223|NCT01051557|20682214|P4|COMPLETED|Overall Study||0
8391224|NCT01051557|20682215|P3|COMPLETED|Overall Study||0
8391225|NCT01051557|20682216|P2|COMPLETED|Overall Study||0
8391226|NCT01051557|20682217|P1|COMPLETED|Overall Study||0
8391227|NCT01051557|20682211|P7|STARTED|Overall Study||6
8391228|NCT01051557|20682212|P6|STARTED|Overall Study||6
8391229|NCT01051557|20682213|P5|STARTED|Overall Study||8
8391230|NCT01051557|20682214|P4|STARTED|Overall Study||3
8391231|NCT01051557|20682215|P3|STARTED|Overall Study||6
8391232|NCT01051557|20682216|P2|STARTED|Overall Study||3
8391233|NCT01051557|20682217|P1|STARTED|Overall Study||4
8391234|NCT01051518|20682236|P1|NOT COMPLETED|Overall Study||73
8391235|NCT01051518|20682236|P1|COMPLETED|Overall Study||53
8391236|NCT01051518|20682236|P1|STARTED|Overall Study||126
8391237|NCT01051466|20682248|P2|NOT COMPLETED|Overall Study||5
8391238|NCT01051466|20682249|P1|NOT COMPLETED|Overall Study||8
8391239|NCT01051466|20682248|P2|COMPLETED|Overall Study||23
8391240|NCT01051466|20682249|P1|COMPLETED|Overall Study||24
8391241|NCT01051466|20682248|P2|STARTED|Overall Study||28
8391242|NCT01051466|20682249|P1|STARTED|Overall Study||32
8391243|NCT01051440|20682283|P2|NOT COMPLETED|Overall Study||0
8391244|NCT01051440|20682284|P1|NOT COMPLETED|Overall Study||0
8391245|NCT01051440|20682283|P2|COMPLETED|Overall Study||1
8391246|NCT01051440|20682284|P1|COMPLETED|Overall Study||1
8391247|NCT01051440|20682283|P2|STARTED|Overall Study||1
8391248|NCT01051440|20682284|P1|STARTED|Overall Study||1
8391249|NCT01051349|20682294|P1|NOT COMPLETED|Overall Study||173
8391250|NCT01051349|20682294|P1|COMPLETED|Overall Study||237
8391251|NCT01051349|20682294|P1|STARTED|Overall Study||410
8391252|NCT01051323|20682323|P1|NOT COMPLETED|Overall Study||539
8391253|NCT01051323|20682323|P1|COMPLETED|Overall Study||1041
8391254|NCT01051323|20682323|P1|Received at Least One Dose|Overall Study||1547
8391255|NCT01051323|20682323|P1|STARTED|Overall Study||1580
8391256|NCT01051310|20682345|P1|NOT COMPLETED|Overall Study||5
8391257|NCT01051310|20682345|P1|COMPLETED|Overall Study||13
8391258|NCT01051310|20682345|P1|STARTED|Overall Study||18
8391259|NCT01051063|20682352|P2|NOT COMPLETED|Overall Study||4
8391260|NCT01051063|20682353|P1|NOT COMPLETED|Overall Study||10
8391261|NCT01051063|20682352|P2|COMPLETED|Overall Study||1
8391262|NCT01051063|20682353|P1|COMPLETED|Overall Study||2
8391263|NCT01051063|20682352|P2|STARTED|Overall Study||5
8391264|NCT01051063|20682353|P1|STARTED|Overall Study||12
8391265|NCT01050998|20682373|P5|NOT COMPLETED|Overall Study||14
8391266|NCT01050998|20682374|P4|NOT COMPLETED|Overall Study||3
8391267|NCT01050998|20682375|P3|NOT COMPLETED|Overall Study||3
8391268|NCT01050998|20682376|P2|NOT COMPLETED|Overall Study||2
8391269|NCT01050998|20682377|P1|NOT COMPLETED|Overall Study||4
8391270|NCT01050998|20682373|P5|COMPLETED|Overall Study||82
8391271|NCT01050998|20682374|P4|COMPLETED|Overall Study||45
8391272|NCT01050998|20682375|P3|COMPLETED|Overall Study||46
8391273|NCT01050998|20682376|P2|COMPLETED|Overall Study||47
8391274|NCT01050998|20682377|P1|COMPLETED|Overall Study||44
8391275|NCT01050998|20682373|P5|STARTED|Overall Study||96
8391276|NCT01050998|20682374|P4|STARTED|Overall Study||48
8391277|NCT01050998|20682375|P3|STARTED|Overall Study||49
8391278|NCT01050998|20682376|P2|STARTED|Overall Study||49
8391279|NCT01050998|20682377|P1|STARTED|Overall Study||48
8391280|NCT01050946|20682701|P1|NOT COMPLETED|Overall Study||0
8391281|NCT01050946|20682701|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
8391282|NCT01050946|20682701|P1|STARTED|Overall Study||1
8391283|NCT01050907|20682711|P1|NOT COMPLETED|Overall Study||0
8391284|NCT01050907|20682711|P1|COMPLETED|Overall Study||4
8391285|NCT01050907|20682711|P1|STARTED|Overall Study||4
8391286|NCT01050816|20682716|P1|NOT COMPLETED|Overall Study||4
8391287|NCT01050816|20682716|P1|COMPLETED|Overall Study||26
8391288|NCT01050816|20682716|P1|STARTED|Overall Study||30
8391289|NCT01050790|20682722|P1|NOT COMPLETED|Overall Study||1
8391290|NCT01050790|20682722|P1|COMPLETED|Overall Study||16
8391291|NCT01050790|20682722|P1|STARTED|Overall Study||17
8391292|NCT01050764|20682732|P1|NOT COMPLETED|Overall Study||3
8391293|NCT01050764|20682732|P1|COMPLETED|Overall Study||7
8391294|NCT01050764|20682732|P1|Received Infusion of T-con Cells|Overall Study||7
8391295|NCT01050764|20682732|P1|Received Infusion of T-reg Cells|Overall Study||7
8391296|NCT01050764|20682732|P1|Received HSCT Graft|Overall Study||8
8391297|NCT01050764|20682732|P1|STARTED|Overall Study||10
8391298|NCT01050673|20682743|P2|NOT COMPLETED|Overall Study||5
8391299|NCT01050673|20682744|P1|NOT COMPLETED|Overall Study||4
8391300|NCT01050673|20682743|P2|COMPLETED|Overall Study||14
8391301|NCT01050673|20682744|P1|COMPLETED|Overall Study||17
8391302|NCT01050673|20682743|P2|STARTED|Overall Study||19
8391303|NCT01050673|20682744|P1|STARTED|Overall Study||21
8391304|NCT01050660|20682768|P2|NOT COMPLETED|Overall Study||0
8391305|NCT01050660|20682769|P1|NOT COMPLETED|Overall Study||0
8391306|NCT01050660|20682768|P2|COMPLETED|Overall Study||69
8391307|NCT01050660|20682769|P1|COMPLETED|Overall Study||67
8391308|NCT01050660|20682768|P2|STARTED|Overall Study||69
8391309|NCT01050660|20682769|P1|STARTED|Overall Study||67
8391310|NCT01050647|20682795|P2|NOT COMPLETED|Overall Study||0
8391311|NCT01050647|20682796|P1|NOT COMPLETED|Overall Study||0
8391312|NCT01050647|20682795|P2|COMPLETED|Overall Study||11
8391313|NCT01050647|20682796|P1|COMPLETED|Overall Study||10
8391314|NCT01050647|20682795|P2|STARTED|Overall Study||11
8391315|NCT01050647|20682796|P1|STARTED|Overall Study||10
8391316|NCT01050634|20682812|P1|NOT COMPLETED|Overall Study||128
8391317|NCT01050634|20682812|P1|COMPLETED|Overall Study||852
8391318|NCT01050634|20682812|P1|Received Treatment|Overall Study||924
8391319|NCT01050634|20682812|P1|STARTED|Overall Study||980
8391320|NCT01050582|20682822|P2|NOT COMPLETED|Overall Study||0
8391321|NCT01050582|20682823|P1|NOT COMPLETED|Overall Study||0
8391322|NCT01050582|20682822|P2|COMPLETED|Overall Study||51
8391323|NCT01050582|20682823|P1|COMPLETED|Overall Study||133
8391324|NCT01050582|20682822|P2|STARTED|Overall Study||51
8391325|NCT01050582|20682823|P1|STARTED|Overall Study||133
8391326|NCT01050569|20682836|P3|NOT COMPLETED|Overall Study||33
8391327|NCT01050569|20682837|P2|NOT COMPLETED|Overall Study||24
8391328|NCT01050569|20682838|P1|NOT COMPLETED|Overall Study||38
8391329|NCT01050569|20682836|P3|COMPLETED|Overall Study||47
8391330|NCT01050569|20682837|P2|COMPLETED|Overall Study||52
8391331|NCT01050569|20682838|P1|COMPLETED|Overall Study||41
8391332|NCT01050569|20682836|P3|STARTED|Overall Study||80
8391333|NCT01050569|20682837|P2|STARTED|Overall Study||76
8391334|NCT01050569|20682838|P1|STARTED|Overall Study||79
8391335|NCT01050543|20682857|P2|NOT COMPLETED|Overall Study||4
8391336|NCT01050543|20682858|P1|NOT COMPLETED|Overall Study||4
8391337|NCT01050543|20682857|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
8391338|NCT01050543|20682858|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
8391339|NCT01050543|20682857|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
8391340|NCT01050543|20682858|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
8391341|NCT01050530|20682866|P2|NOT COMPLETED|Overall Study||10
8391342|NCT01050530|20682867|P1|NOT COMPLETED|Overall Study||8
8391343|NCT01050530|20682866|P2|COMPLETED|Overall Study||70
8391344|NCT01050530|20682867|P1|COMPLETED|Overall Study||74
8391345|NCT01050530|20682866|P2|STARTED|Overall Study||80
8391346|NCT01050530|20682867|P1|STARTED|Overall Study||82
8391347|NCT01050257|20682878|P3|NOT COMPLETED|Overall Study||7
8391348|NCT01050257|20682879|P2|NOT COMPLETED|Overall Study||13
8391349|NCT01050257|20682880|P1|NOT COMPLETED|Overall Study||11
8391350|NCT01050257|20682878|P3|COMPLETED|Overall Study||8
8391351|NCT01050257|20682879|P2|COMPLETED|Overall Study||40
8391352|NCT01050257|20682880|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
8391353|NCT01050257|20682878|P3|Switched to Oral Treatment|Overall Study||3
8391354|NCT01050257|20682879|P2|Switched to Oral Treatment|Overall Study||31
8391355|NCT01050257|20682880|P1|Switched to Oral Treatment|Overall Study||28
8391356|NCT01050257|20682878|P3|Intent-to-treat Infected Confirmed|Overall Study||10
8391357|NCT01050257|20682879|P2|Intent-to-treat Infected Confirmed|Overall Study||32
8391358|NCT01050257|20682880|P1|Intent-to-treat Infected Confirmed|Overall Study||30
8391359|NCT01050257|20682878|P3|Safety Population: Actual Dose Received|Overall Study||14
8391360|NCT01050257|20682879|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
8391361|NCT01050257|20682880|P1|Safety Population: Actual Dose Received|Overall Study||48
8391362|NCT01050257|20682878|P3|Received Treatment|Overall Study||14
8391363|NCT01050257|20682879|P2|Received Treatment|Overall Study||50
8391364|NCT01050257|20682880|P1|Received Treatment|Overall Study||49
8391365|NCT01050257|20682878|P3|STARTED|Overall Study||15
8391366|NCT01050257|20682879|P2|STARTED|Overall Study||53
8391367|NCT01050257|20682880|P1|STARTED|Overall Study||50
8391368|NCT01050218|20682915|P1|NOT COMPLETED|Overall Study||95
8391369|NCT01050218|20682915|P1|COMPLETED|Overall Study||142
8391370|NCT01050218|20682915|P1|STARTED|Overall Study||237
8391371|NCT01050205|20682921|P2|NOT COMPLETED|Overall Study||4
8391372|NCT01050205|20682922|P1|NOT COMPLETED|Overall Study||11
8391373|NCT01050205|20682921|P2|COMPLETED|Overall Study||71
8391374|NCT01050205|20682922|P1|COMPLETED|Overall Study||137
8391375|NCT01050205|20682921|P2|STARTED|Overall Study||75
8391376|NCT01050205|20682922|P1|STARTED|Overall Study||148
8391377|NCT01050153|20682952|P2|NOT COMPLETED|Overall Study||0
8391378|NCT01050153|20682953|P1|NOT COMPLETED|Overall Study||0
8391379|NCT01050153|20682952|P2|COMPLETED|Overall Study||25
8391380|NCT01050153|20682953|P1|COMPLETED|Overall Study||25
8391381|NCT01050153|20682952|P2|STARTED|Overall Study||25
8391382|NCT01050153|20682953|P1|STARTED|Overall Study||25
8391383|NCT01050062|20682979|P2|NOT COMPLETED|Overall Study||112
8391384|NCT01050062|20682980|P1|NOT COMPLETED|Overall Study||271
8391385|NCT01050062|20682979|P2|COMPLETED|Overall Study||243
8391386|NCT01050062|20682980|P1|COMPLETED|Overall Study||799
8391387|NCT01050062|20682979|P2|STARTED|Overall Study||355
8391388|NCT01050062|20682980|P1|STARTED|Overall Study||1070
8391389|NCT01049984|20683002|P2|NOT COMPLETED|Overall Study||19
8391390|NCT01049984|20683003|P1|NOT COMPLETED|Overall Study||19
8391391|NCT01049984|20683002|P2|COMPLETED|Overall Study||146
8391392|NCT01049984|20683003|P1|COMPLETED|Overall Study||144
8391393|NCT01049984|20683002|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
8391394|NCT01049984|20683003|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
8391395|NCT01049984|20683002|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
8391396|NCT01049984|20683003|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
8391397|NCT01049984|20683002|P2|STARTED|Overall Study||165
8391398|NCT01049984|20683003|P1|STARTED|Overall Study||163
8391399|NCT01049945|20683021|P6|NOT COMPLETED|Overall Study||0
8391400|NCT01049945|20683022|P5|NOT COMPLETED|Overall Study||0
8391401|NCT01049945|20683023|P4|NOT COMPLETED|Overall Study||0
8391402|NCT01049945|20683024|P3|NOT COMPLETED|Overall Study||0
8391403|NCT01049945|20683025|P2|NOT COMPLETED|Overall Study||0
8391404|NCT01049945|20683026|P1|NOT COMPLETED|Overall Study||0
8391405|NCT01049945|20683021|P6|COMPLETED|Overall Study||49
8391406|NCT01049945|20683022|P5|COMPLETED|Overall Study||3
8391407|NCT01049945|20683023|P4|COMPLETED|Overall Study||6
8391408|NCT01049945|20683024|P3|COMPLETED|Overall Study||3
8391409|NCT01049945|20683025|P2|COMPLETED|Overall Study||6
8391410|NCT01049945|20683026|P1|COMPLETED|Overall Study||3
8391411|NCT01049945|20683021|P6|STARTED|Overall Study||49
8391412|NCT01049945|20683022|P5|STARTED|Overall Study||3
8391413|NCT01049945|20683023|P4|STARTED|Overall Study||6
8391414|NCT01049945|20683024|P3|STARTED|Overall Study||3
8391415|NCT01049945|20683025|P2|STARTED|Overall Study||6
8391416|NCT01049945|20683026|P1|STARTED|Overall Study||3
8391417|NCT01049802|20683046|P2|NOT COMPLETED|Overall Study||0
8391418|NCT01049802|20683047|P1|NOT COMPLETED|Overall Study||0
8391419|NCT01049802|20683046|P2|COMPLETED|Overall Study||10
8391420|NCT01049802|20683047|P1|COMPLETED|Overall Study||20
8391421|NCT01049802|20683046|P2|STARTED|Overall Study||10
8391422|NCT01049802|20683047|P1|STARTED|Overall Study||20
8391423|NCT01049776|20683061|P1|NOT COMPLETED|Overall Study||20
8391424|NCT01049776|20683061|P1|COMPLETED|Overall Study||12
8391425|NCT01049776|20683061|P1|STARTED|Overall Study||32
8391426|NCT01049581|20683067|P2|NOT COMPLETED|Overall Study||1
8391427|NCT01049581|20683068|P1|NOT COMPLETED|Overall Study||2
8391428|NCT01049581|20683067|P2|COMPLETED|Overall Study||13
8391429|NCT01049581|20683068|P1|COMPLETED|Overall Study||11
8391430|NCT01049581|20683067|P2|STARTED|Overall Study||14
8391431|NCT01049581|20683068|P1|STARTED|Overall Study||13
8391432|NCT01049503|20683083|P6|NOT COMPLETED|Overall Study||8
8391433|NCT01049503|20683084|P5|NOT COMPLETED|Overall Study||27
8391434|NCT01049503|20683085|P4|NOT COMPLETED|Overall Study||26
8391435|NCT01049503|20683086|P3|NOT COMPLETED|Overall Study||24
8391436|NCT01049503|20683087|P2|NOT COMPLETED|Overall Study||12
8391437|NCT01049503|20683088|P1|NOT COMPLETED|Overall Study||11
8391438|NCT01049503|20683083|P6|COMPLETED|Overall Study||40
8391439|NCT01049503|20683084|P5|COMPLETED|Overall Study||29
8391440|NCT01049503|20683085|P4|COMPLETED|Overall Study||29
8391441|NCT01049503|20683086|P3|COMPLETED|Overall Study||32
8391442|NCT01049503|20683087|P2|COMPLETED|Overall Study||36
8391443|NCT01049503|20683088|P1|COMPLETED|Overall Study||41
8391444|NCT01049503|20683083|P6|STARTED|Overall Study||48
8391445|NCT01049503|20683084|P5|STARTED|Overall Study||56
8391446|NCT01049503|20683085|P4|STARTED|Overall Study||55
8391447|NCT01049503|20683086|P3|STARTED|Overall Study||56
8391448|NCT01049503|20683087|P2|STARTED|Overall Study||48
8391449|NCT01049503|20683088|P1|STARTED|Overall Study||52
8391450|NCT01049412|20683119|P2|NOT COMPLETED|Period II||3
8391451|NCT01049412|20683120|P1|NOT COMPLETED|Period II||4
8391452|NCT01049412|20683119|P2|COMPLETED|Period II||52
8391453|NCT01049412|20683120|P1|COMPLETED|Period II||58
8391454|NCT01049412|20683119|P2|STARTED|Period II||55
8391455|NCT01049412|20683120|P1|STARTED|Period II||62
8391456|NCT01049412|20683119|P2|NOT COMPLETED|Period I||13
8391457|NCT01049412|20683120|P1|NOT COMPLETED|Period I||8
8391458|NCT01049412|20683119|P2|COMPLETED|Period I||55
8391459|NCT01049412|20683120|P1|COMPLETED|Period I||62
8391460|NCT01049412|20683119|P2|Took at Least One Dose of Study Drug|Period I||68
8391461|NCT01049412|20683120|P1|Took at Least One Dose of Study Drug|Period I||69
8391462|NCT01049412|20683119|P2|STARTED|Period I||68
8391463|NCT01049412|20683120|P1|STARTED|Period I||70
8391464|NCT01049373|20683149|P2|NOT COMPLETED|Overall Study||44
8391465|NCT01049373|20683150|P1|NOT COMPLETED|Overall Study||39
8391466|NCT01049373|20683149|P2|COMPLETED|Overall Study||65
8391467|NCT01049373|20683150|P1|COMPLETED|Overall Study||73
8391468|NCT01049373|20683149|P2|STARTED|Overall Study||109
8391469|NCT01049373|20683150|P1|STARTED|Overall Study||112
8391470|NCT01049360|20683164|P20|NOT COMPLETED|Period 4||0
8391471|NCT01049360|20683165|P19|NOT COMPLETED|Period 4||0
8391472|NCT01049360|20683166|P18|NOT COMPLETED|Period 4||1
8391473|NCT01049360|20683167|P17|NOT COMPLETED|Period 4||0
8391474|NCT01049360|20683168|P16|NOT COMPLETED|Period 4||0
8391475|NCT01049360|20683169|P15|NOT COMPLETED|Period 4||0
8391476|NCT01049360|20683170|P14|NOT COMPLETED|Period 4||0
8391477|NCT01049360|20683171|P13|NOT COMPLETED|Period 4||0
8391478|NCT01049360|20683172|P12|NOT COMPLETED|Period 4||0
8391479|NCT01049360|20683173|P11|NOT COMPLETED|Period 4||0
8391480|NCT01049360|20683174|P10|NOT COMPLETED|Period 4||0
8391481|NCT01049360|20683175|P9|NOT COMPLETED|Period 4||0
8391482|NCT01049360|20683176|P8|NOT COMPLETED|Period 4||0
8391483|NCT01049360|20683177|P7|NOT COMPLETED|Period 4||0
8391484|NCT01049360|20683178|P6|NOT COMPLETED|Period 4||0
8391485|NCT01049360|20683179|P5|NOT COMPLETED|Period 4||0
8391486|NCT01049360|20683180|P4|NOT COMPLETED|Period 4||1
8391487|NCT01049360|20683181|P3|NOT COMPLETED|Period 4||0
8391488|NCT01049360|20683182|P2|NOT COMPLETED|Period 4||0
8391489|NCT01049360|20683183|P1|NOT COMPLETED|Period 4||0
8391490|NCT01049360|20683164|P20|COMPLETED|Period 4||5
8391491|NCT01049360|20683165|P19|COMPLETED|Period 4||5
8391492|NCT01049360|20683166|P18|COMPLETED|Period 4||5
8391493|NCT01049360|20683167|P17|COMPLETED|Period 4||5
8391494|NCT01049360|20683168|P16|COMPLETED|Period 4||6
8391495|NCT01049360|20683169|P15|COMPLETED|Period 4||5
8391496|NCT01049360|20683170|P14|COMPLETED|Period 4||6
8391497|NCT01049360|20683171|P13|COMPLETED|Period 4||4
8391498|NCT01049360|20683172|P12|COMPLETED|Period 4||6
8391499|NCT01049360|20683173|P11|COMPLETED|Period 4||5
8391500|NCT01049360|20683174|P10|COMPLETED|Period 4||6
8391501|NCT01049360|20683175|P9|COMPLETED|Period 4||4
8391502|NCT01049360|20683176|P8|COMPLETED|Period 4||4
8391503|NCT01049360|20683177|P7|COMPLETED|Period 4||6
8391504|NCT01049360|20683178|P6|COMPLETED|Period 4||5
8391505|NCT01049360|20683179|P5|COMPLETED|Period 4||7
8391506|NCT01049360|20683180|P4|COMPLETED|Period 4||3
8391507|NCT01049360|20683181|P3|COMPLETED|Period 4||7
8391508|NCT01049360|20683182|P2|COMPLETED|Period 4||4
8391509|NCT01049360|20683183|P1|COMPLETED|Period 4||6
8391510|NCT01049360|20683164|P20|STARTED|Period 4||5
8391511|NCT01049360|20683165|P19|STARTED|Period 4||5
8391512|NCT01049360|20683166|P18|STARTED|Period 4||6
8391513|NCT01049360|20683167|P17|STARTED|Period 4||5
8391514|NCT01049360|20683168|P16|STARTED|Period 4||6
8391515|NCT01049360|20683169|P15|STARTED|Period 4||5
8391516|NCT01049360|20683170|P14|STARTED|Period 4||6
8391517|NCT01049360|20683171|P13|STARTED|Period 4||4
8391518|NCT01049360|20683172|P12|STARTED|Period 4||6
8391519|NCT01049360|20683173|P11|STARTED|Period 4||5
8391520|NCT01049360|20683174|P10|STARTED|Period 4||6
8391521|NCT01049360|20683175|P9|STARTED|Period 4||4
8391522|NCT01049360|20683176|P8|STARTED|Period 4||4
8391523|NCT01049360|20683177|P7|STARTED|Period 4||6
8391524|NCT01049360|20683178|P6|STARTED|Period 4||5
8391525|NCT01049360|20683179|P5|STARTED|Period 4||7
8391526|NCT01049360|20683180|P4|STARTED|Period 4||4
8391527|NCT01049360|20683181|P3|STARTED|Period 4||7
8391528|NCT01049360|20683182|P2|STARTED|Period 4||4
8391529|NCT01049360|20683183|P1|STARTED|Period 4||6
8391530|NCT01049360|20683164|P20|NOT COMPLETED|Period 3||0
8391531|NCT01049360|20683165|P19|NOT COMPLETED|Period 3||0
8391532|NCT01049360|20683166|P18|NOT COMPLETED|Period 3||0
8391533|NCT01049360|20683167|P17|NOT COMPLETED|Period 3||0
8391534|NCT01049360|20683168|P16|NOT COMPLETED|Period 3||0
8391535|NCT01049360|20683169|P15|NOT COMPLETED|Period 3||0
8391536|NCT01049360|20683170|P14|NOT COMPLETED|Period 3||0
8391537|NCT01049360|20683171|P13|NOT COMPLETED|Period 3||0
8391538|NCT01049360|20683172|P12|NOT COMPLETED|Period 3||0
8391539|NCT01049360|20683173|P11|NOT COMPLETED|Period 3||0
8391540|NCT01049360|20683174|P10|NOT COMPLETED|Period 3||0
8391541|NCT01049360|20683175|P9|NOT COMPLETED|Period 3||0
8391542|NCT01049360|20683176|P8|NOT COMPLETED|Period 3||0
8391543|NCT01049360|20683177|P7|NOT COMPLETED|Period 3||0
8391544|NCT01049360|20683178|P6|NOT COMPLETED|Period 3||0
8391545|NCT01049360|20683179|P5|NOT COMPLETED|Period 3||0
8391546|NCT01049360|20683180|P4|NOT COMPLETED|Period 3||0
8391547|NCT01049360|20683181|P3|NOT COMPLETED|Period 3||0
8391548|NCT01049360|20683182|P2|NOT COMPLETED|Period 3||0
8391549|NCT01049360|20683183|P1|NOT COMPLETED|Period 3||0
8391550|NCT01049360|20683164|P20|COMPLETED|Period 3||5
8391551|NCT01049360|20683165|P19|COMPLETED|Period 3||5
8391552|NCT01049360|20683166|P18|COMPLETED|Period 3||6
8391553|NCT01049360|20683167|P17|COMPLETED|Period 3||5
8391554|NCT01049360|20683168|P16|COMPLETED|Period 3||6
8391555|NCT01049360|20683169|P15|COMPLETED|Period 3||5
8391556|NCT01049360|20683170|P14|COMPLETED|Period 3||6
8391557|NCT01049360|20683171|P13|COMPLETED|Period 3||4
8391558|NCT01049360|20683172|P12|COMPLETED|Period 3||6
8391559|NCT01049360|20683173|P11|COMPLETED|Period 3||5
8391560|NCT01049360|20683174|P10|COMPLETED|Period 3||6
8391561|NCT01049360|20683175|P9|COMPLETED|Period 3||4
8391562|NCT01049360|20683176|P8|COMPLETED|Period 3||4
8391563|NCT01049360|20683177|P7|COMPLETED|Period 3||6
8391564|NCT01049360|20683178|P6|COMPLETED|Period 3||5
8391565|NCT01049360|20683179|P5|COMPLETED|Period 3||7
8391566|NCT01049360|20683180|P4|COMPLETED|Period 3||4
8391567|NCT01049360|20683181|P3|COMPLETED|Period 3||7
8391568|NCT01049360|20683182|P2|COMPLETED|Period 3||4
8391569|NCT01049360|20683183|P1|COMPLETED|Period 3||6
8391570|NCT01049360|20683164|P20|STARTED|Period 3||5
8391571|NCT01049360|20683165|P19|STARTED|Period 3||5
8391572|NCT01049360|20683166|P18|STARTED|Period 3||6
8391573|NCT01049360|20683167|P17|STARTED|Period 3||5
8391574|NCT01049360|20683168|P16|STARTED|Period 3||6
8391575|NCT01049360|20683169|P15|STARTED|Period 3||5
8391576|NCT01049360|20683170|P14|STARTED|Period 3||6
8391577|NCT01049360|20683171|P13|STARTED|Period 3||4
8391578|NCT01049360|20683172|P12|STARTED|Period 3||6
8391579|NCT01049360|20683173|P11|STARTED|Period 3||5
8391580|NCT01049360|20683174|P10|STARTED|Period 3||6
8391581|NCT01049360|20683175|P9|STARTED|Period 3||4
8391582|NCT01049360|20683176|P8|STARTED|Period 3||4
8391583|NCT01049360|20683177|P7|STARTED|Period 3||6
8391584|NCT01049360|20683178|P6|STARTED|Period 3||5
8391585|NCT01049360|20683179|P5|STARTED|Period 3||7
8391586|NCT01049360|20683180|P4|STARTED|Period 3||4
8391587|NCT01049360|20683181|P3|STARTED|Period 3||7
8391588|NCT01049360|20683182|P2|STARTED|Period 3||4
8391589|NCT01049360|20683183|P1|STARTED|Period 3||6
8391590|NCT01049360|20683164|P20|NOT COMPLETED|Period 2||2
8391591|NCT01049360|20683165|P19|NOT COMPLETED|Period 2||0
8391592|NCT01049360|20683166|P18|NOT COMPLETED|Period 2||0
8391593|NCT01049360|20683167|P17|NOT COMPLETED|Period 2||0
8391594|NCT01049360|20683168|P16|NOT COMPLETED|Period 2||1
8391595|NCT01049360|20683169|P15|NOT COMPLETED|Period 2||2
8391596|NCT01049360|20683170|P14|NOT COMPLETED|Period 2||0
8391597|NCT01049360|20683171|P13|NOT COMPLETED|Period 2||0
8391598|NCT01049360|20683172|P12|NOT COMPLETED|Period 2||0
8391599|NCT01049360|20683173|P11|NOT COMPLETED|Period 2||0
8391600|NCT01049360|20683174|P10|NOT COMPLETED|Period 2||0
8391601|NCT01049360|20683175|P9|NOT COMPLETED|Period 2||1
8391602|NCT01049360|20683176|P8|NOT COMPLETED|Period 2||0
8391603|NCT01049360|20683177|P7|NOT COMPLETED|Period 2||0
8391604|NCT01049360|20683178|P6|NOT COMPLETED|Period 2||1
8391605|NCT01049360|20683179|P5|NOT COMPLETED|Period 2||0
8391606|NCT01049360|20683180|P4|NOT COMPLETED|Period 2||2
8391607|NCT01049360|20683181|P3|NOT COMPLETED|Period 2||0
8391608|NCT01049360|20683182|P2|NOT COMPLETED|Period 2||1
8391609|NCT01049360|20683183|P1|NOT COMPLETED|Period 2||0
8391610|NCT01049360|20683164|P20|COMPLETED|Period 2||5
8391611|NCT01049360|20683165|P19|COMPLETED|Period 2||5
8391612|NCT01049360|20683166|P18|COMPLETED|Period 2||6
8391613|NCT01049360|20683167|P17|COMPLETED|Period 2||5
8391614|NCT01049360|20683168|P16|COMPLETED|Period 2||6
8391615|NCT01049360|20683169|P15|COMPLETED|Period 2||5
8391616|NCT01049360|20683170|P14|COMPLETED|Period 2||6
8391617|NCT01049360|20683171|P13|COMPLETED|Period 2||4
8391618|NCT01049360|20683172|P12|COMPLETED|Period 2||6
8391619|NCT01049360|20683173|P11|COMPLETED|Period 2||5
8391620|NCT01049360|20683174|P10|COMPLETED|Period 2||6
8391621|NCT01049360|20683175|P9|COMPLETED|Period 2||4
8391622|NCT01049360|20683176|P8|COMPLETED|Period 2||4
8391623|NCT01049360|20683177|P7|COMPLETED|Period 2||6
8391624|NCT01049360|20683178|P6|COMPLETED|Period 2||5
8391625|NCT01049360|20683179|P5|COMPLETED|Period 2||7
8391626|NCT01049360|20683180|P4|COMPLETED|Period 2||4
8391627|NCT01049360|20683181|P3|COMPLETED|Period 2||7
8391628|NCT01049360|20683182|P2|COMPLETED|Period 2||4
8391629|NCT01049360|20683183|P1|COMPLETED|Period 2||6
8391630|NCT01049360|20683164|P20|STARTED|Period 2||7
8391631|NCT01049360|20683165|P19|STARTED|Period 2||5
8391632|NCT01049360|20683166|P18|STARTED|Period 2||6
8391633|NCT01049360|20683167|P17|STARTED|Period 2||5
8391634|NCT01049360|20683168|P16|STARTED|Period 2||7
8391635|NCT01049360|20683169|P15|STARTED|Period 2||7
8391636|NCT01049360|20683170|P14|STARTED|Period 2||6
8391637|NCT01049360|20683171|P13|STARTED|Period 2||4
8391638|NCT01049360|20683172|P12|STARTED|Period 2||6
8391639|NCT01049360|20683173|P11|STARTED|Period 2||5
8391640|NCT01049360|20683174|P10|STARTED|Period 2||6
8391641|NCT01049360|20683175|P9|STARTED|Period 2||5
8391642|NCT01049360|20683176|P8|STARTED|Period 2||4
8391643|NCT01049360|20683177|P7|STARTED|Period 2||6
8391644|NCT01049360|20683178|P6|STARTED|Period 2||6
8391645|NCT01049360|20683179|P5|STARTED|Period 2||7
8391646|NCT01049360|20683180|P4|STARTED|Period 2||6
8391647|NCT01049360|20683181|P3|STARTED|Period 2||7
8391648|NCT01049360|20683182|P2|STARTED|Period 2||5
8391649|NCT01049360|20683183|P1|STARTED|Period 2||6
8391650|NCT01049360|20683164|P20|NOT COMPLETED|Period 1||0
8391651|NCT01049360|20683165|P19|NOT COMPLETED|Period 1||1
8391652|NCT01049360|20683166|P18|NOT COMPLETED|Period 1||0
8391653|NCT01049360|20683167|P17|NOT COMPLETED|Period 1||1
8391654|NCT01049360|20683168|P16|NOT COMPLETED|Period 1||0
8391655|NCT01049360|20683169|P15|NOT COMPLETED|Period 1||0
8391656|NCT01049360|20683170|P14|NOT COMPLETED|Period 1||1
8391657|NCT01049360|20683171|P13|NOT COMPLETED|Period 1||2
8391658|NCT01049360|20683172|P12|NOT COMPLETED|Period 1||0
8391659|NCT01049360|20683173|P11|NOT COMPLETED|Period 1||1
8391660|NCT01049360|20683174|P10|NOT COMPLETED|Period 1||0
8391661|NCT01049360|20683175|P9|NOT COMPLETED|Period 1||2
8391662|NCT01049360|20683176|P8|NOT COMPLETED|Period 1||2
8391663|NCT01049360|20683177|P7|NOT COMPLETED|Period 1||0
8391664|NCT01049360|20683178|P6|NOT COMPLETED|Period 1||0
8391665|NCT01049360|20683179|P5|NOT COMPLETED|Period 1||0
8391666|NCT01049360|20683180|P4|NOT COMPLETED|Period 1||1
8391667|NCT01049360|20683181|P3|NOT COMPLETED|Period 1||0
8391668|NCT01049360|20683182|P2|NOT COMPLETED|Period 1||1
8391669|NCT01049360|20683183|P1|NOT COMPLETED|Period 1||0
8391670|NCT01049360|20683164|P20|COMPLETED|Period 1||7
8391671|NCT01049360|20683165|P19|COMPLETED|Period 1||5
8391672|NCT01049360|20683166|P18|COMPLETED|Period 1||6
8391673|NCT01049360|20683167|P17|COMPLETED|Period 1||5
8391674|NCT01049360|20683168|P16|COMPLETED|Period 1||7
8391675|NCT01049360|20683169|P15|COMPLETED|Period 1||7
8391676|NCT01049360|20683170|P14|COMPLETED|Period 1||6
8391677|NCT01049360|20683171|P13|COMPLETED|Period 1||4
8391678|NCT01049360|20683172|P12|COMPLETED|Period 1||6
8391679|NCT01049360|20683173|P11|COMPLETED|Period 1||5
8391680|NCT01049360|20683174|P10|COMPLETED|Period 1||6
8391681|NCT01049360|20683175|P9|COMPLETED|Period 1||5
8391682|NCT01049360|20683176|P8|COMPLETED|Period 1||4
8391683|NCT01049360|20683177|P7|COMPLETED|Period 1||6
8391684|NCT01049360|20683178|P6|COMPLETED|Period 1||6
8391685|NCT01049360|20683179|P5|COMPLETED|Period 1||7
8391686|NCT01049360|20683180|P4|COMPLETED|Period 1||6
8391687|NCT01049360|20683181|P3|COMPLETED|Period 1||7
8391688|NCT01049360|20683182|P2|COMPLETED|Period 1||5
8391689|NCT01049360|20683183|P1|COMPLETED|Period 1||6
8391690|NCT01049360|20683164|P20|STARTED|Period 1||7
8391691|NCT01049360|20683165|P19|STARTED|Period 1||6
8391692|NCT01049360|20683166|P18|STARTED|Period 1||6
8391693|NCT01049360|20683167|P17|STARTED|Period 1||6
8391694|NCT01049360|20683168|P16|STARTED|Period 1||7
8391695|NCT01049360|20683169|P15|STARTED|Period 1||7
8391696|NCT01049360|20683170|P14|STARTED|Period 1||7
8391697|NCT01049360|20683171|P13|STARTED|Period 1||6
8391698|NCT01049360|20683172|P12|STARTED|Period 1||6
8391699|NCT01049360|20683173|P11|STARTED|Period 1||6
8391700|NCT01049360|20683174|P10|STARTED|Period 1||6
8391701|NCT01049360|20683175|P9|STARTED|Period 1||7
8391702|NCT01049360|20683176|P8|STARTED|Period 1||6
8391703|NCT01049360|20683177|P7|STARTED|Period 1||6
8391704|NCT01049360|20683178|P6|STARTED|Period 1||6
8391705|NCT01049360|20683179|P5|STARTED|Period 1||7
8391706|NCT01049360|20683180|P4|STARTED|Period 1||7
8391707|NCT01049360|20683181|P3|STARTED|Period 1||7
8391708|NCT01049360|20683182|P2|STARTED|Period 1||6
8391709|NCT01049360|20683183|P1|STARTED|Period 1||6
8391710|NCT01049334|20683207|P2|NOT COMPLETED|Overall Study||7
8391711|NCT01049334|20683208|P1|NOT COMPLETED|Overall Study||9
8391712|NCT01049334|20683207|P2|COMPLETED|Overall Study||95
8391713|NCT01049334|20683208|P1|COMPLETED|Overall Study||93
8391714|NCT01049334|20683207|P2|STARTED|Overall Study||102
8391715|NCT01049334|20683208|P1|STARTED|Overall Study||102
8391716|NCT01049308|20683244|P1|NOT COMPLETED|Pill Counts||83
8391717|NCT01049308|20683244|P1|COMPLETED|Pill Counts||168
8391718|NCT01049308|20683244|P1|STARTED|Pill Counts||251
8391719|NCT01049308|20683244|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
8391720|NCT01049308|20683244|P1|COMPLETED|Evaluation of Cognitive Impairment||251
8391721|NCT01049308|20683244|P1|STARTED|Evaluation of Cognitive Impairment||251
8391722|NCT01049243|20683251|P1|NOT COMPLETED|Overall Study||2
8391723|NCT01049243|20683251|P1|COMPLETED|Overall Study||18
8391724|NCT01049243|20683251|P1|STARTED|Overall Study||20
8391725|NCT01049035|20683263|P7|NOT COMPLETED|Overall Study||15
8391726|NCT01049035|20683264|P6|NOT COMPLETED|Overall Study||12
8391727|NCT01049035|20683265|P5|NOT COMPLETED|Overall Study||4
8391728|NCT01049035|20683266|P4|NOT COMPLETED|Overall Study||11
8391729|NCT01049035|20683267|P3|NOT COMPLETED|Overall Study||27
8391730|NCT01049035|20683268|P2|NOT COMPLETED|Overall Study||21
8391731|NCT01049035|20683269|P1|NOT COMPLETED|Overall Study||33
8391732|NCT01049035|20683263|P7|COMPLETED|Overall Study||39
8391733|NCT01049035|20683264|P6|COMPLETED|Overall Study||42
8391734|NCT01049035|20683265|P5|COMPLETED|Overall Study||71
8391735|NCT01049035|20683266|P4|COMPLETED|Overall Study||64
8391736|NCT01049035|20683267|P3|COMPLETED|Overall Study||80
8391737|NCT01049035|20683268|P2|COMPLETED|Overall Study||87
8391738|NCT01049035|20683269|P1|COMPLETED|Overall Study||74
8391739|NCT01049035|20683263|P7|Safety Population|Overall Study||49
8391740|NCT01049035|20683264|P6|Safety Population|Overall Study||52
8391741|NCT01049035|20683265|P5|Safety Population|Overall Study||70
8391742|NCT01049035|20683266|P4|Safety Population|Overall Study||74
8391743|NCT01049035|20683267|P3|Safety Population|Overall Study||100
8391744|NCT01049035|20683268|P2|Safety Population|Overall Study||102
8391745|NCT01049035|20683269|P1|Safety Population|Overall Study||104
8391746|NCT01049035|20683263|P7|STARTED|Overall Study||54
8391747|NCT01049035|20683264|P6|STARTED|Overall Study||54
8391748|NCT01049035|20683265|P5|STARTED|Overall Study||75
8391749|NCT01049035|20683266|P4|STARTED|Overall Study||75
8391750|NCT01049035|20683267|P3|STARTED|Overall Study||107
8391751|NCT01049035|20683268|P2|STARTED|Overall Study||108
8391752|NCT01049035|20683269|P1|STARTED|Overall Study||107
8391753|NCT01049009|20683428|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
8391754|NCT01049009|20683429|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
8391755|NCT01049009|20683428|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
8391756|NCT01049009|20683429|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
8391757|NCT01049009|20683428|P2|STARTED|Treatment Period 2 (12 Weeks)||18
8391758|NCT01049009|20683429|P1|STARTED|Treatment Period 2 (12 Weeks)||21
8391759|NCT01049009|20683428|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
8391760|NCT01049009|20683429|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
8391761|NCT01049009|20683428|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
8391762|NCT01049009|20683429|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
8391763|NCT01049009|20683428|P2|STARTED|Treatment Period 1 (12 Weeks)||21
8391764|NCT01049009|20683429|P1|STARTED|Treatment Period 1 (12 Weeks)||23
8391765|NCT01048944|20683441|P4|NOT COMPLETED|Overall Study||2
8391766|NCT01048944|20683442|P3|NOT COMPLETED|Overall Study||10
8391767|NCT01048944|20683443|P2|NOT COMPLETED|Overall Study||10
8391768|NCT01048944|20683444|P1|NOT COMPLETED|Overall Study||8
8391769|NCT01048944|20683441|P4|COMPLETED|Overall Study||19
8391770|NCT01048944|20683442|P3|COMPLETED|Overall Study||25
8391771|NCT01048944|20683443|P2|COMPLETED|Overall Study||28
8391772|NCT01048944|20683444|P1|COMPLETED|Overall Study||24
8391773|NCT01048944|20683441|P4|STARTED|Overall Study||21
8391774|NCT01048944|20683442|P3|STARTED|Overall Study||35
8391775|NCT01048944|20683443|P2|STARTED|Overall Study||38
8391776|NCT01048944|20683444|P1|STARTED|Overall Study||32
8391777|NCT01048879|20683461|P3|NOT COMPLETED|Overall Study||0
8391778|NCT01048879|20683462|P2|NOT COMPLETED|Overall Study||0
8391779|NCT01048879|20683463|P1|NOT COMPLETED|Overall Study||0
8391780|NCT01048879|20683461|P3|COMPLETED|Overall Study||5
8391781|NCT01048879|20683462|P2|COMPLETED|Overall Study||9
8391782|NCT01048879|20683463|P1|COMPLETED|Overall Study||1
8391783|NCT01048879|20683461|P3|STARTED|Overall Study||5
8391784|NCT01048879|20683462|P2|STARTED|Overall Study||9
8391785|NCT01048879|20683463|P1|STARTED|Overall Study||1
8391786|NCT01048866|20683476|P2|NOT COMPLETED|Overall Study||5
8391787|NCT01048866|20683477|P1|NOT COMPLETED|Overall Study||4
8391788|NCT01048866|20683476|P2|COMPLETED|Overall Study||92
8391789|NCT01048866|20683477|P1|COMPLETED|Overall Study||97
8391790|NCT01048866|20683476|P2|STARTED|Overall Study||97
8391791|NCT01048866|20683477|P1|STARTED|Overall Study||101
8391792|NCT01048788|20683522|P3|NOT COMPLETED|Overall Study||2
8391793|NCT01048788|20683523|P2|NOT COMPLETED|Overall Study||2
8391794|NCT01048788|20683524|P1|NOT COMPLETED|Overall Study||5
8391795|NCT01048788|20683522|P3|COMPLETED|Overall Study||11
8391796|NCT01048788|20683523|P2|COMPLETED|Overall Study||28
8391797|NCT01048788|20683524|P1|COMPLETED|Overall Study||3
8391798|NCT01048788|20683522|P3|STARTED|Overall Study||13
8391799|NCT01048788|20683523|P2|STARTED|Overall Study||30
8391800|NCT01048788|20683524|P1|STARTED|Overall Study||8
8391801|NCT01048723|20683532|P1|NOT COMPLETED|Overall Study||0
8391802|NCT01048723|20683532|P1|COMPLETED|Overall Study||2
8391803|NCT01048723|20683532|P1|STARTED|Overall Study||2
8391804|NCT01048697|20683539|P1|NOT COMPLETED|Overall Study||0
8391805|NCT01048697|20683539|P1|COMPLETED|Overall Study||18
8391806|NCT01048697|20683539|P1|STARTED|Overall Study||18
8391807|NCT01048671|20683546|P3|NOT COMPLETED|Overall Study||1
8391808|NCT01048671|20683547|P2|NOT COMPLETED|Overall Study||1
8391809|NCT01048671|20683548|P1|NOT COMPLETED|Overall Study||0
8391810|NCT01048671|20683546|P3|COMPLETED|Overall Study||151
8391811|NCT01048671|20683547|P2|COMPLETED|Overall Study||263
8391812|NCT01048671|20683548|P1|COMPLETED|Overall Study||66
8391813|NCT01048671|20683546|P3|STARTED|Overall Study||152
8391814|NCT01048671|20683547|P2|STARTED|Overall Study||264
8391815|NCT01048671|20683548|P1|STARTED|Overall Study||66
8391816|NCT01048658|20683571|P2|NOT COMPLETED|Overall Study||0
8391817|NCT01048658|20683572|P1|NOT COMPLETED|Overall Study||0
8391818|NCT01048658|20683571|P2|COMPLETED|Overall Study||80
8391819|NCT01048658|20683572|P1|COMPLETED|Overall Study||80
8391820|NCT01048658|20683571|P2|STARTED|Overall Study||80
8391821|NCT01048658|20683572|P1|STARTED|Overall Study||80
8391822|NCT01048606|20683590|P4|NOT COMPLETED|Overall Study||5
8391823|NCT01048606|20683591|P3|NOT COMPLETED|Overall Study||10
8391824|NCT01048606|20683592|P2|NOT COMPLETED|Overall Study||7
8391825|NCT01048606|20683593|P1|NOT COMPLETED|Overall Study||12
8391826|NCT01048606|20683590|P4|COMPLETED|Overall Study||5
8391827|NCT01048606|20683591|P3|COMPLETED|Overall Study||16
8391828|NCT01048606|20683592|P2|COMPLETED|Overall Study||8
8391829|NCT01048606|20683593|P1|COMPLETED|Overall Study||16
8391830|NCT01048606|20683590|P4|STARTED|Overall Study||10
8391831|NCT01048606|20683591|P3|STARTED|Overall Study||26
8391832|NCT01048606|20683592|P2|STARTED|Overall Study||15
8391833|NCT01048606|20683593|P1|STARTED|Overall Study||28
8391834|NCT01048593|20683606|P3|NOT COMPLETED|Overall Study||0
8391835|NCT01048593|20683607|P2|NOT COMPLETED|Overall Study||0
8391836|NCT01048593|20683608|P1|NOT COMPLETED|Overall Study||0
8391837|NCT01048593|20683606|P3|COMPLETED|Overall Study||1
8391838|NCT01048593|20683607|P2|COMPLETED|Overall Study||2
8391839|NCT01048593|20683608|P1|COMPLETED|Overall Study||3
8391840|NCT01048593|20683606|P3|STARTED|Overall Study||1
8391841|NCT01048593|20683607|P2|STARTED|Overall Study||2
8391842|NCT01048593|20683608|P1|STARTED|Overall Study||3
8391843|NCT01048541|20683628|P2|NOT COMPLETED|Overall Study||0
8391844|NCT01048541|20683629|P1|NOT COMPLETED|Overall Study||1
8391845|NCT01048541|20683628|P2|COMPLETED|Overall Study||19
8391846|NCT01048541|20683629|P1|COMPLETED|Overall Study||17
8391847|NCT01048541|20683628|P2|STARTED|Overall Study||19
8391848|NCT01048541|20683629|P1|STARTED|Overall Study||18
8391849|NCT01048502|20683639|P4|NOT COMPLETED|Overall Study||4
8391850|NCT01048502|20683640|P3|NOT COMPLETED|Overall Study||5
8391851|NCT01048502|20683641|P2|NOT COMPLETED|Overall Study||7
8391852|NCT01048502|20683642|P1|NOT COMPLETED|Overall Study||4
8391853|NCT01048502|20683639|P4|COMPLETED|Overall Study||21
8391854|NCT01048502|20683640|P3|COMPLETED|Overall Study||23
8391855|NCT01048502|20683641|P2|COMPLETED|Overall Study||16
8391856|NCT01048502|20683642|P1|COMPLETED|Overall Study||20
8391857|NCT01048502|20683639|P4|STARTED|Overall Study||25
8391858|NCT01048502|20683640|P3|STARTED|Overall Study||28
8391859|NCT01048502|20683641|P2|STARTED|Overall Study||23
8391860|NCT01048502|20683642|P1|STARTED|Overall Study||24
8391861|NCT01048424|20683655|P2|NOT COMPLETED|Overall Study||0
8391862|NCT01048424|20683656|P1|NOT COMPLETED|Overall Study||2
8391863|NCT01048424|20683655|P2|COMPLETED|Overall Study||10
8391864|NCT01048424|20683656|P1|COMPLETED|Overall Study||8
8391865|NCT01048424|20683655|P2|STARTED|Overall Study||10
8391866|NCT01048424|20683656|P1|STARTED|Overall Study||10
8391867|NCT01048333|20683678|P6|NOT COMPLETED|Treatment Period 3||0
8391868|NCT01048333|20683679|P5|NOT COMPLETED|Treatment Period 3||0
8391869|NCT01048333|20683680|P4|NOT COMPLETED|Treatment Period 3||0
8391870|NCT01048333|20683681|P3|NOT COMPLETED|Treatment Period 3||0
8391871|NCT01048333|20683682|P2|NOT COMPLETED|Treatment Period 3||0
8391872|NCT01048333|20683683|P1|NOT COMPLETED|Treatment Period 3||0
8391873|NCT01048333|20683678|P6|COMPLETED|Treatment Period 3||18
8391874|NCT01048333|20683679|P5|COMPLETED|Treatment Period 3||17
8391875|NCT01048333|20683680|P4|COMPLETED|Treatment Period 3||18
8391876|NCT01048333|20683681|P3|COMPLETED|Treatment Period 3||16
8391877|NCT01048333|20683682|P2|COMPLETED|Treatment Period 3||18
8391878|NCT01048333|20683683|P1|COMPLETED|Treatment Period 3||21
8391879|NCT01048333|20683678|P6|STARTED|Treatment Period 3||18
8391880|NCT01048333|20683679|P5|STARTED|Treatment Period 3||17
8391881|NCT01048333|20683680|P4|STARTED|Treatment Period 3||18
8391882|NCT01048333|20683681|P3|STARTED|Treatment Period 3||16
8391883|NCT01048333|20683682|P2|STARTED|Treatment Period 3||18
8391884|NCT01048333|20683683|P1|STARTED|Treatment Period 3||21
8391885|NCT01048333|20683678|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391886|NCT01048333|20683679|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391887|NCT01048333|20683680|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391888|NCT01048333|20683681|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391889|NCT01048333|20683682|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
8391890|NCT01048333|20683683|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391891|NCT01048333|20683678|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8391892|NCT01048333|20683679|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
8391893|NCT01048333|20683680|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8391894|NCT01048333|20683681|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
8391895|NCT01048333|20683682|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8391896|NCT01048333|20683683|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
8391897|NCT01048333|20683678|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
8391898|NCT01048333|20683679|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
8391899|NCT01048333|20683680|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
8391900|NCT01048333|20683681|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
8391901|NCT01048333|20683682|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
8391902|NCT01048333|20683683|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
8391903|NCT01048333|20683678|P6|NOT COMPLETED|Treatment Period 2||0
8391904|NCT01048333|20683679|P5|NOT COMPLETED|Treatment Period 2||0
8391905|NCT01048333|20683680|P4|NOT COMPLETED|Treatment Period 2||0
8391906|NCT01048333|20683681|P3|NOT COMPLETED|Treatment Period 2||0
8391907|NCT01048333|20683682|P2|NOT COMPLETED|Treatment Period 2||0
8391908|NCT01048333|20683683|P1|NOT COMPLETED|Treatment Period 2||0
8391909|NCT01048333|20683678|P6|COMPLETED|Treatment Period 2||18
8391910|NCT01048333|20683679|P5|COMPLETED|Treatment Period 2||17
8391911|NCT01048333|20683680|P4|COMPLETED|Treatment Period 2||18
8391912|NCT01048333|20683681|P3|COMPLETED|Treatment Period 2||16
8391913|NCT01048333|20683682|P2|COMPLETED|Treatment Period 2||19
8391914|NCT01048333|20683683|P1|COMPLETED|Treatment Period 2||21
8391915|NCT01048333|20683678|P6|STARTED|Treatment Period 2||18
8391916|NCT01048333|20683679|P5|STARTED|Treatment Period 2||17
8391917|NCT01048333|20683680|P4|STARTED|Treatment Period 2||18
8391918|NCT01048333|20683681|P3|STARTED|Treatment Period 2||16
8391919|NCT01048333|20683682|P2|STARTED|Treatment Period 2||19
8391920|NCT01048333|20683683|P1|STARTED|Treatment Period 2||21
8391921|NCT01048333|20683678|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391922|NCT01048333|20683679|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391923|NCT01048333|20683680|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391924|NCT01048333|20683681|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391925|NCT01048333|20683682|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391926|NCT01048333|20683683|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391927|NCT01048333|20683678|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
8391928|NCT01048333|20683679|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
8391929|NCT01048333|20683680|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
8391930|NCT01048333|20683681|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
8391931|NCT01048333|20683682|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
8391932|NCT01048333|20683683|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
8391933|NCT01048333|20683678|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
8391934|NCT01048333|20683679|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
8391935|NCT01048333|20683680|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
8391936|NCT01048333|20683681|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
8391937|NCT01048333|20683682|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
8391938|NCT01048333|20683683|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
8391939|NCT01048333|20683678|P6|NOT COMPLETED|Treatment Period 1||0
8391940|NCT01048333|20683679|P5|NOT COMPLETED|Treatment Period 1||0
8391941|NCT01048333|20683680|P4|NOT COMPLETED|Treatment Period 1||0
8391942|NCT01048333|20683681|P3|NOT COMPLETED|Treatment Period 1||0
8391943|NCT01048333|20683682|P2|NOT COMPLETED|Treatment Period 1||0
8391944|NCT01048333|20683683|P1|NOT COMPLETED|Treatment Period 1||0
8391945|NCT01048333|20683678|P6|COMPLETED|Treatment Period 1||18
8391946|NCT01048333|20683679|P5|COMPLETED|Treatment Period 1||17
8391947|NCT01048333|20683680|P4|COMPLETED|Treatment Period 1||18
8391948|NCT01048333|20683681|P3|COMPLETED|Treatment Period 1||16
8391949|NCT01048333|20683682|P2|COMPLETED|Treatment Period 1||19
8391950|NCT01048333|20683683|P1|COMPLETED|Treatment Period 1||21
8391951|NCT01048333|20683678|P6|STARTED|Treatment Period 1||18
8391952|NCT01048333|20683679|P5|STARTED|Treatment Period 1||17
8391953|NCT01048333|20683680|P4|STARTED|Treatment Period 1||18
8391954|NCT01048333|20683681|P3|STARTED|Treatment Period 1||16
8391955|NCT01048333|20683682|P2|STARTED|Treatment Period 1||19
8391956|NCT01048333|20683683|P1|STARTED|Treatment Period 1||21
8391957|NCT01048242|20683705|P2|NOT COMPLETED|Overall Study||2
8391958|NCT01048242|20683706|P1|NOT COMPLETED|Overall Study||4
8391959|NCT01048242|20683705|P2|COMPLETED|Overall Study||13
8391960|NCT01048242|20683706|P1|COMPLETED|Overall Study||8
8391961|NCT01048242|20683705|P2|STARTED|Overall Study||15
8391962|NCT01048242|20683706|P1|STARTED|Overall Study||12
8391963|NCT01048125|20683714|P2|NOT COMPLETED|Overall Study||0
8391964|NCT01048125|20683715|P1|NOT COMPLETED|Overall Study||0
8391965|NCT01048125|20683714|P2|COMPLETED|Overall Study||0
8391966|NCT01048125|20683715|P1|COMPLETED|Overall Study||0
8391967|NCT01048125|20683714|P2|STARTED|Overall Study||0
8391968|NCT01048125|20683715|P1|STARTED|Overall Study||0
8391969|NCT01048099|20683721|P1|NOT COMPLETED|Treatment Per Protocol||14
8391970|NCT01048099|20683721|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
8391971|NCT01048099|20683721|P1|STARTED|Treatment Per Protocol||14
8391972|NCT01048099|20683721|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
8391973|NCT01048099|20683721|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
8391974|NCT01048099|20683721|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
8391975|NCT01048099|20683721|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
8391976|NCT01048099|20683721|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
8391977|NCT01048099|20683721|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
8391978|NCT01048099|20683721|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
8391979|NCT01048099|20683721|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
8391980|NCT01048099|20683721|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
8391981|NCT01047839|20683732|P3|NOT COMPLETED|Overall Study||6
8391982|NCT01047839|20683733|P2|NOT COMPLETED|Overall Study||0
8391983|NCT01047839|20683734|P1|NOT COMPLETED|Overall Study||2
8391984|NCT01047839|20683732|P3|COMPLETED|Overall Study||53
8391985|NCT01047839|20683733|P2|COMPLETED|Overall Study||29
8391986|NCT01047839|20683734|P1|COMPLETED|Overall Study||10
8391987|NCT01047839|20683732|P3|STARTED|Overall Study||59
8391988|NCT01047839|20683733|P2|STARTED|Overall Study||29
8391989|NCT01047839|20683734|P1|STARTED|Overall Study||12
8391990|NCT01047709|20683760|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
8391991|NCT01047709|20683761|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
8391992|NCT01047709|20683760|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
8391993|NCT01047709|20683761|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
8391994|NCT01047709|20683760|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
8391995|NCT01047709|20683761|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
8391996|NCT01047709|20683760|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
8391997|NCT01047709|20683761|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
8391998|NCT01047709|20683760|P2|COMPLETED|Positional Therapy (1 Night)||9
8391999|NCT01047709|20683761|P1|COMPLETED|Positional Therapy (1 Night)||9
8392000|NCT01047709|20683760|P2|STARTED|Positional Therapy (1 Night)||9
8392001|NCT01047709|20683761|P1|STARTED|Positional Therapy (1 Night)||9
8392002|NCT01047553|20683769|P2|NOT COMPLETED|Overall Study||9
8392003|NCT01047553|20683770|P1|NOT COMPLETED|Overall Study||17
8392004|NCT01047553|20683769|P2|COMPLETED|Overall Study||117
8392005|NCT01047553|20683770|P1|COMPLETED|Overall Study||108
8392006|NCT01047553|20683769|P2|STARTED|Overall Study||126
8392007|NCT01047553|20683770|P1|STARTED|Overall Study||125
8392008|NCT01047527|20683855|P3|NOT COMPLETED|Overall Study||65
8392009|NCT01047527|20683856|P2|NOT COMPLETED|Overall Study||61
8392010|NCT01047527|20683857|P1|NOT COMPLETED|Overall Study||85
8392011|NCT01047527|20683855|P3|COMPLETED|Overall Study||107
8392012|NCT01047527|20683856|P2|COMPLETED|Overall Study||112
8392013|NCT01047527|20683857|P1|COMPLETED|Overall Study||95
8392014|NCT01047527|20683855|P3|24 Weeks|Overall Study||119
8392015|NCT01047527|20683856|P2|24 Weeks|Overall Study||123
8392016|NCT01047527|20683857|P1|24 Weeks|Overall Study||111
8392017|NCT01047527|20683855|P3|8 Weeks|Overall Study||138
8392018|NCT01047527|20683856|P2|8 Weeks|Overall Study||142
8392019|NCT01047527|20683857|P1|8 Weeks|Overall Study||148
8392020|NCT01047527|20683855|P3|STARTED|Overall Study||172
8392021|NCT01047527|20683856|P2|STARTED|Overall Study||173
8392022|NCT01047527|20683857|P1|STARTED|Overall Study||180
8392023|NCT01047475|20683868|P2|NOT COMPLETED|Overall Study||7
8392024|NCT01047475|20683869|P1|NOT COMPLETED|Overall Study||5
8392025|NCT01047475|20683868|P2|COMPLETED|Overall Study||31
8392026|NCT01047475|20683869|P1|COMPLETED|Overall Study||29
8392027|NCT01047475|20683868|P2|STARTED|Overall Study||38
8392028|NCT01047475|20683869|P1|STARTED|Overall Study||34
8392029|NCT01047436|20683877|P2|NOT COMPLETED|Overall Study||0
8392030|NCT01047436|20683878|P1|NOT COMPLETED|Overall Study||1
8392031|NCT01047436|20683877|P2|COMPLETED|Overall Study||15
8392032|NCT01047436|20683878|P1|COMPLETED|Overall Study||15
8392033|NCT01047436|20683877|P2|STARTED|Overall Study||15
8392034|NCT01047436|20683878|P1|STARTED|Overall Study||16
8392035|NCT01047358|20683894|P1|NOT COMPLETED|Overall Study||0
8392036|NCT01047358|20683894|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
8392037|NCT01047358|20683894|P1|STARTED|Overall Study||206
8392038|NCT01047345|20683903|P3|NOT COMPLETED|Extension||6
8392039|NCT01047345|20683904|P2|NOT COMPLETED|Extension||0
8392040|NCT01047345|20683905|P1|NOT COMPLETED|Extension||0
8392041|NCT01047345|20683903|P3|COMPLETED|Extension||96
8392042|NCT01047345|20683904|P2|COMPLETED|Extension||0
8392043|NCT01047345|20683905|P1|COMPLETED|Extension||0
8392044|NCT01047345|20683903|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
8392045|NCT01047345|20683904|P2|Vaccination 6|Extension||0
8392046|NCT01047345|20683905|P1|Vaccination 6|Extension||0
8392047|NCT01047345|20683903|P3|Vaccination 5|Extension||99
8392048|NCT01047345|20683904|P2|Vaccination 5|Extension||0
8392049|NCT01047345|20683905|P1|Vaccination 5|Extension||0
8392050|NCT01047345|20683903|P3|Vaccination 4|Extension||102
8392051|NCT01047345|20683904|P2|Vaccination 4|Extension||0
8392052|NCT01047345|20683905|P1|Vaccination 4|Extension||0
8392053|NCT01047345|20683903|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
8392054|NCT01047345|20683904|P2|STARTED|Extension||0
8392055|NCT01047345|20683905|P1|STARTED|Extension||0
8392056|NCT01047345|20683903|P3|NOT COMPLETED|Base Study||0
8392057|NCT01047345|20683904|P2|NOT COMPLETED|Base Study||6
8392058|NCT01047345|20683905|P1|NOT COMPLETED|Base Study||22
8392059|NCT01047345|20683903|P3|COMPLETED|Base Study||0
8392060|NCT01047345|20683904|P2|COMPLETED|Base Study||300
8392061|NCT01047345|20683905|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
8392062|NCT01047345|20683903|P3|Vaccination 3|Base Study||0
8392063|NCT01047345|20683904|P2|Vaccination 3|Base Study||300
8392064|NCT01047345|20683905|P1|Vaccination 3|Base Study||597
8392065|NCT01047345|20683903|P3|Vaccination 2|Base Study||0
8392066|NCT01047345|20683904|P2|Vaccination 2|Base Study||304
8392067|NCT01047345|20683905|P1|Vaccination 2|Base Study||604
8392068|NCT01047345|20683903|P3|Vaccination 1|Base Study||0
8392069|NCT01047345|20683904|P2|Vaccination 1|Base Study||306
8392070|NCT01047345|20683905|P1|Vaccination 1|Base Study||615
8392071|NCT01047345|20683903|P3|STARTED|Base Study||0
8392072|NCT01047345|20683904|P2|STARTED|Base Study||306
8392073|NCT01047345|20683905|P1|STARTED|Base Study||618
8392074|NCT01047332|20683927|P2|NOT COMPLETED|Overall Study||64
8392075|NCT01047332|20683928|P1|NOT COMPLETED|Overall Study||57
8392076|NCT01047332|20683927|P2|COMPLETED|Overall Study|Alive at final follow-up|4
8392077|NCT01047332|20683928|P1|COMPLETED|Overall Study|Alive at final follow-up|4
8392078|NCT01047332|20683927|P2|STARTED|Overall Study||68
8392079|NCT01047332|20683928|P1|STARTED|Overall Study||61
8392080|NCT01047319|20683943|P3|NOT COMPLETED|Overall Study||352
8392081|NCT01047319|20683944|P2|NOT COMPLETED|Overall Study||350
8392082|NCT01047319|20683945|P1|NOT COMPLETED|Overall Study||345
8392083|NCT01047319|20683943|P3|COMPLETED|Overall Study||0
8392084|NCT01047319|20683944|P2|COMPLETED|Overall Study||0
8392085|NCT01047319|20683945|P1|COMPLETED|Overall Study||0
8392086|NCT01047319|20683943|P3|STARTED|Overall Study||352
8392087|NCT01047319|20683944|P2|STARTED|Overall Study||350
8392088|NCT01047319|20683945|P1|STARTED|Overall Study||345
8392089|NCT01047306|20683967|P2|NOT COMPLETED|Overall Study||0
8392090|NCT01047306|20683968|P1|NOT COMPLETED|Overall Study||3
8392091|NCT01047306|20683967|P2|COMPLETED|Overall Study||6
8392092|NCT01047306|20683968|P1|COMPLETED|Overall Study||16
8392093|NCT01047306|20683967|P2|Discontinued From the Study|Overall Study||0
8392094|NCT01047306|20683968|P1|Discontinued From the Study|Overall Study||3
8392095|NCT01047306|20683967|P2|STARTED|Overall Study||6
8392096|NCT01047306|20683968|P1|STARTED|Overall Study||19
8392097|NCT01047293|20684042|P4|NOT COMPLETED|Overall Study||0
8392098|NCT01047293|20684043|P3|NOT COMPLETED|Overall Study||0
8392099|NCT01047293|20684044|P2|NOT COMPLETED|Overall Study||1
8392100|NCT01047293|20684045|P1|NOT COMPLETED|Overall Study||1
8392101|NCT01047293|20684042|P4|COMPLETED|Overall Study||26
8392102|NCT01047293|20684043|P3|COMPLETED|Overall Study||9
8392103|NCT01047293|20684044|P2|COMPLETED|Overall Study||7
8392104|NCT01047293|20684045|P1|COMPLETED|Overall Study||3
8392105|NCT01047293|20684042|P4|STARTED|Overall Study||26
8392106|NCT01047293|20684043|P3|STARTED|Overall Study||9
8392107|NCT01047293|20684044|P2|STARTED|Overall Study||8
8392108|NCT01047293|20684045|P1|STARTED|Overall Study||4
8392109|NCT01047241|20684052|P1|NOT COMPLETED|Overall Study||0
8392110|NCT01047241|20684052|P1|COMPLETED|Overall Study||50
8392111|NCT01047241|20684052|P1|STARTED|Overall Study||50
8392112|NCT01047189|20684063|P2|NOT COMPLETED|Overall Study||0
8392113|NCT01047189|20684064|P1|NOT COMPLETED|Overall Study||4
8392114|NCT01047189|20684063|P2|COMPLETED|Overall Study||13
8392115|NCT01047189|20684064|P1|COMPLETED|Overall Study||9
8392116|NCT01047189|20684063|P2|STARTED|Overall Study||13
8392117|NCT01047189|20684064|P1|STARTED|Overall Study||13
8392118|NCT01047007|20684076|P4|NOT COMPLETED|Overall Study||0
8392119|NCT01047007|20684077|P3|NOT COMPLETED|Overall Study||2
8392120|NCT01047007|20684078|P2|NOT COMPLETED|Overall Study||6
8392121|NCT01047007|20684079|P1|NOT COMPLETED|Overall Study||2
8392122|NCT01047007|20684076|P4|COMPLETED|Overall Study||0
8392123|NCT01047007|20684077|P3|COMPLETED|Overall Study||0
8392124|NCT01047007|20684078|P2|COMPLETED|Overall Study||0
8392125|NCT01047007|20684079|P1|COMPLETED|Overall Study||1
8392126|NCT01047007|20684076|P4|Treated|Overall Study||0
8392127|NCT01047007|20684077|P3|Treated|Overall Study||2
8392128|NCT01047007|20684078|P2|Treated|Overall Study||6
8392129|NCT01047007|20684079|P1|Treated|Overall Study||3
8392130|NCT01047007|20684076|P4|STARTED|Overall Study||0
8392131|NCT01047007|20684077|P3|STARTED|Overall Study||2
8392132|NCT01047007|20684078|P2|STARTED|Overall Study||6
8392133|NCT01047007|20684079|P1|STARTED|Overall Study||3
8392134|NCT01046903|20684090|P1|NOT COMPLETED|Overall Study||28
8392135|NCT01046903|20684090|P1|COMPLETED|Overall Study||475
8392136|NCT01046903|20684090|P1|STARTED|Overall Study||503
8392137|NCT01046877|20684103|P1|NOT COMPLETED|Overall Study||18
8392138|NCT01046877|20684103|P1|COMPLETED|Overall Study||7
8392139|NCT01046877|20684103|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
8392140|NCT01046877|20684103|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
8392141|NCT01046877|20684103|P1|STARTED|Overall Study||25
8392142|NCT01046695|20684119|P2|NOT COMPLETED|Overall Study||2
8392143|NCT01046695|20684120|P1|NOT COMPLETED|Overall Study||0
8392144|NCT01046695|20684119|P2|COMPLETED|Overall Study||20
8392145|NCT01046695|20684120|P1|COMPLETED|Overall Study||20
8392146|NCT01046695|20684119|P2|STARTED|Overall Study||22
8392147|NCT01046695|20684120|P1|STARTED|Overall Study||20
8392148|NCT01046682|20684132|P2|NOT COMPLETED|Overall Study||0
8392149|NCT01046682|20684133|P1|NOT COMPLETED|Overall Study||2
8392150|NCT01046682|20684132|P2|COMPLETED|Overall Study||20
8392151|NCT01046682|20684133|P1|COMPLETED|Overall Study||18
8392152|NCT01046682|20684132|P2|STARTED|Overall Study||20
8392153|NCT01046682|20684133|P1|STARTED|Overall Study||20
8392154|NCT01046669|20684141|P2|NOT COMPLETED|Overall Study||1
8392155|NCT01046669|20684142|P1|NOT COMPLETED|Overall Study||0
8392156|NCT01046669|20684141|P2|COMPLETED|Overall Study||223
8392157|NCT01046669|20684142|P1|COMPLETED|Overall Study||226
8392158|NCT01046669|20684141|P2|STARTED|Overall Study||224
8392159|NCT01046669|20684142|P1|STARTED|Overall Study||226
8392160|NCT01046643|20684150|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
8392161|NCT01046643|20684151|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
8392162|NCT01046643|20684152|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
8392163|NCT01046643|20684153|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
8392164|NCT01046643|20684150|P4|COMPLETED|Second Period Treatment or Placebo||7
8392165|NCT01046643|20684151|P3|COMPLETED|Second Period Treatment or Placebo||7
8392166|NCT01046643|20684152|P2|COMPLETED|Second Period Treatment or Placebo||6
8392167|NCT01046643|20684153|P1|COMPLETED|Second Period Treatment or Placebo||9
8392168|NCT01046643|20684150|P4|STARTED|Second Period Treatment or Placebo||7
8392169|NCT01046643|20684151|P3|STARTED|Second Period Treatment or Placebo||7
8392170|NCT01046643|20684152|P2|STARTED|Second Period Treatment or Placebo||6
8392171|NCT01046643|20684153|P1|STARTED|Second Period Treatment or Placebo||9
8392172|NCT01046643|20684150|P4|NOT COMPLETED|Washout Period||0
8392173|NCT01046643|20684151|P3|NOT COMPLETED|Washout Period||0
8392174|NCT01046643|20684152|P2|NOT COMPLETED|Washout Period||0
8392175|NCT01046643|20684153|P1|NOT COMPLETED|Washout Period||0
8392176|NCT01046643|20684150|P4|COMPLETED|Washout Period||7
8392177|NCT01046643|20684151|P3|COMPLETED|Washout Period||7
8392178|NCT01046643|20684152|P2|COMPLETED|Washout Period||6
8392179|NCT01046643|20684153|P1|COMPLETED|Washout Period||9
8392180|NCT01046643|20684150|P4|STARTED|Washout Period||7
8392181|NCT01046643|20684151|P3|STARTED|Washout Period||7
8392182|NCT01046643|20684152|P2|STARTED|Washout Period||6
8392183|NCT01046643|20684153|P1|STARTED|Washout Period||9
8392184|NCT01046643|20684150|P4|NOT COMPLETED|First Period Treatment or Placebo||0
8392185|NCT01046643|20684151|P3|NOT COMPLETED|First Period Treatment or Placebo||0
8392186|NCT01046643|20684152|P2|NOT COMPLETED|First Period Treatment or Placebo||1
8392187|NCT01046643|20684153|P1|NOT COMPLETED|First Period Treatment or Placebo||0
8392188|NCT01046643|20684150|P4|COMPLETED|First Period Treatment or Placebo||7
8392189|NCT01046643|20684151|P3|COMPLETED|First Period Treatment or Placebo||7
8392190|NCT01046643|20684152|P2|COMPLETED|First Period Treatment or Placebo||6
8392191|NCT01046643|20684153|P1|COMPLETED|First Period Treatment or Placebo||9
8392192|NCT01046643|20684150|P4|STARTED|First Period Treatment or Placebo||7
8392193|NCT01046643|20684151|P3|STARTED|First Period Treatment or Placebo||7
8392194|NCT01046643|20684152|P2|STARTED|First Period Treatment or Placebo||7
8392195|NCT01046643|20684153|P1|STARTED|First Period Treatment or Placebo||9
8392196|NCT01046565|20684175|P1|NOT COMPLETED|Overall Study||9
8392197|NCT01046565|20684175|P1|COMPLETED|Overall Study||66
8392198|NCT01046565|20684175|P1|STARTED|Overall Study||75
8392199|NCT01046396|20684184|P1|NOT COMPLETED|Overall Study||5
8392200|NCT01046396|20684184|P1|COMPLETED|Overall Study||64
8392201|NCT01046396|20684184|P1|STARTED|Overall Study||69
8392202|NCT01046253|20684195|P2|NOT COMPLETED|Fourth Intervention||0
8392203|NCT01046253|20684196|P1|NOT COMPLETED|Fourth Intervention||0
8392204|NCT01046253|20684195|P2|COMPLETED|Fourth Intervention||23
8392205|NCT01046253|20684196|P1|COMPLETED|Fourth Intervention||25
8392206|NCT01046253|20684195|P2|STARTED|Fourth Intervention||23
8392207|NCT01046253|20684196|P1|STARTED|Fourth Intervention||25
8392208|NCT01046253|20684195|P2|NOT COMPLETED|Third Washout of 7 Days||0
8392209|NCT01046253|20684196|P1|NOT COMPLETED|Third Washout of 7 Days||0
8392210|NCT01046253|20684195|P2|COMPLETED|Third Washout of 7 Days||23
8392211|NCT01046253|20684196|P1|COMPLETED|Third Washout of 7 Days||25
8392212|NCT01046253|20684195|P2|STARTED|Third Washout of 7 Days||23
8392213|NCT01046253|20684196|P1|STARTED|Third Washout of 7 Days||25
8392214|NCT01046253|20684195|P2|NOT COMPLETED|Third Intervention||0
8392215|NCT01046253|20684196|P1|NOT COMPLETED|Third Intervention||0
8392216|NCT01046253|20684195|P2|COMPLETED|Third Intervention||23
8392217|NCT01046253|20684196|P1|COMPLETED|Third Intervention||25
8392218|NCT01046253|20684195|P2|STARTED|Third Intervention||23
8392219|NCT01046253|20684196|P1|STARTED|Third Intervention||25
8392220|NCT01046253|20684195|P2|NOT COMPLETED|Second Washout of 7 Days||0
8392221|NCT01046253|20684196|P1|NOT COMPLETED|Second Washout of 7 Days||0
8392222|NCT01046253|20684195|P2|COMPLETED|Second Washout of 7 Days||23
8392223|NCT01046253|20684196|P1|COMPLETED|Second Washout of 7 Days||25
8392224|NCT01046253|20684195|P2|STARTED|Second Washout of 7 Days||23
8392225|NCT01046253|20684196|P1|STARTED|Second Washout of 7 Days||25
8392226|NCT01046253|20684195|P2|NOT COMPLETED|Second Intervention||2
8392227|NCT01046253|20684196|P1|NOT COMPLETED|Second Intervention||0
8392228|NCT01046253|20684195|P2|COMPLETED|Second Intervention||23
8392229|NCT01046253|20684196|P1|COMPLETED|Second Intervention||25
8392230|NCT01046253|20684195|P2|STARTED|Second Intervention||25
8392231|NCT01046253|20684196|P1|STARTED|Second Intervention||25
8392232|NCT01046253|20684195|P2|NOT COMPLETED|First Washout of 7 Days||0
8392233|NCT01046253|20684196|P1|NOT COMPLETED|First Washout of 7 Days||0
8392234|NCT01046253|20684195|P2|COMPLETED|First Washout of 7 Days||25
8392235|NCT01046253|20684196|P1|COMPLETED|First Washout of 7 Days||25
8392236|NCT01046253|20684195|P2|STARTED|First Washout of 7 Days||25
8392237|NCT01046253|20684196|P1|STARTED|First Washout of 7 Days||25
8392238|NCT01046253|20684195|P2|NOT COMPLETED|First Intervention||0
8392239|NCT01046253|20684196|P1|NOT COMPLETED|First Intervention||0
8392240|NCT01046253|20684195|P2|COMPLETED|First Intervention||25
8392241|NCT01046253|20684196|P1|COMPLETED|First Intervention||25
8392242|NCT01046253|20684195|P2|STARTED|First Intervention||25
8392243|NCT01046253|20684196|P1|STARTED|First Intervention||25
8392244|NCT01046136|20684208|P2|NOT COMPLETED|Overall Study||8
8392245|NCT01046136|20684209|P1|NOT COMPLETED|Overall Study||4
8392246|NCT01046136|20684208|P2|COMPLETED|Overall Study||182
8392247|NCT01046136|20684209|P1|COMPLETED|Overall Study||184
8392248|NCT01046136|20684208|P2|STARTED|Overall Study||190
8392249|NCT01046136|20684209|P1|STARTED|Overall Study||188
8392250|NCT01046110|20684221|P2|NOT COMPLETED|Overall Study||55
8392251|NCT01046110|20684222|P1|NOT COMPLETED|Overall Study||55
8392252|NCT01046110|20684221|P2|COMPLETED|Overall Study||174
8392253|NCT01046110|20684222|P1|COMPLETED|Overall Study||174
8392254|NCT01046110|20684221|P2|Exposed|Overall Study|1 subject was randomised in error|228
8392255|NCT01046110|20684222|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
8392256|NCT01046110|20684221|P2|STARTED|Overall Study||229
8392257|NCT01046110|20684222|P1|STARTED|Overall Study||229
8392258|NCT01046084|20684232|P2|NOT COMPLETED|Fourth Intervention||0
8392259|NCT01046084|20684233|P1|NOT COMPLETED|Fourth Intervention||0
8392260|NCT01046084|20684232|P2|COMPLETED|Fourth Intervention||25
8392261|NCT01046084|20684233|P1|COMPLETED|Fourth Intervention||23
8392262|NCT01046084|20684232|P2|STARTED|Fourth Intervention||25
8392263|NCT01046084|20684233|P1|STARTED|Fourth Intervention||23
8392264|NCT01046084|20684232|P2|NOT COMPLETED|Third Washout of 7 Days||0
8392265|NCT01046084|20684233|P1|NOT COMPLETED|Third Washout of 7 Days||2
8392266|NCT01046084|20684232|P2|COMPLETED|Third Washout of 7 Days||25
8392267|NCT01046084|20684233|P1|COMPLETED|Third Washout of 7 Days||23
8392268|NCT01046084|20684232|P2|STARTED|Third Washout of 7 Days||25
8392269|NCT01046084|20684233|P1|STARTED|Third Washout of 7 Days||25
8392270|NCT01046084|20684232|P2|NOT COMPLETED|Third Intervention||0
8392271|NCT01046084|20684233|P1|NOT COMPLETED|Third Intervention||0
8392272|NCT01046084|20684232|P2|COMPLETED|Third Intervention||25
8392273|NCT01046084|20684233|P1|COMPLETED|Third Intervention||25
8392274|NCT01046084|20684232|P2|STARTED|Third Intervention||25
8392275|NCT01046084|20684233|P1|STARTED|Third Intervention||25
8392276|NCT01046084|20684232|P2|NOT COMPLETED|Second Washout of 7 Days||0
8392277|NCT01046084|20684233|P1|NOT COMPLETED|Second Washout of 7 Days||0
8392278|NCT01046084|20684232|P2|COMPLETED|Second Washout of 7 Days||25
8392279|NCT01046084|20684233|P1|COMPLETED|Second Washout of 7 Days||25
8392280|NCT01046084|20684232|P2|STARTED|Second Washout of 7 Days||25
8392281|NCT01046084|20684233|P1|STARTED|Second Washout of 7 Days||25
8392282|NCT01046084|20684232|P2|NOT COMPLETED|Second Intervention||0
8392283|NCT01046084|20684233|P1|NOT COMPLETED|Second Intervention||0
8392284|NCT01046084|20684232|P2|COMPLETED|Second Intervention||25
8392285|NCT01046084|20684233|P1|COMPLETED|Second Intervention||25
8392286|NCT01046084|20684232|P2|STARTED|Second Intervention||25
8392287|NCT01046084|20684233|P1|STARTED|Second Intervention||25
8392288|NCT01046084|20684232|P2|NOT COMPLETED|First Washout of 7 Days||0
8392289|NCT01046084|20684233|P1|NOT COMPLETED|First Washout of 7 Days||0
8392290|NCT01046084|20684232|P2|COMPLETED|First Washout of 7 Days||25
8392291|NCT01046084|20684233|P1|COMPLETED|First Washout of 7 Days||25
8392292|NCT01046084|20684232|P2|STARTED|First Washout of 7 Days||25
8392293|NCT01046084|20684233|P1|STARTED|First Washout of 7 Days||25
8392294|NCT01046084|20684232|P2|NOT COMPLETED|First Intervention||0
8392295|NCT01046084|20684233|P1|NOT COMPLETED|First Intervention||0
8392296|NCT01046084|20684232|P2|COMPLETED|First Intervention||25
8392297|NCT01046084|20684233|P1|COMPLETED|First Intervention||25
8392298|NCT01046084|20684232|P2|STARTED|First Intervention||25
8392299|NCT01046084|20684233|P1|STARTED|First Intervention||25
8392300|NCT01045993|20684247|P4|NOT COMPLETED|Overall Study||0
8392301|NCT01045993|20684248|P3|NOT COMPLETED|Overall Study||0
8392302|NCT01045993|20684249|P2|NOT COMPLETED|Overall Study||1
8392303|NCT01045993|20684250|P1|NOT COMPLETED|Overall Study||0
8392304|NCT01045993|20684247|P4|COMPLETED|Overall Study||25
8392305|NCT01045993|20684248|P3|COMPLETED|Overall Study||5
8392306|NCT01045993|20684249|P2|COMPLETED|Overall Study||4
8392307|NCT01045993|20684250|P1|COMPLETED|Overall Study||26
8392308|NCT01045993|20684247|P4|STARTED|Overall Study||25
8392309|NCT01045993|20684248|P3|STARTED|Overall Study||5
8392310|NCT01045993|20684249|P2|STARTED|Overall Study||5
8392311|NCT01045993|20684250|P1|STARTED|Overall Study||26
8392312|NCT01045967|20684326|P2|NOT COMPLETED|Second Intervention||1
8392313|NCT01045967|20684327|P1|NOT COMPLETED|Second Intervention||0
8392314|NCT01045967|20684326|P2|COMPLETED|Second Intervention||27
8392315|NCT01045967|20684327|P1|COMPLETED|Second Intervention||28
8392316|NCT01045967|20684326|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
8392317|NCT01045967|20684327|P1|STARTED|Second Intervention||28
8392318|NCT01045967|20684326|P2|NOT COMPLETED|Washout of 7 Days||0
8392319|NCT01045967|20684327|P1|NOT COMPLETED|Washout of 7 Days||0
8392320|NCT01045967|20684326|P2|COMPLETED|Washout of 7 Days||28
8392321|NCT01045967|20684327|P1|COMPLETED|Washout of 7 Days||28
8392322|NCT01045967|20684326|P2|STARTED|Washout of 7 Days||28
8392323|NCT01045967|20684327|P1|STARTED|Washout of 7 Days||28
8392324|NCT01045967|20684326|P2|NOT COMPLETED|First Intervention||0
8392325|NCT01045967|20684327|P1|NOT COMPLETED|First Intervention||0
8392326|NCT01045967|20684326|P2|COMPLETED|First Intervention||28
8392327|NCT01045967|20684327|P1|COMPLETED|First Intervention||28
8392328|NCT01045967|20684326|P2|STARTED|First Intervention||28
8392329|NCT01045967|20684327|P1|STARTED|First Intervention||28
8392330|NCT01045798|20684339|P2|NOT COMPLETED|Overall Study||4
8392331|NCT01045798|20684340|P1|NOT COMPLETED|Overall Study||2
8392332|NCT01045798|20684339|P2|COMPLETED|Overall Study||5
8392333|NCT01045798|20684340|P1|COMPLETED|Overall Study||4
8392334|NCT01045798|20684339|P2|STARTED|Overall Study||9
8392335|NCT01045798|20684340|P1|STARTED|Overall Study||6
8392429|NCT01045421|20684415|P10|STARTED|Phase 1||0
8392336|NCT01045707|20684348|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
8392337|NCT01045707|20684349|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
8392338|NCT01045707|20684348|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
8392339|NCT01045707|20684349|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
8392340|NCT01045707|20684348|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
8392341|NCT01045707|20684349|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
8392342|NCT01045707|20684348|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
8392343|NCT01045707|20684349|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
8392344|NCT01045707|20684348|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
8392345|NCT01045707|20684349|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
8392346|NCT01045707|20684348|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
8392347|NCT01045707|20684349|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
8392348|NCT01045707|20684348|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
8392349|NCT01045707|20684349|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
8392350|NCT01045694|20684365|P1|NOT COMPLETED|Overall Study||2
8392351|NCT01045694|20684365|P1|COMPLETED|Overall Study||6
8392352|NCT01045694|20684365|P1|STARTED|Overall Study||8
8392353|NCT01045551|20684371|P1|NOT COMPLETED|Overall Study||0
8392354|NCT01045551|20684371|P1|COMPLETED|Overall Study||10
8392355|NCT01045551|20684371|P1|STARTED|Overall Study||10
8392356|NCT01045499|20684379|P1|NOT COMPLETED|Overall Study||10
8392357|NCT01045499|20684379|P1|COMPLETED|Overall Study||127
8392358|NCT01045499|20684379|P1|STARTED|Overall Study||137
8392359|NCT01045460|20684386|P2|NOT COMPLETED|Overall Study||3
8392360|NCT01045460|20684387|P1|NOT COMPLETED|Overall Study||6
8392361|NCT01045460|20684386|P2|COMPLETED|Overall Study||15
8392362|NCT01045460|20684387|P1|COMPLETED|Overall Study||11
8392363|NCT01045460|20684386|P2|STARTED|Overall Study||18
8392364|NCT01045460|20684387|P1|STARTED|Overall Study||17
8392365|NCT01045447|20684399|P2|NOT COMPLETED|Overall Study||28
8392366|NCT01045447|20684400|P1|NOT COMPLETED|Overall Study||36
8392367|NCT01045447|20684399|P2|COMPLETED|Overall Study||205
8392368|NCT01045447|20684400|P1|COMPLETED|Overall Study||196
8392369|NCT01045447|20684399|P2|Exposed|Overall Study||233
8392370|NCT01045447|20684400|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
8392371|NCT01045447|20684399|P2|STARTED|Overall Study||233
8392372|NCT01045447|20684400|P1|STARTED|Overall Study||232
8392373|NCT01045421|20684414|P11|NOT COMPLETED|Phase 2||2
8392374|NCT01045421|20684415|P10|NOT COMPLETED|Phase 2||3
8392375|NCT01045421|20684416|P9|NOT COMPLETED|Phase 2||2
8392376|NCT01045421|20684417|P8|NOT COMPLETED|Phase 2||5
8392377|NCT01045421|20684418|P7|NOT COMPLETED|Phase 2||0
8392378|NCT01045421|20684419|P6|NOT COMPLETED|Phase 2||0
8392379|NCT01045421|20684420|P5|NOT COMPLETED|Phase 2||0
8392380|NCT01045421|20684421|P4|NOT COMPLETED|Phase 2||0
8392381|NCT01045421|20684422|P3|NOT COMPLETED|Phase 2||0
8392382|NCT01045421|20684423|P2|NOT COMPLETED|Phase 2||0
8392383|NCT01045421|20684424|P1|NOT COMPLETED|Phase 2||0
8392384|NCT01045421|20684414|P11|COMPLETED|Phase 2||58
8392385|NCT01045421|20684415|P10|COMPLETED|Phase 2||23
8392386|NCT01045421|20684416|P9|COMPLETED|Phase 2||53
8392387|NCT01045421|20684417|P8|COMPLETED|Phase 2||50
8392388|NCT01045421|20684418|P7|COMPLETED|Phase 2||53
8392389|NCT01045421|20684419|P6|COMPLETED|Phase 2||0
8392390|NCT01045421|20684420|P5|COMPLETED|Phase 2||0
8392391|NCT01045421|20684421|P4|COMPLETED|Phase 2||0
8392392|NCT01045421|20684422|P3|COMPLETED|Phase 2||0
8392393|NCT01045421|20684423|P2|COMPLETED|Phase 2||0
8392394|NCT01045421|20684424|P1|COMPLETED|Phase 2||0
8392395|NCT01045421|20684414|P11|STARTED|Phase 2||60
8392396|NCT01045421|20684415|P10|STARTED|Phase 2||26
8392397|NCT01045421|20684416|P9|STARTED|Phase 2||55
8392398|NCT01045421|20684417|P8|STARTED|Phase 2||55
8392399|NCT01045421|20684418|P7|STARTED|Phase 2||53
8392400|NCT01045421|20684419|P6|STARTED|Phase 2||0
8392401|NCT01045421|20684420|P5|STARTED|Phase 2||0
8392402|NCT01045421|20684421|P4|STARTED|Phase 2||0
8392403|NCT01045421|20684422|P3|STARTED|Phase 2||0
8392404|NCT01045421|20684423|P2|STARTED|Phase 2||0
8392405|NCT01045421|20684424|P1|STARTED|Phase 2||0
8392406|NCT01045421|20684414|P11|NOT COMPLETED|Phase 1||0
8392407|NCT01045421|20684415|P10|NOT COMPLETED|Phase 1||0
8392408|NCT01045421|20684416|P9|NOT COMPLETED|Phase 1||0
8392409|NCT01045421|20684417|P8|NOT COMPLETED|Phase 1||0
8392410|NCT01045421|20684418|P7|NOT COMPLETED|Phase 1||0
8392411|NCT01045421|20684419|P6|NOT COMPLETED|Phase 1||0
8392412|NCT01045421|20684420|P5|NOT COMPLETED|Phase 1||1
8392413|NCT01045421|20684421|P4|NOT COMPLETED|Phase 1||1
8392414|NCT01045421|20684422|P3|NOT COMPLETED|Phase 1||0
8392415|NCT01045421|20684423|P2|NOT COMPLETED|Phase 1||0
8392416|NCT01045421|20684424|P1|NOT COMPLETED|Phase 1||0
8392417|NCT01045421|20684414|P11|COMPLETED|Phase 1||0
8392418|NCT01045421|20684415|P10|COMPLETED|Phase 1||0
8392419|NCT01045421|20684416|P9|COMPLETED|Phase 1||0
8392420|NCT01045421|20684417|P8|COMPLETED|Phase 1||0
8392421|NCT01045421|20684418|P7|COMPLETED|Phase 1||0
8392422|NCT01045421|20684419|P6|COMPLETED|Phase 1||1
8392423|NCT01045421|20684420|P5|COMPLETED|Phase 1||2
8392424|NCT01045421|20684421|P4|COMPLETED|Phase 1||11
8392425|NCT01045421|20684422|P3|COMPLETED|Phase 1||4
8392426|NCT01045421|20684423|P2|COMPLETED|Phase 1||3
8392427|NCT01045421|20684424|P1|COMPLETED|Phase 1||1
8392428|NCT01045421|20684414|P11|STARTED|Phase 1||0
8392430|NCT01045421|20684416|P9|STARTED|Phase 1||0
8392431|NCT01045421|20684417|P8|STARTED|Phase 1||0
8392432|NCT01045421|20684418|P7|STARTED|Phase 1||0
8392433|NCT01045421|20684419|P6|STARTED|Phase 1||1
8392434|NCT01045421|20684420|P5|STARTED|Phase 1||3
8392435|NCT01045421|20684421|P4|STARTED|Phase 1||12
8392436|NCT01045421|20684422|P3|STARTED|Phase 1||4
8392437|NCT01045421|20684423|P2|STARTED|Phase 1||3
8392438|NCT01045421|20684424|P1|STARTED|Phase 1||1
8392439|NCT01045265|20684504|P1|NOT COMPLETED|Overall Study||0
8392440|NCT01045265|20684504|P1|COMPLETED|Overall Study||16
8392441|NCT01045265|20684504|P1|STARTED|Overall Study||16
8392442|NCT01045187|20684511|P1|NOT COMPLETED|Overall Study||0
8392443|NCT01045187|20684511|P1|COMPLETED|Overall Study||15
8392444|NCT01045187|20684511|P1|STARTED|Overall Study||15
8392445|NCT01045174|20684517|P2|NOT COMPLETED|Overall Study||0
8392446|NCT01045174|20684518|P1|NOT COMPLETED|Overall Study||0
8392447|NCT01045174|20684517|P2|COMPLETED|Overall Study||90
8392448|NCT01045174|20684518|P1|COMPLETED|Overall Study||90
8392449|NCT01045174|20684517|P2|STARTED|Overall Study||90
8392450|NCT01045174|20684518|P1|STARTED|Overall Study||90
8392451|NCT01045161|20684533|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
8392452|NCT01045161|20684534|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
8392453|NCT01045161|20684535|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
8392454|NCT01045161|20684533|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
8392455|NCT01045161|20684534|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
8392456|NCT01045161|20684535|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
8392457|NCT01045161|20684533|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
8392458|NCT01045161|20684534|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
8392459|NCT01045161|20684535|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
8392460|NCT01045161|20684533|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
8392461|NCT01045161|20684534|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
8392462|NCT01045161|20684535|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
8392463|NCT01045161|20684533|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
8392464|NCT01045161|20684534|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
8392465|NCT01045161|20684535|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
8392466|NCT01045161|20684533|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
8392467|NCT01045161|20684534|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
8392468|NCT01045161|20684535|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
8392469|NCT01045135|20684555|P1|NOT COMPLETED|Overall Study||26
8392470|NCT01045135|20684555|P1|COMPLETED|Overall Study||274
8392471|NCT01045135|20684555|P1|STARTED|Overall Study||300
8392472|NCT01045122|20684562|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
8392473|NCT01045122|20684563|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
8392474|NCT01045122|20684562|P2|COMPLETED|Propofol Then Dexmedetomidine||6
8392475|NCT01045122|20684563|P1|COMPLETED|Propofol Then Dexmedetomidine||5
8392476|NCT01045122|20684562|P2|STARTED|Propofol Then Dexmedetomidine||6
8392477|NCT01045122|20684563|P1|STARTED|Propofol Then Dexmedetomidine||5
8392478|NCT01045122|20684562|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
8392479|NCT01045122|20684563|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
8392480|NCT01045122|20684562|P2|COMPLETED|Dexmedetomidine Then Propofol||6
8392481|NCT01045122|20684563|P1|COMPLETED|Dexmedetomidine Then Propofol||5
8392482|NCT01045122|20684562|P2|STARTED|Dexmedetomidine Then Propofol||6
8392483|NCT01045122|20684563|P1|STARTED|Dexmedetomidine Then Propofol||5
8392484|NCT01045096|20684572|P3|NOT COMPLETED|Overall Study||0
8392485|NCT01045096|20684573|P2|NOT COMPLETED|Overall Study||0
8392486|NCT01045096|20684574|P1|NOT COMPLETED|Overall Study||3
8392487|NCT01045096|20684572|P3|COMPLETED|Overall Study||12
8392488|NCT01045096|20684573|P2|COMPLETED|Overall Study||12
8392489|NCT01045096|20684574|P1|COMPLETED|Overall Study||9
8392490|NCT01045096|20684572|P3|Pharmacokinetic Set|Overall Study||11
8392491|NCT01045096|20684573|P2|Pharmacokinetic Set|Overall Study||11
8392492|NCT01045096|20684574|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
8392493|NCT01045096|20684572|P3|STARTED|Overall Study||12
8392494|NCT01045096|20684573|P2|STARTED|Overall Study||12
8392495|NCT01045096|20684574|P1|STARTED|Overall Study||12
8392496|NCT01045057|20684600|P1|NOT COMPLETED|Overall Study||0
8392497|NCT01045057|20684600|P1|COMPLETED|Overall Study||27
8392498|NCT01045057|20684600|P1|STARTED|Overall Study||27
8392499|NCT01045031|20684609|P2|NOT COMPLETED|Overall Study||6
8392500|NCT01045031|20684610|P1|NOT COMPLETED|Overall Study||9
8392501|NCT01045031|20684609|P2|COMPLETED|Overall Study||50
8392502|NCT01045031|20684610|P1|COMPLETED|Overall Study||49
8392503|NCT01045031|20684609|P2|STARTED|Overall Study||56
8392504|NCT01045031|20684610|P1|STARTED|Overall Study||58
8392505|NCT01044966|20684620|P1|NOT COMPLETED|Consolidation Phase||10
8392506|NCT01044966|20684620|P1|COMPLETED|Consolidation Phase||2
8392507|NCT01044966|20684620|P1|STARTED|Consolidation Phase||12
8392508|NCT01044966|20684620|P1|NOT COMPLETED|Induction Phase||0
8392509|NCT01044966|20684620|P1|COMPLETED|Induction Phase||12
8392510|NCT01044966|20684620|P1|STARTED|Induction Phase||12
8392511|NCT01044862|20684631|P3|NOT COMPLETED|Overall Study||52
8392512|NCT01044862|20684632|P2|NOT COMPLETED|Overall Study||49
8392513|NCT01044862|20684633|P1|NOT COMPLETED|Overall Study||53
8392514|NCT01044862|20684631|P3|COMPLETED|Overall Study||249
8392515|NCT01044862|20684632|P2|COMPLETED|Overall Study||251
8392516|NCT01044862|20684633|P1|COMPLETED|Overall Study||246
8392517|NCT01044862|20684631|P3|STARTED|Overall Study||301
8392518|NCT01044862|20684632|P2|STARTED|Overall Study||300
8392519|NCT01044862|20684633|P1|STARTED|Overall Study||299
8392520|NCT01044771|20684650|P1|NOT COMPLETED|Overall Study||0
8392521|NCT01044771|20684650|P1|COMPLETED|Overall Study||20
8392522|NCT01044771|20684650|P1|STARTED|Overall Study||20
8392523|NCT01044758|20684662|P7|NOT COMPLETED|Overall Study||10
8392524|NCT01044758|20684663|P6|NOT COMPLETED|Overall Study||3
8392525|NCT01044758|20684664|P5|NOT COMPLETED|Overall Study||2
8392526|NCT01044758|20684665|P4|NOT COMPLETED|Overall Study||2
8392527|NCT01044758|20684666|P3|NOT COMPLETED|Overall Study||4
8392528|NCT01044758|20684667|P2|NOT COMPLETED|Overall Study||0
8392529|NCT01044758|20684668|P1|NOT COMPLETED|Overall Study||4
8392530|NCT01044758|20684662|P7|COMPLETED|Overall Study||17
8392531|NCT01044758|20684663|P6|COMPLETED|Overall Study||8
8392532|NCT01044758|20684664|P5|COMPLETED|Overall Study||9
8392533|NCT01044758|20684665|P4|COMPLETED|Overall Study||10
8392534|NCT01044758|20684666|P3|COMPLETED|Overall Study||7
8392535|NCT01044758|20684667|P2|COMPLETED|Overall Study||12
8392536|NCT01044758|20684668|P1|COMPLETED|Overall Study||8
8392537|NCT01044758|20684662|P7|STARTED|Overall Study||27
8392538|NCT01044758|20684663|P6|STARTED|Overall Study||11
8392539|NCT01044758|20684664|P5|STARTED|Overall Study||11
8392540|NCT01044758|20684665|P4|STARTED|Overall Study||12
8392541|NCT01044758|20684666|P3|STARTED|Overall Study||11
8392542|NCT01044758|20684667|P2|STARTED|Overall Study||12
8392543|NCT01044758|20684668|P1|STARTED|Overall Study||12
8392544|NCT01044745|20684691|P1|NOT COMPLETED|Overall Study||2
8392545|NCT01044745|20684691|P1|COMPLETED|Overall Study||18
8392546|NCT01044745|20684691|P1|STARTED|Overall Study||20
8392547|NCT01044732|20684700|P2|NOT COMPLETED|Overall Study||50
8392548|NCT01044732|20684701|P1|NOT COMPLETED|Overall Study||49
8392549|NCT01044732|20684700|P2|COMPLETED|Overall Study||176
8392550|NCT01044732|20684701|P1|COMPLETED|Overall Study||173
8392551|NCT01044732|20684700|P2|STARTED|Overall Study||226
8392552|NCT01044732|20684701|P1|STARTED|Overall Study||222
8392553|NCT01044706|20684711|P2|NOT COMPLETED|Overall Study||0
8392554|NCT01044706|20684712|P1|NOT COMPLETED|Overall Study||0
8392555|NCT01044706|20684711|P2|COMPLETED|Overall Study||30
8392556|NCT01044706|20684712|P1|COMPLETED|Overall Study||30
8392557|NCT01044706|20684711|P2|STARTED|Overall Study||30
8392558|NCT01044706|20684712|P1|STARTED|Overall Study||30
8392559|NCT01044693|20684720|P16|NOT COMPLETED|Overall Study||0
8392560|NCT01044693|20684721|P15|NOT COMPLETED|Overall Study||0
8392561|NCT01044693|20684722|P14|NOT COMPLETED|Overall Study||0
8392562|NCT01044693|20684723|P13|NOT COMPLETED|Overall Study||0
8392563|NCT01044693|20684724|P12|NOT COMPLETED|Overall Study||0
8392564|NCT01044693|20684725|P11|NOT COMPLETED|Overall Study||0
8392565|NCT01044693|20684726|P10|NOT COMPLETED|Overall Study||0
8392566|NCT01044693|20684727|P9|NOT COMPLETED|Overall Study||0
8392567|NCT01044693|20684728|P8|NOT COMPLETED|Overall Study||0
8392568|NCT01044693|20684729|P7|NOT COMPLETED|Overall Study||0
8392569|NCT01044693|20684730|P6|NOT COMPLETED|Overall Study||0
8392570|NCT01044693|20684731|P5|NOT COMPLETED|Overall Study||0
8392571|NCT01044693|20684732|P4|NOT COMPLETED|Overall Study||0
8392572|NCT01044693|20684733|P3|NOT COMPLETED|Overall Study||0
8392573|NCT01044693|20684734|P2|NOT COMPLETED|Overall Study||0
8392574|NCT01044693|20684735|P1|NOT COMPLETED|Overall Study||0
8392575|NCT01044693|20684720|P16|COMPLETED|Overall Study||1
8392576|NCT01044693|20684721|P15|COMPLETED|Overall Study||1
8392577|NCT01044693|20684722|P14|COMPLETED|Overall Study||1
8392578|NCT01044693|20684723|P13|COMPLETED|Overall Study||2
8392579|NCT01044693|20684724|P12|COMPLETED|Overall Study||1
8392580|NCT01044693|20684725|P11|COMPLETED|Overall Study||1
8392581|NCT01044693|20684726|P10|COMPLETED|Overall Study||1
8392582|NCT01044693|20684727|P9|COMPLETED|Overall Study||1
8392583|NCT01044693|20684728|P8|COMPLETED|Overall Study||1
8392584|NCT01044693|20684729|P7|COMPLETED|Overall Study||1
8392585|NCT01044693|20684730|P6|COMPLETED|Overall Study||2
8392586|NCT01044693|20684731|P5|COMPLETED|Overall Study||1
8392587|NCT01044693|20684732|P4|COMPLETED|Overall Study||1
8392588|NCT01044693|20684733|P3|COMPLETED|Overall Study||1
8392589|NCT01044693|20684734|P2|COMPLETED|Overall Study||1
8392590|NCT01044693|20684735|P1|COMPLETED|Overall Study||3
8392591|NCT01044693|20684720|P16|STARTED|Overall Study||1
8392592|NCT01044693|20684721|P15|STARTED|Overall Study||1
8392593|NCT01044693|20684722|P14|STARTED|Overall Study||1
8392594|NCT01044693|20684723|P13|STARTED|Overall Study||2
8392595|NCT01044693|20684724|P12|STARTED|Overall Study||1
8392596|NCT01044693|20684725|P11|STARTED|Overall Study||1
8392597|NCT01044693|20684726|P10|STARTED|Overall Study||1
8392598|NCT01044693|20684727|P9|STARTED|Overall Study||1
8392599|NCT01044693|20684728|P8|STARTED|Overall Study||1
8392600|NCT01044693|20684729|P7|STARTED|Overall Study||1
8392601|NCT01044693|20684730|P6|STARTED|Overall Study||2
8392602|NCT01044693|20684731|P5|STARTED|Overall Study||1
8392603|NCT01044693|20684732|P4|STARTED|Overall Study||1
8392604|NCT01044693|20684733|P3|STARTED|Overall Study||1
8392605|NCT01044693|20684734|P2|STARTED|Overall Study||1
8392606|NCT01044693|20684735|P1|STARTED|Overall Study||3
8392607|NCT01044589|20684759|P2|NOT COMPLETED|Overall Study||5
8392608|NCT01044589|20684760|P1|NOT COMPLETED|Overall Study||3
8392609|NCT01044589|20684759|P2|COMPLETED|Overall Study||2
8392610|NCT01044589|20684760|P1|COMPLETED|Overall Study||3
8392611|NCT01044589|20684759|P2|STARTED|Overall Study||7
8392612|NCT01044589|20684760|P1|STARTED|Overall Study||6
8392613|NCT01044537|20684775|P7|NOT COMPLETED|Overall Study||0
8392614|NCT01044537|20684776|P6|NOT COMPLETED|Overall Study||0
8392615|NCT01044537|20684777|P5|NOT COMPLETED|Overall Study||0
8392616|NCT01044537|20684778|P4|NOT COMPLETED|Overall Study||0
8392617|NCT01044537|20684779|P3|NOT COMPLETED|Overall Study||0
8392618|NCT01044537|20684780|P2|NOT COMPLETED|Overall Study||0
8392619|NCT01044537|20684781|P1|NOT COMPLETED|Overall Study||0
8392620|NCT01044537|20684775|P7|COMPLETED|Overall Study||16
8392621|NCT01044537|20684776|P6|COMPLETED|Overall Study||5
8392622|NCT01044537|20684777|P5|COMPLETED|Overall Study||5
8392623|NCT01044537|20684778|P4|COMPLETED|Overall Study||6
8392624|NCT01044537|20684779|P3|COMPLETED|Overall Study||6
8392625|NCT01044537|20684780|P2|COMPLETED|Overall Study||6
8392626|NCT01044537|20684781|P1|COMPLETED|Overall Study||6
8392627|NCT01044537|20684775|P7|STARTED|Overall Study||16
8392628|NCT01044537|20684776|P6|STARTED|Overall Study||5
8392629|NCT01044537|20684777|P5|STARTED|Overall Study||5
8392630|NCT01044537|20684778|P4|STARTED|Overall Study||6
8392631|NCT01044537|20684779|P3|STARTED|Overall Study||6
8392632|NCT01044537|20684780|P2|STARTED|Overall Study||6
8392633|NCT01044537|20684781|P1|STARTED|Overall Study||6
8392634|NCT01044498|20684890|P2|NOT COMPLETED|Overall Study||2
8392635|NCT01044498|20684891|P1|NOT COMPLETED|Overall Study||3
8392636|NCT01044498|20684890|P2|COMPLETED|Overall Study||21
8392637|NCT01044498|20684891|P1|COMPLETED|Overall Study||20
8392638|NCT01044498|20684890|P2|STARTED|Overall Study||23
8392639|NCT01044498|20684891|P1|STARTED|Overall Study||23
8392640|NCT01044459|20684917|P2|NOT COMPLETED|Overall Study||131
8392641|NCT01044459|20684918|P1|NOT COMPLETED|Overall Study||133
8392642|NCT01044459|20684917|P2|COMPLETED|Overall Study||162
8392643|NCT01044459|20684918|P1|COMPLETED|Overall Study||179
8392644|NCT01044459|20684917|P2|STARTED|Overall Study||293
8392645|NCT01044459|20684918|P1|STARTED|Overall Study||312
8392646|NCT01044433|20684926|P1|NOT COMPLETED|Overall Study||6
8392647|NCT01044433|20684926|P1|COMPLETED|Overall Study||38
8392648|NCT01044433|20684926|P1|STARTED|Overall Study||44
8392649|NCT01044303|20684934|P1|NOT COMPLETED|Overall Study||2
8392650|NCT01044303|20684934|P1|COMPLETED|Overall Study||30
8392651|NCT01044303|20684934|P1|STARTED|Overall Study||32
8392652|NCT01044290|20684944|P3|NOT COMPLETED|Follow-Up 2||2
8392653|NCT01044290|20684945|P2|NOT COMPLETED|Follow-Up 2||2
8392654|NCT01044290|20684946|P1|NOT COMPLETED|Follow-Up 2||0
8392655|NCT01044290|20684944|P3|COMPLETED|Follow-Up 2||69
8392656|NCT01044290|20684945|P2|COMPLETED|Follow-Up 2||67
8392657|NCT01044290|20684946|P1|COMPLETED|Follow-Up 2||70
8392658|NCT01044290|20684944|P3|Completed F2 Interview|Follow-Up 2||64
8392659|NCT01044290|20684945|P2|Completed F2 Interview|Follow-Up 2||57
8392660|NCT01044290|20684946|P1|Completed F2 Interview|Follow-Up 2||64
8392661|NCT01044290|20684944|P3|STARTED|Follow-Up 2||71
8392662|NCT01044290|20684945|P2|STARTED|Follow-Up 2||69
8392663|NCT01044290|20684946|P1|STARTED|Follow-Up 2||70
8392664|NCT01044290|20684944|P3|NOT COMPLETED|Follow-up 1||1
8392665|NCT01044290|20684945|P2|NOT COMPLETED|Follow-up 1||5
8392666|NCT01044290|20684946|P1|NOT COMPLETED|Follow-up 1||5
8392667|NCT01044290|20684944|P3|COMPLETED|Follow-up 1||71
8392668|NCT01044290|20684945|P2|COMPLETED|Follow-up 1||69
8392669|NCT01044290|20684946|P1|COMPLETED|Follow-up 1||70
8392670|NCT01044290|20684944|P3|Completed F1 Interview|Follow-up 1||61
8392671|NCT01044290|20684945|P2|Completed F1 Interview|Follow-up 1||60
8392672|NCT01044290|20684946|P1|Completed F1 Interview|Follow-up 1||61
8392673|NCT01044290|20684944|P3|STARTED|Follow-up 1||72
8392674|NCT01044290|20684945|P2|STARTED|Follow-up 1||74
8392675|NCT01044290|20684946|P1|STARTED|Follow-up 1||75
8392676|NCT01044290|20684944|P3|NOT COMPLETED|Randomization||0
8392677|NCT01044290|20684945|P2|NOT COMPLETED|Randomization||0
8392678|NCT01044290|20684946|P1|NOT COMPLETED|Randomization||0
8392679|NCT01044290|20684944|P3|COMPLETED|Randomization||72
8392680|NCT01044290|20684945|P2|COMPLETED|Randomization||74
8392681|NCT01044290|20684946|P1|COMPLETED|Randomization||75
8392682|NCT01044290|20684944|P3|Randomized|Randomization||72
8392683|NCT01044290|20684945|P2|Randomized|Randomization||74
8392684|NCT01044290|20684946|P1|Randomized|Randomization||75
8392685|NCT01044290|20684944|P3|STARTED|Randomization||72
8392686|NCT01044290|20684945|P2|STARTED|Randomization||74
8392687|NCT01044290|20684946|P1|STARTED|Randomization||75
8392688|NCT01044264|20684972|P3|NOT COMPLETED|Overall Study||92
8392689|NCT01044264|20684973|P2|NOT COMPLETED|Overall Study||94
8392690|NCT01044264|20684974|P1|NOT COMPLETED|Overall Study||90
8392691|NCT01044264|20684972|P3|COMPLETED|Overall Study||108
8392692|NCT01044264|20684973|P2|COMPLETED|Overall Study||108
8392693|NCT01044264|20684974|P1|COMPLETED|Overall Study||110
8392694|NCT01044264|20684972|P3|STARTED|Overall Study||200
8392695|NCT01044264|20684973|P2|STARTED|Overall Study||202
8392696|NCT01044264|20684974|P1|STARTED|Overall Study||200
8392697|NCT01044212|20684984|P2|NOT COMPLETED|Overall Study||7
8392698|NCT01044212|20684985|P1|NOT COMPLETED|Overall Study||5
8392699|NCT01044212|20684984|P2|COMPLETED|Overall Study||30
8392700|NCT01044212|20684985|P1|COMPLETED|Overall Study||30
8392701|NCT01044212|20684984|P2|STARTED|Overall Study||37
8392702|NCT01044212|20684985|P1|STARTED|Overall Study||35
8392703|NCT01044056|20684998|P3|NOT COMPLETED|Overall Study||0
8392704|NCT01044056|20684999|P2|NOT COMPLETED|Overall Study||0
8392705|NCT01044056|20685000|P1|NOT COMPLETED|Overall Study||0
8392706|NCT01044056|20684998|P3|COMPLETED|Overall Study||8
8392707|NCT01044056|20684999|P2|COMPLETED|Overall Study||8
8392708|NCT01044056|20685000|P1|COMPLETED|Overall Study||8
8392709|NCT01044056|20684998|P3|STARTED|Overall Study||8
8392710|NCT01044056|20684999|P2|STARTED|Overall Study||8
8392711|NCT01044056|20685000|P1|STARTED|Overall Study||8
8392712|NCT01044030|20685019|P2|NOT COMPLETED|Overall Study||20
8392713|NCT01044030|20685020|P1|NOT COMPLETED|Overall Study||19
8392714|NCT01044030|20685019|P2|COMPLETED|Overall Study||146
8392715|NCT01044030|20685020|P1|COMPLETED|Overall Study||141
8392716|NCT01044030|20685019|P2|STARTED|Overall Study||166
8392717|NCT01044030|20685020|P1|STARTED|Overall Study||160
8392718|NCT01043939|20685034|P2|NOT COMPLETED|Second Intervention||0
8392719|NCT01043939|20685035|P1|NOT COMPLETED|Second Intervention||0
8392720|NCT01043939|20685034|P2|COMPLETED|Second Intervention||12
8392721|NCT01043939|20685035|P1|COMPLETED|Second Intervention||12
8392722|NCT01043939|20685034|P2|STARTED|Second Intervention||12
8392723|NCT01043939|20685035|P1|STARTED|Second Intervention||12
8392724|NCT01043939|20685034|P2|NOT COMPLETED|Washout Period||0
8392725|NCT01043939|20685035|P1|NOT COMPLETED|Washout Period||0
8392726|NCT01043939|20685034|P2|COMPLETED|Washout Period||12
8392727|NCT01043939|20685035|P1|COMPLETED|Washout Period||12
8392728|NCT01043939|20685034|P2|STARTED|Washout Period||12
8392729|NCT01043939|20685035|P1|STARTED|Washout Period||12
8392730|NCT01043939|20685034|P2|NOT COMPLETED|First Intervention||0
8392731|NCT01043939|20685035|P1|NOT COMPLETED|First Intervention||0
8392732|NCT01043939|20685034|P2|COMPLETED|First Intervention||12
8392733|NCT01043939|20685035|P1|COMPLETED|First Intervention||12
8392734|NCT01043939|20685034|P2|STARTED|First Intervention||12
8392735|NCT01043939|20685035|P1|STARTED|First Intervention||12
8392736|NCT01043926|20685049|P4|NOT COMPLETED|Overall Study||0
8392737|NCT01043926|20685050|P3|NOT COMPLETED|Overall Study||0
8392738|NCT01043926|20685051|P2|NOT COMPLETED|Overall Study||0
8392739|NCT01043926|20685052|P1|NOT COMPLETED|Overall Study||0
8392740|NCT01043926|20685049|P4|COMPLETED|Overall Study||0
8392741|NCT01043926|20685050|P3|COMPLETED|Overall Study||0
8392742|NCT01043926|20685051|P2|COMPLETED|Overall Study||8
8392743|NCT01043926|20685052|P1|COMPLETED|Overall Study||8
8392744|NCT01043926|20685049|P4|STARTED|Overall Study||0
8392745|NCT01043926|20685050|P3|STARTED|Overall Study||0
8392746|NCT01043926|20685051|P2|STARTED|Overall Study||8
8392747|NCT01043926|20685052|P1|STARTED|Overall Study||8
8392748|NCT01043874|20685066|P1|NOT COMPLETED|Overall Study||6
8392749|NCT01043874|20685066|P1|COMPLETED|Overall Study||39
8392750|NCT01043874|20685066|P1|STARTED|Overall Study||45
8392751|NCT01043705|20685076|P3|NOT COMPLETED|Overall Study||80
8392752|NCT01043705|20685077|P2|NOT COMPLETED|Overall Study||131
8392753|NCT01043705|20685078|P1|NOT COMPLETED|Overall Study||107
8392754|NCT01043705|20685076|P3|COMPLETED|Overall Study||498
8392755|NCT01043705|20685077|P2|COMPLETED|Overall Study||447
8392756|NCT01043705|20685078|P1|COMPLETED|Overall Study||352
8392757|NCT01043705|20685076|P3|STARTED|Overall Study||578
8392758|NCT01043705|20685077|P2|STARTED|Overall Study||578
8392759|NCT01043705|20685078|P1|STARTED|Overall Study||459
8392760|NCT01043653|20685088|P1|NOT COMPLETED|Overall Study||64
8392761|NCT01043653|20685088|P1|COMPLETED|Overall Study||186
8392762|NCT01043653|20685088|P1|STARTED|Overall Study||250
8392763|NCT01043640|20685093|P1|NOT COMPLETED|Overall Study||0
8392764|NCT01043640|20685093|P1|COMPLETED|Overall Study||46
8392765|NCT01043640|20685093|P1|STARTED|Overall Study||46
8392766|NCT01043562|20685108|P1|NOT COMPLETED|Overall Study||0
8392767|NCT01043562|20685108|P1|COMPLETED|Overall Study||20
8392768|NCT01043562|20685108|P1|STARTED|Overall Study||20
8392769|NCT01043523|20685115|P1|NOT COMPLETED|Overall Study||0
8392770|NCT01043523|20685115|P1|COMPLETED|Overall Study||52
8392771|NCT01043523|20685115|P1|Participants With Unenhanced Images|Overall Study||51
8392772|NCT01043523|20685115|P1|STARTED|Overall Study||52
8392773|NCT01043432|20685144|P4|NOT COMPLETED|Overall Study||0
8392774|NCT01043432|20685145|P3|NOT COMPLETED|Overall Study||0
8392775|NCT01043432|20685146|P2|NOT COMPLETED|Overall Study||0
8392776|NCT01043432|20685147|P1|NOT COMPLETED|Overall Study||0
8392777|NCT01043432|20685144|P4|COMPLETED|Overall Study||48
8392778|NCT01043432|20685145|P3|COMPLETED|Overall Study||12
8392779|NCT01043432|20685146|P2|COMPLETED|Overall Study||51
8392780|NCT01043432|20685147|P1|COMPLETED|Overall Study||22
8392781|NCT01043432|20685144|P4|STARTED|Overall Study||48
8392782|NCT01043432|20685145|P3|STARTED|Overall Study||12
8392783|NCT01043432|20685146|P2|STARTED|Overall Study||51
8392784|NCT01043432|20685147|P1|STARTED|Overall Study||22
8392785|NCT01043393|20685156|P2|NOT COMPLETED|Overall Study||0
8392786|NCT01043393|20685157|P1|NOT COMPLETED|Overall Study||0
8392787|NCT01043393|20685156|P2|COMPLETED|Overall Study||12
8392788|NCT01043393|20685157|P1|COMPLETED|Overall Study||12
8392789|NCT01043393|20685156|P2|STARTED|Overall Study||12
8392790|NCT01043393|20685157|P1|STARTED|Overall Study||12
8392791|NCT01043185|20685167|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392792|NCT01043185|20685168|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392793|NCT01043185|20685169|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392794|NCT01043185|20685170|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392795|NCT01043185|20685171|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392796|NCT01043185|20685172|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392797|NCT01043185|20685173|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392798|NCT01043185|20685174|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392799|NCT01043185|20685175|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392800|NCT01043185|20685176|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392801|NCT01043185|20685167|P10|COMPLETED|Period 7 - Fourth Intervention||3
8392802|NCT01043185|20685168|P9|COMPLETED|Period 7 - Fourth Intervention||2
8392803|NCT01043185|20685169|P8|COMPLETED|Period 7 - Fourth Intervention||3
8392804|NCT01043185|20685170|P7|COMPLETED|Period 7 - Fourth Intervention||3
8392805|NCT01043185|20685171|P6|COMPLETED|Period 7 - Fourth Intervention||3
8392806|NCT01043185|20685172|P5|COMPLETED|Period 7 - Fourth Intervention||2
8392807|NCT01043185|20685173|P4|COMPLETED|Period 7 - Fourth Intervention||2
8392808|NCT01043185|20685174|P3|COMPLETED|Period 7 - Fourth Intervention||3
8392809|NCT01043185|20685175|P2|COMPLETED|Period 7 - Fourth Intervention||2
8392810|NCT01043185|20685176|P1|COMPLETED|Period 7 - Fourth Intervention||3
8392811|NCT01043185|20685167|P10|STARTED|Period 7 - Fourth Intervention||3
8392812|NCT01043185|20685168|P9|STARTED|Period 7 - Fourth Intervention||2
8392813|NCT01043185|20685169|P8|STARTED|Period 7 - Fourth Intervention||3
8392814|NCT01043185|20685170|P7|STARTED|Period 7 - Fourth Intervention||3
8392815|NCT01043185|20685171|P6|STARTED|Period 7 - Fourth Intervention||3
8392816|NCT01043185|20685172|P5|STARTED|Period 7 - Fourth Intervention||2
8392817|NCT01043185|20685173|P4|STARTED|Period 7 - Fourth Intervention||2
8392818|NCT01043185|20685174|P3|STARTED|Period 7 - Fourth Intervention||3
8392819|NCT01043185|20685175|P2|STARTED|Period 7 - Fourth Intervention||2
8392820|NCT01043185|20685176|P1|STARTED|Period 7 - Fourth Intervention||3
8392821|NCT01043185|20685167|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
8392822|NCT01043185|20685168|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
8392823|NCT01043185|20685169|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
8392824|NCT01043185|20685170|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
8392825|NCT01043185|20685171|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
8392826|NCT01043185|20685172|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
8392827|NCT01043185|20685173|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
8392828|NCT01043185|20685174|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
8392829|NCT01043185|20685175|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
8392830|NCT01043185|20685176|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
8392831|NCT01043185|20685167|P10|COMPLETED|Period 6 - Third Washout Period||3
8392832|NCT01043185|20685168|P9|COMPLETED|Period 6 - Third Washout Period||2
8392833|NCT01043185|20685169|P8|COMPLETED|Period 6 - Third Washout Period||3
8392834|NCT01043185|20685170|P7|COMPLETED|Period 6 - Third Washout Period||3
8392835|NCT01043185|20685171|P6|COMPLETED|Period 6 - Third Washout Period||3
8392836|NCT01043185|20685172|P5|COMPLETED|Period 6 - Third Washout Period||2
8392837|NCT01043185|20685173|P4|COMPLETED|Period 6 - Third Washout Period||2
8392838|NCT01043185|20685174|P3|COMPLETED|Period 6 - Third Washout Period||3
8392839|NCT01043185|20685175|P2|COMPLETED|Period 6 - Third Washout Period||2
8392840|NCT01043185|20685176|P1|COMPLETED|Period 6 - Third Washout Period||3
8392841|NCT01043185|20685167|P10|STARTED|Period 6 - Third Washout Period||3
8392842|NCT01043185|20685168|P9|STARTED|Period 6 - Third Washout Period||3
8392843|NCT01043185|20685169|P8|STARTED|Period 6 - Third Washout Period||3
8392844|NCT01043185|20685170|P7|STARTED|Period 6 - Third Washout Period||3
8392845|NCT01043185|20685171|P6|STARTED|Period 6 - Third Washout Period||3
8392846|NCT01043185|20685172|P5|STARTED|Period 6 - Third Washout Period||2
8392847|NCT01043185|20685173|P4|STARTED|Period 6 - Third Washout Period||2
8392848|NCT01043185|20685174|P3|STARTED|Period 6 - Third Washout Period||3
8392849|NCT01043185|20685175|P2|STARTED|Period 6 - Third Washout Period||2
8392850|NCT01043185|20685176|P1|STARTED|Period 6 - Third Washout Period||3
8392851|NCT01043185|20685167|P10|NOT COMPLETED|Period 5 - Third Intervention||0
8392852|NCT01043185|20685168|P9|NOT COMPLETED|Period 5 - Third Intervention||0
8392853|NCT01043185|20685169|P8|NOT COMPLETED|Period 5 - Third Intervention||0
8392854|NCT01043185|20685170|P7|NOT COMPLETED|Period 5 - Third Intervention||0
8392855|NCT01043185|20685171|P6|NOT COMPLETED|Period 5 - Third Intervention||0
8392856|NCT01043185|20685172|P5|NOT COMPLETED|Period 5 - Third Intervention||0
8392857|NCT01043185|20685173|P4|NOT COMPLETED|Period 5 - Third Intervention||0
8392858|NCT01043185|20685174|P3|NOT COMPLETED|Period 5 - Third Intervention||0
8392859|NCT01043185|20685175|P2|NOT COMPLETED|Period 5 - Third Intervention||0
8392860|NCT01043185|20685176|P1|NOT COMPLETED|Period 5 - Third Intervention||0
8392861|NCT01043185|20685167|P10|COMPLETED|Period 5 - Third Intervention||3
8392862|NCT01043185|20685168|P9|COMPLETED|Period 5 - Third Intervention||3
8392863|NCT01043185|20685169|P8|COMPLETED|Period 5 - Third Intervention||3
8392864|NCT01043185|20685170|P7|COMPLETED|Period 5 - Third Intervention||3
8392865|NCT01043185|20685171|P6|COMPLETED|Period 5 - Third Intervention||3
8392866|NCT01043185|20685172|P5|COMPLETED|Period 5 - Third Intervention||2
8392867|NCT01043185|20685173|P4|COMPLETED|Period 5 - Third Intervention||2
8392868|NCT01043185|20685174|P3|COMPLETED|Period 5 - Third Intervention||3
8392869|NCT01043185|20685175|P2|COMPLETED|Period 5 - Third Intervention||2
8392870|NCT01043185|20685176|P1|COMPLETED|Period 5 - Third Intervention||3
8392871|NCT01043185|20685167|P10|STARTED|Period 5 - Third Intervention||3
8392872|NCT01043185|20685168|P9|STARTED|Period 5 - Third Intervention||3
8392873|NCT01043185|20685169|P8|STARTED|Period 5 - Third Intervention||3
8392874|NCT01043185|20685170|P7|STARTED|Period 5 - Third Intervention||3
8392875|NCT01043185|20685171|P6|STARTED|Period 5 - Third Intervention||3
8392876|NCT01043185|20685172|P5|STARTED|Period 5 - Third Intervention||2
8392877|NCT01043185|20685173|P4|STARTED|Period 5 - Third Intervention||2
8392878|NCT01043185|20685174|P3|STARTED|Period 5 - Third Intervention||3
8392879|NCT01043185|20685175|P2|STARTED|Period 5 - Third Intervention||2
8392880|NCT01043185|20685176|P1|STARTED|Period 5 - Third Intervention||3
8392881|NCT01043185|20685167|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
8392882|NCT01043185|20685168|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
8392883|NCT01043185|20685169|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
8392884|NCT01043185|20685170|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
8392885|NCT01043185|20685171|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
8392886|NCT01043185|20685172|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
8392887|NCT01043185|20685173|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
8392888|NCT01043185|20685174|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
8392889|NCT01043185|20685175|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
8392890|NCT01043185|20685176|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
8392891|NCT01043185|20685167|P10|COMPLETED|Period 4 - Second Washout Period||3
8392892|NCT01043185|20685168|P9|COMPLETED|Period 4 - Second Washout Period||3
8392893|NCT01043185|20685169|P8|COMPLETED|Period 4 - Second Washout Period||3
8392894|NCT01043185|20685170|P7|COMPLETED|Period 4 - Second Washout Period||3
8392895|NCT01043185|20685171|P6|COMPLETED|Period 4 - Second Washout Period||3
8392896|NCT01043185|20685172|P5|COMPLETED|Period 4 - Second Washout Period||2
8392897|NCT01043185|20685173|P4|COMPLETED|Period 4 - Second Washout Period||2
8392898|NCT01043185|20685174|P3|COMPLETED|Period 4 - Second Washout Period||3
8392899|NCT01043185|20685175|P2|COMPLETED|Period 4 - Second Washout Period||2
8392900|NCT01043185|20685176|P1|COMPLETED|Period 4 - Second Washout Period||3
8392901|NCT01043185|20685167|P10|STARTED|Period 4 - Second Washout Period||3
8392902|NCT01043185|20685168|P9|STARTED|Period 4 - Second Washout Period||3
8392903|NCT01043185|20685169|P8|STARTED|Period 4 - Second Washout Period||3
8392904|NCT01043185|20685170|P7|STARTED|Period 4 - Second Washout Period||3
8392905|NCT01043185|20685171|P6|STARTED|Period 4 - Second Washout Period||3
8392906|NCT01043185|20685172|P5|STARTED|Period 4 - Second Washout Period||2
8392907|NCT01043185|20685173|P4|STARTED|Period 4 - Second Washout Period||2
8392908|NCT01043185|20685174|P3|STARTED|Period 4 - Second Washout Period||3
8392909|NCT01043185|20685175|P2|STARTED|Period 4 - Second Washout Period||2
8392910|NCT01043185|20685176|P1|STARTED|Period 4 - Second Washout Period||3
8392911|NCT01043185|20685167|P10|NOT COMPLETED|Period 3 - Second Intervention||0
8392912|NCT01043185|20685168|P9|NOT COMPLETED|Period 3 - Second Intervention||0
8392913|NCT01043185|20685169|P8|NOT COMPLETED|Period 3 - Second Intervention||0
8392914|NCT01043185|20685170|P7|NOT COMPLETED|Period 3 - Second Intervention||0
8392915|NCT01043185|20685171|P6|NOT COMPLETED|Period 3 - Second Intervention||0
8392916|NCT01043185|20685172|P5|NOT COMPLETED|Period 3 - Second Intervention||0
8392917|NCT01043185|20685173|P4|NOT COMPLETED|Period 3 - Second Intervention||0
8392918|NCT01043185|20685174|P3|NOT COMPLETED|Period 3 - Second Intervention||0
8392919|NCT01043185|20685175|P2|NOT COMPLETED|Period 3 - Second Intervention||0
8392920|NCT01043185|20685176|P1|NOT COMPLETED|Period 3 - Second Intervention||0
8392921|NCT01043185|20685167|P10|COMPLETED|Period 3 - Second Intervention||3
8392922|NCT01043185|20685168|P9|COMPLETED|Period 3 - Second Intervention||3
8392923|NCT01043185|20685169|P8|COMPLETED|Period 3 - Second Intervention||3
8392924|NCT01043185|20685170|P7|COMPLETED|Period 3 - Second Intervention||3
8392925|NCT01043185|20685171|P6|COMPLETED|Period 3 - Second Intervention||3
8392926|NCT01043185|20685172|P5|COMPLETED|Period 3 - Second Intervention||2
8392927|NCT01043185|20685173|P4|COMPLETED|Period 3 - Second Intervention||2
8392928|NCT01043185|20685174|P3|COMPLETED|Period 3 - Second Intervention||3
8392929|NCT01043185|20685175|P2|COMPLETED|Period 3 - Second Intervention||2
8392930|NCT01043185|20685176|P1|COMPLETED|Period 3 - Second Intervention||3
8392931|NCT01043185|20685167|P10|STARTED|Period 3 - Second Intervention||3
8392932|NCT01043185|20685168|P9|STARTED|Period 3 - Second Intervention||3
8392933|NCT01043185|20685169|P8|STARTED|Period 3 - Second Intervention||3
8392934|NCT01043185|20685170|P7|STARTED|Period 3 - Second Intervention||3
8392935|NCT01043185|20685171|P6|STARTED|Period 3 - Second Intervention||3
8392936|NCT01043185|20685172|P5|STARTED|Period 3 - Second Intervention||2
8392937|NCT01043185|20685173|P4|STARTED|Period 3 - Second Intervention||2
8392938|NCT01043185|20685174|P3|STARTED|Period 3 - Second Intervention||3
8392939|NCT01043185|20685175|P2|STARTED|Period 3 - Second Intervention||2
8392940|NCT01043185|20685176|P1|STARTED|Period 3 - Second Intervention||3
8392941|NCT01043185|20685167|P10|NOT COMPLETED|Period 2 - First Washout Period||0
8392942|NCT01043185|20685168|P9|NOT COMPLETED|Period 2 - First Washout Period||0
8392943|NCT01043185|20685169|P8|NOT COMPLETED|Period 2 - First Washout Period||0
8392944|NCT01043185|20685170|P7|NOT COMPLETED|Period 2 - First Washout Period||0
8392945|NCT01043185|20685171|P6|NOT COMPLETED|Period 2 - First Washout Period||0
8392946|NCT01043185|20685172|P5|NOT COMPLETED|Period 2 - First Washout Period||0
8392947|NCT01043185|20685173|P4|NOT COMPLETED|Period 2 - First Washout Period||0
8392948|NCT01043185|20685174|P3|NOT COMPLETED|Period 2 - First Washout Period||0
8392949|NCT01043185|20685175|P2|NOT COMPLETED|Period 2 - First Washout Period||0
8392950|NCT01043185|20685176|P1|NOT COMPLETED|Period 2 - First Washout Period||0
8392951|NCT01043185|20685167|P10|COMPLETED|Period 2 - First Washout Period||3
8392952|NCT01043185|20685168|P9|COMPLETED|Period 2 - First Washout Period||3
8392953|NCT01043185|20685169|P8|COMPLETED|Period 2 - First Washout Period||3
8392954|NCT01043185|20685170|P7|COMPLETED|Period 2 - First Washout Period||3
8392955|NCT01043185|20685171|P6|COMPLETED|Period 2 - First Washout Period||3
8392956|NCT01043185|20685172|P5|COMPLETED|Period 2 - First Washout Period||2
8392957|NCT01043185|20685173|P4|COMPLETED|Period 2 - First Washout Period||2
8392958|NCT01043185|20685174|P3|COMPLETED|Period 2 - First Washout Period||3
8392959|NCT01043185|20685175|P2|COMPLETED|Period 2 - First Washout Period||2
8392960|NCT01043185|20685176|P1|COMPLETED|Period 2 - First Washout Period||3
8392961|NCT01043185|20685167|P10|STARTED|Period 2 - First Washout Period||3
8392962|NCT01043185|20685168|P9|STARTED|Period 2 - First Washout Period||3
8392963|NCT01043185|20685169|P8|STARTED|Period 2 - First Washout Period||3
8392964|NCT01043185|20685170|P7|STARTED|Period 2 - First Washout Period||3
8392965|NCT01043185|20685171|P6|STARTED|Period 2 - First Washout Period||3
8392966|NCT01043185|20685172|P5|STARTED|Period 2 - First Washout Period||2
8392967|NCT01043185|20685173|P4|STARTED|Period 2 - First Washout Period||2
8392968|NCT01043185|20685174|P3|STARTED|Period 2 - First Washout Period||3
8392969|NCT01043185|20685175|P2|STARTED|Period 2 - First Washout Period||2
8392970|NCT01043185|20685176|P1|STARTED|Period 2 - First Washout Period||3
8392971|NCT01043185|20685167|P10|NOT COMPLETED|Period 1 - First Intervention||0
8392972|NCT01043185|20685168|P9|NOT COMPLETED|Period 1 - First Intervention||0
8392973|NCT01043185|20685169|P8|NOT COMPLETED|Period 1 - First Intervention||0
8392974|NCT01043185|20685170|P7|NOT COMPLETED|Period 1 - First Intervention||0
8392975|NCT01043185|20685171|P6|NOT COMPLETED|Period 1 - First Intervention||0
8392976|NCT01043185|20685172|P5|NOT COMPLETED|Period 1 - First Intervention||0
8392977|NCT01043185|20685173|P4|NOT COMPLETED|Period 1 - First Intervention||0
8392978|NCT01043185|20685174|P3|NOT COMPLETED|Period 1 - First Intervention||0
8392979|NCT01043185|20685175|P2|NOT COMPLETED|Period 1 - First Intervention||0
8392980|NCT01043185|20685176|P1|NOT COMPLETED|Period 1 - First Intervention||0
8392981|NCT01043185|20685167|P10|COMPLETED|Period 1 - First Intervention||3
8392982|NCT01043185|20685168|P9|COMPLETED|Period 1 - First Intervention||3
8392983|NCT01043185|20685169|P8|COMPLETED|Period 1 - First Intervention||3
8392984|NCT01043185|20685170|P7|COMPLETED|Period 1 - First Intervention||3
8392985|NCT01043185|20685171|P6|COMPLETED|Period 1 - First Intervention||3
8392986|NCT01043185|20685172|P5|COMPLETED|Period 1 - First Intervention||2
8392987|NCT01043185|20685173|P4|COMPLETED|Period 1 - First Intervention||2
8392988|NCT01043185|20685174|P3|COMPLETED|Period 1 - First Intervention||3
8392989|NCT01043185|20685175|P2|COMPLETED|Period 1 - First Intervention||2
8392990|NCT01043185|20685176|P1|COMPLETED|Period 1 - First Intervention||3
8392991|NCT01043185|20685167|P10|STARTED|Period 1 - First Intervention||3
8392992|NCT01043185|20685168|P9|STARTED|Period 1 - First Intervention||3
8392993|NCT01043185|20685169|P8|STARTED|Period 1 - First Intervention||3
8392994|NCT01043185|20685170|P7|STARTED|Period 1 - First Intervention||3
8392995|NCT01043185|20685171|P6|STARTED|Period 1 - First Intervention||3
8392996|NCT01043185|20685172|P5|STARTED|Period 1 - First Intervention||2
8392997|NCT01043185|20685173|P4|STARTED|Period 1 - First Intervention||2
8392998|NCT01043185|20685174|P3|STARTED|Period 1 - First Intervention||3
8392999|NCT01043185|20685175|P2|STARTED|Period 1 - First Intervention||2
8393000|NCT01043185|20685176|P1|STARTED|Period 1 - First Intervention||3
8393001|NCT01043146|20685209|P6|NOT COMPLETED|Overall Study||0
8393002|NCT01043146|20685210|P5|NOT COMPLETED|Overall Study||0
8393003|NCT01043146|20685211|P4|NOT COMPLETED|Overall Study||0
8393004|NCT01043146|20685212|P3|NOT COMPLETED|Overall Study||0
8393005|NCT01043146|20685213|P2|NOT COMPLETED|Overall Study||0
8393006|NCT01043146|20685214|P1|NOT COMPLETED|Overall Study||0
8393007|NCT01043146|20685209|P6|COMPLETED|Overall Study||8
8393008|NCT01043146|20685210|P5|COMPLETED|Overall Study||8
8393009|NCT01043146|20685211|P4|COMPLETED|Overall Study||8
8393010|NCT01043146|20685212|P3|COMPLETED|Overall Study||8
8393011|NCT01043146|20685213|P2|COMPLETED|Overall Study||8
8393012|NCT01043146|20685214|P1|COMPLETED|Overall Study||10
8393013|NCT01043146|20685209|P6|STARTED|Overall Study||8
8393014|NCT01043146|20685210|P5|STARTED|Overall Study||8
8393015|NCT01043146|20685211|P4|STARTED|Overall Study||8
8393016|NCT01043146|20685212|P3|STARTED|Overall Study||8
8393017|NCT01043146|20685213|P2|STARTED|Overall Study||8
8393018|NCT01043146|20685214|P1|STARTED|Overall Study||10
8393019|NCT01043133|20685230|P2|NOT COMPLETED|Overall Study||2
8393020|NCT01043133|20685231|P1|NOT COMPLETED|Overall Study||1
8393021|NCT01043133|20685230|P2|COMPLETED|Overall Study||78
8393022|NCT01043133|20685231|P1|COMPLETED|Overall Study||74
8393023|NCT01043133|20685230|P2|STARTED|Overall Study||80
8393024|NCT01043133|20685231|P1|STARTED|Overall Study||75
8393025|NCT01043094|20685241|P2|NOT COMPLETED|Overall Study||0
8393026|NCT01043094|20685242|P1|NOT COMPLETED|Overall Study||0
8393027|NCT01043094|20685241|P2|COMPLETED|Overall Study||8
8393028|NCT01043094|20685242|P1|COMPLETED|Overall Study||8
8393029|NCT01043094|20685241|P2|STARTED|Overall Study||8
8393030|NCT01043094|20685242|P1|STARTED|Overall Study||8
8393031|NCT01042977|20685252|P2|NOT COMPLETED|Overall Study||55
8393032|NCT01042977|20685253|P1|NOT COMPLETED|Overall Study||41
8393033|NCT01042977|20685252|P2|COMPLETED|Overall Study||428
8393034|NCT01042977|20685253|P1|COMPLETED|Overall Study||441
8393035|NCT01042977|20685252|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
8393036|NCT01042977|20685253|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
8393037|NCT01042938|20685273|P2|NOT COMPLETED|Overall Study||2
8393038|NCT01042938|20685274|P1|NOT COMPLETED|Overall Study||3
8393039|NCT01042938|20685273|P2|COMPLETED|Overall Study||16
8393040|NCT01042938|20685274|P1|COMPLETED|Overall Study||14
8393041|NCT01042938|20685273|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
8393042|NCT01042938|20685274|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
8393043|NCT01042795|20685286|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
8393044|NCT01042795|20685286|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
8393045|NCT01042795|20685286|P1|STARTED|Follow up - 22 Months After Drug Start||2
8393127|NCT01042366|20685424|P2|COMPLETED|Overall Study||6
8393046|NCT01042795|20685286|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
8393047|NCT01042795|20685286|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
8393048|NCT01042795|20685286|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
8393049|NCT01042678|20685293|P6|NOT COMPLETED|Overall Study||0
8393050|NCT01042678|20685294|P5|NOT COMPLETED|Overall Study||0
8393051|NCT01042678|20685295|P4|NOT COMPLETED|Overall Study||0
8393052|NCT01042678|20685296|P3|NOT COMPLETED|Overall Study||0
8393053|NCT01042678|20685297|P2|NOT COMPLETED|Overall Study||0
8393054|NCT01042678|20685298|P1|NOT COMPLETED|Overall Study||1
8393055|NCT01042678|20685293|P6|COMPLETED|Overall Study||0
8393056|NCT01042678|20685294|P5|COMPLETED|Overall Study||0
8393057|NCT01042678|20685295|P4|COMPLETED|Overall Study||0
8393058|NCT01042678|20685296|P3|COMPLETED|Overall Study||6
8393059|NCT01042678|20685297|P2|COMPLETED|Overall Study||6
8393060|NCT01042678|20685298|P1|COMPLETED|Overall Study||5
8393061|NCT01042678|20685293|P6|STARTED|Overall Study||0
8393062|NCT01042678|20685294|P5|STARTED|Overall Study||0
8393063|NCT01042678|20685295|P4|STARTED|Overall Study||0
8393064|NCT01042678|20685296|P3|STARTED|Overall Study||6
8393065|NCT01042678|20685297|P2|STARTED|Overall Study||6
8393066|NCT01042678|20685298|P1|STARTED|Overall Study||6
8393067|NCT01042613|20685323|P2|NOT COMPLETED|Overall Study||0
8393068|NCT01042613|20685324|P1|NOT COMPLETED|Overall Study||0
8393069|NCT01042613|20685323|P2|COMPLETED|Overall Study||74
8393070|NCT01042613|20685324|P1|COMPLETED|Overall Study||72
8393071|NCT01042613|20685323|P2|STARTED|Overall Study||74
8393072|NCT01042613|20685324|P1|STARTED|Overall Study||72
8393073|NCT01042600|20685336|P2|NOT COMPLETED|Overall Study||0
8393074|NCT01042600|20685337|P1|NOT COMPLETED|Overall Study||1
8393075|NCT01042600|20685336|P2|COMPLETED|Overall Study||30
8393076|NCT01042600|20685337|P1|COMPLETED|Overall Study||30
8393077|NCT01042600|20685336|P2|STARTED|Overall Study||30
8393078|NCT01042600|20685337|P1|STARTED|Overall Study||31
8393079|NCT01042535|20685357|P1|NOT COMPLETED|Overall Study||8
8393080|NCT01042535|20685357|P1|COMPLETED|Overall Study||36
8393081|NCT01042535|20685357|P1|STARTED|Overall Study||44
8393082|NCT01042509|20685365|P1|NOT COMPLETED|Overall Study||0
8393083|NCT01042509|20685365|P1|COMPLETED|Overall Study||15
8393084|NCT01042509|20685365|P1|STARTED|Overall Study||15
8393085|NCT01042496|20685372|P2|NOT COMPLETED|Overall Study||0
8393086|NCT01042496|20685373|P1|NOT COMPLETED|Overall Study||0
8393087|NCT01042496|20685372|P2|COMPLETED|Overall Study||33
8393088|NCT01042496|20685373|P1|COMPLETED|Overall Study||29
8393089|NCT01042496|20685372|P2|STARTED|Overall Study||33
8393090|NCT01042496|20685373|P1|STARTED|Overall Study||29
8393091|NCT01042392|20685391|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
8393092|NCT01042392|20685392|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
8393093|NCT01042392|20685393|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
8393094|NCT01042392|20685394|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
8393095|NCT01042392|20685391|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
8393096|NCT01042392|20685392|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
8393097|NCT01042392|20685393|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
8393098|NCT01042392|20685394|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
8393099|NCT01042392|20685391|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
8393100|NCT01042392|20685392|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
8393101|NCT01042392|20685393|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
8393102|NCT01042392|20685394|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
8393103|NCT01042392|20685391|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
8393104|NCT01042392|20685392|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
8393105|NCT01042392|20685393|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
8393106|NCT01042392|20685394|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
8393107|NCT01042392|20685391|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393108|NCT01042392|20685392|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
8393109|NCT01042392|20685393|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393110|NCT01042392|20685394|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
8393111|NCT01042392|20685391|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393112|NCT01042392|20685392|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
8393113|NCT01042392|20685393|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393114|NCT01042392|20685394|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
8393115|NCT01042392|20685391|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
8393116|NCT01042392|20685392|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
8393117|NCT01042392|20685393|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
8393118|NCT01042392|20685394|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
8393119|NCT01042392|20685391|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
8393120|NCT01042392|20685392|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
8393121|NCT01042392|20685393|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
8393122|NCT01042392|20685394|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
8393123|NCT01042366|20685423|P3|NOT COMPLETED|Overall Study||0
8393124|NCT01042366|20685424|P2|NOT COMPLETED|Overall Study||0
8393125|NCT01042366|20685425|P1|NOT COMPLETED|Overall Study||0
8393126|NCT01042366|20685423|P3|COMPLETED|Overall Study||4
8393128|NCT01042366|20685425|P1|COMPLETED|Overall Study||5
8393129|NCT01042366|20685423|P3|STARTED|Overall Study||4
8393130|NCT01042366|20685424|P2|STARTED|Overall Study||6
8393131|NCT01042366|20685425|P1|STARTED|Overall Study||5
8393132|NCT01042288|20685434|P1|NOT COMPLETED|Overall Study||69
8393133|NCT01042288|20685434|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
8393134|NCT01042288|20685434|P1|Maintenance|Overall Study||27
8393135|NCT01042288|20685434|P1|STARTED|Overall Study||69
8393136|NCT01042236|20685442|P6|NOT COMPLETED|Treatment Period 3||0
8393137|NCT01042236|20685443|P5|NOT COMPLETED|Treatment Period 3||0
8393138|NCT01042236|20685444|P4|NOT COMPLETED|Treatment Period 3||2
8393139|NCT01042236|20685445|P3|NOT COMPLETED|Treatment Period 3||0
8393140|NCT01042236|20685446|P2|NOT COMPLETED|Treatment Period 3||0
8393141|NCT01042236|20685447|P1|NOT COMPLETED|Treatment Period 3||0
8393142|NCT01042236|20685442|P6|COMPLETED|Treatment Period 3||3
8393143|NCT01042236|20685443|P5|COMPLETED|Treatment Period 3||3
8393144|NCT01042236|20685444|P4|COMPLETED|Treatment Period 3||3
8393145|NCT01042236|20685445|P3|COMPLETED|Treatment Period 3||3
8393146|NCT01042236|20685446|P2|COMPLETED|Treatment Period 3||3
8393147|NCT01042236|20685447|P1|COMPLETED|Treatment Period 3||3
8393148|NCT01042236|20685442|P6|STARTED|Treatment Period 3||3
8393149|NCT01042236|20685443|P5|STARTED|Treatment Period 3||3
8393150|NCT01042236|20685444|P4|STARTED|Treatment Period 3||5
8393151|NCT01042236|20685445|P3|STARTED|Treatment Period 3||3
8393152|NCT01042236|20685446|P2|STARTED|Treatment Period 3||3
8393153|NCT01042236|20685447|P1|STARTED|Treatment Period 3||3
8393154|NCT01042236|20685442|P6|NOT COMPLETED|Treatment Period 2||0
8393155|NCT01042236|20685443|P5|NOT COMPLETED|Treatment Period 2||0
8393156|NCT01042236|20685444|P4|NOT COMPLETED|Treatment Period 2||0
8393157|NCT01042236|20685445|P3|NOT COMPLETED|Treatment Period 2||0
8393158|NCT01042236|20685446|P2|NOT COMPLETED|Treatment Period 2||0
8393159|NCT01042236|20685447|P1|NOT COMPLETED|Treatment Period 2||0
8393160|NCT01042236|20685442|P6|COMPLETED|Treatment Period 2||3
8393161|NCT01042236|20685443|P5|COMPLETED|Treatment Period 2||3
8393162|NCT01042236|20685444|P4|COMPLETED|Treatment Period 2||5
8393163|NCT01042236|20685445|P3|COMPLETED|Treatment Period 2||3
8393164|NCT01042236|20685446|P2|COMPLETED|Treatment Period 2||3
8393165|NCT01042236|20685447|P1|COMPLETED|Treatment Period 2||3
8393166|NCT01042236|20685442|P6|STARTED|Treatment Period 2||3
8393167|NCT01042236|20685443|P5|STARTED|Treatment Period 2||3
8393168|NCT01042236|20685444|P4|STARTED|Treatment Period 2||5
8393169|NCT01042236|20685445|P3|STARTED|Treatment Period 2||3
8393170|NCT01042236|20685446|P2|STARTED|Treatment Period 2||3
8393171|NCT01042236|20685447|P1|STARTED|Treatment Period 2||3
8393172|NCT01042236|20685442|P6|NOT COMPLETED|Treatment Period 1||0
8393173|NCT01042236|20685443|P5|NOT COMPLETED|Treatment Period 1||1
8393174|NCT01042236|20685444|P4|NOT COMPLETED|Treatment Period 1||0
8393175|NCT01042236|20685445|P3|NOT COMPLETED|Treatment Period 1||0
8393176|NCT01042236|20685446|P2|NOT COMPLETED|Treatment Period 1||1
8393177|NCT01042236|20685447|P1|NOT COMPLETED|Treatment Period 1||0
8393178|NCT01042236|20685442|P6|COMPLETED|Treatment Period 1||3
8393179|NCT01042236|20685443|P5|COMPLETED|Treatment Period 1||3
8393180|NCT01042236|20685444|P4|COMPLETED|Treatment Period 1||5
8393181|NCT01042236|20685445|P3|COMPLETED|Treatment Period 1||3
8393182|NCT01042236|20685446|P2|COMPLETED|Treatment Period 1||3
8393183|NCT01042236|20685447|P1|COMPLETED|Treatment Period 1||3
8393184|NCT01042236|20685442|P6|STARTED|Treatment Period 1||3
8393185|NCT01042236|20685443|P5|STARTED|Treatment Period 1||4
8393186|NCT01042236|20685444|P4|STARTED|Treatment Period 1||5
8393187|NCT01042236|20685445|P3|STARTED|Treatment Period 1||3
8393188|NCT01042236|20685446|P2|STARTED|Treatment Period 1||4
8393189|NCT01042236|20685447|P1|STARTED|Treatment Period 1||3
8393190|NCT01042158|20685484|P1|NOT COMPLETED|Overall Study||1
8393191|NCT01042158|20685484|P1|COMPLETED|Overall Study||24
8393192|NCT01042158|20685484|P1|STARTED|Overall Study||25
8393193|NCT01042145|20685493|P2|NOT COMPLETED|Overall Study||1
8393194|NCT01042145|20685494|P1|NOT COMPLETED|Overall Study||1
8393195|NCT01042145|20685493|P2|COMPLETED|Overall Study||45
8393196|NCT01042145|20685494|P1|COMPLETED|Overall Study||40
8393197|NCT01042145|20685493|P2|STARTED|Overall Study||46
8393198|NCT01042145|20685494|P1|STARTED|Overall Study||41
8393199|NCT01042093|20685514|P4|NOT COMPLETED|Overall Study||4
8393200|NCT01042093|20685515|P3|NOT COMPLETED|Overall Study||2
8393201|NCT01042093|20685516|P2|NOT COMPLETED|Overall Study||2
8393202|NCT01042093|20685517|P1|NOT COMPLETED|Overall Study||2
8393203|NCT01042093|20685514|P4|COMPLETED|Overall Study||36
8393204|NCT01042093|20685515|P3|COMPLETED|Overall Study||38
8393205|NCT01042093|20685516|P2|COMPLETED|Overall Study||38
8393206|NCT01042093|20685517|P1|COMPLETED|Overall Study||38
8393207|NCT01042093|20685514|P4|STARTED|Overall Study||40
8393208|NCT01042093|20685515|P3|STARTED|Overall Study||40
8393209|NCT01042093|20685516|P2|STARTED|Overall Study||40
8393210|NCT01042093|20685517|P1|STARTED|Overall Study||40
8393211|NCT01041976|20685537|P2|NOT COMPLETED|Overall Study||4
8393212|NCT01041976|20685538|P1|NOT COMPLETED|Overall Study||5
8393213|NCT01041976|20685537|P2|COMPLETED|Overall Study||38
8393214|NCT01041976|20685538|P1|COMPLETED|Overall Study||37
8393215|NCT01041976|20685537|P2|18 Month Follow-up|Overall Study||38
8393216|NCT01041976|20685538|P1|18 Month Follow-up|Overall Study||37
8393217|NCT01041976|20685537|P2|12 Month Follow-up|Overall Study||38
8393218|NCT01041976|20685538|P1|12 Month Follow-up|Overall Study||37
8393219|NCT01041976|20685537|P2|6 Month Follow-up|Overall Study||41
8393220|NCT01041976|20685538|P1|6 Month Follow-up|Overall Study||39
8393221|NCT01041976|20685537|P2|STARTED|Overall Study||42
8393222|NCT01041976|20685538|P1|STARTED|Overall Study||42
8393223|NCT01041859|20685548|P3|NOT COMPLETED|Double-Blind Maintenance||45
8393224|NCT01041859|20685549|P2|NOT COMPLETED|Double-Blind Maintenance||46
8393225|NCT01041859|20685550|P1|NOT COMPLETED|Double-Blind Maintenance||0
8393226|NCT01041859|20685548|P3|COMPLETED|Double-Blind Maintenance||107
8393227|NCT01041859|20685549|P2|COMPLETED|Double-Blind Maintenance||120
8393228|NCT01041859|20685550|P1|COMPLETED|Double-Blind Maintenance||0
8393229|NCT01041859|20685548|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
8393230|NCT01041859|20685549|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
8393231|NCT01041859|20685550|P1|STARTED|Double-Blind Maintenance||0
8393232|NCT01041859|20685548|P3|NOT COMPLETED|Open-Label Titration||0
8393233|NCT01041859|20685549|P2|NOT COMPLETED|Open-Label Titration||0
8393234|NCT01041859|20685550|P1|NOT COMPLETED|Open-Label Titration||101
8393235|NCT01041859|20685548|P3|COMPLETED|Open-Label Titration||0
8393236|NCT01041859|20685549|P2|COMPLETED|Open-Label Titration||0
8393237|NCT01041859|20685550|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
8393238|NCT01041859|20685548|P3|STARTED|Open-Label Titration||0
8393239|NCT01041859|20685549|P2|STARTED|Open-Label Titration||0
8393240|NCT01041859|20685550|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
8393241|NCT01041781|20685567|P2|NOT COMPLETED|Overall Study||0
8393242|NCT01041781|20685568|P1|NOT COMPLETED|Overall Study||0
8393243|NCT01041781|20685567|P2|COMPLETED|Overall Study||158
8393244|NCT01041781|20685568|P1|COMPLETED|Overall Study||154
8393245|NCT01041781|20685567|P2|STARTED|Overall Study||158
8393246|NCT01041781|20685568|P1|STARTED|Overall Study||154
8393250|NCT01041573|20685596|P4|NOT COMPLETED|Overall Study||2
8393251|NCT01041573|20685597|P3|NOT COMPLETED|Overall Study||7
8393252|NCT01041573|20685598|P2|NOT COMPLETED|Overall Study||13
8393253|NCT01041573|20685599|P1|NOT COMPLETED|Overall Study||5
8393254|NCT01041573|20685596|P4|COMPLETED|Overall Study||62
8393255|NCT01041573|20685597|P3|COMPLETED|Overall Study||387
8393256|NCT01041573|20685598|P2|COMPLETED|Overall Study||858
8393257|NCT01041573|20685599|P1|COMPLETED|Overall Study||535
8393258|NCT01041573|20685596|P4|STARTED|Overall Study||64
8393259|NCT01041573|20685597|P3|STARTED|Overall Study||394
8393260|NCT01041573|20685598|P2|STARTED|Overall Study||871
8393261|NCT01041573|20685599|P1|STARTED|Overall Study||540
8393262|NCT01041521|20685611|P2|NOT COMPLETED|Overall Study||16
8393263|NCT01041521|20685612|P1|NOT COMPLETED|Overall Study||17
8393264|NCT01041521|20685611|P2|COMPLETED|Overall Study||40
8393265|NCT01041521|20685612|P1|COMPLETED|Overall Study||44
8393266|NCT01041521|20685611|P2|STARTED|Overall Study||56
8393267|NCT01041521|20685612|P1|STARTED|Overall Study||61
8393268|NCT01041417|20685622|P2|NOT COMPLETED|Overall Study||3
8393269|NCT01041417|20685623|P1|NOT COMPLETED|Overall Study||7
8393270|NCT01041417|20685622|P2|COMPLETED|Overall Study||76
8393271|NCT01041417|20685623|P1|COMPLETED|Overall Study||73
8393272|NCT01041417|20685622|P2|STARTED|Overall Study||79
8393273|NCT01041417|20685623|P1|STARTED|Overall Study||80
8393274|NCT01041404|20685661|P2|NOT COMPLETED|Overall Study||294
8393275|NCT01041404|20685662|P1|NOT COMPLETED|Overall Study||290
8393276|NCT01041404|20685661|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
8393277|NCT01041404|20685662|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
8393278|NCT01041404|20685661|P2|Alive in Follow-up|Overall Study||41
8393279|NCT01041404|20685662|P1|Alive in Follow-up|Overall Study||40
8393280|NCT01041404|20685661|P2|Lost to Follow-up|Overall Study||10
8393281|NCT01041404|20685662|P1|Lost to Follow-up|Overall Study||12
8393282|NCT01041404|20685661|P2|Died in Follow-up|Overall Study||200
8393283|NCT01041404|20685662|P1|Died in Follow-up|Overall Study||199
8393284|NCT01041404|20685661|P2|Entered Follow-Up|Overall Study||251
8393285|NCT01041404|20685662|P1|Entered Follow-Up|Overall Study||251
8393286|NCT01041404|20685661|P2|STARTED|Overall Study||294
8393287|NCT01041404|20685662|P1|STARTED|Overall Study||290
8393288|NCT01041287|20685703|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
8393289|NCT01041287|20685704|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
8393290|NCT01041287|20685703|P2|COMPLETED|Treatment Period 2 (3 Months)||14
8393291|NCT01041287|20685704|P1|COMPLETED|Treatment Period 2 (3 Months)||16
8393292|NCT01041287|20685703|P2|STARTED|Treatment Period 2 (3 Months)||19
8393293|NCT01041287|20685704|P1|STARTED|Treatment Period 2 (3 Months)||19
8393294|NCT01041287|20685703|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
8393295|NCT01041287|20685704|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
8393296|NCT01041287|20685703|P2|COMPLETED|Treatment Period 1 (3 Months)||19
8393297|NCT01041287|20685704|P1|COMPLETED|Treatment Period 1 (3 Months)||19
8393298|NCT01041287|20685703|P2|STARTED|Treatment Period 1 (3 Months)||19
8393299|NCT01041287|20685704|P1|STARTED|Treatment Period 1 (3 Months)||19
8393300|NCT01041274|20685716|P2|NOT COMPLETED|Overall Study||21
8393301|NCT01041274|20685717|P1|NOT COMPLETED|Overall Study||23
8393302|NCT01041274|20685716|P2|COMPLETED|Overall Study||25
8393303|NCT01041274|20685717|P1|COMPLETED|Overall Study||26
8393304|NCT01041274|20685716|P2|STARTED|Overall Study||46
8393305|NCT01041274|20685717|P1|STARTED|Overall Study||49
8393306|NCT01041209|20685733|P2|NOT COMPLETED|Overall Study||0
8393307|NCT01041209|20685734|P1|NOT COMPLETED|Overall Study||0
8393308|NCT01041209|20685733|P2|COMPLETED|Overall Study||60
8393309|NCT01041209|20685734|P1|COMPLETED|Overall Study||60
8393310|NCT01041209|20685733|P2|STARTED|Overall Study||60
8393311|NCT01041209|20685734|P1|STARTED|Overall Study||60
8393312|NCT01040871|20685744|P2|NOT COMPLETED|Overall Study||7
8393313|NCT01040871|20685745|P1|NOT COMPLETED|Overall Study||13
8393314|NCT01040871|20685744|P2|COMPLETED|Overall Study||73
8393315|NCT01040871|20685745|P1|COMPLETED|Overall Study||71
8393316|NCT01040871|20685744|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
8393317|NCT01040871|20685745|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
8393318|NCT01040858|20685765|P2|NOT COMPLETED|Overall Study||0
8393319|NCT01040858|20685766|P1|NOT COMPLETED|Overall Study||9
8393320|NCT01040858|20685765|P2|COMPLETED|Overall Study||69
8393321|NCT01040858|20685766|P1|COMPLETED|Overall Study||50
8393322|NCT01040858|20685765|P2|STARTED|Overall Study||69
8393323|NCT01040858|20685766|P1|STARTED|Overall Study||59
8393324|NCT01040845|20685796|P2|NOT COMPLETED|Overall Study||1
8393325|NCT01040845|20685797|P1|NOT COMPLETED|Overall Study||2
8393326|NCT01040845|20685796|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
8393327|NCT01040845|20685797|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
8393328|NCT01040845|20685796|P2|STARTED|Overall Study||15
8393329|NCT01040845|20685797|P1|STARTED|Overall Study||15
8393330|NCT01040832|20685812|P2|NOT COMPLETED|Overall Study||37
8393331|NCT01040832|20685813|P1|NOT COMPLETED|Overall Study||46
8393332|NCT01040832|20685812|P2|COMPLETED|Overall Study||16
8393333|NCT01040832|20685813|P1|COMPLETED|Overall Study||8
8393334|NCT01040832|20685812|P2|STARTED|Overall Study||53
8393335|NCT01040832|20685813|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
8393336|NCT01040819|20685829|P2|NOT COMPLETED|Overall Study||0
8393337|NCT01040819|20685830|P1|NOT COMPLETED|Overall Study||0
8393338|NCT01040819|20685829|P2|COMPLETED|Overall Study||12
8393339|NCT01040819|20685830|P1|COMPLETED|Overall Study||13
8393340|NCT01040819|20685829|P2|STARTED|Overall Study||12
8393341|NCT01040819|20685830|P1|STARTED|Overall Study||13
8393342|NCT01040793|20685836|P6|NOT COMPLETED|Overall Study||1
8393343|NCT01040793|20685837|P5|NOT COMPLETED|Overall Study||4
8393344|NCT01040793|20685838|P4|NOT COMPLETED|Overall Study||4
8393345|NCT01040793|20685839|P3|NOT COMPLETED|Overall Study||3
8393346|NCT01040793|20685840|P2|NOT COMPLETED|Overall Study||5
8393347|NCT01040793|20685841|P1|NOT COMPLETED|Overall Study||6
8393348|NCT01040793|20685836|P6|COMPLETED|Overall Study||26
8393349|NCT01040793|20685837|P5|COMPLETED|Overall Study||22
8393350|NCT01040793|20685838|P4|COMPLETED|Overall Study||22
8393351|NCT01040793|20685839|P3|COMPLETED|Overall Study||23
8393352|NCT01040793|20685840|P2|COMPLETED|Overall Study||21
8393353|NCT01040793|20685841|P1|COMPLETED|Overall Study||20
8393354|NCT01040793|20685836|P6|STARTED|Overall Study||27
8393355|NCT01040793|20685837|P5|STARTED|Overall Study||26
8393356|NCT01040793|20685838|P4|STARTED|Overall Study||26
8393357|NCT01040793|20685839|P3|STARTED|Overall Study||26
8393358|NCT01040793|20685840|P2|STARTED|Overall Study||26
8393359|NCT01040793|20685841|P1|STARTED|Overall Study|Entered and treated|26
8393360|NCT01040780|20685920|P2|NOT COMPLETED|Overall Study||3
8393361|NCT01040780|20685921|P1|NOT COMPLETED|Overall Study||1
8393362|NCT01040780|20685920|P2|COMPLETED|Overall Study||196
8393363|NCT01040780|20685921|P1|COMPLETED|Overall Study||199
8393364|NCT01040780|20685920|P2|STARTED|Overall Study||199
8393365|NCT01040780|20685921|P1|STARTED|Overall Study||200
8393366|NCT01040728|20685935|P4|NOT COMPLETED|Overall Study||6
8393367|NCT01040728|20685936|P3|NOT COMPLETED|Overall Study||1
8393368|NCT01040728|20685937|P2|NOT COMPLETED|Overall Study||11
8393369|NCT01040728|20685938|P1|NOT COMPLETED|Overall Study||4
8393370|NCT01040728|20685935|P4|COMPLETED|Overall Study||24
8393371|NCT01040728|20685936|P3|COMPLETED|Overall Study||30
8393372|NCT01040728|20685937|P2|COMPLETED|Overall Study||19
8393373|NCT01040728|20685938|P1|COMPLETED|Overall Study||27
8393374|NCT01040728|20685935|P4|STARTED|Overall Study||30
8393375|NCT01040728|20685936|P3|STARTED|Overall Study||31
8393376|NCT01040728|20685937|P2|STARTED|Overall Study||30
8393377|NCT01040728|20685938|P1|STARTED|Overall Study||31
8393378|NCT01040689|20686008|P4|NOT COMPLETED|Overall Study||4
8393379|NCT01040689|20686009|P3|NOT COMPLETED|Overall Study||4
8393380|NCT01040689|20686010|P2|NOT COMPLETED|Overall Study||2
8393381|NCT01040689|20686011|P1|NOT COMPLETED|Overall Study||3
8393382|NCT01040689|20686008|P4|COMPLETED|Overall Study||23
8393383|NCT01040689|20686009|P3|COMPLETED|Overall Study||23
8393384|NCT01040689|20686010|P2|COMPLETED|Overall Study||25
8393385|NCT01040689|20686011|P1|COMPLETED|Overall Study||24
8393386|NCT01040689|20686008|P4|STARTED|Overall Study||27
8393387|NCT01040689|20686009|P3|STARTED|Overall Study||27
8393388|NCT01040689|20686010|P2|STARTED|Overall Study||27
8393389|NCT01040689|20686011|P1|STARTED|Overall Study||27
8393390|NCT01040624|20686083|P2|NOT COMPLETED|Overall Study||0
8393391|NCT01040624|20686084|P1|NOT COMPLETED|Overall Study||0
8393392|NCT01040624|20686083|P2|COMPLETED|Overall Study||19
8393393|NCT01040624|20686084|P1|COMPLETED|Overall Study||58
8393394|NCT01040624|20686083|P2|STARTED|Overall Study||19
8393395|NCT01040624|20686084|P1|STARTED|Overall Study||58
8393396|NCT01040403|20686090|P1|NOT COMPLETED|Overall Study||20
8393397|NCT01040403|20686090|P1|COMPLETED|Overall Study|All treatment periods|213
8393398|NCT01040403|20686090|P1|Completed T+O 5/10|Overall Study||107
8393399|NCT01040403|20686090|P1|Completed T+O 2.5/10|Overall Study||110
8393400|NCT01040403|20686090|P1|Completed T+O 1.25/10|Overall Study||106
8393401|NCT01040403|20686090|P1|Completed Olo 10|Overall Study||109
8393402|NCT01040403|20686090|P1|Completed T+O 5/5|Overall Study||106
8393403|NCT01040403|20686090|P1|Completed T+O 2.5/5|Overall Study||111
8393404|NCT01040403|20686090|P1|Completed T+O 1.25/5|Overall Study||105
8393405|NCT01040403|20686090|P1|Completed Olo 5|Overall Study||106
8393406|NCT01040403|20686090|P1|STARTED|Overall Study||233
8393407|NCT01040351|20686278|P2|NOT COMPLETED|Overall Study||2
8393408|NCT01040351|20686279|P1|NOT COMPLETED|Overall Study||1
8393409|NCT01040351|20686278|P2|COMPLETED|Overall Study|May 2010|53
8393410|NCT01040351|20686279|P1|COMPLETED|Overall Study|May 2010|54
8393411|NCT01040351|20686278|P2|STARTED|Overall Study|October 2006|55
8393412|NCT01040351|20686279|P1|STARTED|Overall Study|October 2006|55
8393413|NCT01040260|20686289|P2|NOT COMPLETED|Overall Study||11
8393414|NCT01040260|20686290|P1|NOT COMPLETED|Overall Study||15
8393415|NCT01040260|20686289|P2|COMPLETED|Overall Study||39
8393416|NCT01040260|20686290|P1|COMPLETED|Overall Study||38
8393417|NCT01040260|20686289|P2|STARTED|Overall Study||50
8393418|NCT01040260|20686290|P1|STARTED|Overall Study||53
8393419|NCT01040208|20686299|P3|NOT COMPLETED|Overall Study||3
8393420|NCT01040208|20686300|P2|NOT COMPLETED|Overall Study||13
8393421|NCT01040208|20686301|P1|NOT COMPLETED|Overall Study||6
8393422|NCT01040208|20686299|P3|COMPLETED|Overall Study||35
8393423|NCT01040208|20686300|P2|COMPLETED|Overall Study||15
8393424|NCT01040208|20686301|P1|COMPLETED|Overall Study||39
8393425|NCT01040208|20686299|P3|STARTED|Overall Study||38
8393426|NCT01040208|20686300|P2|STARTED|Overall Study||28
8393427|NCT01040208|20686301|P1|STARTED|Overall Study||45
8393428|NCT01040169|20686317|P2|NOT COMPLETED|Overall Study||8
8393429|NCT01040169|20686318|P1|NOT COMPLETED|Overall Study||3
8393430|NCT01040169|20686317|P2|COMPLETED|Overall Study||36
8393431|NCT01040169|20686318|P1|COMPLETED|Overall Study||32
8393432|NCT01040169|20686317|P2|STARTED|Overall Study||44
8393433|NCT01040169|20686318|P1|STARTED|Overall Study||35
8393434|NCT01040130|20686326|P6|NOT COMPLETED|Overall Study||4
8393435|NCT01040130|20686327|P5|NOT COMPLETED|Overall Study||0
8393436|NCT01040130|20686328|P4|NOT COMPLETED|Overall Study||5
8393437|NCT01040130|20686329|P3|NOT COMPLETED|Overall Study||2
8393438|NCT01040130|20686330|P2|NOT COMPLETED|Overall Study||3
8393439|NCT01040130|20686331|P1|NOT COMPLETED|Overall Study||3
8393440|NCT01040130|20686326|P6|COMPLETED|Overall Study||22
8393441|NCT01040130|20686327|P5|COMPLETED|Overall Study||25
8393442|NCT01040130|20686328|P4|COMPLETED|Overall Study||20
8393443|NCT01040130|20686329|P3|COMPLETED|Overall Study||23
8393444|NCT01040130|20686330|P2|COMPLETED|Overall Study||22
8393445|NCT01040130|20686331|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
8393446|NCT01040130|20686326|P6|STARTED|Overall Study||26
8393447|NCT01040130|20686327|P5|STARTED|Overall Study||25
8393448|NCT01040130|20686328|P4|STARTED|Overall Study||25
8393449|NCT01040130|20686329|P3|STARTED|Overall Study||25
8393450|NCT01040130|20686330|P2|STARTED|Overall Study||25
8393451|NCT01040130|20686331|P1|STARTED|Overall Study|Number of patients entered and treated|25
8393452|NCT01040052|20686408|P1|NOT COMPLETED|Overall Study||0
8393453|NCT01040052|20686408|P1|COMPLETED|Overall Study||30
8393454|NCT01040052|20686408|P1|STARTED|Overall Study||30
8393455|NCT01039792|20686414|P2|NOT COMPLETED|Overall Study||1
8393456|NCT01039792|20686415|P1|NOT COMPLETED|Overall Study||6
8393457|NCT01039792|20686414|P2|COMPLETED|Overall Study||27
8393458|NCT01039792|20686415|P1|COMPLETED|Overall Study||23
8393459|NCT01039792|20686414|P2|STARTED|Overall Study||28
8393460|NCT01039792|20686415|P1|STARTED|Overall Study||29
8393461|NCT01039688|20686424|P3|NOT COMPLETED|Overall Study||80
8393462|NCT01039688|20686425|P2|NOT COMPLETED|Overall Study||111
8393463|NCT01039688|20686426|P1|NOT COMPLETED|Overall Study||107
8393464|NCT01039688|20686424|P3|COMPLETED|Overall Study||106
8393465|NCT01039688|20686425|P2|COMPLETED|Overall Study||286
8393466|NCT01039688|20686426|P1|COMPLETED|Overall Study||266
8393467|NCT01039688|20686424|P3|STARTED|Overall Study||186
8393468|NCT01039688|20686425|P2|STARTED|Overall Study||397
8393469|NCT01039688|20686426|P1|STARTED|Overall Study||373
8393470|NCT01039675|20686697|P2|NOT COMPLETED|Overall Study||7
8393471|NCT01039675|20686698|P1|NOT COMPLETED|Overall Study||0
8393472|NCT01039675|20686697|P2|COMPLETED|Overall Study||35
8393473|NCT01039675|20686698|P1|COMPLETED|Overall Study||9
8393474|NCT01039675|20686697|P2|STARTED|Overall Study||42
8393475|NCT01039675|20686698|P1|STARTED|Overall Study||9
8393476|NCT01039584|20686711|P3|NOT COMPLETED|Overall Study||57
8393477|NCT01039584|20686712|P2|NOT COMPLETED|Overall Study||97
8393478|NCT01039584|20686713|P1|NOT COMPLETED|Overall Study||103
8393479|NCT01039584|20686711|P3|COMPLETED|Overall Study||65
8393480|NCT01039584|20686712|P2|COMPLETED|Overall Study||146
8393481|NCT01039584|20686713|P1|COMPLETED|Overall Study||143
8393482|NCT01039584|20686711|P3|STARTED|Overall Study||122
8393483|NCT01039584|20686712|P2|STARTED|Overall Study||243
8393484|NCT01039584|20686713|P1|STARTED|Overall Study||246
8393485|NCT01039519|20686727|P1|NOT COMPLETED|Survival Follow-up||27
8393486|NCT01039519|20686727|P1|COMPLETED|Survival Follow-up||0
8393487|NCT01039519|20686727|P1|STARTED|Survival Follow-up||27
8393488|NCT01039519|20686727|P1|NOT COMPLETED|Treatment||27
8393489|NCT01039519|20686727|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
8393490|NCT01039519|20686727|P1|STARTED|Treatment||27
8393491|NCT01039467|20686738|P2|NOT COMPLETED|Overall Study||49
8393492|NCT01039467|20686739|P1|NOT COMPLETED|Overall Study||40
8393493|NCT01039467|20686738|P2|COMPLETED|Overall Study||140
8393494|NCT01039467|20686739|P1|COMPLETED|Overall Study||156
8393495|NCT01039467|20686738|P2|STARTED|Overall Study||189
8393496|NCT01039467|20686739|P1|STARTED|Overall Study||196
8393497|NCT01039428|20686763|P2|NOT COMPLETED|Overall Study||0
8393498|NCT01039428|20686764|P1|NOT COMPLETED|Overall Study||2
8393499|NCT01039428|20686763|P2|COMPLETED|Overall Study||28
8393500|NCT01039428|20686764|P1|COMPLETED|Overall Study||33
8393501|NCT01039428|20686763|P2|STARTED|Overall Study||28
8393502|NCT01039428|20686764|P1|STARTED|Overall Study||35
8393503|NCT01039376|20686788|P2|NOT COMPLETED|Overall Study||126
8393504|NCT01039376|20686789|P1|NOT COMPLETED|Overall Study||130
8393505|NCT01039376|20686788|P2|COMPLETED|Overall Study||114
8393506|NCT01039376|20686789|P1|COMPLETED|Overall Study||110
8393507|NCT01039376|20686788|P2|STARTED|Overall Study||240
8393508|NCT01039376|20686789|P1|STARTED|Overall Study||240
8393509|NCT01039207|20686848|P1|NOT COMPLETED|Overall Study||0
8393510|NCT01039207|20686848|P1|COMPLETED|Overall Study||31
8393511|NCT01039207|20686848|P1|STARTED|Overall Study||31
8393512|NCT01038921|20686858|P2|NOT COMPLETED|Overall Study||0
8393513|NCT01038921|20686859|P1|NOT COMPLETED|Overall Study||2
8393514|NCT01038921|20686858|P2|COMPLETED|Overall Study||20
8393515|NCT01038921|20686859|P1|COMPLETED|Overall Study|2 subjects withdrew|17
8393516|NCT01038921|20686858|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
8393517|NCT01038921|20686859|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
8393518|NCT01038869|20686865|P1|NOT COMPLETED|Overall Study||7
8393519|NCT01038869|20686865|P1|COMPLETED|Overall Study||13
8393520|NCT01038869|20686865|P1|STARTED|Overall Study||20
8393521|NCT01038856|20686873|P1|NOT COMPLETED|Overall Study||2
8393522|NCT01038856|20686873|P1|COMPLETED|Overall Study||3
8393523|NCT01038856|20686873|P1|STARTED|Overall Study||5
8393524|NCT01038752|20686882|P2|NOT COMPLETED|Overall Study||5
8393525|NCT01038752|20686883|P1|NOT COMPLETED|Overall Study||5
8393526|NCT01038752|20686882|P2|COMPLETED|Overall Study||1
8393527|NCT01038752|20686883|P1|COMPLETED|Overall Study||3
8393528|NCT01038752|20686882|P2|STARTED|Overall Study||6
8393529|NCT01038752|20686883|P1|STARTED|Overall Study||8
8393530|NCT01038713|20686906|P3|NOT COMPLETED|Overall Study||1
8393531|NCT01038713|20686907|P2|NOT COMPLETED|Overall Study||3
8393532|NCT01038713|20686908|P1|NOT COMPLETED|Overall Study||5
8393533|NCT01038713|20686906|P3|COMPLETED|Overall Study||16
8393534|NCT01038713|20686907|P2|COMPLETED|Overall Study||17
8393535|NCT01038713|20686908|P1|COMPLETED|Overall Study||21
8393536|NCT01038713|20686906|P3|STARTED|Overall Study||17
8393537|NCT01038713|20686907|P2|STARTED|Overall Study||20
8393538|NCT01038713|20686908|P1|STARTED|Overall Study||26
8393539|NCT01038687|20686931|P3|NOT COMPLETED|Overall Study||1
8393540|NCT01038687|20686932|P2|NOT COMPLETED|Overall Study||2
8393541|NCT01038687|20686933|P1|NOT COMPLETED|Overall Study||0
8393542|NCT01038687|20686931|P3|COMPLETED|Overall Study||12
8393543|NCT01038687|20686932|P2|COMPLETED|Overall Study||9
8393544|NCT01038687|20686933|P1|COMPLETED|Overall Study||12
8393545|NCT01038687|20686931|P3|STARTED|Overall Study||13
8393546|NCT01038687|20686932|P2|STARTED|Overall Study||11
8393547|NCT01038687|20686933|P1|STARTED|Overall Study||12
8393548|NCT01038635|20686974|P9|NOT COMPLETED|Overall Study||2
8393549|NCT01038635|20686975|P8|NOT COMPLETED|Overall Study||5
8393550|NCT01038635|20686976|P7|NOT COMPLETED|Overall Study||2
8393551|NCT01038635|20686977|P6|NOT COMPLETED|Overall Study||0
8393552|NCT01038635|20686978|P5|NOT COMPLETED|Overall Study||1
8393553|NCT01038635|20686979|P4|NOT COMPLETED|Overall Study||0
8393554|NCT01038635|20686980|P3|NOT COMPLETED|Overall Study||0
8393555|NCT01038635|20686981|P2|NOT COMPLETED|Overall Study||0
8393556|NCT01038635|20686982|P1|NOT COMPLETED|Overall Study||2
8393557|NCT01038635|20686974|P9|COMPLETED|Overall Study||38
8393558|NCT01038635|20686975|P8|COMPLETED|Overall Study||15
8393559|NCT01038635|20686976|P7|COMPLETED|Overall Study||5
8393560|NCT01038635|20686977|P6|COMPLETED|Overall Study||3
8393561|NCT01038635|20686978|P5|COMPLETED|Overall Study||3
8393562|NCT01038635|20686979|P4|COMPLETED|Overall Study||3
8393563|NCT01038635|20686980|P3|COMPLETED|Overall Study||3
8393564|NCT01038635|20686981|P2|COMPLETED|Overall Study||3
8393565|NCT01038635|20686982|P1|COMPLETED|Overall Study||3
8393566|NCT01038635|20686974|P9|STARTED|Overall Study||40
8393567|NCT01038635|20686975|P8|STARTED|Overall Study||20
8393568|NCT01038635|20686976|P7|STARTED|Overall Study||7
8393569|NCT01038635|20686977|P6|STARTED|Overall Study||3
8393570|NCT01038635|20686978|P5|STARTED|Overall Study||4
8393571|NCT01038635|20686979|P4|STARTED|Overall Study||3
8393572|NCT01038635|20686980|P3|STARTED|Overall Study||3
8393573|NCT01038635|20686981|P2|STARTED|Overall Study||3
8393574|NCT01038635|20686982|P1|STARTED|Overall Study||5
8393575|NCT01038609|20687008|P5|NOT COMPLETED|Overall Study||1
8393576|NCT01038609|20687009|P4|NOT COMPLETED|Overall Study||1
8393577|NCT01038609|20687010|P3|NOT COMPLETED|Overall Study||1
8393578|NCT01038609|20687011|P2|NOT COMPLETED|Overall Study||1
8393579|NCT01038609|20687012|P1|NOT COMPLETED|Overall Study||1
8393580|NCT01038609|20687008|P5|COMPLETED|Overall Study||50
8393581|NCT01038609|20687009|P4|COMPLETED|Overall Study||47
8393582|NCT01038609|20687010|P3|COMPLETED|Overall Study||48
8393583|NCT01038609|20687011|P2|COMPLETED|Overall Study||51
8393584|NCT01038609|20687012|P1|COMPLETED|Overall Study||49
8393585|NCT01038609|20687008|P5|STARTED|Overall Study||51
8393586|NCT01038609|20687009|P4|STARTED|Overall Study||48
8393587|NCT01038609|20687010|P3|STARTED|Overall Study||49
8393588|NCT01038609|20687011|P2|STARTED|Overall Study||52
8393589|NCT01038609|20687012|P1|STARTED|Overall Study||50
8393590|NCT01038557|20687057|P3|NOT COMPLETED|Overall Study||0
8393591|NCT01038557|20687058|P2|NOT COMPLETED|Overall Study||0
8393592|NCT01038557|20687059|P1|NOT COMPLETED|Overall Study||0
8393593|NCT01038557|20687057|P3|COMPLETED|Overall Study||86
8393594|NCT01038557|20687058|P2|COMPLETED|Overall Study||86
8393595|NCT01038557|20687059|P1|COMPLETED|Overall Study||82
8393596|NCT01038557|20687057|P3|STARTED|Overall Study||86
8393597|NCT01038557|20687058|P2|STARTED|Overall Study||86
8393598|NCT01038557|20687059|P1|STARTED|Overall Study||82
8393599|NCT01038336|20687097|P3|NOT COMPLETED|Overall Study||0
8393600|NCT01038336|20687098|P2|NOT COMPLETED|Overall Study||0
8393601|NCT01038336|20687099|P1|NOT COMPLETED|Overall Study||0
8393602|NCT01038336|20687097|P3|COMPLETED|Overall Study||44
8393603|NCT01038336|20687098|P2|COMPLETED|Overall Study||42
8393604|NCT01038336|20687099|P1|COMPLETED|Overall Study||43
8393605|NCT01038336|20687097|P3|STARTED|Overall Study||44
8393606|NCT01038336|20687098|P2|STARTED|Overall Study||42
8393607|NCT01038336|20687099|P1|STARTED|Overall Study||43
8393608|NCT01038323|20687131|P3|NOT COMPLETED|Overall Study||4
8393609|NCT01038323|20687132|P2|NOT COMPLETED|Overall Study||2
8393610|NCT01038323|20687133|P1|NOT COMPLETED|Overall Study||3
8393611|NCT01038323|20687131|P3|COMPLETED|Overall Study||15
8393612|NCT01038323|20687132|P2|COMPLETED|Overall Study||17
8393613|NCT01038323|20687133|P1|COMPLETED|Overall Study||17
8393614|NCT01038323|20687131|P3|STARTED|Overall Study||19
8393615|NCT01038323|20687132|P2|STARTED|Overall Study||19
8393616|NCT01038323|20687133|P1|STARTED|Overall Study||20
8393617|NCT01038128|20687147|P1|NOT COMPLETED|Overall Study||4
8393618|NCT01038128|20687147|P1|COMPLETED|Overall Study||1
8393619|NCT01038128|20687147|P1|Baseline Visit|Overall Study||3
8393620|NCT01038128|20687147|P1|STARTED|Overall Study||5
8393621|NCT01037881|20687162|P7|NOT COMPLETED|Overall Study||2
8393622|NCT01037881|20687163|P6|NOT COMPLETED|Overall Study||3
8393623|NCT01037881|20687164|P5|NOT COMPLETED|Overall Study||3
8393624|NCT01037881|20687165|P4|NOT COMPLETED|Overall Study||1
8393625|NCT01037881|20687166|P3|NOT COMPLETED|Overall Study||3
8393626|NCT01037881|20687167|P2|NOT COMPLETED|Overall Study||2
8393627|NCT01037881|20687168|P1|NOT COMPLETED|Overall Study||6
8393628|NCT01037881|20687162|P7|COMPLETED|Overall Study||23
8393629|NCT01037881|20687163|P6|COMPLETED|Overall Study||27
8393630|NCT01037881|20687164|P5|COMPLETED|Overall Study||26
8393631|NCT01037881|20687165|P4|COMPLETED|Overall Study||24
8393632|NCT01037881|20687166|P3|COMPLETED|Overall Study||22
8393633|NCT01037881|20687167|P2|COMPLETED|Overall Study||22
8393634|NCT01037881|20687168|P1|COMPLETED|Overall Study||19
8393635|NCT01037881|20687162|P7|STARTED|Overall Study||25
8393636|NCT01037881|20687163|P6|STARTED|Overall Study||30
8393637|NCT01037881|20687164|P5|STARTED|Overall Study||29
8393638|NCT01037881|20687165|P4|STARTED|Overall Study||25
8393639|NCT01037881|20687166|P3|STARTED|Overall Study||25
8393640|NCT01037881|20687167|P2|STARTED|Overall Study||24
8393641|NCT01037881|20687168|P1|STARTED|Overall Study||25
8393642|NCT01037452|20687230|P4|NOT COMPLETED|Overall Study||0
8393643|NCT01037452|20687231|P3|NOT COMPLETED|Overall Study||0
8393644|NCT01037452|20687232|P2|NOT COMPLETED|Overall Study||0
8393645|NCT01037452|20687233|P1|NOT COMPLETED|Overall Study||0
8393646|NCT01037452|20687230|P4|COMPLETED|Overall Study||30
8393647|NCT01037452|20687231|P3|COMPLETED|Overall Study||30
8393648|NCT01037452|20687232|P2|COMPLETED|Overall Study||30
8393649|NCT01037452|20687233|P1|COMPLETED|Overall Study||30
8393650|NCT01037452|20687230|P4|STARTED|Overall Study||30
8393651|NCT01037452|20687231|P3|STARTED|Overall Study||30
8393652|NCT01037452|20687232|P2|STARTED|Overall Study||30
8393653|NCT01037452|20687233|P1|STARTED|Overall Study||30
8393654|NCT01037309|20687261|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
8393655|NCT01037309|20687262|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
8393656|NCT01037309|20687263|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
8393657|NCT01037309|20687264|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
8393658|NCT01037309|20687265|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
8393659|NCT01037309|20687266|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
8393660|NCT01037309|20687267|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
8393661|NCT01037309|20687268|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
8393662|NCT01037309|20687269|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
8393663|NCT01037309|20687261|P9|COMPLETED|Intravenous Period 7 - 9||3
8393664|NCT01037309|20687262|P8|COMPLETED|Intravenous Period 7 - 9||3
8393665|NCT01037309|20687263|P7|COMPLETED|Intravenous Period 7 - 9||3
8393666|NCT01037309|20687264|P6|COMPLETED|Intravenous Period 7 - 9||0
8393667|NCT01037309|20687265|P5|COMPLETED|Intravenous Period 7 - 9||0
8393668|NCT01037309|20687266|P4|COMPLETED|Intravenous Period 7 - 9||0
8393669|NCT01037309|20687267|P3|COMPLETED|Intravenous Period 7 - 9||0
8393670|NCT01037309|20687268|P2|COMPLETED|Intravenous Period 7 - 9||0
8393671|NCT01037309|20687269|P1|COMPLETED|Intravenous Period 7 - 9||0
8393672|NCT01037309|20687261|P9|STARTED|Intravenous Period 7 - 9||3
8393673|NCT01037309|20687262|P8|STARTED|Intravenous Period 7 - 9||3
8393674|NCT01037309|20687263|P7|STARTED|Intravenous Period 7 - 9||3
8393675|NCT01037309|20687264|P6|STARTED|Intravenous Period 7 - 9||0
8393676|NCT01037309|20687265|P5|STARTED|Intravenous Period 7 - 9||0
8393677|NCT01037309|20687266|P4|STARTED|Intravenous Period 7 - 9||0
8393678|NCT01037309|20687267|P3|STARTED|Intravenous Period 7 - 9||0
8393679|NCT01037309|20687268|P2|STARTED|Intravenous Period 7 - 9||0
8393680|NCT01037309|20687269|P1|STARTED|Intravenous Period 7 - 9||0
8393681|NCT01037309|20687261|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393682|NCT01037309|20687262|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393683|NCT01037309|20687263|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393684|NCT01037309|20687264|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393685|NCT01037309|20687265|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393686|NCT01037309|20687266|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393687|NCT01037309|20687267|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393688|NCT01037309|20687268|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393689|NCT01037309|20687269|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393690|NCT01037309|20687261|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
8393691|NCT01037309|20687262|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
8393692|NCT01037309|20687263|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
8393693|NCT01037309|20687264|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393694|NCT01037309|20687265|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393695|NCT01037309|20687266|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393696|NCT01037309|20687267|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393697|NCT01037309|20687268|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393698|NCT01037309|20687269|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393699|NCT01037309|20687261|P9|STARTED|Subcutaneous Cohort 1 - 6||0
8393700|NCT01037309|20687262|P8|STARTED|Subcutaneous Cohort 1 - 6||0
8393701|NCT01037309|20687263|P7|STARTED|Subcutaneous Cohort 1 - 6||0
8393702|NCT01037309|20687264|P6|STARTED|Subcutaneous Cohort 1 - 6||3
8393703|NCT01037309|20687265|P5|STARTED|Subcutaneous Cohort 1 - 6||3
8393704|NCT01037309|20687266|P4|STARTED|Subcutaneous Cohort 1 - 6||3
8393705|NCT01037309|20687267|P3|STARTED|Subcutaneous Cohort 1 - 6||3
8393706|NCT01037309|20687268|P2|STARTED|Subcutaneous Cohort 1 - 6||3
8393707|NCT01037309|20687269|P1|STARTED|Subcutaneous Cohort 1 - 6||3
8393708|NCT01037244|20687311|P4|NOT COMPLETED|Overall Study||14
8393709|NCT01037244|20687312|P3|NOT COMPLETED|Overall Study||14
8393710|NCT01037244|20687313|P2|NOT COMPLETED|Overall Study||14
8393711|NCT01037244|20687314|P1|NOT COMPLETED|Overall Study||13
8393712|NCT01037244|20687311|P4|COMPLETED|Overall Study||140
8393713|NCT01037244|20687312|P3|COMPLETED|Overall Study||144
8393714|NCT01037244|20687313|P2|COMPLETED|Overall Study||138
8393715|NCT01037244|20687314|P1|COMPLETED|Overall Study||141
8393716|NCT01037244|20687311|P4|Safety Population|Overall Study||152
8393717|NCT01037244|20687312|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
8393718|NCT01037244|20687313|P2|Safety Population|Overall Study||150
8393719|NCT01037244|20687314|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
8393720|NCT01037244|20687311|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
8393721|NCT01037244|20687312|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
8393722|NCT01037244|20687313|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
8393723|NCT01037244|20687314|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
8393724|NCT01037244|20687311|P4|STARTED|Overall Study||154
8393725|NCT01037244|20687312|P3|STARTED|Overall Study||158
8393726|NCT01037244|20687313|P2|STARTED|Overall Study||152
8393727|NCT01037244|20687314|P1|STARTED|Overall Study||154
8393728|NCT01037218|20687376|P4|NOT COMPLETED|Overall Study||16
8393729|NCT01037218|20687377|P3|NOT COMPLETED|Overall Study||21
8393730|NCT01037218|20687378|P2|NOT COMPLETED|Overall Study||21
8393731|NCT01037218|20687379|P1|NOT COMPLETED|Overall Study||16
8393732|NCT01037218|20687376|P4|COMPLETED|Overall Study||134
8393733|NCT01037218|20687377|P3|COMPLETED|Overall Study||134
8393734|NCT01037218|20687378|P2|COMPLETED|Overall Study||128
8393735|NCT01037218|20687379|P1|COMPLETED|Overall Study||131
8393736|NCT01037218|20687376|P4|mITT Population|Overall Study||141
8393737|NCT01037218|20687377|P3|mITT Population|Overall Study||147
8393738|NCT01037218|20687378|P2|mITT Population|Overall Study||140
8393739|NCT01037218|20687379|P1|mITT Population|Overall Study||141
8393740|NCT01037218|20687376|P4|Safety Population|Overall Study||150
8393741|NCT01037218|20687377|P3|Safety Population|Overall Study||154
8393742|NCT01037218|20687378|P2|Safety Population|Overall Study||148
8393743|NCT01037218|20687379|P1|Safety Population|Overall Study||147
8393744|NCT01037218|20687376|P4|STARTED|Overall Study||150
8393745|NCT01037218|20687377|P3|STARTED|Overall Study||155
8393746|NCT01037218|20687378|P2|STARTED|Overall Study||149
8393747|NCT01037218|20687379|P1|STARTED|Overall Study||147
8393748|NCT01037192|20687439|P2|NOT COMPLETED|Overall Study||0
8393749|NCT01037192|20687440|P1|NOT COMPLETED|Overall Study||0
8393750|NCT01037192|20687439|P2|COMPLETED|Overall Study||1
8393751|NCT01037192|20687440|P1|COMPLETED|Overall Study||3
8393752|NCT01037192|20687439|P2|STARTED|Overall Study||1
8393753|NCT01037192|20687440|P1|STARTED|Overall Study||3
8393754|NCT01037127|20687450|P2|NOT COMPLETED|Overall Study||21
8393755|NCT01037127|20687451|P1|NOT COMPLETED|Overall Study||5
8393756|NCT01037127|20687450|P2|COMPLETED|Overall Study||36
8393757|NCT01037127|20687451|P1|COMPLETED|Overall Study||35
8393758|NCT01037127|20687450|P2|STARTED|Overall Study||57
8393759|NCT01037127|20687451|P1|STARTED|Overall Study||40
8393760|NCT01037114|20687483|P1|NOT COMPLETED|Year 20||1
8393761|NCT01037114|20687483|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
8393762|NCT01037114|20687483|P1|STARTED|Year 20||45
8393763|NCT01037114|20687483|P1|NOT COMPLETED|Year 19||0
8393764|NCT01037114|20687483|P1|COMPLETED|Year 19||45
8393765|NCT01037114|20687483|P1|STARTED|Year 19||45
8393766|NCT01037114|20687483|P1|NOT COMPLETED|Year 18||0
8393767|NCT01037114|20687483|P1|COMPLETED|Year 18||44
8393768|NCT01037114|20687483|P1|STARTED|Year 18||44
8393769|NCT01037114|20687483|P1|NOT COMPLETED|Year 17||0
8393770|NCT01037114|20687483|P1|COMPLETED|Year 17||48
8393771|NCT01037114|20687483|P1|STARTED|Year 17||48
8393772|NCT01037114|20687483|P1|NOT COMPLETED|Year 16||0
8393773|NCT01037114|20687483|P1|COMPLETED|Year 16||49
8393774|NCT01037114|20687483|P1|STARTED|Year 16||49
8393775|NCT01037088|20687496|P1|NOT COMPLETED|Overall Study||3
8393776|NCT01037088|20687496|P1|COMPLETED|Overall Study||36
8393777|NCT01037088|20687496|P1|Received Placebo|Overall Study||38
8393778|NCT01037088|20687496|P1|Received 1.29% THC|Overall Study||37
8393779|NCT01037088|20687496|P1|Received 3.53% THC|Overall Study||36
8393780|NCT01037088|20687496|P1|STARTED|Overall Study||39
8393781|NCT01036802|20687509|P2|NOT COMPLETED|Overall Study||0
8393782|NCT01036802|20687510|P1|NOT COMPLETED|Overall Study||0
8393783|NCT01036802|20687509|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
8393784|NCT01036802|20687510|P1|COMPLETED|Overall Study||2
8393785|NCT01036802|20687509|P2|STARTED|Overall Study||1
8393786|NCT01036802|20687510|P1|STARTED|Overall Study||2
8393787|NCT01036763|20687528|P1|NOT COMPLETED|Overall Study||93
8393788|NCT01036763|20687528|P1|COMPLETED|Overall Study||1171
8393789|NCT01036763|20687528|P1|STARTED|Overall Study||1264
8393790|NCT01036724|20687540|P2|NOT COMPLETED|Overall Study||8
8393791|NCT01036724|20687541|P1|NOT COMPLETED|Overall Study||6
8393792|NCT01036724|20687540|P2|COMPLETED|Overall Study||47
8393793|NCT01036724|20687541|P1|COMPLETED|Overall Study||46
8393794|NCT01036724|20687540|P2|STARTED|Overall Study||55
8393795|NCT01036724|20687541|P1|STARTED|Overall Study||52
8393796|NCT01036594|20687549|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
8393797|NCT01036594|20687550|P1|NOT COMPLETED|Treatment Regiments Post Week 12||2
8393798|NCT01036594|20687549|P2|COMPLETED|Treatment Regiments Post Week 12||5
8393799|NCT01036594|20687550|P1|COMPLETED|Treatment Regiments Post Week 12||13
8393800|NCT01036594|20687549|P2|STARTED|Treatment Regiments Post Week 12||9
8393801|NCT01036594|20687550|P1|STARTED|Treatment Regiments Post Week 12||15
8393802|NCT01036594|20687549|P2|NOT COMPLETED|Week 12 Evaluation||0
8393803|NCT01036594|20687550|P1|NOT COMPLETED|Week 12 Evaluation||6
8393804|NCT01036594|20687549|P2|COMPLETED|Week 12 Evaluation||0
8393805|NCT01036594|20687550|P1|COMPLETED|Week 12 Evaluation||24
8393806|NCT01036594|20687549|P2|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8393807|NCT01036594|20687550|P1|STARTED|Week 12 Evaluation||30
8393808|NCT01036594|20687549|P2|NOT COMPLETED|First Treatment Regimen||0
8393809|NCT01036594|20687550|P1|NOT COMPLETED|First Treatment Regimen||1
8393810|NCT01036594|20687549|P2|COMPLETED|First Treatment Regimen||0
8393811|NCT01036594|20687550|P1|COMPLETED|First Treatment Regimen||30
8393812|NCT01036594|20687549|P2|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8393813|NCT01036594|20687550|P1|STARTED|First Treatment Regimen||31
8393814|NCT01036594|20687549|P2|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
8393815|NCT01036594|20687550|P1|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
8393816|NCT01036594|20687549|P2|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
8393817|NCT01036594|20687550|P1|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
8393818|NCT01036594|20687549|P2|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8393819|NCT01036594|20687550|P1|STARTED|Run-In: Ketoconazole Only (200 mg)||32
8393820|NCT01036529|20687574|P2|NOT COMPLETED|Overall Study||15
8393821|NCT01036529|20687575|P1|NOT COMPLETED|Overall Study||13
8393822|NCT01036529|20687574|P2|COMPLETED|Overall Study||0
8393823|NCT01036529|20687575|P1|COMPLETED|Overall Study||0
8393824|NCT01036529|20687574|P2|Crossover to Other Group|Overall Study||1
8393825|NCT01036529|20687575|P1|Crossover to Other Group|Overall Study||1
8393826|NCT01036529|20687574|P2|Requested Crossover|Overall Study||2
8393827|NCT01036529|20687575|P1|Requested Crossover|Overall Study||1
8393828|NCT01036529|20687574|P2|12 Month Follow-up|Overall Study||3
8393829|NCT01036529|20687575|P1|12 Month Follow-up|Overall Study||4
8393830|NCT01036529|20687574|P2|6 Month Follow-up|Overall Study||7
8393831|NCT01036529|20687575|P1|6 Month Follow-up|Overall Study||6
8393832|NCT01036529|20687574|P2|3 Month Follow-up|Overall Study||9
8393833|NCT01036529|20687575|P1|3 Month Follow-up|Overall Study||7
8393834|NCT01036529|20687574|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
8393835|NCT01036529|20687575|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
8393836|NCT01036529|20687574|P2|Baseline Visit|Overall Study||13
8393837|NCT01036529|20687575|P1|Baseline Visit|Overall Study||10
8393838|NCT01036529|20687574|P2|STARTED|Overall Study||15
8393839|NCT01036529|20687575|P1|STARTED|Overall Study||13
8393840|NCT01036490|20687583|P2|NOT COMPLETED|Overall Study||0
8393841|NCT01036490|20687584|P1|NOT COMPLETED|Overall Study||4
8393842|NCT01036490|20687583|P2|COMPLETED|Overall Study||18
8393843|NCT01036490|20687584|P1|COMPLETED|Overall Study||14
8393844|NCT01036490|20687583|P2|STARTED|Overall Study||18
8393845|NCT01036490|20687584|P1|STARTED|Overall Study||18
8393846|NCT01036438|20687602|P2|NOT COMPLETED|Overall Study||10
8393847|NCT01036438|20687603|P1|NOT COMPLETED|Overall Study||10
8393848|NCT01036438|20687602|P2|COMPLETED|Overall Study||90
8393849|NCT01036438|20687603|P1|COMPLETED|Overall Study||91
8393850|NCT01036438|20687602|P2|STARTED|Overall Study||100
8393851|NCT01036438|20687603|P1|STARTED|Overall Study||101
8393852|NCT01036321|20687611|P2|NOT COMPLETED|Overall Study||4
8393853|NCT01036321|20687612|P1|NOT COMPLETED|Overall Study||5
8393854|NCT01036321|20687611|P2|COMPLETED|Overall Study||31
8393855|NCT01036321|20687612|P1|COMPLETED|Overall Study||31
8393856|NCT01036321|20687611|P2|STARTED|Overall Study||35
8393857|NCT01036321|20687612|P1|STARTED|Overall Study||36
8393858|NCT01036165|20687636|P1|NOT COMPLETED|Overall Study||15
8393859|NCT01036165|20687636|P1|COMPLETED|Overall Study||88
8393860|NCT01036165|20687636|P1|STARTED|Overall Study||103
8393861|NCT01036022|20687647|P6|NOT COMPLETED|Overall Study||3
8393862|NCT01036022|20687648|P5|NOT COMPLETED|Overall Study||3
8393863|NCT01036022|20687649|P4|NOT COMPLETED|Overall Study||2
8393864|NCT01036022|20687650|P3|NOT COMPLETED|Overall Study||4
8393865|NCT01036022|20687651|P2|NOT COMPLETED|Overall Study||4
8393866|NCT01036022|20687652|P1|NOT COMPLETED|Overall Study||2
8393867|NCT01036022|20687647|P6|COMPLETED|Overall Study||13
8393868|NCT01036022|20687648|P5|COMPLETED|Overall Study||9
8393869|NCT01036022|20687649|P4|COMPLETED|Overall Study||10
8393870|NCT01036022|20687650|P3|COMPLETED|Overall Study||8
8393871|NCT01036022|20687651|P2|COMPLETED|Overall Study||7
8393872|NCT01036022|20687652|P1|COMPLETED|Overall Study||13
8393873|NCT01036022|20687647|P6|STARTED|Overall Study||16
8393874|NCT01036022|20687648|P5|STARTED|Overall Study||12
8393875|NCT01036022|20687649|P4|STARTED|Overall Study||12
8393876|NCT01036022|20687650|P3|STARTED|Overall Study||12
8393877|NCT01036022|20687651|P2|STARTED|Overall Study||11
8393878|NCT01036022|20687652|P1|STARTED|Overall Study||15
8393879|NCT01036009|20687754|P2|NOT COMPLETED|Overall Study||0
8393880|NCT01036009|20687755|P1|NOT COMPLETED|Overall Study||0
8393881|NCT01036009|20687754|P2|COMPLETED|Overall Study||26
8393882|NCT01036009|20687755|P1|COMPLETED|Overall Study||17
8393883|NCT01036009|20687754|P2|STARTED|Overall Study||26
8393884|NCT01036009|20687755|P1|STARTED|Overall Study||17
8393885|NCT01035944|20687773|P4|NOT COMPLETED|Overall Study||0
8393886|NCT01035944|20687774|P3|NOT COMPLETED|Overall Study||1
8393887|NCT01035944|20687775|P2|NOT COMPLETED|Overall Study||1
8393888|NCT01035944|20687776|P1|NOT COMPLETED|Overall Study||3
8393889|NCT01035944|20687773|P4|COMPLETED|Overall Study||4
8393890|NCT01035944|20687774|P3|COMPLETED|Overall Study||4
8393891|NCT01035944|20687775|P2|COMPLETED|Overall Study||13
8393892|NCT01035944|20687776|P1|COMPLETED|Overall Study||11
8393893|NCT01035944|20687773|P4|STARTED|Overall Study||4
8393894|NCT01035944|20687774|P3|STARTED|Overall Study||5
8393895|NCT01035944|20687775|P2|STARTED|Overall Study||14
8393896|NCT01035944|20687776|P1|STARTED|Overall Study||14
8393897|NCT01035905|20687788|P2|NOT COMPLETED|Overall Study||1
8393898|NCT01035905|20687789|P1|NOT COMPLETED|Overall Study||1
8393899|NCT01035905|20687788|P2|COMPLETED|Overall Study||30
8393900|NCT01035905|20687789|P1|COMPLETED|Overall Study||31
8393901|NCT01035905|20687788|P2|STARTED|Overall Study||31
8393902|NCT01035905|20687789|P1|STARTED|Overall Study||32
8393903|NCT01035788|20687797|P2|NOT COMPLETED|Overall Study||14
8393904|NCT01035788|20687798|P1|NOT COMPLETED|Overall Study||6
8393905|NCT01035788|20687797|P2|COMPLETED|Overall Study||9
8393906|NCT01035788|20687798|P1|COMPLETED|Overall Study||17
8393907|NCT01035788|20687797|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
8393908|NCT01035788|20687798|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
8393909|NCT01035749|20687808|P4|NOT COMPLETED|Overall Study||0
8393910|NCT01035749|20687809|P3|NOT COMPLETED|Overall Study||0
8393911|NCT01035749|20687810|P2|NOT COMPLETED|Overall Study||0
8393912|NCT01035749|20687811|P1|NOT COMPLETED|Overall Study||0
8393913|NCT01035749|20687808|P4|COMPLETED|Overall Study||110
8393914|NCT01035749|20687809|P3|COMPLETED|Overall Study||68
8393915|NCT01035749|20687810|P2|COMPLETED|Overall Study||66
8393916|NCT01035749|20687811|P1|COMPLETED|Overall Study||66
8393917|NCT01035749|20687808|P4|STARTED|Overall Study||110
8393918|NCT01035749|20687809|P3|STARTED|Overall Study||68
8393919|NCT01035749|20687810|P2|STARTED|Overall Study||66
8393920|NCT01035749|20687811|P1|STARTED|Overall Study||66
8393921|NCT01035658|20687933|P4|NOT COMPLETED|Overall Study||0
8393922|NCT01035658|20687934|P3|NOT COMPLETED|Overall Study||0
8393923|NCT01035658|20687935|P2|NOT COMPLETED|Overall Study||0
8393924|NCT01035658|20687936|P1|NOT COMPLETED|Overall Study||0
8393925|NCT01035658|20687933|P4|COMPLETED|Overall Study||6
8393926|NCT01035658|20687934|P3|COMPLETED|Overall Study||3
8393927|NCT01035658|20687935|P2|COMPLETED|Overall Study||8
8393928|NCT01035658|20687936|P1|COMPLETED|Overall Study||5
8393929|NCT01035658|20687933|P4|STARTED|Overall Study||6
8393930|NCT01035658|20687934|P3|STARTED|Overall Study||3
8393931|NCT01035658|20687935|P2|STARTED|Overall Study||8
8393932|NCT01035658|20687936|P1|STARTED|Overall Study||5
8393933|NCT01035606|20687962|P3|NOT COMPLETED|Overall Study||4
8393934|NCT01035606|20687963|P2|NOT COMPLETED|Overall Study||3
8393935|NCT01035606|20687964|P1|NOT COMPLETED|Overall Study||3
8393936|NCT01035606|20687962|P3|COMPLETED|Overall Study||7
8393937|NCT01035606|20687963|P2|COMPLETED|Overall Study||16
8393938|NCT01035606|20687964|P1|COMPLETED|Overall Study||16
8393939|NCT01035606|20687962|P3|STARTED|Overall Study||11
8393940|NCT01035606|20687963|P2|STARTED|Overall Study||19
8393941|NCT01035606|20687964|P1|STARTED|Overall Study||19
8393942|NCT01035463|20687980|P6|NOT COMPLETED|Overall Study||18
8393943|NCT01035463|20687981|P5|NOT COMPLETED|Overall Study||6
8393944|NCT01035463|20687982|P4|NOT COMPLETED|Overall Study||2
8393945|NCT01035463|20687983|P3|NOT COMPLETED|Overall Study||5
8393946|NCT01035463|20687984|P2|NOT COMPLETED|Overall Study||2
8393947|NCT01035463|20687985|P1|NOT COMPLETED|Overall Study||0
8393948|NCT01035463|20687980|P6|COMPLETED|Overall Study||15
8393949|NCT01035463|20687981|P5|COMPLETED|Overall Study||1
8393950|NCT01035463|20687982|P4|COMPLETED|Overall Study||2
8393951|NCT01035463|20687983|P3|COMPLETED|Overall Study||1
8393952|NCT01035463|20687984|P2|COMPLETED|Overall Study||1
8393953|NCT01035463|20687985|P1|COMPLETED|Overall Study||6
8393954|NCT01035463|20687980|P6|STARTED|Overall Study||33
8393955|NCT01035463|20687981|P5|STARTED|Overall Study||7
8393956|NCT01035463|20687982|P4|STARTED|Overall Study||4
8393957|NCT01035463|20687983|P3|STARTED|Overall Study||6
8393958|NCT01035463|20687984|P2|STARTED|Overall Study||3
8393959|NCT01035463|20687985|P1|STARTED|Overall Study||6
8393960|NCT01035346|20687996|P2|NOT COMPLETED|Overall Study||0
8393961|NCT01035346|20687997|P1|NOT COMPLETED|Overall Study||0
8393962|NCT01035346|20687996|P2|COMPLETED|Overall Study||9
8393963|NCT01035346|20687997|P1|COMPLETED|Overall Study||7
8393964|NCT01035346|20687996|P2|STARTED|Overall Study||9
8393965|NCT01035346|20687997|P1|STARTED|Overall Study||7
8393966|NCT01035333|20688015|P1|NOT COMPLETED|Overall Study||10
8393967|NCT01035333|20688015|P1|COMPLETED|Overall Study||9
8393968|NCT01035333|20688015|P1|STARTED|Overall Study||19
8393969|NCT01035255|20688022|P2|NOT COMPLETED|Overall Study||862
8393970|NCT01035255|20688023|P1|NOT COMPLETED|Overall Study||741
8393971|NCT01035255|20688022|P2|COMPLETED|Overall Study||3371
8393972|NCT01035255|20688023|P1|COMPLETED|Overall Study||3468
8393973|NCT01035255|20688022|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
8393974|NCT01035255|20688023|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
8393975|NCT01035255|20688022|P2|Mis-randomized|Overall Study||2
8393976|NCT01035255|20688023|P1|Mis-randomized|Overall Study||4
8393977|NCT01035255|20688022|P2|GCP Violations|Overall Study||19
8393978|NCT01035255|20688023|P1|GCP Violations|Overall Study||18
8393979|NCT01035255|20688022|P2|STARTED|Overall Study||4233
8393980|NCT01035255|20688023|P1|STARTED|Overall Study||4209
8393981|NCT01035229|20688041|P2|NOT COMPLETED|Overall Study||184
8393982|NCT01035229|20688042|P1|NOT COMPLETED|Overall Study||362
8393983|NCT01035229|20688041|P2|COMPLETED|Overall Study||0
8393984|NCT01035229|20688042|P1|COMPLETED|Overall Study||0
8393985|NCT01035229|20688041|P2|STARTED|Overall Study||184
8393986|NCT01035229|20688042|P1|STARTED|Overall Study||362
8393987|NCT01035151|20688062|P2|NOT COMPLETED|Overall Study||15
8393988|NCT01035151|20688063|P1|NOT COMPLETED|Overall Study||21
8393989|NCT01035151|20688062|P2|COMPLETED|Overall Study||185
8393990|NCT01035151|20688063|P1|COMPLETED|Overall Study||188
8393991|NCT01035151|20688062|P2|STARTED|Overall Study||200
8393992|NCT01035151|20688063|P1|STARTED|Overall Study||209
8393993|NCT01035138|20688072|P3|NOT COMPLETED|Overall Study||47
8393994|NCT01035138|20688073|P2|NOT COMPLETED|Overall Study||60
8393995|NCT01035138|20688074|P1|NOT COMPLETED|Overall Study||73
8393996|NCT01035138|20688072|P3|COMPLETED|Overall Study||0
8393997|NCT01035138|20688073|P2|COMPLETED|Overall Study||0
8393998|NCT01035138|20688074|P1|COMPLETED|Overall Study||0
8393999|NCT01035138|20688072|P3|STARTED|Overall Study||47
8394000|NCT01035138|20688073|P2|STARTED|Overall Study||60
8394001|NCT01035138|20688074|P1|STARTED|Overall Study||73
8394002|NCT01035099|20688130|P2|NOT COMPLETED|Overall Study||0
8394003|NCT01035099|20688131|P1|NOT COMPLETED|Overall Study||0
8394004|NCT01035099|20688130|P2|COMPLETED|Overall Study||22
8394005|NCT01035099|20688131|P1|COMPLETED|Overall Study||18
8394006|NCT01035099|20688130|P2|STARTED|Overall Study||22
8394007|NCT01035099|20688131|P1|STARTED|Overall Study||18
8394008|NCT01035073|20688167|P1|NOT COMPLETED|Overall Study||0
8394009|NCT01035073|20688167|P1|COMPLETED|Overall Study||0
8394010|NCT01035073|20688167|P1|STARTED|Overall Study||0
8394011|NCT01035060|20688174|P2|NOT COMPLETED|Overall Study||14
8394012|NCT01035060|20688175|P1|NOT COMPLETED|Overall Study||24
8394013|NCT01035060|20688174|P2|COMPLETED|Overall Study||15
8394014|NCT01035060|20688175|P1|COMPLETED|Overall Study||15
8394015|NCT01035060|20688174|P2|STARTED|Overall Study||29
8394016|NCT01035060|20688175|P1|STARTED|Overall Study||39
8394017|NCT01035047|20688183|P2|NOT COMPLETED|Overall Study||0
8394018|NCT01035047|20688184|P1|NOT COMPLETED|Overall Study||0
8394019|NCT01035047|20688183|P2|COMPLETED|Overall Study||53
8394020|NCT01035047|20688184|P1|COMPLETED|Overall Study||52
8394021|NCT01035047|20688183|P2|STARTED|Overall Study||53
8394022|NCT01035047|20688184|P1|STARTED|Overall Study||52
8394023|NCT01034709|20688200|P2|NOT COMPLETED|Overall Study||16
8394024|NCT01034709|20688201|P1|NOT COMPLETED|Overall Study||9
8394025|NCT01034709|20688200|P2|COMPLETED|Overall Study||42
8394026|NCT01034709|20688201|P1|COMPLETED|Overall Study||44
8394027|NCT01034709|20688200|P2|STARTED|Overall Study||58
8394028|NCT01034709|20688201|P1|STARTED|Overall Study||53
8394029|NCT01034657|20688207|P3|NOT COMPLETED|Randomized Phase||1
8394030|NCT01034657|20688208|P2|NOT COMPLETED|Randomized Phase||6
8394031|NCT01034657|20688209|P1|NOT COMPLETED|Randomized Phase||5
8394032|NCT01034657|20688207|P3|COMPLETED|Randomized Phase||0
8394033|NCT01034657|20688208|P2|COMPLETED|Randomized Phase||0
8394034|NCT01034657|20688209|P1|COMPLETED|Randomized Phase||1
8394035|NCT01034657|20688207|P3|STARTED|Randomized Phase||1
8394036|NCT01034657|20688208|P2|STARTED|Randomized Phase||6
8394037|NCT01034657|20688209|P1|STARTED|Randomized Phase||6
8394038|NCT01034657|20688207|P3|NOT COMPLETED|Core Phase||0
8394039|NCT01034657|20688208|P2|NOT COMPLETED|Core Phase||0
8394040|NCT01034657|20688209|P1|NOT COMPLETED|Core Phase||14
8394041|NCT01034657|20688207|P3|COMPLETED|Core Phase||0
8394042|NCT01034657|20688208|P2|COMPLETED|Core Phase||0
8394043|NCT01034657|20688209|P1|COMPLETED|Core Phase||20
8394044|NCT01034657|20688207|P3|STARTED|Core Phase||0
8394045|NCT01034657|20688208|P2|STARTED|Core Phase||0
8394046|NCT01034657|20688209|P1|STARTED|Core Phase||34
8394047|NCT01034631|20688250|P3|NOT COMPLETED|Phase II||2
8394048|NCT01034631|20688251|P2|NOT COMPLETED|Phase II||1
8394049|NCT01034631|20688252|P1|NOT COMPLETED|Phase II||0
8394050|NCT01034631|20688250|P3|COMPLETED|Phase II||67
8394051|NCT01034631|20688251|P2|COMPLETED|Phase II||69
8394052|NCT01034631|20688252|P1|COMPLETED|Phase II||0
8394053|NCT01034631|20688250|P3|STARTED|Phase II||69
8394054|NCT01034631|20688251|P2|STARTED|Phase II||70
8394055|NCT01034631|20688252|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
8394056|NCT01034631|20688250|P3|NOT COMPLETED|Phase I||0
8394057|NCT01034631|20688251|P2|NOT COMPLETED|Phase I||0
8394058|NCT01034631|20688252|P1|NOT COMPLETED|Phase I||3
8394059|NCT01034631|20688250|P3|COMPLETED|Phase I||0
8394060|NCT01034631|20688251|P2|COMPLETED|Phase I||0
8394061|NCT01034631|20688252|P1|COMPLETED|Phase I||12
8394062|NCT01034631|20688250|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
8394063|NCT01034631|20688251|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
8394064|NCT01034631|20688252|P1|STARTED|Phase I||15
8394065|NCT01034592|20688271|P1|NOT COMPLETED|Overall Study||0
8394066|NCT01034592|20688271|P1|COMPLETED|Overall Study||2
8394067|NCT01034592|20688271|P1|STARTED|Overall Study||2
8394068|NCT01034579|20688283|P2|NOT COMPLETED|Overall Study||0
8394069|NCT01034579|20688284|P1|NOT COMPLETED|Overall Study||0
8394070|NCT01034579|20688283|P2|COMPLETED|Overall Study||166
8394071|NCT01034579|20688284|P1|COMPLETED|Overall Study||158
8394072|NCT01034579|20688283|P2|STARTED|Overall Study||166
8394073|NCT01034579|20688284|P1|STARTED|Overall Study||158
8394074|NCT01034553|20688298|P6|NOT COMPLETED|Overall Study||0
8394075|NCT01034553|20688299|P5|NOT COMPLETED|Overall Study||0
8394076|NCT01034553|20688300|P4|NOT COMPLETED|Overall Study||0
8394077|NCT01034553|20688301|P3|NOT COMPLETED|Overall Study||0
8394078|NCT01034553|20688302|P2|NOT COMPLETED|Overall Study||0
8394079|NCT01034553|20688303|P1|NOT COMPLETED|Overall Study||0
8394080|NCT01034553|20688298|P6|COMPLETED|Overall Study||7
8394081|NCT01034553|20688299|P5|COMPLETED|Overall Study||6
8394082|NCT01034553|20688300|P4|COMPLETED|Overall Study||3
8394083|NCT01034553|20688301|P3|COMPLETED|Overall Study||3
8394084|NCT01034553|20688302|P2|COMPLETED|Overall Study||4
8394085|NCT01034553|20688303|P1|COMPLETED|Overall Study||3
8394086|NCT01034553|20688298|P6|STARTED|Overall Study||7
8394087|NCT01034553|20688299|P5|STARTED|Overall Study||6
8394088|NCT01034553|20688300|P4|STARTED|Overall Study||3
8394089|NCT01034553|20688301|P3|STARTED|Overall Study||3
8394090|NCT01034553|20688302|P2|STARTED|Overall Study||4
8394091|NCT01034553|20688303|P1|STARTED|Overall Study||3
8394092|NCT01034540|20688319|P2|NOT COMPLETED|Overall Study||1
8394093|NCT01034540|20688320|P1|NOT COMPLETED|Overall Study||0
8394094|NCT01034540|20688319|P2|COMPLETED|Overall Study||11
8394095|NCT01034540|20688320|P1|COMPLETED|Overall Study||11
8394096|NCT01034540|20688319|P2|Completed 1st Treatment Intervention|Overall Study||11
8394097|NCT01034540|20688320|P1|Completed 1st Treatment Intervention|Overall Study||11
8394098|NCT01034540|20688319|P2|STARTED|Overall Study||12
8394099|NCT01034540|20688320|P1|STARTED|Overall Study||11
8394100|NCT01034527|20688330|P2|NOT COMPLETED|Overall Study||0
8394101|NCT01034527|20688331|P1|NOT COMPLETED|Overall Study||0
8394102|NCT01034527|20688330|P2|COMPLETED|Overall Study||216
8394103|NCT01034527|20688331|P1|COMPLETED|Overall Study||307
8394104|NCT01034527|20688330|P2|STARTED|Overall Study||216
8394105|NCT01034527|20688331|P1|STARTED|Overall Study||307
8394106|NCT01034462|20688339|P2|NOT COMPLETED|Overall Study||54
8394107|NCT01034462|20688340|P1|NOT COMPLETED|Overall Study||45
8394108|NCT01034462|20688339|P2|COMPLETED|Overall Study||163
8394109|NCT01034462|20688340|P1|COMPLETED|Overall Study||172
8394110|NCT01034462|20688339|P2|STARTED|Overall Study||217
8394111|NCT01034462|20688340|P1|STARTED|Overall Study||217
8394112|NCT01034397|20688350|P2|NOT COMPLETED|Overall Study||2
8394113|NCT01034397|20688351|P1|NOT COMPLETED|Overall Study||7
8394114|NCT01034397|20688350|P2|COMPLETED|Overall Study||17
8394115|NCT01034397|20688351|P1|COMPLETED|Overall Study||28
8394116|NCT01034397|20688350|P2|STARTED|Overall Study||19
8394117|NCT01034397|20688351|P1|STARTED|Overall Study||35
8394118|NCT01034358|20688500|P1|NOT COMPLETED|Overall Study||2
8394119|NCT01034358|20688500|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
8394120|NCT01034358|20688500|P1|STARTED|Overall Study||15
8394121|NCT01034306|20688506|P2|NOT COMPLETED|Overall Study||3
8394122|NCT01034306|20688507|P1|NOT COMPLETED|Overall Study||5
8394123|NCT01034306|20688506|P2|COMPLETED|Overall Study||34
8394124|NCT01034306|20688507|P1|COMPLETED|Overall Study||37
8394125|NCT01034306|20688506|P2|STARTED|Overall Study||37
8394126|NCT01034306|20688507|P1|STARTED|Overall Study||42
8394127|NCT01034176|20688515|P2|NOT COMPLETED|Overall Study||2
8394128|NCT01034176|20688516|P1|NOT COMPLETED|Overall Study||2
8394129|NCT01034176|20688515|P2|COMPLETED|Overall Study||19
8394130|NCT01034176|20688516|P1|COMPLETED|Overall Study||20
8394131|NCT01034176|20688515|P2|STARTED|Overall Study||21
8394132|NCT01034176|20688516|P1|STARTED|Overall Study||22
8394133|NCT01034163|20688526|P2|NOT COMPLETED|Overall Study||14
8394134|NCT01034163|20688527|P1|NOT COMPLETED|Overall Study||27
8394135|NCT01034163|20688526|P2|COMPLETED|Overall Study||0
8394136|NCT01034163|20688527|P1|COMPLETED|Overall Study||0
8394137|NCT01034163|20688526|P2|In Open Label Phase After Unblinding|Overall Study||0
8394138|NCT01034163|20688527|P1|In Open Label Phase After Unblinding|Overall Study||5
8394139|NCT01034163|20688526|P2|Safety Set|Overall Study||12
8394140|NCT01034163|20688527|P1|Safety Set|Overall Study||26
8394141|NCT01034163|20688526|P2|Untreated (Not in Safety Set)|Overall Study||2
8394142|NCT01034163|20688527|P1|Untreated (Not in Safety Set)|Overall Study||1
8394143|NCT01034163|20688526|P2|STARTED|Overall Study||14
8394144|NCT01034163|20688527|P1|STARTED|Overall Study||27
8394145|NCT01034137|20688536|P3|NOT COMPLETED|Overall Study||30
8394146|NCT01034137|20688537|P2|NOT COMPLETED|Overall Study||22
8394147|NCT01034137|20688538|P1|NOT COMPLETED|Overall Study||28
8394148|NCT01034137|20688536|P3|COMPLETED|Overall Study||78
8394149|NCT01034137|20688537|P2|COMPLETED|Overall Study||81
8394150|NCT01034137|20688538|P1|COMPLETED|Overall Study||78
8394151|NCT01034137|20688536|P3|STARTED|Overall Study||108
8394152|NCT01034137|20688537|P2|STARTED|Overall Study||103
8394153|NCT01034137|20688538|P1|STARTED|Overall Study||106
8394154|NCT01034111|20688669|P1|NOT COMPLETED|Overall Study||0
8394155|NCT01034111|20688669|P1|COMPLETED|Overall Study||30
8394156|NCT01034111|20688669|P1|STARTED|Overall Study||30
8394157|NCT01033942|20688677|P3|NOT COMPLETED|Overall Study||1
8394158|NCT01033942|20688678|P2|NOT COMPLETED|Overall Study||4
8394159|NCT01033942|20688679|P1|NOT COMPLETED|Overall Study||2
8394160|NCT01033942|20688677|P3|COMPLETED|Overall Study||18
8394161|NCT01033942|20688678|P2|COMPLETED|Overall Study||15
8394162|NCT01033942|20688679|P1|COMPLETED|Overall Study||18
8394163|NCT01033942|20688677|P3|STARTED|Overall Study||19
8394164|NCT01033942|20688678|P2|STARTED|Overall Study||19
8394165|NCT01033942|20688679|P1|STARTED|Overall Study||20
8394166|NCT01033864|20688951|P2|NOT COMPLETED|Overall Study||0
8394167|NCT01033864|20688952|P1|NOT COMPLETED|Overall Study||0
8394168|NCT01033864|20688951|P2|COMPLETED|Overall Study||11
8394169|NCT01033864|20688952|P1|COMPLETED|Overall Study||12
8394170|NCT01033864|20688951|P2|STARTED|Overall Study||11
8394171|NCT01033864|20688952|P1|STARTED|Overall Study||12
8394172|NCT01033851|20688977|P2|NOT COMPLETED|Overall Study||7
8394173|NCT01033851|20688978|P1|NOT COMPLETED|Overall Study||3
8394174|NCT01033851|20688977|P2|COMPLETED|Overall Study||34
8394175|NCT01033851|20688978|P1|COMPLETED|Overall Study||45
8394176|NCT01033851|20688977|P2|STARTED|Overall Study||41
8394177|NCT01033851|20688978|P1|STARTED|Overall Study||48
8394178|NCT01033825|20688993|P7|NOT COMPLETED|Overall Study||0
8394179|NCT01033825|20688994|P6|NOT COMPLETED|Overall Study||0
8394180|NCT01033825|20688995|P5|NOT COMPLETED|Overall Study||2
8394181|NCT01033825|20688996|P4|NOT COMPLETED|Overall Study||2
8394182|NCT01033825|20688997|P3|NOT COMPLETED|Overall Study||2
8394183|NCT01033825|20688998|P2|NOT COMPLETED|Overall Study||3
8394184|NCT01033825|20688999|P1|NOT COMPLETED|Overall Study||3
8394185|NCT01033825|20688993|P7|COMPLETED|Overall Study||18
8394186|NCT01033825|20688994|P6|COMPLETED|Overall Study||18
8394187|NCT01033825|20688995|P5|COMPLETED|Overall Study||56
8394188|NCT01033825|20688996|P4|COMPLETED|Overall Study||46
8394189|NCT01033825|20688997|P3|COMPLETED|Overall Study||55
8394190|NCT01033825|20688998|P2|COMPLETED|Overall Study||57
8394191|NCT01033825|20688999|P1|COMPLETED|Overall Study||48
8394192|NCT01033825|20688993|P7|STARTED|Overall Study||18
8394193|NCT01033825|20688994|P6|STARTED|Overall Study||18
8394194|NCT01033825|20688995|P5|STARTED|Overall Study||58
8394195|NCT01033825|20688996|P4|STARTED|Overall Study||48
8394196|NCT01033825|20688997|P3|STARTED|Overall Study||57
8394197|NCT01033825|20688998|P2|STARTED|Overall Study||60
8394198|NCT01033825|20688999|P1|STARTED|Overall Study||51
8394199|NCT01033773|20689218|P1|NOT COMPLETED|Overall Study||35
8394200|NCT01033773|20689218|P1|COMPLETED|Overall Study||51
8394201|NCT01033773|20689218|P1|STARTED|Overall Study||86
8394202|NCT01033747|20689226|P2|NOT COMPLETED|Overall Study||15
8394203|NCT01033747|20689227|P1|NOT COMPLETED|Overall Study||37
8394204|NCT01033747|20689226|P2|COMPLETED|Overall Study||4
8394205|NCT01033747|20689227|P1|COMPLETED|Overall Study||14
8394206|NCT01033747|20689226|P2|STARTED|Overall Study||19
8394207|NCT01033747|20689227|P1|STARTED|Overall Study||51
8394208|NCT01033734|20689235|P1|NOT COMPLETED|Overall Study||1
8394209|NCT01033734|20689235|P1|COMPLETED|Overall Study||7
8394210|NCT01033734|20689235|P1|STARTED|Overall Study||8
8394211|NCT01033565|20689287|P1|NOT COMPLETED|Overall Study||0
8394212|NCT01033565|20689287|P1|COMPLETED|Overall Study||1
8394213|NCT01033565|20689287|P1|STARTED|Overall Study||1
8394214|NCT01033487|20689291|P10|NOT COMPLETED|Fifth Intervention Period||0
8394215|NCT01033487|20689292|P9|NOT COMPLETED|Fifth Intervention Period||0
8394216|NCT01033487|20689293|P8|NOT COMPLETED|Fifth Intervention Period||0
8394217|NCT01033487|20689294|P7|NOT COMPLETED|Fifth Intervention Period||0
8394218|NCT01033487|20689295|P6|NOT COMPLETED|Fifth Intervention Period||0
8394219|NCT01033487|20689296|P5|NOT COMPLETED|Fifth Intervention Period||0
8394220|NCT01033487|20689297|P4|NOT COMPLETED|Fifth Intervention Period||0
8394221|NCT01033487|20689298|P3|NOT COMPLETED|Fifth Intervention Period||0
8394222|NCT01033487|20689299|P2|NOT COMPLETED|Fifth Intervention Period||0
8394223|NCT01033487|20689300|P1|NOT COMPLETED|Fifth Intervention Period||0
8394224|NCT01033487|20689291|P10|COMPLETED|Fifth Intervention Period||2
8394225|NCT01033487|20689292|P9|COMPLETED|Fifth Intervention Period||1
8394226|NCT01033487|20689293|P8|COMPLETED|Fifth Intervention Period||3
8394227|NCT01033487|20689294|P7|COMPLETED|Fifth Intervention Period||2
8394228|NCT01033487|20689295|P6|COMPLETED|Fifth Intervention Period||2
8394229|NCT01033487|20689296|P5|COMPLETED|Fifth Intervention Period||2
8394230|NCT01033487|20689297|P4|COMPLETED|Fifth Intervention Period||2
8394231|NCT01033487|20689298|P3|COMPLETED|Fifth Intervention Period||2
8394232|NCT01033487|20689299|P2|COMPLETED|Fifth Intervention Period||3
8394233|NCT01033487|20689300|P1|COMPLETED|Fifth Intervention Period||2
8394234|NCT01033487|20689291|P10|STARTED|Fifth Intervention Period||2
8394235|NCT01033487|20689292|P9|STARTED|Fifth Intervention Period||1
8394236|NCT01033487|20689293|P8|STARTED|Fifth Intervention Period||3
8394237|NCT01033487|20689294|P7|STARTED|Fifth Intervention Period||2
8394238|NCT01033487|20689295|P6|STARTED|Fifth Intervention Period||2
8394239|NCT01033487|20689296|P5|STARTED|Fifth Intervention Period||2
8394240|NCT01033487|20689297|P4|STARTED|Fifth Intervention Period||2
8394241|NCT01033487|20689298|P3|STARTED|Fifth Intervention Period||2
8394242|NCT01033487|20689299|P2|STARTED|Fifth Intervention Period||3
8394243|NCT01033487|20689300|P1|STARTED|Fifth Intervention Period||2
8394244|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394245|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394246|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394247|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394248|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394249|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394250|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394251|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394252|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394253|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394254|NCT01033487|20689291|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394255|NCT01033487|20689292|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
8394256|NCT01033487|20689293|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
8394257|NCT01033487|20689294|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394258|NCT01033487|20689295|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394259|NCT01033487|20689296|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394260|NCT01033487|20689297|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394261|NCT01033487|20689298|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394262|NCT01033487|20689299|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
8394263|NCT01033487|20689300|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394264|NCT01033487|20689291|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394265|NCT01033487|20689292|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
8394266|NCT01033487|20689293|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
8394267|NCT01033487|20689294|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394268|NCT01033487|20689295|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394269|NCT01033487|20689296|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394270|NCT01033487|20689297|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394271|NCT01033487|20689298|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394272|NCT01033487|20689299|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
8394273|NCT01033487|20689300|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394274|NCT01033487|20689291|P10|NOT COMPLETED|Fourth Intervention Period||0
8394275|NCT01033487|20689292|P9|NOT COMPLETED|Fourth Intervention Period||1
8394276|NCT01033487|20689293|P8|NOT COMPLETED|Fourth Intervention Period||0
8394277|NCT01033487|20689294|P7|NOT COMPLETED|Fourth Intervention Period||0
8394278|NCT01033487|20689295|P6|NOT COMPLETED|Fourth Intervention Period||0
8394279|NCT01033487|20689296|P5|NOT COMPLETED|Fourth Intervention Period||0
8394280|NCT01033487|20689297|P4|NOT COMPLETED|Fourth Intervention Period||0
8394281|NCT01033487|20689298|P3|NOT COMPLETED|Fourth Intervention Period||0
8394282|NCT01033487|20689299|P2|NOT COMPLETED|Fourth Intervention Period||0
8394283|NCT01033487|20689300|P1|NOT COMPLETED|Fourth Intervention Period||0
8394284|NCT01033487|20689291|P10|COMPLETED|Fourth Intervention Period||2
8394285|NCT01033487|20689292|P9|COMPLETED|Fourth Intervention Period||1
8394286|NCT01033487|20689293|P8|COMPLETED|Fourth Intervention Period||3
8394287|NCT01033487|20689294|P7|COMPLETED|Fourth Intervention Period||2
8394288|NCT01033487|20689295|P6|COMPLETED|Fourth Intervention Period||2
8394289|NCT01033487|20689296|P5|COMPLETED|Fourth Intervention Period||2
8394290|NCT01033487|20689297|P4|COMPLETED|Fourth Intervention Period||2
8394291|NCT01033487|20689298|P3|COMPLETED|Fourth Intervention Period||2
8394292|NCT01033487|20689299|P2|COMPLETED|Fourth Intervention Period||3
8394293|NCT01033487|20689300|P1|COMPLETED|Fourth Intervention Period||2
8394294|NCT01033487|20689291|P10|STARTED|Fourth Intervention Period||2
8394295|NCT01033487|20689292|P9|STARTED|Fourth Intervention Period||2
8394296|NCT01033487|20689293|P8|STARTED|Fourth Intervention Period||3
8394297|NCT01033487|20689294|P7|STARTED|Fourth Intervention Period||2
8394298|NCT01033487|20689295|P6|STARTED|Fourth Intervention Period||2
8394299|NCT01033487|20689296|P5|STARTED|Fourth Intervention Period||2
8394300|NCT01033487|20689297|P4|STARTED|Fourth Intervention Period||2
8394301|NCT01033487|20689298|P3|STARTED|Fourth Intervention Period||2
8394302|NCT01033487|20689299|P2|STARTED|Fourth Intervention Period||3
8394303|NCT01033487|20689300|P1|STARTED|Fourth Intervention Period||2
8394304|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394305|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394306|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394307|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394308|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394309|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394310|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394311|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394312|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394313|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394314|NCT01033487|20689291|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394315|NCT01033487|20689292|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394316|NCT01033487|20689293|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
8394317|NCT01033487|20689294|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394318|NCT01033487|20689295|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394319|NCT01033487|20689296|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394320|NCT01033487|20689297|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394321|NCT01033487|20689298|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394322|NCT01033487|20689299|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
8394323|NCT01033487|20689300|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394324|NCT01033487|20689291|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394325|NCT01033487|20689292|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394326|NCT01033487|20689293|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
8394327|NCT01033487|20689294|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394328|NCT01033487|20689295|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394329|NCT01033487|20689296|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394330|NCT01033487|20689297|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394331|NCT01033487|20689298|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394332|NCT01033487|20689299|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
8394333|NCT01033487|20689300|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394334|NCT01033487|20689291|P10|NOT COMPLETED|Third Intervention Period||0
8394335|NCT01033487|20689292|P9|NOT COMPLETED|Third Intervention Period||0
8394336|NCT01033487|20689293|P8|NOT COMPLETED|Third Intervention Period||0
8394337|NCT01033487|20689294|P7|NOT COMPLETED|Third Intervention Period||0
8394338|NCT01033487|20689295|P6|NOT COMPLETED|Third Intervention Period||0
8394339|NCT01033487|20689296|P5|NOT COMPLETED|Third Intervention Period||0
8394340|NCT01033487|20689297|P4|NOT COMPLETED|Third Intervention Period||0
8394341|NCT01033487|20689298|P3|NOT COMPLETED|Third Intervention Period||0
8394342|NCT01033487|20689299|P2|NOT COMPLETED|Third Intervention Period||0
8394343|NCT01033487|20689300|P1|NOT COMPLETED|Third Intervention Period||0
8394344|NCT01033487|20689291|P10|COMPLETED|Third Intervention Period||2
8394345|NCT01033487|20689292|P9|COMPLETED|Third Intervention Period||2
8394346|NCT01033487|20689293|P8|COMPLETED|Third Intervention Period||3
8394347|NCT01033487|20689294|P7|COMPLETED|Third Intervention Period||2
8394348|NCT01033487|20689295|P6|COMPLETED|Third Intervention Period||2
8394349|NCT01033487|20689296|P5|COMPLETED|Third Intervention Period||2
8394350|NCT01033487|20689297|P4|COMPLETED|Third Intervention Period||2
8394351|NCT01033487|20689298|P3|COMPLETED|Third Intervention Period||2
8394352|NCT01033487|20689299|P2|COMPLETED|Third Intervention Period||3
8394353|NCT01033487|20689300|P1|COMPLETED|Third Intervention Period||2
8394354|NCT01033487|20689291|P10|STARTED|Third Intervention Period||2
8394355|NCT01033487|20689292|P9|STARTED|Third Intervention Period||2
8394356|NCT01033487|20689293|P8|STARTED|Third Intervention Period||3
8394357|NCT01033487|20689294|P7|STARTED|Third Intervention Period||2
8394358|NCT01033487|20689295|P6|STARTED|Third Intervention Period||2
8394359|NCT01033487|20689296|P5|STARTED|Third Intervention Period||2
8394360|NCT01033487|20689297|P4|STARTED|Third Intervention Period||2
8394361|NCT01033487|20689298|P3|STARTED|Third Intervention Period||2
8394362|NCT01033487|20689299|P2|STARTED|Third Intervention Period||3
8394363|NCT01033487|20689300|P1|STARTED|Third Intervention Period||2
8394364|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394365|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394366|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394367|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394368|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394369|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394370|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394371|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394372|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394373|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394374|NCT01033487|20689291|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394375|NCT01033487|20689292|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394376|NCT01033487|20689293|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
8394377|NCT01033487|20689294|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394378|NCT01033487|20689295|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394379|NCT01033487|20689296|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394380|NCT01033487|20689297|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394381|NCT01033487|20689298|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394382|NCT01033487|20689299|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
8394383|NCT01033487|20689300|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394384|NCT01033487|20689291|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394385|NCT01033487|20689292|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394386|NCT01033487|20689293|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
8394387|NCT01033487|20689294|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394388|NCT01033487|20689295|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394389|NCT01033487|20689296|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394390|NCT01033487|20689297|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394391|NCT01033487|20689298|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394392|NCT01033487|20689299|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
8394393|NCT01033487|20689300|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394394|NCT01033487|20689291|P10|NOT COMPLETED|Second Intervention Period||0
8394395|NCT01033487|20689292|P9|NOT COMPLETED|Second Intervention Period||0
8394396|NCT01033487|20689293|P8|NOT COMPLETED|Second Intervention Period||0
8394397|NCT01033487|20689294|P7|NOT COMPLETED|Second Intervention Period||0
8394398|NCT01033487|20689295|P6|NOT COMPLETED|Second Intervention Period||0
8394399|NCT01033487|20689296|P5|NOT COMPLETED|Second Intervention Period||0
8394400|NCT01033487|20689297|P4|NOT COMPLETED|Second Intervention Period||0
8394401|NCT01033487|20689298|P3|NOT COMPLETED|Second Intervention Period||0
8394402|NCT01033487|20689299|P2|NOT COMPLETED|Second Intervention Period||0
8394403|NCT01033487|20689300|P1|NOT COMPLETED|Second Intervention Period||0
8394404|NCT01033487|20689291|P10|COMPLETED|Second Intervention Period||2
8394405|NCT01033487|20689292|P9|COMPLETED|Second Intervention Period||2
8394406|NCT01033487|20689293|P8|COMPLETED|Second Intervention Period||3
8394407|NCT01033487|20689294|P7|COMPLETED|Second Intervention Period||2
8394408|NCT01033487|20689295|P6|COMPLETED|Second Intervention Period||2
8394409|NCT01033487|20689296|P5|COMPLETED|Second Intervention Period||2
8394410|NCT01033487|20689297|P4|COMPLETED|Second Intervention Period||2
8394411|NCT01033487|20689298|P3|COMPLETED|Second Intervention Period||2
8394412|NCT01033487|20689299|P2|COMPLETED|Second Intervention Period||3
8394413|NCT01033487|20689300|P1|COMPLETED|Second Intervention Period||2
8394414|NCT01033487|20689291|P10|STARTED|Second Intervention Period||2
8394415|NCT01033487|20689292|P9|STARTED|Second Intervention Period||2
8394416|NCT01033487|20689293|P8|STARTED|Second Intervention Period||3
8394417|NCT01033487|20689294|P7|STARTED|Second Intervention Period||2
8394418|NCT01033487|20689295|P6|STARTED|Second Intervention Period||2
8394419|NCT01033487|20689296|P5|STARTED|Second Intervention Period||2
8394420|NCT01033487|20689297|P4|STARTED|Second Intervention Period||2
8394421|NCT01033487|20689298|P3|STARTED|Second Intervention Period||2
8394422|NCT01033487|20689299|P2|STARTED|Second Intervention Period||3
8394423|NCT01033487|20689300|P1|STARTED|Second Intervention Period||2
8394424|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394425|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394426|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394427|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394428|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394429|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394430|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394431|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394432|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394433|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394434|NCT01033487|20689291|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394435|NCT01033487|20689292|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394436|NCT01033487|20689293|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
8394437|NCT01033487|20689294|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394438|NCT01033487|20689295|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394439|NCT01033487|20689296|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394440|NCT01033487|20689297|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394441|NCT01033487|20689298|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394442|NCT01033487|20689299|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
8394443|NCT01033487|20689300|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394444|NCT01033487|20689291|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394445|NCT01033487|20689292|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394446|NCT01033487|20689293|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
8394447|NCT01033487|20689294|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394448|NCT01033487|20689295|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394449|NCT01033487|20689296|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394450|NCT01033487|20689297|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394451|NCT01033487|20689298|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394452|NCT01033487|20689299|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
8394453|NCT01033487|20689300|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394454|NCT01033487|20689291|P10|NOT COMPLETED|First Intervention Period||0
8394455|NCT01033487|20689292|P9|NOT COMPLETED|First Intervention Period||0
8394456|NCT01033487|20689293|P8|NOT COMPLETED|First Intervention Period||0
8394457|NCT01033487|20689294|P7|NOT COMPLETED|First Intervention Period||0
8394458|NCT01033487|20689295|P6|NOT COMPLETED|First Intervention Period||0
8394459|NCT01033487|20689296|P5|NOT COMPLETED|First Intervention Period||0
8394460|NCT01033487|20689297|P4|NOT COMPLETED|First Intervention Period||0
8394461|NCT01033487|20689298|P3|NOT COMPLETED|First Intervention Period||0
8394462|NCT01033487|20689299|P2|NOT COMPLETED|First Intervention Period||0
8394463|NCT01033487|20689300|P1|NOT COMPLETED|First Intervention Period||0
8394464|NCT01033487|20689291|P10|COMPLETED|First Intervention Period||2
8394465|NCT01033487|20689292|P9|COMPLETED|First Intervention Period||2
8394466|NCT01033487|20689293|P8|COMPLETED|First Intervention Period||3
8394467|NCT01033487|20689294|P7|COMPLETED|First Intervention Period||2
8394468|NCT01033487|20689295|P6|COMPLETED|First Intervention Period||2
8394469|NCT01033487|20689296|P5|COMPLETED|First Intervention Period||2
8394470|NCT01033487|20689297|P4|COMPLETED|First Intervention Period||2
8394471|NCT01033487|20689298|P3|COMPLETED|First Intervention Period||2
8394472|NCT01033487|20689299|P2|COMPLETED|First Intervention Period||3
8394473|NCT01033487|20689300|P1|COMPLETED|First Intervention Period||2
8394474|NCT01033487|20689291|P10|STARTED|First Intervention Period||2
8394475|NCT01033487|20689292|P9|STARTED|First Intervention Period||2
8394476|NCT01033487|20689293|P8|STARTED|First Intervention Period||3
8394477|NCT01033487|20689294|P7|STARTED|First Intervention Period||2
8394478|NCT01033487|20689295|P6|STARTED|First Intervention Period||2
8394479|NCT01033487|20689296|P5|STARTED|First Intervention Period||2
8394480|NCT01033487|20689297|P4|STARTED|First Intervention Period||2
8394481|NCT01033487|20689298|P3|STARTED|First Intervention Period||2
8394482|NCT01033487|20689299|P2|STARTED|First Intervention Period||3
8394483|NCT01033487|20689300|P1|STARTED|First Intervention Period||2
8394484|NCT01033448|20689354|P1|NOT COMPLETED|Overall Study||12
8394485|NCT01033448|20689354|P1|COMPLETED|Overall Study||47
8394486|NCT01033448|20689354|P1|STARTED|Overall Study||59
8394487|NCT01033422|20689365|P3|NOT COMPLETED|Overall Study||1
8394488|NCT01033422|20689366|P2|NOT COMPLETED|Overall Study||4
8394489|NCT01033422|20689367|P1|NOT COMPLETED|Overall Study||1
8394490|NCT01033422|20689365|P3|COMPLETED|Overall Study||22
8394491|NCT01033422|20689366|P2|COMPLETED|Overall Study||28
8394492|NCT01033422|20689367|P1|COMPLETED|Overall Study||33
8394493|NCT01033422|20689365|P3|STARTED|Overall Study||23
8394494|NCT01033422|20689366|P2|STARTED|Overall Study||32
8394495|NCT01033422|20689367|P1|STARTED|Overall Study||34
8394496|NCT01033383|20689379|P4|NOT COMPLETED|Overall Study||0
8394497|NCT01033383|20689380|P3|NOT COMPLETED|Overall Study||0
8394498|NCT01033383|20689381|P2|NOT COMPLETED|Overall Study||0
8394499|NCT01033383|20689382|P1|NOT COMPLETED|Overall Study||0
8394500|NCT01033383|20689379|P4|COMPLETED|Overall Study||20
8394501|NCT01033383|20689380|P3|COMPLETED|Overall Study||20
8394502|NCT01033383|20689381|P2|COMPLETED|Overall Study||20
8394503|NCT01033383|20689382|P1|COMPLETED|Overall Study||20
8394504|NCT01033383|20689379|P4|STARTED|Overall Study||20
8394505|NCT01033383|20689380|P3|STARTED|Overall Study||20
8394506|NCT01033383|20689381|P2|STARTED|Overall Study||20
8394507|NCT01033383|20689382|P1|STARTED|Overall Study||20
8394508|NCT01033227|20689402|P2|NOT COMPLETED|Overall Study||0
8394509|NCT01033227|20689403|P1|NOT COMPLETED|Overall Study||0
8394510|NCT01033227|20689402|P2|COMPLETED|Overall Study||2
8394511|NCT01033227|20689403|P1|COMPLETED|Overall Study||3
8394512|NCT01033227|20689402|P2|STARTED|Overall Study||2
8394513|NCT01033227|20689403|P1|STARTED|Overall Study||3
8394514|NCT01033136|20689413|P2|NOT COMPLETED|Follow-Up (3 Month)||2
8394515|NCT01033136|20689414|P1|NOT COMPLETED|Follow-Up (3 Month)||2
8394516|NCT01033136|20689413|P2|COMPLETED|Follow-Up (3 Month)||13
8394517|NCT01033136|20689414|P1|COMPLETED|Follow-Up (3 Month)||14
8394518|NCT01033136|20689413|P2|STARTED|Follow-Up (3 Month)||15
8394519|NCT01033136|20689414|P1|STARTED|Follow-Up (3 Month)||16
8394520|NCT01033136|20689413|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
8394521|NCT01033136|20689414|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
8394522|NCT01033136|20689413|P2|COMPLETED|Post-Treatment (1 Week)||15
8394523|NCT01033136|20689414|P1|COMPLETED|Post-Treatment (1 Week)||16
8394524|NCT01033136|20689413|P2|STARTED|Post-Treatment (1 Week)||26
8394525|NCT01033136|20689414|P1|STARTED|Post-Treatment (1 Week)||30
8394526|NCT01033136|20689413|P2|NOT COMPLETED|Baseline Assessment||6
8394527|NCT01033136|20689414|P1|NOT COMPLETED|Baseline Assessment||6
8394528|NCT01033136|20689413|P2|COMPLETED|Baseline Assessment||26
8394529|NCT01033136|20689414|P1|COMPLETED|Baseline Assessment||30
8394530|NCT01033136|20689413|P2|STARTED|Baseline Assessment||32
8394531|NCT01033136|20689414|P1|STARTED|Baseline Assessment||36
8394532|NCT01033071|20689425|P3|NOT COMPLETED|Overall Study||47
8394533|NCT01033071|20689426|P2|NOT COMPLETED|Overall Study||77
8394534|NCT01033071|20689427|P1|NOT COMPLETED|Overall Study||55
8394535|NCT01033071|20689425|P3|COMPLETED|Overall Study||317
8394536|NCT01033071|20689426|P2|COMPLETED|Overall Study||275
8394537|NCT01033071|20689427|P1|COMPLETED|Overall Study||300
8394538|NCT01033071|20689425|P3|STARTED|Overall Study||364
8394539|NCT01033071|20689426|P2|STARTED|Overall Study||352
8394540|NCT01033071|20689427|P1|STARTED|Overall Study||355
8394541|NCT01033032|20689486|P4|NOT COMPLETED|Phase II||0
8394542|NCT01033032|20689487|P3|NOT COMPLETED|Phase II||66
8394543|NCT01033032|20689488|P2|NOT COMPLETED|Phase II||0
8394544|NCT01033032|20689489|P1|NOT COMPLETED|Phase II||0
8394545|NCT01033032|20689486|P4|COMPLETED|Phase II||0
8394546|NCT01033032|20689487|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
8394547|NCT01033032|20689488|P2|COMPLETED|Phase II||0
8394548|NCT01033032|20689489|P1|COMPLETED|Phase II||0
8394549|NCT01033032|20689486|P4|STARTED|Phase II||0
8394550|NCT01033032|20689487|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
8394551|NCT01033032|20689488|P2|STARTED|Phase II||0
8394552|NCT01033032|20689489|P1|STARTED|Phase II||0
8394553|NCT01033032|20689486|P4|NOT COMPLETED|Phase I||6
8394554|NCT01033032|20689487|P3|NOT COMPLETED|Phase I||0
8394555|NCT01033032|20689488|P2|NOT COMPLETED|Phase I||3
8394556|NCT01033032|20689489|P1|NOT COMPLETED|Phase I||3
8394557|NCT01033032|20689486|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8394558|NCT01033032|20689487|P3|COMPLETED|Phase I||3
8394559|NCT01033032|20689488|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8394560|NCT01033032|20689489|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8394561|NCT01033032|20689486|P4|STARTED|Phase I||6
8394562|NCT01033032|20689487|P3|STARTED|Phase I||3
8394563|NCT01033032|20689488|P2|STARTED|Phase I||3
8394564|NCT01033032|20689489|P1|STARTED|Phase I||3
8394565|NCT01033019|20689498|P2|NOT COMPLETED|Overall Study||0
8394566|NCT01033019|20689499|P1|NOT COMPLETED|Overall Study||1
8394567|NCT01033019|20689498|P2|COMPLETED|Overall Study||8
8394568|NCT01033019|20689499|P1|COMPLETED|Overall Study||15
8394569|NCT01033019|20689498|P2|STARTED|Overall Study||8
8394570|NCT01033019|20689499|P1|STARTED|Overall Study||16
8394571|NCT01032993|20689508|P2|NOT COMPLETED|Overall Study||0
8394572|NCT01032993|20689509|P1|NOT COMPLETED|Overall Study||0
8394573|NCT01032993|20689508|P2|COMPLETED|Overall Study||20
8394574|NCT01032993|20689509|P1|COMPLETED|Overall Study||19
8394575|NCT01032993|20689508|P2|STARTED|Overall Study||20
8394576|NCT01032993|20689509|P1|STARTED|Overall Study||19
8394577|NCT01032954|20689524|P3|NOT COMPLETED|Overall Study||0
8394578|NCT01032954|20689525|P2|NOT COMPLETED|Overall Study||1
8394579|NCT01032954|20689526|P1|NOT COMPLETED|Overall Study||4
8394580|NCT01032954|20689524|P3|COMPLETED|Overall Study||30
8394581|NCT01032954|20689525|P2|COMPLETED|Overall Study||29
8394582|NCT01032954|20689526|P1|COMPLETED|Overall Study||26
8394583|NCT01032954|20689524|P3|STARTED|Overall Study||30
8394584|NCT01032954|20689525|P2|STARTED|Overall Study||30
8394585|NCT01032954|20689526|P1|STARTED|Overall Study||30
8394586|NCT01032928|20689540|P1|NOT COMPLETED|Overall Study||0
8394587|NCT01032928|20689540|P1|COMPLETED|Overall Study||30
8394588|NCT01032928|20689540|P1|STARTED|Overall Study||30
8394589|NCT01032915|20689556|P4|NOT COMPLETED|Overall Study||7
8394590|NCT01032915|20689557|P3|NOT COMPLETED|Overall Study||7
8394591|NCT01032915|20689558|P2|NOT COMPLETED|Overall Study||11
8394592|NCT01032915|20689559|P1|NOT COMPLETED|Overall Study||8
8394593|NCT01032915|20689556|P4|COMPLETED|Overall Study||27
8394594|NCT01032915|20689557|P3|COMPLETED|Overall Study||24
8394595|NCT01032915|20689558|P2|COMPLETED|Overall Study||20
8394596|NCT01032915|20689559|P1|COMPLETED|Overall Study||21
8394597|NCT01032915|20689556|P4|STARTED|Overall Study||34
8394598|NCT01032915|20689557|P3|STARTED|Overall Study||31
8394599|NCT01032915|20689558|P2|STARTED|Overall Study||31
8394600|NCT01032915|20689559|P1|STARTED|Overall Study||29
8394601|NCT01032889|20689584|P3|NOT COMPLETED|Overall Study||3
8394602|NCT01032889|20689585|P2|NOT COMPLETED|Overall Study||15
8394603|NCT01032889|20689586|P1|NOT COMPLETED|Overall Study||8
8394604|NCT01032889|20689584|P3|COMPLETED|Overall Study||42
8394605|NCT01032889|20689585|P2|COMPLETED|Overall Study||28
8394606|NCT01032889|20689586|P1|COMPLETED|Overall Study||33
8394607|NCT01032889|20689584|P3|Received Treatment|Overall Study||45
8394608|NCT01032889|20689585|P2|Received Treatment|Overall Study||43
8394609|NCT01032889|20689586|P1|Received Treatment|Overall Study||41
8394610|NCT01032889|20689584|P3|STARTED|Overall Study||45
8394611|NCT01032889|20689585|P2|STARTED|Overall Study||43
8394612|NCT01032889|20689586|P1|STARTED|Overall Study||41
8394613|NCT01032850|20689606|P1|NOT COMPLETED|Overall Study||2
8394614|NCT01032850|20689606|P1|COMPLETED|Overall Study||13
8394615|NCT01032850|20689606|P1|STARTED|Overall Study||15
8394616|NCT01032837|20689617|P4|NOT COMPLETED|Overall Study||3
8394617|NCT01032837|20689618|P3|NOT COMPLETED|Overall Study||1
8394618|NCT01032837|20689619|P2|NOT COMPLETED|Overall Study||3
8394619|NCT01032837|20689620|P1|NOT COMPLETED|Overall Study||0
8394620|NCT01032837|20689617|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
8394621|NCT01032837|20689618|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
8394622|NCT01032837|20689619|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
8394623|NCT01032837|20689620|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
8394624|NCT01032837|20689617|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
8394625|NCT01032837|20689618|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
8394626|NCT01032837|20689619|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
8394627|NCT01032837|20689620|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
8394628|NCT01032837|20689617|P4|STARTED|Overall Study||25
8394629|NCT01032837|20689618|P3|STARTED|Overall Study||25
8394630|NCT01032837|20689619|P2|STARTED|Overall Study||26
8394631|NCT01032837|20689620|P1|STARTED|Overall Study||26
8394632|NCT01032759|20689668|P2|NOT COMPLETED|Overall Study||3
8394633|NCT01032759|20689669|P1|NOT COMPLETED|Overall Study||1
8394634|NCT01032759|20689668|P2|COMPLETED|Overall Study||28
8394635|NCT01032759|20689669|P1|COMPLETED|Overall Study||31
8394636|NCT01032759|20689668|P2|Completed 48 Hour Assessment|Overall Study||28
8394637|NCT01032759|20689669|P1|Completed 48 Hour Assessment|Overall Study||31
8394638|NCT01032759|20689668|P2|Completed 24 Hour Assessment|Overall Study||30
8394639|NCT01032759|20689669|P1|Completed 24 Hour Assessment|Overall Study||32
8394640|NCT01032759|20689668|P2|STARTED|Overall Study||31
8394641|NCT01032759|20689669|P1|STARTED|Overall Study||32
8394642|NCT01032733|20689689|P2|NOT COMPLETED|Overall Study||1
8394643|NCT01032733|20689690|P1|NOT COMPLETED|Overall Study||1
8394644|NCT01032733|20689689|P2|COMPLETED|Overall Study||16
8394645|NCT01032733|20689690|P1|COMPLETED|Overall Study||16
8394646|NCT01032733|20689689|P2|STARTED|Overall Study||17
8394647|NCT01032733|20689690|P1|STARTED|Overall Study||17
8394648|NCT01032694|20689706|P2|NOT COMPLETED|Overall Study||0
8394649|NCT01032694|20689707|P1|NOT COMPLETED|Overall Study||0
8394650|NCT01032694|20689706|P2|COMPLETED|Overall Study||10
8394651|NCT01032694|20689707|P1|COMPLETED|Overall Study||20
8394652|NCT01032694|20689706|P2|STARTED|Overall Study||10
8394653|NCT01032694|20689707|P1|STARTED|Overall Study||20
8394654|NCT01032629|20689720|P3|NOT COMPLETED|Overall Study||88
8394655|NCT01032629|20689721|P2|NOT COMPLETED|Overall Study||101
8394656|NCT01032629|20689722|P1|NOT COMPLETED|Overall Study||145
8394657|NCT01032629|20689720|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
8394658|NCT01032629|20689721|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
8394659|NCT01032629|20689722|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
8394660|NCT01032629|20689720|P3|Treated|Overall Study||1441
8394661|NCT01032629|20689721|P2|Treated|Overall Study||1445
8394662|NCT01032629|20689722|P1|Treated|Overall Study||1441
8394663|NCT01032629|20689720|P3|STARTED|Overall Study||1443
8394664|NCT01032629|20689721|P2|STARTED|Overall Study||1445
8394665|NCT01032629|20689722|P1|STARTED|Overall Study||1442
8394666|NCT01032603|20689769|P2|NOT COMPLETED|Overall Study||19
8394667|NCT01032603|20689770|P1|NOT COMPLETED|Overall Study||15
8394668|NCT01032603|20689769|P2|COMPLETED|Overall Study||77
8394669|NCT01032603|20689770|P1|COMPLETED|Overall Study||86
8394670|NCT01032603|20689769|P2|STARTED|Overall Study||96
8394671|NCT01032603|20689770|P1|STARTED|Overall Study||101
8394672|NCT01032538|20689826|P1|NOT COMPLETED|Overall Study||0
8394673|NCT01032538|20689826|P1|COMPLETED|Overall Study|Knees|99
8394674|NCT01032538|20689826|P1|STARTED|Overall Study|Knees|99
8394675|NCT01032382|20689834|P2|NOT COMPLETED|Overall Study||5
8394676|NCT01032382|20689835|P1|NOT COMPLETED|Overall Study||5
8394677|NCT01032382|20689834|P2|COMPLETED|Overall Study||9
8394678|NCT01032382|20689835|P1|COMPLETED|Overall Study||11
8394679|NCT01032382|20689834|P2|STARTED|Overall Study||14
8394680|NCT01032382|20689835|P1|STARTED|Overall Study||16
8394681|NCT01032330|20689865|P4|NOT COMPLETED|Overall Study||14
8394682|NCT01032330|20689866|P3|NOT COMPLETED|Overall Study||10
8394683|NCT01032330|20689867|P2|NOT COMPLETED|Overall Study||24
8394684|NCT01032330|20689868|P1|NOT COMPLETED|Overall Study||18
8394685|NCT01032330|20689865|P4|COMPLETED|Overall Study||90
8394686|NCT01032330|20689866|P3|COMPLETED|Overall Study||87
8394687|NCT01032330|20689867|P2|COMPLETED|Overall Study||151
8394688|NCT01032330|20689868|P1|COMPLETED|Overall Study||165
8394689|NCT01032330|20689865|P4|STARTED|Overall Study||104
8394690|NCT01032330|20689866|P3|STARTED|Overall Study||97
8394691|NCT01032330|20689867|P2|STARTED|Overall Study||175
8394692|NCT01032330|20689868|P1|STARTED|Overall Study||183
8394693|NCT01032291|20689923|P3|NOT COMPLETED|Proof of Concept||3
8394694|NCT01032291|20689924|P2|NOT COMPLETED|Proof of Concept||8
8394695|NCT01032291|20689925|P1|NOT COMPLETED|Proof of Concept||0
8394696|NCT01032291|20689923|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
8394697|NCT01032291|20689924|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
8394698|NCT01032291|20689925|P1|COMPLETED|Proof of Concept||0
8394699|NCT01032291|20689923|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
8394700|NCT01032291|20689924|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
8394701|NCT01032291|20689925|P1|Intent to Treat and Safety Populations|Proof of Concept||0
8394702|NCT01032291|20689923|P3|STARTED|Proof of Concept||21
8394703|NCT01032291|20689924|P2|STARTED|Proof of Concept||22
8394704|NCT01032291|20689925|P1|STARTED|Proof of Concept||0
8394705|NCT01032291|20689923|P3|NOT COMPLETED|Safety Lead-in||0
8394706|NCT01032291|20689924|P2|NOT COMPLETED|Safety Lead-in||0
8394707|NCT01032291|20689925|P1|NOT COMPLETED|Safety Lead-in||2
8394708|NCT01032291|20689923|P3|COMPLETED|Safety Lead-in||0
8394709|NCT01032291|20689924|P2|COMPLETED|Safety Lead-in||0
8394710|NCT01032291|20689925|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
8394711|NCT01032291|20689923|P3|STARTED|Safety Lead-in||0
8394712|NCT01032291|20689924|P2|STARTED|Safety Lead-in||0
8394713|NCT01032291|20689925|P1|STARTED|Safety Lead-in||8
8394714|NCT01032265|20689951|P2|NOT COMPLETED|Overall Study||17
8394715|NCT01032265|20689952|P1|NOT COMPLETED|Overall Study||13
8394716|NCT01032265|20689951|P2|COMPLETED|Overall Study||107
8394717|NCT01032265|20689952|P1|COMPLETED|Overall Study||113
8394718|NCT01032265|20689951|P2|STARTED|Overall Study||124
8394719|NCT01032265|20689952|P1|STARTED|Overall Study||126
8394720|NCT01032239|20689972|P2|NOT COMPLETED|Overall Study||5
8394721|NCT01032239|20689973|P1|NOT COMPLETED|Overall Study||7
8394722|NCT01032239|20689972|P2|COMPLETED|Overall Study||24
8394723|NCT01032239|20689973|P1|COMPLETED|Overall Study||24
8394724|NCT01032239|20689972|P2|Implant|Overall Study||0
8394725|NCT01032239|20689973|P1|Implant|Overall Study|implanted|25
8394726|NCT01032239|20689972|P2|STARTED|Overall Study|randomized to BMT arm|29
8394727|NCT01032239|20689973|P1|STARTED|Overall Study|randomized to ITB arm|31
8394728|NCT01032200|20690003|P2|NOT COMPLETED|Overall Study||7
8394729|NCT01032200|20690004|P1|NOT COMPLETED|Overall Study||4
8394730|NCT01032200|20690003|P2|COMPLETED|Overall Study||21
8394731|NCT01032200|20690004|P1|COMPLETED|Overall Study||22
8394732|NCT01032200|20690003|P2|STARTED|Overall Study||28
8394733|NCT01032200|20690004|P1|STARTED|Overall Study||26
8394734|NCT01032174|20690020|P2|NOT COMPLETED|Overall Study||1
8394735|NCT01032174|20690021|P1|NOT COMPLETED|Overall Study||0
8394736|NCT01032174|20690020|P2|COMPLETED|Overall Study||59
8394737|NCT01032174|20690021|P1|COMPLETED|Overall Study||63
8394738|NCT01032174|20690020|P2|STARTED|Overall Study||60
8394739|NCT01032174|20690021|P1|STARTED|Overall Study||63
8394740|NCT01032135|20690036|P7|NOT COMPLETED|8 Week Randomization||18
8394741|NCT01032135|20690037|P6|NOT COMPLETED|8 Week Randomization||17
8394742|NCT01032135|20690038|P5|NOT COMPLETED|8 Week Randomization||9
8394743|NCT01032135|20690039|P4|NOT COMPLETED|8 Week Randomization||11
8394744|NCT01032135|20690040|P3|NOT COMPLETED|8 Week Randomization||0
8394745|NCT01032135|20690041|P2|NOT COMPLETED|8 Week Randomization||0
8394746|NCT01032135|20690042|P1|NOT COMPLETED|8 Week Randomization||26
8394747|NCT01032135|20690036|P7|COMPLETED|8 Week Randomization||36
8394748|NCT01032135|20690037|P6|COMPLETED|8 Week Randomization||31
8394749|NCT01032135|20690038|P5|COMPLETED|8 Week Randomization||34
8394750|NCT01032135|20690039|P4|COMPLETED|8 Week Randomization||30
8394751|NCT01032135|20690040|P3|COMPLETED|8 Week Randomization||0
8394752|NCT01032135|20690041|P2|COMPLETED|8 Week Randomization||0
8394753|NCT01032135|20690042|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
8394754|NCT01032135|20690036|P7|12 Week Follow up|8 Week Randomization||41
8394755|NCT01032135|20690037|P6|12 Week Follow up|8 Week Randomization||36
8394756|NCT01032135|20690038|P5|12 Week Follow up|8 Week Randomization||38
8394757|NCT01032135|20690039|P4|12 Week Follow up|8 Week Randomization||34
8394758|NCT01032135|20690040|P3|12 Week Follow up|8 Week Randomization||0
8394759|NCT01032135|20690041|P2|12 Week Follow up|8 Week Randomization||0
8394760|NCT01032135|20690042|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
8394761|NCT01032135|20690036|P7|STARTED|8 Week Randomization||54
8394762|NCT01032135|20690037|P6|STARTED|8 Week Randomization||48
8394763|NCT01032135|20690038|P5|STARTED|8 Week Randomization||43
8394764|NCT01032135|20690039|P4|STARTED|8 Week Randomization||41
8394765|NCT01032135|20690040|P3|STARTED|8 Week Randomization||0
8394766|NCT01032135|20690041|P2|STARTED|8 Week Randomization||0
8394767|NCT01032135|20690042|P1|STARTED|8 Week Randomization||227
8394768|NCT01032135|20690036|P7|NOT COMPLETED|2 Week Randomization||0
8394769|NCT01032135|20690037|P6|NOT COMPLETED|2 Week Randomization||0
8394770|NCT01032135|20690038|P5|NOT COMPLETED|2 Week Randomization||0
8394771|NCT01032135|20690039|P4|NOT COMPLETED|2 Week Randomization||0
8394772|NCT01032135|20690040|P3|NOT COMPLETED|2 Week Randomization||0
8394773|NCT01032135|20690041|P2|NOT COMPLETED|2 Week Randomization||0
8394774|NCT01032135|20690042|P1|NOT COMPLETED|2 Week Randomization||0
8394775|NCT01032135|20690036|P7|COMPLETED|2 Week Randomization||0
8394776|NCT01032135|20690037|P6|COMPLETED|2 Week Randomization||0
8394777|NCT01032135|20690038|P5|COMPLETED|2 Week Randomization||0
8394778|NCT01032135|20690039|P4|COMPLETED|2 Week Randomization||0
8394779|NCT01032135|20690040|P3|COMPLETED|2 Week Randomization||96
8394780|NCT01032135|20690041|P2|COMPLETED|2 Week Randomization||93
8394781|NCT01032135|20690042|P1|COMPLETED|2 Week Randomization||311
8394782|NCT01032135|20690036|P7|STARTED|2 Week Randomization||0
8394783|NCT01032135|20690037|P6|STARTED|2 Week Randomization||0
8394784|NCT01032135|20690038|P5|STARTED|2 Week Randomization||0
8394785|NCT01032135|20690039|P4|STARTED|2 Week Randomization||0
8394786|NCT01032135|20690040|P3|STARTED|2 Week Randomization||96
8394787|NCT01032135|20690041|P2|STARTED|2 Week Randomization||93
8394788|NCT01032135|20690042|P1|STARTED|2 Week Randomization||311
8394789|NCT01032070|20690261|P2|NOT COMPLETED|Overall Study||12
8394790|NCT01032070|20690262|P1|NOT COMPLETED|Overall Study||13
8394791|NCT01032070|20690261|P2|COMPLETED|Overall Study||0
8394792|NCT01032070|20690262|P1|COMPLETED|Overall Study||0
8394793|NCT01032070|20690261|P2|STARTED|Overall Study||12
8394794|NCT01032070|20690262|P1|STARTED|Overall Study||13
8394795|NCT01032044|20690291|P2|NOT COMPLETED|Overall Study||20
8394796|NCT01032044|20690292|P1|NOT COMPLETED|Overall Study||25
8394797|NCT01032044|20690291|P2|COMPLETED|Overall Study||62
8394798|NCT01032044|20690292|P1|COMPLETED|Overall Study||57
8394799|NCT01032044|20690291|P2|Procedure|Overall Study||75
8394800|NCT01032044|20690292|P1|Procedure|Overall Study||74
8394801|NCT01032044|20690291|P2|STARTED|Overall Study||82
8394802|NCT01032044|20690292|P1|STARTED|Overall Study||82
8394803|NCT01032018|20690300|P2|NOT COMPLETED|Overall Study||6
8394804|NCT01032018|20690301|P1|NOT COMPLETED|Overall Study||6
8394805|NCT01032018|20690300|P2|COMPLETED|Overall Study||67
8394806|NCT01032018|20690301|P1|COMPLETED|Overall Study||71
8394807|NCT01032018|20690300|P2|STARTED|Overall Study||73
8394808|NCT01032018|20690301|P1|STARTED|Overall Study||77
8394809|NCT01031979|20690311|P2|NOT COMPLETED|Overall Study||4
8394810|NCT01031979|20690312|P1|NOT COMPLETED|Overall Study||5
8394811|NCT01031979|20690311|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
8394812|NCT01031979|20690312|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
8394813|NCT01031979|20690311|P2|Completed Primary Outcome Measure|Overall Study||12
8394814|NCT01031979|20690312|P1|Completed Primary Outcome Measure|Overall Study||12
8394815|NCT01031979|20690311|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
8394816|NCT01031979|20690312|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
8394817|NCT01031953|20690324|P1|NOT COMPLETED|Overall Study||0
8394818|NCT01031953|20690324|P1|COMPLETED|Overall Study||11
8394819|NCT01031953|20690324|P1|STARTED|Overall Study||11
8394820|NCT01031914|20690335|P1|NOT COMPLETED|Overall Study||0
8394821|NCT01031914|20690335|P1|COMPLETED|Overall Study||36
8394822|NCT01031914|20690335|P1|STARTED|Overall Study||36
8394823|NCT01031836|20690345|P6|NOT COMPLETED|Stage II||1
8394824|NCT01031836|20690346|P5|NOT COMPLETED|Stage II||2
8394825|NCT01031836|20690347|P4|NOT COMPLETED|Stage II||3
8394826|NCT01031836|20690348|P3|NOT COMPLETED|Stage II||2
8394827|NCT01031836|20690349|P2|NOT COMPLETED|Stage II||0
8394828|NCT01031836|20690350|P1|NOT COMPLETED|Stage II||2
8394829|NCT01031836|20690345|P6|COMPLETED|Stage II||3
8394830|NCT01031836|20690346|P5|COMPLETED|Stage II||3
8394831|NCT01031836|20690347|P4|COMPLETED|Stage II||1
8394832|NCT01031836|20690348|P3|COMPLETED|Stage II||2
8394833|NCT01031836|20690349|P2|COMPLETED|Stage II||1
8394834|NCT01031836|20690350|P1|COMPLETED|Stage II||1
8394835|NCT01031836|20690345|P6|STARTED|Stage II||4
8394836|NCT01031836|20690346|P5|STARTED|Stage II||5
8394837|NCT01031836|20690347|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
8394838|NCT01031836|20690348|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
8394839|NCT01031836|20690349|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
8394840|NCT01031836|20690350|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
8394841|NCT01031836|20690345|P6|NOT COMPLETED|Stage I||1
8394842|NCT01031836|20690346|P5|NOT COMPLETED|Stage I||0
8394843|NCT01031836|20690347|P4|NOT COMPLETED|Stage I||0
8394844|NCT01031836|20690348|P3|NOT COMPLETED|Stage I||0
8394845|NCT01031836|20690349|P2|NOT COMPLETED|Stage I||2
8394846|NCT01031836|20690350|P1|NOT COMPLETED|Stage I||1
8394847|NCT01031836|20690345|P6|COMPLETED|Stage I||4
8394848|NCT01031836|20690346|P5|COMPLETED|Stage I||5
8394849|NCT01031836|20690347|P4|COMPLETED|Stage I||5
8394850|NCT01031836|20690348|P3|COMPLETED|Stage I||5
8394851|NCT01031836|20690349|P2|COMPLETED|Stage I||3
8394852|NCT01031836|20690350|P1|COMPLETED|Stage I||4
8394853|NCT01031836|20690345|P6|STARTED|Stage I||5
8394854|NCT01031836|20690346|P5|STARTED|Stage I||5
8394855|NCT01031836|20690347|P4|STARTED|Stage I||5
8394856|NCT01031836|20690348|P3|STARTED|Stage I||5
8394857|NCT01031836|20690349|P2|STARTED|Stage I||5
8394858|NCT01031836|20690350|P1|STARTED|Stage I||5
8394859|NCT01031810|20690400|P1|NOT COMPLETED|Overall Study||4
8394860|NCT01031810|20690400|P1|COMPLETED|Overall Study||9
8394861|NCT01031810|20690400|P1|STARTED|Overall Study||13
8394862|NCT01031706|20690411|P2|NOT COMPLETED|Overall Study||1
8394863|NCT01031706|20690412|P1|NOT COMPLETED|Overall Study||2
8394864|NCT01031706|20690411|P2|COMPLETED|Overall Study||8
8394865|NCT01031706|20690412|P1|COMPLETED|Overall Study||12
8394866|NCT01031706|20690411|P2|STARTED|Overall Study||9
8394867|NCT01031706|20690412|P1|STARTED|Overall Study||14
8394868|NCT01031680|20690422|P2|NOT COMPLETED|Overall Study||58
8394869|NCT01031680|20690423|P1|NOT COMPLETED|Overall Study||57
8394870|NCT01031680|20690422|P2|COMPLETED|Overall Study||404
8394871|NCT01031680|20690423|P1|COMPLETED|Overall Study||403
8394872|NCT01031680|20690422|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
8394873|NCT01031680|20690423|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
8394874|NCT01031628|20690443|P4|NOT COMPLETED|Overall Study||0
8394875|NCT01031628|20690444|P3|NOT COMPLETED|Overall Study||3
8394876|NCT01031628|20690445|P2|NOT COMPLETED|Overall Study||1
8394877|NCT01031628|20690446|P1|NOT COMPLETED|Overall Study||0
8394878|NCT01031628|20690443|P4|COMPLETED|Overall Study||0
8394879|NCT01031628|20690444|P3|COMPLETED|Overall Study||0
8394880|NCT01031628|20690445|P2|COMPLETED|Overall Study||0
8394881|NCT01031628|20690446|P1|COMPLETED|Overall Study||0
8394882|NCT01031628|20690443|P4|STARTED|Overall Study||0
8394883|NCT01031628|20690444|P3|STARTED|Overall Study||3
8394884|NCT01031628|20690445|P2|STARTED|Overall Study||1
8394885|NCT01031628|20690446|P1|STARTED|Overall Study||0
8394886|NCT01031550|20690458|P2|NOT COMPLETED|Overall Study||0
8394887|NCT01031550|20690459|P1|NOT COMPLETED|Overall Study||0
8394888|NCT01031550|20690458|P2|COMPLETED|Overall Study||3
8394889|NCT01031550|20690459|P1|COMPLETED|Overall Study||5
8394890|NCT01031550|20690458|P2|STARTED|Overall Study||3
8394891|NCT01031550|20690459|P1|STARTED|Overall Study||5
8394892|NCT01031537|20690471|P1|NOT COMPLETED|Overall Study||32
8394893|NCT01031537|20690471|P1|COMPLETED|Overall Study||34
8394894|NCT01031537|20690471|P1|STARTED|Overall Study||66
8394895|NCT01031498|20690479|P3|NOT COMPLETED|Overall Study||2
8394896|NCT01031498|20690480|P2|NOT COMPLETED|Overall Study||3
8394897|NCT01031498|20690481|P1|NOT COMPLETED|Overall Study||2
8394898|NCT01031498|20690479|P3|COMPLETED|Overall Study||48
8394899|NCT01031498|20690480|P2|COMPLETED|Overall Study||48
8394900|NCT01031498|20690481|P1|COMPLETED|Overall Study||47
8394901|NCT01031498|20690479|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
8394902|NCT01031498|20690480|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
8394903|NCT01031498|20690481|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
8394904|NCT01031446|20690489|P1|NOT COMPLETED|Overall Study||55
8394905|NCT01031446|20690489|P1|COMPLETED|Overall Study||0
8394906|NCT01031446|20690489|P1|STARTED|Overall Study||55
8394907|NCT01031420|20690498|P1|NOT COMPLETED|Overall Study||10
8394908|NCT01031420|20690498|P1|COMPLETED|Overall Study||44
8394909|NCT01031420|20690498|P1|STARTED|Overall Study||54
8394910|NCT01031381|20690503|P1|NOT COMPLETED|Overall Study||9
8394911|NCT01031381|20690503|P1|COMPLETED|Overall Study||50
8394912|NCT01031381|20690503|P1|STARTED|Overall Study||59
8394913|NCT01031134|20690510|P2|NOT COMPLETED|Overall Study||10
8394914|NCT01031134|20690511|P1|NOT COMPLETED|Overall Study||11
8394915|NCT01031134|20690510|P2|COMPLETED|Overall Study||78
8394916|NCT01031134|20690511|P1|COMPLETED|Overall Study||103
8394917|NCT01031134|20690510|P2|STARTED|Overall Study||88
8394918|NCT01031134|20690511|P1|STARTED|Overall Study||114
8394919|NCT01031095|20690521|P2|NOT COMPLETED|Overall Study||0
8394920|NCT01031095|20690522|P1|NOT COMPLETED|Overall Study||0
8394921|NCT01031095|20690521|P2|COMPLETED|Overall Study||100
8394922|NCT01031095|20690522|P1|COMPLETED|Overall Study||100
8394923|NCT01031095|20690521|P2|STARTED|Overall Study||100
8394924|NCT01031095|20690522|P1|STARTED|Overall Study||100
8394925|NCT01031069|20690532|P4|NOT COMPLETED|Overall Study||34
8394926|NCT01031069|20690533|P3|NOT COMPLETED|Overall Study||41
8394927|NCT01031069|20690534|P2|NOT COMPLETED|Overall Study||11
8394928|NCT01031069|20690535|P1|NOT COMPLETED|Overall Study||12
8394929|NCT01031069|20690532|P4|COMPLETED|Overall Study||111
8394930|NCT01031069|20690533|P3|COMPLETED|Overall Study||103
8394931|NCT01031069|20690534|P2|COMPLETED|Overall Study||117
8394932|NCT01031069|20690535|P1|COMPLETED|Overall Study||117
8394933|NCT01031069|20690532|P4|STARTED|Overall Study||145
8394934|NCT01031069|20690533|P3|STARTED|Overall Study||144
8394935|NCT01031069|20690534|P2|STARTED|Overall Study||128
8394936|NCT01031069|20690535|P1|STARTED|Overall Study||129
8394937|NCT01031043|20690631|P1|NOT COMPLETED|Overall Study||1
8394938|NCT01031043|20690631|P1|COMPLETED|Overall Study||4
8394939|NCT01031043|20690631|P1|STARTED|Overall Study||5
8394940|NCT01031004|20690637|P2|NOT COMPLETED|Overall Study||1
8394941|NCT01031004|20690638|P1|NOT COMPLETED|Overall Study||1
8394942|NCT01031004|20690637|P2|COMPLETED|Overall Study||24
8394943|NCT01031004|20690638|P1|COMPLETED|Overall Study||24
8394944|NCT01031004|20690637|P2|STARTED|Overall Study||25
8394945|NCT01031004|20690638|P1|STARTED|Overall Study||25
8394946|NCT01030965|20690682|P4|NOT COMPLETED|Overall Study||7
8394947|NCT01030965|20690683|P3|NOT COMPLETED|Overall Study||4
8394948|NCT01030965|20690684|P2|NOT COMPLETED|Overall Study||6
8394949|NCT01030965|20690685|P1|NOT COMPLETED|Overall Study||4
8394950|NCT01030965|20690682|P4|COMPLETED|Overall Study||64
8394951|NCT01030965|20690683|P3|COMPLETED|Overall Study||68
8394952|NCT01030965|20690684|P2|COMPLETED|Overall Study||65
8394953|NCT01030965|20690685|P1|COMPLETED|Overall Study||67
8394954|NCT01030965|20690682|P4|STARTED|Overall Study||71
8394955|NCT01030965|20690683|P3|STARTED|Overall Study||72
8394956|NCT01030965|20690684|P2|STARTED|Overall Study||71
8394957|NCT01030965|20690685|P1|STARTED|Overall Study||71
8394958|NCT01030952|20690705|P2|NOT COMPLETED|Overall Study||3
8394959|NCT01030952|20690706|P1|NOT COMPLETED|Overall Study||2
8394960|NCT01030952|20690705|P2|COMPLETED|Overall Study||49
8394961|NCT01030952|20690706|P1|COMPLETED|Overall Study||49
8394962|NCT01030952|20690705|P2|STARTED|Overall Study||52
8394963|NCT01030952|20690706|P1|STARTED|Overall Study||51
8394964|NCT01030861|20690742|P2|NOT COMPLETED|Overall Study||0
8394965|NCT01030861|20690743|P1|NOT COMPLETED|Overall Study||0
8394966|NCT01030861|20690742|P2|COMPLETED|Overall Study||32
8394967|NCT01030861|20690743|P1|COMPLETED|Overall Study||44
8394968|NCT01030861|20690742|P2|STARTED|Overall Study||32
8394969|NCT01030861|20690743|P1|STARTED|Overall Study||44
8394970|NCT01030822|20690754|P3|NOT COMPLETED|Overall Study||26
8394971|NCT01030822|20690755|P2|NOT COMPLETED|Overall Study||24
8394972|NCT01030822|20690756|P1|NOT COMPLETED|Overall Study||31
8394973|NCT01030822|20690754|P3|COMPLETED|Overall Study||61
8394974|NCT01030822|20690755|P2|COMPLETED|Overall Study||71
8394975|NCT01030822|20690756|P1|COMPLETED|Overall Study||69
8394976|NCT01030822|20690754|P3|STARTED|Overall Study||87
8394977|NCT01030822|20690755|P2|STARTED|Overall Study||95
8394978|NCT01030822|20690756|P1|STARTED|Overall Study||100
8394979|NCT01030783|20690805|P2|NOT COMPLETED|Overall Study||26
8394980|NCT01030783|20690806|P1|NOT COMPLETED|Overall Study||49
8394981|NCT01030783|20690805|P2|COMPLETED|Overall Study||231
8394982|NCT01030783|20690806|P1|COMPLETED|Overall Study||211
8394983|NCT01030783|20690805|P2|STARTED|Overall Study||257
8394984|NCT01030783|20690806|P1|STARTED|Overall Study||260
8394985|NCT01030757|20690823|P1|NOT COMPLETED|Overall Study||0
8394986|NCT01030757|20690823|P1|COMPLETED|Overall Study||2
8394987|NCT01030757|20690823|P1|STARTED|Overall Study||2
8394988|NCT01030718|20690831|P3|NOT COMPLETED|Study CA180-036 Only||5
8394989|NCT01030718|20690832|P2|NOT COMPLETED|Study CA180-036 Only||7
8394990|NCT01030718|20690833|P1|NOT COMPLETED|Study CA180-036 Only||3
8394991|NCT01030718|20690831|P3|COMPLETED|Study CA180-036 Only||1
8394992|NCT01030718|20690832|P2|COMPLETED|Study CA180-036 Only||2
8394993|NCT01030718|20690833|P1|COMPLETED|Study CA180-036 Only||26
8394994|NCT01030718|20690831|P3|STARTED|Study CA180-036 Only||6
8394995|NCT01030718|20690832|P2|STARTED|Study CA180-036 Only||9
8394996|NCT01030718|20690833|P1|STARTED|Study CA180-036 Only||29
8394997|NCT01030718|20690831|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
8394998|NCT01030718|20690832|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
8394999|NCT01030718|20690833|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
8395000|NCT01030718|20690831|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
8395001|NCT01030718|20690832|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
8395002|NCT01030718|20690833|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
8395003|NCT01030718|20690831|P3|STARTED|Studies CA180-031 and -036 Combined||13
8395004|NCT01030718|20690832|P2|STARTED|Studies CA180-031 and -036 Combined||11
8395005|NCT01030718|20690833|P1|STARTED|Studies CA180-031 and -036 Combined||30
8395006|NCT01030666|20690894|P2|NOT COMPLETED|Overall Study||2
8395007|NCT01030666|20690895|P1|NOT COMPLETED|Overall Study||3
8395008|NCT01030666|20690894|P2|COMPLETED|Overall Study||31
8395009|NCT01030666|20690895|P1|COMPLETED|Overall Study||25
8395010|NCT01030666|20690894|P2|STARTED|Overall Study||33
8395011|NCT01030666|20690895|P1|STARTED|Overall Study||28
8395012|NCT01030653|20690905|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
8395013|NCT01030653|20690906|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
8395014|NCT01030653|20690905|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
8395015|NCT01030653|20690906|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
8395016|NCT01030653|20690905|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
8395017|NCT01030653|20690906|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
8395018|NCT01030653|20690905|P2|NOT COMPLETED|7-Day Washout Period||0
8395019|NCT01030653|20690906|P1|NOT COMPLETED|7-Day Washout Period||0
8395020|NCT01030653|20690905|P2|COMPLETED|7-Day Washout Period||4
8395021|NCT01030653|20690906|P1|COMPLETED|7-Day Washout Period||4
8395022|NCT01030653|20690905|P2|STARTED|7-Day Washout Period||4
8395023|NCT01030653|20690906|P1|STARTED|7-Day Washout Period||4
8395024|NCT01030653|20690905|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
8395025|NCT01030653|20690906|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
8395026|NCT01030653|20690905|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
8395027|NCT01030653|20690906|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
8395028|NCT01030653|20690905|P2|STARTED|Loading Dose & First Maintenance Regimen||4
8395029|NCT01030653|20690906|P1|STARTED|Loading Dose & First Maintenance Regimen||4
8395030|NCT01030536|20690920|P5|NOT COMPLETED|Overall Study||1
8395031|NCT01030536|20690921|P4|NOT COMPLETED|Overall Study||3
8395032|NCT01030536|20690922|P3|NOT COMPLETED|Overall Study||6
8395033|NCT01030536|20690923|P2|NOT COMPLETED|Overall Study||6
8395034|NCT01030536|20690924|P1|NOT COMPLETED|Overall Study||7
8395035|NCT01030536|20690920|P5|COMPLETED|Overall Study||0
8395036|NCT01030536|20690921|P4|COMPLETED|Overall Study||0
8395037|NCT01030536|20690922|P3|COMPLETED|Overall Study||0
8395038|NCT01030536|20690923|P2|COMPLETED|Overall Study||0
8395039|NCT01030536|20690924|P1|COMPLETED|Overall Study||0
8395040|NCT01030536|20690920|P5|STARTED|Overall Study||1
8395041|NCT01030536|20690921|P4|STARTED|Overall Study||3
8395042|NCT01030536|20690922|P3|STARTED|Overall Study||6
8395043|NCT01030536|20690923|P2|STARTED|Overall Study||6
8395044|NCT01030536|20690924|P1|STARTED|Overall Study||7
8395045|NCT01030523|20691029|P2|NOT COMPLETED|Overall Study||5
8395046|NCT01030523|20691030|P1|NOT COMPLETED|Overall Study||6
8395047|NCT01030523|20691029|P2|COMPLETED|Overall Study||46
8395048|NCT01030523|20691030|P1|COMPLETED|Overall Study||44
8395049|NCT01030523|20691029|P2|STARTED|Overall Study||51
8395050|NCT01030523|20691030|P1|STARTED|Overall Study||50
8395051|NCT01030458|20691044|P2|NOT COMPLETED|Overall Study||32
8395052|NCT01030458|20691045|P1|NOT COMPLETED|Overall Study||27
8395053|NCT01030458|20691044|P2|COMPLETED|Overall Study||57
8395054|NCT01030458|20691045|P1|COMPLETED|Overall Study||67
8395055|NCT01030458|20691044|P2|STARTED|Overall Study||89
8395056|NCT01030458|20691045|P1|STARTED|Overall Study||94
8395057|NCT01030406|20691062|P5|NOT COMPLETED|Overall Study||0
8395058|NCT01030406|20691063|P4|NOT COMPLETED|Overall Study||1
8395059|NCT01030406|20691064|P3|NOT COMPLETED|Overall Study||1
8395060|NCT01030406|20691065|P2|NOT COMPLETED|Overall Study||0
8395061|NCT01030406|20691066|P1|NOT COMPLETED|Overall Study||0
8395062|NCT01030406|20691062|P5|COMPLETED|Overall Study||9
8395063|NCT01030406|20691063|P4|COMPLETED|Overall Study||9
8395064|NCT01030406|20691064|P3|COMPLETED|Overall Study||9
8395065|NCT01030406|20691065|P2|COMPLETED|Overall Study||10
8395066|NCT01030406|20691066|P1|COMPLETED|Overall Study||10
8395067|NCT01030406|20691062|P5|STARTED|Overall Study||9
8395068|NCT01030406|20691063|P4|STARTED|Overall Study||10
8395069|NCT01030406|20691064|P3|STARTED|Overall Study||10
8395070|NCT01030406|20691065|P2|STARTED|Overall Study||10
8395071|NCT01030406|20691066|P1|STARTED|Overall Study||10
8395072|NCT01030341|20691078|P1|NOT COMPLETED|Overall Study||3
8395073|NCT01030341|20691078|P1|COMPLETED|Overall Study|42 participants completed the study|42
8395074|NCT01030341|20691078|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
8395075|NCT01030289|20691083|P2|NOT COMPLETED|Overall Study||0
8395076|NCT01030289|20691084|P1|NOT COMPLETED|Overall Study||0
8395077|NCT01030289|20691083|P2|COMPLETED|Overall Study||10
8395078|NCT01030289|20691084|P1|COMPLETED|Overall Study||9
8395079|NCT01030289|20691083|P2|STARTED|Overall Study||10
8395080|NCT01030289|20691084|P1|STARTED|Overall Study||9
8395081|NCT01030198|20691101|P2|NOT COMPLETED|Overall Study||7
8395082|NCT01030198|20691102|P1|NOT COMPLETED|Overall Study||0
8395083|NCT01030198|20691101|P2|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
8395084|NCT01030198|20691102|P1|COMPLETED|Overall Study|None recruited|0
8395085|NCT01030198|20691101|P2|STARTED|Overall Study||7
8395086|NCT01030198|20691102|P1|STARTED|Overall Study|None recruited|0
8395087|NCT01030133|20691110|P2|NOT COMPLETED|Overall Study||2
8395088|NCT01030133|20691111|P1|NOT COMPLETED|Overall Study||2
8395089|NCT01030133|20691110|P2|COMPLETED|Overall Study||12
8395090|NCT01030133|20691111|P1|COMPLETED|Overall Study||12
8395091|NCT01030133|20691110|P2|STARTED|Overall Study||14
8395092|NCT01030133|20691111|P1|STARTED|Overall Study||14
8395093|NCT01029925|20691123|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
8395094|NCT01029925|20691123|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
8395095|NCT01029925|20691123|P1|STARTED|Completion of Cycle 2 (56 Days)||3
8395096|NCT01029925|20691123|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
8395097|NCT01029925|20691123|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
8395098|NCT01029925|20691123|P1|STARTED|Completion of Cycle 1 (28 Days)||7
8395099|NCT01029912|20691129|P2|NOT COMPLETED|Overall Study||0
8395100|NCT01029912|20691130|P1|NOT COMPLETED|Overall Study||2
8395101|NCT01029912|20691129|P2|COMPLETED|Overall Study||12
8395102|NCT01029912|20691130|P1|COMPLETED|Overall Study||12
8395103|NCT01029912|20691129|P2|STARTED|Overall Study||12
8395104|NCT01029912|20691130|P1|STARTED|Overall Study||14
8395105|NCT01029886|20691142|P2|NOT COMPLETED|Overall Study||60
8395106|NCT01029886|20691143|P1|NOT COMPLETED|Overall Study||61
8395107|NCT01029886|20691142|P2|COMPLETED|Overall Study||391
8395108|NCT01029886|20691143|P1|COMPLETED|Overall Study||400
8395109|NCT01029886|20691142|P2|Intent to Treat (ITT)|Overall Study||450
8395110|NCT01029886|20691143|P1|Intent to Treat (ITT)|Overall Study||461
8395111|NCT01029886|20691142|P2|STARTED|Overall Study||451
8395112|NCT01029886|20691143|P1|STARTED|Overall Study||461
8395113|NCT01029795|20691171|P2|NOT COMPLETED|Overall Study||22
8395114|NCT01029795|20691172|P1|NOT COMPLETED|Overall Study||16
8395115|NCT01029795|20691171|P2|COMPLETED|Overall Study||0
8395116|NCT01029795|20691172|P1|COMPLETED|Overall Study||0
8395117|NCT01029795|20691171|P2|STARTED|Overall Study||22
8395118|NCT01029795|20691172|P1|STARTED|Overall Study||16
8395119|NCT01029782|20691226|P2|NOT COMPLETED|Overall Study||8
8395120|NCT01029782|20691227|P1|NOT COMPLETED|Overall Study||3
8395121|NCT01029782|20691226|P2|COMPLETED|Overall Study||96
8395122|NCT01029782|20691227|P1|COMPLETED|Overall Study||99
8395123|NCT01029782|20691226|P2|STARTED|Overall Study||104
8395124|NCT01029782|20691227|P1|STARTED|Overall Study||102
8395125|NCT01029730|20691233|P1|NOT COMPLETED|Maintenance Therapy||23
8395126|NCT01029730|20691233|P1|COMPLETED|Maintenance Therapy||14
8395127|NCT01029730|20691233|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
8395128|NCT01029730|20691233|P1|NOT COMPLETED|Combination Therapy||16
8395129|NCT01029730|20691233|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
8395130|NCT01029730|20691233|P1|STARTED|Combination Therapy||55
8395131|NCT01029704|20691245|P5|NOT COMPLETED|Overall Study||0
8395132|NCT01029704|20691246|P4|NOT COMPLETED|Overall Study||0
8395133|NCT01029704|20691247|P3|NOT COMPLETED|Overall Study||0
8395134|NCT01029704|20691248|P2|NOT COMPLETED|Overall Study||0
8395135|NCT01029704|20691249|P1|NOT COMPLETED|Overall Study||0
8395136|NCT01029704|20691245|P5|COMPLETED|Overall Study||26
8395137|NCT01029704|20691246|P4|COMPLETED|Overall Study||28
8395138|NCT01029704|20691247|P3|COMPLETED|Overall Study||23
8395139|NCT01029704|20691248|P2|COMPLETED|Overall Study||24
8395140|NCT01029704|20691249|P1|COMPLETED|Overall Study||28
8395141|NCT01029704|20691245|P5|STARTED|Overall Study||26
8395142|NCT01029704|20691246|P4|STARTED|Overall Study||28
8395143|NCT01029704|20691247|P3|STARTED|Overall Study||23
8395144|NCT01029704|20691248|P2|STARTED|Overall Study||24
8395145|NCT01029704|20691249|P1|STARTED|Overall Study||28
8395146|NCT01029691|20691279|P3|NOT COMPLETED|Continued APAP to Delivery||1
8395147|NCT01029691|20691280|P2|NOT COMPLETED|Continued APAP to Delivery||0
8395148|NCT01029691|20691281|P1|NOT COMPLETED|Continued APAP to Delivery||0
8395149|NCT01029691|20691279|P3|COMPLETED|Continued APAP to Delivery||76
8395150|NCT01029691|20691280|P2|COMPLETED|Continued APAP to Delivery||16
8395151|NCT01029691|20691281|P1|COMPLETED|Continued APAP to Delivery||20
8395152|NCT01029691|20691279|P3|STARTED|Continued APAP to Delivery||77
8395153|NCT01029691|20691280|P2|STARTED|Continued APAP to Delivery||16
8395154|NCT01029691|20691281|P1|STARTED|Continued APAP to Delivery||20
8395155|NCT01029691|20691279|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
8395156|NCT01029691|20691280|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
8395157|NCT01029691|20691281|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
8395158|NCT01029691|20691279|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
8395159|NCT01029691|20691280|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
8395160|NCT01029691|20691281|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
8395161|NCT01029691|20691279|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
8395162|NCT01029691|20691280|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
8395163|NCT01029691|20691281|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
8395164|NCT01029691|20691279|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
8395165|NCT01029691|20691280|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
8395166|NCT01029691|20691281|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
8395167|NCT01029691|20691279|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
8395168|NCT01029691|20691280|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
8395169|NCT01029691|20691281|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
8395170|NCT01029652|20691306|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
8395171|NCT01029652|20691307|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
8395172|NCT01029652|20691306|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
8395173|NCT01029652|20691307|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
8395174|NCT01029652|20691306|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
8395175|NCT01029652|20691307|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
8395176|NCT01029652|20691306|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
8395177|NCT01029652|20691307|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
8395178|NCT01029652|20691306|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
8395179|NCT01029652|20691307|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
8395180|NCT01029652|20691306|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
8395181|NCT01029652|20691307|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
8395182|NCT01029652|20691306|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
8395183|NCT01029652|20691307|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
8395184|NCT01029652|20691306|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
8395185|NCT01029652|20691307|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
8395186|NCT01029652|20691306|P2|COMPLETED|Core Study (0-12 Weeks)||105
8395187|NCT01029652|20691307|P1|COMPLETED|Core Study (0-12 Weeks)||109
8395188|NCT01029652|20691306|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
8395189|NCT01029652|20691307|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
8395190|NCT01029652|20691306|P2|STARTED|Core Study (0-12 Weeks)||115
8395191|NCT01029652|20691307|P1|STARTED|Core Study (0-12 Weeks)||115
8395192|NCT01029587|20691385|P1|NOT COMPLETED|Overall Study||0
8395193|NCT01029587|20691385|P1|COMPLETED|Overall Study||1
8395194|NCT01029587|20691385|P1|STARTED|Overall Study||1
8395195|NCT01029535|20691391|P1|NOT COMPLETED|Overall Study||31
8395196|NCT01029535|20691391|P1|COMPLETED|Overall Study||72
8395197|NCT01029535|20691391|P1|STARTED|Overall Study||103
8395198|NCT01029405|20691420|P4|NOT COMPLETED|Overall Study||5
8395199|NCT01029405|20691421|P3|NOT COMPLETED|Overall Study||4
8395200|NCT01029405|20691422|P2|NOT COMPLETED|Overall Study||3
8395201|NCT01029405|20691423|P1|NOT COMPLETED|Overall Study||2
8395202|NCT01029405|20691420|P4|COMPLETED|Overall Study||32
8395203|NCT01029405|20691421|P3|COMPLETED|Overall Study||31
8395204|NCT01029405|20691422|P2|COMPLETED|Overall Study||34
8395205|NCT01029405|20691423|P1|COMPLETED|Overall Study||34
8395206|NCT01029405|20691420|P4|STARTED|Overall Study||37
8395207|NCT01029405|20691421|P3|STARTED|Overall Study||35
8395208|NCT01029405|20691422|P2|STARTED|Overall Study||37
8395209|NCT01029405|20691423|P1|STARTED|Overall Study||36
8395210|NCT01029392|20691435|P2|NOT COMPLETED|Overall Study||11
8395211|NCT01029392|20691436|P1|NOT COMPLETED|Overall Study||20
8395212|NCT01029392|20691435|P2|COMPLETED|Overall Study||27
8395213|NCT01029392|20691436|P1|COMPLETED|Overall Study||17
8395214|NCT01029392|20691435|P2|STARTED|Overall Study||38
8395215|NCT01029392|20691436|P1|STARTED|Overall Study||37
8395216|NCT01029366|20691446|P2|NOT COMPLETED|Overall Study||2
8395217|NCT01029366|20691447|P1|NOT COMPLETED|Overall Study||4
8395218|NCT01029366|20691446|P2|COMPLETED|Overall Study||6
8395219|NCT01029366|20691447|P1|COMPLETED|Overall Study||14
8395220|NCT01029366|20691446|P2|STARTED|Overall Study||8
8395221|NCT01029366|20691447|P1|STARTED|Overall Study||18
8395222|NCT01029340|20691459|P6|NOT COMPLETED|Part C Follow up Period||0
8395223|NCT01029340|20691460|P5|NOT COMPLETED|Part C Follow up Period||0
8395224|NCT01029340|20691461|P4|NOT COMPLETED|Part C Follow up Period||0
8395225|NCT01029340|20691462|P3|NOT COMPLETED|Part C Follow up Period||0
8395226|NCT01029340|20691463|P2|NOT COMPLETED|Part C Follow up Period||0
8395227|NCT01029340|20691464|P1|NOT COMPLETED|Part C Follow up Period||0
8395228|NCT01029340|20691459|P6|COMPLETED|Part C Follow up Period||0
8395229|NCT01029340|20691460|P5|COMPLETED|Part C Follow up Period||5
8395230|NCT01029340|20691461|P4|COMPLETED|Part C Follow up Period||0
8395231|NCT01029340|20691462|P3|COMPLETED|Part C Follow up Period||0
8395232|NCT01029340|20691463|P2|COMPLETED|Part C Follow up Period||0
8395233|NCT01029340|20691464|P1|COMPLETED|Part C Follow up Period||0
8395234|NCT01029340|20691459|P6|STARTED|Part C Follow up Period||0
8395235|NCT01029340|20691460|P5|STARTED|Part C Follow up Period||5
8395236|NCT01029340|20691461|P4|STARTED|Part C Follow up Period||0
8395237|NCT01029340|20691462|P3|STARTED|Part C Follow up Period||0
8395238|NCT01029340|20691463|P2|STARTED|Part C Follow up Period||0
8395239|NCT01029340|20691464|P1|STARTED|Part C Follow up Period||0
8395240|NCT01029340|20691459|P6|NOT COMPLETED|Part C Treatment Period||0
8395241|NCT01029340|20691460|P5|NOT COMPLETED|Part C Treatment Period||0
8395242|NCT01029340|20691461|P4|NOT COMPLETED|Part C Treatment Period||0
8395243|NCT01029340|20691462|P3|NOT COMPLETED|Part C Treatment Period||0
8395244|NCT01029340|20691463|P2|NOT COMPLETED|Part C Treatment Period||0
8395245|NCT01029340|20691464|P1|NOT COMPLETED|Part C Treatment Period||0
8395246|NCT01029340|20691459|P6|COMPLETED|Part C Treatment Period||0
8395247|NCT01029340|20691460|P5|COMPLETED|Part C Treatment Period||5
8395248|NCT01029340|20691461|P4|COMPLETED|Part C Treatment Period||0
8395249|NCT01029340|20691462|P3|COMPLETED|Part C Treatment Period||0
8395250|NCT01029340|20691463|P2|COMPLETED|Part C Treatment Period||0
8395251|NCT01029340|20691464|P1|COMPLETED|Part C Treatment Period||0
8395252|NCT01029340|20691459|P6|Participants Received Treatment|Part C Treatment Period||0
8395253|NCT01029340|20691460|P5|Participants Received Treatment|Part C Treatment Period||5
8395254|NCT01029340|20691461|P4|Participants Received Treatment|Part C Treatment Period||0
8395255|NCT01029340|20691462|P3|Participants Received Treatment|Part C Treatment Period||0
8395256|NCT01029340|20691463|P2|Participants Received Treatment|Part C Treatment Period||0
8395257|NCT01029340|20691464|P1|Participants Received Treatment|Part C Treatment Period||0
8395258|NCT01029340|20691459|P6|STARTED|Part C Treatment Period||0
8395259|NCT01029340|20691460|P5|STARTED|Part C Treatment Period||5
8395260|NCT01029340|20691461|P4|STARTED|Part C Treatment Period||0
8395261|NCT01029340|20691462|P3|STARTED|Part C Treatment Period||0
8395262|NCT01029340|20691463|P2|STARTED|Part C Treatment Period||0
8395263|NCT01029340|20691464|P1|STARTED|Part C Treatment Period||0
8395264|NCT01029340|20691459|P6|NOT COMPLETED|Extension Period||12
8395265|NCT01029340|20691460|P5|NOT COMPLETED|Extension Period||0
8395266|NCT01029340|20691461|P4|NOT COMPLETED|Extension Period||0
8395267|NCT01029340|20691462|P3|NOT COMPLETED|Extension Period||0
8395268|NCT01029340|20691463|P2|NOT COMPLETED|Extension Period||0
8395269|NCT01029340|20691464|P1|NOT COMPLETED|Extension Period||0
8395270|NCT01029340|20691459|P6|COMPLETED|Extension Period||43
8395271|NCT01029340|20691460|P5|COMPLETED|Extension Period||0
8395272|NCT01029340|20691461|P4|COMPLETED|Extension Period||0
8395273|NCT01029340|20691462|P3|COMPLETED|Extension Period||0
8395274|NCT01029340|20691463|P2|COMPLETED|Extension Period||0
8395275|NCT01029340|20691464|P1|COMPLETED|Extension Period||0
8395276|NCT01029340|20691459|P6|STARTED|Extension Period||55
8395277|NCT01029340|20691460|P5|STARTED|Extension Period||0
8395278|NCT01029340|20691461|P4|STARTED|Extension Period||0
8395279|NCT01029340|20691462|P3|STARTED|Extension Period||0
8395280|NCT01029340|20691463|P2|STARTED|Extension Period||0
8395281|NCT01029340|20691464|P1|STARTED|Extension Period||0
8395282|NCT01029340|20691459|P6|NOT COMPLETED|Part B Follow up Period||0
8395283|NCT01029340|20691460|P5|NOT COMPLETED|Part B Follow up Period||0
8395284|NCT01029340|20691461|P4|NOT COMPLETED|Part B Follow up Period||0
8395285|NCT01029340|20691462|P3|NOT COMPLETED|Part B Follow up Period||0
8395286|NCT01029340|20691463|P2|NOT COMPLETED|Part B Follow up Period||0
8395287|NCT01029340|20691464|P1|NOT COMPLETED|Part B Follow up Period||0
8395288|NCT01029340|20691459|P6|COMPLETED|Part B Follow up Period||0
8395289|NCT01029340|20691460|P5|COMPLETED|Part B Follow up Period||0
8395290|NCT01029340|20691461|P4|COMPLETED|Part B Follow up Period||32
8395291|NCT01029340|20691462|P3|COMPLETED|Part B Follow up Period||29
8395292|NCT01029340|20691463|P2|COMPLETED|Part B Follow up Period||0
8395293|NCT01029340|20691464|P1|COMPLETED|Part B Follow up Period||0
8395294|NCT01029340|20691459|P6|STARTED|Part B Follow up Period||0
8395295|NCT01029340|20691460|P5|STARTED|Part B Follow up Period||0
8395296|NCT01029340|20691461|P4|STARTED|Part B Follow up Period||32
8395297|NCT01029340|20691462|P3|STARTED|Part B Follow up Period||29
8395298|NCT01029340|20691463|P2|STARTED|Part B Follow up Period||0
8395299|NCT01029340|20691464|P1|STARTED|Part B Follow up Period||0
8395300|NCT01029340|20691459|P6|NOT COMPLETED|Part B Treatment Period||0
8395301|NCT01029340|20691460|P5|NOT COMPLETED|Part B Treatment Period||0
8395302|NCT01029340|20691461|P4|NOT COMPLETED|Part B Treatment Period||0
8395303|NCT01029340|20691462|P3|NOT COMPLETED|Part B Treatment Period||2
8395304|NCT01029340|20691463|P2|NOT COMPLETED|Part B Treatment Period||0
8395305|NCT01029340|20691464|P1|NOT COMPLETED|Part B Treatment Period||0
8395306|NCT01029340|20691459|P6|COMPLETED|Part B Treatment Period||0
8395307|NCT01029340|20691460|P5|COMPLETED|Part B Treatment Period||0
8395308|NCT01029340|20691461|P4|COMPLETED|Part B Treatment Period||32
8395309|NCT01029340|20691462|P3|COMPLETED|Part B Treatment Period||29
8395310|NCT01029340|20691463|P2|COMPLETED|Part B Treatment Period||0
8395311|NCT01029340|20691464|P1|COMPLETED|Part B Treatment Period||0
8395312|NCT01029340|20691459|P6|Participants Received Treatment|Part B Treatment Period||0
8395313|NCT01029340|20691460|P5|Participants Received Treatment|Part B Treatment Period||0
8395314|NCT01029340|20691461|P4|Participants Received Treatment|Part B Treatment Period||32
8395315|NCT01029340|20691462|P3|Participants Received Treatment|Part B Treatment Period||30
8395316|NCT01029340|20691463|P2|Participants Received Treatment|Part B Treatment Period||0
8395317|NCT01029340|20691464|P1|Participants Received Treatment|Part B Treatment Period||0
8395318|NCT01029340|20691459|P6|STARTED|Part B Treatment Period||0
8395319|NCT01029340|20691460|P5|STARTED|Part B Treatment Period||0
8395320|NCT01029340|20691461|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
8395321|NCT01029340|20691462|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
8395322|NCT01029340|20691463|P2|STARTED|Part B Treatment Period||0
8395323|NCT01029340|20691464|P1|STARTED|Part B Treatment Period||0
8395324|NCT01029340|20691459|P6|NOT COMPLETED|Part A Follow up Period||0
8395325|NCT01029340|20691460|P5|NOT COMPLETED|Part A Follow up Period||0
8395326|NCT01029340|20691461|P4|NOT COMPLETED|Part A Follow up Period||0
8395327|NCT01029340|20691462|P3|NOT COMPLETED|Part A Follow up Period||0
8395328|NCT01029340|20691463|P2|NOT COMPLETED|Part A Follow up Period||0
8395329|NCT01029340|20691464|P1|NOT COMPLETED|Part A Follow up Period||0
8395330|NCT01029340|20691459|P6|COMPLETED|Part A Follow up Period||0
8395331|NCT01029340|20691460|P5|COMPLETED|Part A Follow up Period||0
8395332|NCT01029340|20691461|P4|COMPLETED|Part A Follow up Period||0
8395333|NCT01029340|20691462|P3|COMPLETED|Part A Follow up Period||0
8395334|NCT01029340|20691463|P2|COMPLETED|Part A Follow up Period||14
8395335|NCT01029340|20691464|P1|COMPLETED|Part A Follow up Period||14
8395336|NCT01029340|20691459|P6|STARTED|Part A Follow up Period||0
8395337|NCT01029340|20691460|P5|STARTED|Part A Follow up Period||0
8395338|NCT01029340|20691461|P4|STARTED|Part A Follow up Period||0
8395339|NCT01029340|20691462|P3|STARTED|Part A Follow up Period||0
8395340|NCT01029340|20691463|P2|STARTED|Part A Follow up Period||14
8395341|NCT01029340|20691464|P1|STARTED|Part A Follow up Period||14
8395342|NCT01029340|20691459|P6|NOT COMPLETED|Part A Treatment Period||0
8395343|NCT01029340|20691460|P5|NOT COMPLETED|Part A Treatment Period||0
8395344|NCT01029340|20691461|P4|NOT COMPLETED|Part A Treatment Period||0
8395345|NCT01029340|20691462|P3|NOT COMPLETED|Part A Treatment Period||0
8395346|NCT01029340|20691463|P2|NOT COMPLETED|Part A Treatment Period||0
8395347|NCT01029340|20691464|P1|NOT COMPLETED|Part A Treatment Period||0
8395348|NCT01029340|20691459|P6|COMPLETED|Part A Treatment Period||0
8395349|NCT01029340|20691460|P5|COMPLETED|Part A Treatment Period||0
8395350|NCT01029340|20691461|P4|COMPLETED|Part A Treatment Period||0
8395351|NCT01029340|20691462|P3|COMPLETED|Part A Treatment Period||0
8395352|NCT01029340|20691463|P2|COMPLETED|Part A Treatment Period||14
8395353|NCT01029340|20691464|P1|COMPLETED|Part A Treatment Period||14
8395354|NCT01029340|20691459|P6|Safety Population|Part A Treatment Period||0
8395355|NCT01029340|20691460|P5|Safety Population|Part A Treatment Period||0
8395356|NCT01029340|20691461|P4|Safety Population|Part A Treatment Period||0
8395357|NCT01029340|20691462|P3|Safety Population|Part A Treatment Period||0
8395358|NCT01029340|20691463|P2|Safety Population|Part A Treatment Period||14
8395359|NCT01029340|20691464|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
8395360|NCT01029340|20691459|P6|Participants Received Treatment|Part A Treatment Period||0
8395361|NCT01029340|20691460|P5|Participants Received Treatment|Part A Treatment Period||0
8395362|NCT01029340|20691461|P4|Participants Received Treatment|Part A Treatment Period||0
8395363|NCT01029340|20691462|P3|Participants Received Treatment|Part A Treatment Period||0
8395364|NCT01029340|20691463|P2|Participants Received Treatment|Part A Treatment Period||14
8395365|NCT01029340|20691464|P1|Participants Received Treatment|Part A Treatment Period||14
8395366|NCT01029340|20691459|P6|STARTED|Part A Treatment Period||0
8395367|NCT01029340|20691460|P5|STARTED|Part A Treatment Period||0
8395368|NCT01029340|20691461|P4|STARTED|Part A Treatment Period||0
8395369|NCT01029340|20691462|P3|STARTED|Part A Treatment Period||0
8395370|NCT01029340|20691463|P2|STARTED|Part A Treatment Period||14
8395371|NCT01029340|20691464|P1|STARTED|Part A Treatment Period||14
8395372|NCT01029262|20691495|P2|NOT COMPLETED|Overall Study||160
8395373|NCT01029262|20691496|P1|NOT COMPLETED|Overall Study||79
8395374|NCT01029262|20691495|P2|COMPLETED|Overall Study||0
8395375|NCT01029262|20691496|P1|COMPLETED|Overall Study||0
8395376|NCT01029262|20691495|P2|STARTED|Overall Study||160
8395377|NCT01029262|20691496|P1|STARTED|Overall Study||79
8395378|NCT01029054|20691558|P3|NOT COMPLETED|Phase II||0
8395379|NCT01029054|20691559|P2|NOT COMPLETED|Phase II||0
8395380|NCT01029054|20691560|P1|NOT COMPLETED|Phase II||0
8395381|NCT01029054|20691558|P3|COMPLETED|Phase II||18
8395382|NCT01029054|20691559|P2|COMPLETED|Phase II||0
8395383|NCT01029054|20691560|P1|COMPLETED|Phase II||0
8395384|NCT01029054|20691558|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
8395385|NCT01029054|20691559|P2|STARTED|Phase II||0
8395386|NCT01029054|20691560|P1|STARTED|Phase II||0
8395387|NCT01029054|20691558|P3|NOT COMPLETED|Phase I||0
8395388|NCT01029054|20691559|P2|NOT COMPLETED|Phase I||0
8395389|NCT01029054|20691560|P1|NOT COMPLETED|Phase I||0
8395390|NCT01029054|20691558|P3|COMPLETED|Phase I||18
8395391|NCT01029054|20691559|P2|COMPLETED|Phase I||13
8395392|NCT01029054|20691560|P1|COMPLETED|Phase I||4
8395393|NCT01029054|20691558|P3|STARTED|Phase I||18
8395394|NCT01029054|20691559|P2|STARTED|Phase I||13
8395395|NCT01029054|20691560|P1|STARTED|Phase I||4
8395396|NCT01028937|20691566|P1|NOT COMPLETED|Overall Study||0
8395397|NCT01028937|20691566|P1|COMPLETED|Overall Study||6
8395398|NCT01028937|20691566|P1|STARTED|Overall Study||6
8395399|NCT01028911|20691573|P2|NOT COMPLETED|Overall Study||0
8395400|NCT01028911|20691574|P1|NOT COMPLETED|Overall Study||0
8395401|NCT01028911|20691573|P2|COMPLETED|Overall Study||2
8395402|NCT01028911|20691574|P1|COMPLETED|Overall Study||7
8395403|NCT01028911|20691573|P2|STARTED|Overall Study||2
8395404|NCT01028911|20691574|P1|STARTED|Overall Study||7
8395405|NCT01028820|20691639|P1|NOT COMPLETED|Overall Study||1
8395406|NCT01028820|20691639|P1|COMPLETED|Overall Study||12
8395407|NCT01028820|20691639|P1|STARTED|Overall Study||13
8395408|NCT01028677|20691648|P2|NOT COMPLETED|Overall Study||1
8395409|NCT01028677|20691649|P1|NOT COMPLETED|Overall Study||2
8395410|NCT01028677|20691648|P2|COMPLETED|Overall Study||6
8395411|NCT01028677|20691649|P1|COMPLETED|Overall Study||8
8395412|NCT01028677|20691648|P2|STARTED|Overall Study||7
8395413|NCT01028677|20691649|P1|STARTED|Overall Study||10
8395414|NCT01028651|20691665|P1|NOT COMPLETED|Overall Study||3
8395415|NCT01028651|20691665|P1|COMPLETED|Overall Study||10
8395416|NCT01028651|20691665|P1|STARTED|Overall Study||13
8395417|NCT01028560|20691688|P2|NOT COMPLETED|Overall Study||18
8395418|NCT01028560|20691689|P1|NOT COMPLETED|Overall Study||10
8395419|NCT01028560|20691688|P2|COMPLETED|Overall Study||13
8395420|NCT01028560|20691689|P1|COMPLETED|Overall Study||17
8395421|NCT01028560|20691688|P2|Started Study Protocol|Overall Study||27
8395422|NCT01028560|20691689|P1|Started Study Protocol|Overall Study||23
8395423|NCT01028560|20691688|P2|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
8395424|NCT01028560|20691689|P1|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
8395425|NCT01028391|20691703|P2|NOT COMPLETED|Overall Study||11
8395426|NCT01028391|20691704|P1|NOT COMPLETED|Overall Study||14
8395427|NCT01028391|20691703|P2|COMPLETED|Overall Study||142
8395428|NCT01028391|20691704|P1|COMPLETED|Overall Study||150
8395429|NCT01028391|20691703|P2|STARTED|Overall Study||153
8395430|NCT01028391|20691704|P1|STARTED|Overall Study||164
8395431|NCT01028378|20691712|P1|NOT COMPLETED|Overall Study||17
8395432|NCT01028378|20691712|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
8395433|NCT01028378|20691712|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
8395434|NCT01028352|20691724|P1|NOT COMPLETED|Overall Study||6
8395435|NCT01028352|20691724|P1|COMPLETED|Overall Study||29
8395436|NCT01028352|20691724|P1|STARTED|Overall Study||35
8395437|NCT01028300|20691729|P1|NOT COMPLETED|Overall Study||4
8395438|NCT01028300|20691729|P1|COMPLETED|Overall Study||0
8395439|NCT01028300|20691729|P1|STARTED|Overall Study||4
8395440|NCT01028222|20691738|P2|NOT COMPLETED|Overall Study||13
8395441|NCT01028222|20691739|P1|NOT COMPLETED|Overall Study||38
8395442|NCT01028222|20691738|P2|COMPLETED|Overall Study||0
8395443|NCT01028222|20691739|P1|COMPLETED|Overall Study||4
8395444|NCT01028222|20691738|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
8395445|NCT01028222|20691739|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
8395446|NCT01028222|20691738|P2|STARTED|Overall Study||13
8395447|NCT01028222|20691739|P1|STARTED|Overall Study||42
8395448|NCT01028131|20691764|P4|NOT COMPLETED|Overall Study||4
8395449|NCT01028131|20691765|P3|NOT COMPLETED|Overall Study||6
8395450|NCT01028131|20691766|P2|NOT COMPLETED|Overall Study||3
8395451|NCT01028131|20691767|P1|NOT COMPLETED|Overall Study||3
8395452|NCT01028131|20691764|P4|COMPLETED|Overall Study||26
8395453|NCT01028131|20691765|P3|COMPLETED|Overall Study||22
8395454|NCT01028131|20691766|P2|COMPLETED|Overall Study||23
8395455|NCT01028131|20691767|P1|COMPLETED|Overall Study||23
8395456|NCT01028131|20691764|P4|Completed Intervention/Control Session|Overall Study||30
8395457|NCT01028131|20691765|P3|Completed Intervention/Control Session|Overall Study||28
8395458|NCT01028131|20691766|P2|Completed Intervention/Control Session|Overall Study||26
8395459|NCT01028131|20691767|P1|Completed Intervention/Control Session|Overall Study||26
8395460|NCT01028131|20691764|P4|STARTED|Overall Study||30
8395461|NCT01028131|20691765|P3|STARTED|Overall Study||28
8395462|NCT01028131|20691766|P2|STARTED|Overall Study||26
8395463|NCT01028131|20691767|P1|STARTED|Overall Study||26
8395464|NCT01028053|20691781|P1|NOT COMPLETED|Overall Study||133
8395465|NCT01028053|20691781|P1|COMPLETED|Overall Study||232
8395466|NCT01028053|20691781|P1|STARTED|Overall Study||365
8395467|NCT01028027|20691789|P2|NOT COMPLETED|Overall Study||13
8395468|NCT01028027|20691790|P1|NOT COMPLETED|Overall Study||16
8395469|NCT01028027|20691789|P2|COMPLETED|Overall Study||164
8395470|NCT01028027|20691790|P1|COMPLETED|Overall Study||164
8395471|NCT01028027|20691789|P2|STARTED|Overall Study||177
8395472|NCT01028027|20691790|P1|STARTED|Overall Study||180
8395473|NCT01028014|20691812|P6|NOT COMPLETED|Overall Study||2
8395474|NCT01028014|20691813|P5|NOT COMPLETED|Overall Study||1
8395475|NCT01028014|20691814|P4|NOT COMPLETED|Overall Study||1
8395476|NCT01028014|20691815|P3|NOT COMPLETED|Overall Study||0
8395477|NCT01028014|20691816|P2|NOT COMPLETED|Overall Study||2
8395478|NCT01028014|20691817|P1|NOT COMPLETED|Overall Study||1
8395479|NCT01028014|20691812|P6|COMPLETED|Overall Study||4
8395480|NCT01028014|20691813|P5|COMPLETED|Overall Study||9
8395481|NCT01028014|20691814|P4|COMPLETED|Overall Study||9
8395482|NCT01028014|20691815|P3|COMPLETED|Overall Study||10
8395483|NCT01028014|20691816|P2|COMPLETED|Overall Study||8
8395484|NCT01028014|20691817|P1|COMPLETED|Overall Study||9
8395485|NCT01028014|20691812|P6|STARTED|Overall Study||6
8395486|NCT01028014|20691813|P5|STARTED|Overall Study||10
8395487|NCT01028014|20691814|P4|STARTED|Overall Study||10
8395488|NCT01028014|20691815|P3|STARTED|Overall Study||10
8395489|NCT01028014|20691816|P2|STARTED|Overall Study||10
8395490|NCT01028014|20691817|P1|STARTED|Overall Study||10
8395491|NCT01027910|20691845|P2|NOT COMPLETED|Overall Study||0
8395492|NCT01027910|20691846|P1|NOT COMPLETED|Overall Study||0
8395493|NCT01027910|20691845|P2|COMPLETED|Overall Study||14
8395494|NCT01027910|20691846|P1|COMPLETED|Overall Study||6
8395495|NCT01027910|20691845|P2|STARTED|Overall Study||14
8395496|NCT01027910|20691846|P1|STARTED|Overall Study||6
8395497|NCT01027897|20691858|P1|NOT COMPLETED|Overall Study||2
8395498|NCT01027897|20691858|P1|COMPLETED|Overall Study||28
8395499|NCT01027897|20691858|P1|STARTED|Overall Study||30
8395500|NCT01027884|20691866|P2|NOT COMPLETED|Overall Study||7
8395501|NCT01027884|20691867|P1|NOT COMPLETED|Overall Study||4
8395502|NCT01027884|20691866|P2|COMPLETED|Overall Study||25
8395503|NCT01027884|20691867|P1|COMPLETED|Overall Study||30
8395504|NCT01027884|20691866|P2|STARTED|Overall Study||32
8395505|NCT01027884|20691867|P1|STARTED|Overall Study||34
8395506|NCT01027871|20691884|P3|NOT COMPLETED|Overall Study||7
8395507|NCT01027871|20691885|P2|NOT COMPLETED|Overall Study||13
8395508|NCT01027871|20691886|P1|NOT COMPLETED|Overall Study||2
8395509|NCT01027871|20691884|P3|COMPLETED|Overall Study||91
8395510|NCT01027871|20691885|P2|COMPLETED|Overall Study||85
8395511|NCT01027871|20691886|P1|COMPLETED|Overall Study||91
8395512|NCT01027871|20691884|P3|Received at Least One Dose of Study Drug|Overall Study||97
8395513|NCT01027871|20691885|P2|Received at Least One Dose of Study Drug|Overall Study||98
8395514|NCT01027871|20691886|P1|Received at Least One Dose of Study Drug|Overall Study||93
8395515|NCT01027871|20691884|P3|STARTED|Overall Study||98
8395516|NCT01027871|20691885|P2|STARTED|Overall Study||98
8395517|NCT01027871|20691886|P1|STARTED|Overall Study||93
8395518|NCT01027845|20691945|P4|NOT COMPLETED|Booster Vaccination Phase||0
8395519|NCT01027845|20691946|P3|NOT COMPLETED|Booster Vaccination Phase||0
8395520|NCT01027845|20691947|P2|NOT COMPLETED|Booster Vaccination Phase||0
8395521|NCT01027845|20691948|P1|NOT COMPLETED|Booster Vaccination Phase||2
8395522|NCT01027845|20691945|P4|COMPLETED|Booster Vaccination Phase||1
8395523|NCT01027845|20691946|P3|COMPLETED|Booster Vaccination Phase||119
8395524|NCT01027845|20691947|P2|COMPLETED|Booster Vaccination Phase||0
8395525|NCT01027845|20691948|P1|COMPLETED|Booster Vaccination Phase||226
8395526|NCT01027845|20691945|P4|STARTED|Booster Vaccination Phase||1
8395527|NCT01027845|20691946|P3|STARTED|Booster Vaccination Phase||119
8395528|NCT01027845|20691947|P2|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
8395529|NCT01027845|20691948|P1|STARTED|Booster Vaccination Phase||228
8395530|NCT01027845|20691945|P4|NOT COMPLETED|Primary Vaccination Phase||0
8395531|NCT01027845|20691946|P3|NOT COMPLETED|Primary Vaccination Phase||0
8395532|NCT01027845|20691947|P2|NOT COMPLETED|Primary Vaccination Phase||1
8395533|NCT01027845|20691948|P1|NOT COMPLETED|Primary Vaccination Phase||4
8395534|NCT01027845|20691945|P4|COMPLETED|Primary Vaccination Phase||0
8395535|NCT01027845|20691946|P3|COMPLETED|Primary Vaccination Phase||0
8395536|NCT01027845|20691947|P2|COMPLETED|Primary Vaccination Phase||122
8395537|NCT01027845|20691948|P1|COMPLETED|Primary Vaccination Phase||233
8395538|NCT01027845|20691945|P4|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
8395539|NCT01027845|20691946|P3|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
8395540|NCT01027845|20691947|P2|STARTED|Primary Vaccination Phase||123
8395541|NCT01027845|20691948|P1|STARTED|Primary Vaccination Phase||237
8395542|NCT01027819|20692000|P2|NOT COMPLETED|Overall Study||0
8395543|NCT01027819|20692001|P1|NOT COMPLETED|Overall Study||0
8395544|NCT01027819|20692000|P2|COMPLETED|Overall Study||40
8395545|NCT01027819|20692001|P1|COMPLETED|Overall Study||40
8395546|NCT01027819|20692000|P2|STARTED|Overall Study||40
8395547|NCT01027819|20692001|P1|STARTED|Overall Study||40
8395548|NCT01027806|20692009|P2|NOT COMPLETED|Overall Study||3
8395549|NCT01027806|20692010|P1|NOT COMPLETED|Overall Study||4
8395550|NCT01027806|20692009|P2|COMPLETED|Overall Study||29
8395551|NCT01027806|20692010|P1|COMPLETED|Overall Study||28
8395552|NCT01027806|20692009|P2|STARTED|Overall Study||32
8395553|NCT01027806|20692010|P1|STARTED|Overall Study||32
8395554|NCT01027793|20692018|P2|NOT COMPLETED|Overall Study||3
8395555|NCT01027793|20692019|P1|NOT COMPLETED|Overall Study||7
8395556|NCT01027793|20692018|P2|COMPLETED|Overall Study||12
8395557|NCT01027793|20692019|P1|COMPLETED|Overall Study||10
8395558|NCT01027793|20692018|P2|STARTED|Overall Study||15
8395559|NCT01027793|20692019|P1|STARTED|Overall Study||17
8395560|NCT01027780|20692033|P2|NOT COMPLETED|Overall Study||1
8395561|NCT01027780|20692034|P1|NOT COMPLETED|Overall Study||0
8395562|NCT01027780|20692033|P2|COMPLETED|Overall Study||102
8395563|NCT01027780|20692034|P1|COMPLETED|Overall Study||105
8395564|NCT01027780|20692033|P2|STARTED|Overall Study||103
8395565|NCT01027780|20692034|P1|STARTED|Overall Study||105
8395566|NCT01027754|20692046|P2|NOT COMPLETED|Overall Study||8
8395567|NCT01027754|20692047|P1|NOT COMPLETED|Overall Study||2
8395568|NCT01027754|20692046|P2|COMPLETED|Overall Study||47
8395569|NCT01027754|20692047|P1|COMPLETED|Overall Study||55
8395570|NCT01027754|20692046|P2|STARTED|Overall Study||55
8395571|NCT01027754|20692047|P1|STARTED|Overall Study||57
8395572|NCT01027702|20692081|P7|NOT COMPLETED|Overall Study||1
8395573|NCT01027702|20692082|P6|NOT COMPLETED|Overall Study||0
8395574|NCT01027702|20692083|P5|NOT COMPLETED|Overall Study||1
8395575|NCT01027702|20692084|P4|NOT COMPLETED|Overall Study||4
8395576|NCT01027702|20692085|P3|NOT COMPLETED|Overall Study||1
8395577|NCT01027702|20692086|P2|NOT COMPLETED|Overall Study||2
8395578|NCT01027702|20692087|P1|NOT COMPLETED|Overall Study||1
8395579|NCT01027702|20692081|P7|COMPLETED|Overall Study||1
8395580|NCT01027702|20692082|P6|COMPLETED|Overall Study||1
8395581|NCT01027702|20692083|P5|COMPLETED|Overall Study||9
8395582|NCT01027702|20692084|P4|COMPLETED|Overall Study||10
8395583|NCT01027702|20692085|P3|COMPLETED|Overall Study||2
8395584|NCT01027702|20692086|P2|COMPLETED|Overall Study||2
8395585|NCT01027702|20692087|P1|COMPLETED|Overall Study||3
8395586|NCT01027702|20692081|P7|STARTED|Overall Study||2
8395587|NCT01027702|20692082|P6|STARTED|Overall Study||1
8395588|NCT01027702|20692083|P5|STARTED|Overall Study||10
8395589|NCT01027702|20692084|P4|STARTED|Overall Study||14
8395590|NCT01027702|20692085|P3|STARTED|Overall Study||3
8395591|NCT01027702|20692086|P2|STARTED|Overall Study||4
8395592|NCT01027702|20692087|P1|STARTED|Overall Study||4
8395593|NCT01027650|20692113|P8|NOT COMPLETED|Overall Study||0
8395594|NCT01027650|20692114|P7|NOT COMPLETED|Overall Study||1
8395595|NCT01027650|20692115|P6|NOT COMPLETED|Overall Study||2
8395596|NCT01027650|20692116|P5|NOT COMPLETED|Overall Study||2
8395597|NCT01027650|20692117|P4|NOT COMPLETED|Overall Study||0
8395598|NCT01027650|20692118|P3|NOT COMPLETED|Overall Study||0
8395599|NCT01027650|20692119|P2|NOT COMPLETED|Overall Study||0
8395600|NCT01027650|20692120|P1|NOT COMPLETED|Overall Study||0
8395601|NCT01027650|20692113|P8|COMPLETED|Overall Study||24
8395602|NCT01027650|20692114|P7|COMPLETED|Overall Study||24
8395603|NCT01027650|20692115|P6|COMPLETED|Overall Study||24
8395604|NCT01027650|20692116|P5|COMPLETED|Overall Study||23
8395605|NCT01027650|20692117|P4|COMPLETED|Overall Study||3
8395606|NCT01027650|20692118|P3|COMPLETED|Overall Study||6
8395607|NCT01027650|20692119|P2|COMPLETED|Overall Study||6
8395608|NCT01027650|20692120|P1|COMPLETED|Overall Study||6
8395609|NCT01027650|20692113|P8|STARTED|Overall Study||24
8395610|NCT01027650|20692114|P7|STARTED|Overall Study||25
8395611|NCT01027650|20692115|P6|STARTED|Overall Study||26
8395612|NCT01027650|20692116|P5|STARTED|Overall Study||25
8395613|NCT01027650|20692117|P4|STARTED|Overall Study||3
8395614|NCT01027650|20692118|P3|STARTED|Overall Study||6
8395615|NCT01027650|20692119|P2|STARTED|Overall Study||6
8395616|NCT01027650|20692120|P1|STARTED|Overall Study||6
8395617|NCT01027598|20692164|P2|NOT COMPLETED|Overall Study||67
8395618|NCT01027598|20692165|P1|NOT COMPLETED|Overall Study||134
8395706|NCT01027195|20692439|P1|COMPLETED|Overall Study||71
8395619|NCT01027598|20692164|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
8395620|NCT01027598|20692165|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
8395621|NCT01027598|20692164|P2|STARTED|Overall Study||67
8395622|NCT01027598|20692165|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
8395623|NCT01027559|20692178|P3|NOT COMPLETED|Overall Study||9
8395624|NCT01027559|20692179|P2|NOT COMPLETED|Overall Study||8
8395625|NCT01027559|20692180|P1|NOT COMPLETED|Overall Study||6
8395626|NCT01027559|20692178|P3|COMPLETED|Overall Study||22
8395627|NCT01027559|20692179|P2|COMPLETED|Overall Study||26
8395628|NCT01027559|20692180|P1|COMPLETED|Overall Study||20
8395629|NCT01027559|20692178|P3|STARTED|Overall Study||31
8395630|NCT01027559|20692179|P2|STARTED|Overall Study||34
8395631|NCT01027559|20692180|P1|STARTED|Overall Study||26
8395632|NCT01027468|20692190|P1|NOT COMPLETED|Overall Study||0
8395633|NCT01027468|20692190|P1|COMPLETED|Overall Study||160
8395634|NCT01027468|20692190|P1|STARTED|Overall Study||160
8395635|NCT01027416|20692198|P2|NOT COMPLETED|Overall Study||5
8395636|NCT01027416|20692199|P1|NOT COMPLETED|Overall Study||1
8395637|NCT01027416|20692198|P2|COMPLETED|Overall Study||23
8395638|NCT01027416|20692199|P1|COMPLETED|Overall Study||30
8395639|NCT01027416|20692198|P2|STARTED|Overall Study||28
8395640|NCT01027416|20692199|P1|STARTED|Overall Study||31
8395641|NCT01027364|20692211|P4|NOT COMPLETED|Overall Study||1
8395642|NCT01027364|20692212|P3|NOT COMPLETED|Overall Study||1
8395643|NCT01027364|20692213|P2|NOT COMPLETED|Overall Study||2
8395644|NCT01027364|20692214|P1|NOT COMPLETED|Overall Study||4
8395645|NCT01027364|20692211|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
8395646|NCT01027364|20692212|P3|COMPLETED|Overall Study||26
8395647|NCT01027364|20692213|P2|COMPLETED|Overall Study||27
8395648|NCT01027364|20692214|P1|COMPLETED|Overall Study||59
8395649|NCT01027364|20692211|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
8395650|NCT01027364|20692212|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
8395651|NCT01027364|20692213|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
8395652|NCT01027364|20692214|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
8395653|NCT01027364|20692211|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
8395654|NCT01027364|20692212|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
8395655|NCT01027364|20692213|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
8395656|NCT01027364|20692214|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
8395657|NCT01027364|20692211|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
8395658|NCT01027364|20692212|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
8395659|NCT01027364|20692213|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
8395660|NCT01027364|20692214|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
8395661|NCT01027364|20692211|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
8395662|NCT01027364|20692212|P3|STARTED|Overall Study||27
8395663|NCT01027364|20692213|P2|STARTED|Overall Study||29
8395664|NCT01027364|20692214|P1|STARTED|Overall Study||63
8395665|NCT01027351|20692309|P6|NOT COMPLETED|Overall Study||5
8395666|NCT01027351|20692310|P5|NOT COMPLETED|Overall Study||11
8395667|NCT01027351|20692311|P4|NOT COMPLETED|Overall Study||2
8395668|NCT01027351|20692312|P3|NOT COMPLETED|Overall Study||1
8395669|NCT01027351|20692313|P2|NOT COMPLETED|Overall Study||1
8395670|NCT01027351|20692314|P1|NOT COMPLETED|Overall Study||3
8395671|NCT01027351|20692309|P6|COMPLETED|Overall Study||45
8395672|NCT01027351|20692310|P5|COMPLETED|Overall Study||32
8395673|NCT01027351|20692311|P4|COMPLETED|Overall Study||6
8395674|NCT01027351|20692312|P3|COMPLETED|Overall Study||13
8395675|NCT01027351|20692313|P2|COMPLETED|Overall Study||18
8395676|NCT01027351|20692314|P1|COMPLETED|Overall Study||26
8395677|NCT01027351|20692309|P6|STARTED|Overall Study||50
8395678|NCT01027351|20692310|P5|STARTED|Overall Study||43
8395679|NCT01027351|20692311|P4|STARTED|Overall Study||8
8395680|NCT01027351|20692312|P3|STARTED|Overall Study||14
8395681|NCT01027351|20692313|P2|STARTED|Overall Study||19
8395682|NCT01027351|20692314|P1|STARTED|Overall Study||29
8395683|NCT01027286|20692398|P2|NOT COMPLETED|Overall Study||1
8395684|NCT01027286|20692399|P1|NOT COMPLETED|Overall Study||1
8395685|NCT01027286|20692398|P2|COMPLETED|Overall Study||49
8395686|NCT01027286|20692399|P1|COMPLETED|Overall Study||49
8395687|NCT01027286|20692398|P2|12 Week Postoperative|Overall Study||49
8395688|NCT01027286|20692399|P1|12 Week Postoperative|Overall Study||49
8395689|NCT01027286|20692398|P2|4 Week Postoperative|Overall Study||50
8395690|NCT01027286|20692399|P1|4 Week Postoperative|Overall Study||49
8395691|NCT01027286|20692398|P2|Day of Surgery|Overall Study||50
8395692|NCT01027286|20692399|P1|Day of Surgery|Overall Study||50
8395693|NCT01027286|20692398|P2|Preoperative|Overall Study||50
8395694|NCT01027286|20692399|P1|Preoperative|Overall Study||50
8395695|NCT01027286|20692398|P2|STARTED|Overall Study||50
8395696|NCT01027286|20692399|P1|STARTED|Overall Study||50
8395697|NCT01027273|20692419|P2|NOT COMPLETED|Overall Study||33
8395698|NCT01027273|20692420|P1|NOT COMPLETED|Overall Study||59
8395699|NCT01027273|20692419|P2|COMPLETED|Overall Study||266
8395700|NCT01027273|20692420|P1|COMPLETED|Overall Study||242
8395701|NCT01027273|20692419|P2|STARTED|Overall Study||299
8395702|NCT01027273|20692420|P1|STARTED|Overall Study||301
8395703|NCT01027195|20692438|P2|NOT COMPLETED|Overall Study||0
8395704|NCT01027195|20692439|P1|NOT COMPLETED|Overall Study||0
8395705|NCT01027195|20692438|P2|COMPLETED|Overall Study||69
8395707|NCT01027195|20692438|P2|STARTED|Overall Study||69
8395708|NCT01027195|20692439|P1|STARTED|Overall Study||71
8395709|NCT01027000|20692459|P1|NOT COMPLETED|Overall Study||0
8395710|NCT01027000|20692459|P1|COMPLETED|Overall Study||68
8395711|NCT01027000|20692459|P1|STARTED|Overall Study||68
8395712|NCT01026974|20692467|P4|NOT COMPLETED|Overall Study||3
8395713|NCT01026974|20692468|P3|NOT COMPLETED|Overall Study||12
8395714|NCT01026974|20692469|P2|NOT COMPLETED|Overall Study||2
8395715|NCT01026974|20692470|P1|NOT COMPLETED|Overall Study||1
8395716|NCT01026974|20692467|P4|COMPLETED|Overall Study||46
8395717|NCT01026974|20692468|P3|COMPLETED|Overall Study||29
8395718|NCT01026974|20692469|P2|COMPLETED|Overall Study||12
8395719|NCT01026974|20692470|P1|COMPLETED|Overall Study||15
8395720|NCT01026974|20692467|P4|STARTED|Overall Study||49
8395721|NCT01026974|20692468|P3|STARTED|Overall Study||41
8395722|NCT01026974|20692469|P2|STARTED|Overall Study||14
8395723|NCT01026974|20692470|P1|STARTED|Overall Study||16
8395724|NCT01026948|20692527|P1|NOT COMPLETED|Overall Study||8
8395725|NCT01026948|20692527|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
8395726|NCT01026948|20692527|P1|STARTED|Overall Study||70
8395727|NCT01026909|20692534|P2|NOT COMPLETED|Overall Study||0
8395728|NCT01026909|20692535|P1|NOT COMPLETED|Overall Study||0
8395729|NCT01026909|20692534|P2|COMPLETED|Overall Study||2
8395730|NCT01026909|20692535|P1|COMPLETED|Overall Study||1
8395731|NCT01026909|20692534|P2|STARTED|Overall Study||2
8395732|NCT01026909|20692535|P1|STARTED|Overall Study||1
8395733|NCT01026844|20692545|P2|NOT COMPLETED|Overall Study||0
8395734|NCT01026844|20692546|P1|NOT COMPLETED|Overall Study||0
8395735|NCT01026844|20692545|P2|COMPLETED|Overall Study||8
8395736|NCT01026844|20692546|P1|COMPLETED|Overall Study||19
8395737|NCT01026844|20692545|P2|STARTED|Overall Study||8
8395738|NCT01026844|20692546|P1|STARTED|Overall Study||19
8395739|NCT01026831|20692560|P2|NOT COMPLETED|Overall Study||11
8395740|NCT01026831|20692561|P1|NOT COMPLETED|Overall Study||14
8395741|NCT01026831|20692560|P2|COMPLETED|Overall Study||312
8395742|NCT01026831|20692561|P1|COMPLETED|Overall Study||306
8395743|NCT01026831|20692560|P2|STARTED|Overall Study|randomized|323
8395744|NCT01026831|20692561|P1|STARTED|Overall Study|randomized|320
8395745|NCT01026818|20692572|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
8395746|NCT01026818|20692573|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
8395747|NCT01026818|20692574|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
8395748|NCT01026818|20692575|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
8395749|NCT01026818|20692572|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
8395750|NCT01026818|20692573|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
8395751|NCT01026818|20692574|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
8395752|NCT01026818|20692575|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
8395753|NCT01026818|20692572|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
8395754|NCT01026818|20692573|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
8395755|NCT01026818|20692574|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
8395756|NCT01026818|20692575|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
8395757|NCT01026818|20692572|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
8395758|NCT01026818|20692573|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
8395759|NCT01026818|20692574|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
8395760|NCT01026818|20692575|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
8395761|NCT01026818|20692572|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
8395762|NCT01026818|20692573|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
8395763|NCT01026818|20692574|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
8395764|NCT01026818|20692575|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
8395765|NCT01026818|20692572|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
8395766|NCT01026818|20692573|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
8395767|NCT01026818|20692574|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
8395768|NCT01026818|20692575|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
8395769|NCT01026818|20692572|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
8395770|NCT01026818|20692573|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
8395771|NCT01026818|20692574|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
8395772|NCT01026818|20692575|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
8395773|NCT01026818|20692572|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
8395774|NCT01026818|20692573|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
8395775|NCT01026818|20692574|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
8395776|NCT01026818|20692575|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
8395777|NCT01026818|20692572|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
8395778|NCT01026818|20692573|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
8395779|NCT01026818|20692574|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
8395780|NCT01026818|20692575|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
8395781|NCT01026818|20692572|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
8395782|NCT01026818|20692573|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
8395783|NCT01026818|20692574|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
8395784|NCT01026818|20692575|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
8395785|NCT01026818|20692572|P4|NOT COMPLETED|Screening Period||0
8395786|NCT01026818|20692573|P3|NOT COMPLETED|Screening Period||0
8395787|NCT01026818|20692574|P2|NOT COMPLETED|Screening Period||0
8395788|NCT01026818|20692575|P1|NOT COMPLETED|Screening Period||160
8395789|NCT01026818|20692572|P4|COMPLETED|Screening Period||0
8395790|NCT01026818|20692573|P3|COMPLETED|Screening Period||0
8395791|NCT01026818|20692574|P2|COMPLETED|Screening Period||0
8395792|NCT01026818|20692575|P1|COMPLETED|Screening Period||423
8395793|NCT01026818|20692572|P4|STARTED|Screening Period||0
8395794|NCT01026818|20692573|P3|STARTED|Screening Period||0
8395795|NCT01026818|20692574|P2|STARTED|Screening Period||0
8395796|NCT01026818|20692575|P1|STARTED|Screening Period||583
8395797|NCT01026805|20692653|P1|NOT COMPLETED|Overall Study||0
8395798|NCT01026805|20692653|P1|COMPLETED|Overall Study||11
8395799|NCT01026805|20692653|P1|STARTED|Overall Study||11
8395800|NCT01026792|20692663|P1|NOT COMPLETED|Overall Study||1
8395801|NCT01026792|20692663|P1|COMPLETED|Overall Study||37
8395802|NCT01026792|20692663|P1|STARTED|Overall Study||38
8395803|NCT01026623|20692670|P3|NOT COMPLETED|Overall Study||0
8395804|NCT01026623|20692671|P2|NOT COMPLETED|Overall Study||0
8395805|NCT01026623|20692672|P1|NOT COMPLETED|Overall Study||0
8395806|NCT01026623|20692670|P3|COMPLETED|Overall Study||5
8395807|NCT01026623|20692671|P2|COMPLETED|Overall Study||5
8395808|NCT01026623|20692672|P1|COMPLETED|Overall Study||6
8395809|NCT01026623|20692670|P3|STARTED|Overall Study||5
8395810|NCT01026623|20692671|P2|STARTED|Overall Study||5
8395811|NCT01026623|20692672|P1|STARTED|Overall Study||6
8395812|NCT01026493|20692706|P8|NOT COMPLETED|Overall Study||1
8395813|NCT01026493|20692707|P7|NOT COMPLETED|Overall Study||4
8395814|NCT01026493|20692708|P6|NOT COMPLETED|Overall Study||3
8395815|NCT01026493|20692709|P5|NOT COMPLETED|Overall Study||2
8395816|NCT01026493|20692710|P4|NOT COMPLETED|Overall Study||0
8395817|NCT01026493|20692711|P3|NOT COMPLETED|Overall Study||0
8395818|NCT01026493|20692712|P2|NOT COMPLETED|Overall Study||1
8395819|NCT01026493|20692713|P1|NOT COMPLETED|Overall Study||0
8395820|NCT01026493|20692706|P8|COMPLETED|Overall Study||37
8395821|NCT01026493|20692707|P7|COMPLETED|Overall Study||32
8395822|NCT01026493|20692708|P6|COMPLETED|Overall Study||73
8395823|NCT01026493|20692709|P5|COMPLETED|Overall Study||73
8395824|NCT01026493|20692710|P4|COMPLETED|Overall Study||8
8395825|NCT01026493|20692711|P3|COMPLETED|Overall Study||9
8395826|NCT01026493|20692712|P2|COMPLETED|Overall Study||6
8395827|NCT01026493|20692713|P1|COMPLETED|Overall Study||8
8395828|NCT01026493|20692706|P8|STARTED|Overall Study||38
8395829|NCT01026493|20692707|P7|STARTED|Overall Study||36
8395830|NCT01026493|20692708|P6|STARTED|Overall Study||76
8395831|NCT01026493|20692709|P5|STARTED|Overall Study||75
8395832|NCT01026493|20692710|P4|STARTED|Overall Study||8
8395833|NCT01026493|20692711|P3|STARTED|Overall Study||9
8395834|NCT01026493|20692712|P2|STARTED|Overall Study||7
8395835|NCT01026493|20692713|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
8395836|NCT01026454|20692741|P2|NOT COMPLETED|Second Intervention||1
8395837|NCT01026454|20692742|P1|NOT COMPLETED|Second Intervention||1
8395838|NCT01026454|20692741|P2|COMPLETED|Second Intervention||13
8395839|NCT01026454|20692742|P1|COMPLETED|Second Intervention||16
8395840|NCT01026454|20692741|P2|STARTED|Second Intervention||14
8395841|NCT01026454|20692742|P1|STARTED|Second Intervention||17
8395842|NCT01026454|20692741|P2|NOT COMPLETED|Washout||0
8395843|NCT01026454|20692742|P1|NOT COMPLETED|Washout||0
8395844|NCT01026454|20692741|P2|COMPLETED|Washout||14
8395845|NCT01026454|20692742|P1|COMPLETED|Washout||18
8395846|NCT01026454|20692741|P2|STARTED|Washout||14
8395847|NCT01026454|20692742|P1|STARTED|Washout||18
8395848|NCT01026454|20692741|P2|NOT COMPLETED|First Intervention||0
8395849|NCT01026454|20692742|P1|NOT COMPLETED|First Intervention||0
8395850|NCT01026454|20692741|P2|COMPLETED|First Intervention||14
8395851|NCT01026454|20692742|P1|COMPLETED|First Intervention||18
8395852|NCT01026454|20692741|P2|STARTED|First Intervention||14
8395853|NCT01026454|20692742|P1|STARTED|First Intervention||18
8395854|NCT01026402|20692765|P17|NOT COMPLETED|Overall Study||0
8395855|NCT01026402|20692766|P16|NOT COMPLETED|Overall Study||0
8395856|NCT01026402|20692767|P15|NOT COMPLETED|Overall Study||0
8395857|NCT01026402|20692768|P14|NOT COMPLETED|Overall Study||0
8395858|NCT01026402|20692769|P13|NOT COMPLETED|Overall Study||0
8395859|NCT01026402|20692770|P12|NOT COMPLETED|Overall Study||0
8395860|NCT01026402|20692771|P11|NOT COMPLETED|Overall Study||0
8395861|NCT01026402|20692772|P10|NOT COMPLETED|Overall Study||0
8395862|NCT01026402|20692773|P9|NOT COMPLETED|Overall Study||0
8395863|NCT01026402|20692774|P8|NOT COMPLETED|Overall Study||0
8395864|NCT01026402|20692775|P7|NOT COMPLETED|Overall Study||0
8395865|NCT01026402|20692776|P6|NOT COMPLETED|Overall Study||0
8395866|NCT01026402|20692777|P5|NOT COMPLETED|Overall Study||0
8395867|NCT01026402|20692778|P4|NOT COMPLETED|Overall Study||0
8395868|NCT01026402|20692779|P3|NOT COMPLETED|Overall Study||0
8395869|NCT01026402|20692780|P2|NOT COMPLETED|Overall Study||0
8395870|NCT01026402|20692781|P1|NOT COMPLETED|Overall Study||0
8395871|NCT01026402|20692765|P17|COMPLETED|Overall Study||4
8395872|NCT01026402|20692766|P16|COMPLETED|Overall Study||5
8395873|NCT01026402|20692767|P15|COMPLETED|Overall Study||3
8395874|NCT01026402|20692768|P14|COMPLETED|Overall Study||6
8395875|NCT01026402|20692769|P13|COMPLETED|Overall Study||8
8395876|NCT01026402|20692770|P12|COMPLETED|Overall Study||8
8395877|NCT01026402|20692771|P11|COMPLETED|Overall Study||7
8395878|NCT01026402|20692772|P10|COMPLETED|Overall Study||3
8395879|NCT01026402|20692773|P9|COMPLETED|Overall Study||7
8395880|NCT01026402|20692774|P8|COMPLETED|Overall Study||3
8395881|NCT01026402|20692775|P7|COMPLETED|Overall Study||8
8395882|NCT01026402|20692776|P6|COMPLETED|Overall Study||5
8395883|NCT01026402|20692777|P5|COMPLETED|Overall Study||3
8395884|NCT01026402|20692778|P4|COMPLETED|Overall Study||18
8395885|NCT01026402|20692779|P3|COMPLETED|Overall Study||33
8395886|NCT01026402|20692780|P2|COMPLETED|Overall Study||8
8395887|NCT01026402|20692781|P1|COMPLETED|Overall Study||6
8395888|NCT01026402|20692765|P17|STARTED|Overall Study||4
8395889|NCT01026402|20692766|P16|STARTED|Overall Study||5
8395890|NCT01026402|20692767|P15|STARTED|Overall Study||3
8395891|NCT01026402|20692768|P14|STARTED|Overall Study||6
8395892|NCT01026402|20692769|P13|STARTED|Overall Study||8
8395893|NCT01026402|20692770|P12|STARTED|Overall Study||8
8395894|NCT01026402|20692771|P11|STARTED|Overall Study||7
8395895|NCT01026402|20692772|P10|STARTED|Overall Study||3
8395896|NCT01026402|20692773|P9|STARTED|Overall Study||7
8395897|NCT01026402|20692774|P8|STARTED|Overall Study||3
8395898|NCT01026402|20692775|P7|STARTED|Overall Study||8
8395899|NCT01026402|20692776|P6|STARTED|Overall Study||5
8395900|NCT01026402|20692777|P5|STARTED|Overall Study||3
8395901|NCT01026402|20692778|P4|STARTED|Overall Study||18
8395902|NCT01026402|20692779|P3|STARTED|Overall Study||33
8395903|NCT01026402|20692780|P2|STARTED|Overall Study||8
8395904|NCT01026402|20692781|P1|STARTED|Overall Study||6
8395905|NCT01026389|20693091|P2|NOT COMPLETED|Overall Study||5
8395906|NCT01026389|20693092|P1|NOT COMPLETED|Overall Study||5
8395907|NCT01026389|20693091|P2|COMPLETED|Overall Study||88
8395908|NCT01026389|20693092|P1|COMPLETED|Overall Study||88
8395909|NCT01026389|20693091|P2|STARTED|Overall Study||93
8395910|NCT01026389|20693092|P1|STARTED|Overall Study||93
8395911|NCT01026324|20693107|P3|NOT COMPLETED|Follow up/Survival||0
8395912|NCT01026324|20693108|P2|NOT COMPLETED|Follow up/Survival||0
8395913|NCT01026324|20693109|P1|NOT COMPLETED|Follow up/Survival||1
8395914|NCT01026324|20693107|P3|COMPLETED|Follow up/Survival||4
8395915|NCT01026324|20693108|P2|COMPLETED|Follow up/Survival||3
8395916|NCT01026324|20693109|P1|COMPLETED|Follow up/Survival||4
8395917|NCT01026324|20693107|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
8395918|NCT01026324|20693108|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
8395919|NCT01026324|20693109|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
8395920|NCT01026324|20693107|P3|STARTED|Follow up/Survival||4
8395921|NCT01026324|20693108|P2|STARTED|Follow up/Survival||3
8395922|NCT01026324|20693109|P1|STARTED|Follow up/Survival||5
8395923|NCT01026324|20693107|P3|NOT COMPLETED|Treatment Allocation||0
8395924|NCT01026324|20693108|P2|NOT COMPLETED|Treatment Allocation||0
8395925|NCT01026324|20693109|P1|NOT COMPLETED|Treatment Allocation||0
8395926|NCT01026324|20693107|P3|COMPLETED|Treatment Allocation||4
8395927|NCT01026324|20693108|P2|COMPLETED|Treatment Allocation||3
8395928|NCT01026324|20693109|P1|COMPLETED|Treatment Allocation||5
8395929|NCT01026324|20693107|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
8395930|NCT01026324|20693108|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
8395931|NCT01026324|20693109|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
8395932|NCT01026324|20693107|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
8395933|NCT01026324|20693108|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
8395934|NCT01026324|20693109|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
8395935|NCT01026324|20693107|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
8395936|NCT01026324|20693108|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
8395937|NCT01026324|20693109|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
8395938|NCT01026324|20693107|P3|STARTED|Treatment Allocation||4
8395939|NCT01026324|20693108|P2|STARTED|Treatment Allocation||3
8395940|NCT01026324|20693109|P1|STARTED|Treatment Allocation||5
8395941|NCT01026220|20693119|P3|NOT COMPLETED|Consolidation Maintenance||14
8395942|NCT01026220|20693120|P2|NOT COMPLETED|Consolidation Maintenance||6
8395943|NCT01026220|20693121|P1|NOT COMPLETED|Consolidation Maintenance||0
8395944|NCT01026220|20693119|P3|COMPLETED|Consolidation Maintenance||66
8395945|NCT01026220|20693120|P2|COMPLETED|Consolidation Maintenance||75
8395946|NCT01026220|20693121|P1|COMPLETED|Consolidation Maintenance||0
8395947|NCT01026220|20693119|P3|STARTED|Consolidation Maintenance||80
8395948|NCT01026220|20693120|P2|STARTED|Consolidation Maintenance||81
8395949|NCT01026220|20693121|P1|STARTED|Consolidation Maintenance||0
8395950|NCT01026220|20693119|P3|NOT COMPLETED|Induction||0
8395951|NCT01026220|20693120|P2|NOT COMPLETED|Induction||0
8395952|NCT01026220|20693121|P1|NOT COMPLETED|Induction||25
8395953|NCT01026220|20693119|P3|COMPLETED|Induction||0
8395954|NCT01026220|20693120|P2|COMPLETED|Induction||0
8395955|NCT01026220|20693121|P1|COMPLETED|Induction||141
8395956|NCT01026220|20693119|P3|STARTED|Induction||0
8395957|NCT01026220|20693120|P2|STARTED|Induction||0
8395958|NCT01026220|20693121|P1|STARTED|Induction||166
8395959|NCT01026194|20693145|P2|NOT COMPLETED|Period 2：Open-label Period||10
8395960|NCT01026194|20693146|P1|NOT COMPLETED|Period 2：Open-label Period||7
8395961|NCT01026194|20693145|P2|COMPLETED|Period 2：Open-label Period||88
8395962|NCT01026194|20693146|P1|COMPLETED|Period 2：Open-label Period||91
8395963|NCT01026194|20693145|P2|STARTED|Period 2：Open-label Period||98
8395964|NCT01026194|20693146|P1|STARTED|Period 2：Open-label Period||98
8395965|NCT01026194|20693145|P2|NOT COMPLETED|Period 1：Double Blind Period||5
8395966|NCT01026194|20693146|P1|NOT COMPLETED|Period 1：Double Blind Period||3
8395967|NCT01026194|20693145|P2|COMPLETED|Period 1：Double Blind Period||98
8395968|NCT01026194|20693146|P1|COMPLETED|Period 1：Double Blind Period||98
8395969|NCT01026194|20693145|P2|STARTED|Period 1：Double Blind Period||103
8395970|NCT01026194|20693146|P1|STARTED|Period 1：Double Blind Period||101
8395971|NCT01026181|20693163|P3|NOT COMPLETED|Overall Study||0
8395972|NCT01026181|20693164|P2|NOT COMPLETED|Overall Study||0
8395973|NCT01026181|20693165|P1|NOT COMPLETED|Overall Study||0
8395974|NCT01026181|20693163|P3|COMPLETED|Overall Study||48
8395975|NCT01026181|20693164|P2|COMPLETED|Overall Study||51
8395976|NCT01026181|20693165|P1|COMPLETED|Overall Study||51
8395977|NCT01026181|20693163|P3|STARTED|Overall Study||48
8395978|NCT01026181|20693164|P2|STARTED|Overall Study||51
8395979|NCT01026181|20693165|P1|STARTED|Overall Study||51
8395980|NCT01026142|20693178|P2|NOT COMPLETED|Overall Study||163
8395981|NCT01026142|20693179|P1|NOT COMPLETED|Overall Study||172
8395982|NCT01026142|20693178|P2|COMPLETED|Overall Study||65
8395983|NCT01026142|20693179|P1|COMPLETED|Overall Study||52
8395984|NCT01026142|20693178|P2|STARTED|Overall Study||228
8395985|NCT01026142|20693179|P1|STARTED|Overall Study||224
8395986|NCT01026103|20693201|P1|NOT COMPLETED|Overall Study||2
8395987|NCT01026103|20693201|P1|COMPLETED|Overall Study||28
8395988|NCT01026103|20693201|P1|Consented|Overall Study||30
8395989|NCT01026103|20693201|P1|STARTED|Overall Study||30
8395990|NCT01026038|20693211|P3|NOT COMPLETED|Overall Study||0
8395991|NCT01026038|20693212|P2|NOT COMPLETED|Overall Study||1
8395992|NCT01026038|20693213|P1|NOT COMPLETED|Overall Study||1
8395993|NCT01026038|20693211|P3|COMPLETED|Overall Study||67
8395994|NCT01026038|20693212|P2|COMPLETED|Overall Study||64
8395995|NCT01026038|20693213|P1|COMPLETED|Overall Study||129
8395996|NCT01026038|20693211|P3|STARTED|Overall Study||67
8395997|NCT01026038|20693212|P2|STARTED|Overall Study||65
8395998|NCT01026038|20693213|P1|STARTED|Overall Study||130
8395999|NCT01026012|20693248|P1|NOT COMPLETED|Overall Study||0
8396000|NCT01026012|20693248|P1|COMPLETED|Overall Study||40
8396001|NCT01026012|20693248|P1|STARTED|Overall Study||40
8396002|NCT01025843|20693262|P10|NOT COMPLETED|Period 5||0
8396003|NCT01025843|20693263|P9|NOT COMPLETED|Period 5||0
8396004|NCT01025843|20693264|P8|NOT COMPLETED|Period 5||0
8396005|NCT01025843|20693265|P7|NOT COMPLETED|Period 5||0
8396006|NCT01025843|20693266|P6|NOT COMPLETED|Period 5||0
8396007|NCT01025843|20693267|P5|NOT COMPLETED|Period 5||0
8396008|NCT01025843|20693268|P4|NOT COMPLETED|Period 5||0
8396009|NCT01025843|20693269|P3|NOT COMPLETED|Period 5||0
8396010|NCT01025843|20693270|P2|NOT COMPLETED|Period 5||0
8396011|NCT01025843|20693271|P1|NOT COMPLETED|Period 5||0
8396012|NCT01025843|20693262|P10|COMPLETED|Period 5||2
8396013|NCT01025843|20693263|P9|COMPLETED|Period 5||2
8396014|NCT01025843|20693264|P8|COMPLETED|Period 5||2
8396015|NCT01025843|20693265|P7|COMPLETED|Period 5||2
8396016|NCT01025843|20693266|P6|COMPLETED|Period 5||2
8396017|NCT01025843|20693267|P5|COMPLETED|Period 5||2
8396018|NCT01025843|20693268|P4|COMPLETED|Period 5||1
8396019|NCT01025843|20693269|P3|COMPLETED|Period 5||1
8396020|NCT01025843|20693270|P2|COMPLETED|Period 5||2
8396021|NCT01025843|20693271|P1|COMPLETED|Period 5||2
8396022|NCT01025843|20693262|P10|STARTED|Period 5||2
8396023|NCT01025843|20693263|P9|STARTED|Period 5||2
8396024|NCT01025843|20693264|P8|STARTED|Period 5||2
8396025|NCT01025843|20693265|P7|STARTED|Period 5||2
8396026|NCT01025843|20693266|P6|STARTED|Period 5||2
8396027|NCT01025843|20693267|P5|STARTED|Period 5||2
8396028|NCT01025843|20693268|P4|STARTED|Period 5||1
8396029|NCT01025843|20693269|P3|STARTED|Period 5||1
8396030|NCT01025843|20693270|P2|STARTED|Period 5||2
8396031|NCT01025843|20693271|P1|STARTED|Period 5||2
8396032|NCT01025843|20693262|P10|NOT COMPLETED|Washout 4||0
8396033|NCT01025843|20693263|P9|NOT COMPLETED|Washout 4||0
8396034|NCT01025843|20693264|P8|NOT COMPLETED|Washout 4||0
8396035|NCT01025843|20693265|P7|NOT COMPLETED|Washout 4||0
8396036|NCT01025843|20693266|P6|NOT COMPLETED|Washout 4||0
8396037|NCT01025843|20693267|P5|NOT COMPLETED|Washout 4||0
8396038|NCT01025843|20693268|P4|NOT COMPLETED|Washout 4||1
8396039|NCT01025843|20693269|P3|NOT COMPLETED|Washout 4||1
8396040|NCT01025843|20693270|P2|NOT COMPLETED|Washout 4||0
8396041|NCT01025843|20693271|P1|NOT COMPLETED|Washout 4||0
8396042|NCT01025843|20693262|P10|COMPLETED|Washout 4||2
8396043|NCT01025843|20693263|P9|COMPLETED|Washout 4||2
8396044|NCT01025843|20693264|P8|COMPLETED|Washout 4||2
8396045|NCT01025843|20693265|P7|COMPLETED|Washout 4||2
8396046|NCT01025843|20693266|P6|COMPLETED|Washout 4||2
8396047|NCT01025843|20693267|P5|COMPLETED|Washout 4||2
8396048|NCT01025843|20693268|P4|COMPLETED|Washout 4||1
8396049|NCT01025843|20693269|P3|COMPLETED|Washout 4||1
8396050|NCT01025843|20693270|P2|COMPLETED|Washout 4||2
8396051|NCT01025843|20693271|P1|COMPLETED|Washout 4||2
8396052|NCT01025843|20693262|P10|STARTED|Washout 4||2
8396053|NCT01025843|20693263|P9|STARTED|Washout 4||2
8396054|NCT01025843|20693264|P8|STARTED|Washout 4||2
8396055|NCT01025843|20693265|P7|STARTED|Washout 4||2
8396056|NCT01025843|20693266|P6|STARTED|Washout 4||2
8396057|NCT01025843|20693267|P5|STARTED|Washout 4||2
8396058|NCT01025843|20693268|P4|STARTED|Washout 4||2
8396059|NCT01025843|20693269|P3|STARTED|Washout 4||2
8396060|NCT01025843|20693270|P2|STARTED|Washout 4||2
8396061|NCT01025843|20693271|P1|STARTED|Washout 4||2
8396062|NCT01025843|20693262|P10|NOT COMPLETED|Period 4||0
8396063|NCT01025843|20693263|P9|NOT COMPLETED|Period 4||0
8396064|NCT01025843|20693264|P8|NOT COMPLETED|Period 4||0
8396065|NCT01025843|20693265|P7|NOT COMPLETED|Period 4||0
8396066|NCT01025843|20693266|P6|NOT COMPLETED|Period 4||0
8396067|NCT01025843|20693267|P5|NOT COMPLETED|Period 4||0
8396068|NCT01025843|20693268|P4|NOT COMPLETED|Period 4||0
8396069|NCT01025843|20693269|P3|NOT COMPLETED|Period 4||0
8396070|NCT01025843|20693270|P2|NOT COMPLETED|Period 4||0
8396071|NCT01025843|20693271|P1|NOT COMPLETED|Period 4||0
8396072|NCT01025843|20693262|P10|COMPLETED|Period 4||2
8396073|NCT01025843|20693263|P9|COMPLETED|Period 4||2
8396074|NCT01025843|20693264|P8|COMPLETED|Period 4||2
8396075|NCT01025843|20693265|P7|COMPLETED|Period 4||2
8396076|NCT01025843|20693266|P6|COMPLETED|Period 4||2
8396077|NCT01025843|20693267|P5|COMPLETED|Period 4||2
8396078|NCT01025843|20693268|P4|COMPLETED|Period 4||2
8396079|NCT01025843|20693269|P3|COMPLETED|Period 4||2
8396080|NCT01025843|20693270|P2|COMPLETED|Period 4||2
8396081|NCT01025843|20693271|P1|COMPLETED|Period 4||2
8396082|NCT01025843|20693262|P10|STARTED|Period 4||2
8396083|NCT01025843|20693263|P9|STARTED|Period 4||2
8396084|NCT01025843|20693264|P8|STARTED|Period 4||2
8396085|NCT01025843|20693265|P7|STARTED|Period 4||2
8396086|NCT01025843|20693266|P6|STARTED|Period 4||2
8396087|NCT01025843|20693267|P5|STARTED|Period 4||2
8396088|NCT01025843|20693268|P4|STARTED|Period 4||2
8396089|NCT01025843|20693269|P3|STARTED|Period 4||2
8396090|NCT01025843|20693270|P2|STARTED|Period 4||2
8396091|NCT01025843|20693271|P1|STARTED|Period 4||2
8396092|NCT01025843|20693262|P10|NOT COMPLETED|Washout 3||0
8396093|NCT01025843|20693263|P9|NOT COMPLETED|Washout 3||0
8396094|NCT01025843|20693264|P8|NOT COMPLETED|Washout 3||0
8396095|NCT01025843|20693265|P7|NOT COMPLETED|Washout 3||0
8396096|NCT01025843|20693266|P6|NOT COMPLETED|Washout 3||0
8396097|NCT01025843|20693267|P5|NOT COMPLETED|Washout 3||0
8396098|NCT01025843|20693268|P4|NOT COMPLETED|Washout 3||0
8396099|NCT01025843|20693269|P3|NOT COMPLETED|Washout 3||0
8396100|NCT01025843|20693270|P2|NOT COMPLETED|Washout 3||0
8396101|NCT01025843|20693271|P1|NOT COMPLETED|Washout 3||0
8396102|NCT01025843|20693262|P10|COMPLETED|Washout 3||2
8396103|NCT01025843|20693263|P9|COMPLETED|Washout 3||2
8396104|NCT01025843|20693264|P8|COMPLETED|Washout 3||2
8396105|NCT01025843|20693265|P7|COMPLETED|Washout 3||2
8396106|NCT01025843|20693266|P6|COMPLETED|Washout 3||2
8396107|NCT01025843|20693267|P5|COMPLETED|Washout 3||2
8396108|NCT01025843|20693268|P4|COMPLETED|Washout 3||2
8396109|NCT01025843|20693269|P3|COMPLETED|Washout 3||2
8396110|NCT01025843|20693270|P2|COMPLETED|Washout 3||2
8396111|NCT01025843|20693271|P1|COMPLETED|Washout 3||2
8396112|NCT01025843|20693262|P10|STARTED|Washout 3||2
8396113|NCT01025843|20693263|P9|STARTED|Washout 3||2
8396114|NCT01025843|20693264|P8|STARTED|Washout 3||2
8396115|NCT01025843|20693265|P7|STARTED|Washout 3||2
8396116|NCT01025843|20693266|P6|STARTED|Washout 3||2
8396117|NCT01025843|20693267|P5|STARTED|Washout 3||2
8396118|NCT01025843|20693268|P4|STARTED|Washout 3||2
8396119|NCT01025843|20693269|P3|STARTED|Washout 3||2
8396120|NCT01025843|20693270|P2|STARTED|Washout 3||2
8396121|NCT01025843|20693271|P1|STARTED|Washout 3||2
8396122|NCT01025843|20693262|P10|NOT COMPLETED|Period 3||0
8396123|NCT01025843|20693263|P9|NOT COMPLETED|Period 3||0
8396124|NCT01025843|20693264|P8|NOT COMPLETED|Period 3||0
8396125|NCT01025843|20693265|P7|NOT COMPLETED|Period 3||0
8396126|NCT01025843|20693266|P6|NOT COMPLETED|Period 3||0
8396127|NCT01025843|20693267|P5|NOT COMPLETED|Period 3||0
8396128|NCT01025843|20693268|P4|NOT COMPLETED|Period 3||0
8396129|NCT01025843|20693269|P3|NOT COMPLETED|Period 3||0
8396130|NCT01025843|20693270|P2|NOT COMPLETED|Period 3||0
8396131|NCT01025843|20693271|P1|NOT COMPLETED|Period 3||0
8396132|NCT01025843|20693262|P10|COMPLETED|Period 3||2
8396133|NCT01025843|20693263|P9|COMPLETED|Period 3||2
8396134|NCT01025843|20693264|P8|COMPLETED|Period 3||2
8396135|NCT01025843|20693265|P7|COMPLETED|Period 3||2
8396136|NCT01025843|20693266|P6|COMPLETED|Period 3||2
8396137|NCT01025843|20693267|P5|COMPLETED|Period 3||2
8396138|NCT01025843|20693268|P4|COMPLETED|Period 3||2
8396139|NCT01025843|20693269|P3|COMPLETED|Period 3||2
8396140|NCT01025843|20693270|P2|COMPLETED|Period 3||2
8396141|NCT01025843|20693271|P1|COMPLETED|Period 3||2
8396142|NCT01025843|20693262|P10|STARTED|Period 3||2
8396143|NCT01025843|20693263|P9|STARTED|Period 3||2
8396144|NCT01025843|20693264|P8|STARTED|Period 3||2
8396145|NCT01025843|20693265|P7|STARTED|Period 3||2
8396146|NCT01025843|20693266|P6|STARTED|Period 3||2
8396147|NCT01025843|20693267|P5|STARTED|Period 3||2
8396148|NCT01025843|20693268|P4|STARTED|Period 3||2
8396149|NCT01025843|20693269|P3|STARTED|Period 3||2
8396150|NCT01025843|20693270|P2|STARTED|Period 3||2
8396151|NCT01025843|20693271|P1|STARTED|Period 3||2
8396152|NCT01025843|20693262|P10|NOT COMPLETED|Washout 2||0
8396153|NCT01025843|20693263|P9|NOT COMPLETED|Washout 2||0
8396154|NCT01025843|20693264|P8|NOT COMPLETED|Washout 2||0
8396155|NCT01025843|20693265|P7|NOT COMPLETED|Washout 2||0
8396156|NCT01025843|20693266|P6|NOT COMPLETED|Washout 2||0
8396157|NCT01025843|20693267|P5|NOT COMPLETED|Washout 2||0
8396158|NCT01025843|20693268|P4|NOT COMPLETED|Washout 2||0
8396159|NCT01025843|20693269|P3|NOT COMPLETED|Washout 2||0
8396160|NCT01025843|20693270|P2|NOT COMPLETED|Washout 2||0
8396161|NCT01025843|20693271|P1|NOT COMPLETED|Washout 2||0
8396162|NCT01025843|20693262|P10|COMPLETED|Washout 2||2
8396163|NCT01025843|20693263|P9|COMPLETED|Washout 2||2
8396164|NCT01025843|20693264|P8|COMPLETED|Washout 2||2
8396165|NCT01025843|20693265|P7|COMPLETED|Washout 2||2
8396166|NCT01025843|20693266|P6|COMPLETED|Washout 2||2
8396167|NCT01025843|20693267|P5|COMPLETED|Washout 2||2
8396168|NCT01025843|20693268|P4|COMPLETED|Washout 2||2
8396169|NCT01025843|20693269|P3|COMPLETED|Washout 2||2
8396170|NCT01025843|20693270|P2|COMPLETED|Washout 2||2
8396171|NCT01025843|20693271|P1|COMPLETED|Washout 2||2
8396172|NCT01025843|20693262|P10|STARTED|Washout 2||2
8396173|NCT01025843|20693263|P9|STARTED|Washout 2||2
8396174|NCT01025843|20693264|P8|STARTED|Washout 2||2
8396175|NCT01025843|20693265|P7|STARTED|Washout 2||2
8396176|NCT01025843|20693266|P6|STARTED|Washout 2||2
8396177|NCT01025843|20693267|P5|STARTED|Washout 2||2
8396178|NCT01025843|20693268|P4|STARTED|Washout 2||2
8396179|NCT01025843|20693269|P3|STARTED|Washout 2||2
8396180|NCT01025843|20693270|P2|STARTED|Washout 2||2
8396181|NCT01025843|20693271|P1|STARTED|Washout 2||2
8396182|NCT01025843|20693262|P10|NOT COMPLETED|Period 2||0
8396183|NCT01025843|20693263|P9|NOT COMPLETED|Period 2||0
8396184|NCT01025843|20693264|P8|NOT COMPLETED|Period 2||0
8396185|NCT01025843|20693265|P7|NOT COMPLETED|Period 2||0
8396186|NCT01025843|20693266|P6|NOT COMPLETED|Period 2||0
8396187|NCT01025843|20693267|P5|NOT COMPLETED|Period 2||0
8396188|NCT01025843|20693268|P4|NOT COMPLETED|Period 2||0
8396189|NCT01025843|20693269|P3|NOT COMPLETED|Period 2||0
8396190|NCT01025843|20693270|P2|NOT COMPLETED|Period 2||0
8396191|NCT01025843|20693271|P1|NOT COMPLETED|Period 2||0
8396192|NCT01025843|20693262|P10|COMPLETED|Period 2||2
8396193|NCT01025843|20693263|P9|COMPLETED|Period 2||2
8396194|NCT01025843|20693264|P8|COMPLETED|Period 2||2
8396195|NCT01025843|20693265|P7|COMPLETED|Period 2||2
8396196|NCT01025843|20693266|P6|COMPLETED|Period 2||2
8396197|NCT01025843|20693267|P5|COMPLETED|Period 2||2
8396198|NCT01025843|20693268|P4|COMPLETED|Period 2||2
8396199|NCT01025843|20693269|P3|COMPLETED|Period 2||2
8396200|NCT01025843|20693270|P2|COMPLETED|Period 2||2
8396201|NCT01025843|20693271|P1|COMPLETED|Period 2||2
8396202|NCT01025843|20693262|P10|STARTED|Period 2||2
8396203|NCT01025843|20693263|P9|STARTED|Period 2||2
8396204|NCT01025843|20693264|P8|STARTED|Period 2||2
8396205|NCT01025843|20693265|P7|STARTED|Period 2||2
8396206|NCT01025843|20693266|P6|STARTED|Period 2||2
8396207|NCT01025843|20693267|P5|STARTED|Period 2||2
8396208|NCT01025843|20693268|P4|STARTED|Period 2||2
8396209|NCT01025843|20693269|P3|STARTED|Period 2||2
8396210|NCT01025843|20693270|P2|STARTED|Period 2||2
8396211|NCT01025843|20693271|P1|STARTED|Period 2||2
8396212|NCT01025843|20693262|P10|NOT COMPLETED|Washout 1||0
8396213|NCT01025843|20693263|P9|NOT COMPLETED|Washout 1||0
8396214|NCT01025843|20693264|P8|NOT COMPLETED|Washout 1||0
8396215|NCT01025843|20693265|P7|NOT COMPLETED|Washout 1||0
8396216|NCT01025843|20693266|P6|NOT COMPLETED|Washout 1||0
8396217|NCT01025843|20693267|P5|NOT COMPLETED|Washout 1||0
8396218|NCT01025843|20693268|P4|NOT COMPLETED|Washout 1||0
8396219|NCT01025843|20693269|P3|NOT COMPLETED|Washout 1||0
8396220|NCT01025843|20693270|P2|NOT COMPLETED|Washout 1||0
8396221|NCT01025843|20693271|P1|NOT COMPLETED|Washout 1||0
8396222|NCT01025843|20693262|P10|COMPLETED|Washout 1||2
8396223|NCT01025843|20693263|P9|COMPLETED|Washout 1||2
8396224|NCT01025843|20693264|P8|COMPLETED|Washout 1||2
8396225|NCT01025843|20693265|P7|COMPLETED|Washout 1||2
8396226|NCT01025843|20693266|P6|COMPLETED|Washout 1||2
8396227|NCT01025843|20693267|P5|COMPLETED|Washout 1||2
8396228|NCT01025843|20693268|P4|COMPLETED|Washout 1||2
8396229|NCT01025843|20693269|P3|COMPLETED|Washout 1||2
8396230|NCT01025843|20693270|P2|COMPLETED|Washout 1||2
8396231|NCT01025843|20693271|P1|COMPLETED|Washout 1||2
8396232|NCT01025843|20693262|P10|STARTED|Washout 1||2
8396233|NCT01025843|20693263|P9|STARTED|Washout 1||2
8396234|NCT01025843|20693264|P8|STARTED|Washout 1||2
8396235|NCT01025843|20693265|P7|STARTED|Washout 1||2
8396236|NCT01025843|20693266|P6|STARTED|Washout 1||2
8396237|NCT01025843|20693267|P5|STARTED|Washout 1||2
8396238|NCT01025843|20693268|P4|STARTED|Washout 1||2
8396239|NCT01025843|20693269|P3|STARTED|Washout 1||2
8396240|NCT01025843|20693270|P2|STARTED|Washout 1||2
8396241|NCT01025843|20693271|P1|STARTED|Washout 1||2
8396242|NCT01025843|20693262|P10|NOT COMPLETED|Period 1||0
8396243|NCT01025843|20693263|P9|NOT COMPLETED|Period 1||0
8396244|NCT01025843|20693264|P8|NOT COMPLETED|Period 1||0
8396245|NCT01025843|20693265|P7|NOT COMPLETED|Period 1||0
8396246|NCT01025843|20693266|P6|NOT COMPLETED|Period 1||0
8396247|NCT01025843|20693267|P5|NOT COMPLETED|Period 1||0
8396248|NCT01025843|20693268|P4|NOT COMPLETED|Period 1||0
8396249|NCT01025843|20693269|P3|NOT COMPLETED|Period 1||0
8396250|NCT01025843|20693270|P2|NOT COMPLETED|Period 1||0
8396251|NCT01025843|20693271|P1|NOT COMPLETED|Period 1||0
8396252|NCT01025843|20693262|P10|COMPLETED|Period 1||2
8396253|NCT01025843|20693263|P9|COMPLETED|Period 1||2
8396254|NCT01025843|20693264|P8|COMPLETED|Period 1||2
8396255|NCT01025843|20693265|P7|COMPLETED|Period 1||2
8396256|NCT01025843|20693266|P6|COMPLETED|Period 1||2
8396257|NCT01025843|20693267|P5|COMPLETED|Period 1||2
8396258|NCT01025843|20693268|P4|COMPLETED|Period 1||2
8396259|NCT01025843|20693269|P3|COMPLETED|Period 1||2
8396260|NCT01025843|20693270|P2|COMPLETED|Period 1||2
8396261|NCT01025843|20693271|P1|COMPLETED|Period 1||2
8396262|NCT01025843|20693262|P10|STARTED|Period 1||2
8396263|NCT01025843|20693263|P9|STARTED|Period 1||2
8396264|NCT01025843|20693264|P8|STARTED|Period 1||2
8396265|NCT01025843|20693265|P7|STARTED|Period 1||2
8396266|NCT01025843|20693266|P6|STARTED|Period 1||2
8396267|NCT01025843|20693267|P5|STARTED|Period 1||2
8396268|NCT01025843|20693268|P4|STARTED|Period 1||2
8396269|NCT01025843|20693269|P3|STARTED|Period 1||2
8396270|NCT01025843|20693270|P2|STARTED|Period 1||2
8396271|NCT01025843|20693271|P1|STARTED|Period 1||2
8396272|NCT01025830|20693345|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
8396273|NCT01025830|20693346|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
8396274|NCT01025830|20693345|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
8396275|NCT01025830|20693346|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
8396276|NCT01025830|20693345|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
8396277|NCT01025830|20693346|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
8396278|NCT01025830|20693345|P2|NOT COMPLETED|Washout Period of 30 Days||0
8396279|NCT01025830|20693346|P1|NOT COMPLETED|Washout Period of 30 Days||0
8396280|NCT01025830|20693345|P2|COMPLETED|Washout Period of 30 Days||12
8396281|NCT01025830|20693346|P1|COMPLETED|Washout Period of 30 Days||8
8396282|NCT01025830|20693345|P2|STARTED|Washout Period of 30 Days||12
8396283|NCT01025830|20693346|P1|STARTED|Washout Period of 30 Days||8
8396284|NCT01025830|20693345|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
8396285|NCT01025830|20693346|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
8396286|NCT01025830|20693345|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
8396287|NCT01025830|20693346|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
8396288|NCT01025830|20693345|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
8396289|NCT01025830|20693346|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
8396290|NCT01025817|20693365|P2|NOT COMPLETED|Completed Study||22
8396291|NCT01025817|20693366|P1|NOT COMPLETED|Completed Study||16
8396292|NCT01025817|20693365|P2|COMPLETED|Completed Study|Completed study phase|282
8396293|NCT01025817|20693366|P1|COMPLETED|Completed Study|Completed study phase|293
8396294|NCT01025817|20693365|P2|STARTED|Completed Study||304
8396295|NCT01025817|20693366|P1|STARTED|Completed Study||309
8396296|NCT01025817|20693365|P2|NOT COMPLETED|Completed Study Medication||72
8396297|NCT01025817|20693366|P1|NOT COMPLETED|Completed Study Medication||105
8396298|NCT01025817|20693365|P2|COMPLETED|Completed Study Medication||232
8396299|NCT01025817|20693366|P1|COMPLETED|Completed Study Medication||204
8396300|NCT01025817|20693365|P2|STARTED|Completed Study Medication||304
8396301|NCT01025817|20693366|P1|STARTED|Completed Study Medication||309
8396302|NCT01025791|20693387|P14|NOT COMPLETED|Period 5||0
8396303|NCT01025791|20693388|P13|NOT COMPLETED|Period 5||0
8396304|NCT01025791|20693389|P12|NOT COMPLETED|Period 5||0
8396305|NCT01025791|20693390|P11|NOT COMPLETED|Period 5||0
8396306|NCT01025791|20693391|P10|NOT COMPLETED|Period 5||0
8396307|NCT01025791|20693392|P9|NOT COMPLETED|Period 5||0
8396308|NCT01025791|20693393|P8|NOT COMPLETED|Period 5||0
8396309|NCT01025791|20693394|P7|NOT COMPLETED|Period 5||0
8396310|NCT01025791|20693395|P6|NOT COMPLETED|Period 5||0
8396311|NCT01025791|20693396|P5|NOT COMPLETED|Period 5||0
8396312|NCT01025791|20693397|P4|NOT COMPLETED|Period 5||0
8396313|NCT01025791|20693398|P3|NOT COMPLETED|Period 5||0
8396314|NCT01025791|20693399|P2|NOT COMPLETED|Period 5||0
8396315|NCT01025791|20693400|P1|NOT COMPLETED|Period 5||0
8396316|NCT01025791|20693387|P14|COMPLETED|Period 5||0
8396317|NCT01025791|20693388|P13|COMPLETED|Period 5||0
8396318|NCT01025791|20693389|P12|COMPLETED|Period 5||0
8396319|NCT01025791|20693390|P11|COMPLETED|Period 5||0
8396320|NCT01025791|20693391|P10|COMPLETED|Period 5||0
8396321|NCT01025791|20693392|P9|COMPLETED|Period 5||0
8396322|NCT01025791|20693393|P8|COMPLETED|Period 5||0
8396323|NCT01025791|20693394|P7|COMPLETED|Period 5||0
8396324|NCT01025791|20693395|P6|COMPLETED|Period 5||0
8396325|NCT01025791|20693396|P5|COMPLETED|Period 5||0
8396326|NCT01025791|20693397|P4|COMPLETED|Period 5||2
8396327|NCT01025791|20693398|P3|COMPLETED|Period 5||2
8396328|NCT01025791|20693399|P2|COMPLETED|Period 5||2
8396329|NCT01025791|20693400|P1|COMPLETED|Period 5||2
8396330|NCT01025791|20693387|P14|STARTED|Period 5||0
8396331|NCT01025791|20693388|P13|STARTED|Period 5||0
8396332|NCT01025791|20693389|P12|STARTED|Period 5||0
8396333|NCT01025791|20693390|P11|STARTED|Period 5||0
8396334|NCT01025791|20693391|P10|STARTED|Period 5||0
8396335|NCT01025791|20693392|P9|STARTED|Period 5||0
8396336|NCT01025791|20693393|P8|STARTED|Period 5||0
8396337|NCT01025791|20693394|P7|STARTED|Period 5||0
8396338|NCT01025791|20693395|P6|STARTED|Period 5||0
8396339|NCT01025791|20693396|P5|STARTED|Period 5||0
8396340|NCT01025791|20693397|P4|STARTED|Period 5||2
8396341|NCT01025791|20693398|P3|STARTED|Period 5||2
8396342|NCT01025791|20693399|P2|STARTED|Period 5||2
8396343|NCT01025791|20693400|P1|STARTED|Period 5||2
8396344|NCT01025791|20693387|P14|NOT COMPLETED|Period 4||0
8396345|NCT01025791|20693388|P13|NOT COMPLETED|Period 4||0
8396346|NCT01025791|20693389|P12|NOT COMPLETED|Period 4||0
8396347|NCT01025791|20693390|P11|NOT COMPLETED|Period 4||0
8396348|NCT01025791|20693391|P10|NOT COMPLETED|Period 4||0
8396349|NCT01025791|20693392|P9|NOT COMPLETED|Period 4||0
8396350|NCT01025791|20693393|P8|NOT COMPLETED|Period 4||0
8396351|NCT01025791|20693394|P7|NOT COMPLETED|Period 4||0
8396352|NCT01025791|20693395|P6|NOT COMPLETED|Period 4||0
8396353|NCT01025791|20693396|P5|NOT COMPLETED|Period 4||0
8396354|NCT01025791|20693397|P4|NOT COMPLETED|Period 4||0
8396355|NCT01025791|20693398|P3|NOT COMPLETED|Period 4||0
8396356|NCT01025791|20693399|P2|NOT COMPLETED|Period 4||0
8396357|NCT01025791|20693400|P1|NOT COMPLETED|Period 4||0
8396358|NCT01025791|20693387|P14|COMPLETED|Period 4||1
8396359|NCT01025791|20693388|P13|COMPLETED|Period 4||2
8396360|NCT01025791|20693389|P12|COMPLETED|Period 4||1
8396361|NCT01025791|20693390|P11|COMPLETED|Period 4||2
8396362|NCT01025791|20693391|P10|COMPLETED|Period 4||1
8396363|NCT01025791|20693392|P9|COMPLETED|Period 4||2
8396364|NCT01025791|20693393|P8|COMPLETED|Period 4||2
8396365|NCT01025791|20693394|P7|COMPLETED|Period 4||2
8396366|NCT01025791|20693395|P6|COMPLETED|Period 4||2
8396367|NCT01025791|20693396|P5|COMPLETED|Period 4||2
8396368|NCT01025791|20693397|P4|COMPLETED|Period 4||2
8396369|NCT01025791|20693398|P3|COMPLETED|Period 4||2
8396370|NCT01025791|20693399|P2|COMPLETED|Period 4||2
8396371|NCT01025791|20693400|P1|COMPLETED|Period 4||2
8396372|NCT01025791|20693387|P14|STARTED|Period 4||1
8396373|NCT01025791|20693388|P13|STARTED|Period 4||2
8396374|NCT01025791|20693389|P12|STARTED|Period 4||1
8396375|NCT01025791|20693390|P11|STARTED|Period 4||2
8396376|NCT01025791|20693391|P10|STARTED|Period 4||1
8396377|NCT01025791|20693392|P9|STARTED|Period 4||2
8396378|NCT01025791|20693393|P8|STARTED|Period 4||2
8396379|NCT01025791|20693394|P7|STARTED|Period 4||2
8396380|NCT01025791|20693395|P6|STARTED|Period 4||2
8396381|NCT01025791|20693396|P5|STARTED|Period 4||2
8396382|NCT01025791|20693397|P4|STARTED|Period 4||2
8396383|NCT01025791|20693398|P3|STARTED|Period 4||2
8396384|NCT01025791|20693399|P2|STARTED|Period 4||2
8396385|NCT01025791|20693400|P1|STARTED|Period 4||2
8396386|NCT01025791|20693387|P14|NOT COMPLETED|Period 3||0
8396387|NCT01025791|20693388|P13|NOT COMPLETED|Period 3||0
8396388|NCT01025791|20693389|P12|NOT COMPLETED|Period 3||0
8396389|NCT01025791|20693390|P11|NOT COMPLETED|Period 3||0
8396390|NCT01025791|20693391|P10|NOT COMPLETED|Period 3||0
8396391|NCT01025791|20693392|P9|NOT COMPLETED|Period 3||0
8396392|NCT01025791|20693393|P8|NOT COMPLETED|Period 3||0
8396393|NCT01025791|20693394|P7|NOT COMPLETED|Period 3||0
8396394|NCT01025791|20693395|P6|NOT COMPLETED|Period 3||0
8396395|NCT01025791|20693396|P5|NOT COMPLETED|Period 3||0
8396396|NCT01025791|20693397|P4|NOT COMPLETED|Period 3||0
8396397|NCT01025791|20693398|P3|NOT COMPLETED|Period 3||0
8396398|NCT01025791|20693399|P2|NOT COMPLETED|Period 3||0
8396399|NCT01025791|20693400|P1|NOT COMPLETED|Period 3||0
8396400|NCT01025791|20693387|P14|COMPLETED|Period 3||1
8396401|NCT01025791|20693388|P13|COMPLETED|Period 3||2
8396402|NCT01025791|20693389|P12|COMPLETED|Period 3||1
8396403|NCT01025791|20693390|P11|COMPLETED|Period 3||2
8396404|NCT01025791|20693391|P10|COMPLETED|Period 3||1
8396405|NCT01025791|20693392|P9|COMPLETED|Period 3||2
8396406|NCT01025791|20693393|P8|COMPLETED|Period 3||2
8396407|NCT01025791|20693394|P7|COMPLETED|Period 3||2
8396408|NCT01025791|20693395|P6|COMPLETED|Period 3||2
8396409|NCT01025791|20693396|P5|COMPLETED|Period 3||2
8396410|NCT01025791|20693397|P4|COMPLETED|Period 3||2
8396411|NCT01025791|20693398|P3|COMPLETED|Period 3||2
8396412|NCT01025791|20693399|P2|COMPLETED|Period 3||2
8396413|NCT01025791|20693400|P1|COMPLETED|Period 3||2
8396414|NCT01025791|20693387|P14|STARTED|Period 3||1
8396415|NCT01025791|20693388|P13|STARTED|Period 3||2
8396416|NCT01025791|20693389|P12|STARTED|Period 3||1
8396417|NCT01025791|20693390|P11|STARTED|Period 3||2
8396418|NCT01025791|20693391|P10|STARTED|Period 3||1
8396419|NCT01025791|20693392|P9|STARTED|Period 3||2
8396420|NCT01025791|20693393|P8|STARTED|Period 3||2
8396421|NCT01025791|20693394|P7|STARTED|Period 3||2
8396422|NCT01025791|20693395|P6|STARTED|Period 3||2
8396423|NCT01025791|20693396|P5|STARTED|Period 3||2
8396424|NCT01025791|20693397|P4|STARTED|Period 3||2
8396425|NCT01025791|20693398|P3|STARTED|Period 3||2
8396426|NCT01025791|20693399|P2|STARTED|Period 3||2
8396427|NCT01025791|20693400|P1|STARTED|Period 3||2
8396428|NCT01025791|20693387|P14|NOT COMPLETED|Period 2||0
8396429|NCT01025791|20693388|P13|NOT COMPLETED|Period 2||0
8396430|NCT01025791|20693389|P12|NOT COMPLETED|Period 2||0
8396431|NCT01025791|20693390|P11|NOT COMPLETED|Period 2||0
8396432|NCT01025791|20693391|P10|NOT COMPLETED|Period 2||0
8396433|NCT01025791|20693392|P9|NOT COMPLETED|Period 2||0
8396434|NCT01025791|20693393|P8|NOT COMPLETED|Period 2||0
8396435|NCT01025791|20693394|P7|NOT COMPLETED|Period 2||0
8396436|NCT01025791|20693395|P6|NOT COMPLETED|Period 2||0
8396437|NCT01025791|20693396|P5|NOT COMPLETED|Period 2||0
8396438|NCT01025791|20693397|P4|NOT COMPLETED|Period 2||0
8396439|NCT01025791|20693398|P3|NOT COMPLETED|Period 2||0
8396440|NCT01025791|20693399|P2|NOT COMPLETED|Period 2||0
8396441|NCT01025791|20693400|P1|NOT COMPLETED|Period 2||0
8396442|NCT01025791|20693387|P14|COMPLETED|Period 2||1
8396443|NCT01025791|20693388|P13|COMPLETED|Period 2||2
8396444|NCT01025791|20693389|P12|COMPLETED|Period 2||1
8396445|NCT01025791|20693390|P11|COMPLETED|Period 2||2
8396446|NCT01025791|20693391|P10|COMPLETED|Period 2||1
8396447|NCT01025791|20693392|P9|COMPLETED|Period 2||2
8396448|NCT01025791|20693393|P8|COMPLETED|Period 2||2
8396449|NCT01025791|20693394|P7|COMPLETED|Period 2||2
8396450|NCT01025791|20693395|P6|COMPLETED|Period 2||2
8396451|NCT01025791|20693396|P5|COMPLETED|Period 2||2
8396452|NCT01025791|20693397|P4|COMPLETED|Period 2||2
8396453|NCT01025791|20693398|P3|COMPLETED|Period 2||2
8396454|NCT01025791|20693399|P2|COMPLETED|Period 2||2
8396455|NCT01025791|20693400|P1|COMPLETED|Period 2||2
8396456|NCT01025791|20693387|P14|STARTED|Period 2||1
8396457|NCT01025791|20693388|P13|STARTED|Period 2||2
8396458|NCT01025791|20693389|P12|STARTED|Period 2||1
8396459|NCT01025791|20693390|P11|STARTED|Period 2||2
8396460|NCT01025791|20693391|P10|STARTED|Period 2||1
8396461|NCT01025791|20693392|P9|STARTED|Period 2||2
8396462|NCT01025791|20693393|P8|STARTED|Period 2||2
8396463|NCT01025791|20693394|P7|STARTED|Period 2||2
8396464|NCT01025791|20693395|P6|STARTED|Period 2||2
8396465|NCT01025791|20693396|P5|STARTED|Period 2||2
8396466|NCT01025791|20693397|P4|STARTED|Period 2||2
8396467|NCT01025791|20693398|P3|STARTED|Period 2||2
8396468|NCT01025791|20693399|P2|STARTED|Period 2||2
8396469|NCT01025791|20693400|P1|STARTED|Period 2||2
8396470|NCT01025791|20693387|P14|NOT COMPLETED|Period 1||0
8396471|NCT01025791|20693388|P13|NOT COMPLETED|Period 1||0
8396472|NCT01025791|20693389|P12|NOT COMPLETED|Period 1||0
8396473|NCT01025791|20693390|P11|NOT COMPLETED|Period 1||0
8396474|NCT01025791|20693391|P10|NOT COMPLETED|Period 1||0
8396475|NCT01025791|20693392|P9|NOT COMPLETED|Period 1||0
8396476|NCT01025791|20693393|P8|NOT COMPLETED|Period 1||0
8396477|NCT01025791|20693394|P7|NOT COMPLETED|Period 1||0
8396478|NCT01025791|20693395|P6|NOT COMPLETED|Period 1||0
8396479|NCT01025791|20693396|P5|NOT COMPLETED|Period 1||0
8396480|NCT01025791|20693397|P4|NOT COMPLETED|Period 1||0
8396481|NCT01025791|20693398|P3|NOT COMPLETED|Period 1||0
8396482|NCT01025791|20693399|P2|NOT COMPLETED|Period 1||0
8396483|NCT01025791|20693400|P1|NOT COMPLETED|Period 1||0
8396484|NCT01025791|20693387|P14|COMPLETED|Period 1||1
8396485|NCT01025791|20693388|P13|COMPLETED|Period 1||2
8396486|NCT01025791|20693389|P12|COMPLETED|Period 1||1
8396487|NCT01025791|20693390|P11|COMPLETED|Period 1||2
8396488|NCT01025791|20693391|P10|COMPLETED|Period 1||1
8396489|NCT01025791|20693392|P9|COMPLETED|Period 1||2
8396490|NCT01025791|20693393|P8|COMPLETED|Period 1||2
8396491|NCT01025791|20693394|P7|COMPLETED|Period 1||2
8396492|NCT01025791|20693395|P6|COMPLETED|Period 1||2
8396493|NCT01025791|20693396|P5|COMPLETED|Period 1||2
8396494|NCT01025791|20693397|P4|COMPLETED|Period 1||2
8396495|NCT01025791|20693398|P3|COMPLETED|Period 1||2
8396496|NCT01025791|20693399|P2|COMPLETED|Period 1||2
8396497|NCT01025791|20693400|P1|COMPLETED|Period 1||2
8396498|NCT01025791|20693387|P14|STARTED|Period 1||1
8396499|NCT01025791|20693388|P13|STARTED|Period 1||2
8396500|NCT01025791|20693389|P12|STARTED|Period 1||1
8396501|NCT01025791|20693390|P11|STARTED|Period 1||2
8396502|NCT01025791|20693391|P10|STARTED|Period 1||1
8396503|NCT01025791|20693392|P9|STARTED|Period 1||2
8396504|NCT01025791|20693393|P8|STARTED|Period 1||2
8396505|NCT01025791|20693394|P7|STARTED|Period 1||2
8396506|NCT01025791|20693395|P6|STARTED|Period 1||2
8396507|NCT01025791|20693396|P5|STARTED|Period 1||2
8396508|NCT01025791|20693397|P4|STARTED|Period 1||2
8396509|NCT01025791|20693398|P3|STARTED|Period 1||2
8396510|NCT01025791|20693399|P2|STARTED|Period 1||2
8396511|NCT01025791|20693400|P1|STARTED|Period 1||2
8396512|NCT01025752|20693532|P2|NOT COMPLETED|Overall Study||13
8396513|NCT01025752|20693533|P1|NOT COMPLETED|Overall Study||8
8396514|NCT01025752|20693532|P2|COMPLETED|Overall Study||50
8396515|NCT01025752|20693533|P1|COMPLETED|Overall Study||54
8396516|NCT01025752|20693532|P2|STARTED|Overall Study||63
8396517|NCT01025752|20693533|P1|STARTED|Overall Study||62
8396518|NCT01025635|20693553|P2|NOT COMPLETED|Overall Study||25
8396519|NCT01025635|20693554|P1|NOT COMPLETED|Overall Study||23
8396520|NCT01025635|20693553|P2|COMPLETED|Overall Study||178
8396521|NCT01025635|20693554|P1|COMPLETED|Overall Study||175
8396522|NCT01025635|20693553|P2|STARTED|Overall Study||203
8396523|NCT01025635|20693554|P1|STARTED|Overall Study||198
8396524|NCT01025492|20693566|P1|NOT COMPLETED|Overall Study||0
8396525|NCT01025492|20693566|P1|COMPLETED|Overall Study||24
8396526|NCT01025492|20693566|P1|STARTED|Overall Study||24
8396527|NCT01025453|20693570|P1|NOT COMPLETED|Overall Study||0
8396528|NCT01025453|20693570|P1|COMPLETED|Overall Study||37
8396529|NCT01025453|20693570|P1|STARTED|Overall Study||37
8396530|NCT01025427|20693577|P1|NOT COMPLETED|Overall Study||0
8396531|NCT01025427|20693577|P1|COMPLETED|Overall Study||16
8396532|NCT01025427|20693577|P1|STARTED|Overall Study||16
8396533|NCT01025336|20693586|P5|NOT COMPLETED|Overall Study||0
8396534|NCT01025336|20693587|P4|NOT COMPLETED|Overall Study||2
8396535|NCT01025336|20693588|P3|NOT COMPLETED|Overall Study||0
8396536|NCT01025336|20693589|P2|NOT COMPLETED|Overall Study||0
8396537|NCT01025336|20693590|P1|NOT COMPLETED|Overall Study||0
8396538|NCT01025336|20693586|P5|COMPLETED|Overall Study||222
8396539|NCT01025336|20693587|P4|COMPLETED|Overall Study||219
8396540|NCT01025336|20693588|P3|COMPLETED|Overall Study||179
8396541|NCT01025336|20693589|P2|COMPLETED|Overall Study||210
8396542|NCT01025336|20693590|P1|COMPLETED|Overall Study||130
8396543|NCT01025336|20693586|P5|STARTED|Overall Study||222
8396544|NCT01025336|20693587|P4|STARTED|Overall Study||221
8396545|NCT01025336|20693588|P3|STARTED|Overall Study||179
8396546|NCT01025336|20693589|P2|STARTED|Overall Study||210
8396547|NCT01025336|20693590|P1|STARTED|Overall Study||130
8396548|NCT01025284|20693645|P3|NOT COMPLETED|Overall Study||0
8396549|NCT01025284|20693646|P2|NOT COMPLETED|Overall Study||2
8396550|NCT01025284|20693647|P1|NOT COMPLETED|Overall Study||0
8396551|NCT01025284|20693645|P3|COMPLETED|Overall Study||8
8396552|NCT01025284|20693646|P2|COMPLETED|Overall Study||16
8396553|NCT01025284|20693647|P1|COMPLETED|Overall Study||38
8396554|NCT01025284|20693645|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8396555|NCT01025284|20693646|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
8396556|NCT01025284|20693647|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
8396557|NCT01025284|20693645|P3|STARTED|Overall Study||8
8396558|NCT01025284|20693646|P2|STARTED|Overall Study||18
8396559|NCT01025284|20693647|P1|STARTED|Overall Study||38
8396560|NCT01025271|20693665|P1|NOT COMPLETED|Overall Study||0
8396561|NCT01025271|20693665|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
8396562|NCT01025271|20693665|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
8396563|NCT01025232|20693672|P2|NOT COMPLETED|Overall Study||6
8396564|NCT01025232|20693673|P1|NOT COMPLETED|Overall Study||3
8396565|NCT01025232|20693672|P2|COMPLETED|Overall Study||36
8396566|NCT01025232|20693673|P1|COMPLETED|Overall Study||43
8396567|NCT01025232|20693672|P2|STARTED|Overall Study||42
8396568|NCT01025232|20693673|P1|STARTED|Overall Study||46
8396569|NCT01025193|20693691|P1|NOT COMPLETED|Overall Study||4
8396570|NCT01025193|20693691|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
8396571|NCT01025193|20693691|P1|STARTED|Overall Study||8
8396572|NCT01025154|20693701|P1|NOT COMPLETED|Overall Study||2
8396573|NCT01025154|20693701|P1|COMPLETED|Overall Study||57
8396574|NCT01025154|20693701|P1|STARTED|Overall Study||59
8396575|NCT01025076|20693706|P1|NOT COMPLETED|Overall Study||0
8396576|NCT01025076|20693706|P1|COMPLETED|Overall Study||14
8396577|NCT01025076|20693706|P1|STARTED|Overall Study||14
8396578|NCT01025037|20693710|P1|NOT COMPLETED|Overall Study||11
8396579|NCT01025037|20693710|P1|COMPLETED|Overall Study||50
8396580|NCT01025037|20693710|P1|STARTED|Overall Study||61
8396581|NCT01024972|20693721|P2|NOT COMPLETED|Overall Study||0
8396582|NCT01024972|20693722|P1|NOT COMPLETED|Overall Study||0
8396583|NCT01024972|20693721|P2|COMPLETED|Overall Study||15
8396584|NCT01024972|20693722|P1|COMPLETED|Overall Study||16
8396585|NCT01024972|20693721|P2|STARTED|Overall Study||15
8396586|NCT01024972|20693722|P1|STARTED|Overall Study||16
8396587|NCT01024959|20693732|P1|NOT COMPLETED|Overall Study||41
8396588|NCT01024959|20693732|P1|COMPLETED|Overall Study||466
8396589|NCT01024959|20693732|P1|STARTED|Overall Study||507
8396590|NCT01024946|20693741|P1|NOT COMPLETED|Overall Study||5
8396591|NCT01024946|20693741|P1|COMPLETED|Overall Study||6
8396592|NCT01024946|20693741|P1|STARTED|Overall Study||11
8396593|NCT01024920|20693747|P2|NOT COMPLETED|Overall Study||22
8396594|NCT01024920|20693748|P1|NOT COMPLETED|Overall Study||45
8396595|NCT01024920|20693747|P2|COMPLETED|Overall Study||10
8396596|NCT01024920|20693748|P1|COMPLETED|Overall Study||22
8396597|NCT01024920|20693747|P2|Treated|Overall Study||32
8396598|NCT01024920|20693748|P1|Treated|Overall Study||64
8396599|NCT01024920|20693747|P2|STARTED|Overall Study||32
8396600|NCT01024920|20693748|P1|STARTED|Overall Study||67
8396601|NCT01024855|20693766|P1|NOT COMPLETED|Overall Study||1
8396602|NCT01024855|20693766|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
8396603|NCT01024855|20693766|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
8396604|NCT01024751|20693773|P2|NOT COMPLETED|Eligible Participants||3
8396605|NCT01024751|20693774|P1|NOT COMPLETED|Eligible Participants||0
8396606|NCT01024751|20693773|P2|COMPLETED|Eligible Participants||149
8396607|NCT01024751|20693774|P1|COMPLETED|Eligible Participants||153
8396608|NCT01024751|20693773|P2|STARTED|Eligible Participants||152
8396609|NCT01024751|20693774|P1|STARTED|Eligible Participants||153
8396610|NCT01024751|20693773|P2|NOT COMPLETED|Enrolled Participants||4
8396611|NCT01024751|20693774|P1|NOT COMPLETED|Enrolled Participants||3
8396612|NCT01024751|20693773|P2|COMPLETED|Enrolled Participants||152
8396613|NCT01024751|20693774|P1|COMPLETED|Enrolled Participants||153
8396614|NCT01024751|20693773|P2|STARTED|Enrolled Participants||156
8396615|NCT01024751|20693774|P1|STARTED|Enrolled Participants||156
8396616|NCT01024738|20693785|P3|NOT COMPLETED|Third Intervention:||0
8396617|NCT01024738|20693786|P2|NOT COMPLETED|Third Intervention:||0
8396618|NCT01024738|20693787|P1|NOT COMPLETED|Third Intervention:||0
8396619|NCT01024738|20693785|P3|COMPLETED|Third Intervention:||8
8396620|NCT01024738|20693786|P2|COMPLETED|Third Intervention:||7
8396621|NCT01024738|20693787|P1|COMPLETED|Third Intervention:||7
8396622|NCT01024738|20693785|P3|STARTED|Third Intervention:||8
8396623|NCT01024738|20693786|P2|STARTED|Third Intervention:||7
8396624|NCT01024738|20693787|P1|STARTED|Third Intervention:||7
8396625|NCT01024738|20693785|P3|NOT COMPLETED|Washout After 2nd Intervention||0
8396626|NCT01024738|20693786|P2|NOT COMPLETED|Washout After 2nd Intervention||0
8396627|NCT01024738|20693787|P1|NOT COMPLETED|Washout After 2nd Intervention||0
8396628|NCT01024738|20693785|P3|COMPLETED|Washout After 2nd Intervention||8
8396629|NCT01024738|20693786|P2|COMPLETED|Washout After 2nd Intervention||7
8396630|NCT01024738|20693787|P1|COMPLETED|Washout After 2nd Intervention||7
8396631|NCT01024738|20693785|P3|STARTED|Washout After 2nd Intervention||8
8396632|NCT01024738|20693786|P2|STARTED|Washout After 2nd Intervention||7
8396633|NCT01024738|20693787|P1|STARTED|Washout After 2nd Intervention||7
8396634|NCT01024738|20693785|P3|NOT COMPLETED|Second Intervention:||0
8396635|NCT01024738|20693786|P2|NOT COMPLETED|Second Intervention:||0
8396636|NCT01024738|20693787|P1|NOT COMPLETED|Second Intervention:||0
8396637|NCT01024738|20693785|P3|COMPLETED|Second Intervention:||8
8396638|NCT01024738|20693786|P2|COMPLETED|Second Intervention:||7
8396639|NCT01024738|20693787|P1|COMPLETED|Second Intervention:||7
8396640|NCT01024738|20693785|P3|STARTED|Second Intervention:||8
8396641|NCT01024738|20693786|P2|STARTED|Second Intervention:||7
8396642|NCT01024738|20693787|P1|STARTED|Second Intervention:||7
8396643|NCT01024738|20693785|P3|NOT COMPLETED|Washout After 1st Intervention||0
8396644|NCT01024738|20693786|P2|NOT COMPLETED|Washout After 1st Intervention||0
8396645|NCT01024738|20693787|P1|NOT COMPLETED|Washout After 1st Intervention||0
8396646|NCT01024738|20693785|P3|COMPLETED|Washout After 1st Intervention||8
8396647|NCT01024738|20693786|P2|COMPLETED|Washout After 1st Intervention||7
8396648|NCT01024738|20693787|P1|COMPLETED|Washout After 1st Intervention||7
8396649|NCT01024738|20693785|P3|STARTED|Washout After 1st Intervention||8
8396650|NCT01024738|20693786|P2|STARTED|Washout After 1st Intervention||7
8396651|NCT01024738|20693787|P1|STARTED|Washout After 1st Intervention||7
8396652|NCT01024738|20693785|P3|NOT COMPLETED|First Intervention:||0
8396653|NCT01024738|20693786|P2|NOT COMPLETED|First Intervention:||0
8396654|NCT01024738|20693787|P1|NOT COMPLETED|First Intervention:||0
8396655|NCT01024738|20693785|P3|COMPLETED|First Intervention:||8
8396656|NCT01024738|20693786|P2|COMPLETED|First Intervention:||7
8396657|NCT01024738|20693787|P1|COMPLETED|First Intervention:||7
8396658|NCT01024738|20693785|P3|STARTED|First Intervention:||8
8396659|NCT01024738|20693786|P2|STARTED|First Intervention:||7
8396660|NCT01024738|20693787|P1|STARTED|First Intervention:||7
8396661|NCT01024686|20693798|P3|NOT COMPLETED|Overall Study||0
8396662|NCT01024686|20693799|P2|NOT COMPLETED|Overall Study||0
8396663|NCT01024686|20693800|P1|NOT COMPLETED|Overall Study||0
8396664|NCT01024686|20693798|P3|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
8396665|NCT01024686|20693799|P2|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
8396666|NCT01024686|20693800|P1|COMPLETED|Overall Study||6
8396667|NCT01024686|20693798|P3|STARTED|Overall Study||0
8396668|NCT01024686|20693799|P2|STARTED|Overall Study||0
8396669|NCT01024686|20693800|P1|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
8396670|NCT01024608|20693831|P2|NOT COMPLETED|Overall Study||4
8396671|NCT01024608|20693832|P1|NOT COMPLETED|Overall Study||4
8396672|NCT01024608|20693831|P2|COMPLETED|Overall Study||167
8396673|NCT01024608|20693832|P1|COMPLETED|Overall Study||165
8396674|NCT01024608|20693831|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
8396675|NCT01024608|20693832|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
8396676|NCT01024608|20693831|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
8396677|NCT01024608|20693832|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
8396678|NCT01024608|20693831|P2|STARTED|Overall Study||171
8396679|NCT01024608|20693832|P1|STARTED|Overall Study||169
8396680|NCT01024569|20693846|P2|NOT COMPLETED|Overall Study||11
8396681|NCT01024569|20693847|P1|NOT COMPLETED|Overall Study||25
8396682|NCT01024569|20693846|P2|COMPLETED|Overall Study||268
8396683|NCT01024569|20693847|P1|COMPLETED|Overall Study||251
8396684|NCT01024569|20693846|P2|STARTED|Overall Study||279
8396685|NCT01024569|20693847|P1|STARTED|Overall Study||276
8396686|NCT01024465|20693861|P1|NOT COMPLETED|Overall Study||3
8396687|NCT01024465|20693861|P1|COMPLETED|Overall Study||23
8396688|NCT01024465|20693861|P1|STARTED|Overall Study||26
8396689|NCT01024387|20693865|P1|NOT COMPLETED|Overall Study||60
8396690|NCT01024387|20693865|P1|COMPLETED|Overall Study||0
8396691|NCT01024387|20693865|P1|Evaluable for Response|Overall Study||53
8396692|NCT01024387|20693865|P1|Evaluable for PFS|Overall Study||54
8396693|NCT01024387|20693865|P1|STARTED|Overall Study||60
8396694|NCT01024335|20693875|P2|NOT COMPLETED|Overall Study||26
8396695|NCT01024335|20693876|P1|NOT COMPLETED|Overall Study||13
8396696|NCT01024335|20693875|P2|COMPLETED|Overall Study||14
8396697|NCT01024335|20693876|P1|COMPLETED|Overall Study||7
8396698|NCT01024335|20693875|P2|STARTED|Overall Study||40
8396699|NCT01024335|20693876|P1|STARTED|Overall Study||20
8396700|NCT01024309|20693886|P2|NOT COMPLETED|Overall Study||4
8396701|NCT01024309|20693887|P1|NOT COMPLETED|Overall Study||8
8396702|NCT01024309|20693886|P2|COMPLETED|Overall Study||27
8396703|NCT01024309|20693887|P1|COMPLETED|Overall Study||27
8396704|NCT01024309|20693886|P2|STARTED|Overall Study||31
8396705|NCT01024309|20693887|P1|STARTED|Overall Study||35
8396706|NCT01024296|20693909|P1|NOT COMPLETED|Overall Study||0
8396707|NCT01024296|20693909|P1|COMPLETED|Overall Study||4
8396708|NCT01024296|20693909|P1|STARTED|Overall Study||4
8396709|NCT01024244|20693919|P5|NOT COMPLETED|Overall Study||14
8396710|NCT01024244|20693920|P4|NOT COMPLETED|Overall Study||13
8396711|NCT01024244|20693921|P3|NOT COMPLETED|Overall Study||14
8396712|NCT01024244|20693922|P2|NOT COMPLETED|Overall Study||11
8396713|NCT01024244|20693923|P1|NOT COMPLETED|Overall Study||17
8396714|NCT01024244|20693919|P5|COMPLETED|Overall Study||1
8396715|NCT01024244|20693920|P4|COMPLETED|Overall Study||1
8396716|NCT01024244|20693921|P3|COMPLETED|Overall Study||1
8396717|NCT01024244|20693922|P2|COMPLETED|Overall Study||1
8396718|NCT01024244|20693923|P1|COMPLETED|Overall Study||5
8396719|NCT01024244|20693919|P5|STARTED|Overall Study||15
8396720|NCT01024244|20693920|P4|STARTED|Overall Study||14
8396721|NCT01024244|20693921|P3|STARTED|Overall Study||15
8396722|NCT01024244|20693922|P2|STARTED|Overall Study||12
8396723|NCT01024244|20693923|P1|STARTED|Overall Study||22
8396724|NCT01024036|20694037|P2|NOT COMPLETED|Follow-Up Period||3
8396725|NCT01024036|20694038|P1|NOT COMPLETED|Follow-Up Period||5
8396726|NCT01024036|20694037|P2|COMPLETED|Follow-Up Period||3
8396727|NCT01024036|20694038|P1|COMPLETED|Follow-Up Period||9
8396728|NCT01024036|20694037|P2|STARTED|Follow-Up Period||6
8396729|NCT01024036|20694038|P1|STARTED|Follow-Up Period||14
8396730|NCT01024036|20694037|P2|NOT COMPLETED|Unblinded Treatment||3
8396731|NCT01024036|20694038|P1|NOT COMPLETED|Unblinded Treatment||0
8396732|NCT01024036|20694037|P2|COMPLETED|Unblinded Treatment||10
8396733|NCT01024036|20694038|P1|COMPLETED|Unblinded Treatment||0
8396734|NCT01024036|20694037|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
8396735|NCT01024036|20694038|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
8396736|NCT01024036|20694037|P2|NOT COMPLETED|Blinded Treatment||20
8396737|NCT01024036|20694038|P1|NOT COMPLETED|Blinded Treatment||22
8396738|NCT01024036|20694037|P2|COMPLETED|Blinded Treatment||6
8396739|NCT01024036|20694038|P1|COMPLETED|Blinded Treatment||31
8396740|NCT01024036|20694037|P2|STARTED|Blinded Treatment||26
8396741|NCT01024036|20694038|P1|STARTED|Blinded Treatment||53
8396742|NCT01024010|20694071|P2|NOT COMPLETED|Overall Study||0
8396743|NCT01024010|20694072|P1|NOT COMPLETED|Overall Study||0
8396744|NCT01024010|20694071|P2|COMPLETED|Overall Study||34
8396745|NCT01024010|20694072|P1|COMPLETED|Overall Study||48
8396746|NCT01024010|20694071|P2|STARTED|Overall Study||34
8396747|NCT01024010|20694072|P1|STARTED|Overall Study||48
8396748|NCT01023958|20694085|P1|NOT COMPLETED|Overall Study||50
8396749|NCT01023958|20694085|P1|COMPLETED|Overall Study||0
8396750|NCT01023958|20694085|P1|STARTED|Overall Study||50
8396751|NCT01023841|20694114|P2|NOT COMPLETED|Overall Study||0
8396752|NCT01023841|20694115|P1|NOT COMPLETED|Overall Study||1
8396753|NCT01023841|20694114|P2|COMPLETED|Overall Study||23
8396754|NCT01023841|20694115|P1|COMPLETED|Overall Study||47
8396755|NCT01023841|20694114|P2|STARTED|Overall Study||23
8396756|NCT01023841|20694115|P1|STARTED|Overall Study||48
8396757|NCT01023815|20694133|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
8396758|NCT01023815|20694134|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
8396759|NCT01023815|20694135|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
8396760|NCT01023815|20694136|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
8396761|NCT01023815|20694133|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
8396762|NCT01023815|20694134|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
8396763|NCT01023815|20694135|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
8396764|NCT01023815|20694136|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
8396765|NCT01023815|20694133|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
8396766|NCT01023815|20694134|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
8396767|NCT01023815|20694135|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
8396768|NCT01023815|20694136|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
8396769|NCT01023815|20694133|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396770|NCT01023815|20694134|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396771|NCT01023815|20694135|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396772|NCT01023815|20694136|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
8396773|NCT01023815|20694133|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396774|NCT01023815|20694134|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396775|NCT01023815|20694135|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396776|NCT01023815|20694136|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
8396777|NCT01023815|20694133|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
8396778|NCT01023815|20694134|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
8396779|NCT01023815|20694135|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
8396780|NCT01023815|20694136|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
8396781|NCT01023789|20694155|P1|NOT COMPLETED|3 - Year Visit||43
8396782|NCT01023789|20694155|P1|COMPLETED|3 - Year Visit||769
8396783|NCT01023789|20694155|P1|STARTED|3 - Year Visit||812
8396784|NCT01023789|20694155|P1|NOT COMPLETED|2 - Year Visit||0
8396785|NCT01023789|20694155|P1|COMPLETED|2 - Year Visit||812
8396786|NCT01023789|20694155|P1|STARTED|2 - Year Visit||812
8396787|NCT01023789|20694155|P1|NOT COMPLETED|1 - Year Visit||0
8396788|NCT01023789|20694155|P1|COMPLETED|1 - Year Visit||812
8396789|NCT01023789|20694155|P1|STARTED|1 - Year Visit||812
8396790|NCT01023789|20694155|P1|NOT COMPLETED|180-day Clinical Follow-up||0
8396791|NCT01023789|20694155|P1|COMPLETED|180-day Clinical Follow-up||812
8396792|NCT01023789|20694155|P1|STARTED|180-day Clinical Follow-up||812
8396793|NCT01023789|20694155|P1|NOT COMPLETED|30-day Follow-up Visit||0
8396794|NCT01023789|20694155|P1|COMPLETED|30-day Follow-up Visit||812
8396795|NCT01023789|20694155|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
8396796|NCT01023776|20694222|P1|NOT COMPLETED|Overall Study||0
8396797|NCT01023776|20694222|P1|COMPLETED|Overall Study||20
8396798|NCT01023776|20694222|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
8396799|NCT01023724|20694229|P2|NOT COMPLETED|Overall Study||3
8396800|NCT01023724|20694230|P1|NOT COMPLETED|Overall Study||4
8396801|NCT01023724|20694229|P2|COMPLETED|Overall Study||22
8396802|NCT01023724|20694230|P1|COMPLETED|Overall Study||21
8396803|NCT01023724|20694229|P2|STARTED|Overall Study||25
8396804|NCT01023724|20694230|P1|STARTED|Overall Study||25
8396805|NCT01023711|20694236|P1|NOT COMPLETED|Overall Study||0
8396806|NCT01023711|20694236|P1|COMPLETED|Overall Study||107
8396807|NCT01023711|20694236|P1|STARTED|Overall Study||107
8396808|NCT01023672|20694241|P1|NOT COMPLETED|Overall Study||3
8396809|NCT01023672|20694241|P1|COMPLETED|Overall Study||17
8396810|NCT01023672|20694241|P1|STARTED|Overall Study||20
8396811|NCT01023659|20694248|P3|NOT COMPLETED|Overall Study||99
8396812|NCT01023659|20694249|P2|NOT COMPLETED|Overall Study||228
8396813|NCT01023659|20694250|P1|NOT COMPLETED|Overall Study||73
8396814|NCT01023659|20694248|P3|COMPLETED|Overall Study||165
8396815|NCT01023659|20694249|P2|COMPLETED|Overall Study||137
8396816|NCT01023659|20694250|P1|COMPLETED|Overall Study||185
8396817|NCT01023659|20694248|P3|STARTED|Overall Study||264
8396818|NCT01023659|20694249|P2|STARTED|Overall Study||365
8396819|NCT01023659|20694250|P1|STARTED|Overall Study||258
8396820|NCT01023620|20694261|P2|NOT COMPLETED|Overall Study||0
8396821|NCT01023620|20694262|P1|NOT COMPLETED|Overall Study||0
8396822|NCT01023620|20694261|P2|COMPLETED|Overall Study||0
8396823|NCT01023620|20694262|P1|COMPLETED|Overall Study||0
8396824|NCT01023620|20694261|P2|STARTED|Overall Study||0
8396825|NCT01023620|20694262|P1|STARTED|Overall Study||0
8396826|NCT01023581|20694277|P7|NOT COMPLETED|Overall Study||20
8396827|NCT01023581|20694278|P6|NOT COMPLETED|Overall Study||19
8396828|NCT01023581|20694279|P5|NOT COMPLETED|Overall Study||16
8396829|NCT01023581|20694280|P4|NOT COMPLETED|Overall Study||20
8396830|NCT01023581|20694281|P3|NOT COMPLETED|Overall Study||42
8396831|NCT01023581|20694282|P2|NOT COMPLETED|Overall Study||23
8396832|NCT01023581|20694283|P1|NOT COMPLETED|Overall Study||35
8396833|NCT01023581|20694277|P7|COMPLETED|Overall Study||94
8396834|NCT01023581|20694278|P6|COMPLETED|Overall Study||92
8396835|NCT01023581|20694279|P5|COMPLETED|Overall Study||95
8396836|NCT01023581|20694280|P4|COMPLETED|Overall Study||94
8396837|NCT01023581|20694281|P3|COMPLETED|Overall Study||71
8396838|NCT01023581|20694282|P2|COMPLETED|Overall Study||89
8396839|NCT01023581|20694283|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
8396840|NCT01023581|20694277|P7|Received Study Treatment|Overall Study||114
8396841|NCT01023581|20694278|P6|Received Study Treatment|Overall Study||106
8396842|NCT01023581|20694279|P5|Received Study Treatment|Overall Study||111
8396843|NCT01023581|20694280|P4|Received Study Treatment|Overall Study||109
8396844|NCT01023581|20694281|P3|Received Study Treatment|Overall Study||110
8396845|NCT01023581|20694282|P2|Received Study Treatment|Overall Study||112
8396846|NCT01023581|20694283|P1|Received Study Treatment|Overall Study||106
8396847|NCT01023581|20694277|P7|STARTED|Overall Study||114
8396848|NCT01023581|20694278|P6|STARTED|Overall Study||111
8396849|NCT01023581|20694279|P5|STARTED|Overall Study||111
8396850|NCT01023581|20694280|P4|STARTED|Overall Study||114
8396851|NCT01023581|20694281|P3|STARTED|Overall Study||113
8396852|NCT01023581|20694282|P2|STARTED|Overall Study||112
8396853|NCT01023581|20694283|P1|STARTED|Overall Study||109
8396854|NCT01023568|20694316|P3|NOT COMPLETED|Overall Study||0
8396855|NCT01023568|20694317|P2|NOT COMPLETED|Overall Study||0
8396856|NCT01023568|20694318|P1|NOT COMPLETED|Overall Study||0
8396857|NCT01023568|20694316|P3|COMPLETED|Overall Study||45
8396858|NCT01023568|20694317|P2|COMPLETED|Overall Study||44
8396859|NCT01023568|20694318|P1|COMPLETED|Overall Study||45
8396860|NCT01023568|20694316|P3|STARTED|Overall Study||45
8396861|NCT01023568|20694317|P2|STARTED|Overall Study||44
8396862|NCT01023568|20694318|P1|STARTED|Overall Study||45
8396863|NCT01023516|20694340|P2|NOT COMPLETED|Overall Study||18
8396864|NCT01023516|20694341|P1|NOT COMPLETED|Overall Study||24
8396865|NCT01023516|20694340|P2|COMPLETED|Overall Study||284
8396866|NCT01023516|20694341|P1|COMPLETED|Overall Study||289
8396867|NCT01023516|20694340|P2|STARTED|Overall Study||302
8396868|NCT01023516|20694341|P1|STARTED|Overall Study||313
8396869|NCT01023308|20694423|P2|NOT COMPLETED|Overall Study||279
8396870|NCT01023308|20694424|P1|NOT COMPLETED|Overall Study||285
8396871|NCT01023308|20694423|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
8396872|NCT01023308|20694424|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
8396873|NCT01023308|20694423|P2|STARTED|Overall Study||381
8396874|NCT01023308|20694424|P1|STARTED|Overall Study||387
8396875|NCT01023269|20694450|P2|NOT COMPLETED|Overall Study||0
8396876|NCT01023269|20694451|P1|NOT COMPLETED|Overall Study||2
8396877|NCT01023269|20694450|P2|COMPLETED|Overall Study||2
8396878|NCT01023269|20694451|P1|COMPLETED|Overall Study||1
8396879|NCT01023269|20694450|P2|STARTED|Overall Study||2
8396880|NCT01023269|20694451|P1|STARTED|Overall Study||3
8396881|NCT01023256|20694459|P4|NOT COMPLETED|Overall Study||5
8396882|NCT01023256|20694460|P3|NOT COMPLETED|Overall Study||1
8396883|NCT01023256|20694461|P2|NOT COMPLETED|Overall Study||3
8396884|NCT01023256|20694462|P1|NOT COMPLETED|Overall Study||4
8396885|NCT01023256|20694459|P4|COMPLETED|Overall Study||22
8396886|NCT01023256|20694460|P3|COMPLETED|Overall Study||23
8396887|NCT01023256|20694461|P2|COMPLETED|Overall Study||19
8396888|NCT01023256|20694462|P1|COMPLETED|Overall Study||21
8396889|NCT01023256|20694459|P4|STARTED|Overall Study||27
8396890|NCT01023256|20694460|P3|STARTED|Overall Study||24
8396891|NCT01023256|20694461|P2|STARTED|Overall Study||22
8396892|NCT01023256|20694462|P1|STARTED|Overall Study||25
8396893|NCT01023217|20694504|P2|NOT COMPLETED|Overall Study||0
8396894|NCT01023217|20694505|P1|NOT COMPLETED|Overall Study||1
8396895|NCT01023217|20694504|P2|COMPLETED|Overall Study||45
8396896|NCT01023217|20694505|P1|COMPLETED|Overall Study||44
8396897|NCT01023217|20694504|P2|STARTED|Overall Study||45
8396898|NCT01023217|20694505|P1|STARTED|Overall Study||45
8396899|NCT01023178|20694514|P3|NOT COMPLETED|Overall Study||3
8396900|NCT01023178|20694515|P2|NOT COMPLETED|Overall Study||2
8396901|NCT01023178|20694516|P1|NOT COMPLETED|Overall Study||2
8396902|NCT01023178|20694514|P3|COMPLETED|Overall Study||4
8396903|NCT01023178|20694515|P2|COMPLETED|Overall Study||6
8396904|NCT01023178|20694516|P1|COMPLETED|Overall Study||3
8396905|NCT01023178|20694514|P3|STARTED|Overall Study||7
8396906|NCT01023178|20694515|P2|STARTED|Overall Study||8
8396907|NCT01023178|20694516|P1|STARTED|Overall Study||5
8396908|NCT01023074|20694527|P3|NOT COMPLETED|Overall Study||0
8396909|NCT01023074|20694528|P2|NOT COMPLETED|Overall Study||0
8396910|NCT01023074|20694529|P1|NOT COMPLETED|Overall Study||0
8396911|NCT01023074|20694527|P3|COMPLETED|Overall Study||13
8396912|NCT01023074|20694528|P2|COMPLETED|Overall Study||13
8396913|NCT01023074|20694529|P1|COMPLETED|Overall Study||26
8396914|NCT01023074|20694527|P3|STARTED|Overall Study||13
8396915|NCT01023074|20694528|P2|STARTED|Overall Study||13
8396916|NCT01023074|20694529|P1|STARTED|Overall Study||26
8396917|NCT01023061|20694543|P1|NOT COMPLETED|Overall Study||2
8396918|NCT01023061|20694543|P1|COMPLETED|Overall Study||22
8396919|NCT01023061|20694543|P1|STARTED|Overall Study||24
8396938|NCT01023022|20694564|P1|NOT COMPLETED|Overall Study||14
8396939|NCT01023022|20694564|P1|COMPLETED|Overall Study||162
8396940|NCT01023022|20694564|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
8396941|NCT01022996|20694570|P1|NOT COMPLETED|Overall Study||57
8396942|NCT01022996|20694570|P1|COMPLETED|Overall Study||0
8396943|NCT01022996|20694570|P1|STARTED|Overall Study||57
8396944|NCT01022853|20694584|P5|NOT COMPLETED|Overall Study||2
8396945|NCT01022853|20694585|P4|NOT COMPLETED|Overall Study||8
8396946|NCT01022853|20694586|P3|NOT COMPLETED|Overall Study||13
8396947|NCT01022853|20694587|P2|NOT COMPLETED|Overall Study||4
8396948|NCT01022853|20694588|P1|NOT COMPLETED|Overall Study||3
8396949|NCT01022853|20694584|P5|COMPLETED|Overall Study||0
8396950|NCT01022853|20694585|P4|COMPLETED|Overall Study||0
8396951|NCT01022853|20694586|P3|COMPLETED|Overall Study||0
8396952|NCT01022853|20694587|P2|COMPLETED|Overall Study||0
8396953|NCT01022853|20694588|P1|COMPLETED|Overall Study||0
8396954|NCT01022853|20694584|P5|STARTED|Overall Study|entered and treated|2
8396955|NCT01022853|20694585|P4|STARTED|Overall Study|entered and treated|8
8396956|NCT01022853|20694586|P3|STARTED|Overall Study|entered and treated|13
8396957|NCT01022853|20694587|P2|STARTED|Overall Study|entered and treated|4
8396958|NCT01022853|20694588|P1|STARTED|Overall Study|entered and treated|3
8396959|NCT01022762|20694667|P2|NOT COMPLETED|Overall Study||28
8396960|NCT01022762|20694668|P1|NOT COMPLETED|Overall Study||22
8396961|NCT01022762|20694667|P2|COMPLETED|Overall Study||194
8396962|NCT01022762|20694668|P1|COMPLETED|Overall Study||196
8396963|NCT01022762|20694667|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
8396964|NCT01022762|20694668|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
8396965|NCT01022762|20694667|P2|STARTED|Overall Study||222
8396966|NCT01022762|20694668|P1|STARTED|Overall Study||218
8396967|NCT01022567|20694696|P2|NOT COMPLETED|Overall Study||15
8396968|NCT01022567|20694697|P1|NOT COMPLETED|Overall Study||1
8396969|NCT01022567|20694696|P2|COMPLETED|Overall Study||242
8396970|NCT01022567|20694697|P1|COMPLETED|Overall Study||272
8396971|NCT01022567|20694696|P2|STARTED|Overall Study||257
8396972|NCT01022567|20694697|P1|STARTED|Overall Study||273
8396973|NCT01022502|20694703|P1|NOT COMPLETED|Overall Study||3
8396974|NCT01022502|20694703|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
8396975|NCT01022502|20694703|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
8396976|NCT01022424|20694717|P1|NOT COMPLETED|Overall Study||4
8396977|NCT01022424|20694717|P1|COMPLETED|Overall Study||9
8396978|NCT01022424|20694717|P1|STARTED|Overall Study||13
8396979|NCT01022398|20694732|P2|NOT COMPLETED|Overall Study||2
8396980|NCT01022398|20694733|P1|NOT COMPLETED|Overall Study||2
8396981|NCT01022398|20694732|P2|COMPLETED|Overall Study||0
8396982|NCT01022398|20694733|P1|COMPLETED|Overall Study||0
8396983|NCT01022398|20694732|P2|STARTED|Overall Study||2
8396984|NCT01022398|20694733|P1|STARTED|Overall Study||2
8396985|NCT01022307|20694740|P2|NOT COMPLETED|Overall Study||4
8396986|NCT01022307|20694741|P1|NOT COMPLETED|Overall Study||0
8396987|NCT01022307|20694740|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
8396988|NCT01022307|20694741|P1|COMPLETED|Overall Study||184
8396989|NCT01022307|20694740|P2|STARTED|Overall Study||28
8396990|NCT01022307|20694741|P1|STARTED|Overall Study||184
8396991|NCT01022242|20694749|P2|NOT COMPLETED|Overall Study||19
8396992|NCT01022242|20694750|P1|NOT COMPLETED|Overall Study||21
8396993|NCT01022242|20694749|P2|COMPLETED|Overall Study||46
8396994|NCT01022242|20694750|P1|COMPLETED|Overall Study||49
8396995|NCT01022242|20694749|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
8396996|NCT01022242|20694750|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
8396997|NCT01022203|20694758|P2|NOT COMPLETED|Follow-Up Assessment||2
8396998|NCT01022203|20694759|P1|NOT COMPLETED|Follow-Up Assessment||2
8396999|NCT01022203|20694758|P2|COMPLETED|Follow-Up Assessment||40
8397000|NCT01022203|20694759|P1|COMPLETED|Follow-Up Assessment||42
8397001|NCT01022203|20694758|P2|STARTED|Follow-Up Assessment||42
8397002|NCT01022203|20694759|P1|STARTED|Follow-Up Assessment||44
8397003|NCT01022203|20694758|P2|NOT COMPLETED|Post Treatment Assessment||14
8397004|NCT01022203|20694759|P1|NOT COMPLETED|Post Treatment Assessment||14
8397005|NCT01022203|20694758|P2|COMPLETED|Post Treatment Assessment||42
8397006|NCT01022203|20694759|P1|COMPLETED|Post Treatment Assessment||44
8397007|NCT01022203|20694758|P2|STARTED|Post Treatment Assessment||56
8397008|NCT01022203|20694759|P1|STARTED|Post Treatment Assessment||58
8397009|NCT01022203|20694758|P2|NOT COMPLETED|PreTreatment Assessment||0
8397010|NCT01022203|20694759|P1|NOT COMPLETED|PreTreatment Assessment||0
8397011|NCT01022203|20694758|P2|COMPLETED|PreTreatment Assessment||56
8397012|NCT01022203|20694759|P1|COMPLETED|PreTreatment Assessment||58
8397013|NCT01022203|20694758|P2|STARTED|PreTreatment Assessment||56
8397014|NCT01022203|20694759|P1|STARTED|PreTreatment Assessment||58
8397015|NCT01022190|20694769|P1|NOT COMPLETED|Overall Study||0
8397016|NCT01022190|20694769|P1|COMPLETED|Overall Study||42
8397017|NCT01022190|20694769|P1|STARTED|Overall Study||42
8397018|NCT01022112|20694778|P5|NOT COMPLETED|Overall Study||10
8397019|NCT01022112|20694779|P4|NOT COMPLETED|Overall Study||3
8397020|NCT01022112|20694780|P3|NOT COMPLETED|Overall Study||3
8397021|NCT01022112|20694781|P2|NOT COMPLETED|Overall Study||3
8397022|NCT01022112|20694782|P1|NOT COMPLETED|Overall Study||3
8397023|NCT01022112|20694778|P5|COMPLETED|Overall Study||65
8397024|NCT01022112|20694779|P4|COMPLETED|Overall Study||72
8397025|NCT01022112|20694780|P3|COMPLETED|Overall Study||74
8397026|NCT01022112|20694781|P2|COMPLETED|Overall Study||71
8397027|NCT01022112|20694782|P1|COMPLETED|Overall Study||79
8397028|NCT01022112|20694778|P5|STARTED|Overall Study||75
8397029|NCT01022112|20694779|P4|STARTED|Overall Study||75
8397030|NCT01022112|20694780|P3|STARTED|Overall Study||77
8397031|NCT01022112|20694781|P2|STARTED|Overall Study||74
8397032|NCT01022112|20694782|P1|STARTED|Overall Study||82
8397033|NCT01022073|20694796|P2|NOT COMPLETED|Overall Study||18
8397034|NCT01022073|20694797|P1|NOT COMPLETED|Overall Study||19
8397035|NCT01022073|20694796|P2|COMPLETED|Overall Study||52
8397036|NCT01022073|20694797|P1|COMPLETED|Overall Study||67
8397037|NCT01022073|20694796|P2|STARTED|Overall Study||70
8397038|NCT01022073|20694797|P1|STARTED|Overall Study||86
8397039|NCT01021956|20694807|P4|NOT COMPLETED|Overall Study||0
8397040|NCT01021956|20694808|P3|NOT COMPLETED|Overall Study||0
8397041|NCT01021956|20694809|P2|NOT COMPLETED|Overall Study||0
8397042|NCT01021956|20694810|P1|NOT COMPLETED|Overall Study||0
8397043|NCT01021956|20694807|P4|COMPLETED|Overall Study||1
8397044|NCT01021956|20694808|P3|COMPLETED|Overall Study||3
8397045|NCT01021956|20694809|P2|COMPLETED|Overall Study||3
8397046|NCT01021956|20694810|P1|COMPLETED|Overall Study||3
8397047|NCT01021956|20694807|P4|STARTED|Overall Study||1
8397048|NCT01021956|20694808|P3|STARTED|Overall Study||3
8397049|NCT01021956|20694809|P2|STARTED|Overall Study||3
8397050|NCT01021956|20694810|P1|STARTED|Overall Study||3
8397051|NCT01021878|20694831|P2|NOT COMPLETED|Overall Study||10
8397052|NCT01021878|20694832|P1|NOT COMPLETED|Overall Study||16
8397053|NCT01021878|20694831|P2|COMPLETED|Overall Study||17
8397054|NCT01021878|20694832|P1|COMPLETED|Overall Study||17
8397055|NCT01021878|20694831|P2|Completed Follow-up|Overall Study||17
8397056|NCT01021878|20694832|P1|Completed Follow-up|Overall Study||17
8397057|NCT01021878|20694831|P2|STARTED|Overall Study||27
8397058|NCT01021878|20694832|P1|STARTED|Overall Study||33
8397059|NCT01021852|20694854|P8|NOT COMPLETED|Treatment Period 2||2
8397060|NCT01021852|20694855|P7|NOT COMPLETED|Treatment Period 2||3
8397061|NCT01021852|20694856|P6|NOT COMPLETED|Treatment Period 2||1
8397062|NCT01021852|20694857|P5|NOT COMPLETED|Treatment Period 2||2
8397063|NCT01021852|20694858|P4|NOT COMPLETED|Treatment Period 2||0
8397064|NCT01021852|20694859|P3|NOT COMPLETED|Treatment Period 2||1
8397065|NCT01021852|20694860|P2|NOT COMPLETED|Treatment Period 2||1
8397066|NCT01021852|20694861|P1|NOT COMPLETED|Treatment Period 2||0
8397067|NCT01021852|20694854|P8|COMPLETED|Treatment Period 2||38
8397068|NCT01021852|20694855|P7|COMPLETED|Treatment Period 2||37
8397069|NCT01021852|20694856|P6|COMPLETED|Treatment Period 2||37
8397070|NCT01021852|20694857|P5|COMPLETED|Treatment Period 2||37
8397071|NCT01021852|20694858|P4|COMPLETED|Treatment Period 2||37
8397072|NCT01021852|20694859|P3|COMPLETED|Treatment Period 2||38
8397073|NCT01021852|20694860|P2|COMPLETED|Treatment Period 2||38
8397074|NCT01021852|20694861|P1|COMPLETED|Treatment Period 2||37
8397075|NCT01021852|20694854|P8|STARTED|Treatment Period 2||40
8397076|NCT01021852|20694855|P7|STARTED|Treatment Period 2||40
8397077|NCT01021852|20694856|P6|STARTED|Treatment Period 2||38
8397078|NCT01021852|20694857|P5|STARTED|Treatment Period 2||39
8397079|NCT01021852|20694858|P4|STARTED|Treatment Period 2||37
8397080|NCT01021852|20694859|P3|STARTED|Treatment Period 2||39
8397081|NCT01021852|20694860|P2|STARTED|Treatment Period 2||39
8397082|NCT01021852|20694861|P1|STARTED|Treatment Period 2||37
8397083|NCT01021852|20694854|P8|NOT COMPLETED|Washout Period-No Drug||0
8397084|NCT01021852|20694855|P7|NOT COMPLETED|Washout Period-No Drug||0
8397085|NCT01021852|20694856|P6|NOT COMPLETED|Washout Period-No Drug||1
8397086|NCT01021852|20694857|P5|NOT COMPLETED|Washout Period-No Drug||0
8397087|NCT01021852|20694858|P4|NOT COMPLETED|Washout Period-No Drug||0
8397088|NCT01021852|20694859|P3|NOT COMPLETED|Washout Period-No Drug||0
8397089|NCT01021852|20694860|P2|NOT COMPLETED|Washout Period-No Drug||0
8397090|NCT01021852|20694861|P1|NOT COMPLETED|Washout Period-No Drug||1
8397091|NCT01021852|20694854|P8|COMPLETED|Washout Period-No Drug||40
8397092|NCT01021852|20694855|P7|COMPLETED|Washout Period-No Drug||40
8397093|NCT01021852|20694856|P6|COMPLETED|Washout Period-No Drug||38
8397094|NCT01021852|20694857|P5|COMPLETED|Washout Period-No Drug||39
8397095|NCT01021852|20694858|P4|COMPLETED|Washout Period-No Drug||37
8397096|NCT01021852|20694859|P3|COMPLETED|Washout Period-No Drug||39
8397097|NCT01021852|20694860|P2|COMPLETED|Washout Period-No Drug||39
8397098|NCT01021852|20694861|P1|COMPLETED|Washout Period-No Drug||37
8397099|NCT01021852|20694854|P8|STARTED|Washout Period-No Drug||40
8397100|NCT01021852|20694855|P7|STARTED|Washout Period-No Drug||40
8397101|NCT01021852|20694856|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
8397102|NCT01021852|20694857|P5|STARTED|Washout Period-No Drug||39
8397103|NCT01021852|20694858|P4|STARTED|Washout Period-No Drug||37
8397104|NCT01021852|20694859|P3|STARTED|Washout Period-No Drug||39
8397105|NCT01021852|20694860|P2|STARTED|Washout Period-No Drug||39
8397106|NCT01021852|20694861|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
8397107|NCT01021852|20694854|P8|NOT COMPLETED|Washout Period-Placebo||0
8397108|NCT01021852|20694855|P7|NOT COMPLETED|Washout Period-Placebo||1
8397109|NCT01021852|20694856|P6|NOT COMPLETED|Washout Period-Placebo||1
8397110|NCT01021852|20694857|P5|NOT COMPLETED|Washout Period-Placebo||1
8397111|NCT01021852|20694858|P4|NOT COMPLETED|Washout Period-Placebo||1
8397112|NCT01021852|20694859|P3|NOT COMPLETED|Washout Period-Placebo||0
8397113|NCT01021852|20694860|P2|NOT COMPLETED|Washout Period-Placebo||0
8397114|NCT01021852|20694861|P1|NOT COMPLETED|Washout Period-Placebo||0
8397115|NCT01021852|20694854|P8|COMPLETED|Washout Period-Placebo||40
8397116|NCT01021852|20694855|P7|COMPLETED|Washout Period-Placebo||40
8397117|NCT01021852|20694856|P6|COMPLETED|Washout Period-Placebo||38
8397118|NCT01021852|20694857|P5|COMPLETED|Washout Period-Placebo||39
8397119|NCT01021852|20694858|P4|COMPLETED|Washout Period-Placebo||37
8397120|NCT01021852|20694859|P3|COMPLETED|Washout Period-Placebo||39
8397121|NCT01021852|20694860|P2|COMPLETED|Washout Period-Placebo||39
8397122|NCT01021852|20694861|P1|COMPLETED|Washout Period-Placebo||37
8397123|NCT01021852|20694854|P8|STARTED|Washout Period-Placebo||40
8397124|NCT01021852|20694855|P7|STARTED|Washout Period-Placebo||41
8397125|NCT01021852|20694856|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
8397126|NCT01021852|20694857|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
8397127|NCT01021852|20694858|P4|STARTED|Washout Period-Placebo||38
8397128|NCT01021852|20694859|P3|STARTED|Washout Period-Placebo||39
8397129|NCT01021852|20694860|P2|STARTED|Washout Period-Placebo||39
8397130|NCT01021852|20694861|P1|STARTED|Washout Period-Placebo||37
8397131|NCT01021852|20694854|P8|NOT COMPLETED|Treatment Period 1||1
8397132|NCT01021852|20694855|P7|NOT COMPLETED|Treatment Period 1||0
8397133|NCT01021852|20694856|P6|NOT COMPLETED|Treatment Period 1||2
8397134|NCT01021852|20694857|P5|NOT COMPLETED|Treatment Period 1||3
8397135|NCT01021852|20694858|P4|NOT COMPLETED|Treatment Period 1||2
8397136|NCT01021852|20694859|P3|NOT COMPLETED|Treatment Period 1||2
8397137|NCT01021852|20694860|P2|NOT COMPLETED|Treatment Period 1||1
8397138|NCT01021852|20694861|P1|NOT COMPLETED|Treatment Period 1||3
8397139|NCT01021852|20694854|P8|COMPLETED|Treatment Period 1||40
8397140|NCT01021852|20694855|P7|COMPLETED|Treatment Period 1||41
8397141|NCT01021852|20694856|P6|COMPLETED|Treatment Period 1||39
8397142|NCT01021852|20694857|P5|COMPLETED|Treatment Period 1||39
8397143|NCT01021852|20694858|P4|COMPLETED|Treatment Period 1||38
8397144|NCT01021852|20694859|P3|COMPLETED|Treatment Period 1||39
8397145|NCT01021852|20694860|P2|COMPLETED|Treatment Period 1||39
8397146|NCT01021852|20694861|P1|COMPLETED|Treatment Period 1||37
8397147|NCT01021852|20694854|P8|Treated|Treatment Period 1||41
8397148|NCT01021852|20694855|P7|Treated|Treatment Period 1||41
8397149|NCT01021852|20694856|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
8397150|NCT01021852|20694857|P5|Treated|Treatment Period 1||42
8397151|NCT01021852|20694858|P4|Treated|Treatment Period 1||38
8397152|NCT01021852|20694859|P3|Treated|Treatment Period 1||41
8397153|NCT01021852|20694860|P2|Treated|Treatment Period 1||40
8397154|NCT01021852|20694861|P1|Treated|Treatment Period 1||40
8397155|NCT01021852|20694854|P8|STARTED|Treatment Period 1||41
8397156|NCT01021852|20694855|P7|STARTED|Treatment Period 1||41
8397157|NCT01021852|20694856|P6|STARTED|Treatment Period 1||41
8397158|NCT01021852|20694857|P5|STARTED|Treatment Period 1||42
8397159|NCT01021852|20694858|P4|STARTED|Treatment Period 1||40
8397160|NCT01021852|20694859|P3|STARTED|Treatment Period 1||41
8397161|NCT01021852|20694860|P2|STARTED|Treatment Period 1||40
8397162|NCT01021852|20694861|P1|STARTED|Treatment Period 1||40
8397163|NCT01021813|20694897|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
8397164|NCT01021813|20694898|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
8397165|NCT01021813|20694899|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
8397166|NCT01021813|20694900|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
8397167|NCT01021813|20694901|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
8397168|NCT01021813|20694897|P5|COMPLETED|DB Randomized Discontinuation Phase||157
8397169|NCT01021813|20694898|P4|COMPLETED|DB Randomized Discontinuation Phase||161
8397170|NCT01021813|20694899|P3|COMPLETED|DB Randomized Discontinuation Phase||152
8397171|NCT01021813|20694900|P2|COMPLETED|DB Randomized Discontinuation Phase||0
8397172|NCT01021813|20694901|P1|COMPLETED|DB Randomized Discontinuation Phase||0
8397173|NCT01021813|20694897|P5|STARTED|DB Randomized Discontinuation Phase||162
8397174|NCT01021813|20694898|P4|STARTED|DB Randomized Discontinuation Phase||166
8397175|NCT01021813|20694899|P3|STARTED|DB Randomized Discontinuation Phase||156
8397176|NCT01021813|20694900|P2|STARTED|DB Randomized Discontinuation Phase||0
8397177|NCT01021813|20694901|P1|STARTED|DB Randomized Discontinuation Phase||0
8397178|NCT01021813|20694897|P5|NOT COMPLETED|DB Treatment Phase||0
8397179|NCT01021813|20694898|P4|NOT COMPLETED|DB Treatment Phase||0
8397180|NCT01021813|20694899|P3|NOT COMPLETED|DB Treatment Phase||0
8397181|NCT01021813|20694900|P2|NOT COMPLETED|DB Treatment Phase||97
8397182|NCT01021813|20694901|P1|NOT COMPLETED|DB Treatment Phase||200
8397183|NCT01021813|20694897|P5|COMPLETED|DB Treatment Phase||0
8397184|NCT01021813|20694898|P4|COMPLETED|DB Treatment Phase||0
8397185|NCT01021813|20694899|P3|COMPLETED|DB Treatment Phase||0
8397186|NCT01021813|20694900|P2|COMPLETED|DB Treatment Phase||162
8397187|NCT01021813|20694901|P1|COMPLETED|DB Treatment Phase||322
8397188|NCT01021813|20694897|P5|Treated|DB Treatment Phase||0
8397189|NCT01021813|20694898|P4|Treated|DB Treatment Phase||0
8397190|NCT01021813|20694899|P3|Treated|DB Treatment Phase||0
8397191|NCT01021813|20694900|P2|Treated|DB Treatment Phase||258
8397192|NCT01021813|20694901|P1|Treated|DB Treatment Phase||521
8397193|NCT01021813|20694897|P5|STARTED|DB Treatment Phase||0
8397194|NCT01021813|20694898|P4|STARTED|DB Treatment Phase||0
8397195|NCT01021813|20694899|P3|STARTED|DB Treatment Phase||0
8397196|NCT01021813|20694900|P2|STARTED|DB Treatment Phase||259
8397197|NCT01021813|20694901|P1|STARTED|DB Treatment Phase||522
8397198|NCT01021761|20694943|P3|NOT COMPLETED|Overall Study||0
8397199|NCT01021761|20694944|P2|NOT COMPLETED|Overall Study||4
8397200|NCT01021761|20694945|P1|NOT COMPLETED|Overall Study||1
8397201|NCT01021761|20694943|P3|COMPLETED|Overall Study||42
8397202|NCT01021761|20694944|P2|COMPLETED|Overall Study||38
8397203|NCT01021761|20694945|P1|COMPLETED|Overall Study||41
8397204|NCT01021761|20694943|P3|STARTED|Overall Study||42
8397205|NCT01021761|20694944|P2|STARTED|Overall Study||42
8397206|NCT01021761|20694945|P1|STARTED|Overall Study||42
8397207|NCT01021748|20694962|P9|NOT COMPLETED|Overall Study||16
8397208|NCT01021748|20694963|P8|NOT COMPLETED|Overall Study||6
8397209|NCT01021748|20694964|P7|NOT COMPLETED|Overall Study||3
8397210|NCT01021748|20694965|P6|NOT COMPLETED|Overall Study||3
8397211|NCT01021748|20694966|P5|NOT COMPLETED|Overall Study||9
8397212|NCT01021748|20694967|P4|NOT COMPLETED|Overall Study||7
8397213|NCT01021748|20694968|P3|NOT COMPLETED|Overall Study||7
8397214|NCT01021748|20694969|P2|NOT COMPLETED|Overall Study||5
8397215|NCT01021748|20694970|P1|NOT COMPLETED|Overall Study||6
8397216|NCT01021748|20694962|P9|COMPLETED|Overall Study||1
8397217|NCT01021748|20694963|P8|COMPLETED|Overall Study||0
8397218|NCT01021748|20694964|P7|COMPLETED|Overall Study||0
8397219|NCT01021748|20694965|P6|COMPLETED|Overall Study||0
8397220|NCT01021748|20694966|P5|COMPLETED|Overall Study||0
8397221|NCT01021748|20694967|P4|COMPLETED|Overall Study||0
8397222|NCT01021748|20694968|P3|COMPLETED|Overall Study||0
8397223|NCT01021748|20694969|P2|COMPLETED|Overall Study||0
8397224|NCT01021748|20694970|P1|COMPLETED|Overall Study||0
8397225|NCT01021748|20694962|P9|Treated|Overall Study||17
8397226|NCT01021748|20694963|P8|Treated|Overall Study||6
8397227|NCT01021748|20694964|P7|Treated|Overall Study||3
8397228|NCT01021748|20694965|P6|Treated|Overall Study||3
8397229|NCT01021748|20694966|P5|Treated|Overall Study||9
8397230|NCT01021748|20694967|P4|Treated|Overall Study||7
8397231|NCT01021748|20694968|P3|Treated|Overall Study||7
8397232|NCT01021748|20694969|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
8397233|NCT01021748|20694970|P1|Treated|Overall Study||6
8397234|NCT01021748|20694962|P9|STARTED|Overall Study||17
8397235|NCT01021748|20694963|P8|STARTED|Overall Study||6
8397236|NCT01021748|20694964|P7|STARTED|Overall Study||3
8397237|NCT01021748|20694965|P6|STARTED|Overall Study||3
8397238|NCT01021748|20694966|P5|STARTED|Overall Study||9
8397239|NCT01021748|20694967|P4|STARTED|Overall Study||7
8397240|NCT01021748|20694968|P3|STARTED|Overall Study||7
8397241|NCT01021748|20694969|P2|STARTED|Overall Study||5
8397242|NCT01021748|20694970|P1|STARTED|Overall Study||6
8397243|NCT01021683|20695017|P1|NOT COMPLETED|Overall Study||71
8397244|NCT01021683|20695017|P1|COMPLETED|Overall Study||132
8397245|NCT01021683|20695017|P1|STARTED|Overall Study||203
8397246|NCT01021618|20695031|P2|NOT COMPLETED|Overall Study||0
8397247|NCT01021618|20695032|P1|NOT COMPLETED|Overall Study||0
8397248|NCT01021618|20695031|P2|COMPLETED|Overall Study||96
8397249|NCT01021618|20695032|P1|COMPLETED|Overall Study||44
8397250|NCT01021618|20695031|P2|STARTED|Overall Study||96
8397251|NCT01021618|20695032|P1|STARTED|Overall Study||44
8397252|NCT01021553|20695043|P3|NOT COMPLETED|Overall Study||3
8397253|NCT01021553|20695044|P2|NOT COMPLETED|Overall Study||5
8397254|NCT01021553|20695045|P1|NOT COMPLETED|Overall Study||4
8397255|NCT01021553|20695043|P3|COMPLETED|Overall Study||25
8397256|NCT01021553|20695044|P2|COMPLETED|Overall Study||17
8397257|NCT01021553|20695045|P1|COMPLETED|Overall Study||23
8397258|NCT01021553|20695043|P3|STARTED|Overall Study||28
8397259|NCT01021553|20695044|P2|STARTED|Overall Study||22
8397260|NCT01021553|20695045|P1|STARTED|Overall Study||27
8397261|NCT01021423|20695099|P2|NOT COMPLETED|Overall Study||5
8397262|NCT01021423|20695100|P1|NOT COMPLETED|Overall Study||4
8397263|NCT01021423|20695099|P2|COMPLETED|Overall Study||0
8397264|NCT01021423|20695100|P1|COMPLETED|Overall Study||0
8397265|NCT01021423|20695099|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
8397266|NCT01021423|20695100|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
8397267|NCT01021332|20695116|P1|NOT COMPLETED|Overall Study||106
8397268|NCT01021332|20695116|P1|COMPLETED|Overall Study||960
8397269|NCT01021332|20695116|P1|Full Analysis Set (FAS)|Overall Study||1009
8397270|NCT01021332|20695116|P1|Safety Analysis Set (SAF)|Overall Study||1066
8397271|NCT01021332|20695116|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
8397272|NCT01021306|20695154|P4|NOT COMPLETED|6 Month (Follow-up)||3
8397273|NCT01021306|20695155|P3|NOT COMPLETED|6 Month (Follow-up)||0
8397274|NCT01021306|20695156|P2|NOT COMPLETED|6 Month (Follow-up)||1
8397275|NCT01021306|20695157|P1|NOT COMPLETED|6 Month (Follow-up)||3
8397276|NCT01021306|20695154|P4|COMPLETED|6 Month (Follow-up)||14
8397277|NCT01021306|20695155|P3|COMPLETED|6 Month (Follow-up)||14
8397278|NCT01021306|20695156|P2|COMPLETED|6 Month (Follow-up)||13
8397279|NCT01021306|20695157|P1|COMPLETED|6 Month (Follow-up)||11
8397280|NCT01021306|20695154|P4|STARTED|6 Month (Follow-up)||17
8397281|NCT01021306|20695155|P3|STARTED|6 Month (Follow-up)||14
8397282|NCT01021306|20695156|P2|STARTED|6 Month (Follow-up)||14
8397283|NCT01021306|20695157|P1|STARTED|6 Month (Follow-up)||14
8397284|NCT01021306|20695154|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
8397285|NCT01021306|20695155|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
8397286|NCT01021306|20695156|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
8397287|NCT01021306|20695157|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
8397288|NCT01021306|20695154|P4|COMPLETED|2 Month (Primary Outcome)||17
8397289|NCT01021306|20695155|P3|COMPLETED|2 Month (Primary Outcome)||14
8397290|NCT01021306|20695156|P2|COMPLETED|2 Month (Primary Outcome)||14
8397291|NCT01021306|20695157|P1|COMPLETED|2 Month (Primary Outcome)||14
8397292|NCT01021306|20695154|P4|STARTED|2 Month (Primary Outcome)||21
8397293|NCT01021306|20695155|P3|STARTED|2 Month (Primary Outcome)||19
8397294|NCT01021306|20695156|P2|STARTED|2 Month (Primary Outcome)||20
8397295|NCT01021306|20695157|P1|STARTED|2 Month (Primary Outcome)||20
8397296|NCT01021293|20695177|P2|NOT COMPLETED|Overall Study||24
8397297|NCT01021293|20695178|P1|NOT COMPLETED|Overall Study||12
8397298|NCT01021293|20695177|P2|COMPLETED|Overall Study||526
8397299|NCT01021293|20695178|P1|COMPLETED|Overall Study||538
8397300|NCT01021293|20695177|P2|STARTED|Overall Study||550
8397301|NCT01021293|20695178|P1|STARTED|Overall Study||550
8397302|NCT01021215|20695197|P2|NOT COMPLETED|Overall Study||0
8397303|NCT01021215|20695198|P1|NOT COMPLETED|Overall Study||3
8397304|NCT01021215|20695197|P2|COMPLETED|Overall Study||20
8397305|NCT01021215|20695198|P1|COMPLETED|Overall Study||57
8397306|NCT01021215|20695197|P2|Received Allocated Intervention|Overall Study||20
8397307|NCT01021215|20695198|P1|Received Allocated Intervention|Overall Study||60
8397308|NCT01021215|20695197|P2|STARTED|Overall Study||20
8397309|NCT01021215|20695198|P1|STARTED|Overall Study||60
8397310|NCT01021137|20695212|P4|NOT COMPLETED|Overall Study||9
8397311|NCT01021137|20695213|P3|NOT COMPLETED|Overall Study||2
8397312|NCT01021137|20695214|P2|NOT COMPLETED|Overall Study||4
8397313|NCT01021137|20695215|P1|NOT COMPLETED|Overall Study||10
8397314|NCT01021137|20695212|P4|COMPLETED|Overall Study||32
8397315|NCT01021137|20695213|P3|COMPLETED|Overall Study||9
8397316|NCT01021137|20695214|P2|COMPLETED|Overall Study||16
8397317|NCT01021137|20695215|P1|COMPLETED|Overall Study||52
8397318|NCT01021137|20695212|P4|STARTED|Overall Study||41
8397319|NCT01021137|20695213|P3|STARTED|Overall Study||11
8397320|NCT01021137|20695214|P2|STARTED|Overall Study||20
8397321|NCT01021137|20695215|P1|STARTED|Overall Study||62
8397322|NCT01021111|20695253|P1|NOT COMPLETED|Overall Study||0
8397323|NCT01021111|20695253|P1|COMPLETED|Overall Study||17
8397324|NCT01021111|20695253|P1|STARTED|Overall Study||17
8397325|NCT01021020|20695258|P1|NOT COMPLETED|Period III||0
8397326|NCT01021020|20695258|P1|COMPLETED|Period III||25
8397327|NCT01021020|20695258|P1|STARTED|Period III||25
8397328|NCT01021020|20695258|P1|NOT COMPLETED|14 Day Washout Period B||0
8397329|NCT01021020|20695258|P1|COMPLETED|14 Day Washout Period B||25
8397330|NCT01021020|20695258|P1|STARTED|14 Day Washout Period B||25
8397331|NCT01021020|20695258|P1|NOT COMPLETED|Period II||0
8397332|NCT01021020|20695258|P1|COMPLETED|Period II||25
8397333|NCT01021020|20695258|P1|STARTED|Period II||25
8397334|NCT01021020|20695258|P1|NOT COMPLETED|14 Day Washout Period A||1
8397335|NCT01021020|20695258|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
8397336|NCT01021020|20695258|P1|STARTED|14 Day Washout Period A||26
8397337|NCT01021020|20695258|P1|NOT COMPLETED|Period I||2
8397338|NCT01021020|20695258|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
8397339|NCT01021020|20695258|P1|STARTED|Period I||28
8397340|NCT01021007|20695274|P2|NOT COMPLETED|Overall Study||4
8397341|NCT01021007|20695275|P1|NOT COMPLETED|Overall Study||2
8397342|NCT01021007|20695274|P2|COMPLETED|Overall Study||33
8397343|NCT01021007|20695275|P1|COMPLETED|Overall Study||34
8397344|NCT01021007|20695274|P2|STARTED|Overall Study||37
8397345|NCT01021007|20695275|P1|STARTED|Overall Study||36
8397346|NCT01020981|20695287|P2|NOT COMPLETED|Overall Study||90
8397347|NCT01020981|20695288|P1|NOT COMPLETED|Overall Study||84
8397348|NCT01020981|20695287|P2|COMPLETED|Overall Study||60
8397349|NCT01020981|20695288|P1|COMPLETED|Overall Study||66
8397350|NCT01020981|20695287|P2|STARTED|Overall Study||150
8397351|NCT01020981|20695288|P1|STARTED|Overall Study||150
8397352|NCT01020903|20695300|P2|NOT COMPLETED|Overall Study||0
8397353|NCT01020903|20695301|P1|NOT COMPLETED|Overall Study||0
8397354|NCT01020903|20695300|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
8397355|NCT01020903|20695301|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
8397356|NCT01020903|20695300|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
8397357|NCT01020903|20695301|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
8397358|NCT01020877|20695309|P2|NOT COMPLETED|Second Intervention||0
8397359|NCT01020877|20695310|P1|NOT COMPLETED|Second Intervention||1
8397360|NCT01020877|20695309|P2|COMPLETED|Second Intervention||19
8397361|NCT01020877|20695310|P1|COMPLETED|Second Intervention||18
8397362|NCT01020877|20695309|P2|STARTED|Second Intervention||19
8397363|NCT01020877|20695310|P1|STARTED|Second Intervention||19
8397364|NCT01020877|20695309|P2|NOT COMPLETED|Washout of 7 Days||0
8397365|NCT01020877|20695310|P1|NOT COMPLETED|Washout of 7 Days||0
8397366|NCT01020877|20695309|P2|COMPLETED|Washout of 7 Days||19
8397367|NCT01020877|20695310|P1|COMPLETED|Washout of 7 Days||19
8397368|NCT01020877|20695309|P2|STARTED|Washout of 7 Days||19
8397369|NCT01020877|20695310|P1|STARTED|Washout of 7 Days||19
8397370|NCT01020877|20695309|P2|NOT COMPLETED|First Intervention||0
8397371|NCT01020877|20695310|P1|NOT COMPLETED|First Intervention||0
8397372|NCT01020877|20695309|P2|COMPLETED|First Intervention||19
8397373|NCT01020877|20695310|P1|COMPLETED|First Intervention||19
8397374|NCT01020877|20695309|P2|STARTED|First Intervention||19
8397375|NCT01020877|20695310|P1|STARTED|First Intervention||19
8397376|NCT01020838|20695320|P1|NOT COMPLETED|Overall Study||183
8397377|NCT01020838|20695320|P1|COMPLETED|Overall Study||35
8397378|NCT01020838|20695320|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
8397379|NCT01020838|20695320|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
8397380|NCT01020838|20695320|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
8397381|NCT01020838|20695320|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
8397382|NCT01020838|20695320|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
8397383|NCT01020838|20695320|P1|STARTED|Overall Study||218
8397384|NCT01020812|20695335|P1|NOT COMPLETED|Overall Study||3
8397385|NCT01020812|20695335|P1|COMPLETED|Overall Study||8
8397386|NCT01020812|20695335|P1|STARTED|Overall Study||11
8397387|NCT01020799|20695345|P3|NOT COMPLETED|Overall Study||7
8397388|NCT01020799|20695346|P2|NOT COMPLETED|Overall Study||14
8397389|NCT01020799|20695347|P1|NOT COMPLETED|Overall Study||19
8397390|NCT01020799|20695345|P3|COMPLETED|Overall Study||43
8397391|NCT01020799|20695346|P2|COMPLETED|Overall Study||85
8397392|NCT01020799|20695347|P1|COMPLETED|Overall Study||79
8397393|NCT01020799|20695345|P3|Full Analysis Set|Overall Study||49
8397394|NCT01020799|20695346|P2|Full Analysis Set|Overall Study||94
8397395|NCT01020799|20695347|P1|Full Analysis Set|Overall Study||91
8397396|NCT01020799|20695345|P3|Patients Received Treatment|Overall Study||50
8397397|NCT01020799|20695346|P2|Patients Received Treatment|Overall Study||99
8397398|NCT01020799|20695347|P1|Patients Received Treatment|Overall Study||96
8397399|NCT01020799|20695345|P3|STARTED|Overall Study||50
8397400|NCT01020799|20695346|P2|STARTED|Overall Study||99
8397401|NCT01020799|20695347|P1|STARTED|Overall Study||98
8397402|NCT01020786|20695370|P1|NOT COMPLETED|Maintenance Period||60
8397403|NCT01020786|20695370|P1|COMPLETED|Maintenance Period||0
8397404|NCT01020786|20695370|P1|STARTED|Maintenance Period||60
8397405|NCT01020786|20695370|P1|NOT COMPLETED|Induction Period||49
8397406|NCT01020786|20695370|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
8397407|NCT01020786|20695370|P1|STARTED|Induction Period||109
8397408|NCT01020773|20695384|P2|NOT COMPLETED|Overall Study||3
8397409|NCT01020773|20695385|P1|NOT COMPLETED|Overall Study||4
8397410|NCT01020773|20695384|P2|COMPLETED|Overall Study||29
8397411|NCT01020773|20695385|P1|COMPLETED|Overall Study||31
8397412|NCT01020773|20695384|P2|STARTED|Overall Study||32
8397413|NCT01020773|20695385|P1|STARTED|Overall Study||35
8397414|NCT01020747|20695391|P1|NOT COMPLETED|Overall Study||1
8397415|NCT01020747|20695391|P1|COMPLETED|Overall Study||19
8397416|NCT01020747|20695391|P1|STARTED|Overall Study||20
8397417|NCT01020591|20695398|P2|NOT COMPLETED|Overall Study||0
8397418|NCT01020591|20695399|P1|NOT COMPLETED|Overall Study||0
8397419|NCT01020591|20695398|P2|COMPLETED|Overall Study||15
8397420|NCT01020591|20695399|P1|COMPLETED|Overall Study||15
8397421|NCT01020591|20695398|P2|STARTED|Overall Study||15
8397422|NCT01020591|20695399|P1|STARTED|Overall Study||15
8397423|NCT01020448|20695407|P1|NOT COMPLETED|Treatment||26
8397424|NCT01020448|20695407|P1|COMPLETED|Treatment||299
8397425|NCT01020448|20695407|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
8397426|NCT01020448|20695407|P1|NOT COMPLETED|Pre-assignment||13
8397427|NCT01020448|20695407|P1|COMPLETED|Pre-assignment||326
8397428|NCT01020448|20695407|P1|STARTED|Pre-assignment||339
8397429|NCT01020435|20695418|P2|NOT COMPLETED|Overall Study||1
8397430|NCT01020435|20695419|P1|NOT COMPLETED|Overall Study||0
8397431|NCT01020435|20695418|P2|COMPLETED|Overall Study||26
8397432|NCT01020435|20695419|P1|COMPLETED|Overall Study||24
8397433|NCT01020435|20695418|P2|STARTED|Overall Study||27
8397434|NCT01020435|20695419|P1|STARTED|Overall Study||24
8397435|NCT01020305|20695427|P1|NOT COMPLETED|Overall Study||2
8397436|NCT01020305|20695427|P1|COMPLETED|Overall Study||3
8397437|NCT01020305|20695427|P1|STARTED|Overall Study||5
8397438|NCT01020123|20695438|P7|NOT COMPLETED|Extention Period||1
8397439|NCT01020123|20695439|P6|NOT COMPLETED|Extention Period||2
8397440|NCT01020123|20695440|P5|NOT COMPLETED|Extention Period||0
8397441|NCT01020123|20695441|P4|NOT COMPLETED|Extention Period||1
8397442|NCT01020123|20695442|P3|NOT COMPLETED|Extention Period||2
8397443|NCT01020123|20695443|P2|NOT COMPLETED|Extention Period||2
8397444|NCT01020123|20695444|P1|NOT COMPLETED|Extention Period||3
8397445|NCT01020123|20695438|P7|COMPLETED|Extention Period||18
8397446|NCT01020123|20695439|P6|COMPLETED|Extention Period||36
8397447|NCT01020123|20695440|P5|COMPLETED|Extention Period||31
8397448|NCT01020123|20695441|P4|COMPLETED|Extention Period||12
8397449|NCT01020123|20695442|P3|COMPLETED|Extention Period||17
8397450|NCT01020123|20695443|P2|COMPLETED|Extention Period||33
8397451|NCT01020123|20695444|P1|COMPLETED|Extention Period||37
8397452|NCT01020123|20695438|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
8397453|NCT01020123|20695439|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
8397454|NCT01020123|20695440|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
8397455|NCT01020123|20695441|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
8397456|NCT01020123|20695442|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
8397457|NCT01020123|20695443|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
8397458|NCT01020123|20695444|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
8397459|NCT01020123|20695438|P7|NOT COMPLETED|Main Period||11
8397460|NCT01020123|20695439|P6|NOT COMPLETED|Main Period||11
8397461|NCT01020123|20695440|P5|NOT COMPLETED|Main Period||11
8397462|NCT01020123|20695441|P4|NOT COMPLETED|Main Period||7
8397463|NCT01020123|20695442|P3|NOT COMPLETED|Main Period||8
8397464|NCT01020123|20695443|P2|NOT COMPLETED|Main Period||14
8397465|NCT01020123|20695444|P1|NOT COMPLETED|Main Period||17
8397466|NCT01020123|20695438|P7|COMPLETED|Main Period||61
8397467|NCT01020123|20695439|P6|COMPLETED|Main Period||83
8397468|NCT01020123|20695440|P5|COMPLETED|Main Period||77
8397469|NCT01020123|20695441|P4|COMPLETED|Main Period||33
8397470|NCT01020123|20695442|P3|COMPLETED|Main Period||44
8397471|NCT01020123|20695443|P2|COMPLETED|Main Period||77
8397472|NCT01020123|20695444|P1|COMPLETED|Main Period||76
8397473|NCT01020123|20695438|P7|STARTED|Main Period||72
8397474|NCT01020123|20695439|P6|STARTED|Main Period||94
8397475|NCT01020123|20695440|P5|STARTED|Main Period||88
8397476|NCT01020123|20695441|P4|STARTED|Main Period||40
8397477|NCT01020123|20695442|P3|STARTED|Main Period||52
8397478|NCT01020123|20695443|P2|STARTED|Main Period||91
8397479|NCT01020123|20695444|P1|STARTED|Main Period||93
8397480|NCT01020019|20695639|P2|NOT COMPLETED|Overall Study||29
8397481|NCT01020019|20695640|P1|NOT COMPLETED|Overall Study||26
8397482|NCT01020019|20695639|P2|COMPLETED|Overall Study||32
8397483|NCT01020019|20695640|P1|COMPLETED|Overall Study||35
8397484|NCT01020019|20695639|P2|STARTED|Overall Study||61
8397485|NCT01020019|20695640|P1|STARTED|Overall Study||61
8397486|NCT01020006|20695649|P3|NOT COMPLETED|Overall Study||16
8397487|NCT01020006|20695650|P2|NOT COMPLETED|Overall Study||18
8397488|NCT01020006|20695651|P1|NOT COMPLETED|Overall Study||8
8397489|NCT01020006|20695649|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8397490|NCT01020006|20695650|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8397491|NCT01020006|20695651|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8397492|NCT01020006|20695649|P3|STARTED|Overall Study||16
8397493|NCT01020006|20695650|P2|STARTED|Overall Study||18
8397494|NCT01020006|20695651|P1|STARTED|Overall Study||8
8397495|NCT01019980|20695661|P2|NOT COMPLETED|Overall Study||0
8397496|NCT01019980|20695662|P1|NOT COMPLETED|Overall Study||2
8397497|NCT01019980|20695661|P2|COMPLETED|Overall Study||0
8397498|NCT01019980|20695662|P1|COMPLETED|Overall Study||0
8397499|NCT01019980|20695661|P2|Discontinued|Overall Study||0
8397500|NCT01019980|20695662|P1|Discontinued|Overall Study||2
8397501|NCT01019980|20695661|P2|STARTED|Overall Study||0
8397502|NCT01019980|20695662|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
8397503|NCT01019928|20695670|P2|NOT COMPLETED|Period 3||0
8397504|NCT01019928|20695671|P1|NOT COMPLETED|Period 3||0
8397505|NCT01019928|20695670|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8397506|NCT01019928|20695671|P1|COMPLETED|Period 3||7
8397507|NCT01019928|20695670|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8397508|NCT01019928|20695671|P1|STARTED|Period 3||7
8397509|NCT01019928|20695670|P2|NOT COMPLETED|Period 2||1
8397510|NCT01019928|20695671|P1|NOT COMPLETED|Period 2||0
8397511|NCT01019928|20695670|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8397512|NCT01019928|20695671|P1|COMPLETED|Period 2||7
8397513|NCT01019928|20695670|P2|STARTED|Period 2||7
8397514|NCT01019928|20695671|P1|STARTED|Period 2||7
8397515|NCT01019928|20695670|P2|NOT COMPLETED|Period 1||0
8397516|NCT01019928|20695671|P1|NOT COMPLETED|Period 1||0
8397517|NCT01019928|20695670|P2|COMPLETED|Period 1||7
8397518|NCT01019928|20695671|P1|COMPLETED|Period 1||7
8397519|NCT01019928|20695670|P2|STARTED|Period 1||7
8397520|NCT01019928|20695671|P1|STARTED|Period 1||7
8397521|NCT01019707|20695711|P2|NOT COMPLETED|Second Phase||0
8397522|NCT01019707|20695712|P1|NOT COMPLETED|Second Phase||0
8397523|NCT01019707|20695711|P2|COMPLETED|Second Phase||1
8397524|NCT01019707|20695712|P1|COMPLETED|Second Phase||3
8397525|NCT01019707|20695711|P2|STARTED|Second Phase||1
8397526|NCT01019707|20695712|P1|STARTED|Second Phase||3
8397527|NCT01019707|20695711|P2|NOT COMPLETED|Washout||2
8397528|NCT01019707|20695712|P1|NOT COMPLETED|Washout||0
8397529|NCT01019707|20695711|P2|COMPLETED|Washout||1
8397530|NCT01019707|20695712|P1|COMPLETED|Washout||3
8397531|NCT01019707|20695711|P2|STARTED|Washout||3
8397532|NCT01019707|20695712|P1|STARTED|Washout||3
8397533|NCT01019707|20695711|P2|NOT COMPLETED|First Phase||0
8397534|NCT01019707|20695712|P1|NOT COMPLETED|First Phase||0
8397535|NCT01019707|20695711|P2|COMPLETED|First Phase||3
8397536|NCT01019707|20695712|P1|COMPLETED|First Phase||3
8397537|NCT01019707|20695711|P2|STARTED|First Phase||3
8397538|NCT01019707|20695712|P1|STARTED|First Phase||3
8397539|NCT01019694|20695725|P3|NOT COMPLETED|Overall Study||47
8397540|NCT01019694|20695726|P2|NOT COMPLETED|Overall Study||38
8397541|NCT01019694|20695727|P1|NOT COMPLETED|Overall Study||24
8397542|NCT01019694|20695725|P3|COMPLETED|Overall Study||110
8397543|NCT01019694|20695726|P2|COMPLETED|Overall Study||118
8397544|NCT01019694|20695727|P1|COMPLETED|Overall Study||133
8397545|NCT01019694|20695725|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
8397546|NCT01019694|20695726|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
8397547|NCT01019694|20695727|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
8397548|NCT01019486|20695852|P3|NOT COMPLETED|Overall Study||1
8397549|NCT01019486|20695853|P2|NOT COMPLETED|Overall Study||1
8397550|NCT01019486|20695854|P1|NOT COMPLETED|Overall Study||1
8397551|NCT01019486|20695852|P3|COMPLETED|Overall Study||15
8397552|NCT01019486|20695853|P2|COMPLETED|Overall Study||4
8397553|NCT01019486|20695854|P1|COMPLETED|Overall Study||4
8397554|NCT01019486|20695852|P3|STARTED|Overall Study||16
8397555|NCT01019486|20695853|P2|STARTED|Overall Study||5
8397556|NCT01019486|20695854|P1|STARTED|Overall Study||5
8397557|NCT01019369|20695868|P2|NOT COMPLETED|Overall Study||7
8397558|NCT01019369|20695869|P1|NOT COMPLETED|Overall Study||10
8397559|NCT01019369|20695868|P2|COMPLETED|Overall Study||39
8397560|NCT01019369|20695869|P1|COMPLETED|Overall Study||76
8397561|NCT01019369|20695868|P2|STARTED|Overall Study||46
8397562|NCT01019369|20695869|P1|STARTED|Overall Study||86
8397563|NCT01019317|20695885|P1|NOT COMPLETED|Overall Study||4
8397564|NCT01019317|20695885|P1|COMPLETED|Overall Study||147
8397565|NCT01019317|20695885|P1|STARTED|Overall Study||151
8397566|NCT01019252|20695891|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
8397567|NCT01019252|20695892|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
8397568|NCT01019252|20695891|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
8397569|NCT01019252|20695892|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
8397570|NCT01019252|20695891|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
8397571|NCT01019252|20695892|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
8397572|NCT01019252|20695891|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
8397573|NCT01019252|20695892|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
8397574|NCT01019252|20695891|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
8397575|NCT01019252|20695892|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
8397576|NCT01019252|20695891|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
8397577|NCT01019252|20695892|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
8397578|NCT01019135|20695905|P3|NOT COMPLETED|Overall Study||31
8397579|NCT01019135|20695906|P2|NOT COMPLETED|Overall Study||19
8397580|NCT01019135|20695907|P1|NOT COMPLETED|Overall Study||20
8397581|NCT01019135|20695905|P3|COMPLETED|Overall Study||24
8397582|NCT01019135|20695906|P2|COMPLETED|Overall Study||40
8397583|NCT01019135|20695907|P1|COMPLETED|Overall Study||35
8397584|NCT01019135|20695905|P3|STARTED|Overall Study||55
8397585|NCT01019135|20695906|P2|STARTED|Overall Study||59
8397586|NCT01019135|20695907|P1|STARTED|Overall Study||55
8397587|NCT01018992|20695935|P2|NOT COMPLETED|Overall Study||16
8397588|NCT01018992|20695936|P1|NOT COMPLETED|Overall Study||16
8397589|NCT01018992|20695935|P2|COMPLETED|Overall Study||49
8397590|NCT01018992|20695936|P1|COMPLETED|Overall Study||47
8397591|NCT01018992|20695935|P2|STARTED|Overall Study||65
8397592|NCT01018992|20695936|P1|STARTED|Overall Study||63
8397593|NCT01018979|20695950|P2|NOT COMPLETED|Overall Study||10
8397594|NCT01018979|20695951|P1|NOT COMPLETED|Overall Study||3
8397595|NCT01018979|20695950|P2|COMPLETED|Overall Study||3
8397596|NCT01018979|20695951|P1|COMPLETED|Overall Study||4
8397597|NCT01018979|20695950|P2|Received at Least One Dose|Overall Study||12
8397598|NCT01018979|20695951|P1|Received at Least One Dose|Overall Study||7
8397599|NCT01018979|20695950|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
8397600|NCT01018979|20695951|P1|STARTED|Overall Study||7
8397601|NCT01018953|20695981|P1|NOT COMPLETED|Overall Study||8
8397602|NCT01018953|20695981|P1|COMPLETED|Overall Study||0
8397603|NCT01018953|20695981|P1|BIM 23A760 4 mg|Overall Study||3
8397604|NCT01018953|20695981|P1|BIM 23A760 2 mg|Overall Study||2
8397605|NCT01018953|20695981|P1|BIM 23A760 1 mg|Overall Study||3
8397606|NCT01018953|20695981|P1|STARTED|Overall Study||8
8397607|NCT01018862|20695994|P3|NOT COMPLETED|Overall Study||16
8397608|NCT01018862|20695995|P2|NOT COMPLETED|Overall Study||10
8397609|NCT01018862|20695996|P1|NOT COMPLETED|Overall Study||13
8397610|NCT01018862|20695994|P3|COMPLETED|Overall Study||146
8397611|NCT01018862|20695995|P2|COMPLETED|Overall Study||156
8397612|NCT01018862|20695996|P1|COMPLETED|Overall Study||148
8397613|NCT01018862|20695994|P3|STARTED|Overall Study||162
8397614|NCT01018862|20695995|P2|STARTED|Overall Study||166
8397615|NCT01018862|20695996|P1|STARTED|Overall Study||161
8397616|NCT01018810|20696018|P5|NOT COMPLETED|Overall Study||1
8397617|NCT01018810|20696019|P4|NOT COMPLETED|Overall Study||1
8397618|NCT01018810|20696020|P3|NOT COMPLETED|Overall Study||1
8397619|NCT01018810|20696021|P2|NOT COMPLETED|Overall Study||1
8397620|NCT01018810|20696022|P1|NOT COMPLETED|Overall Study||2
8397621|NCT01018810|20696018|P5|COMPLETED|Overall Study||0
8397622|NCT01018810|20696019|P4|COMPLETED|Overall Study||0
8397623|NCT01018810|20696020|P3|COMPLETED|Overall Study||0
8397624|NCT01018810|20696021|P2|COMPLETED|Overall Study||0
8397625|NCT01018810|20696022|P1|COMPLETED|Overall Study||2
8397626|NCT01018810|20696018|P5|STARTED|Overall Study||1
8397627|NCT01018810|20696019|P4|STARTED|Overall Study||1
8397628|NCT01018810|20696020|P3|STARTED|Overall Study||1
8397629|NCT01018810|20696021|P2|STARTED|Overall Study||1
8397630|NCT01018810|20696022|P1|STARTED|Overall Study||4
8397631|NCT01018732|20696082|P3|NOT COMPLETED|Overall Study||4
8397632|NCT01018732|20696083|P2|NOT COMPLETED|Overall Study||2
8397633|NCT01018732|20696084|P1|NOT COMPLETED|Overall Study||1
8397634|NCT01018732|20696082|P3|COMPLETED|Overall Study||50
8397635|NCT01018732|20696083|P2|COMPLETED|Overall Study||49
8397636|NCT01018732|20696084|P1|COMPLETED|Overall Study||49
8397637|NCT01018732|20696082|P3|STARTED|Overall Study||54
8397638|NCT01018732|20696083|P2|STARTED|Overall Study||51
8397639|NCT01018732|20696084|P1|STARTED|Overall Study||50
8397640|NCT01018680|20696118|P2|NOT COMPLETED|Overall Study||75
8397641|NCT01018680|20696119|P1|NOT COMPLETED|Overall Study||61
8397642|NCT01018680|20696118|P2|COMPLETED|Overall Study||189
8397643|NCT01018680|20696119|P1|COMPLETED|Overall Study||199
8397644|NCT01018680|20696118|P2|STARTED|Overall Study||264
8397645|NCT01018680|20696119|P1|STARTED|Overall Study||260
8397646|NCT01020487|20696162|P3|NOT COMPLETED|Part 2 Open-label Period||1
8397647|NCT01020487|20696163|P2|NOT COMPLETED|Part 2 Open-label Period||4
8397648|NCT01020487|20696164|P1|NOT COMPLETED|Part 2 Open-label Period||0
8397649|NCT01020487|20696162|P3|COMPLETED|Part 2 Open-label Period||12
8397650|NCT01020487|20696163|P2|COMPLETED|Part 2 Open-label Period||12
8397651|NCT01020487|20696164|P1|COMPLETED|Part 2 Open-label Period||0
8397652|NCT01020487|20696162|P3|STARTED|Part 2 Open-label Period||13
8397653|NCT01020487|20696163|P2|STARTED|Part 2 Open-label Period||16
8397654|NCT01020487|20696164|P1|STARTED|Part 2 Open-label Period||0
8397655|NCT01020487|20696162|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
8397656|NCT01020487|20696163|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
8397657|NCT01020487|20696164|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
8397658|NCT01020487|20696162|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
8397659|NCT01020487|20696163|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
8397660|NCT01020487|20696164|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
8397661|NCT01020487|20696162|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
8397662|NCT01020487|20696163|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
8397663|NCT01020487|20696164|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
8397664|NCT01020487|20696162|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
8397665|NCT01020487|20696163|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
8397666|NCT01020487|20696164|P1|STARTED|Part 2 Double-blind Treatment Period||0
8397667|NCT01020487|20696162|P3|NOT COMPLETED|Part 1||0
8397668|NCT01020487|20696163|P2|NOT COMPLETED|Part 1||0
8397669|NCT01020487|20696164|P1|NOT COMPLETED|Part 1||0
8397670|NCT01020487|20696162|P3|COMPLETED|Part 1||0
8397671|NCT01020487|20696163|P2|COMPLETED|Part 1||0
8397672|NCT01020487|20696164|P1|COMPLETED|Part 1||12
8397673|NCT01020487|20696162|P3|STARTED|Part 1||0
8397674|NCT01020487|20696163|P2|STARTED|Part 1||0
8397675|NCT01020487|20696164|P1|STARTED|Part 1||12
8397676|NCT01018511|20696189|P4|NOT COMPLETED|Overall Study||33
8397677|NCT01018511|20696190|P3|NOT COMPLETED|Overall Study||40
8397678|NCT01018511|20696191|P2|NOT COMPLETED|Overall Study||32
8397679|NCT01018511|20696192|P1|NOT COMPLETED|Overall Study||26
8397680|NCT01018511|20696189|P4|COMPLETED|Overall Study||294
8397681|NCT01018511|20696190|P3|COMPLETED|Overall Study||299
8397682|NCT01018511|20696191|P2|COMPLETED|Overall Study||295
8397683|NCT01018511|20696192|P1|COMPLETED|Overall Study||315
8397684|NCT01018511|20696189|P4|Randomized and Treated|Overall Study||324
8397685|NCT01018511|20696190|P3|Randomized and Treated|Overall Study||338
8397686|NCT01018511|20696191|P2|Randomized and Treated|Overall Study||326
8397687|NCT01018511|20696192|P1|Randomized and Treated|Overall Study||341
8397688|NCT01018511|20696189|P4|STARTED|Overall Study||327
8397689|NCT01018511|20696190|P3|STARTED|Overall Study||339
8397690|NCT01018511|20696191|P2|STARTED|Overall Study||327
8397691|NCT01018511|20696192|P1|STARTED|Overall Study||341
8397692|NCT01018420|20696361|P2|NOT COMPLETED|Overall Study||0
8397693|NCT01018420|20696362|P1|NOT COMPLETED|Overall Study||0
8397694|NCT01018420|20696361|P2|COMPLETED|Overall Study||3
8397695|NCT01018420|20696362|P1|COMPLETED|Overall Study||15
8397696|NCT01018420|20696361|P2|STARTED|Overall Study||3
8397697|NCT01018420|20696362|P1|STARTED|Overall Study||15
8397698|NCT01018394|20696389|P2|NOT COMPLETED|Overall Study||8
8397699|NCT01018394|20696390|P1|NOT COMPLETED|Overall Study||9
8397700|NCT01018394|20696389|P2|COMPLETED|Overall Study||33
8397701|NCT01018394|20696390|P1|COMPLETED|Overall Study||31
8397702|NCT01018394|20696389|P2|STARTED|Overall Study||41
8397703|NCT01018394|20696390|P1|STARTED|Overall Study||40
8397704|NCT01018264|20696400|P2|NOT COMPLETED|Overall Study||1
8397705|NCT01018264|20696401|P1|NOT COMPLETED|Overall Study||1
8397706|NCT01018264|20696400|P2|COMPLETED|Overall Study||12
8397707|NCT01018264|20696401|P1|COMPLETED|Overall Study||9
8397708|NCT01018264|20696400|P2|STARTED|Overall Study||13
8397709|NCT01018264|20696401|P1|STARTED|Overall Study||10
8397710|NCT01018186|20696418|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
8397711|NCT01018186|20696419|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
8397712|NCT01018186|20696420|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
8397713|NCT01018186|20696421|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
8397714|NCT01018186|20696418|P4|COMPLETED|52-week Double-blind Treatment Period||71
8397715|NCT01018186|20696419|P3|COMPLETED|52-week Double-blind Treatment Period||161
8397716|NCT01018186|20696420|P2|COMPLETED|52-week Double-blind Treatment Period||161
8397717|NCT01018186|20696421|P1|COMPLETED|52-week Double-blind Treatment Period||0
8397718|NCT01018186|20696418|P4|STARTED|52-week Double-blind Treatment Period||100
8397719|NCT01018186|20696419|P3|STARTED|52-week Double-blind Treatment Period||202
8397720|NCT01018186|20696420|P2|STARTED|52-week Double-blind Treatment Period||201
8397721|NCT01018186|20696421|P1|STARTED|52-week Double-blind Treatment Period||0
8397722|NCT01018186|20696418|P4|NOT COMPLETED|2-week Run-in Period||0
8397723|NCT01018186|20696419|P3|NOT COMPLETED|2-week Run-in Period||0
8397724|NCT01018186|20696420|P2|NOT COMPLETED|2-week Run-in Period||0
8397725|NCT01018186|20696421|P1|NOT COMPLETED|2-week Run-in Period||114
8397726|NCT01018186|20696418|P4|COMPLETED|2-week Run-in Period||0
8397727|NCT01018186|20696419|P3|COMPLETED|2-week Run-in Period||0
8397728|NCT01018186|20696420|P2|COMPLETED|2-week Run-in Period||0
8397729|NCT01018186|20696421|P1|COMPLETED|2-week Run-in Period||503
8397730|NCT01018186|20696418|P4|STARTED|2-week Run-in Period||0
8397731|NCT01018186|20696419|P3|STARTED|2-week Run-in Period||0
8397732|NCT01018186|20696420|P2|STARTED|2-week Run-in Period||0
8397733|NCT01018186|20696421|P1|STARTED|2-week Run-in Period||617
8397734|NCT01018134|20696513|P6|NOT COMPLETED|Overall Study||0
8397735|NCT01018134|20696514|P5|NOT COMPLETED|Overall Study||0
8397736|NCT01018134|20696515|P4|NOT COMPLETED|Overall Study||0
8397737|NCT01018134|20696516|P3|NOT COMPLETED|Overall Study||1
8397738|NCT01018134|20696517|P2|NOT COMPLETED|Overall Study||1
8397739|NCT01018134|20696518|P1|NOT COMPLETED|Overall Study||0
8397740|NCT01018134|20696513|P6|COMPLETED|Overall Study||15
8397741|NCT01018134|20696514|P5|COMPLETED|Overall Study||15
8397742|NCT01018134|20696515|P4|COMPLETED|Overall Study||29
8397743|NCT01018134|20696516|P3|COMPLETED|Overall Study||29
8397744|NCT01018134|20696517|P2|COMPLETED|Overall Study||30
8397745|NCT01018134|20696518|P1|COMPLETED|Overall Study||30
8397746|NCT01018134|20696513|P6|STARTED|Overall Study||15
8397747|NCT01018134|20696514|P5|STARTED|Overall Study||15
8397748|NCT01018134|20696515|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
8397749|NCT01018134|20696516|P3|STARTED|Overall Study||30
8397750|NCT01018134|20696517|P2|STARTED|Overall Study||31
8397751|NCT01018134|20696518|P1|STARTED|Overall Study||30
8397752|NCT01018095|20696558|P2|NOT COMPLETED|Overall Study||62
8397753|NCT01018095|20696559|P1|NOT COMPLETED|Overall Study||56
8397754|NCT01018095|20696558|P2|COMPLETED|Overall Study||73
8397755|NCT01018095|20696559|P1|COMPLETED|Overall Study||79
8397756|NCT01018095|20696558|P2|STARTED|Overall Study||135
8397757|NCT01018095|20696559|P1|STARTED|Overall Study||135
8397758|NCT01018056|20696570|P3|NOT COMPLETED|Overall Study||1
8397759|NCT01018056|20696571|P2|NOT COMPLETED|Overall Study||2
8397760|NCT01018056|20696572|P1|NOT COMPLETED|Overall Study||3
8397761|NCT01018056|20696570|P3|COMPLETED|Overall Study||5
8397762|NCT01018056|20696571|P2|COMPLETED|Overall Study||10
8397763|NCT01018056|20696572|P1|COMPLETED|Overall Study||9
8397764|NCT01018056|20696570|P3|STARTED|Overall Study||6
8397765|NCT01018056|20696571|P2|STARTED|Overall Study||12
8397766|NCT01018056|20696572|P1|STARTED|Overall Study||12
8397767|NCT01018030|20696622|P3|NOT COMPLETED|Overall Study||13
8397768|NCT01018030|20696623|P2|NOT COMPLETED|Overall Study||11
8397769|NCT01018030|20696624|P1|NOT COMPLETED|Overall Study||19
8397770|NCT01018030|20696622|P3|COMPLETED|Overall Study||239
8397771|NCT01018030|20696623|P2|COMPLETED|Overall Study||232
8397772|NCT01018030|20696624|P1|COMPLETED|Overall Study||227
8397773|NCT01018030|20696622|P3|STARTED|Overall Study||252
8397774|NCT01018030|20696623|P2|STARTED|Overall Study||243
8397775|NCT01018030|20696624|P1|STARTED|Overall Study||246
8397776|NCT01017952|20696675|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
8397777|NCT01017952|20696676|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
8397778|NCT01017952|20696677|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
8397779|NCT01017952|20696678|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
8397780|NCT01017952|20696679|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
8397781|NCT01017952|20696675|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
8397782|NCT01017952|20696676|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
8397783|NCT01017952|20696677|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
8397784|NCT01017952|20696678|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
8397785|NCT01017952|20696679|P1|COMPLETED|52-week, Double-blind Treatment Period||0
8397786|NCT01017952|20696675|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
8397787|NCT01017952|20696676|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
8397788|NCT01017952|20696677|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
8397873|NCT01017237|20696878|P1|NOT COMPLETED|Overall Study||5
8397874|NCT01017237|20696877|P2|COMPLETED|Overall Study||6
8397789|NCT01017952|20696678|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
8397790|NCT01017952|20696679|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
8397791|NCT01017952|20696675|P5|STARTED|52-week, Double-blind Treatment Period||409
8397792|NCT01017952|20696676|P4|STARTED|52-week, Double-blind Treatment Period||403
8397793|NCT01017952|20696677|P3|STARTED|52-week, Double-blind Treatment Period||412
8397794|NCT01017952|20696678|P2|STARTED|52-week, Double-blind Treatment Period||409
8397795|NCT01017952|20696679|P1|STARTED|52-week, Double-blind Treatment Period||0
8397796|NCT01017952|20696675|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397797|NCT01017952|20696676|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397798|NCT01017952|20696677|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397799|NCT01017952|20696678|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397800|NCT01017952|20696679|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
8397801|NCT01017952|20696675|P5|COMPLETED|4-week, Open-label Run-In Period||0
8397802|NCT01017952|20696676|P4|COMPLETED|4-week, Open-label Run-In Period||0
8397803|NCT01017952|20696677|P3|COMPLETED|4-week, Open-label Run-In Period||0
8397804|NCT01017952|20696678|P2|COMPLETED|4-week, Open-label Run-In Period||0
8397805|NCT01017952|20696679|P1|COMPLETED|4-week, Open-label Run-In Period||1633
8397806|NCT01017952|20696675|P5|STARTED|4-week, Open-label Run-In Period||0
8397807|NCT01017952|20696676|P4|STARTED|4-week, Open-label Run-In Period||0
8397808|NCT01017952|20696677|P3|STARTED|4-week, Open-label Run-In Period||0
8397809|NCT01017952|20696678|P2|STARTED|4-week, Open-label Run-In Period||0
8397810|NCT01017952|20696679|P1|STARTED|4-week, Open-label Run-In Period||2092
8397811|NCT01017874|20696703|P2|NOT COMPLETED|Overall Study||26
8397812|NCT01017874|20696704|P1|NOT COMPLETED|Overall Study||30
8397813|NCT01017874|20696703|P2|COMPLETED|Overall Study||92
8397814|NCT01017874|20696704|P1|COMPLETED|Overall Study||88
8397815|NCT01017874|20696703|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
8397816|NCT01017874|20696704|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
8397817|NCT01017874|20696703|P2|STARTED|Overall Study||118
8397818|NCT01017874|20696704|P1|STARTED|Overall Study||118
8397819|NCT01017731|20696722|P1|NOT COMPLETED|Overall Study||8
8397820|NCT01017731|20696722|P1|COMPLETED|Overall Study||60
8397821|NCT01017731|20696722|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
8397822|NCT01017731|20696722|P1|STARTED|Overall Study||68
8397823|NCT01017653|20696739|P1|NOT COMPLETED|Overall Study||0
8397824|NCT01017653|20696739|P1|COMPLETED|Overall Study||16
8397825|NCT01017653|20696739|P1|STARTED|Overall Study||16
8397826|NCT01017601|20696751|P2|NOT COMPLETED|Overall Study||13
8397827|NCT01017601|20696752|P1|NOT COMPLETED|Overall Study||12
8397828|NCT01017601|20696751|P2|COMPLETED|Overall Study||11
8397829|NCT01017601|20696752|P1|COMPLETED|Overall Study||14
8397830|NCT01017601|20696751|P2|STARTED|Overall Study||24
8397831|NCT01017601|20696752|P1|STARTED|Overall Study||26
8397832|NCT01017575|20696779|P5|NOT COMPLETED|Overall Study||3
8397833|NCT01017575|20696780|P4|NOT COMPLETED|Overall Study||1
8397834|NCT01017575|20696781|P3|NOT COMPLETED|Overall Study||0
8397835|NCT01017575|20696782|P2|NOT COMPLETED|Overall Study||2
8397836|NCT01017575|20696783|P1|NOT COMPLETED|Overall Study||1
8397837|NCT01017575|20696779|P5|COMPLETED|Overall Study||6
8397838|NCT01017575|20696780|P4|COMPLETED|Overall Study||7
8397839|NCT01017575|20696781|P3|COMPLETED|Overall Study||8
8397840|NCT01017575|20696782|P2|COMPLETED|Overall Study||7
8397841|NCT01017575|20696783|P1|COMPLETED|Overall Study||7
8397842|NCT01017575|20696779|P5|STARTED|Overall Study||9
8397843|NCT01017575|20696780|P4|STARTED|Overall Study||8
8397844|NCT01017575|20696781|P3|STARTED|Overall Study||8
8397845|NCT01017575|20696782|P2|STARTED|Overall Study||9
8397846|NCT01017575|20696783|P1|STARTED|Overall Study||8
8397847|NCT01017549|20696820|P1|NOT COMPLETED|5 Year Follow-up||12
8397848|NCT01017549|20696820|P1|COMPLETED|5 Year Follow-up||24
8397849|NCT01017549|20696820|P1|STARTED|5 Year Follow-up||36
8397850|NCT01017549|20696820|P1|NOT COMPLETED|One-year Follow-up||7
8397851|NCT01017549|20696820|P1|COMPLETED|One-year Follow-up||36
8397852|NCT01017549|20696820|P1|STARTED|One-year Follow-up||43
8397853|NCT01017549|20696820|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
8397854|NCT01017549|20696820|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
8397855|NCT01017549|20696820|P1|STARTED|Eligibility Through 6 Month Follow-up||44
8397856|NCT01017536|20696827|P2|NOT COMPLETED|Overall Study||0
8397857|NCT01017536|20696828|P1|NOT COMPLETED|Overall Study||0
8397858|NCT01017536|20696827|P2|COMPLETED|Overall Study||13
8397859|NCT01017536|20696828|P1|COMPLETED|Overall Study||13
8397860|NCT01017536|20696827|P2|STARTED|Overall Study||13
8397861|NCT01017536|20696828|P1|STARTED|Overall Study||13
8397862|NCT01017497|20696838|P1|NOT COMPLETED|Overall Study||0
8397863|NCT01017497|20696838|P1|COMPLETED|Overall Study||49
8397864|NCT01017497|20696838|P1|STARTED|Overall Study||49
8397865|NCT01017263|20696851|P1|NOT COMPLETED|Overall Study||12
8397866|NCT01017263|20696851|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
8397867|NCT01017263|20696851|P1|STARTED|Overall Study||14
8397868|NCT01017250|20696855|P1|NOT COMPLETED|Overall Study||0
8397869|NCT01017250|20696855|P1|COMPLETED|Overall Study||15
8397870|NCT01017250|20696855|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
8397871|NCT01017250|20696855|P1|STARTED|Overall Study||15
8397872|NCT01017237|20696877|P2|NOT COMPLETED|Overall Study||2
8397875|NCT01017237|20696878|P1|COMPLETED|Overall Study||5
8397876|NCT01017237|20696877|P2|STARTED|Overall Study||8
8397877|NCT01017237|20696878|P1|STARTED|Overall Study||10
8397878|NCT01017146|20696932|P2|NOT COMPLETED|Overall Study||39
8397879|NCT01017146|20696933|P1|NOT COMPLETED|Overall Study||66
8397880|NCT01017146|20696932|P2|COMPLETED|Overall Study||333
8397881|NCT01017146|20696933|P1|COMPLETED|Overall Study||306
8397882|NCT01017146|20696932|P2|STARTED|Overall Study||372
8397883|NCT01017146|20696933|P1|STARTED|Overall Study||372
8397884|NCT01017120|20696971|P2|NOT COMPLETED|Overall Study||35
8397885|NCT01017120|20696972|P1|NOT COMPLETED|Overall Study||66
8397886|NCT01017120|20696971|P2|COMPLETED|Overall Study||334
8397887|NCT01017120|20696972|P1|COMPLETED|Overall Study||307
8397888|NCT01017120|20696971|P2|STARTED|Overall Study||369
8397889|NCT01017120|20696972|P1|STARTED|Overall Study||373
8397890|NCT01017042|20697020|P1|NOT COMPLETED|Overall Study||0
8397891|NCT01017042|20697020|P1|COMPLETED|Overall Study||13
8397892|NCT01017042|20697020|P1|STARTED|Overall Study||13
8397893|NCT01017029|20697033|P2|NOT COMPLETED|Overall Study||2
8397894|NCT01017029|20697034|P1|NOT COMPLETED|Overall Study||4
8397895|NCT01017029|20697033|P2|COMPLETED|Overall Study||90
8397896|NCT01017029|20697034|P1|COMPLETED|Overall Study||85
8397897|NCT01017029|20697033|P2|STARTED|Overall Study||92
8397898|NCT01017029|20697034|P1|STARTED|Overall Study||89
8397899|NCT01017003|20697050|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
8397900|NCT01017003|20697050|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
8397901|NCT01017003|20697050|P1|STARTED|Colchicine 0.6 mg Final Dose||13
8397902|NCT01017003|20697050|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
8397903|NCT01017003|20697050|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
8397904|NCT01017003|20697050|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
8397905|NCT01017003|20697050|P1|NOT COMPLETED|14 Day Washout Period||0
8397906|NCT01017003|20697050|P1|COMPLETED|14 Day Washout Period||13
8397907|NCT01017003|20697050|P1|STARTED|14 Day Washout Period||13
8397908|NCT01017003|20697050|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
8397909|NCT01017003|20697050|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
8397910|NCT01017003|20697050|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
8397911|NCT01016977|20697062|P2|NOT COMPLETED|Overall Study||2
8397912|NCT01016977|20697063|P1|NOT COMPLETED|Overall Study||3
8397913|NCT01016977|20697062|P2|COMPLETED|Overall Study||18
8397914|NCT01016977|20697063|P1|COMPLETED|Overall Study||17
8397915|NCT01016977|20697062|P2|STARTED|Overall Study||20
8397916|NCT01016977|20697063|P1|STARTED|Overall Study||20
8397917|NCT01016964|20697099|P2|NOT COMPLETED|Overall Study||3
8397918|NCT01016964|20697100|P1|NOT COMPLETED|Overall Study||3
8397919|NCT01016964|20697099|P2|COMPLETED|Overall Study||39
8397920|NCT01016964|20697100|P1|COMPLETED|Overall Study||18
8397921|NCT01016964|20697099|P2|STARTED|Overall Study||42
8397922|NCT01016964|20697100|P1|STARTED|Overall Study||21
8397923|NCT01016938|20697106|P1|NOT COMPLETED|Overall Study||9
8397924|NCT01016938|20697106|P1|COMPLETED|Overall Study||7
8397925|NCT01016938|20697106|P1|STARTED|Overall Study||16
8397926|NCT01016912|20697116|P5|NOT COMPLETED|Follow-up Period||0
8397927|NCT01016912|20697117|P4|NOT COMPLETED|Follow-up Period||1
8397928|NCT01016912|20697118|P3|NOT COMPLETED|Follow-up Period||1
8397929|NCT01016912|20697119|P2|NOT COMPLETED|Follow-up Period||0
8397930|NCT01016912|20697120|P1|NOT COMPLETED|Follow-up Period||0
8397931|NCT01016912|20697116|P5|COMPLETED|Follow-up Period||9
8397932|NCT01016912|20697117|P4|COMPLETED|Follow-up Period||8
8397933|NCT01016912|20697118|P3|COMPLETED|Follow-up Period||9
8397934|NCT01016912|20697119|P2|COMPLETED|Follow-up Period||9
8397935|NCT01016912|20697120|P1|COMPLETED|Follow-up Period||8
8397936|NCT01016912|20697116|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8397937|NCT01016912|20697117|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8397938|NCT01016912|20697118|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
8397939|NCT01016912|20697119|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8397940|NCT01016912|20697120|P1|STARTED|Follow-up Period||8
8397941|NCT01016912|20697116|P5|NOT COMPLETED|End of Treatment Period||4
8397942|NCT01016912|20697117|P4|NOT COMPLETED|End of Treatment Period||4
8397943|NCT01016912|20697118|P3|NOT COMPLETED|End of Treatment Period||1
8397944|NCT01016912|20697119|P2|NOT COMPLETED|End of Treatment Period||3
8397945|NCT01016912|20697120|P1|NOT COMPLETED|End of Treatment Period||0
8397946|NCT01016912|20697116|P5|COMPLETED|End of Treatment Period||5
8397947|NCT01016912|20697117|P4|COMPLETED|End of Treatment Period||5
8397948|NCT01016912|20697118|P3|COMPLETED|End of Treatment Period||9
8397949|NCT01016912|20697119|P2|COMPLETED|End of Treatment Period||6
8397950|NCT01016912|20697120|P1|COMPLETED|End of Treatment Period||8
8397951|NCT01016912|20697116|P5|Received Treatment|End of Treatment Period||9
8397952|NCT01016912|20697117|P4|Received Treatment|End of Treatment Period||9
8397953|NCT01016912|20697118|P3|Received Treatment|End of Treatment Period||10
8397954|NCT01016912|20697119|P2|Received Treatment|End of Treatment Period||9
8397955|NCT01016912|20697120|P1|Received Treatment|End of Treatment Period||8
8397956|NCT01016912|20697116|P5|STARTED|End of Treatment Period||9
8397957|NCT01016912|20697117|P4|STARTED|End of Treatment Period||9
8397958|NCT01016912|20697118|P3|STARTED|End of Treatment Period||10
8397959|NCT01016912|20697119|P2|STARTED|End of Treatment Period||9
8397960|NCT01016912|20697120|P1|STARTED|End of Treatment Period||8
8397961|NCT01016873|20697165|P3|NOT COMPLETED|36 Months||6
8397962|NCT01016873|20697166|P2|NOT COMPLETED|36 Months||4
8397963|NCT01016873|20697167|P1|NOT COMPLETED|36 Months||11
8397964|NCT01016873|20697165|P3|COMPLETED|36 Months||67
8397965|NCT01016873|20697166|P2|COMPLETED|36 Months||64
8397966|NCT01016873|20697167|P1|COMPLETED|36 Months||58
8397967|NCT01016873|20697165|P3|STARTED|36 Months||73
8397968|NCT01016873|20697166|P2|STARTED|36 Months||68
8397969|NCT01016873|20697167|P1|STARTED|36 Months||69
8397970|NCT01016873|20697165|P3|NOT COMPLETED|24 Months||6
8397971|NCT01016873|20697166|P2|NOT COMPLETED|24 Months||4
8397972|NCT01016873|20697167|P1|NOT COMPLETED|24 Months||5
8397973|NCT01016873|20697165|P3|COMPLETED|24 Months||73
8397974|NCT01016873|20697166|P2|COMPLETED|24 Months||68
8397975|NCT01016873|20697167|P1|COMPLETED|24 Months||69
8397976|NCT01016873|20697165|P3|STARTED|24 Months||79
8397977|NCT01016873|20697166|P2|STARTED|24 Months||72
8397978|NCT01016873|20697167|P1|STARTED|24 Months||74
8397979|NCT01016873|20697165|P3|NOT COMPLETED|12 Months||1
8397980|NCT01016873|20697166|P2|NOT COMPLETED|12 Months||3
8397981|NCT01016873|20697167|P1|NOT COMPLETED|12 Months||1
8397982|NCT01016873|20697165|P3|COMPLETED|12 Months||79
8397983|NCT01016873|20697166|P2|COMPLETED|12 Months||72
8397984|NCT01016873|20697167|P1|COMPLETED|12 Months||74
8397985|NCT01016873|20697165|P3|STARTED|12 Months||80
8397986|NCT01016873|20697166|P2|STARTED|12 Months||75
8397987|NCT01016873|20697167|P1|STARTED|12 Months||75
8397988|NCT01016847|20697198|P2|NOT COMPLETED|Overall Study||0
8397989|NCT01016847|20697199|P1|NOT COMPLETED|Overall Study||0
8397990|NCT01016847|20697198|P2|COMPLETED|Overall Study||2
8397991|NCT01016847|20697199|P1|COMPLETED|Overall Study||1
8397992|NCT01016847|20697198|P2|STARTED|Overall Study||2
8397993|NCT01016847|20697199|P1|STARTED|Overall Study||1
8397994|NCT01016834|20697215|P1|NOT COMPLETED|Overall Study||22
8397995|NCT01016834|20697215|P1|COMPLETED|Overall Study||220
8397996|NCT01016834|20697215|P1|STARTED|Overall Study||242
8397997|NCT01016769|20697225|P4|NOT COMPLETED|Overall Study||0
8397998|NCT01016769|20697226|P3|NOT COMPLETED|Overall Study||1
8397999|NCT01016769|20697227|P2|NOT COMPLETED|Overall Study||1
8398000|NCT01016769|20697228|P1|NOT COMPLETED|Overall Study||1
8398001|NCT01016769|20697225|P4|COMPLETED|Overall Study||30
8398002|NCT01016769|20697226|P3|COMPLETED|Overall Study||6
8398003|NCT01016769|20697227|P2|COMPLETED|Overall Study||6
8398004|NCT01016769|20697228|P1|COMPLETED|Overall Study||3
8398005|NCT01016769|20697225|P4|STARTED|Overall Study||30
8398006|NCT01016769|20697226|P3|STARTED|Overall Study||7
8398007|NCT01016769|20697227|P2|STARTED|Overall Study||7
8398008|NCT01016769|20697228|P1|STARTED|Overall Study||4
8398009|NCT01016691|20697242|P3|NOT COMPLETED|Overall Study||0
8398010|NCT01016691|20697243|P2|NOT COMPLETED|Overall Study||0
8398011|NCT01016691|20697244|P1|NOT COMPLETED|Overall Study||0
8398012|NCT01016691|20697242|P3|COMPLETED|Overall Study||18
8398013|NCT01016691|20697243|P2|COMPLETED|Overall Study||12
8398014|NCT01016691|20697244|P1|COMPLETED|Overall Study||17
8398015|NCT01016691|20697242|P3|STARTED|Overall Study||18
8398016|NCT01016691|20697243|P2|STARTED|Overall Study||12
8398017|NCT01016691|20697244|P1|STARTED|Overall Study||17
8398018|NCT01016678|20697252|P5|NOT COMPLETED|Overall Study||6
8398019|NCT01016678|20697253|P4|NOT COMPLETED|Overall Study||0
8398020|NCT01016678|20697254|P3|NOT COMPLETED|Overall Study||4
8398021|NCT01016678|20697255|P2|NOT COMPLETED|Overall Study||3
8398022|NCT01016678|20697256|P1|NOT COMPLETED|Overall Study||2
8398023|NCT01016678|20697252|P5|COMPLETED|Overall Study||13
8398024|NCT01016678|20697253|P4|COMPLETED|Overall Study||19
8398025|NCT01016678|20697254|P3|COMPLETED|Overall Study||15
8398026|NCT01016678|20697255|P2|COMPLETED|Overall Study||14
8398027|NCT01016678|20697256|P1|COMPLETED|Overall Study||18
8398028|NCT01016678|20697252|P5|STARTED|Overall Study||19
8398029|NCT01016678|20697253|P4|STARTED|Overall Study||19
8398030|NCT01016678|20697254|P3|STARTED|Overall Study||19
8398031|NCT01016678|20697255|P2|STARTED|Overall Study||17
8398032|NCT01016678|20697256|P1|STARTED|Overall Study||20
8398033|NCT01016652|20697278|P2|NOT COMPLETED|Period 2||0
8398034|NCT01016652|20697279|P1|NOT COMPLETED|Period 2||0
8398035|NCT01016652|20697278|P2|COMPLETED|Period 2||24
8398036|NCT01016652|20697279|P1|COMPLETED|Period 2||25
8398037|NCT01016652|20697278|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
8398038|NCT01016652|20697279|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
8398039|NCT01016652|20697278|P2|NOT COMPLETED|Period 1||0
8398040|NCT01016652|20697279|P1|NOT COMPLETED|Period 1||0
8398041|NCT01016652|20697278|P2|COMPLETED|Period 1||24
8398042|NCT01016652|20697279|P1|COMPLETED|Period 1||25
8398043|NCT01016652|20697278|P2|STARTED|Period 1||24
8398044|NCT01016652|20697279|P1|STARTED|Period 1||25
8398045|NCT01016600|20697299|P4|NOT COMPLETED|Overall Study||0
8398046|NCT01016600|20697300|P3|NOT COMPLETED|Overall Study||0
8398047|NCT01016600|20697301|P2|NOT COMPLETED|Overall Study||0
8398048|NCT01016600|20697302|P1|NOT COMPLETED|Overall Study||1
8398049|NCT01016600|20697299|P4|COMPLETED|Overall Study||12
8398050|NCT01016600|20697300|P3|COMPLETED|Overall Study||6
8398051|NCT01016600|20697301|P2|COMPLETED|Overall Study||4
8398052|NCT01016600|20697302|P1|COMPLETED|Overall Study||8
8398053|NCT01016600|20697299|P4|STARTED|Overall Study||12
8398054|NCT01016600|20697300|P3|STARTED|Overall Study||6
8398055|NCT01016600|20697301|P2|STARTED|Overall Study||4
8398056|NCT01016600|20697302|P1|STARTED|Overall Study||9
8398057|NCT01016483|20697369|P4|NOT COMPLETED|Phase II||0
8398058|NCT01016483|20697370|P3|NOT COMPLETED|Phase II||0
8398059|NCT01016483|20697371|P2|NOT COMPLETED|Phase II||0
8398060|NCT01016483|20697372|P1|NOT COMPLETED|Phase II||0
8398061|NCT01016483|20697369|P4|COMPLETED|Phase II||44
8398062|NCT01016483|20697370|P3|COMPLETED|Phase II||44
8398063|NCT01016483|20697371|P2|COMPLETED|Phase II||0
8398064|NCT01016483|20697372|P1|COMPLETED|Phase II||0
8398065|NCT01016483|20697369|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
8398066|NCT01016483|20697370|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
8398067|NCT01016483|20697371|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
8398068|NCT01016483|20697372|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
8398069|NCT01016483|20697369|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
8398070|NCT01016483|20697370|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
8398071|NCT01016483|20697371|P2|STARTED|Phase II||0
8398072|NCT01016483|20697372|P1|STARTED|Phase II||0
8398073|NCT01016483|20697369|P4|NOT COMPLETED|Safety Run-in Part||0
8398074|NCT01016483|20697370|P3|NOT COMPLETED|Safety Run-in Part||0
8398075|NCT01016483|20697371|P2|NOT COMPLETED|Safety Run-in Part||0
8398076|NCT01016483|20697372|P1|NOT COMPLETED|Safety Run-in Part||0
8398077|NCT01016483|20697369|P4|COMPLETED|Safety Run-in Part||0
8398078|NCT01016483|20697370|P3|COMPLETED|Safety Run-in Part||0
8398079|NCT01016483|20697371|P2|COMPLETED|Safety Run-in Part||26
8398080|NCT01016483|20697372|P1|COMPLETED|Safety Run-in Part||27
8398081|NCT01016483|20697369|P4|STARTED|Safety Run-in Part||0
8398082|NCT01016483|20697370|P3|STARTED|Safety Run-in Part||0
8398083|NCT01016483|20697371|P2|STARTED|Safety Run-in Part||26
8398084|NCT01016483|20697372|P1|STARTED|Safety Run-in Part||27
8398085|NCT01016353|20697480|P2|NOT COMPLETED|Overall Study||1
8398086|NCT01016353|20697481|P1|NOT COMPLETED|Overall Study||2
8398087|NCT01016353|20697480|P2|COMPLETED|Overall Study||102
8398088|NCT01016353|20697481|P1|COMPLETED|Overall Study||178
8398089|NCT01016353|20697480|P2|STARTED|Overall Study||103
8398090|NCT01016353|20697481|P1|STARTED|Overall Study||180
8398091|NCT01016262|20697490|P6|NOT COMPLETED|Open-Label Phase||0
8398092|NCT01016262|20697491|P5|NOT COMPLETED|Open-Label Phase||2
8398093|NCT01016262|20697492|P4|NOT COMPLETED|Open-Label Phase||2
8398094|NCT01016262|20697493|P3|NOT COMPLETED|Open-Label Phase||0
8398095|NCT01016262|20697494|P2|NOT COMPLETED|Open-Label Phase||0
8398096|NCT01016262|20697495|P1|NOT COMPLETED|Open-Label Phase||0
8398097|NCT01016262|20697490|P6|COMPLETED|Open-Label Phase||20
8398098|NCT01016262|20697491|P5|COMPLETED|Open-Label Phase||50
8398099|NCT01016262|20697492|P4|COMPLETED|Open-Label Phase||42
8398100|NCT01016262|20697493|P3|COMPLETED|Open-Label Phase||0
8398101|NCT01016262|20697494|P2|COMPLETED|Open-Label Phase||0
8398102|NCT01016262|20697495|P1|COMPLETED|Open-Label Phase||0
8398103|NCT01016262|20697490|P6|STARTED|Open-Label Phase||20
8398104|NCT01016262|20697491|P5|STARTED|Open-Label Phase||52
8398105|NCT01016262|20697492|P4|STARTED|Open-Label Phase||44
8398106|NCT01016262|20697493|P3|STARTED|Open-Label Phase||0
8398107|NCT01016262|20697494|P2|STARTED|Open-Label Phase||0
8398108|NCT01016262|20697495|P1|STARTED|Open-Label Phase||0
8398109|NCT01016262|20697490|P6|NOT COMPLETED|Double-blind Phase||0
8398110|NCT01016262|20697491|P5|NOT COMPLETED|Double-blind Phase||0
8398111|NCT01016262|20697492|P4|NOT COMPLETED|Double-blind Phase||0
8398112|NCT01016262|20697493|P3|NOT COMPLETED|Double-blind Phase||9
8398113|NCT01016262|20697494|P2|NOT COMPLETED|Double-blind Phase||1
8398114|NCT01016262|20697495|P1|NOT COMPLETED|Double-blind Phase||1
8398115|NCT01016262|20697490|P6|COMPLETED|Double-blind Phase||0
8398116|NCT01016262|20697491|P5|COMPLETED|Double-blind Phase||0
8398117|NCT01016262|20697492|P4|COMPLETED|Double-blind Phase||0
8398118|NCT01016262|20697493|P3|COMPLETED|Double-blind Phase||30
8398119|NCT01016262|20697494|P2|COMPLETED|Double-blind Phase||38
8398120|NCT01016262|20697495|P1|COMPLETED|Double-blind Phase||40
8398121|NCT01016262|20697490|P6|STARTED|Double-blind Phase||0
8398122|NCT01016262|20697491|P5|STARTED|Double-blind Phase||0
8398123|NCT01016262|20697492|P4|STARTED|Double-blind Phase||0
8398124|NCT01016262|20697493|P3|STARTED|Double-blind Phase||39
8398125|NCT01016262|20697494|P2|STARTED|Double-blind Phase||39
8398126|NCT01016262|20697495|P1|STARTED|Double-blind Phase||41
8398127|NCT01016132|20697518|P1|NOT COMPLETED|Overall Study||1
8398128|NCT01016132|20697518|P1|COMPLETED|Overall Study||151
8398129|NCT01016132|20697518|P1|STARTED|Overall Study||152
8398130|NCT01016106|20697524|P2|NOT COMPLETED|Overall Study||0
8398131|NCT01016106|20697525|P1|NOT COMPLETED|Overall Study||0
8398132|NCT01016106|20697524|P2|COMPLETED|Overall Study||18
8398133|NCT01016106|20697525|P1|COMPLETED|Overall Study||17
8398134|NCT01016106|20697524|P2|STARTED|Overall Study||18
8398135|NCT01016106|20697525|P1|STARTED|Overall Study||17
8398136|NCT01016067|20697533|P2|NOT COMPLETED|Overall Study||4
8398137|NCT01016067|20697534|P1|NOT COMPLETED|Overall Study||2
8398138|NCT01016067|20697533|P2|COMPLETED|Overall Study||8
8398139|NCT01016067|20697534|P1|COMPLETED|Overall Study||9
8398140|NCT01016067|20697533|P2|STARTED|Overall Study||12
8398141|NCT01016067|20697534|P1|STARTED|Overall Study||11
8398142|NCT01016015|20697552|P1|NOT COMPLETED|Overall Study||19
8398143|NCT01016015|20697552|P1|COMPLETED|Overall Study||159
8398144|NCT01016015|20697552|P1|STARTED|Overall Study||178
8398145|NCT01015976|20697556|P2|NOT COMPLETED|Overall Study||0
8398146|NCT01015976|20697557|P1|NOT COMPLETED|Overall Study||0
8398147|NCT01015976|20697556|P2|COMPLETED|Overall Study||5
8398148|NCT01015976|20697557|P1|COMPLETED|Overall Study||5
8398149|NCT01015976|20697556|P2|STARTED|Overall Study||5
8398150|NCT01015976|20697557|P1|STARTED|Overall Study||5
8398151|NCT01015833|20697563|P2|NOT COMPLETED|Overall Study||5
8398152|NCT01015833|20697564|P1|NOT COMPLETED|Overall Study||13
8398153|NCT01015833|20697563|P2|COMPLETED|Overall Study||171
8398154|NCT01015833|20697564|P1|COMPLETED|Overall Study||167
8398155|NCT01015833|20697563|P2|STARTED|Overall Study||176
8398156|NCT01015833|20697564|P1|STARTED|Overall Study||180
8398157|NCT01015820|20697580|P2|NOT COMPLETED|Overall Study||0
8398158|NCT01015820|20697581|P1|NOT COMPLETED|Overall Study||1
8398159|NCT01015820|20697580|P2|COMPLETED|Overall Study||15
8398160|NCT01015820|20697581|P1|COMPLETED|Overall Study||14
8398161|NCT01015820|20697580|P2|STARTED|Overall Study||15
8398162|NCT01015820|20697581|P1|STARTED|Overall Study||15
8398163|NCT01015807|20697592|P3|NOT COMPLETED|Overall Study||0
8398164|NCT01015807|20697593|P2|NOT COMPLETED|Overall Study||0
8398165|NCT01015807|20697594|P1|NOT COMPLETED|Overall Study||0
8398166|NCT01015807|20697592|P3|COMPLETED|Overall Study||30
8398167|NCT01015807|20697593|P2|COMPLETED|Overall Study||30
8398168|NCT01015807|20697594|P1|COMPLETED|Overall Study||30
8398169|NCT01015807|20697592|P3|STARTED|Overall Study||30
8398170|NCT01015807|20697593|P2|STARTED|Overall Study||30
8398171|NCT01015807|20697594|P1|STARTED|Overall Study||30
8398172|NCT01015781|20697604|P2|NOT COMPLETED|Overall Study||29
8398173|NCT01015781|20697605|P1|NOT COMPLETED|Overall Study||37
8398174|NCT01015781|20697604|P2|COMPLETED|Overall Study||121
8398175|NCT01015781|20697605|P1|COMPLETED|Overall Study||113
8398176|NCT01015781|20697604|P2|STARTED|Overall Study||150
8398177|NCT01015781|20697605|P1|STARTED|Overall Study||150
8398178|NCT01015768|20697611|P2|NOT COMPLETED|Overall Study||4
8398179|NCT01015768|20697612|P1|NOT COMPLETED|Overall Study||4
8398180|NCT01015768|20697611|P2|COMPLETED|Overall Study||26
8398181|NCT01015768|20697612|P1|COMPLETED|Overall Study||26
8398182|NCT01015768|20697611|P2|STARTED|Overall Study||30
8398183|NCT01015768|20697612|P1|STARTED|Overall Study||30
8398184|NCT01015703|20697627|P5|NOT COMPLETED|Overall Study||0
8398185|NCT01015703|20697628|P4|NOT COMPLETED|Overall Study||0
8398186|NCT01015703|20697629|P3|NOT COMPLETED|Overall Study||0
8398187|NCT01015703|20697630|P2|NOT COMPLETED|Overall Study||1
8398188|NCT01015703|20697631|P1|NOT COMPLETED|Overall Study||2
8398189|NCT01015703|20697627|P5|COMPLETED|Overall Study||10
8398190|NCT01015703|20697628|P4|COMPLETED|Overall Study||10
8398191|NCT01015703|20697629|P3|COMPLETED|Overall Study||10
8398192|NCT01015703|20697630|P2|COMPLETED|Overall Study||9
8398193|NCT01015703|20697631|P1|COMPLETED|Overall Study||8
8398194|NCT01015703|20697627|P5|STARTED|Overall Study||10
8398195|NCT01015703|20697628|P4|STARTED|Overall Study||10
8398196|NCT01015703|20697629|P3|STARTED|Overall Study||10
8398197|NCT01015703|20697630|P2|STARTED|Overall Study||10
8398198|NCT01015703|20697631|P1|STARTED|Overall Study||10
8398199|NCT01015677|20697646|P3|NOT COMPLETED|Overall Study||0
8398200|NCT01015677|20697647|P2|NOT COMPLETED|Overall Study||4
8398201|NCT01015677|20697648|P1|NOT COMPLETED|Overall Study||1
8398202|NCT01015677|20697646|P3|COMPLETED|Overall Study||33
8398203|NCT01015677|20697647|P2|COMPLETED|Overall Study||28
8398204|NCT01015677|20697648|P1|COMPLETED|Overall Study||33
8398205|NCT01015677|20697646|P3|STARTED|Overall Study||33
8398206|NCT01015677|20697647|P2|STARTED|Overall Study||32
8398207|NCT01015677|20697648|P1|STARTED|Overall Study||34
8398208|NCT01015638|20697670|P2|NOT COMPLETED|Overall Study||0
8398209|NCT01015638|20697671|P1|NOT COMPLETED|Overall Study||1
8398210|NCT01015638|20697670|P2|COMPLETED|Overall Study||19
8398211|NCT01015638|20697671|P1|COMPLETED|Overall Study||16
8398212|NCT01015638|20697670|P2|STARTED|Overall Study||19
8398213|NCT01015638|20697671|P1|STARTED|Overall Study||17
8398214|NCT01015612|20697699|P1|NOT COMPLETED|Overall Study||153
8398215|NCT01015612|20697699|P1|COMPLETED|Overall Study||481
8398216|NCT01015612|20697699|P1|STARTED|Overall Study||634
8398217|NCT01015586|20697711|P2|NOT COMPLETED|Overall Study||11
8398218|NCT01015586|20697712|P1|NOT COMPLETED|Overall Study||7
8398219|NCT01015586|20697711|P2|COMPLETED|Overall Study||11
8398220|NCT01015586|20697712|P1|COMPLETED|Overall Study||14
8398221|NCT01015586|20697711|P2|STARTED|Overall Study||22
8398222|NCT01015586|20697712|P1|STARTED|Overall Study||21
8398223|NCT01015560|20697730|P1|NOT COMPLETED|Overall Study||3
8398224|NCT01015560|20697730|P1|COMPLETED|Overall Study||41
8398225|NCT01015560|20697730|P1|Eligible and Analyzable|Overall Study||43
8398226|NCT01015560|20697730|P1|STARTED|Overall Study||44
8398227|NCT01015534|20697736|P2|NOT COMPLETED|Overall Study||0
8398228|NCT01015534|20697737|P1|NOT COMPLETED|Overall Study||1
8398229|NCT01015534|20697736|P2|COMPLETED|Overall Study||27
8398230|NCT01015534|20697737|P1|COMPLETED|Overall Study||27
8398231|NCT01015534|20697736|P2|STARTED|Overall Study||27
8398232|NCT01015534|20697737|P1|STARTED|Overall Study||28
8398233|NCT01015443|20697751|P2|NOT COMPLETED|Overall Study||0
8398234|NCT01015443|20697752|P1|NOT COMPLETED|Overall Study||0
8398235|NCT01015443|20697751|P2|COMPLETED|Overall Study||94
8398236|NCT01015443|20697752|P1|COMPLETED|Overall Study||191
8398237|NCT01015443|20697751|P2|Treated|Overall Study||93
8398238|NCT01015443|20697752|P1|Treated|Overall Study||191
8398239|NCT01015443|20697751|P2|STARTED|Overall Study||94
8398240|NCT01015443|20697752|P1|STARTED|Overall Study||191
8398241|NCT01015326|20697770|P2|NOT COMPLETED|Overall Study||2
8398242|NCT01015326|20697771|P1|NOT COMPLETED|Overall Study||1
8398243|NCT01015326|20697770|P2|COMPLETED|Overall Study||18
8398244|NCT01015326|20697771|P1|COMPLETED|Overall Study||11
8398245|NCT01015326|20697770|P2|STARTED|Overall Study||20
8398246|NCT01015326|20697771|P1|STARTED|Overall Study||12
8398247|NCT01015287|20697779|P2|NOT COMPLETED|Overall Study||79
8398248|NCT01015287|20697780|P1|NOT COMPLETED|Overall Study||72
8398249|NCT01015287|20697779|P2|COMPLETED|Overall Study||1958
8398250|NCT01015287|20697780|P1|COMPLETED|Overall Study||1924
8398251|NCT01015287|20697779|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
8398252|NCT01015287|20697780|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
8398253|NCT01015287|20697779|P2|STARTED|Overall Study||2037
8398254|NCT01015287|20697780|P1|STARTED|Overall Study||1996
8398255|NCT01015170|20697806|P1|NOT COMPLETED|Overall Study||239
8398256|NCT01015170|20697806|P1|COMPLETED|Overall Study||215
8398257|NCT01015170|20697806|P1|STARTED|Overall Study||454
8398261|NCT01015118|20697828|P2|NOT COMPLETED|Overall Study||327
8398262|NCT01015118|20697829|P1|NOT COMPLETED|Overall Study||669
8398263|NCT01015118|20697828|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
8398264|NCT01015118|20697829|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
8398265|NCT01015118|20697828|P2|STARTED|Overall Study||455
8398266|NCT01015118|20697829|P1|STARTED|Overall Study||911
8398267|NCT01014988|20697857|P6|NOT COMPLETED|Overall Study||3
8398268|NCT01014988|20697858|P5|NOT COMPLETED|Overall Study||1
8398269|NCT01014988|20697859|P4|NOT COMPLETED|Overall Study||0
8398270|NCT01014988|20697860|P3|NOT COMPLETED|Overall Study||2
8398271|NCT01014988|20697861|P2|NOT COMPLETED|Overall Study||0
8398272|NCT01014988|20697862|P1|NOT COMPLETED|Overall Study||23
8398273|NCT01014988|20697857|P6|COMPLETED|Overall Study||11
8398274|NCT01014988|20697858|P5|COMPLETED|Overall Study||26
8398275|NCT01014988|20697859|P4|COMPLETED|Overall Study||12
8398276|NCT01014988|20697860|P3|COMPLETED|Overall Study||9
8398277|NCT01014988|20697861|P2|COMPLETED|Overall Study||7
8398278|NCT01014988|20697862|P1|COMPLETED|Overall Study||107
8398279|NCT01014988|20697857|P6|STARTED|Overall Study||14
8398280|NCT01014988|20697858|P5|STARTED|Overall Study||27
8398281|NCT01014988|20697859|P4|STARTED|Overall Study||12
8398282|NCT01014988|20697860|P3|STARTED|Overall Study||11
8398283|NCT01014988|20697861|P2|STARTED|Overall Study||7
8398284|NCT01014988|20697862|P1|STARTED|Overall Study||130
8398285|NCT01014975|20698034|P3|NOT COMPLETED|Overall Study||6
8398286|NCT01014975|20698035|P2|NOT COMPLETED|Overall Study||3
8398287|NCT01014975|20698036|P1|NOT COMPLETED|Overall Study||4
8398288|NCT01014975|20698034|P3|COMPLETED|Overall Study||10
8398289|NCT01014975|20698035|P2|COMPLETED|Overall Study||13
8398290|NCT01014975|20698036|P1|COMPLETED|Overall Study||4
8398291|NCT01014975|20698034|P3|STARTED|Overall Study||16
8398292|NCT01014975|20698035|P2|STARTED|Overall Study||16
8398293|NCT01014975|20698036|P1|STARTED|Overall Study||8
8398294|NCT01014936|20698047|P3|NOT COMPLETED|Overall Study||0
8398295|NCT01014936|20698048|P2|NOT COMPLETED|Overall Study||0
8398296|NCT01014936|20698049|P1|NOT COMPLETED|Overall Study||0
8398297|NCT01014936|20698047|P3|COMPLETED|Overall Study||62
8398298|NCT01014936|20698048|P2|COMPLETED|Overall Study||45
8398299|NCT01014936|20698049|P1|COMPLETED|Overall Study||42
8398300|NCT01014936|20698047|P3|STARTED|Overall Study||62
8398301|NCT01014936|20698048|P2|STARTED|Overall Study||45
8398302|NCT01014936|20698049|P1|STARTED|Overall Study||42
8398303|NCT01014910|20698541|P2|NOT COMPLETED|Overall Study||2
8398304|NCT01014910|20698542|P1|NOT COMPLETED|Overall Study||0
8398305|NCT01014910|20698541|P2|COMPLETED|Overall Study||79
8398306|NCT01014910|20698542|P1|COMPLETED|Overall Study||80
8398307|NCT01014910|20698541|P2|STARTED|Overall Study||81
8398308|NCT01014910|20698542|P1|STARTED|Overall Study||80
8398312|NCT01014767|20698560|P4|NOT COMPLETED|Overall Study||1
8398313|NCT01014767|20698561|P3|NOT COMPLETED|Overall Study||4
8398314|NCT01014767|20698562|P2|NOT COMPLETED|Overall Study||1
8398315|NCT01014767|20698563|P1|NOT COMPLETED|Overall Study||12
8398316|NCT01014767|20698560|P4|COMPLETED|Overall Study||0
8398317|NCT01014767|20698561|P3|COMPLETED|Overall Study||0
8398318|NCT01014767|20698562|P2|COMPLETED|Overall Study||0
8398319|NCT01014767|20698563|P1|COMPLETED|Overall Study||0
8398320|NCT01014767|20698560|P4|STARTED|Overall Study||1
8398321|NCT01014767|20698561|P3|STARTED|Overall Study||4
8398322|NCT01014767|20698562|P2|STARTED|Overall Study||1
8398323|NCT01014767|20698563|P1|STARTED|Overall Study||12
8398324|NCT01014741|20698579|P2|NOT COMPLETED|Overall Study||5
8398325|NCT01014741|20698580|P1|NOT COMPLETED|Overall Study||11
8398326|NCT01014741|20698579|P2|COMPLETED|Overall Study||90
8398327|NCT01014741|20698580|P1|COMPLETED|Overall Study||94
8398328|NCT01014741|20698579|P2|STARTED|Overall Study||95
8398329|NCT01014741|20698580|P1|STARTED|Overall Study||105
8398330|NCT01014728|20698594|P2|NOT COMPLETED|Overall Study||0
8398331|NCT01014728|20698595|P1|NOT COMPLETED|Overall Study||0
8398332|NCT01014728|20698594|P2|COMPLETED|Overall Study||15
8398333|NCT01014728|20698595|P1|COMPLETED|Overall Study||18
8398334|NCT01014728|20698594|P2|STARTED|Overall Study||15
8398335|NCT01014728|20698595|P1|STARTED|Overall Study||18
8398342|NCT01014624|20698618|P2|NOT COMPLETED|Overall Study||1
8398343|NCT01014624|20698619|P1|NOT COMPLETED|Overall Study||2
8398344|NCT01014624|20698618|P2|COMPLETED|Overall Study||26
8398345|NCT01014624|20698619|P1|COMPLETED|Overall Study||27
8398346|NCT01014624|20698618|P2|STARTED|Overall Study||27
8398347|NCT01014624|20698619|P1|STARTED|Overall Study||29
8398348|NCT01014585|20698643|P4|NOT COMPLETED|Overall Study||30
8398349|NCT01014585|20698644|P3|NOT COMPLETED|Overall Study||23
8398350|NCT01014585|20698645|P2|NOT COMPLETED|Overall Study||25
8398351|NCT01014585|20698646|P1|NOT COMPLETED|Overall Study||20
8398352|NCT01014585|20698643|P4|COMPLETED|Overall Study||99
8398353|NCT01014585|20698644|P3|COMPLETED|Overall Study||37
8398354|NCT01014585|20698645|P2|COMPLETED|Overall Study||75
8398355|NCT01014585|20698646|P1|COMPLETED|Overall Study||31
8398356|NCT01014585|20698643|P4|STARTED|Overall Study||129
8398357|NCT01014585|20698644|P3|STARTED|Overall Study||60
8398358|NCT01014585|20698645|P2|STARTED|Overall Study||100
8398359|NCT01014585|20698646|P1|STARTED|Overall Study||51
8398360|NCT01014533|20698666|P2|NOT COMPLETED|Overall Study||5
8398361|NCT01014533|20698667|P1|NOT COMPLETED|Overall Study||5
8398362|NCT01014533|20698666|P2|COMPLETED|Overall Study||25
8398363|NCT01014533|20698667|P1|COMPLETED|Overall Study||24
8398364|NCT01014533|20698666|P2|STARTED|Overall Study||30
8398365|NCT01014533|20698667|P1|STARTED|Overall Study||29
8398366|NCT01014455|20698679|P2|NOT COMPLETED|Overall Study||0
8398367|NCT01014455|20698680|P1|NOT COMPLETED|Overall Study||0
8398368|NCT01014455|20698679|P2|COMPLETED|Overall Study||87
8398369|NCT01014455|20698680|P1|COMPLETED|Overall Study||82
8398370|NCT01014455|20698679|P2|STARTED|Overall Study||87
8398371|NCT01014455|20698680|P1|STARTED|Overall Study||82
8398372|NCT01014442|20698688|P2|NOT COMPLETED|Overall Study||19
8398373|NCT01014442|20698689|P1|NOT COMPLETED|Overall Study||7
8398374|NCT01014442|20698688|P2|COMPLETED|Overall Study||16
8398375|NCT01014442|20698689|P1|COMPLETED|Overall Study||26
8398376|NCT01014442|20698688|P2|STARTED|Overall Study||35
8398377|NCT01014442|20698689|P1|STARTED|Overall Study||33
8398378|NCT01014403|20698803|P2|NOT COMPLETED|Overall Study||0
8398379|NCT01014403|20698804|P1|NOT COMPLETED|Overall Study||0
8398380|NCT01014403|20698803|P2|COMPLETED|Overall Study||28
8398381|NCT01014403|20698804|P1|COMPLETED|Overall Study||34
8398382|NCT01014403|20698803|P2|STARTED|Overall Study||28
8398383|NCT01014403|20698804|P1|STARTED|Overall Study||34
8398384|NCT01014390|20698814|P1|NOT COMPLETED|Overall Study||10
8398385|NCT01014390|20698814|P1|COMPLETED|Overall Study||177
8398386|NCT01014390|20698814|P1|STARTED|Overall Study||187
8398387|NCT01014351|20698818|P1|NOT COMPLETED|Overall Study||37
8398388|NCT01014351|20698818|P1|COMPLETED|Overall Study||33
8398389|NCT01014351|20698818|P1|STARTED|Overall Study||70
8398390|NCT01014208|20698826|P2|NOT COMPLETED|Overall Study||100
8398391|NCT01014208|20698827|P1|NOT COMPLETED|Overall Study||94
8398392|NCT01014208|20698826|P2|COMPLETED|Overall Study||122
8398393|NCT01014208|20698827|P1|COMPLETED|Overall Study||131
8398394|NCT01014208|20698826|P2|Intent-to-Treat Population|Overall Study||222
8398395|NCT01014208|20698827|P1|Intent-to-Treat Population|Overall Study||223
8398396|NCT01014208|20698826|P2|STARTED|Overall Study||222
8398397|NCT01014208|20698827|P1|STARTED|Overall Study||225
8398398|NCT01014169|20698855|P2|NOT COMPLETED|Overall Study||13
8398399|NCT01014169|20698856|P1|NOT COMPLETED|Overall Study||7
8398400|NCT01014169|20698855|P2|COMPLETED|Overall Study||48
8398401|NCT01014169|20698856|P1|COMPLETED|Overall Study||58
8398402|NCT01014169|20698855|P2|STARTED|Overall Study||61
8398403|NCT01014169|20698856|P1|STARTED|Overall Study||65
8398404|NCT01014143|20698869|P3|NOT COMPLETED|Third Intervention||0
8398405|NCT01014143|20698870|P2|NOT COMPLETED|Third Intervention||0
8398406|NCT01014143|20698871|P1|NOT COMPLETED|Third Intervention||0
8398407|NCT01014143|20698869|P3|COMPLETED|Third Intervention||9
8398408|NCT01014143|20698870|P2|COMPLETED|Third Intervention||9
8398409|NCT01014143|20698871|P1|COMPLETED|Third Intervention||8
8398410|NCT01014143|20698869|P3|STARTED|Third Intervention||9
8398411|NCT01014143|20698870|P2|STARTED|Third Intervention||9
8398412|NCT01014143|20698871|P1|STARTED|Third Intervention||8
8398413|NCT01014143|20698869|P3|NOT COMPLETED|Washout After 2nd Intervention||0
8398414|NCT01014143|20698870|P2|NOT COMPLETED|Washout After 2nd Intervention||0
8398415|NCT01014143|20698871|P1|NOT COMPLETED|Washout After 2nd Intervention||0
8398416|NCT01014143|20698869|P3|COMPLETED|Washout After 2nd Intervention||9
8398417|NCT01014143|20698870|P2|COMPLETED|Washout After 2nd Intervention||9
8398418|NCT01014143|20698871|P1|COMPLETED|Washout After 2nd Intervention||8
8398419|NCT01014143|20698869|P3|STARTED|Washout After 2nd Intervention||9
8398420|NCT01014143|20698870|P2|STARTED|Washout After 2nd Intervention||9
8398421|NCT01014143|20698871|P1|STARTED|Washout After 2nd Intervention||8
8398422|NCT01014143|20698869|P3|NOT COMPLETED|Second Intervention||0
8398423|NCT01014143|20698870|P2|NOT COMPLETED|Second Intervention||0
8398424|NCT01014143|20698871|P1|NOT COMPLETED|Second Intervention||2
8398425|NCT01014143|20698869|P3|COMPLETED|Second Intervention||9
8398426|NCT01014143|20698870|P2|COMPLETED|Second Intervention||9
8398427|NCT01014143|20698871|P1|COMPLETED|Second Intervention||8
8398428|NCT01014143|20698869|P3|STARTED|Second Intervention||9
8398429|NCT01014143|20698870|P2|STARTED|Second Intervention||9
8398430|NCT01014143|20698871|P1|STARTED|Second Intervention||10
8398431|NCT01014143|20698869|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
8398432|NCT01014143|20698870|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
8398433|NCT01014143|20698871|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
8398434|NCT01014143|20698869|P3|COMPLETED|Washout Period After 1st Intervention||9
8398435|NCT01014143|20698870|P2|COMPLETED|Washout Period After 1st Intervention||9
8398436|NCT01014143|20698871|P1|COMPLETED|Washout Period After 1st Intervention||10
8398437|NCT01014143|20698869|P3|STARTED|Washout Period After 1st Intervention||9
8398438|NCT01014143|20698870|P2|STARTED|Washout Period After 1st Intervention||9
8398439|NCT01014143|20698871|P1|STARTED|Washout Period After 1st Intervention||10
8398440|NCT01014143|20698869|P3|NOT COMPLETED|First Intervention||0
8398441|NCT01014143|20698870|P2|NOT COMPLETED|First Intervention||0
8398442|NCT01014143|20698871|P1|NOT COMPLETED|First Intervention||0
8398443|NCT01014143|20698869|P3|COMPLETED|First Intervention||9
8398444|NCT01014143|20698870|P2|COMPLETED|First Intervention||9
8398445|NCT01014143|20698871|P1|COMPLETED|First Intervention||10
8398446|NCT01014143|20698869|P3|STARTED|First Intervention||9
8398447|NCT01014143|20698870|P2|STARTED|First Intervention||9
8398448|NCT01014143|20698871|P1|STARTED|First Intervention||10
8398449|NCT01014091|20698885|P6|NOT COMPLETED|Overall Study||0
8398450|NCT01014091|20698886|P5|NOT COMPLETED|Overall Study||0
8398451|NCT01014091|20698887|P4|NOT COMPLETED|Overall Study||0
8398452|NCT01014091|20698888|P3|NOT COMPLETED|Overall Study||0
8398453|NCT01014091|20698889|P2|NOT COMPLETED|Overall Study||0
8398454|NCT01014091|20698890|P1|NOT COMPLETED|Overall Study||0
8398455|NCT01014091|20698885|P6|COMPLETED|Overall Study||12
8398456|NCT01014091|20698886|P5|COMPLETED|Overall Study||6
8398457|NCT01014091|20698887|P4|COMPLETED|Overall Study||15
8398458|NCT01014091|20698888|P3|COMPLETED|Overall Study||5
8398459|NCT01014091|20698889|P2|COMPLETED|Overall Study||13
8398460|NCT01014091|20698890|P1|COMPLETED|Overall Study||7
8398461|NCT01014091|20698885|P6|STARTED|Overall Study||12
8398462|NCT01014091|20698886|P5|STARTED|Overall Study||6
8398463|NCT01014091|20698887|P4|STARTED|Overall Study||15
8398464|NCT01014091|20698888|P3|STARTED|Overall Study||5
8398465|NCT01014091|20698889|P2|STARTED|Overall Study||13
8398466|NCT01014091|20698890|P1|STARTED|Overall Study||7
8398467|NCT01014013|20698966|P2|NOT COMPLETED|Overall Study||56
8398468|NCT01014013|20698967|P1|NOT COMPLETED|Overall Study||51
8398469|NCT01014013|20698966|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
8398470|NCT01014013|20698967|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
8398471|NCT01014013|20698966|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
8398472|NCT01014013|20698967|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous
~infusion at least 3 days"|87
8398473|NCT01014013|20698966|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
8398474|NCT01014013|20698967|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
8398475|NCT01014013|20698966|P2|STARTED|Overall Study||136
8398476|NCT01014013|20698967|P1|STARTED|Overall Study||135
8398477|NCT01013961|20698979|P2|NOT COMPLETED|Overall Study||3
8398478|NCT01013961|20698980|P1|NOT COMPLETED|Overall Study||3
8398479|NCT01013961|20698979|P2|COMPLETED|Overall Study||12
8398480|NCT01013961|20698980|P1|COMPLETED|Overall Study||13
8398481|NCT01013961|20698979|P2|STARTED|Overall Study||15
8398482|NCT01013961|20698980|P1|STARTED|Overall Study||16
8398483|NCT01013883|20698998|P2|NOT COMPLETED|Overall Study||2
8398484|NCT01013883|20698999|P1|NOT COMPLETED|Overall Study||2
8398485|NCT01013883|20698998|P2|COMPLETED|Overall Study||241
8398486|NCT01013883|20698999|P1|COMPLETED|Overall Study||268
8398487|NCT01013883|20698998|P2|STARTED|Overall Study||243
8398488|NCT01013883|20698999|P1|STARTED|Overall Study||270
8398489|NCT01013870|20699011|P2|NOT COMPLETED|Overall Study||3
8398490|NCT01013870|20699012|P1|NOT COMPLETED|Overall Study||1
8398491|NCT01013870|20699011|P2|COMPLETED|Overall Study||21
8398492|NCT01013870|20699012|P1|COMPLETED|Overall Study||27
8398493|NCT01013870|20699011|P2|STARTED|Overall Study||24
8398494|NCT01013870|20699012|P1|STARTED|Overall Study||28
8398495|NCT01013844|20699036|P2|NOT COMPLETED|Overall Study||0
8398496|NCT01013844|20699037|P1|NOT COMPLETED|Overall Study||0
8398497|NCT01013844|20699036|P2|COMPLETED|Overall Study||65
8398498|NCT01013844|20699037|P1|COMPLETED|Overall Study||65
8398499|NCT01013844|20699036|P2|STARTED|Overall Study||65
8398500|NCT01013844|20699037|P1|STARTED|Overall Study||65
8398501|NCT01013792|20699061|P2|NOT COMPLETED|Overall Study||5
8398502|NCT01013792|20699062|P1|NOT COMPLETED|Overall Study||2
8398503|NCT01013792|20699061|P2|COMPLETED|Overall Study||11
8398504|NCT01013792|20699062|P1|COMPLETED|Overall Study||12
8398505|NCT01013792|20699061|P2|STARTED|Overall Study||16
8398506|NCT01013792|20699062|P1|STARTED|Overall Study||14
8398507|NCT01013753|20699068|P1|NOT COMPLETED|Overall Study||16
8398508|NCT01013753|20699068|P1|COMPLETED|Overall Study||182
8398509|NCT01013753|20699068|P1|Received Form 12 mcg Bid|Overall Study||125
8398510|NCT01013753|20699068|P1|Received Olo 20 mcg qd|Overall Study||124
8398511|NCT01013753|20699068|P1|Received Olo 10 mcg qd|Overall Study||127
8398512|NCT01013753|20699068|P1|Received Olo 5 mcg qd|Overall Study||130
8398513|NCT01013753|20699068|P1|Received Olo 2 mcg qd|Overall Study||121
8398514|NCT01013753|20699068|P1|Received Placebo|Overall Study||125
8398515|NCT01013753|20699068|P1|STARTED|Overall Study|Entered and treated|198
8398516|NCT01013740|20699264|P2|NOT COMPLETED|Overall Study||19
8398517|NCT01013740|20699265|P1|NOT COMPLETED|Overall Study||11
8398518|NCT01013740|20699264|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
8398519|NCT01013740|20699265|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
8398520|NCT01013740|20699264|P2|Ongoing|Overall Study||0
8398521|NCT01013740|20699265|P1|Ongoing|Overall Study||0
8398522|NCT01013740|20699264|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
8398523|NCT01013740|20699265|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
8398524|NCT01013701|20699289|P1|NOT COMPLETED|Overall Study||7
8398525|NCT01013701|20699289|P1|COMPLETED|Overall Study||0
8398526|NCT01013701|20699289|P1|STARTED|Overall Study||7
8398527|NCT01013597|20699296|P1|NOT COMPLETED|Overall Study||1
8398528|NCT01013597|20699296|P1|COMPLETED|Overall Study||12
8398529|NCT01013597|20699296|P1|STARTED|Overall Study||13
8398530|NCT01013350|20699308|P2|NOT COMPLETED|Overall Study||192
8398531|NCT01013350|20699309|P1|NOT COMPLETED|Overall Study||38
8398532|NCT01013350|20699308|P2|COMPLETED|Overall Study||771
8398533|NCT01013350|20699309|P1|COMPLETED|Overall Study||160
8398534|NCT01013350|20699308|P2|Safety Analysis Set|Overall Study||950
8398535|NCT01013350|20699309|P1|Safety Analysis Set|Overall Study||198
8398536|NCT01013350|20699308|P2|STARTED|Overall Study||963
8398537|NCT01013350|20699309|P1|STARTED|Overall Study||198
8398538|NCT01013285|20699322|P2|NOT COMPLETED|Overall Study||89
8398539|NCT01013285|20699323|P1|NOT COMPLETED|Overall Study||48
8398540|NCT01013285|20699322|P2|COMPLETED|Overall Study||21
8398541|NCT01013285|20699323|P1|COMPLETED|Overall Study||22
8398542|NCT01013285|20699322|P2|STARTED|Overall Study||110
8398543|NCT01013285|20699323|P1|STARTED|Overall Study||70
8398544|NCT01013207|20699336|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
8398545|NCT01013207|20699336|P1|COMPLETED|CPAP Post Nexus (S9)||44
8398546|NCT01013207|20699336|P1|STARTED|CPAP Post Nexus (S9)||50
8398547|NCT01013207|20699336|P1|NOT COMPLETED|Nexus (S9)||0
8398548|NCT01013207|20699336|P1|COMPLETED|Nexus (S9)||50
8398549|NCT01013207|20699336|P1|STARTED|Nexus (S9)||50
8398550|NCT01013207|20699336|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
8398551|NCT01013207|20699336|P1|COMPLETED|CPAP Pre Nexus (S9)||50
8398552|NCT01013207|20699336|P1|STARTED|CPAP Pre Nexus (S9)||50
8398553|NCT01013194|20699343|P2|NOT COMPLETED|Overall Study||0
8398554|NCT01013194|20699344|P1|NOT COMPLETED|Overall Study||0
8398555|NCT01013194|20699343|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
8398556|NCT01013194|20699344|P1|COMPLETED|Overall Study|Consecutive patients|9
8398557|NCT01013194|20699343|P2|STARTED|Overall Study||16
8398558|NCT01013194|20699344|P1|STARTED|Overall Study||9
8398559|NCT01012999|20699354|P1|NOT COMPLETED|Overall Study||1
8398560|NCT01012999|20699354|P1|COMPLETED|Overall Study||15
8398561|NCT01012999|20699354|P1|STARTED|Overall Study||16
8398562|NCT01012973|20699360|P2|NOT COMPLETED|Overall Study||19
8398563|NCT01012973|20699361|P1|NOT COMPLETED|Overall Study||16
8398564|NCT01012973|20699360|P2|COMPLETED|Overall Study||52
8398565|NCT01012973|20699361|P1|COMPLETED|Overall Study||90
8398566|NCT01012973|20699360|P2|Completed Week 52, From FAS|Overall Study||52
8398567|NCT01012973|20699361|P1|Completed Week 52, From FAS|Overall Study||91
8398568|NCT01012973|20699360|P2|Completed Week 24, From FAS|Overall Study||57
8398569|NCT01012973|20699361|P1|Completed Week 24, From FAS|Overall Study||97
8398570|NCT01012973|20699360|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
8398571|NCT01012973|20699361|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
8398572|NCT01012973|20699360|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
8398573|NCT01012973|20699361|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
8398574|NCT01012973|20699360|P2|STARTED|Overall Study||71
8398575|NCT01012973|20699361|P1|STARTED|Overall Study||106
8398576|NCT01012947|20699386|P5|NOT COMPLETED|Overall Study||142
8398577|NCT01012947|20699387|P4|NOT COMPLETED|Overall Study||118
8398578|NCT01012947|20699388|P3|NOT COMPLETED|Overall Study||130
8398579|NCT01012947|20699389|P2|NOT COMPLETED|Overall Study||135
8398580|NCT01012947|20699390|P1|NOT COMPLETED|Overall Study||131
8398581|NCT01012947|20699386|P5|COMPLETED|Overall Study||94
8398582|NCT01012947|20699387|P4|COMPLETED|Overall Study||93
8398583|NCT01012947|20699388|P3|COMPLETED|Overall Study||111
8398584|NCT01012947|20699389|P2|COMPLETED|Overall Study||80
8398585|NCT01012947|20699390|P1|COMPLETED|Overall Study||81
8398586|NCT01012947|20699386|P5|STARTED|Overall Study||236
8398587|NCT01012947|20699387|P4|STARTED|Overall Study||211
8398588|NCT01012947|20699388|P3|STARTED|Overall Study||241
8398589|NCT01012947|20699389|P2|STARTED|Overall Study||215
8398590|NCT01012947|20699390|P1|STARTED|Overall Study||212
8398591|NCT01012921|20699404|P2|NOT COMPLETED|Overall Study||13
8398592|NCT01012921|20699405|P1|NOT COMPLETED|Overall Study||10
8398593|NCT01012921|20699404|P2|COMPLETED|Overall Study||47
8398594|NCT01012921|20699405|P1|COMPLETED|Overall Study||47
8398595|NCT01012921|20699404|P2|STARTED|Overall Study||60
8398596|NCT01012921|20699405|P1|STARTED|Overall Study||57
8398597|NCT01012765|20699411|P6|NOT COMPLETED|Treatment Period 3||0
8398598|NCT01012765|20699412|P5|NOT COMPLETED|Treatment Period 3||0
8398599|NCT01012765|20699413|P4|NOT COMPLETED|Treatment Period 3||0
8398600|NCT01012765|20699414|P3|NOT COMPLETED|Treatment Period 3||0
8398601|NCT01012765|20699415|P2|NOT COMPLETED|Treatment Period 3||0
8398602|NCT01012765|20699416|P1|NOT COMPLETED|Treatment Period 3||0
8398603|NCT01012765|20699411|P6|COMPLETED|Treatment Period 3||24
8398604|NCT01012765|20699412|P5|COMPLETED|Treatment Period 3||18
8398605|NCT01012765|20699413|P4|COMPLETED|Treatment Period 3||15
8398606|NCT01012765|20699414|P3|COMPLETED|Treatment Period 3||18
8398607|NCT01012765|20699415|P2|COMPLETED|Treatment Period 3||19
8398608|NCT01012765|20699416|P1|COMPLETED|Treatment Period 3||16
8398609|NCT01012765|20699411|P6|STARTED|Treatment Period 3||24
8398610|NCT01012765|20699412|P5|STARTED|Treatment Period 3||18
8398611|NCT01012765|20699413|P4|STARTED|Treatment Period 3||15
8398612|NCT01012765|20699414|P3|STARTED|Treatment Period 3||18
8398613|NCT01012765|20699415|P2|STARTED|Treatment Period 3||19
8398614|NCT01012765|20699416|P1|STARTED|Treatment Period 3||16
8398615|NCT01012765|20699411|P6|NOT COMPLETED|Treatment Period 2||1
8398616|NCT01012765|20699412|P5|NOT COMPLETED|Treatment Period 2||1
8398617|NCT01012765|20699413|P4|NOT COMPLETED|Treatment Period 2||0
8398618|NCT01012765|20699414|P3|NOT COMPLETED|Treatment Period 2||3
8398619|NCT01012765|20699415|P2|NOT COMPLETED|Treatment Period 2||2
8398620|NCT01012765|20699416|P1|NOT COMPLETED|Treatment Period 2||1
8398621|NCT01012765|20699411|P6|COMPLETED|Treatment Period 2||24
8398622|NCT01012765|20699412|P5|COMPLETED|Treatment Period 2||18
8398623|NCT01012765|20699413|P4|COMPLETED|Treatment Period 2||15
8398624|NCT01012765|20699414|P3|COMPLETED|Treatment Period 2||18
8398625|NCT01012765|20699415|P2|COMPLETED|Treatment Period 2||19
8398626|NCT01012765|20699416|P1|COMPLETED|Treatment Period 2||16
8398627|NCT01012765|20699411|P6|STARTED|Treatment Period 2||25
8398628|NCT01012765|20699412|P5|STARTED|Treatment Period 2||19
8398629|NCT01012765|20699413|P4|STARTED|Treatment Period 2||15
8398630|NCT01012765|20699414|P3|STARTED|Treatment Period 2||21
8398631|NCT01012765|20699415|P2|STARTED|Treatment Period 2||21
8398632|NCT01012765|20699416|P1|STARTED|Treatment Period 2||17
8398633|NCT01012765|20699411|P6|NOT COMPLETED|Treatment Period 1||0
8398634|NCT01012765|20699412|P5|NOT COMPLETED|Treatment Period 1||3
8398635|NCT01012765|20699413|P4|NOT COMPLETED|Treatment Period 1||3
8398636|NCT01012765|20699414|P3|NOT COMPLETED|Treatment Period 1||2
8398637|NCT01012765|20699415|P2|NOT COMPLETED|Treatment Period 1||0
8398638|NCT01012765|20699416|P1|NOT COMPLETED|Treatment Period 1||3
8398639|NCT01012765|20699411|P6|COMPLETED|Treatment Period 1||25
8398640|NCT01012765|20699412|P5|COMPLETED|Treatment Period 1||19
8398641|NCT01012765|20699413|P4|COMPLETED|Treatment Period 1||15
8398642|NCT01012765|20699414|P3|COMPLETED|Treatment Period 1||21
8398643|NCT01012765|20699415|P2|COMPLETED|Treatment Period 1||21
8398644|NCT01012765|20699416|P1|COMPLETED|Treatment Period 1||17
8398645|NCT01012765|20699411|P6|STARTED|Treatment Period 1||25
8398646|NCT01012765|20699412|P5|STARTED|Treatment Period 1||22
8398647|NCT01012765|20699413|P4|STARTED|Treatment Period 1||18
8398648|NCT01012765|20699414|P3|STARTED|Treatment Period 1||23
8398649|NCT01012765|20699415|P2|STARTED|Treatment Period 1||21
8398650|NCT01012765|20699416|P1|STARTED|Treatment Period 1||20
8398651|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 4||0
8398652|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 4||0
8398653|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 4||0
8398654|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 4||0
8398655|NCT01012739|20699445|P4|COMPLETED|Treatment Period 4||7
8398656|NCT01012739|20699446|P3|COMPLETED|Treatment Period 4||9
8398657|NCT01012739|20699447|P2|COMPLETED|Treatment Period 4||8
8398658|NCT01012739|20699448|P1|COMPLETED|Treatment Period 4||9
8398659|NCT01012739|20699445|P4|STARTED|Treatment Period 4||7
8398660|NCT01012739|20699446|P3|STARTED|Treatment Period 4||9
8398661|NCT01012739|20699447|P2|STARTED|Treatment Period 4||8
8398662|NCT01012739|20699448|P1|STARTED|Treatment Period 4||9
8398663|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 3||0
8398664|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 3||0
8398665|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 3||0
8398666|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 3||0
8398667|NCT01012739|20699445|P4|COMPLETED|Treatment Period 3||7
8398668|NCT01012739|20699446|P3|COMPLETED|Treatment Period 3||9
8398669|NCT01012739|20699447|P2|COMPLETED|Treatment Period 3||8
8398670|NCT01012739|20699448|P1|COMPLETED|Treatment Period 3||9
8398671|NCT01012739|20699445|P4|STARTED|Treatment Period 3||7
8398672|NCT01012739|20699446|P3|STARTED|Treatment Period 3||9
8398673|NCT01012739|20699447|P2|STARTED|Treatment Period 3||8
8398674|NCT01012739|20699448|P1|STARTED|Treatment Period 3||9
8398675|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 2||1
8398676|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 2||0
8398677|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 2||0
8398678|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 2||0
8398679|NCT01012739|20699445|P4|COMPLETED|Treatment Period 2||7
8398680|NCT01012739|20699446|P3|COMPLETED|Treatment Period 2||9
8398681|NCT01012739|20699447|P2|COMPLETED|Treatment Period 2||8
8398682|NCT01012739|20699448|P1|COMPLETED|Treatment Period 2||9
8398683|NCT01012739|20699445|P4|STARTED|Treatment Period 2||8
8398684|NCT01012739|20699446|P3|STARTED|Treatment Period 2||9
8398685|NCT01012739|20699447|P2|STARTED|Treatment Period 2||8
8398686|NCT01012739|20699448|P1|STARTED|Treatment Period 2||9
8398687|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 1||1
8398688|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 1||0
8398689|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 1||0
8398690|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 1||0
8398691|NCT01012739|20699445|P4|COMPLETED|Treatment Period 1||8
8398692|NCT01012739|20699446|P3|COMPLETED|Treatment Period 1||9
8398693|NCT01012739|20699447|P2|COMPLETED|Treatment Period 1||8
8398694|NCT01012739|20699448|P1|COMPLETED|Treatment Period 1||9
8398695|NCT01012739|20699445|P4|STARTED|Treatment Period 1||9
8398696|NCT01012739|20699446|P3|STARTED|Treatment Period 1||9
8398697|NCT01012739|20699447|P2|STARTED|Treatment Period 1||8
8398698|NCT01012739|20699448|P1|STARTED|Treatment Period 1||9
8398699|NCT01012713|20699476|P1|NOT COMPLETED|Overall Study||3
8398700|NCT01012713|20699476|P1|COMPLETED|Overall Study||27
8398701|NCT01012713|20699476|P1|STARTED|Overall Study||30
8398702|NCT01012674|20699482|P1|NOT COMPLETED|Overall Study||24
8398703|NCT01012674|20699482|P1|COMPLETED|Overall Study||187
8398704|NCT01012674|20699482|P1|STARTED|Overall Study||211
8398705|NCT01012661|20699494|P1|NOT COMPLETED|Overall Study||0
8398706|NCT01012661|20699494|P1|COMPLETED|Overall Study||50
8398707|NCT01012661|20699494|P1|STARTED|Overall Study||50
8398708|NCT01012622|20699502|P1|NOT COMPLETED|Overall Study||31
8398709|NCT01012622|20699502|P1|COMPLETED|Overall Study||111
8398710|NCT01012622|20699502|P1|STARTED|Overall Study||142
8398711|NCT01012492|20699521|P1|NOT COMPLETED|Overall Study||0
8398712|NCT01012492|20699521|P1|COMPLETED|Overall Study||10
8398713|NCT01012492|20699521|P1|STARTED|Overall Study||10
8398714|NCT01012440|20699528|P1|NOT COMPLETED|Overall Study||2
8398715|NCT01012440|20699528|P1|COMPLETED|Overall Study||3
8398716|NCT01012440|20699528|P1|STARTED|Overall Study||5
8398717|NCT01012414|20699532|P1|NOT COMPLETED|Overall Study||10
8398718|NCT01012414|20699532|P1|COMPLETED|Overall Study|No subjects completed the study.|0
8398719|NCT01012414|20699532|P1|STARTED|Overall Study||10
8398720|NCT01012388|20699539|P1|NOT COMPLETED|Overall Study||0
8398721|NCT01012388|20699539|P1|COMPLETED|Overall Study||100
8398722|NCT01012388|20699539|P1|STARTED|Overall Study||100
8398723|NCT01012362|20699549|P5|NOT COMPLETED|Overall Study||0
8398724|NCT01012362|20699550|P4|NOT COMPLETED|Overall Study||0
8398725|NCT01012362|20699551|P3|NOT COMPLETED|Overall Study||0
8398726|NCT01012362|20699552|P2|NOT COMPLETED|Overall Study||0
8398727|NCT01012362|20699553|P1|NOT COMPLETED|Overall Study||0
8398728|NCT01012362|20699549|P5|COMPLETED|Overall Study||9
8398729|NCT01012362|20699550|P4|COMPLETED|Overall Study||4
8398730|NCT01012362|20699551|P3|COMPLETED|Overall Study||3
8398731|NCT01012362|20699552|P2|COMPLETED|Overall Study||6
8398732|NCT01012362|20699553|P1|COMPLETED|Overall Study||9
8398733|NCT01012362|20699549|P5|STARTED|Overall Study||9
8398734|NCT01012362|20699550|P4|STARTED|Overall Study||4
8398735|NCT01012362|20699551|P3|STARTED|Overall Study||3
8398736|NCT01012362|20699552|P2|STARTED|Overall Study||6
8398737|NCT01012362|20699553|P1|STARTED|Overall Study||9
8398738|NCT01012336|20699569|P1|NOT COMPLETED|Overall Study||0
8398739|NCT01012336|20699569|P1|COMPLETED|Overall Study||85
8398740|NCT01012336|20699569|P1|STARTED|Overall Study||85
8398741|NCT01012323|20699573|P1|NOT COMPLETED|Overall Study||1
8398742|NCT01012323|20699573|P1|COMPLETED|Overall Study||50
8398743|NCT01012323|20699573|P1|STARTED|Overall Study||51
8398744|NCT01012297|20699597|P2|NOT COMPLETED|Overall Study||0
8398745|NCT01012297|20699598|P1|NOT COMPLETED|Overall Study||0
8398746|NCT01012297|20699597|P2|COMPLETED|Overall Study||53
8398747|NCT01012297|20699598|P1|COMPLETED|Overall Study||54
8398748|NCT01012297|20699597|P2|STARTED|Overall Study||53
8398749|NCT01012297|20699598|P1|STARTED|Overall Study||54
8398750|NCT01012258|20699610|P1|NOT COMPLETED|Overall Study||66
8398751|NCT01012258|20699610|P1|COMPLETED|Overall Study||0
8398752|NCT01012258|20699610|P1|STARTED|Overall Study||66
8398756|NCT01012219|20699657|P1|NOT COMPLETED|Period 3||0
8398757|NCT01012219|20699657|P1|COMPLETED|Period 3||20
8398758|NCT01012219|20699657|P1|STARTED|Period 3|of the 36 who started Period 1|20
8398759|NCT01012219|20699657|P1|NOT COMPLETED|Period 2||1
8398760|NCT01012219|20699657|P1|COMPLETED|Period 2||34
8398761|NCT01012219|20699657|P1|STARTED|Period 2|Number who completed Period 1|35
8398762|NCT01012219|20699657|P1|NOT COMPLETED|Period 1||1
8398763|NCT01012219|20699657|P1|COMPLETED|Period 1||35
8398764|NCT01012219|20699657|P1|STARTED|Period 1|Number randomized|36
8398765|NCT01012167|20699667|P3|NOT COMPLETED|Overall Study||4
8398766|NCT01012167|20699668|P2|NOT COMPLETED|Overall Study||2
8398767|NCT01012167|20699669|P1|NOT COMPLETED|Overall Study||2
8398768|NCT01012167|20699667|P3|COMPLETED|Overall Study||17
8398769|NCT01012167|20699668|P2|COMPLETED|Overall Study||18
8398770|NCT01012167|20699669|P1|COMPLETED|Overall Study||15
8398771|NCT01012167|20699667|P3|Exposed to Study Drug|Overall Study||20
8398772|NCT01012167|20699668|P2|Exposed to Study Drug|Overall Study||20
8398773|NCT01012167|20699669|P1|Exposed to Study Drug|Overall Study||16
8398774|NCT01012167|20699667|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
8398775|NCT01012167|20699668|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
8398776|NCT01012167|20699669|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
8398777|NCT01012167|20699667|P3|STARTED|Overall Study||21
8398778|NCT01012167|20699668|P2|STARTED|Overall Study||20
8398779|NCT01012167|20699669|P1|STARTED|Overall Study||17
8398780|NCT01012089|20699925|P1|NOT COMPLETED|Overall Study||0
8398781|NCT01012089|20699925|P1|COMPLETED|Overall Study||6
8398782|NCT01012089|20699925|P1|STARTED|Overall Study||6
8398783|NCT01012037|20699948|P3|NOT COMPLETED|Overall Study||10
8398784|NCT01012037|20699949|P2|NOT COMPLETED|Overall Study||16
8398785|NCT01012037|20699950|P1|NOT COMPLETED|Overall Study||1
8398786|NCT01012037|20699948|P3|COMPLETED|Overall Study||214
8398787|NCT01012037|20699949|P2|COMPLETED|Overall Study||207
8398788|NCT01012037|20699950|P1|COMPLETED|Overall Study||43
8398789|NCT01012037|20699948|P3|STARTED|Overall Study||224
8398790|NCT01012037|20699949|P2|STARTED|Overall Study||223
8398791|NCT01012037|20699950|P1|STARTED|Overall Study||44
8398792|NCT01011946|20699985|P1|NOT COMPLETED|Overall Study||3
8398793|NCT01011946|20699985|P1|COMPLETED|Overall Study||33
8398794|NCT01011946|20699985|P1|STARTED|Overall Study||36
8398795|NCT01011933|20699989|P1|NOT COMPLETED|Overall Study||4
8398796|NCT01011933|20699989|P1|COMPLETED|Overall Study|total eligible and evaluable|50
8398797|NCT01011933|20699989|P1|STARTED|Overall Study|total enrolled|54
8398798|NCT01011907|20700006|P2|NOT COMPLETED|Overall Study||15
8398799|NCT01011907|20700007|P1|NOT COMPLETED|Overall Study||14
8398800|NCT01011907|20700006|P2|COMPLETED|Overall Study||18
8398801|NCT01011907|20700007|P1|COMPLETED|Overall Study||17
8398802|NCT01011907|20700006|P2|STARTED|Overall Study||33
8398803|NCT01011907|20700007|P1|STARTED|Overall Study||31
8398804|NCT01011894|20700017|P1|NOT COMPLETED|Overall Study||0
8398805|NCT01011894|20700017|P1|COMPLETED|Overall Study||26
8398806|NCT01011894|20700017|P1|STARTED|Overall Study||26
8398807|NCT01011868|20700024|P3|NOT COMPLETED|After Week 78 Follow-up||44
8398808|NCT01011868|20700025|P2|NOT COMPLETED|After Week 78 Follow-up||38
8398809|NCT01011868|20700026|P1|NOT COMPLETED|After Week 78 Follow-up||52
8398810|NCT01011868|20700024|P3|COMPLETED|After Week 78 Follow-up||111
8398811|NCT01011868|20700025|P2|COMPLETED|After Week 78 Follow-up||131
8398812|NCT01011868|20700026|P1|COMPLETED|After Week 78 Follow-up||118
8398813|NCT01011868|20700024|P3|STARTED|After Week 78 Follow-up||155
8398814|NCT01011868|20700025|P2|STARTED|After Week 78 Follow-up||169
8398815|NCT01011868|20700026|P1|STARTED|After Week 78 Follow-up||170
8398816|NCT01011868|20700024|P3|NOT COMPLETED|After Week 18 Follow-up||26
8398817|NCT01011868|20700025|P2|NOT COMPLETED|After Week 18 Follow-up||16
8398818|NCT01011868|20700026|P1|NOT COMPLETED|After Week 18 Follow-up||23
8398819|NCT01011868|20700024|P3|COMPLETED|After Week 18 Follow-up||129
8398820|NCT01011868|20700025|P2|COMPLETED|After Week 18 Follow-up||153
8398821|NCT01011868|20700026|P1|COMPLETED|After Week 18 Follow-up||147
8398822|NCT01011868|20700024|P3|STARTED|After Week 18 Follow-up||155
8398823|NCT01011868|20700025|P2|STARTED|After Week 18 Follow-up||169
8398824|NCT01011868|20700026|P1|STARTED|After Week 18 Follow-up||170
8398825|NCT01011829|20700063|P2|NOT COMPLETED|Overall Study||9
8398826|NCT01011829|20700064|P1|NOT COMPLETED|Overall Study||4
8398827|NCT01011829|20700063|P2|COMPLETED|Overall Study||1
8398828|NCT01011829|20700064|P1|COMPLETED|Overall Study||6
8398829|NCT01011829|20700063|P2|STARTED|Overall Study||10
8398830|NCT01011829|20700064|P1|STARTED|Overall Study||10
8398831|NCT01011816|20700074|P2|NOT COMPLETED|78-Week Extended Follow-up||28
8398832|NCT01011816|20700075|P1|NOT COMPLETED|78-Week Extended Follow-up||72
8398833|NCT01011816|20700074|P2|COMPLETED|78-Week Extended Follow-up||26
8398834|NCT01011816|20700075|P1|COMPLETED|78-Week Extended Follow-up||85
8398835|NCT01011816|20700074|P2|STARTED|78-Week Extended Follow-up||54
8398836|NCT01011816|20700075|P1|STARTED|78-Week Extended Follow-up||157
8398837|NCT01011816|20700074|P2|NOT COMPLETED|26-Week Primary Endpoint||2
8398838|NCT01011816|20700075|P1|NOT COMPLETED|26-Week Primary Endpoint||7
8398839|NCT01011816|20700074|P2|COMPLETED|26-Week Primary Endpoint||54
8398840|NCT01011816|20700075|P1|COMPLETED|26-Week Primary Endpoint||157
8398841|NCT01011816|20700074|P2|STARTED|26-Week Primary Endpoint||56
8398842|NCT01011816|20700075|P1|STARTED|26-Week Primary Endpoint||164
8398843|NCT01011738|20700088|P3|NOT COMPLETED|Overall Study||17
8398844|NCT01011738|20700089|P2|NOT COMPLETED|Overall Study||294
8398845|NCT01011738|20700090|P1|NOT COMPLETED|Overall Study||324
8398846|NCT01011738|20700088|P3|COMPLETED|Overall Study||36
8398847|NCT01011738|20700089|P2|COMPLETED|Overall Study||618
8398848|NCT01011738|20700090|P1|COMPLETED|Overall Study||553
8398849|NCT01011738|20700088|P3|STARTED|Overall Study||53
8398850|NCT01011738|20700089|P2|STARTED|Overall Study||912
8398851|NCT01011738|20700090|P1|STARTED|Overall Study||877
8398852|NCT01011673|20700130|P2|NOT COMPLETED|24 Hour Follow-up||3
8398853|NCT01011673|20700131|P1|NOT COMPLETED|24 Hour Follow-up||3
8398854|NCT01011673|20700130|P2|COMPLETED|24 Hour Follow-up||57
8398855|NCT01011673|20700131|P1|COMPLETED|24 Hour Follow-up||57
8398856|NCT01011673|20700130|P2|STARTED|24 Hour Follow-up||60
8398857|NCT01011673|20700131|P1|STARTED|24 Hour Follow-up||60
8398858|NCT01011673|20700130|P2|NOT COMPLETED|Emergency Department Portion||0
8398859|NCT01011673|20700131|P1|NOT COMPLETED|Emergency Department Portion||0
8398860|NCT01011673|20700130|P2|COMPLETED|Emergency Department Portion||60
8398861|NCT01011673|20700131|P1|COMPLETED|Emergency Department Portion||60
8398862|NCT01011673|20700130|P2|STARTED|Emergency Department Portion||60
8398863|NCT01011673|20700131|P1|STARTED|Emergency Department Portion||60
8398864|NCT01011673|20700130|P2|NOT COMPLETED|Randomized||1
8398865|NCT01011673|20700131|P1|NOT COMPLETED|Randomized||2
8398866|NCT01011673|20700130|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
8398867|NCT01011673|20700131|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
8398868|NCT01011673|20700130|P2|STARTED|Randomized||61
8398869|NCT01011673|20700131|P1|STARTED|Randomized||62
8398870|NCT01011634|20700141|P2|NOT COMPLETED|Overall Study||1
8398871|NCT01011634|20700142|P1|NOT COMPLETED|Overall Study||0
8398872|NCT01011634|20700141|P2|COMPLETED|Overall Study||8
8398873|NCT01011634|20700142|P1|COMPLETED|Overall Study||9
8398874|NCT01011634|20700141|P2|STARTED|Overall Study||9
8398875|NCT01011634|20700142|P1|STARTED|Overall Study||9
8398876|NCT01011556|20700154|P4|NOT COMPLETED|Overall Study||13
8398877|NCT01011556|20700155|P3|NOT COMPLETED|Overall Study||10
8398878|NCT01011556|20700156|P2|NOT COMPLETED|Overall Study||8
8398879|NCT01011556|20700157|P1|NOT COMPLETED|Overall Study||6
8398880|NCT01011556|20700154|P4|COMPLETED|Overall Study||51
8398881|NCT01011556|20700155|P3|COMPLETED|Overall Study||45
8398882|NCT01011556|20700156|P2|COMPLETED|Overall Study||48
8398883|NCT01011556|20700157|P1|COMPLETED|Overall Study||52
8398884|NCT01011556|20700154|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
8398885|NCT01011556|20700155|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
8398886|NCT01011556|20700156|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
8398887|NCT01011556|20700157|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
8398888|NCT01011556|20700154|P4|STARTED|Overall Study||64
8398889|NCT01011556|20700155|P3|STARTED|Overall Study||55
8398890|NCT01011556|20700156|P2|STARTED|Overall Study||56
8398891|NCT01011556|20700157|P1|STARTED|Overall Study||58
8398892|NCT01011465|20700235|P8|NOT COMPLETED|Overall Study||0
8398893|NCT01011465|20700236|P7|NOT COMPLETED|Overall Study||1
8398894|NCT01011465|20700237|P6|NOT COMPLETED|Overall Study||0
8398895|NCT01011465|20700238|P5|NOT COMPLETED|Overall Study||1
8398896|NCT01011465|20700239|P4|NOT COMPLETED|Overall Study||0
8398897|NCT01011465|20700240|P3|NOT COMPLETED|Overall Study||0
8398898|NCT01011465|20700241|P2|NOT COMPLETED|Overall Study||1
8398899|NCT01011465|20700242|P1|NOT COMPLETED|Overall Study||2
8398900|NCT01011465|20700235|P8|COMPLETED|Overall Study||32
8398901|NCT01011465|20700236|P7|COMPLETED|Overall Study||51
8398902|NCT01011465|20700237|P6|COMPLETED|Overall Study||29
8398903|NCT01011465|20700238|P5|COMPLETED|Overall Study||46
8398904|NCT01011465|20700239|P4|COMPLETED|Overall Study||18
8398905|NCT01011465|20700240|P3|COMPLETED|Overall Study||36
8398906|NCT01011465|20700241|P2|COMPLETED|Overall Study||19
8398907|NCT01011465|20700242|P1|COMPLETED|Overall Study||34
8398908|NCT01011465|20700235|P8|STARTED|Overall Study||32
8398909|NCT01011465|20700236|P7|STARTED|Overall Study||52
8398910|NCT01011465|20700237|P6|STARTED|Overall Study||29
8398911|NCT01011465|20700238|P5|STARTED|Overall Study||47
8398912|NCT01011465|20700239|P4|STARTED|Overall Study||18
8398913|NCT01011465|20700240|P3|STARTED|Overall Study||36
8398914|NCT01011465|20700241|P2|STARTED|Overall Study||20
8398915|NCT01011465|20700242|P1|STARTED|Overall Study||36
8398916|NCT01011439|20700270|P1|NOT COMPLETED|Overall Study||57
8398917|NCT01011439|20700270|P1|COMPLETED|Overall Study||15
8398918|NCT01011439|20700270|P1|STARTED|Overall Study||72
8398919|NCT01011413|20700282|P2|NOT COMPLETED|Overall Study||25
8398920|NCT01011413|20700283|P1|NOT COMPLETED|Overall Study||26
8398921|NCT01011413|20700282|P2|COMPLETED|Overall Study||299
8398922|NCT01011413|20700283|P1|COMPLETED|Overall Study||286
8398923|NCT01011413|20700282|P2|Lost to Follow-up Between Week 48 and 96|Overall Study||4
8398924|NCT01011413|20700283|P1|Lost to Follow-up Between Week 48 and 96|Overall Study||10
8398925|NCT01011413|20700282|P2|Withdrew Consent Between Week 48 and 96|Overall Study||6
8398926|NCT01011413|20700283|P1|Withdrew Consent Between Week 48 and 96|Overall Study||2
8398927|NCT01011413|20700282|P2|Died Between Week 48 and 96|Overall Study||3
8398928|NCT01011413|20700283|P1|Died Between Week 48 and 96|Overall Study||2
8398929|NCT01011413|20700282|P2|Attended w48 Visit|Overall Study||311
8398930|NCT01011413|20700283|P1|Attended w48 Visit|Overall Study||295
8398931|NCT01011413|20700282|P2|Withdrew Consent Before w48|Overall Study||3
8398932|NCT01011413|20700283|P1|Withdrew Consent Before w48|Overall Study||3
8398933|NCT01011413|20700282|P2|Lost to Follow up Before w48|Overall Study||4
8398934|NCT01011413|20700283|P1|Lost to Follow up Before w48|Overall Study||3
8398935|NCT01011413|20700282|P2|Died Before Week 48|Overall Study||2
8398936|NCT01011413|20700283|P1|Died Before Week 48|Overall Study||3
8398937|NCT01011413|20700282|P2|In Modified ITT|Overall Study||321
8398938|NCT01011413|20700283|P1|In Modified ITT|Overall Study||309
8398939|NCT01011413|20700282|P2|Did Not Start Study Drug|Overall Study||3
8398940|NCT01011413|20700283|P1|Did Not Start Study Drug|Overall Study||3
8398941|NCT01011413|20700282|P2|STARTED|Overall Study|324 randomised|324
8398942|NCT01011413|20700283|P1|STARTED|Overall Study|312 randomised|312
8398943|NCT01011387|20700307|P1|NOT COMPLETED|Overall Study||6
8398944|NCT01011387|20700307|P1|COMPLETED|Overall Study||10
8398945|NCT01011387|20700307|P1|STARTED|Overall Study||16
8398946|NCT01011335|20700315|P13|NOT COMPLETED|Overall Study||3
8398947|NCT01011335|20700316|P12|NOT COMPLETED|Overall Study||1
8398948|NCT01011335|20700317|P11|NOT COMPLETED|Overall Study||6
8398949|NCT01011335|20700318|P10|NOT COMPLETED|Overall Study||0
8398950|NCT01011335|20700319|P9|NOT COMPLETED|Overall Study||2
8398951|NCT01011335|20700320|P8|NOT COMPLETED|Overall Study||2
8398952|NCT01011335|20700321|P7|NOT COMPLETED|Overall Study||3
8398953|NCT01011335|20700322|P6|NOT COMPLETED|Overall Study||1
8398954|NCT01011335|20700323|P5|NOT COMPLETED|Overall Study||1
8398955|NCT01011335|20700324|P4|NOT COMPLETED|Overall Study||2
8398956|NCT01011335|20700325|P3|NOT COMPLETED|Overall Study||1
8398957|NCT01011335|20700326|P2|NOT COMPLETED|Overall Study||1
8398958|NCT01011335|20700327|P1|NOT COMPLETED|Overall Study||1
8398959|NCT01011335|20700315|P13|COMPLETED|Overall Study||19
8398960|NCT01011335|20700316|P12|COMPLETED|Overall Study||21
8398961|NCT01011335|20700317|P11|COMPLETED|Overall Study||6
8398962|NCT01011335|20700318|P10|COMPLETED|Overall Study||12
8398963|NCT01011335|20700319|P9|COMPLETED|Overall Study||10
8398964|NCT01011335|20700320|P8|COMPLETED|Overall Study||10
8398965|NCT01011335|20700321|P7|COMPLETED|Overall Study||9
8398966|NCT01011335|20700322|P6|COMPLETED|Overall Study||11
8398967|NCT01011335|20700323|P5|COMPLETED|Overall Study||12
8398968|NCT01011335|20700324|P4|COMPLETED|Overall Study||10
8398969|NCT01011335|20700325|P3|COMPLETED|Overall Study||11
8398970|NCT01011335|20700326|P2|COMPLETED|Overall Study||11
8398971|NCT01011335|20700327|P1|COMPLETED|Overall Study||10
8398972|NCT01011335|20700315|P13|STARTED|Overall Study||22
8398973|NCT01011335|20700316|P12|STARTED|Overall Study||22
8398974|NCT01011335|20700317|P11|STARTED|Overall Study||12
8398975|NCT01011335|20700318|P10|STARTED|Overall Study||12
8398976|NCT01011335|20700319|P9|STARTED|Overall Study||12
8398977|NCT01011335|20700320|P8|STARTED|Overall Study||12
8398978|NCT01011335|20700321|P7|STARTED|Overall Study||12
8398979|NCT01011335|20700322|P6|STARTED|Overall Study||12
8398980|NCT01011335|20700323|P5|STARTED|Overall Study||13
8398981|NCT01011335|20700324|P4|STARTED|Overall Study||12
8398982|NCT01011335|20700325|P3|STARTED|Overall Study||12
8398983|NCT01011335|20700326|P2|STARTED|Overall Study||12
8398984|NCT01011335|20700327|P1|STARTED|Overall Study||11
8398985|NCT01011309|20700367|P3|NOT COMPLETED|Overall Study||5
8398986|NCT01011309|20700368|P2|NOT COMPLETED|Overall Study||3
8398987|NCT01011309|20700369|P1|NOT COMPLETED|Overall Study||2
8398988|NCT01011309|20700367|P3|COMPLETED|Overall Study||16
8398989|NCT01011309|20700368|P2|COMPLETED|Overall Study||7
8398990|NCT01011309|20700369|P1|COMPLETED|Overall Study||12
8398991|NCT01011309|20700367|P3|STARTED|Overall Study||21
8398992|NCT01011309|20700368|P2|STARTED|Overall Study||10
8398993|NCT01011309|20700369|P1|STARTED|Overall Study||14
8398994|NCT01011283|20700385|P2|NOT COMPLETED|Overall Study||11
8398995|NCT01011283|20700386|P1|NOT COMPLETED|Overall Study||11
8398996|NCT01011283|20700385|P2|COMPLETED|Overall Study||2
8398997|NCT01011283|20700386|P1|COMPLETED|Overall Study||2
8398998|NCT01011283|20700385|P2|STARTED|Overall Study||13
8398999|NCT01011283|20700386|P1|STARTED|Overall Study||13
8399000|NCT01011218|20700398|P4|NOT COMPLETED|Overall Study||0
8399001|NCT01011218|20700399|P3|NOT COMPLETED|Overall Study||0
8399002|NCT01011218|20700400|P2|NOT COMPLETED|Overall Study||0
8399003|NCT01011218|20700401|P1|NOT COMPLETED|Overall Study||0
8399004|NCT01011218|20700398|P4|COMPLETED|Overall Study||26
8399005|NCT01011218|20700399|P3|COMPLETED|Overall Study||26
8399006|NCT01011218|20700400|P2|COMPLETED|Overall Study||9
8399007|NCT01011218|20700401|P1|COMPLETED|Overall Study||9
8399008|NCT01011218|20700398|P4|STARTED|Overall Study||26
8399009|NCT01011218|20700399|P3|STARTED|Overall Study||26
8399010|NCT01011218|20700400|P2|STARTED|Overall Study||9
8399011|NCT01011218|20700401|P1|STARTED|Overall Study||9
8399012|NCT01011179|20700425|P2|NOT COMPLETED|Overall Study||2
8399013|NCT01011179|20700426|P1|NOT COMPLETED|Overall Study||4
8399014|NCT01011179|20700425|P2|COMPLETED|Overall Study||20
8399015|NCT01011179|20700426|P1|COMPLETED|Overall Study||20
8399016|NCT01011179|20700425|P2|STARTED|Overall Study||22
8399017|NCT01011179|20700426|P1|STARTED|Overall Study||24
8399018|NCT01011153|20700435|P3|NOT COMPLETED|Overall Study||9
8399019|NCT01011153|20700436|P2|NOT COMPLETED|Overall Study||11
8399020|NCT01011153|20700437|P1|NOT COMPLETED|Overall Study||8
8399021|NCT01011153|20700435|P3|COMPLETED|Overall Study||45
8399022|NCT01011153|20700436|P2|COMPLETED|Overall Study||64
8399023|NCT01011153|20700437|P1|COMPLETED|Overall Study||46
8399024|NCT01011153|20700435|P3|STARTED|Overall Study||54
8399025|NCT01011153|20700436|P2|STARTED|Overall Study||75
8399026|NCT01011153|20700437|P1|STARTED|Overall Study||54
8399027|NCT01011075|20700455|P1|NOT COMPLETED|Overall Study||0
8399028|NCT01011075|20700455|P1|COMPLETED|Overall Study||34
8399029|NCT01011075|20700455|P1|STARTED|Overall Study||34
8399030|NCT01011049|20700466|P4|NOT COMPLETED|Overall Study||0
8399031|NCT01011049|20700467|P3|NOT COMPLETED|Overall Study||4
8399032|NCT01011049|20700468|P2|NOT COMPLETED|Overall Study||2
8399033|NCT01011049|20700469|P1|NOT COMPLETED|Overall Study||1
8399034|NCT01011049|20700466|P4|COMPLETED|Overall Study||246
8399035|NCT01011049|20700467|P3|COMPLETED|Overall Study||239
8399036|NCT01011049|20700468|P2|COMPLETED|Overall Study||250
8399037|NCT01011049|20700469|P1|COMPLETED|Overall Study||506
8399038|NCT01011049|20700466|P4|STARTED|Overall Study||246
8399039|NCT01011049|20700467|P3|STARTED|Overall Study||243
8399040|NCT01011049|20700468|P2|STARTED|Overall Study||252
8399041|NCT01011049|20700469|P1|STARTED|Overall Study||507
8399042|NCT01010984|20700491|P1|NOT COMPLETED|Overall Study||0
8399043|NCT01010984|20700491|P1|COMPLETED|Overall Study||20
8399044|NCT01010984|20700491|P1|STARTED|Overall Study||20
8399045|NCT01010971|20700499|P3|NOT COMPLETED|Overall Study||13
8399046|NCT01010971|20700500|P2|NOT COMPLETED|Overall Study||8
8399047|NCT01010971|20700501|P1|NOT COMPLETED|Overall Study||3
8399048|NCT01010971|20700499|P3|COMPLETED|Overall Study||207
8399049|NCT01010971|20700500|P2|COMPLETED|Overall Study||218
8399050|NCT01010971|20700501|P1|COMPLETED|Overall Study||222
8399051|NCT01010971|20700499|P3|STARTED|Overall Study||220
8399052|NCT01010971|20700500|P2|STARTED|Overall Study||226
8399053|NCT01010971|20700501|P1|STARTED|Overall Study||225
8399054|NCT01010932|20700586|P1|NOT COMPLETED|Overall Study||22
8399055|NCT01010932|20700586|P1|COMPLETED|Overall Study||200
8399056|NCT01010932|20700586|P1|STARTED|Overall Study||222
8399057|NCT01010906|20700604|P6|NOT COMPLETED|Overall Study||0
8399058|NCT01010906|20700605|P5|NOT COMPLETED|Overall Study||0
8399059|NCT01010906|20700606|P4|NOT COMPLETED|Overall Study||0
8399060|NCT01010906|20700607|P3|NOT COMPLETED|Overall Study||0
8399061|NCT01010906|20700608|P2|NOT COMPLETED|Overall Study||0
8399062|NCT01010906|20700609|P1|NOT COMPLETED|Overall Study||0
8399063|NCT01010906|20700604|P6|COMPLETED|Overall Study||10
8399064|NCT01010906|20700605|P5|COMPLETED|Overall Study||10
8399065|NCT01010906|20700606|P4|COMPLETED|Overall Study||10
8399066|NCT01010906|20700607|P3|COMPLETED|Overall Study||10
8399067|NCT01010906|20700608|P2|COMPLETED|Overall Study||10
8399068|NCT01010906|20700609|P1|COMPLETED|Overall Study||10
8399069|NCT01010906|20700604|P6|STARTED|Overall Study||10
8399070|NCT01010906|20700605|P5|STARTED|Overall Study||10
8399071|NCT01010906|20700606|P4|STARTED|Overall Study||10
8399072|NCT01010906|20700607|P3|STARTED|Overall Study||10
8399073|NCT01010906|20700608|P2|STARTED|Overall Study||10
8399074|NCT01010906|20700609|P1|STARTED|Overall Study||10
8399075|NCT01010867|20700629|P1|NOT COMPLETED|Overall Study||1
8399076|NCT01010867|20700629|P1|COMPLETED|Overall Study||30
8399077|NCT01010867|20700629|P1|STARTED|Overall Study||31
8399078|NCT01010854|20700636|P1|NOT COMPLETED|Overall Study||0
8399079|NCT01010854|20700636|P1|COMPLETED|Overall Study||6
8399080|NCT01010854|20700636|P1|STARTED|Overall Study||6
8399081|NCT01010776|20700641|P1|NOT COMPLETED|Extension Phase||3
8399082|NCT01010776|20700641|P1|COMPLETED|Extension Phase||156
8399083|NCT01010776|20700641|P1|STARTED|Extension Phase||159
8399084|NCT01010776|20700641|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
8399085|NCT01010776|20700641|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
8399086|NCT01010776|20700641|P1|STARTED|In-Between Main Phase & Extension Phase||174
8399087|NCT01010776|20700641|P1|NOT COMPLETED|Main Phase||49
8399088|NCT01010776|20700641|P1|COMPLETED|Main Phase||174
8399089|NCT01010776|20700641|P1|Treated|Main Phase||218
8399090|NCT01010776|20700641|P1|STARTED|Main Phase||223
8399091|NCT01010763|20700665|P2|NOT COMPLETED|Overall Study||30
8399092|NCT01010763|20700666|P1|NOT COMPLETED|Overall Study||35
8399093|NCT01010763|20700665|P2|COMPLETED|Overall Study||54
8399094|NCT01010763|20700666|P1|COMPLETED|Overall Study||61
8399095|NCT01010763|20700665|P2|STARTED|Overall Study||84
8399096|NCT01010763|20700666|P1|STARTED|Overall Study||96
8399097|NCT01010750|20700698|P6|NOT COMPLETED|Third Intervention||0
8399098|NCT01010750|20700699|P5|NOT COMPLETED|Third Intervention||0
8399099|NCT01010750|20700700|P4|NOT COMPLETED|Third Intervention||0
8399100|NCT01010750|20700701|P3|NOT COMPLETED|Third Intervention||0
8399101|NCT01010750|20700702|P2|NOT COMPLETED|Third Intervention||0
8399102|NCT01010750|20700703|P1|NOT COMPLETED|Third Intervention||0
8399103|NCT01010750|20700698|P6|COMPLETED|Third Intervention||3
8399104|NCT01010750|20700699|P5|COMPLETED|Third Intervention||2
8399105|NCT01010750|20700700|P4|COMPLETED|Third Intervention||3
8399106|NCT01010750|20700701|P3|COMPLETED|Third Intervention||3
8399107|NCT01010750|20700702|P2|COMPLETED|Third Intervention||3
8399108|NCT01010750|20700703|P1|COMPLETED|Third Intervention||3
8399109|NCT01010750|20700698|P6|STARTED|Third Intervention||3
8399110|NCT01010750|20700699|P5|STARTED|Third Intervention||2
8399111|NCT01010750|20700700|P4|STARTED|Third Intervention||3
8399112|NCT01010750|20700701|P3|STARTED|Third Intervention||3
8399113|NCT01010750|20700702|P2|STARTED|Third Intervention||3
8399114|NCT01010750|20700703|P1|STARTED|Third Intervention||3
8399115|NCT01010750|20700698|P6|NOT COMPLETED|Second Intervention||0
8399116|NCT01010750|20700699|P5|NOT COMPLETED|Second Intervention||0
8399117|NCT01010750|20700700|P4|NOT COMPLETED|Second Intervention||0
8399118|NCT01010750|20700701|P3|NOT COMPLETED|Second Intervention||0
8399119|NCT01010750|20700702|P2|NOT COMPLETED|Second Intervention||1
8399120|NCT01010750|20700703|P1|NOT COMPLETED|Second Intervention||0
8399121|NCT01010750|20700698|P6|COMPLETED|Second Intervention||3
8399122|NCT01010750|20700699|P5|COMPLETED|Second Intervention||2
8399123|NCT01010750|20700700|P4|COMPLETED|Second Intervention||3
8399124|NCT01010750|20700701|P3|COMPLETED|Second Intervention||3
8399125|NCT01010750|20700702|P2|COMPLETED|Second Intervention||3
8399126|NCT01010750|20700703|P1|COMPLETED|Second Intervention||3
8399127|NCT01010750|20700698|P6|STARTED|Second Intervention||3
8399128|NCT01010750|20700699|P5|STARTED|Second Intervention||2
8399129|NCT01010750|20700700|P4|STARTED|Second Intervention||3
8399130|NCT01010750|20700701|P3|STARTED|Second Intervention||3
8399131|NCT01010750|20700702|P2|STARTED|Second Intervention||4
8399132|NCT01010750|20700703|P1|STARTED|Second Intervention||3
8399133|NCT01010750|20700698|P6|NOT COMPLETED|First Intervention||0
8399134|NCT01010750|20700699|P5|NOT COMPLETED|First Intervention||0
8399135|NCT01010750|20700700|P4|NOT COMPLETED|First Intervention||0
8399136|NCT01010750|20700701|P3|NOT COMPLETED|First Intervention||0
8399137|NCT01010750|20700702|P2|NOT COMPLETED|First Intervention||0
8399138|NCT01010750|20700703|P1|NOT COMPLETED|First Intervention||0
8399139|NCT01010750|20700698|P6|COMPLETED|First Intervention||3
8399140|NCT01010750|20700699|P5|COMPLETED|First Intervention||2
8399141|NCT01010750|20700700|P4|COMPLETED|First Intervention||3
8399142|NCT01010750|20700701|P3|COMPLETED|First Intervention||3
8399143|NCT01010750|20700702|P2|COMPLETED|First Intervention||4
8399144|NCT01010750|20700703|P1|COMPLETED|First Intervention||3
8399145|NCT01010750|20700698|P6|STARTED|First Intervention||3
8399146|NCT01010750|20700699|P5|STARTED|First Intervention||2
8399147|NCT01010750|20700700|P4|STARTED|First Intervention||3
8399148|NCT01010750|20700701|P3|STARTED|First Intervention||3
8399149|NCT01010750|20700702|P2|STARTED|First Intervention||4
8399150|NCT01010750|20700703|P1|STARTED|First Intervention||3
8399151|NCT01010633|20700728|P2|NOT COMPLETED|Overall Study||5
8399152|NCT01010633|20700729|P1|NOT COMPLETED|Overall Study||4
8399153|NCT01010633|20700728|P2|COMPLETED|Overall Study||198
8399154|NCT01010633|20700729|P1|COMPLETED|Overall Study||199
8399155|NCT01010633|20700728|P2|STARTED|Overall Study||203
8399156|NCT01010633|20700729|P1|STARTED|Overall Study||203
8399157|NCT01010568|20700739|P1|NOT COMPLETED|Overall Study||5
8399158|NCT01010568|20700739|P1|COMPLETED|Overall Study||5
8399159|NCT01010568|20700739|P1|STARTED|Overall Study||10
8399160|NCT01010555|20700745|P2|NOT COMPLETED|Second Four Weeks of Wear||0
8399161|NCT01010555|20700746|P1|NOT COMPLETED|Second Four Weeks of Wear||0
8399162|NCT01010555|20700745|P2|COMPLETED|Second Four Weeks of Wear||9
8399163|NCT01010555|20700746|P1|COMPLETED|Second Four Weeks of Wear||10
8399164|NCT01010555|20700745|P2|STARTED|Second Four Weeks of Wear||9
8399165|NCT01010555|20700746|P1|STARTED|Second Four Weeks of Wear||10
8399166|NCT01010555|20700745|P2|NOT COMPLETED|First Four Weeks of Wear||0
8399167|NCT01010555|20700746|P1|NOT COMPLETED|First Four Weeks of Wear||0
8399168|NCT01010555|20700745|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
8399169|NCT01010555|20700746|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
8399170|NCT01010555|20700745|P2|STARTED|First Four Weeks of Wear||10
8399171|NCT01010555|20700746|P1|STARTED|First Four Weeks of Wear||11
8399172|NCT01010503|20700756|P1|NOT COMPLETED|Overall Study||2
8399173|NCT01010503|20700756|P1|COMPLETED|Overall Study||30
8399174|NCT01010503|20700756|P1|STARTED|Overall Study||32
8399175|NCT01010477|20700776|P2|NOT COMPLETED|Overall Study||3
8399176|NCT01010477|20700777|P1|NOT COMPLETED|Overall Study||6
8399177|NCT01010477|20700776|P2|COMPLETED|Overall Study||22
8399178|NCT01010477|20700777|P1|COMPLETED|Overall Study||21
8399179|NCT01010477|20700776|P2|STARTED|Overall Study||25
8399180|NCT01010477|20700777|P1|STARTED|Overall Study||27
8399181|NCT01010399|20700783|P1|NOT COMPLETED|Overall Study||5
8399182|NCT01010399|20700783|P1|COMPLETED|Overall Study||31
8399183|NCT01010399|20700783|P1|STARTED|Overall Study||36
8399184|NCT01010282|20700791|P3|NOT COMPLETED|Overall Study||19
8399185|NCT01010282|20700792|P2|NOT COMPLETED|Overall Study||7
8399186|NCT01010282|20700793|P1|NOT COMPLETED|Overall Study||6
8399187|NCT01010282|20700791|P3|COMPLETED|Overall Study||77
8399188|NCT01010282|20700792|P2|COMPLETED|Overall Study||88
8399189|NCT01010282|20700793|P1|COMPLETED|Overall Study||91
8399190|NCT01010282|20700791|P3|STARTED|Overall Study||96
8399191|NCT01010282|20700792|P2|STARTED|Overall Study||95
8399192|NCT01010282|20700793|P1|STARTED|Overall Study||97
8399193|NCT01010230|20700815|P2|NOT COMPLETED|Overall Study||7
8399194|NCT01010230|20700816|P1|NOT COMPLETED|Overall Study||10
8399195|NCT01010230|20700815|P2|COMPLETED|Overall Study||26
8399196|NCT01010230|20700816|P1|COMPLETED|Overall Study||22
8399197|NCT01010230|20700815|P2|STARTED|Overall Study||33
8399198|NCT01010230|20700816|P1|STARTED|Overall Study||32
8399199|NCT01010217|20700851|P5|NOT COMPLETED|Overall Study||3
8399200|NCT01010217|20700852|P4|NOT COMPLETED|Overall Study||6
8399201|NCT01010217|20700853|P3|NOT COMPLETED|Overall Study||1
8399202|NCT01010217|20700854|P2|NOT COMPLETED|Overall Study||5
8399203|NCT01010217|20700855|P1|NOT COMPLETED|Overall Study||5
8399204|NCT01010217|20700851|P5|COMPLETED|Overall Study||0
8399205|NCT01010217|20700852|P4|COMPLETED|Overall Study||0
8399206|NCT01010217|20700853|P3|COMPLETED|Overall Study||21
8399207|NCT01010217|20700854|P2|COMPLETED|Overall Study||51
8399208|NCT01010217|20700855|P1|COMPLETED|Overall Study||84
8399209|NCT01010217|20700851|P5|STARTED|Overall Study||3
8399210|NCT01010217|20700852|P4|STARTED|Overall Study||6
8399211|NCT01010217|20700853|P3|STARTED|Overall Study||22
8399212|NCT01010217|20700854|P2|STARTED|Overall Study||56
8399213|NCT01010217|20700855|P1|STARTED|Overall Study||89
8399214|NCT01010204|20700894|P2|NOT COMPLETED|Overall Study||9
8399215|NCT01010204|20700895|P1|NOT COMPLETED|Overall Study||7
8399216|NCT01010204|20700894|P2|COMPLETED|Overall Study||20
8399217|NCT01010204|20700895|P1|COMPLETED|Overall Study||24
8399218|NCT01010204|20700894|P2|STARTED|Overall Study||29
8399219|NCT01010204|20700895|P1|STARTED|Overall Study||31
8399220|NCT01010126|20700911|P6|NOT COMPLETED|Overall Study||0
8399221|NCT01010126|20700912|P5|NOT COMPLETED|Overall Study||3
8399222|NCT01010126|20700913|P4|NOT COMPLETED|Overall Study||0
8399223|NCT01010126|20700914|P3|NOT COMPLETED|Overall Study||1
8399224|NCT01010126|20700915|P2|NOT COMPLETED|Overall Study||0
8399225|NCT01010126|20700916|P1|NOT COMPLETED|Overall Study||1
8399226|NCT01010126|20700911|P6|COMPLETED|Overall Study||24
8399227|NCT01010126|20700912|P5|COMPLETED|Overall Study||55
8399228|NCT01010126|20700913|P4|COMPLETED|Overall Study||57
8399229|NCT01010126|20700914|P3|COMPLETED|Overall Study||27
8399230|NCT01010126|20700915|P2|COMPLETED|Overall Study||58
8399231|NCT01010126|20700916|P1|COMPLETED|Overall Study||26
8399232|NCT01010126|20700911|P6|STARTED|Overall Study||24
8399233|NCT01010126|20700912|P5|STARTED|Overall Study||58
8399234|NCT01010126|20700913|P4|STARTED|Overall Study||57
8399235|NCT01010126|20700914|P3|STARTED|Overall Study||28
8399236|NCT01010126|20700915|P2|STARTED|Overall Study||58
8399237|NCT01010126|20700916|P1|STARTED|Overall Study||27
8399238|NCT01010061|20700968|P2|NOT COMPLETED|Overall Study||40
8399239|NCT01010061|20700969|P1|NOT COMPLETED|Overall Study||48
8399240|NCT01010061|20700968|P2|COMPLETED|Overall Study||78
8399241|NCT01010061|20700969|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
8399242|NCT01010061|20700968|P2|Received Study Drug|Overall Study||116
8399243|NCT01010061|20700969|P1|Received Study Drug|Overall Study||236
8399244|NCT01010061|20700968|P2|STARTED|Overall Study||118
8399245|NCT01010061|20700969|P1|STARTED|Overall Study||238
8399246|NCT01010009|20701004|P3|NOT COMPLETED|Overall Study||0
8399247|NCT01010009|20701005|P2|NOT COMPLETED|Overall Study||0
8399248|NCT01010009|20701006|P1|NOT COMPLETED|Overall Study||0
8399249|NCT01010009|20701004|P3|COMPLETED|Overall Study||8
8399250|NCT01010009|20701005|P2|COMPLETED|Overall Study||8
8399251|NCT01010009|20701006|P1|COMPLETED|Overall Study||8
8399252|NCT01010009|20701004|P3|STARTED|Overall Study||8
8399253|NCT01010009|20701005|P2|STARTED|Overall Study||8
8399254|NCT01010009|20701006|P1|STARTED|Overall Study||8
8399255|NCT01009983|20701020|P1|NOT COMPLETED|Overall Study||1
8399256|NCT01009983|20701020|P1|COMPLETED|Overall Study||13
8399257|NCT01009983|20701020|P1|STARTED|Overall Study||14
8399258|NCT01009931|20701027|P1|NOT COMPLETED|Overall Study||1
8399259|NCT01009931|20701027|P1|COMPLETED|Overall Study||0
8399260|NCT01009931|20701027|P1|STARTED|Overall Study||1
8399261|NCT01009840|20701033|P1|NOT COMPLETED|Overall Study||14
8399262|NCT01009840|20701033|P1|COMPLETED|Overall Study||16
8399263|NCT01009840|20701033|P1|STARTED|Overall Study||30
8399264|NCT01009814|20701051|P5|NOT COMPLETED|Overall Study||0
8399265|NCT01009814|20701052|P4|NOT COMPLETED|Overall Study||0
8399266|NCT01009814|20701053|P3|NOT COMPLETED|Overall Study||0
8399267|NCT01009814|20701054|P2|NOT COMPLETED|Overall Study||1
8399268|NCT01009814|20701055|P1|NOT COMPLETED|Overall Study||1
8399269|NCT01009814|20701051|P5|COMPLETED|Overall Study||10
8399270|NCT01009814|20701052|P4|COMPLETED|Overall Study||10
8399271|NCT01009814|20701053|P3|COMPLETED|Overall Study||10
8399272|NCT01009814|20701054|P2|COMPLETED|Overall Study||9
8399273|NCT01009814|20701055|P1|COMPLETED|Overall Study||9
8399274|NCT01009814|20701051|P5|STARTED|Overall Study||10
8399275|NCT01009814|20701052|P4|STARTED|Overall Study||10
8399276|NCT01009814|20701053|P3|STARTED|Overall Study||10
8399277|NCT01009814|20701054|P2|STARTED|Overall Study||10
8399278|NCT01009814|20701055|P1|STARTED|Overall Study||10
8399279|NCT01009762|20701164|P2|NOT COMPLETED|Overall Study||0
8399280|NCT01009762|20701165|P1|NOT COMPLETED|Overall Study||0
8399281|NCT01009762|20701164|P2|COMPLETED|Overall Study|10 participants received vaccine|10
8399282|NCT01009762|20701165|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
8399283|NCT01009762|20701164|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
8399284|NCT01009762|20701165|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
8399285|NCT01009762|20701164|P2|STARTED|Overall Study||10
8399286|NCT01009762|20701165|P1|STARTED|Overall Study||1
8399287|NCT01009645|20701179|P4|NOT COMPLETED|Overall Study||5
8399288|NCT01009645|20701180|P3|NOT COMPLETED|Overall Study||4
8399289|NCT01009645|20701181|P2|NOT COMPLETED|Overall Study||8
8399290|NCT01009645|20701182|P1|NOT COMPLETED|Overall Study||2
8399291|NCT01009645|20701179|P4|COMPLETED|Overall Study||26
8399292|NCT01009645|20701180|P3|COMPLETED|Overall Study||28
8399293|NCT01009645|20701181|P2|COMPLETED|Overall Study||23
8399294|NCT01009645|20701182|P1|COMPLETED|Overall Study||29
8399295|NCT01009645|20701179|P4|STARTED|Overall Study||31
8399296|NCT01009645|20701180|P3|STARTED|Overall Study||32
8399297|NCT01009645|20701181|P2|STARTED|Overall Study||31
8399298|NCT01009645|20701182|P1|STARTED|Overall Study||31
8399299|NCT01009619|20701198|P2|NOT COMPLETED|Overall Study||0
8399300|NCT01009619|20701199|P1|NOT COMPLETED|Overall Study||0
8399301|NCT01009619|20701198|P2|COMPLETED|Overall Study||43
8399302|NCT01009619|20701199|P1|COMPLETED|Overall Study||40
8399303|NCT01009619|20701198|P2|STARTED|Overall Study||43
8399304|NCT01009619|20701199|P1|STARTED|Overall Study||40
8399305|NCT01009580|20701219|P2|NOT COMPLETED|Overall Study||35
8399306|NCT01009580|20701220|P1|NOT COMPLETED|Overall Study||27
8399307|NCT01009580|20701219|P2|COMPLETED|Overall Study||188
8399308|NCT01009580|20701220|P1|COMPLETED|Overall Study||197
8399309|NCT01009580|20701219|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
8399310|NCT01009580|20701220|P1|Exposed|Overall Study||224
8399311|NCT01009580|20701219|P2|STARTED|Overall Study||223
8399312|NCT01009580|20701220|P1|STARTED|Overall Study||224
8399313|NCT01009554|20701234|P2|NOT COMPLETED|Overall Study||7
8399314|NCT01009554|20701235|P1|NOT COMPLETED|Overall Study||2
8399315|NCT01009554|20701234|P2|COMPLETED|Overall Study||41
8399316|NCT01009554|20701235|P1|COMPLETED|Overall Study||46
8399317|NCT01009554|20701234|P2|STARTED|Overall Study||48
8399318|NCT01009554|20701235|P1|STARTED|Overall Study||48
8399319|NCT01009515|20701367|P1|NOT COMPLETED|Overall Study||3
8399320|NCT01009515|20701367|P1|COMPLETED|Overall Study||16
8399321|NCT01009515|20701367|P1|STARTED|Overall Study||19
8399322|NCT01009463|20701378|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
8399323|NCT01009463|20701379|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
8399324|NCT01009463|20701380|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
8399325|NCT01009463|20701381|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
8399326|NCT01009463|20701382|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
8399327|NCT01009463|20701378|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
8399328|NCT01009463|20701379|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
8399329|NCT01009463|20701380|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
8399330|NCT01009463|20701381|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
8399331|NCT01009463|20701382|P1|COMPLETED|52-week, Double-blind Treatment Period||0
8399332|NCT01009463|20701378|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
8399333|NCT01009463|20701379|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
8399334|NCT01009463|20701380|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
8399335|NCT01009463|20701381|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
8399336|NCT01009463|20701382|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
8399337|NCT01009463|20701378|P5|STARTED|52-week, Double-blind Treatment Period||402
8399338|NCT01009463|20701379|P4|STARTED|52-week, Double-blind Treatment Period||403
8399339|NCT01009463|20701380|P3|STARTED|52-week, Double-blind Treatment Period||408
8399340|NCT01009463|20701381|P2|STARTED|52-week, Double-blind Treatment Period||409
8399341|NCT01009463|20701382|P1|STARTED|52-week, Double-blind Treatment Period||0
8399342|NCT01009463|20701378|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399343|NCT01009463|20701379|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399344|NCT01009463|20701380|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399345|NCT01009463|20701381|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399346|NCT01009463|20701382|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
8399347|NCT01009463|20701378|P5|COMPLETED|4-week, Open-label Run-In Period||0
8399348|NCT01009463|20701379|P4|COMPLETED|4-week, Open-label Run-In Period||0
8399349|NCT01009463|20701380|P3|COMPLETED|4-week, Open-label Run-In Period||0
8399350|NCT01009463|20701381|P2|COMPLETED|4-week, Open-label Run-In Period||0
8399351|NCT01009463|20701382|P1|COMPLETED|4-week, Open-label Run-In Period||1622
8399352|NCT01009463|20701378|P5|STARTED|4-week, Open-label Run-In Period||0
8399353|NCT01009463|20701379|P4|STARTED|4-week, Open-label Run-In Period||0
8399354|NCT01009463|20701380|P3|STARTED|4-week, Open-label Run-In Period||0
8399355|NCT01009463|20701381|P2|STARTED|4-week, Open-label Run-In Period||0
8399356|NCT01009463|20701382|P1|STARTED|4-week, Open-label Run-In Period||2071
8399357|NCT01009346|20701404|P1|NOT COMPLETED|Overall Study||4
8399358|NCT01009346|20701404|P1|COMPLETED|Overall Study||5
8399359|NCT01009346|20701404|P1|STARTED|Overall Study||9
8399360|NCT01009333|20701409|P6|NOT COMPLETED|Week 3||0
8399361|NCT01009333|20701410|P5|NOT COMPLETED|Week 3||0
8399362|NCT01009333|20701411|P4|NOT COMPLETED|Week 3||0
8399363|NCT01009333|20701412|P3|NOT COMPLETED|Week 3||0
8399364|NCT01009333|20701413|P2|NOT COMPLETED|Week 3||0
8399365|NCT01009333|20701414|P1|NOT COMPLETED|Week 3||0
8399366|NCT01009333|20701409|P6|COMPLETED|Week 3||2
8399367|NCT01009333|20701410|P5|COMPLETED|Week 3||2
8399368|NCT01009333|20701411|P4|COMPLETED|Week 3||2
8399369|NCT01009333|20701412|P3|COMPLETED|Week 3||2
8399370|NCT01009333|20701413|P2|COMPLETED|Week 3||2
8399371|NCT01009333|20701414|P1|COMPLETED|Week 3||2
8399372|NCT01009333|20701409|P6|STARTED|Week 3||2
8399373|NCT01009333|20701410|P5|STARTED|Week 3||2
8399374|NCT01009333|20701411|P4|STARTED|Week 3||2
8399375|NCT01009333|20701412|P3|STARTED|Week 3||2
8399376|NCT01009333|20701413|P2|STARTED|Week 3||2
8399377|NCT01009333|20701414|P1|STARTED|Week 3||2
8399378|NCT01009333|20701409|P6|NOT COMPLETED|Week 2||0
8399379|NCT01009333|20701410|P5|NOT COMPLETED|Week 2||0
8399380|NCT01009333|20701411|P4|NOT COMPLETED|Week 2||0
8399381|NCT01009333|20701412|P3|NOT COMPLETED|Week 2||0
8399382|NCT01009333|20701413|P2|NOT COMPLETED|Week 2||0
8399383|NCT01009333|20701414|P1|NOT COMPLETED|Week 2||0
8399384|NCT01009333|20701409|P6|COMPLETED|Week 2||2
8399385|NCT01009333|20701410|P5|COMPLETED|Week 2||2
8399386|NCT01009333|20701411|P4|COMPLETED|Week 2||2
8399387|NCT01009333|20701412|P3|COMPLETED|Week 2||2
8399388|NCT01009333|20701413|P2|COMPLETED|Week 2||2
8399389|NCT01009333|20701414|P1|COMPLETED|Week 2||2
8399390|NCT01009333|20701409|P6|STARTED|Week 2||2
8399391|NCT01009333|20701410|P5|STARTED|Week 2||2
8399392|NCT01009333|20701411|P4|STARTED|Week 2||2
8399393|NCT01009333|20701412|P3|STARTED|Week 2||2
8399394|NCT01009333|20701413|P2|STARTED|Week 2||2
8399395|NCT01009333|20701414|P1|STARTED|Week 2||2
8399396|NCT01009333|20701409|P6|NOT COMPLETED|Week 1||0
8399397|NCT01009333|20701410|P5|NOT COMPLETED|Week 1||0
8399398|NCT01009333|20701411|P4|NOT COMPLETED|Week 1||0
8399399|NCT01009333|20701412|P3|NOT COMPLETED|Week 1||0
8399400|NCT01009333|20701413|P2|NOT COMPLETED|Week 1||0
8399401|NCT01009333|20701414|P1|NOT COMPLETED|Week 1||0
8399402|NCT01009333|20701409|P6|COMPLETED|Week 1||2
8399403|NCT01009333|20701410|P5|COMPLETED|Week 1||2
8399404|NCT01009333|20701411|P4|COMPLETED|Week 1||2
8399405|NCT01009333|20701412|P3|COMPLETED|Week 1||2
8399406|NCT01009333|20701413|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
8399407|NCT01009333|20701414|P1|COMPLETED|Week 1||2
8399408|NCT01009333|20701409|P6|STARTED|Week 1||2
8399409|NCT01009333|20701410|P5|STARTED|Week 1||2
8399410|NCT01009333|20701411|P4|STARTED|Week 1||2
8399411|NCT01009333|20701412|P3|STARTED|Week 1||2
8399412|NCT01009333|20701413|P2|STARTED|Week 1||3
8399413|NCT01009333|20701414|P1|STARTED|Week 1||2
8399414|NCT01009294|20701428|P1|NOT COMPLETED|Overall Study||6
8399415|NCT01009294|20701428|P1|COMPLETED|Overall Study||0
8399416|NCT01009294|20701428|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8399417|NCT01009294|20701428|P1|STARTED|Overall Study||6
8399418|NCT01009203|20701449|P1|NOT COMPLETED|Overall Study||7
8399419|NCT01009203|20701449|P1|COMPLETED|Overall Study||6
8399420|NCT01009203|20701449|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
8399421|NCT01009203|20701449|P1|STARTED|Overall Study||13
8399422|NCT01009138|20701458|P2|NOT COMPLETED|Overall Study||20
8399423|NCT01009138|20701459|P1|NOT COMPLETED|Overall Study||13
8399424|NCT01009138|20701458|P2|COMPLETED|Overall Study||88
8399425|NCT01009138|20701459|P1|COMPLETED|Overall Study||93
8399426|NCT01009138|20701458|P2|STARTED|Overall Study||108
8399427|NCT01009138|20701459|P1|STARTED|Overall Study||106
8399428|NCT01009099|20701489|P2|NOT COMPLETED|Overall Study||4
8399429|NCT01009099|20701490|P1|NOT COMPLETED|Overall Study||5
8399430|NCT01009099|20701489|P2|COMPLETED|Overall Study||57
8399431|NCT01009099|20701490|P1|COMPLETED|Overall Study||53
8399432|NCT01009099|20701489|P2|STARTED|Overall Study||61
8399433|NCT01009099|20701490|P1|STARTED|Overall Study||58
8399434|NCT01009086|20701499|P3|NOT COMPLETED|Overall Study||34
8399435|NCT01009086|20701500|P2|NOT COMPLETED|Overall Study||47
8399436|NCT01009086|20701501|P1|NOT COMPLETED|Overall Study||44
8399437|NCT01009086|20701499|P3|COMPLETED|Overall Study||170
8399438|NCT01009086|20701500|P2|COMPLETED|Overall Study||158
8399439|NCT01009086|20701501|P1|COMPLETED|Overall Study||162
8399440|NCT01009086|20701499|P3|STARTED|Overall Study||204
8399441|NCT01009086|20701500|P2|STARTED|Overall Study||205
8399442|NCT01009086|20701501|P1|STARTED|Overall Study||206
8399443|NCT01009060|20701536|P2|NOT COMPLETED|Overall Study||5
8399444|NCT01009060|20701537|P1|NOT COMPLETED|Overall Study||4
8399445|NCT01009060|20701536|P2|COMPLETED|Overall Study||20
8399446|NCT01009060|20701537|P1|COMPLETED|Overall Study||21
8399447|NCT01009060|20701536|P2|STARTED|Overall Study||25
8399448|NCT01009060|20701537|P1|STARTED|Overall Study||25
8399449|NCT01009047|20701575|P2|NOT COMPLETED|Overall Study||26
8399450|NCT01009047|20701576|P1|NOT COMPLETED|Overall Study||28
8399451|NCT01009047|20701575|P2|COMPLETED|Overall Study||89
8399452|NCT01009047|20701576|P1|COMPLETED|Overall Study||85
8399453|NCT01009047|20701575|P2|STARTED|Overall Study||115
8399454|NCT01009047|20701576|P1|STARTED|Overall Study||113
8399455|NCT01009034|20701598|P1|NOT COMPLETED|Overall Study||4
8399456|NCT01009034|20701598|P1|COMPLETED|Overall Study||10
8399457|NCT01009034|20701598|P1|STARTED|Overall Study||14
8399458|NCT01008995|20701606|P4|NOT COMPLETED|After Controlled Period||1
8399459|NCT01008995|20701607|P3|NOT COMPLETED|After Controlled Period||2
8399460|NCT01008995|20701608|P2|NOT COMPLETED|After Controlled Period||0
8399461|NCT01008995|20701609|P1|NOT COMPLETED|After Controlled Period||0
8399462|NCT01008995|20701606|P4|COMPLETED|After Controlled Period||156
8399463|NCT01008995|20701607|P3|COMPLETED|After Controlled Period||156
8399464|NCT01008995|20701608|P2|COMPLETED|After Controlled Period||0
8399465|NCT01008995|20701609|P1|COMPLETED|After Controlled Period||0
8399466|NCT01008995|20701606|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
8399467|NCT01008995|20701607|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
8399468|NCT01008995|20701608|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8399469|NCT01008995|20701609|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8399470|NCT01008995|20701606|P4|NOT COMPLETED|Controlled Period||0
8399471|NCT01008995|20701607|P3|NOT COMPLETED|Controlled Period||0
8399472|NCT01008995|20701608|P2|NOT COMPLETED|Controlled Period||3
8399473|NCT01008995|20701609|P1|NOT COMPLETED|Controlled Period||3
8399474|NCT01008995|20701606|P4|COMPLETED|Controlled Period||0
8399475|NCT01008995|20701607|P3|COMPLETED|Controlled Period||0
8399476|NCT01008995|20701608|P2|COMPLETED|Controlled Period||157
8399477|NCT01008995|20701609|P1|COMPLETED|Controlled Period||159
8399478|NCT01008995|20701606|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8399479|NCT01008995|20701607|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8399480|NCT01008995|20701608|P2|STARTED|Controlled Period||160
8399481|NCT01008995|20701609|P1|STARTED|Controlled Period||162
8399482|NCT01008969|20701621|P1|NOT COMPLETED|Overall Study||0
8399483|NCT01008969|20701621|P1|COMPLETED|Overall Study||10
8399484|NCT01008969|20701621|P1|STARTED|Overall Study||10
8399485|NCT01008943|20701626|P1|NOT COMPLETED|Overall Study||1
8399486|NCT01008943|20701626|P1|COMPLETED|Overall Study||15
8399487|NCT01008943|20701626|P1|STARTED|Overall Study||16
8399488|NCT01008904|20701633|P1|NOT COMPLETED|Overall Study||4
8399489|NCT01008904|20701633|P1|COMPLETED|Overall Study||25
8399490|NCT01008904|20701633|P1|STARTED|Overall Study||29
8399491|NCT01008748|20701638|P1|NOT COMPLETED|Overall Study||81
8399492|NCT01008748|20701638|P1|COMPLETED|Overall Study||119
8399493|NCT01008748|20701638|P1|Week 26|Overall Study||119
8399494|NCT01008748|20701638|P1|Week 3|Overall Study||168
8399495|NCT01008748|20701638|P1|Week 0|Overall Study||182
8399496|NCT01008748|20701638|P1|Baseline|Overall Study||188
8399497|NCT01008748|20701638|P1|STARTED|Overall Study||200
8399498|NCT01008722|20701652|P2|NOT COMPLETED|Overall Study||0
8399499|NCT01008722|20701653|P1|NOT COMPLETED|Overall Study||0
8399500|NCT01008722|20701652|P2|COMPLETED|Overall Study||71
8399501|NCT01008722|20701653|P1|COMPLETED|Overall Study||36
8399502|NCT01008722|20701652|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
8399503|NCT01008722|20701653|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
8399504|NCT01008696|20701663|P2|NOT COMPLETED|Overall Study||17
8399505|NCT01008696|20701664|P1|NOT COMPLETED|Overall Study||17
8399506|NCT01008696|20701663|P2|COMPLETED|Overall Study||92
8399507|NCT01008696|20701664|P1|COMPLETED|Overall Study||91
8399508|NCT01008696|20701663|P2|STARTED|Overall Study||109
8399509|NCT01008696|20701664|P1|STARTED|Overall Study||108
8399510|NCT01008618|20701674|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
8399511|NCT01008618|20701675|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
8399512|NCT01008618|20701676|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
8399513|NCT01008618|20701674|P3|COMPLETED|Period 2 (Double-Blind Period)||39
8399514|NCT01008618|20701675|P2|COMPLETED|Period 2 (Double-Blind Period)||37
8399515|NCT01008618|20701676|P1|COMPLETED|Period 2 (Double-Blind Period)||0
8399516|NCT01008618|20701674|P3|STARTED|Period 2 (Double-Blind Period)||77
8399517|NCT01008618|20701675|P2|STARTED|Period 2 (Double-Blind Period)||73
8399518|NCT01008618|20701676|P1|STARTED|Period 2 (Double-Blind Period)||0
8399519|NCT01008618|20701674|P3|NOT COMPLETED|Period 1 (Titration Period)||0
8399520|NCT01008618|20701675|P2|NOT COMPLETED|Period 1 (Titration Period)||0
8399521|NCT01008618|20701676|P1|NOT COMPLETED|Period 1 (Titration Period)||68
8399522|NCT01008618|20701674|P3|COMPLETED|Period 1 (Titration Period)||0
8399523|NCT01008618|20701675|P2|COMPLETED|Period 1 (Titration Period)||0
8399524|NCT01008618|20701676|P1|COMPLETED|Period 1 (Titration Period)||150
8399525|NCT01008618|20701674|P3|STARTED|Period 1 (Titration Period)||0
8399526|NCT01008618|20701675|P2|STARTED|Period 1 (Titration Period)||0
8399527|NCT01008618|20701676|P1|STARTED|Period 1 (Titration Period)||218
8399528|NCT01008605|20701701|P1|NOT COMPLETED|Overall Study||0
8399529|NCT01008605|20701701|P1|COMPLETED|Overall Study||48
8399530|NCT01008605|20701701|P1|STARTED|Overall Study||48
8399531|NCT01008553|20701725|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
8399532|NCT01008553|20701726|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
8399533|NCT01008553|20701727|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
8399534|NCT01008553|20701725|P3|COMPLETED|Period 2 (Double-Blind Period)||28
8399535|NCT01008553|20701726|P2|COMPLETED|Period 2 (Double-Blind Period)||47
8399536|NCT01008553|20701727|P1|COMPLETED|Period 2 (Double-Blind Period)||0
8399537|NCT01008553|20701725|P3|STARTED|Period 2 (Double-Blind Period)||79
8399538|NCT01008553|20701726|P2|STARTED|Period 2 (Double-Blind Period)||84
8399539|NCT01008553|20701727|P1|STARTED|Period 2 (Double-Blind Period)||0
8399540|NCT01008553|20701725|P3|NOT COMPLETED|Period 1 (Titration Period)||0
8399541|NCT01008553|20701726|P2|NOT COMPLETED|Period 1 (Titration Period)||0
8399542|NCT01008553|20701727|P1|NOT COMPLETED|Period 1 (Titration Period)||95
8399543|NCT01008553|20701725|P3|COMPLETED|Period 1 (Titration Period)||0
8399544|NCT01008553|20701726|P2|COMPLETED|Period 1 (Titration Period)||0
8399545|NCT01008553|20701727|P1|COMPLETED|Period 1 (Titration Period)||163
8399546|NCT01008553|20701725|P3|STARTED|Period 1 (Titration Period)||0
8399547|NCT01008553|20701726|P2|STARTED|Period 1 (Titration Period)||0
8399548|NCT01008553|20701727|P1|STARTED|Period 1 (Titration Period)||258
8399549|NCT01008475|20701759|P7|NOT COMPLETED|Overall Study||4
8399550|NCT01008475|20701760|P6|NOT COMPLETED|Overall Study||6
8399551|NCT01008475|20701761|P5|NOT COMPLETED|Overall Study||5
8399552|NCT01008475|20701762|P4|NOT COMPLETED|Overall Study||0
8399553|NCT01008475|20701763|P3|NOT COMPLETED|Overall Study||0
8399554|NCT01008475|20701764|P2|NOT COMPLETED|Overall Study||0
8399555|NCT01008475|20701765|P1|NOT COMPLETED|Overall Study||0
8399556|NCT01008475|20701759|P7|COMPLETED|Overall Study||67
8399557|NCT01008475|20701760|P6|COMPLETED|Overall Study||67
8399558|NCT01008475|20701761|P5|COMPLETED|Overall Study||67
8399559|NCT01008475|20701762|P4|COMPLETED|Overall Study||3
8399560|NCT01008475|20701763|P3|COMPLETED|Overall Study||7
8399561|NCT01008475|20701764|P2|COMPLETED|Overall Study||3
8399562|NCT01008475|20701765|P1|COMPLETED|Overall Study||3
8399563|NCT01008475|20701759|P7|Safety Analysis Set|Overall Study||69
8399564|NCT01008475|20701760|P6|Safety Analysis Set|Overall Study||72
8399565|NCT01008475|20701761|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
8399566|NCT01008475|20701762|P4|Safety Analysis Set|Overall Study||3
8399567|NCT01008475|20701763|P3|Safety Analysis Set|Overall Study||7
8399568|NCT01008475|20701764|P2|Safety Analysis Set|Overall Study||3
8399569|NCT01008475|20701765|P1|Safety Analysis Set|Overall Study||3
8399570|NCT01008475|20701759|P7|STARTED|Overall Study||71
8399571|NCT01008475|20701760|P6|STARTED|Overall Study||73
8399572|NCT01008475|20701761|P5|STARTED|Overall Study||72
8399573|NCT01008475|20701762|P4|STARTED|Overall Study||3
8399574|NCT01008475|20701763|P3|STARTED|Overall Study||7
8399575|NCT01008475|20701764|P2|STARTED|Overall Study||3
8399576|NCT01008475|20701765|P1|STARTED|Overall Study||3
8399577|NCT01008462|20701793|P1|NOT COMPLETED|Overall Study||0
8399578|NCT01008462|20701793|P1|COMPLETED|Overall Study||16
8399579|NCT01008462|20701793|P1|STARTED|Overall Study||16
8399580|NCT01008449|20701805|P2|NOT COMPLETED|Overall Study||19
8399581|NCT01008449|20701806|P1|NOT COMPLETED|Overall Study||29
8399582|NCT01008449|20701805|P2|COMPLETED|Overall Study||179
8399583|NCT01008449|20701806|P1|COMPLETED|Overall Study||171
8399584|NCT01008449|20701805|P2|STARTED|Overall Study||198
8399585|NCT01008449|20701806|P1|STARTED|Overall Study||200
8399586|NCT01008423|20701828|P2|NOT COMPLETED|Overall Study||22
8399587|NCT01008423|20701829|P1|NOT COMPLETED|Overall Study||19
8399588|NCT01008423|20701828|P2|COMPLETED|Overall Study||125
8399589|NCT01008423|20701829|P1|COMPLETED|Overall Study||115
8399590|NCT01008423|20701828|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
8399591|NCT01008423|20701829|P1|Received at Least 1 Dose of Study Drug|Overall Study||134
8399592|NCT01008423|20701828|P2|STARTED|Overall Study||147
8399593|NCT01008423|20701829|P1|STARTED|Overall Study||134
8399594|NCT01008410|20701855|P2|NOT COMPLETED|Overall Study||16
8399595|NCT01008410|20701856|P1|NOT COMPLETED|Overall Study||25
8399596|NCT01008410|20701855|P2|COMPLETED|Overall Study||116
8399597|NCT01008410|20701856|P1|COMPLETED|Overall Study||108
8399598|NCT01008410|20701855|P2|Received at Least 1 Dose of Study Drug|Overall Study||132
8399599|NCT01008410|20701856|P1|Received at Least 1 Dose of Study Drug|Overall Study||133
8399600|NCT01008410|20701855|P2|STARTED|Overall Study||132
8399601|NCT01008410|20701856|P1|STARTED|Overall Study||133
8399602|NCT01008319|20701882|P2|NOT COMPLETED|Overall Study||0
8399603|NCT01008319|20701883|P1|NOT COMPLETED|Overall Study||0
8399604|NCT01008319|20701882|P2|COMPLETED|Overall Study||60
8399605|NCT01008319|20701883|P1|COMPLETED|Overall Study||60
8399606|NCT01008319|20701882|P2|STARTED|Overall Study||60
8399607|NCT01008319|20701883|P1|STARTED|Overall Study||60
8399608|NCT01008280|20701895|P2|NOT COMPLETED|Overall Study||19
8399609|NCT01008280|20701896|P1|NOT COMPLETED|Overall Study||21
8399610|NCT01008280|20701895|P2|COMPLETED|Overall Study||73
8399611|NCT01008280|20701896|P1|COMPLETED|Overall Study||67
8399612|NCT01008280|20701895|P2|STARTED|Overall Study||92
8399613|NCT01008280|20701896|P1|STARTED|Overall Study||88
8399614|NCT01008150|20701910|P4|NOT COMPLETED|Overall Study||0
8399615|NCT01008150|20701911|P3|NOT COMPLETED|Overall Study||1
8399616|NCT01008150|20701912|P2|NOT COMPLETED|Overall Study||1
8399617|NCT01008150|20701913|P1|NOT COMPLETED|Overall Study||1
8399618|NCT01008150|20701910|P4|COMPLETED|Overall Study||12
8399619|NCT01008150|20701911|P3|COMPLETED|Overall Study||42
8399620|NCT01008150|20701912|P2|COMPLETED|Overall Study||42
8399621|NCT01008150|20701913|P1|COMPLETED|Overall Study||42
8399622|NCT01008150|20701910|P4|STARTED|Overall Study||12
8399623|NCT01008150|20701911|P3|STARTED|Overall Study||43
8399624|NCT01008150|20701912|P2|STARTED|Overall Study||43
8399625|NCT01008150|20701913|P1|STARTED|Overall Study||43
8399626|NCT01008059|20701943|P8|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399627|NCT01008059|20701944|P7|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399628|NCT01008059|20701945|P6|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399629|NCT01008059|20701946|P5|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399630|NCT01008059|20701947|P4|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399631|NCT01008059|20701948|P3|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399632|NCT01008059|20701949|P2|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399633|NCT01008059|20701950|P1|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399634|NCT01008059|20701943|P8|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
8399635|NCT01008059|20701944|P7|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399636|NCT01008059|20701945|P6|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399637|NCT01008059|20701946|P5|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399638|NCT01008059|20701947|P4|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399639|NCT01008059|20701948|P3|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399640|NCT01008059|20701949|P2|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399641|NCT01008059|20701950|P1|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399642|NCT01008059|20701943|P8|STARTED|Ketoconazole Simultaneous Alfentanil||6
8399643|NCT01008059|20701944|P7|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399644|NCT01008059|20701945|P6|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399645|NCT01008059|20701946|P5|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399646|NCT01008059|20701947|P4|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399647|NCT01008059|20701948|P3|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399648|NCT01008059|20701949|P2|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399649|NCT01008059|20701950|P1|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399650|NCT01008059|20701943|P8|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399651|NCT01008059|20701944|P7|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399652|NCT01008059|20701945|P6|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399653|NCT01008059|20701946|P5|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399654|NCT01008059|20701947|P4|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399655|NCT01008059|20701948|P3|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399656|NCT01008059|20701949|P2|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399657|NCT01008059|20701950|P1|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399658|NCT01008059|20701943|P8|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399659|NCT01008059|20701944|P7|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
8399660|NCT01008059|20701945|P6|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399661|NCT01008059|20701946|P5|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399662|NCT01008059|20701947|P4|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399663|NCT01008059|20701948|P3|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399664|NCT01008059|20701949|P2|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399665|NCT01008059|20701950|P1|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399666|NCT01008059|20701943|P8|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399667|NCT01008059|20701944|P7|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
8399668|NCT01008059|20701945|P6|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399669|NCT01008059|20701946|P5|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399670|NCT01008059|20701947|P4|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399671|NCT01008059|20701948|P3|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399672|NCT01008059|20701949|P2|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399673|NCT01008059|20701950|P1|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399674|NCT01008059|20701943|P8|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399675|NCT01008059|20701944|P7|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399676|NCT01008059|20701945|P6|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399677|NCT01008059|20701946|P5|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399678|NCT01008059|20701947|P4|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399679|NCT01008059|20701948|P3|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399680|NCT01008059|20701949|P2|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399681|NCT01008059|20701950|P1|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399682|NCT01008059|20701943|P8|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399683|NCT01008059|20701944|P7|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399684|NCT01008059|20701945|P6|COMPLETED|Rifampin Simultaneous Alfentanil||6
8399685|NCT01008059|20701946|P5|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399686|NCT01008059|20701947|P4|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399687|NCT01008059|20701948|P3|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399688|NCT01008059|20701949|P2|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399689|NCT01008059|20701950|P1|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399690|NCT01008059|20701943|P8|STARTED|Rifampin Simultaneous Alfentanil||0
8399691|NCT01008059|20701944|P7|STARTED|Rifampin Simultaneous Alfentanil||0
8399692|NCT01008059|20701945|P6|STARTED|Rifampin Simultaneous Alfentanil||6
8399693|NCT01008059|20701946|P5|STARTED|Rifampin Simultaneous Alfentanil||0
8399694|NCT01008059|20701947|P4|STARTED|Rifampin Simultaneous Alfentanil||0
8399695|NCT01008059|20701948|P3|STARTED|Rifampin Simultaneous Alfentanil||0
8399696|NCT01008059|20701949|P2|STARTED|Rifampin Simultaneous Alfentanil||0
8399697|NCT01008059|20701950|P1|STARTED|Rifampin Simultaneous Alfentanil||0
8399698|NCT01008059|20701943|P8|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399699|NCT01008059|20701944|P7|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399700|NCT01008059|20701945|P6|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399701|NCT01008059|20701946|P5|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399702|NCT01008059|20701947|P4|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399703|NCT01008059|20701948|P3|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399704|NCT01008059|20701949|P2|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399705|NCT01008059|20701950|P1|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399706|NCT01008059|20701943|P8|COMPLETED|Control Simultaneous Alfentanil||0
8399707|NCT01008059|20701944|P7|COMPLETED|Control Simultaneous Alfentanil||0
8399708|NCT01008059|20701945|P6|COMPLETED|Control Simultaneous Alfentanil||0
8399709|NCT01008059|20701946|P5|COMPLETED|Control Simultaneous Alfentanil||6
8399710|NCT01008059|20701947|P4|COMPLETED|Control Simultaneous Alfentanil||0
8399711|NCT01008059|20701948|P3|COMPLETED|Control Simultaneous Alfentanil||0
8399712|NCT01008059|20701949|P2|COMPLETED|Control Simultaneous Alfentanil||0
8399713|NCT01008059|20701950|P1|COMPLETED|Control Simultaneous Alfentanil||0
8399714|NCT01008059|20701943|P8|STARTED|Control Simultaneous Alfentanil||0
8399715|NCT01008059|20701944|P7|STARTED|Control Simultaneous Alfentanil||0
8399716|NCT01008059|20701945|P6|STARTED|Control Simultaneous Alfentanil||0
8399717|NCT01008059|20701946|P5|STARTED|Control Simultaneous Alfentanil||6
8399718|NCT01008059|20701947|P4|STARTED|Control Simultaneous Alfentanil||0
8399719|NCT01008059|20701948|P3|STARTED|Control Simultaneous Alfentanil||0
8399720|NCT01008059|20701949|P2|STARTED|Control Simultaneous Alfentanil||0
8399721|NCT01008059|20701950|P1|STARTED|Control Simultaneous Alfentanil||0
8399722|NCT01008059|20701943|P8|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399723|NCT01008059|20701944|P7|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399724|NCT01008059|20701945|P6|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399725|NCT01008059|20701946|P5|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399726|NCT01008059|20701947|P4|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399727|NCT01008059|20701948|P3|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399728|NCT01008059|20701949|P2|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399729|NCT01008059|20701950|P1|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399730|NCT01008059|20701943|P8|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399731|NCT01008059|20701944|P7|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399732|NCT01008059|20701945|P6|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399733|NCT01008059|20701946|P5|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399734|NCT01008059|20701947|P4|COMPLETED|Ketoconazole Sequential Alfentanil||6
8399735|NCT01008059|20701948|P3|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399736|NCT01008059|20701949|P2|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399737|NCT01008059|20701950|P1|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399738|NCT01008059|20701943|P8|STARTED|Ketoconazole Sequential Alfentanil||0
8399739|NCT01008059|20701944|P7|STARTED|Ketoconazole Sequential Alfentanil||0
8399740|NCT01008059|20701945|P6|STARTED|Ketoconazole Sequential Alfentanil||0
8399741|NCT01008059|20701946|P5|STARTED|Ketoconazole Sequential Alfentanil||0
8399742|NCT01008059|20701947|P4|STARTED|Ketoconazole Sequential Alfentanil||6
8399743|NCT01008059|20701948|P3|STARTED|Ketoconazole Sequential Alfentanil||0
8399744|NCT01008059|20701949|P2|STARTED|Ketoconazole Sequential Alfentanil||0
8399745|NCT01008059|20701950|P1|STARTED|Ketoconazole Sequential Alfentanil||0
8399746|NCT01008059|20701943|P8|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399747|NCT01008059|20701944|P7|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399748|NCT01008059|20701945|P6|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399749|NCT01008059|20701946|P5|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399750|NCT01008059|20701947|P4|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399751|NCT01008059|20701948|P3|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399752|NCT01008059|20701949|P2|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399753|NCT01008059|20701950|P1|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399754|NCT01008059|20701943|P8|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399755|NCT01008059|20701944|P7|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399756|NCT01008059|20701945|P6|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399757|NCT01008059|20701946|P5|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399758|NCT01008059|20701947|P4|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399759|NCT01008059|20701948|P3|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
8399760|NCT01008059|20701949|P2|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399761|NCT01008059|20701950|P1|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399762|NCT01008059|20701943|P8|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399763|NCT01008059|20701944|P7|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399764|NCT01008059|20701945|P6|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399765|NCT01008059|20701946|P5|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399766|NCT01008059|20701947|P4|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399767|NCT01008059|20701948|P3|STARTED|Grapefruit Juice Sequential Alfentanil||6
8399768|NCT01008059|20701949|P2|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399769|NCT01008059|20701950|P1|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399770|NCT01008059|20701943|P8|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399771|NCT01008059|20701944|P7|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399772|NCT01008059|20701945|P6|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399773|NCT01008059|20701946|P5|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399774|NCT01008059|20701947|P4|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399775|NCT01008059|20701948|P3|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399776|NCT01008059|20701949|P2|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399777|NCT01008059|20701950|P1|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399778|NCT01008059|20701943|P8|COMPLETED|Rifampin Sequential Alfentanil||0
8399779|NCT01008059|20701944|P7|COMPLETED|Rifampin Sequential Alfentanil||0
8399780|NCT01008059|20701945|P6|COMPLETED|Rifampin Sequential Alfentanil||0
8399781|NCT01008059|20701946|P5|COMPLETED|Rifampin Sequential Alfentanil||0
8399782|NCT01008059|20701947|P4|COMPLETED|Rifampin Sequential Alfentanil||0
8399783|NCT01008059|20701948|P3|COMPLETED|Rifampin Sequential Alfentanil||0
8399784|NCT01008059|20701949|P2|COMPLETED|Rifampin Sequential Alfentanil||6
8399785|NCT01008059|20701950|P1|COMPLETED|Rifampin Sequential Alfentanil||0
8399786|NCT01008059|20701943|P8|STARTED|Rifampin Sequential Alfentanil||0
8399787|NCT01008059|20701944|P7|STARTED|Rifampin Sequential Alfentanil||0
8399788|NCT01008059|20701945|P6|STARTED|Rifampin Sequential Alfentanil||0
8399789|NCT01008059|20701946|P5|STARTED|Rifampin Sequential Alfentanil||0
8399790|NCT01008059|20701947|P4|STARTED|Rifampin Sequential Alfentanil||0
8399791|NCT01008059|20701948|P3|STARTED|Rifampin Sequential Alfentanil||0
8399792|NCT01008059|20701949|P2|STARTED|Rifampin Sequential Alfentanil||6
8399793|NCT01008059|20701950|P1|STARTED|Rifampin Sequential Alfentanil||0
8399794|NCT01008059|20701943|P8|NOT COMPLETED|Control Sequential Alfentanil||0
8399795|NCT01008059|20701944|P7|NOT COMPLETED|Control Sequential Alfentanil||0
8399796|NCT01008059|20701945|P6|NOT COMPLETED|Control Sequential Alfentanil||0
8399797|NCT01008059|20701946|P5|NOT COMPLETED|Control Sequential Alfentanil||0
8399798|NCT01008059|20701947|P4|NOT COMPLETED|Control Sequential Alfentanil||0
8399799|NCT01008059|20701948|P3|NOT COMPLETED|Control Sequential Alfentanil||0
8399800|NCT01008059|20701949|P2|NOT COMPLETED|Control Sequential Alfentanil||0
8399801|NCT01008059|20701950|P1|NOT COMPLETED|Control Sequential Alfentanil||0
8399802|NCT01008059|20701943|P8|COMPLETED|Control Sequential Alfentanil||0
8399803|NCT01008059|20701944|P7|COMPLETED|Control Sequential Alfentanil||0
8399804|NCT01008059|20701945|P6|COMPLETED|Control Sequential Alfentanil||0
8399805|NCT01008059|20701946|P5|COMPLETED|Control Sequential Alfentanil||0
8399806|NCT01008059|20701947|P4|COMPLETED|Control Sequential Alfentanil||0
8399807|NCT01008059|20701948|P3|COMPLETED|Control Sequential Alfentanil||0
8399808|NCT01008059|20701949|P2|COMPLETED|Control Sequential Alfentanil||0
8399809|NCT01008059|20701950|P1|COMPLETED|Control Sequential Alfentanil||6
8399810|NCT01008059|20701943|P8|STARTED|Control Sequential Alfentanil||0
8399811|NCT01008059|20701944|P7|STARTED|Control Sequential Alfentanil||0
8399812|NCT01008059|20701945|P6|STARTED|Control Sequential Alfentanil||0
8399813|NCT01008059|20701946|P5|STARTED|Control Sequential Alfentanil||0
8399814|NCT01008059|20701947|P4|STARTED|Control Sequential Alfentanil||0
8399815|NCT01008059|20701948|P3|STARTED|Control Sequential Alfentanil||0
8399816|NCT01008059|20701949|P2|STARTED|Control Sequential Alfentanil||0
8399817|NCT01008059|20701950|P1|STARTED|Control Sequential Alfentanil||6
8399818|NCT01007916|20701961|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
8399819|NCT01007916|20701962|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
8399820|NCT01007916|20701961|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
8399821|NCT01007916|20701962|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
8399822|NCT01007916|20701961|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
8399823|NCT01007916|20701962|P1|STARTED|Period 2, 4 Weeks of Wear||22
8399824|NCT01007916|20701961|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
8399825|NCT01007916|20701962|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
8399826|NCT01007916|20701961|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
8399827|NCT01007916|20701962|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
8399828|NCT01007916|20701961|P2|STARTED|Period 1, 4 Weeks of Wear||26
8399829|NCT01007916|20701962|P1|STARTED|Period 1, 4 Weeks of Wear||23
8399830|NCT01007942|20701970|P2|NOT COMPLETED|Overall Study||278
8399831|NCT01007942|20701971|P1|NOT COMPLETED|Overall Study||281
8399832|NCT01007942|20701970|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
8399833|NCT01007942|20701971|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
8399834|NCT01007942|20701970|P2|STARTED|Overall Study||285
8399835|NCT01007942|20701971|P1|STARTED|Overall Study||284
8399836|NCT01007838|20701997|P4|NOT COMPLETED|Overall Study||0
8399837|NCT01007838|20701998|P3|NOT COMPLETED|Overall Study||0
8399838|NCT01007838|20701999|P2|NOT COMPLETED|Overall Study||0
8399839|NCT01007838|20702000|P1|NOT COMPLETED|Overall Study||3
8399840|NCT01007838|20701997|P4|COMPLETED|Overall Study||4
8399841|NCT01007838|20701998|P3|COMPLETED|Overall Study||5
8399842|NCT01007838|20701999|P2|COMPLETED|Overall Study||11
8399843|NCT01007838|20702000|P1|COMPLETED|Overall Study||9
8399844|NCT01007838|20701997|P4|STARTED|Overall Study||4
8399845|NCT01007838|20701998|P3|STARTED|Overall Study||5
8399846|NCT01007838|20701999|P2|STARTED|Overall Study||11
8399847|NCT01007838|20702000|P1|STARTED|Overall Study||12
8399848|NCT01007812|20702010|P2|NOT COMPLETED|Period 2, One Week||0
8399849|NCT01007812|20702011|P1|NOT COMPLETED|Period 2, One Week||0
8399850|NCT01007812|20702010|P2|COMPLETED|Period 2, One Week||24
8399851|NCT01007812|20702011|P1|COMPLETED|Period 2, One Week||24
8399852|NCT01007812|20702010|P2|STARTED|Period 2, One Week||24
8399853|NCT01007812|20702011|P1|STARTED|Period 2, One Week||24
8399854|NCT01007812|20702010|P2|NOT COMPLETED|Period 1, One Week||1
8399855|NCT01007812|20702011|P1|NOT COMPLETED|Period 1, One Week||1
8399856|NCT01007812|20702010|P2|COMPLETED|Period 1, One Week||24
8399857|NCT01007812|20702011|P1|COMPLETED|Period 1, One Week||24
8399858|NCT01007812|20702010|P2|STARTED|Period 1, One Week||25
8399859|NCT01007812|20702011|P1|STARTED|Period 1, One Week||25
8399860|NCT01007656|20702017|P1|NOT COMPLETED|Overall Study||0
8399861|NCT01007656|20702017|P1|COMPLETED|Overall Study||31
8399862|NCT01007656|20702017|P1|STARTED|Overall Study||31
8399863|NCT01007643|20702037|P2|NOT COMPLETED|Overall Study||0
8399864|NCT01007643|20702038|P1|NOT COMPLETED|Overall Study||0
8399865|NCT01007643|20702037|P2|COMPLETED|Overall Study||14
8399866|NCT01007643|20702038|P1|COMPLETED|Overall Study||8
8399867|NCT01007643|20702037|P2|STARTED|Overall Study||14
8399868|NCT01007643|20702038|P1|STARTED|Overall Study||8
8399869|NCT01007591|20702046|P2|NOT COMPLETED|Overall Study||1
8399870|NCT01007591|20702047|P1|NOT COMPLETED|Overall Study||1
8399871|NCT01007591|20702046|P2|COMPLETED|Overall Study||12
8399872|NCT01007591|20702047|P1|COMPLETED|Overall Study||26
8399873|NCT01007591|20702046|P2|STARTED|Overall Study||13
8399874|NCT01007591|20702047|P1|STARTED|Overall Study||27
8399875|NCT01007552|20702061|P1|NOT COMPLETED|Overall Study||1
8399876|NCT01007552|20702061|P1|COMPLETED|Overall Study||49
8399877|NCT01007552|20702061|P1|STARTED|Overall Study||50
8399878|NCT01007526|20702071|P1|NOT COMPLETED|Overall Study||0
8399879|NCT01007526|20702071|P1|COMPLETED|Overall Study||31
8399880|NCT01007526|20702071|P1|STARTED|Overall Study||31
8399881|NCT01007448|20702077|P2|NOT COMPLETED|Overall Study||9
8399882|NCT01007448|20702078|P1|NOT COMPLETED|Overall Study||10
8399883|NCT01007448|20702077|P2|COMPLETED|Overall Study||20
8399884|NCT01007448|20702078|P1|COMPLETED|Overall Study||20
8399885|NCT01007448|20702077|P2|Safety Population|Overall Study||29
8399886|NCT01007448|20702078|P1|Safety Population|Overall Study||30
8399887|NCT01007448|20702077|P2|Full Analysis Population|Overall Study||29
8399888|NCT01007448|20702078|P1|Full Analysis Population|Overall Study||30
8399889|NCT01007448|20702077|P2|STARTED|Overall Study||29
8399890|NCT01007448|20702078|P1|STARTED|Overall Study||30
8399891|NCT01007435|20702110|P4|NOT COMPLETED|Overall Study||56
8399892|NCT01007435|20702111|P3|NOT COMPLETED|Overall Study||64
8399893|NCT01007435|20702112|P2|NOT COMPLETED|Overall Study||59
8399894|NCT01007435|20702113|P1|NOT COMPLETED|Overall Study||63
8399895|NCT01007435|20702110|P4|COMPLETED|Overall Study||236
8399896|NCT01007435|20702111|P3|COMPLETED|Overall Study||227
8399897|NCT01007435|20702112|P2|COMPLETED|Overall Study||231
8399898|NCT01007435|20702113|P1|COMPLETED|Overall Study||226
8399899|NCT01007435|20702110|P4|STARTED|Overall Study||292
8399900|NCT01007435|20702111|P3|STARTED|Overall Study||291
8399901|NCT01007435|20702112|P2|STARTED|Overall Study||290
8399902|NCT01007435|20702113|P1|STARTED|Overall Study||289
8399903|NCT01007396|20702155|P1|NOT COMPLETED|Overall Study||47
8399904|NCT01007396|20702155|P1|COMPLETED|Overall Study||275
8399905|NCT01007396|20702155|P1|STARTED|Overall Study||322
8399906|NCT01007253|20702160|P4|NOT COMPLETED|Fourth Intervention||0
8399907|NCT01007253|20702161|P3|NOT COMPLETED|Fourth Intervention||0
8399908|NCT01007253|20702162|P2|NOT COMPLETED|Fourth Intervention||0
8399909|NCT01007253|20702163|P1|NOT COMPLETED|Fourth Intervention||0
8399910|NCT01007253|20702160|P4|COMPLETED|Fourth Intervention||5
8399911|NCT01007253|20702161|P3|COMPLETED|Fourth Intervention||5
8399912|NCT01007253|20702162|P2|COMPLETED|Fourth Intervention||5
8399913|NCT01007253|20702163|P1|COMPLETED|Fourth Intervention||5
8399914|NCT01007253|20702160|P4|STARTED|Fourth Intervention||5
8399915|NCT01007253|20702161|P3|STARTED|Fourth Intervention||5
8399916|NCT01007253|20702162|P2|STARTED|Fourth Intervention||5
8399917|NCT01007253|20702163|P1|STARTED|Fourth Intervention||5
8399918|NCT01007253|20702160|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8399919|NCT01007253|20702161|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8399920|NCT01007253|20702162|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8399921|NCT01007253|20702163|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
8399922|NCT01007253|20702160|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
8399923|NCT01007253|20702161|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
8399924|NCT01007253|20702162|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
8399925|NCT01007253|20702163|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
8399926|NCT01007253|20702160|P4|STARTED|Washout Period (2 Weeks) # 3||5
8399927|NCT01007253|20702161|P3|STARTED|Washout Period (2 Weeks) # 3||5
8399928|NCT01007253|20702162|P2|STARTED|Washout Period (2 Weeks) # 3||5
8399929|NCT01007253|20702163|P1|STARTED|Washout Period (2 Weeks) # 3||6
8399930|NCT01007253|20702160|P4|NOT COMPLETED|Third Intervention||0
8399931|NCT01007253|20702161|P3|NOT COMPLETED|Third Intervention||0
8399932|NCT01007253|20702162|P2|NOT COMPLETED|Third Intervention||0
8399933|NCT01007253|20702163|P1|NOT COMPLETED|Third Intervention||0
8399934|NCT01007253|20702160|P4|COMPLETED|Third Intervention||5
8399935|NCT01007253|20702161|P3|COMPLETED|Third Intervention||5
8399936|NCT01007253|20702162|P2|COMPLETED|Third Intervention||5
8399937|NCT01007253|20702163|P1|COMPLETED|Third Intervention||6
8399938|NCT01007253|20702160|P4|STARTED|Third Intervention||5
8399939|NCT01007253|20702161|P3|STARTED|Third Intervention||5
8399940|NCT01007253|20702162|P2|STARTED|Third Intervention||5
8399941|NCT01007253|20702163|P1|STARTED|Third Intervention||6
8399942|NCT01007253|20702160|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399943|NCT01007253|20702161|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399944|NCT01007253|20702162|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399945|NCT01007253|20702163|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399946|NCT01007253|20702160|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
8399947|NCT01007253|20702161|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
8399948|NCT01007253|20702162|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
8399949|NCT01007253|20702163|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
8399950|NCT01007253|20702160|P4|STARTED|Washout Period (2 Weeks) # 2||5
8399951|NCT01007253|20702161|P3|STARTED|Washout Period (2 Weeks) # 2||5
8399952|NCT01007253|20702162|P2|STARTED|Washout Period (2 Weeks) # 2||5
8399953|NCT01007253|20702163|P1|STARTED|Washout Period (2 Weeks) # 2||6
8399954|NCT01007253|20702160|P4|NOT COMPLETED|Second Intervention||0
8399955|NCT01007253|20702161|P3|NOT COMPLETED|Second Intervention||0
8399956|NCT01007253|20702162|P2|NOT COMPLETED|Second Intervention||0
8399957|NCT01007253|20702163|P1|NOT COMPLETED|Second Intervention||0
8399958|NCT01007253|20702160|P4|COMPLETED|Second Intervention||5
8399959|NCT01007253|20702161|P3|COMPLETED|Second Intervention||5
8399960|NCT01007253|20702162|P2|COMPLETED|Second Intervention||5
8399961|NCT01007253|20702163|P1|COMPLETED|Second Intervention||6
8399962|NCT01007253|20702160|P4|STARTED|Second Intervention||5
8399963|NCT01007253|20702161|P3|STARTED|Second Intervention||5
8399964|NCT01007253|20702162|P2|STARTED|Second Intervention||5
8399965|NCT01007253|20702163|P1|STARTED|Second Intervention||6
8399966|NCT01007253|20702160|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399967|NCT01007253|20702161|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399968|NCT01007253|20702162|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399969|NCT01007253|20702163|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399970|NCT01007253|20702160|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
8399971|NCT01007253|20702161|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
8399972|NCT01007253|20702162|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
8399973|NCT01007253|20702163|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
8399974|NCT01007253|20702160|P4|STARTED|Washout Period (2 Weeks) # 1||5
8399975|NCT01007253|20702161|P3|STARTED|Washout Period (2 Weeks) # 1||5
8399976|NCT01007253|20702162|P2|STARTED|Washout Period (2 Weeks) # 1||5
8399977|NCT01007253|20702163|P1|STARTED|Washout Period (2 Weeks) # 1||6
8399978|NCT01007253|20702160|P4|NOT COMPLETED|First Intervention||0
8399979|NCT01007253|20702161|P3|NOT COMPLETED|First Intervention||0
8399980|NCT01007253|20702162|P2|NOT COMPLETED|First Intervention||0
8399981|NCT01007253|20702163|P1|NOT COMPLETED|First Intervention||0
8399982|NCT01007253|20702160|P4|COMPLETED|First Intervention||5
8399983|NCT01007253|20702161|P3|COMPLETED|First Intervention||5
8399984|NCT01007253|20702162|P2|COMPLETED|First Intervention||5
8399985|NCT01007253|20702163|P1|COMPLETED|First Intervention||6
8399986|NCT01007253|20702160|P4|STARTED|First Intervention||5
8399987|NCT01007253|20702161|P3|STARTED|First Intervention||5
8399988|NCT01007253|20702162|P2|STARTED|First Intervention||5
8399989|NCT01007253|20702163|P1|STARTED|First Intervention||6
8399990|NCT01007149|20702195|P2|NOT COMPLETED|Overall Study||1
8399991|NCT01007149|20702196|P1|NOT COMPLETED|Overall Study||0
8399992|NCT01007149|20702195|P2|COMPLETED|Overall Study||20
8399993|NCT01007149|20702196|P1|COMPLETED|Overall Study||20
8399994|NCT01007149|20702195|P2|STARTED|Overall Study||21
8399995|NCT01007149|20702196|P1|STARTED|Overall Study||20
8399996|NCT01007136|20702223|P5|NOT COMPLETED|Overall Study||0
8399997|NCT01007136|20702224|P4|NOT COMPLETED|Overall Study||0
8399998|NCT01007136|20702225|P3|NOT COMPLETED|Overall Study||0
8399999|NCT01007136|20702226|P2|NOT COMPLETED|Overall Study||4
8400000|NCT01007136|20702227|P1|NOT COMPLETED|Overall Study||4
8400001|NCT01007136|20702223|P5|COMPLETED|Overall Study||4
8400002|NCT01007136|20702224|P4|COMPLETED|Overall Study||6
8400003|NCT01007136|20702225|P3|COMPLETED|Overall Study||15
8400004|NCT01007136|20702226|P2|COMPLETED|Overall Study||13
8400005|NCT01007136|20702227|P1|COMPLETED|Overall Study||15
8400006|NCT01007136|20702223|P5|STARTED|Overall Study||4
8400007|NCT01007136|20702224|P4|STARTED|Overall Study||6
8400008|NCT01007136|20702225|P3|STARTED|Overall Study||15
8400009|NCT01007136|20702226|P2|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
8400010|NCT01007136|20702227|P1|STARTED|Overall Study||19
8400011|NCT01007123|20702270|P4|NOT COMPLETED|Overall Study||6
8400012|NCT01007123|20702271|P3|NOT COMPLETED|Overall Study||11
8400013|NCT01007123|20702272|P2|NOT COMPLETED|Overall Study||6
8400014|NCT01007123|20702273|P1|NOT COMPLETED|Overall Study||6
8400015|NCT01007123|20702270|P4|COMPLETED|Overall Study||41
8400016|NCT01007123|20702271|P3|COMPLETED|Overall Study||37
8400017|NCT01007123|20702272|P2|COMPLETED|Overall Study||41
8400018|NCT01007123|20702273|P1|COMPLETED|Overall Study||42
8400019|NCT01007123|20702270|P4|STARTED|Overall Study||47
8400020|NCT01007123|20702271|P3|STARTED|Overall Study||48
8400021|NCT01007123|20702272|P2|STARTED|Overall Study||47
8400022|NCT01007123|20702273|P1|STARTED|Overall Study||48
8400023|NCT01007110|20702304|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
8400024|NCT01007110|20702305|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
8400025|NCT01007110|20702304|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
8400026|NCT01007110|20702305|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
8400027|NCT01007110|20702304|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
8400028|NCT01007110|20702305|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
8400029|NCT01007110|20702304|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
8400030|NCT01007110|20702305|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
8400031|NCT01007110|20702304|P2|COMPLETED|Follow-Up at 36 Weeks||20
8400032|NCT01007110|20702305|P1|COMPLETED|Follow-Up at 36 Weeks||24
8400033|NCT01007110|20702304|P2|STARTED|Follow-Up at 36 Weeks||22
8400034|NCT01007110|20702305|P1|STARTED|Follow-Up at 36 Weeks||24
8400035|NCT01007110|20702304|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
8400036|NCT01007110|20702305|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
8400037|NCT01007110|20702304|P2|COMPLETED|Follow-Up at 32 Weeks||22
8400038|NCT01007110|20702305|P1|COMPLETED|Follow-Up at 32 Weeks||24
8400039|NCT01007110|20702304|P2|STARTED|Follow-Up at 32 Weeks||23
8400040|NCT01007110|20702305|P1|STARTED|Follow-Up at 32 Weeks||25
8400041|NCT01007110|20702304|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
8400042|NCT01007110|20702305|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
8400043|NCT01007110|20702304|P2|COMPLETED|Follow-Up at 24 Weeks||23
8400044|NCT01007110|20702305|P1|COMPLETED|Follow-Up at 24 Weeks||25
8400045|NCT01007110|20702304|P2|STARTED|Follow-Up at 24 Weeks||27
8400046|NCT01007110|20702305|P1|STARTED|Follow-Up at 24 Weeks||25
8400047|NCT01007110|20702304|P2|NOT COMPLETED|Allocation||8
8400048|NCT01007110|20702305|P1|NOT COMPLETED|Allocation||7
8400049|NCT01007110|20702304|P2|COMPLETED|Allocation||27
8400050|NCT01007110|20702305|P1|COMPLETED|Allocation||25
8400051|NCT01007110|20702304|P2|STARTED|Allocation||35
8400052|NCT01007110|20702305|P1|STARTED|Allocation||32
8400053|NCT01007071|20702321|P2|NOT COMPLETED|Overall Study||0
8400054|NCT01007071|20702322|P1|NOT COMPLETED|Overall Study||0
8400055|NCT01007071|20702321|P2|COMPLETED|Overall Study||5
8400056|NCT01007071|20702322|P1|COMPLETED|Overall Study||6
8400057|NCT01007071|20702321|P2|STARTED|Overall Study||5
8400058|NCT01007071|20702322|P1|STARTED|Overall Study||6
8400059|NCT01007032|20702334|P4|NOT COMPLETED|Overall Study||1
8400060|NCT01007032|20702335|P3|NOT COMPLETED|Overall Study||1
8400061|NCT01007032|20702336|P2|NOT COMPLETED|Overall Study||1
8400062|NCT01007032|20702337|P1|NOT COMPLETED|Overall Study||0
8400063|NCT01007032|20702334|P4|COMPLETED|Overall Study||6
8400064|NCT01007032|20702335|P3|COMPLETED|Overall Study||2
8400065|NCT01007032|20702336|P2|COMPLETED|Overall Study||6
8400066|NCT01007032|20702337|P1|COMPLETED|Overall Study||4
8400067|NCT01007032|20702334|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8400068|NCT01007032|20702335|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8400069|NCT01007032|20702336|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
8400070|NCT01007032|20702337|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8400071|NCT01007032|20702334|P4|STARTED|Overall Study||7
8400072|NCT01007032|20702335|P3|STARTED|Overall Study||3
8400073|NCT01007032|20702336|P2|STARTED|Overall Study||7
8400074|NCT01007032|20702337|P1|STARTED|Overall Study||4
8400075|NCT01006980|20702381|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
8400076|NCT01006980|20702382|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8400077|NCT01006980|20702381|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8400078|NCT01006980|20702382|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8400079|NCT01006980|20702381|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
8400080|NCT01006980|20702382|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
8400081|NCT01006980|20702381|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
8400082|NCT01006980|20702382|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
8400083|NCT01006980|20702381|P2|COMPLETED|Vemurafenib and Dacarbazine||0
8400084|NCT01006980|20702382|P1|COMPLETED|Vemurafenib and Dacarbazine||0
8400085|NCT01006980|20702381|P2|Treated|Vemurafenib and Dacarbazine||293
8400086|NCT01006980|20702382|P1|Treated|Vemurafenib and Dacarbazine||336
8400087|NCT01006980|20702381|P2|STARTED|Vemurafenib and Dacarbazine||338
8400088|NCT01006980|20702382|P1|STARTED|Vemurafenib and Dacarbazine||337
8400089|NCT01006967|20702404|P2|NOT COMPLETED|Overall Study||63
8400090|NCT01006967|20702405|P1|NOT COMPLETED|Overall Study||66
8400091|NCT01006967|20702404|P2|COMPLETED|Overall Study||190
8400092|NCT01006967|20702405|P1|COMPLETED|Overall Study||187
8400093|NCT01006967|20702404|P2|3 Month Follow-up|Overall Study||210
8400094|NCT01006967|20702405|P1|3 Month Follow-up|Overall Study||212
8400095|NCT01006967|20702404|P2|Received Treatment|Overall Study||245
8400096|NCT01006967|20702405|P1|Received Treatment|Overall Study||245
8400097|NCT01006967|20702404|P2|STARTED|Overall Study||253
8400098|NCT01006967|20702405|P1|STARTED|Overall Study||253
8400099|NCT01006889|20702421|P1|NOT COMPLETED|Overall Study||3
8400100|NCT01006889|20702421|P1|COMPLETED|Overall Study||17
8400101|NCT01006889|20702421|P1|STARTED|Overall Study||20
8400102|NCT01006707|20702432|P3|NOT COMPLETED|Study Session 3||0
8400103|NCT01006707|20702433|P2|NOT COMPLETED|Study Session 3||0
8400104|NCT01006707|20702434|P1|NOT COMPLETED|Study Session 3||0
8400105|NCT01006707|20702432|P3|COMPLETED|Study Session 3||6
8400106|NCT01006707|20702433|P2|COMPLETED|Study Session 3||4
8400107|NCT01006707|20702434|P1|COMPLETED|Study Session 3||0
8400108|NCT01006707|20702432|P3|STARTED|Study Session 3||6
8400109|NCT01006707|20702433|P2|STARTED|Study Session 3||4
8400110|NCT01006707|20702434|P1|STARTED|Study Session 3||0
8400111|NCT01006707|20702432|P3|NOT COMPLETED|Study Session 2||0
8400112|NCT01006707|20702433|P2|NOT COMPLETED|Study Session 2||0
8400113|NCT01006707|20702434|P1|NOT COMPLETED|Study Session 2||0
8400114|NCT01006707|20702432|P3|COMPLETED|Study Session 2||6
8400115|NCT01006707|20702433|P2|COMPLETED|Study Session 2||4
8400116|NCT01006707|20702434|P1|COMPLETED|Study Session 2||0
8400117|NCT01006707|20702432|P3|STARTED|Study Session 2||6
8400118|NCT01006707|20702433|P2|STARTED|Study Session 2||4
8400119|NCT01006707|20702434|P1|STARTED|Study Session 2||0
8400120|NCT01006707|20702432|P3|NOT COMPLETED|Study Session 1||0
8400121|NCT01006707|20702433|P2|NOT COMPLETED|Study Session 1||0
8400122|NCT01006707|20702434|P1|NOT COMPLETED|Study Session 1||5
8400123|NCT01006707|20702432|P3|COMPLETED|Study Session 1||0
8400124|NCT01006707|20702433|P2|COMPLETED|Study Session 1||0
8400125|NCT01006707|20702434|P1|COMPLETED|Study Session 1||10
8400126|NCT01006707|20702432|P3|STARTED|Study Session 1||0
8400127|NCT01006707|20702433|P2|STARTED|Study Session 1||0
8400128|NCT01006707|20702434|P1|STARTED|Study Session 1||15
8400129|NCT01006655|20702447|P2|NOT COMPLETED|Second Intervention||0
8400130|NCT01006655|20702448|P1|NOT COMPLETED|Second Intervention||0
8400131|NCT01006655|20702447|P2|COMPLETED|Second Intervention||10
8400132|NCT01006655|20702448|P1|COMPLETED|Second Intervention||11
8400133|NCT01006655|20702447|P2|STARTED|Second Intervention||10
8400134|NCT01006655|20702448|P1|STARTED|Second Intervention||11
8400135|NCT01006655|20702447|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8400136|NCT01006655|20702448|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8400137|NCT01006655|20702447|P2|COMPLETED|Washout Period of 2 Weeks||10
8400138|NCT01006655|20702448|P1|COMPLETED|Washout Period of 2 Weeks||11
8400139|NCT01006655|20702447|P2|STARTED|Washout Period of 2 Weeks||10
8400140|NCT01006655|20702448|P1|STARTED|Washout Period of 2 Weeks||11
8400141|NCT01006655|20702447|P2|NOT COMPLETED|First Intervention||0
8400142|NCT01006655|20702448|P1|NOT COMPLETED|First Intervention||0
8400143|NCT01006655|20702447|P2|COMPLETED|First Intervention||10
8400144|NCT01006655|20702448|P1|COMPLETED|First Intervention||11
8400145|NCT01006655|20702447|P2|STARTED|First Intervention||10
8400146|NCT01006655|20702448|P1|STARTED|First Intervention||11
8400147|NCT01006629|20702454|P1|NOT COMPLETED|Overall Study||6
8400148|NCT01006629|20702454|P1|COMPLETED|Overall Study||94
8400149|NCT01006629|20702454|P1|STARTED|Overall Study||100
8400150|NCT01006616|20702469|P4|NOT COMPLETED|Period 2 (18 Months)||82
8400151|NCT01006616|20702470|P3|NOT COMPLETED|Period 2 (18 Months)||55
8400152|NCT01006616|20702471|P2|NOT COMPLETED|Period 2 (18 Months)||63
8400153|NCT01006616|20702472|P1|NOT COMPLETED|Period 2 (18 Months)||75
8400154|NCT01006616|20702469|P4|COMPLETED|Period 2 (18 Months)||0
8400155|NCT01006616|20702470|P3|COMPLETED|Period 2 (18 Months)||0
8400156|NCT01006616|20702471|P2|COMPLETED|Period 2 (18 Months)||0
8400157|NCT01006616|20702472|P1|COMPLETED|Period 2 (18 Months)||0
8400158|NCT01006616|20702469|P4|Treated|Period 2 (18 Months)||82
8400159|NCT01006616|20702470|P3|Treated|Period 2 (18 Months)||55
8400160|NCT01006616|20702471|P2|Treated|Period 2 (18 Months)||63
8400161|NCT01006616|20702472|P1|Treated|Period 2 (18 Months)||75
8400162|NCT01006616|20702469|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
8400163|NCT01006616|20702470|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
8400164|NCT01006616|20702471|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
8400165|NCT01006616|20702472|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
8400166|NCT01006616|20702469|P4|NOT COMPLETED|Period 1 (6 Months)||27
8400167|NCT01006616|20702470|P3|NOT COMPLETED|Period 1 (6 Months)||51
8400168|NCT01006616|20702471|P2|NOT COMPLETED|Period 1 (6 Months)||54
8400169|NCT01006616|20702472|P1|NOT COMPLETED|Period 1 (6 Months)||26
8400170|NCT01006616|20702469|P4|COMPLETED|Period 1 (6 Months)||128
8400171|NCT01006616|20702470|P3|COMPLETED|Period 1 (6 Months)||102
8400172|NCT01006616|20702471|P2|COMPLETED|Period 1 (6 Months)||102
8400173|NCT01006616|20702472|P1|COMPLETED|Period 1 (6 Months)||126
8400174|NCT01006616|20702469|P4|Treated|Period 1 (6 Months)||154
8400175|NCT01006616|20702470|P3|Treated|Period 1 (6 Months)||152
8400176|NCT01006616|20702471|P2|Treated|Period 1 (6 Months)||156
8400177|NCT01006616|20702472|P1|Treated|Period 1 (6 Months)||152
8400178|NCT01006616|20702469|P4|STARTED|Period 1 (6 Months)||155
8400179|NCT01006616|20702470|P3|STARTED|Period 1 (6 Months)||153
8400180|NCT01006616|20702471|P2|STARTED|Period 1 (6 Months)||156
8400181|NCT01006616|20702472|P1|STARTED|Period 1 (6 Months)||152
8400182|NCT01006603|20702608|P2|NOT COMPLETED|Overall Study||75
8400183|NCT01006603|20702609|P1|NOT COMPLETED|Overall Study||71
8400184|NCT01006603|20702608|P2|COMPLETED|Overall Study||285
8400185|NCT01006603|20702609|P1|COMPLETED|Overall Study||289
8400337|NCT01005966|20702799|P1|COMPLETED|Washout Period 2 (4 Days)||13
8400186|NCT01006603|20702608|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
8400187|NCT01006603|20702609|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
8400188|NCT01006590|20702629|P2|NOT COMPLETED|Overall Study||32
8400189|NCT01006590|20702630|P1|NOT COMPLETED|Overall Study||28
8400190|NCT01006590|20702629|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
8400191|NCT01006590|20702630|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
8400192|NCT01006590|20702629|P2|STARTED|Overall Study|Randomised and treated|139
8400193|NCT01006590|20702630|P1|STARTED|Overall Study|Randomised and treated|147
8400194|NCT01006538|20702648|P2|NOT COMPLETED|Overall Study||4
8400195|NCT01006538|20702649|P1|NOT COMPLETED|Overall Study||11
8400196|NCT01006538|20702648|P2|COMPLETED|Overall Study||115
8400197|NCT01006538|20702649|P1|COMPLETED|Overall Study||233
8400198|NCT01006538|20702648|P2|STARTED|Overall Study||119
8400199|NCT01006538|20702649|P1|STARTED|Overall Study||244
8400200|NCT01006356|20702669|P1|NOT COMPLETED|Overall Study||42
8400201|NCT01006356|20702669|P1|COMPLETED|Overall Study||99
8400202|NCT01006356|20702669|P1|STARTED|Overall Study||141
8400203|NCT01006291|20702684|P3|NOT COMPLETED|Overall Study||27
8400204|NCT01006291|20702685|P2|NOT COMPLETED|Overall Study||24
8400205|NCT01006291|20702686|P1|NOT COMPLETED|Overall Study||26
8400206|NCT01006291|20702684|P3|COMPLETED|Overall Study||203
8400207|NCT01006291|20702685|P2|COMPLETED|Overall Study||204
8400208|NCT01006291|20702686|P1|COMPLETED|Overall Study||203
8400209|NCT01006291|20702684|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
8400210|NCT01006291|20702685|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
8400211|NCT01006291|20702686|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
8400212|NCT01006291|20702684|P3|STARTED|Overall Study||230
8400213|NCT01006291|20702685|P2|STARTED|Overall Study||228
8400214|NCT01006291|20702686|P1|STARTED|Overall Study||229
8400215|NCT01006252|20702705|P2|NOT COMPLETED|Overall Study||0
8400216|NCT01006252|20702706|P1|NOT COMPLETED|Overall Study||0
8400217|NCT01006252|20702705|P2|COMPLETED|Overall Study||168
8400218|NCT01006252|20702706|P1|COMPLETED|Overall Study||168
8400219|NCT01006252|20702705|P2|Received Treatment|Overall Study||161
8400220|NCT01006252|20702706|P1|Received Treatment|Overall Study||164
8400221|NCT01006252|20702705|P2|STARTED|Overall Study||168
8400222|NCT01006252|20702706|P1|STARTED|Overall Study||168
8400223|NCT01006135|20702736|P1|NOT COMPLETED|Overall Study||140
8400224|NCT01006135|20702736|P1|COMPLETED|Overall Study||4712
8400225|NCT01006135|20702736|P1|STARTED|Overall Study||4852
8400226|NCT01006122|20702743|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
8400227|NCT01006122|20702744|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
8400228|NCT01006122|20702743|P2|COMPLETED|Second Double-blind Intervention Period||24
8400229|NCT01006122|20702744|P1|COMPLETED|Second Double-blind Intervention Period||29
8400230|NCT01006122|20702743|P2|STARTED|Second Double-blind Intervention Period||31
8400231|NCT01006122|20702744|P1|STARTED|Second Double-blind Intervention Period||31
8400232|NCT01006122|20702743|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8400233|NCT01006122|20702744|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8400234|NCT01006122|20702743|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
8400235|NCT01006122|20702744|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
8400236|NCT01006122|20702743|P2|STARTED|Wash-out Period (at Least 7 Days)||31
8400237|NCT01006122|20702744|P1|STARTED|Wash-out Period (at Least 7 Days)||31
8400238|NCT01006122|20702743|P2|NOT COMPLETED|First Double-blind Intervention Period||17
8400239|NCT01006122|20702744|P1|NOT COMPLETED|First Double-blind Intervention Period||16
8400240|NCT01006122|20702743|P2|COMPLETED|First Double-blind Intervention Period||31
8400241|NCT01006122|20702744|P1|COMPLETED|First Double-blind Intervention Period||31
8400242|NCT01006122|20702743|P2|STARTED|First Double-blind Intervention Period||48
8400243|NCT01006122|20702744|P1|STARTED|First Double-blind Intervention Period||47
8400244|NCT01006018|20702785|P3|NOT COMPLETED|Overall Study||0
8400245|NCT01006018|20702786|P2|NOT COMPLETED|Overall Study||0
8400246|NCT01006018|20702787|P1|NOT COMPLETED|Overall Study||0
8400247|NCT01006018|20702785|P3|COMPLETED|Overall Study||0
8400248|NCT01006018|20702786|P2|COMPLETED|Overall Study||0
8400249|NCT01006018|20702787|P1|COMPLETED|Overall Study||0
8400250|NCT01006018|20702785|P3|STARTED|Overall Study||0
8400251|NCT01006018|20702786|P2|STARTED|Overall Study||0
8400252|NCT01006018|20702787|P1|STARTED|Overall Study||0
8400253|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400254|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400255|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400256|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400257|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400258|NCT01005966|20702795|P5|COMPLETED|Treatment Period 5 (14 Days)||10
8400259|NCT01005966|20702796|P4|COMPLETED|Treatment Period 5 (14 Days)||11
8400260|NCT01005966|20702797|P3|COMPLETED|Treatment Period 5 (14 Days)||11
8400261|NCT01005966|20702798|P2|COMPLETED|Treatment Period 5 (14 Days)||12
8400262|NCT01005966|20702799|P1|COMPLETED|Treatment Period 5 (14 Days)||9
8400263|NCT01005966|20702795|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
8400264|NCT01005966|20702796|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
8400265|NCT01005966|20702797|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
8400338|NCT01005966|20702795|P5|STARTED|Washout Period 2 (4 Days)||11
8400266|NCT01005966|20702798|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
8400267|NCT01005966|20702799|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
8400268|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400269|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400270|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400271|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400272|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400273|NCT01005966|20702795|P5|COMPLETED|Washout Period 4 (4 Days)||12
8400274|NCT01005966|20702796|P4|COMPLETED|Washout Period 4 (4 Days)||10
8400275|NCT01005966|20702797|P3|COMPLETED|Washout Period 4 (4 Days)||11
8400276|NCT01005966|20702798|P2|COMPLETED|Washout Period 4 (4 Days)||10
8400277|NCT01005966|20702799|P1|COMPLETED|Washout Period 4 (4 Days)||10
8400278|NCT01005966|20702795|P5|STARTED|Washout Period 4 (4 Days)||12
8400279|NCT01005966|20702796|P4|STARTED|Washout Period 4 (4 Days)||10
8400280|NCT01005966|20702797|P3|STARTED|Washout Period 4 (4 Days)||11
8400281|NCT01005966|20702798|P2|STARTED|Washout Period 4 (4 Days)||10
8400282|NCT01005966|20702799|P1|STARTED|Washout Period 4 (4 Days)||10
8400283|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
8400284|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8400285|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8400286|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
8400287|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8400288|NCT01005966|20702795|P5|COMPLETED|Treatment Period 4 (14 Days)||12
8400289|NCT01005966|20702796|P4|COMPLETED|Treatment Period 4 (14 Days)||10
8400290|NCT01005966|20702797|P3|COMPLETED|Treatment Period 4 (14 Days)||11
8400291|NCT01005966|20702798|P2|COMPLETED|Treatment Period 4 (14 Days)||10
8400292|NCT01005966|20702799|P1|COMPLETED|Treatment Period 4 (14 Days)||10
8400293|NCT01005966|20702795|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
8400294|NCT01005966|20702796|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8400295|NCT01005966|20702797|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8400296|NCT01005966|20702798|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8400297|NCT01005966|20702799|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8400298|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400299|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400300|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400301|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400302|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400303|NCT01005966|20702795|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
8400304|NCT01005966|20702796|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
8400305|NCT01005966|20702797|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
8400306|NCT01005966|20702798|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
8400307|NCT01005966|20702799|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
8400308|NCT01005966|20702795|P5|STARTED|Washout Period 3 ( 4 Days)||11
8400309|NCT01005966|20702796|P4|STARTED|Washout Period 3 ( 4 Days)||13
8400310|NCT01005966|20702797|P3|STARTED|Washout Period 3 ( 4 Days)||12
8400311|NCT01005966|20702798|P2|STARTED|Washout Period 3 ( 4 Days)||7
8400312|NCT01005966|20702799|P1|STARTED|Washout Period 3 ( 4 Days)||12
8400313|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8400314|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8400315|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8400316|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8400317|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8400318|NCT01005966|20702795|P5|COMPLETED|Treatment Period 3 (14 Days)||11
8400319|NCT01005966|20702796|P4|COMPLETED|Treatment Period 3 (14 Days)||13
8400320|NCT01005966|20702797|P3|COMPLETED|Treatment Period 3 (14 Days)||12
8400321|NCT01005966|20702798|P2|COMPLETED|Treatment Period 3 (14 Days)||7
8400322|NCT01005966|20702799|P1|COMPLETED|Treatment Period 3 (14 Days)||12
8400323|NCT01005966|20702795|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8400324|NCT01005966|20702796|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
8400325|NCT01005966|20702797|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8400326|NCT01005966|20702798|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
8400327|NCT01005966|20702799|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8400328|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400329|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400330|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400331|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400332|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400333|NCT01005966|20702795|P5|COMPLETED|Washout Period 2 (4 Days)||11
8400334|NCT01005966|20702796|P4|COMPLETED|Washout Period 2 (4 Days)||11
8400335|NCT01005966|20702797|P3|COMPLETED|Washout Period 2 (4 Days)||10
8400336|NCT01005966|20702798|P2|COMPLETED|Washout Period 2 (4 Days)||12
8400339|NCT01005966|20702796|P4|STARTED|Washout Period 2 (4 Days)||11
8400340|NCT01005966|20702797|P3|STARTED|Washout Period 2 (4 Days)||10
8400341|NCT01005966|20702798|P2|STARTED|Washout Period 2 (4 Days)||12
8400342|NCT01005966|20702799|P1|STARTED|Washout Period 2 (4 Days)||13
8400343|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8400344|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8400345|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8400346|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8400347|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8400348|NCT01005966|20702795|P5|COMPLETED|Treatment Period 2 (14 Days)||11
8400349|NCT01005966|20702796|P4|COMPLETED|Treatment Period 2 (14 Days)||11
8400350|NCT01005966|20702797|P3|COMPLETED|Treatment Period 2 (14 Days)||10
8400351|NCT01005966|20702798|P2|COMPLETED|Treatment Period 2 (14 Days)||12
8400352|NCT01005966|20702799|P1|COMPLETED|Treatment Period 2 (14 Days)||13
8400353|NCT01005966|20702795|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
8400354|NCT01005966|20702796|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
8400355|NCT01005966|20702797|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
8400356|NCT01005966|20702798|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8400357|NCT01005966|20702799|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8400358|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400359|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
8400360|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400361|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400362|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400363|NCT01005966|20702795|P5|COMPLETED|Washout Period 1 (4 Days)||13
8400364|NCT01005966|20702796|P4|COMPLETED|Washout Period 1 (4 Days)||12
8400365|NCT01005966|20702797|P3|COMPLETED|Washout Period 1 (4 Days)||12
8400366|NCT01005966|20702798|P2|COMPLETED|Washout Period 1 (4 Days)||13
8400367|NCT01005966|20702799|P1|COMPLETED|Washout Period 1 (4 Days)||11
8400368|NCT01005966|20702795|P5|STARTED|Washout Period 1 (4 Days)||13
8400369|NCT01005966|20702796|P4|STARTED|Washout Period 1 (4 Days)||13
8400370|NCT01005966|20702797|P3|STARTED|Washout Period 1 (4 Days)||12
8400371|NCT01005966|20702798|P2|STARTED|Washout Period 1 (4 Days)||13
8400372|NCT01005966|20702799|P1|STARTED|Washout Period 1 (4 Days)||11
8400373|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8400374|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8400375|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8400376|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8400377|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8400378|NCT01005966|20702795|P5|COMPLETED|Treatment Period 1 (14 Days)||13
8400379|NCT01005966|20702796|P4|COMPLETED|Treatment Period 1 (14 Days)||13
8400380|NCT01005966|20702797|P3|COMPLETED|Treatment Period 1 (14 Days)||12
8400381|NCT01005966|20702798|P2|COMPLETED|Treatment Period 1 (14 Days)||13
8400382|NCT01005966|20702799|P1|COMPLETED|Treatment Period 1 (14 Days)||11
8400383|NCT01005966|20702795|P5|STARTED|Treatment Period 1 (14 Days)||13
8400384|NCT01005966|20702796|P4|STARTED|Treatment Period 1 (14 Days)||13
8400385|NCT01005966|20702797|P3|STARTED|Treatment Period 1 (14 Days)||13
8400386|NCT01005966|20702798|P2|STARTED|Treatment Period 1 (14 Days)||13
8400387|NCT01005966|20702799|P1|STARTED|Treatment Period 1 (14 Days)||13
8400388|NCT01005914|20702819|P1|NOT COMPLETED|Overall Study||10
8400389|NCT01005914|20702819|P1|COMPLETED|Overall Study||1
8400390|NCT01005914|20702819|P1|STARTED|Overall Study||11
8400391|NCT01005901|20702825|P2|NOT COMPLETED|Overall Study||58
8400392|NCT01005901|20702826|P1|NOT COMPLETED|Overall Study||102
8400393|NCT01005901|20702825|P2|COMPLETED|Overall Study||212
8400394|NCT01005901|20702826|P1|COMPLETED|Overall Study||450
8400395|NCT01005901|20702825|P2|Full Analysis Set|Overall Study||260
8400396|NCT01005901|20702826|P1|Full Analysis Set|Overall Study||534
8400397|NCT01005901|20702825|P2|Safety Population|Overall Study||267
8400398|NCT01005901|20702826|P1|Safety Population|Overall Study||550
8400399|NCT01005901|20702825|P2|STARTED|Overall Study||270
8400400|NCT01005901|20702826|P1|STARTED|Overall Study||552
8400401|NCT01005888|20702868|P2|NOT COMPLETED|Second Intervention||1
8400402|NCT01005888|20702869|P1|NOT COMPLETED|Second Intervention||1
8400403|NCT01005888|20702868|P2|COMPLETED|Second Intervention||10
8400404|NCT01005888|20702869|P1|COMPLETED|Second Intervention||10
8400405|NCT01005888|20702868|P2|STARTED|Second Intervention||11
8400406|NCT01005888|20702869|P1|STARTED|Second Intervention||11
8400407|NCT01005888|20702868|P2|NOT COMPLETED|First Intervention||1
8400408|NCT01005888|20702869|P1|NOT COMPLETED|First Intervention||1
8400409|NCT01005888|20702868|P2|COMPLETED|First Intervention||11
8400410|NCT01005888|20702869|P1|COMPLETED|First Intervention||11
8400411|NCT01005888|20702868|P2|STARTED|First Intervention||12
8400412|NCT01005888|20702869|P1|STARTED|First Intervention||12
8400413|NCT01005875|20702889|P1|NOT COMPLETED|Overall Study||3
8400414|NCT01005875|20702889|P1|COMPLETED|Overall Study||2
8400415|NCT01005875|20702889|P1|STARTED|Overall Study||5
8400416|NCT01005810|20702899|P2|NOT COMPLETED|Overall Study||25
8400417|NCT01005810|20702900|P1|NOT COMPLETED|Overall Study||21
8400418|NCT01005810|20702899|P2|COMPLETED|Overall Study||33
8400419|NCT01005810|20702900|P1|COMPLETED|Overall Study||37
8400420|NCT01005810|20702899|P2|STARTED|Overall Study||58
8400421|NCT01005810|20702900|P1|STARTED|Overall Study||58
8400422|NCT01005745|20702906|P1|NOT COMPLETED|Overall Study||6
8400423|NCT01005745|20702906|P1|COMPLETED|Overall Study||13
8400424|NCT01005745|20702906|P1|STARTED|Overall Study||19
8400425|NCT01005732|20702911|P1|NOT COMPLETED|Overall Study||11
8400426|NCT01005732|20702911|P1|COMPLETED|Overall Study||43
8400427|NCT01005732|20702911|P1|STARTED|Overall Study||54
8400428|NCT01005719|20702927|P6|NOT COMPLETED|Period 3||0
8400429|NCT01005719|20702928|P5|NOT COMPLETED|Period 3||0
8400430|NCT01005719|20702929|P4|NOT COMPLETED|Period 3||0
8400431|NCT01005719|20702930|P3|NOT COMPLETED|Period 3||0
8400432|NCT01005719|20702931|P2|NOT COMPLETED|Period 3||0
8400433|NCT01005719|20702932|P1|NOT COMPLETED|Period 3||0
8400434|NCT01005719|20702927|P6|COMPLETED|Period 3||9
8400435|NCT01005719|20702928|P5|COMPLETED|Period 3||10
8400436|NCT01005719|20702929|P4|COMPLETED|Period 3||10
8400437|NCT01005719|20702930|P3|COMPLETED|Period 3||10
8400438|NCT01005719|20702931|P2|COMPLETED|Period 3||10
8400439|NCT01005719|20702932|P1|COMPLETED|Period 3||10
8400440|NCT01005719|20702927|P6|STARTED|Period 3||9
8400441|NCT01005719|20702928|P5|STARTED|Period 3||10
8400442|NCT01005719|20702929|P4|STARTED|Period 3||10
8400443|NCT01005719|20702930|P3|STARTED|Period 3||10
8400444|NCT01005719|20702931|P2|STARTED|Period 3||10
8400445|NCT01005719|20702932|P1|STARTED|Period 3||10
8400446|NCT01005719|20702927|P6|NOT COMPLETED|Period 2||1
8400447|NCT01005719|20702928|P5|NOT COMPLETED|Period 2||1
8400448|NCT01005719|20702929|P4|NOT COMPLETED|Period 2||0
8400449|NCT01005719|20702930|P3|NOT COMPLETED|Period 2||0
8400450|NCT01005719|20702931|P2|NOT COMPLETED|Period 2||0
8400451|NCT01005719|20702932|P1|NOT COMPLETED|Period 2||0
8400452|NCT01005719|20702927|P6|COMPLETED|Period 2||9
8400453|NCT01005719|20702928|P5|COMPLETED|Period 2||10
8400454|NCT01005719|20702929|P4|COMPLETED|Period 2||10
8400455|NCT01005719|20702930|P3|COMPLETED|Period 2||10
8400456|NCT01005719|20702931|P2|COMPLETED|Period 2||10
8400457|NCT01005719|20702932|P1|COMPLETED|Period 2||10
8400458|NCT01005719|20702927|P6|STARTED|Period 2||10
8400459|NCT01005719|20702928|P5|STARTED|Period 2||11
8400460|NCT01005719|20702929|P4|STARTED|Period 2||10
8400461|NCT01005719|20702930|P3|STARTED|Period 2||10
8400462|NCT01005719|20702931|P2|STARTED|Period 2||10
8400463|NCT01005719|20702932|P1|STARTED|Period 2||10
8400464|NCT01005719|20702927|P6|NOT COMPLETED|Period 1||1
8400465|NCT01005719|20702928|P5|NOT COMPLETED|Period 1||0
8400466|NCT01005719|20702929|P4|NOT COMPLETED|Period 1||1
8400467|NCT01005719|20702930|P3|NOT COMPLETED|Period 1||0
8400468|NCT01005719|20702931|P2|NOT COMPLETED|Period 1||0
8400469|NCT01005719|20702932|P1|NOT COMPLETED|Period 1||0
8400470|NCT01005719|20702927|P6|COMPLETED|Period 1||10
8400471|NCT01005719|20702928|P5|COMPLETED|Period 1||11
8400472|NCT01005719|20702929|P4|COMPLETED|Period 1||10
8400473|NCT01005719|20702930|P3|COMPLETED|Period 1||10
8400474|NCT01005719|20702931|P2|COMPLETED|Period 1||10
8400475|NCT01005719|20702932|P1|COMPLETED|Period 1||10
8400476|NCT01005719|20702927|P6|STARTED|Period 1||11
8400477|NCT01005719|20702928|P5|STARTED|Period 1||11
8400478|NCT01005719|20702929|P4|STARTED|Period 1||11
8400479|NCT01005719|20702930|P3|STARTED|Period 1||10
8400480|NCT01005719|20702931|P2|STARTED|Period 1||10
8400481|NCT01005719|20702932|P1|STARTED|Period 1||10
8400482|NCT01005706|20702990|P2|NOT COMPLETED|Overall Study||0
8400483|NCT01005706|20702991|P1|NOT COMPLETED|Overall Study||0
8400484|NCT01005706|20702990|P2|COMPLETED|Overall Study||17
8400485|NCT01005706|20702991|P1|COMPLETED|Overall Study||23
8400486|NCT01005706|20702990|P2|STARTED|Overall Study||17
8400487|NCT01005706|20702991|P1|STARTED|Overall Study||23
8400488|NCT01005680|20702999|P2|NOT COMPLETED|Overall Study||11
8400489|NCT01005680|20703000|P1|NOT COMPLETED|Overall Study||6
8400490|NCT01005680|20702999|P2|COMPLETED|Overall Study||119
8400491|NCT01005680|20703000|P1|COMPLETED|Overall Study||120
8400492|NCT01005680|20702999|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
8400493|NCT01005680|20703000|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
8400494|NCT01005680|20702999|P2|STARTED|Overall Study||130
8400495|NCT01005680|20703000|P1|STARTED|Overall Study||126
8400496|NCT01005602|20703024|P2|NOT COMPLETED|Overall Study||0
8400497|NCT01005602|20703025|P1|NOT COMPLETED|Overall Study||1
8400498|NCT01005602|20703024|P2|COMPLETED|Overall Study||66
8400499|NCT01005602|20703025|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
8400500|NCT01005602|20703024|P2|STARTED|Overall Study||66
8400501|NCT01005602|20703025|P1|STARTED|Overall Study||66
8400502|NCT01005576|20703045|P1|NOT COMPLETED|Overall Study||0
8400503|NCT01005576|20703045|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
8400504|NCT01005576|20703045|P1|STARTED|Overall Study||21
8400505|NCT01005459|20703055|P2|NOT COMPLETED|Overall Study||0
8400506|NCT01005459|20703056|P1|NOT COMPLETED|Overall Study||0
8400507|NCT01005459|20703055|P2|COMPLETED|Overall Study||23
8400508|NCT01005459|20703056|P1|COMPLETED|Overall Study||23
8400509|NCT01005459|20703055|P2|STARTED|Overall Study||23
8400510|NCT01005459|20703056|P1|STARTED|Overall Study||23
8400511|NCT01005407|20703064|P2|NOT COMPLETED|Overall Study||32
8400512|NCT01005407|20703065|P1|NOT COMPLETED|Overall Study||151
8400513|NCT01005407|20703064|P2|COMPLETED|Overall Study||451
8400514|NCT01005407|20703065|P1|COMPLETED|Overall Study||1818
8400515|NCT01005407|20703064|P2|STARTED|Overall Study||483
8400516|NCT01005407|20703065|P1|STARTED|Overall Study||1969
8400517|NCT01005355|20703076|P3|NOT COMPLETED|Overall Study||0
8400518|NCT01005355|20703077|P2|NOT COMPLETED|Overall Study||0
8400519|NCT01005355|20703078|P1|NOT COMPLETED|Overall Study||0
8400520|NCT01005355|20703076|P3|COMPLETED|Overall Study||6
8400521|NCT01005355|20703077|P2|COMPLETED|Overall Study||6
8400522|NCT01005355|20703078|P1|COMPLETED|Overall Study||3
8400523|NCT01005355|20703076|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8400524|NCT01005355|20703077|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8400525|NCT01005355|20703078|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8400526|NCT01005355|20703076|P3|STARTED|Overall Study||6
8400527|NCT01005355|20703077|P2|STARTED|Overall Study||6
8400528|NCT01005355|20703078|P1|STARTED|Overall Study||3
8400529|NCT01005329|20703113|P1|NOT COMPLETED|Overall Study||4
8400530|NCT01005329|20703113|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
8400531|NCT01005329|20703113|P1|STARTED|Overall Study||34
8400532|NCT01005316|20703126|P4|NOT COMPLETED|Overall Study||108
8400533|NCT01005316|20703127|P3|NOT COMPLETED|Overall Study||11
8400534|NCT01005316|20703128|P2|NOT COMPLETED|Overall Study||76
8400535|NCT01005316|20703129|P1|NOT COMPLETED|Overall Study||50
8400536|NCT01005316|20703126|P4|COMPLETED|Overall Study||19
8400537|NCT01005316|20703127|P3|COMPLETED|Overall Study||5
8400538|NCT01005316|20703128|P2|COMPLETED|Overall Study||21
8400539|NCT01005316|20703129|P1|COMPLETED|Overall Study||0
8400540|NCT01005316|20703126|P4|STARTED|Overall Study||127
8400541|NCT01005316|20703127|P3|STARTED|Overall Study||16
8400542|NCT01005316|20703128|P2|STARTED|Overall Study||97
8400543|NCT01005316|20703129|P1|STARTED|Overall Study||50
8400544|NCT01005290|20703181|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
8400545|NCT01005290|20703182|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
8400546|NCT01005290|20703183|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
8400547|NCT01005290|20703181|P3|COMPLETED|Period 2 (5 Weeks)||7
8400548|NCT01005290|20703182|P2|COMPLETED|Period 2 (5 Weeks)||13
8400549|NCT01005290|20703183|P1|COMPLETED|Period 2 (5 Weeks)||0
8400550|NCT01005290|20703181|P3|STARTED|Period 2 (5 Weeks)||9
8400551|NCT01005290|20703182|P2|STARTED|Period 2 (5 Weeks)||13
8400552|NCT01005290|20703183|P1|STARTED|Period 2 (5 Weeks)||0
8400553|NCT01005290|20703181|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
8400554|NCT01005290|20703182|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8400555|NCT01005290|20703183|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8400556|NCT01005290|20703181|P3|COMPLETED|Washout Period (2 Weeks)||9
8400557|NCT01005290|20703182|P2|COMPLETED|Washout Period (2 Weeks)||13
8400558|NCT01005290|20703183|P1|COMPLETED|Washout Period (2 Weeks)||0
8400559|NCT01005290|20703181|P3|STARTED|Washout Period (2 Weeks)||9
8400560|NCT01005290|20703182|P2|STARTED|Washout Period (2 Weeks)||13
8400561|NCT01005290|20703183|P1|STARTED|Washout Period (2 Weeks)||0
8400562|NCT01005290|20703181|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
8400563|NCT01005290|20703182|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
8400564|NCT01005290|20703183|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
8400565|NCT01005290|20703181|P3|COMPLETED|Period 1 (5 Weeks)||9
8400566|NCT01005290|20703182|P2|COMPLETED|Period 1 (5 Weeks)||13
8400567|NCT01005290|20703183|P1|COMPLETED|Period 1 (5 Weeks)||0
8400568|NCT01005290|20703181|P3|STARTED|Period 1 (5 Weeks)||18
8400569|NCT01005290|20703182|P2|STARTED|Period 1 (5 Weeks)||20
8400570|NCT01005290|20703183|P1|STARTED|Period 1 (5 Weeks)||0
8400571|NCT01005290|20703181|P3|NOT COMPLETED|Run-In||0
8400572|NCT01005290|20703182|P2|NOT COMPLETED|Run-In||0
8400573|NCT01005290|20703183|P1|NOT COMPLETED|Run-In||14
8400574|NCT01005290|20703181|P3|COMPLETED|Run-In||0
8400575|NCT01005290|20703182|P2|COMPLETED|Run-In||0
8400576|NCT01005290|20703183|P1|COMPLETED|Run-In||38
8400577|NCT01005290|20703181|P3|STARTED|Run-In||0
8400578|NCT01005290|20703182|P2|STARTED|Run-In||0
8400579|NCT01005290|20703183|P1|STARTED|Run-In||52
8400580|NCT01005251|20703196|P5|NOT COMPLETED|Overall Study||18
8400581|NCT01005251|20703197|P4|NOT COMPLETED|Overall Study||12
8400582|NCT01005251|20703198|P3|NOT COMPLETED|Overall Study||22
8400583|NCT01005251|20703199|P2|NOT COMPLETED|Overall Study||16
8400584|NCT01005251|20703200|P1|NOT COMPLETED|Overall Study||13
8400585|NCT01005251|20703196|P5|COMPLETED|Overall Study||122
8400586|NCT01005251|20703197|P4|COMPLETED|Overall Study||114
8400587|NCT01005251|20703198|P3|COMPLETED|Overall Study||114
8400588|NCT01005251|20703199|P2|COMPLETED|Overall Study||109
8400589|NCT01005251|20703200|P1|COMPLETED|Overall Study||121
8400590|NCT01005251|20703196|P5|STARTED|Overall Study||140
8400591|NCT01005251|20703197|P4|STARTED|Overall Study||126
8400592|NCT01005251|20703198|P3|STARTED|Overall Study||136
8400593|NCT01005251|20703199|P2|STARTED|Overall Study||125
8400594|NCT01005251|20703200|P1|STARTED|Overall Study||134
8400595|NCT01004991|20703217|P1|NOT COMPLETED|Overall Study||0
8400596|NCT01004991|20703217|P1|COMPLETED|Overall Study||12
8400597|NCT01004991|20703217|P1|STARTED|Overall Study||12
8400598|NCT01004939|20703221|P1|NOT COMPLETED|Overall Study||0
8400599|NCT01004939|20703221|P1|COMPLETED|Overall Study||120
8400600|NCT01004939|20703221|P1|STARTED|Overall Study||120
8400604|NCT01004861|20703284|P13|NOT COMPLETED|Overall Study||20
8400605|NCT01004861|20703285|P12|NOT COMPLETED|Overall Study||8
8400606|NCT01004861|20703286|P11|NOT COMPLETED|Overall Study||9
8400607|NCT01004861|20703287|P10|NOT COMPLETED|Overall Study||11
8400608|NCT01004861|20703288|P9|NOT COMPLETED|Overall Study||39
8400609|NCT01004861|20703289|P8|NOT COMPLETED|Overall Study||4
8400610|NCT01004861|20703290|P7|NOT COMPLETED|Overall Study||7
8400611|NCT01004861|20703291|P6|NOT COMPLETED|Overall Study||6
8400612|NCT01004861|20703292|P5|NOT COMPLETED|Overall Study||7
8400613|NCT01004861|20703293|P4|NOT COMPLETED|Overall Study||6
8400614|NCT01004861|20703294|P3|NOT COMPLETED|Overall Study||6
8400615|NCT01004861|20703295|P2|NOT COMPLETED|Overall Study||6
8400616|NCT01004861|20703296|P1|NOT COMPLETED|Overall Study||3
8400617|NCT01004861|20703284|P13|COMPLETED|Overall Study||0
8400618|NCT01004861|20703285|P12|COMPLETED|Overall Study||0
8400619|NCT01004861|20703286|P11|COMPLETED|Overall Study||0
8400620|NCT01004861|20703287|P10|COMPLETED|Overall Study||0
8400621|NCT01004861|20703288|P9|COMPLETED|Overall Study||0
8400622|NCT01004861|20703289|P8|COMPLETED|Overall Study||0
8400623|NCT01004861|20703290|P7|COMPLETED|Overall Study||0
8400624|NCT01004861|20703291|P6|COMPLETED|Overall Study||0
8400625|NCT01004861|20703292|P5|COMPLETED|Overall Study||0
8400626|NCT01004861|20703293|P4|COMPLETED|Overall Study||0
8400627|NCT01004861|20703294|P3|COMPLETED|Overall Study||0
8400628|NCT01004861|20703295|P2|COMPLETED|Overall Study||0
8400629|NCT01004861|20703296|P1|COMPLETED|Overall Study||0
8400630|NCT01004861|20703284|P13|STARTED|Overall Study||20
8400631|NCT01004861|20703285|P12|STARTED|Overall Study||8
8400632|NCT01004861|20703286|P11|STARTED|Overall Study||9
8400633|NCT01004861|20703287|P10|STARTED|Overall Study||11
8400634|NCT01004861|20703288|P9|STARTED|Overall Study||39
8400635|NCT01004861|20703289|P8|STARTED|Overall Study||4
8400636|NCT01004861|20703290|P7|STARTED|Overall Study||7
8400637|NCT01004861|20703291|P6|STARTED|Overall Study||6
8400638|NCT01004861|20703292|P5|STARTED|Overall Study||7
8400639|NCT01004861|20703293|P4|STARTED|Overall Study||6
8400640|NCT01004861|20703294|P3|STARTED|Overall Study||6
8400641|NCT01004861|20703295|P2|STARTED|Overall Study||6
8400642|NCT01004861|20703296|P1|STARTED|Overall Study||3
8400643|NCT01004848|20703362|P2|NOT COMPLETED|Overall Study||45
8400644|NCT01004848|20703363|P1|NOT COMPLETED|Overall Study||55
8400645|NCT01004848|20703362|P2|COMPLETED|Overall Study||147
8400646|NCT01004848|20703363|P1|COMPLETED|Overall Study||155
8400647|NCT01004848|20703362|P2|STARTED|Overall Study||192
8400648|NCT01004848|20703363|P1|STARTED|Overall Study||210
8400649|NCT01004822|20703401|P8|NOT COMPLETED|Overall Study||5
8400650|NCT01004822|20703402|P7|NOT COMPLETED|Overall Study||4
8400651|NCT01004822|20703403|P6|NOT COMPLETED|Overall Study||4
8400652|NCT01004822|20703404|P5|NOT COMPLETED|Overall Study||4
8400653|NCT01004822|20703405|P4|NOT COMPLETED|Overall Study||4
8400654|NCT01004822|20703406|P3|NOT COMPLETED|Overall Study||4
8400655|NCT01004822|20703407|P2|NOT COMPLETED|Overall Study||3
8400656|NCT01004822|20703408|P1|NOT COMPLETED|Overall Study||3
8400657|NCT01004822|20703401|P8|COMPLETED|Overall Study||0
8400658|NCT01004822|20703402|P7|COMPLETED|Overall Study||0
8400659|NCT01004822|20703403|P6|COMPLETED|Overall Study||0
8400660|NCT01004822|20703404|P5|COMPLETED|Overall Study||0
8400661|NCT01004822|20703405|P4|COMPLETED|Overall Study||0
8400662|NCT01004822|20703406|P3|COMPLETED|Overall Study||0
8400663|NCT01004822|20703407|P2|COMPLETED|Overall Study||0
8400664|NCT01004822|20703408|P1|COMPLETED|Overall Study||0
8400665|NCT01004822|20703401|P8|Treated|Overall Study||5
8400666|NCT01004822|20703402|P7|Treated|Overall Study||4
8400667|NCT01004822|20703403|P6|Treated|Overall Study||4
8400668|NCT01004822|20703404|P5|Treated|Overall Study||4
8400669|NCT01004822|20703405|P4|Treated|Overall Study||4
8400670|NCT01004822|20703406|P3|Treated|Overall Study||3
8400671|NCT01004822|20703407|P2|Treated|Overall Study||3
8400672|NCT01004822|20703408|P1|Treated|Overall Study||3
8400673|NCT01004822|20703401|P8|STARTED|Overall Study||5
8400674|NCT01004822|20703402|P7|STARTED|Overall Study||4
8400675|NCT01004822|20703403|P6|STARTED|Overall Study||4
8400676|NCT01004822|20703404|P5|STARTED|Overall Study||4
8400677|NCT01004822|20703405|P4|STARTED|Overall Study||4
8400678|NCT01004822|20703406|P3|STARTED|Overall Study||4
8400679|NCT01004822|20703407|P2|STARTED|Overall Study||3
8400680|NCT01004822|20703408|P1|STARTED|Overall Study||3
8400681|NCT01004770|20703522|P5|NOT COMPLETED|Overall Study||0
8400682|NCT01004770|20703523|P4|NOT COMPLETED|Overall Study||0
8400683|NCT01004770|20703524|P3|NOT COMPLETED|Overall Study||0
8400684|NCT01004770|20703525|P2|NOT COMPLETED|Overall Study||0
8400685|NCT01004770|20703526|P1|NOT COMPLETED|Overall Study||0
8400686|NCT01004770|20703522|P5|COMPLETED|Overall Study||10
8400687|NCT01004770|20703523|P4|COMPLETED|Overall Study||10
8400688|NCT01004770|20703524|P3|COMPLETED|Overall Study||10
8400689|NCT01004770|20703525|P2|COMPLETED|Overall Study||10
8400690|NCT01004770|20703526|P1|COMPLETED|Overall Study||10
8400691|NCT01004770|20703522|P5|STARTED|Overall Study||10
8400692|NCT01004770|20703523|P4|STARTED|Overall Study||10
8400693|NCT01004770|20703524|P3|STARTED|Overall Study||10
8400694|NCT01004770|20703525|P2|STARTED|Overall Study||10
8400695|NCT01004770|20703526|P1|STARTED|Overall Study||10
8400696|NCT01004744|20703558|P1|NOT COMPLETED|Overall Study||0
8400697|NCT01004744|20703558|P1|COMPLETED|Overall Study||10
8400698|NCT01004744|20703558|P1|STARTED|Overall Study||10
8400699|NCT01004705|20703562|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
8400700|NCT01004705|20703563|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
8400701|NCT01004705|20703564|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
8400702|NCT01004705|20703562|P3|COMPLETED|Period 2 (12 Weeks)||9
8400703|NCT01004705|20703563|P2|COMPLETED|Period 2 (12 Weeks)||13
8400704|NCT01004705|20703564|P1|COMPLETED|Period 2 (12 Weeks)||0
8400705|NCT01004705|20703562|P3|STARTED|Period 2 (12 Weeks)||13
8400706|NCT01004705|20703563|P2|STARTED|Period 2 (12 Weeks)||13
8400707|NCT01004705|20703564|P1|STARTED|Period 2 (12 Weeks)||0
8400708|NCT01004705|20703562|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
8400709|NCT01004705|20703563|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
8400710|NCT01004705|20703564|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
8400711|NCT01004705|20703562|P3|COMPLETED|Washout Period (6 Weeks)||13
8400712|NCT01004705|20703563|P2|COMPLETED|Washout Period (6 Weeks)||13
8400713|NCT01004705|20703564|P1|COMPLETED|Washout Period (6 Weeks)||0
8400714|NCT01004705|20703562|P3|STARTED|Washout Period (6 Weeks)||13
8400715|NCT01004705|20703563|P2|STARTED|Washout Period (6 Weeks)||13
8400716|NCT01004705|20703564|P1|STARTED|Washout Period (6 Weeks)||0
8400717|NCT01004705|20703562|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
8400718|NCT01004705|20703563|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
8400719|NCT01004705|20703564|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
8400720|NCT01004705|20703562|P3|COMPLETED|Period 1 (12 Weeks)||13
8400721|NCT01004705|20703563|P2|COMPLETED|Period 1 (12 Weeks)||13
8400722|NCT01004705|20703564|P1|COMPLETED|Period 1 (12 Weeks)||0
8400723|NCT01004705|20703562|P3|STARTED|Period 1 (12 Weeks)||18
8400724|NCT01004705|20703563|P2|STARTED|Period 1 (12 Weeks)||18
8400725|NCT01004705|20703564|P1|STARTED|Period 1 (12 Weeks)||0
8400726|NCT01004705|20703562|P3|NOT COMPLETED|Run-In||0
8400727|NCT01004705|20703563|P2|NOT COMPLETED|Run-In||0
8400728|NCT01004705|20703564|P1|NOT COMPLETED|Run-In||8
8400729|NCT01004705|20703562|P3|COMPLETED|Run-In||0
8400730|NCT01004705|20703563|P2|COMPLETED|Run-In||0
8400731|NCT01004705|20703564|P1|COMPLETED|Run-In||36
8400732|NCT01004705|20703562|P3|STARTED|Run-In||0
8400733|NCT01004705|20703563|P2|STARTED|Run-In||0
8400734|NCT01004705|20703564|P1|STARTED|Run-In||44
8400735|NCT01004510|20703573|P1|NOT COMPLETED|Overall Study||1
8400736|NCT01004510|20703573|P1|COMPLETED|Overall Study||2
8400737|NCT01004510|20703573|P1|STARTED|Overall Study||3
8400738|NCT01004432|20703577|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
8400739|NCT01004432|20703578|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400740|NCT01004432|20703579|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400741|NCT01004432|20703580|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400742|NCT01004432|20703581|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400743|NCT01004432|20703577|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
8400744|NCT01004432|20703578|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400745|NCT01004432|20703579|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400746|NCT01004432|20703580|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400747|NCT01004432|20703581|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400748|NCT01004432|20703577|P5|STARTED|OL Study Extension (Week 52 - 76)||212
8400749|NCT01004432|20703578|P4|STARTED|OL Study Extension (Week 52 - 76)||0
8400750|NCT01004432|20703579|P3|STARTED|OL Study Extension (Week 52 - 76)||0
8400751|NCT01004432|20703580|P2|STARTED|OL Study Extension (Week 52 - 76)||0
8400752|NCT01004432|20703581|P1|STARTED|OL Study Extension (Week 52 - 76)||0
8400753|NCT01004432|20703577|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400754|NCT01004432|20703578|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
8400755|NCT01004432|20703579|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
8400756|NCT01004432|20703580|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
8400757|NCT01004432|20703581|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400758|NCT01004432|20703577|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400759|NCT01004432|20703578|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
8400760|NCT01004432|20703579|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
8400761|NCT01004432|20703580|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
8400762|NCT01004432|20703581|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400763|NCT01004432|20703577|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400764|NCT01004432|20703578|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
8400765|NCT01004432|20703579|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
8400766|NCT01004432|20703580|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
8400767|NCT01004432|20703581|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400768|NCT01004432|20703577|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400769|NCT01004432|20703578|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400770|NCT01004432|20703579|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400771|NCT01004432|20703580|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400772|NCT01004432|20703581|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
8400773|NCT01004432|20703577|P5|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400774|NCT01004432|20703578|P4|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400775|NCT01004432|20703579|P3|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400776|NCT01004432|20703580|P2|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400777|NCT01004432|20703581|P1|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
8400778|NCT01004432|20703577|P5|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400779|NCT01004432|20703578|P4|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400780|NCT01004432|20703579|P3|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400781|NCT01004432|20703580|P2|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400782|NCT01004432|20703581|P1|STARTED|Open-label (OL) Period (Week 0 - 16)||433
8400783|NCT01004406|20703603|P2|NOT COMPLETED|Overall Study||0
8400784|NCT01004406|20703604|P1|NOT COMPLETED|Overall Study||3
8400785|NCT01004406|20703603|P2|COMPLETED|Overall Study||10
8400786|NCT01004406|20703604|P1|COMPLETED|Overall Study||18
8400787|NCT01004406|20703603|P2|STARTED|Overall Study||10
8400788|NCT01004406|20703604|P1|STARTED|Overall Study||21
8400789|NCT01004393|20703616|P1|NOT COMPLETED|Overall Study||0
8400790|NCT01004393|20703616|P1|COMPLETED|Overall Study||12
8400791|NCT01004393|20703616|P1|STARTED|Overall Study||12
8400792|NCT01004354|20703627|P1|NOT COMPLETED|Overall Study||0
8400793|NCT01004354|20703627|P1|COMPLETED|Overall Study||12
8400794|NCT01004354|20703627|P1|STARTED|Overall Study||12
8400795|NCT01004263|20703639|P1|NOT COMPLETED|Overall Study||179
8400796|NCT01004263|20703639|P1|COMPLETED|Overall Study||427
8400797|NCT01004263|20703639|P1|STARTED|Overall Study|Participants who took study drug|606
8400798|NCT01004250|20703647|P1|NOT COMPLETED|Follow-Up (FU) Period||1
8400799|NCT01004250|20703647|P1|COMPLETED|Follow-Up (FU) Period||100
8400800|NCT01004250|20703647|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
8400801|NCT01004250|20703647|P1|NOT COMPLETED|Maintenance Therapy Period||26
8400802|NCT01004250|20703647|P1|COMPLETED|Maintenance Therapy Period||46
8400803|NCT01004250|20703647|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
8400804|NCT01004250|20703647|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
8400805|NCT01004250|20703647|P1|NOT COMPLETED|Induction Therapy Period||15
8400806|NCT01004250|20703647|P1|COMPLETED|Induction Therapy Period||94
8400807|NCT01004250|20703647|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
8400808|NCT01004250|20703647|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
8400809|NCT01004250|20703647|P1|STARTED|Induction Therapy Period||109
8400810|NCT01004185|20703659|P2|NOT COMPLETED|Overall Study||9
8400811|NCT01004185|20703660|P1|NOT COMPLETED|Overall Study||9
8400812|NCT01004185|20703659|P2|COMPLETED|Overall Study||11
8400813|NCT01004185|20703660|P1|COMPLETED|Overall Study||10
8400814|NCT01004185|20703659|P2|STARTED|Overall Study||20
8400815|NCT01004185|20703660|P1|STARTED|Overall Study||19
8400816|NCT01004172|20703668|P1|NOT COMPLETED|Overall Study||38
8400817|NCT01004172|20703668|P1|COMPLETED|Overall Study||0
8400818|NCT01004172|20703668|P1|STARTED|Overall Study||38
8400819|NCT01004159|20703676|P1|NOT COMPLETED|Overall Study||20
8400820|NCT01004159|20703676|P1|COMPLETED|Overall Study||0
8400821|NCT01004159|20703676|P1|STARTED|Overall Study||20
8400822|NCT01004146|20703683|P2|NOT COMPLETED|Overall Study||5
8400823|NCT01004146|20703684|P1|NOT COMPLETED|Overall Study||4
8400824|NCT01004146|20703683|P2|COMPLETED|Overall Study||20
8400825|NCT01004146|20703684|P1|COMPLETED|Overall Study||21
8400826|NCT01004146|20703683|P2|Have Incentive Spirometry Data|Overall Study||20
8400827|NCT01004146|20703684|P1|Have Incentive Spirometry Data|Overall Study||21
8400828|NCT01004146|20703683|P2|STARTED|Overall Study||25
8400829|NCT01004146|20703684|P1|STARTED|Overall Study||25
8400830|NCT01004107|20703692|P2|NOT COMPLETED|Overall Study||2
8400831|NCT01004107|20703693|P1|NOT COMPLETED|Overall Study||1
8400832|NCT01004107|20703692|P2|COMPLETED|Overall Study||23
8400833|NCT01004107|20703693|P1|COMPLETED|Overall Study||75
8400834|NCT01004107|20703692|P2|STARTED|Overall Study||25
8400835|NCT01004107|20703693|P1|STARTED|Overall Study||76
8400836|NCT01004042|20703771|P2|NOT COMPLETED|Overall Study||0
8400837|NCT01004042|20703772|P1|NOT COMPLETED|Overall Study||4
8400838|NCT01004042|20703771|P2|COMPLETED|Overall Study||25
8400839|NCT01004042|20703772|P1|COMPLETED|Overall Study||21
8400840|NCT01004042|20703771|P2|STARTED|Overall Study||25
8400841|NCT01004042|20703772|P1|STARTED|Overall Study||25
8400842|NCT01004003|20703795|P9|NOT COMPLETED|Overall Study||30
8400843|NCT01004003|20703796|P8|NOT COMPLETED|Overall Study||60
8400844|NCT01004003|20703797|P7|NOT COMPLETED|Overall Study||8
8400845|NCT01004003|20703798|P6|NOT COMPLETED|Overall Study||4
8400846|NCT01004003|20703799|P5|NOT COMPLETED|Overall Study||4
8400847|NCT01004003|20703800|P4|NOT COMPLETED|Overall Study||3
8400848|NCT01004003|20703801|P3|NOT COMPLETED|Overall Study||4
8400849|NCT01004003|20703802|P2|NOT COMPLETED|Overall Study||3
8400850|NCT01004003|20703803|P1|NOT COMPLETED|Overall Study||6
8400851|NCT01004003|20703795|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
8400852|NCT01004003|20703796|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
8400853|NCT01004003|20703797|P7|COMPLETED|Overall Study||0
8400854|NCT01004003|20703798|P6|COMPLETED|Overall Study||0
8400855|NCT01004003|20703799|P5|COMPLETED|Overall Study||0
8400856|NCT01004003|20703800|P4|COMPLETED|Overall Study||0
8400857|NCT01004003|20703801|P3|COMPLETED|Overall Study||0
8400858|NCT01004003|20703802|P2|COMPLETED|Overall Study||0
8400859|NCT01004003|20703803|P1|COMPLETED|Overall Study||0
8400860|NCT01004003|20703795|P9|STARTED|Overall Study||31
8400861|NCT01004003|20703796|P8|STARTED|Overall Study||62
8400862|NCT01004003|20703797|P7|STARTED|Overall Study||8
8400863|NCT01004003|20703798|P6|STARTED|Overall Study||4
8400864|NCT01004003|20703799|P5|STARTED|Overall Study||4
8400865|NCT01004003|20703800|P4|STARTED|Overall Study||3
8400866|NCT01004003|20703801|P3|STARTED|Overall Study||4
8400867|NCT01004003|20703802|P2|STARTED|Overall Study||3
8400868|NCT01004003|20703803|P1|STARTED|Overall Study||6
8400869|NCT01003990|20703834|P3|NOT COMPLETED|Overall Study||43
8400870|NCT01003990|20703835|P2|NOT COMPLETED|Overall Study||51
8400871|NCT01003990|20703836|P1|NOT COMPLETED|Overall Study||92
8400872|NCT01003990|20703834|P3|COMPLETED|Overall Study||53
8400873|NCT01003990|20703835|P2|COMPLETED|Overall Study||103
8400874|NCT01003990|20703836|P1|COMPLETED|Overall Study||367
8400875|NCT01003990|20703834|P3|STARTED|Overall Study||96
8400876|NCT01003990|20703835|P2|STARTED|Overall Study||154
8400877|NCT01003990|20703836|P1|STARTED|Overall Study||459
8400878|NCT01003938|20703844|P1|NOT COMPLETED|Overall Study||0
8400879|NCT01003938|20703844|P1|COMPLETED|Overall Study||6
8400880|NCT01003938|20703844|P1|STARTED|Overall Study||6
8400881|NCT01003899|20703853|P1|NOT COMPLETED|Overall Study||47
8400882|NCT01003899|20703853|P1|COMPLETED|Overall Study||0
8400883|NCT01003899|20703853|P1|STARTED|Overall Study|enrolled|47
8400884|NCT01003769|20703862|P1|NOT COMPLETED|Overall Study||0
8400885|NCT01003769|20703862|P1|COMPLETED|Overall Study||5
8400886|NCT01003769|20703862|P1|STARTED|Overall Study||5
8400887|NCT01003639|20703874|P2|NOT COMPLETED|Overall Study||22
8400888|NCT01003639|20703875|P1|NOT COMPLETED|Overall Study||17
8400889|NCT01003639|20703874|P2|COMPLETED|Overall Study||57
8400890|NCT01003639|20703875|P1|COMPLETED|Overall Study||69
8400891|NCT01003639|20703874|P2|STARTED|Overall Study||79
8400892|NCT01003639|20703875|P1|STARTED|Overall Study||86
8400893|NCT01003418|20703889|P2|NOT COMPLETED|Overall Study||0
8400894|NCT01003418|20703890|P1|NOT COMPLETED|Overall Study||0
8400895|NCT01003418|20703889|P2|COMPLETED|Overall Study||3
8400896|NCT01003418|20703890|P1|COMPLETED|Overall Study||5
8400897|NCT01003418|20703889|P2|STARTED|Overall Study||3
8400898|NCT01003418|20703890|P1|STARTED|Overall Study||5
8400899|NCT01003301|20703908|P2|NOT COMPLETED|Overall Study||0
8400900|NCT01003301|20703909|P1|NOT COMPLETED|Overall Study||0
8400901|NCT01003301|20703908|P2|COMPLETED|Overall Study||9
8400902|NCT01003301|20703909|P1|COMPLETED|Overall Study||10
8400903|NCT01003301|20703908|P2|STARTED|Overall Study||9
8400904|NCT01003301|20703909|P1|STARTED|Overall Study||10
8400905|NCT01003288|20703917|P1|NOT COMPLETED|Overall Study||0
8400906|NCT01003288|20703917|P1|COMPLETED|Overall Study||255
8400907|NCT01003288|20703917|P1|STARTED|Overall Study||255
8400908|NCT01003275|20703924|P2|NOT COMPLETED|Overall Study||0
8400909|NCT01003275|20703925|P1|NOT COMPLETED|Overall Study||1
8400910|NCT01003275|20703924|P2|COMPLETED|Overall Study||11
8400911|NCT01003275|20703925|P1|COMPLETED|Overall Study||10
8400912|NCT01003275|20703924|P2|STARTED|Overall Study||11
8400913|NCT01003275|20703925|P1|STARTED|Overall Study||11
8400914|NCT01003249|20703931|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8400915|NCT01003249|20703932|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8400916|NCT01003249|20703931|P2|COMPLETED|Second Intervention (4 Weeks)||2
8400917|NCT01003249|20703932|P1|COMPLETED|Second Intervention (4 Weeks)||3
8400918|NCT01003249|20703931|P2|STARTED|Second Intervention (4 Weeks)||3
8400919|NCT01003249|20703932|P1|STARTED|Second Intervention (4 Weeks)||4
8400920|NCT01003249|20703931|P2|NOT COMPLETED|Washout (3 Weeks)||0
8400921|NCT01003249|20703932|P1|NOT COMPLETED|Washout (3 Weeks)||0
8400922|NCT01003249|20703931|P2|COMPLETED|Washout (3 Weeks)||3
8400923|NCT01003249|20703932|P1|COMPLETED|Washout (3 Weeks)||4
8400924|NCT01003249|20703931|P2|STARTED|Washout (3 Weeks)||3
8400925|NCT01003249|20703932|P1|STARTED|Washout (3 Weeks)||4
8400926|NCT01003249|20703931|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
8400927|NCT01003249|20703932|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8400928|NCT01003249|20703931|P2|COMPLETED|First Intervention (4 Weeks)||3
8400929|NCT01003249|20703932|P1|COMPLETED|First Intervention (4 Weeks)||5
8400930|NCT01003249|20703931|P2|Received Intervention|First Intervention (4 Weeks)||5
8400931|NCT01003249|20703932|P1|Received Intervention|First Intervention (4 Weeks)||7
8400932|NCT01003249|20703931|P2|STARTED|First Intervention (4 Weeks)||5
8400933|NCT01003249|20703932|P1|STARTED|First Intervention (4 Weeks)||7
8400934|NCT01003210|20703950|P2|NOT COMPLETED|Overall Study||3
8400935|NCT01003210|20703951|P1|NOT COMPLETED|Overall Study||1
8400936|NCT01003210|20703950|P2|COMPLETED|Overall Study||102
8400937|NCT01003210|20703951|P1|COMPLETED|Overall Study||104
8400938|NCT01003210|20703950|P2|STARTED|Overall Study||105
8400939|NCT01003210|20703951|P1|STARTED|Overall Study||105
8400940|NCT01003184|20703963|P2|NOT COMPLETED|Overall Study||12
8400941|NCT01003184|20703964|P1|NOT COMPLETED|Overall Study||19
8400942|NCT01003184|20703963|P2|COMPLETED|Overall Study||99
8400943|NCT01003184|20703964|P1|COMPLETED|Overall Study||92
8400944|NCT01003184|20703963|P2|Full Analysis Set (FAS)|Overall Study||105
8400945|NCT01003184|20703964|P1|Full Analysis Set (FAS)|Overall Study||111
8400946|NCT01003184|20703963|P2|STARTED|Overall Study||111
8400947|NCT01003184|20703964|P1|STARTED|Overall Study||111
8400948|NCT01003106|20704000|P8|NOT COMPLETED|Month 6-Month 36||0
8400949|NCT01003106|20704001|P7|NOT COMPLETED|Month 6-Month 36||1
8400950|NCT01003106|20704002|P6|NOT COMPLETED|Month 6-Month 36||0
8400951|NCT01003106|20704003|P5|NOT COMPLETED|Month 6-Month 36||0
8400952|NCT01003106|20704004|P4|NOT COMPLETED|Month 6-Month 36||0
8400953|NCT01003106|20704005|P3|NOT COMPLETED|Month 6-Month 36||1
8400954|NCT01003106|20704006|P2|NOT COMPLETED|Month 6-Month 36||0
8400955|NCT01003106|20704007|P1|NOT COMPLETED|Month 6-Month 36||0
8400956|NCT01003106|20704000|P8|COMPLETED|Month 6-Month 36||18
8400957|NCT01003106|20704001|P7|COMPLETED|Month 6-Month 36||19
8400958|NCT01003106|20704002|P6|COMPLETED|Month 6-Month 36||0
8400959|NCT01003106|20704003|P5|COMPLETED|Month 6-Month 36||0
8400960|NCT01003106|20704004|P4|COMPLETED|Month 6-Month 36||20
8400961|NCT01003106|20704005|P3|COMPLETED|Month 6-Month 36||18
8400962|NCT01003106|20704006|P2|COMPLETED|Month 6-Month 36||0
8400963|NCT01003106|20704007|P1|COMPLETED|Month 6-Month 36||0
8400964|NCT01003106|20704000|P8|STARTED|Month 6-Month 36||18
8400965|NCT01003106|20704001|P7|STARTED|Month 6-Month 36||20
8400966|NCT01003106|20704002|P6|STARTED|Month 6-Month 36||0
8400967|NCT01003106|20704003|P5|STARTED|Month 6-Month 36||0
8400968|NCT01003106|20704004|P4|STARTED|Month 6-Month 36||20
8400969|NCT01003106|20704005|P3|STARTED|Month 6-Month 36||19
8400970|NCT01003106|20704006|P2|STARTED|Month 6-Month 36||0
8400971|NCT01003106|20704007|P1|STARTED|Month 6-Month 36||0
8400972|NCT01003106|20704000|P8|NOT COMPLETED|Baseline to Month 6||0
8400973|NCT01003106|20704001|P7|NOT COMPLETED|Baseline to Month 6||0
8400974|NCT01003106|20704002|P6|NOT COMPLETED|Baseline to Month 6||0
8400975|NCT01003106|20704003|P5|NOT COMPLETED|Baseline to Month 6||0
8400976|NCT01003106|20704004|P4|NOT COMPLETED|Baseline to Month 6||0
8400977|NCT01003106|20704005|P3|NOT COMPLETED|Baseline to Month 6||0
8400978|NCT01003106|20704006|P2|NOT COMPLETED|Baseline to Month 6||0
8400979|NCT01003106|20704007|P1|NOT COMPLETED|Baseline to Month 6||0
8400980|NCT01003106|20704000|P8|COMPLETED|Baseline to Month 6||0
8400981|NCT01003106|20704001|P7|COMPLETED|Baseline to Month 6||0
8400982|NCT01003106|20704002|P6|COMPLETED|Baseline to Month 6||20
8400983|NCT01003106|20704003|P5|COMPLETED|Baseline to Month 6||19
8400984|NCT01003106|20704004|P4|COMPLETED|Baseline to Month 6||0
8400985|NCT01003106|20704005|P3|COMPLETED|Baseline to Month 6||0
8400986|NCT01003106|20704006|P2|COMPLETED|Baseline to Month 6||20
8400987|NCT01003106|20704007|P1|COMPLETED|Baseline to Month 6||22
8400988|NCT01003106|20704000|P8|STARTED|Baseline to Month 6||0
8400989|NCT01003106|20704001|P7|STARTED|Baseline to Month 6||0
8400990|NCT01003106|20704002|P6|STARTED|Baseline to Month 6||20
8400991|NCT01003106|20704003|P5|STARTED|Baseline to Month 6||19
8400992|NCT01003106|20704004|P4|STARTED|Baseline to Month 6||0
8400993|NCT01003106|20704005|P3|STARTED|Baseline to Month 6||0
8400994|NCT01003106|20704006|P2|STARTED|Baseline to Month 6||20
8400995|NCT01003106|20704007|P1|STARTED|Baseline to Month 6||22
8400996|NCT01003080|20704031|P2|NOT COMPLETED|Overall Study||0
8400997|NCT01003080|20704032|P1|NOT COMPLETED|Overall Study||0
8400998|NCT01003080|20704031|P2|COMPLETED|Overall Study||61
8400999|NCT01003080|20704032|P1|COMPLETED|Overall Study||50
8401000|NCT01003080|20704031|P2|STARTED|Overall Study||61
8401001|NCT01003080|20704032|P1|STARTED|Overall Study||50
8401002|NCT01003067|20704040|P2|NOT COMPLETED|Overall Study||24
8401003|NCT01003067|20704041|P1|NOT COMPLETED|Overall Study||33
8401004|NCT01003067|20704040|P2|COMPLETED|Overall Study||107
8401005|NCT01003067|20704041|P1|COMPLETED|Overall Study||103
8401006|NCT01003067|20704040|P2|STARTED|Overall Study||131
8401007|NCT01003067|20704041|P1|STARTED|Overall Study||136
8401008|NCT01002989|20704047|P1|NOT COMPLETED|Overall Study||5
8401009|NCT01002989|20704047|P1|COMPLETED|Overall Study||93
8401010|NCT01002989|20704047|P1|STARTED|Overall Study||98
8401011|NCT01002755|20704054|P1|NOT COMPLETED|Overall Study||0
8401012|NCT01002755|20704054|P1|COMPLETED|Overall Study||36
8401013|NCT01002755|20704054|P1|STARTED|Overall Study||36
8401014|NCT01002742|20704062|P2|NOT COMPLETED|Overall Study||1
8401015|NCT01002742|20704063|P1|NOT COMPLETED|Overall Study||0
8401016|NCT01002742|20704062|P2|COMPLETED|Overall Study||116
8401017|NCT01002742|20704063|P1|COMPLETED|Overall Study||119
8401018|NCT01002742|20704062|P2|STARTED|Overall Study||117
8401019|NCT01002742|20704063|P1|STARTED|Overall Study||119
8401020|NCT01002573|20704099|P2|NOT COMPLETED|Overall Study||7
8401021|NCT01002573|20704100|P1|NOT COMPLETED|Overall Study||11
8401022|NCT01002573|20704099|P2|COMPLETED|Overall Study||53
8401023|NCT01002573|20704100|P1|COMPLETED|Overall Study||47
8401024|NCT01002573|20704099|P2|STARTED|Overall Study||60
8401025|NCT01002573|20704100|P1|STARTED|Overall Study||58
8401026|NCT01002547|20704121|P3|NOT COMPLETED|Overall Study||8
8401027|NCT01002547|20704122|P2|NOT COMPLETED|Overall Study||3
8401028|NCT01002547|20704123|P1|NOT COMPLETED|Overall Study||8
8401029|NCT01002547|20704121|P3|COMPLETED|Overall Study||29
8401030|NCT01002547|20704122|P2|COMPLETED|Overall Study||33
8401031|NCT01002547|20704123|P1|COMPLETED|Overall Study||24
8401032|NCT01002547|20704121|P3|STARTED|Overall Study||37
8401033|NCT01002547|20704122|P2|STARTED|Overall Study||36
8401034|NCT01002547|20704123|P1|STARTED|Overall Study||32
8401035|NCT01002482|20704181|P2|NOT COMPLETED|Overall Study||21
8401036|NCT01002482|20704182|P1|NOT COMPLETED|Overall Study||15
8401037|NCT01002482|20704181|P2|COMPLETED|Overall Study||1312
8401038|NCT01002482|20704182|P1|COMPLETED|Overall Study||1336
8401039|NCT01002482|20704181|P2|STARTED|Overall Study||1333
8401040|NCT01002482|20704182|P1|STARTED|Overall Study||1351
8401041|NCT01002456|20704204|P2|NOT COMPLETED|Overall Study||0
8401042|NCT01002456|20704205|P1|NOT COMPLETED|Overall Study||0
8401043|NCT01002456|20704204|P2|COMPLETED|Overall Study||122
8401044|NCT01002456|20704205|P1|COMPLETED|Overall Study||98
8401045|NCT01002456|20704204|P2|STARTED|Overall Study||122
8401046|NCT01002456|20704205|P1|STARTED|Overall Study||98
8401047|NCT01002339|20704216|P3|NOT COMPLETED|Overall Study||5
8401048|NCT01002339|20704217|P2|NOT COMPLETED|Overall Study||1
8401049|NCT01002339|20704218|P1|NOT COMPLETED|Overall Study||0
8401050|NCT01002339|20704216|P3|COMPLETED|Overall Study||42
8401051|NCT01002339|20704217|P2|COMPLETED|Overall Study||42
8401052|NCT01002339|20704218|P1|COMPLETED|Overall Study||44
8401053|NCT01002339|20704216|P3|STARTED|Overall Study||47
8401054|NCT01002339|20704217|P2|STARTED|Overall Study||43
8401055|NCT01002339|20704218|P1|STARTED|Overall Study||44
8401056|NCT01002287|20704273|P2|NOT COMPLETED|Overall Study||0
8401057|NCT01002287|20704274|P1|NOT COMPLETED|Overall Study||0
8401058|NCT01002287|20704273|P2|COMPLETED|Overall Study||3
8401059|NCT01002287|20704274|P1|COMPLETED|Overall Study||8
8401060|NCT01002287|20704273|P2|STARTED|Overall Study||3
8401061|NCT01002287|20704274|P1|STARTED|Overall Study||8
8401062|NCT01002118|20704286|P1|NOT COMPLETED|Overall Study||0
8401063|NCT01002118|20704286|P1|COMPLETED|Overall Study||1
8401064|NCT01002118|20704286|P1|Randomized Only Patient|Overall Study||1
8401065|NCT01002118|20704286|P1|STARTED|Overall Study||1
8401066|NCT01002105|20704294|P2|NOT COMPLETED|Overall Study||21
8401067|NCT01002105|20704295|P1|NOT COMPLETED|Overall Study||19
8401068|NCT01002105|20704294|P2|COMPLETED|Overall Study||11
8401069|NCT01002105|20704295|P1|COMPLETED|Overall Study||13
8401070|NCT01002105|20704294|P2|STARTED|Overall Study||32
8401071|NCT01002105|20704295|P1|STARTED|Overall Study||32
8401072|NCT01001988|20704311|P1|NOT COMPLETED|Overall Study||117
8401073|NCT01001988|20704311|P1|COMPLETED|Overall Study||479
8401074|NCT01001988|20704311|P1|STARTED|Overall Study||596
8401075|NCT01001975|20704318|P2|NOT COMPLETED|Overall Study||0
8401076|NCT01001975|20704319|P1|NOT COMPLETED|Overall Study||0
8401077|NCT01001975|20704318|P2|COMPLETED|Overall Study||5
8401078|NCT01001975|20704319|P1|COMPLETED|Overall Study||5
8401079|NCT01001975|20704318|P2|STARTED|Overall Study||5
8401080|NCT01001975|20704319|P1|STARTED|Overall Study||5
8401081|NCT01001832|20704329|P2|NOT COMPLETED|Follow-up Period||21
8401082|NCT01001832|20704330|P1|NOT COMPLETED|Follow-up Period||18
8401083|NCT01001832|20704329|P2|COMPLETED|Follow-up Period||30
8401084|NCT01001832|20704330|P1|COMPLETED|Follow-up Period||34
8401085|NCT01001832|20704329|P2|STARTED|Follow-up Period||51
8401086|NCT01001832|20704330|P1|STARTED|Follow-up Period||52
8401087|NCT01001832|20704329|P2|NOT COMPLETED|Long-term Period||5
8401088|NCT01001832|20704330|P1|NOT COMPLETED|Long-term Period||4
8401089|NCT01001832|20704329|P2|COMPLETED|Long-term Period||51
8401090|NCT01001832|20704330|P1|COMPLETED|Long-term Period||52
8401091|NCT01001832|20704329|P2|STARTED|Long-term Period||56
8401092|NCT01001832|20704330|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
8401093|NCT01001832|20704329|P2|NOT COMPLETED|Short-term Period||3
8401094|NCT01001832|20704330|P1|NOT COMPLETED|Short-term Period||2
8401095|NCT01001832|20704329|P2|COMPLETED|Short-term Period||56
8401096|NCT01001832|20704330|P1|COMPLETED|Short-term Period||57
8401097|NCT01001832|20704329|P2|STARTED|Short-term Period||59
8401098|NCT01001832|20704330|P1|STARTED|Short-term Period||59
8401099|NCT01001806|20704376|P3|NOT COMPLETED|Overall Study||4
8401100|NCT01001806|20704377|P2|NOT COMPLETED|Overall Study||1
8401101|NCT01001806|20704378|P1|NOT COMPLETED|Overall Study||0
8401102|NCT01001806|20704376|P3|COMPLETED|Overall Study||38
8401103|NCT01001806|20704377|P2|COMPLETED|Overall Study||41
8401104|NCT01001806|20704378|P1|COMPLETED|Overall Study||42
8401105|NCT01001806|20704376|P3|STARTED|Overall Study||42
8401106|NCT01001806|20704377|P2|STARTED|Overall Study||42
8401107|NCT01001806|20704378|P1|STARTED|Overall Study||42
8401108|NCT01001767|20704388|P2|NOT COMPLETED|Overall Study||0
8401109|NCT01001767|20704389|P1|NOT COMPLETED|Overall Study||4
8401110|NCT01001767|20704388|P2|COMPLETED|Overall Study||17
8401111|NCT01001767|20704389|P1|COMPLETED|Overall Study||14
8401112|NCT01001767|20704388|P2|STARTED|Overall Study||17
8401113|NCT01001767|20704389|P1|STARTED|Overall Study||18
8401114|NCT01001702|20704395|P1|NOT COMPLETED|Overall Study||72
8401115|NCT01001702|20704395|P1|COMPLETED|Overall Study||13
8401116|NCT01001702|20704395|P1|STARTED|Overall Study||85
8401117|NCT01001598|20704406|P1|NOT COMPLETED|Overall Study||2
8401118|NCT01001598|20704406|P1|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
8401119|NCT01001598|20704406|P1|STARTED|Overall Study||5
8401120|NCT01001572|20704414|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
8401121|NCT01001572|20704415|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
8401122|NCT01001572|20704416|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
8401123|NCT01001572|20704414|P3|COMPLETED|Double-Blind Treatment Phase||306
8401124|NCT01001572|20704415|P2|COMPLETED|Double-Blind Treatment Phase||319
8401125|NCT01001572|20704416|P1|COMPLETED|Double-Blind Treatment Phase||0
8401126|NCT01001572|20704414|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
8401127|NCT01001572|20704415|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
8401128|NCT01001572|20704416|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
8401129|NCT01001572|20704414|P3|STARTED|Double-Blind Treatment Phase||325
8401130|NCT01001572|20704415|P2|STARTED|Double-Blind Treatment Phase||329
8401131|NCT01001572|20704416|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
8401132|NCT01001572|20704414|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
8401133|NCT01001572|20704415|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
8401134|NCT01001572|20704416|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
8401135|NCT01001572|20704414|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
8401136|NCT01001572|20704415|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
8401137|NCT01001572|20704416|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
8401138|NCT01001572|20704414|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
8401139|NCT01001572|20704415|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
8401140|NCT01001572|20704416|P1|STARTED|Single-Blind Valsartan 160 mg||932
8401141|NCT01001559|20704432|P2|NOT COMPLETED|Overall Study||0
8401142|NCT01001559|20704433|P1|NOT COMPLETED|Overall Study||0
8401143|NCT01001559|20704432|P2|COMPLETED|Overall Study||147
8401144|NCT01001559|20704433|P1|COMPLETED|Overall Study||95
8401145|NCT01001559|20704432|P2|STARTED|Overall Study||147
8401146|NCT01001559|20704433|P1|STARTED|Overall Study||95
8401147|NCT01001546|20704447|P2|NOT COMPLETED|Overall Study||0
8401148|NCT01001546|20704448|P1|NOT COMPLETED|Overall Study||0
8401149|NCT01001546|20704447|P2|COMPLETED|Overall Study||207
8401150|NCT01001546|20704448|P1|COMPLETED|Overall Study||206
8401151|NCT01001546|20704447|P2|STARTED|Overall Study||207
8401152|NCT01001546|20704448|P1|STARTED|Overall Study||206
8401153|NCT01001520|20704454|P2|NOT COMPLETED|Medication Period 2||3
8401154|NCT01001520|20704455|P1|NOT COMPLETED|Medication Period 2||0
8401155|NCT01001520|20704454|P2|COMPLETED|Medication Period 2||13
8401156|NCT01001520|20704455|P1|COMPLETED|Medication Period 2||16
8401157|NCT01001520|20704454|P2|STARTED|Medication Period 2||16
8401158|NCT01001520|20704455|P1|STARTED|Medication Period 2||16
8401159|NCT01001520|20704454|P2|NOT COMPLETED|Washout Period||1
8401160|NCT01001520|20704455|P1|NOT COMPLETED|Washout Period||2
8401161|NCT01001520|20704454|P2|COMPLETED|Washout Period||16
8401162|NCT01001520|20704455|P1|COMPLETED|Washout Period||16
8401163|NCT01001520|20704454|P2|STARTED|Washout Period||17
8401164|NCT01001520|20704455|P1|STARTED|Washout Period||18
8401165|NCT01001520|20704454|P2|NOT COMPLETED|Medication Period 1||7
8401166|NCT01001520|20704455|P1|NOT COMPLETED|Medication Period 1||4
8401167|NCT01001520|20704454|P2|COMPLETED|Medication Period 1||17
8401168|NCT01001520|20704455|P1|COMPLETED|Medication Period 1||18
8401169|NCT01001520|20704454|P2|STARTED|Medication Period 1||24
8401170|NCT01001520|20704455|P1|STARTED|Medication Period 1||22
8401171|NCT01001494|20704482|P3|NOT COMPLETED|Overall Study||41
8401172|NCT01001494|20704483|P2|NOT COMPLETED|Overall Study||17
8401173|NCT01001494|20704484|P1|NOT COMPLETED|Overall Study||24
8401174|NCT01001494|20704482|P3|COMPLETED|Overall Study||232
8401175|NCT01001494|20704483|P2|COMPLETED|Overall Study||252
8401176|NCT01001494|20704484|P1|COMPLETED|Overall Study||253
8401177|NCT01001494|20704482|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
8401178|NCT01001494|20704483|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
8401179|NCT01001494|20704484|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
8401180|NCT01001442|20704512|P8|NOT COMPLETED|Overall Study||2
8401181|NCT01001442|20704513|P7|NOT COMPLETED|Overall Study||4
8401182|NCT01001442|20704514|P6|NOT COMPLETED|Overall Study||0
8401183|NCT01001442|20704515|P5|NOT COMPLETED|Overall Study||2
8401184|NCT01001442|20704516|P4|NOT COMPLETED|Overall Study||0
8401185|NCT01001442|20704517|P3|NOT COMPLETED|Overall Study||0
8401186|NCT01001442|20704518|P2|NOT COMPLETED|Overall Study||0
8401187|NCT01001442|20704519|P1|NOT COMPLETED|Overall Study||0
8401188|NCT01001442|20704512|P8|COMPLETED|Overall Study||2
8401189|NCT01001442|20704513|P7|COMPLETED|Overall Study||6
8401190|NCT01001442|20704514|P6|COMPLETED|Overall Study||3
8401191|NCT01001442|20704515|P5|COMPLETED|Overall Study||2
8401192|NCT01001442|20704516|P4|COMPLETED|Overall Study||3
8401193|NCT01001442|20704517|P3|COMPLETED|Overall Study||4
8401194|NCT01001442|20704518|P2|COMPLETED|Overall Study||3
8401195|NCT01001442|20704519|P1|COMPLETED|Overall Study||4
8401196|NCT01001442|20704512|P8|STARTED|Overall Study||4
8401197|NCT01001442|20704513|P7|STARTED|Overall Study||10
8401198|NCT01001442|20704514|P6|STARTED|Overall Study||3
8401199|NCT01001442|20704515|P5|STARTED|Overall Study||4
8401200|NCT01001442|20704516|P4|STARTED|Overall Study||3
8401201|NCT01001442|20704517|P3|STARTED|Overall Study||4
8401202|NCT01001442|20704518|P2|STARTED|Overall Study||3
8401203|NCT01001442|20704519|P1|STARTED|Overall Study||4
8401204|NCT01001429|20704569|P2|NOT COMPLETED|Overall Study||1
8401205|NCT01001429|20704570|P1|NOT COMPLETED|Overall Study||0
8401206|NCT01001429|20704569|P2|COMPLETED|Overall Study||37
8401207|NCT01001429|20704570|P1|COMPLETED|Overall Study||39
8401208|NCT01001429|20704569|P2|STARTED|Overall Study||38
8401209|NCT01001429|20704570|P1|STARTED|Overall Study||39
8401210|NCT01001403|20704602|P2|NOT COMPLETED|Overall Study||0
8401211|NCT01001403|20704603|P1|NOT COMPLETED|Overall Study||0
8401212|NCT01001403|20704602|P2|COMPLETED|Overall Study||31
8401213|NCT01001403|20704603|P1|COMPLETED|Overall Study||31
8401214|NCT01001403|20704602|P2|STARTED|Overall Study||31
8401215|NCT01001403|20704603|P1|STARTED|Overall Study||31
8401216|NCT01001390|20704609|P2|NOT COMPLETED|Overall Study||0
8401217|NCT01001390|20704610|P1|NOT COMPLETED|Overall Study||2
8401218|NCT01001390|20704609|P2|COMPLETED|Overall Study||0
8401219|NCT01001390|20704610|P1|COMPLETED|Overall Study||0
8401220|NCT01001390|20704609|P2|STARTED|Overall Study||0
8401221|NCT01001390|20704610|P1|STARTED|Overall Study||2
8401222|NCT01001377|20704618|P2|NOT COMPLETED|Overall Study||421
8401223|NCT01001377|20704619|P1|NOT COMPLETED|Overall Study||426
8401224|NCT01001377|20704618|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
8401225|NCT01001377|20704619|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
8401226|NCT01001377|20704618|P2|Received Treatment|Overall Study||499
8401227|NCT01001377|20704619|P1|Received Treatment|Overall Study||500
8401228|NCT01001377|20704618|P2|STARTED|Overall Study||506
8401229|NCT01001377|20704619|P1|STARTED|Overall Study||504
8401230|NCT01001325|20704649|P2|NOT COMPLETED|Overall Study||10
8401231|NCT01001325|20704650|P1|NOT COMPLETED|Overall Study||18
8401232|NCT01001325|20704649|P2|COMPLETED|Overall Study||224
8401233|NCT01001325|20704650|P1|COMPLETED|Overall Study||216
8401234|NCT01001325|20704649|P2|STARTED|Overall Study||234
8401235|NCT01001325|20704650|P1|STARTED|Overall Study||234
8401236|NCT01001299|20704656|P1|NOT COMPLETED|Overall Study||25
8401237|NCT01001299|20704656|P1|COMPLETED|Overall Study||0
8401238|NCT01001299|20704656|P1|STARTED|Overall Study||25
8401239|NCT01001234|20704685|P5|NOT COMPLETED|Overall Study||0
8401240|NCT01001234|20704686|P4|NOT COMPLETED|Overall Study||25
8401241|NCT01001234|20704687|P3|NOT COMPLETED|Overall Study||32
8401242|NCT01001234|20704688|P2|NOT COMPLETED|Overall Study||26
8401243|NCT01001234|20704689|P1|NOT COMPLETED|Overall Study||405
8401244|NCT01001234|20704685|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
8401245|NCT01001234|20704686|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
8401246|NCT01001234|20704687|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
8401247|NCT01001234|20704688|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
8401248|NCT01001234|20704689|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
8401249|NCT01001234|20704685|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
8401250|NCT01001234|20704686|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
8401251|NCT01001234|20704687|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
8401252|NCT01001234|20704688|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
8401253|NCT01001234|20704689|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
8401254|NCT01001234|20704685|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
8401255|NCT01001234|20704686|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
8401256|NCT01001234|20704687|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
8401257|NCT01001234|20704688|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
8401258|NCT01001234|20704689|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
8401259|NCT01001234|20704685|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
8401260|NCT01001234|20704686|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
8401261|NCT01001234|20704687|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
8401262|NCT01001234|20704688|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
8401263|NCT01001234|20704689|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
8401264|NCT01001221|20704705|P5|NOT COMPLETED|Overall Study||0
8401265|NCT01001221|20704706|P4|NOT COMPLETED|Overall Study||6
8401266|NCT01001221|20704707|P3|NOT COMPLETED|Overall Study||3
8401267|NCT01001221|20704708|P2|NOT COMPLETED|Overall Study||5
8401268|NCT01001221|20704709|P1|NOT COMPLETED|Overall Study||5
8401269|NCT01001221|20704705|P5|COMPLETED|Overall Study||0
8401270|NCT01001221|20704706|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401271|NCT01001221|20704707|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401272|NCT01001221|20704708|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401273|NCT01001221|20704709|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401274|NCT01001221|20704705|P5|Completed 1st Treatment Cycle|Overall Study||0
8401275|NCT01001221|20704706|P4|Completed 1st Treatment Cycle|Overall Study||6
8401276|NCT01001221|20704707|P3|Completed 1st Treatment Cycle|Overall Study||2
8401277|NCT01001221|20704708|P2|Completed 1st Treatment Cycle|Overall Study||5
8401278|NCT01001221|20704709|P1|Completed 1st Treatment Cycle|Overall Study||5
8401279|NCT01001221|20704705|P5|Treated|Overall Study||0
8401280|NCT01001221|20704706|P4|Treated|Overall Study||6
8401281|NCT01001221|20704707|P3|Treated|Overall Study||2
8401282|NCT01001221|20704708|P2|Treated|Overall Study||5
8401283|NCT01001221|20704709|P1|Treated|Overall Study||5
8401284|NCT01001221|20704705|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
8401285|NCT01001221|20704706|P4|STARTED|Overall Study||6
8401286|NCT01001221|20704707|P3|STARTED|Overall Study||3
8401287|NCT01001221|20704708|P2|STARTED|Overall Study||5
8401288|NCT01001221|20704709|P1|STARTED|Overall Study||5
8401289|NCT01001208|20704884|P2|NOT COMPLETED|Overall Study||33
8401290|NCT01001208|20704885|P1|NOT COMPLETED|Overall Study||28
8401291|NCT01001208|20704884|P2|COMPLETED|Overall Study||206
8401292|NCT01001208|20704885|P1|COMPLETED|Overall Study||211
8401293|NCT01001208|20704884|P2|STARTED|Overall Study||239
8401294|NCT01001208|20704885|P1|STARTED|Overall Study||239
8401295|NCT01001195|20704913|P4|NOT COMPLETED|Overall Study||0
8401296|NCT01001195|20704914|P3|NOT COMPLETED|Overall Study||0
8401297|NCT01001195|20704915|P2|NOT COMPLETED|Overall Study||2
8401298|NCT01001195|20704916|P1|NOT COMPLETED|Overall Study||2
8401299|NCT01001195|20704913|P4|COMPLETED|Overall Study||41
8401300|NCT01001195|20704914|P3|COMPLETED|Overall Study||44
8401301|NCT01001195|20704915|P2|COMPLETED|Overall Study||39
8401302|NCT01001195|20704916|P1|COMPLETED|Overall Study||37
8401303|NCT01001195|20704913|P4|STARTED|Overall Study||41
8401304|NCT01001195|20704914|P3|STARTED|Overall Study||44
8401305|NCT01001195|20704915|P2|STARTED|Overall Study||41
8401306|NCT01001195|20704916|P1|STARTED|Overall Study||39
8401307|NCT01001169|20704928|P2|NOT COMPLETED|Overall Study||1
8401308|NCT01001169|20704929|P1|NOT COMPLETED|Overall Study||2
8401309|NCT01001169|20704928|P2|COMPLETED|Overall Study||29
8401310|NCT01001169|20704929|P1|COMPLETED|Overall Study||28
8401311|NCT01001169|20704928|P2|STARTED|Overall Study||30
8401312|NCT01001169|20704929|P1|STARTED|Overall Study||30
8401313|NCT01001104|20705037|P4|NOT COMPLETED|Overall Study||3
8401314|NCT01001104|20705038|P3|NOT COMPLETED|Overall Study||1
8401315|NCT01001104|20705039|P2|NOT COMPLETED|Overall Study||1
8401316|NCT01001104|20705040|P1|NOT COMPLETED|Overall Study||2
8401317|NCT01001104|20705037|P4|COMPLETED|Overall Study||34
8401318|NCT01001104|20705038|P3|COMPLETED|Overall Study||35
8401319|NCT01001104|20705039|P2|COMPLETED|Overall Study||36
8401320|NCT01001104|20705040|P1|COMPLETED|Overall Study||33
8401321|NCT01001104|20705037|P4|STARTED|Overall Study||37
8401322|NCT01001104|20705038|P3|STARTED|Overall Study||36
8401323|NCT01001104|20705039|P2|STARTED|Overall Study||37
8401324|NCT01001104|20705040|P1|STARTED|Overall Study||35
8401325|NCT01001078|20705087|P2|NOT COMPLETED|Overall Study||0
8401326|NCT01001078|20705088|P1|NOT COMPLETED|Overall Study||0
8401327|NCT01001078|20705087|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
8401328|NCT01001078|20705088|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
8401329|NCT01001078|20705087|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
8401330|NCT01001078|20705088|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
8401331|NCT01001078|20705087|P2|Intubated|Overall Study||1
8401332|NCT01001078|20705088|P1|Intubated|Overall Study||2
8401333|NCT01001078|20705087|P2|Received Crossover|Overall Study||3
8401334|NCT01001078|20705088|P1|Received Crossover|Overall Study||2
8401335|NCT01001078|20705087|P2|Received Allocated Intervention|Overall Study||46
8401336|NCT01001078|20705088|P1|Received Allocated Intervention|Overall Study||46
8401337|NCT01001078|20705087|P2|STARTED|Overall Study||50
8401338|NCT01001078|20705088|P1|STARTED|Overall Study||50
8401339|NCT01001052|20705104|P2|NOT COMPLETED|Overall Study||0
8401340|NCT01001052|20705105|P1|NOT COMPLETED|Overall Study||0
8401341|NCT01001052|20705104|P2|COMPLETED|Overall Study||18
8401342|NCT01001052|20705105|P1|COMPLETED|Overall Study||20
8401343|NCT01001052|20705104|P2|STARTED|Overall Study||18
8401344|NCT01001052|20705105|P1|STARTED|Overall Study||20
8401345|NCT01000987|20705118|P3|NOT COMPLETED|Overall Study||0
8401346|NCT01000987|20705119|P2|NOT COMPLETED|Overall Study||0
8401347|NCT01000987|20705120|P1|NOT COMPLETED|Overall Study||0
8401348|NCT01000987|20705118|P3|COMPLETED|Overall Study||17
8401349|NCT01000987|20705119|P2|COMPLETED|Overall Study||15
8401350|NCT01000987|20705120|P1|COMPLETED|Overall Study||12
8401351|NCT01000987|20705118|P3|STARTED|Overall Study||17
8401352|NCT01000987|20705119|P2|STARTED|Overall Study||15
8401353|NCT01000987|20705120|P1|STARTED|Overall Study||12
8401354|NCT01000974|20705131|P3|NOT COMPLETED|Booster Vaccination Phase||14
8401355|NCT01000974|20705132|P2|NOT COMPLETED|Booster Vaccination Phase||12
8401356|NCT01000974|20705133|P1|NOT COMPLETED|Booster Vaccination Phase||67
8401357|NCT01000974|20705131|P3|COMPLETED|Booster Vaccination Phase||386
8401358|NCT01000974|20705132|P2|COMPLETED|Booster Vaccination Phase||423
8401359|NCT01000974|20705133|P1|COMPLETED|Booster Vaccination Phase||2270
8401360|NCT01000974|20705131|P3|STARTED|Booster Vaccination Phase||400
8401361|NCT01000974|20705132|P2|STARTED|Booster Vaccination Phase||435
8401362|NCT01000974|20705133|P1|STARTED|Booster Vaccination Phase||2337
8401363|NCT01000974|20705131|P3|NOT COMPLETED|Primary Vaccination Phase||63
8401364|NCT01000974|20705132|P2|NOT COMPLETED|Primary Vaccination Phase||50
8401365|NCT01000974|20705133|P1|NOT COMPLETED|Primary Vaccination Phase||338
8401366|NCT01000974|20705131|P3|COMPLETED|Primary Vaccination Phase||457
8401367|NCT01000974|20705132|P2|COMPLETED|Primary Vaccination Phase||470
8401368|NCT01000974|20705133|P1|COMPLETED|Primary Vaccination Phase||2625
8401369|NCT01000974|20705131|P3|STARTED|Primary Vaccination Phase||520
8401370|NCT01000974|20705132|P2|STARTED|Primary Vaccination Phase||520
8401371|NCT01000974|20705133|P1|STARTED|Primary Vaccination Phase||2963
8401372|NCT01000961|20705240|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8401373|NCT01000961|20705241|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8401374|NCT01000961|20705240|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
8401375|NCT01000961|20705241|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
8401376|NCT01000961|20705240|P2|STARTED|Second Intervention (3 Weeks)||20
8401377|NCT01000961|20705241|P1|STARTED|Second Intervention (3 Weeks)||21
8401378|NCT01000961|20705240|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
8401379|NCT01000961|20705241|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8401380|NCT01000961|20705240|P2|COMPLETED|First Intervention (3 Weeks)||20
8401381|NCT01000961|20705241|P1|COMPLETED|First Intervention (3 Weeks)||21
8401382|NCT01000961|20705240|P2|STARTED|First Intervention (3 Weeks)||22
8401383|NCT01000961|20705241|P1|STARTED|First Intervention (3 Weeks)||21
8401384|NCT01000961|20705240|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
8401385|NCT01000961|20705241|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
8401386|NCT01000961|20705240|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
8401387|NCT01000961|20705241|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
8401388|NCT01000961|20705240|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
8401389|NCT01000961|20705241|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
8401390|NCT01000818|20705253|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
8401391|NCT01000818|20705253|P1|COMPLETED|Omeprazole + Raltegravir||18
8401392|NCT01000818|20705253|P1|STARTED|Omeprazole + Raltegravir||18
8401393|NCT01000818|20705253|P1|NOT COMPLETED|Famotidine + Raltegravir||0
8401394|NCT01000818|20705253|P1|COMPLETED|Famotidine + Raltegravir||18
8401395|NCT01000818|20705253|P1|STARTED|Famotidine + Raltegravir||18
8401396|NCT01000818|20705253|P1|NOT COMPLETED|Raltegravir||0
8401397|NCT01000818|20705253|P1|COMPLETED|Raltegravir||18
8401398|NCT01000818|20705253|P1|STARTED|Raltegravir||18
8401399|NCT01000805|20705264|P2|NOT COMPLETED|Overall Study||62
8401400|NCT01000805|20705265|P1|NOT COMPLETED|Overall Study||70
8401401|NCT01000805|20705264|P2|COMPLETED|Overall Study||204
8401402|NCT01000805|20705265|P1|COMPLETED|Overall Study||192
8401403|NCT01000805|20705264|P2|STARTED|Overall Study||266
8401404|NCT01000805|20705265|P1|STARTED|Overall Study||262
8401405|NCT01000727|20705299|P2|NOT COMPLETED|Overall Study||176
8401406|NCT01000727|20705300|P1|NOT COMPLETED|Overall Study||175
8401407|NCT01000727|20705299|P2|COMPLETED|Overall Study||6328
8401408|NCT01000727|20705300|P1|COMPLETED|Overall Study||6347
8401409|NCT01000727|20705299|P2|STARTED|Overall Study||6504
8401410|NCT01000727|20705300|P1|STARTED|Overall Study||6522
8401411|NCT01000662|20705330|P2|NOT COMPLETED|Overall Study||8
8401412|NCT01000662|20705331|P1|NOT COMPLETED|Overall Study||4
8401413|NCT01000662|20705330|P2|COMPLETED|Overall Study||198
8401414|NCT01000662|20705331|P1|COMPLETED|Overall Study||202
8401415|NCT01000662|20705330|P2|STARTED|Overall Study||206
8401416|NCT01000662|20705331|P1|STARTED|Overall Study||206
8401417|NCT01000649|20705365|P4|NOT COMPLETED|Overall Study||6
8401418|NCT01000649|20705366|P3|NOT COMPLETED|Overall Study||2
8401419|NCT01000649|20705367|P2|NOT COMPLETED|Overall Study||3
8401420|NCT01000649|20705368|P1|NOT COMPLETED|Overall Study||5
8401421|NCT01000649|20705365|P4|COMPLETED|Overall Study||15
8401422|NCT01000649|20705366|P3|COMPLETED|Overall Study||0
8401423|NCT01000649|20705367|P2|COMPLETED|Overall Study||16
8401424|NCT01000649|20705368|P1|COMPLETED|Overall Study||5
8401425|NCT01000649|20705365|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
8401426|NCT01000649|20705366|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
8401427|NCT01000649|20705367|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
8401428|NCT01000649|20705368|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
8401429|NCT01000649|20705365|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
8401430|NCT01000649|20705366|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
8401431|NCT01000649|20705367|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
8401432|NCT01000649|20705368|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
8401433|NCT01000610|20705449|P1|NOT COMPLETED|Overall Study||6
8401434|NCT01000610|20705449|P1|COMPLETED|Overall Study||12
8401435|NCT01000610|20705449|P1|STARTED|Overall Study||18
8401436|NCT01000506|20705460|P4|NOT COMPLETED|Overall Study||23
8401437|NCT01000506|20705461|P3|NOT COMPLETED|Overall Study||21
8401438|NCT01000506|20705462|P2|NOT COMPLETED|Overall Study||24
8401439|NCT01000506|20705463|P1|NOT COMPLETED|Overall Study||28
8401440|NCT01000506|20705460|P4|COMPLETED|Overall Study||133
8401441|NCT01000506|20705461|P3|COMPLETED|Overall Study||131
8401442|NCT01000506|20705462|P2|COMPLETED|Overall Study||129
8401443|NCT01000506|20705463|P1|COMPLETED|Overall Study||127
8401444|NCT01000506|20705460|P4|STARTED|Overall Study||156
8401445|NCT01000506|20705461|P3|STARTED|Overall Study||152
8401446|NCT01000506|20705462|P2|STARTED|Overall Study||153
8401447|NCT01000506|20705463|P1|STARTED|Overall Study||155
8401448|NCT01000493|20705507|P2|NOT COMPLETED|Overall Study||55
8401449|NCT01000493|20705508|P1|NOT COMPLETED|Overall Study||39
8401450|NCT01000493|20705507|P2|COMPLETED|Overall Study||14
8401451|NCT01000493|20705508|P1|COMPLETED|Overall Study||21
8401452|NCT01000493|20705507|P2|STARTED|Overall Study||69
8401453|NCT01000493|20705508|P1|STARTED|Overall Study||60
8401454|NCT01000480|20705558|P1|NOT COMPLETED|Follow-Up Period||0
8401455|NCT01000480|20705558|P1|COMPLETED|Follow-Up Period||88
8401456|NCT01000480|20705558|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
8401457|NCT01000480|20705558|P1|NOT COMPLETED|Concurrent Therapy Phase||10
8401458|NCT01000480|20705558|P1|COMPLETED|Concurrent Therapy Phase||65
8401459|NCT01000480|20705558|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
8401460|NCT01000480|20705558|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
8401461|NCT01000480|20705558|P1|NOT COMPLETED|Induction Phase||7
8401462|NCT01000480|20705558|P1|COMPLETED|Induction Phase||83
8401463|NCT01000480|20705558|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
8401464|NCT01000480|20705558|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
8401465|NCT01000480|20705558|P1|STARTED|Induction Phase||90
8401466|NCT01000376|20705566|P2|NOT COMPLETED|Cycle 1 Day 15||0
8401467|NCT01000376|20705567|P1|NOT COMPLETED|Cycle 1 Day 15||0
8401468|NCT01000376|20705566|P2|COMPLETED|Cycle 1 Day 15||6
8401469|NCT01000376|20705567|P1|COMPLETED|Cycle 1 Day 15||4
8401470|NCT01000376|20705566|P2|STARTED|Cycle 1 Day 15||6
8401471|NCT01000376|20705567|P1|STARTED|Cycle 1 Day 15||4
8401472|NCT01000376|20705566|P2|NOT COMPLETED|Cycle 1 Day 1||0
8401473|NCT01000376|20705567|P1|NOT COMPLETED|Cycle 1 Day 1||2
8401474|NCT01000376|20705566|P2|COMPLETED|Cycle 1 Day 1||6
8401475|NCT01000376|20705567|P1|COMPLETED|Cycle 1 Day 1||4
8401476|NCT01000376|20705566|P2|STARTED|Cycle 1 Day 1||6
8401477|NCT01000376|20705567|P1|STARTED|Cycle 1 Day 1||6
8401478|NCT01000337|20705577|P2|NOT COMPLETED|Overall Study||3
8401479|NCT01000337|20705578|P1|NOT COMPLETED|Overall Study||4
8401480|NCT01000337|20705577|P2|COMPLETED|Overall Study||30
8401481|NCT01000337|20705578|P1|COMPLETED|Overall Study||30
8401482|NCT01000337|20705577|P2|STARTED|Overall Study||33
8401483|NCT01000337|20705578|P1|STARTED|Overall Study||34
8401484|NCT01000324|20705584|P1|NOT COMPLETED|Year 20||0
8401485|NCT01000324|20705584|P1|COMPLETED|Year 20||28
8401486|NCT01000324|20705584|P1|STARTED|Year 20||28
8401487|NCT01000324|20705584|P1|NOT COMPLETED|Year 19||0
8401488|NCT01000324|20705584|P1|COMPLETED|Year 19||28
8401489|NCT01000324|20705584|P1|STARTED|Year 19||28
8401490|NCT01000324|20705584|P1|NOT COMPLETED|Year 18||0
8401491|NCT01000324|20705584|P1|COMPLETED|Year 18||29
8401492|NCT01000324|20705584|P1|STARTED|Year 18||29
8401493|NCT01000324|20705584|P1|NOT COMPLETED|Year 17||0
8401494|NCT01000324|20705584|P1|COMPLETED|Year 17||32
8401495|NCT01000324|20705584|P1|STARTED|Year 17||32
8401496|NCT01000324|20705584|P1|NOT COMPLETED|Year 16||0
8401497|NCT01000324|20705584|P1|COMPLETED|Year 16||40
8401498|NCT01000324|20705584|P1|STARTED|Year 16||40
8401499|NCT01000311|20705596|P2|NOT COMPLETED|Overall Study||70
8401500|NCT01000311|20705597|P1|NOT COMPLETED|Overall Study||45
8401501|NCT01000311|20705596|P2|COMPLETED|Overall Study||201
8401502|NCT01000311|20705597|P1|COMPLETED|Overall Study||213
8401503|NCT01000311|20705596|P2|STARTED|Overall Study||271
8401504|NCT01000311|20705597|P1|STARTED|Overall Study||258
8401505|NCT01000285|20705627|P1|NOT COMPLETED|Overall Study||0
8401506|NCT01000285|20705627|P1|COMPLETED|Overall Study||18
8401507|NCT01000285|20705627|P1|STARTED|Overall Study||18
8401508|NCT01000155|20705647|P1|NOT COMPLETED|Overall Study||2
8401509|NCT01000155|20705647|P1|COMPLETED|Overall Study||3
8401510|NCT01000155|20705647|P1|STARTED|Overall Study||5
8401511|NCT01000064|20705653|P2|NOT COMPLETED|Overall Study||1
8401512|NCT01000064|20705654|P1|NOT COMPLETED|Overall Study||1
8401513|NCT01000064|20705653|P2|COMPLETED|Overall Study||5
8401514|NCT01000064|20705654|P1|COMPLETED|Overall Study||6
8401515|NCT01000064|20705653|P2|STARTED|Overall Study||6
8401516|NCT01000064|20705654|P1|STARTED|Overall Study||7
8401517|NCT01000051|20705677|P2|NOT COMPLETED|Overall Study||1
8401518|NCT01000051|20705678|P1|NOT COMPLETED|Overall Study||3
8401519|NCT01000051|20705677|P2|COMPLETED|Overall Study||17
8401520|NCT01000051|20705678|P1|COMPLETED|Overall Study||39
8401521|NCT01000051|20705677|P2|STARTED|Overall Study||18
8401522|NCT01000051|20705678|P1|STARTED|Overall Study||42
8401523|NCT01000025|20705686|P2|NOT COMPLETED|Overall Study||238
8401524|NCT01000025|20705687|P1|NOT COMPLETED|Overall Study||468
8401525|NCT01000025|20705686|P2|COMPLETED|Overall Study||2
8401526|NCT01000025|20705687|P1|COMPLETED|Overall Study||12
8401527|NCT01000025|20705686|P2|STARTED|Overall Study||240
8401528|NCT01000025|20705687|P1|STARTED|Overall Study||480
8401529|NCT00999921|20705705|P2|NOT COMPLETED|Overall Study||19
8401530|NCT00999921|20705706|P1|NOT COMPLETED|Overall Study||10
8401531|NCT00999921|20705705|P2|COMPLETED|Overall Study||110
8401532|NCT00999921|20705706|P1|COMPLETED|Overall Study||117
8401533|NCT00999921|20705705|P2|STARTED|Overall Study||129
8401534|NCT00999921|20705706|P1|STARTED|Overall Study||127
8401535|NCT00999908|20705716|P3|NOT COMPLETED|Treatment Period 3||0
8401536|NCT00999908|20705717|P2|NOT COMPLETED|Treatment Period 3||0
8401537|NCT00999908|20705718|P1|NOT COMPLETED|Treatment Period 3||0
8401538|NCT00999908|20705716|P3|COMPLETED|Treatment Period 3||19
8401539|NCT00999908|20705717|P2|COMPLETED|Treatment Period 3||16
8401540|NCT00999908|20705718|P1|COMPLETED|Treatment Period 3||16
8401541|NCT00999908|20705716|P3|STARTED|Treatment Period 3||19
8401542|NCT00999908|20705717|P2|STARTED|Treatment Period 3||16
8401543|NCT00999908|20705718|P1|STARTED|Treatment Period 3||16
8401544|NCT00999908|20705716|P3|NOT COMPLETED|Treatment Period 2||0
8401545|NCT00999908|20705717|P2|NOT COMPLETED|Treatment Period 2||0
8401546|NCT00999908|20705718|P1|NOT COMPLETED|Treatment Period 2||1
8401547|NCT00999908|20705716|P3|COMPLETED|Treatment Period 2||19
8401548|NCT00999908|20705717|P2|COMPLETED|Treatment Period 2||16
8401549|NCT00999908|20705718|P1|COMPLETED|Treatment Period 2||16
8401550|NCT00999908|20705716|P3|STARTED|Treatment Period 2||19
8401551|NCT00999908|20705717|P2|STARTED|Treatment Period 2||16
8401552|NCT00999908|20705718|P1|STARTED|Treatment Period 2||17
8401553|NCT00999908|20705716|P3|NOT COMPLETED|Treatment Period 1||0
8401554|NCT00999908|20705717|P2|NOT COMPLETED|Treatment Period 1||0
8401555|NCT00999908|20705718|P1|NOT COMPLETED|Treatment Period 1||2
8401556|NCT00999908|20705716|P3|COMPLETED|Treatment Period 1||19
8401557|NCT00999908|20705717|P2|COMPLETED|Treatment Period 1||16
8401558|NCT00999908|20705718|P1|COMPLETED|Treatment Period 1||17
8401559|NCT00999908|20705716|P3|STARTED|Treatment Period 1||19
8401560|NCT00999908|20705717|P2|STARTED|Treatment Period 1||16
8401561|NCT00999908|20705718|P1|STARTED|Treatment Period 1||19
8401562|NCT00999830|20705734|P2|NOT COMPLETED|Overall Study||0
8401563|NCT00999830|20705735|P1|NOT COMPLETED|Overall Study||0
8401564|NCT00999830|20705734|P2|COMPLETED|Overall Study||13
8401565|NCT00999830|20705735|P1|COMPLETED|Overall Study||14
8401566|NCT00999830|20705734|P2|STARTED|Overall Study||13
8401567|NCT00999830|20705735|P1|STARTED|Overall Study||14
8401568|NCT00999804|20705747|P2|NOT COMPLETED|Overall Study||5
8401569|NCT00999804|20705748|P1|NOT COMPLETED|Overall Study||21
8401570|NCT00999804|20705747|P2|COMPLETED|Overall Study||38
8401571|NCT00999804|20705748|P1|COMPLETED|Overall Study||64
8401572|NCT00999804|20705747|P2|STARTED|Overall Study||43
8401573|NCT00999804|20705748|P1|STARTED|Overall Study||85
8401574|NCT00999713|20705762|P2|NOT COMPLETED|Overall Study||0
8401575|NCT00999713|20705763|P1|NOT COMPLETED|Overall Study||2
8401576|NCT00999713|20705762|P2|COMPLETED|Overall Study||17
8401577|NCT00999713|20705763|P1|COMPLETED|Overall Study||24
8401578|NCT00999713|20705762|P2|STARTED|Overall Study||17
8401579|NCT00999713|20705763|P1|STARTED|Overall Study||26
8401580|NCT00999687|20705777|P1|NOT COMPLETED|Second Intervention||3
8401581|NCT00999687|20705777|P1|COMPLETED|Second Intervention||27
8401582|NCT00999687|20705777|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
8401583|NCT00999687|20705777|P1|NOT COMPLETED|First Intervention||1
8401584|NCT00999687|20705777|P1|COMPLETED|First Intervention||30
8401585|NCT00999687|20705777|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
8401586|NCT00999661|20705784|P1|NOT COMPLETED|Overall Study||70
8401587|NCT00999661|20705784|P1|COMPLETED|Overall Study||161
8401588|NCT00999661|20705784|P1|STARTED|Overall Study||231
8401589|NCT00999609|20705792|P2|NOT COMPLETED|Overall Study||1
8401590|NCT00999609|20705793|P1|NOT COMPLETED|Overall Study||1
8401591|NCT00999609|20705792|P2|COMPLETED|Overall Study|1 year post intervention|9
8401592|NCT00999609|20705793|P1|COMPLETED|Overall Study|1 year post intervention|20
8401593|NCT00999609|20705792|P2|STARTED|Overall Study||10
8401594|NCT00999609|20705793|P1|STARTED|Overall Study|Before intervention|21
8401595|NCT00999596|20705805|P1|NOT COMPLETED|Overall Study||101
8401596|NCT00999596|20705805|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
8401597|NCT00999596|20705805|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
8401598|NCT00999596|20705805|P1|STARTED|Overall Study||107
8401599|NCT00999544|20705810|P1|NOT COMPLETED|Overall Study||1
8401600|NCT00999544|20705810|P1|COMPLETED|Overall Study||8
8401601|NCT00999544|20705810|P1|STARTED|Overall Study||9
8401602|NCT00999466|20705846|P3|NOT COMPLETED|Main Part||4
8401603|NCT00999466|20705847|P2|NOT COMPLETED|Main Part||4
8401604|NCT00999466|20705848|P1|NOT COMPLETED|Main Part||0
8401605|NCT00999466|20705846|P3|COMPLETED|Main Part||21
8401606|NCT00999466|20705847|P2|COMPLETED|Main Part||22
8401607|NCT00999466|20705848|P1|COMPLETED|Main Part||0
8401608|NCT00999466|20705846|P3|STARTED|Main Part||25
8401609|NCT00999466|20705847|P2|STARTED|Main Part||26
8401610|NCT00999466|20705848|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
8401611|NCT00999466|20705846|P3|NOT COMPLETED|Pilot Part||0
8401612|NCT00999466|20705847|P2|NOT COMPLETED|Pilot Part||0
8401613|NCT00999466|20705848|P1|NOT COMPLETED|Pilot Part||0
8401614|NCT00999466|20705846|P3|COMPLETED|Pilot Part||3
8401615|NCT00999466|20705847|P2|COMPLETED|Pilot Part||0
8401616|NCT00999466|20705848|P1|COMPLETED|Pilot Part||6
8401617|NCT00999466|20705846|P3|STARTED|Pilot Part||3
8401618|NCT00999466|20705847|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
8401619|NCT00999466|20705848|P1|STARTED|Pilot Part||6
8401620|NCT00999167|20706125|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
8401621|NCT00999167|20706126|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
8401622|NCT00999167|20706127|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
8401623|NCT00999167|20706125|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
8401624|NCT00999167|20706126|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
8401625|NCT00999167|20706127|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
8401626|NCT00999167|20706125|P3|STARTED|Part B: Randomized, Placebo Controlled||88
8401627|NCT00999167|20706126|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
8401628|NCT00999167|20706127|P1|STARTED|Part B: Randomized, Placebo Controlled||0
8401629|NCT00999167|20706125|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
8401630|NCT00999167|20706126|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
8401631|NCT00999167|20706127|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
8401632|NCT00999167|20706125|P3|COMPLETED|Part A: Open Label Safety run-in||0
8401633|NCT00999167|20706126|P2|COMPLETED|Part A: Open Label Safety run-in||0
8401634|NCT00999167|20706127|P1|COMPLETED|Part A: Open Label Safety run-in||8
8401635|NCT00999167|20706125|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
8401636|NCT00999167|20706126|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
8401637|NCT00999167|20706127|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
8401638|NCT00999167|20706125|P3|STARTED|Part A: Open Label Safety run-in||0
8401639|NCT00999167|20706126|P2|STARTED|Part A: Open Label Safety run-in||0
8401640|NCT00999167|20706127|P1|STARTED|Part A: Open Label Safety run-in||15
8401641|NCT00999141|20706141|P1|NOT COMPLETED|Overall Study||0
8401642|NCT00999141|20706141|P1|COMPLETED|Overall Study||75
8401643|NCT00999141|20706141|P1|STARTED|Overall Study|Randomized and treated|75
8401644|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
8401645|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
8401646|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
8401647|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
8401648|NCT00999102|20706223|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
8401649|NCT00999102|20706224|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
8401650|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
8401651|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
8401652|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
8401653|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
8401654|NCT00999102|20706223|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
8401655|NCT00999102|20706224|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
8401656|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
8401657|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
8401658|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
8401659|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
8401660|NCT00999102|20706223|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
8401661|NCT00999102|20706224|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
8401662|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
8401663|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
8401664|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
8401665|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
8401666|NCT00999102|20706223|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
8401667|NCT00999102|20706224|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
8401668|NCT00999037|20706240|P2|NOT COMPLETED|Overall Study||0
8401669|NCT00999037|20706241|P1|NOT COMPLETED|Overall Study||0
8401670|NCT00999037|20706240|P2|COMPLETED|Overall Study||9
8401671|NCT00999037|20706241|P1|COMPLETED|Overall Study||9
8401672|NCT00999037|20706240|P2|STARTED|Overall Study|20|9
8401673|NCT00999037|20706241|P1|STARTED|Overall Study||9
8401674|NCT00998985|20706265|P14|NOT COMPLETED|Overall Study||0
8401675|NCT00998985|20706266|P13|NOT COMPLETED|Overall Study||0
8401676|NCT00998985|20706267|P12|NOT COMPLETED|Overall Study||0
8401677|NCT00998985|20706268|P11|NOT COMPLETED|Overall Study||0
8401678|NCT00998985|20706269|P10|NOT COMPLETED|Overall Study||0
8401679|NCT00998985|20706270|P9|NOT COMPLETED|Overall Study||1
8401680|NCT00998985|20706271|P8|NOT COMPLETED|Overall Study||0
8401681|NCT00998985|20706272|P7|NOT COMPLETED|Overall Study||0
8401682|NCT00998985|20706273|P6|NOT COMPLETED|Overall Study||1
8401683|NCT00998985|20706274|P5|NOT COMPLETED|Overall Study||0
8401684|NCT00998985|20706275|P4|NOT COMPLETED|Overall Study||0
8401685|NCT00998985|20706276|P3|NOT COMPLETED|Overall Study||0
8401686|NCT00998985|20706277|P2|NOT COMPLETED|Overall Study||0
8401687|NCT00998985|20706278|P1|NOT COMPLETED|Overall Study||0
8401688|NCT00998985|20706265|P14|COMPLETED|Overall Study||15
8401689|NCT00998985|20706266|P13|COMPLETED|Overall Study||5
8401690|NCT00998985|20706267|P12|COMPLETED|Overall Study||5
8401691|NCT00998985|20706268|P11|COMPLETED|Overall Study||5
8401692|NCT00998985|20706269|P10|COMPLETED|Overall Study||5
8401693|NCT00998985|20706270|P9|COMPLETED|Overall Study||5
8401694|NCT00998985|20706271|P8|COMPLETED|Overall Study||5
8401695|NCT00998985|20706272|P7|COMPLETED|Overall Study||5
8401696|NCT00998985|20706273|P6|COMPLETED|Overall Study||4
8401697|NCT00998985|20706274|P5|COMPLETED|Overall Study||5
8401698|NCT00998985|20706275|P4|COMPLETED|Overall Study||5
8401699|NCT00998985|20706276|P3|COMPLETED|Overall Study||15
8401700|NCT00998985|20706277|P2|COMPLETED|Overall Study||5
8401701|NCT00998985|20706278|P1|COMPLETED|Overall Study||5
8401702|NCT00998985|20706265|P14|STARTED|Overall Study||15
8401703|NCT00998985|20706266|P13|STARTED|Overall Study||5
8401704|NCT00998985|20706267|P12|STARTED|Overall Study||5
8401705|NCT00998985|20706268|P11|STARTED|Overall Study||5
8401706|NCT00998985|20706269|P10|STARTED|Overall Study||5
8401707|NCT00998985|20706270|P9|STARTED|Overall Study||6
8401708|NCT00998985|20706271|P8|STARTED|Overall Study||5
8401709|NCT00998985|20706272|P7|STARTED|Overall Study||5
8401710|NCT00998985|20706273|P6|STARTED|Overall Study||5
8401711|NCT00998985|20706274|P5|STARTED|Overall Study||5
8401712|NCT00998985|20706275|P4|STARTED|Overall Study||5
8401713|NCT00998985|20706276|P3|STARTED|Overall Study||15
8401714|NCT00998985|20706277|P2|STARTED|Overall Study||5
8401715|NCT00998985|20706278|P1|STARTED|Overall Study||5
8401716|NCT00998881|20706346|P2|NOT COMPLETED|Overall Study||2
8401717|NCT00998881|20706347|P1|NOT COMPLETED|Overall Study||8
8401718|NCT00998881|20706346|P2|COMPLETED|Overall Study||97
8401719|NCT00998881|20706347|P1|COMPLETED|Overall Study||96
8401720|NCT00998881|20706346|P2|STARTED|Overall Study||99
8401721|NCT00998881|20706347|P1|STARTED|Overall Study||104
8401722|NCT00998868|20706359|P1|NOT COMPLETED|Overall Study||0
8401723|NCT00998868|20706359|P1|COMPLETED|Overall Study||51
8401724|NCT00998868|20706359|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
8401725|NCT00998790|20706366|P1|NOT COMPLETED|Overall Study||21
8401726|NCT00998790|20706366|P1|COMPLETED|Overall Study||93
8401727|NCT00998790|20706366|P1|Participants Who Were Treated|Overall Study||113
8401728|NCT00998790|20706366|P1|STARTED|Overall Study||114
8401729|NCT00998764|20706376|P2|NOT COMPLETED|Overall Study||274
8401730|NCT00998764|20706377|P1|NOT COMPLETED|Overall Study||216
8401731|NCT00998764|20706376|P2|COMPLETED|Overall Study||2
8401732|NCT00998764|20706377|P1|COMPLETED|Overall Study||0
8401733|NCT00998764|20706376|P2|Treated|Overall Study||275
8401734|NCT00998764|20706377|P1|Treated|Overall Study||215
8401735|NCT00998764|20706376|P2|STARTED|Overall Study||276
8401736|NCT00998764|20706377|P1|STARTED|Overall Study||216
8401737|NCT00998738|20706399|P1|NOT COMPLETED|Overall Study||1
8401738|NCT00998738|20706399|P1|COMPLETED|Overall Study||0
8401739|NCT00998738|20706399|P1|STARTED|Overall Study||1
8401740|NCT00998660|20706414|P1|NOT COMPLETED|Overall Study||13
8401741|NCT00998660|20706414|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
8401742|NCT00998660|20706414|P1|Month 3 Visit|Overall Study||87
8401743|NCT00998660|20706414|P1|Implanted|Overall Study||93
8401744|NCT00998660|20706414|P1|STARTED|Overall Study||100
8401745|NCT00998582|20706420|P2|NOT COMPLETED|Overall Study||0
8401746|NCT00998582|20706421|P1|NOT COMPLETED|Overall Study||0
8401747|NCT00998582|20706420|P2|COMPLETED|Overall Study||14
8401748|NCT00998582|20706421|P1|COMPLETED|Overall Study||13
8401749|NCT00998582|20706420|P2|STARTED|Overall Study||14
8401750|NCT00998582|20706421|P1|STARTED|Overall Study||13
8401751|NCT00998517|20706432|P3|NOT COMPLETED|Overall Study||0
8401752|NCT00998517|20706433|P2|NOT COMPLETED|Overall Study||0
8401753|NCT00998517|20706434|P1|NOT COMPLETED|Overall Study||0
8401754|NCT00998517|20706432|P3|COMPLETED|Overall Study||918
8401755|NCT00998517|20706433|P2|COMPLETED|Overall Study||906
8401756|NCT00998517|20706434|P1|COMPLETED|Overall Study||888
8401757|NCT00998517|20706432|P3|STARTED|Overall Study||918
8401758|NCT00998517|20706433|P2|STARTED|Overall Study||906
8401759|NCT00998517|20706434|P1|STARTED|Overall Study||888
8401760|NCT00998426|20706460|P1|NOT COMPLETED|Overall Study||0
8401761|NCT00998426|20706460|P1|COMPLETED|Overall Study||5
8401762|NCT00998426|20706460|P1|Blood Glucose Monitoring|Overall Study||5
8401763|NCT00998426|20706460|P1|STARTED|Overall Study||5
8401764|NCT00998400|20706467|P2|NOT COMPLETED|Overall Study||2
8401765|NCT00998400|20706468|P1|NOT COMPLETED|Overall Study||2
8401766|NCT00998400|20706467|P2|COMPLETED|Overall Study||48
8401767|NCT00998400|20706468|P1|COMPLETED|Overall Study||48
8401768|NCT00998400|20706467|P2|STARTED|Overall Study||50
8401769|NCT00998400|20706468|P1|STARTED|Overall Study||50
8401770|NCT00998374|20706498|P2|NOT COMPLETED|Overall Study||11
8401771|NCT00998374|20706499|P1|NOT COMPLETED|Overall Study||12
8401772|NCT00998374|20706498|P2|COMPLETED|Overall Study||12
8401773|NCT00998374|20706499|P1|COMPLETED|Overall Study||27
8401774|NCT00998374|20706498|P2|STARTED|Overall Study||23
8401775|NCT00998374|20706499|P1|STARTED|Overall Study||39
8401776|NCT00998335|20706513|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
8401777|NCT00998335|20706514|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
8401778|NCT00998335|20706513|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
8401779|NCT00998335|20706514|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
8401780|NCT00998335|20706513|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
8401781|NCT00998335|20706514|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
8401782|NCT00998335|20706513|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
8401783|NCT00998335|20706514|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
8401784|NCT00998335|20706513|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
8401785|NCT00998335|20706514|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
8401786|NCT00998335|20706513|P2|STARTED|Initial Treatment (Months 0 - 3)||0
8401787|NCT00998335|20706514|P1|STARTED|Initial Treatment (Months 0 - 3)||30
8401788|NCT00998309|20706542|P1|NOT COMPLETED|Overall Study||4
8401789|NCT00998309|20706542|P1|COMPLETED|Overall Study||498
8401790|NCT00998309|20706542|P1|STARTED|Overall Study||502
8401791|NCT00998296|20706609|P11|NOT COMPLETED|Overall Study||7
8401792|NCT00998296|20706610|P10|NOT COMPLETED|Overall Study||18
8401793|NCT00998296|20706611|P9|NOT COMPLETED|Overall Study||2
8401794|NCT00998296|20706612|P8|NOT COMPLETED|Overall Study||2
8401795|NCT00998296|20706613|P7|NOT COMPLETED|Overall Study||1
8401796|NCT00998296|20706614|P6|NOT COMPLETED|Overall Study||0
8401797|NCT00998296|20706615|P5|NOT COMPLETED|Overall Study||2
8401798|NCT00998296|20706616|P4|NOT COMPLETED|Overall Study||0
8401799|NCT00998296|20706617|P3|NOT COMPLETED|Overall Study||0
8401800|NCT00998296|20706618|P2|NOT COMPLETED|Overall Study||1
8401801|NCT00998296|20706619|P1|NOT COMPLETED|Overall Study||0
8401802|NCT00998296|20706609|P11|COMPLETED|Overall Study||0
8401803|NCT00998296|20706610|P10|COMPLETED|Overall Study||0
8401804|NCT00998296|20706611|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
8401805|NCT00998296|20706612|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
8401806|NCT00998296|20706613|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8401807|NCT00998296|20706614|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8401808|NCT00998296|20706615|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8401809|NCT00998296|20706616|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8401810|NCT00998296|20706617|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8401811|NCT00998296|20706618|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
8401812|NCT00998296|20706619|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8401813|NCT00998296|20706609|P11|STARTED|Overall Study||7
8401814|NCT00998296|20706610|P10|STARTED|Overall Study||18
8401815|NCT00998296|20706611|P9|STARTED|Overall Study||6
8401816|NCT00998296|20706612|P8|STARTED|Overall Study||6
8401817|NCT00998296|20706613|P7|STARTED|Overall Study||7
8401818|NCT00998296|20706614|P6|STARTED|Overall Study||3
8401819|NCT00998296|20706615|P5|STARTED|Overall Study||8
8401820|NCT00998296|20706616|P4|STARTED|Overall Study||3
8401821|NCT00998296|20706617|P3|STARTED|Overall Study||3
8401822|NCT00998296|20706618|P2|STARTED|Overall Study||3
8401823|NCT00998296|20706619|P1|STARTED|Overall Study||6
8401824|NCT00998205|20706686|P1|NOT COMPLETED|Overall Study||0
8401825|NCT00998205|20706686|P1|COMPLETED|Overall Study||16
8401826|NCT00998205|20706686|P1|STARTED|Overall Study||16
8401827|NCT00998049|20706691|P1|NOT COMPLETED|Overall Study||0
8401828|NCT00998049|20706691|P1|COMPLETED|Overall Study||39
8401829|NCT00998049|20706691|P1|STARTED|Overall Study||39
8401830|NCT00998023|20706702|P2|NOT COMPLETED|Overall Study||0
8401831|NCT00998023|20706703|P1|NOT COMPLETED|Overall Study||0
8401832|NCT00998023|20706702|P2|COMPLETED|Overall Study||32
8401833|NCT00998023|20706703|P1|COMPLETED|Overall Study||32
8401834|NCT00998023|20706702|P2|STARTED|Overall Study||32
8401835|NCT00998023|20706703|P1|STARTED|Overall Study||32
8401836|NCT00998010|20706711|P1|NOT COMPLETED|Overall Study||0
8401837|NCT00998010|20706711|P1|COMPLETED|Overall Study||24
8401838|NCT00998010|20706711|P1|STARTED|Overall Study||24
8401839|NCT00997984|20706722|P3|NOT COMPLETED|Overall Study||26
8401840|NCT00997984|20706723|P2|NOT COMPLETED|Overall Study||34
8401841|NCT00997984|20706724|P1|NOT COMPLETED|Overall Study||37
8401842|NCT00997984|20706722|P3|COMPLETED|Overall Study||88
8401843|NCT00997984|20706723|P2|COMPLETED|Overall Study||79
8401844|NCT00997984|20706724|P1|COMPLETED|Overall Study||76
8401845|NCT00997984|20706722|P3|STARTED|Overall Study||114
8401846|NCT00997984|20706723|P2|STARTED|Overall Study||113
8401847|NCT00997984|20706724|P1|STARTED|Overall Study||113
8401848|NCT00997932|20706790|P1|NOT COMPLETED|Overall Study||2
8401849|NCT00997932|20706790|P1|COMPLETED|Overall Study||27
8401850|NCT00997932|20706790|P1|STARTED|Overall Study||29
8401851|NCT00997893|20706798|P3|NOT COMPLETED|Overall Study||0
8401852|NCT00997893|20706799|P2|NOT COMPLETED|Overall Study||1
8401853|NCT00997893|20706800|P1|NOT COMPLETED|Overall Study||2
8401854|NCT00997893|20706798|P3|COMPLETED|Overall Study||13
8401855|NCT00997893|20706799|P2|COMPLETED|Overall Study||12
8401856|NCT00997893|20706800|P1|COMPLETED|Overall Study||12
8401857|NCT00997893|20706798|P3|STARTED|Overall Study||13
8401858|NCT00997893|20706799|P2|STARTED|Overall Study||13
8401859|NCT00997893|20706800|P1|STARTED|Overall Study||14
8401860|NCT00997672|20706822|P2|NOT COMPLETED|Overall Study||4
8401861|NCT00997672|20706823|P1|NOT COMPLETED|Overall Study||4
8401862|NCT00997672|20706822|P2|COMPLETED|Overall Study||1
8401863|NCT00997672|20706823|P1|COMPLETED|Overall Study||0
8401864|NCT00997672|20706822|P2|STARTED|Overall Study||5
8401865|NCT00997672|20706823|P1|STARTED|Overall Study||4
8401866|NCT00997620|20706831|P2|NOT COMPLETED|Overall Study||0
8401867|NCT00997620|20706832|P1|NOT COMPLETED|Overall Study||0
8401868|NCT00997620|20706831|P2|COMPLETED|Overall Study||21
8401869|NCT00997620|20706832|P1|COMPLETED|Overall Study||19
8401870|NCT00997620|20706831|P2|STARTED|Overall Study||21
8401871|NCT00997620|20706832|P1|STARTED|Overall Study||19
8401872|NCT00997594|20706850|P2|NOT COMPLETED|Overall Study||0
8401873|NCT00997594|20706851|P1|NOT COMPLETED|Overall Study||0
8401874|NCT00997594|20706850|P2|COMPLETED|Overall Study||9
8401875|NCT00997594|20706851|P1|COMPLETED|Overall Study||9
8401876|NCT00997594|20706850|P2|Completion of Ablation Procedure|Overall Study||9
8401877|NCT00997594|20706851|P1|Completion of Ablation Procedure|Overall Study||9
8401878|NCT00997594|20706850|P2|STARTED|Overall Study||9
8401879|NCT00997594|20706851|P1|STARTED|Overall Study||9
8401880|NCT00997555|20706859|P2|NOT COMPLETED|Overall Study||0
8401881|NCT00997555|20706860|P1|NOT COMPLETED|Overall Study||0
8401882|NCT00997555|20706859|P2|COMPLETED|Overall Study||15
8401883|NCT00997555|20706860|P1|COMPLETED|Overall Study||13
8401884|NCT00997555|20706859|P2|STARTED|Overall Study||15
8401885|NCT00997555|20706860|P1|STARTED|Overall Study||13
8401886|NCT00997516|20706878|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
8401887|NCT00997516|20706879|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
8401888|NCT00997516|20706878|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
8401889|NCT00997516|20706879|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
8401890|NCT00997516|20706878|P2|STARTED|Long-term Follow-up (After 6 Months)||38
8401891|NCT00997516|20706879|P1|STARTED|Long-term Follow-up (After 6 Months)||37
8401892|NCT00997516|20706878|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
8401893|NCT00997516|20706879|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
8401894|NCT00997516|20706878|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
8401895|NCT00997516|20706879|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
8401896|NCT00997516|20706878|P2|STARTED|Short-term Follow-up (Post Operative)||38
8401897|NCT00997516|20706879|P1|STARTED|Short-term Follow-up (Post Operative)||37
8401898|NCT00997503|20706907|P1|NOT COMPLETED|Overall Study||273
8401899|NCT00997503|20706907|P1|COMPLETED|Overall Study||3926
8401900|NCT00997503|20706907|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
8401901|NCT00997503|20706907|P1|STARTED|Overall Study||4199
8401902|NCT00997438|20706950|P3|NOT COMPLETED|Overall Study||4
8401903|NCT00997438|20706951|P2|NOT COMPLETED|Overall Study||3
8401904|NCT00997438|20706952|P1|NOT COMPLETED|Overall Study||5
8401905|NCT00997438|20706950|P3|COMPLETED|Overall Study||20
8401906|NCT00997438|20706951|P2|COMPLETED|Overall Study||21
8401907|NCT00997438|20706952|P1|COMPLETED|Overall Study||16
8401908|NCT00997438|20706950|P3|STARTED|Overall Study||24
8401909|NCT00997438|20706951|P2|STARTED|Overall Study||24
8401910|NCT00997438|20706952|P1|STARTED|Overall Study||21
8401911|NCT00997425|20706987|P1|NOT COMPLETED|Overall Study||0
8401912|NCT00997425|20706987|P1|COMPLETED|Overall Study||19
8401913|NCT00997425|20706987|P1|STARTED|Overall Study||19
8401914|NCT00997386|20706992|P1|NOT COMPLETED|Overall Study||7
8401915|NCT00997386|20706992|P1|COMPLETED|Overall Study||9
8401916|NCT00997386|20706992|P1|STARTED|Overall Study||16
8401917|NCT00997373|20707001|P2|NOT COMPLETED|Overall Study||0
8401918|NCT00997373|20707002|P1|NOT COMPLETED|Overall Study||15
8401919|NCT00997373|20707001|P2|COMPLETED|Overall Study||15
8401920|NCT00997373|20707002|P1|COMPLETED|Overall Study||13
8401921|NCT00997373|20707001|P2|Completed Hysterectomy|Overall Study||15
8401922|NCT00997373|20707002|P1|Completed Hysterectomy|Overall Study||17
8401923|NCT00997373|20707001|P2|Received Letrozole|Overall Study||0
8401924|NCT00997373|20707002|P1|Received Letrozole|Overall Study||23
8401925|NCT00997373|20707001|P2|STARTED|Overall Study||15
8401926|NCT00997373|20707002|P1|STARTED|Overall Study||28
8401927|NCT00997334|20707008|P1|NOT COMPLETED|Overall Study||25
8401928|NCT00997334|20707008|P1|COMPLETED|Overall Study||35
8402016|NCT00996918|20707206|P3|STARTED|Overall Study||37
8401929|NCT00997334|20707008|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
8401930|NCT00997334|20707008|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
8401931|NCT00997334|20707008|P1|STARTED|Overall Study||60
8401932|NCT00997321|20707017|P2|NOT COMPLETED|Overall Study||3
8401933|NCT00997321|20707018|P1|NOT COMPLETED|Overall Study||0
8401934|NCT00997321|20707017|P2|COMPLETED|Overall Study||47
8401935|NCT00997321|20707018|P1|COMPLETED|Overall Study||50
8401936|NCT00997321|20707017|P2|STARTED|Overall Study||50
8401937|NCT00997321|20707018|P1|STARTED|Overall Study||50
8401938|NCT00997243|20707030|P1|NOT COMPLETED|Overall Study||7
8401939|NCT00997243|20707030|P1|COMPLETED|Overall Study||0
8401940|NCT00997243|20707030|P1|STARTED|Overall Study||7
8401941|NCT00997204|20707042|P2|NOT COMPLETED|Self-administration Phase||1
8401942|NCT00997204|20707043|P1|NOT COMPLETED|Self-administration Phase||0
8401943|NCT00997204|20707042|P2|COMPLETED|Self-administration Phase||77
8401944|NCT00997204|20707043|P1|COMPLETED|Self-administration Phase||19
8401945|NCT00997204|20707042|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
8401946|NCT00997204|20707043|P1|STARTED|Self-administration Phase||19
8401947|NCT00997204|20707042|P2|NOT COMPLETED|Naive Treatment Phase||79
8401948|NCT00997204|20707043|P1|NOT COMPLETED|Naive Treatment Phase||6
8401949|NCT00997204|20707042|P2|COMPLETED|Naive Treatment Phase||0
8401950|NCT00997204|20707043|P1|COMPLETED|Naive Treatment Phase||19
8401951|NCT00997204|20707042|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
8401952|NCT00997204|20707043|P1|STARTED|Naive Treatment Phase||25
8401953|NCT00997139|20707054|P1|NOT COMPLETED|Overall Study||186
8401954|NCT00997139|20707054|P1|COMPLETED|Overall Study||30
8401955|NCT00997139|20707054|P1|Treated for Positive Baseline Culture|Overall Study||30
8401956|NCT00997139|20707054|P1|STARTED|Overall Study||216
8401957|NCT00997126|20707062|P2|NOT COMPLETED|Overall Study||11
8401958|NCT00997126|20707063|P1|NOT COMPLETED|Overall Study||7
8401959|NCT00997126|20707062|P2|COMPLETED|Overall Study||52
8401960|NCT00997126|20707063|P1|COMPLETED|Overall Study||56
8401961|NCT00997126|20707062|P2|STARTED|Overall Study||63
8401962|NCT00997126|20707063|P1|STARTED|Overall Study||63
8401963|NCT00997113|20707079|P2|NOT COMPLETED|Overall Study||0
8401964|NCT00997113|20707080|P1|NOT COMPLETED|Overall Study||0
8401965|NCT00997113|20707079|P2|COMPLETED|Overall Study||10
8401966|NCT00997113|20707080|P1|COMPLETED|Overall Study||10
8401967|NCT00997113|20707079|P2|STARTED|Overall Study||10
8401968|NCT00997113|20707080|P1|STARTED|Overall Study||10
8401969|NCT00997035|20707092|P2|NOT COMPLETED|3-month Follow-up Visit||6
8401970|NCT00997035|20707093|P1|NOT COMPLETED|3-month Follow-up Visit||12
8401971|NCT00997035|20707092|P2|COMPLETED|3-month Follow-up Visit||107
8401972|NCT00997035|20707093|P1|COMPLETED|3-month Follow-up Visit||100
8401973|NCT00997035|20707092|P2|STARTED|3-month Follow-up Visit||113
8401974|NCT00997035|20707093|P1|STARTED|3-month Follow-up Visit||112
8401975|NCT00997035|20707092|P2|NOT COMPLETED|3-week Followup Visit||6
8401976|NCT00997035|20707093|P1|NOT COMPLETED|3-week Followup Visit||9
8401977|NCT00997035|20707092|P2|COMPLETED|3-week Followup Visit||113
8401978|NCT00997035|20707093|P1|COMPLETED|3-week Followup Visit||112
8401979|NCT00997035|20707092|P2|STARTED|3-week Followup Visit||119
8401980|NCT00997035|20707093|P1|STARTED|3-week Followup Visit||121
8401981|NCT00996996|20707117|P1|NOT COMPLETED|Overall Study||33
8401982|NCT00996996|20707117|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
8401983|NCT00996996|20707117|P1|STARTED|Overall Study||77
8401984|NCT00996944|20707151|P2|NOT COMPLETED|Long-term Treatment Period||5
8401985|NCT00996944|20707152|P1|NOT COMPLETED|Long-term Treatment Period||12
8401986|NCT00996944|20707151|P2|COMPLETED|Long-term Treatment Period||0
8401987|NCT00996944|20707152|P1|COMPLETED|Long-term Treatment Period||0
8401988|NCT00996944|20707151|P2|STARTED|Long-term Treatment Period||5
8401989|NCT00996944|20707152|P1|STARTED|Long-term Treatment Period||12
8401990|NCT00996944|20707151|P2|NOT COMPLETED|Double-blind Treatment Period||7
8401991|NCT00996944|20707152|P1|NOT COMPLETED|Double-blind Treatment Period||10
8401992|NCT00996944|20707151|P2|COMPLETED|Double-blind Treatment Period||5
8401993|NCT00996944|20707152|P1|COMPLETED|Double-blind Treatment Period||12
8401994|NCT00996944|20707151|P2|STARTED|Double-blind Treatment Period||12
8401995|NCT00996944|20707152|P1|STARTED|Double-blind Treatment Period||22
8401996|NCT00996931|20707194|P1|NOT COMPLETED|Overall Study||0
8401997|NCT00996931|20707194|P1|COMPLETED|Overall Study||6
8401998|NCT00996931|20707194|P1|STARTED|Overall Study||6
8401999|NCT00996918|20707204|P5|NOT COMPLETED|Overall Study||4
8402000|NCT00996918|20707205|P4|NOT COMPLETED|Overall Study||56
8402001|NCT00996918|20707206|P3|NOT COMPLETED|Overall Study||37
8402002|NCT00996918|20707207|P2|NOT COMPLETED|Overall Study||66
8402003|NCT00996918|20707208|P1|NOT COMPLETED|Overall Study||39
8402004|NCT00996918|20707204|P5|COMPLETED|Overall Study||0
8402005|NCT00996918|20707205|P4|COMPLETED|Overall Study||0
8402006|NCT00996918|20707206|P3|COMPLETED|Overall Study||0
8402007|NCT00996918|20707207|P2|COMPLETED|Overall Study||0
8402008|NCT00996918|20707208|P1|COMPLETED|Overall Study||0
8402009|NCT00996918|20707204|P5|Treated|Overall Study||4
8402010|NCT00996918|20707205|P4|Treated|Overall Study||56
8402011|NCT00996918|20707206|P3|Treated|Overall Study||37
8402012|NCT00996918|20707207|P2|Treated|Overall Study||66
8402013|NCT00996918|20707208|P1|Treated|Overall Study||39
8402014|NCT00996918|20707204|P5|STARTED|Overall Study||4
8402015|NCT00996918|20707205|P4|STARTED|Overall Study||56
8402017|NCT00996918|20707207|P2|STARTED|Overall Study||66
8402018|NCT00996918|20707208|P1|STARTED|Overall Study||39
8402019|NCT00996892|20707252|P20|NOT COMPLETED|Expansion Stage 2A||45
8402020|NCT00996892|20707253|P19|NOT COMPLETED|Expansion Stage 2A||0
8402021|NCT00996892|20707254|P18|NOT COMPLETED|Expansion Stage 2A||0
8402022|NCT00996892|20707255|P17|NOT COMPLETED|Expansion Stage 2A||0
8402023|NCT00996892|20707256|P16|NOT COMPLETED|Expansion Stage 2A||0
8402024|NCT00996892|20707257|P15|NOT COMPLETED|Expansion Stage 2A||0
8402025|NCT00996892|20707258|P14|NOT COMPLETED|Expansion Stage 2A||0
8402026|NCT00996892|20707259|P13|NOT COMPLETED|Expansion Stage 2A||0
8402027|NCT00996892|20707260|P12|NOT COMPLETED|Expansion Stage 2A||0
8402028|NCT00996892|20707261|P11|NOT COMPLETED|Expansion Stage 2A||0
8402029|NCT00996892|20707262|P10|NOT COMPLETED|Expansion Stage 2A||0
8402030|NCT00996892|20707263|P9|NOT COMPLETED|Expansion Stage 2A||0
8402031|NCT00996892|20707264|P8|NOT COMPLETED|Expansion Stage 2A||0
8402032|NCT00996892|20707265|P7|NOT COMPLETED|Expansion Stage 2A||0
8402033|NCT00996892|20707266|P6|NOT COMPLETED|Expansion Stage 2A||0
8402034|NCT00996892|20707267|P5|NOT COMPLETED|Expansion Stage 2A||0
8402035|NCT00996892|20707268|P4|NOT COMPLETED|Expansion Stage 2A||0
8402036|NCT00996892|20707269|P3|NOT COMPLETED|Expansion Stage 2A||0
8402037|NCT00996892|20707270|P2|NOT COMPLETED|Expansion Stage 2A||0
8402038|NCT00996892|20707271|P1|NOT COMPLETED|Expansion Stage 2A||0
8402039|NCT00996892|20707252|P20|COMPLETED|Expansion Stage 2A||0
8402040|NCT00996892|20707253|P19|COMPLETED|Expansion Stage 2A||0
8402041|NCT00996892|20707254|P18|COMPLETED|Expansion Stage 2A||0
8402042|NCT00996892|20707255|P17|COMPLETED|Expansion Stage 2A||0
8402043|NCT00996892|20707256|P16|COMPLETED|Expansion Stage 2A||0
8402044|NCT00996892|20707257|P15|COMPLETED|Expansion Stage 2A||0
8402045|NCT00996892|20707258|P14|COMPLETED|Expansion Stage 2A||0
8402046|NCT00996892|20707259|P13|COMPLETED|Expansion Stage 2A||0
8402047|NCT00996892|20707260|P12|COMPLETED|Expansion Stage 2A||0
8402048|NCT00996892|20707261|P11|COMPLETED|Expansion Stage 2A||0
8402049|NCT00996892|20707262|P10|COMPLETED|Expansion Stage 2A||0
8402050|NCT00996892|20707263|P9|COMPLETED|Expansion Stage 2A||0
8402051|NCT00996892|20707264|P8|COMPLETED|Expansion Stage 2A||0
8402052|NCT00996892|20707265|P7|COMPLETED|Expansion Stage 2A||0
8402053|NCT00996892|20707266|P6|COMPLETED|Expansion Stage 2A||0
8402054|NCT00996892|20707267|P5|COMPLETED|Expansion Stage 2A||0
8402055|NCT00996892|20707268|P4|COMPLETED|Expansion Stage 2A||0
8402056|NCT00996892|20707269|P3|COMPLETED|Expansion Stage 2A||0
8402057|NCT00996892|20707270|P2|COMPLETED|Expansion Stage 2A||0
8402058|NCT00996892|20707271|P1|COMPLETED|Expansion Stage 2A||0
8402059|NCT00996892|20707252|P20|STARTED|Expansion Stage 2A||45
8402060|NCT00996892|20707253|P19|STARTED|Expansion Stage 2A||0
8402061|NCT00996892|20707254|P18|STARTED|Expansion Stage 2A||0
8402062|NCT00996892|20707255|P17|STARTED|Expansion Stage 2A||0
8402063|NCT00996892|20707256|P16|STARTED|Expansion Stage 2A||0
8402064|NCT00996892|20707257|P15|STARTED|Expansion Stage 2A||0
8402065|NCT00996892|20707258|P14|STARTED|Expansion Stage 2A||0
8402066|NCT00996892|20707259|P13|STARTED|Expansion Stage 2A||0
8402067|NCT00996892|20707260|P12|STARTED|Expansion Stage 2A||0
8402068|NCT00996892|20707261|P11|STARTED|Expansion Stage 2A||0
8402069|NCT00996892|20707262|P10|STARTED|Expansion Stage 2A||0
8402070|NCT00996892|20707263|P9|STARTED|Expansion Stage 2A||0
8402071|NCT00996892|20707264|P8|STARTED|Expansion Stage 2A||0
8402072|NCT00996892|20707265|P7|STARTED|Expansion Stage 2A||0
8402073|NCT00996892|20707266|P6|STARTED|Expansion Stage 2A||0
8402074|NCT00996892|20707267|P5|STARTED|Expansion Stage 2A||0
8402075|NCT00996892|20707268|P4|STARTED|Expansion Stage 2A||0
8402076|NCT00996892|20707269|P3|STARTED|Expansion Stage 2A||0
8402077|NCT00996892|20707270|P2|STARTED|Expansion Stage 2A||0
8402078|NCT00996892|20707271|P1|STARTED|Expansion Stage 2A||0
8402079|NCT00996892|20707252|P20|NOT COMPLETED|Expansion Stage 2||0
8402080|NCT00996892|20707253|P19|NOT COMPLETED|Expansion Stage 2||35
8402081|NCT00996892|20707254|P18|NOT COMPLETED|Expansion Stage 2||0
8402082|NCT00996892|20707255|P17|NOT COMPLETED|Expansion Stage 2||0
8402083|NCT00996892|20707256|P16|NOT COMPLETED|Expansion Stage 2||0
8402084|NCT00996892|20707257|P15|NOT COMPLETED|Expansion Stage 2||0
8402085|NCT00996892|20707258|P14|NOT COMPLETED|Expansion Stage 2||0
8402086|NCT00996892|20707259|P13|NOT COMPLETED|Expansion Stage 2||0
8402087|NCT00996892|20707260|P12|NOT COMPLETED|Expansion Stage 2||0
8402088|NCT00996892|20707261|P11|NOT COMPLETED|Expansion Stage 2||0
8402089|NCT00996892|20707262|P10|NOT COMPLETED|Expansion Stage 2||0
8402090|NCT00996892|20707263|P9|NOT COMPLETED|Expansion Stage 2||0
8402091|NCT00996892|20707264|P8|NOT COMPLETED|Expansion Stage 2||0
8402092|NCT00996892|20707265|P7|NOT COMPLETED|Expansion Stage 2||0
8402093|NCT00996892|20707266|P6|NOT COMPLETED|Expansion Stage 2||0
8402094|NCT00996892|20707267|P5|NOT COMPLETED|Expansion Stage 2||0
8402095|NCT00996892|20707268|P4|NOT COMPLETED|Expansion Stage 2||0
8402096|NCT00996892|20707269|P3|NOT COMPLETED|Expansion Stage 2||0
8402097|NCT00996892|20707270|P2|NOT COMPLETED|Expansion Stage 2||0
8402098|NCT00996892|20707271|P1|NOT COMPLETED|Expansion Stage 2||0
8402099|NCT00996892|20707252|P20|COMPLETED|Expansion Stage 2||0
8402100|NCT00996892|20707253|P19|COMPLETED|Expansion Stage 2||0
8402101|NCT00996892|20707254|P18|COMPLETED|Expansion Stage 2||0
8402102|NCT00996892|20707255|P17|COMPLETED|Expansion Stage 2||0
8402103|NCT00996892|20707256|P16|COMPLETED|Expansion Stage 2||0
8402104|NCT00996892|20707257|P15|COMPLETED|Expansion Stage 2||0
8402105|NCT00996892|20707258|P14|COMPLETED|Expansion Stage 2||0
8402106|NCT00996892|20707259|P13|COMPLETED|Expansion Stage 2||0
8402107|NCT00996892|20707260|P12|COMPLETED|Expansion Stage 2||0
8402108|NCT00996892|20707261|P11|COMPLETED|Expansion Stage 2||0
8402109|NCT00996892|20707262|P10|COMPLETED|Expansion Stage 2||0
8402110|NCT00996892|20707263|P9|COMPLETED|Expansion Stage 2||0
8402111|NCT00996892|20707264|P8|COMPLETED|Expansion Stage 2||0
8402112|NCT00996892|20707265|P7|COMPLETED|Expansion Stage 2||0
8402113|NCT00996892|20707266|P6|COMPLETED|Expansion Stage 2||0
8402114|NCT00996892|20707267|P5|COMPLETED|Expansion Stage 2||0
8402115|NCT00996892|20707268|P4|COMPLETED|Expansion Stage 2||0
8402116|NCT00996892|20707269|P3|COMPLETED|Expansion Stage 2||0
8402117|NCT00996892|20707270|P2|COMPLETED|Expansion Stage 2||0
8402118|NCT00996892|20707271|P1|COMPLETED|Expansion Stage 2||0
8402119|NCT00996892|20707252|P20|STARTED|Expansion Stage 2||0
8402120|NCT00996892|20707253|P19|STARTED|Expansion Stage 2||35
8402121|NCT00996892|20707254|P18|STARTED|Expansion Stage 2||0
8402122|NCT00996892|20707255|P17|STARTED|Expansion Stage 2||0
8402123|NCT00996892|20707256|P16|STARTED|Expansion Stage 2||0
8402124|NCT00996892|20707257|P15|STARTED|Expansion Stage 2||0
8402125|NCT00996892|20707258|P14|STARTED|Expansion Stage 2||0
8402126|NCT00996892|20707259|P13|STARTED|Expansion Stage 2||0
8402127|NCT00996892|20707260|P12|STARTED|Expansion Stage 2||0
8402128|NCT00996892|20707261|P11|STARTED|Expansion Stage 2||0
8402129|NCT00996892|20707262|P10|STARTED|Expansion Stage 2||0
8402130|NCT00996892|20707263|P9|STARTED|Expansion Stage 2||0
8402131|NCT00996892|20707264|P8|STARTED|Expansion Stage 2||0
8402132|NCT00996892|20707265|P7|STARTED|Expansion Stage 2||0
8402133|NCT00996892|20707266|P6|STARTED|Expansion Stage 2||0
8402134|NCT00996892|20707267|P5|STARTED|Expansion Stage 2||0
8402135|NCT00996892|20707268|P4|STARTED|Expansion Stage 2||0
8402136|NCT00996892|20707269|P3|STARTED|Expansion Stage 2||0
8402137|NCT00996892|20707270|P2|STARTED|Expansion Stage 2||0
8402138|NCT00996892|20707271|P1|STARTED|Expansion Stage 2||0
8402139|NCT00996892|20707252|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402140|NCT00996892|20707253|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402141|NCT00996892|20707254|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
8402142|NCT00996892|20707255|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
8402143|NCT00996892|20707256|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
8402144|NCT00996892|20707257|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
8402145|NCT00996892|20707258|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402146|NCT00996892|20707259|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402147|NCT00996892|20707260|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402148|NCT00996892|20707261|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402149|NCT00996892|20707262|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402150|NCT00996892|20707263|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402151|NCT00996892|20707264|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402152|NCT00996892|20707265|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402153|NCT00996892|20707266|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402154|NCT00996892|20707267|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402155|NCT00996892|20707268|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402156|NCT00996892|20707269|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402157|NCT00996892|20707270|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402158|NCT00996892|20707271|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402159|NCT00996892|20707252|P20|COMPLETED|Dose-Escalation Stage 1B||0
8402160|NCT00996892|20707253|P19|COMPLETED|Dose-Escalation Stage 1B||0
8402161|NCT00996892|20707254|P18|COMPLETED|Dose-Escalation Stage 1B||0
8402162|NCT00996892|20707255|P17|COMPLETED|Dose-Escalation Stage 1B||0
8402163|NCT00996892|20707256|P16|COMPLETED|Dose-Escalation Stage 1B||0
8402164|NCT00996892|20707257|P15|COMPLETED|Dose-Escalation Stage 1B||0
8402165|NCT00996892|20707258|P14|COMPLETED|Dose-Escalation Stage 1B||0
8402166|NCT00996892|20707259|P13|COMPLETED|Dose-Escalation Stage 1B||0
8402167|NCT00996892|20707260|P12|COMPLETED|Dose-Escalation Stage 1B||0
8402168|NCT00996892|20707261|P11|COMPLETED|Dose-Escalation Stage 1B||0
8402169|NCT00996892|20707262|P10|COMPLETED|Dose-Escalation Stage 1B||0
8402170|NCT00996892|20707263|P9|COMPLETED|Dose-Escalation Stage 1B||0
8402171|NCT00996892|20707264|P8|COMPLETED|Dose-Escalation Stage 1B||0
8402172|NCT00996892|20707265|P7|COMPLETED|Dose-Escalation Stage 1B||0
8402173|NCT00996892|20707266|P6|COMPLETED|Dose-Escalation Stage 1B||0
8402174|NCT00996892|20707267|P5|COMPLETED|Dose-Escalation Stage 1B||0
8402175|NCT00996892|20707268|P4|COMPLETED|Dose-Escalation Stage 1B||0
8402176|NCT00996892|20707269|P3|COMPLETED|Dose-Escalation Stage 1B||0
8402177|NCT00996892|20707270|P2|COMPLETED|Dose-Escalation Stage 1B||0
8402178|NCT00996892|20707271|P1|COMPLETED|Dose-Escalation Stage 1B||0
8402179|NCT00996892|20707252|P20|STARTED|Dose-Escalation Stage 1B||0
8402180|NCT00996892|20707253|P19|STARTED|Dose-Escalation Stage 1B||0
8402181|NCT00996892|20707254|P18|STARTED|Dose-Escalation Stage 1B||5
8402182|NCT00996892|20707255|P17|STARTED|Dose-Escalation Stage 1B||3
8402183|NCT00996892|20707256|P16|STARTED|Dose-Escalation Stage 1B||3
8402184|NCT00996892|20707257|P15|STARTED|Dose-Escalation Stage 1B||4
8402185|NCT00996892|20707258|P14|STARTED|Dose-Escalation Stage 1B||0
8402186|NCT00996892|20707259|P13|STARTED|Dose-Escalation Stage 1B||0
8402187|NCT00996892|20707260|P12|STARTED|Dose-Escalation Stage 1B||0
8402188|NCT00996892|20707261|P11|STARTED|Dose-Escalation Stage 1B||0
8402189|NCT00996892|20707262|P10|STARTED|Dose-Escalation Stage 1B||0
8402190|NCT00996892|20707263|P9|STARTED|Dose-Escalation Stage 1B||0
8402191|NCT00996892|20707264|P8|STARTED|Dose-Escalation Stage 1B||0
8402192|NCT00996892|20707265|P7|STARTED|Dose-Escalation Stage 1B||0
8402193|NCT00996892|20707266|P6|STARTED|Dose-Escalation Stage 1B||0
8402194|NCT00996892|20707267|P5|STARTED|Dose-Escalation Stage 1B||0
8402195|NCT00996892|20707268|P4|STARTED|Dose-Escalation Stage 1B||0
8402196|NCT00996892|20707269|P3|STARTED|Dose-Escalation Stage 1B||0
8402197|NCT00996892|20707270|P2|STARTED|Dose-Escalation Stage 1B||0
8402198|NCT00996892|20707271|P1|STARTED|Dose-Escalation Stage 1B||0
8402199|NCT00996892|20707252|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402200|NCT00996892|20707253|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402201|NCT00996892|20707254|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402202|NCT00996892|20707255|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402203|NCT00996892|20707256|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402204|NCT00996892|20707257|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402205|NCT00996892|20707258|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
8402206|NCT00996892|20707259|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
8402207|NCT00996892|20707260|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
8402208|NCT00996892|20707261|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
8402209|NCT00996892|20707262|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
8402210|NCT00996892|20707263|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
8402211|NCT00996892|20707264|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
8402212|NCT00996892|20707265|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402213|NCT00996892|20707266|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402214|NCT00996892|20707267|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402215|NCT00996892|20707268|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402216|NCT00996892|20707269|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402217|NCT00996892|20707270|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402218|NCT00996892|20707271|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402219|NCT00996892|20707252|P20|COMPLETED|Dose-Escalation Stage 1A||0
8402220|NCT00996892|20707253|P19|COMPLETED|Dose-Escalation Stage 1A||0
8402221|NCT00996892|20707254|P18|COMPLETED|Dose-Escalation Stage 1A||0
8402222|NCT00996892|20707255|P17|COMPLETED|Dose-Escalation Stage 1A||0
8402223|NCT00996892|20707256|P16|COMPLETED|Dose-Escalation Stage 1A||0
8402224|NCT00996892|20707257|P15|COMPLETED|Dose-Escalation Stage 1A||0
8402225|NCT00996892|20707258|P14|COMPLETED|Dose-Escalation Stage 1A||0
8402226|NCT00996892|20707259|P13|COMPLETED|Dose-Escalation Stage 1A||0
8402227|NCT00996892|20707260|P12|COMPLETED|Dose-Escalation Stage 1A||0
8402228|NCT00996892|20707261|P11|COMPLETED|Dose-Escalation Stage 1A||0
8402229|NCT00996892|20707262|P10|COMPLETED|Dose-Escalation Stage 1A||0
8402230|NCT00996892|20707263|P9|COMPLETED|Dose-Escalation Stage 1A||0
8402231|NCT00996892|20707264|P8|COMPLETED|Dose-Escalation Stage 1A||0
8402232|NCT00996892|20707265|P7|COMPLETED|Dose-Escalation Stage 1A||0
8402233|NCT00996892|20707266|P6|COMPLETED|Dose-Escalation Stage 1A||0
8402234|NCT00996892|20707267|P5|COMPLETED|Dose-Escalation Stage 1A||0
8402235|NCT00996892|20707268|P4|COMPLETED|Dose-Escalation Stage 1A||0
8402236|NCT00996892|20707269|P3|COMPLETED|Dose-Escalation Stage 1A||0
8402237|NCT00996892|20707270|P2|COMPLETED|Dose-Escalation Stage 1A||0
8402238|NCT00996892|20707271|P1|COMPLETED|Dose-Escalation Stage 1A||0
8402239|NCT00996892|20707252|P20|STARTED|Dose-Escalation Stage 1A||0
8402240|NCT00996892|20707253|P19|STARTED|Dose-Escalation Stage 1A||0
8402241|NCT00996892|20707254|P18|STARTED|Dose-Escalation Stage 1A||0
8402242|NCT00996892|20707255|P17|STARTED|Dose-Escalation Stage 1A||0
8402243|NCT00996892|20707256|P16|STARTED|Dose-Escalation Stage 1A||0
8402244|NCT00996892|20707257|P15|STARTED|Dose-Escalation Stage 1A||0
8402245|NCT00996892|20707258|P14|STARTED|Dose-Escalation Stage 1A||5
8402246|NCT00996892|20707259|P13|STARTED|Dose-Escalation Stage 1A||8
8402247|NCT00996892|20707260|P12|STARTED|Dose-Escalation Stage 1A||9
8402248|NCT00996892|20707261|P11|STARTED|Dose-Escalation Stage 1A||7
8402249|NCT00996892|20707262|P10|STARTED|Dose-Escalation Stage 1A||4
8402250|NCT00996892|20707263|P9|STARTED|Dose-Escalation Stage 1A||3
8402251|NCT00996892|20707264|P8|STARTED|Dose-Escalation Stage 1A||3
8402252|NCT00996892|20707265|P7|STARTED|Dose-Escalation Stage 1A||0
8402253|NCT00996892|20707266|P6|STARTED|Dose-Escalation Stage 1A||0
8402254|NCT00996892|20707267|P5|STARTED|Dose-Escalation Stage 1A||0
8402255|NCT00996892|20707268|P4|STARTED|Dose-Escalation Stage 1A||0
8402256|NCT00996892|20707269|P3|STARTED|Dose-Escalation Stage 1A||0
8402257|NCT00996892|20707270|P2|STARTED|Dose-Escalation Stage 1A||0
8402258|NCT00996892|20707271|P1|STARTED|Dose-Escalation Stage 1A||0
8402259|NCT00996892|20707252|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
8402260|NCT00996892|20707253|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
8402261|NCT00996892|20707254|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
8402262|NCT00996892|20707255|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
8402263|NCT00996892|20707256|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
8402264|NCT00996892|20707257|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
8402265|NCT00996892|20707258|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
8402266|NCT00996892|20707259|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
8402267|NCT00996892|20707260|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
8402268|NCT00996892|20707261|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
8402269|NCT00996892|20707262|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
8402270|NCT00996892|20707263|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
8402271|NCT00996892|20707264|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
8402272|NCT00996892|20707265|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
8402273|NCT00996892|20707266|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
8402274|NCT00996892|20707267|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
8402275|NCT00996892|20707268|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
8402276|NCT00996892|20707269|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
8402277|NCT00996892|20707270|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
8402278|NCT00996892|20707271|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
8402279|NCT00996892|20707252|P20|COMPLETED|Dose-Escalation Stage 1||0
8402280|NCT00996892|20707253|P19|COMPLETED|Dose-Escalation Stage 1||0
8402281|NCT00996892|20707254|P18|COMPLETED|Dose-Escalation Stage 1||0
8402282|NCT00996892|20707255|P17|COMPLETED|Dose-Escalation Stage 1||0
8402283|NCT00996892|20707256|P16|COMPLETED|Dose-Escalation Stage 1||0
8402284|NCT00996892|20707257|P15|COMPLETED|Dose-Escalation Stage 1||0
8402285|NCT00996892|20707258|P14|COMPLETED|Dose-Escalation Stage 1||0
8402286|NCT00996892|20707259|P13|COMPLETED|Dose-Escalation Stage 1||0
8402287|NCT00996892|20707260|P12|COMPLETED|Dose-Escalation Stage 1||0
8402288|NCT00996892|20707261|P11|COMPLETED|Dose-Escalation Stage 1||0
8402289|NCT00996892|20707262|P10|COMPLETED|Dose-Escalation Stage 1||0
8402290|NCT00996892|20707263|P9|COMPLETED|Dose-Escalation Stage 1||0
8402291|NCT00996892|20707264|P8|COMPLETED|Dose-Escalation Stage 1||0
8402292|NCT00996892|20707265|P7|COMPLETED|Dose-Escalation Stage 1||0
8402293|NCT00996892|20707266|P6|COMPLETED|Dose-Escalation Stage 1||0
8402294|NCT00996892|20707267|P5|COMPLETED|Dose-Escalation Stage 1||0
8402295|NCT00996892|20707268|P4|COMPLETED|Dose-Escalation Stage 1||0
8402296|NCT00996892|20707269|P3|COMPLETED|Dose-Escalation Stage 1||0
8402297|NCT00996892|20707270|P2|COMPLETED|Dose-Escalation Stage 1||0
8402298|NCT00996892|20707271|P1|COMPLETED|Dose-Escalation Stage 1||0
8402299|NCT00996892|20707252|P20|STARTED|Dose-Escalation Stage 1||0
8402300|NCT00996892|20707253|P19|STARTED|Dose-Escalation Stage 1||0
8402301|NCT00996892|20707254|P18|STARTED|Dose-Escalation Stage 1||0
8402302|NCT00996892|20707255|P17|STARTED|Dose-Escalation Stage 1||0
8402303|NCT00996892|20707256|P16|STARTED|Dose-Escalation Stage 1||0
8402304|NCT00996892|20707257|P15|STARTED|Dose-Escalation Stage 1||0
8402305|NCT00996892|20707258|P14|STARTED|Dose-Escalation Stage 1||0
8402306|NCT00996892|20707259|P13|STARTED|Dose-Escalation Stage 1||0
8402307|NCT00996892|20707260|P12|STARTED|Dose-Escalation Stage 1||0
8402308|NCT00996892|20707261|P11|STARTED|Dose-Escalation Stage 1||0
8402309|NCT00996892|20707262|P10|STARTED|Dose-Escalation Stage 1||0
8402310|NCT00996892|20707263|P9|STARTED|Dose-Escalation Stage 1||0
8402311|NCT00996892|20707264|P8|STARTED|Dose-Escalation Stage 1||0
8402312|NCT00996892|20707265|P7|STARTED|Dose-Escalation Stage 1||4
8402313|NCT00996892|20707266|P6|STARTED|Dose-Escalation Stage 1||10
8402314|NCT00996892|20707267|P5|STARTED|Dose-Escalation Stage 1||11
8402315|NCT00996892|20707268|P4|STARTED|Dose-Escalation Stage 1||9
8402316|NCT00996892|20707269|P3|STARTED|Dose-Escalation Stage 1||3
8402317|NCT00996892|20707270|P2|STARTED|Dose-Escalation Stage 1||3
8402318|NCT00996892|20707271|P1|STARTED|Dose-Escalation Stage 1||4
8402319|NCT00996840|20707865|P5|NOT COMPLETED|Overall Study||2
8402320|NCT00996840|20707866|P4|NOT COMPLETED|Overall Study||1
8402321|NCT00996840|20707867|P3|NOT COMPLETED|Overall Study||1
8402322|NCT00996840|20707868|P2|NOT COMPLETED|Overall Study||2
8402323|NCT00996840|20707869|P1|NOT COMPLETED|Overall Study||1
8402324|NCT00996840|20707865|P5|COMPLETED|Overall Study||16
8402325|NCT00996840|20707866|P4|COMPLETED|Overall Study||17
8402326|NCT00996840|20707867|P3|COMPLETED|Overall Study||11
8402327|NCT00996840|20707868|P2|COMPLETED|Overall Study||7
8402328|NCT00996840|20707869|P1|COMPLETED|Overall Study||19
8402329|NCT00996840|20707865|P5|STARTED|Overall Study||18
8402330|NCT00996840|20707866|P4|STARTED|Overall Study||18
8402331|NCT00996840|20707867|P3|STARTED|Overall Study||12
8402332|NCT00996840|20707868|P2|STARTED|Overall Study||9
8402333|NCT00996840|20707869|P1|STARTED|Overall Study||20
8402334|NCT00996801|20708019|P6|NOT COMPLETED|Overall Study||19
8402335|NCT00996801|20708020|P5|NOT COMPLETED|Overall Study||88
8402336|NCT00996801|20708021|P4|NOT COMPLETED|Overall Study||31
8402337|NCT00996801|20708022|P3|NOT COMPLETED|Overall Study||23
8402338|NCT00996801|20708023|P2|NOT COMPLETED|Overall Study||16
8402339|NCT00996801|20708024|P1|NOT COMPLETED|Overall Study||20
8402340|NCT00996801|20708019|P6|COMPLETED|Overall Study||68
8402341|NCT00996801|20708020|P5|COMPLETED|Overall Study||0
8402342|NCT00996801|20708021|P4|COMPLETED|Overall Study||56
8402343|NCT00996801|20708022|P3|COMPLETED|Overall Study||65
8402344|NCT00996801|20708023|P2|COMPLETED|Overall Study||72
8402345|NCT00996801|20708024|P1|COMPLETED|Overall Study||68
8402346|NCT00996801|20708019|P6|STARTED|Overall Study||87
8402347|NCT00996801|20708020|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
8402348|NCT00996801|20708021|P4|STARTED|Overall Study||87
8402349|NCT00996801|20708022|P3|STARTED|Overall Study||88
8402350|NCT00996801|20708023|P2|STARTED|Overall Study||88
8402351|NCT00996801|20708024|P1|STARTED|Overall Study||88
8402352|NCT00996775|20708127|P2|NOT COMPLETED|Overall Study||14
8402353|NCT00996775|20708128|P1|NOT COMPLETED|Overall Study||11
8402354|NCT00996775|20708127|P2|COMPLETED|Overall Study||75
8402355|NCT00996775|20708128|P1|COMPLETED|Overall Study||67
8402356|NCT00996775|20708127|P2|STARTED|Overall Study||89
8402357|NCT00996775|20708128|P1|STARTED|Overall Study||78
8402358|NCT00996736|20708136|P2|NOT COMPLETED|Overall Study||18
8402359|NCT00996736|20708137|P1|NOT COMPLETED|Overall Study||21
8402360|NCT00996736|20708136|P2|COMPLETED|Overall Study||143
8402361|NCT00996736|20708137|P1|COMPLETED|Overall Study||141
8402362|NCT00996736|20708136|P2|3-month Visit|Overall Study||146
8402363|NCT00996736|20708137|P1|3-month Visit|Overall Study||146
8402364|NCT00996736|20708136|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
8402365|NCT00996736|20708137|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
8402366|NCT00996736|20708136|P2|STARTED|Overall Study||161
8402367|NCT00996736|20708137|P1|STARTED|Overall Study||162
8402368|NCT00996658|20708157|P2|NOT COMPLETED|Overall Study||21
8402369|NCT00996658|20708158|P1|NOT COMPLETED|Overall Study||16
8402370|NCT00996658|20708157|P2|COMPLETED|Overall Study||165
8402371|NCT00996658|20708158|P1|COMPLETED|Overall Study||76
8402372|NCT00996658|20708157|P2|STARTED|Overall Study||186
8402373|NCT00996658|20708158|P1|STARTED|Overall Study||92
8402374|NCT00996632|20708186|P2|NOT COMPLETED|Overall Study||0
8402375|NCT00996632|20708187|P1|NOT COMPLETED|Overall Study||0
8402376|NCT00996632|20708186|P2|COMPLETED|Overall Study||56
8402377|NCT00996632|20708187|P1|COMPLETED|Overall Study||38
8402378|NCT00996632|20708186|P2|STARTED|Overall Study||56
8402379|NCT00996632|20708187|P1|STARTED|Overall Study||38
8402380|NCT00996606|20708195|P1|NOT COMPLETED|Overall Study||8
8402381|NCT00996606|20708195|P1|COMPLETED|Overall Study||50
8402382|NCT00996606|20708195|P1|STARTED|Overall Study||58
8402383|NCT00996593|20708289|P1|NOT COMPLETED|Long-Term Follow-Up||3
8402384|NCT00996593|20708289|P1|COMPLETED|Long-Term Follow-Up||6
8402385|NCT00996593|20708289|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
8402386|NCT00996593|20708289|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
8402387|NCT00996593|20708289|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8402388|NCT00996593|20708289|P1|STARTED|Dosimetric and Therapeutic Treatment||43
8402389|NCT00996580|20708317|P1|NOT COMPLETED|Overall Study||1453
8402390|NCT00996580|20708317|P1|COMPLETED|Overall Study||2144
8402391|NCT00996580|20708317|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
8402392|NCT00996580|20708317|P1|STARTED|Overall Study||3597
8402393|NCT00996502|20708345|P1|NOT COMPLETED|Overall Study||0
8402394|NCT00996502|20708345|P1|COMPLETED|Overall Study||4
8402395|NCT00996502|20708345|P1|STARTED|Overall Study||4
8402396|NCT00996489|20708352|P1|NOT COMPLETED|Overall Study||161
8402397|NCT00996489|20708352|P1|COMPLETED|Overall Study||298
8402398|NCT00996489|20708352|P1|STARTED|Overall Study||459
8402399|NCT00996476|20708372|P5|NOT COMPLETED|Overall Study||2
8402400|NCT00996476|20708373|P4|NOT COMPLETED|Overall Study||0
8402401|NCT00996476|20708374|P3|NOT COMPLETED|Overall Study||1
8402402|NCT00996476|20708375|P2|NOT COMPLETED|Overall Study||3
8402403|NCT00996476|20708376|P1|NOT COMPLETED|Overall Study||1
8402404|NCT00996476|20708372|P5|COMPLETED|Overall Study||11
8402405|NCT00996476|20708373|P4|COMPLETED|Overall Study||13
8402406|NCT00996476|20708374|P3|COMPLETED|Overall Study||12
8402407|NCT00996476|20708375|P2|COMPLETED|Overall Study||23
8402408|NCT00996476|20708376|P1|COMPLETED|Overall Study||26
8402409|NCT00996476|20708372|P5|STARTED|Overall Study||13
8402410|NCT00996476|20708373|P4|STARTED|Overall Study||13
8402411|NCT00996476|20708374|P3|STARTED|Overall Study||13
8402412|NCT00996476|20708375|P2|STARTED|Overall Study||26
8402413|NCT00996476|20708376|P1|STARTED|Overall Study||27
8402414|NCT00996437|20708444|P2|NOT COMPLETED|Overall Study||7
8402415|NCT00996437|20708445|P1|NOT COMPLETED|Overall Study||5
8402416|NCT00996437|20708444|P2|COMPLETED|Overall Study||129
8402417|NCT00996437|20708445|P1|COMPLETED|Overall Study||120
8402418|NCT00996437|20708444|P2|STARTED|Overall Study||136
8402419|NCT00996437|20708445|P1|STARTED|Overall Study||125
8402420|NCT00996372|20708467|P2|NOT COMPLETED|Overall Study||84
8402421|NCT00996372|20708468|P1|NOT COMPLETED|Overall Study||103
8402422|NCT00996372|20708467|P2|COMPLETED|Overall Study||397
8402423|NCT00996372|20708468|P1|COMPLETED|Overall Study||365
8402424|NCT00996372|20708467|P2|STARTED|Overall Study||481
8402425|NCT00996372|20708468|P1|STARTED|Overall Study||468
8402426|NCT00996346|20708481|P3|NOT COMPLETED|Overall Study||0
8402427|NCT00996346|20708482|P2|NOT COMPLETED|Overall Study||0
8402428|NCT00996346|20708483|P1|NOT COMPLETED|Overall Study||0
8402429|NCT00996346|20708481|P3|COMPLETED|Overall Study||3
8402430|NCT00996346|20708482|P2|COMPLETED|Overall Study||8
8402431|NCT00996346|20708483|P1|COMPLETED|Overall Study||6
8402432|NCT00996346|20708481|P3|STARTED|Overall Study||3
8402433|NCT00996346|20708482|P2|STARTED|Overall Study||8
8402434|NCT00996346|20708483|P1|STARTED|Overall Study||6
8402435|NCT00996333|20708490|P1|NOT COMPLETED|Overall Study||13
8402436|NCT00996333|20708490|P1|COMPLETED|Overall Study||33
8402437|NCT00996333|20708490|P1|STARTED|Overall Study||46
8402438|NCT00996307|20708500|P4|NOT COMPLETED|Overall Study||21
8402439|NCT00996307|20708501|P3|NOT COMPLETED|Overall Study||14
8402440|NCT00996307|20708502|P2|NOT COMPLETED|Overall Study||17
8402441|NCT00996307|20708503|P1|NOT COMPLETED|Overall Study||20
8402442|NCT00996307|20708500|P4|COMPLETED|Overall Study||144
8402443|NCT00996307|20708501|P3|COMPLETED|Overall Study||146
8402444|NCT00996307|20708502|P2|COMPLETED|Overall Study||148
8402445|NCT00996307|20708503|P1|COMPLETED|Overall Study||144
8402446|NCT00996307|20708500|P4|STARTED|Overall Study||165
8402447|NCT00996307|20708501|P3|STARTED|Overall Study||160
8402448|NCT00996307|20708502|P2|STARTED|Overall Study||165
8402449|NCT00996307|20708503|P1|STARTED|Overall Study||164
8402450|NCT00996281|20708563|P2|NOT COMPLETED|Overall Study||89
8402451|NCT00996281|20708564|P1|NOT COMPLETED|Overall Study||131
8402452|NCT00996281|20708563|P2|COMPLETED|Overall Study||330
8402453|NCT00996281|20708564|P1|COMPLETED|Overall Study||287
8402454|NCT00996281|20708563|P2|STARTED|Overall Study||419
8402455|NCT00996281|20708564|P1|STARTED|Overall Study||418
8402456|NCT00996216|20708572|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
8402457|NCT00996216|20708572|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
8402458|NCT00996216|20708572|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
8402459|NCT00996216|20708572|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
8402460|NCT00996216|20708572|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
8402461|NCT00996216|20708572|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
8402462|NCT00996203|20708588|P1|NOT COMPLETED|Overall Study||7
8402463|NCT00996203|20708588|P1|COMPLETED|Overall Study||194
8402464|NCT00996203|20708588|P1|STARTED|Overall Study||201
8402465|NCT00996164|20708609|P2|NOT COMPLETED|Overall Study||101
8402466|NCT00996164|20708610|P1|NOT COMPLETED|Overall Study||135
8402467|NCT00996164|20708609|P2|COMPLETED|Overall Study||446
8402468|NCT00996164|20708610|P1|COMPLETED|Overall Study||408
8402469|NCT00996164|20708609|P2|STARTED|Overall Study||547
8402470|NCT00996164|20708610|P1|STARTED|Overall Study||543
8402471|NCT00996125|20708620|P2|NOT COMPLETED|Overall Study||11
8402472|NCT00996125|20708621|P1|NOT COMPLETED|Overall Study||5
8402473|NCT00996125|20708620|P2|COMPLETED|Overall Study||365
8402474|NCT00996125|20708621|P1|COMPLETED|Overall Study||369
8402475|NCT00996125|20708620|P2|STARTED|Overall Study||376
8402476|NCT00996125|20708621|P1|STARTED|Overall Study||374
8402477|NCT00996034|20708641|P1|NOT COMPLETED|Overall Study||3
8402478|NCT00996034|20708641|P1|COMPLETED|Overall Study||11
8402479|NCT00996034|20708641|P1|STARTED|Overall Study||14
8402480|NCT00995930|20708647|P2|NOT COMPLETED|Overall Study||28
8402481|NCT00995930|20708648|P1|NOT COMPLETED|Overall Study||21
8402482|NCT00995930|20708647|P2|COMPLETED|Overall Study||67
8402483|NCT00995930|20708648|P1|COMPLETED|Overall Study||73
8402484|NCT00995930|20708647|P2|Imaging Analysis Set|Overall Study||92
8402485|NCT00995930|20708648|P1|Imaging Analysis Set|Overall Study||92
8402486|NCT00995930|20708647|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
8402487|NCT00995930|20708648|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
8402488|NCT00995930|20708647|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
8402489|NCT00995930|20708648|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8402490|NCT00995930|20708647|P2|Safety Analysis Set|Overall Study||95
8402491|NCT00995930|20708648|P1|Safety Analysis Set|Overall Study||94
8402492|NCT00995930|20708647|P2|STARTED|Overall Study||95
8402493|NCT00995930|20708648|P1|STARTED|Overall Study||94
8402494|NCT00995904|20708677|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402495|NCT00995904|20708678|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402496|NCT00995904|20708679|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402497|NCT00995904|20708680|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402498|NCT00995904|20708681|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402499|NCT00995904|20708682|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402500|NCT00995904|20708677|P6|COMPLETED|Follow-up Visit (Final Visit)||3
8402501|NCT00995904|20708678|P5|COMPLETED|Follow-up Visit (Final Visit)||5
8402502|NCT00995904|20708679|P4|COMPLETED|Follow-up Visit (Final Visit)||5
8402503|NCT00995904|20708680|P3|COMPLETED|Follow-up Visit (Final Visit)||4
8402504|NCT00995904|20708681|P2|COMPLETED|Follow-up Visit (Final Visit)||3
8402505|NCT00995904|20708682|P1|COMPLETED|Follow-up Visit (Final Visit)||4
8402506|NCT00995904|20708677|P6|STARTED|Follow-up Visit (Final Visit)||3
8402507|NCT00995904|20708678|P5|STARTED|Follow-up Visit (Final Visit)||5
8402508|NCT00995904|20708679|P4|STARTED|Follow-up Visit (Final Visit)||5
8402509|NCT00995904|20708680|P3|STARTED|Follow-up Visit (Final Visit)||4
8402510|NCT00995904|20708681|P2|STARTED|Follow-up Visit (Final Visit)||3
8402511|NCT00995904|20708682|P1|STARTED|Follow-up Visit (Final Visit)||4
8402512|NCT00995904|20708677|P6|NOT COMPLETED|Visit 4||0
8402513|NCT00995904|20708678|P5|NOT COMPLETED|Visit 4||0
8402514|NCT00995904|20708679|P4|NOT COMPLETED|Visit 4||0
8402515|NCT00995904|20708680|P3|NOT COMPLETED|Visit 4||0
8402516|NCT00995904|20708681|P2|NOT COMPLETED|Visit 4||0
8402517|NCT00995904|20708682|P1|NOT COMPLETED|Visit 4||0
8402518|NCT00995904|20708677|P6|COMPLETED|Visit 4||3
8402519|NCT00995904|20708678|P5|COMPLETED|Visit 4||5
8402520|NCT00995904|20708679|P4|COMPLETED|Visit 4||5
8402521|NCT00995904|20708680|P3|COMPLETED|Visit 4||4
8402522|NCT00995904|20708681|P2|COMPLETED|Visit 4||3
8402523|NCT00995904|20708682|P1|COMPLETED|Visit 4||4
8402524|NCT00995904|20708677|P6|STARTED|Visit 4||3
8402525|NCT00995904|20708678|P5|STARTED|Visit 4||5
8402526|NCT00995904|20708679|P4|STARTED|Visit 4||5
8402527|NCT00995904|20708680|P3|STARTED|Visit 4||4
8402528|NCT00995904|20708681|P2|STARTED|Visit 4||3
8402529|NCT00995904|20708682|P1|STARTED|Visit 4||4
8402530|NCT00995904|20708677|P6|NOT COMPLETED|Visit 3||0
8402531|NCT00995904|20708678|P5|NOT COMPLETED|Visit 3||0
8402532|NCT00995904|20708679|P4|NOT COMPLETED|Visit 3||0
8402533|NCT00995904|20708680|P3|NOT COMPLETED|Visit 3||0
8402534|NCT00995904|20708681|P2|NOT COMPLETED|Visit 3||0
8402535|NCT00995904|20708682|P1|NOT COMPLETED|Visit 3||0
8402536|NCT00995904|20708677|P6|COMPLETED|Visit 3||3
8402537|NCT00995904|20708678|P5|COMPLETED|Visit 3||5
8402538|NCT00995904|20708679|P4|COMPLETED|Visit 3||5
8402539|NCT00995904|20708680|P3|COMPLETED|Visit 3||4
8402540|NCT00995904|20708681|P2|COMPLETED|Visit 3||3
8402541|NCT00995904|20708682|P1|COMPLETED|Visit 3||4
8402542|NCT00995904|20708677|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
8402543|NCT00995904|20708678|P5|STARTED|Visit 3||5
8402544|NCT00995904|20708679|P4|STARTED|Visit 3||5
8402545|NCT00995904|20708680|P3|STARTED|Visit 3||4
8402546|NCT00995904|20708681|P2|STARTED|Visit 3||3
8402547|NCT00995904|20708682|P1|STARTED|Visit 3||4
8402548|NCT00995904|20708677|P6|NOT COMPLETED|Visit 2 (Randomization)||0
8402549|NCT00995904|20708678|P5|NOT COMPLETED|Visit 2 (Randomization)||0
8402550|NCT00995904|20708679|P4|NOT COMPLETED|Visit 2 (Randomization)||0
8402551|NCT00995904|20708680|P3|NOT COMPLETED|Visit 2 (Randomization)||0
8402552|NCT00995904|20708681|P2|NOT COMPLETED|Visit 2 (Randomization)||0
8402553|NCT00995904|20708682|P1|NOT COMPLETED|Visit 2 (Randomization)||0
8402554|NCT00995904|20708677|P6|COMPLETED|Visit 2 (Randomization)||4
8402555|NCT00995904|20708678|P5|COMPLETED|Visit 2 (Randomization)||5
8402556|NCT00995904|20708679|P4|COMPLETED|Visit 2 (Randomization)||5
8402557|NCT00995904|20708680|P3|COMPLETED|Visit 2 (Randomization)||4
8402558|NCT00995904|20708681|P2|COMPLETED|Visit 2 (Randomization)||3
8402559|NCT00995904|20708682|P1|COMPLETED|Visit 2 (Randomization)||4
8402560|NCT00995904|20708677|P6|STARTED|Visit 2 (Randomization)||4
8402561|NCT00995904|20708678|P5|STARTED|Visit 2 (Randomization)||5
8402562|NCT00995904|20708679|P4|STARTED|Visit 2 (Randomization)||5
8402563|NCT00995904|20708680|P3|STARTED|Visit 2 (Randomization)||4
8402564|NCT00995904|20708681|P2|STARTED|Visit 2 (Randomization)||3
8402565|NCT00995904|20708682|P1|STARTED|Visit 2 (Randomization)||4
8402566|NCT00995865|20708699|P3|NOT COMPLETED|Overall Study||1
8402567|NCT00995865|20708700|P2|NOT COMPLETED|Overall Study||0
8402568|NCT00995865|20708701|P1|NOT COMPLETED|Overall Study||2
8402569|NCT00995865|20708699|P3|COMPLETED|Overall Study||11
8402570|NCT00995865|20708700|P2|COMPLETED|Overall Study||24
8402571|NCT00995865|20708701|P1|COMPLETED|Overall Study||22
8402572|NCT00995865|20708699|P3|STARTED|Overall Study||12
8402573|NCT00995865|20708700|P2|STARTED|Overall Study||24
8402574|NCT00995865|20708701|P1|STARTED|Overall Study||24
8402575|NCT00995774|20708723|P2|NOT COMPLETED|Training Period 2||0
8402576|NCT00995774|20708724|P1|NOT COMPLETED|Training Period 2||2
8402577|NCT00995774|20708723|P2|COMPLETED|Training Period 2||5
8402578|NCT00995774|20708724|P1|COMPLETED|Training Period 2||5
8402579|NCT00995774|20708723|P2|STARTED|Training Period 2||5
8402580|NCT00995774|20708724|P1|STARTED|Training Period 2||7
8402581|NCT00995774|20708723|P2|NOT COMPLETED|Washout Period||0
8402582|NCT00995774|20708724|P1|NOT COMPLETED|Washout Period||0
8402583|NCT00995774|20708723|P2|COMPLETED|Washout Period||5
8402584|NCT00995774|20708724|P1|COMPLETED|Washout Period||7
8402585|NCT00995774|20708723|P2|STARTED|Washout Period||5
8402586|NCT00995774|20708724|P1|STARTED|Washout Period||7
8402587|NCT00995774|20708723|P2|NOT COMPLETED|Training Period 1||0
8402588|NCT00995774|20708724|P1|NOT COMPLETED|Training Period 1||0
8402589|NCT00995774|20708723|P2|COMPLETED|Training Period 1||5
8402590|NCT00995774|20708724|P1|COMPLETED|Training Period 1||7
8402591|NCT00995774|20708723|P2|STARTED|Training Period 1||5
8402592|NCT00995774|20708724|P1|STARTED|Training Period 1||7
8402593|NCT00995761|20708734|P1|NOT COMPLETED|Overall Study||0
8402594|NCT00995761|20708734|P1|COMPLETED|Overall Study||48
8402595|NCT00995761|20708734|P1|STARTED|Overall Study||48
8402596|NCT00995722|20708740|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
8402597|NCT00995722|20708741|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
8402598|NCT00995722|20708740|P2|COMPLETED|Overall Study: 36 Weeks||2
8402599|NCT00995722|20708741|P1|COMPLETED|Overall Study: 36 Weeks||3
8402600|NCT00995722|20708740|P2|STARTED|Overall Study: 36 Weeks||4
8402601|NCT00995722|20708741|P1|STARTED|Overall Study: 36 Weeks||5
8402602|NCT00995722|20708740|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
8402603|NCT00995722|20708741|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
8402604|NCT00995722|20708740|P2|COMPLETED|Double Blinded: 16 Weeks||4
8402605|NCT00995722|20708741|P1|COMPLETED|Double Blinded: 16 Weeks||5
8402606|NCT00995722|20708740|P2|STARTED|Double Blinded: 16 Weeks||5
8402607|NCT00995722|20708741|P1|STARTED|Double Blinded: 16 Weeks||6
8402608|NCT00995709|20708758|P3|NOT COMPLETED|Overall Study||5
8402609|NCT00995709|20708759|P2|NOT COMPLETED|Overall Study||9
8402610|NCT00995709|20708760|P1|NOT COMPLETED|Overall Study||7
8402611|NCT00995709|20708758|P3|COMPLETED|Overall Study||34
8402612|NCT00995709|20708759|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
8402613|NCT00995709|20708760|P1|COMPLETED|Overall Study||32
8402614|NCT00995709|20708758|P3|STARTED|Overall Study||39
8402615|NCT00995709|20708759|P2|STARTED|Overall Study||40
8402616|NCT00995709|20708760|P1|STARTED|Overall Study||39
8402617|NCT00995670|20708786|P3|NOT COMPLETED|Overall Study||3
8402618|NCT00995670|20708787|P2|NOT COMPLETED|Overall Study||0
8402619|NCT00995670|20708788|P1|NOT COMPLETED|Overall Study||1
8402620|NCT00995670|20708786|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
8402621|NCT00995670|20708787|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
8402622|NCT00995670|20708788|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
8402623|NCT00995670|20708786|P3|STARTED|Overall Study||17
8402624|NCT00995670|20708787|P2|STARTED|Overall Study||16
8402625|NCT00995670|20708788|P1|STARTED|Overall Study||26
8402626|NCT00995566|20708796|P1|NOT COMPLETED|Overall Study||54
8402627|NCT00995566|20708796|P1|COMPLETED|Overall Study||0
8402628|NCT00995566|20708796|P1|STARTED|Overall Study||54
8402629|NCT00995553|20708810|P2|NOT COMPLETED|Overall Study||6
8402630|NCT00995553|20708811|P1|NOT COMPLETED|Overall Study||2
8402631|NCT00995553|20708810|P2|COMPLETED|Overall Study||35
8402632|NCT00995553|20708811|P1|COMPLETED|Overall Study||38
8402633|NCT00995553|20708810|P2|STARTED|Overall Study||41
8402634|NCT00995553|20708811|P1|STARTED|Overall Study||40
8402635|NCT00995501|20708827|P8|NOT COMPLETED|Overall Study||0
8402636|NCT00995501|20708828|P7|NOT COMPLETED|Overall Study||0
8402637|NCT00995501|20708829|P6|NOT COMPLETED|Overall Study||0
8402638|NCT00995501|20708830|P5|NOT COMPLETED|Overall Study||0
8402639|NCT00995501|20708831|P4|NOT COMPLETED|Overall Study||0
8402640|NCT00995501|20708832|P3|NOT COMPLETED|Overall Study||0
8402641|NCT00995501|20708833|P2|NOT COMPLETED|Overall Study||0
8402642|NCT00995501|20708834|P1|NOT COMPLETED|Overall Study||0
8402643|NCT00995501|20708827|P8|COMPLETED|Overall Study||46
8402644|NCT00995501|20708828|P7|COMPLETED|Overall Study||49
8402645|NCT00995501|20708829|P6|COMPLETED|Overall Study||44
8402646|NCT00995501|20708830|P5|COMPLETED|Overall Study||46
8402647|NCT00995501|20708831|P4|COMPLETED|Overall Study||46
8402648|NCT00995501|20708832|P3|COMPLETED|Overall Study||47
8402649|NCT00995501|20708833|P2|COMPLETED|Overall Study||51
8402650|NCT00995501|20708834|P1|COMPLETED|Overall Study||52
8402651|NCT00995501|20708827|P8|STARTED|Overall Study||46
8402652|NCT00995501|20708828|P7|STARTED|Overall Study||49
8402653|NCT00995501|20708829|P6|STARTED|Overall Study||44
8402654|NCT00995501|20708830|P5|STARTED|Overall Study||46
8402655|NCT00995501|20708831|P4|STARTED|Overall Study||46
8402656|NCT00995501|20708832|P3|STARTED|Overall Study||47
8402657|NCT00995501|20708833|P2|STARTED|Overall Study||51
8402658|NCT00995501|20708834|P1|STARTED|Overall Study||52
8402659|NCT00995488|20708860|P1|NOT COMPLETED|Overall Study||1
8402660|NCT00995488|20708860|P1|COMPLETED|Overall Study||15
8402661|NCT00995488|20708860|P1|STARTED|Overall Study||16
8402662|NCT00995475|20708865|P2|NOT COMPLETED|Second Intervention||0
8402663|NCT00995475|20708866|P1|NOT COMPLETED|Second Intervention||0
8402664|NCT00995475|20708865|P2|COMPLETED|Second Intervention||9
8402665|NCT00995475|20708866|P1|COMPLETED|Second Intervention||9
8402666|NCT00995475|20708865|P2|STARTED|Second Intervention||9
8402667|NCT00995475|20708866|P1|STARTED|Second Intervention||9
8402668|NCT00995475|20708865|P2|NOT COMPLETED|Wash-out Two Week||0
8402669|NCT00995475|20708866|P1|NOT COMPLETED|Wash-out Two Week||0
8402670|NCT00995475|20708865|P2|COMPLETED|Wash-out Two Week||9
8402671|NCT00995475|20708866|P1|COMPLETED|Wash-out Two Week||9
8402672|NCT00995475|20708865|P2|STARTED|Wash-out Two Week||9
8402673|NCT00995475|20708866|P1|STARTED|Wash-out Two Week||9
8402674|NCT00995475|20708865|P2|NOT COMPLETED|First Intervention||0
8402675|NCT00995475|20708866|P1|NOT COMPLETED|First Intervention||0
8402676|NCT00995475|20708865|P2|COMPLETED|First Intervention||9
8402677|NCT00995475|20708866|P1|COMPLETED|First Intervention||9
8402678|NCT00995475|20708865|P2|STARTED|First Intervention||9
8402679|NCT00995475|20708866|P1|STARTED|First Intervention||9
8402680|NCT00995449|20708880|P4|NOT COMPLETED|Overall Study||0
8402681|NCT00995449|20708881|P3|NOT COMPLETED|Overall Study||2
8402682|NCT00995449|20708882|P2|NOT COMPLETED|Overall Study||0
8402683|NCT00995449|20708883|P1|NOT COMPLETED|Overall Study||0
8402684|NCT00995449|20708880|P4|COMPLETED|Overall Study||2
8402685|NCT00995449|20708881|P3|COMPLETED|Overall Study||5
8402686|NCT00995449|20708882|P2|COMPLETED|Overall Study||0
8402687|NCT00995449|20708883|P1|COMPLETED|Overall Study||0
8402688|NCT00995449|20708880|P4|STARTED|Overall Study||2
8402689|NCT00995449|20708881|P3|STARTED|Overall Study||7
8402690|NCT00995449|20708882|P2|STARTED|Overall Study||0
8402691|NCT00995449|20708883|P1|STARTED|Overall Study||0
8402692|NCT00995436|20708894|P3|NOT COMPLETED|Overall Study||0
8402693|NCT00995436|20708895|P2|NOT COMPLETED|Overall Study||5
8402694|NCT00995436|20708896|P1|NOT COMPLETED|Overall Study||2
8402695|NCT00995436|20708894|P3|COMPLETED|Overall Study||26
8402696|NCT00995436|20708895|P2|COMPLETED|Overall Study||22
8402697|NCT00995436|20708896|P1|COMPLETED|Overall Study||23
8402698|NCT00995436|20708894|P3|STARTED|Overall Study||26
8402699|NCT00995436|20708895|P2|STARTED|Overall Study||27
8402700|NCT00995436|20708896|P1|STARTED|Overall Study|25|25
8402701|NCT00995410|20708904|P1|NOT COMPLETED|Overall Study||88
8402702|NCT00995410|20708904|P1|COMPLETED|Overall Study||292
8402703|NCT00995410|20708904|P1|Treated|Overall Study||379
8402704|NCT00995410|20708904|P1|STARTED|Overall Study||380
8402705|NCT00995371|20708911|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
8402706|NCT00995371|20708912|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
8402707|NCT00995371|20708911|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
8402708|NCT00995371|20708912|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
8402709|NCT00995371|20708911|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
8402710|NCT00995371|20708912|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
8402711|NCT00995371|20708911|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
8402712|NCT00995371|20708912|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
8402713|NCT00995371|20708911|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
8402714|NCT00995371|20708912|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
8402715|NCT00995371|20708911|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
8402716|NCT00995371|20708912|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
8402717|NCT00995345|20708930|P5|NOT COMPLETED|Overall Study||5
8402718|NCT00995345|20708931|P4|NOT COMPLETED|Overall Study||5
8402719|NCT00995345|20708932|P3|NOT COMPLETED|Overall Study||7
8402720|NCT00995345|20708933|P2|NOT COMPLETED|Overall Study||7
8402721|NCT00995345|20708934|P1|NOT COMPLETED|Overall Study||11
8402722|NCT00995345|20708930|P5|COMPLETED|Overall Study||75
8402723|NCT00995345|20708931|P4|COMPLETED|Overall Study||76
8402724|NCT00995345|20708932|P3|COMPLETED|Overall Study||73
8402725|NCT00995345|20708933|P2|COMPLETED|Overall Study||74
8402726|NCT00995345|20708934|P1|COMPLETED|Overall Study||70
8402727|NCT00995345|20708930|P5|STARTED|Overall Study||80
8402728|NCT00995345|20708931|P4|STARTED|Overall Study||81
8402729|NCT00995345|20708932|P3|STARTED|Overall Study||80
8402730|NCT00995345|20708933|P2|STARTED|Overall Study||81
8402731|NCT00995345|20708934|P1|STARTED|Overall Study||81
8402732|NCT00995215|20708961|P1|NOT COMPLETED|Overall Study||0
8402733|NCT00995215|20708961|P1|COMPLETED|Overall Study||6
8402734|NCT00995215|20708961|P1|STARTED|Overall Study||6
8402735|NCT00995085|20708966|P1|NOT COMPLETED|Overall Study||5
8402736|NCT00995085|20708966|P1|COMPLETED|Overall Study||38
8402737|NCT00995085|20708966|P1|STARTED|Overall Study||43
8402738|NCT00995072|20708972|P2|NOT COMPLETED|Overall Study||3
8402739|NCT00995072|20708973|P1|NOT COMPLETED|Overall Study||1
8402740|NCT00995072|20708972|P2|COMPLETED|Overall Study||12
8402741|NCT00995072|20708973|P1|COMPLETED|Overall Study||9
8402742|NCT00995072|20708972|P2|STARTED|Overall Study||15
8402743|NCT00995072|20708973|P1|STARTED|Overall Study||10
8402744|NCT00995020|20708983|P2|NOT COMPLETED|Overall Study||7
8402745|NCT00995020|20708984|P1|NOT COMPLETED|Overall Study||3
8402746|NCT00995020|20708983|P2|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|45
8402747|NCT00995020|20708984|P1|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|48
8402748|NCT00995020|20708983|P2|STARTED|Overall Study||52
8402749|NCT00995020|20708984|P1|STARTED|Overall Study||51
8402750|NCT00995007|20708994|P2|NOT COMPLETED|Overall Study||2
8402751|NCT00995007|20708995|P1|NOT COMPLETED|Overall Study||17
8402752|NCT00995007|20708994|P2|COMPLETED|Overall Study||54
8402753|NCT00995007|20708995|P1|COMPLETED|Overall Study||39
8402754|NCT00995007|20708994|P2|Crossover to Vandetanib|Overall Study||0
8402755|NCT00995007|20708995|P1|Crossover to Vandetanib|Overall Study||42
8402756|NCT00995007|20708994|P2|STARTED|Overall Study||56
8402757|NCT00995007|20708995|P1|STARTED|Overall Study||56
8402758|NCT00994929|20709011|P1|NOT COMPLETED|Overall Study||0
8402759|NCT00994929|20709011|P1|COMPLETED|Overall Study||9
8402760|NCT00994929|20709011|P1|STARTED|Overall Study||9
8402761|NCT00994760|20709017|P1|NOT COMPLETED|Overall Study||24
8402762|NCT00994760|20709017|P1|COMPLETED|Overall Study||107
8402763|NCT00994760|20709017|P1|STARTED|Overall Study||131
8402764|NCT00994682|20709058|P2|NOT COMPLETED|Pioglitazone Open Label||7
8402765|NCT00994682|20709059|P1|NOT COMPLETED|Pioglitazone Open Label||13
8402766|NCT00994682|20709058|P2|COMPLETED|Pioglitazone Open Label||34
8402767|NCT00994682|20709059|P1|COMPLETED|Pioglitazone Open Label||29
8402768|NCT00994682|20709058|P2|STARTED|Pioglitazone Open Label||41
8402769|NCT00994682|20709059|P1|STARTED|Pioglitazone Open Label||42
8402770|NCT00994682|20709058|P2|NOT COMPLETED|Double Bilnd||9
8402771|NCT00994682|20709059|P1|NOT COMPLETED|Double Bilnd||9
8402772|NCT00994682|20709058|P2|COMPLETED|Double Bilnd||41
8402773|NCT00994682|20709059|P1|COMPLETED|Double Bilnd||42
8402774|NCT00994682|20709058|P2|STARTED|Double Bilnd||50
8402775|NCT00994682|20709059|P1|STARTED|Double Bilnd||51
8402776|NCT00994643|20709103|P1|NOT COMPLETED|Overall Study||1
8402777|NCT00994643|20709103|P1|COMPLETED|Overall Study||10
8402778|NCT00994643|20709103|P1|STARTED|Overall Study||11
8402779|NCT00994604|20709107|P1|NOT COMPLETED|Overall Study||6
8402780|NCT00994604|20709107|P1|COMPLETED|Overall Study||45
8402781|NCT00994604|20709107|P1|STARTED|Overall Study||51
8402791|NCT00994448|20709147|P2|NOT COMPLETED|Overall Study||2
8402792|NCT00994448|20709148|P1|NOT COMPLETED|Overall Study||8
8402793|NCT00994448|20709147|P2|COMPLETED|Overall Study||5
8402794|NCT00994448|20709148|P1|COMPLETED|Overall Study||4
8402795|NCT00994448|20709147|P2|STARTED|Overall Study||7
8402796|NCT00994448|20709148|P1|STARTED|Overall Study||12
8402797|NCT00994422|20709156|P2|NOT COMPLETED|Overall Study||1
8402798|NCT00994422|20709157|P1|NOT COMPLETED|Overall Study||7
8402799|NCT00994422|20709156|P2|COMPLETED|Overall Study||54
8402800|NCT00994422|20709157|P1|COMPLETED|Overall Study||185
8402801|NCT00994422|20709156|P2|STARTED|Overall Study||55
8402802|NCT00994422|20709157|P1|STARTED|Overall Study||192
8402803|NCT00994318|20709170|P3|NOT COMPLETED|Overall Study||67
8402804|NCT00994318|20709171|P2|NOT COMPLETED|Overall Study||18
8402805|NCT00994318|20709172|P1|NOT COMPLETED|Overall Study||22
8402806|NCT00994318|20709170|P3|COMPLETED|Overall Study||250
8402807|NCT00994318|20709171|P2|COMPLETED|Overall Study||136
8402808|NCT00994318|20709172|P1|COMPLETED|Overall Study||133
8402809|NCT00994318|20709170|P3|STARTED|Overall Study||317
8402810|NCT00994318|20709171|P2|STARTED|Overall Study||154
8402811|NCT00994318|20709172|P1|STARTED|Overall Study||155
8402812|NCT00994279|20709182|P2|NOT COMPLETED|Overall Study||5
8402813|NCT00994279|20709183|P1|NOT COMPLETED|Overall Study||4
8402814|NCT00994279|20709182|P2|COMPLETED|Overall Study||13
8402815|NCT00994279|20709183|P1|COMPLETED|Overall Study||18
8402816|NCT00994279|20709182|P2|STARTED|Overall Study||18
8402817|NCT00994279|20709183|P1|STARTED|Overall Study||22
8402818|NCT00994240|20709193|P2|NOT COMPLETED|Overall Study||5
8402819|NCT00994240|20709194|P1|NOT COMPLETED|Overall Study||6
8402820|NCT00994240|20709193|P2|COMPLETED|Overall Study||39
8402821|NCT00994240|20709194|P1|COMPLETED|Overall Study||35
8402822|NCT00994240|20709193|P2|STARTED|Overall Study||44
8402823|NCT00994240|20709194|P1|STARTED|Overall Study||41
8402824|NCT00994214|20709204|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
8402825|NCT00994214|20709205|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
8402826|NCT00994214|20709206|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
8402827|NCT00994214|20709207|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
8402828|NCT00994214|20709204|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402829|NCT00994214|20709205|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402830|NCT00994214|20709206|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402831|NCT00994214|20709207|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402832|NCT00994214|20709204|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
8402833|NCT00994214|20709205|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
8402834|NCT00994214|20709206|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
8402835|NCT00994214|20709207|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
8402836|NCT00994214|20709204|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
8402837|NCT00994214|20709205|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
8402838|NCT00994214|20709206|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
8402839|NCT00994214|20709207|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
8402840|NCT00994214|20709204|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8402841|NCT00994214|20709205|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8402842|NCT00994214|20709206|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8402843|NCT00994214|20709207|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
8402844|NCT00994214|20709204|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402845|NCT00994214|20709205|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402846|NCT00994214|20709206|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402847|NCT00994214|20709207|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402848|NCT00994214|20709204|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
8402849|NCT00994214|20709205|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
8402850|NCT00994214|20709206|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
8402851|NCT00994214|20709207|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
8402852|NCT00994214|20709204|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
8402853|NCT00994214|20709205|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
8402854|NCT00994214|20709206|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
8402855|NCT00994214|20709207|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
8402856|NCT00994214|20709204|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8402857|NCT00994214|20709205|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8402858|NCT00994214|20709206|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
8402859|NCT00994214|20709207|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8402860|NCT00994214|20709204|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
8402861|NCT00994214|20709205|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
8402862|NCT00994214|20709206|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
8402863|NCT00994214|20709207|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
8402864|NCT00994175|20709251|P2|NOT COMPLETED|Second Intervention||0
8402865|NCT00994175|20709252|P1|NOT COMPLETED|Second Intervention||0
8402866|NCT00994175|20709251|P2|COMPLETED|Second Intervention||8
8402867|NCT00994175|20709252|P1|COMPLETED|Second Intervention||4
8402868|NCT00994175|20709251|P2|STARTED|Second Intervention||8
8402869|NCT00994175|20709252|P1|STARTED|Second Intervention||4
8402870|NCT00994175|20709251|P2|NOT COMPLETED|First Intervention||1
8402871|NCT00994175|20709252|P1|NOT COMPLETED|First Intervention||2
8402872|NCT00994175|20709251|P2|COMPLETED|First Intervention||8
8402873|NCT00994175|20709252|P1|COMPLETED|First Intervention||4
8402874|NCT00994175|20709251|P2|STARTED|First Intervention||9
8402875|NCT00994175|20709252|P1|STARTED|First Intervention||6
8402876|NCT00994123|20709263|P3|NOT COMPLETED|Overall Study||0
8402877|NCT00994123|20709264|P2|NOT COMPLETED|Overall Study||0
8402878|NCT00994123|20709265|P1|NOT COMPLETED|Overall Study||0
8402879|NCT00994123|20709263|P3|COMPLETED|Overall Study||44
8402880|NCT00994123|20709264|P2|COMPLETED|Overall Study||85
8402881|NCT00994123|20709265|P1|COMPLETED|Overall Study||33
8402882|NCT00994123|20709263|P3|STARTED|Overall Study||44
8402883|NCT00994123|20709264|P2|STARTED|Overall Study||85
8402884|NCT00994123|20709265|P1|STARTED|Overall Study||33
8402885|NCT00994110|20709286|P2|NOT COMPLETED|Overall Study||74
8402886|NCT00994110|20709287|P1|NOT COMPLETED|Overall Study||65
8402887|NCT00994110|20709286|P2|COMPLETED|Overall Study||148
8402888|NCT00994110|20709287|P1|COMPLETED|Overall Study||152
8402889|NCT00994110|20709286|P2|STARTED|Overall Study||222
8402890|NCT00994110|20709287|P1|STARTED|Overall Study||217
8402891|NCT00993967|20709293|P1|NOT COMPLETED|Overall Study||61
8402892|NCT00993967|20709293|P1|COMPLETED|Overall Study||139
8402893|NCT00993967|20709293|P1|STARTED|Overall Study||200
8402894|NCT00993954|20709300|P2|NOT COMPLETED|Overall Study||2
8402895|NCT00993954|20709301|P1|NOT COMPLETED|Overall Study||21
8402896|NCT00993954|20709300|P2|COMPLETED|Overall Study||121
8402897|NCT00993954|20709301|P1|COMPLETED|Overall Study||124
8402898|NCT00993954|20709300|P2|STARTED|Overall Study||123
8402899|NCT00993954|20709301|P1|STARTED|Overall Study||145
8402900|NCT00993928|20709314|P2|NOT COMPLETED|Overall Study||7
8402901|NCT00993928|20709315|P1|NOT COMPLETED|Overall Study||5
8402902|NCT00993928|20709314|P2|COMPLETED|Overall Study||38
8402903|NCT00993928|20709315|P1|COMPLETED|Overall Study||43
8402904|NCT00993928|20709314|P2|STARTED|Overall Study||45
8402905|NCT00993928|20709315|P1|STARTED|Overall Study||48
8402909|NCT00993824|20709340|P2|NOT COMPLETED|Overall Study||0
8402910|NCT00993824|20709341|P1|NOT COMPLETED|Overall Study||0
8402911|NCT00993824|20709340|P2|COMPLETED|Overall Study||10
8402912|NCT00993824|20709341|P1|COMPLETED|Overall Study||11
8402913|NCT00993824|20709340|P2|STARTED|Overall Study||10
8402914|NCT00993824|20709341|P1|STARTED|Overall Study||11
8402915|NCT00993668|20709355|P2|NOT COMPLETED|Open-Label Period||15
8402916|NCT00993668|20709356|P1|NOT COMPLETED|Open-Label Period||23
8402917|NCT00993668|20709355|P2|COMPLETED|Open-Label Period||91
8402918|NCT00993668|20709356|P1|COMPLETED|Open-Label Period||86
8402919|NCT00993668|20709355|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
8402920|NCT00993668|20709356|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
8402921|NCT00993668|20709355|P2|NOT COMPLETED|Single-Blind Period||3
8402922|NCT00993668|20709356|P1|NOT COMPLETED|Single-Blind Period||4
8402923|NCT00993668|20709355|P2|COMPLETED|Single-Blind Period||107
8402924|NCT00993668|20709356|P1|COMPLETED|Single-Blind Period||110
8402925|NCT00993668|20709355|P2|STARTED|Single-Blind Period||110
8402926|NCT00993668|20709356|P1|STARTED|Single-Blind Period||114
8402927|NCT00993655|20709384|P3|NOT COMPLETED|Overall Study||0
8402928|NCT00993655|20709385|P2|NOT COMPLETED|Overall Study||0
8402929|NCT00993655|20709386|P1|NOT COMPLETED|Overall Study||0
8402930|NCT00993655|20709384|P3|COMPLETED|Overall Study||102
8402931|NCT00993655|20709385|P2|COMPLETED|Overall Study||72
8402932|NCT00993655|20709386|P1|COMPLETED|Overall Study||101
8402933|NCT00993655|20709384|P3|STARTED|Overall Study||102
8402934|NCT00993655|20709385|P2|STARTED|Overall Study||72
8402935|NCT00993655|20709386|P1|STARTED|Overall Study||101
8402936|NCT00993616|20709400|P1|NOT COMPLETED|Overall Study||2
8402937|NCT00993616|20709400|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
8402938|NCT00993616|20709400|P1|STARTED|Overall Study||29
8402939|NCT00993499|20709418|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
8402940|NCT00993499|20709419|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
8402941|NCT00993499|20709420|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
8402942|NCT00993499|20709421|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
8402943|NCT00993499|20709422|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
8402944|NCT00993499|20709423|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
8402945|NCT00993499|20709418|P6|COMPLETED|Discontinued After Starting Course 3||0
8402946|NCT00993499|20709419|P5|COMPLETED|Discontinued After Starting Course 3||0
8402947|NCT00993499|20709420|P4|COMPLETED|Discontinued After Starting Course 3||1
8402948|NCT00993499|20709421|P3|COMPLETED|Discontinued After Starting Course 3||3
8402949|NCT00993499|20709422|P2|COMPLETED|Discontinued After Starting Course 3||4
8402950|NCT00993499|20709423|P1|COMPLETED|Discontinued After Starting Course 3||4
8402951|NCT00993499|20709418|P6|STARTED|Discontinued After Starting Course 3||3
8402952|NCT00993499|20709419|P5|STARTED|Discontinued After Starting Course 3||3
8402953|NCT00993499|20709420|P4|STARTED|Discontinued After Starting Course 3||3
8402954|NCT00993499|20709421|P3|STARTED|Discontinued After Starting Course 3||9
8402955|NCT00993499|20709422|P2|STARTED|Discontinued After Starting Course 3||9
8402956|NCT00993499|20709423|P1|STARTED|Discontinued After Starting Course 3||12
8402957|NCT00993499|20709418|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
8402958|NCT00993499|20709419|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
8402959|NCT00993499|20709420|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
8402960|NCT00993499|20709421|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
8402961|NCT00993499|20709422|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
8402962|NCT00993499|20709423|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
8402963|NCT00993499|20709418|P6|COMPLETED|Discontinued Before Starting Course 3||3
8402964|NCT00993499|20709419|P5|COMPLETED|Discontinued Before Starting Course 3||3
8402965|NCT00993499|20709420|P4|COMPLETED|Discontinued Before Starting Course 3||2
8402966|NCT00993499|20709421|P3|COMPLETED|Discontinued Before Starting Course 3||6
8402967|NCT00993499|20709422|P2|COMPLETED|Discontinued Before Starting Course 3||5
8402968|NCT00993499|20709423|P1|COMPLETED|Discontinued Before Starting Course 3||8
8402969|NCT00993499|20709418|P6|STARTED|Discontinued Before Starting Course 3||3
8402970|NCT00993499|20709419|P5|STARTED|Discontinued Before Starting Course 3||3
8402971|NCT00993499|20709420|P4|STARTED|Discontinued Before Starting Course 3||3
8402972|NCT00993499|20709421|P3|STARTED|Discontinued Before Starting Course 3||9
8402973|NCT00993499|20709422|P2|STARTED|Discontinued Before Starting Course 3||9
8402974|NCT00993499|20709423|P1|STARTED|Discontinued Before Starting Course 3||12
8402975|NCT00993499|20709418|P6|NOT COMPLETED|Run-in Period (8 Days)||0
8402976|NCT00993499|20709419|P5|NOT COMPLETED|Run-in Period (8 Days)||0
8402977|NCT00993499|20709420|P4|NOT COMPLETED|Run-in Period (8 Days)||0
8402978|NCT00993499|20709421|P3|NOT COMPLETED|Run-in Period (8 Days)||1
8402979|NCT00993499|20709422|P2|NOT COMPLETED|Run-in Period (8 Days)||3
8402980|NCT00993499|20709423|P1|NOT COMPLETED|Run-in Period (8 Days)||1
8402981|NCT00993499|20709418|P6|COMPLETED|Run-in Period (8 Days)||3
8402982|NCT00993499|20709419|P5|COMPLETED|Run-in Period (8 Days)||3
8402983|NCT00993499|20709420|P4|COMPLETED|Run-in Period (8 Days)||3
8402984|NCT00993499|20709421|P3|COMPLETED|Run-in Period (8 Days)||9
8402985|NCT00993499|20709422|P2|COMPLETED|Run-in Period (8 Days)||9
8402986|NCT00993499|20709423|P1|COMPLETED|Run-in Period (8 Days)||12
8402987|NCT00993499|20709418|P6|STARTED|Run-in Period (8 Days)||3
8402988|NCT00993499|20709419|P5|STARTED|Run-in Period (8 Days)||3
8402989|NCT00993499|20709420|P4|STARTED|Run-in Period (8 Days)||3
8402990|NCT00993499|20709421|P3|STARTED|Run-in Period (8 Days)||10
8402991|NCT00993499|20709422|P2|STARTED|Run-in Period (8 Days)||12
8402992|NCT00993499|20709423|P1|STARTED|Run-in Period (8 Days)||13
8402993|NCT00993473|20709505|P2|NOT COMPLETED|Overall Study||10
8402994|NCT00993473|20709506|P1|NOT COMPLETED|Overall Study||4
8402995|NCT00993473|20709505|P2|COMPLETED|Overall Study||54
8402996|NCT00993473|20709506|P1|COMPLETED|Overall Study||57
8402997|NCT00993473|20709505|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
8402998|NCT00993473|20709506|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
8402999|NCT00993447|20709544|P2|NOT COMPLETED|Overall Study||19
8403000|NCT00993447|20709545|P1|NOT COMPLETED|Overall Study||37
8403001|NCT00993447|20709544|P2|COMPLETED|Overall Study||180
8403002|NCT00993447|20709545|P1|COMPLETED|Overall Study||364
8403003|NCT00993447|20709544|P2|STARTED|Overall Study||199
8403004|NCT00993447|20709545|P1|STARTED|Overall Study||401
8403005|NCT00993421|20709582|P7|NOT COMPLETED|Overall Study||42
8403006|NCT00993421|20709583|P6|NOT COMPLETED|Overall Study||46
8403007|NCT00993421|20709584|P5|NOT COMPLETED|Overall Study||46
8403008|NCT00993421|20709585|P4|NOT COMPLETED|Overall Study||45
8403009|NCT00993421|20709586|P3|NOT COMPLETED|Overall Study||43
8403010|NCT00993421|20709587|P2|NOT COMPLETED|Overall Study||45
8403011|NCT00993421|20709588|P1|NOT COMPLETED|Overall Study||44
8403012|NCT00993421|20709582|P7|COMPLETED|Overall Study||4
8403013|NCT00993421|20709583|P6|COMPLETED|Overall Study||4
8403014|NCT00993421|20709584|P5|COMPLETED|Overall Study||6
8403015|NCT00993421|20709585|P4|COMPLETED|Overall Study||4
8403016|NCT00993421|20709586|P3|COMPLETED|Overall Study||5
8403017|NCT00993421|20709587|P2|COMPLETED|Overall Study||4
8403018|NCT00993421|20709588|P1|COMPLETED|Overall Study||5
8403019|NCT00993421|20709582|P7|STARTED|Overall Study||46
8403020|NCT00993421|20709583|P6|STARTED|Overall Study||50
8403021|NCT00993421|20709584|P5|STARTED|Overall Study||52
8403022|NCT00993421|20709585|P4|STARTED|Overall Study||49
8403023|NCT00993421|20709586|P3|STARTED|Overall Study||48
8403024|NCT00993421|20709587|P2|STARTED|Overall Study||49
8403025|NCT00993421|20709588|P1|STARTED|Overall Study||49
8403026|NCT00993317|20709739|P2|NOT COMPLETED|Overall Study||25
8403027|NCT00993317|20709740|P1|NOT COMPLETED|Overall Study||21
8403028|NCT00993317|20709739|P2|COMPLETED|Overall Study||60
8403029|NCT00993317|20709740|P1|COMPLETED|Overall Study||21
8403030|NCT00993317|20709739|P2|STARTED|Overall Study||85
8403031|NCT00993317|20709740|P1|STARTED|Overall Study||42
8403032|NCT00993291|20709758|P1|NOT COMPLETED|Overall Study||1
8403033|NCT00993291|20709758|P1|COMPLETED|Overall Study||19
8403034|NCT00993291|20709758|P1|STARTED|Overall Study||20
8403035|NCT00993265|20709764|P2|NOT COMPLETED|Overall Study||0
8403036|NCT00993265|20709765|P1|NOT COMPLETED|Overall Study||4
8403037|NCT00993265|20709764|P2|COMPLETED|Overall Study||19
8403038|NCT00993265|20709765|P1|COMPLETED|Overall Study||16
8403039|NCT00993265|20709764|P2|STARTED|Overall Study||19
8403040|NCT00993265|20709765|P1|STARTED|Overall Study||20
8403041|NCT00993200|20709785|P2|NOT COMPLETED|Overall Study||0
8403042|NCT00993200|20709786|P1|NOT COMPLETED|Overall Study||0
8403043|NCT00993200|20709785|P2|COMPLETED|Overall Study||13
8403044|NCT00993200|20709786|P1|COMPLETED|Overall Study||13
8403045|NCT00993200|20709785|P2|STARTED|Overall Study||13
8403046|NCT00993200|20709786|P1|STARTED|Overall Study||13
8403047|NCT00993187|20709798|P2|NOT COMPLETED|Overall Study||37
8403048|NCT00993187|20709799|P1|NOT COMPLETED|Overall Study||26
8403049|NCT00993187|20709798|P2|COMPLETED|Overall Study||108
8403050|NCT00993187|20709799|P1|COMPLETED|Overall Study||121
8403051|NCT00993187|20709798|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
8403052|NCT00993187|20709799|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
8403053|NCT00993187|20709798|P2|STARTED|Overall Study||145
8403054|NCT00993187|20709799|P1|STARTED|Overall Study||147
8403055|NCT00993148|20709817|P1|NOT COMPLETED|Overall Study||3
8403056|NCT00993148|20709817|P1|COMPLETED|Overall Study||22
8403057|NCT00993148|20709817|P1|STARTED|Overall Study||25
8403058|NCT00993044|20709829|P1|NOT COMPLETED|Irinotecan 50 mg||1
8403059|NCT00993044|20709829|P1|COMPLETED|Irinotecan 50 mg||6
8403060|NCT00993044|20709829|P1|STARTED|Irinotecan 50 mg||7
8403061|NCT00993044|20709829|P1|NOT COMPLETED|Irinotecan 30 mg||0
8403062|NCT00993044|20709829|P1|COMPLETED|Irinotecan 30 mg||6
8403063|NCT00993044|20709829|P1|STARTED|Irinotecan 30 mg||6
8403064|NCT00993031|20709836|P2|NOT COMPLETED|Overall Study||19
8403065|NCT00993031|20709837|P1|NOT COMPLETED|Overall Study||22
8403066|NCT00993031|20709836|P2|COMPLETED|Overall Study||175
8403067|NCT00993031|20709837|P1|COMPLETED|Overall Study||173
8403068|NCT00993031|20709836|P2|Delivered|Overall Study||190
8403069|NCT00993031|20709837|P1|Delivered|Overall Study||187
8403070|NCT00993031|20709836|P2|STARTED|Overall Study||194
8403071|NCT00993031|20709837|P1|STARTED|Overall Study||195
8403072|NCT00992992|20709869|P1|NOT COMPLETED|Overall Study||25
8403073|NCT00992992|20709869|P1|COMPLETED|Overall Study||0
8403074|NCT00992992|20709869|P1|STARTED|Overall Study||25
8403075|NCT00992927|20709891|P2|NOT COMPLETED|Overall Study||0
8403076|NCT00992927|20709892|P1|NOT COMPLETED|Overall Study||0
8403077|NCT00992927|20709891|P2|COMPLETED|Overall Study||22
8403078|NCT00992927|20709892|P1|COMPLETED|Overall Study||32
8403079|NCT00992927|20709891|P2|STARTED|Overall Study||22
8403080|NCT00992927|20709892|P1|STARTED|Overall Study||32
8403081|NCT00992836|20709900|P1|NOT COMPLETED|Overall Study||5
8403082|NCT00992836|20709900|P1|COMPLETED|Overall Study||150
8403083|NCT00992836|20709900|P1|Received Both Study Vaccinations|Overall Study||150
8403084|NCT00992836|20709900|P1|STARTED|Overall Study||155
8403085|NCT00992784|20709915|P3|NOT COMPLETED|Overall Study||1
8403086|NCT00992784|20709916|P2|NOT COMPLETED|Overall Study||2
8403087|NCT00992784|20709917|P1|NOT COMPLETED|Overall Study||3
8403088|NCT00992784|20709915|P3|COMPLETED|Overall Study||85
8403089|NCT00992784|20709916|P2|COMPLETED|Overall Study||102
8403090|NCT00992784|20709917|P1|COMPLETED|Overall Study||177
8403091|NCT00992784|20709915|P3|STARTED|Overall Study||86
8403092|NCT00992784|20709916|P2|STARTED|Overall Study||104
8403093|NCT00992784|20709917|P1|STARTED|Overall Study||180
8403094|NCT00992719|20709988|P3|NOT COMPLETED|Overall Study||0
8403095|NCT00992719|20709989|P2|NOT COMPLETED|Overall Study||1
8403096|NCT00992719|20709990|P1|NOT COMPLETED|Overall Study||1
8403097|NCT00992719|20709988|P3|COMPLETED|Overall Study||28
8403098|NCT00992719|20709989|P2|COMPLETED|Overall Study||27
8403099|NCT00992719|20709990|P1|COMPLETED|Overall Study||27
8403100|NCT00992719|20709988|P3|STARTED|Overall Study||28
8403101|NCT00992719|20709989|P2|STARTED|Overall Study||28
8403102|NCT00992719|20709990|P1|STARTED|Overall Study||28
8403103|NCT00992602|20710024|P1|NOT COMPLETED|Overall Study||3
8403104|NCT00992602|20710024|P1|COMPLETED|Overall Study||0
8403105|NCT00992602|20710024|P1|STARTED|Overall Study||3
8403106|NCT00992589|20710029|P4|NOT COMPLETED|Double-Blind Phase||10
8403107|NCT00992589|20710030|P3|NOT COMPLETED|Double-Blind Phase||13
8403108|NCT00992589|20710031|P2|NOT COMPLETED|Double-Blind Phase||13
8403109|NCT00992589|20710032|P1|NOT COMPLETED|Double-Blind Phase||0
8403110|NCT00992589|20710029|P4|COMPLETED|Double-Blind Phase||78
8403111|NCT00992589|20710030|P3|COMPLETED|Double-Blind Phase||77
8403112|NCT00992589|20710031|P2|COMPLETED|Double-Blind Phase||76
8403113|NCT00992589|20710032|P1|COMPLETED|Double-Blind Phase||0
8403114|NCT00992589|20710029|P4|STARTED|Double-Blind Phase||88
8403115|NCT00992589|20710030|P3|STARTED|Double-Blind Phase||90
8403116|NCT00992589|20710031|P2|STARTED|Double-Blind Phase||89
8403117|NCT00992589|20710032|P1|STARTED|Double-Blind Phase||0
8403118|NCT00992589|20710029|P4|NOT COMPLETED|Open-Label Phase||0
8403119|NCT00992589|20710030|P3|NOT COMPLETED|Open-Label Phase||0
8403120|NCT00992589|20710031|P2|NOT COMPLETED|Open-Label Phase||0
8403121|NCT00992589|20710032|P1|NOT COMPLETED|Open-Label Phase||77
8403122|NCT00992589|20710029|P4|COMPLETED|Open-Label Phase||0
8403123|NCT00992589|20710030|P3|COMPLETED|Open-Label Phase||0
8403124|NCT00992589|20710031|P2|COMPLETED|Open-Label Phase||0
8403125|NCT00992589|20710032|P1|COMPLETED|Open-Label Phase||267
8403126|NCT00992589|20710029|P4|STARTED|Open-Label Phase||0
8403127|NCT00992589|20710030|P3|STARTED|Open-Label Phase||0
8403128|NCT00992589|20710031|P2|STARTED|Open-Label Phase||0
8403129|NCT00992589|20710032|P1|STARTED|Open-Label Phase||344
8403130|NCT00992511|20710078|P4|NOT COMPLETED|Overall Study||5
8403131|NCT00992511|20710079|P3|NOT COMPLETED|Overall Study||2
8403132|NCT00992511|20710080|P2|NOT COMPLETED|Overall Study||0
8403133|NCT00992511|20710081|P1|NOT COMPLETED|Overall Study||2
8403134|NCT00992511|20710078|P4|COMPLETED|Overall Study||70
8403135|NCT00992511|20710079|P3|COMPLETED|Overall Study||74
8403136|NCT00992511|20710080|P2|COMPLETED|Overall Study||73
8403137|NCT00992511|20710081|P1|COMPLETED|Overall Study||74
8403138|NCT00992511|20710078|P4|STARTED|Overall Study||75
8403139|NCT00992511|20710079|P3|STARTED|Overall Study||76
8403140|NCT00992511|20710080|P2|STARTED|Overall Study||73
8403141|NCT00992511|20710081|P1|STARTED|Overall Study||76
8403142|NCT00992459|20710165|P2|NOT COMPLETED|Overall Study||1
8403143|NCT00992459|20710166|P1|NOT COMPLETED|Overall Study||1
8403144|NCT00992459|20710165|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
8403145|NCT00992459|20710166|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
8403146|NCT00992459|20710165|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
8403147|NCT00992459|20710166|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
8403148|NCT00992446|20710190|P1|NOT COMPLETED|Overall Study||8
8403149|NCT00992446|20710190|P1|COMPLETED|Overall Study||19
8403150|NCT00992446|20710190|P1|STARTED|Overall Study||27
8403151|NCT00992433|20710200|P2|NOT COMPLETED|Overall Study||7
8403152|NCT00992433|20710201|P1|NOT COMPLETED|Overall Study||4
8403153|NCT00992433|20710200|P2|COMPLETED|Overall Study||90
8403154|NCT00992433|20710201|P1|COMPLETED|Overall Study||91
8403155|NCT00992433|20710200|P2|STARTED|Overall Study||97
8403156|NCT00992433|20710201|P1|STARTED|Overall Study||95
8403157|NCT00992407|20710265|P2|NOT COMPLETED|Overall Study||24
8403158|NCT00992407|20710266|P1|NOT COMPLETED|Overall Study||31
8403159|NCT00992407|20710265|P2|COMPLETED|Overall Study||14
8403160|NCT00992407|20710266|P1|COMPLETED|Overall Study||6
8403161|NCT00992407|20710265|P2|Treated|Overall Study||25
8403162|NCT00992407|20710266|P1|Treated|Overall Study||20
8403163|NCT00992407|20710265|P2|STARTED|Overall Study||38
8403164|NCT00992407|20710266|P1|STARTED|Overall Study||37
8403165|NCT00992394|20710316|P2|NOT COMPLETED|Overall Study||14
8403166|NCT00992394|20710317|P1|NOT COMPLETED|Overall Study||24
8403167|NCT00992394|20710316|P2|COMPLETED|Overall Study||72
8403168|NCT00992394|20710317|P1|COMPLETED|Overall Study||64
8403169|NCT00992394|20710316|P2|mITT Population|Overall Study||84
8403170|NCT00992394|20710317|P1|mITT Population|Overall Study||86
8403171|NCT00992394|20710316|P2|Safety Population|Overall Study||84
8403172|NCT00992394|20710317|P1|Safety Population|Overall Study||87
8403173|NCT00992394|20710316|P2|STARTED|Overall Study||86
8403174|NCT00992394|20710317|P1|STARTED|Overall Study||88
8403175|NCT00992264|20710375|P16|NOT COMPLETED|Overall Study||0
8403176|NCT00992264|20710376|P15|NOT COMPLETED|Overall Study||0
8403177|NCT00992264|20710377|P14|NOT COMPLETED|Overall Study||0
8403178|NCT00992264|20710378|P13|NOT COMPLETED|Overall Study||0
8403179|NCT00992264|20710379|P12|NOT COMPLETED|Overall Study||0
8403180|NCT00992264|20710380|P11|NOT COMPLETED|Overall Study||0
8403181|NCT00992264|20710381|P10|NOT COMPLETED|Overall Study||0
8403182|NCT00992264|20710382|P9|NOT COMPLETED|Overall Study||0
8403183|NCT00992264|20710383|P8|NOT COMPLETED|Overall Study||0
8403184|NCT00992264|20710384|P7|NOT COMPLETED|Overall Study||0
8403185|NCT00992264|20710385|P6|NOT COMPLETED|Overall Study||0
8403186|NCT00992264|20710386|P5|NOT COMPLETED|Overall Study||0
8403187|NCT00992264|20710387|P4|NOT COMPLETED|Overall Study||0
8403188|NCT00992264|20710388|P3|NOT COMPLETED|Overall Study||0
8403189|NCT00992264|20710389|P2|NOT COMPLETED|Overall Study||0
8403190|NCT00992264|20710390|P1|NOT COMPLETED|Overall Study||0
8403191|NCT00992264|20710375|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403192|NCT00992264|20710376|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403193|NCT00992264|20710377|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403194|NCT00992264|20710378|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403195|NCT00992264|20710379|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403196|NCT00992264|20710380|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403197|NCT00992264|20710381|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403198|NCT00992264|20710382|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403199|NCT00992264|20710383|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403200|NCT00992264|20710384|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403201|NCT00992264|20710385|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403202|NCT00992264|20710386|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403203|NCT00992264|20710387|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403204|NCT00992264|20710388|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403205|NCT00992264|20710389|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403206|NCT00992264|20710390|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403207|NCT00992264|20710375|P16|STARTED|Overall Study||116
8403208|NCT00992264|20710376|P15|STARTED|Overall Study||117
8403209|NCT00992264|20710377|P14|STARTED|Overall Study||117
8403210|NCT00992264|20710378|P13|STARTED|Overall Study||116
8403211|NCT00992264|20710379|P12|STARTED|Overall Study||117
8403212|NCT00992264|20710380|P11|STARTED|Overall Study||117
8403213|NCT00992264|20710381|P10|STARTED|Overall Study||116
8403214|NCT00992264|20710382|P9|STARTED|Overall Study||116
8403215|NCT00992264|20710383|P8|STARTED|Overall Study||117
8403216|NCT00992264|20710384|P7|STARTED|Overall Study||116
8403217|NCT00992264|20710385|P6|STARTED|Overall Study||117
8403218|NCT00992264|20710386|P5|STARTED|Overall Study||117
8403219|NCT00992264|20710387|P4|STARTED|Overall Study||117
8403220|NCT00992264|20710388|P3|STARTED|Overall Study||117
8403221|NCT00992264|20710389|P2|STARTED|Overall Study||116
8403222|NCT00992264|20710390|P1|STARTED|Overall Study||116
8403223|NCT00992225|20710404|P1|NOT COMPLETED|Overall Study||10
8403224|NCT00992225|20710404|P1|COMPLETED|Overall Study||33
8403225|NCT00992225|20710404|P1|Received at Least One Dose of Study Drug|Overall Study||33
8403226|NCT00992225|20710404|P1|STARTED|Overall Study||43
8403227|NCT00992186|20710414|P1|NOT COMPLETED|Overall Study||46
8403228|NCT00992186|20710414|P1|COMPLETED|Overall Study||0
8403229|NCT00992186|20710414|P1|STARTED|Overall Study||46
8403230|NCT00992108|20710433|P2|NOT COMPLETED|Overall Study||1
8403231|NCT00992108|20710434|P1|NOT COMPLETED|Overall Study||0
8403232|NCT00992108|20710433|P2|COMPLETED|Overall Study||9
8403233|NCT00992108|20710434|P1|COMPLETED|Overall Study||7
8403234|NCT00992108|20710433|P2|STARTED|Overall Study||10
8403235|NCT00992108|20710434|P1|STARTED|Overall Study||7
8403236|NCT00992056|20710448|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
8403237|NCT00992056|20710449|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
8403238|NCT00992056|20710448|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
8403239|NCT00992056|20710449|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
8403240|NCT00992056|20710448|P2|STARTED|Treatment Period 2 (6 Weeks)||10
8403241|NCT00992056|20710449|P1|STARTED|Treatment Period 2 (6 Weeks)||10
8403242|NCT00992056|20710448|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8403243|NCT00992056|20710449|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
8403244|NCT00992056|20710448|P2|COMPLETED|Washout Period (2 Weeks)||10
8403245|NCT00992056|20710449|P1|COMPLETED|Washout Period (2 Weeks)||10
8403246|NCT00992056|20710448|P2|STARTED|Washout Period (2 Weeks)||10
8403247|NCT00992056|20710449|P1|STARTED|Washout Period (2 Weeks)||11
8403248|NCT00992056|20710448|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
8403249|NCT00992056|20710449|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
8403250|NCT00992056|20710448|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
8403251|NCT00992056|20710449|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
8403252|NCT00992056|20710448|P2|STARTED|Treatment Period 1 (6 Weeks)||12
8403253|NCT00992056|20710449|P1|STARTED|Treatment Period 1 (6 Weeks)||12
8403254|NCT00992017|20710455|P1|NOT COMPLETED|Overall Study||10
8403255|NCT00992017|20710455|P1|COMPLETED|Overall Study||118
8403256|NCT00992017|20710455|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
8403257|NCT00992017|20710455|P1|Received Both Study Vaccinations|Overall Study||124
8403258|NCT00992017|20710455|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
8403259|NCT00991952|20710470|P2|NOT COMPLETED|Overall Study||1
8403260|NCT00991952|20710471|P1|NOT COMPLETED|Overall Study||0
8403261|NCT00991952|20710470|P2|COMPLETED|Overall Study||5
8403262|NCT00991952|20710471|P1|COMPLETED|Overall Study||13
8403263|NCT00991952|20710470|P2|STARTED|Overall Study||6
8403264|NCT00991952|20710471|P1|STARTED|Overall Study||13
8403265|NCT00991939|20710479|P2|NOT COMPLETED|Overall Study||2
8403266|NCT00991939|20710480|P1|NOT COMPLETED|Overall Study||5
8403267|NCT00991939|20710479|P2|COMPLETED|Overall Study||1
8403268|NCT00991939|20710480|P1|COMPLETED|Overall Study||0
8403269|NCT00991939|20710479|P2|STARTED|Overall Study||3
8403270|NCT00991939|20710480|P1|STARTED|Overall Study||5
8403271|NCT00991887|20710514|P2|NOT COMPLETED|Overall Study||1
8403272|NCT00991887|20710515|P1|NOT COMPLETED|Overall Study||2
8403273|NCT00991887|20710514|P2|COMPLETED|Overall Study||21
8403274|NCT00991887|20710515|P1|COMPLETED|Overall Study||24
8403275|NCT00991887|20710514|P2|STARTED|Overall Study||22
8403276|NCT00991887|20710515|P1|STARTED|Overall Study||26
8403277|NCT00991809|20710523|P2|NOT COMPLETED|Overall Study||6
8403278|NCT00991809|20710524|P1|NOT COMPLETED|Overall Study||4
8403279|NCT00991809|20710523|P2|COMPLETED|Overall Study||4
8403280|NCT00991809|20710524|P1|COMPLETED|Overall Study||8
8403281|NCT00991809|20710523|P2|STARTED|Overall Study||10
8403282|NCT00991809|20710524|P1|STARTED|Overall Study||12
8403283|NCT00991510|20710534|P2|NOT COMPLETED|Period III (Days 29-112)||1
8403284|NCT00991510|20710535|P1|NOT COMPLETED|Period III (Days 29-112)||1
8403285|NCT00991510|20710534|P2|COMPLETED|Period III (Days 29-112)||20
8403286|NCT00991510|20710535|P1|COMPLETED|Period III (Days 29-112)||20
8403287|NCT00991510|20710534|P2|STARTED|Period III (Days 29-112)||21
8403288|NCT00991510|20710535|P1|STARTED|Period III (Days 29-112)||21
8403289|NCT00991510|20710534|P2|NOT COMPLETED|Period II (Days 15-28)||0
8403290|NCT00991510|20710535|P1|NOT COMPLETED|Period II (Days 15-28)||0
8403291|NCT00991510|20710534|P2|COMPLETED|Period II (Days 15-28)||21
8403292|NCT00991510|20710535|P1|COMPLETED|Period II (Days 15-28)||21
8403293|NCT00991510|20710534|P2|STARTED|Period II (Days 15-28)||21
8403294|NCT00991510|20710535|P1|STARTED|Period II (Days 15-28)||21
8403295|NCT00991510|20710534|P2|NOT COMPLETED|Period I (Days 1-14)||0
8403296|NCT00991510|20710535|P1|NOT COMPLETED|Period I (Days 1-14)||1
8403297|NCT00991510|20710534|P2|COMPLETED|Period I (Days 1-14)||21
8403298|NCT00991510|20710535|P1|COMPLETED|Period I (Days 1-14)||21
8403299|NCT00991510|20710534|P2|STARTED|Period I (Days 1-14)||21
8403300|NCT00991510|20710535|P1|STARTED|Period I (Days 1-14)||22
8403301|NCT00991458|20710560|P3|NOT COMPLETED|Overall Study||25
8403302|NCT00991458|20710561|P2|NOT COMPLETED|Overall Study||28
8403303|NCT00991458|20710562|P1|NOT COMPLETED|Overall Study||20
8403304|NCT00991458|20710560|P3|COMPLETED|Overall Study||180
8403305|NCT00991458|20710561|P2|COMPLETED|Overall Study||181
8403306|NCT00991458|20710562|P1|COMPLETED|Overall Study||187
8403307|NCT00991458|20710560|P3|STARTED|Overall Study||205
8403308|NCT00991458|20710561|P2|STARTED|Overall Study||209
8403309|NCT00991458|20710562|P1|STARTED|Overall Study||207
8403310|NCT00991406|20710579|P1|NOT COMPLETED|Overall Study||1
8403311|NCT00991406|20710579|P1|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
8403312|NCT00991406|20710579|P1|STARTED|Overall Study||9
8403313|NCT00991341|20710588|P2|NOT COMPLETED|Overall Study||179
8403314|NCT00991341|20710589|P1|NOT COMPLETED|Overall Study||204
8403315|NCT00991341|20710588|P2|COMPLETED|Overall Study||560
8403316|NCT00991341|20710589|P1|COMPLETED|Overall Study||538
8403317|NCT00991341|20710588|P2|STARTED|Overall Study||739
8403318|NCT00991341|20710589|P1|STARTED|Overall Study||742
8403319|NCT00991302|20710627|P2|NOT COMPLETED|Overall Study||13
8403320|NCT00991302|20710628|P1|NOT COMPLETED|Overall Study||14
8403321|NCT00991302|20710627|P2|COMPLETED|Overall Study||73
8403322|NCT00991302|20710628|P1|COMPLETED|Overall Study||72
8403323|NCT00991302|20710627|P2|STARTED|Overall Study||86
8403324|NCT00991302|20710628|P1|STARTED|Overall Study||86
8403325|NCT00991289|20710644|P1|NOT COMPLETED|Overall Study||12
8403326|NCT00991289|20710644|P1|COMPLETED|Overall Study|Completed study.|55
8403327|NCT00991289|20710644|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
8403328|NCT00991289|20710644|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
8403419|NCT00991185|20710767|P1|NOT COMPLETED|Overall Study||0
8403420|NCT00991185|20710767|P1|COMPLETED|Overall Study||8
8403421|NCT00991185|20710767|P1|STARTED|Overall Study||8
8403422|NCT00991081|20710773|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
8403423|NCT00991081|20710774|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
8403424|NCT00991081|20710775|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
8403425|NCT00991081|20710773|P3|COMPLETED|Phase II, Randomized Control Trial||15
8403426|NCT00991081|20710774|P2|COMPLETED|Phase II, Randomized Control Trial||15
8403427|NCT00991081|20710775|P1|COMPLETED|Phase II, Randomized Control Trial||0
8403428|NCT00991081|20710773|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
8403429|NCT00991081|20710774|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
8403430|NCT00991081|20710775|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
8403431|NCT00991081|20710773|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
8403432|NCT00991081|20710774|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
8403433|NCT00991081|20710775|P1|STARTED|Phase II, Randomized Control Trial||0
8403434|NCT00991081|20710773|P3|NOT COMPLETED|Phase I, Formative Research||0
8403435|NCT00991081|20710774|P2|NOT COMPLETED|Phase I, Formative Research||0
8403436|NCT00991081|20710775|P1|NOT COMPLETED|Phase I, Formative Research||0
8403437|NCT00991081|20710773|P3|COMPLETED|Phase I, Formative Research||0
8403438|NCT00991081|20710774|P2|COMPLETED|Phase I, Formative Research||0
8403439|NCT00991081|20710775|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
8403440|NCT00991081|20710773|P3|STARTED|Phase I, Formative Research||0
8403441|NCT00991081|20710774|P2|STARTED|Phase I, Formative Research||0
8403442|NCT00991081|20710775|P1|STARTED|Phase I, Formative Research||20
8403443|NCT00991029|20710809|P2|NOT COMPLETED|Overall Study||168
8403444|NCT00991029|20710810|P1|NOT COMPLETED|Overall Study||156
8403445|NCT00991029|20710809|P2|COMPLETED|Overall Study||2281
8403446|NCT00991029|20710810|P1|COMPLETED|Overall Study||2276
8403447|NCT00991029|20710809|P2|STARTED|Overall Study||2449
8403448|NCT00991029|20710810|P1|STARTED|Overall Study||2432
8403449|NCT00990964|20710840|P1|NOT COMPLETED|Overall Study||212
8403450|NCT00990964|20710840|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
8403451|NCT00990964|20710840|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
8403452|NCT00990964|20710840|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
8403453|NCT00990938|20710851|P6|NOT COMPLETED|Overall Study||0
8403454|NCT00990938|20710852|P5|NOT COMPLETED|Overall Study||0
8403455|NCT00990938|20710853|P4|NOT COMPLETED|Overall Study||0
8403456|NCT00990938|20710854|P3|NOT COMPLETED|Overall Study||0
8403457|NCT00990938|20710855|P2|NOT COMPLETED|Overall Study||0
8403458|NCT00990938|20710856|P1|NOT COMPLETED|Overall Study||0
8403459|NCT00990938|20710851|P6|COMPLETED|Overall Study||12
8403460|NCT00990938|20710852|P5|COMPLETED|Overall Study||12
8403461|NCT00990938|20710853|P4|COMPLETED|Overall Study||12
8403462|NCT00990938|20710854|P3|COMPLETED|Overall Study||12
8403463|NCT00990938|20710855|P2|COMPLETED|Overall Study||12
8403464|NCT00990938|20710856|P1|COMPLETED|Overall Study||3
8403465|NCT00990938|20710851|P6|STARTED|Overall Study||12
8403466|NCT00990938|20710852|P5|STARTED|Overall Study||12
8403467|NCT00990938|20710853|P4|STARTED|Overall Study||12
8403468|NCT00990938|20710854|P3|STARTED|Overall Study||12
8403469|NCT00990938|20710855|P2|STARTED|Overall Study||12
8403470|NCT00990938|20710856|P1|STARTED|Overall Study||3
8403471|NCT00990821|20710884|P14|NOT COMPLETED|Overall Study||1
8403472|NCT00990821|20710885|P13|NOT COMPLETED|Overall Study||2
8403473|NCT00990821|20710886|P12|NOT COMPLETED|Overall Study||5
8403474|NCT00990821|20710887|P11|NOT COMPLETED|Overall Study||3
8403475|NCT00990821|20710888|P10|NOT COMPLETED|Overall Study||1
8403476|NCT00990821|20710889|P9|NOT COMPLETED|Overall Study||0
8403477|NCT00990821|20710890|P8|NOT COMPLETED|Overall Study||0
8403478|NCT00990821|20710891|P7|NOT COMPLETED|Overall Study||1
8403479|NCT00990821|20710892|P6|NOT COMPLETED|Overall Study||3
8403480|NCT00990821|20710893|P5|NOT COMPLETED|Overall Study||3
8403481|NCT00990821|20710894|P4|NOT COMPLETED|Overall Study||0
8403482|NCT00990821|20710895|P3|NOT COMPLETED|Overall Study||0
8403483|NCT00990821|20710896|P2|NOT COMPLETED|Overall Study||2
8403484|NCT00990821|20710897|P1|NOT COMPLETED|Overall Study||0
8403485|NCT00990821|20710884|P14|COMPLETED|Overall Study||11
8403486|NCT00990821|20710885|P13|COMPLETED|Overall Study||10
8403487|NCT00990821|20710886|P12|COMPLETED|Overall Study||9
8403488|NCT00990821|20710887|P11|COMPLETED|Overall Study||9
8403489|NCT00990821|20710888|P10|COMPLETED|Overall Study||13
8403490|NCT00990821|20710889|P9|COMPLETED|Overall Study||12
8403491|NCT00990821|20710890|P8|COMPLETED|Overall Study||14
8403492|NCT00990821|20710891|P7|COMPLETED|Overall Study||11
8403493|NCT00990821|20710892|P6|COMPLETED|Overall Study||14
8403494|NCT00990821|20710893|P5|COMPLETED|Overall Study||14
8403495|NCT00990821|20710894|P4|COMPLETED|Overall Study||8
8403496|NCT00990821|20710895|P3|COMPLETED|Overall Study||14
8403497|NCT00990821|20710896|P2|COMPLETED|Overall Study||14
8403498|NCT00990821|20710897|P1|COMPLETED|Overall Study||14
8403499|NCT00990821|20710884|P14|STARTED|Overall Study||12
8403500|NCT00990821|20710885|P13|STARTED|Overall Study||12
8403501|NCT00990821|20710886|P12|STARTED|Overall Study||14
8403502|NCT00990821|20710887|P11|STARTED|Overall Study||12
8403503|NCT00990821|20710888|P10|STARTED|Overall Study||14
8403504|NCT00990821|20710889|P9|STARTED|Overall Study||12
8403505|NCT00990821|20710890|P8|STARTED|Overall Study||14
8403506|NCT00990821|20710891|P7|STARTED|Overall Study||12
8403507|NCT00990821|20710892|P6|STARTED|Overall Study||17
8403508|NCT00990821|20710893|P5|STARTED|Overall Study||17
8403509|NCT00990821|20710894|P4|STARTED|Overall Study||8
8403510|NCT00990821|20710895|P3|STARTED|Overall Study||14
8403511|NCT00990821|20710896|P2|STARTED|Overall Study||16
8403512|NCT00990821|20710897|P1|STARTED|Overall Study||14
8403513|NCT00990782|20710914|P1|NOT COMPLETED|Overall Study||5
8403514|NCT00990782|20710914|P1|COMPLETED|Overall Study||88
8403515|NCT00990782|20710914|P1|STARTED|Overall Study||93
8403516|NCT00990769|20710921|P2|NOT COMPLETED|Overall Study||0
8403517|NCT00990769|20710922|P1|NOT COMPLETED|Overall Study||0
8403518|NCT00990769|20710921|P2|COMPLETED|Overall Study||18
8403519|NCT00990769|20710922|P1|COMPLETED|Overall Study||22
8403520|NCT00990769|20710921|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
8403521|NCT00990769|20710922|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
8403522|NCT00990704|20710934|P2|NOT COMPLETED|Overall Study||2
8403523|NCT00990704|20710935|P1|NOT COMPLETED|Overall Study||1
8403524|NCT00990704|20710934|P2|COMPLETED|Overall Study||31
8403525|NCT00990704|20710935|P1|COMPLETED|Overall Study||13
8403526|NCT00990704|20710934|P2|STARTED|Overall Study||33
8403527|NCT00990704|20710935|P1|STARTED|Overall Study||14
8403528|NCT00990665|20710955|P1|NOT COMPLETED|Overall Study||48
8403529|NCT00990665|20710955|P1|COMPLETED|Overall Study||130
8403530|NCT00990665|20710955|P1|STARTED|Overall Study||178
8403531|NCT00990652|20710962|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
8403532|NCT00990652|20710962|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
8403533|NCT00990652|20710962|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
8403534|NCT00990652|20710962|P1|NOT COMPLETED|Surgical Resection||0
8403535|NCT00990652|20710962|P1|COMPLETED|Surgical Resection||9
8403536|NCT00990652|20710962|P1|STARTED|Surgical Resection||9
8403537|NCT00990652|20710962|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
8403538|NCT00990652|20710962|P1|COMPLETED|Pre-surgical Bortezomib||9
8403539|NCT00990652|20710962|P1|STARTED|Pre-surgical Bortezomib||10
8403540|NCT00990561|20710972|P4|NOT COMPLETED|Period 2||2
8403541|NCT00990561|20710973|P3|NOT COMPLETED|Period 2||0
8403542|NCT00990561|20710974|P2|NOT COMPLETED|Period 2||0
8403543|NCT00990561|20710975|P1|NOT COMPLETED|Period 2||0
8403544|NCT00990561|20710972|P4|COMPLETED|Period 2||17
8403545|NCT00990561|20710973|P3|COMPLETED|Period 2||20
8403546|NCT00990561|20710974|P2|COMPLETED|Period 2||0
8403547|NCT00990561|20710975|P1|COMPLETED|Period 2||0
8403548|NCT00990561|20710972|P4|STARTED|Period 2||19
8403549|NCT00990561|20710973|P3|STARTED|Period 2||20
8403550|NCT00990561|20710974|P2|STARTED|Period 2||0
8403551|NCT00990561|20710975|P1|STARTED|Period 2||0
8403552|NCT00990561|20710972|P4|NOT COMPLETED|Period 1||0
8403553|NCT00990561|20710973|P3|NOT COMPLETED|Period 1||0
8403554|NCT00990561|20710974|P2|NOT COMPLETED|Period 1||1
8403555|NCT00990561|20710975|P1|NOT COMPLETED|Period 1||0
8403556|NCT00990561|20710972|P4|COMPLETED|Period 1||0
8403557|NCT00990561|20710973|P3|COMPLETED|Period 1||0
8403558|NCT00990561|20710974|P2|COMPLETED|Period 1||19
8403559|NCT00990561|20710975|P1|COMPLETED|Period 1||20
8403560|NCT00990561|20710972|P4|STARTED|Period 1||0
8403561|NCT00990561|20710973|P3|STARTED|Period 1||0
8403562|NCT00990561|20710974|P2|STARTED|Period 1||20
8403563|NCT00990561|20710975|P1|STARTED|Period 1||20
8403564|NCT00990509|20710983|P2|NOT COMPLETED|Overall Study||1
8403565|NCT00990509|20710984|P1|NOT COMPLETED|Overall Study||0
8403566|NCT00990509|20710983|P2|COMPLETED|Overall Study||8
8403567|NCT00990509|20710984|P1|COMPLETED|Overall Study||5
8403568|NCT00990509|20710983|P2|STARTED|Overall Study||9
8403569|NCT00990509|20710984|P1|STARTED|Overall Study||5
8403570|NCT00990340|20710996|P2|NOT COMPLETED|Second 14-day Treatment||0
8403571|NCT00990340|20710997|P1|NOT COMPLETED|Second 14-day Treatment||0
8403572|NCT00990340|20710996|P2|COMPLETED|Second 14-day Treatment||21
8403573|NCT00990340|20710997|P1|COMPLETED|Second 14-day Treatment||21
8403574|NCT00990340|20710996|P2|STARTED|Second 14-day Treatment||21
8403575|NCT00990340|20710997|P1|STARTED|Second 14-day Treatment||21
8403576|NCT00990340|20710996|P2|NOT COMPLETED|First 14-day Treatment||4
8403577|NCT00990340|20710997|P1|NOT COMPLETED|First 14-day Treatment||6
8403578|NCT00990340|20710996|P2|COMPLETED|First 14-day Treatment||21
8403579|NCT00990340|20710997|P1|COMPLETED|First 14-day Treatment||21
8403580|NCT00990340|20710996|P2|STARTED|First 14-day Treatment||25
8403581|NCT00990340|20710997|P1|STARTED|First 14-day Treatment||27
8403582|NCT00990314|20711011|P1|NOT COMPLETED|Overall Study||12
8403583|NCT00990314|20711011|P1|COMPLETED|Overall Study||19
8403584|NCT00990314|20711011|P1|STARTED|Overall Study||31
8403585|NCT00990288|20711022|P2|NOT COMPLETED|Overall Study||0
8403586|NCT00990288|20711023|P1|NOT COMPLETED|Overall Study||0
8403587|NCT00990288|20711022|P2|COMPLETED|Overall Study||99
8403588|NCT00990288|20711023|P1|COMPLETED|Overall Study||97
8403589|NCT00990288|20711022|P2|STARTED|Overall Study||99
8403590|NCT00990288|20711023|P1|STARTED|Overall Study||97
8403591|NCT00990249|20711053|P1|NOT COMPLETED|Overall Study||13
8403592|NCT00990249|20711053|P1|COMPLETED|Overall Study||107
8403593|NCT00990249|20711053|P1|STARTED|Overall Study||120
8403594|NCT00990236|20711059|P2|NOT COMPLETED|Overall Study||0
8403595|NCT00990236|20711060|P1|NOT COMPLETED|Overall Study||0
8403596|NCT00990236|20711059|P2|COMPLETED|Overall Study||96
8403597|NCT00990236|20711060|P1|COMPLETED|Overall Study||89
8403598|NCT00990236|20711059|P2|STARTED|Overall Study||96
8403599|NCT00990236|20711060|P1|STARTED|Overall Study||89
8403600|NCT00990184|20711068|P1|NOT COMPLETED|Overall Study||1
8403601|NCT00990184|20711068|P1|COMPLETED|Overall Study||20
8403602|NCT00990184|20711068|P1|STARTED|Overall Study||21
8403603|NCT00990106|20711076|P2|NOT COMPLETED|Overall Study||12
8403604|NCT00990106|20711077|P1|NOT COMPLETED|Overall Study||9
8403605|NCT00990106|20711076|P2|COMPLETED|Overall Study||23
8403606|NCT00990106|20711077|P1|COMPLETED|Overall Study||23
8403607|NCT00990106|20711076|P2|STARTED|Overall Study||35
8403608|NCT00990106|20711077|P1|STARTED|Overall Study||32
8403609|NCT00990093|20711087|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
8403610|NCT00990093|20711088|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
8403611|NCT00990093|20711087|P2|COMPLETED|Test Period 2 (15-28 Days)||14
8403612|NCT00990093|20711088|P1|COMPLETED|Test Period 2 (15-28 Days)||13
8403613|NCT00990093|20711087|P2|STARTED|Test Period 2 (15-28 Days)||15
8403614|NCT00990093|20711088|P1|STARTED|Test Period 2 (15-28 Days)||15
8403615|NCT00990093|20711087|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
8403616|NCT00990093|20711088|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
8403617|NCT00990093|20711087|P2|COMPLETED|Test Period 1 (1-14 Days)||15
8403618|NCT00990093|20711088|P1|COMPLETED|Test Period 1 (1-14 Days)||15
8403619|NCT00990093|20711087|P2|STARTED|Test Period 1 (1-14 Days)||17
8403620|NCT00990093|20711088|P1|STARTED|Test Period 1 (1-14 Days)||19
8403621|NCT00989989|20711097|P3|NOT COMPLETED|Overall Study||23
8403622|NCT00989989|20711098|P2|NOT COMPLETED|Overall Study||10
8403623|NCT00989989|20711099|P1|NOT COMPLETED|Overall Study||18
8403624|NCT00989989|20711097|P3|COMPLETED|Overall Study||108
8403625|NCT00989989|20711098|P2|COMPLETED|Overall Study||123
8403626|NCT00989989|20711099|P1|COMPLETED|Overall Study||114
8403627|NCT00989989|20711097|P3|STARTED|Overall Study||131
8403628|NCT00989989|20711098|P2|STARTED|Overall Study||133
8403629|NCT00989989|20711099|P1|STARTED|Overall Study||132
8403630|NCT00989963|20711140|P3|NOT COMPLETED|Overall Study||1
8403631|NCT00989963|20711141|P2|NOT COMPLETED|Overall Study||1
8403632|NCT00989963|20711142|P1|NOT COMPLETED|Overall Study||1
8403633|NCT00989963|20711140|P3|COMPLETED|Overall Study||11
8403634|NCT00989963|20711141|P2|COMPLETED|Overall Study||11
8403635|NCT00989963|20711142|P1|COMPLETED|Overall Study||11
8403636|NCT00989963|20711140|P3|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
8403637|NCT00989963|20711141|P2|Per-Protocol Population|Overall Study||11
8403638|NCT00989963|20711142|P1|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
8403639|NCT00989963|20711140|P3|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
8403640|NCT00989963|20711141|P2|Safety Population|Overall Study||12
8403641|NCT00989963|20711142|P1|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
8403642|NCT00989963|20711140|P3|STARTED|Overall Study||12
8403643|NCT00989963|20711141|P2|STARTED|Overall Study||12
8403644|NCT00989963|20711142|P1|STARTED|Overall Study||12
8403645|NCT00989950|20711178|P4|NOT COMPLETED|Randomized Phase||0
8403646|NCT00989950|20711179|P3|NOT COMPLETED|Randomized Phase||0
8403647|NCT00989950|20711180|P2|NOT COMPLETED|Randomized Phase||1
8403648|NCT00989950|20711181|P1|NOT COMPLETED|Randomized Phase||1
8403649|NCT00989950|20711178|P4|COMPLETED|Randomized Phase||7
8403650|NCT00989950|20711179|P3|COMPLETED|Randomized Phase||4
8403651|NCT00989950|20711180|P2|COMPLETED|Randomized Phase||8
8403652|NCT00989950|20711181|P1|COMPLETED|Randomized Phase||5
8403653|NCT00989950|20711178|P4|STARTED|Randomized Phase||7
8403654|NCT00989950|20711179|P3|STARTED|Randomized Phase||4
8403655|NCT00989950|20711180|P2|STARTED|Randomized Phase||9
8403656|NCT00989950|20711181|P1|STARTED|Randomized Phase||6
8403657|NCT00989950|20711178|P4|NOT COMPLETED|Open Label Dose Optimization||0
8403658|NCT00989950|20711179|P3|NOT COMPLETED|Open Label Dose Optimization||0
8403659|NCT00989950|20711180|P2|NOT COMPLETED|Open Label Dose Optimization||0
8403660|NCT00989950|20711181|P1|NOT COMPLETED|Open Label Dose Optimization||0
8403661|NCT00989950|20711178|P4|COMPLETED|Open Label Dose Optimization||7
8403662|NCT00989950|20711179|P3|COMPLETED|Open Label Dose Optimization||4
8403663|NCT00989950|20711180|P2|COMPLETED|Open Label Dose Optimization||9
8403664|NCT00989950|20711181|P1|COMPLETED|Open Label Dose Optimization||6
8403665|NCT00989950|20711178|P4|STARTED|Open Label Dose Optimization||7
8403666|NCT00989950|20711179|P3|STARTED|Open Label Dose Optimization||4
8403667|NCT00989950|20711180|P2|STARTED|Open Label Dose Optimization||9
8403668|NCT00989950|20711181|P1|STARTED|Open Label Dose Optimization||6
8403669|NCT00989937|20711191|P1|NOT COMPLETED|Overall Study||0
8403670|NCT00989937|20711191|P1|COMPLETED|Overall Study||0
8403671|NCT00989937|20711191|P1|STARTED|Overall Study||0
8403672|NCT00989911|20711206|P1|NOT COMPLETED|Overall Study||3
8403673|NCT00989911|20711206|P1|COMPLETED|Overall Study||7
8403674|NCT00989911|20711206|P1|STARTED|Overall Study||10
8403675|NCT00989833|20711213|P3|NOT COMPLETED|Overall Study||2
8403676|NCT00989833|20711214|P2|NOT COMPLETED|Overall Study||3
8403677|NCT00989833|20711215|P1|NOT COMPLETED|Overall Study||2
8403678|NCT00989833|20711213|P3|COMPLETED|Overall Study||21
8403679|NCT00989833|20711214|P2|COMPLETED|Overall Study||19
8403680|NCT00989833|20711215|P1|COMPLETED|Overall Study||19
8403681|NCT00989833|20711213|P3|STARTED|Overall Study||23
8403682|NCT00989833|20711214|P2|STARTED|Overall Study||22
8403683|NCT00989833|20711215|P1|STARTED|Overall Study||21
8403684|NCT00989781|20711246|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
8403685|NCT00989781|20711247|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
8403686|NCT00989781|20711246|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
8403687|NCT00989781|20711247|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
8403688|NCT00989781|20711246|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
8403689|NCT00989781|20711247|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
8403690|NCT00989781|20711246|P2|NOT COMPLETED|Ovarian Response to hCG||2
8403691|NCT00989781|20711247|P1|NOT COMPLETED|Ovarian Response to hCG||3
8403692|NCT00989781|20711246|P2|COMPLETED|Ovarian Response to hCG||18
8403693|NCT00989781|20711247|P1|COMPLETED|Ovarian Response to hCG||18
8403694|NCT00989781|20711246|P2|STARTED|Ovarian Response to hCG||20
8403695|NCT00989781|20711247|P1|STARTED|Ovarian Response to hCG||21
8403696|NCT00989768|20711266|P1|NOT COMPLETED|Overall Study||1
8403697|NCT00989768|20711266|P1|COMPLETED|Overall Study||28
8403698|NCT00989768|20711266|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
8403699|NCT00989664|20711277|P1|NOT COMPLETED|Long-Term Follow-Up||3
8403700|NCT00989664|20711277|P1|COMPLETED|Long-Term Follow-Up||11
8403701|NCT00989664|20711277|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
8403702|NCT00989664|20711277|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
8403703|NCT00989664|20711277|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8403704|NCT00989664|20711277|P1|STARTED|Dosimetric and Therapeutic Treatment||61
8403705|NCT00989612|20711305|P1|NOT COMPLETED|Overall Study||0
8403706|NCT00989612|20711305|P1|COMPLETED|Overall Study||100
8403707|NCT00989612|20711305|P1|STARTED|Overall Study||100
8403708|NCT00989586|20711346|P2|NOT COMPLETED|Overall Study||0
8403709|NCT00989586|20711347|P1|NOT COMPLETED|Overall Study||0
8403710|NCT00989586|20711346|P2|COMPLETED|Overall Study||17
8403711|NCT00989586|20711347|P1|COMPLETED|Overall Study||18
8403712|NCT00989586|20711346|P2|STARTED|Overall Study||17
8403713|NCT00989586|20711347|P1|STARTED|Overall Study||18
8403714|NCT00989287|20711362|P2|NOT COMPLETED|Overall Study||1
8403715|NCT00989287|20711363|P1|NOT COMPLETED|Overall Study||1
8403716|NCT00989287|20711362|P2|COMPLETED|Overall Study||65
8403717|NCT00989287|20711363|P1|COMPLETED|Overall Study||64
8403718|NCT00989287|20711362|P2|STARTED|Overall Study||66
8403719|NCT00989287|20711363|P1|STARTED|Overall Study||65
8403720|NCT00989261|20711465|P2|NOT COMPLETED|Overall Study||22
8403721|NCT00989261|20711466|P1|NOT COMPLETED|Overall Study||15
8403722|NCT00989261|20711465|P2|COMPLETED|Overall Study||154
8403723|NCT00989261|20711466|P1|COMPLETED|Overall Study||142
8403724|NCT00989261|20711465|P2|STARTED|Overall Study||176
8403725|NCT00989261|20711466|P1|STARTED|Overall Study||157
8403726|NCT00989235|20711496|P2|NOT COMPLETED|Overall Study||6
8403727|NCT00989235|20711497|P1|NOT COMPLETED|Overall Study||3
8403728|NCT00989235|20711496|P2|COMPLETED|Overall Study||44
8403729|NCT00989235|20711497|P1|COMPLETED|Overall Study||55
8403730|NCT00989235|20711496|P2|Number Completing Double-Blind Treatment|Overall Study||41
8403731|NCT00989235|20711497|P1|Number Completing Double-Blind Treatment|Overall Study||51
8403732|NCT00989235|20711496|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
8403733|NCT00989235|20711497|P1|Number Rescued to Open-Label Treatment|Overall Study||4
8403734|NCT00989235|20711496|P2|STARTED|Overall Study||50
8403735|NCT00989235|20711497|P1|STARTED|Overall Study||58
8403736|NCT00989196|20711542|P2|NOT COMPLETED|Treatment Period||0
8403737|NCT00989196|20711543|P1|NOT COMPLETED|Treatment Period||1
8403738|NCT00989196|20711542|P2|COMPLETED|Treatment Period||12
8403739|NCT00989196|20711543|P1|COMPLETED|Treatment Period||9
8403740|NCT00989196|20711542|P2|STARTED|Treatment Period||12
8403741|NCT00989196|20711543|P1|STARTED|Treatment Period||10
8403742|NCT00989196|20711542|P2|NOT COMPLETED|PK Crossover Period||0
8403743|NCT00989196|20711543|P1|NOT COMPLETED|PK Crossover Period||0
8403744|NCT00989196|20711542|P2|COMPLETED|PK Crossover Period||12
8403745|NCT00989196|20711543|P1|COMPLETED|PK Crossover Period||10
8403746|NCT00989196|20711542|P2|STARTED|PK Crossover Period||12
8403747|NCT00989196|20711543|P1|STARTED|PK Crossover Period||10
8403748|NCT00989157|20711564|P2|NOT COMPLETED|Overall Study||0
8403749|NCT00989157|20711565|P1|NOT COMPLETED|Overall Study||0
8403750|NCT00989157|20711564|P2|COMPLETED|Overall Study||10
8403751|NCT00989157|20711565|P1|COMPLETED|Overall Study||10
8403752|NCT00989157|20711564|P2|STARTED|Overall Study||10
8403753|NCT00989157|20711565|P1|STARTED|Overall Study||10
8403754|NCT00989092|20711581|P2|NOT COMPLETED|Overall Study||28
8403755|NCT00989092|20711582|P1|NOT COMPLETED|Overall Study||90
8403756|NCT00989092|20711581|P2|COMPLETED|Overall Study||31
8403757|NCT00989092|20711582|P1|COMPLETED|Overall Study||138
8403758|NCT00989092|20711581|P2|Treated With Darbepoetin Alfa|Overall Study||33
8403759|NCT00989092|20711582|P1|Treated With Darbepoetin Alfa|Overall Study||226
8403760|NCT00989092|20711581|P2|STARTED|Overall Study||59
8403761|NCT00989092|20711582|P1|STARTED|Overall Study||228
8403774|NCT00988884|20711634|P2|NOT COMPLETED|Overall Study||36
8403775|NCT00988884|20711635|P1|NOT COMPLETED|Overall Study||35
8403776|NCT00988884|20711634|P2|COMPLETED|Overall Study||584
8403777|NCT00988884|20711635|P1|COMPLETED|Overall Study||586
8403778|NCT00988884|20711634|P2|STARTED|Overall Study||620
8403779|NCT00988884|20711635|P1|STARTED|Overall Study||621
8403780|NCT00988858|20711657|P1|NOT COMPLETED|Overall Study||10
8403781|NCT00988858|20711657|P1|COMPLETED|Overall Study||45
8403782|NCT00988858|20711657|P1|STARTED|Overall Study||55
8403783|NCT00988832|20711669|P1|NOT COMPLETED|Overall Study||0
8403784|NCT00988832|20711669|P1|COMPLETED|Overall Study||380
8403785|NCT00988832|20711669|P1|STARTED|Overall Study||380
8403786|NCT00988637|20711706|P2|NOT COMPLETED|Overall Study||3
8403787|NCT00988637|20711707|P1|NOT COMPLETED|Overall Study||3
8403788|NCT00988637|20711706|P2|COMPLETED|Overall Study||65
8403789|NCT00988637|20711707|P1|COMPLETED|Overall Study||67
8403790|NCT00988637|20711706|P2|STARTED|Overall Study||68
8403791|NCT00988637|20711707|P1|STARTED|Overall Study||70
8403792|NCT00988598|20711739|P2|NOT COMPLETED|Overall Study||0
8403793|NCT00988598|20711740|P1|NOT COMPLETED|Overall Study||2
8403794|NCT00988598|20711739|P2|COMPLETED|Overall Study||5
8403795|NCT00988598|20711740|P1|COMPLETED|Overall Study||8
8403796|NCT00988598|20711739|P2|STARTED|Overall Study||5
8403797|NCT00988598|20711740|P1|STARTED|Overall Study||10
8403798|NCT00988559|20711768|P4|NOT COMPLETED|Overall Study||1
8403799|NCT00988559|20711769|P3|NOT COMPLETED|Overall Study||2
8403800|NCT00988559|20711770|P2|NOT COMPLETED|Overall Study||2
8403801|NCT00988559|20711771|P1|NOT COMPLETED|Overall Study||1
8403802|NCT00988559|20711768|P4|COMPLETED|Overall Study||6
8403803|NCT00988559|20711769|P3|COMPLETED|Overall Study||9
8403804|NCT00988559|20711770|P2|COMPLETED|Overall Study||9
8403805|NCT00988559|20711771|P1|COMPLETED|Overall Study||9
8403806|NCT00988559|20711768|P4|STARTED|Overall Study||7
8403807|NCT00988559|20711769|P3|STARTED|Overall Study||11
8403808|NCT00988559|20711770|P2|STARTED|Overall Study||11
8403809|NCT00988559|20711771|P1|STARTED|Overall Study||10
8403810|NCT00988533|20711785|P1|NOT COMPLETED|Overall Study||3
8403811|NCT00988533|20711785|P1|COMPLETED|Overall Study||27
8403812|NCT00988533|20711785|P1|STARTED|Overall Study||30
8403813|NCT00988442|20711799|P2|NOT COMPLETED|Overall Study||28
8403814|NCT00988442|20711800|P1|NOT COMPLETED|Overall Study||30
8403815|NCT00988442|20711799|P2|COMPLETED|Overall Study||1
8403816|NCT00988442|20711800|P1|COMPLETED|Overall Study||0
8403817|NCT00988442|20711799|P2|STARTED|Overall Study||29
8403818|NCT00988442|20711800|P1|STARTED|Overall Study||30
8403819|NCT00988429|20711863|P3|NOT COMPLETED|Overall Study||69
8403820|NCT00988429|20711864|P2|NOT COMPLETED|Overall Study||43
8403821|NCT00988429|20711865|P1|NOT COMPLETED|Overall Study||37
8403822|NCT00988429|20711863|P3|COMPLETED|Overall Study||142
8403823|NCT00988429|20711864|P2|COMPLETED|Overall Study||173
8403824|NCT00988429|20711865|P1|COMPLETED|Overall Study||189
8403825|NCT00988429|20711863|P3|Intention-to-treat (ITT) Population|Overall Study||205
8403826|NCT00988429|20711864|P2|Intention-to-treat (ITT) Population|Overall Study||215
8403827|NCT00988429|20711865|P1|Intention-to-treat (ITT) Population|Overall Study||220
8403828|NCT00988429|20711863|P3|Safety Population|Overall Study||210
8403829|NCT00988429|20711864|P2|Safety Population|Overall Study||216
8403830|NCT00988429|20711865|P1|Safety Population|Overall Study||224
8403831|NCT00988429|20711863|P3|STARTED|Overall Study||211
8403832|NCT00988429|20711864|P2|STARTED|Overall Study||216
8403833|NCT00988429|20711865|P1|STARTED|Overall Study||226
8403834|NCT00988351|20711878|P2|NOT COMPLETED|Overall Study||12
8403835|NCT00988351|20711879|P1|NOT COMPLETED|Overall Study||19
8403836|NCT00988351|20711878|P2|COMPLETED|Overall Study||66
8403837|NCT00988351|20711879|P1|COMPLETED|Overall Study||59
8403838|NCT00988351|20711878|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
8403839|NCT00988351|20711879|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
8403840|NCT00988351|20711878|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
8403841|NCT00988351|20711879|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
8403842|NCT00988351|20711878|P2|PAP Setup|Overall Study|APAP treatment started|78
8403843|NCT00988351|20711879|P1|PAP Setup|Overall Study|CPAP treatment started|70
8403844|NCT00988351|20711878|P2|CPAP Titration|Overall Study|no titration needed|78
8403845|NCT00988351|20711879|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
8403846|NCT00988351|20711878|P2|STARTED|Overall Study||78
8403847|NCT00988351|20711879|P1|STARTED|Overall Study||78
8403848|NCT00988325|20711896|P3|NOT COMPLETED|Overall Study||0
8403849|NCT00988325|20711897|P2|NOT COMPLETED|Overall Study||0
8403850|NCT00988325|20711898|P1|NOT COMPLETED|Overall Study||0
8403851|NCT00988325|20711896|P3|COMPLETED|Overall Study||5
8403852|NCT00988325|20711897|P2|COMPLETED|Overall Study||20
8403853|NCT00988325|20711898|P1|COMPLETED|Overall Study||40
8403854|NCT00988325|20711896|P3|STARTED|Overall Study||5
8403855|NCT00988325|20711897|P2|STARTED|Overall Study||20
8403856|NCT00988325|20711898|P1|STARTED|Overall Study||40
8403857|NCT00988247|20711956|P2|NOT COMPLETED|Overall Study||26
8403858|NCT00988247|20711957|P1|NOT COMPLETED|Overall Study||83
8403859|NCT00988247|20711956|P2|COMPLETED|Overall Study||85
8403860|NCT00988247|20711957|P1|COMPLETED|Overall Study||335
8403861|NCT00988247|20711956|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
8403947|NCT00988091|20712232|P2|NOT COMPLETED|Double-blind Period||47
8403862|NCT00988247|20711957|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
8403863|NCT00988247|20711956|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
8403864|NCT00988247|20711957|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
8403865|NCT00988247|20711956|P2|STARTED|Overall Study||111
8403866|NCT00988247|20711957|P1|STARTED|Overall Study||418
8403867|NCT00988221|20711976|P4|NOT COMPLETED|Part III||0
8403868|NCT00988221|20711977|P3|NOT COMPLETED|Part III||3
8403869|NCT00988221|20711978|P2|NOT COMPLETED|Part III||1
8403870|NCT00988221|20711979|P1|NOT COMPLETED|Part III||1
8403871|NCT00988221|20711976|P4|COMPLETED|Part III||0
8403872|NCT00988221|20711977|P3|COMPLETED|Part III||103
8403873|NCT00988221|20711978|P2|COMPLETED|Part III||23
8403874|NCT00988221|20711979|P1|COMPLETED|Part III||29
8403875|NCT00988221|20711976|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
8403876|NCT00988221|20711977|P3|STARTED|Part III||106
8403877|NCT00988221|20711978|P2|STARTED|Part III||24
8403878|NCT00988221|20711979|P1|STARTED|Part III||30
8403879|NCT00988221|20711976|P4|NOT COMPLETED|Part II||3
8403880|NCT00988221|20711977|P3|NOT COMPLETED|Part II||3
8403881|NCT00988221|20711978|P2|NOT COMPLETED|Part II||0
8403882|NCT00988221|20711979|P1|NOT COMPLETED|Part II||1
8403883|NCT00988221|20711976|P4|COMPLETED|Part II||81
8403884|NCT00988221|20711977|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
8403885|NCT00988221|20711978|P2|COMPLETED|Part II||11
8403886|NCT00988221|20711979|P1|COMPLETED|Part II||15
8403887|NCT00988221|20711976|P4|STARTED|Part II||84
8403888|NCT00988221|20711977|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
8403889|NCT00988221|20711978|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
8403890|NCT00988221|20711979|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
8403891|NCT00988221|20711976|P4|NOT COMPLETED|Part I||0
8403892|NCT00988221|20711977|P3|NOT COMPLETED|Part I||8
8403893|NCT00988221|20711978|P2|NOT COMPLETED|Part I||10
8403894|NCT00988221|20711979|P1|NOT COMPLETED|Part I||4
8403895|NCT00988221|20711976|P4|COMPLETED|Part I||0
8403896|NCT00988221|20711977|P3|COMPLETED|Part I||111
8403897|NCT00988221|20711978|P2|COMPLETED|Part I||24
8403898|NCT00988221|20711979|P1|COMPLETED|Part I||31
8403899|NCT00988221|20711976|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
8403900|NCT00988221|20711977|P3|STARTED|Part I||119
8403901|NCT00988221|20711978|P2|STARTED|Part I||34
8403902|NCT00988221|20711979|P1|STARTED|Part I||35
8403903|NCT00988208|20712152|P2|NOT COMPLETED|Overall Study||438
8403904|NCT00988208|20712153|P1|NOT COMPLETED|Overall Study||431
8403905|NCT00988208|20712152|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
8403906|NCT00988208|20712153|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
8403907|NCT00988208|20712152|P2|Treated|Overall Study||525
8403908|NCT00988208|20712153|P1|Treated|Overall Study||521
8403909|NCT00988208|20712152|P2|STARTED|Overall Study||533
8403910|NCT00988208|20712153|P1|STARTED|Overall Study||526
8403911|NCT00988169|20712171|P1|NOT COMPLETED|Overall Study||1
8403912|NCT00988169|20712171|P1|COMPLETED|Overall Study||5
8403913|NCT00988169|20712171|P1|STARTED|Overall Study||6
8403914|NCT00988156|20712177|P2|NOT COMPLETED|Overall Study||20
8403915|NCT00988156|20712178|P1|NOT COMPLETED|Overall Study||17
8403916|NCT00988156|20712177|P2|COMPLETED|Overall Study||135
8403917|NCT00988156|20712178|P1|COMPLETED|Overall Study||132
8403918|NCT00988156|20712177|P2|Safety Set|Overall Study||134
8403919|NCT00988156|20712178|P1|Safety Set|Overall Study||129
8403920|NCT00988156|20712177|P2|Per Protocol Set (PP)|Overall Study||97
8403921|NCT00988156|20712178|P1|Per Protocol Set (PP)|Overall Study||101
8403922|NCT00988156|20712177|P2|Intention-to-Treat Set (ITT)|Overall Study||134
8403923|NCT00988156|20712178|P1|Intention-to-Treat Set (ITT)|Overall Study||129
8403924|NCT00988156|20712177|P2|STARTED|Overall Study||155
8403925|NCT00988156|20712178|P1|STARTED|Overall Study||149
8403926|NCT00988143|20712189|P3|NOT COMPLETED|Overall Study||0
8403927|NCT00988143|20712190|P2|NOT COMPLETED|Overall Study||0
8403928|NCT00988143|20712191|P1|NOT COMPLETED|Overall Study||0
8403929|NCT00988143|20712189|P3|COMPLETED|Overall Study||190
8403930|NCT00988143|20712190|P2|COMPLETED|Overall Study||190
8403931|NCT00988143|20712191|P1|COMPLETED|Overall Study||220
8403932|NCT00988143|20712189|P3|STARTED|Overall Study||190
8403933|NCT00988143|20712190|P2|STARTED|Overall Study||190
8403934|NCT00988143|20712191|P1|STARTED|Overall Study||220
8403935|NCT00988117|20712223|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
8403936|NCT00988117|20712223|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
8403937|NCT00988117|20712223|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
8403938|NCT00988117|20712223|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
8403939|NCT00988117|20712223|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
8403940|NCT00988117|20712223|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
8403941|NCT00988091|20712232|P2|NOT COMPLETED|Open-label Period||33
8403942|NCT00988091|20712233|P1|NOT COMPLETED|Open-label Period||21
8403943|NCT00988091|20712232|P2|COMPLETED|Open-label Period||192
8403944|NCT00988091|20712233|P1|COMPLETED|Open-label Period||208
8403945|NCT00988091|20712232|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
8403946|NCT00988091|20712233|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
8403948|NCT00988091|20712233|P1|NOT COMPLETED|Double-blind Period||43
8403949|NCT00988091|20712232|P2|COMPLETED|Double-blind Period||251
8403950|NCT00988091|20712233|P1|COMPLETED|Double-blind Period||255
8403951|NCT00988091|20712232|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
8403952|NCT00988091|20712233|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
8403953|NCT00988091|20712232|P2|STARTED|Double-blind Period||298
8403954|NCT00988091|20712233|P1|STARTED|Double-blind Period||298
8403955|NCT00988065|20712255|P3|NOT COMPLETED|Overall Study||15
8403956|NCT00988065|20712256|P2|NOT COMPLETED|Overall Study||23
8403957|NCT00988065|20712257|P1|NOT COMPLETED|Overall Study||13
8403958|NCT00988065|20712255|P3|COMPLETED|Overall Study||135
8403959|NCT00988065|20712256|P2|COMPLETED|Overall Study||127
8403960|NCT00988065|20712257|P1|COMPLETED|Overall Study||135
8403961|NCT00988065|20712255|P3|Received Third Randomized Dose|Overall Study||135
8403962|NCT00988065|20712256|P2|Received Third Randomized Dose|Overall Study||127
8403963|NCT00988065|20712257|P1|Received Third Randomized Dose|Overall Study||135
8403964|NCT00988065|20712255|P3|Received Second Randomized Dose|Overall Study||145
8403965|NCT00988065|20712256|P2|Received Second Randomized Dose|Overall Study||135
8403966|NCT00988065|20712257|P1|Received Second Randomized Dose|Overall Study||139
8403967|NCT00988065|20712255|P3|Received First Randomized Dose|Overall Study||150
8403968|NCT00988065|20712256|P2|Received First Randomized Dose|Overall Study||150
8403969|NCT00988065|20712257|P1|Received First Randomized Dose|Overall Study||148
8403970|NCT00988065|20712255|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
8403971|NCT00988065|20712256|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
8403972|NCT00988065|20712257|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
8403973|NCT00988052|20712279|P2|NOT COMPLETED|Overall Study||416
8403974|NCT00988052|20712280|P1|NOT COMPLETED|Overall Study||423
8403975|NCT00988052|20712279|P2|COMPLETED|Overall Study||0
8403976|NCT00988052|20712280|P1|COMPLETED|Overall Study||0
8403977|NCT00988052|20712279|P2|STARTED|Overall Study||416
8403978|NCT00988052|20712280|P1|STARTED|Overall Study||423
8403979|NCT00988000|20712297|P3|NOT COMPLETED|Overall Study||0
8403980|NCT00988000|20712298|P2|NOT COMPLETED|Overall Study||0
8403981|NCT00988000|20712299|P1|NOT COMPLETED|Overall Study||0
8403982|NCT00988000|20712297|P3|COMPLETED|Overall Study||57
8403983|NCT00988000|20712298|P2|COMPLETED|Overall Study||51
8403984|NCT00988000|20712299|P1|COMPLETED|Overall Study||49
8403985|NCT00988000|20712297|P3|STARTED|Overall Study||57
8403986|NCT00988000|20712298|P2|STARTED|Overall Study||51
8403987|NCT00988000|20712299|P1|STARTED|Overall Study||49
8403988|NCT00987948|20712310|P1|NOT COMPLETED|Overall Study||3
8403989|NCT00987948|20712310|P1|COMPLETED|Overall Study||12
8403990|NCT00987948|20712310|P1|STARTED|Overall Study||15
8403991|NCT00987935|20712324|P9|NOT COMPLETED|Overall Study||32
8403992|NCT00987935|20712325|P8|NOT COMPLETED|Overall Study||62
8403993|NCT00987935|20712326|P7|NOT COMPLETED|Overall Study||15
8403994|NCT00987935|20712327|P6|NOT COMPLETED|Overall Study||3
8403995|NCT00987935|20712328|P5|NOT COMPLETED|Overall Study||7
8403996|NCT00987935|20712329|P4|NOT COMPLETED|Overall Study||3
8403997|NCT00987935|20712330|P3|NOT COMPLETED|Overall Study||3
8403998|NCT00987935|20712331|P2|NOT COMPLETED|Overall Study||3
8403999|NCT00987935|20712332|P1|NOT COMPLETED|Overall Study||4
8404000|NCT00987935|20712324|P9|COMPLETED|Overall Study||0
8404001|NCT00987935|20712325|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
8404002|NCT00987935|20712326|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
8404003|NCT00987935|20712327|P6|COMPLETED|Overall Study||0
8404004|NCT00987935|20712328|P5|COMPLETED|Overall Study||0
8404005|NCT00987935|20712329|P4|COMPLETED|Overall Study||0
8404006|NCT00987935|20712330|P3|COMPLETED|Overall Study||0
8404007|NCT00987935|20712331|P2|COMPLETED|Overall Study||0
8404008|NCT00987935|20712332|P1|COMPLETED|Overall Study||0
8404009|NCT00987935|20712324|P9|STARTED|Overall Study||32
8404010|NCT00987935|20712325|P8|STARTED|Overall Study||63
8404011|NCT00987935|20712326|P7|STARTED|Overall Study||16
8404012|NCT00987935|20712327|P6|STARTED|Overall Study||3
8404013|NCT00987935|20712328|P5|STARTED|Overall Study||7
8404014|NCT00987935|20712329|P4|STARTED|Overall Study||3
8404015|NCT00987935|20712330|P3|STARTED|Overall Study||3
8404016|NCT00987935|20712331|P2|STARTED|Overall Study||3
8404017|NCT00987935|20712332|P1|STARTED|Overall Study||4
8404018|NCT00987831|20712388|P3|NOT COMPLETED|Overall Study||0
8404019|NCT00987831|20712389|P2|NOT COMPLETED|Overall Study||3
8404020|NCT00987831|20712390|P1|NOT COMPLETED|Overall Study||1
8404021|NCT00987831|20712388|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
8404022|NCT00987831|20712389|P2|COMPLETED|Overall Study|all controls returned for two visits|52
8404023|NCT00987831|20712390|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
8404024|NCT00987831|20712388|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
8404025|NCT00987831|20712389|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
8404026|NCT00987831|20712390|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
8404027|NCT00987727|20712401|P2|NOT COMPLETED|Overall Study||7
8404028|NCT00987727|20712402|P1|NOT COMPLETED|Overall Study||5
8404029|NCT00987727|20712401|P2|COMPLETED|Overall Study||34
8404030|NCT00987727|20712402|P1|COMPLETED|Overall Study||36
8404031|NCT00987727|20712401|P2|STARTED|Overall Study||41
8404032|NCT00987727|20712402|P1|STARTED|Overall Study||41
8404033|NCT00987623|20712412|P2|NOT COMPLETED|Overall Study||3
8404034|NCT00987623|20712413|P1|NOT COMPLETED|Overall Study||5
8404035|NCT00987623|20712412|P2|COMPLETED|Overall Study||151
8404036|NCT00987623|20712413|P1|COMPLETED|Overall Study||140
8404037|NCT00987623|20712412|P2|STARTED|Overall Study||154
8404038|NCT00987623|20712413|P1|STARTED|Overall Study||145
8404039|NCT00987558|20712419|P2|NOT COMPLETED|Overall Study||5
8404040|NCT00987558|20712420|P1|NOT COMPLETED|Overall Study||1
8404041|NCT00987558|20712419|P2|COMPLETED|Overall Study||12
8404042|NCT00987558|20712420|P1|COMPLETED|Overall Study||12
8404043|NCT00987558|20712419|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
8404044|NCT00987558|20712420|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
8404045|NCT00987558|20712419|P2|Washout|Overall Study||12
8404046|NCT00987558|20712420|P1|Washout|Overall Study||13
8404047|NCT00987558|20712419|P2|Simvastatin|Overall Study||12
8404048|NCT00987558|20712420|P1|Simvastatin|Overall Study||13
8404049|NCT00987558|20712419|P2|STARTED|Overall Study||17
8404050|NCT00987558|20712420|P1|STARTED|Overall Study||13
8404051|NCT00987480|20712433|P1|NOT COMPLETED|Overall Study||0
8404052|NCT00987480|20712433|P1|COMPLETED|Overall Study||45
8404053|NCT00987480|20712433|P1|STARTED|Overall Study||45
8404054|NCT00987467|20712442|P1|NOT COMPLETED|Overall Study||2
8404055|NCT00987467|20712442|P1|COMPLETED|Overall Study||10
8404056|NCT00987467|20712442|P1|STARTED|Overall Study||12
8404057|NCT00987415|20712449|P2|NOT COMPLETED|Overall Study||9
8404058|NCT00987415|20712450|P1|NOT COMPLETED|Overall Study||9
8404059|NCT00987415|20712449|P2|COMPLETED|Overall Study||116
8404060|NCT00987415|20712450|P1|COMPLETED|Overall Study||119
8404061|NCT00987415|20712449|P2|STARTED|Overall Study||125
8404062|NCT00987415|20712450|P1|STARTED|Overall Study||128
8404063|NCT00987402|20712466|P2|NOT COMPLETED|Overall Study||98
8404064|NCT00987402|20712467|P1|NOT COMPLETED|Overall Study||86
8404065|NCT00987402|20712466|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
8404066|NCT00987402|20712467|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
8404067|NCT00987402|20712466|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
8404068|NCT00987402|20712467|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
8404069|NCT00987389|20712475|P4|NOT COMPLETED|Overall Study||3
8404070|NCT00987389|20712476|P3|NOT COMPLETED|Overall Study||8
8404071|NCT00987389|20712477|P2|NOT COMPLETED|Overall Study||8
8404072|NCT00987389|20712478|P1|NOT COMPLETED|Overall Study||9
8404073|NCT00987389|20712475|P4|COMPLETED|Overall Study||174
8404074|NCT00987389|20712476|P3|COMPLETED|Overall Study||167
8404075|NCT00987389|20712477|P2|COMPLETED|Overall Study||168
8404076|NCT00987389|20712478|P1|COMPLETED|Overall Study||167
8404077|NCT00987389|20712475|P4|STARTED|Overall Study||177
8404078|NCT00987389|20712476|P3|STARTED|Overall Study||175
8404079|NCT00987389|20712477|P2|STARTED|Overall Study||176
8404080|NCT00987389|20712478|P1|STARTED|Overall Study||176
8404081|NCT00987337|20712497|P3|NOT COMPLETED|Overall Study||51
8404082|NCT00987337|20712498|P2|NOT COMPLETED|Overall Study||55
8404083|NCT00987337|20712499|P1|NOT COMPLETED|Overall Study||57
8404084|NCT00987337|20712497|P3|COMPLETED|Overall Study||45
8404085|NCT00987337|20712498|P2|COMPLETED|Overall Study||41
8404086|NCT00987337|20712499|P1|COMPLETED|Overall Study||39
8404087|NCT00987337|20712497|P3|STARTED|Overall Study||96
8404088|NCT00987337|20712498|P2|STARTED|Overall Study||96
8404089|NCT00987337|20712499|P1|STARTED|Overall Study||96
8404090|NCT00986999|20712543|P1|NOT COMPLETED|Overall Study||1
8404091|NCT00986999|20712543|P1|COMPLETED|Overall Study||6
8404092|NCT00986999|20712543|P1|STARTED|Overall Study||7
8404093|NCT00986986|20712554|P2|NOT COMPLETED|Overall Study||1
8404094|NCT00986986|20712555|P1|NOT COMPLETED|Overall Study||0
8404095|NCT00986986|20712554|P2|COMPLETED|Overall Study||9
8404096|NCT00986986|20712555|P1|COMPLETED|Overall Study||10
8404097|NCT00986986|20712554|P2|STARTED|Overall Study||10
8404098|NCT00986986|20712555|P1|STARTED|Overall Study||10
8404099|NCT00986973|20712565|P1|NOT COMPLETED|Overall Study||1
8404100|NCT00986973|20712565|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
8404101|NCT00986973|20712565|P1|STARTED|Overall Study||6
8404102|NCT00986947|20712575|P1|NOT COMPLETED|Overall Study||20
8404103|NCT00986947|20712575|P1|COMPLETED|Overall Study||0
8404104|NCT00986947|20712575|P1|STARTED|Overall Study||20
8404105|NCT00986921|20712582|P2|NOT COMPLETED|Overall Study||0
8404106|NCT00986921|20712583|P1|NOT COMPLETED|Overall Study||1
8404107|NCT00986921|20712582|P2|COMPLETED|Overall Study||25
8404108|NCT00986921|20712583|P1|COMPLETED|Overall Study||24
8404109|NCT00986921|20712582|P2|STARTED|Overall Study||25
8404110|NCT00986921|20712583|P1|STARTED|Overall Study||25
8404111|NCT00986856|20712595|P2|NOT COMPLETED|Overall Study||0
8404112|NCT00986856|20712596|P1|NOT COMPLETED|Overall Study||0
8404113|NCT00986856|20712595|P2|COMPLETED|Overall Study||16
8404114|NCT00986856|20712596|P1|COMPLETED|Overall Study||42
8404115|NCT00986856|20712595|P2|STARTED|Overall Study||16
8404116|NCT00986856|20712596|P1|STARTED|Overall Study||42
8404117|NCT00986830|20712616|P1|NOT COMPLETED|Overall Study||8
8404118|NCT00986830|20712616|P1|COMPLETED|Overall Study||66
8404119|NCT00986830|20712616|P1|Treated|Overall Study||69
8404120|NCT00986830|20712616|P1|STARTED|Overall Study||74
8404121|NCT00986674|20712631|P3|NOT COMPLETED|Overall Study||48
8404122|NCT00986674|20712632|P2|NOT COMPLETED|Overall Study||45
8404123|NCT00986674|20712633|P1|NOT COMPLETED|Overall Study||47
8404124|NCT00986674|20712631|P3|COMPLETED|Overall Study||0
8404125|NCT00986674|20712632|P2|COMPLETED|Overall Study||0
8404126|NCT00986674|20712633|P1|COMPLETED|Overall Study||0
8404127|NCT00986674|20712631|P3|Eligible and Treated|Overall Study||47
8404128|NCT00986674|20712632|P2|Eligible and Treated|Overall Study||41
8404129|NCT00986674|20712633|P1|Eligible and Treated|Overall Study||39
8404130|NCT00986674|20712631|P3|Treated|Overall Study||47
8404131|NCT00986674|20712632|P2|Treated|Overall Study||42
8404132|NCT00986674|20712633|P1|Treated|Overall Study||43
8404133|NCT00986674|20712631|P3|STARTED|Overall Study||48
8404134|NCT00986674|20712632|P2|STARTED|Overall Study||45
8404135|NCT00986674|20712633|P1|STARTED|Overall Study||47
8404136|NCT00986583|20712649|P2|NOT COMPLETED|Overall Study||0
8404137|NCT00986583|20712650|P1|NOT COMPLETED|Overall Study||0
8404138|NCT00986583|20712649|P2|COMPLETED|Overall Study||32
8404139|NCT00986583|20712650|P1|COMPLETED|Overall Study||38
8404140|NCT00986583|20712649|P2|STARTED|Overall Study||32
8404141|NCT00986583|20712650|P1|STARTED|Overall Study||38
8404142|NCT00986570|20712666|P1|NOT COMPLETED|Overall Study||7
8404143|NCT00986570|20712666|P1|COMPLETED|Overall Study||114
8404144|NCT00986570|20712666|P1|STARTED|Overall Study||121
8404145|NCT00986544|20712672|P2|NOT COMPLETED|Overall Study||0
8404146|NCT00986544|20712673|P1|NOT COMPLETED|Overall Study||0
8404147|NCT00986544|20712672|P2|COMPLETED|Overall Study||53
8404148|NCT00986544|20712673|P1|COMPLETED|Overall Study||53
8404149|NCT00986544|20712672|P2|STARTED|Overall Study||53
8404150|NCT00986544|20712673|P1|STARTED|Overall Study||53
8404151|NCT00986479|20712683|P2|NOT COMPLETED|Period 2||0
8404152|NCT00986479|20712684|P1|NOT COMPLETED|Period 2||0
8404153|NCT00986479|20712683|P2|COMPLETED|Period 2||10
8404154|NCT00986479|20712684|P1|COMPLETED|Period 2||10
8404155|NCT00986479|20712683|P2|STARTED|Period 2||10
8404156|NCT00986479|20712684|P1|STARTED|Period 2||10
8404157|NCT00986479|20712683|P2|NOT COMPLETED|Period 1||0
8404158|NCT00986479|20712684|P1|NOT COMPLETED|Period 1||2
8404159|NCT00986479|20712683|P2|COMPLETED|Period 1||10
8404160|NCT00986479|20712684|P1|COMPLETED|Period 1||10
8404161|NCT00986479|20712683|P2|STARTED|Period 1||10
8404162|NCT00986479|20712684|P1|STARTED|Period 1||12
8404163|NCT00986453|20712714|P1|NOT COMPLETED|Overall Study||2
8404164|NCT00986453|20712714|P1|COMPLETED|Overall Study||43
8404165|NCT00986453|20712714|P1|STARTED|Overall Study||45
8404166|NCT00986440|20712730|P2|NOT COMPLETED|Overall Study||43
8404167|NCT00986440|20712731|P1|NOT COMPLETED|Overall Study||41
8404168|NCT00986440|20712730|P2|COMPLETED|Overall Study||0
8404169|NCT00986440|20712731|P1|COMPLETED|Overall Study||0
8404170|NCT00986440|20712730|P2|Randomized, But Not Dosed|Overall Study||1
8404171|NCT00986440|20712731|P1|Randomized, But Not Dosed|Overall Study||0
8404172|NCT00986440|20712730|P2|STARTED|Overall Study||43
8404173|NCT00986440|20712731|P1|STARTED|Overall Study||41
8404174|NCT00986427|20712749|P2|NOT COMPLETED|Overall Study||0
8404175|NCT00986427|20712750|P1|NOT COMPLETED|Overall Study||4
8404176|NCT00986427|20712749|P2|COMPLETED|Overall Study||12
8404177|NCT00986427|20712750|P1|COMPLETED|Overall Study||8
8404178|NCT00986427|20712749|P2|STARTED|Overall Study||12
8404179|NCT00986427|20712750|P1|STARTED|Overall Study||12
8404180|NCT00986401|20712766|P2|NOT COMPLETED|Period 2||0
8404181|NCT00986401|20712767|P1|NOT COMPLETED|Period 2||0
8404182|NCT00986401|20712766|P2|COMPLETED|Period 2||21
8404183|NCT00986401|20712767|P1|COMPLETED|Period 2||22
8404184|NCT00986401|20712766|P2|STARTED|Period 2||21
8404185|NCT00986401|20712767|P1|STARTED|Period 2||22
8404186|NCT00986401|20712766|P2|NOT COMPLETED|Period 1||1
8404187|NCT00986401|20712767|P1|NOT COMPLETED|Period 1||0
8404188|NCT00986401|20712766|P2|COMPLETED|Period 1||21
8404189|NCT00986401|20712767|P1|COMPLETED|Period 1||22
8404190|NCT00986401|20712766|P2|STARTED|Period 1||22
8404191|NCT00986401|20712767|P1|STARTED|Period 1||22
8404192|NCT00986362|20712778|P2|NOT COMPLETED|Overall Study||1
8404193|NCT00986362|20712779|P1|NOT COMPLETED|Overall Study||2
8404194|NCT00986362|20712778|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
8404195|NCT00986362|20712779|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
8404196|NCT00986362|20712778|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
8404197|NCT00986362|20712779|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
8404198|NCT00986349|20712785|P1|NOT COMPLETED|Overall Study||7
8404199|NCT00986349|20712785|P1|COMPLETED|Overall Study||16
8404200|NCT00986349|20712785|P1|Early Explant|Overall Study||4
8404201|NCT00986349|20712785|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
8404202|NCT00986349|20712785|P1|STARTED|Overall Study|attempted implant procedures|23
8404203|NCT00986310|20712800|P2|NOT COMPLETED|Overall Study||0
8404204|NCT00986310|20712801|P1|NOT COMPLETED|Overall Study||0
8404205|NCT00986310|20712800|P2|COMPLETED|Overall Study||0
8404206|NCT00986310|20712801|P1|COMPLETED|Overall Study||0
8404207|NCT00986310|20712800|P2|STARTED|Overall Study||0
8404208|NCT00986310|20712801|P1|STARTED|Overall Study||0
8404209|NCT00986258|20712809|P1|NOT COMPLETED|Maintenance Period||9
8404210|NCT00986258|20712809|P1|COMPLETED|Maintenance Period||93
8404211|NCT00986258|20712809|P1|STARTED|Maintenance Period||102
8404212|NCT00986258|20712809|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
8404213|NCT00986258|20712809|P1|COMPLETED|Titration and Optimal Dose Period||102
8404214|NCT00986258|20712809|P1|STARTED|Titration and Optimal Dose Period||125
8404215|NCT00986258|20712809|P1|NOT COMPLETED|Observation Period||11
8404216|NCT00986258|20712809|P1|COMPLETED|Observation Period||125
8404217|NCT00986258|20712809|P1|STARTED|Observation Period||136
8404218|NCT00986245|20712837|P2|NOT COMPLETED|Second Intervention||1
8404219|NCT00986245|20712838|P1|NOT COMPLETED|Second Intervention||2
8404220|NCT00986245|20712837|P2|COMPLETED|Second Intervention||32
8404221|NCT00986245|20712838|P1|COMPLETED|Second Intervention||29
8404222|NCT00986245|20712837|P2|STARTED|Second Intervention||33
8404223|NCT00986245|20712838|P1|STARTED|Second Intervention||31
8404224|NCT00986245|20712837|P2|NOT COMPLETED|First Intervention||8
8404225|NCT00986245|20712838|P1|NOT COMPLETED|First Intervention||10
8404226|NCT00986245|20712837|P2|COMPLETED|First Intervention||33
8404227|NCT00986245|20712838|P1|COMPLETED|First Intervention||31
8404228|NCT00986245|20712837|P2|STARTED|First Intervention||41
8404229|NCT00986245|20712838|P1|STARTED|First Intervention||41
8404230|NCT00986232|20712875|P4|NOT COMPLETED|Overall Study||20
8404231|NCT00986232|20712876|P3|NOT COMPLETED|Overall Study||35
8404232|NCT00986232|20712877|P2|NOT COMPLETED|Overall Study||50
8404233|NCT00986232|20712878|P1|NOT COMPLETED|Overall Study||51
8404234|NCT00986232|20712875|P4|COMPLETED|Overall Study||370
8404235|NCT00986232|20712876|P3|COMPLETED|Overall Study||346
8404236|NCT00986232|20712877|P2|COMPLETED|Overall Study||343
8404237|NCT00986232|20712878|P1|COMPLETED|Overall Study||336
8404238|NCT00986232|20712875|P4|Vaccination Visit 2|Overall Study||0
8404239|NCT00986232|20712876|P3|Vaccination Visit 2|Overall Study||360
8404240|NCT00986232|20712877|P2|Vaccination Visit 2|Overall Study||365
8404241|NCT00986232|20712878|P1|Vaccination Visit 2|Overall Study||360
8404242|NCT00986232|20712875|P4|Vaccination Visit 1|Overall Study||390
8404243|NCT00986232|20712876|P3|Vaccination Visit 1|Overall Study||381
8404244|NCT00986232|20712877|P2|Vaccination Visit 1|Overall Study||393
8404245|NCT00986232|20712878|P1|Vaccination Visit 1|Overall Study||387
8404246|NCT00986232|20712875|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
8404247|NCT00986232|20712876|P3|STARTED|Overall Study||381
8404248|NCT00986232|20712877|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
8404249|NCT00986232|20712878|P1|STARTED|Overall Study||387
8404250|NCT00986180|20712952|P2|NOT COMPLETED|Overall Study||56
8404251|NCT00986180|20712953|P1|NOT COMPLETED|Overall Study||44
8404252|NCT00986180|20712952|P2|COMPLETED|Overall Study||268
8404253|NCT00986180|20712953|P1|COMPLETED|Overall Study||277
8404254|NCT00986180|20712952|P2|STARTED|Overall Study||324
8404255|NCT00986180|20712953|P1|STARTED|Overall Study||321
8404256|NCT00986154|20713031|P2|NOT COMPLETED|Overall Study||194
8404257|NCT00986154|20713032|P1|NOT COMPLETED|Overall Study||206
8404258|NCT00986154|20713031|P2|COMPLETED|Overall Study||3955
8404259|NCT00986154|20713032|P1|COMPLETED|Overall Study||3937
8404260|NCT00986154|20713031|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
8404261|NCT00986154|20713032|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
8404262|NCT00986154|20713031|P2|STARTED|Overall Study||4149
8404263|NCT00986154|20713032|P1|STARTED|Overall Study||4143
8404264|NCT00986102|20713046|P4|NOT COMPLETED|Overall Study||1
8404265|NCT00986102|20713047|P3|NOT COMPLETED|Overall Study||0
8404266|NCT00986102|20713048|P2|NOT COMPLETED|Overall Study||2
8404267|NCT00986102|20713049|P1|NOT COMPLETED|Overall Study||1
8404268|NCT00986102|20713046|P4|COMPLETED|Overall Study||66
8404269|NCT00986102|20713047|P3|COMPLETED|Overall Study||19
8404270|NCT00986102|20713048|P2|COMPLETED|Overall Study||75
8404271|NCT00986102|20713049|P1|COMPLETED|Overall Study||52
8404272|NCT00986102|20713046|P4|STARTED|Overall Study|Number of participants who received study medication|67
8404273|NCT00986102|20713047|P3|STARTED|Overall Study|Number of participants who received study medication|19
8404274|NCT00986102|20713048|P2|STARTED|Overall Study|Number of participants who received study medication|77
8404275|NCT00986102|20713049|P1|STARTED|Overall Study|Number of participants who received study medication|53
8404276|NCT00985985|20713099|P4|NOT COMPLETED|Overall Study||13
8404277|NCT00985985|20713100|P3|NOT COMPLETED|Overall Study||11
8404278|NCT00985985|20713101|P2|NOT COMPLETED|Overall Study||24
8404279|NCT00985985|20713102|P1|NOT COMPLETED|Overall Study||24
8404280|NCT00985985|20713099|P4|COMPLETED|Overall Study||107
8404281|NCT00985985|20713100|P3|COMPLETED|Overall Study||109
8404282|NCT00985985|20713101|P2|COMPLETED|Overall Study||218
8404283|NCT00985985|20713102|P1|COMPLETED|Overall Study||217
8404284|NCT00985985|20713099|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
8404285|NCT00985985|20713100|P3|Full Analysis Set (FAS) Population|Overall Study||120
8404286|NCT00985985|20713101|P2|Full Analysis Set (FAS) Population|Overall Study||242
8404287|NCT00985985|20713102|P1|Full Analysis Set (FAS) Population|Overall Study||241
8404288|NCT00985985|20713099|P4|Safety Population|Overall Study||118
8404289|NCT00985985|20713100|P3|Safety Population|Overall Study||119
8404290|NCT00985985|20713101|P2|Safety Population|Overall Study||242
8404291|NCT00985985|20713102|P1|Safety Population|Overall Study||241
8404292|NCT00985985|20713099|P4|STARTED|Overall Study||120
8404293|NCT00985985|20713100|P3|STARTED|Overall Study||120
8404294|NCT00985985|20713101|P2|STARTED|Overall Study||242
8404295|NCT00985985|20713102|P1|STARTED|Overall Study||241
8404296|NCT00985959|20713143|P3|NOT COMPLETED|Overall Study||59
8404297|NCT00985959|20713144|P2|NOT COMPLETED|Overall Study||3
8404298|NCT00985959|20713145|P1|NOT COMPLETED|Overall Study||3
8404299|NCT00985959|20713143|P3|COMPLETED|Overall Study||28
8404300|NCT00985959|20713144|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
8404301|NCT00985959|20713145|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
8404302|NCT00985959|20713143|P3|STARTED|Overall Study|Number of participants treated|87
8404303|NCT00985959|20713144|P2|STARTED|Overall Study|Number of participants treated|6
8404304|NCT00985959|20713145|P1|STARTED|Overall Study|Number of participants treated|6
8404305|NCT00985946|20713168|P1|NOT COMPLETED|Overall Study||7
8404306|NCT00985946|20713168|P1|COMPLETED|Overall Study||8
8404307|NCT00985946|20713168|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
8404308|NCT00985907|20713176|P1|NOT COMPLETED|Overall Study||13
8404309|NCT00985907|20713176|P1|COMPLETED|Overall Study||0
8404310|NCT00985907|20713176|P1|STARTED|Overall Study||13
8404311|NCT00985829|20713186|P1|NOT COMPLETED|Overall Study||0
8404312|NCT00985829|20713186|P1|COMPLETED|Overall Study||28
8404313|NCT00985829|20713186|P1|STARTED|Overall Study||28
8404314|NCT00985790|20713197|P2|NOT COMPLETED|Overall Study||8
8404315|NCT00985790|20713198|P1|NOT COMPLETED|Overall Study||7
8404316|NCT00985790|20713197|P2|COMPLETED|Overall Study||293
8404317|NCT00985790|20713198|P1|COMPLETED|Overall Study||291
8404318|NCT00985790|20713197|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
8404319|NCT00985790|20713198|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
8404320|NCT00985751|20713239|P5|NOT COMPLETED|Overall Study||1
8404321|NCT00985751|20713240|P4|NOT COMPLETED|Overall Study||0
8404322|NCT00985751|20713241|P3|NOT COMPLETED|Overall Study||0
8404323|NCT00985751|20713242|P2|NOT COMPLETED|Overall Study||0
8404324|NCT00985751|20713243|P1|NOT COMPLETED|Overall Study||0
8404325|NCT00985751|20713239|P5|COMPLETED|Overall Study||50
8404326|NCT00985751|20713240|P4|COMPLETED|Overall Study||51
8404327|NCT00985751|20713241|P3|COMPLETED|Overall Study||52
8404328|NCT00985751|20713242|P2|COMPLETED|Overall Study||52
8404329|NCT00985751|20713243|P1|COMPLETED|Overall Study||51
8404330|NCT00985751|20713239|P5|STARTED|Overall Study||51
8404331|NCT00985751|20713240|P4|STARTED|Overall Study||51
8404332|NCT00985751|20713241|P3|STARTED|Overall Study||52
8404333|NCT00985751|20713242|P2|STARTED|Overall Study||52
8404334|NCT00985751|20713243|P1|STARTED|Overall Study||51
8404335|NCT00985738|20713306|P2|NOT COMPLETED|Overall Study||8
8404336|NCT00985738|20713307|P1|NOT COMPLETED|Overall Study||8
8404337|NCT00985738|20713306|P2|COMPLETED|Overall Study||0
8404338|NCT00985738|20713307|P1|COMPLETED|Overall Study||0
8404339|NCT00985738|20713306|P2|STARTED|Overall Study||8
8404340|NCT00985738|20713307|P1|STARTED|Overall Study||8
8404341|NCT00985725|20713315|P2|NOT COMPLETED|Overall Study||13
8404342|NCT00985725|20713316|P1|NOT COMPLETED|Overall Study||11
8404343|NCT00985725|20713315|P2|COMPLETED|Overall Study||59
8404344|NCT00985725|20713316|P1|COMPLETED|Overall Study||60
8404345|NCT00985725|20713315|P2|STARTED|Overall Study||72
8404346|NCT00985725|20713316|P1|STARTED|Overall Study||71
8404347|NCT00985712|20713352|P2|NOT COMPLETED|Overall Study||7
8404348|NCT00985712|20713353|P1|NOT COMPLETED|Overall Study||6
8404349|NCT00985712|20713352|P2|COMPLETED|Overall Study||123
8404350|NCT00985712|20713353|P1|COMPLETED|Overall Study||127
8404351|NCT00985712|20713352|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
8404352|NCT00985712|20713353|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
8404353|NCT00985712|20713352|P2|Received at Least One Dose of Study Drug|Overall Study||130
8404354|NCT00985712|20713353|P1|Received at Least One Dose of Study Drug|Overall Study||131
8404355|NCT00985712|20713352|P2|STARTED|Overall Study||130
8404356|NCT00985712|20713353|P1|STARTED|Overall Study||133
8404357|NCT00985686|20713371|P4|NOT COMPLETED|Overall Study||2
8404358|NCT00985686|20713372|P3|NOT COMPLETED|Overall Study||0
8404359|NCT00985686|20713373|P2|NOT COMPLETED|Overall Study||1
8404360|NCT00985686|20713374|P1|NOT COMPLETED|Overall Study||1
8404361|NCT00985686|20713371|P4|COMPLETED|Overall Study||14
8404362|NCT00985686|20713372|P3|COMPLETED|Overall Study||13
8404363|NCT00985686|20713373|P2|COMPLETED|Overall Study||15
8404364|NCT00985686|20713374|P1|COMPLETED|Overall Study||17
8404365|NCT00985686|20713371|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
8404366|NCT00985686|20713372|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
8404367|NCT00985686|20713373|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
8404368|NCT00985686|20713374|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
8404369|NCT00985686|20713371|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
8404370|NCT00985686|20713372|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
8404371|NCT00985686|20713373|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
8404372|NCT00985686|20713374|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
8404373|NCT00985686|20713371|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
8404374|NCT00985686|20713372|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
8404375|NCT00985686|20713373|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
8404376|NCT00985686|20713374|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
8404377|NCT00985686|20713371|P4|Visit 1: Baseline Data Collection|Overall Study||16
8404378|NCT00985686|20713372|P3|Visit 1: Baseline Data Collection|Overall Study||13
8404379|NCT00985686|20713373|P2|Visit 1: Baseline Data Collection|Overall Study||15
8404380|NCT00985686|20713374|P1|Visit 1: Baseline Data Collection|Overall Study||18
8404381|NCT00985686|20713371|P4|STARTED|Overall Study||16
8404382|NCT00985686|20713372|P3|STARTED|Overall Study||13
8404383|NCT00985686|20713373|P2|STARTED|Overall Study||16
8404384|NCT00985686|20713374|P1|STARTED|Overall Study||18
8404385|NCT00985673|20713388|P6|NOT COMPLETED|Overall Study||6
8404386|NCT00985673|20713389|P5|NOT COMPLETED|Overall Study||8
8404387|NCT00985673|20713390|P4|NOT COMPLETED|Overall Study||12
8404388|NCT00985673|20713391|P3|NOT COMPLETED|Overall Study||12
8404389|NCT00985673|20713392|P2|NOT COMPLETED|Overall Study||11
8404390|NCT00985673|20713393|P1|NOT COMPLETED|Overall Study||7
8404391|NCT00985673|20713388|P6|COMPLETED|Overall Study||96
8404392|NCT00985673|20713389|P5|COMPLETED|Overall Study||93
8404393|NCT00985673|20713390|P4|COMPLETED|Overall Study||88
8404394|NCT00985673|20713391|P3|COMPLETED|Overall Study||90
8404395|NCT00985673|20713392|P2|COMPLETED|Overall Study||93
8404396|NCT00985673|20713393|P1|COMPLETED|Overall Study||95
8404397|NCT00985673|20713388|P6|STARTED|Overall Study||102
8404398|NCT00985673|20713389|P5|STARTED|Overall Study||101
8404399|NCT00985673|20713390|P4|STARTED|Overall Study||100
8404400|NCT00985673|20713391|P3|STARTED|Overall Study||102
8404401|NCT00985673|20713392|P2|STARTED|Overall Study||104
8404402|NCT00985673|20713393|P1|STARTED|Overall Study||102
8404403|NCT00985543|20713644|P1|NOT COMPLETED|Overall Study||0
8404404|NCT00985543|20713644|P1|COMPLETED|Overall Study||22
8404405|NCT00985543|20713644|P1|STARTED|Overall Study||22
8404406|NCT00985517|20713657|P4|NOT COMPLETED|Overall Study||3
8404407|NCT00985517|20713658|P3|NOT COMPLETED|Overall Study||1
8404408|NCT00985517|20713659|P2|NOT COMPLETED|Overall Study||0
8404409|NCT00985517|20713660|P1|NOT COMPLETED|Overall Study||0
8404410|NCT00985517|20713657|P4|COMPLETED|Overall Study||24
8404411|NCT00985517|20713658|P3|COMPLETED|Overall Study||23
8404412|NCT00985517|20713659|P2|COMPLETED|Overall Study||3
8404413|NCT00985517|20713660|P1|COMPLETED|Overall Study||3
8404414|NCT00985517|20713657|P4|STARTED|Overall Study||27
8404415|NCT00985517|20713658|P3|STARTED|Overall Study||24
8404416|NCT00985517|20713659|P2|STARTED|Overall Study||3
8404417|NCT00985517|20713660|P1|STARTED|Overall Study||3
8404418|NCT00985504|20713676|P2|NOT COMPLETED|Optimization Period||23
8404419|NCT00985504|20713677|P1|NOT COMPLETED|Optimization Period||26
8404420|NCT00985504|20713676|P2|COMPLETED|Optimization Period||204
8404421|NCT00985504|20713677|P1|COMPLETED|Optimization Period||203
8404422|NCT00985504|20713676|P2|STARTED|Optimization Period||227
8404423|NCT00985504|20713677|P1|STARTED|Optimization Period||229
8404424|NCT00985504|20713676|P2|NOT COMPLETED|Acute Treatment Period||12
8404425|NCT00985504|20713677|P1|NOT COMPLETED|Acute Treatment Period||15
8404426|NCT00985504|20713676|P2|COMPLETED|Acute Treatment Period||227
8404427|NCT00985504|20713677|P1|COMPLETED|Acute Treatment Period||229
8404428|NCT00985504|20713676|P2|STARTED|Acute Treatment Period||239
8404429|NCT00985504|20713677|P1|STARTED|Acute Treatment Period||244
8404430|NCT00985491|20713703|P1|NOT COMPLETED|Overall Study||19
8404431|NCT00985491|20713703|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
8404432|NCT00985491|20713703|P1|Received Device|Overall Study||43
8404433|NCT00985491|20713703|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
8404434|NCT00985465|20713710|P2|NOT COMPLETED|Overall Study||3
8404435|NCT00985465|20713711|P1|NOT COMPLETED|Overall Study||1
8404436|NCT00985465|20713710|P2|COMPLETED|Overall Study||66
8404437|NCT00985465|20713711|P1|COMPLETED|Overall Study||140
8404438|NCT00985465|20713710|P2|STARTED|Overall Study||69
8404439|NCT00985465|20713711|P1|STARTED|Overall Study||141
8404440|NCT00985439|20713738|P4|NOT COMPLETED|Overall Study||0
8404441|NCT00985439|20713739|P3|NOT COMPLETED|Overall Study||1
8404442|NCT00985439|20713740|P2|NOT COMPLETED|Overall Study||0
8404443|NCT00985439|20713741|P1|NOT COMPLETED|Overall Study||0
8404444|NCT00985439|20713738|P4|COMPLETED|Overall Study||51
8404445|NCT00985439|20713739|P3|COMPLETED|Overall Study||50
8404446|NCT00985439|20713740|P2|COMPLETED|Overall Study||51
8404447|NCT00985439|20713741|P1|COMPLETED|Overall Study||49
8404448|NCT00985439|20713738|P4|STARTED|Overall Study||51
8404449|NCT00985439|20713739|P3|STARTED|Overall Study||51
8404450|NCT00985439|20713740|P2|STARTED|Overall Study||51
8404451|NCT00985439|20713741|P1|STARTED|Overall Study||49
8404452|NCT00985426|20713753|P2|NOT COMPLETED|Overall Study||44
8404453|NCT00985426|20713754|P1|NOT COMPLETED|Overall Study||43
8404454|NCT00985426|20713753|P2|COMPLETED|Overall Study||219
8404455|NCT00985426|20713754|P1|COMPLETED|Overall Study||215
8404456|NCT00985426|20713753|P2|STARTED|Overall Study||263
8404457|NCT00985426|20713754|P1|STARTED|Overall Study||258
8404458|NCT00985257|20713770|P1|NOT COMPLETED|Overall Study||0
8404459|NCT00985257|20713770|P1|COMPLETED|Overall Study||123
8404460|NCT00985257|20713770|P1|STARTED|Overall Study||123
8404461|NCT00985231|20713776|P2|NOT COMPLETED|Overall Study||3
8404462|NCT00985231|20713777|P1|NOT COMPLETED|Overall Study||3
8404463|NCT00985231|20713776|P2|COMPLETED|Overall Study||129
8404464|NCT00985231|20713777|P1|COMPLETED|Overall Study||130
8404465|NCT00985231|20713776|P2|STARTED|Overall Study||132
8404466|NCT00985231|20713777|P1|STARTED|Overall Study||133
8404467|NCT00985192|20713785|P1|NOT COMPLETED|Overall Study||4
8404468|NCT00985192|20713785|P1|COMPLETED|Overall Study||45
8404469|NCT00985192|20713785|P1|STARTED|Overall Study||49
8404470|NCT00985166|20713797|P3|NOT COMPLETED|Overall Study||7
8404471|NCT00985166|20713798|P2|NOT COMPLETED|Overall Study||4
8404472|NCT00985166|20713799|P1|NOT COMPLETED|Overall Study||9
8404473|NCT00985166|20713797|P3|COMPLETED|Overall Study||188
8404474|NCT00985166|20713798|P2|COMPLETED|Overall Study||201
8404475|NCT00985166|20713799|P1|COMPLETED|Overall Study||392
8404476|NCT00985166|20713797|P3|Vaccinated at Visit 1|Overall Study||195
8404477|NCT00985166|20713798|P2|Vaccinated at Visit 1|Overall Study||205
8404478|NCT00985166|20713799|P1|Vaccinated at Visit 1|Overall Study||399
8404479|NCT00985166|20713797|P3|STARTED|Overall Study||195
8404480|NCT00985166|20713798|P2|STARTED|Overall Study||205
8404481|NCT00985166|20713799|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
8404482|NCT00985153|20713819|P4|NOT COMPLETED|Overall Study||47
8404483|NCT00985153|20713820|P3|NOT COMPLETED|Overall Study||44
8404484|NCT00985153|20713821|P2|NOT COMPLETED|Overall Study||44
8404485|NCT00985153|20713822|P1|NOT COMPLETED|Overall Study||35
8404486|NCT00985153|20713819|P4|COMPLETED|Overall Study||965
8404487|NCT00985153|20713820|P3|COMPLETED|Overall Study||918
8404488|NCT00985153|20713821|P2|COMPLETED|Overall Study||924
8404489|NCT00985153|20713822|P1|COMPLETED|Overall Study||950
8404490|NCT00985153|20713819|P4|Vaccinated at Visit 1|Overall Study||1012
8404491|NCT00985153|20713820|P3|Vaccinated at Visit 1|Overall Study||962
8404492|NCT00985153|20713821|P2|Vaccinated at Visit 1|Overall Study||968
8404493|NCT00985153|20713822|P1|Vaccinated at Visit 1|Overall Study||985
8404494|NCT00985153|20713819|P4|STARTED|Overall Study||1012
8404495|NCT00985153|20713820|P3|STARTED|Overall Study||962
8404496|NCT00985153|20713821|P2|STARTED|Overall Study||968
8404497|NCT00985153|20713822|P1|STARTED|Overall Study||985
8404498|NCT00985140|20713864|P1|NOT COMPLETED|Overall Study||0
8404499|NCT00985140|20713864|P1|COMPLETED|Overall Study||15
8404500|NCT00985140|20713864|P1|STARTED|Overall Study||15
8404501|NCT00985114|20713870|P2|NOT COMPLETED|Overall Study||2
8404502|NCT00985114|20713871|P1|NOT COMPLETED|Overall Study||1
8404503|NCT00985114|20713870|P2|COMPLETED|Overall Study||37
8404504|NCT00985114|20713871|P1|COMPLETED|Overall Study||33
8404505|NCT00985114|20713870|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
8404506|NCT00985114|20713871|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
8404507|NCT00985114|20713870|P2|STARTED|Overall Study||39
8404508|NCT00985114|20713871|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
8404509|NCT00985088|20713885|P8|NOT COMPLETED|Overall Study||6
8404510|NCT00985088|20713886|P7|NOT COMPLETED|Overall Study||4
8404511|NCT00985088|20713887|P6|NOT COMPLETED|Overall Study||7
8404512|NCT00985088|20713888|P5|NOT COMPLETED|Overall Study||9
8404513|NCT00985088|20713889|P4|NOT COMPLETED|Overall Study||7
8404514|NCT00985088|20713890|P3|NOT COMPLETED|Overall Study||4
8404515|NCT00985088|20713891|P2|NOT COMPLETED|Overall Study||2
8404516|NCT00985088|20713892|P1|NOT COMPLETED|Overall Study||11
8404517|NCT00985088|20713885|P8|COMPLETED|Overall Study||216
8404518|NCT00985088|20713886|P7|COMPLETED|Overall Study||107
8404519|NCT00985088|20713887|P6|COMPLETED|Overall Study||108
8404520|NCT00985088|20713888|P5|COMPLETED|Overall Study||214
8404521|NCT00985088|20713889|P4|COMPLETED|Overall Study||214
8404522|NCT00985088|20713890|P3|COMPLETED|Overall Study||108
8404523|NCT00985088|20713891|P2|COMPLETED|Overall Study||112
8404524|NCT00985088|20713892|P1|COMPLETED|Overall Study||211
8404525|NCT00985088|20713885|P8|STARTED|Overall Study||222
8404526|NCT00985088|20713886|P7|STARTED|Overall Study||111
8404527|NCT00985088|20713887|P6|STARTED|Overall Study||115
8404528|NCT00985088|20713888|P5|STARTED|Overall Study||223
8404529|NCT00985088|20713889|P4|STARTED|Overall Study||221
8404530|NCT00985088|20713890|P3|STARTED|Overall Study||112
8404531|NCT00985088|20713891|P2|STARTED|Overall Study||114
8404532|NCT00985088|20713892|P1|STARTED|Overall Study||222
8404533|NCT00985010|20714150|P2|NOT COMPLETED|Overall Study||0
8404534|NCT00985010|20714151|P1|NOT COMPLETED|Overall Study||0
8404535|NCT00985010|20714150|P2|COMPLETED|Overall Study||5
8404536|NCT00985010|20714151|P1|COMPLETED|Overall Study||4
8404537|NCT00985010|20714150|P2|STARTED|Overall Study||5
8404538|NCT00985010|20714151|P1|STARTED|Overall Study||4
8404539|NCT00984867|20714161|P2|NOT COMPLETED|Overall Study||17
8404540|NCT00984867|20714162|P1|NOT COMPLETED|Overall Study||23
8404541|NCT00984867|20714161|P2|COMPLETED|Overall Study||208
8404542|NCT00984867|20714162|P1|COMPLETED|Overall Study||203
8404543|NCT00984867|20714161|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
8404544|NCT00984867|20714162|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
8404545|NCT00984815|20714180|P1|NOT COMPLETED|Overall Study||30
8404546|NCT00984815|20714180|P1|COMPLETED|Overall Study||56
8404547|NCT00984815|20714180|P1|STARTED|Overall Study||86
8404548|NCT00984698|20714189|P2|NOT COMPLETED|Overall Study||8
8404549|NCT00984698|20714190|P1|NOT COMPLETED|Overall Study||3
8404550|NCT00984698|20714189|P2|COMPLETED|Overall Study||14
8404551|NCT00984698|20714190|P1|COMPLETED|Overall Study||18
8404552|NCT00984698|20714189|P2|STARTED|Overall Study||22
8404553|NCT00984698|20714190|P1|STARTED|Overall Study||21
8404554|NCT00984659|20714202|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
8404555|NCT00984659|20714203|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
8404556|NCT00984659|20714204|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
8404557|NCT00984659|20714205|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
8404558|NCT00984659|20714202|P4|COMPLETED|6-week Double-blind Treatment Period||126
8404559|NCT00984659|20714203|P3|COMPLETED|6-week Double-blind Treatment Period||141
8404560|NCT00984659|20714204|P2|COMPLETED|6-week Double-blind Treatment Period||69
8404561|NCT00984659|20714205|P1|COMPLETED|6-week Double-blind Treatment Period||0
8404562|NCT00984659|20714202|P4|STARTED|6-week Double-blind Treatment Period||139
8404563|NCT00984659|20714203|P3|STARTED|6-week Double-blind Treatment Period||152
8404564|NCT00984659|20714204|P2|STARTED|6-week Double-blind Treatment Period||75
8404565|NCT00984659|20714205|P1|STARTED|6-week Double-blind Treatment Period||0
8404566|NCT00984659|20714202|P4|NOT COMPLETED|2-week Run-in Period||0
8404567|NCT00984659|20714203|P3|NOT COMPLETED|2-week Run-in Period||0
8404568|NCT00984659|20714204|P2|NOT COMPLETED|2-week Run-in Period||0
8404569|NCT00984659|20714205|P1|NOT COMPLETED|2-week Run-in Period||52
8404570|NCT00984659|20714202|P4|COMPLETED|2-week Run-in Period||0
8404571|NCT00984659|20714203|P3|COMPLETED|2-week Run-in Period||0
8404572|NCT00984659|20714204|P2|COMPLETED|2-week Run-in Period||0
8404573|NCT00984659|20714205|P1|COMPLETED|2-week Run-in Period||366
8404574|NCT00984659|20714202|P4|STARTED|2-week Run-in Period||0
8404575|NCT00984659|20714203|P3|STARTED|2-week Run-in Period||0
8404576|NCT00984659|20714204|P2|STARTED|2-week Run-in Period||0
8404577|NCT00984659|20714205|P1|STARTED|2-week Run-in Period||418
8404578|NCT00984620|20714232|P2|NOT COMPLETED|Overall Study||12
8404579|NCT00984620|20714233|P1|NOT COMPLETED|Overall Study||6
8404580|NCT00984620|20714232|P2|COMPLETED|Overall Study||67
8404581|NCT00984620|20714233|P1|COMPLETED|Overall Study||75
8404582|NCT00984620|20714232|P2|STARTED|Overall Study||79
8404583|NCT00984620|20714233|P1|STARTED|Overall Study||81
8404584|NCT00984594|20714271|P2|NOT COMPLETED|Overall Study||1
8404585|NCT00984594|20714272|P1|NOT COMPLETED|Overall Study||1
8404586|NCT00984594|20714271|P2|COMPLETED|Overall Study||1
8404587|NCT00984594|20714272|P1|COMPLETED|Overall Study||1
8404588|NCT00984594|20714271|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
8404589|NCT00984594|20714272|P1|STARTED|Overall Study||2
8404590|NCT00984568|20714288|P2|NOT COMPLETED|Overall Study||6
8404591|NCT00984568|20714289|P1|NOT COMPLETED|Overall Study||8
8404592|NCT00984568|20714288|P2|COMPLETED|Overall Study||7
8404593|NCT00984568|20714289|P1|COMPLETED|Overall Study||7
8404594|NCT00984568|20714288|P2|STARTED|Overall Study||13
8404595|NCT00984568|20714289|P1|STARTED|Overall Study||15
8404596|NCT00984542|20714297|P1|NOT COMPLETED|Overall Study||41
8404597|NCT00984542|20714297|P1|COMPLETED|Overall Study||9
8404598|NCT00984542|20714297|P1|STARTED|Overall Study||50
8404599|NCT00984490|20714305|P1|NOT COMPLETED|Overall Study||0
8404600|NCT00984490|20714305|P1|COMPLETED|Overall Study||5
8404601|NCT00984490|20714305|P1|STARTED|Overall Study||5
8404602|NCT00984334|20714315|P5|NOT COMPLETED|Overall Study||1
8404603|NCT00984334|20714316|P4|NOT COMPLETED|Overall Study||1
8404604|NCT00984334|20714317|P3|NOT COMPLETED|Overall Study||0
8404605|NCT00984334|20714318|P2|NOT COMPLETED|Overall Study||1
8404606|NCT00984334|20714319|P1|NOT COMPLETED|Overall Study||1
8404607|NCT00984334|20714315|P5|COMPLETED|Overall Study||7
8404608|NCT00984334|20714316|P4|COMPLETED|Overall Study||7
8404609|NCT00984334|20714317|P3|COMPLETED|Overall Study||8
8404610|NCT00984334|20714318|P2|COMPLETED|Overall Study||7
8404611|NCT00984334|20714319|P1|COMPLETED|Overall Study||7
8404612|NCT00984334|20714315|P5|STARTED|Overall Study||8
8404613|NCT00984334|20714316|P4|STARTED|Overall Study||8
8404614|NCT00984334|20714317|P3|STARTED|Overall Study||8
8404615|NCT00984334|20714318|P2|STARTED|Overall Study||8
8404616|NCT00984334|20714319|P1|STARTED|Overall Study||8
8404617|NCT00984308|20714333|P2|NOT COMPLETED|Overall Study||6
8404618|NCT00984308|20714334|P1|NOT COMPLETED|Overall Study||18
8404619|NCT00984308|20714333|P2|COMPLETED|Overall Study||109
8404620|NCT00984308|20714334|P1|COMPLETED|Overall Study||92
8404621|NCT00984308|20714333|P2|STARTED|Overall Study||115
8404622|NCT00984308|20714334|P1|STARTED|Overall Study||110
8404623|NCT00984295|20714347|P3|NOT COMPLETED|Overall Study||37
8404624|NCT00984295|20714348|P2|NOT COMPLETED|Overall Study||32
8404625|NCT00984295|20714349|P1|NOT COMPLETED|Overall Study||65
8404626|NCT00984295|20714347|P3|COMPLETED|Overall Study||442
8404627|NCT00984295|20714348|P2|COMPLETED|Overall Study||453
8404628|NCT00984295|20714349|P1|COMPLETED|Overall Study||884
8404629|NCT00984295|20714347|P3|Visit 2|Overall Study||453
8404630|NCT00984295|20714348|P2|Visit 2|Overall Study||468
8404631|NCT00984295|20714349|P1|Visit 2|Overall Study||909
8404632|NCT00984295|20714347|P3|Visit 1|Overall Study||479
8404633|NCT00984295|20714348|P2|Visit 1|Overall Study||485
8404634|NCT00984295|20714349|P1|Visit 1|Overall Study||949
8404635|NCT00984295|20714347|P3|STARTED|Overall Study||479
8404636|NCT00984295|20714348|P2|STARTED|Overall Study||485
8404637|NCT00984295|20714349|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
8404638|NCT00984282|20714416|P2|NOT COMPLETED|Long Term Follow-up||120
8404639|NCT00984282|20714417|P1|NOT COMPLETED|Long Term Follow-up||69
8404640|NCT00984282|20714416|P2|COMPLETED|Long Term Follow-up||4
8404641|NCT00984282|20714417|P1|COMPLETED|Long Term Follow-up||3
8404642|NCT00984282|20714416|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
8404643|NCT00984282|20714417|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
8404644|NCT00984282|20714416|P2|NOT COMPLETED|Open-label Treatment||161
8404645|NCT00984282|20714417|P1|NOT COMPLETED|Open-label Treatment||86
8404646|NCT00984282|20714416|P2|COMPLETED|Open-label Treatment||0
8404647|NCT00984282|20714417|P1|COMPLETED|Open-label Treatment||0
8404648|NCT00984282|20714416|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
8404649|NCT00984282|20714417|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
8404650|NCT00984282|20714416|P2|STARTED|Open-label Treatment||161
8404651|NCT00984282|20714417|P1|STARTED|Open-label Treatment||86
8404652|NCT00984282|20714416|P2|NOT COMPLETED|Double Blind Treatment||38
8404653|NCT00984282|20714417|P1|NOT COMPLETED|Double Blind Treatment||104
8404654|NCT00984282|20714416|P2|COMPLETED|Double Blind Treatment||172
8404655|NCT00984282|20714417|P1|COMPLETED|Double Blind Treatment||103
8404656|NCT00984282|20714416|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
8404657|NCT00984282|20714417|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
8404658|NCT00984282|20714416|P2|STARTED|Double Blind Treatment||210
8404659|NCT00984282|20714417|P1|STARTED|Double Blind Treatment||207
8404660|NCT00984256|20714440|P2|NOT COMPLETED|Overall Study||1
8404661|NCT00984256|20714441|P1|NOT COMPLETED|Overall Study||0
8404662|NCT00984256|20714440|P2|COMPLETED|Overall Study||29
8404663|NCT00984256|20714441|P1|COMPLETED|Overall Study||6
8404664|NCT00984256|20714440|P2|STARTED|Overall Study||30
8404665|NCT00984256|20714441|P1|STARTED|Overall Study||6
8404666|NCT00984204|20714461|P1|NOT COMPLETED|Overall Study||15
8404667|NCT00984204|20714461|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
8404668|NCT00984204|20714461|P1|STARTED|Overall Study||188
8404669|NCT00984165|20714471|P4|NOT COMPLETED|Overall Study||4
8404670|NCT00984165|20714472|P3|NOT COMPLETED|Overall Study||0
8404671|NCT00984165|20714473|P2|NOT COMPLETED|Overall Study||1
8404672|NCT00984165|20714474|P1|NOT COMPLETED|Overall Study||7
8404673|NCT00984165|20714471|P4|COMPLETED|Overall Study||0
8404674|NCT00984165|20714472|P3|COMPLETED|Overall Study||4
8404675|NCT00984165|20714473|P2|COMPLETED|Overall Study||0
8404676|NCT00984165|20714474|P1|COMPLETED|Overall Study||2
8404677|NCT00984165|20714471|P4|STARTED|Overall Study||4
8404678|NCT00984165|20714472|P3|STARTED|Overall Study||4
8404679|NCT00984165|20714473|P2|STARTED|Overall Study||1
8404680|NCT00984165|20714474|P1|STARTED|Overall Study||9
8404681|NCT00984139|20714487|P1|NOT COMPLETED|Overall Study||0
8404682|NCT00984139|20714487|P1|COMPLETED|Overall Study||306
8404683|NCT00984139|20714487|P1|STARTED|Overall Study||306
8404684|NCT00984126|20714503|P4|NOT COMPLETED|Overall Study||59
8404685|NCT00984126|20714504|P3|NOT COMPLETED|Overall Study||7
8404686|NCT00984126|20714505|P2|NOT COMPLETED|Overall Study||8
8404687|NCT00984126|20714506|P1|NOT COMPLETED|Overall Study||7
8404688|NCT00984126|20714503|P4|COMPLETED|Overall Study||76
8404689|NCT00984126|20714504|P3|COMPLETED|Overall Study||16
8404690|NCT00984126|20714505|P2|COMPLETED|Overall Study||20
8404691|NCT00984126|20714506|P1|COMPLETED|Overall Study||20
8404692|NCT00984126|20714503|P4|STARTED|Overall Study||135
8404693|NCT00984126|20714504|P3|STARTED|Overall Study||23
8404694|NCT00984126|20714505|P2|STARTED|Overall Study||28
8404695|NCT00984126|20714506|P1|STARTED|Overall Study||27
8404696|NCT00984061|20714531|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
8404697|NCT00984061|20714531|P1|COMPLETED|Colchicine With Clarithromycin||23
8404698|NCT00984061|20714531|P1|STARTED|Colchicine With Clarithromycin||23
8404699|NCT00984061|20714531|P1|NOT COMPLETED|Clarithromycin Alone||1
8404700|NCT00984061|20714531|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
8404701|NCT00984061|20714531|P1|STARTED|Clarithromycin Alone||24
8404702|NCT00984061|20714531|P1|NOT COMPLETED|21 Day Washout Period||0
8404703|NCT00984061|20714531|P1|COMPLETED|21 Day Washout Period||24
8404704|NCT00984061|20714531|P1|STARTED|21 Day Washout Period||24
8404705|NCT00984061|20714531|P1|NOT COMPLETED|Colchicine Alone||0
8404706|NCT00984061|20714531|P1|COMPLETED|Colchicine Alone||24
8404707|NCT00984061|20714531|P1|STARTED|Colchicine Alone||24
8404708|NCT00984022|20714544|P2|NOT COMPLETED|Overall Study||14
8404709|NCT00984022|20714545|P1|NOT COMPLETED|Overall Study||10
8404710|NCT00984022|20714544|P2|COMPLETED|Overall Study||35
8404711|NCT00984022|20714545|P1|COMPLETED|Overall Study||33
8404712|NCT00984022|20714544|P2|STARTED|Overall Study||49
8404713|NCT00984022|20714545|P1|STARTED|Overall Study||43
8404714|NCT00984009|20714555|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
8404715|NCT00984009|20714555|P1|COMPLETED|Colchicine With Grapefruit Juice||21
8404716|NCT00984009|20714555|P1|STARTED|Colchicine With Grapefruit Juice||21
8404717|NCT00984009|20714555|P1|NOT COMPLETED|Grapefruit Juice Alone||1
8404718|NCT00984009|20714555|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
8404719|NCT00984009|20714555|P1|STARTED|Grapefruit Juice Alone||22
8404720|NCT00984009|20714555|P1|NOT COMPLETED|14 Day Washout Period||0
8404721|NCT00984009|20714555|P1|COMPLETED|14 Day Washout Period||22
8404722|NCT00984009|20714555|P1|STARTED|14 Day Washout Period||22
8404723|NCT00984009|20714555|P1|NOT COMPLETED|Colchicine Alone||0
8404724|NCT00984009|20714555|P1|COMPLETED|Colchicine Alone||22
8404725|NCT00984009|20714555|P1|STARTED|Colchicine Alone||22
8404726|NCT00983983|20714569|P3|NOT COMPLETED|Overall Study||1
8404727|NCT00983983|20714570|P2|NOT COMPLETED|Overall Study||1
8404728|NCT00983983|20714571|P1|NOT COMPLETED|Overall Study||2
8404729|NCT00983983|20714569|P3|COMPLETED|Overall Study||6
8404730|NCT00983983|20714570|P2|COMPLETED|Overall Study||8
8404731|NCT00983983|20714571|P1|COMPLETED|Overall Study||6
8404732|NCT00983983|20714569|P3|STARTED|Overall Study||7
8404733|NCT00983983|20714570|P2|STARTED|Overall Study||9
8404734|NCT00983983|20714571|P1|STARTED|Overall Study||8
8404735|NCT00983957|20714588|P1|NOT COMPLETED|Overall Study||2
8404736|NCT00983957|20714588|P1|COMPLETED|Overall Study||18
8404737|NCT00983957|20714588|P1|Treatment C|Overall Study||18
8404738|NCT00983957|20714588|P1|Treatment B|Overall Study||20
8404739|NCT00983957|20714588|P1|Treatment A|Overall Study||20
8404740|NCT00983957|20714588|P1|STARTED|Overall Study||20
8404741|NCT00983931|20714622|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
8404742|NCT00983931|20714622|P1|COMPLETED|Colchicine With Cyclosporine||23
8404743|NCT00983931|20714622|P1|STARTED|Colchicine With Cyclosporine||23
8404744|NCT00983931|20714622|P1|NOT COMPLETED|14 Day Washout Period||1
8404745|NCT00983931|20714622|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
8404746|NCT00983931|20714622|P1|STARTED|14 Day Washout Period||24
8404747|NCT00983931|20714622|P1|NOT COMPLETED|Colchicine Alone||0
8404748|NCT00983931|20714622|P1|COMPLETED|Colchicine Alone||24
8404749|NCT00983931|20714622|P1|STARTED|Colchicine Alone||24
8404750|NCT00983918|20714636|P4|NOT COMPLETED|Overall Study||2
8404751|NCT00983918|20714637|P3|NOT COMPLETED|Overall Study||2
8404752|NCT00983918|20714638|P2|NOT COMPLETED|Overall Study||2
8404753|NCT00983918|20714639|P1|NOT COMPLETED|Overall Study||0
8404754|NCT00983918|20714636|P4|COMPLETED|Overall Study||18
8404755|NCT00983918|20714637|P3|COMPLETED|Overall Study||18
8404756|NCT00983918|20714638|P2|COMPLETED|Overall Study||18
8404757|NCT00983918|20714639|P1|COMPLETED|Overall Study||20
8404758|NCT00983918|20714636|P4|STARTED|Overall Study||20
8404759|NCT00983918|20714637|P3|STARTED|Overall Study||20
8404760|NCT00983918|20714638|P2|STARTED|Overall Study||20
8404761|NCT00983918|20714639|P1|STARTED|Overall Study||20
8404762|NCT00983905|20714649|P1|NOT COMPLETED|Theophylline With Colchicine||0
8404763|NCT00983905|20714649|P1|COMPLETED|Theophylline With Colchicine||27
8404764|NCT00983905|20714649|P1|STARTED|Theophylline With Colchicine||27
8404765|NCT00983905|20714649|P1|NOT COMPLETED|Colchicine Alone||2
8404766|NCT00983905|20714649|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
8404767|NCT00983905|20714649|P1|STARTED|Colchicine Alone||29
8404768|NCT00983905|20714649|P1|NOT COMPLETED|4 Day Washout Period||0
8404769|NCT00983905|20714649|P1|COMPLETED|4 Day Washout Period||29
8404770|NCT00983905|20714649|P1|STARTED|4 Day Washout Period||29
8404771|NCT00983905|20714649|P1|NOT COMPLETED|Theophylline Alone||1
8404772|NCT00983905|20714649|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
8404773|NCT00983905|20714649|P1|STARTED|Theophylline Alone||30
8404774|NCT00983892|20714662|P2|NOT COMPLETED|Overall Study||12
8404775|NCT00983892|20714663|P1|NOT COMPLETED|Overall Study||10
8404776|NCT00983892|20714662|P2|COMPLETED|Overall Study||56
8404777|NCT00983892|20714663|P1|COMPLETED|Overall Study||56
8404778|NCT00983892|20714662|P2|STARTED|Overall Study||68
8404779|NCT00983892|20714663|P1|STARTED|Overall Study||66
8404780|NCT00983853|20714675|P6|NOT COMPLETED|Overall Study||1
8404781|NCT00983853|20714676|P5|NOT COMPLETED|Overall Study||3
8404782|NCT00983853|20714677|P4|NOT COMPLETED|Overall Study||2
8404783|NCT00983853|20714678|P3|NOT COMPLETED|Overall Study||3
8404784|NCT00983853|20714679|P2|NOT COMPLETED|Overall Study||2
8404785|NCT00983853|20714680|P1|NOT COMPLETED|Overall Study||1
8404786|NCT00983853|20714675|P6|COMPLETED|Overall Study||7
8404787|NCT00983853|20714676|P5|COMPLETED|Overall Study||12
8404788|NCT00983853|20714677|P4|COMPLETED|Overall Study||6
8404789|NCT00983853|20714678|P3|COMPLETED|Overall Study||14
8404790|NCT00983853|20714679|P2|COMPLETED|Overall Study||5
8404791|NCT00983853|20714680|P1|COMPLETED|Overall Study||6
8404792|NCT00983853|20714675|P6|STARTED|Overall Study||8
8404793|NCT00983853|20714676|P5|STARTED|Overall Study||15
8404794|NCT00983853|20714677|P4|STARTED|Overall Study||8
8404795|NCT00983853|20714678|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
8404796|NCT00983853|20714679|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
8404797|NCT00983853|20714680|P1|STARTED|Overall Study||7
8404798|NCT00983827|20714708|P1|NOT COMPLETED|Overall Study||1
8404799|NCT00983827|20714708|P1|COMPLETED|Overall Study||7
8404800|NCT00983827|20714708|P1|STARTED|Overall Study||8
8404801|NCT00983801|20714712|P1|NOT COMPLETED|Overall Study||0
8404802|NCT00983801|20714712|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
8404803|NCT00983801|20714712|P1|STARTED|Overall Study|Participants who received treatment.|52
8404804|NCT00983749|20714726|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
8404805|NCT00983749|20714727|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
8404806|NCT00983749|20714726|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
8404807|NCT00983749|20714727|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
8404808|NCT00983749|20714726|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
8404809|NCT00983749|20714727|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
8404810|NCT00983749|20714726|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
8404811|NCT00983749|20714727|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
8404812|NCT00983749|20714726|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
8404813|NCT00983749|20714727|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
8404814|NCT00983749|20714726|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
8404815|NCT00983749|20714727|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
8404816|NCT00983645|20714737|P2|NOT COMPLETED|Overall Study||0
8404817|NCT00983645|20714738|P1|NOT COMPLETED|Overall Study||0
8404818|NCT00983645|20714737|P2|COMPLETED|Overall Study||7
8404819|NCT00983645|20714738|P1|COMPLETED|Overall Study||8
8404820|NCT00983645|20714737|P2|STARTED|Overall Study||7
8404821|NCT00983645|20714738|P1|STARTED|Overall Study||8
8404822|NCT00983619|20714762|P12|NOT COMPLETED|Overall Study||11
8404823|NCT00983619|20714763|P11|NOT COMPLETED|Overall Study||11
8404824|NCT00983619|20714764|P10|NOT COMPLETED|Overall Study||3
8404825|NCT00983619|20714765|P9|NOT COMPLETED|Overall Study||1
8404826|NCT00983619|20714766|P8|NOT COMPLETED|Overall Study||2
8404827|NCT00983619|20714767|P7|NOT COMPLETED|Overall Study||3
8404828|NCT00983619|20714768|P6|NOT COMPLETED|Overall Study||67
8404829|NCT00983619|20714769|P5|NOT COMPLETED|Overall Study||3
8404830|NCT00983619|20714770|P4|NOT COMPLETED|Overall Study||5
8404831|NCT00983619|20714771|P3|NOT COMPLETED|Overall Study||3
8404832|NCT00983619|20714772|P2|NOT COMPLETED|Overall Study||4
8404833|NCT00983619|20714773|P1|NOT COMPLETED|Overall Study||3
8404834|NCT00983619|20714762|P12|COMPLETED|Overall Study||3
8404835|NCT00983619|20714763|P11|COMPLETED|Overall Study||6
8404836|NCT00983619|20714764|P10|COMPLETED|Overall Study||0
8404837|NCT00983619|20714765|P9|COMPLETED|Overall Study||0
8404838|NCT00983619|20714766|P8|COMPLETED|Overall Study||1
8404839|NCT00983619|20714767|P7|COMPLETED|Overall Study||0
8404840|NCT00983619|20714768|P6|COMPLETED|Overall Study||9
8404841|NCT00983619|20714769|P5|COMPLETED|Overall Study||0
8404842|NCT00983619|20714770|P4|COMPLETED|Overall Study||1
8404843|NCT00983619|20714771|P3|COMPLETED|Overall Study||0
8404844|NCT00983619|20714772|P2|COMPLETED|Overall Study||0
8404845|NCT00983619|20714773|P1|COMPLETED|Overall Study||0
8404846|NCT00983619|20714762|P12|STARTED|Overall Study||14
8404847|NCT00983619|20714763|P11|STARTED|Overall Study||17
8404848|NCT00983619|20714764|P10|STARTED|Overall Study||3
8404849|NCT00983619|20714765|P9|STARTED|Overall Study||1
8404850|NCT00983619|20714766|P8|STARTED|Overall Study||3
8404851|NCT00983619|20714767|P7|STARTED|Overall Study||3
8404852|NCT00983619|20714768|P6|STARTED|Overall Study||76
8404853|NCT00983619|20714769|P5|STARTED|Overall Study||3
8404854|NCT00983619|20714770|P4|STARTED|Overall Study||6
8404855|NCT00983619|20714771|P3|STARTED|Overall Study||3
8404856|NCT00983619|20714772|P2|STARTED|Overall Study||4
8404857|NCT00983619|20714773|P1|STARTED|Overall Study||3
8404858|NCT00983580|20715078|P2|NOT COMPLETED|Overall Study||4
8404859|NCT00983580|20715079|P1|NOT COMPLETED|Overall Study||5
8404860|NCT00983580|20715078|P2|COMPLETED|Overall Study||49
8404861|NCT00983580|20715079|P1|COMPLETED|Overall Study||49
8404862|NCT00983580|20715078|P2|STARTED|Overall Study||53
8404863|NCT00983580|20715079|P1|STARTED|Overall Study||54
8404864|NCT00983541|20715095|P1|NOT COMPLETED|Overall Study||0
8404865|NCT00983541|20715095|P1|COMPLETED|Overall Study||1
8404866|NCT00983541|20715095|P1|STARTED|Overall Study||1
8404867|NCT00983528|20715105|P1|NOT COMPLETED|Overall Study||6
8404868|NCT00983528|20715105|P1|COMPLETED|Overall Study||0
8404869|NCT00983528|20715105|P1|STARTED|Overall Study||6
8404870|NCT00983515|20715110|P1|NOT COMPLETED|Colchicine With Ritonavir||1
8404871|NCT00983515|20715110|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
8404872|NCT00983515|20715110|P1|STARTED|Colchicine With Ritonavir||18
8404873|NCT00983515|20715110|P1|NOT COMPLETED|Ritonavir Alone||6
8404874|NCT00983515|20715110|P1|COMPLETED|Ritonavir Alone||18
8404875|NCT00983515|20715110|P1|STARTED|Ritonavir Alone||24
8404876|NCT00983515|20715110|P1|NOT COMPLETED|14 Day Washout Period||0
8404877|NCT00983515|20715110|P1|COMPLETED|14 Day Washout Period||24
8404878|NCT00983515|20715110|P1|STARTED|14 Day Washout Period||24
8404879|NCT00983515|20715110|P1|NOT COMPLETED|Colchicine Alone||0
8404880|NCT00983515|20715110|P1|COMPLETED|Colchicine Alone||24
8404881|NCT00983515|20715110|P1|STARTED|Colchicine Alone||24
8404882|NCT00983489|20715124|P3|NOT COMPLETED|Overall Study||312
8404883|NCT00983489|20715125|P2|NOT COMPLETED|Overall Study||285
8404884|NCT00983489|20715126|P1|NOT COMPLETED|Overall Study||185
8404885|NCT00983489|20715124|P3|COMPLETED|Overall Study||135
8404886|NCT00983489|20715125|P2|COMPLETED|Overall Study||168
8404887|NCT00983489|20715126|P1|COMPLETED|Overall Study||326
8404888|NCT00983489|20715124|P3|STARTED|Overall Study||447
8404889|NCT00983489|20715125|P2|STARTED|Overall Study||453
8404890|NCT00983489|20715126|P1|STARTED|Overall Study||511
8404891|NCT00983476|20715137|P3|NOT COMPLETED|Overall Study||0
8404892|NCT00983476|20715138|P2|NOT COMPLETED|Overall Study||22
8404893|NCT00983476|20715139|P1|NOT COMPLETED|Overall Study||17
8404894|NCT00983476|20715137|P3|COMPLETED|Overall Study||88
8404895|NCT00983476|20715138|P2|COMPLETED|Overall Study||71
8404896|NCT00983476|20715139|P1|COMPLETED|Overall Study||78
8404897|NCT00983476|20715137|P3|6 Month Follow up Assessment|Overall Study||74
8404898|NCT00983476|20715138|P2|6 Month Follow up Assessment|Overall Study||62
8404899|NCT00983476|20715139|P1|6 Month Follow up Assessment|Overall Study||71
8404900|NCT00983476|20715137|P3|STARTED|Overall Study||88
8404901|NCT00983476|20715138|P2|STARTED|Overall Study||93
8404902|NCT00983476|20715139|P1|STARTED|Overall Study||95
8404903|NCT00983437|20715171|P1|NOT COMPLETED|Overall Study||47
8404904|NCT00983437|20715171|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
8404905|NCT00983437|20715171|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
8404906|NCT00983437|20715171|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
8404907|NCT00983437|20715171|P1|STARTED|Overall Study||47
8404908|NCT00983385|20715190|P1|NOT COMPLETED|Maintenance Period||23
8404909|NCT00983385|20715190|P1|COMPLETED|Maintenance Period||117
8404910|NCT00983385|20715190|P1|STARTED|Maintenance Period||140
8404911|NCT00983385|20715190|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
8404912|NCT00983385|20715190|P1|COMPLETED|Titration and Optimal Dose Period||140
8404913|NCT00983385|20715190|P1|STARTED|Titration and Optimal Dose Period||176
8404914|NCT00983385|20715190|P1|NOT COMPLETED|Observation Period||32
8404915|NCT00983385|20715190|P1|COMPLETED|Observation Period||176
8404916|NCT00983385|20715190|P1|STARTED|Observation Period||208
8404917|NCT00983372|20715235|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
8404918|NCT00983372|20715235|P1|COMPLETED|Colchicine With Diltiazem ER||20
8404919|NCT00983372|20715235|P1|STARTED|Colchicine With Diltiazem ER||20
8404920|NCT00983372|20715235|P1|NOT COMPLETED|Diltiazem ER Alone||3
8404921|NCT00983372|20715235|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
8404922|NCT00983372|20715235|P1|STARTED|Diltiazem ER Alone||23
8404923|NCT00983372|20715235|P1|NOT COMPLETED|14 Day Washout Period||1
8404924|NCT00983372|20715235|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
8404925|NCT00983372|20715235|P1|STARTED|14 Day Washout Period||24
8404926|NCT00983372|20715235|P1|NOT COMPLETED|Colchicine Alone||0
8404927|NCT00983372|20715235|P1|COMPLETED|Colchicine Alone||24
8404928|NCT00983372|20715235|P1|STARTED|Colchicine Alone||24
8404929|NCT00983359|20715246|P1|NOT COMPLETED|Overall Study||1
8404930|NCT00983359|20715246|P1|COMPLETED|Overall Study||39
8404931|NCT00983359|20715246|P1|Not Eligible for Analysis|Overall Study||1
8404932|NCT00983359|20715246|P1|STARTED|Overall Study||40
8404933|NCT00983346|20715254|P1|NOT COMPLETED|Overall Study||0
8404934|NCT00983346|20715254|P1|COMPLETED|Overall Study||17
8404935|NCT00983346|20715254|P1|STARTED|Overall Study||17
8404936|NCT00983307|20715258|P1|NOT COMPLETED|Overall Study||0
8404937|NCT00983307|20715258|P1|COMPLETED|Overall Study||17
8404938|NCT00983307|20715258|P1|STARTED|Overall Study||17
8404939|NCT00983294|20715262|P1|NOT COMPLETED|Colchicine With Azithromycin||1
8404940|NCT00983294|20715262|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
8404941|NCT00983294|20715262|P1|STARTED|Colchicine With Azithromycin||22
8404942|NCT00983294|20715262|P1|NOT COMPLETED|Azithromycin Alone||0
8404943|NCT00983294|20715262|P1|COMPLETED|Azithromycin Alone||22
8404944|NCT00983294|20715262|P1|STARTED|Azithromycin Alone||22
8404945|NCT00983294|20715262|P1|NOT COMPLETED|14 Day Washout Period||2
8404946|NCT00983294|20715262|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
8404947|NCT00983294|20715262|P1|STARTED|14 Day Washout Period||24
8404948|NCT00983294|20715262|P1|NOT COMPLETED|Colchicine Alone||0
8404949|NCT00983294|20715262|P1|COMPLETED|Colchicine Alone||24
8404950|NCT00983294|20715262|P1|STARTED|Colchicine Alone||24
8404951|NCT00983281|20715275|P2|NOT COMPLETED|Overall Study||0
8404952|NCT00983281|20715276|P1|NOT COMPLETED|Overall Study||0
8404953|NCT00983281|20715275|P2|COMPLETED|Overall Study||909
8404954|NCT00983281|20715276|P1|COMPLETED|Overall Study||805
8404955|NCT00983281|20715275|P2|STARTED|Overall Study||909
8404956|NCT00983281|20715276|P1|STARTED|Overall Study||805
8404957|NCT00983242|20715282|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
8404958|NCT00983242|20715282|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
8404959|NCT00983242|20715282|P1|STARTED|Colchicine With Verapamil HCl ER||24
8404960|NCT00983242|20715282|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
8404961|NCT00983242|20715282|P1|COMPLETED|Verapamil HCl ER Alone||24
8404962|NCT00983242|20715282|P1|STARTED|Verapamil HCl ER Alone||24
8404963|NCT00983242|20715282|P1|NOT COMPLETED|14 Day Washout Period||0
8404964|NCT00983242|20715282|P1|COMPLETED|14 Day Washout Period||24
8404965|NCT00983242|20715282|P1|STARTED|14 Day Washout Period||24
8404966|NCT00983242|20715282|P1|NOT COMPLETED|Colchicine Alone||0
8404967|NCT00983242|20715282|P1|COMPLETED|Colchicine Alone||24
8404968|NCT00983242|20715282|P1|STARTED|Colchicine Alone||24
8404969|NCT00983216|20715293|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
8404970|NCT00983216|20715293|P1|COMPLETED|Colchicine With Ketoconazole||24
8404971|NCT00983216|20715293|P1|STARTED|Colchicine With Ketoconazole||24
8404972|NCT00983216|20715293|P1|NOT COMPLETED|Ketoconazole Alone||0
8404973|NCT00983216|20715293|P1|COMPLETED|Ketoconazole Alone||24
8404974|NCT00983216|20715293|P1|STARTED|Ketoconazole Alone||24
8404975|NCT00983216|20715293|P1|NOT COMPLETED|14 Day Washout Period||0
8404976|NCT00983216|20715293|P1|COMPLETED|14 Day Washout Period||24
8404977|NCT00983216|20715293|P1|STARTED|14 Day Washout Period||24
8404978|NCT00983216|20715293|P1|NOT COMPLETED|Colchicine Alone||0
8404979|NCT00983216|20715293|P1|COMPLETED|Colchicine Alone||24
8404980|NCT00983216|20715293|P1|STARTED|Colchicine Alone||24
8404981|NCT00983073|20715304|P1|NOT COMPLETED|Maintenance Period||16
8404982|NCT00983073|20715304|P1|COMPLETED|Maintenance Period||144
8404983|NCT00983073|20715304|P1|STARTED|Maintenance Period||160
8404984|NCT00983073|20715304|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
8404985|NCT00983073|20715304|P1|COMPLETED|Titration and Optimal Dose Period||160
8404986|NCT00983073|20715304|P1|STARTED|Titration and Optimal Dose Period||200
8404987|NCT00983073|20715304|P1|NOT COMPLETED|Observation Period||24
8404988|NCT00983073|20715304|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
8404989|NCT00983073|20715304|P1|STARTED|Observation Period||224
8404990|NCT00982995|20715325|P1|NOT COMPLETED|Overall Study||0
8404991|NCT00982995|20715325|P1|COMPLETED|Overall Study||3
8404992|NCT00982995|20715325|P1|STARTED|Overall Study||3
8404993|NCT00982878|20715330|P1|NOT COMPLETED|Overall Study||1
8404994|NCT00982878|20715330|P1|COMPLETED|Overall Study||12
8404995|NCT00982878|20715330|P1|STARTED|Overall Study||13
8404996|NCT00982865|20715339|P4|NOT COMPLETED|Overall Study||0
8404997|NCT00982865|20715340|P3|NOT COMPLETED|Overall Study||0
8404998|NCT00982865|20715341|P2|NOT COMPLETED|Overall Study||0
8404999|NCT00982865|20715342|P1|NOT COMPLETED|Overall Study||0
8405000|NCT00982865|20715339|P4|COMPLETED|Overall Study||34
8405001|NCT00982865|20715340|P3|COMPLETED|Overall Study||15
8405002|NCT00982865|20715341|P2|COMPLETED|Overall Study||82
8405003|NCT00982865|20715342|P1|COMPLETED|Overall Study||49
8405004|NCT00982865|20715339|P4|STARTED|Overall Study||34
8405005|NCT00982865|20715340|P3|STARTED|Overall Study||15
8405006|NCT00982865|20715341|P2|STARTED|Overall Study||82
8405007|NCT00982865|20715342|P1|STARTED|Overall Study||49
8405008|NCT00982735|20715628|P1|NOT COMPLETED|Overall Study||230
8405009|NCT00982735|20715628|P1|COMPLETED|Overall Study||757
8405010|NCT00982735|20715628|P1|STARTED|Overall Study||987
8405011|NCT00982657|20715638|P4|NOT COMPLETED|Overall Study||9
8405012|NCT00982657|20715639|P3|NOT COMPLETED|Overall Study||2
8405013|NCT00982657|20715640|P2|NOT COMPLETED|Overall Study||0
8405014|NCT00982657|20715641|P1|NOT COMPLETED|Overall Study||1
8405015|NCT00982657|20715638|P4|COMPLETED|Overall Study||7
8405016|NCT00982657|20715639|P3|COMPLETED|Overall Study||1
8405017|NCT00982657|20715640|P2|COMPLETED|Overall Study||3
8405018|NCT00982657|20715641|P1|COMPLETED|Overall Study||11
8405019|NCT00982657|20715638|P4|STARTED|Overall Study||16
8405020|NCT00982657|20715639|P3|STARTED|Overall Study||3
8405021|NCT00982657|20715640|P2|STARTED|Overall Study||3
8405022|NCT00982657|20715641|P1|STARTED|Overall Study||12
8405023|NCT00982644|20715682|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
8405024|NCT00982644|20715683|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
8405025|NCT00982644|20715682|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
8405026|NCT00982644|20715683|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
8405027|NCT00982644|20715682|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
8405028|NCT00982644|20715683|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
8405029|NCT00982644|20715682|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
8405030|NCT00982644|20715683|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
8405031|NCT00982644|20715682|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
8405032|NCT00982644|20715683|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
8405033|NCT00982644|20715682|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
8405034|NCT00982644|20715683|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
8405035|NCT00982644|20715682|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
8405036|NCT00982644|20715683|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
8405037|NCT00982644|20715682|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
8405038|NCT00982644|20715683|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
8405039|NCT00982592|20715707|P2|NOT COMPLETED|Overall Study||33
8405040|NCT00982592|20715708|P1|NOT COMPLETED|Overall Study||31
8405041|NCT00982592|20715707|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
8405042|NCT00982592|20715708|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
8405043|NCT00982592|20715707|P2|Treatment Received|Overall Study||52
8405044|NCT00982592|20715708|P1|Treatment Received|Overall Study||63
8405045|NCT00982592|20715707|P2|STARTED|Overall Study||60
8405046|NCT00982592|20715708|P1|STARTED|Overall Study||64
8405047|NCT00982553|20715722|P1|NOT COMPLETED|Phase3||0
8405048|NCT00982553|20715722|P1|COMPLETED|Phase3||14
8405049|NCT00982553|20715722|P1|STARTED|Phase3||14
8405050|NCT00982553|20715722|P1|NOT COMPLETED|Phase2||0
8405051|NCT00982553|20715722|P1|COMPLETED|Phase2||14
8405052|NCT00982553|20715722|P1|STARTED|Phase2||14
8405053|NCT00982553|20715722|P1|NOT COMPLETED|Phase1||0
8405054|NCT00982553|20715722|P1|COMPLETED|Phase1||14
8405055|NCT00982553|20715722|P1|STARTED|Phase1||14
8405056|NCT00982488|20715738|P5|NOT COMPLETED|Overall Study||1
8405057|NCT00982488|20715739|P4|NOT COMPLETED|Overall Study||3
8405058|NCT00982488|20715740|P3|NOT COMPLETED|Overall Study||34
8405059|NCT00982488|20715741|P2|NOT COMPLETED|Overall Study||14
8405060|NCT00982488|20715742|P1|NOT COMPLETED|Overall Study||185
8405061|NCT00982488|20715738|P5|COMPLETED|Overall Study|Still receiving treatment|0
8405062|NCT00982488|20715739|P4|COMPLETED|Overall Study|Still receiving treatment|0
8405063|NCT00982488|20715740|P3|COMPLETED|Overall Study|Still receiving treatment|0
8405064|NCT00982488|20715741|P2|COMPLETED|Overall Study|Still receiving treatment|0
8405065|NCT00982488|20715742|P1|COMPLETED|Overall Study|Still receiving treatment|0
8405066|NCT00982488|20715738|P5|STARTED|Overall Study|Received treatment|1
8405067|NCT00982488|20715739|P4|STARTED|Overall Study|Received treatment|3
8405068|NCT00982488|20715740|P3|STARTED|Overall Study|Received treatment|34
8405069|NCT00982488|20715741|P2|STARTED|Overall Study|Received treatment|14
8405070|NCT00982488|20715742|P1|STARTED|Overall Study|Received treatment|185
8405071|NCT00982423|20715756|P2|NOT COMPLETED|Overall Study||0
8405072|NCT00982423|20715757|P1|NOT COMPLETED|Overall Study||0
8405073|NCT00982423|20715756|P2|COMPLETED|Overall Study||19
8405074|NCT00982423|20715757|P1|COMPLETED|Overall Study||13
8405075|NCT00982423|20715756|P2|STARTED|Overall Study||19
8405076|NCT00982423|20715757|P1|STARTED|Overall Study||13
8405077|NCT00982410|20715775|P2|NOT COMPLETED|12-month Follow-up Assessment||9
8405078|NCT00982410|20715776|P1|NOT COMPLETED|12-month Follow-up Assessment||9
8405079|NCT00982410|20715775|P2|COMPLETED|12-month Follow-up Assessment||55
8405080|NCT00982410|20715776|P1|COMPLETED|12-month Follow-up Assessment||56
8405081|NCT00982410|20715775|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
8405082|NCT00982410|20715776|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
8405083|NCT00982410|20715775|P2|NOT COMPLETED|6-month Follow-up Assessment||11
8405084|NCT00982410|20715776|P1|NOT COMPLETED|6-month Follow-up Assessment||6
8405085|NCT00982410|20715775|P2|COMPLETED|6-month Follow-up Assessment||53
8405086|NCT00982410|20715776|P1|COMPLETED|6-month Follow-up Assessment||59
8405087|NCT00982410|20715775|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
8405088|NCT00982410|20715776|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
8405089|NCT00982410|20715775|P2|NOT COMPLETED|3-month Follow-up Assessment||13
8405090|NCT00982410|20715776|P1|NOT COMPLETED|3-month Follow-up Assessment||9
8405091|NCT00982410|20715775|P2|COMPLETED|3-month Follow-up Assessment||53
8405092|NCT00982410|20715776|P1|COMPLETED|3-month Follow-up Assessment||56
8405093|NCT00982410|20715775|P2|STARTED|3-month Follow-up Assessment||66
8405094|NCT00982410|20715776|P1|STARTED|3-month Follow-up Assessment||65
8405095|NCT00982397|20715800|P2|NOT COMPLETED|Phase II/Overall Study||0
8405096|NCT00982397|20715801|P1|NOT COMPLETED|Phase II/Overall Study||0
8405097|NCT00982397|20715800|P2|COMPLETED|Phase II/Overall Study||751
8405098|NCT00982397|20715801|P1|COMPLETED|Phase II/Overall Study||2019
8405099|NCT00982397|20715800|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
8405100|NCT00982397|20715801|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
8405101|NCT00982397|20715800|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
8405102|NCT00982397|20715801|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
8405103|NCT00982397|20715800|P2|STARTED|Phase II/Overall Study||751
8405104|NCT00982397|20715801|P1|STARTED|Phase II/Overall Study||2019
8405105|NCT00982397|20715800|P2|NOT COMPLETED|Phase I||0
8405106|NCT00982397|20715801|P1|NOT COMPLETED|Phase I||0
8405107|NCT00982397|20715800|P2|COMPLETED|Phase I||0
8405108|NCT00982397|20715801|P1|COMPLETED|Phase I||236
8405109|NCT00982397|20715800|P2|STARTED|Phase I||0
8405110|NCT00982397|20715801|P1|STARTED|Phase I||236
8405111|NCT00982345|20715811|P1|NOT COMPLETED|Overall Study||2
8405112|NCT00982345|20715811|P1|COMPLETED|Overall Study||18
8405113|NCT00982345|20715811|P1|STARTED|Overall Study||20
8405114|NCT00982319|20715817|P2|NOT COMPLETED|Overall Study||2
8405115|NCT00982319|20715818|P1|NOT COMPLETED|Overall Study||2
8405116|NCT00982319|20715817|P2|COMPLETED|Overall Study||15
8405117|NCT00982319|20715818|P1|COMPLETED|Overall Study||15
8405118|NCT00982319|20715817|P2|STARTED|Overall Study||17
8405119|NCT00982319|20715818|P1|STARTED|Overall Study||17
8405120|NCT00982280|20715826|P1|NOT COMPLETED|Maintenance Period||1
8405121|NCT00982280|20715826|P1|COMPLETED|Maintenance Period||54
8405122|NCT00982280|20715826|P1|STARTED|Maintenance Period||55
8405123|NCT00982280|20715826|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
8405124|NCT00982280|20715826|P1|COMPLETED|Titration and Optimal Dose Period||55
8405125|NCT00982280|20715826|P1|STARTED|Titration and Optimal Dose Period||63
8405126|NCT00982280|20715826|P1|NOT COMPLETED|Observation Period||19
8405127|NCT00982280|20715826|P1|COMPLETED|Observation Period||63
8405128|NCT00982280|20715826|P1|STARTED|Observation Period||82
8405129|NCT00982228|20715851|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
8405130|NCT00982228|20715852|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
8405131|NCT00982228|20715851|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
8405132|NCT00982228|20715852|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
8405133|NCT00982228|20715851|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
8405134|NCT00982228|20715852|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
8405135|NCT00982228|20715851|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
8405136|NCT00982228|20715852|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
8405137|NCT00982228|20715851|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
8405138|NCT00982228|20715852|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
8405139|NCT00982228|20715851|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
8405140|NCT00982228|20715852|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
8405141|NCT00982228|20715851|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
8405142|NCT00982228|20715852|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
8405143|NCT00982228|20715851|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
8405144|NCT00982228|20715852|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
8405145|NCT00982189|20715880|P4|NOT COMPLETED|Overall Study||0
8405146|NCT00982189|20715881|P3|NOT COMPLETED|Overall Study||0
8405147|NCT00982189|20715882|P2|NOT COMPLETED|Overall Study||0
8405148|NCT00982189|20715883|P1|NOT COMPLETED|Overall Study||0
8405149|NCT00982189|20715880|P4|COMPLETED|Overall Study||9
8405150|NCT00982189|20715881|P3|COMPLETED|Overall Study||9
8405151|NCT00982189|20715882|P2|COMPLETED|Overall Study||9
8405152|NCT00982189|20715883|P1|COMPLETED|Overall Study||10
8405153|NCT00982189|20715880|P4|STARTED|Overall Study||9
8405154|NCT00982189|20715881|P3|STARTED|Overall Study||9
8405155|NCT00982189|20715882|P2|STARTED|Overall Study||9
8405156|NCT00982189|20715883|P1|STARTED|Overall Study||10
8405157|NCT00982137|20715911|P4|NOT COMPLETED|Overall Study||1
8405158|NCT00982137|20715912|P3|NOT COMPLETED|Overall Study||0
8405159|NCT00982137|20715913|P2|NOT COMPLETED|Overall Study||1
8405160|NCT00982137|20715914|P1|NOT COMPLETED|Overall Study||0
8405161|NCT00982137|20715911|P4|COMPLETED|Overall Study||17
8405162|NCT00982137|20715912|P3|COMPLETED|Overall Study||18
8405163|NCT00982137|20715913|P2|COMPLETED|Overall Study||35
8405164|NCT00982137|20715914|P1|COMPLETED|Overall Study||36
8405165|NCT00982137|20715911|P4|STARTED|Overall Study||18
8405166|NCT00982137|20715912|P3|STARTED|Overall Study||18
8405167|NCT00982137|20715913|P2|STARTED|Overall Study||36
8405168|NCT00982137|20715914|P1|STARTED|Overall Study||36
8405169|NCT00982111|20715946|P2|NOT COMPLETED|Overall Study||66
8405170|NCT00982111|20715947|P1|NOT COMPLETED|Overall Study||75
8405171|NCT00982111|20715946|P2|COMPLETED|Overall Study||252
8405172|NCT00982111|20715947|P1|COMPLETED|Overall Study||240
8405173|NCT00982111|20715946|P2|On Study at Conclusion, Off Treatment|Overall Study||6
8405174|NCT00982111|20715947|P1|On Study at Conclusion, Off Treatment|Overall Study||4
8405175|NCT00982111|20715946|P2|Death Due to Any Cause|Overall Study||246
8405176|NCT00982111|20715947|P1|Death Due to Any Cause|Overall Study||236
8405177|NCT00982111|20715946|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
8405178|NCT00982111|20715947|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
8405179|NCT00982111|20715946|P2|STARTED|Overall Study||318
8405180|NCT00982111|20715947|P1|STARTED|Overall Study||315
8405181|NCT00982033|20715971|P2|NOT COMPLETED|Overall Study||0
8405182|NCT00982033|20715972|P1|NOT COMPLETED|Overall Study||0
8405183|NCT00982033|20715971|P2|COMPLETED|Overall Study||27
8405184|NCT00982033|20715972|P1|COMPLETED|Overall Study||25
8405185|NCT00982033|20715971|P2|STARTED|Overall Study||27
8405186|NCT00982033|20715972|P1|STARTED|Overall Study||25
8405187|NCT00982020|20715980|P2|NOT COMPLETED|Overall Study||64
8405188|NCT00982020|20715981|P1|NOT COMPLETED|Overall Study||57
8405189|NCT00982020|20715980|P2|COMPLETED|Overall Study||37
8405190|NCT00982020|20715981|P1|COMPLETED|Overall Study||45
8405191|NCT00982020|20715980|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
8405192|NCT00982020|20715981|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
8405193|NCT00982020|20715980|P2|STARTED|Overall Study||101
8405194|NCT00982020|20715981|P1|STARTED|Overall Study||102
8405195|NCT00982007|20716005|P4|NOT COMPLETED|Overall Study||6
8405196|NCT00982007|20716006|P3|NOT COMPLETED|Overall Study||0
8405197|NCT00982007|20716007|P2|NOT COMPLETED|Overall Study||4
8405198|NCT00982007|20716008|P1|NOT COMPLETED|Overall Study||4
8405199|NCT00982007|20716005|P4|COMPLETED|Overall Study||245
8405200|NCT00982007|20716006|P3|COMPLETED|Overall Study||253
8405201|NCT00982007|20716007|P2|COMPLETED|Overall Study||253
8405202|NCT00982007|20716008|P1|COMPLETED|Overall Study||246
8405203|NCT00982007|20716005|P4|STARTED|Overall Study||251
8405204|NCT00982007|20716006|P3|STARTED|Overall Study||253
8405205|NCT00982007|20716007|P2|STARTED|Overall Study||257
8405206|NCT00982007|20716008|P1|STARTED|Overall Study||250
8405207|NCT00981825|20716020|P2|NOT COMPLETED|Second Intervention||0
8405208|NCT00981825|20716021|P1|NOT COMPLETED|Second Intervention||0
8405209|NCT00981825|20716020|P2|COMPLETED|Second Intervention||11
8405210|NCT00981825|20716021|P1|COMPLETED|Second Intervention||11
8405211|NCT00981825|20716020|P2|STARTED|Second Intervention||11
8405212|NCT00981825|20716021|P1|STARTED|Second Intervention||11
8405213|NCT00981825|20716020|P2|NOT COMPLETED|Washout After 1st Intervention||0
8405214|NCT00981825|20716021|P1|NOT COMPLETED|Washout After 1st Intervention||0
8405215|NCT00981825|20716020|P2|COMPLETED|Washout After 1st Intervention||11
8405216|NCT00981825|20716021|P1|COMPLETED|Washout After 1st Intervention||11
8405217|NCT00981825|20716020|P2|STARTED|Washout After 1st Intervention||11
8405218|NCT00981825|20716021|P1|STARTED|Washout After 1st Intervention||11
8405219|NCT00981825|20716020|P2|NOT COMPLETED|First Intervention||0
8405220|NCT00981825|20716021|P1|NOT COMPLETED|First Intervention||0
8405221|NCT00981825|20716020|P2|COMPLETED|First Intervention||11
8405222|NCT00981825|20716021|P1|COMPLETED|First Intervention||11
8405223|NCT00981825|20716020|P2|STARTED|First Intervention||11
8405224|NCT00981825|20716021|P1|STARTED|First Intervention||11
8405225|NCT00981812|20716027|P1|NOT COMPLETED|Overall Study||0
8405226|NCT00981812|20716027|P1|COMPLETED|Overall Study||20
8405227|NCT00981812|20716027|P1|STARTED|Overall Study||20
8405228|NCT00981799|20716035|P4|NOT COMPLETED|Overall Study||0
8405229|NCT00981799|20716036|P3|NOT COMPLETED|Overall Study||0
8405230|NCT00981799|20716037|P2|NOT COMPLETED|Overall Study||1
8405231|NCT00981799|20716038|P1|NOT COMPLETED|Overall Study||1
8405232|NCT00981799|20716035|P4|COMPLETED|Overall Study||0
8405233|NCT00981799|20716036|P3|COMPLETED|Overall Study||10
8405234|NCT00981799|20716037|P2|COMPLETED|Overall Study||6
8405235|NCT00981799|20716038|P1|COMPLETED|Overall Study||5
8405236|NCT00981799|20716035|P4|STARTED|Overall Study||0
8405237|NCT00981799|20716036|P3|STARTED|Overall Study||10
8405238|NCT00981799|20716037|P2|STARTED|Overall Study||7
8405239|NCT00981799|20716038|P1|STARTED|Overall Study||6
8405240|NCT00981747|20716052|P1|NOT COMPLETED|Sildenafil and Losartan||0
8405241|NCT00981747|20716052|P1|COMPLETED|Sildenafil and Losartan||9
8405242|NCT00981747|20716052|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
8405243|NCT00981747|20716052|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
8405244|NCT00981747|20716052|P1|STARTED|Sildenafil and Losartan||9
8405245|NCT00981747|20716052|P1|NOT COMPLETED|Sildenafil||0
8405246|NCT00981747|20716052|P1|COMPLETED|Sildenafil||9
8405247|NCT00981747|20716052|P1|Completed Sildenafil|Sildenafil||9
8405248|NCT00981747|20716052|P1|Started Sildenafil|Sildenafil||9
8405249|NCT00981747|20716052|P1|STARTED|Sildenafil||9
8405250|NCT00981747|20716052|P1|NOT COMPLETED|Placebo Oral Tablet||1
8405251|NCT00981747|20716052|P1|COMPLETED|Placebo Oral Tablet||9
8405252|NCT00981747|20716052|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
8405253|NCT00981747|20716052|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
8405254|NCT00981747|20716052|P1|STARTED|Placebo Oral Tablet||10
8405255|NCT00981747|20716052|P1|NOT COMPLETED|Losartan||2
8405256|NCT00981747|20716052|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
8405257|NCT00981747|20716052|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
8405258|NCT00981747|20716052|P1|Started Losartan|Losartan||12
8405259|NCT00981747|20716052|P1|STARTED|Losartan||12
8405260|NCT00981682|20716070|P1|NOT COMPLETED|Overall Study||142
8405261|NCT00981682|20716070|P1|COMPLETED|Overall Study||234
8405262|NCT00981682|20716070|P1|STARTED|Overall Study||376
8405263|NCT00981669|20716076|P2|NOT COMPLETED|Overall Study||0
8405264|NCT00981669|20716077|P1|NOT COMPLETED|Overall Study||1
8405265|NCT00981669|20716076|P2|COMPLETED|Overall Study||40
8405266|NCT00981669|20716077|P1|COMPLETED|Overall Study||39
8405267|NCT00981669|20716076|P2|STARTED|Overall Study||40
8405268|NCT00981669|20716077|P1|STARTED|Overall Study||40
8405269|NCT00981630|20716089|P4|NOT COMPLETED|Overall Study||0
8405270|NCT00981630|20716090|P3|NOT COMPLETED|Overall Study||0
8405271|NCT00981630|20716091|P2|NOT COMPLETED|Overall Study||0
8405272|NCT00981630|20716092|P1|NOT COMPLETED|Overall Study||0
8405273|NCT00981630|20716089|P4|COMPLETED|Overall Study||32
8405274|NCT00981630|20716090|P3|COMPLETED|Overall Study||32
8405275|NCT00981630|20716091|P2|COMPLETED|Overall Study||32
8405276|NCT00981630|20716092|P1|COMPLETED|Overall Study||32
8405277|NCT00981630|20716089|P4|STARTED|Overall Study||32
8405278|NCT00981630|20716090|P3|STARTED|Overall Study||32
8405279|NCT00981630|20716091|P2|STARTED|Overall Study||32
8405280|NCT00981630|20716092|P1|STARTED|Overall Study||32
8405281|NCT00981578|20716122|P1|NOT COMPLETED|Overall Study||3
8405282|NCT00981578|20716122|P1|COMPLETED|Overall Study||14
8405283|NCT00981578|20716122|P1|STARTED|Overall Study||17
8405284|NCT00981526|20716130|P2|NOT COMPLETED|Overall Study||6
8405285|NCT00981526|20716131|P1|NOT COMPLETED|Overall Study||4
8405286|NCT00981526|20716130|P2|COMPLETED|Overall Study||22
8405287|NCT00981526|20716131|P1|COMPLETED|Overall Study||22
8405288|NCT00981526|20716130|P2|STARTED|Overall Study||28
8405289|NCT00981526|20716131|P1|STARTED|Overall Study||26
8405290|NCT00981461|20716149|P2|NOT COMPLETED|Overall Study||2
8405291|NCT00981461|20716150|P1|NOT COMPLETED|Overall Study||5
8405292|NCT00981461|20716149|P2|COMPLETED|Overall Study||22
8405293|NCT00981461|20716150|P1|COMPLETED|Overall Study||43
8405294|NCT00981461|20716149|P2|STARTED|Overall Study||24
8405295|NCT00981461|20716150|P1|STARTED|Overall Study||48
8405296|NCT00981435|20716159|P3|NOT COMPLETED|Overall Study||0
8405297|NCT00981435|20716160|P2|NOT COMPLETED|Overall Study||0
8405298|NCT00981435|20716161|P1|NOT COMPLETED|Overall Study||0
8405299|NCT00981435|20716159|P3|COMPLETED|Overall Study||37
8405300|NCT00981435|20716160|P2|COMPLETED|Overall Study||29
8405301|NCT00981435|20716161|P1|COMPLETED|Overall Study||31
8405302|NCT00981435|20716159|P3|STARTED|Overall Study||37
8405303|NCT00981435|20716160|P2|STARTED|Overall Study||29
8405304|NCT00981435|20716161|P1|STARTED|Overall Study||31
8405305|NCT00981409|20716174|P2|NOT COMPLETED|Overall Study||1
8405306|NCT00981409|20716175|P1|NOT COMPLETED|Overall Study||6
8405307|NCT00981409|20716174|P2|COMPLETED|Overall Study||10
8405308|NCT00981409|20716175|P1|COMPLETED|Overall Study||24
8405309|NCT00981409|20716174|P2|STARTED|Overall Study||11
8405310|NCT00981409|20716175|P1|STARTED|Overall Study||30
8405311|NCT00981370|20716189|P1|NOT COMPLETED|Overall Study||0
8405312|NCT00981370|20716189|P1|COMPLETED|Overall Study||0
8405313|NCT00981370|20716189|P1|STARTED|Overall Study||0
8405314|NCT00981305|20716195|P2|NOT COMPLETED|Overall Study||10
8405315|NCT00981305|20716196|P1|NOT COMPLETED|Overall Study||19
8405316|NCT00981305|20716195|P2|COMPLETED|Overall Study||57
8405317|NCT00981305|20716196|P1|COMPLETED|Overall Study||50
8405318|NCT00981305|20716195|P2|STARTED|Overall Study||67
8405319|NCT00981305|20716196|P1|STARTED|Overall Study||69
8405320|NCT00981292|20716214|P6|NOT COMPLETED|Day 3||1
8405321|NCT00981292|20716215|P5|NOT COMPLETED|Day 3||0
8405322|NCT00981292|20716216|P4|NOT COMPLETED|Day 3||0
8405323|NCT00981292|20716217|P3|NOT COMPLETED|Day 3||0
8405324|NCT00981292|20716218|P2|NOT COMPLETED|Day 3||0
8405325|NCT00981292|20716219|P1|NOT COMPLETED|Day 3||0
8405326|NCT00981292|20716214|P6|COMPLETED|Day 3||4
8405327|NCT00981292|20716215|P5|COMPLETED|Day 3||4
8405328|NCT00981292|20716216|P4|COMPLETED|Day 3||4
8405329|NCT00981292|20716217|P3|COMPLETED|Day 3||6
8405330|NCT00981292|20716218|P2|COMPLETED|Day 3||4
8405331|NCT00981292|20716219|P1|COMPLETED|Day 3||4
8405332|NCT00981292|20716214|P6|STARTED|Day 3||5
8405333|NCT00981292|20716215|P5|STARTED|Day 3||4
8405334|NCT00981292|20716216|P4|STARTED|Day 3||4
8405335|NCT00981292|20716217|P3|STARTED|Day 3||6
8405336|NCT00981292|20716218|P2|STARTED|Day 3||4
8405337|NCT00981292|20716219|P1|STARTED|Day 3||4
8405338|NCT00981292|20716214|P6|NOT COMPLETED|Day 2||0
8405339|NCT00981292|20716215|P5|NOT COMPLETED|Day 2||0
8405340|NCT00981292|20716216|P4|NOT COMPLETED|Day 2||0
8405341|NCT00981292|20716217|P3|NOT COMPLETED|Day 2||0
8405342|NCT00981292|20716218|P2|NOT COMPLETED|Day 2||0
8405343|NCT00981292|20716219|P1|NOT COMPLETED|Day 2||2
8405344|NCT00981292|20716214|P6|COMPLETED|Day 2||5
8405345|NCT00981292|20716215|P5|COMPLETED|Day 2||4
8405346|NCT00981292|20716216|P4|COMPLETED|Day 2||4
8405347|NCT00981292|20716217|P3|COMPLETED|Day 2||6
8405348|NCT00981292|20716218|P2|COMPLETED|Day 2||4
8405349|NCT00981292|20716219|P1|COMPLETED|Day 2||4
8405350|NCT00981292|20716214|P6|STARTED|Day 2||5
8405351|NCT00981292|20716215|P5|STARTED|Day 2||4
8405352|NCT00981292|20716216|P4|STARTED|Day 2||4
8405353|NCT00981292|20716217|P3|STARTED|Day 2||6
8405354|NCT00981292|20716218|P2|STARTED|Day 2||4
8405355|NCT00981292|20716219|P1|STARTED|Day 2||6
8405356|NCT00981292|20716214|P6|NOT COMPLETED|Day 1||2
8405357|NCT00981292|20716215|P5|NOT COMPLETED|Day 1||0
8405358|NCT00981292|20716216|P4|NOT COMPLETED|Day 1||0
8405359|NCT00981292|20716217|P3|NOT COMPLETED|Day 1||0
8405360|NCT00981292|20716218|P2|NOT COMPLETED|Day 1||0
8405361|NCT00981292|20716219|P1|NOT COMPLETED|Day 1||1
8405362|NCT00981292|20716214|P6|COMPLETED|Day 1||5
8405363|NCT00981292|20716215|P5|COMPLETED|Day 1||4
8405364|NCT00981292|20716216|P4|COMPLETED|Day 1||4
8405365|NCT00981292|20716217|P3|COMPLETED|Day 1||6
8405366|NCT00981292|20716218|P2|COMPLETED|Day 1||4
8405367|NCT00981292|20716219|P1|COMPLETED|Day 1||6
8405368|NCT00981292|20716214|P6|STARTED|Day 1||7
8405369|NCT00981292|20716215|P5|STARTED|Day 1||4
8405370|NCT00981292|20716216|P4|STARTED|Day 1||4
8405371|NCT00981292|20716217|P3|STARTED|Day 1||6
8405372|NCT00981292|20716218|P2|STARTED|Day 1||4
8405373|NCT00981292|20716219|P1|STARTED|Day 1||7
8405374|NCT00981253|20716238|P2|NOT COMPLETED|Overall Study||3
8405375|NCT00981253|20716239|P1|NOT COMPLETED|Overall Study||3
8405376|NCT00981253|20716238|P2|COMPLETED|Overall Study||72
8405377|NCT00981253|20716239|P1|COMPLETED|Overall Study||73
8405378|NCT00981253|20716238|P2|STARTED|Overall Study||75
8405379|NCT00981253|20716239|P1|STARTED|Overall Study||76
8405380|NCT00981227|20716263|P6|NOT COMPLETED|Overall Study||18
8405381|NCT00981227|20716264|P5|NOT COMPLETED|Overall Study||30
8405382|NCT00981227|20716265|P4|NOT COMPLETED|Overall Study||21
8405383|NCT00981227|20716266|P3|NOT COMPLETED|Overall Study||21
8405384|NCT00981227|20716267|P2|NOT COMPLETED|Overall Study||19
8405385|NCT00981227|20716268|P1|NOT COMPLETED|Overall Study||22
8405386|NCT00981227|20716263|P6|COMPLETED|Overall Study||75
8405387|NCT00981227|20716264|P5|COMPLETED|Overall Study||60
8405388|NCT00981227|20716265|P4|COMPLETED|Overall Study||73
8405389|NCT00981227|20716266|P3|COMPLETED|Overall Study||73
8405390|NCT00981227|20716267|P2|COMPLETED|Overall Study||75
8405391|NCT00981227|20716268|P1|COMPLETED|Overall Study||80
8405392|NCT00981227|20716263|P6|Per-Protocol|Overall Study||70
8405393|NCT00981227|20716264|P5|Per-Protocol|Overall Study||50
8405394|NCT00981227|20716265|P4|Per-Protocol|Overall Study||68
8405395|NCT00981227|20716266|P3|Per-Protocol|Overall Study||67
8405396|NCT00981227|20716267|P2|Per-Protocol|Overall Study||72
8405397|NCT00981227|20716268|P1|Per-Protocol|Overall Study||69
8405398|NCT00981227|20716263|P6|Safety Population|Overall Study||93
8405399|NCT00981227|20716264|P5|Safety Population|Overall Study||90
8405400|NCT00981227|20716265|P4|Safety Population|Overall Study||94
8405401|NCT00981227|20716266|P3|Safety Population|Overall Study||94
8405402|NCT00981227|20716267|P2|Safety Population|Overall Study||94
8405403|NCT00981227|20716268|P1|Safety Population|Overall Study||102
8405404|NCT00981227|20716263|P6|Randomized|Overall Study||93
8405405|NCT00981227|20716264|P5|Randomized|Overall Study||90
8405406|NCT00981227|20716265|P4|Randomized|Overall Study||94
8405407|NCT00981227|20716266|P3|Randomized|Overall Study||94
8405408|NCT00981227|20716267|P2|Randomized|Overall Study||94
8405409|NCT00981227|20716268|P1|Randomized|Overall Study||102
8405410|NCT00981227|20716263|P6|STARTED|Overall Study||93
8405411|NCT00981227|20716264|P5|STARTED|Overall Study||90
8405412|NCT00981227|20716265|P4|STARTED|Overall Study||94
8405413|NCT00981227|20716266|P3|STARTED|Overall Study||94
8405414|NCT00981227|20716267|P2|STARTED|Overall Study||94
8405415|NCT00981227|20716268|P1|STARTED|Overall Study||102
8405416|NCT00981214|20716286|P1|NOT COMPLETED|Overall Study||0
8405417|NCT00981214|20716286|P1|COMPLETED|Overall Study||19
8405418|NCT00981214|20716286|P1|STARTED|Overall Study||19
8405419|NCT00981175|20716303|P2|NOT COMPLETED|Booster Dose Vaccination||3
8405420|NCT00981175|20716304|P1|NOT COMPLETED|Booster Dose Vaccination||2
8405421|NCT00981175|20716303|P2|COMPLETED|Booster Dose Vaccination||40
8405422|NCT00981175|20716304|P1|COMPLETED|Booster Dose Vaccination||53
8405423|NCT00981175|20716303|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
8405424|NCT00981175|20716304|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
8405425|NCT00981175|20716303|P2|NOT COMPLETED|Primary Dose Vaccination||2
8405426|NCT00981175|20716304|P1|NOT COMPLETED|Primary Dose Vaccination||3
8405427|NCT00981175|20716303|P2|COMPLETED|Primary Dose Vaccination||99
8405428|NCT00981175|20716304|P1|COMPLETED|Primary Dose Vaccination||98
8405429|NCT00981175|20716303|P2|STARTED|Primary Dose Vaccination||101
8405430|NCT00981175|20716304|P1|STARTED|Primary Dose Vaccination||101
8405431|NCT00981149|20716329|P2|NOT COMPLETED|Overall Study||3
8405432|NCT00981149|20716330|P1|NOT COMPLETED|Overall Study||2
8405433|NCT00981149|20716329|P2|COMPLETED|Overall Study||9
8405434|NCT00981149|20716330|P1|COMPLETED|Overall Study||10
8405435|NCT00981149|20716329|P2|STARTED|Overall Study||12
8405436|NCT00981149|20716330|P1|STARTED|Overall Study||12
8405437|NCT00981084|20716340|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
8405438|NCT00981084|20716341|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
8405439|NCT00981084|20716340|P2|COMPLETED|Post Intervention (Data Analysis)||16
8405440|NCT00981084|20716341|P1|COMPLETED|Post Intervention (Data Analysis)||14
8405441|NCT00981084|20716340|P2|STARTED|Post Intervention (Data Analysis)||17
8405442|NCT00981084|20716341|P1|STARTED|Post Intervention (Data Analysis)||16
8405443|NCT00981084|20716340|P2|NOT COMPLETED|Second Intervention (One Day)||0
8405444|NCT00981084|20716341|P1|NOT COMPLETED|Second Intervention (One Day)||0
8405445|NCT00981084|20716340|P2|COMPLETED|Second Intervention (One Day)||17
8405446|NCT00981084|20716341|P1|COMPLETED|Second Intervention (One Day)||16
8405447|NCT00981084|20716340|P2|STARTED|Second Intervention (One Day)||17
8405448|NCT00981084|20716341|P1|STARTED|Second Intervention (One Day)||16
8405449|NCT00981084|20716340|P2|NOT COMPLETED|Washout Period (7 Days)||0
8405450|NCT00981084|20716341|P1|NOT COMPLETED|Washout Period (7 Days)||0
8405451|NCT00981084|20716340|P2|COMPLETED|Washout Period (7 Days)||17
8405452|NCT00981084|20716341|P1|COMPLETED|Washout Period (7 Days)||16
8405453|NCT00981084|20716340|P2|STARTED|Washout Period (7 Days)||17
8405454|NCT00981084|20716341|P1|STARTED|Washout Period (7 Days)||16
8405455|NCT00981084|20716340|P2|NOT COMPLETED|First Intervention (One Day)||0
8405456|NCT00981084|20716341|P1|NOT COMPLETED|First Intervention (One Day)||0
8405457|NCT00981084|20716340|P2|COMPLETED|First Intervention (One Day)||17
8405458|NCT00981084|20716341|P1|COMPLETED|First Intervention (One Day)||16
8405459|NCT00981084|20716340|P2|STARTED|First Intervention (One Day)||17
8405460|NCT00981084|20716341|P1|STARTED|First Intervention (One Day)||16
8405461|NCT00981058|20716357|P2|NOT COMPLETED|Overall Study||97
8405462|NCT00981058|20716358|P1|NOT COMPLETED|Overall Study||120
8405463|NCT00981058|20716357|P2|COMPLETED|Overall Study||451
8405464|NCT00981058|20716358|P1|COMPLETED|Overall Study||425
8405465|NCT00981058|20716357|P2|Death Due to Any Cause|Overall Study||442
8405466|NCT00981058|20716358|P1|Death Due to Any Cause|Overall Study||418
8405467|NCT00981058|20716357|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
8405468|NCT00981058|20716358|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
8405469|NCT00981058|20716357|P2|STARTED|Overall Study||548
8405470|NCT00981058|20716358|P1|STARTED|Overall Study||545
8405471|NCT00981045|20716380|P2|NOT COMPLETED|Overall Study||9
8405472|NCT00981045|20716381|P1|NOT COMPLETED|Overall Study||14
8405473|NCT00981045|20716380|P2|COMPLETED|Overall Study||1285
8405474|NCT00981045|20716381|P1|COMPLETED|Overall Study||1276
8405475|NCT00981045|20716380|P2|STARTED|Overall Study||1294
8405476|NCT00981045|20716381|P1|STARTED|Overall Study||1290
8405477|NCT00981019|20716389|P1|NOT COMPLETED|Overall Study||477
8405478|NCT00981019|20716389|P1|COMPLETED|Overall Study||301
8405479|NCT00981019|20716389|P1|STARTED|Overall Study||778
8405480|NCT00980980|20716396|P3|NOT COMPLETED|Overall Study||0
8405481|NCT00980980|20716397|P2|NOT COMPLETED|Overall Study||1
8405482|NCT00980980|20716398|P1|NOT COMPLETED|Overall Study||0
8405483|NCT00980980|20716396|P3|COMPLETED|Overall Study||13
8405484|NCT00980980|20716397|P2|COMPLETED|Overall Study||13
8405485|NCT00980980|20716398|P1|COMPLETED|Overall Study||16
8405486|NCT00980980|20716396|P3|STARTED|Overall Study||13
8405487|NCT00980980|20716397|P2|STARTED|Overall Study||14
8405488|NCT00980980|20716398|P1|STARTED|Overall Study||16
8405489|NCT00980798|20716429|P2|NOT COMPLETED|Overall Study||55
8405490|NCT00980798|20716430|P1|NOT COMPLETED|Overall Study||33
8405491|NCT00980798|20716429|P2|COMPLETED|Overall Study||84
8405492|NCT00980798|20716430|P1|COMPLETED|Overall Study||116
8405493|NCT00980798|20716429|P2|STARTED|Overall Study||139
8405494|NCT00980798|20716430|P1|STARTED|Overall Study||149
8405495|NCT00980785|20716440|P2|NOT COMPLETED|Overall Study||0
8405496|NCT00980785|20716441|P1|NOT COMPLETED|Overall Study||0
8405497|NCT00980785|20716440|P2|COMPLETED|Overall Study||8
8405498|NCT00980785|20716441|P1|COMPLETED|Overall Study||6
8405499|NCT00980785|20716440|P2|STARTED|Overall Study||8
8405500|NCT00980785|20716441|P1|STARTED|Overall Study||6
8405501|NCT00980746|20716459|P6|NOT COMPLETED|Overall Study||18
8405502|NCT00980746|20716460|P5|NOT COMPLETED|Overall Study||17
8405503|NCT00980746|20716461|P4|NOT COMPLETED|Overall Study||36
8405504|NCT00980746|20716462|P3|NOT COMPLETED|Overall Study||20
8405505|NCT00980746|20716463|P2|NOT COMPLETED|Overall Study||22
8405506|NCT00980746|20716464|P1|NOT COMPLETED|Overall Study||27
8405507|NCT00980746|20716459|P6|COMPLETED|Overall Study||78
8405508|NCT00980746|20716460|P5|COMPLETED|Overall Study||75
8405509|NCT00980746|20716461|P4|COMPLETED|Overall Study||64
8405510|NCT00980746|20716462|P3|COMPLETED|Overall Study||75
8405511|NCT00980746|20716463|P2|COMPLETED|Overall Study||67
8405512|NCT00980746|20716464|P1|COMPLETED|Overall Study||58
8405513|NCT00980746|20716459|P6|Per-protocol|Overall Study||74
8405514|NCT00980746|20716460|P5|Per-protocol|Overall Study||73
8405515|NCT00980746|20716461|P4|Per-protocol|Overall Study||62
8405516|NCT00980746|20716462|P3|Per-protocol|Overall Study||73
8405517|NCT00980746|20716463|P2|Per-protocol|Overall Study||66
8405518|NCT00980746|20716464|P1|Per-protocol|Overall Study||55
8405519|NCT00980746|20716459|P6|Safety Population|Overall Study||96
8405520|NCT00980746|20716460|P5|Safety Population|Overall Study||92
8405521|NCT00980746|20716461|P4|Safety Population|Overall Study||100
8405522|NCT00980746|20716462|P3|Safety Population|Overall Study||95
8405523|NCT00980746|20716463|P2|Safety Population|Overall Study||89
8405524|NCT00980746|20716464|P1|Safety Population|Overall Study||85
8405525|NCT00980746|20716459|P6|Randomized|Overall Study||96
8405526|NCT00980746|20716460|P5|Randomized|Overall Study||92
8405527|NCT00980746|20716461|P4|Randomized|Overall Study||100
8405528|NCT00980746|20716462|P3|Randomized|Overall Study||95
8405529|NCT00980746|20716463|P2|Randomized|Overall Study||89
8405530|NCT00980746|20716464|P1|Randomized|Overall Study||85
8405531|NCT00980746|20716459|P6|STARTED|Overall Study||96
8405532|NCT00980746|20716460|P5|STARTED|Overall Study||92
8405533|NCT00980746|20716461|P4|STARTED|Overall Study||100
8405534|NCT00980746|20716462|P3|STARTED|Overall Study||95
8405535|NCT00980746|20716463|P2|STARTED|Overall Study||89
8405536|NCT00980746|20716464|P1|STARTED|Overall Study||85
8405537|NCT00980681|20716478|P1|NOT COMPLETED|Dotarem MRA||0
8405538|NCT00980681|20716478|P1|COMPLETED|Dotarem MRA||10
8405539|NCT00980681|20716478|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
8405540|NCT00980681|20716478|P1|NOT COMPLETED|TOF MRA||0
8405541|NCT00980681|20716478|P1|COMPLETED|TOF MRA||10
8405542|NCT00980681|20716478|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
8405543|NCT00980655|20716486|P2|NOT COMPLETED|Overall Study||51
8405544|NCT00980655|20716487|P1|NOT COMPLETED|Overall Study||16
8405545|NCT00980655|20716486|P2|COMPLETED|Overall Study||139
8405546|NCT00980655|20716487|P1|COMPLETED|Overall Study||45
8405547|NCT00980655|20716486|P2|Vaccinated 23vPS Dose|Overall Study||140
8405548|NCT00980655|20716487|P1|Vaccinated 23vPS Dose|Overall Study||45
8405549|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
8405550|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
8405551|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
8405552|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
8405553|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
8405554|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
8405555|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
8405556|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
8405557|NCT00980655|20716486|P2|STARTED|Overall Study||190
8405558|NCT00980655|20716487|P1|STARTED|Overall Study||61
8405559|NCT00980642|20716535|P2|NOT COMPLETED|Overall Study||0
8405560|NCT00980642|20716536|P1|NOT COMPLETED|Overall Study||0
8405561|NCT00980642|20716535|P2|COMPLETED|Overall Study||20
8405562|NCT00980642|20716536|P1|COMPLETED|Overall Study||36
8405563|NCT00980642|20716535|P2|STARTED|Overall Study||20
8405564|NCT00980642|20716536|P1|STARTED|Overall Study||36
8405565|NCT00980590|20716548|P2|NOT COMPLETED|Overall Study||0
8405566|NCT00980590|20716549|P1|NOT COMPLETED|Overall Study||0
8405567|NCT00980590|20716548|P2|COMPLETED|Overall Study||50
8405568|NCT00980590|20716549|P1|COMPLETED|Overall Study||50
8405569|NCT00980590|20716548|P2|STARTED|Overall Study||50
8405570|NCT00980590|20716549|P1|STARTED|Overall Study||50
8405571|NCT00980395|20716561|P1|NOT COMPLETED|Overall Study||0
8405572|NCT00980395|20716561|P1|COMPLETED|Overall Study||24
8405573|NCT00980395|20716561|P1|STARTED|Overall Study||24
8405574|NCT00980343|20716570|P2|NOT COMPLETED|Overall Study||3
8405575|NCT00980343|20716571|P1|NOT COMPLETED|Overall Study||1
8405576|NCT00980343|20716570|P2|COMPLETED|Overall Study||20
8405577|NCT00980343|20716571|P1|COMPLETED|Overall Study||20
8405578|NCT00980343|20716570|P2|STARTED|Overall Study||23
8405579|NCT00980343|20716571|P1|STARTED|Overall Study||21
8405580|NCT00980330|20716595|P7|NOT COMPLETED|Overall Study||7
8405581|NCT00980330|20716596|P6|NOT COMPLETED|Overall Study||4
8405582|NCT00980330|20716597|P5|NOT COMPLETED|Overall Study||5
8405583|NCT00980330|20716598|P4|NOT COMPLETED|Overall Study||5
8405584|NCT00980330|20716599|P3|NOT COMPLETED|Overall Study||8
8405585|NCT00980330|20716600|P2|NOT COMPLETED|Overall Study||5
8405586|NCT00980330|20716601|P1|NOT COMPLETED|Overall Study||5
8405587|NCT00980330|20716595|P7|COMPLETED|Overall Study||59
8405588|NCT00980330|20716596|P6|COMPLETED|Overall Study||61
8405589|NCT00980330|20716597|P5|COMPLETED|Overall Study||63
8405590|NCT00980330|20716598|P4|COMPLETED|Overall Study||61
8405591|NCT00980330|20716599|P3|COMPLETED|Overall Study||58
8405592|NCT00980330|20716600|P2|COMPLETED|Overall Study||60
8405593|NCT00980330|20716601|P1|COMPLETED|Overall Study||61
8405594|NCT00980330|20716595|P7|STARTED|Overall Study||66
8405595|NCT00980330|20716596|P6|STARTED|Overall Study||65
8405596|NCT00980330|20716597|P5|STARTED|Overall Study||68
8405597|NCT00980330|20716598|P4|STARTED|Overall Study||66
8405598|NCT00980330|20716599|P3|STARTED|Overall Study||66
8405599|NCT00980330|20716600|P2|STARTED|Overall Study||65
8405600|NCT00980330|20716601|P1|STARTED|Overall Study||66
8405601|NCT00980278|20716701|P2|NOT COMPLETED|Overall Study||0
8405602|NCT00980278|20716702|P1|NOT COMPLETED|Overall Study||2
8405603|NCT00980278|20716701|P2|COMPLETED|Overall Study||13
8405604|NCT00980278|20716702|P1|COMPLETED|Overall Study||11
8405605|NCT00980278|20716701|P2|STARTED|Overall Study||13
8405606|NCT00980278|20716702|P1|STARTED|Overall Study||13
8405607|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 5||0
8405608|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 5||0
8405609|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 5||0
8405610|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 5||0
8405611|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 5||0
8405612|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 5||14
8405613|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 5||16
8405614|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 5||15
8405615|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 5||12
8405616|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 5||15
8405617|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 5||14
8405618|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 5||16
8405619|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 5||15
8405620|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 5||12
8405621|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 5||15
8405622|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 4||0
8405623|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 4||0
8405624|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 4||0
8405625|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 4||0
8405626|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 4||0
8405627|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 4||14
8405628|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 4||16
8405629|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 4||15
8405630|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 4||12
8405631|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 4||15
8405632|NCT00980200|20716716|P5|STARTED|7-day Washout Period 4||14
8405633|NCT00980200|20716717|P4|STARTED|7-day Washout Period 4||16
8405634|NCT00980200|20716718|P3|STARTED|7-day Washout Period 4||15
8405635|NCT00980200|20716719|P2|STARTED|7-day Washout Period 4||12
8405636|NCT00980200|20716720|P1|STARTED|7-day Washout Period 4||15
8405637|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 4||0
8405638|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 4||0
8405639|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 4||0
8405640|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 4||0
8405641|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 4||0
8405642|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 4||14
8405643|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 4||16
8405644|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 4||15
8405645|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 4||12
8405646|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 4||15
8405647|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 4||14
8405648|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 4||16
8405649|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 4||15
8405650|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 4||12
8405651|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 4||15
8405652|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 3||0
8405653|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 3||0
8405654|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 3||0
8405655|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 3||0
8405656|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 3||0
8405657|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 3||14
8405658|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 3||16
8405659|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 3||15
8405660|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 3||12
8405661|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 3||15
8405662|NCT00980200|20716716|P5|STARTED|7-day Washout Period 3||14
8405663|NCT00980200|20716717|P4|STARTED|7-day Washout Period 3||16
8405664|NCT00980200|20716718|P3|STARTED|7-day Washout Period 3||15
8405665|NCT00980200|20716719|P2|STARTED|7-day Washout Period 3||12
8405666|NCT00980200|20716720|P1|STARTED|7-day Washout Period 3||15
8405667|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 3||1
8405668|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 3||0
8405669|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 3||0
8405670|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 3||1
8405671|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 3||0
8405672|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 3||14
8405673|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 3||16
8405674|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 3||15
8405675|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 3||12
8405676|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 3||15
8405677|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 3||15
8405678|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 3||16
8405679|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 3||15
8405680|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 3||13
8405681|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 3||15
8405682|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 2||0
8405683|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 2||0
8405684|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 2||0
8405685|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 2||0
8405686|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 2||0
8405687|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 2||15
8405688|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 2||16
8405689|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 2||15
8405690|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 2||13
8405691|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 2||15
8405692|NCT00980200|20716716|P5|STARTED|7-day Washout Period 2||15
8405693|NCT00980200|20716717|P4|STARTED|7-day Washout Period 2||16
8405694|NCT00980200|20716718|P3|STARTED|7-day Washout Period 2||15
8405695|NCT00980200|20716719|P2|STARTED|7-day Washout Period 2||13
8405696|NCT00980200|20716720|P1|STARTED|7-day Washout Period 2||15
8405697|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 2||0
8405698|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 2||0
8405699|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 2||0
8405700|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 2||0
8405701|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 2||0
8405702|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 2||15
8405703|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 2||16
8405704|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 2||15
8405705|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 2||13
8405706|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 2||15
8405707|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 2||15
8405708|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 2||16
8405709|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 2||15
8405710|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 2||13
8405711|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 2||15
8405712|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 1||0
8405713|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 1||0
8405714|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 1||0
8405715|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 1||0
8405716|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 1||0
8405717|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 1||15
8405718|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 1||16
8405719|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 1||15
8405720|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 1||13
8405721|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 1||15
8405722|NCT00980200|20716716|P5|STARTED|7-day Washout Period 1||15
8405723|NCT00980200|20716717|P4|STARTED|7-day Washout Period 1||16
8405724|NCT00980200|20716718|P3|STARTED|7-day Washout Period 1||15
8405725|NCT00980200|20716719|P2|STARTED|7-day Washout Period 1||13
8405726|NCT00980200|20716720|P1|STARTED|7-day Washout Period 1||15
8405727|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 1||0
8405728|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 1||0
8405729|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 1||0
8405730|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 1||1
8405731|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 1||0
8405732|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 1||15
8405733|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 1||16
8405734|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 1||15
8405735|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 1||13
8405736|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 1||15
8405737|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 1||15
8405738|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 1||16
8405739|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 1||15
8405740|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 1||14
8405741|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 1||15
8405742|NCT00980174|20716739|P2|NOT COMPLETED|Overall Study||10
8405743|NCT00980174|20716740|P1|NOT COMPLETED|Overall Study||4
8405744|NCT00980174|20716739|P2|COMPLETED|Overall Study||111
8405745|NCT00980174|20716740|P1|COMPLETED|Overall Study||117
8405746|NCT00980174|20716739|P2|STARTED|Overall Study||121
8405747|NCT00980174|20716740|P1|STARTED|Overall Study||121
8405748|NCT00980148|20716758|P2|NOT COMPLETED|Overall Study||128
8405749|NCT00980148|20716759|P1|NOT COMPLETED|Overall Study||129
8405750|NCT00980148|20716758|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
8405751|NCT00980148|20716759|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
8405752|NCT00980148|20716758|P2|STARTED|Overall Study||283
8405753|NCT00980148|20716759|P1|STARTED|Overall Study||284
8405754|NCT00980057|20716767|P2|NOT COMPLETED|Overall Study||5
8405755|NCT00980057|20716768|P1|NOT COMPLETED|Overall Study||19
8405756|NCT00980057|20716767|P2|COMPLETED|Overall Study||155
8405757|NCT00980057|20716768|P1|COMPLETED|Overall Study||299
8405758|NCT00980057|20716767|P2|STARTED|Overall Study||160
8405759|NCT00980057|20716768|P1|STARTED|Overall Study||318
8405760|NCT00980044|20716791|P3|NOT COMPLETED|Overall Study||5
8405761|NCT00980044|20716792|P2|NOT COMPLETED|Overall Study||7
8405762|NCT00980044|20716793|P1|NOT COMPLETED|Overall Study||5
8405763|NCT00980044|20716791|P3|COMPLETED|Overall Study||12
8405764|NCT00980044|20716792|P2|COMPLETED|Overall Study||12
8405765|NCT00980044|20716793|P1|COMPLETED|Overall Study||12
8405766|NCT00980044|20716791|P3|STARTED|Overall Study||17
8405767|NCT00980044|20716792|P2|STARTED|Overall Study||19
8405768|NCT00980044|20716793|P1|STARTED|Overall Study||17
8405769|NCT00980005|20716812|P2|NOT COMPLETED|Overall Study||63
8405770|NCT00980005|20716813|P1|NOT COMPLETED|Overall Study||47
8405771|NCT00980005|20716812|P2|COMPLETED|Overall Study||998
8405772|NCT00980005|20716813|P1|COMPLETED|Overall Study||1008
8405773|NCT00980005|20716812|P2|STARTED|Overall Study||1061
8405774|NCT00980005|20716813|P1|STARTED|Overall Study||1055
8405775|NCT00979992|20716853|P1|NOT COMPLETED|Overall Study||5
8405776|NCT00979992|20716853|P1|COMPLETED|Overall Study||30
8405777|NCT00979992|20716853|P1|STARTED|Overall Study||35
8405778|NCT00979953|20716865|P4|NOT COMPLETED|Overall Study||7
8405779|NCT00979953|20716866|P3|NOT COMPLETED|Overall Study||22
8405780|NCT00979953|20716867|P2|NOT COMPLETED|Overall Study||5
8405781|NCT00979953|20716868|P1|NOT COMPLETED|Overall Study||8
8405782|NCT00979953|20716865|P4|COMPLETED|Overall Study||97
8405783|NCT00979953|20716866|P3|COMPLETED|Overall Study||82
8405784|NCT00979953|20716867|P2|COMPLETED|Overall Study||94
8405785|NCT00979953|20716868|P1|COMPLETED|Overall Study||93
8405786|NCT00979953|20716865|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
8405787|NCT00979953|20716866|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
8405788|NCT00979953|20716867|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
8405789|NCT00979953|20716868|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
8405790|NCT00979953|20716865|P4|STARTED|Overall Study||104
8405791|NCT00979953|20716866|P3|STARTED|Overall Study||104
8405792|NCT00979953|20716867|P2|STARTED|Overall Study||99
8405793|NCT00979953|20716868|P1|STARTED|Overall Study||101
8405794|NCT00979940|20716880|P2|NOT COMPLETED|Overall Study||0
8405795|NCT00979940|20716881|P1|NOT COMPLETED|Overall Study||0
8405796|NCT00979940|20716880|P2|COMPLETED|Overall Study||28
8405797|NCT00979940|20716881|P1|COMPLETED|Overall Study||32
8405798|NCT00979940|20716880|P2|STARTED|Overall Study||28
8405799|NCT00979940|20716881|P1|STARTED|Overall Study||32
8405800|NCT00979901|20716891|P4|NOT COMPLETED|Overall Study||116
8405801|NCT00979901|20716892|P3|NOT COMPLETED|Overall Study||29
8405802|NCT00979901|20716893|P2|NOT COMPLETED|Overall Study||12
8405803|NCT00979901|20716894|P1|NOT COMPLETED|Overall Study||18
8405804|NCT00979901|20716891|P4|COMPLETED|Overall Study||159
8405805|NCT00979901|20716892|P3|COMPLETED|Overall Study||573
8405806|NCT00979901|20716893|P2|COMPLETED|Overall Study||336
8405807|NCT00979901|20716894|P1|COMPLETED|Overall Study||334
8405808|NCT00979901|20716891|P4|STARTED|Overall Study||275
8405809|NCT00979901|20716892|P3|STARTED|Overall Study||602
8405810|NCT00979901|20716893|P2|STARTED|Overall Study||348
8405811|NCT00979901|20716894|P1|STARTED|Overall Study||352
8405812|NCT00979875|20716918|P6|NOT COMPLETED|Intervention 3||0
8405813|NCT00979875|20716919|P5|NOT COMPLETED|Intervention 3||0
8405814|NCT00979875|20716920|P4|NOT COMPLETED|Intervention 3||0
8405815|NCT00979875|20716921|P3|NOT COMPLETED|Intervention 3||0
8405816|NCT00979875|20716922|P2|NOT COMPLETED|Intervention 3||0
8405817|NCT00979875|20716923|P1|NOT COMPLETED|Intervention 3||0
8405818|NCT00979875|20716918|P6|COMPLETED|Intervention 3||2
8405819|NCT00979875|20716919|P5|COMPLETED|Intervention 3||3
8405820|NCT00979875|20716920|P4|COMPLETED|Intervention 3||2
8405821|NCT00979875|20716921|P3|COMPLETED|Intervention 3||3
8405822|NCT00979875|20716922|P2|COMPLETED|Intervention 3||2
8405823|NCT00979875|20716923|P1|COMPLETED|Intervention 3||2
8405824|NCT00979875|20716918|P6|STARTED|Intervention 3||2
8405825|NCT00979875|20716919|P5|STARTED|Intervention 3||3
8405826|NCT00979875|20716920|P4|STARTED|Intervention 3||2
8405827|NCT00979875|20716921|P3|STARTED|Intervention 3||3
8405828|NCT00979875|20716922|P2|STARTED|Intervention 3||2
8405829|NCT00979875|20716923|P1|STARTED|Intervention 3||2
8405830|NCT00979875|20716918|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405831|NCT00979875|20716919|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405832|NCT00979875|20716920|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405833|NCT00979875|20716921|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405834|NCT00979875|20716922|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405835|NCT00979875|20716923|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405836|NCT00979875|20716918|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
8405837|NCT00979875|20716919|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
8405838|NCT00979875|20716920|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
8405839|NCT00979875|20716921|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
8405840|NCT00979875|20716922|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
8405841|NCT00979875|20716923|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
8405842|NCT00979875|20716918|P6|STARTED|Washout 2 (3 to 14 Days)||2
8405843|NCT00979875|20716919|P5|STARTED|Washout 2 (3 to 14 Days)||3
8405844|NCT00979875|20716920|P4|STARTED|Washout 2 (3 to 14 Days)||2
8405845|NCT00979875|20716921|P3|STARTED|Washout 2 (3 to 14 Days)||3
8405846|NCT00979875|20716922|P2|STARTED|Washout 2 (3 to 14 Days)||2
8405847|NCT00979875|20716923|P1|STARTED|Washout 2 (3 to 14 Days)||2
8405848|NCT00979875|20716918|P6|NOT COMPLETED|Intervention 2||0
8405849|NCT00979875|20716919|P5|NOT COMPLETED|Intervention 2||0
8405850|NCT00979875|20716920|P4|NOT COMPLETED|Intervention 2||0
8405851|NCT00979875|20716921|P3|NOT COMPLETED|Intervention 2||0
8405852|NCT00979875|20716922|P2|NOT COMPLETED|Intervention 2||0
8405853|NCT00979875|20716923|P1|NOT COMPLETED|Intervention 2||0
8405854|NCT00979875|20716918|P6|COMPLETED|Intervention 2||2
8405855|NCT00979875|20716919|P5|COMPLETED|Intervention 2||3
8405856|NCT00979875|20716920|P4|COMPLETED|Intervention 2||2
8405857|NCT00979875|20716921|P3|COMPLETED|Intervention 2||3
8405858|NCT00979875|20716922|P2|COMPLETED|Intervention 2||2
8405859|NCT00979875|20716923|P1|COMPLETED|Intervention 2||2
8405860|NCT00979875|20716918|P6|STARTED|Intervention 2||2
8405861|NCT00979875|20716919|P5|STARTED|Intervention 2||3
8405862|NCT00979875|20716920|P4|STARTED|Intervention 2||2
8405863|NCT00979875|20716921|P3|STARTED|Intervention 2||3
8405864|NCT00979875|20716922|P2|STARTED|Intervention 2||2
8405865|NCT00979875|20716923|P1|STARTED|Intervention 2||2
8405866|NCT00979875|20716918|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405867|NCT00979875|20716919|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405868|NCT00979875|20716920|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405869|NCT00979875|20716921|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405870|NCT00979875|20716922|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405871|NCT00979875|20716923|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405872|NCT00979875|20716918|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
8405873|NCT00979875|20716919|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
8405874|NCT00979875|20716920|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
8405875|NCT00979875|20716921|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
8405876|NCT00979875|20716922|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
8405877|NCT00979875|20716923|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
8405878|NCT00979875|20716918|P6|STARTED|Washout 1 (3 to 14 Days)||2
8405879|NCT00979875|20716919|P5|STARTED|Washout 1 (3 to 14 Days)||3
8405880|NCT00979875|20716920|P4|STARTED|Washout 1 (3 to 14 Days)||2
8405881|NCT00979875|20716921|P3|STARTED|Washout 1 (3 to 14 Days)||3
8405882|NCT00979875|20716922|P2|STARTED|Washout 1 (3 to 14 Days)||2
8405883|NCT00979875|20716923|P1|STARTED|Washout 1 (3 to 14 Days)||2
8405884|NCT00979875|20716918|P6|NOT COMPLETED|Intervention 1||0
8405885|NCT00979875|20716919|P5|NOT COMPLETED|Intervention 1||0
8405886|NCT00979875|20716920|P4|NOT COMPLETED|Intervention 1||0
8405887|NCT00979875|20716921|P3|NOT COMPLETED|Intervention 1||0
8405888|NCT00979875|20716922|P2|NOT COMPLETED|Intervention 1||0
8405889|NCT00979875|20716923|P1|NOT COMPLETED|Intervention 1||0
8405890|NCT00979875|20716918|P6|COMPLETED|Intervention 1||2
8405891|NCT00979875|20716919|P5|COMPLETED|Intervention 1||3
8405892|NCT00979875|20716920|P4|COMPLETED|Intervention 1||2
8405893|NCT00979875|20716921|P3|COMPLETED|Intervention 1||3
8405894|NCT00979875|20716922|P2|COMPLETED|Intervention 1||2
8405895|NCT00979875|20716923|P1|COMPLETED|Intervention 1||2
8405896|NCT00979875|20716918|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405897|NCT00979875|20716919|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
8405898|NCT00979875|20716920|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405899|NCT00979875|20716921|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
8405900|NCT00979875|20716922|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405901|NCT00979875|20716923|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405902|NCT00979875|20716918|P6|STARTED|Intervention 1||2
8405903|NCT00979875|20716919|P5|STARTED|Intervention 1||3
8405904|NCT00979875|20716920|P4|STARTED|Intervention 1||2
8405905|NCT00979875|20716921|P3|STARTED|Intervention 1||3
8405906|NCT00979875|20716922|P2|STARTED|Intervention 1||2
8405907|NCT00979875|20716923|P1|STARTED|Intervention 1||2
8405908|NCT00979810|20716967|P1|NOT COMPLETED|Overall Study||0
8405909|NCT00979810|20716967|P1|COMPLETED|Overall Study||11
8405910|NCT00979810|20716967|P1|STARTED|Overall Study||11
8405911|NCT00979654|20716974|P1|NOT COMPLETED|Overall Study||36
8405912|NCT00979654|20716974|P1|COMPLETED|Overall Study||67
8405913|NCT00979654|20716974|P1|STARTED|Overall Study||103
8405914|NCT00979628|20716989|P3|NOT COMPLETED|Overall Study||6
8405915|NCT00979628|20716990|P2|NOT COMPLETED|Overall Study||9
8405916|NCT00979628|20716991|P1|NOT COMPLETED|Overall Study||9
8405917|NCT00979628|20716989|P3|COMPLETED|Overall Study||74
8405918|NCT00979628|20716990|P2|COMPLETED|Overall Study||133
8405919|NCT00979628|20716991|P1|COMPLETED|Overall Study||144
8405920|NCT00979628|20716989|P3|STARTED|Overall Study||80
8405921|NCT00979628|20716990|P2|STARTED|Overall Study||142
8405922|NCT00979628|20716991|P1|STARTED|Overall Study||153
8405923|NCT00979615|20717004|P2|NOT COMPLETED|Overall Study||8
8405924|NCT00979615|20717005|P1|NOT COMPLETED|Overall Study||6
8405925|NCT00979615|20717004|P2|COMPLETED|Overall Study||58
8405926|NCT00979615|20717005|P1|COMPLETED|Overall Study||57
8405927|NCT00979615|20717004|P2|STARTED|Overall Study||66
8405928|NCT00979615|20717005|P1|STARTED|Overall Study||63
8405929|NCT00979602|20717021|P2|NOT COMPLETED|Overall Study||133
8405930|NCT00979602|20717022|P1|NOT COMPLETED|Overall Study||145
8405931|NCT00979602|20717021|P2|COMPLETED|Overall Study||1890
8405932|NCT00979602|20717022|P1|COMPLETED|Overall Study||1880
8405933|NCT00979602|20717021|P2|STARTED|Overall Study||2023
8405934|NCT00979602|20717022|P1|STARTED|Overall Study||2025
8405935|NCT00979576|20717193|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
8405936|NCT00979576|20717194|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
8405937|NCT00979576|20717195|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
8405938|NCT00979576|20717193|P3|COMPLETED|Combination Followed by Monotherapy||0
8405939|NCT00979576|20717194|P2|COMPLETED|Combination Followed by Monotherapy||0
8405940|NCT00979576|20717195|P1|COMPLETED|Combination Followed by Monotherapy||0
8405941|NCT00979576|20717193|P3|STARTED|Combination Followed by Monotherapy||1
8405942|NCT00979576|20717194|P2|STARTED|Combination Followed by Monotherapy||2
8405943|NCT00979576|20717195|P1|STARTED|Combination Followed by Monotherapy||0
8405944|NCT00979576|20717193|P3|NOT COMPLETED|Combination Treatment Phase||9
8405945|NCT00979576|20717194|P2|NOT COMPLETED|Combination Treatment Phase||6
8405946|NCT00979576|20717195|P1|NOT COMPLETED|Combination Treatment Phase||3
8405947|NCT00979576|20717193|P3|COMPLETED|Combination Treatment Phase||0
8405948|NCT00979576|20717194|P2|COMPLETED|Combination Treatment Phase||0
8405949|NCT00979576|20717195|P1|COMPLETED|Combination Treatment Phase||0
8405950|NCT00979576|20717193|P3|STARTED|Combination Treatment Phase||9
8405951|NCT00979576|20717194|P2|STARTED|Combination Treatment Phase||6
8405952|NCT00979576|20717195|P1|STARTED|Combination Treatment Phase||3
8405953|NCT00979550|20717228|P2|NOT COMPLETED|Overall Study||0
8405954|NCT00979550|20717229|P1|NOT COMPLETED|Overall Study||0
8405955|NCT00979550|20717228|P2|COMPLETED|Overall Study||3
8405956|NCT00979550|20717229|P1|COMPLETED|Overall Study||4
8405957|NCT00979550|20717228|P2|STARTED|Overall Study||3
8405958|NCT00979550|20717229|P1|STARTED|Overall Study||4
8405959|NCT00979459|20717235|P2|NOT COMPLETED|Second Intervention||0
8405960|NCT00979459|20717236|P1|NOT COMPLETED|Second Intervention||0
8405961|NCT00979459|20717235|P2|COMPLETED|Second Intervention||6
8405962|NCT00979459|20717236|P1|COMPLETED|Second Intervention||6
8405963|NCT00979459|20717235|P2|STARTED|Second Intervention||6
8405964|NCT00979459|20717236|P1|STARTED|Second Intervention||6
8405965|NCT00979459|20717235|P2|NOT COMPLETED|7-day Washout Period||0
8405966|NCT00979459|20717236|P1|NOT COMPLETED|7-day Washout Period||0
8405967|NCT00979459|20717235|P2|COMPLETED|7-day Washout Period||6
8405968|NCT00979459|20717236|P1|COMPLETED|7-day Washout Period||6
8405969|NCT00979459|20717235|P2|STARTED|7-day Washout Period||6
8405970|NCT00979459|20717236|P1|STARTED|7-day Washout Period||6
8405971|NCT00979459|20717235|P2|NOT COMPLETED|First Intervention||0
8405972|NCT00979459|20717236|P1|NOT COMPLETED|First Intervention||0
8405973|NCT00979459|20717235|P2|COMPLETED|First Intervention||6
8405974|NCT00979459|20717236|P1|COMPLETED|First Intervention||6
8405975|NCT00979459|20717235|P2|STARTED|First Intervention||6
8405976|NCT00979459|20717236|P1|STARTED|First Intervention||6
8405977|NCT00979420|20717252|P4|NOT COMPLETED|Overall Study||2
8405978|NCT00979420|20717253|P3|NOT COMPLETED|Overall Study||1
8405979|NCT00979420|20717254|P2|NOT COMPLETED|Overall Study||0
8405980|NCT00979420|20717255|P1|NOT COMPLETED|Overall Study||7
8405981|NCT00979420|20717252|P4|COMPLETED|Overall Study||59
8405982|NCT00979420|20717253|P3|COMPLETED|Overall Study||59
8405983|NCT00979420|20717254|P2|COMPLETED|Overall Study||57
8405984|NCT00979420|20717255|P1|COMPLETED|Overall Study||171
8405985|NCT00979420|20717252|P4|STARTED|Overall Study||61
8405986|NCT00979420|20717253|P3|STARTED|Overall Study||60
8405987|NCT00979420|20717254|P2|STARTED|Overall Study||57
8405988|NCT00979420|20717255|P1|STARTED|Overall Study||178
8405989|NCT00979407|20717325|P2|NOT COMPLETED|Overall Study||7
8405990|NCT00979407|20717326|P1|NOT COMPLETED|Overall Study||6
8405991|NCT00979407|20717325|P2|COMPLETED|Overall Study||160
8405992|NCT00979407|20717326|P1|COMPLETED|Overall Study||161
8405993|NCT00979407|20717325|P2|STARTED|Overall Study||167
8405994|NCT00979407|20717326|P1|STARTED|Overall Study||167
8405995|NCT00979303|20717368|P2|NOT COMPLETED|Overall Study||0
8405996|NCT00979303|20717369|P1|NOT COMPLETED|Overall Study||0
8405997|NCT00979303|20717368|P2|COMPLETED|Overall Study||37
8405998|NCT00979303|20717369|P1|COMPLETED|Overall Study||37
8405999|NCT00979303|20717368|P2|STARTED|Overall Study||37
8406000|NCT00979303|20717369|P1|STARTED|Overall Study||37
8406001|NCT00979212|20717379|P2|NOT COMPLETED|Overall Study||8
8406002|NCT00979212|20717380|P1|NOT COMPLETED|Overall Study||2
8406003|NCT00979212|20717379|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
8406004|NCT00979212|20717380|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
8406005|NCT00979212|20717379|P2|STARTED|Overall Study||47
8406006|NCT00979212|20717380|P1|STARTED|Overall Study||24
8406007|NCT00979199|20717398|P1|NOT COMPLETED|Overall Study||222
8406008|NCT00979199|20717398|P1|COMPLETED|Overall Study||475
8406009|NCT00979199|20717398|P1|STARTED|Overall Study||697
8406010|NCT00979147|20717404|P2|NOT COMPLETED|Overall Study||0
8406011|NCT00979147|20717405|P1|NOT COMPLETED|Overall Study||0
8406012|NCT00979147|20717404|P2|COMPLETED|Overall Study||0
8406013|NCT00979147|20717405|P1|COMPLETED|Overall Study||0
8406014|NCT00979147|20717404|P2|STARTED|Overall Study||0
8406015|NCT00979147|20717405|P1|STARTED|Overall Study||0
8406016|NCT00979134|20717417|P3|NOT COMPLETED|Overall Study||40
8406017|NCT00979134|20717418|P2|NOT COMPLETED|Overall Study||6
8406018|NCT00979134|20717419|P1|NOT COMPLETED|Overall Study||33
8406019|NCT00979134|20717417|P3|COMPLETED|Overall Study|At DCO|5
8406020|NCT00979134|20717418|P2|COMPLETED|Overall Study|At DCO|0
8406021|NCT00979134|20717419|P1|COMPLETED|Overall Study|At DCO|10
8406022|NCT00979134|20717417|P3|STARTED|Overall Study||45
8406023|NCT00979134|20717418|P2|STARTED|Overall Study||6
8406024|NCT00979134|20717419|P1|STARTED|Overall Study||43
8406025|NCT00979121|20717471|P2|NOT COMPLETED|Overall Study||0
8406026|NCT00979121|20717472|P1|NOT COMPLETED|Overall Study||0
8406027|NCT00979121|20717471|P2|COMPLETED|Overall Study||366
8406028|NCT00979121|20717472|P1|COMPLETED|Overall Study||379
8406029|NCT00979121|20717471|P2|STARTED|Overall Study||366
8406030|NCT00979121|20717472|P1|STARTED|Overall Study||379
8406031|NCT00979069|20717490|P2|NOT COMPLETED|Overall Study||2
8406032|NCT00979069|20717491|P1|NOT COMPLETED|Overall Study||0
8406033|NCT00979069|20717490|P2|COMPLETED|Overall Study||8
8406034|NCT00979069|20717491|P1|COMPLETED|Overall Study||10
8406035|NCT00979069|20717490|P2|STARTED|Overall Study||10
8406036|NCT00979069|20717491|P1|STARTED|Overall Study||10
8406037|NCT00979017|20717497|P1|NOT COMPLETED|Overall Study||0
8406038|NCT00979017|20717497|P1|COMPLETED|Overall Study||41
8406039|NCT00979017|20717497|P1|STARTED|Overall Study||41
8406040|NCT00978757|20717507|P2|NOT COMPLETED|Overall Study||3
8406041|NCT00978757|20717508|P1|NOT COMPLETED|Overall Study||1
8406042|NCT00978757|20717507|P2|COMPLETED|Overall Study|June 2008|17
8406043|NCT00978757|20717508|P1|COMPLETED|Overall Study|June 2008|21
8406044|NCT00978757|20717507|P2|STARTED|Overall Study|June 2001|20
8406045|NCT00978757|20717508|P1|STARTED|Overall Study|June 2001|22
8406046|NCT00978731|20717518|P4|NOT COMPLETED|Overall Study||4
8406047|NCT00978731|20717519|P3|NOT COMPLETED|Overall Study||5
8406048|NCT00978731|20717520|P2|NOT COMPLETED|Overall Study||15
8406049|NCT00978731|20717521|P1|NOT COMPLETED|Overall Study||22
8406050|NCT00978731|20717518|P4|COMPLETED|Overall Study||0
8406051|NCT00978731|20717519|P3|COMPLETED|Overall Study||0
8406052|NCT00978731|20717520|P2|COMPLETED|Overall Study||0
8406053|NCT00978731|20717521|P1|COMPLETED|Overall Study||0
8406054|NCT00978731|20717518|P4|STARTED|Overall Study||4
8406055|NCT00978731|20717519|P3|STARTED|Overall Study||5
8406056|NCT00978731|20717520|P2|STARTED|Overall Study||15
8406057|NCT00978731|20717521|P1|STARTED|Overall Study||22
8406058|NCT00978627|20717561|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
8406059|NCT00978627|20717562|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
8406060|NCT00978627|20717561|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
8406061|NCT00978627|20717562|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
8406062|NCT00978627|20717561|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
8406063|NCT00978627|20717562|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
8406064|NCT00978627|20717561|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
8406065|NCT00978627|20717562|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
8406066|NCT00978627|20717561|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
8406067|NCT00978627|20717562|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
8406068|NCT00978627|20717561|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
8406069|NCT00978627|20717562|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
8406070|NCT00978627|20717561|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
8406071|NCT00978627|20717562|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
8406072|NCT00978562|20717584|P1|NOT COMPLETED|Overall Study||0
8406073|NCT00978562|20717584|P1|COMPLETED|Overall Study||7
8406074|NCT00978562|20717584|P1|STARTED|Overall Study||7
8406075|NCT00978445|20717589|P2|NOT COMPLETED|Overall Study||1
8406076|NCT00978445|20717590|P1|NOT COMPLETED|Overall Study||2
8406077|NCT00978445|20717589|P2|COMPLETED|Overall Study||12
8406078|NCT00978445|20717590|P1|COMPLETED|Overall Study||10
8406079|NCT00978445|20717589|P2|STARTED|Overall Study||13
8406080|NCT00978445|20717590|P1|STARTED|Overall Study||12
8406081|NCT00978432|20717600|P3|NOT COMPLETED|Overall Study||5
8406082|NCT00978432|20717601|P2|NOT COMPLETED|Overall Study||1
8406083|NCT00978432|20717602|P1|NOT COMPLETED|Overall Study||3
8406084|NCT00978432|20717600|P3|COMPLETED|Overall Study||13
8406085|NCT00978432|20717601|P2|COMPLETED|Overall Study||4
8406086|NCT00978432|20717602|P1|COMPLETED|Overall Study||7
8406087|NCT00978432|20717600|P3|STARTED|Overall Study||18
8406088|NCT00978432|20717601|P2|STARTED|Overall Study||5
8406089|NCT00978432|20717602|P1|STARTED|Overall Study||10
8406090|NCT00978419|20717624|P2|NOT COMPLETED|Overall Study||0
8406091|NCT00978419|20717625|P1|NOT COMPLETED|Overall Study||0
8406092|NCT00978419|20717624|P2|COMPLETED|Overall Study||0
8406093|NCT00978419|20717625|P1|COMPLETED|Overall Study||0
8406094|NCT00978419|20717624|P2|STARTED|Overall Study||0
8406095|NCT00978419|20717625|P1|STARTED|Overall Study||0
8406096|NCT00978380|20717653|P1|NOT COMPLETED|Overall Study||19
8406097|NCT00978380|20717653|P1|COMPLETED|Overall Study||44
8406098|NCT00978380|20717653|P1|STARTED|Overall Study||63
8406099|NCT00978341|20717659|P2|NOT COMPLETED|Second Intervention||0
8406100|NCT00978341|20717660|P1|NOT COMPLETED|Second Intervention||0
8406101|NCT00978341|20717659|P2|COMPLETED|Second Intervention||7
8406102|NCT00978341|20717660|P1|COMPLETED|Second Intervention||7
8406103|NCT00978341|20717659|P2|STARTED|Second Intervention||7
8406104|NCT00978341|20717660|P1|STARTED|Second Intervention||7
8406105|NCT00978341|20717659|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8406106|NCT00978341|20717660|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
8406107|NCT00978341|20717659|P2|COMPLETED|Washout Period of 2 Weeks||7
8406108|NCT00978341|20717660|P1|COMPLETED|Washout Period of 2 Weeks||7
8406109|NCT00978341|20717659|P2|STARTED|Washout Period of 2 Weeks||7
8406110|NCT00978341|20717660|P1|STARTED|Washout Period of 2 Weeks||8
8406111|NCT00978341|20717659|P2|NOT COMPLETED|First Intervention||0
8406112|NCT00978341|20717660|P1|NOT COMPLETED|First Intervention||0
8406113|NCT00978341|20717659|P2|COMPLETED|First Intervention||7
8406114|NCT00978341|20717660|P1|COMPLETED|First Intervention||8
8406115|NCT00978341|20717659|P2|STARTED|First Intervention||7
8406116|NCT00978341|20717660|P1|STARTED|First Intervention||8
8406117|NCT00978250|20717682|P4|NOT COMPLETED|Overall Study||1
8406118|NCT00978250|20717683|P3|NOT COMPLETED|Overall Study||0
8406119|NCT00978250|20717684|P2|NOT COMPLETED|Overall Study||1
8406120|NCT00978250|20717685|P1|NOT COMPLETED|Overall Study||0
8406121|NCT00978250|20717682|P4|COMPLETED|Overall Study||21
8406122|NCT00978250|20717683|P3|COMPLETED|Overall Study||18
8406123|NCT00978250|20717684|P2|COMPLETED|Overall Study||29
8406124|NCT00978250|20717685|P1|COMPLETED|Overall Study||25
8406125|NCT00978250|20717682|P4|STARTED|Overall Study||22
8406126|NCT00978250|20717683|P3|STARTED|Overall Study||18
8406127|NCT00978250|20717684|P2|STARTED|Overall Study||30
8406128|NCT00978250|20717685|P1|STARTED|Overall Study||25
8406129|NCT00978120|20717701|P4|NOT COMPLETED|Overall Study||2
8406130|NCT00978120|20717702|P3|NOT COMPLETED|Overall Study||3
8406131|NCT00978120|20717703|P2|NOT COMPLETED|Overall Study||0
8406132|NCT00978120|20717704|P1|NOT COMPLETED|Overall Study||2
8406133|NCT00978120|20717701|P4|COMPLETED|Overall Study||84
8406134|NCT00978120|20717702|P3|COMPLETED|Overall Study||84
8406135|NCT00978120|20717703|P2|COMPLETED|Overall Study||107
8406136|NCT00978120|20717704|P1|COMPLETED|Overall Study||108
8406137|NCT00978120|20717701|P4|STARTED|Overall Study||86
8406138|NCT00978120|20717702|P3|STARTED|Overall Study||87
8406139|NCT00978120|20717703|P2|STARTED|Overall Study||107
8406140|NCT00978120|20717704|P1|STARTED|Overall Study||110
8406141|NCT00978068|20717756|P2|NOT COMPLETED|Overall Study||9
8406142|NCT00978068|20717757|P1|NOT COMPLETED|Overall Study||4
8406143|NCT00978068|20717756|P2|COMPLETED|Overall Study||80
8406144|NCT00978068|20717757|P1|COMPLETED|Overall Study||83
8406145|NCT00978068|20717756|P2|Initiated Study Drugs|Overall Study||86
8406146|NCT00978068|20717757|P1|Initiated Study Drugs|Overall Study||84
8406147|NCT00978068|20717756|P2|STARTED|Overall Study||89
8406148|NCT00978068|20717757|P1|STARTED|Overall Study||87
8406149|NCT00978042|20717775|P2|NOT COMPLETED|Received Repeat Treatment||3
8406150|NCT00978042|20717776|P1|NOT COMPLETED|Received Repeat Treatment||43
8406151|NCT00978042|20717775|P2|COMPLETED|Received Repeat Treatment||23
8406152|NCT00978042|20717776|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
8406153|NCT00978042|20717775|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
8406154|NCT00978042|20717776|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
8406155|NCT00978042|20717775|P2|NOT COMPLETED|Initial Treatment Period||15
8406156|NCT00978042|20717776|P1|NOT COMPLETED|Initial Treatment Period||61
8406157|NCT00978042|20717775|P2|COMPLETED|Initial Treatment Period||32
8406158|NCT00978042|20717776|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
8406159|NCT00978042|20717775|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
8406160|NCT00978042|20717776|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
8406161|NCT00978042|20717775|P2|STARTED|Initial Treatment Period||47
8406162|NCT00978042|20717776|P1|STARTED|Initial Treatment Period||235
8406163|NCT00978029|20717789|P3|NOT COMPLETED|Overall Study||6
8406164|NCT00978029|20717790|P2|NOT COMPLETED|Overall Study||3
8406165|NCT00978029|20717791|P1|NOT COMPLETED|Overall Study||1
8406166|NCT00978029|20717789|P3|COMPLETED|Overall Study||59
8406167|NCT00978029|20717790|P2|COMPLETED|Overall Study||63
8406168|NCT00978029|20717791|P1|COMPLETED|Overall Study||64
8406169|NCT00978029|20717789|P3|STARTED|Overall Study||65
8406170|NCT00978029|20717790|P2|STARTED|Overall Study||66
8406171|NCT00978029|20717791|P1|STARTED|Overall Study||65
8406172|NCT00977938|20717818|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
8406173|NCT00977938|20717819|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
8406174|NCT00977938|20717820|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
8406175|NCT00977938|20717821|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
8406176|NCT00977938|20717818|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
8406177|NCT00977938|20717819|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
8406178|NCT00977938|20717820|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
8406179|NCT00977938|20717821|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
8406180|NCT00977938|20717818|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
8406181|NCT00977938|20717819|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
8406182|NCT00977938|20717820|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
8406183|NCT00977938|20717821|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
8406184|NCT00977938|20717818|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
8406185|NCT00977938|20717819|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
8406186|NCT00977938|20717820|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
8406187|NCT00977938|20717821|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
8406188|NCT00977938|20717818|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
8406189|NCT00977938|20717819|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
8406190|NCT00977938|20717820|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
8406191|NCT00977938|20717821|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
8406192|NCT00977938|20717818|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
8406193|NCT00977938|20717819|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
8406194|NCT00977938|20717820|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
8406195|NCT00977938|20717821|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
8406196|NCT00977808|20717855|P1|NOT COMPLETED|Overall Study||1
8406197|NCT00977808|20717855|P1|COMPLETED|Overall Study||11
8406198|NCT00977808|20717855|P1|Completion of Closed-Loop Admission|Overall Study||11
8406199|NCT00977808|20717855|P1|Completion of Open-Loop Admission|Overall Study||12
8406200|NCT00977808|20717855|P1|STARTED|Overall Study||12
8406201|NCT00977769|20717863|P3|NOT COMPLETED|Overall Study||0
8406202|NCT00977769|20717864|P2|NOT COMPLETED|Overall Study||0
8406203|NCT00977769|20717865|P1|NOT COMPLETED|Overall Study||0
8406204|NCT00977769|20717863|P3|COMPLETED|Overall Study||25
8406205|NCT00977769|20717864|P2|COMPLETED|Overall Study||26
8406206|NCT00977769|20717865|P1|COMPLETED|Overall Study||25
8406207|NCT00977769|20717863|P3|STARTED|Overall Study||25
8406208|NCT00977769|20717864|P2|STARTED|Overall Study||26
8406209|NCT00977769|20717865|P1|STARTED|Overall Study||25
8406210|NCT00977704|20717879|P1|NOT COMPLETED|Overall Study||0
8406211|NCT00977704|20717879|P1|COMPLETED|Overall Study||20
8406212|NCT00977704|20717879|P1|STARTED|Overall Study||20
8406213|NCT00977691|20717886|P3|NOT COMPLETED|Overall Study||0
8406214|NCT00977691|20717887|P2|NOT COMPLETED|Overall Study||1
8406215|NCT00977691|20717888|P1|NOT COMPLETED|Overall Study||0
8406216|NCT00977691|20717886|P3|COMPLETED|Overall Study||12
8406217|NCT00977691|20717887|P2|COMPLETED|Overall Study||7
8406218|NCT00977691|20717888|P1|COMPLETED|Overall Study||3
8406219|NCT00977691|20717886|P3|STARTED|Overall Study||12
8406220|NCT00977691|20717887|P2|STARTED|Overall Study||8
8406221|NCT00977691|20717888|P1|STARTED|Overall Study||3
8406222|NCT00977665|20717898|P2|NOT COMPLETED|Overall Study||15
8406223|NCT00977665|20717899|P1|NOT COMPLETED|Overall Study||21
8406224|NCT00977665|20717898|P2|COMPLETED|Overall Study||75
8406225|NCT00977665|20717899|P1|COMPLETED|Overall Study||63
8406226|NCT00977665|20717898|P2|STARTED|Overall Study||90
8406227|NCT00977665|20717899|P1|STARTED|Overall Study||84
8406228|NCT00977613|20717931|P1|NOT COMPLETED|Overall Study||16
8406229|NCT00977613|20717931|P1|COMPLETED|Overall Study||34
8406230|NCT00977613|20717931|P1|STARTED|Overall Study||50
8406240|NCT00977561|20717959|P2|NOT COMPLETED|Overall Study||4
8406241|NCT00977561|20717960|P1|NOT COMPLETED|Overall Study||5
8406242|NCT00977561|20717959|P2|COMPLETED|Overall Study||0
8406243|NCT00977561|20717960|P1|COMPLETED|Overall Study||0
8406244|NCT00977561|20717959|P2|STARTED|Overall Study||4
8406245|NCT00977561|20717960|P1|STARTED|Overall Study||5
8406246|NCT00977548|20717987|P1|NOT COMPLETED|Overall Study||13
8406247|NCT00977548|20717987|P1|COMPLETED|Overall Study||26
8406248|NCT00977548|20717987|P1|STARTED|Overall Study||39
8406249|NCT00977470|20717996|P2|NOT COMPLETED|Overall Study||38
8406250|NCT00977470|20717997|P1|NOT COMPLETED|Overall Study||38
8406251|NCT00977470|20717996|P2|COMPLETED|Overall Study||0
8406252|NCT00977470|20717997|P1|COMPLETED|Overall Study||0
8406253|NCT00977470|20717996|P2|STARTED|Overall Study||38
8406254|NCT00977470|20717997|P1|STARTED|Overall Study||38
8406255|NCT00977431|20718020|P5|NOT COMPLETED|Overall Study||13
8406256|NCT00977431|20718021|P4|NOT COMPLETED|Overall Study||3
8406257|NCT00977431|20718022|P3|NOT COMPLETED|Overall Study||7
8406258|NCT00977431|20718023|P2|NOT COMPLETED|Overall Study||6
8406259|NCT00977431|20718024|P1|NOT COMPLETED|Overall Study||7
8406260|NCT00977431|20718020|P5|COMPLETED|Overall Study||0
8406261|NCT00977431|20718021|P4|COMPLETED|Overall Study||0
8406262|NCT00977431|20718022|P3|COMPLETED|Overall Study||0
8406263|NCT00977431|20718023|P2|COMPLETED|Overall Study||0
8406264|NCT00977431|20718024|P1|COMPLETED|Overall Study||0
8406265|NCT00977431|20718020|P5|Discontinued Afatinib Before/on Day 42|Overall Study||3
8406266|NCT00977431|20718021|P4|Discontinued Afatinib Before/on Day 42|Overall Study||0
8406267|NCT00977431|20718022|P3|Discontinued Afatinib Before/on Day 42|Overall Study||4
8406268|NCT00977431|20718023|P2|Discontinued Afatinib Before/on Day 42|Overall Study||0
8406269|NCT00977431|20718024|P1|Discontinued Afatinib Before/on Day 42|Overall Study||1
8406270|NCT00977431|20718020|P5|STARTED|Overall Study||13
8406271|NCT00977431|20718021|P4|STARTED|Overall Study||3
8406272|NCT00977431|20718022|P3|STARTED|Overall Study||7
8406273|NCT00977431|20718023|P2|STARTED|Overall Study||6
8406274|NCT00977431|20718024|P1|STARTED|Overall Study||7
8406275|NCT00977379|20718057|P2|NOT COMPLETED|Overall Study||12
8406276|NCT00977379|20718058|P1|NOT COMPLETED|Overall Study||12
8406277|NCT00977379|20718057|P2|COMPLETED|Overall Study||0
8406278|NCT00977379|20718058|P1|COMPLETED|Overall Study||0
8406279|NCT00977379|20718057|P2|Treated|Overall Study||11
8406280|NCT00977379|20718058|P1|Treated|Overall Study||12
8406281|NCT00977379|20718057|P2|STARTED|Overall Study|Randomized|12
8406282|NCT00977379|20718058|P1|STARTED|Overall Study|Randomized|12
8406283|NCT00977314|20718094|P2|NOT COMPLETED|Overall Study||0
8406284|NCT00977314|20718095|P1|NOT COMPLETED|Overall Study||2
8406285|NCT00977314|20718094|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
8406286|NCT00977314|20718095|P1|COMPLETED|Overall Study||28
8406287|NCT00977314|20718094|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
8406288|NCT00977314|20718095|P1|STARTED|Overall Study||30
8406289|NCT00977197|20718103|P2|NOT COMPLETED|Overall Study||9
8406290|NCT00977197|20718104|P1|NOT COMPLETED|Overall Study||9
8406291|NCT00977197|20718103|P2|COMPLETED|Overall Study||35
8406292|NCT00977197|20718104|P1|COMPLETED|Overall Study||32
8406293|NCT00977197|20718103|P2|STARTED|Overall Study||44
8406294|NCT00977197|20718104|P1|STARTED|Overall Study||41
8406295|NCT00977184|20718134|P2|NOT COMPLETED|Overall Study||0
8406296|NCT00977184|20718135|P1|NOT COMPLETED|Overall Study||0
8406297|NCT00977184|20718134|P2|COMPLETED|Overall Study||13
8406298|NCT00977184|20718135|P1|COMPLETED|Overall Study||13
8406299|NCT00977184|20718134|P2|STARTED|Overall Study||13
8406300|NCT00977184|20718135|P1|STARTED|Overall Study||13
8406301|NCT00977171|20718161|P1|NOT COMPLETED|Overall Study||0
8406302|NCT00977171|20718161|P1|COMPLETED|Overall Study||3
8406303|NCT00977171|20718161|P1|STARTED|Overall Study||3
8406304|NCT00977106|20718167|P2|NOT COMPLETED|Overall Study||11
8406305|NCT00977106|20718168|P1|NOT COMPLETED|Overall Study||10
8406306|NCT00977106|20718167|P2|COMPLETED|Overall Study||45
8406307|NCT00977106|20718168|P1|COMPLETED|Overall Study||37
8406308|NCT00977106|20718167|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
8406309|NCT00977106|20718168|P1|STARTED|Overall Study||47
8406310|NCT00977080|20718260|P4|NOT COMPLETED|Overall Study||17
8406311|NCT00977080|20718261|P3|NOT COMPLETED|Overall Study||16
8406312|NCT00977080|20718262|P2|NOT COMPLETED|Overall Study||20
8406313|NCT00977080|20718263|P1|NOT COMPLETED|Overall Study||12
8406314|NCT00977080|20718260|P4|COMPLETED|Overall Study||53
8406315|NCT00977080|20718261|P3|COMPLETED|Overall Study||56
8406316|NCT00977080|20718262|P2|COMPLETED|Overall Study||44
8406317|NCT00977080|20718263|P1|COMPLETED|Overall Study||50
8406318|NCT00977080|20718260|P4|STARTED|Overall Study||70
8406319|NCT00977080|20718261|P3|STARTED|Overall Study||72
8406320|NCT00977080|20718262|P2|STARTED|Overall Study||64
8406321|NCT00977080|20718263|P1|STARTED|Overall Study||62
8406322|NCT00976989|20718296|P3|NOT COMPLETED|Overall Study||17
8406323|NCT00976989|20718297|P2|NOT COMPLETED|Overall Study||12
8406324|NCT00976989|20718298|P1|NOT COMPLETED|Overall Study||13
8406325|NCT00976989|20718296|P3|COMPLETED|Overall Study||60
8406326|NCT00976989|20718297|P2|COMPLETED|Overall Study||63
8406327|NCT00976989|20718298|P1|COMPLETED|Overall Study||60
8406328|NCT00976989|20718296|P3|STARTED|Overall Study||77
8406329|NCT00976989|20718297|P2|STARTED|Overall Study||75
8406330|NCT00976989|20718298|P1|STARTED|Overall Study||73
8406331|NCT00976950|20718339|P1|NOT COMPLETED|Overall Study||6
8406332|NCT00976950|20718339|P1|COMPLETED|Overall Study||36
8406333|NCT00976950|20718339|P1|STARTED|Overall Study||42
8406334|NCT00976937|20718347|P2|NOT COMPLETED|Overall Study||11
8406335|NCT00976937|20718348|P1|NOT COMPLETED|Overall Study||16
8406336|NCT00976937|20718347|P2|COMPLETED|Overall Study||150
8406337|NCT00976937|20718348|P1|COMPLETED|Overall Study||142
8406338|NCT00976937|20718347|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
8406339|NCT00976937|20718348|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
8406340|NCT00976937|20718347|P2|Treated/Safety Population|Overall Study||161
8406341|NCT00976937|20718348|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
8406342|NCT00976937|20718347|P2|STARTED|Overall Study||161
8406343|NCT00976937|20718348|P1|STARTED|Overall Study|Randomized|158
8406344|NCT00976911|20718390|P2|NOT COMPLETED|Overall Study||179
8406345|NCT00976911|20718391|P1|NOT COMPLETED|Overall Study||182
8406346|NCT00976911|20718390|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
8406347|NCT00976911|20718391|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
8406348|NCT00976911|20718390|P2|STARTED|Overall Study||179
8406349|NCT00976911|20718391|P1|STARTED|Overall Study||182
8406350|NCT00976898|20718409|P1|NOT COMPLETED|Overall Study||5
8406351|NCT00976898|20718409|P1|COMPLETED|Overall Study||78
8406352|NCT00976898|20718409|P1|STARTED|Overall Study||83
8406353|NCT00976820|20718420|P4|NOT COMPLETED|Overall Study||7
8406354|NCT00976820|20718421|P3|NOT COMPLETED|Overall Study||4
8406355|NCT00976820|20718422|P2|NOT COMPLETED|Overall Study||20
8406356|NCT00976820|20718423|P1|NOT COMPLETED|Overall Study||8
8406357|NCT00976820|20718420|P4|COMPLETED|Overall Study||56
8406358|NCT00976820|20718421|P3|COMPLETED|Overall Study||60
8406359|NCT00976820|20718422|P2|COMPLETED|Overall Study||108
8406360|NCT00976820|20718423|P1|COMPLETED|Overall Study||59
8406361|NCT00976820|20718420|P4|STARTED|Overall Study||63
8406362|NCT00976820|20718421|P3|STARTED|Overall Study||64
8406363|NCT00976820|20718422|P2|STARTED|Overall Study||128
8406364|NCT00976820|20718423|P1|STARTED|Overall Study||67
8406368|NCT00976703|20718777|P2|NOT COMPLETED|Overall Study||3
8406369|NCT00976703|20718778|P1|NOT COMPLETED|Overall Study||3
8406370|NCT00976703|20718777|P2|COMPLETED|Overall Study||95
8406371|NCT00976703|20718778|P1|COMPLETED|Overall Study||96
8406372|NCT00976703|20718777|P2|STARTED|Overall Study||98
8406373|NCT00976703|20718778|P1|STARTED|Overall Study||99
8406374|NCT00976677|20718792|P2|NOT COMPLETED|Overall Study||5
8406375|NCT00976677|20718793|P1|NOT COMPLETED|Overall Study||5
8406376|NCT00976677|20718792|P2|COMPLETED|Overall Study||0
8406377|NCT00976677|20718793|P1|COMPLETED|Overall Study||0
8406378|NCT00976677|20718792|P2|STARTED|Overall Study||5
8406379|NCT00976677|20718793|P1|STARTED|Overall Study||5
8406380|NCT00976664|20718801|P2|NOT COMPLETED|Overall Study||1
8406381|NCT00976664|20718802|P1|NOT COMPLETED|Overall Study||3
8406382|NCT00976664|20718801|P2|COMPLETED|Overall Study||24
8406383|NCT00976664|20718802|P1|COMPLETED|Overall Study||22
8406384|NCT00976664|20718801|P2|STARTED|Overall Study||25
8406385|NCT00976664|20718802|P1|STARTED|Overall Study||25
8406386|NCT00976599|20718812|P2|NOT COMPLETED|Overall Study||0
8406387|NCT00976599|20718813|P1|NOT COMPLETED|Overall Study||0
8406388|NCT00976599|20718812|P2|COMPLETED|Overall Study||14
8406389|NCT00976599|20718813|P1|COMPLETED|Overall Study||15
8406390|NCT00976599|20718812|P2|STARTED|Overall Study||14
8406391|NCT00976599|20718813|P1|STARTED|Overall Study||15
8406392|NCT00976573|20719001|P2|NOT COMPLETED|Overall Study||3
8406393|NCT00976573|20719002|P1|NOT COMPLETED|Overall Study||4
8406394|NCT00976573|20719001|P2|COMPLETED|Overall Study||71
8406395|NCT00976573|20719002|P1|COMPLETED|Overall Study||71
8406396|NCT00976573|20719001|P2|STARTED|Overall Study||74
8406397|NCT00976573|20719002|P1|STARTED|Overall Study||75
8406398|NCT00976560|20719016|P2|NOT COMPLETED|Overall Study||13
8406399|NCT00976560|20719017|P1|NOT COMPLETED|Overall Study||14
8406400|NCT00976560|20719016|P2|COMPLETED|Overall Study||51
8406401|NCT00976560|20719017|P1|COMPLETED|Overall Study||50
8406402|NCT00976560|20719016|P2|STARTED|Overall Study||64
8406403|NCT00976560|20719017|P1|STARTED|Overall Study||64
8406404|NCT00976521|20719069|P4|NOT COMPLETED|Overall Study||19
8406405|NCT00976521|20719070|P3|NOT COMPLETED|Overall Study||9
8406406|NCT00976521|20719071|P2|NOT COMPLETED|Overall Study||12
8406407|NCT00976521|20719072|P1|NOT COMPLETED|Overall Study||9
8406408|NCT00976521|20719069|P4|COMPLETED|Overall Study||93
8406409|NCT00976521|20719070|P3|COMPLETED|Overall Study||102
8406410|NCT00976521|20719071|P2|COMPLETED|Overall Study||99
8406411|NCT00976521|20719072|P1|COMPLETED|Overall Study||109
8406412|NCT00976521|20719069|P4|STARTED|Overall Study||112
8406413|NCT00976521|20719070|P3|STARTED|Overall Study||111
8406414|NCT00976521|20719071|P2|STARTED|Overall Study||111
8406415|NCT00976521|20719072|P1|STARTED|Overall Study||118
8406416|NCT00976508|20719086|P2|NOT COMPLETED|Overall Study||6
8406417|NCT00976508|20719087|P1|NOT COMPLETED|Overall Study||14
8406418|NCT00976508|20719086|P2|COMPLETED|Overall Study||0
8406419|NCT00976508|20719087|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
8406420|NCT00976508|20719086|P2|STARTED|Overall Study||6
8406421|NCT00976508|20719087|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
8406422|NCT00976495|20719120|P3|NOT COMPLETED|Overall Study||0
8406423|NCT00976495|20719121|P2|NOT COMPLETED|Overall Study||1
8406424|NCT00976495|20719122|P1|NOT COMPLETED|Overall Study||0
8406425|NCT00976495|20719120|P3|COMPLETED|Overall Study||26
8406426|NCT00976495|20719121|P2|COMPLETED|Overall Study||23
8406427|NCT00976495|20719122|P1|COMPLETED|Overall Study||25
8406428|NCT00976495|20719120|P3|STARTED|Overall Study||26
8406429|NCT00976495|20719121|P2|STARTED|Overall Study||24
8406430|NCT00976495|20719122|P1|STARTED|Overall Study||25
8406431|NCT00976482|20719139|P1|NOT COMPLETED|Overall Study||259
8406432|NCT00976482|20719139|P1|COMPLETED|Overall Study||1486
8406433|NCT00976482|20719139|P1|Eligible for Last Follow up|Overall Study||1487
8406434|NCT00976482|20719139|P1|STARTED|Overall Study||1745
8406435|NCT00976456|20719145|P2|NOT COMPLETED|Overall Study||38
8406436|NCT00976456|20719146|P1|NOT COMPLETED|Overall Study||43
8406437|NCT00976456|20719145|P2|COMPLETED|Overall Study||98
8406438|NCT00976456|20719146|P1|COMPLETED|Overall Study||92
8406439|NCT00976456|20719145|P2|STARTED|Overall Study||136
8406440|NCT00976456|20719146|P1|STARTED|Overall Study||135
8406441|NCT00976404|20719156|P2|NOT COMPLETED|Overall Study||0
8406442|NCT00976404|20719157|P1|NOT COMPLETED|Overall Study||0
8406443|NCT00976404|20719156|P2|COMPLETED|Overall Study||14
8406444|NCT00976404|20719157|P1|COMPLETED|Overall Study||14
8406445|NCT00976404|20719156|P2|STARTED|Overall Study||14
8406446|NCT00976404|20719157|P1|STARTED|Overall Study||14
8406447|NCT00976391|20719173|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
8406448|NCT00976391|20719174|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
8406449|NCT00976391|20719173|P2|COMPLETED|Follow-up Period (8 Weeks)||247
8406450|NCT00976391|20719174|P1|COMPLETED|Follow-up Period (8 Weeks)||256
8406451|NCT00976391|20719173|P2|STARTED|Follow-up Period (8 Weeks)||281
8406452|NCT00976391|20719174|P1|STARTED|Follow-up Period (8 Weeks)||285
8406453|NCT00976391|20719173|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
8406454|NCT00976391|20719174|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
8406455|NCT00976391|20719173|P2|COMPLETED|Treatment Period (52 Weeks)||242
8406456|NCT00976391|20719174|P1|COMPLETED|Treatment Period (52 Weeks)||243
8406457|NCT00976391|20719173|P2|STARTED|Treatment Period (52 Weeks)||281
8406458|NCT00976391|20719174|P1|STARTED|Treatment Period (52 Weeks)||285
8406459|NCT00976352|20719196|P2|NOT COMPLETED|Overall Study||4
8406460|NCT00976352|20719197|P1|NOT COMPLETED|Overall Study||0
8406461|NCT00976352|20719196|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
8406462|NCT00976352|20719197|P1|COMPLETED|Overall Study||3
8406463|NCT00976352|20719196|P2|STARTED|Overall Study||10
8406464|NCT00976352|20719197|P1|STARTED|Overall Study||3
8406465|NCT00976339|20719211|P2|NOT COMPLETED|Overall Study||0
8406466|NCT00976339|20719212|P1|NOT COMPLETED|Overall Study||0
8406467|NCT00976339|20719211|P2|COMPLETED|Overall Study||10
8406468|NCT00976339|20719212|P1|COMPLETED|Overall Study||10
8406469|NCT00976339|20719211|P2|STARTED|Overall Study||10
8406470|NCT00976339|20719212|P1|STARTED|Overall Study||10
8406471|NCT00976274|20719222|P2|NOT COMPLETED|Overall Study||8
8406472|NCT00976274|20719223|P1|NOT COMPLETED|Overall Study||7
8406473|NCT00976274|20719222|P2|COMPLETED|Overall Study||21
8406474|NCT00976274|20719223|P1|COMPLETED|Overall Study||24
8406475|NCT00976274|20719222|P2|STARTED|Overall Study||29
8406476|NCT00976274|20719223|P1|STARTED|Overall Study||31
8406477|NCT00976248|20719231|P1|NOT COMPLETED|Overall Study||0
8406478|NCT00976248|20719231|P1|COMPLETED|Overall Study||33
8406479|NCT00976248|20719231|P1|STARTED|Overall Study||33
8406480|NCT00976209|20719239|P2|NOT COMPLETED|Treatment Period 2||2
8406481|NCT00976209|20719240|P1|NOT COMPLETED|Treatment Period 2||0
8406482|NCT00976209|20719239|P2|COMPLETED|Treatment Period 2||161
8406483|NCT00976209|20719240|P1|COMPLETED|Treatment Period 2||158
8406484|NCT00976209|20719239|P2|STARTED|Treatment Period 2||163
8406485|NCT00976209|20719240|P1|STARTED|Treatment Period 2||158
8406486|NCT00976209|20719239|P2|NOT COMPLETED|Wash-out Period||2
8406487|NCT00976209|20719240|P1|NOT COMPLETED|Wash-out Period||4
8406488|NCT00976209|20719239|P2|COMPLETED|Wash-out Period||163
8406489|NCT00976209|20719240|P1|COMPLETED|Wash-out Period||158
8406490|NCT00976209|20719239|P2|STARTED|Wash-out Period||165
8406491|NCT00976209|20719240|P1|STARTED|Wash-out Period||162
8406492|NCT00976209|20719239|P2|NOT COMPLETED|Treatment Period 1||1
8406493|NCT00976209|20719240|P1|NOT COMPLETED|Treatment Period 1||3
8406494|NCT00976209|20719239|P2|COMPLETED|Treatment Period 1||165
8406495|NCT00976209|20719240|P1|COMPLETED|Treatment Period 1||162
8406496|NCT00976209|20719239|P2|STARTED|Treatment Period 1||166
8406497|NCT00976209|20719240|P1|STARTED|Treatment Period 1||165
8406498|NCT00976183|20719246|P1|NOT COMPLETED|Overall Study||0
8406499|NCT00976183|20719246|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
8406500|NCT00976183|20719246|P1|STARTED|Overall Study||18
8406501|NCT00976027|20719253|P2|NOT COMPLETED|Overall Study||215
8406502|NCT00976027|20719254|P1|NOT COMPLETED|Overall Study||411
8406503|NCT00976027|20719253|P2|COMPLETED|Overall Study||2835
8406504|NCT00976027|20719254|P1|COMPLETED|Overall Study||5697
8406505|NCT00976027|20719253|P2|STARTED|Overall Study||3050
8406506|NCT00976027|20719254|P1|STARTED|Overall Study||6108
8406507|NCT00975975|20719266|P1|NOT COMPLETED|Overall Study||6
8406508|NCT00975975|20719266|P1|COMPLETED|Overall Study||11
8406509|NCT00975975|20719266|P1|STARTED|Overall Study||17
8406510|NCT00975923|20719274|P2|NOT COMPLETED|Overall Study||1
8406511|NCT00975923|20719275|P1|NOT COMPLETED|Overall Study||0
8406512|NCT00975923|20719274|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
8406513|NCT00975923|20719275|P1|COMPLETED|Overall Study||30
8406514|NCT00975923|20719274|P2|STARTED|Overall Study||30
8406515|NCT00975923|20719275|P1|STARTED|Overall Study||30
8406516|NCT00975884|20719285|P2|NOT COMPLETED|Overall Study||15
8406517|NCT00975884|20719286|P1|NOT COMPLETED|Overall Study||16
8406518|NCT00975884|20719285|P2|COMPLETED|Overall Study||107
8406519|NCT00975884|20719286|P1|COMPLETED|Overall Study||168
8406520|NCT00975884|20719285|P2|STARTED|Overall Study||122
8406521|NCT00975884|20719286|P1|STARTED|Overall Study||184
8406522|NCT00975806|20719443|P3|NOT COMPLETED|Overall Study||4
8406523|NCT00975806|20719444|P2|NOT COMPLETED|Overall Study||7
8406524|NCT00975806|20719445|P1|NOT COMPLETED|Overall Study||5
8406525|NCT00975806|20719443|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8406526|NCT00975806|20719444|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8406527|NCT00975806|20719445|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8406528|NCT00975806|20719443|P3|STARTED|Overall Study||4
8406529|NCT00975806|20719444|P2|STARTED|Overall Study||7
8406530|NCT00975806|20719445|P1|STARTED|Overall Study||5
8406531|NCT00975780|20719469|P2|NOT COMPLETED|Follow Up||157
8406532|NCT00975780|20719470|P1|NOT COMPLETED|Follow Up||102
8406533|NCT00975780|20719469|P2|COMPLETED|Follow Up||277
8406534|NCT00975780|20719470|P1|COMPLETED|Follow Up||298
8406535|NCT00975780|20719469|P2|STARTED|Follow Up||434
8406536|NCT00975780|20719470|P1|STARTED|Follow Up||400
8406537|NCT00975780|20719469|P2|NOT COMPLETED|Allocation||0
8406538|NCT00975780|20719470|P1|NOT COMPLETED|Allocation||0
8406539|NCT00975780|20719469|P2|COMPLETED|Allocation||434
8406540|NCT00975780|20719470|P1|COMPLETED|Allocation||400
8406541|NCT00975780|20719469|P2|STARTED|Allocation||434
8406542|NCT00975780|20719470|P1|STARTED|Allocation||400
8406543|NCT00975715|20719480|P2|NOT COMPLETED|Maintenance Period||1
8406544|NCT00975715|20719481|P1|NOT COMPLETED|Maintenance Period||2
8406545|NCT00975715|20719480|P2|COMPLETED|Maintenance Period||50
8406546|NCT00975715|20719481|P1|COMPLETED|Maintenance Period||39
8406547|NCT00975715|20719480|P2|STARTED|Maintenance Period||51
8406548|NCT00975715|20719481|P1|STARTED|Maintenance Period||41
8406549|NCT00975715|20719480|P2|NOT COMPLETED|Titration Period||0
8406550|NCT00975715|20719481|P1|NOT COMPLETED|Titration Period||7
8406551|NCT00975715|20719480|P2|COMPLETED|Titration Period||51
8406552|NCT00975715|20719481|P1|COMPLETED|Titration Period||41
8406553|NCT00975715|20719480|P2|STARTED|Titration Period||51
8406554|NCT00975715|20719481|P1|STARTED|Titration Period||48
8406555|NCT00975689|20719497|P2|NOT COMPLETED|Overall Study||3
8406556|NCT00975689|20719498|P1|NOT COMPLETED|Overall Study||2
8406557|NCT00975689|20719497|P2|COMPLETED|Overall Study||15
8406558|NCT00975689|20719498|P1|COMPLETED|Overall Study||15
8406559|NCT00975689|20719497|P2|STARTED|Overall Study||18
8406560|NCT00975689|20719498|P1|STARTED|Overall Study||17
8406561|NCT00975650|20719504|P4|NOT COMPLETED|Period 4||0
8406562|NCT00975650|20719505|P3|NOT COMPLETED|Period 4||0
8406563|NCT00975650|20719506|P2|NOT COMPLETED|Period 4||0
8406564|NCT00975650|20719507|P1|NOT COMPLETED|Period 4||0
8406565|NCT00975650|20719504|P4|COMPLETED|Period 4||14
8406566|NCT00975650|20719505|P3|COMPLETED|Period 4||14
8406567|NCT00975650|20719506|P2|COMPLETED|Period 4||14
8406568|NCT00975650|20719507|P1|COMPLETED|Period 4||12
8406569|NCT00975650|20719504|P4|STARTED|Period 4||14
8406570|NCT00975650|20719505|P3|STARTED|Period 4||14
8406571|NCT00975650|20719506|P2|STARTED|Period 4||14
8406572|NCT00975650|20719507|P1|STARTED|Period 4||12
8406573|NCT00975650|20719504|P4|NOT COMPLETED|Period 3||0
8406574|NCT00975650|20719505|P3|NOT COMPLETED|Period 3||0
8406575|NCT00975650|20719506|P2|NOT COMPLETED|Period 3||0
8406576|NCT00975650|20719507|P1|NOT COMPLETED|Period 3||0
8406577|NCT00975650|20719504|P4|COMPLETED|Period 3||14
8406578|NCT00975650|20719505|P3|COMPLETED|Period 3||14
8406579|NCT00975650|20719506|P2|COMPLETED|Period 3||14
8406580|NCT00975650|20719507|P1|COMPLETED|Period 3||12
8406581|NCT00975650|20719504|P4|STARTED|Period 3||14
8406582|NCT00975650|20719505|P3|STARTED|Period 3||14
8406583|NCT00975650|20719506|P2|STARTED|Period 3||14
8406584|NCT00975650|20719507|P1|STARTED|Period 3||12
8406585|NCT00975650|20719504|P4|NOT COMPLETED|Period 2||0
8406586|NCT00975650|20719505|P3|NOT COMPLETED|Period 2||0
8406587|NCT00975650|20719506|P2|NOT COMPLETED|Period 2||2
8406588|NCT00975650|20719507|P1|NOT COMPLETED|Period 2||1
8406589|NCT00975650|20719504|P4|COMPLETED|Period 2||14
8406590|NCT00975650|20719505|P3|COMPLETED|Period 2||14
8406591|NCT00975650|20719506|P2|COMPLETED|Period 2||14
8406592|NCT00975650|20719507|P1|COMPLETED|Period 2||12
8406593|NCT00975650|20719504|P4|STARTED|Period 2||14
8406594|NCT00975650|20719505|P3|STARTED|Period 2||14
8406595|NCT00975650|20719506|P2|STARTED|Period 2||16
8406596|NCT00975650|20719507|P1|STARTED|Period 2||13
8406597|NCT00975650|20719504|P4|NOT COMPLETED|Period 1||0
8406598|NCT00975650|20719505|P3|NOT COMPLETED|Period 1||0
8406599|NCT00975650|20719506|P2|NOT COMPLETED|Period 1||0
8406600|NCT00975650|20719507|P1|NOT COMPLETED|Period 1||0
8406601|NCT00975650|20719504|P4|COMPLETED|Period 1||14
8406602|NCT00975650|20719505|P3|COMPLETED|Period 1||14
8406603|NCT00975650|20719506|P2|COMPLETED|Period 1||16
8406604|NCT00975650|20719507|P1|COMPLETED|Period 1||13
8406605|NCT00975650|20719504|P4|STARTED|Period 1||14
8406606|NCT00975650|20719505|P3|STARTED|Period 1||14
8406607|NCT00975650|20719506|P2|STARTED|Period 1||16
8406608|NCT00975650|20719507|P1|STARTED|Period 1||13
8406609|NCT00975637|20719546|P5|NOT COMPLETED|Overall Study||2
8406610|NCT00975637|20719547|P4|NOT COMPLETED|Overall Study||6
8406611|NCT00975637|20719548|P3|NOT COMPLETED|Overall Study||2
8406612|NCT00975637|20719549|P2|NOT COMPLETED|Overall Study||1
8406613|NCT00975637|20719550|P1|NOT COMPLETED|Overall Study||3
8406614|NCT00975637|20719546|P5|COMPLETED|Overall Study||37
8406615|NCT00975637|20719547|P4|COMPLETED|Overall Study||32
8406616|NCT00975637|20719548|P3|COMPLETED|Overall Study||40
8406617|NCT00975637|20719549|P2|COMPLETED|Overall Study||38
8406618|NCT00975637|20719550|P1|COMPLETED|Overall Study||37
8406619|NCT00975637|20719546|P5|STARTED|Overall Study||39
8406620|NCT00975637|20719547|P4|STARTED|Overall Study||38
8406621|NCT00975637|20719548|P3|STARTED|Overall Study||42
8406622|NCT00975637|20719549|P2|STARTED|Overall Study||39
8406623|NCT00975637|20719550|P1|STARTED|Overall Study||40
8406624|NCT00975611|20719567|P1|NOT COMPLETED|Overall Study||17
8406625|NCT00975611|20719567|P1|COMPLETED|Overall Study||5
8406626|NCT00975611|20719567|P1|STARTED|Overall Study||22
8406627|NCT00975585|20719573|P2|NOT COMPLETED|Overall Study||12
8406628|NCT00975585|20719574|P1|NOT COMPLETED|Overall Study||7
8406629|NCT00975585|20719573|P2|COMPLETED|Overall Study||183
8406630|NCT00975585|20719574|P1|COMPLETED|Overall Study||177
8406631|NCT00975585|20719573|P2|STARTED|Overall Study||195
8406632|NCT00975585|20719574|P1|STARTED|Overall Study||184
8406633|NCT00975507|20719594|P2|NOT COMPLETED|Overall Study||4
8406634|NCT00975507|20719595|P1|NOT COMPLETED|Overall Study||20
8406635|NCT00975507|20719594|P2|COMPLETED|Overall Study||153
8406636|NCT00975507|20719595|P1|COMPLETED|Overall Study||303
8406637|NCT00975507|20719594|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
8406638|NCT00975507|20719595|P1|Vaccinated at Visit 2|Overall Study||310
8406639|NCT00975507|20719594|P2|Vaccinated at Visit 1|Overall Study||157
8406640|NCT00975507|20719595|P1|Vaccinated at Visit 1|Overall Study||323
8406641|NCT00975507|20719594|P2|STARTED|Overall Study||157
8406642|NCT00975507|20719595|P1|STARTED|Overall Study||323
8406643|NCT00975481|20719615|P6|NOT COMPLETED|Sixth Intervention Period||0
8406644|NCT00975481|20719616|P5|NOT COMPLETED|Sixth Intervention Period||0
8406645|NCT00975481|20719617|P4|NOT COMPLETED|Sixth Intervention Period||0
8406646|NCT00975481|20719618|P3|NOT COMPLETED|Sixth Intervention Period||0
8406647|NCT00975481|20719619|P2|NOT COMPLETED|Sixth Intervention Period||0
8406648|NCT00975481|20719620|P1|NOT COMPLETED|Sixth Intervention Period||0
8406649|NCT00975481|20719615|P6|COMPLETED|Sixth Intervention Period||6
8406650|NCT00975481|20719616|P5|COMPLETED|Sixth Intervention Period||5
8406651|NCT00975481|20719617|P4|COMPLETED|Sixth Intervention Period||5
8406652|NCT00975481|20719618|P3|COMPLETED|Sixth Intervention Period||4
8406653|NCT00975481|20719619|P2|COMPLETED|Sixth Intervention Period||5
8406654|NCT00975481|20719620|P1|COMPLETED|Sixth Intervention Period||4
8406655|NCT00975481|20719615|P6|STARTED|Sixth Intervention Period||6
8406656|NCT00975481|20719616|P5|STARTED|Sixth Intervention Period||5
8406657|NCT00975481|20719617|P4|STARTED|Sixth Intervention Period||5
8406658|NCT00975481|20719618|P3|STARTED|Sixth Intervention Period||4
8406659|NCT00975481|20719619|P2|STARTED|Sixth Intervention Period||5
8406660|NCT00975481|20719620|P1|STARTED|Sixth Intervention Period||4
8406661|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406662|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406663|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406664|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406665|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406666|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406667|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406668|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||5
8406669|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||5
8406670|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||4
8406671|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406672|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406673|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406674|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||5
8406675|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||5
8406676|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||4
8406677|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406678|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406679|NCT00975481|20719615|P6|NOT COMPLETED|Fifth Intervention Period||0
8406680|NCT00975481|20719616|P5|NOT COMPLETED|Fifth Intervention Period||1
8406681|NCT00975481|20719617|P4|NOT COMPLETED|Fifth Intervention Period||0
8406682|NCT00975481|20719618|P3|NOT COMPLETED|Fifth Intervention Period||0
8406683|NCT00975481|20719619|P2|NOT COMPLETED|Fifth Intervention Period||0
8406684|NCT00975481|20719620|P1|NOT COMPLETED|Fifth Intervention Period||0
8406685|NCT00975481|20719615|P6|COMPLETED|Fifth Intervention Period||6
8406686|NCT00975481|20719616|P5|COMPLETED|Fifth Intervention Period||5
8406687|NCT00975481|20719617|P4|COMPLETED|Fifth Intervention Period||5
8406688|NCT00975481|20719618|P3|COMPLETED|Fifth Intervention Period||4
8406689|NCT00975481|20719619|P2|COMPLETED|Fifth Intervention Period||5
8406690|NCT00975481|20719620|P1|COMPLETED|Fifth Intervention Period||4
8406691|NCT00975481|20719615|P6|STARTED|Fifth Intervention Period||6
8406692|NCT00975481|20719616|P5|STARTED|Fifth Intervention Period||6
8406693|NCT00975481|20719617|P4|STARTED|Fifth Intervention Period||5
8406694|NCT00975481|20719618|P3|STARTED|Fifth Intervention Period||4
8406695|NCT00975481|20719619|P2|STARTED|Fifth Intervention Period||5
8406696|NCT00975481|20719620|P1|STARTED|Fifth Intervention Period||4
8406697|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406698|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406699|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406700|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406701|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406702|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406703|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406704|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406705|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||5
8406706|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||4
8406707|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406708|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406709|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406710|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406711|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||5
8406712|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||4
8406713|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406714|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406715|NCT00975481|20719615|P6|NOT COMPLETED|Fourth Intervention Period||0
8406716|NCT00975481|20719616|P5|NOT COMPLETED|Fourth Intervention Period||0
8406717|NCT00975481|20719617|P4|NOT COMPLETED|Fourth Intervention Period||1
8406718|NCT00975481|20719618|P3|NOT COMPLETED|Fourth Intervention Period||1
8406719|NCT00975481|20719619|P2|NOT COMPLETED|Fourth Intervention Period||0
8406720|NCT00975481|20719620|P1|NOT COMPLETED|Fourth Intervention Period||0
8406721|NCT00975481|20719615|P6|COMPLETED|Fourth Intervention Period||6
8406722|NCT00975481|20719616|P5|COMPLETED|Fourth Intervention Period||6
8406723|NCT00975481|20719617|P4|COMPLETED|Fourth Intervention Period||5
8406724|NCT00975481|20719618|P3|COMPLETED|Fourth Intervention Period||4
8406725|NCT00975481|20719619|P2|COMPLETED|Fourth Intervention Period||5
8406726|NCT00975481|20719620|P1|COMPLETED|Fourth Intervention Period||4
8406727|NCT00975481|20719615|P6|STARTED|Fourth Intervention Period||6
8406728|NCT00975481|20719616|P5|STARTED|Fourth Intervention Period||6
8406729|NCT00975481|20719617|P4|STARTED|Fourth Intervention Period||6
8406730|NCT00975481|20719618|P3|STARTED|Fourth Intervention Period||5
8406731|NCT00975481|20719619|P2|STARTED|Fourth Intervention Period||5
8406732|NCT00975481|20719620|P1|STARTED|Fourth Intervention Period||4
8406733|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406734|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406735|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406736|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406737|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406738|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406739|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406740|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406741|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||6
8406742|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||5
8406743|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406744|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406745|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406746|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406747|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||6
8406748|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||5
8406749|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406750|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406751|NCT00975481|20719615|P6|NOT COMPLETED|Third Intervention Period||0
8406752|NCT00975481|20719616|P5|NOT COMPLETED|Third Intervention Period||0
8406753|NCT00975481|20719617|P4|NOT COMPLETED|Third Intervention Period||0
8406754|NCT00975481|20719618|P3|NOT COMPLETED|Third Intervention Period||0
8406755|NCT00975481|20719619|P2|NOT COMPLETED|Third Intervention Period||0
8406756|NCT00975481|20719620|P1|NOT COMPLETED|Third Intervention Period||0
8406757|NCT00975481|20719615|P6|COMPLETED|Third Intervention Period||6
8406758|NCT00975481|20719616|P5|COMPLETED|Third Intervention Period||6
8406759|NCT00975481|20719617|P4|COMPLETED|Third Intervention Period||6
8406760|NCT00975481|20719618|P3|COMPLETED|Third Intervention Period||5
8406761|NCT00975481|20719619|P2|COMPLETED|Third Intervention Period||5
8406762|NCT00975481|20719620|P1|COMPLETED|Third Intervention Period||4
8406763|NCT00975481|20719615|P6|STARTED|Third Intervention Period||6
8406764|NCT00975481|20719616|P5|STARTED|Third Intervention Period||6
8406765|NCT00975481|20719617|P4|STARTED|Third Intervention Period||6
8406766|NCT00975481|20719618|P3|STARTED|Third Intervention Period||5
8406767|NCT00975481|20719619|P2|STARTED|Third Intervention Period||5
8406768|NCT00975481|20719620|P1|STARTED|Third Intervention Period||4
8406769|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406770|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406771|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406772|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406773|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406774|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406775|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406776|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406777|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||6
8406778|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||5
8406779|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406780|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406781|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406782|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406783|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||6
8406784|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||5
8406785|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406786|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406787|NCT00975481|20719615|P6|NOT COMPLETED|Second Intervention Period||0
8406788|NCT00975481|20719616|P5|NOT COMPLETED|Second Intervention Period||0
8406789|NCT00975481|20719617|P4|NOT COMPLETED|Second Intervention Period||0
8406790|NCT00975481|20719618|P3|NOT COMPLETED|Second Intervention Period||1
8406791|NCT00975481|20719619|P2|NOT COMPLETED|Second Intervention Period||1
8406792|NCT00975481|20719620|P1|NOT COMPLETED|Second Intervention Period||2
8406793|NCT00975481|20719615|P6|COMPLETED|Second Intervention Period||6
8406794|NCT00975481|20719616|P5|COMPLETED|Second Intervention Period||6
8406795|NCT00975481|20719617|P4|COMPLETED|Second Intervention Period||6
8406796|NCT00975481|20719618|P3|COMPLETED|Second Intervention Period||5
8406797|NCT00975481|20719619|P2|COMPLETED|Second Intervention Period||5
8406798|NCT00975481|20719620|P1|COMPLETED|Second Intervention Period||4
8406799|NCT00975481|20719615|P6|STARTED|Second Intervention Period||6
8406800|NCT00975481|20719616|P5|STARTED|Second Intervention Period||6
8406801|NCT00975481|20719617|P4|STARTED|Second Intervention Period||6
8406802|NCT00975481|20719618|P3|STARTED|Second Intervention Period||6
8406803|NCT00975481|20719619|P2|STARTED|Second Intervention Period||6
8406804|NCT00975481|20719620|P1|STARTED|Second Intervention Period||6
8406805|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406806|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406807|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406808|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406809|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406810|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406811|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406812|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406813|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||6
8406814|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||6
8406815|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||6
8406816|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||6
8406817|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406818|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406819|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||6
8406820|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||6
8406821|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||6
8406822|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||6
8406823|NCT00975481|20719615|P6|NOT COMPLETED|First Intervention Period||0
8406824|NCT00975481|20719616|P5|NOT COMPLETED|First Intervention Period||0
8406825|NCT00975481|20719617|P4|NOT COMPLETED|First Intervention Period||0
8406826|NCT00975481|20719618|P3|NOT COMPLETED|First Intervention Period||0
8406827|NCT00975481|20719619|P2|NOT COMPLETED|First Intervention Period||0
8406828|NCT00975481|20719620|P1|NOT COMPLETED|First Intervention Period||0
8406829|NCT00975481|20719615|P6|COMPLETED|First Intervention Period||6
8406830|NCT00975481|20719616|P5|COMPLETED|First Intervention Period||6
8406831|NCT00975481|20719617|P4|COMPLETED|First Intervention Period||6
8406832|NCT00975481|20719618|P3|COMPLETED|First Intervention Period||6
8406833|NCT00975481|20719619|P2|COMPLETED|First Intervention Period||6
8406834|NCT00975481|20719620|P1|COMPLETED|First Intervention Period||6
8406835|NCT00975481|20719615|P6|STARTED|First Intervention Period||6
8406836|NCT00975481|20719616|P5|STARTED|First Intervention Period||6
8406837|NCT00975481|20719617|P4|STARTED|First Intervention Period||6
8406838|NCT00975481|20719618|P3|STARTED|First Intervention Period||6
8406839|NCT00975481|20719619|P2|STARTED|First Intervention Period||6
8406840|NCT00975481|20719620|P1|STARTED|First Intervention Period||6
8406841|NCT00975416|20719720|P2|NOT COMPLETED|Overall Study||5
8406842|NCT00975416|20719721|P1|NOT COMPLETED|Overall Study||3
8406843|NCT00975416|20719720|P2|COMPLETED|Overall Study||11
8406844|NCT00975416|20719721|P1|COMPLETED|Overall Study||11
8406845|NCT00975416|20719720|P2|STARTED|Overall Study||16
8406846|NCT00975416|20719721|P1|STARTED|Overall Study||14
8406847|NCT00975286|20719730|P2|NOT COMPLETED|Overall Study||29
8406848|NCT00975286|20719731|P1|NOT COMPLETED|Overall Study||12
8406849|NCT00975286|20719730|P2|COMPLETED|Overall Study||194
8406850|NCT00975286|20719731|P1|COMPLETED|Overall Study||211
8406851|NCT00975286|20719730|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
8406852|NCT00975286|20719731|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
8406853|NCT00975286|20719730|P2|Safety Population|Overall Study||223
8406854|NCT00975286|20719731|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
8406855|NCT00975286|20719730|P2|STARTED|Overall Study||223
8406856|NCT00975286|20719731|P1|STARTED|Overall Study|Randomized.|223
8406857|NCT00975221|20719763|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
8406858|NCT00975221|20719764|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
8406859|NCT00975221|20719763|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
8406860|NCT00975221|20719764|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
8406861|NCT00975221|20719763|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
8406862|NCT00975221|20719764|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
8406863|NCT00975221|20719763|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
8406864|NCT00975221|20719764|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
8406865|NCT00975221|20719763|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
8406866|NCT00975221|20719764|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
8406867|NCT00975221|20719763|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
8406868|NCT00975221|20719764|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
8406869|NCT00975221|20719763|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
8406870|NCT00975221|20719764|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
8406871|NCT00975221|20719763|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
8406872|NCT00975221|20719764|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
8406873|NCT00975221|20719763|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
8406874|NCT00975221|20719764|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
8406875|NCT00975221|20719763|P2|STARTED|Titration Phase (Weeks 1-12)||33
8406876|NCT00975221|20719764|P1|STARTED|Titration Phase (Weeks 1-12)||34
8406877|NCT00975195|20719780|P2|NOT COMPLETED|Overall Study||233
8406878|NCT00975195|20719781|P1|NOT COMPLETED|Overall Study||228
8406879|NCT00975195|20719780|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
8406880|NCT00975195|20719781|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
8406881|NCT00975195|20719780|P2|STARTED|Overall Study||1244
8406882|NCT00975195|20719781|P1|STARTED|Overall Study||1244
8406883|NCT00975156|20719841|P2|NOT COMPLETED|Overall Study||1
8406884|NCT00975156|20719842|P1|NOT COMPLETED|Overall Study||0
8406885|NCT00975156|20719841|P2|COMPLETED|Overall Study||9
8406886|NCT00975156|20719842|P1|COMPLETED|Overall Study||11
8406887|NCT00975156|20719841|P2|STARTED|Overall Study||10
8406888|NCT00975156|20719842|P1|STARTED|Overall Study||11
8406889|NCT00975143|20719854|P2|NOT COMPLETED|Overall Study||60
8406890|NCT00975143|20719855|P1|NOT COMPLETED|Overall Study||70
8406891|NCT00975143|20719854|P2|COMPLETED|Overall Study||401
8406892|NCT00975143|20719855|P1|COMPLETED|Overall Study||394
8406893|NCT00975143|20719854|P2|Completed Treatment (Week 20)|Overall Study||410
8406894|NCT00975143|20719855|P1|Completed Treatment (Week 20)|Overall Study||403
8406895|NCT00975143|20719854|P2|STARTED|Overall Study||461
8406896|NCT00975143|20719855|P1|STARTED|Overall Study||464
8406897|NCT00975130|20719865|P3|NOT COMPLETED|Study Part 2||17
8406898|NCT00975130|20719866|P2|NOT COMPLETED|Study Part 2||38
8406899|NCT00975130|20719867|P1|NOT COMPLETED|Study Part 2||0
8406900|NCT00975130|20719865|P3|COMPLETED|Study Part 2||238
8406901|NCT00975130|20719866|P2|COMPLETED|Study Part 2||212
8406902|NCT00975130|20719867|P1|COMPLETED|Study Part 2||0
8406903|NCT00975130|20719865|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
8406904|NCT00975130|20719866|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
8406905|NCT00975130|20719867|P1|STARTED|Study Part 2||0
8406906|NCT00975130|20719865|P3|NOT COMPLETED|Study Part 1||0
8406907|NCT00975130|20719866|P2|NOT COMPLETED|Study Part 1||0
8406908|NCT00975130|20719867|P1|NOT COMPLETED|Study Part 1||280
8406909|NCT00975130|20719865|P3|COMPLETED|Study Part 1||0
8406910|NCT00975130|20719866|P2|COMPLETED|Study Part 1||0
8406911|NCT00975130|20719867|P1|COMPLETED|Study Part 1||3086
8406912|NCT00975130|20719865|P3|STARTED|Study Part 1||0
8406913|NCT00975130|20719866|P2|STARTED|Study Part 1||0
8406914|NCT00975130|20719867|P1|STARTED|Study Part 1||3366
8406915|NCT00975000|20720051|P2|NOT COMPLETED|Overall Study||5
8406916|NCT00975000|20720052|P1|NOT COMPLETED|Overall Study||5
8406917|NCT00975000|20720051|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
8406918|NCT00975000|20720052|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
8406919|NCT00975000|20720051|P2|Completed Maintenance Phase|Overall Study||52
8406920|NCT00975000|20720052|P1|Completed Maintenance Phase|Overall Study||52
8406921|NCT00975000|20720051|P2|Completed Efficacy Assessment Phase|Overall Study||54
8406922|NCT00975000|20720052|P1|Completed Efficacy Assessment Phase|Overall Study||54
8406923|NCT00975000|20720051|P2|Completed Titration Phase|Overall Study||55
8406924|NCT00975000|20720052|P1|Completed Titration Phase|Overall Study||54
8406925|NCT00975000|20720051|P2|STARTED|Overall Study||57
8406926|NCT00975000|20720052|P1|STARTED|Overall Study||57
8406927|NCT00974974|20720076|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
8406928|NCT00974974|20720077|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
8406929|NCT00974974|20720076|P2|COMPLETED|Maintenance - Double Blind Treatment||182
8406930|NCT00974974|20720077|P1|COMPLETED|Maintenance - Double Blind Treatment||186
8406931|NCT00974974|20720076|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
8406932|NCT00974974|20720077|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
8406933|NCT00974974|20720076|P2|NOT COMPLETED|IPX066 Dose Conversion||0
8406934|NCT00974974|20720077|P1|NOT COMPLETED|IPX066 Dose Conversion||57
8406935|NCT00974974|20720076|P2|COMPLETED|IPX066 Dose Conversion||0
8406936|NCT00974974|20720077|P1|COMPLETED|IPX066 Dose Conversion||393
8406937|NCT00974974|20720076|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
8406938|NCT00974974|20720077|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
8406939|NCT00974974|20720076|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
8406940|NCT00974974|20720077|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
8406941|NCT00974974|20720076|P2|COMPLETED|IR CD-LD Dose Adjustment||450
8406942|NCT00974974|20720077|P1|COMPLETED|IR CD-LD Dose Adjustment||0
8406943|NCT00974974|20720076|P2|STARTED|IR CD-LD Dose Adjustment||471
8406944|NCT00974974|20720077|P1|STARTED|IR CD-LD Dose Adjustment||0
8406945|NCT00974922|20720087|P1|NOT COMPLETED|Overall Study||24
8406946|NCT00974922|20720087|P1|COMPLETED|Overall Study||16
8406947|NCT00974922|20720087|P1|STARTED|Overall Study||40
8406948|NCT00974818|20720094|P2|NOT COMPLETED|Overall Study||0
8406949|NCT00974818|20720095|P1|NOT COMPLETED|Overall Study||0
8406950|NCT00974818|20720094|P2|COMPLETED|Overall Study||25
8406951|NCT00974818|20720095|P1|COMPLETED|Overall Study||25
8406952|NCT00974818|20720094|P2|STARTED|Overall Study||25
8406953|NCT00974818|20720095|P1|STARTED|Overall Study||25
8406954|NCT00974675|20720105|P4|NOT COMPLETED|Overall Study||2
8406955|NCT00974675|20720106|P3|NOT COMPLETED|Overall Study||2
8406956|NCT00974675|20720107|P2|NOT COMPLETED|Overall Study||1
8406957|NCT00974675|20720108|P1|NOT COMPLETED|Overall Study||2
8406958|NCT00974675|20720105|P4|COMPLETED|Overall Study||2
8406959|NCT00974675|20720106|P3|COMPLETED|Overall Study||1
8406960|NCT00974675|20720107|P2|COMPLETED|Overall Study||7
8406961|NCT00974675|20720108|P1|COMPLETED|Overall Study||6
8406962|NCT00974675|20720105|P4|STARTED|Overall Study||4
8406963|NCT00974675|20720106|P3|STARTED|Overall Study||3
8406964|NCT00974675|20720107|P2|STARTED|Overall Study||8
8406965|NCT00974675|20720108|P1|STARTED|Overall Study||8
8406966|NCT00974571|20720157|P3|NOT COMPLETED|Overall Study||83
8406967|NCT00974571|20720158|P2|NOT COMPLETED|Overall Study||16
8406968|NCT00974571|20720159|P1|NOT COMPLETED|Overall Study||68
8406969|NCT00974571|20720157|P3|COMPLETED|Overall Study||530
8406970|NCT00974571|20720158|P2|COMPLETED|Overall Study||106
8406971|NCT00974571|20720159|P1|COMPLETED|Overall Study||562
8406972|NCT00974571|20720157|P3|STARTED|Overall Study||613
8406973|NCT00974571|20720158|P2|STARTED|Overall Study||122
8406974|NCT00974571|20720159|P1|STARTED|Overall Study||630
8406975|NCT00974493|20720181|P2|NOT COMPLETED|Overall Study||21
8406976|NCT00974493|20720182|P1|NOT COMPLETED|Overall Study||18
8406977|NCT00974493|20720181|P2|COMPLETED|Overall Study||506
8406978|NCT00974493|20720182|P1|COMPLETED|Overall Study||509
8406979|NCT00974493|20720181|P2|STARTED|Overall Study||527
8406980|NCT00974493|20720182|P1|STARTED|Overall Study||527
8406981|NCT00974480|20720191|P3|NOT COMPLETED|Overall Study||10
8406982|NCT00974480|20720192|P2|NOT COMPLETED|Overall Study||7
8406983|NCT00974480|20720193|P1|NOT COMPLETED|Overall Study||11
8406984|NCT00974480|20720191|P3|COMPLETED|Overall Study||30
8406985|NCT00974480|20720192|P2|COMPLETED|Overall Study||33
8406986|NCT00974480|20720193|P1|COMPLETED|Overall Study||29
8406987|NCT00974480|20720191|P3|STARTED|Overall Study||40
8406988|NCT00974480|20720192|P2|STARTED|Overall Study||40
8406989|NCT00974480|20720193|P1|STARTED|Overall Study||40
8406990|NCT00974376|20720233|P2|NOT COMPLETED|Overall Study||33
8406991|NCT00974376|20720234|P1|NOT COMPLETED|Overall Study||34
8406992|NCT00974376|20720233|P2|COMPLETED|Overall Study||42
8406993|NCT00974376|20720234|P1|COMPLETED|Overall Study||41
8406994|NCT00974376|20720233|P2|STARTED|Overall Study||75
8406995|NCT00974376|20720234|P1|STARTED|Overall Study||75
8406996|NCT00974363|20720242|P2|NOT COMPLETED|Overall Study||0
8406997|NCT00974363|20720243|P1|NOT COMPLETED|Overall Study||0
8406998|NCT00974363|20720242|P2|COMPLETED|Overall Study||168
8406999|NCT00974363|20720243|P1|COMPLETED|Overall Study||521
8407000|NCT00974363|20720242|P2|STARTED|Overall Study||168
8407001|NCT00974363|20720243|P1|STARTED|Overall Study||521
8407002|NCT00974311|20720265|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
8407003|NCT00974311|20720266|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
8407004|NCT00974311|20720265|P2|COMPLETED|OLE Phase (up to 77 Months)||0
8407005|NCT00974311|20720266|P1|COMPLETED|OLE Phase (up to 77 Months)||0
8407006|NCT00974311|20720265|P2|STARTED|OLE Phase (up to 77 Months)||50
8407007|NCT00974311|20720266|P1|STARTED|OLE Phase (up to 77 Months)||109
8407008|NCT00974311|20720265|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
8407009|NCT00974311|20720266|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
8407010|NCT00974311|20720265|P2|COMPLETED|DB Phase (up to 24 Months)||50
8407011|NCT00974311|20720266|P1|COMPLETED|DB Phase (up to 24 Months)||109
8407012|NCT00974311|20720265|P2|STARTED|DB Phase (up to 24 Months)||399
8407013|NCT00974311|20720266|P1|STARTED|DB Phase (up to 24 Months)||800
8407014|NCT00974259|20720304|P2|NOT COMPLETED|Overall Study||1
8407015|NCT00974259|20720305|P1|NOT COMPLETED|Overall Study||2
8407016|NCT00974259|20720304|P2|COMPLETED|Overall Study||62
8407017|NCT00974259|20720305|P1|COMPLETED|Overall Study||57
8407018|NCT00974259|20720304|P2|STARTED|Overall Study||63
8407019|NCT00974259|20720305|P1|STARTED|Overall Study||59
8407020|NCT00974246|20720317|P1|NOT COMPLETED|Overall Study||0
8407021|NCT00974246|20720317|P1|COMPLETED|Overall Study||27
8407022|NCT00974246|20720317|P1|STARTED|Overall Study||27
8407023|NCT00974233|20720323|P1|NOT COMPLETED|Maintenance Lenalidomide||13
8407024|NCT00974233|20720323|P1|COMPLETED|Maintenance Lenalidomide||6
8407025|NCT00974233|20720323|P1|STARTED|Maintenance Lenalidomide||19
8407026|NCT00974233|20720323|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
8407027|NCT00974233|20720323|P1|COMPLETED|Induction Chemoimmunotherapy||19
8407028|NCT00974233|20720323|P1|STARTED|Induction Chemoimmunotherapy||34
8407029|NCT00974220|20720338|P2|NOT COMPLETED|Treatment Period 2||0
8407030|NCT00974220|20720339|P1|NOT COMPLETED|Treatment Period 2||0
8407031|NCT00974220|20720338|P2|COMPLETED|Treatment Period 2||5
8407032|NCT00974220|20720339|P1|COMPLETED|Treatment Period 2||7
8407033|NCT00974220|20720338|P2|STARTED|Treatment Period 2||5
8407034|NCT00974220|20720339|P1|STARTED|Treatment Period 2||7
8407035|NCT00974220|20720338|P2|NOT COMPLETED|Treatment Period 1||2
8407036|NCT00974220|20720339|P1|NOT COMPLETED|Treatment Period 1||2
8407037|NCT00974220|20720338|P2|COMPLETED|Treatment Period 1||5
8407038|NCT00974220|20720339|P1|COMPLETED|Treatment Period 1||7
8407039|NCT00974220|20720338|P2|STARTED|Treatment Period 1||7
8407040|NCT00974220|20720339|P1|STARTED|Treatment Period 1||9
8407041|NCT00974142|20720349|P2|NOT COMPLETED|Overall Study||0
8407042|NCT00974142|20720350|P1|NOT COMPLETED|Overall Study||0
8407043|NCT00974142|20720349|P2|COMPLETED|Overall Study||9
8407044|NCT00974142|20720350|P1|COMPLETED|Overall Study||8
8407045|NCT00974142|20720349|P2|STARTED|Overall Study||9
8407046|NCT00974142|20720350|P1|STARTED|Overall Study||8
8407047|NCT00974090|20720384|P2|NOT COMPLETED|Period 2: Open-label Period||10
8407048|NCT00974090|20720385|P1|NOT COMPLETED|Period 2: Open-label Period||8
8407049|NCT00974090|20720384|P2|COMPLETED|Period 2: Open-label Period||85
8407050|NCT00974090|20720385|P1|COMPLETED|Period 2: Open-label Period||87
8407051|NCT00974090|20720384|P2|STARTED|Period 2: Open-label Period||95
8407052|NCT00974090|20720385|P1|STARTED|Period 2: Open-label Period||95
8407053|NCT00974090|20720384|P2|NOT COMPLETED|Period 1: Double Blind Period||1
8407054|NCT00974090|20720385|P1|NOT COMPLETED|Period 1: Double Blind Period||3
8407055|NCT00974090|20720384|P2|COMPLETED|Period 1: Double Blind Period||95
8407056|NCT00974090|20720385|P1|COMPLETED|Period 1: Double Blind Period||95
8407057|NCT00974090|20720384|P2|STARTED|Period 1: Double Blind Period||96
8407058|NCT00974090|20720385|P1|STARTED|Period 1: Double Blind Period||98
8407059|NCT00974051|20720399|P3|NOT COMPLETED|Overall Study||0
8407060|NCT00974051|20720400|P2|NOT COMPLETED|Overall Study||0
8407061|NCT00974051|20720401|P1|NOT COMPLETED|Overall Study||0
8407062|NCT00974051|20720399|P3|COMPLETED|Overall Study||6
8407063|NCT00974051|20720400|P2|COMPLETED|Overall Study||4
8407064|NCT00974051|20720401|P1|COMPLETED|Overall Study||6
8407065|NCT00974051|20720399|P3|STARTED|Overall Study||6
8407066|NCT00974051|20720400|P2|STARTED|Overall Study||4
8407067|NCT00974051|20720401|P1|STARTED|Overall Study||6
8407068|NCT00973973|20720421|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
8407069|NCT00973973|20720422|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
8407070|NCT00973973|20720421|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
8407071|NCT00973973|20720422|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
8407072|NCT00973973|20720421|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
8407073|NCT00973973|20720422|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
8407074|NCT00973973|20720421|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
8407075|NCT00973973|20720422|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
8407076|NCT00973973|20720421|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
8407077|NCT00973973|20720422|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
8407078|NCT00973973|20720421|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
8407079|NCT00973973|20720422|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
8407080|NCT00973973|20720421|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
8407081|NCT00973973|20720422|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
8407082|NCT00973921|20720482|P1|NOT COMPLETED|Overall Study||9
8407083|NCT00973921|20720482|P1|COMPLETED|Overall Study||31
8407084|NCT00973921|20720482|P1|STARTED|Overall Study||40
8407085|NCT00973856|20720491|P2|NOT COMPLETED|Overall Study||0
8407086|NCT00973856|20720492|P1|NOT COMPLETED|Overall Study||0
8407087|NCT00973856|20720491|P2|COMPLETED|Overall Study||2
8407088|NCT00973856|20720492|P1|COMPLETED|Overall Study||3
8407089|NCT00973856|20720491|P2|STARTED|Overall Study||2
8407090|NCT00973856|20720492|P1|STARTED|Overall Study||3
8407091|NCT00973765|20720499|P2|NOT COMPLETED|Overall Study||14
8407092|NCT00973765|20720500|P1|NOT COMPLETED|Overall Study||8
8407093|NCT00973765|20720499|P2|COMPLETED|Overall Study|102|102
8407094|NCT00973765|20720500|P1|COMPLETED|Overall Study|88|88
8407095|NCT00973765|20720499|P2|STARTED|Overall Study|116|116
8407096|NCT00973765|20720500|P1|STARTED|Overall Study|96|96
8407097|NCT00973752|20720506|P1|NOT COMPLETED|Overall Study||0
8407098|NCT00973752|20720506|P1|COMPLETED|Overall Study||30
8407099|NCT00973752|20720506|P1|STARTED|Overall Study||30
8407100|NCT00973739|20720510|P1|NOT COMPLETED|Overall Study||4
8407101|NCT00973739|20720510|P1|COMPLETED|Overall Study||17
8407102|NCT00973739|20720510|P1|STARTED|Overall Study||21
8407103|NCT00973700|20720522|P5|NOT COMPLETED|Overall Study||10
8407104|NCT00973700|20720523|P4|NOT COMPLETED|Overall Study||18
8407105|NCT00973700|20720524|P3|NOT COMPLETED|Overall Study||10
8407106|NCT00973700|20720525|P2|NOT COMPLETED|Overall Study||2
8407107|NCT00973700|20720526|P1|NOT COMPLETED|Overall Study||7
8407108|NCT00973700|20720522|P5|COMPLETED|Overall Study||158
8407109|NCT00973700|20720523|P4|COMPLETED|Overall Study||318
8407110|NCT00973700|20720524|P3|COMPLETED|Overall Study||158
8407111|NCT00973700|20720525|P2|COMPLETED|Overall Study||54
8407112|NCT00973700|20720526|P1|COMPLETED|Overall Study||49
8407113|NCT00973700|20720522|P5|STARTED|Overall Study||168
8407114|NCT00973700|20720523|P4|STARTED|Overall Study||336
8407115|NCT00973700|20720524|P3|STARTED|Overall Study||168
8407116|NCT00973700|20720525|P2|STARTED|Overall Study||56
8407117|NCT00973700|20720526|P1|STARTED|Overall Study||56
8407118|NCT00973674|20720575|P2|NOT COMPLETED|Overall Study||0
8407119|NCT00973674|20720576|P1|NOT COMPLETED|Overall Study||2
8407120|NCT00973674|20720575|P2|COMPLETED|Overall Study||26
8407121|NCT00973674|20720576|P1|COMPLETED|Overall Study||22
8407122|NCT00973674|20720575|P2|STARTED|Overall Study||26
8407123|NCT00973674|20720576|P1|STARTED|Overall Study||24
8407124|NCT00973622|20720590|P2|NOT COMPLETED|Overall Study||5
8407125|NCT00973622|20720591|P1|NOT COMPLETED|Overall Study||31
8407126|NCT00973622|20720590|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
8407127|NCT00973622|20720591|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
8407128|NCT00973622|20720590|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
8407129|NCT00973622|20720591|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
8407130|NCT00973479|20720599|P2|NOT COMPLETED|Overall Study||69
8407131|NCT00973479|20720600|P1|NOT COMPLETED|Overall Study||37
8407132|NCT00973479|20720599|P2|COMPLETED|Overall Study||326
8407133|NCT00973479|20720600|P1|COMPLETED|Overall Study||160
8407134|NCT00973479|20720599|P2|STARTED|Overall Study||395
8407135|NCT00973479|20720600|P1|STARTED|Overall Study||197
8407136|NCT00973362|20720618|P2|NOT COMPLETED|3-Year Follow-up||0
8407137|NCT00973362|20720619|P1|NOT COMPLETED|3-Year Follow-up||17
8407138|NCT00973362|20720618|P2|COMPLETED|3-Year Follow-up||0
8407139|NCT00973362|20720619|P1|COMPLETED|3-Year Follow-up||10854
8407140|NCT00973362|20720618|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
8407141|NCT00973362|20720619|P1|STARTED|3-Year Follow-up||10871
8407142|NCT00973362|20720618|P2|NOT COMPLETED|Baseline Evaluation||223
8407143|NCT00973362|20720619|P1|NOT COMPLETED|Baseline Evaluation||773
8407144|NCT00973362|20720618|P2|COMPLETED|Baseline Evaluation||1029
8407145|NCT00973362|20720619|P1|COMPLETED|Baseline Evaluation||10871
8407146|NCT00973362|20720618|P2|Conclusive Disease Status|Baseline Evaluation||939
8407147|NCT00973362|20720619|P1|Conclusive Disease Status|Baseline Evaluation||819
8407148|NCT00973362|20720618|P2|Evaluable for Analysis|Baseline Evaluation||958
8407149|NCT00973362|20720619|P1|Evaluable for Analysis|Baseline Evaluation||10871
8407150|NCT00973362|20720618|P2|STARTED|Baseline Evaluation||1252
8407151|NCT00973362|20720619|P1|STARTED|Baseline Evaluation||11644
8407152|NCT00973349|20720644|P16|NOT COMPLETED|Overall Study||2
8407153|NCT00973349|20720645|P15|NOT COMPLETED|Overall Study||2
8407154|NCT00973349|20720646|P14|NOT COMPLETED|Overall Study||0
8407155|NCT00973349|20720647|P13|NOT COMPLETED|Overall Study||1
8407156|NCT00973349|20720648|P12|NOT COMPLETED|Overall Study||2
8407157|NCT00973349|20720649|P11|NOT COMPLETED|Overall Study||0
8407158|NCT00973349|20720650|P10|NOT COMPLETED|Overall Study||6
8407159|NCT00973349|20720651|P9|NOT COMPLETED|Overall Study||4
8407160|NCT00973349|20720652|P8|NOT COMPLETED|Overall Study||3
8407161|NCT00973349|20720653|P7|NOT COMPLETED|Overall Study||2
8407162|NCT00973349|20720654|P6|NOT COMPLETED|Overall Study||4
8407163|NCT00973349|20720655|P5|NOT COMPLETED|Overall Study||5
8407164|NCT00973349|20720656|P4|NOT COMPLETED|Overall Study||5
8407165|NCT00973349|20720657|P3|NOT COMPLETED|Overall Study||5
8407166|NCT00973349|20720658|P2|NOT COMPLETED|Overall Study||3
8407167|NCT00973349|20720659|P1|NOT COMPLETED|Overall Study||4
8407168|NCT00973349|20720644|P16|COMPLETED|Overall Study||165
8407169|NCT00973349|20720645|P15|COMPLETED|Overall Study||168
8407170|NCT00973349|20720646|P14|COMPLETED|Overall Study||171
8407171|NCT00973349|20720647|P13|COMPLETED|Overall Study||168
8407172|NCT00973349|20720648|P12|COMPLETED|Overall Study||167
8407173|NCT00973349|20720649|P11|COMPLETED|Overall Study||174
8407174|NCT00973349|20720650|P10|COMPLETED|Overall Study||163
8407175|NCT00973349|20720651|P9|COMPLETED|Overall Study||167
8407176|NCT00973349|20720652|P8|COMPLETED|Overall Study||166
8407177|NCT00973349|20720653|P7|COMPLETED|Overall Study||172
8407178|NCT00973349|20720654|P6|COMPLETED|Overall Study||165
8407179|NCT00973349|20720655|P5|COMPLETED|Overall Study||165
8407180|NCT00973349|20720656|P4|COMPLETED|Overall Study||163
8407181|NCT00973349|20720657|P3|COMPLETED|Overall Study||166
8407182|NCT00973349|20720658|P2|COMPLETED|Overall Study||165
8407183|NCT00973349|20720659|P1|COMPLETED|Overall Study||166
8407184|NCT00973349|20720644|P16|STARTED|Overall Study||167
8407185|NCT00973349|20720645|P15|STARTED|Overall Study||170
8407186|NCT00973349|20720646|P14|STARTED|Overall Study||171
8407187|NCT00973349|20720647|P13|STARTED|Overall Study||169
8407188|NCT00973349|20720648|P12|STARTED|Overall Study||169
8407189|NCT00973349|20720649|P11|STARTED|Overall Study||174
8407190|NCT00973349|20720650|P10|STARTED|Overall Study||169
8407191|NCT00973349|20720651|P9|STARTED|Overall Study||171
8407192|NCT00973349|20720652|P8|STARTED|Overall Study||169
8407193|NCT00973349|20720653|P7|STARTED|Overall Study||174
8407194|NCT00973349|20720654|P6|STARTED|Overall Study||169
8407195|NCT00973349|20720655|P5|STARTED|Overall Study||170
8407196|NCT00973349|20720656|P4|STARTED|Overall Study||168
8407197|NCT00973349|20720657|P3|STARTED|Overall Study||171
8407198|NCT00973349|20720658|P2|STARTED|Overall Study||168
8407199|NCT00973349|20720659|P1|STARTED|Overall Study||170
8407200|NCT00973102|20720759|P2|NOT COMPLETED|Overall Study||1
8407201|NCT00973102|20720760|P1|NOT COMPLETED|Overall Study||1
8407202|NCT00973102|20720759|P2|COMPLETED|Overall Study||25
8407203|NCT00973102|20720760|P1|COMPLETED|Overall Study||23
8407204|NCT00973102|20720759|P2|STARTED|Overall Study||26
8407205|NCT00973102|20720760|P1|STARTED|Overall Study||24
8407206|NCT00972959|20720768|P1|NOT COMPLETED|Overall Study||0
8407207|NCT00972959|20720768|P1|COMPLETED|Overall Study||17
8407208|NCT00972959|20720768|P1|STARTED|Overall Study||17
8407209|NCT00972816|20720791|P8|NOT COMPLETED|Overall Study||9
8407210|NCT00972816|20720792|P7|NOT COMPLETED|Overall Study||10
8407211|NCT00972816|20720793|P6|NOT COMPLETED|Overall Study||11
8407212|NCT00972816|20720794|P5|NOT COMPLETED|Overall Study||12
8407213|NCT00972816|20720795|P4|NOT COMPLETED|Overall Study||8
8407214|NCT00972816|20720796|P3|NOT COMPLETED|Overall Study||9
8407215|NCT00972816|20720797|P2|NOT COMPLETED|Overall Study||11
8407216|NCT00972816|20720798|P1|NOT COMPLETED|Overall Study||17
8407217|NCT00972816|20720791|P8|COMPLETED|Overall Study||161
8407218|NCT00972816|20720792|P7|COMPLETED|Overall Study||159
8407219|NCT00972816|20720793|P6|COMPLETED|Overall Study||158
8407220|NCT00972816|20720794|P5|COMPLETED|Overall Study||157
8407221|NCT00972816|20720795|P4|COMPLETED|Overall Study||161
8407222|NCT00972816|20720796|P3|COMPLETED|Overall Study||160
8407223|NCT00972816|20720797|P2|COMPLETED|Overall Study||158
8407224|NCT00972816|20720798|P1|COMPLETED|Overall Study||156
8407225|NCT00972816|20720791|P8|STARTED|Overall Study||170
8407226|NCT00972816|20720792|P7|STARTED|Overall Study||169
8407227|NCT00972816|20720793|P6|STARTED|Overall Study||169
8407228|NCT00972816|20720794|P5|STARTED|Overall Study||169
8407229|NCT00972816|20720795|P4|STARTED|Overall Study||169
8407230|NCT00972816|20720796|P3|STARTED|Overall Study||169
8407231|NCT00972816|20720797|P2|STARTED|Overall Study||169
8407232|NCT00972816|20720798|P1|STARTED|Overall Study||173
8407233|NCT00972777|20720882|P2|NOT COMPLETED|Overall Study||14
8407234|NCT00972777|20720883|P1|NOT COMPLETED|Overall Study||14
8407235|NCT00972777|20720882|P2|COMPLETED|Overall Study||229
8407236|NCT00972777|20720883|P1|COMPLETED|Overall Study||217
8407237|NCT00972777|20720882|P2|STARTED|Overall Study||243
8407238|NCT00972777|20720883|P1|STARTED|Overall Study||231
8407239|NCT00972738|20720898|P3|NOT COMPLETED|Overall Study||29
8407240|NCT00972738|20720899|P2|NOT COMPLETED|Overall Study||6
8407241|NCT00972738|20720900|P1|NOT COMPLETED|Overall Study||21
8407242|NCT00972738|20720898|P3|COMPLETED|Overall Study||492
8407243|NCT00972738|20720899|P2|COMPLETED|Overall Study||165
8407244|NCT00972738|20720900|P1|COMPLETED|Overall Study||501
8407245|NCT00972738|20720898|P3|STARTED|Overall Study||521
8407246|NCT00972738|20720899|P2|STARTED|Overall Study||171
8407247|NCT00972738|20720900|P1|STARTED|Overall Study||522
8407248|NCT00972725|20720925|P2|NOT COMPLETED|Overall Study||0
8407249|NCT00972725|20720926|P1|NOT COMPLETED|Overall Study||0
8407250|NCT00972725|20720925|P2|COMPLETED|Overall Study||15
8407251|NCT00972725|20720926|P1|COMPLETED|Overall Study||13
8407252|NCT00972725|20720925|P2|STARTED|Overall Study||15
8407253|NCT00972725|20720926|P1|STARTED|Overall Study||13
8407254|NCT00972621|20721008|P2|NOT COMPLETED|Overall Study||1
8407255|NCT00972621|20721009|P1|NOT COMPLETED|Overall Study||0
8407256|NCT00972621|20721008|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
8407257|NCT00972621|20721009|P1|COMPLETED|Overall Study||200
8407258|NCT00972621|20721008|P2|STARTED|Overall Study||200
8407259|NCT00972621|20721009|P1|STARTED|Overall Study||200
8407260|NCT00972595|20721017|P2|NOT COMPLETED|Period 2||0
8407261|NCT00972595|20721018|P1|NOT COMPLETED|Period 2||0
8407262|NCT00972595|20721017|P2|COMPLETED|Period 2||22
8407263|NCT00972595|20721018|P1|COMPLETED|Period 2||22
8407264|NCT00972595|20721017|P2|STARTED|Period 2||22
8407265|NCT00972595|20721018|P1|STARTED|Period 2||22
8407266|NCT00972595|20721017|P2|NOT COMPLETED|Period 1||0
8407267|NCT00972595|20721018|P1|NOT COMPLETED|Period 1||1
8407268|NCT00972595|20721017|P2|COMPLETED|Period 1||22
8407269|NCT00972595|20721018|P1|COMPLETED|Period 1||22
8407270|NCT00972595|20721017|P2|STARTED|Period 1||22
8407271|NCT00972595|20721018|P1|STARTED|Period 1||23
8407272|NCT00972543|20721028|P2|NOT COMPLETED|Overall Study||1
8407273|NCT00972543|20721029|P1|NOT COMPLETED|Overall Study||5
8407274|NCT00972543|20721028|P2|COMPLETED|Overall Study||0
8407275|NCT00972543|20721029|P1|COMPLETED|Overall Study||0
8407276|NCT00972543|20721028|P2|STARTED|Overall Study||1
8407277|NCT00972543|20721029|P1|STARTED|Overall Study||5
8407278|NCT00972530|20721105|P2|NOT COMPLETED|Overall Study||0
8407279|NCT00972530|20721106|P1|NOT COMPLETED|Overall Study||0
8407280|NCT00972530|20721105|P2|COMPLETED|Overall Study||46
8407281|NCT00972530|20721106|P1|COMPLETED|Overall Study||44
8407282|NCT00972530|20721105|P2|STARTED|Overall Study||46
8407283|NCT00972530|20721106|P1|STARTED|Overall Study||44
8407284|NCT00972517|20721112|P6|NOT COMPLETED|Overall Study||0
8407285|NCT00972517|20721113|P5|NOT COMPLETED|Overall Study||1
8407286|NCT00972517|20721114|P4|NOT COMPLETED|Overall Study||3
8407287|NCT00972517|20721115|P3|NOT COMPLETED|Overall Study||0
8407288|NCT00972517|20721116|P2|NOT COMPLETED|Overall Study||1
8407289|NCT00972517|20721117|P1|NOT COMPLETED|Overall Study||0
8407290|NCT00972517|20721112|P6|COMPLETED|Overall Study||58
8407291|NCT00972517|20721113|P5|COMPLETED|Overall Study||33
8407292|NCT00972517|20721114|P4|COMPLETED|Overall Study||27
8407293|NCT00972517|20721115|P3|COMPLETED|Overall Study||60
8407294|NCT00972517|20721116|P2|COMPLETED|Overall Study||30
8407295|NCT00972517|20721117|P1|COMPLETED|Overall Study||31
8407296|NCT00972517|20721112|P6|STARTED|Overall Study||58
8407297|NCT00972517|20721113|P5|STARTED|Overall Study||34
8407298|NCT00972517|20721114|P4|STARTED|Overall Study||30
8407299|NCT00972517|20721115|P3|STARTED|Overall Study||60
8407300|NCT00972517|20721116|P2|STARTED|Overall Study||31
8407301|NCT00972517|20721117|P1|STARTED|Overall Study||31
8407302|NCT00972504|20721212|P1|NOT COMPLETED|Overall Study||3
8407303|NCT00972504|20721212|P1|COMPLETED|Overall Study||51
8407304|NCT00972504|20721212|P1|STARTED|Overall Study||54
8407305|NCT00972478|20721244|P2|NOT COMPLETED|Overall Study||38
8407306|NCT00972478|20721245|P1|NOT COMPLETED|Overall Study||7
8407307|NCT00972478|20721244|P2|COMPLETED|Overall Study||34
8407308|NCT00972478|20721245|P1|COMPLETED|Overall Study||4
8407309|NCT00972478|20721244|P2|Eligible and Began Protocol Therapy|Overall Study||63
8407310|NCT00972478|20721245|P1|Eligible and Began Protocol Therapy|Overall Study||9
8407311|NCT00972478|20721244|P2|STARTED|Overall Study||72
8407312|NCT00972478|20721245|P1|STARTED|Overall Study||11
8407313|NCT00972439|20721257|P2|NOT COMPLETED|Overall Study||0
8407314|NCT00972439|20721258|P1|NOT COMPLETED|Overall Study||0
8407315|NCT00972439|20721257|P2|COMPLETED|Overall Study||16
8407316|NCT00972439|20721258|P1|COMPLETED|Overall Study||17
8407317|NCT00972439|20721257|P2|STARTED|Overall Study||16
8407318|NCT00972439|20721258|P1|STARTED|Overall Study||17
8407319|NCT00972374|20721267|P3|NOT COMPLETED|Overall Study||1
8407320|NCT00972374|20721268|P2|NOT COMPLETED|Overall Study||0
8407321|NCT00972374|20721269|P1|NOT COMPLETED|Overall Study||2
8407322|NCT00972374|20721267|P3|COMPLETED|Overall Study||13
8407323|NCT00972374|20721268|P2|COMPLETED|Overall Study||15
8407324|NCT00972374|20721269|P1|COMPLETED|Overall Study||13
8407325|NCT00972374|20721267|P3|STARTED|Overall Study||14
8407326|NCT00972374|20721268|P2|STARTED|Overall Study||15
8407327|NCT00972374|20721269|P1|STARTED|Overall Study||15
8407328|NCT00972335|20721283|P1|NOT COMPLETED|Overall Study||17
8407329|NCT00972335|20721283|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
8407330|NCT00972335|20721283|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
8407331|NCT00972322|20721290|P2|NOT COMPLETED|Overall Study||3
8407332|NCT00972322|20721291|P1|NOT COMPLETED|Overall Study||3
8407333|NCT00972322|20721290|P2|COMPLETED|Overall Study||25
8407334|NCT00972322|20721291|P1|COMPLETED|Overall Study||25
8407335|NCT00972322|20721290|P2|STARTED|Overall Study||28
8407336|NCT00972322|20721291|P1|STARTED|Overall Study||28
8407337|NCT00972283|20721303|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
8407338|NCT00972283|20721304|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
8407339|NCT00972283|20721303|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
8407340|NCT00972283|20721304|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
8407341|NCT00972283|20721303|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
8407342|NCT00972283|20721304|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
8407343|NCT00972283|20721303|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
8407344|NCT00972283|20721304|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
8407345|NCT00972283|20721303|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
8407346|NCT00972283|20721304|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
8407347|NCT00972283|20721303|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
8407348|NCT00972283|20721304|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
8407349|NCT00972283|20721303|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
8407350|NCT00972283|20721304|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
8407351|NCT00972283|20721303|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
8407352|NCT00972283|20721304|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
8407353|NCT00972244|20721331|P5|NOT COMPLETED|Overall Study||9
8407354|NCT00972244|20721332|P4|NOT COMPLETED|Overall Study||0
8407355|NCT00972244|20721333|P3|NOT COMPLETED|Overall Study||2
8407356|NCT00972244|20721334|P2|NOT COMPLETED|Overall Study||5
8407357|NCT00972244|20721335|P1|NOT COMPLETED|Overall Study||5
8407358|NCT00972244|20721331|P5|COMPLETED|Overall Study||45
8407359|NCT00972244|20721332|P4|COMPLETED|Overall Study||52
8407360|NCT00972244|20721333|P3|COMPLETED|Overall Study||56
8407361|NCT00972244|20721334|P2|COMPLETED|Overall Study||51
8407362|NCT00972244|20721335|P1|COMPLETED|Overall Study||54
8407363|NCT00972244|20721331|P5|STARTED|Overall Study||54
8407364|NCT00972244|20721332|P4|STARTED|Overall Study||52
8407365|NCT00972244|20721333|P3|STARTED|Overall Study||58
8407366|NCT00972244|20721334|P2|STARTED|Overall Study||56
8407367|NCT00972244|20721335|P1|STARTED|Overall Study||59
8407368|NCT00972205|20721357|P1|NOT COMPLETED|Overall Study||0
8407369|NCT00972205|20721357|P1|COMPLETED|Overall Study||12
8407370|NCT00972205|20721357|P1|STARTED|Overall Study||12
8407371|NCT00972153|20721367|P3|NOT COMPLETED|Overall Study||0
8407372|NCT00972153|20721368|P2|NOT COMPLETED|Overall Study||1
8407373|NCT00972153|20721369|P1|NOT COMPLETED|Overall Study||0
8407374|NCT00972153|20721367|P3|COMPLETED|Overall Study||12
8407375|NCT00972153|20721368|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
8407376|NCT00972153|20721369|P1|COMPLETED|Overall Study||12
8407377|NCT00972153|20721367|P3|STARTED|Overall Study||12
8407378|NCT00972153|20721368|P2|STARTED|Overall Study||12
8407379|NCT00972153|20721369|P1|STARTED|Overall Study||12
8407380|NCT00972088|20721380|P1|NOT COMPLETED|Overall Study||0
8407381|NCT00972088|20721380|P1|COMPLETED|Overall Study||26
8407382|NCT00972088|20721380|P1|STARTED|Overall Study||26
8407383|NCT00972023|20721384|P1|NOT COMPLETED|Overall Study||1
8407384|NCT00972023|20721384|P1|COMPLETED|Overall Study||0
8407385|NCT00972023|20721384|P1|STARTED|Overall Study||1
8407386|NCT00971997|20721391|P1|NOT COMPLETED|Overall Study||19
8407387|NCT00971997|20721391|P1|COMPLETED|Overall Study||116
8407388|NCT00971997|20721391|P1|STARTED|Overall Study||135
8407389|NCT00971932|20721409|P1|NOT COMPLETED|Overall Study||7
8407390|NCT00971932|20721409|P1|COMPLETED|Overall Study||26
8407391|NCT00971932|20721409|P1|STARTED|Overall Study|Number of participants treated.|33
8407392|NCT00971841|20721419|P1|NOT COMPLETED|Overall Study||0
8407393|NCT00971841|20721419|P1|COMPLETED|Overall Study||1
8407394|NCT00971841|20721419|P1|STARTED|Overall Study||1
8407395|NCT00971789|20721424|P1|NOT COMPLETED|Overall Study||0
8407396|NCT00971789|20721424|P1|COMPLETED|Overall Study||18
8407397|NCT00971789|20721424|P1|STARTED|Overall Study||18
8407398|NCT00971750|20721429|P1|NOT COMPLETED|Overall Study||0
8407399|NCT00971750|20721429|P1|COMPLETED|Overall Study||253
8407400|NCT00971750|20721429|P1|STARTED|Overall Study||253
8407401|NCT00971737|20721440|P2|NOT COMPLETED|Overall Study||0
8407402|NCT00971737|20721441|P1|NOT COMPLETED|Overall Study||0
8407403|NCT00971737|20721440|P2|COMPLETED|Overall Study||30
8407404|NCT00971737|20721441|P1|COMPLETED|Overall Study||30
8407405|NCT00971737|20721440|P2|STARTED|Overall Study||30
8407406|NCT00971737|20721441|P1|STARTED|Overall Study||30
8407407|NCT00971633|20721459|P6|NOT COMPLETED|Period 3||0
8407408|NCT00971633|20721460|P5|NOT COMPLETED|Period 3||0
8407409|NCT00971633|20721461|P4|NOT COMPLETED|Period 3||0
8407410|NCT00971633|20721462|P3|NOT COMPLETED|Period 3||0
8407411|NCT00971633|20721463|P2|NOT COMPLETED|Period 3||0
8407412|NCT00971633|20721464|P1|NOT COMPLETED|Period 3||0
8407413|NCT00971633|20721459|P6|COMPLETED|Period 3||2
8407414|NCT00971633|20721460|P5|COMPLETED|Period 3||2
8407415|NCT00971633|20721461|P4|COMPLETED|Period 3||2
8407416|NCT00971633|20721462|P3|COMPLETED|Period 3||2
8407417|NCT00971633|20721463|P2|COMPLETED|Period 3||2
8407418|NCT00971633|20721464|P1|COMPLETED|Period 3||2
8407419|NCT00971633|20721459|P6|STARTED|Period 3||2
8407420|NCT00971633|20721460|P5|STARTED|Period 3||2
8407421|NCT00971633|20721461|P4|STARTED|Period 3||2
8407422|NCT00971633|20721462|P3|STARTED|Period 3||2
8407423|NCT00971633|20721463|P2|STARTED|Period 3||2
8407424|NCT00971633|20721464|P1|STARTED|Period 3||2
8407425|NCT00971633|20721459|P6|NOT COMPLETED|Period 2||0
8407426|NCT00971633|20721460|P5|NOT COMPLETED|Period 2||0
8407427|NCT00971633|20721461|P4|NOT COMPLETED|Period 2||0
8407428|NCT00971633|20721462|P3|NOT COMPLETED|Period 2||0
8407429|NCT00971633|20721463|P2|NOT COMPLETED|Period 2||0
8407430|NCT00971633|20721464|P1|NOT COMPLETED|Period 2||0
8407431|NCT00971633|20721459|P6|COMPLETED|Period 2||2
8407432|NCT00971633|20721460|P5|COMPLETED|Period 2||2
8407433|NCT00971633|20721461|P4|COMPLETED|Period 2||2
8407434|NCT00971633|20721462|P3|COMPLETED|Period 2||2
8407435|NCT00971633|20721463|P2|COMPLETED|Period 2||2
8407436|NCT00971633|20721464|P1|COMPLETED|Period 2||2
8407437|NCT00971633|20721459|P6|STARTED|Period 2||2
8407438|NCT00971633|20721460|P5|STARTED|Period 2||2
8407439|NCT00971633|20721461|P4|STARTED|Period 2||2
8407440|NCT00971633|20721462|P3|STARTED|Period 2||2
8407441|NCT00971633|20721463|P2|STARTED|Period 2||2
8407442|NCT00971633|20721464|P1|STARTED|Period 2||2
8407443|NCT00971633|20721459|P6|NOT COMPLETED|Period 1||0
8407444|NCT00971633|20721460|P5|NOT COMPLETED|Period 1||0
8407445|NCT00971633|20721461|P4|NOT COMPLETED|Period 1||0
8407446|NCT00971633|20721462|P3|NOT COMPLETED|Period 1||0
8407447|NCT00971633|20721463|P2|NOT COMPLETED|Period 1||0
8407448|NCT00971633|20721464|P1|NOT COMPLETED|Period 1||0
8407449|NCT00971633|20721459|P6|COMPLETED|Period 1||2
8407450|NCT00971633|20721460|P5|COMPLETED|Period 1||2
8407451|NCT00971633|20721461|P4|COMPLETED|Period 1||2
8407452|NCT00971633|20721462|P3|COMPLETED|Period 1||2
8407453|NCT00971633|20721463|P2|COMPLETED|Period 1||2
8407454|NCT00971633|20721464|P1|COMPLETED|Period 1||2
8407455|NCT00971633|20721459|P6|STARTED|Period 1||2
8407456|NCT00971633|20721460|P5|STARTED|Period 1||2
8407457|NCT00971633|20721461|P4|STARTED|Period 1||2
8407458|NCT00971633|20721462|P3|STARTED|Period 1||2
8407459|NCT00971633|20721463|P2|STARTED|Period 1||2
8407460|NCT00971633|20721464|P1|STARTED|Period 1||2
8407461|NCT00971620|20721477|P2|NOT COMPLETED|Overall Study||0
8407462|NCT00971620|20721478|P1|NOT COMPLETED|Overall Study||0
8407463|NCT00971620|20721477|P2|COMPLETED|Overall Study||9
8407464|NCT00971620|20721478|P1|COMPLETED|Overall Study||9
8407465|NCT00971620|20721477|P2|STARTED|Overall Study||9
8407466|NCT00971620|20721478|P1|STARTED|Overall Study||9
8407467|NCT00971425|20721510|P2|NOT COMPLETED|Overall Study||2
8407468|NCT00971425|20721511|P1|NOT COMPLETED|Overall Study||1
8407469|NCT00971425|20721510|P2|COMPLETED|Overall Study||71
8407470|NCT00971425|20721511|P1|COMPLETED|Overall Study||71
8407471|NCT00971425|20721510|P2|STARTED|Overall Study||73
8407472|NCT00971425|20721511|P1|STARTED|Overall Study||72
8407473|NCT00971321|20721547|P2|NOT COMPLETED|Up to Month 11-12||3
8407474|NCT00971321|20721548|P1|NOT COMPLETED|Up to Month 11-12||5
8407475|NCT00971321|20721547|P2|COMPLETED|Up to Month 11-12||50
8407476|NCT00971321|20721548|P1|COMPLETED|Up to Month 11-12||99
8407477|NCT00971321|20721547|P2|STARTED|Up to Month 11-12||53
8407478|NCT00971321|20721548|P1|STARTED|Up to Month 11-12||104
8407479|NCT00971321|20721547|P2|NOT COMPLETED|Up to Month 7||2
8407480|NCT00971321|20721548|P1|NOT COMPLETED|Up to Month 7||4
8407481|NCT00971321|20721547|P2|COMPLETED|Up to Month 7||51
8407482|NCT00971321|20721548|P1|COMPLETED|Up to Month 7||100
8407483|NCT00971321|20721547|P2|STARTED|Up to Month 7||53
8407484|NCT00971321|20721548|P1|STARTED|Up to Month 7||104
8407485|NCT00971321|20721547|P2|NOT COMPLETED|Up to Day 42||0
8407486|NCT00971321|20721548|P1|NOT COMPLETED|Up to Day 42||0
8407487|NCT00971321|20721547|P2|COMPLETED|Up to Day 42||53
8407488|NCT00971321|20721548|P1|COMPLETED|Up to Day 42||104
8407489|NCT00971321|20721547|P2|STARTED|Up to Day 42||53
8407490|NCT00971321|20721548|P1|STARTED|Up to Day 42||104
8407491|NCT00971295|20721598|P2|NOT COMPLETED|Overall Study||1
8407492|NCT00971295|20721599|P1|NOT COMPLETED|Overall Study||0
8407493|NCT00971295|20721598|P2|COMPLETED|Overall Study||9
8407494|NCT00971295|20721599|P1|COMPLETED|Overall Study||10
8407495|NCT00971295|20721598|P2|STARTED|Overall Study||10
8407496|NCT00971295|20721599|P1|STARTED|Overall Study||10
8407500|NCT00971243|20721628|P5|NOT COMPLETED|Open-label Period||6
8407501|NCT00971243|20721629|P4|NOT COMPLETED|Open-label Period||10
8407502|NCT00971243|20721630|P3|NOT COMPLETED|Open-label Period||5
8407503|NCT00971243|20721631|P2|NOT COMPLETED|Open-label Period||10
8407504|NCT00971243|20721632|P1|NOT COMPLETED|Open-label Period||8
8407505|NCT00971243|20721628|P5|COMPLETED|Open-label Period||64
8407506|NCT00971243|20721629|P4|COMPLETED|Open-label Period||64
8407507|NCT00971243|20721630|P3|COMPLETED|Open-label Period||66
8407508|NCT00971243|20721631|P2|COMPLETED|Open-label Period||71
8407509|NCT00971243|20721632|P1|COMPLETED|Open-label Period||60
8407510|NCT00971243|20721628|P5|STARTED|Open-label Period||70
8407511|NCT00971243|20721629|P4|STARTED|Open-label Period||74
8407512|NCT00971243|20721630|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
8407513|NCT00971243|20721631|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
8407514|NCT00971243|20721632|P1|STARTED|Open-label Period||68
8407515|NCT00971243|20721628|P5|NOT COMPLETED|Double Blind Period||18
8407516|NCT00971243|20721629|P4|NOT COMPLETED|Double Blind Period||14
8407517|NCT00971243|20721630|P3|NOT COMPLETED|Double Blind Period||19
8407518|NCT00971243|20721631|P2|NOT COMPLETED|Double Blind Period||11
8407519|NCT00971243|20721632|P1|NOT COMPLETED|Double Blind Period||19
8407520|NCT00971243|20721628|P5|COMPLETED|Double Blind Period||70
8407521|NCT00971243|20721629|P4|COMPLETED|Double Blind Period||74
8407522|NCT00971243|20721630|P3|COMPLETED|Double Blind Period||72
8407523|NCT00971243|20721631|P2|COMPLETED|Double Blind Period||82
8407524|NCT00971243|20721632|P1|COMPLETED|Double Blind Period||68
8407525|NCT00971243|20721628|P5|STARTED|Double Blind Period||88
8407526|NCT00971243|20721629|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
8407527|NCT00971243|20721630|P3|STARTED|Double Blind Period||91
8407528|NCT00971243|20721631|P2|STARTED|Double Blind Period||93
8407529|NCT00971243|20721632|P1|STARTED|Double Blind Period||87
8407530|NCT00971204|20721649|P1|NOT COMPLETED|Overall Study||24
8407531|NCT00971204|20721649|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
8407532|NCT00971204|20721649|P1|Treated|Overall Study||86
8407533|NCT00971204|20721649|P1|STARTED|Overall Study|100 enrolled participants|100
8407534|NCT00971178|20721656|P3|NOT COMPLETED|Overall Study||2
8407535|NCT00971178|20721657|P2|NOT COMPLETED|Overall Study||2
8407536|NCT00971178|20721658|P1|NOT COMPLETED|Overall Study||2
8407537|NCT00971178|20721656|P3|COMPLETED|Overall Study||33
8407538|NCT00971178|20721657|P2|COMPLETED|Overall Study||33
8407539|NCT00971178|20721658|P1|COMPLETED|Overall Study||33
8407540|NCT00971178|20721656|P3|STARTED|Overall Study||35
8407541|NCT00971178|20721657|P2|STARTED|Overall Study||35
8407542|NCT00971178|20721658|P1|STARTED|Overall Study||35
8407543|NCT00971048|20721670|P4|NOT COMPLETED|Overall Study||2
8407544|NCT00971048|20721671|P3|NOT COMPLETED|Overall Study||1
8407545|NCT00971048|20721672|P2|NOT COMPLETED|Overall Study||2
8407546|NCT00971048|20721673|P1|NOT COMPLETED|Overall Study||1
8407547|NCT00971048|20721670|P4|COMPLETED|Overall Study||11
8407548|NCT00971048|20721671|P3|COMPLETED|Overall Study||11
8407549|NCT00971048|20721672|P2|COMPLETED|Overall Study||31
8407550|NCT00971048|20721673|P1|COMPLETED|Overall Study||29
8407551|NCT00971048|20721670|P4|STARTED|Overall Study||13
8407552|NCT00971048|20721671|P3|STARTED|Overall Study||12
8407553|NCT00971048|20721672|P2|STARTED|Overall Study||33
8407554|NCT00971048|20721673|P1|STARTED|Overall Study||30
8407555|NCT00970944|20721697|P2|NOT COMPLETED|Overall Study||2
8407556|NCT00970944|20721698|P1|NOT COMPLETED|Overall Study||1
8407557|NCT00970944|20721697|P2|COMPLETED|Overall Study||95
8407558|NCT00970944|20721698|P1|COMPLETED|Overall Study||86
8407559|NCT00970944|20721697|P2|STARTED|Overall Study||97
8407560|NCT00970944|20721698|P1|STARTED|Overall Study||87
8407561|NCT00970853|20721708|P2|NOT COMPLETED|Overall Study||0
8407562|NCT00970853|20721709|P1|NOT COMPLETED|Overall Study||0
8407563|NCT00970853|20721708|P2|COMPLETED|Overall Study||98
8407564|NCT00970853|20721709|P1|COMPLETED|Overall Study||89
8407565|NCT00970853|20721708|P2|STARTED|Overall Study||98
8407566|NCT00970853|20721709|P1|STARTED|Overall Study||89
8407567|NCT00970814|20721733|P2|NOT COMPLETED|Overall Study||14
8407568|NCT00970814|20721734|P1|NOT COMPLETED|Overall Study||8
8407569|NCT00970814|20721733|P2|COMPLETED|Overall Study||50
8407570|NCT00970814|20721734|P1|COMPLETED|Overall Study||58
8407571|NCT00970814|20721733|P2|STARTED|Overall Study||64
8407572|NCT00970814|20721734|P1|STARTED|Overall Study||66
8407573|NCT00970736|20721744|P1|NOT COMPLETED|Overall Study||2
8407574|NCT00970736|20721744|P1|COMPLETED|Overall Study||18
8407575|NCT00970736|20721744|P1|STARTED|Overall Study||20
8407576|NCT00970684|20721750|P1|NOT COMPLETED|Overall Study||10
8407577|NCT00970684|20721750|P1|COMPLETED|Overall Study||3
8407578|NCT00970684|20721750|P1|STARTED|Overall Study||13
8407579|NCT00970632|20721759|P3|NOT COMPLETED|Overall Study||18
8407580|NCT00970632|20721760|P2|NOT COMPLETED|Overall Study||15
8407581|NCT00970632|20721761|P1|NOT COMPLETED|Overall Study||24
8407582|NCT00970632|20721759|P3|COMPLETED|Overall Study||150
8407583|NCT00970632|20721760|P2|COMPLETED|Overall Study||156
8407584|NCT00970632|20721761|P1|COMPLETED|Overall Study||148
8407585|NCT00970632|20721759|P3|STARTED|Overall Study||168
8407586|NCT00970632|20721760|P2|STARTED|Overall Study||171
8407587|NCT00970632|20721761|P1|STARTED|Overall Study||172
8407588|NCT00970606|20721819|P2|NOT COMPLETED|Overall Study||0
8407589|NCT00970606|20721820|P1|NOT COMPLETED|Overall Study||0
8407590|NCT00970606|20721819|P2|COMPLETED|Overall Study||3
8407591|NCT00970606|20721820|P1|COMPLETED|Overall Study||4
8407592|NCT00970606|20721819|P2|STARTED|Overall Study||3
8407593|NCT00970606|20721820|P1|STARTED|Overall Study||4
8407594|NCT00970593|20721833|P7|NOT COMPLETED|Overall Study||2
8407595|NCT00970593|20721834|P6|NOT COMPLETED|Overall Study||0
8407596|NCT00970593|20721835|P5|NOT COMPLETED|Overall Study||0
8407597|NCT00970593|20721836|P4|NOT COMPLETED|Overall Study||0
8407598|NCT00970593|20721837|P3|NOT COMPLETED|Overall Study||6
8407599|NCT00970593|20721838|P2|NOT COMPLETED|Overall Study||1
8407600|NCT00970593|20721839|P1|NOT COMPLETED|Overall Study||1
8407601|NCT00970593|20721833|P7|COMPLETED|Overall Study||14
8407602|NCT00970593|20721834|P6|COMPLETED|Overall Study||5
8407603|NCT00970593|20721835|P5|COMPLETED|Overall Study||20
8407604|NCT00970593|20721836|P4|COMPLETED|Overall Study||12
8407605|NCT00970593|20721837|P3|COMPLETED|Overall Study||7
8407606|NCT00970593|20721838|P2|COMPLETED|Overall Study||14
8407607|NCT00970593|20721839|P1|COMPLETED|Overall Study||10
8407608|NCT00970593|20721833|P7|STARTED|Overall Study||16
8407609|NCT00970593|20721834|P6|STARTED|Overall Study||5
8407610|NCT00970593|20721835|P5|STARTED|Overall Study||20
8407611|NCT00970593|20721836|P4|STARTED|Overall Study||12
8407612|NCT00970593|20721837|P3|STARTED|Overall Study||13
8407613|NCT00970593|20721838|P2|STARTED|Overall Study||15
8407614|NCT00970593|20721839|P1|STARTED|Overall Study||11
8407615|NCT00970502|20721921|P1|NOT COMPLETED|Overall Study||1
8407616|NCT00970502|20721921|P1|COMPLETED|Overall Study||14
8407617|NCT00970502|20721921|P1|STARTED|Overall Study||15
8407618|NCT00970489|20721932|P2|NOT COMPLETED|Overall Study||41
8407619|NCT00970489|20721933|P1|NOT COMPLETED|Overall Study||54
8407620|NCT00970489|20721932|P2|COMPLETED|Overall Study||717
8407621|NCT00970489|20721933|P1|COMPLETED|Overall Study||704
8407622|NCT00970489|20721932|P2|STARTED|Overall Study||758
8407623|NCT00970489|20721933|P1|STARTED|Overall Study||758
8407624|NCT00970359|20721945|P1|NOT COMPLETED|Overall Study||4
8407625|NCT00970359|20721945|P1|COMPLETED|Overall Study||20
8407626|NCT00970359|20721945|P1|STARTED|Overall Study||24
8407627|NCT00970320|20721956|P5|NOT COMPLETED|Overall Study||540
8407628|NCT00970320|20721957|P4|NOT COMPLETED|Overall Study||14
8407629|NCT00970320|20721958|P3|NOT COMPLETED|Overall Study||13
8407630|NCT00970320|20721959|P2|NOT COMPLETED|Overall Study||11
8407631|NCT00970320|20721960|P1|NOT COMPLETED|Overall Study||0
8407632|NCT00970320|20721956|P5|COMPLETED|Overall Study||1031
8407633|NCT00970320|20721957|P4|COMPLETED|Overall Study||36
8407634|NCT00970320|20721958|P3|COMPLETED|Overall Study||35
8407635|NCT00970320|20721959|P2|COMPLETED|Overall Study||13
8407636|NCT00970320|20721960|P1|COMPLETED|Overall Study||25
8407637|NCT00970320|20721956|P5|STARTED|Overall Study||1571
8407638|NCT00970320|20721957|P4|STARTED|Overall Study||50
8407639|NCT00970320|20721958|P3|STARTED|Overall Study||48
8407640|NCT00970320|20721959|P2|STARTED|Overall Study||24
8407641|NCT00970320|20721960|P1|STARTED|Overall Study||25
8407642|NCT00970307|20721975|P3|NOT COMPLETED|Overall Study||2
8407643|NCT00970307|20721976|P2|NOT COMPLETED|Overall Study||3
8407644|NCT00970307|20721977|P1|NOT COMPLETED|Overall Study||3
8407645|NCT00970307|20721975|P3|COMPLETED|Overall Study||139
8407646|NCT00970307|20721976|P2|COMPLETED|Overall Study||136
8407647|NCT00970307|20721977|P1|COMPLETED|Overall Study||138
8407648|NCT00970307|20721975|P3|STARTED|Overall Study||141
8407649|NCT00970307|20721976|P2|STARTED|Overall Study||139
8407650|NCT00970307|20721977|P1|STARTED|Overall Study||141
8407651|NCT00970294|20722051|P1|NOT COMPLETED|Overall Study||5
8407652|NCT00970294|20722051|P1|COMPLETED|Overall Study||6
8407653|NCT00970294|20722051|P1|STARTED|Overall Study||11
8407654|NCT00970281|20722059|P2|NOT COMPLETED|Overall Study||16
8407655|NCT00970281|20722060|P1|NOT COMPLETED|Overall Study||2
8407656|NCT00970281|20722059|P2|COMPLETED|Overall Study||29
8407657|NCT00970281|20722060|P1|COMPLETED|Overall Study||44
8407658|NCT00970281|20722059|P2|Full Analysis Set|Overall Study||45
8407659|NCT00970281|20722060|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
8407660|NCT00970281|20722059|P2|STARTED|Overall Study||45
8407661|NCT00970281|20722060|P1|STARTED|Overall Study||46
8407662|NCT00970268|20722078|P2|NOT COMPLETED|Overall Study||49
8407663|NCT00970268|20722079|P1|NOT COMPLETED|Overall Study||43
8407664|NCT00970268|20722078|P2|COMPLETED|Overall Study||103
8407665|NCT00970268|20722079|P1|COMPLETED|Overall Study||96
8407666|NCT00970268|20722078|P2|STARTED|Overall Study||152
8407667|NCT00970268|20722079|P1|STARTED|Overall Study||139
8407668|NCT00970216|20722093|P1|NOT COMPLETED|Overall Study||80
8407669|NCT00970216|20722093|P1|COMPLETED|Overall Study||80
8407670|NCT00970216|20722093|P1|STARTED|Overall Study||160
8407671|NCT00970203|20722099|P2|NOT COMPLETED|Overall Study||0
8407672|NCT00970203|20722100|P1|NOT COMPLETED|Overall Study||0
8407673|NCT00970203|20722099|P2|COMPLETED|Overall Study||6
8407674|NCT00970203|20722100|P1|COMPLETED|Overall Study||7
8407675|NCT00970203|20722099|P2|STARTED|Overall Study||6
8407676|NCT00970203|20722100|P1|STARTED|Overall Study||7
8407677|NCT00970073|20722123|P3|NOT COMPLETED|Overall Study||0
8407678|NCT00970073|20722124|P2|NOT COMPLETED|Overall Study||0
8407679|NCT00970073|20722125|P1|NOT COMPLETED|Overall Study||0
8407680|NCT00970073|20722123|P3|COMPLETED|Overall Study||10
8407681|NCT00970073|20722124|P2|COMPLETED|Overall Study||10
8407682|NCT00970073|20722125|P1|COMPLETED|Overall Study||10
8407683|NCT00970073|20722123|P3|STARTED|Overall Study||10
8407684|NCT00970073|20722124|P2|STARTED|Overall Study||10
8407685|NCT00970073|20722125|P1|STARTED|Overall Study||10
8407686|NCT00969878|20722144|P2|NOT COMPLETED|Overall Study||26
8407687|NCT00969878|20722145|P1|NOT COMPLETED|Overall Study||30
8407688|NCT00969878|20722144|P2|COMPLETED|Overall Study||126
8407689|NCT00969878|20722145|P1|COMPLETED|Overall Study||118
8407690|NCT00969878|20722144|P2|STARTED|Overall Study||152
8407691|NCT00969878|20722145|P1|STARTED|Overall Study||148
8407692|NCT00969761|20722165|P12|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407693|NCT00969761|20722166|P11|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407694|NCT00969761|20722167|P10|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
8407695|NCT00969761|20722168|P9|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
8407696|NCT00969761|20722169|P8|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
8407697|NCT00969761|20722170|P7|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407698|NCT00969761|20722171|P6|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407699|NCT00969761|20722172|P5|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407700|NCT00969761|20722173|P4|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
8407701|NCT00969761|20722174|P3|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
8407702|NCT00969761|20722175|P2|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407703|NCT00969761|20722176|P1|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
8407704|NCT00969761|20722165|P12|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407705|NCT00969761|20722166|P11|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407706|NCT00969761|20722167|P10|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407707|NCT00969761|20722168|P9|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407708|NCT00969761|20722169|P8|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407709|NCT00969761|20722170|P7|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407710|NCT00969761|20722171|P6|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407711|NCT00969761|20722172|P5|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407712|NCT00969761|20722173|P4|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407713|NCT00969761|20722174|P3|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407714|NCT00969761|20722175|P2|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407715|NCT00969761|20722176|P1|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407716|NCT00969761|20722165|P12|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407717|NCT00969761|20722166|P11|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407718|NCT00969761|20722167|P10|STARTED|Treated in and Beyond Treat. Cycle 2||2
8407719|NCT00969761|20722168|P9|STARTED|Treated in and Beyond Treat. Cycle 2||11
8407720|NCT00969761|20722169|P8|STARTED|Treated in and Beyond Treat. Cycle 2||6
8407721|NCT00969761|20722170|P7|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407722|NCT00969761|20722171|P6|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407723|NCT00969761|20722172|P5|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407724|NCT00969761|20722173|P4|STARTED|Treated in and Beyond Treat. Cycle 2||5
8407725|NCT00969761|20722174|P3|STARTED|Treated in and Beyond Treat. Cycle 2||10
8407726|NCT00969761|20722175|P2|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407727|NCT00969761|20722176|P1|STARTED|Treated in and Beyond Treat. Cycle 2||2
8407728|NCT00969761|20722165|P12|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407729|NCT00969761|20722166|P11|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407730|NCT00969761|20722167|P10|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8407731|NCT00969761|20722168|P9|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407732|NCT00969761|20722169|P8|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407733|NCT00969761|20722170|P7|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407734|NCT00969761|20722171|P6|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407735|NCT00969761|20722172|P5|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407736|NCT00969761|20722173|P4|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8407737|NCT00969761|20722174|P3|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407738|NCT00969761|20722175|P2|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407739|NCT00969761|20722176|P1|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8407740|NCT00969761|20722165|P12|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407741|NCT00969761|20722166|P11|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407742|NCT00969761|20722167|P10|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407743|NCT00969761|20722168|P9|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
8407744|NCT00969761|20722169|P8|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
8407745|NCT00969761|20722170|P7|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407746|NCT00969761|20722171|P6|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407747|NCT00969761|20722172|P5|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407748|NCT00969761|20722173|P4|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
8407749|NCT00969761|20722174|P3|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
8407750|NCT00969761|20722175|P2|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407751|NCT00969761|20722176|P1|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407752|NCT00969761|20722165|P12|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407753|NCT00969761|20722166|P11|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407754|NCT00969761|20722167|P10|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407755|NCT00969761|20722168|P9|STARTED|Discont. Before Start of Treat. Cycle 2||13
8407756|NCT00969761|20722169|P8|STARTED|Discont. Before Start of Treat. Cycle 2||6
8407757|NCT00969761|20722170|P7|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407758|NCT00969761|20722171|P6|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407759|NCT00969761|20722172|P5|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407760|NCT00969761|20722173|P4|STARTED|Discont. Before Start of Treat. Cycle 2||6
8407761|NCT00969761|20722174|P3|STARTED|Discont. Before Start of Treat. Cycle 2||12
8407762|NCT00969761|20722175|P2|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407763|NCT00969761|20722176|P1|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407764|NCT00969709|20722482|P4|NOT COMPLETED|Overall Study||63
8407765|NCT00969709|20722483|P3|NOT COMPLETED|Overall Study||58
8407766|NCT00969709|20722484|P2|NOT COMPLETED|Overall Study||48
8407767|NCT00969709|20722485|P1|NOT COMPLETED|Overall Study||38
8407768|NCT00969709|20722482|P4|COMPLETED|Overall Study||117
8407769|NCT00969709|20722483|P3|COMPLETED|Overall Study||121
8407770|NCT00969709|20722484|P2|COMPLETED|Overall Study||130
8407771|NCT00969709|20722485|P1|COMPLETED|Overall Study||138
8407772|NCT00969709|20722482|P4|STARTED|Overall Study||180
8407773|NCT00969709|20722483|P3|STARTED|Overall Study||179
8407774|NCT00969709|20722484|P2|STARTED|Overall Study||178
8407775|NCT00969709|20722485|P1|STARTED|Overall Study||176
8407776|NCT00969618|20722499|P1|NOT COMPLETED|Overall Study||78
8407777|NCT00969618|20722499|P1|COMPLETED|Overall Study||133
8407778|NCT00969618|20722499|P1|STARTED|Overall Study||211
8407779|NCT00969553|20722519|P9|NOT COMPLETED|Overall Study||3
8407780|NCT00969553|20722520|P8|NOT COMPLETED|Overall Study||14
8407781|NCT00969553|20722521|P7|NOT COMPLETED|Overall Study||4
8407782|NCT00969553|20722522|P6|NOT COMPLETED|Overall Study||4
8407783|NCT00969553|20722523|P5|NOT COMPLETED|Overall Study||3
8407784|NCT00969553|20722524|P4|NOT COMPLETED|Overall Study||16
8407785|NCT00969553|20722525|P3|NOT COMPLETED|Overall Study||6
8407786|NCT00969553|20722526|P2|NOT COMPLETED|Overall Study||3
8407787|NCT00969553|20722527|P1|NOT COMPLETED|Overall Study||3
8407788|NCT00969553|20722519|P9|COMPLETED|Overall Study||0
8407789|NCT00969553|20722520|P8|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
8407790|NCT00969553|20722521|P7|COMPLETED|Overall Study||0
8407791|NCT00969553|20722522|P6|COMPLETED|Overall Study||0
8407792|NCT00969553|20722523|P5|COMPLETED|Overall Study||0
8407793|NCT00969553|20722524|P4|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
8407794|NCT00969553|20722525|P3|COMPLETED|Overall Study||0
8407795|NCT00969553|20722526|P2|COMPLETED|Overall Study||0
8407796|NCT00969553|20722527|P1|COMPLETED|Overall Study||0
8407797|NCT00969553|20722519|P9|STARTED|Overall Study||3
8407798|NCT00969553|20722520|P8|STARTED|Overall Study||16
8407799|NCT00969553|20722521|P7|STARTED|Overall Study||4
8407800|NCT00969553|20722522|P6|STARTED|Overall Study||4
8407801|NCT00969553|20722523|P5|STARTED|Overall Study||3
8407802|NCT00969553|20722524|P4|STARTED|Overall Study||17
8407803|NCT00969553|20722525|P3|STARTED|Overall Study||6
8407804|NCT00969553|20722526|P2|STARTED|Overall Study||3
8407805|NCT00969553|20722527|P1|STARTED|Overall Study||3
8407806|NCT00969540|20722670|P2|NOT COMPLETED|Overall Study||1
8407807|NCT00969540|20722671|P1|NOT COMPLETED|Overall Study||1
8407808|NCT00969540|20722670|P2|COMPLETED|Overall Study||3
8407809|NCT00969540|20722671|P1|COMPLETED|Overall Study||3
8407810|NCT00969540|20722670|P2|STARTED|Overall Study||4
8407811|NCT00969540|20722671|P1|STARTED|Overall Study||4
8407812|NCT00969501|20722689|P1|NOT COMPLETED|Overall Study||5
8407813|NCT00969501|20722689|P1|COMPLETED|Overall Study||27
8407814|NCT00969501|20722689|P1|STARTED|Overall Study||32
8407815|NCT00969436|20722696|P3|NOT COMPLETED|Overall Study||11
8407816|NCT00969436|20722697|P2|NOT COMPLETED|Overall Study||21
8407817|NCT00969436|20722698|P1|NOT COMPLETED|Overall Study||25
8407818|NCT00969436|20722696|P3|COMPLETED|Overall Study||79
8407819|NCT00969436|20722697|P2|COMPLETED|Overall Study||159
8407820|NCT00969436|20722698|P1|COMPLETED|Overall Study||155
8407821|NCT00969436|20722696|P3|STARTED|Overall Study||90
8407822|NCT00969436|20722697|P2|STARTED|Overall Study||180
8407823|NCT00969436|20722698|P1|STARTED|Overall Study||180
8407824|NCT00969332|20722730|P1|NOT COMPLETED|Overall Study||11
8407825|NCT00969332|20722730|P1|COMPLETED|Overall Study||51
8407826|NCT00969332|20722730|P1|STARTED|Overall Study||62
8407827|NCT00969280|20722746|P2|NOT COMPLETED|Overall Study||3
8407828|NCT00969280|20722747|P1|NOT COMPLETED|Overall Study||2
8407829|NCT00969280|20722746|P2|COMPLETED|Overall Study||18
8407830|NCT00969280|20722747|P1|COMPLETED|Overall Study||19
8407831|NCT00969280|20722746|P2|STARTED|Overall Study||21
8407832|NCT00969280|20722747|P1|STARTED|Overall Study||21
8407833|NCT00969228|20722755|P2|NOT COMPLETED|Overall Study||14
8407834|NCT00969228|20722756|P1|NOT COMPLETED|Overall Study||43
8407835|NCT00969228|20722755|P2|COMPLETED|Overall Study||162
8407836|NCT00969228|20722756|P1|COMPLETED|Overall Study||465
8407837|NCT00969228|20722755|P2|STARTED|Overall Study||176
8407838|NCT00969228|20722756|P1|STARTED|Overall Study||508
8407839|NCT00969150|20722774|P2|NOT COMPLETED|Overall Study||40
8407840|NCT00969150|20722775|P1|NOT COMPLETED|Overall Study||33
8407841|NCT00969150|20722774|P2|COMPLETED|Overall Study||135
8407842|NCT00969150|20722775|P1|COMPLETED|Overall Study||149
8407843|NCT00969150|20722774|P2|STARTED|Overall Study||175
8407844|NCT00969150|20722775|P1|STARTED|Overall Study||182
8407845|NCT00969124|20722783|P1|NOT COMPLETED|Overall Study||30
8407846|NCT00969124|20722783|P1|COMPLETED|Overall Study||298
8407847|NCT00969124|20722783|P1|STARTED|Overall Study||328
8407848|NCT00968981|20722792|P3|NOT COMPLETED|Overall Study||22
8407849|NCT00968981|20722793|P2|NOT COMPLETED|Overall Study||22
8407850|NCT00968981|20722794|P1|NOT COMPLETED|Overall Study||22
8407851|NCT00968981|20722792|P3|COMPLETED|Overall Study||0
8407852|NCT00968981|20722793|P2|COMPLETED|Overall Study||0
8407853|NCT00968981|20722794|P1|COMPLETED|Overall Study||1
8407854|NCT00968981|20722792|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
8407855|NCT00968981|20722793|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
8407856|NCT00968981|20722794|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
8407857|NCT00968981|20722792|P3|STARTED|Overall Study||22
8407858|NCT00968981|20722793|P2|STARTED|Overall Study||22
8407859|NCT00968981|20722794|P1|STARTED|Overall Study||23
8407860|NCT00968968|20722832|P2|NOT COMPLETED|Overall Study||14
8407861|NCT00968968|20722833|P1|NOT COMPLETED|Overall Study||16
8407862|NCT00968968|20722832|P2|COMPLETED|Overall Study||3
8407863|NCT00968968|20722833|P1|COMPLETED|Overall Study||4
8407864|NCT00968968|20722832|P2|STARTED|Overall Study||17
8407865|NCT00968968|20722833|P1|STARTED|Overall Study||20
8407866|NCT00968890|20722850|P2|NOT COMPLETED|Overall Study||0
8407867|NCT00968890|20722851|P1|NOT COMPLETED|Overall Study||0
8407868|NCT00968890|20722850|P2|COMPLETED|Overall Study||84
8407869|NCT00968890|20722851|P1|COMPLETED|Overall Study||84
8407870|NCT00968890|20722850|P2|STARTED|Overall Study||84
8407871|NCT00968890|20722851|P1|STARTED|Overall Study||84
8407872|NCT00968864|20722879|P1|NOT COMPLETED|Overall Study||1
8407873|NCT00968864|20722879|P1|COMPLETED|Overall Study||52
8407874|NCT00968864|20722879|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
8407875|NCT00968838|20722897|P2|NOT COMPLETED|Overall Study||0
8407876|NCT00968838|20722898|P1|NOT COMPLETED|Overall Study||0
8407877|NCT00968838|20722897|P2|COMPLETED|Overall Study||58
8407878|NCT00968838|20722898|P1|COMPLETED|Overall Study||50
8407879|NCT00968838|20722897|P2|STARTED|Overall Study||58
8407880|NCT00968838|20722898|P1|STARTED|Overall Study||50
8407881|NCT00968812|20722907|P3|NOT COMPLETED|Overall Study||168
8407882|NCT00968812|20722908|P2|NOT COMPLETED|Overall Study||162
8407883|NCT00968812|20722909|P1|NOT COMPLETED|Overall Study||140
8407884|NCT00968812|20722907|P3|COMPLETED|Overall Study||314
8407885|NCT00968812|20722908|P2|COMPLETED|Overall Study||323
8407886|NCT00968812|20722909|P1|COMPLETED|Overall Study||343
8407887|NCT00968812|20722907|P3|STARTED|Overall Study||482
8407888|NCT00968812|20722908|P2|STARTED|Overall Study||485
8407889|NCT00968812|20722909|P1|STARTED|Overall Study||483
8407890|NCT00968799|20722929|P1|NOT COMPLETED|Overall Study||2
8407891|NCT00968799|20722929|P1|COMPLETED|Overall Study||4
8407892|NCT00968799|20722929|P1|STARTED|Overall Study||6
8407893|NCT00968708|20722939|P2|NOT COMPLETED|Overall Study||298
8407894|NCT00968708|20722940|P1|NOT COMPLETED|Overall Study||318
8407895|NCT00968708|20722939|P2|COMPLETED|Overall Study||2403
8407896|NCT00968708|20722940|P1|COMPLETED|Overall Study||2361
8407897|NCT00968708|20722939|P2|Treated|Overall Study||2698
8407898|NCT00968708|20722940|P1|Treated|Overall Study||2676
8407899|NCT00968708|20722939|P2|STARTED|Overall Study||2701
8407900|NCT00968708|20722940|P1|STARTED|Overall Study||2679
8407901|NCT00968669|20722952|P4|NOT COMPLETED|Overall Study||9
8407902|NCT00968669|20722953|P3|NOT COMPLETED|Overall Study||11
8407903|NCT00968669|20722954|P2|NOT COMPLETED|Overall Study||18
8407904|NCT00968669|20722955|P1|NOT COMPLETED|Overall Study||18
8407905|NCT00968669|20722952|P4|COMPLETED|Overall Study||72
8407906|NCT00968669|20722953|P3|COMPLETED|Overall Study||72
8407907|NCT00968669|20722954|P2|COMPLETED|Overall Study||63
8407908|NCT00968669|20722955|P1|COMPLETED|Overall Study||64
8407909|NCT00968669|20722952|P4|STARTED|Overall Study||81
8407910|NCT00968669|20722953|P3|STARTED|Overall Study||83
8407911|NCT00968669|20722954|P2|STARTED|Overall Study||81
8407912|NCT00968669|20722955|P1|STARTED|Overall Study||82
8407913|NCT00968617|20723045|P1|NOT COMPLETED|Overall Study||6
8407914|NCT00968617|20723045|P1|COMPLETED|Overall Study||1
8407915|NCT00968617|20723045|P1|STARTED|Overall Study||7
8407916|NCT00968539|20723059|P2|NOT COMPLETED|Overall Study||0
8407917|NCT00968539|20723060|P1|NOT COMPLETED|Overall Study||1
8407918|NCT00968539|20723059|P2|COMPLETED|Overall Study||66
8407919|NCT00968539|20723060|P1|COMPLETED|Overall Study||63
8407920|NCT00968539|20723059|P2|STARTED|Overall Study||66
8407921|NCT00968539|20723060|P1|STARTED|Overall Study||64
8407922|NCT00968526|20723120|P2|NOT COMPLETED|Overall Study||0
8407923|NCT00968526|20723121|P1|NOT COMPLETED|Overall Study||3
8407924|NCT00968526|20723120|P2|COMPLETED|Overall Study||102
8407925|NCT00968526|20723121|P1|COMPLETED|Overall Study||135
8407926|NCT00968526|20723120|P2|STARTED|Overall Study||102
8407927|NCT00968526|20723121|P1|STARTED|Overall Study||138
8407928|NCT00968344|20723213|P2|NOT COMPLETED|Overall Study||11
8407929|NCT00968344|20723214|P1|NOT COMPLETED|Overall Study||10
8407930|NCT00968344|20723213|P2|COMPLETED|Overall Study||9
8407931|NCT00968344|20723214|P1|COMPLETED|Overall Study||10
8407932|NCT00968344|20723213|P2|STARTED|Overall Study|Includes screen fails|20
8407933|NCT00968344|20723214|P1|STARTED|Overall Study|Includes screen fails|20
8407934|NCT00968253|20723223|P3|NOT COMPLETED|Overall Study||7
8407935|NCT00968253|20723224|P2|NOT COMPLETED|Overall Study||3
8407936|NCT00968253|20723225|P1|NOT COMPLETED|Overall Study||0
8407937|NCT00968253|20723223|P3|COMPLETED|Overall Study||5
8407938|NCT00968253|20723224|P2|COMPLETED|Overall Study||6
8407939|NCT00968253|20723225|P1|COMPLETED|Overall Study||3
8407940|NCT00968253|20723223|P3|STARTED|Overall Study||12
8407941|NCT00968253|20723224|P2|STARTED|Overall Study||9
8407942|NCT00968253|20723225|P1|STARTED|Overall Study||3
8407943|NCT00968227|20723239|P1|NOT COMPLETED|Overall Study||0
8407944|NCT00968227|20723239|P1|COMPLETED|Overall Study||56
8407945|NCT00968227|20723239|P1|STARTED|Overall Study||56
8407946|NCT00968201|20723246|P3|NOT COMPLETED|Extension Study - (Period III)||280
8407947|NCT00968201|20723247|P2|NOT COMPLETED|Extension Study - (Period III)||124
8407948|NCT00968201|20723248|P1|NOT COMPLETED|Extension Study - (Period III)||0
8407949|NCT00968201|20723246|P3|COMPLETED|Extension Study - (Period III)||84
8407950|NCT00968201|20723247|P2|COMPLETED|Extension Study - (Period III)||33
8407951|NCT00968201|20723248|P1|COMPLETED|Extension Study - (Period III)||0
8407952|NCT00968201|20723246|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
8407953|NCT00968201|20723247|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
8407954|NCT00968201|20723248|P1|STARTED|Extension Study - (Period III)||0
8407955|NCT00968201|20723246|P3|NOT COMPLETED|Base Study - (Period II)||45
8407956|NCT00968201|20723247|P2|NOT COMPLETED|Base Study - (Period II)||0
8407957|NCT00968201|20723248|P1|NOT COMPLETED|Base Study - (Period II)||26
8407958|NCT00968201|20723246|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
8407959|NCT00968201|20723247|P2|COMPLETED|Base Study - (Period II)||0
8407960|NCT00968201|20723248|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
8407961|NCT00968201|20723246|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
8407962|NCT00968201|20723247|P2|STARTED|Base Study - (Period II)||0
8407963|NCT00968201|20723248|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
8407964|NCT00968149|20723309|P2|NOT COMPLETED|Overall Study||6
8407965|NCT00968149|20723310|P1|NOT COMPLETED|Overall Study||11
8407966|NCT00968149|20723309|P2|COMPLETED|Overall Study||127
8407967|NCT00968149|20723310|P1|COMPLETED|Overall Study||269
8407968|NCT00968149|20723309|P2|STARTED|Overall Study||133
8407969|NCT00968149|20723310|P1|STARTED|Overall Study||280
8407970|NCT00968071|20723330|P1|NOT COMPLETED|Overall Study||0
8407971|NCT00968071|20723330|P1|COMPLETED|Overall Study||71
8407972|NCT00968071|20723330|P1|STARTED|Overall Study||71
8407973|NCT00968032|20723334|P1|NOT COMPLETED|Overall Study||2
8407974|NCT00968032|20723334|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage
~1 patient denied latest FU"|61
8407975|NCT00968032|20723334|P1|STARTED|Overall Study||63
8407976|NCT00968019|20723338|P1|NOT COMPLETED|Overall Study||15
8407977|NCT00968019|20723338|P1|COMPLETED|Overall Study||303
8407978|NCT00968019|20723338|P1|STARTED|Overall Study||318
8407979|NCT00967993|20723359|P1|NOT COMPLETED|Overall Study||4
8407980|NCT00967993|20723359|P1|COMPLETED|Overall Study||18
8407981|NCT00967993|20723359|P1|STARTED|Overall Study||22
8407982|NCT00967941|20723366|P3|NOT COMPLETED|Overall Study||4
8407983|NCT00967941|20723367|P2|NOT COMPLETED|Overall Study||3
8407984|NCT00967941|20723368|P1|NOT COMPLETED|Overall Study||5
8407985|NCT00967941|20723366|P3|COMPLETED|Overall Study||56
8407986|NCT00967941|20723367|P2|COMPLETED|Overall Study||51
8407987|NCT00967941|20723368|P1|COMPLETED|Overall Study||62
8407988|NCT00967941|20723366|P3|STARTED|Overall Study||60
8407989|NCT00967941|20723367|P2|STARTED|Overall Study||54
8407990|NCT00967941|20723368|P1|STARTED|Overall Study||67
8407991|NCT00967798|20723378|P2|NOT COMPLETED|Overall Study||3
8407992|NCT00967798|20723379|P1|NOT COMPLETED|Overall Study||9
8407993|NCT00967798|20723378|P2|COMPLETED|Overall Study||13
8407994|NCT00967798|20723379|P1|COMPLETED|Overall Study||8
8407995|NCT00967798|20723378|P2|STARTED|Overall Study||16
8407996|NCT00967798|20723379|P1|STARTED|Overall Study||17
8407997|NCT00967694|20723393|P1|NOT COMPLETED|Overall Study||6
8407998|NCT00967694|20723393|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
8407999|NCT00967694|20723393|P1|STARTED|Overall Study||26
8408000|NCT00967668|20723400|P3|NOT COMPLETED|Overall Study||69
8408001|NCT00967668|20723401|P2|NOT COMPLETED|Overall Study||56
8408002|NCT00967668|20723402|P1|NOT COMPLETED|Overall Study||71
8408003|NCT00967668|20723400|P3|COMPLETED|Overall Study||90
8408004|NCT00967668|20723401|P2|COMPLETED|Overall Study||104
8408005|NCT00967668|20723402|P1|COMPLETED|Overall Study||91
8408006|NCT00967668|20723400|P3|18-mo Assessment|Overall Study||92
8408007|NCT00967668|20723401|P2|18-mo Assessment|Overall Study||102
8408008|NCT00967668|20723402|P1|18-mo Assessment|Overall Study||95
8408009|NCT00967668|20723400|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
8408010|NCT00967668|20723401|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
8408011|NCT00967668|20723402|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
8408012|NCT00967668|20723400|P3|3-mo Assessment|Overall Study||115
8408013|NCT00967668|20723401|P2|3-mo Assessment|Overall Study||127
8408014|NCT00967668|20723402|P1|3-mo Assessment|Overall Study||131
8408015|NCT00967668|20723400|P3|STARTED|Overall Study||159
8408016|NCT00967668|20723401|P2|STARTED|Overall Study||160
8408017|NCT00967668|20723402|P1|STARTED|Overall Study||162
8408018|NCT00967616|20723415|P2|NOT COMPLETED|Overall Study||50
8408019|NCT00967616|20723416|P1|NOT COMPLETED|Overall Study||50
8408020|NCT00967616|20723415|P2|COMPLETED|Overall Study||0
8408021|NCT00967616|20723416|P1|COMPLETED|Overall Study||0
8408022|NCT00967616|20723415|P2|STARTED|Overall Study||50
8408023|NCT00967616|20723416|P1|STARTED|Overall Study||50
8408024|NCT00967551|20723432|P2|NOT COMPLETED|Overall Study||0
8408025|NCT00967551|20723433|P1|NOT COMPLETED|Overall Study||0
8408026|NCT00967551|20723432|P2|COMPLETED|Overall Study||75
8408027|NCT00967551|20723433|P1|COMPLETED|Overall Study||68
8408028|NCT00967551|20723432|P2|STARTED|Overall Study||75
8408029|NCT00967551|20723433|P1|STARTED|Overall Study||68
8408030|NCT00967499|20723443|P2|NOT COMPLETED|Overall Study||60
8408031|NCT00967499|20723444|P1|NOT COMPLETED|Overall Study||65
8408032|NCT00967499|20723443|P2|COMPLETED|Overall Study||49
8408033|NCT00967499|20723444|P1|COMPLETED|Overall Study||46
8408034|NCT00967499|20723443|P2|Treated (Full Analysis Set)|Overall Study||50
8408035|NCT00967499|20723444|P1|Treated (Full Analysis Set)|Overall Study||48
8408036|NCT00967499|20723443|P2|STARTED|Overall Study||109
8408037|NCT00967499|20723444|P1|STARTED|Overall Study||111
8408038|NCT00967486|20723462|P2|NOT COMPLETED|Overall Study||0
8408039|NCT00967486|20723463|P1|NOT COMPLETED|Overall Study||0
8408040|NCT00967486|20723462|P2|COMPLETED|Overall Study||102
8408041|NCT00967486|20723463|P1|COMPLETED|Overall Study||98
8408042|NCT00967486|20723462|P2|STARTED|Overall Study||102
8408043|NCT00967486|20723463|P1|STARTED|Overall Study||98
8408044|NCT00967473|20723469|P1|NOT COMPLETED|Overall Study||0
8408045|NCT00967473|20723469|P1|COMPLETED|Overall Study||15
8408046|NCT00967473|20723469|P1|STARTED|Overall Study||15
8408047|NCT00967447|20723475|P1|NOT COMPLETED|Overall Study||0
8408048|NCT00967447|20723475|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
8408049|NCT00967447|20723475|P1|STARTED|Overall Study|there are no collected data in CRF|2
8408050|NCT00967369|20723484|P2|NOT COMPLETED|Overall Study||0
8408051|NCT00967369|20723485|P1|NOT COMPLETED|Overall Study||0
8408052|NCT00967369|20723484|P2|COMPLETED|Overall Study||10
8408053|NCT00967369|20723485|P1|COMPLETED|Overall Study||10
8408054|NCT00967369|20723484|P2|Refractory|Overall Study||3
8408055|NCT00967369|20723485|P1|Refractory|Overall Study||6
8408056|NCT00967369|20723484|P2|Relapsed|Overall Study||7
8408057|NCT00967369|20723485|P1|Relapsed|Overall Study||4
8408058|NCT00967369|20723484|P2|STARTED|Overall Study||10
8408059|NCT00967369|20723485|P1|STARTED|Overall Study||10
8408060|NCT00967343|20723501|P1|NOT COMPLETED|Overall Study||38
8408061|NCT00967343|20723501|P1|COMPLETED|Overall Study||2
8408062|NCT00967343|20723501|P1|STARTED|Overall Study||40
8408063|NCT00967330|20723507|P2|NOT COMPLETED|Overall Study||60
8408064|NCT00967330|20723508|P1|NOT COMPLETED|Overall Study||122
8408065|NCT00967330|20723507|P2|COMPLETED|Overall Study||0
8408066|NCT00967330|20723508|P1|COMPLETED|Overall Study||0
8408067|NCT00967330|20723507|P2|STARTED|Overall Study||60
8408068|NCT00967330|20723508|P1|STARTED|Overall Study||122
8408069|NCT00967226|20723538|P2|NOT COMPLETED|Overall Study||6
8408070|NCT00967226|20723539|P1|NOT COMPLETED|Overall Study||2
8408071|NCT00967226|20723538|P2|COMPLETED|Overall Study||2
8408072|NCT00967226|20723539|P1|COMPLETED|Overall Study||9
8408073|NCT00967226|20723538|P2|STARTED|Overall Study||8
8408074|NCT00967226|20723539|P1|STARTED|Overall Study||11
8408075|NCT00967044|20723569|P1|NOT COMPLETED|Overall Study||0
8408076|NCT00967044|20723569|P1|COMPLETED|Overall Study||30
8408077|NCT00967044|20723569|P1|STARTED|Overall Study||30
8408078|NCT00967018|20723573|P1|NOT COMPLETED|Overall Study||21
8408079|NCT00967018|20723573|P1|COMPLETED|Overall Study||56
8408080|NCT00967018|20723573|P1|STARTED|Overall Study||77
8408081|NCT00967005|20723582|P2|NOT COMPLETED|Overall Study||10
8408082|NCT00967005|20723583|P1|NOT COMPLETED|Overall Study||7
8408083|NCT00967005|20723582|P2|COMPLETED|Overall Study||5
8408084|NCT00967005|20723583|P1|COMPLETED|Overall Study||6
8408085|NCT00967005|20723582|P2|Treatment Completion|Overall Study||10
8408086|NCT00967005|20723583|P1|Treatment Completion|Overall Study||10
8408087|NCT00967005|20723582|P2|STARTED|Overall Study||15
8408088|NCT00967005|20723583|P1|STARTED|Overall Study||13
8408089|NCT00966992|20723637|P2|NOT COMPLETED|Overall Study||0
8408090|NCT00966992|20723638|P1|NOT COMPLETED|Overall Study||0
8408091|NCT00966992|20723637|P2|COMPLETED|Overall Study||0
8408092|NCT00966992|20723638|P1|COMPLETED|Overall Study||3
8408093|NCT00966992|20723637|P2|STARTED|Overall Study||0
8408094|NCT00966992|20723638|P1|STARTED|Overall Study||3
8408095|NCT00966953|20723658|P4|NOT COMPLETED|4th Intervention Order||0
8408096|NCT00966953|20723659|P3|NOT COMPLETED|4th Intervention Order||0
8408097|NCT00966953|20723660|P2|NOT COMPLETED|4th Intervention Order||0
8408098|NCT00966953|20723661|P1|NOT COMPLETED|4th Intervention Order||0
8408099|NCT00966953|20723658|P4|COMPLETED|4th Intervention Order||7
8408100|NCT00966953|20723659|P3|COMPLETED|4th Intervention Order||6
8408101|NCT00966953|20723660|P2|COMPLETED|4th Intervention Order||6
8408102|NCT00966953|20723661|P1|COMPLETED|4th Intervention Order||6
8408103|NCT00966953|20723658|P4|STARTED|4th Intervention Order||7
8408104|NCT00966953|20723659|P3|STARTED|4th Intervention Order||6
8408105|NCT00966953|20723660|P2|STARTED|4th Intervention Order||6
8408106|NCT00966953|20723661|P1|STARTED|4th Intervention Order||6
8408107|NCT00966953|20723658|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408108|NCT00966953|20723659|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408109|NCT00966953|20723660|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408110|NCT00966953|20723661|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408111|NCT00966953|20723658|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
8408112|NCT00966953|20723659|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
8408113|NCT00966953|20723660|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
8408114|NCT00966953|20723661|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
8408115|NCT00966953|20723658|P4|STARTED|1 Week Washout After 3rd Intervention||7
8408116|NCT00966953|20723659|P3|STARTED|1 Week Washout After 3rd Intervention||6
8408117|NCT00966953|20723660|P2|STARTED|1 Week Washout After 3rd Intervention||6
8408118|NCT00966953|20723661|P1|STARTED|1 Week Washout After 3rd Intervention||6
8408119|NCT00966953|20723658|P4|NOT COMPLETED|3rd Intervention Order||0
8408120|NCT00966953|20723659|P3|NOT COMPLETED|3rd Intervention Order||0
8408121|NCT00966953|20723660|P2|NOT COMPLETED|3rd Intervention Order||0
8408122|NCT00966953|20723661|P1|NOT COMPLETED|3rd Intervention Order||0
8408123|NCT00966953|20723658|P4|COMPLETED|3rd Intervention Order||7
8408124|NCT00966953|20723659|P3|COMPLETED|3rd Intervention Order||6
8408125|NCT00966953|20723660|P2|COMPLETED|3rd Intervention Order||6
8408126|NCT00966953|20723661|P1|COMPLETED|3rd Intervention Order||6
8408127|NCT00966953|20723658|P4|STARTED|3rd Intervention Order||7
8408128|NCT00966953|20723659|P3|STARTED|3rd Intervention Order||6
8408129|NCT00966953|20723660|P2|STARTED|3rd Intervention Order||6
8408130|NCT00966953|20723661|P1|STARTED|3rd Intervention Order||6
8408131|NCT00966953|20723658|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408132|NCT00966953|20723659|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408133|NCT00966953|20723660|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408134|NCT00966953|20723661|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408135|NCT00966953|20723658|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
8408136|NCT00966953|20723659|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
8408137|NCT00966953|20723660|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
8408138|NCT00966953|20723661|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
8408139|NCT00966953|20723658|P4|STARTED|1 Week Washout After 2nd Intervention||7
8408140|NCT00966953|20723659|P3|STARTED|1 Week Washout After 2nd Intervention||6
8408141|NCT00966953|20723660|P2|STARTED|1 Week Washout After 2nd Intervention||6
8408142|NCT00966953|20723661|P1|STARTED|1 Week Washout After 2nd Intervention||6
8408143|NCT00966953|20723658|P4|NOT COMPLETED|2nd Intervention||0
8408144|NCT00966953|20723659|P3|NOT COMPLETED|2nd Intervention||0
8408145|NCT00966953|20723660|P2|NOT COMPLETED|2nd Intervention||0
8408146|NCT00966953|20723661|P1|NOT COMPLETED|2nd Intervention||0
8408147|NCT00966953|20723658|P4|COMPLETED|2nd Intervention||7
8408148|NCT00966953|20723659|P3|COMPLETED|2nd Intervention||6
8408149|NCT00966953|20723660|P2|COMPLETED|2nd Intervention||6
8408150|NCT00966953|20723661|P1|COMPLETED|2nd Intervention||6
8408151|NCT00966953|20723658|P4|STARTED|2nd Intervention||7
8408152|NCT00966953|20723659|P3|STARTED|2nd Intervention||6
8408153|NCT00966953|20723660|P2|STARTED|2nd Intervention||6
8408154|NCT00966953|20723661|P1|STARTED|2nd Intervention||6
8408155|NCT00966953|20723658|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408156|NCT00966953|20723659|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408157|NCT00966953|20723660|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408158|NCT00966953|20723661|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408159|NCT00966953|20723658|P4|COMPLETED|1 Week Washout After 1st Intervention||7
8408160|NCT00966953|20723659|P3|COMPLETED|1 Week Washout After 1st Intervention||6
8408161|NCT00966953|20723660|P2|COMPLETED|1 Week Washout After 1st Intervention||6
8408162|NCT00966953|20723661|P1|COMPLETED|1 Week Washout After 1st Intervention||6
8408163|NCT00966953|20723658|P4|STARTED|1 Week Washout After 1st Intervention||7
8408164|NCT00966953|20723659|P3|STARTED|1 Week Washout After 1st Intervention||6
8408165|NCT00966953|20723660|P2|STARTED|1 Week Washout After 1st Intervention||6
8408166|NCT00966953|20723661|P1|STARTED|1 Week Washout After 1st Intervention||6
8408167|NCT00966953|20723658|P4|NOT COMPLETED|1st Intervention||0
8408168|NCT00966953|20723659|P3|NOT COMPLETED|1st Intervention||0
8408169|NCT00966953|20723660|P2|NOT COMPLETED|1st Intervention||0
8408170|NCT00966953|20723661|P1|NOT COMPLETED|1st Intervention||0
8408171|NCT00966953|20723658|P4|COMPLETED|1st Intervention||7
8408172|NCT00966953|20723659|P3|COMPLETED|1st Intervention||6
8408173|NCT00966953|20723660|P2|COMPLETED|1st Intervention||6
8408174|NCT00966953|20723661|P1|COMPLETED|1st Intervention||6
8408175|NCT00966953|20723658|P4|STARTED|1st Intervention||7
8408176|NCT00966953|20723659|P3|STARTED|1st Intervention||6
8408177|NCT00966953|20723660|P2|STARTED|1st Intervention||6
8408178|NCT00966953|20723661|P1|STARTED|1st Intervention||6
8408179|NCT00966940|20723669|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
8408180|NCT00966940|20723670|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
8408181|NCT00966940|20723669|P2|COMPLETED|Period 2, Second 6 Weeks||23
8408182|NCT00966940|20723670|P1|COMPLETED|Period 2, Second 6 Weeks||25
8408183|NCT00966940|20723669|P2|STARTED|Period 2, Second 6 Weeks||23
8408184|NCT00966940|20723670|P1|STARTED|Period 2, Second 6 Weeks||25
8408185|NCT00966940|20723669|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
8408186|NCT00966940|20723670|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
8408187|NCT00966940|20723669|P2|COMPLETED|Period 1, First 6 Weeks||23
8408188|NCT00966940|20723670|P1|COMPLETED|Period 1, First 6 Weeks||25
8408189|NCT00966940|20723669|P2|STARTED|Period 1, First 6 Weeks||23
8408190|NCT00966940|20723670|P1|STARTED|Period 1, First 6 Weeks||28
8408191|NCT00966875|20723697|P9|NOT COMPLETED|Part B||18
8408192|NCT00966875|20723698|P8|NOT COMPLETED|Part B||19
8408193|NCT00966875|20723699|P7|NOT COMPLETED|Part B||22
8408194|NCT00966875|20723700|P6|NOT COMPLETED|Part B||6
8408195|NCT00966875|20723701|P5|NOT COMPLETED|Part B||7
8408196|NCT00966875|20723702|P4|NOT COMPLETED|Part B||3
8408197|NCT00966875|20723703|P3|NOT COMPLETED|Part B||6
8408198|NCT00966875|20723704|P2|NOT COMPLETED|Part B||3
8408199|NCT00966875|20723705|P1|NOT COMPLETED|Part B||5
8408200|NCT00966875|20723697|P9|COMPLETED|Part B||32
8408201|NCT00966875|20723698|P8|COMPLETED|Part B||38
8408202|NCT00966875|20723699|P7|COMPLETED|Part B||29
8408203|NCT00966875|20723700|P6|COMPLETED|Part B||26
8408204|NCT00966875|20723701|P5|COMPLETED|Part B||44
8408205|NCT00966875|20723702|P4|COMPLETED|Part B||31
8408206|NCT00966875|20723703|P3|COMPLETED|Part B||27
8408207|NCT00966875|20723704|P2|COMPLETED|Part B||33
8408208|NCT00966875|20723705|P1|COMPLETED|Part B||41
8408209|NCT00966875|20723697|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
8408210|NCT00966875|20723698|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
8408211|NCT00966875|20723699|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
8408212|NCT00966875|20723700|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
8408213|NCT00966875|20723701|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
8408214|NCT00966875|20723702|P4|STARTED|Part B||34
8408215|NCT00966875|20723703|P3|STARTED|Part B||33
8408216|NCT00966875|20723704|P2|STARTED|Part B||36
8408217|NCT00966875|20723705|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
8408218|NCT00966875|20723697|P9|NOT COMPLETED|Part A||8
8408219|NCT00966875|20723698|P8|NOT COMPLETED|Part A||7
8408220|NCT00966875|20723699|P7|NOT COMPLETED|Part A||12
8408221|NCT00966875|20723700|P6|NOT COMPLETED|Part A||4
8408222|NCT00966875|20723701|P5|NOT COMPLETED|Part A||5
8408223|NCT00966875|20723702|P4|NOT COMPLETED|Part A||3
8408224|NCT00966875|20723703|P3|NOT COMPLETED|Part A||2
8408225|NCT00966875|20723704|P2|NOT COMPLETED|Part A||4
8408226|NCT00966875|20723705|P1|NOT COMPLETED|Part A||6
8408227|NCT00966875|20723697|P9|COMPLETED|Part A||51
8408228|NCT00966875|20723698|P8|COMPLETED|Part A||58
8408229|NCT00966875|20723699|P7|COMPLETED|Part A||52
8408230|NCT00966875|20723700|P6|COMPLETED|Part A||33
8408231|NCT00966875|20723701|P5|COMPLETED|Part A||52
8408232|NCT00966875|20723702|P4|COMPLETED|Part A||34
8408233|NCT00966875|20723703|P3|COMPLETED|Part A||33
8408234|NCT00966875|20723704|P2|COMPLETED|Part A||36
8408235|NCT00966875|20723705|P1|COMPLETED|Part A||48
8408236|NCT00966875|20723697|P9|Received ≥1 Doses of Study Drug|Part A||59
8408237|NCT00966875|20723698|P8|Received ≥1 Doses of Study Drug|Part A||65
8408238|NCT00966875|20723699|P7|Received ≥1 Doses of Study Drug|Part A||64
8408239|NCT00966875|20723700|P6|Received ≥1 Doses of Study Drug|Part A||37
8408240|NCT00966875|20723701|P5|Received ≥1 Doses of Study Drug|Part A||57
8408241|NCT00966875|20723702|P4|Received ≥1 Doses of Study Drug|Part A||37
8408242|NCT00966875|20723703|P3|Received ≥1 Doses of Study Drug|Part A||35
8408243|NCT00966875|20723704|P2|Received ≥1 Doses of Study Drug|Part A||40
8408244|NCT00966875|20723705|P1|Received ≥1 Doses of Study Drug|Part A||54
8408245|NCT00966875|20723697|P9|STARTED|Part A||59
8408246|NCT00966875|20723698|P8|STARTED|Part A||65
8408247|NCT00966875|20723699|P7|STARTED|Part A||64
8408248|NCT00966875|20723700|P6|STARTED|Part A||37
8408249|NCT00966875|20723701|P5|STARTED|Part A||57
8408250|NCT00966875|20723702|P4|STARTED|Part A||37
8408251|NCT00966875|20723703|P3|STARTED|Part A||35
8408252|NCT00966875|20723704|P2|STARTED|Part A||40
8408253|NCT00966875|20723705|P1|STARTED|Part A||54
8408254|NCT00966849|20724027|P3|NOT COMPLETED|Overall Study||1293
8408255|NCT00966849|20724028|P2|NOT COMPLETED|Overall Study||1478
8408256|NCT00966849|20724029|P1|NOT COMPLETED|Overall Study||1541
8408257|NCT00966849|20724027|P3|COMPLETED|Overall Study||1876
8408258|NCT00966849|20724028|P2|COMPLETED|Overall Study||2498
8408259|NCT00966849|20724029|P1|COMPLETED|Overall Study||2119
8408260|NCT00966849|20724027|P3|STARTED|Overall Study||3169
8408261|NCT00966849|20724028|P2|STARTED|Overall Study||3976
8408262|NCT00966849|20724029|P1|STARTED|Overall Study||3660
8408263|NCT00966823|20724046|P1|NOT COMPLETED|Overall Study||1
8408264|NCT00966823|20724046|P1|COMPLETED|Overall Study||2
8408265|NCT00966823|20724046|P1|STARTED|Overall Study||3
8408266|NCT00966719|20724056|P2|NOT COMPLETED|Overall Study||11
8408267|NCT00966719|20724057|P1|NOT COMPLETED|Overall Study||6
8408268|NCT00966719|20724056|P2|COMPLETED|Overall Study||38
8408269|NCT00966719|20724057|P1|COMPLETED|Overall Study||44
8408270|NCT00966719|20724056|P2|STARTED|Overall Study||49
8408271|NCT00966719|20724057|P1|STARTED|Overall Study||50
8408272|NCT00966693|20724081|P4|NOT COMPLETED|Overall Study||23
8408273|NCT00966693|20724082|P3|NOT COMPLETED|Overall Study||3
8408274|NCT00966693|20724083|P2|NOT COMPLETED|Overall Study||0
8408275|NCT00966693|20724084|P1|NOT COMPLETED|Overall Study||1
8408276|NCT00966693|20724081|P4|COMPLETED|Overall Study||26
8408277|NCT00966693|20724082|P3|COMPLETED|Overall Study||6
8408278|NCT00966693|20724083|P2|COMPLETED|Overall Study||3
8408279|NCT00966693|20724084|P1|COMPLETED|Overall Study||2
8408280|NCT00966693|20724081|P4|Phase 2 Completed|Overall Study||46
8408281|NCT00966693|20724082|P3|Phase 2 Completed|Overall Study||0
8408282|NCT00966693|20724083|P2|Phase 2 Completed|Overall Study||0
8408283|NCT00966693|20724084|P1|Phase 2 Completed|Overall Study||0
8408284|NCT00966693|20724081|P4|Phase 1 Completed|Overall Study||0
8408285|NCT00966693|20724082|P3|Phase 1 Completed|Overall Study||6
8408286|NCT00966693|20724083|P2|Phase 1 Completed|Overall Study||3
8408287|NCT00966693|20724084|P1|Phase 1 Completed|Overall Study||2
8408288|NCT00966693|20724081|P4|STARTED|Overall Study||49
8408289|NCT00966693|20724082|P3|STARTED|Overall Study||9
8408290|NCT00966693|20724083|P2|STARTED|Overall Study||3
8408291|NCT00966693|20724084|P1|STARTED|Overall Study||3
8408292|NCT00966654|20724118|P1|NOT COMPLETED|Overall Study||12
8408293|NCT00966654|20724118|P1|COMPLETED|Overall Study||0
8408294|NCT00966654|20724118|P1|STARTED|Overall Study||12
8408295|NCT00966641|20724126|P2|NOT COMPLETED|Second Intervention||0
8408296|NCT00966641|20724127|P1|NOT COMPLETED|Second Intervention||0
8408297|NCT00966641|20724126|P2|COMPLETED|Second Intervention||17
8408298|NCT00966641|20724127|P1|COMPLETED|Second Intervention||17
8408299|NCT00966641|20724126|P2|STARTED|Second Intervention||17
8408300|NCT00966641|20724127|P1|STARTED|Second Intervention||17
8408301|NCT00966641|20724126|P2|NOT COMPLETED|First Intervention||0
8408302|NCT00966641|20724127|P1|NOT COMPLETED|First Intervention||0
8408303|NCT00966641|20724126|P2|COMPLETED|First Intervention||17
8408304|NCT00966641|20724127|P1|COMPLETED|First Intervention||17
8408305|NCT00966641|20724126|P2|STARTED|First Intervention||17
8408306|NCT00966641|20724127|P1|STARTED|First Intervention||17
8408307|NCT00966550|20724135|P2|NOT COMPLETED|Overall Study||0
8408308|NCT00966550|20724136|P1|NOT COMPLETED|Overall Study||0
8408309|NCT00966550|20724135|P2|COMPLETED|Overall Study||12
8408310|NCT00966550|20724136|P1|COMPLETED|Overall Study||13
8408311|NCT00966550|20724135|P2|STARTED|Overall Study||12
8408312|NCT00966550|20724136|P1|STARTED|Overall Study||13
8408313|NCT00966446|20724145|P3|NOT COMPLETED|Overall Study||21
8408314|NCT00966446|20724146|P2|NOT COMPLETED|Overall Study||25
8408315|NCT00966446|20724147|P1|NOT COMPLETED|Overall Study||28
8408316|NCT00966446|20724145|P3|COMPLETED|Overall Study||52
8408317|NCT00966446|20724146|P2|COMPLETED|Overall Study||49
8408318|NCT00966446|20724147|P1|COMPLETED|Overall Study||48
8408319|NCT00966446|20724145|P3|STARTED|Overall Study||73
8408320|NCT00966446|20724146|P2|STARTED|Overall Study||74
8408321|NCT00966446|20724147|P1|STARTED|Overall Study||76
8408322|NCT00966433|20724164|P3|NOT COMPLETED|Overall Study||0
8408323|NCT00966433|20724165|P2|NOT COMPLETED|Overall Study||1
8408324|NCT00966433|20724166|P1|NOT COMPLETED|Overall Study||1
8408325|NCT00966433|20724164|P3|COMPLETED|Overall Study||11
8408326|NCT00966433|20724165|P2|COMPLETED|Overall Study||10
8408327|NCT00966433|20724166|P1|COMPLETED|Overall Study||10
8408328|NCT00966433|20724164|P3|STARTED|Overall Study||11
8408329|NCT00966433|20724165|P2|STARTED|Overall Study||11
8408330|NCT00966433|20724166|P1|STARTED|Overall Study||11
8408331|NCT00966355|20724192|P3|NOT COMPLETED|Overall Study||84
8408332|NCT00966355|20724193|P2|NOT COMPLETED|Overall Study||86
8408333|NCT00966355|20724194|P1|NOT COMPLETED|Overall Study||84
8408334|NCT00966355|20724192|P3|COMPLETED|Overall Study||261
8408335|NCT00966355|20724193|P2|COMPLETED|Overall Study||259
8408336|NCT00966355|20724194|P1|COMPLETED|Overall Study||260
8408337|NCT00966355|20724192|P3|STARTED|Overall Study||345
8408338|NCT00966355|20724193|P2|STARTED|Overall Study||345
8408339|NCT00966355|20724194|P1|STARTED|Overall Study||344
8408340|NCT00966277|20724207|P2|NOT COMPLETED|Overall Study||4
8408341|NCT00966277|20724208|P1|NOT COMPLETED|Overall Study||4
8408342|NCT00966277|20724207|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
8408343|NCT00966277|20724208|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
8408344|NCT00966277|20724207|P2|STARTED|Overall Study||37
8408345|NCT00966277|20724208|P1|STARTED|Overall Study||38
8408346|NCT00966264|20724216|P2|NOT COMPLETED|Overall Study||3
8408347|NCT00966264|20724217|P1|NOT COMPLETED|Overall Study||4
8408348|NCT00966264|20724216|P2|COMPLETED|Overall Study|5 years results|114
8408349|NCT00966264|20724217|P1|COMPLETED|Overall Study|5 years results|115
8408350|NCT00966264|20724216|P2|STARTED|Overall Study||117
8408351|NCT00966264|20724217|P1|STARTED|Overall Study||119
8408352|NCT00966238|20724229|P6|NOT COMPLETED|Overall Study||0
8408353|NCT00966238|20724230|P5|NOT COMPLETED|Overall Study||0
8408354|NCT00966238|20724231|P4|NOT COMPLETED|Overall Study||0
8408355|NCT00966238|20724232|P3|NOT COMPLETED|Overall Study||0
8408356|NCT00966238|20724233|P2|NOT COMPLETED|Overall Study||0
8408357|NCT00966238|20724234|P1|NOT COMPLETED|Overall Study||0
8408358|NCT00966238|20724229|P6|COMPLETED|Overall Study||20
8408359|NCT00966238|20724230|P5|COMPLETED|Overall Study||20
8408360|NCT00966238|20724231|P4|COMPLETED|Overall Study||20
8408361|NCT00966238|20724232|P3|COMPLETED|Overall Study||20
8408362|NCT00966238|20724233|P2|COMPLETED|Overall Study||20
8408363|NCT00966238|20724234|P1|COMPLETED|Overall Study||20
8408364|NCT00966238|20724229|P6|STARTED|Overall Study||20
8408365|NCT00966238|20724230|P5|STARTED|Overall Study||20
8408366|NCT00966238|20724231|P4|STARTED|Overall Study||20
8408367|NCT00966238|20724232|P3|STARTED|Overall Study||20
8408368|NCT00966238|20724233|P2|STARTED|Overall Study||20
8408369|NCT00966238|20724234|P1|STARTED|Overall Study||20
8408370|NCT00966186|20724256|P2|NOT COMPLETED|Overall Study||0
8408371|NCT00966186|20724257|P1|NOT COMPLETED|Overall Study||0
8408372|NCT00966186|20724256|P2|COMPLETED|Overall Study||60
8408373|NCT00966186|20724257|P1|COMPLETED|Overall Study||60
8408374|NCT00966186|20724256|P2|STARTED|Overall Study||60
8408375|NCT00966186|20724257|P1|STARTED|Overall Study||60
8408376|NCT00965848|20724263|P3|NOT COMPLETED|Overall Study||10
8408377|NCT00965848|20724264|P2|NOT COMPLETED|Overall Study||2
8408378|NCT00965848|20724265|P1|NOT COMPLETED|Overall Study||29
8408379|NCT00965848|20724263|P3|COMPLETED|Overall Study||117
8408380|NCT00965848|20724264|P2|COMPLETED|Overall Study||32
8408381|NCT00965848|20724265|P1|COMPLETED|Overall Study||78
8408382|NCT00965848|20724263|P3|STARTED|Overall Study||127
8408383|NCT00965848|20724264|P2|STARTED|Overall Study||34
8408384|NCT00965848|20724265|P1|STARTED|Overall Study||107
8408385|NCT00965757|20724284|P4|NOT COMPLETED|Extension Phase||24
8408386|NCT00965757|20724285|P3|NOT COMPLETED|Extension Phase||33
8408387|NCT00965757|20724286|P2|NOT COMPLETED|Extension Phase||0
8408388|NCT00965757|20724287|P1|NOT COMPLETED|Extension Phase||0
8408389|NCT00965757|20724284|P4|COMPLETED|Extension Phase||64
8408390|NCT00965757|20724285|P3|COMPLETED|Extension Phase||132
8408391|NCT00965757|20724286|P2|COMPLETED|Extension Phase||0
8408392|NCT00965757|20724287|P1|COMPLETED|Extension Phase||0
8408393|NCT00965757|20724284|P4|STARTED|Extension Phase||88
8408394|NCT00965757|20724285|P3|STARTED|Extension Phase||165
8408395|NCT00965757|20724286|P2|STARTED|Extension Phase||0
8408396|NCT00965757|20724287|P1|STARTED|Extension Phase||0
8408397|NCT00965757|20724284|P4|NOT COMPLETED|Double-blind Phase||0
8408398|NCT00965757|20724285|P3|NOT COMPLETED|Double-blind Phase||0
8408399|NCT00965757|20724286|P2|NOT COMPLETED|Double-blind Phase||18
8408400|NCT00965757|20724287|P1|NOT COMPLETED|Double-blind Phase||17
8408401|NCT00965757|20724284|P4|COMPLETED|Double-blind Phase||0
8408402|NCT00965757|20724285|P3|COMPLETED|Double-blind Phase||0
8408403|NCT00965757|20724286|P2|COMPLETED|Double-blind Phase||70
8408404|NCT00965757|20724287|P1|COMPLETED|Double-blind Phase||148
8408405|NCT00965757|20724284|P4|STARTED|Double-blind Phase||0
8408406|NCT00965757|20724285|P3|STARTED|Double-blind Phase||0
8408407|NCT00965757|20724286|P2|STARTED|Double-blind Phase||88
8408408|NCT00965757|20724287|P1|STARTED|Double-blind Phase||165
8408409|NCT00965731|20724321|P2|NOT COMPLETED|Overall Study||20
8408410|NCT00965731|20724322|P1|NOT COMPLETED|Overall Study||7
8408411|NCT00965731|20724321|P2|COMPLETED|Overall Study||0
8408412|NCT00965731|20724322|P1|COMPLETED|Overall Study||0
8408413|NCT00965731|20724321|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
8408414|NCT00965731|20724322|P1|STARTED|Overall Study||7
8408415|NCT00965718|20724386|P1|NOT COMPLETED|Overall Study||4
8408416|NCT00965718|20724386|P1|COMPLETED|Overall Study||16
8408417|NCT00965718|20724386|P1|STARTED|Overall Study||20
8408418|NCT00965575|20724398|P2|NOT COMPLETED|Overall Study||0
8408419|NCT00965575|20724399|P1|NOT COMPLETED|Overall Study||1
8408420|NCT00965575|20724398|P2|COMPLETED|Overall Study||5
8408421|NCT00965575|20724399|P1|COMPLETED|Overall Study||5
8408422|NCT00965575|20724398|P2|STARTED|Overall Study|cross over, total enrolled 11|5
8408423|NCT00965575|20724399|P1|STARTED|Overall Study|cross over, total enrolled 11|6
8408424|NCT00965562|20724410|P3|NOT COMPLETED|Overall Study||3
8408425|NCT00965562|20724411|P2|NOT COMPLETED|Overall Study||4
8408426|NCT00965562|20724412|P1|NOT COMPLETED|Overall Study||3
8408427|NCT00965562|20724410|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8408428|NCT00965562|20724411|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8408429|NCT00965562|20724412|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8408430|NCT00965562|20724410|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
8408431|NCT00965562|20724411|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
8408432|NCT00965562|20724412|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
8408433|NCT00965562|20724410|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
8408434|NCT00965562|20724411|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
8408435|NCT00965562|20724412|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
8408436|NCT00965562|20724410|P3|STARTED|Overall Study||16
8408437|NCT00965562|20724411|P2|STARTED|Overall Study||17
8408438|NCT00965562|20724412|P1|STARTED|Overall Study||16
8408439|NCT00965523|20724450|P1|NOT COMPLETED|Study 224||6
8408440|NCT00965523|20724450|P1|COMPLETED|Study 224||0
8408441|NCT00965523|20724450|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
8408442|NCT00965523|20724450|P1|NOT COMPLETED|Study 221||7
8408443|NCT00965523|20724450|P1|COMPLETED|Study 221||74
8408444|NCT00965523|20724450|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
8408445|NCT00965497|20724455|P1|NOT COMPLETED|Overall Study||1
8408446|NCT00965497|20724455|P1|COMPLETED|Overall Study||13
8408447|NCT00965497|20724455|P1|STARTED|Overall Study||14
8408448|NCT00965484|20724460|P1|NOT COMPLETED|Overall Study||2
8408449|NCT00965484|20724460|P1|COMPLETED|Overall Study||134
8408450|NCT00965484|20724460|P1|STARTED|Overall Study||136
8408451|NCT00965458|20724469|P2|NOT COMPLETED|Overall Study||4
8408452|NCT00965458|20724470|P1|NOT COMPLETED|Overall Study||2
8408453|NCT00965458|20724469|P2|COMPLETED|Overall Study||12
8408454|NCT00965458|20724470|P1|COMPLETED|Overall Study||31
8408455|NCT00965458|20724469|P2|STARTED|Overall Study||16
8408456|NCT00965458|20724470|P1|STARTED|Overall Study||33
8408457|NCT00965419|20724486|P1|NOT COMPLETED|Follow-up Phase||62
8408458|NCT00965419|20724486|P1|COMPLETED|Follow-up Phase||18
8408459|NCT00965419|20724486|P1|STARTED|Follow-up Phase||80
8408460|NCT00965419|20724486|P1|NOT COMPLETED|Open Label Treatment for Responders||247
8408461|NCT00965419|20724486|P1|COMPLETED|Open Label Treatment for Responders||20
8408462|NCT00965419|20724486|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
8408463|NCT00965419|20724486|P1|STARTED|Open Label Treatment for Responders||267
8408464|NCT00965341|20724532|P2|NOT COMPLETED|Overall Study||8
8408465|NCT00965341|20724533|P1|NOT COMPLETED|Overall Study||6
8408466|NCT00965341|20724532|P2|COMPLETED|Overall Study||16
8408467|NCT00965341|20724533|P1|COMPLETED|Overall Study||13
8408468|NCT00965341|20724532|P2|STARTED|Overall Study||24
8408469|NCT00965341|20724533|P1|STARTED|Overall Study||19
8408470|NCT00965263|20724543|P2|NOT COMPLETED|Overall Study||3
8408471|NCT00965263|20724544|P1|NOT COMPLETED|Overall Study||2
8408472|NCT00965263|20724543|P2|COMPLETED|Overall Study||6
8408473|NCT00965263|20724544|P1|COMPLETED|Overall Study||4
8408474|NCT00965263|20724543|P2|STARTED|Overall Study||9
8408475|NCT00965263|20724544|P1|STARTED|Overall Study||6
8408476|NCT00965250|20724576|P2|NOT COMPLETED|Overall Study||0
8408477|NCT00965250|20724577|P1|NOT COMPLETED|Overall Study||0
8408478|NCT00965250|20724576|P2|COMPLETED|Overall Study||12
8408479|NCT00965250|20724577|P1|COMPLETED|Overall Study||37
8408480|NCT00965250|20724576|P2|STARTED|Overall Study||12
8408481|NCT00965250|20724577|P1|STARTED|Overall Study||37
8408482|NCT00965237|20724595|P2|NOT COMPLETED|Period 2, One Week of Wear||0
8408483|NCT00965237|20724596|P1|NOT COMPLETED|Period 2, One Week of Wear||0
8408484|NCT00965237|20724595|P2|COMPLETED|Period 2, One Week of Wear||8
8408485|NCT00965237|20724596|P1|COMPLETED|Period 2, One Week of Wear||8
8408486|NCT00965237|20724595|P2|STARTED|Period 2, One Week of Wear||8
8408487|NCT00965237|20724596|P1|STARTED|Period 2, One Week of Wear||8
8408488|NCT00965237|20724595|P2|NOT COMPLETED|Period 1, One Week of Wear||0
8408489|NCT00965237|20724596|P1|NOT COMPLETED|Period 1, One Week of Wear||0
8408490|NCT00965237|20724595|P2|COMPLETED|Period 1, One Week of Wear||8
8408491|NCT00965237|20724596|P1|COMPLETED|Period 1, One Week of Wear||8
8408492|NCT00965237|20724595|P2|STARTED|Period 1, One Week of Wear||8
8408493|NCT00965237|20724596|P1|STARTED|Period 1, One Week of Wear||8
8408494|NCT00965185|20724604|P2|NOT COMPLETED|Overall Study||1
8408495|NCT00965185|20724605|P1|NOT COMPLETED|Overall Study||2
8408496|NCT00965185|20724604|P2|COMPLETED|Overall Study||20
8408497|NCT00965185|20724605|P1|COMPLETED|Overall Study||17
8408498|NCT00965185|20724604|P2|9 Month Visit|Overall Study||21
8408499|NCT00965185|20724605|P1|9 Month Visit|Overall Study||18
8408500|NCT00965185|20724604|P2|6 Month Visit|Overall Study||21
8408501|NCT00965185|20724605|P1|6 Month Visit|Overall Study||18
8408502|NCT00965185|20724604|P2|3 Month Visit|Overall Study||21
8408503|NCT00965185|20724605|P1|3 Month Visit|Overall Study||18
8408504|NCT00965185|20724604|P2|1 Month Visit|Overall Study||21
8408505|NCT00965185|20724605|P1|1 Month Visit|Overall Study||18
8408506|NCT00965185|20724604|P2|STARTED|Overall Study||21
8408507|NCT00965185|20724605|P1|STARTED|Overall Study||19
8408508|NCT00965146|20724625|P1|NOT COMPLETED|Overall Study||210
8408509|NCT00965146|20724625|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
8408510|NCT00965146|20724625|P1|STARTED|Overall Study||210
8408511|NCT00965094|20724632|P2|NOT COMPLETED|Overall Study||1
8408512|NCT00965094|20724633|P1|NOT COMPLETED|Overall Study||5
8408513|NCT00965094|20724632|P2|COMPLETED|Overall Study||16
8408514|NCT00965094|20724633|P1|COMPLETED|Overall Study||14
8408515|NCT00965094|20724632|P2|STARTED|Overall Study||17
8408516|NCT00965094|20724633|P1|STARTED|Overall Study||19
8408517|NCT00965081|20724649|P2|NOT COMPLETED|Overall Study||43
8408518|NCT00965081|20724650|P1|NOT COMPLETED|Overall Study||34
8408519|NCT00965081|20724649|P2|COMPLETED|Overall Study||110
8408520|NCT00965081|20724650|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
8408521|NCT00965081|20724649|P2|STARTED|Overall Study||153
8408522|NCT00965081|20724650|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
8408523|NCT00965055|20724673|P1|NOT COMPLETED|Overall Study||0
8408524|NCT00965055|20724673|P1|COMPLETED|Overall Study||2
8408525|NCT00965055|20724673|P1|STARTED|Overall Study||2
8408526|NCT00964886|20724682|P4|NOT COMPLETED|Overall Study||9
8408527|NCT00964886|20724683|P3|NOT COMPLETED|Overall Study||16
8408528|NCT00964886|20724684|P2|NOT COMPLETED|Overall Study||7
8408529|NCT00964886|20724685|P1|NOT COMPLETED|Overall Study||11
8408530|NCT00964886|20724682|P4|COMPLETED|Overall Study||24
8408531|NCT00964886|20724683|P3|COMPLETED|Overall Study||21
8408532|NCT00964886|20724684|P2|COMPLETED|Overall Study||27
8408533|NCT00964886|20724685|P1|COMPLETED|Overall Study||27
8408534|NCT00964886|20724682|P4|STARTED|Overall Study||33
8408535|NCT00964886|20724683|P3|STARTED|Overall Study||37
8408536|NCT00964886|20724684|P2|STARTED|Overall Study||34
8408537|NCT00964886|20724685|P1|STARTED|Overall Study||38
8408538|NCT00964860|20724701|P2|NOT COMPLETED|Overall Study||1
8408539|NCT00964860|20724702|P1|NOT COMPLETED|Overall Study||0
8408540|NCT00964860|20724701|P2|COMPLETED|Overall Study||29
8408541|NCT00964860|20724702|P1|COMPLETED|Overall Study||30
8408542|NCT00964860|20724701|P2|STARTED|Overall Study||30
8408543|NCT00964860|20724702|P1|STARTED|Overall Study||30
8408544|NCT00964795|20724710|P1|NOT COMPLETED|Overall Study||307
8408545|NCT00964795|20724710|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
8408546|NCT00964795|20724710|P1|Number of Participants Treated|Overall Study||320
8408547|NCT00964795|20724710|P1|STARTED|Overall Study|randomized|323
8408548|NCT00964782|20724719|P2|NOT COMPLETED|Overall Study||0
8408549|NCT00964782|20724720|P1|NOT COMPLETED|Overall Study||1
8408550|NCT00964782|20724719|P2|COMPLETED|Overall Study||8
8408551|NCT00964782|20724720|P1|COMPLETED|Overall Study||7
8408552|NCT00964782|20724719|P2|STARTED|Overall Study||8
8408553|NCT00964782|20724720|P1|STARTED|Overall Study||8
8408554|NCT00964743|20724734|P1|NOT COMPLETED|Overall Study||2
8408555|NCT00964743|20724734|P1|COMPLETED|Overall Study||0
8408556|NCT00964743|20724734|P1|STARTED|Overall Study||2
8408557|NCT00964678|20724742|P1|NOT COMPLETED|Overall Study||4
8408558|NCT00964678|20724742|P1|COMPLETED|Overall Study||6
8408559|NCT00964678|20724742|P1|STARTED|Overall Study||10
8408560|NCT00964548|20724751|P2|NOT COMPLETED|Overall Study||0
8408561|NCT00964548|20724752|P1|NOT COMPLETED|Overall Study||0
8408562|NCT00964548|20724751|P2|COMPLETED|Overall Study||5
8408563|NCT00964548|20724752|P1|COMPLETED|Overall Study||5
8408564|NCT00964548|20724751|P2|STARTED|Overall Study||5
8408565|NCT00964548|20724752|P1|STARTED|Overall Study||5
8408566|NCT00964496|20724764|P2|NOT COMPLETED|Overall Study||1
8408567|NCT00964496|20724765|P1|NOT COMPLETED|Overall Study||2
8408568|NCT00964496|20724764|P2|COMPLETED|Overall Study||26
8408569|NCT00964496|20724765|P1|COMPLETED|Overall Study||26
8408570|NCT00964496|20724764|P2|STARTED|Overall Study||27
8408571|NCT00964496|20724765|P1|STARTED|Overall Study||28
8408572|NCT00964444|20724783|P1|NOT COMPLETED|Overall Study||0
8408573|NCT00964444|20724783|P1|COMPLETED|Overall Study||10
8408574|NCT00964444|20724783|P1|STARTED|Overall Study||10
8408575|NCT00964431|20724791|P4|NOT COMPLETED|Overall Study||0
8408576|NCT00964431|20724792|P3|NOT COMPLETED|Overall Study||0
8408577|NCT00964431|20724793|P2|NOT COMPLETED|Overall Study||0
8408578|NCT00964431|20724794|P1|NOT COMPLETED|Overall Study||0
8408579|NCT00964431|20724791|P4|COMPLETED|Overall Study||51
8408580|NCT00964431|20724792|P3|COMPLETED|Overall Study||51
8408581|NCT00964431|20724793|P2|COMPLETED|Overall Study||51
8408582|NCT00964431|20724794|P1|COMPLETED|Overall Study||50
8408583|NCT00964431|20724791|P4|STARTED|Overall Study||51
8408584|NCT00964431|20724792|P3|STARTED|Overall Study||51
8408585|NCT00964431|20724793|P2|STARTED|Overall Study||51
8408586|NCT00964431|20724794|P1|STARTED|Overall Study||50
8408587|NCT00964392|20724806|P2|NOT COMPLETED|Overall Study||190
8408588|NCT00964392|20724807|P1|NOT COMPLETED|Overall Study||53
8408589|NCT00964392|20724806|P2|COMPLETED|Overall Study||92
8408590|NCT00964392|20724807|P1|COMPLETED|Overall Study||72
8408591|NCT00964392|20724806|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
8408592|NCT00964392|20724807|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
8408593|NCT00964366|20724817|P2|NOT COMPLETED|Overall Study||1
8408594|NCT00964366|20724818|P1|NOT COMPLETED|Overall Study||1
8408595|NCT00964366|20724817|P2|COMPLETED|Overall Study||24
8408596|NCT00964366|20724818|P1|COMPLETED|Overall Study||27
8408597|NCT00964366|20724817|P2|STARTED|Overall Study||25
8408598|NCT00964366|20724818|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
8408599|NCT00964353|20724834|P2|NOT COMPLETED|Overall Study||0
8408600|NCT00964353|20724835|P1|NOT COMPLETED|Overall Study||0
8408601|NCT00964353|20724834|P2|COMPLETED|Overall Study||178
8408602|NCT00964353|20724835|P1|COMPLETED|Overall Study||181
8408603|NCT00964353|20724834|P2|STARTED|Overall Study||178
8408604|NCT00964353|20724835|P1|STARTED|Overall Study||181
8408605|NCT00964223|20724843|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
8408606|NCT00964223|20724843|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
8408607|NCT00964223|20724843|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
8408608|NCT00964223|20724843|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
8408609|NCT00964223|20724843|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
8408610|NCT00964223|20724843|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
8408611|NCT00964158|20724911|P3|NOT COMPLETED|Overall Study||8
8408612|NCT00964158|20724912|P2|NOT COMPLETED|Overall Study||1
8408613|NCT00964158|20724913|P1|NOT COMPLETED|Overall Study||0
8408614|NCT00964158|20724911|P3|COMPLETED|Overall Study||92
8408615|NCT00964158|20724912|P2|COMPLETED|Overall Study||56
8408616|NCT00964158|20724913|P1|COMPLETED|Overall Study||53
8408617|NCT00964158|20724911|P3|STARTED|Overall Study||100
8408618|NCT00964158|20724912|P2|STARTED|Overall Study||57
8408619|NCT00964158|20724913|P1|STARTED|Overall Study||53
8408620|NCT00964119|20724982|P1|NOT COMPLETED|Overall Study||0
8408621|NCT00964119|20724982|P1|COMPLETED|Overall Study||15
8408622|NCT00964119|20724982|P1|STARTED|Overall Study||15
8408623|NCT00964028|20724988|P2|NOT COMPLETED|Overall Study||1
8408624|NCT00964028|20724989|P1|NOT COMPLETED|Overall Study||0
8408625|NCT00964028|20724988|P2|COMPLETED|Overall Study||24
8408626|NCT00964028|20724989|P1|COMPLETED|Overall Study||25
8408627|NCT00964028|20724988|P2|STARTED|Overall Study||25
8408628|NCT00964028|20724989|P1|STARTED|Overall Study||25
8408629|NCT00963937|20725004|P3|NOT COMPLETED|Overall Study||4
8408630|NCT00963937|20725005|P2|NOT COMPLETED|Overall Study||11
8408631|NCT00963937|20725006|P1|NOT COMPLETED|Overall Study||19
8408632|NCT00963937|20725004|P3|COMPLETED|Overall Study||41
8408633|NCT00963937|20725005|P2|COMPLETED|Overall Study||33
8408634|NCT00963937|20725006|P1|COMPLETED|Overall Study||70
8408635|NCT00963937|20725004|P3|STARTED|Overall Study||45
8408636|NCT00963937|20725005|P2|STARTED|Overall Study||44
8408637|NCT00963937|20725006|P1|STARTED|Overall Study||89
8408638|NCT00963924|20725044|P2|NOT COMPLETED|Overall Study||3
8408639|NCT00963924|20725045|P1|NOT COMPLETED|Overall Study||1
8408640|NCT00963924|20725044|P2|COMPLETED|Overall Study||15
8408641|NCT00963924|20725045|P1|COMPLETED|Overall Study||17
8408642|NCT00963924|20725044|P2|STARTED|Overall Study||18
8408643|NCT00963924|20725045|P1|STARTED|Overall Study||18
8408647|NCT00963872|20725078|P2|NOT COMPLETED|Overall Study||1
8408648|NCT00963872|20725079|P1|NOT COMPLETED|Overall Study||1
8408649|NCT00963872|20725078|P2|COMPLETED|Overall Study||5
8408650|NCT00963872|20725079|P1|COMPLETED|Overall Study||24
8408651|NCT00963872|20725078|P2|STARTED|Overall Study||6
8408652|NCT00963872|20725079|P1|STARTED|Overall Study||25
8408653|NCT00963859|20725123|P1|NOT COMPLETED|Overall Study||0
8408654|NCT00963859|20725123|P1|COMPLETED|Overall Study||11
8408655|NCT00963859|20725123|P1|STARTED|Overall Study||11
8408656|NCT00963820|20725128|P12|NOT COMPLETED|Expansion Phase||4
8408657|NCT00963820|20725129|P11|NOT COMPLETED|Expansion Phase||5
8408658|NCT00963820|20725130|P10|NOT COMPLETED|Expansion Phase||9
8408659|NCT00963820|20725131|P9|NOT COMPLETED|Expansion Phase||10
8408660|NCT00963820|20725132|P8|NOT COMPLETED|Expansion Phase||0
8408661|NCT00963820|20725133|P7|NOT COMPLETED|Expansion Phase||0
8408662|NCT00963820|20725134|P6|NOT COMPLETED|Expansion Phase||0
8408663|NCT00963820|20725135|P5|NOT COMPLETED|Expansion Phase||0
8408664|NCT00963820|20725136|P4|NOT COMPLETED|Expansion Phase||0
8408665|NCT00963820|20725137|P3|NOT COMPLETED|Expansion Phase||0
8408666|NCT00963820|20725138|P2|NOT COMPLETED|Expansion Phase||0
8408667|NCT00963820|20725139|P1|NOT COMPLETED|Expansion Phase||0
8408668|NCT00963820|20725128|P12|COMPLETED|Expansion Phase||0
8408669|NCT00963820|20725129|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8408670|NCT00963820|20725130|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8408671|NCT00963820|20725131|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8408672|NCT00963820|20725132|P8|COMPLETED|Expansion Phase||0
8408673|NCT00963820|20725133|P7|COMPLETED|Expansion Phase||0
8408674|NCT00963820|20725134|P6|COMPLETED|Expansion Phase||0
8408675|NCT00963820|20725135|P5|COMPLETED|Expansion Phase||0
8408676|NCT00963820|20725136|P4|COMPLETED|Expansion Phase||0
8408677|NCT00963820|20725137|P3|COMPLETED|Expansion Phase||0
8408678|NCT00963820|20725138|P2|COMPLETED|Expansion Phase||0
8408679|NCT00963820|20725139|P1|COMPLETED|Expansion Phase||0
8408680|NCT00963820|20725128|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
8408681|NCT00963820|20725129|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
8408682|NCT00963820|20725130|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
8408683|NCT00963820|20725131|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
8408684|NCT00963820|20725132|P8|STARTED|Expansion Phase||0
8408685|NCT00963820|20725133|P7|STARTED|Expansion Phase||0
8408686|NCT00963820|20725134|P6|STARTED|Expansion Phase||0
8408687|NCT00963820|20725135|P5|STARTED|Expansion Phase||0
8408688|NCT00963820|20725136|P4|STARTED|Expansion Phase||0
8408689|NCT00963820|20725137|P3|STARTED|Expansion Phase||0
8408690|NCT00963820|20725138|P2|STARTED|Expansion Phase||0
8408691|NCT00963820|20725139|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
8408692|NCT00963820|20725128|P12|NOT COMPLETED|Dose Escalation Phase||0
8408693|NCT00963820|20725129|P11|NOT COMPLETED|Dose Escalation Phase||0
8408694|NCT00963820|20725130|P10|NOT COMPLETED|Dose Escalation Phase||0
8408695|NCT00963820|20725131|P9|NOT COMPLETED|Dose Escalation Phase||0
8408696|NCT00963820|20725132|P8|NOT COMPLETED|Dose Escalation Phase||5
8408697|NCT00963820|20725133|P7|NOT COMPLETED|Dose Escalation Phase||8
8408698|NCT00963820|20725134|P6|NOT COMPLETED|Dose Escalation Phase||3
8408699|NCT00963820|20725135|P5|NOT COMPLETED|Dose Escalation Phase||4
8408700|NCT00963820|20725136|P4|NOT COMPLETED|Dose Escalation Phase||3
8408701|NCT00963820|20725137|P3|NOT COMPLETED|Dose Escalation Phase||3
8408702|NCT00963820|20725138|P2|NOT COMPLETED|Dose Escalation Phase||3
8408703|NCT00963820|20725139|P1|NOT COMPLETED|Dose Escalation Phase||3
8408704|NCT00963820|20725128|P12|COMPLETED|Dose Escalation Phase||0
8408705|NCT00963820|20725129|P11|COMPLETED|Dose Escalation Phase||0
8408706|NCT00963820|20725130|P10|COMPLETED|Dose Escalation Phase||0
8408707|NCT00963820|20725131|P9|COMPLETED|Dose Escalation Phase||0
8408708|NCT00963820|20725132|P8|COMPLETED|Dose Escalation Phase||0
8408709|NCT00963820|20725133|P7|COMPLETED|Dose Escalation Phase||0
8408710|NCT00963820|20725134|P6|COMPLETED|Dose Escalation Phase||0
8408711|NCT00963820|20725135|P5|COMPLETED|Dose Escalation Phase||0
8408712|NCT00963820|20725136|P4|COMPLETED|Dose Escalation Phase||0
8408713|NCT00963820|20725137|P3|COMPLETED|Dose Escalation Phase||0
8408714|NCT00963820|20725138|P2|COMPLETED|Dose Escalation Phase||0
8408715|NCT00963820|20725139|P1|COMPLETED|Dose Escalation Phase||0
8408716|NCT00963820|20725128|P12|STARTED|Dose Escalation Phase||0
8408717|NCT00963820|20725129|P11|STARTED|Dose Escalation Phase||0
8408718|NCT00963820|20725130|P10|STARTED|Dose Escalation Phase||0
8408719|NCT00963820|20725131|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
8408720|NCT00963820|20725132|P8|STARTED|Dose Escalation Phase||5
8408721|NCT00963820|20725133|P7|STARTED|Dose Escalation Phase||8
8408722|NCT00963820|20725134|P6|STARTED|Dose Escalation Phase||3
8408723|NCT00963820|20725135|P5|STARTED|Dose Escalation Phase||4
8408724|NCT00963820|20725136|P4|STARTED|Dose Escalation Phase||3
8408725|NCT00963820|20725137|P3|STARTED|Dose Escalation Phase||3
8408726|NCT00963820|20725138|P2|STARTED|Dose Escalation Phase||3
8408727|NCT00963820|20725139|P1|STARTED|Dose Escalation Phase||3
8408728|NCT00963807|20725275|P1|NOT COMPLETED|Overall Study||18
8408729|NCT00963807|20725275|P1|COMPLETED|Overall Study||8
8408730|NCT00963807|20725275|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
8408731|NCT00963807|20725275|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
8408732|NCT00963807|20725275|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
8408733|NCT00963807|20725275|P1|Completed Baseline Imaging|Overall Study||11
8408734|NCT00963807|20725275|P1|STARTED|Overall Study||26
8408735|NCT00963677|20725286|P2|NOT COMPLETED|Overall Study||2
8408736|NCT00963677|20725287|P1|NOT COMPLETED|Overall Study||0
8408737|NCT00963677|20725286|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
8408738|NCT00963677|20725287|P1|COMPLETED|Overall Study||35
8408739|NCT00963677|20725286|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
8408740|NCT00963677|20725287|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
8408741|NCT00963638|20725297|P2|NOT COMPLETED|Overall Study||0
8408742|NCT00963638|20725298|P1|NOT COMPLETED|Overall Study||0
8408743|NCT00963638|20725297|P2|COMPLETED|Overall Study||20
8408744|NCT00963638|20725298|P1|COMPLETED|Overall Study||20
8408745|NCT00963638|20725297|P2|STARTED|Overall Study||20
8408746|NCT00963638|20725298|P1|STARTED|Overall Study||20
8408747|NCT00963599|20725308|P4|NOT COMPLETED|Overall Study||14
8408748|NCT00963599|20725309|P3|NOT COMPLETED|Overall Study||9
8408749|NCT00963599|20725310|P2|NOT COMPLETED|Overall Study||6
8408750|NCT00963599|20725311|P1|NOT COMPLETED|Overall Study||6
8408751|NCT00963599|20725308|P4|COMPLETED|Overall Study||288
8408752|NCT00963599|20725309|P3|COMPLETED|Overall Study||292
8408753|NCT00963599|20725310|P2|COMPLETED|Overall Study||149
8408754|NCT00963599|20725311|P1|COMPLETED|Overall Study||143
8408755|NCT00963599|20725308|P4|STARTED|Overall Study||302
8408756|NCT00963599|20725309|P3|STARTED|Overall Study||301
8408757|NCT00963599|20725310|P2|STARTED|Overall Study||155
8408758|NCT00963599|20725311|P1|STARTED|Overall Study||149
8408759|NCT00963560|20725368|P3|NOT COMPLETED|Overall Study||0
8408760|NCT00963560|20725369|P2|NOT COMPLETED|Overall Study||3
8408761|NCT00963560|20725370|P1|NOT COMPLETED|Overall Study||3
8408762|NCT00963560|20725368|P3|COMPLETED|Overall Study||41
8408763|NCT00963560|20725369|P2|COMPLETED|Overall Study||41
8408764|NCT00963560|20725370|P1|COMPLETED|Overall Study||44
8408765|NCT00963560|20725368|P3|STARTED|Overall Study||41
8408766|NCT00963560|20725369|P2|STARTED|Overall Study||44
8408767|NCT00963560|20725370|P1|STARTED|Overall Study||47
8408768|NCT00963547|20725382|P7|NOT COMPLETED|Overall Study||0
8408769|NCT00963547|20725383|P6|NOT COMPLETED|Overall Study||0
8408770|NCT00963547|20725384|P5|NOT COMPLETED|Overall Study||0
8408771|NCT00963547|20725385|P4|NOT COMPLETED|Overall Study||6
8408772|NCT00963547|20725386|P3|NOT COMPLETED|Overall Study||12
8408773|NCT00963547|20725387|P2|NOT COMPLETED|Overall Study||11
8408774|NCT00963547|20725388|P1|NOT COMPLETED|Overall Study||4
8408775|NCT00963547|20725382|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8408776|NCT00963547|20725383|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8408777|NCT00963547|20725384|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8408778|NCT00963547|20725385|P4|COMPLETED|Overall Study||0
8408779|NCT00963547|20725386|P3|COMPLETED|Overall Study||0
8408780|NCT00963547|20725387|P2|COMPLETED|Overall Study||0
8408781|NCT00963547|20725388|P1|COMPLETED|Overall Study||0
8408782|NCT00963547|20725382|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8408783|NCT00963547|20725383|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8408784|NCT00963547|20725384|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8408785|NCT00963547|20725385|P4|Treated|Overall Study||6
8408786|NCT00963547|20725386|P3|Treated|Overall Study||11
8408787|NCT00963547|20725387|P2|Treated|Overall Study||11
8408788|NCT00963547|20725388|P1|Treated|Overall Study||3
8408789|NCT00963547|20725382|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8408790|NCT00963547|20725383|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8408791|NCT00963547|20725384|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8408792|NCT00963547|20725385|P4|STARTED|Overall Study||6
8408793|NCT00963547|20725386|P3|STARTED|Overall Study||12
8408794|NCT00963547|20725387|P2|STARTED|Overall Study||11
8408795|NCT00963547|20725388|P1|STARTED|Overall Study||4
8408796|NCT00963508|20725414|P2|NOT COMPLETED|Overall Study||28
8408797|NCT00963508|20725415|P1|NOT COMPLETED|Overall Study||10
8408798|NCT00963508|20725414|P2|COMPLETED|Overall Study||169
8408799|NCT00963508|20725415|P1|COMPLETED|Overall Study||196
8408800|NCT00963508|20725414|P2|STARTED|Overall Study||197
8408801|NCT00963508|20725415|P1|STARTED|Overall Study||206
8408802|NCT00963482|20725425|P2|NOT COMPLETED|Overall Study||17
8408803|NCT00963482|20725426|P1|NOT COMPLETED|Overall Study||28
8408804|NCT00963482|20725425|P2|COMPLETED|Overall Study||33
8408805|NCT00963482|20725426|P1|COMPLETED|Overall Study||25
8408806|NCT00963482|20725425|P2|STARTED|Overall Study||50
8408807|NCT00963482|20725426|P1|STARTED|Overall Study||53
8408808|NCT00963469|20725435|P3|NOT COMPLETED|Overall Study||10
8408809|NCT00963469|20725436|P2|NOT COMPLETED|Overall Study||28
8408810|NCT00963469|20725437|P1|NOT COMPLETED|Overall Study||41
8408811|NCT00963469|20725435|P3|COMPLETED|Overall Study||170
8408812|NCT00963469|20725436|P2|COMPLETED|Overall Study||420
8408813|NCT00963469|20725437|P1|COMPLETED|Overall Study||410
8408814|NCT00963469|20725435|P3|STARTED|Overall Study||180
8408815|NCT00963469|20725436|P2|STARTED|Overall Study||448
8408816|NCT00963469|20725437|P1|STARTED|Overall Study||451
8408817|NCT00963430|20725465|P2|NOT COMPLETED|Overall Study||3
8408818|NCT00963430|20725466|P1|NOT COMPLETED|Overall Study||1
8408819|NCT00963430|20725465|P2|COMPLETED|Overall Study||57
8408820|NCT00963430|20725466|P1|COMPLETED|Overall Study||59
8408821|NCT00963430|20725465|P2|STARTED|Overall Study||60
8408822|NCT00963430|20725466|P1|STARTED|Overall Study||60
8408823|NCT00963235|20725504|P1|NOT COMPLETED|Overall Study||60
8408824|NCT00963235|20725504|P1|COMPLETED|Overall Study||271
8408825|NCT00963235|20725504|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
8408826|NCT00963235|20725504|P1|Vaccinated Dose 3|Overall Study||279
8408827|NCT00963235|20725504|P1|Vaccinated Dose 2|Overall Study||300
8408828|NCT00963235|20725504|P1|Vaccinated Dose 1|Overall Study||329
8408829|NCT00963235|20725504|P1|STARTED|Overall Study||331
8408830|NCT00963157|20725528|P5|NOT COMPLETED|Overall Study||2
8408831|NCT00963157|20725529|P4|NOT COMPLETED|Overall Study||7
8408832|NCT00963157|20725530|P3|NOT COMPLETED|Overall Study||5
8408833|NCT00963157|20725531|P2|NOT COMPLETED|Overall Study||4
8408834|NCT00963157|20725532|P1|NOT COMPLETED|Overall Study||5
8408835|NCT00963157|20725528|P5|COMPLETED|Overall Study||151
8408836|NCT00963157|20725529|P4|COMPLETED|Overall Study||150
8408837|NCT00963157|20725530|P3|COMPLETED|Overall Study||155
8408838|NCT00963157|20725531|P2|COMPLETED|Overall Study||159
8408839|NCT00963157|20725532|P1|COMPLETED|Overall Study||151
8408840|NCT00963157|20725528|P5|STARTED|Overall Study||153
8408841|NCT00963157|20725529|P4|STARTED|Overall Study||157
8408842|NCT00963157|20725530|P3|STARTED|Overall Study||160
8408843|NCT00963157|20725531|P2|STARTED|Overall Study||163
8408844|NCT00963157|20725532|P1|STARTED|Overall Study||156
8408845|NCT00963105|20725727|P3|NOT COMPLETED|Overall Study||0
8408846|NCT00963105|20725728|P2|NOT COMPLETED|Overall Study||0
8408847|NCT00963105|20725729|P1|NOT COMPLETED|Overall Study||0
8408848|NCT00963105|20725727|P3|COMPLETED|Overall Study||35
8408849|NCT00963105|20725728|P2|COMPLETED|Overall Study||35
8408850|NCT00963105|20725729|P1|COMPLETED|Overall Study||34
8408851|NCT00963105|20725727|P3|Received Treatment|Overall Study||35
8408852|NCT00963105|20725728|P2|Received Treatment|Overall Study||34
8408853|NCT00963105|20725729|P1|Received Treatment|Overall Study||34
8408854|NCT00963105|20725727|P3|STARTED|Overall Study||35
8408855|NCT00963105|20725728|P2|STARTED|Overall Study||35
8408856|NCT00963105|20725729|P1|STARTED|Overall Study||34
8408857|NCT00962949|20725760|P2|NOT COMPLETED|Overall Study||0
8408858|NCT00962949|20725761|P1|NOT COMPLETED|Overall Study||0
8408859|NCT00962949|20725760|P2|COMPLETED|Overall Study||15
8408860|NCT00962949|20725761|P1|COMPLETED|Overall Study||13
8408861|NCT00962949|20725760|P2|STARTED|Overall Study||15
8408862|NCT00962949|20725761|P1|STARTED|Overall Study||13
8408863|NCT00962871|20725777|P4|NOT COMPLETED|Overall Study||0
8408864|NCT00962871|20725778|P3|NOT COMPLETED|Overall Study||0
8408865|NCT00962871|20725779|P2|NOT COMPLETED|Overall Study||0
8408866|NCT00962871|20725780|P1|NOT COMPLETED|Overall Study||0
8408867|NCT00962871|20725777|P4|COMPLETED|Overall Study||6
8408868|NCT00962871|20725778|P3|COMPLETED|Overall Study||12
8408869|NCT00962871|20725779|P2|COMPLETED|Overall Study||6
8408870|NCT00962871|20725780|P1|COMPLETED|Overall Study||6
8408871|NCT00962871|20725777|P4|STARTED|Overall Study||6
8408872|NCT00962871|20725778|P3|STARTED|Overall Study||12
8408873|NCT00962871|20725779|P2|STARTED|Overall Study||6
8408874|NCT00962871|20725780|P1|STARTED|Overall Study||6
8408875|NCT00962780|20725796|P2|NOT COMPLETED|Overall Study||14
8408876|NCT00962780|20725797|P1|NOT COMPLETED|Overall Study||10
8408877|NCT00962780|20725796|P2|COMPLETED|Overall Study||138
8408878|NCT00962780|20725797|P1|COMPLETED|Overall Study||141
8408879|NCT00962780|20725796|P2|Vaccinated 23vPS Dose|Overall Study||139
8408880|NCT00962780|20725797|P1|Vaccinated 23vPS Dose|Overall Study||143
8408881|NCT00962780|20725796|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
8408882|NCT00962780|20725797|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
8408883|NCT00962780|20725796|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
8408884|NCT00962780|20725797|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
8408885|NCT00962780|20725796|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
8408886|NCT00962780|20725797|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
8408887|NCT00962780|20725796|P2|STARTED|Overall Study||152
8408888|NCT00962780|20725797|P1|STARTED|Overall Study||151
8408889|NCT00962754|20725861|P2|NOT COMPLETED|Overall Study||0
8408890|NCT00962754|20725862|P1|NOT COMPLETED|Overall Study||0
8408891|NCT00962754|20725861|P2|COMPLETED|Overall Study||84
8408892|NCT00962754|20725862|P1|COMPLETED|Overall Study||86
8408893|NCT00962754|20725861|P2|STARTED|Overall Study||84
8408894|NCT00962754|20725862|P1|STARTED|Overall Study||86
8408895|NCT00962741|20725872|P1|NOT COMPLETED|Overall Study||8
8408896|NCT00962741|20725872|P1|COMPLETED|Overall Study||119
8408897|NCT00962741|20725872|P1|STARTED|Overall Study||127
8408898|NCT00962650|20725963|P1|NOT COMPLETED|Overall Study||2
8408899|NCT00962650|20725963|P1|COMPLETED|Overall Study||8
8408900|NCT00962650|20725963|P1|STARTED|Overall Study||10
8408901|NCT00962598|20725969|P2|NOT COMPLETED|Overall Study||0
8408902|NCT00962598|20725970|P1|NOT COMPLETED|Overall Study||0
8408903|NCT00962598|20725969|P2|COMPLETED|Overall Study||9
8408904|NCT00962598|20725970|P1|COMPLETED|Overall Study||7
8408905|NCT00962598|20725969|P2|STARTED|Overall Study||9
8408906|NCT00962598|20725970|P1|STARTED|Overall Study||7
8408907|NCT00962585|20725982|P4|NOT COMPLETED|Overall Study||0
8408908|NCT00962585|20725983|P3|NOT COMPLETED|Overall Study||3
8408909|NCT00962585|20725984|P2|NOT COMPLETED|Overall Study||2
8408910|NCT00962585|20725985|P1|NOT COMPLETED|Overall Study||6
8408911|NCT00962585|20725982|P4|COMPLETED|Overall Study||42
8408912|NCT00962585|20725983|P3|COMPLETED|Overall Study||39
8408913|NCT00962585|20725984|P2|COMPLETED|Overall Study||40
8408914|NCT00962585|20725985|P1|COMPLETED|Overall Study||37
8408915|NCT00962585|20725982|P4|STARTED|Overall Study||42
8408916|NCT00962585|20725983|P3|STARTED|Overall Study||42
8408917|NCT00962585|20725984|P2|STARTED|Overall Study||42
8408918|NCT00962585|20725985|P1|STARTED|Overall Study||43
8408919|NCT00962429|20726045|P2|NOT COMPLETED|Overall Study||0
8408920|NCT00962429|20726046|P1|NOT COMPLETED|Overall Study||0
8408921|NCT00962429|20726045|P2|COMPLETED|Overall Study||0
8408922|NCT00962429|20726046|P1|COMPLETED|Overall Study||0
8408923|NCT00962429|20726045|P2|STARTED|Overall Study||0
8408924|NCT00962429|20726046|P1|STARTED|Overall Study||0
8408925|NCT00962390|20726062|P4|NOT COMPLETED|Overall Study||1
8408926|NCT00962390|20726063|P3|NOT COMPLETED|Overall Study||4
8408927|NCT00962390|20726064|P2|NOT COMPLETED|Overall Study||3
8408928|NCT00962390|20726065|P1|NOT COMPLETED|Overall Study||4
8408929|NCT00962390|20726062|P4|COMPLETED|Overall Study||28
8408930|NCT00962390|20726063|P3|COMPLETED|Overall Study||25
8408931|NCT00962390|20726064|P2|COMPLETED|Overall Study||26
8408932|NCT00962390|20726065|P1|COMPLETED|Overall Study||25
8408933|NCT00962390|20726062|P4|STARTED|Overall Study||29
8408934|NCT00962390|20726063|P3|STARTED|Overall Study||29
8408935|NCT00962390|20726064|P2|STARTED|Overall Study||29
8408936|NCT00962390|20726065|P1|STARTED|Overall Study||29
8408937|NCT00962247|20726127|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
8408938|NCT00962247|20726127|P1|COMPLETED|50% Reduction of Sedentary Activity||56
8408939|NCT00962247|20726127|P1|STARTED|50% Reduction of Sedentary Activity||56
8408940|NCT00962247|20726127|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
8408941|NCT00962247|20726127|P1|COMPLETED|25% Reduction of Sedentary Activity||56
8408942|NCT00962247|20726127|P1|STARTED|25% Reduction of Sedentary Activity||61
8408943|NCT00962247|20726127|P1|NOT COMPLETED|Usual Sedentary||0
8408944|NCT00962247|20726127|P1|COMPLETED|Usual Sedentary||61
8408945|NCT00962247|20726127|P1|STARTED|Usual Sedentary||61
8408946|NCT00962208|20726138|P2|NOT COMPLETED|Overall Study||10
8408947|NCT00962208|20726139|P1|NOT COMPLETED|Overall Study||14
8408948|NCT00962208|20726138|P2|COMPLETED|Overall Study||41
8408949|NCT00962208|20726139|P1|COMPLETED|Overall Study||37
8408950|NCT00962208|20726138|P2|STARTED|Overall Study||51
8408951|NCT00962208|20726139|P1|STARTED|Overall Study||51
8408952|NCT00962104|20726147|P2|NOT COMPLETED|Overall Study||25
8408953|NCT00962104|20726148|P1|NOT COMPLETED|Overall Study||40
8408954|NCT00962104|20726147|P2|COMPLETED|Overall Study||171
8408955|NCT00962104|20726148|P1|COMPLETED|Overall Study||155
8408956|NCT00962104|20726147|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
8408957|NCT00962104|20726148|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
8408958|NCT00962104|20726147|P2|STARTED|Overall Study||196
8408959|NCT00962104|20726148|P1|STARTED|Overall Study||195
8408960|NCT00962091|20726181|P7|NOT COMPLETED|Overall Study||1
8408961|NCT00962091|20726182|P6|NOT COMPLETED|Overall Study||1
8408962|NCT00962091|20726183|P5|NOT COMPLETED|Overall Study||0
8408963|NCT00962091|20726184|P4|NOT COMPLETED|Overall Study||1
8408964|NCT00962091|20726185|P3|NOT COMPLETED|Overall Study||1
8408965|NCT00962091|20726186|P2|NOT COMPLETED|Overall Study||2
8408966|NCT00962091|20726187|P1|NOT COMPLETED|Overall Study||1
8408967|NCT00962091|20726181|P7|COMPLETED|Overall Study||11
8408968|NCT00962091|20726182|P6|COMPLETED|Overall Study||11
8408969|NCT00962091|20726183|P5|COMPLETED|Overall Study||3
8408970|NCT00962091|20726184|P4|COMPLETED|Overall Study||2
8408971|NCT00962091|20726185|P3|COMPLETED|Overall Study||9
8408972|NCT00962091|20726186|P2|COMPLETED|Overall Study||7
8408973|NCT00962091|20726187|P1|COMPLETED|Overall Study||3
8408974|NCT00962091|20726181|P7|STARTED|Overall Study||12
8408975|NCT00962091|20726182|P6|STARTED|Overall Study||12
8408976|NCT00962091|20726183|P5|STARTED|Overall Study||3
8408977|NCT00962091|20726184|P4|STARTED|Overall Study||3
8408978|NCT00962091|20726185|P3|STARTED|Overall Study||10
8408979|NCT00962091|20726186|P2|STARTED|Overall Study||9
8408980|NCT00962091|20726187|P1|STARTED|Overall Study||4
8408981|NCT00962078|20726234|P2|NOT COMPLETED|Overall Study||6
8408982|NCT00962078|20726235|P1|NOT COMPLETED|Overall Study||5
8408983|NCT00962078|20726234|P2|COMPLETED|Overall Study||30
8408984|NCT00962078|20726235|P1|COMPLETED|Overall Study||30
8408985|NCT00962078|20726234|P2|STARTED|Overall Study||36
8408986|NCT00962078|20726235|P1|STARTED|Overall Study||35
8408987|NCT00962065|20726246|P3|NOT COMPLETED|Overall Study||0
8408988|NCT00962065|20726247|P2|NOT COMPLETED|Overall Study||0
8408989|NCT00962065|20726248|P1|NOT COMPLETED|Overall Study||0
8408990|NCT00962065|20726246|P3|COMPLETED|Overall Study||12
8408991|NCT00962065|20726247|P2|COMPLETED|Overall Study||12
8408992|NCT00962065|20726248|P1|COMPLETED|Overall Study||12
8408993|NCT00962065|20726246|P3|STARTED|Overall Study||12
8408994|NCT00962065|20726247|P2|STARTED|Overall Study||12
8408995|NCT00962065|20726248|P1|STARTED|Overall Study||12
8408996|NCT00962039|20726273|P2|NOT COMPLETED|Overall Study||4
8408997|NCT00962039|20726274|P1|NOT COMPLETED|Overall Study||5
8408998|NCT00962039|20726273|P2|COMPLETED|Overall Study||37
8408999|NCT00962039|20726274|P1|COMPLETED|Overall Study||35
8409000|NCT00962039|20726273|P2|STARTED|Overall Study||41
8409001|NCT00962039|20726274|P1|STARTED|Overall Study||40
8409002|NCT00962013|20726290|P1|NOT COMPLETED|Overall Study||68
8409003|NCT00962013|20726290|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
8409004|NCT00962013|20726290|P1|STARTED|Overall Study||120
8409005|NCT00962000|20726299|P2|NOT COMPLETED|Period 4 - 1 Week||0
8409006|NCT00962000|20726300|P1|NOT COMPLETED|Period 4 - 1 Week||0
8409007|NCT00962000|20726299|P2|COMPLETED|Period 4 - 1 Week||21
8409008|NCT00962000|20726300|P1|COMPLETED|Period 4 - 1 Week||21
8409009|NCT00962000|20726299|P2|STARTED|Period 4 - 1 Week||21
8409010|NCT00962000|20726300|P1|STARTED|Period 4 - 1 Week||21
8409011|NCT00962000|20726299|P2|NOT COMPLETED|Period 3 - 1 Week||0
8409012|NCT00962000|20726300|P1|NOT COMPLETED|Period 3 - 1 Week||0
8409013|NCT00962000|20726299|P2|COMPLETED|Period 3 - 1 Week||21
8409014|NCT00962000|20726300|P1|COMPLETED|Period 3 - 1 Week||21
8409015|NCT00962000|20726299|P2|STARTED|Period 3 - 1 Week||21
8409016|NCT00962000|20726300|P1|STARTED|Period 3 - 1 Week||21
8409017|NCT00962000|20726299|P2|NOT COMPLETED|Period 2 - 1 Week||0
8409018|NCT00962000|20726300|P1|NOT COMPLETED|Period 2 - 1 Week||0
8409019|NCT00962000|20726299|P2|COMPLETED|Period 2 - 1 Week||21
8409020|NCT00962000|20726300|P1|COMPLETED|Period 2 - 1 Week||21
8409021|NCT00962000|20726299|P2|STARTED|Period 2 - 1 Week||21
8409022|NCT00962000|20726300|P1|STARTED|Period 2 - 1 Week||21
8409023|NCT00962000|20726299|P2|NOT COMPLETED|Period 1 - 1 Week||0
8409024|NCT00962000|20726300|P1|NOT COMPLETED|Period 1 - 1 Week||0
8409025|NCT00962000|20726299|P2|COMPLETED|Period 1 - 1 Week||21
8409026|NCT00962000|20726300|P1|COMPLETED|Period 1 - 1 Week||21
8409027|NCT00962000|20726299|P2|STARTED|Period 1 - 1 Week||21
8409028|NCT00962000|20726300|P1|STARTED|Period 1 - 1 Week||21
8409029|NCT00961961|20726314|P4|NOT COMPLETED|Phase II||8
8409030|NCT00961961|20726315|P3|NOT COMPLETED|Phase II||12
8409031|NCT00961961|20726316|P2|NOT COMPLETED|Phase II||0
8409032|NCT00961961|20726317|P1|NOT COMPLETED|Phase II||0
8409033|NCT00961961|20726314|P4|COMPLETED|Phase II||14
8409034|NCT00961961|20726315|P3|COMPLETED|Phase II||17
8409035|NCT00961961|20726316|P2|COMPLETED|Phase II||0
8409036|NCT00961961|20726317|P1|COMPLETED|Phase II||0
8409037|NCT00961961|20726314|P4|STARTED|Phase II||22
8409038|NCT00961961|20726315|P3|STARTED|Phase II||29
8409039|NCT00961961|20726316|P2|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
8409040|NCT00961961|20726317|P1|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
8409041|NCT00961961|20726314|P4|NOT COMPLETED|Phase I||0
8409042|NCT00961961|20726315|P3|NOT COMPLETED|Phase I||0
8409043|NCT00961961|20726316|P2|NOT COMPLETED|Phase I||0
8409044|NCT00961961|20726317|P1|NOT COMPLETED|Phase I||126
8409045|NCT00961961|20726314|P4|COMPLETED|Phase I||0
8409046|NCT00961961|20726315|P3|COMPLETED|Phase I||0
8409047|NCT00961961|20726316|P2|COMPLETED|Phase I||0
8409048|NCT00961961|20726317|P1|COMPLETED|Phase I||51
8409049|NCT00961961|20726314|P4|STARTED|Phase I||0
8409050|NCT00961961|20726315|P3|STARTED|Phase I||0
8409051|NCT00961961|20726316|P2|STARTED|Phase I||0
8409052|NCT00961961|20726317|P1|STARTED|Phase I||177
8409053|NCT00961896|20726342|P3|NOT COMPLETED|Overall Study||1
8409054|NCT00961896|20726343|P2|NOT COMPLETED|Overall Study||0
8409055|NCT00961896|20726344|P1|NOT COMPLETED|Overall Study||0
8409056|NCT00961896|20726342|P3|COMPLETED|Overall Study||6
8409057|NCT00961896|20726343|P2|COMPLETED|Overall Study||3
8409058|NCT00961896|20726344|P1|COMPLETED|Overall Study||8
8409059|NCT00961896|20726342|P3|STARTED|Overall Study||7
8409060|NCT00961896|20726343|P2|STARTED|Overall Study||3
8409061|NCT00961896|20726344|P1|STARTED|Overall Study||8
8409062|NCT00961805|20726365|P2|NOT COMPLETED|Overall Study||0
8409063|NCT00961805|20726366|P1|NOT COMPLETED|Overall Study||0
8409064|NCT00961805|20726365|P2|COMPLETED|Overall Study||40
8409065|NCT00961805|20726366|P1|COMPLETED|Overall Study||40
8409066|NCT00961805|20726365|P2|STARTED|Overall Study||40
8409067|NCT00961805|20726366|P1|STARTED|Overall Study||40
8409068|NCT00961662|20726397|P3|NOT COMPLETED|Overall Study||19
8409069|NCT00961662|20726398|P2|NOT COMPLETED|Overall Study||19
8409070|NCT00961662|20726399|P1|NOT COMPLETED|Overall Study||22
8409071|NCT00961662|20726397|P3|COMPLETED|Overall Study||34
8409072|NCT00961662|20726398|P2|COMPLETED|Overall Study||32
8409073|NCT00961662|20726399|P1|COMPLETED|Overall Study||35
8409074|NCT00961662|20726397|P3|STARTED|Overall Study||53
8409075|NCT00961662|20726398|P2|STARTED|Overall Study||51
8409076|NCT00961662|20726399|P1|STARTED|Overall Study||57
8409077|NCT00961649|20726411|P4|NOT COMPLETED|Overall Study||4
8409078|NCT00961649|20726412|P3|NOT COMPLETED|Overall Study||5
8409079|NCT00961649|20726413|P2|NOT COMPLETED|Overall Study||4
8409080|NCT00961649|20726414|P1|NOT COMPLETED|Overall Study||9
8409081|NCT00961649|20726411|P4|COMPLETED|Overall Study||37
8409082|NCT00961649|20726412|P3|COMPLETED|Overall Study||39
8409083|NCT00961649|20726413|P2|COMPLETED|Overall Study||40
8409084|NCT00961649|20726414|P1|COMPLETED|Overall Study||32
8409085|NCT00961649|20726411|P4|STARTED|Overall Study||41
8409086|NCT00961649|20726412|P3|STARTED|Overall Study||44
8409087|NCT00961649|20726413|P2|STARTED|Overall Study||44
8409088|NCT00961649|20726414|P1|STARTED|Overall Study||41
8409089|NCT00961636|20726428|P3|NOT COMPLETED|Overall Study||32
8409090|NCT00961636|20726429|P2|NOT COMPLETED|Overall Study||131
8409091|NCT00961636|20726430|P1|NOT COMPLETED|Overall Study||107
8409092|NCT00961636|20726428|P3|COMPLETED|Overall Study||201
8409093|NCT00961636|20726429|P2|COMPLETED|Overall Study||325
8409094|NCT00961636|20726430|P1|COMPLETED|Overall Study||356
8409095|NCT00961636|20726428|P3|STARTED|Overall Study||233
8409096|NCT00961636|20726429|P2|STARTED|Overall Study||456
8409097|NCT00961636|20726430|P1|STARTED|Overall Study||463
8409098|NCT00961571|20726441|P1|NOT COMPLETED|Overall Study||39
8409099|NCT00961571|20726441|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
8409100|NCT00961571|20726441|P1|STARTED|Overall Study||50
8409101|NCT00961532|20726445|P1|NOT COMPLETED|Overall Study||0
8409102|NCT00961532|20726445|P1|COMPLETED|Overall Study||14
8409103|NCT00961532|20726445|P1|STARTED|Overall Study||14
8409104|NCT00961441|20726452|P2|NOT COMPLETED|Overall Study||0
8409105|NCT00961441|20726453|P1|NOT COMPLETED|Overall Study||0
8409106|NCT00961441|20726452|P2|COMPLETED|Overall Study||13
8409107|NCT00961441|20726453|P1|COMPLETED|Overall Study||12
8409108|NCT00961441|20726452|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
8409109|NCT00961441|20726453|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
8409110|NCT00961441|20726452|P2|STARTED|Overall Study||13
8409111|NCT00961441|20726453|P1|STARTED|Overall Study||12
8409112|NCT00961415|20726469|P3|NOT COMPLETED|Maintenance Treatment Phase||45
8409113|NCT00961415|20726470|P2|NOT COMPLETED|Maintenance Treatment Phase||48
8409114|NCT00961415|20726471|P1|NOT COMPLETED|Maintenance Treatment Phase||0
8409115|NCT00961415|20726469|P3|COMPLETED|Maintenance Treatment Phase||83
8409116|NCT00961415|20726470|P2|COMPLETED|Maintenance Treatment Phase||77
8409117|NCT00961415|20726471|P1|COMPLETED|Maintenance Treatment Phase||0
8409118|NCT00961415|20726469|P3|STARTED|Maintenance Treatment Phase||128
8409119|NCT00961415|20726470|P2|STARTED|Maintenance Treatment Phase||125
8409120|NCT00961415|20726471|P1|STARTED|Maintenance Treatment Phase||0
8409121|NCT00961415|20726469|P3|NOT COMPLETED|Induction Treatment Phase||0
8409122|NCT00961415|20726470|P2|NOT COMPLETED|Induction Treatment Phase||0
8409123|NCT00961415|20726471|P1|NOT COMPLETED|Induction Treatment Phase||123
8409124|NCT00961415|20726469|P3|COMPLETED|Induction Treatment Phase||0
8409125|NCT00961415|20726470|P2|COMPLETED|Induction Treatment Phase||0
8409126|NCT00961415|20726471|P1|COMPLETED|Induction Treatment Phase||253
8409127|NCT00961415|20726469|P3|STARTED|Induction Treatment Phase||0
8409128|NCT00961415|20726470|P2|STARTED|Induction Treatment Phase||0
8409129|NCT00961415|20726471|P1|STARTED|Induction Treatment Phase||376
8409130|NCT00961402|20726496|P2|NOT COMPLETED|Overall Study||5
8409131|NCT00961402|20726497|P1|NOT COMPLETED|Overall Study||1
8409132|NCT00961402|20726496|P2|COMPLETED|Overall Study||61
8409133|NCT00961402|20726497|P1|COMPLETED|Overall Study||63
8409134|NCT00961402|20726496|P2|Randomized|Overall Study||66
8409135|NCT00961402|20726497|P1|Randomized|Overall Study||64
8409136|NCT00961402|20726496|P2|STARTED|Overall Study||66
8409137|NCT00961402|20726497|P1|STARTED|Overall Study||64
8409138|NCT00961350|20726511|P2|NOT COMPLETED|Overall Study||67
8409139|NCT00961350|20726512|P1|NOT COMPLETED|Overall Study||47
8409140|NCT00961350|20726511|P2|COMPLETED|Overall Study||198
8409141|NCT00961350|20726512|P1|COMPLETED|Overall Study||218
8409142|NCT00961350|20726511|P2|Safety Population|Overall Study||265
8409143|NCT00961350|20726512|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
8409144|NCT00961350|20726511|P2|Intent-to-Treat Population (ITT)|Overall Study||265
8409145|NCT00961350|20726512|P1|Intent-to-Treat Population (ITT)|Overall Study||265
8409146|NCT00961350|20726511|P2|STARTED|Overall Study||265
8409147|NCT00961350|20726512|P1|STARTED|Overall Study||265
8409148|NCT00961311|20726526|P1|NOT COMPLETED|Overall Study||0
8409149|NCT00961311|20726526|P1|COMPLETED|Overall Study||51
8409150|NCT00961311|20726526|P1|STARTED|Overall Study||51
8409151|NCT00961298|20726533|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
8409152|NCT00961298|20726533|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
8409153|NCT00961298|20726533|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
8409154|NCT00961298|20726533|P1|NOT COMPLETED|Two Week Placebo Run in||1
8409155|NCT00961298|20726533|P1|COMPLETED|Two Week Placebo Run in||14
8409156|NCT00961298|20726533|P1|STARTED|Two Week Placebo Run in||15
8409157|NCT00961259|20726540|P3|NOT COMPLETED|Third Intervention||0
8409158|NCT00961259|20726541|P2|NOT COMPLETED|Third Intervention||0
8409159|NCT00961259|20726542|P1|NOT COMPLETED|Third Intervention||0
8409160|NCT00961259|20726540|P3|COMPLETED|Third Intervention||18
8409161|NCT00961259|20726541|P2|COMPLETED|Third Intervention||17
8409162|NCT00961259|20726542|P1|COMPLETED|Third Intervention||18
8409163|NCT00961259|20726540|P3|STARTED|Third Intervention||18
8409164|NCT00961259|20726541|P2|STARTED|Third Intervention||17
8409165|NCT00961259|20726542|P1|STARTED|Third Intervention||18
8409166|NCT00961259|20726540|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409167|NCT00961259|20726541|P2|NOT COMPLETED|Washout Period of 7 Days||0
8409168|NCT00961259|20726542|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409169|NCT00961259|20726540|P3|COMPLETED|Washout Period of 7 Days||18
8409170|NCT00961259|20726541|P2|COMPLETED|Washout Period of 7 Days||17
8409171|NCT00961259|20726542|P1|COMPLETED|Washout Period of 7 Days||18
8409172|NCT00961259|20726540|P3|STARTED|Washout Period of 7 Days||18
8409173|NCT00961259|20726541|P2|STARTED|Washout Period of 7 Days||17
8409174|NCT00961259|20726542|P1|STARTED|Washout Period of 7 Days||18
8409175|NCT00961259|20726540|P3|NOT COMPLETED|Second Intervention||0
8409176|NCT00961259|20726541|P2|NOT COMPLETED|Second Intervention||0
8409177|NCT00961259|20726542|P1|NOT COMPLETED|Second Intervention||0
8409178|NCT00961259|20726540|P3|COMPLETED|Second Intervention||18
8409179|NCT00961259|20726541|P2|COMPLETED|Second Intervention||17
8409180|NCT00961259|20726542|P1|COMPLETED|Second Intervention||18
8409181|NCT00961259|20726540|P3|STARTED|Second Intervention||18
8409182|NCT00961259|20726541|P2|STARTED|Second Intervention||17
8409183|NCT00961259|20726542|P1|STARTED|Second Intervention||18
8409184|NCT00961259|20726540|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409185|NCT00961259|20726541|P2|NOT COMPLETED|Washout Period of 7 Days||1
8409186|NCT00961259|20726542|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409187|NCT00961259|20726540|P3|COMPLETED|Washout Period of 7 Days||18
8409188|NCT00961259|20726541|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
8409189|NCT00961259|20726542|P1|COMPLETED|Washout Period of 7 Days||18
8409190|NCT00961259|20726540|P3|STARTED|Washout Period of 7 Days||18
8409191|NCT00961259|20726541|P2|STARTED|Washout Period of 7 Days||18
8409192|NCT00961259|20726542|P1|STARTED|Washout Period of 7 Days||18
8409193|NCT00961259|20726540|P3|NOT COMPLETED|First Intervention||0
8409194|NCT00961259|20726541|P2|NOT COMPLETED|First Intervention||0
8409195|NCT00961259|20726542|P1|NOT COMPLETED|First Intervention||0
8409196|NCT00961259|20726540|P3|COMPLETED|First Intervention||18
8409197|NCT00961259|20726541|P2|COMPLETED|First Intervention||18
8409198|NCT00961259|20726542|P1|COMPLETED|First Intervention||18
8409199|NCT00961259|20726540|P3|STARTED|First Intervention||18
8409200|NCT00961259|20726541|P2|STARTED|First Intervention||18
8409201|NCT00961259|20726542|P1|STARTED|First Intervention||18
8409202|NCT00961233|20726561|P2|NOT COMPLETED|Overall Study||1
8409203|NCT00961233|20726562|P1|NOT COMPLETED|Overall Study||2
8409204|NCT00961233|20726561|P2|COMPLETED|Overall Study||11
8409205|NCT00961233|20726562|P1|COMPLETED|Overall Study||11
8409206|NCT00961233|20726561|P2|STARTED|Overall Study||12
8409207|NCT00961233|20726562|P1|STARTED|Overall Study||13
8409208|NCT00961220|20726570|P1|NOT COMPLETED|Overall Study||7
8409209|NCT00961220|20726570|P1|COMPLETED|Overall Study||10
8409210|NCT00961220|20726570|P1|STARTED|Overall Study||17
8409211|NCT00961181|20726586|P1|NOT COMPLETED|Overall Study||5
8409212|NCT00961181|20726586|P1|COMPLETED|Overall Study||76
8409213|NCT00961181|20726586|P1|STARTED|Overall Study||81
8409214|NCT00961116|20726599|P2|NOT COMPLETED|Second Intervention||0
8409215|NCT00961116|20726600|P1|NOT COMPLETED|Second Intervention||0
8409216|NCT00961116|20726599|P2|COMPLETED|Second Intervention||24
8409217|NCT00961116|20726600|P1|COMPLETED|Second Intervention||25
8409218|NCT00961116|20726599|P2|STARTED|Second Intervention||24
8409219|NCT00961116|20726600|P1|STARTED|Second Intervention||25
8409220|NCT00961116|20726599|P2|NOT COMPLETED|Washout Period of 7 Days||3
8409221|NCT00961116|20726600|P1|NOT COMPLETED|Washout Period of 7 Days||2
8409222|NCT00961116|20726599|P2|COMPLETED|Washout Period of 7 Days||24
8409223|NCT00961116|20726600|P1|COMPLETED|Washout Period of 7 Days||25
8409224|NCT00961116|20726599|P2|STARTED|Washout Period of 7 Days||27
8409225|NCT00961116|20726600|P1|STARTED|Washout Period of 7 Days||27
8409226|NCT00961116|20726599|P2|NOT COMPLETED|First Intervention||0
8409227|NCT00961116|20726600|P1|NOT COMPLETED|First Intervention||0
8409228|NCT00961116|20726599|P2|COMPLETED|First Intervention||27
8409229|NCT00961116|20726600|P1|COMPLETED|First Intervention||27
8409230|NCT00961116|20726599|P2|STARTED|First Intervention||27
8409231|NCT00961116|20726600|P1|STARTED|First Intervention||27
8409232|NCT00961064|20726610|P1|NOT COMPLETED|Overall Study||0
8409233|NCT00961064|20726610|P1|COMPLETED|Overall Study||30
8409234|NCT00961064|20726610|P1|STARTED|Overall Study||30
8409235|NCT00961051|20726616|P2|NOT COMPLETED|Overall Study||14
8409236|NCT00961051|20726617|P1|NOT COMPLETED|Overall Study||12
8409237|NCT00961051|20726616|P2|COMPLETED|Overall Study||79
8409238|NCT00961051|20726617|P1|COMPLETED|Overall Study||165
8409239|NCT00961051|20726616|P2|STARTED|Overall Study||93
8409240|NCT00961051|20726617|P1|STARTED|Overall Study||177
8409241|NCT00960999|20726627|P2|NOT COMPLETED|Overall Study||2
8409242|NCT00960999|20726628|P1|NOT COMPLETED|Overall Study||8
8409243|NCT00960999|20726627|P2|COMPLETED|Overall Study||45
8409244|NCT00960999|20726628|P1|COMPLETED|Overall Study||39
8409245|NCT00960999|20726627|P2|DLCO by Best Response|Overall Study||28
8409246|NCT00960999|20726628|P1|DLCO by Best Response|Overall Study||23
8409247|NCT00960999|20726627|P2|FEV1 by Best Response|Overall Study||33
8409248|NCT00960999|20726628|P1|FEV1 by Best Response|Overall Study||26
8409249|NCT00960999|20726627|P2|Normalized SUV at 1 Year|Overall Study||7
8409250|NCT00960999|20726628|P1|Normalized SUV at 1 Year|Overall Study||4
8409251|NCT00960999|20726627|P2|Normalized SUV at 8 Weeks|Overall Study||9
8409252|NCT00960999|20726628|P1|Normalized SUV at 8 Weeks|Overall Study||3
8409253|NCT00960999|20726627|P2|Peak SUV at 1 Year|Overall Study||7
8409254|NCT00960999|20726628|P1|Peak SUV at 1 Year|Overall Study||4
8409255|NCT00960999|20726627|P2|Peak SUV at 8 Weeks|Overall Study||11
8409256|NCT00960999|20726628|P1|Peak SUV at 8 Weeks|Overall Study||3
8409257|NCT00960999|20726627|P2|Primary Endpoint Population|Overall Study||38
8409258|NCT00960999|20726628|P1|Primary Endpoint Population|Overall Study||38
8409259|NCT00960999|20726627|P2|Started Protocol Treatment|Overall Study||45
8409260|NCT00960999|20726628|P1|Started Protocol Treatment|Overall Study||39
8409261|NCT00960999|20726627|P2|Eligible|Overall Study||45
8409262|NCT00960999|20726628|P1|Eligible|Overall Study||39
8409263|NCT00960999|20726627|P2|STARTED|Overall Study||47
8409264|NCT00960999|20726628|P1|STARTED|Overall Study||47
8409265|NCT00960986|20726660|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
8409266|NCT00960986|20726661|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
8409267|NCT00960986|20726662|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
8409268|NCT00960986|20726663|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
8409269|NCT00960986|20726660|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
8409270|NCT00960986|20726661|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
8409271|NCT00960986|20726662|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
8409272|NCT00960986|20726663|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
8409273|NCT00960986|20726660|P4|STARTED|Period 3 (7-week Therapy Period)||61
8409274|NCT00960986|20726661|P3|STARTED|Period 3 (7-week Therapy Period)||59
8409275|NCT00960986|20726662|P2|STARTED|Period 3 (7-week Therapy Period)||59
8409276|NCT00960986|20726663|P1|STARTED|Period 3 (7-week Therapy Period)||56
8409277|NCT00960986|20726660|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409278|NCT00960986|20726661|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409279|NCT00960986|20726662|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409280|NCT00960986|20726663|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409281|NCT00960986|20726660|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
8409282|NCT00960986|20726661|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
8409283|NCT00960986|20726662|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
8409284|NCT00960986|20726663|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
8409285|NCT00960986|20726660|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
8409286|NCT00960986|20726661|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
8409287|NCT00960986|20726662|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
8409288|NCT00960986|20726663|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
8409289|NCT00960986|20726660|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
8409290|NCT00960986|20726661|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
8409291|NCT00960986|20726662|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
8409292|NCT00960986|20726663|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
8409293|NCT00960986|20726660|P4|COMPLETED|Period 1 (Screening and Washout)||61
8409294|NCT00960986|20726661|P3|COMPLETED|Period 1 (Screening and Washout)||59
8409295|NCT00960986|20726662|P2|COMPLETED|Period 1 (Screening and Washout)||59
8409296|NCT00960986|20726663|P1|COMPLETED|Period 1 (Screening and Washout)||56
8409297|NCT00960986|20726660|P4|STARTED|Period 1 (Screening and Washout)||64
8409298|NCT00960986|20726661|P3|STARTED|Period 1 (Screening and Washout)||63
8409299|NCT00960986|20726662|P2|STARTED|Period 1 (Screening and Washout)||63
8409300|NCT00960986|20726663|P1|STARTED|Period 1 (Screening and Washout)||59
8409301|NCT00960934|20726739|P6|NOT COMPLETED|Overall Study||64
8409302|NCT00960934|20726740|P5|NOT COMPLETED|Overall Study||64
8409303|NCT00960934|20726741|P4|NOT COMPLETED|Overall Study||64
8409304|NCT00960934|20726742|P3|NOT COMPLETED|Overall Study||64
8409305|NCT00960934|20726743|P2|NOT COMPLETED|Overall Study||63
8409306|NCT00960934|20726744|P1|NOT COMPLETED|Overall Study||64
8409307|NCT00960934|20726739|P6|COMPLETED|Overall Study||0
8409308|NCT00960934|20726740|P5|COMPLETED|Overall Study||0
8409309|NCT00960934|20726741|P4|COMPLETED|Overall Study||0
8409310|NCT00960934|20726742|P3|COMPLETED|Overall Study||0
8409311|NCT00960934|20726743|P2|COMPLETED|Overall Study||0
8409312|NCT00960934|20726744|P1|COMPLETED|Overall Study||0
8409313|NCT00960934|20726739|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
8409314|NCT00960934|20726740|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
8409315|NCT00960934|20726741|P4|Number Treated|Overall Study||64
8409316|NCT00960934|20726742|P3|Number Treated|Overall Study||64
8409317|NCT00960934|20726743|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
8409318|NCT00960934|20726744|P1|Number Treated|Overall Study||64
8409319|NCT00960934|20726739|P6|STARTED|Overall Study||64
8409320|NCT00960934|20726740|P5|STARTED|Overall Study||64
8409321|NCT00960934|20726741|P4|STARTED|Overall Study||64
8409322|NCT00960934|20726742|P3|STARTED|Overall Study||64
8409323|NCT00960934|20726743|P2|STARTED|Overall Study||63
8409324|NCT00960934|20726744|P1|STARTED|Overall Study||64
8409325|NCT00960869|20726856|P2|NOT COMPLETED|Overall Study||62
8409326|NCT00960869|20726857|P1|NOT COMPLETED|Overall Study||53
8409327|NCT00960869|20726856|P2|COMPLETED|Overall Study||198
8409328|NCT00960869|20726857|P1|COMPLETED|Overall Study||206
8409329|NCT00960869|20726856|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
8409330|NCT00960869|20726857|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
8409331|NCT00960869|20726856|P2|Intent-to-Treat Population (ITT)|Overall Study||260
8409332|NCT00960869|20726857|P1|Intent-to-Treat Population (ITT)|Overall Study||259
8409333|NCT00960869|20726856|P2|STARTED|Overall Study||260
8409334|NCT00960869|20726857|P1|STARTED|Overall Study||259
8409335|NCT00960856|20726871|P4|NOT COMPLETED|Period IV||0
8409336|NCT00960856|20726872|P3|NOT COMPLETED|Period IV||0
8409337|NCT00960856|20726873|P2|NOT COMPLETED|Period IV||0
8409338|NCT00960856|20726874|P1|NOT COMPLETED|Period IV||0
8409339|NCT00960856|20726871|P4|COMPLETED|Period IV||9
8409340|NCT00960856|20726872|P3|COMPLETED|Period IV||8
8409341|NCT00960856|20726873|P2|COMPLETED|Period IV||7
8409342|NCT00960856|20726874|P1|COMPLETED|Period IV||10
8409343|NCT00960856|20726871|P4|STARTED|Period IV||9
8409344|NCT00960856|20726872|P3|STARTED|Period IV||8
8409345|NCT00960856|20726873|P2|STARTED|Period IV||7
8409346|NCT00960856|20726874|P1|STARTED|Period IV||10
8409347|NCT00960856|20726871|P4|NOT COMPLETED|Washout Period of 7 Days||0
8409348|NCT00960856|20726872|P3|NOT COMPLETED|Washout Period of 7 Days||1
8409349|NCT00960856|20726873|P2|NOT COMPLETED|Washout Period of 7 Days||0
8409350|NCT00960856|20726874|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409351|NCT00960856|20726871|P4|COMPLETED|Washout Period of 7 Days||9
8409352|NCT00960856|20726872|P3|COMPLETED|Washout Period of 7 Days||8
8409353|NCT00960856|20726873|P2|COMPLETED|Washout Period of 7 Days||7
8409354|NCT00960856|20726874|P1|COMPLETED|Washout Period of 7 Days||10
8409355|NCT00960856|20726871|P4|STARTED|Washout Period of 7 Days||9
8409356|NCT00960856|20726872|P3|STARTED|Washout Period of 7 Days||9
8409357|NCT00960856|20726873|P2|STARTED|Washout Period of 7 Days||7
8409358|NCT00960856|20726874|P1|STARTED|Washout Period of 7 Days||10
8409359|NCT00960856|20726871|P4|NOT COMPLETED|Period III||0
8409360|NCT00960856|20726872|P3|NOT COMPLETED|Period III||0
8409361|NCT00960856|20726873|P2|NOT COMPLETED|Period III||0
8409362|NCT00960856|20726874|P1|NOT COMPLETED|Period III||0
8409363|NCT00960856|20726871|P4|COMPLETED|Period III||9
8409364|NCT00960856|20726872|P3|COMPLETED|Period III||9
8409365|NCT00960856|20726873|P2|COMPLETED|Period III||7
8409366|NCT00960856|20726874|P1|COMPLETED|Period III||10
8409367|NCT00960856|20726871|P4|STARTED|Period III||9
8409368|NCT00960856|20726872|P3|STARTED|Period III||9
8409369|NCT00960856|20726873|P2|STARTED|Period III||7
8409370|NCT00960856|20726874|P1|STARTED|Period III||10
8409371|NCT00960856|20726871|P4|NOT COMPLETED|Washout Period of 7 Days||0
8409372|NCT00960856|20726872|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409373|NCT00960856|20726873|P2|NOT COMPLETED|Washout Period of 7 Days||0
8409374|NCT00960856|20726874|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409375|NCT00960856|20726871|P4|COMPLETED|Washout Period of 7 Days||9
8409376|NCT00960856|20726872|P3|COMPLETED|Washout Period of 7 Days||9
8409377|NCT00960856|20726873|P2|COMPLETED|Washout Period of 7 Days||7
8409378|NCT00960856|20726874|P1|COMPLETED|Washout Period of 7 Days||10
8409379|NCT00960856|20726871|P4|STARTED|Washout Period of 7 Days||9
8409380|NCT00960856|20726872|P3|STARTED|Washout Period of 7 Days||9
8409381|NCT00960856|20726873|P2|STARTED|Washout Period of 7 Days||7
8409382|NCT00960856|20726874|P1|STARTED|Washout Period of 7 Days||10
8409383|NCT00960856|20726871|P4|NOT COMPLETED|Period II||0
8409384|NCT00960856|20726872|P3|NOT COMPLETED|Period II||0
8409385|NCT00960856|20726873|P2|NOT COMPLETED|Period II||0
8409386|NCT00960856|20726874|P1|NOT COMPLETED|Period II||0
8409387|NCT00960856|20726871|P4|COMPLETED|Period II||9
8409388|NCT00960856|20726872|P3|COMPLETED|Period II||9
8409389|NCT00960856|20726873|P2|COMPLETED|Period II||7
8409390|NCT00960856|20726874|P1|COMPLETED|Period II||10
8409391|NCT00960856|20726871|P4|STARTED|Period II||9
8409392|NCT00960856|20726872|P3|STARTED|Period II||9
8409393|NCT00960856|20726873|P2|STARTED|Period II||7
8409394|NCT00960856|20726874|P1|STARTED|Period II||10
8409395|NCT00960856|20726871|P4|NOT COMPLETED|Washout Period of 7 Days||0
8409396|NCT00960856|20726872|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409397|NCT00960856|20726873|P2|NOT COMPLETED|Washout Period of 7 Days||2
8409398|NCT00960856|20726874|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409399|NCT00960856|20726871|P4|COMPLETED|Washout Period of 7 Days||9
8409400|NCT00960856|20726872|P3|COMPLETED|Washout Period of 7 Days||9
8409401|NCT00960856|20726873|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
8409402|NCT00960856|20726874|P1|COMPLETED|Washout Period of 7 Days||10
8409403|NCT00960856|20726871|P4|STARTED|Washout Period of 7 Days||9
8409404|NCT00960856|20726872|P3|STARTED|Washout Period of 7 Days||9
8409405|NCT00960856|20726873|P2|STARTED|Washout Period of 7 Days||9
8409406|NCT00960856|20726874|P1|STARTED|Washout Period of 7 Days||10
8409407|NCT00960856|20726871|P4|NOT COMPLETED|Period I||0
8409408|NCT00960856|20726872|P3|NOT COMPLETED|Period I||0
8409409|NCT00960856|20726873|P2|NOT COMPLETED|Period I||0
8409410|NCT00960856|20726874|P1|NOT COMPLETED|Period I||0
8409411|NCT00960856|20726871|P4|COMPLETED|Period I||9
8409412|NCT00960856|20726872|P3|COMPLETED|Period I||9
8409413|NCT00960856|20726873|P2|COMPLETED|Period I||9
8409414|NCT00960856|20726874|P1|COMPLETED|Period I||10
8409415|NCT00960856|20726871|P4|STARTED|Period I||9
8409416|NCT00960856|20726872|P3|STARTED|Period I||9
8409417|NCT00960856|20726873|P2|STARTED|Period I||9
8409418|NCT00960856|20726874|P1|STARTED|Period I||10
8409419|NCT00960843|20726894|P2|NOT COMPLETED|Overall Study||5
8409420|NCT00960843|20726895|P1|NOT COMPLETED|Overall Study||2
8409421|NCT00960843|20726894|P2|COMPLETED|Overall Study||21
8409422|NCT00960843|20726895|P1|COMPLETED|Overall Study||23
8409423|NCT00960843|20726894|P2|STARTED|Overall Study||26
8409424|NCT00960843|20726895|P1|STARTED|Overall Study||25
8409425|NCT00960778|20726907|P2|NOT COMPLETED|Overall Study||3
8409426|NCT00960778|20726908|P1|NOT COMPLETED|Overall Study||9
8409427|NCT00960778|20726907|P2|COMPLETED|Overall Study||13
8409428|NCT00960778|20726908|P1|COMPLETED|Overall Study||8
8409429|NCT00960778|20726907|P2|STARTED|Overall Study||16
8409430|NCT00960778|20726908|P1|STARTED|Overall Study||17
8409431|NCT00960687|20726916|P2|NOT COMPLETED|Second Intervention||0
8409432|NCT00960687|20726917|P1|NOT COMPLETED|Second Intervention||0
8409433|NCT00960687|20726916|P2|COMPLETED|Second Intervention||24
8409434|NCT00960687|20726917|P1|COMPLETED|Second Intervention||23
8409435|NCT00960687|20726916|P2|STARTED|Second Intervention||24
8409436|NCT00960687|20726917|P1|STARTED|Second Intervention||23
8409437|NCT00960687|20726916|P2|NOT COMPLETED|Washout Period of 7 Days||3
8409438|NCT00960687|20726917|P1|NOT COMPLETED|Washout Period of 7 Days||4
8409439|NCT00960687|20726916|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
8409440|NCT00960687|20726917|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
8409441|NCT00960687|20726916|P2|STARTED|Washout Period of 7 Days||27
8409442|NCT00960687|20726917|P1|STARTED|Washout Period of 7 Days||27
8409443|NCT00960687|20726916|P2|NOT COMPLETED|First Intervention||0
8409444|NCT00960687|20726917|P1|NOT COMPLETED|First Intervention||0
8409445|NCT00960687|20726916|P2|COMPLETED|First Intervention||27
8409446|NCT00960687|20726917|P1|COMPLETED|First Intervention||27
8409447|NCT00960687|20726916|P2|STARTED|First Intervention||27
8409448|NCT00960687|20726917|P1|STARTED|First Intervention||27
8409449|NCT00960661|20726929|P3|NOT COMPLETED|Interventional Phase||46
8409450|NCT00960661|20726930|P2|NOT COMPLETED|Interventional Phase||52
8409451|NCT00960661|20726931|P1|NOT COMPLETED|Interventional Phase||0
8409452|NCT00960661|20726929|P3|COMPLETED|Interventional Phase||275
8409453|NCT00960661|20726930|P2|COMPLETED|Interventional Phase||264
8409454|NCT00960661|20726931|P1|COMPLETED|Interventional Phase||0
8409455|NCT00960661|20726929|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
8409456|NCT00960661|20726930|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
8409457|NCT00960661|20726931|P1|Per Protocol Population|Interventional Phase||0
8409458|NCT00960661|20726929|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
8409459|NCT00960661|20726930|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
8409460|NCT00960661|20726931|P1|Intent to Treat Population|Interventional Phase||0
8409461|NCT00960661|20726929|P3|STARTED|Interventional Phase||321
8409462|NCT00960661|20726930|P2|STARTED|Interventional Phase||316
8409463|NCT00960661|20726931|P1|STARTED|Interventional Phase||0
8409464|NCT00960661|20726929|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409465|NCT00960661|20726930|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409466|NCT00960661|20726931|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
8409467|NCT00960661|20726929|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409468|NCT00960661|20726930|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409469|NCT00960661|20726931|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
8409470|NCT00960661|20726929|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
8409471|NCT00960661|20726930|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
8409472|NCT00960661|20726931|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
8409473|NCT00960622|20726963|P2|NOT COMPLETED|Overall Study||3
8409474|NCT00960622|20726964|P1|NOT COMPLETED|Overall Study||0
8409475|NCT00960622|20726963|P2|COMPLETED|Overall Study||7
8409476|NCT00960622|20726964|P1|COMPLETED|Overall Study||10
8409477|NCT00960622|20726963|P2|STARTED|Overall Study||10
8409478|NCT00960622|20726964|P1|STARTED|Overall Study||10
8409479|NCT00960570|20726970|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
8409480|NCT00960570|20726970|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
8409481|NCT00960570|20726970|P1|STARTED|Efavirenz and Fenofibric Acid||25
8409482|NCT00960570|20726970|P1|NOT COMPLETED|1 Day Period Between Dosing||3
8409483|NCT00960570|20726970|P1|COMPLETED|1 Day Period Between Dosing||25
8409484|NCT00960570|20726970|P1|STARTED|1 Day Period Between Dosing||28
8409485|NCT00960570|20726970|P1|NOT COMPLETED|Fenofibric Acid Alone||0
8409486|NCT00960570|20726970|P1|COMPLETED|Fenofibric Acid Alone||28
8409487|NCT00960570|20726970|P1|STARTED|Fenofibric Acid Alone||28
8409488|NCT00960570|20726970|P1|NOT COMPLETED|21 Day Washout Period||2
8409489|NCT00960570|20726970|P1|COMPLETED|21 Day Washout Period||28
8409490|NCT00960570|20726970|P1|STARTED|21 Day Washout Period||30
8409491|NCT00960570|20726970|P1|NOT COMPLETED|Efavirenz Alone||0
8409492|NCT00960570|20726970|P1|COMPLETED|Efavirenz Alone||30
8409493|NCT00960570|20726970|P1|STARTED|Efavirenz Alone||30
8409494|NCT00960531|20726991|P10|NOT COMPLETED|Overall Study||1
8409495|NCT00960531|20726992|P9|NOT COMPLETED|Overall Study||14
8409496|NCT00960531|20726993|P8|NOT COMPLETED|Overall Study||4
8409497|NCT00960531|20726994|P7|NOT COMPLETED|Overall Study||24
8409498|NCT00960531|20726995|P6|NOT COMPLETED|Overall Study||3
8409499|NCT00960531|20726996|P5|NOT COMPLETED|Overall Study||2
8409500|NCT00960531|20726997|P4|NOT COMPLETED|Overall Study||8
8409501|NCT00960531|20726998|P3|NOT COMPLETED|Overall Study||26
8409502|NCT00960531|20726999|P2|NOT COMPLETED|Overall Study||1
8409503|NCT00960531|20727000|P1|NOT COMPLETED|Overall Study||10
8409504|NCT00960531|20726991|P10|COMPLETED|Overall Study|Completed study|3
8409505|NCT00960531|20726992|P9|COMPLETED|Overall Study|Completed study|2
8409506|NCT00960531|20726993|P8|COMPLETED|Overall Study|Completed study|2
8409507|NCT00960531|20726994|P7|COMPLETED|Overall Study|Completed study|3
8409508|NCT00960531|20726995|P6|COMPLETED|Overall Study|Completed study|6
8409509|NCT00960531|20726996|P5|COMPLETED|Overall Study|Completed study|3
8409510|NCT00960531|20726997|P4|COMPLETED|Overall Study|Completed study|17
8409511|NCT00960531|20726998|P3|COMPLETED|Overall Study|Completed study|15
8409512|NCT00960531|20726999|P2|COMPLETED|Overall Study|Completed study|5
8409513|NCT00960531|20727000|P1|COMPLETED|Overall Study|Completed study|11
8409514|NCT00960531|20726991|P10|Completed Treatment|Overall Study||4
8409515|NCT00960531|20726992|P9|Completed Treatment|Overall Study||2
8409516|NCT00960531|20726993|P8|Completed Treatment|Overall Study||3
8409517|NCT00960531|20726994|P7|Completed Treatment|Overall Study||4
8409518|NCT00960531|20726995|P6|Completed Treatment|Overall Study||7
8409519|NCT00960531|20726996|P5|Completed Treatment|Overall Study||3
8409520|NCT00960531|20726997|P4|Completed Treatment|Overall Study||17
8409521|NCT00960531|20726998|P3|Completed Treatment|Overall Study||15
8409522|NCT00960531|20726999|P2|Completed Treatment|Overall Study||5
8409523|NCT00960531|20727000|P1|Completed Treatment|Overall Study||12
8409524|NCT00960531|20726991|P10|Treated|Overall Study||4
8409525|NCT00960531|20726992|P9|Treated|Overall Study||16
8409526|NCT00960531|20726993|P8|Treated|Overall Study||6
8409527|NCT00960531|20726994|P7|Treated|Overall Study||27
8409528|NCT00960531|20726995|P6|Treated|Overall Study||9
8409529|NCT00960531|20726996|P5|Treated|Overall Study||5
8409530|NCT00960531|20726997|P4|Treated|Overall Study||24
8409531|NCT00960531|20726998|P3|Treated|Overall Study||41
8409532|NCT00960531|20726999|P2|Treated|Overall Study||6
8409533|NCT00960531|20727000|P1|Treated|Overall Study||21
8409534|NCT00960531|20726991|P10|STARTED|Overall Study|Started=Randomized|4
8409535|NCT00960531|20726992|P9|STARTED|Overall Study|Started=Randomized|16
8409536|NCT00960531|20726993|P8|STARTED|Overall Study|Started=Randomized|6
8409537|NCT00960531|20726994|P7|STARTED|Overall Study|Started=Randomized|27
8409538|NCT00960531|20726995|P6|STARTED|Overall Study|Started=Randomized|9
8409539|NCT00960531|20726996|P5|STARTED|Overall Study|Started=Randomized|5
8409540|NCT00960531|20726997|P4|STARTED|Overall Study|Started=Randomized.|25
8409541|NCT00960531|20726998|P3|STARTED|Overall Study|Started=Randomized|41
8409542|NCT00960531|20726999|P2|STARTED|Overall Study|Started=Randomized|6
8409543|NCT00960531|20727000|P1|STARTED|Overall Study|Started=Randomized|21
8409544|NCT00960505|20727047|P3|NOT COMPLETED|Overall Study||8
8409545|NCT00960505|20727048|P2|NOT COMPLETED|Overall Study||10
8409546|NCT00960505|20727049|P1|NOT COMPLETED|Overall Study||13
8409547|NCT00960505|20727047|P3|COMPLETED|Overall Study||23
8409548|NCT00960505|20727048|P2|COMPLETED|Overall Study||25
8409549|NCT00960505|20727049|P1|COMPLETED|Overall Study||21
8409550|NCT00960505|20727047|P3|STARTED|Overall Study||31
8409551|NCT00960505|20727048|P2|STARTED|Overall Study||35
8409552|NCT00960505|20727049|P1|STARTED|Overall Study||34
8409553|NCT00960440|20727082|P4|NOT COMPLETED|Overall Study||18
8409554|NCT00960440|20727083|P3|NOT COMPLETED|Overall Study||13
8409555|NCT00960440|20727084|P2|NOT COMPLETED|Overall Study||31
8409556|NCT00960440|20727085|P1|NOT COMPLETED|Overall Study||26
8409557|NCT00960440|20727082|P4|COMPLETED|Overall Study||48
8409558|NCT00960440|20727083|P3|COMPLETED|Overall Study||53
8409559|NCT00960440|20727084|P2|COMPLETED|Overall Study||103
8409560|NCT00960440|20727085|P1|COMPLETED|Overall Study||107
8409561|NCT00960440|20727082|P4|STARTED|Overall Study||66
8409562|NCT00960440|20727083|P3|STARTED|Overall Study||66
8409563|NCT00960440|20727084|P2|STARTED|Overall Study||134
8409564|NCT00960440|20727085|P1|STARTED|Overall Study||133
8409565|NCT00960375|20727257|P2|NOT COMPLETED|Overall Study||22
8409566|NCT00960375|20727258|P1|NOT COMPLETED|Overall Study||20
8409567|NCT00960375|20727257|P2|COMPLETED|Overall Study||65
8409568|NCT00960375|20727258|P1|COMPLETED|Overall Study||72
8409569|NCT00960375|20727257|P2|STARTED|Overall Study||87
8409570|NCT00960375|20727258|P1|STARTED|Overall Study||92
8409571|NCT00960323|20727266|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
8409572|NCT00960323|20727266|P1|COMPLETED|Colchicine and Atorvastatin||23
8409573|NCT00960323|20727266|P1|STARTED|Colchicine and Atorvastatin||23
8409574|NCT00960323|20727266|P1|NOT COMPLETED|Atorvastatin Alone||1
8409575|NCT00960323|20727266|P1|COMPLETED|Atorvastatin Alone||23
8409576|NCT00960323|20727266|P1|STARTED|Atorvastatin Alone||24
8409577|NCT00960323|20727266|P1|NOT COMPLETED|14 Day Washout Period||0
8409578|NCT00960323|20727266|P1|COMPLETED|14 Day Washout Period||24
8409579|NCT00960323|20727266|P1|STARTED|14 Day Washout Period||24
8409580|NCT00960323|20727266|P1|NOT COMPLETED|Colchicine Alone||0
8409581|NCT00960323|20727266|P1|COMPLETED|Colchicine Alone||24
8409582|NCT00960323|20727266|P1|STARTED|Colchicine Alone||24
8409583|NCT00960297|20727277|P1|NOT COMPLETED|Overall Study||3
8409584|NCT00960297|20727277|P1|COMPLETED|Overall Study||1
8409585|NCT00960297|20727277|P1|STARTED|Overall Study||4
8409586|NCT00960206|20727284|P3|NOT COMPLETED|Overall Study||12
8409587|NCT00960206|20727285|P2|NOT COMPLETED|Overall Study||27
8409588|NCT00960206|20727286|P1|NOT COMPLETED|Overall Study||40
8409589|NCT00960206|20727284|P3|COMPLETED|Overall Study||77
8409590|NCT00960206|20727285|P2|COMPLETED|Overall Study||158
8409591|NCT00960206|20727286|P1|COMPLETED|Overall Study||150
8409592|NCT00960206|20727284|P3|STARTED|Overall Study||89
8409593|NCT00960206|20727285|P2|STARTED|Overall Study||185
8409594|NCT00960206|20727286|P1|STARTED|Overall Study||190
8409595|NCT00960193|20727304|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
8409596|NCT00960193|20727304|P1|COMPLETED|Colchicine With Seville Orange Juice||23
8409597|NCT00960193|20727304|P1|STARTED|Colchicine With Seville Orange Juice||23
8409598|NCT00960193|20727304|P1|NOT COMPLETED|Seville Orange Juice Alone||0
8409599|NCT00960193|20727304|P1|COMPLETED|Seville Orange Juice Alone||23
8409600|NCT00960193|20727304|P1|STARTED|Seville Orange Juice Alone||23
8409601|NCT00960193|20727304|P1|NOT COMPLETED|14 Day Washout Period||1
8409602|NCT00960193|20727304|P1|COMPLETED|14 Day Washout Period||23
8409603|NCT00960193|20727304|P1|STARTED|14 Day Washout Period||24
8409604|NCT00960193|20727304|P1|NOT COMPLETED|Colchicine Alone||0
8409605|NCT00960193|20727304|P1|COMPLETED|Colchicine Alone||24
8409606|NCT00960193|20727304|P1|STARTED|Colchicine Alone||24
8409607|NCT00960154|20727317|P2|NOT COMPLETED|Overall Study||25
8409608|NCT00960154|20727318|P1|NOT COMPLETED|Overall Study||25
8409609|NCT00960154|20727317|P2|COMPLETED|Overall Study||0
8409610|NCT00960154|20727318|P1|COMPLETED|Overall Study||0
8409611|NCT00960154|20727317|P2|STARTED|Overall Study||25
8409612|NCT00960154|20727318|P1|STARTED|Overall Study||25
8409613|NCT00960141|20727329|P3|NOT COMPLETED|Overall Study||7
8409614|NCT00960141|20727330|P2|NOT COMPLETED|Overall Study||17
8409615|NCT00960141|20727331|P1|NOT COMPLETED|Overall Study||10
8409616|NCT00960141|20727329|P3|COMPLETED|Overall Study||163
8409617|NCT00960141|20727330|P2|COMPLETED|Overall Study||309
8409618|NCT00960141|20727331|P1|COMPLETED|Overall Study||323
8409619|NCT00960141|20727329|P3|STARTED|Overall Study||170
8409620|NCT00960141|20727330|P2|STARTED|Overall Study||326
8409621|NCT00960141|20727331|P1|STARTED|Overall Study||333
8409622|NCT00960115|20727356|P2|NOT COMPLETED|Overall Study||15
8409623|NCT00960115|20727357|P1|NOT COMPLETED|Overall Study||19
8409624|NCT00960115|20727356|P2|COMPLETED|Overall Study||43
8409625|NCT00960115|20727357|P1|COMPLETED|Overall Study||95
8409626|NCT00960115|20727356|P2|STARTED|Overall Study||58
8409627|NCT00960115|20727357|P1|STARTED|Overall Study||114
8409628|NCT00960076|20727371|P2|NOT COMPLETED|Overall Study||25
8409629|NCT00960076|20727372|P1|NOT COMPLETED|Overall Study||8
8409630|NCT00960076|20727371|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
8409631|NCT00960076|20727372|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
8409632|NCT00960076|20727371|P2|STARTED|Overall Study|Randomized and treated|144
8409633|NCT00960076|20727372|P1|STARTED|Overall Study|Randomized and treated|138
8409634|NCT00960063|20727387|P3|NOT COMPLETED|Overall Study||3
8409635|NCT00960063|20727388|P2|NOT COMPLETED|Overall Study||0
8409636|NCT00960063|20727389|P1|NOT COMPLETED|Overall Study||1
8409637|NCT00960063|20727387|P3|COMPLETED|Overall Study||0
8409638|NCT00960063|20727388|P2|COMPLETED|Overall Study||0
8409639|NCT00960063|20727389|P1|COMPLETED|Overall Study||0
8409640|NCT00960063|20727387|P3|STARTED|Overall Study||3
8409641|NCT00960063|20727388|P2|STARTED|Overall Study||0
8409642|NCT00960063|20727389|P1|STARTED|Overall Study||1
8409643|NCT00960011|20727429|P2|NOT COMPLETED|Overall Study||2
8409644|NCT00960011|20727430|P1|NOT COMPLETED|Overall Study||11
8409645|NCT00960011|20727429|P2|COMPLETED|Overall Study||23
8409646|NCT00960011|20727430|P1|COMPLETED|Overall Study||22
8409647|NCT00960011|20727429|P2|STARTED|Overall Study||25
8409648|NCT00960011|20727430|P1|STARTED|Overall Study||33
8409649|NCT00959985|20727474|P4|NOT COMPLETED|Overall Study||0
8409650|NCT00959985|20727475|P3|NOT COMPLETED|Overall Study||0
8409651|NCT00959985|20727476|P2|NOT COMPLETED|Overall Study||0
8409652|NCT00959985|20727477|P1|NOT COMPLETED|Overall Study||0
8409653|NCT00959985|20727474|P4|COMPLETED|Overall Study||4
8409654|NCT00959985|20727475|P3|COMPLETED|Overall Study||4
8409655|NCT00959985|20727476|P2|COMPLETED|Overall Study||7
8409656|NCT00959985|20727477|P1|COMPLETED|Overall Study||8
8409657|NCT00959985|20727474|P4|STARTED|Overall Study||4
8409658|NCT00959985|20727475|P3|STARTED|Overall Study||4
8409659|NCT00959985|20727476|P2|STARTED|Overall Study||7
8409660|NCT00959985|20727477|P1|STARTED|Overall Study||8
8409661|NCT00959946|20727523|P8|NOT COMPLETED|Overall Study||2
8409662|NCT00959946|20727524|P7|NOT COMPLETED|Overall Study||2
8409663|NCT00959946|20727525|P6|NOT COMPLETED|Overall Study||9
8409664|NCT00959946|20727526|P5|NOT COMPLETED|Overall Study||4
8409665|NCT00959946|20727527|P4|NOT COMPLETED|Overall Study||5
8409666|NCT00959946|20727528|P3|NOT COMPLETED|Overall Study||4
8409667|NCT00959946|20727529|P2|NOT COMPLETED|Overall Study||4
8409668|NCT00959946|20727530|P1|NOT COMPLETED|Overall Study||2
8409669|NCT00959946|20727523|P8|COMPLETED|Overall Study||0
8409670|NCT00959946|20727524|P7|COMPLETED|Overall Study||0
8409671|NCT00959946|20727525|P6|COMPLETED|Overall Study||0
8409672|NCT00959946|20727526|P5|COMPLETED|Overall Study||0
8409673|NCT00959946|20727527|P4|COMPLETED|Overall Study||0
8409674|NCT00959946|20727528|P3|COMPLETED|Overall Study||0
8409675|NCT00959946|20727529|P2|COMPLETED|Overall Study||0
8409676|NCT00959946|20727530|P1|COMPLETED|Overall Study||0
8409677|NCT00959946|20727523|P8|STARTED|Overall Study||2
8409678|NCT00959946|20727524|P7|STARTED|Overall Study||2
8409679|NCT00959946|20727525|P6|STARTED|Overall Study||9
8409680|NCT00959946|20727526|P5|STARTED|Overall Study||4
8409681|NCT00959946|20727527|P4|STARTED|Overall Study||5
8409682|NCT00959946|20727528|P3|STARTED|Overall Study||4
8409683|NCT00959946|20727529|P2|STARTED|Overall Study||4
8409684|NCT00959946|20727530|P1|STARTED|Overall Study||2
8409685|NCT00959920|20727583|P2|NOT COMPLETED|Overall Study||1
8409686|NCT00959920|20727584|P1|NOT COMPLETED|Overall Study||0
8409687|NCT00959920|20727583|P2|COMPLETED|Overall Study||66
8409688|NCT00959920|20727584|P1|COMPLETED|Overall Study||72
8409689|NCT00959920|20727583|P2|STARTED|Overall Study||67
8409690|NCT00959920|20727584|P1|STARTED|Overall Study||72
8409691|NCT00959907|20727594|P2|NOT COMPLETED|Overall Study||1
8409692|NCT00959907|20727595|P1|NOT COMPLETED|Overall Study||3
8409693|NCT00959907|20727594|P2|COMPLETED|Overall Study||28
8409694|NCT00959907|20727595|P1|COMPLETED|Overall Study||27
8409695|NCT00959907|20727594|P2|STARTED|Overall Study||29
8409696|NCT00959907|20727595|P1|STARTED|Overall Study||30
8409697|NCT00959894|20727605|P1|NOT COMPLETED|Overall Study||16
8409698|NCT00959894|20727605|P1|COMPLETED|Overall Study||63
8409699|NCT00959894|20727605|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
8409700|NCT00959764|20727636|P3|NOT COMPLETED|Overall Study||36
8409701|NCT00959764|20727637|P2|NOT COMPLETED|Overall Study||57
8409702|NCT00959764|20727638|P1|NOT COMPLETED|Overall Study||95
8409703|NCT00959764|20727636|P3|COMPLETED|Overall Study||73
8409704|NCT00959764|20727637|P2|COMPLETED|Overall Study||128
8409705|NCT00959764|20727638|P1|COMPLETED|Overall Study||176
8409706|NCT00959764|20727636|P3|STARTED|Overall Study||109
8409707|NCT00959764|20727637|P2|STARTED|Overall Study||185
8409708|NCT00959764|20727638|P1|STARTED|Overall Study||271
8409709|NCT00959751|20727654|P2|NOT COMPLETED|Overall Study||12
8409710|NCT00959751|20727655|P1|NOT COMPLETED|Overall Study||9
8409711|NCT00959751|20727654|P2|COMPLETED|Overall Study||86
8409712|NCT00959751|20727655|P1|COMPLETED|Overall Study||88
8409713|NCT00959751|20727654|P2|STARTED|Overall Study||98
8409714|NCT00959751|20727655|P1|STARTED|Overall Study||97
8409715|NCT00959699|20727677|P2|NOT COMPLETED|Follow-up Period||6
8409716|NCT00959699|20727678|P1|NOT COMPLETED|Follow-up Period||6
8409717|NCT00959699|20727677|P2|COMPLETED|Follow-up Period||56
8409718|NCT00959699|20727678|P1|COMPLETED|Follow-up Period||27
8409719|NCT00959699|20727677|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
8409720|NCT00959699|20727678|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
8409721|NCT00959699|20727677|P2|NOT COMPLETED|Treatment Period||25
8409722|NCT00959699|20727678|P1|NOT COMPLETED|Treatment Period||23
8409723|NCT00959699|20727677|P2|COMPLETED|Treatment Period||40
8409724|NCT00959699|20727678|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
8409725|NCT00959699|20727677|P2|Treated|Treatment Period||64
8409726|NCT00959699|20727678|P1|Treated|Treatment Period||34
8409727|NCT00959699|20727677|P2|STARTED|Treatment Period||65
8409728|NCT00959699|20727678|P1|STARTED|Treatment Period||34
8409729|NCT00959660|20727699|P4|NOT COMPLETED|Overall Study||3
8409730|NCT00959660|20727700|P3|NOT COMPLETED|Overall Study||3
8409731|NCT00959660|20727701|P2|NOT COMPLETED|Overall Study||0
8409732|NCT00959660|20727702|P1|NOT COMPLETED|Overall Study||2
8409733|NCT00959660|20727699|P4|COMPLETED|Overall Study||22
8409734|NCT00959660|20727700|P3|COMPLETED|Overall Study||22
8409735|NCT00959660|20727701|P2|COMPLETED|Overall Study||24
8409736|NCT00959660|20727702|P1|COMPLETED|Overall Study||24
8409737|NCT00959660|20727699|P4|STARTED|Overall Study||25
8409738|NCT00959660|20727700|P3|STARTED|Overall Study||25
8409739|NCT00959660|20727701|P2|STARTED|Overall Study||24
8409740|NCT00959660|20727702|P1|STARTED|Overall Study||26
8409741|NCT00959647|20727724|P1|NOT COMPLETED|Overall Study||19
8409742|NCT00959647|20727724|P1|COMPLETED|Overall Study||0
8409743|NCT00959647|20727724|P1|STARTED|Overall Study||19
8409744|NCT00959374|20727729|P1|NOT COMPLETED|Overall Study||23
8409745|NCT00959374|20727729|P1|COMPLETED|Overall Study||218
8409746|NCT00959374|20727729|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
8409747|NCT00959192|20727743|P4|NOT COMPLETED|Overall Study||1
8409748|NCT00959192|20727744|P3|NOT COMPLETED|Overall Study||3
8409749|NCT00959192|20727745|P2|NOT COMPLETED|Overall Study||1
8409750|NCT00959192|20727746|P1|NOT COMPLETED|Overall Study||2
8409751|NCT00959192|20727743|P4|COMPLETED|Overall Study||7
8409752|NCT00959192|20727744|P3|COMPLETED|Overall Study||6
8409753|NCT00959192|20727745|P2|COMPLETED|Overall Study||8
8409754|NCT00959192|20727746|P1|COMPLETED|Overall Study||4
8409755|NCT00959192|20727743|P4|STARTED|Overall Study||8
8409756|NCT00959192|20727744|P3|STARTED|Overall Study||9
8409757|NCT00959192|20727745|P2|STARTED|Overall Study||9
8409758|NCT00959192|20727746|P1|STARTED|Overall Study||6
8409759|NCT00959166|20727790|P2|NOT COMPLETED|Overall Study||0
8409760|NCT00959166|20727791|P1|NOT COMPLETED|Overall Study||0
8409761|NCT00959166|20727790|P2|COMPLETED|Overall Study||57
8409762|NCT00959166|20727791|P1|COMPLETED|Overall Study||24
8409763|NCT00959166|20727790|P2|STARTED|Overall Study||57
8409764|NCT00959166|20727791|P1|STARTED|Overall Study||24
8409765|NCT00959049|20727805|P6|NOT COMPLETED|Overall Study||1
8409766|NCT00959049|20727806|P5|NOT COMPLETED|Overall Study||9
8409767|NCT00959049|20727807|P4|NOT COMPLETED|Overall Study||11
8409768|NCT00959049|20727808|P3|NOT COMPLETED|Overall Study||1
8409769|NCT00959049|20727809|P2|NOT COMPLETED|Overall Study||7
8409770|NCT00959049|20727810|P1|NOT COMPLETED|Overall Study||18
8409771|NCT00959049|20727805|P6|COMPLETED|Overall Study||249
8409772|NCT00959049|20727806|P5|COMPLETED|Overall Study||248
8409773|NCT00959049|20727807|P4|COMPLETED|Overall Study||217
8409774|NCT00959049|20727808|P3|COMPLETED|Overall Study||253
8409775|NCT00959049|20727809|P2|COMPLETED|Overall Study||247
8409776|NCT00959049|20727810|P1|COMPLETED|Overall Study||213
8409777|NCT00959049|20727805|P6|STARTED|Overall Study||250
8409778|NCT00959049|20727806|P5|STARTED|Overall Study||257
8409779|NCT00959049|20727807|P4|STARTED|Overall Study||228
8409780|NCT00959049|20727808|P3|STARTED|Overall Study||254
8409781|NCT00959049|20727809|P2|STARTED|Overall Study||254
8409782|NCT00959049|20727810|P1|STARTED|Overall Study||231
8409783|NCT00958919|20727860|P2|NOT COMPLETED|Second Intervention||0
8409784|NCT00958919|20727861|P1|NOT COMPLETED|Second Intervention||0
8409785|NCT00958919|20727860|P2|COMPLETED|Second Intervention||7
8409786|NCT00958919|20727861|P1|COMPLETED|Second Intervention||7
8409787|NCT00958919|20727860|P2|STARTED|Second Intervention||7
8409788|NCT00958919|20727861|P1|STARTED|Second Intervention||7
8409789|NCT00958919|20727860|P2|NOT COMPLETED|First Intervention||0
8409790|NCT00958919|20727861|P1|NOT COMPLETED|First Intervention||0
8409791|NCT00958919|20727860|P2|COMPLETED|First Intervention||7
8409792|NCT00958919|20727861|P1|COMPLETED|First Intervention||7
8409793|NCT00958919|20727860|P2|STARTED|First Intervention||7
8409794|NCT00958919|20727861|P1|STARTED|First Intervention||7
8409795|NCT00958893|20727875|P1|NOT COMPLETED|Overall Study||4
8409796|NCT00958893|20727875|P1|COMPLETED|Overall Study||0
8409797|NCT00958893|20727875|P1|STARTED|Overall Study||4
8409798|NCT00958880|20727881|P2|NOT COMPLETED|Overall Study||2
8409799|NCT00958880|20727882|P1|NOT COMPLETED|Overall Study||2
8409800|NCT00958880|20727881|P2|COMPLETED|Overall Study||18
8409801|NCT00958880|20727882|P1|COMPLETED|Overall Study||18
8409802|NCT00958880|20727881|P2|STARTED|Overall Study||20
8409803|NCT00958880|20727882|P1|STARTED|Overall Study||20
8409804|NCT00958841|20727890|P1|NOT COMPLETED|Overall Study||96
8409805|NCT00958841|20727890|P1|COMPLETED|Overall Study|Completed = Completed extension|22
8409806|NCT00958841|20727890|P1|Entered in Extension|Overall Study||63
8409807|NCT00958841|20727890|P1|Completed Month 6 (M6)|Overall Study||90
8409808|NCT00958841|20727890|P1|STARTED|Overall Study||118
8409809|NCT00958828|20727908|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
8409810|NCT00958828|20727909|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
8409811|NCT00958828|20727908|P2|COMPLETED|Period 2, 1 Week of Wear||87
8409812|NCT00958828|20727909|P1|COMPLETED|Period 2, 1 Week of Wear||89
8409813|NCT00958828|20727908|P2|STARTED|Period 2, 1 Week of Wear||88
8409814|NCT00958828|20727909|P1|STARTED|Period 2, 1 Week of Wear||89
8409815|NCT00958828|20727908|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
8409816|NCT00958828|20727909|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
8409817|NCT00958828|20727908|P2|COMPLETED|Period 1, 1 Week of Wear||88
8409818|NCT00958828|20727909|P1|COMPLETED|Period 1, 1 Week of Wear||89
8409819|NCT00958828|20727908|P2|STARTED|Period 1, 1 Week of Wear||89
8409820|NCT00958828|20727909|P1|STARTED|Period 1, 1 Week of Wear||89
8409821|NCT00958789|20727915|P1|NOT COMPLETED|Overall Study||50
8409822|NCT00958789|20727915|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
8409823|NCT00958789|20727915|P1|STARTED|Overall Study||180
8409824|NCT00958776|20727935|P2|NOT COMPLETED|Overall Study||29
8409825|NCT00958776|20727936|P1|NOT COMPLETED|Overall Study||16
8409826|NCT00958776|20727935|P2|COMPLETED|Overall Study||239
8409827|NCT00958776|20727936|P1|COMPLETED|Overall Study||121
8409828|NCT00958776|20727935|P2|STARTED|Overall Study||268
8409829|NCT00958776|20727936|P1|STARTED|Overall Study||137
8409830|NCT00958724|20727966|P1|NOT COMPLETED|Overall Study||6
8409831|NCT00958724|20727966|P1|COMPLETED|Overall Study||0
8409832|NCT00958724|20727966|P1|STARTED|Overall Study||6
8409833|NCT00958711|20727978|P2|NOT COMPLETED|Overall Study||21
8409834|NCT00958711|20727979|P1|NOT COMPLETED|Overall Study||13
8409835|NCT00958711|20727978|P2|COMPLETED|Overall Study||27
8409836|NCT00958711|20727979|P1|COMPLETED|Overall Study||29
8409837|NCT00958711|20727978|P2|STARTED|Overall Study||48
8409838|NCT00958711|20727979|P1|STARTED|Overall Study||42
8409839|NCT00958581|20728008|P3|NOT COMPLETED|Overall Study||0
8409840|NCT00958581|20728009|P2|NOT COMPLETED|Overall Study||0
8409841|NCT00958581|20728010|P1|NOT COMPLETED|Overall Study||0
8409842|NCT00958581|20728008|P3|COMPLETED|Overall Study||55
8409843|NCT00958581|20728009|P2|COMPLETED|Overall Study||61
8409844|NCT00958581|20728010|P1|COMPLETED|Overall Study||61
8409845|NCT00958581|20728008|P3|STARTED|Overall Study||55
8409846|NCT00958581|20728009|P2|STARTED|Overall Study||61
8409847|NCT00958581|20728010|P1|STARTED|Overall Study||61
8409848|NCT00958568|20728024|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
8409849|NCT00958568|20728025|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
8409850|NCT00958568|20728026|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409851|NCT00958568|20728027|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409852|NCT00958568|20728024|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
8409853|NCT00958568|20728025|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
8409854|NCT00958568|20728026|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409855|NCT00958568|20728027|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409856|NCT00958568|20728024|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
8409857|NCT00958568|20728025|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
8409858|NCT00958568|20728026|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409859|NCT00958568|20728027|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409860|NCT00958568|20728024|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409861|NCT00958568|20728025|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409862|NCT00958568|20728026|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
8409863|NCT00958568|20728027|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409864|NCT00958568|20728024|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409865|NCT00958568|20728025|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409866|NCT00958568|20728026|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
8409867|NCT00958568|20728027|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409868|NCT00958568|20728024|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409869|NCT00958568|20728025|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409870|NCT00958568|20728026|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
8409871|NCT00958568|20728027|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409872|NCT00958568|20728024|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409873|NCT00958568|20728025|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409874|NCT00958568|20728026|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409875|NCT00958568|20728027|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
8409876|NCT00958568|20728024|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409877|NCT00958568|20728025|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409878|NCT00958568|20728026|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409879|NCT00958568|20728027|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
8409880|NCT00958568|20728024|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8409881|NCT00958568|20728025|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8409882|NCT00958568|20728026|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8409883|NCT00958568|20728027|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
8409884|NCT00958477|20728112|P4|NOT COMPLETED|Overall Study||0
8409885|NCT00958477|20728113|P3|NOT COMPLETED|Overall Study||0
8409886|NCT00958477|20728114|P2|NOT COMPLETED|Overall Study||0
8409887|NCT00958477|20728115|P1|NOT COMPLETED|Overall Study||0
8409888|NCT00958477|20728112|P4|COMPLETED|Overall Study||6
8409889|NCT00958477|20728113|P3|COMPLETED|Overall Study||6
8409890|NCT00958477|20728114|P2|COMPLETED|Overall Study||6
8409891|NCT00958477|20728115|P1|COMPLETED|Overall Study||8
8409892|NCT00958477|20728112|P4|STARTED|Overall Study||6
8409893|NCT00958477|20728113|P3|STARTED|Overall Study||6
8409894|NCT00958477|20728114|P2|STARTED|Overall Study||6
8409895|NCT00958477|20728115|P1|STARTED|Overall Study||8
8409896|NCT00958438|20728264|P3|NOT COMPLETED|Overall Study||6
8409897|NCT00958438|20728265|P2|NOT COMPLETED|Overall Study||10
8409898|NCT00958438|20728266|P1|NOT COMPLETED|Overall Study||10
8409899|NCT00958438|20728264|P3|COMPLETED|Overall Study||78
8409900|NCT00958438|20728265|P2|COMPLETED|Overall Study||72
8409901|NCT00958438|20728266|P1|COMPLETED|Overall Study||72
8409902|NCT00958438|20728264|P3|STARTED|Overall Study||84
8409903|NCT00958438|20728265|P2|STARTED|Overall Study||82
8409904|NCT00958438|20728266|P1|STARTED|Overall Study||82
8409905|NCT00958412|20728289|P1|NOT COMPLETED|Overall Study||18
8409906|NCT00958412|20728289|P1|COMPLETED|Overall Study||0
8409907|NCT00958412|20728289|P1|STARTED|Overall Study||18
8409908|NCT00958360|20728295|P2|NOT COMPLETED|Overall Study||10
8409909|NCT00958360|20728296|P1|NOT COMPLETED|Overall Study||11
8409910|NCT00958360|20728295|P2|COMPLETED|Overall Study||150
8409911|NCT00958360|20728296|P1|COMPLETED|Overall Study||152
8409912|NCT00958360|20728295|P2|STARTED|Overall Study||160
8409913|NCT00958360|20728296|P1|STARTED|Overall Study||163
8409914|NCT00958347|20728310|P1|NOT COMPLETED|Overall Study||226
8409915|NCT00958347|20728310|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
8409916|NCT00958347|20728310|P1|STARTED|Overall Study||226
8409917|NCT00958334|20728317|P3|NOT COMPLETED|Overall Study||13
8409918|NCT00958334|20728318|P2|NOT COMPLETED|Overall Study||17
8409919|NCT00958334|20728319|P1|NOT COMPLETED|Overall Study||14
8409920|NCT00958334|20728317|P3|COMPLETED|Overall Study||8
8409921|NCT00958334|20728318|P2|COMPLETED|Overall Study||5
8409922|NCT00958334|20728319|P1|COMPLETED|Overall Study||8
8409923|NCT00958334|20728317|P3|STARTED|Overall Study||21
8409924|NCT00958334|20728318|P2|STARTED|Overall Study||22
8409925|NCT00958334|20728319|P1|STARTED|Overall Study||22
8409926|NCT00958308|20728333|P3|NOT COMPLETED|Overall Study||0
8409927|NCT00958308|20728334|P2|NOT COMPLETED|Overall Study||0
8409928|NCT00958308|20728335|P1|NOT COMPLETED|Overall Study||0
8409929|NCT00958308|20728333|P3|COMPLETED|Overall Study||86
8409930|NCT00958308|20728334|P2|COMPLETED|Overall Study||85
8409931|NCT00958308|20728335|P1|COMPLETED|Overall Study||84
8409932|NCT00958308|20728333|P3|STARTED|Overall Study||86
8409933|NCT00958308|20728334|P2|STARTED|Overall Study||85
8409934|NCT00958308|20728335|P1|STARTED|Overall Study||84
8409935|NCT00958282|20728345|P2|NOT COMPLETED|Overall Study||6
8409936|NCT00958282|20728346|P1|NOT COMPLETED|Overall Study||10
8409937|NCT00958282|20728345|P2|COMPLETED|Overall Study||15
8409938|NCT00958282|20728346|P1|COMPLETED|Overall Study||12
8409939|NCT00958282|20728345|P2|STARTED|Overall Study||21
8409940|NCT00958282|20728346|P1|STARTED|Overall Study||22
8409941|NCT00958256|20728354|P1|NOT COMPLETED|Overall Study||3
8409942|NCT00958256|20728354|P1|COMPLETED|Overall Study||18
8409943|NCT00958256|20728354|P1|STARTED|Overall Study||21
8409944|NCT00958243|20728364|P6|NOT COMPLETED|Overall Study||10
8409945|NCT00958243|20728365|P5|NOT COMPLETED|Overall Study||9
8409946|NCT00958243|20728366|P4|NOT COMPLETED|Overall Study||3
8409947|NCT00958243|20728367|P3|NOT COMPLETED|Overall Study||14
8409948|NCT00958243|20728368|P2|NOT COMPLETED|Overall Study||6
8409949|NCT00958243|20728369|P1|NOT COMPLETED|Overall Study||2
8409950|NCT00958243|20728364|P6|COMPLETED|Overall Study||99
8409951|NCT00958243|20728365|P5|COMPLETED|Overall Study||100
8409952|NCT00958243|20728366|P4|COMPLETED|Overall Study||25
8409953|NCT00958243|20728367|P3|COMPLETED|Overall Study||82
8409954|NCT00958243|20728368|P2|COMPLETED|Overall Study||99
8409955|NCT00958243|20728369|P1|COMPLETED|Overall Study||24
8409956|NCT00958243|20728364|P6|STARTED|Overall Study||109
8409957|NCT00958243|20728365|P5|STARTED|Overall Study||109
8409958|NCT00958243|20728366|P4|STARTED|Overall Study||28
8409959|NCT00958243|20728367|P3|STARTED|Overall Study||96
8409960|NCT00958243|20728368|P2|STARTED|Overall Study||105
8409961|NCT00958243|20728369|P1|STARTED|Overall Study||26
8409962|NCT00958217|20728427|P2|NOT COMPLETED|Overall Study||25
8409963|NCT00958217|20728428|P1|NOT COMPLETED|Overall Study||24
8409964|NCT00958217|20728427|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
8409965|NCT00958217|20728428|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
8409966|NCT00958217|20728427|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
8409967|NCT00958217|20728428|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
8409968|NCT00958217|20728427|P2|STARTED|Overall Study||62
8409969|NCT00958217|20728428|P1|STARTED|Overall Study||61
8409970|NCT00958191|20728439|P1|NOT COMPLETED|Overall Study||111
8409971|NCT00958191|20728439|P1|COMPLETED|Overall Study||110
8409972|NCT00958191|20728439|P1|STARTED|Overall Study||221
8409973|NCT00958165|20728454|P1|NOT COMPLETED|Overall Study||14
8409974|NCT00958165|20728454|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
8409975|NCT00958165|20728454|P1|Treated|Overall Study||72
8409976|NCT00958165|20728454|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
8409977|NCT00958126|20728466|P8|NOT COMPLETED|Overall Study||0
8409978|NCT00958126|20728467|P7|NOT COMPLETED|Overall Study||1
8409979|NCT00958126|20728468|P6|NOT COMPLETED|Overall Study||1
8409980|NCT00958126|20728469|P5|NOT COMPLETED|Overall Study||0
8409981|NCT00958126|20728470|P4|NOT COMPLETED|Overall Study||11
8409982|NCT00958126|20728471|P3|NOT COMPLETED|Overall Study||10
8409983|NCT00958126|20728472|P2|NOT COMPLETED|Overall Study||9
8409984|NCT00958126|20728473|P1|NOT COMPLETED|Overall Study||1
8409985|NCT00958126|20728466|P8|COMPLETED|Overall Study||202
8409986|NCT00958126|20728467|P7|COMPLETED|Overall Study||199
8409987|NCT00958126|20728468|P6|COMPLETED|Overall Study||202
8409988|NCT00958126|20728469|P5|COMPLETED|Overall Study||50
8409989|NCT00958126|20728470|P4|COMPLETED|Overall Study||192
8409990|NCT00958126|20728471|P3|COMPLETED|Overall Study||191
8409991|NCT00958126|20728472|P2|COMPLETED|Overall Study||196
8409992|NCT00958126|20728473|P1|COMPLETED|Overall Study||48
8409993|NCT00958126|20728466|P8|STARTED|Overall Study||202
8409994|NCT00958126|20728467|P7|STARTED|Overall Study||200
8409995|NCT00958126|20728468|P6|STARTED|Overall Study||203
8409996|NCT00958126|20728469|P5|STARTED|Overall Study||50
8409997|NCT00958126|20728470|P4|STARTED|Overall Study||203
8409998|NCT00958126|20728471|P3|STARTED|Overall Study||201
8409999|NCT00958126|20728472|P2|STARTED|Overall Study||205
8410000|NCT00958126|20728473|P1|STARTED|Overall Study||49
8410001|NCT00958074|20728545|P2|NOT COMPLETED|Overall Study||1
8410002|NCT00958074|20728546|P1|NOT COMPLETED|Overall Study||0
8410003|NCT00958074|20728545|P2|COMPLETED|Overall Study||6
8410004|NCT00958074|20728546|P1|COMPLETED|Overall Study||4
8410005|NCT00958074|20728545|P2|STARTED|Overall Study||7
8410006|NCT00958074|20728546|P1|STARTED|Overall Study||4
8410007|NCT00958035|20728562|P2|NOT COMPLETED|Overall Study||4
8410008|NCT00958035|20728563|P1|NOT COMPLETED|Overall Study||3
8410009|NCT00958035|20728562|P2|COMPLETED|Overall Study||39
8410010|NCT00958035|20728563|P1|COMPLETED|Overall Study||43
8410011|NCT00958035|20728562|P2|STARTED|Overall Study||43
8410012|NCT00958035|20728563|P1|STARTED|Overall Study||46
8410013|NCT00958009|20728569|P1|NOT COMPLETED|Overall Study||2
8410014|NCT00958009|20728569|P1|COMPLETED|Overall Study||107
8410015|NCT00958009|20728569|P1|STARTED|Overall Study||109
8410016|NCT00957996|20728576|P2|NOT COMPLETED|Overall Study||28
8410017|NCT00957996|20728577|P1|NOT COMPLETED|Overall Study||26
8410018|NCT00957996|20728576|P2|COMPLETED|Overall Study||89
8410019|NCT00957996|20728577|P1|COMPLETED|Overall Study||91
8410020|NCT00957996|20728576|P2|STARTED|Overall Study||117
8410021|NCT00957996|20728577|P1|STARTED|Overall Study||117
8410022|NCT00957944|20728609|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
8410023|NCT00957944|20728610|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
8410024|NCT00957944|20728609|P2|COMPLETED|Second Intervention- 24 Hours||19
8410025|NCT00957944|20728610|P1|COMPLETED|Second Intervention- 24 Hours||20
8410026|NCT00957944|20728609|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
8410027|NCT00957944|20728610|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
8410028|NCT00957944|20728609|P2|STARTED|Second Intervention- 24 Hours||19
8410029|NCT00957944|20728610|P1|STARTED|Second Intervention- 24 Hours||20
8410030|NCT00957944|20728609|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
8410031|NCT00957944|20728610|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
8410032|NCT00957944|20728609|P2|COMPLETED|Washout Period of at Least 5 Days||19
8410033|NCT00957944|20728610|P1|COMPLETED|Washout Period of at Least 5 Days||20
8410034|NCT00957944|20728609|P2|STARTED|Washout Period of at Least 5 Days||19
8410035|NCT00957944|20728610|P1|STARTED|Washout Period of at Least 5 Days||20
8410036|NCT00957944|20728609|P2|NOT COMPLETED|First Intervention- 24 Hours||1
8410037|NCT00957944|20728610|P1|NOT COMPLETED|First Intervention- 24 Hours||0
8410038|NCT00957944|20728609|P2|COMPLETED|First Intervention- 24 Hours||19
8410039|NCT00957944|20728610|P1|COMPLETED|First Intervention- 24 Hours||20
8410040|NCT00957944|20728609|P2|STARTED|First Intervention- 24 Hours||20
8410041|NCT00957944|20728610|P1|STARTED|First Intervention- 24 Hours||20
8410042|NCT00957931|20728644|P1|NOT COMPLETED|Overall Study||4
8410043|NCT00957931|20728644|P1|COMPLETED|Overall Study||2
8410044|NCT00957931|20728644|P1|STARTED|Overall Study||6
8410045|NCT00957905|20728654|P2|NOT COMPLETED|Part B||4
8410046|NCT00957905|20728655|P1|NOT COMPLETED|Part B||0
8410047|NCT00957905|20728654|P2|COMPLETED|Part B||25
8410048|NCT00957905|20728655|P1|COMPLETED|Part B||0
8410049|NCT00957905|20728654|P2|STARTED|Part B||29
8410050|NCT00957905|20728655|P1|STARTED|Part B||0
8410051|NCT00957905|20728654|P2|NOT COMPLETED|Part A||0
8410052|NCT00957905|20728655|P1|NOT COMPLETED|Part A||0
8410053|NCT00957905|20728654|P2|COMPLETED|Part A||0
8410054|NCT00957905|20728655|P1|COMPLETED|Part A||7
8410055|NCT00957905|20728654|P2|STARTED|Part A||0
8410056|NCT00957905|20728655|P1|STARTED|Part A||7
8410057|NCT00957853|20728664|P3|NOT COMPLETED|Overall Study||0
8410058|NCT00957853|20728665|P2|NOT COMPLETED|Overall Study||0
8410059|NCT00957853|20728666|P1|NOT COMPLETED|Overall Study||1
8410060|NCT00957853|20728664|P3|COMPLETED|Overall Study||5
8410061|NCT00957853|20728665|P2|COMPLETED|Overall Study||6
8410062|NCT00957853|20728666|P1|COMPLETED|Overall Study||3
8410063|NCT00957853|20728664|P3|Neoadjuvant Tx Completion|Overall Study||5
8410064|NCT00957853|20728665|P2|Neoadjuvant Tx Completion|Overall Study||6
8410065|NCT00957853|20728666|P1|Neoadjuvant Tx Completion|Overall Study||3
8410066|NCT00957853|20728664|P3|Randomization|Overall Study||5
8410067|NCT00957853|20728665|P2|Randomization|Overall Study||6
8410068|NCT00957853|20728666|P1|Randomization|Overall Study||4
8410069|NCT00957853|20728664|P3|STARTED|Overall Study||5
8410070|NCT00957853|20728665|P2|STARTED|Overall Study||6
8410071|NCT00957853|20728666|P1|STARTED|Overall Study||4
8410072|NCT00957827|20728679|P2|NOT COMPLETED|Overall Study||0
8410073|NCT00957827|20728680|P1|NOT COMPLETED|Overall Study||0
8410074|NCT00957827|20728679|P2|COMPLETED|Overall Study||2
8410075|NCT00957827|20728680|P1|COMPLETED|Overall Study||2
8410076|NCT00957827|20728679|P2|STARTED|Overall Study||2
8410077|NCT00957827|20728680|P1|STARTED|Overall Study||2
8410078|NCT00957801|20728690|P4|NOT COMPLETED|Overall Study||1
8410079|NCT00957801|20728691|P3|NOT COMPLETED|Overall Study||0
8410080|NCT00957801|20728692|P2|NOT COMPLETED|Overall Study||0
8410081|NCT00957801|20728693|P1|NOT COMPLETED|Overall Study||0
8410082|NCT00957801|20728690|P4|COMPLETED|Overall Study||7
8410083|NCT00957801|20728691|P3|COMPLETED|Overall Study||7
8410084|NCT00957801|20728692|P2|COMPLETED|Overall Study||7
8410085|NCT00957801|20728693|P1|COMPLETED|Overall Study||7
8410086|NCT00957801|20728690|P4|STARTED|Overall Study||8
8410087|NCT00957801|20728691|P3|STARTED|Overall Study||7
8410088|NCT00957801|20728692|P2|STARTED|Overall Study||7
8410089|NCT00957801|20728693|P1|STARTED|Overall Study||7
8410090|NCT00957723|20728859|P1|NOT COMPLETED|Overall Study||113
8410091|NCT00957723|20728859|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
8410092|NCT00957723|20728859|P1|STARTED|Overall Study||411
8410093|NCT00957684|20728877|P5|NOT COMPLETED|PART II||75
8410094|NCT00957684|20728878|P4|NOT COMPLETED|PART II||0
8410095|NCT00957684|20728879|P3|NOT COMPLETED|PART II||0
8410096|NCT00957684|20728880|P2|NOT COMPLETED|PART II||0
8410097|NCT00957684|20728881|P1|NOT COMPLETED|PART II||0
8410098|NCT00957684|20728877|P5|COMPLETED|PART II||239
8410099|NCT00957684|20728878|P4|COMPLETED|PART II||0
8410100|NCT00957684|20728879|P3|COMPLETED|PART II||0
8410101|NCT00957684|20728880|P2|COMPLETED|PART II||0
8410102|NCT00957684|20728881|P1|COMPLETED|PART II||0
8410103|NCT00957684|20728877|P5|Patients Entered Part II|PART II||314
8410104|NCT00957684|20728878|P4|Patients Entered Part II|PART II||0
8410105|NCT00957684|20728879|P3|Patients Entered Part II|PART II||0
8410106|NCT00957684|20728880|P2|Patients Entered Part II|PART II||0
8410107|NCT00957684|20728881|P1|Patients Entered Part II|PART II||0
8410108|NCT00957684|20728877|P5|STARTED|PART II||314
8410109|NCT00957684|20728878|P4|STARTED|PART II||0
8410110|NCT00957684|20728879|P3|STARTED|PART II||0
8410111|NCT00957684|20728880|P2|STARTED|PART II||0
8410112|NCT00957684|20728881|P1|STARTED|PART II||0
8410113|NCT00957684|20728877|P5|NOT COMPLETED|PART I||0
8410114|NCT00957684|20728878|P4|NOT COMPLETED|PART I||18
8410115|NCT00957684|20728879|P3|NOT COMPLETED|PART I||10
8410116|NCT00957684|20728880|P2|NOT COMPLETED|PART I||13
8410117|NCT00957684|20728881|P1|NOT COMPLETED|PART I||31
8410118|NCT00957684|20728877|P5|COMPLETED|PART I||0
8410119|NCT00957684|20728878|P4|COMPLETED|PART I||84
8410120|NCT00957684|20728879|P3|COMPLETED|PART I||90
8410121|NCT00957684|20728880|P2|COMPLETED|PART I||85
8410122|NCT00957684|20728881|P1|COMPLETED|PART I||71
8410123|NCT00957684|20728877|P5|Per-protocol (PP)Population|PART I||0
8410124|NCT00957684|20728878|P4|Per-protocol (PP)Population|PART I||91
8410125|NCT00957684|20728879|P3|Per-protocol (PP)Population|PART I||94
8410126|NCT00957684|20728880|P2|Per-protocol (PP)Population|PART I||86
8410127|NCT00957684|20728881|P1|Per-protocol (PP)Population|PART I||72
8410128|NCT00957684|20728877|P5|Intention-to-treat (ITT) Population|PART I||0
8410129|NCT00957684|20728878|P4|Intention-to-treat (ITT) Population|PART I||102
8410130|NCT00957684|20728879|P3|Intention-to-treat (ITT) Population|PART I||99
8410131|NCT00957684|20728880|P2|Intention-to-treat (ITT) Population|PART I||98
8410132|NCT00957684|20728881|P1|Intention-to-treat (ITT) Population|PART I||98
8410133|NCT00957684|20728877|P5|Randomised (Safety Population)|PART I||0
8410134|NCT00957684|20728878|P4|Randomised (Safety Population)|PART I||102
8410135|NCT00957684|20728879|P3|Randomised (Safety Population)|PART I||100
8410136|NCT00957684|20728880|P2|Randomised (Safety Population)|PART I||98
8410137|NCT00957684|20728881|P1|Randomised (Safety Population)|PART I||102
8410138|NCT00957684|20728877|P5|STARTED|PART I||0
8410139|NCT00957684|20728878|P4|STARTED|PART I||102
8410140|NCT00957684|20728879|P3|STARTED|PART I||100
8410141|NCT00957684|20728880|P2|STARTED|PART I||98
8410142|NCT00957684|20728881|P1|STARTED|PART I||102
8410143|NCT00957671|20728891|P1|NOT COMPLETED|Overall Study||0
8410144|NCT00957671|20728891|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
8410145|NCT00957671|20728891|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
8410146|NCT00957658|20728948|P1|NOT COMPLETED|Overall Study||65
8410147|NCT00957658|20728948|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
8410148|NCT00957658|20728948|P1|STARTED|Overall Study||234
8410149|NCT00957593|20728963|P2|NOT COMPLETED|Overall Study||0
8410150|NCT00957593|20728964|P1|NOT COMPLETED|Overall Study||0
8410151|NCT00957593|20728963|P2|COMPLETED|Overall Study||125
8410152|NCT00957593|20728964|P1|COMPLETED|Overall Study||127
8410153|NCT00957593|20728963|P2|STARTED|Overall Study||125
8410154|NCT00957593|20728964|P1|STARTED|Overall Study||127
8410155|NCT00957580|20728975|P3|NOT COMPLETED|Overall Study||0
8410156|NCT00957580|20728976|P2|NOT COMPLETED|Overall Study||2
8410157|NCT00957580|20728977|P1|NOT COMPLETED|Overall Study||0
8410158|NCT00957580|20728975|P3|COMPLETED|Overall Study||15
8410159|NCT00957580|20728976|P2|COMPLETED|Overall Study||31
8410160|NCT00957580|20728977|P1|COMPLETED|Overall Study||33
8410161|NCT00957580|20728975|P3|Treated|Overall Study||15
8410162|NCT00957580|20728976|P2|Treated|Overall Study||32
8410163|NCT00957580|20728977|P1|Treated|Overall Study||33
8410164|NCT00957580|20728975|P3|STARTED|Overall Study||15
8410165|NCT00957580|20728976|P2|STARTED|Overall Study||33
8410166|NCT00957580|20728977|P1|STARTED|Overall Study||33
8410167|NCT00957528|20729124|P3|NOT COMPLETED|Overall Study||1
8410168|NCT00957528|20729125|P2|NOT COMPLETED|Overall Study||1
8410169|NCT00957528|20729126|P1|NOT COMPLETED|Overall Study||0
8410170|NCT00957528|20729124|P3|COMPLETED|Overall Study||8
8410171|NCT00957528|20729125|P2|COMPLETED|Overall Study||8
8410172|NCT00957528|20729126|P1|COMPLETED|Overall Study||8
8410173|NCT00957528|20729124|P3|STARTED|Overall Study||9
8410174|NCT00957528|20729125|P2|STARTED|Overall Study||9
8410175|NCT00957528|20729126|P1|STARTED|Overall Study||8
8410176|NCT00957424|20729149|P1|NOT COMPLETED|Overall Study||23
8410177|NCT00957424|20729149|P1|COMPLETED|Overall Study||44
8410178|NCT00957424|20729149|P1|Follow-up #2|Overall Study||50
8410179|NCT00957424|20729149|P1|Follow-up #1|Overall Study||59
8410180|NCT00957424|20729149|P1|STARTED|Overall Study||67
8410181|NCT00957372|20729159|P4|NOT COMPLETED|PART II||44
8410182|NCT00957372|20729160|P3|NOT COMPLETED|PART II||0
8410183|NCT00957372|20729161|P2|NOT COMPLETED|PART II||0
8410184|NCT00957372|20729162|P1|NOT COMPLETED|PART II||0
8410185|NCT00957372|20729159|P4|COMPLETED|PART II||150
8410186|NCT00957372|20729160|P3|COMPLETED|PART II||0
8410187|NCT00957372|20729161|P2|COMPLETED|PART II||0
8410188|NCT00957372|20729162|P1|COMPLETED|PART II||0
8410189|NCT00957372|20729159|P4|Per-Protocol Population|PART II||108
8410190|NCT00957372|20729160|P3|Per-Protocol Population|PART II||0
8410191|NCT00957372|20729161|P2|Per-Protocol Population|PART II||0
8410192|NCT00957372|20729162|P1|Per-Protocol Population|PART II||0
8410193|NCT00957372|20729159|P4|Intention-to-treat (ITT) Population|PART II||191
8410194|NCT00957372|20729160|P3|Intention-to-treat (ITT) Population|PART II||0
8410195|NCT00957372|20729161|P2|Intention-to-treat (ITT) Population|PART II||0
8410196|NCT00957372|20729162|P1|Intention-to-treat (ITT) Population|PART II||0
8410197|NCT00957372|20729159|P4|Safety Population|PART II||194
8410198|NCT00957372|20729160|P3|Safety Population|PART II||0
8410199|NCT00957372|20729161|P2|Safety Population|PART II||0
8410200|NCT00957372|20729162|P1|Safety Population|PART II||0
8410201|NCT00957372|20729159|P4|STARTED|PART II||194
8410202|NCT00957372|20729160|P3|STARTED|PART II||0
8410203|NCT00957372|20729161|P2|STARTED|PART II||0
8410204|NCT00957372|20729162|P1|STARTED|PART II||0
8410205|NCT00957372|20729159|P4|NOT COMPLETED|PART I||0
8410206|NCT00957372|20729160|P3|NOT COMPLETED|PART I||1
8410207|NCT00957372|20729161|P2|NOT COMPLETED|PART I||0
8410208|NCT00957372|20729162|P1|NOT COMPLETED|PART I||0
8410209|NCT00957372|20729159|P4|COMPLETED|PART I||0
8410210|NCT00957372|20729160|P3|COMPLETED|PART I||87
8410211|NCT00957372|20729161|P2|COMPLETED|PART I||85
8410212|NCT00957372|20729162|P1|COMPLETED|PART I||80
8410213|NCT00957372|20729159|P4|Randomized But Not Treated|PART I||0
8410214|NCT00957372|20729160|P3|Randomized But Not Treated|PART I||1
8410215|NCT00957372|20729161|P2|Randomized But Not Treated|PART I||0
8410216|NCT00957372|20729162|P1|Randomized But Not Treated|PART I||0
8410217|NCT00957372|20729159|P4|Per-Protocol Population|PART I||0
8410218|NCT00957372|20729160|P3|Per-Protocol Population|PART I||51
8410219|NCT00957372|20729161|P2|Per-Protocol Population|PART I||47
8410220|NCT00957372|20729162|P1|Per-Protocol Population|PART I||35
8410221|NCT00957372|20729159|P4|Intention-to-Treat Population|PART I||0
8410222|NCT00957372|20729160|P3|Intention-to-Treat Population|PART I||84
8410223|NCT00957372|20729161|P2|Intention-to-Treat Population|PART I||84
8410224|NCT00957372|20729162|P1|Intention-to-Treat Population|PART I||77
8410225|NCT00957372|20729159|P4|Safety Population|PART I||0
8410226|NCT00957372|20729160|P3|Safety Population|PART I||87
8410227|NCT00957372|20729161|P2|Safety Population|PART I||85
8410228|NCT00957372|20729162|P1|Safety Population|PART I||80
8410229|NCT00957372|20729159|P4|STARTED|PART I||0
8410230|NCT00957372|20729160|P3|STARTED|PART I||88
8410231|NCT00957372|20729161|P2|STARTED|PART I||85
8410232|NCT00957372|20729162|P1|STARTED|PART I||80
8410233|NCT00957359|20729180|P2|NOT COMPLETED|Overall Study||0
8410234|NCT00957359|20729181|P1|NOT COMPLETED|Overall Study||0
8410235|NCT00957359|20729180|P2|COMPLETED|Overall Study||15
8410236|NCT00957359|20729181|P1|COMPLETED|Overall Study||14
8410237|NCT00957359|20729180|P2|STARTED|Overall Study||15
8410238|NCT00957359|20729181|P1|STARTED|Overall Study||14
8410239|NCT00957333|20729293|P1|NOT COMPLETED|Overall Study||0
8410240|NCT00957333|20729293|P1|COMPLETED|Overall Study||44
8410241|NCT00957333|20729293|P1|STARTED|Overall Study||44
8410242|NCT00957268|20729302|P5|NOT COMPLETED|Overall Study||0
8410243|NCT00957268|20729303|P4|NOT COMPLETED|Overall Study||0
8410244|NCT00957268|20729304|P3|NOT COMPLETED|Overall Study||1
8410245|NCT00957268|20729305|P2|NOT COMPLETED|Overall Study||0
8410246|NCT00957268|20729306|P1|NOT COMPLETED|Overall Study||0
8410247|NCT00957268|20729302|P5|COMPLETED|Overall Study||22
8410248|NCT00957268|20729303|P4|COMPLETED|Overall Study||7
8410249|NCT00957268|20729304|P3|COMPLETED|Overall Study||7
8410250|NCT00957268|20729305|P2|COMPLETED|Overall Study||4
8410251|NCT00957268|20729306|P1|COMPLETED|Overall Study||5
8410252|NCT00957268|20729302|P5|STARTED|Overall Study||22
8410253|NCT00957268|20729303|P4|STARTED|Overall Study||7
8410254|NCT00957268|20729304|P3|STARTED|Overall Study||8
8410255|NCT00957268|20729305|P2|STARTED|Overall Study||4
8410256|NCT00957268|20729306|P1|STARTED|Overall Study||5
8410257|NCT00957242|20729370|P2|NOT COMPLETED|Overall Study||0
8410258|NCT00957242|20729371|P1|NOT COMPLETED|Overall Study||0
8410259|NCT00957242|20729370|P2|COMPLETED|Overall Study||72
8410260|NCT00957242|20729371|P1|COMPLETED|Overall Study||73
8410261|NCT00957242|20729370|P2|STARTED|Overall Study||72
8410262|NCT00957242|20729371|P1|STARTED|Overall Study||73
8410263|NCT00957229|20729401|P2|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
8410264|NCT00957229|20729402|P1|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
8410265|NCT00957229|20729401|P2|COMPLETED|Reallocated to or Continued Vismodegib||21
8410266|NCT00957229|20729402|P1|COMPLETED|Reallocated to or Continued Vismodegib||11
8410267|NCT00957229|20729401|P2|STARTED|Reallocated to or Continued Vismodegib||23
8410268|NCT00957229|20729402|P1|STARTED|Reallocated to or Continued Vismodegib||14
8410269|NCT00957229|20729401|P2|NOT COMPLETED|Study Start||3
8410270|NCT00957229|20729402|P1|NOT COMPLETED|Study Start||1
8410271|NCT00957229|20729401|P2|COMPLETED|Study Start||23
8410272|NCT00957229|20729402|P1|COMPLETED|Study Start||14
8410273|NCT00957229|20729401|P2|STARTED|Study Start||26
8410274|NCT00957229|20729402|P1|STARTED|Study Start||15
8410275|NCT00957047|20729416|P5|NOT COMPLETED|PART II||102
8410276|NCT00957047|20729417|P4|NOT COMPLETED|PART II||0
8410277|NCT00957047|20729418|P3|NOT COMPLETED|PART II||0
8410278|NCT00957047|20729419|P2|NOT COMPLETED|PART II||0
8410279|NCT00957047|20729420|P1|NOT COMPLETED|PART II||0
8410280|NCT00957047|20729416|P5|COMPLETED|PART II||223
8410281|NCT00957047|20729417|P4|COMPLETED|PART II||0
8410282|NCT00957047|20729418|P3|COMPLETED|PART II||0
8410283|NCT00957047|20729419|P2|COMPLETED|PART II||0
8410284|NCT00957047|20729420|P1|COMPLETED|PART II||0
8410285|NCT00957047|20729416|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
8410286|NCT00957047|20729417|P4|Terminated Prematurely|PART II||0
8410287|NCT00957047|20729418|P3|Terminated Prematurely|PART II||0
8410288|NCT00957047|20729419|P2|Terminated Prematurely|PART II||0
8410289|NCT00957047|20729420|P1|Terminated Prematurely|PART II||0
8410290|NCT00957047|20729416|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
8410291|NCT00957047|20729417|P4|STARTED|PART II||0
8410292|NCT00957047|20729418|P3|STARTED|PART II||0
8410293|NCT00957047|20729419|P2|STARTED|PART II||0
8410294|NCT00957047|20729420|P1|STARTED|PART II||0
8410295|NCT00957047|20729416|P5|NOT COMPLETED|PART I||0
8410296|NCT00957047|20729417|P4|NOT COMPLETED|PART I||30
8410297|NCT00957047|20729418|P3|NOT COMPLETED|PART I||21
8410298|NCT00957047|20729419|P2|NOT COMPLETED|PART I||13
8410299|NCT00957047|20729420|P1|NOT COMPLETED|PART I||6
8410300|NCT00957047|20729416|P5|COMPLETED|PART I||0
8410301|NCT00957047|20729417|P4|COMPLETED|PART I||68
8410302|NCT00957047|20729418|P3|COMPLETED|PART I||80
8410303|NCT00957047|20729419|P2|COMPLETED|PART I||83
8410304|NCT00957047|20729420|P1|COMPLETED|PART I||94
8410305|NCT00957047|20729416|P5|Per-Protocol Population|PART I||0
8410306|NCT00957047|20729417|P4|Per-Protocol Population|PART I||54
8410307|NCT00957047|20729418|P3|Per-Protocol Population|PART I||75
8410308|NCT00957047|20729419|P2|Per-Protocol Population|PART I||70
8410309|NCT00957047|20729420|P1|Per-Protocol Population|PART I||81
8410310|NCT00957047|20729416|P5|Intention-to-treat (ITT) Population|PART I||0
8410311|NCT00957047|20729417|P4|Intention-to-treat (ITT) Population|PART I||97
8410312|NCT00957047|20729418|P3|Intention-to-treat (ITT) Population|PART I||100
8410313|NCT00957047|20729419|P2|Intention-to-treat (ITT) Population|PART I||96
8410314|NCT00957047|20729420|P1|Intention-to-treat (ITT) Population|PART I||100
8410315|NCT00957047|20729416|P5|Randomized/Safety Population|PART I||0
8410316|NCT00957047|20729417|P4|Randomized/Safety Population|PART I||98
8410317|NCT00957047|20729418|P3|Randomized/Safety Population|PART I||101
8410318|NCT00957047|20729419|P2|Randomized/Safety Population|PART I||96
8410319|NCT00957047|20729420|P1|Randomized/Safety Population|PART I||100
8410320|NCT00957047|20729416|P5|STARTED|PART I||0
8410321|NCT00957047|20729417|P4|STARTED|PART I||98
8410322|NCT00957047|20729418|P3|STARTED|PART I||101
8410323|NCT00957047|20729419|P2|STARTED|PART I||96
8410324|NCT00957047|20729420|P1|STARTED|PART I||100
8410325|NCT00957034|20729441|P3|NOT COMPLETED|Overall Study||6
8410326|NCT00957034|20729442|P2|NOT COMPLETED|Overall Study||4
8410327|NCT00957034|20729443|P1|NOT COMPLETED|Overall Study||6
8410328|NCT00957034|20729441|P3|COMPLETED|Overall Study||1
8410329|NCT00957034|20729442|P2|COMPLETED|Overall Study||0
8410330|NCT00957034|20729443|P1|COMPLETED|Overall Study||0
8410331|NCT00957034|20729441|P3|STARTED|Overall Study||7
8410332|NCT00957034|20729442|P2|STARTED|Overall Study||4
8410333|NCT00957034|20729443|P1|STARTED|Overall Study||6
8410334|NCT00957021|20729466|P1|NOT COMPLETED|Overall Study||117
8410335|NCT00957021|20729466|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
8410336|NCT00957021|20729466|P1|STARTED|Overall Study||354
8410337|NCT00957008|20729479|P4|NOT COMPLETED|Overall Study||24
8410338|NCT00957008|20729480|P3|NOT COMPLETED|Overall Study||17
8410339|NCT00957008|20729481|P2|NOT COMPLETED|Overall Study||12
8410340|NCT00957008|20729482|P1|NOT COMPLETED|Overall Study||21
8410341|NCT00957008|20729479|P4|COMPLETED|Overall Study||26
8410342|NCT00957008|20729480|P3|COMPLETED|Overall Study||32
8410343|NCT00957008|20729481|P2|COMPLETED|Overall Study||37
8410344|NCT00957008|20729482|P1|COMPLETED|Overall Study||28
8410345|NCT00957008|20729479|P4|STARTED|Overall Study||50
8410346|NCT00957008|20729480|P3|STARTED|Overall Study||49
8410347|NCT00957008|20729481|P2|STARTED|Overall Study||49
8410348|NCT00957008|20729482|P1|STARTED|Overall Study||49
8410349|NCT00956943|20729510|P2|NOT COMPLETED|Overall Study||10
8410350|NCT00956943|20729511|P1|NOT COMPLETED|Overall Study||9
8410351|NCT00956943|20729510|P2|COMPLETED|Overall Study||34
8410352|NCT00956943|20729511|P1|COMPLETED|Overall Study||34
8410353|NCT00956943|20729510|P2|Baseline|Overall Study||44
8410354|NCT00956943|20729511|P1|Baseline|Overall Study||43
8410355|NCT00956943|20729510|P2|STARTED|Overall Study||44
8410356|NCT00956943|20729511|P1|STARTED|Overall Study||43
8410357|NCT00956930|20729521|P2|NOT COMPLETED|Overall Study||0
8410358|NCT00956930|20729522|P1|NOT COMPLETED|Overall Study||0
8410359|NCT00956930|20729521|P2|COMPLETED|Overall Study||21
8410360|NCT00956930|20729522|P1|COMPLETED|Overall Study||24
8410361|NCT00956930|20729521|P2|STARTED|Overall Study||21
8410362|NCT00956930|20729522|P1|STARTED|Overall Study||24
8410363|NCT00956839|20729535|P3|NOT COMPLETED|Overall Study||3
8410364|NCT00956839|20729536|P2|NOT COMPLETED|Overall Study||0
8410365|NCT00956839|20729537|P1|NOT COMPLETED|Overall Study||3
8410366|NCT00956839|20729535|P3|COMPLETED|Overall Study||10
8410367|NCT00956839|20729536|P2|COMPLETED|Overall Study||13
8410368|NCT00956839|20729537|P1|COMPLETED|Overall Study||11
8410369|NCT00956839|20729535|P3|STARTED|Overall Study||13
8410370|NCT00956839|20729536|P2|STARTED|Overall Study||13
8410371|NCT00956839|20729537|P1|STARTED|Overall Study||14
8410372|NCT00956813|20729550|P2|NOT COMPLETED|Continuation Phase||0
8410373|NCT00956813|20729551|P1|NOT COMPLETED|Continuation Phase||0
8410374|NCT00956813|20729550|P2|COMPLETED|Continuation Phase||0
8410375|NCT00956813|20729551|P1|COMPLETED|Continuation Phase||80
8410376|NCT00956813|20729550|P2|STARTED|Continuation Phase||0
8410377|NCT00956813|20729551|P1|STARTED|Continuation Phase||80
8410378|NCT00956813|20729550|P2|NOT COMPLETED|Flaxseed and Placebo||5
8410379|NCT00956813|20729551|P1|NOT COMPLETED|Flaxseed and Placebo||8
8410380|NCT00956813|20729550|P2|COMPLETED|Flaxseed and Placebo||100
8410381|NCT00956813|20729551|P1|COMPLETED|Flaxseed and Placebo||97
8410382|NCT00956813|20729550|P2|STARTED|Flaxseed and Placebo||105
8410383|NCT00956813|20729551|P1|STARTED|Flaxseed and Placebo||105
8410384|NCT00956761|20729566|P1|NOT COMPLETED|Overall Study||0
8410385|NCT00956761|20729566|P1|COMPLETED|Overall Study||63
8410386|NCT00956761|20729566|P1|STARTED|Overall Study||63
8410387|NCT00956709|20729575|P2|NOT COMPLETED|Overall Study||0
8410388|NCT00956709|20729576|P1|NOT COMPLETED|Overall Study||0
8410389|NCT00956709|20729575|P2|COMPLETED|Overall Study||19
8410390|NCT00956709|20729576|P1|COMPLETED|Overall Study||16
8410391|NCT00956709|20729575|P2|STARTED|Overall Study||19
8410392|NCT00956709|20729576|P1|STARTED|Overall Study||16
8410393|NCT00956657|20729588|P2|NOT COMPLETED|Overall Study||0
8410394|NCT00956657|20729589|P1|NOT COMPLETED|Overall Study||0
8410395|NCT00956657|20729588|P2|COMPLETED|Overall Study||13
8410396|NCT00956657|20729589|P1|COMPLETED|Overall Study||18
8410397|NCT00956657|20729588|P2|STARTED|Overall Study||13
8410398|NCT00956657|20729589|P1|STARTED|Overall Study||18
8410399|NCT00956631|20729595|P1|NOT COMPLETED|Overall Study||16
8410400|NCT00956631|20729595|P1|COMPLETED|Overall Study||62
8410401|NCT00956631|20729595|P1|STARTED|Overall Study||78
8410402|NCT00956592|20729603|P2|NOT COMPLETED|Overall Study||3
8410403|NCT00956592|20729604|P1|NOT COMPLETED|Overall Study||1
8410404|NCT00956592|20729603|P2|COMPLETED|Overall Study||147
8410405|NCT00956592|20729604|P1|COMPLETED|Overall Study||149
8410406|NCT00956592|20729603|P2|STARTED|Overall Study||150
8410407|NCT00956592|20729604|P1|STARTED|Overall Study||150
8410408|NCT00956540|20729624|P4|NOT COMPLETED|Overall Study||4
8410409|NCT00956540|20729625|P3|NOT COMPLETED|Overall Study||3
8410410|NCT00956540|20729626|P2|NOT COMPLETED|Overall Study||4
8410411|NCT00956540|20729627|P1|NOT COMPLETED|Overall Study||3
8410412|NCT00956540|20729624|P4|COMPLETED|Overall Study||41
8410413|NCT00956540|20729625|P3|COMPLETED|Overall Study||43
8410414|NCT00956540|20729626|P2|COMPLETED|Overall Study||46
8410415|NCT00956540|20729627|P1|COMPLETED|Overall Study||51
8410416|NCT00956540|20729624|P4|STARTED|Overall Study||45
8410417|NCT00956540|20729625|P3|STARTED|Overall Study||46
8410418|NCT00956540|20729626|P2|STARTED|Overall Study||50
8410419|NCT00956540|20729627|P1|STARTED|Overall Study||54
8410420|NCT00956293|20729639|P3|NOT COMPLETED|Follow-up Period||0
8410421|NCT00956293|20729640|P2|NOT COMPLETED|Follow-up Period||32
8410422|NCT00956293|20729641|P1|NOT COMPLETED|Follow-up Period||20
8410423|NCT00956293|20729639|P3|COMPLETED|Follow-up Period||0
8410424|NCT00956293|20729640|P2|COMPLETED|Follow-up Period||0
8410425|NCT00956293|20729641|P1|COMPLETED|Follow-up Period||0
8410426|NCT00956293|20729639|P3|STARTED|Follow-up Period||0
8410427|NCT00956293|20729640|P2|STARTED|Follow-up Period||32
8410428|NCT00956293|20729641|P1|STARTED|Follow-up Period||20
8410429|NCT00956293|20729639|P3|NOT COMPLETED|Main Period (Randomization)||0
8410430|NCT00956293|20729640|P2|NOT COMPLETED|Main Period (Randomization)||27
8410431|NCT00956293|20729641|P1|NOT COMPLETED|Main Period (Randomization)||1
8410432|NCT00956293|20729639|P3|COMPLETED|Main Period (Randomization)||0
8410433|NCT00956293|20729640|P2|COMPLETED|Main Period (Randomization)||26
8410434|NCT00956293|20729641|P1|COMPLETED|Main Period (Randomization)||23
8410435|NCT00956293|20729639|P3|Randomized Safety Set|Main Period (Randomization)||0
8410436|NCT00956293|20729640|P2|Randomized Safety Set|Main Period (Randomization)||51
8410437|NCT00956293|20729641|P1|Randomized Safety Set|Main Period (Randomization)||24
8410438|NCT00956293|20729639|P3|Full Analysis Set|Main Period (Randomization)||0
8410439|NCT00956293|20729640|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
8410440|NCT00956293|20729641|P1|Full Analysis Set|Main Period (Randomization)||24
8410441|NCT00956293|20729639|P3|STARTED|Main Period (Randomization)||0
8410442|NCT00956293|20729640|P2|STARTED|Main Period (Randomization)||53
8410443|NCT00956293|20729641|P1|STARTED|Main Period (Randomization)||24
8410444|NCT00956293|20729639|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
8410445|NCT00956293|20729640|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
8410446|NCT00956293|20729641|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
8410447|NCT00956293|20729639|P3|COMPLETED|Main Period (Pre-randomization)||77
8410448|NCT00956293|20729640|P2|COMPLETED|Main Period (Pre-randomization)||0
8410449|NCT00956293|20729641|P1|COMPLETED|Main Period (Pre-randomization)||0
8410450|NCT00956293|20729639|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
8410451|NCT00956293|20729640|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
8410452|NCT00956293|20729641|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
8410453|NCT00956293|20729639|P3|STARTED|Main Period (Pre-randomization)||207
8410454|NCT00956293|20729640|P2|STARTED|Main Period (Pre-randomization)||0
8410455|NCT00956293|20729641|P1|STARTED|Main Period (Pre-randomization)||0
8410456|NCT00956254|20729665|P1|NOT COMPLETED|Overall Study||0
8410457|NCT00956254|20729665|P1|COMPLETED|Overall Study||18
8410458|NCT00956254|20729665|P1|STARTED|Overall Study||18
8410459|NCT00956085|20729675|P1|NOT COMPLETED|Overall Study||0
8410460|NCT00956085|20729675|P1|COMPLETED|Overall Study||12
8410461|NCT00956085|20729675|P1|STARTED|Overall Study||12
8410462|NCT00956020|20729679|P1|NOT COMPLETED|Overall Study||0
8410463|NCT00956020|20729679|P1|COMPLETED|Overall Study||4
8410464|NCT00956020|20729679|P1|STARTED|Overall Study||4
8410465|NCT00955968|20729696|P2|NOT COMPLETED|Overall Study||126
8410466|NCT00955968|20729697|P1|NOT COMPLETED|Overall Study||137
8410467|NCT00955968|20729696|P2|COMPLETED|Overall Study||699
8410468|NCT00955968|20729697|P1|COMPLETED|Overall Study||691
8410469|NCT00955968|20729696|P2|STARTED|Overall Study||825
8410470|NCT00955968|20729697|P1|STARTED|Overall Study||828
8410471|NCT00955955|20729739|P3|NOT COMPLETED|Overall Study||0
8410472|NCT00955955|20729740|P2|NOT COMPLETED|Overall Study||0
8410473|NCT00955955|20729741|P1|NOT COMPLETED|Overall Study||2
8410474|NCT00955955|20729739|P3|COMPLETED|Overall Study||28
8410475|NCT00955955|20729740|P2|COMPLETED|Overall Study||28
8410476|NCT00955955|20729741|P1|COMPLETED|Overall Study||17
8410477|NCT00955955|20729739|P3|STARTED|Overall Study||28
8410478|NCT00955955|20729740|P2|STARTED|Overall Study||28
8410479|NCT00955955|20729741|P1|STARTED|Overall Study||19
8410480|NCT00955916|20729755|P1|NOT COMPLETED|Overall Study||0
8410481|NCT00955916|20729755|P1|COMPLETED|Overall Study||38
8410482|NCT00955916|20729755|P1|STARTED|Overall Study||38
8410483|NCT00955903|20729764|P3|NOT COMPLETED|Overall Study||7
8410484|NCT00955903|20729765|P2|NOT COMPLETED|Overall Study||3
8410485|NCT00955903|20729766|P1|NOT COMPLETED|Overall Study||6
8410486|NCT00955903|20729764|P3|COMPLETED|Overall Study||48
8410487|NCT00955903|20729765|P2|COMPLETED|Overall Study||51
8410488|NCT00955903|20729766|P1|COMPLETED|Overall Study||49
8410489|NCT00955903|20729764|P3|STARTED|Overall Study||55
8410490|NCT00955903|20729765|P2|STARTED|Overall Study||54
8410491|NCT00955903|20729766|P1|STARTED|Overall Study||55
8410492|NCT00955877|20729783|P3|NOT COMPLETED|Overall Study||0
8410493|NCT00955877|20729784|P2|NOT COMPLETED|Overall Study||0
8410494|NCT00955877|20729785|P1|NOT COMPLETED|Overall Study||0
8410495|NCT00955877|20729783|P3|COMPLETED|Overall Study||7
8410496|NCT00955877|20729784|P2|COMPLETED|Overall Study||0
8410497|NCT00955877|20729785|P1|COMPLETED|Overall Study||6
8410498|NCT00955877|20729783|P3|STARTED|Overall Study||7
8410499|NCT00955877|20729784|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
8410500|NCT00955877|20729785|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
8410501|NCT00955825|20729825|P2|NOT COMPLETED|Overall Study||17
8410502|NCT00955825|20729826|P1|NOT COMPLETED|Overall Study||26
8410503|NCT00955825|20729825|P2|COMPLETED|Overall Study||223
8410504|NCT00955825|20729826|P1|COMPLETED|Overall Study||207
8410505|NCT00955825|20729825|P2|STARTED|Overall Study||240
8410506|NCT00955825|20729826|P1|STARTED|Overall Study||233
8410507|NCT00955747|20729834|P2|NOT COMPLETED|Overall Study||69
8410508|NCT00955747|20729835|P1|NOT COMPLETED|Overall Study||69
8410509|NCT00955747|20729834|P2|COMPLETED|Overall Study||172
8410510|NCT00955747|20729835|P1|COMPLETED|Overall Study||184
8410511|NCT00955747|20729834|P2|STARTED|Overall Study||241
8410512|NCT00955747|20729835|P1|STARTED|Overall Study||253
8410513|NCT00955721|20729843|P2|NOT COMPLETED|Overall Study||0
8410514|NCT00955721|20729844|P1|NOT COMPLETED|Overall Study||3
8410515|NCT00955721|20729843|P2|COMPLETED|Overall Study||0
8410516|NCT00955721|20729844|P1|COMPLETED|Overall Study||6
8410517|NCT00955721|20729843|P2|STARTED|Overall Study||0
8410518|NCT00955721|20729844|P1|STARTED|Overall Study||9
8410519|NCT00955708|20729854|P1|NOT COMPLETED|Overall Study||1058
8410520|NCT00955708|20729854|P1|COMPLETED|Overall Study||250
8410521|NCT00955708|20729854|P1|STARTED|Overall Study||1308
8410552|NCT00955617|20729971|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
8410553|NCT00955617|20729972|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
8410554|NCT00955617|20729971|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
8410555|NCT00955617|20729972|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
8410556|NCT00955617|20729971|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
8410557|NCT00955617|20729972|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
8410558|NCT00955617|20729971|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
8410559|NCT00955617|20729972|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
8410560|NCT00955617|20729971|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
8410561|NCT00955617|20729972|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
8410562|NCT00955617|20729971|P2|STARTED|First MRA (Between Day0 and Day21)||10
8410563|NCT00955617|20729972|P1|STARTED|First MRA (Between Day0 and Day21)||10
8410564|NCT00955513|20729985|P3|NOT COMPLETED|Overall Study||3
8410565|NCT00955513|20729986|P2|NOT COMPLETED|Overall Study||2
8410566|NCT00955513|20729987|P1|NOT COMPLETED|Overall Study||1
8410567|NCT00955513|20729985|P3|COMPLETED|Overall Study||79
8410568|NCT00955513|20729986|P2|COMPLETED|Overall Study||78
8410569|NCT00955513|20729987|P1|COMPLETED|Overall Study||79
8410570|NCT00955513|20729985|P3|STARTED|Overall Study||82
8410571|NCT00955513|20729986|P2|STARTED|Overall Study||80
8410572|NCT00955513|20729987|P1|STARTED|Overall Study||80
8410573|NCT00955487|20729997|P6|NOT COMPLETED|Overall Study||0
8410574|NCT00955487|20729998|P5|NOT COMPLETED|Overall Study||0
8410575|NCT00955487|20729999|P4|NOT COMPLETED|Overall Study||0
8410576|NCT00955487|20730000|P3|NOT COMPLETED|Overall Study||0
8410577|NCT00955487|20730001|P2|NOT COMPLETED|Overall Study||0
8410578|NCT00955487|20730002|P1|NOT COMPLETED|Overall Study||0
8410579|NCT00955487|20729997|P6|COMPLETED|Overall Study||35
8410580|NCT00955487|20729998|P5|COMPLETED|Overall Study||32
8410581|NCT00955487|20729999|P4|COMPLETED|Overall Study||21
8410582|NCT00955487|20730000|P3|COMPLETED|Overall Study||17
8410583|NCT00955487|20730001|P2|COMPLETED|Overall Study||9
8410584|NCT00955487|20730002|P1|COMPLETED|Overall Study||10
8410585|NCT00955487|20729997|P6|STARTED|Overall Study||35
8410586|NCT00955487|20729998|P5|STARTED|Overall Study||32
8410587|NCT00955487|20729999|P4|STARTED|Overall Study||21
8410588|NCT00955487|20730000|P3|STARTED|Overall Study||17
8410589|NCT00955487|20730001|P2|STARTED|Overall Study||9
8410590|NCT00955487|20730002|P1|STARTED|Overall Study||10
8410591|NCT00955474|20730036|P2|NOT COMPLETED|Overall Study||5
8410592|NCT00955474|20730037|P1|NOT COMPLETED|Overall Study||7
8410593|NCT00955474|20730036|P2|COMPLETED|Overall Study||8
8410594|NCT00955474|20730037|P1|COMPLETED|Overall Study||5
8410595|NCT00955474|20730036|P2|STARTED|Overall Study||13
8410596|NCT00955474|20730037|P1|STARTED|Overall Study||12
8410597|NCT00955357|20730073|P2|NOT COMPLETED|Maintenance Phase||45
8410598|NCT00955357|20730074|P1|NOT COMPLETED|Maintenance Phase||12
8410599|NCT00955357|20730073|P2|COMPLETED|Maintenance Phase||249
8410600|NCT00955357|20730074|P1|COMPLETED|Maintenance Phase||68
8410601|NCT00955357|20730073|P2|STARTED|Maintenance Phase||294
8410602|NCT00955357|20730074|P1|STARTED|Maintenance Phase||80
8410603|NCT00955357|20730073|P2|NOT COMPLETED|Titration Phase||66
8410604|NCT00955357|20730074|P1|NOT COMPLETED|Titration Phase||16
8410605|NCT00955357|20730073|P2|COMPLETED|Titration Phase||294
8410606|NCT00955357|20730074|P1|COMPLETED|Titration Phase||80
8410607|NCT00955357|20730073|P2|STARTED|Titration Phase||360
8410608|NCT00955357|20730074|P1|STARTED|Titration Phase||96
8410609|NCT00955305|20730082|P2|NOT COMPLETED|Overall Study||87
8410610|NCT00955305|20730083|P1|NOT COMPLETED|Overall Study||88
8410611|NCT00955305|20730082|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8410612|NCT00955305|20730083|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8410613|NCT00955305|20730082|P2|Eligible and Treated|Overall Study||75
8410614|NCT00955305|20730083|P1|Eligible and Treated|Overall Study||78
8410615|NCT00955305|20730082|P2|Treated|Overall Study||82
8410616|NCT00955305|20730083|P1|Treated|Overall Study||83
8410617|NCT00955305|20730082|P2|STARTED|Overall Study||87
8410618|NCT00955305|20730083|P1|STARTED|Overall Study||88
8410619|NCT00955279|20730096|P3|NOT COMPLETED|Overall Study||8
8410620|NCT00955279|20730097|P2|NOT COMPLETED|Overall Study||4
8410621|NCT00955279|20730098|P1|NOT COMPLETED|Overall Study||3
8410622|NCT00955279|20730096|P3|COMPLETED|Overall Study||52
8410623|NCT00955279|20730097|P2|COMPLETED|Overall Study||51
8410624|NCT00955279|20730098|P1|COMPLETED|Overall Study||55
8410625|NCT00955279|20730096|P3|STARTED|Overall Study||60
8410626|NCT00955279|20730097|P2|STARTED|Overall Study||55
8410627|NCT00955279|20730098|P1|STARTED|Overall Study||58
8410628|NCT00955266|20730120|P2|NOT COMPLETED|Overall Study||0
8410629|NCT00955266|20730121|P1|NOT COMPLETED|Overall Study||0
8410630|NCT00955266|20730120|P2|COMPLETED|Overall Study||4
8410631|NCT00955266|20730121|P1|COMPLETED|Overall Study||4
8410632|NCT00955266|20730120|P2|STARTED|Overall Study||4
8410633|NCT00955266|20730121|P1|STARTED|Overall Study||4
8410634|NCT00955253|20730135|P2|NOT COMPLETED|Second Intervention (Day 4)||0
8410635|NCT00955253|20730136|P1|NOT COMPLETED|Second Intervention (Day 4)||0
8410636|NCT00955253|20730135|P2|COMPLETED|Second Intervention (Day 4)||6
8410637|NCT00955253|20730136|P1|COMPLETED|Second Intervention (Day 4)||7
8410638|NCT00955253|20730135|P2|STARTED|Second Intervention (Day 4)||6
8410639|NCT00955253|20730136|P1|STARTED|Second Intervention (Day 4)||7
8410640|NCT00955253|20730135|P2|NOT COMPLETED|First Intervention (Day 2)||0
8410641|NCT00955253|20730136|P1|NOT COMPLETED|First Intervention (Day 2)||0
8410642|NCT00955253|20730135|P2|COMPLETED|First Intervention (Day 2)||6
8410643|NCT00955253|20730136|P1|COMPLETED|First Intervention (Day 2)||7
8410644|NCT00955253|20730135|P2|STARTED|First Intervention (Day 2)||6
8410645|NCT00955253|20730136|P1|STARTED|First Intervention (Day 2)||7
8410646|NCT00955201|20730145|P4|NOT COMPLETED|Overall Study||4
8410647|NCT00955201|20730146|P3|NOT COMPLETED|Overall Study||1
8410648|NCT00955201|20730147|P2|NOT COMPLETED|Overall Study||0
8410649|NCT00955201|20730148|P1|NOT COMPLETED|Overall Study||4
8410650|NCT00955201|20730145|P4|COMPLETED|Overall Study||7
8410651|NCT00955201|20730146|P3|COMPLETED|Overall Study||10
8410652|NCT00955201|20730147|P2|COMPLETED|Overall Study||11
8410653|NCT00955201|20730148|P1|COMPLETED|Overall Study||8
8410654|NCT00955201|20730145|P4|STARTED|Overall Study||11
8410655|NCT00955201|20730146|P3|STARTED|Overall Study||11
8410656|NCT00955201|20730147|P2|STARTED|Overall Study||11
8410657|NCT00955201|20730148|P1|STARTED|Overall Study||12
8410658|NCT00955110|20730306|P1|NOT COMPLETED|Treatment Phase||6
8410659|NCT00955110|20730306|P1|COMPLETED|Treatment Phase||35
8410660|NCT00955110|20730306|P1|Oxycodone CR 60 mg|Treatment Phase||40
8410661|NCT00955110|20730306|P1|Oxycodone CR 30 mg|Treatment Phase||40
8410662|NCT00955110|20730306|P1|Oxymorphone ER 30 mg|Treatment Phase||38
8410663|NCT00955110|20730306|P1|Oxymorphone ER 15 mg|Treatment Phase||37
8410664|NCT00955110|20730306|P1|Placebo|Treatment Phase||38
8410665|NCT00955110|20730306|P1|STARTED|Treatment Phase||41
8410666|NCT00955110|20730306|P1|NOT COMPLETED|Qualification Phase||24
8410667|NCT00955110|20730306|P1|COMPLETED|Qualification Phase||54
8410668|NCT00955110|20730306|P1|STARTED|Qualification Phase||78
8410669|NCT00955032|20730320|P2|NOT COMPLETED|Overall Study||0
8410670|NCT00955032|20730321|P1|NOT COMPLETED|Overall Study||0
8410671|NCT00955032|20730320|P2|COMPLETED|Overall Study||8
8410672|NCT00955032|20730321|P1|COMPLETED|Overall Study||16
8410673|NCT00955032|20730320|P2|STARTED|Overall Study||8
8410674|NCT00955032|20730321|P1|STARTED|Overall Study||16
8410675|NCT00954993|20730341|P1|NOT COMPLETED|Period 2||0
8410676|NCT00954993|20730341|P1|COMPLETED|Period 2||3
8410677|NCT00954993|20730341|P1|STARTED|Period 2||3
8410678|NCT00954993|20730341|P1|NOT COMPLETED|Washout||0
8410679|NCT00954993|20730341|P1|COMPLETED|Washout||3
8410680|NCT00954993|20730341|P1|STARTED|Washout||3
8410681|NCT00954993|20730341|P1|NOT COMPLETED|Period 1||0
8410682|NCT00954993|20730341|P1|COMPLETED|Period 1||3
8410683|NCT00954993|20730341|P1|STARTED|Period 1||3
8410684|NCT00954941|20730353|P2|NOT COMPLETED|Overall Study||7
8410685|NCT00954941|20730354|P1|NOT COMPLETED|Overall Study||8
8410686|NCT00954941|20730353|P2|COMPLETED|Overall Study||41
8410687|NCT00954941|20730354|P1|COMPLETED|Overall Study||42
8410688|NCT00954941|20730353|P2|STARTED|Overall Study||48
8410689|NCT00954941|20730354|P1|STARTED|Overall Study||50
8410690|NCT00954915|20730362|P1|NOT COMPLETED|Overall Study||0
8410691|NCT00954915|20730362|P1|COMPLETED|Overall Study||1
8410692|NCT00954915|20730362|P1|STARTED|Overall Study||1
8410693|NCT00954824|20730366|P1|NOT COMPLETED|Overall Study||50
8410694|NCT00954824|20730366|P1|COMPLETED|Overall Study||50
8410695|NCT00954824|20730366|P1|STARTED|Overall Study||100
8410696|NCT00954733|20730370|P1|NOT COMPLETED|Overall Study||1
8410697|NCT00954733|20730370|P1|COMPLETED|Overall Study||39
8410698|NCT00954733|20730370|P1|STARTED|Overall Study||40
8410699|NCT00954707|20730374|P1|NOT COMPLETED|Overall Study||167
8410700|NCT00954707|20730374|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
8410701|NCT00954707|20730374|P1|STARTED|Overall Study||2509
8410702|NCT00954681|20730390|P1|NOT COMPLETED|Overall Study||5
8410703|NCT00954681|20730390|P1|COMPLETED|Overall Study||10
8410704|NCT00954681|20730390|P1|STARTED|Overall Study||15
8410705|NCT00954538|20730396|P6|NOT COMPLETED|Part III||0
8410706|NCT00954538|20730397|P5|NOT COMPLETED|Part III||1
8410707|NCT00954538|20730398|P4|NOT COMPLETED|Part III||0
8410708|NCT00954538|20730399|P3|NOT COMPLETED|Part III||0
8410709|NCT00954538|20730400|P2|NOT COMPLETED|Part III||0
8410710|NCT00954538|20730401|P1|NOT COMPLETED|Part III||0
8410711|NCT00954538|20730396|P6|COMPLETED|Part III||2
8410712|NCT00954538|20730397|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
8410713|NCT00954538|20730398|P4|COMPLETED|Part III||4
8410714|NCT00954538|20730399|P3|COMPLETED|Part III||0
8410715|NCT00954538|20730400|P2|COMPLETED|Part III||0
8410716|NCT00954538|20730401|P1|COMPLETED|Part III||0
8410717|NCT00954538|20730396|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
8410718|NCT00954538|20730397|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
8410719|NCT00954538|20730398|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
8410720|NCT00954538|20730399|P3|STARTED|Part III||0
8410721|NCT00954538|20730400|P2|STARTED|Part III||0
8410722|NCT00954538|20730401|P1|STARTED|Part III||0
8410723|NCT00954538|20730396|P6|NOT COMPLETED|Part II||0
8410724|NCT00954538|20730397|P5|NOT COMPLETED|Part II||0
8410725|NCT00954538|20730398|P4|NOT COMPLETED|Part II||0
8410726|NCT00954538|20730399|P3|NOT COMPLETED|Part II||0
8410727|NCT00954538|20730400|P2|NOT COMPLETED|Part II||0
8410728|NCT00954538|20730401|P1|NOT COMPLETED|Part II||0
8410729|NCT00954538|20730396|P6|COMPLETED|Part II||2
8410730|NCT00954538|20730397|P5|COMPLETED|Part II||0
8410731|NCT00954538|20730398|P4|COMPLETED|Part II||0
8410732|NCT00954538|20730399|P3|COMPLETED|Part II||3
8410733|NCT00954538|20730400|P2|COMPLETED|Part II||1
8410734|NCT00954538|20730401|P1|COMPLETED|Part II||0
8410735|NCT00954538|20730396|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
8410736|NCT00954538|20730397|P5|STARTED|Part II||0
8410737|NCT00954538|20730398|P4|STARTED|Part II||0
8410738|NCT00954538|20730399|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
8410739|NCT00954538|20730400|P2|STARTED|Part II|This subject did not participate in Part I or III|1
8410740|NCT00954538|20730401|P1|STARTED|Part II||0
8410741|NCT00954538|20730396|P6|NOT COMPLETED|Part I||0
8410742|NCT00954538|20730397|P5|NOT COMPLETED|Part I||0
8410743|NCT00954538|20730398|P4|NOT COMPLETED|Part I||0
8410744|NCT00954538|20730399|P3|NOT COMPLETED|Part I||0
8410745|NCT00954538|20730400|P2|NOT COMPLETED|Part I||0
8410746|NCT00954538|20730401|P1|NOT COMPLETED|Part I||0
8410747|NCT00954538|20730396|P6|COMPLETED|Part I||0
8410748|NCT00954538|20730397|P5|COMPLETED|Part I||0
8410749|NCT00954538|20730398|P4|COMPLETED|Part I||0
8410750|NCT00954538|20730399|P3|COMPLETED|Part I||0
8410751|NCT00954538|20730400|P2|COMPLETED|Part I||0
8410752|NCT00954538|20730401|P1|COMPLETED|Part I||3
8410753|NCT00954538|20730396|P6|STARTED|Part I||0
8410754|NCT00954538|20730397|P5|STARTED|Part I||0
8410755|NCT00954538|20730398|P4|STARTED|Part I||0
8410756|NCT00954538|20730399|P3|STARTED|Part I||0
8410757|NCT00954538|20730400|P2|STARTED|Part I||0
8410758|NCT00954538|20730401|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
8410759|NCT00954512|20730418|P6|NOT COMPLETED|Overall Study||4
8410760|NCT00954512|20730419|P5|NOT COMPLETED|Overall Study||4
8410761|NCT00954512|20730420|P4|NOT COMPLETED|Overall Study||2
8410762|NCT00954512|20730421|P3|NOT COMPLETED|Overall Study||0
8410763|NCT00954512|20730422|P2|NOT COMPLETED|Overall Study||3
8410764|NCT00954512|20730423|P1|NOT COMPLETED|Overall Study||2
8410765|NCT00954512|20730418|P6|COMPLETED|Overall Study||0
8410766|NCT00954512|20730419|P5|COMPLETED|Overall Study||0
8410767|NCT00954512|20730420|P4|COMPLETED|Overall Study||0
8410768|NCT00954512|20730421|P3|COMPLETED|Overall Study||0
8410769|NCT00954512|20730422|P2|COMPLETED|Overall Study||0
8410770|NCT00954512|20730423|P1|COMPLETED|Overall Study||0
8410771|NCT00954512|20730418|P6|STARTED|Overall Study||4
8410772|NCT00954512|20730419|P5|STARTED|Overall Study||4
8410773|NCT00954512|20730420|P4|STARTED|Overall Study||2
8410774|NCT00954512|20730421|P3|STARTED|Overall Study||0
8410775|NCT00954512|20730422|P2|STARTED|Overall Study||3
8410776|NCT00954512|20730423|P1|STARTED|Overall Study||2
8410777|NCT00954447|20730444|P2|NOT COMPLETED|Overall Study||88
8410778|NCT00954447|20730445|P1|NOT COMPLETED|Overall Study||110
8410779|NCT00954447|20730444|P2|COMPLETED|Overall Study||543
8410780|NCT00954447|20730445|P1|COMPLETED|Overall Study||520
8410781|NCT00954447|20730444|P2|STARTED|Overall Study||631
8410782|NCT00954447|20730445|P1|STARTED|Overall Study||630
8410783|NCT00954421|20730481|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
8410784|NCT00954421|20730481|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
8410785|NCT00954421|20730481|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
8410786|NCT00954421|20730481|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
8410787|NCT00954421|20730481|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
8410788|NCT00954421|20730481|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
8410789|NCT00954421|20730481|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
8410790|NCT00954421|20730481|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
8410791|NCT00954421|20730481|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
8410792|NCT00954421|20730481|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
8410793|NCT00954421|20730481|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
8410794|NCT00954421|20730481|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
8410795|NCT00954421|20730481|P1|NOT COMPLETED|6 Months of DBS||1
8410796|NCT00954421|20730481|P1|COMPLETED|6 Months of DBS||12
8410797|NCT00954421|20730481|P1|STARTED|6 Months of DBS||13
8410798|NCT00954421|20730481|P1|NOT COMPLETED|Baseline||0
8410799|NCT00954421|20730481|P1|COMPLETED|Baseline||13
8410800|NCT00954421|20730481|P1|STARTED|Baseline||13
8410801|NCT00954421|20730481|P1|NOT COMPLETED|Screening||3
8410802|NCT00954421|20730481|P1|COMPLETED|Screening||13
8410803|NCT00954421|20730481|P1|STARTED|Screening||16
8410804|NCT00954356|20730489|P2|NOT COMPLETED|Overall Study||0
8410805|NCT00954356|20730490|P1|NOT COMPLETED|Overall Study||0
8410806|NCT00954356|20730489|P2|COMPLETED|Overall Study||20
8410807|NCT00954356|20730490|P1|COMPLETED|Overall Study||41
8410808|NCT00954356|20730489|P2|STARTED|Overall Study||20
8410809|NCT00954356|20730490|P1|STARTED|Overall Study||41
8410810|NCT00954187|20730520|P2|NOT COMPLETED|Overall Study||0
8410811|NCT00954187|20730521|P1|NOT COMPLETED|Overall Study||0
8410812|NCT00954187|20730520|P2|COMPLETED|Overall Study||0
8410813|NCT00954187|20730521|P1|COMPLETED|Overall Study||0
8410814|NCT00954187|20730520|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
8410815|NCT00954187|20730521|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
8410816|NCT00954174|20730531|P4|NOT COMPLETED|Overall Study||25
8410817|NCT00954174|20730532|P3|NOT COMPLETED|Overall Study||24
8410818|NCT00954174|20730533|P2|NOT COMPLETED|Overall Study||123
8410819|NCT00954174|20730534|P1|NOT COMPLETED|Overall Study||126
8410820|NCT00954174|20730531|P4|COMPLETED|Overall Study||25
8410821|NCT00954174|20730532|P3|COMPLETED|Overall Study||27
8410822|NCT00954174|20730533|P2|COMPLETED|Overall Study||145
8410823|NCT00954174|20730534|P1|COMPLETED|Overall Study||142
8410824|NCT00954174|20730531|P4|STARTED|Overall Study||50
8410825|NCT00954174|20730532|P3|STARTED|Overall Study||51
8410826|NCT00954174|20730533|P2|STARTED|Overall Study||268
8410827|NCT00954174|20730534|P1|STARTED|Overall Study||268
8410828|NCT00954122|20730554|P1|NOT COMPLETED|Overall Study||7
8410829|NCT00954122|20730554|P1|COMPLETED|Overall Study||28
8410830|NCT00954122|20730554|P1|STARTED|Overall Study||35
8410831|NCT00954109|20730564|P1|NOT COMPLETED|Overall Study||0
8410832|NCT00954109|20730564|P1|COMPLETED|Overall Study||11
8410833|NCT00954109|20730564|P1|STARTED|Overall Study||11
8410834|NCT00953927|20730571|P2|NOT COMPLETED|Overall Study||95
8410835|NCT00953927|20730572|P1|NOT COMPLETED|Overall Study||105
8410836|NCT00953927|20730571|P2|COMPLETED|Overall Study||1303
8410837|NCT00953927|20730572|P1|COMPLETED|Overall Study||1294
8410838|NCT00953927|20730571|P2|STARTED|Overall Study||1398
8410839|NCT00953927|20730572|P1|STARTED|Overall Study||1399
8410840|NCT00953862|20730590|P1|NOT COMPLETED|Overall Study||6
8410841|NCT00953862|20730590|P1|COMPLETED|Overall Study||12
8410842|NCT00953862|20730590|P1|STARTED|Overall Study||18
8410843|NCT00953849|20730600|P4|NOT COMPLETED|Overall Study||0
8410844|NCT00953849|20730601|P3|NOT COMPLETED|Overall Study||0
8410845|NCT00953849|20730602|P2|NOT COMPLETED|Overall Study||0
8410846|NCT00953849|20730603|P1|NOT COMPLETED|Overall Study||0
8410847|NCT00953849|20730600|P4|COMPLETED|Overall Study||5
8410848|NCT00953849|20730601|P3|COMPLETED|Overall Study||4
8410849|NCT00953849|20730602|P2|COMPLETED|Overall Study||6
8410850|NCT00953849|20730603|P1|COMPLETED|Overall Study||6
8410851|NCT00953849|20730600|P4|STARTED|Overall Study||5
8410852|NCT00953849|20730601|P3|STARTED|Overall Study||4
8410853|NCT00953849|20730602|P2|STARTED|Overall Study||6
8410854|NCT00953849|20730603|P1|STARTED|Overall Study||6
8410855|NCT00953745|20730627|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410856|NCT00953745|20730628|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410857|NCT00953745|20730627|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410858|NCT00953745|20730628|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
8410859|NCT00953745|20730627|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410860|NCT00953745|20730628|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
8410861|NCT00953745|20730627|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8410862|NCT00953745|20730628|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
8410863|NCT00953745|20730627|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8410864|NCT00953745|20730628|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
8410865|NCT00953745|20730627|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8410866|NCT00953745|20730628|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
8410867|NCT00953745|20730627|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
8410868|NCT00953745|20730628|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
8410869|NCT00953745|20730627|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
8410870|NCT00953745|20730628|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
8410871|NCT00953745|20730627|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
8410872|NCT00953745|20730628|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
8410873|NCT00953719|20730638|P2|NOT COMPLETED|Overall Study||5
8410874|NCT00953719|20730639|P1|NOT COMPLETED|Overall Study||19
8410875|NCT00953719|20730638|P2|COMPLETED|Overall Study||69
8410876|NCT00953719|20730639|P1|COMPLETED|Overall Study||150
8410877|NCT00953719|20730638|P2|STARTED|Overall Study||74
8410878|NCT00953719|20730639|P1|STARTED|Overall Study||169
8410879|NCT00953706|20730661|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
8410880|NCT00953706|20730662|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
8410881|NCT00953706|20730663|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
8410882|NCT00953706|20730664|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
8410883|NCT00953706|20730661|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410884|NCT00953706|20730662|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410885|NCT00953706|20730663|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410886|NCT00953706|20730664|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410887|NCT00953706|20730661|P4|STARTED|Part B (96-Week Open-Label Extension)||33
8410888|NCT00953706|20730662|P3|STARTED|Part B (96-Week Open-Label Extension)||5
8410889|NCT00953706|20730663|P2|STARTED|Part B (96-Week Open-Label Extension)||0
8410890|NCT00953706|20730664|P1|STARTED|Part B (96-Week Open-Label Extension)||0
8410891|NCT00953706|20730661|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410892|NCT00953706|20730662|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410893|NCT00953706|20730663|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
8410894|NCT00953706|20730664|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
8410895|NCT00953706|20730661|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410896|NCT00953706|20730662|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410897|NCT00953706|20730663|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
8410898|NCT00953706|20730664|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
8410899|NCT00953706|20730661|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
8410900|NCT00953706|20730662|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
8410901|NCT00953706|20730663|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
8410902|NCT00953706|20730664|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
8410903|NCT00953680|20730696|P2|NOT COMPLETED|Period 2||0
8410904|NCT00953680|20730697|P1|NOT COMPLETED|Period 2||0
8410905|NCT00953680|20730696|P2|COMPLETED|Period 2||38
8410906|NCT00953680|20730697|P1|COMPLETED|Period 2||38
8410907|NCT00953680|20730696|P2|STARTED|Period 2||38
8410908|NCT00953680|20730697|P1|STARTED|Period 2||38
8410909|NCT00953680|20730696|P2|NOT COMPLETED|Period 1||1
8410910|NCT00953680|20730697|P1|NOT COMPLETED|Period 1||0
8410911|NCT00953680|20730696|P2|COMPLETED|Period 1||38
8410912|NCT00953680|20730697|P1|COMPLETED|Period 1||38
8410913|NCT00953680|20730696|P2|STARTED|Period 1||39
8410914|NCT00953680|20730697|P1|STARTED|Period 1||38
8410915|NCT00953667|20730709|P1|NOT COMPLETED|Overall Study||123
8410916|NCT00953667|20730709|P1|COMPLETED|Overall Study||277
8410917|NCT00953667|20730709|P1|STARTED|Overall Study||400
8410918|NCT00953654|20730717|P3|NOT COMPLETED|Overall Study||0
8410919|NCT00953654|20730718|P2|NOT COMPLETED|Overall Study||0
8410920|NCT00953654|20730719|P1|NOT COMPLETED|Overall Study||0
8410921|NCT00953654|20730717|P3|COMPLETED|Overall Study||10
8410922|NCT00953654|20730718|P2|COMPLETED|Overall Study||10
8410923|NCT00953654|20730719|P1|COMPLETED|Overall Study||10
8410924|NCT00953654|20730717|P3|STARTED|Overall Study||10
8410925|NCT00953654|20730718|P2|STARTED|Overall Study||10
8410926|NCT00953654|20730719|P1|STARTED|Overall Study||10
8410927|NCT00953615|20730730|P1|NOT COMPLETED|Overall Study||1
8410928|NCT00953615|20730730|P1|COMPLETED|Overall Study||0
8410929|NCT00953615|20730730|P1|STARTED|Overall Study||1
8410930|NCT00953576|20730739|P2|NOT COMPLETED|Overall Study||1
8410931|NCT00953576|20730740|P1|NOT COMPLETED|Overall Study||2
8410932|NCT00953576|20730739|P2|COMPLETED|Overall Study||4
8410933|NCT00953576|20730740|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
8410934|NCT00953576|20730739|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
8410935|NCT00953576|20730740|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
8410936|NCT00953576|20730739|P2|Treated|Overall Study||5
8410937|NCT00953576|20730740|P1|Treated|Overall Study||4
8410938|NCT00953576|20730739|P2|DLT Evaluable|Overall Study||5
8410939|NCT00953576|20730740|P1|DLT Evaluable|Overall Study||3
8410940|NCT00953576|20730739|P2|STARTED|Overall Study||5
8410941|NCT00953576|20730740|P1|STARTED|Overall Study||6
8410942|NCT00953524|20730755|P4|NOT COMPLETED|Overall Study||8
8410943|NCT00953524|20730756|P3|NOT COMPLETED|Overall Study||14
8410944|NCT00953524|20730757|P2|NOT COMPLETED|Overall Study||15
8410945|NCT00953524|20730758|P1|NOT COMPLETED|Overall Study||22
8410946|NCT00953524|20730755|P4|COMPLETED|Overall Study||91
8410947|NCT00953524|20730756|P3|COMPLETED|Overall Study||233
8410948|NCT00953524|20730757|P2|COMPLETED|Overall Study||239
8410949|NCT00953524|20730758|P1|COMPLETED|Overall Study||227
8410950|NCT00953524|20730755|P4|STARTED|Overall Study||99
8410951|NCT00953524|20730756|P3|STARTED|Overall Study||247
8410952|NCT00953524|20730757|P2|STARTED|Overall Study||254
8410953|NCT00953524|20730758|P1|STARTED|Overall Study||249
8410954|NCT00953407|20730801|P5|NOT COMPLETED|Overall Study||1
8410955|NCT00953407|20730802|P4|NOT COMPLETED|Overall Study||2
8410956|NCT00953407|20730803|P3|NOT COMPLETED|Overall Study||1
8410957|NCT00953407|20730804|P2|NOT COMPLETED|Overall Study||1
8410958|NCT00953407|20730805|P1|NOT COMPLETED|Overall Study||1
8410959|NCT00953407|20730801|P5|COMPLETED|Overall Study||23
8410960|NCT00953407|20730802|P4|COMPLETED|Overall Study||23
8410961|NCT00953407|20730803|P3|COMPLETED|Overall Study||25
8410962|NCT00953407|20730804|P2|COMPLETED|Overall Study||24
8410963|NCT00953407|20730805|P1|COMPLETED|Overall Study||25
8410964|NCT00953407|20730801|P5|STARTED|Overall Study||24
8410965|NCT00953407|20730802|P4|STARTED|Overall Study||25
8410966|NCT00953407|20730803|P3|STARTED|Overall Study||26
8410967|NCT00953407|20730804|P2|STARTED|Overall Study||25
8410968|NCT00953407|20730805|P1|STARTED|Overall Study||26
8410969|NCT00953329|20730817|P1|NOT COMPLETED|Overall Study||1
8410970|NCT00953329|20730817|P1|COMPLETED|Overall Study||0
8410971|NCT00953329|20730817|P1|STARTED|Overall Study||1
8410972|NCT00953290|20730821|P1|NOT COMPLETED|Overall Study||0
8410973|NCT00953290|20730821|P1|COMPLETED|Overall Study||4
8410974|NCT00953290|20730821|P1|STARTED|Overall Study||4
8410975|NCT00953225|20730830|P2|NOT COMPLETED|Overall Study||0
8410976|NCT00953225|20730831|P1|NOT COMPLETED|Overall Study||2
8410977|NCT00953225|20730830|P2|COMPLETED|Overall Study||37
8410978|NCT00953225|20730831|P1|COMPLETED|Overall Study||44
8410979|NCT00953225|20730830|P2|STARTED|Overall Study||37
8410980|NCT00953225|20730831|P1|STARTED|Overall Study||46
8410981|NCT00953212|20730843|P4|NOT COMPLETED|Overall Study||0
8410982|NCT00953212|20730844|P3|NOT COMPLETED|Overall Study||0
8410983|NCT00953212|20730845|P2|NOT COMPLETED|Overall Study||0
8410984|NCT00953212|20730846|P1|NOT COMPLETED|Overall Study||0
8410985|NCT00953212|20730843|P4|COMPLETED|Overall Study||76
8410986|NCT00953212|20730844|P3|COMPLETED|Overall Study||78
8410987|NCT00953212|20730845|P2|COMPLETED|Overall Study||74
8410988|NCT00953212|20730846|P1|COMPLETED|Overall Study||76
8410989|NCT00953212|20730843|P4|STARTED|Overall Study||76
8410990|NCT00953212|20730844|P3|STARTED|Overall Study||78
8410991|NCT00953212|20730845|P2|STARTED|Overall Study||74
8410992|NCT00953212|20730846|P1|STARTED|Overall Study||76
8410993|NCT00953199|20730902|P2|NOT COMPLETED|Overall Study||0
8410994|NCT00953199|20730903|P1|NOT COMPLETED|Overall Study||0
8410995|NCT00953199|20730902|P2|COMPLETED|Overall Study||252
8410996|NCT00953199|20730903|P1|COMPLETED|Overall Study||254
8410997|NCT00953199|20730902|P2|STARTED|Overall Study||252
8410998|NCT00953199|20730903|P1|STARTED|Overall Study||254
8410999|NCT00953173|20730911|P1|NOT COMPLETED|Overall Study||282
8411000|NCT00953173|20730911|P1|COMPLETED|Overall Study||389
8411001|NCT00953173|20730911|P1|STARTED|Overall Study||671
8411002|NCT00953160|20730915|P1|NOT COMPLETED|Overall Study||27
8411003|NCT00953160|20730915|P1|COMPLETED|Overall Study||49
8411004|NCT00953160|20730915|P1|STARTED|Overall Study||76
8411005|NCT00953147|20730924|P3|NOT COMPLETED|Overall Study||42
8411006|NCT00953147|20730925|P2|NOT COMPLETED|Overall Study||66
8411007|NCT00953147|20730926|P1|NOT COMPLETED|Overall Study||37
8411008|NCT00953147|20730924|P3|COMPLETED|Overall Study||265
8411009|NCT00953147|20730925|P2|COMPLETED|Overall Study||439
8411010|NCT00953147|20730926|P1|COMPLETED|Overall Study||261
8411011|NCT00953147|20730924|P3|STARTED|Overall Study||307
8411012|NCT00953147|20730925|P2|STARTED|Overall Study||505
8411013|NCT00953147|20730926|P1|STARTED|Overall Study||298
8411014|NCT00953121|20730976|P3|NOT COMPLETED|Overall Study||0
8411015|NCT00953121|20730977|P2|NOT COMPLETED|Overall Study||0
8411016|NCT00953121|20730978|P1|NOT COMPLETED|Overall Study||0
8411017|NCT00953121|20730976|P3|COMPLETED|Overall Study||25
8411018|NCT00953121|20730977|P2|COMPLETED|Overall Study||39
8411019|NCT00953121|20730978|P1|COMPLETED|Overall Study||40
8411020|NCT00953121|20730976|P3|STARTED|Overall Study||25
8411021|NCT00953121|20730977|P2|STARTED|Overall Study||39
8411022|NCT00953121|20730978|P1|STARTED|Overall Study||40
8411023|NCT00953056|20731004|P6|NOT COMPLETED|Overall Study||4
8411024|NCT00953056|20731005|P5|NOT COMPLETED|Overall Study||2
8411025|NCT00953056|20731006|P4|NOT COMPLETED|Overall Study||0
8411026|NCT00953056|20731007|P3|NOT COMPLETED|Overall Study||0
8411027|NCT00953056|20731008|P2|NOT COMPLETED|Overall Study||0
8411028|NCT00953056|20731009|P1|NOT COMPLETED|Overall Study||0
8411029|NCT00953056|20731004|P6|COMPLETED|Overall Study||20
8411030|NCT00953056|20731005|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
8411031|NCT00953056|20731006|P4|COMPLETED|Overall Study||24
8411032|NCT00953056|20731007|P3|COMPLETED|Overall Study||24
8411033|NCT00953056|20731008|P2|COMPLETED|Overall Study||24
8411034|NCT00953056|20731009|P1|COMPLETED|Overall Study||24
8411035|NCT00953056|20731004|P6|STARTED|Overall Study||24
8411036|NCT00953056|20731005|P5|STARTED|Overall Study||24
8411037|NCT00953056|20731006|P4|STARTED|Overall Study||24
8411038|NCT00953056|20731007|P3|STARTED|Overall Study||24
8411039|NCT00953056|20731008|P2|STARTED|Overall Study||24
8411040|NCT00953056|20731009|P1|STARTED|Overall Study||24
8411041|NCT00953043|20731033|P2|NOT COMPLETED|Overall Study||2
8411042|NCT00953043|20731034|P1|NOT COMPLETED|Overall Study||4
8411043|NCT00953043|20731033|P2|COMPLETED|Overall Study||28
8411044|NCT00953043|20731034|P1|COMPLETED|Overall Study||26
8411045|NCT00953043|20731033|P2|STARTED|Overall Study||30
8411046|NCT00953043|20731034|P1|STARTED|Overall Study||30
8411047|NCT00953017|20731058|P4|NOT COMPLETED|Overall Study||5
8411048|NCT00953017|20731059|P3|NOT COMPLETED|Overall Study||6
8411049|NCT00953017|20731060|P2|NOT COMPLETED|Overall Study||6
8411050|NCT00953017|20731061|P1|NOT COMPLETED|Overall Study||5
8411051|NCT00953017|20731058|P4|COMPLETED|Overall Study||101
8411052|NCT00953017|20731059|P3|COMPLETED|Overall Study||100
8411053|NCT00953017|20731060|P2|COMPLETED|Overall Study||101
8411054|NCT00953017|20731061|P1|COMPLETED|Overall Study||101
8411055|NCT00953017|20731058|P4|STARTED|Overall Study||106
8411056|NCT00953017|20731059|P3|STARTED|Overall Study||106
8411057|NCT00953017|20731060|P2|STARTED|Overall Study||107
8411058|NCT00953017|20731061|P1|STARTED|Overall Study||106
8411059|NCT00952848|20731083|P1|NOT COMPLETED|Overall Study||4
8411060|NCT00952848|20731083|P1|COMPLETED|Overall Study||14
8411061|NCT00952848|20731083|P1|STARTED|Overall Study||18
8411062|NCT00952822|20731090|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8411063|NCT00952822|20731091|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
8411064|NCT00952822|20731092|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8411065|NCT00952822|20731093|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8411066|NCT00952822|20731090|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
8411067|NCT00952822|20731091|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
8411068|NCT00952822|20731092|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
8411069|NCT00952822|20731093|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
8411070|NCT00952822|20731090|P4|STARTED|2nd Pharmacokinetic Evaluation||4
8411071|NCT00952822|20731091|P3|STARTED|2nd Pharmacokinetic Evaluation||11
8411072|NCT00952822|20731092|P2|STARTED|2nd Pharmacokinetic Evaluation||17
8411073|NCT00952822|20731093|P1|STARTED|2nd Pharmacokinetic Evaluation||9
8411074|NCT00952822|20731090|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8411075|NCT00952822|20731091|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8411076|NCT00952822|20731092|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
8411077|NCT00952822|20731093|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8411078|NCT00952822|20731090|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
8411079|NCT00952822|20731091|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
8411080|NCT00952822|20731092|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
8411081|NCT00952822|20731093|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
8411082|NCT00952822|20731090|P4|STARTED|1st Pharmacokinetic Evaluation||4
8411083|NCT00952822|20731091|P3|STARTED|1st Pharmacokinetic Evaluation||11
8411084|NCT00952822|20731092|P2|STARTED|1st Pharmacokinetic Evaluation||18
8411085|NCT00952822|20731093|P1|STARTED|1st Pharmacokinetic Evaluation||9
8411086|NCT00952731|20731125|P2|NOT COMPLETED|Overall Study||0
8411087|NCT00952731|20731126|P1|NOT COMPLETED|Overall Study||1
8411088|NCT00952731|20731125|P2|COMPLETED|Overall Study||14
8411089|NCT00952731|20731126|P1|COMPLETED|Overall Study||12
8411090|NCT00952731|20731125|P2|Follow-up|Overall Study||14
8411091|NCT00952731|20731126|P1|Follow-up|Overall Study||12
8411092|NCT00952731|20731125|P2|Surgery|Overall Study||14
8411093|NCT00952731|20731126|P1|Surgery|Overall Study||12
8411094|NCT00952731|20731125|P2|Treatment & Pre-Surgery|Overall Study||14
8411095|NCT00952731|20731126|P1|Treatment & Pre-Surgery|Overall Study||12
8411096|NCT00952731|20731125|P2|Randomization|Overall Study||14
8411097|NCT00952731|20731126|P1|Randomization|Overall Study||13
8411098|NCT00952731|20731125|P2|STARTED|Overall Study||14
8411099|NCT00952731|20731126|P1|STARTED|Overall Study||13
8411100|NCT00952718|20731144|P2|NOT COMPLETED|Overall Study||6
8411101|NCT00952718|20731145|P1|NOT COMPLETED|Overall Study||6
8411102|NCT00952718|20731144|P2|COMPLETED|Overall Study||13
8411103|NCT00952718|20731145|P1|COMPLETED|Overall Study||13
8411104|NCT00952718|20731144|P2|STARTED|Overall Study||19
8411105|NCT00952718|20731145|P1|STARTED|Overall Study||19
8411106|NCT00952705|20731158|P3|NOT COMPLETED|Overall Study||10
8411107|NCT00952705|20731159|P2|NOT COMPLETED|Overall Study||10
8411108|NCT00952705|20731160|P1|NOT COMPLETED|Overall Study||33
8411109|NCT00952705|20731158|P3|COMPLETED|Overall Study||288
8411110|NCT00952705|20731159|P2|COMPLETED|Overall Study||290
8411111|NCT00952705|20731160|P1|COMPLETED|Overall Study||1169
8411112|NCT00952705|20731158|P3|STARTED|Overall Study||298
8411113|NCT00952705|20731159|P2|STARTED|Overall Study||300
8411114|NCT00952705|20731160|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
8411115|NCT00952653|20731222|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
8411116|NCT00952653|20731222|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
8411117|NCT00952653|20731222|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
8411118|NCT00952653|20731222|P1|NOT COMPLETED|Period 1: MDZ Alone||0
8411119|NCT00952653|20731222|P1|COMPLETED|Period 1: MDZ Alone||28
8411120|NCT00952653|20731222|P1|STARTED|Period 1: MDZ Alone||28
8411121|NCT00952614|20731247|P1|NOT COMPLETED|Overall Study||7
8411122|NCT00952614|20731247|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
8411123|NCT00952614|20731247|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
8411124|NCT00952614|20731247|P1|STARTED|Overall Study||30
8411125|NCT00952588|20731254|P2|NOT COMPLETED|Overall Study||24
8411126|NCT00952588|20731255|P1|NOT COMPLETED|Overall Study||36
8411127|NCT00952588|20731254|P2|COMPLETED|Overall Study||2
8411128|NCT00952588|20731255|P1|COMPLETED|Overall Study||12
8411129|NCT00952588|20731254|P2|STARTED|Overall Study||26
8411130|NCT00952588|20731255|P1|STARTED|Overall Study||48
8411131|NCT00952523|20731273|P1|NOT COMPLETED|Overall Study||7
8411132|NCT00952523|20731273|P1|COMPLETED|Overall Study||155
8411133|NCT00952523|20731273|P1|STARTED|Overall Study||162
8411134|NCT00952484|20731282|P3|NOT COMPLETED|Overall Study||0
8411135|NCT00952484|20731283|P2|NOT COMPLETED|Overall Study||1
8411136|NCT00952484|20731284|P1|NOT COMPLETED|Overall Study||0
8411137|NCT00952484|20731282|P3|COMPLETED|Overall Study||16
8411138|NCT00952484|20731283|P2|COMPLETED|Overall Study||6
8411139|NCT00952484|20731284|P1|COMPLETED|Overall Study||6
8411140|NCT00952484|20731282|P3|STARTED|Overall Study||16
8411141|NCT00952484|20731283|P2|STARTED|Overall Study||7
8411142|NCT00952484|20731284|P1|STARTED|Overall Study||6
8411143|NCT00952419|20731311|P3|NOT COMPLETED|Overall Study||0
8411144|NCT00952419|20731312|P2|NOT COMPLETED|Overall Study||10
8411145|NCT00952419|20731313|P1|NOT COMPLETED|Overall Study||6
8411146|NCT00952419|20731311|P3|COMPLETED|Overall Study||51
8411147|NCT00952419|20731312|P2|COMPLETED|Overall Study||198
8411148|NCT00952419|20731313|P1|COMPLETED|Overall Study||209
8411149|NCT00952419|20731311|P3|STARTED|Overall Study||51
8411150|NCT00952419|20731312|P2|STARTED|Overall Study||208
8411151|NCT00952419|20731313|P1|STARTED|Overall Study||215
8411152|NCT00952393|20731345|P1|NOT COMPLETED|Overall Study||0
8411153|NCT00952393|20731345|P1|COMPLETED|Overall Study||10
8411154|NCT00952393|20731345|P1|STARTED|Overall Study|10|10
8411155|NCT00952380|20731354|P5|NOT COMPLETED|Overall Study||6
8411156|NCT00952380|20731355|P4|NOT COMPLETED|Overall Study||3
8411157|NCT00952380|20731356|P3|NOT COMPLETED|Overall Study||2
8411158|NCT00952380|20731357|P2|NOT COMPLETED|Overall Study||1
8411159|NCT00952380|20731358|P1|NOT COMPLETED|Overall Study||0
8411160|NCT00952380|20731354|P5|COMPLETED|Overall Study||14
8411161|NCT00952380|20731355|P4|COMPLETED|Overall Study||4
8411162|NCT00952380|20731356|P3|COMPLETED|Overall Study||6
8411163|NCT00952380|20731357|P2|COMPLETED|Overall Study||1
8411164|NCT00952380|20731358|P1|COMPLETED|Overall Study||1
8411165|NCT00952380|20731354|P5|STARTED|Overall Study||20
8411166|NCT00952380|20731355|P4|STARTED|Overall Study||7
8411167|NCT00952380|20731356|P3|STARTED|Overall Study||8
8411168|NCT00952380|20731357|P2|STARTED|Overall Study||2
8411169|NCT00952380|20731358|P1|STARTED|Overall Study||1
8411170|NCT00952367|20731459|P1|NOT COMPLETED|Overall Study||6
8411171|NCT00952367|20731459|P1|COMPLETED|Overall Study||3635
8411172|NCT00952367|20731459|P1|STARTED|Overall Study||3641
8411173|NCT00952341|20731474|P2|NOT COMPLETED|Cycle 2||12
8411174|NCT00952341|20731475|P1|NOT COMPLETED|Cycle 2||9
8411175|NCT00952341|20731474|P2|COMPLETED|Cycle 2||118
8411176|NCT00952341|20731475|P1|COMPLETED|Cycle 2||101
8411177|NCT00952341|20731474|P2|STARTED|Cycle 2||130
8411178|NCT00952341|20731475|P1|STARTED|Cycle 2||110
8411179|NCT00952341|20731474|P2|NOT COMPLETED|Cycle 1||13
8411180|NCT00952341|20731475|P1|NOT COMPLETED|Cycle 1||20
8411181|NCT00952341|20731474|P2|COMPLETED|Cycle 1||199
8411182|NCT00952341|20731475|P1|COMPLETED|Cycle 1||189
8411183|NCT00952341|20731474|P2|STARTED|Cycle 1||212
8411184|NCT00952341|20731475|P1|STARTED|Cycle 1||209
8411185|NCT00952315|20731498|P3|NOT COMPLETED|Overall Study||19
8411186|NCT00952315|20731499|P2|NOT COMPLETED|Overall Study||24
8411187|NCT00952315|20731500|P1|NOT COMPLETED|Overall Study||26
8411188|NCT00952315|20731498|P3|COMPLETED|Overall Study||71
8411189|NCT00952315|20731499|P2|COMPLETED|Overall Study||66
8411190|NCT00952315|20731500|P1|COMPLETED|Overall Study||64
8411191|NCT00952315|20731498|P3|STARTED|Overall Study||90
8411192|NCT00952315|20731499|P2|STARTED|Overall Study||90
8411193|NCT00952315|20731500|P1|STARTED|Overall Study||90
8411194|NCT00952289|20731537|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
8411195|NCT00952289|20731538|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
8411196|NCT00952289|20731537|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
8411197|NCT00952289|20731538|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
8411198|NCT00952289|20731537|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
8411199|NCT00952289|20731538|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
8411200|NCT00952289|20731537|P2|NOT COMPLETED|All Participants||40
8411201|NCT00952289|20731538|P1|NOT COMPLETED|All Participants||21
8411202|NCT00952289|20731537|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
8411203|NCT00952289|20731538|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
8411204|NCT00952289|20731537|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
8411205|NCT00952289|20731538|P1|Safety Population|All Participants||155
8411206|NCT00952289|20731537|P2|STARTED|All Participants||154
8411207|NCT00952289|20731538|P1|STARTED|All Participants||155
8411208|NCT00952276|20731567|P5|NOT COMPLETED|Overall Study||0
8411209|NCT00952276|20731568|P4|NOT COMPLETED|Overall Study||1
8411210|NCT00952276|20731569|P3|NOT COMPLETED|Overall Study||0
8411211|NCT00952276|20731570|P2|NOT COMPLETED|Overall Study||0
8411212|NCT00952276|20731571|P1|NOT COMPLETED|Overall Study||1
8411213|NCT00952276|20731567|P5|COMPLETED|Overall Study||63
8411214|NCT00952276|20731568|P4|COMPLETED|Overall Study||120
8411215|NCT00952276|20731569|P3|COMPLETED|Overall Study||122
8411216|NCT00952276|20731570|P2|COMPLETED|Overall Study||115
8411217|NCT00952276|20731571|P1|COMPLETED|Overall Study||126
8411218|NCT00952276|20731567|P5|STARTED|Overall Study||63
8411219|NCT00952276|20731568|P4|STARTED|Overall Study||121
8411220|NCT00952276|20731569|P3|STARTED|Overall Study||122
8411221|NCT00952276|20731570|P2|STARTED|Overall Study||115
8411222|NCT00952276|20731571|P1|STARTED|Overall Study||127
8411223|NCT00952211|20731620|P2|NOT COMPLETED|Overall Study||0
8411224|NCT00952211|20731621|P1|NOT COMPLETED|Overall Study||0
8411225|NCT00952211|20731620|P2|COMPLETED|Overall Study||0
8411226|NCT00952211|20731621|P1|COMPLETED|Overall Study||3
8411227|NCT00952211|20731620|P2|STARTED|Overall Study||0
8411228|NCT00952211|20731621|P1|STARTED|Overall Study||3
8411229|NCT00952133|20731631|P2|NOT COMPLETED|Overall Study||0
8411230|NCT00952133|20731632|P1|NOT COMPLETED|Overall Study||0
8411231|NCT00952133|20731631|P2|COMPLETED|Overall Study||59
8411232|NCT00952133|20731632|P1|COMPLETED|Overall Study||59
8411233|NCT00952133|20731631|P2|STARTED|Overall Study||59
8411234|NCT00952133|20731632|P1|STARTED|Overall Study||59
8411235|NCT00952120|20731643|P3|NOT COMPLETED|Overall Study||0
8411236|NCT00952120|20731644|P2|NOT COMPLETED|Overall Study||0
8411237|NCT00952120|20731645|P1|NOT COMPLETED|Overall Study||0
8411238|NCT00952120|20731643|P3|COMPLETED|Overall Study||5
8411239|NCT00952120|20731644|P2|COMPLETED|Overall Study||47
8411240|NCT00952120|20731645|P1|COMPLETED|Overall Study||52
8411241|NCT00952120|20731643|P3|STARTED|Overall Study||5
8411242|NCT00952120|20731644|P2|STARTED|Overall Study||47
8411243|NCT00952120|20731645|P1|STARTED|Overall Study||52
8411244|NCT00952081|20731653|P1|NOT COMPLETED|Overall Study||0
8411245|NCT00952081|20731653|P1|COMPLETED|Overall Study||22
8411246|NCT00952081|20731653|P1|STARTED|Overall Study||22
8411247|NCT00952068|20731657|P1|NOT COMPLETED|Overall Study||7
8411248|NCT00952068|20731657|P1|COMPLETED|Overall Study||40
8411249|NCT00952068|20731657|P1|STARTED|Overall Study||47
8411250|NCT00951912|20731668|P3|NOT COMPLETED|Overall Study||2
8411251|NCT00951912|20731669|P2|NOT COMPLETED|Overall Study||5
8411252|NCT00951912|20731670|P1|NOT COMPLETED|Overall Study||7
8411253|NCT00951912|20731668|P3|COMPLETED|Overall Study||54
8411254|NCT00951912|20731669|P2|COMPLETED|Overall Study||50
8411255|NCT00951912|20731670|P1|COMPLETED|Overall Study||47
8411256|NCT00951912|20731668|P3|STARTED|Overall Study||56
8411257|NCT00951912|20731669|P2|STARTED|Overall Study||55
8411258|NCT00951912|20731670|P1|STARTED|Overall Study||54
8411259|NCT00951899|20731722|P2|NOT COMPLETED|Overall Study||0
8411260|NCT00951899|20731723|P1|NOT COMPLETED|Overall Study||0
8411261|NCT00951899|20731722|P2|COMPLETED|Overall Study||19
8411262|NCT00951899|20731723|P1|COMPLETED|Overall Study||19
8411263|NCT00951899|20731722|P2|STARTED|Overall Study||19
8411264|NCT00951899|20731723|P1|STARTED|Overall Study||19
8411265|NCT00951821|20731747|P2|NOT COMPLETED|Overall Study||0
8411266|NCT00951821|20731748|P1|NOT COMPLETED|Overall Study||0
8411267|NCT00951821|20731747|P2|COMPLETED|Overall Study||8
8411268|NCT00951821|20731748|P1|COMPLETED|Overall Study||16
8411269|NCT00951821|20731747|P2|STARTED|Overall Study||8
8411270|NCT00951821|20731748|P1|STARTED|Overall Study||16
8411271|NCT00951808|20731756|P3|NOT COMPLETED|Overall Study||4
8411272|NCT00951808|20731757|P2|NOT COMPLETED|Overall Study||0
8411273|NCT00951808|20731758|P1|NOT COMPLETED|Overall Study||0
8411274|NCT00951808|20731756|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
8411275|NCT00951808|20731757|P2|COMPLETED|Overall Study||6
8411276|NCT00951808|20731758|P1|COMPLETED|Overall Study||4
8411277|NCT00951808|20731756|P3|STARTED|Overall Study||227
8411278|NCT00951808|20731757|P2|STARTED|Overall Study||6
8411279|NCT00951808|20731758|P1|STARTED|Overall Study||4
8411280|NCT00951665|20731770|P6|NOT COMPLETED|Phase 2a||7
8411281|NCT00951665|20731771|P5|NOT COMPLETED|Phase 2a||12
8411282|NCT00951665|20731772|P4|NOT COMPLETED|Phase 2a||0
8411283|NCT00951665|20731773|P3|NOT COMPLETED|Phase 2a||0
8411284|NCT00951665|20731774|P2|NOT COMPLETED|Phase 2a||0
8411285|NCT00951665|20731775|P1|NOT COMPLETED|Phase 2a||0
8411286|NCT00951665|20731770|P6|COMPLETED|Phase 2a||15
8411287|NCT00951665|20731771|P5|COMPLETED|Phase 2a||10
8411288|NCT00951665|20731772|P4|COMPLETED|Phase 2a||0
8411289|NCT00951665|20731773|P3|COMPLETED|Phase 2a||0
8411290|NCT00951665|20731774|P2|COMPLETED|Phase 2a||0
8411291|NCT00951665|20731775|P1|COMPLETED|Phase 2a||0
8411292|NCT00951665|20731770|P6|STARTED|Phase 2a||22
8411293|NCT00951665|20731771|P5|STARTED|Phase 2a||22
8411294|NCT00951665|20731772|P4|STARTED|Phase 2a||0
8411295|NCT00951665|20731773|P3|STARTED|Phase 2a||0
8411296|NCT00951665|20731774|P2|STARTED|Phase 2a||0
8411297|NCT00951665|20731775|P1|STARTED|Phase 2a||0
8411298|NCT00951665|20731770|P6|NOT COMPLETED|Phase 1b||0
8411299|NCT00951665|20731771|P5|NOT COMPLETED|Phase 1b||0
8411300|NCT00951665|20731772|P4|NOT COMPLETED|Phase 1b||1
8411301|NCT00951665|20731773|P3|NOT COMPLETED|Phase 1b||17
8411302|NCT00951665|20731774|P2|NOT COMPLETED|Phase 1b||4
8411303|NCT00951665|20731775|P1|NOT COMPLETED|Phase 1b||22
8411304|NCT00951665|20731770|P6|COMPLETED|Phase 1b||0
8411305|NCT00951665|20731771|P5|COMPLETED|Phase 1b||0
8411306|NCT00951665|20731772|P4|COMPLETED|Phase 1b||2
8411307|NCT00951665|20731773|P3|COMPLETED|Phase 1b||4
8411308|NCT00951665|20731774|P2|COMPLETED|Phase 1b||6
8411309|NCT00951665|20731775|P1|COMPLETED|Phase 1b||7
8411310|NCT00951665|20731770|P6|Started Treatment|Phase 1b||0
8411311|NCT00951665|20731771|P5|Started Treatment|Phase 1b||0
8411312|NCT00951665|20731772|P4|Started Treatment|Phase 1b||3
8411313|NCT00951665|20731773|P3|Started Treatment|Phase 1b||21
8411314|NCT00951665|20731774|P2|Started Treatment|Phase 1b||10
8411315|NCT00951665|20731775|P1|Started Treatment|Phase 1b||26
8411316|NCT00951665|20731770|P6|STARTED|Phase 1b||0
8411317|NCT00951665|20731771|P5|STARTED|Phase 1b||0
8411318|NCT00951665|20731772|P4|STARTED|Phase 1b||3
8411319|NCT00951665|20731773|P3|STARTED|Phase 1b||21
8411320|NCT00951665|20731774|P2|STARTED|Phase 1b||10
8411321|NCT00951665|20731775|P1|STARTED|Phase 1b||29
8411322|NCT00951561|20731876|P4|NOT COMPLETED|Overall Study||1
8411323|NCT00951561|20731877|P3|NOT COMPLETED|Overall Study||3
8411324|NCT00951561|20731878|P2|NOT COMPLETED|Overall Study||0
8411325|NCT00951561|20731879|P1|NOT COMPLETED|Overall Study||0
8411326|NCT00951561|20731876|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
8411327|NCT00951561|20731877|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
8411328|NCT00951561|20731878|P2|COMPLETED|Overall Study||29
8411329|NCT00951561|20731879|P1|COMPLETED|Overall Study||25
8411330|NCT00951561|20731876|P4|STARTED|Overall Study||27
8411331|NCT00951561|20731877|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
8411332|NCT00951561|20731878|P2|STARTED|Overall Study||29
8411333|NCT00951561|20731879|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
8411334|NCT00951509|20731884|P1|NOT COMPLETED|Overall Study||2
8411335|NCT00951509|20731884|P1|COMPLETED|Overall Study||29
8411336|NCT00951509|20731884|P1|Driving Condition 5|Overall Study||30
8411337|NCT00951509|20731884|P1|Driving Condition 4|Overall Study||28
8411338|NCT00951509|20731884|P1|Driving Condition 3|Overall Study||25
8411339|NCT00951509|20731884|P1|Driving Condition 2|Overall Study||29
8411340|NCT00951509|20731884|P1|Driving Condition 1|Overall Study||29
8411341|NCT00951509|20731884|P1|STARTED|Overall Study||31
8411351|NCT00951483|20731925|P2|NOT COMPLETED|Overall Study||0
8411352|NCT00951483|20731926|P1|NOT COMPLETED|Overall Study||19
8411353|NCT00951483|20731925|P2|COMPLETED|Overall Study||44
8411354|NCT00951483|20731926|P1|COMPLETED|Overall Study||28
8411355|NCT00951483|20731925|P2|STARTED|Overall Study||44
8411356|NCT00951483|20731926|P1|STARTED|Overall Study||47
8411357|NCT00951379|20731946|P2|NOT COMPLETED|Overall Study||2
8411358|NCT00951379|20731947|P1|NOT COMPLETED|Overall Study||6
8411359|NCT00951379|20731946|P2|COMPLETED|Overall Study||23
8411360|NCT00951379|20731947|P1|COMPLETED|Overall Study||21
8411361|NCT00951379|20731946|P2|STARTED|Overall Study||25
8411362|NCT00951379|20731947|P1|STARTED|Overall Study||27
8411363|NCT00951275|20731989|P1|NOT COMPLETED|Overall Study||13
8411364|NCT00951275|20731989|P1|COMPLETED|Overall Study||92
8411365|NCT00951275|20731989|P1|STARTED|Overall Study||105
8411366|NCT00951171|20732021|P2|NOT COMPLETED|Overall Study||0
8411367|NCT00951171|20732022|P1|NOT COMPLETED|Overall Study||2
8411368|NCT00951171|20732021|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
8411369|NCT00951171|20732022|P1|COMPLETED|Overall Study||38
8411370|NCT00951171|20732021|P2|Pregnancy|Overall Study||7
8411371|NCT00951171|20732022|P1|Pregnancy|Overall Study||1
8411372|NCT00951171|20732021|P2|STARTED|Overall Study||55
8411373|NCT00951171|20732022|P1|STARTED|Overall Study||40
8411374|NCT00951093|20732028|P1|NOT COMPLETED|6 Months After GBP||0
8411375|NCT00951093|20732028|P1|COMPLETED|6 Months After GBP||53
8411376|NCT00951093|20732028|P1|STARTED|6 Months After GBP||53
8411377|NCT00951093|20732028|P1|NOT COMPLETED|Before GBP||0
8411378|NCT00951093|20732028|P1|COMPLETED|Before GBP||53
8411379|NCT00951093|20732028|P1|STARTED|Before GBP||53
8411380|NCT00951080|20732054|P2|NOT COMPLETED|Overall Study||27
8411381|NCT00951080|20732055|P1|NOT COMPLETED|Overall Study||26
8411382|NCT00951080|20732054|P2|COMPLETED|Overall Study||41
8411383|NCT00951080|20732055|P1|COMPLETED|Overall Study||38
8411384|NCT00951080|20732054|P2|STARTED|Overall Study||68
8411385|NCT00951080|20732055|P1|STARTED|Overall Study||64
8411386|NCT00951041|20732063|P2|NOT COMPLETED|Overall Study||1
8411387|NCT00951041|20732064|P1|NOT COMPLETED|Overall Study||5
8411388|NCT00951041|20732063|P2|COMPLETED|Overall Study||65
8411389|NCT00951041|20732064|P1|COMPLETED|Overall Study||59
8411390|NCT00951041|20732063|P2|STARTED|Overall Study||66
8411391|NCT00951041|20732064|P1|STARTED|Overall Study||64
8411392|NCT00951015|20732119|P5|NOT COMPLETED|Open-label Phase||50
8411393|NCT00951015|20732120|P4|NOT COMPLETED|Open-label Phase||0
8411394|NCT00951015|20732121|P3|NOT COMPLETED|Open-label Phase||0
8411395|NCT00951015|20732122|P2|NOT COMPLETED|Open-label Phase||0
8411396|NCT00951015|20732123|P1|NOT COMPLETED|Open-label Phase||0
8411397|NCT00951015|20732119|P5|COMPLETED|Open-label Phase||88
8411398|NCT00951015|20732120|P4|COMPLETED|Open-label Phase||0
8411399|NCT00951015|20732121|P3|COMPLETED|Open-label Phase||0
8411400|NCT00951015|20732122|P2|COMPLETED|Open-label Phase||0
8411401|NCT00951015|20732123|P1|COMPLETED|Open-label Phase||0
8411402|NCT00951015|20732119|P5|STARTED|Open-label Phase||138
8411403|NCT00951015|20732120|P4|STARTED|Open-label Phase||0
8411404|NCT00951015|20732121|P3|STARTED|Open-label Phase||0
8411405|NCT00951015|20732122|P2|STARTED|Open-label Phase||0
8411406|NCT00951015|20732123|P1|STARTED|Open-label Phase||0
8411407|NCT00951015|20732119|P5|NOT COMPLETED|Randomization Phase 96 Week||0
8411408|NCT00951015|20732120|P4|NOT COMPLETED|Randomization Phase 96 Week||10
8411409|NCT00951015|20732121|P3|NOT COMPLETED|Randomization Phase 96 Week||5
8411410|NCT00951015|20732122|P2|NOT COMPLETED|Randomization Phase 96 Week||7
8411411|NCT00951015|20732123|P1|NOT COMPLETED|Randomization Phase 96 Week||5
8411412|NCT00951015|20732119|P5|COMPLETED|Randomization Phase 96 Week||0
8411413|NCT00951015|20732120|P4|COMPLETED|Randomization Phase 96 Week||40
8411414|NCT00951015|20732121|P3|COMPLETED|Randomization Phase 96 Week||46
8411415|NCT00951015|20732122|P2|COMPLETED|Randomization Phase 96 Week||44
8411416|NCT00951015|20732123|P1|COMPLETED|Randomization Phase 96 Week||48
8411417|NCT00951015|20732119|P5|STARTED|Randomization Phase 96 Week||0
8411418|NCT00951015|20732120|P4|STARTED|Randomization Phase 96 Week||50
8411419|NCT00951015|20732121|P3|STARTED|Randomization Phase 96 Week||51
8411420|NCT00951015|20732122|P2|STARTED|Randomization Phase 96 Week||51
8411421|NCT00951015|20732123|P1|STARTED|Randomization Phase 96 Week||53
8411422|NCT00950963|20732220|P2|NOT COMPLETED|Overall Study||24
8411423|NCT00950963|20732221|P1|NOT COMPLETED|Overall Study||29
8411424|NCT00950963|20732220|P2|COMPLETED|Overall Study||357
8411425|NCT00950963|20732221|P1|COMPLETED|Overall Study||352
8411426|NCT00950963|20732220|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
8411427|NCT00950963|20732221|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
8411428|NCT00950950|20732237|P2|NOT COMPLETED|Overall Study||1
8411429|NCT00950950|20732238|P1|NOT COMPLETED|Overall Study||1
8411430|NCT00950950|20732237|P2|COMPLETED|Overall Study||11
8411431|NCT00950950|20732238|P1|COMPLETED|Overall Study||11
8411432|NCT00950950|20732237|P2|STARTED|Overall Study||12
8411433|NCT00950950|20732238|P1|STARTED|Overall Study||12
8411434|NCT00950937|20732301|P2|NOT COMPLETED|Overall Study||0
8411435|NCT00950937|20732302|P1|NOT COMPLETED|Overall Study||0
8411436|NCT00950937|20732301|P2|COMPLETED|Overall Study||14
8411437|NCT00950937|20732302|P1|COMPLETED|Overall Study||14
8411438|NCT00950937|20732301|P2|STARTED|Overall Study||14
8411439|NCT00950937|20732302|P1|STARTED|Overall Study||14
8411440|NCT00950911|20732320|P2|NOT COMPLETED|Overall Study||15
8411441|NCT00950911|20732321|P1|NOT COMPLETED|Overall Study||12
8411442|NCT00950911|20732320|P2|COMPLETED|Overall Study||3
8411443|NCT00950911|20732321|P1|COMPLETED|Overall Study||5
8411444|NCT00950911|20732320|P2|STARTED|Overall Study||18
8411445|NCT00950911|20732321|P1|STARTED|Overall Study||17
8411446|NCT00950872|20732327|P1|NOT COMPLETED|Overall Study||3
8411447|NCT00950872|20732327|P1|COMPLETED|Overall Study||26
8411448|NCT00950872|20732327|P1|STARTED|Overall Study||29
8411449|NCT00950859|20732336|P2|NOT COMPLETED|Overall Study||10
8411450|NCT00950859|20732337|P1|NOT COMPLETED|Overall Study||16
8411451|NCT00950859|20732336|P2|COMPLETED|Overall Study||14
8411452|NCT00950859|20732337|P1|COMPLETED|Overall Study||11
8411453|NCT00950859|20732336|P2|STARTED|Overall Study||24
8411454|NCT00950859|20732337|P1|STARTED|Overall Study||27
8411455|NCT00950833|20732380|P3|NOT COMPLETED|Overall Study||0
8411456|NCT00950833|20732381|P2|NOT COMPLETED|Overall Study||0
8411457|NCT00950833|20732382|P1|NOT COMPLETED|Overall Study||0
8411458|NCT00950833|20732380|P3|COMPLETED|Overall Study||223
8411459|NCT00950833|20732381|P2|COMPLETED|Overall Study||108
8411460|NCT00950833|20732382|P1|COMPLETED|Overall Study||112
8411461|NCT00950833|20732380|P3|STARTED|Overall Study||223
8411462|NCT00950833|20732381|P2|STARTED|Overall Study||108
8411463|NCT00950833|20732382|P1|STARTED|Overall Study||112
8411464|NCT00950807|20732436|P10|NOT COMPLETED|Treatment Period 3||1
8411465|NCT00950807|20732437|P9|NOT COMPLETED|Treatment Period 3||0
8411466|NCT00950807|20732438|P8|NOT COMPLETED|Treatment Period 3||1
8411467|NCT00950807|20732439|P7|NOT COMPLETED|Treatment Period 3||1
8411468|NCT00950807|20732440|P6|NOT COMPLETED|Treatment Period 3||0
8411469|NCT00950807|20732441|P5|NOT COMPLETED|Treatment Period 3||0
8411470|NCT00950807|20732442|P4|NOT COMPLETED|Treatment Period 3||0
8411471|NCT00950807|20732443|P3|NOT COMPLETED|Treatment Period 3||0
8411472|NCT00950807|20732444|P2|NOT COMPLETED|Treatment Period 3||0
8411473|NCT00950807|20732445|P1|NOT COMPLETED|Treatment Period 3||1
8411474|NCT00950807|20732436|P10|COMPLETED|Treatment Period 3||10
8411475|NCT00950807|20732437|P9|COMPLETED|Treatment Period 3||9
8411476|NCT00950807|20732438|P8|COMPLETED|Treatment Period 3||9
8411477|NCT00950807|20732439|P7|COMPLETED|Treatment Period 3||11
8411478|NCT00950807|20732440|P6|COMPLETED|Treatment Period 3||9
8411479|NCT00950807|20732441|P5|COMPLETED|Treatment Period 3||12
8411480|NCT00950807|20732442|P4|COMPLETED|Treatment Period 3||11
8411481|NCT00950807|20732443|P3|COMPLETED|Treatment Period 3||10
8411482|NCT00950807|20732444|P2|COMPLETED|Treatment Period 3||9
8411483|NCT00950807|20732445|P1|COMPLETED|Treatment Period 3||45
8411484|NCT00950807|20732436|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411485|NCT00950807|20732437|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8411486|NCT00950807|20732438|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411487|NCT00950807|20732439|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
8411488|NCT00950807|20732440|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8411489|NCT00950807|20732441|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
8411490|NCT00950807|20732442|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411491|NCT00950807|20732443|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411492|NCT00950807|20732444|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8411493|NCT00950807|20732445|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
8411494|NCT00950807|20732436|P10|NOT COMPLETED|Washout Period 2||0
8411495|NCT00950807|20732437|P9|NOT COMPLETED|Washout Period 2||0
8411496|NCT00950807|20732438|P8|NOT COMPLETED|Washout Period 2||1
8411497|NCT00950807|20732439|P7|NOT COMPLETED|Washout Period 2||1
8411498|NCT00950807|20732440|P6|NOT COMPLETED|Washout Period 2||0
8411499|NCT00950807|20732441|P5|NOT COMPLETED|Washout Period 2||1
8411500|NCT00950807|20732442|P4|NOT COMPLETED|Washout Period 2||1
8411501|NCT00950807|20732443|P3|NOT COMPLETED|Washout Period 2||0
8411502|NCT00950807|20732444|P2|NOT COMPLETED|Washout Period 2||1
8411503|NCT00950807|20732445|P1|NOT COMPLETED|Washout Period 2||4
8411504|NCT00950807|20732436|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411505|NCT00950807|20732437|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411506|NCT00950807|20732438|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
8411507|NCT00950807|20732439|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
8411508|NCT00950807|20732440|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
8411509|NCT00950807|20732441|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
8411510|NCT00950807|20732442|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411511|NCT00950807|20732443|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
8411512|NCT00950807|20732444|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411513|NCT00950807|20732445|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
8411514|NCT00950807|20732436|P10|STARTED|Washout Period 2||11
8411515|NCT00950807|20732437|P9|STARTED|Washout Period 2||11
8411516|NCT00950807|20732438|P8|STARTED|Washout Period 2||10
8411517|NCT00950807|20732439|P7|STARTED|Washout Period 2||9
8411518|NCT00950807|20732440|P6|STARTED|Washout Period 2||9
8411519|NCT00950807|20732441|P5|STARTED|Washout Period 2||13
8411520|NCT00950807|20732442|P4|STARTED|Washout Period 2||12
8411521|NCT00950807|20732443|P3|STARTED|Washout Period 2||10
8411522|NCT00950807|20732444|P2|STARTED|Washout Period 2||12
8411523|NCT00950807|20732445|P1|STARTED|Washout Period 2||51
8411524|NCT00950807|20732436|P10|NOT COMPLETED|Treatment Period 2||0
8411525|NCT00950807|20732437|P9|NOT COMPLETED|Treatment Period 2||0
8411526|NCT00950807|20732438|P8|NOT COMPLETED|Treatment Period 2||3
8411527|NCT00950807|20732439|P7|NOT COMPLETED|Treatment Period 2||1
8411528|NCT00950807|20732440|P6|NOT COMPLETED|Treatment Period 2||1
8411529|NCT00950807|20732441|P5|NOT COMPLETED|Treatment Period 2||0
8411530|NCT00950807|20732442|P4|NOT COMPLETED|Treatment Period 2||1
8411531|NCT00950807|20732443|P3|NOT COMPLETED|Treatment Period 2||0
8411532|NCT00950807|20732444|P2|NOT COMPLETED|Treatment Period 2||1
8411533|NCT00950807|20732445|P1|NOT COMPLETED|Treatment Period 2||2
8411534|NCT00950807|20732436|P10|COMPLETED|Treatment Period 2||11
8411535|NCT00950807|20732437|P9|COMPLETED|Treatment Period 2||11
8411536|NCT00950807|20732438|P8|COMPLETED|Treatment Period 2||10
8411537|NCT00950807|20732439|P7|COMPLETED|Treatment Period 2||9
8411538|NCT00950807|20732440|P6|COMPLETED|Treatment Period 2||9
8411539|NCT00950807|20732441|P5|COMPLETED|Treatment Period 2||13
8411540|NCT00950807|20732442|P4|COMPLETED|Treatment Period 2||12
8411541|NCT00950807|20732443|P3|COMPLETED|Treatment Period 2||10
8411542|NCT00950807|20732444|P2|COMPLETED|Treatment Period 2||12
8411543|NCT00950807|20732445|P1|COMPLETED|Treatment Period 2||51
8411544|NCT00950807|20732436|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411545|NCT00950807|20732437|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411546|NCT00950807|20732438|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411547|NCT00950807|20732439|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411548|NCT00950807|20732440|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411549|NCT00950807|20732441|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411626|NCT00950729|20732530|P1|NOT COMPLETED|Driving With Aircast||0
8411550|NCT00950807|20732442|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411551|NCT00950807|20732443|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411552|NCT00950807|20732444|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411553|NCT00950807|20732445|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
8411554|NCT00950807|20732436|P10|NOT COMPLETED|Washout Period 1||0
8411555|NCT00950807|20732437|P9|NOT COMPLETED|Washout Period 1||1
8411556|NCT00950807|20732438|P8|NOT COMPLETED|Washout Period 1||1
8411557|NCT00950807|20732439|P7|NOT COMPLETED|Washout Period 1||2
8411558|NCT00950807|20732440|P6|NOT COMPLETED|Washout Period 1||0
8411559|NCT00950807|20732441|P5|NOT COMPLETED|Washout Period 1||1
8411560|NCT00950807|20732442|P4|NOT COMPLETED|Washout Period 1||1
8411561|NCT00950807|20732443|P3|NOT COMPLETED|Washout Period 1||0
8411562|NCT00950807|20732444|P2|NOT COMPLETED|Washout Period 1||0
8411563|NCT00950807|20732445|P1|NOT COMPLETED|Washout Period 1||5
8411564|NCT00950807|20732436|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411565|NCT00950807|20732437|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411566|NCT00950807|20732438|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411567|NCT00950807|20732439|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
8411568|NCT00950807|20732440|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411569|NCT00950807|20732441|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411570|NCT00950807|20732442|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411571|NCT00950807|20732443|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411572|NCT00950807|20732444|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411573|NCT00950807|20732445|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
8411574|NCT00950807|20732436|P10|STARTED|Washout Period 1||13
8411575|NCT00950807|20732437|P9|STARTED|Washout Period 1||12
8411576|NCT00950807|20732438|P8|STARTED|Washout Period 1||14
8411577|NCT00950807|20732439|P7|STARTED|Washout Period 1||12
8411578|NCT00950807|20732440|P6|STARTED|Washout Period 1||11
8411579|NCT00950807|20732441|P5|STARTED|Washout Period 1||12
8411580|NCT00950807|20732442|P4|STARTED|Washout Period 1||12
8411581|NCT00950807|20732443|P3|STARTED|Washout Period 1||13
8411582|NCT00950807|20732444|P2|STARTED|Washout Period 1||13
8411583|NCT00950807|20732445|P1|STARTED|Washout Period 1||56
8411584|NCT00950807|20732436|P10|NOT COMPLETED|Treatment Period 1||0
8411585|NCT00950807|20732437|P9|NOT COMPLETED|Treatment Period 1||1
8411586|NCT00950807|20732438|P8|NOT COMPLETED|Treatment Period 1||0
8411587|NCT00950807|20732439|P7|NOT COMPLETED|Treatment Period 1||0
8411588|NCT00950807|20732440|P6|NOT COMPLETED|Treatment Period 1||2
8411589|NCT00950807|20732441|P5|NOT COMPLETED|Treatment Period 1||1
8411590|NCT00950807|20732442|P4|NOT COMPLETED|Treatment Period 1||0
8411591|NCT00950807|20732443|P3|NOT COMPLETED|Treatment Period 1||1
8411592|NCT00950807|20732444|P2|NOT COMPLETED|Treatment Period 1||0
8411593|NCT00950807|20732445|P1|NOT COMPLETED|Treatment Period 1||3
8411594|NCT00950807|20732436|P10|COMPLETED|Treatment Period 1||13
8411595|NCT00950807|20732437|P9|COMPLETED|Treatment Period 1||12
8411596|NCT00950807|20732438|P8|COMPLETED|Treatment Period 1||14
8411597|NCT00950807|20732439|P7|COMPLETED|Treatment Period 1||12
8411598|NCT00950807|20732440|P6|COMPLETED|Treatment Period 1||11
8411599|NCT00950807|20732441|P5|COMPLETED|Treatment Period 1||12
8411600|NCT00950807|20732442|P4|COMPLETED|Treatment Period 1||12
8411601|NCT00950807|20732443|P3|COMPLETED|Treatment Period 1||13
8411602|NCT00950807|20732444|P2|COMPLETED|Treatment Period 1||13
8411603|NCT00950807|20732445|P1|COMPLETED|Treatment Period 1||56
8411604|NCT00950807|20732436|P10|STARTED|Treatment Period 1||13
8411605|NCT00950807|20732437|P9|STARTED|Treatment Period 1||13
8411606|NCT00950807|20732438|P8|STARTED|Treatment Period 1||14
8411607|NCT00950807|20732439|P7|STARTED|Treatment Period 1||12
8411608|NCT00950807|20732440|P6|STARTED|Treatment Period 1||13
8411609|NCT00950807|20732441|P5|STARTED|Treatment Period 1||13
8411610|NCT00950807|20732442|P4|STARTED|Treatment Period 1||12
8411611|NCT00950807|20732443|P3|STARTED|Treatment Period 1||14
8411612|NCT00950807|20732444|P2|STARTED|Treatment Period 1||13
8411613|NCT00950807|20732445|P1|STARTED|Treatment Period 1||59
8411614|NCT00950755|20732487|P1|NOT COMPLETED|Long-Term Follow-Up||9
8411615|NCT00950755|20732487|P1|COMPLETED|Long-Term Follow-Up||9
8411616|NCT00950755|20732487|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
8411617|NCT00950755|20732487|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
8411618|NCT00950755|20732487|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8411619|NCT00950755|20732487|P1|STARTED|Dosimetric and Therapeutic Treatment||41
8411620|NCT00950742|20732513|P2|NOT COMPLETED|Overall Study||2
8411621|NCT00950742|20732514|P1|NOT COMPLETED|Overall Study||16
8411622|NCT00950742|20732513|P2|COMPLETED|Overall Study||0
8411623|NCT00950742|20732514|P1|COMPLETED|Overall Study||0
8411624|NCT00950742|20732513|P2|STARTED|Overall Study|entered and treated|2
8411625|NCT00950742|20732514|P1|STARTED|Overall Study|entered and treated|16
8411627|NCT00950729|20732530|P1|COMPLETED|Driving With Aircast||48
8411628|NCT00950729|20732530|P1|STARTED|Driving With Aircast||48
8411629|NCT00950729|20732530|P1|NOT COMPLETED|Driving With Plaster Cast||0
8411630|NCT00950729|20732530|P1|COMPLETED|Driving With Plaster Cast||48
8411631|NCT00950729|20732530|P1|STARTED|Driving With Plaster Cast||48
8411632|NCT00950729|20732530|P1|NOT COMPLETED|Driving With Running Shoes||0
8411633|NCT00950729|20732530|P1|COMPLETED|Driving With Running Shoes|June 2007|48
8411634|NCT00950729|20732530|P1|STARTED|Driving With Running Shoes|March 2007|48
8411638|NCT00950664|20732542|P2|NOT COMPLETED|Second Intervention||48
8411639|NCT00950664|20732543|P1|NOT COMPLETED|Second Intervention||46
8411640|NCT00950664|20732542|P2|COMPLETED|Second Intervention||0
8411641|NCT00950664|20732543|P1|COMPLETED|Second Intervention||0
8411642|NCT00950664|20732542|P2|STARTED|Second Intervention||48
8411643|NCT00950664|20732543|P1|STARTED|Second Intervention||46
8411644|NCT00950664|20732542|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
8411645|NCT00950664|20732543|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
8411646|NCT00950664|20732542|P2|COMPLETED|Washout Period of 4 Weeks||48
8411647|NCT00950664|20732543|P1|COMPLETED|Washout Period of 4 Weeks||46
8411648|NCT00950664|20732542|P2|STARTED|Washout Period of 4 Weeks||48
8411649|NCT00950664|20732543|P1|STARTED|Washout Period of 4 Weeks||46
8411650|NCT00950664|20732542|P2|NOT COMPLETED|First Intervention||5
8411651|NCT00950664|20732543|P1|NOT COMPLETED|First Intervention||3
8411652|NCT00950664|20732542|P2|COMPLETED|First Intervention||48
8411653|NCT00950664|20732543|P1|COMPLETED|First Intervention||46
8411654|NCT00950664|20732542|P2|STARTED|First Intervention||53
8411655|NCT00950664|20732543|P1|STARTED|First Intervention||49
8411656|NCT00950651|20732563|P2|NOT COMPLETED|Overall Study||35
8411657|NCT00950651|20732564|P1|NOT COMPLETED|Overall Study||31
8411658|NCT00950651|20732563|P2|COMPLETED|Overall Study||181
8411659|NCT00950651|20732564|P1|COMPLETED|Overall Study||184
8411660|NCT00950651|20732563|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
8411661|NCT00950651|20732564|P1|STARTED|Overall Study||215
8411662|NCT00950612|20732612|P2|NOT COMPLETED|Overall Study||0
8411663|NCT00950612|20732613|P1|NOT COMPLETED|Overall Study||0
8411664|NCT00950612|20732612|P2|COMPLETED|Overall Study||20
8411665|NCT00950612|20732613|P1|COMPLETED|Overall Study||40
8411666|NCT00950612|20732612|P2|STARTED|Overall Study||20
8411667|NCT00950612|20732613|P1|STARTED|Overall Study||40
8411668|NCT00950599|20732657|P10|NOT COMPLETED|Follow-Up Period||2
8411669|NCT00950599|20732658|P9|NOT COMPLETED|Follow-Up Period||13
8411670|NCT00950599|20732659|P8|NOT COMPLETED|Follow-Up Period||0
8411671|NCT00950599|20732660|P7|NOT COMPLETED|Follow-Up Period||0
8411672|NCT00950599|20732661|P6|NOT COMPLETED|Follow-Up Period||0
8411673|NCT00950599|20732662|P5|NOT COMPLETED|Follow-Up Period||0
8411674|NCT00950599|20732663|P4|NOT COMPLETED|Follow-Up Period||0
8411675|NCT00950599|20732664|P3|NOT COMPLETED|Follow-Up Period||0
8411676|NCT00950599|20732665|P2|NOT COMPLETED|Follow-Up Period||0
8411677|NCT00950599|20732666|P1|NOT COMPLETED|Follow-Up Period||0
8411678|NCT00950599|20732657|P10|COMPLETED|Follow-Up Period||78
8411679|NCT00950599|20732658|P9|COMPLETED|Follow-Up Period||296
8411680|NCT00950599|20732659|P8|COMPLETED|Follow-Up Period||0
8411681|NCT00950599|20732660|P7|COMPLETED|Follow-Up Period||0
8411682|NCT00950599|20732661|P6|COMPLETED|Follow-Up Period||0
8411683|NCT00950599|20732662|P5|COMPLETED|Follow-Up Period||0
8411684|NCT00950599|20732663|P4|COMPLETED|Follow-Up Period||0
8411685|NCT00950599|20732664|P3|COMPLETED|Follow-Up Period||0
8411686|NCT00950599|20732665|P2|COMPLETED|Follow-Up Period||0
8411687|NCT00950599|20732666|P1|COMPLETED|Follow-Up Period||0
8411688|NCT00950599|20732657|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
8411689|NCT00950599|20732658|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
8411690|NCT00950599|20732659|P8|STARTED|Follow-Up Period||0
8411691|NCT00950599|20732660|P7|STARTED|Follow-Up Period||0
8411692|NCT00950599|20732661|P6|STARTED|Follow-Up Period||0
8411693|NCT00950599|20732662|P5|STARTED|Follow-Up Period||0
8411694|NCT00950599|20732663|P4|STARTED|Follow-Up Period||0
8411695|NCT00950599|20732664|P3|STARTED|Follow-Up Period||0
8411696|NCT00950599|20732665|P2|STARTED|Follow-Up Period||0
8411697|NCT00950599|20732666|P1|STARTED|Follow-Up Period||0
8411698|NCT00950599|20732657|P10|NOT COMPLETED|Double-Blind Treatment Period||0
8411699|NCT00950599|20732658|P9|NOT COMPLETED|Double-Blind Treatment Period||0
8411700|NCT00950599|20732659|P8|NOT COMPLETED|Double-Blind Treatment Period||6
8411701|NCT00950599|20732660|P7|NOT COMPLETED|Double-Blind Treatment Period||0
8411702|NCT00950599|20732661|P6|NOT COMPLETED|Double-Blind Treatment Period||12
8411703|NCT00950599|20732662|P5|NOT COMPLETED|Double-Blind Treatment Period||7
8411704|NCT00950599|20732663|P4|NOT COMPLETED|Double-Blind Treatment Period||11
8411705|NCT00950599|20732664|P3|NOT COMPLETED|Double-Blind Treatment Period||9
8411706|NCT00950599|20732665|P2|NOT COMPLETED|Double-Blind Treatment Period||10
8411707|NCT00950599|20732666|P1|NOT COMPLETED|Double-Blind Treatment Period||7
8411708|NCT00950599|20732657|P10|COMPLETED|Double-Blind Treatment Period||0
8411709|NCT00950599|20732658|P9|COMPLETED|Double-Blind Treatment Period||0
8411710|NCT00950599|20732659|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
8411711|NCT00950599|20732660|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
8411712|NCT00950599|20732661|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
8411713|NCT00950599|20732662|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
8411714|NCT00950599|20732663|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
8411715|NCT00950599|20732664|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
8411716|NCT00950599|20732665|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
8411717|NCT00950599|20732666|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
8411718|NCT00950599|20732657|P10|STARTED|Double-Blind Treatment Period||0
8411719|NCT00950599|20732658|P9|STARTED|Double-Blind Treatment Period||0
8411720|NCT00950599|20732659|P8|STARTED|Double-Blind Treatment Period||41
8411721|NCT00950599|20732660|P7|STARTED|Double-Blind Treatment Period||44
8411722|NCT00950599|20732661|P6|STARTED|Double-Blind Treatment Period||67
8411723|NCT00950599|20732662|P5|STARTED|Double-Blind Treatment Period||52
8411724|NCT00950599|20732663|P4|STARTED|Double-Blind Treatment Period||54
8411725|NCT00950599|20732664|P3|STARTED|Double-Blind Treatment Period||63
8411726|NCT00950599|20732665|P2|STARTED|Double-Blind Treatment Period||47
8411727|NCT00950599|20732666|P1|STARTED|Double-Blind Treatment Period||55
8411728|NCT00950365|20733230|P2|NOT COMPLETED|Overall Study||2
8411729|NCT00950365|20733231|P1|NOT COMPLETED|Overall Study||2
8411730|NCT00950365|20733230|P2|COMPLETED|Overall Study||50
8411731|NCT00950365|20733231|P1|COMPLETED|Overall Study||25
8411732|NCT00950365|20733230|P2|STARTED|Overall Study||52
8411733|NCT00950365|20733231|P1|STARTED|Overall Study||27
8411734|NCT00950352|20733243|P2|NOT COMPLETED|Overall Study||11
8411735|NCT00950352|20733244|P1|NOT COMPLETED|Overall Study||42
8411736|NCT00950352|20733243|P2|COMPLETED|Overall Study||21
8411737|NCT00950352|20733244|P1|COMPLETED|Overall Study||30
8411738|NCT00950352|20733243|P2|STARTED|Overall Study||32
8411739|NCT00950352|20733244|P1|STARTED|Overall Study||72
8411740|NCT00950300|20733252|P2|NOT COMPLETED|SFU Period||78
8411741|NCT00950300|20733253|P1|NOT COMPLETED|SFU Period||78
8411742|NCT00950300|20733252|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
8411743|NCT00950300|20733253|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
8411744|NCT00950300|20733252|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
8411745|NCT00950300|20733253|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
8411746|NCT00950300|20733252|P2|NOT COMPLETED|TFFU Period||107
8411747|NCT00950300|20733253|P1|NOT COMPLETED|TFFU Period||100
8411748|NCT00950300|20733252|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
8411749|NCT00950300|20733253|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
8411750|NCT00950300|20733252|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
8411751|NCT00950300|20733253|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
8411752|NCT00950300|20733252|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
8411753|NCT00950300|20733253|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
8411754|NCT00950300|20733252|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
8411755|NCT00950300|20733253|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
8411756|NCT00950300|20733252|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
8411757|NCT00950300|20733253|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
8411758|NCT00950300|20733252|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
8411759|NCT00950300|20733253|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
8411760|NCT00950300|20733252|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
8411761|NCT00950300|20733253|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
8411762|NCT00950300|20733252|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
8411763|NCT00950300|20733253|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
8411764|NCT00950248|20733302|P3|NOT COMPLETED|Year 2&3 Treatment Randomization||5
8411765|NCT00950248|20733303|P2|NOT COMPLETED|Year 2&3 Treatment Randomization||6
8411766|NCT00950248|20733304|P1|NOT COMPLETED|Year 2&3 Treatment Randomization||0
8411767|NCT00950248|20733302|P3|COMPLETED|Year 2&3 Treatment Randomization||33
8411768|NCT00950248|20733303|P2|COMPLETED|Year 2&3 Treatment Randomization||33
8411769|NCT00950248|20733304|P1|COMPLETED|Year 2&3 Treatment Randomization||0
8411770|NCT00950248|20733302|P3|STARTED|Year 2&3 Treatment Randomization||38
8411771|NCT00950248|20733303|P2|STARTED|Year 2&3 Treatment Randomization||39
8411772|NCT00950248|20733304|P1|STARTED|Year 2&3 Treatment Randomization||0
8411773|NCT00950248|20733302|P3|NOT COMPLETED|Year 1: Baseline||0
8411774|NCT00950248|20733303|P2|NOT COMPLETED|Year 1: Baseline||0
8411775|NCT00950248|20733304|P1|NOT COMPLETED|Year 1: Baseline||8
8411776|NCT00950248|20733302|P3|COMPLETED|Year 1: Baseline||0
8411777|NCT00950248|20733303|P2|COMPLETED|Year 1: Baseline||0
8411778|NCT00950248|20733304|P1|COMPLETED|Year 1: Baseline||77
8411779|NCT00950248|20733302|P3|STARTED|Year 1: Baseline||0
8411780|NCT00950248|20733303|P2|STARTED|Year 1: Baseline||0
8411781|NCT00950248|20733304|P1|STARTED|Year 1: Baseline||85
8411782|NCT00950235|20733325|P2|NOT COMPLETED|Overall Study||4
8411783|NCT00950235|20733326|P1|NOT COMPLETED|Overall Study||2
8411784|NCT00950235|20733325|P2|COMPLETED|Overall Study||54
8411785|NCT00950235|20733326|P1|COMPLETED|Overall Study||58
8411786|NCT00950235|20733325|P2|STARTED|Overall Study||58
8411787|NCT00950235|20733326|P1|STARTED|Overall Study||60
8411788|NCT00950183|20733336|P1|NOT COMPLETED|Overall Study||36
8411789|NCT00950183|20733336|P1|COMPLETED|Overall Study||0
8411790|NCT00950183|20733336|P1|STARTED|Overall Study||36
8411791|NCT00950170|20733344|P1|NOT COMPLETED|Overall Study||4
8411792|NCT00950170|20733344|P1|COMPLETED|Overall Study||19
8411793|NCT00950170|20733344|P1|STARTED|Overall Study||23
8411794|NCT00949988|20733395|P1|NOT COMPLETED|Overall Study||3
8411795|NCT00949988|20733395|P1|COMPLETED|Overall Study||0
8411796|NCT00949988|20733395|P1|STARTED|Overall Study||3
8411797|NCT00949975|20733410|P4|NOT COMPLETED|Overall Study||28
8411798|NCT00949975|20733411|P3|NOT COMPLETED|Overall Study||19
8411799|NCT00949975|20733412|P2|NOT COMPLETED|Overall Study||29
8411800|NCT00949975|20733413|P1|NOT COMPLETED|Overall Study||27
8411801|NCT00949975|20733410|P4|COMPLETED|Overall Study||190
8411802|NCT00949975|20733411|P3|COMPLETED|Overall Study||183
8411803|NCT00949975|20733412|P2|COMPLETED|Overall Study||177
8411804|NCT00949975|20733413|P1|COMPLETED|Overall Study||185
8411805|NCT00949975|20733410|P4|STARTED|Overall Study||218
8411806|NCT00949975|20733411|P3|STARTED|Overall Study||202
8411807|NCT00949975|20733412|P2|STARTED|Overall Study||206
8411808|NCT00949975|20733413|P1|STARTED|Overall Study||212
8411809|NCT00949910|20733531|P1|NOT COMPLETED|Overall Study||6576
8411810|NCT00949910|20733531|P1|COMPLETED|Overall Study||10
8411811|NCT00949910|20733531|P1|STARTED|Overall Study||6586
8411812|NCT00949884|20733544|P3|NOT COMPLETED|Overall Study||58
8411813|NCT00949884|20733545|P2|NOT COMPLETED|Overall Study||15
8411814|NCT00949884|20733546|P1|NOT COMPLETED|Overall Study||50
8411815|NCT00949884|20733544|P3|COMPLETED|Overall Study||411
8411816|NCT00949884|20733545|P2|COMPLETED|Overall Study||37
8411817|NCT00949884|20733546|P1|COMPLETED|Overall Study||370
8411818|NCT00949884|20733544|P3|STARTED|Overall Study||469
8411819|NCT00949884|20733545|P2|STARTED|Overall Study||52
8411820|NCT00949884|20733546|P1|STARTED|Overall Study||420
8411821|NCT00949715|20733601|P2|NOT COMPLETED|Overall Study||0
8411822|NCT00949715|20733602|P1|NOT COMPLETED|Overall Study||4
8411823|NCT00949715|20733601|P2|COMPLETED|Overall Study||33
8411824|NCT00949715|20733602|P1|COMPLETED|Overall Study||28
8411825|NCT00949715|20733601|P2|STARTED|Overall Study||33
8411826|NCT00949715|20733602|P1|STARTED|Overall Study||32
8411827|NCT00949702|20733613|P1|NOT COMPLETED|Overall Study||48
8411828|NCT00949702|20733613|P1|COMPLETED|Overall Study||84
8411829|NCT00949702|20733613|P1|STARTED|Overall Study||132
8411830|NCT00949650|20733630|P2|NOT COMPLETED|Overall Study||115
8411831|NCT00949650|20733631|P1|NOT COMPLETED|Overall Study||230
8411832|NCT00949650|20733630|P2|COMPLETED|Overall Study||0
8411833|NCT00949650|20733631|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
8411834|NCT00949650|20733630|P2|STARTED|Overall Study|Treated patients.|115
8411835|NCT00949650|20733631|P1|STARTED|Overall Study|Treated patients.|230
8411836|NCT00949533|20733669|P2|NOT COMPLETED|Overall Study||1
8411837|NCT00949533|20733670|P1|NOT COMPLETED|Overall Study||0
8411838|NCT00949533|20733669|P2|COMPLETED|Overall Study||17
8411839|NCT00949533|20733670|P1|COMPLETED|Overall Study||19
8411840|NCT00949533|20733669|P2|STARTED|Overall Study||18
8411841|NCT00949533|20733670|P1|STARTED|Overall Study||19
8411842|NCT00949403|20733682|P1|NOT COMPLETED|Overall Study||0
8411843|NCT00949403|20733682|P1|COMPLETED|Overall Study||9
8411844|NCT00949403|20733682|P1|STARTED|Overall Study||9
8411845|NCT00949325|20733686|P3|NOT COMPLETED|Overall Study||0
8411846|NCT00949325|20733687|P2|NOT COMPLETED|Overall Study||2
8411847|NCT00949325|20733688|P1|NOT COMPLETED|Overall Study||0
8411848|NCT00949325|20733686|P3|COMPLETED|Overall Study||3
8411849|NCT00949325|20733687|P2|COMPLETED|Overall Study||16
8411850|NCT00949325|20733688|P1|COMPLETED|Overall Study||3
8411851|NCT00949325|20733686|P3|STARTED|Overall Study||3
8411852|NCT00949325|20733687|P2|STARTED|Overall Study||18
8411853|NCT00949325|20733688|P1|STARTED|Overall Study||3
8411854|NCT00949234|20733706|P1|NOT COMPLETED|Overall Study||42
8411855|NCT00949234|20733706|P1|COMPLETED|Overall Study||225
8411856|NCT00949234|20733706|P1|STARTED|Overall Study||267
8411857|NCT00949117|20733712|P2|NOT COMPLETED|Overall Study||5
8411858|NCT00949117|20733713|P1|NOT COMPLETED|Overall Study||3
8411859|NCT00949117|20733712|P2|COMPLETED|Overall Study||0
8411860|NCT00949117|20733713|P1|COMPLETED|Overall Study||1
8411861|NCT00949117|20733712|P2|STARTED|Overall Study||5
8411862|NCT00949117|20733713|P1|STARTED|Overall Study||4
8411863|NCT00949078|20733729|P2|NOT COMPLETED|Overall Study||0
8411864|NCT00949078|20733730|P1|NOT COMPLETED|Overall Study||0
8411865|NCT00949078|20733729|P2|COMPLETED|Overall Study||9
8411866|NCT00949078|20733730|P1|COMPLETED|Overall Study||5
8411867|NCT00949078|20733729|P2|STARTED|Overall Study||9
8411868|NCT00949078|20733730|P1|STARTED|Overall Study||5
8411869|NCT00948974|20733754|P2|NOT COMPLETED|Overall Study||20
8411870|NCT00948974|20733755|P1|NOT COMPLETED|Overall Study||23
8411871|NCT00948974|20733754|P2|COMPLETED|Overall Study||28
8411872|NCT00948974|20733755|P1|COMPLETED|Overall Study||17
8411873|NCT00948974|20733754|P2|STARTED|Overall Study||48
8411874|NCT00948974|20733755|P1|STARTED|Overall Study||40
8411875|NCT00948935|20733765|P1|NOT COMPLETED|Overall Study||0
8411876|NCT00948935|20733765|P1|COMPLETED|Overall Study||35
8411877|NCT00948935|20733765|P1|STARTED|Overall Study||35
8411878|NCT00948922|20733773|P3|NOT COMPLETED|Overall Study||1
8411879|NCT00948922|20733774|P2|NOT COMPLETED|Overall Study||14
8411880|NCT00948922|20733775|P1|NOT COMPLETED|Overall Study||8
8411881|NCT00948922|20733773|P3|COMPLETED|Overall Study||38
8411882|NCT00948922|20733774|P2|COMPLETED|Overall Study||37
8411883|NCT00948922|20733775|P1|COMPLETED|Overall Study||26
8411884|NCT00948922|20733773|P3|STARTED|Overall Study||39
8411885|NCT00948922|20733774|P2|STARTED|Overall Study||51
8411886|NCT00948922|20733775|P1|STARTED|Overall Study||34
8411887|NCT00948896|20733798|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
8411888|NCT00948896|20733799|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
8411889|NCT00948896|20733800|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8411890|NCT00948896|20733801|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
8411891|NCT00948896|20733802|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8411892|NCT00948896|20733803|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
8411893|NCT00948896|20733804|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8411894|NCT00948896|20733805|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
8411895|NCT00948896|20733798|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
8411896|NCT00948896|20733799|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
8411897|NCT00948896|20733800|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
8411898|NCT00948896|20733801|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
8411899|NCT00948896|20733802|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
8411900|NCT00948896|20733803|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
8411901|NCT00948896|20733804|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
8411902|NCT00948896|20733805|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
8411903|NCT00948896|20733798|P8|STARTED|24 Months of Age to 36 Months of Age||45
8411904|NCT00948896|20733799|P7|STARTED|24 Months of Age to 36 Months of Age||43
8411905|NCT00948896|20733800|P6|STARTED|24 Months of Age to 36 Months of Age||42
8411906|NCT00948896|20733801|P5|STARTED|24 Months of Age to 36 Months of Age||44
8411907|NCT00948896|20733802|P4|STARTED|24 Months of Age to 36 Months of Age||87
8411908|NCT00948896|20733803|P3|STARTED|24 Months of Age to 36 Months of Age||90
8411909|NCT00948896|20733804|P2|STARTED|24 Months of Age to 36 Months of Age||85
8411910|NCT00948896|20733805|P1|STARTED|24 Months of Age to 36 Months of Age||90
8411911|NCT00948896|20733798|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
8411912|NCT00948896|20733799|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
8411913|NCT00948896|20733800|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
8411914|NCT00948896|20733801|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
8411915|NCT00948896|20733802|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
8411916|NCT00948896|20733803|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
8411917|NCT00948896|20733804|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
8411918|NCT00948896|20733805|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
8411919|NCT00948896|20733798|P8|COMPLETED|Randomization to 24 Months of Age||45
8411920|NCT00948896|20733799|P7|COMPLETED|Randomization to 24 Months of Age||43
8411921|NCT00948896|20733800|P6|COMPLETED|Randomization to 24 Months of Age||42
8411922|NCT00948896|20733801|P5|COMPLETED|Randomization to 24 Months of Age||44
8411923|NCT00948896|20733802|P4|COMPLETED|Randomization to 24 Months of Age||87
8411924|NCT00948896|20733803|P3|COMPLETED|Randomization to 24 Months of Age||90
8411925|NCT00948896|20733804|P2|COMPLETED|Randomization to 24 Months of Age||85
8411926|NCT00948896|20733805|P1|COMPLETED|Randomization to 24 Months of Age||90
8411927|NCT00948896|20733798|P8|STARTED|Randomization to 24 Months of Age||47
8411928|NCT00948896|20733799|P7|STARTED|Randomization to 24 Months of Age||47
8411929|NCT00948896|20733800|P6|STARTED|Randomization to 24 Months of Age||46
8411930|NCT00948896|20733801|P5|STARTED|Randomization to 24 Months of Age||46
8411931|NCT00948896|20733802|P4|STARTED|Randomization to 24 Months of Age||98
8411932|NCT00948896|20733803|P3|STARTED|Randomization to 24 Months of Age||99
8411933|NCT00948896|20733804|P2|STARTED|Randomization to 24 Months of Age||98
8411934|NCT00948896|20733805|P1|STARTED|Randomization to 24 Months of Age||98
8411935|NCT00948857|20733841|P2|NOT COMPLETED|Overall Study||0
8411936|NCT00948857|20733842|P1|NOT COMPLETED|Overall Study||1
8411937|NCT00948857|20733841|P2|COMPLETED|Overall Study||2
8411938|NCT00948857|20733842|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
8411939|NCT00948857|20733841|P2|STARTED|Overall Study||2
8411940|NCT00948857|20733842|P1|STARTED|Overall Study||3
8411941|NCT00948818|20733850|P2|NOT COMPLETED|Overall Study||94
8411942|NCT00948818|20733851|P1|NOT COMPLETED|Overall Study||62
8411943|NCT00948818|20733850|P2|COMPLETED|Overall Study||312
8411944|NCT00948818|20733851|P1|COMPLETED|Overall Study||335
8411945|NCT00948818|20733850|P2|STARTED|Overall Study||406
8411946|NCT00948818|20733851|P1|STARTED|Overall Study||397
8411947|NCT00948792|20733886|P1|NOT COMPLETED|Overall Study||0
8411948|NCT00948792|20733886|P1|COMPLETED|Overall Study||21
8411949|NCT00948792|20733886|P1|STARTED|Overall Study||21
8411950|NCT00948766|20733898|P2|NOT COMPLETED|Extension Study||0
8411951|NCT00948766|20733899|P1|NOT COMPLETED|Extension Study||91
8411952|NCT00948766|20733898|P2|COMPLETED|Extension Study||0
8411953|NCT00948766|20733899|P1|COMPLETED|Extension Study||306
8411954|NCT00948766|20733898|P2|Exposed to Study Medication|Extension Study||0
8411955|NCT00948766|20733899|P1|Exposed to Study Medication|Extension Study||396
8411956|NCT00948766|20733898|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
8411957|NCT00948766|20733899|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
8411958|NCT00948766|20733898|P2|NOT COMPLETED|Core Study||126
8411959|NCT00948766|20733899|P1|NOT COMPLETED|Core Study||127
8411960|NCT00948766|20733898|P2|COMPLETED|Core Study||234
8411961|NCT00948766|20733899|P1|COMPLETED|Core Study||229
8411962|NCT00948766|20733898|P2|Exposed to Study Medication|Core Study||359
8411963|NCT00948766|20733899|P1|Exposed to Study Medication|Core Study||355
8411964|NCT00948766|20733898|P2|STARTED|Core Study||360
8411965|NCT00948766|20733899|P1|STARTED|Core Study||356
8411966|NCT00948688|20733915|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
8411967|NCT00948688|20733916|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
8411968|NCT00948688|20733915|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
8411969|NCT00948688|20733916|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
8411970|NCT00948688|20733915|P2|STARTED|Period 2: 100 mg Vorinostat||6
8411971|NCT00948688|20733916|P1|STARTED|Period 2: 100 mg Vorinostat||0
8411972|NCT00948688|20733915|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
8411973|NCT00948688|20733916|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
8411974|NCT00948688|20733915|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
8411975|NCT00948688|20733916|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
8411976|NCT00948688|20733915|P2|STARTED|Period 1: 200 mg Vorinostat||0
8411977|NCT00948688|20733916|P1|STARTED|Period 1: 200 mg Vorinostat||4
8411984|NCT00948610|20733947|P2|NOT COMPLETED|Overall Study||1
8411985|NCT00948610|20733948|P1|NOT COMPLETED|Overall Study||1
8411986|NCT00948610|20733947|P2|COMPLETED|Overall Study||9
8411987|NCT00948610|20733948|P1|COMPLETED|Overall Study||9
8411988|NCT00948610|20733947|P2|STARTED|Overall Study||10
8411989|NCT00948610|20733948|P1|STARTED|Overall Study||10
8411990|NCT00948506|20733958|P2|NOT COMPLETED|Overall Study||1
8411991|NCT00948506|20733959|P1|NOT COMPLETED|Overall Study||3
8411992|NCT00948506|20733958|P2|COMPLETED|Overall Study||8
8411993|NCT00948506|20733959|P1|COMPLETED|Overall Study||8
8411994|NCT00948506|20733958|P2|STARTED|Overall Study||9
8411995|NCT00948506|20733959|P1|STARTED|Overall Study||11
8411996|NCT00948441|20733970|P2|NOT COMPLETED|Overall Study||4
8411997|NCT00948441|20733971|P1|NOT COMPLETED|Overall Study||1
8411998|NCT00948441|20733970|P2|COMPLETED|Overall Study||4
8411999|NCT00948441|20733971|P1|COMPLETED|Overall Study||7
8412000|NCT00948441|20733970|P2|STARTED|Overall Study||8
8412001|NCT00948441|20733971|P1|STARTED|Overall Study||8
8412002|NCT00948428|20733982|P3|NOT COMPLETED|Overall Study||8
8412003|NCT00948428|20733983|P2|NOT COMPLETED|Overall Study||18
8412004|NCT00948428|20733984|P1|NOT COMPLETED|Overall Study||18
8412005|NCT00948428|20733982|P3|COMPLETED|Overall Study||84
8412006|NCT00948428|20733983|P2|COMPLETED|Overall Study||167
8412007|NCT00948428|20733984|P1|COMPLETED|Overall Study||167
8412008|NCT00948428|20733982|P3|STARTED|Overall Study||92
8412009|NCT00948428|20733983|P2|STARTED|Overall Study||185
8412010|NCT00948428|20733984|P1|STARTED|Overall Study||185
8412011|NCT00948389|20734003|P5|NOT COMPLETED|Overall Study||1
8412012|NCT00948389|20734004|P4|NOT COMPLETED|Overall Study||9
8412013|NCT00948389|20734005|P3|NOT COMPLETED|Overall Study||7
8412014|NCT00948389|20734006|P2|NOT COMPLETED|Overall Study||3
8412015|NCT00948389|20734007|P1|NOT COMPLETED|Overall Study||6
8412016|NCT00948389|20734003|P5|COMPLETED|Overall Study||0
8412017|NCT00948389|20734004|P4|COMPLETED|Overall Study||0
8412018|NCT00948389|20734005|P3|COMPLETED|Overall Study||0
8412019|NCT00948389|20734006|P2|COMPLETED|Overall Study||0
8412020|NCT00948389|20734007|P1|COMPLETED|Overall Study||0
8412021|NCT00948389|20734003|P5|STARTED|Overall Study||1
8412022|NCT00948389|20734004|P4|STARTED|Overall Study||9
8412023|NCT00948389|20734005|P3|STARTED|Overall Study||7
8412024|NCT00948389|20734006|P2|STARTED|Overall Study||3
8412025|NCT00948389|20734007|P1|STARTED|Overall Study||6
8412026|NCT00948298|20734046|P2|NOT COMPLETED|Overall Study||5
8412027|NCT00948298|20734047|P1|NOT COMPLETED|Overall Study||10
8412028|NCT00948298|20734046|P2|COMPLETED|Overall Study||60
8412029|NCT00948298|20734047|P1|COMPLETED|Overall Study||55
8412030|NCT00948298|20734046|P2|STARTED|Overall Study||65
8412031|NCT00948298|20734047|P1|STARTED|Overall Study||65
8412032|NCT00948246|20734055|P1|NOT COMPLETED|Overall Study||24
8412033|NCT00948246|20734055|P1|COMPLETED|Overall Study||86
8412034|NCT00948246|20734055|P1|STARTED|Overall Study||110
8412035|NCT00948155|20734064|P2|NOT COMPLETED|Second Intervention 21 Days||3
8412036|NCT00948155|20734065|P1|NOT COMPLETED|Second Intervention 21 Days||2
8412037|NCT00948155|20734064|P2|COMPLETED|Second Intervention 21 Days||8
8412038|NCT00948155|20734065|P1|COMPLETED|Second Intervention 21 Days||9
8412039|NCT00948155|20734064|P2|STARTED|Second Intervention 21 Days||11
8412040|NCT00948155|20734065|P1|STARTED|Second Intervention 21 Days||11
8412041|NCT00948155|20734064|P2|NOT COMPLETED|Washout 14 Days||2
8412042|NCT00948155|20734065|P1|NOT COMPLETED|Washout 14 Days||1
8412043|NCT00948155|20734064|P2|COMPLETED|Washout 14 Days||11
8412044|NCT00948155|20734065|P1|COMPLETED|Washout 14 Days||11
8412045|NCT00948155|20734064|P2|STARTED|Washout 14 Days||13
8412046|NCT00948155|20734065|P1|STARTED|Washout 14 Days||12
8412047|NCT00948155|20734064|P2|NOT COMPLETED|First Intervention 21 Days||2
8412048|NCT00948155|20734065|P1|NOT COMPLETED|First Intervention 21 Days||2
8412049|NCT00948155|20734064|P2|COMPLETED|First Intervention 21 Days||13
8412050|NCT00948155|20734065|P1|COMPLETED|First Intervention 21 Days||12
8412051|NCT00948155|20734064|P2|STARTED|First Intervention 21 Days||15
8412052|NCT00948155|20734065|P1|STARTED|First Intervention 21 Days||14
8412053|NCT00948090|20734087|P4|NOT COMPLETED|Overall Study||11
8412054|NCT00948090|20734088|P3|NOT COMPLETED|Overall Study||56
8412055|NCT00948090|20734089|P2|NOT COMPLETED|Overall Study||1
8412056|NCT00948090|20734090|P1|NOT COMPLETED|Overall Study||43
8412057|NCT00948090|20734087|P4|COMPLETED|Overall Study||7
8412058|NCT00948090|20734088|P3|COMPLETED|Overall Study||67
8412059|NCT00948090|20734089|P2|COMPLETED|Overall Study||0
8412060|NCT00948090|20734090|P1|COMPLETED|Overall Study||22
8412061|NCT00948090|20734087|P4|STARTED|Overall Study||18
8412062|NCT00948090|20734088|P3|STARTED|Overall Study||123
8412063|NCT00948090|20734089|P2|STARTED|Overall Study||1
8412064|NCT00948090|20734090|P1|STARTED|Overall Study||65
8412065|NCT00948064|20734112|P3|NOT COMPLETED|Phase II||1
8412066|NCT00948064|20734113|P2|NOT COMPLETED|Phase II||1
8412067|NCT00948064|20734114|P1|NOT COMPLETED|Phase II||0
8412068|NCT00948064|20734112|P3|COMPLETED|Phase II||26
8412069|NCT00948064|20734113|P2|COMPLETED|Phase II||51
8412070|NCT00948064|20734114|P1|COMPLETED|Phase II||0
8412071|NCT00948064|20734112|P3|STARTED|Phase II||27
8412072|NCT00948064|20734113|P2|STARTED|Phase II||52
8412073|NCT00948064|20734114|P1|STARTED|Phase II||0
8412074|NCT00948064|20734112|P3|NOT COMPLETED|Phase I||0
8412075|NCT00948064|20734113|P2|NOT COMPLETED|Phase I||0
8412076|NCT00948064|20734114|P1|NOT COMPLETED|Phase I||1
8412077|NCT00948064|20734112|P3|COMPLETED|Phase I||0
8412078|NCT00948064|20734113|P2|COMPLETED|Phase I||0
8412079|NCT00948064|20734114|P1|COMPLETED|Phase I||30
8412080|NCT00948064|20734112|P3|STARTED|Phase I||0
8412081|NCT00948064|20734113|P2|STARTED|Phase I||0
8412082|NCT00948064|20734114|P1|STARTED|Phase I||31
8412083|NCT00948025|20734127|P2|NOT COMPLETED|Phase 2 (Comparative Phase)||0
8412084|NCT00948025|20734128|P1|NOT COMPLETED|Phase 2 (Comparative Phase)||0
8412085|NCT00948025|20734127|P2|COMPLETED|Phase 2 (Comparative Phase)||0
8412086|NCT00948025|20734128|P1|COMPLETED|Phase 2 (Comparative Phase)||0
8412087|NCT00948025|20734127|P2|STARTED|Phase 2 (Comparative Phase)||0
8412088|NCT00948025|20734128|P1|STARTED|Phase 2 (Comparative Phase)||0
8412089|NCT00948025|20734127|P2|NOT COMPLETED|Phase 1 (Pilot Phase)||3
8412090|NCT00948025|20734128|P1|NOT COMPLETED|Phase 1 (Pilot Phase)||9
8412091|NCT00948025|20734127|P2|COMPLETED|Phase 1 (Pilot Phase)||6
8412092|NCT00948025|20734128|P1|COMPLETED|Phase 1 (Pilot Phase)||5
8412093|NCT00948025|20734127|P2|STARTED|Phase 1 (Pilot Phase)||9
8412094|NCT00948025|20734128|P1|STARTED|Phase 1 (Pilot Phase)||14
8412095|NCT00947882|20734156|P4|NOT COMPLETED|Overall Study||82
8412096|NCT00947882|20734157|P3|NOT COMPLETED|Overall Study||79
8412097|NCT00947882|20734158|P2|NOT COMPLETED|Overall Study||77
8412098|NCT00947882|20734159|P1|NOT COMPLETED|Overall Study||74
8412099|NCT00947882|20734156|P4|COMPLETED|Overall Study||20
8412100|NCT00947882|20734157|P3|COMPLETED|Overall Study||22
8412101|NCT00947882|20734158|P2|COMPLETED|Overall Study||24
8412102|NCT00947882|20734159|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
8412103|NCT00947882|20734156|P4|Visit 12, Month 6|Overall Study||95
8412104|NCT00947882|20734157|P3|Visit 12, Month 6|Overall Study||90
8412105|NCT00947882|20734158|P2|Visit 12, Month 6|Overall Study||91
8412106|NCT00947882|20734159|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
8412107|NCT00947882|20734156|P4|Safety Analysis Set|Overall Study||105
8412108|NCT00947882|20734157|P3|Safety Analysis Set|Overall Study||100
8412109|NCT00947882|20734158|P2|Safety Analysis Set|Overall Study||101
8412110|NCT00947882|20734159|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
8412111|NCT00947882|20734156|P4|Actual Treatment|Overall Study||105
8412112|NCT00947882|20734157|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
8412113|NCT00947882|20734158|P2|Actual Treatment|Overall Study||101
8412114|NCT00947882|20734159|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
8412115|NCT00947882|20734156|P4|Full Analysis Set (FAS)|Overall Study||102
8412116|NCT00947882|20734157|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
8412117|NCT00947882|20734158|P2|Full Analysis Set (FAS)|Overall Study||101
8412118|NCT00947882|20734159|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
8412119|NCT00947882|20734156|P4|STARTED|Overall Study||102
8412120|NCT00947882|20734157|P3|STARTED|Overall Study||101
8412121|NCT00947882|20734158|P2|STARTED|Overall Study||101
8412122|NCT00947882|20734159|P1|STARTED|Overall Study|Started: Randomised.|100
8412123|NCT00947856|20734187|P2|NOT COMPLETED|Follow-up Period||23
8412124|NCT00947856|20734188|P1|NOT COMPLETED|Follow-up Period||51
8412125|NCT00947856|20734187|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
8412126|NCT00947856|20734188|P1|COMPLETED|Follow-up Period||27
8412127|NCT00947856|20734187|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
8412128|NCT00947856|20734188|P1|STARTED|Follow-up Period||78
8412129|NCT00947856|20734187|P2|NOT COMPLETED|Treatment Period||32
8412130|NCT00947856|20734188|P1|NOT COMPLETED|Treatment Period||78
8412131|NCT00947856|20734187|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
8412132|NCT00947856|20734188|P1|COMPLETED|Treatment Period||0
8412133|NCT00947856|20734187|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
8412134|NCT00947856|20734188|P1|STARTED|Treatment Period||78
8412135|NCT00947791|20734217|P2|NOT COMPLETED|Overall Study||0
8412136|NCT00947791|20734218|P1|NOT COMPLETED|Overall Study||0
8412137|NCT00947791|20734217|P2|COMPLETED|Overall Study||1
8412138|NCT00947791|20734218|P1|COMPLETED|Overall Study||0
8412139|NCT00947791|20734217|P2|STARTED|Overall Study||1
8412140|NCT00947791|20734218|P1|STARTED|Overall Study||0
8412141|NCT00947765|20734236|P2|NOT COMPLETED|Overall Study||0
8412142|NCT00947765|20734237|P1|NOT COMPLETED|Overall Study||0
8412143|NCT00947765|20734236|P2|COMPLETED|Overall Study||30
8412144|NCT00947765|20734237|P1|COMPLETED|Overall Study||30
8412145|NCT00947765|20734236|P2|STARTED|Overall Study||30
8412146|NCT00947765|20734237|P1|STARTED|Overall Study||30
8412147|NCT00947752|20734259|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
8412148|NCT00947752|20734260|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
8412149|NCT00947752|20734259|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
8412150|NCT00947752|20734260|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
8412151|NCT00947752|20734259|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
8412152|NCT00947752|20734260|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
8412153|NCT00947752|20734259|P2|NOT COMPLETED|1st 14-day Treatment Period||0
8412154|NCT00947752|20734260|P1|NOT COMPLETED|1st 14-day Treatment Period||0
8412155|NCT00947752|20734259|P2|COMPLETED|1st 14-day Treatment Period||71
8412156|NCT00947752|20734260|P1|COMPLETED|1st 14-day Treatment Period||76
8412157|NCT00947752|20734259|P2|STARTED|1st 14-day Treatment Period||71
8412158|NCT00947752|20734260|P1|STARTED|1st 14-day Treatment Period||76
8412159|NCT00947752|20734259|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
8412160|NCT00947752|20734260|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
8412161|NCT00947752|20734259|P2|COMPLETED|7-Day Run-in Treatment Period||0
8412162|NCT00947752|20734260|P1|COMPLETED|7-Day Run-in Treatment Period||147
8412163|NCT00947752|20734259|P2|STARTED|7-Day Run-in Treatment Period||0
8412164|NCT00947752|20734260|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
8412165|NCT00947661|20734270|P2|NOT COMPLETED|Overall Study||15
8412166|NCT00947661|20734271|P1|NOT COMPLETED|Overall Study||13
8412167|NCT00947661|20734270|P2|COMPLETED|Overall Study||274
8412168|NCT00947661|20734271|P1|COMPLETED|Overall Study||276
8412169|NCT00947661|20734270|P2|STARTED|Overall Study||289
8412170|NCT00947661|20734271|P1|STARTED|Overall Study||289
8412171|NCT00947544|20734277|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
8412172|NCT00947544|20734278|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
8412173|NCT00947544|20734277|P2|COMPLETED|Safety-Extension Period (12 Months)||6
8412174|NCT00947544|20734278|P1|COMPLETED|Safety-Extension Period (12 Months)||10
8412175|NCT00947544|20734277|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
8412176|NCT00947544|20734278|P1|STARTED|Safety-Extension Period (12 Months)||11
8412177|NCT00947544|20734277|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
8412178|NCT00947544|20734278|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
8412179|NCT00947544|20734277|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
8412180|NCT00947544|20734278|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
8412181|NCT00947544|20734277|P2|STARTED|Switch-Over Period (2 Weeks)||0
8412182|NCT00947544|20734278|P1|STARTED|Switch-Over Period (2 Weeks)||11
8412183|NCT00947531|20734304|P2|NOT COMPLETED|Overall Study||11
8412184|NCT00947531|20734305|P1|NOT COMPLETED|Overall Study||14
8412185|NCT00947531|20734304|P2|COMPLETED|Overall Study||110
8412186|NCT00947531|20734305|P1|COMPLETED|Overall Study||107
8412187|NCT00947531|20734304|P2|STARTED|Overall Study||121
8412188|NCT00947531|20734305|P1|STARTED|Overall Study||121
8412189|NCT00947518|20734316|P3|NOT COMPLETED|Overall Study||0
8412190|NCT00947518|20734317|P2|NOT COMPLETED|Overall Study||0
8412191|NCT00947518|20734318|P1|NOT COMPLETED|Overall Study||0
8412192|NCT00947518|20734316|P3|COMPLETED|Overall Study||20
8412193|NCT00947518|20734317|P2|COMPLETED|Overall Study||20
8412194|NCT00947518|20734318|P1|COMPLETED|Overall Study||20
8412195|NCT00947518|20734316|P3|STARTED|Overall Study||20
8412196|NCT00947518|20734317|P2|STARTED|Overall Study||20
8412197|NCT00947518|20734318|P1|STARTED|Overall Study||20
8412198|NCT00947505|20734334|P2|NOT COMPLETED|Overall Study||2
8412199|NCT00947505|20734335|P1|NOT COMPLETED|Overall Study||9
8412200|NCT00947505|20734334|P2|COMPLETED|Overall Study||14
8412201|NCT00947505|20734335|P1|COMPLETED|Overall Study||24
8412202|NCT00947505|20734334|P2|STARTED|Overall Study||16
8412203|NCT00947505|20734335|P1|STARTED|Overall Study||33
8412204|NCT00947427|20734343|P2|NOT COMPLETED|Overall Study||4
8412205|NCT00947427|20734344|P1|NOT COMPLETED|Overall Study||1
8412206|NCT00947427|20734343|P2|COMPLETED|Overall Study||45
8412207|NCT00947427|20734344|P1|COMPLETED|Overall Study||21
8412208|NCT00947427|20734343|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
8412209|NCT00947427|20734344|P1|STARTED|Overall Study||22
8412210|NCT00947349|20734354|P4|NOT COMPLETED|Overall Study Standard of Care||2
8412211|NCT00947349|20734355|P3|NOT COMPLETED|Overall Study Standard of Care||2
8412212|NCT00947349|20734356|P2|NOT COMPLETED|Overall Study Standard of Care||0
8412213|NCT00947349|20734357|P1|NOT COMPLETED|Overall Study Standard of Care||0
8412214|NCT00947349|20734354|P4|COMPLETED|Overall Study Standard of Care||4
8412215|NCT00947349|20734355|P3|COMPLETED|Overall Study Standard of Care||4
8412216|NCT00947349|20734356|P2|COMPLETED|Overall Study Standard of Care||5
8412217|NCT00947349|20734357|P1|COMPLETED|Overall Study Standard of Care||4
8412218|NCT00947349|20734354|P4|STARTED|Overall Study Standard of Care||6
8412219|NCT00947349|20734355|P3|STARTED|Overall Study Standard of Care||6
8412220|NCT00947349|20734356|P2|STARTED|Overall Study Standard of Care||5
8412221|NCT00947349|20734357|P1|STARTED|Overall Study Standard of Care||4
8412222|NCT00947349|20734354|P4|NOT COMPLETED|Triple Treatment Combination Period||0
8412223|NCT00947349|20734355|P3|NOT COMPLETED|Triple Treatment Combination Period||0
8412224|NCT00947349|20734356|P2|NOT COMPLETED|Triple Treatment Combination Period||1
8412225|NCT00947349|20734357|P1|NOT COMPLETED|Triple Treatment Combination Period||0
8412226|NCT00947349|20734354|P4|COMPLETED|Triple Treatment Combination Period||6
8412227|NCT00947349|20734355|P3|COMPLETED|Triple Treatment Combination Period||6
8412228|NCT00947349|20734356|P2|COMPLETED|Triple Treatment Combination Period||5
8412229|NCT00947349|20734357|P1|COMPLETED|Triple Treatment Combination Period||4
8412230|NCT00947349|20734354|P4|STARTED|Triple Treatment Combination Period||6
8412231|NCT00947349|20734355|P3|STARTED|Triple Treatment Combination Period||6
8412232|NCT00947349|20734356|P2|STARTED|Triple Treatment Combination Period||6
8412233|NCT00947349|20734357|P1|STARTED|Triple Treatment Combination Period||4
8412234|NCT00947310|20734492|P3|NOT COMPLETED|Overall Study||0
8412235|NCT00947310|20734493|P2|NOT COMPLETED|Overall Study||0
8412236|NCT00947310|20734494|P1|NOT COMPLETED|Overall Study||0
8412237|NCT00947310|20734492|P3|COMPLETED|Overall Study||486
8412238|NCT00947310|20734493|P2|COMPLETED|Overall Study||500
8412239|NCT00947310|20734494|P1|COMPLETED|Overall Study||514
8412240|NCT00947310|20734492|P3|STARTED|Overall Study||486
8412241|NCT00947310|20734493|P2|STARTED|Overall Study||500
8412242|NCT00947310|20734494|P1|STARTED|Overall Study||514
8412243|NCT00947297|20734508|P1|NOT COMPLETED|Overall Study||7
8412244|NCT00947297|20734508|P1|COMPLETED|Overall Study||53
8412245|NCT00947297|20734508|P1|STARTED|Overall Study||60
8412246|NCT00947284|20734515|P2|NOT COMPLETED|Overall Study||3
8412247|NCT00947284|20734516|P1|NOT COMPLETED|Overall Study||0
8412248|NCT00947284|20734515|P2|COMPLETED|Overall Study||0
8412249|NCT00947284|20734516|P1|COMPLETED|Overall Study||0
8412250|NCT00947284|20734515|P2|STARTED|Overall Study||3
8412251|NCT00947284|20734516|P1|STARTED|Overall Study||0
8412252|NCT00947271|20734524|P4|NOT COMPLETED|12 Months Post Intervention||62
8412253|NCT00947271|20734525|P3|NOT COMPLETED|12 Months Post Intervention||59
8412254|NCT00947271|20734526|P2|NOT COMPLETED|12 Months Post Intervention||60
8412255|NCT00947271|20734527|P1|NOT COMPLETED|12 Months Post Intervention||71
8412256|NCT00947271|20734524|P4|COMPLETED|12 Months Post Intervention||188
8412257|NCT00947271|20734525|P3|COMPLETED|12 Months Post Intervention||195
8412258|NCT00947271|20734526|P2|COMPLETED|12 Months Post Intervention||192
8412259|NCT00947271|20734527|P1|COMPLETED|12 Months Post Intervention||183
8412260|NCT00947271|20734524|P4|STARTED|12 Months Post Intervention||250
8412261|NCT00947271|20734525|P3|STARTED|12 Months Post Intervention||254
8412262|NCT00947271|20734526|P2|STARTED|12 Months Post Intervention||252
8412263|NCT00947271|20734527|P1|STARTED|12 Months Post Intervention||254
8412264|NCT00947271|20734524|P4|NOT COMPLETED|9 Months Post Intervention||59
8412265|NCT00947271|20734525|P3|NOT COMPLETED|9 Months Post Intervention||61
8412266|NCT00947271|20734526|P2|NOT COMPLETED|9 Months Post Intervention||60
8412267|NCT00947271|20734527|P1|NOT COMPLETED|9 Months Post Intervention||70
8412268|NCT00947271|20734524|P4|COMPLETED|9 Months Post Intervention||191
8412269|NCT00947271|20734525|P3|COMPLETED|9 Months Post Intervention||193
8412270|NCT00947271|20734526|P2|COMPLETED|9 Months Post Intervention||192
8412271|NCT00947271|20734527|P1|COMPLETED|9 Months Post Intervention||184
8412272|NCT00947271|20734524|P4|STARTED|9 Months Post Intervention||250
8412273|NCT00947271|20734525|P3|STARTED|9 Months Post Intervention||254
8412274|NCT00947271|20734526|P2|STARTED|9 Months Post Intervention||252
8412275|NCT00947271|20734527|P1|STARTED|9 Months Post Intervention||254
8412276|NCT00947271|20734524|P4|NOT COMPLETED|6 Months Post Intervention||54
8412277|NCT00947271|20734525|P3|NOT COMPLETED|6 Months Post Intervention||58
8412278|NCT00947271|20734526|P2|NOT COMPLETED|6 Months Post Intervention||53
8412279|NCT00947271|20734527|P1|NOT COMPLETED|6 Months Post Intervention||55
8412280|NCT00947271|20734524|P4|COMPLETED|6 Months Post Intervention||196
8412281|NCT00947271|20734525|P3|COMPLETED|6 Months Post Intervention||196
8412282|NCT00947271|20734526|P2|COMPLETED|6 Months Post Intervention||199
8412283|NCT00947271|20734527|P1|COMPLETED|6 Months Post Intervention||199
8412284|NCT00947271|20734524|P4|STARTED|6 Months Post Intervention||250
8412285|NCT00947271|20734525|P3|STARTED|6 Months Post Intervention||254
8412286|NCT00947271|20734526|P2|STARTED|6 Months Post Intervention||252
8412287|NCT00947271|20734527|P1|STARTED|6 Months Post Intervention||254
8412288|NCT00947271|20734524|P4|NOT COMPLETED|3 Months Post Intervention||44
8412289|NCT00947271|20734525|P3|NOT COMPLETED|3 Months Post Intervention||36
8412290|NCT00947271|20734526|P2|NOT COMPLETED|3 Months Post Intervention||48
8412291|NCT00947271|20734527|P1|NOT COMPLETED|3 Months Post Intervention||52
8412292|NCT00947271|20734524|P4|COMPLETED|3 Months Post Intervention||206
8412293|NCT00947271|20734525|P3|COMPLETED|3 Months Post Intervention||218
8412294|NCT00947271|20734526|P2|COMPLETED|3 Months Post Intervention||204
8412295|NCT00947271|20734527|P1|COMPLETED|3 Months Post Intervention||202
8412296|NCT00947271|20734524|P4|STARTED|3 Months Post Intervention||250
8412297|NCT00947271|20734525|P3|STARTED|3 Months Post Intervention||254
8412298|NCT00947271|20734526|P2|STARTED|3 Months Post Intervention||252
8412299|NCT00947271|20734527|P1|STARTED|3 Months Post Intervention||254
8412300|NCT00947219|20734556|P3|NOT COMPLETED|Overall Study||4
8412301|NCT00947219|20734557|P2|NOT COMPLETED|Overall Study||4
8412302|NCT00947219|20734558|P1|NOT COMPLETED|Overall Study||6
8412303|NCT00947219|20734556|P3|COMPLETED|Overall Study||22
8412304|NCT00947219|20734557|P2|COMPLETED|Overall Study||21
8412305|NCT00947219|20734558|P1|COMPLETED|Overall Study||22
8412306|NCT00947219|20734556|P3|STARTED|Overall Study||26
8412307|NCT00947219|20734557|P2|STARTED|Overall Study||25
8412308|NCT00947219|20734558|P1|STARTED|Overall Study||28
8412309|NCT00947193|20734566|P2|NOT COMPLETED|Overall Study||0
8412310|NCT00947193|20734567|P1|NOT COMPLETED|Overall Study||3
8412311|NCT00947193|20734566|P2|COMPLETED|Overall Study||10
8412312|NCT00947193|20734567|P1|COMPLETED|Overall Study||0
8412313|NCT00947193|20734566|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8412314|NCT00947193|20734567|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8412315|NCT00947193|20734566|P2|STARTED|Overall Study||10
8412316|NCT00947193|20734567|P1|STARTED|Overall Study||3
8412317|NCT00947167|20734577|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
8412318|NCT00947167|20734577|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
8412319|NCT00947167|20734577|P1|STARTED|Erlotinib Added to Pertuzumab||3
8412320|NCT00947167|20734577|P1|NOT COMPLETED|Pertuzumab Alone||0
8412321|NCT00947167|20734577|P1|COMPLETED|Pertuzumab Alone||4
8412322|NCT00947167|20734577|P1|STARTED|Pertuzumab Alone||4
8412323|NCT00947154|20734582|P1|NOT COMPLETED|Overall Study||1
8412324|NCT00947154|20734582|P1|COMPLETED|Overall Study||11
8412325|NCT00947154|20734582|P1|STARTED|Overall Study||12
8412326|NCT00947115|20734592|P3|NOT COMPLETED|Overall Study||15
8412327|NCT00947115|20734593|P2|NOT COMPLETED|Overall Study||22
8412328|NCT00947115|20734594|P1|NOT COMPLETED|Overall Study||17
8412329|NCT00947115|20734592|P3|COMPLETED|Overall Study||156
8412330|NCT00947115|20734593|P2|COMPLETED|Overall Study||172
8412331|NCT00947115|20734594|P1|COMPLETED|Overall Study||142
8412332|NCT00947115|20734592|P3|STARTED|Overall Study||171
8412333|NCT00947115|20734593|P2|STARTED|Overall Study||194
8412334|NCT00947115|20734594|P1|STARTED|Overall Study||159
8412335|NCT00947011|20734656|P1|NOT COMPLETED|Overall Study||12
8412336|NCT00947011|20734656|P1|COMPLETED|Overall Study||0
8412337|NCT00947011|20734656|P1|STARTED|Overall Study||12
8412338|NCT00946998|20734666|P2|NOT COMPLETED|Overall Study||3
8412339|NCT00946998|20734667|P1|NOT COMPLETED|Overall Study||5
8412340|NCT00946998|20734666|P2|COMPLETED|Overall Study||96
8412341|NCT00946998|20734667|P1|COMPLETED|Overall Study||97
8412342|NCT00946998|20734666|P2|Received Treatment as Randomized|Overall Study||99
8412343|NCT00946998|20734667|P1|Received Treatment as Randomized|Overall Study||102
8412344|NCT00946998|20734666|P2|STARTED|Overall Study||99
8412345|NCT00946998|20734667|P1|STARTED|Overall Study||102
8412346|NCT00946985|20734681|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
8412347|NCT00946985|20734681|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
8412348|NCT00946985|20734681|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
8412349|NCT00946985|20734681|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
8412350|NCT00946985|20734681|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
8412351|NCT00946985|20734681|P1|STARTED|Stabilization Phase (25 Weeks)||162
8412352|NCT00946920|20734687|P2|NOT COMPLETED|Overall Study||44
8412353|NCT00946920|20734688|P1|NOT COMPLETED|Overall Study||110
8412354|NCT00946920|20734687|P2|COMPLETED|Overall Study||239
8412355|NCT00946920|20734688|P1|COMPLETED|Overall Study||455
8412356|NCT00946920|20734687|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
8412357|NCT00946920|20734688|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
8412358|NCT00946920|20734687|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
8412359|NCT00946920|20734688|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
8412360|NCT00946881|20734703|P1|NOT COMPLETED|Retreatment||1
8412361|NCT00946881|20734703|P1|COMPLETED|Retreatment||7
8412362|NCT00946881|20734703|P1|STARTED|Retreatment||8
8412363|NCT00946881|20734703|P1|NOT COMPLETED|First Treatment||2
8412364|NCT00946881|20734703|P1|COMPLETED|First Treatment||28
8412365|NCT00946881|20734703|P1|STARTED|First Treatment||30
8412366|NCT00946712|20734734|P2|NOT COMPLETED|Overall Study||662
8412367|NCT00946712|20734735|P1|NOT COMPLETED|Overall Study||547
8412368|NCT00946712|20734734|P2|COMPLETED|Overall Study||0
8412369|NCT00946712|20734735|P1|COMPLETED|Overall Study||124
8412370|NCT00946712|20734734|P2|STARTED|Overall Study||662
8412371|NCT00946712|20734735|P1|STARTED|Overall Study||671
8412372|NCT00946647|20734754|P5|NOT COMPLETED|Phase ll Part||42
8412373|NCT00946647|20734755|P4|NOT COMPLETED|Phase ll Part||40
8412374|NCT00946647|20734756|P3|NOT COMPLETED|Phase ll Part||0
8412375|NCT00946647|20734757|P2|NOT COMPLETED|Phase ll Part||0
8412376|NCT00946647|20734758|P1|NOT COMPLETED|Phase ll Part||0
8412377|NCT00946647|20734754|P5|COMPLETED|Phase ll Part||0
8412378|NCT00946647|20734755|P4|COMPLETED|Phase ll Part||0
8412379|NCT00946647|20734756|P3|COMPLETED|Phase ll Part||0
8412380|NCT00946647|20734757|P2|COMPLETED|Phase ll Part||0
8412381|NCT00946647|20734758|P1|COMPLETED|Phase ll Part||0
8412382|NCT00946647|20734754|P5|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
8412383|NCT00946647|20734755|P4|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
8412384|NCT00946647|20734756|P3|Safety Set|Phase ll Part||0
8412385|NCT00946647|20734757|P2|Safety Set|Phase ll Part||0
8412386|NCT00946647|20734758|P1|Safety Set|Phase ll Part||0
8412387|NCT00946647|20734754|P5|STARTED|Phase ll Part||42
8412388|NCT00946647|20734755|P4|STARTED|Phase ll Part||40
8412389|NCT00946647|20734756|P3|STARTED|Phase ll Part||0
8412390|NCT00946647|20734757|P2|STARTED|Phase ll Part||0
8412391|NCT00946647|20734758|P1|STARTED|Phase ll Part||0
8412392|NCT00946647|20734754|P5|NOT COMPLETED|Phase 1 Part||0
8412393|NCT00946647|20734755|P4|NOT COMPLETED|Phase 1 Part||0
8412394|NCT00946647|20734756|P3|NOT COMPLETED|Phase 1 Part||7
8412395|NCT00946647|20734757|P2|NOT COMPLETED|Phase 1 Part||18
8412396|NCT00946647|20734758|P1|NOT COMPLETED|Phase 1 Part||6
8412397|NCT00946647|20734754|P5|COMPLETED|Phase 1 Part||0
8412398|NCT00946647|20734755|P4|COMPLETED|Phase 1 Part||0
8412399|NCT00946647|20734756|P3|COMPLETED|Phase 1 Part||0
8412400|NCT00946647|20734757|P2|COMPLETED|Phase 1 Part||0
8412401|NCT00946647|20734758|P1|COMPLETED|Phase 1 Part||0
8412402|NCT00946647|20734754|P5|STARTED|Phase 1 Part||0
8412403|NCT00946647|20734755|P4|STARTED|Phase 1 Part||0
8412404|NCT00946647|20734756|P3|STARTED|Phase 1 Part||7
8412405|NCT00946647|20734757|P2|STARTED|Phase 1 Part||18
8412406|NCT00946647|20734758|P1|STARTED|Phase 1 Part||6
8412407|NCT00946530|20734792|P4|NOT COMPLETED|Overall Study||4
8412408|NCT00946530|20734793|P3|NOT COMPLETED|Overall Study||1
8412409|NCT00946530|20734794|P2|NOT COMPLETED|Overall Study||4
8412410|NCT00946530|20734795|P1|NOT COMPLETED|Overall Study||1
8412411|NCT00946530|20734792|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
8412412|NCT00946530|20734793|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
8412413|NCT00946530|20734794|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
8412414|NCT00946530|20734795|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
8412415|NCT00946530|20734792|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
8412416|NCT00946530|20734793|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
8412417|NCT00946530|20734794|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
8412418|NCT00946530|20734795|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
8412419|NCT00946478|20734811|P2|NOT COMPLETED|Overall Study||0
8412420|NCT00946478|20734812|P1|NOT COMPLETED|Overall Study||0
8412421|NCT00946478|20734811|P2|COMPLETED|Overall Study||20
8412422|NCT00946478|20734812|P1|COMPLETED|Overall Study||20
8412423|NCT00946478|20734811|P2|STARTED|Overall Study||20
8412424|NCT00946478|20734812|P1|STARTED|Overall Study||20
8412425|NCT00946348|20734820|P2|NOT COMPLETED|Overall Study||0
8412426|NCT00946348|20734821|P1|NOT COMPLETED|Overall Study||0
8412427|NCT00946348|20734820|P2|COMPLETED|Overall Study||6
8412428|NCT00946348|20734821|P1|COMPLETED|Overall Study||6
8412429|NCT00946348|20734820|P2|STARTED|Overall Study||6
8412430|NCT00946348|20734821|P1|STARTED|Overall Study||6
8412431|NCT00946322|20734827|P1|NOT COMPLETED|Post-treatment||2
8412432|NCT00946322|20734827|P1|COMPLETED|Post-treatment||9
8412433|NCT00946322|20734827|P1|STARTED|Post-treatment||11
8412434|NCT00946322|20734827|P1|NOT COMPLETED|Pre-treatment||1
8412435|NCT00946322|20734827|P1|COMPLETED|Pre-treatment||11
8412436|NCT00946322|20734827|P1|STARTED|Pre-treatment||12
8412437|NCT00946309|20734840|P2|NOT COMPLETED|Overall Study||4
8412438|NCT00946309|20734841|P1|NOT COMPLETED|Overall Study||1
8412439|NCT00946309|20734840|P2|COMPLETED|Overall Study||19
8412440|NCT00946309|20734841|P1|COMPLETED|Overall Study||21
8412441|NCT00946309|20734840|P2|STARTED|Overall Study||23
8412442|NCT00946309|20734841|P1|STARTED|Overall Study||22
8412443|NCT00946296|20734859|P2|NOT COMPLETED|Overall Study||0
8412444|NCT00946296|20734860|P1|NOT COMPLETED|Overall Study||3
8412445|NCT00946296|20734859|P2|COMPLETED|Overall Study||15
8412446|NCT00946296|20734860|P1|COMPLETED|Overall Study||18
8412447|NCT00946296|20734859|P2|STARTED|Overall Study||15
8412448|NCT00946296|20734860|P1|STARTED|Overall Study||21
8412449|NCT00946270|20734869|P3|NOT COMPLETED|Overall Study||0
8412450|NCT00946270|20734870|P2|NOT COMPLETED|Overall Study||0
8412451|NCT00946270|20734871|P1|NOT COMPLETED|Overall Study||0
8412452|NCT00946270|20734869|P3|COMPLETED|Overall Study||29
8412453|NCT00946270|20734870|P2|COMPLETED|Overall Study||20
8412454|NCT00946270|20734871|P1|COMPLETED|Overall Study||21
8412455|NCT00946270|20734869|P3|STARTED|Overall Study||29
8412456|NCT00946270|20734870|P2|STARTED|Overall Study||20
8412457|NCT00946270|20734871|P1|STARTED|Overall Study||21
8412458|NCT00946192|20734882|P3|NOT COMPLETED|Overall Study||12
8412459|NCT00946192|20734883|P2|NOT COMPLETED|Overall Study||18
8412460|NCT00946192|20734884|P1|NOT COMPLETED|Overall Study||18
8412461|NCT00946192|20734882|P3|COMPLETED|Overall Study||26
8412462|NCT00946192|20734883|P2|COMPLETED|Overall Study||22
8412463|NCT00946192|20734884|P1|COMPLETED|Overall Study||25
8412464|NCT00946192|20734882|P3|STARTED|Overall Study||38
8412465|NCT00946192|20734883|P2|STARTED|Overall Study||40
8412466|NCT00946192|20734884|P1|STARTED|Overall Study||43
8412467|NCT00946153|20734900|P5|NOT COMPLETED|Phase 2||13
8412468|NCT00946153|20734901|P4|NOT COMPLETED|Phase 2||0
8412469|NCT00946153|20734902|P3|NOT COMPLETED|Phase 2||0
8412470|NCT00946153|20734903|P2|NOT COMPLETED|Phase 2||0
8412471|NCT00946153|20734904|P1|NOT COMPLETED|Phase 2||0
8412472|NCT00946153|20734900|P5|COMPLETED|Phase 2||33
8412473|NCT00946153|20734901|P4|COMPLETED|Phase 2||0
8412474|NCT00946153|20734902|P3|COMPLETED|Phase 2||0
8412475|NCT00946153|20734903|P2|COMPLETED|Phase 2||0
8412476|NCT00946153|20734904|P1|COMPLETED|Phase 2||0
8412477|NCT00946153|20734900|P5|STARTED|Phase 2||46
8412478|NCT00946153|20734901|P4|STARTED|Phase 2||0
8412479|NCT00946153|20734902|P3|STARTED|Phase 2||0
8412480|NCT00946153|20734903|P2|STARTED|Phase 2||0
8412481|NCT00946153|20734904|P1|STARTED|Phase 2||0
8412482|NCT00946153|20734900|P5|NOT COMPLETED|Phase 1||0
8412483|NCT00946153|20734901|P4|NOT COMPLETED|Phase 1||0
8412484|NCT00946153|20734902|P3|NOT COMPLETED|Phase 1||0
8412485|NCT00946153|20734903|P2|NOT COMPLETED|Phase 1||0
8412486|NCT00946153|20734904|P1|NOT COMPLETED|Phase 1||0
8412487|NCT00946153|20734900|P5|COMPLETED|Phase 1||0
8412488|NCT00946153|20734901|P4|COMPLETED|Phase 1||5
8412489|NCT00946153|20734902|P3|COMPLETED|Phase 1||6
8412490|NCT00946153|20734903|P2|COMPLETED|Phase 1||3
8412491|NCT00946153|20734904|P1|COMPLETED|Phase 1||6
8412492|NCT00946153|20734900|P5|STARTED|Phase 1||0
8412493|NCT00946153|20734901|P4|STARTED|Phase 1||5
8412494|NCT00946153|20734902|P3|STARTED|Phase 1||6
8412495|NCT00946153|20734903|P2|STARTED|Phase 1||3
8412496|NCT00946153|20734904|P1|STARTED|Phase 1||6
8412503|NCT00946101|20734941|P2|NOT COMPLETED|Overall Study||2
8412504|NCT00946101|20734942|P1|NOT COMPLETED|Overall Study||4
8412505|NCT00946101|20734941|P2|COMPLETED|Overall Study||63
8412506|NCT00946101|20734942|P1|COMPLETED|Overall Study||257
8412507|NCT00946101|20734941|P2|Day 15 Post Dose 2|Overall Study||63
8412508|NCT00946101|20734942|P1|Day 15 Post Dose 2|Overall Study||254
8412509|NCT00946101|20734941|P2|Day 15 Post Dose 1|Overall Study||64
8412510|NCT00946101|20734942|P1|Day 15 Post Dose 1|Overall Study||260
8412511|NCT00946101|20734941|P2|STARTED|Overall Study||65
8412512|NCT00946101|20734942|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
8412513|NCT00946088|20735008|P2|NOT COMPLETED|Overall Study||1
8412514|NCT00946088|20735009|P1|NOT COMPLETED|Overall Study||0
8412515|NCT00946088|20735008|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
8412516|NCT00946088|20735009|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
8412517|NCT00946088|20735008|P2|STARTED|Overall Study||3
8412518|NCT00946088|20735009|P1|STARTED|Overall Study||4
8412519|NCT00946023|20735031|P1|NOT COMPLETED|Overall Study||0
8412520|NCT00946023|20735031|P1|COMPLETED|Overall Study||83
8412521|NCT00946023|20735031|P1|STARTED|Overall Study||83
8412522|NCT00945958|20735046|P1|NOT COMPLETED|Overall Study||12
8412523|NCT00945958|20735046|P1|COMPLETED|Overall Study||149
8412524|NCT00945958|20735046|P1|STARTED|Overall Study||161
8412525|NCT00945945|20735053|P2|NOT COMPLETED|Overall Study||55
8412526|NCT00945945|20735054|P1|NOT COMPLETED|Overall Study||36
8412527|NCT00945945|20735053|P2|COMPLETED|Overall Study||162
8412528|NCT00945945|20735054|P1|COMPLETED|Overall Study||171
8412529|NCT00945945|20735053|P2|STARTED|Overall Study||217
8412530|NCT00945945|20735054|P1|STARTED|Overall Study||207
8412531|NCT00945906|20735080|P1|NOT COMPLETED|Overall Study||7
8412532|NCT00945906|20735080|P1|COMPLETED|Overall Study||54
8412533|NCT00945906|20735080|P1|STARTED|Overall Study||61
8412534|NCT00945893|20735091|P2|NOT COMPLETED|Overall Study||10
8412535|NCT00945893|20735092|P1|NOT COMPLETED|Overall Study||3
8412536|NCT00945893|20735091|P2|COMPLETED|Overall Study||230
8412537|NCT00945893|20735092|P1|COMPLETED|Overall Study||57
8412538|NCT00945893|20735091|P2|Day 15 Post Dose 2|Overall Study||226
8412539|NCT00945893|20735092|P1|Day 15 Post Dose 2|Overall Study||54
8412540|NCT00945893|20735091|P2|Day 15 Post Dose 1|Overall Study||238
8412541|NCT00945893|20735092|P1|Day 15 Post Dose 1|Overall Study||60
8412542|NCT00945893|20735091|P2|STARTED|Overall Study||240
8412543|NCT00945893|20735092|P1|STARTED|Overall Study||60
8412544|NCT00945854|20735158|P2|NOT COMPLETED|Overall Study||4
8412545|NCT00945854|20735159|P1|NOT COMPLETED|Overall Study||2
8412546|NCT00945854|20735158|P2|COMPLETED|Overall Study||26
8412547|NCT00945854|20735159|P1|COMPLETED|Overall Study||28
8412548|NCT00945854|20735158|P2|STARTED|Overall Study||30
8412549|NCT00945854|20735159|P1|STARTED|Overall Study||30
8412550|NCT00945815|20735169|P1|NOT COMPLETED|Overall Study||8
8412551|NCT00945815|20735169|P1|COMPLETED|Overall Study||27
8412552|NCT00945815|20735169|P1|Eligible and Began Protocol Therapy|Overall Study||31
8412553|NCT00945815|20735169|P1|Eligible|Overall Study||32
8412554|NCT00945815|20735169|P1|STARTED|Overall Study||35
8412555|NCT00945750|20735180|P6|NOT COMPLETED|Period III||0
8412556|NCT00945750|20735181|P5|NOT COMPLETED|Period III||0
8412557|NCT00945750|20735182|P4|NOT COMPLETED|Period III||0
8412558|NCT00945750|20735183|P3|NOT COMPLETED|Period III||0
8412559|NCT00945750|20735184|P2|NOT COMPLETED|Period III||0
8412560|NCT00945750|20735185|P1|NOT COMPLETED|Period III||0
8412561|NCT00945750|20735180|P6|COMPLETED|Period III||5
8412562|NCT00945750|20735181|P5|COMPLETED|Period III||5
8412563|NCT00945750|20735182|P4|COMPLETED|Period III||5
8412564|NCT00945750|20735183|P3|COMPLETED|Period III||5
8412565|NCT00945750|20735184|P2|COMPLETED|Period III||5
8412566|NCT00945750|20735185|P1|COMPLETED|Period III||5
8412567|NCT00945750|20735180|P6|STARTED|Period III||5
8412568|NCT00945750|20735181|P5|STARTED|Period III||5
8412569|NCT00945750|20735182|P4|STARTED|Period III||5
8412570|NCT00945750|20735183|P3|STARTED|Period III||5
8412571|NCT00945750|20735184|P2|STARTED|Period III||5
8412572|NCT00945750|20735185|P1|STARTED|Period III||5
8412573|NCT00945750|20735180|P6|NOT COMPLETED|Period II||0
8412574|NCT00945750|20735181|P5|NOT COMPLETED|Period II||0
8412575|NCT00945750|20735182|P4|NOT COMPLETED|Period II||0
8412576|NCT00945750|20735183|P3|NOT COMPLETED|Period II||0
8412577|NCT00945750|20735184|P2|NOT COMPLETED|Period II||0
8412578|NCT00945750|20735185|P1|NOT COMPLETED|Period II||0
8412579|NCT00945750|20735180|P6|COMPLETED|Period II||5
8412580|NCT00945750|20735181|P5|COMPLETED|Period II||5
8412581|NCT00945750|20735182|P4|COMPLETED|Period II||5
8412582|NCT00945750|20735183|P3|COMPLETED|Period II||5
8412583|NCT00945750|20735184|P2|COMPLETED|Period II||5
8412584|NCT00945750|20735185|P1|COMPLETED|Period II||5
8412585|NCT00945750|20735180|P6|STARTED|Period II||5
8412586|NCT00945750|20735181|P5|STARTED|Period II||5
8412587|NCT00945750|20735182|P4|STARTED|Period II||5
8412588|NCT00945750|20735183|P3|STARTED|Period II||5
8412589|NCT00945750|20735184|P2|STARTED|Period II||5
8412590|NCT00945750|20735185|P1|STARTED|Period II||5
8412591|NCT00945750|20735180|P6|NOT COMPLETED|Period I||0
8412592|NCT00945750|20735181|P5|NOT COMPLETED|Period I||0
8412593|NCT00945750|20735182|P4|NOT COMPLETED|Period I||0
8412594|NCT00945750|20735183|P3|NOT COMPLETED|Period I||0
8412595|NCT00945750|20735184|P2|NOT COMPLETED|Period I||0
8412596|NCT00945750|20735185|P1|NOT COMPLETED|Period I||0
8412597|NCT00945750|20735180|P6|COMPLETED|Period I||5
8412598|NCT00945750|20735181|P5|COMPLETED|Period I||5
8412599|NCT00945750|20735182|P4|COMPLETED|Period I||5
8412600|NCT00945750|20735183|P3|COMPLETED|Period I||5
8412601|NCT00945750|20735184|P2|COMPLETED|Period I||5
8412602|NCT00945750|20735185|P1|COMPLETED|Period I||5
8412603|NCT00945750|20735180|P6|STARTED|Period I||5
8412604|NCT00945750|20735181|P5|STARTED|Period I||5
8412605|NCT00945750|20735182|P4|STARTED|Period I||5
8412606|NCT00945750|20735183|P3|STARTED|Period I||5
8412607|NCT00945750|20735184|P2|STARTED|Period I||5
8412608|NCT00945750|20735185|P1|STARTED|Period I||5
8412609|NCT00945659|20735201|P3|NOT COMPLETED|Overall Study||17
8412610|NCT00945659|20735202|P2|NOT COMPLETED|Overall Study||20
8412611|NCT00945659|20735203|P1|NOT COMPLETED|Overall Study||7
8412612|NCT00945659|20735201|P3|COMPLETED|Overall Study||20
8412613|NCT00945659|20735202|P2|COMPLETED|Overall Study||20
8412614|NCT00945659|20735203|P1|COMPLETED|Overall Study||32
8412615|NCT00945659|20735201|P3|12-Months|Overall Study||20
8412616|NCT00945659|20735202|P2|12-Months|Overall Study||20
8412617|NCT00945659|20735203|P1|12-Months|Overall Study||32
8412618|NCT00945659|20735201|P3|9-Months|Overall Study||20
8412619|NCT00945659|20735202|P2|9-Months|Overall Study||20
8412620|NCT00945659|20735203|P1|9-Months|Overall Study||32
8412621|NCT00945659|20735201|P3|6-Months|Overall Study||25
8412622|NCT00945659|20735202|P2|6-Months|Overall Study||29
8412623|NCT00945659|20735203|P1|6-Months|Overall Study||31
8412624|NCT00945659|20735201|P3|3-Months|Overall Study||35
8412625|NCT00945659|20735202|P2|3-Months|Overall Study||39
8412626|NCT00945659|20735203|P1|3-Months|Overall Study||38
8412627|NCT00945659|20735201|P3|Baseline|Overall Study||37
8412628|NCT00945659|20735202|P2|Baseline|Overall Study||40
8412629|NCT00945659|20735203|P1|Baseline|Overall Study||39
8412630|NCT00945659|20735201|P3|STARTED|Overall Study||37
8412631|NCT00945659|20735202|P2|STARTED|Overall Study||40
8412632|NCT00945659|20735203|P1|STARTED|Overall Study||39
8412633|NCT00945594|20735249|P2|NOT COMPLETED|Overall Study||0
8412634|NCT00945594|20735250|P1|NOT COMPLETED|Overall Study||0
8412635|NCT00945594|20735249|P2|COMPLETED|Overall Study||50
8412636|NCT00945594|20735250|P1|COMPLETED|Overall Study||50
8412637|NCT00945594|20735249|P2|STARTED|Overall Study||50
8412638|NCT00945594|20735250|P1|STARTED|Overall Study||50
8412639|NCT00945555|20735260|P1|NOT COMPLETED|Overall Study||28
8412640|NCT00945555|20735260|P1|COMPLETED|Overall Study||236
8412641|NCT00945555|20735260|P1|STARTED|Overall Study||264
8412642|NCT00945477|20735271|P1|NOT COMPLETED|Overall Study||6
8412643|NCT00945477|20735271|P1|COMPLETED|Overall Study||5
8412644|NCT00945477|20735271|P1|STARTED|Overall Study||11
8412645|NCT00945334|20735278|P2|NOT COMPLETED|Overall Study||3
8412646|NCT00945334|20735279|P1|NOT COMPLETED|Overall Study||3
8412647|NCT00945334|20735278|P2|COMPLETED|Overall Study||15
8412648|NCT00945334|20735279|P1|COMPLETED|Overall Study||16
8412649|NCT00945334|20735278|P2|STARTED|Overall Study||18
8412650|NCT00945334|20735279|P1|STARTED|Overall Study||19
8412651|NCT00945321|20735287|P6|NOT COMPLETED|Period 4||1
8412652|NCT00945321|20735288|P5|NOT COMPLETED|Period 4||0
8412653|NCT00945321|20735289|P4|NOT COMPLETED|Period 4||0
8412654|NCT00945321|20735290|P3|NOT COMPLETED|Period 4||0
8412655|NCT00945321|20735291|P2|NOT COMPLETED|Period 4||0
8412656|NCT00945321|20735292|P1|NOT COMPLETED|Period 4||0
8412657|NCT00945321|20735287|P6|COMPLETED|Period 4||6
8412658|NCT00945321|20735288|P5|COMPLETED|Period 4||6
8412659|NCT00945321|20735289|P4|COMPLETED|Period 4||7
8412660|NCT00945321|20735290|P3|COMPLETED|Period 4||7
8412661|NCT00945321|20735291|P2|COMPLETED|Period 4||7
8412662|NCT00945321|20735292|P1|COMPLETED|Period 4||7
8412663|NCT00945321|20735287|P6|STARTED|Period 4||7
8412664|NCT00945321|20735288|P5|STARTED|Period 4||6
8412665|NCT00945321|20735289|P4|STARTED|Period 4||7
8412666|NCT00945321|20735290|P3|STARTED|Period 4||7
8412667|NCT00945321|20735291|P2|STARTED|Period 4||7
8412668|NCT00945321|20735292|P1|STARTED|Period 4||7
8412669|NCT00945321|20735287|P6|NOT COMPLETED|Period 3||0
8412670|NCT00945321|20735288|P5|NOT COMPLETED|Period 3||0
8412671|NCT00945321|20735289|P4|NOT COMPLETED|Period 3||0
8412672|NCT00945321|20735290|P3|NOT COMPLETED|Period 3||0
8412673|NCT00945321|20735291|P2|NOT COMPLETED|Period 3||0
8412674|NCT00945321|20735292|P1|NOT COMPLETED|Period 3||0
8412675|NCT00945321|20735287|P6|COMPLETED|Period 3||7
8412676|NCT00945321|20735288|P5|COMPLETED|Period 3||6
8412677|NCT00945321|20735289|P4|COMPLETED|Period 3||7
8412678|NCT00945321|20735290|P3|COMPLETED|Period 3||7
8412679|NCT00945321|20735291|P2|COMPLETED|Period 3||7
8412680|NCT00945321|20735292|P1|COMPLETED|Period 3||7
8412681|NCT00945321|20735287|P6|STARTED|Period 3||7
8412682|NCT00945321|20735288|P5|STARTED|Period 3||6
8412683|NCT00945321|20735289|P4|STARTED|Period 3||7
8412684|NCT00945321|20735290|P3|STARTED|Period 3||7
8412685|NCT00945321|20735291|P2|STARTED|Period 3||7
8412686|NCT00945321|20735292|P1|STARTED|Period 3||7
8412687|NCT00945321|20735287|P6|NOT COMPLETED|Period 2||0
8412688|NCT00945321|20735288|P5|NOT COMPLETED|Period 2||0
8412689|NCT00945321|20735289|P4|NOT COMPLETED|Period 2||0
8412690|NCT00945321|20735290|P3|NOT COMPLETED|Period 2||0
8412691|NCT00945321|20735291|P2|NOT COMPLETED|Period 2||0
8412692|NCT00945321|20735292|P1|NOT COMPLETED|Period 2||0
8412693|NCT00945321|20735287|P6|COMPLETED|Period 2||7
8412694|NCT00945321|20735288|P5|COMPLETED|Period 2||6
8412695|NCT00945321|20735289|P4|COMPLETED|Period 2||7
8412696|NCT00945321|20735290|P3|COMPLETED|Period 2||7
8412697|NCT00945321|20735291|P2|COMPLETED|Period 2||7
8412698|NCT00945321|20735292|P1|COMPLETED|Period 2||7
8412699|NCT00945321|20735287|P6|STARTED|Period 2||7
8412700|NCT00945321|20735288|P5|STARTED|Period 2||6
8412701|NCT00945321|20735289|P4|STARTED|Period 2||7
8412702|NCT00945321|20735290|P3|STARTED|Period 2||7
8412703|NCT00945321|20735291|P2|STARTED|Period 2||7
8412704|NCT00945321|20735292|P1|STARTED|Period 2||7
8412705|NCT00945321|20735287|P6|NOT COMPLETED|Period 1||0
8412706|NCT00945321|20735288|P5|NOT COMPLETED|Period 1||1
8412707|NCT00945321|20735289|P4|NOT COMPLETED|Period 1||0
8412708|NCT00945321|20735290|P3|NOT COMPLETED|Period 1||0
8412709|NCT00945321|20735291|P2|NOT COMPLETED|Period 1||0
8412710|NCT00945321|20735292|P1|NOT COMPLETED|Period 1||0
8412711|NCT00945321|20735287|P6|COMPLETED|Period 1||7
8412712|NCT00945321|20735288|P5|COMPLETED|Period 1||6
8412713|NCT00945321|20735289|P4|COMPLETED|Period 1||7
8412714|NCT00945321|20735290|P3|COMPLETED|Period 1||7
8412715|NCT00945321|20735291|P2|COMPLETED|Period 1||7
8412716|NCT00945321|20735292|P1|COMPLETED|Period 1||7
8412717|NCT00945321|20735287|P6|STARTED|Period 1||7
8412718|NCT00945321|20735288|P5|STARTED|Period 1||7
8412719|NCT00945321|20735289|P4|STARTED|Period 1||7
8412720|NCT00945321|20735290|P3|STARTED|Period 1||7
8412721|NCT00945321|20735291|P2|STARTED|Period 1||7
8412722|NCT00945321|20735292|P1|STARTED|Period 1||7
8412723|NCT00945295|20735314|P2|NOT COMPLETED|Overall Study||2
8412724|NCT00945295|20735315|P1|NOT COMPLETED|Overall Study||0
8412725|NCT00945295|20735314|P2|COMPLETED|Overall Study||14
8412726|NCT00945295|20735315|P1|COMPLETED|Overall Study||15
8412727|NCT00945295|20735314|P2|STARTED|Overall Study||16
8412728|NCT00945295|20735315|P1|STARTED|Overall Study||15
8412729|NCT00945282|20735325|P2|NOT COMPLETED|Overall Study||0
8412730|NCT00945282|20735326|P1|NOT COMPLETED|Overall Study||0
8412731|NCT00945282|20735325|P2|COMPLETED|Overall Study||2
8412732|NCT00945282|20735326|P1|COMPLETED|Overall Study||6
8412733|NCT00945282|20735325|P2|STARTED|Overall Study||2
8412734|NCT00945282|20735326|P1|STARTED|Overall Study||6
8412735|NCT00945256|20735409|P5|NOT COMPLETED|Overall Study||1
8412736|NCT00945256|20735410|P4|NOT COMPLETED|Overall Study||9
8412737|NCT00945256|20735411|P3|NOT COMPLETED|Overall Study||8
8412738|NCT00945256|20735412|P2|NOT COMPLETED|Overall Study||2
8412739|NCT00945256|20735413|P1|NOT COMPLETED|Overall Study||4
8412740|NCT00945256|20735409|P5|COMPLETED|Overall Study||7
8412741|NCT00945256|20735410|P4|COMPLETED|Overall Study||7
8412742|NCT00945256|20735411|P3|COMPLETED|Overall Study||7
8412743|NCT00945256|20735412|P2|COMPLETED|Overall Study||8
8412744|NCT00945256|20735413|P1|COMPLETED|Overall Study||9
8412745|NCT00945256|20735409|P5|STARTED|Overall Study||8
8412746|NCT00945256|20735410|P4|STARTED|Overall Study||16
8412747|NCT00945256|20735411|P3|STARTED|Overall Study||15
8412748|NCT00945256|20735412|P2|STARTED|Overall Study||10
8412749|NCT00945256|20735413|P1|STARTED|Overall Study||13
8412750|NCT00945243|20735425|P1|NOT COMPLETED|Overall Study||3
8412751|NCT00945243|20735425|P1|COMPLETED|Overall Study||8
8412752|NCT00945243|20735425|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
8412753|NCT00945191|20735431|P1|NOT COMPLETED|Overall Study||24
8412754|NCT00945191|20735431|P1|COMPLETED|Overall Study||0
8412755|NCT00945191|20735431|P1|STARTED|Overall Study||24
8412756|NCT00945139|20735437|P1|NOT COMPLETED|Overall Study||0
8412757|NCT00945139|20735437|P1|COMPLETED|Overall Study||46
8412758|NCT00945139|20735437|P1|STARTED|Overall Study||46
8412759|NCT00945100|20735448|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
8412760|NCT00945100|20735449|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
8412761|NCT00945100|20735448|P2|COMPLETED|Post-10 Week Primary Outcome||56
8412762|NCT00945100|20735449|P1|COMPLETED|Post-10 Week Primary Outcome||51
8412763|NCT00945100|20735448|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
8412764|NCT00945100|20735449|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
8412765|NCT00945100|20735448|P2|NOT COMPLETED|10-week Primary Outcome||3
8412766|NCT00945100|20735449|P1|NOT COMPLETED|10-week Primary Outcome||1
8412767|NCT00945100|20735448|P2|COMPLETED|10-week Primary Outcome||83
8412768|NCT00945100|20735449|P1|COMPLETED|10-week Primary Outcome||82
8412769|NCT00945100|20735448|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
8412770|NCT00945100|20735449|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
8412771|NCT00945100|20735448|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
8412772|NCT00945100|20735449|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
8412773|NCT00945100|20735448|P2|STARTED|10-week Primary Outcome||86
8412774|NCT00945100|20735449|P1|STARTED|10-week Primary Outcome||83
8412775|NCT00945061|20735515|P2|NOT COMPLETED|Overall Study||0
8412776|NCT00945061|20735516|P1|NOT COMPLETED|Overall Study||0
8412777|NCT00945061|20735515|P2|COMPLETED|Overall Study||1
8412778|NCT00945061|20735516|P1|COMPLETED|Overall Study||12
8412779|NCT00945061|20735515|P2|STARTED|Overall Study||1
8412780|NCT00945061|20735516|P1|STARTED|Overall Study||12
8412781|NCT00945035|20735615|P2|NOT COMPLETED|Period 2||0
8412782|NCT00945035|20735616|P1|NOT COMPLETED|Period 2||0
8412783|NCT00945035|20735615|P2|COMPLETED|Period 2||18
8412784|NCT00945035|20735616|P1|COMPLETED|Period 2||18
8412785|NCT00945035|20735615|P2|STARTED|Period 2||18
8412786|NCT00945035|20735616|P1|STARTED|Period 2||18
8412787|NCT00945035|20735615|P2|NOT COMPLETED|Period 1||0
8412788|NCT00945035|20735616|P1|NOT COMPLETED|Period 1||0
8412789|NCT00945035|20735615|P2|COMPLETED|Period 1||18
8412790|NCT00945035|20735616|P1|COMPLETED|Period 1||18
8412791|NCT00945035|20735615|P2|STARTED|Period 1||18
8412792|NCT00945035|20735616|P1|STARTED|Period 1||18
8412793|NCT00945009|20735627|P3|NOT COMPLETED|Overall Study||3
8412794|NCT00945009|20735628|P2|NOT COMPLETED|Overall Study||7
8412795|NCT00945009|20735629|P1|NOT COMPLETED|Overall Study||45
8412796|NCT00945009|20735627|P3|COMPLETED|Overall Study||6
8412797|NCT00945009|20735628|P2|COMPLETED|Overall Study||32
8412798|NCT00945009|20735629|P1|COMPLETED|Overall Study||156
8412799|NCT00945009|20735627|P3|STARTED|Overall Study||9
8412800|NCT00945009|20735628|P2|STARTED|Overall Study||39
8412801|NCT00945009|20735629|P1|STARTED|Overall Study||201
8412802|NCT00944749|20735639|P1|NOT COMPLETED|Overall Study||1
8412803|NCT00944749|20735639|P1|COMPLETED|Overall Study||22
8412804|NCT00944749|20735639|P1|STARTED|Overall Study||23
8412805|NCT00944710|20735646|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
8412806|NCT00944710|20735647|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
8412807|NCT00944710|20735646|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
8412808|NCT00944710|20735647|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
8412809|NCT00944710|20735646|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
8412810|NCT00944710|20735647|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
8412811|NCT00944710|20735646|P2|STARTED|Additional Post 10-week Primary Outcome||33
8412812|NCT00944710|20735647|P1|STARTED|Additional Post 10-week Primary Outcome||40
8412813|NCT00944710|20735646|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
8412814|NCT00944710|20735647|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
8412815|NCT00944710|20735646|P2|COMPLETED|12-week Visit (Off-treatment)||33
8412816|NCT00944710|20735647|P1|COMPLETED|12-week Visit (Off-treatment)||40
8412817|NCT00944710|20735646|P2|STARTED|12-week Visit (Off-treatment)||33
8412818|NCT00944710|20735647|P1|STARTED|12-week Visit (Off-treatment)||40
8412819|NCT00944710|20735646|P2|NOT COMPLETED|10-week Primary Outcome||0
8412820|NCT00944710|20735647|P1|NOT COMPLETED|10-week Primary Outcome||0
8412821|NCT00944710|20735646|P2|COMPLETED|10-week Primary Outcome||33
8412822|NCT00944710|20735647|P1|COMPLETED|10-week Primary Outcome||40
8412823|NCT00944710|20735646|P2|STARTED|10-week Primary Outcome||33
8412824|NCT00944710|20735647|P1|STARTED|10-week Primary Outcome||40
8412825|NCT00944697|20735705|P2|NOT COMPLETED|Overall Study||5
8412826|NCT00944697|20735706|P1|NOT COMPLETED|Overall Study||2
8412827|NCT00944697|20735705|P2|COMPLETED|Overall Study||43
8412828|NCT00944697|20735706|P1|COMPLETED|Overall Study||48
8412829|NCT00944697|20735705|P2|STARTED|Overall Study||48
8412830|NCT00944697|20735706|P1|STARTED|Overall Study||50
8412831|NCT00944671|20735718|P6|NOT COMPLETED|Period III||0
8412832|NCT00944671|20735719|P5|NOT COMPLETED|Period III||0
8412833|NCT00944671|20735720|P4|NOT COMPLETED|Period III||0
8412834|NCT00944671|20735721|P3|NOT COMPLETED|Period III||0
8412835|NCT00944671|20735722|P2|NOT COMPLETED|Period III||0
8412836|NCT00944671|20735723|P1|NOT COMPLETED|Period III||0
8412837|NCT00944671|20735718|P6|COMPLETED|Period III||4
8412838|NCT00944671|20735719|P5|COMPLETED|Period III||4
8412839|NCT00944671|20735720|P4|COMPLETED|Period III||4
8412840|NCT00944671|20735721|P3|COMPLETED|Period III||4
8412841|NCT00944671|20735722|P2|COMPLETED|Period III||4
8412842|NCT00944671|20735723|P1|COMPLETED|Period III||4
8412843|NCT00944671|20735718|P6|STARTED|Period III||4
8412844|NCT00944671|20735719|P5|STARTED|Period III||4
8412845|NCT00944671|20735720|P4|STARTED|Period III||4
8412846|NCT00944671|20735721|P3|STARTED|Period III||4
8412847|NCT00944671|20735722|P2|STARTED|Period III||4
8412848|NCT00944671|20735723|P1|STARTED|Period III||4
8412849|NCT00944671|20735718|P6|NOT COMPLETED|Period II||0
8412850|NCT00944671|20735719|P5|NOT COMPLETED|Period II||0
8412851|NCT00944671|20735720|P4|NOT COMPLETED|Period II||0
8412852|NCT00944671|20735721|P3|NOT COMPLETED|Period II||0
8412853|NCT00944671|20735722|P2|NOT COMPLETED|Period II||0
8412854|NCT00944671|20735723|P1|NOT COMPLETED|Period II||0
8412855|NCT00944671|20735718|P6|COMPLETED|Period II||4
8412856|NCT00944671|20735719|P5|COMPLETED|Period II||4
8412857|NCT00944671|20735720|P4|COMPLETED|Period II||4
8412858|NCT00944671|20735721|P3|COMPLETED|Period II||4
8412859|NCT00944671|20735722|P2|COMPLETED|Period II||4
8412860|NCT00944671|20735723|P1|COMPLETED|Period II||4
8412861|NCT00944671|20735718|P6|STARTED|Period II||4
8412862|NCT00944671|20735719|P5|STARTED|Period II||4
8412863|NCT00944671|20735720|P4|STARTED|Period II||4
8412864|NCT00944671|20735721|P3|STARTED|Period II||4
8412865|NCT00944671|20735722|P2|STARTED|Period II||4
8412866|NCT00944671|20735723|P1|STARTED|Period II||4
8412867|NCT00944671|20735718|P6|NOT COMPLETED|Period I||0
8412868|NCT00944671|20735719|P5|NOT COMPLETED|Period I||0
8412869|NCT00944671|20735720|P4|NOT COMPLETED|Period I||0
8412870|NCT00944671|20735721|P3|NOT COMPLETED|Period I||0
8412871|NCT00944671|20735722|P2|NOT COMPLETED|Period I||0
8412872|NCT00944671|20735723|P1|NOT COMPLETED|Period I||0
8412873|NCT00944671|20735718|P6|COMPLETED|Period I||4
8412874|NCT00944671|20735719|P5|COMPLETED|Period I||4
8412875|NCT00944671|20735720|P4|COMPLETED|Period I||4
8412876|NCT00944671|20735721|P3|COMPLETED|Period I||4
8412877|NCT00944671|20735722|P2|COMPLETED|Period I||4
8412878|NCT00944671|20735723|P1|COMPLETED|Period I||4
8412879|NCT00944671|20735718|P6|STARTED|Period I||4
8412880|NCT00944671|20735719|P5|STARTED|Period I||4
8412881|NCT00944671|20735720|P4|STARTED|Period I||4
8412882|NCT00944671|20735721|P3|STARTED|Period I||4
8412883|NCT00944671|20735722|P2|STARTED|Period I||4
8412884|NCT00944671|20735723|P1|STARTED|Period I||4
8412885|NCT00944658|20735738|P2|NOT COMPLETED|Follow up 4 Weeks||0
8412886|NCT00944658|20735739|P1|NOT COMPLETED|Follow up 4 Weeks||0
8412887|NCT00944658|20735738|P2|COMPLETED|Follow up 4 Weeks||17
8412888|NCT00944658|20735739|P1|COMPLETED|Follow up 4 Weeks||19
8412889|NCT00944658|20735738|P2|STARTED|Follow up 4 Weeks||17
8412890|NCT00944658|20735739|P1|STARTED|Follow up 4 Weeks||19
8412891|NCT00944658|20735738|P2|NOT COMPLETED|Treatment 12 Weeks||2
8412892|NCT00944658|20735739|P1|NOT COMPLETED|Treatment 12 Weeks||0
8412893|NCT00944658|20735738|P2|COMPLETED|Treatment 12 Weeks||17
8412894|NCT00944658|20735739|P1|COMPLETED|Treatment 12 Weeks||19
8412895|NCT00944658|20735738|P2|STARTED|Treatment 12 Weeks||19
8412896|NCT00944658|20735739|P1|STARTED|Treatment 12 Weeks||19
8412897|NCT00944645|20735751|P2|NOT COMPLETED|Period 2||9
8412898|NCT00944645|20735752|P1|NOT COMPLETED|Period 2||8
8412899|NCT00944645|20735751|P2|COMPLETED|Period 2||85
8412900|NCT00944645|20735752|P1|COMPLETED|Period 2||86
8412901|NCT00944645|20735751|P2|STARTED|Period 2||94
8412902|NCT00944645|20735752|P1|STARTED|Period 2||94
8412903|NCT00944645|20735751|P2|NOT COMPLETED|Period 1||0
8412904|NCT00944645|20735752|P1|NOT COMPLETED|Period 1||0
8412905|NCT00944645|20735751|P2|COMPLETED|Period 1||94
8412906|NCT00944645|20735752|P1|COMPLETED|Period 1||94
8412907|NCT00944645|20735751|P2|STARTED|Period 1||94
8412908|NCT00944645|20735752|P1|STARTED|Period 1||94
8412909|NCT00944554|20735766|P2|NOT COMPLETED|Overall Study||29
8412910|NCT00944554|20735767|P1|NOT COMPLETED|Overall Study||28
8412911|NCT00944554|20735766|P2|COMPLETED|Overall Study||25
8412912|NCT00944554|20735767|P1|COMPLETED|Overall Study||22
8412913|NCT00944554|20735766|P2|STARTED|Overall Study||54
8412914|NCT00944554|20735767|P1|STARTED|Overall Study||50
8412924|NCT00944450|20735790|P2|NOT COMPLETED|Period 2||0
8412925|NCT00944450|20735791|P1|NOT COMPLETED|Period 2||0
8412926|NCT00944450|20735790|P2|COMPLETED|Period 2||6
8412927|NCT00944450|20735791|P1|COMPLETED|Period 2||6
8412928|NCT00944450|20735790|P2|STARTED|Period 2||6
8412929|NCT00944450|20735791|P1|STARTED|Period 2||6
8412930|NCT00944450|20735790|P2|NOT COMPLETED|Period 1||0
8412931|NCT00944450|20735791|P1|NOT COMPLETED|Period 1||0
8412932|NCT00944450|20735790|P2|COMPLETED|Period 1||6
8412933|NCT00944450|20735791|P1|COMPLETED|Period 1||6
8412934|NCT00944450|20735790|P2|STARTED|Period 1||6
8412935|NCT00944450|20735791|P1|STARTED|Period 1||6
8412936|NCT00944229|20735799|P1|NOT COMPLETED|Overall Study||25
8412937|NCT00944229|20735799|P1|COMPLETED|Overall Study||33
8412938|NCT00944229|20735799|P1|STARTED|Overall Study||58
8412939|NCT00944125|20735805|P2|NOT COMPLETED|6 Months to Study Completion||2
8412940|NCT00944125|20735806|P1|NOT COMPLETED|6 Months to Study Completion||0
8412941|NCT00944125|20735805|P2|COMPLETED|6 Months to Study Completion||18
8412942|NCT00944125|20735806|P1|COMPLETED|6 Months to Study Completion||19
8412943|NCT00944125|20735805|P2|STARTED|6 Months to Study Completion||20
8412944|NCT00944125|20735806|P1|STARTED|6 Months to Study Completion||19
8412945|NCT00944125|20735805|P2|NOT COMPLETED|3 to 6 Months||2
8412946|NCT00944125|20735806|P1|NOT COMPLETED|3 to 6 Months||0
8412947|NCT00944125|20735805|P2|COMPLETED|3 to 6 Months||20
8412948|NCT00944125|20735806|P1|COMPLETED|3 to 6 Months||19
8412949|NCT00944125|20735805|P2|STARTED|3 to 6 Months||22
8412950|NCT00944125|20735806|P1|STARTED|3 to 6 Months||19
8412951|NCT00944125|20735805|P2|NOT COMPLETED|Baseline to 3 Months||0
8412952|NCT00944125|20735806|P1|NOT COMPLETED|Baseline to 3 Months||0
8412953|NCT00944125|20735805|P2|COMPLETED|Baseline to 3 Months||22
8412954|NCT00944125|20735806|P1|COMPLETED|Baseline to 3 Months||19
8412955|NCT00944125|20735805|P2|STARTED|Baseline to 3 Months||22
8412956|NCT00944125|20735806|P1|STARTED|Baseline to 3 Months||19
8412957|NCT00944073|20735814|P2|NOT COMPLETED|Overall Study||4
8412958|NCT00944073|20735815|P1|NOT COMPLETED|Overall Study||5
8412959|NCT00944073|20735814|P2|COMPLETED|Overall Study||287
8412960|NCT00944073|20735815|P1|COMPLETED|Overall Study||287
8412961|NCT00944073|20735814|P2|STARTED|Overall Study||291
8412962|NCT00944073|20735815|P1|STARTED|Overall Study||292
8412963|NCT00944047|20735893|P1|NOT COMPLETED|Overall Study||5
8412964|NCT00944047|20735893|P1|COMPLETED|Overall Study||27
8412965|NCT00944047|20735893|P1|STARTED|Overall Study||32
8412966|NCT00944034|20735909|P12|NOT COMPLETED|Overall Study||4
8412967|NCT00944034|20735910|P11|NOT COMPLETED|Overall Study||1
8412968|NCT00944034|20735911|P10|NOT COMPLETED|Overall Study||10
8412969|NCT00944034|20735912|P9|NOT COMPLETED|Overall Study||10
8412970|NCT00944034|20735913|P8|NOT COMPLETED|Overall Study||5
8412971|NCT00944034|20735914|P7|NOT COMPLETED|Overall Study||4
8412972|NCT00944034|20735915|P6|NOT COMPLETED|Overall Study||20
8412973|NCT00944034|20735916|P5|NOT COMPLETED|Overall Study||14
8412974|NCT00944034|20735917|P4|NOT COMPLETED|Overall Study||4
8412975|NCT00944034|20735918|P3|NOT COMPLETED|Overall Study||9
8412976|NCT00944034|20735919|P2|NOT COMPLETED|Overall Study||7
8412977|NCT00944034|20735920|P1|NOT COMPLETED|Overall Study||5
8412978|NCT00944034|20735909|P12|COMPLETED|Overall Study||52
8412979|NCT00944034|20735910|P11|COMPLETED|Overall Study||50
8412980|NCT00944034|20735911|P10|COMPLETED|Overall Study||236
8412981|NCT00944034|20735912|P9|COMPLETED|Overall Study||63
8412982|NCT00944034|20735913|P8|COMPLETED|Overall Study||73
8412983|NCT00944034|20735914|P7|COMPLETED|Overall Study||102
8412984|NCT00944034|20735915|P6|COMPLETED|Overall Study||123
8412985|NCT00944034|20735916|P5|COMPLETED|Overall Study||150
8412986|NCT00944034|20735917|P4|COMPLETED|Overall Study||170
8412987|NCT00944034|20735918|P3|COMPLETED|Overall Study||143
8412988|NCT00944034|20735919|P2|COMPLETED|Overall Study||150
8412989|NCT00944034|20735920|P1|COMPLETED|Overall Study||183
8412990|NCT00944034|20735909|P12|STARTED|Overall Study||56
8412991|NCT00944034|20735910|P11|STARTED|Overall Study||51
8412992|NCT00944034|20735911|P10|STARTED|Overall Study||246
8412993|NCT00944034|20735912|P9|STARTED|Overall Study||73
8412994|NCT00944034|20735913|P8|STARTED|Overall Study||78
8412995|NCT00944034|20735914|P7|STARTED|Overall Study||106
8412996|NCT00944034|20735915|P6|STARTED|Overall Study||143
8412997|NCT00944034|20735916|P5|STARTED|Overall Study||164
8412998|NCT00944034|20735917|P4|STARTED|Overall Study||174
8412999|NCT00944034|20735918|P3|STARTED|Overall Study||152
8413000|NCT00944034|20735919|P2|STARTED|Overall Study||157
8413001|NCT00944034|20735920|P1|STARTED|Overall Study||188
8413002|NCT00944021|20735990|P5|NOT COMPLETED|Overall Study||0
8413003|NCT00944021|20735991|P4|NOT COMPLETED|Overall Study||0
8413004|NCT00944021|20735992|P3|NOT COMPLETED|Overall Study||0
8413005|NCT00944021|20735993|P2|NOT COMPLETED|Overall Study||0
8413006|NCT00944021|20735994|P1|NOT COMPLETED|Overall Study||1
8413007|NCT00944021|20735990|P5|COMPLETED|Overall Study||8
8413008|NCT00944021|20735991|P4|COMPLETED|Overall Study||16
8413009|NCT00944021|20735992|P3|COMPLETED|Overall Study||15
8413010|NCT00944021|20735993|P2|COMPLETED|Overall Study||15
8413011|NCT00944021|20735994|P1|COMPLETED|Overall Study||14
8413012|NCT00944021|20735990|P5|STARTED|Overall Study||8
8413013|NCT00944021|20735991|P4|STARTED|Overall Study||16
8413014|NCT00944021|20735992|P3|STARTED|Overall Study||15
8413015|NCT00944021|20735993|P2|STARTED|Overall Study||15
8413016|NCT00944021|20735994|P1|STARTED|Overall Study||15
8413017|NCT00943917|20736066|P15|NOT COMPLETED|Stage II Continuation||4
8413018|NCT00943917|20736067|P14|NOT COMPLETED|Stage II Continuation||3
8413019|NCT00943917|20736068|P13|NOT COMPLETED|Stage II Continuation||3
8413020|NCT00943917|20736069|P12|NOT COMPLETED|Stage II Continuation||2
8413021|NCT00943917|20736070|P11|NOT COMPLETED|Stage II Continuation||0
8413022|NCT00943917|20736071|P10|NOT COMPLETED|Stage II Continuation||1
8413023|NCT00943917|20736072|P9|NOT COMPLETED|Stage II Continuation||0
8413024|NCT00943917|20736073|P8|NOT COMPLETED|Stage II Continuation||0
8413025|NCT00943917|20736074|P7|NOT COMPLETED|Stage II Continuation||0
8413026|NCT00943917|20736075|P6|NOT COMPLETED|Stage II Continuation||0
8413027|NCT00943917|20736076|P5|NOT COMPLETED|Stage II Continuation||0
8413028|NCT00943917|20736077|P4|NOT COMPLETED|Stage II Continuation||0
8413029|NCT00943917|20736078|P3|NOT COMPLETED|Stage II Continuation||0
8413030|NCT00943917|20736079|P2|NOT COMPLETED|Stage II Continuation||0
8413031|NCT00943917|20736080|P1|NOT COMPLETED|Stage II Continuation||0
8413032|NCT00943917|20736066|P15|COMPLETED|Stage II Continuation||8
8413033|NCT00943917|20736067|P14|COMPLETED|Stage II Continuation||12
8413034|NCT00943917|20736068|P13|COMPLETED|Stage II Continuation||13
8413035|NCT00943917|20736069|P12|COMPLETED|Stage II Continuation||11
8413036|NCT00943917|20736070|P11|COMPLETED|Stage II Continuation||15
8413037|NCT00943917|20736071|P10|COMPLETED|Stage II Continuation||14
8413038|NCT00943917|20736072|P9|COMPLETED|Stage II Continuation||0
8413039|NCT00943917|20736073|P8|COMPLETED|Stage II Continuation||0
8413040|NCT00943917|20736074|P7|COMPLETED|Stage II Continuation||0
8413041|NCT00943917|20736075|P6|COMPLETED|Stage II Continuation||0
8413042|NCT00943917|20736076|P5|COMPLETED|Stage II Continuation||0
8413043|NCT00943917|20736077|P4|COMPLETED|Stage II Continuation||0
8413044|NCT00943917|20736078|P3|COMPLETED|Stage II Continuation||0
8413045|NCT00943917|20736079|P2|COMPLETED|Stage II Continuation||0
8413046|NCT00943917|20736080|P1|COMPLETED|Stage II Continuation||0
8413047|NCT00943917|20736066|P15|STARTED|Stage II Continuation||12
8413048|NCT00943917|20736067|P14|STARTED|Stage II Continuation||15
8413049|NCT00943917|20736068|P13|STARTED|Stage II Continuation||16
8413050|NCT00943917|20736069|P12|STARTED|Stage II Continuation||13
8413051|NCT00943917|20736070|P11|STARTED|Stage II Continuation||15
8413052|NCT00943917|20736071|P10|STARTED|Stage II Continuation||15
8413053|NCT00943917|20736072|P9|STARTED|Stage II Continuation||0
8413054|NCT00943917|20736073|P8|STARTED|Stage II Continuation||0
8413055|NCT00943917|20736074|P7|STARTED|Stage II Continuation||0
8413056|NCT00943917|20736075|P6|STARTED|Stage II Continuation||0
8413057|NCT00943917|20736076|P5|STARTED|Stage II Continuation||0
8413058|NCT00943917|20736077|P4|STARTED|Stage II Continuation||0
8413059|NCT00943917|20736078|P3|STARTED|Stage II Continuation||0
8413060|NCT00943917|20736079|P2|STARTED|Stage II Continuation||0
8413061|NCT00943917|20736080|P1|STARTED|Stage II Continuation||0
8413062|NCT00943917|20736066|P15|NOT COMPLETED|Stage II||0
8413063|NCT00943917|20736067|P14|NOT COMPLETED|Stage II||0
8413064|NCT00943917|20736068|P13|NOT COMPLETED|Stage II||0
8413065|NCT00943917|20736069|P12|NOT COMPLETED|Stage II||0
8413066|NCT00943917|20736070|P11|NOT COMPLETED|Stage II||0
8413067|NCT00943917|20736071|P10|NOT COMPLETED|Stage II||0
8413068|NCT00943917|20736072|P9|NOT COMPLETED|Stage II||1
8413069|NCT00943917|20736073|P8|NOT COMPLETED|Stage II||0
8413070|NCT00943917|20736074|P7|NOT COMPLETED|Stage II||3
8413071|NCT00943917|20736075|P6|NOT COMPLETED|Stage II||3
8413072|NCT00943917|20736076|P5|NOT COMPLETED|Stage II||0
8413073|NCT00943917|20736077|P4|NOT COMPLETED|Stage II||0
8413074|NCT00943917|20736078|P3|NOT COMPLETED|Stage II||0
8413075|NCT00943917|20736079|P2|NOT COMPLETED|Stage II||0
8413076|NCT00943917|20736080|P1|NOT COMPLETED|Stage II||0
8413077|NCT00943917|20736066|P15|COMPLETED|Stage II||0
8413078|NCT00943917|20736067|P14|COMPLETED|Stage II||0
8413079|NCT00943917|20736068|P13|COMPLETED|Stage II||0
8413080|NCT00943917|20736069|P12|COMPLETED|Stage II||0
8413081|NCT00943917|20736070|P11|COMPLETED|Stage II||0
8413082|NCT00943917|20736071|P10|COMPLETED|Stage II||0
8413083|NCT00943917|20736072|P9|COMPLETED|Stage II||20
8413084|NCT00943917|20736073|P8|COMPLETED|Stage II||23
8413085|NCT00943917|20736074|P7|COMPLETED|Stage II||20
8413086|NCT00943917|20736075|P6|COMPLETED|Stage II||20
8413087|NCT00943917|20736076|P5|COMPLETED|Stage II||21
8413088|NCT00943917|20736077|P4|COMPLETED|Stage II||20
8413089|NCT00943917|20736078|P3|COMPLETED|Stage II||0
8413090|NCT00943917|20736079|P2|COMPLETED|Stage II||0
8413091|NCT00943917|20736080|P1|COMPLETED|Stage II||0
8413092|NCT00943917|20736066|P15|STARTED|Stage II||0
8413093|NCT00943917|20736067|P14|STARTED|Stage II||0
8413094|NCT00943917|20736068|P13|STARTED|Stage II||0
8413095|NCT00943917|20736069|P12|STARTED|Stage II||0
8413096|NCT00943917|20736070|P11|STARTED|Stage II||0
8413097|NCT00943917|20736071|P10|STARTED|Stage II||0
8413098|NCT00943917|20736072|P9|STARTED|Stage II||21
8413099|NCT00943917|20736073|P8|STARTED|Stage II||23
8413100|NCT00943917|20736074|P7|STARTED|Stage II||23
8413101|NCT00943917|20736075|P6|STARTED|Stage II||23
8413102|NCT00943917|20736076|P5|STARTED|Stage II||21
8413103|NCT00943917|20736077|P4|STARTED|Stage II||20
8413104|NCT00943917|20736078|P3|STARTED|Stage II||0
8413105|NCT00943917|20736079|P2|STARTED|Stage II||0
8413106|NCT00943917|20736080|P1|STARTED|Stage II||0
8413107|NCT00943917|20736066|P15|NOT COMPLETED|Stage I||0
8413108|NCT00943917|20736067|P14|NOT COMPLETED|Stage I||0
8413109|NCT00943917|20736068|P13|NOT COMPLETED|Stage I||0
8413110|NCT00943917|20736069|P12|NOT COMPLETED|Stage I||0
8413111|NCT00943917|20736070|P11|NOT COMPLETED|Stage I||0
8413112|NCT00943917|20736071|P10|NOT COMPLETED|Stage I||0
8413113|NCT00943917|20736072|P9|NOT COMPLETED|Stage I||0
8413114|NCT00943917|20736073|P8|NOT COMPLETED|Stage I||0
8413115|NCT00943917|20736074|P7|NOT COMPLETED|Stage I||0
8413116|NCT00943917|20736075|P6|NOT COMPLETED|Stage I||0
8413117|NCT00943917|20736076|P5|NOT COMPLETED|Stage I||0
8413118|NCT00943917|20736077|P4|NOT COMPLETED|Stage I||0
8413119|NCT00943917|20736078|P3|NOT COMPLETED|Stage I||6
8413120|NCT00943917|20736079|P2|NOT COMPLETED|Stage I||3
8413121|NCT00943917|20736080|P1|NOT COMPLETED|Stage I||4
8413122|NCT00943917|20736066|P15|COMPLETED|Stage I||0
8413123|NCT00943917|20736067|P14|COMPLETED|Stage I||0
8413124|NCT00943917|20736068|P13|COMPLETED|Stage I||0
8413125|NCT00943917|20736069|P12|COMPLETED|Stage I||0
8413126|NCT00943917|20736070|P11|COMPLETED|Stage I||0
8413127|NCT00943917|20736071|P10|COMPLETED|Stage I||0
8413128|NCT00943917|20736072|P9|COMPLETED|Stage I||0
8413129|NCT00943917|20736073|P8|COMPLETED|Stage I||0
8413130|NCT00943917|20736074|P7|COMPLETED|Stage I||0
8413131|NCT00943917|20736075|P6|COMPLETED|Stage I||0
8413132|NCT00943917|20736076|P5|COMPLETED|Stage I||0
8413133|NCT00943917|20736077|P4|COMPLETED|Stage I||0
8413134|NCT00943917|20736078|P3|COMPLETED|Stage I||47
8413135|NCT00943917|20736079|P2|COMPLETED|Stage I||48
8413136|NCT00943917|20736080|P1|COMPLETED|Stage I||47
8413137|NCT00943917|20736066|P15|STARTED|Stage I||0
8413138|NCT00943917|20736067|P14|STARTED|Stage I||0
8413139|NCT00943917|20736068|P13|STARTED|Stage I||0
8413140|NCT00943917|20736069|P12|STARTED|Stage I||0
8413141|NCT00943917|20736070|P11|STARTED|Stage I||0
8413142|NCT00943917|20736071|P10|STARTED|Stage I||0
8413143|NCT00943917|20736072|P9|STARTED|Stage I||0
8413144|NCT00943917|20736073|P8|STARTED|Stage I||0
8413145|NCT00943917|20736074|P7|STARTED|Stage I||0
8413146|NCT00943917|20736075|P6|STARTED|Stage I||0
8413147|NCT00943917|20736076|P5|STARTED|Stage I||0
8413148|NCT00943917|20736077|P4|STARTED|Stage I||0
8413149|NCT00943917|20736078|P3|STARTED|Stage I||53
8413150|NCT00943917|20736079|P2|STARTED|Stage I||51
8413151|NCT00943917|20736080|P1|STARTED|Stage I||51
8413152|NCT00943878|20736131|P4|NOT COMPLETED|Overall Study||2
8413153|NCT00943878|20736132|P3|NOT COMPLETED|Overall Study||6
8413154|NCT00943878|20736133|P2|NOT COMPLETED|Overall Study||2
8413155|NCT00943878|20736134|P1|NOT COMPLETED|Overall Study||2
8413156|NCT00943878|20736131|P4|COMPLETED|Overall Study||198
8413157|NCT00943878|20736132|P3|COMPLETED|Overall Study||197
8413158|NCT00943878|20736133|P2|COMPLETED|Overall Study||198
8413159|NCT00943878|20736134|P1|COMPLETED|Overall Study||200
8413160|NCT00943878|20736131|P4|STARTED|Overall Study||200
8413161|NCT00943878|20736132|P3|STARTED|Overall Study||203
8413162|NCT00943878|20736133|P2|STARTED|Overall Study||200
8413163|NCT00943878|20736134|P1|STARTED|Overall Study||202
8413164|NCT00943852|20736256|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413165|NCT00943852|20736257|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413166|NCT00943852|20736258|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413167|NCT00943852|20736259|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413168|NCT00943852|20736260|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413169|NCT00943852|20736261|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413170|NCT00943852|20736262|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413171|NCT00943852|20736263|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413172|NCT00943852|20736264|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413173|NCT00943852|20736265|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413174|NCT00943852|20736256|P10|COMPLETED|Fifth Period of Treatment Intervention||1
8413175|NCT00943852|20736257|P9|COMPLETED|Fifth Period of Treatment Intervention||1
8413176|NCT00943852|20736258|P8|COMPLETED|Fifth Period of Treatment Intervention||0
8413177|NCT00943852|20736259|P7|COMPLETED|Fifth Period of Treatment Intervention||0
8413178|NCT00943852|20736260|P6|COMPLETED|Fifth Period of Treatment Intervention||0
8413179|NCT00943852|20736261|P5|COMPLETED|Fifth Period of Treatment Intervention||1
8413180|NCT00943852|20736262|P4|COMPLETED|Fifth Period of Treatment Intervention||0
8413181|NCT00943852|20736263|P3|COMPLETED|Fifth Period of Treatment Intervention||0
8413182|NCT00943852|20736264|P2|COMPLETED|Fifth Period of Treatment Intervention||1
8413183|NCT00943852|20736265|P1|COMPLETED|Fifth Period of Treatment Intervention||1
8413184|NCT00943852|20736256|P10|STARTED|Fifth Period of Treatment Intervention||1
8413185|NCT00943852|20736257|P9|STARTED|Fifth Period of Treatment Intervention||1
8413186|NCT00943852|20736258|P8|STARTED|Fifth Period of Treatment Intervention||0
8413187|NCT00943852|20736259|P7|STARTED|Fifth Period of Treatment Intervention||0
8413188|NCT00943852|20736260|P6|STARTED|Fifth Period of Treatment Intervention||0
8413189|NCT00943852|20736261|P5|STARTED|Fifth Period of Treatment Intervention||1
8413190|NCT00943852|20736262|P4|STARTED|Fifth Period of Treatment Intervention||0
8413191|NCT00943852|20736263|P3|STARTED|Fifth Period of Treatment Intervention||0
8413192|NCT00943852|20736264|P2|STARTED|Fifth Period of Treatment Intervention||1
8413193|NCT00943852|20736265|P1|STARTED|Fifth Period of Treatment Intervention||1
8413194|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413195|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413196|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413197|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413198|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413199|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413200|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413201|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413202|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413203|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413204|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 4 Treatment||1
8413205|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 4 Treatment||1
8413206|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 4 Treatment||0
8413207|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 4 Treatment||0
8413208|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 4 Treatment||0
8413209|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 4 Treatment||1
8413210|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 4 Treatment||0
8413211|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 4 Treatment||0
8413212|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 4 Treatment||1
8413213|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 4 Treatment||1
8413214|NCT00943852|20736256|P10|STARTED|Washout Period After Period 4 Treatment||1
8413215|NCT00943852|20736257|P9|STARTED|Washout Period After Period 4 Treatment||1
8413216|NCT00943852|20736258|P8|STARTED|Washout Period After Period 4 Treatment||1
8413217|NCT00943852|20736259|P7|STARTED|Washout Period After Period 4 Treatment||1
8413218|NCT00943852|20736260|P6|STARTED|Washout Period After Period 4 Treatment||0
8413219|NCT00943852|20736261|P5|STARTED|Washout Period After Period 4 Treatment||1
8413220|NCT00943852|20736262|P4|STARTED|Washout Period After Period 4 Treatment||1
8413221|NCT00943852|20736263|P3|STARTED|Washout Period After Period 4 Treatment||1
8413222|NCT00943852|20736264|P2|STARTED|Washout Period After Period 4 Treatment||1
8413223|NCT00943852|20736265|P1|STARTED|Washout Period After Period 4 Treatment||2
8413224|NCT00943852|20736256|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413225|NCT00943852|20736257|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413226|NCT00943852|20736258|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413227|NCT00943852|20736259|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413228|NCT00943852|20736260|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413229|NCT00943852|20736261|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413230|NCT00943852|20736262|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413231|NCT00943852|20736263|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413232|NCT00943852|20736264|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413233|NCT00943852|20736265|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413234|NCT00943852|20736256|P10|COMPLETED|Fourth Period of Treatment Intervention||1
8413235|NCT00943852|20736257|P9|COMPLETED|Fourth Period of Treatment Intervention||1
8413236|NCT00943852|20736258|P8|COMPLETED|Fourth Period of Treatment Intervention||1
8413237|NCT00943852|20736259|P7|COMPLETED|Fourth Period of Treatment Intervention||1
8413238|NCT00943852|20736260|P6|COMPLETED|Fourth Period of Treatment Intervention||0
8413239|NCT00943852|20736261|P5|COMPLETED|Fourth Period of Treatment Intervention||1
8413240|NCT00943852|20736262|P4|COMPLETED|Fourth Period of Treatment Intervention||1
8413241|NCT00943852|20736263|P3|COMPLETED|Fourth Period of Treatment Intervention||1
8413242|NCT00943852|20736264|P2|COMPLETED|Fourth Period of Treatment Intervention||1
8413243|NCT00943852|20736265|P1|COMPLETED|Fourth Period of Treatment Intervention||2
8413244|NCT00943852|20736256|P10|STARTED|Fourth Period of Treatment Intervention||1
8413245|NCT00943852|20736257|P9|STARTED|Fourth Period of Treatment Intervention||1
8413246|NCT00943852|20736258|P8|STARTED|Fourth Period of Treatment Intervention||1
8413247|NCT00943852|20736259|P7|STARTED|Fourth Period of Treatment Intervention||1
8413248|NCT00943852|20736260|P6|STARTED|Fourth Period of Treatment Intervention||0
8413249|NCT00943852|20736261|P5|STARTED|Fourth Period of Treatment Intervention||1
8413250|NCT00943852|20736262|P4|STARTED|Fourth Period of Treatment Intervention||1
8413251|NCT00943852|20736263|P3|STARTED|Fourth Period of Treatment Intervention||1
8413252|NCT00943852|20736264|P2|STARTED|Fourth Period of Treatment Intervention||1
8413253|NCT00943852|20736265|P1|STARTED|Fourth Period of Treatment Intervention||2
8413254|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413255|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413256|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413257|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
8413258|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413259|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413260|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413261|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413262|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413263|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413264|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 3 Treatment||1
8413265|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 3 Treatment||1
8413266|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 3 Treatment||1
8413267|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 3 Treatment||1
8413268|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 3 Treatment||0
8413269|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 3 Treatment||1
8413270|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 3 Treatment||1
8413271|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 3 Treatment||1
8413272|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 3 Treatment||1
8413273|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 3 Treatment||2
8413274|NCT00943852|20736256|P10|STARTED|Washout Period After Period 3 Treatment||1
8413275|NCT00943852|20736257|P9|STARTED|Washout Period After Period 3 Treatment||1
8413276|NCT00943852|20736258|P8|STARTED|Washout Period After Period 3 Treatment||1
8413277|NCT00943852|20736259|P7|STARTED|Washout Period After Period 3 Treatment||2
8413278|NCT00943852|20736260|P6|STARTED|Washout Period After Period 3 Treatment||0
8413279|NCT00943852|20736261|P5|STARTED|Washout Period After Period 3 Treatment||1
8413280|NCT00943852|20736262|P4|STARTED|Washout Period After Period 3 Treatment||1
8413281|NCT00943852|20736263|P3|STARTED|Washout Period After Period 3 Treatment||1
8413282|NCT00943852|20736264|P2|STARTED|Washout Period After Period 3 Treatment||1
8413283|NCT00943852|20736265|P1|STARTED|Washout Period After Period 3 Treatment||2
8413284|NCT00943852|20736256|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
8413285|NCT00943852|20736257|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
8413286|NCT00943852|20736258|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
8413287|NCT00943852|20736259|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
8413288|NCT00943852|20736260|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
8413289|NCT00943852|20736261|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
8413290|NCT00943852|20736262|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
8413291|NCT00943852|20736263|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
8413292|NCT00943852|20736264|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
8413293|NCT00943852|20736265|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
8413294|NCT00943852|20736256|P10|COMPLETED|Third Period of Treatment Intervention||1
8413295|NCT00943852|20736257|P9|COMPLETED|Third Period of Treatment Intervention||1
8413296|NCT00943852|20736258|P8|COMPLETED|Third Period of Treatment Intervention||1
8413297|NCT00943852|20736259|P7|COMPLETED|Third Period of Treatment Intervention||2
8413298|NCT00943852|20736260|P6|COMPLETED|Third Period of Treatment Intervention||0
8413299|NCT00943852|20736261|P5|COMPLETED|Third Period of Treatment Intervention||1
8413300|NCT00943852|20736262|P4|COMPLETED|Third Period of Treatment Intervention||1
8413301|NCT00943852|20736263|P3|COMPLETED|Third Period of Treatment Intervention||1
8413302|NCT00943852|20736264|P2|COMPLETED|Third Period of Treatment Intervention||1
8413303|NCT00943852|20736265|P1|COMPLETED|Third Period of Treatment Intervention||2
8413304|NCT00943852|20736256|P10|STARTED|Third Period of Treatment Intervention||1
8413305|NCT00943852|20736257|P9|STARTED|Third Period of Treatment Intervention||1
8413306|NCT00943852|20736258|P8|STARTED|Third Period of Treatment Intervention||1
8413307|NCT00943852|20736259|P7|STARTED|Third Period of Treatment Intervention||2
8413308|NCT00943852|20736260|P6|STARTED|Third Period of Treatment Intervention||0
8413309|NCT00943852|20736261|P5|STARTED|Third Period of Treatment Intervention||1
8413310|NCT00943852|20736262|P4|STARTED|Third Period of Treatment Intervention||1
8413311|NCT00943852|20736263|P3|STARTED|Third Period of Treatment Intervention||1
8413312|NCT00943852|20736264|P2|STARTED|Third Period of Treatment Intervention||1
8413313|NCT00943852|20736265|P1|STARTED|Third Period of Treatment Intervention||2
8413314|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413315|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413316|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413317|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413318|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
8413319|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413320|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413321|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413322|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413323|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413324|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 2 Treatment||1
8413325|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 2 Treatment||1
8413326|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 2 Treatment||1
8413327|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 2 Treatment||2
8413328|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 2 Treatment||0
8413329|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 2 Treatment||1
8413330|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 2 Treatment||1
8413331|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 2 Treatment||1
8413332|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 2 Treatment||1
8413333|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 2 Treatment||2
8413334|NCT00943852|20736256|P10|STARTED|Washout Period After Period 2 Treatment||1
8413335|NCT00943852|20736257|P9|STARTED|Washout Period After Period 2 Treatment||1
8413336|NCT00943852|20736258|P8|STARTED|Washout Period After Period 2 Treatment||1
8413337|NCT00943852|20736259|P7|STARTED|Washout Period After Period 2 Treatment||2
8413338|NCT00943852|20736260|P6|STARTED|Washout Period After Period 2 Treatment||1
8413339|NCT00943852|20736261|P5|STARTED|Washout Period After Period 2 Treatment||1
8413340|NCT00943852|20736262|P4|STARTED|Washout Period After Period 2 Treatment||1
8413341|NCT00943852|20736263|P3|STARTED|Washout Period After Period 2 Treatment||1
8413342|NCT00943852|20736264|P2|STARTED|Washout Period After Period 2 Treatment||1
8413343|NCT00943852|20736265|P1|STARTED|Washout Period After Period 2 Treatment||2
8413344|NCT00943852|20736256|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
8413345|NCT00943852|20736257|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
8413346|NCT00943852|20736258|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
8413347|NCT00943852|20736259|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
8413348|NCT00943852|20736260|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
8413349|NCT00943852|20736261|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
8413350|NCT00943852|20736262|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
8413351|NCT00943852|20736263|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
8413352|NCT00943852|20736264|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
8413353|NCT00943852|20736265|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
8413354|NCT00943852|20736256|P10|COMPLETED|Second Period of Treatment Intervention||1
8413355|NCT00943852|20736257|P9|COMPLETED|Second Period of Treatment Intervention||1
8413356|NCT00943852|20736258|P8|COMPLETED|Second Period of Treatment Intervention||1
8413357|NCT00943852|20736259|P7|COMPLETED|Second Period of Treatment Intervention||2
8413358|NCT00943852|20736260|P6|COMPLETED|Second Period of Treatment Intervention||1
8413359|NCT00943852|20736261|P5|COMPLETED|Second Period of Treatment Intervention||1
8413360|NCT00943852|20736262|P4|COMPLETED|Second Period of Treatment Intervention||1
8413361|NCT00943852|20736263|P3|COMPLETED|Second Period of Treatment Intervention||1
8413362|NCT00943852|20736264|P2|COMPLETED|Second Period of Treatment Intervention||1
8413363|NCT00943852|20736265|P1|COMPLETED|Second Period of Treatment Intervention||2
8413364|NCT00943852|20736256|P10|STARTED|Second Period of Treatment Intervention||1
8413365|NCT00943852|20736257|P9|STARTED|Second Period of Treatment Intervention||1
8413366|NCT00943852|20736258|P8|STARTED|Second Period of Treatment Intervention||1
8413367|NCT00943852|20736259|P7|STARTED|Second Period of Treatment Intervention||2
8413368|NCT00943852|20736260|P6|STARTED|Second Period of Treatment Intervention||1
8413369|NCT00943852|20736261|P5|STARTED|Second Period of Treatment Intervention||1
8413370|NCT00943852|20736262|P4|STARTED|Second Period of Treatment Intervention||1
8413371|NCT00943852|20736263|P3|STARTED|Second Period of Treatment Intervention||1
8413372|NCT00943852|20736264|P2|STARTED|Second Period of Treatment Intervention||1
8413373|NCT00943852|20736265|P1|STARTED|Second Period of Treatment Intervention||2
8413374|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413375|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413376|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413377|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413378|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413379|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413380|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
8413381|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413382|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413383|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413384|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 1 Treatment||1
8413385|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 1 Treatment||1
8413386|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 1 Treatment||1
8413387|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 1 Treatment||2
8413388|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 1 Treatment||1
8413389|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 1 Treatment||1
8413390|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 1 Treatment||1
8413391|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 1 Treatment||1
8413392|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 1 Treatment||1
8413393|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 1 Treatment||2
8413394|NCT00943852|20736256|P10|STARTED|Washout Period After Period 1 Treatment||1
8413395|NCT00943852|20736257|P9|STARTED|Washout Period After Period 1 Treatment||1
8413396|NCT00943852|20736258|P8|STARTED|Washout Period After Period 1 Treatment||1
8413397|NCT00943852|20736259|P7|STARTED|Washout Period After Period 1 Treatment||2
8413398|NCT00943852|20736260|P6|STARTED|Washout Period After Period 1 Treatment||1
8413399|NCT00943852|20736261|P5|STARTED|Washout Period After Period 1 Treatment||1
8413400|NCT00943852|20736262|P4|STARTED|Washout Period After Period 1 Treatment||2
8413401|NCT00943852|20736263|P3|STARTED|Washout Period After Period 1 Treatment||1
8413402|NCT00943852|20736264|P2|STARTED|Washout Period After Period 1 Treatment||1
8413403|NCT00943852|20736265|P1|STARTED|Washout Period After Period 1 Treatment||2
8413404|NCT00943852|20736256|P10|NOT COMPLETED|First Period of Treatment Intervention||0
8413405|NCT00943852|20736257|P9|NOT COMPLETED|First Period of Treatment Intervention||0
8413406|NCT00943852|20736258|P8|NOT COMPLETED|First Period of Treatment Intervention||0
8413407|NCT00943852|20736259|P7|NOT COMPLETED|First Period of Treatment Intervention||0
8413408|NCT00943852|20736260|P6|NOT COMPLETED|First Period of Treatment Intervention||0
8413409|NCT00943852|20736261|P5|NOT COMPLETED|First Period of Treatment Intervention||0
8413410|NCT00943852|20736262|P4|NOT COMPLETED|First Period of Treatment Intervention||0
8413411|NCT00943852|20736263|P3|NOT COMPLETED|First Period of Treatment Intervention||0
8413412|NCT00943852|20736264|P2|NOT COMPLETED|First Period of Treatment Intervention||0
8413413|NCT00943852|20736265|P1|NOT COMPLETED|First Period of Treatment Intervention||0
8413414|NCT00943852|20736256|P10|COMPLETED|First Period of Treatment Intervention||1
8413415|NCT00943852|20736257|P9|COMPLETED|First Period of Treatment Intervention||1
8413416|NCT00943852|20736258|P8|COMPLETED|First Period of Treatment Intervention||1
8413417|NCT00943852|20736259|P7|COMPLETED|First Period of Treatment Intervention||2
8413418|NCT00943852|20736260|P6|COMPLETED|First Period of Treatment Intervention||1
8413419|NCT00943852|20736261|P5|COMPLETED|First Period of Treatment Intervention||1
8413420|NCT00943852|20736262|P4|COMPLETED|First Period of Treatment Intervention||2
8413421|NCT00943852|20736263|P3|COMPLETED|First Period of Treatment Intervention||1
8413422|NCT00943852|20736264|P2|COMPLETED|First Period of Treatment Intervention||1
8413423|NCT00943852|20736265|P1|COMPLETED|First Period of Treatment Intervention||2
8413424|NCT00943852|20736256|P10|STARTED|First Period of Treatment Intervention||1
8413425|NCT00943852|20736257|P9|STARTED|First Period of Treatment Intervention||1
8413426|NCT00943852|20736258|P8|STARTED|First Period of Treatment Intervention||1
8413427|NCT00943852|20736259|P7|STARTED|First Period of Treatment Intervention||2
8413428|NCT00943852|20736260|P6|STARTED|First Period of Treatment Intervention||1
8413429|NCT00943852|20736261|P5|STARTED|First Period of Treatment Intervention||1
8413430|NCT00943852|20736262|P4|STARTED|First Period of Treatment Intervention||2
8413431|NCT00943852|20736263|P3|STARTED|First Period of Treatment Intervention||1
8413432|NCT00943852|20736264|P2|STARTED|First Period of Treatment Intervention||1
8413433|NCT00943852|20736265|P1|STARTED|First Period of Treatment Intervention||2
8413434|NCT00943826|20736278|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
8413435|NCT00943826|20736279|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
8413436|NCT00943826|20736278|P2|COMPLETED|After Primary Overall Survival Analysis||0
8413437|NCT00943826|20736279|P1|COMPLETED|After Primary Overall Survival Analysis||0
8413438|NCT00943826|20736278|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
8413439|NCT00943826|20736279|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
8413440|NCT00943826|20736278|P2|NOT COMPLETED|Monotherapy Phase||16
8413441|NCT00943826|20736279|P1|NOT COMPLETED|Monotherapy Phase||65
8413442|NCT00943826|20736278|P2|COMPLETED|Monotherapy Phase||143
8413443|NCT00943826|20736279|P1|COMPLETED|Monotherapy Phase||204
8413444|NCT00943826|20736278|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
8413445|NCT00943826|20736279|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
8413446|NCT00943826|20736278|P2|NOT COMPLETED|Maintenance Phase||39
8413447|NCT00943826|20736279|P1|NOT COMPLETED|Maintenance Phase||43
8413448|NCT00943826|20736278|P2|COMPLETED|Maintenance Phase||331
8413449|NCT00943826|20736279|P1|COMPLETED|Maintenance Phase||353
8413450|NCT00943826|20736278|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
8413451|NCT00943826|20736279|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
8413452|NCT00943826|20736278|P2|NOT COMPLETED|Concurrent Phase||42
8413453|NCT00943826|20736279|P1|NOT COMPLETED|Concurrent Phase||61
8413454|NCT00943826|20736278|P2|COMPLETED|Concurrent Phase||421
8413455|NCT00943826|20736279|P1|COMPLETED|Concurrent Phase||397
8413456|NCT00943826|20736278|P2|Treated|Concurrent Phase||459
8413457|NCT00943826|20736279|P1|Treated|Concurrent Phase||452
8413458|NCT00943826|20736278|P2|STARTED|Concurrent Phase||463
8413459|NCT00943826|20736279|P1|STARTED|Concurrent Phase||458
8413460|NCT00943800|20736297|P1|NOT COMPLETED|Overall Study||0
8413461|NCT00943800|20736297|P1|COMPLETED|Overall Study||87
8413462|NCT00943800|20736297|P1|STARTED|Overall Study||87
8413463|NCT00943787|20736303|P1|NOT COMPLETED|Overall Study||7
8413464|NCT00943787|20736303|P1|COMPLETED|Overall Study||34
8413465|NCT00943787|20736303|P1|STARTED|Overall Study||41
8413472|NCT00943735|20736323|P1|NOT COMPLETED|Overall Study||32
8413473|NCT00943735|20736323|P1|COMPLETED|Overall Study||742
8413474|NCT00943735|20736323|P1|Per Protocol Population|Overall Study||500
8413475|NCT00943735|20736323|P1|STARTED|Overall Study||774
8413506|NCT00943683|20736395|P2|NOT COMPLETED|Overall Study||6
8413507|NCT00943683|20736396|P1|NOT COMPLETED|Overall Study||7
8413508|NCT00943683|20736395|P2|COMPLETED|Overall Study||169
8413509|NCT00943683|20736396|P1|COMPLETED|Overall Study||74
8413510|NCT00943683|20736395|P2|STARTED|Overall Study||175
8413511|NCT00943683|20736396|P1|STARTED|Overall Study||81
8413512|NCT00943670|20736402|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
8413513|NCT00943670|20736402|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
8413514|NCT00943670|20736402|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
8413515|NCT00943670|20736402|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
8413516|NCT00943670|20736402|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
8413517|NCT00943670|20736402|P1|Treated|Single-agent Trastuzumab Emtansine||51
8413518|NCT00943670|20736402|P1|STARTED|Single-agent Trastuzumab Emtansine||51
8413519|NCT00943631|20736438|P2|NOT COMPLETED|Overall Study||2
8413520|NCT00943631|20736439|P1|NOT COMPLETED|Overall Study||4
8413521|NCT00943631|20736438|P2|COMPLETED|Overall Study||202
8413522|NCT00943631|20736439|P1|COMPLETED|Overall Study||198
8413523|NCT00943631|20736438|P2|STARTED|Overall Study||204
8413524|NCT00943631|20736439|P1|STARTED|Overall Study||202
8413525|NCT00943605|20736491|P2|NOT COMPLETED|Overall Study||30
8413526|NCT00943605|20736492|P1|NOT COMPLETED|Overall Study||30
8413527|NCT00943605|20736491|P2|COMPLETED|Overall Study||0
8413528|NCT00943605|20736492|P1|COMPLETED|Overall Study||0
8413529|NCT00943605|20736491|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
8413530|NCT00943605|20736492|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
8413531|NCT00943592|20736502|P1|NOT COMPLETED|Overall Study||3
8413532|NCT00943592|20736502|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
8413533|NCT00943592|20736502|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
8413534|NCT00943592|20736502|P1|STARTED|Overall Study||82
8413535|NCT00943579|20736515|P2|NOT COMPLETED|Overall Study||5
8413536|NCT00943579|20736516|P1|NOT COMPLETED|Overall Study||6
8413537|NCT00943579|20736515|P2|COMPLETED|Overall Study||15
8413538|NCT00943579|20736516|P1|COMPLETED|Overall Study||15
8413539|NCT00943579|20736515|P2|STARTED|Overall Study||20
8413540|NCT00943579|20736516|P1|STARTED|Overall Study||21
8413541|NCT00943488|20736537|P2|NOT COMPLETED|Overall Study||2
8413542|NCT00943488|20736538|P1|NOT COMPLETED|Overall Study||1
8413543|NCT00943488|20736537|P2|COMPLETED|Overall Study||202
8413544|NCT00943488|20736538|P1|COMPLETED|Overall Study||203
8413545|NCT00943488|20736537|P2|STARTED|Overall Study||204
8413546|NCT00943488|20736538|P1|STARTED|Overall Study||204
8413547|NCT00943436|20736594|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
8413548|NCT00943436|20736595|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
8413549|NCT00943436|20736594|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
8413550|NCT00943436|20736595|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
8413551|NCT00943436|20736594|P2|STARTED|Rest Session: 45 Minutes of Reading||10
8413552|NCT00943436|20736595|P1|STARTED|Rest Session: 45 Minutes of Reading||10
8413553|NCT00943436|20736594|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
8413554|NCT00943436|20736595|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
8413555|NCT00943436|20736594|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
8413556|NCT00943436|20736595|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
8413557|NCT00943436|20736594|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
8413558|NCT00943436|20736595|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
8413559|NCT00943397|20736617|P2|NOT COMPLETED|Overall Study||72
8413560|NCT00943397|20736618|P1|NOT COMPLETED|Overall Study||15
8413561|NCT00943397|20736617|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
8413562|NCT00943397|20736618|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
8413563|NCT00943397|20736617|P2|STARTED|Overall Study||158
8413564|NCT00943397|20736618|P1|STARTED|Overall Study||32
8413565|NCT00943384|20736624|P1|NOT COMPLETED|Overall Study||49
8413566|NCT00943384|20736624|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
8413567|NCT00943384|20736624|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
8413568|NCT00943384|20736624|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
8413569|NCT00943384|20736624|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
8413570|NCT00943319|20736638|P1|NOT COMPLETED|Overall Study||1
8413571|NCT00943319|20736638|P1|COMPLETED|Overall Study||49
8413572|NCT00943319|20736638|P1|STARTED|Overall Study||50
8413573|NCT00943306|20736644|P1|NOT COMPLETED|Overall Study||3
8413574|NCT00943306|20736644|P1|COMPLETED|Overall Study||16
8413575|NCT00943306|20736644|P1|STARTED|Overall Study||19
8413576|NCT00943202|20736705|P4|NOT COMPLETED|Overall Study||1
8413577|NCT00943202|20736706|P3|NOT COMPLETED|Overall Study||0
8413578|NCT00943202|20736707|P2|NOT COMPLETED|Overall Study||2
8413579|NCT00943202|20736708|P1|NOT COMPLETED|Overall Study||1
8413580|NCT00943202|20736705|P4|COMPLETED|Overall Study||131
8413581|NCT00943202|20736706|P3|COMPLETED|Overall Study||133
8413582|NCT00943202|20736707|P2|COMPLETED|Overall Study||131
8413583|NCT00943202|20736708|P1|COMPLETED|Overall Study||132
8413584|NCT00943202|20736705|P4|STARTED|Overall Study||132
8413585|NCT00943202|20736706|P3|STARTED|Overall Study||133
8413586|NCT00943202|20736707|P2|STARTED|Overall Study||133
8413587|NCT00943202|20736708|P1|STARTED|Overall Study||133
8413588|NCT00943150|20736924|P2|NOT COMPLETED|Overall Study||0
8413589|NCT00943150|20736925|P1|NOT COMPLETED|Overall Study||0
8413590|NCT00943150|20736924|P2|COMPLETED|Overall Study||10
8413591|NCT00943150|20736925|P1|COMPLETED|Overall Study||10
8413592|NCT00943150|20736924|P2|STARTED|Overall Study||10
8413593|NCT00943150|20736925|P1|STARTED|Overall Study||10
8413594|NCT00943124|20736946|P2|NOT COMPLETED|Period 2||0
8413595|NCT00943124|20736947|P1|NOT COMPLETED|Period 2||0
8413596|NCT00943124|20736946|P2|COMPLETED|Period 2||108
8413597|NCT00943124|20736947|P1|COMPLETED|Period 2||108
8413598|NCT00943124|20736946|P2|STARTED|Period 2||108
8413599|NCT00943124|20736947|P1|STARTED|Period 2||108
8413600|NCT00943124|20736946|P2|NOT COMPLETED|Period 1||2
8413601|NCT00943124|20736947|P1|NOT COMPLETED|Period 1||2
8413602|NCT00943124|20736946|P2|COMPLETED|Period 1||108
8413603|NCT00943124|20736947|P1|COMPLETED|Period 1||108
8413604|NCT00943124|20736946|P2|STARTED|Period 1||110
8413605|NCT00943124|20736947|P1|STARTED|Period 1||110
8413606|NCT00943111|20736969|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
8413607|NCT00943111|20736970|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
8413608|NCT00943111|20736971|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
8413609|NCT00943111|20736969|P3|COMPLETED|5 Years Long-term Treatment Period||77
8413610|NCT00943111|20736970|P2|COMPLETED|5 Years Long-term Treatment Period||0
8413611|NCT00943111|20736971|P1|COMPLETED|5 Years Long-term Treatment Period||0
8413612|NCT00943111|20736969|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
8413613|NCT00943111|20736970|P2|STARTED|5 Years Long-term Treatment Period||0
8413614|NCT00943111|20736971|P1|STARTED|5 Years Long-term Treatment Period||0
8413615|NCT00943111|20736969|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
8413616|NCT00943111|20736970|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
8413617|NCT00943111|20736971|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
8413618|NCT00943111|20736969|P3|COMPLETED|52-Weeks Primary Analysis Period||0
8413619|NCT00943111|20736970|P2|COMPLETED|52-Weeks Primary Analysis Period||52
8413620|NCT00943111|20736971|P1|COMPLETED|52-Weeks Primary Analysis Period||104
8413621|NCT00943111|20736969|P3|Treated|52-Weeks Primary Analysis Period||0
8413622|NCT00943111|20736970|P2|Treated|52-Weeks Primary Analysis Period||53
8413623|NCT00943111|20736971|P1|Treated|52-Weeks Primary Analysis Period||106
8413624|NCT00943111|20736969|P3|STARTED|52-Weeks Primary Analysis Period||0
8413625|NCT00943111|20736970|P2|STARTED|52-Weeks Primary Analysis Period||54
8413626|NCT00943111|20736971|P1|STARTED|52-Weeks Primary Analysis Period||106
8413627|NCT00943098|20737004|P2|NOT COMPLETED|Overall Study||0
8413628|NCT00943098|20737005|P1|NOT COMPLETED|Overall Study||0
8413629|NCT00943098|20737004|P2|COMPLETED|Overall Study||72
8413630|NCT00943098|20737005|P1|COMPLETED|Overall Study||70
8413631|NCT00943098|20737004|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
8413632|NCT00943098|20737005|P1|STARTED|Overall Study||70
8413633|NCT00943072|20737039|P2|NOT COMPLETED|Overall Study||14
8413634|NCT00943072|20737040|P1|NOT COMPLETED|Overall Study||5
8413635|NCT00943072|20737039|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
8413636|NCT00943072|20737040|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
8413637|NCT00943072|20737039|P2|Full Analysis Set (FAS) Population|Overall Study||73
8413638|NCT00943072|20737040|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
8413639|NCT00943072|20737039|P2|Participants Received Treatment|Overall Study||74
8413640|NCT00943072|20737040|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
8413641|NCT00943072|20737039|P2|STARTED|Overall Study||74
8413642|NCT00943072|20737040|P1|STARTED|Overall Study||115
8413643|NCT00942994|20737058|P2|NOT COMPLETED|Overall Study||19
8413644|NCT00942994|20737059|P1|NOT COMPLETED|Overall Study||16
8413645|NCT00942994|20737058|P2|COMPLETED|Overall Study||190
8413646|NCT00942994|20737059|P1|COMPLETED|Overall Study||187
8413647|NCT00942994|20737058|P2|STARTED|Overall Study||209
8413648|NCT00942994|20737059|P1|STARTED|Overall Study||203
8413649|NCT00942968|20737075|P1|NOT COMPLETED|Overall Study||229
8413650|NCT00942968|20737075|P1|COMPLETED|Overall Study||109
8413651|NCT00942968|20737075|P1|Treated|Overall Study||334
8413652|NCT00942968|20737075|P1|STARTED|Overall Study||338
8413653|NCT00942903|20737096|P1|NOT COMPLETED|Overall Study||0
8413654|NCT00942903|20737096|P1|COMPLETED|Overall Study||20
8413655|NCT00942903|20737096|P1|STARTED|Overall Study||20
8413656|NCT00942890|20737103|P2|NOT COMPLETED|Overall Study||0
8413657|NCT00942890|20737104|P1|NOT COMPLETED|Overall Study||0
8413658|NCT00942890|20737103|P2|COMPLETED|Overall Study||23
8413659|NCT00942890|20737104|P1|COMPLETED|Overall Study||21
8413660|NCT00942890|20737103|P2|STARTED|Overall Study||23
8413661|NCT00942890|20737104|P1|STARTED|Overall Study||21
8413662|NCT00942851|20737126|P2|NOT COMPLETED|Overall Study||1
8413663|NCT00942851|20737127|P1|NOT COMPLETED|Overall Study||0
8413664|NCT00942851|20737126|P2|COMPLETED|Overall Study||11
8413665|NCT00942851|20737127|P1|COMPLETED|Overall Study||12
8413666|NCT00942851|20737126|P2|STARTED|Overall Study||12
8413667|NCT00942851|20737127|P1|STARTED|Overall Study||12
8413668|NCT00942825|20737139|P2|NOT COMPLETED|Overall Study||0
8413669|NCT00942825|20737140|P1|NOT COMPLETED|Overall Study||0
8413670|NCT00942825|20737139|P2|COMPLETED|Overall Study||98
8413671|NCT00942825|20737140|P1|COMPLETED|Overall Study||97
8413672|NCT00942825|20737139|P2|STARTED|Overall Study||98
8413673|NCT00942825|20737140|P1|STARTED|Overall Study||97
8413674|NCT00942786|20737146|P1|NOT COMPLETED|Overall Study||0
8413675|NCT00942786|20737146|P1|COMPLETED|Overall Study|date of last follow-up|297
8413676|NCT00942786|20737146|P1|STARTED|Overall Study||297
8413677|NCT00942734|20737153|P1|NOT COMPLETED|Overall Study||8
8413678|NCT00942734|20737153|P1|COMPLETED|Overall Study||35
8413679|NCT00942734|20737153|P1|STARTED|Overall Study||43
8413680|NCT00942708|20737157|P1|NOT COMPLETED|Overall Study||1
8413681|NCT00942708|20737157|P1|COMPLETED|Overall Study||5
8413682|NCT00942708|20737157|P1|STARTED|Overall Study||6
8413683|NCT00942604|20737165|P2|NOT COMPLETED|Overall Study||4
8413684|NCT00942604|20737166|P1|NOT COMPLETED|Overall Study||2
8413685|NCT00942604|20737165|P2|COMPLETED|Overall Study||99
8413686|NCT00942604|20737166|P1|COMPLETED|Overall Study||98
8413687|NCT00942604|20737165|P2|STARTED|Overall Study||103
8413688|NCT00942604|20737166|P1|STARTED|Overall Study||100
8413689|NCT00942578|20737177|P3|NOT COMPLETED|Expansion Phase||0
8413690|NCT00942578|20737178|P2|NOT COMPLETED|Expansion Phase||0
8413691|NCT00942578|20737179|P1|NOT COMPLETED|Expansion Phase||0
8413692|NCT00942578|20737177|P3|COMPLETED|Expansion Phase||43
8413693|NCT00942578|20737178|P2|COMPLETED|Expansion Phase||0
8413694|NCT00942578|20737179|P1|COMPLETED|Expansion Phase||11
8413695|NCT00942578|20737177|P3|STARTED|Expansion Phase||43
8413696|NCT00942578|20737178|P2|STARTED|Expansion Phase||0
8413697|NCT00942578|20737179|P1|STARTED|Expansion Phase||11
8413698|NCT00942578|20737177|P3|NOT COMPLETED|Dose Escalation Phase||0
8413699|NCT00942578|20737178|P2|NOT COMPLETED|Dose Escalation Phase||0
8413700|NCT00942578|20737179|P1|NOT COMPLETED|Dose Escalation Phase||0
8413701|NCT00942578|20737177|P3|COMPLETED|Dose Escalation Phase||3
8413702|NCT00942578|20737178|P2|COMPLETED|Dose Escalation Phase||3
8413703|NCT00942578|20737179|P1|COMPLETED|Dose Escalation Phase||3
8413704|NCT00942578|20737177|P3|STARTED|Dose Escalation Phase||3
8413705|NCT00942578|20737178|P2|STARTED|Dose Escalation Phase||3
8413706|NCT00942578|20737179|P1|STARTED|Dose Escalation Phase||3
8413707|NCT00942448|20737209|P4|NOT COMPLETED|Overall Study||0
8413708|NCT00942448|20737210|P3|NOT COMPLETED|Overall Study||0
8413709|NCT00942448|20737211|P2|NOT COMPLETED|Overall Study||0
8413710|NCT00942448|20737212|P1|NOT COMPLETED|Overall Study||0
8413711|NCT00942448|20737209|P4|COMPLETED|Overall Study||75
8413712|NCT00942448|20737210|P3|COMPLETED|Overall Study||78
8413713|NCT00942448|20737211|P2|COMPLETED|Overall Study||76
8413714|NCT00942448|20737212|P1|COMPLETED|Overall Study||77
8413715|NCT00942448|20737209|P4|STARTED|Overall Study||75
8413716|NCT00942448|20737210|P3|STARTED|Overall Study||78
8413717|NCT00942448|20737211|P2|STARTED|Overall Study||76
8413718|NCT00942448|20737212|P1|STARTED|Overall Study||77
8413719|NCT00942422|20737274|P1|NOT COMPLETED|Overall Study||3
8413720|NCT00942422|20737274|P1|COMPLETED|Overall Study||5
8413721|NCT00942422|20737274|P1|STARTED|Overall Study||8
8413722|NCT00942409|20737278|P1|NOT COMPLETED|Overall Study||3
8413723|NCT00942409|20737278|P1|COMPLETED|Overall Study||2
8413724|NCT00942409|20737278|P1|STARTED|Overall Study||5
8413725|NCT00942357|20737284|P2|NOT COMPLETED|Overall Study||40
8413726|NCT00942357|20737285|P1|NOT COMPLETED|Overall Study||37
8413727|NCT00942357|20737284|P2|COMPLETED|Overall Study||366
8413728|NCT00942357|20737285|P1|COMPLETED|Overall Study||370
8413729|NCT00942357|20737284|P2|STARTED|Overall Study||406
8413730|NCT00942357|20737285|P1|STARTED|Overall Study||407
8413737|NCT00942266|20737314|P2|NOT COMPLETED|Overall Study||15
8413738|NCT00942266|20737315|P1|NOT COMPLETED|Overall Study||43
8413739|NCT00942266|20737314|P2|COMPLETED|Overall Study||0
8413740|NCT00942266|20737315|P1|COMPLETED|Overall Study||0
8413741|NCT00942266|20737314|P2|STARTED|Overall Study||15
8413742|NCT00942266|20737315|P1|STARTED|Overall Study||43
8413743|NCT00942188|20737337|P4|NOT COMPLETED|Overall Study||4
8413744|NCT00942188|20737338|P3|NOT COMPLETED|Overall Study||9
8413745|NCT00942188|20737339|P2|NOT COMPLETED|Overall Study||10
8413746|NCT00942188|20737340|P1|NOT COMPLETED|Overall Study||4
8413747|NCT00942188|20737337|P4|COMPLETED|Overall Study||23
8413748|NCT00942188|20737338|P3|COMPLETED|Overall Study||18
8413749|NCT00942188|20737339|P2|COMPLETED|Overall Study||16
8413750|NCT00942188|20737340|P1|COMPLETED|Overall Study||22
8413751|NCT00942188|20737337|P4|STARTED|Overall Study||27
8413752|NCT00942188|20737338|P3|STARTED|Overall Study||27
8413753|NCT00942188|20737339|P2|STARTED|Overall Study||26
8413754|NCT00942188|20737340|P1|STARTED|Overall Study||26
8413755|NCT00942175|20737379|P4|NOT COMPLETED|Overall Study||2
8413756|NCT00942175|20737380|P3|NOT COMPLETED|Overall Study||2
8413757|NCT00942175|20737381|P2|NOT COMPLETED|Overall Study||4
8413758|NCT00942175|20737382|P1|NOT COMPLETED|Overall Study||2
8413759|NCT00942175|20737379|P4|COMPLETED|Overall Study||38
8413760|NCT00942175|20737380|P3|COMPLETED|Overall Study||38
8413761|NCT00942175|20737381|P2|COMPLETED|Overall Study||36
8413762|NCT00942175|20737382|P1|COMPLETED|Overall Study||38
8413763|NCT00942175|20737379|P4|STARTED|Overall Study||40
8413764|NCT00942175|20737380|P3|STARTED|Overall Study||40
8413765|NCT00942175|20737381|P2|STARTED|Overall Study||40
8413766|NCT00942175|20737382|P1|STARTED|Overall Study||40
8413767|NCT00942162|20737435|P3|NOT COMPLETED|Overall Study||2
8413768|NCT00942162|20737436|P2|NOT COMPLETED|Overall Study||50
8413769|NCT00942162|20737437|P1|NOT COMPLETED|Overall Study||70
8413770|NCT00942162|20737435|P3|COMPLETED|Overall Study||0
8413771|NCT00942162|20737436|P2|COMPLETED|Overall Study||0
8413772|NCT00942162|20737437|P1|COMPLETED|Overall Study||1
8413773|NCT00942162|20737435|P3|STARTED|Overall Study||2
8413774|NCT00942162|20737436|P2|STARTED|Overall Study||50
8413775|NCT00942162|20737437|P1|STARTED|Overall Study||71
8413776|NCT00942149|20737504|P1|NOT COMPLETED|Overall Study||0
8413777|NCT00942149|20737504|P1|COMPLETED|Overall Study||20
8413778|NCT00942149|20737504|P1|STARTED|Overall Study||20
8413779|NCT00942084|20737508|P1|NOT COMPLETED|Overall Study||2
8413780|NCT00942084|20737508|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
8413781|NCT00942084|20737508|P1|STARTED|Overall Study||32
8413782|NCT00941993|20737517|P1|NOT COMPLETED|Overall Study||0
8413783|NCT00941993|20737517|P1|COMPLETED|Overall Study||109
8413784|NCT00941993|20737517|P1|STARTED|Overall Study||109
8413785|NCT00941928|20737525|P1|NOT COMPLETED|Overall Study||2
8413786|NCT00941928|20737525|P1|COMPLETED|Overall Study||0
8413787|NCT00941928|20737525|P1|STARTED|Overall Study||2
8413788|NCT00941889|20737531|P2|NOT COMPLETED|Overall Study||12
8413789|NCT00941889|20737532|P1|NOT COMPLETED|Overall Study||12
8413790|NCT00941889|20737531|P2|COMPLETED|Overall Study||3
8413791|NCT00941889|20737532|P1|COMPLETED|Overall Study||5
8413792|NCT00941889|20737531|P2|STARTED|Overall Study||15
8413793|NCT00941889|20737532|P1|STARTED|Overall Study||17
8413794|NCT00941863|20737543|P5|NOT COMPLETED|Continued After PCD||19
8413795|NCT00941863|20737544|P4|NOT COMPLETED|Continued After PCD||0
8413796|NCT00941863|20737545|P3|NOT COMPLETED|Continued After PCD||0
8413797|NCT00941863|20737546|P2|NOT COMPLETED|Continued After PCD||0
8413798|NCT00941863|20737547|P1|NOT COMPLETED|Continued After PCD||0
8413799|NCT00941863|20737543|P5|COMPLETED|Continued After PCD||6
8413800|NCT00941863|20737544|P4|COMPLETED|Continued After PCD||0
8413801|NCT00941863|20737545|P3|COMPLETED|Continued After PCD||0
8413802|NCT00941863|20737546|P2|COMPLETED|Continued After PCD||0
8413803|NCT00941863|20737547|P1|COMPLETED|Continued After PCD||0
8413804|NCT00941863|20737543|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
8413805|NCT00941863|20737544|P4|STARTED|Continued After PCD||0
8413806|NCT00941863|20737545|P3|STARTED|Continued After PCD||0
8413807|NCT00941863|20737546|P2|STARTED|Continued After PCD||0
8413808|NCT00941863|20737547|P1|STARTED|Continued After PCD||0
8413809|NCT00941863|20737543|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
8413810|NCT00941863|20737544|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
8413811|NCT00941863|20737545|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
8413812|NCT00941863|20737546|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
8413813|NCT00941863|20737547|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
8413814|NCT00941863|20737543|P5|COMPLETED|Until Primary Completion Date (PCD)||25
8413815|NCT00941863|20737544|P4|COMPLETED|Until Primary Completion Date (PCD)||0
8413816|NCT00941863|20737545|P3|COMPLETED|Until Primary Completion Date (PCD)||0
8413817|NCT00941863|20737546|P2|COMPLETED|Until Primary Completion Date (PCD)||0
8413818|NCT00941863|20737547|P1|COMPLETED|Until Primary Completion Date (PCD)||0
8413819|NCT00941863|20737543|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
8413820|NCT00941863|20737544|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
8413821|NCT00941863|20737545|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
8413822|NCT00941863|20737546|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
8413823|NCT00941863|20737547|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
8413824|NCT00941863|20737543|P5|STARTED|Until Primary Completion Date (PCD)||119
8413825|NCT00941863|20737544|P4|STARTED|Until Primary Completion Date (PCD)||17
8413826|NCT00941863|20737545|P3|STARTED|Until Primary Completion Date (PCD)||12
8413827|NCT00941863|20737546|P2|STARTED|Until Primary Completion Date (PCD)||3
8413828|NCT00941863|20737547|P1|STARTED|Until Primary Completion Date (PCD)||7
8413829|NCT00941798|20737574|P2|NOT COMPLETED|Overall Study||185
8413830|NCT00941798|20737575|P1|NOT COMPLETED|Overall Study||194
8413831|NCT00941798|20737574|P2|COMPLETED|Overall Study||578
8413832|NCT00941798|20737575|P1|COMPLETED|Overall Study||561
8413833|NCT00941798|20737574|P2|Full Analysis Set|Overall Study||759
8413834|NCT00941798|20737575|P1|Full Analysis Set|Overall Study||749
8413835|NCT00941798|20737574|P2|STARTED|Overall Study||763
8413836|NCT00941798|20737575|P1|STARTED|Overall Study||755
8413837|NCT00941733|20737605|P2|NOT COMPLETED|Overall Study||28
8413838|NCT00941733|20737606|P1|NOT COMPLETED|Overall Study||74
8413839|NCT00941733|20737605|P2|COMPLETED|Overall Study|1 year follow-up|91
8413840|NCT00941733|20737606|P1|COMPLETED|Overall Study|1 year follow-up|165
8413841|NCT00941733|20737605|P2|STARTED|Overall Study||119
8413842|NCT00941733|20737606|P1|STARTED|Overall Study||239
8413843|NCT00941720|20737646|P1|NOT COMPLETED|Overall Study||14
8413844|NCT00941720|20737646|P1|COMPLETED|Overall Study||57
8413845|NCT00941720|20737646|P1|STARTED|Overall Study||71
8413846|NCT00941681|20737655|P3|NOT COMPLETED|Overall Study||0
8413847|NCT00941681|20737656|P2|NOT COMPLETED|Overall Study||1
8413848|NCT00941681|20737657|P1|NOT COMPLETED|Overall Study||0
8413849|NCT00941681|20737655|P3|COMPLETED|Overall Study||12
8413850|NCT00941681|20737656|P2|COMPLETED|Overall Study||10
8413851|NCT00941681|20737657|P1|COMPLETED|Overall Study||12
8413852|NCT00941681|20737655|P3|STARTED|Overall Study||12
8413853|NCT00941681|20737656|P2|STARTED|Overall Study||11
8413854|NCT00941681|20737657|P1|STARTED|Overall Study||12
8413855|NCT00941668|20737682|P2|NOT COMPLETED|Overall Study||25
8413856|NCT00941668|20737683|P1|NOT COMPLETED|Overall Study||24
8413857|NCT00941668|20737682|P2|COMPLETED|Overall Study||0
8413858|NCT00941668|20737683|P1|COMPLETED|Overall Study||0
8413859|NCT00941668|20737682|P2|STARTED|Overall Study||25
8413860|NCT00941668|20737683|P1|STARTED|Overall Study||24
8413861|NCT00941655|20737693|P2|NOT COMPLETED|Overall Study||5
8413862|NCT00941655|20737694|P1|NOT COMPLETED|Overall Study||5
8413863|NCT00941655|20737693|P2|COMPLETED|Overall Study||2
8413864|NCT00941655|20737694|P1|COMPLETED|Overall Study||3
8413865|NCT00941655|20737693|P2|STARTED|Overall Study||7
8413866|NCT00941655|20737694|P1|STARTED|Overall Study||8
8413867|NCT00941603|20737719|P6|NOT COMPLETED|Overall Study||3
8413868|NCT00941603|20737720|P5|NOT COMPLETED|Overall Study||4
8413869|NCT00941603|20737721|P4|NOT COMPLETED|Overall Study||4
8413870|NCT00941603|20737722|P3|NOT COMPLETED|Overall Study||5
8413871|NCT00941603|20737723|P2|NOT COMPLETED|Overall Study||16
8413872|NCT00941603|20737724|P1|NOT COMPLETED|Overall Study||11
8413873|NCT00941603|20737719|P6|COMPLETED|Overall Study||94
8413874|NCT00941603|20737720|P5|COMPLETED|Overall Study||101
8413875|NCT00941603|20737721|P4|COMPLETED|Overall Study||100
8413876|NCT00941603|20737722|P3|COMPLETED|Overall Study||99
8413877|NCT00941603|20737723|P2|COMPLETED|Overall Study||89
8413878|NCT00941603|20737724|P1|COMPLETED|Overall Study||93
8413879|NCT00941603|20737719|P6|STARTED|Overall Study||97
8413880|NCT00941603|20737720|P5|STARTED|Overall Study||105
8413881|NCT00941603|20737721|P4|STARTED|Overall Study||104
8413882|NCT00941603|20737722|P3|STARTED|Overall Study||104
8413883|NCT00941603|20737723|P2|STARTED|Overall Study||105
8413884|NCT00941603|20737724|P1|STARTED|Overall Study||104
8413885|NCT00941330|20737746|P2|NOT COMPLETED|Overall Study||2
8413886|NCT00941330|20737747|P1|NOT COMPLETED|Overall Study||1
8413887|NCT00941330|20737746|P2|COMPLETED|Overall Study||9
8413888|NCT00941330|20737747|P1|COMPLETED|Overall Study||14
8413889|NCT00941330|20737746|P2|STARTED|Overall Study||11
8413890|NCT00941330|20737747|P1|STARTED|Overall Study||15
8413891|NCT00941304|20737760|P5|NOT COMPLETED|Overall Study||0
8413892|NCT00941304|20737761|P4|NOT COMPLETED|Overall Study||0
8413893|NCT00941304|20737762|P3|NOT COMPLETED|Overall Study||0
8413894|NCT00941304|20737763|P2|NOT COMPLETED|Overall Study||0
8413895|NCT00941304|20737764|P1|NOT COMPLETED|Overall Study||1
8413896|NCT00941304|20737760|P5|COMPLETED|Overall Study||31
8413897|NCT00941304|20737761|P4|COMPLETED|Overall Study||30
8413898|NCT00941304|20737762|P3|COMPLETED|Overall Study||31
8413899|NCT00941304|20737763|P2|COMPLETED|Overall Study||30
8413900|NCT00941304|20737764|P1|COMPLETED|Overall Study||30
8413901|NCT00941304|20737760|P5|STARTED|Overall Study||31
8413902|NCT00941304|20737761|P4|STARTED|Overall Study||30
8413903|NCT00941304|20737762|P3|STARTED|Overall Study||31
8413904|NCT00941304|20737763|P2|STARTED|Overall Study||30
8413905|NCT00941304|20737764|P1|STARTED|Overall Study||31
8413906|NCT00941070|20737826|P1|NOT COMPLETED|Overall Study||1
8413907|NCT00941070|20737826|P1|COMPLETED|Overall Study||25
8413908|NCT00941070|20737826|P1|STARTED|Overall Study||26
8413909|NCT00941031|20737846|P7|NOT COMPLETED|Maintenance Period||43
8413910|NCT00941031|20737847|P6|NOT COMPLETED|Maintenance Period||6
8413911|NCT00941031|20737848|P5|NOT COMPLETED|Maintenance Period||9
8413912|NCT00941031|20737849|P4|NOT COMPLETED|Maintenance Period||0
8413913|NCT00941031|20737850|P3|NOT COMPLETED|Maintenance Period||0
8413914|NCT00941031|20737851|P2|NOT COMPLETED|Maintenance Period||0
8413915|NCT00941031|20737852|P1|NOT COMPLETED|Maintenance Period||0
8413916|NCT00941031|20737846|P7|COMPLETED|Maintenance Period||204
8413917|NCT00941031|20737847|P6|COMPLETED|Maintenance Period||61
8413918|NCT00941031|20737848|P5|COMPLETED|Maintenance Period||56
8413919|NCT00941031|20737849|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
8413920|NCT00941031|20737850|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413921|NCT00941031|20737851|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413922|NCT00941031|20737852|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413923|NCT00941031|20737846|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
8413924|NCT00941031|20737847|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
8413925|NCT00941031|20737848|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
8413926|NCT00941031|20737849|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
8413927|NCT00941031|20737850|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413928|NCT00941031|20737851|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413929|NCT00941031|20737852|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413930|NCT00941031|20737846|P7|NOT COMPLETED|Induction Period||0
8413931|NCT00941031|20737847|P6|NOT COMPLETED|Induction Period||0
8413932|NCT00941031|20737848|P5|NOT COMPLETED|Induction Period||0
8413933|NCT00941031|20737849|P4|NOT COMPLETED|Induction Period||9
8413934|NCT00941031|20737850|P3|NOT COMPLETED|Induction Period||6
8413935|NCT00941031|20737851|P2|NOT COMPLETED|Induction Period||4
8413936|NCT00941031|20737852|P1|NOT COMPLETED|Induction Period||5
8413937|NCT00941031|20737846|P7|COMPLETED|Induction Period||0
8413938|NCT00941031|20737847|P6|COMPLETED|Induction Period||0
8413939|NCT00941031|20737848|P5|COMPLETED|Induction Period||0
8413940|NCT00941031|20737849|P4|COMPLETED|Induction Period||58
8413941|NCT00941031|20737850|P3|COMPLETED|Induction Period||127
8413942|NCT00941031|20737851|P2|COMPLETED|Induction Period||134
8413943|NCT00941031|20737852|P1|COMPLETED|Induction Period||61
8413944|NCT00941031|20737846|P7|STARTED|Induction Period||0
8413945|NCT00941031|20737847|P6|STARTED|Induction Period||0
8413946|NCT00941031|20737848|P5|STARTED|Induction Period||0
8413947|NCT00941031|20737849|P4|STARTED|Induction Period||67
8413948|NCT00941031|20737850|P3|STARTED|Induction Period||133
8413949|NCT00941031|20737851|P2|STARTED|Induction Period||138
8413950|NCT00941031|20737852|P1|STARTED|Induction Period||66
8413951|NCT00941005|20737877|P2|NOT COMPLETED|Overall Study||0
8413952|NCT00941005|20737878|P1|NOT COMPLETED|Overall Study||0
8413953|NCT00941005|20737877|P2|COMPLETED|Overall Study||61
8413954|NCT00941005|20737878|P1|COMPLETED|Overall Study||61
8413955|NCT00941005|20737877|P2|STARTED|Overall Study||61
8413956|NCT00941005|20737878|P1|STARTED|Overall Study||61
8413957|NCT00940992|20737899|P3|NOT COMPLETED|Overall Study||2
8413958|NCT00940992|20737900|P2|NOT COMPLETED|Overall Study||2
8413959|NCT00940992|20737901|P1|NOT COMPLETED|Overall Study||4
8413960|NCT00940992|20737899|P3|COMPLETED|Overall Study||28
8413961|NCT00940992|20737900|P2|COMPLETED|Overall Study||28
8413962|NCT00940992|20737901|P1|COMPLETED|Overall Study||28
8413963|NCT00940992|20737899|P3|STARTED|Overall Study||30
8413964|NCT00940992|20737900|P2|STARTED|Overall Study||30
8413965|NCT00940992|20737901|P1|STARTED|Overall Study||32
8413966|NCT00940927|20737912|P1|NOT COMPLETED|Overall Study||0
8413967|NCT00940927|20737912|P1|COMPLETED|Overall Study||81
8413968|NCT00940927|20737912|P1|STARTED|Overall Study||81
8413969|NCT00940901|20737919|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
8413970|NCT00940901|20737920|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
8413971|NCT00940901|20737919|P2|COMPLETED|Week 9-16 (Phase 2)||4
8413972|NCT00940901|20737920|P1|COMPLETED|Week 9-16 (Phase 2)||4
8413973|NCT00940901|20737919|P2|STARTED|Week 9-16 (Phase 2)||7
8413974|NCT00940901|20737920|P1|STARTED|Week 9-16 (Phase 2)||6
8413975|NCT00940901|20737919|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
8413976|NCT00940901|20737920|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
8413977|NCT00940901|20737919|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
8413978|NCT00940901|20737920|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
8413979|NCT00940901|20737919|P2|STARTED|Weeks 1-8 (Phase 1)||7
8413980|NCT00940901|20737920|P1|STARTED|Weeks 1-8 (Phase 1)||6
8413981|NCT00940888|20737930|P1|NOT COMPLETED|Overall Study||835
8413982|NCT00940888|20737930|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
8413983|NCT00940888|20737930|P1|STARTED|Overall Study|Total number of subjects consented|1701
8413984|NCT00940875|20737937|P2|NOT COMPLETED|Post-Study Treatment||3
8413985|NCT00940875|20737938|P1|NOT COMPLETED|Post-Study Treatment||0
8413986|NCT00940875|20737937|P2|COMPLETED|Post-Study Treatment||1
8413987|NCT00940875|20737938|P1|COMPLETED|Post-Study Treatment||0
8413988|NCT00940875|20737937|P2|STARTED|Post-Study Treatment||4
8413989|NCT00940875|20737938|P1|STARTED|Post-Study Treatment||0
8413990|NCT00940875|20737937|P2|NOT COMPLETED|Treatment Phase||19
8413991|NCT00940875|20737938|P1|NOT COMPLETED|Treatment Phase||26
8413992|NCT00940875|20737937|P2|COMPLETED|Treatment Phase||4
8413993|NCT00940875|20737938|P1|COMPLETED|Treatment Phase||5
8413994|NCT00940875|20737937|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
8413995|NCT00940875|20737938|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
8413996|NCT00940823|20737958|P2|NOT COMPLETED|Overall Study||32
8413997|NCT00940823|20737959|P1|NOT COMPLETED|Overall Study||35
8413998|NCT00940823|20737958|P2|COMPLETED|Overall Study||82
8413999|NCT00940823|20737959|P1|COMPLETED|Overall Study||89
8414000|NCT00940823|20737958|P2|STARTED|Overall Study||114
8414001|NCT00940823|20737959|P1|STARTED|Overall Study||124
8414002|NCT00940771|20737975|P1|NOT COMPLETED|24 Weeks||0
8414003|NCT00940771|20737975|P1|COMPLETED|24 Weeks||10
8414004|NCT00940771|20737975|P1|STARTED|24 Weeks||10
8414005|NCT00940771|20737975|P1|NOT COMPLETED|12 Weeks||0
8414006|NCT00940771|20737975|P1|COMPLETED|12 Weeks||10
8414007|NCT00940771|20737975|P1|STARTED|12 Weeks||10
8414008|NCT00940771|20737975|P1|NOT COMPLETED|4 Weeks||0
8414009|NCT00940771|20737975|P1|COMPLETED|4 Weeks||10
8414010|NCT00940771|20737975|P1|STARTED|4 Weeks||10
8414011|NCT00940771|20737975|P1|NOT COMPLETED|Pre-Entry||0
8414012|NCT00940771|20737975|P1|COMPLETED|Pre-Entry||10
8414013|NCT00940771|20737975|P1|STARTED|Pre-Entry||10
8414014|NCT00940602|20737984|P2|NOT COMPLETED|Overall Study||76
8414015|NCT00940602|20737985|P1|NOT COMPLETED|Overall Study||149
8414016|NCT00940602|20737984|P2|COMPLETED|Overall Study||0
8414017|NCT00940602|20737985|P1|COMPLETED|Overall Study||0
8414018|NCT00940602|20737984|P2|Untreated|Overall Study||0
8414019|NCT00940602|20737985|P1|Untreated|Overall Study||1
8414020|NCT00940602|20737984|P2|Treated|Overall Study||76
8414021|NCT00940602|20737985|P1|Treated|Overall Study||148
8414022|NCT00940602|20737984|P2|Full Analysis Set|Overall Study||76
8414023|NCT00940602|20737985|P1|Full Analysis Set|Overall Study||149
8414024|NCT00940602|20737984|P2|Safety Analysis Set|Overall Study||76
8414025|NCT00940602|20737985|P1|Safety Analysis Set|Overall Study||148
8414026|NCT00940602|20737984|P2|STARTED|Overall Study||76
8414027|NCT00940602|20737985|P1|STARTED|Overall Study||149
8414028|NCT00940589|20738024|P2|NOT COMPLETED|Overall Study||5
8414029|NCT00940589|20738025|P1|NOT COMPLETED|Overall Study||8
8414030|NCT00940589|20738024|P2|COMPLETED|Overall Study||29
8414031|NCT00940589|20738025|P1|COMPLETED|Overall Study||31
8414032|NCT00940589|20738024|P2|STARTED|Overall Study||34
8414033|NCT00940589|20738025|P1|STARTED|Overall Study||39
8414034|NCT00940576|20738035|P2|NOT COMPLETED|Overall Study||0
8414035|NCT00940576|20738036|P1|NOT COMPLETED|Overall Study||0
8414036|NCT00940576|20738035|P2|COMPLETED|Overall Study||9
8414037|NCT00940576|20738036|P1|COMPLETED|Overall Study||8
8414038|NCT00940576|20738035|P2|STARTED|Overall Study||9
8414039|NCT00940576|20738036|P1|STARTED|Overall Study||8
8414040|NCT00940537|20738045|P2|NOT COMPLETED|Overall Study||0
8414041|NCT00940537|20738046|P1|NOT COMPLETED|Overall Study||0
8414042|NCT00940537|20738045|P2|COMPLETED|Overall Study||9
8414043|NCT00940537|20738046|P1|COMPLETED|Overall Study||5
8414044|NCT00940537|20738045|P2|STARTED|Overall Study||9
8414045|NCT00940537|20738046|P1|STARTED|Overall Study||5
8414046|NCT00940498|20738063|P8|NOT COMPLETED|Overall Study||1
8414047|NCT00940498|20738064|P7|NOT COMPLETED|Overall Study||1
8414048|NCT00940498|20738065|P6|NOT COMPLETED|Overall Study||1
8414049|NCT00940498|20738066|P5|NOT COMPLETED|Overall Study||9
8414050|NCT00940498|20738067|P4|NOT COMPLETED|Overall Study||2
8414051|NCT00940498|20738068|P3|NOT COMPLETED|Overall Study||3
8414052|NCT00940498|20738069|P2|NOT COMPLETED|Overall Study||1
8414053|NCT00940498|20738070|P1|NOT COMPLETED|Overall Study||3
8414054|NCT00940498|20738063|P8|COMPLETED|Overall Study||3
8414055|NCT00940498|20738064|P7|COMPLETED|Overall Study||7
8414056|NCT00940498|20738065|P6|COMPLETED|Overall Study||6
8414057|NCT00940498|20738066|P5|COMPLETED|Overall Study||34
8414058|NCT00940498|20738067|P4|COMPLETED|Overall Study||2
8414059|NCT00940498|20738068|P3|COMPLETED|Overall Study||1
8414060|NCT00940498|20738069|P2|COMPLETED|Overall Study||3
8414061|NCT00940498|20738070|P1|COMPLETED|Overall Study||1
8414062|NCT00940498|20738063|P8|STARTED|Overall Study||4
8414063|NCT00940498|20738064|P7|STARTED|Overall Study||8
8414064|NCT00940498|20738065|P6|STARTED|Overall Study||7
8414065|NCT00940498|20738066|P5|STARTED|Overall Study||43
8414066|NCT00940498|20738067|P4|STARTED|Overall Study||4
8414067|NCT00940498|20738068|P3|STARTED|Overall Study||4
8414068|NCT00940498|20738069|P2|STARTED|Overall Study||4
8414069|NCT00940498|20738070|P1|STARTED|Overall Study||4
8414070|NCT00940485|20738188|P2|NOT COMPLETED|Overall Study||7
8414071|NCT00940485|20738189|P1|NOT COMPLETED|Overall Study||15
8414072|NCT00940485|20738188|P2|COMPLETED|Overall Study||93
8414073|NCT00940485|20738189|P1|COMPLETED|Overall Study||82
8414074|NCT00940485|20738188|P2|STARTED|Overall Study||100
8414075|NCT00940485|20738189|P1|STARTED|Overall Study||97
8414076|NCT00940446|20738215|P2|NOT COMPLETED|Overall Study||0
8414077|NCT00940446|20738216|P1|NOT COMPLETED|Overall Study||0
8414078|NCT00940446|20738215|P2|COMPLETED|Overall Study||30
8414079|NCT00940446|20738216|P1|COMPLETED|Overall Study||30
8414080|NCT00940446|20738215|P2|STARTED|Overall Study||30
8414081|NCT00940446|20738216|P1|STARTED|Overall Study||30
8414082|NCT00940342|20738227|P3|NOT COMPLETED|Overall Study||1
8414083|NCT00940342|20738228|P2|NOT COMPLETED|Overall Study||2
8414084|NCT00940342|20738229|P1|NOT COMPLETED|Overall Study||0
8414085|NCT00940342|20738227|P3|COMPLETED|Overall Study||39
8414086|NCT00940342|20738228|P2|COMPLETED|Overall Study||38
8414087|NCT00940342|20738229|P1|COMPLETED|Overall Study||50
8414088|NCT00940342|20738227|P3|STARTED|Overall Study||40
8414089|NCT00940342|20738228|P2|STARTED|Overall Study||40
8414090|NCT00940342|20738229|P1|STARTED|Overall Study||50
8414091|NCT00940316|20738240|P3|NOT COMPLETED|Follow up Every 3 Months||0
8414092|NCT00940316|20738241|P2|NOT COMPLETED|Follow up Every 3 Months||0
8414093|NCT00940316|20738242|P1|NOT COMPLETED|Follow up Every 3 Months||0
8414094|NCT00940316|20738240|P3|COMPLETED|Follow up Every 3 Months||2
8414095|NCT00940316|20738241|P2|COMPLETED|Follow up Every 3 Months||13
8414096|NCT00940316|20738242|P1|COMPLETED|Follow up Every 3 Months||13
8414097|NCT00940316|20738240|P3|STARTED|Follow up Every 3 Months||2
8414098|NCT00940316|20738241|P2|STARTED|Follow up Every 3 Months||13
8414099|NCT00940316|20738242|P1|STARTED|Follow up Every 3 Months||13
8414100|NCT00940316|20738240|P3|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8414101|NCT00940316|20738241|P2|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8414102|NCT00940316|20738242|P1|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8414103|NCT00940316|20738240|P3|COMPLETED|Crossed Over to Arm A After Progression||0
8414104|NCT00940316|20738241|P2|COMPLETED|Crossed Over to Arm A After Progression||3
8414105|NCT00940316|20738242|P1|COMPLETED|Crossed Over to Arm A After Progression||0
8414106|NCT00940316|20738240|P3|Treated for Cycle One|Crossed Over to Arm A After Progression||0
8414107|NCT00940316|20738241|P2|Treated for Cycle One|Crossed Over to Arm A After Progression||3
8414108|NCT00940316|20738242|P1|Treated for Cycle One|Crossed Over to Arm A After Progression||0
8414109|NCT00940316|20738240|P3|STARTED|Crossed Over to Arm A After Progression||0
8414110|NCT00940316|20738241|P2|STARTED|Crossed Over to Arm A After Progression||3
8414111|NCT00940316|20738242|P1|STARTED|Crossed Over to Arm A After Progression||0
8414112|NCT00940316|20738240|P3|NOT COMPLETED|Treated After Cycle 5||1
8414113|NCT00940316|20738241|P2|NOT COMPLETED|Treated After Cycle 5||1
8414114|NCT00940316|20738242|P1|NOT COMPLETED|Treated After Cycle 5||0
8414115|NCT00940316|20738240|P3|COMPLETED|Treated After Cycle 5||1
8414116|NCT00940316|20738241|P2|COMPLETED|Treated After Cycle 5||8
8414117|NCT00940316|20738242|P1|COMPLETED|Treated After Cycle 5||8
8414118|NCT00940316|20738240|P3|STARTED|Treated After Cycle 5||2
8414119|NCT00940316|20738241|P2|STARTED|Treated After Cycle 5||9
8414120|NCT00940316|20738242|P1|STARTED|Treated After Cycle 5||8
8414121|NCT00940316|20738240|P3|NOT COMPLETED|Moved on to be Treated Cycle 5||0
8414122|NCT00940316|20738241|P2|NOT COMPLETED|Moved on to be Treated Cycle 5||0
8414123|NCT00940316|20738242|P1|NOT COMPLETED|Moved on to be Treated Cycle 5||2
8414124|NCT00940316|20738240|P3|COMPLETED|Moved on to be Treated Cycle 5||2
8414125|NCT00940316|20738241|P2|COMPLETED|Moved on to be Treated Cycle 5||9
8414126|NCT00940316|20738242|P1|COMPLETED|Moved on to be Treated Cycle 5||8
8414127|NCT00940316|20738240|P3|STARTED|Moved on to be Treated Cycle 5||2
8414128|NCT00940316|20738241|P2|STARTED|Moved on to be Treated Cycle 5||9
8414129|NCT00940316|20738242|P1|STARTED|Moved on to be Treated Cycle 5||10
8414130|NCT00940316|20738240|P3|NOT COMPLETED|Reached First Response at 8 Weeks||0
8414131|NCT00940316|20738241|P2|NOT COMPLETED|Reached First Response at 8 Weeks||4
8414132|NCT00940316|20738242|P1|NOT COMPLETED|Reached First Response at 8 Weeks||3
8414133|NCT00940316|20738240|P3|COMPLETED|Reached First Response at 8 Weeks||2
8414134|NCT00940316|20738241|P2|COMPLETED|Reached First Response at 8 Weeks||9
8414135|NCT00940316|20738242|P1|COMPLETED|Reached First Response at 8 Weeks||10
8414136|NCT00940316|20738240|P3|STARTED|Reached First Response at 8 Weeks||2
8414137|NCT00940316|20738241|P2|STARTED|Reached First Response at 8 Weeks||13
8414138|NCT00940316|20738242|P1|STARTED|Reached First Response at 8 Weeks||13
8414139|NCT00940290|20738268|P4|NOT COMPLETED|Overall Study||0
8414140|NCT00940290|20738269|P3|NOT COMPLETED|Overall Study||0
8414141|NCT00940290|20738270|P2|NOT COMPLETED|Overall Study||0
8414142|NCT00940290|20738271|P1|NOT COMPLETED|Overall Study||0
8414143|NCT00940290|20738268|P4|COMPLETED|Overall Study||54
8414144|NCT00940290|20738269|P3|COMPLETED|Overall Study||55
8414145|NCT00940290|20738270|P2|COMPLETED|Overall Study||53
8414146|NCT00940290|20738271|P1|COMPLETED|Overall Study||54
8414147|NCT00940290|20738268|P4|STARTED|Overall Study||54
8414148|NCT00940290|20738269|P3|STARTED|Overall Study||55
8414149|NCT00940290|20738270|P2|STARTED|Overall Study||53
8414150|NCT00940290|20738271|P1|STARTED|Overall Study||54
8414151|NCT00940108|20738285|P4|NOT COMPLETED|Overall Study||5
8414152|NCT00940108|20738286|P3|NOT COMPLETED|Overall Study||3
8414153|NCT00940108|20738287|P2|NOT COMPLETED|Overall Study||9
8414154|NCT00940108|20738288|P1|NOT COMPLETED|Overall Study||5
8414155|NCT00940108|20738285|P4|COMPLETED|Overall Study||99
8414156|NCT00940108|20738286|P3|COMPLETED|Overall Study||100
8414157|NCT00940108|20738287|P2|COMPLETED|Overall Study||71
8414158|NCT00940108|20738288|P1|COMPLETED|Overall Study||77
8414159|NCT00940108|20738285|P4|STARTED|Overall Study||104
8414160|NCT00940108|20738286|P3|STARTED|Overall Study||103
8414161|NCT00940108|20738287|P2|STARTED|Overall Study||80
8414162|NCT00940108|20738288|P1|STARTED|Overall Study||82
8414163|NCT00940017|20738338|P1|NOT COMPLETED|Overall Study||4
8414164|NCT00940017|20738338|P1|COMPLETED|Overall Study||20
8414165|NCT00940017|20738338|P1|Subjects Treated|Overall Study||21
8414166|NCT00940017|20738338|P1|STARTED|Overall Study||24
8414167|NCT00939991|20738359|P2|NOT COMPLETED|Overall Study||0
8414168|NCT00939991|20738360|P1|NOT COMPLETED|Overall Study||0
8414169|NCT00939991|20738359|P2|COMPLETED|Overall Study||39
8414170|NCT00939991|20738360|P1|COMPLETED|Overall Study||9
8414171|NCT00939991|20738359|P2|STARTED|Overall Study||39
8414172|NCT00939991|20738360|P1|STARTED|Overall Study||9
8414173|NCT00939952|20738370|P1|NOT COMPLETED|Overall Study||0
8414174|NCT00939952|20738370|P1|COMPLETED|Overall Study||7
8414175|NCT00939952|20738370|P1|STARTED|Overall Study||7
8414176|NCT00939900|20738382|P2|NOT COMPLETED|Overall Study||7
8414177|NCT00939900|20738383|P1|NOT COMPLETED|Overall Study||2
8414178|NCT00939900|20738382|P2|COMPLETED|Overall Study||48
8414179|NCT00939900|20738383|P1|COMPLETED|Overall Study||53
8414180|NCT00939900|20738382|P2|STARTED|Overall Study||55
8414181|NCT00939900|20738383|P1|STARTED|Overall Study||55
8414182|NCT00939874|20738389|P1|NOT COMPLETED|Overall Study||20
8414183|NCT00939874|20738389|P1|COMPLETED|Overall Study||32
8414184|NCT00939874|20738389|P1|Completed Week 48|Overall Study||37
8414185|NCT00939874|20738389|P1|STARTED|Overall Study||52
8414186|NCT00939822|20738396|P2|NOT COMPLETED|Overall Study||3
8414187|NCT00939822|20738397|P1|NOT COMPLETED|Overall Study||2
8414188|NCT00939822|20738396|P2|COMPLETED|Overall Study||41
8414189|NCT00939822|20738397|P1|COMPLETED|Overall Study||42
8414190|NCT00939822|20738396|P2|STARTED|Overall Study||44
8414191|NCT00939822|20738397|P1|STARTED|Overall Study||44
8414192|NCT00939809|20738409|P1|NOT COMPLETED|Overall Study||3
8414193|NCT00939809|20738409|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
8414194|NCT00939809|20738409|P1|STARTED|Overall Study||31
8414195|NCT00939796|20738418|P1|NOT COMPLETED|Overall Study||0
8414196|NCT00939796|20738418|P1|COMPLETED|Overall Study||16
8414197|NCT00939796|20738418|P1|STARTED|Overall Study||16
8414198|NCT00939783|20738424|P1|NOT COMPLETED|Overall Study||649
8414199|NCT00939783|20738424|P1|COMPLETED|Overall Study||0
8414200|NCT00939783|20738424|P1|Treated|Overall Study||648
8414201|NCT00939783|20738424|P1|STARTED|Overall Study||649
8414202|NCT00939770|20738439|P8|NOT COMPLETED|Overall Study||10
8414203|NCT00939770|20738440|P7|NOT COMPLETED|Overall Study||14
8414204|NCT00939770|20738441|P6|NOT COMPLETED|Overall Study||11
8414205|NCT00939770|20738442|P5|NOT COMPLETED|Overall Study||37
8414206|NCT00939770|20738443|P4|NOT COMPLETED|Overall Study||11
8414207|NCT00939770|20738444|P3|NOT COMPLETED|Overall Study||20
8414208|NCT00939770|20738445|P2|NOT COMPLETED|Overall Study||8
8414209|NCT00939770|20738446|P1|NOT COMPLETED|Overall Study||5
8414210|NCT00939770|20738439|P8|COMPLETED|Overall Study||0
8414211|NCT00939770|20738440|P7|COMPLETED|Overall Study||0
8414212|NCT00939770|20738441|P6|COMPLETED|Overall Study||0
8414213|NCT00939770|20738442|P5|COMPLETED|Overall Study||1
8414214|NCT00939770|20738443|P4|COMPLETED|Overall Study||1
8414215|NCT00939770|20738444|P3|COMPLETED|Overall Study||3
8414216|NCT00939770|20738445|P2|COMPLETED|Overall Study||0
8414217|NCT00939770|20738446|P1|COMPLETED|Overall Study||1
8414218|NCT00939770|20738439|P8|STARTED|Overall Study||10
8414219|NCT00939770|20738440|P7|STARTED|Overall Study||14
8414220|NCT00939770|20738441|P6|STARTED|Overall Study||11
8414221|NCT00939770|20738442|P5|STARTED|Overall Study||38
8414222|NCT00939770|20738443|P4|STARTED|Overall Study||12
8414223|NCT00939770|20738444|P3|STARTED|Overall Study||23
8414224|NCT00939770|20738445|P2|STARTED|Overall Study||8
8414225|NCT00939770|20738446|P1|STARTED|Overall Study||6
8414226|NCT00939731|20738497|P2|NOT COMPLETED|Second Intervention Period||0
8414227|NCT00939731|20738498|P1|NOT COMPLETED|Second Intervention Period||0
8414228|NCT00939731|20738497|P2|COMPLETED|Second Intervention Period||12
8414229|NCT00939731|20738498|P1|COMPLETED|Second Intervention Period||12
8414230|NCT00939731|20738497|P2|STARTED|Second Intervention Period||12
8414231|NCT00939731|20738498|P1|STARTED|Second Intervention Period||12
8414232|NCT00939731|20738497|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8414233|NCT00939731|20738498|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8414234|NCT00939731|20738497|P2|COMPLETED|Washout Period (at Least 14 Days)||12
8414235|NCT00939731|20738498|P1|COMPLETED|Washout Period (at Least 14 Days)||12
8414236|NCT00939731|20738497|P2|STARTED|Washout Period (at Least 14 Days)||12
8414237|NCT00939731|20738498|P1|STARTED|Washout Period (at Least 14 Days)||12
8414238|NCT00939731|20738497|P2|NOT COMPLETED|First Intervention Period||0
8414239|NCT00939731|20738498|P1|NOT COMPLETED|First Intervention Period||0
8414240|NCT00939731|20738497|P2|COMPLETED|First Intervention Period||12
8414241|NCT00939731|20738498|P1|COMPLETED|First Intervention Period||12
8414242|NCT00939731|20738497|P2|STARTED|First Intervention Period||12
8414243|NCT00939731|20738498|P1|STARTED|First Intervention Period||12
8414244|NCT00939705|20738518|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
8414245|NCT00939705|20738519|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
8414246|NCT00939705|20738518|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
8414247|NCT00939705|20738519|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
8414248|NCT00939705|20738518|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
8414249|NCT00939705|20738519|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
8414250|NCT00939705|20738518|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
8414251|NCT00939705|20738519|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
8414252|NCT00939705|20738518|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
8414253|NCT00939705|20738519|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
8414254|NCT00939705|20738518|P2|STARTED|Period 2 - Washout Period - 21 Days||9
8414255|NCT00939705|20738519|P1|STARTED|Period 2 - Washout Period - 21 Days||9
8414256|NCT00939705|20738518|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8414257|NCT00939705|20738519|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8414258|NCT00939705|20738518|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
8414259|NCT00939705|20738519|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
8414260|NCT00939705|20738518|P2|STARTED|Period 1 - First Intervention - 5 Days||9
8414261|NCT00939705|20738519|P1|STARTED|Period 1 - First Intervention - 5 Days||9
8414262|NCT00939692|20738531|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
8414263|NCT00939692|20738532|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
8414264|NCT00939692|20738531|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
8414265|NCT00939692|20738532|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
8414266|NCT00939692|20738531|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
8414267|NCT00939692|20738532|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
8414268|NCT00939692|20738531|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8414269|NCT00939692|20738532|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
8414270|NCT00939692|20738531|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
8414271|NCT00939692|20738532|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
8414272|NCT00939692|20738531|P2|STARTED|Period 1 - First Intervention - 5 Days||13
8414273|NCT00939692|20738532|P1|STARTED|Period 1 - First Intervention - 5 Days||13
8414274|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 4||0
8414275|NCT00939653|20738542|P1|COMPLETED|Treatment Course 4||0
8414276|NCT00939653|20738542|P1|STARTED|Treatment Course 4||0
8414277|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 3||0
8414278|NCT00939653|20738542|P1|COMPLETED|Treatment Course 3||0
8414279|NCT00939653|20738542|P1|STARTED|Treatment Course 3||0
8414280|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 2||0
8414281|NCT00939653|20738542|P1|COMPLETED|Treatment Course 2||2
8414282|NCT00939653|20738542|P1|STARTED|Treatment Course 2||2
8414283|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 1||0
8414284|NCT00939653|20738542|P1|COMPLETED|Treatment Course 1||6
8414285|NCT00939653|20738542|P1|STARTED|Treatment Course 1||6
8414286|NCT00939640|20738547|P1|NOT COMPLETED|Overall Study||1
8414287|NCT00939640|20738547|P1|COMPLETED|Overall Study||13
8414288|NCT00939640|20738547|P1|STARTED|Overall Study||14
8414289|NCT00939627|20738568|P3|NOT COMPLETED|Overall Study||0
8414290|NCT00939627|20738569|P2|NOT COMPLETED|Overall Study||28
8414291|NCT00939627|20738570|P1|NOT COMPLETED|Overall Study||27
8414292|NCT00939627|20738568|P3|COMPLETED|Overall Study||0
8414293|NCT00939627|20738569|P2|COMPLETED|Overall Study||0
8414294|NCT00939627|20738570|P1|COMPLETED|Overall Study||0
8414295|NCT00939627|20738568|P3|STARTED|Overall Study||0
8414296|NCT00939627|20738569|P2|STARTED|Overall Study||28
8414297|NCT00939627|20738570|P1|STARTED|Overall Study||27
8414298|NCT00939562|20738588|P2|NOT COMPLETED|Period 2||0
8414299|NCT00939562|20738589|P1|NOT COMPLETED|Period 2||0
8414300|NCT00939562|20738588|P2|COMPLETED|Period 2||12
8414301|NCT00939562|20738589|P1|COMPLETED|Period 2||12
8414302|NCT00939562|20738588|P2|STARTED|Period 2||12
8414303|NCT00939562|20738589|P1|STARTED|Period 2||12
8414304|NCT00939562|20738588|P2|NOT COMPLETED|Period 1||0
8414305|NCT00939562|20738589|P1|NOT COMPLETED|Period 1||0
8414306|NCT00939562|20738588|P2|COMPLETED|Period 1||12
8414307|NCT00939562|20738589|P1|COMPLETED|Period 1||12
8414308|NCT00939562|20738588|P2|STARTED|Period 1||12
8414309|NCT00939562|20738589|P1|STARTED|Period 1||12
8414310|NCT00939536|20738599|P2|NOT COMPLETED|Second Intervention||0
8414311|NCT00939536|20738600|P1|NOT COMPLETED|Second Intervention||0
8414312|NCT00939536|20738599|P2|COMPLETED|Second Intervention||12
8414313|NCT00939536|20738600|P1|COMPLETED|Second Intervention||12
8414314|NCT00939536|20738599|P2|STARTED|Second Intervention||12
8414315|NCT00939536|20738600|P1|STARTED|Second Intervention||12
8414316|NCT00939536|20738599|P2|NOT COMPLETED|First Intervention||0
8414317|NCT00939536|20738600|P1|NOT COMPLETED|First Intervention||0
8414318|NCT00939536|20738599|P2|COMPLETED|First Intervention||12
8414319|NCT00939536|20738600|P1|COMPLETED|First Intervention||12
8414320|NCT00939536|20738599|P2|STARTED|First Intervention||12
8414321|NCT00939536|20738600|P1|STARTED|First Intervention||12
8414322|NCT00939523|20738610|P1|NOT COMPLETED|Overall Study||3
8414323|NCT00939523|20738610|P1|COMPLETED|Overall Study||6
8414324|NCT00939523|20738610|P1|STARTED|Overall Study||9
8414325|NCT00939510|20738617|P1|NOT COMPLETED|Overall Study||1
8414326|NCT00939510|20738617|P1|COMPLETED|Overall Study||31
8414327|NCT00939510|20738617|P1|STARTED|Overall Study||32
8414328|NCT00939484|20738626|P3|NOT COMPLETED|Overall Study||3
8414329|NCT00939484|20738627|P2|NOT COMPLETED|Overall Study||20
8414330|NCT00939484|20738628|P1|NOT COMPLETED|Overall Study||8
8414331|NCT00939484|20738626|P3|COMPLETED|Overall Study||0
8414332|NCT00939484|20738627|P2|COMPLETED|Overall Study||0
8414333|NCT00939484|20738628|P1|COMPLETED|Overall Study||0
8414334|NCT00939484|20738626|P3|STARTED|Overall Study||3
8414335|NCT00939484|20738627|P2|STARTED|Overall Study||20
8414336|NCT00939484|20738628|P1|STARTED|Overall Study||8
8414337|NCT00939471|20738641|P1|NOT COMPLETED|Overall Study||11
8414338|NCT00939471|20738641|P1|COMPLETED|Overall Study||33
8414339|NCT00939471|20738641|P1|STARTED|Overall Study||44
8414340|NCT00939393|20738654|P2|NOT COMPLETED|Overall Study||0
8414341|NCT00939393|20738655|P1|NOT COMPLETED|Overall Study||4
8414342|NCT00939393|20738654|P2|COMPLETED|Overall Study||35
8414343|NCT00939393|20738655|P1|COMPLETED|Overall Study||33
8414344|NCT00939393|20738654|P2|STARTED|Overall Study||35
8414345|NCT00939393|20738655|P1|STARTED|Overall Study||37
8414346|NCT00939367|20738675|P2|NOT COMPLETED|Second Intervention||0
8414347|NCT00939367|20738676|P1|NOT COMPLETED|Second Intervention||0
8414348|NCT00939367|20738675|P2|COMPLETED|Second Intervention||15
8414349|NCT00939367|20738676|P1|COMPLETED|Second Intervention||15
8414350|NCT00939367|20738675|P2|STARTED|Second Intervention||15
8414351|NCT00939367|20738676|P1|STARTED|Second Intervention||15
8414352|NCT00939367|20738675|P2|NOT COMPLETED|First Intervention||0
8414353|NCT00939367|20738676|P1|NOT COMPLETED|First Intervention||0
8414354|NCT00939367|20738675|P2|COMPLETED|First Intervention||15
8414355|NCT00939367|20738676|P1|COMPLETED|First Intervention||15
8414356|NCT00939367|20738675|P2|STARTED|First Intervention||15
8414357|NCT00939367|20738676|P1|STARTED|First Intervention||15
8414358|NCT00939341|20738686|P1|NOT COMPLETED|Overall Study||66
8414359|NCT00939341|20738686|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
8414360|NCT00939341|20738686|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
8414361|NCT00939211|20738706|P1|NOT COMPLETED|Placebo||0
8414362|NCT00939211|20738706|P1|COMPLETED|Placebo||28
8414363|NCT00939211|20738706|P1|STARTED|Placebo||28
8414364|NCT00939211|20738706|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
8414365|NCT00939211|20738706|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
8414366|NCT00939211|20738706|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
8414367|NCT00939211|20738706|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
8414368|NCT00939211|20738706|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
8414369|NCT00939211|20738706|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
8414370|NCT00939211|20738706|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
8414371|NCT00939211|20738706|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
8414372|NCT00939211|20738706|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
8414373|NCT00939211|20738706|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
8414374|NCT00939211|20738706|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
8414375|NCT00939211|20738706|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
8414376|NCT00939198|20738768|P1|NOT COMPLETED|Overall Study||0
8414377|NCT00939198|20738768|P1|COMPLETED|Overall Study||87
8414378|NCT00939198|20738768|P1|STARTED|Overall Study||87
8414379|NCT00939185|20738773|P1|NOT COMPLETED|Overall Study||25
8414380|NCT00939185|20738773|P1|COMPLETED|Overall Study||375
8414381|NCT00939185|20738773|P1|Received Treatment|Overall Study||390
8414382|NCT00939185|20738773|P1|STARTED|Overall Study||400
8414383|NCT00939159|20738780|P1|NOT COMPLETED|Overall Study||0
8414384|NCT00939159|20738780|P1|COMPLETED|Overall Study||13
8414385|NCT00939159|20738780|P1|STARTED|Overall Study||13
8414386|NCT00939120|20738786|P2|NOT COMPLETED|Overall Study||5
8414387|NCT00939120|20738787|P1|NOT COMPLETED|Overall Study||8
8414388|NCT00939120|20738786|P2|COMPLETED|Overall Study||18
8414389|NCT00939120|20738787|P1|COMPLETED|Overall Study||15
8414390|NCT00939120|20738786|P2|STARTED|Overall Study||23
8414391|NCT00939120|20738787|P1|STARTED|Overall Study||23
8414392|NCT00939107|20738811|P2|NOT COMPLETED|Overall Study||12
8414393|NCT00939107|20738812|P1|NOT COMPLETED|Overall Study||14
8414394|NCT00939107|20738811|P2|COMPLETED|Overall Study||163
8414395|NCT00939107|20738812|P1|COMPLETED|Overall Study||161
8414396|NCT00939107|20738811|P2|12 Months Follow-up|Overall Study||163
8414397|NCT00939107|20738812|P1|12 Months Follow-up|Overall Study||161
8414398|NCT00939107|20738811|P2|STARTED|Overall Study||175
8414399|NCT00939107|20738812|P1|STARTED|Overall Study||175
8414400|NCT00939094|20738826|P2|NOT COMPLETED|Overall Study||10
8414401|NCT00939094|20738827|P1|NOT COMPLETED|Overall Study||14
8414402|NCT00939094|20738826|P2|COMPLETED|Overall Study||35
8414403|NCT00939094|20738827|P1|COMPLETED|Overall Study||28
8414404|NCT00939094|20738826|P2|STARTED|Overall Study||45
8414405|NCT00939094|20738827|P1|STARTED|Overall Study||42
8414406|NCT00939055|20738849|P2|NOT COMPLETED|Overall Study||0
8414407|NCT00939055|20738850|P1|NOT COMPLETED|Overall Study||4
8414408|NCT00939055|20738849|P2|COMPLETED|Overall Study||39
8414409|NCT00939055|20738850|P1|COMPLETED|Overall Study||69
8414410|NCT00939055|20738849|P2|STARTED|Overall Study||39
8414411|NCT00939055|20738850|P1|STARTED|Overall Study||73
8414412|NCT00939029|20738860|P2|NOT COMPLETED|Overall Study||12
8414413|NCT00939029|20738861|P1|NOT COMPLETED|Overall Study||6
8414414|NCT00939029|20738860|P2|COMPLETED|Overall Study||15
8414415|NCT00939029|20738861|P1|COMPLETED|Overall Study||19
8414416|NCT00939029|20738860|P2|STARTED|Overall Study||27
8414417|NCT00939029|20738861|P1|STARTED|Overall Study||25
8414418|NCT00939003|20738873|P2|NOT COMPLETED|Open-label Treatment Period||29
8414419|NCT00939003|20738874|P1|NOT COMPLETED|Open-label Treatment Period||29
8414420|NCT00939003|20738873|P2|COMPLETED|Open-label Treatment Period||62
8414421|NCT00939003|20738874|P1|COMPLETED|Open-label Treatment Period||66
8414422|NCT00939003|20738873|P2|STARTED|Open-label Treatment Period||91
8414423|NCT00939003|20738874|P1|STARTED|Open-label Treatment Period||95
8414424|NCT00939003|20738873|P2|NOT COMPLETED|Double-blind Treatment Period||4
8414425|NCT00939003|20738874|P1|NOT COMPLETED|Double-blind Treatment Period||2
8414426|NCT00939003|20738873|P2|COMPLETED|Double-blind Treatment Period||91
8414427|NCT00939003|20738874|P1|COMPLETED|Double-blind Treatment Period||95
8414428|NCT00939003|20738873|P2|STARTED|Double-blind Treatment Period||95
8414429|NCT00939003|20738874|P1|STARTED|Double-blind Treatment Period||97
8414430|NCT00938964|20738911|P2|NOT COMPLETED|Overall Study||28
8414431|NCT00938964|20738912|P1|NOT COMPLETED|Overall Study||30
8414432|NCT00938964|20738911|P2|COMPLETED|Overall Study||209
8414433|NCT00938964|20738912|P1|COMPLETED|Overall Study||211
8414434|NCT00938964|20738911|P2|STARTED|Overall Study||237
8414435|NCT00938964|20738912|P1|STARTED|Overall Study||241
8414436|NCT00938886|20738976|P2|NOT COMPLETED|Overall Study||10
8414437|NCT00938886|20738977|P1|NOT COMPLETED|Overall Study||7
8414438|NCT00938886|20738976|P2|COMPLETED|Overall Study||65
8414439|NCT00938886|20738977|P1|COMPLETED|Overall Study||68
8414440|NCT00938886|20738976|P2|Attended 1 Counseling Session|Overall Study||70
8414441|NCT00938886|20738977|P1|Attended 1 Counseling Session|Overall Study||70
8414442|NCT00938886|20738976|P2|STARTED|Overall Study||75
8414443|NCT00938886|20738977|P1|STARTED|Overall Study||75
8414444|NCT00938860|20738987|P2|NOT COMPLETED|Overall Study||17
8414445|NCT00938860|20738988|P1|NOT COMPLETED|Overall Study||25
8414446|NCT00938860|20738987|P2|COMPLETED|Overall Study||25
8414447|NCT00938860|20738988|P1|COMPLETED|Overall Study||25
8414448|NCT00938860|20738987|P2|Efficacy Population|Overall Study||41
8414449|NCT00938860|20738988|P1|Efficacy Population|Overall Study||40
8414450|NCT00938860|20738987|P2|STARTED|Overall Study||42
8414451|NCT00938860|20738988|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
8414452|NCT00938782|20739012|P2|NOT COMPLETED|Overall Study||0
8414453|NCT00938782|20739013|P1|NOT COMPLETED|Overall Study||0
8414454|NCT00938782|20739012|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
8414455|NCT00938782|20739013|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
8414456|NCT00938782|20739012|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
8414457|NCT00938782|20739013|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
8414458|NCT00938717|20739021|P2|NOT COMPLETED|Overall Study||108
8414459|NCT00938717|20739022|P1|NOT COMPLETED|Overall Study||98
8414460|NCT00938717|20739021|P2|COMPLETED|Overall Study||294
8414461|NCT00938717|20739022|P1|COMPLETED|Overall Study||305
8414462|NCT00938717|20739021|P2|STARTED|Overall Study||402
8414463|NCT00938717|20739022|P1|STARTED|Overall Study||403
8414464|NCT00938704|20739056|P2|NOT COMPLETED|Overall Study||0
8414465|NCT00938704|20739057|P1|NOT COMPLETED|Overall Study||0
8414466|NCT00938704|20739056|P2|COMPLETED|Overall Study||37
8414467|NCT00938704|20739057|P1|COMPLETED|Overall Study||33
8414468|NCT00938704|20739056|P2|STARTED|Overall Study||37
8414469|NCT00938704|20739057|P1|STARTED|Overall Study||33
8414470|NCT00938639|20739073|P2|NOT COMPLETED|Overall Study||4
8414471|NCT00938639|20739074|P1|NOT COMPLETED|Overall Study||3
8414472|NCT00938639|20739073|P2|COMPLETED|Overall Study||116
8414473|NCT00938639|20739074|P1|COMPLETED|Overall Study||117
8414474|NCT00938639|20739073|P2|STARTED|Overall Study||120
8414475|NCT00938639|20739074|P1|STARTED|Overall Study||120
8414476|NCT00938548|20739144|P2|NOT COMPLETED|Overall Study||0
8414477|NCT00938548|20739145|P1|NOT COMPLETED|Overall Study||0
8414478|NCT00938548|20739144|P2|COMPLETED|Overall Study||35
8414479|NCT00938548|20739145|P1|COMPLETED|Overall Study||35
8414480|NCT00938548|20739144|P2|STARTED|Overall Study||35
8414481|NCT00938548|20739145|P1|STARTED|Overall Study||35
8414482|NCT00938470|20739157|P2|NOT COMPLETED|Overall Study||3
8414483|NCT00938470|20739158|P1|NOT COMPLETED|Overall Study||7
8414484|NCT00938470|20739157|P2|COMPLETED|Overall Study||25
8414485|NCT00938470|20739158|P1|COMPLETED|Overall Study||27
8414486|NCT00938470|20739157|P2|STARTED|Overall Study||28
8414487|NCT00938470|20739158|P1|STARTED|Overall Study||34
8414488|NCT00938457|20739172|P1|NOT COMPLETED|Overall Study||0
8414489|NCT00938457|20739172|P1|COMPLETED|Overall Study||3
8414490|NCT00938457|20739172|P1|STARTED|Overall Study||3
8414491|NCT00938431|20739188|P3|NOT COMPLETED|Overall Study||8
8414492|NCT00938431|20739189|P2|NOT COMPLETED|Overall Study||9
8414493|NCT00938431|20739190|P1|NOT COMPLETED|Overall Study||6
8414494|NCT00938431|20739188|P3|COMPLETED|Overall Study||1
8414495|NCT00938431|20739189|P2|COMPLETED|Overall Study||14
8414496|NCT00938431|20739190|P1|COMPLETED|Overall Study||9
8414497|NCT00938431|20739188|P3|STARTED|Overall Study||9
8414498|NCT00938431|20739189|P2|STARTED|Overall Study||23
8414499|NCT00938431|20739190|P1|STARTED|Overall Study||15
8414500|NCT00938392|20739217|P2|NOT COMPLETED|Overall Study||4
8414501|NCT00938392|20739218|P1|NOT COMPLETED|Overall Study||2
8414502|NCT00938392|20739217|P2|COMPLETED|Overall Study||358
8414503|NCT00938392|20739218|P1|COMPLETED|Overall Study||360
8414504|NCT00938392|20739217|P2|STARTED|Overall Study||362
8414505|NCT00938392|20739218|P1|STARTED|Overall Study||362
8414506|NCT00938366|20739244|P2|NOT COMPLETED|Overall Study||0
8414507|NCT00938366|20739245|P1|NOT COMPLETED|Overall Study||1
8414508|NCT00938366|20739244|P2|COMPLETED|Overall Study||9
8414509|NCT00938366|20739245|P1|COMPLETED|Overall Study||8
8414510|NCT00938366|20739244|P2|STARTED|Overall Study||9
8414511|NCT00938366|20739245|P1|STARTED|Overall Study||9
8414512|NCT00938340|20739265|P1|NOT COMPLETED|Overall Study||5
8414513|NCT00938340|20739265|P1|COMPLETED|Overall Study||15
8414514|NCT00938340|20739265|P1|Received Walnut Oil Intervention|Overall Study||15
8414515|NCT00938340|20739265|P1|Received Walnut Skins Intervention|Overall Study||15
8414516|NCT00938340|20739265|P1|Received Walnut Nutmeat Intervention|Overall Study||19
8414517|NCT00938340|20739265|P1|Received Whole Walnut Intervention|Overall Study||16
8414518|NCT00938340|20739265|P1|STARTED|Overall Study||20
8414519|NCT00938327|20739395|P1|NOT COMPLETED|Overall Study||60
8414520|NCT00938327|20739395|P1|COMPLETED|Overall Study||272
8414521|NCT00938327|20739395|P1|STARTED|Overall Study||332
8414522|NCT00938314|20739406|P4|NOT COMPLETED|Cohort 3||1
8414523|NCT00938314|20739407|P3|NOT COMPLETED|Cohort 3||4
8414524|NCT00938314|20739408|P2|NOT COMPLETED|Cohort 3||0
8414525|NCT00938314|20739409|P1|NOT COMPLETED|Cohort 3||0
8414526|NCT00938314|20739406|P4|COMPLETED|Cohort 3||7
8414527|NCT00938314|20739407|P3|COMPLETED|Cohort 3||20
8414528|NCT00938314|20739408|P2|COMPLETED|Cohort 3||0
8414529|NCT00938314|20739409|P1|COMPLETED|Cohort 3||0
8414530|NCT00938314|20739406|P4|STARTED|Cohort 3||8
8414531|NCT00938314|20739407|P3|STARTED|Cohort 3||24
8414532|NCT00938314|20739408|P2|STARTED|Cohort 3||0
8414533|NCT00938314|20739409|P1|STARTED|Cohort 3||0
8414534|NCT00938314|20739406|P4|NOT COMPLETED|Cohort 2||2
8414535|NCT00938314|20739407|P3|NOT COMPLETED|Cohort 2||0
8414536|NCT00938314|20739408|P2|NOT COMPLETED|Cohort 2||6
8414537|NCT00938314|20739409|P1|NOT COMPLETED|Cohort 2||0
8414538|NCT00938314|20739406|P4|COMPLETED|Cohort 2||6
8414539|NCT00938314|20739407|P3|COMPLETED|Cohort 2||0
8414540|NCT00938314|20739408|P2|COMPLETED|Cohort 2||18
8414541|NCT00938314|20739409|P1|COMPLETED|Cohort 2||0
8414542|NCT00938314|20739406|P4|STARTED|Cohort 2||8
8414543|NCT00938314|20739407|P3|STARTED|Cohort 2||0
8414544|NCT00938314|20739408|P2|STARTED|Cohort 2||24
8414545|NCT00938314|20739409|P1|STARTED|Cohort 2||0
8414546|NCT00938314|20739406|P4|NOT COMPLETED|Cohort 1||2
8414547|NCT00938314|20739407|P3|NOT COMPLETED|Cohort 1||0
8414548|NCT00938314|20739408|P2|NOT COMPLETED|Cohort 1||0
8414549|NCT00938314|20739409|P1|NOT COMPLETED|Cohort 1||2
8414550|NCT00938314|20739406|P4|COMPLETED|Cohort 1||6
8414551|NCT00938314|20739407|P3|COMPLETED|Cohort 1||0
8414552|NCT00938314|20739408|P2|COMPLETED|Cohort 1||0
8414553|NCT00938314|20739409|P1|COMPLETED|Cohort 1||22
8414554|NCT00938314|20739406|P4|STARTED|Cohort 1||8
8414555|NCT00938314|20739407|P3|STARTED|Cohort 1||0
8414556|NCT00938314|20739408|P2|STARTED|Cohort 1||0
8414557|NCT00938314|20739409|P1|STARTED|Cohort 1||24
8414558|NCT00938041|20739463|P1|NOT COMPLETED|Overall Study||27
8414559|NCT00938041|20739463|P1|COMPLETED|Overall Study||5
8414560|NCT00938041|20739463|P1|STARTED|Overall Study||32
8414561|NCT00938015|20739472|P1|NOT COMPLETED|Overall Study||147
8414562|NCT00938015|20739472|P1|COMPLETED|Overall Study||156
8414563|NCT00938015|20739472|P1|STARTED|Overall Study||303
8414564|NCT00937950|20739488|P1|NOT COMPLETED|Overall Study||216
8414565|NCT00937950|20739488|P1|COMPLETED|Overall Study||1787
8414566|NCT00937950|20739488|P1|STARTED|Overall Study||2003
8414567|NCT00937937|20739504|P1|NOT COMPLETED|Overall Study||72
8414568|NCT00937937|20739504|P1|COMPLETED|Overall Study||0
8414569|NCT00937937|20739504|P1|STARTED|Overall Study||72
8414570|NCT00937859|20739513|P2|NOT COMPLETED|Overall Study||19
8414571|NCT00937859|20739514|P1|NOT COMPLETED|Overall Study||19
8414572|NCT00937859|20739513|P2|COMPLETED|Overall Study||134
8414573|NCT00937859|20739514|P1|COMPLETED|Overall Study||129
8414574|NCT00937859|20739513|P2|STARTED|Overall Study||153
8414575|NCT00937859|20739514|P1|STARTED|Overall Study||148
8414576|NCT00937833|20739524|P2|NOT COMPLETED|Overall Study||17
8414577|NCT00937833|20739525|P1|NOT COMPLETED|Overall Study||15
8414578|NCT00937833|20739524|P2|COMPLETED|Overall Study||60
8414579|NCT00937833|20739525|P1|COMPLETED|Overall Study||58
8414580|NCT00937833|20739524|P2|STARTED|Overall Study||77
8414581|NCT00937833|20739525|P1|STARTED|Overall Study||73
8414582|NCT00937794|20739531|P1|NOT COMPLETED|Overall Study||0
8414583|NCT00937794|20739531|P1|COMPLETED|Overall Study||33
8414584|NCT00937794|20739531|P1|STARTED|Overall Study||33
8414585|NCT00937768|20739538|P2|NOT COMPLETED|Overall Study||8
8414586|NCT00937768|20739539|P1|NOT COMPLETED|Overall Study||8
8414587|NCT00937768|20739538|P2|COMPLETED|Overall Study||0
8414588|NCT00937768|20739539|P1|COMPLETED|Overall Study||0
8414589|NCT00937768|20739538|P2|STARTED|Overall Study||8
8414590|NCT00937768|20739539|P1|STARTED|Overall Study||8
8414591|NCT00937560|20739559|P1|NOT COMPLETED|Maintenance Treatment||18
8414592|NCT00937560|20739559|P1|COMPLETED|Maintenance Treatment||150
8414593|NCT00937560|20739559|P1|STARTED|Maintenance Treatment||168
8414594|NCT00937560|20739559|P1|NOT COMPLETED|Initial Treatment||21
8414595|NCT00937560|20739559|P1|COMPLETED|Initial Treatment||168
8414596|NCT00937560|20739559|P1|Received Treatment|Initial Treatment||189
8414597|NCT00937560|20739559|P1|STARTED|Initial Treatment||189
8414598|NCT00937547|20739570|P3|NOT COMPLETED|Overall Study||7
8414599|NCT00937547|20739571|P2|NOT COMPLETED|Overall Study||6
8414600|NCT00937547|20739572|P1|NOT COMPLETED|Overall Study||1
8414601|NCT00937547|20739570|P3|COMPLETED|Overall Study||142
8414602|NCT00937547|20739571|P2|COMPLETED|Overall Study||78
8414603|NCT00937547|20739572|P1|COMPLETED|Overall Study||95
8414604|NCT00937547|20739570|P3|Histological Samples|Overall Study||142
8414605|NCT00937547|20739571|P2|Histological Samples|Overall Study||78
8414606|NCT00937547|20739572|P1|Histological Samples|Overall Study||95
8414607|NCT00937547|20739570|P3|STARTED|Overall Study||149
8414608|NCT00937547|20739571|P2|STARTED|Overall Study||84
8414609|NCT00937547|20739572|P1|STARTED|Overall Study||96
8414610|NCT00937521|20739609|P8|NOT COMPLETED|Booster Phase||2
8414611|NCT00937521|20739610|P7|NOT COMPLETED|Booster Phase||5
8414612|NCT00937521|20739611|P6|NOT COMPLETED|Booster Phase||5
8414613|NCT00937521|20739612|P5|NOT COMPLETED|Booster Phase||5
8414614|NCT00937521|20739613|P4|NOT COMPLETED|Booster Phase||3
8414615|NCT00937521|20739614|P3|NOT COMPLETED|Booster Phase||5
8414616|NCT00937521|20739615|P2|NOT COMPLETED|Booster Phase||2
8414617|NCT00937521|20739616|P1|NOT COMPLETED|Booster Phase||3
8414618|NCT00937521|20739609|P8|COMPLETED|Booster Phase||159
8414619|NCT00937521|20739610|P7|COMPLETED|Booster Phase||160
8414620|NCT00937521|20739611|P6|COMPLETED|Booster Phase||160
8414621|NCT00937521|20739612|P5|COMPLETED|Booster Phase||163
8414622|NCT00937521|20739613|P4|COMPLETED|Booster Phase||167
8414623|NCT00937521|20739614|P3|COMPLETED|Booster Phase||164
8414624|NCT00937521|20739615|P2|COMPLETED|Booster Phase||161
8414625|NCT00937521|20739616|P1|COMPLETED|Booster Phase||152
8414626|NCT00937521|20739609|P8|Premature Withdrawal|Booster Phase||2
8414627|NCT00937521|20739610|P7|Premature Withdrawal|Booster Phase||5
8414628|NCT00937521|20739611|P6|Premature Withdrawal|Booster Phase||5
8414629|NCT00937521|20739612|P5|Premature Withdrawal|Booster Phase||5
8414630|NCT00937521|20739613|P4|Premature Withdrawal|Booster Phase||3
8414631|NCT00937521|20739614|P3|Premature Withdrawal|Booster Phase||5
8414632|NCT00937521|20739615|P2|Premature Withdrawal|Booster Phase||2
8414633|NCT00937521|20739616|P1|Premature Withdrawal|Booster Phase||3
8414634|NCT00937521|20739609|P8|STARTED|Booster Phase||161
8414635|NCT00937521|20739610|P7|STARTED|Booster Phase||165
8414636|NCT00937521|20739611|P6|STARTED|Booster Phase||165
8414637|NCT00937521|20739612|P5|STARTED|Booster Phase||168
8414638|NCT00937521|20739613|P4|STARTED|Booster Phase||170
8414639|NCT00937521|20739614|P3|STARTED|Booster Phase||169
8414640|NCT00937521|20739615|P2|STARTED|Booster Phase||163
8414641|NCT00937521|20739616|P1|STARTED|Booster Phase||155
8414642|NCT00937521|20739609|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8414643|NCT00937521|20739610|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
8414644|NCT00937521|20739611|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8414645|NCT00937521|20739612|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
8414646|NCT00937521|20739613|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8414647|NCT00937521|20739614|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
8414648|NCT00937521|20739615|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
8414649|NCT00937521|20739616|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
8414650|NCT00937521|20739609|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
8414651|NCT00937521|20739610|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
8414652|NCT00937521|20739611|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
8414653|NCT00937521|20739612|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
8414654|NCT00937521|20739613|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
8414655|NCT00937521|20739614|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
8414656|NCT00937521|20739615|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
8414657|NCT00937521|20739616|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
8414658|NCT00937521|20739609|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8414659|NCT00937521|20739610|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
8414660|NCT00937521|20739611|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8414661|NCT00937521|20739612|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
8414662|NCT00937521|20739613|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8414663|NCT00937521|20739614|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
8414664|NCT00937521|20739615|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
8414665|NCT00937521|20739616|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
8414666|NCT00937521|20739609|P8|STARTED|Overall Study - Prior to Booster Dose||184
8414667|NCT00937521|20739610|P7|STARTED|Overall Study - Prior to Booster Dose||186
8414668|NCT00937521|20739611|P6|STARTED|Overall Study - Prior to Booster Dose||188
8414669|NCT00937521|20739612|P5|STARTED|Overall Study - Prior to Booster Dose||191
8414670|NCT00937521|20739613|P4|STARTED|Overall Study - Prior to Booster Dose||188
8414671|NCT00937521|20739614|P3|STARTED|Overall Study - Prior to Booster Dose||192
8414672|NCT00937521|20739615|P2|STARTED|Overall Study - Prior to Booster Dose||190
8414673|NCT00937521|20739616|P1|STARTED|Overall Study - Prior to Booster Dose||188
8414674|NCT00937495|20739722|P1|NOT COMPLETED|Overall Study||2
8414675|NCT00937495|20739722|P1|COMPLETED|Overall Study||14
8414676|NCT00937495|20739722|P1|STARTED|Overall Study||16
8414677|NCT00937404|20739728|P1|NOT COMPLETED|Overall Study||2
8414678|NCT00937404|20739728|P1|COMPLETED|Overall Study||23
8414679|NCT00937404|20739728|P1|STARTED|Overall Study||25
8414680|NCT00937391|20739737|P1|NOT COMPLETED|Stage 2||1
8414681|NCT00937391|20739737|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
8414682|NCT00937391|20739737|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
8414683|NCT00937391|20739737|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
8414684|NCT00937391|20739737|P1|NOT COMPLETED|Stage 1||0
8414685|NCT00937391|20739737|P1|COMPLETED|Stage 1||20
8414686|NCT00937391|20739737|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
8414687|NCT00937391|20739737|P1|STARTED|Stage 1||20
8414688|NCT00937378|20739790|P2|NOT COMPLETED|Overall Study||18
8414689|NCT00937378|20739791|P1|NOT COMPLETED|Overall Study||18
8414690|NCT00937378|20739790|P2|COMPLETED|Overall Study||141
8414691|NCT00937378|20739791|P1|COMPLETED|Overall Study||149
8414692|NCT00937378|20739790|P2|STARTED|Overall Study||159
8414693|NCT00937378|20739791|P1|STARTED|Overall Study||167
8414694|NCT00937326|20739804|P5|NOT COMPLETED|Overall Study||5
8414695|NCT00937326|20739805|P4|NOT COMPLETED|Overall Study||5
8414696|NCT00937326|20739806|P3|NOT COMPLETED|Overall Study||4
8414697|NCT00937326|20739807|P2|NOT COMPLETED|Overall Study||7
8414698|NCT00937326|20739808|P1|NOT COMPLETED|Overall Study||3
8414699|NCT00937326|20739804|P5|COMPLETED|Overall Study||40
8414700|NCT00937326|20739805|P4|COMPLETED|Overall Study||40
8414701|NCT00937326|20739806|P3|COMPLETED|Overall Study||42
8414702|NCT00937326|20739807|P2|COMPLETED|Overall Study||38
8414703|NCT00937326|20739808|P1|COMPLETED|Overall Study||43
8414704|NCT00937326|20739804|P5|STARTED|Overall Study||45
8414705|NCT00937326|20739805|P4|STARTED|Overall Study||45
8414706|NCT00937326|20739806|P3|STARTED|Overall Study||46
8414707|NCT00937326|20739807|P2|STARTED|Overall Study||45
8414708|NCT00937326|20739808|P1|STARTED|Overall Study||46
8414709|NCT00937235|20740036|P2|NOT COMPLETED|Overall Study||0
8414710|NCT00937235|20740037|P1|NOT COMPLETED|Overall Study||0
8414711|NCT00937235|20740036|P2|COMPLETED|Overall Study||70
8414712|NCT00937235|20740037|P1|COMPLETED|Overall Study||72
8414713|NCT00937235|20740036|P2|STARTED|Overall Study||70
8414714|NCT00937235|20740037|P1|STARTED|Overall Study||72
8414715|NCT00937157|20740057|P1|NOT COMPLETED|Overall Study||4
8414716|NCT00937157|20740057|P1|COMPLETED|Overall Study||8
8414717|NCT00937157|20740057|P1|STARTED|Overall Study||12
8414718|NCT00937118|20740061|P1|NOT COMPLETED|Overall Study||0
8414719|NCT00937118|20740061|P1|COMPLETED|Overall Study||41
8414720|NCT00937118|20740061|P1|STARTED|Overall Study||41
8414721|NCT00937105|20740070|P2|NOT COMPLETED|Overall Study||39
8414722|NCT00937105|20740071|P1|NOT COMPLETED|Overall Study||40
8414723|NCT00937105|20740070|P2|COMPLETED|Overall Study||70
8414724|NCT00937105|20740071|P1|COMPLETED|Overall Study||69
8414725|NCT00937105|20740070|P2|STARTED|Overall Study||109
8414726|NCT00937105|20740071|P1|STARTED|Overall Study||109
8414727|NCT00937040|20740088|P2|NOT COMPLETED|Overall Study||37
8414728|NCT00937040|20740089|P1|NOT COMPLETED|Overall Study||41
8414729|NCT00937040|20740088|P2|COMPLETED|Overall Study||141
8414730|NCT00937040|20740089|P1|COMPLETED|Overall Study||138
8414731|NCT00937040|20740088|P2|STARTED|Overall Study||178
8414732|NCT00937040|20740089|P1|STARTED|Overall Study||179
8414733|NCT00936975|20740131|P1|NOT COMPLETED|Overall Study||6
8414734|NCT00936975|20740131|P1|COMPLETED|Overall Study||12
8414735|NCT00936975|20740131|P1|STARTED|Overall Study||18
8414736|NCT00936910|20740140|P1|NOT COMPLETED|Overall Study||3
8414737|NCT00936910|20740140|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
8414738|NCT00936910|20740140|P1|STARTED|Overall Study||13
8414739|NCT00936897|20740149|P2|NOT COMPLETED|Overall Study||60
8414740|NCT00936897|20740150|P1|NOT COMPLETED|Overall Study||19
8414741|NCT00936897|20740149|P2|COMPLETED|Overall Study||356
8414742|NCT00936897|20740150|P1|COMPLETED|Overall Study||398
8414743|NCT00936897|20740149|P2|STARTED|Overall Study|Randomized|416
8414744|NCT00936897|20740150|P1|STARTED|Overall Study|Randomized|417
8414745|NCT00936884|20740164|P3|NOT COMPLETED|Open-label||19
8414746|NCT00936884|20740165|P2|NOT COMPLETED|Open-label||0
8414747|NCT00936884|20740166|P1|NOT COMPLETED|Open-label||0
8414748|NCT00936884|20740164|P3|COMPLETED|Open-label||12
8414749|NCT00936884|20740165|P2|COMPLETED|Open-label||0
8414750|NCT00936884|20740166|P1|COMPLETED|Open-label||0
8414751|NCT00936884|20740164|P3|STARTED|Open-label||31
8414752|NCT00936884|20740165|P2|STARTED|Open-label||0
8414753|NCT00936884|20740166|P1|STARTED|Open-label||0
8414754|NCT00936884|20740164|P3|NOT COMPLETED|Double-blind||0
8414755|NCT00936884|20740165|P2|NOT COMPLETED|Double-blind||7
8414756|NCT00936884|20740166|P1|NOT COMPLETED|Double-blind||12
8414757|NCT00936884|20740164|P3|COMPLETED|Double-blind||0
8414758|NCT00936884|20740165|P2|COMPLETED|Double-blind||18
8414759|NCT00936884|20740166|P1|COMPLETED|Double-blind||13
8414760|NCT00936884|20740164|P3|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
8414761|NCT00936884|20740165|P2|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
8414762|NCT00936884|20740166|P1|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
8414763|NCT00936741|20740177|P1|NOT COMPLETED|Overall Study||9
8414764|NCT00936741|20740177|P1|COMPLETED|Overall Study||21
8414765|NCT00936741|20740177|P1|STARTED|Overall Study||30
8414766|NCT00936715|20740182|P1|NOT COMPLETED|Overall Study||6
8414767|NCT00936715|20740182|P1|COMPLETED|Overall Study||18
8414768|NCT00936715|20740182|P1|STARTED|Overall Study||24
8414769|NCT00936702|20740186|P1|NOT COMPLETED|Overall Study||46
8414770|NCT00936702|20740186|P1|COMPLETED|Overall Study||0
8414771|NCT00936702|20740186|P1|STARTED|Overall Study||46
8414772|NCT00936663|20740196|P2|NOT COMPLETED|Overall Study||0
8414773|NCT00936663|20740197|P1|NOT COMPLETED|Overall Study||0
8414774|NCT00936663|20740196|P2|COMPLETED|Overall Study||2
8414775|NCT00936663|20740197|P1|COMPLETED|Overall Study||1
8414776|NCT00936663|20740196|P2|STARTED|Overall Study||2
8414777|NCT00936663|20740197|P1|STARTED|Overall Study||1
8414778|NCT00936598|20740219|P2|NOT COMPLETED|Overall Study||0
8414779|NCT00936598|20740220|P1|NOT COMPLETED|Overall Study||2
8414780|NCT00936598|20740219|P2|COMPLETED|Overall Study||1
8414781|NCT00936598|20740220|P1|COMPLETED|Overall Study||2
8414782|NCT00936598|20740219|P2|STARTED|Overall Study||1
8414783|NCT00936598|20740220|P1|STARTED|Overall Study||4
8414784|NCT00936585|20740230|P1|NOT COMPLETED|Overall Study||0
8414785|NCT00936585|20740230|P1|COMPLETED|Overall Study||2
8414786|NCT00936585|20740230|P1|STARTED|Overall Study||2
8414787|NCT00936481|20740236|P2|NOT COMPLETED|Overall Study||0
8414788|NCT00936481|20740237|P1|NOT COMPLETED|Overall Study||0
8414789|NCT00936481|20740236|P2|COMPLETED|Overall Study||17
8414790|NCT00936481|20740237|P1|COMPLETED|Overall Study||17
8414791|NCT00936481|20740236|P2|STARTED|Overall Study||17
8414792|NCT00936481|20740237|P1|STARTED|Overall Study||17
8414793|NCT00936455|20740247|P2|NOT COMPLETED|Overall Study||0
8414794|NCT00936455|20740248|P1|NOT COMPLETED|Overall Study||0
8414795|NCT00936455|20740247|P2|COMPLETED|Overall Study||38
8414796|NCT00936455|20740248|P1|COMPLETED|Overall Study||37
8414797|NCT00936455|20740247|P2|STARTED|Overall Study||38
8414798|NCT00936455|20740248|P1|STARTED|Overall Study||37
8414799|NCT00936377|20740263|P3|NOT COMPLETED|Overall Study||0
8414800|NCT00936377|20740264|P2|NOT COMPLETED|Overall Study||0
8414801|NCT00936377|20740265|P1|NOT COMPLETED|Overall Study||0
8414802|NCT00936377|20740263|P3|COMPLETED|Overall Study||8
8414803|NCT00936377|20740264|P2|COMPLETED|Overall Study||8
8414804|NCT00936377|20740265|P1|COMPLETED|Overall Study||8
8414805|NCT00936377|20740263|P3|STARTED|Overall Study||8
8414806|NCT00936377|20740264|P2|STARTED|Overall Study||8
8414807|NCT00936377|20740265|P1|STARTED|Overall Study||8
8414808|NCT00936351|20740296|P2|NOT COMPLETED|Overall Study||2
8414809|NCT00936351|20740297|P1|NOT COMPLETED|Overall Study||3
8414810|NCT00936351|20740296|P2|COMPLETED|Overall Study||14
8414811|NCT00936351|20740297|P1|COMPLETED|Overall Study||15
8414812|NCT00936351|20740296|P2|STARTED|Overall Study||16
8414813|NCT00936351|20740297|P1|STARTED|Overall Study||18
8414814|NCT00936299|20740309|P2|NOT COMPLETED|Overall Study||12
8414815|NCT00936299|20740310|P1|NOT COMPLETED|Overall Study||13
8414816|NCT00936299|20740309|P2|COMPLETED|Overall Study||40
8414817|NCT00936299|20740310|P1|COMPLETED|Overall Study||40
8414818|NCT00936299|20740309|P2|STARTED|Overall Study||52
8414819|NCT00936299|20740310|P1|STARTED|Overall Study||53
8414820|NCT00936221|20740322|P2|NOT COMPLETED|Overall Study||1
8414821|NCT00936221|20740323|P1|NOT COMPLETED|Overall Study||1
8414822|NCT00936221|20740322|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
8414823|NCT00936221|20740323|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
8414824|NCT00936221|20740322|P2|Received Treatment|Overall Study||45
8414825|NCT00936221|20740323|P1|Received Treatment|Overall Study||44
8414826|NCT00936221|20740322|P2|STARTED|Overall Study||46
8414827|NCT00936221|20740323|P1|STARTED|Overall Study||45
8414828|NCT00936208|20740337|P2|NOT COMPLETED|Overall Study||22
8414829|NCT00936208|20740338|P1|NOT COMPLETED|Overall Study||37
8414830|NCT00936208|20740337|P2|COMPLETED|Overall Study||1574
8414831|NCT00936208|20740338|P1|COMPLETED|Overall Study||1462
8414832|NCT00936208|20740337|P2|STARTED|Overall Study||1596
8414833|NCT00936208|20740338|P1|STARTED|Overall Study||1499
8414834|NCT00936117|20740356|P1|NOT COMPLETED|Overall Study||10
8414835|NCT00936117|20740356|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
8414836|NCT00936117|20740356|P1|STARTED|Overall Study||20
8414837|NCT00936065|20740364|P3|NOT COMPLETED|Overall Study||7
8414838|NCT00936065|20740365|P2|NOT COMPLETED|Overall Study||4
8414839|NCT00936065|20740366|P1|NOT COMPLETED|Overall Study||4
8414840|NCT00936065|20740364|P3|COMPLETED|Overall Study||12
8414841|NCT00936065|20740365|P2|COMPLETED|Overall Study||16
8414842|NCT00936065|20740366|P1|COMPLETED|Overall Study||17
8414843|NCT00936065|20740364|P3|Study Assessments Performed|Overall Study||18
8414844|NCT00936065|20740365|P2|Study Assessments Performed|Overall Study||19
8414845|NCT00936065|20740366|P1|Study Assessments Performed|Overall Study||21
8414846|NCT00936065|20740364|P3|Received Treatment|Overall Study||18
8414847|NCT00936065|20740365|P2|Received Treatment|Overall Study||20
8414848|NCT00936065|20740366|P1|Received Treatment|Overall Study||21
8414849|NCT00936065|20740364|P3|STARTED|Overall Study||19
8414850|NCT00936065|20740365|P2|STARTED|Overall Study||20
8414851|NCT00936065|20740366|P1|STARTED|Overall Study||21
8414852|NCT00935883|20740472|P2|NOT COMPLETED|Follow-Up Period||0
8414853|NCT00935883|20740473|P1|NOT COMPLETED|Follow-Up Period||0
8414854|NCT00935883|20740472|P2|COMPLETED|Follow-Up Period||38
8414855|NCT00935883|20740473|P1|COMPLETED|Follow-Up Period||19
8414856|NCT00935883|20740472|P2|STARTED|Follow-Up Period||38
8414857|NCT00935883|20740473|P1|STARTED|Follow-Up Period||19
8414858|NCT00935883|20740472|P2|NOT COMPLETED|Treatment Period||2
8414859|NCT00935883|20740473|P1|NOT COMPLETED|Treatment Period||1
8414860|NCT00935883|20740472|P2|COMPLETED|Treatment Period||38
8414861|NCT00935883|20740473|P1|COMPLETED|Treatment Period||19
8414862|NCT00935883|20740472|P2|STARTED|Treatment Period||40
8414863|NCT00935883|20740473|P1|STARTED|Treatment Period||20
8414864|NCT00935857|20740487|P2|NOT COMPLETED|Overall Study||0
8414865|NCT00935857|20740488|P1|NOT COMPLETED|Overall Study||0
8414866|NCT00935857|20740487|P2|COMPLETED|Overall Study||16
8414867|NCT00935857|20740488|P1|COMPLETED|Overall Study||14
8414868|NCT00935857|20740487|P2|STARTED|Overall Study||16
8414869|NCT00935857|20740488|P1|STARTED|Overall Study||14
8414870|NCT00935818|20740500|P2|NOT COMPLETED|Overall Study||100
8414871|NCT00935818|20740501|P1|NOT COMPLETED|Overall Study||91
8414872|NCT00935818|20740500|P2|COMPLETED|Overall Study||157
8414873|NCT00935818|20740501|P1|COMPLETED|Overall Study||158
8414874|NCT00935818|20740500|P2|End of Medication Phase|Overall Study||184
8414875|NCT00935818|20740501|P1|End of Medication Phase|Overall Study||182
8414876|NCT00935818|20740500|P2|STARTED|Overall Study||257
8414877|NCT00935818|20740501|P1|STARTED|Overall Study||249
8414878|NCT00935792|20740522|P3|NOT COMPLETED|Overall Study||0
8414879|NCT00935792|20740523|P2|NOT COMPLETED|Overall Study||3
8414880|NCT00935792|20740524|P1|NOT COMPLETED|Overall Study||1
8414881|NCT00935792|20740522|P3|COMPLETED|Overall Study||12
8414882|NCT00935792|20740523|P2|COMPLETED|Overall Study||6
8414883|NCT00935792|20740524|P1|COMPLETED|Overall Study||6
8414884|NCT00935792|20740522|P3|STARTED|Overall Study||12
8414885|NCT00935792|20740523|P2|STARTED|Overall Study||9
8414886|NCT00935792|20740524|P1|STARTED|Overall Study||7
8414887|NCT00935766|20740541|P2|NOT COMPLETED|Overall Study||7
8414888|NCT00935766|20740542|P1|NOT COMPLETED|Overall Study||7
8414889|NCT00935766|20740541|P2|COMPLETED|Overall Study||27
8414890|NCT00935766|20740542|P1|COMPLETED|Overall Study||35
8414891|NCT00935766|20740541|P2|STARTED|Overall Study||34
8414892|NCT00935766|20740542|P1|STARTED|Overall Study||42
8414893|NCT00935701|20740552|P1|NOT COMPLETED|Overall Study||1
8414894|NCT00935701|20740552|P1|COMPLETED|Overall Study||9
8414895|NCT00935701|20740552|P1|Transition Acupressure to Acupuncture|Overall Study||9
8414896|NCT00935701|20740552|P1|STARTED|Overall Study||10
8414897|NCT00935649|20740559|P1|NOT COMPLETED|Overall Study||5
8414898|NCT00935649|20740559|P1|COMPLETED|Overall Study||134
8414899|NCT00935649|20740559|P1|STARTED|Overall Study||139
8414900|NCT00935584|20740569|P2|NOT COMPLETED|Overall Study||4
8414901|NCT00935584|20740570|P1|NOT COMPLETED|Overall Study||49
8414902|NCT00935584|20740569|P2|COMPLETED|Overall Study||19
8414903|NCT00935584|20740570|P1|COMPLETED|Overall Study||77
8414904|NCT00935584|20740569|P2|STARTED|Overall Study||23
8414905|NCT00935584|20740570|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
8414906|NCT00935532|20740582|P2|NOT COMPLETED|Overall Study||11
8414907|NCT00935532|20740583|P1|NOT COMPLETED|Overall Study||22
8414908|NCT00935532|20740582|P2|COMPLETED|Overall Study||201
8414909|NCT00935532|20740583|P1|COMPLETED|Overall Study||193
8414910|NCT00935532|20740582|P2|STARTED|Overall Study||212
8414911|NCT00935532|20740583|P1|STARTED|Overall Study||215
8414912|NCT00935493|20740612|P3|NOT COMPLETED|Overall Study||1
8414913|NCT00935493|20740613|P2|NOT COMPLETED|Overall Study||2
8414914|NCT00935493|20740614|P1|NOT COMPLETED|Overall Study||1
8414915|NCT00935493|20740612|P3|COMPLETED|Overall Study||40
8414916|NCT00935493|20740613|P2|COMPLETED|Overall Study||39
8414917|NCT00935493|20740614|P1|COMPLETED|Overall Study||40
8414918|NCT00935493|20740612|P3|STARTED|Overall Study||41
8414919|NCT00935493|20740613|P2|STARTED|Overall Study||41
8414920|NCT00935493|20740614|P1|STARTED|Overall Study||41
8414921|NCT00935428|20740628|P1|NOT COMPLETED|Overall Study||0
8414922|NCT00935428|20740628|P1|COMPLETED|Overall Study||231
8414923|NCT00935428|20740628|P1|STARTED|Overall Study||231
8414924|NCT00935311|20740642|P3|NOT COMPLETED|Overall Study||0
8414925|NCT00935311|20740643|P2|NOT COMPLETED|Overall Study||0
8414926|NCT00935311|20740644|P1|NOT COMPLETED|Overall Study||0
8414927|NCT00935311|20740642|P3|COMPLETED|Overall Study||40
8414928|NCT00935311|20740643|P2|COMPLETED|Overall Study||39
8414929|NCT00935311|20740644|P1|COMPLETED|Overall Study||43
8414930|NCT00935311|20740642|P3|STARTED|Overall Study||40
8414931|NCT00935311|20740643|P2|STARTED|Overall Study||39
8414932|NCT00935311|20740644|P1|STARTED|Overall Study||43
8414933|NCT00935272|20740663|P2|NOT COMPLETED|Overall Study||6
8414934|NCT00935272|20740664|P1|NOT COMPLETED|Overall Study||19
8414935|NCT00935272|20740663|P2|COMPLETED|Overall Study||39
8414936|NCT00935272|20740664|P1|COMPLETED|Overall Study||116
8414937|NCT00935272|20740663|P2|STARTED|Overall Study||45
8414938|NCT00935272|20740664|P1|STARTED|Overall Study||135
8414939|NCT00935259|20740673|P2|NOT COMPLETED|Period 2||0
8414940|NCT00935259|20740674|P1|NOT COMPLETED|Period 2||0
8414941|NCT00935259|20740673|P2|COMPLETED|Period 2||14
8414942|NCT00935259|20740674|P1|COMPLETED|Period 2||15
8414943|NCT00935259|20740673|P2|STARTED|Period 2||14
8414944|NCT00935259|20740674|P1|STARTED|Period 2||15
8414945|NCT00935259|20740673|P2|NOT COMPLETED|Period 1||1
8414946|NCT00935259|20740674|P1|NOT COMPLETED|Period 1||1
8414947|NCT00935259|20740673|P2|COMPLETED|Period 1||14
8414948|NCT00935259|20740674|P1|COMPLETED|Period 1||15
8414949|NCT00935259|20740673|P2|STARTED|Period 1||15
8414950|NCT00935259|20740674|P1|STARTED|Period 1||16
8414951|NCT00935220|20740688|P1|NOT COMPLETED|Overall Study||2
8414952|NCT00935220|20740688|P1|COMPLETED|Overall Study||39
8414953|NCT00935220|20740688|P1|STARTED|Overall Study||41
8414954|NCT00935064|20740702|P2|NOT COMPLETED|Overall Study||0
8414955|NCT00935064|20740703|P1|NOT COMPLETED|Overall Study||0
8414956|NCT00935064|20740702|P2|COMPLETED|Overall Study||30
8414957|NCT00935064|20740703|P1|COMPLETED|Overall Study||30
8414958|NCT00935064|20740702|P2|STARTED|Overall Study||30
8414959|NCT00935064|20740703|P1|STARTED|Overall Study||30
8414960|NCT00935012|20740717|P1|NOT COMPLETED|Overall Study||29
8414961|NCT00935012|20740717|P1|COMPLETED|Overall Study||2
8414962|NCT00935012|20740717|P1|STARTED|Overall Study||31
8414963|NCT00934947|20740759|P2|NOT COMPLETED|Overall Study||2
8414964|NCT00934947|20740760|P1|NOT COMPLETED|Overall Study||0
8414965|NCT00934947|20740759|P2|COMPLETED|Overall Study||20
8414966|NCT00934947|20740760|P1|COMPLETED|Overall Study||23
8414967|NCT00934947|20740759|P2|STARTED|Overall Study||22
8414968|NCT00934947|20740760|P1|STARTED|Overall Study||23
8414969|NCT00934921|20740774|P2|NOT COMPLETED|Second Intervention||0
8414970|NCT00934921|20740775|P1|NOT COMPLETED|Second Intervention||0
8414971|NCT00934921|20740774|P2|COMPLETED|Second Intervention||12
8414972|NCT00934921|20740775|P1|COMPLETED|Second Intervention||12
8414973|NCT00934921|20740774|P2|STARTED|Second Intervention||12
8414974|NCT00934921|20740775|P1|STARTED|Second Intervention||12
8414975|NCT00934921|20740774|P2|NOT COMPLETED|First Intervention||0
8414976|NCT00934921|20740775|P1|NOT COMPLETED|First Intervention||0
8414977|NCT00934921|20740774|P2|COMPLETED|First Intervention||12
8414978|NCT00934921|20740775|P1|COMPLETED|First Intervention||12
8414979|NCT00934921|20740774|P2|STARTED|First Intervention||12
8414980|NCT00934921|20740775|P1|STARTED|First Intervention||12
8414981|NCT00934856|20740789|P6|NOT COMPLETED|Extension Part||5
8414982|NCT00934856|20740790|P5|NOT COMPLETED|Extension Part||4
8414983|NCT00934856|20740791|P4|NOT COMPLETED|Extension Part||2
8414984|NCT00934856|20740792|P3|NOT COMPLETED|Extension Part||0
8414985|NCT00934856|20740793|P2|NOT COMPLETED|Extension Part||0
8414986|NCT00934856|20740794|P1|NOT COMPLETED|Extension Part||0
8414987|NCT00934856|20740789|P6|COMPLETED|Extension Part||19
8414988|NCT00934856|20740790|P5|COMPLETED|Extension Part||24
8414989|NCT00934856|20740791|P4|COMPLETED|Extension Part||2
8414990|NCT00934856|20740792|P3|COMPLETED|Extension Part||0
8414991|NCT00934856|20740793|P2|COMPLETED|Extension Part||0
8414992|NCT00934856|20740794|P1|COMPLETED|Extension Part||0
8414993|NCT00934856|20740789|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
8414994|NCT00934856|20740790|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
8414995|NCT00934856|20740791|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
8414996|NCT00934856|20740792|P3|STARTED|Extension Part||0
8414997|NCT00934856|20740793|P2|STARTED|Extension Part||0
8414998|NCT00934856|20740794|P1|STARTED|Extension Part||0
8414999|NCT00934856|20740789|P6|NOT COMPLETED|Feasibility Part||3
8415000|NCT00934856|20740790|P5|NOT COMPLETED|Feasibility Part||0
8415001|NCT00934856|20740791|P4|NOT COMPLETED|Feasibility Part||5
8415002|NCT00934856|20740792|P3|NOT COMPLETED|Feasibility Part||3
8415003|NCT00934856|20740793|P2|NOT COMPLETED|Feasibility Part||5
8415004|NCT00934856|20740794|P1|NOT COMPLETED|Feasibility Part||5
8415005|NCT00934856|20740789|P6|COMPLETED|Feasibility Part||6
8415006|NCT00934856|20740790|P5|COMPLETED|Feasibility Part||12
8415007|NCT00934856|20740791|P4|COMPLETED|Feasibility Part||1
8415008|NCT00934856|20740792|P3|COMPLETED|Feasibility Part||0
8415009|NCT00934856|20740793|P2|COMPLETED|Feasibility Part||1
8415010|NCT00934856|20740794|P1|COMPLETED|Feasibility Part||1
8415011|NCT00934856|20740789|P6|STARTED|Feasibility Part||9
8415012|NCT00934856|20740790|P5|STARTED|Feasibility Part||12
8415013|NCT00934856|20740791|P4|STARTED|Feasibility Part||6
8415014|NCT00934856|20740792|P3|STARTED|Feasibility Part||3
8415015|NCT00934856|20740793|P2|STARTED|Feasibility Part||6
8415016|NCT00934856|20740794|P1|STARTED|Feasibility Part||6
8415017|NCT00934843|20740892|P2|NOT COMPLETED|Overall Study||1
8415018|NCT00934843|20740893|P1|NOT COMPLETED|Overall Study||0
8415019|NCT00934843|20740892|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
8415020|NCT00934843|20740893|P1|COMPLETED|Overall Study||37
8415021|NCT00934843|20740892|P2|STARTED|Overall Study||40
8415022|NCT00934843|20740893|P1|STARTED|Overall Study||37
8415023|NCT00934791|20740909|P2|NOT COMPLETED|Overall Study||0
8415024|NCT00934791|20740910|P1|NOT COMPLETED|Overall Study||1
8415025|NCT00934791|20740909|P2|COMPLETED|Overall Study||0
8415026|NCT00934791|20740910|P1|COMPLETED|Overall Study||0
8415027|NCT00934791|20740909|P2|STARTED|Overall Study||0
8415028|NCT00934791|20740910|P1|STARTED|Overall Study||1
8415029|NCT00934661|20740918|P2|NOT COMPLETED|Overall Study||0
8415030|NCT00934661|20740919|P1|NOT COMPLETED|Overall Study||1
8415031|NCT00934661|20740918|P2|COMPLETED|Overall Study||20
8415032|NCT00934661|20740919|P1|COMPLETED|Overall Study||19
8415033|NCT00934661|20740918|P2|STARTED|Overall Study||20
8415034|NCT00934661|20740919|P1|STARTED|Overall Study||20
8415035|NCT00934648|20740939|P1|NOT COMPLETED|Overall Study||9
8415036|NCT00934648|20740939|P1|COMPLETED|Overall Study||6
8415037|NCT00934648|20740939|P1|STARTED|Overall Study||15
8415038|NCT00934635|20740955|P9|NOT COMPLETED|Overall Study||0
8415039|NCT00934635|20740956|P8|NOT COMPLETED|Overall Study||0
8415040|NCT00934635|20740957|P7|NOT COMPLETED|Overall Study||0
8415041|NCT00934635|20740958|P6|NOT COMPLETED|Overall Study||0
8415042|NCT00934635|20740959|P5|NOT COMPLETED|Overall Study||0
8415043|NCT00934635|20740960|P4|NOT COMPLETED|Overall Study||0
8415044|NCT00934635|20740961|P3|NOT COMPLETED|Overall Study||0
8415045|NCT00934635|20740962|P2|NOT COMPLETED|Overall Study||0
8415046|NCT00934635|20740963|P1|NOT COMPLETED|Overall Study||0
8415047|NCT00934635|20740955|P9|COMPLETED|Overall Study||1
8415048|NCT00934635|20740956|P8|COMPLETED|Overall Study||0
8415049|NCT00934635|20740957|P7|COMPLETED|Overall Study||0
8415050|NCT00934635|20740958|P6|COMPLETED|Overall Study||0
8415051|NCT00934635|20740959|P5|COMPLETED|Overall Study||0
8415052|NCT00934635|20740960|P4|COMPLETED|Overall Study||0
8415053|NCT00934635|20740961|P3|COMPLETED|Overall Study||0
8415054|NCT00934635|20740962|P2|COMPLETED|Overall Study||1
8415055|NCT00934635|20740963|P1|COMPLETED|Overall Study||0
8415056|NCT00934635|20740955|P9|STARTED|Overall Study||1
8415057|NCT00934635|20740956|P8|STARTED|Overall Study||0
8415058|NCT00934635|20740957|P7|STARTED|Overall Study||0
8415059|NCT00934635|20740958|P6|STARTED|Overall Study||0
8415060|NCT00934635|20740959|P5|STARTED|Overall Study||0
8415061|NCT00934635|20740960|P4|STARTED|Overall Study||0
8415062|NCT00934635|20740961|P3|STARTED|Overall Study||0
8415063|NCT00934635|20740962|P2|STARTED|Overall Study||1
8415064|NCT00934635|20740963|P1|STARTED|Overall Study||0
8415065|NCT00934622|20740983|P1|NOT COMPLETED|Overall Study||8
8415066|NCT00934622|20740983|P1|COMPLETED|Overall Study||68
8415067|NCT00934622|20740983|P1|STARTED|Overall Study||76
8415068|NCT00934596|20740990|P2|NOT COMPLETED|Overall Study||0
8415069|NCT00934596|20740991|P1|NOT COMPLETED|Overall Study||0
8415070|NCT00934596|20740990|P2|COMPLETED|Overall Study||10
8415071|NCT00934596|20740991|P1|COMPLETED|Overall Study||10
8415072|NCT00934596|20740990|P2|STARTED|Overall Study||10
8415073|NCT00934596|20740991|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
8415074|NCT00934544|20741021|P3|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
8415075|NCT00934544|20741022|P2|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
8415076|NCT00934544|20741023|P1|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
8415077|NCT00934544|20741021|P3|COMPLETED|Overall Disposition at 5 Year Follow-up||11
8415078|NCT00934544|20741022|P2|COMPLETED|Overall Disposition at 5 Year Follow-up||0
8415079|NCT00934544|20741023|P1|COMPLETED|Overall Disposition at 5 Year Follow-up||39
8415080|NCT00934544|20741021|P3|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
8415081|NCT00934544|20741022|P2|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
8415082|NCT00934544|20741023|P1|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
8415083|NCT00934544|20741021|P3|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
8415084|NCT00934544|20741022|P2|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
8415085|NCT00934544|20741023|P1|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
8415086|NCT00934544|20741021|P3|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
8415087|NCT00934544|20741022|P2|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
8415088|NCT00934544|20741023|P1|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
8415089|NCT00934544|20741021|P3|STARTED|Overall Disposition at 5 Year Follow-up||45
8415090|NCT00934544|20741022|P2|STARTED|Overall Disposition at 5 Year Follow-up||28
8415091|NCT00934544|20741023|P1|STARTED|Overall Disposition at 5 Year Follow-up||146
8415092|NCT00934544|20741021|P3|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
8415093|NCT00934544|20741022|P2|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
8415094|NCT00934544|20741023|P1|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
8415095|NCT00934544|20741021|P3|COMPLETED|Primary Endpoint Analysis (Interim)||0
8415096|NCT00934544|20741022|P2|COMPLETED|Primary Endpoint Analysis (Interim)||31
8415097|NCT00934544|20741023|P1|COMPLETED|Primary Endpoint Analysis (Interim)||91
8415098|NCT00934544|20741021|P3|STARTED|Primary Endpoint Analysis (Interim)||0
8415099|NCT00934544|20741022|P2|STARTED|Primary Endpoint Analysis (Interim)||73
8415100|NCT00934544|20741023|P1|STARTED|Primary Endpoint Analysis (Interim)||146
8415101|NCT00934440|20741059|P1|NOT COMPLETED|Overall Study||1
8415102|NCT00934440|20741059|P1|COMPLETED|Overall Study||10
8415103|NCT00934440|20741059|P1|STARTED|Overall Study||11
8415104|NCT00934375|20741066|P2|NOT COMPLETED|Overall Study||22
8415105|NCT00934375|20741067|P1|NOT COMPLETED|Overall Study||13
8415106|NCT00934375|20741066|P2|COMPLETED|Overall Study||55
8415107|NCT00934375|20741067|P1|COMPLETED|Overall Study||55
8415108|NCT00934375|20741066|P2|STARTED|Overall Study||77
8415109|NCT00934375|20741067|P1|STARTED|Overall Study||68
8415110|NCT00934362|20741075|P2|NOT COMPLETED|Overall Study||0
8415111|NCT00934362|20741076|P1|NOT COMPLETED|Overall Study||1
8415112|NCT00934362|20741075|P2|COMPLETED|Overall Study||8
8415113|NCT00934362|20741076|P1|COMPLETED|Overall Study||7
8415114|NCT00934362|20741075|P2|STARTED|Overall Study||8
8415115|NCT00934362|20741076|P1|STARTED|Overall Study||8
8415116|NCT00934180|20741086|P2|NOT COMPLETED|Second Intervention||0
8415117|NCT00934180|20741087|P1|NOT COMPLETED|Second Intervention||0
8415118|NCT00934180|20741086|P2|COMPLETED|Second Intervention||12
8415119|NCT00934180|20741087|P1|COMPLETED|Second Intervention||12
8415120|NCT00934180|20741086|P2|STARTED|Second Intervention||12
8415121|NCT00934180|20741087|P1|STARTED|Second Intervention||12
8415122|NCT00934180|20741086|P2|NOT COMPLETED|First Intervention||0
8415123|NCT00934180|20741087|P1|NOT COMPLETED|First Intervention||0
8415124|NCT00934180|20741086|P2|COMPLETED|First Intervention||12
8415125|NCT00934180|20741087|P1|COMPLETED|First Intervention||12
8415126|NCT00934180|20741086|P2|STARTED|First Intervention||12
8415127|NCT00934180|20741087|P1|STARTED|First Intervention||12
8415128|NCT00934141|20741099|P4|NOT COMPLETED|Overall Study||3
8415129|NCT00934141|20741100|P3|NOT COMPLETED|Overall Study||0
8415130|NCT00934141|20741101|P2|NOT COMPLETED|Overall Study||3
8415131|NCT00934141|20741102|P1|NOT COMPLETED|Overall Study||4
8415132|NCT00934141|20741099|P4|COMPLETED|Overall Study||51
8415133|NCT00934141|20741100|P3|COMPLETED|Overall Study||48
8415134|NCT00934141|20741101|P2|COMPLETED|Overall Study||47
8415135|NCT00934141|20741102|P1|COMPLETED|Overall Study||45
8415136|NCT00934141|20741099|P4|STARTED|Overall Study||54
8415137|NCT00934141|20741100|P3|STARTED|Overall Study||48
8415138|NCT00934141|20741101|P2|STARTED|Overall Study||50
8415139|NCT00934141|20741102|P1|STARTED|Overall Study||49
8415140|NCT00934128|20741126|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
8415141|NCT00934128|20741127|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
8415142|NCT00934128|20741126|P2|COMPLETED|Second Intervention (2 Hours)||5
8415143|NCT00934128|20741127|P1|COMPLETED|Second Intervention (2 Hours)||3
8415144|NCT00934128|20741126|P2|STARTED|Second Intervention (2 Hours)||8
8415145|NCT00934128|20741127|P1|STARTED|Second Intervention (2 Hours)||3
8415146|NCT00934128|20741126|P2|NOT COMPLETED|Washout Period (1 Hour)||5
8415147|NCT00934128|20741127|P1|NOT COMPLETED|Washout Period (1 Hour)||7
8415148|NCT00934128|20741126|P2|COMPLETED|Washout Period (1 Hour)||8
8415149|NCT00934128|20741127|P1|COMPLETED|Washout Period (1 Hour)||3
8415150|NCT00934128|20741126|P2|STARTED|Washout Period (1 Hour)||13
8415151|NCT00934128|20741127|P1|STARTED|Washout Period (1 Hour)||10
8415152|NCT00934128|20741126|P2|NOT COMPLETED|First Intervention (2 Hours)||2
8415153|NCT00934128|20741127|P1|NOT COMPLETED|First Intervention (2 Hours)||5
8415154|NCT00934128|20741126|P2|COMPLETED|First Intervention (2 Hours)||13
8415155|NCT00934128|20741127|P1|COMPLETED|First Intervention (2 Hours)||10
8415156|NCT00934128|20741126|P2|STARTED|First Intervention (2 Hours)||15
8415157|NCT00934128|20741127|P1|STARTED|First Intervention (2 Hours)||15
8415158|NCT00934102|20741135|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8415159|NCT00934102|20741136|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8415160|NCT00934102|20741137|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8415161|NCT00934102|20741135|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8415162|NCT00934102|20741136|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8415163|NCT00934102|20741137|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8415164|NCT00934102|20741135|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8415165|NCT00934102|20741136|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8415166|NCT00934102|20741137|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8415167|NCT00934102|20741135|P3|NOT COMPLETED|Period 1, One Night of Wear||0
8415168|NCT00934102|20741136|P2|NOT COMPLETED|Period 1, One Night of Wear||0
8415169|NCT00934102|20741137|P1|NOT COMPLETED|Period 1, One Night of Wear||1
8415170|NCT00934102|20741135|P3|COMPLETED|Period 1, One Night of Wear||15
8415171|NCT00934102|20741136|P2|COMPLETED|Period 1, One Night of Wear||15
8415172|NCT00934102|20741137|P1|COMPLETED|Period 1, One Night of Wear||15
8415173|NCT00934102|20741135|P3|STARTED|Period 1, One Night of Wear||15
8415174|NCT00934102|20741136|P2|STARTED|Period 1, One Night of Wear||15
8415175|NCT00934102|20741137|P1|STARTED|Period 1, One Night of Wear||16
8415176|NCT00934050|20741151|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
8415177|NCT00934050|20741152|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
8415178|NCT00934050|20741153|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415179|NCT00934050|20741154|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415180|NCT00934050|20741155|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415181|NCT00934050|20741156|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415182|NCT00934050|20741151|P6|COMPLETED|Enrolled After 15 Dec 2009||23
8415183|NCT00934050|20741152|P5|COMPLETED|Enrolled After 15 Dec 2009||19
8415184|NCT00934050|20741153|P4|COMPLETED|Enrolled After 15 Dec 2009||0
8415185|NCT00934050|20741154|P3|COMPLETED|Enrolled After 15 Dec 2009||0
8415186|NCT00934050|20741155|P2|COMPLETED|Enrolled After 15 Dec 2009||0
8415187|NCT00934050|20741156|P1|COMPLETED|Enrolled After 15 Dec 2009||0
8415188|NCT00934050|20741151|P6|STARTED|Enrolled After 15 Dec 2009||27
8415189|NCT00934050|20741152|P5|STARTED|Enrolled After 15 Dec 2009||26
8415190|NCT00934050|20741153|P4|STARTED|Enrolled After 15 Dec 2009||0
8415191|NCT00934050|20741154|P3|STARTED|Enrolled After 15 Dec 2009||0
8415192|NCT00934050|20741155|P2|STARTED|Enrolled After 15 Dec 2009||0
8415193|NCT00934050|20741156|P1|STARTED|Enrolled After 15 Dec 2009||0
8415194|NCT00934050|20741151|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415195|NCT00934050|20741152|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415196|NCT00934050|20741153|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
8415197|NCT00934050|20741154|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8415198|NCT00934050|20741155|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8415199|NCT00934050|20741156|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8415200|NCT00934050|20741151|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415201|NCT00934050|20741152|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415202|NCT00934050|20741153|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415203|NCT00934050|20741154|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415204|NCT00934050|20741155|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415205|NCT00934050|20741156|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415206|NCT00934050|20741151|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
8415207|NCT00934050|20741152|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
8415208|NCT00934050|20741153|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
8415209|NCT00934050|20741154|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
8415210|NCT00934050|20741155|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
8415211|NCT00934050|20741156|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
8415212|NCT00934024|20741168|P2|NOT COMPLETED|Overall Study||5
8415213|NCT00934024|20741169|P1|NOT COMPLETED|Overall Study||0
8415214|NCT00934024|20741168|P2|COMPLETED|Overall Study||6
8415215|NCT00934024|20741169|P1|COMPLETED|Overall Study||10
8415216|NCT00934024|20741168|P2|STARTED|Overall Study||11
8415217|NCT00934024|20741169|P1|STARTED|Overall Study||10
8415218|NCT00933933|20741179|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8415219|NCT00933933|20741180|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8415220|NCT00933933|20741181|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8415221|NCT00933933|20741179|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
8415222|NCT00933933|20741180|P2|COMPLETED|Pediatric From 2 to 21 Years||64
8415223|NCT00933933|20741181|P1|COMPLETED|Pediatric From 2 to 21 Years||588
8415224|NCT00933933|20741179|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
8415225|NCT00933933|20741180|P2|STARTED|Pediatric From 2 to 21 Years||64
8415226|NCT00933933|20741181|P1|STARTED|Pediatric From 2 to 21 Years||588
8415227|NCT00933933|20741179|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
8415228|NCT00933933|20741180|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
8415229|NCT00933933|20741181|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
8415230|NCT00933933|20741179|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
8415231|NCT00933933|20741180|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
8415232|NCT00933933|20741181|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
8415233|NCT00933933|20741179|P3|STARTED|Pregnant Females Between 16-44 Years||203
8415234|NCT00933933|20741180|P2|STARTED|Pregnant Females Between 16-44 Years||67
8415235|NCT00933933|20741181|P1|STARTED|Pregnant Females Between 16-44 Years||448
8415236|NCT00933933|20741179|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
8415237|NCT00933933|20741180|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
8415238|NCT00933933|20741181|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
8415239|NCT00933933|20741179|P3|COMPLETED|General Population From 16 to 89 Years||1206
8415240|NCT00933933|20741180|P2|COMPLETED|General Population From 16 to 89 Years||1267
8415241|NCT00933933|20741181|P1|COMPLETED|General Population From 16 to 89 Years||6164
8415242|NCT00933933|20741179|P3|STARTED|General Population From 16 to 89 Years||1206
8415243|NCT00933933|20741180|P2|STARTED|General Population From 16 to 89 Years||1287
8415244|NCT00933933|20741181|P1|STARTED|General Population From 16 to 89 Years||6164
8415245|NCT00933686|20741199|P2|NOT COMPLETED|Overall Study||11
8415246|NCT00933686|20741200|P1|NOT COMPLETED|Overall Study||10
8415247|NCT00933686|20741199|P2|COMPLETED|Overall Study||47
8415248|NCT00933686|20741200|P1|COMPLETED|Overall Study||45
8415249|NCT00933686|20741199|P2|STARTED|Overall Study||58
8415250|NCT00933686|20741200|P1|STARTED|Overall Study||55
8415251|NCT00933608|20741220|P2|NOT COMPLETED|Overall Study||2
8415252|NCT00933608|20741221|P1|NOT COMPLETED|Overall Study||5
8415253|NCT00933608|20741220|P2|COMPLETED|Overall Study||8
8415254|NCT00933608|20741221|P1|COMPLETED|Overall Study||2
8415255|NCT00933608|20741220|P2|STARTED|Overall Study||10
8415256|NCT00933608|20741221|P1|STARTED|Overall Study||7
8415257|NCT00933543|20741229|P2|NOT COMPLETED|Overall Study||7
8415258|NCT00933543|20741230|P1|NOT COMPLETED|Overall Study||3
8415259|NCT00933543|20741229|P2|COMPLETED|Overall Study||46
8415260|NCT00933543|20741230|P1|COMPLETED|Overall Study||51
8415261|NCT00933543|20741229|P2|STARTED|Overall Study||53
8415262|NCT00933543|20741230|P1|STARTED|Overall Study||54
8415263|NCT00933491|20741288|P2|NOT COMPLETED|Overall Study||0
8415264|NCT00933491|20741289|P1|NOT COMPLETED|Overall Study||0
8415265|NCT00933491|20741288|P2|COMPLETED|Overall Study||18
8415266|NCT00933491|20741289|P1|COMPLETED|Overall Study||14
8415267|NCT00933491|20741288|P2|STARTED|Overall Study||18
8415268|NCT00933491|20741289|P1|STARTED|Overall Study||14
8415269|NCT00933335|20741299|P2|NOT COMPLETED|Overall Study||16
8415270|NCT00933335|20741300|P1|NOT COMPLETED|Overall Study||2
8415271|NCT00933335|20741299|P2|COMPLETED|Overall Study||20
8415272|NCT00933335|20741300|P1|COMPLETED|Overall Study||0
8415273|NCT00933335|20741299|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
8415274|NCT00933335|20741300|P1|STARTED|Overall Study||2
8415275|NCT00933270|20741370|P1|NOT COMPLETED|Overall Study||87
8415276|NCT00933270|20741370|P1|COMPLETED|Overall Study||177
8415277|NCT00933270|20741370|P1|STARTED|Overall Study|ITT population|264
8415278|NCT00933244|20741464|P3|NOT COMPLETED|Overall Study||3
8415279|NCT00933244|20741465|P2|NOT COMPLETED|Overall Study||1
8415280|NCT00933244|20741466|P1|NOT COMPLETED|Overall Study||5
8415281|NCT00933244|20741464|P3|COMPLETED|Overall Study||73
8415282|NCT00933244|20741465|P2|COMPLETED|Overall Study||74
8415283|NCT00933244|20741466|P1|COMPLETED|Overall Study||74
8415284|NCT00933244|20741464|P3|STARTED|Overall Study||76
8415285|NCT00933244|20741465|P2|STARTED|Overall Study||75
8415286|NCT00933244|20741466|P1|STARTED|Overall Study||79
8415287|NCT00933166|20741483|P1|NOT COMPLETED|Overall Study||18
8415288|NCT00933166|20741483|P1|COMPLETED|Overall Study||151
8415289|NCT00933166|20741483|P1|STARTED|Overall Study||169
8415290|NCT00932893|20741489|P2|NOT COMPLETED|Overall Study||170
8415291|NCT00932893|20741490|P1|NOT COMPLETED|Overall Study||133
8415292|NCT00932893|20741489|P2|COMPLETED|Overall Study||4
8415293|NCT00932893|20741490|P1|COMPLETED|Overall Study||40
8415294|NCT00932893|20741489|P2|Treated|Overall Study||171
8415295|NCT00932893|20741490|P1|Treated|Overall Study||172
8415296|NCT00932893|20741489|P2|STARTED|Overall Study||174
8415297|NCT00932893|20741490|P1|STARTED|Overall Study||173
8415298|NCT00932828|20741521|P1|NOT COMPLETED|Overall Study||5
8415299|NCT00932828|20741521|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
8415300|NCT00932828|20741521|P1|STARTED|Overall Study||37
8415301|NCT00932698|20741538|P11|NOT COMPLETED|Part 2 (Dose Expansion)||2
8415302|NCT00932698|20741539|P10|NOT COMPLETED|Part 2 (Dose Expansion)||6
8415303|NCT00932698|20741540|P9|NOT COMPLETED|Part 2 (Dose Expansion)||12
8415304|NCT00932698|20741541|P8|NOT COMPLETED|Part 2 (Dose Expansion)||20
8415305|NCT00932698|20741542|P7|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415306|NCT00932698|20741543|P6|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415307|NCT00932698|20741544|P5|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415308|NCT00932698|20741545|P4|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415309|NCT00932698|20741546|P3|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415310|NCT00932698|20741547|P2|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415311|NCT00932698|20741548|P1|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415312|NCT00932698|20741538|P11|COMPLETED|Part 2 (Dose Expansion)||0
8415313|NCT00932698|20741539|P10|COMPLETED|Part 2 (Dose Expansion)||0
8415314|NCT00932698|20741540|P9|COMPLETED|Part 2 (Dose Expansion)||0
8415315|NCT00932698|20741541|P8|COMPLETED|Part 2 (Dose Expansion)||0
8415316|NCT00932698|20741542|P7|COMPLETED|Part 2 (Dose Expansion)||0
8415317|NCT00932698|20741543|P6|COMPLETED|Part 2 (Dose Expansion)||0
8415318|NCT00932698|20741544|P5|COMPLETED|Part 2 (Dose Expansion)||0
8415319|NCT00932698|20741545|P4|COMPLETED|Part 2 (Dose Expansion)||0
8415320|NCT00932698|20741546|P3|COMPLETED|Part 2 (Dose Expansion)||0
8415321|NCT00932698|20741547|P2|COMPLETED|Part 2 (Dose Expansion)||0
8415322|NCT00932698|20741548|P1|COMPLETED|Part 2 (Dose Expansion)||0
8415323|NCT00932698|20741538|P11|STARTED|Part 2 (Dose Expansion)||2
8415324|NCT00932698|20741539|P10|STARTED|Part 2 (Dose Expansion)||6
8415325|NCT00932698|20741540|P9|STARTED|Part 2 (Dose Expansion)||12
8415326|NCT00932698|20741541|P8|STARTED|Part 2 (Dose Expansion)||20
8415327|NCT00932698|20741542|P7|STARTED|Part 2 (Dose Expansion)||0
8415328|NCT00932698|20741543|P6|STARTED|Part 2 (Dose Expansion)||0
8415329|NCT00932698|20741544|P5|STARTED|Part 2 (Dose Expansion)||0
8415330|NCT00932698|20741545|P4|STARTED|Part 2 (Dose Expansion)||0
8415331|NCT00932698|20741546|P3|STARTED|Part 2 (Dose Expansion)||0
8415332|NCT00932698|20741547|P2|STARTED|Part 2 (Dose Expansion)||0
8415333|NCT00932698|20741548|P1|STARTED|Part 2 (Dose Expansion)||0
8415334|NCT00932698|20741538|P11|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415335|NCT00932698|20741539|P10|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415336|NCT00932698|20741540|P9|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415337|NCT00932698|20741541|P8|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415338|NCT00932698|20741542|P7|NOT COMPLETED|Part 1 (Dose Escalation)||4
8415339|NCT00932698|20741543|P6|NOT COMPLETED|Part 1 (Dose Escalation)||7
8415340|NCT00932698|20741544|P5|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415341|NCT00932698|20741545|P4|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415342|NCT00932698|20741546|P3|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415343|NCT00932698|20741547|P2|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415344|NCT00932698|20741548|P1|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415345|NCT00932698|20741538|P11|COMPLETED|Part 1 (Dose Escalation)||0
8415346|NCT00932698|20741539|P10|COMPLETED|Part 1 (Dose Escalation)||0
8415347|NCT00932698|20741540|P9|COMPLETED|Part 1 (Dose Escalation)||0
8415348|NCT00932698|20741541|P8|COMPLETED|Part 1 (Dose Escalation)||0
8415349|NCT00932698|20741542|P7|COMPLETED|Part 1 (Dose Escalation)||0
8415350|NCT00932698|20741543|P6|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
8415351|NCT00932698|20741544|P5|COMPLETED|Part 1 (Dose Escalation)||0
8415352|NCT00932698|20741545|P4|COMPLETED|Part 1 (Dose Escalation)||0
8415353|NCT00932698|20741546|P3|COMPLETED|Part 1 (Dose Escalation)||0
8415354|NCT00932698|20741547|P2|COMPLETED|Part 1 (Dose Escalation)||0
8415355|NCT00932698|20741548|P1|COMPLETED|Part 1 (Dose Escalation)||0
8415356|NCT00932698|20741538|P11|STARTED|Part 1 (Dose Escalation)||0
8415357|NCT00932698|20741539|P10|STARTED|Part 1 (Dose Escalation)||0
8415358|NCT00932698|20741540|P9|STARTED|Part 1 (Dose Escalation)||0
8415359|NCT00932698|20741541|P8|STARTED|Part 1 (Dose Escalation)||0
8415360|NCT00932698|20741542|P7|STARTED|Part 1 (Dose Escalation)||4
8415361|NCT00932698|20741543|P6|STARTED|Part 1 (Dose Escalation)||7
8415362|NCT00932698|20741544|P5|STARTED|Part 1 (Dose Escalation)||3
8415363|NCT00932698|20741545|P4|STARTED|Part 1 (Dose Escalation)||3
8415364|NCT00932698|20741546|P3|STARTED|Part 1 (Dose Escalation)||3
8415365|NCT00932698|20741547|P2|STARTED|Part 1 (Dose Escalation)||3
8415366|NCT00932698|20741548|P1|STARTED|Part 1 (Dose Escalation)||3
8415367|NCT00932659|20741717|P1|NOT COMPLETED|Overall Study||0
8415368|NCT00932659|20741717|P1|COMPLETED|Overall Study||8
8415369|NCT00932659|20741717|P1|STARTED|Overall Study||8
8415370|NCT00932646|20741722|P4|NOT COMPLETED|Overall Study||1
8415371|NCT00932646|20741723|P3|NOT COMPLETED|Overall Study||4
8415372|NCT00932646|20741724|P2|NOT COMPLETED|Overall Study||3
8415373|NCT00932646|20741725|P1|NOT COMPLETED|Overall Study||5
8415374|NCT00932646|20741722|P4|COMPLETED|Overall Study||24
8415375|NCT00932646|20741723|P3|COMPLETED|Overall Study||21
8415376|NCT00932646|20741724|P2|COMPLETED|Overall Study||22
8415377|NCT00932646|20741725|P1|COMPLETED|Overall Study||20
8415378|NCT00932646|20741722|P4|STARTED|Overall Study||25
8415379|NCT00932646|20741723|P3|STARTED|Overall Study||25
8415380|NCT00932646|20741724|P2|STARTED|Overall Study||25
8415381|NCT00932646|20741725|P1|STARTED|Overall Study||25
8415382|NCT00932620|20741781|P2|NOT COMPLETED|Overall Study||0
8415383|NCT00932620|20741782|P1|NOT COMPLETED|Overall Study||0
8415384|NCT00932620|20741781|P2|COMPLETED|Overall Study||50
8415385|NCT00932620|20741782|P1|COMPLETED|Overall Study||50
8415386|NCT00932620|20741781|P2|STARTED|Overall Study||50
8415387|NCT00932620|20741782|P1|STARTED|Overall Study||50
8415388|NCT00932477|20741790|P6|NOT COMPLETED|Treatment 3||0
8415389|NCT00932477|20741791|P5|NOT COMPLETED|Treatment 3||0
8415390|NCT00932477|20741792|P4|NOT COMPLETED|Treatment 3||0
8415391|NCT00932477|20741793|P3|NOT COMPLETED|Treatment 3||0
8415392|NCT00932477|20741794|P2|NOT COMPLETED|Treatment 3||0
8415393|NCT00932477|20741795|P1|NOT COMPLETED|Treatment 3||0
8415394|NCT00932477|20741790|P6|COMPLETED|Treatment 3||8
8415395|NCT00932477|20741791|P5|COMPLETED|Treatment 3||8
8415396|NCT00932477|20741792|P4|COMPLETED|Treatment 3||7
8415397|NCT00932477|20741793|P3|COMPLETED|Treatment 3||9
8415398|NCT00932477|20741794|P2|COMPLETED|Treatment 3||8
8415399|NCT00932477|20741795|P1|COMPLETED|Treatment 3||7
8415400|NCT00932477|20741790|P6|STARTED|Treatment 3||8
8415401|NCT00932477|20741791|P5|STARTED|Treatment 3||8
8415402|NCT00932477|20741792|P4|STARTED|Treatment 3||7
8415403|NCT00932477|20741793|P3|STARTED|Treatment 3||9
8415404|NCT00932477|20741794|P2|STARTED|Treatment 3||8
8415405|NCT00932477|20741795|P1|STARTED|Treatment 3||7
8415406|NCT00932477|20741790|P6|NOT COMPLETED|Treatment 2||0
8415407|NCT00932477|20741791|P5|NOT COMPLETED|Treatment 2||0
8415408|NCT00932477|20741792|P4|NOT COMPLETED|Treatment 2||0
8415409|NCT00932477|20741793|P3|NOT COMPLETED|Treatment 2||0
8415410|NCT00932477|20741794|P2|NOT COMPLETED|Treatment 2||0
8415411|NCT00932477|20741795|P1|NOT COMPLETED|Treatment 2||0
8415412|NCT00932477|20741790|P6|COMPLETED|Treatment 2||8
8415413|NCT00932477|20741791|P5|COMPLETED|Treatment 2||8
8415414|NCT00932477|20741792|P4|COMPLETED|Treatment 2||7
8415415|NCT00932477|20741793|P3|COMPLETED|Treatment 2||9
8415416|NCT00932477|20741794|P2|COMPLETED|Treatment 2||8
8415417|NCT00932477|20741795|P1|COMPLETED|Treatment 2||7
8415418|NCT00932477|20741790|P6|STARTED|Treatment 2||8
8415419|NCT00932477|20741791|P5|STARTED|Treatment 2||8
8415420|NCT00932477|20741792|P4|STARTED|Treatment 2||7
8415421|NCT00932477|20741793|P3|STARTED|Treatment 2||9
8415422|NCT00932477|20741794|P2|STARTED|Treatment 2||8
8415423|NCT00932477|20741795|P1|STARTED|Treatment 2||7
8415424|NCT00932477|20741790|P6|NOT COMPLETED|Treatment 1||0
8415425|NCT00932477|20741791|P5|NOT COMPLETED|Treatment 1||0
8415426|NCT00932477|20741792|P4|NOT COMPLETED|Treatment 1||0
8415427|NCT00932477|20741793|P3|NOT COMPLETED|Treatment 1||0
8415428|NCT00932477|20741794|P2|NOT COMPLETED|Treatment 1||0
8415429|NCT00932477|20741795|P1|NOT COMPLETED|Treatment 1||0
8415430|NCT00932477|20741790|P6|COMPLETED|Treatment 1||8
8415431|NCT00932477|20741791|P5|COMPLETED|Treatment 1||8
8415432|NCT00932477|20741792|P4|COMPLETED|Treatment 1||7
8415433|NCT00932477|20741793|P3|COMPLETED|Treatment 1||9
8415434|NCT00932477|20741794|P2|COMPLETED|Treatment 1||8
8415435|NCT00932477|20741795|P1|COMPLETED|Treatment 1||7
8415436|NCT00932477|20741790|P6|STARTED|Treatment 1||8
8415437|NCT00932477|20741791|P5|STARTED|Treatment 1||8
8415438|NCT00932477|20741792|P4|STARTED|Treatment 1||7
8415439|NCT00932477|20741793|P3|STARTED|Treatment 1||9
8415440|NCT00932477|20741794|P2|STARTED|Treatment 1||8
8415441|NCT00932477|20741795|P1|STARTED|Treatment 1||7
8415442|NCT00932451|20741812|P1|NOT COMPLETED|Overall Study||822
8415443|NCT00932451|20741812|P1|COMPLETED|Overall Study||244
8415444|NCT00932451|20741812|P1|STARTED|Overall Study||1066
8415445|NCT00932425|20741836|P2|NOT COMPLETED|Overall Study||2
8415446|NCT00932425|20741837|P1|NOT COMPLETED|Overall Study||0
8415447|NCT00932425|20741836|P2|COMPLETED|Overall Study||18
8415448|NCT00932425|20741837|P1|COMPLETED|Overall Study||20
8415449|NCT00932425|20741836|P2|STARTED|Overall Study||20
8415450|NCT00932425|20741837|P1|STARTED|Overall Study||20
8415451|NCT00932399|20741852|P2|NOT COMPLETED|Overall Study||0
8415452|NCT00932399|20741853|P1|NOT COMPLETED|Overall Study||0
8415453|NCT00932399|20741852|P2|COMPLETED|Overall Study||3790
8415454|NCT00932399|20741853|P1|COMPLETED|Overall Study||759
8415455|NCT00932399|20741852|P2|STARTED|Overall Study||3790
8415456|NCT00932399|20741853|P1|STARTED|Overall Study||759
8415457|NCT00932373|20741870|P11|NOT COMPLETED|Overall Study||3
8415458|NCT00932373|20741871|P10|NOT COMPLETED|Overall Study||13
8415459|NCT00932373|20741872|P9|NOT COMPLETED|Overall Study||2
8415460|NCT00932373|20741873|P8|NOT COMPLETED|Overall Study||3
8415461|NCT00932373|20741874|P7|NOT COMPLETED|Overall Study||1
8415462|NCT00932373|20741875|P6|NOT COMPLETED|Overall Study||3
8415463|NCT00932373|20741876|P5|NOT COMPLETED|Overall Study||14
8415464|NCT00932373|20741877|P4|NOT COMPLETED|Overall Study||0
8415465|NCT00932373|20741878|P3|NOT COMPLETED|Overall Study||1
8415466|NCT00932373|20741879|P2|NOT COMPLETED|Overall Study||1
8415467|NCT00932373|20741880|P1|NOT COMPLETED|Overall Study||3
8415468|NCT00932373|20741870|P11|COMPLETED|Overall Study||0
8415469|NCT00932373|20741871|P10|COMPLETED|Overall Study||3
8415470|NCT00932373|20741872|P9|COMPLETED|Overall Study||1
8415471|NCT00932373|20741873|P8|COMPLETED|Overall Study||0
8415472|NCT00932373|20741874|P7|COMPLETED|Overall Study||2
8415473|NCT00932373|20741875|P6|COMPLETED|Overall Study||0
8415474|NCT00932373|20741876|P5|COMPLETED|Overall Study||1
8415475|NCT00932373|20741877|P4|COMPLETED|Overall Study||1
8415476|NCT00932373|20741878|P3|COMPLETED|Overall Study||0
8415477|NCT00932373|20741879|P2|COMPLETED|Overall Study||0
8415478|NCT00932373|20741880|P1|COMPLETED|Overall Study||0
8415479|NCT00932373|20741870|P11|STARTED|Overall Study||3
8415480|NCT00932373|20741871|P10|STARTED|Overall Study||16
8415481|NCT00932373|20741872|P9|STARTED|Overall Study||3
8415482|NCT00932373|20741873|P8|STARTED|Overall Study||3
8415483|NCT00932373|20741874|P7|STARTED|Overall Study||3
8415484|NCT00932373|20741875|P6|STARTED|Overall Study||3
8415485|NCT00932373|20741876|P5|STARTED|Overall Study||15
8415486|NCT00932373|20741877|P4|STARTED|Overall Study||1
8415487|NCT00932373|20741878|P3|STARTED|Overall Study||1
8415488|NCT00932373|20741879|P2|STARTED|Overall Study||1
8415489|NCT00932373|20741880|P1|STARTED|Overall Study||3
8415490|NCT00932360|20741980|P6|NOT COMPLETED|Visit 3/Week 3||0
8415491|NCT00932360|20741981|P5|NOT COMPLETED|Visit 3/Week 3||0
8415492|NCT00932360|20741982|P4|NOT COMPLETED|Visit 3/Week 3||0
8415493|NCT00932360|20741983|P3|NOT COMPLETED|Visit 3/Week 3||0
8415494|NCT00932360|20741984|P2|NOT COMPLETED|Visit 3/Week 3||0
8415495|NCT00932360|20741985|P1|NOT COMPLETED|Visit 3/Week 3||0
8415496|NCT00932360|20741980|P6|COMPLETED|Visit 3/Week 3||7
8415497|NCT00932360|20741981|P5|COMPLETED|Visit 3/Week 3||2
8415498|NCT00932360|20741982|P4|COMPLETED|Visit 3/Week 3||13
8415499|NCT00932360|20741983|P3|COMPLETED|Visit 3/Week 3||3
8415500|NCT00932360|20741984|P2|COMPLETED|Visit 3/Week 3||6
8415501|NCT00932360|20741985|P1|COMPLETED|Visit 3/Week 3||10
8415502|NCT00932360|20741980|P6|STARTED|Visit 3/Week 3||7
8415503|NCT00932360|20741981|P5|STARTED|Visit 3/Week 3||2
8415504|NCT00932360|20741982|P4|STARTED|Visit 3/Week 3||13
8415505|NCT00932360|20741983|P3|STARTED|Visit 3/Week 3||3
8415506|NCT00932360|20741984|P2|STARTED|Visit 3/Week 3||6
8415507|NCT00932360|20741985|P1|STARTED|Visit 3/Week 3||10
8415508|NCT00932360|20741980|P6|NOT COMPLETED|Washout (One Week)||0
8415509|NCT00932360|20741981|P5|NOT COMPLETED|Washout (One Week)||0
8415510|NCT00932360|20741982|P4|NOT COMPLETED|Washout (One Week)||0
8415511|NCT00932360|20741983|P3|NOT COMPLETED|Washout (One Week)||0
8415512|NCT00932360|20741984|P2|NOT COMPLETED|Washout (One Week)||0
8415513|NCT00932360|20741985|P1|NOT COMPLETED|Washout (One Week)||0
8415514|NCT00932360|20741980|P6|COMPLETED|Washout (One Week)||7
8415515|NCT00932360|20741981|P5|COMPLETED|Washout (One Week)||2
8415516|NCT00932360|20741982|P4|COMPLETED|Washout (One Week)||13
8415517|NCT00932360|20741983|P3|COMPLETED|Washout (One Week)||3
8415518|NCT00932360|20741984|P2|COMPLETED|Washout (One Week)||6
8415519|NCT00932360|20741985|P1|COMPLETED|Washout (One Week)||10
8415520|NCT00932360|20741980|P6|STARTED|Washout (One Week)||7
8415521|NCT00932360|20741981|P5|STARTED|Washout (One Week)||2
8415522|NCT00932360|20741982|P4|STARTED|Washout (One Week)||13
8415523|NCT00932360|20741983|P3|STARTED|Washout (One Week)||3
8415524|NCT00932360|20741984|P2|STARTED|Washout (One Week)||6
8415525|NCT00932360|20741985|P1|STARTED|Washout (One Week)||10
8415526|NCT00932360|20741980|P6|NOT COMPLETED|Visit 2/Week 2||0
8415527|NCT00932360|20741981|P5|NOT COMPLETED|Visit 2/Week 2||0
8415528|NCT00932360|20741982|P4|NOT COMPLETED|Visit 2/Week 2||0
8415529|NCT00932360|20741983|P3|NOT COMPLETED|Visit 2/Week 2||0
8415530|NCT00932360|20741984|P2|NOT COMPLETED|Visit 2/Week 2||0
8415531|NCT00932360|20741985|P1|NOT COMPLETED|Visit 2/Week 2||0
8415532|NCT00932360|20741980|P6|COMPLETED|Visit 2/Week 2||7
8415533|NCT00932360|20741981|P5|COMPLETED|Visit 2/Week 2||2
8415534|NCT00932360|20741982|P4|COMPLETED|Visit 2/Week 2||13
8415535|NCT00932360|20741983|P3|COMPLETED|Visit 2/Week 2||3
8415536|NCT00932360|20741984|P2|COMPLETED|Visit 2/Week 2||6
8415537|NCT00932360|20741985|P1|COMPLETED|Visit 2/Week 2||10
8415538|NCT00932360|20741980|P6|STARTED|Visit 2/Week 2||7
8415539|NCT00932360|20741981|P5|STARTED|Visit 2/Week 2||2
8415540|NCT00932360|20741982|P4|STARTED|Visit 2/Week 2||13
8415541|NCT00932360|20741983|P3|STARTED|Visit 2/Week 2||3
8415542|NCT00932360|20741984|P2|STARTED|Visit 2/Week 2||6
8415543|NCT00932360|20741985|P1|STARTED|Visit 2/Week 2||10
8415544|NCT00932360|20741980|P6|NOT COMPLETED|Washout (One Week)||0
8415545|NCT00932360|20741981|P5|NOT COMPLETED|Washout (One Week)||2
8415546|NCT00932360|20741982|P4|NOT COMPLETED|Washout (One Week)||0
8415547|NCT00932360|20741983|P3|NOT COMPLETED|Washout (One Week)||0
8415548|NCT00932360|20741984|P2|NOT COMPLETED|Washout (One Week)||0
8415549|NCT00932360|20741985|P1|NOT COMPLETED|Washout (One Week)||0
8415550|NCT00932360|20741980|P6|COMPLETED|Washout (One Week)||7
8415551|NCT00932360|20741981|P5|COMPLETED|Washout (One Week)||2
8415552|NCT00932360|20741982|P4|COMPLETED|Washout (One Week)||13
8415553|NCT00932360|20741983|P3|COMPLETED|Washout (One Week)||3
8415554|NCT00932360|20741984|P2|COMPLETED|Washout (One Week)||6
8415555|NCT00932360|20741985|P1|COMPLETED|Washout (One Week)||10
8415556|NCT00932360|20741980|P6|STARTED|Washout (One Week)||7
8415557|NCT00932360|20741981|P5|STARTED|Washout (One Week)||4
8415558|NCT00932360|20741982|P4|STARTED|Washout (One Week)||13
8415559|NCT00932360|20741983|P3|STARTED|Washout (One Week)||3
8415560|NCT00932360|20741984|P2|STARTED|Washout (One Week)||6
8415561|NCT00932360|20741985|P1|STARTED|Washout (One Week)||10
8415562|NCT00932360|20741980|P6|NOT COMPLETED|1: Visit 1/Week1||0
8415563|NCT00932360|20741981|P5|NOT COMPLETED|1: Visit 1/Week1||0
8415564|NCT00932360|20741982|P4|NOT COMPLETED|1: Visit 1/Week1||0
8415565|NCT00932360|20741983|P3|NOT COMPLETED|1: Visit 1/Week1||0
8415566|NCT00932360|20741984|P2|NOT COMPLETED|1: Visit 1/Week1||0
8415567|NCT00932360|20741985|P1|NOT COMPLETED|1: Visit 1/Week1||0
8415568|NCT00932360|20741980|P6|COMPLETED|1: Visit 1/Week1||7
8415569|NCT00932360|20741981|P5|COMPLETED|1: Visit 1/Week1||4
8415570|NCT00932360|20741982|P4|COMPLETED|1: Visit 1/Week1||13
8415571|NCT00932360|20741983|P3|COMPLETED|1: Visit 1/Week1||3
8415572|NCT00932360|20741984|P2|COMPLETED|1: Visit 1/Week1||6
8415573|NCT00932360|20741985|P1|COMPLETED|1: Visit 1/Week1||10
8415574|NCT00932360|20741980|P6|STARTED|1: Visit 1/Week1||7
8415575|NCT00932360|20741981|P5|STARTED|1: Visit 1/Week1||4
8415576|NCT00932360|20741982|P4|STARTED|1: Visit 1/Week1||13
8415577|NCT00932360|20741983|P3|STARTED|1: Visit 1/Week1||3
8415578|NCT00932360|20741984|P2|STARTED|1: Visit 1/Week1||6
8415579|NCT00932360|20741985|P1|STARTED|1: Visit 1/Week1||10
8415580|NCT00932321|20742016|P2|NOT COMPLETED|Overall Study||46
8415581|NCT00932321|20742017|P1|NOT COMPLETED|Overall Study||171
8415582|NCT00932321|20742016|P2|COMPLETED|Overall Study||141
8415583|NCT00932321|20742017|P1|COMPLETED|Overall Study||580
8415584|NCT00932321|20742016|P2|MITT Population|Overall Study||181
8415585|NCT00932321|20742017|P1|MITT Population|Overall Study||705
8415586|NCT00932321|20742016|P2|STARTED|Overall Study||187
8415587|NCT00932321|20742017|P1|STARTED|Overall Study||751
8415588|NCT00932282|20742027|P2|NOT COMPLETED|OIT Maintenance Phase||2
8415589|NCT00932282|20742028|P1|NOT COMPLETED|OIT Maintenance Phase||1
8415590|NCT00932282|20742027|P2|COMPLETED|OIT Maintenance Phase||2
8415591|NCT00932282|20742028|P1|COMPLETED|OIT Maintenance Phase||4
8415592|NCT00932282|20742027|P2|STARTED|OIT Maintenance Phase||4
8415593|NCT00932282|20742028|P1|STARTED|OIT Maintenance Phase||5
8415594|NCT00932282|20742027|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
8415595|NCT00932282|20742028|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
8415596|NCT00932282|20742027|P2|COMPLETED|Biweekly OIT Buildup Phase||4
8415597|NCT00932282|20742028|P1|COMPLETED|Biweekly OIT Buildup Phase||5
8415598|NCT00932282|20742027|P2|STARTED|Biweekly OIT Buildup Phase||5
8415599|NCT00932282|20742028|P1|STARTED|Biweekly OIT Buildup Phase||6
8415600|NCT00932282|20742027|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
8415601|NCT00932282|20742028|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
8415602|NCT00932282|20742027|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
8415603|NCT00932282|20742028|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
8415604|NCT00932282|20742027|P2|STARTED|Modified OIT Rush Desensitization Phase||5
8415605|NCT00932282|20742028|P1|STARTED|Modified OIT Rush Desensitization Phase||6
8415606|NCT00932282|20742027|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
8415607|NCT00932282|20742028|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
8415608|NCT00932282|20742027|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
8415609|NCT00932282|20742028|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
8415610|NCT00932282|20742027|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
8415611|NCT00932282|20742028|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
8415612|NCT00932165|20742042|P1|NOT COMPLETED|Overall Study||1
8415613|NCT00932165|20742042|P1|COMPLETED|Overall Study||450
8415614|NCT00932165|20742042|P1|STARTED|Overall Study||451
8415615|NCT00932152|20742055|P2|NOT COMPLETED|Overall Study||2
8415616|NCT00932152|20742056|P1|NOT COMPLETED|Overall Study||1
8415617|NCT00932152|20742055|P2|COMPLETED|Overall Study||0
8415618|NCT00932152|20742056|P1|COMPLETED|Overall Study||0
8415619|NCT00932152|20742055|P2|STARTED|Overall Study||2
8415620|NCT00932152|20742056|P1|STARTED|Overall Study||1
8415621|NCT00932126|20742066|P8|NOT COMPLETED|Overall Study||10
8415622|NCT00932126|20742067|P7|NOT COMPLETED|Overall Study||5
8415623|NCT00932126|20742068|P6|NOT COMPLETED|Overall Study||3
8415624|NCT00932126|20742069|P5|NOT COMPLETED|Overall Study||5
8415625|NCT00932126|20742070|P4|NOT COMPLETED|Overall Study||3
8415626|NCT00932126|20742071|P3|NOT COMPLETED|Overall Study||3
8415627|NCT00932126|20742072|P2|NOT COMPLETED|Overall Study||3
8415628|NCT00932126|20742073|P1|NOT COMPLETED|Overall Study||3
8415629|NCT00932126|20742066|P8|COMPLETED|Overall Study||0
8415630|NCT00932126|20742067|P7|COMPLETED|Overall Study||0
8415631|NCT00932126|20742068|P6|COMPLETED|Overall Study||0
8415632|NCT00932126|20742069|P5|COMPLETED|Overall Study||0
8415633|NCT00932126|20742070|P4|COMPLETED|Overall Study||0
8415634|NCT00932126|20742071|P3|COMPLETED|Overall Study||0
8415635|NCT00932126|20742072|P2|COMPLETED|Overall Study||0
8415636|NCT00932126|20742073|P1|COMPLETED|Overall Study||0
8415637|NCT00932126|20742066|P8|STARTED|Overall Study||10
8415638|NCT00932126|20742067|P7|STARTED|Overall Study||5
8415639|NCT00932126|20742068|P6|STARTED|Overall Study||3
8415640|NCT00932126|20742069|P5|STARTED|Overall Study||5
8415641|NCT00932126|20742070|P4|STARTED|Overall Study||3
8415642|NCT00932126|20742071|P3|STARTED|Overall Study||3
8415643|NCT00932126|20742072|P2|STARTED|Overall Study||3
8415644|NCT00932126|20742073|P1|STARTED|Overall Study||3
8415645|NCT00932113|20742111|P2|NOT COMPLETED|Overall Study||0
8415646|NCT00932113|20742112|P1|NOT COMPLETED|Overall Study||1
8415647|NCT00932113|20742111|P2|COMPLETED|Overall Study||15
8415648|NCT00932113|20742112|P1|COMPLETED|Overall Study||14
8415649|NCT00932113|20742111|P2|STARTED|Overall Study||15
8415650|NCT00932113|20742112|P1|STARTED|Overall Study||15
8415651|NCT00932035|20742130|P2|NOT COMPLETED|Overall Study||0
8415652|NCT00932035|20742131|P1|NOT COMPLETED|Overall Study||0
8415653|NCT00932035|20742130|P2|COMPLETED|Overall Study||21
8415654|NCT00932035|20742131|P1|COMPLETED|Overall Study||18
8415655|NCT00932035|20742130|P2|STARTED|Overall Study||21
8415656|NCT00932035|20742131|P1|STARTED|Overall Study||18
8415657|NCT00932022|20742143|P2|NOT COMPLETED|Overall Study||4
8415658|NCT00932022|20742144|P1|NOT COMPLETED|Overall Study||5
8415659|NCT00932022|20742143|P2|COMPLETED|Overall Study||59
8415660|NCT00932022|20742144|P1|COMPLETED|Overall Study||59
8415661|NCT00932022|20742143|P2|STARTED|Overall Study||63
8415662|NCT00932022|20742144|P1|STARTED|Overall Study||64
8415663|NCT00931996|20742158|P1|NOT COMPLETED|Overall Study||7
8415664|NCT00931996|20742158|P1|COMPLETED|Overall Study||5
8415665|NCT00931996|20742158|P1|STARTED|Overall Study||12
8415666|NCT00931918|20742164|P2|NOT COMPLETED|Overall Study||17
8415667|NCT00931918|20742165|P1|NOT COMPLETED|Overall Study||17
8415668|NCT00931918|20742164|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
8415669|NCT00931918|20742165|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
8415670|NCT00931918|20742164|P2|Safety Population: Received Study Drug|Overall Study||101
8415671|NCT00931918|20742165|P1|Safety Population: Received Study Drug|Overall Study||100
8415672|NCT00931918|20742164|P2|STARTED|Overall Study||103
8415673|NCT00931918|20742165|P1|STARTED|Overall Study||103
8415674|NCT00931879|20742191|P2|NOT COMPLETED|Overall Study||3
8415675|NCT00931879|20742192|P1|NOT COMPLETED|Overall Study||3
8415676|NCT00931879|20742191|P2|COMPLETED|Overall Study||19
8415677|NCT00931879|20742192|P1|COMPLETED|Overall Study||19
8415678|NCT00931879|20742191|P2|STARTED|Overall Study||22
8415679|NCT00931879|20742192|P1|STARTED|Overall Study||22
8415680|NCT00931801|20742217|P3|NOT COMPLETED|Overall Study||4
8415681|NCT00931801|20742218|P2|NOT COMPLETED|Overall Study||1
8415682|NCT00931801|20742219|P1|NOT COMPLETED|Overall Study||1
8415683|NCT00931801|20742217|P3|COMPLETED|Overall Study||10
8415684|NCT00931801|20742218|P2|COMPLETED|Overall Study||14
8415685|NCT00931801|20742219|P1|COMPLETED|Overall Study||13
8415686|NCT00931801|20742217|P3|STARTED|Overall Study||14
8415687|NCT00931801|20742218|P2|STARTED|Overall Study||15
8415688|NCT00931801|20742219|P1|STARTED|Overall Study||14
8415689|NCT00931723|20742242|P2|NOT COMPLETED|Overall Study||39
8415690|NCT00931723|20742243|P1|NOT COMPLETED|Overall Study||26
8415691|NCT00931723|20742242|P2|COMPLETED|Overall Study||144
8415692|NCT00931723|20742243|P1|COMPLETED|Overall Study||147
8415693|NCT00931723|20742242|P2|STARTED|Overall Study||183
8415694|NCT00931723|20742243|P1|STARTED|Overall Study||173
8415695|NCT00931710|20742291|P2|NOT COMPLETED|Overall Study||38
8415696|NCT00931710|20742292|P1|NOT COMPLETED|Overall Study||34
8415697|NCT00931710|20742291|P2|COMPLETED|Overall Study||209
8415698|NCT00931710|20742292|P1|COMPLETED|Overall Study||207
8415699|NCT00931710|20742291|P2|STARTED|Overall Study||247
8415700|NCT00931710|20742292|P1|STARTED|Overall Study||241
8415701|NCT00931632|20742310|P2|NOT COMPLETED|Overall Study||18
8415702|NCT00931632|20742311|P1|NOT COMPLETED|Overall Study||21
8415703|NCT00931632|20742310|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
8415704|NCT00931632|20742311|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
8415705|NCT00931632|20742310|P2|STARTED|Overall Study|Randomized|222
8415706|NCT00931632|20742311|P1|STARTED|Overall Study|Randomized|229
8415707|NCT00931528|20742333|P2|NOT COMPLETED|Overall Study||60
8415708|NCT00931528|20742334|P1|NOT COMPLETED|Overall Study||41
8415709|NCT00931528|20742333|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
8415710|NCT00931528|20742334|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
8415711|NCT00931528|20742333|P2|STARTED|Overall Study||121
8415712|NCT00931528|20742334|P1|STARTED|Overall Study||121
8415713|NCT00931515|20742354|P2|NOT COMPLETED|Overall Study||5
8415714|NCT00931515|20742355|P1|NOT COMPLETED|Overall Study||2
8415715|NCT00931515|20742354|P2|COMPLETED|Overall Study||10
8415716|NCT00931515|20742355|P1|COMPLETED|Overall Study||13
8415717|NCT00931515|20742354|P2|STARTED|Overall Study||15
8415718|NCT00931515|20742355|P1|STARTED|Overall Study||15
8415719|NCT00931489|20742366|P5|NOT COMPLETED|Overall Study||0
8415720|NCT00931489|20742367|P4|NOT COMPLETED|Overall Study||0
8415721|NCT00931489|20742368|P3|NOT COMPLETED|Overall Study||0
8415722|NCT00931489|20742369|P2|NOT COMPLETED|Overall Study||0
8415723|NCT00931489|20742370|P1|NOT COMPLETED|Overall Study||0
8415724|NCT00931489|20742366|P5|COMPLETED|Overall Study||7
8415725|NCT00931489|20742367|P4|COMPLETED|Overall Study||39
8415726|NCT00931489|20742368|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
8415727|NCT00931489|20742369|P2|COMPLETED|Overall Study||40
8415728|NCT00931489|20742370|P1|COMPLETED|Overall Study||40
8415729|NCT00931489|20742366|P5|STARTED|Overall Study||7
8415730|NCT00931489|20742367|P4|STARTED|Overall Study||39
8415731|NCT00931489|20742368|P3|STARTED|Overall Study||5
8415732|NCT00931489|20742369|P2|STARTED|Overall Study||40
8415733|NCT00931489|20742370|P1|STARTED|Overall Study||40
8415734|NCT00931463|20742385|P2|NOT COMPLETED|Overall Study||5
8415735|NCT00931463|20742386|P1|NOT COMPLETED|Overall Study||17
8415736|NCT00931463|20742385|P2|COMPLETED|Overall Study||265
8415737|NCT00931463|20742386|P1|COMPLETED|Overall Study||254
8415738|NCT00931463|20742385|P2|STARTED|Overall Study||270
8415739|NCT00931463|20742386|P1|STARTED|Overall Study||271
8415740|NCT00931411|20742402|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
8415741|NCT00931411|20742403|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
8415742|NCT00931411|20742402|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
8415743|NCT00931411|20742403|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
8415744|NCT00931411|20742402|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
8415745|NCT00931411|20742403|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
8415746|NCT00931411|20742402|P2|NOT COMPLETED|First Intervention - 42 Days||3
8415747|NCT00931411|20742403|P1|NOT COMPLETED|First Intervention - 42 Days||4
8415748|NCT00931411|20742402|P2|COMPLETED|First Intervention - 42 Days||35
8415749|NCT00931411|20742403|P1|COMPLETED|First Intervention - 42 Days||31
8415750|NCT00931411|20742402|P2|STARTED|First Intervention - 42 Days||38
8415751|NCT00931411|20742403|P1|STARTED|First Intervention - 42 Days||35
8415752|NCT00931385|20742424|P4|NOT COMPLETED|Overall Study||5
8415753|NCT00931385|20742425|P3|NOT COMPLETED|Overall Study||1
8415754|NCT00931385|20742426|P2|NOT COMPLETED|Overall Study||2
8415755|NCT00931385|20742427|P1|NOT COMPLETED|Overall Study||2
8415756|NCT00931385|20742424|P4|COMPLETED|Overall Study||21
8415757|NCT00931385|20742425|P3|COMPLETED|Overall Study||24
8415758|NCT00931385|20742426|P2|COMPLETED|Overall Study||21
8415759|NCT00931385|20742427|P1|COMPLETED|Overall Study||23
8415760|NCT00931385|20742424|P4|STARTED|Overall Study||26
8415761|NCT00931385|20742425|P3|STARTED|Overall Study||25
8415762|NCT00931385|20742426|P2|STARTED|Overall Study||23
8415763|NCT00931385|20742427|P1|STARTED|Overall Study||25
8415764|NCT00931359|20742483|P2|NOT COMPLETED|Overall Study||13
8415765|NCT00931359|20742484|P1|NOT COMPLETED|Overall Study||6
8415766|NCT00931359|20742483|P2|COMPLETED|Overall Study||68
8415767|NCT00931359|20742484|P1|COMPLETED|Overall Study||33
8415768|NCT00931359|20742483|P2|STARTED|Overall Study||81
8415769|NCT00931359|20742484|P1|STARTED|Overall Study||39
8415770|NCT00931307|20742496|P1|NOT COMPLETED|Overall Study||13
8415771|NCT00931307|20742496|P1|COMPLETED|Overall Study||9
8415772|NCT00931307|20742496|P1|STARTED|Overall Study||22
8415773|NCT00931268|20742500|P1|NOT COMPLETED|Overall Study||6
8415774|NCT00931268|20742500|P1|COMPLETED|Overall Study||4
8415775|NCT00931268|20742500|P1|STARTED|Overall Study||10
8415776|NCT00931255|20742512|P2|NOT COMPLETED|Overall Study||3
8415777|NCT00931255|20742513|P1|NOT COMPLETED|Overall Study||2
8415778|NCT00931255|20742512|P2|COMPLETED|Overall Study||12
8415779|NCT00931255|20742513|P1|COMPLETED|Overall Study||15
8415780|NCT00931255|20742512|P2|STARTED|Overall Study||15
8415781|NCT00931255|20742513|P1|STARTED|Overall Study||17
8415782|NCT00931242|20742537|P2|NOT COMPLETED|Overall Study||2
8415783|NCT00931242|20742538|P1|NOT COMPLETED|Overall Study||5
8415784|NCT00931242|20742537|P2|COMPLETED|Overall Study||0
8415785|NCT00931242|20742538|P1|COMPLETED|Overall Study||5
8415786|NCT00931242|20742537|P2|STARTED|Overall Study||2
8415787|NCT00931242|20742538|P1|STARTED|Overall Study||10
8415788|NCT00931164|20742544|P1|NOT COMPLETED|Overall Study||0
8415789|NCT00931164|20742544|P1|COMPLETED|Overall Study||6
8415790|NCT00931164|20742544|P1|STARTED|Overall Study||6
8415791|NCT00930982|20742550|P2|NOT COMPLETED|Overall Study||29
8415792|NCT00930982|20742551|P1|NOT COMPLETED|Overall Study||21
8415793|NCT00930982|20742550|P2|COMPLETED|Overall Study||35
8415794|NCT00930982|20742551|P1|COMPLETED|Overall Study||39
8415795|NCT00930982|20742550|P2|STARTED|Overall Study||64
8415796|NCT00930982|20742551|P1|STARTED|Overall Study||60
8415797|NCT00930969|20742585|P1|NOT COMPLETED|Overall Study||38
8415798|NCT00930969|20742585|P1|COMPLETED|Overall Study||137
8415799|NCT00930969|20742585|P1|STARTED|Overall Study||175
8415800|NCT00930930|20742595|P2|NOT COMPLETED|Overall Study||9
8415801|NCT00930930|20742596|P1|NOT COMPLETED|Overall Study||21
8415802|NCT00930930|20742595|P2|COMPLETED|Overall Study||40
8415803|NCT00930930|20742596|P1|COMPLETED|Overall Study||75
8415804|NCT00930930|20742595|P2|STARTED|Overall Study||49
8415805|NCT00930930|20742596|P1|STARTED|Overall Study||96
8415806|NCT00930813|20742610|P2|NOT COMPLETED|Overall Study||14
8415807|NCT00930813|20742611|P1|NOT COMPLETED|Overall Study||8
8415808|NCT00930813|20742610|P2|COMPLETED|Overall Study||38
8415809|NCT00930813|20742611|P1|COMPLETED|Overall Study||41
8415810|NCT00930813|20742610|P2|STARTED|Overall Study||52
8415811|NCT00930813|20742611|P1|STARTED|Overall Study||49
8415812|NCT00930787|20742621|P2|NOT COMPLETED|Overall Study||0
8415813|NCT00930787|20742622|P1|NOT COMPLETED|Overall Study||0
8415814|NCT00930787|20742621|P2|COMPLETED|Overall Study||9
8415815|NCT00930787|20742622|P1|COMPLETED|Overall Study||14
8415816|NCT00930787|20742621|P2|STARTED|Overall Study||9
8415817|NCT00930787|20742622|P1|STARTED|Overall Study||14
8415818|NCT00930774|20742632|P4|NOT COMPLETED|Overall Study||0
8415819|NCT00930774|20742633|P3|NOT COMPLETED|Overall Study||2
8415820|NCT00930774|20742634|P2|NOT COMPLETED|Overall Study||9
8415821|NCT00930774|20742635|P1|NOT COMPLETED|Overall Study||1
8415822|NCT00930774|20742632|P4|COMPLETED|Overall Study||25
8415823|NCT00930774|20742633|P3|COMPLETED|Overall Study||22
8415824|NCT00930774|20742634|P2|COMPLETED|Overall Study||16
8415825|NCT00930774|20742635|P1|COMPLETED|Overall Study||24
8415826|NCT00930774|20742632|P4|STARTED|Overall Study||25
8415827|NCT00930774|20742633|P3|STARTED|Overall Study||24
8415828|NCT00930774|20742634|P2|STARTED|Overall Study||25
8415829|NCT00930774|20742635|P1|STARTED|Overall Study||25
8415830|NCT00930761|20742675|P2|NOT COMPLETED|Overall Study||3
8415831|NCT00930761|20742676|P1|NOT COMPLETED|Overall Study||4
8415832|NCT00930761|20742675|P2|COMPLETED|Overall Study||48
8415833|NCT00930761|20742676|P1|COMPLETED|Overall Study||46
8415834|NCT00930761|20742675|P2|STARTED|Overall Study||51
8415835|NCT00930761|20742676|P1|STARTED|Overall Study||50
8415836|NCT00930722|20742688|P1|NOT COMPLETED|Overall Study||27
8415837|NCT00930722|20742688|P1|COMPLETED|Overall Study||302
8415838|NCT00930722|20742688|P1|STARTED|Overall Study||329
8415839|NCT00930644|20742703|P1|NOT COMPLETED|Overall Study||23
8415840|NCT00930644|20742703|P1|COMPLETED|Overall Study||65
8415841|NCT00930644|20742703|P1|STARTED|Overall Study||88
8415842|NCT00930553|20742716|P1|NOT COMPLETED|Overall Study||223
8415843|NCT00930553|20742716|P1|COMPLETED|Overall Study||1091
8415844|NCT00930553|20742716|P1|Participants Entered From CAMMS324|Overall Study||685
8415845|NCT00930553|20742716|P1|Participants Entered From CAMMS323|Overall Study||488
8415846|NCT00930553|20742716|P1|Participants Entered From CAMMS223|Overall Study||141
8415847|NCT00930553|20742716|P1|STARTED|Overall Study||1314
8415848|NCT00930293|20742784|P2|NOT COMPLETED|Overall Study||7
8415849|NCT00930293|20742785|P1|NOT COMPLETED|Overall Study||7
8415850|NCT00930293|20742784|P2|COMPLETED|Overall Study||19
8415851|NCT00930293|20742785|P1|COMPLETED|Overall Study||17
8415852|NCT00930293|20742784|P2|STARTED|Overall Study||26
8415853|NCT00930293|20742785|P1|STARTED|Overall Study||24
8415854|NCT00930176|20742793|P1|NOT COMPLETED|Overall Study||1
8415855|NCT00930176|20742793|P1|COMPLETED|Overall Study||15
8415856|NCT00930176|20742793|P1|STARTED|Overall Study||16
8415857|NCT00930059|20742800|P2|NOT COMPLETED|Overall Study||12
8415858|NCT00930059|20742801|P1|NOT COMPLETED|Overall Study||8
8415859|NCT00930059|20742800|P2|COMPLETED|Overall Study||79
8415860|NCT00930059|20742801|P1|COMPLETED|Overall Study||92
8415861|NCT00930059|20742800|P2|STARTED|Overall Study||91
8415862|NCT00930059|20742801|P1|STARTED|Overall Study||100
8415863|NCT00930046|20742831|P2|NOT COMPLETED|Overall Study||2
8415864|NCT00930046|20742832|P1|NOT COMPLETED|Overall Study||1
8415865|NCT00930046|20742831|P2|COMPLETED|Overall Study||5
8415866|NCT00930046|20742832|P1|COMPLETED|Overall Study||7
8415867|NCT00930046|20742831|P2|STARTED|Overall Study||7
8415868|NCT00930046|20742832|P1|STARTED|Overall Study||8
8415869|NCT00929994|20742840|P1|NOT COMPLETED|Overall Study||6
8415870|NCT00929994|20742840|P1|COMPLETED|Overall Study||14
8415871|NCT00929994|20742840|P1|STARTED|Overall Study||20
8415872|NCT00929981|20742847|P1|NOT COMPLETED|Overall Study||0
8415873|NCT00929981|20742847|P1|COMPLETED|Overall Study||80
8415874|NCT00929981|20742847|P1|STARTED|Overall Study||80
8415875|NCT00929864|20742859|P2|NOT COMPLETED|Overall Study||83
8415876|NCT00929864|20742860|P1|NOT COMPLETED|Overall Study||66
8415877|NCT00929864|20742859|P2|COMPLETED|Overall Study||245
8415878|NCT00929864|20742860|P1|COMPLETED|Overall Study||252
8415879|NCT00929864|20742859|P2|STARTED|Overall Study||328
8415880|NCT00929864|20742860|P1|STARTED|Overall Study||318
8415881|NCT00929838|20742882|P4|NOT COMPLETED|Overall Study||9
8415882|NCT00929838|20742883|P3|NOT COMPLETED|Overall Study||10
8415883|NCT00929838|20742884|P2|NOT COMPLETED|Overall Study||9
8415884|NCT00929838|20742885|P1|NOT COMPLETED|Overall Study||10
8415885|NCT00929838|20742882|P4|COMPLETED|Overall Study||55
8415886|NCT00929838|20742883|P3|COMPLETED|Overall Study||53
8415887|NCT00929838|20742884|P2|COMPLETED|Overall Study||56
8415888|NCT00929838|20742885|P1|COMPLETED|Overall Study||53
8415889|NCT00929838|20742882|P4|STARTED|Overall Study||64
8415890|NCT00929838|20742883|P3|STARTED|Overall Study||63
8415891|NCT00929838|20742884|P2|STARTED|Overall Study||65
8415892|NCT00929838|20742885|P1|STARTED|Overall Study||63
8415893|NCT00929773|20742897|P2|NOT COMPLETED|Overall Study||0
8415894|NCT00929773|20742898|P1|NOT COMPLETED|Overall Study||0
8415895|NCT00929773|20742897|P2|COMPLETED|Overall Study||50
8415896|NCT00929773|20742898|P1|COMPLETED|Overall Study||50
8415897|NCT00929773|20742897|P2|STARTED|Overall Study||50
8415898|NCT00929773|20742898|P1|STARTED|Overall Study||50
8415899|NCT00929734|20742916|P2|NOT COMPLETED|Overall Study||3
8415900|NCT00929734|20742917|P1|NOT COMPLETED|Overall Study||2
8415901|NCT00929734|20742916|P2|COMPLETED|Overall Study||47
8415902|NCT00929734|20742917|P1|COMPLETED|Overall Study||47
8415903|NCT00929734|20742916|P2|STARTED|Overall Study||50
8415904|NCT00929734|20742917|P1|STARTED|Overall Study||49
8415905|NCT00929708|20742934|P5|NOT COMPLETED|Overall Study||6
8415906|NCT00929708|20742935|P4|NOT COMPLETED|Overall Study||6
8415907|NCT00929708|20742936|P3|NOT COMPLETED|Overall Study||3
8415908|NCT00929708|20742937|P2|NOT COMPLETED|Overall Study||3
8415909|NCT00929708|20742938|P1|NOT COMPLETED|Overall Study||4
8415910|NCT00929708|20742934|P5|COMPLETED|Overall Study||57
8415911|NCT00929708|20742935|P4|COMPLETED|Overall Study||61
8415912|NCT00929708|20742936|P3|COMPLETED|Overall Study||62
8415913|NCT00929708|20742937|P2|COMPLETED|Overall Study||66
8415914|NCT00929708|20742938|P1|COMPLETED|Overall Study||61
8415915|NCT00929708|20742934|P5|STARTED|Overall Study||63
8415916|NCT00929708|20742935|P4|STARTED|Overall Study||67
8415917|NCT00929708|20742936|P3|STARTED|Overall Study||65
8415918|NCT00929708|20742937|P2|STARTED|Overall Study||69
8415919|NCT00929708|20742938|P1|STARTED|Overall Study||65
8415920|NCT00929695|20742992|P2|NOT COMPLETED|Overall Study||6
8415921|NCT00929695|20742993|P1|NOT COMPLETED|Overall Study||8
8415922|NCT00929695|20742992|P2|COMPLETED|Overall Study||77
8415923|NCT00929695|20742993|P1|COMPLETED|Overall Study||73
8415924|NCT00929695|20742992|P2|STARTED|Overall Study||83
8415925|NCT00929695|20742993|P1|STARTED|Overall Study||81
8415926|NCT00929669|20743023|P1|NOT COMPLETED|Overall Study||1
8415927|NCT00929669|20743023|P1|COMPLETED|Overall Study||1
8415928|NCT00929669|20743023|P1|STARTED|Overall Study||2
8415929|NCT00929656|20743030|P2|NOT COMPLETED|Overall Study||1
8415930|NCT00929656|20743031|P1|NOT COMPLETED|Overall Study||0
8415931|NCT00929656|20743030|P2|COMPLETED|Overall Study||8
8415932|NCT00929656|20743031|P1|COMPLETED|Overall Study||13
8415933|NCT00929656|20743030|P2|STARTED|Overall Study||9
8415934|NCT00929656|20743031|P1|STARTED|Overall Study||13
8415935|NCT00929643|20743045|P1|NOT COMPLETED|Overall Study||2
8415936|NCT00929643|20743045|P1|COMPLETED|Overall Study||201
8415937|NCT00929643|20743045|P1|STARTED|Overall Study||203
8415938|NCT00929578|20743054|P1|NOT COMPLETED|Overall Study||0
8415939|NCT00929578|20743054|P1|COMPLETED|Overall Study||15
8415940|NCT00929578|20743054|P1|STARTED|Overall Study||15
8415941|NCT00929526|20743067|P2|NOT COMPLETED|Overall Study||29
8415942|NCT00929526|20743068|P1|NOT COMPLETED|Overall Study||17
8415943|NCT00929526|20743067|P2|COMPLETED|Overall Study||348
8415944|NCT00929526|20743068|P1|COMPLETED|Overall Study||358
8415945|NCT00929526|20743067|P2|STARTED|Overall Study||377
8415946|NCT00929526|20743068|P1|STARTED|Overall Study||375
8415947|NCT00929500|20743104|P2|NOT COMPLETED|Overall Study||0
8415948|NCT00929500|20743105|P1|NOT COMPLETED|Overall Study||4
8415949|NCT00929500|20743104|P2|COMPLETED|Overall Study||4
8415950|NCT00929500|20743105|P1|COMPLETED|Overall Study||4
8415951|NCT00929500|20743104|P2|STARTED|Overall Study||4
8415952|NCT00929500|20743105|P1|STARTED|Overall Study||8
8415953|NCT00929474|20743119|P2|NOT COMPLETED|Overall Study||9
8415954|NCT00929474|20743120|P1|NOT COMPLETED|Overall Study||8
8415955|NCT00929474|20743119|P2|COMPLETED|Overall Study||0
8415956|NCT00929474|20743120|P1|COMPLETED|Overall Study||0
8415957|NCT00929474|20743119|P2|STARTED|Overall Study||9
8415958|NCT00929474|20743120|P1|STARTED|Overall Study||8
8415959|NCT00929383|20743126|P1|NOT COMPLETED|Overall Study||15
8415960|NCT00929383|20743126|P1|COMPLETED|Overall Study||67
8415961|NCT00929383|20743126|P1|STARTED|Overall Study||82
8415962|NCT00929357|20743136|P2|NOT COMPLETED|Overall Study||0
8415963|NCT00929357|20743137|P1|NOT COMPLETED|Overall Study||0
8415964|NCT00929357|20743136|P2|COMPLETED|Overall Study||64
8415965|NCT00929357|20743137|P1|COMPLETED|Overall Study||92
8415966|NCT00929357|20743136|P2|STARTED|Overall Study||64
8415967|NCT00929357|20743137|P1|STARTED|Overall Study||92
8415968|NCT00929344|20743160|P3|NOT COMPLETED|Overall Study||21
8415969|NCT00929344|20743161|P2|NOT COMPLETED|Overall Study||13
8415970|NCT00929344|20743162|P1|NOT COMPLETED|Overall Study||22
8415971|NCT00929344|20743160|P3|COMPLETED|Overall Study||29
8415972|NCT00929344|20743161|P2|COMPLETED|Overall Study||37
8415973|NCT00929344|20743162|P1|COMPLETED|Overall Study||28
8415974|NCT00929344|20743160|P3|STARTED|Overall Study||50
8415975|NCT00929344|20743161|P2|STARTED|Overall Study||50
8415976|NCT00929344|20743162|P1|STARTED|Overall Study||50
8415977|NCT00929331|20743178|P2|NOT COMPLETED|Overall Study||0
8415978|NCT00929331|20743179|P1|NOT COMPLETED|Overall Study||0
8415979|NCT00929331|20743178|P2|COMPLETED|Overall Study||55
8415980|NCT00929331|20743179|P1|COMPLETED|Overall Study||55
8415981|NCT00929331|20743178|P2|STARTED|Overall Study||55
8415982|NCT00929331|20743179|P1|STARTED|Overall Study||55
8415983|NCT00929305|20743213|P2|NOT COMPLETED|Overall Study||0
8415984|NCT00929305|20743214|P1|NOT COMPLETED|Overall Study||0
8415985|NCT00929305|20743213|P2|COMPLETED|Overall Study||43
8415986|NCT00929305|20743214|P1|COMPLETED|Overall Study||43
8415987|NCT00929305|20743213|P2|STARTED|Overall Study||43
8415988|NCT00929305|20743214|P1|STARTED|Overall Study||43
8415989|NCT00929240|20743222|P3|NOT COMPLETED|Maintenance Phase||91
8415990|NCT00929240|20743223|P2|NOT COMPLETED|Maintenance Phase||94
8415991|NCT00929240|20743224|P1|NOT COMPLETED|Maintenance Phase||0
8415992|NCT00929240|20743222|P3|COMPLETED|Maintenance Phase||0
8415993|NCT00929240|20743223|P2|COMPLETED|Maintenance Phase||0
8415994|NCT00929240|20743224|P1|COMPLETED|Maintenance Phase||0
8415995|NCT00929240|20743222|P3|STARTED|Maintenance Phase||91
8415996|NCT00929240|20743223|P2|STARTED|Maintenance Phase||94
8415997|NCT00929240|20743224|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
8415998|NCT00929240|20743222|P3|NOT COMPLETED|Initial Treatment Phase||0
8415999|NCT00929240|20743223|P2|NOT COMPLETED|Initial Treatment Phase||0
8416000|NCT00929240|20743224|P1|NOT COMPLETED|Initial Treatment Phase||99
8416001|NCT00929240|20743222|P3|COMPLETED|Initial Treatment Phase||0
8416002|NCT00929240|20743223|P2|COMPLETED|Initial Treatment Phase||0
8416003|NCT00929240|20743224|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
8416004|NCT00929240|20743222|P3|STARTED|Initial Treatment Phase||0
8416005|NCT00929240|20743223|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
8416006|NCT00929240|20743224|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
8416007|NCT00929201|20743251|P2|NOT COMPLETED|Period 2||0
8416008|NCT00929201|20743252|P1|NOT COMPLETED|Period 2||0
8416009|NCT00929201|20743251|P2|COMPLETED|Period 2||30
8416010|NCT00929201|20743252|P1|COMPLETED|Period 2||30
8416011|NCT00929201|20743251|P2|STARTED|Period 2||30
8416012|NCT00929201|20743252|P1|STARTED|Period 2||30
8416013|NCT00929201|20743251|P2|NOT COMPLETED|7-day Washout||0
8416014|NCT00929201|20743252|P1|NOT COMPLETED|7-day Washout||0
8416015|NCT00929201|20743251|P2|COMPLETED|7-day Washout||30
8416016|NCT00929201|20743252|P1|COMPLETED|7-day Washout||30
8416017|NCT00929201|20743251|P2|STARTED|7-day Washout||30
8416018|NCT00929201|20743252|P1|STARTED|7-day Washout||30
8416019|NCT00929201|20743251|P2|NOT COMPLETED|Period 1||1
8416020|NCT00929201|20743252|P1|NOT COMPLETED|Period 1||0
8416021|NCT00929201|20743251|P2|COMPLETED|Period 1||30
8416022|NCT00929201|20743252|P1|COMPLETED|Period 1||30
8416023|NCT00929201|20743251|P2|STARTED|Period 1||31
8416024|NCT00929201|20743252|P1|STARTED|Period 1||30
8416025|NCT00929162|20743262|P2|NOT COMPLETED|Overall Study||42
8416026|NCT00929162|20743263|P1|NOT COMPLETED|Overall Study||48
8416027|NCT00929162|20743262|P2|COMPLETED|Overall Study||19
8416028|NCT00929162|20743263|P1|COMPLETED|Overall Study||11
8416029|NCT00929162|20743262|P2|Patients Who Received Treatment|Overall Study||58
8416030|NCT00929162|20743263|P1|Patients Who Received Treatment|Overall Study||58
8416031|NCT00929162|20743262|P2|STARTED|Overall Study||61
8416032|NCT00929162|20743263|P1|STARTED|Overall Study||59
8416033|NCT00929110|20743276|P3|NOT COMPLETED|Overall Study||62
8416034|NCT00929110|20743277|P2|NOT COMPLETED|Overall Study||76
8416035|NCT00929110|20743278|P1|NOT COMPLETED|Overall Study||118
8416036|NCT00929110|20743276|P3|COMPLETED|Overall Study||206
8416037|NCT00929110|20743277|P2|COMPLETED|Overall Study||193
8416038|NCT00929110|20743278|P1|COMPLETED|Overall Study||411
8416039|NCT00929110|20743276|P3|STARTED|Overall Study||268
8416040|NCT00929110|20743277|P2|STARTED|Overall Study||269
8416041|NCT00929110|20743278|P1|STARTED|Overall Study||529
8416042|NCT00929071|20743343|P1|NOT COMPLETED|Overall Study||0
8416043|NCT00929071|20743343|P1|COMPLETED|Overall Study||10
8416044|NCT00929071|20743343|P1|STARTED|Overall Study||10
8416045|NCT00928954|20743350|P2|NOT COMPLETED|Overall Study||0
8416046|NCT00928954|20743351|P1|NOT COMPLETED|Overall Study||0
8416047|NCT00928954|20743350|P2|COMPLETED|Overall Study||6
8416048|NCT00928954|20743351|P1|COMPLETED|Overall Study||4
8416049|NCT00928954|20743350|P2|STARTED|Overall Study||6
8416050|NCT00928954|20743351|P1|STARTED|Overall Study||4
8416051|NCT00928889|20743361|P2|NOT COMPLETED|Overall Study||2
8416052|NCT00928889|20743362|P1|NOT COMPLETED|Overall Study||5
8416053|NCT00928889|20743361|P2|COMPLETED|Overall Study||78
8416054|NCT00928889|20743362|P1|COMPLETED|Overall Study||75
8416055|NCT00928889|20743361|P2|STARTED|Overall Study||80
8416056|NCT00928889|20743362|P1|STARTED|Overall Study||80
8416057|NCT00928772|20743389|P3|NOT COMPLETED|Overall Study||0
8416058|NCT00928772|20743390|P2|NOT COMPLETED|Overall Study||0
8416059|NCT00928772|20743391|P1|NOT COMPLETED|Overall Study||0
8416060|NCT00928772|20743389|P3|COMPLETED|Overall Study||38
8416061|NCT00928772|20743390|P2|COMPLETED|Overall Study||38
8416062|NCT00928772|20743391|P1|COMPLETED|Overall Study||39
8416063|NCT00928772|20743389|P3|STARTED|Overall Study||38
8416064|NCT00928772|20743390|P2|STARTED|Overall Study||38
8416065|NCT00928772|20743391|P1|STARTED|Overall Study||39
8416066|NCT00928746|20743408|P1|NOT COMPLETED|Overall Study||6
8416067|NCT00928746|20743408|P1|COMPLETED|Overall Study||136
8416068|NCT00928746|20743408|P1|STARTED|Overall Study||142
8416069|NCT00928720|20743431|P3|NOT COMPLETED|Overall Study||3
8416070|NCT00928720|20743432|P2|NOT COMPLETED|Overall Study||6
8416071|NCT00928720|20743433|P1|NOT COMPLETED|Overall Study||2
8416072|NCT00928720|20743431|P3|COMPLETED|Overall Study||15
8416073|NCT00928720|20743432|P2|COMPLETED|Overall Study||14
8416074|NCT00928720|20743433|P1|COMPLETED|Overall Study||17
8416075|NCT00928720|20743431|P3|STARTED|Overall Study||18
8416076|NCT00928720|20743432|P2|STARTED|Overall Study||20
8416077|NCT00928720|20743433|P1|STARTED|Overall Study||19
8416078|NCT00928707|20743458|P2|NOT COMPLETED|Overall Study||0
8416079|NCT00928707|20743459|P1|NOT COMPLETED|Overall Study||1
8416080|NCT00928707|20743458|P2|COMPLETED|Overall Study||22
8416081|NCT00928707|20743459|P1|COMPLETED|Overall Study||22
8416082|NCT00928707|20743458|P2|STARTED|Overall Study||22
8416083|NCT00928707|20743459|P1|STARTED|Overall Study||23
8416084|NCT00928694|20743471|P2|NOT COMPLETED|Second Intervention||0
8416085|NCT00928694|20743472|P1|NOT COMPLETED|Second Intervention||0
8416086|NCT00928694|20743471|P2|COMPLETED|Second Intervention||7
8416087|NCT00928694|20743472|P1|COMPLETED|Second Intervention||7
8416088|NCT00928694|20743471|P2|STARTED|Second Intervention||7
8416089|NCT00928694|20743472|P1|STARTED|Second Intervention||7
8416090|NCT00928694|20743471|P2|NOT COMPLETED|First Intervention||0
8416091|NCT00928694|20743472|P1|NOT COMPLETED|First Intervention||0
8416092|NCT00928694|20743471|P2|COMPLETED|First Intervention||7
8416093|NCT00928694|20743472|P1|COMPLETED|First Intervention||7
8416094|NCT00928694|20743471|P2|STARTED|First Intervention||7
8416095|NCT00928694|20743472|P1|STARTED|First Intervention||7
8416096|NCT00928668|20743480|P5|NOT COMPLETED|Overall Study||1
8416097|NCT00928668|20743481|P4|NOT COMPLETED|Overall Study||1
8416098|NCT00928668|20743482|P3|NOT COMPLETED|Overall Study||1
8416099|NCT00928668|20743483|P2|NOT COMPLETED|Overall Study||1
8416100|NCT00928668|20743484|P1|NOT COMPLETED|Overall Study||1
8416101|NCT00928668|20743480|P5|COMPLETED|Overall Study||5
8416102|NCT00928668|20743481|P4|COMPLETED|Overall Study||3
8416103|NCT00928668|20743482|P3|COMPLETED|Overall Study||6
8416104|NCT00928668|20743483|P2|COMPLETED|Overall Study||6
8416105|NCT00928668|20743484|P1|COMPLETED|Overall Study||6
8416106|NCT00928668|20743480|P5|STARTED|Overall Study||6
8416107|NCT00928668|20743481|P4|STARTED|Overall Study||4
8416108|NCT00928668|20743482|P3|STARTED|Overall Study||7
8416109|NCT00928668|20743483|P2|STARTED|Overall Study||7
8416110|NCT00928668|20743484|P1|STARTED|Overall Study||7
8416111|NCT00928642|20743526|P1|NOT COMPLETED|Overall Study||0
8416112|NCT00928642|20743526|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
8416113|NCT00928642|20743526|P1|STARTED|Overall Study||8
8416114|NCT00928512|20743540|P5|NOT COMPLETED|Overall Study||15
8416115|NCT00928512|20743541|P4|NOT COMPLETED|Overall Study||21
8416116|NCT00928512|20743542|P3|NOT COMPLETED|Overall Study||11
8416117|NCT00928512|20743543|P2|NOT COMPLETED|Overall Study||6
8416118|NCT00928512|20743544|P1|NOT COMPLETED|Overall Study||10
8416119|NCT00928512|20743540|P5|COMPLETED|Overall Study||35
8416120|NCT00928512|20743541|P4|COMPLETED|Overall Study||33
8416121|NCT00928512|20743542|P3|COMPLETED|Overall Study||38
8416122|NCT00928512|20743543|P2|COMPLETED|Overall Study||37
8416123|NCT00928512|20743544|P1|COMPLETED|Overall Study||31
8416124|NCT00928512|20743540|P5|Entered/Continued to Week 20 (All)|Overall Study||45
8416125|NCT00928512|20743541|P4|Entered/Continued to Week 20 (All)|Overall Study||45
8416126|NCT00928512|20743542|P3|Entered/Continued to Week 20 (All)|Overall Study||46
8416127|NCT00928512|20743543|P2|Entered/Continued to Week 20 (All)|Overall Study||43
8416128|NCT00928512|20743544|P1|Entered/Continued to Week 20 (All)|Overall Study||37
8416129|NCT00928512|20743540|P5|Completed Week 16|Overall Study||45
8416130|NCT00928512|20743541|P4|Completed Week 16|Overall Study||48
8416131|NCT00928512|20743542|P3|Completed Week 16|Overall Study||47
8416132|NCT00928512|20743543|P2|Completed Week 16|Overall Study||43
8416133|NCT00928512|20743544|P1|Completed Week 16|Overall Study||38
8416134|NCT00928512|20743540|P5|New Groups After Reassignment|Overall Study||0
8416135|NCT00928512|20743541|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
8416136|NCT00928512|20743542|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
8416137|NCT00928512|20743543|P2|New Groups After Reassignment|Overall Study||115
8416138|NCT00928512|20743544|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
8416139|NCT00928512|20743540|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
8416140|NCT00928512|20743541|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
8416141|NCT00928512|20743542|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
8416142|NCT00928512|20743543|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
8416143|NCT00928512|20743544|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
8416144|NCT00928512|20743540|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
8416145|NCT00928512|20743541|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
8416146|NCT00928512|20743542|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
8416147|NCT00928512|20743543|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
8416148|NCT00928512|20743544|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
8416149|NCT00928512|20743540|P5|Discontinued Prior to Week 16|Overall Study||5
8416150|NCT00928512|20743541|P4|Discontinued Prior to Week 16|Overall Study||6
8416151|NCT00928512|20743542|P3|Discontinued Prior to Week 16|Overall Study||2
8416152|NCT00928512|20743543|P2|Discontinued Prior to Week 16|Overall Study||0
8416153|NCT00928512|20743544|P1|Discontinued Prior to Week 16|Overall Study||3
8416154|NCT00928512|20743540|P5|STARTED|Overall Study||50
8416155|NCT00928512|20743541|P4|STARTED|Overall Study||54
8416156|NCT00928512|20743542|P3|STARTED|Overall Study||49
8416157|NCT00928512|20743543|P2|STARTED|Overall Study||43
8416158|NCT00928512|20743544|P1|STARTED|Overall Study||41
8416159|NCT00928486|20743645|P1|NOT COMPLETED|Overall Study||10
8416160|NCT00928486|20743645|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
8416161|NCT00928486|20743645|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
8416162|NCT00928486|20743645|P1|STARTED|Overall Study||25
8416163|NCT00928434|20743654|P3|NOT COMPLETED|Overall Study||44
8416164|NCT00928434|20743655|P2|NOT COMPLETED|Overall Study||14
8416165|NCT00928434|20743656|P1|NOT COMPLETED|Overall Study||44
8416166|NCT00928434|20743654|P3|COMPLETED|Overall Study||134
8416167|NCT00928434|20743655|P2|COMPLETED|Overall Study||36
8416168|NCT00928434|20743656|P1|COMPLETED|Overall Study||131
8416169|NCT00928434|20743654|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
8416170|NCT00928434|20743655|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
8416171|NCT00928434|20743656|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
8416172|NCT00928434|20743654|P3|STARTED|Overall Study|Full Analysis Set Patients|178
8416173|NCT00928434|20743655|P2|STARTED|Overall Study|Full Analysis Set Patients|50
8416174|NCT00928434|20743656|P1|STARTED|Overall Study|Full Analysis Set Patients|175
8416175|NCT00928421|20743728|P1|NOT COMPLETED|Overall Study||0
8416176|NCT00928421|20743728|P1|COMPLETED|Overall Study||16
8416177|NCT00928421|20743728|P1|Treated With Study Drug|Overall Study||16
8416178|NCT00928421|20743728|P1|STARTED|Overall Study||16
8416179|NCT00928408|20743732|P1|NOT COMPLETED|Overall Study||23
8416180|NCT00928408|20743732|P1|COMPLETED|Overall Study||282
8416181|NCT00928408|20743732|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
8416182|NCT00928408|20743732|P1|STARTED|Overall Study|Number Enrolled|305
8416183|NCT00928395|20743761|P1|NOT COMPLETED|Overall Study||21
8416184|NCT00928395|20743761|P1|COMPLETED|Overall Study||29
8416185|NCT00928395|20743761|P1|STARTED|Overall Study||50
8416186|NCT00928304|20743765|P2|NOT COMPLETED|Overall Study||0
8416187|NCT00928304|20743766|P1|NOT COMPLETED|Overall Study||0
8416188|NCT00928304|20743765|P2|COMPLETED|Overall Study||70
8416189|NCT00928304|20743766|P1|COMPLETED|Overall Study||39
8416190|NCT00928304|20743765|P2|STARTED|Overall Study||70
8416191|NCT00928304|20743766|P1|STARTED|Overall Study||39
8416192|NCT00928252|20743778|P1|NOT COMPLETED|Overall Study||3
8416193|NCT00928252|20743778|P1|COMPLETED|Overall Study||42
8416194|NCT00928252|20743778|P1|STARTED|Overall Study||45
8416195|NCT00928226|20743788|P4|NOT COMPLETED|Overall Study||0
8416196|NCT00928226|20743789|P3|NOT COMPLETED|Overall Study||0
8416197|NCT00928226|20743790|P2|NOT COMPLETED|Overall Study||0
8416198|NCT00928226|20743791|P1|NOT COMPLETED|Overall Study||0
8416199|NCT00928226|20743788|P4|COMPLETED|Overall Study||12
8416200|NCT00928226|20743789|P3|COMPLETED|Overall Study||12
8416201|NCT00928226|20743790|P2|COMPLETED|Overall Study||12
8416202|NCT00928226|20743791|P1|COMPLETED|Overall Study||20
8416203|NCT00928226|20743788|P4|Strata D: Large Tumor, Not Resected|Overall Study||0
8416204|NCT00928226|20743789|P3|Strata D: Large Tumor, Not Resected|Overall Study||0
8416205|NCT00928226|20743790|P2|Strata D: Large Tumor, Not Resected|Overall Study||0
8416206|NCT00928226|20743791|P1|Strata D: Large Tumor, Not Resected|Overall Study||1
8416207|NCT00928226|20743788|P4|Strata C: Large Tumor, Resected|Overall Study||6
8416208|NCT00928226|20743789|P3|Strata C: Large Tumor, Resected|Overall Study||6
8416209|NCT00928226|20743790|P2|Strata C: Large Tumor, Resected|Overall Study||6
8416210|NCT00928226|20743791|P1|Strata C: Large Tumor, Resected|Overall Study||8
8416211|NCT00928226|20743788|P4|Strata B: Small Tumor, Not Resected|Overall Study||0
8416212|NCT00928226|20743789|P3|Strata B: Small Tumor, Not Resected|Overall Study||0
8416213|NCT00928226|20743790|P2|Strata B: Small Tumor, Not Resected|Overall Study||0
8416214|NCT00928226|20743791|P1|Strata B: Small Tumor, Not Resected|Overall Study||5
8416215|NCT00928226|20743788|P4|Strata A: Small Tumor, Resected|Overall Study||6
8416216|NCT00928226|20743789|P3|Strata A: Small Tumor, Resected|Overall Study||6
8416217|NCT00928226|20743790|P2|Strata A: Small Tumor, Resected|Overall Study||6
8416218|NCT00928226|20743791|P1|Strata A: Small Tumor, Resected|Overall Study||6
8416219|NCT00928226|20743788|P4|STARTED|Overall Study||12
8416220|NCT00928226|20743789|P3|STARTED|Overall Study||12
8416221|NCT00928226|20743790|P2|STARTED|Overall Study||12
8416222|NCT00928226|20743791|P1|STARTED|Overall Study||20
8416223|NCT00928200|20743829|P1|NOT COMPLETED|Overall Study||0
8416224|NCT00928200|20743829|P1|COMPLETED|Overall Study||1
8416225|NCT00928200|20743829|P1|STARTED|Overall Study||1
8416226|NCT00928187|20743838|P3|NOT COMPLETED|Overall Study||5
8416227|NCT00928187|20743839|P2|NOT COMPLETED|Overall Study||6
8416228|NCT00928187|20743840|P1|NOT COMPLETED|Overall Study||2
8416229|NCT00928187|20743838|P3|COMPLETED|Overall Study||150
8416230|NCT00928187|20743839|P2|COMPLETED|Overall Study||141
8416231|NCT00928187|20743840|P1|COMPLETED|Overall Study||150
8416232|NCT00928187|20743838|P3|Analysed|Overall Study||154
8416233|NCT00928187|20743839|P2|Analysed|Overall Study||145
8416234|NCT00928187|20743840|P1|Analysed|Overall Study||152
8416235|NCT00928187|20743838|P3|STARTED|Overall Study||155
8416236|NCT00928187|20743839|P2|STARTED|Overall Study||147
8416237|NCT00928187|20743840|P1|STARTED|Overall Study||152
8416238|NCT00928174|20743884|P1|NOT COMPLETED|Overall Study||5
8416239|NCT00928174|20743884|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
8416240|NCT00928174|20743884|P1|STARTED|Overall Study||27
8416241|NCT00928083|20743891|P9|NOT COMPLETED|Overall Study||0
8416242|NCT00928083|20743892|P8|NOT COMPLETED|Overall Study||0
8416243|NCT00928083|20743893|P7|NOT COMPLETED|Overall Study||0
8416244|NCT00928083|20743894|P6|NOT COMPLETED|Overall Study||0
8416245|NCT00928083|20743895|P5|NOT COMPLETED|Overall Study||1
8416246|NCT00928083|20743896|P4|NOT COMPLETED|Overall Study||1
8416247|NCT00928083|20743897|P3|NOT COMPLETED|Overall Study||0
8416248|NCT00928083|20743898|P2|NOT COMPLETED|Overall Study||0
8416249|NCT00928083|20743899|P1|NOT COMPLETED|Overall Study||4
8416250|NCT00928083|20743891|P9|COMPLETED|Overall Study||6
8416251|NCT00928083|20743892|P8|COMPLETED|Overall Study||6
8416252|NCT00928083|20743893|P7|COMPLETED|Overall Study||6
8416253|NCT00928083|20743894|P6|COMPLETED|Overall Study||6
8416254|NCT00928083|20743895|P5|COMPLETED|Overall Study||6
8416255|NCT00928083|20743896|P4|COMPLETED|Overall Study||5
8416256|NCT00928083|20743897|P3|COMPLETED|Overall Study||8
8416257|NCT00928083|20743898|P2|COMPLETED|Overall Study||8
8416258|NCT00928083|20743899|P1|COMPLETED|Overall Study||6
8416259|NCT00928083|20743891|P9|STARTED|Overall Study||6
8416260|NCT00928083|20743892|P8|STARTED|Overall Study||6
8416261|NCT00928083|20743893|P7|STARTED|Overall Study||6
8416262|NCT00928083|20743894|P6|STARTED|Overall Study||6
8416263|NCT00928083|20743895|P5|STARTED|Overall Study||7
8416264|NCT00928083|20743896|P4|STARTED|Overall Study||6
8416265|NCT00928083|20743897|P3|STARTED|Overall Study||8
8416266|NCT00928083|20743898|P2|STARTED|Overall Study||8
8416267|NCT00928083|20743899|P1|STARTED|Overall Study||10
8416268|NCT00928070|20744010|P2|NOT COMPLETED|Overall Study||57
8416269|NCT00928070|20744011|P1|NOT COMPLETED|Overall Study||63
8416270|NCT00928070|20744010|P2|COMPLETED|Overall Study||226
8416271|NCT00928070|20744011|P1|COMPLETED|Overall Study||220
8416272|NCT00928070|20744010|P2|Treated|Overall Study||281
8416273|NCT00928070|20744011|P1|Treated|Overall Study||281
8416274|NCT00928070|20744010|P2|STARTED|Overall Study||283
8416275|NCT00928070|20744011|P1|STARTED|Overall Study||283
8416276|NCT00928057|20744069|P2|NOT COMPLETED|Overall Study||4
8416277|NCT00928057|20744070|P1|NOT COMPLETED|Overall Study||2
8416278|NCT00928057|20744069|P2|COMPLETED|Overall Study||85
8416279|NCT00928057|20744070|P1|COMPLETED|Overall Study||82
8416280|NCT00928057|20744069|P2|STARTED|Overall Study||89
8416281|NCT00928057|20744070|P1|STARTED|Overall Study||84
8416282|NCT00928018|20744095|P2|NOT COMPLETED|Overall Study||0
8416283|NCT00928018|20744096|P1|NOT COMPLETED|Overall Study||1
8416284|NCT00928018|20744095|P2|COMPLETED|Overall Study||73
8416285|NCT00928018|20744096|P1|COMPLETED|Overall Study||65
8416286|NCT00928018|20744095|P2|STARTED|Overall Study||73
8416287|NCT00928018|20744096|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
8416288|NCT00927992|20744114|P1|NOT COMPLETED|Overall Study||0
8416289|NCT00927992|20744114|P1|COMPLETED|Overall Study||11
8416290|NCT00927992|20744114|P1|STARTED|Overall Study||11
8416291|NCT00927953|20744126|P2|NOT COMPLETED|Overall Study||1
8416292|NCT00927953|20744127|P1|NOT COMPLETED|Overall Study||2
8416293|NCT00927953|20744126|P2|COMPLETED|Overall Study||6
8416294|NCT00927953|20744127|P1|COMPLETED|Overall Study||4
8416295|NCT00927953|20744126|P2|STARTED|Overall Study||7
8416296|NCT00927953|20744127|P1|STARTED|Overall Study||6
8416297|NCT00927940|20744141|P1|NOT COMPLETED|Overall Study||1
8416298|NCT00927940|20744141|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
8416299|NCT00927940|20744141|P1|STARTED|Overall Study||100
8416300|NCT00927927|20744161|P15|NOT COMPLETED|Overall Study||0
8416301|NCT00927927|20744162|P14|NOT COMPLETED|Overall Study||0
8416302|NCT00927927|20744163|P13|NOT COMPLETED|Overall Study||0
8416303|NCT00927927|20744164|P12|NOT COMPLETED|Overall Study||2
8416304|NCT00927927|20744165|P11|NOT COMPLETED|Overall Study||0
8416305|NCT00927927|20744166|P10|NOT COMPLETED|Overall Study||0
8416306|NCT00927927|20744167|P9|NOT COMPLETED|Overall Study||0
8416307|NCT00927927|20744168|P8|NOT COMPLETED|Overall Study||2
8416308|NCT00927927|20744169|P7|NOT COMPLETED|Overall Study||0
8416309|NCT00927927|20744170|P6|NOT COMPLETED|Overall Study||0
8416310|NCT00927927|20744171|P5|NOT COMPLETED|Overall Study||0
8416311|NCT00927927|20744172|P4|NOT COMPLETED|Overall Study||0
8416312|NCT00927927|20744173|P3|NOT COMPLETED|Overall Study||0
8416313|NCT00927927|20744174|P2|NOT COMPLETED|Overall Study||0
8416314|NCT00927927|20744175|P1|NOT COMPLETED|Overall Study||0
8416315|NCT00927927|20744161|P15|COMPLETED|Overall Study||9
8416316|NCT00927927|20744162|P14|COMPLETED|Overall Study||5
8416317|NCT00927927|20744163|P13|COMPLETED|Overall Study||5
8416318|NCT00927927|20744164|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
8416319|NCT00927927|20744165|P11|COMPLETED|Overall Study||5
8416320|NCT00927927|20744166|P10|COMPLETED|Overall Study||3
8416321|NCT00927927|20744167|P9|COMPLETED|Overall Study||8
8416322|NCT00927927|20744168|P8|COMPLETED|Overall Study||1
8416323|NCT00927927|20744169|P7|COMPLETED|Overall Study||3
8416324|NCT00927927|20744170|P6|COMPLETED|Overall Study||3
8416325|NCT00927927|20744171|P5|COMPLETED|Overall Study||3
8416326|NCT00927927|20744172|P4|COMPLETED|Overall Study||3
8416327|NCT00927927|20744173|P3|COMPLETED|Overall Study||3
8416328|NCT00927927|20744174|P2|COMPLETED|Overall Study||3
8416329|NCT00927927|20744175|P1|COMPLETED|Overall Study||3
8416330|NCT00927927|20744161|P15|Exposed|Overall Study||9
8416331|NCT00927927|20744162|P14|Exposed|Overall Study||5
8416332|NCT00927927|20744163|P13|Exposed|Overall Study||5
8416333|NCT00927927|20744164|P12|Exposed|Overall Study||5
8416334|NCT00927927|20744165|P11|Exposed|Overall Study||5
8416335|NCT00927927|20744166|P10|Exposed|Overall Study||3
8416336|NCT00927927|20744167|P9|Exposed|Overall Study||8
8416337|NCT00927927|20744168|P8|Exposed|Overall Study||3
8416338|NCT00927927|20744169|P7|Exposed|Overall Study||3
8416339|NCT00927927|20744170|P6|Exposed|Overall Study||3
8416340|NCT00927927|20744171|P5|Exposed|Overall Study||3
8416341|NCT00927927|20744172|P4|Exposed|Overall Study||3
8416342|NCT00927927|20744173|P3|Exposed|Overall Study||3
8416343|NCT00927927|20744174|P2|Exposed|Overall Study||3
8416344|NCT00927927|20744175|P1|Exposed|Overall Study||3
8416345|NCT00927927|20744161|P15|STARTED|Overall Study||9
8416346|NCT00927927|20744162|P14|STARTED|Overall Study||5
8416347|NCT00927927|20744163|P13|STARTED|Overall Study||5
8416348|NCT00927927|20744164|P12|STARTED|Overall Study||6
8416349|NCT00927927|20744165|P11|STARTED|Overall Study||5
8416350|NCT00927927|20744166|P10|STARTED|Overall Study||3
8416351|NCT00927927|20744167|P9|STARTED|Overall Study||8
8416352|NCT00927927|20744168|P8|STARTED|Overall Study||3
8416353|NCT00927927|20744169|P7|STARTED|Overall Study||3
8416354|NCT00927927|20744170|P6|STARTED|Overall Study||3
8416355|NCT00927927|20744171|P5|STARTED|Overall Study||3
8416356|NCT00927927|20744172|P4|STARTED|Overall Study||3
8416357|NCT00927927|20744173|P3|STARTED|Overall Study||3
8416358|NCT00927927|20744174|P2|STARTED|Overall Study||3
8416359|NCT00927927|20744175|P1|STARTED|Overall Study||3
8416360|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 4||1
8416361|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 4||1
8416362|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 4||0
8416363|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 4||0
8416364|NCT00927901|20744222|P4|COMPLETED|Treatment Period 4||8
8416365|NCT00927901|20744223|P3|COMPLETED|Treatment Period 4||5
8416366|NCT00927901|20744224|P2|COMPLETED|Treatment Period 4||7
8416367|NCT00927901|20744225|P1|COMPLETED|Treatment Period 4||7
8416368|NCT00927901|20744222|P4|STARTED|Treatment Period 4||9
8416369|NCT00927901|20744223|P3|STARTED|Treatment Period 4||6
8416370|NCT00927901|20744224|P2|STARTED|Treatment Period 4||7
8416371|NCT00927901|20744225|P1|STARTED|Treatment Period 4||7
8416372|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 3||0
8416373|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 3||0
8416374|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 3||0
8416375|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 3||0
8416376|NCT00927901|20744222|P4|COMPLETED|Treatment Period 3||9
8416377|NCT00927901|20744223|P3|COMPLETED|Treatment Period 3||6
8416378|NCT00927901|20744224|P2|COMPLETED|Treatment Period 3||7
8416379|NCT00927901|20744225|P1|COMPLETED|Treatment Period 3||7
8416380|NCT00927901|20744222|P4|STARTED|Treatment Period 3||9
8416381|NCT00927901|20744223|P3|STARTED|Treatment Period 3||6
8416382|NCT00927901|20744224|P2|STARTED|Treatment Period 3||7
8416383|NCT00927901|20744225|P1|STARTED|Treatment Period 3||7
8416384|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 2||0
8416385|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 2||0
8416386|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 2||0
8416387|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 2||0
8416388|NCT00927901|20744222|P4|COMPLETED|Treatment Period 2||9
8416389|NCT00927901|20744223|P3|COMPLETED|Treatment Period 2||6
8416390|NCT00927901|20744224|P2|COMPLETED|Treatment Period 2||7
8416391|NCT00927901|20744225|P1|COMPLETED|Treatment Period 2||7
8416392|NCT00927901|20744222|P4|STARTED|Treatment Period 2||9
8416393|NCT00927901|20744223|P3|STARTED|Treatment Period 2||6
8416394|NCT00927901|20744224|P2|STARTED|Treatment Period 2||7
8416395|NCT00927901|20744225|P1|STARTED|Treatment Period 2||7
8416396|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 1||0
8416397|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 1||1
8416398|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 1||0
8416399|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 1||0
8416400|NCT00927901|20744222|P4|COMPLETED|Treatment Period 1||9
8416401|NCT00927901|20744223|P3|COMPLETED|Treatment Period 1||6
8416402|NCT00927901|20744224|P2|COMPLETED|Treatment Period 1||7
8416403|NCT00927901|20744225|P1|COMPLETED|Treatment Period 1||7
8416404|NCT00927901|20744222|P4|STARTED|Treatment Period 1||9
8416405|NCT00927901|20744223|P3|STARTED|Treatment Period 1||7
8416406|NCT00927901|20744224|P2|STARTED|Treatment Period 1||7
8416407|NCT00927901|20744225|P1|STARTED|Treatment Period 1||7
8416408|NCT00927888|20744255|P2|NOT COMPLETED|Overall Study||0
8416409|NCT00927888|20744256|P1|NOT COMPLETED|Overall Study||0
8416410|NCT00927888|20744255|P2|COMPLETED|Overall Study||27
8416411|NCT00927888|20744256|P1|COMPLETED|Overall Study||29
8416412|NCT00927888|20744255|P2|STARTED|Overall Study||27
8416413|NCT00927888|20744256|P1|STARTED|Overall Study||29
8416414|NCT00927862|20744266|P2|NOT COMPLETED|Overall Study||45
8416415|NCT00927862|20744267|P1|NOT COMPLETED|Overall Study||27
8416416|NCT00927862|20744266|P2|COMPLETED|Overall Study||1866
8416417|NCT00927862|20744267|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
8416418|NCT00927862|20744266|P2|STARTED|Overall Study||1911
8416419|NCT00927862|20744267|P1|STARTED|Overall Study||504
8416420|NCT00927849|20744292|P3|NOT COMPLETED|Overall Study||0
8416421|NCT00927849|20744293|P2|NOT COMPLETED|Overall Study||0
8416422|NCT00927849|20744294|P1|NOT COMPLETED|Overall Study||0
8416423|NCT00927849|20744292|P3|COMPLETED|Overall Study||21
8416424|NCT00927849|20744293|P2|COMPLETED|Overall Study||21
8416425|NCT00927849|20744294|P1|COMPLETED|Overall Study||21
8416426|NCT00927849|20744292|P3|STARTED|Overall Study||21
8416427|NCT00927849|20744293|P2|STARTED|Overall Study||21
8416428|NCT00927849|20744294|P1|STARTED|Overall Study||21
8416429|NCT00927823|20744302|P4|NOT COMPLETED|Continuous Dosing Period||5
8416430|NCT00927823|20744303|P3|NOT COMPLETED|Continuous Dosing Period||26
8416431|NCT00927823|20744304|P2|NOT COMPLETED|Continuous Dosing Period||3
8416432|NCT00927823|20744305|P1|NOT COMPLETED|Continuous Dosing Period||3
8416433|NCT00927823|20744302|P4|COMPLETED|Continuous Dosing Period||0
8416434|NCT00927823|20744303|P3|COMPLETED|Continuous Dosing Period||0
8416435|NCT00927823|20744304|P2|COMPLETED|Continuous Dosing Period||0
8416436|NCT00927823|20744305|P1|COMPLETED|Continuous Dosing Period||0
8416437|NCT00927823|20744302|P4|Treated|Continuous Dosing Period||5
8416438|NCT00927823|20744303|P3|Treated|Continuous Dosing Period||23
8416439|NCT00927823|20744304|P2|Treated|Continuous Dosing Period||3
8416440|NCT00927823|20744305|P1|Treated|Continuous Dosing Period||3
8416441|NCT00927823|20744302|P4|STARTED|Continuous Dosing Period||5
8416442|NCT00927823|20744303|P3|STARTED|Continuous Dosing Period||26
8416443|NCT00927823|20744304|P2|STARTED|Continuous Dosing Period||3
8416444|NCT00927823|20744305|P1|STARTED|Continuous Dosing Period||3
8416445|NCT00927823|20744302|P4|NOT COMPLETED|Lead-In Period||0
8416446|NCT00927823|20744303|P3|NOT COMPLETED|Lead-In Period||0
8416447|NCT00927823|20744304|P2|NOT COMPLETED|Lead-In Period||0
8416448|NCT00927823|20744305|P1|NOT COMPLETED|Lead-In Period||0
8416449|NCT00927823|20744302|P4|COMPLETED|Lead-In Period||5
8416450|NCT00927823|20744303|P3|COMPLETED|Lead-In Period||26
8416451|NCT00927823|20744304|P2|COMPLETED|Lead-In Period||3
8416452|NCT00927823|20744305|P1|COMPLETED|Lead-In Period||3
8416453|NCT00927823|20744302|P4|STARTED|Lead-In Period||5
8416454|NCT00927823|20744303|P3|STARTED|Lead-In Period||26
8416455|NCT00927823|20744304|P2|STARTED|Lead-In Period||3
8416456|NCT00927823|20744305|P1|STARTED|Lead-In Period||3
8416457|NCT00927784|20744371|P2|NOT COMPLETED|Overall Study||0
8416458|NCT00927784|20744372|P1|NOT COMPLETED|Overall Study||2
8416459|NCT00927784|20744371|P2|COMPLETED|Overall Study||2
8416460|NCT00927784|20744372|P1|COMPLETED|Overall Study||6
8416461|NCT00927784|20744371|P2|STARTED|Overall Study||2
8416462|NCT00927784|20744372|P1|STARTED|Overall Study||8
8416463|NCT00927758|20744402|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416464|NCT00927758|20744403|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416465|NCT00927758|20744404|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416466|NCT00927758|20744405|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416467|NCT00927758|20744406|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416468|NCT00927758|20744407|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416469|NCT00927758|20744402|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
8416470|NCT00927758|20744403|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416471|NCT00927758|20744404|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
8416472|NCT00927758|20744405|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416473|NCT00927758|20744406|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416474|NCT00927758|20744407|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416475|NCT00927758|20744402|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
8416476|NCT00927758|20744403|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416477|NCT00927758|20744404|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
8416478|NCT00927758|20744405|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416479|NCT00927758|20744406|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416480|NCT00927758|20744407|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416481|NCT00927758|20744402|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416482|NCT00927758|20744403|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8416483|NCT00927758|20744404|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416484|NCT00927758|20744405|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416485|NCT00927758|20744406|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8416486|NCT00927758|20744407|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8416487|NCT00927758|20744402|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
8416488|NCT00927758|20744403|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416489|NCT00927758|20744404|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416490|NCT00927758|20744405|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416491|NCT00927758|20744406|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416492|NCT00927758|20744407|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416493|NCT00927758|20744402|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
8416494|NCT00927758|20744403|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
8416495|NCT00927758|20744404|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
8416496|NCT00927758|20744405|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
8416497|NCT00927758|20744406|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
8416498|NCT00927758|20744407|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
8416499|NCT00927758|20744402|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416500|NCT00927758|20744403|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416501|NCT00927758|20744404|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
8416502|NCT00927758|20744405|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416503|NCT00927758|20744406|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416504|NCT00927758|20744407|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416505|NCT00927758|20744402|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
8416506|NCT00927758|20744403|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416507|NCT00927758|20744404|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
8416508|NCT00927758|20744405|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416509|NCT00927758|20744406|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416510|NCT00927758|20744407|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416511|NCT00927758|20744402|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416512|NCT00927758|20744403|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416513|NCT00927758|20744404|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
8416514|NCT00927758|20744405|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416515|NCT00927758|20744406|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416516|NCT00927758|20744407|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416517|NCT00927758|20744402|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
8416518|NCT00927758|20744403|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
8416519|NCT00927758|20744404|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
8416520|NCT00927758|20744405|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8416521|NCT00927758|20744406|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8416522|NCT00927758|20744407|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8416523|NCT00927758|20744402|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416524|NCT00927758|20744403|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416525|NCT00927758|20744404|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416526|NCT00927758|20744405|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416527|NCT00927758|20744406|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416528|NCT00927758|20744407|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
8416529|NCT00927589|20744415|P1|NOT COMPLETED|Overall Study||16
8416530|NCT00927589|20744415|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
8416531|NCT00927589|20744415|P1|STARTED|Overall Study||59
8416532|NCT00927576|20744439|P2|NOT COMPLETED|Overall Study||0
8416533|NCT00927576|20744440|P1|NOT COMPLETED|Overall Study||0
8416534|NCT00927576|20744439|P2|COMPLETED|Overall Study||28
8416535|NCT00927576|20744440|P1|COMPLETED|Overall Study||237
8416536|NCT00927576|20744439|P2|Cognitive Testing|Overall Study||28
8416537|NCT00927576|20744440|P1|Cognitive Testing|Overall Study||237
8416538|NCT00927576|20744439|P2|STARTED|Overall Study||28
8416539|NCT00927576|20744440|P1|STARTED|Overall Study||237
8416540|NCT00927563|20744445|P1|NOT COMPLETED|Overall Study||2
8416541|NCT00927563|20744445|P1|COMPLETED|Overall Study||22
8416542|NCT00927563|20744445|P1|STARTED|Overall Study||24
8416543|NCT00927485|20744453|P2|NOT COMPLETED|Overall Study||4
8416544|NCT00927485|20744454|P1|NOT COMPLETED|Overall Study||6
8416545|NCT00927485|20744453|P2|COMPLETED|Overall Study||19
8416546|NCT00927485|20744454|P1|COMPLETED|Overall Study||15
8416547|NCT00927485|20744453|P2|STARTED|Overall Study||23
8416548|NCT00927485|20744454|P1|STARTED|Overall Study||21
8416549|NCT00927472|20744464|P2|NOT COMPLETED|Overall Study||22
8416550|NCT00927472|20744465|P1|NOT COMPLETED|Overall Study||11
8416551|NCT00927472|20744464|P2|COMPLETED|Overall Study||106
8416552|NCT00927472|20744465|P1|COMPLETED|Overall Study||115
8416553|NCT00927472|20744464|P2|STARTED|Overall Study||128
8416554|NCT00927472|20744465|P1|STARTED|Overall Study||126
8416555|NCT00927394|20744491|P2|NOT COMPLETED|Overall Study||85
8416556|NCT00927394|20744492|P1|NOT COMPLETED|Overall Study||77
8416557|NCT00927394|20744491|P2|COMPLETED|Overall Study||483
8416558|NCT00927394|20744492|P1|COMPLETED|Overall Study||498
8416559|NCT00927394|20744491|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
8416560|NCT00927394|20744492|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
8416561|NCT00927394|20744491|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
8416562|NCT00927394|20744492|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
8416563|NCT00927394|20744491|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
8416564|NCT00927394|20744492|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
8416565|NCT00927394|20744491|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
8416566|NCT00927394|20744492|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
8416567|NCT00927394|20744491|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
8416568|NCT00927394|20744492|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
8416569|NCT00927394|20744491|P2|Cohort 2 (Randomized)|Overall Study||403
8416570|NCT00927394|20744492|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
8416571|NCT00927394|20744491|P2|Cohort 1 (Randomized)|Overall Study||165
8416572|NCT00927394|20744492|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
8416573|NCT00927394|20744491|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
8416574|NCT00927394|20744492|P1|STARTED|Overall Study||575
8416575|NCT00927368|20744523|P3|NOT COMPLETED|Overall Study||5
8416576|NCT00927368|20744524|P2|NOT COMPLETED|Overall Study||5
8416577|NCT00927368|20744525|P1|NOT COMPLETED|Overall Study||6
8416578|NCT00927368|20744523|P3|COMPLETED|Overall Study||138
8416579|NCT00927368|20744524|P2|COMPLETED|Overall Study||152
8416580|NCT00927368|20744525|P1|COMPLETED|Overall Study||147
8416581|NCT00927368|20744523|P3|STARTED|Overall Study||143
8416582|NCT00927368|20744524|P2|STARTED|Overall Study||157
8416583|NCT00927368|20744525|P1|STARTED|Overall Study||153
8416584|NCT00927355|20744544|P2|NOT COMPLETED|Overall Study||1
8416585|NCT00927355|20744545|P1|NOT COMPLETED|Overall Study||1
8416586|NCT00927355|20744544|P2|COMPLETED|Overall Study||4
8416587|NCT00927355|20744545|P1|COMPLETED|Overall Study||4
8416588|NCT00927355|20744544|P2|STARTED|Overall Study||5
8416589|NCT00927355|20744545|P1|STARTED|Overall Study||5
8416590|NCT00927264|20744565|P2|NOT COMPLETED|Overall Study||25
8416591|NCT00927264|20744566|P1|NOT COMPLETED|Overall Study||56
8416592|NCT00927264|20744565|P2|COMPLETED|Overall Study||140
8416593|NCT00927264|20744566|P1|COMPLETED|Overall Study||109
8416594|NCT00927264|20744565|P2|STARTED|Overall Study||165
8416595|NCT00927264|20744566|P1|STARTED|Overall Study||165
8416596|NCT00927251|20744580|P1|NOT COMPLETED|Overall Study||8
8416597|NCT00927251|20744580|P1|COMPLETED|Overall Study||82
8416598|NCT00927251|20744580|P1|STARTED|Overall Study||90
8416599|NCT00927186|20744586|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
8416600|NCT00927186|20744587|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
8416601|NCT00927186|20744586|P2|COMPLETED|12 - 24 Months Extension Treatment||11
8416602|NCT00927186|20744587|P1|COMPLETED|12 - 24 Months Extension Treatment||10
8416603|NCT00927186|20744586|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
8416604|NCT00927186|20744587|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
8416605|NCT00927186|20744586|P2|NOT COMPLETED|12 Months Primary Study||4
8416606|NCT00927186|20744587|P1|NOT COMPLETED|12 Months Primary Study||7
8416607|NCT00927186|20744586|P2|COMPLETED|12 Months Primary Study||31
8416608|NCT00927186|20744587|P1|COMPLETED|12 Months Primary Study||27
8416609|NCT00927186|20744586|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
8416610|NCT00927186|20744587|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
8416611|NCT00927186|20744586|P2|STARTED|12 Months Primary Study||35
8416612|NCT00927186|20744587|P1|STARTED|12 Months Primary Study||34
8416613|NCT00927160|20744705|P2|NOT COMPLETED|Overall Study||0
8416614|NCT00927160|20744706|P1|NOT COMPLETED|Overall Study||0
8416615|NCT00927160|20744705|P2|COMPLETED|Overall Study||173
8416616|NCT00927160|20744706|P1|COMPLETED|Overall Study||173
8416617|NCT00927160|20744705|P2|STARTED|Overall Study||173
8416618|NCT00927160|20744706|P1|STARTED|Overall Study||173
8416619|NCT00927095|20744717|P3|NOT COMPLETED|Overall Study||2
8416620|NCT00927095|20744718|P2|NOT COMPLETED|Overall Study||4
8416621|NCT00927095|20744719|P1|NOT COMPLETED|Overall Study||6
8416622|NCT00927095|20744717|P3|COMPLETED|Overall Study||22
8416623|NCT00927095|20744718|P2|COMPLETED|Overall Study||17
8416624|NCT00927095|20744719|P1|COMPLETED|Overall Study||16
8416625|NCT00927095|20744717|P3|STARTED|Overall Study||24
8416626|NCT00927095|20744718|P2|STARTED|Overall Study||21
8416627|NCT00927095|20744719|P1|STARTED|Overall Study||22
8416628|NCT00927082|20744731|P4|NOT COMPLETED|Overall Study||19
8416629|NCT00927082|20744732|P3|NOT COMPLETED|Overall Study||22
8416630|NCT00927082|20744733|P2|NOT COMPLETED|Overall Study||10
8416631|NCT00927082|20744734|P1|NOT COMPLETED|Overall Study||12
8416632|NCT00927082|20744731|P4|COMPLETED|Overall Study||78
8416633|NCT00927082|20744732|P3|COMPLETED|Overall Study||86
8416634|NCT00927082|20744733|P2|COMPLETED|Overall Study||77
8416635|NCT00927082|20744734|P1|COMPLETED|Overall Study||79
8416636|NCT00927082|20744731|P4|STARTED|Overall Study||97
8416637|NCT00927082|20744732|P3|STARTED|Overall Study||108
8416638|NCT00927082|20744733|P2|STARTED|Overall Study||87
8416639|NCT00927082|20744734|P1|STARTED|Overall Study||91
8416640|NCT00927069|20744798|P4|NOT COMPLETED|Week 12 to Week 24||3
8416641|NCT00927069|20744799|P3|NOT COMPLETED|Week 12 to Week 24||3
8416642|NCT00927069|20744800|P2|NOT COMPLETED|Week 12 to Week 24||0
8416643|NCT00927069|20744801|P1|NOT COMPLETED|Week 12 to Week 24||2
8416644|NCT00927069|20744798|P4|COMPLETED|Week 12 to Week 24||20
8416645|NCT00927069|20744799|P3|COMPLETED|Week 12 to Week 24||28
8416646|NCT00927069|20744800|P2|COMPLETED|Week 12 to Week 24||11
8416647|NCT00927069|20744801|P1|COMPLETED|Week 12 to Week 24||16
8416648|NCT00927069|20744798|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
8416649|NCT00927069|20744799|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
8416650|NCT00927069|20744800|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
8416651|NCT00927069|20744801|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
8416652|NCT00927069|20744798|P4|NOT COMPLETED|Week 0 to Week 12||0
8416653|NCT00927069|20744799|P3|NOT COMPLETED|Week 0 to Week 12||0
8416654|NCT00927069|20744800|P2|NOT COMPLETED|Week 0 to Week 12||1
8416655|NCT00927069|20744801|P1|NOT COMPLETED|Week 0 to Week 12||1
8416656|NCT00927069|20744798|P4|COMPLETED|Week 0 to Week 12||0
8416657|NCT00927069|20744799|P3|COMPLETED|Week 0 to Week 12||0
8416658|NCT00927069|20744800|P2|COMPLETED|Week 0 to Week 12||34
8416659|NCT00927069|20744801|P1|COMPLETED|Week 0 to Week 12||49
8416660|NCT00927069|20744798|P4|STARTED|Week 0 to Week 12||0
8416661|NCT00927069|20744799|P3|STARTED|Week 0 to Week 12||0
8416662|NCT00927069|20744800|P2|STARTED|Week 0 to Week 12||35
8416663|NCT00927069|20744801|P1|STARTED|Week 0 to Week 12||50
8416664|NCT00926952|20744811|P1|NOT COMPLETED|Overall Study||0
8416665|NCT00926952|20744811|P1|COMPLETED|Overall Study||20
8416666|NCT00926952|20744811|P1|STARTED|Overall Study||20
8416667|NCT00926887|20744825|P2|NOT COMPLETED|Overall Study||0
8416668|NCT00926887|20744826|P1|NOT COMPLETED|Overall Study||0
8416669|NCT00926887|20744825|P2|COMPLETED|Overall Study||50
8416670|NCT00926887|20744826|P1|COMPLETED|Overall Study||54
8416671|NCT00926887|20744825|P2|STARTED|Overall Study||50
8416672|NCT00926887|20744826|P1|STARTED|Overall Study||54
8416673|NCT00926848|20744838|P2|NOT COMPLETED|Overall Study||0
8416674|NCT00926848|20744839|P1|NOT COMPLETED|Overall Study||0
8416675|NCT00926848|20744838|P2|COMPLETED|Overall Study||34
8416676|NCT00926848|20744839|P1|COMPLETED|Overall Study||34
8416677|NCT00926848|20744838|P2|STARTED|Overall Study||34
8416678|NCT00926848|20744839|P1|STARTED|Overall Study||34
8416679|NCT00926796|20744857|P2|NOT COMPLETED|Overall Study||106
8416680|NCT00926796|20744858|P1|NOT COMPLETED|Overall Study||107
8416681|NCT00926796|20744857|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
8416682|NCT00926796|20744858|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
8416683|NCT00926796|20744857|P2|STARTED|Overall Study|Number randomized|305
8416684|NCT00926796|20744858|P1|STARTED|Overall Study|Number randomized|309
8416685|NCT00926783|20744879|P2|NOT COMPLETED|Overall Study||3
8416686|NCT00926783|20744880|P1|NOT COMPLETED|Overall Study||3
8416687|NCT00926783|20744879|P2|COMPLETED|Overall Study||38
8416688|NCT00926783|20744880|P1|COMPLETED|Overall Study||39
8416689|NCT00926783|20744879|P2|STARTED|Overall Study||41
8416690|NCT00926783|20744880|P1|STARTED|Overall Study||42
8416691|NCT00926588|20744898|P2|NOT COMPLETED|Overall Study||4
8416692|NCT00926588|20744899|P1|NOT COMPLETED|Overall Study||8
8416693|NCT00926588|20744898|P2|COMPLETED|Overall Study||122
8416694|NCT00926588|20744899|P1|COMPLETED|Overall Study||116
8416695|NCT00926588|20744898|P2|STARTED|Overall Study||126
8416696|NCT00926588|20744899|P1|STARTED|Overall Study||124
8416697|NCT00926575|20744907|P2|NOT COMPLETED|Overall Study||17
8416698|NCT00926575|20744908|P1|NOT COMPLETED|Overall Study||16
8416699|NCT00926575|20744907|P2|COMPLETED|Overall Study||53
8416700|NCT00926575|20744908|P1|COMPLETED|Overall Study||54
8416701|NCT00926575|20744907|P2|STARTED|Overall Study||70
8416702|NCT00926575|20744908|P1|STARTED|Overall Study||70
8416703|NCT00926536|20744920|P2|NOT COMPLETED|Overall Study||2
8416704|NCT00926536|20744921|P1|NOT COMPLETED|Overall Study||1
8416705|NCT00926536|20744920|P2|COMPLETED|Overall Study||41
8416706|NCT00926536|20744921|P1|COMPLETED|Overall Study||43
8416707|NCT00926536|20744920|P2|STARTED|Overall Study||43
8416708|NCT00926536|20744921|P1|STARTED|Overall Study||44
8416709|NCT00926497|20744931|P2|NOT COMPLETED|Overall Study||0
8416710|NCT00926497|20744932|P1|NOT COMPLETED|Overall Study||0
8416711|NCT00926497|20744931|P2|COMPLETED|Overall Study||61
8416712|NCT00926497|20744932|P1|COMPLETED|Overall Study||60
8416713|NCT00926497|20744931|P2|STARTED|Overall Study||61
8416714|NCT00926497|20744932|P1|STARTED|Overall Study||60
8416715|NCT00926393|20744942|P2|NOT COMPLETED|Overall Study||3
8416716|NCT00926393|20744943|P1|NOT COMPLETED|Overall Study||2
8416717|NCT00926393|20744942|P2|COMPLETED|Overall Study||67
8416718|NCT00926393|20744943|P1|COMPLETED|Overall Study||67
8416719|NCT00926393|20744942|P2|STARTED|Overall Study||70
8416720|NCT00926393|20744943|P1|STARTED|Overall Study||69
8416721|NCT00926380|20744976|P3|NOT COMPLETED|Year 2||5
8416722|NCT00926380|20744977|P2|NOT COMPLETED|Year 2||2
8416723|NCT00926380|20744978|P1|NOT COMPLETED|Year 2||2
8416724|NCT00926380|20744976|P3|COMPLETED|Year 2||24
8416725|NCT00926380|20744977|P2|COMPLETED|Year 2||28
8416726|NCT00926380|20744978|P1|COMPLETED|Year 2||31
8416727|NCT00926380|20744976|P3|STARTED|Year 2||29
8416728|NCT00926380|20744977|P2|STARTED|Year 2||30
8416729|NCT00926380|20744978|P1|STARTED|Year 2||33
8416730|NCT00926380|20744976|P3|NOT COMPLETED|Year 1||1
8416731|NCT00926380|20744977|P2|NOT COMPLETED|Year 1||1
8416732|NCT00926380|20744978|P1|NOT COMPLETED|Year 1||0
8416733|NCT00926380|20744976|P3|COMPLETED|Year 1||29
8416734|NCT00926380|20744977|P2|COMPLETED|Year 1||30
8416735|NCT00926380|20744978|P1|COMPLETED|Year 1||33
8416736|NCT00926380|20744976|P3|STARTED|Year 1||30
8416737|NCT00926380|20744977|P2|STARTED|Year 1||31
8416738|NCT00926380|20744978|P1|STARTED|Year 1||33
8416739|NCT00926367|20744988|P2|NOT COMPLETED|Overall Study||3
8416740|NCT00926367|20744989|P1|NOT COMPLETED|Overall Study||2
8416741|NCT00926367|20744988|P2|COMPLETED|Overall Study||24
8416742|NCT00926367|20744989|P1|COMPLETED|Overall Study||23
8416743|NCT00926367|20744988|P2|STARTED|Overall Study||27
8416744|NCT00926367|20744989|P1|STARTED|Overall Study||25
8416745|NCT00926328|20745031|P2|NOT COMPLETED|Overall Study||14
8416746|NCT00926328|20745032|P1|NOT COMPLETED|Overall Study||12
8416747|NCT00926328|20745031|P2|COMPLETED|Overall Study||46
8416748|NCT00926328|20745032|P1|COMPLETED|Overall Study||48
8416749|NCT00926328|20745031|P2|STARTED|Overall Study||60
8416750|NCT00926328|20745032|P1|STARTED|Overall Study||60
8416751|NCT00926289|20745042|P2|NOT COMPLETED|Overall Study||36
8416752|NCT00926289|20745043|P1|NOT COMPLETED|Overall Study||25
8416753|NCT00926289|20745042|P2|COMPLETED|Overall Study||558
8416754|NCT00926289|20745043|P1|COMPLETED|Overall Study||269
8416755|NCT00926289|20745042|P2|STARTED|Overall Study|Number of treated patients|594
8416756|NCT00926289|20745043|P1|STARTED|Overall Study|Number of treated patients|294
8416757|NCT00926263|20745079|P2|NOT COMPLETED|Overall Study||0
8416758|NCT00926263|20745080|P1|NOT COMPLETED|Overall Study||0
8416759|NCT00926263|20745079|P2|COMPLETED|Overall Study||12
8416760|NCT00926263|20745080|P1|COMPLETED|Overall Study||16
8416761|NCT00926263|20745079|P2|STARTED|Overall Study||12
8416762|NCT00926263|20745080|P1|STARTED|Overall Study||16
8416763|NCT00926237|20745111|P2|NOT COMPLETED|Overall Study||1
8416764|NCT00926237|20745112|P1|NOT COMPLETED|Overall Study||2
8416765|NCT00926237|20745111|P2|COMPLETED|Overall Study||19
8416766|NCT00926237|20745112|P1|COMPLETED|Overall Study||17
8416767|NCT00926237|20745111|P2|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
8416768|NCT00926237|20745112|P1|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
8416769|NCT00926211|20745122|P1|NOT COMPLETED|Overall Study||1
8416770|NCT00926211|20745122|P1|COMPLETED|Overall Study||35
8416771|NCT00926211|20745122|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
8416772|NCT00926185|20745133|P4|NOT COMPLETED|Overall Study||10
8416773|NCT00926185|20745134|P3|NOT COMPLETED|Overall Study||10
8416774|NCT00926185|20745135|P2|NOT COMPLETED|Overall Study||6
8416775|NCT00926185|20745136|P1|NOT COMPLETED|Overall Study||3
8416776|NCT00926185|20745133|P4|COMPLETED|Overall Study||48
8416777|NCT00926185|20745134|P3|COMPLETED|Overall Study||48
8416778|NCT00926185|20745135|P2|COMPLETED|Overall Study||51
8416779|NCT00926185|20745136|P1|COMPLETED|Overall Study||54
8416780|NCT00926185|20745133|P4|STARTED|Overall Study||58
8416781|NCT00926185|20745134|P3|STARTED|Overall Study||58
8416782|NCT00926185|20745135|P2|STARTED|Overall Study||57
8416783|NCT00926185|20745136|P1|STARTED|Overall Study||57
8416784|NCT00926029|20745153|P3|NOT COMPLETED|Overall Study||1
8416785|NCT00926029|20745154|P2|NOT COMPLETED|Overall Study||1
8416786|NCT00926029|20745155|P1|NOT COMPLETED|Overall Study||2
8416787|NCT00926029|20745153|P3|COMPLETED|Overall Study||33
8416788|NCT00926029|20745154|P2|COMPLETED|Overall Study||33
8416789|NCT00926029|20745155|P1|COMPLETED|Overall Study||32
8416790|NCT00926029|20745153|P3|STARTED|Overall Study||34
8416791|NCT00926029|20745154|P2|STARTED|Overall Study||34
8416792|NCT00926029|20745155|P1|STARTED|Overall Study||34
8416793|NCT00926003|20745169|P3|NOT COMPLETED|Post-Training 3-month Follow-up||0
8416794|NCT00926003|20745170|P2|NOT COMPLETED|Post-Training 3-month Follow-up||0
8416795|NCT00926003|20745171|P1|NOT COMPLETED|Post-Training 3-month Follow-up||1
8416796|NCT00926003|20745169|P3|COMPLETED|Post-Training 3-month Follow-up||52
8416797|NCT00926003|20745170|P2|COMPLETED|Post-Training 3-month Follow-up||54
8416798|NCT00926003|20745171|P1|COMPLETED|Post-Training 3-month Follow-up||51
8416799|NCT00926003|20745169|P3|STARTED|Post-Training 3-month Follow-up||52
8416800|NCT00926003|20745170|P2|STARTED|Post-Training 3-month Follow-up||54
8416801|NCT00926003|20745171|P1|STARTED|Post-Training 3-month Follow-up||52
8416802|NCT00926003|20745169|P3|NOT COMPLETED|Post-Training Evaluation||0
8416803|NCT00926003|20745170|P2|NOT COMPLETED|Post-Training Evaluation||0
8416804|NCT00926003|20745171|P1|NOT COMPLETED|Post-Training Evaluation||1
8416805|NCT00926003|20745169|P3|COMPLETED|Post-Training Evaluation||52
8416806|NCT00926003|20745170|P2|COMPLETED|Post-Training Evaluation||54
8416807|NCT00926003|20745171|P1|COMPLETED|Post-Training Evaluation||52
8416808|NCT00926003|20745169|P3|STARTED|Post-Training Evaluation||52
8416809|NCT00926003|20745170|P2|STARTED|Post-Training Evaluation||54
8416810|NCT00926003|20745171|P1|STARTED|Post-Training Evaluation||53
8416811|NCT00926003|20745169|P3|NOT COMPLETED|Baseline||0
8416812|NCT00926003|20745170|P2|NOT COMPLETED|Baseline||0
8416813|NCT00926003|20745171|P1|NOT COMPLETED|Baseline||0
8416814|NCT00926003|20745169|P3|COMPLETED|Baseline||52
8416815|NCT00926003|20745170|P2|COMPLETED|Baseline||54
8416816|NCT00926003|20745171|P1|COMPLETED|Baseline||53
8416817|NCT00926003|20745169|P3|STARTED|Baseline||52
8416818|NCT00926003|20745170|P2|STARTED|Baseline||54
8416819|NCT00926003|20745171|P1|STARTED|Baseline||53
8416820|NCT00925990|20745184|P2|NOT COMPLETED|Overall Study||11
8416821|NCT00925990|20745185|P1|NOT COMPLETED|Overall Study||5
8416822|NCT00925990|20745184|P2|COMPLETED|Overall Study||24
8416823|NCT00925990|20745185|P1|COMPLETED|Overall Study||30
8416824|NCT00925990|20745184|P2|STARTED|Overall Study||35
8416825|NCT00925990|20745185|P1|STARTED|Overall Study||35
8416826|NCT00925938|20745196|P3|NOT COMPLETED|Overall Study||0
8416827|NCT00925938|20745197|P2|NOT COMPLETED|Overall Study||0
8416828|NCT00925938|20745198|P1|NOT COMPLETED|Overall Study||0
8416829|NCT00925938|20745196|P3|COMPLETED|Overall Study||17
8416830|NCT00925938|20745197|P2|COMPLETED|Overall Study||25
8416831|NCT00925938|20745198|P1|COMPLETED|Overall Study||9
8416832|NCT00925938|20745196|P3|STARTED|Overall Study||17
8416833|NCT00925938|20745197|P2|STARTED|Overall Study||25
8416834|NCT00925938|20745198|P1|STARTED|Overall Study||9
8416835|NCT00925899|20745220|P2|NOT COMPLETED|Part 2||12
8416836|NCT00925899|20745221|P1|NOT COMPLETED|Part 2||6
8416837|NCT00925899|20745220|P2|COMPLETED|Part 2||9
8416838|NCT00925899|20745221|P1|COMPLETED|Part 2||9
8416839|NCT00925899|20745220|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
8416840|NCT00925899|20745221|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
8416841|NCT00925899|20745220|P2|NOT COMPLETED|Part 1||11
8416842|NCT00925899|20745221|P1|NOT COMPLETED|Part 1||11
8416843|NCT00925899|20745220|P2|COMPLETED|Part 1||27
8416844|NCT00925899|20745221|P1|COMPLETED|Part 1||23
8416845|NCT00925899|20745220|P2|STARTED|Part 1||38
8416846|NCT00925899|20745221|P1|STARTED|Part 1||34
8416847|NCT00925782|20745239|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
8416848|NCT00925782|20745240|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
8416849|NCT00925782|20745239|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
8416850|NCT00925782|20745240|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
8416851|NCT00925782|20745239|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
8416852|NCT00925782|20745240|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
8416853|NCT00925782|20745239|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
8416854|NCT00925782|20745240|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
8416855|NCT00925782|20745239|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
8416856|NCT00925782|20745240|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
8416857|NCT00925782|20745239|P2|STARTED|Study Period (Day -3 to Day 0)||12
8416858|NCT00925782|20745240|P1|STARTED|Study Period (Day -3 to Day 0)||12
8416859|NCT00925782|20745239|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
8416860|NCT00925782|20745240|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
8416861|NCT00925782|20745239|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
8416862|NCT00925782|20745240|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
8416863|NCT00925782|20745239|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
8416864|NCT00925782|20745240|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
8416865|NCT00925769|20745249|P6|NOT COMPLETED|Overall Study||3
8416866|NCT00925769|20745250|P5|NOT COMPLETED|Overall Study||3
8416867|NCT00925769|20745251|P4|NOT COMPLETED|Overall Study||6
8416868|NCT00925769|20745252|P3|NOT COMPLETED|Overall Study||6
8416869|NCT00925769|20745253|P2|NOT COMPLETED|Overall Study||6
8416870|NCT00925769|20745254|P1|NOT COMPLETED|Overall Study||6
8416871|NCT00925769|20745249|P6|COMPLETED|Overall Study||0
8416872|NCT00925769|20745250|P5|COMPLETED|Overall Study||0
8416873|NCT00925769|20745251|P4|COMPLETED|Overall Study||0
8416874|NCT00925769|20745252|P3|COMPLETED|Overall Study||0
8416875|NCT00925769|20745253|P2|COMPLETED|Overall Study||0
8416876|NCT00925769|20745254|P1|COMPLETED|Overall Study||0
8416877|NCT00925769|20745249|P6|STARTED|Overall Study||3
8416878|NCT00925769|20745250|P5|STARTED|Overall Study||3
8416879|NCT00925769|20745251|P4|STARTED|Overall Study||6
8416880|NCT00925769|20745252|P3|STARTED|Overall Study||6
8416881|NCT00925769|20745253|P2|STARTED|Overall Study||6
8416882|NCT00925769|20745254|P1|STARTED|Overall Study||6
8416883|NCT00925756|20745316|P1|NOT COMPLETED|Overall Study||0
8416884|NCT00925756|20745316|P1|COMPLETED|Overall Study||32
8416885|NCT00925756|20745316|P1|STARTED|Overall Study||32
8416886|NCT00925704|20745328|P6|NOT COMPLETED|Third Intervention||1
8416887|NCT00925704|20745329|P5|NOT COMPLETED|Third Intervention||0
8416888|NCT00925704|20745330|P4|NOT COMPLETED|Third Intervention||0
8416889|NCT00925704|20745331|P3|NOT COMPLETED|Third Intervention||0
8416890|NCT00925704|20745332|P2|NOT COMPLETED|Third Intervention||0
8416891|NCT00925704|20745333|P1|NOT COMPLETED|Third Intervention||0
8416892|NCT00925704|20745328|P6|COMPLETED|Third Intervention||6
8416893|NCT00925704|20745329|P5|COMPLETED|Third Intervention||5
8416894|NCT00925704|20745330|P4|COMPLETED|Third Intervention||6
8416895|NCT00925704|20745331|P3|COMPLETED|Third Intervention||7
8416896|NCT00925704|20745332|P2|COMPLETED|Third Intervention||7
8416897|NCT00925704|20745333|P1|COMPLETED|Third Intervention||5
8416898|NCT00925704|20745328|P6|STARTED|Third Intervention||7
8416899|NCT00925704|20745329|P5|STARTED|Third Intervention||5
8416900|NCT00925704|20745330|P4|STARTED|Third Intervention||6
8416901|NCT00925704|20745331|P3|STARTED|Third Intervention||7
8416902|NCT00925704|20745332|P2|STARTED|Third Intervention||7
8416903|NCT00925704|20745333|P1|STARTED|Third Intervention||5
8416904|NCT00925704|20745328|P6|NOT COMPLETED|Washout||0
8416905|NCT00925704|20745329|P5|NOT COMPLETED|Washout||0
8416906|NCT00925704|20745330|P4|NOT COMPLETED|Washout||0
8416907|NCT00925704|20745331|P3|NOT COMPLETED|Washout||0
8416908|NCT00925704|20745332|P2|NOT COMPLETED|Washout||0
8416909|NCT00925704|20745333|P1|NOT COMPLETED|Washout||0
8416910|NCT00925704|20745328|P6|COMPLETED|Washout||7
8416911|NCT00925704|20745329|P5|COMPLETED|Washout||5
8416912|NCT00925704|20745330|P4|COMPLETED|Washout||6
8416913|NCT00925704|20745331|P3|COMPLETED|Washout||7
8416914|NCT00925704|20745332|P2|COMPLETED|Washout||7
8416915|NCT00925704|20745333|P1|COMPLETED|Washout||5
8416916|NCT00925704|20745328|P6|STARTED|Washout||7
8416917|NCT00925704|20745329|P5|STARTED|Washout||5
8416918|NCT00925704|20745330|P4|STARTED|Washout||6
8416919|NCT00925704|20745331|P3|STARTED|Washout||7
8416920|NCT00925704|20745332|P2|STARTED|Washout||7
8416921|NCT00925704|20745333|P1|STARTED|Washout||5
8416922|NCT00925704|20745328|P6|NOT COMPLETED|Second Intervention||0
8416923|NCT00925704|20745329|P5|NOT COMPLETED|Second Intervention||1
8416924|NCT00925704|20745330|P4|NOT COMPLETED|Second Intervention||0
8416925|NCT00925704|20745331|P3|NOT COMPLETED|Second Intervention||0
8416926|NCT00925704|20745332|P2|NOT COMPLETED|Second Intervention||0
8416927|NCT00925704|20745333|P1|NOT COMPLETED|Second Intervention||1
8416928|NCT00925704|20745328|P6|COMPLETED|Second Intervention||7
8416929|NCT00925704|20745329|P5|COMPLETED|Second Intervention||5
8416930|NCT00925704|20745330|P4|COMPLETED|Second Intervention||6
8416931|NCT00925704|20745331|P3|COMPLETED|Second Intervention||7
8416932|NCT00925704|20745332|P2|COMPLETED|Second Intervention||7
8416933|NCT00925704|20745333|P1|COMPLETED|Second Intervention||5
8416934|NCT00925704|20745328|P6|STARTED|Second Intervention||7
8416935|NCT00925704|20745329|P5|STARTED|Second Intervention||6
8416936|NCT00925704|20745330|P4|STARTED|Second Intervention||6
8416937|NCT00925704|20745331|P3|STARTED|Second Intervention||7
8416938|NCT00925704|20745332|P2|STARTED|Second Intervention||7
8416939|NCT00925704|20745333|P1|STARTED|Second Intervention||6
8416940|NCT00925704|20745328|P6|NOT COMPLETED|Washout||0
8416941|NCT00925704|20745329|P5|NOT COMPLETED|Washout||0
8416942|NCT00925704|20745330|P4|NOT COMPLETED|Washout||0
8416943|NCT00925704|20745331|P3|NOT COMPLETED|Washout||0
8416944|NCT00925704|20745332|P2|NOT COMPLETED|Washout||0
8416945|NCT00925704|20745333|P1|NOT COMPLETED|Washout||0
8416946|NCT00925704|20745328|P6|COMPLETED|Washout||7
8416947|NCT00925704|20745329|P5|COMPLETED|Washout||6
8416948|NCT00925704|20745330|P4|COMPLETED|Washout||6
8416949|NCT00925704|20745331|P3|COMPLETED|Washout||7
8416950|NCT00925704|20745332|P2|COMPLETED|Washout||7
8416951|NCT00925704|20745333|P1|COMPLETED|Washout||6
8416952|NCT00925704|20745328|P6|STARTED|Washout||7
8416953|NCT00925704|20745329|P5|STARTED|Washout||6
8416954|NCT00925704|20745330|P4|STARTED|Washout||6
8416955|NCT00925704|20745331|P3|STARTED|Washout||7
8416956|NCT00925704|20745332|P2|STARTED|Washout||7
8416957|NCT00925704|20745333|P1|STARTED|Washout||6
8416958|NCT00925704|20745328|P6|NOT COMPLETED|First Intervention||0
8416959|NCT00925704|20745329|P5|NOT COMPLETED|First Intervention||1
8416960|NCT00925704|20745330|P4|NOT COMPLETED|First Intervention||1
8416961|NCT00925704|20745331|P3|NOT COMPLETED|First Intervention||0
8416962|NCT00925704|20745332|P2|NOT COMPLETED|First Intervention||0
8416963|NCT00925704|20745333|P1|NOT COMPLETED|First Intervention||0
8416964|NCT00925704|20745328|P6|COMPLETED|First Intervention||7
8416965|NCT00925704|20745329|P5|COMPLETED|First Intervention||6
8416966|NCT00925704|20745330|P4|COMPLETED|First Intervention||6
8416967|NCT00925704|20745331|P3|COMPLETED|First Intervention||7
8416968|NCT00925704|20745332|P2|COMPLETED|First Intervention||7
8416969|NCT00925704|20745333|P1|COMPLETED|First Intervention||6
8416970|NCT00925704|20745328|P6|STARTED|First Intervention||7
8416971|NCT00925704|20745329|P5|STARTED|First Intervention||7
8416972|NCT00925704|20745330|P4|STARTED|First Intervention||7
8416973|NCT00925704|20745331|P3|STARTED|First Intervention||7
8416974|NCT00925704|20745332|P2|STARTED|First Intervention||7
8416975|NCT00925704|20745333|P1|STARTED|First Intervention||6
8416976|NCT00925600|20745346|P2|NOT COMPLETED|Overall Study||28
8416977|NCT00925600|20745347|P1|NOT COMPLETED|Overall Study||32
8416978|NCT00925600|20745346|P2|COMPLETED|Overall Study||355
8416979|NCT00925600|20745347|P1|COMPLETED|Overall Study||354
8416980|NCT00925600|20745346|P2|Received Treatment|Overall Study||382
8416981|NCT00925600|20745347|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
8416982|NCT00925600|20745346|P2|STARTED|Overall Study||383
8416983|NCT00925600|20745347|P1|STARTED|Overall Study||386
8416984|NCT00925587|20745369|P2|NOT COMPLETED|Overall Study||25
8416985|NCT00925587|20745370|P1|NOT COMPLETED|Overall Study||36
8416986|NCT00925587|20745369|P2|COMPLETED|Overall Study||155
8416987|NCT00925587|20745370|P1|COMPLETED|Overall Study||142
8416988|NCT00925587|20745369|P2|STARTED|Overall Study||180
8416989|NCT00925587|20745370|P1|STARTED|Overall Study||178
8416990|NCT00925548|20745484|P2|NOT COMPLETED|Overall Study||5
8416991|NCT00925548|20745485|P1|NOT COMPLETED|Overall Study||10
8416992|NCT00925548|20745484|P2|COMPLETED|Overall Study||0
8416993|NCT00925548|20745485|P1|COMPLETED|Overall Study||1
8416994|NCT00925548|20745484|P2|STARTED|Overall Study||5
8416995|NCT00925548|20745485|P1|STARTED|Overall Study||11
8416996|NCT00925522|20745511|P1|NOT COMPLETED|Overall Study||20
8416997|NCT00925522|20745511|P1|COMPLETED|Overall Study||0
8416998|NCT00925522|20745511|P1|STARTED|Overall Study||20
8416999|NCT00925353|20745515|P1|NOT COMPLETED|Overall Study||3
8417000|NCT00925353|20745515|P1|COMPLETED|Overall Study||10
8417001|NCT00925353|20745515|P1|STARTED|Overall Study||13
8417002|NCT00925301|20745521|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
8417003|NCT00925301|20745522|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8417004|NCT00925301|20745523|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8417005|NCT00925301|20745524|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8417006|NCT00925301|20745521|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
8417007|NCT00925301|20745522|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
8417008|NCT00925301|20745523|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
8417009|NCT00925301|20745524|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
8417010|NCT00925301|20745521|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
8417011|NCT00925301|20745522|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
8417012|NCT00925301|20745523|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
8417013|NCT00925301|20745524|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
8417014|NCT00925301|20745521|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
8417015|NCT00925301|20745522|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
8417016|NCT00925301|20745523|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
8417017|NCT00925301|20745524|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
8417018|NCT00925301|20745521|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8417019|NCT00925301|20745522|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
8417020|NCT00925301|20745523|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8417021|NCT00925301|20745524|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8417022|NCT00925301|20745521|P4|COMPLETED|6-Month Open-label (Stage 2)||0
8417023|NCT00925301|20745522|P3|COMPLETED|6-Month Open-label (Stage 2)||60
8417024|NCT00925301|20745523|P2|COMPLETED|6-Month Open-label (Stage 2)||0
8417025|NCT00925301|20745524|P1|COMPLETED|6-Month Open-label (Stage 2)||0
8417026|NCT00925301|20745521|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
8417027|NCT00925301|20745522|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
8417028|NCT00925301|20745523|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
8417029|NCT00925301|20745524|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
8417030|NCT00925301|20745521|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
8417031|NCT00925301|20745522|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
8417032|NCT00925301|20745523|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
8417033|NCT00925301|20745524|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
8417034|NCT00925301|20745521|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8417035|NCT00925301|20745522|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8417036|NCT00925301|20745523|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
8417037|NCT00925301|20745524|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8417038|NCT00925301|20745521|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
8417039|NCT00925301|20745522|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
8417040|NCT00925301|20745523|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
8417041|NCT00925301|20745524|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
8417042|NCT00925301|20745521|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
8417043|NCT00925301|20745522|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
8417044|NCT00925301|20745523|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
8417045|NCT00925301|20745524|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
8417046|NCT00925301|20745521|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
8417047|NCT00925301|20745522|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
8417048|NCT00925301|20745523|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
8417049|NCT00925301|20745524|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
8417050|NCT00925301|20745521|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
8417051|NCT00925301|20745522|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
8417052|NCT00925301|20745523|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
8417053|NCT00925301|20745524|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
8417054|NCT00925301|20745521|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
8417055|NCT00925301|20745522|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
8417056|NCT00925301|20745523|P2|STARTED|6-Month Double-blind (Stage 1)||33
8417057|NCT00925301|20745524|P1|STARTED|6-Month Double-blind (Stage 1)||34
8417058|NCT00925288|20745540|P2|NOT COMPLETED|Overall Study||7
8417059|NCT00925288|20745541|P1|NOT COMPLETED|Overall Study||9
8417060|NCT00925288|20745540|P2|COMPLETED|Overall Study||93
8417061|NCT00925288|20745541|P1|COMPLETED|Overall Study||91
8417062|NCT00925288|20745540|P2|STARTED|Overall Study||100
8417063|NCT00925288|20745541|P1|STARTED|Overall Study||100
8417064|NCT00925132|20745553|P5|NOT COMPLETED|Overall Study||5
8417065|NCT00925132|20745554|P4|NOT COMPLETED|Overall Study||0
8417066|NCT00925132|20745555|P3|NOT COMPLETED|Overall Study||0
8417067|NCT00925132|20745556|P2|NOT COMPLETED|Overall Study||0
8417068|NCT00925132|20745557|P1|NOT COMPLETED|Overall Study||2
8417069|NCT00925132|20745553|P5|COMPLETED|Overall Study||17
8417070|NCT00925132|20745554|P4|COMPLETED|Overall Study||4
8417071|NCT00925132|20745555|P3|COMPLETED|Overall Study||4
8417072|NCT00925132|20745556|P2|COMPLETED|Overall Study||4
8417073|NCT00925132|20745557|P1|COMPLETED|Overall Study||3
8417074|NCT00925132|20745553|P5|STARTED|Overall Study||22
8417075|NCT00925132|20745554|P4|STARTED|Overall Study||4
8417076|NCT00925132|20745555|P3|STARTED|Overall Study||4
8417077|NCT00925132|20745556|P2|STARTED|Overall Study||4
8417078|NCT00925132|20745557|P1|STARTED|Overall Study||5
8417079|NCT00925119|20745563|P1|NOT COMPLETED|Overall Study||12
8417080|NCT00925119|20745563|P1|COMPLETED|Overall Study||19
8417081|NCT00925119|20745563|P1|STARTED|Overall Study||31
8417082|NCT00925054|20745578|P5|NOT COMPLETED|Overall Study||0
8417083|NCT00925054|20745579|P4|NOT COMPLETED|Overall Study||1
8417084|NCT00925054|20745580|P3|NOT COMPLETED|Overall Study||1
8417085|NCT00925054|20745581|P2|NOT COMPLETED|Overall Study||1
8417086|NCT00925054|20745582|P1|NOT COMPLETED|Overall Study||0
8417087|NCT00925054|20745578|P5|COMPLETED|Overall Study||10
8417088|NCT00925054|20745579|P4|COMPLETED|Overall Study||0
8417089|NCT00925054|20745580|P3|COMPLETED|Overall Study||12
8417090|NCT00925054|20745581|P2|COMPLETED|Overall Study||8
8417091|NCT00925054|20745582|P1|COMPLETED|Overall Study||7
8417092|NCT00925054|20745578|P5|STARTED|Overall Study||10
8417093|NCT00925054|20745579|P4|STARTED|Overall Study||1
8417094|NCT00925054|20745580|P3|STARTED|Overall Study||13
8417095|NCT00925054|20745581|P2|STARTED|Overall Study||9
8417096|NCT00925054|20745582|P1|STARTED|Overall Study||7
8417097|NCT00925015|20745652|P3|NOT COMPLETED|Overall Study||6
8417098|NCT00925015|20745653|P2|NOT COMPLETED|Overall Study||6
8417099|NCT00925015|20745654|P1|NOT COMPLETED|Overall Study||8
8417100|NCT00925015|20745652|P3|COMPLETED|Overall Study||0
8417101|NCT00925015|20745653|P2|COMPLETED|Overall Study||0
8417102|NCT00925015|20745654|P1|COMPLETED|Overall Study||0
8417103|NCT00925015|20745652|P3|STARTED|Overall Study||6
8417104|NCT00925015|20745653|P2|STARTED|Overall Study||6
8417105|NCT00925015|20745654|P1|STARTED|Overall Study||8
8417106|NCT00924950|20745710|P1|NOT COMPLETED|Overall Study||2
8417107|NCT00924950|20745710|P1|COMPLETED|Overall Study||28
8417108|NCT00924950|20745710|P1|STARTED|Overall Study||30
8417109|NCT00924898|20745717|P1|NOT COMPLETED|Overall Study||2
8417110|NCT00924898|20745717|P1|COMPLETED|Overall Study||90
8417111|NCT00924898|20745717|P1|STARTED|Overall Study||92
8417112|NCT00924885|20745728|P2|NOT COMPLETED|Overall Study||4
8417113|NCT00924885|20745729|P1|NOT COMPLETED|Overall Study||3
8417114|NCT00924885|20745728|P2|COMPLETED|Overall Study||124
8417115|NCT00924885|20745729|P1|COMPLETED|Overall Study||126
8417116|NCT00924885|20745728|P2|STARTED|Overall Study||128
8417117|NCT00924885|20745729|P1|STARTED|Overall Study||129
8417118|NCT00924833|20745740|P3|NOT COMPLETED|Overall Study||0
8417119|NCT00924833|20745741|P2|NOT COMPLETED|Overall Study||0
8417120|NCT00924833|20745742|P1|NOT COMPLETED|Overall Study||0
8417121|NCT00924833|20745740|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
8417122|NCT00924833|20745741|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
8417123|NCT00924833|20745742|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
8417124|NCT00924833|20745740|P3|STARTED|Overall Study||9
8417125|NCT00924833|20745741|P2|STARTED|Overall Study||9
8417126|NCT00924833|20745742|P1|STARTED|Overall Study||9
8417127|NCT00924820|20745756|P1|NOT COMPLETED|Overall Study||7
8417128|NCT00924820|20745756|P1|COMPLETED|Overall Study||13
8417129|NCT00924820|20745756|P1|STARTED|Overall Study||20
8417130|NCT00924807|20745762|P1|NOT COMPLETED|Overall Study||0
8417131|NCT00924807|20745762|P1|COMPLETED|Overall Study||4
8417132|NCT00924807|20745762|P1|STARTED|Overall Study||4
8417133|NCT00924781|20745771|P2|NOT COMPLETED|Overall Study||10
8417134|NCT00924781|20745772|P1|NOT COMPLETED|Overall Study||12
8417135|NCT00924781|20745771|P2|COMPLETED|Overall Study||9
8417136|NCT00924781|20745772|P1|COMPLETED|Overall Study||8
8417137|NCT00924781|20745771|P2|STARTED|Overall Study||19
8417138|NCT00924781|20745772|P1|STARTED|Overall Study||20
8417139|NCT00924729|20745806|P2|NOT COMPLETED|Overall Study||0
8417140|NCT00924729|20745807|P1|NOT COMPLETED|Overall Study||2
8417141|NCT00924729|20745806|P2|COMPLETED|Overall Study||25
8417142|NCT00924729|20745807|P1|COMPLETED|Overall Study||23
8417143|NCT00924729|20745806|P2|STARTED|Overall Study||25
8417144|NCT00924729|20745807|P1|STARTED|Overall Study||25
8417145|NCT00924651|20745817|P2|NOT COMPLETED|Overall Study||25
8417146|NCT00924651|20745818|P1|NOT COMPLETED|Overall Study||25
8417147|NCT00924651|20745817|P2|COMPLETED|Overall Study||312
8417148|NCT00924651|20745818|P1|COMPLETED|Overall Study||331
8417149|NCT00924651|20745817|P2|STARTED|Overall Study||337
8417150|NCT00924651|20745818|P1|STARTED|Overall Study||356
8417151|NCT00924638|20745826|P2|NOT COMPLETED|Overall Study||13
8417152|NCT00924638|20745827|P1|NOT COMPLETED|Overall Study||12
8417153|NCT00924638|20745826|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
8417154|NCT00924638|20745827|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
8417155|NCT00924638|20745826|P2|STARTED|Overall Study|Randomized to Control Arm|220
8417156|NCT00924638|20745827|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
8417157|NCT00924612|20745846|P4|NOT COMPLETED|Overall Study||0
8417158|NCT00924612|20745847|P3|NOT COMPLETED|Overall Study||0
8417159|NCT00924612|20745848|P2|NOT COMPLETED|Overall Study||0
8417160|NCT00924612|20745849|P1|NOT COMPLETED|Overall Study||0
8417161|NCT00924612|20745846|P4|COMPLETED|Overall Study||4
8417162|NCT00924612|20745847|P3|COMPLETED|Overall Study||4
8417163|NCT00924612|20745848|P2|COMPLETED|Overall Study||4
8417164|NCT00924612|20745849|P1|COMPLETED|Overall Study||4
8417165|NCT00924612|20745846|P4|STARTED|Overall Study||4
8417166|NCT00924612|20745847|P3|STARTED|Overall Study||4
8417167|NCT00924612|20745848|P2|STARTED|Overall Study||4
8417168|NCT00924612|20745849|P1|STARTED|Overall Study||4
8417169|NCT00924560|20745864|P3|NOT COMPLETED|Overall Study||83
8417170|NCT00924560|20745865|P2|NOT COMPLETED|Overall Study||208
8417171|NCT00924560|20745866|P1|NOT COMPLETED|Overall Study||211
8417172|NCT00924560|20745864|P3|COMPLETED|Overall Study||372
8417173|NCT00924560|20745865|P2|COMPLETED|Overall Study||240
8417174|NCT00924560|20745866|P1|COMPLETED|Overall Study||247
8417175|NCT00924560|20745864|P3|Received Treatment|Overall Study||0
8417176|NCT00924560|20745865|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
8417177|NCT00924560|20745866|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
8417178|NCT00924560|20745864|P3|STARTED|Overall Study||455
8417179|NCT00924560|20745865|P2|STARTED|Overall Study||448
8417180|NCT00924560|20745866|P1|STARTED|Overall Study||458
8417181|NCT00924508|20745910|P1|NOT COMPLETED|Overall Study||3
8417182|NCT00924508|20745910|P1|COMPLETED|Overall Study||20
8417183|NCT00924508|20745910|P1|STARTED|Overall Study||23
8417184|NCT00924482|20745917|P1|NOT COMPLETED|Overall Study||0
8417185|NCT00924482|20745917|P1|COMPLETED|Overall Study||261
8417186|NCT00924482|20745917|P1|STARTED|Overall Study||261
8417187|NCT00924469|20745924|P2|NOT COMPLETED|Overall Study||2
8417188|NCT00924469|20745925|P1|NOT COMPLETED|Overall Study||2
8417189|NCT00924469|20745924|P2|COMPLETED|Overall Study||26
8417190|NCT00924469|20745925|P1|COMPLETED|Overall Study||28
8417191|NCT00924469|20745924|P2|STARTED|Overall Study||28
8417192|NCT00924469|20745925|P1|STARTED|Overall Study||30
8417193|NCT00924443|20745947|P1|NOT COMPLETED|Overall Study||3
8417194|NCT00924443|20745947|P1|COMPLETED|Overall Study||66
8417195|NCT00924443|20745947|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
8417196|NCT00924443|20745947|P1|STARTED|Overall Study||69
8417197|NCT00924404|20745957|P2|NOT COMPLETED|Overall Study||4
8417198|NCT00924404|20745958|P1|NOT COMPLETED|Overall Study||6
8417199|NCT00924404|20745957|P2|COMPLETED|Overall Study||22
8417200|NCT00924404|20745958|P1|COMPLETED|Overall Study||21
8417201|NCT00924404|20745957|P2|STARTED|Overall Study||26
8417202|NCT00924404|20745958|P1|STARTED|Overall Study||27
8417203|NCT00924352|20745966|P2|NOT COMPLETED|Overall Study||0
8417204|NCT00924352|20745967|P1|NOT COMPLETED|Overall Study||0
8417205|NCT00924352|20745966|P2|COMPLETED|Overall Study||44
8417206|NCT00924352|20745967|P1|COMPLETED|Overall Study||12
8417207|NCT00924352|20745966|P2|STARTED|Overall Study||44
8417208|NCT00924352|20745967|P1|STARTED|Overall Study||12
8417209|NCT00924326|20745989|P9|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417210|NCT00924326|20745990|P8|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417211|NCT00924326|20745991|P7|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417212|NCT00924326|20745992|P6|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417213|NCT00924326|20745993|P5|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417214|NCT00924326|20745994|P4|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417215|NCT00924326|20745995|P3|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417216|NCT00924326|20745996|P2|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417217|NCT00924326|20745997|P1|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417218|NCT00924326|20745989|P9|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417219|NCT00924326|20745990|P8|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417220|NCT00924326|20745991|P7|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417221|NCT00924326|20745992|P6|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417222|NCT00924326|20745993|P5|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417223|NCT00924326|20745994|P4|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417224|NCT00924326|20745995|P3|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417225|NCT00924326|20745996|P2|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8417226|NCT00924326|20745997|P1|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
8417227|NCT00924326|20745989|P9|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417228|NCT00924326|20745990|P8|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417229|NCT00924326|20745991|P7|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417230|NCT00924326|20745992|P6|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417231|NCT00924326|20745993|P5|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417232|NCT00924326|20745994|P4|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417233|NCT00924326|20745995|P3|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417234|NCT00924326|20745996|P2|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8417235|NCT00924326|20745997|P1|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
8417236|NCT00924326|20745989|P9|NOT COMPLETED|Dose Administration||0
8417237|NCT00924326|20745990|P8|NOT COMPLETED|Dose Administration||0
8417238|NCT00924326|20745991|P7|NOT COMPLETED|Dose Administration||0
8417239|NCT00924326|20745992|P6|NOT COMPLETED|Dose Administration||0
8417240|NCT00924326|20745993|P5|NOT COMPLETED|Dose Administration||0
8417241|NCT00924326|20745994|P4|NOT COMPLETED|Dose Administration||0
8417242|NCT00924326|20745995|P3|NOT COMPLETED|Dose Administration||0
8417243|NCT00924326|20745996|P2|NOT COMPLETED|Dose Administration||0
8417244|NCT00924326|20745997|P1|NOT COMPLETED|Dose Administration||0
8417245|NCT00924326|20745989|P9|COMPLETED|Dose Administration||2
8417246|NCT00924326|20745990|P8|COMPLETED|Dose Administration||2
8417247|NCT00924326|20745991|P7|COMPLETED|Dose Administration||1
8417248|NCT00924326|20745992|P6|COMPLETED|Dose Administration||10
8417249|NCT00924326|20745993|P5|COMPLETED|Dose Administration||7
8417250|NCT00924326|20745994|P4|COMPLETED|Dose Administration||6
8417251|NCT00924326|20745995|P3|COMPLETED|Dose Administration||5
8417252|NCT00924326|20745996|P2|COMPLETED|Dose Administration||2
8417253|NCT00924326|20745997|P1|COMPLETED|Dose Administration||8
8417254|NCT00924326|20745989|P9|STARTED|Dose Administration||2
8417255|NCT00924326|20745990|P8|STARTED|Dose Administration||2
8417256|NCT00924326|20745991|P7|STARTED|Dose Administration||1
8417257|NCT00924326|20745992|P6|STARTED|Dose Administration||10
8417258|NCT00924326|20745993|P5|STARTED|Dose Administration||7
8417259|NCT00924326|20745994|P4|STARTED|Dose Administration||6
8417260|NCT00924326|20745995|P3|STARTED|Dose Administration||5
8417261|NCT00924326|20745996|P2|STARTED|Dose Administration||2
8417262|NCT00924326|20745997|P1|STARTED|Dose Administration||8
8417263|NCT00924313|20746029|P1|NOT COMPLETED|Overall Study||1
8417264|NCT00924313|20746029|P1|COMPLETED|Overall Study||39
8417265|NCT00924313|20746029|P1|STARTED|Overall Study||40
8417266|NCT00924287|20746041|P1|NOT COMPLETED|Overall Study||1
8417267|NCT00924287|20746041|P1|COMPLETED|Overall Study||0
8417268|NCT00924287|20746041|P1|STARTED|Overall Study||1
8417269|NCT00924209|20746047|P1|NOT COMPLETED|Overall Study||0
8417270|NCT00924209|20746047|P1|COMPLETED|Overall Study||7
8417271|NCT00924209|20746047|P1|STARTED|Overall Study||7
8417278|NCT00924118|20746098|P2|NOT COMPLETED|Overall Study||0
8417279|NCT00924118|20746099|P1|NOT COMPLETED|Overall Study||0
8417280|NCT00924118|20746098|P2|COMPLETED|Overall Study||15
8417281|NCT00924118|20746099|P1|COMPLETED|Overall Study||15
8417282|NCT00924118|20746098|P2|STARTED|Overall Study||15
8417283|NCT00924118|20746099|P1|STARTED|Overall Study||15
8417284|NCT00924066|20746107|P1|NOT COMPLETED|Overall Study||0
8417285|NCT00924066|20746107|P1|COMPLETED|Overall Study||41
8417286|NCT00924066|20746107|P1|STARTED|Overall Study||41
8417287|NCT00924053|20746116|P4|NOT COMPLETED|Overall Study||0
8417288|NCT00924053|20746117|P3|NOT COMPLETED|Overall Study||0
8417289|NCT00924053|20746118|P2|NOT COMPLETED|Overall Study||0
8417290|NCT00924053|20746119|P1|NOT COMPLETED|Overall Study||0
8417291|NCT00924053|20746116|P4|COMPLETED|Overall Study||6
8417292|NCT00924053|20746117|P3|COMPLETED|Overall Study||6
8417293|NCT00924053|20746118|P2|COMPLETED|Overall Study||6
8417294|NCT00924053|20746119|P1|COMPLETED|Overall Study||6
8417295|NCT00924053|20746116|P4|STARTED|Overall Study||6
8417296|NCT00924053|20746117|P3|STARTED|Overall Study||6
8417297|NCT00924053|20746118|P2|STARTED|Overall Study||6
8417298|NCT00924053|20746119|P1|STARTED|Overall Study||6
8417299|NCT00924040|20746165|P1|NOT COMPLETED|Overall Study||0
8417300|NCT00924040|20746165|P1|COMPLETED|Overall Study||1
8417301|NCT00924040|20746165|P1|STARTED|Overall Study||1
8417302|NCT00924001|20746177|P1|NOT COMPLETED|Overall Study||0
8417303|NCT00924001|20746177|P1|COMPLETED|Overall Study||1
8417304|NCT00924001|20746177|P1|STARTED|Overall Study||1
8417305|NCT00923975|20746183|P1|NOT COMPLETED|Overall Study||1
8417306|NCT00923975|20746183|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
8417307|NCT00923975|20746183|P1|STARTED|Overall Study||51
8417308|NCT00923949|20746190|P1|NOT COMPLETED|Overall Study||0
8417309|NCT00923949|20746190|P1|COMPLETED|Overall Study||1
8417310|NCT00923949|20746190|P1|STARTED|Overall Study||1
8417311|NCT00923936|20746202|P2|NOT COMPLETED|Overall Study||3
8417312|NCT00923936|20746203|P1|NOT COMPLETED|Overall Study||8
8417313|NCT00923936|20746202|P2|COMPLETED|Overall Study||3
8417314|NCT00923936|20746203|P1|COMPLETED|Overall Study||2
8417315|NCT00923936|20746202|P2|STARTED|Overall Study||6
8417316|NCT00923936|20746203|P1|STARTED|Overall Study||10
8417317|NCT00923910|20746219|P2|NOT COMPLETED|Period 2||0
8417318|NCT00923910|20746220|P1|NOT COMPLETED|Period 2||0
8417319|NCT00923910|20746219|P2|COMPLETED|Period 2||5
8417320|NCT00923910|20746220|P1|COMPLETED|Period 2||5
8417321|NCT00923910|20746219|P2|STARTED|Period 2||5
8417322|NCT00923910|20746220|P1|STARTED|Period 2||5
8417323|NCT00923910|20746219|P2|NOT COMPLETED|Period 1||0
8417324|NCT00923910|20746220|P1|NOT COMPLETED|Period 1||0
8417325|NCT00923910|20746219|P2|COMPLETED|Period 1||5
8417326|NCT00923910|20746220|P1|COMPLETED|Period 1||5
8417327|NCT00923910|20746219|P2|STARTED|Period 1||5
8417328|NCT00923910|20746220|P1|STARTED|Period 1||5
8417329|NCT00923845|20746232|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
8417330|NCT00923845|20746233|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
8417331|NCT00923845|20746232|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
8417332|NCT00923845|20746233|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
8417333|NCT00923845|20746232|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
8417334|NCT00923845|20746233|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
8417335|NCT00923845|20746232|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
8417336|NCT00923845|20746233|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
8417337|NCT00923845|20746232|P2|STARTED|Allogeneic Stem Cell Therapy||10
8417338|NCT00923845|20746233|P1|STARTED|Allogeneic Stem Cell Therapy||0
8417339|NCT00923845|20746232|P2|NOT COMPLETED|Induction Therapy||2
8417340|NCT00923845|20746233|P1|NOT COMPLETED|Induction Therapy||0
8417341|NCT00923845|20746232|P2|COMPLETED|Induction Therapy||10
8417342|NCT00923845|20746233|P1|COMPLETED|Induction Therapy||0
8417343|NCT00923845|20746232|P2|STARTED|Induction Therapy||12
8417344|NCT00923845|20746233|P1|STARTED|Induction Therapy||0
8417345|NCT00923845|20746232|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8417346|NCT00923845|20746233|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8417347|NCT00923845|20746232|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8417348|NCT00923845|20746233|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
8417349|NCT00923845|20746232|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
8417350|NCT00923845|20746233|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
8417351|NCT00923845|20746232|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
8417352|NCT00923845|20746233|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
8417353|NCT00923845|20746232|P2|COMPLETED|Donor Lymphocyte Harvest||0
8417354|NCT00923845|20746233|P1|COMPLETED|Donor Lymphocyte Harvest||13
8417355|NCT00923845|20746232|P2|STARTED|Donor Lymphocyte Harvest||0
8417356|NCT00923845|20746233|P1|STARTED|Donor Lymphocyte Harvest||13
8417357|NCT00923598|20746256|P2|NOT COMPLETED|Overall Study||5
8417358|NCT00923598|20746257|P1|NOT COMPLETED|Overall Study||4
8417359|NCT00923598|20746256|P2|COMPLETED|Overall Study||17
8417360|NCT00923598|20746257|P1|COMPLETED|Overall Study||19
8417361|NCT00923598|20746256|P2|STARTED|Overall Study||22
8417362|NCT00923598|20746257|P1|STARTED|Overall Study||23
8417363|NCT00923481|20746263|P1|NOT COMPLETED|Overall Study||0
8417364|NCT00923481|20746263|P1|COMPLETED|Overall Study||37
8417365|NCT00923481|20746263|P1|STARTED|Overall Study||37
8417366|NCT00923364|20746268|P2|NOT COMPLETED|Overall Study||0
8417367|NCT00923364|20746269|P1|NOT COMPLETED|Overall Study||4
8417368|NCT00923364|20746268|P2|COMPLETED|Overall Study||5
8417369|NCT00923364|20746269|P1|COMPLETED|Overall Study||10
8417370|NCT00923364|20746268|P2|STARTED|Overall Study||5
8417371|NCT00923364|20746269|P1|STARTED|Overall Study||14
8417372|NCT00923351|20746281|P3|NOT COMPLETED|Overall Study||12
8417373|NCT00923351|20746282|P2|NOT COMPLETED|Overall Study||0
8417374|NCT00923351|20746283|P1|NOT COMPLETED|Overall Study||0
8417375|NCT00923351|20746281|P3|COMPLETED|Overall Study||0
8417376|NCT00923351|20746282|P2|COMPLETED|Overall Study||26
8417377|NCT00923351|20746283|P1|COMPLETED|Overall Study||6
8417378|NCT00923351|20746281|P3|STARTED|Overall Study||12
8417379|NCT00923351|20746282|P2|STARTED|Overall Study||26
8417380|NCT00923351|20746283|P1|STARTED|Overall Study||6
8417381|NCT00923273|20746298|P5|NOT COMPLETED|Phase II Treatment Period||0
8417382|NCT00923273|20746299|P4|NOT COMPLETED|Phase II Treatment Period||7
8417383|NCT00923273|20746300|P3|NOT COMPLETED|Phase II Treatment Period||0
8417384|NCT00923273|20746301|P2|NOT COMPLETED|Phase II Treatment Period||0
8417385|NCT00923273|20746302|P1|NOT COMPLETED|Phase II Treatment Period||0
8417386|NCT00923273|20746298|P5|COMPLETED|Phase II Treatment Period||0
8417387|NCT00923273|20746299|P4|COMPLETED|Phase II Treatment Period||20
8417388|NCT00923273|20746300|P3|COMPLETED|Phase II Treatment Period||0
8417389|NCT00923273|20746301|P2|COMPLETED|Phase II Treatment Period||0
8417390|NCT00923273|20746302|P1|COMPLETED|Phase II Treatment Period||0
8417391|NCT00923273|20746298|P5|STARTED|Phase II Treatment Period||0
8417392|NCT00923273|20746299|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
8417393|NCT00923273|20746300|P3|STARTED|Phase II Treatment Period||0
8417394|NCT00923273|20746301|P2|STARTED|Phase II Treatment Period||0
8417395|NCT00923273|20746302|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
8417396|NCT00923273|20746298|P5|NOT COMPLETED|Phase I Treatment Period||0
8417397|NCT00923273|20746299|P4|NOT COMPLETED|Phase I Treatment Period||0
8417398|NCT00923273|20746300|P3|NOT COMPLETED|Phase I Treatment Period||0
8417399|NCT00923273|20746301|P2|NOT COMPLETED|Phase I Treatment Period||0
8417400|NCT00923273|20746302|P1|NOT COMPLETED|Phase I Treatment Period||0
8417401|NCT00923273|20746298|P5|COMPLETED|Phase I Treatment Period||5
8417402|NCT00923273|20746299|P4|COMPLETED|Phase I Treatment Period||7
8417403|NCT00923273|20746300|P3|COMPLETED|Phase I Treatment Period||3
8417404|NCT00923273|20746301|P2|COMPLETED|Phase I Treatment Period||3
8417405|NCT00923273|20746302|P1|COMPLETED|Phase I Treatment Period||4
8417406|NCT00923273|20746298|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
8417407|NCT00923273|20746299|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
8417408|NCT00923273|20746300|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
8417409|NCT00923273|20746301|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
8417410|NCT00923273|20746302|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
8417411|NCT00923260|20746327|P2|NOT COMPLETED|Overall Study||1
8417412|NCT00923260|20746328|P1|NOT COMPLETED|Overall Study||1
8417413|NCT00923260|20746327|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
8417414|NCT00923260|20746328|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
8417415|NCT00923260|20746327|P2|STARTED|Overall Study||12
8417416|NCT00923260|20746328|P1|STARTED|Overall Study||12
8417417|NCT00923247|20746462|P2|NOT COMPLETED|Overall Study||0
8417418|NCT00923247|20746463|P1|NOT COMPLETED|Overall Study||0
8417419|NCT00923247|20746462|P2|COMPLETED|Overall Study||1
8417420|NCT00923247|20746463|P1|COMPLETED|Overall Study||21
8417421|NCT00923247|20746462|P2|STARTED|Overall Study||1
8417422|NCT00923247|20746463|P1|STARTED|Overall Study||21
8417423|NCT00923195|20746491|P2|NOT COMPLETED|Overall Study||1
8417424|NCT00923195|20746492|P1|NOT COMPLETED|Overall Study||0
8417425|NCT00923195|20746491|P2|COMPLETED|Overall Study||1
8417426|NCT00923195|20746492|P1|COMPLETED|Overall Study||2
8417427|NCT00923195|20746491|P2|STARTED|Overall Study||2
8417428|NCT00923195|20746492|P1|STARTED|Overall Study||2
8417429|NCT00923156|20746503|P3|NOT COMPLETED|Overall Study||3
8417430|NCT00923156|20746504|P2|NOT COMPLETED|Overall Study||4
8417431|NCT00923156|20746505|P1|NOT COMPLETED|Overall Study||0
8417432|NCT00923156|20746503|P3|COMPLETED|Overall Study||38
8417433|NCT00923156|20746504|P2|COMPLETED|Overall Study||38
8417434|NCT00923156|20746505|P1|COMPLETED|Overall Study||40
8417435|NCT00923156|20746503|P3|STARTED|Overall Study||41
8417436|NCT00923156|20746504|P2|STARTED|Overall Study||42
8417437|NCT00923156|20746505|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
8417438|NCT00923130|20746531|P1|NOT COMPLETED|Overall Study||25
8417439|NCT00923130|20746531|P1|COMPLETED|Overall Study||5
8417440|NCT00923130|20746531|P1|STARTED|Overall Study||30
8417441|NCT00923117|20746549|P2|NOT COMPLETED|Overall Study||0
8417442|NCT00923117|20746550|P1|NOT COMPLETED|Overall Study||0
8417443|NCT00923117|20746549|P2|COMPLETED|Overall Study||43
8417444|NCT00923117|20746550|P1|COMPLETED|Overall Study||44
8417445|NCT00923117|20746549|P2|STARTED|Overall Study||43
8417446|NCT00923117|20746550|P1|STARTED|Overall Study||44
8417447|NCT00923091|20746566|P13|NOT COMPLETED|Period VI (Open-Label)||0
8417448|NCT00923091|20746567|P12|NOT COMPLETED|Period VI (Open-Label)||0
8417449|NCT00923091|20746568|P11|NOT COMPLETED|Period VI (Open-Label)||0
8417450|NCT00923091|20746569|P10|NOT COMPLETED|Period VI (Open-Label)||0
8417451|NCT00923091|20746570|P9|NOT COMPLETED|Period VI (Open-Label)||0
8417452|NCT00923091|20746571|P8|NOT COMPLETED|Period VI (Open-Label)||0
8417453|NCT00923091|20746572|P7|NOT COMPLETED|Period VI (Open-Label)||0
8417454|NCT00923091|20746573|P6|NOT COMPLETED|Period VI (Open-Label)||0
8417455|NCT00923091|20746574|P5|NOT COMPLETED|Period VI (Open-Label)||7
8417456|NCT00923091|20746575|P4|NOT COMPLETED|Period VI (Open-Label)||3
8417457|NCT00923091|20746576|P3|NOT COMPLETED|Period VI (Open-Label)||13
8417458|NCT00923091|20746577|P2|NOT COMPLETED|Period VI (Open-Label)||8
8417459|NCT00923091|20746578|P1|NOT COMPLETED|Period VI (Open-Label)||39
8417460|NCT00923091|20746566|P13|COMPLETED|Period VI (Open-Label)||0
8417461|NCT00923091|20746567|P12|COMPLETED|Period VI (Open-Label)||0
8417462|NCT00923091|20746568|P11|COMPLETED|Period VI (Open-Label)||0
8417463|NCT00923091|20746569|P10|COMPLETED|Period VI (Open-Label)||0
8417464|NCT00923091|20746570|P9|COMPLETED|Period VI (Open-Label)||0
8417465|NCT00923091|20746571|P8|COMPLETED|Period VI (Open-Label)||0
8417466|NCT00923091|20746572|P7|COMPLETED|Period VI (Open-Label)||0
8417467|NCT00923091|20746573|P6|COMPLETED|Period VI (Open-Label)||0
8417468|NCT00923091|20746574|P5|COMPLETED|Period VI (Open-Label)||157
8417469|NCT00923091|20746575|P4|COMPLETED|Period VI (Open-Label)||143
8417470|NCT00923091|20746576|P3|COMPLETED|Period VI (Open-Label)||467
8417471|NCT00923091|20746577|P2|COMPLETED|Period VI (Open-Label)||264
8417472|NCT00923091|20746578|P1|COMPLETED|Period VI (Open-Label)||1408
8417473|NCT00923091|20746566|P13|STARTED|Period VI (Open-Label)||0
8417474|NCT00923091|20746567|P12|STARTED|Period VI (Open-Label)||0
8417475|NCT00923091|20746568|P11|STARTED|Period VI (Open-Label)||0
8417476|NCT00923091|20746569|P10|STARTED|Period VI (Open-Label)||0
8417477|NCT00923091|20746570|P9|STARTED|Period VI (Open-Label)||0
8417478|NCT00923091|20746571|P8|STARTED|Period VI (Open-Label)||0
8417479|NCT00923091|20746572|P7|STARTED|Period VI (Open-Label)||0
8417480|NCT00923091|20746573|P6|STARTED|Period VI (Open-Label)||0
8417481|NCT00923091|20746574|P5|STARTED|Period VI (Open-Label)||164
8417482|NCT00923091|20746575|P4|STARTED|Period VI (Open-Label)||146
8417483|NCT00923091|20746576|P3|STARTED|Period VI (Open-Label)||480
8417484|NCT00923091|20746577|P2|STARTED|Period VI (Open-Label)||272
8417485|NCT00923091|20746578|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
8417486|NCT00923091|20746566|P13|NOT COMPLETED|Period V (Double -Blind)||2
8417487|NCT00923091|20746567|P12|NOT COMPLETED|Period V (Double -Blind)||0
8417488|NCT00923091|20746568|P11|NOT COMPLETED|Period V (Double -Blind)||1
8417489|NCT00923091|20746569|P10|NOT COMPLETED|Period V (Double -Blind)||0
8417490|NCT00923091|20746570|P9|NOT COMPLETED|Period V (Double -Blind)||1
8417491|NCT00923091|20746571|P8|NOT COMPLETED|Period V (Double -Blind)||0
8417492|NCT00923091|20746572|P7|NOT COMPLETED|Period V (Double -Blind)||0
8417493|NCT00923091|20746573|P6|NOT COMPLETED|Period V (Double -Blind)||0
8417494|NCT00923091|20746574|P5|NOT COMPLETED|Period V (Double -Blind)||0
8417495|NCT00923091|20746575|P4|NOT COMPLETED|Period V (Double -Blind)||0
8417496|NCT00923091|20746576|P3|NOT COMPLETED|Period V (Double -Blind)||0
8417497|NCT00923091|20746577|P2|NOT COMPLETED|Period V (Double -Blind)||0
8417498|NCT00923091|20746578|P1|NOT COMPLETED|Period V (Double -Blind)||0
8417499|NCT00923091|20746566|P13|COMPLETED|Period V (Double -Blind)||73
8417500|NCT00923091|20746567|P12|COMPLETED|Period V (Double -Blind)||151
8417501|NCT00923091|20746568|P11|COMPLETED|Period V (Double -Blind)||193
8417502|NCT00923091|20746569|P10|COMPLETED|Period V (Double -Blind)||119
8417503|NCT00923091|20746570|P9|COMPLETED|Period V (Double -Blind)||134
8417504|NCT00923091|20746571|P8|COMPLETED|Period V (Double -Blind)||0
8417505|NCT00923091|20746572|P7|COMPLETED|Period V (Double -Blind)||0
8417506|NCT00923091|20746573|P6|COMPLETED|Period V (Double -Blind)||0
8417507|NCT00923091|20746574|P5|COMPLETED|Period V (Double -Blind)||0
8417508|NCT00923091|20746575|P4|COMPLETED|Period V (Double -Blind)||0
8417509|NCT00923091|20746576|P3|COMPLETED|Period V (Double -Blind)||0
8417510|NCT00923091|20746577|P2|COMPLETED|Period V (Double -Blind)||0
8417511|NCT00923091|20746578|P1|COMPLETED|Period V (Double -Blind)||0
8417512|NCT00923091|20746566|P13|STARTED|Period V (Double -Blind)||75
8417513|NCT00923091|20746567|P12|STARTED|Period V (Double -Blind)||151
8417514|NCT00923091|20746568|P11|STARTED|Period V (Double -Blind)||194
8417515|NCT00923091|20746569|P10|STARTED|Period V (Double -Blind)||119
8417516|NCT00923091|20746570|P9|STARTED|Period V (Double -Blind)||135
8417517|NCT00923091|20746571|P8|STARTED|Period V (Double -Blind)||0
8417518|NCT00923091|20746572|P7|STARTED|Period V (Double -Blind)||0
8417519|NCT00923091|20746573|P6|STARTED|Period V (Double -Blind)||0
8417520|NCT00923091|20746574|P5|STARTED|Period V (Double -Blind)||0
8417521|NCT00923091|20746575|P4|STARTED|Period V (Double -Blind)||0
8417522|NCT00923091|20746576|P3|STARTED|Period V (Double -Blind)||0
8417523|NCT00923091|20746577|P2|STARTED|Period V (Double -Blind)||0
8417524|NCT00923091|20746578|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
8417525|NCT00923091|20746566|P13|NOT COMPLETED|Period IV (Double-Blind)||0
8417526|NCT00923091|20746567|P12|NOT COMPLETED|Period IV (Double-Blind)||0
8417527|NCT00923091|20746568|P11|NOT COMPLETED|Period IV (Double-Blind)||0
8417528|NCT00923091|20746569|P10|NOT COMPLETED|Period IV (Double-Blind)||0
8417529|NCT00923091|20746570|P9|NOT COMPLETED|Period IV (Double-Blind)||0
8417530|NCT00923091|20746571|P8|NOT COMPLETED|Period IV (Double-Blind)||0
8417531|NCT00923091|20746572|P7|NOT COMPLETED|Period IV (Double-Blind)||0
8417532|NCT00923091|20746573|P6|NOT COMPLETED|Period IV (Double-Blind)||0
8417533|NCT00923091|20746574|P5|NOT COMPLETED|Period IV (Double-Blind)||0
8417534|NCT00923091|20746575|P4|NOT COMPLETED|Period IV (Double-Blind)||0
8417535|NCT00923091|20746576|P3|NOT COMPLETED|Period IV (Double-Blind)||0
8417536|NCT00923091|20746577|P2|NOT COMPLETED|Period IV (Double-Blind)||2
8417537|NCT00923091|20746578|P1|NOT COMPLETED|Period IV (Double-Blind)||2
8417538|NCT00923091|20746566|P13|COMPLETED|Period IV (Double-Blind)||0
8417539|NCT00923091|20746567|P12|COMPLETED|Period IV (Double-Blind)||0
8417540|NCT00923091|20746568|P11|COMPLETED|Period IV (Double-Blind)||0
8417541|NCT00923091|20746569|P10|COMPLETED|Period IV (Double-Blind)||0
8417542|NCT00923091|20746570|P9|COMPLETED|Period IV (Double-Blind)||0
8417543|NCT00923091|20746571|P8|COMPLETED|Period IV (Double-Blind)||0
8417544|NCT00923091|20746572|P7|COMPLETED|Period IV (Double-Blind)||0
8417545|NCT00923091|20746573|P6|COMPLETED|Period IV (Double-Blind)||0
8417546|NCT00923091|20746574|P5|COMPLETED|Period IV (Double-Blind)||0
8417547|NCT00923091|20746575|P4|COMPLETED|Period IV (Double-Blind)||0
8417548|NCT00923091|20746576|P3|COMPLETED|Period IV (Double-Blind)||0
8417549|NCT00923091|20746577|P2|COMPLETED|Period IV (Double-Blind)||451
8417550|NCT00923091|20746578|P1|COMPLETED|Period IV (Double-Blind)||226
8417551|NCT00923091|20746566|P13|STARTED|Period IV (Double-Blind)||0
8417552|NCT00923091|20746567|P12|STARTED|Period IV (Double-Blind)||0
8417553|NCT00923091|20746568|P11|STARTED|Period IV (Double-Blind)||0
8417554|NCT00923091|20746569|P10|STARTED|Period IV (Double-Blind)||0
8417555|NCT00923091|20746570|P9|STARTED|Period IV (Double-Blind)||0
8417556|NCT00923091|20746571|P8|STARTED|Period IV (Double-Blind)||0
8417557|NCT00923091|20746572|P7|STARTED|Period IV (Double-Blind)||0
8417558|NCT00923091|20746573|P6|STARTED|Period IV (Double-Blind)||0
8417559|NCT00923091|20746574|P5|STARTED|Period IV (Double-Blind)||0
8417560|NCT00923091|20746575|P4|STARTED|Period IV (Double-Blind)||0
8417561|NCT00923091|20746576|P3|STARTED|Period IV (Double-Blind)||0
8417562|NCT00923091|20746577|P2|STARTED|Period IV (Double-Blind)||453
8417563|NCT00923091|20746578|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
8417564|NCT00923091|20746566|P13|NOT COMPLETED|Period III (Single-Blind)||0
8417565|NCT00923091|20746567|P12|NOT COMPLETED|Period III (Single-Blind)||0
8417566|NCT00923091|20746568|P11|NOT COMPLETED|Period III (Single-Blind)||0
8417567|NCT00923091|20746569|P10|NOT COMPLETED|Period III (Single-Blind)||0
8417568|NCT00923091|20746570|P9|NOT COMPLETED|Period III (Single-Blind)||0
8417569|NCT00923091|20746571|P8|NOT COMPLETED|Period III (Single-Blind)||0
8417570|NCT00923091|20746572|P7|NOT COMPLETED|Period III (Single-Blind)||0
8417571|NCT00923091|20746573|P6|NOT COMPLETED|Period III (Single-Blind)||0
8417572|NCT00923091|20746574|P5|NOT COMPLETED|Period III (Single-Blind)||0
8417573|NCT00923091|20746575|P4|NOT COMPLETED|Period III (Single-Blind)||0
8417574|NCT00923091|20746576|P3|NOT COMPLETED|Period III (Single-Blind)||0
8417575|NCT00923091|20746577|P2|NOT COMPLETED|Period III (Single-Blind)||0
8417576|NCT00923091|20746578|P1|NOT COMPLETED|Period III (Single-Blind)||20
8417577|NCT00923091|20746566|P13|COMPLETED|Period III (Single-Blind)||0
8417578|NCT00923091|20746567|P12|COMPLETED|Period III (Single-Blind)||0
8417579|NCT00923091|20746568|P11|COMPLETED|Period III (Single-Blind)||0
8417580|NCT00923091|20746569|P10|COMPLETED|Period III (Single-Blind)||0
8417581|NCT00923091|20746570|P9|COMPLETED|Period III (Single-Blind)||0
8417582|NCT00923091|20746571|P8|COMPLETED|Period III (Single-Blind)||0
8417583|NCT00923091|20746572|P7|COMPLETED|Period III (Single-Blind)||0
8417584|NCT00923091|20746573|P6|COMPLETED|Period III (Single-Blind)||0
8417585|NCT00923091|20746574|P5|COMPLETED|Period III (Single-Blind)||0
8417586|NCT00923091|20746575|P4|COMPLETED|Period III (Single-Blind)||0
8417587|NCT00923091|20746576|P3|COMPLETED|Period III (Single-Blind)||0
8417588|NCT00923091|20746577|P2|COMPLETED|Period III (Single-Blind)||0
8417589|NCT00923091|20746578|P1|COMPLETED|Period III (Single-Blind)||2520
8417590|NCT00923091|20746566|P13|STARTED|Period III (Single-Blind)||0
8417591|NCT00923091|20746567|P12|STARTED|Period III (Single-Blind)||0
8417592|NCT00923091|20746568|P11|STARTED|Period III (Single-Blind)||0
8417593|NCT00923091|20746569|P10|STARTED|Period III (Single-Blind)||0
8417594|NCT00923091|20746570|P9|STARTED|Period III (Single-Blind)||0
8417595|NCT00923091|20746571|P8|STARTED|Period III (Single-Blind)||0
8417596|NCT00923091|20746572|P7|STARTED|Period III (Single-Blind)||0
8417597|NCT00923091|20746573|P6|STARTED|Period III (Single-Blind)||0
8417598|NCT00923091|20746574|P5|STARTED|Period III (Single-Blind)||0
8417599|NCT00923091|20746575|P4|STARTED|Period III (Single-Blind)||0
8417600|NCT00923091|20746576|P3|STARTED|Period III (Single-Blind)||0
8417601|NCT00923091|20746577|P2|STARTED|Period III (Single-Blind)||0
8417602|NCT00923091|20746578|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
8417603|NCT00923091|20746566|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417604|NCT00923091|20746567|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417605|NCT00923091|20746568|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417606|NCT00923091|20746569|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417607|NCT00923091|20746570|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417608|NCT00923091|20746571|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
8417609|NCT00923091|20746572|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
8417610|NCT00923091|20746573|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
8417611|NCT00923091|20746574|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
8417612|NCT00923091|20746575|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
8417613|NCT00923091|20746576|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
8417614|NCT00923091|20746577|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
8417615|NCT00923091|20746578|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
8417616|NCT00923091|20746566|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417617|NCT00923091|20746567|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417618|NCT00923091|20746568|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417619|NCT00923091|20746569|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417620|NCT00923091|20746570|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417621|NCT00923091|20746571|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
8417622|NCT00923091|20746572|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
8417623|NCT00923091|20746573|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
8417624|NCT00923091|20746574|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
8417625|NCT00923091|20746575|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
8417626|NCT00923091|20746576|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
8417627|NCT00923091|20746577|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
8417628|NCT00923091|20746578|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
8417629|NCT00923091|20746566|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417630|NCT00923091|20746567|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417631|NCT00923091|20746568|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417632|NCT00923091|20746569|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417633|NCT00923091|20746570|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417634|NCT00923091|20746571|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417635|NCT00923091|20746572|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
8417636|NCT00923091|20746573|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
8417637|NCT00923091|20746574|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417638|NCT00923091|20746575|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417639|NCT00923091|20746576|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417640|NCT00923091|20746577|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417641|NCT00923091|20746578|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
8417642|NCT00923078|20746628|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8417643|NCT00923078|20746629|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8417644|NCT00923078|20746630|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8417645|NCT00923078|20746628|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
8417646|NCT00923078|20746629|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
8417647|NCT00923078|20746630|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
8417648|NCT00923078|20746628|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
8417649|NCT00923078|20746629|P2|STARTED|Second Intervention (Weeks 5-8)||19
8417650|NCT00923078|20746630|P1|STARTED|Second Intervention (Weeks 5-8)||19
8417651|NCT00923078|20746628|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
8417652|NCT00923078|20746629|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
8417653|NCT00923078|20746630|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
8417654|NCT00923078|20746628|P3|COMPLETED|First Intervention (Weeks 1-4)||0
8417655|NCT00923078|20746629|P2|COMPLETED|First Intervention (Weeks 1-4)||19
8417656|NCT00923078|20746630|P1|COMPLETED|First Intervention (Weeks 1-4)||19
8417657|NCT00923078|20746628|P3|STARTED|First Intervention (Weeks 1-4)||20
8417658|NCT00923078|20746629|P2|STARTED|First Intervention (Weeks 1-4)||20
8417659|NCT00923078|20746630|P1|STARTED|First Intervention (Weeks 1-4)||20
8417660|NCT00922987|20746649|P1|NOT COMPLETED|Overall Study||4
8417661|NCT00922987|20746649|P1|COMPLETED|Overall Study||277
8417662|NCT00922987|20746649|P1|STARTED|Overall Study||281
8417663|NCT00922974|20746664|P2|NOT COMPLETED|Phase III Component||6
8417664|NCT00922974|20746665|P1|NOT COMPLETED|Phase III Component||8
8417665|NCT00922974|20746664|P2|COMPLETED|Phase III Component||130
8417666|NCT00922974|20746665|P1|COMPLETED|Phase III Component||209
8417667|NCT00922974|20746664|P2|Eligible, Treated, Adverse Event Data|Phase III Component||83
8417668|NCT00922974|20746665|P1|Eligible, Treated, Adverse Event Data|Phase III Component||148
8417669|NCT00922974|20746664|P2|Eligible With Adverse Event Data|Phase III Component||117
8417670|NCT00922974|20746665|P1|Eligible With Adverse Event Data|Phase III Component||202
8417671|NCT00922974|20746664|P2|Eligible With 3 mo. FACT-G Data|Phase III Component||58
8417672|NCT00922974|20746665|P1|Eligible With 3 mo. FACT-G Data|Phase III Component||87
8417673|NCT00922974|20746664|P2|Eligible With 3 mo. NRPS Data|Phase III Component||76
8417674|NCT00922974|20746665|P1|Eligible With 3 mo. NRPS Data|Phase III Component||139
8417675|NCT00922974|20746664|P2|Eligible|Phase III Component||130
8417676|NCT00922974|20746665|P1|Eligible|Phase III Component||209
8417677|NCT00922974|20746664|P2|STARTED|Phase III Component||136
8417678|NCT00922974|20746665|P1|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
8417679|NCT00922974|20746664|P2|NOT COMPLETED|Phase II Component||0
8417680|NCT00922974|20746665|P1|NOT COMPLETED|Phase II Component||7
8417681|NCT00922974|20746664|P2|COMPLETED|Phase II Component||0
8417682|NCT00922974|20746665|P1|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
8417683|NCT00922974|20746664|P2|Eligible, Treated, Adverse Event Data|Phase II Component||0
8417684|NCT00922974|20746665|P1|Eligible, Treated, Adverse Event Data|Phase II Component||34
8417685|NCT00922974|20746664|P2|Eligible and Started Treatment|Phase II Component||0
8417686|NCT00922974|20746665|P1|Eligible and Started Treatment|Phase II Component||39
8417687|NCT00922974|20746664|P2|Eligible|Phase II Component||0
8417688|NCT00922974|20746665|P1|Eligible|Phase II Component||44
8417689|NCT00922974|20746664|P2|STARTED|Phase II Component||0
8417690|NCT00922974|20746665|P1|STARTED|Phase II Component||46
8417691|NCT00922935|20746680|P3|NOT COMPLETED|Overall Study||0
8417692|NCT00922935|20746681|P2|NOT COMPLETED|Overall Study||5
8417693|NCT00922935|20746682|P1|NOT COMPLETED|Overall Study||1
8417694|NCT00922935|20746680|P3|COMPLETED|Overall Study||10
8417695|NCT00922935|20746681|P2|COMPLETED|Overall Study||11
8417696|NCT00922935|20746682|P1|COMPLETED|Overall Study||9
8417697|NCT00922935|20746680|P3|STARTED|Overall Study||10
8417698|NCT00922935|20746681|P2|STARTED|Overall Study||16
8417699|NCT00922935|20746682|P1|STARTED|Overall Study||10
8417700|NCT00922883|20746690|P1|NOT COMPLETED|Overall Study||0
8417701|NCT00922883|20746690|P1|COMPLETED|Overall Study||43
8417702|NCT00922883|20746690|P1|STARTED|Overall Study||43
8417703|NCT00922779|20746694|P1|NOT COMPLETED|Overall Study||2327
8417704|NCT00922779|20746694|P1|COMPLETED|Overall Study||4334
8417705|NCT00922779|20746694|P1|STARTED|Overall Study||6661
8417706|NCT00922766|20746701|P1|NOT COMPLETED|Overall Study||7
8417707|NCT00922766|20746701|P1|COMPLETED|Overall Study||610
8417708|NCT00922766|20746701|P1|STARTED|Overall Study||617
8417709|NCT00922701|20746710|P1|NOT COMPLETED|Overall Study||0
8417710|NCT00922701|20746710|P1|COMPLETED|Overall Study||4
8417711|NCT00922701|20746710|P1|STARTED|Overall Study||4
8417712|NCT00922636|20746719|P5|NOT COMPLETED|Overall Study||16
8417713|NCT00922636|20746720|P4|NOT COMPLETED|Overall Study||17
8417714|NCT00922636|20746721|P3|NOT COMPLETED|Overall Study||20
8417715|NCT00922636|20746722|P2|NOT COMPLETED|Overall Study||16
8417716|NCT00922636|20746723|P1|NOT COMPLETED|Overall Study||7
8417717|NCT00922636|20746719|P5|COMPLETED|Overall Study||59
8417718|NCT00922636|20746720|P4|COMPLETED|Overall Study||58
8417719|NCT00922636|20746721|P3|COMPLETED|Overall Study||56
8417720|NCT00922636|20746722|P2|COMPLETED|Overall Study||62
8417721|NCT00922636|20746723|P1|COMPLETED|Overall Study||29
8417722|NCT00922636|20746719|P5|Entered Optional Taper Phase|Overall Study||12
8417723|NCT00922636|20746720|P4|Entered Optional Taper Phase|Overall Study||7
8417724|NCT00922636|20746721|P3|Entered Optional Taper Phase|Overall Study||15
8417725|NCT00922636|20746722|P2|Entered Optional Taper Phase|Overall Study||10
8417726|NCT00922636|20746723|P1|Entered Optional Taper Phase|Overall Study||4
8417727|NCT00922636|20746719|P5|STARTED|Overall Study||75
8417728|NCT00922636|20746720|P4|STARTED|Overall Study||75
8417729|NCT00922636|20746721|P3|STARTED|Overall Study||76
8417730|NCT00922636|20746722|P2|STARTED|Overall Study||78
8417731|NCT00922636|20746723|P1|STARTED|Overall Study||36
8417732|NCT00922623|20746870|P1|NOT COMPLETED|Overall Study||5
8417733|NCT00922623|20746870|P1|COMPLETED|Overall Study||88
8417734|NCT00922623|20746870|P1|STARTED|Overall Study||93
8417735|NCT00922480|20746878|P2|NOT COMPLETED|Extension Study||3
8417736|NCT00922480|20746879|P1|NOT COMPLETED|Extension Study||5
8417737|NCT00922480|20746878|P2|COMPLETED|Extension Study||82
8417738|NCT00922480|20746879|P1|COMPLETED|Extension Study||68
8417739|NCT00922480|20746878|P2|STARTED|Extension Study||85
8417740|NCT00922480|20746879|P1|STARTED|Extension Study||73
8417741|NCT00922480|20746878|P2|NOT COMPLETED|Main Study||29
8417742|NCT00922480|20746879|P1|NOT COMPLETED|Main Study||37
8417743|NCT00922480|20746878|P2|COMPLETED|Main Study||226
8417744|NCT00922480|20746879|P1|COMPLETED|Main Study||213
8417745|NCT00922480|20746878|P2|STARTED|Main Study||255
8417746|NCT00922480|20746879|P1|STARTED|Main Study||250
8417747|NCT00922441|20746890|P3|NOT COMPLETED|Overall Study||3
8417748|NCT00922441|20746891|P2|NOT COMPLETED|Overall Study||0
8417749|NCT00922441|20746892|P1|NOT COMPLETED|Overall Study||0
8417750|NCT00922441|20746890|P3|COMPLETED|Overall Study||29
8417751|NCT00922441|20746891|P2|COMPLETED|Overall Study||30
8417752|NCT00922441|20746892|P1|COMPLETED|Overall Study||30
8417753|NCT00922441|20746890|P3|STARTED|Overall Study||32
8417754|NCT00922441|20746891|P2|STARTED|Overall Study||30
8417755|NCT00922441|20746892|P1|STARTED|Overall Study||30
8417756|NCT00922428|20746900|P1|NOT COMPLETED|Overall Study||15
8417757|NCT00922428|20746900|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
8417758|NCT00922428|20746900|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
8417759|NCT00922272|20746929|P2|NOT COMPLETED|Double-blind Phase||6
8417760|NCT00922272|20746930|P1|NOT COMPLETED|Double-blind Phase||7
8417761|NCT00922272|20746929|P2|COMPLETED|Double-blind Phase||29
8417762|NCT00922272|20746930|P1|COMPLETED|Double-blind Phase||27
8417763|NCT00922272|20746929|P2|STARTED|Double-blind Phase||35
8417764|NCT00922272|20746930|P1|STARTED|Double-blind Phase||34
8417765|NCT00922272|20746929|P2|NOT COMPLETED|Open-label Phase||0
8417766|NCT00922272|20746930|P1|NOT COMPLETED|Open-label Phase||23
8417767|NCT00922272|20746929|P2|COMPLETED|Open-label Phase||0
8417768|NCT00922272|20746930|P1|COMPLETED|Open-label Phase||69
8417769|NCT00922272|20746929|P2|STARTED|Open-label Phase||0
8417770|NCT00922272|20746930|P1|STARTED|Open-label Phase||92
8417771|NCT00922233|20746986|P1|NOT COMPLETED|Overall Study||4
8417772|NCT00922233|20746986|P1|COMPLETED|Overall Study||68
8417773|NCT00922233|20746986|P1|STARTED|Overall Study||72
8417774|NCT00922207|20746995|P3|NOT COMPLETED|Overall Study||4
8417775|NCT00922207|20746996|P2|NOT COMPLETED|Overall Study||7
8417776|NCT00922207|20746997|P1|NOT COMPLETED|Overall Study||6
8417777|NCT00922207|20746995|P3|COMPLETED|Overall Study||90
8417778|NCT00922207|20746996|P2|COMPLETED|Overall Study||88
8417779|NCT00922207|20746997|P1|COMPLETED|Overall Study||85
8417780|NCT00922207|20746995|P3|STARTED|Overall Study||94
8417781|NCT00922207|20746996|P2|STARTED|Overall Study||95
8417782|NCT00922207|20746997|P1|STARTED|Overall Study||91
8417783|NCT00922194|20747023|P1|NOT COMPLETED|Metformin for 12 Months or More||0
8417784|NCT00922194|20747023|P1|COMPLETED|Metformin for 12 Months or More||102
8417785|NCT00922194|20747023|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
8417786|NCT00922194|20747023|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
8417787|NCT00922194|20747023|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
8417788|NCT00922194|20747023|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
8417789|NCT00922116|20747033|P1|NOT COMPLETED|Overall Study||15
8417790|NCT00922116|20747033|P1|COMPLETED|Overall Study||176
8417791|NCT00922116|20747033|P1|STARTED|Overall Study||191
8417792|NCT00921947|20747044|P2|NOT COMPLETED|Day 28||0
8417793|NCT00921947|20747045|P1|NOT COMPLETED|Day 28||0
8417794|NCT00921947|20747044|P2|COMPLETED|Day 28||30
8417795|NCT00921947|20747045|P1|COMPLETED|Day 28||28
8417796|NCT00921947|20747044|P2|STARTED|Day 28||30
8417797|NCT00921947|20747045|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
8417798|NCT00921947|20747044|P2|NOT COMPLETED|Day 0||0
8417799|NCT00921947|20747045|P1|NOT COMPLETED|Day 0||0
8417800|NCT00921947|20747044|P2|COMPLETED|Day 0||30
8417801|NCT00921947|20747045|P1|COMPLETED|Day 0||30
8417802|NCT00921947|20747044|P2|STARTED|Day 0||30
8417803|NCT00921947|20747045|P1|STARTED|Day 0||30
8417804|NCT00921934|20747055|P1|NOT COMPLETED|Overall Study||0
8417805|NCT00921934|20747055|P1|COMPLETED|Overall Study||68
8417806|NCT00921934|20747055|P1|STARTED|Overall Study||68
8417807|NCT00921895|20747059|P1|NOT COMPLETED|Overall Study||0
8417808|NCT00921895|20747059|P1|COMPLETED|Overall Study||128
8417809|NCT00921895|20747059|P1|STARTED|Overall Study||128
8417810|NCT00921843|20747068|P4|NOT COMPLETED|Overall Study||0
8417811|NCT00921843|20747069|P3|NOT COMPLETED|Overall Study||0
8417812|NCT00921843|20747070|P2|NOT COMPLETED|Overall Study||0
8417813|NCT00921843|20747071|P1|NOT COMPLETED|Overall Study||0
8417814|NCT00921843|20747068|P4|COMPLETED|Overall Study||30
8417815|NCT00921843|20747069|P3|COMPLETED|Overall Study||11
8417816|NCT00921843|20747070|P2|COMPLETED|Overall Study||10
8417817|NCT00921843|20747071|P1|COMPLETED|Overall Study||10
8417818|NCT00921843|20747068|P4|STARTED|Overall Study||30
8417819|NCT00921843|20747069|P3|STARTED|Overall Study||11
8417820|NCT00921843|20747070|P2|STARTED|Overall Study||10
8417821|NCT00921843|20747071|P1|STARTED|Overall Study||10
8417822|NCT00921687|20747083|P2|NOT COMPLETED|Overall Study||0
8417823|NCT00921687|20747084|P1|NOT COMPLETED|Overall Study||0
8417824|NCT00921687|20747083|P2|COMPLETED|Overall Study||363
8417825|NCT00921687|20747084|P1|COMPLETED|Overall Study||418
8417826|NCT00921687|20747083|P2|STARTED|Overall Study||363
8417827|NCT00921687|20747084|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
8417828|NCT00921557|20747095|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
8417829|NCT00921557|20747096|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
8417830|NCT00921557|20747097|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
8417831|NCT00921557|20747095|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
8417832|NCT00921557|20747096|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
8417833|NCT00921557|20747097|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
8417834|NCT00921557|20747095|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
8417835|NCT00921557|20747096|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
8417836|NCT00921557|20747097|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
8417837|NCT00921557|20747095|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
8417838|NCT00921557|20747096|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
8417839|NCT00921557|20747097|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
8417840|NCT00921557|20747095|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
8417841|NCT00921557|20747096|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
8417842|NCT00921557|20747097|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
8417843|NCT00921557|20747095|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
8417844|NCT00921557|20747096|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
8417845|NCT00921557|20747097|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
8417846|NCT00921557|20747095|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
8417847|NCT00921557|20747096|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
8417848|NCT00921557|20747097|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
8417849|NCT00921557|20747095|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
8417850|NCT00921557|20747096|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
8417851|NCT00921557|20747097|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
8417852|NCT00921557|20747095|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
8417853|NCT00921557|20747096|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
8417854|NCT00921557|20747097|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
8417855|NCT00921518|20747157|P2|NOT COMPLETED|Overall Study||0
8417856|NCT00921518|20747158|P1|NOT COMPLETED|Overall Study||0
8417857|NCT00921518|20747157|P2|COMPLETED|Overall Study||44
8417858|NCT00921518|20747158|P1|COMPLETED|Overall Study||48
8417859|NCT00921518|20747157|P2|STARTED|Overall Study||44
8417860|NCT00921518|20747158|P1|STARTED|Overall Study||48
8417861|NCT00921310|20747166|P3|NOT COMPLETED|Overall Study||0
8417862|NCT00921310|20747167|P2|NOT COMPLETED|Overall Study||0
8417863|NCT00921310|20747168|P1|NOT COMPLETED|Overall Study||0
8417864|NCT00921310|20747166|P3|COMPLETED|Overall Study||4
8417865|NCT00921310|20747167|P2|COMPLETED|Overall Study||6
8417866|NCT00921310|20747168|P1|COMPLETED|Overall Study||2
8417867|NCT00921310|20747166|P3|STARTED|Overall Study||4
8417868|NCT00921310|20747167|P2|STARTED|Overall Study||6
8417869|NCT00921310|20747168|P1|STARTED|Overall Study||2
8417870|NCT00921115|20747193|P1|NOT COMPLETED|Overall Study||0
8417871|NCT00921115|20747193|P1|COMPLETED|Overall Study||42
8417872|NCT00921115|20747193|P1|STARTED|Overall Study||42
8417873|NCT00921024|20747199|P2|NOT COMPLETED|Overall Study||3
8417874|NCT00921024|20747200|P1|NOT COMPLETED|Overall Study||4
8417875|NCT00921024|20747199|P2|COMPLETED|Overall Study||39
8417876|NCT00921024|20747200|P1|COMPLETED|Overall Study||81
8417877|NCT00921024|20747199|P2|STARTED|Overall Study||42
8417878|NCT00921024|20747200|P1|STARTED|Overall Study||85
8417879|NCT00920907|20747210|P2|NOT COMPLETED|Maintenance Period||13
8417880|NCT00920907|20747211|P1|NOT COMPLETED|Maintenance Period||12
8417881|NCT00920907|20747210|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
8417882|NCT00920907|20747211|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
8417883|NCT00920907|20747210|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
8417884|NCT00920907|20747211|P1|STARTED|Maintenance Period||15
8417885|NCT00920907|20747210|P2|NOT COMPLETED|Induction Period||22
8417886|NCT00920907|20747211|P1|NOT COMPLETED|Induction Period||22
8417887|NCT00920907|20747210|P2|COMPLETED|Induction Period||16
8417888|NCT00920907|20747211|P1|COMPLETED|Induction Period||15
8417889|NCT00920907|20747210|P2|STARTED|Induction Period||38
8417890|NCT00920907|20747211|P1|STARTED|Induction Period||37
8417891|NCT00920855|20747252|P3|NOT COMPLETED|Overall Study||22
8417892|NCT00920855|20747253|P2|NOT COMPLETED|Overall Study||3
8417893|NCT00920855|20747254|P1|NOT COMPLETED|Overall Study||5
8417894|NCT00920855|20747252|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
8417895|NCT00920855|20747253|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
8417896|NCT00920855|20747254|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
8417897|NCT00920855|20747252|P3|Safety and Efficacy Populations|Overall Study||31
8417898|NCT00920855|20747253|P2|Safety and Efficacy Populations|Overall Study||4
8417899|NCT00920855|20747254|P1|Safety and Efficacy Populations|Overall Study||5
8417900|NCT00920855|20747252|P3|STARTED|Overall Study||31
8417901|NCT00920855|20747253|P2|STARTED|Overall Study||4
8417902|NCT00920855|20747254|P1|STARTED|Overall Study||5
8417903|NCT00920829|20747280|P4|NOT COMPLETED|Available for Analysis||11
8417904|NCT00920829|20747281|P3|NOT COMPLETED|Available for Analysis||10
8417905|NCT00920829|20747282|P2|NOT COMPLETED|Available for Analysis||11
8417906|NCT00920829|20747283|P1|NOT COMPLETED|Available for Analysis||8
8417907|NCT00920829|20747280|P4|COMPLETED|Available for Analysis||24
8417908|NCT00920829|20747281|P3|COMPLETED|Available for Analysis||28
8417909|NCT00920829|20747282|P2|COMPLETED|Available for Analysis||27
8417910|NCT00920829|20747283|P1|COMPLETED|Available for Analysis||27
8417911|NCT00920829|20747280|P4|STARTED|Available for Analysis||35
8417912|NCT00920829|20747281|P3|STARTED|Available for Analysis||38
8417913|NCT00920829|20747282|P2|STARTED|Available for Analysis||38
8417914|NCT00920829|20747283|P1|STARTED|Available for Analysis||35
8417915|NCT00920829|20747280|P4|NOT COMPLETED|Allocation||2
8417916|NCT00920829|20747281|P3|NOT COMPLETED|Allocation||0
8417917|NCT00920829|20747282|P2|NOT COMPLETED|Allocation||1
8417918|NCT00920829|20747283|P1|NOT COMPLETED|Allocation||3
8417919|NCT00920829|20747280|P4|COMPLETED|Allocation||35
8417920|NCT00920829|20747281|P3|COMPLETED|Allocation||38
8417921|NCT00920829|20747282|P2|COMPLETED|Allocation||38
8417922|NCT00920829|20747283|P1|COMPLETED|Allocation||35
8417923|NCT00920829|20747280|P4|STARTED|Allocation||37
8417924|NCT00920829|20747281|P3|STARTED|Allocation||38
8417925|NCT00920829|20747282|P2|STARTED|Allocation||39
8417926|NCT00920829|20747283|P1|STARTED|Allocation||38
8417927|NCT00920816|20747297|P4|NOT COMPLETED|Overall Study||69
8417928|NCT00920816|20747298|P3|NOT COMPLETED|Overall Study||135
8417929|NCT00920816|20747299|P2|NOT COMPLETED|Overall Study||96
8417930|NCT00920816|20747300|P1|NOT COMPLETED|Overall Study||192
8417931|NCT00920816|20747297|P4|COMPLETED|Overall Study||0
8417932|NCT00920816|20747298|P3|COMPLETED|Overall Study||0
8417933|NCT00920816|20747299|P2|COMPLETED|Overall Study||0
8417934|NCT00920816|20747300|P1|COMPLETED|Overall Study||0
8417935|NCT00920816|20747297|P4|Treated|Overall Study||69
8417936|NCT00920816|20747298|P3|Treated|Overall Study||135
8417937|NCT00920816|20747299|P2|Treated|Overall Study||96
8417938|NCT00920816|20747300|P1|Treated|Overall Study||189
8417939|NCT00920816|20747297|P4|STARTED|Overall Study||69
8417940|NCT00920816|20747298|P3|STARTED|Overall Study||135
8417941|NCT00920816|20747299|P2|STARTED|Overall Study||96
8417942|NCT00920816|20747300|P1|STARTED|Overall Study||192
8417943|NCT00920790|20747338|P1|NOT COMPLETED|Overall Study||14
8417944|NCT00920790|20747338|P1|COMPLETED|Overall Study||13
8417945|NCT00920790|20747338|P1|STARTED|Overall Study||27
8417946|NCT00920699|20747350|P3|NOT COMPLETED|Overall Study||4
8417947|NCT00920699|20747351|P2|NOT COMPLETED|Overall Study||1
8417948|NCT00920699|20747352|P1|NOT COMPLETED|Overall Study||2
8417949|NCT00920699|20747350|P3|COMPLETED|Overall Study||28
8417950|NCT00920699|20747351|P2|COMPLETED|Overall Study||29
8417951|NCT00920699|20747352|P1|COMPLETED|Overall Study||27
8417952|NCT00920699|20747350|P3|STARTED|Overall Study||32
8417953|NCT00920699|20747351|P2|STARTED|Overall Study||30
8417954|NCT00920699|20747352|P1|STARTED|Overall Study||29
8417955|NCT00920686|20747369|P3|NOT COMPLETED|Overall Study||13
8417956|NCT00920686|20747370|P2|NOT COMPLETED|Overall Study||22
8417957|NCT00920686|20747371|P1|NOT COMPLETED|Overall Study||19
8417958|NCT00920686|20747369|P3|COMPLETED|Overall Study||62
8417959|NCT00920686|20747370|P2|COMPLETED|Overall Study||60
8417960|NCT00920686|20747371|P1|COMPLETED|Overall Study||63
8417961|NCT00920686|20747369|P3|STARTED|Overall Study||75
8417962|NCT00920686|20747370|P2|STARTED|Overall Study||82
8417963|NCT00920686|20747371|P1|STARTED|Overall Study||82
8417964|NCT00920647|20747395|P4|NOT COMPLETED|Overall Study||0
8417965|NCT00920647|20747396|P3|NOT COMPLETED|Overall Study||0
8417966|NCT00920647|20747397|P2|NOT COMPLETED|Overall Study||0
8417967|NCT00920647|20747398|P1|NOT COMPLETED|Overall Study||0
8417968|NCT00920647|20747395|P4|COMPLETED|Overall Study||4
8417969|NCT00920647|20747396|P3|COMPLETED|Overall Study||4
8417970|NCT00920647|20747397|P2|COMPLETED|Overall Study||4
8417971|NCT00920647|20747398|P1|COMPLETED|Overall Study||4
8417972|NCT00920647|20747395|P4|STARTED|Overall Study||4
8417973|NCT00920647|20747396|P3|STARTED|Overall Study||4
8417974|NCT00920647|20747397|P2|STARTED|Overall Study||4
8417975|NCT00920647|20747398|P1|STARTED|Overall Study||4
8417976|NCT00920556|20747446|P1|NOT COMPLETED|Overall Study||24
8417977|NCT00920556|20747446|P1|COMPLETED|Overall Study||0
8417978|NCT00920556|20747446|P1|STARTED|Overall Study||24
8417979|NCT00920439|20747485|P1|NOT COMPLETED|Overall Study||0
8417980|NCT00920439|20747485|P1|COMPLETED|Overall Study||25
8417981|NCT00920439|20747485|P1|STARTED|Overall Study||25
8417982|NCT00920426|20747495|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417983|NCT00920426|20747496|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417984|NCT00920426|20747497|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417985|NCT00920426|20747498|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417986|NCT00920426|20747495|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
8417987|NCT00920426|20747496|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417988|NCT00920426|20747497|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417989|NCT00920426|20747498|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417990|NCT00920426|20747495|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
8417991|NCT00920426|20747496|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
8417992|NCT00920426|20747497|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
8417993|NCT00920426|20747498|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
8417994|NCT00920426|20747495|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417995|NCT00920426|20747496|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417996|NCT00920426|20747497|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417997|NCT00920426|20747498|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417998|NCT00920426|20747495|P4|COMPLETED|ITZ112929: Randomized Regimen||0
8417999|NCT00920426|20747496|P3|COMPLETED|ITZ112929: Randomized Regimen||2
8418000|NCT00920426|20747497|P2|COMPLETED|ITZ112929: Randomized Regimen||7
8418001|NCT00920426|20747498|P1|COMPLETED|ITZ112929: Randomized Regimen||0
8418002|NCT00920426|20747495|P4|STARTED|ITZ112929: Randomized Regimen||0
8418003|NCT00920426|20747496|P3|STARTED|ITZ112929: Randomized Regimen||2
8418004|NCT00920426|20747497|P2|STARTED|ITZ112929: Randomized Regimen||7
8418005|NCT00920426|20747498|P1|STARTED|ITZ112929: Randomized Regimen||0
8418006|NCT00920426|20747495|P4|NOT COMPLETED|ITZ111451||0
8418007|NCT00920426|20747496|P3|NOT COMPLETED|ITZ111451||0
8418008|NCT00920426|20747497|P2|NOT COMPLETED|ITZ111451||0
8418009|NCT00920426|20747498|P1|NOT COMPLETED|ITZ111451||1
8418010|NCT00920426|20747495|P4|COMPLETED|ITZ111451||0
8418011|NCT00920426|20747496|P3|COMPLETED|ITZ111451||0
8418012|NCT00920426|20747497|P2|COMPLETED|ITZ111451||0
8418013|NCT00920426|20747498|P1|COMPLETED|ITZ111451||7
8418014|NCT00920426|20747495|P4|STARTED|ITZ111451||0
8418015|NCT00920426|20747496|P3|STARTED|ITZ111451||0
8418016|NCT00920426|20747497|P2|STARTED|ITZ111451||0
8418017|NCT00920426|20747498|P1|STARTED|ITZ111451||8
8418018|NCT00920374|20747567|P2|NOT COMPLETED|Overall Study||0
8418019|NCT00920374|20747568|P1|NOT COMPLETED|Overall Study||0
8418020|NCT00920374|20747567|P2|COMPLETED|Overall Study||57
8418021|NCT00920374|20747568|P1|COMPLETED|Overall Study||61
8418022|NCT00920374|20747567|P2|STARTED|Overall Study||57
8418023|NCT00920374|20747568|P1|STARTED|Overall Study||61
8418024|NCT00920309|20747594|P2|NOT COMPLETED|Overall Study||0
8418025|NCT00920309|20747595|P1|NOT COMPLETED|Overall Study||0
8418026|NCT00920309|20747594|P2|COMPLETED|Overall Study||7
8418027|NCT00920309|20747595|P1|COMPLETED|Overall Study||14
8418028|NCT00920309|20747594|P2|STARTED|Overall Study||7
8418029|NCT00920309|20747595|P1|STARTED|Overall Study||14
8418030|NCT00920231|20747605|P2|NOT COMPLETED|Overall Study||0
8418031|NCT00920231|20747606|P1|NOT COMPLETED|Overall Study||0
8418032|NCT00920231|20747605|P2|COMPLETED|Overall Study||8
8418033|NCT00920231|20747606|P1|COMPLETED|Overall Study||8
8418034|NCT00920231|20747605|P2|STARTED|Overall Study||8
8418035|NCT00920231|20747606|P1|STARTED|Overall Study||8
8418036|NCT00920218|20747618|P4|NOT COMPLETED|Overall Study||7
8418037|NCT00920218|20747619|P3|NOT COMPLETED|Overall Study||8
8418038|NCT00920218|20747620|P2|NOT COMPLETED|Overall Study||5
8418039|NCT00920218|20747621|P1|NOT COMPLETED|Overall Study||2
8418040|NCT00920218|20747618|P4|COMPLETED|Overall Study||23
8418041|NCT00920218|20747619|P3|COMPLETED|Overall Study||23
8418042|NCT00920218|20747620|P2|COMPLETED|Overall Study||24
8418043|NCT00920218|20747621|P1|COMPLETED|Overall Study||28
8418044|NCT00920218|20747618|P4|STARTED|Overall Study||30
8418045|NCT00920218|20747619|P3|STARTED|Overall Study||31
8418046|NCT00920218|20747620|P2|STARTED|Overall Study||29
8418047|NCT00920218|20747621|P1|STARTED|Overall Study||30
8418048|NCT00920140|20747724|P5|NOT COMPLETED|Phase 2||11
8418049|NCT00920140|20747725|P4|NOT COMPLETED|Phase 2||22
8418050|NCT00920140|20747726|P3|NOT COMPLETED|Phase 2||50
8418051|NCT00920140|20747727|P2|NOT COMPLETED|Phase 2||0
8418052|NCT00920140|20747728|P1|NOT COMPLETED|Phase 2||0
8418053|NCT00920140|20747724|P5|COMPLETED|Phase 2||0
8418054|NCT00920140|20747725|P4|COMPLETED|Phase 2||0
8418055|NCT00920140|20747726|P3|COMPLETED|Phase 2||0
8418056|NCT00920140|20747727|P2|COMPLETED|Phase 2||0
8418057|NCT00920140|20747728|P1|COMPLETED|Phase 2||0
8418058|NCT00920140|20747724|P5|STARTED|Phase 2||11
8418059|NCT00920140|20747725|P4|STARTED|Phase 2||22
8418060|NCT00920140|20747726|P3|STARTED|Phase 2||50
8418061|NCT00920140|20747727|P2|STARTED|Phase 2||0
8418062|NCT00920140|20747728|P1|STARTED|Phase 2||0
8418063|NCT00920140|20747724|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8418064|NCT00920140|20747725|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8418065|NCT00920140|20747726|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8418066|NCT00920140|20747727|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
8418067|NCT00920140|20747728|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
8418068|NCT00920140|20747724|P5|COMPLETED|Phase 1 (Dose Escalation)||0
8418069|NCT00920140|20747725|P4|COMPLETED|Phase 1 (Dose Escalation)||0
8418070|NCT00920140|20747726|P3|COMPLETED|Phase 1 (Dose Escalation)||0
8418071|NCT00920140|20747727|P2|COMPLETED|Phase 1 (Dose Escalation)||0
8418072|NCT00920140|20747728|P1|COMPLETED|Phase 1 (Dose Escalation)||0
8418073|NCT00920140|20747724|P5|STARTED|Phase 1 (Dose Escalation)||0
8418074|NCT00920140|20747725|P4|STARTED|Phase 1 (Dose Escalation)||0
8418075|NCT00920140|20747726|P3|STARTED|Phase 1 (Dose Escalation)||0
8418076|NCT00920140|20747727|P2|STARTED|Phase 1 (Dose Escalation)||9
8418077|NCT00920140|20747728|P1|STARTED|Phase 1 (Dose Escalation)||5
8418078|NCT00920075|20747766|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
8418079|NCT00920075|20747766|P1|COMPLETED|Post Study, 11 Pts Responded||11
8418080|NCT00920075|20747766|P1|STARTED|Post Study, 11 Pts Responded||11
8418081|NCT00920075|20747766|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
8418082|NCT00920075|20747766|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
8418083|NCT00920075|20747766|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
8418084|NCT00920023|20747772|P1|NOT COMPLETED|Overall Study||0
8418085|NCT00920023|20747772|P1|COMPLETED|Overall Study||15
8418086|NCT00920023|20747772|P1|STARTED|Overall Study||15
8418087|NCT00919932|20747779|P2|NOT COMPLETED|Overall Study||0
8418088|NCT00919932|20747780|P1|NOT COMPLETED|Overall Study||0
8418089|NCT00919932|20747779|P2|COMPLETED|Overall Study||5
8418090|NCT00919932|20747780|P1|COMPLETED|Overall Study||4
8418091|NCT00919932|20747779|P2|STARTED|Overall Study||5
8418092|NCT00919932|20747780|P1|STARTED|Overall Study||4
8418093|NCT00919893|20747790|P2|NOT COMPLETED|Overall Study||9
8418094|NCT00919893|20747791|P1|NOT COMPLETED|Overall Study||19
8418095|NCT00919893|20747790|P2|COMPLETED|Overall Study||60
8418096|NCT00919893|20747791|P1|COMPLETED|Overall Study||51
8418097|NCT00919893|20747790|P2|STARTED|Overall Study||69
8418098|NCT00919893|20747791|P1|STARTED|Overall Study||70
8418099|NCT00919867|20747803|P6|NOT COMPLETED|Third Intervention||0
8418100|NCT00919867|20747804|P5|NOT COMPLETED|Third Intervention||0
8418101|NCT00919867|20747805|P4|NOT COMPLETED|Third Intervention||0
8418102|NCT00919867|20747806|P3|NOT COMPLETED|Third Intervention||0
8418103|NCT00919867|20747807|P2|NOT COMPLETED|Third Intervention||0
8418104|NCT00919867|20747808|P1|NOT COMPLETED|Third Intervention||0
8418105|NCT00919867|20747803|P6|COMPLETED|Third Intervention||6
8418106|NCT00919867|20747804|P5|COMPLETED|Third Intervention||7
8418107|NCT00919867|20747805|P4|COMPLETED|Third Intervention||7
8418108|NCT00919867|20747806|P3|COMPLETED|Third Intervention||6
8418109|NCT00919867|20747807|P2|COMPLETED|Third Intervention||7
8418110|NCT00919867|20747808|P1|COMPLETED|Third Intervention||7
8418111|NCT00919867|20747803|P6|STARTED|Third Intervention||6
8418112|NCT00919867|20747804|P5|STARTED|Third Intervention||7
8418113|NCT00919867|20747805|P4|STARTED|Third Intervention||7
8418114|NCT00919867|20747806|P3|STARTED|Third Intervention||6
8418115|NCT00919867|20747807|P2|STARTED|Third Intervention||7
8418116|NCT00919867|20747808|P1|STARTED|Third Intervention||7
8418117|NCT00919867|20747803|P6|NOT COMPLETED|Washout||0
8418118|NCT00919867|20747804|P5|NOT COMPLETED|Washout||0
8418119|NCT00919867|20747805|P4|NOT COMPLETED|Washout||0
8418120|NCT00919867|20747806|P3|NOT COMPLETED|Washout||0
8418121|NCT00919867|20747807|P2|NOT COMPLETED|Washout||0
8418122|NCT00919867|20747808|P1|NOT COMPLETED|Washout||0
8418123|NCT00919867|20747803|P6|COMPLETED|Washout||6
8418124|NCT00919867|20747804|P5|COMPLETED|Washout||7
8418125|NCT00919867|20747805|P4|COMPLETED|Washout||7
8418126|NCT00919867|20747806|P3|COMPLETED|Washout||6
8418127|NCT00919867|20747807|P2|COMPLETED|Washout||7
8418128|NCT00919867|20747808|P1|COMPLETED|Washout||7
8418129|NCT00919867|20747803|P6|STARTED|Washout||6
8418130|NCT00919867|20747804|P5|STARTED|Washout||7
8418131|NCT00919867|20747805|P4|STARTED|Washout||7
8418132|NCT00919867|20747806|P3|STARTED|Washout||6
8418133|NCT00919867|20747807|P2|STARTED|Washout||7
8418134|NCT00919867|20747808|P1|STARTED|Washout||7
8418135|NCT00919867|20747803|P6|NOT COMPLETED|Second Intervention||0
8418136|NCT00919867|20747804|P5|NOT COMPLETED|Second Intervention||0
8418137|NCT00919867|20747805|P4|NOT COMPLETED|Second Intervention||0
8418138|NCT00919867|20747806|P3|NOT COMPLETED|Second Intervention||0
8418139|NCT00919867|20747807|P2|NOT COMPLETED|Second Intervention||0
8418140|NCT00919867|20747808|P1|NOT COMPLETED|Second Intervention||0
8418141|NCT00919867|20747803|P6|COMPLETED|Second Intervention||6
8418142|NCT00919867|20747804|P5|COMPLETED|Second Intervention||7
8418143|NCT00919867|20747805|P4|COMPLETED|Second Intervention||7
8418144|NCT00919867|20747806|P3|COMPLETED|Second Intervention||6
8418145|NCT00919867|20747807|P2|COMPLETED|Second Intervention||7
8418146|NCT00919867|20747808|P1|COMPLETED|Second Intervention||7
8418147|NCT00919867|20747803|P6|STARTED|Second Intervention||6
8418148|NCT00919867|20747804|P5|STARTED|Second Intervention||7
8418149|NCT00919867|20747805|P4|STARTED|Second Intervention||7
8418150|NCT00919867|20747806|P3|STARTED|Second Intervention||6
8418151|NCT00919867|20747807|P2|STARTED|Second Intervention||7
8418152|NCT00919867|20747808|P1|STARTED|Second Intervention||7
8418153|NCT00919867|20747803|P6|NOT COMPLETED|Washout||0
8418154|NCT00919867|20747804|P5|NOT COMPLETED|Washout||0
8418155|NCT00919867|20747805|P4|NOT COMPLETED|Washout||0
8418156|NCT00919867|20747806|P3|NOT COMPLETED|Washout||0
8418157|NCT00919867|20747807|P2|NOT COMPLETED|Washout||0
8418158|NCT00919867|20747808|P1|NOT COMPLETED|Washout||0
8418159|NCT00919867|20747803|P6|COMPLETED|Washout||6
8418160|NCT00919867|20747804|P5|COMPLETED|Washout||7
8418161|NCT00919867|20747805|P4|COMPLETED|Washout||7
8418162|NCT00919867|20747806|P3|COMPLETED|Washout||6
8418163|NCT00919867|20747807|P2|COMPLETED|Washout||7
8418164|NCT00919867|20747808|P1|COMPLETED|Washout||7
8418165|NCT00919867|20747803|P6|STARTED|Washout||6
8418166|NCT00919867|20747804|P5|STARTED|Washout||7
8418167|NCT00919867|20747805|P4|STARTED|Washout||7
8418168|NCT00919867|20747806|P3|STARTED|Washout||6
8418169|NCT00919867|20747807|P2|STARTED|Washout||7
8418170|NCT00919867|20747808|P1|STARTED|Washout||7
8418171|NCT00919867|20747803|P6|NOT COMPLETED|First Intervention||1
8418172|NCT00919867|20747804|P5|NOT COMPLETED|First Intervention||0
8418173|NCT00919867|20747805|P4|NOT COMPLETED|First Intervention||0
8418174|NCT00919867|20747806|P3|NOT COMPLETED|First Intervention||1
8418175|NCT00919867|20747807|P2|NOT COMPLETED|First Intervention||0
8418176|NCT00919867|20747808|P1|NOT COMPLETED|First Intervention||0
8418177|NCT00919867|20747803|P6|COMPLETED|First Intervention||6
8418178|NCT00919867|20747804|P5|COMPLETED|First Intervention||7
8418179|NCT00919867|20747805|P4|COMPLETED|First Intervention||7
8418180|NCT00919867|20747806|P3|COMPLETED|First Intervention||6
8418181|NCT00919867|20747807|P2|COMPLETED|First Intervention||7
8418182|NCT00919867|20747808|P1|COMPLETED|First Intervention||7
8418183|NCT00919867|20747803|P6|STARTED|First Intervention||7
8418184|NCT00919867|20747804|P5|STARTED|First Intervention||7
8418185|NCT00919867|20747805|P4|STARTED|First Intervention||7
8418186|NCT00919867|20747806|P3|STARTED|First Intervention||7
8418187|NCT00919867|20747807|P2|STARTED|First Intervention||7
8418188|NCT00919867|20747808|P1|STARTED|First Intervention||7
8418189|NCT00919854|20747829|P1|NOT COMPLETED|Overall Study||1
8418190|NCT00919854|20747829|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
8418191|NCT00919854|20747829|P1|STARTED|Overall Study||21
8418192|NCT00919802|20747838|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
8418193|NCT00919802|20747839|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
8418194|NCT00919802|20747838|P2|COMPLETED|Second Intervention - (24 Hours)||13
8418195|NCT00919802|20747839|P1|COMPLETED|Second Intervention - (24 Hours)||12
8418196|NCT00919802|20747838|P2|STARTED|Second Intervention - (24 Hours)||13
8418197|NCT00919802|20747839|P1|STARTED|Second Intervention - (24 Hours)||12
8418198|NCT00919802|20747838|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
8418199|NCT00919802|20747839|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
8418200|NCT00919802|20747838|P2|COMPLETED|First Intervention - (24 Hours)||13
8418201|NCT00919802|20747839|P1|COMPLETED|First Intervention - (24 Hours)||12
8418202|NCT00919802|20747838|P2|STARTED|First Intervention - (24 Hours)||13
8418203|NCT00919802|20747839|P1|STARTED|First Intervention - (24 Hours)||12
8418210|NCT00919724|20747858|P2|NOT COMPLETED|Overall Study||0
8418211|NCT00919724|20747859|P1|NOT COMPLETED|Overall Study||0
8418212|NCT00919724|20747858|P2|COMPLETED|Overall Study||44
8418213|NCT00919724|20747859|P1|COMPLETED|Overall Study||45
8418214|NCT00919724|20747858|P2|STARTED|Overall Study||44
8418215|NCT00919724|20747859|P1|STARTED|Overall Study||45
8418216|NCT00919711|20747867|P2|NOT COMPLETED|Overall Study||13
8418217|NCT00919711|20747868|P1|NOT COMPLETED|Overall Study||33
8418218|NCT00919711|20747867|P2|COMPLETED|Overall Study||422
8418219|NCT00919711|20747868|P1|COMPLETED|Overall Study||402
8418220|NCT00919711|20747867|P2|STARTED|Overall Study||435
8418221|NCT00919711|20747868|P1|STARTED|Overall Study||435
8418222|NCT00919633|20747884|P4|NOT COMPLETED|Overall Study||21
8418223|NCT00919633|20747885|P3|NOT COMPLETED|Overall Study||23
8418224|NCT00919633|20747886|P2|NOT COMPLETED|Overall Study||15
8418225|NCT00919633|20747887|P1|NOT COMPLETED|Overall Study||22
8418226|NCT00919633|20747884|P4|COMPLETED|Overall Study||5
8418227|NCT00919633|20747885|P3|COMPLETED|Overall Study||4
8418228|NCT00919633|20747886|P2|COMPLETED|Overall Study||10
8418229|NCT00919633|20747887|P1|COMPLETED|Overall Study||6
8418230|NCT00919633|20747884|P4|STARTED|Overall Study||26
8418231|NCT00919633|20747885|P3|STARTED|Overall Study||27
8418232|NCT00919633|20747886|P2|STARTED|Overall Study||25
8418233|NCT00919633|20747887|P1|STARTED|Overall Study||28
8418234|NCT00919191|20747905|P1|NOT COMPLETED|Overall Study||0
8418235|NCT00919191|20747905|P1|COMPLETED|Overall Study||26
8418236|NCT00919191|20747905|P1|STARTED|Overall Study||26
8418237|NCT00919126|20747915|P3|NOT COMPLETED|Overall Study||1
8418238|NCT00919126|20747916|P2|NOT COMPLETED|Overall Study||5
8418239|NCT00919126|20747917|P1|NOT COMPLETED|Overall Study||1
8418240|NCT00919126|20747915|P3|COMPLETED|Overall Study||32
8418241|NCT00919126|20747916|P2|COMPLETED|Overall Study||32
8418242|NCT00919126|20747917|P1|COMPLETED|Overall Study||31
8418243|NCT00919126|20747915|P3|STARTED|Overall Study||33
8418244|NCT00919126|20747916|P2|STARTED|Overall Study||37
8418245|NCT00919126|20747917|P1|STARTED|Overall Study||32
8418246|NCT00919113|20747963|P2|NOT COMPLETED|Overall Study||8
8418247|NCT00919113|20747964|P1|NOT COMPLETED|Overall Study||9
8418248|NCT00919113|20747963|P2|COMPLETED|Overall Study||40
8418249|NCT00919113|20747964|P1|COMPLETED|Overall Study||41
8418250|NCT00919113|20747963|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
8418251|NCT00919113|20747964|P1|Received Placebo|Overall Study||0
8418252|NCT00919113|20747963|P2|Received Uracyst|Overall Study||0
8418253|NCT00919113|20747964|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
8418254|NCT00919113|20747963|P2|STARTED|Overall Study||48
8418255|NCT00919113|20747964|P1|STARTED|Overall Study||50
8418256|NCT00919100|20747974|P2|NOT COMPLETED|Overall Study||0
8418257|NCT00919100|20747975|P1|NOT COMPLETED|Overall Study||0
8418258|NCT00919100|20747974|P2|COMPLETED|Overall Study||41
8418259|NCT00919100|20747975|P1|COMPLETED|Overall Study||40
8418260|NCT00919100|20747974|P2|STARTED|Overall Study||41
8418261|NCT00919100|20747975|P1|STARTED|Overall Study||40
8418262|NCT00919061|20747985|P1|NOT COMPLETED|Overall Study||2
8418263|NCT00919061|20747985|P1|COMPLETED|Overall Study||37
8418264|NCT00919061|20747985|P1|STARTED|Overall Study||39
8418265|NCT00919035|20747990|P1|NOT COMPLETED|Overall Study||0
8418266|NCT00919035|20747990|P1|COMPLETED|Overall Study||21
8418267|NCT00919035|20747990|P1|STARTED|Overall Study||21
8418268|NCT00918957|20747998|P2|NOT COMPLETED|Overall Study||0
8418269|NCT00918957|20747999|P1|NOT COMPLETED|Overall Study||3
8418270|NCT00918957|20747998|P2|COMPLETED|Overall Study||30
8418271|NCT00918957|20747999|P1|COMPLETED|Overall Study||29
8418272|NCT00918957|20747998|P2|STARTED|Overall Study||30
8418273|NCT00918957|20747999|P1|STARTED|Overall Study||32
8418274|NCT00918931|20748026|P1|NOT COMPLETED|Overall Study||0
8418275|NCT00918931|20748026|P1|COMPLETED|Overall Study||3
8418276|NCT00918931|20748026|P1|STARTED|Overall Study||3
8418277|NCT00918879|20748032|P2|NOT COMPLETED|Overall Study||6
8418278|NCT00918879|20748033|P1|NOT COMPLETED|Overall Study||6
8418279|NCT00918879|20748032|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
8418280|NCT00918879|20748033|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
8418281|NCT00918879|20748032|P2|STARTED|Overall Study|Randomized and treated|106
8418282|NCT00918879|20748033|P1|STARTED|Overall Study|Randomized and treated|107
8418283|NCT00918866|20748047|P2|NOT COMPLETED|Overall Study||0
8418284|NCT00918866|20748048|P1|NOT COMPLETED|Overall Study||0
8418285|NCT00918866|20748047|P2|COMPLETED|Overall Study||16
8418286|NCT00918866|20748048|P1|COMPLETED|Overall Study||16
8418287|NCT00918866|20748047|P2|STARTED|Overall Study||16
8418288|NCT00918866|20748048|P1|STARTED|Overall Study||16
8418289|NCT00918749|20748065|P3|NOT COMPLETED|Overall Study||7
8418290|NCT00918749|20748066|P2|NOT COMPLETED|Overall Study||3
8418291|NCT00918749|20748067|P1|NOT COMPLETED|Overall Study||7
8418292|NCT00918749|20748065|P3|COMPLETED|Overall Study||62
8418293|NCT00918749|20748066|P2|COMPLETED|Overall Study||63
8418294|NCT00918749|20748067|P1|COMPLETED|Overall Study||63
8418295|NCT00918749|20748065|P3|ITT (Intent to Treat) Population|Overall Study||69
8418296|NCT00918749|20748066|P2|ITT (Intent to Treat) Population|Overall Study||66
8418297|NCT00918749|20748067|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
8418298|NCT00918749|20748065|P3|STARTED|Overall Study||69
8418299|NCT00918749|20748066|P2|STARTED|Overall Study||66
8418300|NCT00918749|20748067|P1|STARTED|Overall Study||70
8418301|NCT00918736|20748099|P1|NOT COMPLETED|Overall Study||4
8418302|NCT00918736|20748099|P1|COMPLETED|Overall Study|October, 2008|46
8418303|NCT00918736|20748099|P1|STARTED|Overall Study|October, 2007|50
8418304|NCT00918723|20748103|P1|NOT COMPLETED|Overall Study||0
8418305|NCT00918723|20748103|P1|COMPLETED|Overall Study||40
8418306|NCT00918723|20748103|P1|STARTED|Overall Study||40
8418307|NCT00918684|20748112|P1|NOT COMPLETED|Treatment Phase||25
8418308|NCT00918684|20748112|P1|COMPLETED|Treatment Phase||65
8418309|NCT00918684|20748112|P1|STARTED|Treatment Phase||90
8418310|NCT00918684|20748112|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
8418311|NCT00918684|20748112|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
8418312|NCT00918684|20748112|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
8418313|NCT00918671|20748118|P1|NOT COMPLETED|Overall Study||0
8418314|NCT00918671|20748118|P1|COMPLETED|Overall Study||60
8418315|NCT00918671|20748118|P1|STARTED|Overall Study||60
8418316|NCT00918645|20748123|P1|NOT COMPLETED|Overall Study||1
8418317|NCT00918645|20748123|P1|COMPLETED|Overall Study||12
8418318|NCT00918645|20748123|P1|STARTED|Overall Study||13
8418319|NCT00918580|20748129|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
8418320|NCT00918580|20748129|P1|COMPLETED|After 6-month FU to 1-year FU||87
8418321|NCT00918580|20748129|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
8418322|NCT00918580|20748129|P1|STARTED|After 6-month FU to 1-year FU||147
8418323|NCT00918580|20748129|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
8418324|NCT00918580|20748129|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
8418325|NCT00918580|20748129|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
8418326|NCT00918580|20748129|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
8418327|NCT00918580|20748129|P1|STARTED|Up to 6-month Follow-up(FU)||158
8418328|NCT00918567|20748149|P2|NOT COMPLETED|Overall Study||2
8418329|NCT00918567|20748150|P1|NOT COMPLETED|Overall Study||5
8418330|NCT00918567|20748149|P2|COMPLETED|Overall Study||25
8418331|NCT00918567|20748150|P1|COMPLETED|Overall Study||24
8418332|NCT00918567|20748149|P2|STARTED|Overall Study||27
8418333|NCT00918567|20748150|P1|STARTED|Overall Study||29
8418334|NCT00918463|20748176|P1|NOT COMPLETED|Overall Study||2
8418335|NCT00918463|20748176|P1|COMPLETED|Overall Study||0
8418336|NCT00918463|20748176|P1|STARTED|Overall Study||2
8418337|NCT00918385|20748184|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
8418338|NCT00918385|20748185|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
8418339|NCT00918385|20748184|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
8418340|NCT00918385|20748185|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
8418341|NCT00918385|20748184|P2|STARTED|Combination Nilutamide and Dasatinib||11
8418342|NCT00918385|20748185|P1|STARTED|Combination Nilutamide and Dasatinib||12
8418343|NCT00918385|20748184|P2|NOT COMPLETED|Monotherapy||6
8418344|NCT00918385|20748185|P1|NOT COMPLETED|Monotherapy||2
8418345|NCT00918385|20748184|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
8418346|NCT00918385|20748185|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
8418347|NCT00918385|20748184|P2|STARTED|Monotherapy||17
8418348|NCT00918385|20748185|P1|STARTED|Monotherapy||14
8418349|NCT00918346|20748194|P2|NOT COMPLETED|Post Study Period||0
8418350|NCT00918346|20748195|P1|NOT COMPLETED|Post Study Period||0
8418351|NCT00918346|20748194|P2|COMPLETED|Post Study Period||21
8418352|NCT00918346|20748195|P1|COMPLETED|Post Study Period||21
8418353|NCT00918346|20748194|P2|STARTED|Post Study Period||21
8418354|NCT00918346|20748195|P1|STARTED|Post Study Period||21
8418355|NCT00918346|20748194|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
8418356|NCT00918346|20748195|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
8418357|NCT00918346|20748194|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
8418358|NCT00918346|20748195|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
8418359|NCT00918346|20748194|P2|STARTED|Second Treatment Period (4 Weeks)||21
8418360|NCT00918346|20748195|P1|STARTED|Second Treatment Period (4 Weeks)||21
8418361|NCT00918346|20748194|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
8418362|NCT00918346|20748195|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
8418363|NCT00918346|20748194|P2|COMPLETED|Washout (at Least 4 Weeks)||21
8418364|NCT00918346|20748195|P1|COMPLETED|Washout (at Least 4 Weeks)||21
8418365|NCT00918346|20748194|P2|STARTED|Washout (at Least 4 Weeks)||21
8418366|NCT00918346|20748195|P1|STARTED|Washout (at Least 4 Weeks)||21
8418367|NCT00918346|20748194|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
8418368|NCT00918346|20748195|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
8418369|NCT00918346|20748194|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
8418370|NCT00918346|20748195|P1|COMPLETED|First Treatment Period (4 Weeks)||21
8418371|NCT00918346|20748194|P2|STARTED|First Treatment Period (4 Weeks)||22
8418372|NCT00918346|20748195|P1|STARTED|First Treatment Period (4 Weeks)||21
8418373|NCT00918333|20748211|P2|NOT COMPLETED|Overall Study||5
8418374|NCT00918333|20748212|P1|NOT COMPLETED|Overall Study||3
8418375|NCT00918333|20748211|P2|COMPLETED|Overall Study||93
8418376|NCT00918333|20748212|P1|COMPLETED|Overall Study||23
8418377|NCT00918333|20748211|P2|STARTED|Overall Study||98
8418378|NCT00918333|20748212|P1|STARTED|Overall Study||26
8418379|NCT00918281|20748232|P1|NOT COMPLETED|Overall Study||29
8418380|NCT00918281|20748232|P1|COMPLETED|Overall Study||41
8418381|NCT00918281|20748232|P1|STARTED|Overall Study||70
8418382|NCT00918255|20748242|P3|NOT COMPLETED|Overall Study||5
8418383|NCT00918255|20748243|P2|NOT COMPLETED|Overall Study||0
8418384|NCT00918255|20748244|P1|NOT COMPLETED|Overall Study||6
8418385|NCT00918255|20748242|P3|COMPLETED|Overall Study||46
8418386|NCT00918255|20748243|P2|COMPLETED|Overall Study||52
8418387|NCT00918255|20748244|P1|COMPLETED|Overall Study||45
8418388|NCT00918255|20748242|P3|STARTED|Overall Study||51
8418389|NCT00918255|20748243|P2|STARTED|Overall Study||52
8418390|NCT00918255|20748244|P1|STARTED|Overall Study||51
8418391|NCT00918229|20748270|P1|NOT COMPLETED|Overall Study||0
8418392|NCT00918229|20748270|P1|COMPLETED|Overall Study||24
8418393|NCT00918229|20748270|P1|STARTED|Overall Study||24
8418394|NCT00918203|20748277|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8418395|NCT00918203|20748278|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8418396|NCT00918203|20748279|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8418397|NCT00918203|20748277|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
8418398|NCT00918203|20748278|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
8418399|NCT00918203|20748279|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
8418400|NCT00918203|20748277|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
8418401|NCT00918203|20748278|P2|STARTED|Crossover to Olaratumab Monotherapy||0
8418402|NCT00918203|20748279|P1|STARTED|Crossover to Olaratumab Monotherapy||0
8418403|NCT00918203|20748277|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
8418404|NCT00918203|20748278|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
8418405|NCT00918203|20748279|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
8418406|NCT00918203|20748277|P3|COMPLETED|Treatment With or Without Olaratumab||0
8418407|NCT00918203|20748278|P2|COMPLETED|Treatment With or Without Olaratumab||57
8418408|NCT00918203|20748279|P1|COMPLETED|Treatment With or Without Olaratumab||64
8418409|NCT00918203|20748277|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
8418410|NCT00918203|20748278|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
8418411|NCT00918203|20748279|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
8418412|NCT00918203|20748277|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
8418413|NCT00918203|20748278|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
8418414|NCT00918203|20748279|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
8418415|NCT00918203|20748277|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
8418416|NCT00918203|20748278|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
8418417|NCT00918203|20748279|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
8418418|NCT00918203|20748277|P3|STARTED|Treatment With or Without Olaratumab||0
8418419|NCT00918203|20748278|P2|STARTED|Treatment With or Without Olaratumab||67
8418420|NCT00918203|20748279|P1|STARTED|Treatment With or Without Olaratumab||70
8418421|NCT00918138|20748310|P2|NOT COMPLETED|Overall Study||1
8418422|NCT00918138|20748311|P1|NOT COMPLETED|Overall Study||2
8418423|NCT00918138|20748310|P2|COMPLETED|Overall Study||46
8418424|NCT00918138|20748311|P1|COMPLETED|Overall Study||44
8418425|NCT00918138|20748310|P2|STARTED|Overall Study||47
8418426|NCT00918138|20748311|P1|STARTED|Overall Study||46
8418427|NCT00918125|20748327|P2|NOT COMPLETED|Overall Study||0
8418428|NCT00918125|20748328|P1|NOT COMPLETED|Overall Study||0
8418429|NCT00918125|20748327|P2|COMPLETED|Overall Study||39
8418430|NCT00918125|20748328|P1|COMPLETED|Overall Study||20
8418431|NCT00918125|20748327|P2|STARTED|Overall Study||39
8418432|NCT00918125|20748328|P1|STARTED|Overall Study||20
8418433|NCT00917865|20748339|P1|NOT COMPLETED|Overall Study||0
8418434|NCT00917865|20748339|P1|COMPLETED|Overall Study||11
8418435|NCT00917865|20748339|P1|STARTED|Overall Study||11
8418436|NCT00917852|20748350|P1|NOT COMPLETED|Overall Study||6
8418437|NCT00917852|20748350|P1|COMPLETED|Overall Study||45
8418438|NCT00917852|20748350|P1|STARTED|Overall Study||51
8418439|NCT00917735|20748357|P2|NOT COMPLETED|Overall Study||63
8418440|NCT00917735|20748358|P1|NOT COMPLETED|Overall Study||75
8418441|NCT00917735|20748357|P2|COMPLETED|Overall Study||474
8418442|NCT00917735|20748358|P1|COMPLETED|Overall Study||463
8418443|NCT00917735|20748357|P2|STARTED|Overall Study||537
8418444|NCT00917735|20748358|P1|STARTED|Overall Study||538
8418463|NCT00917579|20748383|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
8418464|NCT00917579|20748384|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
8418465|NCT00917579|20748383|P2|COMPLETED|Period 2: 2nd Intervention||37
8418466|NCT00917579|20748384|P1|COMPLETED|Period 2: 2nd Intervention||37
8418467|NCT00917579|20748383|P2|STARTED|Period 2: 2nd Intervention||37
8418468|NCT00917579|20748384|P1|STARTED|Period 2: 2nd Intervention||37
8418469|NCT00917579|20748383|P2|NOT COMPLETED|Washout >= 2 Weeks||0
8418470|NCT00917579|20748384|P1|NOT COMPLETED|Washout >= 2 Weeks||2
8418471|NCT00917579|20748383|P2|COMPLETED|Washout >= 2 Weeks||37
8418472|NCT00917579|20748384|P1|COMPLETED|Washout >= 2 Weeks||37
8418473|NCT00917579|20748383|P2|STARTED|Washout >= 2 Weeks||37
8418474|NCT00917579|20748384|P1|STARTED|Washout >= 2 Weeks||39
8418475|NCT00917579|20748383|P2|NOT COMPLETED|Period 1: 1st Intervention||0
8418476|NCT00917579|20748384|P1|NOT COMPLETED|Period 1: 1st Intervention||0
8418477|NCT00917579|20748383|P2|COMPLETED|Period 1: 1st Intervention||37
8418478|NCT00917579|20748384|P1|COMPLETED|Period 1: 1st Intervention||39
8418479|NCT00917579|20748383|P2|STARTED|Period 1: 1st Intervention||37
8418480|NCT00917579|20748384|P1|STARTED|Period 1: 1st Intervention||39
8418481|NCT00917553|20748400|P2|NOT COMPLETED|Overall Study||1
8418482|NCT00917553|20748401|P1|NOT COMPLETED|Overall Study||2
8418483|NCT00917553|20748400|P2|COMPLETED|Overall Study||15
8418484|NCT00917553|20748401|P1|COMPLETED|Overall Study||15
8418485|NCT00917553|20748400|P2|STARTED|Overall Study||16
8418486|NCT00917553|20748401|P1|STARTED|Overall Study||17
8418487|NCT00917501|20748417|P2|NOT COMPLETED|Overall Study||5
8418488|NCT00917501|20748418|P1|NOT COMPLETED|Overall Study||8
8418489|NCT00917501|20748417|P2|COMPLETED|Overall Study||21
8418490|NCT00917501|20748418|P1|COMPLETED|Overall Study||21
8418491|NCT00917501|20748417|P2|STARTED|Overall Study||26
8418492|NCT00917501|20748418|P1|STARTED|Overall Study||29
8418493|NCT00917462|20748424|P1|NOT COMPLETED|Overall Study||1
8418494|NCT00917462|20748424|P1|COMPLETED|Overall Study||34
8418495|NCT00917462|20748424|P1|STARTED|Overall Study||35
8418496|NCT00917384|20748434|P2|NOT COMPLETED|Overall Study||4
8418497|NCT00917384|20748435|P1|NOT COMPLETED|Overall Study||14
8418498|NCT00917384|20748434|P2|COMPLETED|Overall Study||113
8418499|NCT00917384|20748435|P1|COMPLETED|Overall Study||224
8418500|NCT00917384|20748434|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
8418501|NCT00917384|20748435|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
8418502|NCT00917384|20748434|P2|STARTED|Overall Study||117
8418503|NCT00917384|20748435|P1|STARTED|Overall Study||238
8418504|NCT00917267|20748459|P2|NOT COMPLETED|Overall Study||79
8418505|NCT00917267|20748460|P1|NOT COMPLETED|Overall Study||39
8418506|NCT00917267|20748459|P2|COMPLETED|Overall Study||266
8418507|NCT00917267|20748460|P1|COMPLETED|Overall Study||307
8418508|NCT00917267|20748459|P2|Intent to Treat (ITT)|Overall Study||338
8418509|NCT00917267|20748460|P1|Intent to Treat (ITT)|Overall Study||340
8418510|NCT00917267|20748459|P2|STARTED|Overall Study||345
8418511|NCT00917267|20748460|P1|STARTED|Overall Study||346
8418512|NCT00917124|20748488|P2|NOT COMPLETED|Overall Study||6
8418513|NCT00917124|20748489|P1|NOT COMPLETED|Overall Study||4
8418514|NCT00917124|20748488|P2|COMPLETED|Overall Study||94
8418515|NCT00917124|20748489|P1|COMPLETED|Overall Study||96
8418516|NCT00917124|20748488|P2|STARTED|Overall Study||100
8418517|NCT00917124|20748489|P1|STARTED|Overall Study||100
8418518|NCT00916929|20748499|P2|NOT COMPLETED|Overall Study||29
8418519|NCT00916929|20748500|P1|NOT COMPLETED|Overall Study||10
8418520|NCT00916929|20748499|P2|COMPLETED|Overall Study||53
8418521|NCT00916929|20748500|P1|COMPLETED|Overall Study||70
8418522|NCT00916929|20748499|P2|STARTED|Overall Study||82
8418523|NCT00916929|20748500|P1|STARTED|Overall Study||80
8418524|NCT00916721|20748510|P2|NOT COMPLETED|Overall Study||10
8418525|NCT00916721|20748511|P1|NOT COMPLETED|Overall Study||10
8418526|NCT00916721|20748510|P2|COMPLETED|Overall Study||29
8418527|NCT00916721|20748511|P1|COMPLETED|Overall Study||25
8418528|NCT00916721|20748510|P2|STARTED|Overall Study||39
8418529|NCT00916721|20748511|P1|STARTED|Overall Study||35
8418530|NCT00916643|20748523|P1|NOT COMPLETED|Overall Study||0
8418531|NCT00916643|20748523|P1|COMPLETED|Overall Study||113
8418532|NCT00916643|20748523|P1|STARTED|Overall Study||113
8418533|NCT00916617|20748534|P4|NOT COMPLETED|Overall Study||7
8418534|NCT00916617|20748535|P3|NOT COMPLETED|Overall Study||10
8418535|NCT00916617|20748536|P2|NOT COMPLETED|Overall Study||21
8418536|NCT00916617|20748537|P1|NOT COMPLETED|Overall Study||23
8418537|NCT00916617|20748534|P4|COMPLETED|Overall Study||0
8418538|NCT00916617|20748535|P3|COMPLETED|Overall Study||0
8418539|NCT00916617|20748536|P2|COMPLETED|Overall Study||0
8418540|NCT00916617|20748537|P1|COMPLETED|Overall Study||1
8418541|NCT00916617|20748534|P4|STARTED|Overall Study||7
8418542|NCT00916617|20748535|P3|STARTED|Overall Study||10
8418543|NCT00916617|20748536|P2|STARTED|Overall Study||21
8418544|NCT00916617|20748537|P1|STARTED|Overall Study||24
8418545|NCT00916578|20748551|P1|NOT COMPLETED|Overall Study||7
8418546|NCT00916578|20748551|P1|COMPLETED|Overall Study||26
8418547|NCT00916578|20748551|P1|STARTED|Overall Study||33
8418548|NCT00916539|20748557|P2|NOT COMPLETED|Overall Study||0
8418549|NCT00916539|20748558|P1|NOT COMPLETED|Overall Study||0
8418550|NCT00916539|20748557|P2|COMPLETED|Overall Study||31
8418551|NCT00916539|20748558|P1|COMPLETED|Overall Study||31
8418552|NCT00916539|20748557|P2|STARTED|Overall Study||31
8418553|NCT00916539|20748558|P1|STARTED|Overall Study||31
8418554|NCT00916383|20748580|P1|NOT COMPLETED|Overall Study||3
8418555|NCT00916383|20748580|P1|COMPLETED|Overall Study||46
8418556|NCT00916383|20748580|P1|STARTED|Overall Study||49
8418557|NCT00916370|20748608|P2|NOT COMPLETED|Overall Study||2
8418558|NCT00916370|20748609|P1|NOT COMPLETED|Overall Study||5
8418559|NCT00916370|20748608|P2|COMPLETED|Overall Study||102
8418560|NCT00916370|20748609|P1|COMPLETED|Overall Study||396
8418561|NCT00916370|20748608|P2|STARTED|Overall Study||104
8418562|NCT00916370|20748609|P1|STARTED|Overall Study||401
8418563|NCT00916357|20748783|P6|NOT COMPLETED|Period 3||0
8418564|NCT00916357|20748784|P5|NOT COMPLETED|Period 3||0
8418565|NCT00916357|20748785|P4|NOT COMPLETED|Period 3||0
8418566|NCT00916357|20748786|P3|NOT COMPLETED|Period 3||0
8418567|NCT00916357|20748787|P2|NOT COMPLETED|Period 3||0
8418568|NCT00916357|20748788|P1|NOT COMPLETED|Period 3||0
8418569|NCT00916357|20748783|P6|COMPLETED|Period 3||4
8418570|NCT00916357|20748784|P5|COMPLETED|Period 3||3
8418571|NCT00916357|20748785|P4|COMPLETED|Period 3||3
8418572|NCT00916357|20748786|P3|COMPLETED|Period 3||4
8418573|NCT00916357|20748787|P2|COMPLETED|Period 3||4
8418574|NCT00916357|20748788|P1|COMPLETED|Period 3||3
8418575|NCT00916357|20748783|P6|STARTED|Period 3||4
8418576|NCT00916357|20748784|P5|STARTED|Period 3||3
8418577|NCT00916357|20748785|P4|STARTED|Period 3||3
8418578|NCT00916357|20748786|P3|STARTED|Period 3||4
8418579|NCT00916357|20748787|P2|STARTED|Period 3||4
8418580|NCT00916357|20748788|P1|STARTED|Period 3||3
8418581|NCT00916357|20748783|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
8418582|NCT00916357|20748784|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
8418583|NCT00916357|20748785|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
8418584|NCT00916357|20748786|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
8418585|NCT00916357|20748787|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
8418586|NCT00916357|20748788|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
8418587|NCT00916357|20748783|P6|COMPLETED|Washout (3 to 14 Days)||4
8418588|NCT00916357|20748784|P5|COMPLETED|Washout (3 to 14 Days)||3
8418589|NCT00916357|20748785|P4|COMPLETED|Washout (3 to 14 Days)||3
8418590|NCT00916357|20748786|P3|COMPLETED|Washout (3 to 14 Days)||4
8418591|NCT00916357|20748787|P2|COMPLETED|Washout (3 to 14 Days)||4
8418592|NCT00916357|20748788|P1|COMPLETED|Washout (3 to 14 Days)||3
8418593|NCT00916357|20748783|P6|STARTED|Washout (3 to 14 Days)||4
8418594|NCT00916357|20748784|P5|STARTED|Washout (3 to 14 Days)||3
8418595|NCT00916357|20748785|P4|STARTED|Washout (3 to 14 Days)||3
8418596|NCT00916357|20748786|P3|STARTED|Washout (3 to 14 Days)||4
8418597|NCT00916357|20748787|P2|STARTED|Washout (3 to 14 Days)||4
8418598|NCT00916357|20748788|P1|STARTED|Washout (3 to 14 Days)||3
8418599|NCT00916357|20748783|P6|NOT COMPLETED|Period 2||0
8418600|NCT00916357|20748784|P5|NOT COMPLETED|Period 2||0
8418601|NCT00916357|20748785|P4|NOT COMPLETED|Period 2||1
8418602|NCT00916357|20748786|P3|NOT COMPLETED|Period 2||0
8418603|NCT00916357|20748787|P2|NOT COMPLETED|Period 2||0
8418604|NCT00916357|20748788|P1|NOT COMPLETED|Period 2||0
8418605|NCT00916357|20748783|P6|COMPLETED|Period 2||4
8418606|NCT00916357|20748784|P5|COMPLETED|Period 2||3
8418607|NCT00916357|20748785|P4|COMPLETED|Period 2||3
8418608|NCT00916357|20748786|P3|COMPLETED|Period 2||4
8418609|NCT00916357|20748787|P2|COMPLETED|Period 2||4
8418610|NCT00916357|20748788|P1|COMPLETED|Period 2||3
8418611|NCT00916357|20748783|P6|STARTED|Period 2||4
8418612|NCT00916357|20748784|P5|STARTED|Period 2||3
8418613|NCT00916357|20748785|P4|STARTED|Period 2||4
8418614|NCT00916357|20748786|P3|STARTED|Period 2||4
8418615|NCT00916357|20748787|P2|STARTED|Period 2||4
8418616|NCT00916357|20748788|P1|STARTED|Period 2||3
8418617|NCT00916357|20748783|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
8418618|NCT00916357|20748784|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
8418619|NCT00916357|20748785|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
8418620|NCT00916357|20748786|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
8418621|NCT00916357|20748787|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
8418622|NCT00916357|20748788|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
8418623|NCT00916357|20748783|P6|COMPLETED|Washout (3 to 14 Days)||4
8418624|NCT00916357|20748784|P5|COMPLETED|Washout (3 to 14 Days)||3
8418625|NCT00916357|20748785|P4|COMPLETED|Washout (3 to 14 Days)||4
8418626|NCT00916357|20748786|P3|COMPLETED|Washout (3 to 14 Days)||4
8418627|NCT00916357|20748787|P2|COMPLETED|Washout (3 to 14 Days)||4
8418628|NCT00916357|20748788|P1|COMPLETED|Washout (3 to 14 Days)||3
8418629|NCT00916357|20748783|P6|STARTED|Washout (3 to 14 Days)||4
8418630|NCT00916357|20748784|P5|STARTED|Washout (3 to 14 Days)||3
8418631|NCT00916357|20748785|P4|STARTED|Washout (3 to 14 Days)||4
8418632|NCT00916357|20748786|P3|STARTED|Washout (3 to 14 Days)||4
8418633|NCT00916357|20748787|P2|STARTED|Washout (3 to 14 Days)||4
8418634|NCT00916357|20748788|P1|STARTED|Washout (3 to 14 Days)||3
8418635|NCT00916357|20748783|P6|NOT COMPLETED|Period 1||0
8418636|NCT00916357|20748784|P5|NOT COMPLETED|Period 1||0
8418637|NCT00916357|20748785|P4|NOT COMPLETED|Period 1||0
8418638|NCT00916357|20748786|P3|NOT COMPLETED|Period 1||0
8418639|NCT00916357|20748787|P2|NOT COMPLETED|Period 1||0
8418640|NCT00916357|20748788|P1|NOT COMPLETED|Period 1||1
8418641|NCT00916357|20748783|P6|COMPLETED|Period 1||4
8418642|NCT00916357|20748784|P5|COMPLETED|Period 1||3
8418643|NCT00916357|20748785|P4|COMPLETED|Period 1||4
8418644|NCT00916357|20748786|P3|COMPLETED|Period 1||4
8418645|NCT00916357|20748787|P2|COMPLETED|Period 1||4
8418646|NCT00916357|20748788|P1|COMPLETED|Period 1||3
8418647|NCT00916357|20748783|P6|Received at Least 1 Dose of Study Drug|Period 1||4
8418648|NCT00916357|20748784|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8418649|NCT00916357|20748785|P4|Received at Least 1 Dose of Study Drug|Period 1||4
8418650|NCT00916357|20748786|P3|Received at Least 1 Dose of Study Drug|Period 1||4
8418651|NCT00916357|20748787|P2|Received at Least 1 Dose of Study Drug|Period 1||4
8418652|NCT00916357|20748788|P1|Received at Least 1 Dose of Study Drug|Period 1||4
8418653|NCT00916357|20748783|P6|STARTED|Period 1||4
8418654|NCT00916357|20748784|P5|STARTED|Period 1||3
8418655|NCT00916357|20748785|P4|STARTED|Period 1||4
8418656|NCT00916357|20748786|P3|STARTED|Period 1||4
8418657|NCT00916357|20748787|P2|STARTED|Period 1||4
8418658|NCT00916357|20748788|P1|STARTED|Period 1||4
8418659|NCT00916344|20748826|P1|NOT COMPLETED|Overall Study||8
8418660|NCT00916344|20748826|P1|COMPLETED|Overall Study||167
8418661|NCT00916344|20748826|P1|STARTED|Overall Study||175
8418662|NCT00916305|20748833|P2|NOT COMPLETED|Overall Study||28
8418663|NCT00916305|20748834|P1|NOT COMPLETED|Overall Study||21
8418664|NCT00916305|20748833|P2|COMPLETED|Overall Study||9
8418665|NCT00916305|20748834|P1|COMPLETED|Overall Study||7
8418666|NCT00916305|20748833|P2|STARTED|Overall Study||37
8418667|NCT00916305|20748834|P1|STARTED|Overall Study||28
8418668|NCT00916279|20748842|P1|NOT COMPLETED|Overall Study||4
8418669|NCT00916279|20748842|P1|COMPLETED|Overall Study||37
8418670|NCT00916279|20748842|P1|24 Months|Overall Study||37
8418671|NCT00916279|20748842|P1|6 Months|Overall Study||41
8418672|NCT00916279|20748842|P1|30 Days|Overall Study||41
8418673|NCT00916279|20748842|P1|STARTED|Overall Study||41
8418674|NCT00916149|20748853|P3|NOT COMPLETED|Overall Study||0
8418675|NCT00916149|20748854|P2|NOT COMPLETED|Overall Study||2
8418676|NCT00916149|20748855|P1|NOT COMPLETED|Overall Study||4
8418677|NCT00916149|20748853|P3|COMPLETED|Overall Study||5
8418678|NCT00916149|20748854|P2|COMPLETED|Overall Study||8
8418679|NCT00916149|20748855|P1|COMPLETED|Overall Study||12
8418680|NCT00916149|20748853|P3|STARTED|Overall Study||5
8418681|NCT00916149|20748854|P2|STARTED|Overall Study||10
8418682|NCT00916149|20748855|P1|STARTED|Overall Study||16
8418683|NCT00916136|20748926|P2|NOT COMPLETED|Overall Study||0
8418684|NCT00916136|20748927|P1|NOT COMPLETED|Overall Study||0
8418685|NCT00916136|20748926|P2|COMPLETED|Overall Study||29
8418686|NCT00916136|20748927|P1|COMPLETED|Overall Study||37
8418687|NCT00916136|20748926|P2|STARTED|Overall Study||29
8418688|NCT00916136|20748927|P1|STARTED|Overall Study||37
8418689|NCT00916058|20748942|P7|NOT COMPLETED|Phase 2||3
8418690|NCT00916058|20748943|P6|NOT COMPLETED|Phase 2||0
8418691|NCT00916058|20748944|P5|NOT COMPLETED|Phase 2||0
8418692|NCT00916058|20748945|P4|NOT COMPLETED|Phase 2||0
8418693|NCT00916058|20748946|P3|NOT COMPLETED|Phase 2||0
8418694|NCT00916058|20748947|P2|NOT COMPLETED|Phase 2||0
8418695|NCT00916058|20748948|P1|NOT COMPLETED|Phase 2||0
8418696|NCT00916058|20748942|P7|COMPLETED|Phase 2||28
8418697|NCT00916058|20748943|P6|COMPLETED|Phase 2||0
8418698|NCT00916058|20748944|P5|COMPLETED|Phase 2||0
8418699|NCT00916058|20748945|P4|COMPLETED|Phase 2||0
8418700|NCT00916058|20748946|P3|COMPLETED|Phase 2||0
8418701|NCT00916058|20748947|P2|COMPLETED|Phase 2||0
8418702|NCT00916058|20748948|P1|COMPLETED|Phase 2||0
8418703|NCT00916058|20748942|P7|STARTED|Phase 2||31
8418704|NCT00916058|20748943|P6|STARTED|Phase 2||0
8418705|NCT00916058|20748944|P5|STARTED|Phase 2||0
8418706|NCT00916058|20748945|P4|STARTED|Phase 2||0
8418707|NCT00916058|20748946|P3|STARTED|Phase 2||0
8418708|NCT00916058|20748947|P2|STARTED|Phase 2||0
8418709|NCT00916058|20748948|P1|STARTED|Phase 2||0
8418710|NCT00916058|20748942|P7|NOT COMPLETED|Phase 1||0
8418711|NCT00916058|20748943|P6|NOT COMPLETED|Phase 1||1
8418712|NCT00916058|20748944|P5|NOT COMPLETED|Phase 1||0
8418713|NCT00916058|20748945|P4|NOT COMPLETED|Phase 1||0
8418714|NCT00916058|20748946|P3|NOT COMPLETED|Phase 1||0
8418715|NCT00916058|20748947|P2|NOT COMPLETED|Phase 1||0
8418716|NCT00916058|20748948|P1|NOT COMPLETED|Phase 1||0
8418717|NCT00916058|20748942|P7|COMPLETED|Phase 1||0
8418718|NCT00916058|20748943|P6|COMPLETED|Phase 1||7
8418719|NCT00916058|20748944|P5|COMPLETED|Phase 1||3
8418720|NCT00916058|20748945|P4|COMPLETED|Phase 1||3
8418721|NCT00916058|20748946|P3|COMPLETED|Phase 1||3
8418722|NCT00916058|20748947|P2|COMPLETED|Phase 1||6
8418723|NCT00916058|20748948|P1|COMPLETED|Phase 1||3
8418724|NCT00916058|20748942|P7|STARTED|Phase 1||0
8418725|NCT00916058|20748943|P6|STARTED|Phase 1||8
8418726|NCT00916058|20748944|P5|STARTED|Phase 1||3
8418727|NCT00916058|20748945|P4|STARTED|Phase 1||3
8418728|NCT00916058|20748946|P3|STARTED|Phase 1||3
8418729|NCT00916058|20748947|P2|STARTED|Phase 1||6
8418730|NCT00916058|20748948|P1|STARTED|Phase 1||3
8418731|NCT00916032|20748968|P2|NOT COMPLETED|Overall Study||0
8418732|NCT00916032|20748969|P1|NOT COMPLETED|Overall Study||0
8418733|NCT00916032|20748968|P2|COMPLETED|Overall Study||11
8418734|NCT00916032|20748969|P1|COMPLETED|Overall Study||12
8418735|NCT00916032|20748968|P2|STARTED|Overall Study||11
8418736|NCT00916032|20748969|P1|STARTED|Overall Study||12
8418737|NCT00916006|20749011|P2|NOT COMPLETED|Overall Study||7
8418738|NCT00916006|20749012|P1|NOT COMPLETED|Overall Study||3
8418739|NCT00916006|20749011|P2|COMPLETED|Overall Study||127
8418740|NCT00916006|20749012|P1|COMPLETED|Overall Study||132
8418741|NCT00916006|20749011|P2|STARTED|Overall Study||134
8418742|NCT00916006|20749012|P1|STARTED|Overall Study||135
8418743|NCT00915967|20749022|P2|NOT COMPLETED|Overall Study||2
8418744|NCT00915967|20749023|P1|NOT COMPLETED|Overall Study||1
8418745|NCT00915967|20749022|P2|COMPLETED|Overall Study||98
8418746|NCT00915967|20749023|P1|COMPLETED|Overall Study||97
8418747|NCT00915967|20749022|P2|STARTED|Overall Study||100
8418748|NCT00915967|20749023|P1|STARTED|Overall Study||98
8418749|NCT00915954|20749032|P3|NOT COMPLETED|Overall Study||0
8418750|NCT00915954|20749033|P2|NOT COMPLETED|Overall Study||0
8418751|NCT00915954|20749034|P1|NOT COMPLETED|Overall Study||0
8418752|NCT00915954|20749032|P3|COMPLETED|Overall Study||10
8418753|NCT00915954|20749033|P2|COMPLETED|Overall Study||8
8418754|NCT00915954|20749034|P1|COMPLETED|Overall Study||10
8418755|NCT00915954|20749032|P3|STARTED|Overall Study||10
8418756|NCT00915954|20749033|P2|STARTED|Overall Study||8
8418757|NCT00915954|20749034|P1|STARTED|Overall Study||10
8418758|NCT00915928|20749053|P2|NOT COMPLETED|Overall Study||0
8418759|NCT00915928|20749054|P1|NOT COMPLETED|Overall Study||0
8418760|NCT00915928|20749053|P2|COMPLETED|Overall Study||22
8418761|NCT00915928|20749054|P1|COMPLETED|Overall Study||25
8418762|NCT00915928|20749053|P2|STARTED|Overall Study||22
8418763|NCT00915928|20749054|P1|STARTED|Overall Study||25
8418764|NCT00915902|20749063|P2|NOT COMPLETED|2nd Treatment Period||1
8418765|NCT00915902|20749064|P1|NOT COMPLETED|2nd Treatment Period||0
8418766|NCT00915902|20749063|P2|COMPLETED|2nd Treatment Period||20
8418767|NCT00915902|20749064|P1|COMPLETED|2nd Treatment Period||19
8418768|NCT00915902|20749063|P2|STARTED|2nd Treatment Period||21
8418769|NCT00915902|20749064|P1|STARTED|2nd Treatment Period||19
8418770|NCT00915902|20749063|P2|NOT COMPLETED|Washout (4 Weeks)||1
8418771|NCT00915902|20749064|P1|NOT COMPLETED|Washout (4 Weeks)||0
8418772|NCT00915902|20749063|P2|COMPLETED|Washout (4 Weeks)||21
8418773|NCT00915902|20749064|P1|COMPLETED|Washout (4 Weeks)||19
8418774|NCT00915902|20749063|P2|STARTED|Washout (4 Weeks)||22
8418775|NCT00915902|20749064|P1|STARTED|Washout (4 Weeks)||19
8418776|NCT00915902|20749063|P2|NOT COMPLETED|1st Treatment Period||0
8418777|NCT00915902|20749064|P1|NOT COMPLETED|1st Treatment Period||1
8418778|NCT00915902|20749063|P2|COMPLETED|1st Treatment Period||22
8418779|NCT00915902|20749064|P1|COMPLETED|1st Treatment Period||19
8418780|NCT00915902|20749063|P2|STARTED|1st Treatment Period||22
8418781|NCT00915902|20749064|P1|STARTED|1st Treatment Period||20
8418782|NCT00915876|20749074|P2|NOT COMPLETED|Overall Study||1
8418783|NCT00915876|20749075|P1|NOT COMPLETED|Overall Study||0
8418784|NCT00915876|20749074|P2|COMPLETED|Overall Study||20
8418785|NCT00915876|20749075|P1|COMPLETED|Overall Study||20
8418786|NCT00915876|20749074|P2|Moving Beyond First Dose|Overall Study||20
8418787|NCT00915876|20749075|P1|Moving Beyond First Dose|Overall Study||20
8418788|NCT00915876|20749074|P2|STARTED|Overall Study||21
8418789|NCT00915876|20749075|P1|STARTED|Overall Study||20
8418790|NCT00915798|20749085|P4|NOT COMPLETED|Overall Study||0
8418791|NCT00915798|20749086|P3|NOT COMPLETED|Overall Study||0
8418792|NCT00915798|20749087|P2|NOT COMPLETED|Overall Study||0
8418793|NCT00915798|20749088|P1|NOT COMPLETED|Overall Study||0
8418794|NCT00915798|20749085|P4|COMPLETED|Overall Study||26
8418795|NCT00915798|20749086|P3|COMPLETED|Overall Study||23
8418796|NCT00915798|20749087|P2|COMPLETED|Overall Study||21
8418797|NCT00915798|20749088|P1|COMPLETED|Overall Study||19
8418798|NCT00915798|20749085|P4|STARTED|Overall Study||26
8418799|NCT00915798|20749086|P3|STARTED|Overall Study||23
8418800|NCT00915798|20749087|P2|STARTED|Overall Study||21
8418801|NCT00915798|20749088|P1|STARTED|Overall Study||19
8418802|NCT00915772|20749111|P3|NOT COMPLETED|Overall Study||29
8418803|NCT00915772|20749112|P2|NOT COMPLETED|Overall Study||46
8418804|NCT00915772|20749113|P1|NOT COMPLETED|Overall Study||36
8418805|NCT00915772|20749111|P3|COMPLETED|Overall Study||142
8418806|NCT00915772|20749112|P2|COMPLETED|Overall Study||179
8418807|NCT00915772|20749113|P1|COMPLETED|Overall Study||134
8418808|NCT00915772|20749111|P3|STARTED|Overall Study||171
8418809|NCT00915772|20749112|P2|STARTED|Overall Study||225
8418810|NCT00915772|20749113|P1|STARTED|Overall Study||170
8418811|NCT00915759|20749158|P1|NOT COMPLETED|Overall Study||0
8418812|NCT00915759|20749158|P1|COMPLETED|Overall Study|number of participants|40
8418813|NCT00915759|20749158|P1|STARTED|Overall Study|number of participants|40
8418814|NCT00915655|20749168|P1|NOT COMPLETED|Overall Study||0
8418815|NCT00915655|20749168|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
8418816|NCT00915655|20749168|P1|STARTED|Overall Study||12
8418817|NCT00915603|20749175|P2|NOT COMPLETED|Overall Study||55
8418818|NCT00915603|20749176|P1|NOT COMPLETED|Overall Study||56
8418819|NCT00915603|20749175|P2|COMPLETED|Overall Study||0
8418820|NCT00915603|20749176|P1|COMPLETED|Overall Study||0
8418821|NCT00915603|20749175|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
8418822|NCT00915603|20749176|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
8418823|NCT00915590|20749192|P2|NOT COMPLETED|Overall Study||1
8418824|NCT00915590|20749193|P1|NOT COMPLETED|Overall Study||2
8418825|NCT00915590|20749192|P2|COMPLETED|Overall Study||4
8418826|NCT00915590|20749193|P1|COMPLETED|Overall Study||3
8418827|NCT00915590|20749192|P2|STARTED|Overall Study||5
8418828|NCT00915590|20749193|P1|STARTED|Overall Study||5
8418829|NCT00915551|20749212|P2|NOT COMPLETED|Overall Study||1
8418830|NCT00915551|20749213|P1|NOT COMPLETED|Overall Study||0
8418831|NCT00915551|20749212|P2|COMPLETED|Overall Study||135
8418832|NCT00915551|20749213|P1|COMPLETED|Overall Study||142
8418833|NCT00915551|20749212|P2|STARTED|Overall Study||136
8418834|NCT00915551|20749213|P1|STARTED|Overall Study||142
8418835|NCT00915538|20749223|P2|NOT COMPLETED|Overall Study||0
8418836|NCT00915538|20749224|P1|NOT COMPLETED|Overall Study||0
8418837|NCT00915538|20749223|P2|COMPLETED|Overall Study||8
8418838|NCT00915538|20749224|P1|COMPLETED|Overall Study||8
8418839|NCT00915538|20749223|P2|STARTED|Overall Study||8
8418840|NCT00915538|20749224|P1|STARTED|Overall Study||8
8418841|NCT00915525|20749234|P2|NOT COMPLETED|Overall Study||135
8418842|NCT00915525|20749235|P1|NOT COMPLETED|Overall Study||265
8418843|NCT00915525|20749234|P2|COMPLETED|Overall Study||151
8418844|NCT00915525|20749235|P1|COMPLETED|Overall Study||278
8418845|NCT00915525|20749234|P2|STARTED|Overall Study||286
8418846|NCT00915525|20749235|P1|STARTED|Overall Study||543
8418847|NCT00915499|20749338|P2|NOT COMPLETED|Overall Study||2
8418848|NCT00915499|20749339|P1|NOT COMPLETED|Overall Study||4
8418849|NCT00915499|20749338|P2|COMPLETED|Overall Study||31
8418850|NCT00915499|20749339|P1|COMPLETED|Overall Study||29
8418851|NCT00915499|20749338|P2|STARTED|Overall Study||33
8418852|NCT00915499|20749339|P1|STARTED|Overall Study||33
8418853|NCT00915473|20749349|P2|NOT COMPLETED|4-week Follow Up||5
8418854|NCT00915473|20749350|P1|NOT COMPLETED|4-week Follow Up||1
8418855|NCT00915473|20749349|P2|COMPLETED|4-week Follow Up||30
8418856|NCT00915473|20749350|P1|COMPLETED|4-week Follow Up||33
8418857|NCT00915473|20749349|P2|STARTED|4-week Follow Up||35
8418858|NCT00915473|20749350|P1|STARTED|4-week Follow Up||34
8418859|NCT00915473|20749349|P2|NOT COMPLETED|Injection||0
8418860|NCT00915473|20749350|P1|NOT COMPLETED|Injection||0
8418861|NCT00915473|20749349|P2|COMPLETED|Injection||35
8418862|NCT00915473|20749350|P1|COMPLETED|Injection||34
8418863|NCT00915473|20749349|P2|STARTED|Injection||35
8418864|NCT00915473|20749350|P1|STARTED|Injection||34
8418865|NCT00915473|20749349|P2|NOT COMPLETED|Screening||0
8418866|NCT00915473|20749350|P1|NOT COMPLETED|Screening||1
8418867|NCT00915473|20749349|P2|COMPLETED|Screening||35
8418868|NCT00915473|20749350|P1|COMPLETED|Screening||34
8418869|NCT00915473|20749349|P2|STARTED|Screening||35
8418870|NCT00915473|20749350|P1|STARTED|Screening||35
8418871|NCT00915356|20749367|P5|NOT COMPLETED|Overall Study||0
8418872|NCT00915356|20749368|P4|NOT COMPLETED|Overall Study||0
8418873|NCT00915356|20749369|P3|NOT COMPLETED|Overall Study||0
8418874|NCT00915356|20749370|P2|NOT COMPLETED|Overall Study||0
8418875|NCT00915356|20749371|P1|NOT COMPLETED|Overall Study||1
8418876|NCT00915356|20749367|P5|COMPLETED|Overall Study||43
8418877|NCT00915356|20749368|P4|COMPLETED|Overall Study||12
8418878|NCT00915356|20749369|P3|COMPLETED|Overall Study||45
8418879|NCT00915356|20749370|P2|COMPLETED|Overall Study||45
8418880|NCT00915356|20749371|P1|COMPLETED|Overall Study||25
8418881|NCT00915356|20749367|P5|STARTED|Overall Study||43
8418882|NCT00915356|20749368|P4|STARTED|Overall Study||12
8418883|NCT00915356|20749369|P3|STARTED|Overall Study||45
8418884|NCT00915356|20749370|P2|STARTED|Overall Study||45
8418885|NCT00915356|20749371|P1|STARTED|Overall Study||26
8418886|NCT00915343|20749433|P3|NOT COMPLETED|Part B - Open Label Period||2
8418887|NCT00915343|20749434|P2|NOT COMPLETED|Part B - Open Label Period||0
8418888|NCT00915343|20749435|P1|NOT COMPLETED|Part B - Open Label Period||0
8418889|NCT00915343|20749433|P3|COMPLETED|Part B - Open Label Period||57
8418890|NCT00915343|20749434|P2|COMPLETED|Part B - Open Label Period||0
8418891|NCT00915343|20749435|P1|COMPLETED|Part B - Open Label Period||0
8418892|NCT00915343|20749433|P3|STARTED|Part B - Open Label Period||59
8418893|NCT00915343|20749434|P2|STARTED|Part B - Open Label Period||0
8418894|NCT00915343|20749435|P1|STARTED|Part B - Open Label Period||0
8418895|NCT00915343|20749433|P3|NOT COMPLETED|Part A - Second Intervention Period||0
8418896|NCT00915343|20749434|P2|NOT COMPLETED|Part A - Second Intervention Period||0
8418897|NCT00915343|20749435|P1|NOT COMPLETED|Part A - Second Intervention Period||0
8418898|NCT00915343|20749433|P3|COMPLETED|Part A - Second Intervention Period||0
8418899|NCT00915343|20749434|P2|COMPLETED|Part A - Second Intervention Period||32
8418900|NCT00915343|20749435|P1|COMPLETED|Part A - Second Intervention Period||32
8418901|NCT00915343|20749433|P3|STARTED|Part A - Second Intervention Period||0
8418902|NCT00915343|20749434|P2|STARTED|Part A - Second Intervention Period||32
8418903|NCT00915343|20749435|P1|STARTED|Part A - Second Intervention Period||32
8418904|NCT00915343|20749433|P3|NOT COMPLETED|Part A - First Intervention Period||0
8418905|NCT00915343|20749434|P2|NOT COMPLETED|Part A - First Intervention Period||0
8418906|NCT00915343|20749435|P1|NOT COMPLETED|Part A - First Intervention Period||0
8418907|NCT00915343|20749433|P3|COMPLETED|Part A - First Intervention Period||0
8418908|NCT00915343|20749434|P2|COMPLETED|Part A - First Intervention Period||32
8418909|NCT00915343|20749435|P1|COMPLETED|Part A - First Intervention Period||32
8418910|NCT00915343|20749433|P3|STARTED|Part A - First Intervention Period||0
8418911|NCT00915343|20749434|P2|STARTED|Part A - First Intervention Period||32
8418912|NCT00915343|20749435|P1|STARTED|Part A - First Intervention Period||32
8418913|NCT00915278|20749520|P6|NOT COMPLETED|Overall Study||8
8418914|NCT00915278|20749521|P5|NOT COMPLETED|Overall Study||2
8418915|NCT00915278|20749522|P4|NOT COMPLETED|Overall Study||3
8418916|NCT00915278|20749523|P3|NOT COMPLETED|Overall Study||1
8418917|NCT00915278|20749524|P2|NOT COMPLETED|Overall Study||3
8418918|NCT00915278|20749525|P1|NOT COMPLETED|Overall Study||5
8418919|NCT00915278|20749520|P6|COMPLETED|Overall Study||1
8418920|NCT00915278|20749521|P5|COMPLETED|Overall Study||1
8418921|NCT00915278|20749522|P4|COMPLETED|Overall Study||2
8418922|NCT00915278|20749523|P3|COMPLETED|Overall Study||2
8418923|NCT00915278|20749524|P2|COMPLETED|Overall Study||2
8418924|NCT00915278|20749525|P1|COMPLETED|Overall Study||3
8418925|NCT00915278|20749520|P6|STARTED|Overall Study||9
8418926|NCT00915278|20749521|P5|STARTED|Overall Study||3
8418927|NCT00915278|20749522|P4|STARTED|Overall Study||5
8418928|NCT00915278|20749523|P3|STARTED|Overall Study||3
8418929|NCT00915278|20749524|P2|STARTED|Overall Study||5
8418930|NCT00915278|20749525|P1|STARTED|Overall Study||8
8418931|NCT00915148|20749671|P1|NOT COMPLETED|Overall Study||0
8418932|NCT00915148|20749671|P1|COMPLETED|Overall Study|August 2010|110
8418933|NCT00915148|20749671|P1|STARTED|Overall Study|October 2009|110
8418934|NCT00915031|20749678|P2|NOT COMPLETED|Overall Study||0
8418935|NCT00915031|20749679|P1|NOT COMPLETED|Overall Study||0
8418936|NCT00915031|20749678|P2|COMPLETED|Overall Study||24
8418937|NCT00915031|20749679|P1|COMPLETED|Overall Study||714
8418938|NCT00915031|20749678|P2|STARTED|Overall Study||24
8418939|NCT00915031|20749679|P1|STARTED|Overall Study||714
8418940|NCT00915018|20749686|P2|NOT COMPLETED|Overall Study||207
8418941|NCT00915018|20749687|P1|NOT COMPLETED|Overall Study||215
8418942|NCT00915018|20749686|P2|COMPLETED|Overall Study||30
8418943|NCT00915018|20749687|P1|COMPLETED|Overall Study||27
8418944|NCT00915018|20749686|P2|Received Treatment|Overall Study||234
8418945|NCT00915018|20749687|P1|Received Treatment|Overall Study||240
8418946|NCT00915018|20749686|P2|STARTED|Overall Study||237
8418947|NCT00915018|20749687|P1|STARTED|Overall Study||242
8418948|NCT00915005|20749703|P2|NOT COMPLETED|Overall Study||19
8418949|NCT00915005|20749704|P1|NOT COMPLETED|Overall Study||13
8418950|NCT00915005|20749703|P2|COMPLETED|Overall Study||57
8418951|NCT00915005|20749704|P1|COMPLETED|Overall Study||92
8418952|NCT00915005|20749703|P2|STARTED|Overall Study||76
8418953|NCT00915005|20749704|P1|STARTED|Overall Study||105
8418954|NCT00914966|20749712|P1|NOT COMPLETED|Step 3: 2500 Units||0
8418955|NCT00914966|20749712|P1|COMPLETED|Step 3: 2500 Units||12
8418956|NCT00914966|20749712|P1|STARTED|Step 3: 2500 Units||12
8418957|NCT00914966|20749712|P1|NOT COMPLETED|Step 2: 2000 Units||1
8418958|NCT00914966|20749712|P1|COMPLETED|Step 2: 2000 Units||12
8418959|NCT00914966|20749712|P1|STARTED|Step 2: 2000 Units||13
8418960|NCT00914966|20749712|P1|NOT COMPLETED|Step 1: 1500 Units||2
8418961|NCT00914966|20749712|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
8418962|NCT00914966|20749712|P1|STARTED|Step 1: 1500 Units||20
8418963|NCT00914940|20749724|P1|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
8418964|NCT00914940|20749724|P1|COMPLETED|2 Years to 5 Years Post-transplant||28
8418965|NCT00914940|20749724|P1|STARTED|2 Years to 5 Years Post-transplant||31
8418966|NCT00914940|20749724|P1|NOT COMPLETED|D101 to 2 Years Post-transplant||8
8418967|NCT00914940|20749724|P1|COMPLETED|D101 to 2 Years Post-transplant||31
8418968|NCT00914940|20749724|P1|STARTED|D101 to 2 Years Post-transplant||39
8418969|NCT00914940|20749724|P1|NOT COMPLETED|D0 to D100 Post-transplant||2
8418970|NCT00914940|20749724|P1|COMPLETED|D0 to D100 Post-transplant||39
8418971|NCT00914940|20749724|P1|STARTED|D0 to D100 Post-transplant||41
8418972|NCT00914927|20749739|P7|NOT COMPLETED|Overall Study||0
8418973|NCT00914927|20749740|P6|NOT COMPLETED|Overall Study||0
8418974|NCT00914927|20749741|P5|NOT COMPLETED|Overall Study||2
8418975|NCT00914927|20749742|P4|NOT COMPLETED|Overall Study||2
8418976|NCT00914927|20749743|P3|NOT COMPLETED|Overall Study||0
8418977|NCT00914927|20749744|P2|NOT COMPLETED|Overall Study||2
8418978|NCT00914927|20749745|P1|NOT COMPLETED|Overall Study||2
8418979|NCT00914927|20749739|P7|COMPLETED|Overall Study||21
8418980|NCT00914927|20749740|P6|COMPLETED|Overall Study||21
8418981|NCT00914927|20749741|P5|COMPLETED|Overall Study||19
8418982|NCT00914927|20749742|P4|COMPLETED|Overall Study||14
8418983|NCT00914927|20749743|P3|COMPLETED|Overall Study||17
8418984|NCT00914927|20749744|P2|COMPLETED|Overall Study||14
8418985|NCT00914927|20749745|P1|COMPLETED|Overall Study||16
8418986|NCT00914927|20749739|P7|STARTED|Overall Study||21
8418987|NCT00914927|20749740|P6|STARTED|Overall Study||21
8418988|NCT00914927|20749741|P5|STARTED|Overall Study||21
8418989|NCT00914927|20749742|P4|STARTED|Overall Study||16
8418990|NCT00914927|20749743|P3|STARTED|Overall Study||17
8418991|NCT00914927|20749744|P2|STARTED|Overall Study||16
8418992|NCT00914927|20749745|P1|STARTED|Overall Study||18
8418993|NCT00914862|20749794|P5|NOT COMPLETED|Overall Study||0
8418994|NCT00914862|20749795|P4|NOT COMPLETED|Overall Study||0
8418995|NCT00914862|20749796|P3|NOT COMPLETED|Overall Study||0
8418996|NCT00914862|20749797|P2|NOT COMPLETED|Overall Study||0
8418997|NCT00914862|20749798|P1|NOT COMPLETED|Overall Study||0
8418998|NCT00914862|20749794|P5|COMPLETED|Overall Study||28
8418999|NCT00914862|20749795|P4|COMPLETED|Overall Study||8
8419000|NCT00914862|20749796|P3|COMPLETED|Overall Study||8
8419001|NCT00914862|20749797|P2|COMPLETED|Overall Study||6
8419002|NCT00914862|20749798|P1|COMPLETED|Overall Study||6
8419003|NCT00914862|20749794|P5|STARTED|Overall Study||28
8419004|NCT00914862|20749795|P4|STARTED|Overall Study||8
8419005|NCT00914862|20749796|P3|STARTED|Overall Study||8
8419006|NCT00914862|20749797|P2|STARTED|Overall Study||6
8419007|NCT00914862|20749798|P1|STARTED|Overall Study||6
8419008|NCT00914849|20749872|P2|NOT COMPLETED|Overall Study||1
8419009|NCT00914849|20749873|P1|NOT COMPLETED|Overall Study||1
8419010|NCT00914849|20749872|P2|COMPLETED|Overall Study||33
8419011|NCT00914849|20749873|P1|COMPLETED|Overall Study||33
8419012|NCT00914849|20749872|P2|STARTED|Overall Study||34
8419013|NCT00914849|20749873|P1|STARTED|Overall Study||34
8419014|NCT00914810|20749907|P2|NOT COMPLETED|Overall Study||1
8419015|NCT00914810|20749908|P1|NOT COMPLETED|Overall Study||2
8419016|NCT00914810|20749907|P2|COMPLETED|Overall Study||18
8419017|NCT00914810|20749908|P1|COMPLETED|Overall Study||18
8419018|NCT00914810|20749907|P2|STARTED|Overall Study||19
8419019|NCT00914810|20749908|P1|STARTED|Overall Study||20
8419032|NCT00914589|20749951|P3|NOT COMPLETED|Overall Study||12
8419033|NCT00914589|20749952|P2|NOT COMPLETED|Overall Study||16
8419034|NCT00914589|20749953|P1|NOT COMPLETED|Overall Study||25
8419035|NCT00914589|20749951|P3|COMPLETED|Overall Study||126
8419036|NCT00914589|20749952|P2|COMPLETED|Overall Study||127
8419037|NCT00914589|20749953|P1|COMPLETED|Overall Study||103
8419038|NCT00914589|20749951|P3|STARTED|Overall Study||138
8419039|NCT00914589|20749952|P2|STARTED|Overall Study||143
8419040|NCT00914589|20749953|P1|STARTED|Overall Study||128
8419041|NCT00914485|20749973|P1|NOT COMPLETED|Overall Study||0
8419042|NCT00914485|20749973|P1|COMPLETED|Overall Study||369
8419043|NCT00914485|20749973|P1|STARTED|Overall Study||369
8419044|NCT00914459|20749979|P2|NOT COMPLETED|Overall Study||1
8419045|NCT00914459|20749980|P1|NOT COMPLETED|Overall Study||1
8419046|NCT00914459|20749979|P2|COMPLETED|Overall Study||18
8419047|NCT00914459|20749980|P1|COMPLETED|Overall Study||17
8419048|NCT00914459|20749979|P2|STARTED|Overall Study||19
8419049|NCT00914459|20749980|P1|STARTED|Overall Study||18
8419050|NCT00914316|20750010|P4|NOT COMPLETED|Phase 2||0
8419051|NCT00914316|20750011|P3|NOT COMPLETED|Phase 2||1
8419052|NCT00914316|20750012|P2|NOT COMPLETED|Phase 2||0
8419053|NCT00914316|20750013|P1|NOT COMPLETED|Phase 2||1
8419054|NCT00914316|20750010|P4|COMPLETED|Phase 2||6
8419055|NCT00914316|20750011|P3|COMPLETED|Phase 2||2
8419056|NCT00914316|20750012|P2|COMPLETED|Phase 2||4
8419057|NCT00914316|20750013|P1|COMPLETED|Phase 2||1
8419058|NCT00914316|20750010|P4|STARTED|Phase 2||6
8419059|NCT00914316|20750011|P3|STARTED|Phase 2||3
8419060|NCT00914316|20750012|P2|STARTED|Phase 2||4
8419061|NCT00914316|20750013|P1|STARTED|Phase 2||2
8419062|NCT00914316|20750010|P4|NOT COMPLETED|Phase 1||2
8419063|NCT00914316|20750011|P3|NOT COMPLETED|Phase 1||5
8419064|NCT00914316|20750012|P2|NOT COMPLETED|Phase 1||2
8419065|NCT00914316|20750013|P1|NOT COMPLETED|Phase 1||5
8419066|NCT00914316|20750010|P4|COMPLETED|Phase 1||6
8419067|NCT00914316|20750011|P3|COMPLETED|Phase 1||3
8419068|NCT00914316|20750012|P2|COMPLETED|Phase 1||4
8419069|NCT00914316|20750013|P1|COMPLETED|Phase 1||2
8419070|NCT00914316|20750010|P4|STARTED|Phase 1||8
8419071|NCT00914316|20750011|P3|STARTED|Phase 1||8
8419072|NCT00914316|20750012|P2|STARTED|Phase 1||6
8419073|NCT00914316|20750013|P1|STARTED|Phase 1||7
8419074|NCT00914186|20750031|P4|NOT COMPLETED|Overall Study||10
8419075|NCT00914186|20750032|P3|NOT COMPLETED|Overall Study||2
8419076|NCT00914186|20750033|P2|NOT COMPLETED|Overall Study||2
8419077|NCT00914186|20750034|P1|NOT COMPLETED|Overall Study||3
8419078|NCT00914186|20750031|P4|COMPLETED|Overall Study||20
8419079|NCT00914186|20750032|P3|COMPLETED|Overall Study||29
8419080|NCT00914186|20750033|P2|COMPLETED|Overall Study||28
8419081|NCT00914186|20750034|P1|COMPLETED|Overall Study||28
8419082|NCT00914186|20750031|P4|STARTED|Overall Study||30
8419083|NCT00914186|20750032|P3|STARTED|Overall Study||31
8419084|NCT00914186|20750033|P2|STARTED|Overall Study||30
8419085|NCT00914186|20750034|P1|STARTED|Overall Study||31
8419086|NCT00914069|20750068|P2|NOT COMPLETED|Overall Study||0
8419087|NCT00914069|20750069|P1|NOT COMPLETED|Overall Study||0
8419088|NCT00914069|20750068|P2|COMPLETED|Overall Study||88
8419089|NCT00914069|20750069|P1|COMPLETED|Overall Study||84
8419090|NCT00914069|20750068|P2|STARTED|Overall Study||88
8419091|NCT00914069|20750069|P1|STARTED|Overall Study||84
8419092|NCT00913978|20750085|P2|NOT COMPLETED|Overall Study||3
8419093|NCT00913978|20750086|P1|NOT COMPLETED|Overall Study||1
8419094|NCT00913978|20750085|P2|COMPLETED|Overall Study||21
8419095|NCT00913978|20750086|P1|COMPLETED|Overall Study||25
8419096|NCT00913978|20750085|P2|STARTED|Overall Study||24
8419097|NCT00913978|20750086|P1|STARTED|Overall Study||26
8419098|NCT00913913|20750094|P1|NOT COMPLETED|Overall Study||8
8419099|NCT00913913|20750094|P1|COMPLETED|Overall Study||0
8419100|NCT00913913|20750094|P1|STARTED|Overall Study||8
8419101|NCT00913835|20750103|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
8419102|NCT00913835|20750104|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
8419103|NCT00913835|20750103|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
8419104|NCT00913835|20750104|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
8419105|NCT00913835|20750103|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
8419106|NCT00913835|20750104|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
8419107|NCT00913835|20750103|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
8419108|NCT00913835|20750104|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
8419109|NCT00913835|20750103|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
8419110|NCT00913835|20750104|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
8419111|NCT00913835|20750103|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
8419112|NCT00913835|20750104|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
8419113|NCT00913835|20750103|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
8419114|NCT00913835|20750104|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
8419115|NCT00913835|20750103|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
8419116|NCT00913835|20750104|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
8419117|NCT00913770|20750143|P3|NOT COMPLETED|Overall Study||21
8419118|NCT00913770|20750144|P2|NOT COMPLETED|Overall Study||29
8419119|NCT00913770|20750145|P1|NOT COMPLETED|Overall Study||35
8419120|NCT00913770|20750143|P3|COMPLETED|Overall Study||93
8419121|NCT00913770|20750144|P2|COMPLETED|Overall Study||82
8419122|NCT00913770|20750145|P1|COMPLETED|Overall Study||69
8419123|NCT00913770|20750143|P3|STARTED|Overall Study||114
8419124|NCT00913770|20750144|P2|STARTED|Overall Study||111
8419125|NCT00913770|20750145|P1|STARTED|Overall Study||104
8419126|NCT00913744|20750158|P2|NOT COMPLETED|Overall Study||1
8419127|NCT00913744|20750159|P1|NOT COMPLETED|Overall Study||5
8419128|NCT00913744|20750158|P2|COMPLETED|Overall Study||24
8419129|NCT00913744|20750159|P1|COMPLETED|Overall Study||70
8419130|NCT00913744|20750158|P2|STARTED|Overall Study||25
8419131|NCT00913744|20750159|P1|STARTED|Overall Study||75
8419132|NCT00913692|20750165|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
8419133|NCT00913692|20750165|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
8419134|NCT00913692|20750165|P1|STARTED|Treatment Phase 2 (5 Months)||1
8419135|NCT00913692|20750165|P1|NOT COMPLETED|Washout (2 Weeks)||0
8419136|NCT00913692|20750165|P1|COMPLETED|Washout (2 Weeks)||1
8419137|NCT00913692|20750165|P1|STARTED|Washout (2 Weeks)||1
8419138|NCT00913692|20750165|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
8419139|NCT00913692|20750165|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
8419140|NCT00913692|20750165|P1|STARTED|Treatment Phase 1 (5 Months)||2
8419141|NCT00913692|20750165|P1|NOT COMPLETED|Screening (4 Months)||9
8419142|NCT00913692|20750165|P1|COMPLETED|Screening (4 Months)||2
8419143|NCT00913692|20750165|P1|STARTED|Screening (4 Months)||11
8419144|NCT00913627|20750179|P4|NOT COMPLETED|Overall Study||0
8419145|NCT00913627|20750180|P3|NOT COMPLETED|Overall Study||0
8419146|NCT00913627|20750181|P2|NOT COMPLETED|Overall Study||0
8419147|NCT00913627|20750182|P1|NOT COMPLETED|Overall Study||0
8419148|NCT00913627|20750179|P4|COMPLETED|Overall Study||58
8419149|NCT00913627|20750180|P3|COMPLETED|Overall Study||56
8419150|NCT00913627|20750181|P2|COMPLETED|Overall Study||53
8419151|NCT00913627|20750182|P1|COMPLETED|Overall Study||29
8419152|NCT00913627|20750179|P4|STARTED|Overall Study||58
8419153|NCT00913627|20750180|P3|STARTED|Overall Study||56
8419154|NCT00913627|20750181|P2|STARTED|Overall Study||53
8419155|NCT00913627|20750182|P1|STARTED|Overall Study||29
8419156|NCT00913523|20750259|P3|NOT COMPLETED|Overall Study||14
8419157|NCT00913523|20750260|P2|NOT COMPLETED|Overall Study||16
8419158|NCT00913523|20750261|P1|NOT COMPLETED|Overall Study||18
8419159|NCT00913523|20750259|P3|COMPLETED|Overall Study||147
8419160|NCT00913523|20750260|P2|COMPLETED|Overall Study||143
8419161|NCT00913523|20750261|P1|COMPLETED|Overall Study||144
8419162|NCT00913523|20750259|P3|STARTED|Overall Study||161
8419163|NCT00913523|20750260|P2|STARTED|Overall Study||159
8419164|NCT00913523|20750261|P1|STARTED|Overall Study||162
8419165|NCT00913510|20750286|P2|NOT COMPLETED|Overall Study||4
8419166|NCT00913510|20750287|P1|NOT COMPLETED|Overall Study||8
8419167|NCT00913510|20750286|P2|COMPLETED|Overall Study||3
8419168|NCT00913510|20750287|P1|COMPLETED|Overall Study||5
8419169|NCT00913510|20750286|P2|STARTED|Overall Study||7
8419170|NCT00913510|20750287|P1|STARTED|Overall Study||13
8419171|NCT00913458|20750293|P7|NOT COMPLETED|Phase 3||8
8419172|NCT00913458|20750294|P6|NOT COMPLETED|Phase 3||18
8419173|NCT00913458|20750295|P5|NOT COMPLETED|Phase 3||22
8419174|NCT00913458|20750296|P4|NOT COMPLETED|Phase 3||0
8419175|NCT00913458|20750297|P3|NOT COMPLETED|Phase 3||0
8419176|NCT00913458|20750298|P2|NOT COMPLETED|Phase 3||0
8419177|NCT00913458|20750299|P1|NOT COMPLETED|Phase 3||0
8419178|NCT00913458|20750293|P7|COMPLETED|Phase 3||24
8419179|NCT00913458|20750294|P6|COMPLETED|Phase 3||28
8419180|NCT00913458|20750295|P5|COMPLETED|Phase 3||31
8419181|NCT00913458|20750296|P4|COMPLETED|Phase 3||0
8419182|NCT00913458|20750297|P3|COMPLETED|Phase 3||0
8419183|NCT00913458|20750298|P2|COMPLETED|Phase 3||0
8419184|NCT00913458|20750299|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
8419185|NCT00913458|20750293|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
8419186|NCT00913458|20750294|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
8419187|NCT00913458|20750295|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
8419188|NCT00913458|20750296|P4|STARTED|Phase 3||0
8419189|NCT00913458|20750297|P3|STARTED|Phase 3||0
8419190|NCT00913458|20750298|P2|STARTED|Phase 3||0
8419191|NCT00913458|20750299|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
8419192|NCT00913458|20750293|P7|NOT COMPLETED|Phase 2||0
8419193|NCT00913458|20750294|P6|NOT COMPLETED|Phase 2||0
8419194|NCT00913458|20750295|P5|NOT COMPLETED|Phase 2||0
8419195|NCT00913458|20750296|P4|NOT COMPLETED|Phase 2||33
8419196|NCT00913458|20750297|P3|NOT COMPLETED|Phase 2||19
8419197|NCT00913458|20750298|P2|NOT COMPLETED|Phase 2||10
8419198|NCT00913458|20750299|P1|NOT COMPLETED|Phase 2||0
8419199|NCT00913458|20750293|P7|COMPLETED|Phase 2||0
8419200|NCT00913458|20750294|P6|COMPLETED|Phase 2||0
8419201|NCT00913458|20750295|P5|COMPLETED|Phase 2||0
8419202|NCT00913458|20750296|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
8419203|NCT00913458|20750297|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
8419204|NCT00913458|20750298|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
8419205|NCT00913458|20750299|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
8419206|NCT00913458|20750293|P7|STARTED|Phase 2||0
8419207|NCT00913458|20750294|P6|STARTED|Phase 2||0
8419208|NCT00913458|20750295|P5|STARTED|Phase 2||0
8419209|NCT00913458|20750296|P4|STARTED|Phase 2||65
8419210|NCT00913458|20750297|P3|STARTED|Phase 2||65
8419211|NCT00913458|20750298|P2|STARTED|Phase 2||63
8419212|NCT00913458|20750299|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
8419213|NCT00913458|20750293|P7|NOT COMPLETED|Phase 1||0
8419214|NCT00913458|20750294|P6|NOT COMPLETED|Phase 1||0
8419215|NCT00913458|20750295|P5|NOT COMPLETED|Phase 1||0
8419216|NCT00913458|20750296|P4|NOT COMPLETED|Phase 1||0
8419217|NCT00913458|20750297|P3|NOT COMPLETED|Phase 1||0
8419218|NCT00913458|20750298|P2|NOT COMPLETED|Phase 1||0
8419219|NCT00913458|20750299|P1|NOT COMPLETED|Phase 1||112
8419220|NCT00913458|20750293|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8419221|NCT00913458|20750294|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8419222|NCT00913458|20750295|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8419223|NCT00913458|20750296|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8419224|NCT00913458|20750297|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8419225|NCT00913458|20750298|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8419226|NCT00913458|20750299|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
8419227|NCT00913458|20750293|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
8419228|NCT00913458|20750294|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
8419229|NCT00913458|20750295|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
8419230|NCT00913458|20750296|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
8419231|NCT00913458|20750297|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
8419232|NCT00913458|20750298|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
8419233|NCT00913458|20750299|P1|STARTED|Phase 1||306
8419234|NCT00913380|20750392|P2|NOT COMPLETED|Clinical Outcomes||6
8419235|NCT00913380|20750393|P1|NOT COMPLETED|Clinical Outcomes||6
8419236|NCT00913380|20750392|P2|COMPLETED|Clinical Outcomes||441
8419237|NCT00913380|20750393|P1|COMPLETED|Clinical Outcomes||438
8419238|NCT00913380|20750392|P2|STARTED|Clinical Outcomes||447
8419239|NCT00913380|20750393|P1|STARTED|Clinical Outcomes||444
8419240|NCT00913380|20750392|P2|NOT COMPLETED|CT Examination||0
8419241|NCT00913380|20750393|P1|NOT COMPLETED|CT Examination||0
8419242|NCT00913380|20750392|P2|COMPLETED|CT Examination||447
8419243|NCT00913380|20750393|P1|COMPLETED|CT Examination||444
8419244|NCT00913380|20750392|P2|STARTED|CT Examination||447
8419245|NCT00913380|20750393|P1|STARTED|CT Examination||444
8419246|NCT00913263|20750419|P1|NOT COMPLETED|Overall Study||0
8419247|NCT00913263|20750419|P1|COMPLETED|Overall Study||24
8419248|NCT00913263|20750419|P1|STARTED|Overall Study||24
8419249|NCT00913133|20750428|P1|NOT COMPLETED|Overall Study||0
8419250|NCT00913133|20750428|P1|COMPLETED|Overall Study||516
8419251|NCT00913133|20750428|P1|STARTED|Overall Study||516
8419252|NCT00913081|20750433|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
8419253|NCT00913081|20750433|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
8419254|NCT00913081|20750433|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
8419255|NCT00913081|20750433|P1|NOT COMPLETED|Washout #3 (7days)||0
8419256|NCT00913081|20750433|P1|COMPLETED|Washout #3 (7days)||17
8419257|NCT00913081|20750433|P1|STARTED|Washout #3 (7days)||17
8419258|NCT00913081|20750433|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
8419259|NCT00913081|20750433|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
8419260|NCT00913081|20750433|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
8419261|NCT00913081|20750433|P1|NOT COMPLETED|Washout #2 (7 Days)||0
8419262|NCT00913081|20750433|P1|COMPLETED|Washout #2 (7 Days)||17
8419263|NCT00913081|20750433|P1|STARTED|Washout #2 (7 Days)||17
8419264|NCT00913081|20750433|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
8419265|NCT00913081|20750433|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
8419266|NCT00913081|20750433|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
8419267|NCT00913081|20750433|P1|NOT COMPLETED|Washout #1 (7 Days)||0
8419268|NCT00913081|20750433|P1|COMPLETED|Washout #1 (7 Days)||17
8419269|NCT00913081|20750433|P1|STARTED|Washout #1 (7 Days)||17
8419270|NCT00913081|20750433|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
8419271|NCT00913081|20750433|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
8419272|NCT00913081|20750433|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
8419273|NCT00913003|20750445|P2|NOT COMPLETED|Overall Study||0
8419274|NCT00913003|20750446|P1|NOT COMPLETED|Overall Study||0
8419275|NCT00913003|20750445|P2|COMPLETED|Overall Study||11
8419276|NCT00913003|20750446|P1|COMPLETED|Overall Study||11
8419277|NCT00913003|20750445|P2|STARTED|Overall Study||11
8419278|NCT00913003|20750446|P1|STARTED|Overall Study||11
8419279|NCT00912990|20750458|P2|NOT COMPLETED|Overall Study||0
8419280|NCT00912990|20750459|P1|NOT COMPLETED|Overall Study||0
8419281|NCT00912990|20750458|P2|COMPLETED|Overall Study||18
8419282|NCT00912990|20750459|P1|COMPLETED|Overall Study||16
8419283|NCT00912990|20750458|P2|STARTED|Overall Study||18
8419284|NCT00912990|20750459|P1|STARTED|Overall Study||16
8419285|NCT00912964|20750472|P3|NOT COMPLETED|Overall Study||54
8419286|NCT00912964|20750473|P2|NOT COMPLETED|Overall Study||46
8419287|NCT00912964|20750474|P1|NOT COMPLETED|Overall Study||66
8419288|NCT00912964|20750472|P3|COMPLETED|Overall Study||386
8419289|NCT00912964|20750473|P2|COMPLETED|Overall Study||387
8419290|NCT00912964|20750474|P1|COMPLETED|Overall Study||367
8419291|NCT00912964|20750472|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
8419292|NCT00912964|20750473|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
8419293|NCT00912964|20750474|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
8419294|NCT00912964|20750472|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
8419295|NCT00912964|20750473|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
8419296|NCT00912964|20750474|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
8419297|NCT00912964|20750472|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
8419298|NCT00912964|20750473|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
8419299|NCT00912964|20750474|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
8419300|NCT00912964|20750472|P3|STARTED|Overall Study||440
8419301|NCT00912964|20750473|P2|STARTED|Overall Study||433
8419302|NCT00912964|20750474|P1|STARTED|Overall Study||433
8419303|NCT00912925|20750598|P2|NOT COMPLETED|Overall Study||0
8419304|NCT00912925|20750599|P1|NOT COMPLETED|Overall Study||0
8419305|NCT00912925|20750598|P2|COMPLETED|Overall Study||22
8419306|NCT00912925|20750599|P1|COMPLETED|Overall Study||23
8419307|NCT00912925|20750598|P2|STARTED|Overall Study||22
8419308|NCT00912925|20750599|P1|STARTED|Overall Study||23
8419309|NCT00912912|20750617|P1|NOT COMPLETED|Overall Study||4
8419310|NCT00912912|20750617|P1|COMPLETED|Overall Study||1
8419311|NCT00912912|20750617|P1|STARTED|Overall Study||5
8419312|NCT00912808|20750623|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
8419313|NCT00912808|20750624|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
8419314|NCT00912808|20750623|P2|COMPLETED|Second Intervention (6 Weeks)||9
8419315|NCT00912808|20750624|P1|COMPLETED|Second Intervention (6 Weeks)||8
8419316|NCT00912808|20750623|P2|Received Intervention|Second Intervention (6 Weeks)||10
8419317|NCT00912808|20750624|P1|Received Intervention|Second Intervention (6 Weeks)||9
8419318|NCT00912808|20750623|P2|STARTED|Second Intervention (6 Weeks)||10
8419319|NCT00912808|20750624|P1|STARTED|Second Intervention (6 Weeks)||9
8419320|NCT00912808|20750623|P2|NOT COMPLETED|Washout||1
8419321|NCT00912808|20750624|P1|NOT COMPLETED|Washout||0
8419322|NCT00912808|20750623|P2|COMPLETED|Washout||10
8419323|NCT00912808|20750624|P1|COMPLETED|Washout||9
8419324|NCT00912808|20750623|P2|STARTED|Washout||11
8419325|NCT00912808|20750624|P1|STARTED|Washout||9
8419326|NCT00912808|20750623|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
8419327|NCT00912808|20750624|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
8419328|NCT00912808|20750623|P2|COMPLETED|First Intervention (6 Weeks)||11
8419329|NCT00912808|20750624|P1|COMPLETED|First Intervention (6 Weeks)||9
8419330|NCT00912808|20750623|P2|Received Intervention|First Intervention (6 Weeks)||12
8419331|NCT00912808|20750624|P1|Received Intervention|First Intervention (6 Weeks)||11
8419332|NCT00912808|20750623|P2|STARTED|First Intervention (6 Weeks)||12
8419333|NCT00912808|20750624|P1|STARTED|First Intervention (6 Weeks)||11
8419334|NCT00912795|20750634|P2|NOT COMPLETED|Overall Study||58
8419335|NCT00912795|20750635|P1|NOT COMPLETED|Overall Study||47
8419336|NCT00912795|20750634|P2|COMPLETED|Overall Study||17
8419337|NCT00912795|20750635|P1|COMPLETED|Overall Study||29
8419338|NCT00912795|20750634|P2|STARTED|Overall Study||75
8419339|NCT00912795|20750635|P1|STARTED|Overall Study||76
8419340|NCT00912782|20750649|P2|NOT COMPLETED|Overall Study||5
8419341|NCT00912782|20750650|P1|NOT COMPLETED|Overall Study||3
8419342|NCT00912782|20750649|P2|COMPLETED|Overall Study||20
8419343|NCT00912782|20750650|P1|COMPLETED|Overall Study||24
8419344|NCT00912782|20750649|P2|STARTED|Overall Study||25
8419345|NCT00912782|20750650|P1|STARTED|Overall Study||27
8419346|NCT00912743|20750660|P2|NOT COMPLETED|Overall Study||20
8419347|NCT00912743|20750661|P1|NOT COMPLETED|Overall Study||13
8419348|NCT00912743|20750660|P2|COMPLETED|Overall Study||0
8419349|NCT00912743|20750661|P1|COMPLETED|Overall Study||0
8419350|NCT00912743|20750660|P2|STARTED|Overall Study||20
8419351|NCT00912743|20750661|P1|STARTED|Overall Study||13
8419352|NCT00912509|20750673|P2|NOT COMPLETED|Overall Study||3
8419353|NCT00912509|20750674|P1|NOT COMPLETED|Overall Study||5
8419354|NCT00912509|20750673|P2|COMPLETED|Overall Study||7
8419355|NCT00912509|20750674|P1|COMPLETED|Overall Study||15
8419356|NCT00912509|20750673|P2|STARTED|Overall Study||10
8419357|NCT00912509|20750674|P1|STARTED|Overall Study||20
8419358|NCT00912405|20750682|P1|NOT COMPLETED|Overall Study||5
8419359|NCT00912405|20750682|P1|COMPLETED|Overall Study||45
8419360|NCT00912405|20750682|P1|STARTED|Overall Study||50
8419361|NCT00912340|20750692|P3|NOT COMPLETED|Overall Study||4
8419362|NCT00912340|20750693|P2|NOT COMPLETED|Overall Study||4
8419363|NCT00912340|20750694|P1|NOT COMPLETED|Overall Study||2
8419364|NCT00912340|20750692|P3|COMPLETED|Overall Study||0
8419365|NCT00912340|20750693|P2|COMPLETED|Overall Study||26
8419366|NCT00912340|20750694|P1|COMPLETED|Overall Study||22
8419367|NCT00912340|20750692|P3|STARTED|Overall Study||4
8419368|NCT00912340|20750693|P2|STARTED|Overall Study||30
8419369|NCT00912340|20750694|P1|STARTED|Overall Study||24
8419370|NCT00912301|20750708|P3|NOT COMPLETED|Overall Study||0
8419371|NCT00912301|20750709|P2|NOT COMPLETED|Overall Study||0
8419372|NCT00912301|20750710|P1|NOT COMPLETED|Overall Study||0
8419373|NCT00912301|20750708|P3|COMPLETED|Overall Study||13
8419374|NCT00912301|20750709|P2|COMPLETED|Overall Study||12
8419375|NCT00912301|20750710|P1|COMPLETED|Overall Study||11
8419376|NCT00912301|20750708|P3|STARTED|Overall Study||13
8419377|NCT00912301|20750709|P2|STARTED|Overall Study||12
8419378|NCT00912301|20750710|P1|STARTED|Overall Study||11
8419379|NCT00912288|20750732|P2|NOT COMPLETED|Overall Study||40
8419380|NCT00912288|20750733|P1|NOT COMPLETED|Overall Study||41
8419381|NCT00912288|20750732|P2|COMPLETED|Overall Study||2
8419382|NCT00912288|20750733|P1|COMPLETED|Overall Study||3
8419383|NCT00912288|20750732|P2|STARTED|Overall Study||42
8419384|NCT00912288|20750733|P1|STARTED|Overall Study||44
8419385|NCT00912223|20750755|P1|NOT COMPLETED|Overall Study||3
8419386|NCT00912223|20750755|P1|COMPLETED|Overall Study||62
8419387|NCT00912223|20750755|P1|STARTED|Overall Study||65
8419388|NCT00912197|20750773|P2|NOT COMPLETED|Overall Study||3
8419389|NCT00912197|20750774|P1|NOT COMPLETED|Overall Study||3
8419390|NCT00912197|20750773|P2|COMPLETED|Overall Study||10
8419391|NCT00912197|20750774|P1|COMPLETED|Overall Study||12
8419392|NCT00912197|20750773|P2|STARTED|Overall Study||13
8419393|NCT00912197|20750774|P1|STARTED|Overall Study||15
8419394|NCT00912158|20750805|P3|NOT COMPLETED|Overall Study||0
8419395|NCT00912158|20750806|P2|NOT COMPLETED|Overall Study||0
8419396|NCT00912158|20750807|P1|NOT COMPLETED|Overall Study||0
8419397|NCT00912158|20750805|P3|COMPLETED|Overall Study||41
8419398|NCT00912158|20750806|P2|COMPLETED|Overall Study||44
8419399|NCT00912158|20750807|P1|COMPLETED|Overall Study||44
8419400|NCT00912158|20750805|P3|STARTED|Overall Study||41
8419401|NCT00912158|20750806|P2|STARTED|Overall Study||44
8419402|NCT00912158|20750807|P1|STARTED|Overall Study||44
8419403|NCT00912093|20750817|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8419404|NCT00912093|20750818|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8419405|NCT00912093|20750819|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8419406|NCT00912093|20750820|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8419407|NCT00912093|20750821|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8419408|NCT00912093|20750817|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
8419409|NCT00912093|20750818|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
8419410|NCT00912093|20750819|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
8419411|NCT00912093|20750820|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
8419412|NCT00912093|20750821|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
8419413|NCT00912093|20750817|P5|STARTED|The Open Label Extension (OLE) Phase||4
8419414|NCT00912093|20750818|P4|STARTED|The Open Label Extension (OLE) Phase||2
8419415|NCT00912093|20750819|P3|STARTED|The Open Label Extension (OLE) Phase||3
8419416|NCT00912093|20750820|P2|STARTED|The Open Label Extension (OLE) Phase||35
8419417|NCT00912093|20750821|P1|STARTED|The Open Label Extension (OLE) Phase||38
8419418|NCT00912093|20750817|P5|NOT COMPLETED|The Controlled Phase||1
8419419|NCT00912093|20750818|P4|NOT COMPLETED|The Controlled Phase||0
8419420|NCT00912093|20750819|P3|NOT COMPLETED|The Controlled Phase||0
8419421|NCT00912093|20750820|P2|NOT COMPLETED|The Controlled Phase||2
8419422|NCT00912093|20750821|P1|NOT COMPLETED|The Controlled Phase||0
8419423|NCT00912093|20750817|P5|COMPLETED|The Controlled Phase||4
8419424|NCT00912093|20750818|P4|COMPLETED|The Controlled Phase||2
8419425|NCT00912093|20750819|P3|COMPLETED|The Controlled Phase||3
8419426|NCT00912093|20750820|P2|COMPLETED|The Controlled Phase||43
8419427|NCT00912093|20750821|P1|COMPLETED|The Controlled Phase||43
8419428|NCT00912093|20750817|P5|STARTED|The Controlled Phase||5
8419429|NCT00912093|20750818|P4|STARTED|The Controlled Phase||2
8419430|NCT00912093|20750819|P3|STARTED|The Controlled Phase||3
8419431|NCT00912093|20750820|P2|STARTED|The Controlled Phase||45
8419432|NCT00912093|20750821|P1|STARTED|The Controlled Phase||43
8419433|NCT00912028|20750840|P5|NOT COMPLETED|Overall Study||3
8419434|NCT00912028|20750841|P4|NOT COMPLETED|Overall Study||1
8419435|NCT00912028|20750842|P3|NOT COMPLETED|Overall Study||0
8419436|NCT00912028|20750843|P2|NOT COMPLETED|Overall Study||3
8419437|NCT00912028|20750844|P1|NOT COMPLETED|Overall Study||5
8419438|NCT00912028|20750840|P5|COMPLETED|Overall Study||0
8419439|NCT00912028|20750841|P4|COMPLETED|Overall Study||16
8419440|NCT00912028|20750842|P3|COMPLETED|Overall Study||13
8419441|NCT00912028|20750843|P2|COMPLETED|Overall Study||0
8419442|NCT00912028|20750844|P1|COMPLETED|Overall Study||30
8419443|NCT00912028|20750840|P5|STARTED|Overall Study||3
8419444|NCT00912028|20750841|P4|STARTED|Overall Study||17
8419445|NCT00912028|20750842|P3|STARTED|Overall Study||13
8419446|NCT00912028|20750843|P2|STARTED|Overall Study||3
8419447|NCT00912028|20750844|P1|STARTED|Overall Study||35
8419448|NCT00912015|20750873|P4|NOT COMPLETED|Overall Study||2
8419449|NCT00912015|20750874|P3|NOT COMPLETED|Overall Study||3
8419450|NCT00912015|20750875|P2|NOT COMPLETED|Overall Study||8
8419451|NCT00912015|20750876|P1|NOT COMPLETED|Overall Study||16
8419452|NCT00912015|20750873|P4|COMPLETED|Overall Study||0
8419453|NCT00912015|20750874|P3|COMPLETED|Overall Study||22
8419454|NCT00912015|20750875|P2|COMPLETED|Overall Study||62
8419455|NCT00912015|20750876|P1|COMPLETED|Overall Study||125
8419456|NCT00912015|20750873|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
8419457|NCT00912015|20750874|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
8419458|NCT00912015|20750875|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
8419459|NCT00912015|20750876|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
8419460|NCT00912002|20750886|P1|NOT COMPLETED|Overall Study||0
8419461|NCT00912002|20750886|P1|COMPLETED|Overall Study||6
8419462|NCT00912002|20750886|P1|STARTED|Overall Study||6
8419463|NCT00911989|20750892|P1|NOT COMPLETED|Overall Study||1
8419464|NCT00911989|20750892|P1|COMPLETED|Overall Study||3
8419465|NCT00911989|20750892|P1|STARTED|Overall Study||4
8419466|NCT00911937|20750898|P2|NOT COMPLETED|Overall Study||95
8419467|NCT00911937|20750899|P1|NOT COMPLETED|Overall Study||87
8419468|NCT00911937|20750898|P2|COMPLETED|Overall Study||381
8419469|NCT00911937|20750899|P1|COMPLETED|Overall Study||400
8419470|NCT00911937|20750898|P2|Treated|Overall Study||463
8419471|NCT00911937|20750899|P1|Treated|Overall Study||474
8419472|NCT00911937|20750898|P2|STARTED|Overall Study||476
8419473|NCT00911937|20750899|P1|STARTED|Overall Study||487
8419474|NCT00911898|20750959|P1|NOT COMPLETED|Overall Study||0
8419475|NCT00911898|20750959|P1|COMPLETED|Overall Study||20
8419476|NCT00911898|20750959|P1|STARTED|Overall Study||20
8419477|NCT00911859|20750966|P3|NOT COMPLETED|Follow-up Period||41
8419478|NCT00911859|20750967|P2|NOT COMPLETED|Follow-up Period||46
8419479|NCT00911859|20750968|P1|NOT COMPLETED|Follow-up Period||11
8419480|NCT00911859|20750966|P3|COMPLETED|Follow-up Period||11
8419481|NCT00911859|20750967|P2|COMPLETED|Follow-up Period||7
8419482|NCT00911859|20750968|P1|COMPLETED|Follow-up Period||1
8419483|NCT00911859|20750966|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
8419484|NCT00911859|20750967|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
8419485|NCT00911859|20750968|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
8419486|NCT00911859|20750966|P3|NOT COMPLETED|Maintainance Period||21
8419487|NCT00911859|20750967|P2|NOT COMPLETED|Maintainance Period||0
8419488|NCT00911859|20750968|P1|NOT COMPLETED|Maintainance Period||0
8419489|NCT00911859|20750966|P3|COMPLETED|Maintainance Period||0
8419490|NCT00911859|20750967|P2|COMPLETED|Maintainance Period||0
8419491|NCT00911859|20750968|P1|COMPLETED|Maintainance Period||0
8419492|NCT00911859|20750966|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
8419493|NCT00911859|20750967|P2|STARTED|Maintainance Period||0
8419494|NCT00911859|20750968|P1|STARTED|Maintainance Period||0
8419495|NCT00911859|20750966|P3|NOT COMPLETED|Treatment Period||25
8419496|NCT00911859|20750967|P2|NOT COMPLETED|Treatment Period||21
8419497|NCT00911859|20750968|P1|NOT COMPLETED|Treatment Period||8
8419498|NCT00911859|20750966|P3|COMPLETED|Treatment Period||27
8419499|NCT00911859|20750967|P2|COMPLETED|Treatment Period||33
8419500|NCT00911859|20750968|P1|COMPLETED|Treatment Period||4
8419501|NCT00911859|20750966|P3|Received Treatment|Treatment Period||52
8419502|NCT00911859|20750967|P2|Received Treatment|Treatment Period||53
8419503|NCT00911859|20750968|P1|Received Treatment|Treatment Period||12
8419504|NCT00911859|20750966|P3|STARTED|Treatment Period||52
8419505|NCT00911859|20750967|P2|STARTED|Treatment Period||54
8419506|NCT00911859|20750968|P1|STARTED|Treatment Period||12
8419507|NCT00911820|20750994|P2|NOT COMPLETED|Overall Study||43
8419508|NCT00911820|20750995|P1|NOT COMPLETED|Overall Study||45
8419509|NCT00911820|20750994|P2|COMPLETED|Overall Study||0
8419510|NCT00911820|20750995|P1|COMPLETED|Overall Study||0
8419511|NCT00911820|20750994|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
8419512|NCT00911820|20750995|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
8419513|NCT00911820|20750994|P2|STARTED|Overall Study||43
8419514|NCT00911820|20750995|P1|STARTED|Overall Study||45
8419515|NCT00911807|20751012|P3|NOT COMPLETED|Overall Study||23
8419516|NCT00911807|20751013|P2|NOT COMPLETED|Overall Study||18
8419517|NCT00911807|20751014|P1|NOT COMPLETED|Overall Study||17
8419518|NCT00911807|20751012|P3|COMPLETED|Overall Study||52
8419519|NCT00911807|20751013|P2|COMPLETED|Overall Study||52
8419520|NCT00911807|20751014|P1|COMPLETED|Overall Study||55
8419521|NCT00911807|20751012|P3|STARTED|Overall Study||75
8419522|NCT00911807|20751013|P2|STARTED|Overall Study||70
8419523|NCT00911807|20751014|P1|STARTED|Overall Study||72
8419524|NCT00911768|20751024|P2|NOT COMPLETED|Overall Study||4
8419525|NCT00911768|20751025|P1|NOT COMPLETED|Overall Study||6
8419526|NCT00911768|20751024|P2|COMPLETED|Overall Study||46
8419527|NCT00911768|20751025|P1|COMPLETED|Overall Study||44
8419528|NCT00911768|20751024|P2|STARTED|Overall Study||50
8419529|NCT00911768|20751025|P1|STARTED|Overall Study||50
8419530|NCT00911742|20751037|P2|NOT COMPLETED|Treatment Phase II||0
8419531|NCT00911742|20751038|P1|NOT COMPLETED|Treatment Phase II||0
8419532|NCT00911742|20751037|P2|COMPLETED|Treatment Phase II||13
8419533|NCT00911742|20751038|P1|COMPLETED|Treatment Phase II||13
8419534|NCT00911742|20751037|P2|STARTED|Treatment Phase II||13
8419535|NCT00911742|20751038|P1|STARTED|Treatment Phase II||13
8419536|NCT00911742|20751037|P2|NOT COMPLETED|Treatment Phase I||0
8419537|NCT00911742|20751038|P1|NOT COMPLETED|Treatment Phase I||0
8419538|NCT00911742|20751037|P2|COMPLETED|Treatment Phase I||13
8419539|NCT00911742|20751038|P1|COMPLETED|Treatment Phase I||13
8419540|NCT00911742|20751037|P2|STARTED|Treatment Phase I||13
8419541|NCT00911742|20751038|P1|STARTED|Treatment Phase I||13
8419542|NCT00911625|20751054|P2|NOT COMPLETED|Overall Study||0
8419543|NCT00911625|20751055|P1|NOT COMPLETED|Overall Study||7
8419544|NCT00911625|20751054|P2|COMPLETED|Overall Study||57
8419545|NCT00911625|20751055|P1|COMPLETED|Overall Study||50
8419546|NCT00911625|20751054|P2|STARTED|Overall Study||57
8419547|NCT00911625|20751055|P1|STARTED|Overall Study||57
8419548|NCT00911612|20751065|P2|NOT COMPLETED|Overall Study||0
8419549|NCT00911612|20751066|P1|NOT COMPLETED|Overall Study||0
8419550|NCT00911612|20751065|P2|COMPLETED|Overall Study||12
8419551|NCT00911612|20751066|P1|COMPLETED|Overall Study||12
8419552|NCT00911612|20751065|P2|STARTED|Overall Study||12
8419553|NCT00911612|20751066|P1|STARTED|Overall Study||12
8419554|NCT00911586|20751080|P1|NOT COMPLETED|Overall Study||0
8419555|NCT00911586|20751080|P1|COMPLETED|Overall Study||15
8419556|NCT00911586|20751080|P1|STARTED|Overall Study||15
8419557|NCT00911547|20751089|P4|NOT COMPLETED|Overall Study||16
8419558|NCT00911547|20751090|P3|NOT COMPLETED|Overall Study||22
8419559|NCT00911547|20751091|P2|NOT COMPLETED|Overall Study||42
8419560|NCT00911547|20751092|P1|NOT COMPLETED|Overall Study||11
8419561|NCT00911547|20751089|P4|COMPLETED|Overall Study||177
8419562|NCT00911547|20751090|P3|COMPLETED|Overall Study||178
8419563|NCT00911547|20751091|P2|COMPLETED|Overall Study||159
8419564|NCT00911547|20751092|P1|COMPLETED|Overall Study||37
8419565|NCT00911547|20751089|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
8419566|NCT00911547|20751090|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
8419567|NCT00911547|20751091|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
8419568|NCT00911547|20751092|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
8419569|NCT00911534|20751120|P2|NOT COMPLETED|Overall Study||16
8419570|NCT00911534|20751121|P1|NOT COMPLETED|Overall Study||15
8419571|NCT00911534|20751120|P2|COMPLETED|Overall Study||137
8419572|NCT00911534|20751121|P1|COMPLETED|Overall Study||132
8419573|NCT00911534|20751120|P2|STARTED|Overall Study|Randomized (treated)|153
8419574|NCT00911534|20751121|P1|STARTED|Overall Study|Randomized (treated)|147
8419575|NCT00911508|20751135|P2|NOT COMPLETED|Overall Study||130
8419576|NCT00911508|20751136|P1|NOT COMPLETED|Overall Study||106
8419577|NCT00911508|20751135|P2|COMPLETED|Overall Study||966
8419578|NCT00911508|20751136|P1|COMPLETED|Overall Study||1002
8419579|NCT00911508|20751135|P2|STARTED|Overall Study||1096
8419580|NCT00911508|20751136|P1|STARTED|Overall Study||1108
8419581|NCT00911495|20751168|P1|NOT COMPLETED|Overall Study||1
8419582|NCT00911495|20751168|P1|COMPLETED|Overall Study||14
8419583|NCT00911495|20751168|P1|STARTED|Overall Study||15
8419584|NCT00911443|20751181|P5|NOT COMPLETED|Overall Study||0
8419585|NCT00911443|20751182|P4|NOT COMPLETED|Overall Study||0
8419586|NCT00911443|20751183|P3|NOT COMPLETED|Overall Study||0
8419587|NCT00911443|20751184|P2|NOT COMPLETED|Overall Study||0
8419588|NCT00911443|20751185|P1|NOT COMPLETED|Overall Study||0
8419589|NCT00911443|20751181|P5|COMPLETED|Overall Study||97
8419590|NCT00911443|20751182|P4|COMPLETED|Overall Study||99
8419591|NCT00911443|20751183|P3|COMPLETED|Overall Study||98
8419592|NCT00911443|20751184|P2|COMPLETED|Overall Study||97
8419593|NCT00911443|20751185|P1|COMPLETED|Overall Study||97
8419594|NCT00911443|20751181|P5|STARTED|Overall Study||97
8419595|NCT00911443|20751182|P4|STARTED|Overall Study||99
8419596|NCT00911443|20751183|P3|STARTED|Overall Study||98
8419597|NCT00911443|20751184|P2|STARTED|Overall Study||97
8419598|NCT00911443|20751185|P1|STARTED|Overall Study||97
8419599|NCT00911326|20751202|P1|NOT COMPLETED|Overall Study||16
8419600|NCT00911326|20751202|P1|COMPLETED|Overall Study||85
8419601|NCT00911326|20751202|P1|STARTED|Overall Study||101
8419602|NCT00911300|20751211|P2|NOT COMPLETED|Overall Study||43
8419603|NCT00911300|20751212|P1|NOT COMPLETED|Overall Study||35
8419604|NCT00911300|20751211|P2|COMPLETED|Overall Study||131
8419605|NCT00911300|20751212|P1|COMPLETED|Overall Study||140
8419606|NCT00911300|20751211|P2|STARTED|Overall Study||174
8419607|NCT00911300|20751212|P1|STARTED|Overall Study||175
8419608|NCT00911274|20751238|P2|NOT COMPLETED|Period 2||0
8419609|NCT00911274|20751239|P1|NOT COMPLETED|Period 2||0
8419610|NCT00911274|20751238|P2|COMPLETED|Period 2||26
8419611|NCT00911274|20751239|P1|COMPLETED|Period 2||27
8419612|NCT00911274|20751238|P2|STARTED|Period 2||26
8419613|NCT00911274|20751239|P1|STARTED|Period 2||27
8419614|NCT00911274|20751238|P2|NOT COMPLETED|Period 1||0
8419615|NCT00911274|20751239|P1|NOT COMPLETED|Period 1||0
8419616|NCT00911274|20751238|P2|COMPLETED|Period 1||26
8419617|NCT00911274|20751239|P1|COMPLETED|Period 1||27
8419618|NCT00911274|20751238|P2|STARTED|Period 1||26
8419619|NCT00911274|20751239|P1|STARTED|Period 1||27
8419620|NCT00911170|20751249|P2|NOT COMPLETED|Long Term Follow-Up||422
8419621|NCT00911170|20751250|P1|NOT COMPLETED|Long Term Follow-Up||423
8419622|NCT00911170|20751249|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
8419623|NCT00911170|20751250|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
8419624|NCT00911170|20751249|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
8419625|NCT00911170|20751250|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
8419626|NCT00911170|20751249|P2|NOT COMPLETED|Treatment Period||37
8419627|NCT00911170|20751250|P1|NOT COMPLETED|Treatment Period||27
8419628|NCT00911170|20751249|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
8419629|NCT00911170|20751250|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
8419630|NCT00911170|20751249|P2|Received Investigational Product|Treatment Period||419
8419631|NCT00911170|20751250|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
8419632|NCT00911170|20751249|P2|Received Bevacizumab|Treatment Period||420
8419633|NCT00911170|20751250|P1|Received Bevacizumab|Treatment Period||423
8419634|NCT00911170|20751249|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
8419635|NCT00911170|20751250|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
8419636|NCT00911170|20751249|P2|STARTED|Treatment Period||423
8419637|NCT00911170|20751250|P1|STARTED|Treatment Period||424
8419638|NCT00911157|20751274|P2|NOT COMPLETED|Overall Study||2
8419639|NCT00911157|20751275|P1|NOT COMPLETED|Overall Study||7
8419640|NCT00911157|20751274|P2|COMPLETED|Overall Study||8
8419641|NCT00911157|20751275|P1|COMPLETED|Overall Study||22
8419642|NCT00911157|20751274|P2|STARTED|Overall Study||10
8419643|NCT00911157|20751275|P1|STARTED|Overall Study||29
8419644|NCT00911144|20751291|P2|NOT COMPLETED|Overall Study||5
8419645|NCT00911144|20751292|P1|NOT COMPLETED|Overall Study||16
8419646|NCT00911144|20751291|P2|COMPLETED|Overall Study||108
8419647|NCT00911144|20751292|P1|COMPLETED|Overall Study||319
8419648|NCT00911144|20751291|P2|STARTED|Overall Study||113
8419649|NCT00911144|20751292|P1|STARTED|Overall Study||335
8419650|NCT00911053|20751321|P5|NOT COMPLETED|Overall Study||0
8419651|NCT00911053|20751322|P4|NOT COMPLETED|Overall Study||0
8419652|NCT00911053|20751323|P3|NOT COMPLETED|Overall Study||0
8419653|NCT00911053|20751324|P2|NOT COMPLETED|Overall Study||0
8419654|NCT00911053|20751325|P1|NOT COMPLETED|Overall Study||0
8419655|NCT00911053|20751321|P5|COMPLETED|Overall Study||0
8419656|NCT00911053|20751322|P4|COMPLETED|Overall Study||0
8419657|NCT00911053|20751323|P3|COMPLETED|Overall Study||0
8419658|NCT00911053|20751324|P2|COMPLETED|Overall Study||0
8419659|NCT00911053|20751325|P1|COMPLETED|Overall Study||0
8419660|NCT00911053|20751321|P5|STARTED|Overall Study||0
8419661|NCT00911053|20751322|P4|STARTED|Overall Study||0
8419662|NCT00911053|20751323|P3|STARTED|Overall Study||0
8419663|NCT00911053|20751324|P2|STARTED|Overall Study||0
8419664|NCT00911053|20751325|P1|STARTED|Overall Study||0
8419665|NCT00910988|20751346|P4|NOT COMPLETED|Overall Study||0
8419666|NCT00910988|20751347|P3|NOT COMPLETED|Overall Study||3
8419667|NCT00910988|20751348|P2|NOT COMPLETED|Overall Study||4
8419668|NCT00910988|20751349|P1|NOT COMPLETED|Overall Study||2
8419669|NCT00910988|20751346|P4|COMPLETED|Overall Study||6
8419670|NCT00910988|20751347|P3|COMPLETED|Overall Study||5
8419671|NCT00910988|20751348|P2|COMPLETED|Overall Study||12
8419672|NCT00910988|20751349|P1|COMPLETED|Overall Study||14
8419673|NCT00910988|20751346|P4|STARTED|Overall Study||6
8419674|NCT00910988|20751347|P3|STARTED|Overall Study||8
8419675|NCT00910988|20751348|P2|STARTED|Overall Study||16
8419676|NCT00910988|20751349|P1|STARTED|Overall Study||16
8419677|NCT00910962|20751394|P3|NOT COMPLETED|Overall Study||76
8419678|NCT00910962|20751395|P2|NOT COMPLETED|Overall Study||78
8419679|NCT00910962|20751396|P1|NOT COMPLETED|Overall Study||43
8419680|NCT00910962|20751394|P3|COMPLETED|Overall Study||116
8419681|NCT00910962|20751395|P2|COMPLETED|Overall Study||121
8419682|NCT00910962|20751396|P1|COMPLETED|Overall Study||92
8419683|NCT00910962|20751394|P3|STARTED|Overall Study||192
8419684|NCT00910962|20751395|P2|STARTED|Overall Study||199
8419685|NCT00910962|20751396|P1|STARTED|Overall Study||135
8419686|NCT00910910|20751488|P2|NOT COMPLETED|Overall Study||224
8419687|NCT00910910|20751489|P1|NOT COMPLETED|Overall Study||225
8419688|NCT00910910|20751488|P2|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
8419689|NCT00910910|20751489|P1|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
8419690|NCT00910910|20751488|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
8419691|NCT00910910|20751489|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
8419692|NCT00910910|20751488|P2|STARTED|Overall Study||225
8419693|NCT00910910|20751489|P1|STARTED|Overall Study||225
8419694|NCT00910871|20751525|P1|NOT COMPLETED|Overall Study||54
8419695|NCT00910871|20751525|P1|COMPLETED|Overall Study||179
8419696|NCT00910871|20751525|P1|STARTED|Overall Study||233
8419697|NCT00910858|20751533|P3|NOT COMPLETED|Combined Treatment Phase||4
8419698|NCT00910858|20751534|P2|NOT COMPLETED|Combined Treatment Phase||10
8419699|NCT00910858|20751535|P1|NOT COMPLETED|Combined Treatment Phase||9
8419700|NCT00910858|20751533|P3|COMPLETED|Combined Treatment Phase||0
8419701|NCT00910858|20751534|P2|COMPLETED|Combined Treatment Phase||0
8419702|NCT00910858|20751535|P1|COMPLETED|Combined Treatment Phase||0
8419703|NCT00910858|20751533|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
8419704|NCT00910858|20751534|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
8419705|NCT00910858|20751535|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
8419706|NCT00910858|20751533|P3|NOT COMPLETED|Monotherapy Phase||7
8419707|NCT00910858|20751534|P2|NOT COMPLETED|Monotherapy Phase||15
8419708|NCT00910858|20751535|P1|NOT COMPLETED|Monotherapy Phase||17
8419709|NCT00910858|20751533|P3|COMPLETED|Monotherapy Phase||0
8419710|NCT00910858|20751534|P2|COMPLETED|Monotherapy Phase||0
8419711|NCT00910858|20751535|P1|COMPLETED|Monotherapy Phase||0
8419712|NCT00910858|20751533|P3|Pharmacokinetic Population|Monotherapy Phase||7
8419713|NCT00910858|20751534|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
8419714|NCT00910858|20751535|P1|Pharmacokinetic Population|Monotherapy Phase||17
8419715|NCT00910858|20751533|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
8419716|NCT00910858|20751534|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
8419717|NCT00910858|20751535|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
8419718|NCT00910858|20751533|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
8419719|NCT00910858|20751534|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
8419720|NCT00910858|20751535|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
8419721|NCT00910858|20751533|P3|NOT COMPLETED|Pharmacokinetic Phase||0
8419722|NCT00910858|20751534|P2|NOT COMPLETED|Pharmacokinetic Phase||0
8419723|NCT00910858|20751535|P1|NOT COMPLETED|Pharmacokinetic Phase||1
8419724|NCT00910858|20751533|P3|COMPLETED|Pharmacokinetic Phase||3
8419725|NCT00910858|20751534|P2|COMPLETED|Pharmacokinetic Phase||0
8419726|NCT00910858|20751535|P1|COMPLETED|Pharmacokinetic Phase||8
8419727|NCT00910858|20751533|P3|STARTED|Pharmacokinetic Phase||3
8419728|NCT00910858|20751534|P2|STARTED|Pharmacokinetic Phase||0
8419729|NCT00910858|20751535|P1|STARTED|Pharmacokinetic Phase||9
8419730|NCT00910845|20751560|P2|NOT COMPLETED|Treatment Cycle 2||9
8419731|NCT00910845|20751561|P1|NOT COMPLETED|Treatment Cycle 2||5
8419732|NCT00910845|20751560|P2|COMPLETED|Treatment Cycle 2||203
8419733|NCT00910845|20751561|P1|COMPLETED|Treatment Cycle 2||136
8419734|NCT00910845|20751560|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
8419735|NCT00910845|20751561|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
8419736|NCT00910845|20751560|P2|NOT COMPLETED|Treatment Cycle 1||34
8419737|NCT00910845|20751561|P1|NOT COMPLETED|Treatment Cycle 1||31
8419738|NCT00910845|20751560|P2|COMPLETED|Treatment Cycle 1||243
8419739|NCT00910845|20751561|P1|COMPLETED|Treatment Cycle 1||249
8419740|NCT00910845|20751560|P2|STARTED|Treatment Cycle 1||277
8419741|NCT00910845|20751561|P1|STARTED|Treatment Cycle 1||280
8419742|NCT00910728|20751580|P9|NOT COMPLETED|Overall Study||3
8419743|NCT00910728|20751581|P8|NOT COMPLETED|Overall Study||3
8419744|NCT00910728|20751582|P7|NOT COMPLETED|Overall Study||6
8419745|NCT00910728|20751583|P6|NOT COMPLETED|Overall Study||1
8419746|NCT00910728|20751584|P5|NOT COMPLETED|Overall Study||5
8419747|NCT00910728|20751585|P4|NOT COMPLETED|Overall Study||3
8419748|NCT00910728|20751586|P3|NOT COMPLETED|Overall Study||3
8419749|NCT00910728|20751587|P2|NOT COMPLETED|Overall Study||3
8419750|NCT00910728|20751588|P1|NOT COMPLETED|Overall Study||6
8419751|NCT00910728|20751580|P9|COMPLETED|Overall Study||0
8419752|NCT00910728|20751581|P8|COMPLETED|Overall Study||1
8419753|NCT00910728|20751582|P7|COMPLETED|Overall Study||0
8419754|NCT00910728|20751583|P6|COMPLETED|Overall Study||0
8419755|NCT00910728|20751584|P5|COMPLETED|Overall Study||1
8419756|NCT00910728|20751585|P4|COMPLETED|Overall Study||0
8419757|NCT00910728|20751586|P3|COMPLETED|Overall Study||0
8419758|NCT00910728|20751587|P2|COMPLETED|Overall Study||0
8419759|NCT00910728|20751588|P1|COMPLETED|Overall Study||0
8419760|NCT00910728|20751580|P9|STARTED|Overall Study||3
8419761|NCT00910728|20751581|P8|STARTED|Overall Study||4
8419762|NCT00910728|20751582|P7|STARTED|Overall Study||6
8419763|NCT00910728|20751583|P6|STARTED|Overall Study||1
8419764|NCT00910728|20751584|P5|STARTED|Overall Study||6
8419765|NCT00910728|20751585|P4|STARTED|Overall Study||3
8419766|NCT00910728|20751586|P3|STARTED|Overall Study||3
8419767|NCT00910728|20751587|P2|STARTED|Overall Study||3
8419768|NCT00910728|20751588|P1|STARTED|Overall Study||6
8419769|NCT00910715|20751710|P3|NOT COMPLETED|Overall Study||0
8419770|NCT00910715|20751711|P2|NOT COMPLETED|Overall Study||26
8419771|NCT00910715|20751712|P1|NOT COMPLETED|Overall Study||22
8419772|NCT00910715|20751710|P3|COMPLETED|Overall Study||81
8419773|NCT00910715|20751711|P2|COMPLETED|Overall Study||91
8419774|NCT00910715|20751712|P1|COMPLETED|Overall Study||86
8419775|NCT00910715|20751710|P3|STARTED|Overall Study||81
8419776|NCT00910715|20751711|P2|STARTED|Overall Study||117
8419777|NCT00910715|20751712|P1|STARTED|Overall Study||108
8419778|NCT00910689|20751726|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
8419779|NCT00910689|20751727|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
8419780|NCT00910689|20751728|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
8419781|NCT00910689|20751729|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
8419782|NCT00910689|20751726|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
8419783|NCT00910689|20751727|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
8419784|NCT00910689|20751728|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
8419785|NCT00910689|20751729|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
8419786|NCT00910689|20751726|P4|STARTED|Months 11- 16: Evaluation Period II||41
8419787|NCT00910689|20751727|P3|STARTED|Months 11- 16: Evaluation Period II||35
8419788|NCT00910689|20751728|P2|STARTED|Months 11- 16: Evaluation Period II||35
8419789|NCT00910689|20751729|P1|STARTED|Months 11- 16: Evaluation Period II||40
8419790|NCT00910689|20751726|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8419791|NCT00910689|20751727|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8419792|NCT00910689|20751728|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8419793|NCT00910689|20751729|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
8419794|NCT00910689|20751726|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
8419795|NCT00910689|20751727|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
8419796|NCT00910689|20751728|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
8419797|NCT00910689|20751729|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
8419798|NCT00910689|20751726|P4|STARTED|Months 5 - 10: Evaluation Period I||48
8419799|NCT00910689|20751727|P3|STARTED|Months 5 - 10: Evaluation Period I||42
8419800|NCT00910689|20751728|P2|STARTED|Months 5 - 10: Evaluation Period I||42
8419801|NCT00910689|20751729|P1|STARTED|Months 5 - 10: Evaluation Period I||44
8419802|NCT00910689|20751726|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
8419803|NCT00910689|20751727|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
8419804|NCT00910689|20751728|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
8419805|NCT00910689|20751729|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
8419806|NCT00910689|20751726|P4|COMPLETED|Month 2- 4: Treatment Period||48
8419807|NCT00910689|20751727|P3|COMPLETED|Month 2- 4: Treatment Period||42
8419808|NCT00910689|20751728|P2|COMPLETED|Month 2- 4: Treatment Period||42
8419809|NCT00910689|20751729|P1|COMPLETED|Month 2- 4: Treatment Period||44
8419810|NCT00910689|20751726|P4|STARTED|Month 2- 4: Treatment Period||59
8419811|NCT00910689|20751727|P3|STARTED|Month 2- 4: Treatment Period||50
8419812|NCT00910689|20751728|P2|STARTED|Month 2- 4: Treatment Period||52
8419813|NCT00910689|20751729|P1|STARTED|Month 2- 4: Treatment Period||53
8419814|NCT00910689|20751726|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
8419815|NCT00910689|20751727|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
8419816|NCT00910689|20751728|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
8419817|NCT00910689|20751729|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
8419818|NCT00910689|20751726|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
8419819|NCT00910689|20751727|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
8419820|NCT00910689|20751728|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
8419821|NCT00910689|20751729|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
8419822|NCT00910689|20751726|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
8419823|NCT00910689|20751727|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
8419824|NCT00910689|20751728|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
8419825|NCT00910689|20751729|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
8419826|NCT00910663|20751761|P2|NOT COMPLETED|Period 2||0
8419827|NCT00910663|20751762|P1|NOT COMPLETED|Period 2||0
8419828|NCT00910663|20751761|P2|COMPLETED|Period 2||29
8419829|NCT00910663|20751762|P1|COMPLETED|Period 2||30
8419830|NCT00910663|20751761|P2|STARTED|Period 2||29
8419831|NCT00910663|20751762|P1|STARTED|Period 2||30
8419832|NCT00910663|20751761|P2|NOT COMPLETED|Period 1||1
8419833|NCT00910663|20751762|P1|NOT COMPLETED|Period 1||0
8419834|NCT00910663|20751761|P2|COMPLETED|Period 1||29
8419835|NCT00910663|20751762|P1|COMPLETED|Period 1||30
8419836|NCT00910663|20751761|P2|STARTED|Period 1||30
8419837|NCT00910663|20751762|P1|STARTED|Period 1||30
8419862|NCT00910520|20751793|P2|NOT COMPLETED|Treatment Cycle 2||8
8419863|NCT00910520|20751794|P1|NOT COMPLETED|Treatment Cycle 2||7
8419864|NCT00910520|20751793|P2|COMPLETED|Treatment Cycle 2||215
8419865|NCT00910520|20751794|P1|COMPLETED|Treatment Cycle 2||156
8419866|NCT00910520|20751793|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
8419867|NCT00910520|20751794|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
8419868|NCT00910520|20751793|P2|NOT COMPLETED|Treatment Cycle 1||24
8419869|NCT00910520|20751794|P1|NOT COMPLETED|Treatment Cycle 1||20
8419870|NCT00910520|20751793|P2|COMPLETED|Treatment Cycle 1||247
8419871|NCT00910520|20751794|P1|COMPLETED|Treatment Cycle 1||257
8419872|NCT00910520|20751793|P2|STARTED|Treatment Cycle 1||271
8419873|NCT00910520|20751794|P1|STARTED|Treatment Cycle 1||277
8419874|NCT00910429|20751806|P2|NOT COMPLETED|Overall Study||21
8419875|NCT00910429|20751807|P1|NOT COMPLETED|Overall Study||39
8419876|NCT00910429|20751806|P2|COMPLETED|Overall Study|Completed treatment|61
8419877|NCT00910429|20751807|P1|COMPLETED|Overall Study|Completed treatment|116
8419878|NCT00910429|20751806|P2|STARTED|Overall Study||82
8419879|NCT00910429|20751807|P1|STARTED|Overall Study||155
8419880|NCT00910299|20751869|P2|NOT COMPLETED|Overall Study||74
8419881|NCT00910299|20751870|P1|NOT COMPLETED|Overall Study||76
8419882|NCT00910299|20751869|P2|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
8419883|NCT00910299|20751870|P1|COMPLETED|Overall Study||136
8419884|NCT00910299|20751869|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
8419885|NCT00910299|20751870|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
8419886|NCT00910299|20751869|P2|STARTED|Overall Study||211
8419887|NCT00910299|20751870|P1|STARTED|Overall Study||212
8419888|NCT00910273|20751882|P2|NOT COMPLETED|Overall Study||13
8419889|NCT00910273|20751883|P1|NOT COMPLETED|Overall Study||18
8419890|NCT00910273|20751882|P2|COMPLETED|Overall Study||3
8419891|NCT00910273|20751883|P1|COMPLETED|Overall Study||0
8419892|NCT00910273|20751882|P2|STARTED|Overall Study||16
8419893|NCT00910273|20751883|P1|STARTED|Overall Study||18
8419894|NCT00910247|20751933|P1|NOT COMPLETED|Overall Study||69
8419895|NCT00910247|20751933|P1|COMPLETED|Overall Study||205
8419896|NCT00910247|20751933|P1|STARTED|Overall Study||274
8419897|NCT00910208|20751956|P3|NOT COMPLETED|Overall Study||1
8419898|NCT00910208|20751957|P2|NOT COMPLETED|Overall Study||2
8419899|NCT00910208|20751958|P1|NOT COMPLETED|Overall Study||2
8419900|NCT00910208|20751956|P3|COMPLETED|Overall Study||69
8419901|NCT00910208|20751957|P2|COMPLETED|Overall Study||70
8419902|NCT00910208|20751958|P1|COMPLETED|Overall Study||67
8419903|NCT00910208|20751956|P3|STARTED|Overall Study||70
8419904|NCT00910208|20751957|P2|STARTED|Overall Study||72
8419905|NCT00910208|20751958|P1|STARTED|Overall Study||69
8419906|NCT00910091|20751983|P2|NOT COMPLETED|Treatment and Survival||4
8419907|NCT00910091|20751984|P1|NOT COMPLETED|Treatment and Survival||4
8419908|NCT00910091|20751983|P2|COMPLETED|Treatment and Survival||31
8419909|NCT00910091|20751984|P1|COMPLETED|Treatment and Survival||32
8419910|NCT00910091|20751983|P2|STARTED|Treatment and Survival||35
8419911|NCT00910091|20751984|P1|STARTED|Treatment and Survival||36
8419912|NCT00910091|20751983|P2|NOT COMPLETED|Pre-assignment||2
8419913|NCT00910091|20751984|P1|NOT COMPLETED|Pre-assignment||0
8419914|NCT00910091|20751983|P2|COMPLETED|Pre-assignment||35
8419915|NCT00910091|20751984|P1|COMPLETED|Pre-assignment||36
8419916|NCT00910091|20751983|P2|STARTED|Pre-assignment||37
8419917|NCT00910091|20751984|P1|STARTED|Pre-assignment||36
8419918|NCT00910039|20752012|P1|NOT COMPLETED|Overall Study||1
8419919|NCT00910039|20752012|P1|COMPLETED|Overall Study||13
8419920|NCT00910039|20752012|P1|STARTED|Overall Study||14
8419921|NCT00910000|20752029|P6|NOT COMPLETED|Overall Study||1
8419922|NCT00910000|20752030|P5|NOT COMPLETED|Overall Study||1
8419923|NCT00910000|20752031|P4|NOT COMPLETED|Overall Study||2
8419924|NCT00910000|20752032|P3|NOT COMPLETED|Overall Study||3
8419925|NCT00910000|20752033|P2|NOT COMPLETED|Overall Study||3
8419926|NCT00910000|20752034|P1|NOT COMPLETED|Overall Study||0
8419927|NCT00910000|20752029|P6|COMPLETED|Overall Study||0
8419928|NCT00910000|20752030|P5|COMPLETED|Overall Study||2
8419929|NCT00910000|20752031|P4|COMPLETED|Overall Study||0
8419930|NCT00910000|20752032|P3|COMPLETED|Overall Study||0
8419931|NCT00910000|20752033|P2|COMPLETED|Overall Study||0
8419932|NCT00910000|20752034|P1|COMPLETED|Overall Study||3
8419933|NCT00910000|20752029|P6|STARTED|Overall Study||1
8419934|NCT00910000|20752030|P5|STARTED|Overall Study||3
8419935|NCT00910000|20752031|P4|STARTED|Overall Study||2
8419936|NCT00910000|20752032|P3|STARTED|Overall Study||3
8419937|NCT00910000|20752033|P2|STARTED|Overall Study||3
8419938|NCT00910000|20752034|P1|STARTED|Overall Study||3
8419939|NCT00909870|20752052|P2|NOT COMPLETED|Overall Study||27
8419940|NCT00909870|20752053|P1|NOT COMPLETED|Overall Study||23
8419941|NCT00909870|20752052|P2|COMPLETED|Overall Study||236
8419942|NCT00909870|20752053|P1|COMPLETED|Overall Study||251
8419943|NCT00909870|20752052|P2|STARTED|Overall Study||263
8419944|NCT00909870|20752053|P1|STARTED|Overall Study||274
8419945|NCT00909857|20752065|P2|NOT COMPLETED|Overall Study||45
8419946|NCT00909857|20752066|P1|NOT COMPLETED|Overall Study||36
8419947|NCT00909857|20752065|P2|COMPLETED|Overall Study||209
8419948|NCT00909857|20752066|P1|COMPLETED|Overall Study||217
8419949|NCT00909857|20752065|P2|Treated|Overall Study||230
8419950|NCT00909857|20752066|P1|Treated|Overall Study||234
8419951|NCT00909857|20752065|P2|STARTED|Overall Study||254
8419952|NCT00909857|20752066|P1|STARTED|Overall Study||253
8419953|NCT00909844|20752206|P1|NOT COMPLETED|Overall Study||4
8419954|NCT00909844|20752206|P1|COMPLETED|Overall Study||31
8419955|NCT00909844|20752206|P1|STARTED|Overall Study||35
8419956|NCT00909792|20752224|P2|NOT COMPLETED|Period 2||1
8419957|NCT00909792|20752225|P1|NOT COMPLETED|Period 2||1
8419958|NCT00909792|20752224|P2|COMPLETED|Period 2||124
8419959|NCT00909792|20752225|P1|COMPLETED|Period 2||128
8419960|NCT00909792|20752224|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
8419961|NCT00909792|20752225|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
8419962|NCT00909792|20752224|P2|NOT COMPLETED|Period 1||1
8419963|NCT00909792|20752225|P1|NOT COMPLETED|Period 1||0
8419964|NCT00909792|20752224|P2|COMPLETED|Period 1||127
8419965|NCT00909792|20752225|P1|COMPLETED|Period 1||130
8419966|NCT00909792|20752224|P2|STARTED|Period 1||128
8419967|NCT00909792|20752225|P1|STARTED|Period 1||130
8419968|NCT00909779|20752233|P2|NOT COMPLETED|Overall Study||165
8419969|NCT00909779|20752234|P1|NOT COMPLETED|Overall Study||210
8419970|NCT00909779|20752233|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
8419971|NCT00909779|20752234|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
8419972|NCT00909779|20752233|P2|STARTED|Overall Study||420
8419973|NCT00909779|20752234|P1|STARTED|Overall Study||421
8419974|NCT00909753|20752258|P2|NOT COMPLETED|Period: Second Intervention||0
8419975|NCT00909753|20752259|P1|NOT COMPLETED|Period: Second Intervention||1
8419976|NCT00909753|20752258|P2|COMPLETED|Period: Second Intervention||43
8419977|NCT00909753|20752259|P1|COMPLETED|Period: Second Intervention||43
8419978|NCT00909753|20752258|P2|STARTED|Period: Second Intervention||43
8419979|NCT00909753|20752259|P1|STARTED|Period: Second Intervention||44
8419980|NCT00909753|20752258|P2|NOT COMPLETED|Period: Washout of 28 Days||3
8419981|NCT00909753|20752259|P1|NOT COMPLETED|Period: Washout of 28 Days||2
8419982|NCT00909753|20752258|P2|COMPLETED|Period: Washout of 28 Days||43
8419983|NCT00909753|20752259|P1|COMPLETED|Period: Washout of 28 Days||44
8419984|NCT00909753|20752258|P2|STARTED|Period: Washout of 28 Days||46
8419985|NCT00909753|20752259|P1|STARTED|Period: Washout of 28 Days||46
8419986|NCT00909753|20752258|P2|NOT COMPLETED|Period: First Intervention||0
8419987|NCT00909753|20752259|P1|NOT COMPLETED|Period: First Intervention||0
8419988|NCT00909753|20752258|P2|COMPLETED|Period: First Intervention||46
8419989|NCT00909753|20752259|P1|COMPLETED|Period: First Intervention||46
8419990|NCT00909753|20752258|P2|STARTED|Period: First Intervention||46
8419991|NCT00909753|20752259|P1|STARTED|Period: First Intervention||46
8419992|NCT00909727|20752279|P2|NOT COMPLETED|Overall Study||0
8419993|NCT00909727|20752280|P1|NOT COMPLETED|Overall Study||4
8419994|NCT00909727|20752279|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
8419995|NCT00909727|20752280|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
8419996|NCT00909727|20752279|P2|Completed Treatment Period, Week 24|Overall Study||26
8419997|NCT00909727|20752280|P1|Completed Treatment Period, Week 24|Overall Study||23
8419998|NCT00909727|20752279|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
8419999|NCT00909727|20752280|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
8420000|NCT00909649|20752296|P2|NOT COMPLETED|Overall Study||0
8420001|NCT00909649|20752297|P1|NOT COMPLETED|Overall Study||0
8420002|NCT00909649|20752296|P2|COMPLETED|Overall Study||25
8420003|NCT00909649|20752297|P1|COMPLETED|Overall Study||25
8420004|NCT00909649|20752296|P2|STARTED|Overall Study||25
8420005|NCT00909649|20752297|P1|STARTED|Overall Study||25
8420006|NCT00909610|20752303|P2|NOT COMPLETED|Period: Second Intervention||0
8420007|NCT00909610|20752304|P1|NOT COMPLETED|Period: Second Intervention||1
8420008|NCT00909610|20752303|P2|COMPLETED|Period: Second Intervention||33
8420009|NCT00909610|20752304|P1|COMPLETED|Period: Second Intervention||36
8420010|NCT00909610|20752303|P2|STARTED|Period: Second Intervention||33
8420011|NCT00909610|20752304|P1|STARTED|Period: Second Intervention||37
8420012|NCT00909610|20752303|P2|NOT COMPLETED|Period: Washout of 28 Days||6
8420013|NCT00909610|20752304|P1|NOT COMPLETED|Period: Washout of 28 Days||3
8420014|NCT00909610|20752303|P2|COMPLETED|Period: Washout of 28 Days||33
8420015|NCT00909610|20752304|P1|COMPLETED|Period: Washout of 28 Days||37
8420016|NCT00909610|20752303|P2|STARTED|Period: Washout of 28 Days||39
8420017|NCT00909610|20752304|P1|STARTED|Period: Washout of 28 Days||40
8420018|NCT00909610|20752303|P2|NOT COMPLETED|Period: First Intervention||1
8420019|NCT00909610|20752304|P1|NOT COMPLETED|Period: First Intervention||0
8420020|NCT00909610|20752303|P2|COMPLETED|Period: First Intervention||39
8420021|NCT00909610|20752304|P1|COMPLETED|Period: First Intervention||40
8420022|NCT00909610|20752303|P2|STARTED|Period: First Intervention||40
8420023|NCT00909610|20752304|P1|STARTED|Period: First Intervention||40
8420024|NCT00909545|20752326|P4|NOT COMPLETED|Overall Study||5
8420025|NCT00909545|20752327|P3|NOT COMPLETED|Overall Study||1
8420026|NCT00909545|20752328|P2|NOT COMPLETED|Overall Study||1
8420027|NCT00909545|20752329|P1|NOT COMPLETED|Overall Study||1
8420028|NCT00909545|20752326|P4|COMPLETED|Overall Study||19
8420029|NCT00909545|20752327|P3|COMPLETED|Overall Study||25
8420030|NCT00909545|20752328|P2|COMPLETED|Overall Study||22
8420031|NCT00909545|20752329|P1|COMPLETED|Overall Study||25
8420032|NCT00909545|20752326|P4|STARTED|Overall Study||24
8420033|NCT00909545|20752327|P3|STARTED|Overall Study||26
8420034|NCT00909545|20752328|P2|STARTED|Overall Study||23
8420035|NCT00909545|20752329|P1|STARTED|Overall Study||26
8420036|NCT00909532|20752465|P2|NOT COMPLETED|Overall Study||6
8420037|NCT00909532|20752466|P1|NOT COMPLETED|Overall Study||10
8420038|NCT00909532|20752465|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
8420039|NCT00909532|20752466|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
8420040|NCT00909532|20752465|P2|Completed Treatment Period, Week 24|Overall Study||80
8420041|NCT00909532|20752466|P1|Completed Treatment Period, Week 24|Overall Study||71
8420042|NCT00909532|20752465|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
8420043|NCT00909532|20752466|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
8420044|NCT00909480|20752484|P2|NOT COMPLETED|Overall Study||41
8420045|NCT00909480|20752485|P1|NOT COMPLETED|Overall Study||38
8420046|NCT00909480|20752484|P2|COMPLETED|Overall Study||188
8420047|NCT00909480|20752485|P1|COMPLETED|Overall Study||190
8420048|NCT00909480|20752484|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
8420049|NCT00909480|20752485|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
8420050|NCT00909480|20752484|P2|STARTED|Overall Study||229
8420051|NCT00909480|20752485|P1|STARTED|Overall Study||228
8420052|NCT00909428|20752520|P3|NOT COMPLETED|Overall Study||9
8420053|NCT00909428|20752521|P2|NOT COMPLETED|Overall Study||10
8420054|NCT00909428|20752522|P1|NOT COMPLETED|Overall Study||13
8420055|NCT00909428|20752520|P3|COMPLETED|Overall Study||0
8420056|NCT00909428|20752521|P2|COMPLETED|Overall Study||5
8420057|NCT00909428|20752522|P1|COMPLETED|Overall Study||5
8420058|NCT00909428|20752520|P3|STARTED|Overall Study||9
8420059|NCT00909428|20752521|P2|STARTED|Overall Study||15
8420060|NCT00909428|20752522|P1|STARTED|Overall Study||18
8420061|NCT00909389|20752529|P1|NOT COMPLETED|Overall Study||133
8420062|NCT00909389|20752529|P1|COMPLETED|Overall Study||4615
8420063|NCT00909389|20752529|P1|STARTED|Overall Study||4748
8420064|NCT00909363|20752536|P3|NOT COMPLETED|Overall Study||0
8420065|NCT00909363|20752537|P2|NOT COMPLETED|Overall Study||0
8420066|NCT00909363|20752538|P1|NOT COMPLETED|Overall Study||2
8420067|NCT00909363|20752536|P3|COMPLETED|Overall Study||5
8420068|NCT00909363|20752537|P2|COMPLETED|Overall Study||8
8420069|NCT00909363|20752538|P1|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
8420070|NCT00909363|20752536|P3|STARTED|Overall Study||5
8420071|NCT00909363|20752537|P2|STARTED|Overall Study||8
8420072|NCT00909363|20752538|P1|STARTED|Overall Study||11
8420073|NCT00909324|20752557|P2|NOT COMPLETED|Overall Study||0
8420074|NCT00909324|20752558|P1|NOT COMPLETED|Overall Study||0
8420075|NCT00909324|20752557|P2|COMPLETED|Overall Study||90
8420076|NCT00909324|20752558|P1|COMPLETED|Overall Study||72
8420077|NCT00909324|20752557|P2|STARTED|Overall Study||90
8420078|NCT00909324|20752558|P1|STARTED|Overall Study||72
8420079|NCT00909220|20752570|P2|NOT COMPLETED|Overall Study||0
8420080|NCT00909220|20752571|P1|NOT COMPLETED|Overall Study||0
8420081|NCT00909220|20752570|P2|COMPLETED|Overall Study||36
8420082|NCT00909220|20752571|P1|COMPLETED|Overall Study||41
8420083|NCT00909220|20752570|P2|Submission for Publication|Overall Study||36
8420084|NCT00909220|20752571|P1|Submission for Publication|Overall Study||41
8420085|NCT00909220|20752570|P2|Data Analyses|Overall Study||36
8420086|NCT00909220|20752571|P1|Data Analyses|Overall Study||41
8420087|NCT00909220|20752570|P2|Data Entry|Overall Study||36
8420088|NCT00909220|20752571|P1|Data Entry|Overall Study||41
8420089|NCT00909220|20752570|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
8420090|NCT00909220|20752571|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
8420091|NCT00909181|20752585|P3|NOT COMPLETED|Overall Study||33
8420092|NCT00909181|20752586|P2|NOT COMPLETED|Overall Study||18
8420093|NCT00909181|20752587|P1|NOT COMPLETED|Overall Study||39
8420094|NCT00909181|20752585|P3|COMPLETED|Overall Study||169
8420095|NCT00909181|20752586|P2|COMPLETED|Overall Study||196
8420096|NCT00909181|20752587|P1|COMPLETED|Overall Study||171
8420097|NCT00909181|20752585|P3|STARTED|Overall Study||202
8420098|NCT00909181|20752586|P2|STARTED|Overall Study||214
8420099|NCT00909181|20752587|P1|STARTED|Overall Study||210
8420100|NCT00909155|20752598|P3|NOT COMPLETED|Overall Study||7
8420101|NCT00909155|20752599|P2|NOT COMPLETED|Overall Study||5
8420102|NCT00909155|20752600|P1|NOT COMPLETED|Overall Study||3
8420103|NCT00909155|20752598|P3|COMPLETED|Overall Study||14
8420104|NCT00909155|20752599|P2|COMPLETED|Overall Study||9
8420105|NCT00909155|20752600|P1|COMPLETED|Overall Study||12
8420106|NCT00909155|20752598|P3|STARTED|Overall Study||21
8420107|NCT00909155|20752599|P2|STARTED|Overall Study||14
8420108|NCT00909155|20752600|P1|STARTED|Overall Study||15
8420109|NCT00909090|20752613|P2|NOT COMPLETED|Overall Study||17
8420110|NCT00909090|20752614|P1|NOT COMPLETED|Overall Study||17
8420111|NCT00909090|20752613|P2|COMPLETED|Overall Study||39
8420112|NCT00909090|20752614|P1|COMPLETED|Overall Study||36
8420113|NCT00909090|20752613|P2|STARTED|Overall Study||56
8420114|NCT00909090|20752614|P1|STARTED|Overall Study||53
8420115|NCT00909064|20752626|P1|NOT COMPLETED|Overall Study||0
8420116|NCT00909064|20752626|P1|COMPLETED|Overall Study||114
8420117|NCT00909064|20752626|P1|STARTED|Overall Study||114
8420118|NCT00909038|20752632|P1|NOT COMPLETED|Overall Study||417
8420119|NCT00909038|20752632|P1|COMPLETED|Overall Study||1994
8420120|NCT00909038|20752632|P1|STARTED|Overall Study||2411
8420121|NCT00908960|20752644|P3|NOT COMPLETED|Overall Study||2
8420122|NCT00908960|20752645|P2|NOT COMPLETED|Overall Study||1
8420123|NCT00908960|20752646|P1|NOT COMPLETED|Overall Study||1
8420124|NCT00908960|20752644|P3|COMPLETED|Overall Study||32
8420125|NCT00908960|20752645|P2|COMPLETED|Overall Study||11
8420126|NCT00908960|20752646|P1|COMPLETED|Overall Study||23
8420127|NCT00908960|20752644|P3|Evaluable|Overall Study||32
8420128|NCT00908960|20752645|P2|Evaluable|Overall Study||11
8420129|NCT00908960|20752646|P1|Evaluable|Overall Study||23
8420130|NCT00908960|20752644|P3|STARTED|Overall Study||34
8420131|NCT00908960|20752645|P2|STARTED|Overall Study||12
8420132|NCT00908960|20752646|P1|STARTED|Overall Study||24
8420133|NCT00908947|20752660|P1|NOT COMPLETED|Overall Study||90
8420134|NCT00908947|20752660|P1|COMPLETED|Overall Study||83
8420135|NCT00908947|20752660|P1|STARTED|Overall Study||173
8420136|NCT00908908|20752682|P1|NOT COMPLETED|Overall Study||0
8420137|NCT00908908|20752682|P1|COMPLETED|Overall Study||6
8420138|NCT00908908|20752682|P1|Physician Decision|Overall Study||0
8420139|NCT00908908|20752682|P1|Administrative/Other|Overall Study||0
8420140|NCT00908908|20752682|P1|Withdrawl by Subject|Overall Study||0
8420141|NCT00908908|20752682|P1|Adverse Event|Overall Study||0
8420142|NCT00908908|20752682|P1|STARTED|Overall Study||6
8420143|NCT00908895|20752690|P2|NOT COMPLETED|Overall Study||6
8420144|NCT00908895|20752691|P1|NOT COMPLETED|Overall Study||4
8420145|NCT00908895|20752690|P2|COMPLETED|Overall Study||57
8420146|NCT00908895|20752691|P1|COMPLETED|Overall Study||53
8420147|NCT00908895|20752690|P2|STARTED|Overall Study||63
8420148|NCT00908895|20752691|P1|STARTED|Overall Study||57
8420149|NCT00908882|20752701|P2|NOT COMPLETED|Overall Study||30
8420150|NCT00908882|20752702|P1|NOT COMPLETED|Overall Study||28
8420151|NCT00908882|20752701|P2|COMPLETED|Overall Study||59
8420152|NCT00908882|20752702|P1|COMPLETED|Overall Study||61
8420153|NCT00908882|20752701|P2|STARTED|Overall Study||89
8420154|NCT00908882|20752702|P1|STARTED|Overall Study||89
8420155|NCT00908830|20752728|P2|NOT COMPLETED|Overall Study||0
8420156|NCT00908830|20752729|P1|NOT COMPLETED|Overall Study||0
8420157|NCT00908830|20752728|P2|COMPLETED|Overall Study||5
8420158|NCT00908830|20752729|P1|COMPLETED|Overall Study||5
8420159|NCT00908830|20752728|P2|STARTED|Overall Study||5
8420160|NCT00908830|20752729|P1|STARTED|Overall Study||5
8420161|NCT00908791|20752737|P1|NOT COMPLETED|Overall Study||0
8420162|NCT00908791|20752737|P1|COMPLETED|Overall Study||24
8420163|NCT00908791|20752737|P1|STARTED|Overall Study||24
8420164|NCT00908687|20752760|P6|NOT COMPLETED|Overall Study||6
8420165|NCT00908687|20752761|P5|NOT COMPLETED|Overall Study||4
8420166|NCT00908687|20752762|P4|NOT COMPLETED|Overall Study||3
8420167|NCT00908687|20752763|P3|NOT COMPLETED|Overall Study||3
8420168|NCT00908687|20752764|P2|NOT COMPLETED|Overall Study||1
8420169|NCT00908687|20752765|P1|NOT COMPLETED|Overall Study||1
8420170|NCT00908687|20752760|P6|COMPLETED|Overall Study||94
8420171|NCT00908687|20752761|P5|COMPLETED|Overall Study||94
8420172|NCT00908687|20752762|P4|COMPLETED|Overall Study||47
8420173|NCT00908687|20752763|P3|COMPLETED|Overall Study||99
8420174|NCT00908687|20752764|P2|COMPLETED|Overall Study||99
8420175|NCT00908687|20752765|P1|COMPLETED|Overall Study||49
8420176|NCT00908687|20752760|P6|STARTED|Overall Study||100
8420177|NCT00908687|20752761|P5|STARTED|Overall Study||98
8420178|NCT00908687|20752762|P4|STARTED|Overall Study||50
8420179|NCT00908687|20752763|P3|STARTED|Overall Study||102
8420180|NCT00908687|20752764|P2|STARTED|Overall Study||100
8420181|NCT00908687|20752765|P1|STARTED|Overall Study||50
8420182|NCT00908648|20752781|P2|NOT COMPLETED|Overall Study||0
8420183|NCT00908648|20752782|P1|NOT COMPLETED|Overall Study||0
8420184|NCT00908648|20752781|P2|COMPLETED|Overall Study||103
8420185|NCT00908648|20752782|P1|COMPLETED|Overall Study||108
8420186|NCT00908648|20752781|P2|STARTED|Overall Study||103
8420187|NCT00908648|20752782|P1|STARTED|Overall Study||108
8420188|NCT00908596|20752792|P4|NOT COMPLETED|Overall Study||37
8420189|NCT00908596|20752793|P3|NOT COMPLETED|Overall Study||74
8420190|NCT00908596|20752794|P2|NOT COMPLETED|Overall Study||13
8420191|NCT00908596|20752795|P1|NOT COMPLETED|Overall Study||47
8420192|NCT00908596|20752792|P4|COMPLETED|Overall Study||48
8420193|NCT00908596|20752793|P3|COMPLETED|Overall Study||119
8420194|NCT00908596|20752794|P2|COMPLETED|Overall Study||19
8420195|NCT00908596|20752795|P1|COMPLETED|Overall Study||0
8420196|NCT00908596|20752792|P4|STARTED|Overall Study||85
8420197|NCT00908596|20752793|P3|STARTED|Overall Study||193
8420198|NCT00908596|20752794|P2|STARTED|Overall Study||32
8420199|NCT00908596|20752795|P1|STARTED|Overall Study||47
8420200|NCT00908583|20752825|P1|NOT COMPLETED|Phase 5||3
8420201|NCT00908583|20752825|P1|COMPLETED|Phase 5||2
8420202|NCT00908583|20752825|P1|STARTED|Phase 5||5
8420203|NCT00908583|20752825|P1|NOT COMPLETED|Phase 4||2
8420204|NCT00908583|20752825|P1|COMPLETED|Phase 4||3
8420205|NCT00908583|20752825|P1|STARTED|Phase 4||5
8420206|NCT00908583|20752825|P1|NOT COMPLETED|Phase 3||2
8420207|NCT00908583|20752825|P1|COMPLETED|Phase 3||8
8420208|NCT00908583|20752825|P1|STARTED|Phase 3||10
8420209|NCT00908583|20752825|P1|NOT COMPLETED|Phase 2||2
8420210|NCT00908583|20752825|P1|COMPLETED|Phase 2||10
8420211|NCT00908583|20752825|P1|STARTED|Phase 2||12
8420212|NCT00908583|20752825|P1|NOT COMPLETED|Phase 1||5
8420213|NCT00908583|20752825|P1|COMPLETED|Phase 1||15
8420214|NCT00908583|20752825|P1|STARTED|Phase 1||20
8420215|NCT00908544|20752845|P2|NOT COMPLETED|Overall Study||6
8420216|NCT00908544|20752846|P1|NOT COMPLETED|Overall Study||5
8420217|NCT00908544|20752845|P2|COMPLETED|Overall Study||16
8420218|NCT00908544|20752846|P1|COMPLETED|Overall Study||15
8420219|NCT00908544|20752845|P2|STARTED|Overall Study||22
8420220|NCT00908544|20752846|P1|STARTED|Overall Study||20
8420221|NCT00908466|20752888|P2|NOT COMPLETED|Overall Study||1
8420222|NCT00908466|20752889|P1|NOT COMPLETED|Overall Study||1
8420223|NCT00908466|20752888|P2|COMPLETED|Overall Study||14
8420224|NCT00908466|20752889|P1|COMPLETED|Overall Study||14
8420225|NCT00908466|20752888|P2|STARTED|Overall Study||15
8420226|NCT00908466|20752889|P1|STARTED|Overall Study||15
8420227|NCT00908388|20752895|P1|NOT COMPLETED|Overall Study||10
8420228|NCT00908388|20752895|P1|COMPLETED|Overall Study||40
8420229|NCT00908388|20752895|P1|STARTED|Overall Study||50
8420230|NCT00908375|20752905|P2|NOT COMPLETED|Overall Study||10
8420231|NCT00908375|20752906|P1|NOT COMPLETED|Overall Study||10
8420232|NCT00908375|20752905|P2|COMPLETED|Overall Study||9
8420233|NCT00908375|20752906|P1|COMPLETED|Overall Study||10
8420234|NCT00908375|20752905|P2|STARTED|Overall Study||19
8420235|NCT00908375|20752906|P1|STARTED|Overall Study||20
8420236|NCT00908349|20752916|P1|NOT COMPLETED|Overall Study||35
8420237|NCT00908349|20752916|P1|COMPLETED|Overall Study||179
8420238|NCT00908349|20752916|P1|STARTED|Overall Study||214
8420239|NCT00908310|20752920|P1|NOT COMPLETED|Overall Study||60
8420240|NCT00908310|20752920|P1|COMPLETED|Overall Study||153
8420241|NCT00908310|20752920|P1|STARTED|Overall Study||213
8420242|NCT00908232|20752924|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
8420243|NCT00908232|20752925|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
8420244|NCT00908232|20752926|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
8420245|NCT00908232|20752927|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
8420246|NCT00908232|20752924|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
8420247|NCT00908232|20752925|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
8420248|NCT00908232|20752926|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
8420249|NCT00908232|20752927|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
8420250|NCT00908232|20752924|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
8420251|NCT00908232|20752925|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
8420252|NCT00908232|20752926|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
8420253|NCT00908232|20752927|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
8420254|NCT00908232|20752924|P4|NOT COMPLETED|Cycle 1 to 4||0
8420255|NCT00908232|20752925|P3|NOT COMPLETED|Cycle 1 to 4||0
8420256|NCT00908232|20752926|P2|NOT COMPLETED|Cycle 1 to 4||0
8420257|NCT00908232|20752927|P1|NOT COMPLETED|Cycle 1 to 4||28
8420258|NCT00908232|20752924|P4|COMPLETED|Cycle 1 to 4||0
8420259|NCT00908232|20752925|P3|COMPLETED|Cycle 1 to 4||0
8420260|NCT00908232|20752926|P2|COMPLETED|Cycle 1 to 4||0
8420261|NCT00908232|20752927|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
8420262|NCT00908232|20752924|P4|STARTED|Cycle 1 to 4||0
8420263|NCT00908232|20752925|P3|STARTED|Cycle 1 to 4||0
8420264|NCT00908232|20752926|P2|STARTED|Cycle 1 to 4||0
8420265|NCT00908232|20752927|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
8420266|NCT00908141|20752945|P2|NOT COMPLETED|Overall Study||1
8420267|NCT00908141|20752946|P1|NOT COMPLETED|Overall Study||0
8420268|NCT00908141|20752945|P2|COMPLETED|Overall Study||8
8420269|NCT00908141|20752946|P1|COMPLETED|Overall Study||8
8420270|NCT00908141|20752945|P2|STARTED|Overall Study||9
8420271|NCT00908141|20752946|P1|STARTED|Overall Study||8
8420272|NCT00908128|20752954|P2|NOT COMPLETED|Period 4||0
8420273|NCT00908128|20752955|P1|NOT COMPLETED|Period 4||0
8420274|NCT00908128|20752954|P2|COMPLETED|Period 4||19
8420275|NCT00908128|20752955|P1|COMPLETED|Period 4||20
8420276|NCT00908128|20752954|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
8420277|NCT00908128|20752955|P1|STARTED|Period 4||20
8420278|NCT00908128|20752954|P2|NOT COMPLETED|Period 3||0
8420279|NCT00908128|20752955|P1|NOT COMPLETED|Period 3||0
8420280|NCT00908128|20752954|P2|COMPLETED|Period 3||20
8420281|NCT00908128|20752955|P1|COMPLETED|Period 3||20
8420282|NCT00908128|20752954|P2|STARTED|Period 3||20
8420283|NCT00908128|20752955|P1|STARTED|Period 3||20
8420284|NCT00908128|20752954|P2|NOT COMPLETED|Period 2||0
8420285|NCT00908128|20752955|P1|NOT COMPLETED|Period 2||0
8420286|NCT00908128|20752954|P2|COMPLETED|Period 2||20
8420287|NCT00908128|20752955|P1|COMPLETED|Period 2||20
8420288|NCT00908128|20752954|P2|STARTED|Period 2||20
8420289|NCT00908128|20752955|P1|STARTED|Period 2||20
8420290|NCT00908128|20752954|P2|NOT COMPLETED|Period 1||0
8420291|NCT00908128|20752955|P1|NOT COMPLETED|Period 1||0
8420292|NCT00908128|20752954|P2|COMPLETED|Period 1||20
8420293|NCT00908128|20752955|P1|COMPLETED|Period 1||20
8420294|NCT00908128|20752954|P2|STARTED|Period 1||20
8420295|NCT00908128|20752955|P1|STARTED|Period 1||20
8420296|NCT00908115|20752963|P1|NOT COMPLETED|Overall Study||14
8420297|NCT00908115|20752963|P1|COMPLETED|Overall Study||1244
8420298|NCT00908115|20752963|P1|STARTED|Overall Study||1258
8420299|NCT00908076|20752971|P2|NOT COMPLETED|Overall Study||1
8420300|NCT00908076|20752972|P1|NOT COMPLETED|Overall Study||1
8420301|NCT00908076|20752971|P2|COMPLETED|Overall Study||26
8420302|NCT00908076|20752972|P1|COMPLETED|Overall Study||26
8420303|NCT00908076|20752971|P2|STARTED|Overall Study||27
8420304|NCT00908076|20752972|P1|STARTED|Overall Study||27
8420305|NCT00908037|20752985|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
8420306|NCT00908037|20752986|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
8420307|NCT00908037|20752987|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
8420308|NCT00908037|20752988|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420309|NCT00908037|20752989|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420310|NCT00908037|20752990|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420311|NCT00908037|20752991|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420312|NCT00908037|20752992|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420313|NCT00908037|20752993|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420314|NCT00908037|20752994|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420315|NCT00908037|20752995|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420316|NCT00908037|20752996|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420317|NCT00908037|20752985|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
8420318|NCT00908037|20752986|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
8420319|NCT00908037|20752987|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
8420320|NCT00908037|20752988|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420321|NCT00908037|20752989|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420322|NCT00908037|20752990|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420323|NCT00908037|20752991|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420324|NCT00908037|20752992|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420325|NCT00908037|20752993|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420326|NCT00908037|20752994|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420327|NCT00908037|20752995|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420328|NCT00908037|20752996|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420329|NCT00908037|20752985|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
8420330|NCT00908037|20752986|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
8420331|NCT00908037|20752987|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
8420332|NCT00908037|20752988|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420333|NCT00908037|20752989|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420334|NCT00908037|20752990|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420335|NCT00908037|20752991|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420336|NCT00908037|20752992|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420337|NCT00908037|20752993|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420338|NCT00908037|20752994|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420339|NCT00908037|20752995|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420340|NCT00908037|20752996|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420341|NCT00908037|20752985|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420342|NCT00908037|20752986|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420343|NCT00908037|20752987|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420344|NCT00908037|20752988|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
8420345|NCT00908037|20752989|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420346|NCT00908037|20752990|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
8420347|NCT00908037|20752991|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420348|NCT00908037|20752992|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
8420349|NCT00908037|20752993|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
8420350|NCT00908037|20752994|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420351|NCT00908037|20752995|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420352|NCT00908037|20752996|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420353|NCT00908037|20752985|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420354|NCT00908037|20752986|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420355|NCT00908037|20752987|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420356|NCT00908037|20752988|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
8420357|NCT00908037|20752989|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
8420358|NCT00908037|20752990|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
8420359|NCT00908037|20752991|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
8420360|NCT00908037|20752992|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
8420361|NCT00908037|20752993|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
8420362|NCT00908037|20752994|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420363|NCT00908037|20752995|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420364|NCT00908037|20752996|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420365|NCT00908037|20752985|P12|STARTED|Part 2 (7 Week Randomized Period)||0
8420366|NCT00908037|20752986|P11|STARTED|Part 2 (7 Week Randomized Period)||0
8420367|NCT00908037|20752987|P10|STARTED|Part 2 (7 Week Randomized Period)||0
8420368|NCT00908037|20752988|P9|STARTED|Part 2 (7 Week Randomized Period)||10
8420369|NCT00908037|20752989|P8|STARTED|Part 2 (7 Week Randomized Period)||5
8420370|NCT00908037|20752990|P7|STARTED|Part 2 (7 Week Randomized Period)||19
8420371|NCT00908037|20752991|P6|STARTED|Part 2 (7 Week Randomized Period)||9
8420372|NCT00908037|20752992|P5|STARTED|Part 2 (7 Week Randomized Period)||16
8420373|NCT00908037|20752993|P4|STARTED|Part 2 (7 Week Randomized Period)||8
8420374|NCT00908037|20752994|P3|STARTED|Part 2 (7 Week Randomized Period)||0
8420375|NCT00908037|20752995|P2|STARTED|Part 2 (7 Week Randomized Period)||0
8420376|NCT00908037|20752996|P1|STARTED|Part 2 (7 Week Randomized Period)||0
8420377|NCT00908037|20752985|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420378|NCT00908037|20752986|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420379|NCT00908037|20752987|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420380|NCT00908037|20752988|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420381|NCT00908037|20752989|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420382|NCT00908037|20752990|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420383|NCT00908037|20752991|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420384|NCT00908037|20752992|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420385|NCT00908037|20752993|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420386|NCT00908037|20752994|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420387|NCT00908037|20752995|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420388|NCT00908037|20752996|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420389|NCT00908037|20752985|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420390|NCT00908037|20752986|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420391|NCT00908037|20752987|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420392|NCT00908037|20752988|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420393|NCT00908037|20752989|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420394|NCT00908037|20752990|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420395|NCT00908037|20752991|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420396|NCT00908037|20752992|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420397|NCT00908037|20752993|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420398|NCT00908037|20752994|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8420399|NCT00908037|20752995|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8420400|NCT00908037|20752996|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8420401|NCT00908037|20752985|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420402|NCT00908037|20752986|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420403|NCT00908037|20752987|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420404|NCT00908037|20752988|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420405|NCT00908037|20752989|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420406|NCT00908037|20752990|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420407|NCT00908037|20752991|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420408|NCT00908037|20752992|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420409|NCT00908037|20752993|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420410|NCT00908037|20752994|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
8420411|NCT00908037|20752995|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
8420412|NCT00908037|20752996|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
8420413|NCT00908011|20753145|P2|NOT COMPLETED|Overall Study||2
8420414|NCT00908011|20753146|P1|NOT COMPLETED|Overall Study||2
8420415|NCT00908011|20753145|P2|COMPLETED|Overall Study||18
8420416|NCT00908011|20753146|P1|COMPLETED|Overall Study||21
8420417|NCT00908011|20753145|P2|STARTED|Overall Study||20
8420418|NCT00908011|20753146|P1|STARTED|Overall Study||23
8420419|NCT00907907|20753154|P2|NOT COMPLETED|Period 4||0
8420420|NCT00907907|20753155|P1|NOT COMPLETED|Period 4||0
8420421|NCT00907907|20753154|P2|COMPLETED|Period 4||18
8420422|NCT00907907|20753155|P1|COMPLETED|Period 4||19
8420423|NCT00907907|20753154|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
8420424|NCT00907907|20753155|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
8420425|NCT00907907|20753154|P2|NOT COMPLETED|Period 3||0
8420426|NCT00907907|20753155|P1|NOT COMPLETED|Period 3||0
8420427|NCT00907907|20753154|P2|COMPLETED|Period 3||20
8420428|NCT00907907|20753155|P1|COMPLETED|Period 3||20
8420429|NCT00907907|20753154|P2|STARTED|Period 3||20
8420430|NCT00907907|20753155|P1|STARTED|Period 3||20
8420431|NCT00907907|20753154|P2|NOT COMPLETED|Period 2||0
8420432|NCT00907907|20753155|P1|NOT COMPLETED|Period 2||0
8420433|NCT00907907|20753154|P2|COMPLETED|Period 2||20
8420434|NCT00907907|20753155|P1|COMPLETED|Period 2||20
8420435|NCT00907907|20753154|P2|STARTED|Period 2||20
8420436|NCT00907907|20753155|P1|STARTED|Period 2||20
8420437|NCT00907907|20753154|P2|NOT COMPLETED|Period 1||0
8420438|NCT00907907|20753155|P1|NOT COMPLETED|Period 1||0
8420439|NCT00907907|20753154|P2|COMPLETED|Period 1||20
8420440|NCT00907907|20753155|P1|COMPLETED|Period 1||20
8420441|NCT00907907|20753154|P2|STARTED|Period 1||20
8420442|NCT00907907|20753155|P1|STARTED|Period 1||20
8420443|NCT00907881|20753163|P1|NOT COMPLETED|Overall Study||85
8420444|NCT00907881|20753163|P1|COMPLETED|Overall Study||984
8420445|NCT00907881|20753163|P1|STARTED|Overall Study||1069
8420446|NCT00907803|20753173|P3|NOT COMPLETED|Overall Study||0
8420447|NCT00907803|20753174|P2|NOT COMPLETED|Overall Study||3
8420448|NCT00907803|20753175|P1|NOT COMPLETED|Overall Study||3
8420449|NCT00907803|20753173|P3|COMPLETED|Overall Study||16
8420450|NCT00907803|20753174|P2|COMPLETED|Overall Study||43
8420451|NCT00907803|20753175|P1|COMPLETED|Overall Study||42
8420452|NCT00907803|20753173|P3|STARTED|Overall Study||16
8420453|NCT00907803|20753174|P2|STARTED|Overall Study||46
8420454|NCT00907803|20753175|P1|STARTED|Overall Study||45
8420455|NCT00907777|20753206|P2|NOT COMPLETED|Overall Study||1
8420456|NCT00907777|20753207|P1|NOT COMPLETED|Overall Study||0
8420457|NCT00907777|20753206|P2|COMPLETED|Overall Study||26
8420458|NCT00907777|20753207|P1|COMPLETED|Overall Study||25
8420459|NCT00907777|20753206|P2|STARTED|Overall Study||27
8420460|NCT00907777|20753207|P1|STARTED|Overall Study||25
8420461|NCT00907738|20753234|P5|NOT COMPLETED|Overall Study||2
8420462|NCT00907738|20753235|P4|NOT COMPLETED|Overall Study||4
8420463|NCT00907738|20753236|P3|NOT COMPLETED|Overall Study||7
8420464|NCT00907738|20753237|P2|NOT COMPLETED|Overall Study||1
8420465|NCT00907738|20753238|P1|NOT COMPLETED|Overall Study||13
8420466|NCT00907738|20753234|P5|COMPLETED|Overall Study||0
8420467|NCT00907738|20753235|P4|COMPLETED|Overall Study||0
8420468|NCT00907738|20753236|P3|COMPLETED|Overall Study||0
8420469|NCT00907738|20753237|P2|COMPLETED|Overall Study||0
8420470|NCT00907738|20753238|P1|COMPLETED|Overall Study||0
8420471|NCT00907738|20753234|P5|STARTED|Overall Study||2
8420472|NCT00907738|20753235|P4|STARTED|Overall Study||4
8420473|NCT00907738|20753236|P3|STARTED|Overall Study||7
8420474|NCT00907738|20753237|P2|STARTED|Overall Study||1
8420475|NCT00907738|20753238|P1|STARTED|Overall Study||13
8420476|NCT00907621|20753256|P2|NOT COMPLETED|Overall Study||4
8420477|NCT00907621|20753257|P1|NOT COMPLETED|Overall Study||7
8420478|NCT00907621|20753256|P2|COMPLETED|Overall Study||41
8420479|NCT00907621|20753257|P1|COMPLETED|Overall Study||38
8420480|NCT00907621|20753256|P2|STARTED|Overall Study||45
8420481|NCT00907621|20753257|P1|STARTED|Overall Study||45
8420482|NCT00907517|20753270|P5|NOT COMPLETED|Overall Study||5
8420483|NCT00907517|20753271|P4|NOT COMPLETED|Overall Study||4
8420484|NCT00907517|20753272|P3|NOT COMPLETED|Overall Study||4
8420485|NCT00907517|20753273|P2|NOT COMPLETED|Overall Study||3
8420486|NCT00907517|20753274|P1|NOT COMPLETED|Overall Study||3
8420487|NCT00907517|20753270|P5|COMPLETED|Overall Study||1
8420488|NCT00907517|20753271|P4|COMPLETED|Overall Study||2
8420489|NCT00907517|20753272|P3|COMPLETED|Overall Study||2
8420490|NCT00907517|20753273|P2|COMPLETED|Overall Study||0
8420491|NCT00907517|20753274|P1|COMPLETED|Overall Study||0
8420492|NCT00907517|20753270|P5|STARTED|Overall Study||6
8420493|NCT00907517|20753271|P4|STARTED|Overall Study||6
8420494|NCT00907517|20753272|P3|STARTED|Overall Study||6
8420495|NCT00907517|20753273|P2|STARTED|Overall Study||3
8420496|NCT00907517|20753274|P1|STARTED|Overall Study||3
8420497|NCT00907478|20753299|P3|NOT COMPLETED|Overall Study||22
8420498|NCT00907478|20753300|P2|NOT COMPLETED|Overall Study||17
8420499|NCT00907478|20753301|P1|NOT COMPLETED|Overall Study||27
8420500|NCT00907478|20753299|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
8420501|NCT00907478|20753300|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
8420502|NCT00907478|20753301|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
8420503|NCT00907478|20753299|P3|STARTED|Overall Study||69
8420504|NCT00907478|20753300|P2|STARTED|Overall Study||50
8420505|NCT00907478|20753301|P1|STARTED|Overall Study||50
8420506|NCT00907426|20753332|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
8420507|NCT00907426|20753333|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
8420508|NCT00907426|20753334|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
8420509|NCT00907426|20753332|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
8420510|NCT00907426|20753333|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
8420511|NCT00907426|20753334|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
8420512|NCT00907426|20753332|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
8420513|NCT00907426|20753333|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
8420514|NCT00907426|20753334|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
8420515|NCT00907426|20753332|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
8420516|NCT00907426|20753333|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
8420517|NCT00907426|20753334|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
8420518|NCT00907426|20753332|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
8420519|NCT00907426|20753333|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
8420520|NCT00907426|20753334|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
8420521|NCT00907426|20753332|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
8420522|NCT00907426|20753333|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
8420523|NCT00907426|20753334|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
8420524|NCT00907374|20753351|P2|NOT COMPLETED|Overall Study||2
8420525|NCT00907374|20753352|P1|NOT COMPLETED|Overall Study||2
8420526|NCT00907374|20753351|P2|COMPLETED|Overall Study||11
8420527|NCT00907374|20753352|P1|COMPLETED|Overall Study||12
8420528|NCT00907374|20753351|P2|STARTED|Overall Study||13
8420529|NCT00907374|20753352|P1|STARTED|Overall Study||14
8420530|NCT00907335|20753366|P2|NOT COMPLETED|Overall Study||1
8420531|NCT00907335|20753367|P1|NOT COMPLETED|Overall Study||8
8420532|NCT00907335|20753366|P2|COMPLETED|Overall Study||54
8420533|NCT00907335|20753367|P1|COMPLETED|Overall Study||47
8420534|NCT00907335|20753366|P2|STARTED|Overall Study||55
8420535|NCT00907335|20753367|P1|STARTED|Overall Study||55
8420536|NCT00907296|20753393|P10|NOT COMPLETED|Overall Study||7
8420537|NCT00907296|20753394|P9|NOT COMPLETED|Overall Study||4
8420538|NCT00907296|20753395|P8|NOT COMPLETED|Overall Study||7
8420539|NCT00907296|20753396|P7|NOT COMPLETED|Overall Study||6
8420540|NCT00907296|20753397|P6|NOT COMPLETED|Overall Study||9
8420541|NCT00907296|20753398|P5|NOT COMPLETED|Overall Study||1
8420542|NCT00907296|20753399|P4|NOT COMPLETED|Overall Study||4
8420543|NCT00907296|20753400|P3|NOT COMPLETED|Overall Study||2
8420544|NCT00907296|20753401|P2|NOT COMPLETED|Overall Study||5
8420545|NCT00907296|20753402|P1|NOT COMPLETED|Overall Study||20
8420546|NCT00907296|20753393|P10|COMPLETED|Overall Study||28
8420547|NCT00907296|20753394|P9|COMPLETED|Overall Study||27
8420548|NCT00907296|20753395|P8|COMPLETED|Overall Study||26
8420549|NCT00907296|20753396|P7|COMPLETED|Overall Study||27
8420550|NCT00907296|20753397|P6|COMPLETED|Overall Study||24
8420551|NCT00907296|20753398|P5|COMPLETED|Overall Study||32
8420552|NCT00907296|20753399|P4|COMPLETED|Overall Study||29
8420553|NCT00907296|20753400|P3|COMPLETED|Overall Study||32
8420554|NCT00907296|20753401|P2|COMPLETED|Overall Study||29
8420555|NCT00907296|20753402|P1|COMPLETED|Overall Study||83
8420556|NCT00907296|20753393|P10|Received Treatment|Overall Study||35
8420557|NCT00907296|20753394|P9|Received Treatment|Overall Study||30
8420558|NCT00907296|20753395|P8|Received Treatment|Overall Study||32
8420559|NCT00907296|20753396|P7|Received Treatment|Overall Study||31
8420560|NCT00907296|20753397|P6|Received Treatment|Overall Study||32
8420561|NCT00907296|20753398|P5|Received Treatment|Overall Study||33
8420562|NCT00907296|20753399|P4|Received Treatment|Overall Study||32
8420563|NCT00907296|20753400|P3|Received Treatment|Overall Study||34
8420564|NCT00907296|20753401|P2|Received Treatment|Overall Study||34
8420565|NCT00907296|20753402|P1|Received Treatment|Overall Study||100
8420566|NCT00907296|20753393|P10|STARTED|Overall Study||35
8420567|NCT00907296|20753394|P9|STARTED|Overall Study||31
8420568|NCT00907296|20753395|P8|STARTED|Overall Study||33
8420569|NCT00907296|20753396|P7|STARTED|Overall Study||33
8420570|NCT00907296|20753397|P6|STARTED|Overall Study||33
8420571|NCT00907296|20753398|P5|STARTED|Overall Study||33
8420572|NCT00907296|20753399|P4|STARTED|Overall Study||33
8420573|NCT00907296|20753400|P3|STARTED|Overall Study||34
8420574|NCT00907296|20753401|P2|STARTED|Overall Study||34
8420575|NCT00907296|20753402|P1|STARTED|Overall Study||103
8420576|NCT00907257|20753456|P2|NOT COMPLETED|Overall Study||12
8420577|NCT00907257|20753457|P1|NOT COMPLETED|Overall Study||13
8420578|NCT00907257|20753456|P2|COMPLETED|Overall Study||112
8420579|NCT00907257|20753457|P1|COMPLETED|Overall Study||110
8420580|NCT00907257|20753456|P2|STARTED|Overall Study||124
8420581|NCT00907257|20753457|P1|STARTED|Overall Study||123
8420582|NCT00907218|20753467|P1|NOT COMPLETED|Overall Study||0
8420583|NCT00907218|20753467|P1|COMPLETED|Overall Study||2
8420584|NCT00907218|20753467|P1|STARTED|Overall Study||2
8420585|NCT00907153|20753479|P2|NOT COMPLETED|Overall Study||4
8420586|NCT00907153|20753480|P1|NOT COMPLETED|Overall Study||2
8420587|NCT00907153|20753479|P2|COMPLETED|Overall Study||11
8420588|NCT00907153|20753480|P1|COMPLETED|Overall Study||11
8420589|NCT00907153|20753479|P2|STARTED|Overall Study||15
8420590|NCT00907153|20753480|P1|STARTED|Overall Study||13
8420591|NCT00907101|20753522|P1|NOT COMPLETED|Overall Study||0
8420592|NCT00907101|20753522|P1|COMPLETED|Overall Study||30
8420593|NCT00907101|20753522|P1|STARTED|Overall Study||30
8420594|NCT00907088|20753532|P2|NOT COMPLETED|Overall Study||30
8420595|NCT00907088|20753533|P1|NOT COMPLETED|Overall Study||20
8420596|NCT00907088|20753532|P2|COMPLETED|Overall Study||99
8420597|NCT00907088|20753533|P1|COMPLETED|Overall Study||102
8420598|NCT00907088|20753532|P2|STARTED|Overall Study||129
8420599|NCT00907088|20753533|P1|STARTED|Overall Study||122
8420600|NCT00906971|20753541|P2|NOT COMPLETED|Overall Study||3
8420601|NCT00906971|20753542|P1|NOT COMPLETED|Overall Study||8
8420602|NCT00906971|20753541|P2|COMPLETED|Overall Study||33
8420603|NCT00906971|20753542|P1|COMPLETED|Overall Study||28
8420604|NCT00906971|20753541|P2|STARTED|Overall Study||36
8420605|NCT00906971|20753542|P1|STARTED|Overall Study||36
8420606|NCT00906945|20753555|P6|NOT COMPLETED|Overall Study||2
8420607|NCT00906945|20753556|P5|NOT COMPLETED|Overall Study||1
8420608|NCT00906945|20753557|P4|NOT COMPLETED|Overall Study||1
8420609|NCT00906945|20753558|P3|NOT COMPLETED|Overall Study||0
8420610|NCT00906945|20753559|P2|NOT COMPLETED|Overall Study||0
8420611|NCT00906945|20753560|P1|NOT COMPLETED|Overall Study||0
8420612|NCT00906945|20753555|P6|COMPLETED|Overall Study||14
8420613|NCT00906945|20753556|P5|COMPLETED|Overall Study||6
8420614|NCT00906945|20753557|P4|COMPLETED|Overall Study||6
8420615|NCT00906945|20753558|P3|COMPLETED|Overall Study||3
8420616|NCT00906945|20753559|P2|COMPLETED|Overall Study||3
8420617|NCT00906945|20753560|P1|COMPLETED|Overall Study||3
8420618|NCT00906945|20753555|P6|STARTED|Overall Study||16
8420619|NCT00906945|20753556|P5|STARTED|Overall Study||7
8420620|NCT00906945|20753557|P4|STARTED|Overall Study||7
8420621|NCT00906945|20753558|P3|STARTED|Overall Study||3
8420622|NCT00906945|20753559|P2|STARTED|Overall Study||3
8420623|NCT00906945|20753560|P1|STARTED|Overall Study||3
8420624|NCT00906789|20753587|P1|NOT COMPLETED|Overall Study||0
8420625|NCT00906789|20753587|P1|COMPLETED|Overall Study||15
8420626|NCT00906789|20753587|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
8420627|NCT00906776|20753597|P2|NOT COMPLETED|Overall Study||0
8420628|NCT00906776|20753598|P1|NOT COMPLETED|Overall Study||0
8420629|NCT00906776|20753597|P2|COMPLETED|Overall Study||8
8420630|NCT00906776|20753598|P1|COMPLETED|Overall Study||11
8420631|NCT00906776|20753597|P2|STARTED|Overall Study||8
8420632|NCT00906776|20753598|P1|STARTED|Overall Study||11
8420633|NCT00906698|20753620|P6|NOT COMPLETED|Overall Study||5
8420634|NCT00906698|20753621|P5|NOT COMPLETED|Overall Study||18
8420635|NCT00906698|20753622|P4|NOT COMPLETED|Overall Study||4
8420636|NCT00906698|20753623|P3|NOT COMPLETED|Overall Study||6
8420637|NCT00906698|20753624|P2|NOT COMPLETED|Overall Study||19
8420638|NCT00906698|20753625|P1|NOT COMPLETED|Overall Study||3
8420639|NCT00906698|20753620|P6|COMPLETED|Overall Study||0
8420640|NCT00906698|20753621|P5|COMPLETED|Overall Study||0
8420641|NCT00906698|20753622|P4|COMPLETED|Overall Study||0
8420642|NCT00906698|20753623|P3|COMPLETED|Overall Study||0
8420643|NCT00906698|20753624|P2|COMPLETED|Overall Study||0
8420644|NCT00906698|20753625|P1|COMPLETED|Overall Study||0
8420645|NCT00906698|20753620|P6|STARTED|Overall Study||5
8420646|NCT00906698|20753621|P5|STARTED|Overall Study||18
8420647|NCT00906698|20753622|P4|STARTED|Overall Study||4
8420648|NCT00906698|20753623|P3|STARTED|Overall Study||6
8420649|NCT00906698|20753624|P2|STARTED|Overall Study||19
8420650|NCT00906698|20753625|P1|STARTED|Overall Study||3
8420651|NCT00906503|20753707|P1|NOT COMPLETED|Overall Study||0
8420652|NCT00906503|20753707|P1|COMPLETED|Overall Study||9
8420653|NCT00906503|20753707|P1|STARTED|Overall Study||9
8420654|NCT00906425|20753713|P2|NOT COMPLETED|Overall Study||72
8420655|NCT00906425|20753714|P1|NOT COMPLETED|Overall Study||73
8420656|NCT00906425|20753713|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
8420657|NCT00906425|20753714|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
8420658|NCT00906425|20753713|P2|2 Year|Overall Study|ITT population|58
8420659|NCT00906425|20753714|P1|2 Year|Overall Study|ITT population|62
8420660|NCT00906425|20753713|P2|1 Year|Overall Study|ITT population|60
8420661|NCT00906425|20753714|P1|1 Year|Overall Study|ITT population|67
8420662|NCT00906425|20753713|P2|6 Months|Overall Study|ITT population|64
8420663|NCT00906425|20753714|P1|6 Months|Overall Study|ITT population|69
8420664|NCT00906425|20753713|P2|STARTED|Overall Study||72
8420665|NCT00906425|20753714|P1|STARTED|Overall Study||73
8420666|NCT00906399|20753727|P7|NOT COMPLETED|Year 2||29
8420667|NCT00906399|20753728|P6|NOT COMPLETED|Year 2||47
8420668|NCT00906399|20753729|P5|NOT COMPLETED|Year 2||35
8420669|NCT00906399|20753730|P4|NOT COMPLETED|Year 2||30
8420670|NCT00906399|20753731|P3|NOT COMPLETED|Year 2||0
8420671|NCT00906399|20753732|P2|NOT COMPLETED|Year 2||0
8420672|NCT00906399|20753733|P1|NOT COMPLETED|Year 2||0
8420673|NCT00906399|20753727|P7|COMPLETED|Year 2||409
8420674|NCT00906399|20753728|P6|COMPLETED|Year 2||391
8420675|NCT00906399|20753729|P5|COMPLETED|Year 2||193
8420676|NCT00906399|20753730|P4|COMPLETED|Year 2||198
8420677|NCT00906399|20753731|P3|COMPLETED|Year 2||0
8420678|NCT00906399|20753732|P2|COMPLETED|Year 2||0
8420679|NCT00906399|20753733|P1|COMPLETED|Year 2||0
8420680|NCT00906399|20753727|P7|Completed Year 2 Study Treatment|Year 2||411
8420681|NCT00906399|20753728|P6|Completed Year 2 Study Treatment|Year 2||391
8420682|NCT00906399|20753729|P5|Completed Year 2 Study Treatment|Year 2||196
8420683|NCT00906399|20753730|P4|Completed Year 2 Study Treatment|Year 2||200
8420684|NCT00906399|20753731|P3|Completed Year 2 Study Treatment|Year 2||0
8420685|NCT00906399|20753732|P2|Completed Year 2 Study Treatment|Year 2||0
8420686|NCT00906399|20753733|P1|Completed Year 2 Study Treatment|Year 2||0
8420687|NCT00906399|20753727|P7|STARTED|Year 2||438
8420688|NCT00906399|20753728|P6|STARTED|Year 2||438
8420689|NCT00906399|20753729|P5|STARTED|Year 2||228
8420690|NCT00906399|20753730|P4|STARTED|Year 2||228
8420691|NCT00906399|20753731|P3|STARTED|Year 2||0
8420692|NCT00906399|20753732|P2|STARTED|Year 2||0
8420693|NCT00906399|20753733|P1|STARTED|Year 2||0
8420694|NCT00906399|20753727|P7|NOT COMPLETED|Year 1||0
8420695|NCT00906399|20753728|P6|NOT COMPLETED|Year 1||0
8420696|NCT00906399|20753729|P5|NOT COMPLETED|Year 1||0
8420697|NCT00906399|20753730|P4|NOT COMPLETED|Year 1||0
8420698|NCT00906399|20753731|P3|NOT COMPLETED|Year 1||76
8420699|NCT00906399|20753732|P2|NOT COMPLETED|Year 1||63
8420700|NCT00906399|20753733|P1|NOT COMPLETED|Year 1||44
8420701|NCT00906399|20753727|P7|COMPLETED|Year 1||0
8420702|NCT00906399|20753728|P6|COMPLETED|Year 1||0
8420703|NCT00906399|20753729|P5|COMPLETED|Year 1||0
8420704|NCT00906399|20753730|P4|COMPLETED|Year 1||0
8420705|NCT00906399|20753731|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
8420706|NCT00906399|20753732|P2|COMPLETED|Year 1||438
8420707|NCT00906399|20753733|P1|COMPLETED|Year 1||456
8420708|NCT00906399|20753727|P7|Completed Year 1 Study Treatment|Year 1||0
8420709|NCT00906399|20753728|P6|Completed Year 1 Study Treatment|Year 1||0
8420710|NCT00906399|20753729|P5|Completed Year 1 Study Treatment|Year 1||0
8420711|NCT00906399|20753730|P4|Completed Year 1 Study Treatment|Year 1||0
8420712|NCT00906399|20753731|P3|Completed Year 1 Study Treatment|Year 1||438
8420713|NCT00906399|20753732|P2|Completed Year 1 Study Treatment|Year 1||438
8420714|NCT00906399|20753733|P1|Completed Year 1 Study Treatment|Year 1||456
8420715|NCT00906399|20753727|P7|STARTED|Year 1||0
8420716|NCT00906399|20753728|P6|STARTED|Year 1||0
8420717|NCT00906399|20753729|P5|STARTED|Year 1||0
8420718|NCT00906399|20753730|P4|STARTED|Year 1||0
8420719|NCT00906399|20753731|P3|STARTED|Year 1||515
8420720|NCT00906399|20753732|P2|STARTED|Year 1||501
8420721|NCT00906399|20753733|P1|STARTED|Year 1||500
8420722|NCT00906373|20753756|P2|NOT COMPLETED|Overall Study||8
8420723|NCT00906373|20753757|P1|NOT COMPLETED|Overall Study||0
8420724|NCT00906373|20753756|P2|COMPLETED|Overall Study||33
8420725|NCT00906373|20753757|P1|COMPLETED|Overall Study||6
8420726|NCT00906373|20753756|P2|Received Any Amount of Study Drug|Overall Study||41
8420727|NCT00906373|20753757|P1|Received Any Amount of Study Drug|Overall Study||6
8420728|NCT00906373|20753756|P2|STARTED|Overall Study||41
8420729|NCT00906373|20753757|P1|STARTED|Overall Study||6
8420730|NCT00906347|20753796|P2|NOT COMPLETED|Received Study Drug||31
8420731|NCT00906347|20753797|P1|NOT COMPLETED|Received Study Drug||40
8420732|NCT00906347|20753796|P2|COMPLETED|Received Study Drug||143
8420733|NCT00906347|20753797|P1|COMPLETED|Received Study Drug||136
8420734|NCT00906347|20753796|P2|STARTED|Received Study Drug||174
8420735|NCT00906347|20753797|P1|STARTED|Received Study Drug||176
8420736|NCT00906347|20753796|P2|NOT COMPLETED|Randomized||0
8420737|NCT00906347|20753797|P1|NOT COMPLETED|Randomized||0
8420738|NCT00906347|20753796|P2|COMPLETED|Randomized||174
8420739|NCT00906347|20753797|P1|COMPLETED|Randomized||176
8420740|NCT00906347|20753796|P2|STARTED|Randomized||174
8420741|NCT00906347|20753797|P1|STARTED|Randomized||176
8420742|NCT00906282|20753817|P1|NOT COMPLETED|Surgical Resection||0
8420743|NCT00906282|20753817|P1|COMPLETED|Surgical Resection||27
8420744|NCT00906282|20753817|P1|STARTED|Surgical Resection||27
8420745|NCT00906282|20753817|P1|NOT COMPLETED|Preoperative Chemotherapy||19
8420746|NCT00906282|20753817|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
8420747|NCT00906282|20753817|P1|STARTED|Preoperative Chemotherapy||46
8420748|NCT00906243|20753825|P1|NOT COMPLETED|Overall Study||0
8420749|NCT00906243|20753825|P1|COMPLETED|Overall Study||6
8420750|NCT00906243|20753825|P1|STARTED|Overall Study||6
8420751|NCT00906204|20753831|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
8420752|NCT00906204|20753832|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
8420753|NCT00906204|20753831|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
8420754|NCT00906204|20753832|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
8420755|NCT00906204|20753831|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
8420756|NCT00906204|20753832|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
8420757|NCT00906204|20753831|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
8420758|NCT00906204|20753832|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
8420759|NCT00906204|20753831|P2|COMPLETED|Primary Endpoint (Early Safety)||51
8420760|NCT00906204|20753832|P1|COMPLETED|Primary Endpoint (Early Safety)||43
8420761|NCT00906204|20753831|P2|STARTED|Primary Endpoint (Early Safety)||52
8420762|NCT00906204|20753832|P1|STARTED|Primary Endpoint (Early Safety)||45
8420763|NCT00906178|20753850|P2|NOT COMPLETED|Overall Study||16
8420764|NCT00906178|20753851|P1|NOT COMPLETED|Overall Study||15
8420765|NCT00906178|20753850|P2|COMPLETED|Overall Study||167
8420766|NCT00906178|20753851|P1|COMPLETED|Overall Study||168
8420767|NCT00906178|20753850|P2|STARTED|Overall Study||183
8420768|NCT00906178|20753851|P1|STARTED|Overall Study||183
8420769|NCT00906165|20753865|P2|NOT COMPLETED|Overall Study||0
8420770|NCT00906165|20753866|P1|NOT COMPLETED|Overall Study||4
8420771|NCT00906165|20753865|P2|COMPLETED|Overall Study||14
8420772|NCT00906165|20753866|P1|COMPLETED|Overall Study||10
8420773|NCT00906165|20753865|P2|STARTED|Overall Study||14
8420774|NCT00906165|20753866|P1|STARTED|Overall Study||14
8420775|NCT00906087|20753886|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
8420776|NCT00906087|20753886|P1|COMPLETED|Final Washout Period 4 Weeks||12
8420777|NCT00906087|20753886|P1|STARTED|Final Washout Period 4 Weeks||12
8420778|NCT00906087|20753886|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
8420779|NCT00906087|20753886|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
8420780|NCT00906087|20753886|P1|STARTED|Cosopt Treatment 6 Weeks||12
8420781|NCT00906087|20753886|P1|NOT COMPLETED|Initial Washout||2
8420782|NCT00906087|20753886|P1|COMPLETED|Initial Washout||12
8420783|NCT00906087|20753886|P1|Completed Washout and Continue Protocol|Initial Washout||12
8420784|NCT00906087|20753886|P1|Begin Washout|Initial Washout||13
8420785|NCT00906087|20753886|P1|Completed Screening|Initial Washout||14
8420786|NCT00906087|20753886|P1|STARTED|Initial Washout||14
8420787|NCT00906074|20753895|P2|NOT COMPLETED|Overall Study||0
8420788|NCT00906074|20753896|P1|NOT COMPLETED|Overall Study||0
8420789|NCT00906074|20753895|P2|COMPLETED|Overall Study||90
8420790|NCT00906074|20753896|P1|COMPLETED|Overall Study||90
8420791|NCT00906074|20753895|P2|STARTED|Overall Study||90
8420792|NCT00906074|20753896|P1|STARTED|Overall Study||90
8420793|NCT00906035|20753923|P3|NOT COMPLETED|Overall Study||0
8420794|NCT00906035|20753924|P2|NOT COMPLETED|Overall Study||3
8420795|NCT00906035|20753925|P1|NOT COMPLETED|Overall Study||2
8420796|NCT00906035|20753923|P3|COMPLETED|Overall Study||8
8420797|NCT00906035|20753924|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
8420798|NCT00906035|20753925|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
8420799|NCT00906035|20753923|P3|STARTED|Overall Study||8
8420800|NCT00906035|20753924|P2|STARTED|Overall Study||9
8420801|NCT00906035|20753925|P1|STARTED|Overall Study||8
8420802|NCT00905840|20753939|P1|NOT COMPLETED|Overall Study||16
8420803|NCT00905840|20753939|P1|COMPLETED|Overall Study||75
8420804|NCT00905840|20753939|P1|STARTED|Overall Study||91
8420805|NCT00905827|20753951|P3|NOT COMPLETED|Overall Study||0
8420806|NCT00905827|20753952|P2|NOT COMPLETED|Overall Study||0
8420807|NCT00905827|20753953|P1|NOT COMPLETED|Overall Study||0
8420808|NCT00905827|20753951|P3|COMPLETED|Overall Study||73
8420809|NCT00905827|20753952|P2|COMPLETED|Overall Study||69
8420810|NCT00905827|20753953|P1|COMPLETED|Overall Study||70
8420811|NCT00905827|20753951|P3|STARTED|Overall Study||73
8420812|NCT00905827|20753952|P2|STARTED|Overall Study||69
8420813|NCT00905827|20753953|P1|STARTED|Overall Study||70
8420814|NCT00905632|20753970|P7|NOT COMPLETED|Overall Study||4
8420815|NCT00905632|20753971|P6|NOT COMPLETED|Overall Study||1
8420816|NCT00905632|20753972|P5|NOT COMPLETED|Overall Study||0
8420817|NCT00905632|20753973|P4|NOT COMPLETED|Overall Study||0
8420818|NCT00905632|20753974|P3|NOT COMPLETED|Overall Study||0
8420819|NCT00905632|20753975|P2|NOT COMPLETED|Overall Study||0
8420820|NCT00905632|20753976|P1|NOT COMPLETED|Overall Study||0
8420821|NCT00905632|20753970|P7|COMPLETED|Overall Study||7
8420822|NCT00905632|20753971|P6|COMPLETED|Overall Study||8
8420823|NCT00905632|20753972|P5|COMPLETED|Overall Study||10
8420824|NCT00905632|20753973|P4|COMPLETED|Overall Study||6
8420825|NCT00905632|20753974|P3|COMPLETED|Overall Study||7
8420826|NCT00905632|20753975|P2|COMPLETED|Overall Study||6
8420827|NCT00905632|20753976|P1|COMPLETED|Overall Study||8
8420828|NCT00905632|20753970|P7|STARTED|Overall Study||11
8420829|NCT00905632|20753971|P6|STARTED|Overall Study||9
8420830|NCT00905632|20753972|P5|STARTED|Overall Study||10
8420831|NCT00905632|20753973|P4|STARTED|Overall Study||6
8420832|NCT00905632|20753974|P3|STARTED|Overall Study||7
8420833|NCT00905632|20753975|P2|STARTED|Overall Study||6
8420834|NCT00905632|20753976|P1|STARTED|Overall Study||8
8420835|NCT00905606|20754114|P2|NOT COMPLETED|Period 2||0
8420836|NCT00905606|20754115|P1|NOT COMPLETED|Period 2||0
8420837|NCT00905606|20754114|P2|COMPLETED|Period 2||14
8420838|NCT00905606|20754115|P1|COMPLETED|Period 2||14
8420839|NCT00905606|20754114|P2|STARTED|Period 2||14
8420840|NCT00905606|20754115|P1|STARTED|Period 2||14
8420841|NCT00905606|20754114|P2|NOT COMPLETED|Washout||0
8420842|NCT00905606|20754115|P1|NOT COMPLETED|Washout||1
8420843|NCT00905606|20754114|P2|COMPLETED|Washout||14
8420844|NCT00905606|20754115|P1|COMPLETED|Washout||14
8420845|NCT00905606|20754114|P2|STARTED|Washout||14
8420846|NCT00905606|20754115|P1|STARTED|Washout||15
8420847|NCT00905606|20754114|P2|NOT COMPLETED|Period 1||1
8420848|NCT00905606|20754115|P1|NOT COMPLETED|Period 1||0
8420849|NCT00905606|20754114|P2|COMPLETED|Period 1||14
8420850|NCT00905606|20754115|P1|COMPLETED|Period 1||15
8420851|NCT00905606|20754114|P2|STARTED|Period 1||15
8420852|NCT00905606|20754115|P1|STARTED|Period 1||15
8420853|NCT00905580|20754125|P2|NOT COMPLETED|Overall Study||3
8420854|NCT00905580|20754126|P1|NOT COMPLETED|Overall Study||2
8420855|NCT00905580|20754125|P2|COMPLETED|Overall Study||47
8420856|NCT00905580|20754126|P1|COMPLETED|Overall Study||47
8420857|NCT00905580|20754125|P2|STARTED|Overall Study||50
8420858|NCT00905580|20754126|P1|STARTED|Overall Study||49
8420859|NCT00905567|20754140|P2|NOT COMPLETED|Period 2||0
8420860|NCT00905567|20754141|P1|NOT COMPLETED|Period 2||0
8420861|NCT00905567|20754140|P2|COMPLETED|Period 2||11
8420862|NCT00905567|20754141|P1|COMPLETED|Period 2||12
8420863|NCT00905567|20754140|P2|STARTED|Period 2||11
8420864|NCT00905567|20754141|P1|STARTED|Period 2||12
8420865|NCT00905567|20754140|P2|NOT COMPLETED|Washout||1
8420866|NCT00905567|20754141|P1|NOT COMPLETED|Washout||0
8420867|NCT00905567|20754140|P2|COMPLETED|Washout||11
8420868|NCT00905567|20754141|P1|COMPLETED|Washout||12
8420869|NCT00905567|20754140|P2|STARTED|Washout||12
8420870|NCT00905567|20754141|P1|STARTED|Washout||12
8420871|NCT00905567|20754140|P2|NOT COMPLETED|Period 1||0
8420872|NCT00905567|20754141|P1|NOT COMPLETED|Period 1||0
8420873|NCT00905567|20754140|P2|COMPLETED|Period 1||12
8420874|NCT00905567|20754141|P1|COMPLETED|Period 1||12
8420875|NCT00905567|20754140|P2|STARTED|Period 1||12
8420876|NCT00905567|20754141|P1|STARTED|Period 1||12
8420877|NCT00905554|20754151|P2|NOT COMPLETED|Overall Study||0
8420878|NCT00905554|20754152|P1|NOT COMPLETED|Overall Study||0
8420879|NCT00905554|20754151|P2|COMPLETED|Overall Study||114
8420880|NCT00905554|20754152|P1|COMPLETED|Overall Study||116
8420881|NCT00905554|20754151|P2|STARTED|Overall Study||114
8420882|NCT00905554|20754152|P1|STARTED|Overall Study||116
8420883|NCT00905515|20754163|P3|NOT COMPLETED|Overall Study||2
8420884|NCT00905515|20754164|P2|NOT COMPLETED|Overall Study||0
8420885|NCT00905515|20754165|P1|NOT COMPLETED|Overall Study||2
8420886|NCT00905515|20754163|P3|COMPLETED|Overall Study||20
8420887|NCT00905515|20754164|P2|COMPLETED|Overall Study||20
8420888|NCT00905515|20754165|P1|COMPLETED|Overall Study||19
8420889|NCT00905515|20754163|P3|STARTED|Overall Study||22
8420890|NCT00905515|20754164|P2|STARTED|Overall Study||20
8420891|NCT00905515|20754165|P1|STARTED|Overall Study||21
8420892|NCT00905489|20754173|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
8420893|NCT00905489|20754173|P1|COMPLETED|Optional Extension Phase (OEP)||39
8420894|NCT00905489|20754173|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
8420895|NCT00905489|20754173|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
8420896|NCT00905489|20754173|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
8420897|NCT00905489|20754173|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
8420898|NCT00905450|20754228|P8|NOT COMPLETED|Overall Study||1
8420899|NCT00905450|20754229|P7|NOT COMPLETED|Overall Study||2
8420900|NCT00905450|20754230|P6|NOT COMPLETED|Overall Study||2
8420901|NCT00905450|20754231|P5|NOT COMPLETED|Overall Study||0
8420902|NCT00905450|20754232|P4|NOT COMPLETED|Overall Study||0
8420903|NCT00905450|20754233|P3|NOT COMPLETED|Overall Study||0
8420904|NCT00905450|20754234|P2|NOT COMPLETED|Overall Study||1
8420905|NCT00905450|20754235|P1|NOT COMPLETED|Overall Study||1
8420906|NCT00905450|20754228|P8|COMPLETED|Overall Study||59
8420907|NCT00905450|20754229|P7|COMPLETED|Overall Study||58
8420908|NCT00905450|20754230|P6|COMPLETED|Overall Study||58
8420909|NCT00905450|20754231|P5|COMPLETED|Overall Study||59
8420910|NCT00905450|20754232|P4|COMPLETED|Overall Study||60
8420911|NCT00905450|20754233|P3|COMPLETED|Overall Study||28
8420912|NCT00905450|20754234|P2|COMPLETED|Overall Study||27
8420913|NCT00905450|20754235|P1|COMPLETED|Overall Study||59
8420914|NCT00905450|20754228|P8|STARTED|Overall Study||60
8420915|NCT00905450|20754229|P7|STARTED|Overall Study||60
8420916|NCT00905450|20754230|P6|STARTED|Overall Study||60
8420917|NCT00905450|20754231|P5|STARTED|Overall Study||59
8420918|NCT00905450|20754232|P4|STARTED|Overall Study||60
8420919|NCT00905450|20754233|P3|STARTED|Overall Study||28
8420920|NCT00905450|20754234|P2|STARTED|Overall Study||28
8420921|NCT00905450|20754235|P1|STARTED|Overall Study||60
8420922|NCT00905424|20754263|P2|NOT COMPLETED|Overall Study||9
8420923|NCT00905424|20754264|P1|NOT COMPLETED|Overall Study||11
8420924|NCT00905424|20754263|P2|COMPLETED|Overall Study||79
8420925|NCT00905424|20754264|P1|COMPLETED|Overall Study||78
8420926|NCT00905424|20754263|P2|STARTED|Overall Study||88
8420927|NCT00905424|20754264|P1|STARTED|Overall Study||89
8420928|NCT00905359|20754306|P2|NOT COMPLETED|Overall Study||16
8420929|NCT00905359|20754307|P1|NOT COMPLETED|Overall Study||24
8420930|NCT00905359|20754306|P2|COMPLETED|Overall Study||65
8420931|NCT00905359|20754307|P1|COMPLETED|Overall Study||58
8420932|NCT00905359|20754306|P2|24 Months Follow up|Overall Study||65
8420933|NCT00905359|20754307|P1|24 Months Follow up|Overall Study||58
8420934|NCT00905359|20754306|P2|12 Months Follow up|Overall Study||72
8420935|NCT00905359|20754307|P1|12 Months Follow up|Overall Study||68
8420936|NCT00905359|20754306|P2|STARTED|Overall Study||81
8420937|NCT00905359|20754307|P1|STARTED|Overall Study||82
8420938|NCT00905346|20754343|P2|NOT COMPLETED|Period 2||0
8420939|NCT00905346|20754344|P1|NOT COMPLETED|Period 2||0
8420940|NCT00905346|20754343|P2|COMPLETED|Period 2||11
8420941|NCT00905346|20754344|P1|COMPLETED|Period 2||10
8420942|NCT00905346|20754343|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
8420943|NCT00905346|20754344|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
8420944|NCT00905346|20754343|P2|NOT COMPLETED|Period 1||0
8420945|NCT00905346|20754344|P1|NOT COMPLETED|Period 1||1
8420946|NCT00905346|20754343|P2|COMPLETED|Period 1||12
8420947|NCT00905346|20754344|P1|COMPLETED|Period 1||11
8420948|NCT00905346|20754343|P2|STARTED|Period 1||12
8420949|NCT00905346|20754344|P1|STARTED|Period 1||12
8420950|NCT00905307|20754358|P6|NOT COMPLETED|Overall Study||42
8420951|NCT00905307|20754359|P5|NOT COMPLETED|Overall Study||16
8420952|NCT00905307|20754360|P4|NOT COMPLETED|Overall Study||37
8420953|NCT00905307|20754361|P3|NOT COMPLETED|Overall Study||37
8420954|NCT00905307|20754362|P2|NOT COMPLETED|Overall Study||37
8420955|NCT00905307|20754363|P1|NOT COMPLETED|Overall Study||22
8420956|NCT00905307|20754358|P6|COMPLETED|Overall Study||53
8420957|NCT00905307|20754359|P5|COMPLETED|Overall Study||34
8420958|NCT00905307|20754360|P4|COMPLETED|Overall Study||56
8420959|NCT00905307|20754361|P3|COMPLETED|Overall Study||53
8420960|NCT00905307|20754362|P2|COMPLETED|Overall Study||52
8420961|NCT00905307|20754363|P1|COMPLETED|Overall Study||20
8420962|NCT00905307|20754358|P6|STARTED|Overall Study||95
8420963|NCT00905307|20754359|P5|STARTED|Overall Study||50
8420964|NCT00905307|20754360|P4|STARTED|Overall Study||93
8420965|NCT00905307|20754361|P3|STARTED|Overall Study||90
8420966|NCT00905307|20754362|P2|STARTED|Overall Study||89
8420967|NCT00905307|20754363|P1|STARTED|Overall Study||42
8420968|NCT00905268|20754423|P4|NOT COMPLETED|Overall Study||2
8420969|NCT00905268|20754424|P3|NOT COMPLETED|Overall Study||0
8420970|NCT00905268|20754425|P2|NOT COMPLETED|Overall Study||1
8420971|NCT00905268|20754426|P1|NOT COMPLETED|Overall Study||4
8420972|NCT00905268|20754423|P4|COMPLETED|Overall Study||57
8420973|NCT00905268|20754424|P3|COMPLETED|Overall Study||59
8420974|NCT00905268|20754425|P2|COMPLETED|Overall Study||56
8420975|NCT00905268|20754426|P1|COMPLETED|Overall Study||53
8420976|NCT00905268|20754423|P4|STARTED|Overall Study||59
8420977|NCT00905268|20754424|P3|STARTED|Overall Study||59
8420978|NCT00905268|20754425|P2|STARTED|Overall Study||57
8420979|NCT00905268|20754426|P1|STARTED|Overall Study||57
8420980|NCT00905255|20754458|P2|NOT COMPLETED|Overall Study||9
8420981|NCT00905255|20754459|P1|NOT COMPLETED|Overall Study||13
8420982|NCT00905255|20754458|P2|COMPLETED|Overall Study||27
8420983|NCT00905255|20754459|P1|COMPLETED|Overall Study||20
8420984|NCT00905255|20754458|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
8420985|NCT00905255|20754459|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
8420986|NCT00905255|20754458|P2|Safety Population|Overall Study||36
8420987|NCT00905255|20754459|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
8420988|NCT00905255|20754458|P2|STARTED|Overall Study||36
8420989|NCT00905255|20754459|P1|STARTED|Overall Study|Randomized.|33
8420990|NCT00905164|20754477|P2|NOT COMPLETED|Period 2||0
8420991|NCT00905164|20754478|P1|NOT COMPLETED|Period 2||0
8420992|NCT00905164|20754477|P2|COMPLETED|Period 2||11
8420993|NCT00905164|20754478|P1|COMPLETED|Period 2||12
8420994|NCT00905164|20754477|P2|STARTED|Period 2||11
8420995|NCT00905164|20754478|P1|STARTED|Period 2||12
8420996|NCT00905164|20754477|P2|NOT COMPLETED|Period 1||1
8420997|NCT00905164|20754478|P1|NOT COMPLETED|Period 1||0
8420998|NCT00905164|20754477|P2|COMPLETED|Period 1||11
8420999|NCT00905164|20754478|P1|COMPLETED|Period 1||12
8421000|NCT00905164|20754477|P2|STARTED|Period 1||12
8421001|NCT00905164|20754478|P1|STARTED|Period 1||12
8421002|NCT00905151|20754486|P1|NOT COMPLETED|Overall Study||6
8421003|NCT00905151|20754486|P1|COMPLETED|Overall Study||200
8421004|NCT00905151|20754486|P1|STARTED|Overall Study||206
8421005|NCT00905125|20754492|P2|NOT COMPLETED|Overall Study||3
8421006|NCT00905125|20754493|P1|NOT COMPLETED|Overall Study||4
8421007|NCT00905125|20754492|P2|COMPLETED|Overall Study||53
8421008|NCT00905125|20754493|P1|COMPLETED|Overall Study||42
8421009|NCT00905125|20754492|P2|STARTED|Overall Study||56
8421010|NCT00905125|20754493|P1|STARTED|Overall Study||46
8421011|NCT00905034|20754525|P1|NOT COMPLETED|Overall Study||1
8421012|NCT00905034|20754525|P1|COMPLETED|Overall Study||36
8421013|NCT00905034|20754525|P1|STARTED|Overall Study||37
8421014|NCT00905021|20754529|P1|NOT COMPLETED|Overall Study||2
8421015|NCT00905021|20754529|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
8421016|NCT00905021|20754529|P1|STARTED|Overall Study||4
8421017|NCT00904995|20754538|P2|NOT COMPLETED|Overall Study||0
8421018|NCT00904995|20754539|P1|NOT COMPLETED|Overall Study||0
8421019|NCT00904995|20754538|P2|COMPLETED|Overall Study||11
8421020|NCT00904995|20754539|P1|COMPLETED|Overall Study||10
8421021|NCT00904995|20754538|P2|STARTED|Overall Study||11
8421022|NCT00904995|20754539|P1|STARTED|Overall Study||10
8421023|NCT00904982|20754549|P4|NOT COMPLETED|Overall Study||0
8421024|NCT00904982|20754550|P3|NOT COMPLETED|Overall Study||0
8421025|NCT00904982|20754551|P2|NOT COMPLETED|Overall Study||0
8421026|NCT00904982|20754552|P1|NOT COMPLETED|Overall Study||2
8421027|NCT00904982|20754549|P4|COMPLETED|Overall Study||68
8421028|NCT00904982|20754550|P3|COMPLETED|Overall Study||67
8421029|NCT00904982|20754551|P2|COMPLETED|Overall Study||67
8421030|NCT00904982|20754552|P1|COMPLETED|Overall Study||66
8421031|NCT00904982|20754549|P4|STARTED|Overall Study||68
8421032|NCT00904982|20754550|P3|STARTED|Overall Study||67
8421033|NCT00904982|20754551|P2|STARTED|Overall Study||67
8421034|NCT00904982|20754552|P1|STARTED|Overall Study||68
8421035|NCT00904969|20754562|P1|NOT COMPLETED|Overall Study||19
8421036|NCT00904969|20754562|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
8421037|NCT00904969|20754562|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
8421038|NCT00904943|20754614|P2|NOT COMPLETED|Period 2||0
8421039|NCT00904943|20754615|P1|NOT COMPLETED|Period 2||0
8421040|NCT00904943|20754614|P2|COMPLETED|Period 2||8
8421041|NCT00904943|20754615|P1|COMPLETED|Period 2||9
8421042|NCT00904943|20754614|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
8421043|NCT00904943|20754615|P1|STARTED|Period 2||9
8421044|NCT00904943|20754614|P2|NOT COMPLETED|Period 1||0
8421045|NCT00904943|20754615|P1|NOT COMPLETED|Period 1||0
8421046|NCT00904943|20754614|P2|COMPLETED|Period 1||9
8421047|NCT00904943|20754615|P1|COMPLETED|Period 1||9
8421048|NCT00904943|20754614|P2|STARTED|Period 1||9
8421049|NCT00904943|20754615|P1|STARTED|Period 1||9
8421050|NCT00904917|20754627|P4|NOT COMPLETED|Overall Study||2
8421051|NCT00904917|20754628|P3|NOT COMPLETED|Overall Study||2
8421052|NCT00904917|20754629|P2|NOT COMPLETED|Overall Study||2
8421053|NCT00904917|20754630|P1|NOT COMPLETED|Overall Study||2
8421054|NCT00904917|20754627|P4|COMPLETED|Overall Study||6
8421055|NCT00904917|20754628|P3|COMPLETED|Overall Study||6
8421056|NCT00904917|20754629|P2|COMPLETED|Overall Study||9
8421057|NCT00904917|20754630|P1|COMPLETED|Overall Study||5
8421058|NCT00904917|20754627|P4|STARTED|Overall Study||8
8421059|NCT00904917|20754628|P3|STARTED|Overall Study||8
8421060|NCT00904917|20754629|P2|STARTED|Overall Study||11
8421061|NCT00904917|20754630|P1|STARTED|Overall Study||7
8421062|NCT00904839|20754648|P3|NOT COMPLETED|Overall Study||15
8421063|NCT00904839|20754649|P2|NOT COMPLETED|Overall Study||18
8421064|NCT00904839|20754650|P1|NOT COMPLETED|Overall Study||1
8421065|NCT00904839|20754648|P3|COMPLETED|Overall Study||27
8421066|NCT00904839|20754649|P2|COMPLETED|Overall Study||64
8421067|NCT00904839|20754650|P1|COMPLETED|Overall Study||3
8421068|NCT00904839|20754648|P3|STARTED|Overall Study|Randomised|42
8421069|NCT00904839|20754649|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
8421070|NCT00904839|20754650|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
8421071|NCT00904826|20754684|P1|NOT COMPLETED|Overall Study||0
8421072|NCT00904826|20754684|P1|COMPLETED|Overall Study||14
8421073|NCT00904826|20754684|P1|STARTED|Overall Study||14
8421098|NCT00904722|20754725|P1|NOT COMPLETED|Overall Study||1
8421099|NCT00904722|20754725|P1|COMPLETED|Overall Study||29
8421100|NCT00904722|20754725|P1|STARTED|Overall Study||30
8421101|NCT00904670|20754730|P2|NOT COMPLETED|Second Intervention Period||0
8421102|NCT00904670|20754731|P1|NOT COMPLETED|Second Intervention Period||0
8421103|NCT00904670|20754730|P2|COMPLETED|Second Intervention Period||22
8421104|NCT00904670|20754731|P1|COMPLETED|Second Intervention Period||17
8421105|NCT00904670|20754730|P2|STARTED|Second Intervention Period||22
8421106|NCT00904670|20754731|P1|STARTED|Second Intervention Period||17
8421107|NCT00904670|20754730|P2|NOT COMPLETED|First Intervention Period||0
8421108|NCT00904670|20754731|P1|NOT COMPLETED|First Intervention Period||0
8421109|NCT00904670|20754730|P2|COMPLETED|First Intervention Period||22
8421110|NCT00904670|20754731|P1|COMPLETED|First Intervention Period||17
8421111|NCT00904670|20754730|P2|STARTED|First Intervention Period||22
8421112|NCT00904670|20754731|P1|STARTED|First Intervention Period||17
8421113|NCT00904670|20754730|P2|NOT COMPLETED|Open Label Phase||0
8421114|NCT00904670|20754731|P1|NOT COMPLETED|Open Label Phase||6
8421115|NCT00904670|20754730|P2|COMPLETED|Open Label Phase||22
8421116|NCT00904670|20754731|P1|COMPLETED|Open Label Phase||17
8421117|NCT00904670|20754730|P2|STARTED|Open Label Phase||22
8421118|NCT00904670|20754731|P1|STARTED|Open Label Phase||23
8421119|NCT00904618|20754752|P1|NOT COMPLETED|Overall Study||0
8421120|NCT00904618|20754752|P1|COMPLETED|Overall Study||48
8421121|NCT00904618|20754752|P1|STARTED|Overall Study||48
8421122|NCT00904488|20754762|P2|NOT COMPLETED|Overall Study||0
8421123|NCT00904488|20754763|P1|NOT COMPLETED|Overall Study||0
8421124|NCT00904488|20754762|P2|COMPLETED|Overall Study||6
8421125|NCT00904488|20754763|P1|COMPLETED|Overall Study||5
8421126|NCT00904488|20754762|P2|STARTED|Overall Study||6
8421127|NCT00904488|20754763|P1|STARTED|Overall Study||5
8421128|NCT00904423|20754793|P1|NOT COMPLETED|Overall Study||0
8421129|NCT00904423|20754793|P1|COMPLETED|Overall Study||8
8421130|NCT00904423|20754793|P1|STARTED|Overall Study||8
8421131|NCT00904371|20754801|P1|NOT COMPLETED|Overall Study||9
8421132|NCT00904371|20754801|P1|COMPLETED|Overall Study||202
8421133|NCT00904371|20754801|P1|STARTED|Overall Study||211
8421138|NCT00904215|20754826|P1|NOT COMPLETED|Overall Study||135
8421139|NCT00904215|20754826|P1|COMPLETED|Overall Study||960
8421140|NCT00904215|20754826|P1|STARTED|Overall Study||1095
8421141|NCT00904189|20754833|P1|NOT COMPLETED|Overall Study||0
8421142|NCT00904189|20754833|P1|COMPLETED|Overall Study||2
8421143|NCT00904189|20754833|P1|STARTED|Overall Study||2
8421144|NCT00904150|20754840|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
8421145|NCT00904150|20754841|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
8421146|NCT00904150|20754840|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
8421147|NCT00904150|20754841|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
8421148|NCT00904150|20754840|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
8421149|NCT00904150|20754841|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
8421150|NCT00904150|20754840|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
8421151|NCT00904150|20754841|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
8421152|NCT00904150|20754840|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
8421153|NCT00904150|20754841|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
8421154|NCT00904150|20754840|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
8421155|NCT00904150|20754841|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
8421156|NCT00904150|20754840|P2|NOT COMPLETED|Saliva Samples (DNA)||145
8421157|NCT00904150|20754841|P1|NOT COMPLETED|Saliva Samples (DNA)||3
8421158|NCT00904150|20754840|P2|COMPLETED|Saliva Samples (DNA)||155
8421159|NCT00904150|20754841|P1|COMPLETED|Saliva Samples (DNA)||282
8421160|NCT00904150|20754840|P2|STARTED|Saliva Samples (DNA)||300
8421161|NCT00904150|20754841|P1|STARTED|Saliva Samples (DNA)||285
8421162|NCT00904033|20754863|P4|NOT COMPLETED|Overall Study||2
8421163|NCT00904033|20754864|P3|NOT COMPLETED|Overall Study||1
8421164|NCT00904033|20754865|P2|NOT COMPLETED|Overall Study||1
8421165|NCT00904033|20754866|P1|NOT COMPLETED|Overall Study||1
8421166|NCT00904033|20754863|P4|COMPLETED|Overall Study||9
8421167|NCT00904033|20754864|P3|COMPLETED|Overall Study||9
8421168|NCT00904033|20754865|P2|COMPLETED|Overall Study||9
8421169|NCT00904033|20754866|P1|COMPLETED|Overall Study||9
8421170|NCT00904033|20754863|P4|STARTED|Overall Study||11
8421171|NCT00904033|20754864|P3|STARTED|Overall Study||10
8421172|NCT00904033|20754865|P2|STARTED|Overall Study||10
8421173|NCT00904033|20754866|P1|STARTED|Overall Study||10
8421174|NCT00904007|20754890|P2|NOT COMPLETED|Overall Study||0
8421175|NCT00904007|20754891|P1|NOT COMPLETED|Overall Study||0
8421176|NCT00904007|20754890|P2|COMPLETED|Overall Study||56
8421177|NCT00904007|20754891|P1|COMPLETED|Overall Study||55
8421178|NCT00904007|20754890|P2|STARTED|Overall Study||56
8421179|NCT00904007|20754891|P1|STARTED|Overall Study||55
8421180|NCT00903968|20754931|P8|NOT COMPLETED|Overall Study||33
8421181|NCT00903968|20754932|P7|NOT COMPLETED|Overall Study||3
8421182|NCT00903968|20754933|P6|NOT COMPLETED|Overall Study||6
8421183|NCT00903968|20754934|P5|NOT COMPLETED|Overall Study||4
8421184|NCT00903968|20754935|P4|NOT COMPLETED|Overall Study||3
8421185|NCT00903968|20754936|P3|NOT COMPLETED|Overall Study||3
8421186|NCT00903968|20754937|P2|NOT COMPLETED|Overall Study||3
8421187|NCT00903968|20754938|P1|NOT COMPLETED|Overall Study||3
8421188|NCT00903968|20754931|P8|COMPLETED|Overall Study||0
8421189|NCT00903968|20754932|P7|COMPLETED|Overall Study||0
8421190|NCT00903968|20754933|P6|COMPLETED|Overall Study||0
8421191|NCT00903968|20754934|P5|COMPLETED|Overall Study||0
8421192|NCT00903968|20754935|P4|COMPLETED|Overall Study||0
8421193|NCT00903968|20754936|P3|COMPLETED|Overall Study||0
8421194|NCT00903968|20754937|P2|COMPLETED|Overall Study||0
8421195|NCT00903968|20754938|P1|COMPLETED|Overall Study||0
8421196|NCT00903968|20754931|P8|STARTED|Overall Study||33
8421197|NCT00903968|20754932|P7|STARTED|Overall Study||3
8421198|NCT00903968|20754933|P6|STARTED|Overall Study||6
8421199|NCT00903968|20754934|P5|STARTED|Overall Study||4
8421200|NCT00903968|20754935|P4|STARTED|Overall Study||3
8421201|NCT00903968|20754936|P3|STARTED|Overall Study||3
8421202|NCT00903968|20754937|P2|STARTED|Overall Study||3
8421203|NCT00903968|20754938|P1|STARTED|Overall Study||3
8421204|NCT00903929|20754968|P4|NOT COMPLETED|Overall Study||3
8421205|NCT00903929|20754969|P3|NOT COMPLETED|Overall Study||1
8421206|NCT00903929|20754970|P2|NOT COMPLETED|Overall Study||0
8421207|NCT00903929|20754971|P1|NOT COMPLETED|Overall Study||0
8421208|NCT00903929|20754968|P4|COMPLETED|Overall Study||6
8421209|NCT00903929|20754969|P3|COMPLETED|Overall Study||3
8421210|NCT00903929|20754970|P2|COMPLETED|Overall Study||3
8421211|NCT00903929|20754971|P1|COMPLETED|Overall Study||3
8421212|NCT00903929|20754968|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
8421213|NCT00903929|20754969|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
8421214|NCT00903929|20754970|P2|STARTED|Overall Study||3
8421215|NCT00903929|20754971|P1|STARTED|Overall Study||3
8421216|NCT00903877|20754977|P1|NOT COMPLETED|Overall Study||43
8421217|NCT00903877|20754977|P1|COMPLETED|Overall Study||8
8421218|NCT00903877|20754977|P1|STARTED|Overall Study||51
8421219|NCT00903786|20754981|P1|NOT COMPLETED|Overall Study||15
8421220|NCT00903786|20754981|P1|COMPLETED|Overall Study||6
8421221|NCT00903786|20754981|P1|STARTED|Overall Study||21
8421222|NCT00903760|20754991|P2|NOT COMPLETED|Overall Study||16
8421223|NCT00903760|20754992|P1|NOT COMPLETED|Overall Study||19
8421224|NCT00903760|20754991|P2|COMPLETED|Overall Study|Completed all 24 courses|2
8421225|NCT00903760|20754992|P1|COMPLETED|Overall Study|Completed all 24 courses|0
8421226|NCT00903760|20754991|P2|STARTED|Overall Study||18
8421227|NCT00903760|20754992|P1|STARTED|Overall Study||19
8421228|NCT00903695|20755002|P2|NOT COMPLETED|Overall Study||0
8421229|NCT00903695|20755003|P1|NOT COMPLETED|Overall Study||2
8421230|NCT00903695|20755002|P2|COMPLETED|Overall Study||2
8421231|NCT00903695|20755003|P1|COMPLETED|Overall Study||6
8421232|NCT00903695|20755002|P2|STARTED|Overall Study||2
8421233|NCT00903695|20755003|P1|STARTED|Overall Study||8
8421234|NCT00903682|20755025|P2|NOT COMPLETED|Overall Study||15
8421235|NCT00903682|20755026|P1|NOT COMPLETED|Overall Study||16
8421236|NCT00903682|20755025|P2|COMPLETED|Overall Study||63
8421237|NCT00903682|20755026|P1|COMPLETED|Overall Study||63
8421238|NCT00903682|20755025|P2|STARTED|Overall Study||78
8421239|NCT00903682|20755026|P1|STARTED|Overall Study||79
8421240|NCT00903630|20755047|P3|NOT COMPLETED|Phase 2||1
8421241|NCT00903630|20755048|P2|NOT COMPLETED|Phase 2||0
8421242|NCT00903630|20755049|P1|NOT COMPLETED|Phase 2||0
8421243|NCT00903630|20755047|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
8421244|NCT00903630|20755048|P2|COMPLETED|Phase 2||0
8421245|NCT00903630|20755049|P1|COMPLETED|Phase 2||6
8421246|NCT00903630|20755047|P3|STARTED|Phase 2||4
8421247|NCT00903630|20755048|P2|STARTED|Phase 2||0
8421248|NCT00903630|20755049|P1|STARTED|Phase 2||6
8421249|NCT00903630|20755047|P3|NOT COMPLETED|Phase l||0
8421250|NCT00903630|20755048|P2|NOT COMPLETED|Phase l||0
8421251|NCT00903630|20755049|P1|NOT COMPLETED|Phase l||0
8421252|NCT00903630|20755047|P3|COMPLETED|Phase l||0
8421253|NCT00903630|20755048|P2|COMPLETED|Phase l||5
8421254|NCT00903630|20755049|P1|COMPLETED|Phase l||6
8421255|NCT00903630|20755047|P3|STARTED|Phase l||0
8421256|NCT00903630|20755048|P2|STARTED|Phase l||5
8421257|NCT00903630|20755049|P1|STARTED|Phase l||6
8421258|NCT00903617|20755067|P4|NOT COMPLETED|Overall Study||1
8421259|NCT00903617|20755068|P3|NOT COMPLETED|Overall Study||5
8421260|NCT00903617|20755069|P2|NOT COMPLETED|Overall Study||5
8421261|NCT00903617|20755070|P1|NOT COMPLETED|Overall Study||3
8421262|NCT00903617|20755067|P4|COMPLETED|Overall Study||20
8421263|NCT00903617|20755068|P3|COMPLETED|Overall Study||15
8421264|NCT00903617|20755069|P2|COMPLETED|Overall Study||15
8421265|NCT00903617|20755070|P1|COMPLETED|Overall Study||16
8421266|NCT00903617|20755067|P4|STARTED|Overall Study||21
8421267|NCT00903617|20755068|P3|STARTED|Overall Study||20
8421268|NCT00903617|20755069|P2|STARTED|Overall Study||20
8421269|NCT00903617|20755070|P1|STARTED|Overall Study||19
8421270|NCT00903448|20755164|P2|NOT COMPLETED|Period 3: 5 Days||0
8421271|NCT00903448|20755165|P1|NOT COMPLETED|Period 3: 5 Days||0
8421272|NCT00903448|20755164|P2|COMPLETED|Period 3: 5 Days||20
8421273|NCT00903448|20755165|P1|COMPLETED|Period 3: 5 Days||20
8421274|NCT00903448|20755164|P2|STARTED|Period 3: 5 Days||20
8421275|NCT00903448|20755165|P1|STARTED|Period 3: 5 Days||20
8421276|NCT00903448|20755164|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
8421277|NCT00903448|20755165|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
8421278|NCT00903448|20755164|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
8421279|NCT00903448|20755165|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
8421280|NCT00903448|20755164|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
8421281|NCT00903448|20755165|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
8421282|NCT00903448|20755164|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
8421283|NCT00903448|20755165|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
8421284|NCT00903448|20755164|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
8421285|NCT00903448|20755165|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
8421286|NCT00903448|20755164|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
8421287|NCT00903448|20755165|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
8421288|NCT00903409|20755173|P2|NOT COMPLETED|Overall Study||27
8421289|NCT00903409|20755174|P1|NOT COMPLETED|Overall Study||26
8421290|NCT00903409|20755173|P2|COMPLETED|Overall Study||73
8421291|NCT00903409|20755174|P1|COMPLETED|Overall Study||62
8421292|NCT00903409|20755173|P2|STARTED|Overall Study||100
8421293|NCT00903409|20755174|P1|STARTED|Overall Study||88
8421294|NCT00903396|20755192|P4|NOT COMPLETED|Overall Study||0
8421295|NCT00903396|20755193|P3|NOT COMPLETED|Overall Study||0
8421296|NCT00903396|20755194|P2|NOT COMPLETED|Overall Study||0
8421297|NCT00903396|20755195|P1|NOT COMPLETED|Overall Study||0
8421298|NCT00903396|20755192|P4|COMPLETED|Overall Study||1
8421299|NCT00903396|20755193|P3|COMPLETED|Overall Study||3
8421300|NCT00903396|20755194|P2|COMPLETED|Overall Study||1
8421301|NCT00903396|20755195|P1|COMPLETED|Overall Study||2
8421302|NCT00903396|20755192|P4|STARTED|Overall Study||1
8421303|NCT00903396|20755193|P3|STARTED|Overall Study||3
8421304|NCT00903396|20755194|P2|STARTED|Overall Study||1
8421305|NCT00903396|20755195|P1|STARTED|Overall Study||2
8421306|NCT00903383|20755225|P4|NOT COMPLETED|Overall Study||5
8421307|NCT00903383|20755226|P3|NOT COMPLETED|Overall Study||3
8421308|NCT00903383|20755227|P2|NOT COMPLETED|Overall Study||6
8421309|NCT00903383|20755228|P1|NOT COMPLETED|Overall Study||7
8421310|NCT00903383|20755225|P4|COMPLETED|Overall Study||44
8421311|NCT00903383|20755226|P3|COMPLETED|Overall Study||47
8421312|NCT00903383|20755227|P2|COMPLETED|Overall Study||48
8421313|NCT00903383|20755228|P1|COMPLETED|Overall Study||48
8421314|NCT00903383|20755225|P4|STARTED|Overall Study||49
8421315|NCT00903383|20755226|P3|STARTED|Overall Study||50
8421316|NCT00903383|20755227|P2|STARTED|Overall Study||54
8421317|NCT00903383|20755228|P1|STARTED|Overall Study||55
8421318|NCT00903370|20755260|P2|NOT COMPLETED|Overall Study||24
8421319|NCT00903370|20755261|P1|NOT COMPLETED|Overall Study||28
8421320|NCT00903370|20755260|P2|COMPLETED|Overall Study||109
8421321|NCT00903370|20755261|P1|COMPLETED|Overall Study||99
8421322|NCT00903370|20755260|P2|STARTED|Overall Study||133
8421323|NCT00903370|20755261|P1|STARTED|Overall Study||127
8421324|NCT00903357|20755269|P2|NOT COMPLETED|Second Intervention||0
8421325|NCT00903357|20755270|P1|NOT COMPLETED|Second Intervention||1
8421326|NCT00903357|20755269|P2|COMPLETED|Second Intervention||22
8421327|NCT00903357|20755270|P1|COMPLETED|Second Intervention||21
8421328|NCT00903357|20755269|P2|STARTED|Second Intervention||22
8421329|NCT00903357|20755270|P1|STARTED|Second Intervention||22
8421330|NCT00903357|20755269|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
8421331|NCT00903357|20755270|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
8421332|NCT00903357|20755269|P2|COMPLETED|Wash Out Period of 2 Weeks||22
8421333|NCT00903357|20755270|P1|COMPLETED|Wash Out Period of 2 Weeks||22
8421334|NCT00903357|20755269|P2|STARTED|Wash Out Period of 2 Weeks||23
8421335|NCT00903357|20755270|P1|STARTED|Wash Out Period of 2 Weeks||22
8421336|NCT00903357|20755269|P2|NOT COMPLETED|First Intervention||4
8421337|NCT00903357|20755270|P1|NOT COMPLETED|First Intervention||5
8421338|NCT00903357|20755269|P2|COMPLETED|First Intervention||23
8421339|NCT00903357|20755270|P1|COMPLETED|First Intervention||22
8421340|NCT00903357|20755269|P2|STARTED|First Intervention||27
8421341|NCT00903357|20755270|P1|STARTED|First Intervention||27
8421342|NCT00903344|20755282|P2|NOT COMPLETED|Overall Study||3
8421343|NCT00903344|20755283|P1|NOT COMPLETED|Overall Study||5
8421344|NCT00903344|20755282|P2|COMPLETED|Overall Study||7
8421345|NCT00903344|20755283|P1|COMPLETED|Overall Study||7
8421346|NCT00903344|20755282|P2|6 Month Visit|Overall Study||10
8421347|NCT00903344|20755283|P1|6 Month Visit|Overall Study||9
8421348|NCT00903344|20755282|P2|3 Month Visit|Overall Study||10
8421349|NCT00903344|20755283|P1|3 Month Visit|Overall Study||10
8421350|NCT00903344|20755282|P2|STARTED|Overall Study||10
8421351|NCT00903344|20755283|P1|STARTED|Overall Study||12
8421352|NCT00903331|20755301|P2|NOT COMPLETED|Overall Study||18
8421353|NCT00903331|20755302|P1|NOT COMPLETED|Overall Study||5
8421354|NCT00903331|20755301|P2|COMPLETED|Overall Study||101
8421355|NCT00903331|20755302|P1|COMPLETED|Overall Study||54
8421356|NCT00903331|20755301|P2|STARTED|Overall Study||119
8421357|NCT00903331|20755302|P1|STARTED|Overall Study||59
8421358|NCT00903201|20755313|P3|NOT COMPLETED|Overall Study||2
8421359|NCT00903201|20755314|P2|NOT COMPLETED|Overall Study||6
8421360|NCT00903201|20755315|P1|NOT COMPLETED|Overall Study||5
8421361|NCT00903201|20755313|P3|COMPLETED|Overall Study||39
8421362|NCT00903201|20755314|P2|COMPLETED|Overall Study||38
8421363|NCT00903201|20755315|P1|COMPLETED|Overall Study||56
8421364|NCT00903201|20755313|P3|STARTED|Overall Study||41
8421365|NCT00903201|20755314|P2|STARTED|Overall Study||44
8421366|NCT00903201|20755315|P1|STARTED|Overall Study||61
8421367|NCT00903175|20755373|P2|NOT COMPLETED|Period 2 - Second Line||36
8421368|NCT00903175|20755374|P1|NOT COMPLETED|Period 2 - Second Line||49
8421369|NCT00903175|20755373|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
8421370|NCT00903175|20755374|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
8421371|NCT00903175|20755373|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
8421372|NCT00903175|20755374|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
8421373|NCT00903175|20755373|P2|NOT COMPLETED|Period 1 - First Line||89
8421374|NCT00903175|20755374|P1|NOT COMPLETED|Period 1 - First Line||77
8421375|NCT00903175|20755373|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
8421376|NCT00903175|20755374|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
8421377|NCT00903175|20755373|P2|STARTED|Period 1 - First Line||231
8421378|NCT00903175|20755374|P1|STARTED|Period 1 - First Line||238
8421379|NCT00903162|20755404|P1|NOT COMPLETED|Overall Study||4
8421380|NCT00903162|20755404|P1|COMPLETED|Overall Study||12
8421381|NCT00903162|20755404|P1|STARTED|Overall Study||16
8421382|NCT00903032|20755412|P2|NOT COMPLETED|Overall Study||5
8421383|NCT00903032|20755413|P1|NOT COMPLETED|Overall Study||7
8421384|NCT00903032|20755412|P2|COMPLETED|Overall Study||119
8421385|NCT00903032|20755413|P1|COMPLETED|Overall Study||122
8421386|NCT00903032|20755412|P2|STARTED|Overall Study||124
8421387|NCT00903032|20755413|P1|STARTED|Overall Study||129
8421388|NCT00903006|20755423|P4|NOT COMPLETED|Overall Study||0
8421389|NCT00903006|20755424|P3|NOT COMPLETED|Overall Study||1
8421390|NCT00903006|20755425|P2|NOT COMPLETED|Overall Study||3
8421391|NCT00903006|20755426|P1|NOT COMPLETED|Overall Study||2
8421392|NCT00903006|20755423|P4|COMPLETED|Overall Study||0
8421393|NCT00903006|20755424|P3|COMPLETED|Overall Study||0
8421394|NCT00903006|20755425|P2|COMPLETED|Overall Study||0
8421395|NCT00903006|20755426|P1|COMPLETED|Overall Study||0
8421396|NCT00903006|20755423|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
8421397|NCT00903006|20755424|P3|STARTED|Overall Study||1
8421398|NCT00903006|20755425|P2|STARTED|Overall Study||3
8421399|NCT00903006|20755426|P1|STARTED|Overall Study||2
8421400|NCT00902850|20755438|P2|NOT COMPLETED|Overall Study||2
8421401|NCT00902850|20755439|P1|NOT COMPLETED|Overall Study||2
8421402|NCT00902850|20755438|P2|COMPLETED|Overall Study||12
8421403|NCT00902850|20755439|P1|COMPLETED|Overall Study||12
8421404|NCT00902850|20755438|P2|STARTED|Overall Study||14
8421405|NCT00902850|20755439|P1|STARTED|Overall Study||14
8421406|NCT00902746|20755445|P1|NOT COMPLETED|Overall Study||36
8421407|NCT00902746|20755445|P1|COMPLETED|Overall Study||113
8421408|NCT00902746|20755445|P1|Transfer to Step 2|Overall Study||133
8421409|NCT00902746|20755445|P1|Initiation of Study Drug Administration|Overall Study||148
8421410|NCT00902746|20755445|P1|STARTED|Overall Study||149
8421411|NCT00902668|20755450|P1|NOT COMPLETED|Overall Study||3
8421412|NCT00902668|20755450|P1|COMPLETED|Overall Study||0
8421413|NCT00902668|20755450|P1|STARTED|Overall Study||3
8421414|NCT00902577|20755454|P1|NOT COMPLETED|Overall Study||8
8421415|NCT00902577|20755454|P1|COMPLETED|Overall Study||42
8421416|NCT00902577|20755454|P1|DWI MRI|Overall Study||39
8421417|NCT00902577|20755454|P1|DSE MRI|Overall Study||37
8421418|NCT00902577|20755454|P1|DCE MRI|Overall Study||31
8421419|NCT00902577|20755454|P1|FMISO/PET|Overall Study||38
8421420|NCT00902577|20755454|P1|STARTED|Overall Study||50
8421421|NCT00902564|20755483|P1|NOT COMPLETED|Overall Study||2
8421422|NCT00902564|20755483|P1|COMPLETED|Overall Study||28
8421423|NCT00902564|20755483|P1|STARTED|Overall Study||30
8421424|NCT00902538|20755498|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
8421425|NCT00902538|20755499|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
8421426|NCT00902538|20755500|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
8421427|NCT00902538|20755501|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421428|NCT00902538|20755502|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421429|NCT00902538|20755503|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421430|NCT00902538|20755498|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
8421431|NCT00902538|20755499|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
8421432|NCT00902538|20755500|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
8421433|NCT00902538|20755501|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421434|NCT00902538|20755502|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421435|NCT00902538|20755503|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421436|NCT00902538|20755498|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
8421437|NCT00902538|20755499|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
8421438|NCT00902538|20755500|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
8421439|NCT00902538|20755501|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
8421440|NCT00902538|20755502|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
8421441|NCT00902538|20755503|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
8421442|NCT00902538|20755498|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421443|NCT00902538|20755499|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421444|NCT00902538|20755500|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421445|NCT00902538|20755501|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421446|NCT00902538|20755502|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
8421447|NCT00902538|20755503|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421448|NCT00902538|20755498|P6|COMPLETED|3-Single-blind, Single Treatment||0
8421449|NCT00902538|20755499|P5|COMPLETED|3-Single-blind, Single Treatment||0
8421450|NCT00902538|20755500|P4|COMPLETED|3-Single-blind, Single Treatment||0
8421451|NCT00902538|20755501|P3|COMPLETED|3-Single-blind, Single Treatment||0
8421452|NCT00902538|20755502|P2|COMPLETED|3-Single-blind, Single Treatment||767
8421453|NCT00902538|20755503|P1|COMPLETED|3-Single-blind, Single Treatment||0
8421454|NCT00902538|20755498|P6|STARTED|3-Single-blind, Single Treatment||0
8421455|NCT00902538|20755499|P5|STARTED|3-Single-blind, Single Treatment||0
8421456|NCT00902538|20755500|P4|STARTED|3-Single-blind, Single Treatment||0
8421457|NCT00902538|20755501|P3|STARTED|3-Single-blind, Single Treatment||0
8421458|NCT00902538|20755502|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
8421459|NCT00902538|20755503|P1|STARTED|3-Single-blind, Single Treatment||0
8421460|NCT00902538|20755498|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421461|NCT00902538|20755499|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421462|NCT00902538|20755500|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421463|NCT00902538|20755501|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
8421464|NCT00902538|20755502|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
8421465|NCT00902538|20755503|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
8421466|NCT00902538|20755498|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421467|NCT00902538|20755499|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421468|NCT00902538|20755500|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421469|NCT00902538|20755501|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
8421470|NCT00902538|20755502|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
8421471|NCT00902538|20755503|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
8421472|NCT00902538|20755498|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
8421473|NCT00902538|20755499|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
8421474|NCT00902538|20755500|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
8421475|NCT00902538|20755501|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
8421476|NCT00902538|20755502|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
8421477|NCT00902538|20755503|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
8421478|NCT00902538|20755498|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421479|NCT00902538|20755499|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421480|NCT00902538|20755500|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421481|NCT00902538|20755501|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421482|NCT00902538|20755502|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421483|NCT00902538|20755503|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
8421484|NCT00902538|20755498|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421485|NCT00902538|20755499|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421486|NCT00902538|20755500|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421487|NCT00902538|20755501|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421488|NCT00902538|20755502|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421489|NCT00902538|20755503|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
8421490|NCT00902538|20755498|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421491|NCT00902538|20755499|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421492|NCT00902538|20755500|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421493|NCT00902538|20755501|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421494|NCT00902538|20755502|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421495|NCT00902538|20755503|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
8421496|NCT00902486|20755537|P6|NOT COMPLETED|Follow-up (After Week 24)||0
8421497|NCT00902486|20755538|P5|NOT COMPLETED|Follow-up (After Week 24)||0
8421498|NCT00902486|20755539|P4|NOT COMPLETED|Follow-up (After Week 24)||1
8421499|NCT00902486|20755540|P3|NOT COMPLETED|Follow-up (After Week 24)||0
8421500|NCT00902486|20755541|P2|NOT COMPLETED|Follow-up (After Week 24)||0
8421501|NCT00902486|20755542|P1|NOT COMPLETED|Follow-up (After Week 24)||0
8421502|NCT00902486|20755537|P6|COMPLETED|Follow-up (After Week 24)||24
8421503|NCT00902486|20755538|P5|COMPLETED|Follow-up (After Week 24)||29
8421504|NCT00902486|20755539|P4|COMPLETED|Follow-up (After Week 24)||26
8421505|NCT00902486|20755540|P3|COMPLETED|Follow-up (After Week 24)||13
8421506|NCT00902486|20755541|P2|COMPLETED|Follow-up (After Week 24)||14
8421507|NCT00902486|20755542|P1|COMPLETED|Follow-up (After Week 24)||0
8421508|NCT00902486|20755537|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
8421509|NCT00902486|20755538|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
8421510|NCT00902486|20755539|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
8421511|NCT00902486|20755540|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
8421512|NCT00902486|20755541|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
8421513|NCT00902486|20755542|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
8421514|NCT00902486|20755537|P6|STARTED|Follow-up (After Week 24)||24
8421515|NCT00902486|20755538|P5|STARTED|Follow-up (After Week 24)||29
8421516|NCT00902486|20755539|P4|STARTED|Follow-up (After Week 24)||27
8421517|NCT00902486|20755540|P3|STARTED|Follow-up (After Week 24)||13
8421518|NCT00902486|20755541|P2|STARTED|Follow-up (After Week 24)||14
8421519|NCT00902486|20755542|P1|STARTED|Follow-up (After Week 24)||0
8421520|NCT00902486|20755537|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
8421521|NCT00902486|20755538|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
8421522|NCT00902486|20755539|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
8421523|NCT00902486|20755540|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
8421524|NCT00902486|20755541|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
8421525|NCT00902486|20755542|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
8421526|NCT00902486|20755537|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
8421527|NCT00902486|20755538|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
8421528|NCT00902486|20755539|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
8421529|NCT00902486|20755540|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
8421530|NCT00902486|20755541|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
8421531|NCT00902486|20755542|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
8421532|NCT00902486|20755537|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
8421533|NCT00902486|20755538|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
8421534|NCT00902486|20755539|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
8421535|NCT00902486|20755540|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
8421536|NCT00902486|20755541|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
8421537|NCT00902486|20755542|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
8421538|NCT00902486|20755537|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
8421539|NCT00902486|20755538|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
8421540|NCT00902486|20755539|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
8421541|NCT00902486|20755540|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421542|NCT00902486|20755541|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421543|NCT00902486|20755542|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
8421544|NCT00902486|20755537|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
8421545|NCT00902486|20755538|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
8421546|NCT00902486|20755539|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
8421547|NCT00902486|20755540|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421548|NCT00902486|20755541|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421549|NCT00902486|20755542|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
8421550|NCT00902486|20755537|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
8421551|NCT00902486|20755538|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
8421552|NCT00902486|20755539|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
8421553|NCT00902486|20755540|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
8421554|NCT00902486|20755541|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
8421555|NCT00902486|20755542|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
8421556|NCT00902486|20755537|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8421557|NCT00902486|20755538|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
8421558|NCT00902486|20755539|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8421559|NCT00902486|20755540|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
8421560|NCT00902486|20755541|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
8421561|NCT00902486|20755542|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8421562|NCT00902486|20755537|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
8421563|NCT00902486|20755538|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
8421564|NCT00902486|20755539|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
8421565|NCT00902486|20755540|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
8421566|NCT00902486|20755541|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
8421567|NCT00902486|20755542|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
8421568|NCT00902330|20755680|P2|NOT COMPLETED|Overall Study||5
8421569|NCT00902330|20755681|P1|NOT COMPLETED|Overall Study||4
8421570|NCT00902330|20755680|P2|COMPLETED|Overall Study||75
8421571|NCT00902330|20755681|P1|COMPLETED|Overall Study||77
8421572|NCT00902330|20755680|P2|STARTED|Overall Study||80
8421573|NCT00902330|20755681|P1|STARTED|Overall Study||81
8421574|NCT00902304|20755718|P3|NOT COMPLETED|Overall Study||110
8421575|NCT00902304|20755719|P2|NOT COMPLETED|Overall Study||71
8421576|NCT00902304|20755720|P1|NOT COMPLETED|Overall Study||58
8421577|NCT00902304|20755718|P3|COMPLETED|Overall Study||568
8421578|NCT00902304|20755719|P2|COMPLETED|Overall Study||289
8421579|NCT00902304|20755720|P1|COMPLETED|Overall Study||466
8421580|NCT00902304|20755718|P3|STARTED|Overall Study||678
8421581|NCT00902304|20755719|P2|STARTED|Overall Study||360
8421582|NCT00902304|20755720|P1|STARTED|Overall Study||524
8421583|NCT00902278|20755770|P5|NOT COMPLETED|Overall Study||2
8421584|NCT00902278|20755771|P4|NOT COMPLETED|Overall Study||0
8421585|NCT00902278|20755772|P3|NOT COMPLETED|Overall Study||5
8421586|NCT00902278|20755773|P2|NOT COMPLETED|Overall Study||2
8421587|NCT00902278|20755774|P1|NOT COMPLETED|Overall Study||4
8421588|NCT00902278|20755770|P5|COMPLETED|Overall Study||35
8421589|NCT00902278|20755771|P4|COMPLETED|Overall Study||12
8421590|NCT00902278|20755772|P3|COMPLETED|Overall Study||49
8421591|NCT00902278|20755773|P2|COMPLETED|Overall Study||34
8421592|NCT00902278|20755774|P1|COMPLETED|Overall Study||50
8421593|NCT00902278|20755770|P5|STARTED|Overall Study||37
8421594|NCT00902278|20755771|P4|STARTED|Overall Study||12
8421595|NCT00902278|20755772|P3|STARTED|Overall Study||54
8421596|NCT00902278|20755773|P2|STARTED|Overall Study||36
8421597|NCT00902278|20755774|P1|STARTED|Overall Study||54
8421598|NCT00902265|20755791|P1|NOT COMPLETED|Overall Study||6
8421599|NCT00902265|20755791|P1|COMPLETED|Overall Study||132
8421600|NCT00902265|20755791|P1|Participants Who Received Treatment|Overall Study||137
8421601|NCT00902265|20755791|P1|STARTED|Overall Study||138
8421602|NCT00902226|20755803|P1|NOT COMPLETED|Overall Study||0
8421603|NCT00902226|20755803|P1|COMPLETED|Overall Study||30
8421604|NCT00902226|20755803|P1|STARTED|Overall Study||30
8421605|NCT00902174|20755815|P2|NOT COMPLETED|Overall Study||18
8421606|NCT00902174|20755816|P1|NOT COMPLETED|Overall Study||34
8421607|NCT00902174|20755815|P2|COMPLETED|Overall Study||81
8421608|NCT00902174|20755816|P1|COMPLETED|Overall Study||69
8421609|NCT00902174|20755815|P2|STARTED|Overall Study||99
8421610|NCT00902174|20755816|P1|STARTED|Overall Study||103
8421611|NCT00902161|20755854|P3|NOT COMPLETED|Period 2||0
8421612|NCT00902161|20755855|P2|NOT COMPLETED|Period 2||0
8421613|NCT00902161|20755856|P1|NOT COMPLETED|Period 2||0
8421614|NCT00902161|20755854|P3|COMPLETED|Period 2||0
8421615|NCT00902161|20755855|P2|COMPLETED|Period 2||9
8421616|NCT00902161|20755856|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
8421617|NCT00902161|20755854|P3|STARTED|Period 2||0
8421618|NCT00902161|20755855|P2|STARTED|Period 2||9
8421619|NCT00902161|20755856|P1|STARTED|Period 2||8
8421620|NCT00902161|20755854|P3|NOT COMPLETED|Post-clamp Washout||0
8421621|NCT00902161|20755855|P2|NOT COMPLETED|Post-clamp Washout||0
8421622|NCT00902161|20755856|P1|NOT COMPLETED|Post-clamp Washout||0
8421623|NCT00902161|20755854|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
8421624|NCT00902161|20755855|P2|COMPLETED|Post-clamp Washout||0
8421625|NCT00902161|20755856|P1|COMPLETED|Post-clamp Washout||0
8421626|NCT00902161|20755854|P3|STARTED|Post-clamp Washout||22
8421627|NCT00902161|20755855|P2|STARTED|Post-clamp Washout||0
8421628|NCT00902161|20755856|P1|STARTED|Post-clamp Washout||0
8421629|NCT00902161|20755854|P3|NOT COMPLETED|Period 1||0
8421630|NCT00902161|20755855|P2|NOT COMPLETED|Period 1||0
8421631|NCT00902161|20755856|P1|NOT COMPLETED|Period 1||0
8421632|NCT00902161|20755854|P3|COMPLETED|Period 1||0
8421633|NCT00902161|20755855|P2|COMPLETED|Period 1||10
8421634|NCT00902161|20755856|P1|COMPLETED|Period 1||12
8421635|NCT00902161|20755854|P3|STARTED|Period 1||0
8421636|NCT00902161|20755855|P2|STARTED|Period 1||10
8421637|NCT00902161|20755856|P1|STARTED|Period 1||12
8421638|NCT00902161|20755854|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421639|NCT00902161|20755855|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421640|NCT00902161|20755856|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421641|NCT00902161|20755854|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
8421642|NCT00902161|20755855|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421643|NCT00902161|20755856|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421644|NCT00902161|20755854|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
8421645|NCT00902161|20755855|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
8421646|NCT00902161|20755856|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
8421647|NCT00902018|20755874|P3|NOT COMPLETED|Overall Study||0
8421648|NCT00902018|20755875|P2|NOT COMPLETED|Overall Study||0
8421649|NCT00902018|20755876|P1|NOT COMPLETED|Overall Study||0
8421650|NCT00902018|20755874|P3|COMPLETED|Overall Study||10
8421651|NCT00902018|20755875|P2|COMPLETED|Overall Study||3
8421652|NCT00902018|20755876|P1|COMPLETED|Overall Study||7
8421653|NCT00902018|20755874|P3|STARTED|Overall Study||10
8421654|NCT00902018|20755875|P2|STARTED|Overall Study||3
8421655|NCT00902018|20755876|P1|STARTED|Overall Study||7
8421656|NCT00901927|20755891|P1|NOT COMPLETED|Overall Study||6
8421657|NCT00901927|20755891|P1|COMPLETED|Overall Study||8
8421658|NCT00901927|20755891|P1|STARTED|Overall Study||14
8421659|NCT00901901|20755899|P2|NOT COMPLETED|Follow-up Period||341
8421660|NCT00901901|20755900|P1|NOT COMPLETED|Follow-up Period||340
8421661|NCT00901901|20755899|P2|COMPLETED|Follow-up Period||0
8421662|NCT00901901|20755900|P1|COMPLETED|Follow-up Period||0
8421663|NCT00901901|20755899|P2|STARTED|Follow-up Period||341
8421664|NCT00901901|20755900|P1|STARTED|Follow-up Period||340
8421665|NCT00901901|20755899|P2|NOT COMPLETED|Treatment Period||177
8421666|NCT00901901|20755900|P1|NOT COMPLETED|Treatment Period||169
8421667|NCT00901901|20755899|P2|COMPLETED|Treatment Period||181
8421668|NCT00901901|20755900|P1|COMPLETED|Treatment Period||193
8421669|NCT00901901|20755899|P2|Participants Received Treatment|Treatment Period||355
8421670|NCT00901901|20755900|P1|Participants Received Treatment|Treatment Period||362
8421671|NCT00901901|20755899|P2|STARTED|Treatment Period||358
8421672|NCT00901901|20755900|P1|STARTED|Treatment Period||362
8421673|NCT00901628|20755922|P2|NOT COMPLETED|Overall Study||10
8421674|NCT00901628|20755923|P1|NOT COMPLETED|Overall Study||4
8421675|NCT00901628|20755922|P2|COMPLETED|Overall Study||42
8421676|NCT00901628|20755923|P1|COMPLETED|Overall Study||45
8421677|NCT00901628|20755922|P2|STARTED|Overall Study||52
8421678|NCT00901628|20755923|P1|STARTED|Overall Study||49
8421679|NCT00901576|20755945|P6|NOT COMPLETED|Third Intervention||0
8421680|NCT00901576|20755946|P5|NOT COMPLETED|Third Intervention||0
8421681|NCT00901576|20755947|P4|NOT COMPLETED|Third Intervention||0
8421682|NCT00901576|20755948|P3|NOT COMPLETED|Third Intervention||0
8421683|NCT00901576|20755949|P2|NOT COMPLETED|Third Intervention||0
8421684|NCT00901576|20755950|P1|NOT COMPLETED|Third Intervention||0
8421685|NCT00901576|20755945|P6|COMPLETED|Third Intervention||5
8421686|NCT00901576|20755946|P5|COMPLETED|Third Intervention||6
8421687|NCT00901576|20755947|P4|COMPLETED|Third Intervention||5
8421688|NCT00901576|20755948|P3|COMPLETED|Third Intervention||7
8421689|NCT00901576|20755949|P2|COMPLETED|Third Intervention||7
8421690|NCT00901576|20755950|P1|COMPLETED|Third Intervention||5
8421691|NCT00901576|20755945|P6|STARTED|Third Intervention||5
8421692|NCT00901576|20755946|P5|STARTED|Third Intervention||6
8421693|NCT00901576|20755947|P4|STARTED|Third Intervention||5
8421694|NCT00901576|20755948|P3|STARTED|Third Intervention||7
8421695|NCT00901576|20755949|P2|STARTED|Third Intervention||7
8421696|NCT00901576|20755950|P1|STARTED|Third Intervention||5
8421697|NCT00901576|20755945|P6|NOT COMPLETED|Washout||0
8421698|NCT00901576|20755946|P5|NOT COMPLETED|Washout||0
8421699|NCT00901576|20755947|P4|NOT COMPLETED|Washout||0
8421700|NCT00901576|20755948|P3|NOT COMPLETED|Washout||0
8421701|NCT00901576|20755949|P2|NOT COMPLETED|Washout||0
8421702|NCT00901576|20755950|P1|NOT COMPLETED|Washout||0
8421703|NCT00901576|20755945|P6|COMPLETED|Washout||5
8421704|NCT00901576|20755946|P5|COMPLETED|Washout||6
8421705|NCT00901576|20755947|P4|COMPLETED|Washout||5
8421706|NCT00901576|20755948|P3|COMPLETED|Washout||7
8421707|NCT00901576|20755949|P2|COMPLETED|Washout||7
8421708|NCT00901576|20755950|P1|COMPLETED|Washout||5
8421709|NCT00901576|20755945|P6|STARTED|Washout||5
8421710|NCT00901576|20755946|P5|STARTED|Washout||6
8421711|NCT00901576|20755947|P4|STARTED|Washout||5
8421712|NCT00901576|20755948|P3|STARTED|Washout||7
8421713|NCT00901576|20755949|P2|STARTED|Washout||7
8421714|NCT00901576|20755950|P1|STARTED|Washout||5
8421715|NCT00901576|20755945|P6|NOT COMPLETED|Second Intervention||1
8421716|NCT00901576|20755946|P5|NOT COMPLETED|Second Intervention||0
8421717|NCT00901576|20755947|P4|NOT COMPLETED|Second Intervention||1
8421718|NCT00901576|20755948|P3|NOT COMPLETED|Second Intervention||0
8421719|NCT00901576|20755949|P2|NOT COMPLETED|Second Intervention||0
8421720|NCT00901576|20755950|P1|NOT COMPLETED|Second Intervention||1
8421721|NCT00901576|20755945|P6|COMPLETED|Second Intervention||5
8421722|NCT00901576|20755946|P5|COMPLETED|Second Intervention||6
8421723|NCT00901576|20755947|P4|COMPLETED|Second Intervention||5
8421724|NCT00901576|20755948|P3|COMPLETED|Second Intervention||7
8421725|NCT00901576|20755949|P2|COMPLETED|Second Intervention||7
8421726|NCT00901576|20755950|P1|COMPLETED|Second Intervention||5
8421727|NCT00901576|20755945|P6|STARTED|Second Intervention||6
8421728|NCT00901576|20755946|P5|STARTED|Second Intervention||6
8421729|NCT00901576|20755947|P4|STARTED|Second Intervention||6
8421730|NCT00901576|20755948|P3|STARTED|Second Intervention||7
8421731|NCT00901576|20755949|P2|STARTED|Second Intervention||7
8421732|NCT00901576|20755950|P1|STARTED|Second Intervention||6
8421733|NCT00901576|20755945|P6|NOT COMPLETED|Washout||0
8421734|NCT00901576|20755946|P5|NOT COMPLETED|Washout||0
8421735|NCT00901576|20755947|P4|NOT COMPLETED|Washout||0
8421736|NCT00901576|20755948|P3|NOT COMPLETED|Washout||0
8421737|NCT00901576|20755949|P2|NOT COMPLETED|Washout||0
8421738|NCT00901576|20755950|P1|NOT COMPLETED|Washout||0
8421739|NCT00901576|20755945|P6|COMPLETED|Washout||6
8421740|NCT00901576|20755946|P5|COMPLETED|Washout||6
8421741|NCT00901576|20755947|P4|COMPLETED|Washout||6
8421742|NCT00901576|20755948|P3|COMPLETED|Washout||7
8421743|NCT00901576|20755949|P2|COMPLETED|Washout||7
8421744|NCT00901576|20755950|P1|COMPLETED|Washout||6
8421745|NCT00901576|20755945|P6|STARTED|Washout||6
8421746|NCT00901576|20755946|P5|STARTED|Washout||6
8421747|NCT00901576|20755947|P4|STARTED|Washout||6
8421748|NCT00901576|20755948|P3|STARTED|Washout||7
8421749|NCT00901576|20755949|P2|STARTED|Washout||7
8421750|NCT00901576|20755950|P1|STARTED|Washout||6
8421751|NCT00901576|20755945|P6|NOT COMPLETED|First Intervention||0
8421752|NCT00901576|20755946|P5|NOT COMPLETED|First Intervention||0
8421753|NCT00901576|20755947|P4|NOT COMPLETED|First Intervention||0
8421754|NCT00901576|20755948|P3|NOT COMPLETED|First Intervention||0
8421755|NCT00901576|20755949|P2|NOT COMPLETED|First Intervention||0
8421756|NCT00901576|20755950|P1|NOT COMPLETED|First Intervention||0
8421757|NCT00901576|20755945|P6|COMPLETED|First Intervention||6
8421758|NCT00901576|20755946|P5|COMPLETED|First Intervention||6
8421759|NCT00901576|20755947|P4|COMPLETED|First Intervention||6
8421760|NCT00901576|20755948|P3|COMPLETED|First Intervention||7
8421761|NCT00901576|20755949|P2|COMPLETED|First Intervention||7
8421762|NCT00901576|20755950|P1|COMPLETED|First Intervention||6
8421763|NCT00901576|20755945|P6|STARTED|First Intervention||6
8421764|NCT00901576|20755946|P5|STARTED|First Intervention||6
8421765|NCT00901576|20755947|P4|STARTED|First Intervention||6
8421766|NCT00901576|20755948|P3|STARTED|First Intervention||7
8421767|NCT00901576|20755949|P2|STARTED|First Intervention||7
8421768|NCT00901576|20755950|P1|STARTED|First Intervention||6
8421769|NCT00901459|20755971|P1|NOT COMPLETED|Overall Study||6
8421770|NCT00901459|20755971|P1|COMPLETED|Overall Study||15
8421771|NCT00901459|20755971|P1|STARTED|Overall Study||21
8421772|NCT00901394|20755985|P3|NOT COMPLETED|Overall Study||2
8421773|NCT00901394|20755986|P2|NOT COMPLETED|Overall Study||1
8421774|NCT00901394|20755987|P1|NOT COMPLETED|Overall Study||1
8421775|NCT00901394|20755985|P3|COMPLETED|Overall Study||20
8421776|NCT00901394|20755986|P2|COMPLETED|Overall Study||19
8421777|NCT00901394|20755987|P1|COMPLETED|Overall Study||20
8421778|NCT00901394|20755985|P3|STARTED|Overall Study||22
8421779|NCT00901394|20755986|P2|STARTED|Overall Study||20
8421780|NCT00901394|20755987|P1|STARTED|Overall Study||21
8421781|NCT00901342|20755995|P1|NOT COMPLETED|Overall Study||15
8421782|NCT00901342|20755995|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
8421783|NCT00901342|20755995|P1|Received at Least 1 Infusion|Overall Study||98
8421784|NCT00901342|20755995|P1|STARTED|Overall Study||104
8421785|NCT00901316|20756001|P2|NOT COMPLETED|Overall Study||0
8421786|NCT00901316|20756002|P1|NOT COMPLETED|Overall Study||0
8421787|NCT00901316|20756001|P2|COMPLETED|Overall Study||495
8421788|NCT00901316|20756002|P1|COMPLETED|Overall Study||492
8421789|NCT00901316|20756001|P2|STARTED|Overall Study||495
8421790|NCT00901316|20756002|P1|STARTED|Overall Study||492
8421791|NCT00901303|20756010|P2|NOT COMPLETED|Overall Study||0
8421792|NCT00901303|20756011|P1|NOT COMPLETED|Overall Study||0
8421793|NCT00901303|20756010|P2|COMPLETED|Overall Study||1
8421794|NCT00901303|20756011|P1|COMPLETED|Overall Study||5
8421795|NCT00901303|20756010|P2|STARTED|Overall Study||1
8421796|NCT00901303|20756011|P1|STARTED|Overall Study||5
8421797|NCT00901225|20756017|P1|NOT COMPLETED|Overall Study||1
8421798|NCT00901225|20756017|P1|COMPLETED|Overall Study||20
8421799|NCT00901225|20756017|P1|STARTED|Overall Study||21
8421800|NCT00901186|20756028|P2|NOT COMPLETED|Overall Study||11
8421801|NCT00901186|20756029|P1|NOT COMPLETED|Overall Study||9
8421802|NCT00901186|20756028|P2|COMPLETED|Overall Study||32
8421803|NCT00901186|20756029|P1|COMPLETED|Overall Study||31
8421804|NCT00901186|20756028|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
8421805|NCT00901186|20756029|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
8421806|NCT00901186|20756028|P2|Safety Set|Overall Study||43
8421807|NCT00901186|20756029|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
8421808|NCT00901186|20756028|P2|STARTED|Overall Study||43
8421809|NCT00901186|20756029|P1|STARTED|Overall Study||40
8421810|NCT00901017|20756045|P1|NOT COMPLETED|Overall Study||0
8421811|NCT00901017|20756045|P1|COMPLETED|Overall Study||14
8421812|NCT00901017|20756045|P1|STARTED|Overall Study||14
8421813|NCT00900822|20756059|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
8421814|NCT00900822|20756059|P1|COMPLETED|12 Months Clinical Evaluation||11
8421815|NCT00900822|20756059|P1|STARTED|12 Months Clinical Evaluation||11
8421816|NCT00900822|20756059|P1|NOT COMPLETED|9 Months Histological Evaluation||0
8421817|NCT00900822|20756059|P1|COMPLETED|9 Months Histological Evaluation||11
8421818|NCT00900822|20756059|P1|STARTED|9 Months Histological Evaluation||11
8421819|NCT00900796|20756069|P1|NOT COMPLETED|Phase 2||5
8421820|NCT00900796|20756069|P1|COMPLETED|Phase 2||6
8421821|NCT00900796|20756069|P1|STARTED|Phase 2||11
8421822|NCT00900796|20756069|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
8421823|NCT00900796|20756069|P1|COMPLETED|Between Phase 1 and Phase 2||11
8421824|NCT00900796|20756069|P1|STARTED|Between Phase 1 and Phase 2||121
8421825|NCT00900796|20756069|P1|NOT COMPLETED|Phase 1||11
8421826|NCT00900796|20756069|P1|COMPLETED|Phase 1||121
8421827|NCT00900796|20756069|P1|STARTED|Phase 1||132
8421828|NCT00900757|20756079|P1|NOT COMPLETED|Overall Study||19
8421829|NCT00900757|20756079|P1|COMPLETED|Overall Study||38
8421830|NCT00900757|20756079|P1|STARTED|Overall Study||57
8421831|NCT00900731|20756089|P2|NOT COMPLETED|Overall Study||61
8421832|NCT00900731|20756090|P1|NOT COMPLETED|Overall Study||60
8421833|NCT00900731|20756089|P2|COMPLETED|Overall Study||740
8421834|NCT00900731|20756090|P1|COMPLETED|Overall Study||737
8421835|NCT00900731|20756089|P2|Safety Set: Received Study Drug|Overall Study||799
8421836|NCT00900731|20756090|P1|Safety Set: Received Study Drug|Overall Study||794
8421837|NCT00900731|20756089|P2|STARTED|Overall Study||801
8421838|NCT00900731|20756090|P1|STARTED|Overall Study|Randomized participants|797
8421839|NCT00900666|20756112|P2|NOT COMPLETED|Overall Study||0
8421840|NCT00900666|20756113|P1|NOT COMPLETED|Overall Study||0
8421841|NCT00900666|20756112|P2|COMPLETED|Overall Study||9
8421842|NCT00900666|20756113|P1|COMPLETED|Overall Study||10
8421843|NCT00900666|20756112|P2|STARTED|Overall Study||9
8421844|NCT00900666|20756113|P1|STARTED|Overall Study||10
8421845|NCT00900627|20756127|P6|NOT COMPLETED|Overall Study||26
8421846|NCT00900627|20756128|P5|NOT COMPLETED|Overall Study||29
8421847|NCT00900627|20756129|P4|NOT COMPLETED|Overall Study||6
8421848|NCT00900627|20756130|P3|NOT COMPLETED|Overall Study||6
8421849|NCT00900627|20756131|P2|NOT COMPLETED|Overall Study||2
8421850|NCT00900627|20756132|P1|NOT COMPLETED|Overall Study||6
8421851|NCT00900627|20756127|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
8421852|NCT00900627|20756128|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
8421853|NCT00900627|20756129|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421854|NCT00900627|20756130|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421855|NCT00900627|20756131|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421856|NCT00900627|20756132|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421857|NCT00900627|20756127|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
8421858|NCT00900627|20756128|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
8421859|NCT00900627|20756129|P4|STARTED|Overall Study||6
8421860|NCT00900627|20756130|P3|STARTED|Overall Study||6
8421861|NCT00900627|20756131|P2|STARTED|Overall Study||2
8421862|NCT00900627|20756132|P1|STARTED|Overall Study||6
8421863|NCT00900601|20756150|P1|NOT COMPLETED|Overall Study||1
8421864|NCT00900601|20756150|P1|COMPLETED|Overall Study||8
8421865|NCT00900601|20756150|P1|STARTED|Overall Study||9
8421866|NCT00900237|20756158|P2|NOT COMPLETED|Overall Study||0
8421867|NCT00900237|20756159|P1|NOT COMPLETED|Overall Study||0
8421868|NCT00900237|20756158|P2|COMPLETED|Overall Study||7
8421869|NCT00900237|20756159|P1|COMPLETED|Overall Study||7
8421870|NCT00900237|20756158|P2|STARTED|Overall Study||7
8421871|NCT00900237|20756159|P1|STARTED|Overall Study||7
8421872|NCT00900159|20756169|P2|NOT COMPLETED|Second Intervention||0
8421873|NCT00900159|20756170|P1|NOT COMPLETED|Second Intervention||1
8421874|NCT00900159|20756169|P2|COMPLETED|Second Intervention||13
8421875|NCT00900159|20756170|P1|COMPLETED|Second Intervention||10
8421876|NCT00900159|20756169|P2|STARTED|Second Intervention||13
8421877|NCT00900159|20756170|P1|STARTED|Second Intervention||11
8421878|NCT00900159|20756169|P2|NOT COMPLETED|Washout||0
8421879|NCT00900159|20756170|P1|NOT COMPLETED|Washout||0
8421880|NCT00900159|20756169|P2|COMPLETED|Washout||13
8421881|NCT00900159|20756170|P1|COMPLETED|Washout||11
8421882|NCT00900159|20756169|P2|STARTED|Washout||13
8421883|NCT00900159|20756170|P1|STARTED|Washout||11
8421884|NCT00900159|20756169|P2|NOT COMPLETED|First Intervention||0
8421885|NCT00900159|20756170|P1|NOT COMPLETED|First Intervention||0
8421886|NCT00900159|20756169|P2|COMPLETED|First Intervention||13
8421887|NCT00900159|20756170|P1|COMPLETED|First Intervention||11
8421888|NCT00900159|20756169|P2|STARTED|First Intervention||13
8421889|NCT00900159|20756170|P1|STARTED|First Intervention||11
8421890|NCT00900146|20756189|P5|NOT COMPLETED|Intermediate: Period III||167
8421891|NCT00900146|20756190|P4|NOT COMPLETED|Intermediate: Period III||90
8421892|NCT00900146|20756191|P3|NOT COMPLETED|Intermediate: Period III||84
8421893|NCT00900146|20756192|P2|NOT COMPLETED|Intermediate: Period III||93
8421894|NCT00900146|20756193|P1|NOT COMPLETED|Intermediate: Period III||87
8421895|NCT00900146|20756189|P5|COMPLETED|Intermediate: Period III||0
8421896|NCT00900146|20756190|P4|COMPLETED|Intermediate: Period III||0
8421897|NCT00900146|20756191|P3|COMPLETED|Intermediate: Period III||0
8421898|NCT00900146|20756192|P2|COMPLETED|Intermediate: Period III||0
8421899|NCT00900146|20756193|P1|COMPLETED|Intermediate: Period III||0
8421900|NCT00900146|20756189|P5|Safety Set|Intermediate: Period III||166
8421901|NCT00900146|20756190|P4|Safety Set|Intermediate: Period III||90
8421902|NCT00900146|20756191|P3|Safety Set|Intermediate: Period III||84
8421903|NCT00900146|20756192|P2|Safety Set|Intermediate: Period III||92
8421904|NCT00900146|20756193|P1|Safety Set|Intermediate: Period III||86
8421905|NCT00900146|20756189|P5|STARTED|Intermediate: Period III||167
8421906|NCT00900146|20756190|P4|STARTED|Intermediate: Period III||90
8421907|NCT00900146|20756191|P3|STARTED|Intermediate: Period III||84
8421908|NCT00900146|20756192|P2|STARTED|Intermediate: Period III||93
8421909|NCT00900146|20756193|P1|STARTED|Intermediate: Period III||87
8421910|NCT00900146|20756189|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
8421911|NCT00900146|20756190|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
8421912|NCT00900146|20756191|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
8421913|NCT00900146|20756192|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
8421914|NCT00900146|20756193|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
8421915|NCT00900146|20756189|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
8421916|NCT00900146|20756190|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
8421917|NCT00900146|20756191|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
8421918|NCT00900146|20756192|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
8421919|NCT00900146|20756193|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
8421920|NCT00900146|20756189|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
8421921|NCT00900146|20756190|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
8421922|NCT00900146|20756191|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
8421923|NCT00900146|20756192|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
8421924|NCT00900146|20756193|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
8421925|NCT00900146|20756189|P5|STARTED|Dose Finding: Period II (4 Months)||179
8421926|NCT00900146|20756190|P4|STARTED|Dose Finding: Period II (4 Months)||92
8421927|NCT00900146|20756191|P3|STARTED|Dose Finding: Period II (4 Months)||92
8421928|NCT00900146|20756192|P2|STARTED|Dose Finding: Period II (4 Months)||95
8421929|NCT00900146|20756193|P1|STARTED|Dose Finding: Period II (4 Months)||93
8421930|NCT00900029|20756310|P5|NOT COMPLETED|Overall Study||6
8421931|NCT00900029|20756311|P4|NOT COMPLETED|Overall Study||7
8421932|NCT00900029|20756312|P3|NOT COMPLETED|Overall Study||3
8421933|NCT00900029|20756313|P2|NOT COMPLETED|Overall Study||4
8421934|NCT00900029|20756314|P1|NOT COMPLETED|Overall Study||3
8421935|NCT00900029|20756310|P5|COMPLETED|Overall Study||38
8421936|NCT00900029|20756311|P4|COMPLETED|Overall Study||35
8421937|NCT00900029|20756312|P3|COMPLETED|Overall Study||38
8421938|NCT00900029|20756313|P2|COMPLETED|Overall Study||37
8421939|NCT00900029|20756314|P1|COMPLETED|Overall Study||35
8421940|NCT00900029|20756310|P5|STARTED|Overall Study||44
8421941|NCT00900029|20756311|P4|STARTED|Overall Study||42
8421942|NCT00900029|20756312|P3|STARTED|Overall Study||41
8421943|NCT00900029|20756313|P2|STARTED|Overall Study||41
8421944|NCT00900029|20756314|P1|STARTED|Overall Study||38
8421945|NCT00899847|20756331|P1|NOT COMPLETED|Overall Study||2
8421946|NCT00899847|20756331|P1|COMPLETED|Overall Study||7
8421947|NCT00899847|20756331|P1|STARTED|Overall Study||9
8421948|NCT00899717|20756344|P2|NOT COMPLETED|Overall Study||0
8421949|NCT00899717|20756345|P1|NOT COMPLETED|Overall Study||0
8421950|NCT00899717|20756344|P2|COMPLETED|Overall Study||11
8421951|NCT00899717|20756345|P1|COMPLETED|Overall Study||10
8421952|NCT00899717|20756344|P2|STARTED|Overall Study||11
8421953|NCT00899717|20756345|P1|STARTED|Overall Study||10
8421954|NCT00899678|20756362|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
8421955|NCT00899678|20756363|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
8421956|NCT00899678|20756364|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
8421957|NCT00899678|20756362|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
8421958|NCT00899678|20756363|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
8421959|NCT00899678|20756364|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
8421960|NCT00899678|20756362|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
8421961|NCT00899678|20756363|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
8421962|NCT00899678|20756364|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
8421963|NCT00899678|20756362|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
8421964|NCT00899678|20756363|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
8421965|NCT00899678|20756364|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
8421966|NCT00899678|20756362|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
8421967|NCT00899678|20756363|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
8421968|NCT00899678|20756364|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
8421969|NCT00899678|20756362|P3|STARTED|Induction Period (Weeks 0 to 6)||35
8421970|NCT00899678|20756363|P2|STARTED|Induction Period (Weeks 0 to 6)||37
8421971|NCT00899678|20756364|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
8421972|NCT00899600|20756394|P2|NOT COMPLETED|Overall Study||0
8421973|NCT00899600|20756395|P1|NOT COMPLETED|Overall Study||0
8421974|NCT00899600|20756394|P2|COMPLETED|Overall Study||52
8421975|NCT00899600|20756395|P1|COMPLETED|Overall Study||50
8421976|NCT00899600|20756394|P2|STARTED|Overall Study||52
8421977|NCT00899600|20756395|P1|STARTED|Overall Study||50
8421978|NCT00899574|20756409|P1|NOT COMPLETED|Overall Study||0
8421979|NCT00899574|20756409|P1|COMPLETED|Overall Study||10
8421980|NCT00899574|20756409|P1|STARTED|Overall Study||10
8421981|NCT00899548|20756414|P1|NOT COMPLETED|Overall Study||3
8421982|NCT00899548|20756414|P1|COMPLETED|Overall Study||179
8421983|NCT00899548|20756414|P1|STARTED|Overall Study||182
8421984|NCT00899470|20756426|P4|NOT COMPLETED|Fourth Therapy||0
8421985|NCT00899470|20756427|P3|NOT COMPLETED|Fourth Therapy||0
8421986|NCT00899470|20756428|P2|NOT COMPLETED|Fourth Therapy||0
8421987|NCT00899470|20756429|P1|NOT COMPLETED|Fourth Therapy||0
8421988|NCT00899470|20756426|P4|COMPLETED|Fourth Therapy||6
8421989|NCT00899470|20756427|P3|COMPLETED|Fourth Therapy||6
8421990|NCT00899470|20756428|P2|COMPLETED|Fourth Therapy||6
8421991|NCT00899470|20756429|P1|COMPLETED|Fourth Therapy||6
8421992|NCT00899470|20756426|P4|STARTED|Fourth Therapy||6
8421993|NCT00899470|20756427|P3|STARTED|Fourth Therapy||6
8421994|NCT00899470|20756428|P2|STARTED|Fourth Therapy||6
8421995|NCT00899470|20756429|P1|STARTED|Fourth Therapy||6
8421996|NCT00899470|20756426|P4|NOT COMPLETED|Third Washout||0
8421997|NCT00899470|20756427|P3|NOT COMPLETED|Third Washout||0
8421998|NCT00899470|20756428|P2|NOT COMPLETED|Third Washout||0
8421999|NCT00899470|20756429|P1|NOT COMPLETED|Third Washout||0
8422000|NCT00899470|20756426|P4|COMPLETED|Third Washout||6
8422001|NCT00899470|20756427|P3|COMPLETED|Third Washout||6
8422002|NCT00899470|20756428|P2|COMPLETED|Third Washout||6
8422003|NCT00899470|20756429|P1|COMPLETED|Third Washout||6
8422004|NCT00899470|20756426|P4|STARTED|Third Washout||6
8422005|NCT00899470|20756427|P3|STARTED|Third Washout||6
8422006|NCT00899470|20756428|P2|STARTED|Third Washout||6
8422007|NCT00899470|20756429|P1|STARTED|Third Washout||6
8422008|NCT00899470|20756426|P4|NOT COMPLETED|Third Therapy||0
8422009|NCT00899470|20756427|P3|NOT COMPLETED|Third Therapy||0
8422010|NCT00899470|20756428|P2|NOT COMPLETED|Third Therapy||0
8422011|NCT00899470|20756429|P1|NOT COMPLETED|Third Therapy||0
8422012|NCT00899470|20756426|P4|COMPLETED|Third Therapy||6
8422013|NCT00899470|20756427|P3|COMPLETED|Third Therapy||6
8422014|NCT00899470|20756428|P2|COMPLETED|Third Therapy||6
8422015|NCT00899470|20756429|P1|COMPLETED|Third Therapy||6
8422016|NCT00899470|20756426|P4|STARTED|Third Therapy||6
8422017|NCT00899470|20756427|P3|STARTED|Third Therapy||6
8422018|NCT00899470|20756428|P2|STARTED|Third Therapy||6
8422019|NCT00899470|20756429|P1|STARTED|Third Therapy||6
8422020|NCT00899470|20756426|P4|NOT COMPLETED|Second Washout||0
8422021|NCT00899470|20756427|P3|NOT COMPLETED|Second Washout||0
8422022|NCT00899470|20756428|P2|NOT COMPLETED|Second Washout||0
8422023|NCT00899470|20756429|P1|NOT COMPLETED|Second Washout||0
8422024|NCT00899470|20756426|P4|COMPLETED|Second Washout||6
8422025|NCT00899470|20756427|P3|COMPLETED|Second Washout||6
8422026|NCT00899470|20756428|P2|COMPLETED|Second Washout||6
8422027|NCT00899470|20756429|P1|COMPLETED|Second Washout||6
8422028|NCT00899470|20756426|P4|STARTED|Second Washout||6
8422029|NCT00899470|20756427|P3|STARTED|Second Washout||6
8422030|NCT00899470|20756428|P2|STARTED|Second Washout||6
8422031|NCT00899470|20756429|P1|STARTED|Second Washout||6
8422032|NCT00899470|20756426|P4|NOT COMPLETED|Second Therapy||0
8422033|NCT00899470|20756427|P3|NOT COMPLETED|Second Therapy||0
8422034|NCT00899470|20756428|P2|NOT COMPLETED|Second Therapy||0
8422035|NCT00899470|20756429|P1|NOT COMPLETED|Second Therapy||0
8422036|NCT00899470|20756426|P4|COMPLETED|Second Therapy||6
8422037|NCT00899470|20756427|P3|COMPLETED|Second Therapy||6
8422038|NCT00899470|20756428|P2|COMPLETED|Second Therapy||6
8422039|NCT00899470|20756429|P1|COMPLETED|Second Therapy||6
8422040|NCT00899470|20756426|P4|STARTED|Second Therapy||6
8422041|NCT00899470|20756427|P3|STARTED|Second Therapy||6
8422042|NCT00899470|20756428|P2|STARTED|Second Therapy||6
8422043|NCT00899470|20756429|P1|STARTED|Second Therapy||6
8422044|NCT00899470|20756426|P4|NOT COMPLETED|First Washout Period||0
8422045|NCT00899470|20756427|P3|NOT COMPLETED|First Washout Period||0
8422046|NCT00899470|20756428|P2|NOT COMPLETED|First Washout Period||0
8422047|NCT00899470|20756429|P1|NOT COMPLETED|First Washout Period||0
8422048|NCT00899470|20756426|P4|COMPLETED|First Washout Period||6
8422049|NCT00899470|20756427|P3|COMPLETED|First Washout Period||6
8422050|NCT00899470|20756428|P2|COMPLETED|First Washout Period||6
8422051|NCT00899470|20756429|P1|COMPLETED|First Washout Period||6
8422052|NCT00899470|20756426|P4|STARTED|First Washout Period||6
8422053|NCT00899470|20756427|P3|STARTED|First Washout Period||6
8422054|NCT00899470|20756428|P2|STARTED|First Washout Period||6
8422055|NCT00899470|20756429|P1|STARTED|First Washout Period||6
8422056|NCT00899470|20756426|P4|NOT COMPLETED|First Therapy||0
8422057|NCT00899470|20756427|P3|NOT COMPLETED|First Therapy||0
8422058|NCT00899470|20756428|P2|NOT COMPLETED|First Therapy||0
8422059|NCT00899470|20756429|P1|NOT COMPLETED|First Therapy||0
8422060|NCT00899470|20756426|P4|COMPLETED|First Therapy||6
8422061|NCT00899470|20756427|P3|COMPLETED|First Therapy||6
8422062|NCT00899470|20756428|P2|COMPLETED|First Therapy||6
8422063|NCT00899470|20756429|P1|COMPLETED|First Therapy||6
8422064|NCT00899470|20756426|P4|STARTED|First Therapy||6
8422065|NCT00899470|20756427|P3|STARTED|First Therapy||6
8422066|NCT00899470|20756428|P2|STARTED|First Therapy||6
8422067|NCT00899470|20756429|P1|STARTED|First Therapy||6
8422068|NCT00899431|20756508|P3|NOT COMPLETED|Overall Study||0
8422069|NCT00899431|20756509|P2|NOT COMPLETED|Overall Study||0
8422070|NCT00899431|20756510|P1|NOT COMPLETED|Overall Study||1
8422071|NCT00899431|20756508|P3|COMPLETED|Overall Study||9
8422072|NCT00899431|20756509|P2|COMPLETED|Overall Study||8
8422073|NCT00899431|20756510|P1|COMPLETED|Overall Study||21
8422074|NCT00899431|20756508|P3|STARTED|Overall Study||9
8422075|NCT00899431|20756509|P2|STARTED|Overall Study||8
8422076|NCT00899431|20756510|P1|STARTED|Overall Study||22
8422077|NCT00899392|20756523|P2|NOT COMPLETED|Overall Study||24
8422078|NCT00899392|20756524|P1|NOT COMPLETED|Overall Study||21
8422079|NCT00899392|20756523|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
8422080|NCT00899392|20756524|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
8422081|NCT00899392|20756523|P2|STARTED|Overall Study||74
8422082|NCT00899392|20756524|P1|STARTED|Overall Study||68
8422083|NCT00899379|20756541|P5|NOT COMPLETED|Overall Study||31
8422084|NCT00899379|20756542|P4|NOT COMPLETED|Overall Study||37
8422085|NCT00899379|20756543|P3|NOT COMPLETED|Overall Study||29
8422086|NCT00899379|20756544|P2|NOT COMPLETED|Overall Study||29
8422087|NCT00899379|20756545|P1|NOT COMPLETED|Overall Study||34
8422088|NCT00899379|20756541|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
8422089|NCT00899379|20756542|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
8422090|NCT00899379|20756543|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
8422091|NCT00899379|20756544|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
8422092|NCT00899379|20756545|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
8422093|NCT00899379|20756541|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
8422094|NCT00899379|20756542|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
8422095|NCT00899379|20756543|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
8422096|NCT00899379|20756544|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
8422097|NCT00899379|20756545|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
8422098|NCT00899379|20756541|P5|Patients Treated|Overall Study|Patients who took study drug|81
8422099|NCT00899379|20756542|P4|Patients Treated|Overall Study|Patients who took study drug|77
8422100|NCT00899379|20756543|P3|Patients Treated|Overall Study|Patients who took study drug|84
8422101|NCT00899379|20756544|P2|Patients Treated|Overall Study|Patients who took study drug|82
8422102|NCT00899379|20756545|P1|Patients Treated|Overall Study|Patients who took study drug|83
8422103|NCT00899379|20756541|P5|STARTED|Overall Study|Patients who were allocated study drug|94
8422104|NCT00899379|20756542|P4|STARTED|Overall Study|Patients who were allocated study drug|94
8422105|NCT00899379|20756543|P3|STARTED|Overall Study|Patients who were allocated study drug|95
8422106|NCT00899379|20756544|P2|STARTED|Overall Study|Patients who were allocated study drug|95
8422107|NCT00899379|20756545|P1|STARTED|Overall Study|Patients who were allocated study drug|95
8422108|NCT00899353|20756557|P1|NOT COMPLETED|Overall Study||5
8422109|NCT00899353|20756557|P1|COMPLETED|Overall Study||11
8422110|NCT00899353|20756557|P1|STARTED|Overall Study||16
8422111|NCT00898937|20756581|P3|NOT COMPLETED|Overall Study||0
8422112|NCT00898937|20756582|P2|NOT COMPLETED|Overall Study||0
8422113|NCT00898937|20756583|P1|NOT COMPLETED|Overall Study||0
8422114|NCT00898937|20756581|P3|COMPLETED|Overall Study||9
8422115|NCT00898937|20756582|P2|COMPLETED|Overall Study||21
8422116|NCT00898937|20756583|P1|COMPLETED|Overall Study||25
8422117|NCT00898937|20756581|P3|STARTED|Overall Study||9
8422118|NCT00898937|20756582|P2|STARTED|Overall Study||21
8422119|NCT00898937|20756583|P1|STARTED|Overall Study||25
8422120|NCT00898807|20756593|P2|NOT COMPLETED|Overall Study||9
8422121|NCT00898807|20756594|P1|NOT COMPLETED|Overall Study||8
8422122|NCT00898807|20756593|P2|COMPLETED|Overall Study||83
8422123|NCT00898807|20756594|P1|COMPLETED|Overall Study||86
8422124|NCT00898807|20756593|P2|STARTED|Overall Study||92
8422125|NCT00898807|20756594|P1|STARTED|Overall Study||94
8422126|NCT00898677|20756610|P4|NOT COMPLETED|Overall Study||19
8422127|NCT00898677|20756611|P3|NOT COMPLETED|Overall Study||72
8422128|NCT00898677|20756612|P2|NOT COMPLETED|Overall Study||69
8422129|NCT00898677|20756613|P1|NOT COMPLETED|Overall Study||17
8422130|NCT00898677|20756610|P4|COMPLETED|Overall Study||159
8422131|NCT00898677|20756611|P3|COMPLETED|Overall Study||383
8422132|NCT00898677|20756612|P2|COMPLETED|Overall Study||386
8422133|NCT00898677|20756613|P1|COMPLETED|Overall Study||163
8422134|NCT00898677|20756610|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
8422135|NCT00898677|20756611|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
8422136|NCT00898677|20756612|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
8422137|NCT00898677|20756613|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
8422138|NCT00898677|20756610|P4|STARTED|Overall Study||178
8422139|NCT00898677|20756611|P3|STARTED|Overall Study||455
8422140|NCT00898677|20756612|P2|STARTED|Overall Study||455
8422141|NCT00898677|20756613|P1|STARTED|Overall Study||180
8422142|NCT00898560|20756639|P1|NOT COMPLETED|Overall Study||1
8422143|NCT00898560|20756639|P1|COMPLETED|Overall Study||19
8422144|NCT00898560|20756639|P1|STARTED|Overall Study||20
8422145|NCT00898443|20756651|P2|NOT COMPLETED|Overall Study||0
8422146|NCT00898443|20756652|P1|NOT COMPLETED|Overall Study||1
8422147|NCT00898443|20756651|P2|COMPLETED|Overall Study||8
8422148|NCT00898443|20756652|P1|COMPLETED|Overall Study||9
8422149|NCT00898443|20756651|P2|STARTED|Overall Study||8
8422150|NCT00898443|20756652|P1|STARTED|Overall Study||10
8422151|NCT00898222|20756660|P1|NOT COMPLETED|Overall Study||0
8422152|NCT00898222|20756660|P1|COMPLETED|Overall Study||4
8422153|NCT00898222|20756660|P1|STARTED|Overall Study||4
8422154|NCT00897949|20756667|P3|NOT COMPLETED|Overall Study||69
8422155|NCT00897949|20756668|P2|NOT COMPLETED|Overall Study||103
8422156|NCT00897949|20756669|P1|NOT COMPLETED|Overall Study||104
8422157|NCT00897949|20756667|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
8422158|NCT00897949|20756668|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
8422159|NCT00897949|20756669|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
8422160|NCT00897949|20756667|P3|Patients Treated|Overall Study|Patients who took study drug|304
8422161|NCT00897949|20756668|P2|Patients Treated|Overall Study|Patients who took study drug|456
8422162|NCT00897949|20756669|P1|Patients Treated|Overall Study|Patients who took study drug|458
8422163|NCT00897949|20756667|P3|STARTED|Overall Study|Patients who were allocated study drug|370
8422164|NCT00897949|20756668|P2|STARTED|Overall Study|Patients who were allocated study drug|549
8422165|NCT00897949|20756669|P1|STARTED|Overall Study|Patients who were allocated study drug|554
8422166|NCT00897910|20756692|P1|NOT COMPLETED|Overall Study||0
8422167|NCT00897910|20756692|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
8422168|NCT00897910|20756692|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
8422169|NCT00897897|20756696|P1|NOT COMPLETED|Overall Study||0
8422170|NCT00897897|20756696|P1|COMPLETED|Overall Study||33
8422171|NCT00897897|20756696|P1|STARTED|Overall Study||33
8422172|NCT00897715|20756703|P2|NOT COMPLETED|Overall Study||1
8422173|NCT00897715|20756704|P1|NOT COMPLETED|Overall Study||2
8422174|NCT00897715|20756703|P2|COMPLETED|Overall Study||6
8422175|NCT00897715|20756704|P1|COMPLETED|Overall Study||6
8422176|NCT00897715|20756703|P2|STARTED|Overall Study||7
8422177|NCT00897715|20756704|P1|STARTED|Overall Study||8
8422178|NCT00897676|20756712|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
8422179|NCT00897676|20756713|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
8422180|NCT00897676|20756712|P2|COMPLETED|Intervention 2(6 Hours)||7
8422181|NCT00897676|20756713|P1|COMPLETED|Intervention 2(6 Hours)||9
8422182|NCT00897676|20756712|P2|STARTED|Intervention 2(6 Hours)||7
8422183|NCT00897676|20756713|P1|STARTED|Intervention 2(6 Hours)||9
8422184|NCT00897676|20756712|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
8422185|NCT00897676|20756713|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
8422186|NCT00897676|20756712|P2|COMPLETED|Intervention 1(6 Hours)||7
8422187|NCT00897676|20756713|P1|COMPLETED|Intervention 1(6 Hours)||9
8422188|NCT00897676|20756712|P2|STARTED|Intervention 1(6 Hours)||7
8422189|NCT00897676|20756713|P1|STARTED|Intervention 1(6 Hours)||9
8422190|NCT00897390|20756729|P1|NOT COMPLETED|Overall Study||6
8422191|NCT00897390|20756729|P1|COMPLETED|Overall Study||18
8422192|NCT00897390|20756729|P1|STARTED|Overall Study||24
8422193|NCT00897104|20756819|P3|NOT COMPLETED|Overall Study||8
8422194|NCT00897104|20756820|P2|NOT COMPLETED|Overall Study||71
8422195|NCT00897104|20756821|P1|NOT COMPLETED|Overall Study||64
8422196|NCT00897104|20756819|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
8422197|NCT00897104|20756820|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
8422198|NCT00897104|20756821|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
8422199|NCT00897104|20756819|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
8422200|NCT00897104|20756820|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
8422201|NCT00897104|20756821|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
8422202|NCT00897104|20756819|P3|Participants Treated|Overall Study|Participants who took study drug|80
8422203|NCT00897104|20756820|P2|Participants Treated|Overall Study|Participants who took study drug|357
8422204|NCT00897104|20756821|P1|Participants Treated|Overall Study|Participants who took study drug|355
8422205|NCT00897104|20756819|P3|STARTED|Overall Study|Participants who were allocated study drug|87
8422206|NCT00897104|20756820|P2|STARTED|Overall Study|Participants who were allocated study drug|428
8422207|NCT00897104|20756821|P1|STARTED|Overall Study|Participants who were allocated study drug|418
8422208|NCT00896779|20756849|P2|NOT COMPLETED|Overall Study||1
8422209|NCT00896779|20756850|P1|NOT COMPLETED|Overall Study||0
8422210|NCT00896779|20756849|P2|COMPLETED|Overall Study||11
8422211|NCT00896779|20756850|P1|COMPLETED|Overall Study||8
8422212|NCT00896779|20756849|P2|STARTED|Overall Study||12
8422213|NCT00896779|20756850|P1|STARTED|Overall Study||8
8422214|NCT00896649|20756856|P1|NOT COMPLETED|Overall Study||5
8422215|NCT00896649|20756856|P1|COMPLETED|Overall Study||188
8422216|NCT00896649|20756856|P1|STARTED|Overall Study||193
8422217|NCT00896532|20756869|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422218|NCT00896532|20756870|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
8422219|NCT00896532|20756871|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422220|NCT00896532|20756872|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422221|NCT00896532|20756873|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
8422222|NCT00896532|20756874|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422223|NCT00896532|20756875|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422224|NCT00896532|20756876|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422225|NCT00896532|20756877|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422226|NCT00896532|20756878|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422227|NCT00896532|20756879|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422228|NCT00896532|20756880|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422229|NCT00896532|20756881|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422230|NCT00896532|20756882|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422231|NCT00896532|20756883|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422232|NCT00896532|20756884|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422233|NCT00896532|20756885|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422234|NCT00896532|20756886|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422235|NCT00896532|20756887|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422236|NCT00896532|20756888|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422237|NCT00896532|20756889|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422238|NCT00896532|20756890|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422239|NCT00896532|20756891|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422240|NCT00896532|20756869|P23|COMPLETED|Months 48-72: Follow-on Phase||8
8422241|NCT00896532|20756870|P22|COMPLETED|Months 48-72: Follow-on Phase||57
8422242|NCT00896532|20756871|P21|COMPLETED|Months 48-72: Follow-on Phase||12
8422243|NCT00896532|20756872|P20|COMPLETED|Months 48-72: Follow-on Phase||11
8422244|NCT00896532|20756873|P19|COMPLETED|Months 48-72: Follow-on Phase||50
8422245|NCT00896532|20756874|P18|COMPLETED|Months 48-72: Follow-on Phase||0
8422246|NCT00896532|20756875|P17|COMPLETED|Months 48-72: Follow-on Phase||0
8422247|NCT00896532|20756876|P16|COMPLETED|Months 48-72: Follow-on Phase||0
8422248|NCT00896532|20756877|P15|COMPLETED|Months 48-72: Follow-on Phase||0
8422249|NCT00896532|20756878|P14|COMPLETED|Months 48-72: Follow-on Phase||0
8422250|NCT00896532|20756879|P13|COMPLETED|Months 48-72: Follow-on Phase||0
8422251|NCT00896532|20756880|P12|COMPLETED|Months 48-72: Follow-on Phase||0
8422252|NCT00896532|20756881|P11|COMPLETED|Months 48-72: Follow-on Phase||0
8422253|NCT00896532|20756882|P10|COMPLETED|Months 48-72: Follow-on Phase||0
8422254|NCT00896532|20756883|P9|COMPLETED|Months 48-72: Follow-on Phase||0
8422255|NCT00896532|20756884|P8|COMPLETED|Months 48-72: Follow-on Phase||0
8422256|NCT00896532|20756885|P7|COMPLETED|Months 48-72: Follow-on Phase||0
8422257|NCT00896532|20756886|P6|COMPLETED|Months 48-72: Follow-on Phase||0
8422258|NCT00896532|20756887|P5|COMPLETED|Months 48-72: Follow-on Phase||0
8422259|NCT00896532|20756888|P4|COMPLETED|Months 48-72: Follow-on Phase||0
8422260|NCT00896532|20756889|P3|COMPLETED|Months 48-72: Follow-on Phase||0
8422261|NCT00896532|20756890|P2|COMPLETED|Months 48-72: Follow-on Phase||0
8422262|NCT00896532|20756891|P1|COMPLETED|Months 48-72: Follow-on Phase||0
8422263|NCT00896532|20756869|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
8422264|NCT00896532|20756870|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
8422265|NCT00896532|20756871|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
8422266|NCT00896532|20756872|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
8422267|NCT00896532|20756873|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422268|NCT00896532|20756874|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422269|NCT00896532|20756875|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422270|NCT00896532|20756876|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422271|NCT00896532|20756877|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422272|NCT00896532|20756878|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422273|NCT00896532|20756879|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422274|NCT00896532|20756880|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422275|NCT00896532|20756881|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422276|NCT00896532|20756882|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422277|NCT00896532|20756883|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422278|NCT00896532|20756884|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422279|NCT00896532|20756885|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422280|NCT00896532|20756886|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422281|NCT00896532|20756887|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422282|NCT00896532|20756888|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422283|NCT00896532|20756889|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422284|NCT00896532|20756890|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422285|NCT00896532|20756891|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422286|NCT00896532|20756869|P23|STARTED|Months 48-72: Follow-on Phase||8
8422287|NCT00896532|20756870|P22|STARTED|Months 48-72: Follow-on Phase||59
8422288|NCT00896532|20756871|P21|STARTED|Months 48-72: Follow-on Phase||12
8422289|NCT00896532|20756872|P20|STARTED|Months 48-72: Follow-on Phase||11
8422290|NCT00896532|20756873|P19|STARTED|Months 48-72: Follow-on Phase||51
8422291|NCT00896532|20756874|P18|STARTED|Months 48-72: Follow-on Phase||0
8422292|NCT00896532|20756875|P17|STARTED|Months 48-72: Follow-on Phase||0
8422293|NCT00896532|20756876|P16|STARTED|Months 48-72: Follow-on Phase||0
8422294|NCT00896532|20756877|P15|STARTED|Months 48-72: Follow-on Phase||0
8422295|NCT00896532|20756878|P14|STARTED|Months 48-72: Follow-on Phase||0
8422296|NCT00896532|20756879|P13|STARTED|Months 48-72: Follow-on Phase||0
8422297|NCT00896532|20756880|P12|STARTED|Months 48-72: Follow-on Phase||0
8422298|NCT00896532|20756881|P11|STARTED|Months 48-72: Follow-on Phase||0
8422299|NCT00896532|20756882|P10|STARTED|Months 48-72: Follow-on Phase||0
8422300|NCT00896532|20756883|P9|STARTED|Months 48-72: Follow-on Phase||0
8422301|NCT00896532|20756884|P8|STARTED|Months 48-72: Follow-on Phase||0
8422302|NCT00896532|20756885|P7|STARTED|Months 48-72: Follow-on Phase||0
8422303|NCT00896532|20756886|P6|STARTED|Months 48-72: Follow-on Phase||0
8422304|NCT00896532|20756887|P5|STARTED|Months 48-72: Follow-on Phase||0
8422305|NCT00896532|20756888|P4|STARTED|Months 48-72: Follow-on Phase||0
8422306|NCT00896532|20756889|P3|STARTED|Months 48-72: Follow-on Phase||0
8422307|NCT00896532|20756890|P2|STARTED|Months 48-72: Follow-on Phase||0
8422308|NCT00896532|20756891|P1|STARTED|Months 48-72: Follow-on Phase||0
8422309|NCT00896532|20756869|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422310|NCT00896532|20756870|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422311|NCT00896532|20756871|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422312|NCT00896532|20756872|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422313|NCT00896532|20756873|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422314|NCT00896532|20756874|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
8422315|NCT00896532|20756875|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
8422316|NCT00896532|20756876|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
8422317|NCT00896532|20756877|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422318|NCT00896532|20756878|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422319|NCT00896532|20756879|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422320|NCT00896532|20756880|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422321|NCT00896532|20756881|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422322|NCT00896532|20756882|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422323|NCT00896532|20756883|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422324|NCT00896532|20756884|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422325|NCT00896532|20756885|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422326|NCT00896532|20756886|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422327|NCT00896532|20756887|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422328|NCT00896532|20756888|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422329|NCT00896532|20756889|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422330|NCT00896532|20756890|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422331|NCT00896532|20756891|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422332|NCT00896532|20756869|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422333|NCT00896532|20756870|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422334|NCT00896532|20756871|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422335|NCT00896532|20756872|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422336|NCT00896532|20756873|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422337|NCT00896532|20756874|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
8422338|NCT00896532|20756875|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
8422339|NCT00896532|20756876|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
8422340|NCT00896532|20756877|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
8422341|NCT00896532|20756878|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422342|NCT00896532|20756879|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422343|NCT00896532|20756880|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422344|NCT00896532|20756881|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422345|NCT00896532|20756882|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422346|NCT00896532|20756883|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422347|NCT00896532|20756884|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422348|NCT00896532|20756885|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422349|NCT00896532|20756886|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422350|NCT00896532|20756887|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422351|NCT00896532|20756888|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422352|NCT00896532|20756889|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422353|NCT00896532|20756890|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422354|NCT00896532|20756891|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422355|NCT00896532|20756869|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422356|NCT00896532|20756870|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422357|NCT00896532|20756871|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422358|NCT00896532|20756872|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422359|NCT00896532|20756873|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422360|NCT00896532|20756874|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
8422361|NCT00896532|20756875|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
8422362|NCT00896532|20756876|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
8422363|NCT00896532|20756877|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
8422364|NCT00896532|20756878|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422365|NCT00896532|20756879|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422366|NCT00896532|20756880|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422367|NCT00896532|20756881|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422368|NCT00896532|20756882|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422369|NCT00896532|20756883|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422370|NCT00896532|20756884|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422371|NCT00896532|20756885|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422372|NCT00896532|20756886|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422373|NCT00896532|20756887|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422374|NCT00896532|20756888|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422375|NCT00896532|20756889|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422376|NCT00896532|20756890|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422377|NCT00896532|20756891|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422378|NCT00896532|20756869|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
8422379|NCT00896532|20756870|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
8422380|NCT00896532|20756871|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
8422381|NCT00896532|20756872|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
8422382|NCT00896532|20756873|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
8422383|NCT00896532|20756874|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
8422384|NCT00896532|20756875|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
8422385|NCT00896532|20756876|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
8422386|NCT00896532|20756877|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
8422387|NCT00896532|20756878|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
8422388|NCT00896532|20756879|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
8422389|NCT00896532|20756880|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
8422390|NCT00896532|20756881|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
8422391|NCT00896532|20756882|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
8422392|NCT00896532|20756883|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
8422393|NCT00896532|20756884|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
8422394|NCT00896532|20756885|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
8422395|NCT00896532|20756886|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
8422396|NCT00896532|20756887|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
8422397|NCT00896532|20756888|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
8422398|NCT00896532|20756889|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
8422399|NCT00896532|20756890|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
8422400|NCT00896532|20756891|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
8422401|NCT00896532|20756869|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422402|NCT00896532|20756870|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422403|NCT00896532|20756871|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422404|NCT00896532|20756872|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422405|NCT00896532|20756873|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422406|NCT00896532|20756874|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422407|NCT00896532|20756875|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422408|NCT00896532|20756876|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422409|NCT00896532|20756877|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422410|NCT00896532|20756878|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8422411|NCT00896532|20756879|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
8422412|NCT00896532|20756880|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8422413|NCT00896532|20756881|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8422414|NCT00896532|20756882|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422415|NCT00896532|20756883|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
8422416|NCT00896532|20756884|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422417|NCT00896532|20756885|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422418|NCT00896532|20756886|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422419|NCT00896532|20756887|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422420|NCT00896532|20756888|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422421|NCT00896532|20756889|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422422|NCT00896532|20756890|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422423|NCT00896532|20756891|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422424|NCT00896532|20756869|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422425|NCT00896532|20756870|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422426|NCT00896532|20756871|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422427|NCT00896532|20756872|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422428|NCT00896532|20756873|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422429|NCT00896532|20756874|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422430|NCT00896532|20756875|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422431|NCT00896532|20756876|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422432|NCT00896532|20756877|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422433|NCT00896532|20756878|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
8422434|NCT00896532|20756879|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
8422435|NCT00896532|20756880|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
8422436|NCT00896532|20756881|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
8422437|NCT00896532|20756882|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
8422438|NCT00896532|20756883|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
8422439|NCT00896532|20756884|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422440|NCT00896532|20756885|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422441|NCT00896532|20756886|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422442|NCT00896532|20756887|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422443|NCT00896532|20756888|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422444|NCT00896532|20756889|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422445|NCT00896532|20756890|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422446|NCT00896532|20756891|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422447|NCT00896532|20756869|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422448|NCT00896532|20756870|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422449|NCT00896532|20756871|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422450|NCT00896532|20756872|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422451|NCT00896532|20756873|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422452|NCT00896532|20756874|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422453|NCT00896532|20756875|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422454|NCT00896532|20756876|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422455|NCT00896532|20756877|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422456|NCT00896532|20756878|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
8422457|NCT00896532|20756879|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
8422458|NCT00896532|20756880|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
8422459|NCT00896532|20756881|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
8422460|NCT00896532|20756882|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
8422461|NCT00896532|20756883|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
8422462|NCT00896532|20756884|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422463|NCT00896532|20756885|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422464|NCT00896532|20756886|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422465|NCT00896532|20756887|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422466|NCT00896532|20756888|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422467|NCT00896532|20756889|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422468|NCT00896532|20756890|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422469|NCT00896532|20756891|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422470|NCT00896532|20756869|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
8422471|NCT00896532|20756870|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
8422472|NCT00896532|20756871|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
8422473|NCT00896532|20756872|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
8422474|NCT00896532|20756873|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
8422475|NCT00896532|20756874|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
8422476|NCT00896532|20756875|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
8422477|NCT00896532|20756876|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
8422478|NCT00896532|20756877|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
8422479|NCT00896532|20756878|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
8422480|NCT00896532|20756879|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
8422481|NCT00896532|20756880|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
8422482|NCT00896532|20756881|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
8422483|NCT00896532|20756882|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
8422484|NCT00896532|20756883|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
8422485|NCT00896532|20756884|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
8422486|NCT00896532|20756885|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
8422487|NCT00896532|20756886|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
8422488|NCT00896532|20756887|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
8422489|NCT00896532|20756888|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
8422490|NCT00896532|20756889|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
8422491|NCT00896532|20756890|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
8422492|NCT00896532|20756891|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
8422493|NCT00896532|20756869|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422494|NCT00896532|20756870|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422495|NCT00896532|20756871|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422496|NCT00896532|20756872|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422497|NCT00896532|20756873|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422498|NCT00896532|20756874|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422499|NCT00896532|20756875|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422500|NCT00896532|20756876|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422501|NCT00896532|20756877|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422502|NCT00896532|20756878|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422503|NCT00896532|20756879|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422504|NCT00896532|20756880|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422505|NCT00896532|20756881|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422506|NCT00896532|20756882|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422507|NCT00896532|20756883|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422508|NCT00896532|20756884|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
8422509|NCT00896532|20756885|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
8422510|NCT00896532|20756886|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
8422511|NCT00896532|20756887|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
8422512|NCT00896532|20756888|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
8422513|NCT00896532|20756889|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
8422514|NCT00896532|20756890|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
8422515|NCT00896532|20756891|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
8422516|NCT00896532|20756869|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422517|NCT00896532|20756870|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422518|NCT00896532|20756871|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422519|NCT00896532|20756872|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422520|NCT00896532|20756873|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422521|NCT00896532|20756874|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422522|NCT00896532|20756875|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422523|NCT00896532|20756876|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422524|NCT00896532|20756877|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422525|NCT00896532|20756878|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422526|NCT00896532|20756879|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422527|NCT00896532|20756880|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422528|NCT00896532|20756881|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422529|NCT00896532|20756882|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422530|NCT00896532|20756883|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422531|NCT00896532|20756884|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
8422532|NCT00896532|20756885|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
8422533|NCT00896532|20756886|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
8422534|NCT00896532|20756887|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8422535|NCT00896532|20756888|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
8422536|NCT00896532|20756889|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8422537|NCT00896532|20756890|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
8422538|NCT00896532|20756891|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8422539|NCT00896532|20756869|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422540|NCT00896532|20756870|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422541|NCT00896532|20756871|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422542|NCT00896532|20756872|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422543|NCT00896532|20756873|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422544|NCT00896532|20756874|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422545|NCT00896532|20756875|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422546|NCT00896532|20756876|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422547|NCT00896532|20756877|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422548|NCT00896532|20756878|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422549|NCT00896532|20756879|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422550|NCT00896532|20756880|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422551|NCT00896532|20756881|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422552|NCT00896532|20756882|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422553|NCT00896532|20756883|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422554|NCT00896532|20756884|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
8422555|NCT00896532|20756885|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
8422556|NCT00896532|20756886|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
8422557|NCT00896532|20756887|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
8422558|NCT00896532|20756888|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
8422559|NCT00896532|20756889|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
8422560|NCT00896532|20756890|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
8422561|NCT00896532|20756891|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
8422562|NCT00896532|20756869|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422563|NCT00896532|20756870|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422564|NCT00896532|20756871|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422565|NCT00896532|20756872|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422566|NCT00896532|20756873|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422567|NCT00896532|20756874|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422568|NCT00896532|20756875|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422569|NCT00896532|20756876|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422570|NCT00896532|20756877|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422571|NCT00896532|20756878|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422572|NCT00896532|20756879|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422573|NCT00896532|20756880|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422574|NCT00896532|20756881|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422575|NCT00896532|20756882|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422576|NCT00896532|20756883|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422577|NCT00896532|20756884|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
8422578|NCT00896532|20756885|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
8422579|NCT00896532|20756886|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
8422580|NCT00896532|20756887|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
8422581|NCT00896532|20756888|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
8422582|NCT00896532|20756889|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
8422583|NCT00896532|20756890|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
8422584|NCT00896532|20756891|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
8422585|NCT00896532|20756869|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422586|NCT00896532|20756870|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422587|NCT00896532|20756871|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422588|NCT00896532|20756872|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422589|NCT00896532|20756873|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422590|NCT00896532|20756874|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422591|NCT00896532|20756875|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422592|NCT00896532|20756876|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422593|NCT00896532|20756877|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422594|NCT00896532|20756878|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422595|NCT00896532|20756879|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422596|NCT00896532|20756880|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422597|NCT00896532|20756881|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422598|NCT00896532|20756882|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422599|NCT00896532|20756883|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422600|NCT00896532|20756884|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
8422601|NCT00896532|20756885|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
8422602|NCT00896532|20756886|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8422603|NCT00896532|20756887|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
8422604|NCT00896532|20756888|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8422605|NCT00896532|20756889|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
8422606|NCT00896532|20756890|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8422607|NCT00896532|20756891|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
8422608|NCT00896480|20757018|P1|NOT COMPLETED|Overall Study||21
8422609|NCT00896480|20757018|P1|COMPLETED|Overall Study||3
8422610|NCT00896480|20757018|P1|STARTED|Overall Study||24
8422611|NCT00896454|20757066|P1|NOT COMPLETED|Overall Study||33
8422612|NCT00896454|20757066|P1|COMPLETED|Overall Study||0
8422613|NCT00896454|20757066|P1|STARTED|Overall Study||33
8422614|NCT00896441|20757080|P2|NOT COMPLETED|Overall Study||0
8422615|NCT00896441|20757081|P1|NOT COMPLETED|Overall Study||2
8422616|NCT00896441|20757080|P2|COMPLETED|Overall Study||9
8422617|NCT00896441|20757081|P1|COMPLETED|Overall Study||15
8422618|NCT00896441|20757080|P2|STARTED|Overall Study||9
8422619|NCT00896441|20757081|P1|STARTED|Overall Study||17
8422620|NCT00896389|20757088|P1|NOT COMPLETED|HCTZ High Dose||0
8422621|NCT00896389|20757088|P1|COMPLETED|HCTZ High Dose||25
8422622|NCT00896389|20757088|P1|STARTED|HCTZ High Dose||25
8422623|NCT00896389|20757088|P1|NOT COMPLETED|HCTZ Low Dose||0
8422624|NCT00896389|20757088|P1|COMPLETED|HCTZ Low Dose||28
8422625|NCT00896389|20757088|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
8422626|NCT00896389|20757088|P1|NOT COMPLETED|Salt Loading||0
8422627|NCT00896389|20757088|P1|COMPLETED|Salt Loading||124
8422628|NCT00896389|20757088|P1|STARTED|Salt Loading||124
8422629|NCT00896363|20757105|P3|NOT COMPLETED|Overall Study||8
8422630|NCT00896363|20757106|P2|NOT COMPLETED|Overall Study||11
8422631|NCT00896363|20757107|P1|NOT COMPLETED|Overall Study||6
8422632|NCT00896363|20757105|P3|COMPLETED|Overall Study||24
8422633|NCT00896363|20757106|P2|COMPLETED|Overall Study||25
8422634|NCT00896363|20757107|P1|COMPLETED|Overall Study||25
8422635|NCT00896363|20757105|P3|STARTED|Overall Study||32
8422636|NCT00896363|20757106|P2|STARTED|Overall Study||36
8422637|NCT00896363|20757107|P1|STARTED|Overall Study||31
8422638|NCT00896337|20757159|P1|NOT COMPLETED|Overall Study||25
8422639|NCT00896337|20757159|P1|COMPLETED|Overall Study||100
8422640|NCT00896337|20757159|P1|STARTED|Overall Study||125
8422641|NCT00896298|20757228|P2|NOT COMPLETED|Overall Study||3
8422642|NCT00896298|20757229|P1|NOT COMPLETED|Overall Study||3
8422643|NCT00896298|20757228|P2|COMPLETED|Overall Study||9
8422644|NCT00896298|20757229|P1|COMPLETED|Overall Study||10
8422645|NCT00896298|20757228|P2|STARTED|Overall Study||12
8422646|NCT00896298|20757229|P1|STARTED|Overall Study||13
8422647|NCT00896233|20757241|P1|NOT COMPLETED|Overall Study||1
8422648|NCT00896233|20757241|P1|COMPLETED|Overall Study||9
8422649|NCT00896233|20757241|P1|STARTED|Overall Study||10
8422650|NCT00896168|20757254|P2|NOT COMPLETED|Overall Study||19
8422651|NCT00896168|20757255|P1|NOT COMPLETED|Overall Study||14
8422652|NCT00896168|20757254|P2|COMPLETED|Overall Study||111
8422653|NCT00896168|20757255|P1|COMPLETED|Overall Study||90
8422654|NCT00896168|20757254|P2|STARTED|Overall Study||130
8422655|NCT00896168|20757255|P1|STARTED|Overall Study||104
8422656|NCT00896064|20757285|P2|NOT COMPLETED|Overall Study||0
8422657|NCT00896064|20757286|P1|NOT COMPLETED|Overall Study||0
8422658|NCT00896064|20757285|P2|COMPLETED|Overall Study||21
8422659|NCT00896064|20757286|P1|COMPLETED|Overall Study||22
8422660|NCT00896064|20757285|P2|STARTED|Overall Study||21
8422661|NCT00896064|20757286|P1|STARTED|Overall Study||22
8422662|NCT00896051|20757316|P2|NOT COMPLETED|Overall Study||9
8422663|NCT00896051|20757317|P1|NOT COMPLETED|Overall Study||10
8422664|NCT00896051|20757316|P2|COMPLETED|Overall Study||16
8422665|NCT00896051|20757317|P1|COMPLETED|Overall Study||15
8422666|NCT00896051|20757316|P2|STARTED|Overall Study||25
8422667|NCT00896051|20757317|P1|STARTED|Overall Study||25
8422668|NCT00896038|20757359|P2|NOT COMPLETED|Overall Study||1
8422669|NCT00896038|20757360|P1|NOT COMPLETED|Overall Study||4
8422670|NCT00896038|20757359|P2|COMPLETED|Overall Study||27
8422671|NCT00896038|20757360|P1|COMPLETED|Overall Study||26
8422672|NCT00896038|20757359|P2|STARTED|Overall Study||28
8422673|NCT00896038|20757360|P1|STARTED|Overall Study||30
8422674|NCT00896025|20757398|P1|NOT COMPLETED|Overall Study||0
8422675|NCT00896025|20757398|P1|COMPLETED|Overall Study||8
8422676|NCT00896025|20757398|P1|STARTED|Overall Study||8
8422677|NCT00896012|20757412|P2|NOT COMPLETED|Overall Study||11
8422678|NCT00896012|20757413|P1|NOT COMPLETED|Overall Study||11
8422679|NCT00896012|20757412|P2|COMPLETED|Overall Study||12
8422680|NCT00896012|20757413|P1|COMPLETED|Overall Study||18
8422681|NCT00896012|20757412|P2|STARTED|Overall Study||23
8422682|NCT00896012|20757413|P1|STARTED|Overall Study||29
8422683|NCT00895947|20757425|P2|NOT COMPLETED|Overall Study||10
8422684|NCT00895947|20757426|P1|NOT COMPLETED|Overall Study||12
8422685|NCT00895947|20757425|P2|COMPLETED|Overall Study||90
8422686|NCT00895947|20757426|P1|COMPLETED|Overall Study||88
8422687|NCT00895947|20757425|P2|STARTED|Overall Study||100
8422688|NCT00895947|20757426|P1|STARTED|Overall Study||100
8422689|NCT00895934|20757444|P4|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422690|NCT00895934|20757445|P3|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422691|NCT00895934|20757446|P2|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422692|NCT00895934|20757447|P1|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422693|NCT00895934|20757444|P4|COMPLETED|Efficacy of Most Tolerated Dose||37
8422694|NCT00895934|20757445|P3|COMPLETED|Efficacy of Most Tolerated Dose||0
8422695|NCT00895934|20757446|P2|COMPLETED|Efficacy of Most Tolerated Dose||0
8422696|NCT00895934|20757447|P1|COMPLETED|Efficacy of Most Tolerated Dose||0
8422697|NCT00895934|20757444|P4|STARTED|Efficacy of Most Tolerated Dose||37
8422698|NCT00895934|20757445|P3|STARTED|Efficacy of Most Tolerated Dose||0
8422699|NCT00895934|20757446|P2|STARTED|Efficacy of Most Tolerated Dose||0
8422700|NCT00895934|20757447|P1|STARTED|Efficacy of Most Tolerated Dose||0
8422701|NCT00895934|20757444|P4|NOT COMPLETED|Dose Escalation||0
8422702|NCT00895934|20757445|P3|NOT COMPLETED|Dose Escalation||0
8422703|NCT00895934|20757446|P2|NOT COMPLETED|Dose Escalation||0
8422704|NCT00895934|20757447|P1|NOT COMPLETED|Dose Escalation||0
8422705|NCT00895934|20757444|P4|COMPLETED|Dose Escalation||6
8422706|NCT00895934|20757445|P3|COMPLETED|Dose Escalation||3
8422707|NCT00895934|20757446|P2|COMPLETED|Dose Escalation||3
8422708|NCT00895934|20757447|P1|COMPLETED|Dose Escalation||3
8422709|NCT00895934|20757444|P4|STARTED|Dose Escalation||6
8422710|NCT00895934|20757445|P3|STARTED|Dose Escalation||3
8422711|NCT00895934|20757446|P2|STARTED|Dose Escalation||3
8422712|NCT00895934|20757447|P1|STARTED|Dose Escalation||3
8422713|NCT00895921|20757461|P2|NOT COMPLETED|Overall Study||0
8422714|NCT00895921|20757462|P1|NOT COMPLETED|Overall Study||0
8422715|NCT00895921|20757461|P2|COMPLETED|Overall Study||15
8422716|NCT00895921|20757462|P1|COMPLETED|Overall Study||15
8422717|NCT00895921|20757461|P2|STARTED|Overall Study||15
8422718|NCT00895921|20757462|P1|STARTED|Overall Study||15
8422719|NCT00895895|20757477|P5|NOT COMPLETED|Period 2||49
8422720|NCT00895895|20757478|P4|NOT COMPLETED|Period 2||54
8422721|NCT00895895|20757479|P3|NOT COMPLETED|Period 2||49
8422722|NCT00895895|20757480|P2|NOT COMPLETED|Period 2||53
8422723|NCT00895895|20757481|P1|NOT COMPLETED|Period 2||56
8422724|NCT00895895|20757477|P5|COMPLETED|Period 2||35
8422725|NCT00895895|20757478|P4|COMPLETED|Period 2||37
8422726|NCT00895895|20757479|P3|COMPLETED|Period 2||33
8422727|NCT00895895|20757480|P2|COMPLETED|Period 2||31
8422728|NCT00895895|20757481|P1|COMPLETED|Period 2||30
8422729|NCT00895895|20757477|P5|STARTED|Period 2||84
8422730|NCT00895895|20757478|P4|STARTED|Period 2||91
8422731|NCT00895895|20757479|P3|STARTED|Period 2||82
8422732|NCT00895895|20757480|P2|STARTED|Period 2||84
8422733|NCT00895895|20757481|P1|STARTED|Period 2||86
8422734|NCT00895895|20757477|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
8422735|NCT00895895|20757478|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
8422736|NCT00895895|20757479|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
8422737|NCT00895895|20757480|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
8422738|NCT00895895|20757481|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
8422739|NCT00895895|20757477|P5|COMPLETED|After Period 1, Prior to Period 2||84
8422740|NCT00895895|20757478|P4|COMPLETED|After Period 1, Prior to Period 2||91
8422741|NCT00895895|20757479|P3|COMPLETED|After Period 1, Prior to Period 2||82
8422742|NCT00895895|20757480|P2|COMPLETED|After Period 1, Prior to Period 2||84
8422743|NCT00895895|20757481|P1|COMPLETED|After Period 1, Prior to Period 2||86
8422744|NCT00895895|20757477|P5|STARTED|After Period 1, Prior to Period 2||86
8422745|NCT00895895|20757478|P4|STARTED|After Period 1, Prior to Period 2||91
8422746|NCT00895895|20757479|P3|STARTED|After Period 1, Prior to Period 2||84
8422747|NCT00895895|20757480|P2|STARTED|After Period 1, Prior to Period 2||84
8422748|NCT00895895|20757481|P1|STARTED|After Period 1, Prior to Period 2||86
8422749|NCT00895895|20757477|P5|NOT COMPLETED|Period 1||20
8422750|NCT00895895|20757478|P4|NOT COMPLETED|Period 1||13
8422751|NCT00895895|20757479|P3|NOT COMPLETED|Period 1||20
8422752|NCT00895895|20757480|P2|NOT COMPLETED|Period 1||21
8422753|NCT00895895|20757481|P1|NOT COMPLETED|Period 1||21
8422754|NCT00895895|20757477|P5|COMPLETED|Period 1||86
8422755|NCT00895895|20757478|P4|COMPLETED|Period 1||91
8422756|NCT00895895|20757479|P3|COMPLETED|Period 1||84
8422757|NCT00895895|20757480|P2|COMPLETED|Period 1||84
8422758|NCT00895895|20757481|P1|COMPLETED|Period 1||86
8422759|NCT00895895|20757477|P5|Randomized But Not Treated|Period 1||2
8422760|NCT00895895|20757478|P4|Randomized But Not Treated|Period 1||1
8422761|NCT00895895|20757479|P3|Randomized But Not Treated|Period 1||1
8422762|NCT00895895|20757480|P2|Randomized But Not Treated|Period 1||3
8422763|NCT00895895|20757481|P1|Randomized But Not Treated|Period 1||1
8422764|NCT00895895|20757477|P5|STARTED|Period 1||106
8422765|NCT00895895|20757478|P4|STARTED|Period 1||104
8422766|NCT00895895|20757479|P3|STARTED|Period 1||104
8422767|NCT00895895|20757480|P2|STARTED|Period 1||105
8422768|NCT00895895|20757481|P1|STARTED|Period 1||107
8422769|NCT00895843|20757595|P2|NOT COMPLETED|Overall Study||12
8422770|NCT00895843|20757596|P1|NOT COMPLETED|Overall Study||12
8422771|NCT00895843|20757595|P2|COMPLETED|Overall Study||50
8422772|NCT00895843|20757596|P1|COMPLETED|Overall Study||48
8422773|NCT00895843|20757595|P2|STARTED|Overall Study||62
8422774|NCT00895843|20757596|P1|STARTED|Overall Study||60
8422775|NCT00895830|20757607|P5|NOT COMPLETED|Overall Study||0
8422776|NCT00895830|20757608|P4|NOT COMPLETED|Overall Study||0
8422777|NCT00895830|20757609|P3|NOT COMPLETED|Overall Study||0
8422778|NCT00895830|20757610|P2|NOT COMPLETED|Overall Study||0
8422779|NCT00895830|20757611|P1|NOT COMPLETED|Overall Study||0
8422780|NCT00895830|20757607|P5|COMPLETED|Overall Study||55
8422781|NCT00895830|20757608|P4|COMPLETED|Overall Study||52
8422782|NCT00895830|20757609|P3|COMPLETED|Overall Study||49
8422783|NCT00895830|20757610|P2|COMPLETED|Overall Study||50
8422784|NCT00895830|20757611|P1|COMPLETED|Overall Study||51
8422785|NCT00895830|20757607|P5|STARTED|Overall Study||55
8422786|NCT00895830|20757608|P4|STARTED|Overall Study||52
8422787|NCT00895830|20757609|P3|STARTED|Overall Study||49
8422788|NCT00895830|20757610|P2|STARTED|Overall Study||50
8422789|NCT00895830|20757611|P1|STARTED|Overall Study||51
8422790|NCT00895817|20757625|P2|NOT COMPLETED|Overall Study||0
8422791|NCT00895817|20757626|P1|NOT COMPLETED|Overall Study||0
8422792|NCT00895817|20757625|P2|COMPLETED|Overall Study||21
8422793|NCT00895817|20757626|P1|COMPLETED|Overall Study||21
8422794|NCT00895817|20757625|P2|STARTED|Overall Study||21
8422795|NCT00895817|20757626|P1|STARTED|Overall Study||21
8422796|NCT00895752|20757632|P1|NOT COMPLETED|Overall Study||0
8422797|NCT00895752|20757632|P1|COMPLETED|Overall Study||6
8422798|NCT00895752|20757632|P1|STARTED|Overall Study||6
8422799|NCT00895661|20757643|P1|NOT COMPLETED|Overall Study||3
8422800|NCT00895661|20757643|P1|COMPLETED|Overall Study||37
8422801|NCT00895661|20757643|P1|STARTED|Overall Study||40
8422802|NCT00895622|20757653|P3|NOT COMPLETED|Overall Study||4
8422803|NCT00895622|20757654|P2|NOT COMPLETED|Overall Study||4
8422804|NCT00895622|20757655|P1|NOT COMPLETED|Overall Study||5
8422805|NCT00895622|20757653|P3|COMPLETED|Overall Study||53
8422806|NCT00895622|20757654|P2|COMPLETED|Overall Study||52
8422807|NCT00895622|20757655|P1|COMPLETED|Overall Study||60
8422808|NCT00895622|20757653|P3|STARTED|Overall Study||57
8422809|NCT00895622|20757654|P2|STARTED|Overall Study||56
8422810|NCT00895622|20757655|P1|STARTED|Overall Study||65
8422811|NCT00895583|20757682|P2|NOT COMPLETED|Overall Study||12
8422812|NCT00895583|20757683|P1|NOT COMPLETED|Overall Study||44
8422813|NCT00895583|20757682|P2|COMPLETED|Overall Study||111
8422814|NCT00895583|20757683|P1|COMPLETED|Overall Study||87
8422815|NCT00895583|20757682|P2|STARTED|Overall Study||123
8422816|NCT00895583|20757683|P1|STARTED|Overall Study||131
8422817|NCT00895531|20757763|P2|NOT COMPLETED|Overall Study||0
8422818|NCT00895531|20757764|P1|NOT COMPLETED|Overall Study||0
8422819|NCT00895531|20757763|P2|COMPLETED|Overall Study||37
8422820|NCT00895531|20757764|P1|COMPLETED|Overall Study||38
8422821|NCT00895531|20757763|P2|STARTED|Overall Study||37
8422822|NCT00895531|20757764|P1|STARTED|Overall Study||38
8422823|NCT00895453|20757773|P3|NOT COMPLETED|Overall Study||23
8422824|NCT00895453|20757774|P2|NOT COMPLETED|Overall Study||25
8422825|NCT00895453|20757775|P1|NOT COMPLETED|Overall Study||25
8422826|NCT00895453|20757773|P3|COMPLETED|Overall Study||23
8422827|NCT00895453|20757774|P2|COMPLETED|Overall Study||25
8422828|NCT00895453|20757775|P1|COMPLETED|Overall Study||23
8422829|NCT00895453|20757773|P3|STARTED|Overall Study||46
8422830|NCT00895453|20757774|P2|STARTED|Overall Study||50
8422831|NCT00895453|20757775|P1|STARTED|Overall Study||48
8422832|NCT00895414|20757783|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8422833|NCT00895414|20757784|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8422834|NCT00895414|20757783|P2|COMPLETED|Second Intervention (14 Days)||9
8422835|NCT00895414|20757784|P1|COMPLETED|Second Intervention (14 Days)||8
8422836|NCT00895414|20757783|P2|STARTED|Second Intervention (14 Days)||9
8422837|NCT00895414|20757784|P1|STARTED|Second Intervention (14 Days)||8
8422838|NCT00895414|20757783|P2|NOT COMPLETED|First Intervention (14 Days)||1
8422839|NCT00895414|20757784|P1|NOT COMPLETED|First Intervention (14 Days)||1
8422840|NCT00895414|20757783|P2|COMPLETED|First Intervention (14 Days)||9
8422841|NCT00895414|20757784|P1|COMPLETED|First Intervention (14 Days)||8
8422842|NCT00895414|20757783|P2|STARTED|First Intervention (14 Days)||10
8422843|NCT00895414|20757784|P1|STARTED|First Intervention (14 Days)||9
8422844|NCT00895310|20757794|P1|NOT COMPLETED|Overall Study||1
8422845|NCT00895310|20757794|P1|COMPLETED|Overall Study||29
8422846|NCT00895310|20757794|P1|STARTED|Overall Study||30
8422847|NCT00895284|20757803|P2|NOT COMPLETED|Overall Study||0
8422848|NCT00895284|20757804|P1|NOT COMPLETED|Overall Study||0
8422849|NCT00895284|20757803|P2|COMPLETED|Overall Study||0
8422850|NCT00895284|20757804|P1|COMPLETED|Overall Study||3
8422851|NCT00895284|20757803|P2|STARTED|Overall Study||0
8422852|NCT00895284|20757804|P1|STARTED|Overall Study||3
8422853|NCT00895245|20757810|P1|NOT COMPLETED|Overall Study||6
8422854|NCT00895245|20757810|P1|COMPLETED|Overall Study||0
8422855|NCT00895245|20757810|P1|STARTED|Overall Study||6
8422856|NCT00895232|20757820|P3|NOT COMPLETED|Overall Study||5
8422857|NCT00895232|20757821|P2|NOT COMPLETED|Overall Study||4
8422858|NCT00895232|20757822|P1|NOT COMPLETED|Overall Study||3
8422859|NCT00895232|20757820|P3|COMPLETED|Overall Study||3
8422860|NCT00895232|20757821|P2|COMPLETED|Overall Study||2
8422861|NCT00895232|20757822|P1|COMPLETED|Overall Study||4
8422862|NCT00895232|20757820|P3|STARTED|Overall Study||8
8422863|NCT00895232|20757821|P2|STARTED|Overall Study||6
8422864|NCT00895232|20757822|P1|STARTED|Overall Study||7
8422865|NCT00895193|20757840|P4|NOT COMPLETED|Overall Study||0
8422866|NCT00895193|20757841|P3|NOT COMPLETED|Overall Study||0
8422867|NCT00895193|20757842|P2|NOT COMPLETED|Overall Study||0
8422868|NCT00895193|20757843|P1|NOT COMPLETED|Overall Study||0
8422869|NCT00895193|20757840|P4|COMPLETED|Overall Study||25
8422870|NCT00895193|20757841|P3|COMPLETED|Overall Study||25
8422871|NCT00895193|20757842|P2|COMPLETED|Overall Study||25
8422872|NCT00895193|20757843|P1|COMPLETED|Overall Study||25
8422873|NCT00895193|20757840|P4|STARTED|Overall Study||25
8422874|NCT00895193|20757841|P3|STARTED|Overall Study||25
8422875|NCT00895193|20757842|P2|STARTED|Overall Study||25
8422876|NCT00895193|20757843|P1|STARTED|Overall Study||25
8422877|NCT00895180|20757867|P2|NOT COMPLETED|Overall Study||0
8422878|NCT00895180|20757868|P1|NOT COMPLETED|Overall Study||0
8422879|NCT00895180|20757867|P2|COMPLETED|Overall Study||40
8422880|NCT00895180|20757868|P1|COMPLETED|Overall Study||40
8422881|NCT00895180|20757867|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
8422882|NCT00895180|20757868|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
8422883|NCT00895180|20757867|P2|STARTED|Overall Study||40
8422884|NCT00895180|20757868|P1|STARTED|Overall Study||40
8422885|NCT00895154|20757888|P2|NOT COMPLETED|Overall Study||2
8422886|NCT00895154|20757889|P1|NOT COMPLETED|Overall Study||1
8422887|NCT00895154|20757888|P2|COMPLETED|Overall Study||8
8422888|NCT00895154|20757889|P1|COMPLETED|Overall Study||7
8422889|NCT00895154|20757888|P2|Follow Up|Overall Study||8
8422890|NCT00895154|20757889|P1|Follow Up|Overall Study||7
8422891|NCT00895154|20757888|P2|STARTED|Overall Study||10
8422892|NCT00895154|20757889|P1|STARTED|Overall Study||8
8422893|NCT00895037|20757924|P3|NOT COMPLETED|Overall Study||1
8422894|NCT00895037|20757925|P2|NOT COMPLETED|Overall Study||2
8422895|NCT00895037|20757926|P1|NOT COMPLETED|Overall Study||0
8422896|NCT00895037|20757924|P3|COMPLETED|Overall Study||1
8422897|NCT00895037|20757925|P2|COMPLETED|Overall Study||75
8422898|NCT00895037|20757926|P1|COMPLETED|Overall Study||22
8422899|NCT00895037|20757924|P3|STARTED|Overall Study||2
8422900|NCT00895037|20757925|P2|STARTED|Overall Study||77
8422901|NCT00895037|20757926|P1|STARTED|Overall Study||22
8422902|NCT00895011|20757957|P3|NOT COMPLETED|Overall Study||8
8422903|NCT00895011|20757958|P2|NOT COMPLETED|Overall Study||14
8422904|NCT00895011|20757959|P1|NOT COMPLETED|Overall Study||24
8422905|NCT00895011|20757957|P3|COMPLETED|Overall Study||91
8422906|NCT00895011|20757958|P2|COMPLETED|Overall Study||85
8422907|NCT00895011|20757959|P1|COMPLETED|Overall Study||76
8422908|NCT00895011|20757957|P3|STARTED|Overall Study||99
8422909|NCT00895011|20757958|P2|STARTED|Overall Study||99
8422910|NCT00895011|20757959|P1|STARTED|Overall Study||100
8422911|NCT00894933|20757973|P1|NOT COMPLETED|Overall Study||4
8422912|NCT00894933|20757973|P1|COMPLETED|Overall Study||29
8422913|NCT00894933|20757973|P1|STARTED|Overall Study||33
8422914|NCT00894803|20757991|P2|NOT COMPLETED|Overall Study||5
8422915|NCT00894803|20757992|P1|NOT COMPLETED|Overall Study||20
8422916|NCT00894803|20757991|P2|COMPLETED|Overall Study||20
8422917|NCT00894803|20757992|P1|COMPLETED|Overall Study||81
8422918|NCT00894803|20757991|P2|STARTED|Overall Study||25
8422919|NCT00894803|20757992|P1|STARTED|Overall Study||101
8422926|NCT00894738|20758053|P2|NOT COMPLETED|Overall Study||0
8422927|NCT00894738|20758054|P1|NOT COMPLETED|Overall Study||0
8422928|NCT00894738|20758053|P2|COMPLETED|Overall Study||19
8422929|NCT00894738|20758054|P1|COMPLETED|Overall Study||25
8422930|NCT00894738|20758053|P2|STARTED|Overall Study||19
8422931|NCT00894738|20758054|P1|STARTED|Overall Study||25
8422932|NCT00894699|20758064|P2|NOT COMPLETED|Overall Study||0
8422933|NCT00894699|20758065|P1|NOT COMPLETED|Overall Study||0
8422934|NCT00894699|20758064|P2|COMPLETED|Overall Study||19
8422935|NCT00894699|20758065|P1|COMPLETED|Overall Study||21
8422936|NCT00894699|20758064|P2|STARTED|Overall Study||19
8422937|NCT00894699|20758065|P1|STARTED|Overall Study||21
8422938|NCT00894686|20758071|P1|NOT COMPLETED|Overall Study||56
8422939|NCT00894686|20758071|P1|COMPLETED|Overall Study||123
8422940|NCT00894686|20758071|P1|STARTED|Overall Study||179
8422941|NCT00894647|20758095|P2|NOT COMPLETED|Overall Study||14
8422942|NCT00894647|20758096|P1|NOT COMPLETED|Overall Study||10
8422943|NCT00894647|20758095|P2|COMPLETED|Overall Study||112
8422944|NCT00894647|20758096|P1|COMPLETED|Overall Study||111
8422945|NCT00894647|20758095|P2|STARTED|Overall Study||126
8422946|NCT00894647|20758096|P1|STARTED|Overall Study||121
8422947|NCT00894556|20758109|P4|NOT COMPLETED|Treatment Phase||0
8422948|NCT00894556|20758110|P3|NOT COMPLETED|Treatment Phase||1
8422949|NCT00894556|20758111|P2|NOT COMPLETED|Treatment Phase||4
8422950|NCT00894556|20758112|P1|NOT COMPLETED|Treatment Phase||4
8422951|NCT00894556|20758109|P4|COMPLETED|Treatment Phase||0
8422952|NCT00894556|20758110|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
8422953|NCT00894556|20758111|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
8422954|NCT00894556|20758112|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
8422955|NCT00894556|20758109|P4|STARTED|Treatment Phase||0
8422956|NCT00894556|20758110|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
8422957|NCT00894556|20758111|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
8422958|NCT00894556|20758112|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
8422959|NCT00894556|20758109|P4|NOT COMPLETED|Baseline Phase||85
8422960|NCT00894556|20758110|P3|NOT COMPLETED|Baseline Phase||0
8422961|NCT00894556|20758111|P2|NOT COMPLETED|Baseline Phase||0
8422962|NCT00894556|20758112|P1|NOT COMPLETED|Baseline Phase||0
8422963|NCT00894556|20758109|P4|COMPLETED|Baseline Phase||109
8422964|NCT00894556|20758110|P3|COMPLETED|Baseline Phase||0
8422965|NCT00894556|20758111|P2|COMPLETED|Baseline Phase||0
8422966|NCT00894556|20758112|P1|COMPLETED|Baseline Phase||0
8422967|NCT00894556|20758109|P4|STARTED|Baseline Phase||194
8422968|NCT00894556|20758110|P3|STARTED|Baseline Phase||0
8422969|NCT00894556|20758111|P2|STARTED|Baseline Phase||0
8422970|NCT00894556|20758112|P1|STARTED|Baseline Phase||0
8422971|NCT00894543|20758123|P2|NOT COMPLETED|Week 4 to Week 8||2
8422972|NCT00894543|20758124|P1|NOT COMPLETED|Week 4 to Week 8||4
8422973|NCT00894543|20758123|P2|COMPLETED|Week 4 to Week 8||97
8422974|NCT00894543|20758124|P1|COMPLETED|Week 4 to Week 8||97
8422975|NCT00894543|20758123|P2|STARTED|Week 4 to Week 8||99
8422976|NCT00894543|20758124|P1|STARTED|Week 4 to Week 8||101
8422977|NCT00894543|20758123|P2|NOT COMPLETED|Baseline to Week 4||2
8422978|NCT00894543|20758124|P1|NOT COMPLETED|Baseline to Week 4||3
8422979|NCT00894543|20758123|P2|COMPLETED|Baseline to Week 4||99
8422980|NCT00894543|20758124|P1|COMPLETED|Baseline to Week 4||101
8422981|NCT00894543|20758123|P2|STARTED|Baseline to Week 4||101
8422982|NCT00894543|20758124|P1|STARTED|Baseline to Week 4||104
8422983|NCT00894543|20758123|P2|NOT COMPLETED|Baseline||0
8422984|NCT00894543|20758124|P1|NOT COMPLETED|Baseline||0
8422985|NCT00894543|20758123|P2|COMPLETED|Baseline||101
8422986|NCT00894543|20758124|P1|COMPLETED|Baseline||104
8422987|NCT00894543|20758123|P2|STARTED|Baseline||101
8422988|NCT00894543|20758124|P1|STARTED|Baseline||104
8422989|NCT00894517|20758148|P2|NOT COMPLETED|Overall Study||5
8422990|NCT00894517|20758149|P1|NOT COMPLETED|Overall Study||2
8422991|NCT00894517|20758148|P2|COMPLETED|Overall Study||26
8422992|NCT00894517|20758149|P1|COMPLETED|Overall Study||28
8422993|NCT00894517|20758148|P2|STARTED|Overall Study||31
8422994|NCT00894517|20758149|P1|STARTED|Overall Study||30
8422995|NCT00894504|20758163|P1|NOT COMPLETED|Overall Study||71
8422996|NCT00894504|20758163|P1|COMPLETED|Overall Study||0
8422997|NCT00894504|20758163|P1|STARTED|Overall Study||71
8422998|NCT00894465|20758179|P2|NOT COMPLETED|Overall Study||0
8422999|NCT00894465|20758180|P1|NOT COMPLETED|Overall Study||0
8423000|NCT00894465|20758179|P2|COMPLETED|Overall Study||22
8423001|NCT00894465|20758180|P1|COMPLETED|Overall Study||22
8423002|NCT00894465|20758179|P2|STARTED|Overall Study||22
8423003|NCT00894465|20758180|P1|STARTED|Overall Study||22
8423004|NCT00894413|20758190|P2|NOT COMPLETED|Overall Study||8
8423005|NCT00894413|20758191|P1|NOT COMPLETED|Overall Study||0
8423006|NCT00894413|20758190|P2|COMPLETED|Overall Study||17
8423007|NCT00894413|20758191|P1|COMPLETED|Overall Study||15
8423008|NCT00894413|20758190|P2|STARTED|Overall Study||25
8423009|NCT00894413|20758191|P1|STARTED|Overall Study||15
8423010|NCT00894387|20758199|P2|NOT COMPLETED|Overall Study||175
8423011|NCT00894387|20758200|P1|NOT COMPLETED|Overall Study||175
8423012|NCT00894387|20758199|P2|COMPLETED|Overall Study||643
8423013|NCT00894387|20758200|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
8423014|NCT00894387|20758199|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
8423015|NCT00894387|20758200|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
8423016|NCT00894387|20758199|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
8423017|NCT00894387|20758200|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
8423018|NCT00894387|20758199|P2|Full Analysis Set|Overall Study||807
8423019|NCT00894387|20758200|P1|Full Analysis Set|Overall Study||808
8423020|NCT00894387|20758199|P2|Safety Set|Overall Study||810
8423021|NCT00894387|20758200|P1|Safety Set|Overall Study||808
8423022|NCT00894387|20758199|P2|STARTED|Overall Study||818
8423023|NCT00894387|20758200|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
8423024|NCT00894361|20758220|P2|NOT COMPLETED|Overall Study||64
8423025|NCT00894361|20758221|P1|NOT COMPLETED|Overall Study||24
8423026|NCT00894361|20758220|P2|COMPLETED|Overall Study||136
8423027|NCT00894361|20758221|P1|COMPLETED|Overall Study||176
8423028|NCT00894361|20758220|P2|STARTED|Overall Study||200
8423029|NCT00894361|20758221|P1|STARTED|Overall Study||200
8423030|NCT00894322|20758232|P3|NOT COMPLETED|Overall Study||0
8423031|NCT00894322|20758233|P2|NOT COMPLETED|Overall Study||0
8423032|NCT00894322|20758234|P1|NOT COMPLETED|Overall Study||1
8423033|NCT00894322|20758232|P3|COMPLETED|Overall Study||12
8423034|NCT00894322|20758233|P2|COMPLETED|Overall Study||23
8423035|NCT00894322|20758234|P1|COMPLETED|Overall Study||29
8423036|NCT00894322|20758232|P3|STARTED|Overall Study||12
8423037|NCT00894322|20758233|P2|STARTED|Overall Study||23
8423038|NCT00894322|20758234|P1|STARTED|Overall Study||30
8423039|NCT00894244|20758273|P1|NOT COMPLETED|Overall Study||1
8423040|NCT00894244|20758273|P1|COMPLETED|Overall Study||24
8423041|NCT00894244|20758273|P1|STARTED|Overall Study||25
8423042|NCT00894166|20758285|P8|NOT COMPLETED|Overall Study||34
8423043|NCT00894166|20758286|P7|NOT COMPLETED|Overall Study||16
8423044|NCT00894166|20758287|P6|NOT COMPLETED|Overall Study||16
8423045|NCT00894166|20758288|P5|NOT COMPLETED|Overall Study||24
8423046|NCT00894166|20758289|P4|NOT COMPLETED|Overall Study||69
8423047|NCT00894166|20758290|P3|NOT COMPLETED|Overall Study||62
8423048|NCT00894166|20758291|P2|NOT COMPLETED|Overall Study||63
8423049|NCT00894166|20758292|P1|NOT COMPLETED|Overall Study||61
8423050|NCT00894166|20758285|P8|COMPLETED|Overall Study||0
8423051|NCT00894166|20758286|P7|COMPLETED|Overall Study||19
8423052|NCT00894166|20758287|P6|COMPLETED|Overall Study||20
8423053|NCT00894166|20758288|P5|COMPLETED|Overall Study||10
8423054|NCT00894166|20758289|P4|COMPLETED|Overall Study||45
8423055|NCT00894166|20758290|P3|COMPLETED|Overall Study||50
8423056|NCT00894166|20758291|P2|COMPLETED|Overall Study||46
8423057|NCT00894166|20758292|P1|COMPLETED|Overall Study||71
8423058|NCT00894166|20758285|P8|STARTED|Overall Study||34
8423059|NCT00894166|20758286|P7|STARTED|Overall Study||35
8423060|NCT00894166|20758287|P6|STARTED|Overall Study||36
8423061|NCT00894166|20758288|P5|STARTED|Overall Study||34
8423062|NCT00894166|20758289|P4|STARTED|Overall Study||114
8423063|NCT00894166|20758290|P3|STARTED|Overall Study||112
8423064|NCT00894166|20758291|P2|STARTED|Overall Study||109
8423065|NCT00894166|20758292|P1|STARTED|Overall Study||132
8423066|NCT00894127|20758322|P1|NOT COMPLETED|Overall Study||0
8423067|NCT00894127|20758322|P1|COMPLETED|Overall Study||128
8423068|NCT00894127|20758322|P1|STARTED|Overall Study||128
8423069|NCT00893997|20758326|P1|NOT COMPLETED|Overall Study||0
8423070|NCT00893997|20758326|P1|COMPLETED|Overall Study||10
8423071|NCT00893997|20758326|P1|STARTED|Overall Study||10
8423072|NCT00893984|20758331|P1|NOT COMPLETED|Overall Study||6
8423073|NCT00893984|20758331|P1|COMPLETED|Overall Study||0
8423074|NCT00893984|20758331|P1|STARTED|Overall Study||6
8423075|NCT00893971|20758338|P1|NOT COMPLETED|Overall Study||3
8423076|NCT00893971|20758338|P1|COMPLETED|Overall Study||13
8423077|NCT00893971|20758338|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
8423078|NCT00893971|20758338|P1|Placebo + FF MDI (PT005)|Overall Study||13
8423079|NCT00893971|20758338|P1|Placebo + GFF MDI (PT003)|Overall Study||15
8423080|NCT00893971|20758338|P1|Placebo + GP MDI (PT001)|Overall Study||15
8423081|NCT00893971|20758338|P1|STARTED|Overall Study||16
8423082|NCT00893789|20758456|P4|NOT COMPLETED|Overall Study||13
8423083|NCT00893789|20758457|P3|NOT COMPLETED|Overall Study||7
8423084|NCT00893789|20758458|P2|NOT COMPLETED|Overall Study||4
8423085|NCT00893789|20758459|P1|NOT COMPLETED|Overall Study||6
8423086|NCT00893789|20758456|P4|COMPLETED|Overall Study||16
8423087|NCT00893789|20758457|P3|COMPLETED|Overall Study||22
8423088|NCT00893789|20758458|P2|COMPLETED|Overall Study||26
8423089|NCT00893789|20758459|P1|COMPLETED|Overall Study||23
8423090|NCT00893789|20758456|P4|Full Analysis Set (FAS)|Overall Study||27
8423091|NCT00893789|20758457|P3|Full Analysis Set (FAS)|Overall Study||28
8423092|NCT00893789|20758458|P2|Full Analysis Set (FAS)|Overall Study||29
8423093|NCT00893789|20758459|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
8423094|NCT00893789|20758456|P4|Safety Analysis Set (SAS)|Overall Study||29
8423095|NCT00893789|20758457|P3|Safety Analysis Set (SAS)|Overall Study||29
8423096|NCT00893789|20758458|P2|Safety Analysis Set (SAS)|Overall Study||30
8423097|NCT00893789|20758459|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
8423098|NCT00893789|20758456|P4|STARTED|Overall Study||29
8423099|NCT00893789|20758457|P3|STARTED|Overall Study||29
8423100|NCT00893789|20758458|P2|STARTED|Overall Study||30
8423101|NCT00893789|20758459|P1|STARTED|Overall Study||29
8423102|NCT00893763|20758543|P2|NOT COMPLETED|Overall Study||110
8423103|NCT00893763|20758544|P1|NOT COMPLETED|Overall Study||110
8423104|NCT00893763|20758543|P2|COMPLETED|Overall Study||47
8423105|NCT00893763|20758544|P1|COMPLETED|Overall Study||47
8423106|NCT00893763|20758543|P2|STARTED|Overall Study||157
8423107|NCT00893763|20758544|P1|STARTED|Overall Study||157
8423108|NCT00893737|20758552|P1|NOT COMPLETED|Overall Study||12
8423109|NCT00893737|20758552|P1|COMPLETED|Overall Study||135
8423110|NCT00893737|20758552|P1|STARTED|Overall Study||147
8423111|NCT00893464|20758566|P8|NOT COMPLETED|Overall Study||2
8423112|NCT00893464|20758567|P7|NOT COMPLETED|Overall Study||2
8423113|NCT00893464|20758568|P6|NOT COMPLETED|Overall Study||0
8423114|NCT00893464|20758569|P5|NOT COMPLETED|Overall Study||0
8423115|NCT00893464|20758570|P4|NOT COMPLETED|Overall Study||0
8423116|NCT00893464|20758571|P3|NOT COMPLETED|Overall Study||0
8423117|NCT00893464|20758572|P2|NOT COMPLETED|Overall Study||0
8423118|NCT00893464|20758573|P1|NOT COMPLETED|Overall Study||0
8423119|NCT00893464|20758566|P8|COMPLETED|Overall Study||3
8423120|NCT00893464|20758567|P7|COMPLETED|Overall Study||8
8423121|NCT00893464|20758568|P6|COMPLETED|Overall Study||7
8423122|NCT00893464|20758569|P5|COMPLETED|Overall Study||4
8423123|NCT00893464|20758570|P4|COMPLETED|Overall Study||1
8423124|NCT00893464|20758571|P3|COMPLETED|Overall Study||1
8423125|NCT00893464|20758572|P2|COMPLETED|Overall Study||1
8423126|NCT00893464|20758573|P1|COMPLETED|Overall Study||1
8423127|NCT00893464|20758566|P8|STARTED|Overall Study||5
8423128|NCT00893464|20758567|P7|STARTED|Overall Study||10
8423129|NCT00893464|20758568|P6|STARTED|Overall Study||7
8423130|NCT00893464|20758569|P5|STARTED|Overall Study||4
8423131|NCT00893464|20758570|P4|STARTED|Overall Study||1
8423132|NCT00893464|20758571|P3|STARTED|Overall Study||1
8423133|NCT00893464|20758572|P2|STARTED|Overall Study||1
8423134|NCT00893464|20758573|P1|STARTED|Overall Study||1
8423135|NCT00893152|20758691|P2|NOT COMPLETED|Overall Study||0
8423136|NCT00893152|20758692|P1|NOT COMPLETED|Overall Study||0
8423137|NCT00893152|20758691|P2|COMPLETED|Overall Study||36
8423138|NCT00893152|20758692|P1|COMPLETED|Overall Study||47
8423139|NCT00893152|20758691|P2|STARTED|Overall Study||36
8423140|NCT00893152|20758692|P1|STARTED|Overall Study||47
8423141|NCT00893113|20758700|P2|NOT COMPLETED|Overall Study||16
8423142|NCT00893113|20758701|P1|NOT COMPLETED|Overall Study||13
8423143|NCT00893113|20758700|P2|COMPLETED|Overall Study||22
8423144|NCT00893113|20758701|P1|COMPLETED|Overall Study||23
8423145|NCT00893113|20758700|P2|STARTED|Overall Study||38
8423146|NCT00893113|20758701|P1|STARTED|Overall Study||36
8423147|NCT00893074|20758711|P1|NOT COMPLETED|Overall Study||11
8423148|NCT00893074|20758711|P1|COMPLETED|Overall Study||13
8423149|NCT00893074|20758711|P1|STARTED|Overall Study||24
8423150|NCT00892957|20758731|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
8423151|NCT00892957|20758732|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
8423152|NCT00892957|20758731|P2|COMPLETED|Postoperative Day 30 Assessment||66
8423153|NCT00892957|20758732|P1|COMPLETED|Postoperative Day 30 Assessment||70
8423154|NCT00892957|20758731|P2|STARTED|Postoperative Day 30 Assessment||66
8423155|NCT00892957|20758732|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
8423156|NCT00892957|20758731|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
8423157|NCT00892957|20758732|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
8423158|NCT00892957|20758731|P2|COMPLETED|Postoperative Day 14 Assessment||66
8423159|NCT00892957|20758732|P1|COMPLETED|Postoperative Day 14 Assessment||68
8423160|NCT00892957|20758731|P2|STARTED|Postoperative Day 14 Assessment||66
8423161|NCT00892957|20758732|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
8423162|NCT00892957|20758731|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
8423163|NCT00892957|20758732|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
8423164|NCT00892957|20758731|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
8423165|NCT00892957|20758732|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
8423166|NCT00892957|20758731|P2|STARTED|Between Postoperative Day 1 and Day 14||70
8423167|NCT00892957|20758732|P1|STARTED|Between Postoperative Day 1 and Day 14||70
8423168|NCT00892957|20758731|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
8423169|NCT00892957|20758732|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
8423170|NCT00892957|20758731|P2|COMPLETED|Postoperative Day 1 Assessment||70
8423171|NCT00892957|20758732|P1|COMPLETED|Postoperative Day 1 Assessment||70
8423172|NCT00892957|20758731|P2|STARTED|Postoperative Day 1 Assessment||70
8423173|NCT00892957|20758732|P1|STARTED|Postoperative Day 1 Assessment||70
8423174|NCT00892957|20758731|P2|NOT COMPLETED|Intraoperative Day 0||0
8423175|NCT00892957|20758732|P1|NOT COMPLETED|Intraoperative Day 0||0
8423176|NCT00892957|20758731|P2|COMPLETED|Intraoperative Day 0||70
8423177|NCT00892957|20758732|P1|COMPLETED|Intraoperative Day 0||70
8423178|NCT00892957|20758731|P2|STARTED|Intraoperative Day 0||70
8423179|NCT00892957|20758732|P1|STARTED|Intraoperative Day 0||70
8423180|NCT00892775|20758820|P2|NOT COMPLETED|Overall Study||1
8423181|NCT00892775|20758821|P1|NOT COMPLETED|Overall Study||5
8423182|NCT00892775|20758820|P2|COMPLETED|Overall Study||165
8423183|NCT00892775|20758821|P1|COMPLETED|Overall Study||327
8423184|NCT00892775|20758820|P2|STARTED|Overall Study||166
8423185|NCT00892775|20758821|P1|STARTED|Overall Study||332
8423186|NCT00892723|20758848|P3|NOT COMPLETED|Overall Study||2
8423187|NCT00892723|20758849|P2|NOT COMPLETED|Overall Study||4
8423188|NCT00892723|20758850|P1|NOT COMPLETED|Overall Study||2
8423189|NCT00892723|20758848|P3|COMPLETED|Overall Study||17
8423190|NCT00892723|20758849|P2|COMPLETED|Overall Study||15
8423191|NCT00892723|20758850|P1|COMPLETED|Overall Study||19
8423192|NCT00892723|20758848|P3|STARTED|Overall Study||19
8423193|NCT00892723|20758849|P2|STARTED|Overall Study||19
8423194|NCT00892723|20758850|P1|STARTED|Overall Study||21
8423195|NCT00892710|20758894|P3|NOT COMPLETED|Overall Study||55
8423196|NCT00892710|20758895|P2|NOT COMPLETED|Overall Study||59
8423197|NCT00892710|20758896|P1|NOT COMPLETED|Overall Study||48
8423198|NCT00892710|20758894|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8423199|NCT00892710|20758895|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8423200|NCT00892710|20758896|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8423201|NCT00892710|20758894|P3|STARTED|Overall Study||55
8423202|NCT00892710|20758895|P2|STARTED|Overall Study||59
8423203|NCT00892710|20758896|P1|STARTED|Overall Study||48
8423204|NCT00892697|20758919|P1|NOT COMPLETED|Overall Study||0
8423205|NCT00892697|20758919|P1|COMPLETED|Overall Study||15
8423206|NCT00892697|20758919|P1|STARTED|Overall Study||15
8423207|NCT00892606|20758926|P2|NOT COMPLETED|Overall Study||4
8423208|NCT00892606|20758927|P1|NOT COMPLETED|Overall Study||5
8423209|NCT00892606|20758926|P2|COMPLETED|Overall Study||33
8423210|NCT00892606|20758927|P1|COMPLETED|Overall Study||33
8423211|NCT00892606|20758926|P2|STARTED|Overall Study||37
8423212|NCT00892606|20758927|P1|STARTED|Overall Study||38
8423213|NCT00892437|20758939|P2|NOT COMPLETED|Open-Label Extension Phase||4
8423214|NCT00892437|20758940|P1|NOT COMPLETED|Open-Label Extension Phase||12
8423215|NCT00892437|20758939|P2|COMPLETED|Open-Label Extension Phase||15
8423216|NCT00892437|20758940|P1|COMPLETED|Open-Label Extension Phase||32
8423217|NCT00892437|20758939|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
8423218|NCT00892437|20758940|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
8423219|NCT00892437|20758939|P2|NOT COMPLETED|Randomized Phase||5
8423220|NCT00892437|20758940|P1|NOT COMPLETED|Randomized Phase||11
8423221|NCT00892437|20758939|P2|COMPLETED|Randomized Phase||24
8423222|NCT00892437|20758940|P1|COMPLETED|Randomized Phase||45
8423223|NCT00892437|20758939|P2|Randomized and Treated|Randomized Phase||29
8423224|NCT00892437|20758940|P1|Randomized and Treated|Randomized Phase||50
8423225|NCT00892437|20758939|P2|STARTED|Randomized Phase||29
8423226|NCT00892437|20758940|P1|STARTED|Randomized Phase||56
8423227|NCT00892281|20758959|P2|NOT COMPLETED|Overall Study||37
8423228|NCT00892281|20758960|P1|NOT COMPLETED|Overall Study||267
8423229|NCT00892281|20758959|P2|COMPLETED|Overall Study||187
8423230|NCT00892281|20758960|P1|COMPLETED|Overall Study||930
8423231|NCT00892281|20758959|P2|STARTED|Overall Study||224
8423232|NCT00892281|20758960|P1|STARTED|Overall Study||1197
8423233|NCT00892177|20758973|P6|NOT COMPLETED|Phase II||2
8423234|NCT00892177|20758974|P5|NOT COMPLETED|Phase II||5
8423235|NCT00892177|20758975|P4|NOT COMPLETED|Phase II||0
8423236|NCT00892177|20758976|P3|NOT COMPLETED|Phase II||0
8423237|NCT00892177|20758977|P2|NOT COMPLETED|Phase II||0
8423238|NCT00892177|20758978|P1|NOT COMPLETED|Phase II||0
8423239|NCT00892177|20758973|P6|COMPLETED|Phase II||38
8423240|NCT00892177|20758974|P5|COMPLETED|Phase II||83
8423241|NCT00892177|20758975|P4|COMPLETED|Phase II||0
8423242|NCT00892177|20758976|P3|COMPLETED|Phase II||0
8423243|NCT00892177|20758977|P2|COMPLETED|Phase II||0
8423244|NCT00892177|20758978|P1|COMPLETED|Phase II||0
8423245|NCT00892177|20758973|P6|STARTED|Phase II||40
8423246|NCT00892177|20758974|P5|STARTED|Phase II||88
8423247|NCT00892177|20758975|P4|STARTED|Phase II||0
8423248|NCT00892177|20758976|P3|STARTED|Phase II||0
8423249|NCT00892177|20758977|P2|STARTED|Phase II||0
8423250|NCT00892177|20758978|P1|STARTED|Phase II||0
8423251|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 3||0
8423252|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 3||0
8423253|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 3||0
8423254|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 3||0
8423255|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 3||0
8423256|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 3||0
8423257|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 3||0
8423258|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 3||0
8423259|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 3||6
8423260|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 3||0
8423261|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 3||0
8423262|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 3||0
8423263|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 3||0
8423264|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 3||0
8423265|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 3||6
8423266|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 3||0
8423267|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 3||0
8423268|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 3||0
8423269|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 2||0
8423270|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 2||0
8423271|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 2||0
8423272|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 2||0
8423273|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 2||0
8423274|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 2||0
8423275|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 2||0
8423276|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 2||0
8423277|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 2||0
8423278|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 2||3
8423279|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 2||0
8423280|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 2||0
8423281|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 2||0
8423282|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 2||0
8423283|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 2||0
8423284|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 2||3
8423285|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 2||0
8423286|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 2||0
8423287|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 1||0
8423288|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 1||0
8423289|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 1||0
8423290|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 1||0
8423291|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 1||0
8423292|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 1||0
8423293|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 1||0
8423294|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 1||0
8423295|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 1||0
8423296|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 1||0
8423297|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 1||4
8423298|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 1||0
8423299|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 1||0
8423300|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 1||0
8423301|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 1||0
8423302|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 1||0
8423303|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 1||4
8423304|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 1||0
8423305|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 0||0
8423306|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 0||0
8423307|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 0||0
8423308|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 0||0
8423309|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 0||0
8423310|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 0||0
8423311|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 0||0
8423312|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 0||0
8423313|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 0||0
8423314|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 0||0
8423315|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 0||0
8423316|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 0||3
8423317|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 0||0
8423318|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 0||0
8423319|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 0||0
8423320|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 0||0
8423321|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 0||0
8423322|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 0||3
8423323|NCT00892151|20759003|P1|NOT COMPLETED|Overall Study||1
8423324|NCT00892151|20759003|P1|COMPLETED|Overall Study||50
8423325|NCT00892151|20759003|P1|STARTED|Overall Study||51
8423326|NCT00892099|20759012|P3|NOT COMPLETED|Overall Study||7
8423327|NCT00892099|20759013|P2|NOT COMPLETED|Overall Study||1
8423328|NCT00892099|20759014|P1|NOT COMPLETED|Overall Study||5
8423329|NCT00892099|20759012|P3|COMPLETED|Overall Study||29
8423330|NCT00892099|20759013|P2|COMPLETED|Overall Study||32
8423331|NCT00892099|20759014|P1|COMPLETED|Overall Study||31
8423332|NCT00892099|20759012|P3|STARTED|Overall Study||36
8423333|NCT00892099|20759013|P2|STARTED|Overall Study||33
8423334|NCT00892099|20759014|P1|STARTED|Overall Study||36
8423335|NCT00892047|20759039|P2|NOT COMPLETED|Overall Study||7
8423336|NCT00892047|20759040|P1|NOT COMPLETED|Overall Study||4
8423337|NCT00892047|20759039|P2|COMPLETED|Overall Study||83
8423338|NCT00892047|20759040|P1|COMPLETED|Overall Study||87
8423339|NCT00892047|20759039|P2|STARTED|Overall Study||90
8423340|NCT00892047|20759040|P1|STARTED|Overall Study||91
8423341|NCT00892008|20759056|P1|NOT COMPLETED|Overall Study||565
8423342|NCT00892008|20759056|P1|COMPLETED|Overall Study||1713
8423343|NCT00892008|20759056|P1|STARTED|Overall Study||2278
8423344|NCT00891995|20759072|P2|NOT COMPLETED|Overall Study||0
8423345|NCT00891995|20759073|P1|NOT COMPLETED|Overall Study||0
8423346|NCT00891995|20759072|P2|COMPLETED|Overall Study||21
8423347|NCT00891995|20759073|P1|COMPLETED|Overall Study||50
8423348|NCT00891995|20759072|P2|STARTED|Overall Study||21
8423349|NCT00891995|20759073|P1|STARTED|Overall Study||50
8423350|NCT00891982|20759097|P2|NOT COMPLETED|Overall Study||1
8423351|NCT00891982|20759098|P1|NOT COMPLETED|Overall Study||2
8423352|NCT00891982|20759097|P2|COMPLETED|Overall Study||30
8423353|NCT00891982|20759098|P1|COMPLETED|Overall Study||28
8423354|NCT00891982|20759097|P2|STARTED|Overall Study||31
8423355|NCT00891982|20759098|P1|STARTED|Overall Study||30
8423356|NCT00891930|20759142|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
8423357|NCT00891930|20759142|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
8423358|NCT00891930|20759142|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
8423359|NCT00891930|20759142|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
8423360|NCT00891930|20759142|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
8423361|NCT00891930|20759142|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
8423362|NCT00891930|20759142|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
8423363|NCT00891904|20759163|P1|NOT COMPLETED|Overall Study||2
8423364|NCT00891904|20759163|P1|COMPLETED|Overall Study||0
8423365|NCT00891904|20759163|P1|STARTED|Overall Study||2
8423366|NCT00891878|20759172|P2|NOT COMPLETED|Overall Study||0
8423367|NCT00891878|20759173|P1|NOT COMPLETED|Overall Study||0
8423368|NCT00891878|20759172|P2|COMPLETED|Overall Study||6
8423369|NCT00891878|20759173|P1|COMPLETED|Overall Study||6
8423370|NCT00891878|20759172|P2|STARTED|Overall Study||6
8423371|NCT00891878|20759173|P1|STARTED|Overall Study||6
8423372|NCT00891839|20759189|P1|NOT COMPLETED|Overall Study||7
8423373|NCT00891839|20759189|P1|COMPLETED|Overall Study|completed treatment|38
8423374|NCT00891839|20759189|P1|STARTED|Overall Study||45
8423375|NCT00891813|20759198|P1|NOT COMPLETED|Overall Study||12
8423376|NCT00891813|20759198|P1|COMPLETED|Overall Study||88
8423377|NCT00891813|20759198|P1|STARTED|Overall Study||100
8423378|NCT00891774|20759204|P1|NOT COMPLETED|Overall Study||14
8423379|NCT00891774|20759204|P1|COMPLETED|Overall Study||158
8423380|NCT00891774|20759204|P1|STARTED|Overall Study||172
8423381|NCT00891735|20759215|P4|NOT COMPLETED|Overall Study||15
8423382|NCT00891735|20759216|P3|NOT COMPLETED|Overall Study||12
8423383|NCT00891735|20759217|P2|NOT COMPLETED|Overall Study||16
8423384|NCT00891735|20759218|P1|NOT COMPLETED|Overall Study||17
8423385|NCT00891735|20759215|P4|COMPLETED|Overall Study||258
8423386|NCT00891735|20759216|P3|COMPLETED|Overall Study||263
8423387|NCT00891735|20759217|P2|COMPLETED|Overall Study||258
8423388|NCT00891735|20759218|P1|COMPLETED|Overall Study||258
8423389|NCT00891735|20759215|P4|STARTED|Overall Study||273
8423390|NCT00891735|20759216|P3|STARTED|Overall Study||275
8423391|NCT00891735|20759217|P2|STARTED|Overall Study||274
8423392|NCT00891735|20759218|P1|STARTED|Overall Study||275
8423393|NCT00891657|20759258|P2|NOT COMPLETED|Overall Study||1
8423394|NCT00891657|20759259|P1|NOT COMPLETED|Overall Study||1
8423395|NCT00891657|20759258|P2|COMPLETED|Overall Study||5
8423396|NCT00891657|20759259|P1|COMPLETED|Overall Study||8
8423397|NCT00891657|20759258|P2|STARTED|Overall Study||6
8423398|NCT00891657|20759259|P1|STARTED|Overall Study||9
8423399|NCT00891618|20759271|P1|NOT COMPLETED|Overall Study||1
8423400|NCT00891618|20759271|P1|COMPLETED|Overall Study||20
8423401|NCT00891618|20759271|P1|STARTED|Overall Study||21
8423402|NCT00891527|20759275|P1|NOT COMPLETED|Overall Study||2
8423403|NCT00891527|20759275|P1|COMPLETED|Overall Study||48
8423404|NCT00891527|20759275|P1|STARTED|Overall Study||50
8423405|NCT00891462|20759284|P3|NOT COMPLETED|Overall Study||24
8423406|NCT00891462|20759285|P2|NOT COMPLETED|Overall Study||33
8423407|NCT00891462|20759286|P1|NOT COMPLETED|Overall Study||37
8423408|NCT00891462|20759284|P3|COMPLETED|Overall Study||166
8423409|NCT00891462|20759285|P2|COMPLETED|Overall Study||152
8423410|NCT00891462|20759286|P1|COMPLETED|Overall Study||149
8423411|NCT00891462|20759284|P3|STARTED|Overall Study||190
8423412|NCT00891462|20759285|P2|STARTED|Overall Study||185
8423413|NCT00891462|20759286|P1|STARTED|Overall Study||186
8423414|NCT00891436|20759299|P2|NOT COMPLETED|Overall Study||0
8423415|NCT00891436|20759300|P1|NOT COMPLETED|Overall Study||0
8423416|NCT00891436|20759299|P2|COMPLETED|Overall Study||10
8423417|NCT00891436|20759300|P1|COMPLETED|Overall Study||10
8423418|NCT00891436|20759299|P2|STARTED|Overall Study||10
8423419|NCT00891436|20759300|P1|STARTED|Overall Study||10
8423420|NCT00891371|20759308|P1|NOT COMPLETED|Treatment||9
8423421|NCT00891371|20759308|P1|COMPLETED|Treatment||27
8423422|NCT00891371|20759308|P1|STARTED|Treatment||36
8423423|NCT00891371|20759308|P1|NOT COMPLETED|Pre-assignment||6
8423424|NCT00891371|20759308|P1|COMPLETED|Pre-assignment||36
8423425|NCT00891371|20759308|P1|STARTED|Pre-assignment||42
8423426|NCT00891319|20759319|P2|NOT COMPLETED|Overall Study||0
8423427|NCT00891319|20759320|P1|NOT COMPLETED|Overall Study||8
8423428|NCT00891319|20759319|P2|COMPLETED|Overall Study||40
8423429|NCT00891319|20759320|P1|COMPLETED|Overall Study||32
8423430|NCT00891319|20759319|P2|STARTED|Overall Study||40
8423431|NCT00891319|20759320|P1|STARTED|Overall Study||40
8423432|NCT00891293|20759330|P1|NOT COMPLETED|Overall Study||84
8423433|NCT00891293|20759330|P1|COMPLETED|Overall Study||9
8423434|NCT00891293|20759330|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
8423435|NCT00891228|20759345|P3|NOT COMPLETED|Overall Study||15
8423436|NCT00891228|20759346|P2|NOT COMPLETED|Overall Study||13
8423437|NCT00891228|20759347|P1|NOT COMPLETED|Overall Study||11
8423438|NCT00891228|20759345|P3|COMPLETED|Overall Study||19
8423439|NCT00891228|20759346|P2|COMPLETED|Overall Study||20
8423440|NCT00891228|20759347|P1|COMPLETED|Overall Study||21
8423441|NCT00891228|20759345|P3|STARTED|Overall Study||34
8423442|NCT00891228|20759346|P2|STARTED|Overall Study||33
8423443|NCT00891228|20759347|P1|STARTED|Overall Study||32
8423444|NCT00891202|20759369|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
8423445|NCT00891202|20759370|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
8423446|NCT00891202|20759371|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423447|NCT00891202|20759372|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423448|NCT00891202|20759369|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
8423449|NCT00891202|20759370|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
8423450|NCT00891202|20759371|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423451|NCT00891202|20759372|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423452|NCT00891202|20759369|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
8423453|NCT00891202|20759370|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
8423454|NCT00891202|20759371|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
8423455|NCT00891202|20759372|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
8423456|NCT00891202|20759369|P4|NOT COMPLETED|PAP (Up To Week 39)||0
8423457|NCT00891202|20759370|P3|NOT COMPLETED|PAP (Up To Week 39)||0
8423458|NCT00891202|20759371|P2|NOT COMPLETED|PAP (Up To Week 39)||0
8423459|NCT00891202|20759372|P1|NOT COMPLETED|PAP (Up To Week 39)||1
8423460|NCT00891202|20759369|P4|COMPLETED|PAP (Up To Week 39)||0
8423461|NCT00891202|20759370|P3|COMPLETED|PAP (Up To Week 39)||0
8423462|NCT00891202|20759371|P2|COMPLETED|PAP (Up To Week 39)||20
8423463|NCT00891202|20759372|P1|COMPLETED|PAP (Up To Week 39)||19
8423464|NCT00891202|20759369|P4|STARTED|PAP (Up To Week 39)||0
8423465|NCT00891202|20759370|P3|STARTED|PAP (Up To Week 39)||0
8423466|NCT00891202|20759371|P2|STARTED|PAP (Up To Week 39)||20
8423467|NCT00891202|20759372|P1|STARTED|PAP (Up To Week 39)||20
8423468|NCT00891176|20759398|P4|NOT COMPLETED|At 6 Years of Age||0
8423469|NCT00891176|20759399|P3|NOT COMPLETED|At 6 Years of Age||0
8423470|NCT00891176|20759400|P2|NOT COMPLETED|At 6 Years of Age||0
8423471|NCT00891176|20759401|P1|NOT COMPLETED|At 6 Years of Age||0
8423472|NCT00891176|20759398|P4|COMPLETED|At 6 Years of Age||135
8423473|NCT00891176|20759399|P3|COMPLETED|At 6 Years of Age||135
8423474|NCT00891176|20759400|P2|COMPLETED|At 6 Years of Age||138
8423475|NCT00891176|20759401|P1|COMPLETED|At 6 Years of Age||131
8423476|NCT00891176|20759398|P4|STARTED|At 6 Years of Age||135
8423477|NCT00891176|20759399|P3|STARTED|At 6 Years of Age||135
8423478|NCT00891176|20759400|P2|STARTED|At 6 Years of Age||138
8423479|NCT00891176|20759401|P1|STARTED|At 6 Years of Age||131
8423480|NCT00891176|20759398|P4|NOT COMPLETED|At 4 Years of Age||0
8423481|NCT00891176|20759399|P3|NOT COMPLETED|At 4 Years of Age||0
8423482|NCT00891176|20759400|P2|NOT COMPLETED|At 4 Years of Age||0
8423483|NCT00891176|20759401|P1|NOT COMPLETED|At 4 Years of Age||0
8423484|NCT00891176|20759398|P4|COMPLETED|At 4 Years of Age||137
8423485|NCT00891176|20759399|P3|COMPLETED|At 4 Years of Age||142
8423486|NCT00891176|20759400|P2|COMPLETED|At 4 Years of Age||142
8423487|NCT00891176|20759401|P1|COMPLETED|At 4 Years of Age||140
8423488|NCT00891176|20759398|P4|STARTED|At 4 Years of Age||137
8423489|NCT00891176|20759399|P3|STARTED|At 4 Years of Age||142
8423490|NCT00891176|20759400|P2|STARTED|At 4 Years of Age||142
8423491|NCT00891176|20759401|P1|STARTED|At 4 Years of Age||140
8423492|NCT00891176|20759398|P4|NOT COMPLETED|At 3 Years of Age||0
8423493|NCT00891176|20759399|P3|NOT COMPLETED|At 3 Years of Age||0
8423494|NCT00891176|20759400|P2|NOT COMPLETED|At 3 Years of Age||0
8423495|NCT00891176|20759401|P1|NOT COMPLETED|At 3 Years of Age||0
8423496|NCT00891176|20759398|P4|COMPLETED|At 3 Years of Age||141
8423497|NCT00891176|20759399|P3|COMPLETED|At 3 Years of Age||149
8423498|NCT00891176|20759400|P2|COMPLETED|At 3 Years of Age||147
8423499|NCT00891176|20759401|P1|COMPLETED|At 3 Years of Age||144
8423500|NCT00891176|20759398|P4|STARTED|At 3 Years of Age||141
8423501|NCT00891176|20759399|P3|STARTED|At 3 Years of Age||149
8423502|NCT00891176|20759400|P2|STARTED|At 3 Years of Age||147
8423503|NCT00891176|20759401|P1|STARTED|At 3 Years of Age||144
8423504|NCT00891046|20759548|P5|NOT COMPLETED|Overall Study||39
8423505|NCT00891046|20759549|P4|NOT COMPLETED|Overall Study||3
8423506|NCT00891046|20759550|P3|NOT COMPLETED|Overall Study||23
8423507|NCT00891046|20759551|P2|NOT COMPLETED|Overall Study||9
8423508|NCT00891046|20759552|P1|NOT COMPLETED|Overall Study||12
8423509|NCT00891046|20759548|P5|COMPLETED|Overall Study||84
8423510|NCT00891046|20759549|P4|COMPLETED|Overall Study||8
8423511|NCT00891046|20759550|P3|COMPLETED|Overall Study||17
8423512|NCT00891046|20759551|P2|COMPLETED|Overall Study||54
8423513|NCT00891046|20759552|P1|COMPLETED|Overall Study||21
8423514|NCT00891046|20759548|P5|STARTED|Overall Study||123
8423515|NCT00891046|20759549|P4|STARTED|Overall Study||11
8423516|NCT00891046|20759550|P3|STARTED|Overall Study||40
8423517|NCT00891046|20759551|P2|STARTED|Overall Study||63
8423518|NCT00891046|20759552|P1|STARTED|Overall Study||33
8423519|NCT00891020|20759628|P3|NOT COMPLETED|Long-term Extension Period||23
8423520|NCT00891020|20759629|P2|NOT COMPLETED|Long-term Extension Period||24
8423521|NCT00891020|20759630|P1|NOT COMPLETED|Long-term Extension Period||6
8423522|NCT00891020|20759628|P3|COMPLETED|Long-term Extension Period||170
8423523|NCT00891020|20759629|P2|COMPLETED|Long-term Extension Period||172
8423524|NCT00891020|20759630|P1|COMPLETED|Long-term Extension Period||49
8423525|NCT00891020|20759628|P3|STARTED|Long-term Extension Period||193
8423526|NCT00891020|20759629|P2|STARTED|Long-term Extension Period||196
8423527|NCT00891020|20759630|P1|STARTED|Long-term Extension Period||55
8423528|NCT00891020|20759628|P3|NOT COMPLETED|24 Week Treatment Period||58
8423529|NCT00891020|20759629|P2|NOT COMPLETED|24 Week Treatment Period||60
8423530|NCT00891020|20759630|P1|NOT COMPLETED|24 Week Treatment Period||37
8423531|NCT00891020|20759628|P3|COMPLETED|24 Week Treatment Period||302
8423532|NCT00891020|20759629|P2|COMPLETED|24 Week Treatment Period||303
8423533|NCT00891020|20759630|P1|COMPLETED|24 Week Treatment Period||126
8423534|NCT00891020|20759628|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
8423535|NCT00891020|20759629|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
8423536|NCT00891020|20759630|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
8423537|NCT00891020|20759628|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
8423538|NCT00891020|20759629|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
8423539|NCT00891020|20759630|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
8423540|NCT00891020|20759628|P3|STARTED|24 Week Treatment Period||360
8423541|NCT00891020|20759629|P2|STARTED|24 Week Treatment Period||363
8423542|NCT00891020|20759630|P1|STARTED|24 Week Treatment Period||163
8423543|NCT00890981|20759663|P2|NOT COMPLETED|Overall Study||0
8423544|NCT00890981|20759664|P1|NOT COMPLETED|Overall Study||0
8423545|NCT00890981|20759663|P2|COMPLETED|Overall Study||40
8423546|NCT00890981|20759664|P1|COMPLETED|Overall Study||39
8423547|NCT00890981|20759663|P2|STARTED|Overall Study||40
8423548|NCT00890981|20759664|P1|STARTED|Overall Study||39
8423549|NCT00890929|20759694|P1|NOT COMPLETED|Overall Study||6
8423550|NCT00890929|20759694|P1|COMPLETED|Overall Study||39
8423551|NCT00890929|20759694|P1|Initiated Treatment|Overall Study||43
8423552|NCT00890929|20759694|P1|Consented & Enrolled|Overall Study||45
8423553|NCT00890929|20759694|P1|STARTED|Overall Study||45
8423554|NCT00890916|20759706|P1|NOT COMPLETED|"Rehab - NP Off"||0
8423555|NCT00890916|20759706|P1|COMPLETED|"Rehab - NP Off"||10
8423556|NCT00890916|20759706|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
8423557|NCT00890916|20759706|P1|STARTED|"Rehab - NP Off"||10
8423558|NCT00890916|20759706|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
8423559|NCT00890916|20759706|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
8423560|NCT00890916|20759706|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
8423561|NCT00890916|20759706|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
8423562|NCT00890825|20759712|P2|NOT COMPLETED|Overall Study||14
8423563|NCT00890825|20759713|P1|NOT COMPLETED|Overall Study||14
8423564|NCT00890825|20759712|P2|COMPLETED|Overall Study||29
8423565|NCT00890825|20759713|P1|COMPLETED|Overall Study||30
8423566|NCT00890825|20759712|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
8423567|NCT00890825|20759713|P1|STARTED|Overall Study||44
8423568|NCT00890721|20759733|P2|NOT COMPLETED|Overall Study||1
8423569|NCT00890721|20759734|P1|NOT COMPLETED|Overall Study||1
8423570|NCT00890721|20759733|P2|COMPLETED|Overall Study||93
8423571|NCT00890721|20759734|P1|COMPLETED|Overall Study||94
8423572|NCT00890721|20759733|P2|STARTED|Overall Study||94
8423573|NCT00890721|20759734|P1|STARTED|Overall Study||95
8423574|NCT00890695|20759742|P2|NOT COMPLETED|Overall Study||0
8423575|NCT00890695|20759743|P1|NOT COMPLETED|Overall Study||1
8423576|NCT00890695|20759742|P2|COMPLETED|Overall Study||33
8423577|NCT00890695|20759743|P1|COMPLETED|Overall Study||31
8423578|NCT00890695|20759742|P2|STARTED|Overall Study||33
8423579|NCT00890695|20759743|P1|STARTED|Overall Study||32
8423580|NCT00890682|20759761|P2|NOT COMPLETED|Overall Study||2
8423581|NCT00890682|20759762|P1|NOT COMPLETED|Overall Study||4
8423582|NCT00890682|20759761|P2|COMPLETED|Overall Study||94
8423583|NCT00890682|20759762|P1|COMPLETED|Overall Study||93
8423584|NCT00890682|20759761|P2|STARTED|Overall Study||96
8423585|NCT00890682|20759762|P1|STARTED|Overall Study||97
8423586|NCT00890656|20759768|P1|NOT COMPLETED|Overall Study||0
8423587|NCT00890656|20759768|P1|COMPLETED|Overall Study||90
8423588|NCT00890656|20759768|P1|STARTED|Overall Study||90
8423589|NCT00890617|20759772|P1|NOT COMPLETED|Overall Study||0
8423590|NCT00890617|20759772|P1|COMPLETED|Overall Study||9
8423591|NCT00890617|20759772|P1|STARTED|Overall Study||9
8423592|NCT00890591|20759777|P1|NOT COMPLETED|Overall Study||20
8423593|NCT00890591|20759777|P1|COMPLETED|Overall Study||124
8423594|NCT00890591|20759777|P1|STARTED|Overall Study||144
8423595|NCT00890552|20759783|P1|NOT COMPLETED|On-treatment||10
8423596|NCT00890552|20759783|P1|COMPLETED|On-treatment||14
8423597|NCT00890552|20759783|P1|STARTED|On-treatment||24
8423598|NCT00890552|20759783|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
8423599|NCT00890552|20759783|P1|COMPLETED|Enrollment and Pre-treatment||24
8423600|NCT00890552|20759783|P1|STARTED|Enrollment and Pre-treatment||25
8423601|NCT00890409|20759792|P2|NOT COMPLETED|Overall Study||21
8423602|NCT00890409|20759793|P1|NOT COMPLETED|Overall Study||20
8423603|NCT00890409|20759792|P2|COMPLETED|Overall Study||119
8423604|NCT00890409|20759793|P1|COMPLETED|Overall Study||96
8423605|NCT00890409|20759792|P2|STARTED|Overall Study||140
8423606|NCT00890409|20759793|P1|STARTED|Overall Study||116
8423607|NCT00890396|20759803|P2|NOT COMPLETED|Overall Study||2
8423608|NCT00890396|20759804|P1|NOT COMPLETED|Overall Study||5
8423609|NCT00890396|20759803|P2|COMPLETED|Overall Study||34
8423610|NCT00890396|20759804|P1|COMPLETED|Overall Study||122
8423611|NCT00890396|20759803|P2|STARTED|Overall Study||36
8423612|NCT00890396|20759804|P1|STARTED|Overall Study||127
8423613|NCT00890201|20759830|P2|NOT COMPLETED|Overall Study||56
8423614|NCT00890201|20759831|P1|NOT COMPLETED|Overall Study||5
8423615|NCT00890201|20759830|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
8423616|NCT00890201|20759831|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
8423617|NCT00890201|20759830|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
8423618|NCT00890201|20759831|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
8423619|NCT00890162|20759839|P2|NOT COMPLETED|Overall Study||1
8423620|NCT00890162|20759840|P1|NOT COMPLETED|Overall Study||2
8423621|NCT00890162|20759839|P2|COMPLETED|Overall Study||7
8423622|NCT00890162|20759840|P1|COMPLETED|Overall Study||6
8423623|NCT00890162|20759839|P2|STARTED|Overall Study||8
8423624|NCT00890162|20759840|P1|STARTED|Overall Study||8
8423625|NCT00890097|20759849|P3|NOT COMPLETED|Overall Study||77
8423626|NCT00890097|20759850|P2|NOT COMPLETED|Overall Study||86
8423627|NCT00890097|20759851|P1|NOT COMPLETED|Overall Study||68
8423628|NCT00890097|20759849|P3|COMPLETED|Overall Study||184
8423629|NCT00890097|20759850|P2|COMPLETED|Overall Study||173
8423630|NCT00890097|20759851|P1|COMPLETED|Overall Study||184
8423631|NCT00890097|20759849|P3|STARTED|Overall Study||261
8423632|NCT00890097|20759850|P2|STARTED|Overall Study||259
8423633|NCT00890097|20759851|P1|STARTED|Overall Study||252
8423634|NCT00890084|20759859|P1|NOT COMPLETED|Overall Study||142
8423635|NCT00890084|20759859|P1|COMPLETED|Overall Study||2771
8423636|NCT00890084|20759859|P1|STARTED|Overall Study||2913
8423637|NCT00889928|20759870|P1|NOT COMPLETED|Overall Study||0
8423638|NCT00889928|20759870|P1|COMPLETED|Overall Study||7
8423639|NCT00889928|20759870|P1|STARTED|Overall Study||7
8423640|NCT00889915|20759878|P4|NOT COMPLETED|Overall Study||8
8423641|NCT00889915|20759879|P3|NOT COMPLETED|Overall Study||13
8423642|NCT00889915|20759880|P2|NOT COMPLETED|Overall Study||5
8423643|NCT00889915|20759881|P1|NOT COMPLETED|Overall Study||2
8423644|NCT00889915|20759878|P4|COMPLETED|Overall Study||40
8423645|NCT00889915|20759879|P3|COMPLETED|Overall Study||54
8423646|NCT00889915|20759880|P2|COMPLETED|Overall Study||71
8423647|NCT00889915|20759881|P1|COMPLETED|Overall Study||35
8423648|NCT00889915|20759878|P4|STARTED|Overall Study||48
8423649|NCT00889915|20759879|P3|STARTED|Overall Study||67
8423650|NCT00889915|20759880|P2|STARTED|Overall Study||76
8423651|NCT00889915|20759881|P1|STARTED|Overall Study||37
8423652|NCT00889863|20759899|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
8423653|NCT00889863|20759900|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
8423654|NCT00889863|20759899|P2|COMPLETED|Part II: Randomized Double Blind||24
8423655|NCT00889863|20759900|P1|COMPLETED|Part II: Randomized Double Blind||39
8423656|NCT00889863|20759899|P2|STARTED|Part II: Randomized Double Blind||50
8423657|NCT00889863|20759900|P1|STARTED|Part II: Randomized Double Blind||50
8423658|NCT00889863|20759899|P2|NOT COMPLETED|Part I: Open Label||0
8423659|NCT00889863|20759900|P1|NOT COMPLETED|Part I: Open Label||77
8423660|NCT00889863|20759899|P2|COMPLETED|Part I: Open Label||0
8423661|NCT00889863|20759900|P1|COMPLETED|Part I: Open Label||100
8423662|NCT00889863|20759899|P2|Entered Part 1d|Part I: Open Label||0
8423663|NCT00889863|20759900|P1|Entered Part 1d|Part I: Open Label||103
8423664|NCT00889863|20759899|P2|Entered Part Ic|Part I: Open Label||0
8423665|NCT00889863|20759900|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
8423666|NCT00889863|20759899|P2|Entered Part Ib|Part I: Open Label||0
8423667|NCT00889863|20759900|P1|Entered Part Ib|Part I: Open Label||142
8423668|NCT00889863|20759899|P2|Entered Part Ia|Part I: Open Label||0
8423669|NCT00889863|20759900|P1|Entered Part Ia|Part I: Open Label||145
8423670|NCT00889863|20759899|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
8423671|NCT00889863|20759900|P1|STARTED|Part I: Open Label||177
8423672|NCT00889824|20759922|P1|NOT COMPLETED|Overall Study||0
8423673|NCT00889824|20759922|P1|COMPLETED|Overall Study||5
8423674|NCT00889824|20759922|P1|STARTED|Overall Study||5
8423675|NCT00889720|20759926|P1|NOT COMPLETED|Overall Study||8
8423676|NCT00889720|20759926|P1|COMPLETED|Overall Study||8
8423677|NCT00889720|20759926|P1|Surgical Population|Overall Study||12
8423678|NCT00889720|20759926|P1|STARTED|Overall Study||16
8423679|NCT00889707|20759953|P2|NOT COMPLETED|Overall Study||10
8423680|NCT00889707|20759954|P1|NOT COMPLETED|Overall Study||7
8423681|NCT00889707|20759953|P2|COMPLETED|Overall Study||21
8423682|NCT00889707|20759954|P1|COMPLETED|Overall Study||54
8423683|NCT00889707|20759953|P2|STARTED|Overall Study||31
8423684|NCT00889707|20759954|P1|STARTED|Overall Study||61
8423685|NCT00889681|20759962|P1|NOT COMPLETED|Overall Study||3
8423686|NCT00889681|20759962|P1|COMPLETED|Overall Study||78
8423687|NCT00889681|20759962|P1|Received Treatment|Overall Study||78
8423688|NCT00889681|20759962|P1|STARTED|Overall Study||81
8423689|NCT00889603|20759969|P1|NOT COMPLETED|Overall Study||37
8423690|NCT00889603|20759969|P1|COMPLETED|Overall Study||333
8423691|NCT00889603|20759969|P1|STARTED|Overall Study||370
8423692|NCT00889512|20759984|P2|NOT COMPLETED|Overall Study||0
8423693|NCT00889512|20759985|P1|NOT COMPLETED|Overall Study||0
8423694|NCT00889512|20759984|P2|COMPLETED|Overall Study||9
8423695|NCT00889512|20759985|P1|COMPLETED|Overall Study||5
8423696|NCT00889512|20759984|P2|STARTED|Overall Study||9
8423697|NCT00889512|20759985|P1|STARTED|Overall Study||5
8423698|NCT00889421|20759991|P1|NOT COMPLETED|Overall Study||3
8423699|NCT00889421|20759991|P1|COMPLETED|Overall Study||0
8423700|NCT00889421|20759991|P1|STARTED|Overall Study||3
8423701|NCT00889330|20760001|P2|NOT COMPLETED|Overall Study||0
8423702|NCT00889330|20760002|P1|NOT COMPLETED|Overall Study||0
8423703|NCT00889330|20760001|P2|COMPLETED|Overall Study||30
8423704|NCT00889330|20760002|P1|COMPLETED|Overall Study||30
8423705|NCT00889330|20760001|P2|STARTED|Overall Study||30
8423706|NCT00889330|20760002|P1|STARTED|Overall Study||30
8423707|NCT00889265|20760032|P1|NOT COMPLETED|Overall Study||7
8423708|NCT00889265|20760032|P1|COMPLETED|Overall Study||44
8423709|NCT00889265|20760032|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
8423710|NCT00889252|20760039|P2|NOT COMPLETED|Overall Study||4
8423711|NCT00889252|20760040|P1|NOT COMPLETED|Overall Study||7
8423712|NCT00889252|20760039|P2|COMPLETED|Overall Study||78
8423713|NCT00889252|20760040|P1|COMPLETED|Overall Study||161
8423714|NCT00889252|20760039|P2|STARTED|Overall Study||82
8423715|NCT00889252|20760040|P1|STARTED|Overall Study||168
8423716|NCT00889226|20760084|P2|NOT COMPLETED|Overall Study||35
8423717|NCT00889226|20760085|P1|NOT COMPLETED|Overall Study||25
8423718|NCT00889226|20760084|P2|COMPLETED|Overall Study||43
8423719|NCT00889226|20760085|P1|COMPLETED|Overall Study||58
8423720|NCT00889226|20760084|P2|STARTED|Overall Study||78
8423721|NCT00889226|20760085|P1|STARTED|Overall Study||83
8423722|NCT00889200|20760093|P1|NOT COMPLETED|Overall Study||0
8423723|NCT00889200|20760093|P1|COMPLETED|Overall Study||12
8423724|NCT00889200|20760093|P1|STARTED|Overall Study||12
8423725|NCT00889187|20760097|P4|NOT COMPLETED|Overall Study||0
8423726|NCT00889187|20760098|P3|NOT COMPLETED|Overall Study||0
8423727|NCT00889187|20760099|P2|NOT COMPLETED|Overall Study||0
8423728|NCT00889187|20760100|P1|NOT COMPLETED|Overall Study||0
8423729|NCT00889187|20760097|P4|COMPLETED|Overall Study||0
8423730|NCT00889187|20760098|P3|COMPLETED|Overall Study||4
8423731|NCT00889187|20760099|P2|COMPLETED|Overall Study||3
8423732|NCT00889187|20760100|P1|COMPLETED|Overall Study||3
8423733|NCT00889187|20760097|P4|STARTED|Overall Study||0
8423734|NCT00889187|20760098|P3|STARTED|Overall Study||4
8423735|NCT00889187|20760099|P2|STARTED|Overall Study||3
8423736|NCT00889187|20760100|P1|STARTED|Overall Study||3
8423737|NCT00889005|20760117|P2|NOT COMPLETED|Overall Study||2
8423738|NCT00889005|20760118|P1|NOT COMPLETED|Overall Study||8
8423739|NCT00889005|20760117|P2|COMPLETED|Overall Study||72
8423740|NCT00889005|20760118|P1|COMPLETED|Overall Study||57
8423741|NCT00889005|20760117|P2|STARTED|Overall Study||74
8423742|NCT00889005|20760118|P1|STARTED|Overall Study||65
8423743|NCT00888979|20760124|P1|NOT COMPLETED|Overall Study||4
8423744|NCT00888979|20760124|P1|COMPLETED|Overall Study||6
8423745|NCT00888979|20760124|P1|Received the Inhaler/Counseling|Overall Study||8
8423746|NCT00888979|20760124|P1|STARTED|Overall Study||10
8423747|NCT00888940|20760132|P2|NOT COMPLETED|Overall Study||21
8423748|NCT00888940|20760133|P1|NOT COMPLETED|Overall Study||28
8423749|NCT00888940|20760132|P2|COMPLETED|Overall Study||101
8423750|NCT00888940|20760133|P1|COMPLETED|Overall Study||92
8423751|NCT00888940|20760132|P2|Completed Therapy|Overall Study||106
8423752|NCT00888940|20760133|P1|Completed Therapy|Overall Study||107
8423753|NCT00888940|20760132|P2|STARTED|Overall Study||122
8423754|NCT00888940|20760133|P1|STARTED|Overall Study||120
8423755|NCT00888927|20760145|P4|NOT COMPLETED|Overall Study||2
8423756|NCT00888927|20760146|P3|NOT COMPLETED|Overall Study||0
8423757|NCT00888927|20760147|P2|NOT COMPLETED|Overall Study||0
8423758|NCT00888927|20760148|P1|NOT COMPLETED|Overall Study||0
8423759|NCT00888927|20760145|P4|COMPLETED|Overall Study||31
8423760|NCT00888927|20760146|P3|COMPLETED|Overall Study||3
8423761|NCT00888927|20760147|P2|COMPLETED|Overall Study||3
8423762|NCT00888927|20760148|P1|COMPLETED|Overall Study||3
8423763|NCT00888927|20760145|P4|STARTED|Overall Study||33
8423764|NCT00888927|20760146|P3|STARTED|Overall Study||3
8423765|NCT00888927|20760147|P2|STARTED|Overall Study||3
8423766|NCT00888927|20760148|P1|STARTED|Overall Study||3
8423767|NCT00888849|20760164|P2|NOT COMPLETED|Overall Study||9
8423768|NCT00888849|20760165|P1|NOT COMPLETED|Overall Study||5
8423769|NCT00888849|20760164|P2|COMPLETED|Overall Study||129
8423770|NCT00888849|20760165|P1|COMPLETED|Overall Study||137
8423771|NCT00888849|20760164|P2|STARTED|Overall Study||138
8423772|NCT00888849|20760165|P1|STARTED|Overall Study||142
8423773|NCT00888654|20760175|P1|NOT COMPLETED|Overall Study||10
8423774|NCT00888654|20760175|P1|COMPLETED|Overall Study||31
8423775|NCT00888654|20760175|P1|STARTED|Overall Study||41
8423776|NCT00888628|20760181|P1|NOT COMPLETED|Overall Study||3
8423777|NCT00888628|20760181|P1|COMPLETED|Overall Study||4
8423778|NCT00888628|20760181|P1|Transplanted|Overall Study||4
8423779|NCT00888628|20760181|P1|Withdrawn|Overall Study||1
8423780|NCT00888628|20760181|P1|Screen Failure|Overall Study||2
8423781|NCT00888628|20760181|P1|Enrolled|Overall Study||7
8423782|NCT00888628|20760181|P1|STARTED|Overall Study||7
8423783|NCT00888615|20760193|P1|NOT COMPLETED|Overall Study||2
8423784|NCT00888615|20760193|P1|COMPLETED|Overall Study||56
8423785|NCT00888615|20760193|P1|STARTED|Overall Study||58
8423786|NCT00888511|20760202|P1|NOT COMPLETED|Overall Study||0
8423787|NCT00888511|20760202|P1|COMPLETED|Overall Study||15
8423788|NCT00888511|20760202|P1|STARTED|Overall Study||15
8423789|NCT00888459|20760208|P2|NOT COMPLETED|Overall Study||0
8423790|NCT00888459|20760209|P1|NOT COMPLETED|Overall Study||0
8423791|NCT00888459|20760208|P2|COMPLETED|Overall Study||30
8423792|NCT00888459|20760209|P1|COMPLETED|Overall Study||30
8423793|NCT00888459|20760208|P2|STARTED|Overall Study||30
8423794|NCT00888459|20760209|P1|STARTED|Overall Study||30
8423795|NCT00888433|20760217|P2|NOT COMPLETED|Overall Study||3
8423796|NCT00888433|20760218|P1|NOT COMPLETED|Overall Study||3
8423797|NCT00888433|20760217|P2|COMPLETED|Overall Study||51
8423798|NCT00888433|20760218|P1|COMPLETED|Overall Study||49
8423799|NCT00888433|20760217|P2|STARTED|Overall Study||54
8423800|NCT00888433|20760218|P1|STARTED|Overall Study||52
8423801|NCT00888381|20760226|P2|NOT COMPLETED|Overall Study||1
8423802|NCT00888381|20760227|P1|NOT COMPLETED|Overall Study||0
8423803|NCT00888381|20760226|P2|COMPLETED|Overall Study||59
8423804|NCT00888381|20760227|P1|COMPLETED|Overall Study||60
8423805|NCT00888381|20760226|P2|STARTED|Overall Study||60
8423806|NCT00888381|20760227|P1|STARTED|Overall Study||60
8423807|NCT00888355|20760247|P4|NOT COMPLETED|Overall Study||10
8423808|NCT00888355|20760248|P3|NOT COMPLETED|Overall Study||12
8423809|NCT00888355|20760249|P2|NOT COMPLETED|Overall Study||9
8423810|NCT00888355|20760250|P1|NOT COMPLETED|Overall Study||22
8423811|NCT00888355|20760247|P4|COMPLETED|Overall Study||96
8423812|NCT00888355|20760248|P3|COMPLETED|Overall Study||94
8423813|NCT00888355|20760249|P2|COMPLETED|Overall Study||99
8423814|NCT00888355|20760250|P1|COMPLETED|Overall Study||86
8423815|NCT00888355|20760247|P4|STARTED|Overall Study||106
8423816|NCT00888355|20760248|P3|STARTED|Overall Study||106
8423817|NCT00888355|20760249|P2|STARTED|Overall Study||108
8423818|NCT00888355|20760250|P1|STARTED|Overall Study||108
8423819|NCT00888329|20760306|P2|NOT COMPLETED|Overall Study||9
8423820|NCT00888329|20760307|P1|NOT COMPLETED|Overall Study||6
8423821|NCT00888329|20760306|P2|COMPLETED|Overall Study||122
8423822|NCT00888329|20760307|P1|COMPLETED|Overall Study||119
8423823|NCT00888329|20760306|P2|STARTED|Overall Study||131
8423824|NCT00888329|20760307|P1|STARTED|Overall Study||125
8423825|NCT00888238|20760313|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
8423826|NCT00888238|20760314|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
8423827|NCT00888238|20760315|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
8423828|NCT00888238|20760313|P3|COMPLETED|Third Period of Treatment Intervention||3
8423829|NCT00888238|20760314|P2|COMPLETED|Third Period of Treatment Intervention||4
8423830|NCT00888238|20760315|P1|COMPLETED|Third Period of Treatment Intervention||4
8423831|NCT00888238|20760313|P3|STARTED|Third Period of Treatment Intervention||3
8423832|NCT00888238|20760314|P2|STARTED|Third Period of Treatment Intervention||4
8423833|NCT00888238|20760315|P1|STARTED|Third Period of Treatment Intervention||4
8423834|NCT00888238|20760313|P3|NOT COMPLETED|Washout Period After Period 2||1
8423835|NCT00888238|20760314|P2|NOT COMPLETED|Washout Period After Period 2||0
8423836|NCT00888238|20760315|P1|NOT COMPLETED|Washout Period After Period 2||0
8423837|NCT00888238|20760313|P3|COMPLETED|Washout Period After Period 2||3
8423838|NCT00888238|20760314|P2|COMPLETED|Washout Period After Period 2||4
8423839|NCT00888238|20760315|P1|COMPLETED|Washout Period After Period 2||4
8423840|NCT00888238|20760313|P3|STARTED|Washout Period After Period 2||4
8423841|NCT00888238|20760314|P2|STARTED|Washout Period After Period 2||4
8423842|NCT00888238|20760315|P1|STARTED|Washout Period After Period 2||4
8423843|NCT00888238|20760313|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
8423844|NCT00888238|20760314|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
8423845|NCT00888238|20760315|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
8423846|NCT00888238|20760313|P3|COMPLETED|Second Period of Treatment Intervention||4
8423847|NCT00888238|20760314|P2|COMPLETED|Second Period of Treatment Intervention||4
8423848|NCT00888238|20760315|P1|COMPLETED|Second Period of Treatment Intervention||4
8423849|NCT00888238|20760313|P3|STARTED|Second Period of Treatment Intervention||4
8423850|NCT00888238|20760314|P2|STARTED|Second Period of Treatment Intervention||4
8423851|NCT00888238|20760315|P1|STARTED|Second Period of Treatment Intervention||4
8423852|NCT00888238|20760313|P3|NOT COMPLETED|Washout Period After Period 1||0
8423853|NCT00888238|20760314|P2|NOT COMPLETED|Washout Period After Period 1||0
8423854|NCT00888238|20760315|P1|NOT COMPLETED|Washout Period After Period 1||0
8423855|NCT00888238|20760313|P3|COMPLETED|Washout Period After Period 1||4
8423856|NCT00888238|20760314|P2|COMPLETED|Washout Period After Period 1||4
8423857|NCT00888238|20760315|P1|COMPLETED|Washout Period After Period 1||4
8423858|NCT00888238|20760313|P3|STARTED|Washout Period After Period 1||4
8423859|NCT00888238|20760314|P2|STARTED|Washout Period After Period 1||4
8423860|NCT00888238|20760315|P1|STARTED|Washout Period After Period 1||4
8423861|NCT00888238|20760313|P3|NOT COMPLETED|First Period of Treatment Intervention||0
8423862|NCT00888238|20760314|P2|NOT COMPLETED|First Period of Treatment Intervention||0
8423952|NCT00887588|20760553|P1|Arterial Stiffness Set|Core Period||86
8423863|NCT00888238|20760315|P1|NOT COMPLETED|First Period of Treatment Intervention||0
8423864|NCT00888238|20760313|P3|COMPLETED|First Period of Treatment Intervention||4
8423865|NCT00888238|20760314|P2|COMPLETED|First Period of Treatment Intervention||4
8423866|NCT00888238|20760315|P1|COMPLETED|First Period of Treatment Intervention||4
8423867|NCT00888238|20760313|P3|STARTED|First Period of Treatment Intervention||4
8423868|NCT00888238|20760314|P2|STARTED|First Period of Treatment Intervention||4
8423869|NCT00888238|20760315|P1|STARTED|First Period of Treatment Intervention||4
8423870|NCT00888173|20760323|P1|NOT COMPLETED|Overall Study||2
8423871|NCT00888173|20760323|P1|COMPLETED|Overall Study||43
8423872|NCT00888173|20760323|P1|STARTED|Overall Study||45
8423873|NCT00888134|20760331|P1|NOT COMPLETED|Follow-up||1
8423874|NCT00888134|20760331|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
8423875|NCT00888134|20760331|P1|STARTED|Follow-up||27
8423876|NCT00888134|20760331|P1|NOT COMPLETED|Treatment With Study Drug||1
8423877|NCT00888134|20760331|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
8423878|NCT00888134|20760331|P1|STARTED|Treatment With Study Drug||28
8423879|NCT00887978|20760341|P2|NOT COMPLETED|Overall Study||15
8423880|NCT00887978|20760342|P1|NOT COMPLETED|Overall Study||25
8423881|NCT00887978|20760341|P2|COMPLETED|Overall Study||138
8423882|NCT00887978|20760342|P1|COMPLETED|Overall Study||132
8423883|NCT00887978|20760341|P2|STARTED|Overall Study||153
8423884|NCT00887978|20760342|P1|STARTED|Overall Study||157
8423885|NCT00887965|20760378|P1|NOT COMPLETED|Overall Study||0
8423886|NCT00887965|20760378|P1|COMPLETED|Overall Study||15
8423887|NCT00887965|20760378|P1|STARTED|Overall Study||15
8423888|NCT00887926|20760412|P4|NOT COMPLETED|Overall Study||0
8423889|NCT00887926|20760413|P3|NOT COMPLETED|Overall Study||0
8423890|NCT00887926|20760414|P2|NOT COMPLETED|Overall Study||1
8423891|NCT00887926|20760415|P1|NOT COMPLETED|Overall Study||0
8423892|NCT00887926|20760412|P4|COMPLETED|Overall Study||5
8423893|NCT00887926|20760413|P3|COMPLETED|Overall Study||3
8423894|NCT00887926|20760414|P2|COMPLETED|Overall Study||13
8423895|NCT00887926|20760415|P1|COMPLETED|Overall Study||3
8423896|NCT00887926|20760412|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8423897|NCT00887926|20760413|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8423898|NCT00887926|20760414|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8423899|NCT00887926|20760415|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8423900|NCT00887926|20760412|P4|STARTED|Overall Study||5
8423901|NCT00887926|20760413|P3|STARTED|Overall Study||3
8423902|NCT00887926|20760414|P2|STARTED|Overall Study||14
8423903|NCT00887926|20760415|P1|STARTED|Overall Study||3
8423904|NCT00887913|20760450|P1|NOT COMPLETED|Overall Study||6
8423905|NCT00887913|20760450|P1|COMPLETED|Overall Study||63
8423906|NCT00887913|20760450|P1|STARTED|Overall Study||69
8423907|NCT00887822|20760458|P2|NOT COMPLETED|Overall Study||102
8423908|NCT00887822|20760459|P1|NOT COMPLETED|Overall Study||97
8423909|NCT00887822|20760458|P2|COMPLETED|Overall Study||0
8423910|NCT00887822|20760459|P1|COMPLETED|Overall Study||3
8423911|NCT00887822|20760458|P2|Treated (Safety Population)|Overall Study||101
8423912|NCT00887822|20760459|P1|Treated (Safety Population)|Overall Study||100
8423913|NCT00887822|20760458|P2|STARTED|Overall Study||102
8423914|NCT00887822|20760459|P1|STARTED|Overall Study||100
8423915|NCT00887809|20760491|P2|NOT COMPLETED|Overall Study||0
8423916|NCT00887809|20760492|P1|NOT COMPLETED|Overall Study||4
8423917|NCT00887809|20760491|P2|COMPLETED|Overall Study||10
8423918|NCT00887809|20760492|P1|COMPLETED|Overall Study||33
8423919|NCT00887809|20760491|P2|STARTED|Overall Study||10
8423920|NCT00887809|20760492|P1|STARTED|Overall Study||37
8423921|NCT00887783|20760500|P2|NOT COMPLETED|Overall Study||0
8423922|NCT00887783|20760501|P1|NOT COMPLETED|Overall Study||0
8423923|NCT00887783|20760500|P2|COMPLETED|Overall Study||59
8423924|NCT00887783|20760501|P1|COMPLETED|Overall Study||58
8423925|NCT00887783|20760500|P2|STARTED|Overall Study||59
8423926|NCT00887783|20760501|P1|STARTED|Overall Study||58
8423927|NCT00887744|20760513|P1|NOT COMPLETED|Overall Study||34
8423928|NCT00887744|20760513|P1|COMPLETED|Overall Study||128
8423929|NCT00887744|20760513|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
8423930|NCT00887679|20760522|P1|NOT COMPLETED|Overall Study||10
8423931|NCT00887679|20760522|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
8423932|NCT00887679|20760522|P1|STARTED|Overall Study||30
8423933|NCT00887653|20760531|P1|NOT COMPLETED|Overall Study||0
8423934|NCT00887653|20760531|P1|COMPLETED|Overall Study||20
8423935|NCT00887653|20760531|P1|STARTED|Overall Study||20
8423936|NCT00887640|20760537|P1|NOT COMPLETED|Overall Study||0
8423937|NCT00887640|20760537|P1|COMPLETED|Overall Study||11
8423938|NCT00887640|20760537|P1|STARTED|Overall Study||11
8423939|NCT00887588|20760552|P2|NOT COMPLETED|Extension Period||5
8423940|NCT00887588|20760553|P1|NOT COMPLETED|Extension Period||6
8423941|NCT00887588|20760552|P2|COMPLETED|Extension Period||120
8423942|NCT00887588|20760553|P1|COMPLETED|Extension Period||121
8423943|NCT00887588|20760552|P2|Arterial Stiffness Set|Extension Period||94
8423944|NCT00887588|20760553|P1|Arterial Stiffness Set|Extension Period||86
8423945|NCT00887588|20760552|P2|STARTED|Extension Period||125
8423946|NCT00887588|20760553|P1|STARTED|Extension Period||127
8423947|NCT00887588|20760552|P2|NOT COMPLETED|Core Period||21
8423948|NCT00887588|20760553|P1|NOT COMPLETED|Core Period||19
8423949|NCT00887588|20760552|P2|COMPLETED|Core Period||131
8423950|NCT00887588|20760553|P1|COMPLETED|Core Period||130
8423951|NCT00887588|20760552|P2|Arterial Stiffness Set|Core Period||94
8423953|NCT00887588|20760552|P2|Full Analysis Set|Core Period||146
8423954|NCT00887588|20760553|P1|Full Analysis Set|Core Period||148
8423955|NCT00887588|20760552|P2|Extension Efficacy Set|Core Period||125
8423956|NCT00887588|20760553|P1|Extension Efficacy Set|Core Period||127
8423957|NCT00887588|20760552|P2|STARTED|Core Period||152
8423958|NCT00887588|20760553|P1|STARTED|Core Period||149
8423959|NCT00887575|20760605|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
8423960|NCT00887575|20760606|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
8423961|NCT00887575|20760607|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
8423962|NCT00887575|20760605|P3|COMPLETED|Phase II - Maintenance Therapy||0
8423963|NCT00887575|20760606|P2|COMPLETED|Phase II - Maintenance Therapy||0
8423964|NCT00887575|20760607|P1|COMPLETED|Phase II - Maintenance Therapy||6
8423965|NCT00887575|20760605|P3|STARTED|Phase II - Maintenance Therapy||0
8423966|NCT00887575|20760606|P2|STARTED|Phase II - Maintenance Therapy||0
8423967|NCT00887575|20760607|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
8423968|NCT00887575|20760605|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
8423969|NCT00887575|20760606|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
8423970|NCT00887575|20760607|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
8423971|NCT00887575|20760605|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
8423972|NCT00887575|20760606|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
8423973|NCT00887575|20760607|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
8423974|NCT00887575|20760605|P3|STARTED|Phase II - Neoadjuvant Therapy||0
8423975|NCT00887575|20760606|P2|STARTED|Phase II - Neoadjuvant Therapy||0
8423976|NCT00887575|20760607|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
8423977|NCT00887575|20760605|P3|NOT COMPLETED|Phase I||3
8423978|NCT00887575|20760606|P2|NOT COMPLETED|Phase I||6
8423979|NCT00887575|20760607|P1|NOT COMPLETED|Phase I||0
8423980|NCT00887575|20760605|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8423981|NCT00887575|20760606|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8423982|NCT00887575|20760607|P1|COMPLETED|Phase I||6
8423983|NCT00887575|20760605|P3|STARTED|Phase I||3
8423984|NCT00887575|20760606|P2|STARTED|Phase I||6
8423985|NCT00887575|20760607|P1|STARTED|Phase I||6
8423986|NCT00887562|20760618|P3|NOT COMPLETED|Overall Study||1
8423987|NCT00887562|20760619|P2|NOT COMPLETED|Overall Study||2
8423988|NCT00887562|20760620|P1|NOT COMPLETED|Overall Study||3
8423989|NCT00887562|20760618|P3|COMPLETED|Overall Study||7
8423990|NCT00887562|20760619|P2|COMPLETED|Overall Study||7
8423991|NCT00887562|20760620|P1|COMPLETED|Overall Study||7
8423992|NCT00887562|20760618|P3|STARTED|Overall Study||8
8423993|NCT00887562|20760619|P2|STARTED|Overall Study||9
8423994|NCT00887562|20760620|P1|STARTED|Overall Study||10
8423995|NCT00887549|20760634|P1|NOT COMPLETED|Maintenance Therapy||43
8423996|NCT00887549|20760634|P1|COMPLETED|Maintenance Therapy||0
8423997|NCT00887549|20760634|P1|STARTED|Maintenance Therapy||43
8423998|NCT00887549|20760634|P1|NOT COMPLETED|Induction Therapy||27
8423999|NCT00887549|20760634|P1|COMPLETED|Induction Therapy||43
8424000|NCT00887549|20760634|P1|STARTED|Induction Therapy||70
8424001|NCT00887510|20760643|P2|NOT COMPLETED|Overall Study||0
8424002|NCT00887510|20760644|P1|NOT COMPLETED|Overall Study||0
8424003|NCT00887510|20760643|P2|COMPLETED|Overall Study||12
8424004|NCT00887510|20760644|P1|COMPLETED|Overall Study||12
8424005|NCT00887510|20760643|P2|STARTED|Overall Study||12
8424006|NCT00887510|20760644|P1|STARTED|Overall Study||12
8424007|NCT00887484|20760652|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
8424008|NCT00887484|20760652|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
8424009|NCT00887484|20760652|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
8424010|NCT00887484|20760652|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
8424011|NCT00887484|20760652|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
8424012|NCT00887484|20760652|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
8424013|NCT00887471|20760718|P2|NOT COMPLETED|Overall Study||0
8424014|NCT00887471|20760719|P1|NOT COMPLETED|Overall Study||0
8424015|NCT00887471|20760718|P2|COMPLETED|Overall Study||15
8424016|NCT00887471|20760719|P1|COMPLETED|Overall Study||15
8424017|NCT00887471|20760718|P2|STARTED|Overall Study||15
8424018|NCT00887471|20760719|P1|STARTED|Overall Study||15
8424019|NCT00887458|20760729|P2|NOT COMPLETED|Overall Study||4
8424020|NCT00887458|20760730|P1|NOT COMPLETED|Overall Study||0
8424021|NCT00887458|20760729|P2|COMPLETED|Overall Study||25
8424022|NCT00887458|20760730|P1|COMPLETED|Overall Study||17
8424023|NCT00887458|20760729|P2|STARTED|Overall Study||29
8424024|NCT00887458|20760730|P1|STARTED|Overall Study||17
8424025|NCT00887354|20760740|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
8424026|NCT00887354|20760741|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
8424027|NCT00887354|20760740|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
8424028|NCT00887354|20760741|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
8424029|NCT00887354|20760740|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
8424030|NCT00887354|20760741|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
8424031|NCT00887354|20760740|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
8424032|NCT00887354|20760741|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
8424033|NCT00887354|20760740|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
8424034|NCT00887354|20760741|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
8424035|NCT00887354|20760740|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
8424114|NCT00887224|20760845|P2|COMPLETED|Open-label Stability (OLS) Phase||0
8424036|NCT00887354|20760741|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
8424037|NCT00887354|20760740|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
8424038|NCT00887354|20760741|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
8424039|NCT00887354|20760740|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
8424040|NCT00887354|20760741|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
8424041|NCT00887341|20760761|P2|NOT COMPLETED|Overall Study||3
8424042|NCT00887341|20760762|P1|NOT COMPLETED|Overall Study||2
8424043|NCT00887341|20760761|P2|COMPLETED|Overall Study||36
8424044|NCT00887341|20760762|P1|COMPLETED|Overall Study||35
8424045|NCT00887341|20760761|P2|STARTED|Overall Study||39
8424046|NCT00887341|20760762|P1|STARTED|Overall Study||37
8424047|NCT00887315|20760798|P2|NOT COMPLETED|Overall Study||4
8424048|NCT00887315|20760799|P1|NOT COMPLETED|Overall Study||7
8424049|NCT00887315|20760798|P2|COMPLETED|Overall Study||0
8424050|NCT00887315|20760799|P1|COMPLETED|Overall Study||0
8424051|NCT00887315|20760798|P2|STARTED|Overall Study||4
8424052|NCT00887315|20760799|P1|STARTED|Overall Study||7
8424053|NCT00887289|20760807|P1|NOT COMPLETED|Overall Study||95
8424054|NCT00887289|20760807|P1|COMPLETED|Overall Study||1409
8424055|NCT00887289|20760807|P1|STARTED|Overall Study||1504
8424056|NCT00887250|20760819|P3|NOT COMPLETED|Overall Study||13
8424057|NCT00887250|20760820|P2|NOT COMPLETED|Overall Study||12
8424058|NCT00887250|20760821|P1|NOT COMPLETED|Overall Study||18
8424059|NCT00887250|20760819|P3|COMPLETED|Overall Study||110
8424060|NCT00887250|20760820|P2|COMPLETED|Overall Study||115
8424061|NCT00887250|20760821|P1|COMPLETED|Overall Study||98
8424062|NCT00887250|20760819|P3|STARTED|Overall Study||123
8424063|NCT00887250|20760820|P2|STARTED|Overall Study||127
8424064|NCT00887250|20760821|P1|STARTED|Overall Study||116
8424065|NCT00887224|20760844|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
8424066|NCT00887224|20760845|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
8424067|NCT00887224|20760846|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
8424068|NCT00887224|20760844|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
8424069|NCT00887224|20760845|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
8424070|NCT00887224|20760846|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
8424071|NCT00887224|20760844|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
8424072|NCT00887224|20760845|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
8424073|NCT00887224|20760846|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
8424074|NCT00887224|20760844|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
8424075|NCT00887224|20760845|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
8424076|NCT00887224|20760846|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
8424077|NCT00887224|20760844|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
8424078|NCT00887224|20760845|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
8424079|NCT00887224|20760846|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
8424080|NCT00887224|20760844|P3|NOT COMPLETED|Double-blind (DB) Phase||62
8424081|NCT00887224|20760845|P2|NOT COMPLETED|Double-blind (DB) Phase||100
8424082|NCT00887224|20760846|P1|NOT COMPLETED|Double-blind (DB) Phase||0
8424083|NCT00887224|20760844|P3|COMPLETED|Double-blind (DB) Phase||210
8424084|NCT00887224|20760845|P2|COMPLETED|Double-blind (DB) Phase||176
8424085|NCT00887224|20760846|P1|COMPLETED|Double-blind (DB) Phase||0
8424086|NCT00887224|20760844|P3|STARTED|Double-blind (DB) Phase||272
8424087|NCT00887224|20760845|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
8424088|NCT00887224|20760846|P1|STARTED|Double-blind (DB) Phase||0
8424089|NCT00887224|20760844|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
8424090|NCT00887224|20760845|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
8424091|NCT00887224|20760846|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
8424092|NCT00887224|20760844|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
8424093|NCT00887224|20760845|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
8424094|NCT00887224|20760846|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
8424095|NCT00887224|20760844|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
8424096|NCT00887224|20760845|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
8424097|NCT00887224|20760846|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
8424098|NCT00887224|20760844|P3|STARTED|OL Taper Phase / OL Follow Up||0
8424099|NCT00887224|20760845|P2|STARTED|OL Taper Phase / OL Follow Up||0
8424100|NCT00887224|20760846|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
8424101|NCT00887224|20760844|P3|NOT COMPLETED|Between OLS and DB Phases||0
8424102|NCT00887224|20760845|P2|NOT COMPLETED|Between OLS and DB Phases||0
8424103|NCT00887224|20760846|P1|NOT COMPLETED|Between OLS and DB Phases||28
8424104|NCT00887224|20760844|P3|COMPLETED|Between OLS and DB Phases||0
8424105|NCT00887224|20760845|P2|COMPLETED|Between OLS and DB Phases||0
8424106|NCT00887224|20760846|P1|COMPLETED|Between OLS and DB Phases||548
8424107|NCT00887224|20760844|P3|STARTED|Between OLS and DB Phases||0
8424108|NCT00887224|20760845|P2|STARTED|Between OLS and DB Phases||0
8424109|NCT00887224|20760846|P1|STARTED|Between OLS and DB Phases||576
8424110|NCT00887224|20760844|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
8424111|NCT00887224|20760845|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
8424112|NCT00887224|20760846|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
8424113|NCT00887224|20760844|P3|COMPLETED|Open-label Stability (OLS) Phase||0
8424115|NCT00887224|20760846|P1|COMPLETED|Open-label Stability (OLS) Phase||576
8424116|NCT00887224|20760844|P3|STARTED|Open-label Stability (OLS) Phase||0
8424117|NCT00887224|20760845|P2|STARTED|Open-label Stability (OLS) Phase||0
8424118|NCT00887224|20760846|P1|STARTED|Open-label Stability (OLS) Phase||659
8424119|NCT00887224|20760844|P3|NOT COMPLETED|Between OLR and OLS Phases||0
8424120|NCT00887224|20760845|P2|NOT COMPLETED|Between OLR and OLS Phases||0
8424121|NCT00887224|20760846|P1|NOT COMPLETED|Between OLR and OLS Phases||93
8424122|NCT00887224|20760844|P3|COMPLETED|Between OLR and OLS Phases||0
8424123|NCT00887224|20760845|P2|COMPLETED|Between OLR and OLS Phases||0
8424124|NCT00887224|20760846|P1|COMPLETED|Between OLR and OLS Phases||659
8424125|NCT00887224|20760844|P3|STARTED|Between OLR and OLS Phases||0
8424126|NCT00887224|20760845|P2|STARTED|Between OLR and OLS Phases||0
8424127|NCT00887224|20760846|P1|STARTED|Between OLR and OLS Phases||752
8424128|NCT00887224|20760844|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
8424129|NCT00887224|20760845|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
8424130|NCT00887224|20760846|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
8424131|NCT00887224|20760844|P3|COMPLETED|Open-label Response (OLR) Phase||0
8424132|NCT00887224|20760845|P2|COMPLETED|Open-label Response (OLR) Phase||0
8424133|NCT00887224|20760846|P1|COMPLETED|Open-label Response (OLR) Phase||752
8424134|NCT00887224|20760844|P3|STARTED|Open-label Response (OLR) Phase||0
8424135|NCT00887224|20760845|P2|STARTED|Open-label Response (OLR) Phase||0
8424136|NCT00887224|20760846|P1|STARTED|Open-label Response (OLR) Phase||874
8424137|NCT00887198|20760873|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
8424138|NCT00887198|20760874|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
8424139|NCT00887198|20760875|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
8424140|NCT00887198|20760873|P3|COMPLETED|Cross Over (Placebo to AA)||0
8424141|NCT00887198|20760874|P2|COMPLETED|Cross Over (Placebo to AA)||0
8424142|NCT00887198|20760875|P1|COMPLETED|Cross Over (Placebo to AA)||0
8424143|NCT00887198|20760873|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
8424144|NCT00887198|20760874|P2|STARTED|Cross Over (Placebo to AA)||0
8424145|NCT00887198|20760875|P1|STARTED|Cross Over (Placebo to AA)||0
8424146|NCT00887198|20760873|P3|NOT COMPLETED|Randomized Period||0
8424147|NCT00887198|20760874|P2|NOT COMPLETED|Randomized Period||542
8424148|NCT00887198|20760875|P1|NOT COMPLETED|Randomized Period||546
8424149|NCT00887198|20760873|P3|COMPLETED|Randomized Period||0
8424150|NCT00887198|20760874|P2|COMPLETED|Randomized Period||0
8424151|NCT00887198|20760875|P1|COMPLETED|Randomized Period||0
8424152|NCT00887198|20760873|P3|Treated|Randomized Period||0
8424153|NCT00887198|20760874|P2|Treated|Randomized Period||540
8424154|NCT00887198|20760875|P1|Treated|Randomized Period||542
8424155|NCT00887198|20760873|P3|STARTED|Randomized Period||0
8424156|NCT00887198|20760874|P2|STARTED|Randomized Period||542
8424157|NCT00887198|20760875|P1|STARTED|Randomized Period||546
8424158|NCT00887159|20760906|P3|NOT COMPLETED|Overall Study||56
8424159|NCT00887159|20760907|P2|NOT COMPLETED|Overall Study||56
8424160|NCT00887159|20760908|P1|NOT COMPLETED|Overall Study||29
8424161|NCT00887159|20760906|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
8424162|NCT00887159|20760907|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
8424163|NCT00887159|20760908|P1|COMPLETED|Overall Study||27
8424164|NCT00887159|20760906|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
8424165|NCT00887159|20760907|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
8424166|NCT00887159|20760908|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
8424167|NCT00887159|20760906|P3|Eligible and Treated Patients|Overall Study||52
8424168|NCT00887159|20760907|P2|Eligible and Treated Patients|Overall Study||52
8424169|NCT00887159|20760908|P1|Eligible and Treated Patients|Overall Study||48
8424170|NCT00887159|20760906|P3|Patients Who Started Assigned Treatment|Overall Study||52
8424171|NCT00887159|20760907|P2|Patients Who Started Assigned Treatment|Overall Study||53
8424172|NCT00887159|20760908|P1|Patients Who Started Assigned Treatment|Overall Study||53
8424173|NCT00887159|20760906|P3|STARTED|Overall Study||56
8424174|NCT00887159|20760907|P2|STARTED|Overall Study||56
8424175|NCT00887159|20760908|P1|STARTED|Overall Study||56
8424176|NCT00887068|20760926|P2|NOT COMPLETED|Overall Study||0
8424177|NCT00887068|20760927|P1|NOT COMPLETED|Overall Study||6
8424178|NCT00887068|20760926|P2|COMPLETED|Overall Study||94
8424179|NCT00887068|20760927|P1|COMPLETED|Overall Study||87
8424180|NCT00887068|20760926|P2|STARTED|Overall Study||94
8424181|NCT00887068|20760927|P1|STARTED|Overall Study||93
8424182|NCT00886938|20760935|P1|NOT COMPLETED|Overall Study||2
8424183|NCT00886938|20760935|P1|COMPLETED|Overall Study||10
8424184|NCT00886938|20760935|P1|STARTED|Overall Study||12
8424185|NCT00886899|20760939|P1|NOT COMPLETED|Overall Study||0
8424186|NCT00886899|20760939|P1|COMPLETED|Overall Study||147
8424187|NCT00886899|20760939|P1|STARTED|Overall Study||147
8424188|NCT00886834|20760948|P2|NOT COMPLETED|Overall Study||3
8424189|NCT00886834|20760949|P1|NOT COMPLETED|Overall Study||0
8424190|NCT00886834|20760948|P2|COMPLETED|Overall Study||51
8424191|NCT00886834|20760949|P1|COMPLETED|Overall Study||54
8424192|NCT00886834|20760948|P2|STARTED|Overall Study||54
8424193|NCT00886834|20760949|P1|STARTED|Overall Study||54
8424194|NCT00886821|20760971|P14|NOT COMPLETED|Stage 2||1
8424195|NCT00886821|20760972|P13|NOT COMPLETED|Stage 2||5
8424196|NCT00886821|20760973|P12|NOT COMPLETED|Stage 2||1
8424197|NCT00886821|20760974|P11|NOT COMPLETED|Stage 2||0
8424198|NCT00886821|20760975|P10|NOT COMPLETED|Stage 2||0
8424199|NCT00886821|20760976|P9|NOT COMPLETED|Stage 2||0
8424200|NCT00886821|20760977|P8|NOT COMPLETED|Stage 2||0
8424201|NCT00886821|20760978|P7|NOT COMPLETED|Stage 2||0
8424202|NCT00886821|20760979|P6|NOT COMPLETED|Stage 2||0
8424203|NCT00886821|20760980|P5|NOT COMPLETED|Stage 2||0
8424204|NCT00886821|20760981|P4|NOT COMPLETED|Stage 2||0
8424205|NCT00886821|20760982|P3|NOT COMPLETED|Stage 2||0
8424206|NCT00886821|20760983|P2|NOT COMPLETED|Stage 2||0
8424207|NCT00886821|20760984|P1|NOT COMPLETED|Stage 2||0
8424208|NCT00886821|20760971|P14|COMPLETED|Stage 2||8
8424209|NCT00886821|20760972|P13|COMPLETED|Stage 2||8
8424210|NCT00886821|20760973|P12|COMPLETED|Stage 2||8
8424211|NCT00886821|20760974|P11|COMPLETED|Stage 2||9
8424212|NCT00886821|20760975|P10|COMPLETED|Stage 2||0
8424213|NCT00886821|20760976|P9|COMPLETED|Stage 2||0
8424214|NCT00886821|20760977|P8|COMPLETED|Stage 2||0
8424215|NCT00886821|20760978|P7|COMPLETED|Stage 2||0
8424216|NCT00886821|20760979|P6|COMPLETED|Stage 2||0
8424217|NCT00886821|20760980|P5|COMPLETED|Stage 2||0
8424218|NCT00886821|20760981|P4|COMPLETED|Stage 2||0
8424219|NCT00886821|20760982|P3|COMPLETED|Stage 2||0
8424220|NCT00886821|20760983|P2|COMPLETED|Stage 2||0
8424221|NCT00886821|20760984|P1|COMPLETED|Stage 2||0
8424222|NCT00886821|20760971|P14|STARTED|Stage 2||9
8424223|NCT00886821|20760972|P13|STARTED|Stage 2||13
8424224|NCT00886821|20760973|P12|STARTED|Stage 2||9
8424225|NCT00886821|20760974|P11|STARTED|Stage 2||9
8424226|NCT00886821|20760975|P10|STARTED|Stage 2||0
8424227|NCT00886821|20760976|P9|STARTED|Stage 2||0
8424228|NCT00886821|20760977|P8|STARTED|Stage 2||0
8424229|NCT00886821|20760978|P7|STARTED|Stage 2||0
8424230|NCT00886821|20760979|P6|STARTED|Stage 2||0
8424231|NCT00886821|20760980|P5|STARTED|Stage 2||0
8424232|NCT00886821|20760981|P4|STARTED|Stage 2||0
8424233|NCT00886821|20760982|P3|STARTED|Stage 2||0
8424234|NCT00886821|20760983|P2|STARTED|Stage 2||0
8424235|NCT00886821|20760984|P1|STARTED|Stage 2||0
8424236|NCT00886821|20760971|P14|NOT COMPLETED|Stage 1||0
8424237|NCT00886821|20760972|P13|NOT COMPLETED|Stage 1||0
8424238|NCT00886821|20760973|P12|NOT COMPLETED|Stage 1||0
8424239|NCT00886821|20760974|P11|NOT COMPLETED|Stage 1||0
8424240|NCT00886821|20760975|P10|NOT COMPLETED|Stage 1||0
8424241|NCT00886821|20760976|P9|NOT COMPLETED|Stage 1||0
8424242|NCT00886821|20760977|P8|NOT COMPLETED|Stage 1||0
8424243|NCT00886821|20760978|P7|NOT COMPLETED|Stage 1||0
8424244|NCT00886821|20760979|P6|NOT COMPLETED|Stage 1||0
8424245|NCT00886821|20760980|P5|NOT COMPLETED|Stage 1||0
8424246|NCT00886821|20760981|P4|NOT COMPLETED|Stage 1||0
8424247|NCT00886821|20760982|P3|NOT COMPLETED|Stage 1||0
8424248|NCT00886821|20760983|P2|NOT COMPLETED|Stage 1||0
8424249|NCT00886821|20760984|P1|NOT COMPLETED|Stage 1||0
8424250|NCT00886821|20760971|P14|COMPLETED|Stage 1||0
8424251|NCT00886821|20760972|P13|COMPLETED|Stage 1||0
8424252|NCT00886821|20760973|P12|COMPLETED|Stage 1||0
8424253|NCT00886821|20760974|P11|COMPLETED|Stage 1||0
8424254|NCT00886821|20760975|P10|COMPLETED|Stage 1||18
8424255|NCT00886821|20760976|P9|COMPLETED|Stage 1||6
8424256|NCT00886821|20760977|P8|COMPLETED|Stage 1||6
8424257|NCT00886821|20760978|P7|COMPLETED|Stage 1||6
8424258|NCT00886821|20760979|P6|COMPLETED|Stage 1||6
8424259|NCT00886821|20760980|P5|COMPLETED|Stage 1||6
8424260|NCT00886821|20760981|P4|COMPLETED|Stage 1||7
8424261|NCT00886821|20760982|P3|COMPLETED|Stage 1||6
8424262|NCT00886821|20760983|P2|COMPLETED|Stage 1||6
8424263|NCT00886821|20760984|P1|COMPLETED|Stage 1||7
8424264|NCT00886821|20760971|P14|STARTED|Stage 1||0
8424265|NCT00886821|20760972|P13|STARTED|Stage 1||0
8424266|NCT00886821|20760973|P12|STARTED|Stage 1||0
8424267|NCT00886821|20760974|P11|STARTED|Stage 1||0
8424268|NCT00886821|20760975|P10|STARTED|Stage 1||18
8424269|NCT00886821|20760976|P9|STARTED|Stage 1||6
8424270|NCT00886821|20760977|P8|STARTED|Stage 1||6
8424271|NCT00886821|20760978|P7|STARTED|Stage 1||6
8424272|NCT00886821|20760979|P6|STARTED|Stage 1||6
8424273|NCT00886821|20760980|P5|STARTED|Stage 1||6
8424274|NCT00886821|20760981|P4|STARTED|Stage 1||7
8424275|NCT00886821|20760982|P3|STARTED|Stage 1||6
8424276|NCT00886821|20760983|P2|STARTED|Stage 1||6
8424277|NCT00886821|20760984|P1|STARTED|Stage 1||7
8424278|NCT00886795|20761209|P1|NOT COMPLETED|Overall Study||1
8424279|NCT00886795|20761209|P1|COMPLETED|Overall Study||3
8424280|NCT00886795|20761209|P1|STARTED|Overall Study||4
8424281|NCT00886769|20761216|P2|NOT COMPLETED|Overall Study||37
8424282|NCT00886769|20761217|P1|NOT COMPLETED|Overall Study||6
8424283|NCT00886769|20761216|P2|COMPLETED|Overall Study||4
8424284|NCT00886769|20761217|P1|COMPLETED|Overall Study||37
8424285|NCT00886769|20761216|P2|STARTED|Overall Study||41
8424286|NCT00886769|20761217|P1|STARTED|Overall Study||43
8424287|NCT00886743|20761241|P1|NOT COMPLETED|Overall Study||4
8424288|NCT00886743|20761241|P1|COMPLETED|Overall Study||15
8424289|NCT00886743|20761241|P1|STARTED|Overall Study|Received treatment|19
8424290|NCT00886704|20761251|P2|NOT COMPLETED|Overall Study||0
8424291|NCT00886704|20761252|P1|NOT COMPLETED|Overall Study||0
8424292|NCT00886704|20761251|P2|COMPLETED|Overall Study||10
8424293|NCT00886704|20761252|P1|COMPLETED|Overall Study||40
8424294|NCT00886704|20761251|P2|STARTED|Overall Study||10
8424295|NCT00886704|20761252|P1|STARTED|Overall Study||40
8424296|NCT00886691|20761262|P2|NOT COMPLETED|Overall Study||0
8424297|NCT00886691|20761263|P1|NOT COMPLETED|Overall Study||0
8424298|NCT00886691|20761262|P2|COMPLETED|Overall Study||75
8424299|NCT00886691|20761263|P1|COMPLETED|Overall Study||75
8424300|NCT00886691|20761262|P2|STARTED|Overall Study||75
8424301|NCT00886691|20761263|P1|STARTED|Overall Study||75
8424302|NCT00886639|20761279|P1|NOT COMPLETED|Overall Study||16
8424303|NCT00886639|20761279|P1|COMPLETED|Overall Study||111
8424304|NCT00886639|20761279|P1|STARTED|Overall Study||127
8424305|NCT00886626|20761283|P2|NOT COMPLETED|Period 2 (90 Days)||0
8424306|NCT00886626|20761284|P1|NOT COMPLETED|Period 2 (90 Days)||0
8424307|NCT00886626|20761283|P2|COMPLETED|Period 2 (90 Days)||6
8424308|NCT00886626|20761284|P1|COMPLETED|Period 2 (90 Days)||5
8424309|NCT00886626|20761283|P2|STARTED|Period 2 (90 Days)||6
8424310|NCT00886626|20761284|P1|STARTED|Period 2 (90 Days)||5
8424311|NCT00886626|20761283|P2|NOT COMPLETED|Period 1 (90 Days)||0
8424312|NCT00886626|20761284|P1|NOT COMPLETED|Period 1 (90 Days)||1
8424313|NCT00886626|20761283|P2|COMPLETED|Period 1 (90 Days)||6
8424314|NCT00886626|20761284|P1|COMPLETED|Period 1 (90 Days)||5
8424315|NCT00886626|20761283|P2|STARTED|Period 1 (90 Days)||6
8424316|NCT00886626|20761284|P1|STARTED|Period 1 (90 Days)||6
8424317|NCT00886613|20761293|P3|NOT COMPLETED|Overall Study||3
8424318|NCT00886613|20761294|P2|NOT COMPLETED|Overall Study||0
8424319|NCT00886613|20761295|P1|NOT COMPLETED|Overall Study||2
8424320|NCT00886613|20761293|P3|COMPLETED|Overall Study||37
8424321|NCT00886613|20761294|P2|COMPLETED|Overall Study||39
8424322|NCT00886613|20761295|P1|COMPLETED|Overall Study||39
8424323|NCT00886613|20761293|P3|STARTED|Overall Study||40
8424324|NCT00886613|20761294|P2|STARTED|Overall Study||39
8424325|NCT00886613|20761295|P1|STARTED|Overall Study||41
8424326|NCT00886600|20761317|P4|NOT COMPLETED|Combination Therapy Period||0
8424327|NCT00886600|20761318|P3|NOT COMPLETED|Combination Therapy Period||2
8424328|NCT00886600|20761319|P2|NOT COMPLETED|Combination Therapy Period||0
8424329|NCT00886600|20761320|P1|NOT COMPLETED|Combination Therapy Period||0
8424330|NCT00886600|20761317|P4|COMPLETED|Combination Therapy Period||23
8424331|NCT00886600|20761318|P3|COMPLETED|Combination Therapy Period||19
8424332|NCT00886600|20761319|P2|COMPLETED|Combination Therapy Period||21
8424333|NCT00886600|20761320|P1|COMPLETED|Combination Therapy Period||28
8424334|NCT00886600|20761317|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
8424335|NCT00886600|20761318|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
8424336|NCT00886600|20761319|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
8424337|NCT00886600|20761320|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
8424338|NCT00886600|20761317|P4|NOT COMPLETED|Double-blind Monotherapy||2
8424339|NCT00886600|20761318|P3|NOT COMPLETED|Double-blind Monotherapy||1
8424340|NCT00886600|20761319|P2|NOT COMPLETED|Double-blind Monotherapy||1
8424341|NCT00886600|20761320|P1|NOT COMPLETED|Double-blind Monotherapy||2
8424342|NCT00886600|20761317|P4|COMPLETED|Double-blind Monotherapy||29
8424343|NCT00886600|20761318|P3|COMPLETED|Double-blind Monotherapy||29
8424344|NCT00886600|20761319|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
8424345|NCT00886600|20761320|P1|COMPLETED|Double-blind Monotherapy||30
8424346|NCT00886600|20761317|P4|STARTED|Double-blind Monotherapy||31
8424347|NCT00886600|20761318|P3|STARTED|Double-blind Monotherapy||30
8424348|NCT00886600|20761319|P2|STARTED|Double-blind Monotherapy||29
8424349|NCT00886600|20761320|P1|STARTED|Double-blind Monotherapy||32
8424350|NCT00886587|20761344|P2|NOT COMPLETED|Overall Study||2
8424351|NCT00886587|20761345|P1|NOT COMPLETED|Overall Study||4
8424352|NCT00886587|20761344|P2|COMPLETED|Overall Study||39
8424353|NCT00886587|20761345|P1|COMPLETED|Overall Study||37
8424354|NCT00886587|20761344|P2|STARTED|Overall Study||41
8424355|NCT00886587|20761345|P1|STARTED|Overall Study||41
8424356|NCT00886483|20761359|P2|NOT COMPLETED|Overall Study||3
8424357|NCT00886483|20761360|P1|NOT COMPLETED|Overall Study||2
8424358|NCT00886483|20761359|P2|COMPLETED|Overall Study||10
8424359|NCT00886483|20761360|P1|COMPLETED|Overall Study||24
8424360|NCT00886483|20761359|P2|Completed 20 Treatments|Overall Study||11
8424361|NCT00886483|20761360|P1|Completed 20 Treatments|Overall Study||25
8424362|NCT00886483|20761359|P2|STARTED|Overall Study||13
8424363|NCT00886483|20761360|P1|STARTED|Overall Study||26
8424364|NCT00886340|20761378|P2|NOT COMPLETED|Overall Study||7
8424365|NCT00886340|20761379|P1|NOT COMPLETED|Overall Study||0
8424366|NCT00886340|20761378|P2|COMPLETED|Overall Study||24
8424367|NCT00886340|20761379|P1|COMPLETED|Overall Study||27
8424368|NCT00886340|20761378|P2|STARTED|Overall Study||31
8424369|NCT00886340|20761379|P1|STARTED|Overall Study||27
8424370|NCT00886288|20761387|P2|NOT COMPLETED|Overall Study||227
8424371|NCT00886288|20761388|P1|NOT COMPLETED|Overall Study||743
8424372|NCT00886288|20761387|P2|COMPLETED|Overall Study||457
8424373|NCT00886288|20761388|P1|COMPLETED|Overall Study||1284
8424374|NCT00886288|20761387|P2|STARTED|Overall Study|Baseline Population|684
8424375|NCT00886288|20761388|P1|STARTED|Overall Study|Baseline Population|2027
8424376|NCT00886262|20761406|P2|NOT COMPLETED|Overall Study||3
8424377|NCT00886262|20761407|P1|NOT COMPLETED|Overall Study||0
8424378|NCT00886262|20761406|P2|COMPLETED|Overall Study||7
8424379|NCT00886262|20761407|P1|COMPLETED|Overall Study||8
8424380|NCT00886262|20761406|P2|STARTED|Overall Study||10
8424381|NCT00886262|20761407|P1|STARTED|Overall Study||8
8424382|NCT00886236|20761422|P3|NOT COMPLETED|Overall Study||4
8424383|NCT00886236|20761423|P2|NOT COMPLETED|Overall Study||4
8424384|NCT00886236|20761424|P1|NOT COMPLETED|Overall Study||2
8424385|NCT00886236|20761422|P3|COMPLETED|Overall Study||17
8424386|NCT00886236|20761423|P2|COMPLETED|Overall Study||17
8424387|NCT00886236|20761424|P1|COMPLETED|Overall Study||18
8424388|NCT00886236|20761422|P3|STARTED|Overall Study||21
8424389|NCT00886236|20761423|P2|STARTED|Overall Study||21
8424390|NCT00886236|20761424|P1|STARTED|Overall Study||20
8424391|NCT00886145|20761438|P1|NOT COMPLETED|Overall Study||0
8424392|NCT00886145|20761438|P1|COMPLETED|Overall Study||1
8424393|NCT00886145|20761438|P1|STARTED|Overall Study||1
8424394|NCT00886119|20761444|P2|NOT COMPLETED|Period 2||0
8424395|NCT00886119|20761445|P1|NOT COMPLETED|Period 2||0
8424396|NCT00886119|20761444|P2|COMPLETED|Period 2||22
8424397|NCT00886119|20761445|P1|COMPLETED|Period 2||23
8424398|NCT00886119|20761444|P2|STARTED|Period 2||22
8424399|NCT00886119|20761445|P1|STARTED|Period 2||23
8424400|NCT00886119|20761444|P2|NOT COMPLETED|Period 1||0
8424401|NCT00886119|20761445|P1|NOT COMPLETED|Period 1||1
8424402|NCT00886119|20761444|P2|COMPLETED|Period 1||22
8424403|NCT00886119|20761445|P1|COMPLETED|Period 1||23
8424404|NCT00886119|20761444|P2|STARTED|Period 1||22
8424405|NCT00886119|20761445|P1|STARTED|Period 1||24
8424406|NCT00886015|20761453|P2|NOT COMPLETED|Overall Study||2
8424407|NCT00886015|20761454|P1|NOT COMPLETED|Overall Study||0
8424408|NCT00886015|20761453|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
8424409|NCT00886015|20761454|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
8424410|NCT00886015|20761453|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
8424411|NCT00886015|20761454|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
8424412|NCT00885846|20761473|P3|NOT COMPLETED|Overall Study||2
8424413|NCT00885846|20761474|P2|NOT COMPLETED|Overall Study||5
8424414|NCT00885846|20761475|P1|NOT COMPLETED|Overall Study||2
8424415|NCT00885846|20761473|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
8424416|NCT00885846|20761474|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
8424417|NCT00885846|20761475|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
8424418|NCT00885846|20761473|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
8424419|NCT00885846|20761474|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
8424420|NCT00885846|20761475|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
8424421|NCT00885768|20761483|P1|NOT COMPLETED|Overall Study||0
8424422|NCT00885768|20761483|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
8424423|NCT00885768|20761483|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
8424424|NCT00885755|20761490|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8424425|NCT00885755|20761491|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8424426|NCT00885755|20761492|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
8424427|NCT00885755|20761490|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8424428|NCT00885755|20761491|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
8424429|NCT00885755|20761492|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
8424430|NCT00885755|20761490|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
8424431|NCT00885755|20761491|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
8424432|NCT00885755|20761492|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
8424433|NCT00885755|20761490|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
8424434|NCT00885755|20761491|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
8424435|NCT00885755|20761492|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
8424436|NCT00885755|20761490|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
8424437|NCT00885755|20761491|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
8424438|NCT00885755|20761492|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
8424439|NCT00885755|20761490|P3|STARTED|Part I: Trastuzumab+Taxane||1
8424440|NCT00885755|20761491|P2|STARTED|Part I: Trastuzumab+Taxane||1
8424441|NCT00885755|20761492|P1|STARTED|Part I: Trastuzumab+Taxane||31
8424442|NCT00885742|20761517|P1|NOT COMPLETED|Overall Study||0
8424443|NCT00885742|20761517|P1|COMPLETED|Overall Study||41
8424444|NCT00885742|20761517|P1|STARTED|Overall Study||41
8424445|NCT00885703|20761535|P7|NOT COMPLETED|Overall Study||6
8424446|NCT00885703|20761536|P6|NOT COMPLETED|Overall Study||13
8424447|NCT00885703|20761537|P5|NOT COMPLETED|Overall Study||12
8424448|NCT00885703|20761538|P4|NOT COMPLETED|Overall Study||9
8424449|NCT00885703|20761539|P3|NOT COMPLETED|Overall Study||11
8424450|NCT00885703|20761540|P2|NOT COMPLETED|Overall Study||10
8424451|NCT00885703|20761541|P1|NOT COMPLETED|Overall Study||10
8424452|NCT00885703|20761535|P7|COMPLETED|Overall Study||18
8424453|NCT00885703|20761536|P6|COMPLETED|Overall Study||11
8424454|NCT00885703|20761537|P5|COMPLETED|Overall Study||12
8424455|NCT00885703|20761538|P4|COMPLETED|Overall Study||15
8424456|NCT00885703|20761539|P3|COMPLETED|Overall Study||13
8424457|NCT00885703|20761540|P2|COMPLETED|Overall Study||16
8424458|NCT00885703|20761541|P1|COMPLETED|Overall Study||12
8424459|NCT00885703|20761535|P7|STARTED|Overall Study||24
8424460|NCT00885703|20761536|P6|STARTED|Overall Study||24
8424461|NCT00885703|20761537|P5|STARTED|Overall Study||24
8424462|NCT00885703|20761538|P4|STARTED|Overall Study||24
8424463|NCT00885703|20761539|P3|STARTED|Overall Study||24
8424464|NCT00885703|20761540|P2|STARTED|Overall Study||26
8424465|NCT00885703|20761541|P1|STARTED|Overall Study||22
8424466|NCT00885677|20761599|P2|NOT COMPLETED|Overall Study||178
8424467|NCT00885677|20761600|P1|NOT COMPLETED|Overall Study||183
8424468|NCT00885677|20761599|P2|COMPLETED|Overall Study||277
8424469|NCT00885677|20761600|P1|COMPLETED|Overall Study||279
8424470|NCT00885677|20761599|P2|Intention To Treat|Overall Study||428
8424471|NCT00885677|20761600|P1|Intention To Treat|Overall Study||437
8424472|NCT00885677|20761599|P2|STARTED|Overall Study||455
8424473|NCT00885677|20761600|P1|STARTED|Overall Study||462
8424474|NCT00885638|20761608|P2|NOT COMPLETED|Overall Study||0
8424475|NCT00885638|20761609|P1|NOT COMPLETED|Overall Study||0
8424476|NCT00885638|20761608|P2|COMPLETED|Overall Study||6
8424477|NCT00885638|20761609|P1|COMPLETED|Overall Study||6
8424478|NCT00885638|20761608|P2|STARTED|Overall Study||6
8424479|NCT00885638|20761609|P1|STARTED|Overall Study||6
8424480|NCT00885534|20761616|P1|NOT COMPLETED|Overall Study||1
8424481|NCT00885534|20761616|P1|COMPLETED|Overall Study||6
8424482|NCT00885534|20761616|P1|STARTED|Overall Study||7
8424483|NCT00885482|20761620|P1|NOT COMPLETED|Overall Study||4
8424484|NCT00885482|20761620|P1|COMPLETED|Overall Study||36
8424485|NCT00885482|20761620|P1|STARTED|Overall Study||40
8424486|NCT00885378|20761626|P2|NOT COMPLETED|Overall Study||8
8424487|NCT00885378|20761627|P1|NOT COMPLETED|Overall Study||8
8424488|NCT00885378|20761626|P2|COMPLETED|Overall Study||78
8424489|NCT00885378|20761627|P1|COMPLETED|Overall Study||66
8424490|NCT00885378|20761626|P2|STARTED|Overall Study|Number randomized.|86
8424491|NCT00885378|20761627|P1|STARTED|Overall Study|Number randomized.|74
8424492|NCT00885365|20761657|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
8424493|NCT00885365|20761658|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
8424494|NCT00885365|20761657|P2|COMPLETED|4 Weeks OFF Treatment||159
8424495|NCT00885365|20761658|P1|COMPLETED|4 Weeks OFF Treatment||155
8424496|NCT00885365|20761657|P2|STARTED|4 Weeks OFF Treatment||159
8424497|NCT00885365|20761658|P1|STARTED|4 Weeks OFF Treatment||155
8424498|NCT00885365|20761657|P2|NOT COMPLETED|4 Weeks ON Treatment||6
8424499|NCT00885365|20761658|P1|NOT COMPLETED|4 Weeks ON Treatment||4
8424500|NCT00885365|20761657|P2|COMPLETED|4 Weeks ON Treatment||159
8424501|NCT00885365|20761658|P1|COMPLETED|4 Weeks ON Treatment||155
8424502|NCT00885365|20761657|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
8424503|NCT00885365|20761658|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
8424504|NCT00885365|20761657|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
8424505|NCT00885365|20761658|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
8424506|NCT00885365|20761657|P2|STARTED|4 Weeks ON Treatment||165
8424507|NCT00885365|20761658|P1|STARTED|4 Weeks ON Treatment||159
8424508|NCT00885352|20761694|P2|NOT COMPLETED|Overall Study||20
8424509|NCT00885352|20761695|P1|NOT COMPLETED|Overall Study||8
8424510|NCT00885352|20761694|P2|COMPLETED|Overall Study||136
8424511|NCT00885352|20761695|P1|COMPLETED|Overall Study||149
8424512|NCT00885352|20761694|P2|STARTED|Overall Study||156
8424513|NCT00885352|20761695|P1|STARTED|Overall Study||157
8424514|NCT00885170|20761707|P2|NOT COMPLETED|Overall Study||23
8424515|NCT00885170|20761708|P1|NOT COMPLETED|Overall Study||38
8424516|NCT00885170|20761707|P2|COMPLETED|Overall Study||99
8424517|NCT00885170|20761708|P1|COMPLETED|Overall Study||86
8424518|NCT00885170|20761707|P2|Treated|Overall Study||121
8424519|NCT00885170|20761708|P1|Treated|Overall Study||122
8424520|NCT00885170|20761707|P2|STARTED|Overall Study||122
8424521|NCT00885170|20761708|P1|STARTED|Overall Study||124
8424522|NCT00885118|20761767|P5|NOT COMPLETED|Overall Study||1
8424523|NCT00885118|20761768|P4|NOT COMPLETED|Overall Study||0
8424524|NCT00885118|20761769|P3|NOT COMPLETED|Overall Study||1
8424525|NCT00885118|20761770|P2|NOT COMPLETED|Overall Study||0
8424526|NCT00885118|20761771|P1|NOT COMPLETED|Overall Study||1
8424527|NCT00885118|20761767|P5|COMPLETED|Overall Study||18
8424528|NCT00885118|20761768|P4|COMPLETED|Overall Study||20
8424529|NCT00885118|20761769|P3|COMPLETED|Overall Study||20
8424530|NCT00885118|20761770|P2|COMPLETED|Overall Study||19
8424531|NCT00885118|20761771|P1|COMPLETED|Overall Study||20
8424532|NCT00885118|20761767|P5|STARTED|Overall Study||19
8424533|NCT00885118|20761768|P4|STARTED|Overall Study||20
8424534|NCT00885118|20761769|P3|STARTED|Overall Study||21
8424535|NCT00885118|20761770|P2|STARTED|Overall Study||19
8424536|NCT00885118|20761771|P1|STARTED|Overall Study||21
8424537|NCT00885105|20761910|P2|NOT COMPLETED|Overall Study||10
8424538|NCT00885105|20761911|P1|NOT COMPLETED|Overall Study||1
8424539|NCT00885105|20761910|P2|COMPLETED|Overall Study||120
8424540|NCT00885105|20761911|P1|COMPLETED|Overall Study||111
8424541|NCT00885105|20761910|P2|STARTED|Overall Study||130
8424542|NCT00885105|20761911|P1|STARTED|Overall Study||112
8424543|NCT00885092|20761929|P2|NOT COMPLETED|Period 2, 7 Days||0
8424544|NCT00885092|20761930|P1|NOT COMPLETED|Period 2, 7 Days||0
8424545|NCT00885092|20761929|P2|COMPLETED|Period 2, 7 Days||20
8424546|NCT00885092|20761930|P1|COMPLETED|Period 2, 7 Days||20
8424547|NCT00885092|20761929|P2|STARTED|Period 2, 7 Days||20
8424548|NCT00885092|20761930|P1|STARTED|Period 2, 7 Days||20
8424549|NCT00885092|20761929|P2|NOT COMPLETED|Period 1, 7 Days||0
8424550|NCT00885092|20761930|P1|NOT COMPLETED|Period 1, 7 Days||0
8424551|NCT00885092|20761929|P2|COMPLETED|Period 1, 7 Days||20
8424552|NCT00885092|20761930|P1|COMPLETED|Period 1, 7 Days||20
8424553|NCT00885092|20761929|P2|STARTED|Period 1, 7 Days||20
8424554|NCT00885092|20761930|P1|STARTED|Period 1, 7 Days||20
8424555|NCT00885079|20761942|P2|NOT COMPLETED|Overall Study||4
8424556|NCT00885079|20761943|P1|NOT COMPLETED|Overall Study||2
8424557|NCT00885079|20761942|P2|COMPLETED|Overall Study||91
8424558|NCT00885079|20761943|P1|COMPLETED|Overall Study||91
8424559|NCT00885079|20761942|P2|STARTED|Overall Study||95
8424560|NCT00885079|20761943|P1|STARTED|Overall Study||93
8424561|NCT00884949|20761951|P1|NOT COMPLETED|Continuation Period||0
8424562|NCT00884949|20761951|P1|COMPLETED|Continuation Period||18
8424563|NCT00884949|20761951|P1|STARTED|Continuation Period||18
8424564|NCT00884949|20761951|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
8424565|NCT00884949|20761951|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
8424566|NCT00884949|20761951|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
8424567|NCT00884949|20761951|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
8424568|NCT00884949|20761951|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
8424569|NCT00884949|20761951|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
8424570|NCT00884949|20761951|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
8424571|NCT00884949|20761951|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
8424572|NCT00884949|20761951|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
8424573|NCT00884910|20761968|P1|NOT COMPLETED|Overall Study||1
8424574|NCT00884910|20761968|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
8424575|NCT00884910|20761968|P1|STARTED|Overall Study||33
8424576|NCT00884897|20761975|P2|NOT COMPLETED|Overall Study||0
8424577|NCT00884897|20761976|P1|NOT COMPLETED|Overall Study||0
8424578|NCT00884897|20761975|P2|COMPLETED|Overall Study||15
8424579|NCT00884897|20761976|P1|COMPLETED|Overall Study||13
8424580|NCT00884897|20761975|P2|STARTED|Overall Study||15
8424581|NCT00884897|20761976|P1|STARTED|Overall Study||13
8424582|NCT00884832|20761986|P2|NOT COMPLETED|Overall Study||1
8424583|NCT00884832|20761987|P1|NOT COMPLETED|Overall Study||0
8424584|NCT00884832|20761986|P2|COMPLETED|Overall Study||21
8424585|NCT00884832|20761987|P1|COMPLETED|Overall Study||22
8424586|NCT00884832|20761986|P2|STARTED|Overall Study||22
8424587|NCT00884832|20761987|P1|STARTED|Overall Study||22
8424588|NCT00884806|20762017|P1|NOT COMPLETED|Overall Study||0
8424589|NCT00884806|20762017|P1|COMPLETED|Overall Study||110
8424590|NCT00884806|20762017|P1|STARTED|Overall Study||110
8424591|NCT00884793|20762022|P1|NOT COMPLETED|Overall Study||1
8424592|NCT00884793|20762022|P1|COMPLETED|Overall Study||7
8424593|NCT00884793|20762022|P1|STARTED|Overall Study||8
8424594|NCT00884754|20762031|P2|NOT COMPLETED|Overall Study||0
8424595|NCT00884754|20762032|P1|NOT COMPLETED|Overall Study||0
8424596|NCT00884754|20762031|P2|COMPLETED|Overall Study||30
8424597|NCT00884754|20762032|P1|COMPLETED|Overall Study||30
8424598|NCT00884754|20762031|P2|STARTED|Overall Study||30
8424599|NCT00884754|20762032|P1|STARTED|Overall Study||30
8424600|NCT00884741|20762041|P4|NOT COMPLETED|Randomization||8
8424601|NCT00884741|20762042|P3|NOT COMPLETED|Randomization||8
8424602|NCT00884741|20762043|P2|NOT COMPLETED|Randomization||0
8424603|NCT00884741|20762044|P1|NOT COMPLETED|Randomization||0
8424604|NCT00884741|20762041|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
8424605|NCT00884741|20762042|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
8424606|NCT00884741|20762043|P2|COMPLETED|Randomization||0
8424607|NCT00884741|20762044|P1|COMPLETED|Randomization||0
8424608|NCT00884741|20762041|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
8424609|NCT00884741|20762042|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
8424610|NCT00884741|20762043|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
8424611|NCT00884741|20762044|P1|STARTED|Randomization||0
8424612|NCT00884741|20762041|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8424613|NCT00884741|20762042|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8424614|NCT00884741|20762043|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
8424615|NCT00884741|20762044|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8424616|NCT00884741|20762041|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
8424617|NCT00884741|20762042|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
8424618|NCT00884741|20762043|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
8424619|NCT00884741|20762044|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
8424620|NCT00884741|20762041|P4|STARTED|Step 2 Registration: Tissue Analysis||0
8424621|NCT00884741|20762042|P3|STARTED|Step 2 Registration: Tissue Analysis||0
8424622|NCT00884741|20762043|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
8424623|NCT00884741|20762044|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
8424624|NCT00884741|20762041|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8424625|NCT00884741|20762042|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8424626|NCT00884741|20762043|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8424627|NCT00884741|20762044|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
8424628|NCT00884741|20762041|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
8424629|NCT00884741|20762042|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
8424630|NCT00884741|20762043|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
8424631|NCT00884741|20762044|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
8424632|NCT00884741|20762041|P4|STARTED|Step 1 Registration: Tissue Screening||0
8424633|NCT00884741|20762042|P3|STARTED|Step 1 Registration: Tissue Screening||0
8424634|NCT00884741|20762043|P2|STARTED|Step 1 Registration: Tissue Screening||0
8424635|NCT00884741|20762044|P1|STARTED|Step 1 Registration: Tissue Screening||978
8424636|NCT00884611|20762055|P1|NOT COMPLETED|Overall Study||1
8424637|NCT00884611|20762055|P1|COMPLETED|Overall Study||19
8424638|NCT00884611|20762055|P1|Enrolled, Not Treated|Overall Study||1
8424639|NCT00884611|20762055|P1|STARTED|Overall Study||20
8424640|NCT00884585|20762079|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
8424641|NCT00884585|20762080|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
8424642|NCT00884585|20762079|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
8424643|NCT00884585|20762080|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
8424644|NCT00884585|20762079|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
8424645|NCT00884585|20762080|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
8424646|NCT00884585|20762079|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
8424647|NCT00884585|20762080|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
8424648|NCT00884585|20762079|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
8424649|NCT00884585|20762080|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
8424650|NCT00884585|20762079|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
8424651|NCT00884585|20762080|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
8424652|NCT00884585|20762079|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
8424653|NCT00884585|20762080|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
8424654|NCT00884585|20762079|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
8424655|NCT00884585|20762080|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
8424656|NCT00884585|20762079|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
8424657|NCT00884585|20762080|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
8424658|NCT00884390|20762094|P2|NOT COMPLETED|Overall Study||8
8424659|NCT00884390|20762095|P1|NOT COMPLETED|Overall Study||23
8424660|NCT00884390|20762094|P2|COMPLETED|Overall Study||54
8424661|NCT00884390|20762095|P1|COMPLETED|Overall Study||123
8424662|NCT00884390|20762094|P2|STARTED|Overall Study||62
8424663|NCT00884390|20762095|P1|STARTED|Overall Study||146
8424664|NCT00884377|20762113|P2|NOT COMPLETED|Overall Study||1
8424665|NCT00884377|20762114|P1|NOT COMPLETED|Overall Study||2
8424666|NCT00884377|20762113|P2|COMPLETED|Overall Study||27
8424667|NCT00884377|20762114|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
8424668|NCT00884377|20762113|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
8424669|NCT00884377|20762114|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
8424670|NCT00884325|20762136|P2|NOT COMPLETED|Overall Study||4
8424671|NCT00884325|20762137|P1|NOT COMPLETED|Overall Study||3
8424672|NCT00884325|20762136|P2|COMPLETED|Overall Study||16
8424673|NCT00884325|20762137|P1|COMPLETED|Overall Study||17
8424674|NCT00884325|20762136|P2|STARTED|Overall Study||20
8424675|NCT00884325|20762137|P1|STARTED|Overall Study||20
8424676|NCT00884312|20762147|P2|NOT COMPLETED|Overall Study||25
8424677|NCT00884312|20762148|P1|NOT COMPLETED|Overall Study||2
8424678|NCT00884312|20762147|P2|COMPLETED|Overall Study||67
8424679|NCT00884312|20762148|P1|COMPLETED|Overall Study||7
8424680|NCT00884312|20762147|P2|Received Treatment|Overall Study||91
8424681|NCT00884312|20762148|P1|Received Treatment|Overall Study||9
8424682|NCT00884312|20762147|P2|STARTED|Overall Study||92
8424683|NCT00884312|20762148|P1|STARTED|Overall Study||9
8424684|NCT00884286|20762164|P2|NOT COMPLETED|Overall Study||33
8424685|NCT00884286|20762165|P1|NOT COMPLETED|Overall Study||32
8424686|NCT00884286|20762164|P2|COMPLETED|Overall Study||0
8424687|NCT00884286|20762165|P1|COMPLETED|Overall Study||2
8424688|NCT00884286|20762164|P2|STARTED|Overall Study||33
8424689|NCT00884286|20762165|P1|STARTED|Overall Study||34
8424690|NCT00884273|20762179|P2|NOT COMPLETED|Overall Study||5
8424691|NCT00884273|20762180|P1|NOT COMPLETED|Overall Study||2
8424692|NCT00884273|20762179|P2|COMPLETED|Overall Study||93
8424693|NCT00884273|20762180|P1|COMPLETED|Overall Study||82
8424694|NCT00884273|20762179|P2|Safety Analysis Set|Overall Study||98
8424695|NCT00884273|20762180|P1|Safety Analysis Set|Overall Study||84
8424696|NCT00884273|20762179|P2|Per Protocol (PP) Analysis Set|Overall Study||92
8424697|NCT00884273|20762180|P1|Per Protocol (PP) Analysis Set|Overall Study||81
8424698|NCT00884273|20762179|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
8424699|NCT00884273|20762180|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
8424700|NCT00884273|20762179|P2|STARTED|Overall Study|ITT population.|98
8424701|NCT00884273|20762180|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
8424702|NCT00884221|20762206|P2|NOT COMPLETED|Overall Study||32
8424703|NCT00884221|20762207|P1|NOT COMPLETED|Overall Study||34
8424704|NCT00884221|20762206|P2|COMPLETED|Overall Study||343
8424705|NCT00884221|20762207|P1|COMPLETED|Overall Study||340
8424706|NCT00884221|20762206|P2|STARTED|Overall Study||375
8424707|NCT00884221|20762207|P1|STARTED|Overall Study||374
8424708|NCT00884117|20762243|P1|NOT COMPLETED|Overall Study||249
8424709|NCT00884117|20762243|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
8424710|NCT00884117|20762243|P1|STARTED|Overall Study||4561
8424711|NCT00884065|20762287|P2|NOT COMPLETED|Overall Study||0
8424712|NCT00884065|20762288|P1|NOT COMPLETED|Overall Study||0
8424713|NCT00884065|20762287|P2|COMPLETED|Overall Study||25
8424714|NCT00884065|20762288|P1|COMPLETED|Overall Study||25
8424715|NCT00884065|20762287|P2|STARTED|Overall Study||25
8424716|NCT00884065|20762288|P1|STARTED|Overall Study||25
8424717|NCT00884052|20762304|P2|NOT COMPLETED|Overall Study||0
8424718|NCT00884052|20762305|P1|NOT COMPLETED|Overall Study||0
8424719|NCT00884052|20762304|P2|COMPLETED|Overall Study||12
8424720|NCT00884052|20762305|P1|COMPLETED|Overall Study||6
8424721|NCT00884052|20762304|P2|STARTED|Overall Study||12
8424722|NCT00884052|20762305|P1|STARTED|Overall Study||6
8424723|NCT00884039|20762314|P2|NOT COMPLETED|Overall Study||1
8424724|NCT00884039|20762315|P1|NOT COMPLETED|Overall Study||2
8424725|NCT00884039|20762314|P2|COMPLETED|Overall Study||1
8424726|NCT00884039|20762315|P1|COMPLETED|Overall Study||3
8424727|NCT00884039|20762314|P2|STARTED|Overall Study||2
8424728|NCT00884039|20762315|P1|STARTED|Overall Study||5
8424729|NCT00883779|20762323|P2|NOT COMPLETED|Off-study Phase||202
8424730|NCT00883779|20762324|P1|NOT COMPLETED|Off-study Phase||209
8424731|NCT00883779|20762323|P2|COMPLETED|Off-study Phase||0
8424732|NCT00883779|20762324|P1|COMPLETED|Off-study Phase||0
8424733|NCT00883779|20762323|P2|STARTED|Off-study Phase||202
8424734|NCT00883779|20762324|P1|STARTED|Off-study Phase||209
8424735|NCT00883779|20762323|P2|NOT COMPLETED|Post-Study Treatment Phase||135
8424736|NCT00883779|20762324|P1|NOT COMPLETED|Post-Study Treatment Phase||112
8424737|NCT00883779|20762323|P2|COMPLETED|Post-Study Treatment Phase||0
8424738|NCT00883779|20762324|P1|COMPLETED|Post-Study Treatment Phase||0
8424739|NCT00883779|20762323|P2|STARTED|Post-Study Treatment Phase||135
8424740|NCT00883779|20762324|P1|STARTED|Post-Study Treatment Phase||112
8424741|NCT00883779|20762323|P2|NOT COMPLETED|Primary Study Treatment Phase||86
8424742|NCT00883779|20762324|P1|NOT COMPLETED|Primary Study Treatment Phase||105
8424743|NCT00883779|20762323|P2|COMPLETED|Primary Study Treatment Phase||140
8424744|NCT00883779|20762324|P1|COMPLETED|Primary Study Treatment Phase||120
8424745|NCT00883779|20762323|P2|STARTED|Primary Study Treatment Phase||226
8424746|NCT00883779|20762324|P1|STARTED|Primary Study Treatment Phase||225
8424747|NCT00883753|20762360|P1|NOT COMPLETED|Overall Study||107
8424748|NCT00883753|20762360|P1|COMPLETED|Overall Study||827
8424749|NCT00883753|20762360|P1|STARTED|Overall Study||934
8424750|NCT00883740|20762400|P2|NOT COMPLETED|Second Intervention||1
8424751|NCT00883740|20762401|P1|NOT COMPLETED|Second Intervention||1
8424752|NCT00883740|20762400|P2|COMPLETED|Second Intervention||50
8424753|NCT00883740|20762401|P1|COMPLETED|Second Intervention||52
8424754|NCT00883740|20762400|P2|STARTED|Second Intervention||51
8424755|NCT00883740|20762401|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
8424756|NCT00883740|20762400|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
8424757|NCT00883740|20762401|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
8424758|NCT00883740|20762400|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
8424759|NCT00883740|20762401|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
8424760|NCT00883740|20762400|P2|STARTED|Taper and Washout Period (2 Weeks)||51
8424761|NCT00883740|20762401|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
8424762|NCT00883740|20762400|P2|NOT COMPLETED|First Intervention||8
8424763|NCT00883740|20762401|P1|NOT COMPLETED|First Intervention||7
8424764|NCT00883740|20762400|P2|COMPLETED|First Intervention||51
8424765|NCT00883740|20762401|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
8424766|NCT00883740|20762400|P2|STARTED|First Intervention||59
8424767|NCT00883740|20762401|P1|STARTED|First Intervention||60
8424768|NCT00883688|20762441|P1|NOT COMPLETED|Overall Study||2
8424769|NCT00883688|20762441|P1|COMPLETED|Overall Study||22
8424770|NCT00883688|20762441|P1|STARTED|Overall Study||24
8424771|NCT00883675|20762445|P1|NOT COMPLETED|Overall Study||0
8424772|NCT00883675|20762445|P1|COMPLETED|Overall Study||133
8424773|NCT00883675|20762445|P1|STARTED|Overall Study||133
8424774|NCT00883558|20762449|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
8424775|NCT00883558|20762450|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8424776|NCT00883558|20762451|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8424777|NCT00883558|20762449|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
8424778|NCT00883558|20762450|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
8424779|NCT00883558|20762451|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8424780|NCT00883558|20762449|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
8424781|NCT00883558|20762450|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
8424782|NCT00883558|20762451|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
8424783|NCT00883558|20762449|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
8424784|NCT00883558|20762450|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
8424785|NCT00883558|20762451|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
8424786|NCT00883558|20762449|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
8424787|NCT00883558|20762450|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
8424788|NCT00883558|20762451|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
8424789|NCT00883558|20762449|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
8424790|NCT00883558|20762450|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
8424791|NCT00883558|20762451|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
8424792|NCT00883558|20762449|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
8424793|NCT00883558|20762450|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
8424794|NCT00883558|20762451|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
8424795|NCT00883558|20762449|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
8424796|NCT00883558|20762450|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
8424797|NCT00883558|20762451|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
8424798|NCT00883558|20762449|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
8424799|NCT00883558|20762450|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
8424800|NCT00883558|20762451|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
8424801|NCT00883558|20762449|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
8424802|NCT00883558|20762450|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
8424803|NCT00883558|20762451|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
8424804|NCT00883558|20762449|P3|STARTED|Titration Period (Weeks 0 to 4)||0
8424805|NCT00883558|20762450|P2|STARTED|Titration Period (Weeks 0 to 4)||0
8424806|NCT00883558|20762451|P1|STARTED|Titration Period (Weeks 0 to 4)||48
8424807|NCT00883493|20762463|P2|NOT COMPLETED|Overall Study||50
8424808|NCT00883493|20762464|P1|NOT COMPLETED|Overall Study||46
8424809|NCT00883493|20762463|P2|COMPLETED|Overall Study||159
8424810|NCT00883493|20762464|P1|COMPLETED|Overall Study||166
8424811|NCT00883493|20762463|P2|Per Protocol Analysis Population|Overall Study||155
8424812|NCT00883493|20762464|P1|Per Protocol Analysis Population|Overall Study||162
8424813|NCT00883493|20762463|P2|Intention To Treat Analysis Population|Overall Study||195
8424814|NCT00883493|20762464|P1|Intention To Treat Analysis Population|Overall Study||204
8424815|NCT00883493|20762463|P2|STARTED|Overall Study||209
8424816|NCT00883493|20762464|P1|STARTED|Overall Study||212
8424817|NCT00883415|20762488|P1|NOT COMPLETED|Overall Study||2
8424818|NCT00883415|20762488|P1|COMPLETED|Overall Study||18
8424819|NCT00883415|20762488|P1|STARTED|Overall Study||20
8424820|NCT00883389|20762492|P1|NOT COMPLETED|Overall Study||0
8424821|NCT00883389|20762492|P1|COMPLETED|Overall Study||26
8424822|NCT00883389|20762492|P1|STARTED|Overall Study||26
8424823|NCT00883337|20762499|P3|NOT COMPLETED|Extension Treatment Period||19
8424824|NCT00883337|20762500|P2|NOT COMPLETED|Extension Treatment Period||23
8424825|NCT00883337|20762501|P1|NOT COMPLETED|Extension Treatment Period||28
8424826|NCT00883337|20762499|P3|COMPLETED|Extension Treatment Period||40
8424827|NCT00883337|20762500|P2|COMPLETED|Extension Treatment Period||66
8424828|NCT00883337|20762501|P1|COMPLETED|Extension Treatment Period||61
8424829|NCT00883337|20762499|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
8424830|NCT00883337|20762500|P2|STARTED|Extension Treatment Period||89
8424831|NCT00883337|20762501|P1|STARTED|Extension Treatment Period||89
8424832|NCT00883337|20762499|P3|NOT COMPLETED|Core Treatment Period||33
8424833|NCT00883337|20762500|P2|NOT COMPLETED|Core Treatment Period||22
8424834|NCT00883337|20762501|P1|NOT COMPLETED|Core Treatment Period||20
8424835|NCT00883337|20762499|P3|COMPLETED|Core Treatment Period||71
8424836|NCT00883337|20762500|P2|COMPLETED|Core Treatment Period||89
8424837|NCT00883337|20762501|P1|COMPLETED|Core Treatment Period||89
8424838|NCT00883337|20762499|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
8424839|NCT00883337|20762500|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
8424840|NCT00883337|20762501|P1|Treated|Core Treatment Period||109
8424841|NCT00883337|20762499|P3|STARTED|Core Treatment Period||104
8424842|NCT00883337|20762500|P2|STARTED|Core Treatment Period||111
8424843|NCT00883337|20762501|P1|STARTED|Core Treatment Period||109
8424844|NCT00883246|20762533|P1|NOT COMPLETED|Overall Study||173
8424845|NCT00883246|20762533|P1|COMPLETED|Overall Study||626
8424846|NCT00883246|20762533|P1|STARTED|Overall Study||799
8424859|NCT00883181|20762568|P1|NOT COMPLETED|Overall Study||278
8424860|NCT00883181|20762568|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
8424861|NCT00883181|20762568|P1|STARTED|Overall Study|Full analysis set|1347
8424862|NCT00883168|20762781|P4|NOT COMPLETED|Overall Study||15
8424863|NCT00883168|20762782|P3|NOT COMPLETED|Overall Study||19
8424864|NCT00883168|20762783|P2|NOT COMPLETED|Overall Study||15
8424865|NCT00883168|20762784|P1|NOT COMPLETED|Overall Study||14
8424866|NCT00883168|20762781|P4|COMPLETED|Overall Study||433
8424867|NCT00883168|20762782|P3|COMPLETED|Overall Study||431
8424868|NCT00883168|20762783|P2|COMPLETED|Overall Study||430
8424869|NCT00883168|20762784|P1|COMPLETED|Overall Study||434
8424870|NCT00883168|20762781|P4|STARTED|Overall Study||448
8424871|NCT00883168|20762782|P3|STARTED|Overall Study||450
8424872|NCT00883168|20762783|P2|STARTED|Overall Study||445
8424873|NCT00883168|20762784|P1|STARTED|Overall Study||448
8424874|NCT00883129|20762804|P2|NOT COMPLETED|Overall Study||36
8424875|NCT00883129|20762805|P1|NOT COMPLETED|Overall Study||20
8424876|NCT00883129|20762804|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
8424877|NCT00883129|20762805|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
8424878|NCT00883129|20762804|P2|STARTED|Overall Study||73
8424879|NCT00883129|20762805|P1|STARTED|Overall Study||69
8424880|NCT00883116|20762829|P2|NOT COMPLETED|Overall Study||219
8424881|NCT00883116|20762830|P1|NOT COMPLETED|Overall Study||209
8424882|NCT00883116|20762829|P2|COMPLETED|Overall Study||29
8424883|NCT00883116|20762830|P1|COMPLETED|Overall Study||39
8424884|NCT00883116|20762829|P2|Received Treatment|Overall Study||239
8424885|NCT00883116|20762830|P1|Received Treatment|Overall Study||248
8424886|NCT00883116|20762829|P2|STARTED|Overall Study||248
8424887|NCT00883116|20762830|P1|STARTED|Overall Study||248
8424888|NCT00883103|20762845|P2|NOT COMPLETED|Overall Study||0
8424889|NCT00883103|20762846|P1|NOT COMPLETED|Overall Study||0
8424890|NCT00883103|20762845|P2|COMPLETED|Overall Study||68
8424891|NCT00883103|20762846|P1|COMPLETED|Overall Study||69
8424892|NCT00883103|20762845|P2|STARTED|Overall Study||68
8424893|NCT00883103|20762846|P1|STARTED|Overall Study||69
8424894|NCT00883090|20762852|P1|NOT COMPLETED|Overall Study||2
8424895|NCT00883090|20762852|P1|COMPLETED|Overall Study||13
8424896|NCT00883090|20762852|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
8424897|NCT00883051|20762872|P5|NOT COMPLETED|Overall Study||18
8424898|NCT00883051|20762873|P4|NOT COMPLETED|Overall Study||29
8424899|NCT00883051|20762874|P3|NOT COMPLETED|Overall Study||29
8424900|NCT00883051|20762875|P2|NOT COMPLETED|Overall Study||22
8424901|NCT00883051|20762876|P1|NOT COMPLETED|Overall Study||24
8424902|NCT00883051|20762872|P5|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
8424903|NCT00883051|20762873|P4|COMPLETED|Overall Study||70
8424904|NCT00883051|20762874|P3|COMPLETED|Overall Study||71
8424905|NCT00883051|20762875|P2|COMPLETED|Overall Study||82
8424906|NCT00883051|20762876|P1|COMPLETED|Overall Study||82
8424907|NCT00883051|20762872|P5|Received at Least 1 Dose of Study Drug|Overall Study||86
8424908|NCT00883051|20762873|P4|Received at Least 1 Dose of Study Drug|Overall Study||70
8424909|NCT00883051|20762874|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
8424910|NCT00883051|20762875|P2|Received at Least 1 Dose of Study Drug|Overall Study||82
8424911|NCT00883051|20762876|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
8424912|NCT00883051|20762872|P5|No Study Medication Used|Overall Study||17
8424913|NCT00883051|20762873|P4|No Study Medication Used|Overall Study||29
8424914|NCT00883051|20762874|P3|No Study Medication Used|Overall Study||29
8424915|NCT00883051|20762875|P2|No Study Medication Used|Overall Study||22
8424916|NCT00883051|20762876|P1|No Study Medication Used|Overall Study||24
8424917|NCT00883051|20762872|P5|STARTED|Overall Study||103
8424918|NCT00883051|20762873|P4|STARTED|Overall Study||99
8424919|NCT00883051|20762874|P3|STARTED|Overall Study||100
8424920|NCT00883051|20762875|P2|STARTED|Overall Study||104
8424921|NCT00883051|20762876|P1|STARTED|Overall Study||106
8424922|NCT00882999|20762980|P7|NOT COMPLETED|Overall Study||8
8424923|NCT00882999|20762981|P6|NOT COMPLETED|Overall Study||7
8424924|NCT00882999|20762982|P5|NOT COMPLETED|Overall Study||8
8424925|NCT00882999|20762983|P4|NOT COMPLETED|Overall Study||5
8424926|NCT00882999|20762984|P3|NOT COMPLETED|Overall Study||4
8424927|NCT00882999|20762985|P2|NOT COMPLETED|Overall Study||8
8424928|NCT00882999|20762986|P1|NOT COMPLETED|Overall Study||8
8424929|NCT00882999|20762980|P7|COMPLETED|Overall Study||27
8424930|NCT00882999|20762981|P6|COMPLETED|Overall Study||28
8424931|NCT00882999|20762982|P5|COMPLETED|Overall Study||28
8424932|NCT00882999|20762983|P4|COMPLETED|Overall Study||31
8424933|NCT00882999|20762984|P3|COMPLETED|Overall Study||30
8424934|NCT00882999|20762985|P2|COMPLETED|Overall Study||26
8424935|NCT00882999|20762986|P1|COMPLETED|Overall Study||27
8424936|NCT00882999|20762980|P7|Completed Study Treatment|Overall Study||31
8424937|NCT00882999|20762981|P6|Completed Study Treatment|Overall Study||30
8424938|NCT00882999|20762982|P5|Completed Study Treatment|Overall Study||29
8424939|NCT00882999|20762983|P4|Completed Study Treatment|Overall Study||33
8424940|NCT00882999|20762984|P3|Completed Study Treatment|Overall Study||31
8424941|NCT00882999|20762985|P2|Completed Study Treatment|Overall Study||29
8424942|NCT00882999|20762986|P1|Completed Study Treatment|Overall Study||29
8424943|NCT00882999|20762980|P7|Received Any Amount of Study Drug|Overall Study||35
8424944|NCT00882999|20762981|P6|Received Any Amount of Study Drug|Overall Study||35
8424945|NCT00882999|20762982|P5|Received Any Amount of Study Drug|Overall Study||36
8424946|NCT00882999|20762983|P4|Received Any Amount of Study Drug|Overall Study||36
8424947|NCT00882999|20762984|P3|Received Any Amount of Study Drug|Overall Study||34
8424948|NCT00882999|20762985|P2|Received Any Amount of Study Drug|Overall Study||34
8424949|NCT00882999|20762986|P1|Received Any Amount of Study Drug|Overall Study||35
8424950|NCT00882999|20762980|P7|STARTED|Overall Study||35
8424951|NCT00882999|20762981|P6|STARTED|Overall Study||35
8424952|NCT00882999|20762982|P5|STARTED|Overall Study||36
8424953|NCT00882999|20762983|P4|STARTED|Overall Study||36
8424954|NCT00882999|20762984|P3|STARTED|Overall Study||34
8424955|NCT00882999|20762985|P2|STARTED|Overall Study||34
8424956|NCT00882999|20762986|P1|STARTED|Overall Study||35
8424957|NCT00882921|20763113|P1|NOT COMPLETED|Overall Study||11
8424958|NCT00882921|20763113|P1|COMPLETED|Overall Study||15
8424959|NCT00882921|20763113|P1|STARTED|Overall Study||26
8424960|NCT00882908|20763123|P5|NOT COMPLETED|Overall Study||6
8424961|NCT00882908|20763124|P4|NOT COMPLETED|Overall Study||7
8424962|NCT00882908|20763125|P3|NOT COMPLETED|Overall Study||7
8424963|NCT00882908|20763126|P2|NOT COMPLETED|Overall Study||6
8424964|NCT00882908|20763127|P1|NOT COMPLETED|Overall Study||3
8424965|NCT00882908|20763123|P5|COMPLETED|Overall Study||71
8424966|NCT00882908|20763124|P4|COMPLETED|Overall Study||72
8424967|NCT00882908|20763125|P3|COMPLETED|Overall Study||70
8424968|NCT00882908|20763126|P2|COMPLETED|Overall Study||69
8424969|NCT00882908|20763127|P1|COMPLETED|Overall Study||75
8424970|NCT00882908|20763123|P5|STARTED|Overall Study||77
8424971|NCT00882908|20763124|P4|STARTED|Overall Study||79
8424972|NCT00882908|20763125|P3|STARTED|Overall Study||77
8424973|NCT00882908|20763126|P2|STARTED|Overall Study||75
8424974|NCT00882908|20763127|P1|STARTED|Overall Study||78
8424975|NCT00882778|20763202|P1|NOT COMPLETED|Overall Study||0
8424976|NCT00882778|20763202|P1|COMPLETED|Overall Study||86
8424977|NCT00882778|20763202|P1|STARTED|Overall Study||86
8424978|NCT00882713|20763233|P1|NOT COMPLETED|Overall Study||22
8424979|NCT00882713|20763233|P1|COMPLETED|Overall Study||172
8424980|NCT00882713|20763233|P1|STARTED|Overall Study||194
8424981|NCT00882687|20763259|P4|NOT COMPLETED|Overall Study||2
8424982|NCT00882687|20763260|P3|NOT COMPLETED|Overall Study||3
8424983|NCT00882687|20763261|P2|NOT COMPLETED|Overall Study||2
8424984|NCT00882687|20763262|P1|NOT COMPLETED|Overall Study||2
8424985|NCT00882687|20763259|P4|COMPLETED|Overall Study||13
8424986|NCT00882687|20763260|P3|COMPLETED|Overall Study||12
8424987|NCT00882687|20763261|P2|COMPLETED|Overall Study||13
8424988|NCT00882687|20763262|P1|COMPLETED|Overall Study||13
8424989|NCT00882687|20763259|P4|STARTED|Overall Study||15
8424990|NCT00882687|20763260|P3|STARTED|Overall Study||15
8424991|NCT00882687|20763261|P2|STARTED|Overall Study||15
8424992|NCT00882687|20763262|P1|STARTED|Overall Study||15
8424993|NCT00882661|20763295|P2|NOT COMPLETED|Treatment||26
8424994|NCT00882661|20763296|P1|NOT COMPLETED|Treatment||10
8424995|NCT00882661|20763295|P2|COMPLETED|Treatment||114
8424996|NCT00882661|20763296|P1|COMPLETED|Treatment||141
8424997|NCT00882661|20763295|P2|STARTED|Treatment||140
8424998|NCT00882661|20763296|P1|STARTED|Treatment||151
8424999|NCT00882661|20763295|P2|NOT COMPLETED|Investigational Training||0
8425000|NCT00882661|20763296|P1|NOT COMPLETED|Investigational Training||10
8425001|NCT00882661|20763295|P2|COMPLETED|Investigational Training||0
8425002|NCT00882661|20763296|P1|COMPLETED|Investigational Training||79
8425003|NCT00882661|20763295|P2|STARTED|Investigational Training||0
8425004|NCT00882661|20763296|P1|STARTED|Investigational Training||89
8425005|NCT00882583|20763326|P2|NOT COMPLETED|Overall Study||1
8425006|NCT00882583|20763327|P1|NOT COMPLETED|Overall Study||1
8425007|NCT00882583|20763326|P2|COMPLETED|Overall Study||11
8425008|NCT00882583|20763327|P1|COMPLETED|Overall Study||6
8425009|NCT00882583|20763326|P2|STARTED|Overall Study||12
8425010|NCT00882583|20763327|P1|STARTED|Overall Study||7
8425011|NCT00882557|20763335|P2|NOT COMPLETED|Overall Study||1
8425012|NCT00882557|20763336|P1|NOT COMPLETED|Overall Study||2
8425013|NCT00882557|20763335|P2|COMPLETED|Overall Study||7
8425014|NCT00882557|20763336|P1|COMPLETED|Overall Study||6
8425015|NCT00882557|20763335|P2|Completed Dose 2|Overall Study||7
8425016|NCT00882557|20763336|P1|Completed Dose 2|Overall Study||6
8425017|NCT00882557|20763335|P2|Completed Dose 1|Overall Study||7
8425018|NCT00882557|20763336|P1|Completed Dose 1|Overall Study||8
8425019|NCT00882557|20763335|P2|STARTED|Overall Study||8
8425020|NCT00882557|20763336|P1|STARTED|Overall Study||8
8425021|NCT00882518|20763356|P2|NOT COMPLETED|Overall Study||44
8425022|NCT00882518|20763357|P1|NOT COMPLETED|Overall Study||38
8425023|NCT00882518|20763356|P2|COMPLETED|Overall Study||148
8425024|NCT00882518|20763357|P1|COMPLETED|Overall Study||158
8425025|NCT00882518|20763356|P2|STARTED|Overall Study||192
8425026|NCT00882518|20763357|P1|STARTED|Overall Study||196
8425027|NCT00882440|20763386|P7|NOT COMPLETED|Overall Study||4
8425028|NCT00882440|20763387|P6|NOT COMPLETED|Overall Study||7
8425029|NCT00882440|20763388|P5|NOT COMPLETED|Overall Study||10
8425030|NCT00882440|20763389|P4|NOT COMPLETED|Overall Study||3
8425031|NCT00882440|20763390|P3|NOT COMPLETED|Overall Study||7
8425032|NCT00882440|20763391|P2|NOT COMPLETED|Overall Study||8
8425033|NCT00882440|20763392|P1|NOT COMPLETED|Overall Study||11
8425034|NCT00882440|20763386|P7|COMPLETED|Overall Study||79
8425035|NCT00882440|20763387|P6|COMPLETED|Overall Study||77
8425036|NCT00882440|20763388|P5|COMPLETED|Overall Study||80
8425037|NCT00882440|20763389|P4|COMPLETED|Overall Study||76
8425038|NCT00882440|20763390|P3|COMPLETED|Overall Study||75
8425039|NCT00882440|20763391|P2|COMPLETED|Overall Study||72
8425040|NCT00882440|20763392|P1|COMPLETED|Overall Study||67
8425041|NCT00882440|20763386|P7|STARTED|Overall Study||83
8425042|NCT00882440|20763387|P6|STARTED|Overall Study||84
8425043|NCT00882440|20763388|P5|STARTED|Overall Study||90
8425044|NCT00882440|20763389|P4|STARTED|Overall Study||79
8425045|NCT00882440|20763390|P3|STARTED|Overall Study||82
8425046|NCT00882440|20763391|P2|STARTED|Overall Study||80
8425047|NCT00882440|20763392|P1|STARTED|Overall Study||78
8425048|NCT00882362|20763417|P2|NOT COMPLETED|Overall Study||23
8425049|NCT00882362|20763418|P1|NOT COMPLETED|Overall Study||49
8425050|NCT00882362|20763417|P2|COMPLETED|Overall Study||10
8425051|NCT00882362|20763418|P1|COMPLETED|Overall Study||73
8425052|NCT00882362|20763417|P2|STARTED|Overall Study||33
8425053|NCT00882362|20763418|P1|STARTED|Overall Study||122
8425054|NCT00882310|20763424|P1|NOT COMPLETED|Overall Study||22
8425055|NCT00882310|20763424|P1|COMPLETED|Overall Study||15
8425056|NCT00882310|20763424|P1|STARTED|Overall Study||37
8425057|NCT00882206|20763430|P1|NOT COMPLETED|Overall Study||0
8425058|NCT00882206|20763430|P1|COMPLETED|Overall Study||13
8425059|NCT00882206|20763430|P1|STARTED|Overall Study||13
8425060|NCT00882115|20763437|P1|NOT COMPLETED|Overall Study||9
8425061|NCT00882115|20763437|P1|COMPLETED|Overall Study||29
8425062|NCT00882115|20763437|P1|STARTED|Overall Study||38
8425063|NCT00882102|20763441|P1|NOT COMPLETED|Overall Study||0
8425064|NCT00882102|20763441|P1|COMPLETED|Overall Study||40
8425065|NCT00882102|20763441|P1|STARTED|Overall Study||40
8425066|NCT00881959|20763447|P2|NOT COMPLETED|Overall Study||4
8425067|NCT00881959|20763448|P1|NOT COMPLETED|Overall Study||2
8425068|NCT00881959|20763447|P2|COMPLETED|Overall Study||38
8425069|NCT00881959|20763448|P1|COMPLETED|Overall Study||36
8425070|NCT00881959|20763447|P2|STARTED|Overall Study||42
8425071|NCT00881959|20763448|P1|STARTED|Overall Study||38
8425072|NCT00881894|20763456|P2|NOT COMPLETED|Overall Study||3
8425073|NCT00881894|20763457|P1|NOT COMPLETED|Overall Study||1
8425074|NCT00881894|20763456|P2|COMPLETED|Overall Study||23
8425075|NCT00881894|20763457|P1|COMPLETED|Overall Study||25
8425076|NCT00881894|20763456|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
8425077|NCT00881894|20763457|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
8425078|NCT00881894|20763456|P2|STARTED|Overall Study||26
8425079|NCT00881894|20763457|P1|STARTED|Overall Study||26
8425080|NCT00881868|20763489|P2|NOT COMPLETED|Overall Study||2
8425081|NCT00881868|20763490|P1|NOT COMPLETED|Overall Study||8
8425082|NCT00881868|20763489|P2|COMPLETED|Overall Study||38
8425083|NCT00881868|20763490|P1|COMPLETED|Overall Study||33
8425084|NCT00881868|20763489|P2|STARTED|Overall Study||40
8425085|NCT00881868|20763490|P1|STARTED|Overall Study||41
8425086|NCT00881751|20763504|P2|NOT COMPLETED|Overall Study||5
8425087|NCT00881751|20763505|P1|NOT COMPLETED|Overall Study||0
8425088|NCT00881751|20763504|P2|COMPLETED|Overall Study||43
8425089|NCT00881751|20763505|P1|COMPLETED|Overall Study||47
8425090|NCT00881751|20763504|P2|STARTED|Overall Study||48
8425091|NCT00881751|20763505|P1|STARTED|Overall Study||47
8425092|NCT00881712|20763520|P3|NOT COMPLETED|Overall Study||0
8425093|NCT00881712|20763521|P2|NOT COMPLETED|Overall Study||0
8425094|NCT00881712|20763522|P1|NOT COMPLETED|Overall Study||2
8425095|NCT00881712|20763520|P3|COMPLETED|Overall Study||0
8425096|NCT00881712|20763521|P2|COMPLETED|Overall Study||0
8425097|NCT00881712|20763522|P1|COMPLETED|Overall Study||13
8425098|NCT00881712|20763520|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
8425099|NCT00881712|20763521|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
8425100|NCT00881712|20763522|P1|STARTED|Overall Study||15
8425101|NCT00881647|20763544|P2|NOT COMPLETED|Overall Study||1
8425102|NCT00881647|20763545|P1|NOT COMPLETED|Overall Study||2
8425103|NCT00881647|20763544|P2|COMPLETED|Overall Study||15
8425104|NCT00881647|20763545|P1|COMPLETED|Overall Study||27
8425105|NCT00881647|20763544|P2|STARTED|Overall Study||16
8425106|NCT00881647|20763545|P1|STARTED|Overall Study||29
8425107|NCT00881621|20763555|P1|NOT COMPLETED|Overall Study||34
8425108|NCT00881621|20763555|P1|COMPLETED|Overall Study||17
8425109|NCT00881621|20763555|P1|STARTED|Overall Study||51
8425110|NCT00881608|20763567|P1|NOT COMPLETED|Overall Study||11
8425111|NCT00881608|20763567|P1|COMPLETED|Overall Study||0
8425112|NCT00881608|20763567|P1|STARTED|Overall Study||11
8425113|NCT00881569|20763586|P2|NOT COMPLETED|Overall Study||1
8425114|NCT00881569|20763587|P1|NOT COMPLETED|Overall Study||1
8425115|NCT00881569|20763586|P2|COMPLETED|Overall Study||0
8425116|NCT00881569|20763587|P1|COMPLETED|Overall Study||0
8425117|NCT00881569|20763586|P2|STARTED|Overall Study||1
8425118|NCT00881569|20763587|P1|STARTED|Overall Study||1
8425119|NCT00881530|20763603|P6|NOT COMPLETED|Overall Study||5
8425120|NCT00881530|20763604|P5|NOT COMPLETED|Overall Study||14
8425121|NCT00881530|20763605|P4|NOT COMPLETED|Overall Study||9
8425122|NCT00881530|20763606|P3|NOT COMPLETED|Overall Study||5
8425123|NCT00881530|20763607|P2|NOT COMPLETED|Overall Study||5
8425124|NCT00881530|20763608|P1|NOT COMPLETED|Overall Study||14
8425125|NCT00881530|20763603|P6|COMPLETED|Overall Study||51
8425126|NCT00881530|20763604|P5|COMPLETED|Overall Study||152
8425127|NCT00881530|20763605|P4|COMPLETED|Overall Study||157
8425128|NCT00881530|20763606|P3|COMPLETED|Overall Study||51
8425129|NCT00881530|20763607|P2|COMPLETED|Overall Study||104
8425130|NCT00881530|20763608|P1|COMPLETED|Overall Study||92
8425131|NCT00881530|20763603|P6|STARTED|Overall Study||56
8425132|NCT00881530|20763604|P5|STARTED|Overall Study||166
8425133|NCT00881530|20763605|P4|STARTED|Overall Study||166
8425134|NCT00881530|20763606|P3|STARTED|Overall Study||56
8425135|NCT00881530|20763607|P2|STARTED|Overall Study||109
8425136|NCT00881530|20763608|P1|STARTED|Overall Study||106
8425137|NCT00881504|20763664|P1|NOT COMPLETED|Overall Study||1
8425138|NCT00881504|20763664|P1|COMPLETED|Overall Study||8
8425139|NCT00881504|20763664|P1|STARTED|Overall Study||9
8425140|NCT00881465|20763671|P2|NOT COMPLETED|Overall Study||0
8425141|NCT00881465|20763672|P1|NOT COMPLETED|Overall Study||2
8425142|NCT00881465|20763671|P2|COMPLETED|Overall Study||15
8425143|NCT00881465|20763672|P1|COMPLETED|Overall Study||14
8425144|NCT00881465|20763671|P2|STARTED|Overall Study||15
8425145|NCT00881465|20763672|P1|STARTED|Overall Study||16
8425146|NCT00881361|20763684|P3|NOT COMPLETED|Overall Study||2
8425147|NCT00881361|20763685|P2|NOT COMPLETED|Overall Study||9
8425148|NCT00881361|20763686|P1|NOT COMPLETED|Overall Study||44
8425149|NCT00881361|20763684|P3|COMPLETED|Overall Study||0
8425150|NCT00881361|20763685|P2|COMPLETED|Overall Study||38
8425151|NCT00881361|20763686|P1|COMPLETED|Overall Study||663
8425152|NCT00881361|20763684|P3|STARTED|Overall Study||2
8425153|NCT00881361|20763685|P2|STARTED|Overall Study||47
8425154|NCT00881361|20763686|P1|STARTED|Overall Study||707
8425155|NCT00881335|20763701|P2|NOT COMPLETED|Overall Study||2
8425156|NCT00881335|20763702|P1|NOT COMPLETED|Overall Study||3
8425157|NCT00881335|20763701|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
8425158|NCT00881335|20763702|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
8425159|NCT00881335|20763701|P2|STARTED|Overall Study||30
8425160|NCT00881335|20763702|P1|STARTED|Overall Study||30
8425161|NCT00881205|20763722|P2|NOT COMPLETED|Overall Study||7
8425162|NCT00881205|20763723|P1|NOT COMPLETED|Overall Study||11
8425163|NCT00881205|20763722|P2|COMPLETED|Overall Study||34
8425164|NCT00881205|20763723|P1|COMPLETED|Overall Study||34
8425165|NCT00881205|20763722|P2|STARTED|Overall Study||41
8425166|NCT00881205|20763723|P1|STARTED|Overall Study||45
8425167|NCT00880997|20763733|P3|NOT COMPLETED|Overall Study||8
8425168|NCT00880997|20763734|P2|NOT COMPLETED|Overall Study||2
8425169|NCT00880997|20763735|P1|NOT COMPLETED|Overall Study||3
8425170|NCT00880997|20763733|P3|COMPLETED|Overall Study||5
8425171|NCT00880997|20763734|P2|COMPLETED|Overall Study||6
8425172|NCT00880997|20763735|P1|COMPLETED|Overall Study||6
8425173|NCT00880997|20763733|P3|STARTED|Overall Study||13
8425174|NCT00880997|20763734|P2|STARTED|Overall Study||8
8425175|NCT00880997|20763735|P1|STARTED|Overall Study||9
8425176|NCT00880919|20763755|P3|NOT COMPLETED|Overall Study||6
8425177|NCT00880919|20763756|P2|NOT COMPLETED|Overall Study||14
8425178|NCT00880919|20763757|P1|NOT COMPLETED|Overall Study||15
8425179|NCT00880919|20763755|P3|COMPLETED|Overall Study||23
8425180|NCT00880919|20763756|P2|COMPLETED|Overall Study||19
8425181|NCT00880919|20763757|P1|COMPLETED|Overall Study||18
8425182|NCT00880919|20763755|P3|STARTED|Overall Study||29
8425183|NCT00880919|20763756|P2|STARTED|Overall Study||33
8425184|NCT00880919|20763757|P1|STARTED|Overall Study||33
8425185|NCT00880906|20763791|P2|NOT COMPLETED|Overall Study||7
8425186|NCT00880906|20763792|P1|NOT COMPLETED|Overall Study||12
8425187|NCT00880906|20763791|P2|COMPLETED|Overall Study||14
8425188|NCT00880906|20763792|P1|COMPLETED|Overall Study||17
8425189|NCT00880906|20763791|P2|STARTED|Overall Study||21
8425190|NCT00880906|20763792|P1|STARTED|Overall Study||29
8425191|NCT00880893|20763802|P2|NOT COMPLETED|Overall Study||45
8425192|NCT00880893|20763803|P1|NOT COMPLETED|Overall Study||107
8425193|NCT00880893|20763802|P2|COMPLETED|Overall Study||255
8425194|NCT00880893|20763803|P1|COMPLETED|Overall Study||791
8425195|NCT00880893|20763802|P2|STARTED|Overall Study||300
8425196|NCT00880893|20763803|P1|STARTED|Overall Study||898
8425197|NCT00880763|20763855|P4|NOT COMPLETED|Extension Period (Part 2)||3
8425198|NCT00880763|20763856|P3|NOT COMPLETED|Extension Period (Part 2)||3
8425199|NCT00880763|20763857|P2|NOT COMPLETED|Extension Period (Part 2)||3
8425200|NCT00880763|20763858|P1|NOT COMPLETED|Extension Period (Part 2)||0
8425201|NCT00880763|20763855|P4|COMPLETED|Extension Period (Part 2)||19
8425202|NCT00880763|20763856|P3|COMPLETED|Extension Period (Part 2)||20
8425203|NCT00880763|20763857|P2|COMPLETED|Extension Period (Part 2)||19
8425204|NCT00880763|20763858|P1|COMPLETED|Extension Period (Part 2)||23
8425205|NCT00880763|20763855|P4|STARTED|Extension Period (Part 2)||22
8425206|NCT00880763|20763856|P3|STARTED|Extension Period (Part 2)||23
8425207|NCT00880763|20763857|P2|STARTED|Extension Period (Part 2)||22
8425208|NCT00880763|20763858|P1|STARTED|Extension Period (Part 2)||23
8425209|NCT00880763|20763855|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425210|NCT00880763|20763856|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425211|NCT00880763|20763857|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425212|NCT00880763|20763858|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425213|NCT00880763|20763855|P4|COMPLETED|Initial Treatment Period (Part 1)||22
8425214|NCT00880763|20763856|P3|COMPLETED|Initial Treatment Period (Part 1)||23
8425215|NCT00880763|20763857|P2|COMPLETED|Initial Treatment Period (Part 1)||22
8425216|NCT00880763|20763858|P1|COMPLETED|Initial Treatment Period (Part 1)||23
8425217|NCT00880763|20763855|P4|STARTED|Initial Treatment Period (Part 1)||22
8425218|NCT00880763|20763856|P3|STARTED|Initial Treatment Period (Part 1)||23
8425219|NCT00880763|20763857|P2|STARTED|Initial Treatment Period (Part 1)||22
8425220|NCT00880763|20763858|P1|STARTED|Initial Treatment Period (Part 1)||23
8425221|NCT00880750|20763890|P2|NOT COMPLETED|Second Intervention||2
8425222|NCT00880750|20763891|P1|NOT COMPLETED|Second Intervention||4
8425223|NCT00880750|20763890|P2|COMPLETED|Second Intervention||30
8425224|NCT00880750|20763891|P1|COMPLETED|Second Intervention||26
8425225|NCT00880750|20763890|P2|STARTED|Second Intervention||32
8425226|NCT00880750|20763891|P1|STARTED|Second Intervention||30
8425227|NCT00880750|20763890|P2|NOT COMPLETED|Washout Period||0
8425228|NCT00880750|20763891|P1|NOT COMPLETED|Washout Period||0
8425229|NCT00880750|20763890|P2|COMPLETED|Washout Period||32
8425230|NCT00880750|20763891|P1|COMPLETED|Washout Period||30
8425231|NCT00880750|20763890|P2|STARTED|Washout Period||32
8425232|NCT00880750|20763891|P1|STARTED|Washout Period||30
8425233|NCT00880750|20763890|P2|NOT COMPLETED|First Intervention||1
8425234|NCT00880750|20763891|P1|NOT COMPLETED|First Intervention||9
8425235|NCT00880750|20763890|P2|COMPLETED|First Intervention||32
8425236|NCT00880750|20763891|P1|COMPLETED|First Intervention||30
8425237|NCT00880750|20763890|P2|STARTED|First Intervention||33
8425238|NCT00880750|20763891|P1|STARTED|First Intervention||39
8425239|NCT00880698|20763909|P4|NOT COMPLETED|Overall Study||3
8425240|NCT00880698|20763910|P3|NOT COMPLETED|Overall Study||1
8425241|NCT00880698|20763911|P2|NOT COMPLETED|Overall Study||3
8425242|NCT00880698|20763912|P1|NOT COMPLETED|Overall Study||1
8425243|NCT00880698|20763909|P4|COMPLETED|Overall Study||36
8425244|NCT00880698|20763910|P3|COMPLETED|Overall Study||36
8425245|NCT00880698|20763911|P2|COMPLETED|Overall Study||61
8425246|NCT00880698|20763912|P1|COMPLETED|Overall Study||61
8425247|NCT00880698|20763909|P4|STARTED|Overall Study||39
8425248|NCT00880698|20763910|P3|STARTED|Overall Study||37
8425249|NCT00880698|20763911|P2|STARTED|Overall Study||64
8425250|NCT00880698|20763912|P1|STARTED|Overall Study||62
8425251|NCT00880685|20763938|P1|NOT COMPLETED|Memantine 30mg||0
8425252|NCT00880685|20763938|P1|COMPLETED|Memantine 30mg||9
8425253|NCT00880685|20763938|P1|STARTED|Memantine 30mg||9
8425254|NCT00880685|20763938|P1|NOT COMPLETED|Memantine 20mg||1
8425255|NCT00880685|20763938|P1|COMPLETED|Memantine 20mg||9
8425256|NCT00880685|20763938|P1|STARTED|Memantine 20mg||10
8425257|NCT00880685|20763938|P1|NOT COMPLETED|Memantine 10mg||2
8425258|NCT00880685|20763938|P1|COMPLETED|Memantine 10mg||10
8425259|NCT00880685|20763938|P1|STARTED|Memantine 10mg||12
8425260|NCT00880620|20763950|P4|NOT COMPLETED|Overall Study||24
8425261|NCT00880620|20763951|P3|NOT COMPLETED|Overall Study||21
8425262|NCT00880620|20763952|P2|NOT COMPLETED|Overall Study||15
8425263|NCT00880620|20763953|P1|NOT COMPLETED|Overall Study||21
8425264|NCT00880620|20763950|P4|COMPLETED|Overall Study||74
8425265|NCT00880620|20763951|P3|COMPLETED|Overall Study||83
8425266|NCT00880620|20763952|P2|COMPLETED|Overall Study||72
8425267|NCT00880620|20763953|P1|COMPLETED|Overall Study||71
8425268|NCT00880620|20763950|P4|Week 23|Overall Study||74
8425269|NCT00880620|20763951|P3|Week 23|Overall Study||85
8425270|NCT00880620|20763952|P2|Week 23|Overall Study||72
8425271|NCT00880620|20763953|P1|Week 23|Overall Study||71
8425272|NCT00880620|20763950|P4|Week 16|Overall Study||74
8425273|NCT00880620|20763951|P3|Week 16|Overall Study||87
8425274|NCT00880620|20763952|P2|Week 16|Overall Study||73
8425275|NCT00880620|20763953|P1|Week 16|Overall Study||74
8425276|NCT00880620|20763950|P4|Week 9|Overall Study||78
8425277|NCT00880620|20763951|P3|Week 9|Overall Study||88
8425278|NCT00880620|20763952|P2|Week 9|Overall Study||73
8425279|NCT00880620|20763953|P1|Week 9|Overall Study||80
8425280|NCT00880620|20763950|P4|Week 4|Overall Study||86
8425281|NCT00880620|20763951|P3|Week 4|Overall Study||94
8425282|NCT00880620|20763952|P2|Week 4|Overall Study||79
8425283|NCT00880620|20763953|P1|Week 4|Overall Study||88
8425284|NCT00880620|20763950|P4|STARTED|Overall Study||98
8425285|NCT00880620|20763951|P3|STARTED|Overall Study||104
8425286|NCT00880620|20763952|P2|STARTED|Overall Study||87
8425287|NCT00880620|20763953|P1|STARTED|Overall Study||92
8425288|NCT00880607|20763969|P2|NOT COMPLETED|Overall Study||3
8425289|NCT00880607|20763970|P1|NOT COMPLETED|Overall Study||7
8425290|NCT00880607|20763969|P2|COMPLETED|Overall Study||34
8425291|NCT00880607|20763970|P1|COMPLETED|Overall Study||37
8425292|NCT00880607|20763969|P2|Observation After Receiving Medication|Overall Study||35
8425293|NCT00880607|20763970|P1|Observation After Receiving Medication|Overall Study||42
8425294|NCT00880607|20763969|P2|STARTED|Overall Study||37
8425295|NCT00880607|20763970|P1|STARTED|Overall Study||44
8425296|NCT00880581|20763988|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
8425297|NCT00880581|20763988|P1|COMPLETED|Cycle 2 Re-treatment||24
8425298|NCT00880581|20763988|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
8425299|NCT00880581|20763988|P1|NOT COMPLETED|Cycle 1||0
8425300|NCT00880581|20763988|P1|COMPLETED|Cycle 1||30
8425301|NCT00880581|20763988|P1|STARTED|Cycle 1||30
8425302|NCT00880568|20764002|P9|NOT COMPLETED|Overall Study||3
8425303|NCT00880568|20764003|P8|NOT COMPLETED|Overall Study||2
8425304|NCT00880568|20764004|P7|NOT COMPLETED|Overall Study||6
8425305|NCT00880568|20764005|P6|NOT COMPLETED|Overall Study||3
8425306|NCT00880568|20764006|P5|NOT COMPLETED|Overall Study||3
8425307|NCT00880568|20764007|P4|NOT COMPLETED|Overall Study||1
8425308|NCT00880568|20764008|P3|NOT COMPLETED|Overall Study||3
8425309|NCT00880568|20764009|P2|NOT COMPLETED|Overall Study||3
8425310|NCT00880568|20764010|P1|NOT COMPLETED|Overall Study||3
8425311|NCT00880568|20764002|P9|COMPLETED|Overall Study||0
8425312|NCT00880568|20764003|P8|COMPLETED|Overall Study||0
8425313|NCT00880568|20764004|P7|COMPLETED|Overall Study||0
8425314|NCT00880568|20764005|P6|COMPLETED|Overall Study||0
8425315|NCT00880568|20764006|P5|COMPLETED|Overall Study||0
8425316|NCT00880568|20764007|P4|COMPLETED|Overall Study||0
8425317|NCT00880568|20764008|P3|COMPLETED|Overall Study||0
8425318|NCT00880568|20764009|P2|COMPLETED|Overall Study||0
8425319|NCT00880568|20764010|P1|COMPLETED|Overall Study||0
8425320|NCT00880568|20764002|P9|STARTED|Overall Study||3
8425321|NCT00880568|20764003|P8|STARTED|Overall Study||2
8425322|NCT00880568|20764004|P7|STARTED|Overall Study||6
8425323|NCT00880568|20764005|P6|STARTED|Overall Study||3
8425324|NCT00880568|20764006|P5|STARTED|Overall Study||3
8425325|NCT00880568|20764007|P4|STARTED|Overall Study||1
8425326|NCT00880568|20764008|P3|STARTED|Overall Study||3
8425327|NCT00880568|20764009|P2|STARTED|Overall Study||3
8425328|NCT00880568|20764010|P1|STARTED|Overall Study||3
8425329|NCT00880555|20764056|P6|NOT COMPLETED|Overall Study||1
8425330|NCT00880555|20764057|P5|NOT COMPLETED|Overall Study||1
8425331|NCT00880555|20764058|P4|NOT COMPLETED|Overall Study||2
8425332|NCT00880555|20764059|P3|NOT COMPLETED|Overall Study||5
8425333|NCT00880555|20764060|P2|NOT COMPLETED|Overall Study||17
8425334|NCT00880555|20764061|P1|NOT COMPLETED|Overall Study||10
8425335|NCT00880555|20764056|P6|COMPLETED|Overall Study||0
8425336|NCT00880555|20764057|P5|COMPLETED|Overall Study||0
8425337|NCT00880555|20764058|P4|COMPLETED|Overall Study||0
8425338|NCT00880555|20764059|P3|COMPLETED|Overall Study||6
8425339|NCT00880555|20764060|P2|COMPLETED|Overall Study||23
8425340|NCT00880555|20764061|P1|COMPLETED|Overall Study||13
8425341|NCT00880555|20764056|P6|STARTED|Overall Study||1
8425342|NCT00880555|20764057|P5|STARTED|Overall Study||1
8425343|NCT00880555|20764058|P4|STARTED|Overall Study||2
8425344|NCT00880555|20764059|P3|STARTED|Overall Study||11
8425345|NCT00880555|20764060|P2|STARTED|Overall Study||40
8425346|NCT00880555|20764061|P1|STARTED|Overall Study||23
8425347|NCT00880542|20764072|P1|NOT COMPLETED|Follow-up Period||0
8425348|NCT00880542|20764072|P1|COMPLETED|Follow-up Period||7
8425349|NCT00880542|20764072|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
8425350|NCT00880542|20764072|P1|NOT COMPLETED|Continued Treatment Period||0
8425351|NCT00880542|20764072|P1|COMPLETED|Continued Treatment Period||0
8425525|NCT00879710|20764609|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425352|NCT00880542|20764072|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
8425353|NCT00880542|20764072|P1|NOT COMPLETED|Post Surgical Evaluation||0
8425354|NCT00880542|20764072|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
8425355|NCT00880542|20764072|P1|STARTED|Post Surgical Evaluation||3
8425356|NCT00880542|20764072|P1|NOT COMPLETED|REP: Surgical Resection||1
8425357|NCT00880542|20764072|P1|COMPLETED|REP: Surgical Resection||3
8425358|NCT00880542|20764072|P1|STARTED|REP: Surgical Resection||4
8425359|NCT00880542|20764072|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
8425360|NCT00880542|20764072|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
8425361|NCT00880542|20764072|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
8425362|NCT00880542|20764072|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
8425363|NCT00880542|20764072|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
8425364|NCT00880542|20764072|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
8425365|NCT00880425|20764077|P2|NOT COMPLETED|Overall Study||0
8425366|NCT00880425|20764078|P1|NOT COMPLETED|Overall Study||0
8425367|NCT00880425|20764077|P2|COMPLETED|Overall Study||27
8425368|NCT00880425|20764078|P1|COMPLETED|Overall Study||18
8425369|NCT00880425|20764077|P2|STARTED|Overall Study||27
8425370|NCT00880425|20764078|P1|STARTED|Overall Study||18
8425371|NCT00880399|20764089|P3|NOT COMPLETED|Overall Study||26
8425372|NCT00880399|20764090|P2|NOT COMPLETED|Overall Study||29
8425373|NCT00880399|20764091|P1|NOT COMPLETED|Overall Study||31
8425374|NCT00880399|20764089|P3|COMPLETED|Overall Study||81
8425375|NCT00880399|20764090|P2|COMPLETED|Overall Study||84
8425376|NCT00880399|20764091|P1|COMPLETED|Overall Study||77
8425377|NCT00880399|20764089|P3|STARTED|Overall Study||107
8425378|NCT00880399|20764090|P2|STARTED|Overall Study||113
8425379|NCT00880399|20764091|P1|STARTED|Overall Study||108
8425380|NCT00880360|20764147|P1|NOT COMPLETED|Overall Study||0
8425381|NCT00880360|20764147|P1|COMPLETED|Overall Study||19
8425382|NCT00880360|20764147|P1|STARTED|Overall Study||19
8425383|NCT00880334|20764154|P2|NOT COMPLETED|Crossover Phase||0
8425384|NCT00880334|20764155|P1|NOT COMPLETED|Crossover Phase||0
8425385|NCT00880334|20764154|P2|COMPLETED|Crossover Phase||37
8425386|NCT00880334|20764155|P1|COMPLETED|Crossover Phase||0
8425387|NCT00880334|20764154|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
8425388|NCT00880334|20764155|P1|STARTED|Crossover Phase||0
8425389|NCT00880334|20764154|P2|NOT COMPLETED|Randomized Phase||40
8425390|NCT00880334|20764155|P1|NOT COMPLETED|Randomized Phase||4
8425391|NCT00880334|20764154|P2|COMPLETED|Randomized Phase||35
8425392|NCT00880334|20764155|P1|COMPLETED|Randomized Phase||70
8425393|NCT00880334|20764154|P2|Eligible & Treated|Randomized Phase||72
8425394|NCT00880334|20764155|P1|Eligible & Treated|Randomized Phase||70
8425395|NCT00880334|20764154|P2|STARTED|Randomized Phase||75
8425396|NCT00880334|20764155|P1|STARTED|Randomized Phase||74
8425397|NCT00880269|20764172|P2|NOT COMPLETED|Overall Study||27
8425398|NCT00880269|20764173|P1|NOT COMPLETED|Overall Study||32
8425399|NCT00880269|20764172|P2|COMPLETED|Overall Study||0
8425400|NCT00880269|20764173|P1|COMPLETED|Overall Study||0
8425401|NCT00880269|20764172|P2|Discontinued Treatment|Overall Study||27
8425402|NCT00880269|20764173|P1|Discontinued Treatment|Overall Study||32
8425403|NCT00880269|20764172|P2|STARTED|Overall Study||27
8425404|NCT00880269|20764173|P1|STARTED|Overall Study||32
8425405|NCT00880256|20764189|P1|NOT COMPLETED|Overall Study||28
8425406|NCT00880256|20764189|P1|COMPLETED|Overall Study||65
8425407|NCT00880256|20764189|P1|STARTED|Overall Study||93
8425408|NCT00880230|20764194|P1|NOT COMPLETED|Overall Study||7
8425409|NCT00880230|20764194|P1|COMPLETED|Overall Study||134
8425410|NCT00880230|20764194|P1|STARTED|Overall Study||141
8425411|NCT00880191|20764216|P2|NOT COMPLETED|Overall Study||8
8425412|NCT00880191|20764217|P1|NOT COMPLETED|Overall Study||13
8425413|NCT00880191|20764216|P2|COMPLETED|Overall Study||198
8425414|NCT00880191|20764217|P1|COMPLETED|Overall Study||194
8425415|NCT00880191|20764216|P2|Available for Primary Endpoint Analysis|Overall Study||206
8425416|NCT00880191|20764217|P1|Available for Primary Endpoint Analysis|Overall Study||207
8425417|NCT00880191|20764216|P2|STARTED|Overall Study||206
8425418|NCT00880191|20764217|P1|STARTED|Overall Study||207
8425419|NCT00880165|20764237|P2|NOT COMPLETED|Overall Study||50
8425420|NCT00880165|20764238|P1|NOT COMPLETED|Overall Study||62
8425421|NCT00880165|20764237|P2|COMPLETED|Overall Study||98
8425422|NCT00880165|20764238|P1|COMPLETED|Overall Study||86
8425423|NCT00880165|20764237|P2|STARTED|Overall Study||148
8425424|NCT00880165|20764238|P1|STARTED|Overall Study||148
8425425|NCT00880100|20764248|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
8425426|NCT00880100|20764248|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
8425427|NCT00880100|20764248|P1|STARTED|Treatment Phase With Ultrase® MT12||48
8425428|NCT00880100|20764248|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
8425429|NCT00880100|20764248|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
8425430|NCT00880100|20764248|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
8425431|NCT00880087|20764261|P2|NOT COMPLETED|Overall Study||2
8425432|NCT00880087|20764262|P1|NOT COMPLETED|Overall Study||0
8425433|NCT00880087|20764261|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
8425434|NCT00880087|20764262|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
8425435|NCT00880087|20764261|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
8425436|NCT00880087|20764262|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
8425437|NCT00880048|20764277|P3|NOT COMPLETED|Overall Study||35
8425438|NCT00880048|20764278|P2|NOT COMPLETED|Overall Study||33
8425439|NCT00880048|20764279|P1|NOT COMPLETED|Overall Study||28
8425440|NCT00880048|20764277|P3|COMPLETED|Overall Study||77
8425441|NCT00880048|20764278|P2|COMPLETED|Overall Study||82
8425442|NCT00880048|20764279|P1|COMPLETED|Overall Study||88
8425443|NCT00880048|20764277|P3|STARTED|Overall Study||112
8425444|NCT00880048|20764278|P2|STARTED|Overall Study||115
8425445|NCT00880048|20764279|P1|STARTED|Overall Study||116
8425446|NCT00880022|20764337|P2|NOT COMPLETED|Overall Study||3
8425447|NCT00880022|20764338|P1|NOT COMPLETED|Overall Study||2
8425448|NCT00880022|20764337|P2|COMPLETED|Overall Study||21
8425449|NCT00880022|20764338|P1|COMPLETED|Overall Study||21
8425450|NCT00880022|20764337|P2|STARTED|Overall Study||24
8425451|NCT00880022|20764338|P1|STARTED|Overall Study||23
8425452|NCT00880009|20764346|P1|NOT COMPLETED|Overall Study||16
8425453|NCT00880009|20764346|P1|COMPLETED|Overall Study||0
8425454|NCT00880009|20764346|P1|STARTED|Overall Study||16
8425455|NCT00879996|20764370|P2|NOT COMPLETED|Overall Study||13
8425456|NCT00879996|20764371|P1|NOT COMPLETED|Overall Study||15
8425457|NCT00879996|20764370|P2|COMPLETED|Overall Study||13
8425458|NCT00879996|20764371|P1|COMPLETED|Overall Study||13
8425459|NCT00879996|20764370|P2|STARTED|Overall Study||26
8425460|NCT00879996|20764371|P1|STARTED|Overall Study||28
8425461|NCT00879970|20764386|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
8425462|NCT00879970|20764387|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
8425463|NCT00879970|20764388|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8425464|NCT00879970|20764389|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8425465|NCT00879970|20764390|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8425466|NCT00879970|20764386|P5|COMPLETED|Period 2 Vitamin D Randomization||600
8425467|NCT00879970|20764387|P4|COMPLETED|Period 2 Vitamin D Randomization||610
8425468|NCT00879970|20764388|P3|COMPLETED|Period 2 Vitamin D Randomization||0
8425469|NCT00879970|20764389|P2|COMPLETED|Period 2 Vitamin D Randomization||0
8425470|NCT00879970|20764390|P1|COMPLETED|Period 2 Vitamin D Randomization||0
8425471|NCT00879970|20764386|P5|STARTED|Period 2 Vitamin D Randomization||607
8425472|NCT00879970|20764387|P4|STARTED|Period 2 Vitamin D Randomization||614
8425473|NCT00879970|20764388|P3|STARTED|Period 2 Vitamin D Randomization||0
8425474|NCT00879970|20764389|P2|STARTED|Period 2 Vitamin D Randomization||0
8425475|NCT00879970|20764390|P1|STARTED|Period 2 Vitamin D Randomization||0
8425476|NCT00879970|20764386|P5|NOT COMPLETED|Period 1 TZD Randomization||0
8425477|NCT00879970|20764387|P4|NOT COMPLETED|Period 1 TZD Randomization||0
8425478|NCT00879970|20764388|P3|NOT COMPLETED|Period 1 TZD Randomization||6
8425479|NCT00879970|20764389|P2|NOT COMPLETED|Period 1 TZD Randomization||4
8425480|NCT00879970|20764390|P1|NOT COMPLETED|Period 1 TZD Randomization||8
8425481|NCT00879970|20764386|P5|COMPLETED|Period 1 TZD Randomization||0
8425482|NCT00879970|20764387|P4|COMPLETED|Period 1 TZD Randomization||0
8425483|NCT00879970|20764388|P3|COMPLETED|Period 1 TZD Randomization||393
8425484|NCT00879970|20764389|P2|COMPLETED|Period 1 TZD Randomization||388
8425485|NCT00879970|20764390|P1|COMPLETED|Period 1 TZD Randomization||533
8425486|NCT00879970|20764386|P5|STARTED|Period 1 TZD Randomization||0
8425487|NCT00879970|20764387|P4|STARTED|Period 1 TZD Randomization||0
8425488|NCT00879970|20764388|P3|STARTED|Period 1 TZD Randomization||399
8425489|NCT00879970|20764389|P2|STARTED|Period 1 TZD Randomization||392
8425490|NCT00879970|20764390|P1|STARTED|Period 1 TZD Randomization||541
8425494|NCT00879814|20764480|P4|NOT COMPLETED|Overall Study||5
8425495|NCT00879814|20764481|P3|NOT COMPLETED|Overall Study||3
8425496|NCT00879814|20764482|P2|NOT COMPLETED|Overall Study||2
8425497|NCT00879814|20764483|P1|NOT COMPLETED|Overall Study||4
8425498|NCT00879814|20764480|P4|COMPLETED|Overall Study||7
8425499|NCT00879814|20764481|P3|COMPLETED|Overall Study||9
8425500|NCT00879814|20764482|P2|COMPLETED|Overall Study||10
8425501|NCT00879814|20764483|P1|COMPLETED|Overall Study||8
8425502|NCT00879814|20764480|P4|STARTED|Overall Study||12
8425503|NCT00879814|20764481|P3|STARTED|Overall Study||12
8425504|NCT00879814|20764482|P2|STARTED|Overall Study||12
8425505|NCT00879814|20764483|P1|STARTED|Overall Study||12
8425506|NCT00879775|20764591|P2|NOT COMPLETED|Overall Study||1
8425507|NCT00879775|20764592|P1|NOT COMPLETED|Overall Study||2
8425508|NCT00879775|20764591|P2|COMPLETED|Overall Study||20
8425509|NCT00879775|20764592|P1|COMPLETED|Overall Study||18
8425510|NCT00879775|20764591|P2|STARTED|Overall Study||21
8425511|NCT00879775|20764592|P1|STARTED|Overall Study||20
8425512|NCT00879710|20764608|P4|NOT COMPLETED|Phase 2 6 Weeks||0
8425513|NCT00879710|20764609|P3|NOT COMPLETED|Phase 2 6 Weeks||0
8425514|NCT00879710|20764610|P2|NOT COMPLETED|Phase 2 6 Weeks||0
8425515|NCT00879710|20764611|P1|NOT COMPLETED|Phase 2 6 Weeks||0
8425516|NCT00879710|20764608|P4|COMPLETED|Phase 2 6 Weeks||13
8425517|NCT00879710|20764609|P3|COMPLETED|Phase 2 6 Weeks||10
8425518|NCT00879710|20764610|P2|COMPLETED|Phase 2 6 Weeks||14
8425519|NCT00879710|20764611|P1|COMPLETED|Phase 2 6 Weeks||10
8425520|NCT00879710|20764608|P4|STARTED|Phase 2 6 Weeks||13
8425521|NCT00879710|20764609|P3|STARTED|Phase 2 6 Weeks||10
8425522|NCT00879710|20764610|P2|STARTED|Phase 2 6 Weeks||14
8425523|NCT00879710|20764611|P1|STARTED|Phase 2 6 Weeks||10
8425524|NCT00879710|20764608|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425526|NCT00879710|20764610|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425527|NCT00879710|20764611|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425528|NCT00879710|20764608|P4|COMPLETED|Wash Out Period of 4 Weeks||13
8425529|NCT00879710|20764609|P3|COMPLETED|Wash Out Period of 4 Weeks||10
8425530|NCT00879710|20764610|P2|COMPLETED|Wash Out Period of 4 Weeks||14
8425531|NCT00879710|20764611|P1|COMPLETED|Wash Out Period of 4 Weeks||10
8425532|NCT00879710|20764608|P4|STARTED|Wash Out Period of 4 Weeks||13
8425533|NCT00879710|20764609|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
8425534|NCT00879710|20764610|P2|STARTED|Wash Out Period of 4 Weeks||14
8425535|NCT00879710|20764611|P1|STARTED|Wash Out Period of 4 Weeks||10
8425536|NCT00879710|20764608|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
8425537|NCT00879710|20764609|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
8425538|NCT00879710|20764610|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
8425539|NCT00879710|20764611|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
8425540|NCT00879710|20764608|P4|COMPLETED|Phase 1 - 6 Weeks||13
8425541|NCT00879710|20764609|P3|COMPLETED|Phase 1 - 6 Weeks||9
8425542|NCT00879710|20764610|P2|COMPLETED|Phase 1 - 6 Weeks||14
8425543|NCT00879710|20764611|P1|COMPLETED|Phase 1 - 6 Weeks||10
8425544|NCT00879710|20764608|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
8425545|NCT00879710|20764609|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
8425546|NCT00879710|20764610|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
8425547|NCT00879710|20764611|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
8425548|NCT00879697|20764621|P2|NOT COMPLETED|Overall Study||2
8425549|NCT00879697|20764622|P1|NOT COMPLETED|Overall Study||2
8425550|NCT00879697|20764621|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
8425551|NCT00879697|20764622|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
8425552|NCT00879697|20764621|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
8425553|NCT00879697|20764622|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
8425554|NCT00879684|20764628|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
8425555|NCT00879684|20764629|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425556|NCT00879684|20764630|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425557|NCT00879684|20764631|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425558|NCT00879684|20764632|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425559|NCT00879684|20764633|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425560|NCT00879684|20764634|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425561|NCT00879684|20764628|P7|COMPLETED|Stage 2: Expanded Cohort||0
8425562|NCT00879684|20764629|P6|COMPLETED|Stage 2: Expanded Cohort||0
8425563|NCT00879684|20764630|P5|COMPLETED|Stage 2: Expanded Cohort||0
8425564|NCT00879684|20764631|P4|COMPLETED|Stage 2: Expanded Cohort||0
8425565|NCT00879684|20764632|P3|COMPLETED|Stage 2: Expanded Cohort||0
8425566|NCT00879684|20764633|P2|COMPLETED|Stage 2: Expanded Cohort||0
8425567|NCT00879684|20764634|P1|COMPLETED|Stage 2: Expanded Cohort||0
8425568|NCT00879684|20764628|P7|STARTED|Stage 2: Expanded Cohort||13
8425569|NCT00879684|20764629|P6|STARTED|Stage 2: Expanded Cohort||0
8425570|NCT00879684|20764630|P5|STARTED|Stage 2: Expanded Cohort||0
8425571|NCT00879684|20764631|P4|STARTED|Stage 2: Expanded Cohort||0
8425572|NCT00879684|20764632|P3|STARTED|Stage 2: Expanded Cohort||0
8425573|NCT00879684|20764633|P2|STARTED|Stage 2: Expanded Cohort||0
8425574|NCT00879684|20764634|P1|STARTED|Stage 2: Expanded Cohort||0
8425575|NCT00879684|20764628|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
8425576|NCT00879684|20764629|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
8425577|NCT00879684|20764630|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
8425578|NCT00879684|20764631|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
8425579|NCT00879684|20764632|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
8425580|NCT00879684|20764633|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
8425581|NCT00879684|20764634|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
8425582|NCT00879684|20764628|P7|COMPLETED|Stage 1: Dose Escalation||0
8425583|NCT00879684|20764629|P6|COMPLETED|Stage 1: Dose Escalation||0
8425584|NCT00879684|20764630|P5|COMPLETED|Stage 1: Dose Escalation||0
8425585|NCT00879684|20764631|P4|COMPLETED|Stage 1: Dose Escalation||0
8425586|NCT00879684|20764632|P3|COMPLETED|Stage 1: Dose Escalation||0
8425587|NCT00879684|20764633|P2|COMPLETED|Stage 1: Dose Escalation||0
8425588|NCT00879684|20764634|P1|COMPLETED|Stage 1: Dose Escalation||0
8425589|NCT00879684|20764628|P7|STARTED|Stage 1: Dose Escalation||0
8425590|NCT00879684|20764629|P6|STARTED|Stage 1: Dose Escalation||3
8425591|NCT00879684|20764630|P5|STARTED|Stage 1: Dose Escalation||3
8425592|NCT00879684|20764631|P4|STARTED|Stage 1: Dose Escalation||6
8425593|NCT00879684|20764632|P3|STARTED|Stage 1: Dose Escalation||3
8425594|NCT00879684|20764633|P2|STARTED|Stage 1: Dose Escalation||3
8425595|NCT00879684|20764634|P1|STARTED|Stage 1: Dose Escalation||3
8425596|NCT00879658|20764703|P7|NOT COMPLETED|Overall Study||0
8425597|NCT00879658|20764704|P6|NOT COMPLETED|Overall Study||1
8425598|NCT00879658|20764705|P5|NOT COMPLETED|Overall Study||2
8425599|NCT00879658|20764706|P4|NOT COMPLETED|Overall Study||4
8425600|NCT00879658|20764707|P3|NOT COMPLETED|Overall Study||7
8425601|NCT00879658|20764708|P2|NOT COMPLETED|Overall Study||5
8425602|NCT00879658|20764709|P1|NOT COMPLETED|Overall Study||15
8425603|NCT00879658|20764703|P7|COMPLETED|Overall Study||16
8425604|NCT00879658|20764704|P6|COMPLETED|Overall Study||50
8425605|NCT00879658|20764705|P5|COMPLETED|Overall Study||40
8425606|NCT00879658|20764706|P4|COMPLETED|Overall Study||42
8425607|NCT00879658|20764707|P3|COMPLETED|Overall Study||36
8425608|NCT00879658|20764708|P2|COMPLETED|Overall Study||44
8425609|NCT00879658|20764709|P1|COMPLETED|Overall Study||35
8425610|NCT00879658|20764703|P7|STARTED|Overall Study||16
8425611|NCT00879658|20764704|P6|STARTED|Overall Study||51
8425612|NCT00879658|20764705|P5|STARTED|Overall Study||42
8425613|NCT00879658|20764706|P4|STARTED|Overall Study||46
8425614|NCT00879658|20764707|P3|STARTED|Overall Study||43
8425615|NCT00879658|20764708|P2|STARTED|Overall Study||49
8425616|NCT00879658|20764709|P1|STARTED|Overall Study||50
8425617|NCT00879645|20764795|P4|NOT COMPLETED|Overall Study||0
8425618|NCT00879645|20764796|P3|NOT COMPLETED|Overall Study||0
8425619|NCT00879645|20764797|P2|NOT COMPLETED|Overall Study||0
8425620|NCT00879645|20764798|P1|NOT COMPLETED|Overall Study||1
8425621|NCT00879645|20764795|P4|COMPLETED|Overall Study||7
8425622|NCT00879645|20764796|P3|COMPLETED|Overall Study||6
8425623|NCT00879645|20764797|P2|COMPLETED|Overall Study||6
8425624|NCT00879645|20764798|P1|COMPLETED|Overall Study||8
8425625|NCT00879645|20764795|P4|STARTED|Overall Study||7
8425626|NCT00879645|20764796|P3|STARTED|Overall Study||6
8425627|NCT00879645|20764797|P2|STARTED|Overall Study||6
8425628|NCT00879645|20764798|P1|STARTED|Overall Study||9
8425629|NCT00879619|20764816|P1|NOT COMPLETED|Overall Study||0
8425630|NCT00879619|20764816|P1|COMPLETED|Overall Study||4
8425631|NCT00879619|20764816|P1|STARTED|Overall Study||4
8425632|NCT00879411|20764825|P1|NOT COMPLETED|Overall Study||162
8425633|NCT00879411|20764825|P1|COMPLETED|Overall Study||539
8425634|NCT00879411|20764825|P1|STARTED|Overall Study||701
8425635|NCT00879398|20764831|P1|NOT COMPLETED|Overall Study||675
8425636|NCT00879398|20764831|P1|COMPLETED|Overall Study||2434
8425637|NCT00879398|20764831|P1|STARTED|Overall Study||3109
8425638|NCT00879359|20764841|P1|NOT COMPLETED|Overall Study||0
8425639|NCT00879359|20764841|P1|COMPLETED|Overall Study||15
8425640|NCT00879359|20764841|P1|STARTED|Overall Study||15
8425641|NCT00879333|20764849|P2|NOT COMPLETED|Overall Study||217
8425642|NCT00879333|20764850|P1|NOT COMPLETED|Overall Study||428
8425643|NCT00879333|20764849|P2|COMPLETED|Overall Study||0
8425644|NCT00879333|20764850|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
8425645|NCT00879333|20764849|P2|Discontinued Study Treatment|Overall Study||217
8425646|NCT00879333|20764850|P1|Discontinued Study Treatment|Overall Study||428
8425647|NCT00879333|20764849|P2|STARTED|Overall Study||217
8425648|NCT00879333|20764850|P1|STARTED|Overall Study||439
8425649|NCT00879255|20764870|P2|NOT COMPLETED|Overall Study||19
8425650|NCT00879255|20764871|P1|NOT COMPLETED|Overall Study||16
8425651|NCT00879255|20764870|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
8425652|NCT00879255|20764871|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
8425653|NCT00879255|20764870|P2|Completed 3-mo Follow-up|Overall Study||49
8425654|NCT00879255|20764871|P1|Completed 3-mo Follow-up|Overall Study||48
8425655|NCT00879255|20764870|P2|Completed Posttreatment Follow-up|Overall Study||55
8425656|NCT00879255|20764871|P1|Completed Posttreatment Follow-up|Overall Study||50
8425657|NCT00879255|20764870|P2|Received Allocated Intervention:|Overall Study||56
8425658|NCT00879255|20764871|P1|Received Allocated Intervention:|Overall Study||51
8425659|NCT00879255|20764870|P2|STARTED|Overall Study||64
8425660|NCT00879255|20764871|P1|STARTED|Overall Study||61
8425661|NCT00879229|20764883|P2|NOT COMPLETED|Overall Study||14
8425662|NCT00879229|20764884|P1|NOT COMPLETED|Overall Study||22
8425663|NCT00879229|20764883|P2|COMPLETED|Overall Study||1
8425664|NCT00879229|20764884|P1|COMPLETED|Overall Study||3
8425665|NCT00879229|20764883|P2|STARTED|Overall Study||15
8425666|NCT00879229|20764884|P1|STARTED|Overall Study||25
8425667|NCT00879190|20764910|P2|NOT COMPLETED|Overall Study||0
8425668|NCT00879190|20764911|P1|NOT COMPLETED|Overall Study||0
8425669|NCT00879190|20764910|P2|COMPLETED|Overall Study||49
8425670|NCT00879190|20764911|P1|COMPLETED|Overall Study||43
8425671|NCT00879190|20764910|P2|STARTED|Overall Study||49
8425672|NCT00879190|20764911|P1|STARTED|Overall Study||43
8425673|NCT00879034|20764921|P1|NOT COMPLETED|Overall Study||0
8425674|NCT00879034|20764921|P1|COMPLETED|Overall Study||5
8425675|NCT00879034|20764921|P1|Received Treatment|Overall Study||4
8425676|NCT00879034|20764921|P1|STARTED|Overall Study||5
8425677|NCT00878995|20764932|P2|NOT COMPLETED|Midpoint Study - Post Study||0
8425678|NCT00878995|20764933|P1|NOT COMPLETED|Midpoint Study - Post Study||0
8425679|NCT00878995|20764932|P2|COMPLETED|Midpoint Study - Post Study||10
8425680|NCT00878995|20764933|P1|COMPLETED|Midpoint Study - Post Study||12
8425681|NCT00878995|20764932|P2|STARTED|Midpoint Study - Post Study||10
8425682|NCT00878995|20764933|P1|STARTED|Midpoint Study - Post Study||12
8425683|NCT00878995|20764932|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
8425684|NCT00878995|20764933|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
8425685|NCT00878995|20764932|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
8425686|NCT00878995|20764933|P1|COMPLETED|Baseline Study - Midpoint Study||12
8425687|NCT00878995|20764932|P2|Baseline Study|Baseline Study - Midpoint Study||12
8425688|NCT00878995|20764933|P1|Baseline Study|Baseline Study - Midpoint Study||12
8425689|NCT00878995|20764932|P2|STARTED|Baseline Study - Midpoint Study||12
8425690|NCT00878995|20764933|P1|STARTED|Baseline Study - Midpoint Study||12
8425691|NCT00878969|20765034|P3|NOT COMPLETED|Overall Study||11
8425692|NCT00878969|20765035|P2|NOT COMPLETED|Overall Study||15
8425693|NCT00878969|20765036|P1|NOT COMPLETED|Overall Study||15
8425694|NCT00878969|20765034|P3|COMPLETED|Overall Study||15
8425695|NCT00878969|20765035|P2|COMPLETED|Overall Study||12
8425696|NCT00878969|20765036|P1|COMPLETED|Overall Study||10
8425697|NCT00878969|20765034|P3|STARTED|Overall Study||26
8425698|NCT00878969|20765035|P2|STARTED|Overall Study||27
8425699|NCT00878969|20765036|P1|STARTED|Overall Study||25
8425700|NCT00878878|20765046|P2|NOT COMPLETED|Overall Study||0
8425701|NCT00878878|20765047|P1|NOT COMPLETED|Overall Study||0
8425702|NCT00878878|20765046|P2|COMPLETED|Overall Study||15
8425703|NCT00878878|20765047|P1|COMPLETED|Overall Study||15
8425704|NCT00878878|20765046|P2|STARTED|Overall Study||15
8425705|NCT00878878|20765047|P1|STARTED|Overall Study||15
8425706|NCT00878826|20765060|P3|NOT COMPLETED|Overall Study||0
8425707|NCT00878826|20765061|P2|NOT COMPLETED|Overall Study||0
8425708|NCT00878826|20765062|P1|NOT COMPLETED|Overall Study||0
8425709|NCT00878826|20765060|P3|COMPLETED|Overall Study||2
8425710|NCT00878826|20765061|P2|COMPLETED|Overall Study||6
8425711|NCT00878826|20765062|P1|COMPLETED|Overall Study||3
8425712|NCT00878826|20765060|P3|STARTED|Overall Study||2
8425713|NCT00878826|20765061|P2|STARTED|Overall Study||6
8425714|NCT00878826|20765062|P1|STARTED|Overall Study||3
8425715|NCT00878800|20765084|P5|NOT COMPLETED|Overall Study||16
8425716|NCT00878800|20765085|P4|NOT COMPLETED|Overall Study||6
8425717|NCT00878800|20765086|P3|NOT COMPLETED|Overall Study||9
8425718|NCT00878800|20765087|P2|NOT COMPLETED|Overall Study||7
8425719|NCT00878800|20765088|P1|NOT COMPLETED|Overall Study||3
8425720|NCT00878800|20765084|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
8425721|NCT00878800|20765085|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
8425722|NCT00878800|20765086|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
8425723|NCT00878800|20765087|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
8425724|NCT00878800|20765088|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
8425725|NCT00878800|20765084|P5|STARTED|Overall Study||16
8425726|NCT00878800|20765085|P4|STARTED|Overall Study||6
8425727|NCT00878800|20765086|P3|STARTED|Overall Study||9
8425728|NCT00878800|20765087|P2|STARTED|Overall Study||7
8425729|NCT00878800|20765088|P1|STARTED|Overall Study||3
8425730|NCT00878722|20765123|P8|NOT COMPLETED|Overall Study||7
8425731|NCT00878722|20765124|P7|NOT COMPLETED|Overall Study||6
8425732|NCT00878722|20765125|P6|NOT COMPLETED|Overall Study||2
8425733|NCT00878722|20765126|P5|NOT COMPLETED|Overall Study||7
8425734|NCT00878722|20765127|P4|NOT COMPLETED|Overall Study||9
8425735|NCT00878722|20765128|P3|NOT COMPLETED|Overall Study||3
8425736|NCT00878722|20765129|P2|NOT COMPLETED|Overall Study||3
8425737|NCT00878722|20765130|P1|NOT COMPLETED|Overall Study||3
8425738|NCT00878722|20765123|P8|COMPLETED|Overall Study||0
8425739|NCT00878722|20765124|P7|COMPLETED|Overall Study||0
8425740|NCT00878722|20765125|P6|COMPLETED|Overall Study||1
8425741|NCT00878722|20765126|P5|COMPLETED|Overall Study||0
8425742|NCT00878722|20765127|P4|COMPLETED|Overall Study||0
8425743|NCT00878722|20765128|P3|COMPLETED|Overall Study||0
8425744|NCT00878722|20765129|P2|COMPLETED|Overall Study||0
8425745|NCT00878722|20765130|P1|COMPLETED|Overall Study||0
8425746|NCT00878722|20765123|P8|STARTED|Overall Study||7
8425747|NCT00878722|20765124|P7|STARTED|Overall Study||6
8425748|NCT00878722|20765125|P6|STARTED|Overall Study||3
8425749|NCT00878722|20765126|P5|STARTED|Overall Study||7
8425750|NCT00878722|20765127|P4|STARTED|Overall Study||9
8425751|NCT00878722|20765128|P3|STARTED|Overall Study||3
8425752|NCT00878722|20765129|P2|STARTED|Overall Study||3
8425753|NCT00878722|20765130|P1|STARTED|Overall Study||3
8425754|NCT00878709|20765215|P2|NOT COMPLETED|Overall Study||237
8425755|NCT00878709|20765216|P1|NOT COMPLETED|Overall Study||325
8425756|NCT00878709|20765215|P2|COMPLETED|Overall Study||1183
8425757|NCT00878709|20765216|P1|COMPLETED|Overall Study||1095
8425758|NCT00878709|20765215|P2|STARTED|Overall Study||1420
8425759|NCT00878709|20765216|P1|STARTED|Overall Study||1420
8425760|NCT00878644|20765256|P2|NOT COMPLETED|Overall Study||4
8425761|NCT00878644|20765257|P1|NOT COMPLETED|Overall Study||4
8425762|NCT00878644|20765256|P2|COMPLETED|Overall Study||136
8425763|NCT00878644|20765257|P1|COMPLETED|Overall Study||151
8425764|NCT00878644|20765256|P2|STARTED|Overall Study||140
8425765|NCT00878644|20765257|P1|STARTED|Overall Study||155
8425766|NCT00878605|20765273|P4|NOT COMPLETED|Overall Study||3
8425767|NCT00878605|20765274|P3|NOT COMPLETED|Overall Study||1
8425768|NCT00878605|20765275|P2|NOT COMPLETED|Overall Study||3
8425769|NCT00878605|20765276|P1|NOT COMPLETED|Overall Study||3
8425770|NCT00878605|20765273|P4|COMPLETED|Overall Study||6
8425771|NCT00878605|20765274|P3|COMPLETED|Overall Study||8
8425772|NCT00878605|20765275|P2|COMPLETED|Overall Study||7
8425773|NCT00878605|20765276|P1|COMPLETED|Overall Study||7
8425774|NCT00878605|20765273|P4|STARTED|Overall Study||9
8425775|NCT00878605|20765274|P3|STARTED|Overall Study||9
8425776|NCT00878605|20765275|P2|STARTED|Overall Study||10
8425777|NCT00878605|20765276|P1|STARTED|Overall Study||10
8425778|NCT00878553|20765290|P5|NOT COMPLETED|PK Study||0
8425779|NCT00878553|20765291|P4|NOT COMPLETED|PK Study||1
8425780|NCT00878553|20765292|P3|NOT COMPLETED|PK Study||0
8425781|NCT00878553|20765293|P2|NOT COMPLETED|PK Study||0
8425782|NCT00878553|20765294|P1|NOT COMPLETED|PK Study||0
8425783|NCT00878553|20765290|P5|COMPLETED|PK Study||15
8425784|NCT00878553|20765291|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
8425785|NCT00878553|20765292|P3|COMPLETED|PK Study||17
8425786|NCT00878553|20765293|P2|COMPLETED|PK Study||16
8425787|NCT00878553|20765294|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
8425788|NCT00878553|20765290|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
8425871|NCT00878189|20765422|P6|NOT COMPLETED|Overall Study||23
8425872|NCT00878189|20765423|P5|NOT COMPLETED|Overall Study||4
8425789|NCT00878553|20765291|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
8425790|NCT00878553|20765292|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
8425791|NCT00878553|20765293|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
8425792|NCT00878553|20765294|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
8425793|NCT00878553|20765290|P5|NOT COMPLETED|Sleep Study||0
8425794|NCT00878553|20765291|P4|NOT COMPLETED|Sleep Study||0
8425795|NCT00878553|20765292|P3|NOT COMPLETED|Sleep Study||0
8425796|NCT00878553|20765293|P2|NOT COMPLETED|Sleep Study||0
8425797|NCT00878553|20765294|P1|NOT COMPLETED|Sleep Study||5
8425798|NCT00878553|20765290|P5|COMPLETED|Sleep Study||0
8425799|NCT00878553|20765291|P4|COMPLETED|Sleep Study||0
8425800|NCT00878553|20765292|P3|COMPLETED|Sleep Study||0
8425801|NCT00878553|20765293|P2|COMPLETED|Sleep Study||0
8425802|NCT00878553|20765294|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
8425803|NCT00878553|20765290|P5|Number of Patients Receiving 20mg|Sleep Study||0
8425804|NCT00878553|20765291|P4|Number of Patients Receiving 20mg|Sleep Study||0
8425805|NCT00878553|20765292|P3|Number of Patients Receiving 20mg|Sleep Study||0
8425806|NCT00878553|20765293|P2|Number of Patients Receiving 20mg|Sleep Study||0
8425807|NCT00878553|20765294|P1|Number of Patients Receiving 20mg|Sleep Study||65
8425808|NCT00878553|20765290|P5|Number of Patients Receiving 15mg|Sleep Study||0
8425809|NCT00878553|20765291|P4|Number of Patients Receiving 15mg|Sleep Study||0
8425810|NCT00878553|20765292|P3|Number of Patients Receiving 15mg|Sleep Study||0
8425811|NCT00878553|20765293|P2|Number of Patients Receiving 15mg|Sleep Study||0
8425812|NCT00878553|20765294|P1|Number of Patients Receiving 15mg|Sleep Study||65
8425813|NCT00878553|20765290|P5|Number of Patients Receiving 10mg|Sleep Study||0
8425814|NCT00878553|20765291|P4|Number of Patients Receiving 10mg|Sleep Study||0
8425815|NCT00878553|20765292|P3|Number of Patients Receiving 10mg|Sleep Study||0
8425816|NCT00878553|20765293|P2|Number of Patients Receiving 10mg|Sleep Study||0
8425817|NCT00878553|20765294|P1|Number of Patients Receiving 10mg|Sleep Study||65
8425818|NCT00878553|20765290|P5|Number of Patients Receiving Placebo|Sleep Study||0
8425819|NCT00878553|20765291|P4|Number of Patients Receiving Placebo|Sleep Study||0
8425820|NCT00878553|20765292|P3|Number of Patients Receiving Placebo|Sleep Study||0
8425821|NCT00878553|20765293|P2|Number of Patients Receiving Placebo|Sleep Study||0
8425822|NCT00878553|20765294|P1|Number of Patients Receiving Placebo|Sleep Study||66
8425823|NCT00878553|20765290|P5|STARTED|Sleep Study||0
8425824|NCT00878553|20765291|P4|STARTED|Sleep Study||0
8425825|NCT00878553|20765292|P3|STARTED|Sleep Study||0
8425826|NCT00878553|20765293|P2|STARTED|Sleep Study||0
8425827|NCT00878553|20765294|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
8425828|NCT00878501|20765353|P3|NOT COMPLETED|Overall Study||8
8425829|NCT00878501|20765354|P2|NOT COMPLETED|Overall Study||7
8425830|NCT00878501|20765355|P1|NOT COMPLETED|Overall Study||17
8425831|NCT00878501|20765353|P3|COMPLETED|Overall Study||85
8425832|NCT00878501|20765354|P2|COMPLETED|Overall Study||37
8425833|NCT00878501|20765355|P1|COMPLETED|Overall Study||87
8425834|NCT00878501|20765353|P3|Interim Analysis|Overall Study||81
8425835|NCT00878501|20765354|P2|Interim Analysis|Overall Study||37
8425836|NCT00878501|20765355|P1|Interim Analysis|Overall Study||83
8425837|NCT00878501|20765353|P3|STARTED|Overall Study||93
8425838|NCT00878501|20765354|P2|STARTED|Overall Study||44
8425839|NCT00878501|20765355|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
8425840|NCT00878436|20765374|P2|NOT COMPLETED|Overall Study||24
8425841|NCT00878436|20765375|P1|NOT COMPLETED|Overall Study||23
8425842|NCT00878436|20765374|P2|COMPLETED|Overall Study||0
8425843|NCT00878436|20765375|P1|COMPLETED|Overall Study||5
8425844|NCT00878436|20765374|P2|6 Months|Overall Study||0
8425845|NCT00878436|20765375|P1|6 Months|Overall Study||8
8425846|NCT00878436|20765374|P2|Completed 2 Cycles|Overall Study||20
8425847|NCT00878436|20765375|P1|Completed 2 Cycles|Overall Study||21
8425848|NCT00878436|20765374|P2|STARTED|Overall Study||24
8425849|NCT00878436|20765375|P1|STARTED|Overall Study||28
8425850|NCT00878228|20765389|P2|NOT COMPLETED|Overall Study||12
8425851|NCT00878228|20765390|P1|NOT COMPLETED|Overall Study||10
8425852|NCT00878228|20765389|P2|COMPLETED|Overall Study||37
8425853|NCT00878228|20765390|P1|COMPLETED|Overall Study||39
8425854|NCT00878228|20765389|P2|STARTED|Overall Study||49
8425855|NCT00878228|20765390|P1|STARTED|Overall Study||49
8425856|NCT00878215|20765404|P4|NOT COMPLETED|Overall Study||0
8425857|NCT00878215|20765405|P3|NOT COMPLETED|Overall Study||0
8425858|NCT00878215|20765406|P2|NOT COMPLETED|Overall Study||10
8425859|NCT00878215|20765407|P1|NOT COMPLETED|Overall Study||0
8425860|NCT00878215|20765404|P4|COMPLETED|Overall Study||0
8425861|NCT00878215|20765405|P3|COMPLETED|Overall Study||0
8425862|NCT00878215|20765406|P2|COMPLETED|Overall Study||9
8425863|NCT00878215|20765407|P1|COMPLETED|Overall Study||21
8425864|NCT00878215|20765404|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
8425865|NCT00878215|20765405|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
8425866|NCT00878215|20765406|P2|STARTED|Overall Study||19
8425867|NCT00878215|20765407|P1|STARTED|Overall Study||21
8425868|NCT00878189|20765419|P9|NOT COMPLETED|Overall Study||8
8425869|NCT00878189|20765420|P8|NOT COMPLETED|Overall Study||3
8425870|NCT00878189|20765421|P7|NOT COMPLETED|Overall Study||16
8425873|NCT00878189|20765424|P4|NOT COMPLETED|Overall Study||8
8425874|NCT00878189|20765425|P3|NOT COMPLETED|Overall Study||4
8425875|NCT00878189|20765426|P2|NOT COMPLETED|Overall Study||3
8425876|NCT00878189|20765427|P1|NOT COMPLETED|Overall Study||3
8425877|NCT00878189|20765419|P9|COMPLETED|Overall Study||0
8425878|NCT00878189|20765420|P8|COMPLETED|Overall Study||0
8425879|NCT00878189|20765421|P7|COMPLETED|Overall Study||0
8425880|NCT00878189|20765422|P6|COMPLETED|Overall Study||0
8425881|NCT00878189|20765423|P5|COMPLETED|Overall Study||0
8425882|NCT00878189|20765424|P4|COMPLETED|Overall Study||0
8425883|NCT00878189|20765425|P3|COMPLETED|Overall Study||0
8425884|NCT00878189|20765426|P2|COMPLETED|Overall Study||0
8425885|NCT00878189|20765427|P1|COMPLETED|Overall Study||0
8425886|NCT00878189|20765419|P9|STARTED|Overall Study||8
8425887|NCT00878189|20765420|P8|STARTED|Overall Study||3
8425888|NCT00878189|20765421|P7|STARTED|Overall Study||16
8425889|NCT00878189|20765422|P6|STARTED|Overall Study||23
8425890|NCT00878189|20765423|P5|STARTED|Overall Study||4
8425891|NCT00878189|20765424|P4|STARTED|Overall Study||8
8425892|NCT00878189|20765425|P3|STARTED|Overall Study||4
8425893|NCT00878189|20765426|P2|STARTED|Overall Study||3
8425894|NCT00878189|20765427|P1|STARTED|Overall Study||3
8425895|NCT00877929|20765695|P2|NOT COMPLETED|Overall Study||35
8425896|NCT00877929|20765696|P1|NOT COMPLETED|Overall Study||20
8425897|NCT00877929|20765695|P2|COMPLETED|Overall Study||319
8425898|NCT00877929|20765696|P1|COMPLETED|Overall Study||332
8425899|NCT00877929|20765695|P2|STARTED|Overall Study||354
8425900|NCT00877929|20765696|P1|STARTED|Overall Study||352
8425901|NCT00877890|20765784|P2|NOT COMPLETED|Overall Study||30
8425902|NCT00877890|20765785|P1|NOT COMPLETED|Overall Study||20
8425903|NCT00877890|20765784|P2|COMPLETED|Overall Study||95
8425904|NCT00877890|20765785|P1|COMPLETED|Overall Study||109
8425905|NCT00877890|20765784|P2|Intent to Treat (ITT)|Overall Study||123
8425906|NCT00877890|20765785|P1|Intent to Treat (ITT)|Overall Study||129
8425907|NCT00877890|20765784|P2|STARTED|Overall Study||125
8425908|NCT00877890|20765785|P1|STARTED|Overall Study||129
8425909|NCT00877877|20765819|P1|NOT COMPLETED|Year 10||0
8425910|NCT00877877|20765819|P1|COMPLETED|Year 10||495
8425911|NCT00877877|20765819|P1|STARTED|Year 10||495
8425912|NCT00877877|20765819|P1|NOT COMPLETED|Year 9||0
8425913|NCT00877877|20765819|P1|COMPLETED|Year 9||507
8425914|NCT00877877|20765819|P1|STARTED|Year 9||507
8425915|NCT00877877|20765819|P1|NOT COMPLETED|Year 8||0
8425916|NCT00877877|20765819|P1|COMPLETED|Year 8||522
8425917|NCT00877877|20765819|P1|STARTED|Year 8||522
8425918|NCT00877877|20765819|P1|NOT COMPLETED|Year 7||0
8425919|NCT00877877|20765819|P1|COMPLETED|Year 7||523
8425920|NCT00877877|20765819|P1|STARTED|Year 7||523
8425921|NCT00877877|20765819|P1|NOT COMPLETED|Year 6||0
8425922|NCT00877877|20765819|P1|COMPLETED|Year 6||529
8425923|NCT00877877|20765819|P1|STARTED|Year 6||529
8425924|NCT00877877|20765819|P1|NOT COMPLETED|Year 5||0
8425925|NCT00877877|20765819|P1|COMPLETED|Year 5||397
8425926|NCT00877877|20765819|P1|STARTED|Year 5||397
8425927|NCT00877799|20765850|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
8425928|NCT00877799|20765851|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
8425929|NCT00877799|20765852|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425930|NCT00877799|20765853|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425931|NCT00877799|20765854|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425932|NCT00877799|20765850|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
8425933|NCT00877799|20765851|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
8425934|NCT00877799|20765852|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425935|NCT00877799|20765853|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425936|NCT00877799|20765854|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425937|NCT00877799|20765850|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
8425938|NCT00877799|20765851|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
8425939|NCT00877799|20765852|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8425940|NCT00877799|20765853|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8425941|NCT00877799|20765854|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8425942|NCT00877799|20765850|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425943|NCT00877799|20765851|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425944|NCT00877799|20765852|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
8425945|NCT00877799|20765853|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
8425946|NCT00877799|20765854|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
8425947|NCT00877799|20765850|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425948|NCT00877799|20765851|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425949|NCT00877799|20765852|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
8425950|NCT00877799|20765853|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
8425951|NCT00877799|20765854|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
8425952|NCT00877799|20765850|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425953|NCT00877799|20765851|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425954|NCT00877799|20765852|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
8425955|NCT00877799|20765853|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
8425956|NCT00877799|20765854|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
8425957|NCT00877773|20765869|P1|NOT COMPLETED|Overall Study||44
8425958|NCT00877773|20765869|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
8425959|NCT00877773|20765869|P1|STARTED|Overall Study||44
8425960|NCT00877604|20765875|P2|NOT COMPLETED|Overall Study||3
8425961|NCT00877604|20765876|P1|NOT COMPLETED|Overall Study||2
8425962|NCT00877604|20765875|P2|COMPLETED|Overall Study||14
8425963|NCT00877604|20765876|P1|COMPLETED|Overall Study||15
8425964|NCT00877604|20765875|P2|STARTED|Overall Study||17
8425965|NCT00877604|20765876|P1|STARTED|Overall Study||17
8425966|NCT00877487|20765882|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
8425967|NCT00877487|20765883|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
8425968|NCT00877487|20765882|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
8425969|NCT00877487|20765883|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
8425970|NCT00877487|20765882|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
8425971|NCT00877487|20765883|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
8425972|NCT00877487|20765882|P2|NOT COMPLETED|Open-label Treatment Phase||0
8425973|NCT00877487|20765883|P1|NOT COMPLETED|Open-label Treatment Phase||7
8425974|NCT00877487|20765882|P2|COMPLETED|Open-label Treatment Phase||0
8425975|NCT00877487|20765883|P1|COMPLETED|Open-label Treatment Phase||116
8425976|NCT00877487|20765882|P2|STARTED|Open-label Treatment Phase||0
8425977|NCT00877487|20765883|P1|STARTED|Open-label Treatment Phase||123
8425978|NCT00877448|20765900|P7|NOT COMPLETED|Overall Study||0
8425979|NCT00877448|20765901|P6|NOT COMPLETED|Overall Study||1
8425980|NCT00877448|20765902|P5|NOT COMPLETED|Overall Study||0
8425981|NCT00877448|20765903|P4|NOT COMPLETED|Overall Study||1
8425982|NCT00877448|20765904|P3|NOT COMPLETED|Overall Study||0
8425983|NCT00877448|20765905|P2|NOT COMPLETED|Overall Study||1
8425984|NCT00877448|20765906|P1|NOT COMPLETED|Overall Study||0
8425985|NCT00877448|20765900|P7|COMPLETED|Overall Study||3
8425986|NCT00877448|20765901|P6|COMPLETED|Overall Study||9
8425987|NCT00877448|20765902|P5|COMPLETED|Overall Study||10
8425988|NCT00877448|20765903|P4|COMPLETED|Overall Study||9
8425989|NCT00877448|20765904|P3|COMPLETED|Overall Study||10
8425990|NCT00877448|20765905|P2|COMPLETED|Overall Study||9
8425991|NCT00877448|20765906|P1|COMPLETED|Overall Study||10
8425992|NCT00877448|20765900|P7|STARTED|Overall Study||3
8425993|NCT00877448|20765901|P6|STARTED|Overall Study||10
8425994|NCT00877448|20765902|P5|STARTED|Overall Study||10
8425995|NCT00877448|20765903|P4|STARTED|Overall Study||10
8425996|NCT00877448|20765904|P3|STARTED|Overall Study||10
8425997|NCT00877448|20765905|P2|STARTED|Overall Study||10
8425998|NCT00877448|20765906|P1|STARTED|Overall Study||10
8425999|NCT00877383|20765931|P2|NOT COMPLETED|Overall Study||37
8426000|NCT00877383|20765932|P1|NOT COMPLETED|Overall Study||29
8426001|NCT00877383|20765931|P2|COMPLETED|Overall Study||533
8426002|NCT00877383|20765932|P1|COMPLETED|Overall Study||543
8426003|NCT00877383|20765931|P2|STARTED|Overall Study||570
8426004|NCT00877383|20765932|P1|STARTED|Overall Study||572
8426005|NCT00877370|20765948|P1|NOT COMPLETED|Overall Study||0
8426006|NCT00877370|20765948|P1|COMPLETED|Overall Study||8
8426007|NCT00877370|20765948|P1|STARTED|Overall Study||8
8426008|NCT00877071|20765952|P1|NOT COMPLETED|Overall Study||2
8426009|NCT00877071|20765952|P1|COMPLETED|Overall Study||0
8426010|NCT00877071|20765952|P1|STARTED|Overall Study||2
8426011|NCT00877058|20765962|P3|NOT COMPLETED|Overall Study||39
8426012|NCT00877058|20765963|P2|NOT COMPLETED|Overall Study||40
8426013|NCT00877058|20765964|P1|NOT COMPLETED|Overall Study||37
8426014|NCT00877058|20765962|P3|COMPLETED|Overall Study||75
8426015|NCT00877058|20765963|P2|COMPLETED|Overall Study||131
8426016|NCT00877058|20765964|P1|COMPLETED|Overall Study||137
8426017|NCT00877058|20765962|P3|STARTED|Overall Study||114
8426018|NCT00877058|20765963|P2|STARTED|Overall Study||171
8426019|NCT00877058|20765964|P1|STARTED|Overall Study||174
8426020|NCT00877032|20765985|P7|NOT COMPLETED|Overall Study||2
8426021|NCT00877032|20765986|P6|NOT COMPLETED|Overall Study||0
8426022|NCT00877032|20765987|P5|NOT COMPLETED|Overall Study||0
8426023|NCT00877032|20765988|P4|NOT COMPLETED|Overall Study||1
8426024|NCT00877032|20765989|P3|NOT COMPLETED|Overall Study||0
8426025|NCT00877032|20765990|P2|NOT COMPLETED|Overall Study||0
8426026|NCT00877032|20765991|P1|NOT COMPLETED|Overall Study||0
8426027|NCT00877032|20765985|P7|COMPLETED|Overall Study||18
8426028|NCT00877032|20765986|P6|COMPLETED|Overall Study||6
8426029|NCT00877032|20765987|P5|COMPLETED|Overall Study||6
8426030|NCT00877032|20765988|P4|COMPLETED|Overall Study||6
8426031|NCT00877032|20765989|P3|COMPLETED|Overall Study||6
8426032|NCT00877032|20765990|P2|COMPLETED|Overall Study||6
8426033|NCT00877032|20765991|P1|COMPLETED|Overall Study||6
8426034|NCT00877032|20765985|P7|Treated|Overall Study||18
8426035|NCT00877032|20765986|P6|Treated|Overall Study||6
8426036|NCT00877032|20765987|P5|Treated|Overall Study||6
8426037|NCT00877032|20765988|P4|Treated|Overall Study||6
8426038|NCT00877032|20765989|P3|Treated|Overall Study||6
8426039|NCT00877032|20765990|P2|Treated|Overall Study||6
8426040|NCT00877032|20765991|P1|Treated|Overall Study||6
8426041|NCT00877032|20765985|P7|STARTED|Overall Study||20
8426042|NCT00877032|20765986|P6|STARTED|Overall Study||6
8426043|NCT00877032|20765987|P5|STARTED|Overall Study||6
8426044|NCT00877032|20765988|P4|STARTED|Overall Study||7
8426045|NCT00877032|20765989|P3|STARTED|Overall Study||6
8426046|NCT00877032|20765990|P2|STARTED|Overall Study||6
8426047|NCT00877032|20765991|P1|STARTED|Overall Study||6
8426048|NCT00877006|20766092|P2|NOT COMPLETED|Long-Term Follow-up Period||55
8426049|NCT00877006|20766093|P1|NOT COMPLETED|Long-Term Follow-up Period||53
8426050|NCT00877006|20766092|P2|COMPLETED|Long-Term Follow-up Period||154
8426051|NCT00877006|20766093|P1|COMPLETED|Long-Term Follow-up Period||157
8426052|NCT00877006|20766092|P2|STARTED|Long-Term Follow-up Period||209
8426053|NCT00877006|20766093|P1|STARTED|Long-Term Follow-up Period||210
8426054|NCT00877006|20766092|P2|NOT COMPLETED|Treatment Period||27
8426055|NCT00877006|20766093|P1|NOT COMPLETED|Treatment Period||25
8426056|NCT00877006|20766092|P2|COMPLETED|Treatment Period||196
8426057|NCT00877006|20766093|P1|COMPLETED|Treatment Period||199
8426058|NCT00877006|20766092|P2|STARTED|Treatment Period||223
8426059|NCT00877006|20766093|P1|STARTED|Treatment Period||224
8426060|NCT00876993|20766136|P5|NOT COMPLETED|Overall Study||2
8426061|NCT00876993|20766137|P4|NOT COMPLETED|Overall Study||0
8426062|NCT00876993|20766138|P3|NOT COMPLETED|Overall Study||2
8426063|NCT00876993|20766139|P2|NOT COMPLETED|Overall Study||0
8426064|NCT00876993|20766140|P1|NOT COMPLETED|Overall Study||1
8426065|NCT00876993|20766136|P5|COMPLETED|Overall Study||3
8426066|NCT00876993|20766137|P4|COMPLETED|Overall Study||5
8426067|NCT00876993|20766138|P3|COMPLETED|Overall Study||3
8426068|NCT00876993|20766139|P2|COMPLETED|Overall Study||6
8426069|NCT00876993|20766140|P1|COMPLETED|Overall Study||4
8426070|NCT00876993|20766136|P5|STARTED|Overall Study||5
8426071|NCT00876993|20766137|P4|STARTED|Overall Study||5
8426072|NCT00876993|20766138|P3|STARTED|Overall Study||5
8426073|NCT00876993|20766139|P2|STARTED|Overall Study||6
8426074|NCT00876993|20766140|P1|STARTED|Overall Study||5
8426075|NCT00876928|20766169|P2|NOT COMPLETED|Overall Study||5
8426076|NCT00876928|20766170|P1|NOT COMPLETED|Overall Study||3
8426077|NCT00876928|20766169|P2|COMPLETED|Overall Study||56
8426078|NCT00876928|20766170|P1|COMPLETED|Overall Study||53
8426079|NCT00876928|20766169|P2|STARTED|Overall Study||61
8426080|NCT00876928|20766170|P1|STARTED|Overall Study||56
8426081|NCT00876915|20766181|P3|NOT COMPLETED|Overall Study||0
8426082|NCT00876915|20766182|P2|NOT COMPLETED|Overall Study||14
8426083|NCT00876915|20766183|P1|NOT COMPLETED|Overall Study||19
8426084|NCT00876915|20766181|P3|COMPLETED|Overall Study||101
8426085|NCT00876915|20766182|P2|COMPLETED|Overall Study||34
8426086|NCT00876915|20766183|P1|COMPLETED|Overall Study||31
8426087|NCT00876915|20766181|P3|Week 8|Overall Study||0
8426088|NCT00876915|20766182|P2|Week 8|Overall Study||36
8426089|NCT00876915|20766183|P1|Week 8|Overall Study||33
8426090|NCT00876915|20766181|P3|Week 4|Overall Study||0
8426091|NCT00876915|20766182|P2|Week 4|Overall Study||45
8426092|NCT00876915|20766183|P1|Week 4|Overall Study||38
8426093|NCT00876915|20766181|P3|STARTED|Overall Study||101
8426094|NCT00876915|20766182|P2|STARTED|Overall Study||48
8426095|NCT00876915|20766183|P1|STARTED|Overall Study||50
8426096|NCT00876733|20766207|P4|NOT COMPLETED|Overall Study||7
8426097|NCT00876733|20766208|P3|NOT COMPLETED|Overall Study||30
8426098|NCT00876733|20766209|P2|NOT COMPLETED|Overall Study||42
8426099|NCT00876733|20766210|P1|NOT COMPLETED|Overall Study||91
8426100|NCT00876733|20766207|P4|COMPLETED|Overall Study||14
8426101|NCT00876733|20766208|P3|COMPLETED|Overall Study||63
8426102|NCT00876733|20766209|P2|COMPLETED|Overall Study||161
8426103|NCT00876733|20766210|P1|COMPLETED|Overall Study||197
8426104|NCT00876733|20766207|P4|STARTED|Overall Study||21
8426105|NCT00876733|20766208|P3|STARTED|Overall Study||93
8426106|NCT00876733|20766209|P2|STARTED|Overall Study||203
8426107|NCT00876733|20766210|P1|STARTED|Overall Study||288
8426108|NCT00876694|20766318|P2|NOT COMPLETED|Overall Study||12
8426109|NCT00876694|20766319|P1|NOT COMPLETED|Overall Study||21
8426110|NCT00876694|20766318|P2|COMPLETED|Overall Study||49
8426111|NCT00876694|20766319|P1|COMPLETED|Overall Study||104
8426112|NCT00876694|20766318|P2|STARTED|Overall Study||61
8426113|NCT00876694|20766319|P1|STARTED|Overall Study||125
8426114|NCT00876460|20766345|P8|NOT COMPLETED|Mono Therapy Phase||3
8426115|NCT00876460|20766346|P7|NOT COMPLETED|Mono Therapy Phase||1
8426116|NCT00876460|20766347|P6|NOT COMPLETED|Mono Therapy Phase||0
8426117|NCT00876460|20766348|P5|NOT COMPLETED|Mono Therapy Phase||2
8426118|NCT00876460|20766349|P4|NOT COMPLETED|Mono Therapy Phase||1
8426119|NCT00876460|20766350|P3|NOT COMPLETED|Mono Therapy Phase||0
8426120|NCT00876460|20766351|P2|NOT COMPLETED|Mono Therapy Phase||1
8426121|NCT00876460|20766352|P1|NOT COMPLETED|Mono Therapy Phase||0
8426122|NCT00876460|20766345|P8|COMPLETED|Mono Therapy Phase||0
8426123|NCT00876460|20766346|P7|COMPLETED|Mono Therapy Phase||0
8426124|NCT00876460|20766347|P6|COMPLETED|Mono Therapy Phase||0
8426125|NCT00876460|20766348|P5|COMPLETED|Mono Therapy Phase||0
8426126|NCT00876460|20766349|P4|COMPLETED|Mono Therapy Phase||0
8426127|NCT00876460|20766350|P3|COMPLETED|Mono Therapy Phase||0
8426128|NCT00876460|20766351|P2|COMPLETED|Mono Therapy Phase||0
8426129|NCT00876460|20766352|P1|COMPLETED|Mono Therapy Phase||0
8426130|NCT00876460|20766345|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
8426131|NCT00876460|20766346|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8426132|NCT00876460|20766347|P6|STARTED|Mono Therapy Phase||0
8426133|NCT00876460|20766348|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
8426134|NCT00876460|20766349|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8426135|NCT00876460|20766350|P3|STARTED|Mono Therapy Phase||0
8426136|NCT00876460|20766351|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8426137|NCT00876460|20766352|P1|STARTED|Mono Therapy Phase||0
8426138|NCT00876460|20766345|P8|NOT COMPLETED|Combination Therapy Phase||6
8426139|NCT00876460|20766346|P7|NOT COMPLETED|Combination Therapy Phase||8
8426140|NCT00876460|20766347|P6|NOT COMPLETED|Combination Therapy Phase||3
8426141|NCT00876460|20766348|P5|NOT COMPLETED|Combination Therapy Phase||7
8426142|NCT00876460|20766349|P4|NOT COMPLETED|Combination Therapy Phase||6
8426143|NCT00876460|20766350|P3|NOT COMPLETED|Combination Therapy Phase||3
8426144|NCT00876460|20766351|P2|NOT COMPLETED|Combination Therapy Phase||7
8426145|NCT00876460|20766352|P1|NOT COMPLETED|Combination Therapy Phase||3
8426146|NCT00876460|20766345|P8|COMPLETED|Combination Therapy Phase||0
8426147|NCT00876460|20766346|P7|COMPLETED|Combination Therapy Phase||0
8426148|NCT00876460|20766347|P6|COMPLETED|Combination Therapy Phase||0
8426149|NCT00876460|20766348|P5|COMPLETED|Combination Therapy Phase||0
8426150|NCT00876460|20766349|P4|COMPLETED|Combination Therapy Phase||0
8426151|NCT00876460|20766350|P3|COMPLETED|Combination Therapy Phase||0
8426152|NCT00876460|20766351|P2|COMPLETED|Combination Therapy Phase||0
8426153|NCT00876460|20766352|P1|COMPLETED|Combination Therapy Phase||0
8426154|NCT00876460|20766345|P8|STARTED|Combination Therapy Phase||6
8426155|NCT00876460|20766346|P7|STARTED|Combination Therapy Phase||8
8426156|NCT00876460|20766347|P6|STARTED|Combination Therapy Phase||3
8426157|NCT00876460|20766348|P5|STARTED|Combination Therapy Phase||7
8426158|NCT00876460|20766349|P4|STARTED|Combination Therapy Phase||6
8426159|NCT00876460|20766350|P3|STARTED|Combination Therapy Phase||3
8426160|NCT00876460|20766351|P2|STARTED|Combination Therapy Phase||7
8426161|NCT00876460|20766352|P1|STARTED|Combination Therapy Phase||3
8426162|NCT00876447|20766424|P2|NOT COMPLETED|Overall Study||81
8426163|NCT00876447|20766425|P1|NOT COMPLETED|Overall Study||80
8426164|NCT00876447|20766424|P2|COMPLETED|Overall Study||122
8426165|NCT00876447|20766425|P1|COMPLETED|Overall Study||105
8426166|NCT00876447|20766424|P2|STARTED|Overall Study||203
8426167|NCT00876447|20766425|P1|STARTED|Overall Study||185
8426168|NCT00876395|20766485|P2|NOT COMPLETED|Overall Study||239
8426169|NCT00876395|20766486|P1|NOT COMPLETED|Overall Study||480
8426170|NCT00876395|20766485|P2|COMPLETED|Overall Study||0
8426171|NCT00876395|20766486|P1|COMPLETED|Overall Study||0
8426172|NCT00876395|20766485|P2|Untreated|Overall Study||1
8426173|NCT00876395|20766486|P1|Untreated|Overall Study||8
8426174|NCT00876395|20766485|P2|STARTED|Overall Study||239
8426175|NCT00876395|20766486|P1|STARTED|Overall Study||480
8426176|NCT00876343|20766527|P3|NOT COMPLETED|Overall Study||12
8426177|NCT00876343|20766528|P2|NOT COMPLETED|Overall Study||17
8426178|NCT00876343|20766529|P1|NOT COMPLETED|Overall Study||17
8426179|NCT00876343|20766527|P3|COMPLETED|Overall Study||183
8426180|NCT00876343|20766528|P2|COMPLETED|Overall Study||180
8426181|NCT00876343|20766529|P1|COMPLETED|Overall Study||177
8426182|NCT00876343|20766527|P3|STARTED|Overall Study||195
8426183|NCT00876343|20766528|P2|STARTED|Overall Study||197
8426184|NCT00876343|20766529|P1|STARTED|Overall Study||194
8426185|NCT00876265|20766543|P1|NOT COMPLETED|Overall Study||12
8426186|NCT00876265|20766543|P1|COMPLETED|Overall Study||106
8426187|NCT00876265|20766543|P1|STARTED|Overall Study||118
8426188|NCT00876200|20766551|P2|NOT COMPLETED|Overall Study||3
8426189|NCT00876200|20766552|P1|NOT COMPLETED|Overall Study||1
8426190|NCT00876200|20766551|P2|COMPLETED|Overall Study||9
8426191|NCT00876200|20766552|P1|COMPLETED|Overall Study||8
8426192|NCT00876200|20766551|P2|STARTED|Overall Study||12
8426193|NCT00876200|20766552|P1|STARTED|Overall Study||9
8426194|NCT00876018|20766561|P3|NOT COMPLETED|Overall Study||3
8426195|NCT00876018|20766562|P2|NOT COMPLETED|Overall Study||5
8426196|NCT00876018|20766563|P1|NOT COMPLETED|Overall Study||5
8426197|NCT00876018|20766561|P3|COMPLETED|Overall Study||97
8426198|NCT00876018|20766562|P2|COMPLETED|Overall Study||95
8426199|NCT00876018|20766563|P1|COMPLETED|Overall Study||95
8426200|NCT00876018|20766561|P3|STARTED|Overall Study||100
8426201|NCT00876018|20766562|P2|STARTED|Overall Study||100
8426202|NCT00876018|20766563|P1|STARTED|Overall Study||100
8426203|NCT00875979|20766618|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
8426204|NCT00875979|20766619|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
8426205|NCT00875979|20766618|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
8426206|NCT00875979|20766619|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
8426207|NCT00875979|20766618|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
8426208|NCT00875979|20766619|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
8426209|NCT00875979|20766618|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
8426210|NCT00875979|20766619|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8426211|NCT00875979|20766618|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8426212|NCT00875979|20766619|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8426213|NCT00875979|20766618|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
8426214|NCT00875979|20766619|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
8426215|NCT00875979|20766618|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8426216|NCT00875979|20766619|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
8426217|NCT00875979|20766618|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8426218|NCT00875979|20766619|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8426219|NCT00875979|20766618|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
8426220|NCT00875979|20766619|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
8426221|NCT00875836|20766631|P2|NOT COMPLETED|Overall Study||40
8426222|NCT00875836|20766632|P1|NOT COMPLETED|Overall Study||43
8426223|NCT00875836|20766631|P2|COMPLETED|Overall Study||47
8426224|NCT00875836|20766632|P1|COMPLETED|Overall Study||45
8426225|NCT00875836|20766631|P2|STARTED|Overall Study||87
8426226|NCT00875836|20766632|P1|STARTED|Overall Study||88
8426227|NCT00875810|20766642|P1|NOT COMPLETED|Overall Study||46
8426228|NCT00875810|20766642|P1|COMPLETED|Overall Study||148
8426229|NCT00875810|20766642|P1|24 Months Follow up|Overall Study||148
8426230|NCT00875810|20766642|P1|12 Months Follow up|Overall Study||112
8426231|NCT00875810|20766642|P1|6 Months Follow up|Overall Study||80
8426232|NCT00875810|20766642|P1|3 Months Follow up|Overall Study||175
8426233|NCT00875810|20766642|P1|Discharged|Overall Study||177
8426234|NCT00875810|20766642|P1|Implanted|Overall Study||190
8426235|NCT00875810|20766642|P1|STARTED|Overall Study||194
8426236|NCT00875797|20766651|P2|NOT COMPLETED|Overall Study||3
8426237|NCT00875797|20766652|P1|NOT COMPLETED|Overall Study||6
8426238|NCT00875797|20766651|P2|COMPLETED|Overall Study||42
8426239|NCT00875797|20766652|P1|COMPLETED|Overall Study||39
8426240|NCT00875797|20766651|P2|STARTED|Overall Study||45
8426241|NCT00875797|20766652|P1|STARTED|Overall Study||45
8426242|NCT00875706|20766665|P3|NOT COMPLETED|Overall Study||0
8426243|NCT00875706|20766666|P2|NOT COMPLETED|Overall Study||0
8426244|NCT00875706|20766667|P1|NOT COMPLETED|Overall Study||1
8426245|NCT00875706|20766665|P3|COMPLETED|Overall Study||13
8426246|NCT00875706|20766666|P2|COMPLETED|Overall Study||24
8426247|NCT00875706|20766667|P1|COMPLETED|Overall Study||7
8426248|NCT00875706|20766665|P3|STARTED|Overall Study||13
8426249|NCT00875706|20766666|P2|STARTED|Overall Study||24
8426250|NCT00875706|20766667|P1|STARTED|Overall Study||8
8426251|NCT00875667|20766686|P2|NOT COMPLETED|Overall Study||73
8426252|NCT00875667|20766687|P1|NOT COMPLETED|Overall Study||170
8426253|NCT00875667|20766686|P2|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
8426254|NCT00875667|20766687|P1|COMPLETED|Overall Study||0
8426255|NCT00875667|20766686|P2|Participants Treated|Overall Study||83
8426256|NCT00875667|20766687|P1|Participants Treated|Overall Study||167
8426257|NCT00875667|20766686|P2|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
8426258|NCT00875667|20766687|P1|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
8426259|NCT00875667|20766686|P2|STARTED|Overall Study||84
8426260|NCT00875667|20766687|P1|STARTED|Overall Study||170
8426261|NCT00875641|20766788|P3|NOT COMPLETED|Overall Study||0
8426262|NCT00875641|20766789|P2|NOT COMPLETED|Overall Study||0
8426263|NCT00875641|20766790|P1|NOT COMPLETED|Overall Study||0
8426264|NCT00875641|20766788|P3|COMPLETED|Overall Study||159344
8426265|NCT00875641|20766789|P2|COMPLETED|Overall Study||173384
8426266|NCT00875641|20766790|P1|COMPLETED|Overall Study||57931
8426267|NCT00875641|20766788|P3|STARTED|Overall Study||159344
8426268|NCT00875641|20766789|P2|STARTED|Overall Study||173384
8426269|NCT00875641|20766790|P1|STARTED|Overall Study||57931
8426270|NCT00875615|20766822|P1|NOT COMPLETED|Overall Study||1
8426271|NCT00875615|20766822|P1|COMPLETED|Overall Study||10
8426272|NCT00875615|20766822|P1|STARTED|Overall Study||11
8426273|NCT00875589|20766829|P2|NOT COMPLETED|Overall Study||0
8426274|NCT00875589|20766830|P1|NOT COMPLETED|Overall Study||0
8426275|NCT00875589|20766829|P2|COMPLETED|Overall Study||11
8426276|NCT00875589|20766830|P1|COMPLETED|Overall Study||15
8426277|NCT00875589|20766829|P2|STARTED|Overall Study||11
8426278|NCT00875589|20766830|P1|STARTED|Overall Study||15
8426279|NCT00875563|20766836|P1|NOT COMPLETED|Overall Study||24
8426280|NCT00875563|20766836|P1|COMPLETED|Overall Study||18
8426281|NCT00875563|20766836|P1|STARTED|Overall Study||42
8426282|NCT00875550|20766842|P2|NOT COMPLETED|Overall Study||10
8426283|NCT00875550|20766843|P1|NOT COMPLETED|Overall Study||12
8426284|NCT00875550|20766842|P2|COMPLETED|Overall Study||76
8426285|NCT00875550|20766843|P1|COMPLETED|Overall Study||77
8426286|NCT00875550|20766842|P2|STARTED|Overall Study||86
8426287|NCT00875550|20766843|P1|STARTED|Overall Study||89
8426288|NCT00875524|20766861|P2|NOT COMPLETED|Overall Study||6
8426289|NCT00875524|20766862|P1|NOT COMPLETED|Overall Study||8
8426290|NCT00875524|20766861|P2|COMPLETED|Overall Study||54
8426291|NCT00875524|20766862|P1|COMPLETED|Overall Study||112
8426292|NCT00875524|20766861|P2|Received Vaccination 3|Overall Study||58
8426293|NCT00875524|20766862|P1|Received Vaccination 3|Overall Study||114
8426294|NCT00875524|20766861|P2|Received Vaccination 2|Overall Study||58
8426295|NCT00875524|20766862|P1|Received Vaccination 2|Overall Study||116
8426296|NCT00875524|20766861|P2|Received Vaccination 1|Overall Study||60
8426297|NCT00875524|20766862|P1|Received Vaccination 1|Overall Study||120
8426298|NCT00875524|20766861|P2|STARTED|Overall Study||60
8426299|NCT00875524|20766862|P1|STARTED|Overall Study||120
8426300|NCT00875485|20766880|P2|NOT COMPLETED|Challenge Dose Epoch||0
8426301|NCT00875485|20766881|P1|NOT COMPLETED|Challenge Dose Epoch||1
8426302|NCT00875485|20766880|P2|COMPLETED|Challenge Dose Epoch||11
8426303|NCT00875485|20766881|P1|COMPLETED|Challenge Dose Epoch||7
8426304|NCT00875485|20766880|P2|STARTED|Challenge Dose Epoch||11
8426305|NCT00875485|20766881|P1|STARTED|Challenge Dose Epoch||8
8426306|NCT00875485|20766880|P2|NOT COMPLETED|Year 15||0
8426307|NCT00875485|20766881|P1|NOT COMPLETED|Year 15||0
8426308|NCT00875485|20766880|P2|COMPLETED|Year 15||111
8426309|NCT00875485|20766881|P1|COMPLETED|Year 15||98
8426310|NCT00875485|20766880|P2|STARTED|Year 15||111
8426311|NCT00875485|20766881|P1|STARTED|Year 15||98
8426312|NCT00875485|20766880|P2|NOT COMPLETED|Year 14||0
8426313|NCT00875485|20766881|P1|NOT COMPLETED|Year 14||0
8426314|NCT00875485|20766880|P2|COMPLETED|Year 14||113
8426315|NCT00875485|20766881|P1|COMPLETED|Year 14||100
8426316|NCT00875485|20766880|P2|STARTED|Year 14||113
8426317|NCT00875485|20766881|P1|STARTED|Year 14||100
8426318|NCT00875485|20766880|P2|NOT COMPLETED|Year 13||0
8426319|NCT00875485|20766881|P1|NOT COMPLETED|Year 13||0
8426320|NCT00875485|20766880|P2|COMPLETED|Year 13||113
8426321|NCT00875485|20766881|P1|COMPLETED|Year 13||102
8426322|NCT00875485|20766880|P2|STARTED|Year 13||113
8426323|NCT00875485|20766881|P1|STARTED|Year 13||102
8426324|NCT00875485|20766880|P2|NOT COMPLETED|Year 12||0
8426325|NCT00875485|20766881|P1|NOT COMPLETED|Year 12||0
8426326|NCT00875485|20766880|P2|COMPLETED|Year 12||109
8426327|NCT00875485|20766881|P1|COMPLETED|Year 12||101
8426328|NCT00875485|20766880|P2|STARTED|Year 12||109
8426329|NCT00875485|20766881|P1|STARTED|Year 12||101
8426330|NCT00875485|20766880|P2|NOT COMPLETED|Year 11||0
8426331|NCT00875485|20766881|P1|NOT COMPLETED|Year 11||0
8426332|NCT00875485|20766880|P2|COMPLETED|Year 11||111
8426333|NCT00875485|20766881|P1|COMPLETED|Year 11||99
8426334|NCT00875485|20766880|P2|STARTED|Year 11||111
8426335|NCT00875485|20766881|P1|STARTED|Year 11||99
8426336|NCT00875433|20766921|P1|NOT COMPLETED|Overall Study||60
8426337|NCT00875433|20766921|P1|COMPLETED|Overall Study||0
8426338|NCT00875433|20766921|P1|STARTED|Overall Study|Treated|60
8426339|NCT00875420|20766951|P5|NOT COMPLETED|Overall Study||2
8426340|NCT00875420|20766952|P4|NOT COMPLETED|Overall Study||2
8426341|NCT00875420|20766953|P3|NOT COMPLETED|Overall Study||3
8426342|NCT00875420|20766954|P2|NOT COMPLETED|Overall Study||2
8426343|NCT00875420|20766955|P1|NOT COMPLETED|Overall Study||2
8426344|NCT00875420|20766951|P5|COMPLETED|Overall Study||17
8426345|NCT00875420|20766952|P4|COMPLETED|Overall Study||16
8426346|NCT00875420|20766953|P3|COMPLETED|Overall Study||18
8426347|NCT00875420|20766954|P2|COMPLETED|Overall Study||18
8426348|NCT00875420|20766955|P1|COMPLETED|Overall Study||20
8426349|NCT00875420|20766951|P5|STARTED|Overall Study||19
8426350|NCT00875420|20766952|P4|STARTED|Overall Study||18
8426351|NCT00875420|20766953|P3|STARTED|Overall Study||21
8426352|NCT00875420|20766954|P2|STARTED|Overall Study||20
8426353|NCT00875420|20766955|P1|STARTED|Overall Study||22
8426354|NCT00875394|20766985|P3|NOT COMPLETED|Overall Study||0
8426355|NCT00875394|20766986|P2|NOT COMPLETED|Overall Study||0
8426356|NCT00875394|20766987|P1|NOT COMPLETED|Overall Study||0
8426357|NCT00875394|20766985|P3|COMPLETED|Overall Study||9
8426358|NCT00875394|20766986|P2|COMPLETED|Overall Study||23
8426359|NCT00875394|20766987|P1|COMPLETED|Overall Study||36
8426360|NCT00875394|20766985|P3|STARTED|Overall Study||9
8426361|NCT00875394|20766986|P2|STARTED|Overall Study||23
8426362|NCT00875394|20766987|P1|STARTED|Overall Study||36
8426363|NCT00875329|20766995|P1|NOT COMPLETED|Overall Study||0
8426364|NCT00875329|20766995|P1|COMPLETED|Overall Study||97
8426365|NCT00875329|20766995|P1|STARTED|Overall Study||97
8426366|NCT00875277|20766999|P1|NOT COMPLETED|Overall Study||0
8426367|NCT00875277|20766999|P1|COMPLETED|Overall Study||24
8426368|NCT00875277|20766999|P1|STARTED|Overall Study||24
8426369|NCT00875212|20767080|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
8426370|NCT00875212|20767080|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
8426371|NCT00875212|20767080|P1|STARTED|CaGP and Fluoride Dentifrice||12
8426372|NCT00875212|20767080|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
8426373|NCT00875212|20767080|P1|COMPLETED|Fluoride Only Dentifrice||12
8426374|NCT00875212|20767080|P1|STARTED|Fluoride Only Dentifrice||12
8426375|NCT00875212|20767080|P1|NOT COMPLETED|CaGP Only Dentifrice||0
8426376|NCT00875212|20767080|P1|COMPLETED|CaGP Only Dentifrice||12
8426377|NCT00875212|20767080|P1|STARTED|CaGP Only Dentifrice||12
8426378|NCT00875212|20767080|P1|NOT COMPLETED|Placebo Dentifrice||0
8426379|NCT00875212|20767080|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
8426380|NCT00875212|20767080|P1|STARTED|Placebo Dentifrice||12
8426381|NCT00875056|20767094|P3|NOT COMPLETED|Overall Study||6
8426382|NCT00875056|20767095|P2|NOT COMPLETED|Overall Study||9
8426383|NCT00875056|20767096|P1|NOT COMPLETED|Overall Study||23
8426384|NCT00875056|20767094|P3|COMPLETED|Overall Study||0
8426385|NCT00875056|20767095|P2|COMPLETED|Overall Study||2
8426386|NCT00875056|20767096|P1|COMPLETED|Overall Study||16
8426387|NCT00875056|20767094|P3|STARTED|Overall Study||6
8426388|NCT00875056|20767095|P2|STARTED|Overall Study||11
8426389|NCT00875056|20767096|P1|STARTED|Overall Study||39
8426390|NCT00875017|20767122|P6|NOT COMPLETED|Fourth Intervention||1
8426391|NCT00875017|20767123|P5|NOT COMPLETED|Fourth Intervention||0
8426392|NCT00875017|20767124|P4|NOT COMPLETED|Fourth Intervention||0
8426393|NCT00875017|20767125|P3|NOT COMPLETED|Fourth Intervention||0
8426394|NCT00875017|20767126|P2|NOT COMPLETED|Fourth Intervention||0
8426395|NCT00875017|20767127|P1|NOT COMPLETED|Fourth Intervention||0
8426396|NCT00875017|20767122|P6|COMPLETED|Fourth Intervention||4
8426397|NCT00875017|20767123|P5|COMPLETED|Fourth Intervention||3
8426398|NCT00875017|20767124|P4|COMPLETED|Fourth Intervention||4
8426399|NCT00875017|20767125|P3|COMPLETED|Fourth Intervention||2
8426400|NCT00875017|20767126|P2|COMPLETED|Fourth Intervention||3
8426401|NCT00875017|20767127|P1|COMPLETED|Fourth Intervention||3
8426402|NCT00875017|20767122|P6|STARTED|Fourth Intervention||5
8426403|NCT00875017|20767123|P5|STARTED|Fourth Intervention||3
8426404|NCT00875017|20767124|P4|STARTED|Fourth Intervention||4
8426405|NCT00875017|20767125|P3|STARTED|Fourth Intervention||2
8426406|NCT00875017|20767126|P2|STARTED|Fourth Intervention||3
8426407|NCT00875017|20767127|P1|STARTED|Fourth Intervention||3
8426408|NCT00875017|20767122|P6|NOT COMPLETED|Washout||0
8426409|NCT00875017|20767123|P5|NOT COMPLETED|Washout||1
8426410|NCT00875017|20767124|P4|NOT COMPLETED|Washout||0
8426411|NCT00875017|20767125|P3|NOT COMPLETED|Washout||0
8426412|NCT00875017|20767126|P2|NOT COMPLETED|Washout||0
8426413|NCT00875017|20767127|P1|NOT COMPLETED|Washout||0
8426414|NCT00875017|20767122|P6|COMPLETED|Washout||5
8426415|NCT00875017|20767123|P5|COMPLETED|Washout||3
8426416|NCT00875017|20767124|P4|COMPLETED|Washout||4
8426417|NCT00875017|20767125|P3|COMPLETED|Washout||2
8426418|NCT00875017|20767126|P2|COMPLETED|Washout||3
8426419|NCT00875017|20767127|P1|COMPLETED|Washout||3
8426420|NCT00875017|20767122|P6|STARTED|Washout||5
8426421|NCT00875017|20767123|P5|STARTED|Washout||4
8426422|NCT00875017|20767124|P4|STARTED|Washout||4
8426423|NCT00875017|20767125|P3|STARTED|Washout||2
8426424|NCT00875017|20767126|P2|STARTED|Washout||3
8426425|NCT00875017|20767127|P1|STARTED|Washout||3
8426426|NCT00875017|20767122|P6|NOT COMPLETED|Third Intervention||0
8426427|NCT00875017|20767123|P5|NOT COMPLETED|Third Intervention||0
8426428|NCT00875017|20767124|P4|NOT COMPLETED|Third Intervention||0
8426429|NCT00875017|20767125|P3|NOT COMPLETED|Third Intervention||1
8426430|NCT00875017|20767126|P2|NOT COMPLETED|Third Intervention||1
8426431|NCT00875017|20767127|P1|NOT COMPLETED|Third Intervention||0
8426432|NCT00875017|20767122|P6|COMPLETED|Third Intervention||5
8426433|NCT00875017|20767123|P5|COMPLETED|Third Intervention||4
8426434|NCT00875017|20767124|P4|COMPLETED|Third Intervention||4
8426435|NCT00875017|20767125|P3|COMPLETED|Third Intervention||2
8426436|NCT00875017|20767126|P2|COMPLETED|Third Intervention||3
8426437|NCT00875017|20767127|P1|COMPLETED|Third Intervention||3
8426438|NCT00875017|20767122|P6|STARTED|Third Intervention||5
8426439|NCT00875017|20767123|P5|STARTED|Third Intervention||4
8426440|NCT00875017|20767124|P4|STARTED|Third Intervention||4
8426441|NCT00875017|20767125|P3|STARTED|Third Intervention||3
8426442|NCT00875017|20767126|P2|STARTED|Third Intervention||4
8426443|NCT00875017|20767127|P1|STARTED|Third Intervention||3
8426444|NCT00875017|20767122|P6|NOT COMPLETED|Washout||0
8426445|NCT00875017|20767123|P5|NOT COMPLETED|Washout||0
8426446|NCT00875017|20767124|P4|NOT COMPLETED|Washout||0
8426447|NCT00875017|20767125|P3|NOT COMPLETED|Washout||0
8426448|NCT00875017|20767126|P2|NOT COMPLETED|Washout||1
8426449|NCT00875017|20767127|P1|NOT COMPLETED|Washout||0
8426450|NCT00875017|20767122|P6|COMPLETED|Washout||5
8426451|NCT00875017|20767123|P5|COMPLETED|Washout||4
8426452|NCT00875017|20767124|P4|COMPLETED|Washout||4
8426453|NCT00875017|20767125|P3|COMPLETED|Washout||3
8426454|NCT00875017|20767126|P2|COMPLETED|Washout||4
8426455|NCT00875017|20767127|P1|COMPLETED|Washout||3
8426456|NCT00875017|20767122|P6|STARTED|Washout||5
8426457|NCT00875017|20767123|P5|STARTED|Washout||4
8426458|NCT00875017|20767124|P4|STARTED|Washout||4
8426459|NCT00875017|20767125|P3|STARTED|Washout||3
8426460|NCT00875017|20767126|P2|STARTED|Washout||5
8426461|NCT00875017|20767127|P1|STARTED|Washout||3
8426462|NCT00875017|20767122|P6|NOT COMPLETED|Second Intervention||0
8426463|NCT00875017|20767123|P5|NOT COMPLETED|Second Intervention||0
8426464|NCT00875017|20767124|P4|NOT COMPLETED|Second Intervention||1
8426465|NCT00875017|20767125|P3|NOT COMPLETED|Second Intervention||0
8426466|NCT00875017|20767126|P2|NOT COMPLETED|Second Intervention||0
8426467|NCT00875017|20767127|P1|NOT COMPLETED|Second Intervention||0
8426468|NCT00875017|20767122|P6|COMPLETED|Second Intervention||5
8426469|NCT00875017|20767123|P5|COMPLETED|Second Intervention||4
8426470|NCT00875017|20767124|P4|COMPLETED|Second Intervention||4
8426471|NCT00875017|20767125|P3|COMPLETED|Second Intervention||3
8426472|NCT00875017|20767126|P2|COMPLETED|Second Intervention||5
8426473|NCT00875017|20767127|P1|COMPLETED|Second Intervention||3
8426474|NCT00875017|20767122|P6|STARTED|Second Intervention||5
8426475|NCT00875017|20767123|P5|STARTED|Second Intervention||4
8426476|NCT00875017|20767124|P4|STARTED|Second Intervention||5
8426477|NCT00875017|20767125|P3|STARTED|Second Intervention||3
8426478|NCT00875017|20767126|P2|STARTED|Second Intervention||5
8426479|NCT00875017|20767127|P1|STARTED|Second Intervention||3
8426480|NCT00875017|20767122|P6|NOT COMPLETED|Washout||0
8426481|NCT00875017|20767123|P5|NOT COMPLETED|Washout||0
8426482|NCT00875017|20767124|P4|NOT COMPLETED|Washout||0
8426483|NCT00875017|20767125|P3|NOT COMPLETED|Washout||1
8426484|NCT00875017|20767126|P2|NOT COMPLETED|Washout||0
8426485|NCT00875017|20767127|P1|NOT COMPLETED|Washout||0
8426486|NCT00875017|20767122|P6|COMPLETED|Washout||5
8426487|NCT00875017|20767123|P5|COMPLETED|Washout||4
8426488|NCT00875017|20767124|P4|COMPLETED|Washout||5
8426489|NCT00875017|20767125|P3|COMPLETED|Washout||3
8426490|NCT00875017|20767126|P2|COMPLETED|Washout||5
8426491|NCT00875017|20767127|P1|COMPLETED|Washout||3
8426492|NCT00875017|20767122|P6|STARTED|Washout||5
8426493|NCT00875017|20767123|P5|STARTED|Washout||4
8426494|NCT00875017|20767124|P4|STARTED|Washout||5
8426495|NCT00875017|20767125|P3|STARTED|Washout||4
8426496|NCT00875017|20767126|P2|STARTED|Washout||5
8426497|NCT00875017|20767127|P1|STARTED|Washout||3
8426498|NCT00875017|20767122|P6|NOT COMPLETED|First Intervention||0
8426499|NCT00875017|20767123|P5|NOT COMPLETED|First Intervention||1
8426500|NCT00875017|20767124|P4|NOT COMPLETED|First Intervention||1
8426501|NCT00875017|20767125|P3|NOT COMPLETED|First Intervention||1
8426502|NCT00875017|20767126|P2|NOT COMPLETED|First Intervention||0
8426503|NCT00875017|20767127|P1|NOT COMPLETED|First Intervention||2
8426504|NCT00875017|20767122|P6|COMPLETED|First Intervention||5
8426505|NCT00875017|20767123|P5|COMPLETED|First Intervention||4
8426506|NCT00875017|20767124|P4|COMPLETED|First Intervention||5
8426507|NCT00875017|20767125|P3|COMPLETED|First Intervention||4
8426508|NCT00875017|20767126|P2|COMPLETED|First Intervention||5
8426509|NCT00875017|20767127|P1|COMPLETED|First Intervention||3
8426510|NCT00875017|20767122|P6|STARTED|First Intervention||5
8426511|NCT00875017|20767123|P5|STARTED|First Intervention||5
8426512|NCT00875017|20767124|P4|STARTED|First Intervention||6
8426513|NCT00875017|20767125|P3|STARTED|First Intervention||5
8426514|NCT00875017|20767126|P2|STARTED|First Intervention||5
8426515|NCT00875017|20767127|P1|STARTED|First Intervention||5
8426516|NCT00874939|20767141|P1|NOT COMPLETED|Overall Study||4
8426517|NCT00874939|20767141|P1|COMPLETED|Overall Study||0
8426518|NCT00874939|20767141|P1|Treated|Overall Study||0
8426519|NCT00874939|20767141|P1|STARTED|Overall Study||4
8426520|NCT00874887|20767157|P2|NOT COMPLETED|Overall Study||0
8426521|NCT00874887|20767158|P1|NOT COMPLETED|Overall Study||0
8426522|NCT00874887|20767157|P2|COMPLETED|Overall Study||34
8426523|NCT00874887|20767158|P1|COMPLETED|Overall Study||32
8426524|NCT00874887|20767157|P2|STARTED|Overall Study||34
8426525|NCT00874887|20767158|P1|STARTED|Overall Study||32
8426526|NCT00874848|20767174|P2|NOT COMPLETED|Overall Study||28
8426527|NCT00874848|20767175|P1|NOT COMPLETED|Overall Study||59
8426528|NCT00874848|20767174|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
8426529|NCT00874848|20767175|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
8426530|NCT00874848|20767174|P2|Discontinued|Overall Study||28
8426531|NCT00874848|20767175|P1|Discontinued|Overall Study||59
8426532|NCT00874848|20767174|P2|STARTED|Overall Study||29
8426533|NCT00874848|20767175|P1|STARTED|Overall Study||59
8426534|NCT00874822|20767191|P1|NOT COMPLETED|Overall Study||8
8426535|NCT00874822|20767191|P1|COMPLETED|Overall Study||208
8426536|NCT00874822|20767191|P1|STARTED|Overall Study||216
8426537|NCT00874770|20767199|P4|NOT COMPLETED|Overall Study||5
8426538|NCT00874770|20767200|P3|NOT COMPLETED|Overall Study||4
8426539|NCT00874770|20767201|P2|NOT COMPLETED|Overall Study||1
8426540|NCT00874770|20767202|P1|NOT COMPLETED|Overall Study||5
8426541|NCT00874770|20767199|P4|COMPLETED|Overall Study||7
8426542|NCT00874770|20767200|P3|COMPLETED|Overall Study||8
8426543|NCT00874770|20767201|P2|COMPLETED|Overall Study||11
8426544|NCT00874770|20767202|P1|COMPLETED|Overall Study||7
8426545|NCT00874770|20767199|P4|STARTED|Overall Study||12
8426546|NCT00874770|20767200|P3|STARTED|Overall Study||12
8426547|NCT00874770|20767201|P2|STARTED|Overall Study||12
8426548|NCT00874770|20767202|P1|STARTED|Overall Study||12
8426549|NCT00874731|20767236|P3|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
8426550|NCT00874731|20767237|P2|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426551|NCT00874731|20767238|P1|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426552|NCT00874731|20767236|P3|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426553|NCT00874731|20767237|P2|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426554|NCT00874731|20767238|P1|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426555|NCT00874731|20767236|P3|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
8426556|NCT00874731|20767237|P2|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
8426557|NCT00874731|20767238|P1|STARTED|Part 2: Ridaforolimus 40 mg||0
8426558|NCT00874731|20767236|P3|NOT COMPLETED|Washout Period||0
8426559|NCT00874731|20767237|P2|NOT COMPLETED|Washout Period||0
8426560|NCT00874731|20767238|P1|NOT COMPLETED|Washout Period||0
8426561|NCT00874731|20767236|P3|COMPLETED|Washout Period||0
8426562|NCT00874731|20767237|P2|COMPLETED|Washout Period||22
8426563|NCT00874731|20767238|P1|COMPLETED|Washout Period||0
8426564|NCT00874731|20767236|P3|STARTED|Washout Period||0
8426565|NCT00874731|20767237|P2|STARTED|Washout Period||22
8426566|NCT00874731|20767238|P1|STARTED|Washout Period||0
8426567|NCT00874731|20767236|P3|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426568|NCT00874731|20767237|P2|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426569|NCT00874731|20767238|P1|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426570|NCT00874731|20767236|P3|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426571|NCT00874731|20767237|P2|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
8426572|NCT00874731|20767238|P1|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426573|NCT00874731|20767236|P3|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426574|NCT00874731|20767237|P2|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
8426575|NCT00874731|20767238|P1|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
8426576|NCT00874731|20767236|P3|NOT COMPLETED|Part 1, Day 1: Placebo||0
8426577|NCT00874731|20767237|P2|NOT COMPLETED|Part 1, Day 1: Placebo||0
8426578|NCT00874731|20767238|P1|NOT COMPLETED|Part 1, Day 1: Placebo||1
8426579|NCT00874731|20767236|P3|COMPLETED|Part 1, Day 1: Placebo||0
8426580|NCT00874731|20767237|P2|COMPLETED|Part 1, Day 1: Placebo||0
8426581|NCT00874731|20767238|P1|COMPLETED|Part 1, Day 1: Placebo||22
8426582|NCT00874731|20767236|P3|STARTED|Part 1, Day 1: Placebo||0
8426583|NCT00874731|20767237|P2|STARTED|Part 1, Day 1: Placebo||0
8426584|NCT00874731|20767238|P1|STARTED|Part 1, Day 1: Placebo||23
8426585|NCT00874614|20767267|P1|NOT COMPLETED|Overall Study||58
8426586|NCT00874614|20767267|P1|COMPLETED|Overall Study|As of December 2017|16
8426587|NCT00874614|20767267|P1|Received Two Therapeutic Doses|Overall Study||50
8426588|NCT00874614|20767267|P1|Received at Least One Therapeutic Dose|Overall Study||68
8426589|NCT00874614|20767267|P1|STARTED|Overall Study||74
8426590|NCT00874549|20767279|P4|NOT COMPLETED|Overall Study||2
8426591|NCT00874549|20767280|P3|NOT COMPLETED|Overall Study||4
8426592|NCT00874549|20767281|P2|NOT COMPLETED|Overall Study||1
8426593|NCT00874549|20767282|P1|NOT COMPLETED|Overall Study||1
8426594|NCT00874549|20767279|P4|COMPLETED|Overall Study||56
8426595|NCT00874549|20767280|P3|COMPLETED|Overall Study||47
8426596|NCT00874549|20767281|P2|COMPLETED|Overall Study||55
8426597|NCT00874549|20767282|P1|COMPLETED|Overall Study||50
8426598|NCT00874549|20767279|P4|STARTED|Overall Study||58
8426599|NCT00874549|20767280|P3|STARTED|Overall Study||51
8426600|NCT00874549|20767281|P2|STARTED|Overall Study||56
8426601|NCT00874549|20767282|P1|STARTED|Overall Study||51
8426602|NCT00874510|20767350|P2|NOT COMPLETED|Year 2||0
8426603|NCT00874510|20767351|P1|NOT COMPLETED|Year 2||0
8426604|NCT00874510|20767350|P2|COMPLETED|Year 2||87
8426605|NCT00874510|20767351|P1|COMPLETED|Year 2||92
8426606|NCT00874510|20767350|P2|STARTED|Year 2||87
8426607|NCT00874510|20767351|P1|STARTED|Year 2||92
8426608|NCT00874510|20767350|P2|NOT COMPLETED|Year 1||0
8426609|NCT00874510|20767351|P1|NOT COMPLETED|Year 1||0
8426610|NCT00874510|20767350|P2|COMPLETED|Year 1||85
8426611|NCT00874510|20767351|P1|COMPLETED|Year 1||88
8426612|NCT00874510|20767350|P2|STARTED|Year 1||85
8426613|NCT00874510|20767351|P1|STARTED|Year 1||88
8426614|NCT00874497|20767359|P2|NOT COMPLETED|Overall Study||18
8426615|NCT00874497|20767360|P1|NOT COMPLETED|Overall Study||28
8426616|NCT00874497|20767359|P2|COMPLETED|Overall Study||15
8426617|NCT00874497|20767360|P1|COMPLETED|Overall Study||23
8426618|NCT00874497|20767359|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
8426619|NCT00874497|20767360|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
8426620|NCT00874432|20767402|P4|NOT COMPLETED|Overall Study||3
8426621|NCT00874432|20767403|P3|NOT COMPLETED|Overall Study||8
8426622|NCT00874432|20767404|P2|NOT COMPLETED|Overall Study||2
8426623|NCT00874432|20767405|P1|NOT COMPLETED|Overall Study||3
8426624|NCT00874432|20767402|P4|COMPLETED|Overall Study||11
8426625|NCT00874432|20767403|P3|COMPLETED|Overall Study||9
8426626|NCT00874432|20767404|P2|COMPLETED|Overall Study||2
8426627|NCT00874432|20767405|P1|COMPLETED|Overall Study||5
8426628|NCT00874432|20767402|P4|STARTED|Overall Study||14
8426629|NCT00874432|20767403|P3|STARTED|Overall Study||17
8426630|NCT00874432|20767404|P2|STARTED|Overall Study||4
8426631|NCT00874432|20767405|P1|STARTED|Overall Study||8
8426632|NCT00874276|20767423|P2|NOT COMPLETED|Overall Study||1
8426633|NCT00874276|20767424|P1|NOT COMPLETED|Overall Study||1
8426634|NCT00874276|20767423|P2|COMPLETED|Overall Study||7
8426635|NCT00874276|20767424|P1|COMPLETED|Overall Study||5
8426636|NCT00874276|20767423|P2|STARTED|Overall Study||8
8426637|NCT00874276|20767424|P1|STARTED|Overall Study||6
8426638|NCT00874250|20767432|P1|NOT COMPLETED|Overall Study||51
8426639|NCT00874250|20767432|P1|COMPLETED|Overall Study||0
8426640|NCT00874250|20767432|P1|STARTED|Overall Study||51
8426641|NCT00874237|20767444|P6|NOT COMPLETED|Overall Study||0
8426642|NCT00874237|20767445|P5|NOT COMPLETED|Overall Study||0
8426643|NCT00874237|20767446|P4|NOT COMPLETED|Overall Study||0
8426644|NCT00874237|20767447|P3|NOT COMPLETED|Overall Study||1
8426645|NCT00874237|20767448|P2|NOT COMPLETED|Overall Study||1
8426646|NCT00874237|20767449|P1|NOT COMPLETED|Overall Study||0
8426647|NCT00874237|20767444|P6|COMPLETED|Overall Study||8
8426648|NCT00874237|20767445|P5|COMPLETED|Overall Study||8
8426649|NCT00874237|20767446|P4|COMPLETED|Overall Study||8
8426650|NCT00874237|20767447|P3|COMPLETED|Overall Study||7
8426651|NCT00874237|20767448|P2|COMPLETED|Overall Study||7
8426652|NCT00874237|20767449|P1|COMPLETED|Overall Study||8
8426653|NCT00874237|20767444|P6|STARTED|Overall Study||8
8426654|NCT00874237|20767445|P5|STARTED|Overall Study||8
8426655|NCT00874237|20767446|P4|STARTED|Overall Study||8
8426656|NCT00874237|20767447|P3|STARTED|Overall Study||8
8426657|NCT00874237|20767448|P2|STARTED|Overall Study||8
8426658|NCT00874237|20767449|P1|STARTED|Overall Study||8
8426659|NCT00874120|20767467|P2|NOT COMPLETED|Second Intervention||0
8426660|NCT00874120|20767468|P1|NOT COMPLETED|Second Intervention||2
8426661|NCT00874120|20767467|P2|COMPLETED|Second Intervention||56
8426662|NCT00874120|20767468|P1|COMPLETED|Second Intervention||50
8426663|NCT00874120|20767467|P2|STARTED|Second Intervention||56
8426664|NCT00874120|20767468|P1|STARTED|Second Intervention||52
8426665|NCT00874120|20767467|P2|NOT COMPLETED|Wash-out Period||0
8426666|NCT00874120|20767468|P1|NOT COMPLETED|Wash-out Period||0
8426667|NCT00874120|20767467|P2|COMPLETED|Wash-out Period||56
8426668|NCT00874120|20767468|P1|COMPLETED|Wash-out Period||52
8426669|NCT00874120|20767467|P2|STARTED|Wash-out Period||56
8426670|NCT00874120|20767468|P1|STARTED|Wash-out Period||52
8426671|NCT00874120|20767467|P2|NOT COMPLETED|First Intervention||2
8426672|NCT00874120|20767468|P1|NOT COMPLETED|First Intervention||6
8426673|NCT00874120|20767467|P2|COMPLETED|First Intervention||56
8426674|NCT00874120|20767468|P1|COMPLETED|First Intervention||52
8426675|NCT00874120|20767467|P2|STARTED|First Intervention||58
8426676|NCT00874120|20767468|P1|STARTED|First Intervention||58
8426677|NCT00874094|20767474|P1|NOT COMPLETED|Overall Study||0
8426678|NCT00874094|20767474|P1|COMPLETED|Overall Study||15
8426679|NCT00874094|20767474|P1|STARTED|Overall Study||15
8426680|NCT00874029|20767481|P1|NOT COMPLETED|Overall Study||21
8426681|NCT00874029|20767481|P1|COMPLETED|Overall Study||116
8426682|NCT00874029|20767481|P1|STARTED|Overall Study||137
8426683|NCT00873912|20767497|P2|NOT COMPLETED|Overall Study||0
8426684|NCT00873912|20767498|P1|NOT COMPLETED|Overall Study||3
8426685|NCT00873912|20767497|P2|COMPLETED|Overall Study||60
8426686|NCT00873912|20767498|P1|COMPLETED|Overall Study||237
8426687|NCT00873912|20767497|P2|STARTED|Overall Study||60
8426688|NCT00873912|20767498|P1|STARTED|Overall Study||240
8426689|NCT00873873|20767516|P4|NOT COMPLETED|Overall Study||0
8426690|NCT00873873|20767517|P3|NOT COMPLETED|Overall Study||0
8426691|NCT00873873|20767518|P2|NOT COMPLETED|Overall Study||0
8426692|NCT00873873|20767519|P1|NOT COMPLETED|Overall Study||0
8426693|NCT00873873|20767516|P4|COMPLETED|Overall Study||18
8426694|NCT00873873|20767517|P3|COMPLETED|Overall Study||9
8426695|NCT00873873|20767518|P2|COMPLETED|Overall Study||8
8426696|NCT00873873|20767519|P1|COMPLETED|Overall Study||20
8426697|NCT00873873|20767516|P4|STARTED|Overall Study||18
8426698|NCT00873873|20767517|P3|STARTED|Overall Study||9
8426699|NCT00873873|20767518|P2|STARTED|Overall Study||8
8426700|NCT00873873|20767519|P1|STARTED|Overall Study||20
8426701|NCT00873860|20767537|P4|NOT COMPLETED|Overall Study||1
8426702|NCT00873860|20767538|P3|NOT COMPLETED|Overall Study||3
8426703|NCT00873860|20767539|P2|NOT COMPLETED|Overall Study||0
8426704|NCT00873860|20767540|P1|NOT COMPLETED|Overall Study||4
8426705|NCT00873860|20767537|P4|COMPLETED|Overall Study||47
8426706|NCT00873860|20767538|P3|COMPLETED|Overall Study||48
8426707|NCT00873860|20767539|P2|COMPLETED|Overall Study||47
8426708|NCT00873860|20767540|P1|COMPLETED|Overall Study||44
8426709|NCT00873860|20767537|P4|Treated|Overall Study||48
8426710|NCT00873860|20767538|P3|Treated|Overall Study||51
8426711|NCT00873860|20767539|P2|Treated|Overall Study||47
8426712|NCT00873860|20767540|P1|Treated|Overall Study||47
8426713|NCT00873860|20767537|P4|STARTED|Overall Study||48
8426714|NCT00873860|20767538|P3|STARTED|Overall Study||51
8426715|NCT00873860|20767539|P2|STARTED|Overall Study||47
8426716|NCT00873860|20767540|P1|STARTED|Overall Study||48
8426717|NCT00873821|20767611|P2|NOT COMPLETED|Overall Study||0
8426718|NCT00873821|20767612|P1|NOT COMPLETED|Overall Study||0
8426719|NCT00873821|20767611|P2|COMPLETED|Overall Study||22
8426720|NCT00873821|20767612|P1|COMPLETED|Overall Study||22
8426721|NCT00873821|20767611|P2|STARTED|Overall Study||22
8426722|NCT00873821|20767612|P1|STARTED|Overall Study||22
8426723|NCT00873782|20767622|P1|NOT COMPLETED|Overall Study||0
8426724|NCT00873782|20767622|P1|COMPLETED|Overall Study||16
8426725|NCT00873782|20767622|P1|STARTED|Overall Study||16
8426726|NCT00873730|20767628|P2|NOT COMPLETED|Overall Study||5
8426727|NCT00873730|20767629|P1|NOT COMPLETED|Overall Study||6
8426728|NCT00873730|20767628|P2|COMPLETED|Overall Study||49
8426729|NCT00873730|20767629|P1|COMPLETED|Overall Study||48
8426730|NCT00873730|20767628|P2|STARTED|Overall Study||54
8426731|NCT00873730|20767629|P1|STARTED|Overall Study||54
8426732|NCT00873457|20767665|P1|NOT COMPLETED|Overall Study||0
8426733|NCT00873457|20767665|P1|COMPLETED|Overall Study||16
8426734|NCT00873457|20767665|P1|STARTED|Overall Study||16
8426735|NCT00873366|20767672|P1|NOT COMPLETED|Overall Study||6
8426736|NCT00873366|20767672|P1|COMPLETED|Overall Study||71
8426737|NCT00873366|20767672|P1|STARTED|Overall Study||77
8426738|NCT00873327|20767691|P1|NOT COMPLETED|Overall Study||0
8426739|NCT00873327|20767691|P1|COMPLETED|Overall Study||32
8426740|NCT00873327|20767691|P1|STARTED|Overall Study||32
8426741|NCT00873119|20767697|P2|NOT COMPLETED|Overall Study||26
8426742|NCT00873119|20767698|P1|NOT COMPLETED|Overall Study||44
8426743|NCT00873119|20767697|P2|COMPLETED|Overall Study||19
8426744|NCT00873119|20767698|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
8426745|NCT00873119|20767697|P2|STARTED|Overall Study||45
8426746|NCT00873119|20767698|P1|STARTED|Overall Study||44
8426747|NCT00873093|20767719|P5|NOT COMPLETED|Overall Study||2
8426748|NCT00873093|20767720|P4|NOT COMPLETED|Overall Study||11
8426749|NCT00873093|20767721|P3|NOT COMPLETED|Overall Study||16
8426750|NCT00873093|20767722|P2|NOT COMPLETED|Overall Study||27
8426751|NCT00873093|20767723|P1|NOT COMPLETED|Overall Study||1
8426752|NCT00873093|20767719|P5|COMPLETED|Overall Study||8
8426753|NCT00873093|20767720|P4|COMPLETED|Overall Study||12
8426754|NCT00873093|20767721|P3|COMPLETED|Overall Study||33
8426755|NCT00873093|20767722|P2|COMPLETED|Overall Study||35
8426756|NCT00873093|20767723|P1|COMPLETED|Overall Study||3
8426757|NCT00873093|20767719|P5|STARTED|Overall Study||10
8426758|NCT00873093|20767720|P4|STARTED|Overall Study||23
8426759|NCT00873093|20767721|P3|STARTED|Overall Study||49
8426760|NCT00873093|20767722|P2|STARTED|Overall Study||62
8426761|NCT00873093|20767723|P1|STARTED|Overall Study||4
8426762|NCT00873041|20767780|P3|NOT COMPLETED|Extension Study||2
8426763|NCT00873041|20767781|P2|NOT COMPLETED|Extension Study||0
8426764|NCT00873041|20767782|P1|NOT COMPLETED|Extension Study||1
8426765|NCT00873041|20767780|P3|COMPLETED|Extension Study||46
8426766|NCT00873041|20767781|P2|COMPLETED|Extension Study||44
8426767|NCT00873041|20767782|P1|COMPLETED|Extension Study||40
8426768|NCT00873041|20767780|P3|STARTED|Extension Study||48
8426769|NCT00873041|20767781|P2|STARTED|Extension Study||44
8426770|NCT00873041|20767782|P1|STARTED|Extension Study||41
8426771|NCT00873041|20767780|P3|NOT COMPLETED|Core Study||5
8426772|NCT00873041|20767781|P2|NOT COMPLETED|Core Study||6
8426773|NCT00873041|20767782|P1|NOT COMPLETED|Core Study||7
8426774|NCT00873041|20767780|P3|COMPLETED|Core Study||51
8426775|NCT00873041|20767781|P2|COMPLETED|Core Study||49
8426776|NCT00873041|20767782|P1|COMPLETED|Core Study||48
8426777|NCT00873041|20767780|P3|STARTED|Core Study||56
8426778|NCT00873041|20767781|P2|STARTED|Core Study||55
8426779|NCT00873041|20767782|P1|STARTED|Core Study||55
8426780|NCT00873015|20767840|P4|NOT COMPLETED|Overall Study||0
8426781|NCT00873015|20767841|P3|NOT COMPLETED|Overall Study||0
8426782|NCT00873015|20767842|P2|NOT COMPLETED|Overall Study||1
8426783|NCT00873015|20767843|P1|NOT COMPLETED|Overall Study||0
8426784|NCT00873015|20767840|P4|COMPLETED|Overall Study||3
8426785|NCT00873015|20767841|P3|COMPLETED|Overall Study||3
8426786|NCT00873015|20767842|P2|COMPLETED|Overall Study||3
8426787|NCT00873015|20767843|P1|COMPLETED|Overall Study||9
8426788|NCT00873015|20767840|P4|STARTED|Overall Study||3
8426789|NCT00873015|20767841|P3|STARTED|Overall Study||3
8426790|NCT00873015|20767842|P2|STARTED|Overall Study||4
8426791|NCT00873015|20767843|P1|STARTED|Overall Study||9
8426792|NCT00872989|20767860|P2|NOT COMPLETED|Overall Study||63
8426793|NCT00872989|20767861|P1|NOT COMPLETED|Overall Study||65
8426794|NCT00872989|20767860|P2|COMPLETED|Overall Study||0
8426795|NCT00872989|20767861|P1|COMPLETED|Overall Study||1
8426796|NCT00872989|20767860|P2|STARTED|Overall Study||63
8426797|NCT00872989|20767861|P1|STARTED|Overall Study||66
8426798|NCT00872898|20767880|P2|NOT COMPLETED|Part Two - Double Blind||6
8426799|NCT00872898|20767881|P1|NOT COMPLETED|Part Two - Double Blind||11
8426800|NCT00872898|20767880|P2|COMPLETED|Part Two - Double Blind||54
8426801|NCT00872898|20767881|P1|COMPLETED|Part Two - Double Blind||50
8426802|NCT00872898|20767880|P2|STARTED|Part Two - Double Blind||60
8426803|NCT00872898|20767881|P1|STARTED|Part Two - Double Blind||61
8426804|NCT00872898|20767880|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
8426805|NCT00872898|20767881|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
8426806|NCT00872898|20767880|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
8426807|NCT00872898|20767881|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
8426808|NCT00872898|20767880|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
8426809|NCT00872898|20767881|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
8426810|NCT00872833|20767915|P2|NOT COMPLETED|Overall Study||0
8426811|NCT00872833|20767916|P1|NOT COMPLETED|Overall Study||0
8426812|NCT00872833|20767915|P2|COMPLETED|Overall Study||17
8426813|NCT00872833|20767916|P1|COMPLETED|Overall Study||15
8426814|NCT00872833|20767915|P2|STARTED|Overall Study||17
8426815|NCT00872833|20767916|P1|STARTED|Overall Study||15
8426816|NCT00872729|20767925|P1|NOT COMPLETED|Overall Study||0
8426817|NCT00872729|20767925|P1|COMPLETED|Overall Study||9
8426818|NCT00872729|20767925|P1|STARTED|Overall Study||9
8426819|NCT00872599|20767955|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
8426820|NCT00872599|20767956|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
8426821|NCT00872599|20767955|P2|COMPLETED|Second Drug During High Salt Intake||16
8426822|NCT00872599|20767956|P1|COMPLETED|Second Drug During High Salt Intake||15
8426823|NCT00872599|20767955|P2|STARTED|Second Drug During High Salt Intake||16
8426824|NCT00872599|20767956|P1|STARTED|Second Drug During High Salt Intake||15
8426825|NCT00872599|20767955|P2|NOT COMPLETED|Second Washout Period||1
8426826|NCT00872599|20767956|P1|NOT COMPLETED|Second Washout Period||1
8426827|NCT00872599|20767955|P2|COMPLETED|Second Washout Period||16
8426828|NCT00872599|20767956|P1|COMPLETED|Second Washout Period||15
8426829|NCT00872599|20767955|P2|STARTED|Second Washout Period||17
8426830|NCT00872599|20767956|P1|STARTED|Second Washout Period||16
8426831|NCT00872599|20767955|P2|NOT COMPLETED|First Drug During High Salt Intake||0
8426832|NCT00872599|20767956|P1|NOT COMPLETED|First Drug During High Salt Intake||0
8426833|NCT00872599|20767955|P2|COMPLETED|First Drug During High Salt Intake||17
8426834|NCT00872599|20767956|P1|COMPLETED|First Drug During High Salt Intake||16
8426835|NCT00872599|20767955|P2|STARTED|First Drug During High Salt Intake||17
8426836|NCT00872599|20767956|P1|STARTED|First Drug During High Salt Intake||16
8426837|NCT00872599|20767955|P2|NOT COMPLETED|First Washout Period After Low Salt||0
8426838|NCT00872599|20767956|P1|NOT COMPLETED|First Washout Period After Low Salt||0
8426839|NCT00872599|20767955|P2|COMPLETED|First Washout Period After Low Salt||17
8426840|NCT00872599|20767956|P1|COMPLETED|First Washout Period After Low Salt||16
8426841|NCT00872599|20767955|P2|STARTED|First Washout Period After Low Salt||17
8426842|NCT00872599|20767956|P1|STARTED|First Washout Period After Low Salt||16
8426843|NCT00872534|20767966|P2|NOT COMPLETED|Overall Study||3
8426844|NCT00872534|20767967|P1|NOT COMPLETED|Overall Study||3
8426845|NCT00872534|20767966|P2|COMPLETED|Overall Study||101
8426846|NCT00872534|20767967|P1|COMPLETED|Overall Study||97
8426847|NCT00872534|20767966|P2|STARTED|Overall Study||104
8426848|NCT00872534|20767967|P1|STARTED|Overall Study||100
8426849|NCT00872521|20767976|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
8426850|NCT00872521|20767977|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
8426851|NCT00872521|20767978|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
8426852|NCT00872521|20767976|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
8426853|NCT00872521|20767977|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
8426854|NCT00872521|20767978|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
8426855|NCT00872521|20767976|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
8426856|NCT00872521|20767977|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
8426857|NCT00872521|20767978|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
8426858|NCT00872521|20767976|P3|NOT COMPLETED|Completed 3-month Follow up||0
8426859|NCT00872521|20767977|P2|NOT COMPLETED|Completed 3-month Follow up||3
8426860|NCT00872521|20767978|P1|NOT COMPLETED|Completed 3-month Follow up||0
8426861|NCT00872521|20767976|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
8426862|NCT00872521|20767977|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
8426863|NCT00872521|20767978|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
8426864|NCT00872521|20767976|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
8426865|NCT00872521|20767977|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
8426866|NCT00872521|20767978|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
8426867|NCT00872521|20767976|P3|NOT COMPLETED|Primary Endpoint Analysis||1
8426868|NCT00872521|20767977|P2|NOT COMPLETED|Primary Endpoint Analysis||5
8426869|NCT00872521|20767978|P1|NOT COMPLETED|Primary Endpoint Analysis||1
8426870|NCT00872521|20767976|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
8426871|NCT00872521|20767977|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
8426872|NCT00872521|20767978|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
8426873|NCT00872521|20767976|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
8426874|NCT00872521|20767977|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
8426875|NCT00872521|20767978|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
8426876|NCT00872521|20767976|P3|NOT COMPLETED|Completed PAD Induction||0
8426877|NCT00872521|20767977|P2|NOT COMPLETED|Completed PAD Induction||4
8426878|NCT00872521|20767978|P1|NOT COMPLETED|Completed PAD Induction||5
8426879|NCT00872521|20767976|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
8426880|NCT00872521|20767977|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
8426881|NCT00872521|20767978|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
8426882|NCT00872521|20767976|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
8426883|NCT00872521|20767977|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
8426884|NCT00872521|20767978|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
8426885|NCT00872430|20768026|P2|NOT COMPLETED|Second Intervention||0
8426886|NCT00872430|20768027|P1|NOT COMPLETED|Second Intervention||0
8426887|NCT00872430|20768026|P2|COMPLETED|Second Intervention||10
8426888|NCT00872430|20768027|P1|COMPLETED|Second Intervention||10
8426889|NCT00872430|20768026|P2|STARTED|Second Intervention||10
8426890|NCT00872430|20768027|P1|STARTED|Second Intervention||10
8426891|NCT00872430|20768026|P2|NOT COMPLETED|Washout Period||0
8426892|NCT00872430|20768027|P1|NOT COMPLETED|Washout Period||0
8426893|NCT00872430|20768026|P2|COMPLETED|Washout Period||10
8426894|NCT00872430|20768027|P1|COMPLETED|Washout Period||10
8426895|NCT00872430|20768026|P2|STARTED|Washout Period||10
8426896|NCT00872430|20768027|P1|STARTED|Washout Period||10
8426897|NCT00872430|20768026|P2|NOT COMPLETED|First Intervention||0
8426898|NCT00872430|20768027|P1|NOT COMPLETED|First Intervention||0
8426899|NCT00872430|20768026|P2|COMPLETED|First Intervention||10
8426900|NCT00872430|20768027|P1|COMPLETED|First Intervention||10
8426901|NCT00872430|20768026|P2|STARTED|First Intervention||10
8426902|NCT00872430|20768027|P1|STARTED|First Intervention||10
8426903|NCT00872339|20768036|P3|NOT COMPLETED|Overall Study||0
8426904|NCT00872339|20768037|P2|NOT COMPLETED|Overall Study||0
8426905|NCT00872339|20768038|P1|NOT COMPLETED|Overall Study||0
8426906|NCT00872339|20768036|P3|COMPLETED|Overall Study||37
8426907|NCT00872339|20768037|P2|COMPLETED|Overall Study||14
8426908|NCT00872339|20768038|P1|COMPLETED|Overall Study||201
8426909|NCT00872339|20768036|P3|STARTED|Overall Study||37
8426910|NCT00872339|20768037|P2|STARTED|Overall Study||14
8426911|NCT00872339|20768038|P1|STARTED|Overall Study||201
8426912|NCT00872170|20768049|P2|NOT COMPLETED|Overall Study||0
8426913|NCT00872170|20768050|P1|NOT COMPLETED|Overall Study||1
8426914|NCT00872170|20768049|P2|COMPLETED|Overall Study||13
8426915|NCT00872170|20768050|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
8426916|NCT00872170|20768049|P2|STARTED|Overall Study||13
8426917|NCT00872170|20768050|P1|STARTED|Overall Study||14
8426918|NCT00872079|20768065|P1|NOT COMPLETED|Overall Study||0
8426919|NCT00872079|20768065|P1|COMPLETED|Overall Study||175
8426920|NCT00872079|20768065|P1|STARTED|Overall Study||175
8426921|NCT00872027|20768071|P2|NOT COMPLETED|Overall Study||0
8426922|NCT00872027|20768072|P1|NOT COMPLETED|Overall Study||0
8426923|NCT00872027|20768071|P2|COMPLETED|Overall Study||8
8426924|NCT00872027|20768072|P1|COMPLETED|Overall Study||7
8426925|NCT00872027|20768071|P2|STARTED|Overall Study||8
8426926|NCT00872027|20768072|P1|STARTED|Overall Study||7
8426927|NCT00872001|20768080|P2|NOT COMPLETED|Overall Study||131
8426928|NCT00872001|20768081|P1|NOT COMPLETED|Overall Study||136
8426929|NCT00872001|20768080|P2|COMPLETED|Overall Study||1413
8426930|NCT00872001|20768081|P1|COMPLETED|Overall Study||1400
8426931|NCT00872001|20768080|P2|STARTED|Overall Study||1544
8426932|NCT00872001|20768081|P1|STARTED|Overall Study||1536
8426933|NCT00871975|20768089|P1|NOT COMPLETED|Overall Study||22
8426934|NCT00871975|20768089|P1|COMPLETED|Overall Study||133
8426935|NCT00871975|20768089|P1|STARTED|Overall Study||155
8426936|NCT00871871|20768095|P4|NOT COMPLETED|Part II||4
8426937|NCT00871871|20768096|P3|NOT COMPLETED|Part II||4
8426938|NCT00871871|20768097|P2|NOT COMPLETED|Part II||0
8426939|NCT00871871|20768098|P1|NOT COMPLETED|Part II||0
8426940|NCT00871871|20768095|P4|COMPLETED|Part II||11
8426941|NCT00871871|20768096|P3|COMPLETED|Part II||9
8426942|NCT00871871|20768097|P2|COMPLETED|Part II||0
8426943|NCT00871871|20768098|P1|COMPLETED|Part II||0
8426944|NCT00871871|20768095|P4|STARTED|Part II||15
8426945|NCT00871871|20768096|P3|STARTED|Part II||13
8426946|NCT00871871|20768097|P2|STARTED|Part II||0
8426947|NCT00871871|20768098|P1|STARTED|Part II||0
8426948|NCT00871871|20768095|P4|NOT COMPLETED|Part I||0
8426949|NCT00871871|20768096|P3|NOT COMPLETED|Part I||0
8426950|NCT00871871|20768097|P2|NOT COMPLETED|Part I||3
8426951|NCT00871871|20768098|P1|NOT COMPLETED|Part I||3
8426952|NCT00871871|20768095|P4|COMPLETED|Part I||0
8426953|NCT00871871|20768096|P3|COMPLETED|Part I||0
8426954|NCT00871871|20768097|P2|COMPLETED|Part I||15
8426955|NCT00871871|20768098|P1|COMPLETED|Part I||15
8426956|NCT00871871|20768095|P4|STARTED|Part I||0
8426957|NCT00871871|20768096|P3|STARTED|Part I||0
8426958|NCT00871871|20768097|P2|STARTED|Part I||18
8426959|NCT00871871|20768098|P1|STARTED|Part I||18
8426960|NCT00871845|20768120|P2|NOT COMPLETED|Overall Study||0
8426961|NCT00871845|20768121|P1|NOT COMPLETED|Overall Study||0
8426962|NCT00871845|20768120|P2|COMPLETED|Overall Study||25
8426963|NCT00871845|20768121|P1|COMPLETED|Overall Study||11
8426964|NCT00871845|20768120|P2|STARTED|Overall Study||25
8426965|NCT00871845|20768121|P1|STARTED|Overall Study||11
8426966|NCT00871819|20768131|P1|NOT COMPLETED|Overall Study||0
8426967|NCT00871819|20768131|P1|COMPLETED|Overall Study||20
8426968|NCT00871819|20768131|P1|STARTED|Overall Study||20
8426969|NCT00871780|20768135|P1|NOT COMPLETED|Overall Study||27
8426970|NCT00871780|20768135|P1|COMPLETED|Overall Study||197
8426971|NCT00871780|20768135|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
8426972|NCT00871780|20768135|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
8426973|NCT00871780|20768135|P1|STARTED|Overall Study|number enrolled|224
8426974|NCT00871741|20768155|P2|NOT COMPLETED|Overall Study||7
8426975|NCT00871741|20768156|P1|NOT COMPLETED|Overall Study||9
8426976|NCT00871741|20768155|P2|COMPLETED|Overall Study||0
8426977|NCT00871741|20768156|P1|COMPLETED|Overall Study||0
8426978|NCT00871741|20768155|P2|STARTED|Overall Study||7
8426979|NCT00871741|20768156|P1|STARTED|Overall Study||9
8426980|NCT00871728|20768170|P1|NOT COMPLETED|Overall Study||20
8426981|NCT00871728|20768170|P1|COMPLETED|Overall Study||112
8426982|NCT00871728|20768170|P1|Treated|Overall Study||130
8426983|NCT00871728|20768170|P1|STARTED|Overall Study||132
8426984|NCT00871715|20768183|P3|NOT COMPLETED|Overall Study||26
8426985|NCT00871715|20768184|P2|NOT COMPLETED|Overall Study||16
8426986|NCT00871715|20768185|P1|NOT COMPLETED|Overall Study||15
8426987|NCT00871715|20768183|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
8426988|NCT00871715|20768184|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
8426989|NCT00871715|20768185|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
8426990|NCT00871715|20768183|P3|6-mo Follow-up|Overall Study||112
8426991|NCT00871715|20768184|P2|6-mo Follow-up|Overall Study||113
8426992|NCT00871715|20768185|P1|6-mo Follow-up|Overall Study||110
8426993|NCT00871715|20768183|P3|Post-Intervention|Overall Study||115
8426994|NCT00871715|20768184|P2|Post-Intervention|Overall Study||115
8426995|NCT00871715|20768185|P1|Post-Intervention|Overall Study||112
8426996|NCT00871715|20768183|P3|STARTED|Overall Study||122
8426997|NCT00871715|20768184|P2|STARTED|Overall Study||120
8426998|NCT00871715|20768185|P1|STARTED|Overall Study||119
8426999|NCT00871689|20768236|P1|NOT COMPLETED|Overall Study||0
8427000|NCT00871689|20768236|P1|COMPLETED|Overall Study||2
8427001|NCT00871689|20768236|P1|STARTED|Overall Study||2
8427002|NCT00871624|20768249|P2|NOT COMPLETED|Overall Study||1
8427003|NCT00871624|20768250|P1|NOT COMPLETED|Overall Study||2
8427004|NCT00871624|20768249|P2|COMPLETED|Overall Study||17
8427005|NCT00871624|20768250|P1|COMPLETED|Overall Study||16
8427006|NCT00871624|20768249|P2|STARTED|Overall Study||18
8427007|NCT00871624|20768250|P1|STARTED|Overall Study||18
8427008|NCT00871572|20768262|P4|NOT COMPLETED|Overall Study||7
8427009|NCT00871572|20768263|P3|NOT COMPLETED|Overall Study||4
8427010|NCT00871572|20768264|P2|NOT COMPLETED|Overall Study||6
8427011|NCT00871572|20768265|P1|NOT COMPLETED|Overall Study||2
8427012|NCT00871572|20768262|P4|COMPLETED|Overall Study||19
8427013|NCT00871572|20768263|P3|COMPLETED|Overall Study||30
8427014|NCT00871572|20768264|P2|COMPLETED|Overall Study||11
8427015|NCT00871572|20768265|P1|COMPLETED|Overall Study||8
8427016|NCT00871572|20768262|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
8427017|NCT00871572|20768263|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
8427018|NCT00871572|20768264|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
8427019|NCT00871572|20768265|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
8427020|NCT00871572|20768262|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
8427021|NCT00871572|20768263|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
8427022|NCT00871572|20768264|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
8427023|NCT00871572|20768265|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
8427024|NCT00871572|20768262|P4|STARTED|Overall Study||26
8427025|NCT00871572|20768263|P3|STARTED|Overall Study||34
8427026|NCT00871572|20768264|P2|STARTED|Overall Study||17
8427027|NCT00871572|20768265|P1|STARTED|Overall Study||10
8427028|NCT00871494|20768335|P1|NOT COMPLETED|Overall Study||14
8427029|NCT00871494|20768335|P1|COMPLETED|Overall Study||62
8427030|NCT00871494|20768335|P1|STARTED|Overall Study||76
8427031|NCT00871429|20768342|P1|NOT COMPLETED|Overall Study||24
8427032|NCT00871429|20768342|P1|COMPLETED|Overall Study||75
8427033|NCT00871429|20768342|P1|STARTED|Overall Study||99
8427034|NCT00871403|20768353|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
8427035|NCT00871403|20768354|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
8427036|NCT00871403|20768355|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
8427037|NCT00871403|20768353|P3|COMPLETED|Monotherapy Treatment Phase||0
8427038|NCT00871403|20768354|P2|COMPLETED|Monotherapy Treatment Phase||0
8427039|NCT00871403|20768355|P1|COMPLETED|Monotherapy Treatment Phase||0
8427040|NCT00871403|20768353|P3|STARTED|Monotherapy Treatment Phase||1
8427041|NCT00871403|20768354|P2|STARTED|Monotherapy Treatment Phase||13
8427042|NCT00871403|20768355|P1|STARTED|Monotherapy Treatment Phase||0
8427043|NCT00871403|20768353|P3|NOT COMPLETED|Combination Treatment Phase||12
8427044|NCT00871403|20768354|P2|NOT COMPLETED|Combination Treatment Phase||49
8427045|NCT00871403|20768355|P1|NOT COMPLETED|Combination Treatment Phase||9
8427046|NCT00871403|20768353|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
8427047|NCT00871403|20768354|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
8427048|NCT00871403|20768355|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
8427049|NCT00871403|20768353|P3|STARTED|Combination Treatment Phase||35
8427050|NCT00871403|20768354|P2|STARTED|Combination Treatment Phase||62
8427051|NCT00871403|20768355|P1|STARTED|Combination Treatment Phase||9
8427052|NCT00871377|20768368|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427053|NCT00871377|20768369|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427054|NCT00871377|20768370|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
8427055|NCT00871377|20768371|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427056|NCT00871377|20768372|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427057|NCT00871377|20768373|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427058|NCT00871377|20768368|P6|COMPLETED|Third Intervention (10 Weeks)||3
8427059|NCT00871377|20768369|P5|COMPLETED|Third Intervention (10 Weeks)||4
8427060|NCT00871377|20768370|P4|COMPLETED|Third Intervention (10 Weeks)||3
8427061|NCT00871377|20768371|P3|COMPLETED|Third Intervention (10 Weeks)||3
8427062|NCT00871377|20768372|P2|COMPLETED|Third Intervention (10 Weeks)||4
8427063|NCT00871377|20768373|P1|COMPLETED|Third Intervention (10 Weeks)||2
8427064|NCT00871377|20768368|P6|STARTED|Third Intervention (10 Weeks)||3
8427065|NCT00871377|20768369|P5|STARTED|Third Intervention (10 Weeks)||4
8427066|NCT00871377|20768370|P4|STARTED|Third Intervention (10 Weeks)||4
8427067|NCT00871377|20768371|P3|STARTED|Third Intervention (10 Weeks)||3
8427068|NCT00871377|20768372|P2|STARTED|Third Intervention (10 Weeks)||4
8427069|NCT00871377|20768373|P1|STARTED|Third Intervention (10 Weeks)||2
8427070|NCT00871377|20768368|P6|NOT COMPLETED|Washout (6 Weeks)||1
8427071|NCT00871377|20768369|P5|NOT COMPLETED|Washout (6 Weeks)||0
8427072|NCT00871377|20768370|P4|NOT COMPLETED|Washout (6 Weeks)||0
8427073|NCT00871377|20768371|P3|NOT COMPLETED|Washout (6 Weeks)||0
8427074|NCT00871377|20768372|P2|NOT COMPLETED|Washout (6 Weeks)||0
8427075|NCT00871377|20768373|P1|NOT COMPLETED|Washout (6 Weeks)||0
8427076|NCT00871377|20768368|P6|COMPLETED|Washout (6 Weeks)||3
8427077|NCT00871377|20768369|P5|COMPLETED|Washout (6 Weeks)||4
8427078|NCT00871377|20768370|P4|COMPLETED|Washout (6 Weeks)||4
8427079|NCT00871377|20768371|P3|COMPLETED|Washout (6 Weeks)||3
8427080|NCT00871377|20768372|P2|COMPLETED|Washout (6 Weeks)||4
8427081|NCT00871377|20768373|P1|COMPLETED|Washout (6 Weeks)||2
8427082|NCT00871377|20768368|P6|STARTED|Washout (6 Weeks)||4
8427083|NCT00871377|20768369|P5|STARTED|Washout (6 Weeks)||4
8427084|NCT00871377|20768370|P4|STARTED|Washout (6 Weeks)||4
8427085|NCT00871377|20768371|P3|STARTED|Washout (6 Weeks)||3
8427086|NCT00871377|20768372|P2|STARTED|Washout (6 Weeks)||4
8427087|NCT00871377|20768373|P1|STARTED|Washout (6 Weeks)||2
8427088|NCT00871377|20768368|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427089|NCT00871377|20768369|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427090|NCT00871377|20768370|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427091|NCT00871377|20768371|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427092|NCT00871377|20768372|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427093|NCT00871377|20768373|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427094|NCT00871377|20768368|P6|COMPLETED|Second Intervention (10 Weeks)||4
8427095|NCT00871377|20768369|P5|COMPLETED|Second Intervention (10 Weeks)||4
8427096|NCT00871377|20768370|P4|COMPLETED|Second Intervention (10 Weeks)||4
8427097|NCT00871377|20768371|P3|COMPLETED|Second Intervention (10 Weeks)||3
8427098|NCT00871377|20768372|P2|COMPLETED|Second Intervention (10 Weeks)||4
8427099|NCT00871377|20768373|P1|COMPLETED|Second Intervention (10 Weeks)||2
8427100|NCT00871377|20768368|P6|STARTED|Second Intervention (10 Weeks)||4
8427101|NCT00871377|20768369|P5|STARTED|Second Intervention (10 Weeks)||4
8427102|NCT00871377|20768370|P4|STARTED|Second Intervention (10 Weeks)||4
8427103|NCT00871377|20768371|P3|STARTED|Second Intervention (10 Weeks)||3
8427104|NCT00871377|20768372|P2|STARTED|Second Intervention (10 Weeks)||4
8427105|NCT00871377|20768373|P1|STARTED|Second Intervention (10 Weeks)||2
8427106|NCT00871377|20768368|P6|NOT COMPLETED|Washout (6 Weeks)||0
8427107|NCT00871377|20768369|P5|NOT COMPLETED|Washout (6 Weeks)||0
8427108|NCT00871377|20768370|P4|NOT COMPLETED|Washout (6 Weeks)||0
8427109|NCT00871377|20768371|P3|NOT COMPLETED|Washout (6 Weeks)||0
8427110|NCT00871377|20768372|P2|NOT COMPLETED|Washout (6 Weeks)||0
8427111|NCT00871377|20768373|P1|NOT COMPLETED|Washout (6 Weeks)||1
8427112|NCT00871377|20768368|P6|COMPLETED|Washout (6 Weeks)||4
8427113|NCT00871377|20768369|P5|COMPLETED|Washout (6 Weeks)||4
8427114|NCT00871377|20768370|P4|COMPLETED|Washout (6 Weeks)||4
8427115|NCT00871377|20768371|P3|COMPLETED|Washout (6 Weeks)||3
8427116|NCT00871377|20768372|P2|COMPLETED|Washout (6 Weeks)||4
8427117|NCT00871377|20768373|P1|COMPLETED|Washout (6 Weeks)||2
8427118|NCT00871377|20768368|P6|STARTED|Washout (6 Weeks)||4
8427119|NCT00871377|20768369|P5|STARTED|Washout (6 Weeks)||4
8427120|NCT00871377|20768370|P4|STARTED|Washout (6 Weeks)||4
8427121|NCT00871377|20768371|P3|STARTED|Washout (6 Weeks)||3
8427122|NCT00871377|20768372|P2|STARTED|Washout (6 Weeks)||4
8427123|NCT00871377|20768373|P1|STARTED|Washout (6 Weeks)||3
8427124|NCT00871377|20768368|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
8427125|NCT00871377|20768369|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
8427126|NCT00871377|20768370|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
8427127|NCT00871377|20768371|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
8427128|NCT00871377|20768372|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
8427129|NCT00871377|20768373|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
8427130|NCT00871377|20768368|P6|COMPLETED|First Intervention (10 Weeks)||4
8427131|NCT00871377|20768369|P5|COMPLETED|First Intervention (10 Weeks)||4
8427132|NCT00871377|20768370|P4|COMPLETED|First Intervention (10 Weeks)||4
8427133|NCT00871377|20768371|P3|COMPLETED|First Intervention (10 Weeks)||3
8427134|NCT00871377|20768372|P2|COMPLETED|First Intervention (10 Weeks)||4
8427135|NCT00871377|20768373|P1|COMPLETED|First Intervention (10 Weeks)||3
8427136|NCT00871377|20768368|P6|STARTED|First Intervention (10 Weeks)||5
8427137|NCT00871377|20768369|P5|STARTED|First Intervention (10 Weeks)||4
8427138|NCT00871377|20768370|P4|STARTED|First Intervention (10 Weeks)||4
8427139|NCT00871377|20768371|P3|STARTED|First Intervention (10 Weeks)||4
8427140|NCT00871377|20768372|P2|STARTED|First Intervention (10 Weeks)||4
8427141|NCT00871377|20768373|P1|STARTED|First Intervention (10 Weeks)||3
8427142|NCT00871351|20768384|P3|NOT COMPLETED|Overall Study||0
8427143|NCT00871351|20768385|P2|NOT COMPLETED|Overall Study||1
8427144|NCT00871351|20768386|P1|NOT COMPLETED|Overall Study||4
8427145|NCT00871351|20768384|P3|COMPLETED|Overall Study||32
8427146|NCT00871351|20768385|P2|COMPLETED|Overall Study||45
8427147|NCT00871351|20768386|P1|COMPLETED|Overall Study||43
8427148|NCT00871351|20768384|P3|STARTED|Overall Study||32
8427149|NCT00871351|20768385|P2|STARTED|Overall Study||46
8427150|NCT00871351|20768386|P1|STARTED|Overall Study||47
8427151|NCT00871338|20768408|P2|NOT COMPLETED|After Booster||0
8427152|NCT00871338|20768409|P1|NOT COMPLETED|After Booster||0
8427153|NCT00871338|20768408|P2|COMPLETED|After Booster||135
8427154|NCT00871338|20768409|P1|COMPLETED|After Booster||139
8427155|NCT00871338|20768408|P2|STARTED|After Booster||135
8427156|NCT00871338|20768409|P1|STARTED|After Booster||139
8427157|NCT00871338|20768408|P2|NOT COMPLETED|Prior to Booster||3
8427158|NCT00871338|20768409|P1|NOT COMPLETED|Prior to Booster||2
8427159|NCT00871338|20768408|P2|COMPLETED|Prior to Booster||139
8427160|NCT00871338|20768409|P1|COMPLETED|Prior to Booster||140
8427161|NCT00871338|20768408|P2|STARTED|Prior to Booster||142
8427162|NCT00871338|20768409|P1|STARTED|Prior to Booster||142
8427163|NCT00871286|20768489|P2|NOT COMPLETED|Overall Study||6
8427164|NCT00871286|20768490|P1|NOT COMPLETED|Overall Study||0
8427165|NCT00871286|20768489|P2|COMPLETED|Overall Study||14
8427166|NCT00871286|20768490|P1|COMPLETED|Overall Study||20
8427167|NCT00871286|20768489|P2|STARTED|Overall Study||20
8427168|NCT00871286|20768490|P1|STARTED|Overall Study||20
8427169|NCT00871234|20768498|P1|NOT COMPLETED|Overall Study||5
8427170|NCT00871234|20768498|P1|COMPLETED|Overall Study||23
8427171|NCT00871234|20768498|P1|STARTED|Overall Study||28
8427172|NCT00871169|20768502|P1|NOT COMPLETED|Overall Study||3
8427173|NCT00871169|20768502|P1|COMPLETED|Overall Study||58
8427174|NCT00871169|20768502|P1|STARTED|Overall Study||61
8427175|NCT00871143|20768509|P2|NOT COMPLETED|Overall Study||0
8427176|NCT00871143|20768510|P1|NOT COMPLETED|Overall Study||0
8427177|NCT00871143|20768509|P2|COMPLETED|Overall Study||25
8427178|NCT00871143|20768510|P1|COMPLETED|Overall Study||21
8427179|NCT00871143|20768509|P2|STARTED|Overall Study||25
8427180|NCT00871143|20768510|P1|STARTED|Overall Study||21
8427181|NCT00871117|20768530|P2|NOT COMPLETED|Overall Study||10
8427182|NCT00871117|20768531|P1|NOT COMPLETED|Overall Study||5
8427183|NCT00871117|20768530|P2|COMPLETED|Overall Study||227
8427184|NCT00871117|20768531|P1|COMPLETED|Overall Study||234
8427185|NCT00871117|20768530|P2|STARTED|Overall Study||237
8427186|NCT00871117|20768531|P1|STARTED|Overall Study||239
8427187|NCT00871000|20768565|P2|NOT COMPLETED|Overall Study||0
8427188|NCT00871000|20768566|P1|NOT COMPLETED|Overall Study||1
8427189|NCT00871000|20768565|P2|COMPLETED|Overall Study||152
8427190|NCT00871000|20768566|P1|COMPLETED|Overall Study||150
8427191|NCT00871000|20768565|P2|STARTED|Overall Study||152
8427192|NCT00871000|20768566|P1|STARTED|Overall Study||151
8427193|NCT00870896|20768608|P1|NOT COMPLETED|Overall Study||0
8427194|NCT00870896|20768608|P1|COMPLETED|Overall Study||5
8427195|NCT00870896|20768608|P1|STARTED|Overall Study||5
8427196|NCT00870870|20768618|P4|NOT COMPLETED|Overall Study||5
8427197|NCT00870870|20768619|P3|NOT COMPLETED|Overall Study||3
8427198|NCT00870870|20768620|P2|NOT COMPLETED|Overall Study||1
8427199|NCT00870870|20768621|P1|NOT COMPLETED|Overall Study||0
8427200|NCT00870870|20768618|P4|COMPLETED|Overall Study||20
8427201|NCT00870870|20768619|P3|COMPLETED|Overall Study||26
8427202|NCT00870870|20768620|P2|COMPLETED|Overall Study||5
8427203|NCT00870870|20768621|P1|COMPLETED|Overall Study||4
8427204|NCT00870870|20768618|P4|STARTED|Overall Study||25
8427205|NCT00870870|20768619|P3|STARTED|Overall Study||29
8427206|NCT00870870|20768620|P2|STARTED|Overall Study||6
8427207|NCT00870870|20768621|P1|STARTED|Overall Study||4
8427208|NCT00870740|20768665|P6|NOT COMPLETED|Overall Study||17
8427209|NCT00870740|20768666|P5|NOT COMPLETED|Overall Study||11
8427210|NCT00870740|20768667|P4|NOT COMPLETED|Overall Study||12
8427211|NCT00870740|20768668|P3|NOT COMPLETED|Overall Study||10
8427212|NCT00870740|20768669|P2|NOT COMPLETED|Overall Study||9
8427213|NCT00870740|20768670|P1|NOT COMPLETED|Overall Study||12
8427214|NCT00870740|20768665|P6|COMPLETED|Overall Study||70
8427215|NCT00870740|20768666|P5|COMPLETED|Overall Study||77
8427216|NCT00870740|20768667|P4|COMPLETED|Overall Study||74
8427217|NCT00870740|20768668|P3|COMPLETED|Overall Study||76
8427218|NCT00870740|20768669|P2|COMPLETED|Overall Study||75
8427219|NCT00870740|20768670|P1|COMPLETED|Overall Study||74
8427220|NCT00870740|20768665|P6|STARTED|Overall Study|number randomized and dosed|87
8427221|NCT00870740|20768666|P5|STARTED|Overall Study|number randomized and dosed|88
8427222|NCT00870740|20768667|P4|STARTED|Overall Study|number randomized and dosed|86
8427223|NCT00870740|20768668|P3|STARTED|Overall Study|number randomized and dosed|86
8427224|NCT00870740|20768669|P2|STARTED|Overall Study|number randomized and dosed|84
8427225|NCT00870740|20768670|P1|STARTED|Overall Study|number randomized and dosed|86
8427226|NCT00870727|20768746|P2|NOT COMPLETED|Overall Study||5
8427227|NCT00870727|20768747|P1|NOT COMPLETED|Overall Study||1
8427228|NCT00870727|20768746|P2|COMPLETED|Overall Study||11
8427229|NCT00870727|20768747|P1|COMPLETED|Overall Study||16
8427230|NCT00870727|20768746|P2|STARTED|Overall Study||16
8427231|NCT00870727|20768747|P1|STARTED|Overall Study||17
8427232|NCT00870688|20768763|P1|NOT COMPLETED|Overall Study||4
8427233|NCT00870688|20768763|P1|COMPLETED|Overall Study||78
8427234|NCT00870688|20768763|P1|STARTED|Overall Study||82
8427235|NCT00870584|20768768|P2|NOT COMPLETED|Overall Study||13
8427236|NCT00870584|20768769|P1|NOT COMPLETED|Overall Study||16
8427237|NCT00870584|20768768|P2|COMPLETED|Overall Study||122
8427238|NCT00870584|20768769|P1|COMPLETED|Overall Study||120
8427239|NCT00870584|20768768|P2|STARTED|Overall Study||135
8427240|NCT00870584|20768769|P1|STARTED|Overall Study||136
8427241|NCT00870545|20768777|P1|NOT COMPLETED|Overall Study||17
8427242|NCT00870545|20768777|P1|COMPLETED|Overall Study||69
8427243|NCT00870545|20768777|P1|STARTED|Overall Study||86
8427244|NCT00870467|20768788|P6|NOT COMPLETED|Open-label||3
8427245|NCT00870467|20768789|P5|NOT COMPLETED|Open-label||5
8427246|NCT00870467|20768790|P4|NOT COMPLETED|Open-label||7
8427247|NCT00870467|20768791|P3|NOT COMPLETED|Open-label||13
8427248|NCT00870467|20768792|P2|NOT COMPLETED|Open-label||0
8427249|NCT00870467|20768793|P1|NOT COMPLETED|Open-label||0
8427250|NCT00870467|20768788|P6|COMPLETED|Open-label||21
8427251|NCT00870467|20768789|P5|COMPLETED|Open-label||5
8427252|NCT00870467|20768790|P4|COMPLETED|Open-label||120
8427253|NCT00870467|20768791|P3|COMPLETED|Open-label||132
8427254|NCT00870467|20768792|P2|COMPLETED|Open-label||0
8427255|NCT00870467|20768793|P1|COMPLETED|Open-label||0
8427256|NCT00870467|20768788|P6|STARTED|Open-label||24
8427257|NCT00870467|20768789|P5|STARTED|Open-label||10
8427258|NCT00870467|20768790|P4|STARTED|Open-label||127
8427259|NCT00870467|20768791|P3|STARTED|Open-label||145
8427260|NCT00870467|20768792|P2|STARTED|Open-label||0
8427261|NCT00870467|20768793|P1|STARTED|Open-label||0
8427262|NCT00870467|20768788|P6|NOT COMPLETED|Double-blind||0
8427263|NCT00870467|20768789|P5|NOT COMPLETED|Double-blind||0
8427264|NCT00870467|20768790|P4|NOT COMPLETED|Double-blind||0
8427265|NCT00870467|20768791|P3|NOT COMPLETED|Double-blind||0
8427266|NCT00870467|20768792|P2|NOT COMPLETED|Double-blind||12
8427267|NCT00870467|20768793|P1|NOT COMPLETED|Double-blind||16
8427268|NCT00870467|20768788|P6|COMPLETED|Double-blind||0
8427269|NCT00870467|20768789|P5|COMPLETED|Double-blind||0
8427270|NCT00870467|20768790|P4|COMPLETED|Double-blind||0
8427271|NCT00870467|20768791|P3|COMPLETED|Double-blind||0
8427272|NCT00870467|20768792|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
8427273|NCT00870467|20768793|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
8427274|NCT00870467|20768788|P6|STARTED|Double-blind||0
8427275|NCT00870467|20768789|P5|STARTED|Double-blind||0
8427276|NCT00870467|20768790|P4|STARTED|Double-blind||0
8427277|NCT00870467|20768791|P3|STARTED|Double-blind||0
8427278|NCT00870467|20768792|P2|STARTED|Double-blind||163
8427279|NCT00870467|20768793|P1|STARTED|Double-blind||171
8427280|NCT00870363|20768841|P4|NOT COMPLETED|Overall Study||0
8427281|NCT00870363|20768842|P3|NOT COMPLETED|Overall Study||3
8427282|NCT00870363|20768843|P2|NOT COMPLETED|Overall Study||3
8427283|NCT00870363|20768844|P1|NOT COMPLETED|Overall Study||0
8427284|NCT00870363|20768841|P4|COMPLETED|Overall Study||12
8427285|NCT00870363|20768842|P3|COMPLETED|Overall Study||8
8427286|NCT00870363|20768843|P2|COMPLETED|Overall Study||8
8427287|NCT00870363|20768844|P1|COMPLETED|Overall Study||10
8427288|NCT00870363|20768841|P4|STARTED|Overall Study||12
8427289|NCT00870363|20768842|P3|STARTED|Overall Study||11
8427290|NCT00870363|20768843|P2|STARTED|Overall Study||11
8427291|NCT00870363|20768844|P1|STARTED|Overall Study||10
8427292|NCT00870233|20768878|P1|NOT COMPLETED|Overall Study||24
8427293|NCT00870233|20768878|P1|COMPLETED|Overall Study||96
8427294|NCT00870233|20768878|P1|STARTED|Overall Study||120
8427295|NCT00870194|20768887|P2|NOT COMPLETED|Overall Study||14
8427296|NCT00870194|20768888|P1|NOT COMPLETED|Overall Study||26
8427297|NCT00870194|20768887|P2|COMPLETED|Overall Study||114
8427298|NCT00870194|20768888|P1|COMPLETED|Overall Study||101
8427299|NCT00870194|20768887|P2|Per Protocol Set|Overall Study||111
8427300|NCT00870194|20768888|P1|Per Protocol Set|Overall Study||97
8427301|NCT00870194|20768887|P2|STARTED|Overall Study||128
8427302|NCT00870194|20768888|P1|STARTED|Overall Study||127
8427303|NCT00870103|20768926|P1|NOT COMPLETED|Overall Study||4
8427304|NCT00870103|20768926|P1|COMPLETED|Overall Study||60
8427305|NCT00870103|20768926|P1|STARTED|Overall Study||64
8427306|NCT00869999|20768931|P1|NOT COMPLETED|Overall Study||2
8427307|NCT00869999|20768931|P1|COMPLETED|Overall Study||24
8427308|NCT00869999|20768931|P1|STARTED|Overall Study||26
8427309|NCT00869960|20768937|P1|NOT COMPLETED|Overall Study||2
8427310|NCT00869960|20768937|P1|COMPLETED|Overall Study||22
8427311|NCT00869960|20768937|P1|STARTED|Overall Study||24
8427312|NCT00869947|20768950|P2|NOT COMPLETED|Overall Study||0
8427313|NCT00869947|20768951|P1|NOT COMPLETED|Overall Study||0
8427314|NCT00869947|20768950|P2|COMPLETED|Overall Study||8
8427315|NCT00869947|20768951|P1|COMPLETED|Overall Study||8
8427316|NCT00869947|20768950|P2|STARTED|Overall Study||8
8427317|NCT00869947|20768951|P1|STARTED|Overall Study||8
8427318|NCT00869791|20768964|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
8427319|NCT00869791|20768965|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
8427320|NCT00869791|20768964|P2|COMPLETED|Period 2 Treatment for 7 Days||13
8427321|NCT00869791|20768965|P1|COMPLETED|Period 2 Treatment for 7 Days||14
8427322|NCT00869791|20768964|P2|STARTED|Period 2 Treatment for 7 Days||13
8427323|NCT00869791|20768965|P1|STARTED|Period 2 Treatment for 7 Days||14
8427324|NCT00869791|20768964|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
8427325|NCT00869791|20768965|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
8427326|NCT00869791|20768964|P2|COMPLETED|Period 1 Treatment for 7 Days||13
8427327|NCT00869791|20768965|P1|COMPLETED|Period 1 Treatment for 7 Days||14
8427328|NCT00869791|20768964|P2|STARTED|Period 1 Treatment for 7 Days||13
8427329|NCT00869791|20768965|P1|STARTED|Period 1 Treatment for 7 Days||14
8427330|NCT00869778|20768986|P3|NOT COMPLETED|Overall Study||10
8427331|NCT00869778|20768987|P2|NOT COMPLETED|Overall Study||7
8427332|NCT00869778|20768988|P1|NOT COMPLETED|Overall Study||12
8427333|NCT00869778|20768986|P3|COMPLETED|Overall Study||110
8427334|NCT00869778|20768987|P2|COMPLETED|Overall Study||113
8427335|NCT00869778|20768988|P1|COMPLETED|Overall Study||108
8427336|NCT00869778|20768986|P3|STARTED|Overall Study||120
8427337|NCT00869778|20768987|P2|STARTED|Overall Study||120
8427338|NCT00869778|20768988|P1|STARTED|Overall Study||120
8427339|NCT00869622|20769025|P2|NOT COMPLETED|Overall Study||14
8427340|NCT00869622|20769026|P1|NOT COMPLETED|Overall Study||13
8427341|NCT00869622|20769025|P2|COMPLETED|Overall Study||26
8427342|NCT00869622|20769026|P1|COMPLETED|Overall Study||27
8427343|NCT00869622|20769025|P2|STARTED|Overall Study||40
8427344|NCT00869622|20769026|P1|STARTED|Overall Study||40
8427345|NCT00869609|20769036|P2|NOT COMPLETED|Overall Study||3
8427346|NCT00869609|20769037|P1|NOT COMPLETED|Overall Study||6
8427347|NCT00869609|20769036|P2|COMPLETED|Overall Study||26
8427348|NCT00869609|20769037|P1|COMPLETED|Overall Study||25
8427349|NCT00869609|20769036|P2|STARTED|Overall Study||29
8427350|NCT00869609|20769037|P1|STARTED|Overall Study||31
8427351|NCT00869557|20769063|P2|NOT COMPLETED|Extension Phase||3
8427352|NCT00869557|20769064|P1|NOT COMPLETED|Extension Phase||10
8427353|NCT00869557|20769063|P2|COMPLETED|Extension Phase||11
8427354|NCT00869557|20769064|P1|COMPLETED|Extension Phase||35
8427355|NCT00869557|20769063|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
8427356|NCT00869557|20769064|P1|STARTED|Extension Phase||45
8427357|NCT00869557|20769063|P2|NOT COMPLETED|Randomized Phase||2
8427358|NCT00869557|20769064|P1|NOT COMPLETED|Randomized Phase||3
8427359|NCT00869557|20769063|P2|COMPLETED|Randomized Phase||21
8427360|NCT00869557|20769064|P1|COMPLETED|Randomized Phase||45
8427361|NCT00869557|20769063|P2|STARTED|Randomized Phase||23
8427362|NCT00869557|20769064|P1|STARTED|Randomized Phase||48
8427363|NCT00869518|20769083|P2|NOT COMPLETED|Overall Study||1
8427364|NCT00869518|20769084|P1|NOT COMPLETED|Overall Study||1
8427365|NCT00869518|20769083|P2|COMPLETED|Overall Study||5
8427366|NCT00869518|20769084|P1|COMPLETED|Overall Study||5
8427367|NCT00869518|20769083|P2|STARTED|Overall Study||6
8427368|NCT00869518|20769084|P1|STARTED|Overall Study||6
8427369|NCT00869440|20769100|P4|NOT COMPLETED|Overall Study||0
8427370|NCT00869440|20769101|P3|NOT COMPLETED|Overall Study||0
8427371|NCT00869440|20769102|P2|NOT COMPLETED|Overall Study||1
8427372|NCT00869440|20769103|P1|NOT COMPLETED|Overall Study||2
8427373|NCT00869440|20769100|P4|COMPLETED|Overall Study||25
8427374|NCT00869440|20769101|P3|COMPLETED|Overall Study||25
8427375|NCT00869440|20769102|P2|COMPLETED|Overall Study||24
8427376|NCT00869440|20769103|P1|COMPLETED|Overall Study||23
8427377|NCT00869440|20769100|P4|STARTED|Overall Study||25
8427378|NCT00869440|20769101|P3|STARTED|Overall Study||25
8427379|NCT00869440|20769102|P2|STARTED|Overall Study||25
8427380|NCT00869440|20769103|P1|STARTED|Overall Study||25
8427381|NCT00869414|20769121|P3|NOT COMPLETED|Overall Study||0
8427382|NCT00869414|20769122|P2|NOT COMPLETED|Overall Study||0
8427383|NCT00869414|20769123|P1|NOT COMPLETED|Overall Study||0
8427384|NCT00869414|20769121|P3|COMPLETED|Overall Study||0
8427385|NCT00869414|20769122|P2|COMPLETED|Overall Study||0
8427386|NCT00869414|20769123|P1|COMPLETED|Overall Study||0
8427387|NCT00869414|20769121|P3|STARTED|Overall Study||0
8427388|NCT00869414|20769122|P2|STARTED|Overall Study||0
8427389|NCT00869414|20769123|P1|STARTED|Overall Study||0
8427390|NCT00869401|20769137|P5|NOT COMPLETED|Overall Study||3
8427391|NCT00869401|20769138|P4|NOT COMPLETED|Overall Study||5
8427392|NCT00869401|20769139|P3|NOT COMPLETED|Overall Study||0
8427393|NCT00869401|20769140|P2|NOT COMPLETED|Overall Study||0
8427394|NCT00869401|20769141|P1|NOT COMPLETED|Overall Study||0
8427395|NCT00869401|20769137|P5|COMPLETED|Overall Study||63
8427396|NCT00869401|20769138|P4|COMPLETED|Overall Study||133
8427397|NCT00869401|20769139|P3|COMPLETED|Overall Study||7
8427398|NCT00869401|20769140|P2|COMPLETED|Overall Study||3
8427399|NCT00869401|20769141|P1|COMPLETED|Overall Study||3
8427400|NCT00869401|20769137|P5|STARTED|Overall Study||66
8427401|NCT00869401|20769138|P4|STARTED|Overall Study||138
8427402|NCT00869401|20769139|P3|STARTED|Overall Study||7
8427403|NCT00869401|20769140|P2|STARTED|Overall Study||3
8427404|NCT00869401|20769141|P1|STARTED|Overall Study||3
8427405|NCT00869375|20769159|P2|NOT COMPLETED|Overall Study||0
8427406|NCT00869375|20769160|P1|NOT COMPLETED|Overall Study||0
8427407|NCT00869375|20769159|P2|COMPLETED|Overall Study||3
8427408|NCT00869375|20769160|P1|COMPLETED|Overall Study||3
8427409|NCT00869375|20769159|P2|STARTED|Overall Study||3
8427410|NCT00869375|20769160|P1|STARTED|Overall Study||3
8427411|NCT00869362|20769170|P2|NOT COMPLETED|Overall Study||5
8427412|NCT00869362|20769171|P1|NOT COMPLETED|Overall Study||1
8427413|NCT00869362|20769170|P2|COMPLETED|Overall Study||11
8427414|NCT00869362|20769171|P1|COMPLETED|Overall Study||14
8427415|NCT00869362|20769170|P2|STARTED|Overall Study||16
8427416|NCT00869362|20769171|P1|STARTED|Overall Study||15
8427417|NCT00869349|20769181|P2|NOT COMPLETED|Overall Study||4
8427418|NCT00869349|20769182|P1|NOT COMPLETED|Overall Study||7
8427419|NCT00869349|20769181|P2|COMPLETED|Overall Study||36
8427420|NCT00869349|20769182|P1|COMPLETED|Overall Study||32
8427421|NCT00869349|20769181|P2|STARTED|Overall Study||40
8427422|NCT00869349|20769182|P1|STARTED|Overall Study||39
8427423|NCT00869323|20769192|P1|NOT COMPLETED|Maintenance Therapy||1
8427424|NCT00869323|20769192|P1|COMPLETED|Maintenance Therapy||1
8427425|NCT00869323|20769192|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
8427426|NCT00869323|20769192|P1|NOT COMPLETED|Induction Therapy||0
8427427|NCT00869323|20769192|P1|COMPLETED|Induction Therapy||3
8427428|NCT00869323|20769192|P1|STARTED|Induction Therapy||3
8427429|NCT00869258|20769200|P1|NOT COMPLETED|Overall Study||1
8427430|NCT00869258|20769200|P1|COMPLETED|Overall Study||31
8427431|NCT00869258|20769200|P1|STARTED|Overall Study||32
8427432|NCT00869206|20769206|P2|NOT COMPLETED|Overall Study||27
8427433|NCT00869206|20769207|P1|NOT COMPLETED|Overall Study||29
8427434|NCT00869206|20769206|P2|COMPLETED|Overall Study||884
8427435|NCT00869206|20769207|P1|COMPLETED|Overall Study||882
8427436|NCT00869206|20769206|P2|STARTED|Overall Study||911
8427437|NCT00869206|20769207|P1|STARTED|Overall Study||911
8427438|NCT00869167|20769237|P2|NOT COMPLETED|Overall Study||1
8427439|NCT00869167|20769238|P1|NOT COMPLETED|Overall Study||0
8427440|NCT00869167|20769237|P2|COMPLETED|Overall Study||0
8427441|NCT00869167|20769238|P1|COMPLETED|Overall Study||2
8427442|NCT00869167|20769237|P2|STARTED|Overall Study||1
8427443|NCT00869167|20769238|P1|STARTED|Overall Study||2
8427444|NCT00869141|20769254|P2|NOT COMPLETED|Overall Study||0
8427445|NCT00869141|20769255|P1|NOT COMPLETED|Overall Study||0
8427446|NCT00869141|20769254|P2|COMPLETED|Overall Study||26
8427447|NCT00869141|20769255|P1|COMPLETED|Overall Study||26
8427448|NCT00869141|20769254|P2|STARTED|Overall Study||26
8427449|NCT00869141|20769255|P1|STARTED|Overall Study||26
8427450|NCT00869128|20769265|P2|NOT COMPLETED|Overall Study||6
8427451|NCT00869128|20769266|P1|NOT COMPLETED|Overall Study||6
8427452|NCT00869128|20769265|P2|COMPLETED|Overall Study||12
8427453|NCT00869128|20769266|P1|COMPLETED|Overall Study||12
8427454|NCT00869128|20769265|P2|STARTED|Overall Study||18
8427455|NCT00869128|20769266|P1|STARTED|Overall Study||18
8427456|NCT00869089|20769270|P1|NOT COMPLETED|Overall Study||3
8427457|NCT00869089|20769270|P1|COMPLETED|Overall Study||2
8427458|NCT00869089|20769270|P1|STARTED|Overall Study||5
8427459|NCT00869050|20769274|P1|NOT COMPLETED|Overall Study||3
8427460|NCT00869050|20769274|P1|COMPLETED|Overall Study||38
8427461|NCT00869050|20769274|P1|STARTED|Overall Study||41
8427462|NCT00869024|20769281|P2|NOT COMPLETED|Overall Study||5
8427463|NCT00869024|20769282|P1|NOT COMPLETED|Overall Study||2
8427464|NCT00869024|20769281|P2|COMPLETED|Overall Study||4
8427465|NCT00869024|20769282|P1|COMPLETED|Overall Study||14
8427466|NCT00869024|20769281|P2|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
8427467|NCT00869024|20769282|P1|STARTED|Overall Study||16
8427468|NCT00868998|20769298|P1|NOT COMPLETED|Overall Study||5
8427469|NCT00868998|20769298|P1|COMPLETED|Overall Study||0
8427470|NCT00868998|20769298|P1|STARTED|Overall Study||5
8427471|NCT00868959|20769303|P1|NOT COMPLETED|Overall Study||258
8427472|NCT00868959|20769303|P1|COMPLETED|Overall Study||559
8427473|NCT00868959|20769303|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
8427474|NCT00868790|20769309|P14|NOT COMPLETED|Post-study||0
8427475|NCT00868790|20769310|P13|NOT COMPLETED|Post-study||0
8427476|NCT00868790|20769311|P12|NOT COMPLETED|Post-study||0
8427477|NCT00868790|20769312|P11|NOT COMPLETED|Post-study||0
8427478|NCT00868790|20769313|P10|NOT COMPLETED|Post-study||1
8427479|NCT00868790|20769314|P9|NOT COMPLETED|Post-study||0
8427480|NCT00868790|20769315|P8|NOT COMPLETED|Post-study||2
8427481|NCT00868790|20769316|P7|NOT COMPLETED|Post-study||0
8427482|NCT00868790|20769317|P6|NOT COMPLETED|Post-study||0
8427483|NCT00868790|20769318|P5|NOT COMPLETED|Post-study||1
8427484|NCT00868790|20769319|P4|NOT COMPLETED|Post-study||0
8427485|NCT00868790|20769320|P3|NOT COMPLETED|Post-study||0
8427486|NCT00868790|20769321|P2|NOT COMPLETED|Post-study||0
8427487|NCT00868790|20769322|P1|NOT COMPLETED|Post-study||0
8427488|NCT00868790|20769309|P14|COMPLETED|Post-study||7
8427489|NCT00868790|20769310|P13|COMPLETED|Post-study||6
8427490|NCT00868790|20769311|P12|COMPLETED|Post-study||3
8427491|NCT00868790|20769312|P11|COMPLETED|Post-study||5
8427492|NCT00868790|20769313|P10|COMPLETED|Post-study||1
8427493|NCT00868790|20769314|P9|COMPLETED|Post-study||6
8427494|NCT00868790|20769315|P8|COMPLETED|Post-study||12
8427495|NCT00868790|20769316|P7|COMPLETED|Post-study||4
8427496|NCT00868790|20769317|P6|COMPLETED|Post-study||1
8427497|NCT00868790|20769318|P5|COMPLETED|Post-study||17
8427498|NCT00868790|20769319|P4|COMPLETED|Post-study||3
8427499|NCT00868790|20769320|P3|COMPLETED|Post-study||3
8427500|NCT00868790|20769321|P2|COMPLETED|Post-study||6
8427501|NCT00868790|20769322|P1|COMPLETED|Post-study||7
8427502|NCT00868790|20769309|P14|STARTED|Post-study||7
8427503|NCT00868790|20769310|P13|STARTED|Post-study||6
8427504|NCT00868790|20769311|P12|STARTED|Post-study||3
8427505|NCT00868790|20769312|P11|STARTED|Post-study||5
8427506|NCT00868790|20769313|P10|STARTED|Post-study||2
8427507|NCT00868790|20769314|P9|STARTED|Post-study||6
8427508|NCT00868790|20769315|P8|STARTED|Post-study||14
8427509|NCT00868790|20769316|P7|STARTED|Post-study||4
8427510|NCT00868790|20769317|P6|STARTED|Post-study||1
8427511|NCT00868790|20769318|P5|STARTED|Post-study||18
8427512|NCT00868790|20769319|P4|STARTED|Post-study||3
8427513|NCT00868790|20769320|P3|STARTED|Post-study||3
8427514|NCT00868790|20769321|P2|STARTED|Post-study||6
8427515|NCT00868790|20769322|P1|STARTED|Post-study||7
8427516|NCT00868790|20769309|P14|NOT COMPLETED|Period 4||1
8427517|NCT00868790|20769310|P13|NOT COMPLETED|Period 4||1
8427518|NCT00868790|20769311|P12|NOT COMPLETED|Period 4||1
8427519|NCT00868790|20769312|P11|NOT COMPLETED|Period 4||3
8427520|NCT00868790|20769313|P10|NOT COMPLETED|Period 4||0
8427521|NCT00868790|20769314|P9|NOT COMPLETED|Period 4||2
8427522|NCT00868790|20769315|P8|NOT COMPLETED|Period 4||3
8427523|NCT00868790|20769316|P7|NOT COMPLETED|Period 4||0
8427524|NCT00868790|20769317|P6|NOT COMPLETED|Period 4||0
8427525|NCT00868790|20769318|P5|NOT COMPLETED|Period 4||0
8427526|NCT00868790|20769319|P4|NOT COMPLETED|Period 4||0
8427527|NCT00868790|20769320|P3|NOT COMPLETED|Period 4||1
8427528|NCT00868790|20769321|P2|NOT COMPLETED|Period 4||0
8427529|NCT00868790|20769322|P1|NOT COMPLETED|Period 4||2
8427530|NCT00868790|20769309|P14|COMPLETED|Period 4||7
8427531|NCT00868790|20769310|P13|COMPLETED|Period 4||6
8427532|NCT00868790|20769311|P12|COMPLETED|Period 4||3
8427533|NCT00868790|20769312|P11|COMPLETED|Period 4||5
8427534|NCT00868790|20769313|P10|COMPLETED|Period 4||2
8427535|NCT00868790|20769314|P9|COMPLETED|Period 4||6
8427536|NCT00868790|20769315|P8|COMPLETED|Period 4||14
8427537|NCT00868790|20769316|P7|COMPLETED|Period 4||4
8427538|NCT00868790|20769317|P6|COMPLETED|Period 4||1
8427539|NCT00868790|20769318|P5|COMPLETED|Period 4||18
8427540|NCT00868790|20769319|P4|COMPLETED|Period 4||3
8427541|NCT00868790|20769320|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
8427542|NCT00868790|20769321|P2|COMPLETED|Period 4||6
8427543|NCT00868790|20769322|P1|COMPLETED|Period 4||7
8427544|NCT00868790|20769309|P14|STARTED|Period 4||8
8427545|NCT00868790|20769310|P13|STARTED|Period 4||7
8427546|NCT00868790|20769311|P12|STARTED|Period 4||4
8427547|NCT00868790|20769312|P11|STARTED|Period 4||8
8427548|NCT00868790|20769313|P10|STARTED|Period 4||2
8427549|NCT00868790|20769314|P9|STARTED|Period 4||8
8427550|NCT00868790|20769315|P8|STARTED|Period 4||17
8427551|NCT00868790|20769316|P7|STARTED|Period 4||4
8427552|NCT00868790|20769317|P6|STARTED|Period 4||1
8427553|NCT00868790|20769318|P5|STARTED|Period 4||18
8427554|NCT00868790|20769319|P4|STARTED|Period 4||3
8427555|NCT00868790|20769320|P3|STARTED|Period 4||4
8427556|NCT00868790|20769321|P2|STARTED|Period 4||6
8427557|NCT00868790|20769322|P1|STARTED|Period 4||9
8427558|NCT00868790|20769309|P14|NOT COMPLETED|Period 3||0
8427559|NCT00868790|20769310|P13|NOT COMPLETED|Period 3||0
8427560|NCT00868790|20769311|P12|NOT COMPLETED|Period 3||0
8427561|NCT00868790|20769312|P11|NOT COMPLETED|Period 3||1
8427562|NCT00868790|20769313|P10|NOT COMPLETED|Period 3||1
8427563|NCT00868790|20769314|P9|NOT COMPLETED|Period 3||0
8427564|NCT00868790|20769315|P8|NOT COMPLETED|Period 3||0
8427565|NCT00868790|20769316|P7|NOT COMPLETED|Period 3||0
8427566|NCT00868790|20769317|P6|NOT COMPLETED|Period 3||0
8427567|NCT00868790|20769318|P5|NOT COMPLETED|Period 3||0
8427568|NCT00868790|20769319|P4|NOT COMPLETED|Period 3||1
8427569|NCT00868790|20769320|P3|NOT COMPLETED|Period 3||0
8427570|NCT00868790|20769321|P2|NOT COMPLETED|Period 3||0
8427571|NCT00868790|20769322|P1|NOT COMPLETED|Period 3||0
8427572|NCT00868790|20769309|P14|COMPLETED|Period 3||8
8427573|NCT00868790|20769310|P13|COMPLETED|Period 3||7
8427574|NCT00868790|20769311|P12|COMPLETED|Period 3||4
8427575|NCT00868790|20769312|P11|COMPLETED|Period 3||8
8427576|NCT00868790|20769313|P10|COMPLETED|Period 3||2
8427577|NCT00868790|20769314|P9|COMPLETED|Period 3||8
8427578|NCT00868790|20769315|P8|COMPLETED|Period 3||17
8427579|NCT00868790|20769316|P7|COMPLETED|Period 3||4
8427580|NCT00868790|20769317|P6|COMPLETED|Period 3||1
8427581|NCT00868790|20769318|P5|COMPLETED|Period 3||18
8427582|NCT00868790|20769319|P4|COMPLETED|Period 3||3
8427583|NCT00868790|20769320|P3|COMPLETED|Period 3||4
8427584|NCT00868790|20769321|P2|COMPLETED|Period 3||6
8427585|NCT00868790|20769322|P1|COMPLETED|Period 3||9
8427586|NCT00868790|20769309|P14|STARTED|Period 3||8
8427587|NCT00868790|20769310|P13|STARTED|Period 3||7
8427588|NCT00868790|20769311|P12|STARTED|Period 3||4
8427589|NCT00868790|20769312|P11|STARTED|Period 3||9
8427590|NCT00868790|20769313|P10|STARTED|Period 3||3
8427591|NCT00868790|20769314|P9|STARTED|Period 3||8
8427592|NCT00868790|20769315|P8|STARTED|Period 3||17
8427593|NCT00868790|20769316|P7|STARTED|Period 3||4
8427594|NCT00868790|20769317|P6|STARTED|Period 3||1
8427595|NCT00868790|20769318|P5|STARTED|Period 3||18
8427596|NCT00868790|20769319|P4|STARTED|Period 3||4
8427597|NCT00868790|20769320|P3|STARTED|Period 3||4
8427598|NCT00868790|20769321|P2|STARTED|Period 3||6
8427599|NCT00868790|20769322|P1|STARTED|Period 3||9
8427600|NCT00868790|20769309|P14|NOT COMPLETED|Period 2||1
8427601|NCT00868790|20769310|P13|NOT COMPLETED|Period 2||0
8427602|NCT00868790|20769311|P12|NOT COMPLETED|Period 2||0
8427603|NCT00868790|20769312|P11|NOT COMPLETED|Period 2||0
8427604|NCT00868790|20769313|P10|NOT COMPLETED|Period 2||0
8427605|NCT00868790|20769314|P9|NOT COMPLETED|Period 2||2
8427606|NCT00868790|20769315|P8|NOT COMPLETED|Period 2||0
8427607|NCT00868790|20769316|P7|NOT COMPLETED|Period 2||0
8427608|NCT00868790|20769317|P6|NOT COMPLETED|Period 2||1
8427609|NCT00868790|20769318|P5|NOT COMPLETED|Period 2||0
8427610|NCT00868790|20769319|P4|NOT COMPLETED|Period 2||0
8427611|NCT00868790|20769320|P3|NOT COMPLETED|Period 2||0
8427612|NCT00868790|20769321|P2|NOT COMPLETED|Period 2||1
8427613|NCT00868790|20769322|P1|NOT COMPLETED|Period 2||0
8427614|NCT00868790|20769309|P14|COMPLETED|Period 2||8
8427615|NCT00868790|20769310|P13|COMPLETED|Period 2||7
8427616|NCT00868790|20769311|P12|COMPLETED|Period 2||4
8427617|NCT00868790|20769312|P11|COMPLETED|Period 2||9
8427618|NCT00868790|20769313|P10|COMPLETED|Period 2||3
8427619|NCT00868790|20769314|P9|COMPLETED|Period 2||8
8427620|NCT00868790|20769315|P8|COMPLETED|Period 2||17
8427621|NCT00868790|20769316|P7|COMPLETED|Period 2||4
8427622|NCT00868790|20769317|P6|COMPLETED|Period 2||1
8427623|NCT00868790|20769318|P5|COMPLETED|Period 2||18
8427624|NCT00868790|20769319|P4|COMPLETED|Period 2||4
8427625|NCT00868790|20769320|P3|COMPLETED|Period 2||4
8427626|NCT00868790|20769321|P2|COMPLETED|Period 2||6
8427627|NCT00868790|20769322|P1|COMPLETED|Period 2||9
8427628|NCT00868790|20769309|P14|STARTED|Period 2||9
8427629|NCT00868790|20769310|P13|STARTED|Period 2||7
8427630|NCT00868790|20769311|P12|STARTED|Period 2||4
8427631|NCT00868790|20769312|P11|STARTED|Period 2||9
8427632|NCT00868790|20769313|P10|STARTED|Period 2||3
8427633|NCT00868790|20769314|P9|STARTED|Period 2||10
8427634|NCT00868790|20769315|P8|STARTED|Period 2||17
8427635|NCT00868790|20769316|P7|STARTED|Period 2||4
8427636|NCT00868790|20769317|P6|STARTED|Period 2||2
8427637|NCT00868790|20769318|P5|STARTED|Period 2||18
8427638|NCT00868790|20769319|P4|STARTED|Period 2||4
8427639|NCT00868790|20769320|P3|STARTED|Period 2||4
8427640|NCT00868790|20769321|P2|STARTED|Period 2||7
8427641|NCT00868790|20769322|P1|STARTED|Period 2||9
8427642|NCT00868790|20769309|P14|NOT COMPLETED|Period 1||2
8427643|NCT00868790|20769310|P13|NOT COMPLETED|Period 1||0
8427644|NCT00868790|20769311|P12|NOT COMPLETED|Period 1||0
8427645|NCT00868790|20769312|P11|NOT COMPLETED|Period 1||0
8427646|NCT00868790|20769313|P10|NOT COMPLETED|Period 1||0
8427647|NCT00868790|20769314|P9|NOT COMPLETED|Period 1||1
8427648|NCT00868790|20769315|P8|NOT COMPLETED|Period 1||3
8427649|NCT00868790|20769316|P7|NOT COMPLETED|Period 1||0
8427650|NCT00868790|20769317|P6|NOT COMPLETED|Period 1||1
8427651|NCT00868790|20769318|P5|NOT COMPLETED|Period 1||1
8427652|NCT00868790|20769319|P4|NOT COMPLETED|Period 1||0
8427653|NCT00868790|20769320|P3|NOT COMPLETED|Period 1||0
8427654|NCT00868790|20769321|P2|NOT COMPLETED|Period 1||1
8427655|NCT00868790|20769322|P1|NOT COMPLETED|Period 1||2
8427656|NCT00868790|20769309|P14|COMPLETED|Period 1||9
8427657|NCT00868790|20769310|P13|COMPLETED|Period 1||7
8427658|NCT00868790|20769311|P12|COMPLETED|Period 1||4
8427659|NCT00868790|20769312|P11|COMPLETED|Period 1||9
8427660|NCT00868790|20769313|P10|COMPLETED|Period 1||3
8427661|NCT00868790|20769314|P9|COMPLETED|Period 1||10
8427662|NCT00868790|20769315|P8|COMPLETED|Period 1||17
8427663|NCT00868790|20769316|P7|COMPLETED|Period 1||4
8427664|NCT00868790|20769317|P6|COMPLETED|Period 1||2
8427665|NCT00868790|20769318|P5|COMPLETED|Period 1||18
8427666|NCT00868790|20769319|P4|COMPLETED|Period 1||4
8427667|NCT00868790|20769320|P3|COMPLETED|Period 1||4
8427668|NCT00868790|20769321|P2|COMPLETED|Period 1||7
8427669|NCT00868790|20769322|P1|COMPLETED|Period 1||9
8427670|NCT00868790|20769309|P14|STARTED|Period 1||11
8427671|NCT00868790|20769310|P13|STARTED|Period 1||7
8427672|NCT00868790|20769311|P12|STARTED|Period 1||4
8427673|NCT00868790|20769312|P11|STARTED|Period 1||9
8427674|NCT00868790|20769313|P10|STARTED|Period 1||3
8427675|NCT00868790|20769314|P9|STARTED|Period 1||11
8427676|NCT00868790|20769315|P8|STARTED|Period 1||20
8427677|NCT00868790|20769316|P7|STARTED|Period 1||4
8427678|NCT00868790|20769317|P6|STARTED|Period 1||3
8427679|NCT00868790|20769318|P5|STARTED|Period 1||19
8427680|NCT00868790|20769319|P4|STARTED|Period 1||4
8427681|NCT00868790|20769320|P3|STARTED|Period 1||4
8427682|NCT00868790|20769321|P2|STARTED|Period 1||8
8427683|NCT00868790|20769322|P1|STARTED|Period 1||11
8427684|NCT00868751|20769359|P1|NOT COMPLETED|Overall Study||1
8427685|NCT00868751|20769359|P1|COMPLETED|Overall Study||0
8427686|NCT00868751|20769359|P1|STARTED|Overall Study||1
8427687|NCT00868712|20769370|P3|NOT COMPLETED|Overall Study||0
8427688|NCT00868712|20769371|P2|NOT COMPLETED|Overall Study||0
8427689|NCT00868712|20769372|P1|NOT COMPLETED|Overall Study||0
8427690|NCT00868712|20769370|P3|COMPLETED|Overall Study||28
8427691|NCT00868712|20769371|P2|COMPLETED|Overall Study||11
8427692|NCT00868712|20769372|P1|COMPLETED|Overall Study||31
8427693|NCT00868712|20769370|P3|STARTED|Overall Study||28
8427694|NCT00868712|20769371|P2|STARTED|Overall Study||11
8427695|NCT00868712|20769372|P1|STARTED|Overall Study||31
8427696|NCT00868699|20769386|P3|NOT COMPLETED|Overall Study||43
8427697|NCT00868699|20769387|P2|NOT COMPLETED|Overall Study||45
8427698|NCT00868699|20769388|P1|NOT COMPLETED|Overall Study||43
8427699|NCT00868699|20769386|P3|COMPLETED|Overall Study||123
8427700|NCT00868699|20769387|P2|COMPLETED|Overall Study||124
8427701|NCT00868699|20769388|P1|COMPLETED|Overall Study||127
8427702|NCT00868699|20769386|P3|Safety Population|Overall Study||164
8427703|NCT00868699|20769387|P2|Safety Population|Overall Study||167
8427704|NCT00868699|20769388|P1|Safety Population|Overall Study||168
8427705|NCT00868699|20769386|P3|Intent-to-Treat Population|Overall Study||161
8427706|NCT00868699|20769387|P2|Intent-to-Treat Population|Overall Study||162
8427707|NCT00868699|20769388|P1|Intent-to-Treat Population|Overall Study||162
8427708|NCT00868699|20769386|P3|STARTED|Overall Study||166
8427709|NCT00868699|20769387|P2|STARTED|Overall Study||169
8427710|NCT00868699|20769388|P1|STARTED|Overall Study||170
8427711|NCT00868608|20769405|P3|NOT COMPLETED|Overall Study||5
8427712|NCT00868608|20769406|P2|NOT COMPLETED|Overall Study||3
8427713|NCT00868608|20769407|P1|NOT COMPLETED|Overall Study||23
8427714|NCT00868608|20769405|P3|COMPLETED|Overall Study||0
8427715|NCT00868608|20769406|P2|COMPLETED|Overall Study||1
8427716|NCT00868608|20769407|P1|COMPLETED|Overall Study||49
8427717|NCT00868608|20769405|P3|STARTED|Overall Study||5
8427718|NCT00868608|20769406|P2|STARTED|Overall Study||4
8427719|NCT00868608|20769407|P1|STARTED|Overall Study||72
8427720|NCT00868530|20769431|P1|NOT COMPLETED|Overall Study||4
8427721|NCT00868530|20769431|P1|COMPLETED|Overall Study||49
8427722|NCT00868530|20769431|P1|STARTED|Overall Study||53
8427723|NCT00868517|20769446|P3|NOT COMPLETED|Overall Study||2
8427724|NCT00868517|20769447|P2|NOT COMPLETED|Overall Study||4
8427725|NCT00868517|20769448|P1|NOT COMPLETED|Overall Study||4
8427726|NCT00868517|20769446|P3|COMPLETED|Overall Study||9
8427727|NCT00868517|20769447|P2|COMPLETED|Overall Study||8
8427728|NCT00868517|20769448|P1|COMPLETED|Overall Study||8
8427729|NCT00868517|20769446|P3|STARTED|Overall Study||11
8427730|NCT00868517|20769447|P2|STARTED|Overall Study||12
8427731|NCT00868517|20769448|P1|STARTED|Overall Study||12
8427732|NCT00868452|20769473|P2|NOT COMPLETED|Overall Study||29
8427733|NCT00868452|20769474|P1|NOT COMPLETED|Overall Study||40
8427734|NCT00868452|20769473|P2|COMPLETED|Overall Study||136
8427735|NCT00868452|20769474|P1|COMPLETED|Overall Study||143
8427736|NCT00868452|20769473|P2|STARTED|Overall Study||165
8427737|NCT00868452|20769474|P1|STARTED|Overall Study||183
8427738|NCT00868439|20769486|P2|NOT COMPLETED|Overall Study||9
8427739|NCT00868439|20769487|P1|NOT COMPLETED|Overall Study||8
8427740|NCT00868439|20769486|P2|COMPLETED|Overall Study||40
8427741|NCT00868439|20769487|P1|COMPLETED|Overall Study||48
8427742|NCT00868439|20769486|P2|STARTED|Overall Study||49
8427743|NCT00868439|20769487|P1|STARTED|Overall Study||56
8427744|NCT00868374|20769505|P2|NOT COMPLETED|Overall Study||7
8427745|NCT00868374|20769506|P1|NOT COMPLETED|Overall Study||7
8427746|NCT00868374|20769505|P2|COMPLETED|Overall Study||4
8427747|NCT00868374|20769506|P1|COMPLETED|Overall Study||5
8427748|NCT00868374|20769505|P2|STARTED|Overall Study||11
8427749|NCT00868374|20769506|P1|STARTED|Overall Study||12
8427750|NCT00868348|20769514|P2|NOT COMPLETED|Overall Study||0
8427751|NCT00868348|20769515|P1|NOT COMPLETED|Overall Study||0
8427752|NCT00868348|20769514|P2|COMPLETED|Overall Study||30
8427753|NCT00868348|20769515|P1|COMPLETED|Overall Study||30
8427754|NCT00868348|20769514|P2|STARTED|Overall Study||30
8427755|NCT00868348|20769515|P1|STARTED|Overall Study||30
8427756|NCT00868309|20769533|P2|NOT COMPLETED|Overall Study||0
8427757|NCT00868309|20769534|P1|NOT COMPLETED|Overall Study||0
8427758|NCT00868309|20769533|P2|COMPLETED|Overall Study||6
8427759|NCT00868309|20769534|P1|COMPLETED|Overall Study||6
8427760|NCT00868309|20769533|P2|STARTED|Overall Study||6
8427761|NCT00868309|20769534|P1|STARTED|Overall Study||6
8427762|NCT00868296|20769544|P2|NOT COMPLETED|Overall Study||3
8427763|NCT00868296|20769545|P1|NOT COMPLETED|Overall Study||0
8427764|NCT00868296|20769544|P2|COMPLETED|Overall Study||43
8427765|NCT00868296|20769545|P1|COMPLETED|Overall Study||12
8427766|NCT00868296|20769544|P2|STARTED|Overall Study||46
8427767|NCT00868296|20769545|P1|STARTED|Overall Study||12
8427768|NCT00868231|20769553|P6|NOT COMPLETED|Treatment Period 3||0
8427769|NCT00868231|20769554|P5|NOT COMPLETED|Treatment Period 3||0
8427770|NCT00868231|20769555|P4|NOT COMPLETED|Treatment Period 3||0
8427771|NCT00868231|20769556|P3|NOT COMPLETED|Treatment Period 3||1
8427772|NCT00868231|20769557|P2|NOT COMPLETED|Treatment Period 3||0
8427773|NCT00868231|20769558|P1|NOT COMPLETED|Treatment Period 3||0
8427774|NCT00868231|20769553|P6|COMPLETED|Treatment Period 3||5
8427775|NCT00868231|20769554|P5|COMPLETED|Treatment Period 3||4
8427776|NCT00868231|20769555|P4|COMPLETED|Treatment Period 3||5
8427777|NCT00868231|20769556|P3|COMPLETED|Treatment Period 3||4
8427778|NCT00868231|20769557|P2|COMPLETED|Treatment Period 3||5
8427779|NCT00868231|20769558|P1|COMPLETED|Treatment Period 3||4
8427780|NCT00868231|20769553|P6|STARTED|Treatment Period 3||5
8427781|NCT00868231|20769554|P5|STARTED|Treatment Period 3||4
8427782|NCT00868231|20769555|P4|STARTED|Treatment Period 3||5
8427783|NCT00868231|20769556|P3|STARTED|Treatment Period 3||5
8427784|NCT00868231|20769557|P2|STARTED|Treatment Period 3||5
8427785|NCT00868231|20769558|P1|STARTED|Treatment Period 3||4
8427786|NCT00868231|20769553|P6|NOT COMPLETED|Treatment Period 2||0
8427787|NCT00868231|20769554|P5|NOT COMPLETED|Treatment Period 2||0
8427788|NCT00868231|20769555|P4|NOT COMPLETED|Treatment Period 2||0
8427789|NCT00868231|20769556|P3|NOT COMPLETED|Treatment Period 2||0
8427790|NCT00868231|20769557|P2|NOT COMPLETED|Treatment Period 2||0
8427791|NCT00868231|20769558|P1|NOT COMPLETED|Treatment Period 2||1
8427792|NCT00868231|20769553|P6|COMPLETED|Treatment Period 2||5
8427793|NCT00868231|20769554|P5|COMPLETED|Treatment Period 2||4
8427794|NCT00868231|20769555|P4|COMPLETED|Treatment Period 2||5
8427795|NCT00868231|20769556|P3|COMPLETED|Treatment Period 2||5
8427796|NCT00868231|20769557|P2|COMPLETED|Treatment Period 2||5
8427797|NCT00868231|20769558|P1|COMPLETED|Treatment Period 2||4
8427798|NCT00868231|20769553|P6|STARTED|Treatment Period 2||5
8427799|NCT00868231|20769554|P5|STARTED|Treatment Period 2||4
8427800|NCT00868231|20769555|P4|STARTED|Treatment Period 2||5
8427801|NCT00868231|20769556|P3|STARTED|Treatment Period 2||5
8427802|NCT00868231|20769557|P2|STARTED|Treatment Period 2||5
8427803|NCT00868231|20769558|P1|STARTED|Treatment Period 2||5
8427804|NCT00868231|20769553|P6|NOT COMPLETED|Treatment Period 1||0
8427805|NCT00868231|20769554|P5|NOT COMPLETED|Treatment Period 1||1
8427806|NCT00868231|20769555|P4|NOT COMPLETED|Treatment Period 1||0
8427807|NCT00868231|20769556|P3|NOT COMPLETED|Treatment Period 1||0
8427808|NCT00868231|20769557|P2|NOT COMPLETED|Treatment Period 1||0
8427809|NCT00868231|20769558|P1|NOT COMPLETED|Treatment Period 1||0
8427810|NCT00868231|20769553|P6|COMPLETED|Treatment Period 1||5
8427811|NCT00868231|20769554|P5|COMPLETED|Treatment Period 1||4
8427812|NCT00868231|20769555|P4|COMPLETED|Treatment Period 1||5
8427813|NCT00868231|20769556|P3|COMPLETED|Treatment Period 1||5
8427814|NCT00868231|20769557|P2|COMPLETED|Treatment Period 1||5
8427815|NCT00868231|20769558|P1|COMPLETED|Treatment Period 1||5
8427816|NCT00868231|20769553|P6|STARTED|Treatment Period 1||5
8427817|NCT00868231|20769554|P5|STARTED|Treatment Period 1||5
8427818|NCT00868231|20769555|P4|STARTED|Treatment Period 1||5
8427819|NCT00868231|20769556|P3|STARTED|Treatment Period 1||5
8427820|NCT00868231|20769557|P2|STARTED|Treatment Period 1||5
8427821|NCT00868231|20769558|P1|STARTED|Treatment Period 1||5
8427822|NCT00868218|20769603|P4|NOT COMPLETED|Overall Study||0
8427823|NCT00868218|20769604|P3|NOT COMPLETED|Overall Study||0
8427824|NCT00868218|20769605|P2|NOT COMPLETED|Overall Study||0
8427825|NCT00868218|20769606|P1|NOT COMPLETED|Overall Study||0
8427826|NCT00868218|20769603|P4|COMPLETED|Overall Study||15
8427827|NCT00868218|20769604|P3|COMPLETED|Overall Study||15
8427828|NCT00868218|20769605|P2|COMPLETED|Overall Study||15
8427829|NCT00868218|20769606|P1|COMPLETED|Overall Study||15
8427830|NCT00868218|20769603|P4|STARTED|Overall Study||15
8427831|NCT00868218|20769604|P3|STARTED|Overall Study||15
8427832|NCT00868218|20769605|P2|STARTED|Overall Study||15
8427833|NCT00868218|20769606|P1|STARTED|Overall Study||15
8427834|NCT00868192|20769624|P1|NOT COMPLETED|Overall Study||4
8427835|NCT00868192|20769624|P1|COMPLETED|Overall Study||34
8427836|NCT00868192|20769624|P1|STARTED|Overall Study||38
8427837|NCT00868166|20769641|P2|NOT COMPLETED|Overall Study||114
8427838|NCT00868166|20769642|P1|NOT COMPLETED|Overall Study||112
8427839|NCT00868166|20769641|P2|COMPLETED|Overall Study||139
8427840|NCT00868166|20769642|P1|COMPLETED|Overall Study||147
8427841|NCT00868166|20769641|P2|STARTED|Overall Study||253
8427842|NCT00868166|20769642|P1|STARTED|Overall Study||259
8427843|NCT00868140|20769664|P2|NOT COMPLETED|Overall Study||0
8427844|NCT00868140|20769665|P1|NOT COMPLETED|Overall Study||0
8427845|NCT00868140|20769664|P2|COMPLETED|Overall Study||25
8427846|NCT00868140|20769665|P1|COMPLETED|Overall Study||26
8427847|NCT00868140|20769664|P2|STARTED|Overall Study||25
8427848|NCT00868140|20769665|P1|STARTED|Overall Study||26
8427849|NCT00868101|20769683|P2|NOT COMPLETED|Overall Study||0
8427850|NCT00868101|20769684|P1|NOT COMPLETED|Overall Study||0
8427851|NCT00868101|20769683|P2|COMPLETED|Overall Study||10
8427852|NCT00868101|20769684|P1|COMPLETED|Overall Study||12
8427853|NCT00868101|20769683|P2|STARTED|Overall Study||10
8427854|NCT00868101|20769684|P1|STARTED|Overall Study||12
8427855|NCT00867932|20769696|P1|NOT COMPLETED|Overall Study||0
8427856|NCT00867932|20769696|P1|COMPLETED|Overall Study||7
8427857|NCT00867932|20769696|P1|Intent-to-Treat (ITT) Population|Overall Study||7
8427858|NCT00867932|20769696|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8427859|NCT00867932|20769696|P1|Maintenance Phase|Overall Study||7
8427860|NCT00867932|20769696|P1|Induction Phase|Overall Study||7
8427861|NCT00867932|20769696|P1|STARTED|Overall Study||7
8427862|NCT00867815|20769704|P1|NOT COMPLETED|Overall Study||1
8427863|NCT00867815|20769704|P1|COMPLETED|Overall Study||9
8427864|NCT00867815|20769704|P1|STARTED|Overall Study||10
8427865|NCT00867789|20769712|P2|NOT COMPLETED|Overall Study||0
8427866|NCT00867789|20769713|P1|NOT COMPLETED|Overall Study||2
8427867|NCT00867789|20769712|P2|COMPLETED|Overall Study||70
8427868|NCT00867789|20769713|P1|COMPLETED|Overall Study||68
8427869|NCT00867789|20769712|P2|STARTED|Overall Study||70
8427870|NCT00867789|20769713|P1|STARTED|Overall Study||70
8427871|NCT00867659|20769719|P1|NOT COMPLETED|Overall Study||0
8427872|NCT00867659|20769719|P1|COMPLETED|Overall Study|January 2010|20
8427873|NCT00867659|20769719|P1|STARTED|Overall Study|October 2009|20
8427874|NCT00867568|20769724|P1|NOT COMPLETED|Overall Study||15
8427875|NCT00867568|20769724|P1|COMPLETED|Overall Study||3
8427876|NCT00867568|20769724|P1|STARTED|Overall Study||18
8427877|NCT00867529|20769733|P1|NOT COMPLETED|Overall Study||0
8427878|NCT00867529|20769733|P1|COMPLETED|Overall Study||63
8427879|NCT00867529|20769733|P1|STARTED|Overall Study||63
8427880|NCT00867503|20769741|P1|NOT COMPLETED|Overall Study||1
8427881|NCT00867503|20769741|P1|COMPLETED|Overall Study||9
8427882|NCT00867503|20769741|P1|STARTED|Overall Study||10
8427883|NCT00867490|20769747|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
8427884|NCT00867490|20769747|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
8427885|NCT00867490|20769747|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
8427886|NCT00867490|20769747|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
8427887|NCT00867490|20769747|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
8427888|NCT00867490|20769747|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
8427889|NCT00867490|20769747|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
8427890|NCT00867490|20769747|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
8427891|NCT00867490|20769747|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
8427892|NCT00867451|20769766|P2|NOT COMPLETED|Overall Study||0
8427893|NCT00867451|20769767|P1|NOT COMPLETED|Overall Study||0
8427894|NCT00867451|20769766|P2|COMPLETED|Overall Study||4
8427895|NCT00867451|20769767|P1|COMPLETED|Overall Study||4
8427896|NCT00867451|20769766|P2|STARTED|Overall Study||4
8427897|NCT00867451|20769767|P1|STARTED|Overall Study||4
8427898|NCT00867360|20769789|P2|NOT COMPLETED|Overall Study||1
8427899|NCT00867360|20769790|P1|NOT COMPLETED|Overall Study||1
8427900|NCT00867360|20769789|P2|COMPLETED|Overall Study||5
8427901|NCT00867360|20769790|P1|COMPLETED|Overall Study||3
8427902|NCT00867360|20769789|P2|STARTED|Overall Study||6
8427903|NCT00867360|20769790|P1|STARTED|Overall Study||4
8427904|NCT00867334|20769802|P2|NOT COMPLETED|Overall Study||1
8427905|NCT00867334|20769803|P1|NOT COMPLETED|Overall Study||2
8427906|NCT00867334|20769802|P2|COMPLETED|Overall Study||0
8427907|NCT00867334|20769803|P1|COMPLETED|Overall Study||4
8427908|NCT00867334|20769802|P2|STARTED|Overall Study||1
8427909|NCT00867334|20769803|P1|STARTED|Overall Study||6
8427910|NCT00867321|20769814|P6|NOT COMPLETED|Overall Study||0
8427911|NCT00867321|20769815|P5|NOT COMPLETED|Overall Study||0
8427912|NCT00867321|20769816|P4|NOT COMPLETED|Overall Study||0
8427913|NCT00867321|20769817|P3|NOT COMPLETED|Overall Study||0
8427914|NCT00867321|20769818|P2|NOT COMPLETED|Overall Study||1
8427915|NCT00867321|20769819|P1|NOT COMPLETED|Overall Study||0
8427916|NCT00867321|20769814|P6|COMPLETED|Overall Study||3
8427917|NCT00867321|20769815|P5|COMPLETED|Overall Study||5
8427918|NCT00867321|20769816|P4|COMPLETED|Overall Study||6
8427919|NCT00867321|20769817|P3|COMPLETED|Overall Study||3
8427920|NCT00867321|20769818|P2|COMPLETED|Overall Study||2
8427921|NCT00867321|20769819|P1|COMPLETED|Overall Study||4
8427922|NCT00867321|20769814|P6|STARTED|Overall Study||3
8427923|NCT00867321|20769815|P5|STARTED|Overall Study||5
8427924|NCT00867321|20769816|P4|STARTED|Overall Study||6
8427925|NCT00867321|20769817|P3|STARTED|Overall Study||3
8427926|NCT00867321|20769818|P2|STARTED|Overall Study||3
8427927|NCT00867321|20769819|P1|STARTED|Overall Study||4
8427928|NCT00867308|20769839|P2|NOT COMPLETED|Overall Study||18
8427929|NCT00867308|20769840|P1|NOT COMPLETED|Overall Study||9
8427930|NCT00867308|20769839|P2|COMPLETED|Overall Study||0
8427931|NCT00867308|20769840|P1|COMPLETED|Overall Study||0
8427932|NCT00867308|20769839|P2|STARTED|Overall Study||18
8427933|NCT00867308|20769840|P1|STARTED|Overall Study||9
8427934|NCT00867217|20769850|P2|NOT COMPLETED|Overall Study||10
8427935|NCT00867217|20769851|P1|NOT COMPLETED|Overall Study||3
8427936|NCT00867217|20769850|P2|COMPLETED|Overall Study||70
8427937|NCT00867217|20769851|P1|COMPLETED|Overall Study||77
8427938|NCT00867217|20769850|P2|STARTED|Overall Study||80
8427939|NCT00867217|20769851|P1|STARTED|Overall Study||80
8427940|NCT00867165|20769859|P2|NOT COMPLETED|Overall Study||0
8427941|NCT00867165|20769860|P1|NOT COMPLETED|Overall Study||4
8427942|NCT00867165|20769859|P2|COMPLETED|Overall Study||45
8427943|NCT00867165|20769860|P1|COMPLETED|Overall Study||89
8427944|NCT00867165|20769859|P2|STARTED|Overall Study||45
8427945|NCT00867165|20769860|P1|STARTED|Overall Study||93
8427946|NCT00867139|20769965|P3|NOT COMPLETED|Overall Study||1
8427947|NCT00867139|20769966|P2|NOT COMPLETED|Overall Study||0
8427948|NCT00867139|20769967|P1|NOT COMPLETED|Overall Study||0
8427949|NCT00867139|20769965|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
8427950|NCT00867139|20769966|P2|COMPLETED|Overall Study||1
8427951|NCT00867139|20769967|P1|COMPLETED|Overall Study||2
8427952|NCT00867139|20769965|P3|STARTED|Overall Study||4
8427953|NCT00867139|20769966|P2|STARTED|Overall Study||1
8427954|NCT00867139|20769967|P1|STARTED|Overall Study||2
8427955|NCT00867113|20770008|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
8427956|NCT00867113|20770008|P1|COMPLETED|Post Treatment After Survival Follow-up||57
8427957|NCT00867113|20770008|P1|STARTED|Post Treatment After Survival Follow-up||68
8427958|NCT00867113|20770008|P1|NOT COMPLETED|Treatment Period||45
8427959|NCT00867113|20770008|P1|COMPLETED|Treatment Period||46
8427960|NCT00867113|20770008|P1|Full Analysis Set (FAS)|Treatment Period||91
8427961|NCT00867113|20770008|P1|Safety Set|Treatment Period||91
8427962|NCT00867113|20770008|P1|STARTED|Treatment Period||91
8427963|NCT00867100|20770028|P13|NOT COMPLETED|Overall Study||0
8427964|NCT00867100|20770029|P12|NOT COMPLETED|Overall Study||0
8427965|NCT00867100|20770030|P11|NOT COMPLETED|Overall Study||1
8427966|NCT00867100|20770031|P10|NOT COMPLETED|Overall Study||0
8427967|NCT00867100|20770032|P9|NOT COMPLETED|Overall Study||0
8427968|NCT00867100|20770033|P8|NOT COMPLETED|Overall Study||0
8427969|NCT00867100|20770034|P7|NOT COMPLETED|Overall Study||1
8427970|NCT00867100|20770035|P6|NOT COMPLETED|Overall Study||0
8427971|NCT00867100|20770036|P5|NOT COMPLETED|Overall Study||0
8427972|NCT00867100|20770037|P4|NOT COMPLETED|Overall Study||0
8427973|NCT00867100|20770038|P3|NOT COMPLETED|Overall Study||0
8427974|NCT00867100|20770039|P2|NOT COMPLETED|Overall Study||1
8427975|NCT00867100|20770040|P1|NOT COMPLETED|Overall Study||0
8427976|NCT00867100|20770028|P13|COMPLETED|Overall Study||6
8427977|NCT00867100|20770029|P12|COMPLETED|Overall Study||6
8427978|NCT00867100|20770030|P11|COMPLETED|Overall Study||3
8427979|NCT00867100|20770031|P10|COMPLETED|Overall Study||6
8427980|NCT00867100|20770032|P9|COMPLETED|Overall Study||6
8427981|NCT00867100|20770033|P8|COMPLETED|Overall Study||3
8427982|NCT00867100|20770034|P7|COMPLETED|Overall Study||6
8427983|NCT00867100|20770035|P6|COMPLETED|Overall Study||6
8427984|NCT00867100|20770036|P5|COMPLETED|Overall Study||14
8427985|NCT00867100|20770037|P4|COMPLETED|Overall Study||8
8427986|NCT00867100|20770038|P3|COMPLETED|Overall Study||8
8427987|NCT00867100|20770039|P2|COMPLETED|Overall Study||4
8427988|NCT00867100|20770040|P1|COMPLETED|Overall Study||5
8427989|NCT00867100|20770028|P13|STARTED|Overall Study||6
8427990|NCT00867100|20770029|P12|STARTED|Overall Study||6
8427991|NCT00867100|20770030|P11|STARTED|Overall Study||4
8427992|NCT00867100|20770031|P10|STARTED|Overall Study||6
8427993|NCT00867100|20770032|P9|STARTED|Overall Study||6
8427994|NCT00867100|20770033|P8|STARTED|Overall Study||3
8427995|NCT00867100|20770034|P7|STARTED|Overall Study||7
8427996|NCT00867100|20770035|P6|STARTED|Overall Study||6
8427997|NCT00867100|20770036|P5|STARTED|Overall Study||14
8427998|NCT00867100|20770037|P4|STARTED|Overall Study||8
8427999|NCT00867100|20770038|P3|STARTED|Overall Study||8
8428000|NCT00867100|20770039|P2|STARTED|Overall Study||5
8428001|NCT00867100|20770040|P1|STARTED|Overall Study||5
8428002|NCT00867087|20770072|P1|NOT COMPLETED|Overall Study||42
8428003|NCT00867087|20770072|P1|COMPLETED|Overall Study||21
8428004|NCT00867087|20770072|P1|STARTED|Overall Study||63
8428005|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 1 Week||0
8428006|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 1 Week||1
8428007|NCT00867035|20770088|P2|COMPLETED|Baseline to 1 Week||8
8428008|NCT00867035|20770089|P1|COMPLETED|Baseline to 1 Week||11
8428009|NCT00867035|20770088|P2|STARTED|Baseline to 1 Week||8
8428010|NCT00867035|20770089|P1|STARTED|Baseline to 1 Week||12
8428011|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 4 Hours||0
8428012|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 4 Hours||0
8428013|NCT00867035|20770088|P2|COMPLETED|Baseline to 4 Hours||8
8428014|NCT00867035|20770089|P1|COMPLETED|Baseline to 4 Hours||12
8428015|NCT00867035|20770088|P2|STARTED|Baseline to 4 Hours||8
8428016|NCT00867035|20770089|P1|STARTED|Baseline to 4 Hours||12
8428017|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 2 Hours||0
8428018|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 2 Hours||0
8428019|NCT00867035|20770088|P2|COMPLETED|Baseline to 2 Hours||8
8428020|NCT00867035|20770089|P1|COMPLETED|Baseline to 2 Hours||12
8428021|NCT00867035|20770088|P2|STARTED|Baseline to 2 Hours||8
8428022|NCT00867035|20770089|P1|STARTED|Baseline to 2 Hours||12
8428023|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 1 Hour||1
8428024|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 1 Hour||1
8428025|NCT00867035|20770088|P2|COMPLETED|Baseline to 1 Hour||8
8428026|NCT00867035|20770089|P1|COMPLETED|Baseline to 1 Hour||12
8428027|NCT00867035|20770088|P2|STARTED|Baseline to 1 Hour||9
8428028|NCT00867035|20770089|P1|STARTED|Baseline to 1 Hour||13
8428029|NCT00867009|20770115|P1|NOT COMPLETED|Maintenance Period||4
8428030|NCT00867009|20770115|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
8428031|NCT00867009|20770115|P1|STARTED|Maintenance Period||51
8428032|NCT00867009|20770115|P1|NOT COMPLETED|Induction Period||62
8428033|NCT00867009|20770115|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
8428034|NCT00867009|20770115|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
8428035|NCT00867009|20770115|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
8428036|NCT00867009|20770115|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
8428037|NCT00866918|20770124|P2|NOT COMPLETED|Overall Study||12
8428038|NCT00866918|20770125|P1|NOT COMPLETED|Overall Study||16
8428039|NCT00866918|20770124|P2|COMPLETED|Overall Study||27
8428040|NCT00866918|20770125|P1|COMPLETED|Overall Study||53
8428041|NCT00866918|20770124|P2|STARTED|Overall Study||39
8428042|NCT00866918|20770125|P1|STARTED|Overall Study||69
8428043|NCT00866905|20770137|P1|NOT COMPLETED|Overall Study||33
8428044|NCT00866905|20770137|P1|COMPLETED|Overall Study||135
8428045|NCT00866905|20770137|P1|STARTED|Overall Study||168
8428046|NCT00866879|20770144|P2|NOT COMPLETED|Overall Study||0
8428047|NCT00866879|20770145|P1|NOT COMPLETED|Overall Study||0
8428048|NCT00866879|20770144|P2|COMPLETED|Overall Study||185
8428049|NCT00866879|20770145|P1|COMPLETED|Overall Study||90
8428050|NCT00866879|20770144|P2|STARTED|Overall Study||185
8428051|NCT00866879|20770145|P1|STARTED|Overall Study||90
8428052|NCT00866814|20770159|P1|NOT COMPLETED|Overall Study||20
8428053|NCT00866814|20770159|P1|COMPLETED|Overall Study||99
8428054|NCT00866814|20770159|P1|STARTED|Overall Study||119
8428055|NCT00866788|20770172|P4|NOT COMPLETED|Overall Study||5
8428056|NCT00866788|20770173|P3|NOT COMPLETED|Overall Study||2
8428057|NCT00866788|20770174|P2|NOT COMPLETED|Overall Study||6
8428058|NCT00866788|20770175|P1|NOT COMPLETED|Overall Study||6
8428059|NCT00866788|20770172|P4|COMPLETED|Overall Study||16
8428060|NCT00866788|20770173|P3|COMPLETED|Overall Study||23
8428061|NCT00866788|20770174|P2|COMPLETED|Overall Study||17
8428062|NCT00866788|20770175|P1|COMPLETED|Overall Study||15
8428063|NCT00866788|20770172|P4|STARTED|Overall Study||21
8428064|NCT00866788|20770173|P3|STARTED|Overall Study||25
8428065|NCT00866788|20770174|P2|STARTED|Overall Study||23
8428066|NCT00866788|20770175|P1|STARTED|Overall Study||21
8428067|NCT00866775|20770223|P2|NOT COMPLETED|Overall Study||52
8428068|NCT00866775|20770224|P1|NOT COMPLETED|Overall Study||36
8428069|NCT00866775|20770223|P2|COMPLETED|Overall Study||76
8428070|NCT00866775|20770224|P1|COMPLETED|Overall Study||29
8428071|NCT00866775|20770223|P2|STARTED|Overall Study||128
8428072|NCT00866775|20770224|P1|STARTED|Overall Study||65
8428073|NCT00866749|20770260|P1|NOT COMPLETED|Overall Study||0
8428074|NCT00866749|20770260|P1|COMPLETED|Overall Study||120
8428075|NCT00866749|20770260|P1|STARTED|Overall Study||120
8428076|NCT00866723|20770267|P1|NOT COMPLETED|Overall Study||5
8428077|NCT00866723|20770267|P1|COMPLETED|Overall Study||0
8428078|NCT00866723|20770267|P1|STARTED|Overall Study||5
8428085|NCT00866658|20770317|P2|NOT COMPLETED|Overall Study||21
8428086|NCT00866658|20770318|P1|NOT COMPLETED|Overall Study||13
8428087|NCT00866658|20770317|P2|COMPLETED|Overall Study||133
8428088|NCT00866658|20770318|P1|COMPLETED|Overall Study||144
8428089|NCT00866658|20770317|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
8428090|NCT00866658|20770318|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
8428091|NCT00866658|20770317|P2|Safety Population|Overall Study||154
8428092|NCT00866658|20770318|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
8428093|NCT00866658|20770317|P2|STARTED|Overall Study||154
8428094|NCT00866658|20770318|P1|STARTED|Overall Study|Randomized.|157
8428095|NCT00866619|20770350|P4|NOT COMPLETED|Overall Study||630
8428096|NCT00866619|20770351|P3|NOT COMPLETED|Overall Study||889
8428097|NCT00866619|20770352|P2|NOT COMPLETED|Overall Study||1270
8428098|NCT00866619|20770353|P1|NOT COMPLETED|Overall Study||1846
8428099|NCT00866619|20770350|P4|COMPLETED|Overall Study||1549
8428100|NCT00866619|20770351|P3|COMPLETED|Overall Study||2085
8428101|NCT00866619|20770352|P2|COMPLETED|Overall Study||3088
8428102|NCT00866619|20770353|P1|COMPLETED|Overall Study||4102
8428103|NCT00866619|20770350|P4|STARTED|Overall Study||2179
8428104|NCT00866619|20770351|P3|STARTED|Overall Study||2974
8428105|NCT00866619|20770352|P2|STARTED|Overall Study||4358
8428106|NCT00866619|20770353|P1|STARTED|Overall Study||5948
8428107|NCT00866606|20770673|P1|NOT COMPLETED|Overall Study||4
8428108|NCT00866606|20770673|P1|COMPLETED|Overall Study||31
8428109|NCT00866606|20770673|P1|STARTED|Overall Study||35
8428110|NCT00866359|20770687|P4|NOT COMPLETED|Observational Follow-Up Phase||0
8428111|NCT00866359|20770688|P3|NOT COMPLETED|Observational Follow-Up Phase||0
8428112|NCT00866359|20770689|P2|NOT COMPLETED|Observational Follow-Up Phase||0
8428113|NCT00866359|20770690|P1|NOT COMPLETED|Observational Follow-Up Phase||0
8428114|NCT00866359|20770687|P4|COMPLETED|Observational Follow-Up Phase||54
8428115|NCT00866359|20770688|P3|COMPLETED|Observational Follow-Up Phase||54
8428116|NCT00866359|20770689|P2|COMPLETED|Observational Follow-Up Phase||0
8428117|NCT00866359|20770690|P1|COMPLETED|Observational Follow-Up Phase||0
8428118|NCT00866359|20770687|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
8428119|NCT00866359|20770688|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
8428120|NCT00866359|20770689|P2|STARTED|Observational Follow-Up Phase||0
8428121|NCT00866359|20770690|P1|STARTED|Observational Follow-Up Phase||0
8428122|NCT00866359|20770687|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
8428123|NCT00866359|20770688|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
8428124|NCT00866359|20770689|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
8428125|NCT00866359|20770690|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
8428126|NCT00866359|20770687|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
8428127|NCT00866359|20770688|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
8428128|NCT00866359|20770689|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
8428129|NCT00866359|20770690|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
8428130|NCT00866359|20770687|P4|STARTED|Extension Phase (Day 86 to 169)||50
8428131|NCT00866359|20770688|P3|STARTED|Extension Phase (Day 86 to 169)||45
8428132|NCT00866359|20770689|P2|STARTED|Extension Phase (Day 86 to 169)||0
8428133|NCT00866359|20770690|P1|STARTED|Extension Phase (Day 86 to 169)||0
8428134|NCT00866359|20770687|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
8428135|NCT00866359|20770688|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
8428136|NCT00866359|20770689|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
8428137|NCT00866359|20770690|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
8428138|NCT00866359|20770687|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
8428139|NCT00866359|20770688|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
8428140|NCT00866359|20770689|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
8428141|NCT00866359|20770690|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
8428142|NCT00866359|20770687|P4|STARTED|Treatment Phase (Days 1 to 85)||0
8428143|NCT00866359|20770688|P3|STARTED|Treatment Phase (Days 1 to 85)||0
8428144|NCT00866359|20770689|P2|STARTED|Treatment Phase (Days 1 to 85)||55
8428145|NCT00866359|20770690|P1|STARTED|Treatment Phase (Days 1 to 85)||56
8428146|NCT00866333|20770746|P3|NOT COMPLETED|Overall Study||12
8428147|NCT00866333|20770747|P2|NOT COMPLETED|Overall Study||7
8428148|NCT00866333|20770748|P1|NOT COMPLETED|Overall Study||5
8428149|NCT00866333|20770746|P3|COMPLETED|Overall Study||4
8428150|NCT00866333|20770747|P2|COMPLETED|Overall Study||10
8428151|NCT00866333|20770748|P1|COMPLETED|Overall Study||11
8428152|NCT00866333|20770746|P3|STARTED|Overall Study||16
8428153|NCT00866333|20770747|P2|STARTED|Overall Study||17
8428154|NCT00866333|20770748|P1|STARTED|Overall Study||16
8428155|NCT00866320|20770765|P1|NOT COMPLETED|Overall Study||6
8428156|NCT00866320|20770765|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
8428157|NCT00866320|20770765|P1|STARTED|Overall Study||49
8428158|NCT00866307|20770772|P3|NOT COMPLETED|Consolidation/Maintenance||16
8428159|NCT00866307|20770773|P2|NOT COMPLETED|Consolidation/Maintenance||9
8428160|NCT00866307|20770774|P1|NOT COMPLETED|Consolidation/Maintenance||0
8428161|NCT00866307|20770772|P3|COMPLETED|Consolidation/Maintenance||14
8428162|NCT00866307|20770773|P2|COMPLETED|Consolidation/Maintenance||45
8428163|NCT00866307|20770774|P1|COMPLETED|Consolidation/Maintenance||0
8428164|NCT00866307|20770772|P3|STARTED|Consolidation/Maintenance||30
8428165|NCT00866307|20770773|P2|STARTED|Consolidation/Maintenance||54
8428166|NCT00866307|20770774|P1|STARTED|Consolidation/Maintenance||0
8428167|NCT00866307|20770772|P3|NOT COMPLETED|Induction||0
8428168|NCT00866307|20770773|P2|NOT COMPLETED|Induction||0
8428169|NCT00866307|20770774|P1|NOT COMPLETED|Induction||20
8428170|NCT00866307|20770772|P3|COMPLETED|Induction||0
8428171|NCT00866307|20770773|P2|COMPLETED|Induction||0
8428172|NCT00866307|20770774|P1|COMPLETED|Induction||84
8428173|NCT00866307|20770772|P3|STARTED|Induction||0
8428174|NCT00866307|20770773|P2|STARTED|Induction||0
8428175|NCT00866307|20770774|P1|STARTED|Induction||104
8428176|NCT00866294|20770784|P3|NOT COMPLETED|Overall Study||11
8428177|NCT00866294|20770785|P2|NOT COMPLETED|Overall Study||20
8428178|NCT00866294|20770786|P1|NOT COMPLETED|Overall Study||33
8428179|NCT00866294|20770784|P3|COMPLETED|Overall Study||72
8428180|NCT00866294|20770785|P2|COMPLETED|Overall Study||141
8428181|NCT00866294|20770786|P1|COMPLETED|Overall Study||139
8428182|NCT00866294|20770784|P3|STARTED|Overall Study||83
8428183|NCT00866294|20770785|P2|STARTED|Overall Study||161
8428184|NCT00866294|20770786|P1|STARTED|Overall Study||172
8428185|NCT00866281|20770815|P2|NOT COMPLETED|Overall Study||15
8428186|NCT00866281|20770816|P1|NOT COMPLETED|Overall Study||7
8428187|NCT00866281|20770815|P2|COMPLETED|Overall Study||0
8428188|NCT00866281|20770816|P1|COMPLETED|Overall Study||0
8428189|NCT00866281|20770815|P2|STARTED|Overall Study||15
8428190|NCT00866281|20770816|P1|STARTED|Overall Study||7
8428191|NCT00866177|20770832|P1|NOT COMPLETED|Overall Study||152
8428192|NCT00866177|20770832|P1|COMPLETED|Overall Study||15
8428193|NCT00866177|20770832|P1|STARTED|Overall Study||167
8428194|NCT00866047|20770836|P1|NOT COMPLETED|Follow-up Period||5
8428195|NCT00866047|20770836|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
8428196|NCT00866047|20770836|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
8428197|NCT00866047|20770836|P1|NOT COMPLETED|Treatment Period||48
8428198|NCT00866047|20770836|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
8428199|NCT00866047|20770836|P1|STARTED|Treatment Period||58
8428200|NCT00866034|20770854|P2|NOT COMPLETED|Overall Study||8
8428201|NCT00866034|20770855|P1|NOT COMPLETED|Overall Study||16
8428202|NCT00866034|20770854|P2|COMPLETED|Overall Study||301
8428203|NCT00866034|20770855|P1|COMPLETED|Overall Study||292
8428204|NCT00866034|20770854|P2|STARTED|Overall Study||309
8428205|NCT00866034|20770855|P1|STARTED|Overall Study||308
8428206|NCT00865904|20770868|P5|NOT COMPLETED|Overall Study||1
8428207|NCT00865904|20770869|P4|NOT COMPLETED|Overall Study||1
8428208|NCT00865904|20770870|P3|NOT COMPLETED|Overall Study||0
8428209|NCT00865904|20770871|P2|NOT COMPLETED|Overall Study||0
8428210|NCT00865904|20770872|P1|NOT COMPLETED|Overall Study||2
8428211|NCT00865904|20770868|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
8428212|NCT00865904|20770869|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
8428213|NCT00865904|20770870|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
8428214|NCT00865904|20770871|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
8428215|NCT00865904|20770872|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
8428216|NCT00865904|20770868|P5|STARTED|Overall Study|Randomized.|20
8428217|NCT00865904|20770869|P4|STARTED|Overall Study|Randomized.|18
8428218|NCT00865904|20770870|P3|STARTED|Overall Study|Randomized.|18
8428219|NCT00865904|20770871|P2|STARTED|Overall Study|Randomized.|18
8428220|NCT00865904|20770872|P1|STARTED|Overall Study|Randomized.|19
8428221|NCT00865709|20770929|P2|NOT COMPLETED|Long Term Follow-up||49
8428222|NCT00865709|20770930|P1|NOT COMPLETED|Long Term Follow-up||46
8428223|NCT00865709|20770929|P2|COMPLETED|Long Term Follow-up||33
8428224|NCT00865709|20770930|P1|COMPLETED|Long Term Follow-up||24
8428225|NCT00865709|20770929|P2|STARTED|Long Term Follow-up||82
8428226|NCT00865709|20770930|P1|STARTED|Long Term Follow-up||70
8428227|NCT00865709|20770929|P2|NOT COMPLETED|Active Follow-up||1
8428228|NCT00865709|20770930|P1|NOT COMPLETED|Active Follow-up||8
8428229|NCT00865709|20770929|P2|COMPLETED|Active Follow-up||15
8428230|NCT00865709|20770930|P1|COMPLETED|Active Follow-up||17
8428231|NCT00865709|20770929|P2|STARTED|Active Follow-up||16
8428232|NCT00865709|20770930|P1|STARTED|Active Follow-up||25
8428233|NCT00865709|20770929|P2|NOT COMPLETED|Treatment||18
8428234|NCT00865709|20770930|P1|NOT COMPLETED|Treatment||30
8428235|NCT00865709|20770929|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
8428236|NCT00865709|20770930|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
8428237|NCT00865709|20770929|P2|Received Treatment|Treatment|Safety population|101
8428238|NCT00865709|20770930|P1|Received Treatment|Treatment|Safety population|97
8428239|NCT00865709|20770929|P2|STARTED|Treatment||101
8428240|NCT00865709|20770930|P1|STARTED|Treatment||97
8428241|NCT00865566|20770948|P2|NOT COMPLETED|Overall Study||687
8428242|NCT00865566|20770949|P1|NOT COMPLETED|Overall Study||624
8428243|NCT00865566|20770948|P2|COMPLETED|Overall Study||564
8428244|NCT00865566|20770949|P1|COMPLETED|Overall Study||629
8428245|NCT00865566|20770948|P2|Modified Intent-to-Treat Population|Overall Study||1245
8428246|NCT00865566|20770949|P1|Modified Intent-to-Treat Population|Overall Study||1251
8428247|NCT00865566|20770948|P2|STARTED|Overall Study||1251
8428248|NCT00865566|20770949|P1|STARTED|Overall Study||1253
8428249|NCT00865514|20770969|P1|NOT COMPLETED|Overall Study||2
8428250|NCT00865514|20770969|P1|COMPLETED|Overall Study||0
8428251|NCT00865514|20770969|P1|STARTED|Overall Study||2
8428252|NCT00865345|20770974|P1|NOT COMPLETED|Overall Study||2
8428253|NCT00865345|20770974|P1|COMPLETED|Overall Study||61
8428254|NCT00865345|20770974|P1|STARTED|Overall Study||63
8428255|NCT00865306|20770981|P2|NOT COMPLETED|One-Year Follow-Up||0
8428256|NCT00865306|20770982|P1|NOT COMPLETED|One-Year Follow-Up||0
8428257|NCT00865306|20770981|P2|COMPLETED|One-Year Follow-Up||15
8428258|NCT00865306|20770982|P1|COMPLETED|One-Year Follow-Up||29
8428259|NCT00865306|20770981|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
8428260|NCT00865306|20770982|P1|STARTED|One-Year Follow-Up||29
8428261|NCT00865306|20770981|P2|NOT COMPLETED|Controlled Trial||2
8428262|NCT00865306|20770982|P1|NOT COMPLETED|Controlled Trial||5
8428263|NCT00865306|20770981|P2|COMPLETED|Controlled Trial||28
8428264|NCT00865306|20770982|P1|COMPLETED|Controlled Trial||29
8428265|NCT00865306|20770981|P2|STARTED|Controlled Trial||30
8428266|NCT00865306|20770982|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
8428267|NCT00865202|20770994|P2|NOT COMPLETED|Overall Study||0
8428268|NCT00865202|20770995|P1|NOT COMPLETED|Overall Study||0
8428269|NCT00865202|20770994|P2|COMPLETED|Overall Study||149
8428270|NCT00865202|20770995|P1|COMPLETED|Overall Study||152
8428271|NCT00865202|20770994|P2|STARTED|Overall Study||149
8428272|NCT00865202|20770995|P1|STARTED|Overall Study||152
8428273|NCT00865189|20771011|P2|NOT COMPLETED|Overall Study||19
8428274|NCT00865189|20771012|P1|NOT COMPLETED|Overall Study||12
8428275|NCT00865189|20771011|P2|COMPLETED|Overall Study||26
8428276|NCT00865189|20771012|P1|COMPLETED|Overall Study||34
8428277|NCT00865189|20771011|P2|STARTED|Overall Study||45
8428278|NCT00865189|20771012|P1|STARTED|Overall Study||46
8428279|NCT00865124|20771040|P3|NOT COMPLETED|Overall Study||0
8428280|NCT00865124|20771041|P2|NOT COMPLETED|Overall Study||1
8428281|NCT00865124|20771042|P1|NOT COMPLETED|Overall Study||4
8428282|NCT00865124|20771040|P3|COMPLETED|Overall Study||17
8428283|NCT00865124|20771041|P2|COMPLETED|Overall Study||24
8428284|NCT00865124|20771042|P1|COMPLETED|Overall Study||23
8428285|NCT00865124|20771040|P3|STARTED|Overall Study||17
8428286|NCT00865124|20771041|P2|STARTED|Overall Study||25
8428287|NCT00865124|20771042|P1|STARTED|Overall Study||27
8428288|NCT00865098|20771059|P1|NOT COMPLETED|Overall Study||1
8428289|NCT00865098|20771059|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
8428290|NCT00865098|20771059|P1|STARTED|Overall Study||22
8428291|NCT00865046|20771071|P3|NOT COMPLETED|Overall Study||1
8428292|NCT00865046|20771072|P2|NOT COMPLETED|Overall Study||5
8428293|NCT00865046|20771073|P1|NOT COMPLETED|Overall Study||6
8428294|NCT00865046|20771071|P3|COMPLETED|Overall Study||62
8428295|NCT00865046|20771072|P2|COMPLETED|Overall Study||59
8428296|NCT00865046|20771073|P1|COMPLETED|Overall Study||57
8428297|NCT00865046|20771071|P3|STARTED|Overall Study||63
8428298|NCT00865046|20771072|P2|STARTED|Overall Study||64
8428299|NCT00865046|20771073|P1|STARTED|Overall Study||63
8428300|NCT00865020|20771083|P2|NOT COMPLETED|Overall Study||51
8428301|NCT00865020|20771084|P1|NOT COMPLETED|Overall Study||49
8428302|NCT00865020|20771083|P2|COMPLETED|Overall Study||357
8428303|NCT00865020|20771084|P1|COMPLETED|Overall Study||365
8428304|NCT00865020|20771083|P2|STARTED|Overall Study||408
8428305|NCT00865020|20771084|P1|STARTED|Overall Study||414
8428306|NCT00864916|20771100|P2|NOT COMPLETED|Overall Study||4
8428307|NCT00864916|20771101|P1|NOT COMPLETED|Overall Study||6
8428308|NCT00864916|20771100|P2|COMPLETED|Overall Study||5
8428309|NCT00864916|20771101|P1|COMPLETED|Overall Study||4
8428310|NCT00864916|20771100|P2|STARTED|Overall Study||9
8428311|NCT00864916|20771101|P1|STARTED|Overall Study||10
8428312|NCT00864851|20771110|P3|NOT COMPLETED|Overall Study||0
8428313|NCT00864851|20771111|P2|NOT COMPLETED|Overall Study||1
8428314|NCT00864851|20771112|P1|NOT COMPLETED|Overall Study||3
8428315|NCT00864851|20771110|P3|COMPLETED|Overall Study||5
8428316|NCT00864851|20771111|P2|COMPLETED|Overall Study||18
8428317|NCT00864851|20771112|P1|COMPLETED|Overall Study||17
8428318|NCT00864851|20771110|P3|STARTED|Overall Study||5
8428319|NCT00864851|20771111|P2|STARTED|Overall Study||19
8428320|NCT00864851|20771112|P1|STARTED|Overall Study||20
8428321|NCT00864721|20771146|P1|NOT COMPLETED|Overall Study||34
8428322|NCT00864721|20771146|P1|COMPLETED|Overall Study||29
8428323|NCT00864721|20771146|P1|STARTED|Overall Study||63
8428324|NCT00864708|20771154|P1|NOT COMPLETED|Overall Study||0
8428325|NCT00864708|20771154|P1|COMPLETED|Overall Study||1
8428326|NCT00864708|20771154|P1|STARTED|Overall Study||1
8428327|NCT00864682|20771166|P3|NOT COMPLETED|Overall Study||2
8428328|NCT00864682|20771167|P2|NOT COMPLETED|Overall Study||1
8428329|NCT00864682|20771168|P1|NOT COMPLETED|Overall Study||2
8428330|NCT00864682|20771166|P3|COMPLETED|Overall Study||51
8428331|NCT00864682|20771167|P2|COMPLETED|Overall Study||50
8428332|NCT00864682|20771168|P1|COMPLETED|Overall Study||50
8428333|NCT00864682|20771166|P3|STARTED|Overall Study||53
8428334|NCT00864682|20771167|P2|STARTED|Overall Study||51
8428335|NCT00864682|20771168|P1|STARTED|Overall Study||52
8428336|NCT00864539|20771188|P6|NOT COMPLETED|Overall Study||14
8428337|NCT00864539|20771189|P5|NOT COMPLETED|Overall Study||22
8428338|NCT00864539|20771190|P4|NOT COMPLETED|Overall Study||7
8428339|NCT00864539|20771191|P3|NOT COMPLETED|Overall Study||10
8428340|NCT00864539|20771192|P2|NOT COMPLETED|Overall Study||23
8428341|NCT00864539|20771193|P1|NOT COMPLETED|Overall Study||9
8428342|NCT00864539|20771188|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
8428343|NCT00864539|20771189|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
8428344|NCT00864539|20771190|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
8428345|NCT00864539|20771191|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
8428346|NCT00864539|20771192|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
8428347|NCT00864539|20771193|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
8428348|NCT00864539|20771188|P6|STARTED|Overall Study||85
8428349|NCT00864539|20771189|P5|STARTED|Overall Study||103
8428350|NCT00864539|20771190|P4|STARTED|Overall Study||96
8428351|NCT00864539|20771191|P3|STARTED|Overall Study||102
8428352|NCT00864539|20771192|P2|STARTED|Overall Study||95
8428353|NCT00864539|20771193|P1|STARTED|Overall Study||104
8428354|NCT00864513|20771207|P1|NOT COMPLETED|Overall Study||3
8428355|NCT00864513|20771207|P1|COMPLETED|Overall Study||12
8428356|NCT00864513|20771207|P1|STARTED|Overall Study||15
8428357|NCT00864474|20771214|P1|NOT COMPLETED|Overall Study||0
8428358|NCT00864474|20771214|P1|COMPLETED|Overall Study||68
8428359|NCT00864474|20771214|P1|STARTED|Overall Study||68
8428360|NCT00864383|20771255|P3|NOT COMPLETED|Modified Intent to Treat||85
8428361|NCT00864383|20771256|P2|NOT COMPLETED|Modified Intent to Treat||87
8428362|NCT00864383|20771257|P1|NOT COMPLETED|Modified Intent to Treat||85
8428363|NCT00864383|20771255|P3|COMPLETED|Modified Intent to Treat||551
8428364|NCT00864383|20771256|P2|COMPLETED|Modified Intent to Treat||568
8428365|NCT00864383|20771257|P1|COMPLETED|Modified Intent to Treat||555
8428366|NCT00864383|20771255|P3|STARTED|Modified Intent to Treat||636
8428367|NCT00864383|20771256|P2|STARTED|Modified Intent to Treat||655
8428368|NCT00864383|20771257|P1|STARTED|Modified Intent to Treat||640
8428369|NCT00864383|20771255|P3|NOT COMPLETED|Per- Protocol||112
8428370|NCT00864383|20771256|P2|NOT COMPLETED|Per- Protocol||141
8428371|NCT00864383|20771257|P1|NOT COMPLETED|Per- Protocol||130
8428372|NCT00864383|20771255|P3|COMPLETED|Per- Protocol||524
8428373|NCT00864383|20771256|P2|COMPLETED|Per- Protocol||514
8428374|NCT00864383|20771257|P1|COMPLETED|Per- Protocol||510
8428375|NCT00864383|20771255|P3|STARTED|Per- Protocol||636
8428376|NCT00864383|20771256|P2|STARTED|Per- Protocol||655
8428377|NCT00864383|20771257|P1|STARTED|Per- Protocol||640
8428378|NCT00864253|20771291|P2|NOT COMPLETED|Overall Study||58
8428379|NCT00864253|20771292|P1|NOT COMPLETED|Overall Study||99
8428380|NCT00864253|20771291|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
8428381|NCT00864253|20771292|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
8428382|NCT00864253|20771291|P2|Treated|Overall Study||258
8428383|NCT00864253|20771292|P1|Treated|Overall Study||257
8428384|NCT00864253|20771291|P2|STARTED|Overall Study||265
8428385|NCT00864253|20771292|P1|STARTED|Overall Study||264
8428386|NCT00864227|20771322|P1|NOT COMPLETED|Overall Study||4
8428387|NCT00864227|20771322|P1|COMPLETED|Overall Study||50
8428388|NCT00864227|20771322|P1|STARTED|Overall Study||54
8428389|NCT00864123|20771339|P2|NOT COMPLETED|Overall Study||0
8428390|NCT00864123|20771340|P1|NOT COMPLETED|Overall Study||0
8428391|NCT00864123|20771339|P2|COMPLETED|Overall Study||15
8428392|NCT00864123|20771340|P1|COMPLETED|Overall Study||15
8428393|NCT00864123|20771339|P2|STARTED|Overall Study||15
8428394|NCT00864123|20771340|P1|STARTED|Overall Study||15
8428395|NCT00864084|20771350|P1|NOT COMPLETED|Overall Study||3
8428396|NCT00864084|20771350|P1|COMPLETED|Overall Study||11
8428397|NCT00864084|20771350|P1|STARTED|Overall Study||14
8428398|NCT00864032|20771373|P3|NOT COMPLETED|Overall Study||0
8428399|NCT00864032|20771374|P2|NOT COMPLETED|Overall Study||0
8428400|NCT00864032|20771375|P1|NOT COMPLETED|Overall Study||0
8428401|NCT00864032|20771373|P3|COMPLETED|Overall Study||0
8428402|NCT00864032|20771374|P2|COMPLETED|Overall Study||5
8428403|NCT00864032|20771375|P1|COMPLETED|Overall Study||3
8428404|NCT00864032|20771373|P3|STARTED|Overall Study||0
8428405|NCT00864032|20771374|P2|STARTED|Overall Study||5
8428406|NCT00864032|20771375|P1|STARTED|Overall Study||3
8428407|NCT00863928|20771383|P2|NOT COMPLETED|Overall Study||0
8428408|NCT00863928|20771384|P1|NOT COMPLETED|Overall Study||36
8428409|NCT00863928|20771383|P2|COMPLETED|Overall Study||41
8428410|NCT00863928|20771384|P1|COMPLETED|Overall Study||58
8428411|NCT00863928|20771383|P2|STARTED|Overall Study||41
8428412|NCT00863928|20771384|P1|STARTED|Overall Study||94
8428413|NCT00863798|20771393|P3|NOT COMPLETED|Overall Study||25
8428414|NCT00863798|20771394|P2|NOT COMPLETED|Overall Study||30
8428415|NCT00863798|20771395|P1|NOT COMPLETED|Overall Study||32
8428416|NCT00863798|20771393|P3|COMPLETED|Overall Study||202
8428417|NCT00863798|20771394|P2|COMPLETED|Overall Study||198
8428418|NCT00863798|20771395|P1|COMPLETED|Overall Study||195
8428419|NCT00863798|20771393|P3|Treated|Overall Study||224
8428420|NCT00863798|20771394|P2|Treated|Overall Study||226
8428421|NCT00863798|20771395|P1|Treated|Overall Study||223
8428422|NCT00863798|20771393|P3|STARTED|Overall Study||227
8428423|NCT00863798|20771394|P2|STARTED|Overall Study||228
8428424|NCT00863798|20771395|P1|STARTED|Overall Study||227
8428425|NCT00863746|20771447|P2|NOT COMPLETED|Survival Follow up||280
8428426|NCT00863746|20771448|P1|NOT COMPLETED|Survival Follow up||253
8428427|NCT00863746|20771447|P2|COMPLETED|Survival Follow up||51
8428428|NCT00863746|20771448|P1|COMPLETED|Survival Follow up||45
8428429|NCT00863746|20771447|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
8428430|NCT00863746|20771448|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
8428431|NCT00863746|20771447|P2|NOT COMPLETED|Treatment||35
8428432|NCT00863746|20771448|P1|NOT COMPLETED|Treatment||71
8428433|NCT00863746|20771447|P2|COMPLETED|Treatment||318
8428434|NCT00863746|20771448|P1|COMPLETED|Treatment||279
8428435|NCT00863746|20771447|P2|Participants Received Treatment|Treatment|Safety population|351
8428436|NCT00863746|20771448|P1|Participants Received Treatment|Treatment|Safety population|346
8428437|NCT00863746|20771447|P2|STARTED|Treatment||353
8428438|NCT00863746|20771448|P1|STARTED|Treatment||350
8428439|NCT00863707|20771474|P2|NOT COMPLETED|Overall Study||3
8428440|NCT00863707|20771475|P1|NOT COMPLETED|Overall Study||4
8428441|NCT00863707|20771474|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
8428442|NCT00863707|20771475|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
8428443|NCT00863707|20771474|P2|STARTED|Overall Study||337
8428444|NCT00863707|20771475|P1|STARTED|Overall Study||174
8428445|NCT00863681|20771484|P3|NOT COMPLETED|Overall Study||18
8428446|NCT00863681|20771485|P2|NOT COMPLETED|Overall Study||43
8428447|NCT00863681|20771486|P1|NOT COMPLETED|Overall Study||91
8428448|NCT00863681|20771484|P3|COMPLETED|Overall Study|Completed treatment|38
8428449|NCT00863681|20771485|P2|COMPLETED|Overall Study|Completed treatment|66
8428450|NCT00863681|20771486|P1|COMPLETED|Overall Study|Completed treatment|140
8428451|NCT00863681|20771484|P3|STARTED|Overall Study||56
8428452|NCT00863681|20771485|P2|STARTED|Overall Study||109
8428453|NCT00863681|20771486|P1|STARTED|Overall Study||231
8428454|NCT00863655|20771571|P2|NOT COMPLETED|Overall Study||239
8428455|NCT00863655|20771572|P1|NOT COMPLETED|Overall Study||485
8428456|NCT00863655|20771571|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
8428457|NCT00863655|20771572|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
8428458|NCT00863655|20771571|P2|STARTED|Overall Study||239
8428459|NCT00863655|20771572|P1|STARTED|Overall Study||485
8428460|NCT00863551|20771599|P1|NOT COMPLETED|Overall Study||0
8428461|NCT00863551|20771599|P1|COMPLETED|Overall Study||12
8428462|NCT00863551|20771599|P1|STARTED|Overall Study||12
8428463|NCT00863512|20771609|P2|NOT COMPLETED|Overall Study||0
8428464|NCT00863512|20771610|P1|NOT COMPLETED|Overall Study||14
8428465|NCT00863512|20771609|P2|COMPLETED|Overall Study||17
8428466|NCT00863512|20771610|P1|COMPLETED|Overall Study||3
8428467|NCT00863512|20771609|P2|STARTED|Overall Study||17
8428468|NCT00863512|20771610|P1|STARTED|Overall Study||17
8428469|NCT00863434|20771616|P1|NOT COMPLETED|Overall Study||0
8428470|NCT00863434|20771616|P1|COMPLETED|Overall Study||2
8428471|NCT00863434|20771616|P1|STARTED|Overall Study||2
8428472|NCT00863356|20771622|P1|NOT COMPLETED|Overall Study||0
8428473|NCT00863356|20771622|P1|COMPLETED|Overall Study||20
8428474|NCT00863356|20771622|P1|STARTED|Overall Study||20
8428475|NCT00863343|20771628|P2|NOT COMPLETED|Overall Study||0
8428476|NCT00863343|20771629|P1|NOT COMPLETED|Overall Study||0
8428477|NCT00863343|20771628|P2|COMPLETED|Overall Study||374
8428478|NCT00863343|20771629|P1|COMPLETED|Overall Study||17
8428479|NCT00863343|20771628|P2|STARTED|Overall Study||374
8428480|NCT00863343|20771629|P1|STARTED|Overall Study||17
8428481|NCT00863330|20771641|P1|NOT COMPLETED|Overall Study||6
8428482|NCT00863330|20771641|P1|COMPLETED|Overall Study||0
8428483|NCT00863330|20771641|P1|STARTED|Overall Study||6
8428484|NCT00863317|20771647|P2|NOT COMPLETED|Overall Study||9
8428485|NCT00863317|20771648|P1|NOT COMPLETED|Overall Study||8
8428486|NCT00863317|20771647|P2|COMPLETED|Overall Study||64
8428487|NCT00863317|20771648|P1|COMPLETED|Overall Study||60
8428488|NCT00863317|20771647|P2|STARTED|Overall Study||73
8428489|NCT00863317|20771648|P1|STARTED|Overall Study||68
8428490|NCT00863265|20771654|P6|NOT COMPLETED|Overall Study||0
8428491|NCT00863265|20771655|P5|NOT COMPLETED|Overall Study||1
8428492|NCT00863265|20771656|P4|NOT COMPLETED|Overall Study||0
8428493|NCT00863265|20771657|P3|NOT COMPLETED|Overall Study||0
8428494|NCT00863265|20771658|P2|NOT COMPLETED|Overall Study||0
8428495|NCT00863265|20771659|P1|NOT COMPLETED|Overall Study||0
8428496|NCT00863265|20771654|P6|COMPLETED|Overall Study||3
8428497|NCT00863265|20771655|P5|COMPLETED|Overall Study||3
8428498|NCT00863265|20771656|P4|COMPLETED|Overall Study||4
8428499|NCT00863265|20771657|P3|COMPLETED|Overall Study||4
8428500|NCT00863265|20771658|P2|COMPLETED|Overall Study||3
8428501|NCT00863265|20771659|P1|COMPLETED|Overall Study||4
8428502|NCT00863265|20771654|P6|STARTED|Overall Study||3
8428503|NCT00863265|20771655|P5|STARTED|Overall Study||4
8428504|NCT00863265|20771656|P4|STARTED|Overall Study||4
8428505|NCT00863265|20771657|P3|STARTED|Overall Study||4
8428506|NCT00863265|20771658|P2|STARTED|Overall Study||3
8428507|NCT00863265|20771659|P1|STARTED|Overall Study||4
8428508|NCT00863122|20771675|P2|NOT COMPLETED|Overall Study||0
8428509|NCT00863122|20771676|P1|NOT COMPLETED|Overall Study||0
8428510|NCT00863122|20771675|P2|COMPLETED|Overall Study||7
8428511|NCT00863122|20771676|P1|COMPLETED|Overall Study||19
8428512|NCT00863122|20771675|P2|STARTED|Overall Study||7
8428513|NCT00863122|20771676|P1|STARTED|Overall Study||19
8428514|NCT00863109|20771688|P1|NOT COMPLETED|Follow-up Period||11
8428515|NCT00863109|20771688|P1|COMPLETED|Follow-up Period||48
8428516|NCT00863109|20771688|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
8428517|NCT00863109|20771688|P1|NOT COMPLETED|Treatment Period||77
8428518|NCT00863109|20771688|P1|COMPLETED|Treatment Period||53
8428519|NCT00863109|20771688|P1|STARTED|Treatment Period||130
8428520|NCT00863057|20771705|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428521|NCT00863057|20771706|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428522|NCT00863057|20771707|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428523|NCT00863057|20771708|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428524|NCT00863057|20771705|P4|COMPLETED|Period 4 (Weeks 16-20)||2
8428525|NCT00863057|20771706|P3|COMPLETED|Period 4 (Weeks 16-20)||2
8428526|NCT00863057|20771707|P2|COMPLETED|Period 4 (Weeks 16-20)||1
8428527|NCT00863057|20771708|P1|COMPLETED|Period 4 (Weeks 16-20)||3
8428528|NCT00863057|20771705|P4|STARTED|Period 4 (Weeks 16-20)||2
8428529|NCT00863057|20771706|P3|STARTED|Period 4 (Weeks 16-20)||2
8428530|NCT00863057|20771707|P2|STARTED|Period 4 (Weeks 16-20)||1
8428531|NCT00863057|20771708|P1|STARTED|Period 4 (Weeks 16-20)||3
8428532|NCT00863057|20771705|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428533|NCT00863057|20771706|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428534|NCT00863057|20771707|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428535|NCT00863057|20771708|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428536|NCT00863057|20771705|P4|COMPLETED|Period 3 (Weeks 11-15)||2
8428537|NCT00863057|20771706|P3|COMPLETED|Period 3 (Weeks 11-15)||2
8428538|NCT00863057|20771707|P2|COMPLETED|Period 3 (Weeks 11-15)||1
8428539|NCT00863057|20771708|P1|COMPLETED|Period 3 (Weeks 11-15)||3
8428540|NCT00863057|20771705|P4|STARTED|Period 3 (Weeks 11-15)||2
8428541|NCT00863057|20771706|P3|STARTED|Period 3 (Weeks 11-15)||2
8428542|NCT00863057|20771707|P2|STARTED|Period 3 (Weeks 11-15)||1
8428543|NCT00863057|20771708|P1|STARTED|Period 3 (Weeks 11-15)||3
8428544|NCT00863057|20771705|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8428545|NCT00863057|20771706|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8428546|NCT00863057|20771707|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8428547|NCT00863057|20771708|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
8428548|NCT00863057|20771705|P4|COMPLETED|Period 2 (Weeks 6-10)||2
8428549|NCT00863057|20771706|P3|COMPLETED|Period 2 (Weeks 6-10)||2
8428550|NCT00863057|20771707|P2|COMPLETED|Period 2 (Weeks 6-10)||1
8428551|NCT00863057|20771708|P1|COMPLETED|Period 2 (Weeks 6-10)||3
8428552|NCT00863057|20771705|P4|STARTED|Period 2 (Weeks 6-10)||3
8428553|NCT00863057|20771706|P3|STARTED|Period 2 (Weeks 6-10)||3
8428554|NCT00863057|20771707|P2|STARTED|Period 2 (Weeks 6-10)||2
8428555|NCT00863057|20771708|P1|STARTED|Period 2 (Weeks 6-10)||3
8428556|NCT00863057|20771705|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
8428557|NCT00863057|20771706|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
8428558|NCT00863057|20771707|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
8428559|NCT00863057|20771708|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
8428560|NCT00863057|20771705|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8428561|NCT00863057|20771706|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8428562|NCT00863057|20771707|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
8428563|NCT00863057|20771708|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8428564|NCT00863057|20771705|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
8428565|NCT00863057|20771706|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
8428566|NCT00863057|20771707|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
8428567|NCT00863057|20771708|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
8428568|NCT00862979|20771766|P2|NOT COMPLETED|Overall Study||7
8428569|NCT00862979|20771767|P1|NOT COMPLETED|Overall Study||8
8428570|NCT00862979|20771766|P2|COMPLETED|Overall Study||71
8428571|NCT00862979|20771767|P1|COMPLETED|Overall Study||76
8428572|NCT00862979|20771766|P2|Full Analysis Set (FAS)|Overall Study||71
8428573|NCT00862979|20771767|P1|Full Analysis Set (FAS)|Overall Study||74
8428574|NCT00862979|20771766|P2|STARTED|Overall Study||78
8428575|NCT00862979|20771767|P1|STARTED|Overall Study||84
8428576|NCT00862940|20771785|P2|NOT COMPLETED|Overall Study||30
8428577|NCT00862940|20771786|P1|NOT COMPLETED|Overall Study||30
8428578|NCT00862940|20771785|P2|COMPLETED|Overall Study||114
8428579|NCT00862940|20771786|P1|COMPLETED|Overall Study||103
8428580|NCT00862940|20771785|P2|STARTED|Overall Study||144
8428581|NCT00862940|20771786|P1|STARTED|Overall Study||133
8428582|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 6||0
8428583|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 6||0
8428584|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 6||0
8428585|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 6||0
8428586|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 6||0
8428587|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 6||0
8428588|NCT00862849|20771798|P6|COMPLETED|Intervention 6||3
8428589|NCT00862849|20771799|P5|COMPLETED|Intervention 6||4
8428590|NCT00862849|20771800|P4|COMPLETED|Intervention 6||4
8428591|NCT00862849|20771801|P3|COMPLETED|Intervention 6||3
8428592|NCT00862849|20771802|P2|COMPLETED|Intervention 6||3
8428593|NCT00862849|20771803|P1|COMPLETED|Intervention 6||3
8428594|NCT00862849|20771798|P6|STARTED|Intervention 6||3
8428595|NCT00862849|20771799|P5|STARTED|Intervention 6||4
8428596|NCT00862849|20771800|P4|STARTED|Intervention 6||4
8428597|NCT00862849|20771801|P3|STARTED|Intervention 6||3
8428598|NCT00862849|20771802|P2|STARTED|Intervention 6||3
8428599|NCT00862849|20771803|P1|STARTED|Intervention 6||3
8428600|NCT00862849|20771798|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428601|NCT00862849|20771799|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428602|NCT00862849|20771800|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428603|NCT00862849|20771801|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428604|NCT00862849|20771802|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428605|NCT00862849|20771803|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428606|NCT00862849|20771798|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
8428607|NCT00862849|20771799|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
8428608|NCT00862849|20771800|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
8428609|NCT00862849|20771801|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
8428610|NCT00862849|20771802|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
8428611|NCT00862849|20771803|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
8428612|NCT00862849|20771798|P6|STARTED|Washout 5 (3 to 14 Days)||3
8428613|NCT00862849|20771799|P5|STARTED|Washout 5 (3 to 14 Days)||4
8428614|NCT00862849|20771800|P4|STARTED|Washout 5 (3 to 14 Days)||4
8428615|NCT00862849|20771801|P3|STARTED|Washout 5 (3 to 14 Days)||3
8428616|NCT00862849|20771802|P2|STARTED|Washout 5 (3 to 14 Days)||3
8428617|NCT00862849|20771803|P1|STARTED|Washout 5 (3 to 14 Days)||3
8428618|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 5||0
8428619|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 5||0
8428620|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 5||0
8428621|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 5||0
8428622|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 5||0
8428623|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 5||0
8428624|NCT00862849|20771798|P6|COMPLETED|Intervention 5||3
8428625|NCT00862849|20771799|P5|COMPLETED|Intervention 5||4
8428626|NCT00862849|20771800|P4|COMPLETED|Intervention 5||4
8428627|NCT00862849|20771801|P3|COMPLETED|Intervention 5||3
8428628|NCT00862849|20771802|P2|COMPLETED|Intervention 5||3
8428629|NCT00862849|20771803|P1|COMPLETED|Intervention 5||3
8428630|NCT00862849|20771798|P6|STARTED|Intervention 5||3
8428631|NCT00862849|20771799|P5|STARTED|Intervention 5||4
8428632|NCT00862849|20771800|P4|STARTED|Intervention 5||4
8428633|NCT00862849|20771801|P3|STARTED|Intervention 5||3
8428634|NCT00862849|20771802|P2|STARTED|Intervention 5||3
8428635|NCT00862849|20771803|P1|STARTED|Intervention 5||3
8428636|NCT00862849|20771798|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428637|NCT00862849|20771799|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428638|NCT00862849|20771800|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428639|NCT00862849|20771801|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428640|NCT00862849|20771802|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428641|NCT00862849|20771803|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428642|NCT00862849|20771798|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
8428643|NCT00862849|20771799|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
8428644|NCT00862849|20771800|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
8428645|NCT00862849|20771801|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
8428646|NCT00862849|20771802|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
8428647|NCT00862849|20771803|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
8428648|NCT00862849|20771798|P6|STARTED|Washout 4 (3 to 14 Days)||3
8428649|NCT00862849|20771799|P5|STARTED|Washout 4 (3 to 14 Days)||4
8428650|NCT00862849|20771800|P4|STARTED|Washout 4 (3 to 14 Days)||4
8428651|NCT00862849|20771801|P3|STARTED|Washout 4 (3 to 14 Days)||3
8428652|NCT00862849|20771802|P2|STARTED|Washout 4 (3 to 14 Days)||3
8428653|NCT00862849|20771803|P1|STARTED|Washout 4 (3 to 14 Days)||3
8428654|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 4||0
8428655|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 4||0
8428656|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 4||0
8428657|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 4||0
8428658|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 4||0
8428659|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 4||0
8428660|NCT00862849|20771798|P6|COMPLETED|Intervention 4||3
8428661|NCT00862849|20771799|P5|COMPLETED|Intervention 4||4
8428662|NCT00862849|20771800|P4|COMPLETED|Intervention 4||4
8428663|NCT00862849|20771801|P3|COMPLETED|Intervention 4||3
8428664|NCT00862849|20771802|P2|COMPLETED|Intervention 4||3
8428665|NCT00862849|20771803|P1|COMPLETED|Intervention 4||3
8428666|NCT00862849|20771798|P6|STARTED|Intervention 4||3
8428667|NCT00862849|20771799|P5|STARTED|Intervention 4||4
8428668|NCT00862849|20771800|P4|STARTED|Intervention 4||4
8428669|NCT00862849|20771801|P3|STARTED|Intervention 4||3
8428670|NCT00862849|20771802|P2|STARTED|Intervention 4||3
8428671|NCT00862849|20771803|P1|STARTED|Intervention 4||3
8428672|NCT00862849|20771798|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428673|NCT00862849|20771799|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428674|NCT00862849|20771800|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428675|NCT00862849|20771801|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428676|NCT00862849|20771802|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428677|NCT00862849|20771803|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428678|NCT00862849|20771798|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
8428679|NCT00862849|20771799|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
8428680|NCT00862849|20771800|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
8428681|NCT00862849|20771801|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
8428682|NCT00862849|20771802|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
8428683|NCT00862849|20771803|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
8428684|NCT00862849|20771798|P6|STARTED|Washout 3 (3 to 14 Days)||3
8428685|NCT00862849|20771799|P5|STARTED|Washout 3 (3 to 14 Days)||4
8428686|NCT00862849|20771800|P4|STARTED|Washout 3 (3 to 14 Days)||4
8428687|NCT00862849|20771801|P3|STARTED|Washout 3 (3 to 14 Days)||3
8428688|NCT00862849|20771802|P2|STARTED|Washout 3 (3 to 14 Days)||3
8428689|NCT00862849|20771803|P1|STARTED|Washout 3 (3 to 14 Days)||3
8428690|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 3||0
8428691|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 3||0
8428692|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 3||0
8428693|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 3||0
8428694|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 3||0
8428695|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 3||0
8428696|NCT00862849|20771798|P6|COMPLETED|Intervention 3||3
8428697|NCT00862849|20771799|P5|COMPLETED|Intervention 3||4
8428698|NCT00862849|20771800|P4|COMPLETED|Intervention 3||4
8428699|NCT00862849|20771801|P3|COMPLETED|Intervention 3||3
8428700|NCT00862849|20771802|P2|COMPLETED|Intervention 3||3
8428701|NCT00862849|20771803|P1|COMPLETED|Intervention 3||3
8428702|NCT00862849|20771798|P6|STARTED|Intervention 3||3
8428703|NCT00862849|20771799|P5|STARTED|Intervention 3||4
8428704|NCT00862849|20771800|P4|STARTED|Intervention 3||4
8428705|NCT00862849|20771801|P3|STARTED|Intervention 3||3
8428706|NCT00862849|20771802|P2|STARTED|Intervention 3||3
8428707|NCT00862849|20771803|P1|STARTED|Intervention 3||3
8428708|NCT00862849|20771798|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428709|NCT00862849|20771799|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428710|NCT00862849|20771800|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428711|NCT00862849|20771801|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428712|NCT00862849|20771802|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
8428713|NCT00862849|20771803|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428714|NCT00862849|20771798|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
8428715|NCT00862849|20771799|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
8428716|NCT00862849|20771800|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
8428717|NCT00862849|20771801|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
8428718|NCT00862849|20771802|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
8428719|NCT00862849|20771803|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
8428720|NCT00862849|20771798|P6|STARTED|Washout 2 (3 to 14 Days)||3
8428721|NCT00862849|20771799|P5|STARTED|Washout 2 (3 to 14 Days)||4
8428722|NCT00862849|20771800|P4|STARTED|Washout 2 (3 to 14 Days)||4
8428723|NCT00862849|20771801|P3|STARTED|Washout 2 (3 to 14 Days)||3
8428724|NCT00862849|20771802|P2|STARTED|Washout 2 (3 to 14 Days)||4
8428725|NCT00862849|20771803|P1|STARTED|Washout 2 (3 to 14 Days)||3
8428726|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 2||0
8428727|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 2||0
8428728|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 2||0
8428729|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 2||0
8428730|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 2||0
8428731|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 2||0
8428732|NCT00862849|20771798|P6|COMPLETED|Intervention 2||3
8428733|NCT00862849|20771799|P5|COMPLETED|Intervention 2||4
8428734|NCT00862849|20771800|P4|COMPLETED|Intervention 2||4
8428735|NCT00862849|20771801|P3|COMPLETED|Intervention 2||3
8428736|NCT00862849|20771802|P2|COMPLETED|Intervention 2||4
8428737|NCT00862849|20771803|P1|COMPLETED|Intervention 2||3
8428738|NCT00862849|20771798|P6|STARTED|Intervention 2||3
8428739|NCT00862849|20771799|P5|STARTED|Intervention 2||4
8428740|NCT00862849|20771800|P4|STARTED|Intervention 2||4
8428741|NCT00862849|20771801|P3|STARTED|Intervention 2||3
8428742|NCT00862849|20771802|P2|STARTED|Intervention 2||4
8428743|NCT00862849|20771803|P1|STARTED|Intervention 2||3
8428744|NCT00862849|20771798|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428745|NCT00862849|20771799|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428746|NCT00862849|20771800|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428747|NCT00862849|20771801|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428748|NCT00862849|20771802|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
8428749|NCT00862849|20771803|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428750|NCT00862849|20771798|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
8428751|NCT00862849|20771799|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
8428752|NCT00862849|20771800|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
8428753|NCT00862849|20771801|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
8428754|NCT00862849|20771802|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
8428755|NCT00862849|20771803|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
8428756|NCT00862849|20771798|P6|STARTED|Washout 1 (3 to 14 Days)||3
8428757|NCT00862849|20771799|P5|STARTED|Washout 1 (3 to 14 Days)||4
8428758|NCT00862849|20771800|P4|STARTED|Washout 1 (3 to 14 Days)||4
8428759|NCT00862849|20771801|P3|STARTED|Washout 1 (3 to 14 Days)||3
8428760|NCT00862849|20771802|P2|STARTED|Washout 1 (3 to 14 Days)||5
8428761|NCT00862849|20771803|P1|STARTED|Washout 1 (3 to 14 Days)||3
8428762|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 1||0
8428763|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 1||0
8428764|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 1||0
8428765|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 1||0
8428766|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 1||0
8428767|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 1||0
8428768|NCT00862849|20771798|P6|COMPLETED|Intervention 1||3
8428769|NCT00862849|20771799|P5|COMPLETED|Intervention 1||4
8428770|NCT00862849|20771800|P4|COMPLETED|Intervention 1||4
8428771|NCT00862849|20771801|P3|COMPLETED|Intervention 1||3
8428772|NCT00862849|20771802|P2|COMPLETED|Intervention 1||5
8428773|NCT00862849|20771803|P1|COMPLETED|Intervention 1||3
8428774|NCT00862849|20771798|P6|Received at Least One Dose of Study Drug|Intervention 1||3
8428775|NCT00862849|20771799|P5|Received at Least One Dose of Study Drug|Intervention 1||4
8428776|NCT00862849|20771800|P4|Received at Least One Dose of Study Drug|Intervention 1||4
8428777|NCT00862849|20771801|P3|Received at Least One Dose of Study Drug|Intervention 1||3
8428778|NCT00862849|20771802|P2|Received at Least One Dose of Study Drug|Intervention 1||5
8428779|NCT00862849|20771803|P1|Received at Least One Dose of Study Drug|Intervention 1||3
8428780|NCT00862849|20771798|P6|STARTED|Intervention 1||3
8428781|NCT00862849|20771799|P5|STARTED|Intervention 1||4
8428782|NCT00862849|20771800|P4|STARTED|Intervention 1||4
8428783|NCT00862849|20771801|P3|STARTED|Intervention 1||3
8428784|NCT00862849|20771802|P2|STARTED|Intervention 1||5
8428785|NCT00862849|20771803|P1|STARTED|Intervention 1||3
8428786|NCT00862836|20771826|P1|NOT COMPLETED|Overall Study||1
8428787|NCT00862836|20771826|P1|COMPLETED|Overall Study||14
8428788|NCT00862836|20771826|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
8428789|NCT00862836|20771826|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
8428790|NCT00862836|20771826|P1|STARTED|Overall Study||15
8428791|NCT00862823|20771837|P2|NOT COMPLETED|Second Intervention||0
8428792|NCT00862823|20771838|P1|NOT COMPLETED|Second Intervention||0
8428793|NCT00862823|20771837|P2|COMPLETED|Second Intervention||9
8428794|NCT00862823|20771838|P1|COMPLETED|Second Intervention||5
8428795|NCT00862823|20771837|P2|STARTED|Second Intervention||9
8428796|NCT00862823|20771838|P1|STARTED|Second Intervention||5
8428797|NCT00862823|20771837|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8428798|NCT00862823|20771838|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8428799|NCT00862823|20771837|P2|COMPLETED|Washout Period of 2 Weeks||9
8428800|NCT00862823|20771838|P1|COMPLETED|Washout Period of 2 Weeks||5
8428801|NCT00862823|20771837|P2|STARTED|Washout Period of 2 Weeks||9
8428802|NCT00862823|20771838|P1|STARTED|Washout Period of 2 Weeks||5
8428803|NCT00862823|20771837|P2|NOT COMPLETED|First Intervention||1
8428804|NCT00862823|20771838|P1|NOT COMPLETED|First Intervention||1
8428805|NCT00862823|20771837|P2|COMPLETED|First Intervention||9
8428806|NCT00862823|20771838|P1|COMPLETED|First Intervention||5
8428807|NCT00862823|20771837|P2|STARTED|First Intervention||10
8428808|NCT00862823|20771838|P1|STARTED|First Intervention||6
8428809|NCT00862810|20771847|P2|NOT COMPLETED|Overall Study||4
8428810|NCT00862810|20771848|P1|NOT COMPLETED|Overall Study||4
8428811|NCT00862810|20771847|P2|COMPLETED|Overall Study||35
8428812|NCT00862810|20771848|P1|COMPLETED|Overall Study||29
8428813|NCT00862810|20771847|P2|STARTED|Overall Study||39
8428814|NCT00862810|20771848|P1|STARTED|Overall Study||33
8428815|NCT00862784|20771854|P1|NOT COMPLETED|Overall Study||0
8428816|NCT00862784|20771854|P1|COMPLETED|Overall Study||48
8428817|NCT00862784|20771854|P1|Received Any Amount of Study Drug|Overall Study||48
8428818|NCT00862784|20771854|P1|STARTED|Overall Study||48
8428819|NCT00862745|20771876|P2|NOT COMPLETED|Open-label Follow-up||49
8428820|NCT00862745|20771877|P1|NOT COMPLETED|Open-label Follow-up||39
8428821|NCT00862745|20771876|P2|COMPLETED|Open-label Follow-up||225
8428822|NCT00862745|20771877|P1|COMPLETED|Open-label Follow-up||229
8428823|NCT00862745|20771876|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
8428824|NCT00862745|20771877|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
8428825|NCT00862745|20771876|P2|NOT COMPLETED|Randomized Control Trial||39
8428826|NCT00862745|20771877|P1|NOT COMPLETED|Randomized Control Trial||38
8428827|NCT00862745|20771876|P2|COMPLETED|Randomized Control Trial||284
8428828|NCT00862745|20771877|P1|COMPLETED|Randomized Control Trial||284
8428829|NCT00862745|20771876|P2|STARTED|Randomized Control Trial||323
8428830|NCT00862745|20771877|P1|STARTED|Randomized Control Trial||322
8428831|NCT00862719|20771887|P4|NOT COMPLETED|Overall Study||1
8428832|NCT00862719|20771888|P3|NOT COMPLETED|Overall Study||4
8428833|NCT00862719|20771889|P2|NOT COMPLETED|Overall Study||6
8428834|NCT00862719|20771890|P1|NOT COMPLETED|Overall Study||10
8428835|NCT00862719|20771887|P4|COMPLETED|Overall Study||0
8428836|NCT00862719|20771888|P3|COMPLETED|Overall Study||0
8428837|NCT00862719|20771889|P2|COMPLETED|Overall Study||1
8428838|NCT00862719|20771890|P1|COMPLETED|Overall Study||7
8428839|NCT00862719|20771887|P4|STARTED|Overall Study||1
8428840|NCT00862719|20771888|P3|STARTED|Overall Study||4
8428841|NCT00862719|20771889|P2|STARTED|Overall Study||7
8428842|NCT00862719|20771890|P1|STARTED|Overall Study||17
8428855|NCT00862641|20771930|P4|NOT COMPLETED|Overall Study||4
8428856|NCT00862641|20771931|P3|NOT COMPLETED|Overall Study||1
8428857|NCT00862641|20771932|P2|NOT COMPLETED|Overall Study||4
8428858|NCT00862641|20771933|P1|NOT COMPLETED|Overall Study||1
8428859|NCT00862641|20771930|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
8428860|NCT00862641|20771931|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
8428861|NCT00862641|20771932|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
8428862|NCT00862641|20771933|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
8428863|NCT00862641|20771930|P4|STARTED|Overall Study||320
8428864|NCT00862641|20771931|P3|STARTED|Overall Study||152
8428865|NCT00862641|20771932|P2|STARTED|Overall Study||360
8428866|NCT00862641|20771933|P1|STARTED|Overall Study||177
8428867|NCT00862563|20771979|P4|NOT COMPLETED|Overall Study||5
8428868|NCT00862563|20771980|P3|NOT COMPLETED|Overall Study||6
8428869|NCT00862563|20771981|P2|NOT COMPLETED|Overall Study||4
8428870|NCT00862563|20771982|P1|NOT COMPLETED|Overall Study||4
8428871|NCT00862563|20771979|P4|COMPLETED|Overall Study||19
8428872|NCT00862563|20771980|P3|COMPLETED|Overall Study||15
8428873|NCT00862563|20771981|P2|COMPLETED|Overall Study||17
8428874|NCT00862563|20771982|P1|COMPLETED|Overall Study||15
8428875|NCT00862563|20771979|P4|STARTED|Overall Study||24
8428876|NCT00862563|20771980|P3|STARTED|Overall Study||21
8428877|NCT00862563|20771981|P2|STARTED|Overall Study||21
8428878|NCT00862563|20771982|P1|STARTED|Overall Study||19
8428879|NCT00862537|20772020|P1|NOT COMPLETED|Overall Study||7
8428880|NCT00862537|20772020|P1|COMPLETED|Overall Study||11
8428881|NCT00862537|20772020|P1|STARTED|Overall Study||18
8428882|NCT00862459|20772027|P3|NOT COMPLETED|Overall Study||6
8428883|NCT00862459|20772028|P2|NOT COMPLETED|Overall Study||8
8428884|NCT00862459|20772029|P1|NOT COMPLETED|Overall Study||6
8428885|NCT00862459|20772027|P3|COMPLETED|Overall Study||66
8428886|NCT00862459|20772028|P2|COMPLETED|Overall Study||85
8428887|NCT00862459|20772029|P1|COMPLETED|Overall Study||66
8428888|NCT00862459|20772027|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
8428889|NCT00862459|20772028|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
8428890|NCT00862459|20772029|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
8428891|NCT00862459|20772027|P3|STARTED|Overall Study||72
8428892|NCT00862459|20772028|P2|STARTED|Overall Study||93
8428893|NCT00862459|20772029|P1|STARTED|Overall Study||72
8428894|NCT00862446|20772173|P1|NOT COMPLETED|Overall Study||0
8428895|NCT00862446|20772173|P1|COMPLETED|Overall Study||48
8428896|NCT00862446|20772173|P1|STARTED|Overall Study||48
8428897|NCT00862277|20772180|P3|NOT COMPLETED|Overall Study||5
8428898|NCT00862277|20772181|P2|NOT COMPLETED|Overall Study||2
8428899|NCT00862277|20772182|P1|NOT COMPLETED|Overall Study||1
8428900|NCT00862277|20772180|P3|COMPLETED|Overall Study||100
8428901|NCT00862277|20772181|P2|COMPLETED|Overall Study||94
8428902|NCT00862277|20772182|P1|COMPLETED|Overall Study||560
8428903|NCT00862277|20772180|P3|STARTED|Overall Study||105
8428904|NCT00862277|20772181|P2|STARTED|Overall Study||96
8428905|NCT00862277|20772182|P1|STARTED|Overall Study||561
8428906|NCT00862251|20772196|P3|NOT COMPLETED|Overall Study||9
8428907|NCT00862251|20772197|P2|NOT COMPLETED|Overall Study||5
8428908|NCT00862251|20772198|P1|NOT COMPLETED|Overall Study||19
8428909|NCT00862251|20772196|P3|COMPLETED|Overall Study||315
8428910|NCT00862251|20772197|P2|COMPLETED|Overall Study||157
8428911|NCT00862251|20772198|P1|COMPLETED|Overall Study||303
8428912|NCT00862251|20772196|P3|STARTED|Overall Study||324
8428913|NCT00862251|20772197|P2|STARTED|Overall Study||162
8428914|NCT00862251|20772198|P1|STARTED|Overall Study||322
8428915|NCT00862186|20772251|P1|NOT COMPLETED|Overall Study||0
8428916|NCT00862186|20772251|P1|COMPLETED|Overall Study||15
8428917|NCT00862186|20772251|P1|STARTED|Overall Study||15
8428918|NCT00862134|20772258|P2|NOT COMPLETED|Overall Study||12
8428919|NCT00862134|20772259|P1|NOT COMPLETED|Overall Study||11
8428920|NCT00862134|20772258|P2|COMPLETED|Overall Study||11
8428921|NCT00862134|20772259|P1|COMPLETED|Overall Study||8
8428922|NCT00862134|20772258|P2|STARTED|Overall Study||23
8428923|NCT00862134|20772259|P1|STARTED|Overall Study||19
8428924|NCT00862121|20772271|P2|NOT COMPLETED|Overall Study||8
8428925|NCT00862121|20772272|P1|NOT COMPLETED|Overall Study||1
8428926|NCT00862121|20772271|P2|COMPLETED|Overall Study||4
8428927|NCT00862121|20772272|P1|COMPLETED|Overall Study||7
8428928|NCT00862121|20772271|P2|Safety Analysis Set|Overall Study||11
8428929|NCT00862121|20772272|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
8428930|NCT00862121|20772271|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
8428931|NCT00862121|20772272|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
8428932|NCT00862121|20772271|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
8428933|NCT00862121|20772272|P1|STARTED|Overall Study||8
8428934|NCT00862082|20772290|P2|NOT COMPLETED|Overall Study||1
8428935|NCT00862082|20772291|P1|NOT COMPLETED|Overall Study||5
8428936|NCT00862082|20772290|P2|COMPLETED|Overall Study||5
8428937|NCT00862082|20772291|P1|COMPLETED|Overall Study||3
8428938|NCT00862082|20772290|P2|STARTED|Overall Study||6
8428939|NCT00862082|20772291|P1|STARTED|Overall Study||8
8428940|NCT00861913|20772334|P1|NOT COMPLETED|Overall Study||0
8428941|NCT00861913|20772334|P1|COMPLETED|Overall Study||13
8428942|NCT00861913|20772334|P1|STARTED|Overall Study||13
8428943|NCT00861757|20772346|P4|NOT COMPLETED|Overall Study||9
8428944|NCT00861757|20772347|P3|NOT COMPLETED|Overall Study||18
8428945|NCT00861757|20772348|P2|NOT COMPLETED|Overall Study||15
8428946|NCT00861757|20772349|P1|NOT COMPLETED|Overall Study||9
8428947|NCT00861757|20772346|P4|COMPLETED|Overall Study||143
8428948|NCT00861757|20772347|P3|COMPLETED|Overall Study||137
8428949|NCT00861757|20772348|P2|COMPLETED|Overall Study||136
8428950|NCT00861757|20772349|P1|COMPLETED|Overall Study||145
8428951|NCT00861757|20772346|P4|STARTED|Overall Study||152
8428952|NCT00861757|20772347|P3|STARTED|Overall Study||155
8428953|NCT00861757|20772348|P2|STARTED|Overall Study||151
8428954|NCT00861757|20772349|P1|STARTED|Overall Study||154
8428955|NCT00861744|20772407|P4|NOT COMPLETED|Overall Study||33
8428956|NCT00861744|20772408|P3|NOT COMPLETED|Overall Study||24
8428957|NCT00861744|20772409|P2|NOT COMPLETED|Overall Study||29
8428958|NCT00861744|20772410|P1|NOT COMPLETED|Overall Study||17
8428959|NCT00861744|20772407|P4|COMPLETED|Overall Study||275
8428960|NCT00861744|20772408|P3|COMPLETED|Overall Study||280
8428961|NCT00861744|20772409|P2|COMPLETED|Overall Study||275
8428962|NCT00861744|20772410|P1|COMPLETED|Overall Study||287
8428963|NCT00861744|20772407|P4|STARTED|Overall Study||308
8428964|NCT00861744|20772408|P3|STARTED|Overall Study||304
8428965|NCT00861744|20772409|P2|STARTED|Overall Study||304
8428966|NCT00861744|20772410|P1|STARTED|Overall Study||304
8428979|NCT00861692|20772635|P1|NOT COMPLETED|Overall Study||6
8428980|NCT00861692|20772635|P1|COMPLETED|Overall Study||14
8428981|NCT00861692|20772635|P1|STARTED|Overall Study||20
8428982|NCT00861614|20772647|P2|NOT COMPLETED|Overall Study||368
8428983|NCT00861614|20772648|P1|NOT COMPLETED|Overall Study||371
8428984|NCT00861614|20772647|P2|COMPLETED|Overall Study||28
8428985|NCT00861614|20772648|P1|COMPLETED|Overall Study||22
8428986|NCT00861614|20772647|P2|STARTED|Overall Study||396
8428987|NCT00861614|20772648|P1|STARTED|Overall Study||393
8428988|NCT00861601|20772681|P3|NOT COMPLETED|Overall Study||0
8428989|NCT00861601|20772682|P2|NOT COMPLETED|Overall Study||0
8428990|NCT00861601|20772683|P1|NOT COMPLETED|Overall Study||0
8428991|NCT00861601|20772681|P3|COMPLETED|Overall Study||12
8428992|NCT00861601|20772682|P2|COMPLETED|Overall Study||14
8428993|NCT00861601|20772683|P1|COMPLETED|Overall Study||12
8428994|NCT00861601|20772681|P3|STARTED|Overall Study||12
8428995|NCT00861601|20772682|P2|STARTED|Overall Study||14
8428996|NCT00861601|20772683|P1|STARTED|Overall Study||12
8428997|NCT00861471|20772733|P1|NOT COMPLETED|Overall Study||9
8428998|NCT00861471|20772733|P1|COMPLETED|Overall Study||3
8428999|NCT00861471|20772733|P1|STARTED|Overall Study||12
8429000|NCT00861380|20772748|P7|NOT COMPLETED|Overall Study||3020
8429001|NCT00861380|20772749|P6|NOT COMPLETED|Overall Study||6249
8429002|NCT00861380|20772750|P5|NOT COMPLETED|Overall Study||1812
8429003|NCT00861380|20772751|P4|NOT COMPLETED|Overall Study||3689
8429004|NCT00861380|20772752|P3|NOT COMPLETED|Overall Study||8872
8429005|NCT00861380|20772753|P2|NOT COMPLETED|Overall Study||9112
8429006|NCT00861380|20772754|P1|NOT COMPLETED|Overall Study||8427
8429007|NCT00861380|20772748|P7|COMPLETED|Overall Study||0
8429008|NCT00861380|20772749|P6|COMPLETED|Overall Study||0
8429009|NCT00861380|20772750|P5|COMPLETED|Overall Study||0
8429010|NCT00861380|20772751|P4|COMPLETED|Overall Study||0
8429011|NCT00861380|20772752|P3|COMPLETED|Overall Study||0
8429012|NCT00861380|20772753|P2|COMPLETED|Overall Study||0
8429013|NCT00861380|20772754|P1|COMPLETED|Overall Study||0
8429014|NCT00861380|20772748|P7|STARTED|Overall Study||3020
8429015|NCT00861380|20772749|P6|STARTED|Overall Study||6249
8429016|NCT00861380|20772750|P5|STARTED|Overall Study||1812
8429017|NCT00861380|20772751|P4|STARTED|Overall Study||3689
8429018|NCT00861380|20772752|P3|STARTED|Overall Study||8872
8429019|NCT00861380|20772753|P2|STARTED|Overall Study||9112
8429020|NCT00861380|20772754|P1|STARTED|Overall Study||8427
8429021|NCT00861341|20772850|P1|NOT COMPLETED|Overall Study||2
8429022|NCT00861341|20772850|P1|COMPLETED|Overall Study||38
8429023|NCT00861341|20772850|P1|STARTED|Overall Study||40
8429024|NCT00861263|20772855|P1|NOT COMPLETED|Overall Study||0
8429025|NCT00861263|20772855|P1|COMPLETED|Overall Study||193
8429026|NCT00861263|20772855|P1|STARTED|Overall Study||193
8429027|NCT00861198|20772859|P1|NOT COMPLETED|Overall Study||5
8429028|NCT00861198|20772859|P1|COMPLETED|Overall Study||70
8429029|NCT00861198|20772859|P1|STARTED|Overall Study||75
8429030|NCT00861146|20772865|P2|NOT COMPLETED|Overall Study||8
8429031|NCT00861146|20772866|P1|NOT COMPLETED|Overall Study||20
8429032|NCT00861146|20772865|P2|COMPLETED|Overall Study||38
8429033|NCT00861146|20772866|P1|COMPLETED|Overall Study||85
8429034|NCT00861146|20772865|P2|Week 13 Assessment|Overall Study||38
8429035|NCT00861146|20772866|P1|Week 13 Assessment|Overall Study||85
8429036|NCT00861146|20772865|P2|Week 2 Assessment|Overall Study||45
8429037|NCT00861146|20772866|P1|Week 2 Assessment|Overall Study||97
8429038|NCT00861146|20772865|P2|STARTED|Overall Study||46
8429039|NCT00861146|20772866|P1|STARTED|Overall Study||105
8429040|NCT00860951|20772876|P1|NOT COMPLETED|Overall Study||7
8429041|NCT00860951|20772876|P1|COMPLETED|Overall Study||22
8429042|NCT00860951|20772876|P1|STARTED|Overall Study||29
8429043|NCT00860938|20772884|P2|NOT COMPLETED|Overall Study||8
8429044|NCT00860938|20772885|P1|NOT COMPLETED|Overall Study||14
8429045|NCT00860938|20772884|P2|COMPLETED|Overall Study||37
8429046|NCT00860938|20772885|P1|COMPLETED|Overall Study||31
8429047|NCT00860938|20772884|P2|STARTED|Overall Study||45
8429048|NCT00860938|20772885|P1|STARTED|Overall Study||45
8429049|NCT00860847|20772899|P2|NOT COMPLETED|Overall Study||5
8429050|NCT00860847|20772900|P1|NOT COMPLETED|Overall Study||4
8429051|NCT00860847|20772899|P2|COMPLETED|Overall Study||28
8429052|NCT00860847|20772900|P1|COMPLETED|Overall Study||28
8429053|NCT00860847|20772899|P2|STARTED|Overall Study||33
8429054|NCT00860847|20772900|P1|STARTED|Overall Study||32
8429055|NCT00860795|20772908|P2|NOT COMPLETED|Overall Study||0
8429056|NCT00860795|20772909|P1|NOT COMPLETED|Overall Study||0
8429057|NCT00860795|20772908|P2|COMPLETED|Overall Study||10
8429058|NCT00860795|20772909|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
8429059|NCT00860795|20772908|P2|Number to Complete Study Medication|Overall Study||10
8429060|NCT00860795|20772909|P1|Number to Complete Study Medication|Overall Study||9
8429061|NCT00860795|20772908|P2|STARTED|Overall Study||10
8429062|NCT00860795|20772909|P1|STARTED|Overall Study||10
8429063|NCT00860743|20772933|P2|NOT COMPLETED|Overall Study||0
8429064|NCT00860743|20772934|P1|NOT COMPLETED|Overall Study||3
8429065|NCT00860743|20772933|P2|COMPLETED|Overall Study||23
8429066|NCT00860743|20772934|P1|COMPLETED|Overall Study||37
8429067|NCT00860743|20772933|P2|STARTED|Overall Study||23
8429068|NCT00860743|20772934|P1|STARTED|Overall Study||40
8429069|NCT00860535|20772940|P1|NOT COMPLETED|Overall Study||1
8429070|NCT00860535|20772940|P1|COMPLETED|Overall Study||8
8429071|NCT00860535|20772940|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
8429072|NCT00860535|20772940|P1|STARTED|Overall Study||9
8429073|NCT00860470|20772947|P2|NOT COMPLETED|Overall Study||59
8429074|NCT00860470|20772948|P1|NOT COMPLETED|Overall Study||48
8429075|NCT00860470|20772947|P2|COMPLETED|Overall Study||22346
8429076|NCT00860470|20772948|P1|COMPLETED|Overall Study||22114
8429077|NCT00860470|20772947|P2|STARTED|Overall Study||22405
8429078|NCT00860470|20772948|P1|STARTED|Overall Study||22162
8429079|NCT00860457|20772972|P1|NOT COMPLETED|Overall Study||11
8429080|NCT00860457|20772972|P1|COMPLETED|Overall Study||11
8429081|NCT00860457|20772972|P1|STARTED|Overall Study||22
8429082|NCT00860405|20772978|P2|NOT COMPLETED|Overall Study||4
8429083|NCT00860405|20772979|P1|NOT COMPLETED|Overall Study||5
8429084|NCT00860405|20772978|P2|COMPLETED|Overall Study||26
8429085|NCT00860405|20772979|P1|COMPLETED|Overall Study|completed overall study|26
8429086|NCT00860405|20772978|P2|Day 28 Follow-up Performed|Overall Study||29
8429087|NCT00860405|20772979|P1|Day 28 Follow-up Performed|Overall Study||31
8429088|NCT00860405|20772978|P2|Completed Treatment|Overall Study||29
8429089|NCT00860405|20772979|P1|Completed Treatment|Overall Study||31
8429090|NCT00860405|20772978|P2|STARTED|Overall Study||30
8429091|NCT00860405|20772979|P1|STARTED|Overall Study||31
8429092|NCT00860314|20773003|P2|NOT COMPLETED|Overall Study||0
8429093|NCT00860314|20773004|P1|NOT COMPLETED|Overall Study||0
8429094|NCT00860314|20773003|P2|COMPLETED|Overall Study||48
8429095|NCT00860314|20773004|P1|COMPLETED|Overall Study||48
8429096|NCT00860314|20773003|P2|STARTED|Overall Study||48
8429097|NCT00860314|20773004|P1|STARTED|Overall Study||48
8429098|NCT00860262|20773019|P3|NOT COMPLETED|Overall Study||18
8429099|NCT00860262|20773020|P2|NOT COMPLETED|Overall Study||22
8429100|NCT00860262|20773021|P1|NOT COMPLETED|Overall Study||20
8429101|NCT00860262|20773019|P3|COMPLETED|Overall Study||202
8429102|NCT00860262|20773020|P2|COMPLETED|Overall Study||195
8429103|NCT00860262|20773021|P1|COMPLETED|Overall Study||401
8429104|NCT00860262|20773019|P3|STARTED|Overall Study||220
8429105|NCT00860262|20773020|P2|STARTED|Overall Study||217
8429106|NCT00860262|20773021|P1|STARTED|Overall Study||421
8429107|NCT00860249|20773134|P3|NOT COMPLETED|Overall Study||21
8429108|NCT00860249|20773135|P2|NOT COMPLETED|Overall Study||18
8429109|NCT00860249|20773136|P1|NOT COMPLETED|Overall Study||21
8429110|NCT00860249|20773134|P3|COMPLETED|Overall Study||0
8429111|NCT00860249|20773135|P2|COMPLETED|Overall Study||0
8429112|NCT00860249|20773136|P1|COMPLETED|Overall Study||0
8429113|NCT00860249|20773134|P3|STARTED|Overall Study||21
8429114|NCT00860249|20773135|P2|STARTED|Overall Study||18
8429115|NCT00860249|20773136|P1|STARTED|Overall Study||21
8429116|NCT00860171|20773147|P1|NOT COMPLETED|Overall Study||0
8429117|NCT00860171|20773147|P1|COMPLETED|Overall Study||16
8429118|NCT00860171|20773147|P1|STARTED|Overall Study||16
8429119|NCT00860158|20773156|P1|NOT COMPLETED|Overall Study||1
8429120|NCT00860158|20773156|P1|COMPLETED|Overall Study||0
8429121|NCT00860158|20773156|P1|STARTED|Overall Study||1
8429122|NCT00860067|20773168|P3|NOT COMPLETED|Overall Study||9
8429123|NCT00860067|20773169|P2|NOT COMPLETED|Overall Study||9
8429124|NCT00860067|20773170|P1|NOT COMPLETED|Overall Study||51
8429125|NCT00860067|20773168|P3|COMPLETED|Overall Study||292
8429126|NCT00860067|20773169|P2|COMPLETED|Overall Study||290
8429127|NCT00860067|20773170|P1|COMPLETED|Overall Study||1149
8429128|NCT00860067|20773168|P3|STARTED|Overall Study||301
8429129|NCT00860067|20773169|P2|STARTED|Overall Study||299
8429130|NCT00860067|20773170|P1|STARTED|Overall Study||1200
8429131|NCT00860028|20773230|P2|NOT COMPLETED|Smoking Cessation Phase||2
8429132|NCT00860028|20773231|P1|NOT COMPLETED|Smoking Cessation Phase||0
8429133|NCT00860028|20773230|P2|COMPLETED|Smoking Cessation Phase||12
8429134|NCT00860028|20773231|P1|COMPLETED|Smoking Cessation Phase||13
8429135|NCT00860028|20773230|P2|STARTED|Smoking Cessation Phase||14
8429136|NCT00860028|20773231|P1|STARTED|Smoking Cessation Phase||13
8429137|NCT00860028|20773230|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
8429138|NCT00860028|20773231|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
8429139|NCT00860028|20773230|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
8429140|NCT00860028|20773231|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
8429141|NCT00860028|20773230|P2|STARTED|Placebo Controlled Pretreatment Period||15
8429142|NCT00860028|20773231|P1|STARTED|Placebo Controlled Pretreatment Period||15
8429143|NCT00860015|20773241|P1|NOT COMPLETED|Overall Study||0
8429144|NCT00860015|20773241|P1|COMPLETED|Overall Study||12
8429145|NCT00860015|20773241|P1|STARTED|Overall Study||12
8429146|NCT00859976|20773247|P2|NOT COMPLETED|Overall Study||18
8429147|NCT00859976|20773248|P1|NOT COMPLETED|Overall Study||16
8429148|NCT00859976|20773247|P2|COMPLETED|Overall Study||67
8429149|NCT00859976|20773248|P1|COMPLETED|Overall Study||66
8429150|NCT00859976|20773247|P2|STARTED|Overall Study||85
8429151|NCT00859976|20773248|P1|STARTED|Overall Study||82
8429152|NCT00859950|20773264|P2|NOT COMPLETED|Overall Study||0
8429153|NCT00859950|20773265|P1|NOT COMPLETED|Overall Study||0
8429154|NCT00859950|20773264|P2|COMPLETED|Overall Study||21
8429155|NCT00859950|20773265|P1|COMPLETED|Overall Study||49
8429156|NCT00859950|20773264|P2|STARTED|Overall Study||21
8429157|NCT00859950|20773265|P1|STARTED|Overall Study||49
8429158|NCT00859937|20773273|P2|NOT COMPLETED|Overall Study||0
8429159|NCT00859937|20773274|P1|NOT COMPLETED|Overall Study||1
8429160|NCT00859937|20773273|P2|COMPLETED|Overall Study||14
8429161|NCT00859937|20773274|P1|COMPLETED|Overall Study||40
8429162|NCT00859937|20773273|P2|STARTED|Overall Study||14
8429163|NCT00859937|20773274|P1|STARTED|Overall Study||41
8429164|NCT00859898|20773289|P3|NOT COMPLETED|Overall Study||27
8429165|NCT00859898|20773290|P2|NOT COMPLETED|Overall Study||31
8429166|NCT00859898|20773291|P1|NOT COMPLETED|Overall Study||28
8429167|NCT00859898|20773289|P3|COMPLETED|Overall Study||181
8429168|NCT00859898|20773290|P2|COMPLETED|Overall Study||188
8429169|NCT00859898|20773291|P1|COMPLETED|Overall Study||183
8429170|NCT00859898|20773289|P3|STARTED|Overall Study||208
8429171|NCT00859898|20773290|P2|STARTED|Overall Study||219
8429172|NCT00859898|20773291|P1|STARTED|Overall Study||211
8429173|NCT00859833|20773332|P1|NOT COMPLETED|Overall Study||0
8429174|NCT00859833|20773332|P1|COMPLETED|Overall Study||30
8429175|NCT00859833|20773332|P1|STARTED|Overall Study||30
8429176|NCT00859651|20773339|P2|NOT COMPLETED|Overall Study||0
8429177|NCT00859651|20773340|P1|NOT COMPLETED|Overall Study||0
8429178|NCT00859651|20773339|P2|COMPLETED|Overall Study||22
8429179|NCT00859651|20773340|P1|COMPLETED|Overall Study||18
8429180|NCT00859651|20773339|P2|STARTED|Overall Study||22
8429181|NCT00859651|20773340|P1|STARTED|Overall Study||18
8429182|NCT00859638|20773350|P2|NOT COMPLETED|Overall Study||4
8429183|NCT00859638|20773351|P1|NOT COMPLETED|Overall Study||10
8429184|NCT00859638|20773350|P2|COMPLETED|Overall Study||55
8429185|NCT00859638|20773351|P1|COMPLETED|Overall Study||55
8429186|NCT00859638|20773350|P2|STARTED|Overall Study||59
8429187|NCT00859638|20773351|P1|STARTED|Overall Study||65
8429188|NCT00859586|20773357|P1|NOT COMPLETED|Overall Study||4
8429189|NCT00859586|20773357|P1|COMPLETED|Overall Study||4
8429190|NCT00859586|20773357|P1|STARTED|Overall Study||8
8429191|NCT00859573|20773373|P2|NOT COMPLETED|Overall Study||2
8429192|NCT00859573|20773374|P1|NOT COMPLETED|Overall Study||5
8429193|NCT00859573|20773373|P2|COMPLETED|Overall Study||1
8429194|NCT00859573|20773374|P1|COMPLETED|Overall Study||1
8429195|NCT00859573|20773373|P2|STARTED|Overall Study||3
8429196|NCT00859573|20773374|P1|STARTED|Overall Study||6
8429197|NCT00859547|20773380|P1|NOT COMPLETED|Overall Study||2
8429198|NCT00859547|20773380|P1|COMPLETED|Overall Study||28
8429199|NCT00859547|20773380|P1|STARTED|Overall Study||30
8429200|NCT00859521|20773393|P2|NOT COMPLETED|Second Intervention||0
8429201|NCT00859521|20773394|P1|NOT COMPLETED|Second Intervention||0
8429202|NCT00859521|20773393|P2|COMPLETED|Second Intervention||14
8429203|NCT00859521|20773394|P1|COMPLETED|Second Intervention||15
8429204|NCT00859521|20773393|P2|STARTED|Second Intervention||14
8429205|NCT00859521|20773394|P1|STARTED|Second Intervention||15
8429206|NCT00859521|20773393|P2|NOT COMPLETED|Washout||1
8429207|NCT00859521|20773394|P1|NOT COMPLETED|Washout||0
8429208|NCT00859521|20773393|P2|COMPLETED|Washout||14
8429209|NCT00859521|20773394|P1|COMPLETED|Washout||15
8429210|NCT00859521|20773393|P2|STARTED|Washout||15
8429211|NCT00859521|20773394|P1|STARTED|Washout||15
8429212|NCT00859521|20773393|P2|NOT COMPLETED|First Intervention||0
8429213|NCT00859521|20773394|P1|NOT COMPLETED|First Intervention||0
8429214|NCT00859521|20773393|P2|COMPLETED|First Intervention||15
8429215|NCT00859521|20773394|P1|COMPLETED|First Intervention||15
8429216|NCT00859521|20773393|P2|STARTED|First Intervention||15
8429217|NCT00859521|20773394|P1|STARTED|First Intervention||15
8429218|NCT00859508|20773404|P2|NOT COMPLETED|Overall Study||0
8429219|NCT00859508|20773405|P1|NOT COMPLETED|Overall Study||6
8429220|NCT00859508|20773404|P2|COMPLETED|Overall Study||37
8429221|NCT00859508|20773405|P1|COMPLETED|Overall Study||62
8429222|NCT00859508|20773404|P2|STARTED|Overall Study||37
8429223|NCT00859508|20773405|P1|STARTED|Overall Study||68
8429224|NCT00859495|20773411|P1|NOT COMPLETED|Overall Study||0
8429225|NCT00859495|20773411|P1|COMPLETED|Overall Study||9
8429226|NCT00859495|20773411|P1|STARTED|Overall Study||9
8429227|NCT00859469|20773415|P1|NOT COMPLETED|Overall Study||28
8429228|NCT00859469|20773415|P1|COMPLETED|Overall Study||1
8429229|NCT00859469|20773415|P1|6 Cycles|Overall Study||16
8429230|NCT00859469|20773415|P1|STARTED|Overall Study||29
8429231|NCT00859456|20773421|P1|NOT COMPLETED|Overall Study||8
8429232|NCT00859456|20773421|P1|COMPLETED|Overall Study||1
8429233|NCT00859456|20773421|P1|STARTED|Overall Study||9
8429234|NCT00859430|20773427|P2|NOT COMPLETED|Second Intervention||0
8429235|NCT00859430|20773428|P1|NOT COMPLETED|Second Intervention||0
8429236|NCT00859430|20773427|P2|COMPLETED|Second Intervention||10
8429237|NCT00859430|20773428|P1|COMPLETED|Second Intervention||11
8429238|NCT00859430|20773427|P2|STARTED|Second Intervention||10
8429239|NCT00859430|20773428|P1|STARTED|Second Intervention||11
8429240|NCT00859430|20773427|P2|NOT COMPLETED|First Intervention||1
8429241|NCT00859430|20773428|P1|NOT COMPLETED|First Intervention||0
8429242|NCT00859430|20773427|P2|COMPLETED|First Intervention||10
8429243|NCT00859430|20773428|P1|COMPLETED|First Intervention||11
8429244|NCT00859430|20773427|P2|STARTED|First Intervention||11
8429245|NCT00859430|20773428|P1|STARTED|First Intervention||11
8429246|NCT00859339|20773436|P1|NOT COMPLETED|Overall Study||0
8429247|NCT00859339|20773436|P1|COMPLETED|Overall Study||9
8429248|NCT00859339|20773436|P1|STARTED|Overall Study||9
8429249|NCT00859313|20773444|P1|NOT COMPLETED|Overall Study||4
8429250|NCT00859313|20773444|P1|COMPLETED|Overall Study||26
8429251|NCT00859313|20773444|P1|STARTED|Overall Study||30
8429252|NCT00859222|20773451|P5|NOT COMPLETED|Overall Study||15
8429253|NCT00859222|20773452|P4|NOT COMPLETED|Overall Study||24
8429254|NCT00859222|20773453|P3|NOT COMPLETED|Overall Study||6
8429255|NCT00859222|20773454|P2|NOT COMPLETED|Overall Study||3
8429256|NCT00859222|20773455|P1|NOT COMPLETED|Overall Study||3
8429257|NCT00859222|20773451|P5|COMPLETED|Overall Study||0
8429258|NCT00859222|20773452|P4|COMPLETED|Overall Study||0
8429259|NCT00859222|20773453|P3|COMPLETED|Overall Study||0
8429260|NCT00859222|20773454|P2|COMPLETED|Overall Study||0
8429261|NCT00859222|20773455|P1|COMPLETED|Overall Study||0
8429262|NCT00859222|20773451|P5|STARTED|Overall Study||15
8429263|NCT00859222|20773452|P4|STARTED|Overall Study||24
8429264|NCT00859222|20773453|P3|STARTED|Overall Study||6
8429265|NCT00859222|20773454|P2|STARTED|Overall Study||3
8429266|NCT00859222|20773455|P1|STARTED|Overall Study||3
8429267|NCT00859131|20773482|P2|NOT COMPLETED|Overall Study||0
8429268|NCT00859131|20773483|P1|NOT COMPLETED|Overall Study||0
8429269|NCT00859131|20773482|P2|COMPLETED|Overall Study||98
8429270|NCT00859131|20773483|P1|COMPLETED|Overall Study||102
8429271|NCT00859131|20773482|P2|STARTED|Overall Study||98
8429272|NCT00859131|20773483|P1|STARTED|Overall Study||102
8429273|NCT00859053|20773505|P4|NOT COMPLETED|Overall Study||0
8429274|NCT00859053|20773506|P3|NOT COMPLETED|Overall Study||0
8429275|NCT00859053|20773507|P2|NOT COMPLETED|Overall Study||0
8429276|NCT00859053|20773508|P1|NOT COMPLETED|Overall Study||0
8429277|NCT00859053|20773505|P4|COMPLETED|Overall Study||12
8429278|NCT00859053|20773506|P3|COMPLETED|Overall Study||6
8429279|NCT00859053|20773507|P2|COMPLETED|Overall Study||6
8429280|NCT00859053|20773508|P1|COMPLETED|Overall Study||6
8429281|NCT00859053|20773505|P4|STARTED|Overall Study||12
8429282|NCT00859053|20773506|P3|STARTED|Overall Study||6
8429283|NCT00859053|20773507|P2|STARTED|Overall Study||6
8429284|NCT00859053|20773508|P1|STARTED|Overall Study||6
8429285|NCT00859040|20773552|P2|NOT COMPLETED|Overall Study||0
8429286|NCT00859040|20773553|P1|NOT COMPLETED|Overall Study||0
8429287|NCT00859040|20773552|P2|COMPLETED|Overall Study||16
8429288|NCT00859040|20773553|P1|COMPLETED|Overall Study||18
8429289|NCT00859040|20773552|P2|STARTED|Overall Study||16
8429290|NCT00859040|20773553|P1|STARTED|Overall Study||18
8429291|NCT00859027|20773568|P2|NOT COMPLETED|Overall Study||5
8429292|NCT00859027|20773569|P1|NOT COMPLETED|Overall Study||5
8429293|NCT00859027|20773568|P2|COMPLETED|Overall Study||20
8429294|NCT00859027|20773569|P1|COMPLETED|Overall Study||20
8429295|NCT00859027|20773568|P2|STARTED|Overall Study||25
8429296|NCT00859027|20773569|P1|STARTED|Overall Study||25
8429297|NCT00859014|20773577|P1|NOT COMPLETED|Overall Study||5
8429298|NCT00859014|20773577|P1|COMPLETED|Overall Study||20
8429299|NCT00859014|20773577|P1|STARTED|Overall Study||25
8429300|NCT00858988|20773584|P2|NOT COMPLETED|Analysis||1
8429301|NCT00858988|20773585|P1|NOT COMPLETED|Analysis||2
8429302|NCT00858988|20773584|P2|COMPLETED|Analysis||72
8429303|NCT00858988|20773585|P1|COMPLETED|Analysis||72
8429304|NCT00858988|20773584|P2|STARTED|Analysis||73
8429305|NCT00858988|20773585|P1|STARTED|Analysis||74
8429306|NCT00858988|20773584|P2|NOT COMPLETED|Randomized and Allocation||0
8429307|NCT00858988|20773585|P1|NOT COMPLETED|Randomized and Allocation||0
8429308|NCT00858988|20773584|P2|COMPLETED|Randomized and Allocation||73
8429309|NCT00858988|20773585|P1|COMPLETED|Randomized and Allocation||74
8429310|NCT00858988|20773584|P2|STARTED|Randomized and Allocation||73
8429311|NCT00858988|20773585|P1|STARTED|Randomized and Allocation||74
8429312|NCT00858962|20773591|P1|NOT COMPLETED|Overall Study||0
8429313|NCT00858962|20773591|P1|COMPLETED|Overall Study||12
8429314|NCT00858962|20773591|P1|STARTED|Overall Study||12
8429315|NCT00858858|20773595|P1|NOT COMPLETED|Overall Study||18
8429316|NCT00858858|20773595|P1|COMPLETED|Overall Study||42
8429317|NCT00858858|20773595|P1|STARTED|Overall Study||60
8429318|NCT00858845|20773601|P2|NOT COMPLETED|Overall Study||1
8429319|NCT00858845|20773602|P1|NOT COMPLETED|Overall Study||0
8429320|NCT00858845|20773601|P2|COMPLETED|Overall Study||5
8429321|NCT00858845|20773602|P1|COMPLETED|Overall Study||5
8429322|NCT00858845|20773601|P2|STARTED|Overall Study||6
8429323|NCT00858845|20773602|P1|STARTED|Overall Study||5
8429324|NCT00858832|20773614|P2|NOT COMPLETED|Overall Study||1
8429325|NCT00858832|20773615|P1|NOT COMPLETED|Overall Study||1
8429326|NCT00858832|20773614|P2|COMPLETED|Overall Study||22
8429327|NCT00858832|20773615|P1|COMPLETED|Overall Study||20
8429328|NCT00858832|20773614|P2|STARTED|Overall Study||23
8429329|NCT00858832|20773615|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
8429330|NCT00858780|20773621|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
8429331|NCT00858780|20773622|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429332|NCT00858780|20773623|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429333|NCT00858780|20773624|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429334|NCT00858780|20773625|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429335|NCT00858780|20773621|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
8429336|NCT00858780|20773622|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429337|NCT00858780|20773623|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429338|NCT00858780|20773624|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429339|NCT00858780|20773625|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429418|NCT00858637|20773720|P2|STARTED|Active Comparison Phase||0
8429340|NCT00858780|20773621|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
8429341|NCT00858780|20773622|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429342|NCT00858780|20773623|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429343|NCT00858780|20773624|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429344|NCT00858780|20773625|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429345|NCT00858780|20773621|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429346|NCT00858780|20773622|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
8429347|NCT00858780|20773623|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
8429348|NCT00858780|20773624|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
8429349|NCT00858780|20773625|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429350|NCT00858780|20773621|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429351|NCT00858780|20773622|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
8429352|NCT00858780|20773623|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
8429353|NCT00858780|20773624|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
8429354|NCT00858780|20773625|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429355|NCT00858780|20773621|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
8429356|NCT00858780|20773622|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
8429357|NCT00858780|20773623|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
8429358|NCT00858780|20773624|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
8429359|NCT00858780|20773625|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
8429360|NCT00858780|20773621|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429361|NCT00858780|20773622|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429362|NCT00858780|20773623|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429363|NCT00858780|20773624|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429364|NCT00858780|20773625|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
8429365|NCT00858780|20773621|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429366|NCT00858780|20773622|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429367|NCT00858780|20773623|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429368|NCT00858780|20773624|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429369|NCT00858780|20773625|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
8429370|NCT00858780|20773621|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429371|NCT00858780|20773622|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429372|NCT00858780|20773623|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429373|NCT00858780|20773624|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429374|NCT00858780|20773625|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
8429375|NCT00858702|20773700|P2|NOT COMPLETED|Overall Study||2
8429376|NCT00858702|20773701|P1|NOT COMPLETED|Overall Study||5
8429377|NCT00858702|20773700|P2|COMPLETED|Overall Study||50
8429378|NCT00858702|20773701|P1|COMPLETED|Overall Study||48
8429379|NCT00858702|20773700|P2|STARTED|Overall Study||52
8429380|NCT00858702|20773701|P1|STARTED|Overall Study||53
8429381|NCT00858689|20773709|P1|NOT COMPLETED|Overall Study||1
8429382|NCT00858689|20773709|P1|COMPLETED|Overall Study||19
8429383|NCT00858689|20773709|P1|STARTED|Overall Study||20
8429384|NCT00858637|20773716|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8429385|NCT00858637|20773717|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8429386|NCT00858637|20773718|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8429387|NCT00858637|20773719|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8429388|NCT00858637|20773720|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8429389|NCT00858637|20773721|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8429390|NCT00858637|20773716|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
8429391|NCT00858637|20773717|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
8429392|NCT00858637|20773718|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
8429393|NCT00858637|20773719|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
8429394|NCT00858637|20773720|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
8429395|NCT00858637|20773721|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
8429396|NCT00858637|20773716|P6|STARTED|Placebo-controlled Withdrawal Phase||59
8429397|NCT00858637|20773717|P5|STARTED|Placebo-controlled Withdrawal Phase||56
8429398|NCT00858637|20773718|P4|STARTED|Placebo-controlled Withdrawal Phase||0
8429399|NCT00858637|20773719|P3|STARTED|Placebo-controlled Withdrawal Phase||54
8429400|NCT00858637|20773720|P2|STARTED|Placebo-controlled Withdrawal Phase||49
8429401|NCT00858637|20773721|P1|STARTED|Placebo-controlled Withdrawal Phase||0
8429402|NCT00858637|20773716|P6|NOT COMPLETED|Active Comparison Phase||0
8429403|NCT00858637|20773717|P5|NOT COMPLETED|Active Comparison Phase||0
8429404|NCT00858637|20773718|P4|NOT COMPLETED|Active Comparison Phase||18
8429405|NCT00858637|20773719|P3|NOT COMPLETED|Active Comparison Phase||0
8429406|NCT00858637|20773720|P2|NOT COMPLETED|Active Comparison Phase||0
8429407|NCT00858637|20773721|P1|NOT COMPLETED|Active Comparison Phase||24
8429408|NCT00858637|20773716|P6|COMPLETED|Active Comparison Phase||0
8429409|NCT00858637|20773717|P5|COMPLETED|Active Comparison Phase||0
8429410|NCT00858637|20773718|P4|COMPLETED|Active Comparison Phase||115
8429411|NCT00858637|20773719|P3|COMPLETED|Active Comparison Phase||0
8429412|NCT00858637|20773720|P2|COMPLETED|Active Comparison Phase||0
8429413|NCT00858637|20773721|P1|COMPLETED|Active Comparison Phase||103
8429414|NCT00858637|20773716|P6|STARTED|Active Comparison Phase||0
8429415|NCT00858637|20773717|P5|STARTED|Active Comparison Phase||0
8429416|NCT00858637|20773718|P4|STARTED|Active Comparison Phase||133
8429417|NCT00858637|20773719|P3|STARTED|Active Comparison Phase||0
8429419|NCT00858637|20773721|P1|STARTED|Active Comparison Phase||127
8429420|NCT00858507|20773733|P2|NOT COMPLETED|Overall Study||15
8429421|NCT00858507|20773734|P1|NOT COMPLETED|Overall Study||22
8429422|NCT00858507|20773733|P2|COMPLETED|Overall Study||101
8429423|NCT00858507|20773734|P1|COMPLETED|Overall Study||83
8429424|NCT00858507|20773733|P2|STARTED|Overall Study||116
8429425|NCT00858507|20773734|P1|STARTED|Overall Study||105
8429426|NCT00858494|20773740|P1|NOT COMPLETED|Overall Study||4
8429427|NCT00858494|20773740|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
8429428|NCT00858494|20773740|P1|STARTED|Overall Study||49
8429429|NCT00858468|20773747|P2|NOT COMPLETED|Overall Study||0
8429430|NCT00858468|20773748|P1|NOT COMPLETED|Overall Study||0
8429431|NCT00858468|20773747|P2|COMPLETED|Overall Study||192
8429432|NCT00858468|20773748|P1|COMPLETED|Overall Study||201
8429433|NCT00858468|20773747|P2|STARTED|Overall Study||192
8429434|NCT00858468|20773748|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
8429435|NCT00858442|20773762|P2|NOT COMPLETED|Compression:Start to Finish||3
8429436|NCT00858442|20773763|P1|NOT COMPLETED|Compression:Start to Finish||1
8429437|NCT00858442|20773762|P2|COMPLETED|Compression:Start to Finish||20
8429438|NCT00858442|20773763|P1|COMPLETED|Compression:Start to Finish||20
8429439|NCT00858442|20773762|P2|STARTED|Compression:Start to Finish||23
8429440|NCT00858442|20773763|P1|STARTED|Compression:Start to Finish||21
8429441|NCT00858442|20773762|P2|NOT COMPLETED|From Surgery to Start Compression;||0
8429442|NCT00858442|20773763|P1|NOT COMPLETED|From Surgery to Start Compression;||0
8429443|NCT00858442|20773762|P2|COMPLETED|From Surgery to Start Compression;||23
8429444|NCT00858442|20773763|P1|COMPLETED|From Surgery to Start Compression;||21
8429445|NCT00858442|20773762|P2|STARTED|From Surgery to Start Compression;||23
8429446|NCT00858442|20773763|P1|STARTED|From Surgery to Start Compression;||21
8429447|NCT00858403|20773773|P1|NOT COMPLETED|Overall Study||5
8429448|NCT00858403|20773773|P1|COMPLETED|Overall Study||2
8429449|NCT00858403|20773773|P1|STARTED|Overall Study||7
8429450|NCT00858390|20773785|P2|NOT COMPLETED|Overall Study||0
8429451|NCT00858390|20773786|P1|NOT COMPLETED|Overall Study||0
8429452|NCT00858390|20773785|P2|COMPLETED|Overall Study||18
8429453|NCT00858390|20773786|P1|COMPLETED|Overall Study||18
8429454|NCT00858390|20773785|P2|STARTED|Overall Study||18
8429455|NCT00858390|20773786|P1|STARTED|Overall Study||18
8429456|NCT00858364|20773794|P2|NOT COMPLETED|Overall Study||457
8429457|NCT00858364|20773795|P1|NOT COMPLETED|Overall Study||204
8429458|NCT00858364|20773794|P2|COMPLETED|Overall Study||1246
8429459|NCT00858364|20773795|P1|COMPLETED|Overall Study||642
8429460|NCT00858364|20773794|P2|Received Study Drug|Overall Study||1681
8429461|NCT00858364|20773795|P1|Received Study Drug|Overall Study||837
8429462|NCT00858364|20773794|P2|STARTED|Overall Study||1703
8429463|NCT00858364|20773795|P1|STARTED|Overall Study||846
8429464|NCT00858247|20773817|P2|NOT COMPLETED|Week 12 Follow-up||1
8429465|NCT00858247|20773818|P1|NOT COMPLETED|Week 12 Follow-up||0
8429466|NCT00858247|20773817|P2|COMPLETED|Week 12 Follow-up||23
8429467|NCT00858247|20773818|P1|COMPLETED|Week 12 Follow-up||23
8429468|NCT00858247|20773817|P2|STARTED|Week 12 Follow-up||24
8429469|NCT00858247|20773818|P1|STARTED|Week 12 Follow-up||23
8429470|NCT00858247|20773817|P2|NOT COMPLETED|Baseline Assessment||2
8429471|NCT00858247|20773818|P1|NOT COMPLETED|Baseline Assessment||2
8429472|NCT00858247|20773817|P2|COMPLETED|Baseline Assessment||24
8429473|NCT00858247|20773818|P1|COMPLETED|Baseline Assessment||23
8429474|NCT00858247|20773817|P2|STARTED|Baseline Assessment||26
8429475|NCT00858247|20773818|P1|STARTED|Baseline Assessment||25
8429476|NCT00858208|20773834|P1|NOT COMPLETED|Overall Study||79
8429477|NCT00858208|20773834|P1|COMPLETED|Overall Study||6
8429478|NCT00858208|20773834|P1|STARTED|Overall Study||85
8429479|NCT00858143|20773851|P1|NOT COMPLETED|Overall Study||50
8429480|NCT00858143|20773851|P1|COMPLETED|Overall Study||261
8429481|NCT00858143|20773851|P1|STARTED|Overall Study|Baseline|311
8429482|NCT00858130|20773900|P1|NOT COMPLETED|Overall Study||0
8429483|NCT00858130|20773900|P1|COMPLETED|Overall Study||12
8429484|NCT00858130|20773900|P1|STARTED|Overall Study||12
8429485|NCT00858117|20773908|P1|NOT COMPLETED|Follow up for 5 Years||13
8429486|NCT00858117|20773908|P1|COMPLETED|Follow up for 5 Years||17
8429487|NCT00858117|20773908|P1|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
8429488|NCT00858117|20773908|P1|NOT COMPLETED|Treatment on Study||2
8429489|NCT00858117|20773908|P1|COMPLETED|Treatment on Study||28
8429490|NCT00858117|20773908|P1|Completed 18 Weeks of Treatment|Treatment on Study||28
8429491|NCT00858117|20773908|P1|STARTED|Treatment on Study||30
8429492|NCT00858013|20773918|P2|NOT COMPLETED|Overall Study||19
8429493|NCT00858013|20773919|P1|NOT COMPLETED|Overall Study||22
8429494|NCT00858013|20773918|P2|COMPLETED|Overall Study||23
8429495|NCT00858013|20773919|P1|COMPLETED|Overall Study||24
8429496|NCT00858013|20773918|P2|STARTED|Overall Study||42
8429497|NCT00858013|20773919|P1|STARTED|Overall Study||46
8429498|NCT00857961|20773933|P1|NOT COMPLETED|Overall Study||0
8429499|NCT00857961|20773933|P1|COMPLETED|Overall Study||21
8429500|NCT00857961|20773933|P1|STARTED|Overall Study||21
8429501|NCT00857948|20773971|P4|NOT COMPLETED|Overall Study||0
8429502|NCT00857948|20773972|P3|NOT COMPLETED|Overall Study||1
8429503|NCT00857948|20773973|P2|NOT COMPLETED|Overall Study||0
8429504|NCT00857948|20773974|P1|NOT COMPLETED|Overall Study||3
8429505|NCT00857948|20773971|P4|COMPLETED|Overall Study||23
8429506|NCT00857948|20773972|P3|COMPLETED|Overall Study||18
8429507|NCT00857948|20773973|P2|COMPLETED|Overall Study||18
8429508|NCT00857948|20773974|P1|COMPLETED|Overall Study||15
8429509|NCT00857948|20773971|P4|STARTED|Overall Study||23
8429510|NCT00857948|20773972|P3|STARTED|Overall Study||19
8429511|NCT00857948|20773973|P2|STARTED|Overall Study||18
8429512|NCT00857948|20773974|P1|STARTED|Overall Study||18
8429513|NCT00857896|20773996|P1|NOT COMPLETED|Week 5 to Week 8||0
8429514|NCT00857896|20773996|P1|COMPLETED|Week 5 to Week 8||20
8429515|NCT00857896|20773996|P1|STARTED|Week 5 to Week 8||20
8429516|NCT00857896|20773996|P1|NOT COMPLETED|Baseline to Week 4||1
8429517|NCT00857896|20773996|P1|COMPLETED|Baseline to Week 4||20
8429518|NCT00857896|20773996|P1|STARTED|Baseline to Week 4||21
8429519|NCT00857857|20774008|P1|NOT COMPLETED|Overall Study||0
8429520|NCT00857857|20774008|P1|COMPLETED|Overall Study||24
8429521|NCT00857857|20774008|P1|STARTED|Overall Study||24
8429522|NCT00857818|20774152|P2|NOT COMPLETED|Overall Study||8
8429523|NCT00857818|20774153|P1|NOT COMPLETED|Overall Study||11
8429524|NCT00857818|20774152|P2|COMPLETED|Overall Study||6
8429525|NCT00857818|20774153|P1|COMPLETED|Overall Study||3
8429526|NCT00857818|20774152|P2|Received Treatment|Overall Study||12
8429527|NCT00857818|20774153|P1|Received Treatment|Overall Study||14
8429528|NCT00857818|20774152|P2|STARTED|Overall Study||14
8429529|NCT00857818|20774153|P1|STARTED|Overall Study||14
8429530|NCT00857792|20774181|P1|NOT COMPLETED|Overall Study||12
8429531|NCT00857792|20774181|P1|COMPLETED|Overall Study||108
8429532|NCT00857792|20774181|P1|STARTED|Overall Study||120
8429533|NCT00857766|20774187|P2|NOT COMPLETED|Overall Study||30
8429534|NCT00857766|20774188|P1|NOT COMPLETED|Overall Study||31
8429535|NCT00857766|20774187|P2|COMPLETED|Overall Study||96
8429536|NCT00857766|20774188|P1|COMPLETED|Overall Study||92
8429537|NCT00857766|20774187|P2|STARTED|Overall Study||126
8429538|NCT00857766|20774188|P1|STARTED|Overall Study||123
8429539|NCT00857727|20774200|P2|NOT COMPLETED|Overall Study||0
8429540|NCT00857727|20774201|P1|NOT COMPLETED|Overall Study||0
8429541|NCT00857727|20774200|P2|COMPLETED|Overall Study||14
8429542|NCT00857727|20774201|P1|COMPLETED|Overall Study||14
8429543|NCT00857727|20774200|P2|STARTED|Overall Study||14
8429544|NCT00857727|20774201|P1|STARTED|Overall Study||14
8429545|NCT00857714|20774223|P1|NOT COMPLETED|Overall Study||0
8429546|NCT00857714|20774223|P1|COMPLETED|Overall Study||1
8429547|NCT00857714|20774223|P1|STARTED|Overall Study||1
8429548|NCT00857649|20774230|P2|NOT COMPLETED|Overall Study||32
8429549|NCT00857649|20774231|P1|NOT COMPLETED|Overall Study||31
8429550|NCT00857649|20774230|P2|COMPLETED|Overall Study||155
8429551|NCT00857649|20774231|P1|COMPLETED|Overall Study||151
8429552|NCT00857649|20774230|P2|STARTED|Overall Study||187
8429553|NCT00857649|20774231|P1|STARTED|Overall Study||182
8429554|NCT00857623|20774247|P2|NOT COMPLETED|Overall Study||10
8429555|NCT00857623|20774248|P1|NOT COMPLETED|Overall Study||14
8429556|NCT00857623|20774247|P2|COMPLETED|Overall Study||55
8429557|NCT00857623|20774248|P1|COMPLETED|Overall Study||48
8429558|NCT00857623|20774247|P2|STARTED|Overall Study||65
8429559|NCT00857623|20774248|P1|STARTED|Overall Study||62
8429560|NCT00857584|20774272|P2|NOT COMPLETED|Overall Study||5
8429561|NCT00857584|20774273|P1|NOT COMPLETED|Overall Study||4
8429562|NCT00857584|20774272|P2|COMPLETED|Overall Study||8
8429563|NCT00857584|20774273|P1|COMPLETED|Overall Study||10
8429564|NCT00857584|20774272|P2|Week 8|Overall Study||8
8429565|NCT00857584|20774273|P1|Week 8|Overall Study||10
8429566|NCT00857584|20774272|P2|Week 4|Overall Study||9
8429567|NCT00857584|20774273|P1|Week 4|Overall Study||11
8429568|NCT00857584|20774272|P2|Week 2|Overall Study||11
8429569|NCT00857584|20774273|P1|Week 2|Overall Study||14
8429570|NCT00857584|20774272|P2|Week 1|Overall Study||13
8429571|NCT00857584|20774273|P1|Week 1|Overall Study||14
8429572|NCT00857584|20774272|P2|STARTED|Overall Study||13
8429573|NCT00857584|20774273|P1|STARTED|Overall Study||14
8429574|NCT00857545|20774315|P2|NOT COMPLETED|Overall Study||0
8429575|NCT00857545|20774316|P1|NOT COMPLETED|Overall Study||0
8429576|NCT00857545|20774315|P2|COMPLETED|Overall Study||85
8429577|NCT00857545|20774316|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
8429578|NCT00857545|20774315|P2|STARTED|Overall Study||85
8429579|NCT00857545|20774316|P1|STARTED|Overall Study||86
8429580|NCT00857532|20774326|P1|NOT COMPLETED|Overall Study||0
8429581|NCT00857532|20774326|P1|COMPLETED|Overall Study||31
8429582|NCT00857532|20774326|P1|STARTED|Overall Study||31
8429583|NCT00857506|20774337|P3|NOT COMPLETED|Overall Study||18
8429584|NCT00857506|20774338|P2|NOT COMPLETED|Overall Study||15
8429585|NCT00857506|20774339|P1|NOT COMPLETED|Overall Study||15
8429586|NCT00857506|20774337|P3|COMPLETED|Overall Study||51
8429587|NCT00857506|20774338|P2|COMPLETED|Overall Study||37
8429588|NCT00857506|20774339|P1|COMPLETED|Overall Study||16
8429589|NCT00857506|20774337|P3|STARTED|Overall Study||69
8429590|NCT00857506|20774338|P2|STARTED|Overall Study||52
8429591|NCT00857506|20774339|P1|STARTED|Overall Study||31
8429592|NCT00857493|20774367|P2|NOT COMPLETED|Overall Study||0
8429593|NCT00857493|20774368|P1|NOT COMPLETED|Overall Study||3
8429594|NCT00857493|20774367|P2|COMPLETED|Overall Study||58
8429595|NCT00857493|20774368|P1|COMPLETED|Overall Study||59
8429596|NCT00857493|20774367|P2|STARTED|Overall Study||58
8429597|NCT00857493|20774368|P1|STARTED|Overall Study||62
8429598|NCT00857454|20774400|P1|NOT COMPLETED|Overall Study||20
8429599|NCT00857454|20774400|P1|COMPLETED|Overall Study||51
8429600|NCT00857454|20774400|P1|STARTED|Overall Study||71
8429601|NCT00857415|20774413|P2|NOT COMPLETED|Overall Study||0
8429602|NCT00857415|20774414|P1|NOT COMPLETED|Overall Study||117
8429603|NCT00857415|20774413|P2|COMPLETED|Overall Study||74
8429604|NCT00857415|20774414|P1|COMPLETED|Overall Study||35
8429605|NCT00857415|20774413|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
8429606|NCT00857415|20774414|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
8429607|NCT00857415|20774413|P2|STARTED|Overall Study||74
8429608|NCT00857415|20774414|P1|STARTED|Overall Study||152
8429609|NCT00857389|20774421|P1|NOT COMPLETED|Overall Study||2
8429610|NCT00857389|20774421|P1|COMPLETED|Overall Study||58
8429611|NCT00857389|20774421|P1|STARTED|Overall Study||60
8429612|NCT00857311|20774435|P4|NOT COMPLETED|Overall Study||0
8429613|NCT00857311|20774436|P3|NOT COMPLETED|Overall Study||0
8429614|NCT00857311|20774437|P2|NOT COMPLETED|Overall Study||0
8429615|NCT00857311|20774438|P1|NOT COMPLETED|Overall Study||1
8429616|NCT00857311|20774435|P4|COMPLETED|Overall Study||0
8429617|NCT00857311|20774436|P3|COMPLETED|Overall Study||8
8429618|NCT00857311|20774437|P2|COMPLETED|Overall Study||0
8429619|NCT00857311|20774438|P1|COMPLETED|Overall Study||8
8429620|NCT00857311|20774435|P4|STARTED|Overall Study||0
8429621|NCT00857311|20774436|P3|STARTED|Overall Study||8
8429622|NCT00857311|20774437|P2|STARTED|Overall Study||0
8429623|NCT00857311|20774438|P1|STARTED|Overall Study||9
8429624|NCT00857285|20774450|P2|NOT COMPLETED|Overall Study||6
8429625|NCT00857285|20774451|P1|NOT COMPLETED|Overall Study||12
8429626|NCT00857285|20774450|P2|COMPLETED|Overall Study||59
8429627|NCT00857285|20774451|P1|COMPLETED|Overall Study||53
8429628|NCT00857285|20774450|P2|STARTED|Overall Study||65
8429629|NCT00857285|20774451|P1|STARTED|Overall Study||65
8429630|NCT00857272|20774457|P2|NOT COMPLETED|Overall Study||9
8429631|NCT00857272|20774458|P1|NOT COMPLETED|Overall Study||9
8429632|NCT00857272|20774457|P2|COMPLETED|Overall Study||145
8429633|NCT00857272|20774458|P1|COMPLETED|Overall Study||145
8429634|NCT00857272|20774457|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
8429635|NCT00857272|20774458|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
8429636|NCT00857259|20774467|P3|NOT COMPLETED|Overall Study||1
8429637|NCT00857259|20774468|P2|NOT COMPLETED|Overall Study||0
8429638|NCT00857259|20774469|P1|NOT COMPLETED|Overall Study||1
8429639|NCT00857259|20774467|P3|COMPLETED|Overall Study||6
8429640|NCT00857259|20774468|P2|COMPLETED|Overall Study||1
8429641|NCT00857259|20774469|P1|COMPLETED|Overall Study||7
8429642|NCT00857259|20774467|P3|STARTED|Overall Study||7
8429643|NCT00857259|20774468|P2|STARTED|Overall Study||1
8429644|NCT00857259|20774469|P1|STARTED|Overall Study||8
8429645|NCT00857246|20774479|P1|NOT COMPLETED|ChemoRT||3
8429646|NCT00857246|20774479|P1|COMPLETED|ChemoRT||12
8429647|NCT00857246|20774479|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
8429648|NCT00857246|20774479|P1|NOT COMPLETED|Surgery (Curative)||6
8429649|NCT00857246|20774479|P1|COMPLETED|Surgery (Curative)||21
8429650|NCT00857246|20774479|P1|STARTED|Surgery (Curative)||27
8429651|NCT00857246|20774479|P1|NOT COMPLETED|Induction Regimen||3
8429652|NCT00857246|20774479|P1|COMPLETED|Induction Regimen||27
8429653|NCT00857246|20774479|P1|STARTED|Induction Regimen||30
8429654|NCT00857233|20774489|P1|NOT COMPLETED|Overall Study||55
8429655|NCT00857233|20774489|P1|COMPLETED|Overall Study||242
8429656|NCT00857233|20774489|P1|STARTED|Overall Study||297
8429657|NCT00857220|20774498|P1|NOT COMPLETED|Overall Study||183
8429658|NCT00857220|20774498|P1|COMPLETED|Overall Study||121
8429659|NCT00857220|20774498|P1|STARTED|Overall Study||304
8429660|NCT00856999|20774515|P1|NOT COMPLETED|Overall Study||5
8429661|NCT00856999|20774515|P1|COMPLETED|Overall Study||45
8429662|NCT00856999|20774515|P1|STARTED|Overall Study||50
8429663|NCT00856986|20774525|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
8429664|NCT00856986|20774526|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
8429665|NCT00856986|20774527|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
8429666|NCT00856986|20774528|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
8429667|NCT00856986|20774529|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
8429668|NCT00856986|20774525|P5|COMPLETED|Extension Period, Weeks 26-52||0
8429669|NCT00856986|20774526|P4|COMPLETED|Extension Period, Weeks 26-52||0
8429670|NCT00856986|20774527|P3|COMPLETED|Extension Period, Weeks 26-52||432
8429671|NCT00856986|20774528|P2|COMPLETED|Extension Period, Weeks 26-52||130
8429672|NCT00856986|20774529|P1|COMPLETED|Extension Period, Weeks 26-52||108
8429673|NCT00856986|20774525|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
8429674|NCT00856986|20774526|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
8429675|NCT00856986|20774527|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
8429676|NCT00856986|20774528|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
8429677|NCT00856986|20774529|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
8429678|NCT00856986|20774525|P5|STARTED|Extension Period, Weeks 26-52||0
8429679|NCT00856986|20774526|P4|STARTED|Extension Period, Weeks 26-52||0
8429680|NCT00856986|20774527|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
8429681|NCT00856986|20774528|P2|STARTED|Extension Period, Weeks 26-52||144
8429682|NCT00856986|20774529|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
8429683|NCT00856986|20774525|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
8429684|NCT00856986|20774526|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
8429685|NCT00856986|20774527|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
8429686|NCT00856986|20774528|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
8429687|NCT00856986|20774529|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
8429688|NCT00856986|20774525|P5|COMPLETED|Main Period, Weeks 0-26||0
8429689|NCT00856986|20774526|P4|COMPLETED|Main Period, Weeks 0-26||0
8429690|NCT00856986|20774527|P3|COMPLETED|Main Period, Weeks 0-26||470
8429691|NCT00856986|20774528|P2|COMPLETED|Main Period, Weeks 0-26||144
8429692|NCT00856986|20774529|P1|COMPLETED|Main Period, Weeks 0-26||127
8429693|NCT00856986|20774525|P5|STARTED|Main Period, Weeks 0-26||0
8429694|NCT00856986|20774526|P4|STARTED|Main Period, Weeks 0-26||0
8429695|NCT00856986|20774527|P3|STARTED|Main Period, Weeks 0-26||498
8429696|NCT00856986|20774528|P2|STARTED|Main Period, Weeks 0-26||162
8429697|NCT00856986|20774529|P1|STARTED|Main Period, Weeks 0-26||161
8429698|NCT00856986|20774525|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429699|NCT00856986|20774526|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
8429700|NCT00856986|20774527|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429701|NCT00856986|20774528|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429702|NCT00856986|20774529|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429703|NCT00856986|20774525|P5|COMPLETED|Run-in Period, Weeks -12-0||0
8429704|NCT00856986|20774526|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
8429705|NCT00856986|20774527|P3|COMPLETED|Run-in Period, Weeks -12-0||498
8429706|NCT00856986|20774528|P2|COMPLETED|Run-in Period, Weeks -12-0||162
8429707|NCT00856986|20774529|P1|COMPLETED|Run-in Period, Weeks -12-0||161
8429708|NCT00856986|20774525|P5|STARTED|Run-in Period, Weeks -12-0||0
8429709|NCT00856986|20774526|P4|STARTED|Run-in Period, Weeks -12-0||167
8429710|NCT00856986|20774527|P3|STARTED|Run-in Period, Weeks -12-0||498
8429711|NCT00856986|20774528|P2|STARTED|Run-in Period, Weeks -12-0||162
8429712|NCT00856986|20774529|P1|STARTED|Run-in Period, Weeks -12-0||161
8429713|NCT00856973|20774699|P3|NOT COMPLETED|Overall Study||38
8429714|NCT00856973|20774700|P2|NOT COMPLETED|Overall Study||41
8429715|NCT00856973|20774701|P1|NOT COMPLETED|Overall Study||36
8429716|NCT00856973|20774699|P3|COMPLETED|Overall Study||123
8429717|NCT00856973|20774700|P2|COMPLETED|Overall Study||122
8429718|NCT00856973|20774701|P1|COMPLETED|Overall Study||126
8429719|NCT00856973|20774699|P3|STARTED|Overall Study||161
8429720|NCT00856973|20774700|P2|STARTED|Overall Study||163
8429721|NCT00856973|20774701|P1|STARTED|Overall Study||162
8429722|NCT00856934|20774769|P3|NOT COMPLETED|Overall Study||0
8429723|NCT00856934|20774770|P2|NOT COMPLETED|Overall Study||0
8429724|NCT00856934|20774771|P1|NOT COMPLETED|Overall Study||0
8429725|NCT00856934|20774769|P3|COMPLETED|Overall Study||15
8429726|NCT00856934|20774770|P2|COMPLETED|Overall Study||15
8429727|NCT00856934|20774771|P1|COMPLETED|Overall Study||15
8429728|NCT00856934|20774769|P3|STARTED|Overall Study||15
8429729|NCT00856934|20774770|P2|STARTED|Overall Study||15
8429730|NCT00856934|20774771|P1|STARTED|Overall Study||15
8429731|NCT00856908|20774781|P2|NOT COMPLETED|Overall Study||0
8429732|NCT00856908|20774782|P1|NOT COMPLETED|Overall Study||1
8429733|NCT00856908|20774781|P2|COMPLETED|Overall Study||5
8429734|NCT00856908|20774782|P1|COMPLETED|Overall Study||14
8429735|NCT00856908|20774781|P2|STARTED|Overall Study||5
8429736|NCT00856908|20774782|P1|STARTED|Overall Study||15
8429737|NCT00856856|20774807|P1|NOT COMPLETED|5-year Clinical Follow-up||0
8429738|NCT00856856|20774807|P1|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
8429739|NCT00856856|20774807|P1|STARTED|5-year Clinical Follow-up||100
8429740|NCT00856856|20774807|P1|NOT COMPLETED|4-year Clinical Follow-up||1
8429741|NCT00856856|20774807|P1|COMPLETED|4-year Clinical Follow-up||99
8429742|NCT00856856|20774807|P1|STARTED|4-year Clinical Follow-up||100
8429743|NCT00856856|20774807|P1|NOT COMPLETED|3-year Clinical Follow-up||0
8429744|NCT00856856|20774807|P1|COMPLETED|3-year Clinical Follow-up||100
8429745|NCT00856856|20774807|P1|STARTED|3-year Clinical Follow-up||100
8429746|NCT00856856|20774807|P1|NOT COMPLETED|2-year Clinical Follow-up||1
8429747|NCT00856856|20774807|P1|COMPLETED|2-year Clinical Follow-up||100
8429748|NCT00856856|20774807|P1|STARTED|2-year Clinical Follow-up||101
8429749|NCT00856856|20774807|P1|NOT COMPLETED|1-year Clinical Follow-up||0
8429750|NCT00856856|20774807|P1|COMPLETED|1-year Clinical Follow-up||101
8429751|NCT00856856|20774807|P1|STARTED|1-year Clinical Follow-up||101
8429752|NCT00856856|20774807|P1|NOT COMPLETED|270-day Clinical Follow-up||0
8429753|NCT00856856|20774807|P1|COMPLETED|270-day Clinical Follow-up||101
8429754|NCT00856856|20774807|P1|STARTED|270-day Clinical Follow-up||101
8429755|NCT00856856|20774807|P1|NOT COMPLETED|180-day Clinical Follow-up||0
8429756|NCT00856856|20774807|P1|COMPLETED|180-day Clinical Follow-up||101
8429757|NCT00856856|20774807|P1|STARTED|180-day Clinical Follow-up||101
8429758|NCT00856856|20774807|P1|NOT COMPLETED|30-day Clinical Follow-up||0
8429759|NCT00856856|20774807|P1|COMPLETED|30-day Clinical Follow-up||101
8429760|NCT00856856|20774807|P1|STARTED|30-day Clinical Follow-up||101
8429761|NCT00856856|20774807|P1|NOT COMPLETED|Baseline||0
8429762|NCT00856856|20774807|P1|COMPLETED|Baseline||101
8429763|NCT00856856|20774807|P1|STARTED|Baseline||101
8429764|NCT00856843|20775006|P2|NOT COMPLETED|Overall Study||5
8429765|NCT00856843|20775007|P1|NOT COMPLETED|Overall Study||2
8429766|NCT00856843|20775006|P2|COMPLETED|Overall Study||63
8429767|NCT00856843|20775007|P1|COMPLETED|Overall Study||66
8429768|NCT00856843|20775006|P2|STARTED|Overall Study||68
8429769|NCT00856843|20775007|P1|STARTED|Overall Study||68
8429770|NCT00856830|20775043|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429771|NCT00856830|20775044|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429772|NCT00856830|20775045|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429773|NCT00856830|20775046|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429774|NCT00856830|20775043|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
8429775|NCT00856830|20775044|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
8429776|NCT00856830|20775045|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
8429777|NCT00856830|20775046|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
8429778|NCT00856830|20775043|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
8429779|NCT00856830|20775044|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
8429780|NCT00856830|20775045|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
8429781|NCT00856830|20775046|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
8429782|NCT00856830|20775043|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
8429783|NCT00856830|20775044|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
8429784|NCT00856830|20775045|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
8429785|NCT00856830|20775046|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
8429786|NCT00856830|20775043|P4|COMPLETED|Irinotecan & Bendamustine||12
8429787|NCT00856830|20775044|P3|COMPLETED|Irinotecan & Bendamustine||6
8429788|NCT00856830|20775045|P2|COMPLETED|Irinotecan & Bendamustine||6
8429789|NCT00856830|20775046|P1|COMPLETED|Irinotecan & Bendamustine||3
8429790|NCT00856830|20775043|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
8429791|NCT00856830|20775044|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
8429792|NCT00856830|20775045|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
8429793|NCT00856830|20775046|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
8429794|NCT00856830|20775043|P4|STARTED|Irinotecan & Bendamustine||15
8429795|NCT00856830|20775044|P3|STARTED|Irinotecan & Bendamustine||6
8429796|NCT00856830|20775045|P2|STARTED|Irinotecan & Bendamustine||6
8429797|NCT00856830|20775046|P1|STARTED|Irinotecan & Bendamustine||3
8429798|NCT00856791|20775052|P1|NOT COMPLETED|Overall Study||0
8429799|NCT00856791|20775052|P1|COMPLETED|Overall Study||1
8429800|NCT00856791|20775052|P1|STARTED|Overall Study||1
8429801|NCT00856778|20775057|P1|NOT COMPLETED|Overall Study||24
8429802|NCT00856778|20775057|P1|COMPLETED|Overall Study||74
8429803|NCT00856778|20775057|P1|STARTED|Overall Study||98
8429804|NCT00856739|20775076|P3|NOT COMPLETED|Overall Study||0
8429805|NCT00856739|20775077|P2|NOT COMPLETED|Overall Study||0
8429806|NCT00856739|20775078|P1|NOT COMPLETED|Overall Study||0
8429807|NCT00856739|20775076|P3|COMPLETED|Overall Study||55
8429808|NCT00856739|20775077|P2|COMPLETED|Overall Study||52
8429809|NCT00856739|20775078|P1|COMPLETED|Overall Study||70
8429810|NCT00856739|20775076|P3|STARTED|Overall Study||55
8429811|NCT00856739|20775077|P2|STARTED|Overall Study||52
8429812|NCT00856739|20775078|P1|STARTED|Overall Study||70
8429813|NCT00856726|20775089|P1|NOT COMPLETED|Overall Study||0
8429814|NCT00856726|20775089|P1|COMPLETED|Overall Study||26
8429815|NCT00856726|20775089|P1|STARTED|Overall Study||26
8429816|NCT00856661|20775100|P2|NOT COMPLETED|Overall Study||29
8429817|NCT00856661|20775101|P1|NOT COMPLETED|Overall Study||27
8429818|NCT00856661|20775100|P2|COMPLETED|Overall Study||106
8429819|NCT00856661|20775101|P1|COMPLETED|Overall Study||108
8429820|NCT00856661|20775100|P2|Randomized Not Treated|Overall Study||4
8429821|NCT00856661|20775101|P1|Randomized Not Treated|Overall Study||9
8429822|NCT00856661|20775100|P2|Treated|Overall Study||131
8429823|NCT00856661|20775101|P1|Treated|Overall Study||126
8429824|NCT00856661|20775100|P2|STARTED|Overall Study|Randomised|135
8429825|NCT00856661|20775101|P1|STARTED|Overall Study|Randomised|135
8429826|NCT00856635|20775115|P2|NOT COMPLETED|Overall Study||8
8429827|NCT00856635|20775116|P1|NOT COMPLETED|Overall Study||10
8429828|NCT00856635|20775115|P2|COMPLETED|Overall Study||14
8429829|NCT00856635|20775116|P1|COMPLETED|Overall Study||12
8429830|NCT00856635|20775115|P2|Received Study Drug|Overall Study||20
8429831|NCT00856635|20775116|P1|Received Study Drug|Overall Study||20
8429832|NCT00856635|20775115|P2|STARTED|Overall Study||22
8429833|NCT00856635|20775116|P1|STARTED|Overall Study||22
8429834|NCT00856609|20775126|P2|NOT COMPLETED|Overall Study||0
8429835|NCT00856609|20775127|P1|NOT COMPLETED|Overall Study||1
8429836|NCT00856609|20775126|P2|COMPLETED|Overall Study||39
8429837|NCT00856609|20775127|P1|COMPLETED|Overall Study||40
8429838|NCT00856609|20775126|P2|STARTED|Overall Study||39
8429839|NCT00856609|20775127|P1|STARTED|Overall Study||41
8429840|NCT00856583|20775139|P2|NOT COMPLETED|Overall Study||2597
8429841|NCT00856583|20775140|P1|NOT COMPLETED|Overall Study||3137
8429842|NCT00856583|20775139|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
8429843|NCT00856583|20775140|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
8429844|NCT00856583|20775139|P2|STARTED|Overall Study|Patients treated|4904
8429845|NCT00856583|20775140|P1|STARTED|Overall Study|Patients treated|4905
8429846|NCT00856557|20775170|P2|NOT COMPLETED|Overall Study||16
8429847|NCT00856557|20775171|P1|NOT COMPLETED|Overall Study||12
8429848|NCT00856557|20775170|P2|COMPLETED|Overall Study||60
8429849|NCT00856557|20775171|P1|COMPLETED|Overall Study||50
8429850|NCT00856557|20775170|P2|With Patients With Contextual Flags|Overall Study||60
8429851|NCT00856557|20775171|P1|With Patients With Contextual Flags|Overall Study||50
8429852|NCT00856557|20775170|P2|Tested With Standardized Patients|Overall Study||76
8429853|NCT00856557|20775171|P1|Tested With Standardized Patients|Overall Study||62
8429854|NCT00856557|20775170|P2|Received Intervention/Control|Overall Study||76
8429855|NCT00856557|20775171|P1|Received Intervention/Control|Overall Study||62
8429856|NCT00856557|20775170|P2|STARTED|Overall Study||76
8429857|NCT00856557|20775171|P1|STARTED|Overall Study||62
8429858|NCT00856544|20775185|P4|NOT COMPLETED|Overall Study||13
8429859|NCT00856544|20775186|P3|NOT COMPLETED|Overall Study||8
8429860|NCT00856544|20775187|P2|NOT COMPLETED|Overall Study||66
8429861|NCT00856544|20775188|P1|NOT COMPLETED|Overall Study||57
8429862|NCT00856544|20775185|P4|COMPLETED|Overall Study||67
8429863|NCT00856544|20775186|P3|COMPLETED|Overall Study||71
8429864|NCT00856544|20775187|P2|COMPLETED|Overall Study||252
8429865|NCT00856544|20775188|P1|COMPLETED|Overall Study||261
8429866|NCT00856544|20775185|P4|Treated|Overall Study||80
8429867|NCT00856544|20775186|P3|Treated|Overall Study||79
8429868|NCT00856544|20775187|P2|Treated|Overall Study||318
8429869|NCT00856544|20775188|P1|Treated|Overall Study||315
8429870|NCT00856544|20775185|P4|STARTED|Overall Study||80
8429871|NCT00856544|20775186|P3|STARTED|Overall Study||79
8429872|NCT00856544|20775187|P2|STARTED|Overall Study||318
8429873|NCT00856544|20775188|P1|STARTED|Overall Study||318
8429874|NCT00856518|20775367|P2|NOT COMPLETED|Overall Study||2
8429875|NCT00856518|20775368|P1|NOT COMPLETED|Overall Study||4
8429876|NCT00856518|20775367|P2|COMPLETED|Overall Study||16
8429877|NCT00856518|20775368|P1|COMPLETED|Overall Study||20
8429878|NCT00856518|20775367|P2|STARTED|Overall Study||18
8429879|NCT00856518|20775368|P1|STARTED|Overall Study||24
8429880|NCT00856492|20775381|P3|NOT COMPLETED|Overall Study||2
8429881|NCT00856492|20775382|P2|NOT COMPLETED|Overall Study||1
8429882|NCT00856492|20775383|P1|NOT COMPLETED|Overall Study||1
8429883|NCT00856492|20775381|P3|COMPLETED|Overall Study||51
8429884|NCT00856492|20775382|P2|COMPLETED|Overall Study||62
8429885|NCT00856492|20775383|P1|COMPLETED|Overall Study||98
8429886|NCT00856492|20775381|P3|Toxicity Eval|Overall Study||51
8429887|NCT00856492|20775382|P2|Toxicity Eval|Overall Study||60
8429888|NCT00856492|20775383|P1|Toxicity Eval|Overall Study||96
8429889|NCT00856492|20775381|P3|STARTED|Overall Study||53
8429890|NCT00856492|20775382|P2|STARTED|Overall Study||63
8429891|NCT00856492|20775383|P1|STARTED|Overall Study||99
8429892|NCT00856414|20775397|P1|NOT COMPLETED|Overall Study||0
8429893|NCT00856414|20775397|P1|COMPLETED|Overall Study||45
8429894|NCT00856414|20775397|P1|STARTED|Overall Study||45
8429895|NCT00856388|20775405|P1|NOT COMPLETED|Overall Study||1
8429896|NCT00856388|20775405|P1|COMPLETED|Overall Study||61
8429897|NCT00856388|20775405|P1|STARTED|Overall Study||62
8429898|NCT00856349|20775416|P1|NOT COMPLETED|Overall Study||1021
8429899|NCT00856349|20775416|P1|COMPLETED|Overall Study||3111
8429900|NCT00856349|20775416|P1|24 Month Follow-up|Overall Study||1698
8429901|NCT00856349|20775416|P1|18 Month Follow-up|Overall Study||2467
8429902|NCT00856349|20775416|P1|12 Month Follow-up|Overall Study||3228
8429903|NCT00856349|20775416|P1|STARTED|Overall Study||4132
8429904|NCT00856323|20775425|P1|NOT COMPLETED|Overall Study||2
8429905|NCT00856323|20775425|P1|COMPLETED|Overall Study||51
8429906|NCT00856323|20775425|P1|STARTED|Overall Study||53
8429907|NCT00856297|20775437|P5|NOT COMPLETED|Overall Study||0
8429908|NCT00856297|20775438|P4|NOT COMPLETED|Overall Study||0
8429909|NCT00856297|20775439|P3|NOT COMPLETED|Overall Study||0
8429910|NCT00856297|20775440|P2|NOT COMPLETED|Overall Study||0
8429911|NCT00856297|20775441|P1|NOT COMPLETED|Overall Study||2
8429912|NCT00856297|20775437|P5|COMPLETED|Overall Study||31
8429913|NCT00856297|20775438|P4|COMPLETED|Overall Study||44
8429914|NCT00856297|20775439|P3|COMPLETED|Overall Study||107
8429915|NCT00856297|20775440|P2|COMPLETED|Overall Study||76
8429916|NCT00856297|20775441|P1|COMPLETED|Overall Study||129
8429917|NCT00856297|20775437|P5|STARTED|Overall Study||31
8429918|NCT00856297|20775438|P4|STARTED|Overall Study||44
8429919|NCT00856297|20775439|P3|STARTED|Overall Study||107
8429920|NCT00856297|20775440|P2|STARTED|Overall Study||76
8429921|NCT00856297|20775441|P1|STARTED|Overall Study||131
8429922|NCT00856284|20775474|P3|NOT COMPLETED|Overall Study||447
8429923|NCT00856284|20775475|P2|NOT COMPLETED|Overall Study||392
8429924|NCT00856284|20775476|P1|NOT COMPLETED|Overall Study||408
8429925|NCT00856284|20775474|P3|COMPLETED|Overall Study||427
8429926|NCT00856284|20775475|P2|COMPLETED|Overall Study||493
8429927|NCT00856284|20775476|P1|COMPLETED|Overall Study||472
8429928|NCT00856284|20775474|P3|Received Study Drug|Overall Study||869
8429929|NCT00856284|20775475|P2|Received Study Drug|Overall Study||878
8429930|NCT00856284|20775476|P1|Received Study Drug|Overall Study||873
8429931|NCT00856284|20775474|P3|STARTED|Overall Study||874
8429932|NCT00856284|20775475|P2|STARTED|Overall Study||885
8429933|NCT00856284|20775476|P1|STARTED|Overall Study||880
8429934|NCT00856245|20775502|P1|NOT COMPLETED|Overall Study||5
8429935|NCT00856245|20775502|P1|COMPLETED|Overall Study||14
8429936|NCT00856245|20775502|P1|STARTED|Overall Study||19
8429937|NCT00856232|20775510|P3|NOT COMPLETED|Overall Study||0
8429938|NCT00856232|20775511|P2|NOT COMPLETED|Overall Study||0
8429939|NCT00856232|20775512|P1|NOT COMPLETED|Overall Study||0
8429940|NCT00856232|20775510|P3|COMPLETED|Overall Study||36
8429941|NCT00856232|20775511|P2|COMPLETED|Overall Study||29
8429942|NCT00856232|20775512|P1|COMPLETED|Overall Study||26
8429943|NCT00856232|20775510|P3|STARTED|Overall Study||36
8429944|NCT00856232|20775511|P2|STARTED|Overall Study||29
8429945|NCT00856232|20775512|P1|STARTED|Overall Study||26
8429946|NCT00856206|20775525|P2|NOT COMPLETED|Overall Study||161
8429947|NCT00856206|20775526|P1|NOT COMPLETED|Overall Study||54
8429948|NCT00856206|20775525|P2|COMPLETED|Overall Study||824
8429949|NCT00856206|20775526|P1|COMPLETED|Overall Study||276
8429950|NCT00856206|20775525|P2|STARTED|Overall Study||985
8429951|NCT00856206|20775526|P1|STARTED|Overall Study||330
8429952|NCT00856193|20775540|P2|NOT COMPLETED|Period 2||2
8429953|NCT00856193|20775541|P1|NOT COMPLETED|Period 2||0
8429954|NCT00856193|20775540|P2|COMPLETED|Period 2||15
8429955|NCT00856193|20775541|P1|COMPLETED|Period 2||16
8429956|NCT00856193|20775540|P2|STARTED|Period 2||17
8429957|NCT00856193|20775541|P1|STARTED|Period 2||16
8429958|NCT00856193|20775540|P2|NOT COMPLETED|Period 1||0
8429959|NCT00856193|20775541|P1|NOT COMPLETED|Period 1||0
8429960|NCT00856193|20775540|P2|COMPLETED|Period 1||17
8429961|NCT00856193|20775541|P1|COMPLETED|Period 1||16
8429962|NCT00856193|20775540|P2|STARTED|Period 1||17
8429963|NCT00856193|20775541|P1|STARTED|Period 1||16
8429964|NCT00856180|20775553|P1|NOT COMPLETED|Overall Study||20
8429965|NCT00856180|20775553|P1|COMPLETED|Overall Study||0
8429966|NCT00856180|20775553|P1|STARTED|Overall Study||20
8429967|NCT00856050|20775562|P1|NOT COMPLETED|Overall Study||0
8429968|NCT00856050|20775562|P1|COMPLETED|Overall Study||26
8429969|NCT00856050|20775562|P1|STARTED|Overall Study||26
8429970|NCT00856024|20775566|P1|NOT COMPLETED|Overall Study||0
8429971|NCT00856024|20775566|P1|COMPLETED|Overall Study||902
8429972|NCT00856024|20775566|P1|STARTED|Overall Study||902
8429973|NCT00855959|20775578|P1|NOT COMPLETED|Overall Study||9
8429974|NCT00855959|20775578|P1|COMPLETED|Overall Study||99
8429975|NCT00855959|20775578|P1|Patients Who Received Pulmicort Respules|Overall Study||105
8429976|NCT00855959|20775578|P1|STARTED|Overall Study||108
8429977|NCT00855933|20775595|P2|NOT COMPLETED|Overall Study||1
8429978|NCT00855933|20775596|P1|NOT COMPLETED|Overall Study||0
8429979|NCT00855933|20775595|P2|COMPLETED|Overall Study||29
8429980|NCT00855933|20775596|P1|COMPLETED|Overall Study||30
8429981|NCT00855933|20775595|P2|STARTED|Overall Study||30
8429982|NCT00855933|20775596|P1|STARTED|Overall Study||30
8429983|NCT00855920|20775605|P3|NOT COMPLETED|Overall Study||11
8429984|NCT00855920|20775606|P2|NOT COMPLETED|Overall Study||9
8429985|NCT00855920|20775607|P1|NOT COMPLETED|Overall Study||8
8429986|NCT00855920|20775605|P3|COMPLETED|Overall Study||64
8429987|NCT00855920|20775606|P2|COMPLETED|Overall Study||65
8429988|NCT00855920|20775607|P1|COMPLETED|Overall Study||68
8429989|NCT00855920|20775605|P3|Safety Population|Overall Study||75
8429990|NCT00855920|20775606|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
8429991|NCT00855920|20775607|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
8429992|NCT00855920|20775605|P3|STARTED|Overall Study||75
8429993|NCT00855920|20775606|P2|STARTED|Overall Study||74
8429994|NCT00855920|20775607|P1|STARTED|Overall Study||76
8429995|NCT00855894|20775624|P1|NOT COMPLETED|Overall Study||33
8429996|NCT00855894|20775624|P1|COMPLETED|Overall Study||8
8429997|NCT00855894|20775624|P1|STARTED|Overall Study||41
8429998|NCT00855868|20775634|P2|NOT COMPLETED|Overall Study||1
8429999|NCT00855868|20775635|P1|NOT COMPLETED|Overall Study||1
8430000|NCT00855868|20775634|P2|COMPLETED|Overall Study||14
8430001|NCT00855868|20775635|P1|COMPLETED|Overall Study||12
8430002|NCT00855868|20775634|P2|STARTED|Overall Study||15
8430003|NCT00855868|20775635|P1|STARTED|Overall Study||13
8430004|NCT00855842|20775641|P1|NOT COMPLETED|Overall Study||0
8430005|NCT00855842|20775641|P1|COMPLETED|Overall Study||4
8430006|NCT00855842|20775641|P1|STARTED|Overall Study||4
8430007|NCT00855816|20775647|P2|NOT COMPLETED|Overall Study||21
8430008|NCT00855816|20775648|P1|NOT COMPLETED|Overall Study||26
8430009|NCT00855816|20775647|P2|COMPLETED|Overall Study||12
8430010|NCT00855816|20775648|P1|COMPLETED|Overall Study||21
8430011|NCT00855816|20775647|P2|STARTED|Overall Study||33
8430012|NCT00855816|20775648|P1|STARTED|Overall Study||47
8430013|NCT00855738|20775654|P1|NOT COMPLETED|Overall Study||5
8430014|NCT00855738|20775654|P1|COMPLETED|Overall Study||106
8430015|NCT00855738|20775654|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
8430016|NCT00855738|20775654|P1|STARTED|Overall Study||111
8430017|NCT00855595|20775682|P2|NOT COMPLETED|Overall Study||7
8430018|NCT00855595|20775683|P1|NOT COMPLETED|Overall Study||6
8430019|NCT00855595|20775682|P2|COMPLETED|Overall Study||94
8430020|NCT00855595|20775683|P1|COMPLETED|Overall Study||100
8430021|NCT00855595|20775682|P2|STARTED|Overall Study||101
8430022|NCT00855595|20775683|P1|STARTED|Overall Study||106
8430023|NCT00855582|20775722|P3|NOT COMPLETED|Overall Study||30
8430024|NCT00855582|20775723|P2|NOT COMPLETED|Overall Study||24
8430025|NCT00855582|20775724|P1|NOT COMPLETED|Overall Study||26
8430026|NCT00855582|20775722|P3|COMPLETED|Overall Study||170
8430027|NCT00855582|20775723|P2|COMPLETED|Overall Study||184
8430028|NCT00855582|20775724|P1|COMPLETED|Overall Study||172
8430029|NCT00855582|20775722|P3|STARTED|Overall Study||200
8430030|NCT00855582|20775723|P2|STARTED|Overall Study||208
8430031|NCT00855582|20775724|P1|STARTED|Overall Study||198
8430032|NCT00855465|20775813|P2|NOT COMPLETED|Follow-up Period (FUP)||2
8430033|NCT00855465|20775814|P1|NOT COMPLETED|Follow-up Period (FUP)||8
8430034|NCT00855465|20775813|P2|COMPLETED|Follow-up Period (FUP)||2
8430035|NCT00855465|20775814|P1|COMPLETED|Follow-up Period (FUP)||9
8430036|NCT00855465|20775813|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
8430037|NCT00855465|20775814|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
8430038|NCT00855465|20775813|P2|NOT COMPLETED|Treatment Period||5
8430039|NCT00855465|20775814|P1|NOT COMPLETED|Treatment Period||14
8430040|NCT00855465|20775813|P2|COMPLETED|Treatment Period||83
8430041|NCT00855465|20775814|P1|COMPLETED|Treatment Period||160
8430042|NCT00855465|20775813|P2|Participants Received Treatment|Treatment Period||88
8430043|NCT00855465|20775814|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
8430044|NCT00855465|20775813|P2|STARTED|Treatment Period||88
8430045|NCT00855465|20775814|P1|STARTED|Treatment Period||174
8430046|NCT00855439|20775904|P2|NOT COMPLETED|Overall Study||0
8430047|NCT00855439|20775905|P1|NOT COMPLETED|Overall Study||3
8430048|NCT00855439|20775904|P2|COMPLETED|Overall Study||24
8430049|NCT00855439|20775905|P1|COMPLETED|Overall Study||19
8430050|NCT00855439|20775904|P2|STARTED|Overall Study||24
8430051|NCT00855439|20775905|P1|STARTED|Overall Study||22
8430052|NCT00855413|20775917|P1|NOT COMPLETED|Overall Study||0
8430053|NCT00855413|20775917|P1|COMPLETED|Overall Study||15
8430054|NCT00855413|20775917|P1|STARTED|Overall Study||15
8430055|NCT00855335|20775963|P5|NOT COMPLETED|Overall Study||1
8430056|NCT00855335|20775964|P4|NOT COMPLETED|Overall Study||7
8430057|NCT00855335|20775965|P3|NOT COMPLETED|Overall Study||5
8430058|NCT00855335|20775966|P2|NOT COMPLETED|Overall Study||2
8430059|NCT00855335|20775967|P1|NOT COMPLETED|Overall Study||5
8430060|NCT00855335|20775963|P5|COMPLETED|Overall Study||6
8430061|NCT00855335|20775964|P4|COMPLETED|Overall Study||12
8430062|NCT00855335|20775965|P3|COMPLETED|Overall Study||10
8430063|NCT00855335|20775966|P2|COMPLETED|Overall Study||16
8430064|NCT00855335|20775967|P1|COMPLETED|Overall Study||13
8430065|NCT00855335|20775963|P5|STARTED|Overall Study||7
8430066|NCT00855335|20775964|P4|STARTED|Overall Study||19
8430067|NCT00855335|20775965|P3|STARTED|Overall Study||15
8430068|NCT00855335|20775966|P2|STARTED|Overall Study||18
8430069|NCT00855335|20775967|P1|STARTED|Overall Study||18
8430070|NCT00855309|20776054|P2|NOT COMPLETED|Overall Study||0
8430071|NCT00855309|20776055|P1|NOT COMPLETED|Overall Study||1
8430072|NCT00855309|20776054|P2|COMPLETED|Overall Study||55
8430073|NCT00855309|20776055|P1|COMPLETED|Overall Study||56
8430074|NCT00855309|20776054|P2|STARTED|Overall Study||55
8430075|NCT00855309|20776055|P1|STARTED|Overall Study||57
8430076|NCT00855218|20776063|P2|NOT COMPLETED|Overall Study||153
8430077|NCT00855218|20776064|P1|NOT COMPLETED|Overall Study||154
8430078|NCT00855218|20776063|P2|COMPLETED|Overall Study||0
8430079|NCT00855218|20776064|P1|COMPLETED|Overall Study||0
8430080|NCT00855218|20776063|P2|Participants Received Treatment|Overall Study||151
8430081|NCT00855218|20776064|P1|Participants Received Treatment|Overall Study||153
8430082|NCT00855218|20776063|P2|STARTED|Overall Study||153
8430083|NCT00855218|20776064|P1|STARTED|Overall Study||154
8430084|NCT00855166|20776082|P2|NOT COMPLETED|Overall Study||8
8430085|NCT00855166|20776083|P1|NOT COMPLETED|Overall Study||5
8430086|NCT00855166|20776082|P2|COMPLETED|Overall Study||83
8430087|NCT00855166|20776083|P1|COMPLETED|Overall Study||86
8430088|NCT00855166|20776082|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
8430089|NCT00855166|20776083|P1|STARTED|Overall Study||91
8430090|NCT00855062|20776103|P2|NOT COMPLETED|Step2||6
8430091|NCT00855062|20776104|P1|NOT COMPLETED|Step2||6
8430092|NCT00855062|20776103|P2|COMPLETED|Step2||15
8430093|NCT00855062|20776104|P1|COMPLETED|Step2||13
8430094|NCT00855062|20776103|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
8430095|NCT00855062|20776104|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
8430096|NCT00855062|20776103|P2|NOT COMPLETED|Step1||11
8430097|NCT00855062|20776104|P1|NOT COMPLETED|Step1||10
8430098|NCT00855062|20776103|P2|COMPLETED|Step1||26
8430099|NCT00855062|20776104|P1|COMPLETED|Step1||26
8430100|NCT00855062|20776103|P2|STARTED|Step1||37
8430101|NCT00855062|20776104|P1|STARTED|Step1||36
8430102|NCT00855010|20776130|P2|NOT COMPLETED|Overall Study||1
8430103|NCT00855010|20776131|P1|NOT COMPLETED|Overall Study||4
8430104|NCT00855010|20776130|P2|COMPLETED|Overall Study||18
8430105|NCT00855010|20776131|P1|COMPLETED|Overall Study||19
8430106|NCT00855010|20776130|P2|STARTED|Overall Study||19
8430107|NCT00855010|20776131|P1|STARTED|Overall Study||23
8430108|NCT00854906|20776153|P1|NOT COMPLETED|Overall Study||1
8430109|NCT00854906|20776153|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
8430110|NCT00854906|20776153|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
8430111|NCT00854724|20776162|P2|NOT COMPLETED|Second Intervention||1
8430112|NCT00854724|20776163|P1|NOT COMPLETED|Second Intervention||1
8430113|NCT00854724|20776162|P2|COMPLETED|Second Intervention||5
8430114|NCT00854724|20776163|P1|COMPLETED|Second Intervention||5
8430115|NCT00854724|20776162|P2|STARTED|Second Intervention||6
8430116|NCT00854724|20776163|P1|STARTED|Second Intervention||6
8430117|NCT00854724|20776162|P2|NOT COMPLETED|Washout||1
8430118|NCT00854724|20776163|P1|NOT COMPLETED|Washout||1
8430119|NCT00854724|20776162|P2|COMPLETED|Washout||6
8430120|NCT00854724|20776163|P1|COMPLETED|Washout||6
8430121|NCT00854724|20776162|P2|STARTED|Washout||7
8430122|NCT00854724|20776163|P1|STARTED|Washout||7
8430123|NCT00854724|20776162|P2|NOT COMPLETED|First Intervention||1
8430124|NCT00854724|20776163|P1|NOT COMPLETED|First Intervention||1
8430125|NCT00854724|20776162|P2|COMPLETED|First Intervention||7
8430126|NCT00854724|20776163|P1|COMPLETED|First Intervention||7
8430127|NCT00854724|20776162|P2|STARTED|First Intervention||8
8430128|NCT00854724|20776163|P1|STARTED|First Intervention||8
8430129|NCT00854620|20776169|P1|NOT COMPLETED|Overall Study||1
8430130|NCT00854620|20776169|P1|COMPLETED|Overall Study||8
8430131|NCT00854620|20776169|P1|STARTED|Overall Study||9
8430132|NCT00854607|20776173|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
8430133|NCT00854607|20776173|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
8430134|NCT00854607|20776173|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
8430135|NCT00854607|20776173|P1|NOT COMPLETED|Enrollment||0
8430136|NCT00854607|20776173|P1|COMPLETED|Enrollment||116
8430137|NCT00854607|20776173|P1|STARTED|Enrollment||116
8430138|NCT00854594|20776208|P2|NOT COMPLETED|Overall Study||0
8430139|NCT00854594|20776209|P1|NOT COMPLETED|Overall Study||0
8430140|NCT00854594|20776208|P2|COMPLETED|Overall Study||69
8430141|NCT00854594|20776209|P1|COMPLETED|Overall Study||48
8430142|NCT00854594|20776208|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
8430143|NCT00854594|20776209|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
8430144|NCT00854581|20776221|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
8430145|NCT00854581|20776221|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
8430146|NCT00854581|20776221|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
8430147|NCT00854581|20776221|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
8430148|NCT00854581|20776221|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
8430149|NCT00854581|20776221|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
8430150|NCT00854581|20776221|P1|NOT COMPLETED|Induction (Up to Day 21)||6
8430151|NCT00854581|20776221|P1|COMPLETED|Induction (Up to Day 21)||7
8430152|NCT00854581|20776221|P1|STARTED|Induction (Up to Day 21)||13
8430153|NCT00854373|20776236|P2|NOT COMPLETED|Overall Study||4
8430154|NCT00854373|20776237|P1|NOT COMPLETED|Overall Study||2
8430155|NCT00854373|20776236|P2|COMPLETED|Overall Study||89
8430156|NCT00854373|20776237|P1|COMPLETED|Overall Study||93
8430157|NCT00854373|20776236|P2|STARTED|Overall Study||93
8430158|NCT00854373|20776237|P1|STARTED|Overall Study||95
8430159|NCT00854360|20776251|P4|NOT COMPLETED|Overall Study||10
8430160|NCT00854360|20776252|P3|NOT COMPLETED|Overall Study||2
8430161|NCT00854360|20776253|P2|NOT COMPLETED|Overall Study||3
8430162|NCT00854360|20776254|P1|NOT COMPLETED|Overall Study||2
8430163|NCT00854360|20776251|P4|COMPLETED|Overall Study||114
8430164|NCT00854360|20776252|P3|COMPLETED|Overall Study||120
8430165|NCT00854360|20776253|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
8430166|NCT00854360|20776254|P1|COMPLETED|Overall Study||116
8430167|NCT00854360|20776251|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
8430168|NCT00854360|20776252|P3|Intent to Treat / Safety Population|Overall Study||122
8430169|NCT00854360|20776253|P2|Intent to Treat / Safety Population|Overall Study||123
8430170|NCT00854360|20776254|P1|Intent to Treat / Safety Population|Overall Study||118
8430171|NCT00854360|20776251|P4|STARTED|Overall Study||124
8430172|NCT00854360|20776252|P3|STARTED|Overall Study||122
8430173|NCT00854360|20776253|P2|STARTED|Overall Study||123
8430174|NCT00854360|20776254|P1|STARTED|Overall Study||118
8430175|NCT00854308|20776286|P2|NOT COMPLETED|Overall Study||67
8430176|NCT00854308|20776287|P1|NOT COMPLETED|Overall Study||62
8430177|NCT00854308|20776286|P2|COMPLETED|Overall Study||1
8430178|NCT00854308|20776287|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
8430179|NCT00854308|20776286|P2|Received Study Drug|Overall Study||67
8430180|NCT00854308|20776287|P1|Received Study Drug|Overall Study||69
8430181|NCT00854308|20776286|P2|STARTED|Overall Study||68
8430182|NCT00854308|20776287|P1|STARTED|Overall Study||69
8430183|NCT00854113|20776312|P11|NOT COMPLETED|Overall Study||0
8430184|NCT00854113|20776313|P10|NOT COMPLETED|Overall Study||0
8430185|NCT00854113|20776314|P9|NOT COMPLETED|Overall Study||1
8430186|NCT00854113|20776315|P8|NOT COMPLETED|Overall Study||3
8430187|NCT00854113|20776316|P7|NOT COMPLETED|Overall Study||0
8430188|NCT00854113|20776317|P6|NOT COMPLETED|Overall Study||0
8430189|NCT00854113|20776318|P5|NOT COMPLETED|Overall Study||0
8430190|NCT00854113|20776319|P4|NOT COMPLETED|Overall Study||0
8430191|NCT00854113|20776320|P3|NOT COMPLETED|Overall Study||0
8430192|NCT00854113|20776321|P2|NOT COMPLETED|Overall Study||0
8430193|NCT00854113|20776322|P1|NOT COMPLETED|Overall Study||0
8430194|NCT00854113|20776312|P11|COMPLETED|Overall Study||6
8430195|NCT00854113|20776313|P10|COMPLETED|Overall Study||8
8430196|NCT00854113|20776314|P9|COMPLETED|Overall Study||7
8430197|NCT00854113|20776315|P8|COMPLETED|Overall Study||5
8430198|NCT00854113|20776316|P7|COMPLETED|Overall Study||12
8430199|NCT00854113|20776317|P6|COMPLETED|Overall Study||6
8430200|NCT00854113|20776318|P5|COMPLETED|Overall Study||6
8430201|NCT00854113|20776319|P4|COMPLETED|Overall Study||6
8430202|NCT00854113|20776320|P3|COMPLETED|Overall Study||6
8430203|NCT00854113|20776321|P2|COMPLETED|Overall Study||6
8430204|NCT00854113|20776322|P1|COMPLETED|Overall Study||6
8430205|NCT00854113|20776312|P11|STARTED|Overall Study||6
8430206|NCT00854113|20776313|P10|STARTED|Overall Study||8
8430207|NCT00854113|20776314|P9|STARTED|Overall Study||8
8430208|NCT00854113|20776315|P8|STARTED|Overall Study||8
8430209|NCT00854113|20776316|P7|STARTED|Overall Study||12
8430210|NCT00854113|20776317|P6|STARTED|Overall Study||6
8430211|NCT00854113|20776318|P5|STARTED|Overall Study||6
8430212|NCT00854113|20776319|P4|STARTED|Overall Study||6
8430213|NCT00854113|20776320|P3|STARTED|Overall Study||6
8430214|NCT00854113|20776321|P2|STARTED|Overall Study||6
8430215|NCT00854113|20776322|P1|STARTED|Overall Study||6
8430216|NCT00854100|20776426|P3|NOT COMPLETED|Overall Study||11
8430217|NCT00854100|20776427|P2|NOT COMPLETED|Overall Study||6
8430218|NCT00854100|20776428|P1|NOT COMPLETED|Overall Study||9
8430219|NCT00854100|20776426|P3|COMPLETED|Overall Study||63
8430220|NCT00854100|20776427|P2|COMPLETED|Overall Study||70
8430221|NCT00854100|20776428|P1|COMPLETED|Overall Study||72
8430222|NCT00854100|20776426|P3|STARTED|Overall Study||74
8430223|NCT00854100|20776427|P2|STARTED|Overall Study||76
8430224|NCT00854100|20776428|P1|STARTED|Overall Study||81
8430225|NCT00854087|20776442|P2|NOT COMPLETED|Overall Study||19
8430226|NCT00854087|20776443|P1|NOT COMPLETED|Overall Study||19
8430227|NCT00854087|20776442|P2|COMPLETED|Overall Study||40
8430228|NCT00854087|20776443|P1|COMPLETED|Overall Study||40
8430229|NCT00854087|20776442|P2|STARTED|Overall Study||59
8430230|NCT00854087|20776443|P1|STARTED|Overall Study||59
8430231|NCT00854061|20776449|P1|NOT COMPLETED|Overall Study||23
8430232|NCT00854061|20776449|P1|COMPLETED|Overall Study||149
8430233|NCT00854061|20776449|P1|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
8430234|NCT00854061|20776449|P1|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
8430235|NCT00854061|20776449|P1|STARTED|Overall Study||172
8430236|NCT00853996|20776455|P1|NOT COMPLETED|Overall Study||0
8430237|NCT00853996|20776455|P1|COMPLETED|Overall Study||25
8430238|NCT00853996|20776455|P1|STARTED|Overall Study||25
8430239|NCT00853970|20776467|P2|NOT COMPLETED|Overall Study||3
8430240|NCT00853970|20776468|P1|NOT COMPLETED|Overall Study||6
8430241|NCT00853970|20776467|P2|COMPLETED|Overall Study||144
8430242|NCT00853970|20776468|P1|COMPLETED|Overall Study||146
8430243|NCT00853970|20776467|P2|STARTED|Overall Study||147
8430244|NCT00853970|20776468|P1|STARTED|Overall Study||152
8430245|NCT00853957|20776478|P2|NOT COMPLETED|Overall Study||19
8430246|NCT00853957|20776479|P1|NOT COMPLETED|Overall Study||14
8430247|NCT00853957|20776478|P2|COMPLETED|Overall Study||204
8430248|NCT00853957|20776479|P1|COMPLETED|Overall Study||206
8430249|NCT00853957|20776478|P2|STARTED|Overall Study||223
8430250|NCT00853957|20776479|P1|STARTED|Overall Study||220
8430251|NCT00853905|20776497|P2|NOT COMPLETED|Overall Study||4
8430252|NCT00853905|20776498|P1|NOT COMPLETED|Overall Study||2
8430253|NCT00853905|20776497|P2|COMPLETED|Overall Study||36
8430254|NCT00853905|20776498|P1|COMPLETED|Overall Study||35
8430255|NCT00853905|20776497|P2|STARTED|Overall Study||40
8430256|NCT00853905|20776498|P1|STARTED|Overall Study||37
8430257|NCT00853840|20776512|P2|NOT COMPLETED|Period 2||0
8430258|NCT00853840|20776513|P1|NOT COMPLETED|Period 2||0
8430259|NCT00853840|20776512|P2|COMPLETED|Period 2||9
8430260|NCT00853840|20776513|P1|COMPLETED|Period 2||9
8430261|NCT00853840|20776512|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
8430262|NCT00853840|20776513|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
8430263|NCT00853840|20776512|P2|Maraviroc (Days 1 - 3)|Period 2||9
8430264|NCT00853840|20776513|P1|Maraviroc (Days 1 - 3)|Period 2||9
8430265|NCT00853840|20776512|P2|STARTED|Period 2||9
8430266|NCT00853840|20776513|P1|STARTED|Period 2||9
8430267|NCT00853840|20776512|P2|NOT COMPLETED|Period 1||0
8430268|NCT00853840|20776513|P1|NOT COMPLETED|Period 1||0
8430269|NCT00853840|20776512|P2|COMPLETED|Period 1||9
8430270|NCT00853840|20776513|P1|COMPLETED|Period 1||9
8430271|NCT00853840|20776512|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
8430272|NCT00853840|20776513|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
8430273|NCT00853840|20776512|P2|Maraviroc (Days 1 - 4)|Period 1||9
8430274|NCT00853840|20776513|P1|Maraviroc (Days 1 - 4)|Period 1||9
8430275|NCT00853840|20776512|P2|STARTED|Period 1||9
8430276|NCT00853840|20776513|P1|STARTED|Period 1||9
8430277|NCT00853827|20776530|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
8430278|NCT00853827|20776531|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
8430279|NCT00853827|20776530|P2|COMPLETED|Double Blind Period (103 Weeks)||199
8430280|NCT00853827|20776531|P1|COMPLETED|Double Blind Period (103 Weeks)||201
8430281|NCT00853827|20776530|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
8430282|NCT00853827|20776531|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
8430283|NCT00853827|20776530|P2|STARTED|Double Blind Period (103 Weeks)||308
8430284|NCT00853827|20776531|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
8430285|NCT00853827|20776530|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
8430286|NCT00853827|20776531|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
8430287|NCT00853827|20776530|P2|COMPLETED|Single Blind Period (1 Week)||0
8430288|NCT00853827|20776531|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
8430289|NCT00853827|20776530|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
8430290|NCT00853827|20776531|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
8430291|NCT00853762|20776547|P4|NOT COMPLETED|Overall Study||22
8430292|NCT00853762|20776548|P3|NOT COMPLETED|Overall Study||17
8430293|NCT00853762|20776549|P2|NOT COMPLETED|Overall Study||19
8430294|NCT00853762|20776550|P1|NOT COMPLETED|Overall Study||16
8430295|NCT00853762|20776547|P4|COMPLETED|Overall Study||0
8430296|NCT00853762|20776548|P3|COMPLETED|Overall Study||0
8430297|NCT00853762|20776549|P2|COMPLETED|Overall Study||0
8430298|NCT00853762|20776550|P1|COMPLETED|Overall Study||0
8430299|NCT00853762|20776547|P4|STARTED|Overall Study||22
8430300|NCT00853762|20776548|P3|STARTED|Overall Study||17
8430301|NCT00853762|20776549|P2|STARTED|Overall Study||19
8430302|NCT00853762|20776550|P1|STARTED|Overall Study||16
8430303|NCT00853749|20776618|P2|NOT COMPLETED|Overall Study||1
8430304|NCT00853749|20776619|P1|NOT COMPLETED|Overall Study||0
8430305|NCT00853749|20776618|P2|COMPLETED|Overall Study||38
8430306|NCT00853749|20776619|P1|COMPLETED|Overall Study||50
8430307|NCT00853749|20776618|P2|Vaccinated|Overall Study||39
8430308|NCT00853749|20776619|P1|Vaccinated|Overall Study||50
8430309|NCT00853749|20776618|P2|STARTED|Overall Study||39
8430310|NCT00853749|20776619|P1|STARTED|Overall Study||50
8430311|NCT00853723|20776640|P3|NOT COMPLETED|Overall Study||2
8430312|NCT00853723|20776641|P2|NOT COMPLETED|Overall Study||7
8430313|NCT00853723|20776642|P1|NOT COMPLETED|Overall Study||6
8430314|NCT00853723|20776640|P3|COMPLETED|Overall Study||33
8430315|NCT00853723|20776641|P2|COMPLETED|Overall Study||28
8430316|NCT00853723|20776642|P1|COMPLETED|Overall Study||29
8430317|NCT00853723|20776640|P3|STARTED|Overall Study||35
8430318|NCT00853723|20776641|P2|STARTED|Overall Study||35
8430319|NCT00853723|20776642|P1|STARTED|Overall Study||35
8430320|NCT00853671|20776686|P1|NOT COMPLETED|Overall Study||0
8430321|NCT00853671|20776686|P1|COMPLETED|Overall Study||50
8430322|NCT00853671|20776686|P1|STARTED|Overall Study||50
8430323|NCT00853658|20776696|P3|NOT COMPLETED|Overall Study||815
8430324|NCT00853658|20776697|P2|NOT COMPLETED|Overall Study||832
8430325|NCT00853658|20776698|P1|NOT COMPLETED|Overall Study||787
8430326|NCT00853658|20776696|P3|COMPLETED|Overall Study||1539
8430327|NCT00853658|20776697|P2|COMPLETED|Overall Study||1524
8430328|NCT00853658|20776698|P1|COMPLETED|Overall Study||1567
8430329|NCT00853658|20776696|P3|Safety Set|Overall Study||2345
8430330|NCT00853658|20776697|P2|Safety Set|Overall Study||2348
8430331|NCT00853658|20776698|P1|Safety Set|Overall Study||2347
8430332|NCT00853658|20776696|P3|Full Analysis Set (FAS)|Overall Study||2336
8430333|NCT00853658|20776697|P2|Full Analysis Set (FAS)|Overall Study||2340
8430334|NCT00853658|20776698|P1|Full Analysis Set (FAS)|Overall Study||2340
8430335|NCT00853658|20776696|P3|STARTED|Overall Study||2354
8430336|NCT00853658|20776697|P2|STARTED|Overall Study||2356
8430337|NCT00853658|20776698|P1|STARTED|Overall Study||2354
8430338|NCT00853606|20776712|P1|NOT COMPLETED|Overall Study||220
8430339|NCT00853606|20776712|P1|COMPLETED|Overall Study||492
8430340|NCT00853606|20776712|P1|STARTED|Overall Study||712
8430341|NCT00853593|20776718|P1|NOT COMPLETED|Overall Study||45
8430342|NCT00853593|20776718|P1|COMPLETED|Overall Study||152
8430343|NCT00853593|20776718|P1|Model 4396 Lead Attempted|Overall Study||164
8430344|NCT00853593|20776718|P1|Implant Attempted|Overall Study||193
8430345|NCT00853593|20776718|P1|STARTED|Overall Study||197
8430346|NCT00853580|20776745|P2|NOT COMPLETED|Overall Study||16
8430347|NCT00853580|20776746|P1|NOT COMPLETED|Overall Study||7
8430348|NCT00853580|20776745|P2|COMPLETED|Overall Study||56
8430349|NCT00853580|20776746|P1|COMPLETED|Overall Study||67
8430350|NCT00853580|20776745|P2|STARTED|Overall Study||72
8430351|NCT00853580|20776746|P1|STARTED|Overall Study||74
8430352|NCT00853567|20776793|P1|NOT COMPLETED|Overall Study||71
8430353|NCT00853567|20776793|P1|COMPLETED|Overall Study||0
8430354|NCT00853567|20776793|P1|STARTED|Overall Study||71
8430355|NCT00853489|20776803|P2|NOT COMPLETED|Overall Study||2
8430356|NCT00853489|20776804|P1|NOT COMPLETED|Overall Study||5
8430357|NCT00853489|20776803|P2|COMPLETED|Overall Study||12
8430358|NCT00853489|20776804|P1|COMPLETED|Overall Study||11
8430359|NCT00853489|20776803|P2|STARTED|Overall Study||14
8430360|NCT00853489|20776804|P1|STARTED|Overall Study||16
8430361|NCT00853385|20776819|P5|NOT COMPLETED|Overall Study||42
8430362|NCT00853385|20776820|P4|NOT COMPLETED|Overall Study||13
8430363|NCT00853385|20776821|P3|NOT COMPLETED|Overall Study||9
8430364|NCT00853385|20776822|P2|NOT COMPLETED|Overall Study||43
8430365|NCT00853385|20776823|P1|NOT COMPLETED|Overall Study||54
8430366|NCT00853385|20776819|P5|COMPLETED|Overall Study||162
8430367|NCT00853385|20776820|P4|COMPLETED|Overall Study||39
8430368|NCT00853385|20776821|P3|COMPLETED|Overall Study||47
8430369|NCT00853385|20776822|P2|COMPLETED|Overall Study||158
8430370|NCT00853385|20776823|P1|COMPLETED|Overall Study||150
8430371|NCT00853385|20776819|P5|STARTED|Overall Study||204
8430372|NCT00853385|20776820|P4|STARTED|Overall Study||52
8430373|NCT00853385|20776821|P3|STARTED|Overall Study||56
8430374|NCT00853385|20776822|P2|STARTED|Overall Study||201
8430375|NCT00853385|20776823|P1|STARTED|Overall Study||204
8430376|NCT00853372|20777038|P2|NOT COMPLETED|Overall Study||29
8430377|NCT00853372|20777039|P1|NOT COMPLETED|Overall Study||32
8430378|NCT00853372|20777038|P2|COMPLETED|Overall Study||13
8430379|NCT00853372|20777039|P1|COMPLETED|Overall Study||11
8430380|NCT00853372|20777038|P2|STARTED|Overall Study||42
8430381|NCT00853372|20777039|P1|STARTED|Overall Study||43
8430382|NCT00853333|20777076|P3|NOT COMPLETED|Overall Study||0
8430383|NCT00853333|20777077|P2|NOT COMPLETED|Overall Study||0
8430384|NCT00853333|20777078|P1|NOT COMPLETED|Overall Study||0
8430385|NCT00853333|20777076|P3|COMPLETED|Overall Study||31
8430386|NCT00853333|20777077|P2|COMPLETED|Overall Study||27
8430387|NCT00853333|20777078|P1|COMPLETED|Overall Study||28
8430388|NCT00853333|20777076|P3|STARTED|Overall Study||31
8430389|NCT00853333|20777077|P2|STARTED|Overall Study||27
8430390|NCT00853333|20777078|P1|STARTED|Overall Study||28
8430391|NCT00853307|20777088|P2|NOT COMPLETED|Overall Study||5
8430392|NCT00853307|20777089|P1|NOT COMPLETED|Overall Study||2
8430393|NCT00853307|20777088|P2|COMPLETED|Overall Study||20
8430394|NCT00853307|20777089|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
8430395|NCT00853307|20777088|P2|STARTED|Overall Study||25
8430396|NCT00853307|20777089|P1|STARTED|Overall Study||6
8430397|NCT00853242|20777116|P7|NOT COMPLETED|Overall Study||5
8430398|NCT00853242|20777117|P6|NOT COMPLETED|Overall Study||2
8430399|NCT00853242|20777118|P5|NOT COMPLETED|Overall Study||4
8430400|NCT00853242|20777119|P4|NOT COMPLETED|Overall Study||4
8430401|NCT00853242|20777120|P3|NOT COMPLETED|Overall Study||3
8430402|NCT00853242|20777121|P2|NOT COMPLETED|Overall Study||3
8430403|NCT00853242|20777122|P1|NOT COMPLETED|Overall Study||3
8430404|NCT00853242|20777116|P7|COMPLETED|Overall Study||44
8430405|NCT00853242|20777117|P6|COMPLETED|Overall Study||49
8430406|NCT00853242|20777118|P5|COMPLETED|Overall Study||46
8430407|NCT00853242|20777119|P4|COMPLETED|Overall Study||46
8430408|NCT00853242|20777120|P3|COMPLETED|Overall Study||46
8430409|NCT00853242|20777121|P2|COMPLETED|Overall Study||47
8430410|NCT00853242|20777122|P1|COMPLETED|Overall Study||47
8430411|NCT00853242|20777116|P7|Treated|Overall Study||48
8430412|NCT00853242|20777117|P6|Treated|Overall Study||51
8430413|NCT00853242|20777118|P5|Treated|Overall Study||50
8430414|NCT00853242|20777119|P4|Treated|Overall Study||50
8430415|NCT00853242|20777120|P3|Treated|Overall Study||48
8430416|NCT00853242|20777121|P2|Treated|Overall Study||49
8430417|NCT00853242|20777122|P1|Treated|Overall Study||50
8430418|NCT00853242|20777116|P7|STARTED|Overall Study||49
8430419|NCT00853242|20777117|P6|STARTED|Overall Study||51
8430420|NCT00853242|20777118|P5|STARTED|Overall Study||50
8430421|NCT00853242|20777119|P4|STARTED|Overall Study||50
8430422|NCT00853242|20777120|P3|STARTED|Overall Study||49
8430423|NCT00853242|20777121|P2|STARTED|Overall Study||50
8430424|NCT00853242|20777122|P1|STARTED|Overall Study||50
8430425|NCT00853229|20777164|P2|NOT COMPLETED|Phase 2: Cross Over||0
8430426|NCT00853229|20777165|P1|NOT COMPLETED|Phase 2: Cross Over||0
8430427|NCT00853229|20777164|P2|COMPLETED|Phase 2: Cross Over||0
8430428|NCT00853229|20777165|P1|COMPLETED|Phase 2: Cross Over||0
8430429|NCT00853229|20777164|P2|STARTED|Phase 2: Cross Over||0
8430430|NCT00853229|20777165|P1|STARTED|Phase 2: Cross Over||0
8430431|NCT00853229|20777164|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
8430432|NCT00853229|20777165|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
8430433|NCT00853229|20777164|P2|COMPLETED|Phase 1: Initial Intervention||0
8430434|NCT00853229|20777165|P1|COMPLETED|Phase 1: Initial Intervention||0
8430435|NCT00853229|20777164|P2|STARTED|Phase 1: Initial Intervention||8
8430436|NCT00853229|20777165|P1|STARTED|Phase 1: Initial Intervention||8
8430437|NCT00853151|20777175|P4|NOT COMPLETED|Overall Study||3
8430438|NCT00853151|20777176|P3|NOT COMPLETED|Overall Study||8
8430439|NCT00853151|20777177|P2|NOT COMPLETED|Overall Study||13
8430440|NCT00853151|20777178|P1|NOT COMPLETED|Overall Study||10
8430441|NCT00853151|20777175|P4|COMPLETED|Overall Study||15
8430442|NCT00853151|20777176|P3|COMPLETED|Overall Study||30
8430443|NCT00853151|20777177|P2|COMPLETED|Overall Study||24
8430444|NCT00853151|20777178|P1|COMPLETED|Overall Study||28
8430445|NCT00853151|20777175|P4|STARTED|Overall Study||18
8430446|NCT00853151|20777176|P3|STARTED|Overall Study||38
8430447|NCT00853151|20777177|P2|STARTED|Overall Study||37
8430448|NCT00853151|20777178|P1|STARTED|Overall Study||38
8430449|NCT00853125|20777320|P1|NOT COMPLETED|Overall Study||1
8430450|NCT00853125|20777320|P1|COMPLETED|Overall Study||9
8430451|NCT00853125|20777320|P1|STARTED|Overall Study||10
8430452|NCT00853112|20777332|P7|NOT COMPLETED|Overall Study||1
8430453|NCT00853112|20777333|P6|NOT COMPLETED|Overall Study||0
8430454|NCT00853112|20777334|P5|NOT COMPLETED|Overall Study||0
8430455|NCT00853112|20777335|P4|NOT COMPLETED|Overall Study||2
8430456|NCT00853112|20777336|P3|NOT COMPLETED|Overall Study||0
8430457|NCT00853112|20777337|P2|NOT COMPLETED|Overall Study||1
8430458|NCT00853112|20777338|P1|NOT COMPLETED|Overall Study||0
8430459|NCT00853112|20777332|P7|COMPLETED|Overall Study||6
8430460|NCT00853112|20777333|P6|COMPLETED|Overall Study||7
8430461|NCT00853112|20777334|P5|COMPLETED|Overall Study||6
8430462|NCT00853112|20777335|P4|COMPLETED|Overall Study||6
8430463|NCT00853112|20777336|P3|COMPLETED|Overall Study||7
8430464|NCT00853112|20777337|P2|COMPLETED|Overall Study||6
8430465|NCT00853112|20777338|P1|COMPLETED|Overall Study||6
8430466|NCT00853112|20777332|P7|Treated|Overall Study||6
8430467|NCT00853112|20777333|P6|Treated|Overall Study||7
8430468|NCT00853112|20777334|P5|Treated|Overall Study||6
8430469|NCT00853112|20777335|P4|Treated|Overall Study||6
8430470|NCT00853112|20777336|P3|Treated|Overall Study||7
8430471|NCT00853112|20777337|P2|Treated|Overall Study||6
8430472|NCT00853112|20777338|P1|Treated|Overall Study||6
8430473|NCT00853112|20777332|P7|STARTED|Overall Study||7
8430474|NCT00853112|20777333|P6|STARTED|Overall Study||7
8430475|NCT00853112|20777334|P5|STARTED|Overall Study||6
8430476|NCT00853112|20777335|P4|STARTED|Overall Study||8
8430477|NCT00853112|20777336|P3|STARTED|Overall Study||7
8430478|NCT00853112|20777337|P2|STARTED|Overall Study||7
8430479|NCT00853112|20777338|P1|STARTED|Overall Study||6
8430480|NCT00853099|20777448|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
8430481|NCT00853099|20777449|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
8430482|NCT00853099|20777450|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
8430483|NCT00853099|20777451|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
8430484|NCT00853099|20777448|P4|COMPLETED|Double-blind + Open-label Periods||119
8430485|NCT00853099|20777449|P3|COMPLETED|Double-blind + Open-label Periods||0
8430486|NCT00853099|20777450|P2|COMPLETED|Double-blind + Open-label Periods||0
8430487|NCT00853099|20777451|P1|COMPLETED|Double-blind + Open-label Periods||0
8430488|NCT00853099|20777448|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
8430489|NCT00853099|20777449|P3|STARTED|Double-blind + Open-label Periods||0
8430490|NCT00853099|20777450|P2|STARTED|Double-blind + Open-label Periods||0
8430491|NCT00853099|20777451|P1|STARTED|Double-blind + Open-label Periods||0
8430492|NCT00853099|20777448|P4|NOT COMPLETED|Double-blind Period||0
8430493|NCT00853099|20777449|P3|NOT COMPLETED|Double-blind Period||31
8430494|NCT00853099|20777450|P2|NOT COMPLETED|Double-blind Period||29
8430495|NCT00853099|20777451|P1|NOT COMPLETED|Double-blind Period||23
8430496|NCT00853099|20777448|P4|COMPLETED|Double-blind Period||0
8430497|NCT00853099|20777449|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
8430498|NCT00853099|20777450|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
8430499|NCT00853099|20777451|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
8430500|NCT00853099|20777448|P4|Completed Week 8|Double-blind Period||0
8430501|NCT00853099|20777449|P3|Completed Week 8|Double-blind Period||86
8430502|NCT00853099|20777450|P2|Completed Week 8|Double-blind Period||85
8430503|NCT00853099|20777451|P1|Completed Week 8|Double-blind Period||92
8430504|NCT00853099|20777448|P4|Treated|Double-blind Period||0
8430505|NCT00853099|20777449|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
8430506|NCT00853099|20777450|P2|Treated|Double-blind Period||87
8430507|NCT00853099|20777451|P1|Treated|Double-blind Period||96
8430508|NCT00853099|20777448|P4|STARTED|Double-blind Period||0
8430509|NCT00853099|20777449|P3|STARTED|Double-blind Period||91
8430510|NCT00853099|20777450|P2|STARTED|Double-blind Period||87
8430511|NCT00853099|20777451|P1|STARTED|Double-blind Period||96
8430512|NCT00853073|20777493|P2|NOT COMPLETED|Overall Study||2
8430513|NCT00853073|20777494|P1|NOT COMPLETED|Overall Study||3
8430514|NCT00853073|20777493|P2|COMPLETED|Overall Study||29
8430515|NCT00853073|20777494|P1|COMPLETED|Overall Study||29
8430516|NCT00853073|20777493|P2|STARTED|Overall Study||31
8430517|NCT00853073|20777494|P1|STARTED|Overall Study||32
8430518|NCT00853047|20777507|P6|NOT COMPLETED|Open-Label Extension Phase||17
8430519|NCT00853047|20777508|P5|NOT COMPLETED|Open-Label Extension Phase||0
8430520|NCT00853047|20777509|P4|NOT COMPLETED|Open-Label Extension Phase||0
8430521|NCT00853047|20777510|P3|NOT COMPLETED|Open-Label Extension Phase||0
8430522|NCT00853047|20777511|P2|NOT COMPLETED|Open-Label Extension Phase||0
8430523|NCT00853047|20777512|P1|NOT COMPLETED|Open-Label Extension Phase||0
8430524|NCT00853047|20777507|P6|COMPLETED|Open-Label Extension Phase||2
8430525|NCT00853047|20777508|P5|COMPLETED|Open-Label Extension Phase||0
8430526|NCT00853047|20777509|P4|COMPLETED|Open-Label Extension Phase||0
8430527|NCT00853047|20777510|P3|COMPLETED|Open-Label Extension Phase||0
8430528|NCT00853047|20777511|P2|COMPLETED|Open-Label Extension Phase||0
8430529|NCT00853047|20777512|P1|COMPLETED|Open-Label Extension Phase||0
8430530|NCT00853047|20777507|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
8430531|NCT00853047|20777508|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430532|NCT00853047|20777509|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430533|NCT00853047|20777510|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430534|NCT00853047|20777511|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430535|NCT00853047|20777512|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430536|NCT00853047|20777507|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
8430537|NCT00853047|20777508|P5|STARTED|Open-Label Extension Phase||0
8430538|NCT00853047|20777509|P4|STARTED|Open-Label Extension Phase||0
8430539|NCT00853047|20777510|P3|STARTED|Open-Label Extension Phase||0
8430540|NCT00853047|20777511|P2|STARTED|Open-Label Extension Phase||0
8430541|NCT00853047|20777512|P1|STARTED|Open-Label Extension Phase||0
8430542|NCT00853047|20777507|P6|NOT COMPLETED|Core Phase||0
8430543|NCT00853047|20777508|P5|NOT COMPLETED|Core Phase||0
8430544|NCT00853047|20777509|P4|NOT COMPLETED|Core Phase||1
8430545|NCT00853047|20777510|P3|NOT COMPLETED|Core Phase||0
8430546|NCT00853047|20777511|P2|NOT COMPLETED|Core Phase||0
8430547|NCT00853047|20777512|P1|NOT COMPLETED|Core Phase||0
8430548|NCT00853047|20777507|P6|COMPLETED|Core Phase||0
8430549|NCT00853047|20777508|P5|COMPLETED|Core Phase||9
8430550|NCT00853047|20777509|P4|COMPLETED|Core Phase||2
8430551|NCT00853047|20777510|P3|COMPLETED|Core Phase||3
8430552|NCT00853047|20777511|P2|COMPLETED|Core Phase||3
8430553|NCT00853047|20777512|P1|COMPLETED|Core Phase||5
8430554|NCT00853047|20777507|P6|STARTED|Core Phase||0
8430555|NCT00853047|20777508|P5|STARTED|Core Phase||9
8430556|NCT00853047|20777509|P4|STARTED|Core Phase||3
8430557|NCT00853047|20777510|P3|STARTED|Core Phase||3
8430558|NCT00853047|20777511|P2|STARTED|Core Phase||3
8430559|NCT00853047|20777512|P1|STARTED|Core Phase||5
8430560|NCT00853021|20777578|P1|NOT COMPLETED|Overall Study||5
8430561|NCT00853021|20777578|P1|COMPLETED|Overall Study||21
8430562|NCT00853021|20777578|P1|STARTED|Overall Study||26
8430563|NCT00852995|20777590|P5|NOT COMPLETED|Overall Study||4
8430564|NCT00852995|20777591|P4|NOT COMPLETED|Overall Study||5
8430565|NCT00852995|20777592|P3|NOT COMPLETED|Overall Study||5
8430566|NCT00852995|20777593|P2|NOT COMPLETED|Overall Study||1
8430567|NCT00852995|20777594|P1|NOT COMPLETED|Overall Study||8
8430568|NCT00852995|20777590|P5|COMPLETED|Overall Study||46
8430569|NCT00852995|20777591|P4|COMPLETED|Overall Study||40
8430570|NCT00852995|20777592|P3|COMPLETED|Overall Study||39
8430571|NCT00852995|20777593|P2|COMPLETED|Overall Study||42
8430572|NCT00852995|20777594|P1|COMPLETED|Overall Study||38
8430573|NCT00852995|20777590|P5|STARTED|Overall Study||50
8430574|NCT00852995|20777591|P4|STARTED|Overall Study||45
8430575|NCT00852995|20777592|P3|STARTED|Overall Study||44
8430576|NCT00852995|20777593|P2|STARTED|Overall Study||43
8430577|NCT00852995|20777594|P1|STARTED|Overall Study||46
8430578|NCT00852969|20777638|P2|NOT COMPLETED|Overall Study||2
8430579|NCT00852969|20777639|P1|NOT COMPLETED|Overall Study||0
8430580|NCT00852969|20777638|P2|COMPLETED|Overall Study||13
8430581|NCT00852969|20777639|P1|COMPLETED|Overall Study||15
8430582|NCT00852969|20777638|P2|STARTED|Overall Study||15
8430583|NCT00852969|20777639|P1|STARTED|Overall Study||15
8430584|NCT00852930|20777650|P3|NOT COMPLETED|Overall Study||2
8430585|NCT00852930|20777651|P2|NOT COMPLETED|Overall Study||1
8430586|NCT00852930|20777652|P1|NOT COMPLETED|Overall Study||1
8430587|NCT00852930|20777650|P3|COMPLETED|Overall Study||15
8430588|NCT00852930|20777651|P2|COMPLETED|Overall Study||16
8430589|NCT00852930|20777652|P1|COMPLETED|Overall Study||15
8430590|NCT00852930|20777650|P3|STARTED|Overall Study||17
8430591|NCT00852930|20777651|P2|STARTED|Overall Study||17
8430592|NCT00852930|20777652|P1|STARTED|Overall Study||16
8430593|NCT00852917|20777673|P4|NOT COMPLETED|Overall Study||93
8430594|NCT00852917|20777674|P3|NOT COMPLETED|Overall Study||58
8430595|NCT00852917|20777675|P2|NOT COMPLETED|Overall Study||46
8430596|NCT00852917|20777676|P1|NOT COMPLETED|Overall Study||44
8430597|NCT00852917|20777673|P4|COMPLETED|Overall Study||134
8430598|NCT00852917|20777674|P3|COMPLETED|Overall Study||50
8430599|NCT00852917|20777675|P2|COMPLETED|Overall Study||65
8430600|NCT00852917|20777676|P1|COMPLETED|Overall Study||62
8430601|NCT00852917|20777673|P4|STARTED|Overall Study||227
8430602|NCT00852917|20777674|P3|STARTED|Overall Study||108
8430603|NCT00852917|20777675|P2|STARTED|Overall Study||111
8430604|NCT00852917|20777676|P1|STARTED|Overall Study||106
8430605|NCT00852761|20777716|P2|NOT COMPLETED|Overall Study||0
8430606|NCT00852761|20777717|P1|NOT COMPLETED|Overall Study||0
8430607|NCT00852761|20777716|P2|COMPLETED|Overall Study||17
8430608|NCT00852761|20777717|P1|COMPLETED|Overall Study||17
8430609|NCT00852761|20777716|P2|STARTED|Overall Study||17
8430610|NCT00852761|20777717|P1|STARTED|Overall Study||17
8430611|NCT00852644|20777759|P6|NOT COMPLETED|Overall Study||0
8430612|NCT00852644|20777760|P5|NOT COMPLETED|Overall Study||0
8430613|NCT00852644|20777761|P4|NOT COMPLETED|Overall Study||0
8430614|NCT00852644|20777762|P3|NOT COMPLETED|Overall Study||0
8430615|NCT00852644|20777763|P2|NOT COMPLETED|Overall Study||0
8430616|NCT00852644|20777764|P1|NOT COMPLETED|Overall Study||0
8430617|NCT00852644|20777759|P6|COMPLETED|Overall Study||0
8430618|NCT00852644|20777760|P5|COMPLETED|Overall Study||0
8430619|NCT00852644|20777761|P4|COMPLETED|Overall Study||3
8430620|NCT00852644|20777762|P3|COMPLETED|Overall Study||0
8430621|NCT00852644|20777763|P2|COMPLETED|Overall Study||3
8430622|NCT00852644|20777764|P1|COMPLETED|Overall Study||3
8430623|NCT00852644|20777759|P6|STARTED|Overall Study||0
8430624|NCT00852644|20777760|P5|STARTED|Overall Study||0
8430625|NCT00852644|20777761|P4|STARTED|Overall Study||3
8430626|NCT00852644|20777762|P3|STARTED|Overall Study||0
8430627|NCT00852644|20777763|P2|STARTED|Overall Study||3
8430628|NCT00852644|20777764|P1|STARTED|Overall Study||3
8430629|NCT00852631|20777785|P1|NOT COMPLETED|Overall Study||11
8430630|NCT00852631|20777785|P1|COMPLETED|Overall Study||17
8430631|NCT00852631|20777785|P1|STARTED|Overall Study||28
8430632|NCT00852592|20777793|P2|NOT COMPLETED|Overall Study||4
8430633|NCT00852592|20777794|P1|NOT COMPLETED|Overall Study||3
8430634|NCT00852592|20777793|P2|COMPLETED|Overall Study||19
8430635|NCT00852592|20777794|P1|COMPLETED|Overall Study||20
8430636|NCT00852592|20777793|P2|STARTED|Overall Study||23
8430637|NCT00852592|20777794|P1|STARTED|Overall Study||23
8430638|NCT00852540|20777804|P2|NOT COMPLETED|Overall Study||18
8430639|NCT00852540|20777805|P1|NOT COMPLETED|Overall Study||36
8430640|NCT00852540|20777804|P2|COMPLETED|Overall Study||122
8430641|NCT00852540|20777805|P1|COMPLETED|Overall Study||234
8430642|NCT00852540|20777804|P2|STARTED|Overall Study||140
8430643|NCT00852540|20777805|P1|STARTED|Overall Study||270
8430644|NCT00852527|20777831|P2|NOT COMPLETED|Overall Study||0
8430645|NCT00852527|20777832|P1|NOT COMPLETED|Overall Study||0
8430646|NCT00852527|20777831|P2|COMPLETED|Overall Study||242
8430647|NCT00852527|20777832|P1|COMPLETED|Overall Study||196
8430648|NCT00852527|20777831|P2|STARTED|Overall Study||242
8430649|NCT00852527|20777832|P1|STARTED|Overall Study||196
8430650|NCT00852475|20777839|P2|NOT COMPLETED|Overall Study||4
8430651|NCT00852475|20777840|P1|NOT COMPLETED|Overall Study||3
8430652|NCT00852475|20777839|P2|COMPLETED|Overall Study||16
8430653|NCT00852475|20777840|P1|COMPLETED|Overall Study||23
8430654|NCT00852475|20777839|P2|STARTED|Overall Study||20
8430655|NCT00852475|20777840|P1|STARTED|Overall Study||26
8430656|NCT00852397|20777851|P3|NOT COMPLETED|Overall Study||14
8430657|NCT00852397|20777852|P2|NOT COMPLETED|Overall Study||8
8430658|NCT00852397|20777853|P1|NOT COMPLETED|Overall Study||11
8430659|NCT00852397|20777851|P3|COMPLETED|Overall Study||36
8430660|NCT00852397|20777852|P2|COMPLETED|Overall Study||41
8430661|NCT00852397|20777853|P1|COMPLETED|Overall Study||41
8430662|NCT00852397|20777851|P3|Treated Participants|Overall Study||49
8430663|NCT00852397|20777852|P2|Treated Participants|Overall Study||49
8430664|NCT00852397|20777853|P1|Treated Participants|Overall Study||51
8430665|NCT00852397|20777851|P3|STARTED|Overall Study||50
8430666|NCT00852397|20777852|P2|STARTED|Overall Study||49
8430667|NCT00852397|20777853|P1|STARTED|Overall Study||52
8430668|NCT00852241|20777882|P1|NOT COMPLETED|Overall Study||18
8430669|NCT00852241|20777882|P1|COMPLETED|Overall Study||0
8430670|NCT00852241|20777882|P1|STARTED|Overall Study||18
8430671|NCT00852202|20777889|P3|NOT COMPLETED|Overall Study||26
8430672|NCT00852202|20777890|P2|NOT COMPLETED|Overall Study||12
8430673|NCT00852202|20777891|P1|NOT COMPLETED|Overall Study||17
8430674|NCT00852202|20777889|P3|COMPLETED|Overall Study||49
8430675|NCT00852202|20777890|P2|COMPLETED|Overall Study||63
8430676|NCT00852202|20777891|P1|COMPLETED|Overall Study||60
8430677|NCT00852202|20777889|P3|STARTED|Overall Study||75
8430678|NCT00852202|20777890|P2|STARTED|Overall Study||75
8430679|NCT00852202|20777891|P1|STARTED|Overall Study||77
8430680|NCT00852137|20777904|P2|NOT COMPLETED|Overall Study||0
8430681|NCT00852137|20777905|P1|NOT COMPLETED|Overall Study||0
8430682|NCT00852137|20777904|P2|COMPLETED|Overall Study||3
8430683|NCT00852137|20777905|P1|COMPLETED|Overall Study||13
8430684|NCT00852137|20777904|P2|STARTED|Overall Study||3
8430685|NCT00852137|20777905|P1|STARTED|Overall Study||13
8430686|NCT00852124|20777927|P2|NOT COMPLETED|Overall Study||0
8430687|NCT00852124|20777928|P1|NOT COMPLETED|Overall Study||0
8430688|NCT00852124|20777927|P2|COMPLETED|Overall Study||0
8430689|NCT00852124|20777928|P1|COMPLETED|Overall Study||3
8430690|NCT00852124|20777927|P2|STARTED|Overall Study||0
8430691|NCT00852124|20777928|P1|STARTED|Overall Study||3
8430692|NCT00851903|20777933|P1|NOT COMPLETED|Overall Study||2
8430693|NCT00851903|20777933|P1|COMPLETED|Overall Study||110
8430694|NCT00851903|20777933|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
8430695|NCT00851903|20777933|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
8430696|NCT00851903|20777933|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
8430697|NCT00851903|20777933|P1|STARTED|Overall Study||112
8430698|NCT00851890|20777947|P4|NOT COMPLETED|Overall Study||1
8430699|NCT00851890|20777948|P3|NOT COMPLETED|Overall Study||0
8430700|NCT00851890|20777949|P2|NOT COMPLETED|Overall Study||1
8430701|NCT00851890|20777950|P1|NOT COMPLETED|Overall Study||0
8430702|NCT00851890|20777947|P4|COMPLETED|Overall Study||5
8430703|NCT00851890|20777948|P3|COMPLETED|Overall Study||8
8430704|NCT00851890|20777949|P2|COMPLETED|Overall Study||7
8430705|NCT00851890|20777950|P1|COMPLETED|Overall Study||8
8430706|NCT00851890|20777947|P4|STARTED|Overall Study||6
8430707|NCT00851890|20777948|P3|STARTED|Overall Study||8
8430708|NCT00851890|20777949|P2|STARTED|Overall Study||8
8430709|NCT00851890|20777950|P1|STARTED|Overall Study||8
8430710|NCT00851877|20778007|P3|NOT COMPLETED|Phase II||3
8430711|NCT00851877|20778008|P2|NOT COMPLETED|Phase II||0
8430712|NCT00851877|20778009|P1|NOT COMPLETED|Phase II||0
8430713|NCT00851877|20778007|P3|COMPLETED|Phase II||22
8430714|NCT00851877|20778008|P2|COMPLETED|Phase II||0
8430715|NCT00851877|20778009|P1|COMPLETED|Phase II||0
8430716|NCT00851877|20778007|P3|STARTED|Phase II||25
8430717|NCT00851877|20778008|P2|STARTED|Phase II||0
8430718|NCT00851877|20778009|P1|STARTED|Phase II||0
8430719|NCT00851877|20778007|P3|NOT COMPLETED|Phase I-2||0
8430720|NCT00851877|20778008|P2|NOT COMPLETED|Phase I-2||0
8430721|NCT00851877|20778009|P1|NOT COMPLETED|Phase I-2||0
8430722|NCT00851877|20778007|P3|COMPLETED|Phase I-2||0
8430723|NCT00851877|20778008|P2|COMPLETED|Phase I-2||5
8430724|NCT00851877|20778009|P1|COMPLETED|Phase I-2||0
8430725|NCT00851877|20778007|P3|STARTED|Phase I-2||0
8430726|NCT00851877|20778008|P2|STARTED|Phase I-2||5
8430727|NCT00851877|20778009|P1|STARTED|Phase I-2||0
8430728|NCT00851877|20778007|P3|NOT COMPLETED|Phase I-1||0
8430729|NCT00851877|20778008|P2|NOT COMPLETED|Phase I-1||0
8430730|NCT00851877|20778009|P1|NOT COMPLETED|Phase I-1||1
8430731|NCT00851877|20778007|P3|COMPLETED|Phase I-1||0
8430732|NCT00851877|20778008|P2|COMPLETED|Phase I-1||0
8430733|NCT00851877|20778009|P1|COMPLETED|Phase I-1||6
8430734|NCT00851877|20778007|P3|STARTED|Phase I-1||0
8430735|NCT00851877|20778008|P2|STARTED|Phase I-1||0
8430736|NCT00851877|20778009|P1|STARTED|Phase I-1||7
8430737|NCT00851799|20778019|P3|NOT COMPLETED|Overall Study||24
8430738|NCT00851799|20778020|P2|NOT COMPLETED|Overall Study||13
8430739|NCT00851799|20778021|P1|NOT COMPLETED|Overall Study||16
8430740|NCT00851799|20778019|P3|COMPLETED|Overall Study||89
8430741|NCT00851799|20778020|P2|COMPLETED|Overall Study||93
8430742|NCT00851799|20778021|P1|COMPLETED|Overall Study||93
8430743|NCT00851799|20778019|P3|STARTED|Overall Study||113
8430744|NCT00851799|20778020|P2|STARTED|Overall Study||106
8430745|NCT00851799|20778021|P1|STARTED|Overall Study||109
8430746|NCT00851786|20778109|P2|NOT COMPLETED|Overall Study||2
8430747|NCT00851786|20778110|P1|NOT COMPLETED|Overall Study||5
8430748|NCT00851786|20778109|P2|COMPLETED|Overall Study||97
8430749|NCT00851786|20778110|P1|COMPLETED|Overall Study||291
8430750|NCT00851786|20778109|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
8430751|NCT00851786|20778110|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
8430752|NCT00851747|20778123|P3|NOT COMPLETED|Overall Study||6
8430753|NCT00851747|20778124|P2|NOT COMPLETED|Overall Study||6
8430754|NCT00851747|20778125|P1|NOT COMPLETED|Overall Study||6
8430755|NCT00851747|20778123|P3|COMPLETED|Overall Study||0
8430756|NCT00851747|20778124|P2|COMPLETED|Overall Study||0
8430757|NCT00851747|20778125|P1|COMPLETED|Overall Study||0
8430758|NCT00851747|20778123|P3|STARTED|Overall Study||6
8430759|NCT00851747|20778124|P2|STARTED|Overall Study||6
8430760|NCT00851747|20778125|P1|STARTED|Overall Study||6
8430761|NCT00851721|20778134|P2|NOT COMPLETED|Overall Study||1
8430762|NCT00851721|20778135|P1|NOT COMPLETED|Overall Study||2
8430763|NCT00851721|20778134|P2|COMPLETED|Overall Study||16
8430764|NCT00851721|20778135|P1|COMPLETED|Overall Study||17
8430765|NCT00851721|20778134|P2|STARTED|Overall Study||17
8430766|NCT00851721|20778135|P1|STARTED|Overall Study||19
8430767|NCT00851682|20778225|P2|NOT COMPLETED|Overall Study||0
8430768|NCT00851682|20778226|P1|NOT COMPLETED|Overall Study||5
8430769|NCT00851682|20778225|P2|COMPLETED|Overall Study||5
8430770|NCT00851682|20778226|P1|COMPLETED|Overall Study||55
8430771|NCT00851682|20778225|P2|STARTED|Overall Study||5
8430772|NCT00851682|20778226|P1|STARTED|Overall Study||60
8430773|NCT00851643|20778240|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
8430774|NCT00851643|20778241|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
8430775|NCT00851643|20778242|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
8430776|NCT00851643|20778243|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
8430777|NCT00851643|20778244|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
8430778|NCT00851643|20778245|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
8430779|NCT00851643|20778240|P6|COMPLETED|Extension Study (Up to 36 Months)||14
8430780|NCT00851643|20778241|P5|COMPLETED|Extension Study (Up to 36 Months)||19
8430781|NCT00851643|20778242|P4|COMPLETED|Extension Study (Up to 36 Months)||5
8430782|NCT00851643|20778243|P3|COMPLETED|Extension Study (Up to 36 Months)||14
8430783|NCT00851643|20778244|P2|COMPLETED|Extension Study (Up to 36 Months)||15
8430784|NCT00851643|20778245|P1|COMPLETED|Extension Study (Up to 36 Months)||6
8430785|NCT00851643|20778240|P6|STARTED|Extension Study (Up to 36 Months)||15
8430786|NCT00851643|20778241|P5|STARTED|Extension Study (Up to 36 Months)||21
8430787|NCT00851643|20778242|P4|STARTED|Extension Study (Up to 36 Months)||7
8430788|NCT00851643|20778243|P3|STARTED|Extension Study (Up to 36 Months)||19
8430789|NCT00851643|20778244|P2|STARTED|Extension Study (Up to 36 Months)||19
8430790|NCT00851643|20778245|P1|STARTED|Extension Study (Up to 36 Months)||10
8430791|NCT00851643|20778240|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
8430792|NCT00851643|20778241|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430793|NCT00851643|20778242|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430794|NCT00851643|20778243|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430795|NCT00851643|20778244|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430796|NCT00851643|20778245|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
8430797|NCT00851643|20778240|P6|COMPLETED|Base Study (Up to 12 Months)||29
8430798|NCT00851643|20778241|P5|COMPLETED|Base Study (Up to 12 Months)||30
8430799|NCT00851643|20778242|P4|COMPLETED|Base Study (Up to 12 Months)||15
8430800|NCT00851643|20778243|P3|COMPLETED|Base Study (Up to 12 Months)||30
8430801|NCT00851643|20778244|P2|COMPLETED|Base Study (Up to 12 Months)||30
8430802|NCT00851643|20778245|P1|COMPLETED|Base Study (Up to 12 Months)||14
8430803|NCT00851643|20778240|P6|STARTED|Base Study (Up to 12 Months)||30
8430804|NCT00851643|20778241|P5|STARTED|Base Study (Up to 12 Months)||30
8430805|NCT00851643|20778242|P4|STARTED|Base Study (Up to 12 Months)||15
8430806|NCT00851643|20778243|P3|STARTED|Base Study (Up to 12 Months)||30
8430807|NCT00851643|20778244|P2|STARTED|Base Study (Up to 12 Months)||30
8430808|NCT00851643|20778245|P1|STARTED|Base Study (Up to 12 Months)||15
8430809|NCT00851630|20778266|P2|NOT COMPLETED|Overall Study||2
8430810|NCT00851630|20778267|P1|NOT COMPLETED|Overall Study||2
8430811|NCT00851630|20778266|P2|COMPLETED|Overall Study||33
8430812|NCT00851630|20778267|P1|COMPLETED|Overall Study||33
8430813|NCT00851630|20778266|P2|STARTED|Overall Study||35
8430814|NCT00851630|20778267|P1|STARTED|Overall Study||35
8430815|NCT00851591|20778281|P2|NOT COMPLETED|Overall Study||0
8430816|NCT00851591|20778282|P1|NOT COMPLETED|Overall Study||2
8430817|NCT00851591|20778281|P2|COMPLETED|Overall Study||1
8430818|NCT00851591|20778282|P1|COMPLETED|Overall Study||0
8430819|NCT00851591|20778281|P2|STARTED|Overall Study|One received treatment.|1
8430820|NCT00851591|20778282|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
8430821|NCT00851552|20778288|P1|NOT COMPLETED|Overall Study||7
8430822|NCT00851552|20778288|P1|COMPLETED|Overall Study||2
8430823|NCT00851552|20778288|P1|STARTED|Overall Study||9
8430824|NCT00851409|20778293|P1|NOT COMPLETED|Overall Study||0
8430825|NCT00851409|20778293|P1|COMPLETED|Overall Study||25
8430826|NCT00851409|20778293|P1|STARTED|Overall Study||25
8430827|NCT00851357|20778301|P3|NOT COMPLETED|Overall Study||0
8430828|NCT00851357|20778302|P2|NOT COMPLETED|Overall Study||0
8430829|NCT00851357|20778303|P1|NOT COMPLETED|Overall Study||0
8430830|NCT00851357|20778301|P3|COMPLETED|Overall Study||1799
8430831|NCT00851357|20778302|P2|COMPLETED|Overall Study||1201
8430832|NCT00851357|20778303|P1|COMPLETED|Overall Study||1200
8430833|NCT00851357|20778301|P3|STARTED|Overall Study||1799
8430834|NCT00851357|20778302|P2|STARTED|Overall Study||1201
8430835|NCT00851357|20778303|P1|STARTED|Overall Study||1200
8430836|NCT00851318|20778318|P4|NOT COMPLETED|Overall Study||19
8430837|NCT00851318|20778319|P3|NOT COMPLETED|Overall Study||21
8430838|NCT00851318|20778320|P2|NOT COMPLETED|Overall Study||5
8430839|NCT00851318|20778321|P1|NOT COMPLETED|Overall Study||30
8430840|NCT00851318|20778318|P4|COMPLETED|Overall Study||73
8430841|NCT00851318|20778319|P3|COMPLETED|Overall Study||72
8430842|NCT00851318|20778320|P2|COMPLETED|Overall Study||14
8430843|NCT00851318|20778321|P1|COMPLETED|Overall Study||51
8430844|NCT00851318|20778318|P4|Completed Week 52|Overall Study||85
8430845|NCT00851318|20778319|P3|Completed Week 52|Overall Study||87
8430846|NCT00851318|20778320|P2|Completed Week 52|Overall Study||16
8430847|NCT00851318|20778321|P1|Completed Week 52|Overall Study||64
8430848|NCT00851318|20778318|P4|Completed Week 24|Overall Study||87
8430849|NCT00851318|20778319|P3|Completed Week 24|Overall Study||90
8430850|NCT00851318|20778320|P2|Completed Week 24|Overall Study||17
8430851|NCT00851318|20778321|P1|Completed Week 24|Overall Study||69
8430852|NCT00851318|20778318|P4|STARTED|Overall Study||92
8430853|NCT00851318|20778319|P3|STARTED|Overall Study||93
8430854|NCT00851318|20778320|P2|STARTED|Overall Study||19
8430855|NCT00851318|20778321|P1|STARTED|Overall Study||81
8430856|NCT00851279|20778351|P1|NOT COMPLETED|Overall Study||0
8430857|NCT00851279|20778351|P1|COMPLETED|Overall Study||53
8430858|NCT00851279|20778351|P1|STARTED|Overall Study||53
8430859|NCT00851253|20778357|P2|NOT COMPLETED|Overall Study||0
8430860|NCT00851253|20778358|P1|NOT COMPLETED|Overall Study||1
8430861|NCT00851253|20778357|P2|COMPLETED|Overall Study||10
8430862|NCT00851253|20778358|P1|COMPLETED|Overall Study||1
8430863|NCT00851253|20778357|P2|STARTED|Overall Study||10
8430864|NCT00851253|20778358|P1|STARTED|Overall Study||2
8430865|NCT00851084|20778368|P2|NOT COMPLETED|Overall Study||119
8430866|NCT00851084|20778369|P1|NOT COMPLETED|Overall Study||117
8430867|NCT00851084|20778368|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
8430868|NCT00851084|20778369|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
8430869|NCT00851084|20778368|P2|STARTED|Overall Study||119
8430870|NCT00851084|20778369|P1|STARTED|Overall Study||117
8430871|NCT00851006|20778385|P2|NOT COMPLETED|Overall Study||0
8430872|NCT00851006|20778386|P1|NOT COMPLETED|Overall Study||0
8430873|NCT00851006|20778385|P2|COMPLETED|Overall Study||6
8430874|NCT00851006|20778386|P1|COMPLETED|Overall Study||7
8430875|NCT00851006|20778385|P2|STARTED|Overall Study||6
8430876|NCT00851006|20778386|P1|STARTED|Overall Study||7
8430877|NCT00850993|20778397|P4|NOT COMPLETED|Overall Study||1
8430878|NCT00850993|20778398|P3|NOT COMPLETED|Overall Study||0
8430879|NCT00850993|20778399|P2|NOT COMPLETED|Overall Study||0
8430880|NCT00850993|20778400|P1|NOT COMPLETED|Overall Study||1
8430881|NCT00850993|20778397|P4|COMPLETED|Overall Study||14
8430882|NCT00850993|20778398|P3|COMPLETED|Overall Study||8
8430883|NCT00850993|20778399|P2|COMPLETED|Overall Study||18
8430884|NCT00850993|20778400|P1|COMPLETED|Overall Study||16
8430885|NCT00850993|20778397|P4|Per Protocol|Overall Study||13
8430886|NCT00850993|20778398|P3|Per Protocol|Overall Study||5
8430887|NCT00850993|20778399|P2|Per Protocol|Overall Study||13
8430888|NCT00850993|20778400|P1|Per Protocol|Overall Study||10
8430889|NCT00850993|20778397|P4|Received Phototherapy|Overall Study||8
8430890|NCT00850993|20778398|P3|Received Phototherapy|Overall Study||2
8430891|NCT00850993|20778399|P2|Received Phototherapy|Overall Study||6
8430892|NCT00850993|20778400|P1|Received Phototherapy|Overall Study||3
8430893|NCT00850993|20778397|P4|Intent-to-treat|Overall Study||15
8430894|NCT00850993|20778398|P3|Intent-to-treat|Overall Study||8
8430895|NCT00850993|20778399|P2|Intent-to-treat|Overall Study||18
8430896|NCT00850993|20778400|P1|Intent-to-treat|Overall Study||17
8430897|NCT00850993|20778397|P4|Safety|Overall Study||15
8430898|NCT00850993|20778398|P3|Safety|Overall Study||8
8430899|NCT00850993|20778399|P2|Safety|Overall Study||18
8430900|NCT00850993|20778400|P1|Safety|Overall Study||17
8430901|NCT00850993|20778397|P4|STARTED|Overall Study||15
8430902|NCT00850993|20778398|P3|STARTED|Overall Study||8
8430903|NCT00850993|20778399|P2|STARTED|Overall Study||18
8430904|NCT00850993|20778400|P1|STARTED|Overall Study||17
8430905|NCT00850889|20778414|P1|NOT COMPLETED|Overall Study||0
8430906|NCT00850889|20778414|P1|COMPLETED|Overall Study||32
8430907|NCT00850889|20778414|P1|STARTED|Overall Study||32
8430908|NCT00850759|20778429|P4|NOT COMPLETED|Overall Study||3
8430909|NCT00850759|20778430|P3|NOT COMPLETED|Overall Study||5
8430910|NCT00850759|20778431|P2|NOT COMPLETED|Overall Study||5
8430911|NCT00850759|20778432|P1|NOT COMPLETED|Overall Study||7
8430912|NCT00850759|20778429|P4|COMPLETED|Overall Study||55
8430913|NCT00850759|20778430|P3|COMPLETED|Overall Study||52
8430914|NCT00850759|20778431|P2|COMPLETED|Overall Study||52
8430915|NCT00850759|20778432|P1|COMPLETED|Overall Study||52
8430916|NCT00850759|20778429|P4|STARTED|Overall Study||58
8430917|NCT00850759|20778430|P3|STARTED|Overall Study||57
8430918|NCT00850759|20778431|P2|STARTED|Overall Study||57
8430919|NCT00850759|20778432|P1|STARTED|Overall Study||59
8430920|NCT00850720|20778442|P1|NOT COMPLETED|Overall Study||0
8430921|NCT00850720|20778442|P1|COMPLETED|Overall Study||0
8430922|NCT00850720|20778442|P1|STARTED|Overall Study||0
8430923|NCT00850642|20778448|P2|NOT COMPLETED|Overall Study||0
8430924|NCT00850642|20778449|P1|NOT COMPLETED|Overall Study||0
8430925|NCT00850642|20778448|P2|COMPLETED|Overall Study||4
8430926|NCT00850642|20778449|P1|COMPLETED|Overall Study||3
8430927|NCT00850642|20778448|P2|STARTED|Overall Study||4
8430928|NCT00850642|20778449|P1|STARTED|Overall Study||3
8430929|NCT00850603|20778487|P5|NOT COMPLETED|Overall Study||0
8430930|NCT00850603|20778488|P4|NOT COMPLETED|Overall Study||0
8430931|NCT00850603|20778489|P3|NOT COMPLETED|Overall Study||0
8430932|NCT00850603|20778490|P2|NOT COMPLETED|Overall Study||0
8430933|NCT00850603|20778491|P1|NOT COMPLETED|Overall Study||0
8430934|NCT00850603|20778487|P5|COMPLETED|Overall Study||34
8430935|NCT00850603|20778488|P4|COMPLETED|Overall Study||34
8430936|NCT00850603|20778489|P3|COMPLETED|Overall Study||34
8430937|NCT00850603|20778490|P2|COMPLETED|Overall Study||34
8430938|NCT00850603|20778491|P1|COMPLETED|Overall Study||34
8430939|NCT00850603|20778487|P5|STARTED|Overall Study||34
8430940|NCT00850603|20778488|P4|STARTED|Overall Study||34
8430941|NCT00850603|20778489|P3|STARTED|Overall Study||34
8430942|NCT00850603|20778490|P2|STARTED|Overall Study||34
8430943|NCT00850603|20778491|P1|STARTED|Overall Study||34
8430944|NCT00850564|20778513|P1|NOT COMPLETED|Overall Study||2
8430945|NCT00850564|20778513|P1|COMPLETED|Overall Study||13
8430946|NCT00850564|20778513|P1|STARTED|Overall Study||15
8430947|NCT00850538|20778518|P1|NOT COMPLETED|Overall Study||41
8430948|NCT00850538|20778518|P1|COMPLETED|Overall Study||60
8430949|NCT00850538|20778518|P1|STARTED|Overall Study||101
8430950|NCT00850499|20778524|P2|NOT COMPLETED|Overall Study||2
8430951|NCT00850499|20778525|P1|NOT COMPLETED|Overall Study||3
8430952|NCT00850499|20778524|P2|COMPLETED|Overall Study||6
8430953|NCT00850499|20778525|P1|COMPLETED|Overall Study||1
8430954|NCT00850499|20778524|P2|STARTED|Overall Study||8
8430955|NCT00850499|20778525|P1|STARTED|Overall Study||4
8430956|NCT00850473|20778533|P1|NOT COMPLETED|Overall Study||0
8430957|NCT00850473|20778533|P1|COMPLETED|Overall Study||3
8430958|NCT00850473|20778533|P1|STARTED|Overall Study||3
8430959|NCT00850460|20778539|P2|NOT COMPLETED|Overall Study||4
8430960|NCT00850460|20778540|P1|NOT COMPLETED|Overall Study||4
8430961|NCT00850460|20778539|P2|COMPLETED|Overall Study||3
8430962|NCT00850460|20778540|P1|COMPLETED|Overall Study||3
8430963|NCT00850460|20778539|P2|Completion - Week 8|Overall Study||3
8430964|NCT00850460|20778540|P1|Completion - Week 8|Overall Study||3
8430965|NCT00850460|20778539|P2|Started - Week 0|Overall Study||7
8430966|NCT00850460|20778540|P1|Started - Week 0|Overall Study||7
8430967|NCT00850460|20778539|P2|STARTED|Overall Study||7
8430968|NCT00850460|20778540|P1|STARTED|Overall Study||7
8430969|NCT00850421|20778548|P1|NOT COMPLETED|Overall Study||17
8430970|NCT00850421|20778548|P1|COMPLETED|Overall Study||18
8430971|NCT00850421|20778548|P1|STARTED|Overall Study||35
8430972|NCT00850395|20778554|P1|NOT COMPLETED|Overall Study||10
8430973|NCT00850395|20778554|P1|COMPLETED|Overall Study||69
8430974|NCT00850395|20778554|P1|STARTED|Overall Study||79
8430975|NCT00850343|20778574|P4|NOT COMPLETED|Overall Study||13
8430976|NCT00850343|20778575|P3|NOT COMPLETED|Overall Study||14
8430977|NCT00850343|20778576|P2|NOT COMPLETED|Overall Study||3
8430978|NCT00850343|20778577|P1|NOT COMPLETED|Overall Study||46
8430979|NCT00850343|20778574|P4|COMPLETED|Overall Study||30
8430980|NCT00850343|20778575|P3|COMPLETED|Overall Study||29
8430981|NCT00850343|20778576|P2|COMPLETED|Overall Study||9
8430982|NCT00850343|20778577|P1|COMPLETED|Overall Study||64
8430983|NCT00850343|20778574|P4|Completed Week 52|Overall Study||37
8430984|NCT00850343|20778575|P3|Completed Week 52|Overall Study||37
8430985|NCT00850343|20778576|P2|Completed Week 52|Overall Study||11
8430986|NCT00850343|20778577|P1|Completed Week 52|Overall Study||88
8430987|NCT00850343|20778574|P4|Completed Week 24|Overall Study||39
8430988|NCT00850343|20778575|P3|Completed Week 24|Overall Study||39
8430989|NCT00850343|20778576|P2|Completed Week 24|Overall Study||12
8430990|NCT00850343|20778577|P1|Completed Week 24|Overall Study||94
8430991|NCT00850343|20778574|P4|STARTED|Overall Study||43
8430992|NCT00850343|20778575|P3|STARTED|Overall Study||43
8430993|NCT00850343|20778576|P2|STARTED|Overall Study||12
8430994|NCT00850343|20778577|P1|STARTED|Overall Study||110
8430995|NCT00850200|20778607|P1|NOT COMPLETED|Overall Study||5
8430996|NCT00850200|20778607|P1|COMPLETED|Overall Study||15
8430997|NCT00850200|20778607|P1|STARTED|Overall Study||20
8430998|NCT00850174|20778617|P2|NOT COMPLETED|Second Intervention||0
8430999|NCT00850174|20778618|P1|NOT COMPLETED|Second Intervention||1
8431000|NCT00850174|20778617|P2|COMPLETED|Second Intervention||28
8431001|NCT00850174|20778618|P1|COMPLETED|Second Intervention||29
8431002|NCT00850174|20778617|P2|STARTED|Second Intervention||28
8431003|NCT00850174|20778618|P1|STARTED|Second Intervention||30
8431004|NCT00850174|20778617|P2|NOT COMPLETED|Washout: One Week||2
8431005|NCT00850174|20778618|P1|NOT COMPLETED|Washout: One Week||0
8431006|NCT00850174|20778617|P2|COMPLETED|Washout: One Week||28
8431007|NCT00850174|20778618|P1|COMPLETED|Washout: One Week||30
8431008|NCT00850174|20778617|P2|STARTED|Washout: One Week||30
8431009|NCT00850174|20778618|P1|STARTED|Washout: One Week||30
8431010|NCT00850174|20778617|P2|NOT COMPLETED|First Intervention||0
8431011|NCT00850174|20778618|P1|NOT COMPLETED|First Intervention||0
8431012|NCT00850174|20778617|P2|COMPLETED|First Intervention||30
8431013|NCT00850174|20778618|P1|COMPLETED|First Intervention||30
8431014|NCT00850174|20778617|P2|STARTED|First Intervention||30
8431015|NCT00850174|20778618|P1|STARTED|First Intervention||30
8431016|NCT00850135|20778632|P1|NOT COMPLETED|Overall Study||1
8431017|NCT00850135|20778632|P1|COMPLETED|Overall Study||56
8431018|NCT00850135|20778632|P1|STARTED|Overall Study||57
8431019|NCT00850096|20778640|P2|NOT COMPLETED|Overall Study||2
8431020|NCT00850096|20778641|P1|NOT COMPLETED|Overall Study||3
8431021|NCT00850096|20778640|P2|COMPLETED|Overall Study||45
8431022|NCT00850096|20778641|P1|COMPLETED|Overall Study||44
8431023|NCT00850096|20778640|P2|STARTED|Overall Study||47
8431024|NCT00850096|20778641|P1|STARTED|Overall Study||47
8431025|NCT00850070|20778651|P2|NOT COMPLETED|Overall Study||1
8431026|NCT00850070|20778652|P1|NOT COMPLETED|Overall Study||3
8431027|NCT00850070|20778651|P2|COMPLETED|Overall Study||22
8431028|NCT00850070|20778652|P1|COMPLETED|Overall Study||20
8431029|NCT00850070|20778651|P2|STARTED|Overall Study||23
8431030|NCT00850070|20778652|P1|STARTED|Overall Study||23
8431031|NCT00850031|20778676|P1|NOT COMPLETED|Overall Study||17
8431032|NCT00850031|20778676|P1|COMPLETED|Overall Study||101
8431033|NCT00850031|20778676|P1|STARTED|Overall Study||118
8431034|NCT00849940|20778681|P1|NOT COMPLETED|Overall Study||4
8431035|NCT00849940|20778681|P1|COMPLETED|Overall Study||68
8431036|NCT00849940|20778681|P1|STARTED|Overall Study||72
8431037|NCT00849901|20778692|P3|NOT COMPLETED|Extension Phase||17
8431038|NCT00849901|20778693|P2|NOT COMPLETED|Extension Phase||26
8431039|NCT00849901|20778694|P1|NOT COMPLETED|Extension Phase||27
8431040|NCT00849901|20778692|P3|COMPLETED|Extension Phase||69
8431041|NCT00849901|20778693|P2|COMPLETED|Extension Phase||65
8431042|NCT00849901|20778694|P1|COMPLETED|Extension Phase||56
8431043|NCT00849901|20778692|P3|STARTED|Extension Phase||86
8431044|NCT00849901|20778693|P2|STARTED|Extension Phase||91
8431045|NCT00849901|20778694|P1|STARTED|Extension Phase||83
8431046|NCT00849901|20778692|P3|NOT COMPLETED|Acute Treatment Phase||16
8431047|NCT00849901|20778693|P2|NOT COMPLETED|Acute Treatment Phase||26
8431048|NCT00849901|20778694|P1|NOT COMPLETED|Acute Treatment Phase||30
8431049|NCT00849901|20778692|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
8431050|NCT00849901|20778693|P2|COMPLETED|Acute Treatment Phase||91
8431051|NCT00849901|20778694|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
8431052|NCT00849901|20778692|P3|STARTED|Acute Treatment Phase||103
8431053|NCT00849901|20778693|P2|STARTED|Acute Treatment Phase||117
8431054|NCT00849901|20778694|P1|STARTED|Acute Treatment Phase||117
8431055|NCT00849875|20778741|P1|NOT COMPLETED|Overall Study||47
8431056|NCT00849875|20778741|P1|COMPLETED|Overall Study||1
8431057|NCT00849875|20778741|P1|STARTED|Overall Study||48
8431058|NCT00849862|20778823|P2|NOT COMPLETED|Second Intervention||0
8431059|NCT00849862|20778824|P1|NOT COMPLETED|Second Intervention||0
8431060|NCT00849862|20778823|P2|COMPLETED|Second Intervention||11
8431061|NCT00849862|20778824|P1|COMPLETED|Second Intervention||11
8431062|NCT00849862|20778823|P2|STARTED|Second Intervention||11
8431063|NCT00849862|20778824|P1|STARTED|Second Intervention||11
8431064|NCT00849862|20778823|P2|NOT COMPLETED|Washout: 7 Days||0
8431065|NCT00849862|20778824|P1|NOT COMPLETED|Washout: 7 Days||0
8431066|NCT00849862|20778823|P2|COMPLETED|Washout: 7 Days||11
8431067|NCT00849862|20778824|P1|COMPLETED|Washout: 7 Days||11
8431068|NCT00849862|20778823|P2|STARTED|Washout: 7 Days||11
8431069|NCT00849862|20778824|P1|STARTED|Washout: 7 Days||11
8431070|NCT00849862|20778823|P2|NOT COMPLETED|First Intervention||0
8431071|NCT00849862|20778824|P1|NOT COMPLETED|First Intervention||0
8431072|NCT00849862|20778823|P2|COMPLETED|First Intervention||11
8431073|NCT00849862|20778824|P1|COMPLETED|First Intervention||11
8431074|NCT00849862|20778823|P2|STARTED|First Intervention||11
8431075|NCT00849862|20778824|P1|STARTED|First Intervention||11
8431076|NCT00849810|20778832|P1|NOT COMPLETED|Overall Study||0
8431077|NCT00849810|20778832|P1|COMPLETED|Overall Study||1
8431078|NCT00849810|20778832|P1|STARTED|Overall Study||1
8431079|NCT00849797|20778838|P2|NOT COMPLETED|Second Intervention||0
8431080|NCT00849797|20778839|P1|NOT COMPLETED|Second Intervention||0
8431081|NCT00849797|20778838|P2|COMPLETED|Second Intervention||57
8431082|NCT00849797|20778839|P1|COMPLETED|Second Intervention||59
8431083|NCT00849797|20778838|P2|STARTED|Second Intervention||57
8431084|NCT00849797|20778839|P1|STARTED|Second Intervention||59
8431085|NCT00849797|20778838|P2|NOT COMPLETED|Washout: One Week||2
8431086|NCT00849797|20778839|P1|NOT COMPLETED|Washout: One Week||0
8431087|NCT00849797|20778838|P2|COMPLETED|Washout: One Week||57
8431088|NCT00849797|20778839|P1|COMPLETED|Washout: One Week||59
8431089|NCT00849797|20778838|P2|STARTED|Washout: One Week||59
8431090|NCT00849797|20778839|P1|STARTED|Washout: One Week||59
8431091|NCT00849797|20778838|P2|NOT COMPLETED|First Intervention||1
8431092|NCT00849797|20778839|P1|NOT COMPLETED|First Intervention||1
8431093|NCT00849797|20778838|P2|COMPLETED|First Intervention||59
8431094|NCT00849797|20778839|P1|COMPLETED|First Intervention||59
8431095|NCT00849797|20778838|P2|STARTED|First Intervention||60
8431096|NCT00849797|20778839|P1|STARTED|First Intervention||60
8431097|NCT00849693|20778857|P4|NOT COMPLETED|Extension Phase||38
8431098|NCT00849693|20778858|P3|NOT COMPLETED|Extension Phase||35
8431099|NCT00849693|20778859|P2|NOT COMPLETED|Extension Phase||30
8431100|NCT00849693|20778860|P1|NOT COMPLETED|Extension Phase||30
8431101|NCT00849693|20778857|P4|COMPLETED|Extension Phase||44
8431102|NCT00849693|20778858|P3|COMPLETED|Extension Phase||49
8431103|NCT00849693|20778859|P2|COMPLETED|Extension Phase||50
8431104|NCT00849693|20778860|P1|COMPLETED|Extension Phase||43
8431105|NCT00849693|20778857|P4|STARTED|Extension Phase||82
8431106|NCT00849693|20778858|P3|STARTED|Extension Phase||84
8431107|NCT00849693|20778859|P2|STARTED|Extension Phase||80
8431108|NCT00849693|20778860|P1|STARTED|Extension Phase||73
8431109|NCT00849693|20778857|P4|NOT COMPLETED|Acute Treatment Phase||37
8431110|NCT00849693|20778858|P3|NOT COMPLETED|Acute Treatment Phase||33
8431111|NCT00849693|20778859|P2|NOT COMPLETED|Acute Treatment Phase||35
8431112|NCT00849693|20778860|P1|NOT COMPLETED|Acute Treatment Phase||33
8431113|NCT00849693|20778857|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
8431114|NCT00849693|20778858|P3|COMPLETED|Acute Treatment Phase||84
8431115|NCT00849693|20778859|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
8431116|NCT00849693|20778860|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
8431117|NCT00849693|20778857|P4|STARTED|Acute Treatment Phase||122
8431118|NCT00849693|20778858|P3|STARTED|Acute Treatment Phase||117
8431119|NCT00849693|20778859|P2|STARTED|Acute Treatment Phase||116
8431120|NCT00849693|20778860|P1|STARTED|Acute Treatment Phase||108
8431121|NCT00849680|20778927|P8|NOT COMPLETED|Overall Study||8
8431122|NCT00849680|20778928|P7|NOT COMPLETED|Overall Study||17
8431123|NCT00849680|20778929|P6|NOT COMPLETED|Overall Study||15
8431124|NCT00849680|20778930|P5|NOT COMPLETED|Overall Study||10
8431125|NCT00849680|20778931|P4|NOT COMPLETED|Overall Study||14
8431126|NCT00849680|20778932|P3|NOT COMPLETED|Overall Study||15
8431127|NCT00849680|20778933|P2|NOT COMPLETED|Overall Study||3
8431128|NCT00849680|20778934|P1|NOT COMPLETED|Overall Study||11
8431129|NCT00849680|20778927|P8|COMPLETED|Overall Study||23
8431130|NCT00849680|20778928|P7|COMPLETED|Overall Study||61
8431131|NCT00849680|20778929|P6|COMPLETED|Overall Study||27
8431132|NCT00849680|20778930|P5|COMPLETED|Overall Study||32
8431133|NCT00849680|20778931|P4|COMPLETED|Overall Study||28
8431134|NCT00849680|20778932|P3|COMPLETED|Overall Study||27
8431135|NCT00849680|20778933|P2|COMPLETED|Overall Study||10
8431136|NCT00849680|20778934|P1|COMPLETED|Overall Study||16
8431137|NCT00849680|20778927|P8|STARTED|Overall Study||31
8431138|NCT00849680|20778928|P7|STARTED|Overall Study||78
8431139|NCT00849680|20778929|P6|STARTED|Overall Study||42
8431140|NCT00849680|20778930|P5|STARTED|Overall Study||42
8431141|NCT00849680|20778931|P4|STARTED|Overall Study||42
8431142|NCT00849680|20778932|P3|STARTED|Overall Study||42
8431143|NCT00849680|20778933|P2|STARTED|Overall Study||13
8431144|NCT00849680|20778934|P1|STARTED|Overall Study||27
8431145|NCT00849524|20778976|P1|NOT COMPLETED|Overall Study||3
8431146|NCT00849524|20778976|P1|COMPLETED|Overall Study||3
8431147|NCT00849524|20778976|P1|STARTED|Overall Study||6
8431148|NCT00849485|20778984|P2|NOT COMPLETED|Second Intervention||0
8431149|NCT00849485|20778985|P1|NOT COMPLETED|Second Intervention||0
8431150|NCT00849485|20778984|P2|COMPLETED|Second Intervention||11
8431151|NCT00849485|20778985|P1|COMPLETED|Second Intervention||11
8431152|NCT00849485|20778984|P2|STARTED|Second Intervention||11
8431153|NCT00849485|20778985|P1|STARTED|Second Intervention||11
8431154|NCT00849485|20778984|P2|NOT COMPLETED|Washout: 7 Days||0
8431155|NCT00849485|20778985|P1|NOT COMPLETED|Washout: 7 Days||0
8431156|NCT00849485|20778984|P2|COMPLETED|Washout: 7 Days||11
8431157|NCT00849485|20778985|P1|COMPLETED|Washout: 7 Days||11
8431158|NCT00849485|20778984|P2|STARTED|Washout: 7 Days||11
8431159|NCT00849485|20778985|P1|STARTED|Washout: 7 Days||11
8431160|NCT00849485|20778984|P2|NOT COMPLETED|First Intervention||0
8431161|NCT00849485|20778985|P1|NOT COMPLETED|First Intervention||0
8431162|NCT00849485|20778984|P2|COMPLETED|First Intervention||11
8431163|NCT00849485|20778985|P1|COMPLETED|First Intervention||11
8431164|NCT00849485|20778984|P2|STARTED|First Intervention||11
8431165|NCT00849485|20778985|P1|STARTED|First Intervention||11
8431166|NCT00849472|20778993|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
8431167|NCT00849472|20778993|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
8431168|NCT00849472|20778993|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
8431169|NCT00849472|20778993|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
8431170|NCT00849472|20778993|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
8431171|NCT00849472|20778993|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
8431172|NCT00849472|20778993|P1|NOT COMPLETED|Weekly Paclitaxel||16
8431173|NCT00849472|20778993|P1|COMPLETED|Weekly Paclitaxel||78
8431174|NCT00849472|20778993|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
8431175|NCT00849472|20778993|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
8431176|NCT00849472|20778993|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
8431177|NCT00849472|20778993|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
8431178|NCT00849381|20779007|P1|NOT COMPLETED|Overall Study||145
8431179|NCT00849381|20779007|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
8431180|NCT00849381|20779007|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
8431181|NCT00849290|20779013|P1|NOT COMPLETED|Overall Study||55
8431182|NCT00849290|20779013|P1|COMPLETED|Overall Study||58
8431183|NCT00849290|20779013|P1|STARTED|Overall Study||113
8431184|NCT00849251|20779017|P2|NOT COMPLETED|Overall Study||1
8431185|NCT00849251|20779018|P1|NOT COMPLETED|Overall Study||1
8431186|NCT00849251|20779017|P2|COMPLETED|Overall Study||24
8431187|NCT00849251|20779018|P1|COMPLETED|Overall Study||5
8431188|NCT00849251|20779017|P2|STARTED|Overall Study||25
8431189|NCT00849251|20779018|P1|STARTED|Overall Study||6
8431190|NCT00849212|20779024|P1|NOT COMPLETED|Overall Study||7
8431191|NCT00849212|20779024|P1|COMPLETED|Overall Study||23
8431192|NCT00849212|20779024|P1|STARTED|Overall Study||30
8431193|NCT00849186|20779029|P1|NOT COMPLETED|Overall Study||10
8431194|NCT00849186|20779029|P1|COMPLETED|Overall Study||16
8431195|NCT00849186|20779029|P1|STARTED|Overall Study||26
8431196|NCT00849147|20779035|P1|NOT COMPLETED|Overall Study||5
8431197|NCT00849147|20779035|P1|COMPLETED|Overall Study||50
8431198|NCT00849147|20779035|P1|STARTED|Overall Study||55
8431199|NCT00849121|20779052|P2|NOT COMPLETED|Overall Study||0
8431200|NCT00849121|20779053|P1|NOT COMPLETED|Overall Study||0
8431201|NCT00849121|20779052|P2|COMPLETED|Overall Study||9
8431202|NCT00849121|20779053|P1|COMPLETED|Overall Study||8
8431203|NCT00849121|20779052|P2|STARTED|Overall Study||9
8431204|NCT00849121|20779053|P1|STARTED|Overall Study||8
8431205|NCT00849108|20779068|P2|NOT COMPLETED|Cohort 2 Efficacy||10
8431206|NCT00849108|20779069|P1|NOT COMPLETED|Cohort 2 Efficacy||0
8431207|NCT00849108|20779068|P2|COMPLETED|Cohort 2 Efficacy||133
8431208|NCT00849108|20779069|P1|COMPLETED|Cohort 2 Efficacy||0
8431209|NCT00849108|20779068|P2|STARTED|Cohort 2 Efficacy||143
8431210|NCT00849108|20779069|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
8431211|NCT00849108|20779068|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
8431212|NCT00849108|20779069|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
8431213|NCT00849108|20779068|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
8431214|NCT00849108|20779069|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
8431215|NCT00849108|20779068|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
8431216|NCT00849108|20779069|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
8431217|NCT00849056|20779079|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
8431218|NCT00849056|20779080|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
8431219|NCT00849056|20779079|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
8431220|NCT00849056|20779080|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
8431221|NCT00849056|20779079|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
8431222|NCT00849056|20779080|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
8431223|NCT00849056|20779079|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
8431224|NCT00849056|20779080|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
8431225|NCT00849056|20779079|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
8431226|NCT00849056|20779080|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
8431227|NCT00849056|20779079|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
8431228|NCT00849056|20779080|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
8431229|NCT00849017|20779105|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
8431230|NCT00849017|20779106|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
8431231|NCT00849017|20779107|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
8431232|NCT00849017|20779105|P3|COMPLETED|Follow-up Period (8 Weeks)||74
8431233|NCT00849017|20779106|P2|COMPLETED|Follow-up Period (8 Weeks)||83
8431234|NCT00849017|20779107|P1|COMPLETED|Follow-up Period (8 Weeks)||76
8431235|NCT00849017|20779105|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
8431236|NCT00849017|20779106|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8431237|NCT00849017|20779107|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8431238|NCT00849017|20779105|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
8431239|NCT00849017|20779106|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
8431240|NCT00849017|20779107|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
8431241|NCT00849017|20779105|P3|COMPLETED|Treatment Period (156 Weeks)||57
8431242|NCT00849017|20779106|P2|COMPLETED|Treatment Period (156 Weeks)||68
8431243|NCT00849017|20779107|P1|COMPLETED|Treatment Period (156 Weeks)||58
8431244|NCT00849017|20779105|P3|STARTED|Treatment Period (156 Weeks)||99
8431245|NCT00849017|20779106|P2|STARTED|Treatment Period (156 Weeks)||101
8431246|NCT00849017|20779107|P1|STARTED|Treatment Period (156 Weeks)||101
8431247|NCT00848965|20779150|P1|NOT COMPLETED|Overall Study||2
8431248|NCT00848965|20779150|P1|COMPLETED|Overall Study||57
8431249|NCT00848965|20779150|P1|STARTED|Overall Study||59
8431250|NCT00848926|20779192|P1|NOT COMPLETED|Follow-up Period||12
8431251|NCT00848926|20779192|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
8431252|NCT00848926|20779192|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
8431253|NCT00848926|20779192|P1|NOT COMPLETED|Treatment Period||84
8431254|NCT00848926|20779192|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
8431255|NCT00848926|20779192|P1|STARTED|Treatment Period||102
8431256|NCT00848783|20779211|P3|NOT COMPLETED|Overall Study||0
8431257|NCT00848783|20779212|P2|NOT COMPLETED|Overall Study||2
8431258|NCT00848783|20779213|P1|NOT COMPLETED|Overall Study||3
8431259|NCT00848783|20779211|P3|COMPLETED|Overall Study||1
8431260|NCT00848783|20779212|P2|COMPLETED|Overall Study||1
8431261|NCT00848783|20779213|P1|COMPLETED|Overall Study||1
8431262|NCT00848783|20779211|P3|STARTED|Overall Study||1
8431263|NCT00848783|20779212|P2|STARTED|Overall Study||3
8431264|NCT00848783|20779213|P1|STARTED|Overall Study||4
8431265|NCT00848744|20779222|P1|NOT COMPLETED|Overall Study||0
8431266|NCT00848744|20779222|P1|COMPLETED|Overall Study||10
8431267|NCT00848744|20779222|P1|STARTED|Overall Study||10
8431268|NCT00848718|20779242|P13|NOT COMPLETED|Overall Study||8
8431269|NCT00848718|20779243|P12|NOT COMPLETED|Overall Study||6
8431270|NCT00848718|20779244|P11|NOT COMPLETED|Overall Study||4
8431271|NCT00848718|20779245|P10|NOT COMPLETED|Overall Study||9
8431272|NCT00848718|20779246|P9|NOT COMPLETED|Overall Study||4
8431273|NCT00848718|20779247|P8|NOT COMPLETED|Overall Study||5
8431274|NCT00848718|20779248|P7|NOT COMPLETED|Overall Study||3
8431275|NCT00848718|20779249|P6|NOT COMPLETED|Overall Study||5
8431276|NCT00848718|20779250|P5|NOT COMPLETED|Overall Study||6
8431277|NCT00848718|20779251|P4|NOT COMPLETED|Overall Study||5
8431278|NCT00848718|20779252|P3|NOT COMPLETED|Overall Study||6
8431279|NCT00848718|20779253|P2|NOT COMPLETED|Overall Study||9
8431280|NCT00848718|20779254|P1|NOT COMPLETED|Overall Study||7
8431281|NCT00848718|20779242|P13|COMPLETED|Overall Study||0
8431282|NCT00848718|20779243|P12|COMPLETED|Overall Study||0
8431283|NCT00848718|20779244|P11|COMPLETED|Overall Study||0
8431284|NCT00848718|20779245|P10|COMPLETED|Overall Study||0
8431285|NCT00848718|20779246|P9|COMPLETED|Overall Study||0
8431286|NCT00848718|20779247|P8|COMPLETED|Overall Study||0
8431287|NCT00848718|20779248|P7|COMPLETED|Overall Study||0
8431288|NCT00848718|20779249|P6|COMPLETED|Overall Study||0
8431289|NCT00848718|20779250|P5|COMPLETED|Overall Study||0
8431290|NCT00848718|20779251|P4|COMPLETED|Overall Study||0
8431291|NCT00848718|20779252|P3|COMPLETED|Overall Study||0
8431292|NCT00848718|20779253|P2|COMPLETED|Overall Study||0
8431293|NCT00848718|20779254|P1|COMPLETED|Overall Study||0
8431294|NCT00848718|20779242|P13|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
8431295|NCT00848718|20779243|P12|Treated|Overall Study||6
8431296|NCT00848718|20779244|P11|Treated|Overall Study||4
8431297|NCT00848718|20779245|P10|Treated|Overall Study||9
8431298|NCT00848718|20779246|P9|Treated|Overall Study||4
8431299|NCT00848718|20779247|P8|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
8431300|NCT00848718|20779248|P7|Treated|Overall Study||3
8431301|NCT00848718|20779249|P6|Treated|Overall Study||5
8431302|NCT00848718|20779250|P5|Treated|Overall Study||6
8431303|NCT00848718|20779251|P4|Treated|Overall Study||5
8431304|NCT00848718|20779252|P3|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
8431305|NCT00848718|20779253|P2|Treated|Overall Study||9
8431306|NCT00848718|20779254|P1|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
8431307|NCT00848718|20779242|P13|STARTED|Overall Study||8
8431308|NCT00848718|20779243|P12|STARTED|Overall Study||6
8431309|NCT00848718|20779244|P11|STARTED|Overall Study||4
8431310|NCT00848718|20779245|P10|STARTED|Overall Study||9
8431311|NCT00848718|20779246|P9|STARTED|Overall Study||4
8431312|NCT00848718|20779247|P8|STARTED|Overall Study||5
8431313|NCT00848718|20779248|P7|STARTED|Overall Study||3
8431314|NCT00848718|20779249|P6|STARTED|Overall Study||5
8431315|NCT00848718|20779250|P5|STARTED|Overall Study||6
8431316|NCT00848718|20779251|P4|STARTED|Overall Study||5
8431317|NCT00848718|20779252|P3|STARTED|Overall Study||6
8431318|NCT00848718|20779253|P2|STARTED|Overall Study||9
8431319|NCT00848718|20779254|P1|STARTED|Overall Study||7
8431320|NCT00848549|20779355|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
8431321|NCT00848549|20779356|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
8431322|NCT00848549|20779355|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
8431323|NCT00848549|20779356|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
8431324|NCT00848549|20779355|P2|STARTED|E2090-E044-314 (Extension Study)||158
8431325|NCT00848549|20779356|P1|STARTED|E2090-E044-314 (Extension Study)||137
8431326|NCT00848549|20779355|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
8431327|NCT00848549|20779356|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
8431328|NCT00848549|20779355|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
8431329|NCT00848549|20779356|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
8431330|NCT00848549|20779355|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
8431331|NCT00848549|20779356|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
8431332|NCT00848549|20779355|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
8431333|NCT00848549|20779356|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
8431334|NCT00848549|20779355|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
8431335|NCT00848549|20779356|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
8431336|NCT00848549|20779355|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
8431337|NCT00848549|20779356|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
8431338|NCT00848536|20779374|P2|NOT COMPLETED|Overall Study||7
8431339|NCT00848536|20779375|P1|NOT COMPLETED|Overall Study||4
8431340|NCT00848536|20779374|P2|COMPLETED|Overall Study||179
8431341|NCT00848536|20779375|P1|COMPLETED|Overall Study||181
8431342|NCT00848536|20779374|P2|STARTED|Overall Study||186
8431343|NCT00848536|20779375|P1|STARTED|Overall Study||185
8431344|NCT00848510|20779389|P4|NOT COMPLETED|Overall Study||0
8431345|NCT00848510|20779390|P3|NOT COMPLETED|Overall Study||0
8431346|NCT00848510|20779391|P2|NOT COMPLETED|Overall Study||0
8431347|NCT00848510|20779392|P1|NOT COMPLETED|Overall Study||0
8431348|NCT00848510|20779389|P4|COMPLETED|Overall Study||10
8431349|NCT00848510|20779390|P3|COMPLETED|Overall Study||8
8431350|NCT00848510|20779391|P2|COMPLETED|Overall Study||13
8431351|NCT00848510|20779392|P1|COMPLETED|Overall Study||10
8431352|NCT00848510|20779389|P4|STARTED|Overall Study||10
8431353|NCT00848510|20779390|P3|STARTED|Overall Study||8
8431354|NCT00848510|20779391|P2|STARTED|Overall Study||13
8431355|NCT00848510|20779392|P1|STARTED|Overall Study||10
8431356|NCT00848497|20779440|P2|NOT COMPLETED|Overall Study||1
8431357|NCT00848497|20779441|P1|NOT COMPLETED|Overall Study||2
8431358|NCT00848497|20779440|P2|COMPLETED|Overall Study||0
8431359|NCT00848497|20779441|P1|COMPLETED|Overall Study||0
8431360|NCT00848497|20779440|P2|STARTED|Overall Study|Completed Visit 4|1
8431361|NCT00848497|20779441|P1|STARTED|Overall Study||2
8431362|NCT00848484|20779455|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
8431363|NCT00848484|20779456|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
8431364|NCT00848484|20779455|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
8431365|NCT00848484|20779456|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
8431366|NCT00848484|20779455|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
8431367|NCT00848484|20779456|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
8431368|NCT00848484|20779455|P2|STARTED|Second Intervention (Treatment Period 2)||21
8431369|NCT00848484|20779456|P1|STARTED|Second Intervention (Treatment Period 2)||25
8431370|NCT00848484|20779455|P2|NOT COMPLETED|Washout Period of Two Weeks||3
8431371|NCT00848484|20779456|P1|NOT COMPLETED|Washout Period of Two Weeks||0
8431372|NCT00848484|20779455|P2|COMPLETED|Washout Period of Two Weeks||21
8431373|NCT00848484|20779456|P1|COMPLETED|Washout Period of Two Weeks||25
8431374|NCT00848484|20779455|P2|STARTED|Washout Period of Two Weeks||24
8431375|NCT00848484|20779456|P1|STARTED|Washout Period of Two Weeks||25
8431376|NCT00848484|20779455|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
8431377|NCT00848484|20779456|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
8431378|NCT00848484|20779455|P2|COMPLETED|First Intervention (Treatment Period 1)||24
8431379|NCT00848484|20779456|P1|COMPLETED|First Intervention (Treatment Period 1)||25
8431380|NCT00848484|20779455|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
8431381|NCT00848484|20779456|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
8431382|NCT00848484|20779455|P2|STARTED|First Intervention (Treatment Period 1)||27
8431383|NCT00848484|20779456|P1|STARTED|First Intervention (Treatment Period 1)||27
8431384|NCT00848393|20779475|P3|NOT COMPLETED|Overall Study||3
8431385|NCT00848393|20779476|P2|NOT COMPLETED|Overall Study||0
8431386|NCT00848393|20779477|P1|NOT COMPLETED|Overall Study||0
8431387|NCT00848393|20779475|P3|COMPLETED|Overall Study||15
8431388|NCT00848393|20779476|P2|COMPLETED|Overall Study||16
8431389|NCT00848393|20779477|P1|COMPLETED|Overall Study||17
8431390|NCT00848393|20779475|P3|STARTED|Overall Study||18
8431391|NCT00848393|20779476|P2|STARTED|Overall Study||16
8431392|NCT00848393|20779477|P1|STARTED|Overall Study||17
8431393|NCT00848367|20779505|P2|NOT COMPLETED|Overall Study||9
8431394|NCT00848367|20779506|P1|NOT COMPLETED|Overall Study||9
8431395|NCT00848367|20779505|P2|COMPLETED|Overall Study||41
8431396|NCT00848367|20779506|P1|COMPLETED|Overall Study||43
8431397|NCT00848367|20779505|P2|STARTED|Overall Study||50
8431398|NCT00848367|20779506|P1|STARTED|Overall Study||52
8431399|NCT00848354|20779516|P2|NOT COMPLETED|Phase 2 Year 2||7
8431400|NCT00848354|20779517|P1|NOT COMPLETED|Phase 2 Year 2||23
8431401|NCT00848354|20779516|P2|COMPLETED|Phase 2 Year 2||113
8431402|NCT00848354|20779517|P1|COMPLETED|Phase 2 Year 2||218
8431403|NCT00848354|20779516|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
8431404|NCT00848354|20779517|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.
~1 participant discontinued between Year 1 and Year 2."|241
8431405|NCT00848354|20779516|P2|NOT COMPLETED|Phase 2 Year 1||6
8431406|NCT00848354|20779517|P1|NOT COMPLETED|Phase 2 Year 1||18
8431407|NCT00848354|20779516|P2|COMPLETED|Phase 2 Year 1||120
8431408|NCT00848354|20779517|P1|COMPLETED|Phase 2 Year 1||242
8431409|NCT00848354|20779516|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
8431410|NCT00848354|20779517|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
8431411|NCT00848354|20779516|P2|NOT COMPLETED|Phase 1||14
8431412|NCT00848354|20779517|P1|NOT COMPLETED|Phase 1||12
8431413|NCT00848354|20779516|P2|COMPLETED|Phase 1||129
8431414|NCT00848354|20779517|P1|COMPLETED|Phase 1||269
8431415|NCT00848354|20779516|P2|STARTED|Phase 1||143
8431416|NCT00848354|20779517|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
8431417|NCT00848250|20779669|P2|NOT COMPLETED|Overall Study||1
8431418|NCT00848250|20779670|P1|NOT COMPLETED|Overall Study||0
8431419|NCT00848250|20779669|P2|COMPLETED|Overall Study||9
8431420|NCT00848250|20779670|P1|COMPLETED|Overall Study||11
8431421|NCT00848250|20779669|P2|STARTED|Overall Study||10
8431422|NCT00848250|20779670|P1|STARTED|Overall Study||11
8431423|NCT00848237|20779688|P1|NOT COMPLETED|Overall Study||539
8431424|NCT00848237|20779688|P1|COMPLETED|Overall Study||4982
8431425|NCT00848237|20779688|P1|STARTED|Overall Study||5521
8431426|NCT00848211|20779701|P4|NOT COMPLETED|Overall Study||0
8431427|NCT00848211|20779702|P3|NOT COMPLETED|Overall Study||1
8431428|NCT00848211|20779703|P2|NOT COMPLETED|Overall Study||1
8431429|NCT00848211|20779704|P1|NOT COMPLETED|Overall Study||0
8431430|NCT00848211|20779701|P4|COMPLETED|Overall Study||5
8431431|NCT00848211|20779702|P3|COMPLETED|Overall Study||5
8431432|NCT00848211|20779703|P2|COMPLETED|Overall Study||6
8431433|NCT00848211|20779704|P1|COMPLETED|Overall Study||6
8431434|NCT00848211|20779701|P4|STARTED|Overall Study||5
8431435|NCT00848211|20779702|P3|STARTED|Overall Study||6
8431436|NCT00848211|20779703|P2|STARTED|Overall Study||7
8431437|NCT00848211|20779704|P1|STARTED|Overall Study||6
8431438|NCT00848198|20779722|P1|NOT COMPLETED|Overall Study||15
8431439|NCT00848198|20779722|P1|COMPLETED|Overall Study||299
8431440|NCT00848198|20779722|P1|STARTED|Overall Study||314
8431441|NCT00848185|20779763|P3|NOT COMPLETED|Overall Study||0
8431442|NCT00848185|20779764|P2|NOT COMPLETED|Overall Study||0
8431443|NCT00848185|20779765|P1|NOT COMPLETED|Overall Study||0
8431444|NCT00848185|20779763|P3|COMPLETED|Overall Study||32
8431445|NCT00848185|20779764|P2|COMPLETED|Overall Study||32
8431446|NCT00848185|20779765|P1|COMPLETED|Overall Study||32
8431447|NCT00848185|20779763|P3|STARTED|Overall Study||32
8431448|NCT00848185|20779764|P2|STARTED|Overall Study||32
8431449|NCT00848185|20779765|P1|STARTED|Overall Study||32
8431450|NCT00848172|20779775|P2|NOT COMPLETED|Visit 3 - Follow Up||0
8431451|NCT00848172|20779776|P1|NOT COMPLETED|Visit 3 - Follow Up||0
8431452|NCT00848172|20779775|P2|COMPLETED|Visit 3 - Follow Up||8
8431453|NCT00848172|20779776|P1|COMPLETED|Visit 3 - Follow Up||10
8431454|NCT00848172|20779775|P2|STARTED|Visit 3 - Follow Up||8
8431455|NCT00848172|20779776|P1|STARTED|Visit 3 - Follow Up||10
8431456|NCT00848172|20779775|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
8431457|NCT00848172|20779776|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
8431458|NCT00848172|20779775|P2|COMPLETED|Visit 2 - Drug Administration||8
8431459|NCT00848172|20779776|P1|COMPLETED|Visit 2 - Drug Administration||10
8431460|NCT00848172|20779775|P2|STARTED|Visit 2 - Drug Administration||9
8431461|NCT00848172|20779776|P1|STARTED|Visit 2 - Drug Administration||10
8431462|NCT00848120|20779787|P1|NOT COMPLETED|Overall Study||1
8431463|NCT00848120|20779787|P1|COMPLETED|Overall Study||28
8431464|NCT00848120|20779787|P1|STARTED|Overall Study||29
8431465|NCT00848107|20779799|P1|NOT COMPLETED|Overall Study||21
8431466|NCT00848107|20779799|P1|COMPLETED|Overall Study||94
8431467|NCT00848107|20779799|P1|STARTED|Overall Study||115
8431468|NCT00848081|20779809|P2|NOT COMPLETED|Overall Study||18
8431469|NCT00848081|20779810|P1|NOT COMPLETED|Overall Study||20
8431470|NCT00848081|20779809|P2|COMPLETED|Overall Study||140
8431471|NCT00848081|20779810|P1|COMPLETED|Overall Study||140
8431472|NCT00848081|20779809|P2|STARTED|Overall Study||158
8431473|NCT00848081|20779810|P1|STARTED|Overall Study||160
8431474|NCT00848042|20779827|P3|NOT COMPLETED|Overall Study||0
8431475|NCT00848042|20779828|P2|NOT COMPLETED|Overall Study||2
8431476|NCT00848042|20779829|P1|NOT COMPLETED|Overall Study||4
8431477|NCT00848042|20779827|P3|COMPLETED|Overall Study||1
8431478|NCT00848042|20779828|P2|COMPLETED|Overall Study||3
8431479|NCT00848042|20779829|P1|COMPLETED|Overall Study||1
8431480|NCT00848042|20779827|P3|Month 6|Overall Study||1
8431481|NCT00848042|20779828|P2|Month 6|Overall Study||3
8431482|NCT00848042|20779829|P1|Month 6|Overall Study||1
8431483|NCT00848042|20779827|P3|Month 5|Overall Study||1
8431484|NCT00848042|20779828|P2|Month 5|Overall Study||3
8431485|NCT00848042|20779829|P1|Month 5|Overall Study||1
8431486|NCT00848042|20779827|P3|Month 4|Overall Study||1
8431487|NCT00848042|20779828|P2|Month 4|Overall Study||4
8431488|NCT00848042|20779829|P1|Month 4|Overall Study||1
8431489|NCT00848042|20779827|P3|Month 3|Overall Study||1
8431490|NCT00848042|20779828|P2|Month 3|Overall Study||4
8431491|NCT00848042|20779829|P1|Month 3|Overall Study||1
8431492|NCT00848042|20779827|P3|Month 2|Overall Study||1
8431493|NCT00848042|20779828|P2|Month 2|Overall Study||5
8431494|NCT00848042|20779829|P1|Month 2|Overall Study||1
8431495|NCT00848042|20779827|P3|Month 1|Overall Study||1
8431496|NCT00848042|20779828|P2|Month 1|Overall Study||5
8431497|NCT00848042|20779829|P1|Month 1|Overall Study||4
8431498|NCT00848042|20779827|P3|Day 15|Overall Study||1
8431499|NCT00848042|20779828|P2|Day 15|Overall Study||5
8431500|NCT00848042|20779829|P1|Day 15|Overall Study||4
8431501|NCT00848042|20779827|P3|Day 8|Overall Study||1
8431502|NCT00848042|20779828|P2|Day 8|Overall Study||5
8431503|NCT00848042|20779829|P1|Day 8|Overall Study||5
8431504|NCT00848042|20779827|P3|Day 3|Overall Study||1
8431505|NCT00848042|20779828|P2|Day 3|Overall Study||5
8431506|NCT00848042|20779829|P1|Day 3|Overall Study||5
8431507|NCT00848042|20779827|P3|Day 2|Overall Study||1
8431508|NCT00848042|20779828|P2|Day 2|Overall Study||5
8431509|NCT00848042|20779829|P1|Day 2|Overall Study||5
8431510|NCT00848042|20779827|P3|Day 1|Overall Study||1
8431511|NCT00848042|20779828|P2|Day 1|Overall Study||5
8431512|NCT00848042|20779829|P1|Day 1|Overall Study||5
8431513|NCT00848042|20779827|P3|STARTED|Overall Study||1
8431514|NCT00848042|20779828|P2|STARTED|Overall Study||5
8431515|NCT00848042|20779829|P1|STARTED|Overall Study||5
8431516|NCT00848016|20779840|P1|NOT COMPLETED|Overall Study||0
8431517|NCT00848016|20779840|P1|COMPLETED|Overall Study||29
8431518|NCT00848016|20779840|P1|STARTED|Overall Study||29
8431519|NCT00847938|20779850|P4|NOT COMPLETED|Overall Study||0
8431520|NCT00847938|20779851|P3|NOT COMPLETED|Overall Study||1
8431521|NCT00847938|20779852|P2|NOT COMPLETED|Overall Study||1
8431522|NCT00847938|20779853|P1|NOT COMPLETED|Overall Study||0
8431523|NCT00847938|20779850|P4|COMPLETED|Overall Study||15
8431524|NCT00847938|20779851|P3|COMPLETED|Overall Study||15
8431525|NCT00847938|20779852|P2|COMPLETED|Overall Study||14
8431526|NCT00847938|20779853|P1|COMPLETED|Overall Study||16
8431527|NCT00847938|20779850|P4|STARTED|Overall Study||15
8431528|NCT00847938|20779851|P3|STARTED|Overall Study||16
8431529|NCT00847938|20779852|P2|STARTED|Overall Study||15
8431530|NCT00847938|20779853|P1|STARTED|Overall Study||16
8431537|NCT00847886|20779876|P2|NOT COMPLETED|Overall Study||1
8431538|NCT00847886|20779877|P1|NOT COMPLETED|Overall Study||0
8431539|NCT00847886|20779876|P2|COMPLETED|Overall Study||3
8431540|NCT00847886|20779877|P1|COMPLETED|Overall Study||12
8431541|NCT00847886|20779876|P2|STARTED|Overall Study||4
8431542|NCT00847886|20779877|P1|STARTED|Overall Study||12
8431543|NCT00847808|20779903|P1|NOT COMPLETED|Overall Study||15
8431544|NCT00847808|20779903|P1|COMPLETED|Overall Study||163
8431545|NCT00847808|20779903|P1|STARTED|Overall Study||178
8431546|NCT00847730|20779920|P1|NOT COMPLETED|Overall Study||8
8431547|NCT00847730|20779920|P1|COMPLETED|Overall Study||25
8431548|NCT00847730|20779920|P1|STARTED|Overall Study||33
8431549|NCT00847704|20779924|P1|NOT COMPLETED|Overall Study||1
8431550|NCT00847704|20779924|P1|COMPLETED|Overall Study||2
8431551|NCT00847704|20779924|P1|STARTED|Overall Study||3
8431552|NCT00847665|20779935|P2|NOT COMPLETED|Overall Study||0
8431553|NCT00847665|20779936|P1|NOT COMPLETED|Overall Study||1
8431554|NCT00847665|20779935|P2|COMPLETED|Overall Study||165
8431555|NCT00847665|20779936|P1|COMPLETED|Overall Study||164
8431556|NCT00847665|20779935|P2|STARTED|Overall Study||165
8431557|NCT00847665|20779936|P1|STARTED|Overall Study||165
8431558|NCT00847626|20779959|P11|NOT COMPLETED|Overall Study||20
8431559|NCT00847626|20779960|P10|NOT COMPLETED|Overall Study||14
8431560|NCT00847626|20779961|P9|NOT COMPLETED|Overall Study||14
8431561|NCT00847626|20779962|P8|NOT COMPLETED|Overall Study||19
8431562|NCT00847626|20779963|P7|NOT COMPLETED|Overall Study||22
8431563|NCT00847626|20779964|P6|NOT COMPLETED|Overall Study||37
8431564|NCT00847626|20779965|P5|NOT COMPLETED|Overall Study||28
8431565|NCT00847626|20779966|P4|NOT COMPLETED|Overall Study||31
8431566|NCT00847626|20779967|P3|NOT COMPLETED|Overall Study||16
8431567|NCT00847626|20779968|P2|NOT COMPLETED|Overall Study||23
8431568|NCT00847626|20779969|P1|NOT COMPLETED|Overall Study||21
8431569|NCT00847626|20779959|P11|COMPLETED|Overall Study||142
8431570|NCT00847626|20779960|P10|COMPLETED|Overall Study||139
8431571|NCT00847626|20779961|P9|COMPLETED|Overall Study||141
8431572|NCT00847626|20779962|P8|COMPLETED|Overall Study||141
8431573|NCT00847626|20779963|P7|COMPLETED|Overall Study||135
8431574|NCT00847626|20779964|P6|COMPLETED|Overall Study||125
8431575|NCT00847626|20779965|P5|COMPLETED|Overall Study||125
8431576|NCT00847626|20779966|P4|COMPLETED|Overall Study||125
8431577|NCT00847626|20779967|P3|COMPLETED|Overall Study||131
8431578|NCT00847626|20779968|P2|COMPLETED|Overall Study||131
8431579|NCT00847626|20779969|P1|COMPLETED|Overall Study||135
8431580|NCT00847626|20779959|P11|STARTED|Overall Study||162
8431581|NCT00847626|20779960|P10|STARTED|Overall Study||153
8431582|NCT00847626|20779961|P9|STARTED|Overall Study||155
8431583|NCT00847626|20779962|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
8431584|NCT00847626|20779963|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
8431585|NCT00847626|20779964|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
8431586|NCT00847626|20779965|P5|STARTED|Overall Study||153
8431587|NCT00847626|20779966|P4|STARTED|Overall Study||156
8431588|NCT00847626|20779967|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
8431589|NCT00847626|20779968|P2|STARTED|Overall Study||154
8431590|NCT00847626|20779969|P1|STARTED|Overall Study||156
8431591|NCT00847613|20780168|P4|NOT COMPLETED|Overall Study||79
8431592|NCT00847613|20780169|P3|NOT COMPLETED|Overall Study||81
8431593|NCT00847613|20780170|P2|NOT COMPLETED|Overall Study||319
8431594|NCT00847613|20780171|P1|NOT COMPLETED|Overall Study||321
8431595|NCT00847613|20780168|P4|COMPLETED|Overall Study||0
8431596|NCT00847613|20780169|P3|COMPLETED|Overall Study||0
8431597|NCT00847613|20780170|P2|COMPLETED|Overall Study||0
8431598|NCT00847613|20780171|P1|COMPLETED|Overall Study||0
8431599|NCT00847613|20780168|P4|Treated|Overall Study||79
8431600|NCT00847613|20780169|P3|Treated|Overall Study||81
8431601|NCT00847613|20780170|P2|Treated|Overall Study||316
8431602|NCT00847613|20780171|P1|Treated|Overall Study||321
8431603|NCT00847613|20780168|P4|STARTED|Overall Study||79
8431604|NCT00847613|20780169|P3|STARTED|Overall Study||81
8431605|NCT00847613|20780170|P2|STARTED|Overall Study||319
8431606|NCT00847613|20780171|P1|STARTED|Overall Study||321
8431607|NCT00847587|20780411|P2|NOT COMPLETED|Overall Study||0
8431608|NCT00847587|20780412|P1|NOT COMPLETED|Overall Study||1
8431609|NCT00847587|20780411|P2|COMPLETED|Overall Study||34
8431610|NCT00847587|20780412|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
8431611|NCT00847587|20780411|P2|STARTED|Overall Study||34
8431612|NCT00847587|20780412|P1|STARTED|Overall Study||35
8431613|NCT00847561|20780422|P2|NOT COMPLETED|Overall Study||4
8431614|NCT00847561|20780423|P1|NOT COMPLETED|Overall Study||13
8431615|NCT00847561|20780422|P2|COMPLETED|Overall Study||62
8431616|NCT00847561|20780423|P1|COMPLETED|Overall Study||57
8431617|NCT00847561|20780422|P2|STARTED|Overall Study||66
8431618|NCT00847561|20780423|P1|STARTED|Overall Study||70
8431619|NCT00847535|20780429|P3|NOT COMPLETED|Overall Study||1
8431620|NCT00847535|20780430|P2|NOT COMPLETED|Overall Study||2
8431621|NCT00847535|20780431|P1|NOT COMPLETED|Overall Study||2
8431622|NCT00847535|20780429|P3|COMPLETED|Overall Study||15
8431623|NCT00847535|20780430|P2|COMPLETED|Overall Study||22
8431624|NCT00847535|20780431|P1|COMPLETED|Overall Study||22
8431625|NCT00847535|20780429|P3|200 Million AMDC|Overall Study||8
8431626|NCT00847535|20780430|P2|200 Million AMDC|Overall Study||0
8431627|NCT00847535|20780431|P1|200 Million AMDC|Overall Study||0
8431628|NCT00847535|20780429|P3|100 Million AMDC|Overall Study||8
8431629|NCT00847535|20780430|P2|100 Million AMDC|Overall Study||8
8431630|NCT00847535|20780431|P1|100 Million AMDC|Overall Study||8
8431631|NCT00847535|20780429|P3|50 Million AMDC|Overall Study||0
8431632|NCT00847535|20780430|P2|50 Million AMDC|Overall Study||8
8431633|NCT00847535|20780431|P1|50 Million AMDC|Overall Study||8
8431634|NCT00847535|20780429|P3|10 Million AMDC|Overall Study||0
8431635|NCT00847535|20780430|P2|10 Million AMDC|Overall Study||8
8431636|NCT00847535|20780431|P1|10 Million AMDC|Overall Study||8
8431637|NCT00847535|20780429|P3|STARTED|Overall Study||16
8431638|NCT00847535|20780430|P2|STARTED|Overall Study||24
8431639|NCT00847535|20780431|P1|STARTED|Overall Study||24
8431640|NCT00847522|20780439|P1|NOT COMPLETED|Overall Study||0
8431641|NCT00847522|20780439|P1|COMPLETED|Overall Study||90
8431642|NCT00847522|20780439|P1|Phase II|Overall Study||80
8431643|NCT00847522|20780439|P1|Phase I|Overall Study||10
8431644|NCT00847522|20780439|P1|STARTED|Overall Study||90
8431645|NCT00847509|20780444|P1|NOT COMPLETED|Overall Study||11
8431646|NCT00847509|20780444|P1|COMPLETED|Overall Study||38
8431647|NCT00847509|20780444|P1|STARTED|Overall Study||49
8431648|NCT00847405|20780450|P2|NOT COMPLETED|Second Intervention||0
8431649|NCT00847405|20780451|P1|NOT COMPLETED|Second Intervention||0
8431650|NCT00847405|20780450|P2|COMPLETED|Second Intervention||13
8431651|NCT00847405|20780451|P1|COMPLETED|Second Intervention||13
8431652|NCT00847405|20780450|P2|STARTED|Second Intervention||13
8431653|NCT00847405|20780451|P1|STARTED|Second Intervention||13
8431654|NCT00847405|20780450|P2|NOT COMPLETED|Washout of 7 Days||0
8431655|NCT00847405|20780451|P1|NOT COMPLETED|Washout of 7 Days||1
8431656|NCT00847405|20780450|P2|COMPLETED|Washout of 7 Days||13
8431657|NCT00847405|20780451|P1|COMPLETED|Washout of 7 Days||13
8431658|NCT00847405|20780450|P2|STARTED|Washout of 7 Days||13
8431659|NCT00847405|20780451|P1|STARTED|Washout of 7 Days||14
8431660|NCT00847405|20780450|P2|NOT COMPLETED|First Intervention||1
8431661|NCT00847405|20780451|P1|NOT COMPLETED|First Intervention||0
8431662|NCT00847405|20780450|P2|COMPLETED|First Intervention||13
8431663|NCT00847405|20780451|P1|COMPLETED|First Intervention||14
8431664|NCT00847405|20780450|P2|STARTED|First Intervention||14
8431665|NCT00847405|20780451|P1|STARTED|First Intervention||14
8431666|NCT00847379|20780462|P3|NOT COMPLETED|Overall Study||57
8431667|NCT00847379|20780463|P2|NOT COMPLETED|Overall Study||57
8431668|NCT00847379|20780464|P1|NOT COMPLETED|Overall Study||59
8431669|NCT00847379|20780462|P3|COMPLETED|Overall Study||0
8431670|NCT00847379|20780463|P2|COMPLETED|Overall Study||0
8431671|NCT00847379|20780464|P1|COMPLETED|Overall Study||0
8431672|NCT00847379|20780462|P3|As-treated Population|Overall Study||57
8431673|NCT00847379|20780463|P2|As-treated Population|Overall Study||57
8431674|NCT00847379|20780464|P1|As-treated Population|Overall Study||59
8431675|NCT00847379|20780462|P3|STARTED|Overall Study||57
8431676|NCT00847379|20780463|P2|STARTED|Overall Study||57
8431677|NCT00847379|20780464|P1|STARTED|Overall Study||59
8431678|NCT00847301|20780562|P1|NOT COMPLETED|Overall Study||54
8431679|NCT00847301|20780562|P1|COMPLETED|Overall Study||374
8431680|NCT00847301|20780562|P1|STARTED|Overall Study||428
8431681|NCT00847288|20780572|P2|NOT COMPLETED|Overall Study||47
8431682|NCT00847288|20780573|P1|NOT COMPLETED|Overall Study||30
8431683|NCT00847288|20780572|P2|COMPLETED|Overall Study||780
8431684|NCT00847288|20780573|P1|COMPLETED|Overall Study||811
8431685|NCT00847288|20780572|P2|STARTED|Overall Study||827
8431686|NCT00847288|20780573|P1|STARTED|Overall Study||841
8431687|NCT00847210|20780587|P2|NOT COMPLETED|Overall Study||0
8431688|NCT00847210|20780588|P1|NOT COMPLETED|Overall Study||0
8431689|NCT00847210|20780587|P2|COMPLETED|Overall Study||18
8431690|NCT00847210|20780588|P1|COMPLETED|Overall Study||18
8431691|NCT00847210|20780587|P2|STARTED|Overall Study||18
8431692|NCT00847210|20780588|P1|STARTED|Overall Study||18
8431693|NCT00847197|20780610|P2|NOT COMPLETED|Overall Study||5
8431694|NCT00847197|20780611|P1|NOT COMPLETED|Overall Study||24
8431695|NCT00847197|20780610|P2|COMPLETED|Overall Study||70
8431696|NCT00847197|20780611|P1|COMPLETED|Overall Study||92
8431697|NCT00847197|20780610|P2|STARTED|Overall Study||75
8431698|NCT00847197|20780611|P1|STARTED|Overall Study||116
8431699|NCT00847171|20780621|P1|NOT COMPLETED|Overall Study||0
8431700|NCT00847171|20780621|P1|COMPLETED|Overall Study||20
8431701|NCT00847171|20780621|P1|STARTED|Overall Study||20
8431702|NCT00847145|20780635|P8|NOT COMPLETED|Overall Study||4
8431703|NCT00847145|20780636|P7|NOT COMPLETED|Overall Study||9
8431704|NCT00847145|20780637|P6|NOT COMPLETED|Overall Study||4
8431705|NCT00847145|20780638|P5|NOT COMPLETED|Overall Study||6
8431706|NCT00847145|20780639|P4|NOT COMPLETED|Overall Study||1
8431707|NCT00847145|20780640|P3|NOT COMPLETED|Overall Study||11
8431708|NCT00847145|20780641|P2|NOT COMPLETED|Overall Study||6
8431709|NCT00847145|20780642|P1|NOT COMPLETED|Overall Study||6
8431710|NCT00847145|20780635|P8|COMPLETED|Overall Study||136
8431711|NCT00847145|20780636|P7|COMPLETED|Overall Study||143
8431712|NCT00847145|20780637|P6|COMPLETED|Overall Study||152
8431713|NCT00847145|20780638|P5|COMPLETED|Overall Study||131
8431714|NCT00847145|20780639|P4|COMPLETED|Overall Study||116
8431715|NCT00847145|20780640|P3|COMPLETED|Overall Study||274
8431716|NCT00847145|20780641|P2|COMPLETED|Overall Study||627
8431717|NCT00847145|20780642|P1|COMPLETED|Overall Study||623
8431718|NCT00847145|20780635|P8|STARTED|Overall Study||140
8431719|NCT00847145|20780636|P7|STARTED|Overall Study||152
8431720|NCT00847145|20780637|P6|STARTED|Overall Study||156
8431721|NCT00847145|20780638|P5|STARTED|Overall Study||137
8431722|NCT00847145|20780639|P4|STARTED|Overall Study||117
8431723|NCT00847145|20780640|P3|STARTED|Overall Study||285
8431724|NCT00847145|20780641|P2|STARTED|Overall Study||633
8431725|NCT00847145|20780642|P1|STARTED|Overall Study||629
8431726|NCT00847132|20780692|P2|NOT COMPLETED|Overall Study||1
8431727|NCT00847132|20780693|P1|NOT COMPLETED|Overall Study||1
8431728|NCT00847132|20780692|P2|COMPLETED|Overall Study||84
8431729|NCT00847132|20780693|P1|COMPLETED|Overall Study||89
8431730|NCT00847132|20780692|P2|STARTED|Overall Study||85
8431731|NCT00847132|20780693|P1|STARTED|Overall Study||90
8431732|NCT00847015|20780701|P1|NOT COMPLETED|Overall Study||3
8431733|NCT00847015|20780701|P1|COMPLETED|Overall Study||15
8431734|NCT00847015|20780701|P1|STARTED|Overall Study||18
8431735|NCT00847002|20780709|P2|NOT COMPLETED|Overall Study||0
8431736|NCT00847002|20780710|P1|NOT COMPLETED|Overall Study||0
8431737|NCT00847002|20780709|P2|COMPLETED|Overall Study||4
8431738|NCT00847002|20780710|P1|COMPLETED|Overall Study||4
8431739|NCT00847002|20780709|P2|STARTED|Overall Study||4
8431740|NCT00847002|20780710|P1|STARTED|Overall Study||4
8431741|NCT00846885|20780720|P2|NOT COMPLETED|Second Intervention||0
8431742|NCT00846885|20780721|P1|NOT COMPLETED|Second Intervention||0
8431743|NCT00846885|20780720|P2|COMPLETED|Second Intervention||14
8431744|NCT00846885|20780721|P1|COMPLETED|Second Intervention||14
8431745|NCT00846885|20780720|P2|STARTED|Second Intervention||14
8431746|NCT00846885|20780721|P1|STARTED|Second Intervention||14
8431747|NCT00846885|20780720|P2|NOT COMPLETED|Washout of 7 Days||0
8431748|NCT00846885|20780721|P1|NOT COMPLETED|Washout of 7 Days||0
8431749|NCT00846885|20780720|P2|COMPLETED|Washout of 7 Days||14
8431750|NCT00846885|20780721|P1|COMPLETED|Washout of 7 Days||14
8431751|NCT00846885|20780720|P2|STARTED|Washout of 7 Days||14
8431752|NCT00846885|20780721|P1|STARTED|Washout of 7 Days||14
8431753|NCT00846885|20780720|P2|NOT COMPLETED|First Intervention||0
8431754|NCT00846885|20780721|P1|NOT COMPLETED|First Intervention||0
8431755|NCT00846885|20780720|P2|COMPLETED|First Intervention||14
8431756|NCT00846885|20780721|P1|COMPLETED|First Intervention||14
8431757|NCT00846885|20780720|P2|STARTED|First Intervention||14
8431758|NCT00846885|20780721|P1|STARTED|First Intervention||14
8431759|NCT00846846|20780729|P1|NOT COMPLETED|Overall Study||75
8431760|NCT00846846|20780729|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
8431761|NCT00846846|20780729|P1|STARTED|Overall Study||1018
8431762|NCT00846807|20780734|P1|NOT COMPLETED|Overall Study||632
8431763|NCT00846807|20780734|P1|COMPLETED|Overall Study|Completed treatment.|4660
8431764|NCT00846807|20780734|P1|STARTED|Overall Study|Entered and treated.|5292
8431765|NCT00846768|20780742|P4|NOT COMPLETED|Overall Study||0
8431766|NCT00846768|20780743|P3|NOT COMPLETED|Overall Study||0
8431767|NCT00846768|20780744|P2|NOT COMPLETED|Overall Study||1
8431768|NCT00846768|20780745|P1|NOT COMPLETED|Overall Study||0
8431769|NCT00846768|20780742|P4|COMPLETED|Overall Study||12
8431770|NCT00846768|20780743|P3|COMPLETED|Overall Study||12
8431771|NCT00846768|20780744|P2|COMPLETED|Overall Study||11
8431772|NCT00846768|20780745|P1|COMPLETED|Overall Study||11
8431773|NCT00846768|20780742|P4|STARTED|Overall Study||12
8431774|NCT00846768|20780743|P3|STARTED|Overall Study||12
8431775|NCT00846768|20780744|P2|STARTED|Overall Study||12
8431776|NCT00846768|20780745|P1|STARTED|Overall Study||11
8431777|NCT00846742|20780815|P1|NOT COMPLETED|Overall Study||1
8431778|NCT00846742|20780815|P1|COMPLETED|Overall Study||84
8431779|NCT00846742|20780815|P1|Without Radiation Therapy (RT)|Overall Study||68
8431780|NCT00846742|20780815|P1|With Radiation Therapy (RT)|Overall Study||17
8431781|NCT00846742|20780815|P1|STARTED|Overall Study||85
8431782|NCT00846651|20780823|P2|NOT COMPLETED|Overall Study||4
8431783|NCT00846651|20780824|P1|NOT COMPLETED|Overall Study||4
8431784|NCT00846651|20780823|P2|COMPLETED|Overall Study||37
8431785|NCT00846651|20780824|P1|COMPLETED|Overall Study||37
8431786|NCT00846651|20780823|P2|STARTED|Overall Study||41
8431787|NCT00846651|20780824|P1|STARTED|Overall Study||41
8431788|NCT00846586|20780842|P2|NOT COMPLETED|Overall Study||35
8431789|NCT00846586|20780843|P1|NOT COMPLETED|Overall Study||39
8431790|NCT00846586|20780842|P2|COMPLETED|Overall Study||529
8431791|NCT00846586|20780843|P1|COMPLETED|Overall Study||531
8431792|NCT00846586|20780842|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
8431793|NCT00846586|20780843|P1|Received Study Drug|Overall Study||570
8431794|NCT00846586|20780842|P2|STARTED|Overall Study||564
8431795|NCT00846586|20780843|P1|STARTED|Overall Study||570
8431796|NCT00846573|20780862|P4|NOT COMPLETED|Overall Study||0
8431797|NCT00846573|20780863|P3|NOT COMPLETED|Overall Study||0
8431798|NCT00846573|20780864|P2|NOT COMPLETED|Overall Study||0
8431799|NCT00846573|20780865|P1|NOT COMPLETED|Overall Study||0
8431800|NCT00846573|20780862|P4|COMPLETED|Overall Study||0
8431801|NCT00846573|20780863|P3|COMPLETED|Overall Study||7
8431802|NCT00846573|20780864|P2|COMPLETED|Overall Study||2
8431803|NCT00846573|20780865|P1|COMPLETED|Overall Study||5
8431804|NCT00846573|20780862|P4|STARTED|Overall Study||0
8431805|NCT00846573|20780863|P3|STARTED|Overall Study||7
8431806|NCT00846573|20780864|P2|STARTED|Overall Study||2
8431807|NCT00846573|20780865|P1|STARTED|Overall Study||5
8431808|NCT00846547|20780873|P1|NOT COMPLETED|Overall Study||7
8431809|NCT00846547|20780873|P1|COMPLETED|Overall Study||25
8431810|NCT00846547|20780873|P1|STARTED|Overall Study||32
8431811|NCT00846521|20780877|P1|NOT COMPLETED|Overall Study||11
8431812|NCT00846521|20780877|P1|COMPLETED|Overall Study||12
8431813|NCT00846521|20780877|P1|STARTED|Overall Study||23
8431814|NCT00846495|20780884|P2|NOT COMPLETED|Overall Study||3
8431815|NCT00846495|20780885|P1|NOT COMPLETED|Overall Study||8
8431816|NCT00846495|20780884|P2|COMPLETED|Overall Study||24
8431817|NCT00846495|20780885|P1|COMPLETED|Overall Study||20
8431818|NCT00846495|20780884|P2|STARTED|Overall Study||27
8431819|NCT00846495|20780885|P1|STARTED|Overall Study||28
8431820|NCT00846482|20780905|P1|NOT COMPLETED|Overall Study||10
8431821|NCT00846482|20780905|P1|COMPLETED|Overall Study||54
8431822|NCT00846482|20780905|P1|STARTED|Overall Study||64
8431823|NCT00846391|20780913|P3|NOT COMPLETED|Overall Study||3
8431824|NCT00846391|20780914|P2|NOT COMPLETED|Overall Study||2
8431825|NCT00846391|20780915|P1|NOT COMPLETED|Overall Study||1
8431826|NCT00846391|20780913|P3|COMPLETED|Overall Study||3
8431827|NCT00846391|20780914|P2|COMPLETED|Overall Study||2
8431828|NCT00846391|20780915|P1|COMPLETED|Overall Study||3
8431829|NCT00846391|20780913|P3|STARTED|Overall Study||6
8431830|NCT00846391|20780914|P2|STARTED|Overall Study||4
8431831|NCT00846391|20780915|P1|STARTED|Overall Study||4
8431832|NCT00846365|20780926|P3|NOT COMPLETED|Overall Study||33
8431833|NCT00846365|20780927|P2|NOT COMPLETED|Overall Study||49
8431834|NCT00846365|20780928|P1|NOT COMPLETED|Overall Study||55
8431835|NCT00846365|20780926|P3|COMPLETED|Overall Study||323
8431836|NCT00846365|20780927|P2|COMPLETED|Overall Study||308
8431837|NCT00846365|20780928|P1|COMPLETED|Overall Study||317
8431838|NCT00846365|20780926|P3|STARTED|Overall Study||356
8431839|NCT00846365|20780927|P2|STARTED|Overall Study||357
8431840|NCT00846365|20780928|P1|STARTED|Overall Study||372
8431841|NCT00846287|20780983|P2|NOT COMPLETED|Overall Study||5
8431842|NCT00846287|20780984|P1|NOT COMPLETED|Overall Study||10
8431843|NCT00846287|20780983|P2|COMPLETED|Overall Study||10
8431844|NCT00846287|20780984|P1|COMPLETED|Overall Study||6
8431845|NCT00846287|20780983|P2|STARTED|Overall Study||15
8431846|NCT00846287|20780984|P1|STARTED|Overall Study||16
8431847|NCT00846066|20780994|P2|NOT COMPLETED|Overall Study||0
8431848|NCT00846066|20780995|P1|NOT COMPLETED|Overall Study||0
8431849|NCT00846066|20780994|P2|COMPLETED|Overall Study||29
8431850|NCT00846066|20780995|P1|COMPLETED|Overall Study||27
8431851|NCT00846066|20780994|P2|STARTED|Overall Study||29
8431852|NCT00846066|20780995|P1|STARTED|Overall Study||27
8431853|NCT00846053|20781009|P2|NOT COMPLETED|Overall Study||0
8431854|NCT00846053|20781010|P1|NOT COMPLETED|Overall Study||3
8431855|NCT00846053|20781009|P2|COMPLETED|Overall Study||8
8431856|NCT00846053|20781010|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
8431857|NCT00846053|20781009|P2|STARTED|Overall Study||8
8431858|NCT00846053|20781010|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
8431859|NCT00846027|20781018|P1|NOT COMPLETED|Overall Study||90
8431860|NCT00846027|20781018|P1|COMPLETED|Overall Study||0
8431861|NCT00846027|20781018|P1|Received Treatment|Overall Study||83
8431862|NCT00846027|20781018|P1|STARTED|Overall Study||90
8431863|NCT00845975|20781027|P2|NOT COMPLETED|Overall Study||0
8431864|NCT00845975|20781028|P1|NOT COMPLETED|Overall Study||0
8431865|NCT00845975|20781027|P2|COMPLETED|Overall Study||9
8431866|NCT00845975|20781028|P1|COMPLETED|Overall Study||9
8431867|NCT00845975|20781027|P2|STARTED|Overall Study||9
8431868|NCT00845975|20781028|P1|STARTED|Overall Study||9
8431869|NCT00845897|20781041|P3|NOT COMPLETED|Overall Study||3
8431870|NCT00845897|20781042|P2|NOT COMPLETED|Overall Study||5
8431871|NCT00845897|20781043|P1|NOT COMPLETED|Overall Study||2
8431872|NCT00845897|20781041|P3|COMPLETED|Overall Study||2
8431873|NCT00845897|20781042|P2|COMPLETED|Overall Study||2
8431874|NCT00845897|20781043|P1|COMPLETED|Overall Study||3
8431875|NCT00845897|20781041|P3|STARTED|Overall Study||5
8431876|NCT00845897|20781042|P2|STARTED|Overall Study||7
8431877|NCT00845897|20781043|P1|STARTED|Overall Study||5
8431878|NCT00845858|20781057|P3|NOT COMPLETED|Overall Study||8
8431879|NCT00845858|20781058|P2|NOT COMPLETED|Overall Study||12
8431880|NCT00845858|20781059|P1|NOT COMPLETED|Overall Study||8
8431881|NCT00845858|20781057|P3|COMPLETED|Overall Study||87
8431882|NCT00845858|20781058|P2|COMPLETED|Overall Study||84
8431883|NCT00845858|20781059|P1|COMPLETED|Overall Study||88
8431884|NCT00845858|20781057|P3|STARTED|Overall Study||95
8431885|NCT00845858|20781058|P2|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject was not eligible and was not dosed."|96
8431886|NCT00845858|20781059|P1|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject withdrew consent and was not dosed."|96
8431887|NCT00845845|20781072|P2|NOT COMPLETED|Overall Study||4
8431888|NCT00845845|20781073|P1|NOT COMPLETED|Overall Study||0
8431889|NCT00845845|20781072|P2|COMPLETED|Overall Study||2
8431890|NCT00845845|20781073|P1|COMPLETED|Overall Study||3
8431891|NCT00845845|20781072|P2|STARTED|Overall Study||6
8431892|NCT00845845|20781073|P1|STARTED|Overall Study||3
8431893|NCT00845832|20781084|P3|NOT COMPLETED|Extended Safety Follow-Up||7
8431894|NCT00845832|20781085|P2|NOT COMPLETED|Extended Safety Follow-Up||0
8431895|NCT00845832|20781086|P1|NOT COMPLETED|Extended Safety Follow-Up||0
8431896|NCT00845832|20781084|P3|COMPLETED|Extended Safety Follow-Up||0
8431897|NCT00845832|20781085|P2|COMPLETED|Extended Safety Follow-Up||5
8431898|NCT00845832|20781086|P1|COMPLETED|Extended Safety Follow-Up||2
8431899|NCT00845832|20781084|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
8431900|NCT00845832|20781085|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
8431901|NCT00845832|20781086|P1|STARTED|Extended Safety Follow-Up||2
8431902|NCT00845832|20781084|P3|NOT COMPLETED|Safety Follow-Up||0
8431903|NCT00845832|20781085|P2|NOT COMPLETED|Safety Follow-Up||0
8431904|NCT00845832|20781086|P1|NOT COMPLETED|Safety Follow-Up||1
8431905|NCT00845832|20781084|P3|COMPLETED|Safety Follow-Up||12
8431906|NCT00845832|20781085|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
8431907|NCT00845832|20781086|P1|COMPLETED|Safety Follow-Up||2
8431908|NCT00845832|20781084|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
8431909|NCT00845832|20781085|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
8431910|NCT00845832|20781086|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
8431911|NCT00845832|20781084|P3|NOT COMPLETED|Treatment Period||0
8431912|NCT00845832|20781085|P2|NOT COMPLETED|Treatment Period||3
8431913|NCT00845832|20781086|P1|NOT COMPLETED|Treatment Period||1
8431914|NCT00845832|20781084|P3|COMPLETED|Treatment Period||10
8431915|NCT00845832|20781085|P2|COMPLETED|Treatment Period||7
8431916|NCT00845832|20781086|P1|COMPLETED|Treatment Period||3
8431917|NCT00845832|20781084|P3|STARTED|Treatment Period||10
8431918|NCT00845832|20781085|P2|STARTED|Treatment Period||10
8431919|NCT00845832|20781086|P1|STARTED|Treatment Period||4
8431920|NCT00845728|20781132|P2|NOT COMPLETED|Overall Study||342
8431921|NCT00845728|20781133|P1|NOT COMPLETED|Overall Study||386
8431922|NCT00845728|20781132|P2|COMPLETED|Overall Study||1379
8431923|NCT00845728|20781133|P1|COMPLETED|Overall Study||1337
8431924|NCT00845728|20781132|P2|Exposed|Overall Study||1718
8431925|NCT00845728|20781133|P1|Exposed|Overall Study||1721
8431926|NCT00845728|20781132|P2|STARTED|Overall Study||1721
8431927|NCT00845728|20781133|P1|STARTED|Overall Study||1723
8431928|NCT00845702|20781141|P1|NOT COMPLETED|Dotarem MRA||0
8431929|NCT00845702|20781141|P1|COMPLETED|Dotarem MRA||32
8431930|NCT00845702|20781141|P1|STARTED|Dotarem MRA||32
8431931|NCT00845702|20781141|P1|NOT COMPLETED|TOF MRA||1
8431932|NCT00845702|20781141|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
8431933|NCT00845702|20781141|P1|STARTED|TOF MRA||33
8431934|NCT00845676|20781147|P1|NOT COMPLETED|Overall Study||2
8431935|NCT00845676|20781147|P1|COMPLETED|Overall Study||19
8431936|NCT00845676|20781147|P1|STARTED|Overall Study||21
8431937|NCT00845663|20781155|P2|NOT COMPLETED|Overall Study||0
8431938|NCT00845663|20781156|P1|NOT COMPLETED|Overall Study||0
8431939|NCT00845663|20781155|P2|COMPLETED|Overall Study||49
8431940|NCT00845663|20781156|P1|COMPLETED|Overall Study||49
8431941|NCT00845663|20781155|P2|STARTED|Overall Study||49
8431942|NCT00845663|20781156|P1|STARTED|Overall Study||49
8431943|NCT00845650|20781210|P6|NOT COMPLETED|Overall Study||2
8431944|NCT00845650|20781211|P5|NOT COMPLETED|Overall Study||3
8431945|NCT00845650|20781212|P4|NOT COMPLETED|Overall Study||1
8431946|NCT00845650|20781213|P3|NOT COMPLETED|Overall Study||3
8431947|NCT00845650|20781214|P2|NOT COMPLETED|Overall Study||0
8431948|NCT00845650|20781215|P1|NOT COMPLETED|Overall Study||1
8431949|NCT00845650|20781210|P6|COMPLETED|Overall Study||15
8431950|NCT00845650|20781211|P5|COMPLETED|Overall Study||28
8431951|NCT00845650|20781212|P4|COMPLETED|Overall Study||13
8431952|NCT00845650|20781213|P3|COMPLETED|Overall Study||28
8431953|NCT00845650|20781214|P2|COMPLETED|Overall Study||5
8431954|NCT00845650|20781215|P1|COMPLETED|Overall Study||30
8431955|NCT00845650|20781210|P6|STARTED|Overall Study|1 subject not dosed|17
8431956|NCT00845650|20781211|P5|STARTED|Overall Study|2 subjects not dosed|31
8431957|NCT00845650|20781212|P4|STARTED|Overall Study||14
8431958|NCT00845650|20781213|P3|STARTED|Overall Study||31
8431959|NCT00845650|20781214|P2|STARTED|Overall Study||5
8431960|NCT00845650|20781215|P1|STARTED|Overall Study|1 subject not dosed|31
8431961|NCT00845520|20781253|P3|NOT COMPLETED|Overall Study||1
8431962|NCT00845520|20781254|P2|NOT COMPLETED|Overall Study||2
8431963|NCT00845520|20781255|P1|NOT COMPLETED|Overall Study||2
8431964|NCT00845520|20781253|P3|COMPLETED|Overall Study||23
8431965|NCT00845520|20781254|P2|COMPLETED|Overall Study||23
8431966|NCT00845520|20781255|P1|COMPLETED|Overall Study||23
8431967|NCT00845520|20781253|P3|STARTED|Overall Study||24
8431968|NCT00845520|20781254|P2|STARTED|Overall Study||25
8431969|NCT00845520|20781255|P1|STARTED|Overall Study||25
8431970|NCT00845507|20781271|P2|NOT COMPLETED|Overall Study||1
8431971|NCT00845507|20781272|P1|NOT COMPLETED|Overall Study||2
8431972|NCT00845507|20781271|P2|COMPLETED|Overall Study||29
8431973|NCT00845507|20781272|P1|COMPLETED|Overall Study||22
8431974|NCT00845507|20781271|P2|STARTED|Overall Study||30
8431975|NCT00845507|20781272|P1|STARTED|Overall Study||24
8431976|NCT00845481|20781280|P1|NOT COMPLETED|Overall Study||0
8431977|NCT00845481|20781280|P1|COMPLETED|Overall Study||24
8431978|NCT00845481|20781280|P1|STARTED|Overall Study||24
8431979|NCT00845429|20781292|P3|NOT COMPLETED|Overall Study||20
8431980|NCT00845429|20781293|P2|NOT COMPLETED|Overall Study||15
8431981|NCT00845429|20781294|P1|NOT COMPLETED|Overall Study||14
8431982|NCT00845429|20781292|P3|COMPLETED|Overall Study||224
8431983|NCT00845429|20781293|P2|COMPLETED|Overall Study||226
8431984|NCT00845429|20781294|P1|COMPLETED|Overall Study||230
8431985|NCT00845429|20781292|P3|STARTED|Overall Study||244
8431986|NCT00845429|20781293|P2|STARTED|Overall Study||241
8431987|NCT00845429|20781294|P1|STARTED|Overall Study||244
8431988|NCT00845195|20781313|P2|NOT COMPLETED|Overall Study||0
8431989|NCT00845195|20781314|P1|NOT COMPLETED|Overall Study||0
8431990|NCT00845195|20781313|P2|COMPLETED|Overall Study||75
8431991|NCT00845195|20781314|P1|COMPLETED|Overall Study||75
8431992|NCT00845195|20781313|P2|STARTED|Overall Study||75
8431993|NCT00845195|20781314|P1|STARTED|Overall Study||75
8431994|NCT00845182|20781329|P3|NOT COMPLETED|Overall Study||6
8431995|NCT00845182|20781330|P2|NOT COMPLETED|Overall Study||4
8431996|NCT00845182|20781331|P1|NOT COMPLETED|Overall Study||3
8431997|NCT00845182|20781329|P3|COMPLETED|Overall Study||9
8431998|NCT00845182|20781330|P2|COMPLETED|Overall Study||11
8431999|NCT00845182|20781331|P1|COMPLETED|Overall Study||10
8432000|NCT00845182|20781329|P3|STARTED|Overall Study||15
8432001|NCT00845182|20781330|P2|STARTED|Overall Study||15
8432002|NCT00845182|20781331|P1|STARTED|Overall Study||13
8432003|NCT00845130|20781345|P2|NOT COMPLETED|Overall Study||3
8432004|NCT00845130|20781346|P1|NOT COMPLETED|Overall Study||4
8432005|NCT00845130|20781345|P2|COMPLETED|Overall Study||19
8432006|NCT00845130|20781346|P1|COMPLETED|Overall Study||16
8432007|NCT00845130|20781345|P2|STARTED|Overall Study||22
8432008|NCT00845130|20781346|P1|STARTED|Overall Study||20
8432009|NCT00845065|20781356|P2|NOT COMPLETED|Overall Study||55
8432010|NCT00845065|20781357|P1|NOT COMPLETED|Overall Study||47
8432011|NCT00845065|20781356|P2|COMPLETED|Overall Study||79
8432012|NCT00845065|20781357|P1|COMPLETED|Overall Study||20
8432013|NCT00845065|20781356|P2|STARTED|Overall Study||134
8432014|NCT00845065|20781357|P1|STARTED|Overall Study||67
8432015|NCT00845039|20781373|P2|NOT COMPLETED|Overall Study||0
8432016|NCT00845039|20781374|P1|NOT COMPLETED|Overall Study||0
8432017|NCT00845039|20781373|P2|COMPLETED|Overall Study||2
8432018|NCT00845039|20781374|P1|COMPLETED|Overall Study||2
8432019|NCT00845039|20781373|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8432020|NCT00845039|20781374|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8432021|NCT00845039|20781373|P2|STARTED|Overall Study||2
8432022|NCT00845039|20781374|P1|STARTED|Overall Study||2
8432023|NCT00845000|20781401|P6|NOT COMPLETED|Period 3||0
8432024|NCT00845000|20781402|P5|NOT COMPLETED|Period 3||0
8432025|NCT00845000|20781403|P4|NOT COMPLETED|Period 3||0
8432026|NCT00845000|20781404|P3|NOT COMPLETED|Period 3||0
8432027|NCT00845000|20781405|P2|NOT COMPLETED|Period 3||0
8432028|NCT00845000|20781406|P1|NOT COMPLETED|Period 3||0
8432029|NCT00845000|20781401|P6|COMPLETED|Period 3||2
8432030|NCT00845000|20781402|P5|COMPLETED|Period 3||2
8432031|NCT00845000|20781403|P4|COMPLETED|Period 3||2
8432032|NCT00845000|20781404|P3|COMPLETED|Period 3||2
8432033|NCT00845000|20781405|P2|COMPLETED|Period 3||2
8432034|NCT00845000|20781406|P1|COMPLETED|Period 3||2
8432035|NCT00845000|20781401|P6|STARTED|Period 3||2
8432036|NCT00845000|20781402|P5|STARTED|Period 3||2
8432037|NCT00845000|20781403|P4|STARTED|Period 3||2
8432038|NCT00845000|20781404|P3|STARTED|Period 3||2
8432039|NCT00845000|20781405|P2|STARTED|Period 3||2
8432040|NCT00845000|20781406|P1|STARTED|Period 3||2
8432041|NCT00845000|20781401|P6|NOT COMPLETED|Period 2||0
8432042|NCT00845000|20781402|P5|NOT COMPLETED|Period 2||0
8432043|NCT00845000|20781403|P4|NOT COMPLETED|Period 2||0
8432044|NCT00845000|20781404|P3|NOT COMPLETED|Period 2||0
8432045|NCT00845000|20781405|P2|NOT COMPLETED|Period 2||0
8432046|NCT00845000|20781406|P1|NOT COMPLETED|Period 2||0
8432047|NCT00845000|20781401|P6|COMPLETED|Period 2||2
8432048|NCT00845000|20781402|P5|COMPLETED|Period 2||2
8432049|NCT00845000|20781403|P4|COMPLETED|Period 2||2
8432050|NCT00845000|20781404|P3|COMPLETED|Period 2||2
8432051|NCT00845000|20781405|P2|COMPLETED|Period 2||2
8432052|NCT00845000|20781406|P1|COMPLETED|Period 2||2
8432053|NCT00845000|20781401|P6|STARTED|Period 2||2
8432054|NCT00845000|20781402|P5|STARTED|Period 2||2
8432055|NCT00845000|20781403|P4|STARTED|Period 2||2
8432056|NCT00845000|20781404|P3|STARTED|Period 2||2
8432057|NCT00845000|20781405|P2|STARTED|Period 2||2
8432058|NCT00845000|20781406|P1|STARTED|Period 2||2
8432059|NCT00845000|20781401|P6|NOT COMPLETED|Period 1||0
8432060|NCT00845000|20781402|P5|NOT COMPLETED|Period 1||0
8432061|NCT00845000|20781403|P4|NOT COMPLETED|Period 1||0
8432062|NCT00845000|20781404|P3|NOT COMPLETED|Period 1||0
8432063|NCT00845000|20781405|P2|NOT COMPLETED|Period 1||0
8432064|NCT00845000|20781406|P1|NOT COMPLETED|Period 1||0
8432065|NCT00845000|20781401|P6|COMPLETED|Period 1||2
8432066|NCT00845000|20781402|P5|COMPLETED|Period 1||2
8432067|NCT00845000|20781403|P4|COMPLETED|Period 1||2
8432068|NCT00845000|20781404|P3|COMPLETED|Period 1||2
8432069|NCT00845000|20781405|P2|COMPLETED|Period 1||2
8432070|NCT00845000|20781406|P1|COMPLETED|Period 1||2
8432071|NCT00845000|20781401|P6|STARTED|Period 1||2
8432072|NCT00845000|20781402|P5|STARTED|Period 1||2
8432073|NCT00845000|20781403|P4|STARTED|Period 1||2
8432074|NCT00845000|20781404|P3|STARTED|Period 1||2
8432075|NCT00845000|20781405|P2|STARTED|Period 1||2
8432076|NCT00845000|20781406|P1|STARTED|Period 1||2
8432077|NCT00844896|20781425|P2|NOT COMPLETED|Overall Study||17
8432078|NCT00844896|20781426|P1|NOT COMPLETED|Overall Study||12
8432079|NCT00844896|20781425|P2|COMPLETED|Overall Study||11
8432080|NCT00844896|20781426|P1|COMPLETED|Overall Study||17
8432081|NCT00844896|20781425|P2|STARTED|Overall Study||28
8432082|NCT00844896|20781426|P1|STARTED|Overall Study||29
8432083|NCT00844883|20781448|P1|NOT COMPLETED|Overall Study||4
8432084|NCT00844883|20781448|P1|COMPLETED|Overall Study||46
8432085|NCT00844883|20781448|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
8432086|NCT00844883|20781448|P1|STARTED|Overall Study||50
8432087|NCT00844857|20781460|P2|NOT COMPLETED|Overall Study||37
8432088|NCT00844857|20781461|P1|NOT COMPLETED|Overall Study||78
8432089|NCT00844857|20781460|P2|COMPLETED|Overall Study||60
8432090|NCT00844857|20781461|P1|COMPLETED|Overall Study||116
8432091|NCT00844857|20781460|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
8432092|NCT00844857|20781461|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
8432093|NCT00844857|20781460|P2|STARTED|Overall Study||97
8432094|NCT00844857|20781461|P1|STARTED|Overall Study||194
8432095|NCT00844844|20781505|P1|NOT COMPLETED|Post Treatment Period||1
8432096|NCT00844844|20781505|P1|COMPLETED|Post Treatment Period||5
8432097|NCT00844844|20781505|P1|STARTED|Post Treatment Period||6
8432098|NCT00844844|20781505|P1|NOT COMPLETED|Extension Treatment Period||2
8432099|NCT00844844|20781505|P1|COMPLETED|Extension Treatment Period||11
8432100|NCT00844844|20781505|P1|STARTED|Extension Treatment Period||13
8432101|NCT00844844|20781505|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
8432102|NCT00844844|20781505|P1|COMPLETED|Treatment Period (26 Weeks)||15
8432103|NCT00844844|20781505|P1|STARTED|Treatment Period (26 Weeks)||17
8432104|NCT00844844|20781505|P1|NOT COMPLETED|Screening Period||0
8432105|NCT00844844|20781505|P1|COMPLETED|Screening Period||17
8432106|NCT00844844|20781505|P1|STARTED|Screening Period||17
8432107|NCT00844831|20781519|P1|NOT COMPLETED|Overall Study||6
8432108|NCT00844831|20781519|P1|COMPLETED|Overall Study||19
8432109|NCT00844831|20781519|P1|STARTED|Overall Study||25
8432110|NCT00844805|20781529|P4|NOT COMPLETED|Follow-Up Phase||9
8432111|NCT00844805|20781530|P3|NOT COMPLETED|Follow-Up Phase||9
8432112|NCT00844805|20781531|P2|NOT COMPLETED|Follow-Up Phase||0
8432113|NCT00844805|20781532|P1|NOT COMPLETED|Follow-Up Phase||0
8432114|NCT00844805|20781529|P4|COMPLETED|Follow-Up Phase||32
8432115|NCT00844805|20781530|P3|COMPLETED|Follow-Up Phase||32
8432116|NCT00844805|20781531|P2|COMPLETED|Follow-Up Phase||0
8432117|NCT00844805|20781532|P1|COMPLETED|Follow-Up Phase||0
8432118|NCT00844805|20781529|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
8432119|NCT00844805|20781530|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
8432120|NCT00844805|20781531|P2|STARTED|Follow-Up Phase||0
8432121|NCT00844805|20781532|P1|STARTED|Follow-Up Phase||0
8432122|NCT00844805|20781529|P4|NOT COMPLETED|Treatment Phase||0
8432123|NCT00844805|20781530|P3|NOT COMPLETED|Treatment Phase||0
8432124|NCT00844805|20781531|P2|NOT COMPLETED|Treatment Phase||7
8432125|NCT00844805|20781532|P1|NOT COMPLETED|Treatment Phase||10
8432126|NCT00844805|20781529|P4|COMPLETED|Treatment Phase||0
8432127|NCT00844805|20781530|P3|COMPLETED|Treatment Phase||0
8432128|NCT00844805|20781531|P2|COMPLETED|Treatment Phase||45
8432129|NCT00844805|20781532|P1|COMPLETED|Treatment Phase||96
8432130|NCT00844805|20781529|P4|STARTED|Treatment Phase||0
8432131|NCT00844805|20781530|P3|STARTED|Treatment Phase||0
8432132|NCT00844805|20781531|P2|STARTED|Treatment Phase||52
8432133|NCT00844805|20781532|P1|STARTED|Treatment Phase||106
8432134|NCT00844753|20781576|P4|NOT COMPLETED|Overall Study||11
8432135|NCT00844753|20781577|P3|NOT COMPLETED|Overall Study||7
8432136|NCT00844753|20781578|P2|NOT COMPLETED|Overall Study||3
8432137|NCT00844753|20781579|P1|NOT COMPLETED|Overall Study||8
8432138|NCT00844753|20781576|P4|COMPLETED|Overall Study||21
8432139|NCT00844753|20781577|P3|COMPLETED|Overall Study||25
8432140|NCT00844753|20781578|P2|COMPLETED|Overall Study||29
8432141|NCT00844753|20781579|P1|COMPLETED|Overall Study||24
8432142|NCT00844753|20781576|P4|STARTED|Overall Study||32
8432143|NCT00844753|20781577|P3|STARTED|Overall Study||32
8432144|NCT00844753|20781578|P2|STARTED|Overall Study||32
8432145|NCT00844753|20781579|P1|STARTED|Overall Study||32
8432146|NCT00844714|20781591|P1|NOT COMPLETED|Overall Study||0
8432147|NCT00844714|20781591|P1|COMPLETED|Overall Study||20
8432148|NCT00844714|20781591|P1|STARTED|Overall Study||20
8432149|NCT00844649|20781597|P2|NOT COMPLETED|Overall Study||418
8432150|NCT00844649|20781598|P1|NOT COMPLETED|Overall Study||405
8432151|NCT00844649|20781597|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
8432152|NCT00844649|20781598|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
8432153|NCT00844649|20781597|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
8432154|NCT00844649|20781598|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
8432155|NCT00844649|20781597|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
8432156|NCT00844649|20781598|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
8432157|NCT00844597|20781622|P6|NOT COMPLETED|Overall Study||0
8432158|NCT00844597|20781623|P5|NOT COMPLETED|Overall Study||0
8432159|NCT00844597|20781624|P4|NOT COMPLETED|Overall Study||1
8432160|NCT00844597|20781625|P3|NOT COMPLETED|Overall Study||0
8432161|NCT00844597|20781626|P2|NOT COMPLETED|Overall Study||0
8432162|NCT00844597|20781627|P1|NOT COMPLETED|Overall Study||0
8432163|NCT00844597|20781622|P6|COMPLETED|Overall Study||4
8432164|NCT00844597|20781623|P5|COMPLETED|Overall Study||4
8432165|NCT00844597|20781624|P4|COMPLETED|Overall Study||2
8432166|NCT00844597|20781625|P3|COMPLETED|Overall Study||2
8432167|NCT00844597|20781626|P2|COMPLETED|Overall Study||2
8432168|NCT00844597|20781627|P1|COMPLETED|Overall Study||4
8432169|NCT00844597|20781622|P6|STARTED|Overall Study||4
8432170|NCT00844597|20781623|P5|STARTED|Overall Study||4
8432171|NCT00844597|20781624|P4|STARTED|Overall Study||3
8432172|NCT00844597|20781625|P3|STARTED|Overall Study||2
8432173|NCT00844597|20781626|P2|STARTED|Overall Study||2
8432174|NCT00844597|20781627|P1|STARTED|Overall Study||4
8432175|NCT00844558|20781647|P2|NOT COMPLETED|Overall Study||4
8432176|NCT00844558|20781648|P1|NOT COMPLETED|Overall Study||12
8432177|NCT00844558|20781647|P2|COMPLETED|Overall Study||18
8432178|NCT00844558|20781648|P1|COMPLETED|Overall Study||24
8432179|NCT00844558|20781647|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
8432180|NCT00844558|20781648|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
8432181|NCT00844558|20781647|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
8432182|NCT00844558|20781648|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
8432183|NCT00844558|20781647|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)
~Discontinued Intervention (n=1)"|19
8432184|NCT00844558|20781648|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
8432185|NCT00844558|20781647|P2|Received Allocated Intervention|Overall Study||21
8432186|NCT00844558|20781648|P1|Received Allocated Intervention|Overall Study||33
8432187|NCT00844558|20781647|P2|STARTED|Overall Study|"Received allocated intervention (n=21)
~Did not receive allocated intervention (n=1)"|22
8432188|NCT00844558|20781648|P1|STARTED|Overall Study|"Received allocated intervention (n=33)
~Did not receive allocated intervention (n=3)"|36
8432189|NCT00844545|20781664|P1|NOT COMPLETED|Post Treatment Period||1
8432190|NCT00844545|20781664|P1|COMPLETED|Post Treatment Period||5
8432191|NCT00844545|20781664|P1|STARTED|Post Treatment Period||6
8432192|NCT00844545|20781664|P1|NOT COMPLETED|Extension Treatment Period||2
8432193|NCT00844545|20781664|P1|COMPLETED|Extension Treatment Period||11
8432194|NCT00844545|20781664|P1|STARTED|Extension Treatment Period||13
8432195|NCT00844545|20781664|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
8432196|NCT00844545|20781664|P1|COMPLETED|Treatment Period (26 Weeks)||15
8432197|NCT00844545|20781664|P1|STARTED|Treatment Period (26 Weeks)||17
8432198|NCT00844545|20781664|P1|NOT COMPLETED|Screening Period||0
8432199|NCT00844545|20781664|P1|COMPLETED|Screening Period||17
8432200|NCT00844545|20781664|P1|STARTED|Screening Period||17
8432201|NCT00844532|20781678|P1|NOT COMPLETED|Overall Study||39
8432202|NCT00844532|20781678|P1|COMPLETED|Overall Study||112
8432203|NCT00844532|20781678|P1|STARTED|Overall Study||151
8432204|NCT00844519|20781764|P2|NOT COMPLETED|Overall Study||1
8432205|NCT00844519|20781765|P1|NOT COMPLETED|Overall Study||2
8432206|NCT00844519|20781764|P2|COMPLETED|Overall Study||25
8432207|NCT00844519|20781765|P1|COMPLETED|Overall Study||24
8432208|NCT00844519|20781764|P2|STARTED|Overall Study||26
8432209|NCT00844519|20781765|P1|STARTED|Overall Study||26
8432210|NCT00844480|20781773|P2|NOT COMPLETED|Overall Study||3
8432211|NCT00844480|20781774|P1|NOT COMPLETED|Overall Study||2
8432212|NCT00844480|20781773|P2|COMPLETED|Overall Study||6
8432213|NCT00844480|20781774|P1|COMPLETED|Overall Study||6
8432214|NCT00844480|20781773|P2|STARTED|Overall Study||9
8432215|NCT00844480|20781774|P1|STARTED|Overall Study||8
8432216|NCT00844428|20781782|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
8432217|NCT00844428|20781782|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
8432218|NCT00844428|20781782|P1|STARTED|Post Treatment Period (Patients Who Disc||5
8432219|NCT00844428|20781782|P1|NOT COMPLETED|Extension Treatment Period||1
8432220|NCT00844428|20781782|P1|COMPLETED|Extension Treatment Period||18
8432221|NCT00844428|20781782|P1|STARTED|Extension Treatment Period||19
8432222|NCT00844428|20781782|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
8432223|NCT00844428|20781782|P1|COMPLETED|Treatment Period (26 Weeks)||20
8432224|NCT00844428|20781782|P1|STARTED|Treatment Period (26 Weeks)||20
8432225|NCT00844428|20781782|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
8432226|NCT00844428|20781782|P1|COMPLETED|Observation Period (8 Weeks)||20
8432227|NCT00844428|20781782|P1|STARTED|Observation Period (8 Weeks)||20
8432228|NCT00844428|20781782|P1|NOT COMPLETED|Screening Period||3
8432229|NCT00844428|20781782|P1|COMPLETED|Screening Period||20
8432230|NCT00844428|20781782|P1|STARTED|Screening Period||23
8432231|NCT00844415|20781798|P1|NOT COMPLETED|Overall Study||1
8432232|NCT00844415|20781798|P1|COMPLETED|Overall Study|Completed.|8
8432233|NCT00844415|20781798|P1|Pat. Received Single Dose 75mg|Overall Study||1
8432234|NCT00844415|20781798|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
8432235|NCT00844415|20781798|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
8432236|NCT00844415|20781798|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
8432237|NCT00844415|20781798|P1|STARTED|Overall Study|Entered and treated.|9
8432238|NCT00844376|20781812|P2|NOT COMPLETED|Period 2: Second Intervention||0
8432239|NCT00844376|20781813|P1|NOT COMPLETED|Period 2: Second Intervention||0
8432240|NCT00844376|20781812|P2|COMPLETED|Period 2: Second Intervention||6
8432241|NCT00844376|20781813|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
8432242|NCT00844376|20781812|P2|STARTED|Period 2: Second Intervention||6
8432243|NCT00844376|20781813|P1|STARTED|Period 2: Second Intervention||5
8432244|NCT00844376|20781812|P2|NOT COMPLETED|Period 1: First Intervention||0
8432245|NCT00844376|20781813|P1|NOT COMPLETED|Period 1: First Intervention||1
8432246|NCT00844376|20781812|P2|COMPLETED|Period 1: First Intervention||6
8432247|NCT00844376|20781813|P1|COMPLETED|Period 1: First Intervention||5
8432248|NCT00844376|20781812|P2|STARTED|Period 1: First Intervention||6
8432249|NCT00844376|20781813|P1|STARTED|Period 1: First Intervention||6
8432250|NCT00844298|20781831|P1|NOT COMPLETED|Overall Study||0
8432251|NCT00844298|20781831|P1|COMPLETED|Overall Study||91
8432252|NCT00844298|20781831|P1|STARTED|Overall Study||91
8432253|NCT00844194|20781837|P2|NOT COMPLETED|Overall Study||8
8432254|NCT00844194|20781838|P1|NOT COMPLETED|Overall Study||25
8432255|NCT00844194|20781837|P2|COMPLETED|Overall Study||22
8432256|NCT00844194|20781838|P1|COMPLETED|Overall Study||53
8432257|NCT00844194|20781837|P2|STARTED|Overall Study||30
8432258|NCT00844194|20781838|P1|STARTED|Overall Study||78
8432259|NCT00844090|20782044|P2|NOT COMPLETED|Overall Study||8
8432260|NCT00844090|20782045|P1|NOT COMPLETED|Overall Study||6
8432261|NCT00844090|20782044|P2|COMPLETED|Overall Study||46
8432262|NCT00844090|20782045|P1|COMPLETED|Overall Study||46
8432263|NCT00844090|20782044|P2|STARTED|Overall Study||54
8432264|NCT00844090|20782045|P1|STARTED|Overall Study||52
8432265|NCT00844051|20782053|P2|NOT COMPLETED|Overall Study||0
8432266|NCT00844051|20782054|P1|NOT COMPLETED|Overall Study||0
8432267|NCT00844051|20782053|P2|COMPLETED|Overall Study||2368
8432268|NCT00844051|20782054|P1|COMPLETED|Overall Study||2087
8432269|NCT00844051|20782053|P2|STARTED|Overall Study||2368
8432270|NCT00844051|20782054|P1|STARTED|Overall Study||2087
8432271|NCT00843986|20782064|P2|NOT COMPLETED|Overall Study||1
8432272|NCT00843986|20782065|P1|NOT COMPLETED|Overall Study||1
8432273|NCT00843986|20782064|P2|COMPLETED|Overall Study||5
8432274|NCT00843986|20782065|P1|COMPLETED|Overall Study||2
8432275|NCT00843986|20782064|P2|Completed Treatment (Infusion)|Overall Study||6
8432276|NCT00843986|20782065|P1|Completed Treatment (Infusion)|Overall Study||2
8432277|NCT00843986|20782064|P2|STARTED|Overall Study||6
8432278|NCT00843986|20782065|P1|STARTED|Overall Study||3
8432279|NCT00843856|20782093|P2|NOT COMPLETED|Overall Study||2
8432280|NCT00843856|20782094|P1|NOT COMPLETED|Overall Study||1
8432281|NCT00843856|20782093|P2|COMPLETED|Overall Study||18
8432282|NCT00843856|20782094|P1|COMPLETED|Overall Study||19
8432283|NCT00843856|20782093|P2|STARTED|Overall Study||20
8432284|NCT00843856|20782094|P1|STARTED|Overall Study||20
8432285|NCT00843843|20782104|P2|NOT COMPLETED|Overall Study||2
8432286|NCT00843843|20782105|P1|NOT COMPLETED|Overall Study||2
8432287|NCT00843843|20782104|P2|COMPLETED|Overall Study||6
8432288|NCT00843843|20782105|P1|COMPLETED|Overall Study||6
8432289|NCT00843843|20782104|P2|STARTED|Overall Study||8
8432290|NCT00843843|20782105|P1|STARTED|Overall Study||8
8432291|NCT00843830|20782113|P1|NOT COMPLETED|Overall Study||0
8432292|NCT00843830|20782113|P1|COMPLETED|Overall Study||4
8432293|NCT00843830|20782113|P1|STARTED|Overall Study||4
8432294|NCT00843778|20782118|P1|NOT COMPLETED|Overall Study||35
8432295|NCT00843778|20782118|P1|COMPLETED|Overall Study||96
8432296|NCT00843778|20782118|P1|STARTED|Overall Study||131
8432297|NCT00843713|20782153|P2|NOT COMPLETED|Overall Study||0
8432298|NCT00843713|20782154|P1|NOT COMPLETED|Overall Study||0
8432299|NCT00843713|20782153|P2|COMPLETED|Overall Study||26
8432300|NCT00843713|20782154|P1|COMPLETED|Overall Study||30
8432301|NCT00843713|20782153|P2|STARTED|Overall Study||26
8432302|NCT00843713|20782154|P1|STARTED|Overall Study||30
8432303|NCT00843635|20782163|P3|NOT COMPLETED|Overall Study||0
8432304|NCT00843635|20782164|P2|NOT COMPLETED|Overall Study||2
8432305|NCT00843635|20782165|P1|NOT COMPLETED|Overall Study||2
8432306|NCT00843635|20782163|P3|COMPLETED|Overall Study||5
8432307|NCT00843635|20782164|P2|COMPLETED|Overall Study||13
8432308|NCT00843635|20782165|P1|COMPLETED|Overall Study||13
8432309|NCT00843635|20782163|P3|STARTED|Overall Study||5
8432310|NCT00843635|20782164|P2|STARTED|Overall Study||15
8432311|NCT00843635|20782165|P1|STARTED|Overall Study||15
8432312|NCT00843622|20782185|P2|NOT COMPLETED|Overall Study||55
8432313|NCT00843622|20782186|P1|NOT COMPLETED|Overall Study||43
8432314|NCT00843622|20782185|P2|COMPLETED|Overall Study||70
8432315|NCT00843622|20782186|P1|COMPLETED|Overall Study||82
8432316|NCT00843622|20782185|P2|STARTED|Overall Study||125
8432317|NCT00843622|20782186|P1|STARTED|Overall Study||125
8432318|NCT00843531|20782192|P1|NOT COMPLETED|Overall Study||0
8432319|NCT00843531|20782192|P1|COMPLETED|Overall Study||17
8432320|NCT00843531|20782192|P1|STARTED|Overall Study||17
8432321|NCT00843518|20782204|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
8432322|NCT00843518|20782205|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
8432323|NCT00843518|20782204|P2|COMPLETED|Period 3 (Single-blind Washout)||49
8432324|NCT00843518|20782205|P1|COMPLETED|Period 3 (Single-blind Washout)||42
8432325|NCT00843518|20782204|P2|STARTED|Period 3 (Single-blind Washout)||49
8432326|NCT00843518|20782205|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
8432327|NCT00843518|20782204|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
8432328|NCT00843518|20782205|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
8432329|NCT00843518|20782204|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
8432330|NCT00843518|20782205|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
8432331|NCT00843518|20782204|P2|STARTED|Period 2 (Double-blind Treatment)||69
8432332|NCT00843518|20782205|P1|STARTED|Period 2 (Double-blind Treatment)||63
8432333|NCT00843492|20782235|P2|NOT COMPLETED|Overall Study||14
8432334|NCT00843492|20782236|P1|NOT COMPLETED|Overall Study||8
8432335|NCT00843492|20782235|P2|COMPLETED|Overall Study||607
8432336|NCT00843492|20782236|P1|COMPLETED|Overall Study||614
8432337|NCT00843492|20782235|P2|STARTED|Overall Study||621
8432338|NCT00843492|20782236|P1|STARTED|Overall Study||622
8432339|NCT00843479|20782256|P2|NOT COMPLETED|Overall Study||0
8432340|NCT00843479|20782257|P1|NOT COMPLETED|Overall Study||0
8432341|NCT00843479|20782256|P2|COMPLETED|Overall Study||12
8432342|NCT00843479|20782257|P1|COMPLETED|Overall Study||12
8432343|NCT00843479|20782256|P2|STARTED|Overall Study||12
8432344|NCT00843479|20782257|P1|STARTED|Overall Study||12
8432345|NCT00843466|20782275|P2|NOT COMPLETED|Overall Study||0
8432346|NCT00843466|20782276|P1|NOT COMPLETED|Overall Study||0
8432347|NCT00843466|20782275|P2|COMPLETED|Overall Study||18
8432348|NCT00843466|20782276|P1|COMPLETED|Overall Study||24
8432349|NCT00843466|20782275|P2|STARTED|Overall Study||18
8432350|NCT00843466|20782276|P1|STARTED|Overall Study||24
8432351|NCT00843349|20782286|P4|NOT COMPLETED|Overall Study||1
8432352|NCT00843349|20782287|P3|NOT COMPLETED|Overall Study||0
8432353|NCT00843349|20782288|P2|NOT COMPLETED|Overall Study||0
8432354|NCT00843349|20782289|P1|NOT COMPLETED|Overall Study||3
8432355|NCT00843349|20782286|P4|COMPLETED|Overall Study||10
8432356|NCT00843349|20782287|P3|COMPLETED|Overall Study||10
8432357|NCT00843349|20782288|P2|COMPLETED|Overall Study||11
8432358|NCT00843349|20782289|P1|COMPLETED|Overall Study||8
8432359|NCT00843349|20782286|P4|STARTED|Overall Study||11
8432360|NCT00843349|20782287|P3|STARTED|Overall Study||10
8432361|NCT00843349|20782288|P2|STARTED|Overall Study||11
8432362|NCT00843349|20782289|P1|STARTED|Overall Study||11
8432363|NCT00843310|20782303|P1|NOT COMPLETED|Overall Study||7
8432364|NCT00843310|20782303|P1|COMPLETED|Overall Study||1
8432365|NCT00843310|20782303|P1|STARTED|Overall Study||8
8432369|NCT00843193|20782317|P2|NOT COMPLETED|Overall Study||11
8432370|NCT00843193|20782318|P1|NOT COMPLETED|Overall Study||8
8432371|NCT00843193|20782317|P2|COMPLETED|Overall Study||88
8432372|NCT00843193|20782318|P1|COMPLETED|Overall Study||91
8432373|NCT00843193|20782317|P2|STARTED|Overall Study||99
8432374|NCT00843193|20782318|P1|STARTED|Overall Study||99
8432375|NCT00843180|20782354|P2|NOT COMPLETED|Overall Study||0
8432376|NCT00843180|20782355|P1|NOT COMPLETED|Overall Study||0
8432377|NCT00843180|20782354|P2|COMPLETED|Overall Study||7
8432378|NCT00843180|20782355|P1|COMPLETED|Overall Study||16
8432379|NCT00843180|20782354|P2|STARTED|Overall Study||7
8432380|NCT00843180|20782355|P1|STARTED|Overall Study||16
8432381|NCT00843167|20782369|P2|NOT COMPLETED|Follow-up||0
8432382|NCT00843167|20782370|P1|NOT COMPLETED|Follow-up||0
8432383|NCT00843167|20782369|P2|COMPLETED|Follow-up||24
8432384|NCT00843167|20782370|P1|COMPLETED|Follow-up||24
8432385|NCT00843167|20782369|P2|Completed Final Visit|Follow-up||24
8432386|NCT00843167|20782370|P1|Completed Final Visit|Follow-up||24
8432387|NCT00843167|20782369|P2|STARTED|Follow-up||24
8432388|NCT00843167|20782370|P1|STARTED|Follow-up||24
8432389|NCT00843167|20782369|P2|NOT COMPLETED|Treatment Period||8
8432390|NCT00843167|20782370|P1|NOT COMPLETED|Treatment Period||3
8432391|NCT00843167|20782369|P2|COMPLETED|Treatment Period||19
8432392|NCT00843167|20782370|P1|COMPLETED|Treatment Period||24
8432393|NCT00843167|20782369|P2|STARTED|Treatment Period||27
8432394|NCT00843167|20782370|P1|STARTED|Treatment Period||27
8432395|NCT00843115|20782383|P1|NOT COMPLETED|Overall Study||66
8432396|NCT00843115|20782383|P1|COMPLETED|Overall Study||304
8432397|NCT00843115|20782383|P1|STARTED|Overall Study||370
8432398|NCT00843050|20782429|P1|NOT COMPLETED|Overall Study||13
8432399|NCT00843050|20782429|P1|COMPLETED|Overall Study||0
8432400|NCT00843050|20782429|P1|STARTED|Overall Study||13
8432401|NCT00843024|20782439|P6|NOT COMPLETED|Double-blind Treatment Phase||25
8432402|NCT00843024|20782440|P5|NOT COMPLETED|Double-blind Treatment Phase||20
8432403|NCT00843024|20782441|P4|NOT COMPLETED|Double-blind Treatment Phase||23
8432404|NCT00843024|20782442|P3|NOT COMPLETED|Double-blind Treatment Phase||31
8432405|NCT00843024|20782443|P2|NOT COMPLETED|Double-blind Treatment Phase||0
8432406|NCT00843024|20782444|P1|NOT COMPLETED|Double-blind Treatment Phase||0
8432407|NCT00843024|20782439|P6|COMPLETED|Double-blind Treatment Phase||152
8432408|NCT00843024|20782440|P5|COMPLETED|Double-blind Treatment Phase||97
8432409|NCT00843024|20782441|P4|COMPLETED|Double-blind Treatment Phase||96
8432410|NCT00843024|20782442|P3|COMPLETED|Double-blind Treatment Phase||145
8432411|NCT00843024|20782443|P2|COMPLETED|Double-blind Treatment Phase||0
8432412|NCT00843024|20782444|P1|COMPLETED|Double-blind Treatment Phase||0
8432413|NCT00843024|20782439|P6|STARTED|Double-blind Treatment Phase||177
8432414|NCT00843024|20782440|P5|STARTED|Double-blind Treatment Phase||117
8432415|NCT00843024|20782441|P4|STARTED|Double-blind Treatment Phase||119
8432416|NCT00843024|20782442|P3|STARTED|Double-blind Treatment Phase||176
8432417|NCT00843024|20782443|P2|STARTED|Double-blind Treatment Phase||0
8432418|NCT00843024|20782444|P1|STARTED|Double-blind Treatment Phase||0
8432419|NCT00843024|20782439|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432420|NCT00843024|20782440|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432421|NCT00843024|20782441|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432422|NCT00843024|20782442|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432423|NCT00843024|20782443|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
8432424|NCT00843024|20782444|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
8432425|NCT00843024|20782439|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
8432426|NCT00843024|20782440|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
8432427|NCT00843024|20782441|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
8432428|NCT00843024|20782442|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
8432429|NCT00843024|20782443|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
8432430|NCT00843024|20782444|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
8432431|NCT00843024|20782439|P6|STARTED|Single-blind Placebo Run-In Phase||0
8432432|NCT00843024|20782440|P5|STARTED|Single-blind Placebo Run-In Phase||0
8432433|NCT00843024|20782441|P4|STARTED|Single-blind Placebo Run-In Phase||0
8432434|NCT00843024|20782442|P3|STARTED|Single-blind Placebo Run-In Phase||0
8432435|NCT00843024|20782443|P2|STARTED|Single-blind Placebo Run-In Phase||457
8432436|NCT00843024|20782444|P1|STARTED|Single-blind Placebo Run-In Phase||408
8432437|NCT00842985|20782509|P1|NOT COMPLETED|Fourth Intervention||0
8432438|NCT00842985|20782509|P1|COMPLETED|Fourth Intervention||15
8432439|NCT00842985|20782509|P1|STARTED|Fourth Intervention||15
8432440|NCT00842985|20782509|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
8432441|NCT00842985|20782509|P1|COMPLETED|Washout Period of GE 4 Days||15
8432442|NCT00842985|20782509|P1|STARTED|Washout Period of GE 4 Days||15
8432443|NCT00842985|20782509|P1|NOT COMPLETED|Third Intervention||0
8432444|NCT00842985|20782509|P1|COMPLETED|Third Intervention||15
8432445|NCT00842985|20782509|P1|STARTED|Third Intervention||15
8432446|NCT00842985|20782509|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
8432447|NCT00842985|20782509|P1|COMPLETED|Washout Period of GE 4 Days||15
8432448|NCT00842985|20782509|P1|STARTED|Washout Period of GE 4 Days||17
8432449|NCT00842985|20782509|P1|NOT COMPLETED|Second Intervention||1
8432450|NCT00842985|20782509|P1|COMPLETED|Second Intervention||17
8432451|NCT00842985|20782509|P1|STARTED|Second Intervention||18
8432452|NCT00842985|20782509|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
8432453|NCT00842985|20782509|P1|COMPLETED|Washout Period of GE 4 Days||18
8432454|NCT00842985|20782509|P1|STARTED|Washout Period of GE 4 Days||20
8432455|NCT00842985|20782509|P1|NOT COMPLETED|First Intervention||6
8432456|NCT00842985|20782509|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
8432457|NCT00842985|20782509|P1|STARTED|First Intervention|Signed Consent|26
8432458|NCT00842985|20782509|P1|NOT COMPLETED|Screening||27
8432459|NCT00842985|20782509|P1|COMPLETED|Screening||26
8432460|NCT00842985|20782509|P1|STARTED|Screening||53
8432461|NCT00842946|20782518|P2|NOT COMPLETED|Overall Study||5
8432462|NCT00842946|20782519|P1|NOT COMPLETED|Overall Study||5
8432463|NCT00842946|20782518|P2|COMPLETED|Overall Study||19
8432464|NCT00842946|20782519|P1|COMPLETED|Overall Study||16
8432465|NCT00842946|20782518|P2|STARTED|Overall Study||24
8432466|NCT00842946|20782519|P1|STARTED|Overall Study||21
8432467|NCT00842829|20782527|P3|NOT COMPLETED|Continuation Period||61
8432468|NCT00842829|20782528|P2|NOT COMPLETED|Continuation Period||0
8432469|NCT00842829|20782529|P1|NOT COMPLETED|Continuation Period||0
8432470|NCT00842829|20782527|P3|COMPLETED|Continuation Period||27
8432471|NCT00842829|20782528|P2|COMPLETED|Continuation Period||0
8432472|NCT00842829|20782529|P1|COMPLETED|Continuation Period||0
8432473|NCT00842829|20782527|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
8432474|NCT00842829|20782528|P2|Continuation Safety Analysis Set|Continuation Period||0
8432475|NCT00842829|20782529|P1|Continuation Safety Analysis Set|Continuation Period||0
8432476|NCT00842829|20782527|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
8432477|NCT00842829|20782528|P2|STARTED|Continuation Period||0
8432478|NCT00842829|20782529|P1|STARTED|Continuation Period||0
8432479|NCT00842829|20782527|P3|NOT COMPLETED|Treatment Period||63
8432480|NCT00842829|20782528|P2|NOT COMPLETED|Treatment Period||0
8432481|NCT00842829|20782529|P1|NOT COMPLETED|Treatment Period||0
8432482|NCT00842829|20782527|P3|COMPLETED|Treatment Period||218
8432483|NCT00842829|20782528|P2|COMPLETED|Treatment Period||0
8432484|NCT00842829|20782529|P1|COMPLETED|Treatment Period||0
8432485|NCT00842829|20782527|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
8432486|NCT00842829|20782528|P2|Safety Analysis Set|Treatment Period||0
8432487|NCT00842829|20782529|P1|Safety Analysis Set|Treatment Period||0
8432488|NCT00842829|20782527|P3|STARTED|Treatment Period||281
8432489|NCT00842829|20782528|P2|STARTED|Treatment Period||0
8432490|NCT00842829|20782529|P1|STARTED|Treatment Period||0
8432491|NCT00842829|20782527|P3|NOT COMPLETED|Dose Titration Period||0
8432492|NCT00842829|20782528|P2|NOT COMPLETED|Dose Titration Period||23
8432493|NCT00842829|20782529|P1|NOT COMPLETED|Dose Titration Period||26
8432494|NCT00842829|20782527|P3|COMPLETED|Dose Titration Period||0
8432495|NCT00842829|20782528|P2|COMPLETED|Dose Titration Period||151
8432496|NCT00842829|20782529|P1|COMPLETED|Dose Titration Period||130
8432497|NCT00842829|20782527|P3|Titration Safety Analysis Set|Dose Titration Period||0
8432498|NCT00842829|20782528|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
8432499|NCT00842829|20782529|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
8432500|NCT00842829|20782527|P3|STARTED|Dose Titration Period||0
8432501|NCT00842829|20782528|P2|STARTED|Dose Titration Period||174
8432502|NCT00842829|20782529|P1|STARTED|Dose Titration Period||156
8432503|NCT00842764|20782563|P1|NOT COMPLETED|Overall Study||2
8432504|NCT00842764|20782563|P1|COMPLETED|Overall Study||5
8432505|NCT00842764|20782563|P1|STARTED|Overall Study||7
8432506|NCT00842751|20782567|P1|NOT COMPLETED|Overall Study||0
8432507|NCT00842751|20782567|P1|COMPLETED|Overall Study||11
8432508|NCT00842751|20782567|P1|STARTED|Overall Study||11
8432509|NCT00842712|20782588|P7|NOT COMPLETED|Randomized Part||6
8432510|NCT00842712|20782589|P6|NOT COMPLETED|Randomized Part||1
8432511|NCT00842712|20782590|P5|NOT COMPLETED|Randomized Part||0
8432512|NCT00842712|20782591|P4|NOT COMPLETED|Randomized Part||0
8432513|NCT00842712|20782592|P3|NOT COMPLETED|Randomized Part||0
8432514|NCT00842712|20782593|P2|NOT COMPLETED|Randomized Part||0
8432515|NCT00842712|20782594|P1|NOT COMPLETED|Randomized Part||0
8432516|NCT00842712|20782588|P7|COMPLETED|Randomized Part||78
8432517|NCT00842712|20782589|P6|COMPLETED|Randomized Part||50
8432518|NCT00842712|20782590|P5|COMPLETED|Randomized Part||85
8432519|NCT00842712|20782591|P4|COMPLETED|Randomized Part||0
8432520|NCT00842712|20782592|P3|COMPLETED|Randomized Part||0
8432521|NCT00842712|20782593|P2|COMPLETED|Randomized Part||0
8432522|NCT00842712|20782594|P1|COMPLETED|Randomized Part||0
8432523|NCT00842712|20782588|P7|Treated|Randomized Part||80
8432524|NCT00842712|20782589|P6|Treated|Randomized Part||50
8432525|NCT00842712|20782590|P5|Treated|Randomized Part||85
8432526|NCT00842712|20782591|P4|Treated|Randomized Part||0
8432527|NCT00842712|20782592|P3|Treated|Randomized Part||0
8432528|NCT00842712|20782593|P2|Treated|Randomized Part||0
8432529|NCT00842712|20782594|P1|Treated|Randomized Part||0
8432530|NCT00842712|20782588|P7|STARTED|Randomized Part||84
8432531|NCT00842712|20782589|P6|STARTED|Randomized Part||51
8432532|NCT00842712|20782590|P5|STARTED|Randomized Part||85
8432533|NCT00842712|20782591|P4|STARTED|Randomized Part||0
8432534|NCT00842712|20782592|P3|STARTED|Randomized Part||0
8432535|NCT00842712|20782593|P2|STARTED|Randomized Part||0
8432536|NCT00842712|20782594|P1|STARTED|Randomized Part||0
8432537|NCT00842712|20782588|P7|NOT COMPLETED|Safety Run-in Part||0
8432538|NCT00842712|20782589|P6|NOT COMPLETED|Safety Run-in Part||0
8432539|NCT00842712|20782590|P5|NOT COMPLETED|Safety Run-in Part||0
8432540|NCT00842712|20782591|P4|NOT COMPLETED|Safety Run-in Part||1
8432541|NCT00842712|20782592|P3|NOT COMPLETED|Safety Run-in Part||0
8432542|NCT00842712|20782593|P2|NOT COMPLETED|Safety Run-in Part||2
8432543|NCT00842712|20782594|P1|NOT COMPLETED|Safety Run-in Part||3
8432544|NCT00842712|20782588|P7|COMPLETED|Safety Run-in Part||0
8432545|NCT00842712|20782589|P6|COMPLETED|Safety Run-in Part||0
8432546|NCT00842712|20782590|P5|COMPLETED|Safety Run-in Part||0
8432547|NCT00842712|20782591|P4|COMPLETED|Safety Run-in Part||2
8432548|NCT00842712|20782592|P3|COMPLETED|Safety Run-in Part||3
8432549|NCT00842712|20782593|P2|COMPLETED|Safety Run-in Part||1
8432550|NCT00842712|20782594|P1|COMPLETED|Safety Run-in Part||0
8432551|NCT00842712|20782588|P7|STARTED|Safety Run-in Part||0
8432552|NCT00842712|20782589|P6|STARTED|Safety Run-in Part||0
8432553|NCT00842712|20782590|P5|STARTED|Safety Run-in Part||0
8432554|NCT00842712|20782591|P4|STARTED|Safety Run-in Part||3
8432555|NCT00842712|20782592|P3|STARTED|Safety Run-in Part||3
8432556|NCT00842712|20782593|P2|STARTED|Safety Run-in Part||3
8432557|NCT00842712|20782594|P1|STARTED|Safety Run-in Part||3
8432558|NCT00842608|20782626|P4|NOT COMPLETED|Overall Study||1
8432559|NCT00842608|20782627|P3|NOT COMPLETED|Overall Study||0
8432560|NCT00842608|20782628|P2|NOT COMPLETED|Overall Study||1
8432561|NCT00842608|20782629|P1|NOT COMPLETED|Overall Study||4
8432562|NCT00842608|20782626|P4|COMPLETED|Overall Study||100
8432563|NCT00842608|20782627|P3|COMPLETED|Overall Study||99
8432564|NCT00842608|20782628|P2|COMPLETED|Overall Study||176
8432565|NCT00842608|20782629|P1|COMPLETED|Overall Study||170
8432566|NCT00842608|20782626|P4|STARTED|Overall Study||101
8432567|NCT00842608|20782627|P3|STARTED|Overall Study||99
8432568|NCT00842608|20782628|P2|STARTED|Overall Study||177
8432569|NCT00842608|20782629|P1|STARTED|Overall Study||174
8432570|NCT00842543|20782651|P4|NOT COMPLETED|Overall Study||4
8432571|NCT00842543|20782652|P3|NOT COMPLETED|Overall Study||3
8432572|NCT00842543|20782653|P2|NOT COMPLETED|Overall Study||0
8432573|NCT00842543|20782654|P1|NOT COMPLETED|Overall Study||2
8432574|NCT00842543|20782651|P4|COMPLETED|Overall Study||4
8432575|NCT00842543|20782652|P3|COMPLETED|Overall Study||10
8432576|NCT00842543|20782653|P2|COMPLETED|Overall Study||5
8432577|NCT00842543|20782654|P1|COMPLETED|Overall Study||11
8432578|NCT00842543|20782651|P4|STARTED|Overall Study||8
8432579|NCT00842543|20782652|P3|STARTED|Overall Study||13
8432580|NCT00842543|20782653|P2|STARTED|Overall Study||5
8432581|NCT00842543|20782654|P1|STARTED|Overall Study||13
8432582|NCT00842530|20782668|P2|NOT COMPLETED|Overall Study||57
8432583|NCT00842530|20782669|P1|NOT COMPLETED|Overall Study||117
8432584|NCT00842530|20782668|P2|COMPLETED|Overall Study||1276
8432585|NCT00842530|20782669|P1|COMPLETED|Overall Study||2552
8432586|NCT00842530|20782668|P2|Received Vaccination 3|Overall Study||1282
8432587|NCT00842530|20782669|P1|Received Vaccination 3|Overall Study||2557
8432588|NCT00842530|20782668|P2|Received Vaccination 2|Overall Study||1300
8432589|NCT00842530|20782669|P1|Received Vaccination 2|Overall Study||2584
8432590|NCT00842530|20782668|P2|Received Vaccination 1|Overall Study||1331
8432591|NCT00842530|20782669|P1|Received Vaccination 1|Overall Study||2666
8432592|NCT00842530|20782668|P2|STARTED|Overall Study||1333
8432593|NCT00842530|20782669|P1|STARTED|Overall Study||2669
8432594|NCT00842361|20782699|P2|NOT COMPLETED|Overall Study||2
8432595|NCT00842361|20782700|P1|NOT COMPLETED|Overall Study||1
8432596|NCT00842361|20782699|P2|COMPLETED|Overall Study||31
8432597|NCT00842361|20782700|P1|COMPLETED|Overall Study||32
8432598|NCT00842361|20782699|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
8432599|NCT00842361|20782700|P1|Exposed|Overall Study||33
8432600|NCT00842361|20782699|P2|STARTED|Overall Study||33
8432601|NCT00842361|20782700|P1|STARTED|Overall Study||33
8432602|NCT00842348|20782720|P2|NOT COMPLETED|Study 729||38
8432603|NCT00842348|20782721|P1|NOT COMPLETED|Study 729||26
8432604|NCT00842348|20782720|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
8432605|NCT00842348|20782721|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
8432606|NCT00842348|20782720|P2|STARTED|Study 729||47
8432607|NCT00842348|20782721|P1|STARTED|Study 729||42
8432608|NCT00842348|20782720|P2|NOT COMPLETED|Patients Randomised in Study 726||56
8432609|NCT00842348|20782721|P1|NOT COMPLETED|Patients Randomised in Study 726||59
8432610|NCT00842348|20782720|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
8432611|NCT00842348|20782721|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
8432612|NCT00842348|20782720|P2|STARTED|Patients Randomised in Study 726||103
8432613|NCT00842348|20782721|P1|STARTED|Patients Randomised in Study 726||101
8432614|NCT00842335|20782731|P1|NOT COMPLETED|Overall Study||0
8432615|NCT00842335|20782731|P1|COMPLETED|Overall Study||18
8432616|NCT00842335|20782731|P1|STARTED|Overall Study||18
8432617|NCT00842309|20782740|P2|NOT COMPLETED|Overall Study||1
8432618|NCT00842309|20782741|P1|NOT COMPLETED|Overall Study||3
8432619|NCT00842309|20782740|P2|COMPLETED|Overall Study||13
8432620|NCT00842309|20782741|P1|COMPLETED|Overall Study||11
8432621|NCT00842309|20782740|P2|STARTED|Overall Study||14
8432622|NCT00842309|20782741|P1|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
8432623|NCT00842296|20782749|P1|NOT COMPLETED|Overall Study||0
8432624|NCT00842296|20782749|P1|COMPLETED|Overall Study||326
8432625|NCT00842296|20782749|P1|STARTED|Overall Study||326
8432626|NCT00842257|20782775|P1|NOT COMPLETED|Overall Study||1
8432627|NCT00842257|20782775|P1|COMPLETED|Overall Study||19
8432628|NCT00842257|20782775|P1|STARTED|Overall Study||20
8432629|NCT00842244|20782782|P1|NOT COMPLETED|Overall Study||21
8432630|NCT00842244|20782782|P1|COMPLETED|Overall Study||1
8432631|NCT00842244|20782782|P1|STARTED|Overall Study||22
8432632|NCT00842231|20782801|P1|NOT COMPLETED|Overall Study||0
8432633|NCT00842231|20782801|P1|COMPLETED|Overall Study||40
8432634|NCT00842231|20782801|P1|STARTED|Overall Study||40
8432635|NCT00842153|20782809|P2|NOT COMPLETED|Overall Study||3
8432636|NCT00842153|20782810|P1|NOT COMPLETED|Overall Study||1
8432637|NCT00842153|20782809|P2|COMPLETED|Overall Study||27
8432638|NCT00842153|20782810|P1|COMPLETED|Overall Study||27
8432639|NCT00842153|20782809|P2|STARTED|Overall Study||30
8432640|NCT00842153|20782810|P1|STARTED|Overall Study||28
8432641|NCT00842075|20782850|P2|NOT COMPLETED|Overall Study||0
8432642|NCT00842075|20782851|P1|NOT COMPLETED|Overall Study||0
8432643|NCT00842075|20782850|P2|COMPLETED|Overall Study||5
8432644|NCT00842075|20782851|P1|COMPLETED|Overall Study||5
8432645|NCT00842075|20782850|P2|STARTED|Overall Study||5
8432646|NCT00842075|20782851|P1|STARTED|Overall Study||5
8432647|NCT00842023|20782861|P2|NOT COMPLETED|Overall Study||0
8432648|NCT00842023|20782862|P1|NOT COMPLETED|Overall Study||0
8432649|NCT00842023|20782861|P2|COMPLETED|Overall Study||44
8432650|NCT00842023|20782862|P1|COMPLETED|Overall Study||45
8432651|NCT00842023|20782861|P2|STARTED|Overall Study||44
8432652|NCT00842023|20782862|P1|STARTED|Overall Study||45
8432653|NCT00841971|20782874|P2|NOT COMPLETED|Overall Study||1
8432654|NCT00841971|20782875|P1|NOT COMPLETED|Overall Study||2
8432655|NCT00841971|20782874|P2|COMPLETED|Overall Study||99
8432656|NCT00841971|20782875|P1|COMPLETED|Overall Study||98
8432657|NCT00841971|20782874|P2|STARTED|Overall Study||100
8432658|NCT00841971|20782875|P1|STARTED|Overall Study||100
8432659|NCT00841906|20782885|P2|NOT COMPLETED|Overall Study||0
8432660|NCT00841906|20782886|P1|NOT COMPLETED|Overall Study||2
8432661|NCT00841906|20782885|P2|COMPLETED|Overall Study||14
8432662|NCT00841906|20782886|P1|COMPLETED|Overall Study||16
8432663|NCT00841906|20782885|P2|STARTED|Overall Study||14
8432664|NCT00841906|20782886|P1|STARTED|Overall Study||18
8432665|NCT00841828|20782900|P2|NOT COMPLETED|Overall Study||2
8432666|NCT00841828|20782901|P1|NOT COMPLETED|Overall Study||10
8432667|NCT00841828|20782900|P2|COMPLETED|Overall Study||48
8432668|NCT00841828|20782901|P1|COMPLETED|Overall Study||42
8432669|NCT00841828|20782900|P2|STARTED|Overall Study||50
8432670|NCT00841828|20782901|P1|STARTED|Overall Study||52
8432671|NCT00841815|20782911|P2|NOT COMPLETED|Period 2||0
8432672|NCT00841815|20782912|P1|NOT COMPLETED|Period 2||0
8432673|NCT00841815|20782911|P2|COMPLETED|Period 2||13
8432674|NCT00841815|20782912|P1|COMPLETED|Period 2||14
8432675|NCT00841815|20782911|P2|STARTED|Period 2||13
8432676|NCT00841815|20782912|P1|STARTED|Period 2||14
8432677|NCT00841815|20782911|P2|NOT COMPLETED|Washout||1
8432678|NCT00841815|20782912|P1|NOT COMPLETED|Washout||0
8432679|NCT00841815|20782911|P2|COMPLETED|Washout||13
8432680|NCT00841815|20782912|P1|COMPLETED|Washout||14
8432681|NCT00841815|20782911|P2|STARTED|Washout||14
8432682|NCT00841815|20782912|P1|STARTED|Washout||14
8432683|NCT00841815|20782911|P2|NOT COMPLETED|Period 1||0
8432684|NCT00841815|20782912|P1|NOT COMPLETED|Period 1||0
8432685|NCT00841815|20782911|P2|COMPLETED|Period 1||14
8432686|NCT00841815|20782912|P1|COMPLETED|Period 1||14
8432687|NCT00841815|20782911|P2|STARTED|Period 1||14
8432688|NCT00841815|20782912|P1|STARTED|Period 1||14
8432689|NCT00841776|20782922|P2|NOT COMPLETED|Overall Study||3
8432690|NCT00841776|20782923|P1|NOT COMPLETED|Overall Study||2
8432691|NCT00841776|20782922|P2|COMPLETED|Overall Study||24
8432692|NCT00841776|20782923|P1|COMPLETED|Overall Study||25
8432693|NCT00841776|20782922|P2|STARTED|Overall Study||27
8432694|NCT00841776|20782923|P1|STARTED|Overall Study||27
8432695|NCT00841763|20782941|P4|NOT COMPLETED|Overall Study||3
8432696|NCT00841763|20782942|P3|NOT COMPLETED|Overall Study||8
8432697|NCT00841763|20782943|P2|NOT COMPLETED|Overall Study||57
8432698|NCT00841763|20782944|P1|NOT COMPLETED|Overall Study||162
8432699|NCT00841763|20782941|P4|COMPLETED|Overall Study||53
8432700|NCT00841763|20782942|P3|COMPLETED|Overall Study||211
8432701|NCT00841763|20782943|P2|COMPLETED|Overall Study||624
8432702|NCT00841763|20782944|P1|COMPLETED|Overall Study||2529
8432703|NCT00841763|20782941|P4|STARTED|Overall Study||56
8432704|NCT00841763|20782942|P3|STARTED|Overall Study||219
8432705|NCT00841763|20782943|P2|STARTED|Overall Study||681
8432706|NCT00841763|20782944|P1|STARTED|Overall Study||2691
8432707|NCT00841698|20783006|P2|NOT COMPLETED|Second Intervention||0
8432708|NCT00841698|20783007|P1|NOT COMPLETED|Second Intervention||0
8432709|NCT00841698|20783006|P2|COMPLETED|Second Intervention||25
8432710|NCT00841698|20783007|P1|COMPLETED|Second Intervention||24
8432711|NCT00841698|20783006|P2|STARTED|Second Intervention||25
8432712|NCT00841698|20783007|P1|STARTED|Second Intervention||24
8432713|NCT00841698|20783006|P2|NOT COMPLETED|Washout: 2 Weeks||0
8432714|NCT00841698|20783007|P1|NOT COMPLETED|Washout: 2 Weeks||0
8432715|NCT00841698|20783006|P2|COMPLETED|Washout: 2 Weeks||25
8432716|NCT00841698|20783007|P1|COMPLETED|Washout: 2 Weeks||24
8432717|NCT00841698|20783006|P2|STARTED|Washout: 2 Weeks||25
8432718|NCT00841698|20783007|P1|STARTED|Washout: 2 Weeks||24
8432719|NCT00841698|20783006|P2|NOT COMPLETED|First Intervention||0
8432720|NCT00841698|20783007|P1|NOT COMPLETED|First Intervention||1
8432721|NCT00841698|20783006|P2|COMPLETED|First Intervention||25
8432722|NCT00841698|20783007|P1|COMPLETED|First Intervention||24
8432723|NCT00841698|20783006|P2|STARTED|First Intervention||25
8432724|NCT00841698|20783007|P1|STARTED|First Intervention||25
8432725|NCT00841672|20783017|P2|NOT COMPLETED|Overall Study||32
8432726|NCT00841672|20783018|P1|NOT COMPLETED|Overall Study||20
8432727|NCT00841672|20783017|P2|COMPLETED|Overall Study||209
8432728|NCT00841672|20783018|P1|COMPLETED|Overall Study||224
8432729|NCT00841672|20783017|P2|STARTED|Overall Study||241
8432730|NCT00841672|20783018|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
8432731|NCT00841659|20783034|P2|NOT COMPLETED|Second Intervention||0
8432732|NCT00841659|20783035|P1|NOT COMPLETED|Second Intervention||0
8432733|NCT00841659|20783034|P2|COMPLETED|Second Intervention||12
8432734|NCT00841659|20783035|P1|COMPLETED|Second Intervention||11
8432735|NCT00841659|20783034|P2|STARTED|Second Intervention||12
8432736|NCT00841659|20783035|P1|STARTED|Second Intervention||11
8432737|NCT00841659|20783034|P2|NOT COMPLETED|Washout: 2 Weeks||0
8432738|NCT00841659|20783035|P1|NOT COMPLETED|Washout: 2 Weeks||1
8432739|NCT00841659|20783034|P2|COMPLETED|Washout: 2 Weeks||12
8432740|NCT00841659|20783035|P1|COMPLETED|Washout: 2 Weeks||11
8432741|NCT00841659|20783034|P2|STARTED|Washout: 2 Weeks||12
8432742|NCT00841659|20783035|P1|STARTED|Washout: 2 Weeks||12
8432743|NCT00841659|20783034|P2|NOT COMPLETED|First Intervention||0
8432744|NCT00841659|20783035|P1|NOT COMPLETED|First Intervention||0
8432745|NCT00841659|20783034|P2|COMPLETED|First Intervention||12
8432746|NCT00841659|20783035|P1|COMPLETED|First Intervention||12
8432747|NCT00841659|20783034|P2|STARTED|First Intervention||12
8432748|NCT00841659|20783035|P1|STARTED|First Intervention||12
8432749|NCT00841568|20783043|P1|NOT COMPLETED|Overall Study||5
8432750|NCT00841568|20783043|P1|COMPLETED|Overall Study||12
8432751|NCT00841568|20783043|P1|STARTED|Overall Study||17
8432752|NCT00841555|20783059|P3|NOT COMPLETED|Overall Study||0
8432753|NCT00841555|20783060|P2|NOT COMPLETED|Overall Study||0
8432754|NCT00841555|20783061|P1|NOT COMPLETED|Overall Study||0
8432755|NCT00841555|20783059|P3|COMPLETED|Overall Study||3
8432756|NCT00841555|20783060|P2|COMPLETED|Overall Study||3
8432757|NCT00841555|20783061|P1|COMPLETED|Overall Study||3
8432758|NCT00841555|20783059|P3|STARTED|Overall Study||3
8432759|NCT00841555|20783060|P2|STARTED|Overall Study||3
8432760|NCT00841555|20783061|P1|STARTED|Overall Study||3
8432761|NCT00841542|20783071|P2|NOT COMPLETED|Period 2||0
8432762|NCT00841542|20783072|P1|NOT COMPLETED|Period 2||0
8432763|NCT00841542|20783071|P2|COMPLETED|Period 2||14
8432764|NCT00841542|20783072|P1|COMPLETED|Period 2||13
8432765|NCT00841542|20783071|P2|STARTED|Period 2||14
8432766|NCT00841542|20783072|P1|STARTED|Period 2||13
8432767|NCT00841542|20783071|P2|NOT COMPLETED|Period 1||0
8432768|NCT00841542|20783072|P1|NOT COMPLETED|Period 1||1
8432769|NCT00841542|20783071|P2|COMPLETED|Period 1||14
8432770|NCT00841542|20783072|P1|COMPLETED|Period 1||13
8432771|NCT00841542|20783071|P2|STARTED|Period 1||14
8432772|NCT00841542|20783072|P1|STARTED|Period 1||14
8432773|NCT00841412|20783080|P2|NOT COMPLETED|Overall Study||30
8432774|NCT00841412|20783081|P1|NOT COMPLETED|Overall Study||40
8432775|NCT00841412|20783080|P2|COMPLETED|Overall Study||50
8432776|NCT00841412|20783081|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
8432777|NCT00841412|20783080|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
8432778|NCT00841412|20783081|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
8432779|NCT00841321|20783087|P2|NOT COMPLETED|Overall Study||3
8432780|NCT00841321|20783088|P1|NOT COMPLETED|Overall Study||1
8432781|NCT00841321|20783087|P2|COMPLETED|Overall Study||58
8432782|NCT00841321|20783088|P1|COMPLETED|Overall Study||58
8432783|NCT00841321|20783087|P2|STARTED|Overall Study||61
8432784|NCT00841321|20783088|P1|STARTED|Overall Study||59
8432785|NCT00841269|20783102|P2|NOT COMPLETED|Overall Study||9
8432786|NCT00841269|20783103|P1|NOT COMPLETED|Overall Study||8
8432787|NCT00841269|20783102|P2|COMPLETED|Overall Study||13
8432788|NCT00841269|20783103|P1|COMPLETED|Overall Study||12
8432789|NCT00841269|20783102|P2|STARTED|Overall Study||22
8432790|NCT00841269|20783103|P1|STARTED|Overall Study||20
8432791|NCT00841204|20783114|P2|NOT COMPLETED|Overall Study||0
8432792|NCT00841204|20783115|P1|NOT COMPLETED|Overall Study||0
8432793|NCT00841204|20783114|P2|COMPLETED|Overall Study||25
8432794|NCT00841204|20783115|P1|COMPLETED|Overall Study||25
8432795|NCT00841204|20783114|P2|STARTED|Overall Study||25
8432796|NCT00841204|20783115|P1|STARTED|Overall Study||25
8432797|NCT00841100|20783135|P1|NOT COMPLETED|Phase 3 (28 Days)||0
8432798|NCT00841100|20783135|P1|COMPLETED|Phase 3 (28 Days)||4
8432799|NCT00841100|20783135|P1|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
8432800|NCT00841100|20783135|P1|NOT COMPLETED|Phase 2 (2 Weeks)||0
8432801|NCT00841100|20783135|P1|COMPLETED|Phase 2 (2 Weeks)||5
8432802|NCT00841100|20783135|P1|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
8432803|NCT00841100|20783135|P1|NOT COMPLETED|Phase 1 (28 Days)||3
8432804|NCT00841100|20783135|P1|COMPLETED|Phase 1 (28 Days)||15
8432805|NCT00841100|20783135|P1|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
8432806|NCT00841100|20783135|P1|NOT COMPLETED|Acute Component (24 Hours)||0
8432807|NCT00841100|20783135|P1|COMPLETED|Acute Component (24 Hours)||21
8432808|NCT00841100|20783135|P1|STARTED|Acute Component (24 Hours)||21
8432809|NCT00841087|20783141|P2|NOT COMPLETED|Overall Study||0
8432810|NCT00841087|20783142|P1|NOT COMPLETED|Overall Study||0
8432811|NCT00841087|20783141|P2|COMPLETED|Overall Study||32
8432812|NCT00841087|20783142|P1|COMPLETED|Overall Study||33
8432813|NCT00841087|20783141|P2|STARTED|Overall Study||32
8432814|NCT00841087|20783142|P1|STARTED|Overall Study||33
8432815|NCT00841035|20783160|P1|NOT COMPLETED|Phase 2 of Overall Study||0
8432816|NCT00841035|20783160|P1|COMPLETED|Phase 2 of Overall Study||6
8432817|NCT00841035|20783160|P1|STARTED|Phase 2 of Overall Study||6
8432818|NCT00841035|20783160|P1|NOT COMPLETED|Phase 1 Overall Study||13
8432819|NCT00841035|20783160|P1|COMPLETED|Phase 1 Overall Study||6
8432820|NCT00841035|20783160|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
8432821|NCT00840996|20783167|P2|NOT COMPLETED|Overall Study||0
8432822|NCT00840996|20783168|P1|NOT COMPLETED|Overall Study||1
8432823|NCT00840996|20783167|P2|COMPLETED|Overall Study||58
8432824|NCT00840996|20783168|P1|COMPLETED|Overall Study||57
8432825|NCT00840996|20783167|P2|STARTED|Overall Study||58
8432826|NCT00840996|20783168|P1|STARTED|Overall Study||58
8432827|NCT00840970|20783186|P3|NOT COMPLETED|Overall Study||1
8432828|NCT00840970|20783187|P2|NOT COMPLETED|Overall Study||0
8432829|NCT00840970|20783188|P1|NOT COMPLETED|Overall Study||0
8432830|NCT00840970|20783186|P3|COMPLETED|Overall Study||4
8432831|NCT00840970|20783187|P2|COMPLETED|Overall Study||38
8432832|NCT00840970|20783188|P1|COMPLETED|Overall Study||7
8432833|NCT00840970|20783186|P3|STARTED|Overall Study||5
8432834|NCT00840970|20783187|P2|STARTED|Overall Study||38
8432835|NCT00840970|20783188|P1|STARTED|Overall Study||7
8432836|NCT00840879|20783208|P2|NOT COMPLETED|Second Intervention||0
8432837|NCT00840879|20783209|P1|NOT COMPLETED|Second Intervention||1
8432838|NCT00840879|20783208|P2|COMPLETED|Second Intervention||14
8432839|NCT00840879|20783209|P1|COMPLETED|Second Intervention||13
8432840|NCT00840879|20783208|P2|STARTED|Second Intervention||14
8432841|NCT00840879|20783209|P1|STARTED|Second Intervention||14
8432842|NCT00840879|20783208|P2|NOT COMPLETED|Washout: 14 Days||0
8432843|NCT00840879|20783209|P1|NOT COMPLETED|Washout: 14 Days||0
8432844|NCT00840879|20783208|P2|COMPLETED|Washout: 14 Days||14
8432845|NCT00840879|20783209|P1|COMPLETED|Washout: 14 Days||14
8432846|NCT00840879|20783208|P2|STARTED|Washout: 14 Days||14
8432847|NCT00840879|20783209|P1|STARTED|Washout: 14 Days||14
8432848|NCT00840879|20783208|P2|NOT COMPLETED|First Intervention||0
8432849|NCT00840879|20783209|P1|NOT COMPLETED|First Intervention||0
8432850|NCT00840879|20783208|P2|COMPLETED|First Intervention||14
8432851|NCT00840879|20783209|P1|COMPLETED|First Intervention||14
8432852|NCT00840879|20783208|P2|STARTED|First Intervention||14
8432853|NCT00840879|20783209|P1|STARTED|First Intervention||14
8432854|NCT00840866|20783219|P2|NOT COMPLETED|Second Intervention||0
8432855|NCT00840866|20783220|P1|NOT COMPLETED|Second Intervention||0
8432856|NCT00840866|20783219|P2|COMPLETED|Second Intervention||19
8432857|NCT00840866|20783220|P1|COMPLETED|Second Intervention||20
8432858|NCT00840866|20783219|P2|STARTED|Second Intervention||19
8432859|NCT00840866|20783220|P1|STARTED|Second Intervention||20
8432860|NCT00840866|20783219|P2|NOT COMPLETED|Washout of 7 Days||0
8432861|NCT00840866|20783220|P1|NOT COMPLETED|Washout of 7 Days||0
8432862|NCT00840866|20783219|P2|COMPLETED|Washout of 7 Days||19
8432863|NCT00840866|20783220|P1|COMPLETED|Washout of 7 Days||20
8432864|NCT00840866|20783219|P2|STARTED|Washout of 7 Days||19
8432865|NCT00840866|20783220|P1|STARTED|Washout of 7 Days||20
8432866|NCT00840866|20783219|P2|NOT COMPLETED|First Intervention||0
8432867|NCT00840866|20783220|P1|NOT COMPLETED|First Intervention||0
8432868|NCT00840866|20783219|P2|COMPLETED|First Intervention||19
8432869|NCT00840866|20783220|P1|COMPLETED|First Intervention||20
8432870|NCT00840866|20783219|P2|STARTED|First Intervention||19
8432871|NCT00840866|20783220|P1|STARTED|First Intervention||20
8432872|NCT00840840|20783230|P2|NOT COMPLETED|Period 2||0
8432873|NCT00840840|20783231|P1|NOT COMPLETED|Period 2||0
8432874|NCT00840840|20783230|P2|COMPLETED|Period 2||24
8432875|NCT00840840|20783231|P1|COMPLETED|Period 2||23
8432876|NCT00840840|20783230|P2|STARTED|Period 2||24
8432877|NCT00840840|20783231|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
8432878|NCT00840840|20783230|P2|NOT COMPLETED|Period 1||0
8432879|NCT00840840|20783231|P1|NOT COMPLETED|Period 1||0
8432880|NCT00840840|20783230|P2|COMPLETED|Period 1||24
8432881|NCT00840840|20783231|P1|COMPLETED|Period 1||24
8432882|NCT00840840|20783230|P2|STARTED|Period 1||24
8432883|NCT00840840|20783231|P1|STARTED|Period 1||24
8432884|NCT00840827|20783245|P1|NOT COMPLETED|Overall Study||6
8432885|NCT00840827|20783245|P1|COMPLETED|Overall Study||0
8432886|NCT00840827|20783245|P1|STARTED|Overall Study||6
8432887|NCT00840749|20783260|P2|NOT COMPLETED|Overall Study||27
8432888|NCT00840749|20783261|P1|NOT COMPLETED|Overall Study||31
8432889|NCT00840749|20783260|P2|COMPLETED|Overall Study||0
8432890|NCT00840749|20783261|P1|COMPLETED|Overall Study||0
8432891|NCT00840749|20783260|P2|36 Months Post tx|Overall Study||0
8432892|NCT00840749|20783261|P1|36 Months Post tx|Overall Study||1
8432893|NCT00840749|20783260|P2|24 Months Post tx|Overall Study||3
8432894|NCT00840749|20783261|P1|24 Months Post tx|Overall Study||9
8432895|NCT00840749|20783260|P2|18 Months Post tx|Overall Study||6
8432896|NCT00840749|20783261|P1|18 Months Post tx|Overall Study||12
8432897|NCT00840749|20783260|P2|12 Months Post tx|Overall Study||7
8432898|NCT00840749|20783261|P1|12 Months Post tx|Overall Study||14
8432899|NCT00840749|20783260|P2|6 Months Post tx|Overall Study||10
8432900|NCT00840749|20783261|P1|6 Months Post tx|Overall Study||16
8432901|NCT00840749|20783260|P2|1 Month Post tx|Overall Study||15
8432902|NCT00840749|20783261|P1|1 Month Post tx|Overall Study||19
8432903|NCT00840749|20783260|P2|Treatment|Overall Study||16
8432904|NCT00840749|20783261|P1|Treatment|Overall Study||20
8432905|NCT00840749|20783260|P2|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
8432906|NCT00840749|20783261|P1|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
8432907|NCT00840658|20783273|P4|NOT COMPLETED|Overall Study||4
8432908|NCT00840658|20783274|P3|NOT COMPLETED|Overall Study||5
8432909|NCT00840658|20783275|P2|NOT COMPLETED|Overall Study||3
8432910|NCT00840658|20783276|P1|NOT COMPLETED|Overall Study||5
8432911|NCT00840658|20783273|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
8432912|NCT00840658|20783274|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
8432913|NCT00840658|20783275|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
8432914|NCT00840658|20783276|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
8432915|NCT00840658|20783273|P4|STARTED|Overall Study||146
8432916|NCT00840658|20783274|P3|STARTED|Overall Study||148
8432917|NCT00840658|20783275|P2|STARTED|Overall Study||146
8432918|NCT00840658|20783276|P1|STARTED|Overall Study||144
8432919|NCT00840632|20783294|P2|NOT COMPLETED|Second Intervention||0
8432920|NCT00840632|20783295|P1|NOT COMPLETED|Second Intervention||0
8432921|NCT00840632|20783294|P2|COMPLETED|Second Intervention||18
8432922|NCT00840632|20783295|P1|COMPLETED|Second Intervention||19
8432923|NCT00840632|20783294|P2|STARTED|Second Intervention||18
8432924|NCT00840632|20783295|P1|STARTED|Second Intervention||19
8432925|NCT00840632|20783294|P2|NOT COMPLETED|Washout||1
8432926|NCT00840632|20783295|P1|NOT COMPLETED|Washout||1
8432927|NCT00840632|20783294|P2|COMPLETED|Washout||18
8432928|NCT00840632|20783295|P1|COMPLETED|Washout||19
8432929|NCT00840632|20783294|P2|STARTED|Washout||19
8432930|NCT00840632|20783295|P1|STARTED|Washout||20
8432931|NCT00840632|20783294|P2|NOT COMPLETED|First Intervention||1
8432932|NCT00840632|20783295|P1|NOT COMPLETED|First Intervention||0
8432933|NCT00840632|20783294|P2|COMPLETED|First Intervention||19
8432934|NCT00840632|20783295|P1|COMPLETED|First Intervention||20
8432935|NCT00840632|20783294|P2|STARTED|First Intervention||20
8432936|NCT00840632|20783295|P1|STARTED|First Intervention||20
8432937|NCT00840476|20783311|P2|NOT COMPLETED|Second Intervention||0
8432938|NCT00840476|20783312|P1|NOT COMPLETED|Second Intervention||0
8432939|NCT00840476|20783311|P2|COMPLETED|Second Intervention||14
8432940|NCT00840476|20783312|P1|COMPLETED|Second Intervention||14
8432941|NCT00840476|20783311|P2|STARTED|Second Intervention||14
8432942|NCT00840476|20783312|P1|STARTED|Second Intervention||14
8432943|NCT00840476|20783311|P2|NOT COMPLETED|Washout: 14 Days||0
8432944|NCT00840476|20783312|P1|NOT COMPLETED|Washout: 14 Days||0
8432945|NCT00840476|20783311|P2|COMPLETED|Washout: 14 Days||14
8432946|NCT00840476|20783312|P1|COMPLETED|Washout: 14 Days||14
8432947|NCT00840476|20783311|P2|STARTED|Washout: 14 Days||14
8432948|NCT00840476|20783312|P1|STARTED|Washout: 14 Days||14
8432949|NCT00840476|20783311|P2|NOT COMPLETED|First Intervention||0
8432950|NCT00840476|20783312|P1|NOT COMPLETED|First Intervention||0
8432951|NCT00840476|20783311|P2|COMPLETED|First Intervention||14
8432952|NCT00840476|20783312|P1|COMPLETED|First Intervention||14
8432953|NCT00840476|20783311|P2|STARTED|First Intervention||14
8432954|NCT00840476|20783312|P1|STARTED|First Intervention||14
8432955|NCT00840463|20783322|P2|NOT COMPLETED|Overall Study||0
8432956|NCT00840463|20783323|P1|NOT COMPLETED|Overall Study||1
8432957|NCT00840463|20783322|P2|COMPLETED|Overall Study||1
8432958|NCT00840463|20783323|P1|COMPLETED|Overall Study||2
8432959|NCT00840463|20783322|P2|STARTED|Overall Study||1
8432960|NCT00840463|20783323|P1|STARTED|Overall Study||3
8432961|NCT00840450|20783337|P1|NOT COMPLETED|Overall Study||3
8432962|NCT00840450|20783337|P1|COMPLETED|Overall Study||9
8432963|NCT00840450|20783337|P1|STARTED|Overall Study||12
8432964|NCT00840411|20783345|P2|NOT COMPLETED|Second Intervention||0
8432965|NCT00840411|20783346|P1|NOT COMPLETED|Second Intervention||0
8432966|NCT00840411|20783345|P2|COMPLETED|Second Intervention||33
8432967|NCT00840411|20783346|P1|COMPLETED|Second Intervention||31
8432968|NCT00840411|20783345|P2|STARTED|Second Intervention||33
8432969|NCT00840411|20783346|P1|STARTED|Second Intervention||31
8432970|NCT00840411|20783345|P2|NOT COMPLETED|Washout||0
8432971|NCT00840411|20783346|P1|NOT COMPLETED|Washout||1
8432972|NCT00840411|20783345|P2|COMPLETED|Washout||33
8432973|NCT00840411|20783346|P1|COMPLETED|Washout||31
8432974|NCT00840411|20783345|P2|STARTED|Washout||33
8432975|NCT00840411|20783346|P1|STARTED|Washout||32
8432976|NCT00840411|20783345|P2|NOT COMPLETED|First Intervention||0
8432977|NCT00840411|20783346|P1|NOT COMPLETED|First Intervention||1
8432978|NCT00840411|20783345|P2|COMPLETED|First Intervention||33
8432979|NCT00840411|20783346|P1|COMPLETED|First Intervention||32
8432980|NCT00840411|20783345|P2|STARTED|First Intervention||33
8432981|NCT00840411|20783346|P1|STARTED|First Intervention||33
8432982|NCT00840307|20783354|P1|NOT COMPLETED|Overall Study||4
8432983|NCT00840307|20783354|P1|COMPLETED|Overall Study||16
8432984|NCT00840307|20783354|P1|STARTED|Overall Study||20
8432985|NCT00840294|20783360|P2|NOT COMPLETED|Overall Study||5
8432986|NCT00840294|20783361|P1|NOT COMPLETED|Overall Study||3
8432987|NCT00840294|20783360|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
8432988|NCT00840294|20783361|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
8432989|NCT00840294|20783360|P2|STARTED|Overall Study||43
8432990|NCT00840294|20783361|P1|STARTED|Overall Study||42
8432991|NCT00840281|20783371|P2|NOT COMPLETED|Second Intervention||0
8432992|NCT00840281|20783372|P1|NOT COMPLETED|Second Intervention||0
8432993|NCT00840281|20783371|P2|COMPLETED|Second Intervention||19
8432994|NCT00840281|20783372|P1|COMPLETED|Second Intervention||19
8432995|NCT00840281|20783371|P2|STARTED|Second Intervention||19
8432996|NCT00840281|20783372|P1|STARTED|Second Intervention||19
8432997|NCT00840281|20783371|P2|NOT COMPLETED|Washout of 7 Days||0
8432998|NCT00840281|20783372|P1|NOT COMPLETED|Washout of 7 Days||0
8432999|NCT00840281|20783371|P2|COMPLETED|Washout of 7 Days||19
8433000|NCT00840281|20783372|P1|COMPLETED|Washout of 7 Days||19
8433001|NCT00840281|20783371|P2|STARTED|Washout of 7 Days||19
8433002|NCT00840281|20783372|P1|STARTED|Washout of 7 Days||19
8433003|NCT00840281|20783371|P2|NOT COMPLETED|First Intervention||0
8433004|NCT00840281|20783372|P1|NOT COMPLETED|First Intervention||0
8433005|NCT00840281|20783371|P2|COMPLETED|First Intervention||19
8433006|NCT00840281|20783372|P1|COMPLETED|First Intervention||19
8433007|NCT00840281|20783371|P2|STARTED|First Intervention||19
8433008|NCT00840281|20783372|P1|STARTED|First Intervention||19
8433009|NCT00840216|20783382|P2|NOT COMPLETED|Second Intervention||0
8433010|NCT00840216|20783383|P1|NOT COMPLETED|Second Intervention||0
8433011|NCT00840216|20783382|P2|COMPLETED|Second Intervention||11
8433012|NCT00840216|20783383|P1|COMPLETED|Second Intervention||10
8433013|NCT00840216|20783382|P2|STARTED|Second Intervention||11
8433014|NCT00840216|20783383|P1|STARTED|Second Intervention||10
8433015|NCT00840216|20783382|P2|NOT COMPLETED|Washout: 7 Days||0
8433016|NCT00840216|20783383|P1|NOT COMPLETED|Washout: 7 Days||1
8433017|NCT00840216|20783382|P2|COMPLETED|Washout: 7 Days||11
8433018|NCT00840216|20783383|P1|COMPLETED|Washout: 7 Days||10
8433019|NCT00840216|20783382|P2|STARTED|Washout: 7 Days||11
8433020|NCT00840216|20783383|P1|STARTED|Washout: 7 Days||11
8433021|NCT00840216|20783382|P2|NOT COMPLETED|First Intervention||0
8433022|NCT00840216|20783383|P1|NOT COMPLETED|First Intervention||0
8433023|NCT00840216|20783382|P2|COMPLETED|First Intervention||11
8433024|NCT00840216|20783383|P1|COMPLETED|First Intervention||11
8433025|NCT00840216|20783382|P2|STARTED|First Intervention||11
8433026|NCT00840216|20783383|P1|STARTED|First Intervention||11
8433027|NCT00840203|20783393|P2|NOT COMPLETED|Second Intervention||0
8433028|NCT00840203|20783394|P1|NOT COMPLETED|Second Intervention||0
8433029|NCT00840203|20783393|P2|COMPLETED|Second Intervention||34
8433030|NCT00840203|20783394|P1|COMPLETED|Second Intervention||35
8433031|NCT00840203|20783393|P2|STARTED|Second Intervention||34
8433032|NCT00840203|20783394|P1|STARTED|Second Intervention||35
8433033|NCT00840203|20783393|P2|NOT COMPLETED|Washout||0
8433034|NCT00840203|20783394|P1|NOT COMPLETED|Washout||1
8433035|NCT00840203|20783393|P2|COMPLETED|Washout||34
8433036|NCT00840203|20783394|P1|COMPLETED|Washout||35
8433037|NCT00840203|20783393|P2|STARTED|Washout||34
8433038|NCT00840203|20783394|P1|STARTED|Washout||36
8433039|NCT00840203|20783393|P2|NOT COMPLETED|First Intervention||1
8433040|NCT00840203|20783394|P1|NOT COMPLETED|First Intervention||1
8433041|NCT00840203|20783393|P2|COMPLETED|First Intervention||34
8433042|NCT00840203|20783394|P1|COMPLETED|First Intervention||36
8433043|NCT00840203|20783393|P2|STARTED|First Intervention||35
8433044|NCT00840203|20783394|P1|STARTED|First Intervention||37
8433060|NCT00840099|20783432|P2|NOT COMPLETED|Period 2||0
8433061|NCT00840099|20783433|P1|NOT COMPLETED|Period 2||0
8433062|NCT00840099|20783432|P2|COMPLETED|Period 2||24
8433063|NCT00840099|20783433|P1|COMPLETED|Period 2||21
8433064|NCT00840099|20783432|P2|STARTED|Period 2||24
8433065|NCT00840099|20783433|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
8433066|NCT00840099|20783432|P2|NOT COMPLETED|Period 1||0
8433067|NCT00840099|20783433|P1|NOT COMPLETED|Period 1||0
8433068|NCT00840099|20783432|P2|COMPLETED|Period 1||24
8433069|NCT00840099|20783433|P1|COMPLETED|Period 1||24
8433070|NCT00840099|20783432|P2|STARTED|Period 1||24
8433071|NCT00840099|20783433|P1|STARTED|Period 1||24
8433072|NCT00840086|20783447|P1|NOT COMPLETED|Overall Study||4
8433073|NCT00840086|20783447|P1|COMPLETED|Overall Study||146
8433074|NCT00840086|20783447|P1|STARTED|Overall Study||150
8433075|NCT00840073|20783456|P2|NOT COMPLETED|Second Intervention||1
8433076|NCT00840073|20783457|P1|NOT COMPLETED|Second Intervention||1
8433077|NCT00840073|20783456|P2|COMPLETED|Second Intervention||24
8433078|NCT00840073|20783457|P1|COMPLETED|Second Intervention||24
8433079|NCT00840073|20783456|P2|STARTED|Second Intervention||25
8433080|NCT00840073|20783457|P1|STARTED|Second Intervention||25
8433081|NCT00840073|20783456|P2|NOT COMPLETED|First Intervention||0
8433082|NCT00840073|20783457|P1|NOT COMPLETED|First Intervention||0
8433083|NCT00840073|20783456|P2|COMPLETED|First Intervention||25
8433084|NCT00840073|20783457|P1|COMPLETED|First Intervention||25
8433085|NCT00840073|20783456|P2|STARTED|First Intervention||25
8433086|NCT00840073|20783457|P1|STARTED|First Intervention||25
8433087|NCT00840060|20783471|P2|NOT COMPLETED|Overall Study||1
8433088|NCT00840060|20783472|P1|NOT COMPLETED|Overall Study||1
8433089|NCT00840060|20783471|P2|COMPLETED|Overall Study||19
8433090|NCT00840060|20783472|P1|COMPLETED|Overall Study||19
8433091|NCT00840060|20783471|P2|STARTED|Overall Study||20
8433092|NCT00840060|20783472|P1|STARTED|Overall Study||20
8433093|NCT00840034|20783482|P2|NOT COMPLETED|Taper Phase||2
8433094|NCT00840034|20783483|P1|NOT COMPLETED|Taper Phase||3
8433095|NCT00840034|20783482|P2|COMPLETED|Taper Phase||80
8433096|NCT00840034|20783483|P1|COMPLETED|Taper Phase||87
8433097|NCT00840034|20783482|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
8433098|NCT00840034|20783483|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
8433099|NCT00840034|20783482|P2|NOT COMPLETED|Acute Treatment Phase||36
8433100|NCT00840034|20783483|P1|NOT COMPLETED|Acute Treatment Phase||21
8433101|NCT00840034|20783482|P2|COMPLETED|Acute Treatment Phase||80
8433102|NCT00840034|20783483|P1|COMPLETED|Acute Treatment Phase||90
8433103|NCT00840034|20783482|P2|STARTED|Acute Treatment Phase||116
8433104|NCT00840034|20783483|P1|STARTED|Acute Treatment Phase||111
8433105|NCT00839982|20783519|P4|NOT COMPLETED|Overall Study||0
8433106|NCT00839982|20783520|P3|NOT COMPLETED|Overall Study||0
8433107|NCT00839982|20783521|P2|NOT COMPLETED|Overall Study||0
8433108|NCT00839982|20783522|P1|NOT COMPLETED|Overall Study||0
8433109|NCT00839982|20783519|P4|COMPLETED|Overall Study||3
8433110|NCT00839982|20783520|P3|COMPLETED|Overall Study||2
8433111|NCT00839982|20783521|P2|COMPLETED|Overall Study||26
8433112|NCT00839982|20783522|P1|COMPLETED|Overall Study||4
8433113|NCT00839982|20783519|P4|STARTED|Overall Study||3
8433114|NCT00839982|20783520|P3|STARTED|Overall Study||2
8433115|NCT00839982|20783521|P2|STARTED|Overall Study||26
8433116|NCT00839982|20783522|P1|STARTED|Overall Study||4
8433117|NCT00839956|20783536|P1|NOT COMPLETED|Overall Study||12
8433118|NCT00839956|20783536|P1|COMPLETED|Overall Study||19
8433119|NCT00839956|20783536|P1|STARTED|Overall Study||31
8433120|NCT00839930|20783545|P2|NOT COMPLETED|Second Intervention||0
8433121|NCT00839930|20783546|P1|NOT COMPLETED|Second Intervention||0
8433122|NCT00839930|20783545|P2|COMPLETED|Second Intervention||15
8433123|NCT00839930|20783546|P1|COMPLETED|Second Intervention||15
8433124|NCT00839930|20783545|P2|STARTED|Second Intervention||15
8433125|NCT00839930|20783546|P1|STARTED|Second Intervention||15
8433126|NCT00839930|20783545|P2|NOT COMPLETED|Washout: 7 Days||0
8433127|NCT00839930|20783546|P1|NOT COMPLETED|Washout: 7 Days||0
8433128|NCT00839930|20783545|P2|COMPLETED|Washout: 7 Days||15
8433129|NCT00839930|20783546|P1|COMPLETED|Washout: 7 Days||15
8433130|NCT00839930|20783545|P2|STARTED|Washout: 7 Days||15
8433131|NCT00839930|20783546|P1|STARTED|Washout: 7 Days||15
8433132|NCT00839930|20783545|P2|NOT COMPLETED|First Intervention||0
8433133|NCT00839930|20783546|P1|NOT COMPLETED|First Intervention||0
8433134|NCT00839930|20783545|P2|COMPLETED|First Intervention||15
8433135|NCT00839930|20783546|P1|COMPLETED|First Intervention||15
8433136|NCT00839930|20783545|P2|STARTED|First Intervention||15
8433137|NCT00839930|20783546|P1|STARTED|First Intervention||15
8433138|NCT00839917|20783556|P2|NOT COMPLETED|Overall Study||1
8433139|NCT00839917|20783557|P1|NOT COMPLETED|Overall Study||1
8433140|NCT00839917|20783556|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
8433141|NCT00839917|20783557|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
8433142|NCT00839917|20783556|P2|STARTED|Overall Study||17
8433143|NCT00839917|20783557|P1|STARTED|Overall Study||13
8433144|NCT00839852|20783593|P1|NOT COMPLETED|Overall Study||47
8433145|NCT00839852|20783593|P1|COMPLETED|Overall Study||46
8433146|NCT00839852|20783593|P1|STARTED|Overall Study||93
8433147|NCT00839800|20783600|P2|NOT COMPLETED|Overall Study||110
8433148|NCT00839800|20783601|P1|NOT COMPLETED|Overall Study||93
8433149|NCT00839800|20783600|P2|COMPLETED|Overall Study||932
8433150|NCT00839800|20783601|P1|COMPLETED|Overall Study||956
8433151|NCT00839800|20783600|P2|STARTED|Overall Study||1042
8433152|NCT00839800|20783601|P1|STARTED|Overall Study||1049
8433153|NCT00839540|20783634|P3|NOT COMPLETED|Overall Study||0
8433154|NCT00839540|20783635|P2|NOT COMPLETED|Overall Study||0
8433155|NCT00839540|20783636|P1|NOT COMPLETED|Overall Study||0
8433156|NCT00839540|20783634|P3|COMPLETED|Overall Study||5
8433157|NCT00839540|20783635|P2|COMPLETED|Overall Study||8
8433158|NCT00839540|20783636|P1|COMPLETED|Overall Study||8
8433159|NCT00839540|20783634|P3|STARTED|Overall Study||5
8433160|NCT00839540|20783635|P2|STARTED|Overall Study||8
8433161|NCT00839540|20783636|P1|STARTED|Overall Study||8
8433162|NCT00839527|20783647|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
8433163|NCT00839527|20783648|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
8433164|NCT00839527|20783649|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
8433165|NCT00839527|20783647|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
8433166|NCT00839527|20783648|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
8433167|NCT00839527|20783649|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
8433168|NCT00839527|20783647|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
8433169|NCT00839527|20783648|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
8433170|NCT00839527|20783649|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
8433171|NCT00839527|20783647|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
8433172|NCT00839527|20783648|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
8433173|NCT00839527|20783649|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
8433174|NCT00839527|20783647|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
8433175|NCT00839527|20783648|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
8433176|NCT00839527|20783649|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
8433177|NCT00839527|20783647|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
8433178|NCT00839527|20783648|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
8433179|NCT00839527|20783649|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
8433180|NCT00839436|20783684|P3|NOT COMPLETED|Overall Study||1
8433181|NCT00839436|20783685|P2|NOT COMPLETED|Overall Study||1
8433182|NCT00839436|20783686|P1|NOT COMPLETED|Overall Study||1
8433183|NCT00839436|20783684|P3|COMPLETED|Overall Study||0
8433184|NCT00839436|20783685|P2|COMPLETED|Overall Study||4
8433185|NCT00839436|20783686|P1|COMPLETED|Overall Study||2
8433186|NCT00839436|20783684|P3|STARTED|Overall Study||1
8433187|NCT00839436|20783685|P2|STARTED|Overall Study||5
8433188|NCT00839436|20783686|P1|STARTED|Overall Study||3
8433189|NCT00839423|20783698|P4|NOT COMPLETED|Overall Study||20
8433190|NCT00839423|20783699|P3|NOT COMPLETED|Overall Study||18
8433191|NCT00839423|20783700|P2|NOT COMPLETED|Overall Study||10
8433192|NCT00839423|20783701|P1|NOT COMPLETED|Overall Study||18
8433193|NCT00839423|20783698|P4|COMPLETED|Overall Study||93
8433194|NCT00839423|20783699|P3|COMPLETED|Overall Study||82
8433195|NCT00839423|20783700|P2|COMPLETED|Overall Study||98
8433196|NCT00839423|20783701|P1|COMPLETED|Overall Study||87
8433197|NCT00839423|20783698|P4|STARTED|Overall Study||113
8433198|NCT00839423|20783699|P3|STARTED|Overall Study||100
8433199|NCT00839423|20783700|P2|STARTED|Overall Study||108
8433200|NCT00839423|20783701|P1|STARTED|Overall Study||105
8433201|NCT00839332|20783742|P3|NOT COMPLETED|Phase 2||39
8433202|NCT00839332|20783743|P2|NOT COMPLETED|Phase 2||68
8433203|NCT00839332|20783744|P1|NOT COMPLETED|Phase 2||0
8433204|NCT00839332|20783742|P3|COMPLETED|Phase 2||0
8433205|NCT00839332|20783743|P2|COMPLETED|Phase 2||0
8433206|NCT00839332|20783744|P1|COMPLETED|Phase 2||0
8433207|NCT00839332|20783742|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
8433208|NCT00839332|20783743|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
8433209|NCT00839332|20783744|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
8433210|NCT00839332|20783742|P3|STARTED|Phase 2||39
8433211|NCT00839332|20783743|P2|STARTED|Phase 2||68
8433212|NCT00839332|20783744|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
8433213|NCT00839332|20783742|P3|NOT COMPLETED|Phase 1||0
8433214|NCT00839332|20783743|P2|NOT COMPLETED|Phase 1||0
8433215|NCT00839332|20783744|P1|NOT COMPLETED|Phase 1||50
8433216|NCT00839332|20783742|P3|COMPLETED|Phase 1||0
8433217|NCT00839332|20783743|P2|COMPLETED|Phase 1||0
8433218|NCT00839332|20783744|P1|COMPLETED|Phase 1||0
8433219|NCT00839332|20783742|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
8433220|NCT00839332|20783743|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
8433221|NCT00839332|20783744|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
8433222|NCT00839332|20783742|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
8433223|NCT00839332|20783743|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
8433224|NCT00839332|20783744|P1|STARTED|Phase 1||50
8433225|NCT00839319|20783772|P5|NOT COMPLETED|Overall Study||0
8433226|NCT00839319|20783773|P4|NOT COMPLETED|Overall Study||3
8433227|NCT00839319|20783774|P3|NOT COMPLETED|Overall Study||3
8433228|NCT00839319|20783775|P2|NOT COMPLETED|Overall Study||1
8433229|NCT00839319|20783776|P1|NOT COMPLETED|Overall Study||2
8433230|NCT00839319|20783772|P5|COMPLETED|Overall Study||8
8433231|NCT00839319|20783773|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
8433232|NCT00839319|20783774|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
8433233|NCT00839319|20783775|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
8433234|NCT00839319|20783776|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
8433235|NCT00839319|20783772|P5|STARTED|Overall Study||8
8433236|NCT00839319|20783773|P4|STARTED|Overall Study||8
8433237|NCT00839319|20783774|P3|STARTED|Overall Study||8
8433238|NCT00839319|20783775|P2|STARTED|Overall Study||8
8433239|NCT00839319|20783776|P1|STARTED|Overall Study||8
8433240|NCT00839306|20783805|P2|NOT COMPLETED|Overall Study||43
8433241|NCT00839306|20783806|P1|NOT COMPLETED|Overall Study||25
8433242|NCT00839306|20783805|P2|COMPLETED|Overall Study||134
8433243|NCT00839306|20783806|P1|COMPLETED|Overall Study||35
8433244|NCT00839306|20783805|P2|STARTED|Overall Study|Treated|177
8433245|NCT00839306|20783806|P1|STARTED|Overall Study|Treated|60
8433246|NCT00839254|20783822|P8|NOT COMPLETED|Overall Study||15
8433247|NCT00839254|20783823|P7|NOT COMPLETED|Overall Study||28
8433248|NCT00839254|20783824|P6|NOT COMPLETED|Overall Study||26
8433249|NCT00839254|20783825|P5|NOT COMPLETED|Overall Study||37
8433250|NCT00839254|20783826|P4|NOT COMPLETED|Overall Study||62
8433251|NCT00839254|20783827|P3|NOT COMPLETED|Overall Study||90
8433252|NCT00839254|20783828|P2|NOT COMPLETED|Overall Study||92
8433253|NCT00839254|20783829|P1|NOT COMPLETED|Overall Study||153
8433254|NCT00839254|20783822|P8|COMPLETED|Overall Study||256
8433255|NCT00839254|20783823|P7|COMPLETED|Overall Study||340
8433256|NCT00839254|20783824|P6|COMPLETED|Overall Study||178
8433257|NCT00839254|20783825|P5|COMPLETED|Overall Study||204
8433258|NCT00839254|20783826|P4|COMPLETED|Overall Study||797
8433259|NCT00839254|20783827|P3|COMPLETED|Overall Study||979
8433260|NCT00839254|20783828|P2|COMPLETED|Overall Study||1224
8433261|NCT00839254|20783829|P1|COMPLETED|Overall Study||1696
8433262|NCT00839254|20783822|P8|STARTED|Overall Study||271
8433263|NCT00839254|20783823|P7|STARTED|Overall Study||368
8433264|NCT00839254|20783824|P6|STARTED|Overall Study||204
8433265|NCT00839254|20783825|P5|STARTED|Overall Study||241
8433266|NCT00839254|20783826|P4|STARTED|Overall Study||859
8433267|NCT00839254|20783827|P3|STARTED|Overall Study||1069
8433268|NCT00839254|20783828|P2|STARTED|Overall Study||1316
8433269|NCT00839254|20783829|P1|STARTED|Overall Study||1849
8433270|NCT00839241|20784065|P2|NOT COMPLETED|Overall Study||17
8433271|NCT00839241|20784066|P1|NOT COMPLETED|Overall Study||5
8433272|NCT00839241|20784065|P2|COMPLETED|Overall Study||8
8433273|NCT00839241|20784066|P1|COMPLETED|Overall Study||15
8433274|NCT00839241|20784065|P2|STARTED|Overall Study||25
8433275|NCT00839241|20784066|P1|STARTED|Overall Study||20
8433276|NCT00839098|20784153|P3|NOT COMPLETED|Overall Study||7
8433277|NCT00839098|20784154|P2|NOT COMPLETED|Overall Study||1
8433278|NCT00839098|20784155|P1|NOT COMPLETED|Overall Study||2
8433279|NCT00839098|20784153|P3|COMPLETED|Overall Study||6
8433280|NCT00839098|20784154|P2|COMPLETED|Overall Study||11
8433281|NCT00839098|20784155|P1|COMPLETED|Overall Study||1
8433282|NCT00839098|20784153|P3|STARTED|Overall Study||13
8433283|NCT00839098|20784154|P2|STARTED|Overall Study||12
8433284|NCT00839098|20784155|P1|STARTED|Overall Study||3
8433285|NCT00839072|20784181|P2|NOT COMPLETED|Second Intervention Period||0
8433286|NCT00839072|20784182|P1|NOT COMPLETED|Second Intervention Period||1
8433287|NCT00839072|20784181|P2|COMPLETED|Second Intervention Period||11
8433288|NCT00839072|20784182|P1|COMPLETED|Second Intervention Period||9
8433289|NCT00839072|20784181|P2|STARTED|Second Intervention Period||11
8433290|NCT00839072|20784182|P1|STARTED|Second Intervention Period||10
8433291|NCT00839072|20784181|P2|NOT COMPLETED|Washout Period of 7 Days||0
8433292|NCT00839072|20784182|P1|NOT COMPLETED|Washout Period of 7 Days||0
8433293|NCT00839072|20784181|P2|COMPLETED|Washout Period of 7 Days||11
8433294|NCT00839072|20784182|P1|COMPLETED|Washout Period of 7 Days||10
8433295|NCT00839072|20784181|P2|STARTED|Washout Period of 7 Days||11
8433296|NCT00839072|20784182|P1|STARTED|Washout Period of 7 Days||10
8433297|NCT00839072|20784181|P2|NOT COMPLETED|First Intervention Period||1
8433298|NCT00839072|20784182|P1|NOT COMPLETED|First Intervention Period||2
8433299|NCT00839072|20784181|P2|COMPLETED|First Intervention Period||11
8433300|NCT00839072|20784182|P1|COMPLETED|First Intervention Period||10
8433301|NCT00839072|20784181|P2|STARTED|First Intervention Period||12
8433302|NCT00839072|20784182|P1|STARTED|First Intervention Period||12
8433303|NCT00838981|20784202|P4|NOT COMPLETED|Day 4 to Week 11||7
8433304|NCT00838981|20784203|P3|NOT COMPLETED|Day 4 to Week 11||11
8433305|NCT00838981|20784204|P2|NOT COMPLETED|Day 4 to Week 11||8
8433306|NCT00838981|20784205|P1|NOT COMPLETED|Day 4 to Week 11||7
8433307|NCT00838981|20784202|P4|COMPLETED|Day 4 to Week 11||12
8433308|NCT00838981|20784203|P3|COMPLETED|Day 4 to Week 11||16
8433309|NCT00838981|20784204|P2|COMPLETED|Day 4 to Week 11||11
8433310|NCT00838981|20784205|P1|COMPLETED|Day 4 to Week 11||19
8433311|NCT00838981|20784202|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
8433312|NCT00838981|20784203|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
8433313|NCT00838981|20784204|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
8433314|NCT00838981|20784205|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
8433315|NCT00838981|20784202|P4|STARTED|Day 4 to Week 11||19
8433316|NCT00838981|20784203|P3|STARTED|Day 4 to Week 11||27
8433317|NCT00838981|20784204|P2|STARTED|Day 4 to Week 11||19
8433318|NCT00838981|20784205|P1|STARTED|Day 4 to Week 11||26
8433319|NCT00838981|20784202|P4|NOT COMPLETED|Week 1 Days 1-3||0
8433320|NCT00838981|20784203|P3|NOT COMPLETED|Week 1 Days 1-3||0
8433321|NCT00838981|20784204|P2|NOT COMPLETED|Week 1 Days 1-3||0
8433322|NCT00838981|20784205|P1|NOT COMPLETED|Week 1 Days 1-3||0
8433323|NCT00838981|20784202|P4|COMPLETED|Week 1 Days 1-3||19
8433324|NCT00838981|20784203|P3|COMPLETED|Week 1 Days 1-3||27
8433325|NCT00838981|20784204|P2|COMPLETED|Week 1 Days 1-3||19
8433326|NCT00838981|20784205|P1|COMPLETED|Week 1 Days 1-3||26
8433327|NCT00838981|20784202|P4|STARTED|Week 1 Days 1-3||19
8433328|NCT00838981|20784203|P3|STARTED|Week 1 Days 1-3||27
8433329|NCT00838981|20784204|P2|STARTED|Week 1 Days 1-3||19
8433330|NCT00838981|20784205|P1|STARTED|Week 1 Days 1-3||26
8433331|NCT00838929|20784226|P3|NOT COMPLETED|Overall Study||1
8433332|NCT00838929|20784227|P2|NOT COMPLETED|Overall Study||3
8433333|NCT00838929|20784228|P1|NOT COMPLETED|Overall Study||0
8433334|NCT00838929|20784226|P3|COMPLETED|Overall Study||5
8433335|NCT00838929|20784227|P2|COMPLETED|Overall Study||5
8433336|NCT00838929|20784228|P1|COMPLETED|Overall Study||3
8433337|NCT00838929|20784226|P3|STARTED|Overall Study||6
8433338|NCT00838929|20784227|P2|STARTED|Overall Study||8
8433339|NCT00838929|20784228|P1|STARTED|Overall Study||3
8433340|NCT00838916|20784236|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
8433341|NCT00838916|20784237|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
8433342|NCT00838916|20784236|P2|COMPLETED|Follow-up Period (8 Weeks)||190
8433343|NCT00838916|20784237|P1|COMPLETED|Follow-up Period (8 Weeks)||408
8433344|NCT00838916|20784236|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
8433345|NCT00838916|20784237|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
8433346|NCT00838916|20784236|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
8433347|NCT00838916|20784237|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
8433348|NCT00838916|20784236|P2|COMPLETED|Treatment Period (156 Weeks)||164
8433349|NCT00838916|20784237|P1|COMPLETED|Treatment Period (156 Weeks)||308
8433350|NCT00838916|20784236|P2|STARTED|Treatment Period (156 Weeks)||241
8433351|NCT00838916|20784237|P1|STARTED|Treatment Period (156 Weeks)||504
8433352|NCT00838903|20784266|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
8433353|NCT00838903|20784267|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
8433354|NCT00838903|20784268|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
8433355|NCT00838903|20784269|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
8433356|NCT00838903|20784266|P4|COMPLETED|Follow-up Period (8 Weeks)||244
8433357|NCT00838903|20784267|P3|COMPLETED|Follow-up Period (8 Weeks)||243
8433358|NCT00838903|20784268|P2|COMPLETED|Follow-up Period (8 Weeks)||237
8433359|NCT00838903|20784269|P1|COMPLETED|Follow-up Period (8 Weeks)||75
8433360|NCT00838903|20784266|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
8433361|NCT00838903|20784267|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
8433362|NCT00838903|20784268|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
8433363|NCT00838903|20784269|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8433364|NCT00838903|20784266|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
8433365|NCT00838903|20784267|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
8433366|NCT00838903|20784268|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
8433367|NCT00838903|20784269|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
8433368|NCT00838903|20784266|P4|COMPLETED|Treatment Period (156 Weeks)||192
8433369|NCT00838903|20784267|P3|COMPLETED|Treatment Period (156 Weeks)||191
8433370|NCT00838903|20784268|P2|COMPLETED|Treatment Period (156 Weeks)||190
8433371|NCT00838903|20784269|P1|COMPLETED|Treatment Period (156 Weeks)||55
8433372|NCT00838903|20784266|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8433373|NCT00838903|20784267|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8433374|NCT00838903|20784268|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8433375|NCT00838903|20784269|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
8433376|NCT00838903|20784266|P4|STARTED|Treatment Period (156 Weeks)||302
8433377|NCT00838903|20784267|P3|STARTED|Treatment Period (156 Weeks)||307
8433378|NCT00838903|20784268|P2|STARTED|Treatment Period (156 Weeks)||302
8433379|NCT00838903|20784269|P1|STARTED|Treatment Period (156 Weeks)||101
8433380|NCT00838695|20784313|P2|NOT COMPLETED|Overall Study||0
8433381|NCT00838695|20784314|P1|NOT COMPLETED|Overall Study||0
8433382|NCT00838695|20784313|P2|COMPLETED|Overall Study||64
8433383|NCT00838695|20784314|P1|COMPLETED|Overall Study||42
8433384|NCT00838695|20784313|P2|STARTED|Overall Study||64
8433385|NCT00838695|20784314|P1|STARTED|Overall Study||42
8433386|NCT00838682|20784324|P2|NOT COMPLETED|Overall Study||19
8433387|NCT00838682|20784325|P1|NOT COMPLETED|Overall Study||25
8433388|NCT00838682|20784324|P2|COMPLETED|Overall Study||33
8433389|NCT00838682|20784325|P1|COMPLETED|Overall Study||29
8433390|NCT00838682|20784324|P2|STARTED|Overall Study||52
8433391|NCT00838682|20784325|P1|STARTED|Overall Study||54
8433392|NCT00838630|20784343|P2|NOT COMPLETED|Second Intervention||0
8433393|NCT00838630|20784344|P1|NOT COMPLETED|Second Intervention||0
8433394|NCT00838630|20784343|P2|COMPLETED|Second Intervention||18
8433395|NCT00838630|20784344|P1|COMPLETED|Second Intervention||16
8433396|NCT00838630|20784343|P2|STARTED|Second Intervention||18
8433397|NCT00838630|20784344|P1|STARTED|Second Intervention||16
8433398|NCT00838630|20784343|P2|NOT COMPLETED|Washout: 7 Days||0
8433399|NCT00838630|20784344|P1|NOT COMPLETED|Washout: 7 Days||1
8433400|NCT00838630|20784343|P2|COMPLETED|Washout: 7 Days||18
8433401|NCT00838630|20784344|P1|COMPLETED|Washout: 7 Days||16
8433402|NCT00838630|20784343|P2|STARTED|Washout: 7 Days||18
8433403|NCT00838630|20784344|P1|STARTED|Washout: 7 Days||17
8433404|NCT00838630|20784343|P2|NOT COMPLETED|First Intervention||0
8433405|NCT00838630|20784344|P1|NOT COMPLETED|First Intervention||1
8433406|NCT00838630|20784343|P2|COMPLETED|First Intervention||18
8433407|NCT00838630|20784344|P1|COMPLETED|First Intervention||17
8433408|NCT00838630|20784343|P2|STARTED|First Intervention||18
8433409|NCT00838630|20784344|P1|STARTED|First Intervention||18
8433410|NCT00838578|20784352|P1|NOT COMPLETED|Overall Study||2
8433411|NCT00838578|20784352|P1|COMPLETED|Overall Study||63
8433412|NCT00838578|20784352|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
8433413|NCT00838565|20784366|P6|NOT COMPLETED|Overall Study||2
8433414|NCT00838565|20784367|P5|NOT COMPLETED|Overall Study||0
8433415|NCT00838565|20784368|P4|NOT COMPLETED|Overall Study||0
8433416|NCT00838565|20784369|P3|NOT COMPLETED|Overall Study||1
8433417|NCT00838565|20784370|P2|NOT COMPLETED|Overall Study||3
8433418|NCT00838565|20784371|P1|NOT COMPLETED|Overall Study||0
8433419|NCT00838565|20784366|P6|COMPLETED|Overall Study||5
8433420|NCT00838565|20784367|P5|COMPLETED|Overall Study||6
8433421|NCT00838565|20784368|P4|COMPLETED|Overall Study||6
8433422|NCT00838565|20784369|P3|COMPLETED|Overall Study||5
8433423|NCT00838565|20784370|P2|COMPLETED|Overall Study||4
8433424|NCT00838565|20784371|P1|COMPLETED|Overall Study||9
8433425|NCT00838565|20784366|P6|Treated|Overall Study||7
8433426|NCT00838565|20784367|P5|Treated|Overall Study||6
8433427|NCT00838565|20784368|P4|Treated|Overall Study||6
8433428|NCT00838565|20784369|P3|Treated|Overall Study||6
8433429|NCT00838565|20784370|P2|Treated|Overall Study||6
8433430|NCT00838565|20784371|P1|Treated|Overall Study||9
8433431|NCT00838565|20784366|P6|STARTED|Overall Study||7
8433432|NCT00838565|20784367|P5|STARTED|Overall Study||6
8433433|NCT00838565|20784368|P4|STARTED|Overall Study||6
8433434|NCT00838565|20784369|P3|STARTED|Overall Study||6
8433435|NCT00838565|20784370|P2|STARTED|Overall Study||7
8433436|NCT00838565|20784371|P1|STARTED|Overall Study||9
8433437|NCT00838539|20784476|P12|NOT COMPLETED|Overall Study||4
8433438|NCT00838539|20784477|P11|NOT COMPLETED|Overall Study||5
8433439|NCT00838539|20784478|P10|NOT COMPLETED|Overall Study||8
8433440|NCT00838539|20784479|P9|NOT COMPLETED|Overall Study||5
8433441|NCT00838539|20784480|P8|NOT COMPLETED|Overall Study||6
8433442|NCT00838539|20784481|P7|NOT COMPLETED|Overall Study||5
8433443|NCT00838539|20784482|P6|NOT COMPLETED|Overall Study||4
8433444|NCT00838539|20784483|P5|NOT COMPLETED|Overall Study||6
8433445|NCT00838539|20784484|P4|NOT COMPLETED|Overall Study||4
8433446|NCT00838539|20784485|P3|NOT COMPLETED|Overall Study||5
8433447|NCT00838539|20784486|P2|NOT COMPLETED|Overall Study||6
8433448|NCT00838539|20784487|P1|NOT COMPLETED|Overall Study||3
8433449|NCT00838539|20784476|P12|COMPLETED|Overall Study||0
8433450|NCT00838539|20784477|P11|COMPLETED|Overall Study||0
8433451|NCT00838539|20784478|P10|COMPLETED|Overall Study||0
8433452|NCT00838539|20784479|P9|COMPLETED|Overall Study||0
8433453|NCT00838539|20784480|P8|COMPLETED|Overall Study||0
8433454|NCT00838539|20784481|P7|COMPLETED|Overall Study||2
8433455|NCT00838539|20784482|P6|COMPLETED|Overall Study||0
8433456|NCT00838539|20784483|P5|COMPLETED|Overall Study||0
8433457|NCT00838539|20784484|P4|COMPLETED|Overall Study||0
8433458|NCT00838539|20784485|P3|COMPLETED|Overall Study||0
8433459|NCT00838539|20784486|P2|COMPLETED|Overall Study||0
8433460|NCT00838539|20784487|P1|COMPLETED|Overall Study||0
8433461|NCT00838539|20784476|P12|Received Treatment|Overall Study||4
8433462|NCT00838539|20784477|P11|Received Treatment|Overall Study||5
8433463|NCT00838539|20784478|P10|Received Treatment|Overall Study||8
8433464|NCT00838539|20784479|P9|Received Treatment|Overall Study||5
8433465|NCT00838539|20784480|P8|Received Treatment|Overall Study||6
8433466|NCT00838539|20784481|P7|Received Treatment|Overall Study||7
8433467|NCT00838539|20784482|P6|Received Treatment|Overall Study||4
8433468|NCT00838539|20784483|P5|Received Treatment|Overall Study||4
8433469|NCT00838539|20784484|P4|Received Treatment|Overall Study||4
8433470|NCT00838539|20784485|P3|Received Treatment|Overall Study||5
8433471|NCT00838539|20784486|P2|Received Treatment|Overall Study||5
8433472|NCT00838539|20784487|P1|Received Treatment|Overall Study||3
8433473|NCT00838539|20784476|P12|STARTED|Overall Study||4
8433474|NCT00838539|20784477|P11|STARTED|Overall Study||5
8433475|NCT00838539|20784478|P10|STARTED|Overall Study||8
8433476|NCT00838539|20784479|P9|STARTED|Overall Study||5
8433477|NCT00838539|20784480|P8|STARTED|Overall Study||6
8433478|NCT00838539|20784481|P7|STARTED|Overall Study||7
8433479|NCT00838539|20784482|P6|STARTED|Overall Study||4
8433480|NCT00838539|20784483|P5|STARTED|Overall Study||6
8433481|NCT00838539|20784484|P4|STARTED|Overall Study||4
8433482|NCT00838539|20784485|P3|STARTED|Overall Study||5
8433483|NCT00838539|20784486|P2|STARTED|Overall Study||6
8433484|NCT00838539|20784487|P1|STARTED|Overall Study||3
8433485|NCT00838526|20784537|P2|NOT COMPLETED|Overall Study||39
8433486|NCT00838526|20784538|P1|NOT COMPLETED|Overall Study||24
8433487|NCT00838526|20784537|P2|COMPLETED|Overall Study||137
8433488|NCT00838526|20784538|P1|COMPLETED|Overall Study||35
8433489|NCT00838526|20784537|P2|STARTED|Overall Study|Treated|176
8433490|NCT00838526|20784538|P1|STARTED|Overall Study|Treated|59
8433491|NCT00838513|20784546|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
8433492|NCT00838513|20784546|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
8433493|NCT00838513|20784546|P1|STARTED|Post Treatment Period (Patients Who Disc||5
8433494|NCT00838513|20784546|P1|NOT COMPLETED|Extension Treatment Period||1
8433495|NCT00838513|20784546|P1|COMPLETED|Extension Treatment Period||18
8433496|NCT00838513|20784546|P1|STARTED|Extension Treatment Period||19
8433497|NCT00838513|20784546|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
8433498|NCT00838513|20784546|P1|COMPLETED|Treatment Period (26 Weeks)||20
8433499|NCT00838513|20784546|P1|STARTED|Treatment Period (26 Weeks)||20
8433500|NCT00838513|20784546|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
8433501|NCT00838513|20784546|P1|COMPLETED|Observation Period (8 Weeks)||20
8433502|NCT00838513|20784546|P1|STARTED|Observation Period (8 Weeks)||20
8433503|NCT00838513|20784546|P1|NOT COMPLETED|Screening Period||3
8433504|NCT00838513|20784546|P1|COMPLETED|Screening Period||20
8433505|NCT00838513|20784546|P1|STARTED|Screening Period||23
8433506|NCT00838435|20784562|P1|NOT COMPLETED|Part 2 (7 Years)||16
8433507|NCT00838435|20784562|P1|COMPLETED|Part 2 (7 Years)||49
8433508|NCT00838435|20784562|P1|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
8433509|NCT00838435|20784562|P1|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
8433510|NCT00838435|20784562|P1|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
8433511|NCT00838435|20784562|P1|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
8433512|NCT00838435|20784562|P1|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
8433513|NCT00838435|20784562|P1|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
8433514|NCT00838435|20784562|P1|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
8433515|NCT00838435|20784562|P1|NOT COMPLETED|Part 1 (4 Weeks)||0
8433516|NCT00838435|20784562|P1|COMPLETED|Part 1 (4 Weeks)||95
8433517|NCT00838435|20784562|P1|STARTED|Part 1 (4 Weeks)||95
8433518|NCT00838331|20784575|P1|NOT COMPLETED|Aged Blood Transfusion||9
8433519|NCT00838331|20784575|P1|COMPLETED|Aged Blood Transfusion||8
8433520|NCT00838331|20784575|P1|STARTED|Aged Blood Transfusion||17
8433521|NCT00838331|20784575|P1|NOT COMPLETED|Fresh Blood Transfusion||0
8433522|NCT00838331|20784575|P1|COMPLETED|Fresh Blood Transfusion||17
8433523|NCT00838331|20784575|P1|STARTED|Fresh Blood Transfusion||17
8433524|NCT00838279|20784581|P2|NOT COMPLETED|Second Intervention||0
8433525|NCT00838279|20784582|P1|NOT COMPLETED|Second Intervention||0
8433526|NCT00838279|20784581|P2|COMPLETED|Second Intervention||15
8433527|NCT00838279|20784582|P1|COMPLETED|Second Intervention||15
8433528|NCT00838279|20784581|P2|STARTED|Second Intervention||15
8433529|NCT00838279|20784582|P1|STARTED|Second Intervention||15
8433530|NCT00838279|20784581|P2|NOT COMPLETED|Washout||1
8433531|NCT00838279|20784582|P1|NOT COMPLETED|Washout||1
8433532|NCT00838279|20784581|P2|COMPLETED|Washout||15
8433533|NCT00838279|20784582|P1|COMPLETED|Washout||15
8433534|NCT00838279|20784581|P2|STARTED|Washout||16
8433535|NCT00838279|20784582|P1|STARTED|Washout||16
8433536|NCT00838279|20784581|P2|NOT COMPLETED|First Intervention||0
8433537|NCT00838279|20784582|P1|NOT COMPLETED|First Intervention||0
8433538|NCT00838279|20784581|P2|COMPLETED|First Intervention||16
8433539|NCT00838279|20784582|P1|COMPLETED|First Intervention||16
8433540|NCT00838279|20784581|P2|STARTED|First Intervention||16
8433541|NCT00838279|20784582|P1|STARTED|First Intervention||16
8433542|NCT00838201|20784592|P2|NOT COMPLETED|Overall Study||53
8433543|NCT00838201|20784593|P1|NOT COMPLETED|Overall Study||42
8433544|NCT00838201|20784592|P2|COMPLETED|Overall Study||145
8433545|NCT00838201|20784593|P1|COMPLETED|Overall Study||144
8433546|NCT00838201|20784592|P2|STARTED|Overall Study||198
8433547|NCT00838201|20784593|P1|STARTED|Overall Study||186
8433548|NCT00838162|20784603|P4|NOT COMPLETED|Overall Study||0
8433549|NCT00838162|20784604|P3|NOT COMPLETED|Overall Study||0
8433550|NCT00838162|20784605|P2|NOT COMPLETED|Overall Study||0
8433551|NCT00838162|20784606|P1|NOT COMPLETED|Overall Study||0
8433552|NCT00838162|20784603|P4|COMPLETED|Overall Study||8
8433553|NCT00838162|20784604|P3|COMPLETED|Overall Study||8
8433554|NCT00838162|20784605|P2|COMPLETED|Overall Study||8
8433555|NCT00838162|20784606|P1|COMPLETED|Overall Study||9
8433556|NCT00838162|20784603|P4|STARTED|Overall Study||8
8433557|NCT00838162|20784604|P3|STARTED|Overall Study||8
8433558|NCT00838162|20784605|P2|STARTED|Overall Study||8
8433559|NCT00838162|20784606|P1|STARTED|Overall Study||9
8433560|NCT00838136|20784650|P2|NOT COMPLETED|Second Intervention||1
8433561|NCT00838136|20784651|P1|NOT COMPLETED|Second Intervention||0
8433562|NCT00838136|20784650|P2|COMPLETED|Second Intervention||15
8433563|NCT00838136|20784651|P1|COMPLETED|Second Intervention||16
8433564|NCT00838136|20784650|P2|STARTED|Second Intervention||16
8433565|NCT00838136|20784651|P1|STARTED|Second Intervention||16
8433566|NCT00838136|20784650|P2|NOT COMPLETED|First Intervention||0
8433567|NCT00838136|20784651|P1|NOT COMPLETED|First Intervention||0
8433568|NCT00838136|20784650|P2|COMPLETED|First Intervention||16
8433569|NCT00838136|20784651|P1|COMPLETED|First Intervention||16
8433570|NCT00838136|20784650|P2|STARTED|First Intervention||16
8433571|NCT00838136|20784651|P1|STARTED|First Intervention||16
8433572|NCT00838110|20784661|P4|NOT COMPLETED|Overall Study||18
8433573|NCT00838110|20784662|P3|NOT COMPLETED|Overall Study||17
8433574|NCT00838110|20784663|P2|NOT COMPLETED|Overall Study||22
8433575|NCT00838110|20784664|P1|NOT COMPLETED|Overall Study||22
8433576|NCT00838110|20784661|P4|COMPLETED|Overall Study||226
8433577|NCT00838110|20784662|P3|COMPLETED|Overall Study||226
8433578|NCT00838110|20784663|P2|COMPLETED|Overall Study||106
8433579|NCT00838110|20784664|P1|COMPLETED|Overall Study||105
8433580|NCT00838110|20784661|P4|Treated|Overall Study||244
8433581|NCT00838110|20784662|P3|Treated|Overall Study||243
8433582|NCT00838110|20784663|P2|Treated|Overall Study||127
8433583|NCT00838110|20784664|P1|Treated|Overall Study||127
8433584|NCT00838110|20784661|P4|STARTED|Overall Study||244
8433585|NCT00838110|20784662|P3|STARTED|Overall Study||243
8433586|NCT00838110|20784663|P2|STARTED|Overall Study||128
8433587|NCT00838110|20784664|P1|STARTED|Overall Study||127
8433588|NCT00838097|20784684|P1|NOT COMPLETED|Overall Study||176
8433589|NCT00838097|20784684|P1|COMPLETED|Overall Study||145
8433590|NCT00838097|20784684|P1|Received Darbepoetin Alfa|Overall Study||319
8433591|NCT00838097|20784684|P1|STARTED|Overall Study||321
8433592|NCT00838006|20784695|P3|NOT COMPLETED|Overall Study||48
8433593|NCT00838006|20784696|P2|NOT COMPLETED|Overall Study||26
8433594|NCT00838006|20784697|P1|NOT COMPLETED|Overall Study||34
8433595|NCT00838006|20784695|P3|COMPLETED|Overall Study||94
8433596|NCT00838006|20784696|P2|COMPLETED|Overall Study||72
8433597|NCT00838006|20784697|P1|COMPLETED|Overall Study||68
8433598|NCT00838006|20784695|P3|3-month Post-deployment Follow-up|Overall Study||135
8433599|NCT00838006|20784696|P2|3-month Post-deployment Follow-up|Overall Study||80
8433600|NCT00838006|20784697|P1|3-month Post-deployment Follow-up|Overall Study||92
8433601|NCT00838006|20784695|P3|STARTED|Overall Study||142
8433602|NCT00838006|20784696|P2|STARTED|Overall Study||98
8433603|NCT00838006|20784697|P1|STARTED|Overall Study||102
8433604|NCT00837967|20784708|P2|NOT COMPLETED|Second Intervention||0
8433605|NCT00837967|20784709|P1|NOT COMPLETED|Second Intervention||0
8433606|NCT00837967|20784708|P2|COMPLETED|Second Intervention||12
8433607|NCT00837967|20784709|P1|COMPLETED|Second Intervention||11
8433608|NCT00837967|20784708|P2|STARTED|Second Intervention||12
8433609|NCT00837967|20784709|P1|STARTED|Second Intervention||11
8433610|NCT00837967|20784708|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
8433611|NCT00837967|20784709|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
8433612|NCT00837967|20784708|P2|COMPLETED|Washout Period of 7 - 14 Days||12
8433613|NCT00837967|20784709|P1|COMPLETED|Washout Period of 7 - 14 Days||11
8433614|NCT00837967|20784708|P2|STARTED|Washout Period of 7 - 14 Days||12
8433615|NCT00837967|20784709|P1|STARTED|Washout Period of 7 - 14 Days||13
8433616|NCT00837967|20784708|P2|NOT COMPLETED|First Intervention||0
8433617|NCT00837967|20784709|P1|NOT COMPLETED|First Intervention||0
8433618|NCT00837967|20784708|P2|COMPLETED|First Intervention||12
8433619|NCT00837967|20784709|P1|COMPLETED|First Intervention||13
8433620|NCT00837967|20784708|P2|STARTED|First Intervention||12
8433621|NCT00837967|20784709|P1|STARTED|First Intervention||13
8433622|NCT00837902|20784727|P2|NOT COMPLETED|Overall Study||0
8433623|NCT00837902|20784728|P1|NOT COMPLETED|Overall Study||0
8433624|NCT00837902|20784727|P2|COMPLETED|Overall Study||69
8433625|NCT00837902|20784728|P1|COMPLETED|Overall Study||85
8433626|NCT00837902|20784727|P2|STARTED|Overall Study||69
8433627|NCT00837902|20784728|P1|STARTED|Overall Study||85
8433628|NCT00837876|20784735|P1|NOT COMPLETED|Overall Study||37
8433629|NCT00837876|20784735|P1|COMPLETED|Overall Study||0
8433630|NCT00837876|20784735|P1|STARTED|Overall Study||37
8433631|NCT00837824|20784744|P2|NOT COMPLETED|Overall Study||0
8433632|NCT00837824|20784745|P1|NOT COMPLETED|Overall Study||0
8433633|NCT00837824|20784744|P2|COMPLETED|Overall Study||9
8433634|NCT00837824|20784745|P1|COMPLETED|Overall Study||11
8433635|NCT00837824|20784744|P2|STARTED|Overall Study||9
8433636|NCT00837824|20784745|P1|STARTED|Overall Study||11
8433637|NCT00837811|20784757|P3|NOT COMPLETED|Overall Study||1
8433638|NCT00837811|20784758|P2|NOT COMPLETED|Overall Study||34
8433639|NCT00837811|20784759|P1|NOT COMPLETED|Overall Study||7
8433640|NCT00837811|20784757|P3|COMPLETED|Overall Study||0
8433641|NCT00837811|20784758|P2|COMPLETED|Overall Study||87
8433642|NCT00837811|20784759|P1|COMPLETED|Overall Study||53
8433643|NCT00837811|20784757|P3|Included in Efficacy Analyses|Overall Study||1
8433644|NCT00837811|20784758|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
8433645|NCT00837811|20784759|P1|Included in Efficacy Analyses|Overall Study||59
8433646|NCT00837811|20784757|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
8433647|NCT00837811|20784758|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
8433648|NCT00837811|20784759|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
8433649|NCT00837811|20784757|P3|Received Any Amount of Study Drug|Overall Study||1
8433650|NCT00837811|20784758|P2|Received Any Amount of Study Drug|Overall Study||121
8433651|NCT00837811|20784759|P1|Received Any Amount of Study Drug|Overall Study||60
8433652|NCT00837811|20784757|P3|STARTED|Overall Study||1
8433653|NCT00837811|20784758|P2|STARTED|Overall Study||121
8433654|NCT00837811|20784759|P1|STARTED|Overall Study||60
8433655|NCT00837759|20784844|P1|NOT COMPLETED|Overall Study||4
8433656|NCT00837759|20784844|P1|COMPLETED|Overall Study||3
8433657|NCT00837759|20784844|P1|STARTED|Overall Study||7
8433658|NCT00837694|20784859|P6|NOT COMPLETED|Overall Study||1
8433659|NCT00837694|20784860|P5|NOT COMPLETED|Overall Study||1
8433660|NCT00837694|20784861|P4|NOT COMPLETED|Overall Study||1
8433661|NCT00837694|20784862|P3|NOT COMPLETED|Overall Study||2
8433662|NCT00837694|20784863|P2|NOT COMPLETED|Overall Study||0
8433663|NCT00837694|20784864|P1|NOT COMPLETED|Overall Study||2
8433664|NCT00837694|20784859|P6|COMPLETED|Overall Study||10
8433665|NCT00837694|20784860|P5|COMPLETED|Overall Study||11
8433666|NCT00837694|20784861|P4|COMPLETED|Overall Study||10
8433667|NCT00837694|20784862|P3|COMPLETED|Overall Study||8
8433668|NCT00837694|20784863|P2|COMPLETED|Overall Study||11
8433669|NCT00837694|20784864|P1|COMPLETED|Overall Study||8
8433670|NCT00837694|20784859|P6|STARTED|Overall Study||11
8433671|NCT00837694|20784860|P5|STARTED|Overall Study||12
8433672|NCT00837694|20784861|P4|STARTED|Overall Study||11
8433673|NCT00837694|20784862|P3|STARTED|Overall Study||10
8433674|NCT00837694|20784863|P2|STARTED|Overall Study||11
8433675|NCT00837694|20784864|P1|STARTED|Overall Study||10
8433676|NCT00837616|20784880|P2|NOT COMPLETED|Overall Study||1
8433677|NCT00837616|20784881|P1|NOT COMPLETED|Overall Study||0
8433678|NCT00837616|20784880|P2|COMPLETED|Overall Study||20
8433679|NCT00837616|20784881|P1|COMPLETED|Overall Study||20
8433680|NCT00837616|20784880|P2|STARTED|Overall Study||21
8433681|NCT00837616|20784881|P1|STARTED|Overall Study||20
8433682|NCT00837590|20784908|P3|NOT COMPLETED|Overall Study||1
8433683|NCT00837590|20784909|P2|NOT COMPLETED|Overall Study||1
8433684|NCT00837590|20784910|P1|NOT COMPLETED|Overall Study||0
8433685|NCT00837590|20784908|P3|COMPLETED|Overall Study||4
8433686|NCT00837590|20784909|P2|COMPLETED|Overall Study||4
8433687|NCT00837590|20784910|P1|COMPLETED|Overall Study||6
8433688|NCT00837590|20784908|P3|STARTED|Overall Study||5
8433689|NCT00837590|20784909|P2|STARTED|Overall Study||5
8433690|NCT00837590|20784910|P1|STARTED|Overall Study||6
8433691|NCT00837577|20784920|P2|NOT COMPLETED|Open-label Period||9
8433692|NCT00837577|20784921|P1|NOT COMPLETED|Open-label Period||8
8433693|NCT00837577|20784920|P2|COMPLETED|Open-label Period||54
8433694|NCT00837577|20784921|P1|COMPLETED|Open-label Period||60
8433695|NCT00837577|20784920|P2|STARTED|Open-label Period||63
8433696|NCT00837577|20784921|P1|STARTED|Open-label Period||68
8433697|NCT00837577|20784920|P2|NOT COMPLETED|Double-blind Period||0
8433698|NCT00837577|20784921|P1|NOT COMPLETED|Double-blind Period||2
8433699|NCT00837577|20784920|P2|COMPLETED|Double-blind Period||63
8433700|NCT00837577|20784921|P1|COMPLETED|Double-blind Period||68
8433701|NCT00837577|20784920|P2|STARTED|Double-blind Period||63
8433702|NCT00837577|20784921|P1|STARTED|Double-blind Period||70
8433703|NCT00837512|20784932|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
8433704|NCT00837512|20784933|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
8433705|NCT00837512|20784932|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433706|NCT00837512|20784933|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433707|NCT00837512|20784932|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433708|NCT00837512|20784933|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433709|NCT00837512|20784932|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
8433710|NCT00837512|20784933|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
8433711|NCT00837512|20784932|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
8433712|NCT00837512|20784933|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
8433713|NCT00837512|20784932|P2|STARTED|Both Arms: Washout (7-28 Days)||8
8433714|NCT00837512|20784933|P1|STARTED|Both Arms: Washout (7-28 Days)||8
8433715|NCT00837512|20784932|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
8433716|NCT00837512|20784933|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
8433717|NCT00837512|20784932|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
8433718|NCT00837512|20784933|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
8433719|NCT00837512|20784932|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
8433720|NCT00837512|20784933|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
8433721|NCT00837486|20784941|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
8433722|NCT00837486|20784942|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
8433723|NCT00837486|20784941|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
8433724|NCT00837486|20784942|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
8433725|NCT00837486|20784941|P2|STARTED|Long-term Follow-up Phase - Open Label||0
8433726|NCT00837486|20784942|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
8433727|NCT00837486|20784941|P2|NOT COMPLETED|Blinded-treatment Phase||0
8433728|NCT00837486|20784942|P1|NOT COMPLETED|Blinded-treatment Phase||1
8433729|NCT00837486|20784941|P2|COMPLETED|Blinded-treatment Phase||14
8433730|NCT00837486|20784942|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
8433731|NCT00837486|20784941|P2|STARTED|Blinded-treatment Phase||14
8433732|NCT00837486|20784942|P1|STARTED|Blinded-treatment Phase||16
8433733|NCT00837473|20784954|P1|NOT COMPLETED|Overall Study||3
8433734|NCT00837473|20784954|P1|COMPLETED|Overall Study||12
8433735|NCT00837473|20784954|P1|STARTED|Overall Study||15
8433736|NCT00837447|20784967|P1|NOT COMPLETED|Overall Study||0
8433737|NCT00837447|20784967|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
8433738|NCT00837447|20784967|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
8433739|NCT00837434|20784974|P2|NOT COMPLETED|Overall Study||1
8433740|NCT00837434|20784975|P1|NOT COMPLETED|Overall Study||9
8433741|NCT00837434|20784974|P2|COMPLETED|Overall Study||19
8433742|NCT00837434|20784975|P1|COMPLETED|Overall Study||34
8433743|NCT00837434|20784974|P2|STARTED|Overall Study||20
8433744|NCT00837434|20784975|P1|STARTED|Overall Study||43
8433745|NCT00837330|20784995|P2|NOT COMPLETED|Overall Study||3
8433746|NCT00837330|20784996|P1|NOT COMPLETED|Overall Study||1
8433747|NCT00837330|20784995|P2|COMPLETED|Overall Study||7
8433748|NCT00837330|20784996|P1|COMPLETED|Overall Study||9
8433749|NCT00837330|20784995|P2|STARTED|Overall Study||10
8433750|NCT00837330|20784996|P1|STARTED|Overall Study||10
8433751|NCT00837252|20785002|P1|NOT COMPLETED|Overall Study||0
8433752|NCT00837252|20785002|P1|COMPLETED|Overall Study||5
8433753|NCT00837252|20785002|P1|STARTED|Overall Study||5
8433754|NCT00837213|20785019|P2|NOT COMPLETED|Overall Study||5
8433755|NCT00837213|20785020|P1|NOT COMPLETED|Overall Study||6
8433756|NCT00837213|20785019|P2|COMPLETED|Overall Study||12
8433757|NCT00837213|20785020|P1|COMPLETED|Overall Study||10
8433758|NCT00837213|20785019|P2|STARTED|Overall Study||17
8433759|NCT00837213|20785020|P1|STARTED|Overall Study||16
8433760|NCT00837200|20785040|P1|NOT COMPLETED|Overall Study||0
8433761|NCT00837200|20785040|P1|COMPLETED|Overall Study||13
8433762|NCT00837200|20785040|P1|STARTED|Overall Study||13
8433763|NCT00837161|20785046|P1|NOT COMPLETED|Overall Study||2
8433764|NCT00837161|20785046|P1|COMPLETED|Overall Study||9
8433765|NCT00837161|20785046|P1|STARTED|Overall Study||11
8433766|NCT00837148|20785054|P1|NOT COMPLETED|Overall Study||2
8433767|NCT00837148|20785054|P1|COMPLETED|Overall Study||35
8433768|NCT00837148|20785054|P1|STARTED|Overall Study||37
8433769|NCT00837096|20785060|P2|NOT COMPLETED|Overall Study||9
8433770|NCT00837096|20785061|P1|NOT COMPLETED|Overall Study||10
8433771|NCT00837096|20785060|P2|COMPLETED|Overall Study||0
8433772|NCT00837096|20785061|P1|COMPLETED|Overall Study||0
8433773|NCT00837096|20785060|P2|STARTED|Overall Study||9
8433774|NCT00837096|20785061|P1|STARTED|Overall Study||10
8433775|NCT00837031|20785067|P1|NOT COMPLETED|Overall Study||0
8433776|NCT00837031|20785067|P1|COMPLETED|Overall Study||72
8433777|NCT00837031|20785067|P1|STARTED|Overall Study||72
8433778|NCT00836953|20785073|P1|NOT COMPLETED|Overall Study||2
8433779|NCT00836953|20785073|P1|COMPLETED|Overall Study||31
8433780|NCT00836953|20785073|P1|STARTED|Overall Study||33
8433781|NCT00836927|20785084|P5|NOT COMPLETED|Overall Study||1
8433782|NCT00836927|20785085|P4|NOT COMPLETED|Overall Study||1
8433783|NCT00836927|20785086|P3|NOT COMPLETED|Overall Study||0
8433784|NCT00836927|20785087|P2|NOT COMPLETED|Overall Study||0
8433785|NCT00836927|20785088|P1|NOT COMPLETED|Overall Study||3
8433786|NCT00836927|20785084|P5|COMPLETED|Overall Study||0
8433787|NCT00836927|20785085|P4|COMPLETED|Overall Study||0
8433788|NCT00836927|20785086|P3|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
8433789|NCT00836927|20785087|P2|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
8433790|NCT00836927|20785088|P1|COMPLETED|Overall Study||0
8433791|NCT00836927|20785084|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
8433792|NCT00836927|20785085|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
8433793|NCT00836927|20785086|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
8433794|NCT00836927|20785087|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
8433795|NCT00836927|20785088|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
8433796|NCT00836927|20785084|P5|STARTED|Overall Study||1
8433797|NCT00836927|20785085|P4|STARTED|Overall Study||1
8433798|NCT00836927|20785086|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
8433799|NCT00836927|20785087|P2|STARTED|Overall Study||1
8433800|NCT00836927|20785088|P1|STARTED|Overall Study||3
8433801|NCT00836901|20785124|P2|NOT COMPLETED|Second Intervention||0
8433802|NCT00836901|20785125|P1|NOT COMPLETED|Second Intervention||0
8433803|NCT00836901|20785124|P2|COMPLETED|Second Intervention||28
8433804|NCT00836901|20785125|P1|COMPLETED|Second Intervention||23
8433805|NCT00836901|20785124|P2|STARTED|Second Intervention||28
8433806|NCT00836901|20785125|P1|STARTED|Second Intervention||23
8433807|NCT00836901|20785124|P2|NOT COMPLETED|First Intervention||0
8433808|NCT00836901|20785125|P1|NOT COMPLETED|First Intervention||1
8433809|NCT00836901|20785124|P2|COMPLETED|First Intervention||28
8433810|NCT00836901|20785125|P1|COMPLETED|First Intervention||23
8433811|NCT00836901|20785124|P2|STARTED|First Intervention||28
8433812|NCT00836901|20785125|P1|STARTED|First Intervention||24
8433813|NCT00836888|20785143|P4|NOT COMPLETED|Overall Study||3
8433814|NCT00836888|20785144|P3|NOT COMPLETED|Overall Study||6
8433815|NCT00836888|20785145|P2|NOT COMPLETED|Overall Study||3
8433816|NCT00836888|20785146|P1|NOT COMPLETED|Overall Study||3
8433817|NCT00836888|20785143|P4|COMPLETED|Overall Study||0
8433818|NCT00836888|20785144|P3|COMPLETED|Overall Study||0
8433819|NCT00836888|20785145|P2|COMPLETED|Overall Study||2
8433820|NCT00836888|20785146|P1|COMPLETED|Overall Study||0
8433821|NCT00836888|20785143|P4|STARTED|Overall Study||3
8433822|NCT00836888|20785144|P3|STARTED|Overall Study||6
8433823|NCT00836888|20785145|P2|STARTED|Overall Study||5
8433824|NCT00836888|20785146|P1|STARTED|Overall Study||3
8433825|NCT00836875|20785174|P2|NOT COMPLETED|Overall Study||3
8433826|NCT00836875|20785175|P1|NOT COMPLETED|Overall Study||3
8433827|NCT00836875|20785174|P2|COMPLETED|Overall Study||17
8433828|NCT00836875|20785175|P1|COMPLETED|Overall Study||8
8433829|NCT00836875|20785174|P2|STARTED|Overall Study||20
8433830|NCT00836875|20785175|P1|STARTED|Overall Study||11
8433831|NCT00836810|20785191|P2|NOT COMPLETED|Overall Study||0
8433832|NCT00836810|20785192|P1|NOT COMPLETED|Overall Study||1
8433833|NCT00836810|20785191|P2|COMPLETED|Overall Study||6
8433834|NCT00836810|20785192|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
8433835|NCT00836810|20785191|P2|STARTED|Overall Study||6
8433836|NCT00836810|20785192|P1|STARTED|Overall Study||5
8433837|NCT00836758|20785208|P1|NOT COMPLETED|Overall Study||0
8433838|NCT00836758|20785208|P1|COMPLETED|Overall Study||115
8433839|NCT00836758|20785208|P1|STARTED|Overall Study||115
8433840|NCT00836745|20785214|P1|NOT COMPLETED|Overall Study||21
8433841|NCT00836745|20785214|P1|COMPLETED|Overall Study||15
8433842|NCT00836745|20785214|P1|STARTED|Overall Study||36
8433843|NCT00836719|20785221|P1|NOT COMPLETED|Overall Study||0
8433844|NCT00836719|20785221|P1|COMPLETED|Overall Study||10
8433845|NCT00836719|20785221|P1|STARTED|Overall Study||10
8433846|NCT00836706|20785228|P2|NOT COMPLETED|Second Intervention||0
8433847|NCT00836706|20785229|P1|NOT COMPLETED|Second Intervention||0
8433848|NCT00836706|20785228|P2|COMPLETED|Second Intervention||11
8433849|NCT00836706|20785229|P1|COMPLETED|Second Intervention||11
8433850|NCT00836706|20785228|P2|STARTED|Second Intervention||11
8433851|NCT00836706|20785229|P1|STARTED|Second Intervention||11
8433852|NCT00836706|20785228|P2|NOT COMPLETED|Washout: 7 Days||1
8433853|NCT00836706|20785229|P1|NOT COMPLETED|Washout: 7 Days||0
8433854|NCT00836706|20785228|P2|COMPLETED|Washout: 7 Days||11
8433855|NCT00836706|20785229|P1|COMPLETED|Washout: 7 Days||11
8433856|NCT00836706|20785228|P2|STARTED|Washout: 7 Days||12
8433857|NCT00836706|20785229|P1|STARTED|Washout: 7 Days||11
8433858|NCT00836706|20785228|P2|NOT COMPLETED|First Intervention||0
8433859|NCT00836706|20785229|P1|NOT COMPLETED|First Intervention||0
8433860|NCT00836706|20785228|P2|COMPLETED|First Intervention||12
8433861|NCT00836706|20785229|P1|COMPLETED|First Intervention||11
8433862|NCT00836706|20785228|P2|STARTED|First Intervention||12
8433863|NCT00836706|20785229|P1|STARTED|First Intervention||11
8433864|NCT00836693|20785239|P2|NOT COMPLETED|Overall Study||6
8433865|NCT00836693|20785240|P1|NOT COMPLETED|Overall Study||17
8433866|NCT00836693|20785239|P2|COMPLETED|Overall Study||64
8433867|NCT00836693|20785240|P1|COMPLETED|Overall Study||130
8433868|NCT00836693|20785239|P2|STARTED|Overall Study||70
8433869|NCT00836693|20785240|P1|STARTED|Overall Study||147
8433870|NCT00836641|20785282|P2|NOT COMPLETED|Overall Study||0
8433871|NCT00836641|20785283|P1|NOT COMPLETED|Overall Study||0
8433872|NCT00836641|20785282|P2|COMPLETED|Overall Study||34
8433873|NCT00836641|20785283|P1|COMPLETED|Overall Study||36
8433874|NCT00836641|20785282|P2|STARTED|Overall Study||34
8433875|NCT00836641|20785283|P1|STARTED|Overall Study||36
8433876|NCT00836589|20785290|P1|NOT COMPLETED|Overall Study||1266
8433877|NCT00836589|20785290|P1|COMPLETED|Overall Study||731
8433878|NCT00836589|20785290|P1|STARTED|Overall Study||1997
8433879|NCT00836498|20785323|P2|NOT COMPLETED|Overall Study||1
8433880|NCT00836498|20785324|P1|NOT COMPLETED|Overall Study||4
8433881|NCT00836498|20785323|P2|COMPLETED|Overall Study||21
8433882|NCT00836498|20785324|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
8433883|NCT00836498|20785323|P2|STARTED|Overall Study||22
8433884|NCT00836498|20785324|P1|STARTED|Overall Study||44
8433885|NCT00836472|20785356|P2|NOT COMPLETED|Second Intervention||0
8433886|NCT00836472|20785357|P1|NOT COMPLETED|Second Intervention||0
8433887|NCT00836472|20785356|P2|COMPLETED|Second Intervention||27
8433888|NCT00836472|20785357|P1|COMPLETED|Second Intervention||28
8433889|NCT00836472|20785356|P2|STARTED|Second Intervention||27
8433890|NCT00836472|20785357|P1|STARTED|Second Intervention||28
8433891|NCT00836472|20785356|P2|NOT COMPLETED|Washout||3
8433892|NCT00836472|20785357|P1|NOT COMPLETED|Washout||2
8433893|NCT00836472|20785356|P2|COMPLETED|Washout||27
8433894|NCT00836472|20785357|P1|COMPLETED|Washout||28
8433895|NCT00836472|20785356|P2|STARTED|Washout||30
8433896|NCT00836472|20785357|P1|STARTED|Washout||30
8433897|NCT00836472|20785356|P2|NOT COMPLETED|First Intervention||0
8433898|NCT00836472|20785357|P1|NOT COMPLETED|First Intervention||0
8433899|NCT00836472|20785356|P2|COMPLETED|First Intervention||30
8433900|NCT00836472|20785357|P1|COMPLETED|First Intervention||30
8433901|NCT00836472|20785356|P2|STARTED|First Intervention||30
8433902|NCT00836472|20785357|P1|STARTED|First Intervention||30
8433903|NCT00836433|20785373|P2|NOT COMPLETED|Overall Study||7
8433904|NCT00836433|20785374|P1|NOT COMPLETED|Overall Study||12
8433905|NCT00836433|20785373|P2|COMPLETED|Overall Study||321
8433906|NCT00836433|20785374|P1|COMPLETED|Overall Study||349
8433907|NCT00836433|20785373|P2|STARTED|Overall Study||328
8433908|NCT00836433|20785374|P1|STARTED|Overall Study||361
8433909|NCT00836407|20785384|P2|NOT COMPLETED|Overall Study||8
8433910|NCT00836407|20785385|P1|NOT COMPLETED|Overall Study||11
8433911|NCT00836407|20785384|P2|COMPLETED|Overall Study||7
8433912|NCT00836407|20785385|P1|COMPLETED|Overall Study||4
8433913|NCT00836407|20785384|P2|STARTED|Overall Study||15
8433914|NCT00836407|20785385|P1|STARTED|Overall Study||15
8433915|NCT00836355|20785397|P4|NOT COMPLETED|Overall Study||0
8433916|NCT00836355|20785398|P3|NOT COMPLETED|Overall Study||0
8433917|NCT00836355|20785399|P2|NOT COMPLETED|Overall Study||0
8433918|NCT00836355|20785400|P1|NOT COMPLETED|Overall Study||0
8433919|NCT00836355|20785397|P4|COMPLETED|Overall Study||2
8433920|NCT00836355|20785398|P3|COMPLETED|Overall Study||0
8433921|NCT00836355|20785399|P2|COMPLETED|Overall Study||4
8433922|NCT00836355|20785400|P1|COMPLETED|Overall Study||0
8433923|NCT00836355|20785397|P4|STARTED|Overall Study||2
8433924|NCT00836355|20785398|P3|STARTED|Overall Study||0
8433925|NCT00836355|20785399|P2|STARTED|Overall Study||4
8433926|NCT00836355|20785400|P1|STARTED|Overall Study||0
8433927|NCT00836342|20785421|P3|NOT COMPLETED|Overall Study||0
8433928|NCT00836342|20785422|P2|NOT COMPLETED|Overall Study||0
8433929|NCT00836342|20785423|P1|NOT COMPLETED|Overall Study||0
8433930|NCT00836342|20785421|P3|COMPLETED|Overall Study||36
8433931|NCT00836342|20785422|P2|COMPLETED|Overall Study||23
8433932|NCT00836342|20785423|P1|COMPLETED|Overall Study||22
8433933|NCT00836342|20785421|P3|STARTED|Overall Study||36
8433934|NCT00836342|20785422|P2|STARTED|Overall Study||23
8433935|NCT00836342|20785423|P1|STARTED|Overall Study||22
8433936|NCT00836277|20785434|P1|NOT COMPLETED|Overall Study||6
8433937|NCT00836277|20785434|P1|COMPLETED|Overall Study||18
8433938|NCT00836277|20785434|P1|STARTED|Overall Study||24
8433939|NCT00836186|20785442|P1|NOT COMPLETED|Overall Study||1
8433940|NCT00836186|20785442|P1|COMPLETED|Overall Study||81
8433941|NCT00836186|20785442|P1|STARTED|Overall Study||82
8433942|NCT00836095|20785450|P2|NOT COMPLETED|Overall Study||3
8433943|NCT00836095|20785451|P1|NOT COMPLETED|Overall Study||0
8433944|NCT00836095|20785450|P2|COMPLETED|Overall Study||27
8433945|NCT00836095|20785451|P1|COMPLETED|Overall Study||22
8433946|NCT00836095|20785450|P2|STARTED|Overall Study||30
8433947|NCT00836095|20785451|P1|STARTED|Overall Study||22
8433948|NCT00836056|20785461|P2|NOT COMPLETED|Second Intervention||0
8433949|NCT00836056|20785462|P1|NOT COMPLETED|Second Intervention||0
8433950|NCT00836056|20785461|P2|COMPLETED|Second Intervention||12
8433951|NCT00836056|20785462|P1|COMPLETED|Second Intervention||11
8433952|NCT00836056|20785461|P2|STARTED|Second Intervention||12
8433953|NCT00836056|20785462|P1|STARTED|Second Intervention||11
8433954|NCT00836056|20785461|P2|NOT COMPLETED|Washout: 7 Days||0
8433955|NCT00836056|20785462|P1|NOT COMPLETED|Washout: 7 Days||0
8433956|NCT00836056|20785461|P2|COMPLETED|Washout: 7 Days||12
8433957|NCT00836056|20785462|P1|COMPLETED|Washout: 7 Days||11
8433958|NCT00836056|20785461|P2|STARTED|Washout: 7 Days||12
8433959|NCT00836056|20785462|P1|STARTED|Washout: 7 Days||11
8433960|NCT00836056|20785461|P2|NOT COMPLETED|First Intervention||0
8433961|NCT00836056|20785462|P1|NOT COMPLETED|First Intervention||1
8433962|NCT00836056|20785461|P2|COMPLETED|First Intervention||12
8433963|NCT00836056|20785462|P1|COMPLETED|First Intervention||11
8433964|NCT00836056|20785461|P2|STARTED|First Intervention||12
8433965|NCT00836056|20785462|P1|STARTED|First Intervention||12
8433966|NCT00836017|20785470|P1|NOT COMPLETED|Overall Study||544
8433967|NCT00836017|20785470|P1|COMPLETED|Overall Study||502
8433968|NCT00836017|20785470|P1|STARTED|Overall Study||1046
8433969|NCT00836004|20785480|P2|NOT COMPLETED|Second Intervention||0
8433970|NCT00836004|20785481|P1|NOT COMPLETED|Second Intervention||0
8433971|NCT00836004|20785480|P2|COMPLETED|Second Intervention||12
8433972|NCT00836004|20785481|P1|COMPLETED|Second Intervention||12
8433973|NCT00836004|20785480|P2|STARTED|Second Intervention||12
8433974|NCT00836004|20785481|P1|STARTED|Second Intervention||12
8433975|NCT00836004|20785480|P2|NOT COMPLETED|Washout: 7 Days||0
8433976|NCT00836004|20785481|P1|NOT COMPLETED|Washout: 7 Days||0
8433977|NCT00836004|20785480|P2|COMPLETED|Washout: 7 Days||12
8433978|NCT00836004|20785481|P1|COMPLETED|Washout: 7 Days||12
8433979|NCT00836004|20785480|P2|STARTED|Washout: 7 Days||12
8433980|NCT00836004|20785481|P1|STARTED|Washout: 7 Days||12
8433981|NCT00836004|20785480|P2|NOT COMPLETED|First Intervention||0
8433982|NCT00836004|20785481|P1|NOT COMPLETED|First Intervention||0
8433983|NCT00836004|20785480|P2|COMPLETED|First Intervention||12
8433984|NCT00836004|20785481|P1|COMPLETED|First Intervention||12
8433985|NCT00836004|20785480|P2|STARTED|First Intervention||12
8433986|NCT00836004|20785481|P1|STARTED|First Intervention||12
8433987|NCT00835991|20785491|P2|NOT COMPLETED|Second Intervention||0
8433988|NCT00835991|20785492|P1|NOT COMPLETED|Second Intervention||0
8433989|NCT00835991|20785491|P2|COMPLETED|Second Intervention||26
8433990|NCT00835991|20785492|P1|COMPLETED|Second Intervention||27
8433991|NCT00835991|20785491|P2|STARTED|Second Intervention||26
8433992|NCT00835991|20785492|P1|STARTED|Second Intervention||27
8433993|NCT00835991|20785491|P2|NOT COMPLETED|Washout||3
8433994|NCT00835991|20785492|P1|NOT COMPLETED|Washout||3
8433995|NCT00835991|20785491|P2|COMPLETED|Washout||26
8433996|NCT00835991|20785492|P1|COMPLETED|Washout||27
8433997|NCT00835991|20785491|P2|STARTED|Washout||29
8433998|NCT00835991|20785492|P1|STARTED|Washout||30
8433999|NCT00835991|20785491|P2|NOT COMPLETED|First Intervention||1
8434000|NCT00835991|20785492|P1|NOT COMPLETED|First Intervention||0
8434001|NCT00835991|20785491|P2|COMPLETED|First Intervention||29
8434002|NCT00835991|20785492|P1|COMPLETED|First Intervention||30
8434003|NCT00835991|20785491|P2|STARTED|First Intervention||30
8434004|NCT00835991|20785492|P1|STARTED|First Intervention||30
8434005|NCT00835978|20785510|P4|NOT COMPLETED|Overall Study||10
8434006|NCT00835978|20785511|P3|NOT COMPLETED|Overall Study||91
8434007|NCT00835978|20785512|P2|NOT COMPLETED|Overall Study||56
8434008|NCT00835978|20785513|P1|NOT COMPLETED|Overall Study||56
8434100|NCT00835679|20785786|P3|NOT COMPLETED|Overall Study||0
8434009|NCT00835978|20785510|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434010|NCT00835978|20785511|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434011|NCT00835978|20785512|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434012|NCT00835978|20785513|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434013|NCT00835978|20785510|P4|Treated|Overall Study||10
8434014|NCT00835978|20785511|P3|Treated|Overall Study||91
8434015|NCT00835978|20785512|P2|Treated|Overall Study||56
8434016|NCT00835978|20785513|P1|Treated|Overall Study||56
8434017|NCT00835978|20785510|P4|STARTED|Overall Study||10
8434018|NCT00835978|20785511|P3|STARTED|Overall Study||91
8434019|NCT00835978|20785512|P2|STARTED|Overall Study||56
8434020|NCT00835978|20785513|P1|STARTED|Overall Study||56
8434021|NCT00835926|20785573|P2|NOT COMPLETED|Overall Study||0
8434022|NCT00835926|20785574|P1|NOT COMPLETED|Overall Study||0
8434023|NCT00835926|20785573|P2|COMPLETED|Overall Study||60
8434024|NCT00835926|20785574|P1|COMPLETED|Overall Study||61
8434025|NCT00835926|20785573|P2|STARTED|Overall Study||60
8434026|NCT00835926|20785574|P1|STARTED|Overall Study||61
8434027|NCT00835900|20785588|P2|NOT COMPLETED|Overall Study||6
8434028|NCT00835900|20785589|P1|NOT COMPLETED|Overall Study||5
8434029|NCT00835900|20785588|P2|COMPLETED|Overall Study||22
8434030|NCT00835900|20785589|P1|COMPLETED|Overall Study||27
8434031|NCT00835900|20785588|P2|STARTED|Overall Study||28
8434032|NCT00835900|20785589|P1|STARTED|Overall Study||32
8434033|NCT00835861|20785599|P2|NOT COMPLETED|Overall Study||2
8434034|NCT00835861|20785600|P1|NOT COMPLETED|Overall Study||1
8434035|NCT00835861|20785599|P2|COMPLETED|Overall Study||14
8434036|NCT00835861|20785600|P1|COMPLETED|Overall Study||14
8434037|NCT00835861|20785599|P2|STARTED|Overall Study||16
8434038|NCT00835861|20785600|P1|STARTED|Overall Study||15
8434039|NCT00835796|20785624|P2|NOT COMPLETED|Second Intervention||0
8434040|NCT00835796|20785625|P1|NOT COMPLETED|Second Intervention||0
8434041|NCT00835796|20785624|P2|COMPLETED|Second Intervention||9
8434042|NCT00835796|20785625|P1|COMPLETED|Second Intervention||10
8434043|NCT00835796|20785624|P2|STARTED|Second Intervention||9
8434044|NCT00835796|20785625|P1|STARTED|Second Intervention||10
8434045|NCT00835796|20785624|P2|NOT COMPLETED|Washout||0
8434046|NCT00835796|20785625|P1|NOT COMPLETED|Washout||0
8434047|NCT00835796|20785624|P2|COMPLETED|Washout||9
8434048|NCT00835796|20785625|P1|COMPLETED|Washout||10
8434049|NCT00835796|20785624|P2|STARTED|Washout||9
8434050|NCT00835796|20785625|P1|STARTED|Washout||10
8434051|NCT00835796|20785624|P2|NOT COMPLETED|First Intervention||1
8434052|NCT00835796|20785625|P1|NOT COMPLETED|First Intervention||0
8434053|NCT00835796|20785624|P2|COMPLETED|First Intervention||9
8434054|NCT00835796|20785625|P1|COMPLETED|First Intervention||10
8434055|NCT00835796|20785624|P2|STARTED|First Intervention||10
8434056|NCT00835796|20785625|P1|STARTED|First Intervention||10
8434057|NCT00835770|20785635|P2|NOT COMPLETED|Overall Study||493
8434058|NCT00835770|20785636|P1|NOT COMPLETED|Overall Study||484
8434059|NCT00835770|20785635|P2|COMPLETED|Overall Study||375
8434060|NCT00835770|20785636|P1|COMPLETED|Overall Study||384
8434061|NCT00835770|20785635|P2|STARTED|Overall Study||868
8434062|NCT00835770|20785636|P1|STARTED|Overall Study||868
8434063|NCT00835731|20785734|P2|NOT COMPLETED|Overall Study||1
8434064|NCT00835731|20785735|P1|NOT COMPLETED|Overall Study||2
8434065|NCT00835731|20785734|P2|COMPLETED|Overall Study||60
8434066|NCT00835731|20785735|P1|COMPLETED|Overall Study||62
8434067|NCT00835731|20785734|P2|STARTED|Overall Study||61
8434068|NCT00835731|20785735|P1|STARTED|Overall Study||64
8434069|NCT00835705|20785755|P2|NOT COMPLETED|Second Intervention||0
8434070|NCT00835705|20785756|P1|NOT COMPLETED|Second Intervention||1
8434071|NCT00835705|20785755|P2|COMPLETED|Second Intervention||28
8434072|NCT00835705|20785756|P1|COMPLETED|Second Intervention||22
8434073|NCT00835705|20785755|P2|STARTED|Second Intervention||28
8434074|NCT00835705|20785756|P1|STARTED|Second Intervention||23
8434075|NCT00835705|20785755|P2|NOT COMPLETED|First Intervention||0
8434076|NCT00835705|20785756|P1|NOT COMPLETED|First Intervention||1
8434077|NCT00835705|20785755|P2|COMPLETED|First Intervention||28
8434078|NCT00835705|20785756|P1|COMPLETED|First Intervention||23
8434079|NCT00835705|20785755|P2|STARTED|First Intervention||28
8434080|NCT00835705|20785756|P1|STARTED|First Intervention||24
8434081|NCT00835692|20785772|P2|NOT COMPLETED|Second Intervention||0
8434082|NCT00835692|20785773|P1|NOT COMPLETED|Second Intervention||0
8434083|NCT00835692|20785772|P2|COMPLETED|Second Intervention||28
8434084|NCT00835692|20785773|P1|COMPLETED|Second Intervention||27
8434085|NCT00835692|20785772|P2|STARTED|Second Intervention||28
8434086|NCT00835692|20785773|P1|STARTED|Second Intervention||27
8434087|NCT00835692|20785772|P2|NOT COMPLETED|Washout||0
8434088|NCT00835692|20785773|P1|NOT COMPLETED|Washout||0
8434089|NCT00835692|20785772|P2|COMPLETED|Washout||28
8434090|NCT00835692|20785773|P1|COMPLETED|Washout||27
8434091|NCT00835692|20785772|P2|STARTED|Washout||28
8434092|NCT00835692|20785773|P1|STARTED|Washout||27
8434093|NCT00835692|20785772|P2|NOT COMPLETED|First Intervention||0
8434094|NCT00835692|20785773|P1|NOT COMPLETED|First Intervention||1
8434095|NCT00835692|20785772|P2|COMPLETED|First Intervention||28
8434096|NCT00835692|20785773|P1|COMPLETED|First Intervention||27
8434097|NCT00835692|20785772|P2|STARTED|First Intervention||28
8434098|NCT00835692|20785773|P1|STARTED|First Intervention||28
8434099|NCT00835679|20785785|P4|NOT COMPLETED|Overall Study||0
8434101|NCT00835679|20785787|P2|NOT COMPLETED|Overall Study||0
8434102|NCT00835679|20785788|P1|NOT COMPLETED|Overall Study||1
8434103|NCT00835679|20785785|P4|COMPLETED|Overall Study||0
8434104|NCT00835679|20785786|P3|COMPLETED|Overall Study||0
8434105|NCT00835679|20785787|P2|COMPLETED|Overall Study||0
8434106|NCT00835679|20785788|P1|COMPLETED|Overall Study||8
8434107|NCT00835679|20785785|P4|STARTED|Overall Study||0
8434108|NCT00835679|20785786|P3|STARTED|Overall Study||0
8434109|NCT00835679|20785787|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
8434110|NCT00835679|20785788|P1|STARTED|Overall Study||9
8434111|NCT00835666|20785812|P2|NOT COMPLETED|Second Intervention||0
8434112|NCT00835666|20785813|P1|NOT COMPLETED|Second Intervention||0
8434113|NCT00835666|20785812|P2|COMPLETED|Second Intervention||16
8434114|NCT00835666|20785813|P1|COMPLETED|Second Intervention||14
8434115|NCT00835666|20785812|P2|STARTED|Second Intervention||16
8434116|NCT00835666|20785813|P1|STARTED|Second Intervention||14
8434117|NCT00835666|20785812|P2|NOT COMPLETED|Washout||0
8434118|NCT00835666|20785813|P1|NOT COMPLETED|Washout||2
8434119|NCT00835666|20785812|P2|COMPLETED|Washout||16
8434120|NCT00835666|20785813|P1|COMPLETED|Washout||14
8434121|NCT00835666|20785812|P2|STARTED|Washout||16
8434122|NCT00835666|20785813|P1|STARTED|Washout||16
8434123|NCT00835666|20785812|P2|NOT COMPLETED|First Intervention||0
8434124|NCT00835666|20785813|P1|NOT COMPLETED|First Intervention||0
8434125|NCT00835666|20785812|P2|COMPLETED|First Intervention||16
8434126|NCT00835666|20785813|P1|COMPLETED|First Intervention||16
8434127|NCT00835666|20785812|P2|STARTED|First Intervention||16
8434128|NCT00835666|20785813|P1|STARTED|First Intervention||16
8434129|NCT00835640|20785823|P2|NOT COMPLETED|Second Intervention||0
8434130|NCT00835640|20785824|P1|NOT COMPLETED|Second Intervention||1
8434131|NCT00835640|20785823|P2|COMPLETED|Second Intervention||12
8434132|NCT00835640|20785824|P1|COMPLETED|Second Intervention||11
8434133|NCT00835640|20785823|P2|STARTED|Second Intervention||12
8434134|NCT00835640|20785824|P1|STARTED|Second Intervention||12
8434135|NCT00835640|20785823|P2|NOT COMPLETED|Washout of 7 Days||0
8434136|NCT00835640|20785824|P1|NOT COMPLETED|Washout of 7 Days||0
8434137|NCT00835640|20785823|P2|COMPLETED|Washout of 7 Days||12
8434138|NCT00835640|20785824|P1|COMPLETED|Washout of 7 Days||12
8434139|NCT00835640|20785823|P2|STARTED|Washout of 7 Days||12
8434140|NCT00835640|20785824|P1|STARTED|Washout of 7 Days||12
8434141|NCT00835640|20785823|P2|NOT COMPLETED|First Intervention||0
8434142|NCT00835640|20785824|P1|NOT COMPLETED|First Intervention||0
8434143|NCT00835640|20785823|P2|COMPLETED|First Intervention||12
8434144|NCT00835640|20785824|P1|COMPLETED|First Intervention||12
8434145|NCT00835640|20785823|P2|STARTED|First Intervention||12
8434146|NCT00835640|20785824|P1|STARTED|First Intervention||12
8434147|NCT00835614|20785834|P2|NOT COMPLETED|Second Intervention||0
8434148|NCT00835614|20785835|P1|NOT COMPLETED|Second Intervention||0
8434149|NCT00835614|20785834|P2|COMPLETED|Second Intervention||13
8434150|NCT00835614|20785835|P1|COMPLETED|Second Intervention||13
8434151|NCT00835614|20785834|P2|STARTED|Second Intervention||13
8434152|NCT00835614|20785835|P1|STARTED|Second Intervention||13
8434153|NCT00835614|20785834|P2|NOT COMPLETED|Washout of 7 Days||0
8434154|NCT00835614|20785835|P1|NOT COMPLETED|Washout of 7 Days||0
8434155|NCT00835614|20785834|P2|COMPLETED|Washout of 7 Days||13
8434156|NCT00835614|20785835|P1|COMPLETED|Washout of 7 Days||13
8434157|NCT00835614|20785834|P2|STARTED|Washout of 7 Days||13
8434158|NCT00835614|20785835|P1|STARTED|Washout of 7 Days||13
8434159|NCT00835614|20785834|P2|NOT COMPLETED|First Intervention||0
8434160|NCT00835614|20785835|P1|NOT COMPLETED|First Intervention||0
8434161|NCT00835614|20785834|P2|COMPLETED|First Intervention||13
8434162|NCT00835614|20785835|P1|COMPLETED|First Intervention||13
8434163|NCT00835614|20785834|P2|STARTED|First Intervention||13
8434164|NCT00835614|20785835|P1|STARTED|First Intervention||13
8434165|NCT00835588|20785845|P2|NOT COMPLETED|Second Intervention||0
8434166|NCT00835588|20785846|P1|NOT COMPLETED|Second Intervention||0
8434167|NCT00835588|20785845|P2|COMPLETED|Second Intervention||50
8434168|NCT00835588|20785846|P1|COMPLETED|Second Intervention||50
8434169|NCT00835588|20785845|P2|STARTED|Second Intervention||50
8434170|NCT00835588|20785846|P1|STARTED|Second Intervention||50
8434171|NCT00835588|20785845|P2|NOT COMPLETED|Washout: 5 Days||0
8434172|NCT00835588|20785846|P1|NOT COMPLETED|Washout: 5 Days||0
8434173|NCT00835588|20785845|P2|COMPLETED|Washout: 5 Days||50
8434174|NCT00835588|20785846|P1|COMPLETED|Washout: 5 Days||50
8434175|NCT00835588|20785845|P2|STARTED|Washout: 5 Days||50
8434176|NCT00835588|20785846|P1|STARTED|Washout: 5 Days||50
8434177|NCT00835588|20785845|P2|NOT COMPLETED|First Intervention||0
8434178|NCT00835588|20785846|P1|NOT COMPLETED|First Intervention||0
8434179|NCT00835588|20785845|P2|COMPLETED|First Intervention||50
8434180|NCT00835588|20785846|P1|COMPLETED|First Intervention||50
8434181|NCT00835588|20785845|P2|STARTED|First Intervention||50
8434182|NCT00835588|20785846|P1|STARTED|First Intervention||50
8434183|NCT00835575|20785856|P2|NOT COMPLETED|Second Intervention||0
8434184|NCT00835575|20785857|P1|NOT COMPLETED|Second Intervention||0
8434185|NCT00835575|20785856|P2|COMPLETED|Second Intervention||16
8434186|NCT00835575|20785857|P1|COMPLETED|Second Intervention||15
8434187|NCT00835575|20785856|P2|STARTED|Second Intervention||16
8434188|NCT00835575|20785857|P1|STARTED|Second Intervention||15
8434189|NCT00835575|20785856|P2|NOT COMPLETED|Washout of 14 Days||0
8434190|NCT00835575|20785857|P1|NOT COMPLETED|Washout of 14 Days||1
8434191|NCT00835575|20785856|P2|COMPLETED|Washout of 14 Days||16
8434192|NCT00835575|20785857|P1|COMPLETED|Washout of 14 Days||15
8434193|NCT00835575|20785856|P2|STARTED|Washout of 14 Days||16
8434194|NCT00835575|20785857|P1|STARTED|Washout of 14 Days||16
8434195|NCT00835575|20785856|P2|NOT COMPLETED|First Intervention||0
8434196|NCT00835575|20785857|P1|NOT COMPLETED|First Intervention||0
8434197|NCT00835575|20785856|P2|COMPLETED|First Intervention||16
8434198|NCT00835575|20785857|P1|COMPLETED|First Intervention||16
8434199|NCT00835575|20785856|P2|STARTED|First Intervention||16
8434200|NCT00835575|20785857|P1|STARTED|First Intervention||16
8434201|NCT00835549|20785867|P2|NOT COMPLETED|Second Intervention||0
8434202|NCT00835549|20785868|P1|NOT COMPLETED|Second Intervention||0
8434203|NCT00835549|20785867|P2|COMPLETED|Second Intervention||16
8434204|NCT00835549|20785868|P1|COMPLETED|Second Intervention||14
8434205|NCT00835549|20785867|P2|STARTED|Second Intervention||16
8434206|NCT00835549|20785868|P1|STARTED|Second Intervention||14
8434207|NCT00835549|20785867|P2|NOT COMPLETED|Washout of 7 Days||0
8434208|NCT00835549|20785868|P1|NOT COMPLETED|Washout of 7 Days||2
8434209|NCT00835549|20785867|P2|COMPLETED|Washout of 7 Days||16
8434210|NCT00835549|20785868|P1|COMPLETED|Washout of 7 Days||14
8434211|NCT00835549|20785867|P2|STARTED|Washout of 7 Days||16
8434212|NCT00835549|20785868|P1|STARTED|Washout of 7 Days||16
8434213|NCT00835549|20785867|P2|NOT COMPLETED|First Intervention||0
8434214|NCT00835549|20785868|P1|NOT COMPLETED|First Intervention||0
8434215|NCT00835549|20785867|P2|COMPLETED|First Intervention||16
8434216|NCT00835549|20785868|P1|COMPLETED|First Intervention||16
8434217|NCT00835549|20785867|P2|STARTED|First Intervention||16
8434218|NCT00835549|20785868|P1|STARTED|First Intervention||16
8434219|NCT00835536|20785878|P2|NOT COMPLETED|Second Intervention||0
8434220|NCT00835536|20785879|P1|NOT COMPLETED|Second Intervention||0
8434221|NCT00835536|20785878|P2|COMPLETED|Second Intervention||14
8434222|NCT00835536|20785879|P1|COMPLETED|Second Intervention||12
8434223|NCT00835536|20785878|P2|STARTED|Second Intervention||14
8434224|NCT00835536|20785879|P1|STARTED|Second Intervention||12
8434225|NCT00835536|20785878|P2|NOT COMPLETED|Washout of 5 Weeks||0
8434226|NCT00835536|20785879|P1|NOT COMPLETED|Washout of 5 Weeks||1
8434227|NCT00835536|20785878|P2|COMPLETED|Washout of 5 Weeks||14
8434228|NCT00835536|20785879|P1|COMPLETED|Washout of 5 Weeks||12
8434229|NCT00835536|20785878|P2|STARTED|Washout of 5 Weeks||14
8434230|NCT00835536|20785879|P1|STARTED|Washout of 5 Weeks||13
8434231|NCT00835536|20785878|P2|NOT COMPLETED|First Intervention||0
8434232|NCT00835536|20785879|P1|NOT COMPLETED|First Intervention||0
8434233|NCT00835536|20785878|P2|COMPLETED|First Intervention||14
8434234|NCT00835536|20785879|P1|COMPLETED|First Intervention||13
8434235|NCT00835536|20785878|P2|STARTED|First Intervention||14
8434236|NCT00835536|20785879|P1|STARTED|First Intervention||13
8434237|NCT00835510|20785888|P3|NOT COMPLETED|Overall Study||38
8434238|NCT00835510|20785889|P2|NOT COMPLETED|Overall Study||69
8434239|NCT00835510|20785890|P1|NOT COMPLETED|Overall Study||76
8434240|NCT00835510|20785888|P3|COMPLETED|Overall Study||70
8434241|NCT00835510|20785889|P2|COMPLETED|Overall Study||152
8434242|NCT00835510|20785890|P1|COMPLETED|Overall Study||143
8434243|NCT00835510|20785888|P3|Positive Fungal Culture|Overall Study||71
8434244|NCT00835510|20785889|P2|Positive Fungal Culture|Overall Study||155
8434245|NCT00835510|20785890|P1|Positive Fungal Culture|Overall Study||149
8434246|NCT00835510|20785888|P3|STARTED|Overall Study||108
8434247|NCT00835510|20785889|P2|STARTED|Overall Study||221
8434248|NCT00835510|20785890|P1|STARTED|Overall Study||219
8434249|NCT00835497|20785912|P2|NOT COMPLETED|Second Intervention||0
8434250|NCT00835497|20785913|P1|NOT COMPLETED|Second Intervention||0
8434251|NCT00835497|20785912|P2|COMPLETED|Second Intervention||20
8434252|NCT00835497|20785913|P1|COMPLETED|Second Intervention||20
8434253|NCT00835497|20785912|P2|STARTED|Second Intervention||20
8434254|NCT00835497|20785913|P1|STARTED|Second Intervention||20
8434255|NCT00835497|20785912|P2|NOT COMPLETED|Washout: 7 Days||0
8434256|NCT00835497|20785913|P1|NOT COMPLETED|Washout: 7 Days||0
8434257|NCT00835497|20785912|P2|COMPLETED|Washout: 7 Days||20
8434258|NCT00835497|20785913|P1|COMPLETED|Washout: 7 Days||20
8434259|NCT00835497|20785912|P2|STARTED|Washout: 7 Days||20
8434260|NCT00835497|20785913|P1|STARTED|Washout: 7 Days||20
8434261|NCT00835497|20785912|P2|NOT COMPLETED|First Intervention||0
8434262|NCT00835497|20785913|P1|NOT COMPLETED|First Intervention||0
8434263|NCT00835497|20785912|P2|COMPLETED|First Intervention||20
8434264|NCT00835497|20785913|P1|COMPLETED|First Intervention||20
8434265|NCT00835497|20785912|P2|STARTED|First Intervention||20
8434266|NCT00835497|20785913|P1|STARTED|First Intervention||20
8434267|NCT00835484|20785929|P2|NOT COMPLETED|Second Intervention||0
8434268|NCT00835484|20785930|P1|NOT COMPLETED|Second Intervention||0
8434269|NCT00835484|20785929|P2|COMPLETED|Second Intervention||16
8434270|NCT00835484|20785930|P1|COMPLETED|Second Intervention||16
8434271|NCT00835484|20785929|P2|STARTED|Second Intervention||16
8434272|NCT00835484|20785930|P1|STARTED|Second Intervention||16
8434273|NCT00835484|20785929|P2|NOT COMPLETED|Washout of 7 Days||0
8434274|NCT00835484|20785930|P1|NOT COMPLETED|Washout of 7 Days||0
8434275|NCT00835484|20785929|P2|COMPLETED|Washout of 7 Days||16
8434276|NCT00835484|20785930|P1|COMPLETED|Washout of 7 Days||16
8434277|NCT00835484|20785929|P2|STARTED|Washout of 7 Days||16
8434278|NCT00835484|20785930|P1|STARTED|Washout of 7 Days||16
8434279|NCT00835484|20785929|P2|NOT COMPLETED|First Intervention||0
8434280|NCT00835484|20785930|P1|NOT COMPLETED|First Intervention||0
8434281|NCT00835484|20785929|P2|COMPLETED|First Intervention||16
8434282|NCT00835484|20785930|P1|COMPLETED|First Intervention||16
8434283|NCT00835484|20785929|P2|STARTED|First Intervention||16
8434284|NCT00835484|20785930|P1|STARTED|First Intervention||16
8434285|NCT00835406|20785940|P2|NOT COMPLETED|Period: Second Intervention||0
8434286|NCT00835406|20785941|P1|NOT COMPLETED|Period: Second Intervention||0
8434287|NCT00835406|20785940|P2|COMPLETED|Period: Second Intervention||67
8434288|NCT00835406|20785941|P1|COMPLETED|Period: Second Intervention||68
8434289|NCT00835406|20785940|P2|STARTED|Period: Second Intervention||67
8434290|NCT00835406|20785941|P1|STARTED|Period: Second Intervention||68
8434291|NCT00835406|20785940|P2|NOT COMPLETED|Period: Washout of 7 Days||2
8434292|NCT00835406|20785941|P1|NOT COMPLETED|Period: Washout of 7 Days||0
8434293|NCT00835406|20785940|P2|COMPLETED|Period: Washout of 7 Days||67
8434294|NCT00835406|20785941|P1|COMPLETED|Period: Washout of 7 Days||68
8434295|NCT00835406|20785940|P2|STARTED|Period: Washout of 7 Days||69
8434296|NCT00835406|20785941|P1|STARTED|Period: Washout of 7 Days||68
8434297|NCT00835406|20785940|P2|NOT COMPLETED|Period: First Intervention||1
8434298|NCT00835406|20785941|P1|NOT COMPLETED|Period: First Intervention||2
8434299|NCT00835406|20785940|P2|COMPLETED|Period: First Intervention||69
8434300|NCT00835406|20785941|P1|COMPLETED|Period: First Intervention||68
8434301|NCT00835406|20785940|P2|STARTED|Period: First Intervention||70
8434302|NCT00835406|20785941|P1|STARTED|Period: First Intervention||70
8434303|NCT00835380|20785947|P1|NOT COMPLETED|Overall Study||2
8434304|NCT00835380|20785947|P1|COMPLETED|Overall Study||78
8434305|NCT00835380|20785947|P1|STARTED|Overall Study||80
8434306|NCT00835367|20785954|P2|NOT COMPLETED|Second Intervention||1
8434307|NCT00835367|20785955|P1|NOT COMPLETED|Second Intervention||1
8434308|NCT00835367|20785954|P2|COMPLETED|Second Intervention||33
8434309|NCT00835367|20785955|P1|COMPLETED|Second Intervention||30
8434310|NCT00835367|20785954|P2|STARTED|Second Intervention||34
8434311|NCT00835367|20785955|P1|STARTED|Second Intervention||31
8434312|NCT00835367|20785954|P2|NOT COMPLETED|Washout||0
8434313|NCT00835367|20785955|P1|NOT COMPLETED|Washout||3
8434314|NCT00835367|20785954|P2|COMPLETED|Washout||34
8434315|NCT00835367|20785955|P1|COMPLETED|Washout||31
8434316|NCT00835367|20785954|P2|STARTED|Washout||34
8434317|NCT00835367|20785955|P1|STARTED|Washout||34
8434318|NCT00835367|20785954|P2|NOT COMPLETED|First Intervention||0
8434319|NCT00835367|20785955|P1|NOT COMPLETED|First Intervention||0
8434320|NCT00835367|20785954|P2|COMPLETED|First Intervention||34
8434321|NCT00835367|20785955|P1|COMPLETED|First Intervention||34
8434322|NCT00835367|20785954|P2|STARTED|First Intervention||34
8434323|NCT00835367|20785955|P1|STARTED|First Intervention||34
8434324|NCT00835354|20785977|P2|NOT COMPLETED|Second Intervention||0
8434325|NCT00835354|20785978|P1|NOT COMPLETED|Second Intervention||0
8434326|NCT00835354|20785977|P2|COMPLETED|Second Intervention||12
8434327|NCT00835354|20785978|P1|COMPLETED|Second Intervention||13
8434328|NCT00835354|20785977|P2|STARTED|Second Intervention||12
8434329|NCT00835354|20785978|P1|STARTED|Second Intervention||13
8434330|NCT00835354|20785977|P2|NOT COMPLETED|Washout of 7 Days||0
8434331|NCT00835354|20785978|P1|NOT COMPLETED|Washout of 7 Days||0
8434332|NCT00835354|20785977|P2|COMPLETED|Washout of 7 Days||12
8434333|NCT00835354|20785978|P1|COMPLETED|Washout of 7 Days||13
8434334|NCT00835354|20785977|P2|STARTED|Washout of 7 Days||12
8434335|NCT00835354|20785978|P1|STARTED|Washout of 7 Days||13
8434336|NCT00835354|20785977|P2|NOT COMPLETED|First Intervention||1
8434337|NCT00835354|20785978|P1|NOT COMPLETED|First Intervention||0
8434338|NCT00835354|20785977|P2|COMPLETED|First Intervention||12
8434339|NCT00835354|20785978|P1|COMPLETED|First Intervention||13
8434340|NCT00835354|20785977|P2|STARTED|First Intervention||13
8434341|NCT00835354|20785978|P1|STARTED|First Intervention||13
8434342|NCT00835341|20785988|P2|NOT COMPLETED|Overall Study||12
8434343|NCT00835341|20785989|P1|NOT COMPLETED|Overall Study||3
8434344|NCT00835341|20785988|P2|COMPLETED|Overall Study||46
8434345|NCT00835341|20785989|P1|COMPLETED|Overall Study||32
8434346|NCT00835341|20785988|P2|STARTED|Overall Study||58
8434347|NCT00835341|20785989|P1|STARTED|Overall Study||35
8434348|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434349|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434350|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434351|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434352|NCT00835328|20785999|P4|COMPLETED|Cohort 4: Dose Level 4||4
8434353|NCT00835328|20786000|P3|COMPLETED|Cohort 4: Dose Level 4||0
8434354|NCT00835328|20786001|P2|COMPLETED|Cohort 4: Dose Level 4||0
8434355|NCT00835328|20786002|P1|COMPLETED|Cohort 4: Dose Level 4||0
8434356|NCT00835328|20785999|P4|STARTED|Cohort 4: Dose Level 4||4
8434357|NCT00835328|20786000|P3|STARTED|Cohort 4: Dose Level 4||0
8434358|NCT00835328|20786001|P2|STARTED|Cohort 4: Dose Level 4||0
8434359|NCT00835328|20786002|P1|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
8434360|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434361|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434362|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434363|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434364|NCT00835328|20785999|P4|COMPLETED|Cohort 3: Dose Level 3||0
8434365|NCT00835328|20786000|P3|COMPLETED|Cohort 3: Dose Level 3||2
8434366|NCT00835328|20786001|P2|COMPLETED|Cohort 3: Dose Level 3||0
8434367|NCT00835328|20786002|P1|COMPLETED|Cohort 3: Dose Level 3||0
8434368|NCT00835328|20785999|P4|STARTED|Cohort 3: Dose Level 3||0
8434369|NCT00835328|20786000|P3|STARTED|Cohort 3: Dose Level 3||2
8434370|NCT00835328|20786001|P2|STARTED|Cohort 3: Dose Level 3||0
8434371|NCT00835328|20786002|P1|STARTED|Cohort 3: Dose Level 3||0
8434372|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434373|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434374|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434375|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434376|NCT00835328|20785999|P4|COMPLETED|Cohort 2: Dose Level 2||0
8434377|NCT00835328|20786000|P3|COMPLETED|Cohort 2: Dose Level 2||0
8434378|NCT00835328|20786001|P2|COMPLETED|Cohort 2: Dose Level 2||2
8434379|NCT00835328|20786002|P1|COMPLETED|Cohort 2: Dose Level 2||0
8434380|NCT00835328|20785999|P4|STARTED|Cohort 2: Dose Level 2||0
8434381|NCT00835328|20786000|P3|STARTED|Cohort 2: Dose Level 2||0
8434382|NCT00835328|20786001|P2|STARTED|Cohort 2: Dose Level 2||2
8434383|NCT00835328|20786002|P1|STARTED|Cohort 2: Dose Level 2||0
8434384|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434385|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434386|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434387|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434388|NCT00835328|20785999|P4|COMPLETED|Cohort 1: Dose Level 1||0
8434389|NCT00835328|20786000|P3|COMPLETED|Cohort 1: Dose Level 1||0
8434390|NCT00835328|20786001|P2|COMPLETED|Cohort 1: Dose Level 1||0
8434391|NCT00835328|20786002|P1|COMPLETED|Cohort 1: Dose Level 1||5
8434392|NCT00835328|20785999|P4|STARTED|Cohort 1: Dose Level 1||0
8434393|NCT00835328|20786000|P3|STARTED|Cohort 1: Dose Level 1||0
8434394|NCT00835328|20786001|P2|STARTED|Cohort 1: Dose Level 1||0
8434395|NCT00835328|20786002|P1|STARTED|Cohort 1: Dose Level 1||5
8434396|NCT00835276|20786041|P2|NOT COMPLETED|Second Intervention||0
8434397|NCT00835276|20786042|P1|NOT COMPLETED|Second Intervention||0
8434398|NCT00835276|20786041|P2|COMPLETED|Second Intervention||24
8434399|NCT00835276|20786042|P1|COMPLETED|Second Intervention||24
8434400|NCT00835276|20786041|P2|STARTED|Second Intervention||24
8434401|NCT00835276|20786042|P1|STARTED|Second Intervention||24
8434402|NCT00835276|20786041|P2|NOT COMPLETED|Washout of 7 Days||0
8434403|NCT00835276|20786042|P1|NOT COMPLETED|Washout of 7 Days||0
8434404|NCT00835276|20786041|P2|COMPLETED|Washout of 7 Days||24
8434405|NCT00835276|20786042|P1|COMPLETED|Washout of 7 Days||24
8434406|NCT00835276|20786041|P2|STARTED|Washout of 7 Days||24
8434407|NCT00835276|20786042|P1|STARTED|Washout of 7 Days||24
8434408|NCT00835276|20786041|P2|NOT COMPLETED|First Intervention||0
8434409|NCT00835276|20786042|P1|NOT COMPLETED|First Intervention||0
8434410|NCT00835276|20786041|P2|COMPLETED|First Intervention||24
8434411|NCT00835276|20786042|P1|COMPLETED|First Intervention||24
8434412|NCT00835276|20786041|P2|STARTED|First Intervention||24
8434413|NCT00835276|20786042|P1|STARTED|First Intervention||24
8434414|NCT00835263|20786052|P2|NOT COMPLETED|Second Intervention||0
8434415|NCT00835263|20786053|P1|NOT COMPLETED|Second Intervention||1
8434416|NCT00835263|20786052|P2|COMPLETED|Second Intervention||16
8434417|NCT00835263|20786053|P1|COMPLETED|Second Intervention||15
8434418|NCT00835263|20786052|P2|STARTED|Second Intervention||16
8434419|NCT00835263|20786053|P1|STARTED|Second Intervention||16
8434420|NCT00835263|20786052|P2|NOT COMPLETED|First Intervention||0
8434421|NCT00835263|20786053|P1|NOT COMPLETED|First Intervention||0
8434422|NCT00835263|20786052|P2|COMPLETED|First Intervention||16
8434423|NCT00835263|20786053|P1|COMPLETED|First Intervention||16
8434424|NCT00835263|20786052|P2|STARTED|First Intervention||16
8434425|NCT00835263|20786053|P1|STARTED|First Intervention||16
8434426|NCT00835237|20786063|P2|NOT COMPLETED|Overall Study||0
8434427|NCT00835237|20786064|P1|NOT COMPLETED|Overall Study||6
8434428|NCT00835237|20786063|P2|COMPLETED|Overall Study||445
8434429|NCT00835237|20786064|P1|COMPLETED|Overall Study||881
8434430|NCT00835237|20786063|P2|STARTED|Overall Study||445
8434431|NCT00835237|20786064|P1|STARTED|Overall Study||887
8434432|NCT00835224|20786088|P1|NOT COMPLETED|Overall Study||10
8434433|NCT00835224|20786088|P1|COMPLETED|Overall Study||24
8434434|NCT00835224|20786088|P1|STARTED|Overall Study||34
8434435|NCT00835211|20786104|P2|NOT COMPLETED|Second Intervention||0
8434436|NCT00835211|20786105|P1|NOT COMPLETED|Second Intervention||0
8434437|NCT00835211|20786104|P2|COMPLETED|Second Intervention||22
8434438|NCT00835211|20786105|P1|COMPLETED|Second Intervention||21
8434439|NCT00835211|20786104|P2|STARTED|Second Intervention||22
8434440|NCT00835211|20786105|P1|STARTED|Second Intervention||21
8434441|NCT00835211|20786104|P2|NOT COMPLETED|Washout: 7 Days||1
8434442|NCT00835211|20786105|P1|NOT COMPLETED|Washout: 7 Days||3
8434443|NCT00835211|20786104|P2|COMPLETED|Washout: 7 Days||22
8434444|NCT00835211|20786105|P1|COMPLETED|Washout: 7 Days||21
8434445|NCT00835211|20786104|P2|STARTED|Washout: 7 Days||23
8434446|NCT00835211|20786105|P1|STARTED|Washout: 7 Days||24
8434447|NCT00835211|20786104|P2|NOT COMPLETED|First Intervention||1
8434448|NCT00835211|20786105|P1|NOT COMPLETED|First Intervention||0
8434449|NCT00835211|20786104|P2|COMPLETED|First Intervention||23
8434450|NCT00835211|20786105|P1|COMPLETED|First Intervention||24
8434451|NCT00835211|20786104|P2|STARTED|First Intervention||24
8434452|NCT00835211|20786105|P1|STARTED|First Intervention||24
8434453|NCT00835198|20786115|P2|NOT COMPLETED|Overall Study||7
8434454|NCT00835198|20786116|P1|NOT COMPLETED|Overall Study||8
8434455|NCT00835198|20786115|P2|COMPLETED|Overall Study||74
8434456|NCT00835198|20786116|P1|COMPLETED|Overall Study||74
8434457|NCT00835198|20786115|P2|STARTED|Overall Study||81
8434458|NCT00835198|20786116|P1|STARTED|Overall Study||82
8434459|NCT00835185|20786128|P1|NOT COMPLETED|Overall Study||0
8434460|NCT00835185|20786128|P1|COMPLETED|Overall Study||44
8434461|NCT00835185|20786128|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
8434462|NCT00835185|20786128|P1|STARTED|Overall Study||44
8434463|NCT00835172|20786151|P2|NOT COMPLETED|Second Intervention||0
8434464|NCT00835172|20786152|P1|NOT COMPLETED|Second Intervention||0
8434465|NCT00835172|20786151|P2|COMPLETED|Second Intervention||15
8434466|NCT00835172|20786152|P1|COMPLETED|Second Intervention||16
8434467|NCT00835172|20786151|P2|STARTED|Second Intervention||15
8434468|NCT00835172|20786152|P1|STARTED|Second Intervention||16
8434469|NCT00835172|20786151|P2|NOT COMPLETED|Washout||1
8434470|NCT00835172|20786152|P1|NOT COMPLETED|Washout||0
8434471|NCT00835172|20786151|P2|COMPLETED|Washout||15
8434472|NCT00835172|20786152|P1|COMPLETED|Washout||16
8434473|NCT00835172|20786151|P2|STARTED|Washout||16
8434474|NCT00835172|20786152|P1|STARTED|Washout||16
8434475|NCT00835172|20786151|P2|NOT COMPLETED|First Intervention||0
8434476|NCT00835172|20786152|P1|NOT COMPLETED|First Intervention||0
8434477|NCT00835172|20786151|P2|COMPLETED|First Intervention||16
8434478|NCT00835172|20786152|P1|COMPLETED|First Intervention||16
8434479|NCT00835172|20786151|P2|STARTED|First Intervention||16
8434480|NCT00835172|20786152|P1|STARTED|First Intervention||16
8434481|NCT00835159|20786162|P2|NOT COMPLETED|Overall Study||0
8434482|NCT00835159|20786163|P1|NOT COMPLETED|Overall Study||0
8434483|NCT00835159|20786162|P2|COMPLETED|Overall Study||17
8434484|NCT00835159|20786163|P1|COMPLETED|Overall Study||11
8434485|NCT00835159|20786162|P2|STARTED|Overall Study||17
8434486|NCT00835159|20786163|P1|STARTED|Overall Study||11
8434487|NCT00835146|20786171|P2|NOT COMPLETED|Second Intervention||0
8434488|NCT00835146|20786172|P1|NOT COMPLETED|Second Intervention||0
8434489|NCT00835146|20786171|P2|COMPLETED|Second Intervention||14
8434490|NCT00835146|20786172|P1|COMPLETED|Second Intervention||14
8434491|NCT00835146|20786171|P2|STARTED|Second Intervention||14
8434492|NCT00835146|20786172|P1|STARTED|Second Intervention||14
8434493|NCT00835146|20786171|P2|NOT COMPLETED|Washout of 5 Weeks||0
8434494|NCT00835146|20786172|P1|NOT COMPLETED|Washout of 5 Weeks||0
8434495|NCT00835146|20786171|P2|COMPLETED|Washout of 5 Weeks||14
8434496|NCT00835146|20786172|P1|COMPLETED|Washout of 5 Weeks||14
8434497|NCT00835146|20786171|P2|STARTED|Washout of 5 Weeks||14
8434498|NCT00835146|20786172|P1|STARTED|Washout of 5 Weeks||14
8434499|NCT00835146|20786171|P2|NOT COMPLETED|First Intervention||0
8434500|NCT00835146|20786172|P1|NOT COMPLETED|First Intervention||0
8434501|NCT00835146|20786171|P2|COMPLETED|First Intervention||14
8434502|NCT00835146|20786172|P1|COMPLETED|First Intervention||14
8434503|NCT00835146|20786171|P2|STARTED|First Intervention||14
8434504|NCT00835146|20786172|P1|STARTED|First Intervention||14
8434505|NCT00835120|20786178|P1|NOT COMPLETED|Overall Study||8
8434506|NCT00835120|20786178|P1|COMPLETED|Overall Study||26
8434507|NCT00835120|20786178|P1|STARTED|Overall Study||34
8434508|NCT00835081|20786188|P2|NOT COMPLETED|Second Intervention||0
8434509|NCT00835081|20786189|P1|NOT COMPLETED|Second Intervention||0
8434510|NCT00835081|20786188|P2|COMPLETED|Second Intervention||13
8434511|NCT00835081|20786189|P1|COMPLETED|Second Intervention||12
8434512|NCT00835081|20786188|P2|STARTED|Second Intervention||13
8434513|NCT00835081|20786189|P1|STARTED|Second Intervention||12
8434514|NCT00835081|20786188|P2|NOT COMPLETED|Washout of 7 Days||0
8434515|NCT00835081|20786189|P1|NOT COMPLETED|Washout of 7 Days||1
8434516|NCT00835081|20786188|P2|COMPLETED|Washout of 7 Days||13
8434517|NCT00835081|20786189|P1|COMPLETED|Washout of 7 Days||12
8434518|NCT00835081|20786188|P2|STARTED|Washout of 7 Days||13
8434519|NCT00835081|20786189|P1|STARTED|Washout of 7 Days||13
8434520|NCT00835081|20786188|P2|NOT COMPLETED|First Intervention||0
8434521|NCT00835081|20786189|P1|NOT COMPLETED|First Intervention||0
8434522|NCT00835081|20786188|P2|COMPLETED|First Intervention||13
8434523|NCT00835081|20786189|P1|COMPLETED|First Intervention||13
8434524|NCT00835081|20786188|P2|STARTED|First Intervention||13
8434525|NCT00835081|20786189|P1|STARTED|First Intervention||13
8434526|NCT00835068|20786199|P2|NOT COMPLETED|Overall Study||1
8434527|NCT00835068|20786200|P1|NOT COMPLETED|Overall Study||10
8434528|NCT00835068|20786199|P2|COMPLETED|Overall Study||0
8434529|NCT00835068|20786200|P1|COMPLETED|Overall Study||47
8434530|NCT00835068|20786199|P2|STARTED|Overall Study||1
8434531|NCT00835068|20786200|P1|STARTED|Overall Study||57
8434532|NCT00835042|20786220|P2|NOT COMPLETED|Second Intervention||0
8434533|NCT00835042|20786221|P1|NOT COMPLETED|Second Intervention||0
8434534|NCT00835042|20786220|P2|COMPLETED|Second Intervention||24
8434535|NCT00835042|20786221|P1|COMPLETED|Second Intervention||26
8434536|NCT00835042|20786220|P2|STARTED|Second Intervention||24
8434537|NCT00835042|20786221|P1|STARTED|Second Intervention||26
8434538|NCT00835042|20786220|P2|NOT COMPLETED|Washout of 21 Days||2
8434539|NCT00835042|20786221|P1|NOT COMPLETED|Washout of 21 Days||0
8434540|NCT00835042|20786220|P2|COMPLETED|Washout of 21 Days||24
8434541|NCT00835042|20786221|P1|COMPLETED|Washout of 21 Days||26
8434542|NCT00835042|20786220|P2|STARTED|Washout of 21 Days||26
8434543|NCT00835042|20786221|P1|STARTED|Washout of 21 Days||26
8434544|NCT00835042|20786220|P2|NOT COMPLETED|First Intervention||2
8434545|NCT00835042|20786221|P1|NOT COMPLETED|First Intervention||4
8434546|NCT00835042|20786220|P2|COMPLETED|First Intervention||26
8434547|NCT00835042|20786221|P1|COMPLETED|First Intervention||26
8434548|NCT00835042|20786220|P2|STARTED|First Intervention||28
8434549|NCT00835042|20786221|P1|STARTED|First Intervention||30
8434550|NCT00835003|20786243|P2|NOT COMPLETED|Overall Study||0
8434551|NCT00835003|20786244|P1|NOT COMPLETED|Overall Study||0
8434552|NCT00835003|20786243|P2|COMPLETED|Overall Study||638
8434553|NCT00835003|20786244|P1|COMPLETED|Overall Study||636
8434554|NCT00835003|20786243|P2|STARTED|Overall Study||638
8434555|NCT00835003|20786244|P1|STARTED|Overall Study||636
8434556|NCT00834990|20786252|P2|NOT COMPLETED|Second Intervention||0
8434557|NCT00834990|20786253|P1|NOT COMPLETED|Second Intervention||0
8434558|NCT00834990|20786252|P2|COMPLETED|Second Intervention||11
8434559|NCT00834990|20786253|P1|COMPLETED|Second Intervention||12
8434560|NCT00834990|20786252|P2|STARTED|Second Intervention||11
8434561|NCT00834990|20786253|P1|STARTED|Second Intervention||12
8434562|NCT00834990|20786252|P2|NOT COMPLETED|Washout of 7 Days||0
8434563|NCT00834990|20786253|P1|NOT COMPLETED|Washout of 7 Days||0
8434564|NCT00834990|20786252|P2|COMPLETED|Washout of 7 Days||11
8434565|NCT00834990|20786253|P1|COMPLETED|Washout of 7 Days||12
8434566|NCT00834990|20786252|P2|STARTED|Washout of 7 Days||11
8434567|NCT00834990|20786253|P1|STARTED|Washout of 7 Days||12
8434568|NCT00834990|20786252|P2|NOT COMPLETED|First Intervention||0
8434569|NCT00834990|20786253|P1|NOT COMPLETED|First Intervention||0
8434570|NCT00834990|20786252|P2|COMPLETED|First Intervention||11
8434571|NCT00834990|20786253|P1|COMPLETED|First Intervention||12
8434572|NCT00834990|20786252|P2|STARTED|First Intervention||11
8434573|NCT00834990|20786253|P1|STARTED|First Intervention||12
8434574|NCT00834977|20786263|P2|NOT COMPLETED|Second Intervention||0
8434575|NCT00834977|20786264|P1|NOT COMPLETED|Second Intervention||0
8434576|NCT00834977|20786263|P2|COMPLETED|Second Intervention||24
8434577|NCT00834977|20786264|P1|COMPLETED|Second Intervention||24
8434578|NCT00834977|20786263|P2|STARTED|Second Intervention||24
8434579|NCT00834977|20786264|P1|STARTED|Second Intervention||24
8434580|NCT00834977|20786263|P2|NOT COMPLETED|First Intervention||0
8434581|NCT00834977|20786264|P1|NOT COMPLETED|First Intervention||0
8434582|NCT00834977|20786263|P2|COMPLETED|First Intervention||24
8434583|NCT00834977|20786264|P1|COMPLETED|First Intervention||24
8434584|NCT00834977|20786263|P2|STARTED|First Intervention||24
8434585|NCT00834977|20786264|P1|STARTED|First Intervention||24
8434586|NCT00834964|20786286|P2|NOT COMPLETED|Second Intervention||0
8434587|NCT00834964|20786287|P1|NOT COMPLETED|Second Intervention||0
8434588|NCT00834964|20786286|P2|COMPLETED|Second Intervention||15
8434589|NCT00834964|20786287|P1|COMPLETED|Second Intervention||15
8434590|NCT00834964|20786286|P2|STARTED|Second Intervention||15
8434591|NCT00834964|20786287|P1|STARTED|Second Intervention||15
8434592|NCT00834964|20786286|P2|NOT COMPLETED|Washout: 7 Days||0
8434593|NCT00834964|20786287|P1|NOT COMPLETED|Washout: 7 Days||0
8434594|NCT00834964|20786286|P2|COMPLETED|Washout: 7 Days||15
8434595|NCT00834964|20786287|P1|COMPLETED|Washout: 7 Days||15
8434596|NCT00834964|20786286|P2|STARTED|Washout: 7 Days||15
8434597|NCT00834964|20786287|P1|STARTED|Washout: 7 Days||15
8434598|NCT00834964|20786286|P2|NOT COMPLETED|First Intervention||0
8434599|NCT00834964|20786287|P1|NOT COMPLETED|First Intervention||0
8434600|NCT00834964|20786286|P2|COMPLETED|First Intervention||15
8434601|NCT00834964|20786287|P1|COMPLETED|First Intervention||15
8434602|NCT00834964|20786286|P2|STARTED|First Intervention||15
8434603|NCT00834964|20786287|P1|STARTED|First Intervention||15
8434604|NCT00834912|20786307|P6|NOT COMPLETED|Treatment Period 3||0
8434605|NCT00834912|20786308|P5|NOT COMPLETED|Treatment Period 3||0
8434606|NCT00834912|20786309|P4|NOT COMPLETED|Treatment Period 3||0
8434607|NCT00834912|20786310|P3|NOT COMPLETED|Treatment Period 3||0
8434608|NCT00834912|20786311|P2|NOT COMPLETED|Treatment Period 3||0
8434609|NCT00834912|20786312|P1|NOT COMPLETED|Treatment Period 3||0
8434610|NCT00834912|20786307|P6|COMPLETED|Treatment Period 3||6
8434611|NCT00834912|20786308|P5|COMPLETED|Treatment Period 3||5
8434612|NCT00834912|20786309|P4|COMPLETED|Treatment Period 3||5
8434613|NCT00834912|20786310|P3|COMPLETED|Treatment Period 3||5
8434614|NCT00834912|20786311|P2|COMPLETED|Treatment Period 3||5
8434615|NCT00834912|20786312|P1|COMPLETED|Treatment Period 3||6
8434616|NCT00834912|20786307|P6|STARTED|Treatment Period 3||6
8434617|NCT00834912|20786308|P5|STARTED|Treatment Period 3||5
8434618|NCT00834912|20786309|P4|STARTED|Treatment Period 3||5
8434619|NCT00834912|20786310|P3|STARTED|Treatment Period 3||5
8434620|NCT00834912|20786311|P2|STARTED|Treatment Period 3||5
8434621|NCT00834912|20786312|P1|STARTED|Treatment Period 3||6
8434622|NCT00834912|20786307|P6|NOT COMPLETED|Treatment Period 2||0
8434623|NCT00834912|20786308|P5|NOT COMPLETED|Treatment Period 2||1
8434624|NCT00834912|20786309|P4|NOT COMPLETED|Treatment Period 2||0
8434625|NCT00834912|20786310|P3|NOT COMPLETED|Treatment Period 2||1
8434626|NCT00834912|20786311|P2|NOT COMPLETED|Treatment Period 2||0
8434627|NCT00834912|20786312|P1|NOT COMPLETED|Treatment Period 2||0
8434628|NCT00834912|20786307|P6|COMPLETED|Treatment Period 2||6
8434629|NCT00834912|20786308|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
8434630|NCT00834912|20786309|P4|COMPLETED|Treatment Period 2||5
8434631|NCT00834912|20786310|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
8434632|NCT00834912|20786311|P2|COMPLETED|Treatment Period 2||5
8434633|NCT00834912|20786312|P1|COMPLETED|Treatment Period 2||6
8434634|NCT00834912|20786307|P6|STARTED|Treatment Period 2||6
8434635|NCT00834912|20786308|P5|STARTED|Treatment Period 2||6
8434636|NCT00834912|20786309|P4|STARTED|Treatment Period 2||5
8434637|NCT00834912|20786310|P3|STARTED|Treatment Period 2||6
8434638|NCT00834912|20786311|P2|STARTED|Treatment Period 2||5
8434639|NCT00834912|20786312|P1|STARTED|Treatment Period 2||6
8434640|NCT00834912|20786307|P6|NOT COMPLETED|Treatment Period 1||0
8434641|NCT00834912|20786308|P5|NOT COMPLETED|Treatment Period 1||0
8434642|NCT00834912|20786309|P4|NOT COMPLETED|Treatment Period 1||1
8434643|NCT00834912|20786310|P3|NOT COMPLETED|Treatment Period 1||0
8434644|NCT00834912|20786311|P2|NOT COMPLETED|Treatment Period 1||1
8434645|NCT00834912|20786312|P1|NOT COMPLETED|Treatment Period 1||0
8434646|NCT00834912|20786307|P6|COMPLETED|Treatment Period 1||6
8434647|NCT00834912|20786308|P5|COMPLETED|Treatment Period 1||6
8434648|NCT00834912|20786309|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
8434649|NCT00834912|20786310|P3|COMPLETED|Treatment Period 1||6
8434650|NCT00834912|20786311|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
8434651|NCT00834912|20786312|P1|COMPLETED|Treatment Period 1||6
8434652|NCT00834912|20786307|P6|STARTED|Treatment Period 1||6
8434653|NCT00834912|20786308|P5|STARTED|Treatment Period 1||6
8434654|NCT00834912|20786309|P4|STARTED|Treatment Period 1||6
8434655|NCT00834912|20786310|P3|STARTED|Treatment Period 1||6
8434656|NCT00834912|20786311|P2|STARTED|Treatment Period 1||6
8434657|NCT00834912|20786312|P1|STARTED|Treatment Period 1||6
8434658|NCT00834899|20786334|P2|NOT COMPLETED|Overall Study||1
8434659|NCT00834899|20786335|P1|NOT COMPLETED|Overall Study||1
8434660|NCT00834899|20786334|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
8434661|NCT00834899|20786335|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
8434662|NCT00834899|20786334|P2|STARTED|Overall Study||4
8434663|NCT00834899|20786335|P1|STARTED|Overall Study||9
8434664|NCT00834886|20786351|P4|NOT COMPLETED|Overall Study||0
8434665|NCT00834886|20786352|P3|NOT COMPLETED|Overall Study||1
8434666|NCT00834886|20786353|P2|NOT COMPLETED|Overall Study||1
8434667|NCT00834886|20786354|P1|NOT COMPLETED|Overall Study||0
8434668|NCT00834886|20786351|P4|COMPLETED|Overall Study||10
8434669|NCT00834886|20786352|P3|COMPLETED|Overall Study||9
8434670|NCT00834886|20786353|P2|COMPLETED|Overall Study||9
8434671|NCT00834886|20786354|P1|COMPLETED|Overall Study||10
8434672|NCT00834886|20786351|P4|STARTED|Overall Study||10
8434673|NCT00834886|20786352|P3|STARTED|Overall Study||10
8434674|NCT00834886|20786353|P2|STARTED|Overall Study||10
8434675|NCT00834886|20786354|P1|STARTED|Overall Study||10
8434676|NCT00834873|20786374|P2|NOT COMPLETED|Second Intervention||0
8434677|NCT00834873|20786375|P1|NOT COMPLETED|Second Intervention||0
8434678|NCT00834873|20786374|P2|COMPLETED|Second Intervention||11
8434679|NCT00834873|20786375|P1|COMPLETED|Second Intervention||12
8434680|NCT00834873|20786374|P2|STARTED|Second Intervention||11
8434681|NCT00834873|20786375|P1|STARTED|Second Intervention||12
8434682|NCT00834873|20786374|P2|NOT COMPLETED|Washout: 7 Days||0
8434683|NCT00834873|20786375|P1|NOT COMPLETED|Washout: 7 Days||0
8434684|NCT00834873|20786374|P2|COMPLETED|Washout: 7 Days||11
8434685|NCT00834873|20786375|P1|COMPLETED|Washout: 7 Days||12
8434686|NCT00834873|20786374|P2|STARTED|Washout: 7 Days||11
8434687|NCT00834873|20786375|P1|STARTED|Washout: 7 Days||12
8434688|NCT00834873|20786374|P2|NOT COMPLETED|First Intervention||1
8434689|NCT00834873|20786375|P1|NOT COMPLETED|First Intervention||0
8434690|NCT00834873|20786374|P2|COMPLETED|First Intervention||11
8434691|NCT00834873|20786375|P1|COMPLETED|First Intervention||12
8434692|NCT00834873|20786374|P2|STARTED|First Intervention||12
8434693|NCT00834873|20786375|P1|STARTED|First Intervention||12
8434694|NCT00834834|20786385|P2|NOT COMPLETED|Overall Study||3
8434695|NCT00834834|20786386|P1|NOT COMPLETED|Overall Study||4
8434696|NCT00834834|20786385|P2|COMPLETED|Overall Study||39
8434697|NCT00834834|20786386|P1|COMPLETED|Overall Study||38
8434698|NCT00834834|20786385|P2|STARTED|Overall Study||42
8434699|NCT00834834|20786386|P1|STARTED|Overall Study||42
8434700|NCT00834808|20786397|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8434701|NCT00834808|20786398|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8434702|NCT00834808|20786399|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8434703|NCT00834808|20786397|P3|COMPLETED|Treatment Period 3 (Day 15)||9
8434704|NCT00834808|20786398|P2|COMPLETED|Treatment Period 3 (Day 15)||9
8434705|NCT00834808|20786399|P1|COMPLETED|Treatment Period 3 (Day 15)||9
8434706|NCT00834808|20786397|P3|STARTED|Treatment Period 3 (Day 15)||9
8434707|NCT00834808|20786398|P2|STARTED|Treatment Period 3 (Day 15)||9
8434708|NCT00834808|20786399|P1|STARTED|Treatment Period 3 (Day 15)||9
8434709|NCT00834808|20786397|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8434710|NCT00834808|20786398|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8434711|NCT00834808|20786399|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8434712|NCT00834808|20786397|P3|COMPLETED|Treatment Period 2 (Day 8)||9
8434713|NCT00834808|20786398|P2|COMPLETED|Treatment Period 2 (Day 8)||9
8434714|NCT00834808|20786399|P1|COMPLETED|Treatment Period 2 (Day 8)||9
8434715|NCT00834808|20786397|P3|STARTED|Treatment Period 2 (Day 8)||9
8434716|NCT00834808|20786398|P2|STARTED|Treatment Period 2 (Day 8)||9
8434717|NCT00834808|20786399|P1|STARTED|Treatment Period 2 (Day 8)||9
8434718|NCT00834808|20786397|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8434719|NCT00834808|20786398|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8434720|NCT00834808|20786399|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8434721|NCT00834808|20786397|P3|COMPLETED|Treatment Period 1 (Day 1)||9
8434722|NCT00834808|20786398|P2|COMPLETED|Treatment Period 1 (Day 1)||9
8434723|NCT00834808|20786399|P1|COMPLETED|Treatment Period 1 (Day 1)||9
8434724|NCT00834808|20786397|P3|STARTED|Treatment Period 1 (Day 1)||9
8434725|NCT00834808|20786398|P2|STARTED|Treatment Period 1 (Day 1)||9
8434726|NCT00834808|20786399|P1|STARTED|Treatment Period 1 (Day 1)||9
8434727|NCT00834795|20786421|P2|NOT COMPLETED|Second Intervention||0
8434728|NCT00834795|20786422|P1|NOT COMPLETED|Second Intervention||1
8434729|NCT00834795|20786421|P2|COMPLETED|Second Intervention||17
8434730|NCT00834795|20786422|P1|COMPLETED|Second Intervention||17
8434731|NCT00834795|20786421|P2|STARTED|Second Intervention||17
8434732|NCT00834795|20786422|P1|STARTED|Second Intervention||18
8434733|NCT00834795|20786421|P2|NOT COMPLETED|Washout: 7 Days||1
8434734|NCT00834795|20786422|P1|NOT COMPLETED|Washout: 7 Days||0
8434735|NCT00834795|20786421|P2|COMPLETED|Washout: 7 Days||17
8434736|NCT00834795|20786422|P1|COMPLETED|Washout: 7 Days||18
8434737|NCT00834795|20786421|P2|STARTED|Washout: 7 Days||18
8434738|NCT00834795|20786422|P1|STARTED|Washout: 7 Days||18
8434739|NCT00834795|20786421|P2|NOT COMPLETED|First Intervention||0
8434740|NCT00834795|20786422|P1|NOT COMPLETED|First Intervention||0
8434741|NCT00834795|20786421|P2|COMPLETED|First Intervention||18
8434742|NCT00834795|20786422|P1|COMPLETED|First Intervention||18
8434743|NCT00834795|20786421|P2|STARTED|First Intervention||18
8434744|NCT00834795|20786422|P1|STARTED|First Intervention||18
8434745|NCT00834756|20786432|P2|NOT COMPLETED|Second Intervention||0
8434746|NCT00834756|20786433|P1|NOT COMPLETED|Second Intervention||0
8434747|NCT00834756|20786432|P2|COMPLETED|Second Intervention||18
8434748|NCT00834756|20786433|P1|COMPLETED|Second Intervention||16
8434749|NCT00834756|20786432|P2|STARTED|Second Intervention||18
8434750|NCT00834756|20786433|P1|STARTED|Second Intervention||16
8434751|NCT00834756|20786432|P2|NOT COMPLETED|Washout: 21 Days||0
8434752|NCT00834756|20786433|P1|NOT COMPLETED|Washout: 21 Days||1
8434753|NCT00834756|20786432|P2|COMPLETED|Washout: 21 Days||18
8434754|NCT00834756|20786433|P1|COMPLETED|Washout: 21 Days||16
8434755|NCT00834756|20786432|P2|STARTED|Washout: 21 Days||18
8434756|NCT00834756|20786433|P1|STARTED|Washout: 21 Days||17
8434757|NCT00834756|20786432|P2|NOT COMPLETED|First Intervention||0
8434758|NCT00834756|20786433|P1|NOT COMPLETED|First Intervention||1
8434759|NCT00834756|20786432|P2|COMPLETED|First Intervention||18
8434760|NCT00834756|20786433|P1|COMPLETED|First Intervention||17
8434761|NCT00834756|20786432|P2|STARTED|First Intervention||18
8434762|NCT00834756|20786433|P1|STARTED|First Intervention||18
8434763|NCT00834743|20786443|P2|NOT COMPLETED|Second Intervention||0
8434764|NCT00834743|20786444|P1|NOT COMPLETED|Second Intervention||1
8434765|NCT00834743|20786443|P2|COMPLETED|Second Intervention||16
8434766|NCT00834743|20786444|P1|COMPLETED|Second Intervention||15
8434767|NCT00834743|20786443|P2|STARTED|Second Intervention||16
8434768|NCT00834743|20786444|P1|STARTED|Second Intervention||16
8434769|NCT00834743|20786443|P2|NOT COMPLETED|Washout of 7 Days||0
8434770|NCT00834743|20786444|P1|NOT COMPLETED|Washout of 7 Days||0
8434771|NCT00834743|20786443|P2|COMPLETED|Washout of 7 Days||16
8434772|NCT00834743|20786444|P1|COMPLETED|Washout of 7 Days||16
8434773|NCT00834743|20786443|P2|STARTED|Washout of 7 Days||16
8434774|NCT00834743|20786444|P1|STARTED|Washout of 7 Days||16
8434775|NCT00834743|20786443|P2|NOT COMPLETED|First Intervention||0
8434776|NCT00834743|20786444|P1|NOT COMPLETED|First Intervention||0
8434777|NCT00834743|20786443|P2|COMPLETED|First Intervention||16
8434778|NCT00834743|20786444|P1|COMPLETED|First Intervention||16
8434779|NCT00834743|20786443|P2|STARTED|First Intervention||16
8434780|NCT00834743|20786444|P1|STARTED|First Intervention||16
8434781|NCT00834717|20786454|P2|NOT COMPLETED|Second Intervention||0
8434782|NCT00834717|20786455|P1|NOT COMPLETED|Second Intervention||0
8434783|NCT00834717|20786454|P2|COMPLETED|Second Intervention||19
8434784|NCT00834717|20786455|P1|COMPLETED|Second Intervention||19
8434785|NCT00834717|20786454|P2|STARTED|Second Intervention||19
8434786|NCT00834717|20786455|P1|STARTED|Second Intervention||19
8434787|NCT00834717|20786454|P2|NOT COMPLETED|First Intervention||1
8434788|NCT00834717|20786455|P1|NOT COMPLETED|First Intervention||1
8434789|NCT00834717|20786454|P2|COMPLETED|First Intervention||19
8434790|NCT00834717|20786455|P1|COMPLETED|First Intervention||19
8434791|NCT00834717|20786454|P2|STARTED|First Intervention||20
8434792|NCT00834717|20786455|P1|STARTED|First Intervention||20
8434793|NCT00834678|20786463|P1|NOT COMPLETED|Overall Study||0
8434794|NCT00834678|20786463|P1|COMPLETED|Overall Study||11
8434795|NCT00834678|20786463|P1|STARTED|Overall Study||11
8434796|NCT00834652|20786477|P2|NOT COMPLETED|Overall Study||40
8434797|NCT00834652|20786478|P1|NOT COMPLETED|Overall Study||38
8434798|NCT00834652|20786477|P2|COMPLETED|Overall Study||62
8434799|NCT00834652|20786478|P1|COMPLETED|Overall Study||66
8434800|NCT00834652|20786477|P2|STARTED|Overall Study||102
8434801|NCT00834652|20786478|P1|STARTED|Overall Study||104
8434802|NCT00834639|20786486|P2|NOT COMPLETED|Second Intervention||2
8434803|NCT00834639|20786487|P1|NOT COMPLETED|Second Intervention||0
8434804|NCT00834639|20786486|P2|COMPLETED|Second Intervention||10
8434805|NCT00834639|20786487|P1|COMPLETED|Second Intervention||12
8434806|NCT00834639|20786486|P2|STARTED|Second Intervention||12
8434807|NCT00834639|20786487|P1|STARTED|Second Intervention||12
8434808|NCT00834639|20786486|P2|NOT COMPLETED|Washout of 7 Days||0
8434809|NCT00834639|20786487|P1|NOT COMPLETED|Washout of 7 Days||0
8434810|NCT00834639|20786486|P2|COMPLETED|Washout of 7 Days||12
8434811|NCT00834639|20786487|P1|COMPLETED|Washout of 7 Days||12
8434812|NCT00834639|20786486|P2|STARTED|Washout of 7 Days||12
8434813|NCT00834639|20786487|P1|STARTED|Washout of 7 Days||12
8434814|NCT00834639|20786486|P2|NOT COMPLETED|First Intervention||0
8434815|NCT00834639|20786487|P1|NOT COMPLETED|First Intervention||0
8434816|NCT00834639|20786486|P2|COMPLETED|First Intervention||12
8434817|NCT00834639|20786487|P1|COMPLETED|First Intervention||12
8434818|NCT00834639|20786486|P2|STARTED|First Intervention||12
8434819|NCT00834639|20786487|P1|STARTED|First Intervention||12
8434820|NCT00834626|20786495|P1|NOT COMPLETED|Overall Study||0
8434821|NCT00834626|20786495|P1|COMPLETED|Overall Study||30
8434822|NCT00834626|20786495|P1|1 Year Follow-up|Overall Study||30
8434823|NCT00834626|20786495|P1|STARTED|Overall Study||30
8434824|NCT00834613|20786504|P2|NOT COMPLETED|Second Intervention||0
8434825|NCT00834613|20786505|P1|NOT COMPLETED|Second Intervention||0
8434826|NCT00834613|20786504|P2|COMPLETED|Second Intervention||16
8434827|NCT00834613|20786505|P1|COMPLETED|Second Intervention||15
8434828|NCT00834613|20786504|P2|STARTED|Second Intervention||16
8434829|NCT00834613|20786505|P1|STARTED|Second Intervention||15
8434830|NCT00834613|20786504|P2|NOT COMPLETED|Washout of 7 Days||0
8434831|NCT00834613|20786505|P1|NOT COMPLETED|Washout of 7 Days||0
8434832|NCT00834613|20786504|P2|COMPLETED|Washout of 7 Days||16
8434833|NCT00834613|20786505|P1|COMPLETED|Washout of 7 Days||15
8434834|NCT00834613|20786504|P2|STARTED|Washout of 7 Days||16
8434835|NCT00834613|20786505|P1|STARTED|Washout of 7 Days||15
8434836|NCT00834613|20786504|P2|NOT COMPLETED|First Intervention||0
8434837|NCT00834613|20786505|P1|NOT COMPLETED|First Intervention||1
8434838|NCT00834613|20786504|P2|COMPLETED|First Intervention||16
8434839|NCT00834613|20786505|P1|COMPLETED|First Intervention||15
8434840|NCT00834613|20786504|P2|STARTED|First Intervention||16
8434841|NCT00834613|20786505|P1|STARTED|First Intervention||16
8434842|NCT00834587|20786515|P2|NOT COMPLETED|Second Intervention||0
8434843|NCT00834587|20786516|P1|NOT COMPLETED|Second Intervention||0
8434844|NCT00834587|20786515|P2|COMPLETED|Second Intervention||20
8434845|NCT00834587|20786516|P1|COMPLETED|Second Intervention||19
8434846|NCT00834587|20786515|P2|STARTED|Second Intervention||20
8434847|NCT00834587|20786516|P1|STARTED|Second Intervention||19
8434848|NCT00834587|20786515|P2|NOT COMPLETED|Washout: 7 Days||0
8434849|NCT00834587|20786516|P1|NOT COMPLETED|Washout: 7 Days||1
8434850|NCT00834587|20786515|P2|COMPLETED|Washout: 7 Days||20
8434851|NCT00834587|20786516|P1|COMPLETED|Washout: 7 Days||19
8434852|NCT00834587|20786515|P2|STARTED|Washout: 7 Days||20
8434853|NCT00834587|20786516|P1|STARTED|Washout: 7 Days||20
8434854|NCT00834587|20786515|P2|NOT COMPLETED|First Intervention||0
8434855|NCT00834587|20786516|P1|NOT COMPLETED|First Intervention||0
8434856|NCT00834587|20786515|P2|COMPLETED|First Intervention||20
8434857|NCT00834587|20786516|P1|COMPLETED|First Intervention||20
8434858|NCT00834587|20786515|P2|STARTED|First Intervention||20
8434859|NCT00834587|20786516|P1|STARTED|First Intervention||20
8434860|NCT00834574|20786532|P2|NOT COMPLETED|Second Intervention||0
8434861|NCT00834574|20786533|P1|NOT COMPLETED|Second Intervention||0
8434862|NCT00834574|20786532|P2|COMPLETED|Second Intervention||16
8434863|NCT00834574|20786533|P1|COMPLETED|Second Intervention||16
8434864|NCT00834574|20786532|P2|STARTED|Second Intervention||16
8434865|NCT00834574|20786533|P1|STARTED|Second Intervention||16
8434866|NCT00834574|20786532|P2|NOT COMPLETED|Washout of 7 Days||0
8434867|NCT00834574|20786533|P1|NOT COMPLETED|Washout of 7 Days||0
8434868|NCT00834574|20786532|P2|COMPLETED|Washout of 7 Days||16
8434869|NCT00834574|20786533|P1|COMPLETED|Washout of 7 Days||16
8434870|NCT00834574|20786532|P2|STARTED|Washout of 7 Days||16
8434871|NCT00834574|20786533|P1|STARTED|Washout of 7 Days||16
8434872|NCT00834574|20786532|P2|NOT COMPLETED|First Intervention||0
8434873|NCT00834574|20786533|P1|NOT COMPLETED|First Intervention||0
8434874|NCT00834574|20786532|P2|COMPLETED|First Intervention||16
8434875|NCT00834574|20786533|P1|COMPLETED|First Intervention||16
8434876|NCT00834574|20786532|P2|STARTED|First Intervention||16
8434877|NCT00834574|20786533|P1|STARTED|First Intervention||16
8434878|NCT00834561|20786543|P2|NOT COMPLETED|Second Intervention||0
8434879|NCT00834561|20786544|P1|NOT COMPLETED|Second Intervention||0
8434880|NCT00834561|20786543|P2|COMPLETED|Second Intervention||16
8434881|NCT00834561|20786544|P1|COMPLETED|Second Intervention||16
8434882|NCT00834561|20786543|P2|STARTED|Second Intervention||16
8434883|NCT00834561|20786544|P1|STARTED|Second Intervention||16
8434884|NCT00834561|20786543|P2|NOT COMPLETED|First Intervention||0
8434885|NCT00834561|20786544|P1|NOT COMPLETED|First Intervention||0
8434886|NCT00834561|20786543|P2|COMPLETED|First Intervention||16
8434887|NCT00834561|20786544|P1|COMPLETED|First Intervention||16
8434888|NCT00834561|20786543|P2|STARTED|First Intervention||16
8434889|NCT00834561|20786544|P1|STARTED|First Intervention||16
8434890|NCT00834535|20786554|P2|NOT COMPLETED|Second Intervention||0
8434891|NCT00834535|20786555|P1|NOT COMPLETED|Second Intervention||0
8434892|NCT00834535|20786554|P2|COMPLETED|Second Intervention||16
8434893|NCT00834535|20786555|P1|COMPLETED|Second Intervention||16
8434894|NCT00834535|20786554|P2|STARTED|Second Intervention||16
8434895|NCT00834535|20786555|P1|STARTED|Second Intervention||16
8434896|NCT00834535|20786554|P2|NOT COMPLETED|Washout of 7 Days||0
8434897|NCT00834535|20786555|P1|NOT COMPLETED|Washout of 7 Days||0
8434898|NCT00834535|20786554|P2|COMPLETED|Washout of 7 Days||16
8434899|NCT00834535|20786555|P1|COMPLETED|Washout of 7 Days||16
8434900|NCT00834535|20786554|P2|STARTED|Washout of 7 Days||16
8434901|NCT00834535|20786555|P1|STARTED|Washout of 7 Days||16
8434902|NCT00834535|20786554|P2|NOT COMPLETED|First Intervention||0
8434903|NCT00834535|20786555|P1|NOT COMPLETED|First Intervention||0
8434904|NCT00834535|20786554|P2|COMPLETED|First Intervention||16
8434905|NCT00834535|20786555|P1|COMPLETED|First Intervention||16
8434906|NCT00834535|20786554|P2|STARTED|First Intervention||16
8434907|NCT00834535|20786555|P1|STARTED|First Intervention||16
8434908|NCT00834522|20786565|P2|NOT COMPLETED|Second Intervention||0
8434909|NCT00834522|20786566|P1|NOT COMPLETED|Second Intervention||0
8434910|NCT00834522|20786565|P2|COMPLETED|Second Intervention||39
8434911|NCT00834522|20786566|P1|COMPLETED|Second Intervention||37
8434912|NCT00834522|20786565|P2|STARTED|Second Intervention||39
8434913|NCT00834522|20786566|P1|STARTED|Second Intervention||37
8434914|NCT00834522|20786565|P2|NOT COMPLETED|Washout||1
8434915|NCT00834522|20786566|P1|NOT COMPLETED|Washout||3
8434916|NCT00834522|20786565|P2|COMPLETED|Washout||39
8434917|NCT00834522|20786566|P1|COMPLETED|Washout||37
8434918|NCT00834522|20786565|P2|STARTED|Washout||40
8434919|NCT00834522|20786566|P1|STARTED|Washout||40
8434920|NCT00834522|20786565|P2|NOT COMPLETED|First Intervention||0
8434921|NCT00834522|20786566|P1|NOT COMPLETED|First Intervention||0
8434922|NCT00834522|20786565|P2|COMPLETED|First Intervention||40
8434923|NCT00834522|20786566|P1|COMPLETED|First Intervention||40
8434924|NCT00834522|20786565|P2|STARTED|First Intervention||40
8434925|NCT00834522|20786566|P1|STARTED|First Intervention||40
8434926|NCT00834483|20786576|P2|NOT COMPLETED|Overall Study||0
8434927|NCT00834483|20786577|P1|NOT COMPLETED|Overall Study||0
8434928|NCT00834483|20786576|P2|COMPLETED|Overall Study||29
8434929|NCT00834483|20786577|P1|COMPLETED|Overall Study||31
8434930|NCT00834483|20786576|P2|STARTED|Overall Study||29
8434931|NCT00834483|20786577|P1|STARTED|Overall Study||31
8434932|NCT00834444|20786589|P2|NOT COMPLETED|Second Intervention||0
8434933|NCT00834444|20786590|P1|NOT COMPLETED|Second Intervention||1
8434934|NCT00834444|20786589|P2|COMPLETED|Second Intervention||16
8434935|NCT00834444|20786590|P1|COMPLETED|Second Intervention||16
8434936|NCT00834444|20786589|P2|STARTED|Second Intervention||16
8434937|NCT00834444|20786590|P1|STARTED|Second Intervention||17
8434938|NCT00834444|20786589|P2|NOT COMPLETED|Washout of 7 Days||1
8434939|NCT00834444|20786590|P1|NOT COMPLETED|Washout of 7 Days||0
8434940|NCT00834444|20786589|P2|COMPLETED|Washout of 7 Days||16
8434941|NCT00834444|20786590|P1|COMPLETED|Washout of 7 Days||17
8434942|NCT00834444|20786589|P2|STARTED|Washout of 7 Days||17
8434943|NCT00834444|20786590|P1|STARTED|Washout of 7 Days||17
8434944|NCT00834444|20786589|P2|NOT COMPLETED|First Intervention||1
8434945|NCT00834444|20786590|P1|NOT COMPLETED|First Intervention||1
8434946|NCT00834444|20786589|P2|COMPLETED|First Intervention||17
8434947|NCT00834444|20786590|P1|COMPLETED|First Intervention||17
8434948|NCT00834444|20786589|P2|STARTED|First Intervention||18
8434949|NCT00834444|20786590|P1|STARTED|First Intervention||18
8434950|NCT00834431|20786600|P2|NOT COMPLETED|Second Intervention||0
8434951|NCT00834431|20786601|P1|NOT COMPLETED|Second Intervention||0
8434952|NCT00834431|20786600|P2|COMPLETED|Second Intervention||16
8434953|NCT00834431|20786601|P1|COMPLETED|Second Intervention||18
8434954|NCT00834431|20786600|P2|STARTED|Second Intervention||16
8434955|NCT00834431|20786601|P1|STARTED|Second Intervention||18
8434956|NCT00834431|20786600|P2|NOT COMPLETED|Washout of 7 Days||1
8434957|NCT00834431|20786601|P1|NOT COMPLETED|Washout of 7 Days||0
8434958|NCT00834431|20786600|P2|COMPLETED|Washout of 7 Days||16
8434959|NCT00834431|20786601|P1|COMPLETED|Washout of 7 Days||18
8434960|NCT00834431|20786600|P2|STARTED|Washout of 7 Days||17
8434961|NCT00834431|20786601|P1|STARTED|Washout of 7 Days||18
8434962|NCT00834431|20786600|P2|NOT COMPLETED|First Intervention||1
8434963|NCT00834431|20786601|P1|NOT COMPLETED|First Intervention||0
8434964|NCT00834431|20786600|P2|COMPLETED|First Intervention||17
8434965|NCT00834431|20786601|P1|COMPLETED|First Intervention||18
8434966|NCT00834431|20786600|P2|STARTED|First Intervention||18
8434967|NCT00834431|20786601|P1|STARTED|First Intervention||18
8434968|NCT00834418|20786611|P2|NOT COMPLETED|Overall Study||2
8434969|NCT00834418|20786612|P1|NOT COMPLETED|Overall Study||0
8434970|NCT00834418|20786611|P2|COMPLETED|Overall Study||40
8434971|NCT00834418|20786612|P1|COMPLETED|Overall Study||42
8434972|NCT00834418|20786611|P2|STARTED|Overall Study||42
8434973|NCT00834418|20786612|P1|STARTED|Overall Study||42
8434974|NCT00834405|20786620|P2|NOT COMPLETED|Overall Study||0
8434975|NCT00834405|20786621|P1|NOT COMPLETED|Overall Study||0
8434976|NCT00834405|20786620|P2|COMPLETED|Overall Study||17
8434977|NCT00834405|20786621|P1|COMPLETED|Overall Study||20
8434978|NCT00834405|20786620|P2|STARTED|Overall Study||17
8434979|NCT00834405|20786621|P1|STARTED|Overall Study||20
8434980|NCT00834366|20786629|P2|NOT COMPLETED|Treatment Period 2||0
8434981|NCT00834366|20786630|P1|NOT COMPLETED|Treatment Period 2||0
8434982|NCT00834366|20786629|P2|COMPLETED|Treatment Period 2||12
8434983|NCT00834366|20786630|P1|COMPLETED|Treatment Period 2||12
8434984|NCT00834366|20786629|P2|STARTED|Treatment Period 2||12
8434985|NCT00834366|20786630|P1|STARTED|Treatment Period 2||12
8434986|NCT00834366|20786629|P2|NOT COMPLETED|Treatment Period 1||1
8434987|NCT00834366|20786630|P1|NOT COMPLETED|Treatment Period 1||1
8434988|NCT00834366|20786629|P2|COMPLETED|Treatment Period 1||12
8434989|NCT00834366|20786630|P1|COMPLETED|Treatment Period 1||12
8434990|NCT00834366|20786629|P2|STARTED|Treatment Period 1||13
8434991|NCT00834366|20786630|P1|STARTED|Treatment Period 1||13
8434992|NCT00834340|20786646|P2|NOT COMPLETED|Second Intervention||0
8434993|NCT00834340|20786647|P1|NOT COMPLETED|Second Intervention||0
8434994|NCT00834340|20786646|P2|COMPLETED|Second Intervention||16
8434995|NCT00834340|20786647|P1|COMPLETED|Second Intervention||14
8434996|NCT00834340|20786646|P2|STARTED|Second Intervention||16
8434997|NCT00834340|20786647|P1|STARTED|Second Intervention||14
8434998|NCT00834340|20786646|P2|NOT COMPLETED|Washout||0
8434999|NCT00834340|20786647|P1|NOT COMPLETED|Washout||2
8435000|NCT00834340|20786646|P2|COMPLETED|Washout||16
8435001|NCT00834340|20786647|P1|COMPLETED|Washout||14
8435002|NCT00834340|20786646|P2|STARTED|Washout||16
8435003|NCT00834340|20786647|P1|STARTED|Washout||16
8435004|NCT00834340|20786646|P2|NOT COMPLETED|First Intervention||0
8435005|NCT00834340|20786647|P1|NOT COMPLETED|First Intervention||0
8435006|NCT00834340|20786646|P2|COMPLETED|First Intervention||16
8435007|NCT00834340|20786647|P1|COMPLETED|First Intervention||16
8435008|NCT00834340|20786646|P2|STARTED|First Intervention||16
8435009|NCT00834340|20786647|P1|STARTED|First Intervention||16
8435010|NCT00834288|20786657|P2|NOT COMPLETED|Treatment Phase II||0
8435011|NCT00834288|20786658|P1|NOT COMPLETED|Treatment Phase II||0
8435012|NCT00834288|20786657|P2|COMPLETED|Treatment Phase II||13
8435013|NCT00834288|20786658|P1|COMPLETED|Treatment Phase II||13
8435014|NCT00834288|20786657|P2|STARTED|Treatment Phase II||13
8435015|NCT00834288|20786658|P1|STARTED|Treatment Phase II||13
8435016|NCT00834288|20786657|P2|NOT COMPLETED|Treatment Phase I||0
8435017|NCT00834288|20786658|P1|NOT COMPLETED|Treatment Phase I||0
8435018|NCT00834288|20786657|P2|COMPLETED|Treatment Phase I||13
8435019|NCT00834288|20786658|P1|COMPLETED|Treatment Phase I||13
8435020|NCT00834288|20786657|P2|STARTED|Treatment Phase I||13
8435021|NCT00834288|20786658|P1|STARTED|Treatment Phase I||13
8435022|NCT00834275|20786680|P2|NOT COMPLETED|Second Intervention||0
8435023|NCT00834275|20786681|P1|NOT COMPLETED|Second Intervention||0
8435024|NCT00834275|20786680|P2|COMPLETED|Second Intervention||13
8435025|NCT00834275|20786681|P1|COMPLETED|Second Intervention||13
8435026|NCT00834275|20786680|P2|STARTED|Second Intervention||13
8435027|NCT00834275|20786681|P1|STARTED|Second Intervention||13
8435028|NCT00834275|20786680|P2|NOT COMPLETED|Washout of 7 Days||0
8435029|NCT00834275|20786681|P1|NOT COMPLETED|Washout of 7 Days||0
8435030|NCT00834275|20786680|P2|COMPLETED|Washout of 7 Days||13
8435031|NCT00834275|20786681|P1|COMPLETED|Washout of 7 Days||13
8435032|NCT00834275|20786680|P2|STARTED|Washout of 7 Days||13
8435033|NCT00834275|20786681|P1|STARTED|Washout of 7 Days||13
8435034|NCT00834275|20786680|P2|NOT COMPLETED|First Intervention||0
8435035|NCT00834275|20786681|P1|NOT COMPLETED|First Intervention||0
8435036|NCT00834275|20786680|P2|COMPLETED|First Intervention||13
8435037|NCT00834275|20786681|P1|COMPLETED|First Intervention||13
8435038|NCT00834275|20786680|P2|STARTED|First Intervention||13
8435039|NCT00834275|20786681|P1|STARTED|First Intervention||13
8435040|NCT00834249|20786691|P2|NOT COMPLETED|Second Intervention||0
8435041|NCT00834249|20786692|P1|NOT COMPLETED|Second Intervention||1
8435042|NCT00834249|20786691|P2|COMPLETED|Second Intervention||8
8435043|NCT00834249|20786692|P1|COMPLETED|Second Intervention||7
8435044|NCT00834249|20786691|P2|STARTED|Second Intervention||8
8435045|NCT00834249|20786692|P1|STARTED|Second Intervention||8
8435046|NCT00834249|20786691|P2|NOT COMPLETED|Washout: 7 Days||1
8435047|NCT00834249|20786692|P1|NOT COMPLETED|Washout: 7 Days||1
8435048|NCT00834249|20786691|P2|COMPLETED|Washout: 7 Days||8
8435049|NCT00834249|20786692|P1|COMPLETED|Washout: 7 Days||8
8435050|NCT00834249|20786691|P2|STARTED|Washout: 7 Days||9
8435051|NCT00834249|20786692|P1|STARTED|Washout: 7 Days||9
8435052|NCT00834249|20786691|P2|NOT COMPLETED|First Intervention||0
8435053|NCT00834249|20786692|P1|NOT COMPLETED|First Intervention||0
8435054|NCT00834249|20786691|P2|COMPLETED|First Intervention||9
8435055|NCT00834249|20786692|P1|COMPLETED|First Intervention||9
8435056|NCT00834249|20786691|P2|STARTED|First Intervention||9
8435057|NCT00834249|20786692|P1|STARTED|First Intervention||9
8435058|NCT00834236|20786708|P2|NOT COMPLETED|Overall Study||0
8435059|NCT00834236|20786709|P1|NOT COMPLETED|Overall Study||0
8435060|NCT00834236|20786708|P2|COMPLETED|Overall Study||47
8435061|NCT00834236|20786709|P1|COMPLETED|Overall Study||29
8435062|NCT00834236|20786708|P2|STARTED|Overall Study||47
8435063|NCT00834236|20786709|P1|STARTED|Overall Study||29
8435064|NCT00834210|20786717|P2|NOT COMPLETED|Overall Study||8
8435065|NCT00834210|20786718|P1|NOT COMPLETED|Overall Study||3
8435066|NCT00834210|20786717|P2|COMPLETED|Overall Study||77
8435067|NCT00834210|20786718|P1|COMPLETED|Overall Study||83
8435068|NCT00834210|20786717|P2|STARTED|Overall Study||85
8435069|NCT00834210|20786718|P1|STARTED|Overall Study||86
8435070|NCT00834197|20786732|P2|NOT COMPLETED|Second Intervention||0
8435071|NCT00834197|20786733|P1|NOT COMPLETED|Second Intervention||0
8435072|NCT00834197|20786732|P2|COMPLETED|Second Intervention||16
8435073|NCT00834197|20786733|P1|COMPLETED|Second Intervention||16
8435074|NCT00834197|20786732|P2|STARTED|Second Intervention||16
8435075|NCT00834197|20786733|P1|STARTED|Second Intervention||16
8435076|NCT00834197|20786732|P2|NOT COMPLETED|Washout of 14 Days||0
8435077|NCT00834197|20786733|P1|NOT COMPLETED|Washout of 14 Days||0
8435078|NCT00834197|20786732|P2|COMPLETED|Washout of 14 Days||16
8435079|NCT00834197|20786733|P1|COMPLETED|Washout of 14 Days||16
8435080|NCT00834197|20786732|P2|STARTED|Washout of 14 Days||16
8435081|NCT00834197|20786733|P1|STARTED|Washout of 14 Days||16
8435082|NCT00834197|20786732|P2|NOT COMPLETED|First Intervention||0
8435083|NCT00834197|20786733|P1|NOT COMPLETED|First Intervention||0
8435084|NCT00834197|20786732|P2|COMPLETED|First Intervention||16
8435085|NCT00834197|20786733|P1|COMPLETED|First Intervention||16
8435086|NCT00834197|20786732|P2|STARTED|First Intervention||16
8435087|NCT00834197|20786733|P1|STARTED|First Intervention||16
8435088|NCT00834171|20786743|P2|NOT COMPLETED|Overall Study||0
8435089|NCT00834171|20786744|P1|NOT COMPLETED|Overall Study||0
8435090|NCT00834171|20786743|P2|COMPLETED|Overall Study||7
8435091|NCT00834171|20786744|P1|COMPLETED|Overall Study||43
8435092|NCT00834171|20786743|P2|STARTED|Overall Study||7
8435093|NCT00834171|20786744|P1|STARTED|Overall Study||43
8435094|NCT00834132|20786752|P2|NOT COMPLETED|Second Intervention||0
8435095|NCT00834132|20786753|P1|NOT COMPLETED|Second Intervention||0
8435096|NCT00834132|20786752|P2|COMPLETED|Second Intervention||12
8435097|NCT00834132|20786753|P1|COMPLETED|Second Intervention||12
8435098|NCT00834132|20786752|P2|STARTED|Second Intervention||12
8435099|NCT00834132|20786753|P1|STARTED|Second Intervention||12
8435100|NCT00834132|20786752|P2|NOT COMPLETED|Washout: 21 Days||0
8435101|NCT00834132|20786753|P1|NOT COMPLETED|Washout: 21 Days||0
8435102|NCT00834132|20786752|P2|COMPLETED|Washout: 21 Days||12
8435103|NCT00834132|20786753|P1|COMPLETED|Washout: 21 Days||12
8435104|NCT00834132|20786752|P2|STARTED|Washout: 21 Days||12
8435105|NCT00834132|20786753|P1|STARTED|Washout: 21 Days||12
8435106|NCT00834132|20786752|P2|NOT COMPLETED|First Intervention||0
8435107|NCT00834132|20786753|P1|NOT COMPLETED|First Intervention||0
8435108|NCT00834132|20786752|P2|COMPLETED|First Intervention||12
8435109|NCT00834132|20786753|P1|COMPLETED|First Intervention||12
8435110|NCT00834132|20786752|P2|STARTED|First Intervention||12
8435111|NCT00834132|20786753|P1|STARTED|First Intervention||12
8435112|NCT00834106|20786763|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
8435113|NCT00834106|20786764|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
8435114|NCT00834106|20786763|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
8435115|NCT00834106|20786764|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
8435116|NCT00834106|20786763|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
8435117|NCT00834106|20786764|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
8435118|NCT00834106|20786763|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
8435119|NCT00834106|20786764|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
8435120|NCT00834106|20786763|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
8435121|NCT00834106|20786764|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
8435122|NCT00834106|20786763|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
8435123|NCT00834106|20786764|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
8435124|NCT00834106|20786763|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
8435125|NCT00834106|20786764|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
8435126|NCT00834106|20786763|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
8435127|NCT00834106|20786764|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
8435128|NCT00834080|20786788|P1|NOT COMPLETED|Overall Study||23
8435129|NCT00834080|20786788|P1|COMPLETED|Overall Study||15
8435130|NCT00834080|20786788|P1|STARTED|Overall Study||38
8435131|NCT00834067|20786794|P2|NOT COMPLETED|Second Intervention||0
8435132|NCT00834067|20786795|P1|NOT COMPLETED|Second Intervention||0
8435133|NCT00834067|20786794|P2|COMPLETED|Second Intervention||29
8435134|NCT00834067|20786795|P1|COMPLETED|Second Intervention||30
8435135|NCT00834067|20786794|P2|STARTED|Second Intervention||29
8435136|NCT00834067|20786795|P1|STARTED|Second Intervention||30
8435137|NCT00834067|20786794|P2|NOT COMPLETED|Washout of 21 Days||1
8435138|NCT00834067|20786795|P1|NOT COMPLETED|Washout of 21 Days||0
8435139|NCT00834067|20786794|P2|COMPLETED|Washout of 21 Days||29
8435140|NCT00834067|20786795|P1|COMPLETED|Washout of 21 Days||30
8435141|NCT00834067|20786794|P2|STARTED|Washout of 21 Days||30
8435142|NCT00834067|20786795|P1|STARTED|Washout of 21 Days||30
8435143|NCT00834067|20786794|P2|NOT COMPLETED|First Intervention||0
8435144|NCT00834067|20786795|P1|NOT COMPLETED|First Intervention||0
8435145|NCT00834067|20786794|P2|COMPLETED|First Intervention||30
8435146|NCT00834067|20786795|P1|COMPLETED|First Intervention||30
8435147|NCT00834067|20786794|P2|STARTED|First Intervention||30
8435148|NCT00834067|20786795|P1|STARTED|First Intervention||30
8435149|NCT00834041|20786817|P2|NOT COMPLETED|Overall Study||1
8435150|NCT00834041|20786818|P1|NOT COMPLETED|Overall Study||1
8435151|NCT00834041|20786817|P2|COMPLETED|Overall Study||19
8435152|NCT00834041|20786818|P1|COMPLETED|Overall Study||18
8435153|NCT00834041|20786817|P2|STARTED|Overall Study||20
8435154|NCT00834041|20786818|P1|STARTED|Overall Study||19
8435155|NCT00833989|20786836|P4|NOT COMPLETED|Overall Study||2
8435156|NCT00833989|20786837|P3|NOT COMPLETED|Overall Study||1
8435157|NCT00833989|20786838|P2|NOT COMPLETED|Overall Study||0
8435158|NCT00833989|20786839|P1|NOT COMPLETED|Overall Study||3
8435159|NCT00833989|20786836|P4|COMPLETED|Overall Study||6
8435160|NCT00833989|20786837|P3|COMPLETED|Overall Study||8
8435161|NCT00833989|20786838|P2|COMPLETED|Overall Study||8
8435162|NCT00833989|20786839|P1|COMPLETED|Overall Study||14
8435163|NCT00833989|20786836|P4|STARTED|Overall Study||8
8435164|NCT00833989|20786837|P3|STARTED|Overall Study||9
8435165|NCT00833989|20786838|P2|STARTED|Overall Study||8
8435166|NCT00833989|20786839|P1|STARTED|Overall Study||17
8435167|NCT00833976|20786943|P1|NOT COMPLETED|Overall Study||51
8435168|NCT00833976|20786943|P1|COMPLETED|Overall Study||14
8435169|NCT00833976|20786943|P1|STARTED|Overall Study||65
8435170|NCT00833937|20786951|P2|NOT COMPLETED|Second Intervention||0
8435171|NCT00833937|20786952|P1|NOT COMPLETED|Second Intervention||0
8435172|NCT00833937|20786951|P2|COMPLETED|Second Intervention||12
8435173|NCT00833937|20786952|P1|COMPLETED|Second Intervention||11
8435174|NCT00833937|20786951|P2|STARTED|Second Intervention||12
8435175|NCT00833937|20786952|P1|STARTED|Second Intervention||11
8435176|NCT00833937|20786951|P2|NOT COMPLETED|Washout||0
8435177|NCT00833937|20786952|P1|NOT COMPLETED|Washout||1
8435178|NCT00833937|20786951|P2|COMPLETED|Washout||12
8435179|NCT00833937|20786952|P1|COMPLETED|Washout||11
8435180|NCT00833937|20786951|P2|STARTED|Washout||12
8435181|NCT00833937|20786952|P1|STARTED|Washout||12
8435182|NCT00833937|20786951|P2|NOT COMPLETED|First Intervention||0
8435183|NCT00833937|20786952|P1|NOT COMPLETED|First Intervention||0
8435184|NCT00833937|20786951|P2|COMPLETED|First Intervention||12
8435185|NCT00833937|20786952|P1|COMPLETED|First Intervention||12
8435186|NCT00833937|20786951|P2|STARTED|First Intervention||12
8435187|NCT00833937|20786952|P1|STARTED|First Intervention||12
8435188|NCT00833924|20786960|P1|NOT COMPLETED|Overall Study||109
8435189|NCT00833924|20786960|P1|COMPLETED|Overall Study||11
8435190|NCT00833924|20786960|P1|12-month|Overall Study||113
8435191|NCT00833924|20786960|P1|30-day|Overall Study||120
8435192|NCT00833924|20786960|P1|STARTED|Overall Study||120
8435193|NCT00833911|20786965|P1|NOT COMPLETED|Maintenance Phase II||10
8435194|NCT00833911|20786965|P1|COMPLETED|Maintenance Phase II||166
8435195|NCT00833911|20786965|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
8435196|NCT00833911|20786965|P1|NOT COMPLETED|Maintenance Phase I||98
8435197|NCT00833911|20786965|P1|COMPLETED|Maintenance Phase I||273
8435198|NCT00833911|20786965|P1|STARTED|Maintenance Phase I||371
8435199|NCT00833911|20786965|P1|NOT COMPLETED|Titration||21
8435200|NCT00833911|20786965|P1|COMPLETED|Titration||371
8435201|NCT00833911|20786965|P1|STARTED|Titration||392
8435202|NCT00833898|20786975|P2|NOT COMPLETED|Overall Study||36
8435203|NCT00833898|20786976|P1|NOT COMPLETED|Overall Study||40
8435204|NCT00833898|20786975|P2|COMPLETED|Overall Study||38
8435205|NCT00833898|20786976|P1|COMPLETED|Overall Study||34
8435206|NCT00833898|20786975|P2|Month 12 (Post Transplantation)|Overall Study||50
8435207|NCT00833898|20786976|P1|Month 12 (Post Transplantation)|Overall Study||50
8435208|NCT00833898|20786975|P2|Month 6 (Post Transplantation)|Overall Study||54
8435209|NCT00833898|20786976|P1|Month 6 (Post Transplantation)|Overall Study||59
8435210|NCT00833898|20786975|P2|Month 3 (Post Transplantation)|Overall Study||64
8435211|NCT00833898|20786976|P1|Month 3 (Post Transplantation)|Overall Study||66
8435212|NCT00833898|20786975|P2|Month 1 (Post Transplantation)|Overall Study||74
8435213|NCT00833898|20786976|P1|Month 1 (Post Transplantation)|Overall Study||72
8435214|NCT00833898|20786975|P2|STARTED|Overall Study||74
8435215|NCT00833898|20786976|P1|STARTED|Overall Study||74
8435216|NCT00833859|20787022|P1|NOT COMPLETED|Overall Study||0
8435217|NCT00833859|20787022|P1|COMPLETED|Overall Study||2
8435218|NCT00833859|20787022|P1|STARTED|Overall Study||2
8435219|NCT00833833|20787035|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
8435220|NCT00833833|20787036|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
8435221|NCT00833833|20787037|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435222|NCT00833833|20787038|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435223|NCT00833833|20787039|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435224|NCT00833833|20787040|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435225|NCT00833833|20787035|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
8435226|NCT00833833|20787036|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
8435227|NCT00833833|20787037|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435228|NCT00833833|20787038|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435229|NCT00833833|20787039|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435230|NCT00833833|20787040|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435231|NCT00833833|20787035|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
8435232|NCT00833833|20787036|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
8435233|NCT00833833|20787037|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
8435234|NCT00833833|20787038|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
8435235|NCT00833833|20787039|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
8435236|NCT00833833|20787040|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
8435237|NCT00833833|20787035|P6|STARTED|Phase 2 (as of 01 April 2011)||108
8435238|NCT00833833|20787036|P5|STARTED|Phase 2 (as of 01 April 2011)||113
8435239|NCT00833833|20787037|P4|STARTED|Phase 2 (as of 01 April 2011)||0
8435240|NCT00833833|20787038|P3|STARTED|Phase 2 (as of 01 April 2011)||0
8435241|NCT00833833|20787039|P2|STARTED|Phase 2 (as of 01 April 2011)||0
8435242|NCT00833833|20787040|P1|STARTED|Phase 2 (as of 01 April 2011)||0
8435243|NCT00833833|20787035|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
8435244|NCT00833833|20787036|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
8435245|NCT00833833|20787037|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
8435246|NCT00833833|20787038|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
8435247|NCT00833833|20787039|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
8435248|NCT00833833|20787040|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
8435249|NCT00833833|20787035|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
8435250|NCT00833833|20787036|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
8435251|NCT00833833|20787037|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
8435252|NCT00833833|20787038|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
8435253|NCT00833833|20787039|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
8435254|NCT00833833|20787040|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
8435255|NCT00833833|20787035|P6|STARTED|Phase 1 (as of 01 April 2011)||0
8435256|NCT00833833|20787036|P5|STARTED|Phase 1 (as of 01 April 2011)||0
8435257|NCT00833833|20787037|P4|STARTED|Phase 1 (as of 01 April 2011)||10
8435258|NCT00833833|20787038|P3|STARTED|Phase 1 (as of 01 April 2011)||14
8435259|NCT00833833|20787039|P2|STARTED|Phase 1 (as of 01 April 2011)||8
8435260|NCT00833833|20787040|P1|STARTED|Phase 1 (as of 01 April 2011)||6
8435261|NCT00833794|20787080|P2|NOT COMPLETED|Double-blind Phase||49
8435262|NCT00833794|20787081|P1|NOT COMPLETED|Double-blind Phase||106
8435263|NCT00833794|20787080|P2|COMPLETED|Double-blind Phase||165
8435264|NCT00833794|20787081|P1|COMPLETED|Double-blind Phase||326
8435265|NCT00833794|20787080|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
8435266|NCT00833794|20787081|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
8435267|NCT00833794|20787080|P2|NOT COMPLETED|Open-label Phase||0
8435268|NCT00833794|20787081|P1|NOT COMPLETED|Open-label Phase||382
8435269|NCT00833794|20787080|P2|COMPLETED|Open-label Phase||0
8435357|NCT00833586|20787345|P1|NOT COMPLETED|Washout: 14 Days||0
8435270|NCT00833794|20787081|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
8435271|NCT00833794|20787080|P2|Received Open-Label Treatment|Open-label Phase||0
8435272|NCT00833794|20787081|P1|Received Open-Label Treatment|Open-label Phase||1023
8435273|NCT00833794|20787080|P2|Entered run-in Period|Open-label Phase||0
8435274|NCT00833794|20787081|P1|Entered run-in Period|Open-label Phase||1027
8435275|NCT00833794|20787080|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
8435276|NCT00833794|20787081|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
8435277|NCT00833781|20787109|P2|NOT COMPLETED|Overall Study||0
8435278|NCT00833781|20787110|P1|NOT COMPLETED|Overall Study||0
8435279|NCT00833781|20787109|P2|COMPLETED|Overall Study||5
8435280|NCT00833781|20787110|P1|COMPLETED|Overall Study||10
8435281|NCT00833781|20787109|P2|STARTED|Overall Study||5
8435282|NCT00833781|20787110|P1|STARTED|Overall Study||10
8435283|NCT00833755|20787125|P4|NOT COMPLETED|Overall Study||6
8435284|NCT00833755|20787126|P3|NOT COMPLETED|Overall Study||2
8435285|NCT00833755|20787127|P2|NOT COMPLETED|Overall Study||5
8435286|NCT00833755|20787128|P1|NOT COMPLETED|Overall Study||4
8435287|NCT00833755|20787125|P4|COMPLETED|Overall Study||17
8435288|NCT00833755|20787126|P3|COMPLETED|Overall Study||20
8435289|NCT00833755|20787127|P2|COMPLETED|Overall Study||13
8435290|NCT00833755|20787128|P1|COMPLETED|Overall Study||12
8435291|NCT00833755|20787125|P4|STARTED|Overall Study||23
8435292|NCT00833755|20787126|P3|STARTED|Overall Study||22
8435293|NCT00833755|20787127|P2|STARTED|Overall Study||18
8435294|NCT00833755|20787128|P1|STARTED|Overall Study||16
8435295|NCT00833703|20787148|P2|NOT COMPLETED|Overall Study||1
8435296|NCT00833703|20787149|P1|NOT COMPLETED|Overall Study||0
8435297|NCT00833703|20787148|P2|COMPLETED|Overall Study|Completed follow-up|25
8435298|NCT00833703|20787149|P1|COMPLETED|Overall Study|Completed follow-up|23
8435299|NCT00833703|20787148|P2|Completed Treatment|Overall Study||24
8435300|NCT00833703|20787149|P1|Completed Treatment|Overall Study||22
8435301|NCT00833703|20787148|P2|Treated|Overall Study||26
8435302|NCT00833703|20787149|P1|Treated|Overall Study||23
8435303|NCT00833703|20787148|P2|STARTED|Overall Study|Included|26
8435304|NCT00833703|20787149|P1|STARTED|Overall Study|Included|23
8435305|NCT00833690|20787162|P3|NOT COMPLETED|Overall Study||0
8435306|NCT00833690|20787163|P2|NOT COMPLETED|Overall Study||2
8435307|NCT00833690|20787164|P1|NOT COMPLETED|Overall Study||4
8435308|NCT00833690|20787162|P3|COMPLETED|Overall Study||26
8435309|NCT00833690|20787163|P2|COMPLETED|Overall Study||22
8435310|NCT00833690|20787164|P1|COMPLETED|Overall Study||21
8435311|NCT00833690|20787162|P3|STARTED|Overall Study||26
8435312|NCT00833690|20787163|P2|STARTED|Overall Study||24
8435313|NCT00833690|20787164|P1|STARTED|Overall Study||25
8435314|NCT00833664|20787288|P2|NOT COMPLETED|Second Intervention||0
8435315|NCT00833664|20787289|P1|NOT COMPLETED|Second Intervention||0
8435316|NCT00833664|20787288|P2|COMPLETED|Second Intervention||11
8435317|NCT00833664|20787289|P1|COMPLETED|Second Intervention||10
8435318|NCT00833664|20787288|P2|STARTED|Second Intervention||11
8435319|NCT00833664|20787289|P1|STARTED|Second Intervention||10
8435320|NCT00833664|20787288|P2|NOT COMPLETED|Washout: 14 Days||0
8435321|NCT00833664|20787289|P1|NOT COMPLETED|Washout: 14 Days||1
8435322|NCT00833664|20787288|P2|COMPLETED|Washout: 14 Days||11
8435323|NCT00833664|20787289|P1|COMPLETED|Washout: 14 Days||10
8435324|NCT00833664|20787288|P2|STARTED|Washout: 14 Days||11
8435325|NCT00833664|20787289|P1|STARTED|Washout: 14 Days||11
8435326|NCT00833664|20787288|P2|NOT COMPLETED|First Intervention||0
8435327|NCT00833664|20787289|P1|NOT COMPLETED|First Intervention||0
8435328|NCT00833664|20787288|P2|COMPLETED|First Intervention||11
8435329|NCT00833664|20787289|P1|COMPLETED|First Intervention||11
8435330|NCT00833664|20787288|P2|STARTED|First Intervention||11
8435331|NCT00833664|20787289|P1|STARTED|First Intervention||11
8435332|NCT00833638|20787300|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
8435333|NCT00833638|20787301|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
8435334|NCT00833638|20787302|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
8435335|NCT00833638|20787300|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
8435336|NCT00833638|20787301|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
8435337|NCT00833638|20787302|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
8435338|NCT00833638|20787300|P3|STARTED|Phase 3: Open-label Extension Phase||124
8435339|NCT00833638|20787301|P2|STARTED|Phase 3: Open-label Extension Phase||108
8435340|NCT00833638|20787302|P1|STARTED|Phase 3: Open-label Extension Phase||111
8435341|NCT00833638|20787300|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
8435342|NCT00833638|20787301|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
8435343|NCT00833638|20787302|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
8435344|NCT00833638|20787300|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
8435345|NCT00833638|20787301|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
8435346|NCT00833638|20787302|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
8435347|NCT00833638|20787300|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
8435348|NCT00833638|20787301|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
8435349|NCT00833638|20787302|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
8435350|NCT00833586|20787344|P2|NOT COMPLETED|Second Intervention||0
8435351|NCT00833586|20787345|P1|NOT COMPLETED|Second Intervention||0
8435352|NCT00833586|20787344|P2|COMPLETED|Second Intervention||14
8435353|NCT00833586|20787345|P1|COMPLETED|Second Intervention||14
8435354|NCT00833586|20787344|P2|STARTED|Second Intervention||14
8435355|NCT00833586|20787345|P1|STARTED|Second Intervention||14
8435356|NCT00833586|20787344|P2|NOT COMPLETED|Washout: 14 Days||0
8435358|NCT00833586|20787344|P2|COMPLETED|Washout: 14 Days||14
8435359|NCT00833586|20787345|P1|COMPLETED|Washout: 14 Days||14
8435360|NCT00833586|20787344|P2|STARTED|Washout: 14 Days||14
8435361|NCT00833586|20787345|P1|STARTED|Washout: 14 Days||14
8435362|NCT00833586|20787344|P2|NOT COMPLETED|First Intervention||0
8435363|NCT00833586|20787345|P1|NOT COMPLETED|First Intervention||0
8435364|NCT00833586|20787344|P2|COMPLETED|First Intervention||14
8435365|NCT00833586|20787345|P1|COMPLETED|First Intervention||14
8435366|NCT00833586|20787344|P2|STARTED|First Intervention||14
8435367|NCT00833586|20787345|P1|STARTED|First Intervention||14
8435368|NCT00833560|20787353|P1|NOT COMPLETED|Overall Study||42
8435369|NCT00833560|20787353|P1|COMPLETED|Overall Study||353
8435370|NCT00833560|20787353|P1|STARTED|Overall Study||395
8435371|NCT00833547|20787362|P2|NOT COMPLETED|Overall Study||2
8435372|NCT00833547|20787363|P1|NOT COMPLETED|Overall Study||2
8435373|NCT00833547|20787362|P2|COMPLETED|Overall Study||10
8435374|NCT00833547|20787363|P1|COMPLETED|Overall Study||11
8435375|NCT00833547|20787362|P2|STARTED|Overall Study||12
8435376|NCT00833547|20787363|P1|STARTED|Overall Study||13
8435377|NCT00833521|20787373|P2|NOT COMPLETED|Second Intervention||0
8435378|NCT00833521|20787374|P1|NOT COMPLETED|Second Intervention||0
8435379|NCT00833521|20787373|P2|COMPLETED|Second Intervention||19
8435380|NCT00833521|20787374|P1|COMPLETED|Second Intervention||19
8435381|NCT00833521|20787373|P2|STARTED|Second Intervention||19
8435382|NCT00833521|20787374|P1|STARTED|Second Intervention||19
8435383|NCT00833521|20787373|P2|NOT COMPLETED|First Intervention||0
8435384|NCT00833521|20787374|P1|NOT COMPLETED|First Intervention||0
8435385|NCT00833521|20787373|P2|COMPLETED|First Intervention||19
8435386|NCT00833521|20787374|P1|COMPLETED|First Intervention||19
8435387|NCT00833521|20787373|P2|STARTED|First Intervention||19
8435388|NCT00833521|20787374|P1|STARTED|First Intervention||19
8435389|NCT00833482|20787384|P6|NOT COMPLETED|Days 21-30||0
8435390|NCT00833482|20787385|P5|NOT COMPLETED|Days 21-30||1
8435391|NCT00833482|20787386|P4|NOT COMPLETED|Days 21-30||0
8435392|NCT00833482|20787387|P3|NOT COMPLETED|Days 21-30||1
8435393|NCT00833482|20787388|P2|NOT COMPLETED|Days 21-30||0
8435394|NCT00833482|20787389|P1|NOT COMPLETED|Days 21-30||0
8435395|NCT00833482|20787384|P6|COMPLETED|Days 21-30||0
8435396|NCT00833482|20787385|P5|COMPLETED|Days 21-30||7
8435397|NCT00833482|20787386|P4|COMPLETED|Days 21-30||0
8435398|NCT00833482|20787387|P3|COMPLETED|Days 21-30||20
8435399|NCT00833482|20787388|P2|COMPLETED|Days 21-30||0
8435400|NCT00833482|20787389|P1|COMPLETED|Days 21-30||0
8435401|NCT00833482|20787384|P6|STARTED|Days 21-30||0
8435402|NCT00833482|20787385|P5|STARTED|Days 21-30||8
8435403|NCT00833482|20787386|P4|STARTED|Days 21-30||0
8435404|NCT00833482|20787387|P3|STARTED|Days 21-30||21
8435405|NCT00833482|20787388|P2|STARTED|Days 21-30||0
8435406|NCT00833482|20787389|P1|STARTED|Days 21-30||0
8435407|NCT00833482|20787384|P6|NOT COMPLETED|Days 11-20||0
8435408|NCT00833482|20787385|P5|NOT COMPLETED|Days 11-20||0
8435409|NCT00833482|20787386|P4|NOT COMPLETED|Days 11-20||0
8435410|NCT00833482|20787387|P3|NOT COMPLETED|Days 11-20||0
8435411|NCT00833482|20787388|P2|NOT COMPLETED|Days 11-20||3
8435412|NCT00833482|20787389|P1|NOT COMPLETED|Days 11-20||0
8435413|NCT00833482|20787384|P6|COMPLETED|Days 11-20||8
8435414|NCT00833482|20787385|P5|COMPLETED|Days 11-20||0
8435415|NCT00833482|20787386|P4|COMPLETED|Days 11-20||0
8435416|NCT00833482|20787387|P3|COMPLETED|Days 11-20||0
8435417|NCT00833482|20787388|P2|COMPLETED|Days 11-20||21
8435418|NCT00833482|20787389|P1|COMPLETED|Days 11-20||0
8435419|NCT00833482|20787384|P6|STARTED|Days 11-20|Participants who received treatment.|8
8435420|NCT00833482|20787385|P5|STARTED|Days 11-20||0
8435421|NCT00833482|20787386|P4|STARTED|Days 11-20||0
8435422|NCT00833482|20787387|P3|STARTED|Days 11-20||0
8435423|NCT00833482|20787388|P2|STARTED|Days 11-20|Participants who received treatment.|24
8435424|NCT00833482|20787389|P1|STARTED|Days 11-20||0
8435425|NCT00833482|20787384|P6|NOT COMPLETED|Days 1-3||0
8435426|NCT00833482|20787385|P5|NOT COMPLETED|Days 1-3||0
8435427|NCT00833482|20787386|P4|NOT COMPLETED|Days 1-3||0
8435428|NCT00833482|20787387|P3|NOT COMPLETED|Days 1-3||0
8435429|NCT00833482|20787388|P2|NOT COMPLETED|Days 1-3||0
8435430|NCT00833482|20787389|P1|NOT COMPLETED|Days 1-3||0
8435431|NCT00833482|20787384|P6|COMPLETED|Days 1-3||0
8435432|NCT00833482|20787385|P5|COMPLETED|Days 1-3||0
8435433|NCT00833482|20787386|P4|COMPLETED|Days 1-3||8
8435434|NCT00833482|20787387|P3|COMPLETED|Days 1-3||0
8435435|NCT00833482|20787388|P2|COMPLETED|Days 1-3||0
8435436|NCT00833482|20787389|P1|COMPLETED|Days 1-3||24
8435437|NCT00833482|20787384|P6|STARTED|Days 1-3||0
8435438|NCT00833482|20787385|P5|STARTED|Days 1-3||0
8435439|NCT00833482|20787386|P4|STARTED|Days 1-3||8
8435440|NCT00833482|20787387|P3|STARTED|Days 1-3||0
8435441|NCT00833482|20787388|P2|STARTED|Days 1-3|Participants who received treatment|0
8435442|NCT00833482|20787389|P1|STARTED|Days 1-3|Participants who received treatment|24
8435443|NCT00833469|20787445|P1|NOT COMPLETED|Overall Study||2
8435444|NCT00833469|20787445|P1|COMPLETED|Overall Study||3
8435445|NCT00833469|20787445|P1|STARTED|Overall Study||5
8435446|NCT00833443|20787453|P2|NOT COMPLETED|Overall Study||28
8435447|NCT00833443|20787454|P1|NOT COMPLETED|Overall Study||20
8435448|NCT00833443|20787453|P2|COMPLETED|Overall Study||15
8435449|NCT00833443|20787454|P1|COMPLETED|Overall Study||21
8435450|NCT00833443|20787453|P2|STARTED|Overall Study||43
8435451|NCT00833443|20787454|P1|STARTED|Overall Study||41
8435452|NCT00833417|20787468|P2|NOT COMPLETED|Overall Study||71
8435453|NCT00833417|20787469|P1|NOT COMPLETED|Overall Study||33
8435454|NCT00833417|20787468|P2|COMPLETED|Overall Study||0
8435455|NCT00833417|20787469|P1|COMPLETED|Overall Study||0
8435456|NCT00833417|20787468|P2|STARTED|Overall Study||71
8435457|NCT00833417|20787469|P1|STARTED|Overall Study||33
8435458|NCT00833365|20787484|P2|NOT COMPLETED|Overall Study||0
8435459|NCT00833365|20787485|P1|NOT COMPLETED|Overall Study||0
8435460|NCT00833365|20787484|P2|COMPLETED|Overall Study||6
8435461|NCT00833365|20787485|P1|COMPLETED|Overall Study||9
8435462|NCT00833365|20787484|P2|STARTED|Overall Study||6
8435463|NCT00833365|20787485|P1|STARTED|Overall Study||9
8435464|NCT00833261|20787493|P1|NOT COMPLETED|Overall Study||4
8435465|NCT00833261|20787493|P1|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
8435466|NCT00833261|20787493|P1|STARTED|Overall Study||37
8435467|NCT00833248|20787500|P2|NOT COMPLETED|Overall Study||3
8435468|NCT00833248|20787501|P1|NOT COMPLETED|Overall Study||4
8435469|NCT00833248|20787500|P2|COMPLETED|Overall Study||62
8435470|NCT00833248|20787501|P1|COMPLETED|Overall Study||177
8435471|NCT00833248|20787500|P2|Safety Analysis Set|Overall Study||64
8435472|NCT00833248|20787501|P1|Safety Analysis Set|Overall Study||181
8435473|NCT00833248|20787500|P2|Per Protocol (PP) Analysis Set|Overall Study||57
8435474|NCT00833248|20787501|P1|Per Protocol (PP) Analysis Set|Overall Study||164
8435475|NCT00833248|20787500|P2|Full Analysis Set (FAS)|Overall Study||64
8435476|NCT00833248|20787501|P1|Full Analysis Set (FAS)|Overall Study||180
8435477|NCT00833248|20787500|P2|STARTED|Overall Study||65
8435478|NCT00833248|20787501|P1|STARTED|Overall Study||181
8435479|NCT00833105|20787523|P1|NOT COMPLETED|Overall Study||3
8435480|NCT00833105|20787523|P1|COMPLETED|Overall Study||10
8435481|NCT00833105|20787523|P1|STARTED|Overall Study||13
8435482|NCT00833092|20787541|P2|NOT COMPLETED|Overall Study||7
8435483|NCT00833092|20787542|P1|NOT COMPLETED|Overall Study||4
8435484|NCT00833092|20787541|P2|COMPLETED|Overall Study||50
8435485|NCT00833092|20787542|P1|COMPLETED|Overall Study||50
8435486|NCT00833092|20787541|P2|STARTED|Overall Study||57
8435487|NCT00833092|20787542|P1|STARTED|Overall Study||54
8435488|NCT00833053|20787550|P2|NOT COMPLETED|Overall Study||3
8435489|NCT00833053|20787551|P1|NOT COMPLETED|Overall Study||9
8435490|NCT00833053|20787550|P2|COMPLETED|Overall Study||17
8435491|NCT00833053|20787551|P1|COMPLETED|Overall Study||10
8435492|NCT00833053|20787550|P2|STARTED|Overall Study||20
8435493|NCT00833053|20787551|P1|STARTED|Overall Study||19
8435494|NCT00833040|20787569|P6|NOT COMPLETED|Overall Study||1
8435495|NCT00833040|20787570|P5|NOT COMPLETED|Overall Study||0
8435496|NCT00833040|20787571|P4|NOT COMPLETED|Overall Study||0
8435497|NCT00833040|20787572|P3|NOT COMPLETED|Overall Study||0
8435498|NCT00833040|20787573|P2|NOT COMPLETED|Overall Study||0
8435499|NCT00833040|20787574|P1|NOT COMPLETED|Overall Study||0
8435500|NCT00833040|20787569|P6|COMPLETED|Overall Study||4
8435501|NCT00833040|20787570|P5|COMPLETED|Overall Study||5
8435502|NCT00833040|20787571|P4|COMPLETED|Overall Study||6
8435503|NCT00833040|20787572|P3|COMPLETED|Overall Study||6
8435504|NCT00833040|20787573|P2|COMPLETED|Overall Study||6
8435505|NCT00833040|20787574|P1|COMPLETED|Overall Study||6
8435506|NCT00833040|20787569|P6|STARTED|Overall Study||5
8435507|NCT00833040|20787570|P5|STARTED|Overall Study||5
8435508|NCT00833040|20787571|P4|STARTED|Overall Study||6
8435509|NCT00833040|20787572|P3|STARTED|Overall Study||6
8435510|NCT00833040|20787573|P2|STARTED|Overall Study||6
8435511|NCT00833040|20787574|P1|STARTED|Overall Study||6
8435512|NCT00833027|20787579|P1|NOT COMPLETED|Overall Study||211
8435513|NCT00833027|20787579|P1|COMPLETED|Overall Study||397
8435514|NCT00833027|20787579|P1|STARTED|Overall Study||608
8435515|NCT00832975|20787584|P1|NOT COMPLETED|Overall Study||39
8435516|NCT00832975|20787584|P1|COMPLETED|Overall Study||118
8435517|NCT00832975|20787584|P1|STARTED|Overall Study||157
8435518|NCT00832871|20787589|P1|NOT COMPLETED|Overall Study||0
8435519|NCT00832871|20787589|P1|COMPLETED|Overall Study||4
8435520|NCT00832871|20787589|P1|STARTED|Overall Study||4
8435521|NCT00832819|20787598|P3|NOT COMPLETED|Overall Study||1
8435522|NCT00832819|20787599|P2|NOT COMPLETED|Overall Study||1
8435523|NCT00832819|20787600|P1|NOT COMPLETED|Overall Study||0
8435524|NCT00832819|20787598|P3|COMPLETED|Overall Study||15
8435525|NCT00832819|20787599|P2|COMPLETED|Overall Study||5
8435526|NCT00832819|20787600|P1|COMPLETED|Overall Study||6
8435527|NCT00832819|20787598|P3|STARTED|Overall Study||16
8435528|NCT00832819|20787599|P2|STARTED|Overall Study||6
8435529|NCT00832819|20787600|P1|STARTED|Overall Study||6
8435530|NCT00832780|20787606|P1|NOT COMPLETED|Overall Study||25
8435531|NCT00832780|20787606|P1|COMPLETED|Overall Study||19
8435532|NCT00832780|20787606|P1|STARTED|Overall Study||44
8435533|NCT00832767|20787616|P2|NOT COMPLETED|Overall Study||18
8435534|NCT00832767|20787617|P1|NOT COMPLETED|Overall Study||22
8435535|NCT00832767|20787616|P2|COMPLETED|Overall Study||63
8435536|NCT00832767|20787617|P1|COMPLETED|Overall Study||99
8435537|NCT00832767|20787616|P2|STARTED|Overall Study||81
8435538|NCT00832767|20787617|P1|STARTED|Overall Study||121
8435539|NCT00832650|20787648|P3|NOT COMPLETED|Overall Study||1
8435540|NCT00832650|20787649|P2|NOT COMPLETED|Overall Study||0
8435541|NCT00832650|20787650|P1|NOT COMPLETED|Overall Study||0
8435542|NCT00832650|20787648|P3|COMPLETED|Overall Study||22
8435543|NCT00832650|20787649|P2|COMPLETED|Overall Study||12
8435544|NCT00832650|20787650|P1|COMPLETED|Overall Study||25
8435545|NCT00832650|20787648|P3|Treated|Overall Study||22
8435546|NCT00832650|20787649|P2|Treated|Overall Study||12
8435547|NCT00832650|20787650|P1|Treated|Overall Study||25
8435548|NCT00832650|20787648|P3|STARTED|Overall Study||23
8435549|NCT00832650|20787649|P2|STARTED|Overall Study||12
8435550|NCT00832650|20787650|P1|STARTED|Overall Study||25
8435551|NCT00832637|20787682|P1|NOT COMPLETED|Overall Study||0
8435552|NCT00832637|20787682|P1|COMPLETED|Overall Study||33
8435553|NCT00832637|20787682|P1|STARTED|Overall Study||33
8435554|NCT00832624|20787690|P1|NOT COMPLETED|Overall Study||10
8435555|NCT00832624|20787690|P1|COMPLETED|Overall Study||0
8435556|NCT00832624|20787690|P1|STARTED|Overall Study||10
8435557|NCT00832598|20787694|P1|NOT COMPLETED|Overall Study||0
8435558|NCT00832598|20787694|P1|COMPLETED|Overall Study||13
8435559|NCT00832598|20787694|P1|STARTED|Overall Study||13
8435560|NCT00832585|20787700|P1|NOT COMPLETED|Overall Study||2
8435561|NCT00832585|20787700|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
8435562|NCT00832585|20787700|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
8435563|NCT00832572|20787707|P2|NOT COMPLETED|Period 2||0
8435564|NCT00832572|20787708|P1|NOT COMPLETED|Period 2||0
8435565|NCT00832572|20787707|P2|COMPLETED|Period 2||2
8435566|NCT00832572|20787708|P1|COMPLETED|Period 2||3
8435567|NCT00832572|20787707|P2|STARTED|Period 2||2
8435568|NCT00832572|20787708|P1|STARTED|Period 2||3
8435569|NCT00832572|20787707|P2|NOT COMPLETED|Period 1||0
8435570|NCT00832572|20787708|P1|NOT COMPLETED|Period 1||0
8435571|NCT00832572|20787707|P2|COMPLETED|Period 1||2
8435572|NCT00832572|20787708|P1|COMPLETED|Period 1||3
8435573|NCT00832572|20787707|P2|STARTED|Period 1||2
8435574|NCT00832572|20787708|P1|STARTED|Period 1||3
8435575|NCT00832520|20787720|P1|NOT COMPLETED|Overall Study||0
8435576|NCT00832520|20787720|P1|COMPLETED|Overall Study||13
8435577|NCT00832520|20787720|P1|STARTED|Overall Study||13
8435578|NCT00832455|20787725|P1|NOT COMPLETED|Overall Study||72
8435579|NCT00832455|20787725|P1|COMPLETED|Overall Study||373
8435580|NCT00832455|20787725|P1|Week 12|Overall Study||373
8435581|NCT00832455|20787725|P1|Week 8 (Optional)|Overall Study||247
8435582|NCT00832455|20787725|P1|Week 4|Overall Study||411
8435583|NCT00832455|20787725|P1|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
8435584|NCT00832455|20787725|P1|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
8435585|NCT00832416|20787749|P4|NOT COMPLETED|Overall Study||83
8435586|NCT00832416|20787750|P3|NOT COMPLETED|Overall Study||61
8435587|NCT00832416|20787751|P2|NOT COMPLETED|Overall Study||53
8435588|NCT00832416|20787752|P1|NOT COMPLETED|Overall Study||46
8435589|NCT00832416|20787749|P4|COMPLETED|Overall Study||144
8435590|NCT00832416|20787750|P3|COMPLETED|Overall Study||54
8435591|NCT00832416|20787751|P2|COMPLETED|Overall Study||60
8435592|NCT00832416|20787752|P1|COMPLETED|Overall Study||64
8435593|NCT00832416|20787749|P4|STARTED|Overall Study||227
8435594|NCT00832416|20787750|P3|STARTED|Overall Study||115
8435595|NCT00832416|20787751|P2|STARTED|Overall Study||113
8435596|NCT00832416|20787752|P1|STARTED|Overall Study||110
8435597|NCT00832390|20787793|P3|NOT COMPLETED|Overall Study||0
8435598|NCT00832390|20787794|P2|NOT COMPLETED|Overall Study||0
8435599|NCT00832390|20787795|P1|NOT COMPLETED|Overall Study||0
8435600|NCT00832390|20787793|P3|COMPLETED|Overall Study||1
8435601|NCT00832390|20787794|P2|COMPLETED|Overall Study||16
8435602|NCT00832390|20787795|P1|COMPLETED|Overall Study||12
8435603|NCT00832390|20787793|P3|STARTED|Overall Study||1
8435604|NCT00832390|20787794|P2|STARTED|Overall Study||16
8435605|NCT00832390|20787795|P1|STARTED|Overall Study||12
8435606|NCT00832377|20787803|P1|NOT COMPLETED|Overall Study||1
8435607|NCT00832377|20787803|P1|COMPLETED|Overall Study||36
8435608|NCT00832377|20787803|P1|STARTED|Overall Study||37
8435609|NCT00832338|20787810|P1|NOT COMPLETED|Overall Study||0
8435610|NCT00832338|20787810|P1|COMPLETED|Overall Study||23
8435611|NCT00832338|20787810|P1|STARTED|Overall Study||23
8435612|NCT00832299|20787814|P1|NOT COMPLETED|Overall Study||0
8435613|NCT00832299|20787814|P1|COMPLETED|Overall Study||2
8435614|NCT00832299|20787814|P1|STARTED|Overall Study||2
8435615|NCT00832260|20787819|P1|NOT COMPLETED|Overall Study||0
8435616|NCT00832260|20787819|P1|COMPLETED|Overall Study||70
8435617|NCT00832260|20787819|P1|STARTED|Overall Study||70
8435618|NCT00832130|20787826|P2|NOT COMPLETED|Overall Study||0
8435619|NCT00832130|20787827|P1|NOT COMPLETED|Overall Study||0
8435620|NCT00832130|20787826|P2|COMPLETED|Overall Study||70
8435621|NCT00832130|20787827|P1|COMPLETED|Overall Study||69
8435622|NCT00832130|20787826|P2|STARTED|Overall Study||70
8435623|NCT00832130|20787827|P1|STARTED|Overall Study||69
8435624|NCT00832117|20787849|P1|NOT COMPLETED|Overall Study||12
8435625|NCT00832117|20787849|P1|COMPLETED|Overall Study||17
8435626|NCT00832117|20787849|P1|STARTED|Overall Study||29
8435627|NCT00832091|20787868|P2|NOT COMPLETED|Overall Study||2
8435628|NCT00832091|20787869|P1|NOT COMPLETED|Overall Study||5
8435629|NCT00832091|20787868|P2|COMPLETED|Overall Study||53
8435630|NCT00832091|20787869|P1|COMPLETED|Overall Study||12
8435631|NCT00832091|20787868|P2|STARTED|Overall Study||55
8435632|NCT00832091|20787869|P1|STARTED|Overall Study||17
8435633|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
8435634|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
8435635|NCT00832078|20787877|P2|COMPLETED|Test Day 2 - 2 Period||10
8435636|NCT00832078|20787878|P1|COMPLETED|Test Day 2 - 2 Period||12
8435637|NCT00832078|20787877|P2|STARTED|Test Day 2 - 2 Period||10
8435638|NCT00832078|20787878|P1|STARTED|Test Day 2 - 2 Period||13
8435639|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
8435640|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
8435641|NCT00832078|20787877|P2|COMPLETED|Test Day 2 - 1 Period||10
8435642|NCT00832078|20787878|P1|COMPLETED|Test Day 2 - 1 Period||13
8435643|NCT00832078|20787877|P2|STARTED|Test Day 2 - 1 Period||10
8435644|NCT00832078|20787878|P1|STARTED|Test Day 2 - 1 Period||13
8435645|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 1-2 Period||2
8435646|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 1-2 Period||0
8435647|NCT00832078|20787877|P2|COMPLETED|Test Day 1-2 Period||10
8435648|NCT00832078|20787878|P1|COMPLETED|Test Day 1-2 Period||13
8435649|NCT00832078|20787877|P2|STARTED|Test Day 1-2 Period||12
8435650|NCT00832078|20787878|P1|STARTED|Test Day 1-2 Period||13
8435651|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 1- 1 Period||0
8435652|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 1- 1 Period||0
8435653|NCT00832078|20787877|P2|COMPLETED|Test Day 1- 1 Period||12
8435654|NCT00832078|20787878|P1|COMPLETED|Test Day 1- 1 Period||13
8435655|NCT00832078|20787877|P2|STARTED|Test Day 1- 1 Period||12
8435656|NCT00832078|20787878|P1|STARTED|Test Day 1- 1 Period||13
8435657|NCT00832000|20787884|P2|NOT COMPLETED|Overall Study||1
8435658|NCT00832000|20787885|P1|NOT COMPLETED|Overall Study||6
8435659|NCT00832000|20787884|P2|COMPLETED|Overall Study||29
8435660|NCT00832000|20787885|P1|COMPLETED|Overall Study||23
8435661|NCT00832000|20787884|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
8435662|NCT00832000|20787885|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
8435663|NCT00832000|20787884|P2|STARTED|Overall Study|Placebo|30
8435664|NCT00832000|20787885|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
8435665|NCT00831987|20787923|P2|NOT COMPLETED|Overall Study||0
8435666|NCT00831987|20787924|P1|NOT COMPLETED|Overall Study||0
8435667|NCT00831987|20787923|P2|COMPLETED|Overall Study||60
8435668|NCT00831987|20787924|P1|COMPLETED|Overall Study||60
8435669|NCT00831987|20787923|P2|STARTED|Overall Study||60
8435670|NCT00831987|20787924|P1|STARTED|Overall Study||60
8435671|NCT00831844|20787946|P10|NOT COMPLETED|Overall Study||0
8435672|NCT00831844|20787947|P9|NOT COMPLETED|Overall Study||9
8435673|NCT00831844|20787948|P8|NOT COMPLETED|Overall Study||10
8435674|NCT00831844|20787949|P7|NOT COMPLETED|Overall Study||10
8435675|NCT00831844|20787950|P6|NOT COMPLETED|Overall Study||19
8435676|NCT00831844|20787951|P5|NOT COMPLETED|Overall Study||14
8435677|NCT00831844|20787952|P4|NOT COMPLETED|Overall Study||10
8435678|NCT00831844|20787953|P3|NOT COMPLETED|Overall Study||20
8435679|NCT00831844|20787954|P2|NOT COMPLETED|Overall Study||12
8435680|NCT00831844|20787955|P1|NOT COMPLETED|Overall Study||10
8435681|NCT00831844|20787946|P10|COMPLETED|Overall Study||0
8435682|NCT00831844|20787947|P9|COMPLETED|Overall Study||0
8435683|NCT00831844|20787948|P8|COMPLETED|Overall Study||0
8435684|NCT00831844|20787949|P7|COMPLETED|Overall Study||0
8435685|NCT00831844|20787950|P6|COMPLETED|Overall Study||1
8435686|NCT00831844|20787951|P5|COMPLETED|Overall Study||0
8435687|NCT00831844|20787952|P4|COMPLETED|Overall Study||0
8435688|NCT00831844|20787953|P3|COMPLETED|Overall Study||1
8435689|NCT00831844|20787954|P2|COMPLETED|Overall Study||0
8435690|NCT00831844|20787955|P1|COMPLETED|Overall Study||0
8435691|NCT00831844|20787946|P10|STARTED|Overall Study||0
8435692|NCT00831844|20787947|P9|STARTED|Overall Study||9
8435693|NCT00831844|20787948|P8|STARTED|Overall Study||10
8435694|NCT00831844|20787949|P7|STARTED|Overall Study||10
8435695|NCT00831844|20787950|P6|STARTED|Overall Study||20
8435696|NCT00831844|20787951|P5|STARTED|Overall Study||14
8435697|NCT00831844|20787952|P4|STARTED|Overall Study||10
8435698|NCT00831844|20787953|P3|STARTED|Overall Study||21
8435699|NCT00831844|20787954|P2|STARTED|Overall Study||12
8435700|NCT00831844|20787955|P1|STARTED|Overall Study||10
8435701|NCT00831792|20787977|P1|NOT COMPLETED|Overall Study||6
8435702|NCT00831792|20787977|P1|COMPLETED|Overall Study||40
8435703|NCT00831792|20787977|P1|STARTED|Overall Study||46
8435704|NCT00831779|20787983|P2|NOT COMPLETED|Overall Study||1
8435705|NCT00831779|20787984|P1|NOT COMPLETED|Overall Study||1
8435706|NCT00831779|20787983|P2|COMPLETED|Overall Study||22
8435707|NCT00831779|20787984|P1|COMPLETED|Overall Study||20
8435708|NCT00831779|20787983|P2|STARTED|Overall Study||23
8435709|NCT00831779|20787984|P1|STARTED|Overall Study||21
8435710|NCT00831766|20787994|P2|NOT COMPLETED|Overall Study||0
8435711|NCT00831766|20787995|P1|NOT COMPLETED|Overall Study||0
8435712|NCT00831766|20787994|P2|COMPLETED|Overall Study||28
8435713|NCT00831766|20787995|P1|COMPLETED|Overall Study||23
8435714|NCT00831766|20787994|P2|STARTED|Overall Study||28
8435715|NCT00831766|20787995|P1|STARTED|Overall Study||23
8435716|NCT00831753|20788006|P2|NOT COMPLETED|Overall Study||0
8435717|NCT00831753|20788007|P1|NOT COMPLETED|Overall Study||0
8435718|NCT00831753|20788006|P2|COMPLETED|Overall Study||131
8435719|NCT00831753|20788007|P1|COMPLETED|Overall Study||132
8435720|NCT00831753|20788006|P2|STARTED|Overall Study||131
8435721|NCT00831753|20788007|P1|STARTED|Overall Study||132
8435722|NCT00831701|20788021|P2|NOT COMPLETED|Overall Study||5
8435723|NCT00831701|20788022|P1|NOT COMPLETED|Overall Study||5
8435724|NCT00831701|20788021|P2|COMPLETED|Overall Study||45
8435725|NCT00831701|20788022|P1|COMPLETED|Overall Study||45
8435726|NCT00831701|20788021|P2|STARTED|Overall Study||50
8435727|NCT00831701|20788022|P1|STARTED|Overall Study||50
8435728|NCT00831675|20788038|P2|NOT COMPLETED|Overall Study||0
8435729|NCT00831675|20788039|P1|NOT COMPLETED|Overall Study||0
8435730|NCT00831675|20788038|P2|COMPLETED|Overall Study||18
8435731|NCT00831675|20788039|P1|COMPLETED|Overall Study||12
8435732|NCT00831675|20788038|P2|STARTED|Overall Study||18
8435733|NCT00831675|20788039|P1|STARTED|Overall Study||12
8435734|NCT00831493|20788051|P1|NOT COMPLETED|Overall Study||1
8435735|NCT00831493|20788051|P1|COMPLETED|Overall Study||2
8435736|NCT00831493|20788051|P1|STARTED|Overall Study||3
8435737|NCT00831480|20788055|P1|NOT COMPLETED|Overall Study||2
8435738|NCT00831480|20788055|P1|COMPLETED|Overall Study||7
8435739|NCT00831480|20788055|P1|STARTED|Overall Study||9
8435740|NCT00831441|20788061|P2|NOT COMPLETED|Follow Up (30 Days)||174
8435741|NCT00831441|20788062|P1|NOT COMPLETED|Follow Up (30 Days)||133
8435742|NCT00831441|20788061|P2|COMPLETED|Follow Up (30 Days)||3355
8435743|NCT00831441|20788062|P1|COMPLETED|Follow Up (30 Days)||3375
8435744|NCT00831441|20788061|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
8435745|NCT00831441|20788062|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
8435746|NCT00831441|20788061|P2|NOT COMPLETED|Randomized||3705
8435747|NCT00831441|20788062|P1|NOT COMPLETED|Randomized||3687
8435748|NCT00831441|20788061|P2|COMPLETED|Randomized||0
8435749|NCT00831441|20788062|P1|COMPLETED|Randomized||0
8435750|NCT00831441|20788061|P2|Treated|Randomized||3672
8435751|NCT00831441|20788062|P1|Treated|Randomized||3643
8435752|NCT00831441|20788061|P2|STARTED|Randomized||3705
8435753|NCT00831441|20788062|P1|STARTED|Randomized||3687
8435754|NCT00831428|20788090|P1|NOT COMPLETED|Overall Study||0
8435755|NCT00831428|20788090|P1|COMPLETED|Overall Study||97
8435756|NCT00831428|20788090|P1|STARTED|Overall Study||97
8435757|NCT00831415|20788094|P1|NOT COMPLETED|Overall Study||75
8435758|NCT00831415|20788094|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
8435759|NCT00831415|20788094|P1|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
8435760|NCT00831415|20788094|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
8435761|NCT00831415|20788094|P1|STARTED|Overall Study||304
8435762|NCT00831389|20788103|P2|NOT COMPLETED|Overall Study||1
8435763|NCT00831389|20788104|P1|NOT COMPLETED|Overall Study||0
8435764|NCT00831389|20788103|P2|COMPLETED|Overall Study||6
8435765|NCT00831389|20788104|P1|COMPLETED|Overall Study||6
8435766|NCT00831389|20788103|P2|STARTED|Overall Study||7
8435767|NCT00831389|20788104|P1|STARTED|Overall Study||6
8435768|NCT00831311|20788130|P2|NOT COMPLETED|Overall Study||8
8435769|NCT00831311|20788131|P1|NOT COMPLETED|Overall Study||12
8435770|NCT00831311|20788130|P2|COMPLETED|Overall Study||304
8435771|NCT00831311|20788131|P1|COMPLETED|Overall Study||300
8435772|NCT00831311|20788130|P2|STARTED|Overall Study||312
8435773|NCT00831311|20788131|P1|STARTED|Overall Study||312
8435774|NCT00831272|20788153|P4|NOT COMPLETED|Overall Study||10
8435775|NCT00831272|20788154|P3|NOT COMPLETED|Overall Study||10
8435776|NCT00831272|20788155|P2|NOT COMPLETED|Overall Study||7
8435777|NCT00831272|20788156|P1|NOT COMPLETED|Overall Study||8
8435778|NCT00831272|20788153|P4|COMPLETED|Overall Study||56
8435779|NCT00831272|20788154|P3|COMPLETED|Overall Study||63
8435780|NCT00831272|20788155|P2|COMPLETED|Overall Study||37
8435781|NCT00831272|20788156|P1|COMPLETED|Overall Study||30
8435782|NCT00831272|20788153|P4|STARTED|Overall Study||66
8435783|NCT00831272|20788154|P3|STARTED|Overall Study||73
8435784|NCT00831272|20788155|P2|STARTED|Overall Study||44
8435785|NCT00831272|20788156|P1|STARTED|Overall Study||38
8435786|NCT00831233|20788168|P2|NOT COMPLETED|Overall Study||1
8435787|NCT00831233|20788169|P1|NOT COMPLETED|Overall Study||3
8435788|NCT00831233|20788168|P2|COMPLETED|Overall Study||12
8435789|NCT00831233|20788169|P1|COMPLETED|Overall Study||26
8435790|NCT00831233|20788168|P2|Per Protocol (PP) Analysis Set|Overall Study||11
8435791|NCT00831233|20788169|P1|Per Protocol (PP) Analysis Set|Overall Study||26
8435792|NCT00831233|20788168|P2|Full Analysis Set (FAS)|Overall Study||13
8435793|NCT00831233|20788169|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
8435794|NCT00831233|20788168|P2|STARTED|Overall Study|ITT population.|13
8435795|NCT00831233|20788169|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
8435796|NCT00831181|20788193|P1|NOT COMPLETED|Overall Study||12
8435797|NCT00831181|20788193|P1|COMPLETED|Overall Study||15
8435798|NCT00831181|20788193|P1|STARTED|Overall Study||27
8435799|NCT00831129|20788206|P2|NOT COMPLETED|Overall Study||10
8435800|NCT00831129|20788207|P1|NOT COMPLETED|Overall Study||0
8435801|NCT00831129|20788206|P2|COMPLETED|Overall Study||23
8435802|NCT00831129|20788207|P1|COMPLETED|Overall Study||20
8435803|NCT00831129|20788206|P2|STARTED|Overall Study||33
8435804|NCT00831129|20788207|P1|STARTED|Overall Study||20
8435805|NCT00830960|20788249|P6|NOT COMPLETED|Overall Study||37
8435806|NCT00830960|20788250|P5|NOT COMPLETED|Overall Study||32
8435807|NCT00830960|20788251|P4|NOT COMPLETED|Overall Study||32
8435808|NCT00830960|20788252|P3|NOT COMPLETED|Overall Study||29
8435809|NCT00830960|20788253|P2|NOT COMPLETED|Overall Study||28
8435810|NCT00830960|20788254|P1|NOT COMPLETED|Overall Study||33
8435811|NCT00830960|20788249|P6|COMPLETED|Overall Study||63
8435812|NCT00830960|20788250|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
8435813|NCT00830960|20788251|P4|COMPLETED|Overall Study||106
8435814|NCT00830960|20788252|P3|COMPLETED|Overall Study||108
8435815|NCT00830960|20788253|P2|COMPLETED|Overall Study||96
8435816|NCT00830960|20788254|P1|COMPLETED|Overall Study||91
8435817|NCT00830960|20788249|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
8435818|NCT00830960|20788250|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
8435819|NCT00830960|20788251|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
8435820|NCT00830960|20788252|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
8435821|NCT00830960|20788253|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
8435822|NCT00830960|20788254|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
8435823|NCT00830960|20788249|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
8435824|NCT00830960|20788250|P5|STARTED|Overall Study||96
8435825|NCT00830960|20788251|P4|STARTED|Overall Study||138
8435826|NCT00830960|20788252|P3|STARTED|Overall Study||137
8435827|NCT00830960|20788253|P2|STARTED|Overall Study||124
8435828|NCT00830960|20788254|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
8435829|NCT00830947|20788370|P2|NOT COMPLETED|Overall Study||4
8435830|NCT00830947|20788371|P1|NOT COMPLETED|Overall Study||4
8435831|NCT00830947|20788370|P2|COMPLETED|Overall Study||18
8435832|NCT00830947|20788371|P1|COMPLETED|Overall Study||19
8435833|NCT00830947|20788370|P2|STARTED|Overall Study||22
8435834|NCT00830947|20788371|P1|STARTED|Overall Study||23
8435835|NCT00830869|20788389|P12|NOT COMPLETED|Period 2: Part 2||20
8435836|NCT00830869|20788390|P11|NOT COMPLETED|Period 2: Part 2||11
8435837|NCT00830869|20788391|P10|NOT COMPLETED|Period 2: Part 2||20
8435838|NCT00830869|20788392|P9|NOT COMPLETED|Period 2: Part 2||22
8435839|NCT00830869|20788393|P8|NOT COMPLETED|Period 2: Part 2||20
8435840|NCT00830869|20788394|P7|NOT COMPLETED|Period 2: Part 2||0
8435841|NCT00830869|20788395|P6|NOT COMPLETED|Period 2: Part 2||0
8435842|NCT00830869|20788396|P5|NOT COMPLETED|Period 2: Part 2||0
8435843|NCT00830869|20788397|P4|NOT COMPLETED|Period 2: Part 2||0
8435844|NCT00830869|20788398|P3|NOT COMPLETED|Period 2: Part 2||0
8435845|NCT00830869|20788399|P2|NOT COMPLETED|Period 2: Part 2||0
8435846|NCT00830869|20788400|P1|NOT COMPLETED|Period 2: Part 2||0
8435847|NCT00830869|20788389|P12|COMPLETED|Period 2: Part 2||0
8435848|NCT00830869|20788390|P11|COMPLETED|Period 2: Part 2||0
8435849|NCT00830869|20788391|P10|COMPLETED|Period 2: Part 2||0
8435850|NCT00830869|20788392|P9|COMPLETED|Period 2: Part 2||0
8435851|NCT00830869|20788393|P8|COMPLETED|Period 2: Part 2||0
8435852|NCT00830869|20788394|P7|COMPLETED|Period 2: Part 2||0
8435853|NCT00830869|20788395|P6|COMPLETED|Period 2: Part 2||0
8435854|NCT00830869|20788396|P5|COMPLETED|Period 2: Part 2||0
8435855|NCT00830869|20788397|P4|COMPLETED|Period 2: Part 2||0
8435856|NCT00830869|20788398|P3|COMPLETED|Period 2: Part 2||0
8435857|NCT00830869|20788399|P2|COMPLETED|Period 2: Part 2||0
8435858|NCT00830869|20788400|P1|COMPLETED|Period 2: Part 2||0
8435859|NCT00830869|20788389|P12|STARTED|Period 2: Part 2||20
8435860|NCT00830869|20788390|P11|STARTED|Period 2: Part 2||11
8435861|NCT00830869|20788391|P10|STARTED|Period 2: Part 2||20
8435862|NCT00830869|20788392|P9|STARTED|Period 2: Part 2||22
8435863|NCT00830869|20788393|P8|STARTED|Period 2: Part 2||20
8435864|NCT00830869|20788394|P7|STARTED|Period 2: Part 2||0
8435865|NCT00830869|20788395|P6|STARTED|Period 2: Part 2||0
8435866|NCT00830869|20788396|P5|STARTED|Period 2: Part 2||0
8435867|NCT00830869|20788397|P4|STARTED|Period 2: Part 2||0
8435868|NCT00830869|20788398|P3|STARTED|Period 2: Part 2||0
8435869|NCT00830869|20788399|P2|STARTED|Period 2: Part 2||0
8435870|NCT00830869|20788400|P1|STARTED|Period 2: Part 2||0
8435871|NCT00830869|20788389|P12|NOT COMPLETED|Period 1: Part 1||0
8435872|NCT00830869|20788390|P11|NOT COMPLETED|Period 1: Part 1||0
8435873|NCT00830869|20788391|P10|NOT COMPLETED|Period 1: Part 1||0
8435874|NCT00830869|20788392|P9|NOT COMPLETED|Period 1: Part 1||0
8435875|NCT00830869|20788393|P8|NOT COMPLETED|Period 1: Part 1||0
8435876|NCT00830869|20788394|P7|NOT COMPLETED|Period 1: Part 1||3
8435877|NCT00830869|20788395|P6|NOT COMPLETED|Period 1: Part 1||6
8435878|NCT00830869|20788396|P5|NOT COMPLETED|Period 1: Part 1||4
8435879|NCT00830869|20788397|P4|NOT COMPLETED|Period 1: Part 1||7
8435880|NCT00830869|20788398|P3|NOT COMPLETED|Period 1: Part 1||1
8435881|NCT00830869|20788399|P2|NOT COMPLETED|Period 1: Part 1||1
8435882|NCT00830869|20788400|P1|NOT COMPLETED|Period 1: Part 1||1
8435883|NCT00830869|20788389|P12|COMPLETED|Period 1: Part 1||0
8435884|NCT00830869|20788390|P11|COMPLETED|Period 1: Part 1||0
8435885|NCT00830869|20788391|P10|COMPLETED|Period 1: Part 1||0
8435886|NCT00830869|20788392|P9|COMPLETED|Period 1: Part 1||0
8435887|NCT00830869|20788393|P8|COMPLETED|Period 1: Part 1||0
8435888|NCT00830869|20788394|P7|COMPLETED|Period 1: Part 1||0
8435889|NCT00830869|20788395|P6|COMPLETED|Period 1: Part 1||0
8435890|NCT00830869|20788396|P5|COMPLETED|Period 1: Part 1||0
8435891|NCT00830869|20788397|P4|COMPLETED|Period 1: Part 1||0
8435892|NCT00830869|20788398|P3|COMPLETED|Period 1: Part 1||0
8435893|NCT00830869|20788399|P2|COMPLETED|Period 1: Part 1||0
8435894|NCT00830869|20788400|P1|COMPLETED|Period 1: Part 1||0
8435895|NCT00830869|20788389|P12|STARTED|Period 1: Part 1||0
8435896|NCT00830869|20788390|P11|STARTED|Period 1: Part 1||0
8435897|NCT00830869|20788391|P10|STARTED|Period 1: Part 1||0
8435898|NCT00830869|20788392|P9|STARTED|Period 1: Part 1||0
8435899|NCT00830869|20788393|P8|STARTED|Period 1: Part 1||0
8435900|NCT00830869|20788394|P7|STARTED|Period 1: Part 1||3
8435901|NCT00830869|20788395|P6|STARTED|Period 1: Part 1||6
8435902|NCT00830869|20788396|P5|STARTED|Period 1: Part 1||4
8435903|NCT00830869|20788397|P4|STARTED|Period 1: Part 1||7
8435904|NCT00830869|20788398|P3|STARTED|Period 1: Part 1||1
8435905|NCT00830869|20788399|P2|STARTED|Period 1: Part 1||1
8435906|NCT00830869|20788400|P1|STARTED|Period 1: Part 1||1
8435907|NCT00830804|20788536|P1|NOT COMPLETED|Overall Study||15
8435908|NCT00830804|20788536|P1|COMPLETED|Overall Study||97
8435909|NCT00830804|20788536|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
8435910|NCT00830791|20788562|P6|NOT COMPLETED|Overall Study||0
8435911|NCT00830791|20788563|P5|NOT COMPLETED|Overall Study||0
8435912|NCT00830791|20788564|P4|NOT COMPLETED|Overall Study||0
8435913|NCT00830791|20788565|P3|NOT COMPLETED|Overall Study||0
8435914|NCT00830791|20788566|P2|NOT COMPLETED|Overall Study||0
8435915|NCT00830791|20788567|P1|NOT COMPLETED|Overall Study||0
8435916|NCT00830791|20788562|P6|COMPLETED|Overall Study||0
8435917|NCT00830791|20788563|P5|COMPLETED|Overall Study||0
8435918|NCT00830791|20788564|P4|COMPLETED|Overall Study||8
8435919|NCT00830791|20788565|P3|COMPLETED|Overall Study||8
8435920|NCT00830791|20788566|P2|COMPLETED|Overall Study||8
8435921|NCT00830791|20788567|P1|COMPLETED|Overall Study||8
8435922|NCT00830791|20788562|P6|STARTED|Overall Study||0
8435923|NCT00830791|20788563|P5|STARTED|Overall Study||0
8435924|NCT00830791|20788564|P4|STARTED|Overall Study||8
8435925|NCT00830791|20788565|P3|STARTED|Overall Study||8
8435926|NCT00830791|20788566|P2|STARTED|Overall Study||8
8435927|NCT00830791|20788567|P1|STARTED|Overall Study||8
8435928|NCT00830765|20788616|P2|NOT COMPLETED|Overall Study||2
8435929|NCT00830765|20788617|P1|NOT COMPLETED|Overall Study||3
8435930|NCT00830765|20788616|P2|COMPLETED|Overall Study||69
8435931|NCT00830765|20788617|P1|COMPLETED|Overall Study||70
8435932|NCT00830765|20788616|P2|STARTED|Overall Study||71
8435933|NCT00830765|20788617|P1|STARTED|Overall Study||73
8435934|NCT00830596|20788626|P3|NOT COMPLETED|Overall Study||6
8435935|NCT00830596|20788627|P2|NOT COMPLETED|Overall Study||2
8435936|NCT00830596|20788628|P1|NOT COMPLETED|Overall Study||2
8435937|NCT00830596|20788626|P3|COMPLETED|Overall Study||67
8435938|NCT00830596|20788627|P2|COMPLETED|Overall Study||72
8435939|NCT00830596|20788628|P1|COMPLETED|Overall Study||72
8435940|NCT00830596|20788626|P3|STARTED|Overall Study||73
8435941|NCT00830596|20788627|P2|STARTED|Overall Study||74
8435942|NCT00830596|20788628|P1|STARTED|Overall Study||74
8435943|NCT00830518|20788650|P2|NOT COMPLETED|Overall Study||11
8435944|NCT00830518|20788651|P1|NOT COMPLETED|Overall Study||46
8435945|NCT00830518|20788650|P2|COMPLETED|Overall Study||0
8435946|NCT00830518|20788651|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
8435947|NCT00830518|20788650|P2|STARTED|Overall Study||11
8435948|NCT00830518|20788651|P1|STARTED|Overall Study||46
8435949|NCT00830440|20788670|P2|NOT COMPLETED|Overall Study||0
8435950|NCT00830440|20788671|P1|NOT COMPLETED|Overall Study||8
8435951|NCT00830440|20788670|P2|COMPLETED|Overall Study||11
8435952|NCT00830440|20788671|P1|COMPLETED|Overall Study||24
8435953|NCT00830440|20788670|P2|Completed 24 Week Follow up|Overall Study||0
8435954|NCT00830440|20788671|P1|Completed 24 Week Follow up|Overall Study||3
8435955|NCT00830440|20788670|P2|Completed 16 Week Follow up|Overall Study||0
8435956|NCT00830440|20788671|P1|Completed 16 Week Follow up|Overall Study||4
8435957|NCT00830440|20788670|P2|Completed 12 Week Follow up|Overall Study||11
8435958|NCT00830440|20788671|P1|Completed 12 Week Follow up|Overall Study||24
8435959|NCT00830440|20788670|P2|Received Device|Overall Study||0
8435960|NCT00830440|20788671|P1|Received Device|Overall Study||26
8435961|NCT00830440|20788670|P2|STARTED|Overall Study||11
8435962|NCT00830440|20788671|P1|STARTED|Overall Study||32
8435963|NCT00830388|20788681|P1|NOT COMPLETED|Overall Study||0
8435964|NCT00830388|20788681|P1|COMPLETED|Overall Study||11
8435965|NCT00830388|20788681|P1|STARTED|Overall Study||11
8435966|NCT00830375|20788686|P1|NOT COMPLETED|Overall Study||1
8435967|NCT00830375|20788686|P1|COMPLETED|Overall Study||9
8435968|NCT00830375|20788686|P1|STARTED|Overall Study||10
8435969|NCT00830362|20788692|P2|NOT COMPLETED|Overall Study||4
8435970|NCT00830362|20788693|P1|NOT COMPLETED|Overall Study||4
8435971|NCT00830362|20788692|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
8435972|NCT00830362|20788693|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
8435973|NCT00830362|20788692|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
8435974|NCT00830362|20788693|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
8435975|NCT00830362|20788692|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
8435976|NCT00830362|20788693|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
8435977|NCT00830336|20788701|P2|NOT COMPLETED|Second Intervention||0
8435978|NCT00830336|20788702|P1|NOT COMPLETED|Second Intervention||0
8435979|NCT00830336|20788701|P2|COMPLETED|Second Intervention||40
8435980|NCT00830336|20788702|P1|COMPLETED|Second Intervention||39
8435981|NCT00830336|20788701|P2|STARTED|Second Intervention||40
8435982|NCT00830336|20788702|P1|STARTED|Second Intervention||39
8435983|NCT00830336|20788701|P2|NOT COMPLETED|Washout: 21 Days||0
8435984|NCT00830336|20788702|P1|NOT COMPLETED|Washout: 21 Days||1
8435985|NCT00830336|20788701|P2|COMPLETED|Washout: 21 Days||40
8435986|NCT00830336|20788702|P1|COMPLETED|Washout: 21 Days||39
8435987|NCT00830336|20788701|P2|STARTED|Washout: 21 Days||40
8435988|NCT00830336|20788702|P1|STARTED|Washout: 21 Days||40
8435989|NCT00830336|20788701|P2|NOT COMPLETED|First Intervention||0
8435990|NCT00830336|20788702|P1|NOT COMPLETED|First Intervention||0
8435991|NCT00830336|20788701|P2|COMPLETED|First Intervention||40
8435992|NCT00830336|20788702|P1|COMPLETED|First Intervention||40
8435993|NCT00830336|20788701|P2|STARTED|First Intervention||40
8435994|NCT00830336|20788702|P1|STARTED|First Intervention||40
8435995|NCT00830310|20788710|P1|NOT COMPLETED|Overall Study||13
8435996|NCT00830310|20788710|P1|COMPLETED|Overall Study||30
8435997|NCT00830310|20788710|P1|STARTED|Overall Study||43
8435998|NCT00830284|20788722|P1|NOT COMPLETED|Overall Study||2
8435999|NCT00830284|20788722|P1|COMPLETED|Overall Study||10
8436000|NCT00830284|20788722|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
8436001|NCT00830258|20788729|P2|NOT COMPLETED|Second Intervention||0
8436002|NCT00830258|20788730|P1|NOT COMPLETED|Second Intervention||0
8436003|NCT00830258|20788729|P2|COMPLETED|Second Intervention||30
8436004|NCT00830258|20788730|P1|COMPLETED|Second Intervention||28
8436005|NCT00830258|20788729|P2|STARTED|Second Intervention||30
8436006|NCT00830258|20788730|P1|STARTED|Second Intervention||28
8436007|NCT00830258|20788729|P2|NOT COMPLETED|Washout: 7 Days||0
8436008|NCT00830258|20788730|P1|NOT COMPLETED|Washout: 7 Days||1
8436009|NCT00830258|20788729|P2|COMPLETED|Washout: 7 Days||30
8436010|NCT00830258|20788730|P1|COMPLETED|Washout: 7 Days||28
8436011|NCT00830258|20788729|P2|STARTED|Washout: 7 Days||30
8436012|NCT00830258|20788730|P1|STARTED|Washout: 7 Days||29
8436013|NCT00830258|20788729|P2|NOT COMPLETED|First Intervention||0
8436014|NCT00830258|20788730|P1|NOT COMPLETED|First Intervention||1
8436015|NCT00830258|20788729|P2|COMPLETED|First Intervention||30
8436016|NCT00830258|20788730|P1|COMPLETED|First Intervention||29
8436017|NCT00830258|20788729|P2|STARTED|First Intervention||30
8436018|NCT00830258|20788730|P1|STARTED|First Intervention||30
8436019|NCT00830232|20788740|P2|NOT COMPLETED|Overall Study||0
8436020|NCT00830232|20788741|P1|NOT COMPLETED|Overall Study||0
8436021|NCT00830232|20788740|P2|COMPLETED|Overall Study||20
8436022|NCT00830232|20788741|P1|COMPLETED|Overall Study||20
8436023|NCT00830232|20788740|P2|STARTED|Overall Study||20
8436024|NCT00830232|20788741|P1|STARTED|Overall Study||20
8436025|NCT00830219|20788749|P2|NOT COMPLETED|Second Intervention||0
8436026|NCT00830219|20788750|P1|NOT COMPLETED|Second Intervention||0
8436027|NCT00830219|20788749|P2|COMPLETED|Second Intervention||22
8436028|NCT00830219|20788750|P1|COMPLETED|Second Intervention||22
8436029|NCT00830219|20788749|P2|STARTED|Second Intervention||22
8436030|NCT00830219|20788750|P1|STARTED|Second Intervention||22
8436031|NCT00830219|20788749|P2|NOT COMPLETED|Washout of 7 Days||1
8436032|NCT00830219|20788750|P1|NOT COMPLETED|Washout of 7 Days||1
8436033|NCT00830219|20788749|P2|COMPLETED|Washout of 7 Days||22
8436034|NCT00830219|20788750|P1|COMPLETED|Washout of 7 Days||22
8436035|NCT00830219|20788749|P2|STARTED|Washout of 7 Days||23
8436036|NCT00830219|20788750|P1|STARTED|Washout of 7 Days||23
8436037|NCT00830219|20788749|P2|NOT COMPLETED|First Intervention||0
8436038|NCT00830219|20788750|P1|NOT COMPLETED|First Intervention||0
8436039|NCT00830219|20788749|P2|COMPLETED|First Intervention||23
8436040|NCT00830219|20788750|P1|COMPLETED|First Intervention||23
8436041|NCT00830219|20788749|P2|STARTED|First Intervention||23
8436042|NCT00830219|20788750|P1|STARTED|First Intervention||23
8436043|NCT00830206|20788760|P2|NOT COMPLETED|Second Intervention||0
8436044|NCT00830206|20788761|P1|NOT COMPLETED|Second Intervention||0
8436045|NCT00830206|20788760|P2|COMPLETED|Second Intervention||39
8436046|NCT00830206|20788761|P1|COMPLETED|Second Intervention||39
8436047|NCT00830206|20788760|P2|STARTED|Second Intervention||39
8436048|NCT00830206|20788761|P1|STARTED|Second Intervention||39
8436049|NCT00830206|20788760|P2|NOT COMPLETED|Washout: 21 Days||1
8436050|NCT00830206|20788761|P1|NOT COMPLETED|Washout: 21 Days||1
8436051|NCT00830206|20788760|P2|COMPLETED|Washout: 21 Days||39
8436052|NCT00830206|20788761|P1|COMPLETED|Washout: 21 Days||39
8436053|NCT00830206|20788760|P2|STARTED|Washout: 21 Days||40
8436054|NCT00830206|20788761|P1|STARTED|Washout: 21 Days||40
8436055|NCT00830206|20788760|P2|NOT COMPLETED|First Intervention||0
8436056|NCT00830206|20788761|P1|NOT COMPLETED|First Intervention||0
8436057|NCT00830206|20788760|P2|COMPLETED|First Intervention||40
8436058|NCT00830206|20788761|P1|COMPLETED|First Intervention||40
8436059|NCT00830206|20788760|P2|STARTED|First Intervention||40
8436060|NCT00830206|20788761|P1|STARTED|First Intervention||40
8436061|NCT00830167|20788771|P2|NOT COMPLETED|Overall Study||43
8436062|NCT00830167|20788772|P1|NOT COMPLETED|Overall Study||40
8436063|NCT00830167|20788771|P2|COMPLETED|Overall Study||207
8436064|NCT00830167|20788772|P1|COMPLETED|Overall Study||208
8436065|NCT00830167|20788771|P2|STARTED|Overall Study|Treated|250
8436066|NCT00830167|20788772|P1|STARTED|Overall Study|Treated|248
8436067|NCT00830128|20788842|P1|NOT COMPLETED|Overall Study||19
8436068|NCT00830128|20788842|P1|COMPLETED|Overall Study||87
8436069|NCT00830128|20788842|P1|STARTED|Overall Study||106
8436070|NCT00830115|20788857|P1|NOT COMPLETED|Overall Study||3
8436071|NCT00830115|20788857|P1|COMPLETED|Overall Study||1042
8436072|NCT00830115|20788857|P1|STARTED|Overall Study||1045
8436073|NCT00830076|20788873|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
8436074|NCT00830076|20788873|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
8436075|NCT00830076|20788873|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
8436076|NCT00830076|20788873|P1|NOT COMPLETED|7-day Washout||0
8436077|NCT00830076|20788873|P1|COMPLETED|7-day Washout||18
8436078|NCT00830076|20788873|P1|STARTED|7-day Washout||18
8436079|NCT00830076|20788873|P1|NOT COMPLETED|Sitagliptin + Metformin||0
8436080|NCT00830076|20788873|P1|COMPLETED|Sitagliptin + Metformin||18
8436081|NCT00830076|20788873|P1|STARTED|Sitagliptin + Metformin||18
8436082|NCT00830076|20788873|P1|NOT COMPLETED|7-day Washout||0
8436083|NCT00830076|20788873|P1|COMPLETED|7-day Washout||18
8436084|NCT00830076|20788873|P1|STARTED|7-day Washout||18
8436085|NCT00830076|20788873|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
8436086|NCT00830076|20788873|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
8436087|NCT00830076|20788873|P1|STARTED|Metformin + Placebo Sitagliptin||18
8436088|NCT00830076|20788873|P1|NOT COMPLETED|7-day Washout||0
8436089|NCT00830076|20788873|P1|COMPLETED|7-day Washout||18
8436090|NCT00830076|20788873|P1|STARTED|7-day Washout||18
8436091|NCT00830076|20788873|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
8436092|NCT00830076|20788873|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
8436093|NCT00830076|20788873|P1|STARTED|Sitagliptin + Placebo Metformin||18
8436094|NCT00830037|20788884|P2|NOT COMPLETED|Overall Study||19
8436095|NCT00830037|20788885|P1|NOT COMPLETED|Overall Study||18
8436096|NCT00830037|20788884|P2|COMPLETED|Overall Study||50
8436097|NCT00830037|20788885|P1|COMPLETED|Overall Study||49
8436098|NCT00830037|20788884|P2|STARTED|Overall Study||69
8436099|NCT00830037|20788885|P1|STARTED|Overall Study||67
8436100|NCT00830024|20788895|P2|NOT COMPLETED|Second Intervention||0
8436101|NCT00830024|20788896|P1|NOT COMPLETED|Second Intervention||0
8436102|NCT00830024|20788895|P2|COMPLETED|Second Intervention||18
8436103|NCT00830024|20788896|P1|COMPLETED|Second Intervention||17
8436104|NCT00830024|20788895|P2|STARTED|Second Intervention||18
8436105|NCT00830024|20788896|P1|STARTED|Second Intervention||17
8436106|NCT00830024|20788895|P2|NOT COMPLETED|Washout: 7 Days||0
8436107|NCT00830024|20788896|P1|NOT COMPLETED|Washout: 7 Days||1
8436108|NCT00830024|20788895|P2|COMPLETED|Washout: 7 Days||18
8436109|NCT00830024|20788896|P1|COMPLETED|Washout: 7 Days||17
8436110|NCT00830024|20788895|P2|STARTED|Washout: 7 Days||18
8436111|NCT00830024|20788896|P1|STARTED|Washout: 7 Days||18
8436112|NCT00830024|20788895|P2|NOT COMPLETED|First Intervention||0
8436113|NCT00830024|20788896|P1|NOT COMPLETED|First Intervention||0
8436114|NCT00830024|20788895|P2|COMPLETED|First Intervention||18
8436115|NCT00830024|20788896|P1|COMPLETED|First Intervention||18
8436116|NCT00830024|20788895|P2|STARTED|First Intervention||18
8436117|NCT00830024|20788896|P1|STARTED|First Intervention||18
8436118|NCT00829998|20788906|P2|NOT COMPLETED|Second Intervention||0
8436119|NCT00829998|20788907|P1|NOT COMPLETED|Second Intervention||0
8436120|NCT00829998|20788906|P2|COMPLETED|Second Intervention||19
8436121|NCT00829998|20788907|P1|COMPLETED|Second Intervention||21
8436122|NCT00829998|20788906|P2|STARTED|Second Intervention||19
8436123|NCT00829998|20788907|P1|STARTED|Second Intervention||21
8436124|NCT00829998|20788906|P2|NOT COMPLETED|Washout||1
8436125|NCT00829998|20788907|P1|NOT COMPLETED|Washout||0
8436126|NCT00829998|20788906|P2|COMPLETED|Washout||19
8436127|NCT00829998|20788907|P1|COMPLETED|Washout||21
8436128|NCT00829998|20788906|P2|STARTED|Washout||20
8436129|NCT00829998|20788907|P1|STARTED|Washout||21
8436130|NCT00829998|20788906|P2|NOT COMPLETED|First Intervention||0
8436131|NCT00829998|20788907|P1|NOT COMPLETED|First Intervention||0
8436132|NCT00829998|20788906|P2|COMPLETED|First Intervention||20
8436133|NCT00829998|20788907|P1|COMPLETED|First Intervention||21
8436134|NCT00829998|20788906|P2|STARTED|First Intervention||20
8436135|NCT00829998|20788907|P1|STARTED|First Intervention||21
8436136|NCT00829985|20788917|P2|NOT COMPLETED|Overall Study||4
8436137|NCT00829985|20788918|P1|NOT COMPLETED|Overall Study||9
8436138|NCT00829985|20788917|P2|COMPLETED|Overall Study||22
8436139|NCT00829985|20788918|P1|COMPLETED|Overall Study||19
8436140|NCT00829985|20788917|P2|STARTED|Overall Study||26
8436141|NCT00829985|20788918|P1|STARTED|Overall Study||28
8436142|NCT00829933|20788936|P4|NOT COMPLETED|Overall Study||14
8436143|NCT00829933|20788937|P3|NOT COMPLETED|Overall Study||13
8436144|NCT00829933|20788938|P2|NOT COMPLETED|Overall Study||13
8436145|NCT00829933|20788939|P1|NOT COMPLETED|Overall Study||14
8436146|NCT00829933|20788936|P4|COMPLETED|Overall Study||120
8436147|NCT00829933|20788937|P3|COMPLETED|Overall Study||119
8436148|NCT00829933|20788938|P2|COMPLETED|Overall Study||122
8436149|NCT00829933|20788939|P1|COMPLETED|Overall Study||121
8436150|NCT00829933|20788936|P4|Baseline Analysis Population|Overall Study||129
8436151|NCT00829933|20788937|P3|Baseline Analysis Population|Overall Study||131
8436152|NCT00829933|20788938|P2|Baseline Analysis Population|Overall Study||134
8436153|NCT00829933|20788939|P1|Baseline Analysis Population|Overall Study||131
8436154|NCT00829933|20788936|P4|STARTED|Overall Study||134
8436155|NCT00829933|20788937|P3|STARTED|Overall Study||132
8436156|NCT00829933|20788938|P2|STARTED|Overall Study||135
8436157|NCT00829933|20788939|P1|STARTED|Overall Study||135
8436158|NCT00829868|20788951|P2|NOT COMPLETED|Second Intervention||0
8436159|NCT00829868|20788952|P1|NOT COMPLETED|Second Intervention||0
8436160|NCT00829868|20788951|P2|COMPLETED|Second Intervention||21
8436161|NCT00829868|20788952|P1|COMPLETED|Second Intervention||20
8436162|NCT00829868|20788951|P2|STARTED|Second Intervention||21
8436163|NCT00829868|20788952|P1|STARTED|Second Intervention||20
8436164|NCT00829868|20788951|P2|NOT COMPLETED|Washout||0
8436165|NCT00829868|20788952|P1|NOT COMPLETED|Washout||1
8436166|NCT00829868|20788951|P2|COMPLETED|Washout||21
8436167|NCT00829868|20788952|P1|COMPLETED|Washout||20
8436168|NCT00829868|20788951|P2|STARTED|Washout||21
8436169|NCT00829868|20788952|P1|STARTED|Washout||21
8436170|NCT00829868|20788951|P2|NOT COMPLETED|First Intervention||0
8436171|NCT00829868|20788952|P1|NOT COMPLETED|First Intervention||0
8436172|NCT00829868|20788951|P2|COMPLETED|First Intervention||21
8436173|NCT00829868|20788952|P1|COMPLETED|First Intervention||21
8436174|NCT00829868|20788951|P2|STARTED|First Intervention||21
8436175|NCT00829868|20788952|P1|STARTED|First Intervention||21
8436176|NCT00829829|20788963|P3|NOT COMPLETED|Overall Study||11
8436177|NCT00829829|20788964|P2|NOT COMPLETED|Overall Study||16
8436178|NCT00829829|20788965|P1|NOT COMPLETED|Overall Study||22
8436179|NCT00829829|20788963|P3|COMPLETED|Overall Study||70
8436180|NCT00829829|20788964|P2|COMPLETED|Overall Study||64
8436181|NCT00829829|20788965|P1|COMPLETED|Overall Study||58
8436182|NCT00829829|20788963|P3|Treated|Overall Study||81
8436183|NCT00829829|20788964|P2|Treated|Overall Study||80
8436184|NCT00829829|20788965|P1|Treated|Overall Study||79
8436185|NCT00829829|20788963|P3|STARTED|Overall Study||81
8436186|NCT00829829|20788964|P2|STARTED|Overall Study||80
8436187|NCT00829829|20788965|P1|STARTED|Overall Study||80
8436188|NCT00829790|20788990|P2|NOT COMPLETED|Second Intervention||0
8436189|NCT00829790|20788991|P1|NOT COMPLETED|Second Intervention||0
8436190|NCT00829790|20788990|P2|COMPLETED|Second Intervention||14
8436191|NCT00829790|20788991|P1|COMPLETED|Second Intervention||15
8436192|NCT00829790|20788990|P2|STARTED|Second Intervention||14
8436193|NCT00829790|20788991|P1|STARTED|Second Intervention||15
8436194|NCT00829790|20788990|P2|NOT COMPLETED|Washout of 14 Days||1
8436195|NCT00829790|20788991|P1|NOT COMPLETED|Washout of 14 Days||0
8436196|NCT00829790|20788990|P2|COMPLETED|Washout of 14 Days||14
8436197|NCT00829790|20788991|P1|COMPLETED|Washout of 14 Days||15
8436198|NCT00829790|20788990|P2|STARTED|Washout of 14 Days||15
8436199|NCT00829790|20788991|P1|STARTED|Washout of 14 Days||15
8436200|NCT00829790|20788990|P2|NOT COMPLETED|First Intervention||0
8436201|NCT00829790|20788991|P1|NOT COMPLETED|First Intervention||0
8436202|NCT00829790|20788990|P2|COMPLETED|First Intervention||15
8436203|NCT00829790|20788991|P1|COMPLETED|First Intervention||15
8436204|NCT00829790|20788990|P2|STARTED|First Intervention||15
8436205|NCT00829790|20788991|P1|STARTED|First Intervention||15
8436206|NCT00829764|20789001|P2|NOT COMPLETED|Second Intervention||0
8436207|NCT00829764|20789002|P1|NOT COMPLETED|Second Intervention||0
8436208|NCT00829764|20789001|P2|COMPLETED|Second Intervention||14
8436209|NCT00829764|20789002|P1|COMPLETED|Second Intervention||13
8436210|NCT00829764|20789001|P2|STARTED|Second Intervention||14
8436211|NCT00829764|20789002|P1|STARTED|Second Intervention||13
8436212|NCT00829764|20789001|P2|NOT COMPLETED|Washout of 14 Days||0
8436213|NCT00829764|20789002|P1|NOT COMPLETED|Washout of 14 Days||0
8436214|NCT00829764|20789001|P2|COMPLETED|Washout of 14 Days||14
8436215|NCT00829764|20789002|P1|COMPLETED|Washout of 14 Days||13
8436216|NCT00829764|20789001|P2|STARTED|Washout of 14 Days||14
8436217|NCT00829764|20789002|P1|STARTED|Washout of 14 Days||13
8436218|NCT00829764|20789001|P2|NOT COMPLETED|First Intervention||1
8436219|NCT00829764|20789002|P1|NOT COMPLETED|First Intervention||2
8436220|NCT00829764|20789001|P2|COMPLETED|First Intervention||14
8436221|NCT00829764|20789002|P1|COMPLETED|First Intervention||13
8436222|NCT00829764|20789001|P2|STARTED|First Intervention||15
8436223|NCT00829764|20789002|P1|STARTED|First Intervention||15
8436224|NCT00829738|20789010|P1|NOT COMPLETED|Overall Study||8
8436225|NCT00829738|20789010|P1|COMPLETED|Overall Study||4180
8436226|NCT00829738|20789010|P1|STARTED|Overall Study||4188
8436227|NCT00829712|20789028|P2|NOT COMPLETED|Second Intervention||0
8436228|NCT00829712|20789029|P1|NOT COMPLETED|Second Intervention||0
8436229|NCT00829712|20789028|P2|COMPLETED|Second Intervention||11
8436230|NCT00829712|20789029|P1|COMPLETED|Second Intervention||12
8436231|NCT00829712|20789028|P2|STARTED|Second Intervention||11
8436232|NCT00829712|20789029|P1|STARTED|Second Intervention||12
8436233|NCT00829712|20789028|P2|NOT COMPLETED|Washout of 7 Days||1
8436234|NCT00829712|20789029|P1|NOT COMPLETED|Washout of 7 Days||0
8436235|NCT00829712|20789028|P2|COMPLETED|Washout of 7 Days||11
8436236|NCT00829712|20789029|P1|COMPLETED|Washout of 7 Days||12
8436237|NCT00829712|20789028|P2|STARTED|Washout of 7 Days||12
8436238|NCT00829712|20789029|P1|STARTED|Washout of 7 Days||12
8436239|NCT00829712|20789028|P2|NOT COMPLETED|First Intervention||0
8436240|NCT00829712|20789029|P1|NOT COMPLETED|First Intervention||0
8436241|NCT00829712|20789028|P2|COMPLETED|First Intervention||12
8436242|NCT00829712|20789029|P1|COMPLETED|First Intervention||12
8436243|NCT00829712|20789028|P2|STARTED|First Intervention||12
8436244|NCT00829712|20789029|P1|STARTED|First Intervention||12
8436245|NCT00829686|20789039|P2|NOT COMPLETED|Overall Study||0
8436246|NCT00829686|20789040|P1|NOT COMPLETED|Overall Study||0
8436247|NCT00829686|20789039|P2|COMPLETED|Overall Study||18
8436248|NCT00829686|20789040|P1|COMPLETED|Overall Study||13
8436249|NCT00829686|20789039|P2|STARTED|Overall Study||18
8436250|NCT00829686|20789040|P1|STARTED|Overall Study||13
8436251|NCT00829673|20789048|P2|NOT COMPLETED|Second Intervention||0
8436252|NCT00829673|20789049|P1|NOT COMPLETED|Second Intervention||0
8436253|NCT00829673|20789048|P2|COMPLETED|Second Intervention||12
8436254|NCT00829673|20789049|P1|COMPLETED|Second Intervention||11
8436255|NCT00829673|20789048|P2|STARTED|Second Intervention||12
8436256|NCT00829673|20789049|P1|STARTED|Second Intervention||11
8436257|NCT00829673|20789048|P2|NOT COMPLETED|Washout of 7 Days||0
8436258|NCT00829673|20789049|P1|NOT COMPLETED|Washout of 7 Days||1
8436259|NCT00829673|20789048|P2|COMPLETED|Washout of 7 Days||12
8436260|NCT00829673|20789049|P1|COMPLETED|Washout of 7 Days||11
8436261|NCT00829673|20789048|P2|STARTED|Washout of 7 Days||12
8436262|NCT00829673|20789049|P1|STARTED|Washout of 7 Days||12
8436263|NCT00829673|20789048|P2|NOT COMPLETED|First Intervention||0
8436264|NCT00829673|20789049|P1|NOT COMPLETED|First Intervention||0
8436265|NCT00829673|20789048|P2|COMPLETED|First Intervention||12
8436266|NCT00829673|20789049|P1|COMPLETED|First Intervention||12
8436267|NCT00829673|20789048|P2|STARTED|First Intervention||12
8436268|NCT00829673|20789049|P1|STARTED|First Intervention||12
8436269|NCT00829621|20789059|P2|NOT COMPLETED|Overall Study||4
8436270|NCT00829621|20789060|P1|NOT COMPLETED|Overall Study||4
8436271|NCT00829621|20789059|P2|COMPLETED|Overall Study||8
8436272|NCT00829621|20789060|P1|COMPLETED|Overall Study||4
8436273|NCT00829621|20789059|P2|STARTED|Overall Study||12
8436274|NCT00829621|20789060|P1|STARTED|Overall Study||8
8436275|NCT00829530|20789068|P2|NOT COMPLETED|Second Intervention||0
8436276|NCT00829530|20789069|P1|NOT COMPLETED|Second Intervention||1
8436277|NCT00829530|20789068|P2|COMPLETED|Second Intervention||18
8436278|NCT00829530|20789069|P1|COMPLETED|Second Intervention||19
8436279|NCT00829530|20789068|P2|STARTED|Second Intervention||18
8436280|NCT00829530|20789069|P1|STARTED|Second Intervention||20
8436281|NCT00829530|20789068|P2|NOT COMPLETED|Washout of 42 Days||0
8436282|NCT00829530|20789069|P1|NOT COMPLETED|Washout of 42 Days||0
8436283|NCT00829530|20789068|P2|COMPLETED|Washout of 42 Days||18
8436284|NCT00829530|20789069|P1|COMPLETED|Washout of 42 Days||20
8436285|NCT00829530|20789068|P2|STARTED|Washout of 42 Days||18
8436286|NCT00829530|20789069|P1|STARTED|Washout of 42 Days||20
8436287|NCT00829530|20789068|P2|NOT COMPLETED|First Intervention||2
8436288|NCT00829530|20789069|P1|NOT COMPLETED|First Intervention||0
8436289|NCT00829530|20789068|P2|COMPLETED|First Intervention||18
8436290|NCT00829530|20789069|P1|COMPLETED|First Intervention||20
8436291|NCT00829530|20789068|P2|STARTED|First Intervention||20
8436292|NCT00829530|20789069|P1|STARTED|First Intervention||20
8436293|NCT00829504|20789083|P2|NOT COMPLETED|Second Intervention||0
8436294|NCT00829504|20789084|P1|NOT COMPLETED|Second Intervention||1
8436295|NCT00829504|20789083|P2|COMPLETED|Second Intervention||22
8436296|NCT00829504|20789084|P1|COMPLETED|Second Intervention||19
8436297|NCT00829504|20789083|P2|STARTED|Second Intervention||22
8436298|NCT00829504|20789084|P1|STARTED|Second Intervention||20
8436299|NCT00829504|20789083|P2|NOT COMPLETED|Washout of 7 Days||0
8436300|NCT00829504|20789084|P1|NOT COMPLETED|Washout of 7 Days||1
8436301|NCT00829504|20789083|P2|COMPLETED|Washout of 7 Days||22
8436302|NCT00829504|20789084|P1|COMPLETED|Washout of 7 Days||20
8436303|NCT00829504|20789083|P2|STARTED|Washout of 7 Days||22
8436304|NCT00829504|20789084|P1|STARTED|Washout of 7 Days||21
8436305|NCT00829504|20789083|P2|NOT COMPLETED|First Intervention||0
8436306|NCT00829504|20789084|P1|NOT COMPLETED|First Intervention||1
8436307|NCT00829504|20789083|P2|COMPLETED|First Intervention||22
8436308|NCT00829504|20789084|P1|COMPLETED|First Intervention||21
8436309|NCT00829504|20789083|P2|STARTED|First Intervention||22
8436310|NCT00829504|20789084|P1|STARTED|First Intervention||22
8436311|NCT00829452|20789094|P2|NOT COMPLETED|Second Intervention||1
8436312|NCT00829452|20789095|P1|NOT COMPLETED|Second Intervention||0
8436313|NCT00829452|20789094|P2|COMPLETED|Second Intervention||17
8436314|NCT00829452|20789095|P1|COMPLETED|Second Intervention||20
8436315|NCT00829452|20789094|P2|STARTED|Second Intervention||18
8436316|NCT00829452|20789095|P1|STARTED|Second Intervention||20
8436317|NCT00829452|20789094|P2|NOT COMPLETED|Washout of 42 Days||1
8436318|NCT00829452|20789095|P1|NOT COMPLETED|Washout of 42 Days||0
8436319|NCT00829452|20789094|P2|COMPLETED|Washout of 42 Days||18
8436320|NCT00829452|20789095|P1|COMPLETED|Washout of 42 Days||20
8436321|NCT00829452|20789094|P2|STARTED|Washout of 42 Days||19
8436322|NCT00829452|20789095|P1|STARTED|Washout of 42 Days||20
8436323|NCT00829452|20789094|P2|NOT COMPLETED|First Intervention||1
8436324|NCT00829452|20789095|P1|NOT COMPLETED|First Intervention||0
8436325|NCT00829452|20789094|P2|COMPLETED|First Intervention||19
8436326|NCT00829452|20789095|P1|COMPLETED|First Intervention||20
8436327|NCT00829452|20789094|P2|STARTED|First Intervention||20
8436328|NCT00829452|20789095|P1|STARTED|First Intervention||20
8436329|NCT00829439|20789107|P4|NOT COMPLETED|Overall Study||0
8436330|NCT00829439|20789108|P3|NOT COMPLETED|Overall Study||1
8436331|NCT00829439|20789109|P2|NOT COMPLETED|Overall Study||0
8436332|NCT00829439|20789110|P1|NOT COMPLETED|Overall Study||0
8436333|NCT00829439|20789107|P4|COMPLETED|Overall Study||4
8436334|NCT00829439|20789108|P3|COMPLETED|Overall Study||5
8436335|NCT00829439|20789109|P2|COMPLETED|Overall Study||3
8436336|NCT00829439|20789110|P1|COMPLETED|Overall Study||3
8436337|NCT00829439|20789107|P4|STARTED|Overall Study||4
8436338|NCT00829439|20789108|P3|STARTED|Overall Study||6
8436339|NCT00829439|20789109|P2|STARTED|Overall Study||3
8436340|NCT00829439|20789110|P1|STARTED|Overall Study||3
8436341|NCT00829426|20789116|P2|NOT COMPLETED|Second Intervention||0
8436342|NCT00829426|20789117|P1|NOT COMPLETED|Second Intervention||0
8436343|NCT00829426|20789116|P2|COMPLETED|Second Intervention||16
8436344|NCT00829426|20789117|P1|COMPLETED|Second Intervention||15
8436345|NCT00829426|20789116|P2|STARTED|Second Intervention||16
8436346|NCT00829426|20789117|P1|STARTED|Second Intervention||15
8436347|NCT00829426|20789116|P2|NOT COMPLETED|Washout: 7 Days||0
8436348|NCT00829426|20789117|P1|NOT COMPLETED|Washout: 7 Days||1
8436349|NCT00829426|20789116|P2|COMPLETED|Washout: 7 Days||16
8436350|NCT00829426|20789117|P1|COMPLETED|Washout: 7 Days||15
8436351|NCT00829426|20789116|P2|STARTED|Washout: 7 Days||16
8436352|NCT00829426|20789117|P1|STARTED|Washout: 7 Days||16
8436353|NCT00829426|20789116|P2|NOT COMPLETED|First Intervention||0
8436354|NCT00829426|20789117|P1|NOT COMPLETED|First Intervention||0
8436355|NCT00829426|20789116|P2|COMPLETED|First Intervention||16
8436356|NCT00829426|20789117|P1|COMPLETED|First Intervention||16
8436357|NCT00829426|20789116|P2|STARTED|First Intervention||16
8436358|NCT00829426|20789117|P1|STARTED|First Intervention||16
8436359|NCT00829413|20789125|P1|NOT COMPLETED|Overall Study||94
8436360|NCT00829413|20789125|P1|COMPLETED|Overall Study||259
8436361|NCT00829413|20789125|P1|STARTED|Overall Study||353
8436362|NCT00829387|20789174|P2|NOT COMPLETED|Overall Study||3
8436363|NCT00829387|20789175|P1|NOT COMPLETED|Overall Study||3
8436364|NCT00829387|20789174|P2|COMPLETED|Overall Study||21
8436365|NCT00829387|20789175|P1|COMPLETED|Overall Study||20
8436366|NCT00829387|20789174|P2|STARTED|Overall Study||24
8436367|NCT00829387|20789175|P1|STARTED|Overall Study||23
8436368|NCT00829309|20789193|P2|NOT COMPLETED|Second Intervention||0
8436369|NCT00829309|20789194|P1|NOT COMPLETED|Second Intervention||0
8436370|NCT00829309|20789193|P2|COMPLETED|Second Intervention||8
8436371|NCT00829309|20789194|P1|COMPLETED|Second Intervention||7
8436372|NCT00829309|20789193|P2|STARTED|Second Intervention||8
8436373|NCT00829309|20789194|P1|STARTED|Second Intervention||7
8436374|NCT00829309|20789193|P2|NOT COMPLETED|Washout: 7 Days||0
8436375|NCT00829309|20789194|P1|NOT COMPLETED|Washout: 7 Days||1
8436376|NCT00829309|20789193|P2|COMPLETED|Washout: 7 Days||8
8436377|NCT00829309|20789194|P1|COMPLETED|Washout: 7 Days||7
8436378|NCT00829309|20789193|P2|STARTED|Washout: 7 Days||8
8436379|NCT00829309|20789194|P1|STARTED|Washout: 7 Days||8
8436380|NCT00829309|20789193|P2|NOT COMPLETED|First Intervention||0
8436381|NCT00829309|20789194|P1|NOT COMPLETED|First Intervention||0
8436382|NCT00829309|20789193|P2|COMPLETED|First Intervention||8
8436383|NCT00829309|20789194|P1|COMPLETED|First Intervention||8
8436384|NCT00829309|20789193|P2|STARTED|First Intervention||8
8436385|NCT00829309|20789194|P1|STARTED|First Intervention||8
8436386|NCT00829296|20789204|P2|NOT COMPLETED|Overall Study||4
8436387|NCT00829296|20789205|P1|NOT COMPLETED|Overall Study||5
8436388|NCT00829296|20789204|P2|COMPLETED|Overall Study||32
8436389|NCT00829296|20789205|P1|COMPLETED|Overall Study||29
8436390|NCT00829296|20789204|P2|STARTED|Overall Study||36
8436391|NCT00829296|20789205|P1|STARTED|Overall Study||34
8436392|NCT00829283|20789219|P2|NOT COMPLETED|Overall Study||25
8436393|NCT00829283|20789220|P1|NOT COMPLETED|Overall Study||7
8436394|NCT00829283|20789219|P2|COMPLETED|Overall Study||127
8436395|NCT00829283|20789220|P1|COMPLETED|Overall Study||32
8436396|NCT00829283|20789219|P2|STARTED|Overall Study||152
8436397|NCT00829283|20789220|P1|STARTED|Overall Study||39
8436398|NCT00829244|20789230|P2|NOT COMPLETED|Overall Study||21
8436399|NCT00829244|20789231|P1|NOT COMPLETED|Overall Study||14
8436400|NCT00829244|20789230|P2|COMPLETED|Overall Study||83
8436401|NCT00829244|20789231|P1|COMPLETED|Overall Study||82
8436402|NCT00829244|20789230|P2|STARTED|Overall Study||104
8436403|NCT00829244|20789231|P1|STARTED|Overall Study||96
8436404|NCT00829179|20789261|P1|NOT COMPLETED|Overall Study||1
8436405|NCT00829179|20789261|P1|COMPLETED|Overall Study||19
8436406|NCT00829179|20789261|P1|STARTED|Overall Study||20
8436407|NCT00829166|20789267|P2|NOT COMPLETED|Overall Study||496
8436408|NCT00829166|20789268|P1|NOT COMPLETED|Overall Study||495
8436409|NCT00829166|20789267|P2|COMPLETED|Overall Study||0
8436410|NCT00829166|20789268|P1|COMPLETED|Overall Study||0
8436411|NCT00829166|20789267|P2|Treated|Overall Study||488
8436412|NCT00829166|20789268|P1|Treated|Overall Study||490
8436413|NCT00829166|20789267|P2|STARTED|Overall Study||496
8436414|NCT00829166|20789268|P1|STARTED|Overall Study||495
8436415|NCT00829049|20789309|P2|NOT COMPLETED|Overall Study||20
8436416|NCT00829049|20789310|P1|NOT COMPLETED|Overall Study||17
8436417|NCT00829049|20789309|P2|COMPLETED|Overall Study||68
8436418|NCT00829049|20789310|P1|COMPLETED|Overall Study||60
8436419|NCT00829049|20789309|P2|STARTED|Overall Study||88
8436420|NCT00829049|20789310|P1|STARTED|Overall Study||77
8436421|NCT00829036|20789322|P1|NOT COMPLETED|Overall Study||0
8436422|NCT00829036|20789322|P1|COMPLETED|Overall Study||24
8436423|NCT00829036|20789322|P1|STARTED|Overall Study||24
8436424|NCT00829010|20789331|P5|NOT COMPLETED|Overall Study||2
8436425|NCT00829010|20789332|P4|NOT COMPLETED|Overall Study||8
8436426|NCT00829010|20789333|P3|NOT COMPLETED|Overall Study||3
8436427|NCT00829010|20789334|P2|NOT COMPLETED|Overall Study||9
8436428|NCT00829010|20789335|P1|NOT COMPLETED|Overall Study||10
8436429|NCT00829010|20789331|P5|COMPLETED|Overall Study||98
8436430|NCT00829010|20789332|P4|COMPLETED|Overall Study||92
8436431|NCT00829010|20789333|P3|COMPLETED|Overall Study||97
8436432|NCT00829010|20789334|P2|COMPLETED|Overall Study||92
8436433|NCT00829010|20789335|P1|COMPLETED|Overall Study||73
8436434|NCT00829010|20789331|P5|STARTED|Overall Study||100
8436435|NCT00829010|20789332|P4|STARTED|Overall Study||100
8436436|NCT00829010|20789333|P3|STARTED|Overall Study||100
8436437|NCT00829010|20789334|P2|STARTED|Overall Study||101
8436438|NCT00829010|20789335|P1|STARTED|Overall Study||83
8436439|NCT00828984|20789500|P3|NOT COMPLETED|Overall Study||9
8436440|NCT00828984|20789501|P2|NOT COMPLETED|Overall Study||16
8436441|NCT00828984|20789502|P1|NOT COMPLETED|Overall Study||14
8436442|NCT00828984|20789500|P3|COMPLETED|Overall Study||19
8436443|NCT00828984|20789501|P2|COMPLETED|Overall Study||15
8436444|NCT00828984|20789502|P1|COMPLETED|Overall Study||14
8436445|NCT00828984|20789500|P3|Post Intervention Follow-Up|Overall Study||19
8436446|NCT00828984|20789501|P2|Post Intervention Follow-Up|Overall Study||16
8436447|NCT00828984|20789502|P1|Post Intervention Follow-Up|Overall Study||15
8436448|NCT00828984|20789500|P3|Flexible Sigmoidoscopy|Overall Study||19
8436449|NCT00828984|20789501|P2|Flexible Sigmoidoscopy|Overall Study||19
8436450|NCT00828984|20789502|P1|Flexible Sigmoidoscopy|Overall Study||20
8436451|NCT00828984|20789500|P3|Treatment|Overall Study||24
8436452|NCT00828984|20789501|P2|Treatment|Overall Study||26
8436453|NCT00828984|20789502|P1|Treatment|Overall Study||24
8436454|NCT00828984|20789500|P3|Randomization|Overall Study||28
8436455|NCT00828984|20789501|P2|Randomization|Overall Study||31
8436456|NCT00828984|20789502|P1|Randomization|Overall Study||28
8436457|NCT00828984|20789500|P3|STARTED|Overall Study||28
8436458|NCT00828984|20789501|P2|STARTED|Overall Study||31
8436459|NCT00828984|20789502|P1|STARTED|Overall Study||28
8436463|NCT00828841|20789542|P3|NOT COMPLETED|Overall Study||4
8436464|NCT00828841|20789543|P2|NOT COMPLETED|Overall Study||4
8436465|NCT00828841|20789544|P1|NOT COMPLETED|Overall Study||4
8436466|NCT00828841|20789542|P3|COMPLETED|Overall Study||126
8436467|NCT00828841|20789543|P2|COMPLETED|Overall Study||232
8436468|NCT00828841|20789544|P1|COMPLETED|Overall Study||231
8436469|NCT00828841|20789542|P3|STARTED|Overall Study||130
8436470|NCT00828841|20789543|P2|STARTED|Overall Study||236
8436471|NCT00828841|20789544|P1|STARTED|Overall Study||235
8436472|NCT00828750|20789557|P1|NOT COMPLETED|Overall Study||4
8436473|NCT00828750|20789557|P1|COMPLETED|Overall Study||15
8436474|NCT00828750|20789557|P1|STARTED|Overall Study||19
8436475|NCT00828711|20789571|P3|NOT COMPLETED|Overall Study||0
8436476|NCT00828711|20789572|P2|NOT COMPLETED|Overall Study||0
8436477|NCT00828711|20789573|P1|NOT COMPLETED|Overall Study||1
8436478|NCT00828711|20789571|P3|COMPLETED|Overall Study||131
8436479|NCT00828711|20789572|P2|COMPLETED|Overall Study||125
8436480|NCT00828711|20789573|P1|COMPLETED|Overall Study||117
8436481|NCT00828711|20789571|P3|STARTED|Overall Study||131
8436482|NCT00828711|20789572|P2|STARTED|Overall Study||125
8436483|NCT00828711|20789573|P1|STARTED|Overall Study||118
8436484|NCT00828672|20789604|P2|NOT COMPLETED|Follow-up||0
8436485|NCT00828672|20789605|P1|NOT COMPLETED|Follow-up||0
8436486|NCT00828672|20789604|P2|COMPLETED|Follow-up||41
8436487|NCT00828672|20789605|P1|COMPLETED|Follow-up||42
8436488|NCT00828672|20789604|P2|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
8436489|NCT00828672|20789605|P1|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
8436490|NCT00828672|20789604|P2|NOT COMPLETED|Post-surgery (<30 Days)||1
8436491|NCT00828672|20789605|P1|NOT COMPLETED|Post-surgery (<30 Days)||0
8436492|NCT00828672|20789604|P2|COMPLETED|Post-surgery (<30 Days)||38
8436493|NCT00828672|20789605|P1|COMPLETED|Post-surgery (<30 Days)||41
8436494|NCT00828672|20789604|P2|STARTED|Post-surgery (<30 Days)||39
8436495|NCT00828672|20789605|P1|STARTED|Post-surgery (<30 Days)||41
8436496|NCT00828672|20789604|P2|NOT COMPLETED|Study Treatment||2
8436497|NCT00828672|20789605|P1|NOT COMPLETED|Study Treatment||2
8436498|NCT00828672|20789604|P2|COMPLETED|Study Treatment||39
8436499|NCT00828672|20789605|P1|COMPLETED|Study Treatment||41
8436500|NCT00828672|20789604|P2|STARTED|Study Treatment||41
8436501|NCT00828672|20789605|P1|STARTED|Study Treatment||43
8436502|NCT00828672|20789604|P2|NOT COMPLETED|Pre-treatment (Baseline)||0
8436503|NCT00828672|20789605|P1|NOT COMPLETED|Pre-treatment (Baseline)||0
8436504|NCT00828672|20789604|P2|COMPLETED|Pre-treatment (Baseline)||41
8436505|NCT00828672|20789605|P1|COMPLETED|Pre-treatment (Baseline)||43
8436506|NCT00828672|20789604|P2|STARTED|Pre-treatment (Baseline)||41
8436507|NCT00828672|20789605|P1|STARTED|Pre-treatment (Baseline)||43
8436508|NCT00828568|20789626|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
8436509|NCT00828568|20789627|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
8436510|NCT00828568|20789628|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
8436511|NCT00828568|20789626|P3|COMPLETED|Treated - Received at Least One Dose||55
8436512|NCT00828568|20789627|P2|COMPLETED|Treated - Received at Least One Dose||150
8436513|NCT00828568|20789628|P1|COMPLETED|Treated - Received at Least One Dose||153
8436514|NCT00828568|20789626|P3|STARTED|Treated - Received at Least One Dose||60
8436515|NCT00828568|20789627|P2|STARTED|Treated - Received at Least One Dose||179
8436516|NCT00828568|20789628|P1|STARTED|Treated - Received at Least One Dose||183
8436517|NCT00828568|20789626|P3|NOT COMPLETED|Randomized||2
8436518|NCT00828568|20789627|P2|NOT COMPLETED|Randomized||0
8436519|NCT00828568|20789628|P1|NOT COMPLETED|Randomized||1
8436520|NCT00828568|20789626|P3|COMPLETED|Randomized||60
8436521|NCT00828568|20789627|P2|COMPLETED|Randomized||179
8436522|NCT00828568|20789628|P1|COMPLETED|Randomized||183
8436523|NCT00828568|20789626|P3|STARTED|Randomized||62
8436524|NCT00828568|20789627|P2|STARTED|Randomized||179
8436525|NCT00828568|20789628|P1|STARTED|Randomized||184
8436526|NCT00828542|20789643|P2|NOT COMPLETED|Overall Study||3
8436527|NCT00828542|20789644|P1|NOT COMPLETED|Overall Study||3
8436528|NCT00828542|20789643|P2|COMPLETED|Overall Study||20
8436529|NCT00828542|20789644|P1|COMPLETED|Overall Study||20
8436530|NCT00828542|20789643|P2|STARTED|Overall Study||23
8436531|NCT00828542|20789644|P1|STARTED|Overall Study||23
8436532|NCT00828516|20789650|P1|NOT COMPLETED|Clinical Phase: Series 2||0
8436533|NCT00828516|20789650|P1|COMPLETED|Clinical Phase: Series 2||30
8436534|NCT00828516|20789650|P1|STARTED|Clinical Phase: Series 2||30
8436535|NCT00828516|20789650|P1|NOT COMPLETED|Clinical Phase: Series 1||2
8436536|NCT00828516|20789650|P1|COMPLETED|Clinical Phase: Series 1||33
8436537|NCT00828516|20789650|P1|STARTED|Clinical Phase: Series 1||35
8436538|NCT00828464|20789655|P1|NOT COMPLETED|Overall Study||1
8436539|NCT00828464|20789655|P1|COMPLETED|Overall Study||29
8436540|NCT00828464|20789655|P1|STARTED|Overall Study||30
8436541|NCT00828451|20789672|P1|NOT COMPLETED|Overall Study||11
8436542|NCT00828451|20789672|P1|COMPLETED|Overall Study||18
8436543|NCT00828451|20789672|P1|STARTED|Overall Study||29
8436544|NCT00828412|20789680|P2|NOT COMPLETED|Overall Study||2
8436545|NCT00828412|20789681|P1|NOT COMPLETED|Overall Study||9
8436546|NCT00828412|20789680|P2|COMPLETED|Overall Study||48
8436547|NCT00828412|20789681|P1|COMPLETED|Overall Study||41
8436548|NCT00828412|20789680|P2|STARTED|Overall Study||50
8436549|NCT00828412|20789681|P1|STARTED|Overall Study||50
8436550|NCT00828347|20789689|P2|NOT COMPLETED|Overall Study||0
8436551|NCT00828347|20789690|P1|NOT COMPLETED|Overall Study||0
8436552|NCT00828347|20789689|P2|COMPLETED|Overall Study||11
8436553|NCT00828347|20789690|P1|COMPLETED|Overall Study||12
8436554|NCT00828347|20789689|P2|STARTED|Overall Study||11
8436555|NCT00828347|20789690|P1|STARTED|Overall Study||12
8436556|NCT00828321|20789698|P2|NOT COMPLETED|Second Intervention||1
8436557|NCT00828321|20789699|P1|NOT COMPLETED|Second Intervention||0
8436558|NCT00828321|20789698|P2|COMPLETED|Second Intervention||19
8436559|NCT00828321|20789699|P1|COMPLETED|Second Intervention||18
8436560|NCT00828321|20789698|P2|STARTED|Second Intervention||20
8436561|NCT00828321|20789699|P1|STARTED|Second Intervention||18
8436562|NCT00828321|20789698|P2|NOT COMPLETED|Washout of 42 Days||0
8436563|NCT00828321|20789699|P1|NOT COMPLETED|Washout of 42 Days||2
8436564|NCT00828321|20789698|P2|COMPLETED|Washout of 42 Days||20
8436565|NCT00828321|20789699|P1|COMPLETED|Washout of 42 Days||18
8436566|NCT00828321|20789698|P2|STARTED|Washout of 42 Days||20
8436567|NCT00828321|20789699|P1|STARTED|Washout of 42 Days||20
8436568|NCT00828321|20789698|P2|NOT COMPLETED|First Intervention||0
8436569|NCT00828321|20789699|P1|NOT COMPLETED|First Intervention||0
8436570|NCT00828321|20789698|P2|COMPLETED|First Intervention||20
8436571|NCT00828321|20789699|P1|COMPLETED|First Intervention||20
8436572|NCT00828321|20789698|P2|STARTED|First Intervention||20
8436573|NCT00828321|20789699|P1|STARTED|First Intervention||20
8436574|NCT00828308|20789711|P1|NOT COMPLETED|Overall Study||0
8436575|NCT00828308|20789711|P1|COMPLETED|Overall Study||16
8436576|NCT00828308|20789711|P1|STARTED|Overall Study||16
8436577|NCT00828295|20789717|P2|NOT COMPLETED|Overall Study||0
8436578|NCT00828295|20789718|P1|NOT COMPLETED|Overall Study||0
8436579|NCT00828295|20789717|P2|COMPLETED|Overall Study||75
8436580|NCT00828295|20789718|P1|COMPLETED|Overall Study||75
8436581|NCT00828295|20789717|P2|STARTED|Overall Study||75
8436582|NCT00828295|20789718|P1|STARTED|Overall Study||75
8436583|NCT00828204|20789728|P2|NOT COMPLETED|Extension Study||3
8436584|NCT00828204|20789729|P1|NOT COMPLETED|Extension Study||0
8436585|NCT00828204|20789728|P2|COMPLETED|Extension Study||61
8436586|NCT00828204|20789729|P1|COMPLETED|Extension Study||0
8436587|NCT00828204|20789728|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
8436588|NCT00828204|20789729|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
8436589|NCT00828204|20789728|P2|NOT COMPLETED|Main Study: After Study Restart||3
8436590|NCT00828204|20789729|P1|NOT COMPLETED|Main Study: After Study Restart||0
8436591|NCT00828204|20789728|P2|COMPLETED|Main Study: After Study Restart||71
8436592|NCT00828204|20789729|P1|COMPLETED|Main Study: After Study Restart||0
8436593|NCT00828204|20789728|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
8436594|NCT00828204|20789729|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
8436595|NCT00828204|20789728|P2|Completed Manual Injection|Main Study: After Study Restart||74
8436596|NCT00828204|20789729|P1|Completed Manual Injection|Main Study: After Study Restart||0
8436597|NCT00828204|20789728|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
8436598|NCT00828204|20789729|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
8436599|NCT00828204|20789728|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
8436600|NCT00828204|20789729|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
8436601|NCT00828204|20789728|P2|COMPLETED|Main Study: Prior to Study Suspension||0
8436602|NCT00828204|20789729|P1|COMPLETED|Main Study: Prior to Study Suspension||7
8436603|NCT00828204|20789728|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
8436604|NCT00828204|20789729|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
8436605|NCT00828204|20789728|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
8436606|NCT00828204|20789729|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
8436607|NCT00828204|20789728|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
8436608|NCT00828204|20789729|P1|STARTED|Main Study: Prior to Study Suspension||21
8436609|NCT00828191|20789748|P2|NOT COMPLETED|Overall Study||10
8436610|NCT00828191|20789749|P1|NOT COMPLETED|Overall Study||8
8436611|NCT00828191|20789748|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
8436612|NCT00828191|20789749|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
8436613|NCT00828191|20789748|P2|STARTED|Overall Study|Randomized patients|400
8436614|NCT00828191|20789749|P1|STARTED|Overall Study|Randomized patients|400
8436615|NCT00828178|20789761|P2|NOT COMPLETED|Overall Study||2
8436616|NCT00828178|20789762|P1|NOT COMPLETED|Overall Study||0
8436617|NCT00828178|20789761|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
8436618|NCT00828178|20789762|P1|COMPLETED|Overall Study||42
8436619|NCT00828178|20789761|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
8436620|NCT00828178|20789762|P1|STARTED|Overall Study||42
8436621|NCT00828139|20789776|P4|NOT COMPLETED|Overall Study||51
8436622|NCT00828139|20789777|P3|NOT COMPLETED|Overall Study||55
8436623|NCT00828139|20789778|P2|NOT COMPLETED|Overall Study||41
8436624|NCT00828139|20789779|P1|NOT COMPLETED|Overall Study||41
8436625|NCT00828139|20789776|P4|COMPLETED|Overall Study||0
8436626|NCT00828139|20789777|P3|COMPLETED|Overall Study||0
8436627|NCT00828139|20789778|P2|COMPLETED|Overall Study||0
8436628|NCT00828139|20789779|P1|COMPLETED|Overall Study||1
8436629|NCT00828139|20789776|P4|STARTED|Overall Study||51
8436630|NCT00828139|20789777|P3|STARTED|Overall Study||55
8436631|NCT00828139|20789778|P2|STARTED|Overall Study||41
8436632|NCT00828139|20789779|P1|STARTED|Overall Study||42
8436633|NCT00828113|20789799|P2|NOT COMPLETED|Overall Study||31
8436634|NCT00828113|20789800|P1|NOT COMPLETED|Overall Study||30
8436635|NCT00828113|20789799|P2|COMPLETED|Overall Study||20
8436636|NCT00828113|20789800|P1|COMPLETED|Overall Study||20
8436637|NCT00828113|20789799|P2|STARTED|Overall Study||51
8436638|NCT00828113|20789800|P1|STARTED|Overall Study||50
8436639|NCT00828074|20789808|P3|NOT COMPLETED|Overall Study||0
8436640|NCT00828074|20789809|P2|NOT COMPLETED|Overall Study||0
8436641|NCT00828074|20789810|P1|NOT COMPLETED|Overall Study||0
8436642|NCT00828074|20789808|P3|COMPLETED|Overall Study||35
8436643|NCT00828074|20789809|P2|COMPLETED|Overall Study||5
8436644|NCT00828074|20789810|P1|COMPLETED|Overall Study||6
8436645|NCT00828074|20789808|P3|STARTED|Overall Study||35
8436646|NCT00828074|20789809|P2|STARTED|Overall Study||5
8436647|NCT00828074|20789810|P1|STARTED|Overall Study||6
8436648|NCT00828061|20789822|P6|NOT COMPLETED|Period 3||0
8436649|NCT00828061|20789823|P5|NOT COMPLETED|Period 3||0
8436650|NCT00828061|20789824|P4|NOT COMPLETED|Period 3||0
8436651|NCT00828061|20789825|P3|NOT COMPLETED|Period 3||0
8436652|NCT00828061|20789826|P2|NOT COMPLETED|Period 3||0
8436653|NCT00828061|20789827|P1|NOT COMPLETED|Period 3||0
8436654|NCT00828061|20789822|P6|COMPLETED|Period 3||3
8436655|NCT00828061|20789823|P5|COMPLETED|Period 3||3
8436656|NCT00828061|20789824|P4|COMPLETED|Period 3||3
8436657|NCT00828061|20789825|P3|COMPLETED|Period 3||3
8436658|NCT00828061|20789826|P2|COMPLETED|Period 3||3
8436659|NCT00828061|20789827|P1|COMPLETED|Period 3||4
8436660|NCT00828061|20789822|P6|STARTED|Period 3||3
8436661|NCT00828061|20789823|P5|STARTED|Period 3||3
8436662|NCT00828061|20789824|P4|STARTED|Period 3||3
8436663|NCT00828061|20789825|P3|STARTED|Period 3||3
8436664|NCT00828061|20789826|P2|STARTED|Period 3||3
8436665|NCT00828061|20789827|P1|STARTED|Period 3||4
8436666|NCT00828061|20789822|P6|NOT COMPLETED|Period 2||0
8436667|NCT00828061|20789823|P5|NOT COMPLETED|Period 2||0
8436668|NCT00828061|20789824|P4|NOT COMPLETED|Period 2||0
8436669|NCT00828061|20789825|P3|NOT COMPLETED|Period 2||0
8436670|NCT00828061|20789826|P2|NOT COMPLETED|Period 2||0
8436671|NCT00828061|20789827|P1|NOT COMPLETED|Period 2||0
8436672|NCT00828061|20789822|P6|COMPLETED|Period 2||3
8436673|NCT00828061|20789823|P5|COMPLETED|Period 2||3
8436674|NCT00828061|20789824|P4|COMPLETED|Period 2||3
8436675|NCT00828061|20789825|P3|COMPLETED|Period 2||3
8436676|NCT00828061|20789826|P2|COMPLETED|Period 2||3
8436677|NCT00828061|20789827|P1|COMPLETED|Period 2||4
8436678|NCT00828061|20789822|P6|STARTED|Period 2||3
8436679|NCT00828061|20789823|P5|STARTED|Period 2||3
8436680|NCT00828061|20789824|P4|STARTED|Period 2||3
8436681|NCT00828061|20789825|P3|STARTED|Period 2||3
8436682|NCT00828061|20789826|P2|STARTED|Period 2||3
8436683|NCT00828061|20789827|P1|STARTED|Period 2||4
8436684|NCT00828061|20789822|P6|NOT COMPLETED|Period 1||0
8436685|NCT00828061|20789823|P5|NOT COMPLETED|Period 1||0
8436686|NCT00828061|20789824|P4|NOT COMPLETED|Period 1||0
8436687|NCT00828061|20789825|P3|NOT COMPLETED|Period 1||0
8436688|NCT00828061|20789826|P2|NOT COMPLETED|Period 1||0
8436689|NCT00828061|20789827|P1|NOT COMPLETED|Period 1||0
8436690|NCT00828061|20789822|P6|COMPLETED|Period 1||3
8436691|NCT00828061|20789823|P5|COMPLETED|Period 1||3
8436692|NCT00828061|20789824|P4|COMPLETED|Period 1||3
8436693|NCT00828061|20789825|P3|COMPLETED|Period 1||3
8436694|NCT00828061|20789826|P2|COMPLETED|Period 1||3
8436695|NCT00828061|20789827|P1|COMPLETED|Period 1||4
8436696|NCT00828061|20789822|P6|STARTED|Period 1||3
8436697|NCT00828061|20789823|P5|STARTED|Period 1||3
8436698|NCT00828061|20789824|P4|STARTED|Period 1||3
8436699|NCT00828061|20789825|P3|STARTED|Period 1||3
8436700|NCT00828061|20789826|P2|STARTED|Period 1||3
8436701|NCT00828061|20789827|P1|STARTED|Period 1||4
8436702|NCT00828009|20789838|P1|NOT COMPLETED|Step 2 - Maintenance Therapy||33
8436703|NCT00828009|20789838|P1|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
8436704|NCT00828009|20789838|P1|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
8436705|NCT00828009|20789838|P1|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
8436706|NCT00828009|20789838|P1|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
8436707|NCT00828009|20789838|P1|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
8436708|NCT00828009|20789838|P1|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
8436709|NCT00827983|20789847|P2|NOT COMPLETED|Overall Study||16
8436710|NCT00827983|20789848|P1|NOT COMPLETED|Overall Study||18
8436711|NCT00827983|20789847|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
8436712|NCT00827983|20789848|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
8436713|NCT00827983|20789847|P2|STARTED|Overall Study|all randomised patients|344
8436714|NCT00827983|20789848|P1|STARTED|Overall Study|All randomised patients|339
8436715|NCT00827944|20789860|P2|NOT COMPLETED|Overall Study||59
8436716|NCT00827944|20789861|P1|NOT COMPLETED|Overall Study||63
8436717|NCT00827944|20789860|P2|COMPLETED|Overall Study||240
8436718|NCT00827944|20789861|P1|COMPLETED|Overall Study||241
8436719|NCT00827944|20789860|P2|STARTED|Overall Study||299
8436720|NCT00827944|20789861|P1|STARTED|Overall Study||304
8436721|NCT00827931|20789881|P2|NOT COMPLETED|Overall Study||6
8436722|NCT00827931|20789882|P1|NOT COMPLETED|Overall Study||6
8436723|NCT00827931|20789881|P2|COMPLETED|Overall Study||39
8436724|NCT00827931|20789882|P1|COMPLETED|Overall Study||43
8436725|NCT00827931|20789881|P2|STARTED|Overall Study||45
8436726|NCT00827931|20789882|P1|STARTED|Overall Study||49
8436727|NCT00827918|20789903|P3|NOT COMPLETED|Overall Study||21
8436728|NCT00827918|20789904|P2|NOT COMPLETED|Overall Study||9
8436729|NCT00827918|20789905|P1|NOT COMPLETED|Overall Study||28
8436730|NCT00827918|20789903|P3|COMPLETED|Overall Study||62
8436731|NCT00827918|20789904|P2|COMPLETED|Overall Study||38
8436732|NCT00827918|20789905|P1|COMPLETED|Overall Study||58
8436733|NCT00827918|20789903|P3|STARTED|Overall Study||83
8436734|NCT00827918|20789904|P2|STARTED|Overall Study||47
8436735|NCT00827918|20789905|P1|STARTED|Overall Study||86
8436736|NCT00827827|20789933|P2|NOT COMPLETED|Overall Study||0
8436737|NCT00827827|20789934|P1|NOT COMPLETED|Overall Study||8
8436738|NCT00827827|20789933|P2|COMPLETED|Overall Study||16
8436739|NCT00827827|20789934|P1|COMPLETED|Overall Study||14
8436740|NCT00827827|20789933|P2|STARTED|Overall Study||16
8436741|NCT00827827|20789934|P1|STARTED|Overall Study||22
8436742|NCT00827775|20789978|P2|NOT COMPLETED|Overall Study||5
8436743|NCT00827775|20789979|P1|NOT COMPLETED|Overall Study||0
8436744|NCT00827775|20789978|P2|COMPLETED|Overall Study||25
8436745|NCT00827775|20789979|P1|COMPLETED|Overall Study||25
8436746|NCT00827775|20789978|P2|STARTED|Overall Study||30
8436747|NCT00827775|20789979|P1|STARTED|Overall Study||25
8436748|NCT00827632|20789989|P2|NOT COMPLETED|Overall Study||23
8436749|NCT00827632|20789990|P1|NOT COMPLETED|Overall Study||22
8436750|NCT00827632|20789989|P2|COMPLETED|Overall Study||75
8436751|NCT00827632|20789990|P1|COMPLETED|Overall Study||106
8436752|NCT00827632|20789989|P2|STARTED|Overall Study||98
8436753|NCT00827632|20789990|P1|STARTED|Overall Study||128
8436760|NCT00827567|20790064|P1|NOT COMPLETED|Overall Study||4
8436761|NCT00827567|20790064|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
8436762|NCT00827567|20790064|P1|STARTED|Overall Study||4
8436763|NCT00827541|20790070|P2|NOT COMPLETED|Overall Study||11
8436764|NCT00827541|20790071|P1|NOT COMPLETED|Overall Study||4
8436765|NCT00827541|20790070|P2|COMPLETED|Overall Study||85
8436766|NCT00827541|20790071|P1|COMPLETED|Overall Study||15
8436767|NCT00827541|20790070|P2|STARTED|Overall Study||96
8436768|NCT00827541|20790071|P1|STARTED|Overall Study||19
8436769|NCT00827502|20790083|P1|NOT COMPLETED|Overall Study||21
8436770|NCT00827502|20790083|P1|COMPLETED|Overall Study||400
8436771|NCT00827502|20790083|P1|Received Treatment (Number Treated)|Overall Study||410
8436772|NCT00827502|20790083|P1|STARTED|Overall Study||421
8436773|NCT00827372|20790089|P1|NOT COMPLETED|Overall Study||8
8436774|NCT00827372|20790089|P1|COMPLETED|Overall Study||2
8436775|NCT00827372|20790089|P1|STARTED|Overall Study||10
8436776|NCT00827255|20790097|P1|NOT COMPLETED|Overall Study||0
8436777|NCT00827255|20790097|P1|COMPLETED|Overall Study||35
8436778|NCT00827255|20790097|P1|STARTED|Overall Study||35
8436779|NCT00827242|20790104|P2|NOT COMPLETED|Overall Study||12
8436780|NCT00827242|20790105|P1|NOT COMPLETED|Overall Study||13
8436781|NCT00827242|20790104|P2|COMPLETED|Overall Study||152
8436782|NCT00827242|20790105|P1|COMPLETED|Overall Study||148
8436783|NCT00827242|20790104|P2|STARTED|Overall Study||164
8436784|NCT00827242|20790105|P1|STARTED|Overall Study||161
8436785|NCT00827112|20790143|P2|NOT COMPLETED|Overall Study||12
8436786|NCT00827112|20790144|P1|NOT COMPLETED|Overall Study||15
8436787|NCT00827112|20790143|P2|COMPLETED|Overall Study||52
8436788|NCT00827112|20790144|P1|COMPLETED|Overall Study||50
8436789|NCT00827112|20790143|P2|Treated|Overall Study||61
8436790|NCT00827112|20790144|P1|Treated|Overall Study||60
8436791|NCT00827112|20790143|P2|STARTED|Overall Study||64
8436792|NCT00827112|20790144|P1|STARTED|Overall Study||65
8436793|NCT00827099|20790177|P1|NOT COMPLETED|Overall Study||0
8436794|NCT00827099|20790177|P1|COMPLETED|Overall Study||5
8436795|NCT00827099|20790177|P1|STARTED|Overall Study||5
8436796|NCT00827073|20790188|P2|NOT COMPLETED|Overall Study||0
8436797|NCT00827073|20790189|P1|NOT COMPLETED|Overall Study||0
8436798|NCT00827073|20790188|P2|COMPLETED|Overall Study||20
8436799|NCT00827073|20790189|P1|COMPLETED|Overall Study||20
8436800|NCT00827073|20790188|P2|STARTED|Overall Study||20
8436801|NCT00827073|20790189|P1|STARTED|Overall Study||20
8436802|NCT00826943|20790197|P6|NOT COMPLETED|Overall Study||0
8436803|NCT00826943|20790198|P5|NOT COMPLETED|Overall Study||1
8436804|NCT00826943|20790199|P4|NOT COMPLETED|Overall Study||0
8436805|NCT00826943|20790200|P3|NOT COMPLETED|Overall Study||0
8436806|NCT00826943|20790201|P2|NOT COMPLETED|Overall Study||0
8436807|NCT00826943|20790202|P1|NOT COMPLETED|Overall Study||0
8436808|NCT00826943|20790197|P6|COMPLETED|Overall Study||2
8436809|NCT00826943|20790198|P5|COMPLETED|Overall Study||6
8436810|NCT00826943|20790199|P4|COMPLETED|Overall Study||5
8436811|NCT00826943|20790200|P3|COMPLETED|Overall Study||4
8436812|NCT00826943|20790201|P2|COMPLETED|Overall Study||6
8436813|NCT00826943|20790202|P1|COMPLETED|Overall Study||6
8436814|NCT00826943|20790197|P6|STARTED|Overall Study||2
8436815|NCT00826943|20790198|P5|STARTED|Overall Study||7
8436816|NCT00826943|20790199|P4|STARTED|Overall Study||5
8436817|NCT00826943|20790200|P3|STARTED|Overall Study||4
8436818|NCT00826943|20790201|P2|STARTED|Overall Study||6
8436819|NCT00826943|20790202|P1|STARTED|Overall Study||6
8436820|NCT00826800|20790216|P1|NOT COMPLETED|Overall Study||0
8436821|NCT00826800|20790216|P1|COMPLETED|Overall Study||2
8436822|NCT00826800|20790216|P1|STARTED|Overall Study||2
8436823|NCT00826748|20790223|P3|NOT COMPLETED|Overall Study||4
8436824|NCT00826748|20790224|P2|NOT COMPLETED|Overall Study||0
8436825|NCT00826748|20790225|P1|NOT COMPLETED|Overall Study||0
8436826|NCT00826748|20790223|P3|COMPLETED|Overall Study||8
8436827|NCT00826748|20790224|P2|COMPLETED|Overall Study||4
8436828|NCT00826748|20790225|P1|COMPLETED|Overall Study||6
8436829|NCT00826748|20790223|P3|STARTED|Overall Study||12
8436830|NCT00826748|20790224|P2|STARTED|Overall Study||4
8436831|NCT00826748|20790225|P1|STARTED|Overall Study||6
8436832|NCT00826618|20790233|P1|NOT COMPLETED|Overall Study||1
8436833|NCT00826618|20790233|P1|COMPLETED|Overall Study||5
8436834|NCT00826618|20790233|P1|STARTED|Overall Study||6
8436835|NCT00826540|20790237|P1|NOT COMPLETED|Overall Study||4
8436836|NCT00826540|20790237|P1|COMPLETED|Overall Study||79
8436837|NCT00826540|20790237|P1|STARTED|Overall Study||83
8436838|NCT00826449|20790243|P1|NOT COMPLETED|Overall Study||5
8436839|NCT00826449|20790243|P1|COMPLETED|Overall Study||42
8436840|NCT00826449|20790243|P1|Phase II|Overall Study||35
8436841|NCT00826449|20790243|P1|Phase I|Overall Study||12
8436842|NCT00826449|20790243|P1|STARTED|Overall Study||47
8436843|NCT00826280|20790252|P3|NOT COMPLETED|Overall Study||46
8436844|NCT00826280|20790253|P2|NOT COMPLETED|Overall Study||46
8436845|NCT00826280|20790254|P1|NOT COMPLETED|Overall Study||48
8436846|NCT00826280|20790252|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
8436847|NCT00826280|20790253|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
8436848|NCT00826280|20790254|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
8436849|NCT00826280|20790252|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
8436850|NCT00826280|20790253|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
8436851|NCT00826280|20790254|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
8436852|NCT00826280|20790252|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
8436853|NCT00826280|20790253|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
8436854|NCT00826280|20790254|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
8436855|NCT00826280|20790252|P3|STARTED|Overall Study||117
8436856|NCT00826280|20790253|P2|STARTED|Overall Study||116
8436857|NCT00826280|20790254|P1|STARTED|Overall Study||114
8436858|NCT00826267|20790283|P3|NOT COMPLETED|Overall Study||0
8436859|NCT00826267|20790284|P2|NOT COMPLETED|Overall Study||0
8436860|NCT00826267|20790285|P1|NOT COMPLETED|Overall Study||1
8436861|NCT00826267|20790283|P3|COMPLETED|Overall Study||11
8436862|NCT00826267|20790284|P2|COMPLETED|Overall Study||8
8436863|NCT00826267|20790285|P1|COMPLETED|Overall Study||9
8436864|NCT00826267|20790283|P3|STARTED|Overall Study||11
8436865|NCT00826267|20790284|P2|STARTED|Overall Study||8
8436866|NCT00826267|20790285|P1|STARTED|Overall Study||10
8436867|NCT00826241|20790303|P1|NOT COMPLETED|Overall Study||27
8436868|NCT00826241|20790303|P1|COMPLETED|Overall Study||31
8436869|NCT00826241|20790303|P1|STARTED|Overall Study||58
8436870|NCT00826228|20790309|P1|NOT COMPLETED|Overall Study||1
8436871|NCT00826228|20790309|P1|COMPLETED|Overall Study||11
8436872|NCT00826228|20790309|P1|STARTED|Overall Study||12
8436873|NCT00826202|20790316|P2|NOT COMPLETED|Overall Study||13
8436874|NCT00826202|20790317|P1|NOT COMPLETED|Overall Study||10
8436875|NCT00826202|20790316|P2|COMPLETED|Overall Study||11
8436876|NCT00826202|20790317|P1|COMPLETED|Overall Study||10
8436877|NCT00826202|20790316|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
8436878|NCT00826202|20790317|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
8436879|NCT00826202|20790316|P2|STARTED|Overall Study||24
8436880|NCT00826202|20790317|P1|STARTED|Overall Study||20
8436881|NCT00826176|20790331|P2|NOT COMPLETED|Overall Study||0
8436882|NCT00826176|20790332|P1|NOT COMPLETED|Overall Study||13
8436883|NCT00826176|20790331|P2|COMPLETED|Overall Study|treated and completed|36
8436884|NCT00826176|20790332|P1|COMPLETED|Overall Study|treated and completed|115
8436885|NCT00826176|20790331|P2|STARTED|Overall Study|enrolled|36
8436886|NCT00826176|20790332|P1|STARTED|Overall Study|enrolled|128
8436887|NCT00826150|20790345|P3|NOT COMPLETED|Overall Study||3
8436888|NCT00826150|20790346|P2|NOT COMPLETED|Overall Study||2
8436889|NCT00826150|20790347|P1|NOT COMPLETED|Overall Study||6
8436890|NCT00826150|20790345|P3|COMPLETED|Overall Study||0
8436891|NCT00826150|20790346|P2|COMPLETED|Overall Study||1
8436892|NCT00826150|20790347|P1|COMPLETED|Overall Study||2
8436893|NCT00826150|20790345|P3|STARTED|Overall Study||3
8436894|NCT00826150|20790346|P2|STARTED|Overall Study||3
8436895|NCT00826150|20790347|P1|STARTED|Overall Study||8
8436896|NCT00826111|20790381|P2|NOT COMPLETED|Overall Study||2
8436897|NCT00826111|20790382|P1|NOT COMPLETED|Overall Study||7
8436898|NCT00826111|20790381|P2|COMPLETED|Overall Study||3
8436899|NCT00826111|20790382|P1|COMPLETED|Overall Study||7
8436900|NCT00826111|20790381|P2|STARTED|Overall Study||5
8436901|NCT00826111|20790382|P1|STARTED|Overall Study||14
8436902|NCT00826020|20790404|P1|NOT COMPLETED|Overall Study||0
8436903|NCT00826020|20790404|P1|COMPLETED|Overall Study||72
8436904|NCT00826020|20790404|P1|STARTED|Overall Study||72
8436905|NCT00826007|20790411|P2|NOT COMPLETED|Overall Study||0
8436906|NCT00826007|20790412|P1|NOT COMPLETED|Overall Study||0
8436907|NCT00826007|20790411|P2|COMPLETED|Overall Study||279
8436908|NCT00826007|20790412|P1|COMPLETED|Overall Study|Retrospective review|308
8436909|NCT00826007|20790411|P2|STARTED|Overall Study||279
8436910|NCT00826007|20790412|P1|STARTED|Overall Study|Retrospective review|308
8436911|NCT00825994|20790417|P1|NOT COMPLETED|Overall Study||5
8436912|NCT00825994|20790417|P1|COMPLETED|Overall Study||19
8436913|NCT00825994|20790417|P1|STARTED|Overall Study||24
8436914|NCT00825916|20790425|P3|NOT COMPLETED|Overall Study||1
8436915|NCT00825916|20790426|P2|NOT COMPLETED|Overall Study||2
8436916|NCT00825916|20790427|P1|NOT COMPLETED|Overall Study||4
8436917|NCT00825916|20790425|P3|COMPLETED|Overall Study||19
8436918|NCT00825916|20790426|P2|COMPLETED|Overall Study||18
8436919|NCT00825916|20790427|P1|COMPLETED|Overall Study||15
8436920|NCT00825916|20790425|P3|STARTED|Overall Study||20
8436921|NCT00825916|20790426|P2|STARTED|Overall Study||20
8436922|NCT00825916|20790427|P1|STARTED|Overall Study||19
8436923|NCT00825825|20790468|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
8436924|NCT00825825|20790469|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
8436925|NCT00825825|20790470|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
8436926|NCT00825825|20790471|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
8436927|NCT00825825|20790472|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
8436928|NCT00825825|20790473|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
8436929|NCT00825825|20790468|P6|COMPLETED|Third Medication Period (14 Days)||1
8436930|NCT00825825|20790469|P5|COMPLETED|Third Medication Period (14 Days)||3
8436931|NCT00825825|20790470|P4|COMPLETED|Third Medication Period (14 Days)||3
8436932|NCT00825825|20790471|P3|COMPLETED|Third Medication Period (14 Days)||2
8436933|NCT00825825|20790472|P2|COMPLETED|Third Medication Period (14 Days)||2
8436934|NCT00825825|20790473|P1|COMPLETED|Third Medication Period (14 Days)||1
8436935|NCT00825825|20790468|P6|STARTED|Third Medication Period (14 Days)||3
8436936|NCT00825825|20790469|P5|STARTED|Third Medication Period (14 Days)||3
8436937|NCT00825825|20790470|P4|STARTED|Third Medication Period (14 Days)||3
8436938|NCT00825825|20790471|P3|STARTED|Third Medication Period (14 Days)||2
8436939|NCT00825825|20790472|P2|STARTED|Third Medication Period (14 Days)||4
8436940|NCT00825825|20790473|P1|STARTED|Third Medication Period (14 Days)||1
8436941|NCT00825825|20790468|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
8436942|NCT00825825|20790469|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
8436943|NCT00825825|20790470|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
8436944|NCT00825825|20790471|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
8436945|NCT00825825|20790472|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
8436946|NCT00825825|20790473|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
8436947|NCT00825825|20790468|P6|COMPLETED|Second Washout Period (14 Days)||3
8436948|NCT00825825|20790469|P5|COMPLETED|Second Washout Period (14 Days)||3
8436949|NCT00825825|20790470|P4|COMPLETED|Second Washout Period (14 Days)||3
8436950|NCT00825825|20790471|P3|COMPLETED|Second Washout Period (14 Days)||2
8436951|NCT00825825|20790472|P2|COMPLETED|Second Washout Period (14 Days)||4
8436952|NCT00825825|20790473|P1|COMPLETED|Second Washout Period (14 Days)||1
8436953|NCT00825825|20790468|P6|STARTED|Second Washout Period (14 Days)||3
8436954|NCT00825825|20790469|P5|STARTED|Second Washout Period (14 Days)||3
8436955|NCT00825825|20790470|P4|STARTED|Second Washout Period (14 Days)||3
8436956|NCT00825825|20790471|P3|STARTED|Second Washout Period (14 Days)||2
8436957|NCT00825825|20790472|P2|STARTED|Second Washout Period (14 Days)||4
8436958|NCT00825825|20790473|P1|STARTED|Second Washout Period (14 Days)||1
8436959|NCT00825825|20790468|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
8436960|NCT00825825|20790469|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
8436961|NCT00825825|20790470|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
8436962|NCT00825825|20790471|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
8436963|NCT00825825|20790472|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
8436964|NCT00825825|20790473|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
8436965|NCT00825825|20790468|P6|COMPLETED|Second Medication Period (14 Days)||3
8436966|NCT00825825|20790469|P5|COMPLETED|Second Medication Period (14 Days)||3
8436967|NCT00825825|20790470|P4|COMPLETED|Second Medication Period (14 Days)||3
8436968|NCT00825825|20790471|P3|COMPLETED|Second Medication Period (14 Days)||2
8436969|NCT00825825|20790472|P2|COMPLETED|Second Medication Period (14 Days)||4
8436970|NCT00825825|20790473|P1|COMPLETED|Second Medication Period (14 Days)||1
8436971|NCT00825825|20790468|P6|STARTED|Second Medication Period (14 Days)||3
8436972|NCT00825825|20790469|P5|STARTED|Second Medication Period (14 Days)||4
8436973|NCT00825825|20790470|P4|STARTED|Second Medication Period (14 Days)||5
8436974|NCT00825825|20790471|P3|STARTED|Second Medication Period (14 Days)||2
8436975|NCT00825825|20790472|P2|STARTED|Second Medication Period (14 Days)||4
8436976|NCT00825825|20790473|P1|STARTED|Second Medication Period (14 Days)||3
8436977|NCT00825825|20790468|P6|NOT COMPLETED|First Washout Period (14 Days)||0
8436978|NCT00825825|20790469|P5|NOT COMPLETED|First Washout Period (14 Days)||0
8436979|NCT00825825|20790470|P4|NOT COMPLETED|First Washout Period (14 Days)||0
8436980|NCT00825825|20790471|P3|NOT COMPLETED|First Washout Period (14 Days)||0
8436981|NCT00825825|20790472|P2|NOT COMPLETED|First Washout Period (14 Days)||0
8436982|NCT00825825|20790473|P1|NOT COMPLETED|First Washout Period (14 Days)||0
8436983|NCT00825825|20790468|P6|COMPLETED|First Washout Period (14 Days)||3
8436984|NCT00825825|20790469|P5|COMPLETED|First Washout Period (14 Days)||4
8436985|NCT00825825|20790470|P4|COMPLETED|First Washout Period (14 Days)||5
8436986|NCT00825825|20790471|P3|COMPLETED|First Washout Period (14 Days)||2
8436987|NCT00825825|20790472|P2|COMPLETED|First Washout Period (14 Days)||4
8436988|NCT00825825|20790473|P1|COMPLETED|First Washout Period (14 Days)||3
8436989|NCT00825825|20790468|P6|STARTED|First Washout Period (14 Days)||3
8436990|NCT00825825|20790469|P5|STARTED|First Washout Period (14 Days)||4
8436991|NCT00825825|20790470|P4|STARTED|First Washout Period (14 Days)||5
8436992|NCT00825825|20790471|P3|STARTED|First Washout Period (14 Days)||2
8436993|NCT00825825|20790472|P2|STARTED|First Washout Period (14 Days)||4
8436994|NCT00825825|20790473|P1|STARTED|First Washout Period (14 Days)||3
8436995|NCT00825825|20790468|P6|NOT COMPLETED|First Medication Period (14 Days)||2
8436996|NCT00825825|20790469|P5|NOT COMPLETED|First Medication Period (14 Days)||0
8436997|NCT00825825|20790470|P4|NOT COMPLETED|First Medication Period (14 Days)||0
8436998|NCT00825825|20790471|P3|NOT COMPLETED|First Medication Period (14 Days)||1
8436999|NCT00825825|20790472|P2|NOT COMPLETED|First Medication Period (14 Days)||0
8437000|NCT00825825|20790473|P1|NOT COMPLETED|First Medication Period (14 Days)||3
8437001|NCT00825825|20790468|P6|COMPLETED|First Medication Period (14 Days)||3
8437002|NCT00825825|20790469|P5|COMPLETED|First Medication Period (14 Days)||4
8437003|NCT00825825|20790470|P4|COMPLETED|First Medication Period (14 Days)||5
8437004|NCT00825825|20790471|P3|COMPLETED|First Medication Period (14 Days)||2
8437005|NCT00825825|20790472|P2|COMPLETED|First Medication Period (14 Days)||4
8437006|NCT00825825|20790473|P1|COMPLETED|First Medication Period (14 Days)||3
8437007|NCT00825825|20790468|P6|STARTED|First Medication Period (14 Days)||5
8437008|NCT00825825|20790469|P5|STARTED|First Medication Period (14 Days)||4
8437009|NCT00825825|20790470|P4|STARTED|First Medication Period (14 Days)||5
8437010|NCT00825825|20790471|P3|STARTED|First Medication Period (14 Days)||3
8437011|NCT00825825|20790472|P2|STARTED|First Medication Period (14 Days)||4
8437012|NCT00825825|20790473|P1|STARTED|First Medication Period (14 Days)||6
8437013|NCT00825812|20790489|P4|NOT COMPLETED|Overall Study||10
8437014|NCT00825812|20790490|P3|NOT COMPLETED|Overall Study||6
8437015|NCT00825812|20790491|P2|NOT COMPLETED|Overall Study||1
8437016|NCT00825812|20790492|P1|NOT COMPLETED|Overall Study||0
8437017|NCT00825812|20790489|P4|COMPLETED|Overall Study||111
8437018|NCT00825812|20790490|P3|COMPLETED|Overall Study||120
8437019|NCT00825812|20790491|P2|COMPLETED|Overall Study||31
8437020|NCT00825812|20790492|P1|COMPLETED|Overall Study||29
8437021|NCT00825812|20790489|P4|TREATED|Overall Study||111
8437022|NCT00825812|20790490|P3|TREATED|Overall Study||120
8437023|NCT00825812|20790491|P2|TREATED|Overall Study||31
8437024|NCT00825812|20790492|P1|TREATED|Overall Study||29
8437025|NCT00825812|20790489|P4|STARTED|Overall Study||121
8437026|NCT00825812|20790490|P3|STARTED|Overall Study||126
8437027|NCT00825812|20790491|P2|STARTED|Overall Study||32
8437028|NCT00825812|20790492|P1|STARTED|Overall Study||29
8437029|NCT00825786|20790508|P2|NOT COMPLETED|Overall Study||0
8437030|NCT00825786|20790509|P1|NOT COMPLETED|Overall Study||0
8437031|NCT00825786|20790508|P2|COMPLETED|Overall Study||51
8437032|NCT00825786|20790509|P1|COMPLETED|Overall Study||52
8437033|NCT00825786|20790508|P2|STARTED|Overall Study||51
8437034|NCT00825786|20790509|P1|STARTED|Overall Study||52
8437035|NCT00825734|20790527|P3|NOT COMPLETED|Phase II||76
8437036|NCT00825734|20790528|P2|NOT COMPLETED|Phase II||0
8437037|NCT00825734|20790529|P1|NOT COMPLETED|Phase II||0
8437038|NCT00825734|20790527|P3|COMPLETED|Phase II||0
8437039|NCT00825734|20790528|P2|COMPLETED|Phase II||0
8437040|NCT00825734|20790529|P1|COMPLETED|Phase II||0
8437041|NCT00825734|20790527|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
8437042|NCT00825734|20790528|P2|STARTED|Phase II||0
8437043|NCT00825734|20790529|P1|STARTED|Phase II||0
8437044|NCT00825734|20790527|P3|NOT COMPLETED|Phase I||0
8437045|NCT00825734|20790528|P2|NOT COMPLETED|Phase I||3
8437046|NCT00825734|20790529|P1|NOT COMPLETED|Phase I||4
8437047|NCT00825734|20790527|P3|COMPLETED|Phase I||3
8437048|NCT00825734|20790528|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8437049|NCT00825734|20790529|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8437050|NCT00825734|20790527|P3|STARTED|Phase I||3
8437051|NCT00825734|20790528|P2|STARTED|Phase I||3
8437052|NCT00825734|20790529|P1|STARTED|Phase I||4
8437053|NCT00825682|20790539|P2|NOT COMPLETED|Overall Study||5
8437054|NCT00825682|20790540|P1|NOT COMPLETED|Overall Study||13
8437055|NCT00825682|20790539|P2|COMPLETED|Overall Study||20
8437056|NCT00825682|20790540|P1|COMPLETED|Overall Study||34
8437057|NCT00825682|20790539|P2|STARTED|Overall Study||25
8437058|NCT00825682|20790540|P1|STARTED|Overall Study||47
8437059|NCT00825630|20790554|P4|NOT COMPLETED|Overall Study||0
8437060|NCT00825630|20790555|P3|NOT COMPLETED|Overall Study||0
8437061|NCT00825630|20790556|P2|NOT COMPLETED|Overall Study||0
8437062|NCT00825630|20790557|P1|NOT COMPLETED|Overall Study||0
8437063|NCT00825630|20790554|P4|COMPLETED|Overall Study||13
8437064|NCT00825630|20790555|P3|COMPLETED|Overall Study||19
8437065|NCT00825630|20790556|P2|COMPLETED|Overall Study||62
8437066|NCT00825630|20790557|P1|COMPLETED|Overall Study||29
8437067|NCT00825630|20790554|P4|STARTED|Overall Study||13
8437068|NCT00825630|20790555|P3|STARTED|Overall Study||19
8437069|NCT00825630|20790556|P2|STARTED|Overall Study||62
8437070|NCT00825630|20790557|P1|STARTED|Overall Study||29
8437071|NCT00825565|20790567|P1|NOT COMPLETED|Overall Study||0
8437072|NCT00825565|20790567|P1|COMPLETED|Overall Study||8
8437073|NCT00825565|20790567|P1|STARTED|Overall Study||8
8437074|NCT00825500|20790580|P3|NOT COMPLETED|Overall Study||0
8437075|NCT00825500|20790581|P2|NOT COMPLETED|Overall Study||0
8437076|NCT00825500|20790582|P1|NOT COMPLETED|Overall Study||0
8437077|NCT00825500|20790580|P3|COMPLETED|Overall Study||120
8437078|NCT00825500|20790581|P2|COMPLETED|Overall Study||121
8437079|NCT00825500|20790582|P1|COMPLETED|Overall Study||125
8437080|NCT00825500|20790580|P3|STARTED|Overall Study||120
8437081|NCT00825500|20790581|P2|STARTED|Overall Study||121
8437082|NCT00825500|20790582|P1|STARTED|Overall Study||125
8437083|NCT00825370|20790595|P2|NOT COMPLETED|Overall Study||0
8437084|NCT00825370|20790596|P1|NOT COMPLETED|Overall Study||0
8437085|NCT00825370|20790595|P2|COMPLETED|Overall Study||175
8437086|NCT00825370|20790596|P1|COMPLETED|Overall Study||175
8437087|NCT00825370|20790595|P2|STARTED|Overall Study||175
8437088|NCT00825370|20790596|P1|STARTED|Overall Study||175
8437089|NCT00825344|20790610|P2|NOT COMPLETED|Overall Study||1
8437090|NCT00825344|20790611|P1|NOT COMPLETED|Overall Study||1
8437091|NCT00825344|20790610|P2|COMPLETED|Overall Study||42
8437092|NCT00825344|20790611|P1|COMPLETED|Overall Study||33
8437093|NCT00825344|20790610|P2|STARTED|Overall Study||43
8437094|NCT00825344|20790611|P1|STARTED|Overall Study||34
8437095|NCT00825318|20790621|P1|NOT COMPLETED|Overall Study||1
8437096|NCT00825318|20790621|P1|COMPLETED|Overall Study||12
8437097|NCT00825318|20790621|P1|STARTED|Overall Study||13
8437098|NCT00825305|20790631|P2|NOT COMPLETED|Overall Study||23
8437099|NCT00825305|20790632|P1|NOT COMPLETED|Overall Study||17
8437100|NCT00825305|20790631|P2|COMPLETED|Overall Study||252
8437101|NCT00825305|20790632|P1|COMPLETED|Overall Study||533
8437102|NCT00825305|20790631|P2|STARTED|Overall Study||275
8437103|NCT00825305|20790632|P1|STARTED|Overall Study||550
8437104|NCT00825266|20790646|P2|NOT COMPLETED|Overall Study||0
8437105|NCT00825266|20790647|P1|NOT COMPLETED|Overall Study||0
8437106|NCT00825266|20790646|P2|COMPLETED|Overall Study||1
8437107|NCT00825266|20790647|P1|COMPLETED|Overall Study||1
8437108|NCT00825266|20790646|P2|STARTED|Overall Study||1
8437109|NCT00825266|20790647|P1|STARTED|Overall Study||1
8437110|NCT00825227|20790659|P2|NOT COMPLETED|Overall Study||0
8437111|NCT00825227|20790660|P1|NOT COMPLETED|Overall Study||0
8437112|NCT00825227|20790659|P2|COMPLETED|Overall Study||4
8437113|NCT00825227|20790660|P1|COMPLETED|Overall Study||6
8437114|NCT00825227|20790659|P2|STARTED|Overall Study||4
8437115|NCT00825227|20790660|P1|STARTED|Overall Study||6
8437116|NCT00825175|20790672|P2|NOT COMPLETED|Overall Study||5
8437117|NCT00825175|20790673|P1|NOT COMPLETED|Overall Study||0
8437118|NCT00825175|20790672|P2|COMPLETED|Overall Study||7
8437119|NCT00825175|20790673|P1|COMPLETED|Overall Study||10
8437120|NCT00825175|20790672|P2|STARTED|Overall Study||12
8437121|NCT00825175|20790673|P1|STARTED|Overall Study||10
8437122|NCT00825162|20790682|P3|NOT COMPLETED|Overall Study||6
8437123|NCT00825162|20790683|P2|NOT COMPLETED|Overall Study||21
8437124|NCT00825162|20790684|P1|NOT COMPLETED|Overall Study||28
8437125|NCT00825162|20790682|P3|COMPLETED|Overall Study||396
8437126|NCT00825162|20790683|P2|COMPLETED|Overall Study||859
8437127|NCT00825162|20790684|P1|COMPLETED|Overall Study||682
8437128|NCT00825162|20790682|P3|STARTED|Overall Study||402
8437129|NCT00825162|20790683|P2|STARTED|Overall Study||880
8437130|NCT00825162|20790684|P1|STARTED|Overall Study||710
8437131|NCT00824993|20790710|P2|NOT COMPLETED|Overall Study||17
8437132|NCT00824993|20790711|P1|NOT COMPLETED|Overall Study||14
8437133|NCT00824993|20790710|P2|COMPLETED|Overall Study||22
8437134|NCT00824993|20790711|P1|COMPLETED|Overall Study||25
8437135|NCT00824993|20790710|P2|6 Month Follow up|Overall Study||27
8437136|NCT00824993|20790711|P1|6 Month Follow up|Overall Study||33
8437137|NCT00824993|20790710|P2|STARTED|Overall Study||39
8437138|NCT00824993|20790711|P1|STARTED|Overall Study||39
8437139|NCT00824850|20790719|P2|NOT COMPLETED|Overall Study||1
8437140|NCT00824850|20790720|P1|NOT COMPLETED|Overall Study||0
8437141|NCT00824850|20790719|P2|COMPLETED|Overall Study||36
8437142|NCT00824850|20790720|P1|COMPLETED|Overall Study||38
8437143|NCT00824850|20790719|P2|Received Vaccination 13vPnC|Overall Study||36
8437144|NCT00824850|20790720|P1|Received Vaccination 13vPnC|Overall Study||38
8437145|NCT00824850|20790719|P2|STARTED|Overall Study||37
8437146|NCT00824850|20790720|P1|STARTED|Overall Study||38
8437147|NCT00824824|20790766|P2|NOT COMPLETED|Overall Study||0
8437148|NCT00824824|20790767|P1|NOT COMPLETED|Overall Study||0
8437149|NCT00824824|20790766|P2|COMPLETED|Overall Study||3
8437150|NCT00824824|20790767|P1|COMPLETED|Overall Study||4
8437151|NCT00824824|20790766|P2|STARTED|Overall Study||3
8437152|NCT00824824|20790767|P1|STARTED|Overall Study||4
8437153|NCT00824772|20790773|P1|NOT COMPLETED|Overall Study||8
8437154|NCT00824772|20790773|P1|COMPLETED|Overall Study||196
8437155|NCT00824772|20790773|P1|STARTED|Overall Study||204
8437156|NCT00824746|20790778|P1|NOT COMPLETED|Overall Study||0
8437157|NCT00824746|20790778|P1|COMPLETED|Overall Study||23
8437158|NCT00824746|20790778|P1|STARTED|Overall Study||23
8437159|NCT00824733|20790784|P1|NOT COMPLETED|Overall Study||0
8437160|NCT00824733|20790784|P1|COMPLETED|Overall Study||6
8437161|NCT00824733|20790784|P1|STARTED|Overall Study||6
8437162|NCT00824720|20790793|P3|NOT COMPLETED|Overall Study||1
8437163|NCT00824720|20790794|P2|NOT COMPLETED|Overall Study||1
8437164|NCT00824720|20790795|P1|NOT COMPLETED|Overall Study||3
8437165|NCT00824720|20790793|P3|COMPLETED|Overall Study||19
8437166|NCT00824720|20790794|P2|COMPLETED|Overall Study||15
8437167|NCT00824720|20790795|P1|COMPLETED|Overall Study||16
8437168|NCT00824720|20790793|P3|STARTED|Overall Study||20
8437169|NCT00824720|20790794|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
8437170|NCT00824720|20790795|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
8437171|NCT00824655|20790811|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
8437172|NCT00824655|20790812|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
8437173|NCT00824655|20790811|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
8437174|NCT00824655|20790812|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
8437175|NCT00824655|20790811|P2|STARTED|Toddler Dose (12 Months of Age)||116
8437176|NCT00824655|20790812|P1|STARTED|Toddler Dose (12 Months of Age)||118
8437177|NCT00824655|20790811|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
8437178|NCT00824655|20790812|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
8437179|NCT00824655|20790811|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
8437180|NCT00824655|20790812|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
8437181|NCT00824655|20790811|P2|STARTED|After Infant Dose (6 Months of Age)||0
8437182|NCT00824655|20790812|P1|STARTED|After Infant Dose (6 Months of Age)||118
8437183|NCT00824655|20790811|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
8437184|NCT00824655|20790812|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
8437185|NCT00824655|20790811|P2|COMPLETED|Infant Series (5 Months of Age)||0
8437186|NCT00824655|20790812|P1|COMPLETED|Infant Series (5 Months of Age)||118
8437187|NCT00824655|20790811|P2|STARTED|Infant Series (5 Months of Age)||0
8437188|NCT00824655|20790812|P1|STARTED|Infant Series (5 Months of Age)||118
8437189|NCT00824616|20790832|P2|NOT COMPLETED|Overall Study||7
8437190|NCT00824616|20790833|P1|NOT COMPLETED|Overall Study||6
8437191|NCT00824616|20790832|P2|COMPLETED|Overall Study||27
8437192|NCT00824616|20790833|P1|COMPLETED|Overall Study||28
8437193|NCT00824616|20790832|P2|STARTED|Overall Study||34
8437194|NCT00824616|20790833|P1|STARTED|Overall Study||34
8437195|NCT00824564|20790843|P2|NOT COMPLETED|Overall Study||10
8437196|NCT00824564|20790844|P1|NOT COMPLETED|Overall Study||8
8437197|NCT00824564|20790843|P2|COMPLETED|Overall Study||30
8437198|NCT00824564|20790844|P1|COMPLETED|Overall Study||34
8437199|NCT00824564|20790843|P2|Treated|Overall Study||40
8437200|NCT00824564|20790844|P1|Treated|Overall Study||41
8437201|NCT00824564|20790843|P2|STARTED|Overall Study||40
8437202|NCT00824564|20790844|P1|STARTED|Overall Study||42
8437203|NCT00824538|20790862|P1|NOT COMPLETED|Overall Study||2
8437204|NCT00824538|20790862|P1|COMPLETED|Overall Study||11
8437205|NCT00824538|20790862|P1|STARTED|Overall Study|13 patients entered the study|13
8437206|NCT00824512|20790872|P2|NOT COMPLETED|Overall Study||0
8437207|NCT00824512|20790873|P1|NOT COMPLETED|Overall Study||0
8437208|NCT00824512|20790872|P2|COMPLETED|Overall Study||11
8437209|NCT00824512|20790873|P1|COMPLETED|Overall Study||11
8437210|NCT00824512|20790872|P2|STARTED|Overall Study||11
8437211|NCT00824512|20790873|P1|STARTED|Overall Study||11
8437212|NCT00824473|20790923|P2|NOT COMPLETED|Overall Study||13
8437213|NCT00824473|20790924|P1|NOT COMPLETED|Overall Study||15
8437214|NCT00824473|20790923|P2|COMPLETED|Overall Study||238
8437215|NCT00824473|20790924|P1|COMPLETED|Overall Study||240
8437216|NCT00824473|20790923|P2|STARTED|Overall Study||251
8437217|NCT00824473|20790924|P1|STARTED|Overall Study|1 subject was randomized in error|255
8437218|NCT00824460|20790946|P6|NOT COMPLETED|Overall Study||8
8437219|NCT00824460|20790947|P5|NOT COMPLETED|Overall Study||9
8437220|NCT00824460|20790948|P4|NOT COMPLETED|Overall Study||12
8437221|NCT00824460|20790949|P3|NOT COMPLETED|Overall Study||5
8437222|NCT00824460|20790950|P2|NOT COMPLETED|Overall Study||9
8437223|NCT00824460|20790951|P1|NOT COMPLETED|Overall Study||8
8437224|NCT00824460|20790946|P6|COMPLETED|Overall Study||18
8437225|NCT00824460|20790947|P5|COMPLETED|Overall Study||15
8437226|NCT00824460|20790948|P4|COMPLETED|Overall Study||15
8437227|NCT00824460|20790949|P3|COMPLETED|Overall Study||20
8437228|NCT00824460|20790950|P2|COMPLETED|Overall Study||17
8437229|NCT00824460|20790951|P1|COMPLETED|Overall Study||18
8437230|NCT00824460|20790946|P6|STARTED|Overall Study||26
8437231|NCT00824460|20790947|P5|STARTED|Overall Study||24
8437232|NCT00824460|20790948|P4|STARTED|Overall Study||27
8437233|NCT00824460|20790949|P3|STARTED|Overall Study||25
8437234|NCT00824460|20790950|P2|STARTED|Overall Study||26
8437235|NCT00824460|20790951|P1|STARTED|Overall Study||26
8437236|NCT00824434|20790983|P1|NOT COMPLETED|Overall Study||0
8437237|NCT00824434|20790983|P1|COMPLETED|Overall Study||100
8437238|NCT00824434|20790983|P1|STARTED|Overall Study||100
8437239|NCT00824421|20791005|P3|NOT COMPLETED|Overall Study||14
8437240|NCT00824421|20791006|P2|NOT COMPLETED|Overall Study||22
8437241|NCT00824421|20791007|P1|NOT COMPLETED|Overall Study||17
8437242|NCT00824421|20791005|P3|COMPLETED|Overall Study||49
8437243|NCT00824421|20791006|P2|COMPLETED|Overall Study||44
8437244|NCT00824421|20791007|P1|COMPLETED|Overall Study||49
8437245|NCT00824421|20791005|P3|Treated|Overall Study||63
8437246|NCT00824421|20791006|P2|Treated|Overall Study||65
8437247|NCT00824421|20791007|P1|Treated|Overall Study||65
8437248|NCT00824421|20791005|P3|STARTED|Overall Study||63
8437249|NCT00824421|20791006|P2|STARTED|Overall Study||66
8437250|NCT00824421|20791007|P1|STARTED|Overall Study||66
8437251|NCT00824408|20791058|P5|NOT COMPLETED|Randomized Phase||46
8437252|NCT00824408|20791059|P4|NOT COMPLETED|Randomized Phase||46
8437253|NCT00824408|20791060|P3|NOT COMPLETED|Randomized Phase||36
8437254|NCT00824408|20791061|P2|NOT COMPLETED|Randomized Phase||0
8437255|NCT00824408|20791062|P1|NOT COMPLETED|Randomized Phase||0
8437256|NCT00824408|20791058|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8437257|NCT00824408|20791059|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8437258|NCT00824408|20791060|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8437259|NCT00824408|20791061|P2|COMPLETED|Randomized Phase||0
8437260|NCT00824408|20791062|P1|COMPLETED|Randomized Phase||0
8437261|NCT00824408|20791058|P5|STARTED|Randomized Phase||47
8437262|NCT00824408|20791059|P4|STARTED|Randomized Phase||47
8437263|NCT00824408|20791060|P3|STARTED|Randomized Phase||37
8437264|NCT00824408|20791061|P2|STARTED|Randomized Phase||0
8437265|NCT00824408|20791062|P1|STARTED|Randomized Phase||0
8437266|NCT00824408|20791058|P5|NOT COMPLETED|Run-in Phase||0
8437267|NCT00824408|20791059|P4|NOT COMPLETED|Run-in Phase||0
8437268|NCT00824408|20791060|P3|NOT COMPLETED|Run-in Phase||0
8437269|NCT00824408|20791061|P2|NOT COMPLETED|Run-in Phase||6
8437270|NCT00824408|20791062|P1|NOT COMPLETED|Run-in Phase||6
8437271|NCT00824408|20791058|P5|COMPLETED|Run-in Phase||0
8437272|NCT00824408|20791059|P4|COMPLETED|Run-in Phase||0
8437273|NCT00824408|20791060|P3|COMPLETED|Run-in Phase||0
8437274|NCT00824408|20791061|P2|COMPLETED|Run-in Phase||0
8437275|NCT00824408|20791062|P1|COMPLETED|Run-in Phase||0
8437276|NCT00824408|20791058|P5|STARTED|Run-in Phase||0
8437277|NCT00824408|20791059|P4|STARTED|Run-in Phase||0
8437278|NCT00824408|20791060|P3|STARTED|Run-in Phase||0
8437279|NCT00824408|20791061|P2|STARTED|Run-in Phase||6
8437280|NCT00824408|20791062|P1|STARTED|Run-in Phase||6
8437281|NCT00824382|20791114|P4|NOT COMPLETED|Overall Study||5
8437282|NCT00824382|20791115|P3|NOT COMPLETED|Overall Study||3
8437283|NCT00824382|20791116|P2|NOT COMPLETED|Overall Study||2
8437284|NCT00824382|20791117|P1|NOT COMPLETED|Overall Study||5
8437285|NCT00824382|20791114|P4|COMPLETED|Overall Study||81
8437286|NCT00824382|20791115|P3|COMPLETED|Overall Study||76
8437287|NCT00824382|20791116|P2|COMPLETED|Overall Study||82
8437288|NCT00824382|20791117|P1|COMPLETED|Overall Study||74
8437289|NCT00824382|20791114|P4|STARTED|Overall Study||86
8437290|NCT00824382|20791115|P3|STARTED|Overall Study||79
8437291|NCT00824382|20791116|P2|STARTED|Overall Study||84
8437292|NCT00824382|20791117|P1|STARTED|Overall Study||79
8437293|NCT00824369|20791193|P6|NOT COMPLETED|Overall Study||1
8437294|NCT00824369|20791194|P5|NOT COMPLETED|Overall Study||1
8437295|NCT00824369|20791195|P4|NOT COMPLETED|Overall Study||2
8437296|NCT00824369|20791196|P3|NOT COMPLETED|Overall Study||1
8437297|NCT00824369|20791197|P2|NOT COMPLETED|Overall Study||0
8437298|NCT00824369|20791198|P1|NOT COMPLETED|Overall Study||1
8437299|NCT00824369|20791193|P6|COMPLETED|Overall Study||16
8437300|NCT00824369|20791194|P5|COMPLETED|Overall Study||11
8437301|NCT00824369|20791195|P4|COMPLETED|Overall Study||9
8437302|NCT00824369|20791196|P3|COMPLETED|Overall Study||2
8437303|NCT00824369|20791197|P2|COMPLETED|Overall Study||4
8437304|NCT00824369|20791198|P1|COMPLETED|Overall Study||4
8437305|NCT00824369|20791193|P6|STARTED|Overall Study||17
8437306|NCT00824369|20791194|P5|STARTED|Overall Study||12
8437307|NCT00824369|20791195|P4|STARTED|Overall Study||11
8437308|NCT00824369|20791196|P3|STARTED|Overall Study||3
8437309|NCT00824369|20791197|P2|STARTED|Overall Study||4
8437310|NCT00824369|20791198|P1|STARTED|Overall Study||5
8437311|NCT00824291|20791238|P2|NOT COMPLETED|Overall Study||35
8437312|NCT00824291|20791239|P1|NOT COMPLETED|Overall Study||54
8437313|NCT00824291|20791238|P2|COMPLETED|Overall Study||107
8437314|NCT00824291|20791239|P1|COMPLETED|Overall Study||231
8437315|NCT00824291|20791238|P2|STARTED|Overall Study||142
8437316|NCT00824291|20791239|P1|STARTED|Overall Study||285
8437317|NCT00824265|20791261|P2|NOT COMPLETED|Survival Follow-up Phase||16
8437318|NCT00824265|20791262|P1|NOT COMPLETED|Survival Follow-up Phase||9
8437319|NCT00824265|20791261|P2|COMPLETED|Survival Follow-up Phase||73
8437320|NCT00824265|20791262|P1|COMPLETED|Survival Follow-up Phase||87
8437321|NCT00824265|20791261|P2|STARTED|Survival Follow-up Phase||89
8437322|NCT00824265|20791262|P1|STARTED|Survival Follow-up Phase||96
8437323|NCT00824265|20791261|P2|NOT COMPLETED|Follow-up Phase||31
8437324|NCT00824265|20791262|P1|NOT COMPLETED|Follow-up Phase||18
8437325|NCT00824265|20791261|P2|COMPLETED|Follow-up Phase||129
8437326|NCT00824265|20791262|P1|COMPLETED|Follow-up Phase||154
8437327|NCT00824265|20791261|P2|STARTED|Follow-up Phase||160
8437328|NCT00824265|20791262|P1|STARTED|Follow-up Phase||172
8437329|NCT00824265|20791261|P2|NOT COMPLETED|Treatment Phase||80
8437330|NCT00824265|20791262|P1|NOT COMPLETED|Treatment Phase||64
8437331|NCT00824265|20791261|P2|COMPLETED|Treatment Phase||102
8437332|NCT00824265|20791262|P1|COMPLETED|Treatment Phase||119
8437333|NCT00824265|20791261|P2|STARTED|Treatment Phase||182
8437334|NCT00824265|20791262|P1|STARTED|Treatment Phase||183
8437335|NCT00824161|20791323|P1|NOT COMPLETED|Overall Study||2
8437336|NCT00824161|20791323|P1|COMPLETED|Overall Study||26
8437337|NCT00824161|20791323|P1|STARTED|Overall Study||28
8437338|NCT00824070|20791332|P3|NOT COMPLETED|Overall Study||0
8437339|NCT00824070|20791333|P2|NOT COMPLETED|Overall Study||0
8437340|NCT00824070|20791334|P1|NOT COMPLETED|Overall Study||0
8437341|NCT00824070|20791332|P3|COMPLETED|Overall Study||36
8437342|NCT00824070|20791333|P2|COMPLETED|Overall Study||35
8437343|NCT00824070|20791334|P1|COMPLETED|Overall Study||34
8437344|NCT00824070|20791332|P3|STARTED|Overall Study||36
8437345|NCT00824070|20791333|P2|STARTED|Overall Study||35
8437346|NCT00824070|20791334|P1|STARTED|Overall Study||34
8437347|NCT00824044|20791344|P2|NOT COMPLETED|Overall Study||6
8437348|NCT00824044|20791345|P1|NOT COMPLETED|Overall Study||9
8437349|NCT00824044|20791344|P2|COMPLETED|Overall Study||10
8437350|NCT00824044|20791345|P1|COMPLETED|Overall Study||14
8437351|NCT00824044|20791344|P2|STARTED|Overall Study||16
8437352|NCT00824044|20791345|P1|STARTED|Overall Study||23
8437353|NCT00824005|20791389|P2|NOT COMPLETED|Overall Study||2
8437354|NCT00824005|20791390|P1|NOT COMPLETED|Overall Study||0
8437355|NCT00824005|20791389|P2|COMPLETED|Overall Study||59
8437356|NCT00824005|20791390|P1|COMPLETED|Overall Study||31
8437357|NCT00824005|20791389|P2|STARTED|Overall Study||61
8437358|NCT00824005|20791390|P1|STARTED|Overall Study||31
8437359|NCT00823979|20791425|P3|NOT COMPLETED|Overall Study||24
8437360|NCT00823979|20791426|P2|NOT COMPLETED|Overall Study||32
8437361|NCT00823979|20791427|P1|NOT COMPLETED|Overall Study||29
8437362|NCT00823979|20791425|P3|COMPLETED|Overall Study||11
8437363|NCT00823979|20791426|P2|COMPLETED|Overall Study||3
8437364|NCT00823979|20791427|P1|COMPLETED|Overall Study||6
8437365|NCT00823979|20791425|P3|Treated|Overall Study||34
8437366|NCT00823979|20791426|P2|Treated|Overall Study||32
8437367|NCT00823979|20791427|P1|Treated|Overall Study||31
8437368|NCT00823979|20791425|P3|STARTED|Overall Study||35
8437369|NCT00823979|20791426|P2|STARTED|Overall Study||35
8437370|NCT00823979|20791427|P1|STARTED|Overall Study||35
8437371|NCT00823966|20791465|P1|NOT COMPLETED|Overall Study||0
8437372|NCT00823966|20791465|P1|COMPLETED|Overall Study||3
8437373|NCT00823966|20791465|P1|STARTED|Overall Study||3
8437374|NCT00823901|20791472|P2|NOT COMPLETED|Overall Study||2
8437375|NCT00823901|20791473|P1|NOT COMPLETED|Overall Study||4
8437376|NCT00823901|20791472|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
8437377|NCT00823901|20791473|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
8437378|NCT00823901|20791472|P2|STARTED|Overall Study|Randomized to placebo gel|40
8437379|NCT00823901|20791473|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
8437380|NCT00823836|20791481|P2|NOT COMPLETED|Long-term Phase||5
8437381|NCT00823836|20791482|P1|NOT COMPLETED|Long-term Phase||5
8437382|NCT00823836|20791481|P2|COMPLETED|Long-term Phase||79
8437383|NCT00823836|20791482|P1|COMPLETED|Long-term Phase||68
8437384|NCT00823836|20791481|P2|STARTED|Long-term Phase||84
8437385|NCT00823836|20791482|P1|STARTED|Long-term Phase||73
8437386|NCT00823836|20791481|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
8437387|NCT00823836|20791482|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
8437388|NCT00823836|20791481|P2|COMPLETED|NV and PR/XR Switching Phases||117
8437389|NCT00823836|20791482|P1|COMPLETED|NV and PR/XR Switching Phases||124
8437390|NCT00823836|20791481|P2|STARTED|NV and PR/XR Switching Phases||146
8437391|NCT00823836|20791482|P1|STARTED|NV and PR/XR Switching Phases||156
8437392|NCT00823823|20791588|P2|NOT COMPLETED|Overall Study||6
8437393|NCT00823823|20791589|P1|NOT COMPLETED|Overall Study||8
8437394|NCT00823823|20791588|P2|COMPLETED|Overall Study||101
8437395|NCT00823823|20791589|P1|COMPLETED|Overall Study||101
8437396|NCT00823823|20791588|P2|STARTED|Overall Study||107
8437397|NCT00823823|20791589|P1|STARTED|Overall Study||109
8437398|NCT00823797|20791599|P2|NOT COMPLETED|Overall Study||0
8437399|NCT00823797|20791600|P1|NOT COMPLETED|Overall Study||0
8437400|NCT00823797|20791599|P2|COMPLETED|Overall Study||16
8437401|NCT00823797|20791600|P1|COMPLETED|Overall Study||29
8437402|NCT00823797|20791599|P2|STARTED|Overall Study||16
8437403|NCT00823797|20791600|P1|STARTED|Overall Study||29
8437404|NCT00823719|20791613|P2|NOT COMPLETED|Overall Study||11
8437405|NCT00823719|20791614|P1|NOT COMPLETED|Overall Study||6
8437406|NCT00823719|20791613|P2|COMPLETED|Overall Study||24
8437407|NCT00823719|20791614|P1|COMPLETED|Overall Study||20
8437408|NCT00823719|20791613|P2|STARTED|Overall Study||35
8437409|NCT00823719|20791614|P1|STARTED|Overall Study||26
8437410|NCT00823615|20791667|P2|NOT COMPLETED|Period 2||2
8437411|NCT00823615|20791668|P1|NOT COMPLETED|Period 2||3
8437412|NCT00823615|20791667|P2|COMPLETED|Period 2||17
8437413|NCT00823615|20791668|P1|COMPLETED|Period 2||16
8437414|NCT00823615|20791667|P2|STARTED|Period 2||19
8437415|NCT00823615|20791668|P1|STARTED|Period 2||19
8437416|NCT00823615|20791667|P2|NOT COMPLETED|Period 1||0
8437417|NCT00823615|20791668|P1|NOT COMPLETED|Period 1||0
8437418|NCT00823615|20791667|P2|COMPLETED|Period 1||19
8437419|NCT00823615|20791668|P1|COMPLETED|Period 1||19
8437420|NCT00823615|20791667|P2|STARTED|Period 1||19
8437421|NCT00823615|20791668|P1|STARTED|Period 1||19
8437422|NCT00823472|20791678|P2|NOT COMPLETED|Overall Study||28
8437423|NCT00823472|20791679|P1|NOT COMPLETED|Overall Study||24
8437424|NCT00823472|20791678|P2|COMPLETED|Overall Study||39
8437425|NCT00823472|20791679|P1|COMPLETED|Overall Study||56
8437426|NCT00823472|20791678|P2|STARTED|Overall Study||67
8437427|NCT00823472|20791679|P1|STARTED|Overall Study||80
8437428|NCT00823459|20791687|P1|NOT COMPLETED|Overall Study||0
8437429|NCT00823459|20791687|P1|COMPLETED|Overall Study||58
8437430|NCT00823459|20791687|P1|STARTED|Overall Study||58
8437431|NCT00823303|20791697|P2|NOT COMPLETED|Overall Study||11
8437432|NCT00823303|20791698|P1|NOT COMPLETED|Overall Study||9
8437433|NCT00823303|20791697|P2|COMPLETED|Overall Study||45
8437434|NCT00823303|20791698|P1|COMPLETED|Overall Study||45
8437435|NCT00823303|20791697|P2|STARTED|Overall Study||56
8437436|NCT00823303|20791698|P1|STARTED|Overall Study||54
8437437|NCT00823264|20791706|P2|NOT COMPLETED|Overall Study||0
8437438|NCT00823264|20791707|P1|NOT COMPLETED|Overall Study||2
8437439|NCT00823264|20791706|P2|COMPLETED|Overall Study||7
8437440|NCT00823264|20791707|P1|COMPLETED|Overall Study||8
8437441|NCT00823264|20791706|P2|STARTED|Overall Study||7
8437442|NCT00823264|20791707|P1|STARTED|Overall Study||10
8437443|NCT00823212|20791715|P2|NOT COMPLETED|Overall Study||33
8437444|NCT00823212|20791716|P1|NOT COMPLETED|Overall Study||35
8437445|NCT00823212|20791715|P2|COMPLETED|Overall Study|12-month follow-up|735
8437446|NCT00823212|20791716|P1|COMPLETED|Overall Study|12-month follow-up|727
8437447|NCT00823212|20791715|P2|STARTED|Overall Study||768
8437448|NCT00823212|20791716|P1|STARTED|Overall Study||762
8437449|NCT00823199|20791798|P1|NOT COMPLETED|Overall Study||2
8437450|NCT00823199|20791798|P1|COMPLETED|Overall Study||8
8437451|NCT00823199|20791798|P1|STARTED|Overall Study||10
8437452|NCT00823134|20791804|P1|NOT COMPLETED|Overall Study||1
8437453|NCT00823134|20791804|P1|COMPLETED|Overall Study||22
8437454|NCT00823134|20791804|P1|STARTED|Overall Study||23
8437455|NCT00823095|20791814|P1|NOT COMPLETED|Overall Study||0
8437456|NCT00823095|20791814|P1|COMPLETED|Overall Study||7
8437457|NCT00823095|20791814|P1|STARTED|Overall Study||7
8437458|NCT00823082|20791821|P2|NOT COMPLETED|Overall Study||1
8437459|NCT00823082|20791822|P1|NOT COMPLETED|Overall Study||0
8437460|NCT00823082|20791821|P2|COMPLETED|Overall Study||99
8437461|NCT00823082|20791822|P1|COMPLETED|Overall Study||100
8437462|NCT00823082|20791821|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
8437463|NCT00823082|20791822|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
8437464|NCT00823082|20791821|P2|Safety Population|Overall Study||99
8437465|NCT00823082|20791822|P1|Safety Population|Overall Study||100
8437466|NCT00823082|20791821|P2|STARTED|Overall Study||100
8437467|NCT00823082|20791822|P1|STARTED|Overall Study||100
8437468|NCT00823069|20791856|P1|NOT COMPLETED|Overall Study||0
8437469|NCT00823069|20791856|P1|COMPLETED|Overall Study||60
8437470|NCT00823069|20791856|P1|STARTED|Overall Study||60
8437471|NCT00823043|20791863|P2|NOT COMPLETED|Overall Study||0
8437472|NCT00823043|20791864|P1|NOT COMPLETED|Overall Study||0
8437473|NCT00823043|20791863|P2|COMPLETED|Overall Study||39
8437474|NCT00823043|20791864|P1|COMPLETED|Overall Study||64
8437475|NCT00823043|20791863|P2|STARTED|Overall Study||39
8437476|NCT00823043|20791864|P1|STARTED|Overall Study||64
8437477|NCT00822926|20791877|P2|NOT COMPLETED|Second Injection Visit||1
8437478|NCT00822926|20791878|P1|NOT COMPLETED|Second Injection Visit||1
8437479|NCT00822926|20791877|P2|COMPLETED|Second Injection Visit||2
8437480|NCT00822926|20791878|P1|COMPLETED|Second Injection Visit||1
8437481|NCT00822926|20791877|P2|STARTED|Second Injection Visit||3
8437482|NCT00822926|20791878|P1|STARTED|Second Injection Visit||2
8437483|NCT00822926|20791877|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
8437484|NCT00822926|20791878|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
8437485|NCT00822926|20791877|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
8437486|NCT00822926|20791878|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
8437487|NCT00822926|20791877|P2|STARTED|Washout (Varies Based on Scheduling)||3
8437488|NCT00822926|20791878|P1|STARTED|Washout (Varies Based on Scheduling)||2
8437489|NCT00822926|20791877|P2|NOT COMPLETED|First Injection Visit||0
8437490|NCT00822926|20791878|P1|NOT COMPLETED|First Injection Visit||0
8437491|NCT00822926|20791877|P2|COMPLETED|First Injection Visit||3
8437492|NCT00822926|20791878|P1|COMPLETED|First Injection Visit||2
8437493|NCT00822926|20791877|P2|STARTED|First Injection Visit||3
8437494|NCT00822926|20791878|P1|STARTED|First Injection Visit||2
8437495|NCT00822900|20791892|P2|NOT COMPLETED|Overall Study||93
8437496|NCT00822900|20791893|P1|NOT COMPLETED|Overall Study||108
8437497|NCT00822900|20791892|P2|COMPLETED|Overall Study||347
8437498|NCT00822900|20791893|P1|COMPLETED|Overall Study||334
8437499|NCT00822900|20791892|P2|STARTED|Overall Study||440
8437500|NCT00822900|20791893|P1|STARTED|Overall Study||442
8437501|NCT00822770|20791923|P2|NOT COMPLETED|Overall Study||1
8437502|NCT00822770|20791924|P1|NOT COMPLETED|Overall Study||3
8437503|NCT00822770|20791923|P2|COMPLETED|Overall Study||28
8437504|NCT00822770|20791924|P1|COMPLETED|Overall Study||15
8437505|NCT00822770|20791923|P2|STARTED|Overall Study||29
8437506|NCT00822770|20791924|P1|STARTED|Overall Study||18
8437507|NCT00822757|20791933|P2|NOT COMPLETED|Overall Study||0
8437508|NCT00822757|20791934|P1|NOT COMPLETED|Overall Study||0
8437509|NCT00822757|20791933|P2|COMPLETED|Overall Study||10
8437510|NCT00822757|20791934|P1|COMPLETED|Overall Study||41
8437511|NCT00822757|20791933|P2|STARTED|Overall Study||10
8437512|NCT00822757|20791934|P1|STARTED|Overall Study||41
8437513|NCT00822692|20791946|P2|NOT COMPLETED|Overall Study||25
8437514|NCT00822692|20791947|P1|NOT COMPLETED|Overall Study||17
8437515|NCT00822692|20791946|P2|COMPLETED|Overall Study|June 1 , 2009|51
8437516|NCT00822692|20791947|P1|COMPLETED|Overall Study|June 1, 2009|46
8437517|NCT00822692|20791946|P2|STARTED|Overall Study|July 1, 2008|76
8437518|NCT00822692|20791947|P1|STARTED|Overall Study|July 1, 2008|63
8437519|NCT00822679|20791955|P2|NOT COMPLETED|Overall Study||0
8437520|NCT00822679|20791956|P1|NOT COMPLETED|Overall Study||0
8437521|NCT00822679|20791955|P2|COMPLETED|Overall Study||0
8437522|NCT00822679|20791956|P1|COMPLETED|Overall Study||0
8437523|NCT00822679|20791955|P2|STARTED|Overall Study||0
8437524|NCT00822679|20791956|P1|STARTED|Overall Study||0
8437525|NCT00822588|20791964|P2|NOT COMPLETED|Overall Study||4
8437526|NCT00822588|20791965|P1|NOT COMPLETED|Overall Study||7
8437527|NCT00822588|20791964|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
8437528|NCT00822588|20791965|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
8437529|NCT00822588|20791964|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
8437530|NCT00822588|20791965|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
8437531|NCT00822523|20791974|P3|NOT COMPLETED|Overall Study||0
8437532|NCT00822523|20791975|P2|NOT COMPLETED|Overall Study||0
8437533|NCT00822523|20791976|P1|NOT COMPLETED|Overall Study||0
8437534|NCT00822523|20791974|P3|COMPLETED|Overall Study||4
8437535|NCT00822523|20791975|P2|COMPLETED|Overall Study||4
8437536|NCT00822523|20791976|P1|COMPLETED|Overall Study||5
8437537|NCT00822523|20791974|P3|STARTED|Overall Study||4
8437538|NCT00822523|20791975|P2|STARTED|Overall Study||4
8437539|NCT00822523|20791976|P1|STARTED|Overall Study||5
8437540|NCT00822510|20792022|P2|NOT COMPLETED|Overall Study||5
8437541|NCT00822510|20792023|P1|NOT COMPLETED|Overall Study||3
8437542|NCT00822510|20792022|P2|COMPLETED|Overall Study||36
8437543|NCT00822510|20792023|P1|COMPLETED|Overall Study||35
8437544|NCT00822510|20792022|P2|STARTED|Overall Study||41
8437545|NCT00822510|20792023|P1|STARTED|Overall Study||38
8437546|NCT00822354|20792043|P2|NOT COMPLETED|Second Intervention (28 Days)||0
8437547|NCT00822354|20792044|P1|NOT COMPLETED|Second Intervention (28 Days)||1
8437548|NCT00822354|20792043|P2|COMPLETED|Second Intervention (28 Days)||5
8437549|NCT00822354|20792044|P1|COMPLETED|Second Intervention (28 Days)||3
8437550|NCT00822354|20792043|P2|STARTED|Second Intervention (28 Days)||5
8437551|NCT00822354|20792044|P1|STARTED|Second Intervention (28 Days)||4
8437552|NCT00822354|20792043|P2|NOT COMPLETED|Washout (7 Days)||0
8437553|NCT00822354|20792044|P1|NOT COMPLETED|Washout (7 Days)||0
8437554|NCT00822354|20792043|P2|COMPLETED|Washout (7 Days)||5
8437555|NCT00822354|20792044|P1|COMPLETED|Washout (7 Days)||4
8437556|NCT00822354|20792043|P2|STARTED|Washout (7 Days)||5
8437557|NCT00822354|20792044|P1|STARTED|Washout (7 Days)||4
8437558|NCT00822354|20792043|P2|NOT COMPLETED|First Intervention (28 Days)||0
8437559|NCT00822354|20792044|P1|NOT COMPLETED|First Intervention (28 Days)||1
8437560|NCT00822354|20792043|P2|COMPLETED|First Intervention (28 Days)||5
8437561|NCT00822354|20792044|P1|COMPLETED|First Intervention (28 Days)||4
8437562|NCT00822354|20792043|P2|STARTED|First Intervention (28 Days)||5
8437563|NCT00822354|20792044|P1|STARTED|First Intervention (28 Days)||5
8437564|NCT00822328|20792074|P2|NOT COMPLETED|Overall Study||0
8437565|NCT00822328|20792075|P1|NOT COMPLETED|Overall Study||0
8437566|NCT00822328|20792074|P2|COMPLETED|Overall Study||12
8437567|NCT00822328|20792075|P1|COMPLETED|Overall Study||12
8437568|NCT00822328|20792074|P2|STARTED|Overall Study||12
8437569|NCT00822328|20792075|P1|STARTED|Overall Study||12
8437570|NCT00822237|20792085|P2|NOT COMPLETED|Dose 2 Vaccination||11
8437571|NCT00822237|20792086|P1|NOT COMPLETED|Dose 2 Vaccination||4
8437572|NCT00822237|20792085|P2|COMPLETED|Dose 2 Vaccination||262
8437573|NCT00822237|20792086|P1|COMPLETED|Dose 2 Vaccination||270
8437574|NCT00822237|20792085|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
8437575|NCT00822237|20792086|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
8437576|NCT00822237|20792085|P2|NOT COMPLETED|Dose 1 Vaccination||26
8437577|NCT00822237|20792086|P1|NOT COMPLETED|Dose 1 Vaccination||25
8437578|NCT00822237|20792085|P2|COMPLETED|Dose 1 Vaccination||273
8437579|NCT00822237|20792086|P1|COMPLETED|Dose 1 Vaccination||274
8437580|NCT00822237|20792085|P2|STARTED|Dose 1 Vaccination|Number randomized|299
8437581|NCT00822237|20792086|P1|STARTED|Dose 1 Vaccination|Number randomized|299
8437582|NCT00822185|20792096|P5|NOT COMPLETED|Overall Study||0
8437583|NCT00822185|20792097|P4|NOT COMPLETED|Overall Study||0
8437584|NCT00822185|20792098|P3|NOT COMPLETED|Overall Study||0
8437585|NCT00822185|20792099|P2|NOT COMPLETED|Overall Study||0
8437586|NCT00822185|20792100|P1|NOT COMPLETED|Overall Study||0
8437587|NCT00822185|20792096|P5|COMPLETED|Overall Study||8
8437588|NCT00822185|20792097|P4|COMPLETED|Overall Study||6
8437589|NCT00822185|20792098|P3|COMPLETED|Overall Study||6
8437590|NCT00822185|20792099|P2|COMPLETED|Overall Study||6
8437591|NCT00822185|20792100|P1|COMPLETED|Overall Study||6
8437592|NCT00822185|20792096|P5|STARTED|Overall Study||8
8437593|NCT00822185|20792097|P4|STARTED|Overall Study||6
8437594|NCT00822185|20792098|P3|STARTED|Overall Study||6
8437595|NCT00822185|20792099|P2|STARTED|Overall Study||6
8437596|NCT00822185|20792100|P1|STARTED|Overall Study||6
8437597|NCT00822172|20792167|P2|NOT COMPLETED|Overall Study||19
8437598|NCT00822172|20792168|P1|NOT COMPLETED|Overall Study||15
8437599|NCT00822172|20792167|P2|COMPLETED|Overall Study||64
8437600|NCT00822172|20792168|P1|COMPLETED|Overall Study||65
8437601|NCT00822172|20792167|P2|STARTED|Overall Study||83
8437602|NCT00822172|20792168|P1|STARTED|Overall Study||80
8437651|NCT00822107|20792216|P1|NOT COMPLETED|Overall Study||0
8437652|NCT00822107|20792216|P1|COMPLETED|Overall Study||5
8437653|NCT00822107|20792216|P1|STARTED|Overall Study||5
8437654|NCT00822094|20792222|P2|NOT COMPLETED|Overall Study||25
8437655|NCT00822094|20792223|P1|NOT COMPLETED|Overall Study||44
8437656|NCT00822094|20792222|P2|COMPLETED|Overall Study||20
8437657|NCT00822094|20792223|P1|COMPLETED|Overall Study||37
8437658|NCT00822094|20792222|P2|STARTED|Overall Study||45
8437659|NCT00822094|20792223|P1|STARTED|Overall Study||81
8437660|NCT00821964|20792239|P1|NOT COMPLETED|Overall Study||6
8437661|NCT00821964|20792239|P1|COMPLETED|Overall Study||9
8437662|NCT00821964|20792239|P1|Evaluable for Pathologic Response|Overall Study||7
8437663|NCT00821964|20792239|P1|Evaluable for Clinical Response|Overall Study||14
8437664|NCT00821964|20792239|P1|STARTED|Overall Study||15
8437665|NCT00821951|20792248|P1|NOT COMPLETED|Overall Study||5
8437666|NCT00821951|20792248|P1|COMPLETED|Overall Study||12
8437667|NCT00821951|20792248|P1|STARTED|Overall Study||17
8437668|NCT00821886|20792252|P1|NOT COMPLETED|Overall Study||9
8437669|NCT00821886|20792252|P1|COMPLETED|Overall Study||49
8437670|NCT00821886|20792252|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
8437671|NCT00821873|20792259|P1|NOT COMPLETED|Overall Study||4
8437672|NCT00821873|20792259|P1|COMPLETED|Overall Study||5
8437673|NCT00821873|20792259|P1|STARTED|Overall Study||9
8437674|NCT00821821|20792266|P3|NOT COMPLETED|Overall Study||0
8437675|NCT00821821|20792267|P2|NOT COMPLETED|Overall Study||0
8437676|NCT00821821|20792268|P1|NOT COMPLETED|Overall Study||0
8437677|NCT00821821|20792266|P3|COMPLETED|Overall Study||11
8437678|NCT00821821|20792267|P2|COMPLETED|Overall Study||13
8437679|NCT00821821|20792268|P1|COMPLETED|Overall Study||12
8437680|NCT00821821|20792266|P3|STARTED|Overall Study||11
8437681|NCT00821821|20792267|P2|STARTED|Overall Study||13
8437682|NCT00821821|20792268|P1|STARTED|Overall Study||12
8437683|NCT00821795|20792280|P2|NOT COMPLETED|Overall Study||4
8437684|NCT00821795|20792281|P1|NOT COMPLETED|Overall Study||6
8437685|NCT00821795|20792280|P2|COMPLETED|Overall Study||60
8437686|NCT00821795|20792281|P1|COMPLETED|Overall Study||44
8437687|NCT00821795|20792280|P2|STARTED|Overall Study||64
8437688|NCT00821795|20792281|P1|STARTED|Overall Study||50
8437689|NCT00821678|20792289|P2|NOT COMPLETED|Overall Study||14
8437690|NCT00821678|20792290|P1|NOT COMPLETED|Overall Study||21
8437691|NCT00821678|20792289|P2|COMPLETED|Overall Study||118
8437692|NCT00821678|20792290|P1|COMPLETED|Overall Study||112
8437693|NCT00821678|20792289|P2|STARTED|Overall Study||132
8437694|NCT00821678|20792290|P1|STARTED|Overall Study||133
8437695|NCT00821626|20792312|P2|NOT COMPLETED|Overall Study||0
8437696|NCT00821626|20792313|P1|NOT COMPLETED|Overall Study||0
8437697|NCT00821626|20792312|P2|COMPLETED|Overall Study||33
8437698|NCT00821626|20792313|P1|COMPLETED|Overall Study||60
8437699|NCT00821626|20792312|P2|STARTED|Overall Study||33
8437700|NCT00821626|20792313|P1|STARTED|Overall Study||60
8437701|NCT00821587|20792325|P2|NOT COMPLETED|Overall Study||1
8437702|NCT00821587|20792326|P1|NOT COMPLETED|Overall Study||0
8437703|NCT00821587|20792325|P2|COMPLETED|Overall Study||18
8437704|NCT00821587|20792326|P1|COMPLETED|Overall Study||20
8437705|NCT00821587|20792325|P2|STARTED|Overall Study||19
8437706|NCT00821587|20792326|P1|STARTED|Overall Study||20
8437707|NCT00821509|20792335|P3|NOT COMPLETED|Overall Study||34
8437708|NCT00821509|20792336|P2|NOT COMPLETED|Overall Study||11
8437709|NCT00821509|20792337|P1|NOT COMPLETED|Overall Study||12
8437710|NCT00821509|20792335|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
8437711|NCT00821509|20792336|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
8437712|NCT00821509|20792337|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
8437713|NCT00821509|20792335|P3|STARTED|Overall Study||224
8437714|NCT00821509|20792336|P2|STARTED|Overall Study||202
8437715|NCT00821509|20792337|P1|STARTED|Overall Study||257
8437716|NCT00821431|20792350|P2|NOT COMPLETED|Overall Study||5
8437717|NCT00821431|20792351|P1|NOT COMPLETED|Overall Study||15
8437718|NCT00821431|20792350|P2|COMPLETED|Overall Study||47
8437719|NCT00821431|20792351|P1|COMPLETED|Overall Study||23
8437720|NCT00821431|20792350|P2|STARTED|Overall Study||52
8437721|NCT00821431|20792351|P1|STARTED|Overall Study||38
8437722|NCT00821327|20792359|P1|NOT COMPLETED|Overall Study||35
8437723|NCT00821327|20792359|P1|COMPLETED|Overall Study||1
8437724|NCT00821327|20792359|P1|STARTED|Overall Study||36
8437725|NCT00821236|20792368|P1|NOT COMPLETED|Overall Study||3
8437726|NCT00821236|20792368|P1|COMPLETED|Overall Study||37
8437727|NCT00821236|20792368|P1|STARTED|Overall Study||40
8437728|NCT00821184|20792384|P2|NOT COMPLETED|Overall Study||0
8437729|NCT00821184|20792385|P1|NOT COMPLETED|Overall Study||0
8437730|NCT00821184|20792384|P2|COMPLETED|Overall Study||6
8437731|NCT00821184|20792385|P1|COMPLETED|Overall Study||6
8437732|NCT00821184|20792384|P2|STARTED|Overall Study||6
8437733|NCT00821184|20792385|P1|STARTED|Overall Study||6
8437734|NCT00821119|20792395|P2|NOT COMPLETED|Overall Study||0
8437735|NCT00821119|20792396|P1|NOT COMPLETED|Overall Study||0
8437736|NCT00821119|20792395|P2|COMPLETED|Overall Study||100
8437737|NCT00821119|20792396|P1|COMPLETED|Overall Study||100
8437738|NCT00821119|20792395|P2|STARTED|Overall Study||100
8437739|NCT00821119|20792396|P1|STARTED|Overall Study||100
8437740|NCT00821093|20792408|P2|NOT COMPLETED|Overall Study||40
8437741|NCT00821093|20792409|P1|NOT COMPLETED|Overall Study||49
8437742|NCT00821093|20792408|P2|COMPLETED|Overall Study||523
8437743|NCT00821093|20792409|P1|COMPLETED|Overall Study||511
8437744|NCT00821093|20792408|P2|Exposed to Drug|Overall Study||562
8437745|NCT00821093|20792409|P1|Exposed to Drug|Overall Study||559
8437746|NCT00821093|20792408|P2|STARTED|Overall Study||563
8437747|NCT00821093|20792409|P1|STARTED|Overall Study||560
8437748|NCT00821041|20792419|P2|NOT COMPLETED|Overall Study||0
8437749|NCT00821041|20792420|P1|NOT COMPLETED|Overall Study||0
8437750|NCT00821041|20792419|P2|COMPLETED|Overall Study||59
8437751|NCT00821041|20792420|P1|COMPLETED|Overall Study||59
8437752|NCT00821041|20792419|P2|STARTED|Overall Study||59
8437753|NCT00821041|20792420|P1|STARTED|Overall Study||59
8437754|NCT00821015|20792428|P1|NOT COMPLETED|Overall Study||12
8437755|NCT00821015|20792428|P1|COMPLETED|Overall Study||15
8437756|NCT00821015|20792428|P1|STARTED|Overall Study||27
8437757|NCT00820898|20792439|P1|NOT COMPLETED|Overall Study||1
8437758|NCT00820898|20792439|P1|COMPLETED|Overall Study||23
8437759|NCT00820898|20792439|P1|STARTED|Overall Study||24
8437760|NCT00820872|20792449|P1|NOT COMPLETED|Overall Study||0
8437761|NCT00820872|20792449|P1|COMPLETED|Overall Study||30
8437762|NCT00820872|20792449|P1|STARTED|Overall Study||30
8437763|NCT00820755|20792453|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
8437764|NCT00820755|20792454|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
8437765|NCT00820755|20792455|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
8437766|NCT00820755|20792453|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
8437767|NCT00820755|20792454|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
8437768|NCT00820755|20792455|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
8437769|NCT00820755|20792453|P3|STARTED|Period 2: Maintenance Therapy Phase||154
8437770|NCT00820755|20792454|P2|STARTED|Period 2: Maintenance Therapy Phase||157
8437771|NCT00820755|20792455|P1|STARTED|Period 2: Maintenance Therapy Phase||0
8437772|NCT00820755|20792453|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
8437773|NCT00820755|20792454|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
8437774|NCT00820755|20792455|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
8437775|NCT00820755|20792453|P3|COMPLETED|Period 1: Combination Therapy Phase||0
8437776|NCT00820755|20792454|P2|COMPLETED|Period 1: Combination Therapy Phase||0
8437777|NCT00820755|20792455|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
8437778|NCT00820755|20792453|P3|STARTED|Period 1: Combination Therapy Phase||0
8437779|NCT00820755|20792454|P2|STARTED|Period 1: Combination Therapy Phase||0
8437780|NCT00820755|20792455|P1|STARTED|Period 1: Combination Therapy Phase||583
8437781|NCT00820664|20792479|P3|NOT COMPLETED|Overall Study||0
8437782|NCT00820664|20792480|P2|NOT COMPLETED|Overall Study||0
8437783|NCT00820664|20792481|P1|NOT COMPLETED|Overall Study||0
8437784|NCT00820664|20792479|P3|COMPLETED|Overall Study||9
8437785|NCT00820664|20792480|P2|COMPLETED|Overall Study||11
8437786|NCT00820664|20792481|P1|COMPLETED|Overall Study||9
8437787|NCT00820664|20792479|P3|STARTED|Overall Study||9
8437788|NCT00820664|20792480|P2|STARTED|Overall Study||11
8437789|NCT00820664|20792481|P1|STARTED|Overall Study||9
8437790|NCT00820612|20792491|P2|NOT COMPLETED|Overall Study||0
8437791|NCT00820612|20792492|P1|NOT COMPLETED|Overall Study||0
8437792|NCT00820612|20792491|P2|COMPLETED|Overall Study||295
8437793|NCT00820612|20792492|P1|COMPLETED|Overall Study||307
8437794|NCT00820612|20792491|P2|STARTED|Overall Study||295
8437795|NCT00820612|20792492|P1|STARTED|Overall Study||307
8437796|NCT00820599|20792498|P1|NOT COMPLETED|Overall Study||131
8437797|NCT00820599|20792498|P1|COMPLETED|Overall Study||80
8437798|NCT00820599|20792498|P1|STARTED|Overall Study||211
8437799|NCT00820573|20792507|P4|NOT COMPLETED|Overall Study||0
8437800|NCT00820573|20792508|P3|NOT COMPLETED|Overall Study||0
8437801|NCT00820573|20792509|P2|NOT COMPLETED|Overall Study||0
8437802|NCT00820573|20792510|P1|NOT COMPLETED|Overall Study||0
8437803|NCT00820573|20792507|P4|COMPLETED|Overall Study||4
8437804|NCT00820573|20792508|P3|COMPLETED|Overall Study||4
8437805|NCT00820573|20792509|P2|COMPLETED|Overall Study||4
8437806|NCT00820573|20792510|P1|COMPLETED|Overall Study||4
8437807|NCT00820573|20792507|P4|STARTED|Overall Study||4
8437808|NCT00820573|20792508|P3|STARTED|Overall Study||4
8437809|NCT00820573|20792509|P2|STARTED|Overall Study||4
8437810|NCT00820573|20792510|P1|STARTED|Overall Study||4
8437811|NCT00820534|20792534|P2|NOT COMPLETED|Overall Study||0
8437812|NCT00820534|20792535|P1|NOT COMPLETED|Overall Study||0
8437813|NCT00820534|20792534|P2|COMPLETED|Overall Study||62
8437814|NCT00820534|20792535|P1|COMPLETED|Overall Study||64
8437815|NCT00820534|20792534|P2|STARTED|Overall Study||62
8437816|NCT00820534|20792535|P1|STARTED|Overall Study||64
8437817|NCT00820443|20792543|P1|NOT COMPLETED|24 Month||43
8437818|NCT00820443|20792543|P1|COMPLETED|24 Month||202
8437819|NCT00820443|20792543|P1|STARTED|24 Month||245
8437820|NCT00820443|20792543|P1|NOT COMPLETED|12 Month||24
8437821|NCT00820443|20792543|P1|COMPLETED|12 Month||226
8437822|NCT00820443|20792543|P1|STARTED|12 Month||250
8437823|NCT00820443|20792543|P1|NOT COMPLETED|6 Month||20
8437824|NCT00820443|20792543|P1|COMPLETED|6 Month||233
8437825|NCT00820443|20792543|P1|STARTED|6 Month||253
8437826|NCT00820443|20792543|P1|NOT COMPLETED|3 Month||9
8437827|NCT00820443|20792543|P1|COMPLETED|3 Month||244
8437828|NCT00820443|20792543|P1|STARTED|3 Month||253
8437829|NCT00820443|20792543|P1|NOT COMPLETED|Immediately||5
8437830|NCT00820443|20792543|P1|COMPLETED|Immediately||248
8437831|NCT00820443|20792543|P1|STARTED|Immediately||253
8437832|NCT00820443|20792543|P1|NOT COMPLETED|Op||0
8437833|NCT00820443|20792543|P1|COMPLETED|Op||253
8437834|NCT00820443|20792543|P1|STARTED|Op||253
8437835|NCT00820443|20792543|P1|NOT COMPLETED|Pre-Op||0
8437836|NCT00820443|20792543|P1|COMPLETED|Pre-Op||253
8437837|NCT00820443|20792543|P1|STARTED|Pre-Op||253
8437838|NCT00820248|20792553|P2|NOT COMPLETED|Overall Study||1
8437839|NCT00820248|20792554|P1|NOT COMPLETED|Overall Study||4
8437840|NCT00820248|20792553|P2|COMPLETED|Overall Study||159
8437841|NCT00820248|20792554|P1|COMPLETED|Overall Study||156
8437842|NCT00820248|20792553|P2|Received Protocol Treatment|Overall Study||159
8437843|NCT00820248|20792554|P1|Received Protocol Treatment|Overall Study||156
8437844|NCT00820248|20792553|P2|STARTED|Overall Study||160
8437845|NCT00820248|20792554|P1|STARTED|Overall Study||160
8437846|NCT00820235|20792565|P3|NOT COMPLETED|Overall Study||17
8437847|NCT00820235|20792566|P2|NOT COMPLETED|Overall Study||21
8437848|NCT00820235|20792567|P1|NOT COMPLETED|Overall Study||15
8437849|NCT00820235|20792565|P3|COMPLETED|Overall Study||27
8437850|NCT00820235|20792566|P2|COMPLETED|Overall Study||28
8437851|NCT00820235|20792567|P1|COMPLETED|Overall Study||33
8437852|NCT00820235|20792565|P3|STARTED|Overall Study||44
8437853|NCT00820235|20792566|P2|STARTED|Overall Study||49
8437854|NCT00820235|20792567|P1|STARTED|Overall Study||48
8437855|NCT00820222|20792586|P2|NOT COMPLETED|Overall Study||190
8437856|NCT00820222|20792587|P1|NOT COMPLETED|Overall Study||176
8437857|NCT00820222|20792586|P2|COMPLETED|Overall Study||79
8437858|NCT00820222|20792587|P1|COMPLETED|Overall Study||95
8437859|NCT00820222|20792586|P2|STARTED|Overall Study||269
8437860|NCT00820222|20792587|P1|STARTED|Overall Study||271
8437861|NCT00820170|20792618|P5|NOT COMPLETED|Overall Study||4
8437862|NCT00820170|20792619|P4|NOT COMPLETED|Overall Study||0
8437863|NCT00820170|20792620|P3|NOT COMPLETED|Overall Study||0
8437864|NCT00820170|20792621|P2|NOT COMPLETED|Overall Study||0
8437865|NCT00820170|20792622|P1|NOT COMPLETED|Overall Study||0
8437866|NCT00820170|20792618|P5|COMPLETED|Overall Study||0
8437867|NCT00820170|20792619|P4|COMPLETED|Overall Study||40
8437868|NCT00820170|20792620|P3|COMPLETED|Overall Study||3
8437869|NCT00820170|20792621|P2|COMPLETED|Overall Study||5
8437870|NCT00820170|20792622|P1|COMPLETED|Overall Study||3
8437871|NCT00820170|20792618|P5|STARTED|Overall Study||4
8437872|NCT00820170|20792619|P4|STARTED|Overall Study||40
8437873|NCT00820170|20792620|P3|STARTED|Overall Study||3
8437874|NCT00820170|20792621|P2|STARTED|Overall Study||5
8437875|NCT00820170|20792622|P1|STARTED|Overall Study||3
8437876|NCT00820040|20792670|P1|NOT COMPLETED|Overall Study||3
8437877|NCT00820040|20792670|P1|COMPLETED|Overall Study||7
8437878|NCT00820040|20792670|P1|Full Analysis Set|Overall Study||8
8437879|NCT00820040|20792670|P1|Safety Evaluable Population|Overall Study||8
8437880|NCT00820040|20792670|P1|STARTED|Overall Study||10
8437881|NCT00820027|20792682|P4|NOT COMPLETED|Overall Study||13
8437882|NCT00820027|20792683|P3|NOT COMPLETED|Overall Study||21
8437883|NCT00820027|20792684|P2|NOT COMPLETED|Overall Study||14
8437884|NCT00820027|20792685|P1|NOT COMPLETED|Overall Study||26
8437885|NCT00820027|20792682|P4|COMPLETED|Overall Study||85
8437886|NCT00820027|20792683|P3|COMPLETED|Overall Study||203
8437887|NCT00820027|20792684|P2|COMPLETED|Overall Study||216
8437888|NCT00820027|20792685|P1|COMPLETED|Overall Study||198
8437889|NCT00820027|20792682|P4|STARTED|Overall Study||98
8437890|NCT00820027|20792683|P3|STARTED|Overall Study||224
8437891|NCT00820027|20792684|P2|STARTED|Overall Study||230
8437892|NCT00820027|20792685|P1|STARTED|Overall Study||224
8437893|NCT00819910|20792727|P4|NOT COMPLETED|Overall Study||1
8437894|NCT00819910|20792728|P3|NOT COMPLETED|Overall Study||3
8437895|NCT00819910|20792729|P2|NOT COMPLETED|Overall Study||1
8437896|NCT00819910|20792730|P1|NOT COMPLETED|Overall Study||2
8437897|NCT00819910|20792727|P4|COMPLETED|Overall Study||10
8437898|NCT00819910|20792728|P3|COMPLETED|Overall Study||7
8437899|NCT00819910|20792729|P2|COMPLETED|Overall Study||9
8437900|NCT00819910|20792730|P1|COMPLETED|Overall Study||8
8437901|NCT00819910|20792727|P4|STARTED|Overall Study||11
8437902|NCT00819910|20792728|P3|STARTED|Overall Study||10
8437903|NCT00819910|20792729|P2|STARTED|Overall Study||10
8437904|NCT00819910|20792730|P1|STARTED|Overall Study||10
8437905|NCT00819832|20792762|P6|NOT COMPLETED|Overall Study||0
8437906|NCT00819832|20792763|P5|NOT COMPLETED|Overall Study||0
8437907|NCT00819832|20792764|P4|NOT COMPLETED|Overall Study||0
8437908|NCT00819832|20792765|P3|NOT COMPLETED|Overall Study||0
8437909|NCT00819832|20792766|P2|NOT COMPLETED|Overall Study||0
8437910|NCT00819832|20792767|P1|NOT COMPLETED|Overall Study||3
8437911|NCT00819832|20792762|P6|COMPLETED|Overall Study||0
8437912|NCT00819832|20792763|P5|COMPLETED|Overall Study||0
8437913|NCT00819832|20792764|P4|COMPLETED|Overall Study||0
8437914|NCT00819832|20792765|P3|COMPLETED|Overall Study||0
8437915|NCT00819832|20792766|P2|COMPLETED|Overall Study||0
8437916|NCT00819832|20792767|P1|COMPLETED|Overall Study||0
8437917|NCT00819832|20792762|P6|STARTED|Overall Study||0
8437918|NCT00819832|20792763|P5|STARTED|Overall Study||0
8437919|NCT00819832|20792764|P4|STARTED|Overall Study||0
8437920|NCT00819832|20792765|P3|STARTED|Overall Study||0
8437921|NCT00819832|20792766|P2|STARTED|Overall Study||0
8437922|NCT00819832|20792767|P1|STARTED|Overall Study|No patient data analysis.|3
8437923|NCT00819793|20792781|P1|NOT COMPLETED|Overall Study||0
8437924|NCT00819793|20792781|P1|COMPLETED|Overall Study||32
8437925|NCT00819793|20792781|P1|STARTED|Overall Study||32
8437926|NCT00819780|20792788|P2|NOT COMPLETED|Overall Study||21
8437927|NCT00819780|20792789|P1|NOT COMPLETED|Overall Study||28
8437928|NCT00819780|20792788|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
8437929|NCT00819780|20792789|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
8437930|NCT00819780|20792788|P2|Received Study Treatment|Overall Study||139
8437931|NCT00819780|20792789|P1|Received Study Treatment|Overall Study||139
8437932|NCT00819780|20792788|P2|STARTED|Overall Study||143
8437933|NCT00819780|20792789|P1|STARTED|Overall Study||142
8437934|NCT00819767|20792823|P2|NOT COMPLETED|Overall Study||2
8437935|NCT00819767|20792824|P1|NOT COMPLETED|Overall Study||1
8437936|NCT00819767|20792823|P2|COMPLETED|Overall Study||33
8437937|NCT00819767|20792824|P1|COMPLETED|Overall Study||32
8437938|NCT00819767|20792823|P2|STARTED|Overall Study||35
8437939|NCT00819767|20792824|P1|STARTED|Overall Study||33
8437940|NCT00819741|20792836|P2|NOT COMPLETED|Overall Study||14
8437941|NCT00819741|20792837|P1|NOT COMPLETED|Overall Study||22
8437942|NCT00819741|20792836|P2|COMPLETED|Overall Study||201
8437943|NCT00819741|20792837|P1|COMPLETED|Overall Study||196
8437944|NCT00819741|20792836|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
8437945|NCT00819741|20792837|P1|Exposed to Drug|Overall Study||218
8437946|NCT00819741|20792836|P2|STARTED|Overall Study||215
8437947|NCT00819741|20792837|P1|STARTED|Overall Study||218
8437948|NCT00819637|20792874|P3|NOT COMPLETED|Overall Study||0
8437949|NCT00819637|20792875|P2|NOT COMPLETED|Overall Study||0
8437950|NCT00819637|20792876|P1|NOT COMPLETED|Overall Study||0
8437951|NCT00819637|20792874|P3|COMPLETED|Overall Study||0
8437952|NCT00819637|20792875|P2|COMPLETED|Overall Study||0
8437953|NCT00819637|20792876|P1|COMPLETED|Overall Study||2
8437954|NCT00819637|20792874|P3|STARTED|Overall Study||0
8437955|NCT00819637|20792875|P2|STARTED|Overall Study||0
8437956|NCT00819637|20792876|P1|STARTED|Overall Study||2
8437957|NCT00819585|20792891|P11|NOT COMPLETED|Extension Study||2
8437958|NCT00819585|20792892|P10|NOT COMPLETED|Extension Study||1
8437959|NCT00819585|20792893|P9|NOT COMPLETED|Extension Study||8
8437960|NCT00819585|20792894|P8|NOT COMPLETED|Extension Study||0
8437961|NCT00819585|20792895|P7|NOT COMPLETED|Extension Study||0
8437962|NCT00819585|20792896|P6|NOT COMPLETED|Extension Study||0
8437963|NCT00819585|20792897|P5|NOT COMPLETED|Extension Study||0
8437964|NCT00819585|20792898|P4|NOT COMPLETED|Extension Study||0
8437965|NCT00819585|20792899|P3|NOT COMPLETED|Extension Study||0
8437966|NCT00819585|20792900|P2|NOT COMPLETED|Extension Study||0
8437967|NCT00819585|20792901|P1|NOT COMPLETED|Extension Study||0
8437968|NCT00819585|20792891|P11|COMPLETED|Extension Study||58
8437969|NCT00819585|20792892|P10|COMPLETED|Extension Study||24
8437970|NCT00819585|20792893|P9|COMPLETED|Extension Study||173
8437971|NCT00819585|20792894|P8|COMPLETED|Extension Study||75
8437972|NCT00819585|20792895|P7|COMPLETED|Extension Study||0
8437973|NCT00819585|20792896|P6|COMPLETED|Extension Study||0
8437974|NCT00819585|20792897|P5|COMPLETED|Extension Study||0
8437975|NCT00819585|20792898|P4|COMPLETED|Extension Study||0
8437976|NCT00819585|20792899|P3|COMPLETED|Extension Study||0
8437977|NCT00819585|20792900|P2|COMPLETED|Extension Study||0
8437978|NCT00819585|20792901|P1|COMPLETED|Extension Study||0
8437979|NCT00819585|20792891|P11|STARTED|Extension Study||60
8437980|NCT00819585|20792892|P10|STARTED|Extension Study||25
8437981|NCT00819585|20792893|P9|STARTED|Extension Study||181
8437982|NCT00819585|20792894|P8|STARTED|Extension Study||75
8437983|NCT00819585|20792895|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437984|NCT00819585|20792896|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437985|NCT00819585|20792897|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437986|NCT00819585|20792898|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437987|NCT00819585|20792899|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437988|NCT00819585|20792900|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437989|NCT00819585|20792901|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437990|NCT00819585|20792891|P11|NOT COMPLETED|Core Study||0
8437991|NCT00819585|20792892|P10|NOT COMPLETED|Core Study||0
8437992|NCT00819585|20792893|P9|NOT COMPLETED|Core Study||0
8437993|NCT00819585|20792894|P8|NOT COMPLETED|Core Study||0
8437994|NCT00819585|20792895|P7|NOT COMPLETED|Core Study||13
8437995|NCT00819585|20792896|P6|NOT COMPLETED|Core Study||2
8437996|NCT00819585|20792897|P5|NOT COMPLETED|Core Study||3
8437997|NCT00819585|20792898|P4|NOT COMPLETED|Core Study||5
8437998|NCT00819585|20792899|P3|NOT COMPLETED|Core Study||6
8437999|NCT00819585|20792900|P2|NOT COMPLETED|Core Study||6
8438000|NCT00819585|20792901|P1|NOT COMPLETED|Core Study||6
8438001|NCT00819585|20792891|P11|COMPLETED|Core Study||0
8438002|NCT00819585|20792892|P10|COMPLETED|Core Study||0
8438003|NCT00819585|20792893|P9|COMPLETED|Core Study||0
8438004|NCT00819585|20792894|P8|COMPLETED|Core Study||0
8438005|NCT00819585|20792895|P7|COMPLETED|Core Study||95
8438006|NCT00819585|20792896|P6|COMPLETED|Core Study||52
8438007|NCT00819585|20792897|P5|COMPLETED|Core Study||50
8438008|NCT00819585|20792898|P4|COMPLETED|Core Study||49
8438009|NCT00819585|20792899|P3|COMPLETED|Core Study||48
8438010|NCT00819585|20792900|P2|COMPLETED|Core Study||48
8438011|NCT00819585|20792901|P1|COMPLETED|Core Study||49
8438012|NCT00819585|20792891|P11|Received Study Medication|Core Study||0
8438013|NCT00819585|20792892|P10|Received Study Medication|Core Study||0
8438014|NCT00819585|20792893|P9|Received Study Medication|Core Study||0
8438015|NCT00819585|20792894|P8|Received Study Medication|Core Study||0
8438016|NCT00819585|20792895|P7|Received Study Medication|Core Study||108
8438017|NCT00819585|20792896|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
8438018|NCT00819585|20792897|P5|Received Study Medication|Core Study||53
8438019|NCT00819585|20792898|P4|Received Study Medication|Core Study||54
8438020|NCT00819585|20792899|P3|Received Study Medication|Core Study||54
8438021|NCT00819585|20792900|P2|Received Study Medication|Core Study||54
8438022|NCT00819585|20792901|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
8438023|NCT00819585|20792891|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438024|NCT00819585|20792892|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438025|NCT00819585|20792893|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438026|NCT00819585|20792894|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438027|NCT00819585|20792895|P7|STARTED|Core Study||108
8438028|NCT00819585|20792896|P6|STARTED|Core Study||54
8438029|NCT00819585|20792897|P5|STARTED|Core Study||53
8438030|NCT00819585|20792898|P4|STARTED|Core Study||54
8438031|NCT00819585|20792899|P3|STARTED|Core Study||54
8438032|NCT00819585|20792900|P2|STARTED|Core Study||54
8438033|NCT00819585|20792901|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
8438034|NCT00819507|20792972|P1|NOT COMPLETED|Overall Study||0
8438035|NCT00819507|20792972|P1|COMPLETED|Overall Study||25
8438036|NCT00819507|20792972|P1|STARTED|Overall Study||25
8438037|NCT00819403|20792979|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8438038|NCT00819403|20792980|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8438039|NCT00819403|20792979|P2|COMPLETED|Second Intervention (6 Weeks)||8
8438040|NCT00819403|20792980|P1|COMPLETED|Second Intervention (6 Weeks)||7
8438041|NCT00819403|20792979|P2|STARTED|Second Intervention (6 Weeks)||8
8438042|NCT00819403|20792980|P1|STARTED|Second Intervention (6 Weeks)||7
8438043|NCT00819403|20792979|P2|NOT COMPLETED|Washout (14 Days)||0
8438044|NCT00819403|20792980|P1|NOT COMPLETED|Washout (14 Days)||0
8438045|NCT00819403|20792979|P2|COMPLETED|Washout (14 Days)||8
8438046|NCT00819403|20792980|P1|COMPLETED|Washout (14 Days)||7
8438047|NCT00819403|20792979|P2|STARTED|Washout (14 Days)||8
8438048|NCT00819403|20792980|P1|STARTED|Washout (14 Days)||7
8438049|NCT00819403|20792979|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8438050|NCT00819403|20792980|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8438051|NCT00819403|20792979|P2|COMPLETED|First Intervention (6 Weeks)||8
8438052|NCT00819403|20792980|P1|COMPLETED|First Intervention (6 Weeks)||7
8438053|NCT00819403|20792979|P2|STARTED|First Intervention (6 Weeks)||8
8438054|NCT00819403|20792980|P1|STARTED|First Intervention (6 Weeks)||7
8438055|NCT00819390|20792992|P4|NOT COMPLETED|Overall Study||0
8438056|NCT00819390|20792993|P3|NOT COMPLETED|Overall Study||1
8438057|NCT00819390|20792994|P2|NOT COMPLETED|Overall Study||1
8438058|NCT00819390|20792995|P1|NOT COMPLETED|Overall Study||3
8438059|NCT00819390|20792992|P4|COMPLETED|Overall Study||19
8438060|NCT00819390|20792993|P3|COMPLETED|Overall Study||17
8438061|NCT00819390|20792994|P2|COMPLETED|Overall Study||16
8438062|NCT00819390|20792995|P1|COMPLETED|Overall Study||13
8438063|NCT00819390|20792992|P4|STARTED|Overall Study||19
8438064|NCT00819390|20792993|P3|STARTED|Overall Study||18
8438065|NCT00819390|20792994|P2|STARTED|Overall Study||17
8438066|NCT00819390|20792995|P1|STARTED|Overall Study||16
8438067|NCT00819286|20793107|P2|NOT COMPLETED|Overall Study||25
8438068|NCT00819286|20793108|P1|NOT COMPLETED|Overall Study||14
8438069|NCT00819286|20793107|P2|COMPLETED|Overall Study||45
8438070|NCT00819286|20793108|P1|COMPLETED|Overall Study||56
8438071|NCT00819286|20793107|P2|STARTED|Overall Study||70
8438072|NCT00819286|20793108|P1|STARTED|Overall Study||70
8438073|NCT00819260|20793116|P1|NOT COMPLETED|Overall Study||0
8438074|NCT00819260|20793116|P1|COMPLETED|Overall Study||31
8438075|NCT00819260|20793116|P1|STARTED|Overall Study||31
8438076|NCT00819247|20793131|P3|NOT COMPLETED|Overall Study||14
8438077|NCT00819247|20793132|P2|NOT COMPLETED|Overall Study||16
8438078|NCT00819247|20793133|P1|NOT COMPLETED|Overall Study||11
8438079|NCT00819247|20793131|P3|COMPLETED|Overall Study||26
8438080|NCT00819247|20793132|P2|COMPLETED|Overall Study||30
8438081|NCT00819247|20793133|P1|COMPLETED|Overall Study||32
8438082|NCT00819247|20793131|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
8438083|NCT00819247|20793132|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
8438174|NCT00819039|20793607|P1|NOT COMPLETED|Overall Study||2
8438175|NCT00819039|20793605|P3|COMPLETED|Overall Study||24
8438084|NCT00819247|20793133|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
8438085|NCT00819247|20793131|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
8438086|NCT00819247|20793132|P2|Intent-to-treat Population|Overall Study||46
8438087|NCT00819247|20793133|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
8438088|NCT00819247|20793131|P3|Randomized|Overall Study||40
8438089|NCT00819247|20793132|P2|Randomized|Overall Study||46
8438090|NCT00819247|20793133|P1|Randomized|Overall Study||43
8438091|NCT00819247|20793131|P3|STARTED|Overall Study||40
8438092|NCT00819247|20793132|P2|STARTED|Overall Study||46
8438093|NCT00819247|20793133|P1|STARTED|Overall Study||43
8438094|NCT00819234|20793159|P10|NOT COMPLETED|Overall Study||7
8438095|NCT00819234|20793160|P9|NOT COMPLETED|Overall Study||6
8438096|NCT00819234|20793161|P8|NOT COMPLETED|Overall Study||9
8438097|NCT00819234|20793162|P7|NOT COMPLETED|Overall Study||5
8438098|NCT00819234|20793163|P6|NOT COMPLETED|Overall Study||7
8438099|NCT00819234|20793164|P5|NOT COMPLETED|Overall Study||1
8438100|NCT00819234|20793165|P4|NOT COMPLETED|Overall Study||6
8438101|NCT00819234|20793166|P3|NOT COMPLETED|Overall Study||8
8438102|NCT00819234|20793167|P2|NOT COMPLETED|Overall Study||15
8438103|NCT00819234|20793168|P1|NOT COMPLETED|Overall Study||10
8438104|NCT00819234|20793159|P10|COMPLETED|Overall Study||30
8438105|NCT00819234|20793160|P9|COMPLETED|Overall Study||31
8438106|NCT00819234|20793161|P8|COMPLETED|Overall Study||20
8438107|NCT00819234|20793162|P7|COMPLETED|Overall Study||8
8438108|NCT00819234|20793163|P6|COMPLETED|Overall Study||7
8438109|NCT00819234|20793164|P5|COMPLETED|Overall Study||12
8438110|NCT00819234|20793165|P4|COMPLETED|Overall Study||22
8438111|NCT00819234|20793166|P3|COMPLETED|Overall Study||28
8438112|NCT00819234|20793167|P2|COMPLETED|Overall Study||20
8438113|NCT00819234|20793168|P1|COMPLETED|Overall Study||21
8438114|NCT00819234|20793159|P10|STARTED|Overall Study||37
8438115|NCT00819234|20793160|P9|STARTED|Overall Study||37
8438116|NCT00819234|20793161|P8|STARTED|Overall Study||29
8438117|NCT00819234|20793162|P7|STARTED|Overall Study||13
8438118|NCT00819234|20793163|P6|STARTED|Overall Study||14
8438119|NCT00819234|20793164|P5|STARTED|Overall Study||13
8438120|NCT00819234|20793165|P4|STARTED|Overall Study||28
8438121|NCT00819234|20793166|P3|STARTED|Overall Study||36
8438122|NCT00819234|20793167|P2|STARTED|Overall Study||35
8438123|NCT00819234|20793168|P1|STARTED|Overall Study||31
8438124|NCT00819182|20793329|P3|NOT COMPLETED|Overall Study||1
8438125|NCT00819182|20793330|P2|NOT COMPLETED|Overall Study||8
8438126|NCT00819182|20793331|P1|NOT COMPLETED|Overall Study||13
8438127|NCT00819182|20793329|P3|COMPLETED|Overall Study||43
8438128|NCT00819182|20793330|P2|COMPLETED|Overall Study||78
8438129|NCT00819182|20793331|P1|COMPLETED|Overall Study||75
8438130|NCT00819182|20793329|P3|Week 16 Visit|Overall Study||43
8438131|NCT00819182|20793330|P2|Week 16 Visit|Overall Study||78
8438132|NCT00819182|20793331|P1|Week 16 Visit|Overall Study||75
8438133|NCT00819182|20793329|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
8438134|NCT00819182|20793330|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
8438135|NCT00819182|20793331|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
8438136|NCT00819156|20793367|P6|NOT COMPLETED|Overall Study||8
8438137|NCT00819156|20793368|P5|NOT COMPLETED|Overall Study||6
8438138|NCT00819156|20793369|P4|NOT COMPLETED|Overall Study||2
8438139|NCT00819156|20793370|P3|NOT COMPLETED|Overall Study||6
8438140|NCT00819156|20793371|P2|NOT COMPLETED|Overall Study||10
8438141|NCT00819156|20793372|P1|NOT COMPLETED|Overall Study||10
8438142|NCT00819156|20793367|P6|COMPLETED|Overall Study||23
8438143|NCT00819156|20793368|P5|COMPLETED|Overall Study||27
8438144|NCT00819156|20793369|P4|COMPLETED|Overall Study||28
8438145|NCT00819156|20793370|P3|COMPLETED|Overall Study||26
8438146|NCT00819156|20793371|P2|COMPLETED|Overall Study||23
8438147|NCT00819156|20793372|P1|COMPLETED|Overall Study||20
8438148|NCT00819156|20793367|P6|Randomised and Treated (ITT Population)|Overall Study||30
8438149|NCT00819156|20793368|P5|Randomised and Treated (ITT Population)|Overall Study||33
8438150|NCT00819156|20793369|P4|Randomised and Treated (ITT Population)|Overall Study||30
8438151|NCT00819156|20793370|P3|Randomised and Treated (ITT Population)|Overall Study||32
8438152|NCT00819156|20793371|P2|Randomised and Treated (ITT Population)|Overall Study||32
8438153|NCT00819156|20793372|P1|Randomised and Treated (ITT Population)|Overall Study||30
8438154|NCT00819156|20793367|P6|STARTED|Overall Study||31
8438155|NCT00819156|20793368|P5|STARTED|Overall Study||33
8438156|NCT00819156|20793369|P4|STARTED|Overall Study||30
8438157|NCT00819156|20793370|P3|STARTED|Overall Study||32
8438158|NCT00819156|20793371|P2|STARTED|Overall Study||33
8438159|NCT00819156|20793372|P1|STARTED|Overall Study||30
8438160|NCT00819091|20793462|P2|NOT COMPLETED|Overall Study||10
8438161|NCT00819091|20793463|P1|NOT COMPLETED|Overall Study||7
8438162|NCT00819091|20793462|P2|COMPLETED|Overall Study||151
8438163|NCT00819091|20793463|P1|COMPLETED|Overall Study||77
8438164|NCT00819091|20793462|P2|STARTED|Overall Study||161
8438165|NCT00819091|20793463|P1|STARTED|Overall Study||84
8438166|NCT00819052|20793489|P2|NOT COMPLETED|Overall Study||14
8438167|NCT00819052|20793490|P1|NOT COMPLETED|Overall Study||6
8438168|NCT00819052|20793489|P2|COMPLETED|Overall Study||281
8438169|NCT00819052|20793490|P1|COMPLETED|Overall Study||142
8438170|NCT00819052|20793489|P2|STARTED|Overall Study||295
8438171|NCT00819052|20793490|P1|STARTED|Overall Study||148
8438172|NCT00819039|20793605|P3|NOT COMPLETED|Overall Study||1
8438173|NCT00819039|20793606|P2|NOT COMPLETED|Overall Study||0
8438176|NCT00819039|20793606|P2|COMPLETED|Overall Study||27
8438177|NCT00819039|20793607|P1|COMPLETED|Overall Study||44
8438178|NCT00819039|20793605|P3|STARTED|Overall Study||25
8438179|NCT00819039|20793606|P2|STARTED|Overall Study||27
8438180|NCT00819039|20793607|P1|STARTED|Overall Study||46
8438181|NCT00819013|20793637|P4|NOT COMPLETED|Overall Study||4
8438182|NCT00819013|20793638|P3|NOT COMPLETED|Overall Study||5
8438183|NCT00819013|20793639|P2|NOT COMPLETED|Overall Study||1
8438184|NCT00819013|20793640|P1|NOT COMPLETED|Overall Study||3
8438185|NCT00819013|20793637|P4|COMPLETED|Overall Study||17
8438186|NCT00819013|20793638|P3|COMPLETED|Overall Study||16
8438187|NCT00819013|20793639|P2|COMPLETED|Overall Study||22
8438188|NCT00819013|20793640|P1|COMPLETED|Overall Study||19
8438189|NCT00819013|20793637|P4|STARTED|Overall Study||21
8438190|NCT00819013|20793638|P3|STARTED|Overall Study||21
8438191|NCT00819013|20793639|P2|STARTED|Overall Study||23
8438192|NCT00819013|20793640|P1|STARTED|Overall Study||22
8438193|NCT00818961|20793690|P1|NOT COMPLETED|Overall Study||0
8438194|NCT00818961|20793690|P1|COMPLETED|Overall Study||36
8438195|NCT00818961|20793690|P1|STARTED|Overall Study||36
8438196|NCT00818883|20793706|P2|NOT COMPLETED|Overall Study||46
8438197|NCT00818883|20793707|P1|NOT COMPLETED|Overall Study||51
8438198|NCT00818883|20793706|P2|COMPLETED|Overall Study||260
8438199|NCT00818883|20793707|P1|COMPLETED|Overall Study||252
8438200|NCT00818883|20793706|P2|STARTED|Overall Study||306
8438201|NCT00818883|20793707|P1|STARTED|Overall Study||303
8438202|NCT00818805|20793741|P2|NOT COMPLETED|Second Intervention||0
8438203|NCT00818805|20793742|P1|NOT COMPLETED|Second Intervention||0
8438204|NCT00818805|20793741|P2|COMPLETED|Second Intervention||25
8438205|NCT00818805|20793742|P1|COMPLETED|Second Intervention||25
8438206|NCT00818805|20793741|P2|STARTED|Second Intervention||25
8438207|NCT00818805|20793742|P1|STARTED|Second Intervention||25
8438208|NCT00818805|20793741|P2|NOT COMPLETED|First Intervention||0
8438209|NCT00818805|20793742|P1|NOT COMPLETED|First Intervention||0
8438210|NCT00818805|20793741|P2|COMPLETED|First Intervention||25
8438211|NCT00818805|20793742|P1|COMPLETED|First Intervention||25
8438212|NCT00818805|20793741|P2|STARTED|First Intervention||25
8438213|NCT00818805|20793742|P1|STARTED|First Intervention||25
8438214|NCT00818779|20793754|P2|NOT COMPLETED|Overall Study||1
8438215|NCT00818779|20793755|P1|NOT COMPLETED|Overall Study||6
8438216|NCT00818779|20793754|P2|COMPLETED|Overall Study||15
8438217|NCT00818779|20793755|P1|COMPLETED|Overall Study||16
8438218|NCT00818779|20793754|P2|STARTED|Overall Study||16
8438219|NCT00818779|20793755|P1|STARTED|Overall Study||22
8438220|NCT00818766|20793771|P2|NOT COMPLETED|Overall Study||10
8438221|NCT00818766|20793772|P1|NOT COMPLETED|Overall Study||15
8438222|NCT00818766|20793771|P2|COMPLETED|Overall Study||116
8438223|NCT00818766|20793772|P1|COMPLETED|Overall Study||110
8438224|NCT00818766|20793771|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
8438225|NCT00818766|20793772|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
8438226|NCT00818766|20793771|P2|Received Allocated Intervention|Overall Study||126
8438227|NCT00818766|20793772|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
8438228|NCT00818766|20793771|P2|STARTED|Overall Study||126
8438229|NCT00818766|20793772|P1|STARTED|Overall Study||125
8438230|NCT00818753|20793801|P3|NOT COMPLETED|Overall Study||1
8438231|NCT00818753|20793802|P2|NOT COMPLETED|Overall Study||0
8438232|NCT00818753|20793803|P1|NOT COMPLETED|Overall Study||3
8438233|NCT00818753|20793801|P3|COMPLETED|Overall Study||9
8438234|NCT00818753|20793802|P2|COMPLETED|Overall Study||21
8438235|NCT00818753|20793803|P1|COMPLETED|Overall Study||19
8438236|NCT00818753|20793801|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
8438237|NCT00818753|20793802|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
8438238|NCT00818753|20793803|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
8438239|NCT00818662|20793827|P4|NOT COMPLETED|Overall Study||16
8438240|NCT00818662|20793828|P3|NOT COMPLETED|Overall Study||9
8438241|NCT00818662|20793829|P2|NOT COMPLETED|Overall Study||33
8438242|NCT00818662|20793830|P1|NOT COMPLETED|Overall Study||23
8438243|NCT00818662|20793827|P4|COMPLETED|Overall Study||47
8438244|NCT00818662|20793828|P3|COMPLETED|Overall Study||49
8438245|NCT00818662|20793829|P2|COMPLETED|Overall Study||102
8438246|NCT00818662|20793830|P1|COMPLETED|Overall Study||104
8438247|NCT00818662|20793827|P4|STARTED|Overall Study||63
8438248|NCT00818662|20793828|P3|STARTED|Overall Study||58
8438249|NCT00818662|20793829|P2|STARTED|Overall Study||135
8438250|NCT00818662|20793830|P1|STARTED|Overall Study||127
8438251|NCT00818649|20793916|P1|NOT COMPLETED|Overall Study||4
8438252|NCT00818649|20793916|P1|COMPLETED|Overall Study||12
8438253|NCT00818649|20793916|P1|STARTED|Overall Study||16
8438254|NCT00818623|20793930|P8|NOT COMPLETED|Overall Study||1
8438255|NCT00818623|20793931|P7|NOT COMPLETED|Overall Study||4
8438256|NCT00818623|20793932|P6|NOT COMPLETED|Overall Study||3
8438257|NCT00818623|20793933|P5|NOT COMPLETED|Overall Study||4
8438258|NCT00818623|20793934|P4|NOT COMPLETED|Overall Study||5
8438259|NCT00818623|20793935|P3|NOT COMPLETED|Overall Study||4
8438260|NCT00818623|20793936|P2|NOT COMPLETED|Overall Study||4
8438261|NCT00818623|20793937|P1|NOT COMPLETED|Overall Study||2
8438262|NCT00818623|20793930|P8|COMPLETED|Overall Study||26
8438263|NCT00818623|20793931|P7|COMPLETED|Overall Study||23
8438264|NCT00818623|20793932|P6|COMPLETED|Overall Study||21
8438265|NCT00818623|20793933|P5|COMPLETED|Overall Study||23
8438266|NCT00818623|20793934|P4|COMPLETED|Overall Study||19
8438267|NCT00818623|20793935|P3|COMPLETED|Overall Study||9
8438268|NCT00818623|20793936|P2|COMPLETED|Overall Study||8
8438269|NCT00818623|20793937|P1|COMPLETED|Overall Study||24
8438270|NCT00818623|20793930|P8|Intent-to-treat (ITT) Population|Overall Study||27
8438271|NCT00818623|20793931|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
8438272|NCT00818623|20793932|P6|Intent-to-treat (ITT) Population|Overall Study||24
8438273|NCT00818623|20793933|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
8438274|NCT00818623|20793934|P4|Intent-to-treat (ITT) Population|Overall Study||24
8438275|NCT00818623|20793935|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
8438276|NCT00818623|20793936|P2|Intent-to-treat (ITT) Population|Overall Study||12
8438277|NCT00818623|20793937|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
8438278|NCT00818623|20793930|P8|STARTED|Overall Study||27
8438279|NCT00818623|20793931|P7|STARTED|Overall Study||27
8438280|NCT00818623|20793932|P6|STARTED|Overall Study||24
8438281|NCT00818623|20793933|P5|STARTED|Overall Study||27
8438282|NCT00818623|20793934|P4|STARTED|Overall Study||24
8438283|NCT00818623|20793935|P3|STARTED|Overall Study||13
8438284|NCT00818623|20793936|P2|STARTED|Overall Study||12
8438285|NCT00818623|20793937|P1|STARTED|Overall Study||26
8438286|NCT00818519|20794013|P2|NOT COMPLETED|Overall Study||19
8438287|NCT00818519|20794014|P1|NOT COMPLETED|Overall Study||14
8438288|NCT00818519|20794013|P2|COMPLETED|Overall Study||71
8438289|NCT00818519|20794014|P1|COMPLETED|Overall Study||75
8438290|NCT00818519|20794013|P2|Participants Received Treatment|Overall Study|= Baseline|86
8438291|NCT00818519|20794014|P1|Participants Received Treatment|Overall Study|= Baseline|87
8438292|NCT00818519|20794013|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
8438293|NCT00818519|20794014|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
8438294|NCT00818454|20794044|P4|NOT COMPLETED|Treatment Period 3||1
8438295|NCT00818454|20794045|P3|NOT COMPLETED|Treatment Period 3||0
8438296|NCT00818454|20794046|P2|NOT COMPLETED|Treatment Period 3||0
8438297|NCT00818454|20794047|P1|NOT COMPLETED|Treatment Period 3||0
8438298|NCT00818454|20794044|P4|COMPLETED|Treatment Period 3||138
8438299|NCT00818454|20794045|P3|COMPLETED|Treatment Period 3||26
8438300|NCT00818454|20794046|P2|COMPLETED|Treatment Period 3||0
8438301|NCT00818454|20794047|P1|COMPLETED|Treatment Period 3||0
8438302|NCT00818454|20794044|P4|STARTED|Treatment Period 3||139
8438303|NCT00818454|20794045|P3|STARTED|Treatment Period 3||26
8438304|NCT00818454|20794046|P2|STARTED|Treatment Period 3||0
8438305|NCT00818454|20794047|P1|STARTED|Treatment Period 3||0
8438306|NCT00818454|20794044|P4|NOT COMPLETED|Treatment Period 2||0
8438307|NCT00818454|20794045|P3|NOT COMPLETED|Treatment Period 2||0
8438308|NCT00818454|20794046|P2|NOT COMPLETED|Treatment Period 2||1
8438309|NCT00818454|20794047|P1|NOT COMPLETED|Treatment Period 2||2
8438310|NCT00818454|20794044|P4|COMPLETED|Treatment Period 2||0
8438311|NCT00818454|20794045|P3|COMPLETED|Treatment Period 2||0
8438312|NCT00818454|20794046|P2|COMPLETED|Treatment Period 2||106
8438313|NCT00818454|20794047|P1|COMPLETED|Treatment Period 2||106
8438314|NCT00818454|20794044|P4|STARTED|Treatment Period 2||0
8438315|NCT00818454|20794045|P3|STARTED|Treatment Period 2||0
8438316|NCT00818454|20794046|P2|STARTED|Treatment Period 2||107
8438317|NCT00818454|20794047|P1|STARTED|Treatment Period 2||108
8438318|NCT00818454|20794044|P4|NOT COMPLETED|Washout Period of 1 Week||0
8438319|NCT00818454|20794045|P3|NOT COMPLETED|Washout Period of 1 Week||0
8438320|NCT00818454|20794046|P2|NOT COMPLETED|Washout Period of 1 Week||3
8438321|NCT00818454|20794047|P1|NOT COMPLETED|Washout Period of 1 Week||4
8438322|NCT00818454|20794044|P4|COMPLETED|Washout Period of 1 Week||0
8438323|NCT00818454|20794045|P3|COMPLETED|Washout Period of 1 Week||0
8438324|NCT00818454|20794046|P2|COMPLETED|Washout Period of 1 Week||107
8438325|NCT00818454|20794047|P1|COMPLETED|Washout Period of 1 Week||108
8438326|NCT00818454|20794044|P4|STARTED|Washout Period of 1 Week||0
8438327|NCT00818454|20794045|P3|STARTED|Washout Period of 1 Week||0
8438328|NCT00818454|20794046|P2|STARTED|Washout Period of 1 Week||110
8438329|NCT00818454|20794047|P1|STARTED|Washout Period of 1 Week||112
8438330|NCT00818454|20794044|P4|NOT COMPLETED|Treatment Period 1||0
8438331|NCT00818454|20794045|P3|NOT COMPLETED|Treatment Period 1||0
8438332|NCT00818454|20794046|P2|NOT COMPLETED|Treatment Period 1||1
8438333|NCT00818454|20794047|P1|NOT COMPLETED|Treatment Period 1||3
8438334|NCT00818454|20794044|P4|COMPLETED|Treatment Period 1||0
8438335|NCT00818454|20794045|P3|COMPLETED|Treatment Period 1||0
8438336|NCT00818454|20794046|P2|COMPLETED|Treatment Period 1||110
8438337|NCT00818454|20794047|P1|COMPLETED|Treatment Period 1||112
8438338|NCT00818454|20794044|P4|STARTED|Treatment Period 1||0
8438339|NCT00818454|20794045|P3|STARTED|Treatment Period 1||0
8438340|NCT00818454|20794046|P2|STARTED|Treatment Period 1||111
8438341|NCT00818454|20794047|P1|STARTED|Treatment Period 1||115
8438342|NCT00818441|20794075|P2|NOT COMPLETED|Overall Study||30
8438343|NCT00818441|20794076|P1|NOT COMPLETED|Overall Study||89
8438344|NCT00818441|20794075|P2|COMPLETED|Overall Study||0
8438345|NCT00818441|20794076|P1|COMPLETED|Overall Study||0
8438346|NCT00818441|20794075|P2|STARTED|Overall Study||30
8438347|NCT00818441|20794076|P1|STARTED|Overall Study||89
8438348|NCT00818389|20794098|P2|NOT COMPLETED|Overall Study||6
8438349|NCT00818389|20794099|P1|NOT COMPLETED|Overall Study||4
8438350|NCT00818389|20794098|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
8438351|NCT00818389|20794099|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
8438352|NCT00818389|20794098|P2|STARTED|Overall Study||44
8438353|NCT00818389|20794099|P1|STARTED|Overall Study||40
8438354|NCT00818337|20794109|P1|NOT COMPLETED|Overall Study||0
8438355|NCT00818337|20794109|P1|COMPLETED|Overall Study||36
8438356|NCT00818337|20794109|P1|STARTED|Overall Study||36
8438357|NCT00818324|20794114|P1|NOT COMPLETED|Overall Study||27
8438358|NCT00818324|20794114|P1|COMPLETED|Overall Study||127
8438359|NCT00818324|20794114|P1|STARTED|Overall Study||154
8438360|NCT00818272|20794119|P1|NOT COMPLETED|Overall Study||74
8438361|NCT00818272|20794119|P1|COMPLETED|Overall Study||74
8438362|NCT00818272|20794119|P1|STARTED|Overall Study||148
8438363|NCT00818259|20794134|P9|NOT COMPLETED|Part V||0
8438364|NCT00818259|20794135|P8|NOT COMPLETED|Part V||1
8438365|NCT00818259|20794136|P7|NOT COMPLETED|Part V||0
8438366|NCT00818259|20794137|P6|NOT COMPLETED|Part V||0
8438367|NCT00818259|20794138|P5|NOT COMPLETED|Part V||0
8438368|NCT00818259|20794139|P4|NOT COMPLETED|Part V||0
8438369|NCT00818259|20794140|P3|NOT COMPLETED|Part V||0
8438370|NCT00818259|20794141|P2|NOT COMPLETED|Part V||0
8438371|NCT00818259|20794142|P1|NOT COMPLETED|Part V||0
8438372|NCT00818259|20794134|P9|COMPLETED|Part V||6
8438373|NCT00818259|20794135|P8|COMPLETED|Part V||16
8438374|NCT00818259|20794136|P7|COMPLETED|Part V||0
8438375|NCT00818259|20794137|P6|COMPLETED|Part V||0
8438376|NCT00818259|20794138|P5|COMPLETED|Part V||0
8438377|NCT00818259|20794139|P4|COMPLETED|Part V||0
8438378|NCT00818259|20794140|P3|COMPLETED|Part V||0
8438379|NCT00818259|20794141|P2|COMPLETED|Part V||0
8438380|NCT00818259|20794142|P1|COMPLETED|Part V||0
8438381|NCT00818259|20794134|P9|STARTED|Part V|Newly enrolled participants|6
8438382|NCT00818259|20794135|P8|STARTED|Part V|Participants continuing from Part IV|17
8438383|NCT00818259|20794136|P7|STARTED|Part V||0
8438384|NCT00818259|20794137|P6|STARTED|Part V||0
8438385|NCT00818259|20794138|P5|STARTED|Part V||0
8438386|NCT00818259|20794139|P4|STARTED|Part V||0
8438387|NCT00818259|20794140|P3|STARTED|Part V||0
8438388|NCT00818259|20794141|P2|STARTED|Part V||0
8438389|NCT00818259|20794142|P1|STARTED|Part V||0
8438390|NCT00818259|20794134|P9|NOT COMPLETED|Part IV||0
8438391|NCT00818259|20794135|P8|NOT COMPLETED|Part IV||0
8438392|NCT00818259|20794136|P7|NOT COMPLETED|Part IV||0
8438393|NCT00818259|20794137|P6|NOT COMPLETED|Part IV||1
8438394|NCT00818259|20794138|P5|NOT COMPLETED|Part IV||0
8438395|NCT00818259|20794139|P4|NOT COMPLETED|Part IV||0
8438396|NCT00818259|20794140|P3|NOT COMPLETED|Part IV||0
8438397|NCT00818259|20794141|P2|NOT COMPLETED|Part IV||0
8438398|NCT00818259|20794142|P1|NOT COMPLETED|Part IV||0
8438399|NCT00818259|20794134|P9|COMPLETED|Part IV||0
8438400|NCT00818259|20794135|P8|COMPLETED|Part IV||0
8438401|NCT00818259|20794136|P7|COMPLETED|Part IV||5
8438402|NCT00818259|20794137|P6|COMPLETED|Part IV||14
8438403|NCT00818259|20794138|P5|COMPLETED|Part IV||0
8438404|NCT00818259|20794139|P4|COMPLETED|Part IV||0
8438405|NCT00818259|20794140|P3|COMPLETED|Part IV||0
8438406|NCT00818259|20794141|P2|COMPLETED|Part IV||0
8438407|NCT00818259|20794142|P1|COMPLETED|Part IV||0
8438408|NCT00818259|20794134|P9|STARTED|Part IV||0
8438409|NCT00818259|20794135|P8|STARTED|Part IV||0
8438410|NCT00818259|20794136|P7|STARTED|Part IV|Newly enrolled participants|5
8438411|NCT00818259|20794137|P6|STARTED|Part IV|Participants continuing from Part III|15
8438412|NCT00818259|20794138|P5|STARTED|Part IV||0
8438413|NCT00818259|20794139|P4|STARTED|Part IV||0
8438414|NCT00818259|20794140|P3|STARTED|Part IV||0
8438415|NCT00818259|20794141|P2|STARTED|Part IV||0
8438416|NCT00818259|20794142|P1|STARTED|Part IV||0
8438417|NCT00818259|20794134|P9|NOT COMPLETED|Part III||0
8438418|NCT00818259|20794135|P8|NOT COMPLETED|Part III||0
8438419|NCT00818259|20794136|P7|NOT COMPLETED|Part III||0
8438420|NCT00818259|20794137|P6|NOT COMPLETED|Part III||0
8438421|NCT00818259|20794138|P5|NOT COMPLETED|Part III||0
8438422|NCT00818259|20794139|P4|NOT COMPLETED|Part III||0
8438423|NCT00818259|20794140|P3|NOT COMPLETED|Part III||0
8438424|NCT00818259|20794141|P2|NOT COMPLETED|Part III||0
8438425|NCT00818259|20794142|P1|NOT COMPLETED|Part III||0
8438426|NCT00818259|20794134|P9|COMPLETED|Part III||0
8438427|NCT00818259|20794135|P8|COMPLETED|Part III||0
8438428|NCT00818259|20794136|P7|COMPLETED|Part III||0
8438429|NCT00818259|20794137|P6|COMPLETED|Part III||0
8438430|NCT00818259|20794138|P5|COMPLETED|Part III||19
8438431|NCT00818259|20794139|P4|COMPLETED|Part III||0
8438432|NCT00818259|20794140|P3|COMPLETED|Part III||0
8438433|NCT00818259|20794141|P2|COMPLETED|Part III||0
8438434|NCT00818259|20794142|P1|COMPLETED|Part III||0
8438435|NCT00818259|20794134|P9|STARTED|Part III||0
8438436|NCT00818259|20794135|P8|STARTED|Part III||0
8438437|NCT00818259|20794136|P7|STARTED|Part III||0
8438438|NCT00818259|20794137|P6|STARTED|Part III||0
8438439|NCT00818259|20794138|P5|STARTED|Part III|Newly enrolled participants|19
8438440|NCT00818259|20794139|P4|STARTED|Part III||0
8438441|NCT00818259|20794140|P3|STARTED|Part III||0
8438442|NCT00818259|20794141|P2|STARTED|Part III||0
8438443|NCT00818259|20794142|P1|STARTED|Part III||0
8438444|NCT00818259|20794134|P9|NOT COMPLETED|Part II||0
8438445|NCT00818259|20794135|P8|NOT COMPLETED|Part II||0
8438446|NCT00818259|20794136|P7|NOT COMPLETED|Part II||0
8438447|NCT00818259|20794137|P6|NOT COMPLETED|Part II||0
8438448|NCT00818259|20794138|P5|NOT COMPLETED|Part II||0
8438449|NCT00818259|20794139|P4|NOT COMPLETED|Part II||2
8438450|NCT00818259|20794140|P3|NOT COMPLETED|Part II||1
8438451|NCT00818259|20794141|P2|NOT COMPLETED|Part II||0
8438452|NCT00818259|20794142|P1|NOT COMPLETED|Part II||0
8438453|NCT00818259|20794134|P9|COMPLETED|Part II||0
8438454|NCT00818259|20794135|P8|COMPLETED|Part II||0
8438455|NCT00818259|20794136|P7|COMPLETED|Part II||0
8438456|NCT00818259|20794137|P6|COMPLETED|Part II||0
8438457|NCT00818259|20794138|P5|COMPLETED|Part II||0
8438458|NCT00818259|20794139|P4|COMPLETED|Part II||18
8438459|NCT00818259|20794140|P3|COMPLETED|Part II||18
8438460|NCT00818259|20794141|P2|COMPLETED|Part II||0
8438461|NCT00818259|20794142|P1|COMPLETED|Part II||0
8438462|NCT00818259|20794134|P9|Treated|Part II||0
8438463|NCT00818259|20794135|P8|Treated|Part II||0
8438464|NCT00818259|20794136|P7|Treated|Part II||0
8438465|NCT00818259|20794137|P6|Treated|Part II||0
8438466|NCT00818259|20794138|P5|Treated|Part II||0
8438467|NCT00818259|20794139|P4|Treated|Part II||19
8438468|NCT00818259|20794140|P3|Treated|Part II||19
8438469|NCT00818259|20794141|P2|Treated|Part II||0
8438470|NCT00818259|20794142|P1|Treated|Part II||0
8438471|NCT00818259|20794134|P9|STARTED|Part II||0
8438472|NCT00818259|20794135|P8|STARTED|Part II||0
8438473|NCT00818259|20794136|P7|STARTED|Part II||0
8438474|NCT00818259|20794137|P6|STARTED|Part II||0
8438475|NCT00818259|20794138|P5|STARTED|Part II||0
8438476|NCT00818259|20794139|P4|STARTED|Part II|Newly enrolled participants|20
8438477|NCT00818259|20794140|P3|STARTED|Part II|Newly enrolled participants|19
8438478|NCT00818259|20794141|P2|STARTED|Part II||0
8438479|NCT00818259|20794142|P1|STARTED|Part II||0
8438480|NCT00818259|20794134|P9|NOT COMPLETED|Part I||0
8438481|NCT00818259|20794135|P8|NOT COMPLETED|Part I||0
8438482|NCT00818259|20794136|P7|NOT COMPLETED|Part I||0
8438483|NCT00818259|20794137|P6|NOT COMPLETED|Part I||0
8438484|NCT00818259|20794138|P5|NOT COMPLETED|Part I||0
8438485|NCT00818259|20794139|P4|NOT COMPLETED|Part I||0
8438486|NCT00818259|20794140|P3|NOT COMPLETED|Part I||0
8438487|NCT00818259|20794141|P2|NOT COMPLETED|Part I||0
8438488|NCT00818259|20794142|P1|NOT COMPLETED|Part I||1
8438489|NCT00818259|20794134|P9|COMPLETED|Part I||0
8438490|NCT00818259|20794135|P8|COMPLETED|Part I||0
8438491|NCT00818259|20794136|P7|COMPLETED|Part I||0
8438492|NCT00818259|20794137|P6|COMPLETED|Part I||0
8438493|NCT00818259|20794138|P5|COMPLETED|Part I||0
8438494|NCT00818259|20794139|P4|COMPLETED|Part I||0
8438495|NCT00818259|20794140|P3|COMPLETED|Part I||0
8438496|NCT00818259|20794141|P2|COMPLETED|Part I||11
8438497|NCT00818259|20794142|P1|COMPLETED|Part I||11
8438498|NCT00818259|20794134|P9|STARTED|Part I||0
8438499|NCT00818259|20794135|P8|STARTED|Part I||0
8438500|NCT00818259|20794136|P7|STARTED|Part I||0
8438501|NCT00818259|20794137|P6|STARTED|Part I||0
8438502|NCT00818259|20794138|P5|STARTED|Part I||0
8438503|NCT00818259|20794139|P4|STARTED|Part I||0
8438504|NCT00818259|20794140|P3|STARTED|Part I||0
8438505|NCT00818259|20794141|P2|STARTED|Part I|Newly enrolled participants|11
8438506|NCT00818259|20794142|P1|STARTED|Part I|Newly enrolled participants|12
8438507|NCT00818259|20794134|P9|NOT COMPLETED|Randomization||0
8438508|NCT00818259|20794135|P8|NOT COMPLETED|Randomization||0
8438509|NCT00818259|20794136|P7|NOT COMPLETED|Randomization||0
8438510|NCT00818259|20794137|P6|NOT COMPLETED|Randomization||0
8438511|NCT00818259|20794138|P5|NOT COMPLETED|Randomization||0
8438512|NCT00818259|20794139|P4|NOT COMPLETED|Randomization||0
8438513|NCT00818259|20794140|P3|NOT COMPLETED|Randomization||0
8438514|NCT00818259|20794141|P2|NOT COMPLETED|Randomization||0
8438515|NCT00818259|20794142|P1|NOT COMPLETED|Randomization||0
8438516|NCT00818259|20794134|P9|COMPLETED|Randomization||6
8438517|NCT00818259|20794135|P8|COMPLETED|Randomization||0
8438518|NCT00818259|20794136|P7|COMPLETED|Randomization||5
8438519|NCT00818259|20794137|P6|COMPLETED|Randomization||0
8438520|NCT00818259|20794138|P5|COMPLETED|Randomization||19
8438521|NCT00818259|20794139|P4|COMPLETED|Randomization||20
8438522|NCT00818259|20794140|P3|COMPLETED|Randomization||19
8438523|NCT00818259|20794141|P2|COMPLETED|Randomization||11
8438524|NCT00818259|20794142|P1|COMPLETED|Randomization||12
8438525|NCT00818259|20794134|P9|STARTED|Randomization||6
8438526|NCT00818259|20794135|P8|STARTED|Randomization||0
8438527|NCT00818259|20794136|P7|STARTED|Randomization||5
8438528|NCT00818259|20794137|P6|STARTED|Randomization||0
8438529|NCT00818259|20794138|P5|STARTED|Randomization||19
8438530|NCT00818259|20794139|P4|STARTED|Randomization||20
8438531|NCT00818259|20794140|P3|STARTED|Randomization||19
8438532|NCT00818259|20794141|P2|STARTED|Randomization||11
8438533|NCT00818259|20794142|P1|STARTED|Randomization||12
8438534|NCT00818246|20794214|P1|NOT COMPLETED|Overall Study||5
8438535|NCT00818246|20794214|P1|COMPLETED|Overall Study|split-face study|35
8438536|NCT00818246|20794214|P1|STARTED|Overall Study||40
8438537|NCT00818207|20794223|P2|NOT COMPLETED|Overall Study||267
8438538|NCT00818207|20794224|P1|NOT COMPLETED|Overall Study||222
8438539|NCT00818207|20794223|P2|COMPLETED|Overall Study||417
8438540|NCT00818207|20794224|P1|COMPLETED|Overall Study||474
8438541|NCT00818207|20794223|P2|STARTED|Overall Study||684
8438542|NCT00818207|20794224|P1|STARTED|Overall Study||696
8438543|NCT00818168|20794238|P1|NOT COMPLETED|Overall Study||70
8438544|NCT00818168|20794238|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
8438545|NCT00818168|20794238|P1|STARTED|Overall Study||320
8438546|NCT00818116|20794246|P1|NOT COMPLETED|Overall Study||0
8438547|NCT00818116|20794246|P1|COMPLETED|Overall Study||34
8438548|NCT00818116|20794246|P1|STARTED|Overall Study||34
8438549|NCT00817999|20794252|P2|NOT COMPLETED|No Grapefruit Juice||0
8438550|NCT00817999|20794253|P1|NOT COMPLETED|No Grapefruit Juice||0
8438551|NCT00817999|20794252|P2|COMPLETED|No Grapefruit Juice||17
8438552|NCT00817999|20794253|P1|COMPLETED|No Grapefruit Juice||15
8438553|NCT00817999|20794252|P2|STARTED|No Grapefruit Juice||17
8438554|NCT00817999|20794253|P1|STARTED|No Grapefruit Juice||15
8438555|NCT00817999|20794252|P2|NOT COMPLETED|Grapefruit Juice||0
8438556|NCT00817999|20794253|P1|NOT COMPLETED|Grapefruit Juice||0
8438557|NCT00817999|20794252|P2|COMPLETED|Grapefruit Juice||17
8438558|NCT00817999|20794253|P1|COMPLETED|Grapefruit Juice||15
8438559|NCT00817999|20794252|P2|STARTED|Grapefruit Juice||17
8438560|NCT00817999|20794253|P1|STARTED|Grapefruit Juice||15
8438561|NCT00817843|20794261|P2|NOT COMPLETED|Second Period (6 Weeks)||1
8438562|NCT00817843|20794262|P1|NOT COMPLETED|Second Period (6 Weeks)||0
8438563|NCT00817843|20794261|P2|COMPLETED|Second Period (6 Weeks)||44
8438564|NCT00817843|20794262|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
8438565|NCT00817843|20794261|P2|STARTED|Second Period (6 Weeks)||45
8438566|NCT00817843|20794262|P1|STARTED|Second Period (6 Weeks)||41
8438567|NCT00817843|20794261|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
8438568|NCT00817843|20794262|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
8438569|NCT00817843|20794261|P2|COMPLETED|Washout Period (6 Weeks)||45
8438570|NCT00817843|20794262|P1|COMPLETED|Washout Period (6 Weeks)||41
8438571|NCT00817843|20794261|P2|STARTED|Washout Period (6 Weeks)||46
8438572|NCT00817843|20794262|P1|STARTED|Washout Period (6 Weeks)||42
8438573|NCT00817843|20794261|P2|NOT COMPLETED|First Period (6 Weeks)||4
8438574|NCT00817843|20794262|P1|NOT COMPLETED|First Period (6 Weeks)||8
8438575|NCT00817843|20794261|P2|COMPLETED|First Period (6 Weeks)||46
8438576|NCT00817843|20794262|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
8438577|NCT00817843|20794261|P2|STARTED|First Period (6 Weeks)||50
8438578|NCT00817843|20794262|P1|STARTED|First Period (6 Weeks)||50
8438579|NCT00817804|20794269|P2|NOT COMPLETED|Overall Study||0
8438580|NCT00817804|20794270|P1|NOT COMPLETED|Overall Study||0
8438581|NCT00817804|20794269|P2|COMPLETED|Overall Study||2
8438582|NCT00817804|20794270|P1|COMPLETED|Overall Study||1
8438583|NCT00817804|20794269|P2|STARTED|Overall Study||2
8438584|NCT00817804|20794270|P1|STARTED|Overall Study||1
8438585|NCT00817778|20794278|P2|NOT COMPLETED|Overall Study||3
8438586|NCT00817778|20794279|P1|NOT COMPLETED|Overall Study||3
8438587|NCT00817778|20794278|P2|COMPLETED|Overall Study||5
8438588|NCT00817778|20794279|P1|COMPLETED|Overall Study||16
8438589|NCT00817778|20794278|P2|STARTED|Overall Study||8
8438590|NCT00817778|20794279|P1|STARTED|Overall Study||19
8438591|NCT00817596|20794304|P1|NOT COMPLETED|Overall Study||48
8438592|NCT00817596|20794304|P1|COMPLETED|Overall Study||62
8438593|NCT00817596|20794304|P1|STARTED|Overall Study||110
8438594|NCT00817531|20794308|P1|NOT COMPLETED|Overall Study||2
8438595|NCT00817531|20794308|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
8438596|NCT00817531|20794308|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
8438597|NCT00817479|20794314|P2|NOT COMPLETED|Overall Study||1
8438598|NCT00817479|20794315|P1|NOT COMPLETED|Overall Study||1
8438599|NCT00817479|20794314|P2|COMPLETED|Overall Study||13
8438600|NCT00817479|20794315|P1|COMPLETED|Overall Study||5
8438601|NCT00817479|20794314|P2|STARTED|Overall Study||14
8438602|NCT00817479|20794315|P1|STARTED|Overall Study||6
8438603|NCT00817336|20794325|P2|NOT COMPLETED|Overall Study||1
8438604|NCT00817336|20794326|P1|NOT COMPLETED|Overall Study||1
8438605|NCT00817336|20794325|P2|COMPLETED|Overall Study||7
8438606|NCT00817336|20794326|P1|COMPLETED|Overall Study||7
8438607|NCT00817336|20794325|P2|STARTED|Overall Study||8
8438608|NCT00817336|20794326|P1|STARTED|Overall Study||8
8438609|NCT00817219|20794337|P1|NOT COMPLETED|Overall Study||0
8438610|NCT00817219|20794337|P1|COMPLETED|Overall Study||33
8438611|NCT00817219|20794337|P1|STARTED|Overall Study||33
8438612|NCT00817206|20794352|P2|NOT COMPLETED|Overall Study||9
8438613|NCT00817206|20794353|P1|NOT COMPLETED|Overall Study||21
8438614|NCT00817206|20794352|P2|COMPLETED|Overall Study||154
8438615|NCT00817206|20794353|P1|COMPLETED|Overall Study||142
8438616|NCT00817206|20794352|P2|STARTED|Overall Study||163
8438617|NCT00817206|20794353|P1|STARTED|Overall Study||163
8438618|NCT00817089|20794363|P4|NOT COMPLETED|Second Alcohol Challenge||0
8438619|NCT00817089|20794364|P3|NOT COMPLETED|Second Alcohol Challenge||0
8438620|NCT00817089|20794365|P2|NOT COMPLETED|Second Alcohol Challenge||1
8438621|NCT00817089|20794366|P1|NOT COMPLETED|Second Alcohol Challenge||0
8438622|NCT00817089|20794363|P4|COMPLETED|Second Alcohol Challenge||5
8438623|NCT00817089|20794364|P3|COMPLETED|Second Alcohol Challenge||4
8438624|NCT00817089|20794365|P2|COMPLETED|Second Alcohol Challenge||7
8438625|NCT00817089|20794366|P1|COMPLETED|Second Alcohol Challenge||6
8438626|NCT00817089|20794363|P4|STARTED|Second Alcohol Challenge||5
8438627|NCT00817089|20794364|P3|STARTED|Second Alcohol Challenge||4
8438628|NCT00817089|20794365|P2|STARTED|Second Alcohol Challenge||8
8438629|NCT00817089|20794366|P1|STARTED|Second Alcohol Challenge||6
8438630|NCT00817089|20794363|P4|NOT COMPLETED|First Alcohol Challenge||1
8438631|NCT00817089|20794364|P3|NOT COMPLETED|First Alcohol Challenge||0
8438632|NCT00817089|20794365|P2|NOT COMPLETED|First Alcohol Challenge||0
8438633|NCT00817089|20794366|P1|NOT COMPLETED|First Alcohol Challenge||0
8438634|NCT00817089|20794363|P4|COMPLETED|First Alcohol Challenge||5
8438635|NCT00817089|20794364|P3|COMPLETED|First Alcohol Challenge||4
8438636|NCT00817089|20794365|P2|COMPLETED|First Alcohol Challenge||8
8438637|NCT00817089|20794366|P1|COMPLETED|First Alcohol Challenge||6
8438638|NCT00817089|20794363|P4|STARTED|First Alcohol Challenge||6
8438639|NCT00817089|20794364|P3|STARTED|First Alcohol Challenge||4
8438640|NCT00817089|20794365|P2|STARTED|First Alcohol Challenge||8
8438641|NCT00817089|20794366|P1|STARTED|First Alcohol Challenge||6
8438642|NCT00817063|20794382|P2|NOT COMPLETED|Overall Study||170
8438643|NCT00817063|20794383|P1|NOT COMPLETED|Overall Study||137
8438644|NCT00817063|20794382|P2|COMPLETED|Overall Study||128
8438645|NCT00817063|20794383|P1|COMPLETED|Overall Study||161
8438646|NCT00817063|20794382|P2|STARTED|Overall Study||298
8438647|NCT00817063|20794383|P1|STARTED|Overall Study||298
8438648|NCT00816907|20794427|P2|NOT COMPLETED|Overall Study||17
8438649|NCT00816907|20794428|P1|NOT COMPLETED|Overall Study||13
8438650|NCT00816907|20794427|P2|COMPLETED|Overall Study||58
8438651|NCT00816907|20794428|P1|COMPLETED|Overall Study||58
8438652|NCT00816907|20794427|P2|STARTED|Overall Study||75
8438653|NCT00816907|20794428|P1|STARTED|Overall Study||71
8438654|NCT00816829|20794450|P2|NOT COMPLETED|Overall Study||0
8438655|NCT00816829|20794451|P1|NOT COMPLETED|Overall Study||0
8438656|NCT00816829|20794450|P2|COMPLETED|Overall Study||18
8438657|NCT00816829|20794451|P1|COMPLETED|Overall Study||16
8438658|NCT00816829|20794450|P2|STARTED|Overall Study||18
8438659|NCT00816829|20794451|P1|STARTED|Overall Study||16
8438660|NCT00816777|20794477|P2|NOT COMPLETED|Overall Study||0
8438661|NCT00816777|20794478|P1|NOT COMPLETED|Overall Study||0
8438662|NCT00816777|20794477|P2|COMPLETED|Overall Study||2
8438663|NCT00816777|20794478|P1|COMPLETED|Overall Study||2
8438664|NCT00816777|20794477|P2|STARTED|Overall Study||2
8438665|NCT00816777|20794478|P1|STARTED|Overall Study||2
8438666|NCT00816751|20794500|P2|NOT COMPLETED|Overall Study||0
8438667|NCT00816751|20794501|P1|NOT COMPLETED|Overall Study||0
8438668|NCT00816751|20794500|P2|COMPLETED|Overall Study||44
8438669|NCT00816751|20794501|P1|COMPLETED|Overall Study||45
8438670|NCT00816751|20794500|P2|STARTED|Overall Study||44
8438671|NCT00816751|20794501|P1|STARTED|Overall Study||45
8438672|NCT00816595|20794511|P2|NOT COMPLETED|Overall Study||0
8438673|NCT00816595|20794512|P1|NOT COMPLETED|Overall Study||2
8438674|NCT00816595|20794511|P2|COMPLETED|Overall Study||33
8438675|NCT00816595|20794512|P1|COMPLETED|Overall Study||33
8438676|NCT00816595|20794511|P2|STARTED|Overall Study||33
8438677|NCT00816595|20794512|P1|STARTED|Overall Study||35
8438678|NCT00816556|20794525|P3|NOT COMPLETED|Overall Study||3
8438679|NCT00816556|20794526|P2|NOT COMPLETED|Overall Study||2
8438680|NCT00816556|20794527|P1|NOT COMPLETED|Overall Study||2
8438681|NCT00816556|20794525|P3|COMPLETED|Overall Study||19
8438682|NCT00816556|20794526|P2|COMPLETED|Overall Study||19
8438683|NCT00816556|20794527|P1|COMPLETED|Overall Study||18
8438684|NCT00816556|20794525|P3|STARTED|Overall Study||22
8438685|NCT00816556|20794526|P2|STARTED|Overall Study||21
8438686|NCT00816556|20794527|P1|STARTED|Overall Study||20
8438687|NCT00816400|20794550|P9|NOT COMPLETED|Overall Study||6
8438688|NCT00816400|20794551|P8|NOT COMPLETED|Overall Study||5
8438689|NCT00816400|20794552|P7|NOT COMPLETED|Overall Study||2
8438690|NCT00816400|20794553|P6|NOT COMPLETED|Overall Study||3
8438691|NCT00816400|20794554|P5|NOT COMPLETED|Overall Study||2
8438692|NCT00816400|20794555|P4|NOT COMPLETED|Overall Study||3
8438693|NCT00816400|20794556|P3|NOT COMPLETED|Overall Study||5
8438694|NCT00816400|20794557|P2|NOT COMPLETED|Overall Study||3
8438695|NCT00816400|20794558|P1|NOT COMPLETED|Overall Study||2
8438696|NCT00816400|20794550|P9|COMPLETED|Overall Study||0
8438697|NCT00816400|20794551|P8|COMPLETED|Overall Study||1
8438698|NCT00816400|20794552|P7|COMPLETED|Overall Study||1
8438699|NCT00816400|20794553|P6|COMPLETED|Overall Study||0
8438700|NCT00816400|20794554|P5|COMPLETED|Overall Study||1
8438701|NCT00816400|20794555|P4|COMPLETED|Overall Study||0
8438702|NCT00816400|20794556|P3|COMPLETED|Overall Study||0
8438703|NCT00816400|20794557|P2|COMPLETED|Overall Study||0
8438704|NCT00816400|20794558|P1|COMPLETED|Overall Study||1
8438705|NCT00816400|20794550|P9|STARTED|Overall Study||6
8438706|NCT00816400|20794551|P8|STARTED|Overall Study||6
8438707|NCT00816400|20794552|P7|STARTED|Overall Study||3
8438708|NCT00816400|20794553|P6|STARTED|Overall Study||3
8438709|NCT00816400|20794554|P5|STARTED|Overall Study||3
8438710|NCT00816400|20794555|P4|STARTED|Overall Study||3
8438711|NCT00816400|20794556|P3|STARTED|Overall Study||5
8438712|NCT00816400|20794557|P2|STARTED|Overall Study||3
8438713|NCT00816400|20794558|P1|STARTED|Overall Study||3
8438714|NCT00816361|20794749|P9|NOT COMPLETED|Overall Study||10
8438715|NCT00816361|20794750|P8|NOT COMPLETED|Overall Study||9
8438716|NCT00816361|20794751|P7|NOT COMPLETED|Overall Study||3
8438717|NCT00816361|20794752|P6|NOT COMPLETED|Overall Study||3
8438718|NCT00816361|20794753|P5|NOT COMPLETED|Overall Study||2
8438719|NCT00816361|20794754|P4|NOT COMPLETED|Overall Study||3
8438720|NCT00816361|20794755|P3|NOT COMPLETED|Overall Study||3
8438721|NCT00816361|20794756|P2|NOT COMPLETED|Overall Study||3
8438722|NCT00816361|20794757|P1|NOT COMPLETED|Overall Study||4
8438723|NCT00816361|20794749|P9|COMPLETED|Overall Study||0
8438724|NCT00816361|20794750|P8|COMPLETED|Overall Study||1
8438725|NCT00816361|20794751|P7|COMPLETED|Overall Study||0
8438726|NCT00816361|20794752|P6|COMPLETED|Overall Study||0
8438727|NCT00816361|20794753|P5|COMPLETED|Overall Study||1
8438728|NCT00816361|20794754|P4|COMPLETED|Overall Study||0
8438729|NCT00816361|20794755|P3|COMPLETED|Overall Study||1
8438730|NCT00816361|20794756|P2|COMPLETED|Overall Study||0
8438731|NCT00816361|20794757|P1|COMPLETED|Overall Study||0
8438732|NCT00816361|20794749|P9|STARTED|Overall Study||10
8438733|NCT00816361|20794750|P8|STARTED|Overall Study||10
8438734|NCT00816361|20794751|P7|STARTED|Overall Study||3
8438735|NCT00816361|20794752|P6|STARTED|Overall Study||3
8438736|NCT00816361|20794753|P5|STARTED|Overall Study||3
8438737|NCT00816361|20794754|P4|STARTED|Overall Study||3
8438738|NCT00816361|20794755|P3|STARTED|Overall Study||4
8438739|NCT00816361|20794756|P2|STARTED|Overall Study||3
8438740|NCT00816361|20794757|P1|STARTED|Overall Study||4
8438741|NCT00816348|20794910|P1|NOT COMPLETED|Overall Study||0
8438742|NCT00816348|20794910|P1|COMPLETED|Overall Study||15
8438743|NCT00816348|20794910|P1|STARTED|Overall Study||15
8438744|NCT00816166|20794916|P2|NOT COMPLETED|Overall Study||12
8438745|NCT00816166|20794917|P1|NOT COMPLETED|Overall Study||10
8438746|NCT00816166|20794916|P2|COMPLETED|Overall Study||41
8438747|NCT00816166|20794917|P1|COMPLETED|Overall Study||49
8438748|NCT00816166|20794916|P2|ITT Population (Met Eligibility)|Overall Study||53
8438749|NCT00816166|20794917|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
8438750|NCT00816166|20794916|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
8438751|NCT00816166|20794917|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
8438752|NCT00816101|20794926|P3|NOT COMPLETED|Overall Study||0
8438753|NCT00816101|20794927|P2|NOT COMPLETED|Overall Study||0
8438754|NCT00816101|20794928|P1|NOT COMPLETED|Overall Study||0
8438755|NCT00816101|20794926|P3|COMPLETED|Overall Study||5
8438756|NCT00816101|20794927|P2|COMPLETED|Overall Study||8
8438757|NCT00816101|20794928|P1|COMPLETED|Overall Study||13
8438758|NCT00816101|20794926|P3|STARTED|Overall Study||5
8438759|NCT00816101|20794927|P2|STARTED|Overall Study||8
8438760|NCT00816101|20794928|P1|STARTED|Overall Study||13
8438761|NCT00816062|20794942|P1|NOT COMPLETED|Overall Study||127
8438762|NCT00816062|20794942|P1|COMPLETED|Overall Study||133
8438763|NCT00816062|20794942|P1|STARTED|Overall Study||260
8438764|NCT00816036|20794949|P2|NOT COMPLETED|Overall Study||108
8438765|NCT00816036|20794950|P1|NOT COMPLETED|Overall Study||176
8438766|NCT00816036|20794949|P2|COMPLETED|Overall Study||287
8438767|NCT00816036|20794950|P1|COMPLETED|Overall Study||327
8438768|NCT00816036|20794949|P2|STARTED|Overall Study||395
8438769|NCT00816036|20794950|P1|STARTED|Overall Study||503
8438770|NCT00816023|20794964|P4|NOT COMPLETED|Overall Study||12
8438771|NCT00816023|20794965|P3|NOT COMPLETED|Overall Study||9
8438772|NCT00816023|20794966|P2|NOT COMPLETED|Overall Study||6
8438773|NCT00816023|20794967|P1|NOT COMPLETED|Overall Study||9
8438774|NCT00816023|20794964|P4|COMPLETED|Overall Study||62
8438775|NCT00816023|20794965|P3|COMPLETED|Overall Study||60
8438776|NCT00816023|20794966|P2|COMPLETED|Overall Study||56
8438777|NCT00816023|20794967|P1|COMPLETED|Overall Study||62
8438778|NCT00816023|20794964|P4|Completed Therapy|Overall Study||63
8438779|NCT00816023|20794965|P3|Completed Therapy|Overall Study||61
8438780|NCT00816023|20794966|P2|Completed Therapy|Overall Study||59
8438781|NCT00816023|20794967|P1|Completed Therapy|Overall Study||65
8438782|NCT00816023|20794964|P4|STARTED|Overall Study||74
8438783|NCT00816023|20794965|P3|STARTED|Overall Study||69
8438784|NCT00816023|20794966|P2|STARTED|Overall Study||62
8438785|NCT00816023|20794967|P1|STARTED|Overall Study||71
8438786|NCT00815997|20794983|P2|NOT COMPLETED|Overall Study||0
8438787|NCT00815997|20794984|P1|NOT COMPLETED|Overall Study||0
8438788|NCT00815997|20794983|P2|COMPLETED|Overall Study||80
8438789|NCT00815997|20794984|P1|COMPLETED|Overall Study||80
8438790|NCT00815997|20794983|P2|STARTED|Overall Study||80
8438791|NCT00815997|20794984|P1|STARTED|Overall Study||80
8438792|NCT00815919|20795004|P1|NOT COMPLETED|Overall Study||4
8438793|NCT00815919|20795004|P1|COMPLETED|Overall Study||18
8438794|NCT00815919|20795004|P1|STARTED|Overall Study||22
8438795|NCT00815776|20795015|P3|NOT COMPLETED|Overall Study||6
8438796|NCT00815776|20795016|P2|NOT COMPLETED|Overall Study||8
8438797|NCT00815776|20795017|P1|NOT COMPLETED|Overall Study||8
8438798|NCT00815776|20795015|P3|COMPLETED|Overall Study||22
8438799|NCT00815776|20795016|P2|COMPLETED|Overall Study||56
8438800|NCT00815776|20795017|P1|COMPLETED|Overall Study||52
8438801|NCT00815776|20795015|P3|STARTED|Overall Study||28
8438802|NCT00815776|20795016|P2|STARTED|Overall Study||64
8438803|NCT00815776|20795017|P1|STARTED|Overall Study||60
8438804|NCT00815698|20795033|P2|NOT COMPLETED|Overall Study||0
8438805|NCT00815698|20795034|P1|NOT COMPLETED|Overall Study||0
8438806|NCT00815698|20795033|P2|COMPLETED|Overall Study||171
8438807|NCT00815698|20795034|P1|COMPLETED|Overall Study||163
8438808|NCT00815698|20795033|P2|STARTED|Overall Study||171
8438809|NCT00815698|20795034|P1|STARTED|Overall Study||163
8438810|NCT00815685|20795042|P1|NOT COMPLETED|Overall Study||22
8438811|NCT00815685|20795042|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
8438812|NCT00815685|20795042|P1|STARTED|Overall Study||36
8438813|NCT00815659|20795047|P1|NOT COMPLETED|Overall Study||23
8438814|NCT00815659|20795047|P1|COMPLETED|Overall Study||74
8438815|NCT00815659|20795047|P1|STARTED|Overall Study||97
8438816|NCT00815633|20795090|P1|NOT COMPLETED|Overall Study||1
8438817|NCT00815633|20795090|P1|COMPLETED|Overall Study||0
8438818|NCT00815633|20795090|P1|STARTED|Overall Study||1
8438819|NCT00815516|20795097|P2|NOT COMPLETED|Overall Study||1
8438820|NCT00815516|20795098|P1|NOT COMPLETED|Overall Study||4
8438821|NCT00815516|20795097|P2|COMPLETED|Overall Study||9
8438822|NCT00815516|20795098|P1|COMPLETED|Overall Study||16
8438823|NCT00815516|20795097|P2|STARTED|Overall Study||10
8438824|NCT00815516|20795098|P1|STARTED|Overall Study||20
8438825|NCT00815490|20795129|P2|NOT COMPLETED|Overall Study||0
8438826|NCT00815490|20795130|P1|NOT COMPLETED|Overall Study||0
8438827|NCT00815490|20795129|P2|COMPLETED|Overall Study||9
8438828|NCT00815490|20795130|P1|COMPLETED|Overall Study||9
8438829|NCT00815490|20795129|P2|STARTED|Overall Study||9
8438830|NCT00815490|20795130|P1|STARTED|Overall Study||9
8438831|NCT00815360|20795138|P2|NOT COMPLETED|Overall Study||0
8438832|NCT00815360|20795139|P1|NOT COMPLETED|Overall Study||0
8438833|NCT00815360|20795138|P2|COMPLETED|Overall Study||11
8438834|NCT00815360|20795139|P1|COMPLETED|Overall Study||11
8438835|NCT00815360|20795138|P2|STARTED|Overall Study||11
8438836|NCT00815360|20795139|P1|STARTED|Overall Study||11
8438837|NCT00815347|20795147|P1|NOT COMPLETED|Overall Study||4
8438838|NCT00815347|20795147|P1|COMPLETED|Overall Study||7
8438839|NCT00815347|20795147|P1|STARTED|Overall Study||11
8438840|NCT00815308|20795163|P1|NOT COMPLETED|Overall Study||10
8438841|NCT00815308|20795163|P1|COMPLETED|Overall Study||45
8438842|NCT00815308|20795163|P1|STARTED|Overall Study||55
8438843|NCT00815295|20795172|P3|NOT COMPLETED|Overall Study||3
8438844|NCT00815295|20795173|P2|NOT COMPLETED|Overall Study||1
8438845|NCT00815295|20795174|P1|NOT COMPLETED|Overall Study||0
8438846|NCT00815295|20795172|P3|COMPLETED|Overall Study||9
8438847|NCT00815295|20795173|P2|COMPLETED|Overall Study||7
8438848|NCT00815295|20795174|P1|COMPLETED|Overall Study||8
8438849|NCT00815295|20795172|P3|STARTED|Overall Study||12
8438850|NCT00815295|20795173|P2|STARTED|Overall Study||8
8438851|NCT00815295|20795174|P1|STARTED|Overall Study||8
8438852|NCT00815191|20795186|P2|NOT COMPLETED|Overall Study||1
8438853|NCT00815191|20795187|P1|NOT COMPLETED|Overall Study||1
8438854|NCT00815191|20795186|P2|COMPLETED|Overall Study||34
8438855|NCT00815191|20795187|P1|COMPLETED|Overall Study||37
8438856|NCT00815191|20795186|P2|STARTED|Overall Study||35
8438857|NCT00815191|20795187|P1|STARTED|Overall Study||38
8438858|NCT00815087|20795195|P2|NOT COMPLETED|Overall Study||0
8438859|NCT00815087|20795196|P1|NOT COMPLETED|Overall Study||0
8438860|NCT00815087|20795195|P2|COMPLETED|Overall Study||10
8438861|NCT00815087|20795196|P1|COMPLETED|Overall Study||10
8438862|NCT00815087|20795195|P2|STARTED|Overall Study||10
8438863|NCT00815087|20795196|P1|STARTED|Overall Study||10
8438864|NCT00815035|20795204|P3|NOT COMPLETED|Open Label Extension Phase||6
8438865|NCT00815035|20795205|P2|NOT COMPLETED|Open Label Extension Phase||0
8438866|NCT00815035|20795206|P1|NOT COMPLETED|Open Label Extension Phase||0
8438867|NCT00815035|20795204|P3|COMPLETED|Open Label Extension Phase||9
8438868|NCT00815035|20795205|P2|COMPLETED|Open Label Extension Phase||0
8438869|NCT00815035|20795206|P1|COMPLETED|Open Label Extension Phase||0
8438870|NCT00815035|20795204|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
8438871|NCT00815035|20795205|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
8438872|NCT00815035|20795206|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
8438873|NCT00815035|20795204|P3|NOT COMPLETED|Blinded Phase||0
8438874|NCT00815035|20795205|P2|NOT COMPLETED|Blinded Phase||0
8438875|NCT00815035|20795206|P1|NOT COMPLETED|Blinded Phase||1
8438876|NCT00815035|20795204|P3|COMPLETED|Blinded Phase||0
8438877|NCT00815035|20795205|P2|COMPLETED|Blinded Phase||6
8438878|NCT00815035|20795206|P1|COMPLETED|Blinded Phase||9
8438879|NCT00815035|20795204|P3|STARTED|Blinded Phase||0
8438880|NCT00815035|20795205|P2|STARTED|Blinded Phase||6
8438881|NCT00815035|20795206|P1|STARTED|Blinded Phase||10
8438882|NCT00814983|20795224|P2|NOT COMPLETED|Overall Study||0
8438883|NCT00814983|20795225|P1|NOT COMPLETED|Overall Study||3
8438884|NCT00814983|20795224|P2|COMPLETED|Overall Study||0
8438885|NCT00814983|20795225|P1|COMPLETED|Overall Study||12
8438886|NCT00814983|20795224|P2|STARTED|Overall Study||0
8438887|NCT00814983|20795225|P1|STARTED|Overall Study||15
8438888|NCT00814970|20795235|P1|NOT COMPLETED|Overall Study||50
8438889|NCT00814970|20795235|P1|COMPLETED|Overall Study||146
8438890|NCT00814970|20795235|P1|STARTED|Overall Study||196
8438891|NCT00814892|20795256|P1|NOT COMPLETED|Overall Study||2
8438892|NCT00814892|20795256|P1|COMPLETED|Overall Study||0
8438893|NCT00814892|20795256|P1|STARTED|Overall Study||2
8438894|NCT00814879|20795268|P2|NOT COMPLETED|By Week 48||3
8438895|NCT00814879|20795269|P1|NOT COMPLETED|By Week 48||2
8438896|NCT00814879|20795268|P2|COMPLETED|By Week 48||26
8438897|NCT00814879|20795269|P1|COMPLETED|By Week 48||25
8438898|NCT00814879|20795268|P2|STARTED|By Week 48||29
8438899|NCT00814879|20795269|P1|STARTED|By Week 48||27
8438900|NCT00814879|20795268|P2|NOT COMPLETED|By Week 24||1
8438901|NCT00814879|20795269|P1|NOT COMPLETED|By Week 24||1
8438902|NCT00814879|20795268|P2|COMPLETED|By Week 24||29
8438903|NCT00814879|20795269|P1|COMPLETED|By Week 24||27
8438904|NCT00814879|20795268|P2|STARTED|By Week 24||30
8438905|NCT00814879|20795269|P1|STARTED|By Week 24||28
8438906|NCT00814801|20795288|P3|NOT COMPLETED|Overall Study||43
8438907|NCT00814801|20795289|P2|NOT COMPLETED|Overall Study||38
8438908|NCT00814801|20795290|P1|NOT COMPLETED|Overall Study||34
8438909|NCT00814801|20795288|P3|COMPLETED|Overall Study||151
8438910|NCT00814801|20795289|P2|COMPLETED|Overall Study||154
8438911|NCT00814801|20795290|P1|COMPLETED|Overall Study||160
8438912|NCT00814801|20795288|P3|STARTED|Overall Study||194
8438913|NCT00814801|20795289|P2|STARTED|Overall Study||192
8438914|NCT00814801|20795290|P1|STARTED|Overall Study||194
8438915|NCT00814788|20795310|P1|NOT COMPLETED|Overall Study||0
8438916|NCT00814788|20795310|P1|COMPLETED|Overall Study||24
8438917|NCT00814788|20795310|P1|STARTED|Overall Study||24
8438918|NCT00814775|20795318|P2|NOT COMPLETED|Overall Study||0
8438919|NCT00814775|20795319|P1|NOT COMPLETED|Overall Study||0
8438920|NCT00814775|20795318|P2|COMPLETED|Overall Study||20
8438921|NCT00814775|20795319|P1|COMPLETED|Overall Study||23
8438922|NCT00814775|20795318|P2|STARTED|Overall Study||20
8438923|NCT00814775|20795319|P1|STARTED|Overall Study||23
8438924|NCT00814710|20795329|P2|NOT COMPLETED|Overall Study||3
8438925|NCT00814710|20795330|P1|NOT COMPLETED|Overall Study||8
8438926|NCT00814710|20795329|P2|COMPLETED|Overall Study||117
8438927|NCT00814710|20795330|P1|COMPLETED|Overall Study||232
8438928|NCT00814710|20795329|P2|STARTED|Overall Study||120
8438929|NCT00814710|20795330|P1|STARTED|Overall Study||240
8438930|NCT00814697|20795368|P1|NOT COMPLETED|Overall Study||0
8438931|NCT00814697|20795368|P1|COMPLETED|Overall Study||12
8438932|NCT00814697|20795368|P1|STARTED|Overall Study||12
8438933|NCT00814671|20795375|P3|NOT COMPLETED|Overall Study||2
8438934|NCT00814671|20795376|P2|NOT COMPLETED|Overall Study||4
8438935|NCT00814671|20795377|P1|NOT COMPLETED|Overall Study||7
8438936|NCT00814671|20795375|P3|COMPLETED|Overall Study||49
8438937|NCT00814671|20795376|P2|COMPLETED|Overall Study||44
8438938|NCT00814671|20795377|P1|COMPLETED|Overall Study||47
8438939|NCT00814671|20795375|P3|STARTED|Overall Study||51
8438940|NCT00814671|20795376|P2|STARTED|Overall Study||48
8438941|NCT00814671|20795377|P1|STARTED|Overall Study||54
8438942|NCT00814658|20795398|P2|NOT COMPLETED|Overall Study||4
8438943|NCT00814658|20795399|P1|NOT COMPLETED|Overall Study||4
8438944|NCT00814658|20795398|P2|COMPLETED|Overall Study||8
8438945|NCT00814658|20795399|P1|COMPLETED|Overall Study||5
8438946|NCT00814658|20795398|P2|STARTED|Overall Study||12
8438947|NCT00814658|20795399|P1|STARTED|Overall Study||9
8438948|NCT00814632|20795465|P1|NOT COMPLETED|Overall Study||2
8438949|NCT00814632|20795465|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
8438950|NCT00814632|20795465|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
8438951|NCT00814580|20795471|P2|NOT COMPLETED|Overall Study||47
8438952|NCT00814580|20795472|P1|NOT COMPLETED|Overall Study||31
8438953|NCT00814580|20795471|P2|COMPLETED|Overall Study||141
8438954|NCT00814580|20795472|P1|COMPLETED|Overall Study||163
8438955|NCT00814580|20795471|P2|STARTED|Overall Study||188
8438956|NCT00814580|20795472|P1|STARTED|Overall Study||194
8438957|NCT00814502|20795602|P2|NOT COMPLETED|Overall Study||2
8438958|NCT00814502|20795603|P1|NOT COMPLETED|Overall Study||1
8438959|NCT00814502|20795602|P2|COMPLETED|Overall Study||7
8438960|NCT00814502|20795603|P1|COMPLETED|Overall Study||7
8438961|NCT00814502|20795602|P2|STARTED|Overall Study||9
8438962|NCT00814502|20795603|P1|STARTED|Overall Study||8
8438963|NCT00814489|20795616|P3|NOT COMPLETED|Overall Study||1
8438964|NCT00814489|20795617|P2|NOT COMPLETED|Overall Study||0
8438965|NCT00814489|20795618|P1|NOT COMPLETED|Overall Study||2
8438966|NCT00814489|20795616|P3|COMPLETED|Overall Study||7
8438967|NCT00814489|20795617|P2|COMPLETED|Overall Study||17
8438968|NCT00814489|20795618|P1|COMPLETED|Overall Study||13
8438969|NCT00814489|20795616|P3|STARTED|Overall Study||8
8438970|NCT00814489|20795617|P2|STARTED|Overall Study||17
8438971|NCT00814489|20795618|P1|STARTED|Overall Study||15
8438972|NCT00814463|20795650|P1|NOT COMPLETED|Overall Study||1
8438973|NCT00814463|20795650|P1|COMPLETED|Overall Study||0
8438974|NCT00814463|20795650|P1|STARTED|Overall Study||1
8438975|NCT00814346|20795663|P2|NOT COMPLETED|Open Phase (17 Months)||0
8438976|NCT00814346|20795664|P1|NOT COMPLETED|Open Phase (17 Months)||10
8438977|NCT00814346|20795663|P2|COMPLETED|Open Phase (17 Months)||0
8438978|NCT00814346|20795664|P1|COMPLETED|Open Phase (17 Months)||31
8438979|NCT00814346|20795663|P2|AD|Open Phase (17 Months)||0
8438980|NCT00814346|20795664|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
8438981|NCT00814346|20795663|P2|MC|Open Phase (17 Months)||0
8438982|NCT00814346|20795664|P1|MC|Open Phase (17 Months)||20
8438983|NCT00814346|20795663|P2|CNE|Open Phase (17 Months)||0
8438984|NCT00814346|20795664|P1|CNE|Open Phase (17 Months)||21
8438985|NCT00814346|20795663|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
8438986|NCT00814346|20795664|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
8438987|NCT00814346|20795663|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
8438988|NCT00814346|20795664|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
8438989|NCT00814346|20795663|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
8438990|NCT00814346|20795664|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
8438991|NCT00814346|20795663|P2|AD|Double-blind Phase (4 Weeks)||2
8438992|NCT00814346|20795664|P1|AD|Double-blind Phase (4 Weeks)||3
8438993|NCT00814346|20795663|P2|MC|Double-blind Phase (4 Weeks)||11
8438994|NCT00814346|20795664|P1|MC|Double-blind Phase (4 Weeks)||10
8438995|NCT00814346|20795663|P2|CNE|Double-blind Phase (4 Weeks)||13
8438996|NCT00814346|20795664|P1|CNE|Double-blind Phase (4 Weeks)||10
8438997|NCT00814346|20795663|P2|STARTED|Double-blind Phase (4 Weeks)||26
8438998|NCT00814346|20795664|P1|STARTED|Double-blind Phase (4 Weeks)||23
8438999|NCT00814333|20795730|P2|NOT COMPLETED|Treatment Period||0
8439000|NCT00814333|20795731|P1|NOT COMPLETED|Treatment Period||0
8439001|NCT00814333|20795730|P2|COMPLETED|Treatment Period||0
8439002|NCT00814333|20795731|P1|COMPLETED|Treatment Period||0
8439003|NCT00814333|20795730|P2|STARTED|Treatment Period||0
8439004|NCT00814333|20795731|P1|STARTED|Treatment Period||0
8439005|NCT00814333|20795730|P2|NOT COMPLETED|Enrollment||0
8439006|NCT00814333|20795731|P1|NOT COMPLETED|Enrollment||1
8439007|NCT00814333|20795730|P2|COMPLETED|Enrollment||0
8439008|NCT00814333|20795731|P1|COMPLETED|Enrollment||0
8439009|NCT00814333|20795730|P2|STARTED|Enrollment||0
8439010|NCT00814333|20795731|P1|STARTED|Enrollment||1
8439011|NCT00814320|20795739|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
8439012|NCT00814320|20795740|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
8439013|NCT00814320|20795739|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
8439014|NCT00814320|20795740|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
8439015|NCT00814320|20795739|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
8439016|NCT00814320|20795740|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
8439017|NCT00814320|20795739|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
8439018|NCT00814320|20795740|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
8439019|NCT00814320|20795739|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
8439020|NCT00814320|20795740|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
8439021|NCT00814320|20795739|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
8439022|NCT00814320|20795740|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
8439023|NCT00814320|20795739|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
8439024|NCT00814320|20795740|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
8439025|NCT00814320|20795739|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
8439026|NCT00814320|20795740|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
8439027|NCT00814320|20795739|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
8439028|NCT00814320|20795740|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
8439029|NCT00814320|20795739|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
8439030|NCT00814320|20795740|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
8439031|NCT00814320|20795739|P2|COMPLETED|Epoch 1 (IV Treatment)||71
8439032|NCT00814320|20795740|P1|COMPLETED|Epoch 1 (IV Treatment)||13
8439033|NCT00814320|20795739|P2|STARTED|Epoch 1 (IV Treatment)||73
8439034|NCT00814320|20795740|P1|STARTED|Epoch 1 (IV Treatment)||14
8439035|NCT00814307|20795872|P4|NOT COMPLETED|Overall Study||10
8439036|NCT00814307|20795873|P3|NOT COMPLETED|Overall Study||7
8439037|NCT00814307|20795874|P2|NOT COMPLETED|Overall Study||27
8439038|NCT00814307|20795875|P1|NOT COMPLETED|Overall Study||12
8439039|NCT00814307|20795872|P4|COMPLETED|Overall Study||51
8439040|NCT00814307|20795873|P3|COMPLETED|Overall Study||54
8439041|NCT00814307|20795874|P2|COMPLETED|Overall Study||218
8439042|NCT00814307|20795875|P1|COMPLETED|Overall Study||232
8439043|NCT00814307|20795872|P4|Treated|Overall Study||61
8439044|NCT00814307|20795873|P3|Treated|Overall Study||61
8439045|NCT00814307|20795874|P2|Treated|Overall Study||245
8439046|NCT00814307|20795875|P1|Treated|Overall Study||243
8439047|NCT00814307|20795872|P4|STARTED|Overall Study||61
8439048|NCT00814307|20795873|P3|STARTED|Overall Study||61
8439049|NCT00814307|20795874|P2|STARTED|Overall Study||245
8439050|NCT00814307|20795875|P1|STARTED|Overall Study||244
8439051|NCT00814255|20796040|P3|NOT COMPLETED|Overall Study||1
8439052|NCT00814255|20796041|P2|NOT COMPLETED|Overall Study||0
8439053|NCT00814255|20796042|P1|NOT COMPLETED|Overall Study||1
8439054|NCT00814255|20796040|P3|COMPLETED|Overall Study||7
8439055|NCT00814255|20796041|P2|COMPLETED|Overall Study||7
8439056|NCT00814255|20796042|P1|COMPLETED|Overall Study||7
8439057|NCT00814255|20796040|P3|STARTED|Overall Study||8
8439058|NCT00814255|20796041|P2|STARTED|Overall Study||7
8439059|NCT00814255|20796042|P1|STARTED|Overall Study||8
8439060|NCT00814177|20796064|P2|NOT COMPLETED|Overall Study||0
8439061|NCT00814177|20796065|P1|NOT COMPLETED|Overall Study||0
8439062|NCT00814177|20796064|P2|COMPLETED|Overall Study||80
8439063|NCT00814177|20796065|P1|COMPLETED|Overall Study||80
8439064|NCT00814177|20796064|P2|STARTED|Overall Study||80
8439065|NCT00814177|20796065|P1|STARTED|Overall Study||80
8439066|NCT00814164|20796071|P1|NOT COMPLETED|Overall Study||19
8439067|NCT00814164|20796071|P1|COMPLETED|Overall Study||2
8439068|NCT00814164|20796071|P1|STARTED|Overall Study||21
8439069|NCT00814138|20796084|P2|NOT COMPLETED|Overall Study||7
8439070|NCT00814138|20796085|P1|NOT COMPLETED|Overall Study||1
8439071|NCT00814138|20796084|P2|COMPLETED|Overall Study||18
8439072|NCT00814138|20796085|P1|COMPLETED|Overall Study||24
8439073|NCT00814138|20796084|P2|STARTED|Overall Study||25
8439074|NCT00814138|20796085|P1|STARTED|Overall Study||25
8439075|NCT00813995|20796105|P2|NOT COMPLETED|Overall Study||16
8439076|NCT00813995|20796106|P1|NOT COMPLETED|Overall Study||23
8439077|NCT00813995|20796105|P2|COMPLETED|Overall Study||182
8439078|NCT00813995|20796106|P1|COMPLETED|Overall Study||174
8439079|NCT00813995|20796105|P2|STARTED|Overall Study||198
8439080|NCT00813995|20796106|P1|STARTED|Overall Study||197
8439081|NCT00813982|20796120|P1|NOT COMPLETED|Overall Study||0
8439082|NCT00813982|20796120|P1|COMPLETED|Overall Study||59
8439083|NCT00813982|20796120|P1|STARTED|Overall Study||59
8439084|NCT00813943|20796129|P3|NOT COMPLETED|Overall Study||3
8439085|NCT00813943|20796130|P2|NOT COMPLETED|Overall Study||5
8439086|NCT00813943|20796131|P1|NOT COMPLETED|Overall Study||5
8439087|NCT00813943|20796129|P3|COMPLETED|Overall Study||86
8439088|NCT00813943|20796130|P2|COMPLETED|Overall Study||83
8439089|NCT00813943|20796131|P1|COMPLETED|Overall Study||83
8439090|NCT00813943|20796129|P3|STARTED|Overall Study||89
8439091|NCT00813943|20796130|P2|STARTED|Overall Study||88
8439092|NCT00813943|20796131|P1|STARTED|Overall Study||88
8439093|NCT00813917|20796161|P2|NOT COMPLETED|Overall Study||6
8439094|NCT00813917|20796162|P1|NOT COMPLETED|Overall Study||6
8439095|NCT00813917|20796161|P2|COMPLETED|Overall Study||32
8439096|NCT00813917|20796162|P1|COMPLETED|Overall Study||32
8439097|NCT00813917|20796161|P2|STARTED|Overall Study||38
8439098|NCT00813917|20796162|P1|STARTED|Overall Study||38
8439099|NCT00813904|20796168|P1|NOT COMPLETED|Overall Study||1
8439100|NCT00813904|20796168|P1|COMPLETED|Overall Study||30
8439101|NCT00813904|20796168|P1|STARTED|Overall Study||31
8439102|NCT00813865|20796174|P1|NOT COMPLETED|Overall Study||7
8439103|NCT00813865|20796174|P1|COMPLETED|Overall Study||1
8439104|NCT00813865|20796174|P1|Pharmacodynamic (PD) Population|Overall Study||8
8439105|NCT00813865|20796174|P1|Safety Population|Overall Study||8
8439106|NCT00813865|20796174|P1|STARTED|Overall Study||8
8439107|NCT00813813|20796182|P2|NOT COMPLETED|Overall Study||9
8439108|NCT00813813|20796183|P1|NOT COMPLETED|Overall Study||3
8439109|NCT00813813|20796182|P2|COMPLETED|Overall Study||16
8439110|NCT00813813|20796183|P1|COMPLETED|Overall Study||4
8439111|NCT00813813|20796182|P2|STARTED|Overall Study||25
8439112|NCT00813813|20796183|P1|STARTED|Overall Study||7
8439113|NCT00813800|20796199|P1|NOT COMPLETED|Overall Study||6
8439114|NCT00813800|20796199|P1|COMPLETED|Overall Study||5
8439115|NCT00813800|20796199|P1|STARTED|Overall Study||11
8439116|NCT00813761|20796207|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
8439117|NCT00813761|20796208|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
8439118|NCT00813761|20796209|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
8439119|NCT00813761|20796210|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
8439120|NCT00813761|20796207|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
8439121|NCT00813761|20796208|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
8439122|NCT00813761|20796209|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
8439123|NCT00813761|20796210|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
8439124|NCT00813761|20796207|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
8439125|NCT00813761|20796208|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
8439126|NCT00813761|20796209|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
8439127|NCT00813761|20796210|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
8439128|NCT00813761|20796207|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
8439129|NCT00813761|20796208|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
8439130|NCT00813761|20796209|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
8439131|NCT00813761|20796210|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
8439132|NCT00813761|20796207|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
8439133|NCT00813761|20796208|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
8439134|NCT00813761|20796209|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
8439135|NCT00813761|20796210|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
8439136|NCT00813761|20796207|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
8439137|NCT00813761|20796208|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
8439138|NCT00813761|20796209|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
8439139|NCT00813761|20796210|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
8439140|NCT00813748|20796260|P2|NOT COMPLETED|Skin Test Substudy||1
8439141|NCT00813748|20796261|P1|NOT COMPLETED|Skin Test Substudy||0
8439142|NCT00813748|20796260|P2|COMPLETED|Skin Test Substudy||7
8439143|NCT00813748|20796261|P1|COMPLETED|Skin Test Substudy||3
8439144|NCT00813748|20796260|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
8439145|NCT00813748|20796261|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
8439146|NCT00813748|20796260|P2|NOT COMPLETED|Main Observational Study||0
8439147|NCT00813748|20796261|P1|NOT COMPLETED|Main Observational Study||0
8439148|NCT00813748|20796260|P2|COMPLETED|Main Observational Study||88
8439149|NCT00813748|20796261|P1|COMPLETED|Main Observational Study||30
8439150|NCT00813748|20796260|P2|STARTED|Main Observational Study||88
8439151|NCT00813748|20796261|P1|STARTED|Main Observational Study||30
8439152|NCT00813709|20796290|P6|NOT COMPLETED|Open Label Period||11
8439153|NCT00813709|20796291|P5|NOT COMPLETED|Open Label Period||10
8439154|NCT00813709|20796292|P4|NOT COMPLETED|Open Label Period||20
8439155|NCT00813709|20796293|P3|NOT COMPLETED|Open Label Period||0
8439156|NCT00813709|20796294|P2|NOT COMPLETED|Open Label Period||0
8439157|NCT00813709|20796295|P1|NOT COMPLETED|Open Label Period||0
8439158|NCT00813709|20796290|P6|COMPLETED|Open Label Period||35
8439159|NCT00813709|20796291|P5|COMPLETED|Open Label Period||41
8439160|NCT00813709|20796292|P4|COMPLETED|Open Label Period||38
8439161|NCT00813709|20796293|P3|COMPLETED|Open Label Period||0
8439162|NCT00813709|20796294|P2|COMPLETED|Open Label Period||0
8439163|NCT00813709|20796295|P1|COMPLETED|Open Label Period||0
8439164|NCT00813709|20796290|P6|Treated|Open Label Period||45
8439165|NCT00813709|20796291|P5|Treated|Open Label Period||51
8439166|NCT00813709|20796292|P4|Treated|Open Label Period||57
8439167|NCT00813709|20796293|P3|Treated|Open Label Period||0
8439168|NCT00813709|20796294|P2|Treated|Open Label Period||0
8439169|NCT00813709|20796295|P1|Treated|Open Label Period||0
8439170|NCT00813709|20796290|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
8439171|NCT00813709|20796291|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
8439172|NCT00813709|20796292|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
8439173|NCT00813709|20796293|P3|STARTED|Open Label Period||0
8439174|NCT00813709|20796294|P2|STARTED|Open Label Period||0
8439175|NCT00813709|20796295|P1|STARTED|Open Label Period||0
8439176|NCT00813709|20796290|P6|NOT COMPLETED|Double Blind Period||0
8439177|NCT00813709|20796291|P5|NOT COMPLETED|Double Blind Period||0
8439178|NCT00813709|20796292|P4|NOT COMPLETED|Double Blind Period||0
8439179|NCT00813709|20796293|P3|NOT COMPLETED|Double Blind Period||31
8439180|NCT00813709|20796294|P2|NOT COMPLETED|Double Blind Period||41
8439181|NCT00813709|20796295|P1|NOT COMPLETED|Double Blind Period||31
8439182|NCT00813709|20796290|P6|COMPLETED|Double Blind Period||0
8439183|NCT00813709|20796291|P5|COMPLETED|Double Blind Period||0
8439184|NCT00813709|20796292|P4|COMPLETED|Double Blind Period||0
8439185|NCT00813709|20796293|P3|COMPLETED|Double Blind Period||68
8439186|NCT00813709|20796294|P2|COMPLETED|Double Blind Period||76
8439187|NCT00813709|20796295|P1|COMPLETED|Double Blind Period||53
8439188|NCT00813709|20796290|P6|Treated|Double Blind Period||0
8439189|NCT00813709|20796291|P5|Treated|Double Blind Period||0
8439190|NCT00813709|20796292|P4|Treated|Double Blind Period||0
8439191|NCT00813709|20796293|P3|Treated|Double Blind Period||98
8439192|NCT00813709|20796294|P2|Treated|Double Blind Period||114
8439193|NCT00813709|20796295|P1|Treated|Double Blind Period||83
8439194|NCT00813709|20796290|P6|STARTED|Double Blind Period||0
8439195|NCT00813709|20796291|P5|STARTED|Double Blind Period||0
8439196|NCT00813709|20796292|P4|STARTED|Double Blind Period||0
8439197|NCT00813709|20796293|P3|STARTED|Double Blind Period||99
8439198|NCT00813709|20796294|P2|STARTED|Double Blind Period||117
8439199|NCT00813709|20796295|P1|STARTED|Double Blind Period||84
8439200|NCT00813592|20796375|P1|NOT COMPLETED|Overall Study||2
8439201|NCT00813592|20796375|P1|COMPLETED|Overall Study||0
8439202|NCT00813592|20796375|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
8439203|NCT00813592|20796375|P1|Treated|Overall Study|Two patients were treated.|2
8439204|NCT00813592|20796375|P1|STARTED|Overall Study||2
8439205|NCT00813488|20796384|P2|NOT COMPLETED|Open-label Extension||7
8439206|NCT00813488|20796385|P1|NOT COMPLETED|Open-label Extension||12
8439207|NCT00813488|20796384|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
8439208|NCT00813488|20796385|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
8439209|NCT00813488|20796384|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
8439210|NCT00813488|20796385|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
8439211|NCT00813488|20796384|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
8439212|NCT00813488|20796385|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
8439213|NCT00813488|20796384|P2|COMPLETED|Double-blind Treatment Period 2||65
8439214|NCT00813488|20796385|P1|COMPLETED|Double-blind Treatment Period 2||66
8439215|NCT00813488|20796384|P2|STARTED|Double-blind Treatment Period 2||66
8439216|NCT00813488|20796385|P1|STARTED|Double-blind Treatment Period 2||71
8439217|NCT00813488|20796384|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
8439218|NCT00813488|20796385|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
8439219|NCT00813488|20796384|P2|COMPLETED|Double-blind Treatment Period 1||66
8439220|NCT00813488|20796385|P1|COMPLETED|Double-blind Treatment Period 1||71
8439221|NCT00813488|20796384|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
8439222|NCT00813488|20796385|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
8439223|NCT00813488|20796384|P2|NOT COMPLETED|Titration Period 2||10
8439224|NCT00813488|20796385|P1|NOT COMPLETED|Titration Period 2||16
8439225|NCT00813488|20796384|P2|COMPLETED|Titration Period 2||79
8439226|NCT00813488|20796385|P1|COMPLETED|Titration Period 2||64
8439227|NCT00813488|20796384|P2|STARTED|Titration Period 2||89
8439228|NCT00813488|20796385|P1|STARTED|Titration Period 2||80
8439229|NCT00813488|20796384|P2|NOT COMPLETED|Titration Period 1||17
8439230|NCT00813488|20796385|P1|NOT COMPLETED|Titration Period 1||27
8439231|NCT00813488|20796384|P2|COMPLETED|Titration Period 1||89
8439232|NCT00813488|20796385|P1|COMPLETED|Titration Period 1||80
8439233|NCT00813488|20796384|P2|STARTED|Titration Period 1||106
8439234|NCT00813488|20796385|P1|STARTED|Titration Period 1||107
8439235|NCT00813319|20796483|P2|NOT COMPLETED|Overall Study||0
8439236|NCT00813319|20796484|P1|NOT COMPLETED|Overall Study||0
8439237|NCT00813319|20796483|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
8439238|NCT00813319|20796484|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
8439239|NCT00813319|20796483|P2|STARTED|Overall Study||108
8439240|NCT00813319|20796484|P1|STARTED|Overall Study||108
8439241|NCT00813293|20796496|P2|NOT COMPLETED|Overall Study||1
8439242|NCT00813293|20796497|P1|NOT COMPLETED|Overall Study||1
8439243|NCT00813293|20796496|P2|COMPLETED|Overall Study||9
8439244|NCT00813293|20796497|P1|COMPLETED|Overall Study||9
8439245|NCT00813293|20796496|P2|Evaluable RFA|Overall Study||8
8439246|NCT00813293|20796497|P1|Evaluable RFA|Overall Study||7
8439247|NCT00813293|20796496|P2|Started Treatment|Overall Study||10
8439248|NCT00813293|20796497|P1|Started Treatment|Overall Study||9
8439249|NCT00813293|20796496|P2|STARTED|Overall Study||10
8439250|NCT00813293|20796497|P1|STARTED|Overall Study||10
8439251|NCT00813176|20796517|P2|NOT COMPLETED|Overall Study||0
8439252|NCT00813176|20796518|P1|NOT COMPLETED|Overall Study||0
8439253|NCT00813176|20796517|P2|COMPLETED|Overall Study||25
8439254|NCT00813176|20796518|P1|COMPLETED|Overall Study||25
8439255|NCT00813176|20796517|P2|STARTED|Overall Study||25
8439256|NCT00813176|20796518|P1|STARTED|Overall Study||25
8439257|NCT00813150|20796536|P2|NOT COMPLETED|Long Term Follow-up||31
8439258|NCT00813150|20796537|P1|NOT COMPLETED|Long Term Follow-up||24
8439259|NCT00813150|20796536|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
8439260|NCT00813150|20796537|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
8439350|NCT00812929|20796689|P10|COMPLETED|Washout Period 4 (7 Days)||4
8439261|NCT00813150|20796536|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
8439262|NCT00813150|20796537|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
8439263|NCT00813150|20796536|P2|NOT COMPLETED|Treatment Period||32
8439264|NCT00813150|20796537|P1|NOT COMPLETED|Treatment Period||32
8439265|NCT00813150|20796536|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
8439266|NCT00813150|20796537|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
8439267|NCT00813150|20796536|P2|Intent-to-treat Participants|Treatment Period||47
8439268|NCT00813150|20796537|P1|Intent-to-treat Participants|Treatment Period||43
8439269|NCT00813150|20796536|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
8439270|NCT00813150|20796537|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
8439274|NCT00813111|20796555|P2|NOT COMPLETED|Overall Study||0
8439275|NCT00813111|20796556|P1|NOT COMPLETED|Overall Study||2
8439276|NCT00813111|20796555|P2|COMPLETED|Overall Study||70
8439277|NCT00813111|20796556|P1|COMPLETED|Overall Study||64
8439278|NCT00813111|20796555|P2|STARTED|Overall Study||70
8439279|NCT00813111|20796556|P1|STARTED|Overall Study||66
8439280|NCT00813098|20796565|P3|NOT COMPLETED|Overall Study||2
8439281|NCT00813098|20796566|P2|NOT COMPLETED|Overall Study||8
8439282|NCT00813098|20796567|P1|NOT COMPLETED|Overall Study||3
8439283|NCT00813098|20796565|P3|COMPLETED|Overall Study||50
8439284|NCT00813098|20796566|P2|COMPLETED|Overall Study||46
8439285|NCT00813098|20796567|P1|COMPLETED|Overall Study||46
8439286|NCT00813098|20796565|P3|STARTED|Overall Study||52
8439287|NCT00813098|20796566|P2|STARTED|Overall Study||54
8439288|NCT00813098|20796567|P1|STARTED|Overall Study||49
8439289|NCT00812981|20796592|P2|NOT COMPLETED|Overall Study||1
8439290|NCT00812981|20796593|P1|NOT COMPLETED|Overall Study||0
8439291|NCT00812981|20796592|P2|COMPLETED|Overall Study||159
8439292|NCT00812981|20796593|P1|COMPLETED|Overall Study||160
8439293|NCT00812981|20796592|P2|STARTED|Overall Study||160
8439294|NCT00812981|20796593|P1|STARTED|Overall Study||160
8439295|NCT00812968|20796631|P1|NOT COMPLETED|Overall Study||11
8439296|NCT00812968|20796631|P1|COMPLETED|Overall Study||0
8439297|NCT00812968|20796631|P1|STARTED|Overall Study||11
8439298|NCT00812955|20796666|P4|NOT COMPLETED|Overall Study||8
8439299|NCT00812955|20796667|P3|NOT COMPLETED|Overall Study||6
8439300|NCT00812955|20796668|P2|NOT COMPLETED|Overall Study||7
8439301|NCT00812955|20796669|P1|NOT COMPLETED|Overall Study||10
8439302|NCT00812955|20796666|P4|COMPLETED|Overall Study||110
8439303|NCT00812955|20796667|P3|COMPLETED|Overall Study||113
8439304|NCT00812955|20796668|P2|COMPLETED|Overall Study||111
8439305|NCT00812955|20796669|P1|COMPLETED|Overall Study||109
8439306|NCT00812955|20796666|P4|STARTED|Overall Study||118
8439307|NCT00812955|20796667|P3|STARTED|Overall Study||119
8439308|NCT00812955|20796668|P2|STARTED|Overall Study||118
8439309|NCT00812955|20796669|P1|STARTED|Overall Study||119
8439310|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 5||0
8439311|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 5||0
8439312|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 5||0
8439313|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 5||0
8439314|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 5||0
8439315|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 5||0
8439316|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 5||0
8439317|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 5||0
8439318|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 5||0
8439319|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 5||0
8439320|NCT00812929|20796689|P10|COMPLETED|Treatment Period 5||4
8439321|NCT00812929|20796690|P9|COMPLETED|Treatment Period 5||4
8439322|NCT00812929|20796691|P8|COMPLETED|Treatment Period 5||5
8439323|NCT00812929|20796692|P7|COMPLETED|Treatment Period 5||5
8439324|NCT00812929|20796693|P6|COMPLETED|Treatment Period 5||4
8439325|NCT00812929|20796694|P5|COMPLETED|Treatment Period 5||5
8439326|NCT00812929|20796695|P4|COMPLETED|Treatment Period 5||4
8439327|NCT00812929|20796696|P3|COMPLETED|Treatment Period 5||4
8439328|NCT00812929|20796697|P2|COMPLETED|Treatment Period 5||4
8439329|NCT00812929|20796698|P1|COMPLETED|Treatment Period 5||5
8439330|NCT00812929|20796689|P10|STARTED|Treatment Period 5||4
8439331|NCT00812929|20796690|P9|STARTED|Treatment Period 5||4
8439332|NCT00812929|20796691|P8|STARTED|Treatment Period 5||5
8439333|NCT00812929|20796692|P7|STARTED|Treatment Period 5||5
8439334|NCT00812929|20796693|P6|STARTED|Treatment Period 5||4
8439335|NCT00812929|20796694|P5|STARTED|Treatment Period 5||5
8439336|NCT00812929|20796695|P4|STARTED|Treatment Period 5||4
8439337|NCT00812929|20796696|P3|STARTED|Treatment Period 5||4
8439338|NCT00812929|20796697|P2|STARTED|Treatment Period 5||4
8439339|NCT00812929|20796698|P1|STARTED|Treatment Period 5||5
8439340|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439341|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439342|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439343|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439344|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439345|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439346|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439347|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439348|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439349|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439351|NCT00812929|20796690|P9|COMPLETED|Washout Period 4 (7 Days)||4
8439352|NCT00812929|20796691|P8|COMPLETED|Washout Period 4 (7 Days)||5
8439353|NCT00812929|20796692|P7|COMPLETED|Washout Period 4 (7 Days)||5
8439354|NCT00812929|20796693|P6|COMPLETED|Washout Period 4 (7 Days)||4
8439355|NCT00812929|20796694|P5|COMPLETED|Washout Period 4 (7 Days)||5
8439356|NCT00812929|20796695|P4|COMPLETED|Washout Period 4 (7 Days)||4
8439357|NCT00812929|20796696|P3|COMPLETED|Washout Period 4 (7 Days)||4
8439358|NCT00812929|20796697|P2|COMPLETED|Washout Period 4 (7 Days)||4
8439359|NCT00812929|20796698|P1|COMPLETED|Washout Period 4 (7 Days)||5
8439360|NCT00812929|20796689|P10|STARTED|Washout Period 4 (7 Days)||4
8439361|NCT00812929|20796690|P9|STARTED|Washout Period 4 (7 Days)||4
8439362|NCT00812929|20796691|P8|STARTED|Washout Period 4 (7 Days)||5
8439363|NCT00812929|20796692|P7|STARTED|Washout Period 4 (7 Days)||5
8439364|NCT00812929|20796693|P6|STARTED|Washout Period 4 (7 Days)||4
8439365|NCT00812929|20796694|P5|STARTED|Washout Period 4 (7 Days)||5
8439366|NCT00812929|20796695|P4|STARTED|Washout Period 4 (7 Days)||4
8439367|NCT00812929|20796696|P3|STARTED|Washout Period 4 (7 Days)||4
8439368|NCT00812929|20796697|P2|STARTED|Washout Period 4 (7 Days)||4
8439369|NCT00812929|20796698|P1|STARTED|Washout Period 4 (7 Days)||5
8439370|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 4||0
8439371|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 4||0
8439372|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 4||0
8439373|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 4||0
8439374|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 4||0
8439375|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 4||0
8439376|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 4||0
8439377|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 4||0
8439378|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 4||0
8439379|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 4||0
8439380|NCT00812929|20796689|P10|COMPLETED|Treatment Period 4||4
8439381|NCT00812929|20796690|P9|COMPLETED|Treatment Period 4||4
8439382|NCT00812929|20796691|P8|COMPLETED|Treatment Period 4||5
8439383|NCT00812929|20796692|P7|COMPLETED|Treatment Period 4||5
8439384|NCT00812929|20796693|P6|COMPLETED|Treatment Period 4||4
8439385|NCT00812929|20796694|P5|COMPLETED|Treatment Period 4||5
8439386|NCT00812929|20796695|P4|COMPLETED|Treatment Period 4||4
8439387|NCT00812929|20796696|P3|COMPLETED|Treatment Period 4||4
8439388|NCT00812929|20796697|P2|COMPLETED|Treatment Period 4||4
8439389|NCT00812929|20796698|P1|COMPLETED|Treatment Period 4||5
8439390|NCT00812929|20796689|P10|STARTED|Treatment Period 4||4
8439391|NCT00812929|20796690|P9|STARTED|Treatment Period 4||4
8439392|NCT00812929|20796691|P8|STARTED|Treatment Period 4||5
8439393|NCT00812929|20796692|P7|STARTED|Treatment Period 4||5
8439394|NCT00812929|20796693|P6|STARTED|Treatment Period 4||4
8439395|NCT00812929|20796694|P5|STARTED|Treatment Period 4||5
8439396|NCT00812929|20796695|P4|STARTED|Treatment Period 4||4
8439397|NCT00812929|20796696|P3|STARTED|Treatment Period 4||4
8439398|NCT00812929|20796697|P2|STARTED|Treatment Period 4||4
8439399|NCT00812929|20796698|P1|STARTED|Treatment Period 4||5
8439400|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439401|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439402|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439403|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439404|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
8439405|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439406|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439407|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439408|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439409|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439410|NCT00812929|20796689|P10|COMPLETED|Washout Period 3 (7 Days)||4
8439411|NCT00812929|20796690|P9|COMPLETED|Washout Period 3 (7 Days)||4
8439412|NCT00812929|20796691|P8|COMPLETED|Washout Period 3 (7 Days)||5
8439413|NCT00812929|20796692|P7|COMPLETED|Washout Period 3 (7 Days)||5
8439414|NCT00812929|20796693|P6|COMPLETED|Washout Period 3 (7 Days)||4
8439415|NCT00812929|20796694|P5|COMPLETED|Washout Period 3 (7 Days)||5
8439416|NCT00812929|20796695|P4|COMPLETED|Washout Period 3 (7 Days)||4
8439417|NCT00812929|20796696|P3|COMPLETED|Washout Period 3 (7 Days)||4
8439418|NCT00812929|20796697|P2|COMPLETED|Washout Period 3 (7 Days)||4
8439419|NCT00812929|20796698|P1|COMPLETED|Washout Period 3 (7 Days)||5
8439420|NCT00812929|20796689|P10|STARTED|Washout Period 3 (7 Days)||4
8439421|NCT00812929|20796690|P9|STARTED|Washout Period 3 (7 Days)||4
8439422|NCT00812929|20796691|P8|STARTED|Washout Period 3 (7 Days)||5
8439423|NCT00812929|20796692|P7|STARTED|Washout Period 3 (7 Days)||5
8439424|NCT00812929|20796693|P6|STARTED|Washout Period 3 (7 Days)||5
8439425|NCT00812929|20796694|P5|STARTED|Washout Period 3 (7 Days)||5
8439426|NCT00812929|20796695|P4|STARTED|Washout Period 3 (7 Days)||4
8439427|NCT00812929|20796696|P3|STARTED|Washout Period 3 (7 Days)||4
8439428|NCT00812929|20796697|P2|STARTED|Washout Period 3 (7 Days)||4
8439429|NCT00812929|20796698|P1|STARTED|Washout Period 3 (7 Days)||5
8439430|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 3||0
8439431|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 3||0
8439432|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 3||0
8439433|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 3||0
8439434|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 3||0
8439435|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 3||0
8439436|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 3||0
8439437|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 3||0
8439438|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 3||0
8439439|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 3||0
8439440|NCT00812929|20796689|P10|COMPLETED|Treatment Period 3||4
8439441|NCT00812929|20796690|P9|COMPLETED|Treatment Period 3||4
8439442|NCT00812929|20796691|P8|COMPLETED|Treatment Period 3||5
8439443|NCT00812929|20796692|P7|COMPLETED|Treatment Period 3||5
8439444|NCT00812929|20796693|P6|COMPLETED|Treatment Period 3||5
8439445|NCT00812929|20796694|P5|COMPLETED|Treatment Period 3||5
8439446|NCT00812929|20796695|P4|COMPLETED|Treatment Period 3||4
8439447|NCT00812929|20796696|P3|COMPLETED|Treatment Period 3||4
8439448|NCT00812929|20796697|P2|COMPLETED|Treatment Period 3||4
8439449|NCT00812929|20796698|P1|COMPLETED|Treatment Period 3||5
8439450|NCT00812929|20796689|P10|STARTED|Treatment Period 3||4
8439451|NCT00812929|20796690|P9|STARTED|Treatment Period 3||4
8439452|NCT00812929|20796691|P8|STARTED|Treatment Period 3||5
8439453|NCT00812929|20796692|P7|STARTED|Treatment Period 3||5
8439454|NCT00812929|20796693|P6|STARTED|Treatment Period 3||5
8439455|NCT00812929|20796694|P5|STARTED|Treatment Period 3||5
8439456|NCT00812929|20796695|P4|STARTED|Treatment Period 3||4
8439457|NCT00812929|20796696|P3|STARTED|Treatment Period 3||4
8439458|NCT00812929|20796697|P2|STARTED|Treatment Period 3||4
8439459|NCT00812929|20796698|P1|STARTED|Treatment Period 3||5
8439460|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
8439461|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439462|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439463|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439464|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439465|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439466|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439467|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439468|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439469|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439470|NCT00812929|20796689|P10|COMPLETED|Washout Period 2 (7 Days)||4
8439471|NCT00812929|20796690|P9|COMPLETED|Washout Period 2 (7 Days)||4
8439472|NCT00812929|20796691|P8|COMPLETED|Washout Period 2 (7 Days)||5
8439473|NCT00812929|20796692|P7|COMPLETED|Washout Period 2 (7 Days)||5
8439474|NCT00812929|20796693|P6|COMPLETED|Washout Period 2 (7 Days)||5
8439475|NCT00812929|20796694|P5|COMPLETED|Washout Period 2 (7 Days)||5
8439476|NCT00812929|20796695|P4|COMPLETED|Washout Period 2 (7 Days)||4
8439477|NCT00812929|20796696|P3|COMPLETED|Washout Period 2 (7 Days)||4
8439478|NCT00812929|20796697|P2|COMPLETED|Washout Period 2 (7 Days)||4
8439479|NCT00812929|20796698|P1|COMPLETED|Washout Period 2 (7 Days)||5
8439480|NCT00812929|20796689|P10|STARTED|Washout Period 2 (7 Days)||5
8439481|NCT00812929|20796690|P9|STARTED|Washout Period 2 (7 Days)||4
8439482|NCT00812929|20796691|P8|STARTED|Washout Period 2 (7 Days)||5
8439483|NCT00812929|20796692|P7|STARTED|Washout Period 2 (7 Days)||5
8439484|NCT00812929|20796693|P6|STARTED|Washout Period 2 (7 Days)||5
8439485|NCT00812929|20796694|P5|STARTED|Washout Period 2 (7 Days)||5
8439486|NCT00812929|20796695|P4|STARTED|Washout Period 2 (7 Days)||4
8439487|NCT00812929|20796696|P3|STARTED|Washout Period 2 (7 Days)||4
8439488|NCT00812929|20796697|P2|STARTED|Washout Period 2 (7 Days)||4
8439489|NCT00812929|20796698|P1|STARTED|Washout Period 2 (7 Days)||5
8439490|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 2||0
8439491|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 2||0
8439492|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 2||0
8439493|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 2||0
8439494|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 2||0
8439495|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 2||0
8439496|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 2||0
8439497|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 2||0
8439498|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 2||0
8439499|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 2||0
8439500|NCT00812929|20796689|P10|COMPLETED|Treatment Period 2||5
8439501|NCT00812929|20796690|P9|COMPLETED|Treatment Period 2||4
8439502|NCT00812929|20796691|P8|COMPLETED|Treatment Period 2||5
8439503|NCT00812929|20796692|P7|COMPLETED|Treatment Period 2||5
8439504|NCT00812929|20796693|P6|COMPLETED|Treatment Period 2||5
8439505|NCT00812929|20796694|P5|COMPLETED|Treatment Period 2||5
8439506|NCT00812929|20796695|P4|COMPLETED|Treatment Period 2||4
8439507|NCT00812929|20796696|P3|COMPLETED|Treatment Period 2||4
8439508|NCT00812929|20796697|P2|COMPLETED|Treatment Period 2||4
8439509|NCT00812929|20796698|P1|COMPLETED|Treatment Period 2||5
8439510|NCT00812929|20796689|P10|STARTED|Treatment Period 2||5
8439511|NCT00812929|20796690|P9|STARTED|Treatment Period 2||4
8439512|NCT00812929|20796691|P8|STARTED|Treatment Period 2||5
8439513|NCT00812929|20796692|P7|STARTED|Treatment Period 2||5
8439514|NCT00812929|20796693|P6|STARTED|Treatment Period 2||5
8439515|NCT00812929|20796694|P5|STARTED|Treatment Period 2||5
8439516|NCT00812929|20796695|P4|STARTED|Treatment Period 2||4
8439517|NCT00812929|20796696|P3|STARTED|Treatment Period 2||4
8439518|NCT00812929|20796697|P2|STARTED|Treatment Period 2||4
8439519|NCT00812929|20796698|P1|STARTED|Treatment Period 2||5
8439520|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439521|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439522|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439523|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439524|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439525|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439526|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439527|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
8439528|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439529|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439530|NCT00812929|20796689|P10|COMPLETED|Washout Period 1 (7 Days)||5
8439531|NCT00812929|20796690|P9|COMPLETED|Washout Period 1 (7 Days)||4
8439532|NCT00812929|20796691|P8|COMPLETED|Washout Period 1 (7 Days)||5
8439533|NCT00812929|20796692|P7|COMPLETED|Washout Period 1 (7 Days)||5
8439534|NCT00812929|20796693|P6|COMPLETED|Washout Period 1 (7 Days)||5
8439535|NCT00812929|20796694|P5|COMPLETED|Washout Period 1 (7 Days)||5
8439536|NCT00812929|20796695|P4|COMPLETED|Washout Period 1 (7 Days)||4
8439537|NCT00812929|20796696|P3|COMPLETED|Washout Period 1 (7 Days)||4
8439538|NCT00812929|20796697|P2|COMPLETED|Washout Period 1 (7 Days)||4
8439539|NCT00812929|20796698|P1|COMPLETED|Washout Period 1 (7 Days)||5
8439540|NCT00812929|20796689|P10|STARTED|Washout Period 1 (7 Days)||5
8439541|NCT00812929|20796690|P9|STARTED|Washout Period 1 (7 Days)||4
8439542|NCT00812929|20796691|P8|STARTED|Washout Period 1 (7 Days)||5
8439543|NCT00812929|20796692|P7|STARTED|Washout Period 1 (7 Days)||5
8439544|NCT00812929|20796693|P6|STARTED|Washout Period 1 (7 Days)||5
8439545|NCT00812929|20796694|P5|STARTED|Washout Period 1 (7 Days)||5
8439546|NCT00812929|20796695|P4|STARTED|Washout Period 1 (7 Days)||4
8439547|NCT00812929|20796696|P3|STARTED|Washout Period 1 (7 Days)||5
8439548|NCT00812929|20796697|P2|STARTED|Washout Period 1 (7 Days)||4
8439549|NCT00812929|20796698|P1|STARTED|Washout Period 1 (7 Days)||5
8439550|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 1||0
8439551|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 1||0
8439552|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 1||0
8439553|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 1||0
8439554|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 1||0
8439555|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 1||0
8439556|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 1||0
8439557|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 1||0
8439558|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 1||0
8439559|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 1||0
8439560|NCT00812929|20796689|P10|COMPLETED|Treatment Period 1||5
8439561|NCT00812929|20796690|P9|COMPLETED|Treatment Period 1||4
8439562|NCT00812929|20796691|P8|COMPLETED|Treatment Period 1||5
8439563|NCT00812929|20796692|P7|COMPLETED|Treatment Period 1||5
8439564|NCT00812929|20796693|P6|COMPLETED|Treatment Period 1||5
8439565|NCT00812929|20796694|P5|COMPLETED|Treatment Period 1||5
8439566|NCT00812929|20796695|P4|COMPLETED|Treatment Period 1||4
8439567|NCT00812929|20796696|P3|COMPLETED|Treatment Period 1||5
8439568|NCT00812929|20796697|P2|COMPLETED|Treatment Period 1||4
8439569|NCT00812929|20796698|P1|COMPLETED|Treatment Period 1||5
8439570|NCT00812929|20796689|P10|STARTED|Treatment Period 1||5
8439571|NCT00812929|20796690|P9|STARTED|Treatment Period 1||4
8439572|NCT00812929|20796691|P8|STARTED|Treatment Period 1||5
8439573|NCT00812929|20796692|P7|STARTED|Treatment Period 1||5
8439574|NCT00812929|20796693|P6|STARTED|Treatment Period 1||5
8439575|NCT00812929|20796694|P5|STARTED|Treatment Period 1||5
8439576|NCT00812929|20796695|P4|STARTED|Treatment Period 1||4
8439577|NCT00812929|20796696|P3|STARTED|Treatment Period 1||5
8439578|NCT00812929|20796697|P2|STARTED|Treatment Period 1||4
8439579|NCT00812929|20796698|P1|STARTED|Treatment Period 1||5
8439580|NCT00812916|20796814|P1|NOT COMPLETED|Overall Study||3
8439581|NCT00812916|20796814|P1|COMPLETED|Overall Study||203
8439582|NCT00812916|20796814|P1|CFAE - Guided Ablation|Overall Study||203
8439583|NCT00812916|20796814|P1|Data Available|Overall Study||205
8439584|NCT00812916|20796814|P1|STARTED|Overall Study|206 enrolled (consented)|206
8439585|NCT00812877|20796825|P2|NOT COMPLETED|Overall Study||51
8439586|NCT00812877|20796826|P1|NOT COMPLETED|Overall Study||37
8439587|NCT00812877|20796825|P2|COMPLETED|Overall Study||130
8439588|NCT00812877|20796826|P1|COMPLETED|Overall Study||158
8439589|NCT00812877|20796825|P2|STARTED|Overall Study||181
8439590|NCT00812877|20796826|P1|STARTED|Overall Study||195
8439591|NCT00812838|20796836|P2|NOT COMPLETED|Optional Crossover of 16 Weeks||0
8439592|NCT00812838|20796837|P1|NOT COMPLETED|Optional Crossover of 16 Weeks||0
8439593|NCT00812838|20796836|P2|COMPLETED|Optional Crossover of 16 Weeks||4
8439594|NCT00812838|20796837|P1|COMPLETED|Optional Crossover of 16 Weeks||0
8439595|NCT00812838|20796836|P2|STARTED|Optional Crossover of 16 Weeks||4
8439596|NCT00812838|20796837|P1|STARTED|Optional Crossover of 16 Weeks||0
8439597|NCT00812838|20796836|P2|NOT COMPLETED|Treatment Period of 16 Weeks||0
8439598|NCT00812838|20796837|P1|NOT COMPLETED|Treatment Period of 16 Weeks||0
8439599|NCT00812838|20796836|P2|COMPLETED|Treatment Period of 16 Weeks||6
8439600|NCT00812838|20796837|P1|COMPLETED|Treatment Period of 16 Weeks||6
8439601|NCT00812838|20796836|P2|STARTED|Treatment Period of 16 Weeks||6
8439602|NCT00812838|20796837|P1|STARTED|Treatment Period of 16 Weeks||6
8439603|NCT00812812|20796853|P2|NOT COMPLETED|Overall Study||4
8439604|NCT00812812|20796854|P1|NOT COMPLETED|Overall Study||3
8439605|NCT00812812|20796853|P2|COMPLETED|Overall Study||25
8439606|NCT00812812|20796854|P1|COMPLETED|Overall Study||24
8439607|NCT00812812|20796853|P2|STARTED|Overall Study||29
8439608|NCT00812812|20796854|P1|STARTED|Overall Study||27
8439609|NCT00812708|20796867|P1|NOT COMPLETED|Overall Study||8
8439610|NCT00812708|20796867|P1|COMPLETED|Overall Study||64
8439611|NCT00812708|20796867|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
8439612|NCT00812708|20796867|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
8439613|NCT00812604|20796878|P2|NOT COMPLETED|Overall Study||5
8439614|NCT00812604|20796879|P1|NOT COMPLETED|Overall Study||5
8439615|NCT00812604|20796878|P2|COMPLETED|Overall Study||22
8439616|NCT00812604|20796879|P1|COMPLETED|Overall Study||23
8439617|NCT00812604|20796878|P2|STARTED|Overall Study||27
8439618|NCT00812604|20796879|P1|STARTED|Overall Study||28
8439619|NCT00812565|20796895|P8|NOT COMPLETED|Overall Study||1
8439620|NCT00812565|20796896|P7|NOT COMPLETED|Overall Study||0
8439621|NCT00812565|20796897|P6|NOT COMPLETED|Overall Study||1
8439622|NCT00812565|20796898|P5|NOT COMPLETED|Overall Study||1
8439623|NCT00812565|20796899|P4|NOT COMPLETED|Overall Study||2
8439624|NCT00812565|20796900|P3|NOT COMPLETED|Overall Study||0
8439625|NCT00812565|20796901|P2|NOT COMPLETED|Overall Study||1
8439626|NCT00812565|20796902|P1|NOT COMPLETED|Overall Study||3
8439627|NCT00812565|20796895|P8|COMPLETED|Overall Study||6
8439628|NCT00812565|20796896|P7|COMPLETED|Overall Study||8
8439629|NCT00812565|20796897|P6|COMPLETED|Overall Study||6
8439630|NCT00812565|20796898|P5|COMPLETED|Overall Study||6
8439631|NCT00812565|20796899|P4|COMPLETED|Overall Study||5
8439632|NCT00812565|20796900|P3|COMPLETED|Overall Study||7
8439633|NCT00812565|20796901|P2|COMPLETED|Overall Study||6
8439634|NCT00812565|20796902|P1|COMPLETED|Overall Study||5
8439635|NCT00812565|20796895|P8|STARTED|Overall Study||7
8439636|NCT00812565|20796896|P7|STARTED|Overall Study||8
8439637|NCT00812565|20796897|P6|STARTED|Overall Study||7
8439638|NCT00812565|20796898|P5|STARTED|Overall Study||7
8439639|NCT00812565|20796899|P4|STARTED|Overall Study||7
8439640|NCT00812565|20796900|P3|STARTED|Overall Study||7
8439641|NCT00812565|20796901|P2|STARTED|Overall Study||7
8439642|NCT00812565|20796902|P1|STARTED|Overall Study||8
8439643|NCT00812487|20797026|P2|NOT COMPLETED|Overall Study||3
8439644|NCT00812487|20797027|P1|NOT COMPLETED|Overall Study||6
8439645|NCT00812487|20797026|P2|COMPLETED|Overall Study||39
8439646|NCT00812487|20797027|P1|COMPLETED|Overall Study||26
8439647|NCT00812487|20797026|P2|STARTED|Overall Study||42
8439648|NCT00812487|20797027|P1|STARTED|Overall Study||32
8439649|NCT00812461|20797053|P2|NOT COMPLETED|All Treated Patients||147
8439650|NCT00812461|20797054|P1|NOT COMPLETED|All Treated Patients||132
8439651|NCT00812461|20797053|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
8439652|NCT00812461|20797054|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
8439653|NCT00812461|20797053|P2|STARTED|All Treated Patients||341
8439654|NCT00812461|20797054|P1|STARTED|All Treated Patients||337
8439655|NCT00812461|20797053|P2|NOT COMPLETED|All Randomised Patients||17
8439656|NCT00812461|20797054|P1|NOT COMPLETED|All Randomised Patients||23
8439657|NCT00812461|20797053|P2|COMPLETED|All Randomised Patients||341
8439658|NCT00812461|20797054|P1|COMPLETED|All Randomised Patients||337
8439659|NCT00812461|20797053|P2|STARTED|All Randomised Patients||358
8439660|NCT00812461|20797054|P1|STARTED|All Randomised Patients||360
8439661|NCT00812331|20797077|P5|NOT COMPLETED|Overall Study||0
8439662|NCT00812331|20797078|P4|NOT COMPLETED|Overall Study||0
8439663|NCT00812331|20797079|P3|NOT COMPLETED|Overall Study||0
8439664|NCT00812331|20797080|P2|NOT COMPLETED|Overall Study||0
8439665|NCT00812331|20797081|P1|NOT COMPLETED|Overall Study||1
8439666|NCT00812331|20797077|P5|COMPLETED|Overall Study||8
8439667|NCT00812331|20797078|P4|COMPLETED|Overall Study||7
8439668|NCT00812331|20797079|P3|COMPLETED|Overall Study||8
8439669|NCT00812331|20797080|P2|COMPLETED|Overall Study||8
8439670|NCT00812331|20797081|P1|COMPLETED|Overall Study||5
8439671|NCT00812331|20797077|P5|STARTED|Overall Study||8
8439672|NCT00812331|20797078|P4|STARTED|Overall Study||7
8439673|NCT00812331|20797079|P3|STARTED|Overall Study||8
8439674|NCT00812331|20797080|P2|STARTED|Overall Study||8
8439675|NCT00812331|20797081|P1|STARTED|Overall Study||6
8439676|NCT00812253|20797156|P2|NOT COMPLETED|Overall Study||3
8439677|NCT00812253|20797157|P1|NOT COMPLETED|Overall Study||6
8439678|NCT00812253|20797156|P2|COMPLETED|Overall Study||39
8439679|NCT00812253|20797157|P1|COMPLETED|Overall Study||26
8439680|NCT00812253|20797156|P2|STARTED|Overall Study||42
8439681|NCT00812253|20797157|P1|STARTED|Overall Study||32
8439682|NCT00812110|20797173|P1|NOT COMPLETED|Overall Study||0
8439683|NCT00812110|20797173|P1|COMPLETED|Overall Study||292
8439684|NCT00812110|20797173|P1|STARTED|Overall Study||292
8439685|NCT00812097|20797182|P4|NOT COMPLETED|Overall Study||35
8439686|NCT00812097|20797183|P3|NOT COMPLETED|Overall Study||57
8439687|NCT00812097|20797184|P2|NOT COMPLETED|Overall Study||89
8439688|NCT00812097|20797185|P1|NOT COMPLETED|Overall Study||245
8439689|NCT00812097|20797182|P4|COMPLETED|Overall Study||34
8439690|NCT00812097|20797183|P3|COMPLETED|Overall Study||67
8439691|NCT00812097|20797184|P2|COMPLETED|Overall Study||101
8439692|NCT00812097|20797185|P1|COMPLETED|Overall Study||327
8439693|NCT00812097|20797182|P4|STARTED|Overall Study||69
8439694|NCT00812097|20797183|P3|STARTED|Overall Study||124
8439695|NCT00812097|20797184|P2|STARTED|Overall Study||190
8439696|NCT00812097|20797185|P1|STARTED|Overall Study||572
8439697|NCT00812006|20797214|P3|NOT COMPLETED|Overall Study||6
8439698|NCT00812006|20797215|P2|NOT COMPLETED|Overall Study||3
8439699|NCT00812006|20797216|P1|NOT COMPLETED|Overall Study||6
8439700|NCT00812006|20797214|P3|COMPLETED|Overall Study||30
8439701|NCT00812006|20797215|P2|COMPLETED|Overall Study||33
8439702|NCT00812006|20797216|P1|COMPLETED|Overall Study||30
8439703|NCT00812006|20797214|P3|STARTED|Overall Study||36
8439704|NCT00812006|20797215|P2|STARTED|Overall Study||36
8439705|NCT00812006|20797216|P1|STARTED|Overall Study||36
8439706|NCT00811954|20797233|P3|NOT COMPLETED|Overall Study||101
8439707|NCT00811954|20797234|P2|NOT COMPLETED|Overall Study||72
8439708|NCT00811954|20797235|P1|NOT COMPLETED|Overall Study||89
8439709|NCT00811954|20797233|P3|COMPLETED|Overall Study||500
8439710|NCT00811954|20797234|P2|COMPLETED|Overall Study||531
8439711|NCT00811954|20797235|P1|COMPLETED|Overall Study||516
8439712|NCT00811954|20797233|P3|STARTED|Overall Study||601
8439713|NCT00811954|20797234|P2|STARTED|Overall Study||603
8439714|NCT00811954|20797235|P1|STARTED|Overall Study||605
8439715|NCT00811941|20797299|P2|NOT COMPLETED|All Treated Patients||191
8439716|NCT00811941|20797300|P1|NOT COMPLETED|All Treated Patients||52
8439717|NCT00811941|20797299|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
8439718|NCT00811941|20797300|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
8439719|NCT00811941|20797299|P2|STARTED|All Treated Patients||501
8439720|NCT00811941|20797300|P1|STARTED|All Treated Patients||164
8439721|NCT00811941|20797299|P2|NOT COMPLETED|All Randomised Patients||8
8439722|NCT00811941|20797300|P1|NOT COMPLETED|All Randomised Patients||2
8439723|NCT00811941|20797299|P2|COMPLETED|All Randomised Patients||501
8439724|NCT00811941|20797300|P1|COMPLETED|All Randomised Patients||164
8439725|NCT00811941|20797299|P2|STARTED|All Randomised Patients||509
8439726|NCT00811941|20797300|P1|STARTED|All Randomised Patients||166
8439727|NCT00811928|20797338|P2|NOT COMPLETED|Overall Study||33
8439728|NCT00811928|20797339|P1|NOT COMPLETED|Overall Study||39
8439729|NCT00811928|20797338|P2|COMPLETED|Overall Study||90
8439730|NCT00811928|20797339|P1|COMPLETED|Overall Study||90
8439731|NCT00811928|20797338|P2|STARTED|Overall Study||123
8439732|NCT00811928|20797339|P1|STARTED|Overall Study||129
8439733|NCT00811850|20797357|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
8439734|NCT00811850|20797357|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
8439735|NCT00811850|20797357|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
8439736|NCT00811850|20797357|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
8439737|NCT00811850|20797357|P1|COMPLETED|Treatment Period 2: Wash Out||15
8439738|NCT00811850|20797357|P1|STARTED|Treatment Period 2: Wash Out||15
8439739|NCT00811850|20797357|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
8439740|NCT00811850|20797357|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
8439741|NCT00811850|20797357|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
8439742|NCT00811798|20797377|P1|NOT COMPLETED|Overall Study||0
8439743|NCT00811798|20797377|P1|COMPLETED|Overall Study||92
8439744|NCT00811798|20797377|P1|STARTED|Overall Study||92
8439745|NCT00811733|20797383|P2|NOT COMPLETED|Overall Study||10
8439746|NCT00811733|20797384|P1|NOT COMPLETED|Overall Study||11
8439747|NCT00811733|20797383|P2|COMPLETED|Overall Study||12
8439748|NCT00811733|20797384|P1|COMPLETED|Overall Study||4
8439749|NCT00811733|20797383|P2|STARTED|Overall Study||22
8439750|NCT00811733|20797384|P1|STARTED|Overall Study||15
8439751|NCT00811720|20797432|P2|NOT COMPLETED|All Treated Patients||164
8439752|NCT00811720|20797433|P1|NOT COMPLETED|All Treated Patients||96
8439753|NCT00811720|20797432|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
8439754|NCT00811720|20797433|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
8439755|NCT00811720|20797432|P2|STARTED|All Treated Patients||302
8439756|NCT00811720|20797433|P1|STARTED|All Treated Patients||296
8439757|NCT00811720|20797432|P2|NOT COMPLETED|All Randomised Patients||4
8439758|NCT00811720|20797433|P1|NOT COMPLETED|All Randomised Patients||2
8439759|NCT00811720|20797432|P2|COMPLETED|All Randomised Patients||302
8439760|NCT00811720|20797433|P1|COMPLETED|All Randomised Patients||296
8439761|NCT00811720|20797432|P2|STARTED|All Randomised Patients||306
8439762|NCT00811720|20797433|P1|STARTED|All Randomised Patients||298
8439763|NCT00811655|20797451|P1|NOT COMPLETED|Overall Study||1
8439764|NCT00811655|20797451|P1|COMPLETED|Overall Study||5
8439765|NCT00811655|20797451|P1|STARTED|Overall Study||6
8439766|NCT00811642|20797463|P1|NOT COMPLETED|Overall Study||15
8439767|NCT00811642|20797463|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
8439768|NCT00811642|20797463|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
8439769|NCT00811590|20797473|P1|NOT COMPLETED|Overall Study||0
8439770|NCT00811590|20797473|P1|COMPLETED|Overall Study||3
8439771|NCT00811590|20797473|P1|STARTED|Overall Study||3
8439772|NCT00811577|20797479|P2|NOT COMPLETED|Overall Study||1
8439773|NCT00811577|20797480|P1|NOT COMPLETED|Overall Study||10
8439774|NCT00811577|20797479|P2|COMPLETED|Overall Study||23
8439775|NCT00811577|20797480|P1|COMPLETED|Overall Study||116
8439776|NCT00811577|20797479|P2|STARTED|Overall Study||24
8439777|NCT00811577|20797480|P1|STARTED|Overall Study||126
8439778|NCT00811564|20797531|P2|NOT COMPLETED|Overall Study||2
8439779|NCT00811564|20797532|P1|NOT COMPLETED|Overall Study||9
8439780|NCT00811564|20797531|P2|COMPLETED|Overall Study||73
8439781|NCT00811564|20797532|P1|COMPLETED|Overall Study||64
8439782|NCT00811564|20797531|P2|STARTED|Overall Study||75
8439783|NCT00811564|20797532|P1|STARTED|Overall Study||73
8439784|NCT00811473|20797540|P2|NOT COMPLETED|Overall Study||26
8439785|NCT00811473|20797541|P1|NOT COMPLETED|Overall Study||23
8439786|NCT00811473|20797540|P2|COMPLETED|Overall Study||74
8439787|NCT00811473|20797541|P1|COMPLETED|Overall Study||70
8439788|NCT00811473|20797540|P2|STARTED|Overall Study||100
8439789|NCT00811473|20797541|P1|STARTED|Overall Study||93
8439790|NCT00811434|20797557|P2|NOT COMPLETED|Second Intervention||0
8439791|NCT00811434|20797558|P1|NOT COMPLETED|Second Intervention||0
8439792|NCT00811434|20797557|P2|COMPLETED|Second Intervention||5
8439793|NCT00811434|20797558|P1|COMPLETED|Second Intervention||4
8439794|NCT00811434|20797557|P2|STARTED|Second Intervention||5
8439795|NCT00811434|20797558|P1|STARTED|Second Intervention||4
8439796|NCT00811434|20797557|P2|NOT COMPLETED|Washout (1 Month)||0
8439797|NCT00811434|20797558|P1|NOT COMPLETED|Washout (1 Month)||0
8439798|NCT00811434|20797557|P2|COMPLETED|Washout (1 Month)||5
8439799|NCT00811434|20797558|P1|COMPLETED|Washout (1 Month)||4
8439800|NCT00811434|20797557|P2|STARTED|Washout (1 Month)||5
8439801|NCT00811434|20797558|P1|STARTED|Washout (1 Month)||4
8439802|NCT00811434|20797557|P2|NOT COMPLETED|First Intervention||0
8439803|NCT00811434|20797558|P1|NOT COMPLETED|First Intervention||3
8439804|NCT00811434|20797557|P2|COMPLETED|First Intervention||5
8439805|NCT00811434|20797558|P1|COMPLETED|First Intervention||4
8439806|NCT00811434|20797557|P2|STARTED|First Intervention||5
8439807|NCT00811434|20797558|P1|STARTED|First Intervention||7
8439808|NCT00811395|20797572|P6|NOT COMPLETED|Extension Treatment||2
8439809|NCT00811395|20797573|P5|NOT COMPLETED|Extension Treatment||0
8439810|NCT00811395|20797574|P4|NOT COMPLETED|Extension Treatment||3
8439811|NCT00811395|20797575|P3|NOT COMPLETED|Extension Treatment||3
8439812|NCT00811395|20797576|P2|NOT COMPLETED|Extension Treatment||6
8439813|NCT00811395|20797577|P1|NOT COMPLETED|Extension Treatment||2
8439814|NCT00811395|20797572|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
8439815|NCT00811395|20797573|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
8439816|NCT00811395|20797574|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
8439817|NCT00811395|20797575|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
8439818|NCT00811395|20797576|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
8439819|NCT00811395|20797577|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
8439820|NCT00811395|20797572|P6|STARTED|Extension Treatment|continued initial treatment|29
8439821|NCT00811395|20797573|P5|STARTED|Extension Treatment|continued initial treatment|30
8439822|NCT00811395|20797574|P4|STARTED|Extension Treatment|continued initial treatment|37
8439823|NCT00811395|20797575|P3|STARTED|Extension Treatment|continued initial treatment|27
8439824|NCT00811395|20797576|P2|STARTED|Extension Treatment|continued initial treatment|28
8439825|NCT00811395|20797577|P1|STARTED|Extension Treatment|continued initial treatment|31
8439826|NCT00811395|20797572|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
8439827|NCT00811395|20797573|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
8439828|NCT00811395|20797574|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
8439829|NCT00811395|20797575|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
8439830|NCT00811395|20797576|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
8439831|NCT00811395|20797577|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
8439832|NCT00811395|20797572|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
8439833|NCT00811395|20797573|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
8439834|NCT00811395|20797574|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
8439835|NCT00811395|20797575|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
8439836|NCT00811395|20797576|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
8439837|NCT00811395|20797577|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
8439838|NCT00811395|20797572|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
8439839|NCT00811395|20797573|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
8439840|NCT00811395|20797574|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
8439841|NCT00811395|20797575|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
8439842|NCT00811395|20797576|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
8439843|NCT00811395|20797577|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
8439844|NCT00811382|20797641|P2|NOT COMPLETED|Overall Study||0
8439845|NCT00811382|20797642|P1|NOT COMPLETED|Overall Study||0
8439846|NCT00811382|20797641|P2|COMPLETED|Overall Study||75
8439847|NCT00811382|20797642|P1|COMPLETED|Overall Study||88
8439848|NCT00811382|20797641|P2|STARTED|Overall Study||75
8439849|NCT00811382|20797642|P1|STARTED|Overall Study||88
8439850|NCT00811317|20797654|P1|NOT COMPLETED|Overall Study||0
8439851|NCT00811317|20797654|P1|COMPLETED|Overall Study||11
8439852|NCT00811317|20797654|P1|STARTED|Overall Study||11
8439853|NCT00811252|20797683|P3|NOT COMPLETED|Overall Study||23
8439854|NCT00811252|20797684|P2|NOT COMPLETED|Overall Study||20
8439855|NCT00811252|20797685|P1|NOT COMPLETED|Overall Study||17
8439856|NCT00811252|20797683|P3|COMPLETED|Overall Study||128
8439857|NCT00811252|20797684|P2|COMPLETED|Overall Study||136
8439858|NCT00811252|20797685|P1|COMPLETED|Overall Study||128
8439859|NCT00811252|20797683|P3|STARTED|Overall Study||151
8439860|NCT00811252|20797684|P2|STARTED|Overall Study||156
8439861|NCT00811252|20797685|P1|STARTED|Overall Study||145
8439862|NCT00811187|20797731|P2|NOT COMPLETED|Overall Study||3
8439863|NCT00811187|20797732|P1|NOT COMPLETED|Overall Study||3
8439864|NCT00811187|20797731|P2|COMPLETED|Overall Study||37
8439865|NCT00811187|20797732|P1|COMPLETED|Overall Study||37
8439866|NCT00811187|20797731|P2|STARTED|Overall Study||40
8439867|NCT00811187|20797732|P1|STARTED|Overall Study||40
8439868|NCT00811174|20797738|P1|NOT COMPLETED|Overall Study||3
8439869|NCT00811174|20797738|P1|COMPLETED|Overall Study||2
8439870|NCT00811174|20797738|P1|STARTED|Overall Study||5
8439871|NCT00811135|20797749|P1|NOT COMPLETED|Overall Study||88
8439872|NCT00811135|20797749|P1|COMPLETED|Overall Study||0
8439873|NCT00811135|20797749|P1|STARTED|Overall Study||88
8439874|NCT00811070|20797767|P6|NOT COMPLETED|Overall Study||1
8439875|NCT00811070|20797768|P5|NOT COMPLETED|Overall Study||5
8439876|NCT00811070|20797769|P4|NOT COMPLETED|Overall Study||2
8439877|NCT00811070|20797770|P3|NOT COMPLETED|Overall Study||0
8439878|NCT00811070|20797771|P2|NOT COMPLETED|Overall Study||1
8439879|NCT00811070|20797772|P1|NOT COMPLETED|Overall Study||1
8439880|NCT00811070|20797767|P6|COMPLETED|Overall Study||10
8439881|NCT00811070|20797768|P5|COMPLETED|Overall Study||2
8439882|NCT00811070|20797769|P4|COMPLETED|Overall Study||26
8439883|NCT00811070|20797770|P3|COMPLETED|Overall Study||3
8439884|NCT00811070|20797771|P2|COMPLETED|Overall Study||6
8439885|NCT00811070|20797772|P1|COMPLETED|Overall Study||6
8439886|NCT00811070|20797767|P6|STARTED|Overall Study||11
8439887|NCT00811070|20797768|P5|STARTED|Overall Study||7
8439888|NCT00811070|20797769|P4|STARTED|Overall Study||28
8439889|NCT00811070|20797770|P3|STARTED|Overall Study||3
8439890|NCT00811070|20797771|P2|STARTED|Overall Study||7
8439891|NCT00811070|20797772|P1|STARTED|Overall Study||7
8439892|NCT00811057|20797832|P3|NOT COMPLETED|Overall Study||10
8439893|NCT00811057|20797833|P2|NOT COMPLETED|Overall Study||10
8439894|NCT00811057|20797834|P1|NOT COMPLETED|Overall Study||5
8439895|NCT00811057|20797832|P3|COMPLETED|Overall Study||87
8439896|NCT00811057|20797833|P2|COMPLETED|Overall Study||104
8439897|NCT00811057|20797834|P1|COMPLETED|Overall Study||85
8439898|NCT00811057|20797832|P3|STARTED|Overall Study||97
8439899|NCT00811057|20797833|P2|STARTED|Overall Study||114
8439900|NCT00811057|20797834|P1|STARTED|Overall Study||90
8439901|NCT00811018|20797845|P1|NOT COMPLETED|Overall Study||968
8439902|NCT00811018|20797845|P1|COMPLETED|Overall Study||224
8439903|NCT00811018|20797845|P1|STARTED|Overall Study||1192
8439904|NCT00810901|20797863|P2|NOT COMPLETED|Overall Study||58
8439905|NCT00810901|20797864|P1|NOT COMPLETED|Overall Study||88
8439906|NCT00810901|20797863|P2|COMPLETED|Overall Study||118
8439907|NCT00810901|20797864|P1|COMPLETED|Overall Study||165
8439908|NCT00810901|20797863|P2|6-month Follow-up|Overall Study||122
8439909|NCT00810901|20797864|P1|6-month Follow-up|Overall Study||181
8439910|NCT00810901|20797863|P2|1-month Follow up|Overall Study||146
8439911|NCT00810901|20797864|P1|1-month Follow up|Overall Study||242
8439912|NCT00810901|20797863|P2|STARTED|Overall Study||176
8439913|NCT00810901|20797864|P1|STARTED|Overall Study||253
8439914|NCT00810888|20797875|P3|NOT COMPLETED|Overall Study||0
8439915|NCT00810888|20797876|P2|NOT COMPLETED|Overall Study||0
8439916|NCT00810888|20797877|P1|NOT COMPLETED|Overall Study||0
8439917|NCT00810888|20797875|P3|COMPLETED|Overall Study||73
8439918|NCT00810888|20797876|P2|COMPLETED|Overall Study||9
8439919|NCT00810888|20797877|P1|COMPLETED|Overall Study||10
8439920|NCT00810888|20797875|P3|STARTED|Overall Study||73
8439921|NCT00810888|20797876|P2|STARTED|Overall Study||9
8439922|NCT00810888|20797877|P1|STARTED|Overall Study||10
8439923|NCT00810810|20797910|P4|NOT COMPLETED|Overall Study||13
8439924|NCT00810810|20797911|P3|NOT COMPLETED|Overall Study||11
8439925|NCT00810810|20797912|P2|NOT COMPLETED|Overall Study||11
8439926|NCT00810810|20797913|P1|NOT COMPLETED|Overall Study||0
8439927|NCT00810810|20797910|P4|COMPLETED|Overall Study||38
8439928|NCT00810810|20797911|P3|COMPLETED|Overall Study||45
8439929|NCT00810810|20797912|P2|COMPLETED|Overall Study||38
8439930|NCT00810810|20797913|P1|COMPLETED|Overall Study||124
8439931|NCT00810810|20797910|P4|STARTED|Overall Study||51
8439932|NCT00810810|20797911|P3|STARTED|Overall Study||56
8439933|NCT00810810|20797912|P2|STARTED|Overall Study||49
8439934|NCT00810810|20797913|P1|STARTED|Overall Study||124
8439935|NCT00810797|20797927|P1|NOT COMPLETED|Overall Study||0
8439936|NCT00810797|20797927|P1|COMPLETED|Overall Study||36
8439937|NCT00810797|20797927|P1|STARTED|Overall Study||36
8439938|NCT00810771|20797935|P3|NOT COMPLETED|Overall Study||0
8439939|NCT00810771|20797936|P2|NOT COMPLETED|Overall Study||0
8439940|NCT00810771|20797937|P1|NOT COMPLETED|Overall Study||0
8439941|NCT00810771|20797935|P3|COMPLETED|Overall Study||84
8439942|NCT00810771|20797936|P2|COMPLETED|Overall Study||234
8439943|NCT00810771|20797937|P1|COMPLETED|Overall Study||232
8439944|NCT00810771|20797935|P3|STARTED|Overall Study||84
8439945|NCT00810771|20797936|P2|STARTED|Overall Study||234
8439946|NCT00810771|20797937|P1|STARTED|Overall Study||232
8439947|NCT00810719|20797957|P1|NOT COMPLETED|Overall Study||0
8439948|NCT00810719|20797957|P1|COMPLETED|Overall Study||30
8439949|NCT00810719|20797957|P1|STARTED|Overall Study||30
8439950|NCT00810693|20797966|P3|NOT COMPLETED|Follow-up Period (FUP)||4
8439951|NCT00810693|20797967|P2|NOT COMPLETED|Follow-up Period (FUP)||3
8439952|NCT00810693|20797968|P1|NOT COMPLETED|Follow-up Period (FUP)||8
8439953|NCT00810693|20797966|P3|COMPLETED|Follow-up Period (FUP)||12
8439954|NCT00810693|20797967|P2|COMPLETED|Follow-up Period (FUP)||4
8439955|NCT00810693|20797968|P1|COMPLETED|Follow-up Period (FUP)||15
8439956|NCT00810693|20797966|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
8439957|NCT00810693|20797967|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
8439958|NCT00810693|20797968|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
8439959|NCT00810693|20797966|P3|NOT COMPLETED|Treatment Period||16
8439960|NCT00810693|20797967|P2|NOT COMPLETED|Treatment Period||7
8439961|NCT00810693|20797968|P1|NOT COMPLETED|Treatment Period||17
8439962|NCT00810693|20797966|P3|COMPLETED|Treatment Period||111
8439963|NCT00810693|20797967|P2|COMPLETED|Treatment Period||57
8439964|NCT00810693|20797968|P1|COMPLETED|Treatment Period||237
8439965|NCT00810693|20797966|P3|Participants Received Treatment|Treatment Period||126
8439966|NCT00810693|20797967|P2|Participants Received Treatment|Treatment Period||63
8439967|NCT00810693|20797968|P1|Participants Received Treatment|Treatment Period||254
8439968|NCT00810693|20797966|P3|STARTED|Treatment Period|1 randomized but not treated|127
8439969|NCT00810693|20797967|P2|STARTED|Treatment Period|1 randomized but not treated|64
8439970|NCT00810693|20797968|P1|STARTED|Treatment Period||254
8439971|NCT00810641|20798000|P3|NOT COMPLETED|Overall Study||2
8439972|NCT00810641|20798001|P2|NOT COMPLETED|Overall Study||1
8439973|NCT00810641|20798002|P1|NOT COMPLETED|Overall Study||0
8439974|NCT00810641|20798000|P3|COMPLETED|Overall Study||49
8439975|NCT00810641|20798001|P2|COMPLETED|Overall Study||53
8439976|NCT00810641|20798002|P1|COMPLETED|Overall Study||52
8439977|NCT00810641|20798000|P3|STARTED|Overall Study||51
8439978|NCT00810641|20798001|P2|STARTED|Overall Study||54
8439979|NCT00810641|20798002|P1|STARTED|Overall Study||52
8439980|NCT00810615|20798012|P2|NOT COMPLETED|Overall Study||1
8439981|NCT00810615|20798013|P1|NOT COMPLETED|Overall Study||1
8439982|NCT00810615|20798012|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
8439983|NCT00810615|20798013|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
8439984|NCT00810615|20798012|P2|STARTED|Overall Study||25
8439985|NCT00810615|20798013|P1|STARTED|Overall Study||25
8439986|NCT00810602|20798063|P2|NOT COMPLETED|Overall Study||3
8439987|NCT00810602|20798064|P1|NOT COMPLETED|Overall Study||8
8439988|NCT00810602|20798063|P2|COMPLETED|Overall Study||31
8439989|NCT00810602|20798064|P1|COMPLETED|Overall Study||19
8439990|NCT00810602|20798063|P2|STARTED|Overall Study||34
8439991|NCT00810602|20798064|P1|STARTED|Overall Study||27
8439992|NCT00810576|20798071|P1|NOT COMPLETED|Overall Study||0
8439993|NCT00810576|20798071|P1|COMPLETED|Overall Study||1
8439994|NCT00810576|20798071|P1|STARTED|Overall Study||1
8439995|NCT00810511|20798077|P2|NOT COMPLETED|Overall Study||4
8439996|NCT00810511|20798078|P1|NOT COMPLETED|Overall Study||10
8439997|NCT00810511|20798077|P2|COMPLETED|Overall Study||102
8439998|NCT00810511|20798078|P1|COMPLETED|Overall Study||97
8439999|NCT00810511|20798077|P2|STARTED|Overall Study||106
8440000|NCT00810511|20798078|P1|STARTED|Overall Study||107
8440001|NCT00810446|20798084|P1|NOT COMPLETED|Overall Study||0
8440002|NCT00810446|20798084|P1|COMPLETED|Overall Study||72
8440003|NCT00810446|20798084|P1|STARTED|Overall Study||72
8440004|NCT00810407|20798096|P1|NOT COMPLETED|Overall Study||6
8440005|NCT00810407|20798096|P1|COMPLETED|Overall Study||588
8440006|NCT00810407|20798096|P1|STARTED|Overall Study||594
8440007|NCT00810394|20798108|P1|NOT COMPLETED|Overall Study||3
8440008|NCT00810394|20798108|P1|COMPLETED|Overall Study||47
8440009|NCT00810394|20798108|P1|Cycle 3 400mg Twice Daily|Overall Study||5
8440010|NCT00810394|20798108|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
8440011|NCT00810394|20798108|P1|Cycle 2 400mg Once Daily|Overall Study||22
8440012|NCT00810394|20798108|P1|Cycle 2 600mg Twice Daily|Overall Study||13
8440013|NCT00810394|20798108|P1|STARTED|Overall Study||50
8440014|NCT00810368|20798116|P2|NOT COMPLETED|Overall Study||2
8440015|NCT00810368|20798117|P1|NOT COMPLETED|Overall Study||6
8440016|NCT00810368|20798116|P2|COMPLETED|Overall Study||13
8440017|NCT00810368|20798117|P1|COMPLETED|Overall Study||12
8440018|NCT00810368|20798116|P2|STARTED|Overall Study||15
8440019|NCT00810368|20798117|P1|STARTED|Overall Study||18
8440020|NCT00810355|20798138|P3|NOT COMPLETED|Overall Study||11
8440021|NCT00810355|20798139|P2|NOT COMPLETED|Overall Study||17
8440022|NCT00810355|20798140|P1|NOT COMPLETED|Overall Study||14
8440023|NCT00810355|20798138|P3|COMPLETED|Overall Study||14
8440024|NCT00810355|20798139|P2|COMPLETED|Overall Study||8
8440025|NCT00810355|20798140|P1|COMPLETED|Overall Study||11
8440026|NCT00810355|20798138|P3|STARTED|Overall Study||25
8440027|NCT00810355|20798139|P2|STARTED|Overall Study||25
8440028|NCT00810355|20798140|P1|STARTED|Overall Study||25
8440029|NCT00810342|20798156|P2|NOT COMPLETED|12-month Followup||11
8440030|NCT00810342|20798157|P1|NOT COMPLETED|12-month Followup||12
8440031|NCT00810342|20798156|P2|COMPLETED|12-month Followup||136
8440032|NCT00810342|20798157|P1|COMPLETED|12-month Followup||113
8440033|NCT00810342|20798156|P2|STARTED|12-month Followup||147
8440034|NCT00810342|20798157|P1|STARTED|12-month Followup||125
8440035|NCT00810342|20798156|P2|NOT COMPLETED|6-month Follow-up||8
8440036|NCT00810342|20798157|P1|NOT COMPLETED|6-month Follow-up||24
8440037|NCT00810342|20798156|P2|COMPLETED|6-month Follow-up||147
8440038|NCT00810342|20798157|P1|COMPLETED|6-month Follow-up||125
8440039|NCT00810342|20798156|P2|STARTED|6-month Follow-up||155
8440040|NCT00810342|20798157|P1|STARTED|6-month Follow-up||149
8440041|NCT00810342|20798156|P2|NOT COMPLETED|Month 1 Follow-up||2
8440042|NCT00810342|20798157|P1|NOT COMPLETED|Month 1 Follow-up||5
8440043|NCT00810342|20798156|P2|COMPLETED|Month 1 Follow-up||155
8440044|NCT00810342|20798157|P1|COMPLETED|Month 1 Follow-up||149
8440045|NCT00810342|20798156|P2|STARTED|Month 1 Follow-up||157
8440046|NCT00810342|20798157|P1|STARTED|Month 1 Follow-up||154
8440047|NCT00810303|20798165|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
8440048|NCT00810303|20798165|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
8440049|NCT00810303|20798165|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
8440050|NCT00810303|20798165|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
8440051|NCT00810303|20798165|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
8440052|NCT00810303|20798165|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
8440053|NCT00810303|20798165|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
8440054|NCT00810303|20798165|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
8440055|NCT00810303|20798165|P1|STARTED|Ezetimibe Alone - Day 6-15||12
8440056|NCT00810303|20798165|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
8440057|NCT00810303|20798165|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
8440058|NCT00810303|20798165|P1|STARTED|Efavirenz Alone - Day 1-5||12
8440059|NCT00810277|20798190|P1|NOT COMPLETED|Overall Study||1
8440060|NCT00810277|20798190|P1|COMPLETED|Overall Study||13
8440061|NCT00810277|20798190|P1|STARTED|Overall Study||14
8440062|NCT00810264|20798203|P1|NOT COMPLETED|Overall Study||1553
8440063|NCT00810264|20798203|P1|COMPLETED|Overall Study||946
8440064|NCT00810264|20798203|P1|STARTED|Overall Study||2499
8440065|NCT00810199|20798230|P2|NOT COMPLETED|Overall Study||82
8440066|NCT00810199|20798231|P1|NOT COMPLETED|Overall Study||59
8440067|NCT00810199|20798230|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
8440068|NCT00810199|20798231|P1|COMPLETED|Overall Study||220
8440069|NCT00810199|20798230|P2|Completed Week 104|Overall Study||201
8440070|NCT00810199|20798231|P1|Completed Week 104|Overall Study||222
8440071|NCT00810199|20798230|P2|Completed Week 52|Overall Study||229
8440072|NCT00810199|20798231|P1|Completed Week 52|Overall Study||243
8440073|NCT00810199|20798230|P2|Completed Week 24|Overall Study||250
8440074|NCT00810199|20798231|P1|Completed Week 24|Overall Study||259
8440075|NCT00810199|20798230|P2|Received Study Drug|Overall Study||276
8440076|NCT00810199|20798231|P1|Received Study Drug|Overall Study||277
8440077|NCT00810199|20798230|P2|STARTED|Overall Study||277
8440078|NCT00810199|20798231|P1|STARTED|Overall Study||279
8440079|NCT00810108|20798309|P2|NOT COMPLETED|Overall Study||0
8440080|NCT00810108|20798310|P1|NOT COMPLETED|Overall Study||1
8440081|NCT00810108|20798309|P2|COMPLETED|Overall Study||7
8440082|NCT00810108|20798310|P1|COMPLETED|Overall Study||5
8440083|NCT00810108|20798309|P2|STARTED|Overall Study||7
8440084|NCT00810108|20798310|P1|STARTED|Overall Study||6
8440085|NCT00810095|20798315|P1|NOT COMPLETED|Overall Study||0
8440086|NCT00810095|20798315|P1|COMPLETED|Overall Study||40
8440087|NCT00810095|20798315|P1|STARTED|Overall Study||40
8440088|NCT00810082|20798324|P2|NOT COMPLETED|Overall Study||4
8440089|NCT00810082|20798325|P1|NOT COMPLETED|Overall Study||0
8440090|NCT00810082|20798324|P2|COMPLETED|Overall Study||27
8440091|NCT00810082|20798325|P1|COMPLETED|Overall Study||34
8440092|NCT00810082|20798324|P2|STARTED|Overall Study||31
8440093|NCT00810082|20798325|P1|STARTED|Overall Study||34
8440094|NCT00810069|20798333|P3|NOT COMPLETED|Double-Blind Period II||72
8440095|NCT00810069|20798334|P2|NOT COMPLETED|Double-Blind Period II||56
8440096|NCT00810069|20798335|P1|NOT COMPLETED|Double-Blind Period II||0
8440097|NCT00810069|20798333|P3|COMPLETED|Double-Blind Period II||212
8440098|NCT00810069|20798334|P2|COMPLETED|Double-Blind Period II||226
8440099|NCT00810069|20798335|P1|COMPLETED|Double-Blind Period II||0
8440100|NCT00810069|20798333|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
8440101|NCT00810069|20798334|P2|STARTED|Double-Blind Period II||282
8440102|NCT00810069|20798335|P1|STARTED|Double-Blind Period II||0
8440103|NCT00810069|20798333|P3|NOT COMPLETED|Lead-in Period I||0
8440104|NCT00810069|20798334|P2|NOT COMPLETED|Lead-in Period I||0
8440105|NCT00810069|20798335|P1|NOT COMPLETED|Lead-in Period I||274
8440106|NCT00810069|20798333|P3|COMPLETED|Lead-in Period I||0
8440107|NCT00810069|20798334|P2|COMPLETED|Lead-in Period I||0
8440108|NCT00810069|20798335|P1|COMPLETED|Lead-in Period I||566
8440109|NCT00810069|20798333|P3|STARTED|Lead-in Period I||0
8440110|NCT00810069|20798334|P2|STARTED|Lead-in Period I||0
8440111|NCT00810069|20798335|P1|STARTED|Lead-in Period I||840
8440112|NCT00810043|20798380|P3|NOT COMPLETED|Overall Study||8
8440113|NCT00810043|20798381|P2|NOT COMPLETED|Overall Study||1
8440114|NCT00810043|20798382|P1|NOT COMPLETED|Overall Study||4
8440115|NCT00810043|20798380|P3|COMPLETED|Overall Study||0
8440116|NCT00810043|20798381|P2|COMPLETED|Overall Study||54
8440117|NCT00810043|20798382|P1|COMPLETED|Overall Study||53
8440118|NCT00810043|20798380|P3|STARTED|Overall Study||8
8440119|NCT00810043|20798381|P2|STARTED|Overall Study||55
8440120|NCT00810043|20798382|P1|STARTED|Overall Study||57
8440121|NCT00809965|20798404|P3|NOT COMPLETED|Overall Study||844
8440122|NCT00809965|20798405|P2|NOT COMPLETED|Overall Study||775
8440123|NCT00809965|20798406|P1|NOT COMPLETED|Overall Study||783
8440124|NCT00809965|20798404|P3|COMPLETED|Overall Study||4332
8440125|NCT00809965|20798405|P2|COMPLETED|Overall Study||4399
8440126|NCT00809965|20798406|P1|COMPLETED|Overall Study||4393
8440127|NCT00809965|20798404|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
8440128|NCT00809965|20798405|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
8440129|NCT00809965|20798406|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
8440130|NCT00809965|20798404|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
8440131|NCT00809965|20798405|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
8440132|NCT00809965|20798406|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
8440133|NCT00809965|20798404|P3|STARTED|Overall Study||5176
8440134|NCT00809965|20798405|P2|STARTED|Overall Study||5174
8440135|NCT00809965|20798406|P1|STARTED|Overall Study||5176
8440136|NCT00809926|20798428|P2|NOT COMPLETED|Overall Study||23
8440137|NCT00809926|20798429|P1|NOT COMPLETED|Overall Study||31
8440138|NCT00809926|20798428|P2|COMPLETED|Overall Study||196
8440139|NCT00809926|20798429|P1|COMPLETED|Overall Study||201
8440140|NCT00809926|20798428|P2|STARTED|Overall Study||219
8440141|NCT00809926|20798429|P1|STARTED|Overall Study||232
8440142|NCT00809848|20798458|P5|NOT COMPLETED|Overall Study||3
8440143|NCT00809848|20798459|P4|NOT COMPLETED|Overall Study||1
8440144|NCT00809848|20798460|P3|NOT COMPLETED|Overall Study||0
8440145|NCT00809848|20798461|P2|NOT COMPLETED|Overall Study||0
8440146|NCT00809848|20798462|P1|NOT COMPLETED|Overall Study||0
8440147|NCT00809848|20798458|P5|COMPLETED|Overall Study||34
8440148|NCT00809848|20798459|P4|COMPLETED|Overall Study||30
8440149|NCT00809848|20798460|P3|COMPLETED|Overall Study||34
8440150|NCT00809848|20798461|P2|COMPLETED|Overall Study||34
8440151|NCT00809848|20798462|P1|COMPLETED|Overall Study||36
8440152|NCT00809848|20798458|P5|STARTED|Overall Study||37
8440153|NCT00809848|20798459|P4|STARTED|Overall Study||31
8440154|NCT00809848|20798460|P3|STARTED|Overall Study||34
8440155|NCT00809848|20798461|P2|STARTED|Overall Study||34
8440156|NCT00809848|20798462|P1|STARTED|Overall Study||36
8440157|NCT00809835|20798483|P4|NOT COMPLETED|Overall Study||2
8440158|NCT00809835|20798484|P3|NOT COMPLETED|Overall Study||11
8440159|NCT00809835|20798485|P2|NOT COMPLETED|Overall Study||7
8440160|NCT00809835|20798486|P1|NOT COMPLETED|Overall Study||8
8440161|NCT00809835|20798483|P4|COMPLETED|Overall Study||25
8440162|NCT00809835|20798484|P3|COMPLETED|Overall Study||27
8440163|NCT00809835|20798485|P2|COMPLETED|Overall Study||20
8440164|NCT00809835|20798486|P1|COMPLETED|Overall Study||20
8440165|NCT00809835|20798483|P4|STARTED|Overall Study||27
8440166|NCT00809835|20798484|P3|STARTED|Overall Study||38
8440167|NCT00809835|20798485|P2|STARTED|Overall Study||27
8440168|NCT00809835|20798486|P1|STARTED|Overall Study||28
8440169|NCT00809809|20798506|P2|NOT COMPLETED|Overall Study||2
8440170|NCT00809809|20798507|P1|NOT COMPLETED|Overall Study||3
8440171|NCT00809809|20798506|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
8440172|NCT00809809|20798507|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
8440173|NCT00809809|20798506|P2|STARTED|Overall Study||79
8440174|NCT00809809|20798507|P1|STARTED|Overall Study||78
8440175|NCT00809757|20798516|P3|NOT COMPLETED|Overall Study||11
8440176|NCT00809757|20798517|P2|NOT COMPLETED|Overall Study||5
8440177|NCT00809757|20798518|P1|NOT COMPLETED|Overall Study||6
8440178|NCT00809757|20798516|P3|COMPLETED|Overall Study||53
8440179|NCT00809757|20798517|P2|COMPLETED|Overall Study||60
8440180|NCT00809757|20798518|P1|COMPLETED|Overall Study||62
8440181|NCT00809757|20798516|P3|STARTED|Overall Study||64
8440182|NCT00809757|20798517|P2|STARTED|Overall Study||65
8440183|NCT00809757|20798518|P1|STARTED|Overall Study||68
8440184|NCT00809614|20798603|P2|NOT COMPLETED|Overall Study||4
8440185|NCT00809614|20798604|P1|NOT COMPLETED|Overall Study||3
8440186|NCT00809614|20798603|P2|COMPLETED|Overall Study||10
8440187|NCT00809614|20798604|P1|COMPLETED|Overall Study||25
8440188|NCT00809614|20798603|P2|Pharmacodynamic (PD) Set|Overall Study||13
8440189|NCT00809614|20798604|P1|Pharmacodynamic (PD) Set|Overall Study||24
8440190|NCT00809614|20798603|P2|Pharmacokinetic Safety Set|Overall Study||14
8440191|NCT00809614|20798604|P1|Pharmacokinetic Safety Set|Overall Study||27
8440192|NCT00809614|20798603|P2|STARTED|Overall Study||14
8440193|NCT00809614|20798604|P1|STARTED|Overall Study||28
8440194|NCT00809523|20798634|P2|NOT COMPLETED|Overall Study||4
8440195|NCT00809523|20798635|P1|NOT COMPLETED|Overall Study||7
8440196|NCT00809523|20798634|P2|COMPLETED|Overall Study||48
8440197|NCT00809523|20798635|P1|COMPLETED|Overall Study||47
8440198|NCT00809523|20798634|P2|STARTED|Overall Study||52
8440199|NCT00809523|20798635|P1|STARTED|Overall Study||54
8440200|NCT00809471|20798648|P3|NOT COMPLETED|Overall Study||17
8440201|NCT00809471|20798649|P2|NOT COMPLETED|Overall Study||20
8440202|NCT00809471|20798650|P1|NOT COMPLETED|Overall Study||20
8440203|NCT00809471|20798648|P3|COMPLETED|Overall Study||114
8440204|NCT00809471|20798649|P2|COMPLETED|Overall Study||109
8440205|NCT00809471|20798650|P1|COMPLETED|Overall Study||110
8440206|NCT00809471|20798648|P3|STARTED|Overall Study||131
8440207|NCT00809471|20798649|P2|STARTED|Overall Study||129
8440208|NCT00809471|20798650|P1|STARTED|Overall Study||130
8440209|NCT00809458|20798666|P2|NOT COMPLETED|Overall Study||1
8440210|NCT00809458|20798667|P1|NOT COMPLETED|Overall Study||1
8440211|NCT00809458|20798666|P2|COMPLETED|Overall Study||5
8440212|NCT00809458|20798667|P1|COMPLETED|Overall Study||8
8440213|NCT00809458|20798666|P2|STARTED|Overall Study||6
8440214|NCT00809458|20798667|P1|STARTED|Overall Study||9
8440215|NCT00809445|20798680|P3|NOT COMPLETED|6 Month Follow-up||24
8440216|NCT00809445|20798681|P2|NOT COMPLETED|6 Month Follow-up||23
8440217|NCT00809445|20798682|P1|NOT COMPLETED|6 Month Follow-up||24
8440218|NCT00809445|20798680|P3|COMPLETED|6 Month Follow-up||395
8440219|NCT00809445|20798681|P2|COMPLETED|6 Month Follow-up||410
8440220|NCT00809445|20798682|P1|COMPLETED|6 Month Follow-up||405
8440221|NCT00809445|20798680|P3|STARTED|6 Month Follow-up||419
8440222|NCT00809445|20798681|P2|STARTED|6 Month Follow-up||433
8440223|NCT00809445|20798682|P1|STARTED|6 Month Follow-up||429
8440224|NCT00809445|20798680|P3|NOT COMPLETED|1 Month Follow-up||4
8440225|NCT00809445|20798681|P2|NOT COMPLETED|1 Month Follow-up||4
8440226|NCT00809445|20798682|P1|NOT COMPLETED|1 Month Follow-up||2
8440227|NCT00809445|20798680|P3|COMPLETED|1 Month Follow-up||415
8440228|NCT00809445|20798681|P2|COMPLETED|1 Month Follow-up||429
8440229|NCT00809445|20798682|P1|COMPLETED|1 Month Follow-up||427
8440230|NCT00809445|20798680|P3|STARTED|1 Month Follow-up||419
8440231|NCT00809445|20798681|P2|STARTED|1 Month Follow-up||433
8440232|NCT00809445|20798682|P1|STARTED|1 Month Follow-up||429
8440233|NCT00809341|20798701|P2|NOT COMPLETED|Overall Study||1
8440234|NCT00809341|20798702|P1|NOT COMPLETED|Overall Study||0
8440235|NCT00809341|20798701|P2|COMPLETED|Overall Study||4
8440236|NCT00809341|20798702|P1|COMPLETED|Overall Study||20
8440237|NCT00809341|20798701|P2|STARTED|Overall Study||5
8440238|NCT00809341|20798702|P1|STARTED|Overall Study||20
8440239|NCT00809328|20798710|P1|NOT COMPLETED|Overall Study||29
8440240|NCT00809328|20798710|P1|COMPLETED|Overall Study||73
8440241|NCT00809328|20798710|P1|STARTED|Overall Study||102
8440242|NCT00809276|20798718|P1|NOT COMPLETED|Overall Study||0
8440243|NCT00809276|20798718|P1|COMPLETED|Overall Study||92
8440244|NCT00809276|20798718|P1|STARTED|Overall Study||92
8440245|NCT00809185|20798722|P1|NOT COMPLETED|Overall Study||0
8440246|NCT00809185|20798722|P1|COMPLETED|Overall Study||7
8440247|NCT00809185|20798722|P1|STARTED|Overall Study||7
8440248|NCT00809159|20798732|P6|NOT COMPLETED|Part 1 and 2||3
8440249|NCT00809159|20798733|P5|NOT COMPLETED|Part 1 and 2||6
8440250|NCT00809159|20798734|P4|NOT COMPLETED|Part 1 and 2||5
8440251|NCT00809159|20798735|P3|NOT COMPLETED|Part 1 and 2||10
8440252|NCT00809159|20798736|P2|NOT COMPLETED|Part 1 and 2||0
8440253|NCT00809159|20798737|P1|NOT COMPLETED|Part 1 and 2||0
8440254|NCT00809159|20798732|P6|COMPLETED|Part 1 and 2||3
8440255|NCT00809159|20798733|P5|COMPLETED|Part 1 and 2||6
8440256|NCT00809159|20798734|P4|COMPLETED|Part 1 and 2||7
8440257|NCT00809159|20798735|P3|COMPLETED|Part 1 and 2||20
8440258|NCT00809159|20798736|P2|COMPLETED|Part 1 and 2||0
8440259|NCT00809159|20798737|P1|COMPLETED|Part 1 and 2||0
8440260|NCT00809159|20798732|P6|PD Analysis Set|Part 1 and 2||6
8440261|NCT00809159|20798733|P5|PD Analysis Set|Part 1 and 2||12
8440262|NCT00809159|20798734|P4|PD Analysis Set|Part 1 and 2||12
8440263|NCT00809159|20798735|P3|PD Analysis Set|Part 1 and 2||28
8440264|NCT00809159|20798736|P2|PD Analysis Set|Part 1 and 2||0
8440265|NCT00809159|20798737|P1|PD Analysis Set|Part 1 and 2||0
8440266|NCT00809159|20798732|P6|PK Analysis Set|Part 1 and 2||6
8440267|NCT00809159|20798733|P5|PK Analysis Set|Part 1 and 2||12
8440268|NCT00809159|20798734|P4|PK Analysis Set|Part 1 and 2||12
8440269|NCT00809159|20798735|P3|PK Analysis Set|Part 1 and 2||30
8440270|NCT00809159|20798736|P2|PK Analysis Set|Part 1 and 2||0
8440271|NCT00809159|20798737|P1|PK Analysis Set|Part 1 and 2||0
8440272|NCT00809159|20798732|P6|STARTED|Part 1 and 2||6
8440273|NCT00809159|20798733|P5|STARTED|Part 1 and 2||12
8440274|NCT00809159|20798734|P4|STARTED|Part 1 and 2||12
8440275|NCT00809159|20798735|P3|STARTED|Part 1 and 2||30
8440276|NCT00809159|20798736|P2|STARTED|Part 1 and 2||0
8440277|NCT00809159|20798737|P1|STARTED|Part 1 and 2||0
8440278|NCT00809159|20798732|P6|NOT COMPLETED|Part 1||0
8440279|NCT00809159|20798733|P5|NOT COMPLETED|Part 1||0
8440280|NCT00809159|20798734|P4|NOT COMPLETED|Part 1||0
8440281|NCT00809159|20798735|P3|NOT COMPLETED|Part 1||0
8440282|NCT00809159|20798736|P2|NOT COMPLETED|Part 1||3
8440283|NCT00809159|20798737|P1|NOT COMPLETED|Part 1||8
8440284|NCT00809159|20798732|P6|COMPLETED|Part 1||0
8440285|NCT00809159|20798733|P5|COMPLETED|Part 1||0
8440286|NCT00809159|20798734|P4|COMPLETED|Part 1||0
8440287|NCT00809159|20798735|P3|COMPLETED|Part 1||0
8440288|NCT00809159|20798736|P2|COMPLETED|Part 1||3
8440289|NCT00809159|20798737|P1|COMPLETED|Part 1||16
8440290|NCT00809159|20798732|P6|PD Analysis Set|Part 1||0
8440291|NCT00809159|20798733|P5|PD Analysis Set|Part 1||0
8440292|NCT00809159|20798734|P4|PD Analysis Set|Part 1||0
8440293|NCT00809159|20798735|P3|PD Analysis Set|Part 1||0
8440294|NCT00809159|20798736|P2|PD Analysis Set|Part 1||6
8440295|NCT00809159|20798737|P1|PD Analysis Set|Part 1||23
8440296|NCT00809159|20798732|P6|PK Analysis Set|Part 1||0
8440297|NCT00809159|20798733|P5|PK Analysis Set|Part 1||0
8440298|NCT00809159|20798734|P4|PK Analysis Set|Part 1||0
8440299|NCT00809159|20798735|P3|PK Analysis Set|Part 1||0
8440300|NCT00809159|20798736|P2|PK Analysis Set|Part 1||6
8440301|NCT00809159|20798737|P1|PK Analysis Set|Part 1||24
8440302|NCT00809159|20798732|P6|STARTED|Part 1||0
8440303|NCT00809159|20798733|P5|STARTED|Part 1||0
8440304|NCT00809159|20798734|P4|STARTED|Part 1||0
8440305|NCT00809159|20798735|P3|STARTED|Part 1||0
8440306|NCT00809159|20798736|P2|STARTED|Part 1||6
8440307|NCT00809159|20798737|P1|STARTED|Part 1||24
8440308|NCT00809146|20798803|P2|NOT COMPLETED|Overall Study||0
8440309|NCT00809146|20798804|P1|NOT COMPLETED|Overall Study||0
8440310|NCT00809146|20798803|P2|COMPLETED|Overall Study||445
8440311|NCT00809146|20798804|P1|COMPLETED|Overall Study||448
8440312|NCT00809146|20798803|P2|STARTED|Overall Study||445
8440313|NCT00809146|20798804|P1|STARTED|Overall Study||448
8440314|NCT00809133|20798842|P14|NOT COMPLETED|Overall Study||7
8440315|NCT00809133|20798843|P13|NOT COMPLETED|Overall Study||5
8440316|NCT00809133|20798844|P12|NOT COMPLETED|Overall Study||8
8440317|NCT00809133|20798845|P11|NOT COMPLETED|Overall Study||6
8440318|NCT00809133|20798846|P10|NOT COMPLETED|Overall Study||9
8440319|NCT00809133|20798847|P9|NOT COMPLETED|Overall Study||3
8440320|NCT00809133|20798848|P8|NOT COMPLETED|Overall Study||8
8440321|NCT00809133|20798849|P7|NOT COMPLETED|Overall Study||6
8440322|NCT00809133|20798850|P6|NOT COMPLETED|Overall Study||7
8440323|NCT00809133|20798851|P5|NOT COMPLETED|Overall Study||5
8440324|NCT00809133|20798852|P4|NOT COMPLETED|Overall Study||3
8440325|NCT00809133|20798853|P3|NOT COMPLETED|Overall Study||6
8440326|NCT00809133|20798854|P2|NOT COMPLETED|Overall Study||7
8440327|NCT00809133|20798855|P1|NOT COMPLETED|Overall Study||3
8440328|NCT00809133|20798842|P14|COMPLETED|Overall Study||0
8440329|NCT00809133|20798843|P13|COMPLETED|Overall Study||0
8440330|NCT00809133|20798844|P12|COMPLETED|Overall Study||0
8440331|NCT00809133|20798845|P11|COMPLETED|Overall Study||0
8440332|NCT00809133|20798846|P10|COMPLETED|Overall Study||0
8440333|NCT00809133|20798847|P9|COMPLETED|Overall Study||0
8440334|NCT00809133|20798848|P8|COMPLETED|Overall Study||0
8440335|NCT00809133|20798849|P7|COMPLETED|Overall Study||0
8440336|NCT00809133|20798850|P6|COMPLETED|Overall Study||0
8440337|NCT00809133|20798851|P5|COMPLETED|Overall Study||0
8440338|NCT00809133|20798852|P4|COMPLETED|Overall Study||0
8440339|NCT00809133|20798853|P3|COMPLETED|Overall Study||0
8440340|NCT00809133|20798854|P2|COMPLETED|Overall Study||0
8440341|NCT00809133|20798855|P1|COMPLETED|Overall Study||0
8440342|NCT00809133|20798842|P14|STARTED|Overall Study||7
8440343|NCT00809133|20798843|P13|STARTED|Overall Study||5
8440344|NCT00809133|20798844|P12|STARTED|Overall Study||8
8440345|NCT00809133|20798845|P11|STARTED|Overall Study||6
8440346|NCT00809133|20798846|P10|STARTED|Overall Study||9
8440347|NCT00809133|20798847|P9|STARTED|Overall Study||3
8440348|NCT00809133|20798848|P8|STARTED|Overall Study||8
8440349|NCT00809133|20798849|P7|STARTED|Overall Study||6
8440350|NCT00809133|20798850|P6|STARTED|Overall Study||7
8440351|NCT00809133|20798851|P5|STARTED|Overall Study||5
8440352|NCT00809133|20798852|P4|STARTED|Overall Study||3
8440353|NCT00809133|20798853|P3|STARTED|Overall Study||6
8440354|NCT00809133|20798854|P2|STARTED|Overall Study||7
8440355|NCT00809133|20798855|P1|STARTED|Overall Study||3
8440356|NCT00809094|20799009|P2|NOT COMPLETED|Overall Study||1
8440357|NCT00809094|20799010|P1|NOT COMPLETED|Overall Study||0
8440358|NCT00809094|20799009|P2|COMPLETED|Overall Study||33
8440359|NCT00809094|20799010|P1|COMPLETED|Overall Study||36
8440360|NCT00809094|20799009|P2|STARTED|Overall Study||34
8440361|NCT00809094|20799010|P1|STARTED|Overall Study||36
8440362|NCT00809055|20799030|P2|NOT COMPLETED|Overall Study||7
8440363|NCT00809055|20799031|P1|NOT COMPLETED|Overall Study||9
8440364|NCT00809055|20799030|P2|COMPLETED|Overall Study||30
8440365|NCT00809055|20799031|P1|COMPLETED|Overall Study||28
8440366|NCT00809055|20799030|P2|STARTED|Overall Study||37
8440367|NCT00809055|20799031|P1|STARTED|Overall Study||37
8440368|NCT00808899|20799055|P1|NOT COMPLETED|Overall Study||4
8440369|NCT00808899|20799055|P1|COMPLETED|Overall Study||0
8440370|NCT00808899|20799055|P1|STARTED|Overall Study||4
8440371|NCT00808834|20799059|P2|NOT COMPLETED|Period 2||0
8440372|NCT00808834|20799060|P1|NOT COMPLETED|Period 2||0
8440373|NCT00808834|20799059|P2|COMPLETED|Period 2||99
8440374|NCT00808834|20799060|P1|COMPLETED|Period 2||97
8440375|NCT00808834|20799059|P2|STARTED|Period 2||99
8440376|NCT00808834|20799060|P1|STARTED|Period 2||97
8440377|NCT00808834|20799059|P2|NOT COMPLETED|Period 1||0
8440378|NCT00808834|20799060|P1|NOT COMPLETED|Period 1||0
8440379|NCT00808834|20799059|P2|COMPLETED|Period 1||99
8440380|NCT00808834|20799060|P1|COMPLETED|Period 1||97
8440381|NCT00808834|20799059|P2|STARTED|Period 1||99
8440382|NCT00808834|20799060|P1|STARTED|Period 1||97
8440383|NCT00808808|20799069|P3|NOT COMPLETED|Overall Study||2557
8440384|NCT00808808|20799070|P2|NOT COMPLETED|Overall Study||2437
8440385|NCT00808808|20799071|P1|NOT COMPLETED|Overall Study||2817
8440386|NCT00808808|20799069|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
8440387|NCT00808808|20799070|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
8440388|NCT00808808|20799071|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
8440389|NCT00808808|20799069|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
8440390|NCT00808808|20799070|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
8440391|NCT00808808|20799071|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
8440392|NCT00808808|20799069|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
8440393|NCT00808808|20799070|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
8440394|NCT00808808|20799071|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
8440395|NCT00808769|20799097|P2|NOT COMPLETED|Second Intervention||0
8440396|NCT00808769|20799098|P1|NOT COMPLETED|Second Intervention||0
8440397|NCT00808769|20799097|P2|COMPLETED|Second Intervention||15
8440398|NCT00808769|20799098|P1|COMPLETED|Second Intervention||15
8440399|NCT00808769|20799097|P2|STARTED|Second Intervention||15
8440400|NCT00808769|20799098|P1|STARTED|Second Intervention||15
8440401|NCT00808769|20799097|P2|NOT COMPLETED|First Intervention||0
8440402|NCT00808769|20799098|P1|NOT COMPLETED|First Intervention||0
8440403|NCT00808769|20799097|P2|COMPLETED|First Intervention||15
8440404|NCT00808769|20799098|P1|COMPLETED|First Intervention||15
8440405|NCT00808769|20799097|P2|STARTED|First Intervention||15
8440406|NCT00808769|20799098|P1|STARTED|First Intervention||15
8440407|NCT00808665|20799106|P2|NOT COMPLETED|Overall Study||3
8440408|NCT00808665|20799107|P1|NOT COMPLETED|Overall Study||6
8440409|NCT00808665|20799106|P2|COMPLETED|Overall Study||29
8440410|NCT00808665|20799107|P1|COMPLETED|Overall Study||25
8440411|NCT00808665|20799106|P2|Completed Post Operative Doses|Overall Study||29
8440412|NCT00808665|20799107|P1|Completed Post Operative Doses|Overall Study||25
8440413|NCT00808665|20799106|P2|Completed Intra-operative Dose|Overall Study||32
8440414|NCT00808665|20799107|P1|Completed Intra-operative Dose|Overall Study||26
8440415|NCT00808665|20799106|P2|Medication Started|Overall Study||32
8440416|NCT00808665|20799107|P1|Medication Started|Overall Study||30
8440417|NCT00808665|20799106|P2|STARTED|Overall Study||32
8440418|NCT00808665|20799107|P1|STARTED|Overall Study||31
8440419|NCT00808639|20799113|P1|NOT COMPLETED|Overall Study||1
8440420|NCT00808639|20799113|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
8440421|NCT00808639|20799113|P1|STARTED|Overall Study||39
8440422|NCT00808509|20799121|P2|NOT COMPLETED|Observation Phase||0
8440423|NCT00808509|20799122|P1|NOT COMPLETED|Observation Phase||0
8440424|NCT00808509|20799121|P2|COMPLETED|Observation Phase||15
8440425|NCT00808509|20799122|P1|COMPLETED|Observation Phase||16
8440426|NCT00808509|20799121|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
8440427|NCT00808509|20799122|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
8440428|NCT00808509|20799121|P2|NOT COMPLETED|Randomized Phase||5
8440429|NCT00808509|20799122|P1|NOT COMPLETED|Randomized Phase||2
8440430|NCT00808509|20799121|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
8440431|NCT00808509|20799122|P1|COMPLETED|Randomized Phase||15
8440432|NCT00808509|20799121|P2|Received Rescue Therapy|Randomized Phase||9
8440433|NCT00808509|20799122|P1|Received Rescue Therapy|Randomized Phase||0
8440434|NCT00808509|20799121|P2|STARTED|Randomized Phase||16
8440435|NCT00808509|20799122|P1|STARTED|Randomized Phase||17
8440436|NCT00808483|20799220|P2|NOT COMPLETED|From 5 Months to 12 Months||0
8440437|NCT00808483|20799221|P1|NOT COMPLETED|From 5 Months to 12 Months||1
8440438|NCT00808483|20799220|P2|COMPLETED|From 5 Months to 12 Months||32
8440439|NCT00808483|20799221|P1|COMPLETED|From 5 Months to 12 Months||32
8440440|NCT00808483|20799220|P2|STARTED|From 5 Months to 12 Months||32
8440441|NCT00808483|20799221|P1|STARTED|From 5 Months to 12 Months||33
8440442|NCT00808483|20799220|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
8440443|NCT00808483|20799221|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
8440444|NCT00808483|20799220|P2|COMPLETED|From 3 to 5 Months After Surgery||32
8440445|NCT00808483|20799221|P1|COMPLETED|From 3 to 5 Months After Surgery||33
8440446|NCT00808483|20799220|P2|STARTED|From 3 to 5 Months After Surgery||33
8440447|NCT00808483|20799221|P1|STARTED|From 3 to 5 Months After Surgery||35
8440448|NCT00808470|20799243|P2|NOT COMPLETED|Overall Study||0
8440449|NCT00808470|20799244|P1|NOT COMPLETED|Overall Study||2
8440450|NCT00808470|20799243|P2|COMPLETED|Overall Study||35
8440451|NCT00808470|20799244|P1|COMPLETED|Overall Study||35
8440452|NCT00808470|20799243|P2|STARTED|Overall Study||35
8440453|NCT00808470|20799244|P1|STARTED|Overall Study||37
8440454|NCT00808444|20799258|P2|NOT COMPLETED|Overall Study||1
8440455|NCT00808444|20799259|P1|NOT COMPLETED|Overall Study||1
8440456|NCT00808444|20799258|P2|COMPLETED|Overall Study||232
8440457|NCT00808444|20799259|P1|COMPLETED|Overall Study||232
8440458|NCT00808444|20799258|P2|STARTED|Overall Study||233
8440459|NCT00808444|20799259|P1|STARTED|Overall Study||233
8440460|NCT00808405|20799299|P2|NOT COMPLETED|Overall Study||0
8440461|NCT00808405|20799300|P1|NOT COMPLETED|Overall Study||0
8440462|NCT00808405|20799299|P2|COMPLETED|Overall Study||27
8440463|NCT00808405|20799300|P1|COMPLETED|Overall Study||61
8440464|NCT00808405|20799299|P2|STARTED|Overall Study||27
8440465|NCT00808405|20799300|P1|STARTED|Overall Study||61
8440466|NCT00808340|20799308|P6|NOT COMPLETED|Third Intervention||0
8440467|NCT00808340|20799309|P5|NOT COMPLETED|Third Intervention||0
8440468|NCT00808340|20799310|P4|NOT COMPLETED|Third Intervention||0
8440469|NCT00808340|20799311|P3|NOT COMPLETED|Third Intervention||0
8440470|NCT00808340|20799312|P2|NOT COMPLETED|Third Intervention||0
8440471|NCT00808340|20799313|P1|NOT COMPLETED|Third Intervention||0
8440472|NCT00808340|20799308|P6|COMPLETED|Third Intervention||6
8440473|NCT00808340|20799309|P5|COMPLETED|Third Intervention||5
8440474|NCT00808340|20799310|P4|COMPLETED|Third Intervention||3
8440475|NCT00808340|20799311|P3|COMPLETED|Third Intervention||7
8440476|NCT00808340|20799312|P2|COMPLETED|Third Intervention||9
8440477|NCT00808340|20799313|P1|COMPLETED|Third Intervention||4
8440478|NCT00808340|20799308|P6|STARTED|Third Intervention||6
8440479|NCT00808340|20799309|P5|STARTED|Third Intervention||5
8440480|NCT00808340|20799310|P4|STARTED|Third Intervention||3
8440481|NCT00808340|20799311|P3|STARTED|Third Intervention||7
8440482|NCT00808340|20799312|P2|STARTED|Third Intervention||9
8440483|NCT00808340|20799313|P1|STARTED|Third Intervention||4
8440484|NCT00808340|20799308|P6|NOT COMPLETED|Second Intervention||0
8440485|NCT00808340|20799309|P5|NOT COMPLETED|Second Intervention||0
8440486|NCT00808340|20799310|P4|NOT COMPLETED|Second Intervention||0
8440487|NCT00808340|20799311|P3|NOT COMPLETED|Second Intervention||0
8440488|NCT00808340|20799312|P2|NOT COMPLETED|Second Intervention||0
8440489|NCT00808340|20799313|P1|NOT COMPLETED|Second Intervention||0
8440490|NCT00808340|20799308|P6|COMPLETED|Second Intervention||6
8440491|NCT00808340|20799309|P5|COMPLETED|Second Intervention||5
8440492|NCT00808340|20799310|P4|COMPLETED|Second Intervention||3
8440493|NCT00808340|20799311|P3|COMPLETED|Second Intervention||7
8440494|NCT00808340|20799312|P2|COMPLETED|Second Intervention||9
8440495|NCT00808340|20799313|P1|COMPLETED|Second Intervention||4
8440496|NCT00808340|20799308|P6|STARTED|Second Intervention||6
8440497|NCT00808340|20799309|P5|STARTED|Second Intervention||5
8440498|NCT00808340|20799310|P4|STARTED|Second Intervention||3
8440499|NCT00808340|20799311|P3|STARTED|Second Intervention||7
8440500|NCT00808340|20799312|P2|STARTED|Second Intervention||9
8440501|NCT00808340|20799313|P1|STARTED|Second Intervention||4
8440502|NCT00808340|20799308|P6|NOT COMPLETED|First Intervention||0
8440503|NCT00808340|20799309|P5|NOT COMPLETED|First Intervention||0
8440504|NCT00808340|20799310|P4|NOT COMPLETED|First Intervention||0
8440505|NCT00808340|20799311|P3|NOT COMPLETED|First Intervention||0
8440506|NCT00808340|20799312|P2|NOT COMPLETED|First Intervention||0
8440507|NCT00808340|20799313|P1|NOT COMPLETED|First Intervention||0
8440508|NCT00808340|20799308|P6|COMPLETED|First Intervention||6
8440509|NCT00808340|20799309|P5|COMPLETED|First Intervention||5
8440510|NCT00808340|20799310|P4|COMPLETED|First Intervention||3
8440511|NCT00808340|20799311|P3|COMPLETED|First Intervention||7
8440512|NCT00808340|20799312|P2|COMPLETED|First Intervention||9
8440513|NCT00808340|20799313|P1|COMPLETED|First Intervention||4
8440514|NCT00808340|20799308|P6|STARTED|First Intervention||6
8440515|NCT00808340|20799309|P5|STARTED|First Intervention||5
8440516|NCT00808340|20799310|P4|STARTED|First Intervention||3
8440517|NCT00808340|20799311|P3|STARTED|First Intervention||7
8440518|NCT00808340|20799312|P2|STARTED|First Intervention||9
8440519|NCT00808340|20799313|P1|STARTED|First Intervention||4
8440520|NCT00808249|20799334|P4|NOT COMPLETED|Overall Study||16
8440521|NCT00808249|20799335|P3|NOT COMPLETED|Overall Study||22
8440522|NCT00808249|20799336|P2|NOT COMPLETED|Overall Study||15
8440523|NCT00808249|20799337|P1|NOT COMPLETED|Overall Study||17
8440524|NCT00808249|20799334|P4|COMPLETED|Overall Study||90
8440525|NCT00808249|20799335|P3|COMPLETED|Overall Study||83
8440526|NCT00808249|20799336|P2|COMPLETED|Overall Study||91
8440527|NCT00808249|20799337|P1|COMPLETED|Overall Study||90
8440528|NCT00808249|20799334|P4|STARTED|Overall Study||106
8440529|NCT00808249|20799335|P3|STARTED|Overall Study||105
8440530|NCT00808249|20799336|P2|STARTED|Overall Study||106
8440531|NCT00808249|20799337|P1|STARTED|Overall Study||107
8440532|NCT00808236|20799365|P2|NOT COMPLETED|Overall Study||91
8440533|NCT00808236|20799366|P1|NOT COMPLETED|Overall Study||82
8440534|NCT00808236|20799365|P2|COMPLETED|Overall Study||13
8440535|NCT00808236|20799366|P1|COMPLETED|Overall Study||14
8440536|NCT00808236|20799365|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
8440537|NCT00808236|20799366|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
8440538|NCT00808236|20799365|P2|Achieved ROSC|Overall Study||43
8440539|NCT00808236|20799366|P1|Achieved ROSC|Overall Study||33
8440540|NCT00808236|20799365|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
8440541|NCT00808236|20799366|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
8440542|NCT00808236|20799365|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
8440543|NCT00808236|20799366|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
8440544|NCT00808236|20799365|P2|STARTED|Overall Study||104
8440545|NCT00808236|20799366|P1|STARTED|Overall Study||96
8440546|NCT00808210|20799396|P2|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
8440547|NCT00808210|20799397|P1|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
8440548|NCT00808210|20799396|P2|COMPLETED|Open Label Ocrelizumab Treatment Period||0
8440549|NCT00808210|20799397|P1|COMPLETED|Open Label Ocrelizumab Treatment Period||0
8440550|NCT00808210|20799396|P2|STARTED|Open Label Ocrelizumab Treatment Period||4
8440551|NCT00808210|20799397|P1|STARTED|Open Label Ocrelizumab Treatment Period||9
8440552|NCT00808210|20799396|P2|NOT COMPLETED|Double-Blind TX Period||3
8440553|NCT00808210|20799397|P1|NOT COMPLETED|Double-Blind TX Period||2
8440554|NCT00808210|20799396|P2|COMPLETED|Double-Blind TX Period||10
8440555|NCT00808210|20799397|P1|COMPLETED|Double-Blind TX Period||13
8440556|NCT00808210|20799396|P2|STARTED|Double-Blind TX Period||13
8440557|NCT00808210|20799397|P1|STARTED|Double-Blind TX Period||15
8440558|NCT00808210|20799396|P2|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
8440559|NCT00808210|20799397|P1|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
8440560|NCT00808210|20799396|P2|COMPLETED|Study Period + 48 Weeks of Follow-up||4
8440561|NCT00808210|20799397|P1|COMPLETED|Study Period + 48 Weeks of Follow-up||6
8440562|NCT00808210|20799396|P2|STARTED|Study Period + 48 Weeks of Follow-up||13
8440563|NCT00808210|20799397|P1|STARTED|Study Period + 48 Weeks of Follow-up||15
8440564|NCT00808132|20799422|P5|NOT COMPLETED|Overall Study||100
8440565|NCT00808132|20799423|P4|NOT COMPLETED|Overall Study||69
8440566|NCT00808132|20799424|P3|NOT COMPLETED|Overall Study||54
8440567|NCT00808132|20799425|P2|NOT COMPLETED|Overall Study||88
8440568|NCT00808132|20799426|P1|NOT COMPLETED|Overall Study||98
8440569|NCT00808132|20799422|P5|COMPLETED|Overall Study||383
8440570|NCT00808132|20799423|P4|COMPLETED|Overall Study||159
8440571|NCT00808132|20799424|P3|COMPLETED|Overall Study||185
8440572|NCT00808132|20799425|P2|COMPLETED|Overall Study||393
8440573|NCT00808132|20799426|P1|COMPLETED|Overall Study||357
8440574|NCT00808132|20799422|P5|Treated|Overall Study||474
8440575|NCT00808132|20799423|P4|Treated|Overall Study||220
8440576|NCT00808132|20799424|P3|Treated|Overall Study||230
8440577|NCT00808132|20799425|P2|Treated|Overall Study||474
8440578|NCT00808132|20799426|P1|Treated|Overall Study||445
8440579|NCT00808132|20799422|P5|STARTED|Overall Study||483
8440580|NCT00808132|20799423|P4|STARTED|Overall Study||228
8440581|NCT00808132|20799424|P3|STARTED|Overall Study||239
8440582|NCT00808132|20799425|P2|STARTED|Overall Study||481
8440583|NCT00808132|20799426|P1|STARTED|Overall Study||455
8440584|NCT00808080|20799498|P1|NOT COMPLETED|Overall Study||6
8440585|NCT00808080|20799498|P1|COMPLETED|Overall Study||0
8440586|NCT00808080|20799498|P1|STARTED|Overall Study||6
8440587|NCT00808067|20799505|P2|NOT COMPLETED|Overall Study||518
8440588|NCT00808067|20799506|P1|NOT COMPLETED|Overall Study||481
8440589|NCT00808067|20799505|P2|COMPLETED|Overall Study||2438
8440590|NCT00808067|20799506|P1|COMPLETED|Overall Study||2446
8440591|NCT00808067|20799505|P2|STARTED|Overall Study|Number of patients which are treated.|2956
8440592|NCT00808067|20799506|P1|STARTED|Overall Study|Number of patients which are treated.|2927
8440593|NCT00808028|20799542|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
8440594|NCT00808028|20799543|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
8440595|NCT00808028|20799544|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
8440596|NCT00808028|20799545|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
8440597|NCT00808028|20799542|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
8440598|NCT00808028|20799543|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
8440599|NCT00808028|20799544|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
8440600|NCT00808028|20799545|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
8440601|NCT00808028|20799542|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
8440602|NCT00808028|20799543|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
8440603|NCT00808028|20799544|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
8440604|NCT00808028|20799545|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
8440605|NCT00808028|20799542|P4|NOT COMPLETED|Stage 1 (6 Months)||15
8440606|NCT00808028|20799543|P3|NOT COMPLETED|Stage 1 (6 Months)||7
8440607|NCT00808028|20799544|P2|NOT COMPLETED|Stage 1 (6 Months)||1
8440608|NCT00808028|20799545|P1|NOT COMPLETED|Stage 1 (6 Months)||5
8440609|NCT00808028|20799542|P4|COMPLETED|Stage 1 (6 Months)||183
8440610|NCT00808028|20799543|P3|COMPLETED|Stage 1 (6 Months)||191
8440611|NCT00808028|20799544|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
8440612|NCT00808028|20799545|P1|COMPLETED|Stage 1 (6 Months)||116
8440613|NCT00808028|20799542|P4|STARTED|Stage 1 (6 Months)||198
8440614|NCT00808028|20799543|P3|STARTED|Stage 1 (6 Months)||198
8440615|NCT00808028|20799544|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
8440616|NCT00808028|20799545|P1|STARTED|Stage 1 (6 Months)||121
8440617|NCT00808015|20799581|P1|NOT COMPLETED|Overall Study||344
8440618|NCT00808015|20799581|P1|COMPLETED|Overall Study||1033
8440619|NCT00808015|20799581|P1|Treated|Overall Study||1373
8440620|NCT00808015|20799581|P1|STARTED|Overall Study||1377
8440621|NCT00807989|20799595|P2|NOT COMPLETED|Overall Study||2
8440622|NCT00807989|20799596|P1|NOT COMPLETED|Overall Study||3
8440623|NCT00807989|20799595|P2|COMPLETED|Overall Study||98
8440624|NCT00807989|20799596|P1|COMPLETED|Overall Study||104
8440625|NCT00807989|20799595|P2|STARTED|Overall Study||100
8440626|NCT00807989|20799596|P1|STARTED|Overall Study||107
8440627|NCT00807937|20799610|P4|NOT COMPLETED|Overall Study||15
8440628|NCT00807937|20799611|P3|NOT COMPLETED|Overall Study||14
8440629|NCT00807937|20799612|P2|NOT COMPLETED|Overall Study||25
8440630|NCT00807937|20799613|P1|NOT COMPLETED|Overall Study||27
8440631|NCT00807937|20799610|P4|COMPLETED|Overall Study||77
8440632|NCT00807937|20799611|P3|COMPLETED|Overall Study||78
8440633|NCT00807937|20799612|P2|COMPLETED|Overall Study||67
8440634|NCT00807937|20799613|P1|COMPLETED|Overall Study||66
8440635|NCT00807937|20799610|P4|STARTED|Overall Study||92
8440636|NCT00807937|20799611|P3|STARTED|Overall Study||92
8440637|NCT00807937|20799612|P2|STARTED|Overall Study||92
8440638|NCT00807937|20799613|P1|STARTED|Overall Study||93
8440639|NCT00807885|20799648|P9|NOT COMPLETED|Overall Study||0
8440640|NCT00807885|20799649|P8|NOT COMPLETED|Overall Study||0
8440641|NCT00807885|20799650|P7|NOT COMPLETED|Overall Study||0
8440642|NCT00807885|20799651|P6|NOT COMPLETED|Overall Study||1
8440643|NCT00807885|20799652|P5|NOT COMPLETED|Overall Study||0
8440644|NCT00807885|20799653|P4|NOT COMPLETED|Overall Study||0
8440645|NCT00807885|20799654|P3|NOT COMPLETED|Overall Study||0
8440646|NCT00807885|20799655|P2|NOT COMPLETED|Overall Study||0
8440647|NCT00807885|20799656|P1|NOT COMPLETED|Overall Study||0
8440648|NCT00807885|20799648|P9|COMPLETED|Overall Study||11
8440649|NCT00807885|20799649|P8|COMPLETED|Overall Study||11
8440650|NCT00807885|20799650|P7|COMPLETED|Overall Study||12
8440651|NCT00807885|20799651|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
8440652|NCT00807885|20799652|P5|COMPLETED|Overall Study||12
8440653|NCT00807885|20799653|P4|COMPLETED|Overall Study||10
8440654|NCT00807885|20799654|P3|COMPLETED|Overall Study||11
8440655|NCT00807885|20799655|P2|COMPLETED|Overall Study||11
8440656|NCT00807885|20799656|P1|COMPLETED|Overall Study||10
8440657|NCT00807885|20799648|P9|STARTED|Overall Study||11
8440658|NCT00807885|20799649|P8|STARTED|Overall Study||11
8440659|NCT00807885|20799650|P7|STARTED|Overall Study||12
8440660|NCT00807885|20799651|P6|STARTED|Overall Study||12
8440661|NCT00807885|20799652|P5|STARTED|Overall Study||12
8440662|NCT00807885|20799653|P4|STARTED|Overall Study||10
8440663|NCT00807885|20799654|P3|STARTED|Overall Study||11
8440664|NCT00807885|20799655|P2|STARTED|Overall Study||11
8440665|NCT00807885|20799656|P1|STARTED|Overall Study||10
8440672|NCT00807768|20799740|P2|NOT COMPLETED|Overall Study||0
8440673|NCT00807768|20799741|P1|NOT COMPLETED|Overall Study||0
8440674|NCT00807768|20799740|P2|COMPLETED|Overall Study||300
8440675|NCT00807768|20799741|P1|COMPLETED|Overall Study||301
8440676|NCT00807768|20799740|P2|STARTED|Overall Study||300
8440677|NCT00807768|20799741|P1|STARTED|Overall Study||301
8440678|NCT00807742|20799759|P2|NOT COMPLETED|Overall Study||54
8440679|NCT00807742|20799760|P1|NOT COMPLETED|Overall Study||46
8440680|NCT00807742|20799759|P2|COMPLETED|Overall Study||114
8440681|NCT00807742|20799760|P1|COMPLETED|Overall Study||126
8440682|NCT00807742|20799759|P2|STARTED|Overall Study||168
8440683|NCT00807742|20799760|P1|STARTED|Overall Study||172
8440684|NCT00807664|20799806|P2|NOT COMPLETED|Overall Study||19
8440685|NCT00807664|20799807|P1|NOT COMPLETED|Overall Study||11
8440686|NCT00807664|20799806|P2|COMPLETED|Overall Study||75
8440687|NCT00807664|20799807|P1|COMPLETED|Overall Study||77
8440688|NCT00807664|20799806|P2|STARTED|Overall Study||94
8440689|NCT00807664|20799807|P1|STARTED|Overall Study||88
8440690|NCT00807599|20799819|P3|NOT COMPLETED|Overall Study||17
8440691|NCT00807599|20799820|P2|NOT COMPLETED|Overall Study||0
8440692|NCT00807599|20799821|P1|NOT COMPLETED|Overall Study||0
8440693|NCT00807599|20799819|P3|COMPLETED|Overall Study||0
8440694|NCT00807599|20799820|P2|COMPLETED|Overall Study||24
8440695|NCT00807599|20799821|P1|COMPLETED|Overall Study||26
8440696|NCT00807599|20799819|P3|STARTED|Overall Study||17
8440697|NCT00807599|20799820|P2|STARTED|Overall Study||24
8440698|NCT00807599|20799821|P1|STARTED|Overall Study||26
8440699|NCT00807586|20799835|P2|NOT COMPLETED|Overall Study||1
8440700|NCT00807586|20799836|P1|NOT COMPLETED|Overall Study||6
8440701|NCT00807586|20799835|P2|COMPLETED|Overall Study||58
8440702|NCT00807586|20799836|P1|COMPLETED|Overall Study||54
8440703|NCT00807586|20799835|P2|STARTED|Overall Study||59
8440704|NCT00807586|20799836|P1|STARTED|Overall Study||60
8440705|NCT00807573|20799848|P1|NOT COMPLETED|Overall Study||2
8440706|NCT00807573|20799848|P1|COMPLETED|Overall Study||42
8440707|NCT00807573|20799848|P1|STARTED|Overall Study||44
8440708|NCT00807560|20799854|P2|NOT COMPLETED|Overall Study||0
8440709|NCT00807560|20799855|P1|NOT COMPLETED|Overall Study||0
8440710|NCT00807560|20799854|P2|COMPLETED|Overall Study||39
8440711|NCT00807560|20799855|P1|COMPLETED|Overall Study||38
8440712|NCT00807560|20799854|P2|STARTED|Overall Study||39
8440713|NCT00807560|20799855|P1|STARTED|Overall Study||38
8440714|NCT00807495|20799894|P5|NOT COMPLETED|Overall Study||5
8440715|NCT00807495|20799895|P4|NOT COMPLETED|Overall Study||1
8440716|NCT00807495|20799896|P3|NOT COMPLETED|Overall Study||4
8440717|NCT00807495|20799897|P2|NOT COMPLETED|Overall Study||6
8440718|NCT00807495|20799898|P1|NOT COMPLETED|Overall Study||8
8440719|NCT00807495|20799894|P5|COMPLETED|Overall Study||2
8440720|NCT00807495|20799895|P4|COMPLETED|Overall Study||0
8440721|NCT00807495|20799896|P3|COMPLETED|Overall Study||1
8440722|NCT00807495|20799897|P2|COMPLETED|Overall Study||7
8440723|NCT00807495|20799898|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
8440724|NCT00807495|20799894|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
8440725|NCT00807495|20799895|P4|STARTED|Overall Study||1
8440726|NCT00807495|20799896|P3|STARTED|Overall Study||5
8440727|NCT00807495|20799897|P2|STARTED|Overall Study||13
8440728|NCT00807495|20799898|P1|STARTED|Overall Study||22
8440729|NCT00807456|20799940|P1|NOT COMPLETED|Overall Study||0
8440730|NCT00807456|20799940|P1|COMPLETED|Overall Study||65
8440731|NCT00807456|20799940|P1|STARTED|Overall Study||65
8440732|NCT00807365|20799944|P1|NOT COMPLETED|Overall Study||5
8440733|NCT00807365|20799944|P1|COMPLETED|Overall Study||0
8440734|NCT00807365|20799944|P1|STARTED|Overall Study||5
8440735|NCT00807248|20799952|P4|NOT COMPLETED|Overall Study||14
8440736|NCT00807248|20799953|P3|NOT COMPLETED|Overall Study||18
8440737|NCT00807248|20799954|P2|NOT COMPLETED|Overall Study||12
8440738|NCT00807248|20799955|P1|NOT COMPLETED|Overall Study||21
8440739|NCT00807248|20799952|P4|COMPLETED|Overall Study||126
8440740|NCT00807248|20799953|P3|COMPLETED|Overall Study||121
8440741|NCT00807248|20799954|P2|COMPLETED|Overall Study||128
8440742|NCT00807248|20799955|P1|COMPLETED|Overall Study||50
8440743|NCT00807248|20799952|P4|STARTED|Overall Study||140
8440744|NCT00807248|20799953|P3|STARTED|Overall Study||139
8440745|NCT00807248|20799954|P2|STARTED|Overall Study||140
8440746|NCT00807248|20799955|P1|STARTED|Overall Study||71
8440747|NCT00807235|20799999|P2|NOT COMPLETED|Overall Study||0
8440748|NCT00807235|20800000|P1|NOT COMPLETED|Overall Study||1
8440749|NCT00807235|20799999|P2|COMPLETED|Overall Study||6
8440750|NCT00807235|20800000|P1|COMPLETED|Overall Study||10
8440751|NCT00807235|20799999|P2|STARTED|Overall Study||6
8440752|NCT00807235|20800000|P1|STARTED|Overall Study||11
8440753|NCT00807209|20800033|P3|NOT COMPLETED|Overall Study||0
8440754|NCT00807209|20800034|P2|NOT COMPLETED|Overall Study||0
8440755|NCT00807209|20800035|P1|NOT COMPLETED|Overall Study||0
8440756|NCT00807209|20800033|P3|COMPLETED|Overall Study||1
8440757|NCT00807209|20800034|P2|COMPLETED|Overall Study||1
8440758|NCT00807209|20800035|P1|COMPLETED|Overall Study||1
8440759|NCT00807209|20800033|P3|STARTED|Overall Study||1
8440760|NCT00807209|20800034|P2|STARTED|Overall Study||1
8440761|NCT00807209|20800035|P1|STARTED|Overall Study||1
8440762|NCT00807092|20800045|P2|NOT COMPLETED|Overall Study||4
8440763|NCT00807092|20800046|P1|NOT COMPLETED|Overall Study||1
8440764|NCT00807092|20800045|P2|COMPLETED|Overall Study||69
8440765|NCT00807092|20800046|P1|COMPLETED|Overall Study||71
8440766|NCT00807092|20800045|P2|Exposed to Drug|Overall Study||73
8440767|NCT00807092|20800046|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
8440768|NCT00807092|20800045|P2|STARTED|Overall Study||73
8440769|NCT00807092|20800046|P1|STARTED|Overall Study||72
8440770|NCT00807040|20800076|P2|NOT COMPLETED|Overall Study||41
8440771|NCT00807040|20800077|P1|NOT COMPLETED|Overall Study||36
8440772|NCT00807040|20800076|P2|COMPLETED|Overall Study||84
8440773|NCT00807040|20800077|P1|COMPLETED|Overall Study||90
8440774|NCT00807040|20800076|P2|STARTED|Overall Study||125
8440775|NCT00807040|20800077|P1|STARTED|Overall Study||126
8440776|NCT00807014|20800087|P2|NOT COMPLETED|Overall Study||27
8440777|NCT00807014|20800088|P1|NOT COMPLETED|Overall Study||27
8440778|NCT00807014|20800087|P2|COMPLETED|Overall Study||58
8440779|NCT00807014|20800088|P1|COMPLETED|Overall Study||56
8440780|NCT00807014|20800087|P2|STARTED|Overall Study||85
8440781|NCT00807014|20800088|P1|STARTED|Overall Study||83
8440782|NCT00807001|20800119|P5|NOT COMPLETED|Overall Study||0
8440783|NCT00807001|20800120|P4|NOT COMPLETED|Overall Study||0
8440784|NCT00807001|20800121|P3|NOT COMPLETED|Overall Study||0
8440785|NCT00807001|20800122|P2|NOT COMPLETED|Overall Study||1
8440786|NCT00807001|20800123|P1|NOT COMPLETED|Overall Study||0
8440787|NCT00807001|20800119|P5|COMPLETED|Overall Study||9
8440788|NCT00807001|20800120|P4|COMPLETED|Overall Study||8
8440789|NCT00807001|20800121|P3|COMPLETED|Overall Study||8
8440790|NCT00807001|20800122|P2|COMPLETED|Overall Study||7
8440791|NCT00807001|20800123|P1|COMPLETED|Overall Study||8
8440792|NCT00807001|20800119|P5|STARTED|Overall Study||9
8440793|NCT00807001|20800120|P4|STARTED|Overall Study||8
8440794|NCT00807001|20800121|P3|STARTED|Overall Study||8
8440795|NCT00807001|20800122|P2|STARTED|Overall Study||8
8440796|NCT00807001|20800123|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
8440797|NCT00806988|20800142|P2|NOT COMPLETED|Overall Study||43
8440798|NCT00806988|20800143|P1|NOT COMPLETED|Overall Study||27
8440799|NCT00806988|20800142|P2|COMPLETED|Overall Study||108
8440800|NCT00806988|20800143|P1|COMPLETED|Overall Study||123
8440801|NCT00806988|20800142|P2|STARTED|Overall Study||151
8440802|NCT00806988|20800143|P1|STARTED|Overall Study||150
8440803|NCT00806819|20800153|P2|NOT COMPLETED|Overall Study||358
8440804|NCT00806819|20800154|P1|NOT COMPLETED|Overall Study||346
8440805|NCT00806819|20800153|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
8440806|NCT00806819|20800154|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
8440807|NCT00806819|20800153|P2|STARTED|Overall Study|randomised patients|360
8440808|NCT00806819|20800154|P1|STARTED|Overall Study|randomised patients|353
8440809|NCT00806676|20800189|P3|NOT COMPLETED|Overall Study||6
8440810|NCT00806676|20800190|P2|NOT COMPLETED|Overall Study||0
8440811|NCT00806676|20800191|P1|NOT COMPLETED|Overall Study||4
8440812|NCT00806676|20800189|P3|COMPLETED|Overall Study||23
8440813|NCT00806676|20800190|P2|COMPLETED|Overall Study||9
8440814|NCT00806676|20800191|P1|COMPLETED|Overall Study||25
8440815|NCT00806676|20800189|P3|STARTED|Overall Study||29
8440816|NCT00806676|20800190|P2|STARTED|Overall Study||9
8440817|NCT00806676|20800191|P1|STARTED|Overall Study||29
8440818|NCT00806624|20800223|P3|NOT COMPLETED|Overall Study||6
8440819|NCT00806624|20800224|P2|NOT COMPLETED|Overall Study||12
8440820|NCT00806624|20800225|P1|NOT COMPLETED|Overall Study||9
8440821|NCT00806624|20800223|P3|COMPLETED|Overall Study||69
8440822|NCT00806624|20800224|P2|COMPLETED|Overall Study||68
8440823|NCT00806624|20800225|P1|COMPLETED|Overall Study||70
8440824|NCT00806624|20800223|P3|STARTED|Overall Study||75
8440825|NCT00806624|20800224|P2|STARTED|Overall Study||80
8440826|NCT00806624|20800225|P1|STARTED|Overall Study||79
8440827|NCT00806598|20800233|P1|NOT COMPLETED|Overall Study||0
8440828|NCT00806598|20800233|P1|COMPLETED|Overall Study||48
8440829|NCT00806598|20800233|P1|STARTED|Overall Study||48
8440830|NCT00806585|20800242|P5|NOT COMPLETED|Overall Study||31
8440831|NCT00806585|20800243|P4|NOT COMPLETED|Overall Study||15
8440832|NCT00806585|20800244|P3|NOT COMPLETED|Overall Study||32
8440833|NCT00806585|20800245|P2|NOT COMPLETED|Overall Study||31
8440834|NCT00806585|20800246|P1|NOT COMPLETED|Overall Study||32
8440835|NCT00806585|20800242|P5|COMPLETED|Overall Study||106
8440836|NCT00806585|20800243|P4|COMPLETED|Overall Study||56
8440837|NCT00806585|20800244|P3|COMPLETED|Overall Study||109
8440838|NCT00806585|20800245|P2|COMPLETED|Overall Study||103
8440839|NCT00806585|20800246|P1|COMPLETED|Overall Study||105
8440840|NCT00806585|20800242|P5|STARTED|Overall Study||137
8440841|NCT00806585|20800243|P4|STARTED|Overall Study||71
8440842|NCT00806585|20800244|P3|STARTED|Overall Study||141
8440843|NCT00806585|20800245|P2|STARTED|Overall Study||134
8440844|NCT00806585|20800246|P1|STARTED|Overall Study||137
8440845|NCT00806546|20800278|P1|NOT COMPLETED|Overall Study||307
8440846|NCT00806546|20800278|P1|COMPLETED|Overall Study||207
8440847|NCT00806546|20800278|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
8440848|NCT00806494|20800282|P1|NOT COMPLETED|Overall Study||80
8440849|NCT00806494|20800282|P1|COMPLETED|Overall Study||251
8440850|NCT00806494|20800282|P1|STARTED|Overall Study||331
8440851|NCT00806442|20800306|P2|NOT COMPLETED|Overall Study||7
8440852|NCT00806442|20800307|P1|NOT COMPLETED|Overall Study||4
8440853|NCT00806442|20800306|P2|COMPLETED|Overall Study||14
8440854|NCT00806442|20800307|P1|COMPLETED|Overall Study||14
8440855|NCT00806442|20800306|P2|Second Intervention (3 Wks)|Overall Study||14
8440856|NCT00806442|20800307|P1|Second Intervention (3 Wks)|Overall Study||15
8440857|NCT00806442|20800306|P2|Washout (3 Wks)|Overall Study||14
8440858|NCT00806442|20800307|P1|Washout (3 Wks)|Overall Study||15
8440859|NCT00806442|20800306|P2|First Intervention (3 Wks)|Overall Study||21
8440860|NCT00806442|20800307|P1|First Intervention (3 Wks)|Overall Study||18
8440861|NCT00806442|20800306|P2|STARTED|Overall Study||21
8440862|NCT00806442|20800307|P1|STARTED|Overall Study||18
8440863|NCT00806416|20800329|P4|NOT COMPLETED|Period 2 - Part II||0
8440864|NCT00806416|20800330|P3|NOT COMPLETED|Period 2 - Part II||0
8440865|NCT00806416|20800331|P2|NOT COMPLETED|Period 2 - Part II||0
8440866|NCT00806416|20800332|P1|NOT COMPLETED|Period 2 - Part II||0
8440867|NCT00806416|20800329|P4|COMPLETED|Period 2 - Part II||14
8440868|NCT00806416|20800330|P3|COMPLETED|Period 2 - Part II||14
8440869|NCT00806416|20800331|P2|COMPLETED|Period 2 - Part II||0
8440870|NCT00806416|20800332|P1|COMPLETED|Period 2 - Part II||0
8440871|NCT00806416|20800329|P4|STARTED|Period 2 - Part II||14
8440872|NCT00806416|20800330|P3|STARTED|Period 2 - Part II||14
8440873|NCT00806416|20800331|P2|STARTED|Period 2 - Part II||0
8440874|NCT00806416|20800332|P1|STARTED|Period 2 - Part II||0
8440875|NCT00806416|20800329|P4|NOT COMPLETED|Period 1 - Part II||2
8440876|NCT00806416|20800330|P3|NOT COMPLETED|Period 1 - Part II||0
8440877|NCT00806416|20800331|P2|NOT COMPLETED|Period 1 - Part II||0
8440878|NCT00806416|20800332|P1|NOT COMPLETED|Period 1 - Part II||0
8440879|NCT00806416|20800329|P4|COMPLETED|Period 1 - Part II||14
8440880|NCT00806416|20800330|P3|COMPLETED|Period 1 - Part II||14
8440881|NCT00806416|20800331|P2|COMPLETED|Period 1 - Part II||0
8440882|NCT00806416|20800332|P1|COMPLETED|Period 1 - Part II||0
8440883|NCT00806416|20800329|P4|STARTED|Period 1 - Part II||16
8440884|NCT00806416|20800330|P3|STARTED|Period 1 - Part II||14
8440885|NCT00806416|20800331|P2|STARTED|Period 1 - Part II||0
8440886|NCT00806416|20800332|P1|STARTED|Period 1 - Part II||0
8440887|NCT00806416|20800329|P4|NOT COMPLETED|Period 2 - Part I||0
8440888|NCT00806416|20800330|P3|NOT COMPLETED|Period 2 - Part I||0
8440889|NCT00806416|20800331|P2|NOT COMPLETED|Period 2 - Part I||0
8440890|NCT00806416|20800332|P1|NOT COMPLETED|Period 2 - Part I||0
8440891|NCT00806416|20800329|P4|COMPLETED|Period 2 - Part I||0
8440892|NCT00806416|20800330|P3|COMPLETED|Period 2 - Part I||0
8440893|NCT00806416|20800331|P2|COMPLETED|Period 2 - Part I||103
8440894|NCT00806416|20800332|P1|COMPLETED|Period 2 - Part I||104
8440895|NCT00806416|20800329|P4|STARTED|Period 2 - Part I||0
8440896|NCT00806416|20800330|P3|STARTED|Period 2 - Part I||0
8440897|NCT00806416|20800331|P2|STARTED|Period 2 - Part I||103
8440898|NCT00806416|20800332|P1|STARTED|Period 2 - Part I||104
8440899|NCT00806416|20800329|P4|NOT COMPLETED|Period 1 - Part I||0
8440900|NCT00806416|20800330|P3|NOT COMPLETED|Period 1 - Part I||0
8440901|NCT00806416|20800331|P2|NOT COMPLETED|Period 1 - Part I||4
8440902|NCT00806416|20800332|P1|NOT COMPLETED|Period 1 - Part I||3
8440903|NCT00806416|20800329|P4|COMPLETED|Period 1 - Part I||0
8440904|NCT00806416|20800330|P3|COMPLETED|Period 1 - Part I||0
8440905|NCT00806416|20800331|P2|COMPLETED|Period 1 - Part I||103
8440906|NCT00806416|20800332|P1|COMPLETED|Period 1 - Part I||104
8440907|NCT00806416|20800329|P4|STARTED|Period 1 - Part I||0
8440908|NCT00806416|20800330|P3|STARTED|Period 1 - Part I||0
8440909|NCT00806416|20800331|P2|STARTED|Period 1 - Part I||107
8440910|NCT00806416|20800332|P1|STARTED|Period 1 - Part I||107
8440911|NCT00806403|20800345|P2|NOT COMPLETED|Overall Study||3
8440912|NCT00806403|20800346|P1|NOT COMPLETED|Overall Study||4
8440913|NCT00806403|20800345|P2|COMPLETED|Overall Study||98
8440914|NCT00806403|20800346|P1|COMPLETED|Overall Study||100
8440915|NCT00806403|20800345|P2|STARTED|Overall Study||101
8440916|NCT00806403|20800346|P1|STARTED|Overall Study||104
8440917|NCT00806390|20800360|P2|NOT COMPLETED|Overall Study||0
8440918|NCT00806390|20800361|P1|NOT COMPLETED|Overall Study||0
8440919|NCT00806390|20800360|P2|COMPLETED|Overall Study||8
8440920|NCT00806390|20800361|P1|COMPLETED|Overall Study||7
8440921|NCT00806390|20800360|P2|STARTED|Overall Study||8
8440922|NCT00806390|20800361|P1|STARTED|Overall Study||7
8440923|NCT00806351|20800369|P2|NOT COMPLETED|Overall Study||4
8440924|NCT00806351|20800370|P1|NOT COMPLETED|Overall Study||5
8440925|NCT00806351|20800369|P2|COMPLETED|Overall Study||2
8440926|NCT00806351|20800370|P1|COMPLETED|Overall Study||10
8440927|NCT00806351|20800369|P2|STARTED|Overall Study||6
8440928|NCT00806351|20800370|P1|STARTED|Overall Study||15
8440929|NCT00806286|20800404|P3|NOT COMPLETED|Overall Study||3
8440930|NCT00806286|20800405|P2|NOT COMPLETED|Overall Study||54
8440931|NCT00806286|20800406|P1|NOT COMPLETED|Overall Study||54
8440932|NCT00806286|20800404|P3|COMPLETED|Overall Study||0
8440933|NCT00806286|20800405|P2|COMPLETED|Overall Study||0
8440934|NCT00806286|20800406|P1|COMPLETED|Overall Study||0
8440935|NCT00806286|20800404|P3|STARTED|Overall Study||3
8440936|NCT00806286|20800405|P2|STARTED|Overall Study||54
8440937|NCT00806286|20800406|P1|STARTED|Overall Study||54
8440938|NCT00806260|20800428|P6|NOT COMPLETED|Period 3||0
8440939|NCT00806260|20800429|P5|NOT COMPLETED|Period 3||0
8440940|NCT00806260|20800430|P4|NOT COMPLETED|Period 3||0
8440941|NCT00806260|20800431|P3|NOT COMPLETED|Period 3||1
8440942|NCT00806260|20800432|P2|NOT COMPLETED|Period 3||1
8440943|NCT00806260|20800433|P1|NOT COMPLETED|Period 3||1
8440944|NCT00806260|20800428|P6|COMPLETED|Period 3||0
8440945|NCT00806260|20800429|P5|COMPLETED|Period 3||0
8440946|NCT00806260|20800430|P4|COMPLETED|Period 3||12
8440947|NCT00806260|20800431|P3|COMPLETED|Period 3||5
8440948|NCT00806260|20800432|P2|COMPLETED|Period 3||7
8440949|NCT00806260|20800433|P1|COMPLETED|Period 3||12
8440950|NCT00806260|20800428|P6|STARTED|Period 3||0
8440951|NCT00806260|20800429|P5|STARTED|Period 3||0
8440952|NCT00806260|20800430|P4|STARTED|Period 3||12
8440953|NCT00806260|20800431|P3|STARTED|Period 3||6
8440954|NCT00806260|20800432|P2|STARTED|Period 3||8
8440955|NCT00806260|20800433|P1|STARTED|Period 3||13
8440956|NCT00806260|20800428|P6|NOT COMPLETED|Period 2||0
8440957|NCT00806260|20800429|P5|NOT COMPLETED|Period 2||0
8440958|NCT00806260|20800430|P4|NOT COMPLETED|Period 2||2
8440959|NCT00806260|20800431|P3|NOT COMPLETED|Period 2||2
8440960|NCT00806260|20800432|P2|NOT COMPLETED|Period 2||0
8440961|NCT00806260|20800433|P1|NOT COMPLETED|Period 2||2
8440962|NCT00806260|20800428|P6|COMPLETED|Period 2||0
8440963|NCT00806260|20800429|P5|COMPLETED|Period 2||0
8440964|NCT00806260|20800430|P4|COMPLETED|Period 2||12
8440965|NCT00806260|20800431|P3|COMPLETED|Period 2||6
8440966|NCT00806260|20800432|P2|COMPLETED|Period 2||8
8440967|NCT00806260|20800433|P1|COMPLETED|Period 2||13
8440968|NCT00806260|20800428|P6|STARTED|Period 2||0
8440969|NCT00806260|20800429|P5|STARTED|Period 2||0
8440970|NCT00806260|20800430|P4|STARTED|Period 2||14
8440971|NCT00806260|20800431|P3|STARTED|Period 2||8
8440972|NCT00806260|20800432|P2|STARTED|Period 2||8
8440973|NCT00806260|20800433|P1|STARTED|Period 2||15
8440974|NCT00806260|20800428|P6|NOT COMPLETED|Period 1 (1 Day)||0
8440975|NCT00806260|20800429|P5|NOT COMPLETED|Period 1 (1 Day)||3
8440976|NCT00806260|20800430|P4|NOT COMPLETED|Period 1 (1 Day)||0
8440977|NCT00806260|20800431|P3|NOT COMPLETED|Period 1 (1 Day)||0
8440978|NCT00806260|20800432|P2|NOT COMPLETED|Period 1 (1 Day)||0
8440979|NCT00806260|20800433|P1|NOT COMPLETED|Period 1 (1 Day)||0
8440980|NCT00806260|20800428|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
8440981|NCT00806260|20800429|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
8440982|NCT00806260|20800430|P4|COMPLETED|Period 1 (1 Day)||14
8440983|NCT00806260|20800431|P3|COMPLETED|Period 1 (1 Day)||8
8440984|NCT00806260|20800432|P2|COMPLETED|Period 1 (1 Day)||8
8440985|NCT00806260|20800433|P1|COMPLETED|Period 1 (1 Day)||15
8440986|NCT00806260|20800428|P6|STARTED|Period 1 (1 Day)||17
8440987|NCT00806260|20800429|P5|STARTED|Period 1 (1 Day)||18
8440988|NCT00806260|20800430|P4|STARTED|Period 1 (1 Day)||14
8440989|NCT00806260|20800431|P3|STARTED|Period 1 (1 Day)||8
8440990|NCT00806260|20800432|P2|STARTED|Period 1 (1 Day)||8
8440991|NCT00806260|20800433|P1|STARTED|Period 1 (1 Day)||15
8440992|NCT00806234|20800448|P3|NOT COMPLETED|Overall Study||12
8440993|NCT00806234|20800449|P2|NOT COMPLETED|Overall Study||12
8440994|NCT00806234|20800450|P1|NOT COMPLETED|Overall Study||13
8440995|NCT00806234|20800448|P3|COMPLETED|Overall Study||37
8440996|NCT00806234|20800449|P2|COMPLETED|Overall Study||19
8440997|NCT00806234|20800450|P1|COMPLETED|Overall Study||34
8440998|NCT00806234|20800448|P3|STARTED|Overall Study||49
8440999|NCT00806234|20800449|P2|STARTED|Overall Study||31
8441000|NCT00806234|20800450|P1|STARTED|Overall Study||47
8441001|NCT00806221|20800467|P1|NOT COMPLETED|Overall Study||2
8441002|NCT00806221|20800467|P1|COMPLETED|Overall Study||20
8441003|NCT00806221|20800467|P1|STARTED|Overall Study||22
8441004|NCT00806195|20800478|P4|NOT COMPLETED|Overall Study||106
8441005|NCT00806195|20800479|P3|NOT COMPLETED|Overall Study||270
8441006|NCT00806195|20800480|P2|NOT COMPLETED|Overall Study||162
8441007|NCT00806195|20800481|P1|NOT COMPLETED|Overall Study||514
8441008|NCT00806195|20800478|P4|COMPLETED|Overall Study||383
8441009|NCT00806195|20800479|P3|COMPLETED|Overall Study||1139
8441010|NCT00806195|20800480|P2|COMPLETED|Overall Study||1321
8441011|NCT00806195|20800481|P1|COMPLETED|Overall Study||3849
8441012|NCT00806195|20800478|P4|STARTED|Overall Study||489
8441013|NCT00806195|20800479|P3|STARTED|Overall Study||1409
8441014|NCT00806195|20800480|P2|STARTED|Overall Study||1483
8441015|NCT00806195|20800481|P1|STARTED|Overall Study||4363
8441016|NCT00806078|20800495|P2|NOT COMPLETED|Second Intervention||0
8441017|NCT00806078|20800496|P1|NOT COMPLETED|Second Intervention||0
8441018|NCT00806078|20800495|P2|COMPLETED|Second Intervention||9
8441019|NCT00806078|20800496|P1|COMPLETED|Second Intervention||9
8441020|NCT00806078|20800495|P2|STARTED|Second Intervention||9
8441021|NCT00806078|20800496|P1|STARTED|Second Intervention||9
8441022|NCT00806078|20800495|P2|NOT COMPLETED|7 Day Washout Period||0
8441023|NCT00806078|20800496|P1|NOT COMPLETED|7 Day Washout Period||0
8441024|NCT00806078|20800495|P2|COMPLETED|7 Day Washout Period||9
8441025|NCT00806078|20800496|P1|COMPLETED|7 Day Washout Period||9
8441026|NCT00806078|20800495|P2|STARTED|7 Day Washout Period||9
8441027|NCT00806078|20800496|P1|STARTED|7 Day Washout Period||9
8441028|NCT00806078|20800495|P2|NOT COMPLETED|First Intervention||0
8441029|NCT00806078|20800496|P1|NOT COMPLETED|First Intervention||0
8441030|NCT00806078|20800495|P2|COMPLETED|First Intervention||9
8441031|NCT00806078|20800496|P1|COMPLETED|First Intervention||9
8441032|NCT00806078|20800495|P2|STARTED|First Intervention||9
8441033|NCT00806078|20800496|P1|STARTED|First Intervention||9
8441034|NCT00806026|20800512|P6|NOT COMPLETED|Overall Study||32
8441035|NCT00806026|20800513|P5|NOT COMPLETED|Overall Study||30
8441036|NCT00806026|20800514|P4|NOT COMPLETED|Overall Study||29
8441037|NCT00806026|20800515|P3|NOT COMPLETED|Overall Study||93
8441038|NCT00806026|20800516|P2|NOT COMPLETED|Overall Study||101
8441039|NCT00806026|20800517|P1|NOT COMPLETED|Overall Study||92
8441040|NCT00806026|20800512|P6|COMPLETED|Overall Study||29
8441041|NCT00806026|20800513|P5|COMPLETED|Overall Study||29
8441042|NCT00806026|20800514|P4|COMPLETED|Overall Study||32
8441043|NCT00806026|20800515|P3|COMPLETED|Overall Study||89
8441044|NCT00806026|20800516|P2|COMPLETED|Overall Study||82
8441045|NCT00806026|20800517|P1|COMPLETED|Overall Study||93
8441046|NCT00806026|20800512|P6|Treated|Overall Study||61
8441047|NCT00806026|20800513|P5|Treated|Overall Study||59
8441048|NCT00806026|20800514|P4|Treated|Overall Study||59
8441049|NCT00806026|20800515|P3|Treated|Overall Study||180
8441050|NCT00806026|20800516|P2|Treated|Overall Study||178
8441051|NCT00806026|20800517|P1|Treated|Overall Study||182
8441052|NCT00806026|20800512|P6|STARTED|Overall Study||61
8441053|NCT00806026|20800513|P5|STARTED|Overall Study||59
8441054|NCT00806026|20800514|P4|STARTED|Overall Study||61
8441055|NCT00806026|20800515|P3|STARTED|Overall Study||182
8441056|NCT00806026|20800516|P2|STARTED|Overall Study||183
8441057|NCT00806026|20800517|P1|STARTED|Overall Study||185
8441058|NCT00805961|20800612|P1|NOT COMPLETED|Maintenance Treatment||34
8441059|NCT00805961|20800612|P1|COMPLETED|Maintenance Treatment||23
8441060|NCT00805961|20800612|P1|STARTED|Maintenance Treatment||57
8441061|NCT00805961|20800612|P1|NOT COMPLETED|Treatment-Free Interval||7
8441062|NCT00805961|20800612|P1|COMPLETED|Treatment-Free Interval||57
8441063|NCT00805961|20800612|P1|STARTED|Treatment-Free Interval||64
8441064|NCT00805961|20800612|P1|NOT COMPLETED|Modality Therapy||4
8441065|NCT00805961|20800612|P1|COMPLETED|Modality Therapy||64
8441066|NCT00805961|20800612|P1|STARTED|Modality Therapy||68
8441067|NCT00805948|20800620|P2|NOT COMPLETED|Overall Study||96
8441068|NCT00805948|20800621|P1|NOT COMPLETED|Overall Study||68
8441069|NCT00805948|20800620|P2|COMPLETED|Overall Study||99
8441070|NCT00805948|20800621|P1|COMPLETED|Overall Study||86
8441071|NCT00805948|20800620|P2|STARTED|Overall Study||195
8441072|NCT00805948|20800621|P1|STARTED|Overall Study||154
8441073|NCT00805935|20800636|P4|NOT COMPLETED|Overall Study||11
8441074|NCT00805935|20800637|P3|NOT COMPLETED|Overall Study||15
8441075|NCT00805935|20800638|P2|NOT COMPLETED|Overall Study||19
8441076|NCT00805935|20800639|P1|NOT COMPLETED|Overall Study||13
8441077|NCT00805935|20800636|P4|COMPLETED|Overall Study||19
8441078|NCT00805935|20800637|P3|COMPLETED|Overall Study||13
8441079|NCT00805935|20800638|P2|COMPLETED|Overall Study||8
8441080|NCT00805935|20800639|P1|COMPLETED|Overall Study||12
8441081|NCT00805935|20800636|P4|STARTED|Overall Study||30
8441082|NCT00805935|20800637|P3|STARTED|Overall Study||28
8441083|NCT00805935|20800638|P2|STARTED|Overall Study||27
8441084|NCT00805935|20800639|P1|STARTED|Overall Study||25
8441085|NCT00805870|20800693|P2|NOT COMPLETED|Overall Study||0
8441086|NCT00805870|20800694|P1|NOT COMPLETED|Overall Study||0
8441087|NCT00805870|20800693|P2|COMPLETED|Overall Study||10
8441088|NCT00805870|20800694|P1|COMPLETED|Overall Study||10
8441089|NCT00805870|20800693|P2|STARTED|Overall Study||10
8441090|NCT00805870|20800694|P1|STARTED|Overall Study||10
8441091|NCT00805792|20800706|P1|NOT COMPLETED|Overall Study||5
8441092|NCT00805792|20800706|P1|COMPLETED|Overall Study||28
8441093|NCT00805792|20800706|P1|STARTED|Overall Study||33
8441094|NCT00805766|20800714|P1|NOT COMPLETED|Increased Dose Period||13
8441095|NCT00805766|20800714|P1|COMPLETED|Increased Dose Period||26
8441096|NCT00805766|20800714|P1|STARTED|Increased Dose Period||39
8441097|NCT00805766|20800714|P1|NOT COMPLETED|Screening Period||6
8441098|NCT00805766|20800714|P1|COMPLETED|Screening Period||39
8441099|NCT00805766|20800714|P1|STARTED|Screening Period||45
8441100|NCT00805740|20800728|P2|NOT COMPLETED|Overall Study||4
8441101|NCT00805740|20800729|P1|NOT COMPLETED|Overall Study||11
8441102|NCT00805740|20800728|P2|COMPLETED|Overall Study||9
8441103|NCT00805740|20800729|P1|COMPLETED|Overall Study||17
8441104|NCT00805740|20800728|P2|Treated|Overall Study||13
8441105|NCT00805740|20800729|P1|Treated|Overall Study||26
8441106|NCT00805740|20800728|P2|STARTED|Overall Study||13
8441107|NCT00805740|20800729|P1|STARTED|Overall Study||28
8441108|NCT00805675|20800754|P3|NOT COMPLETED|Overall Study||1
8441109|NCT00805675|20800755|P2|NOT COMPLETED|Overall Study||0
8441110|NCT00805675|20800756|P1|NOT COMPLETED|Overall Study||0
8441111|NCT00805675|20800754|P3|COMPLETED|Overall Study||15
8441112|NCT00805675|20800755|P2|COMPLETED|Overall Study||14
8441113|NCT00805675|20800756|P1|COMPLETED|Overall Study||16
8441114|NCT00805675|20800754|P3|STARTED|Overall Study||16
8441115|NCT00805675|20800755|P2|STARTED|Overall Study||14
8441116|NCT00805675|20800756|P1|STARTED|Overall Study||16
8441117|NCT00805545|20800790|P2|NOT COMPLETED|Overall Study||3
8441118|NCT00805545|20800791|P1|NOT COMPLETED|Overall Study||6
8441119|NCT00805545|20800790|P2|COMPLETED|Overall Study||197
8441120|NCT00805545|20800791|P1|COMPLETED|Overall Study||194
8441121|NCT00805545|20800790|P2|STARTED|Overall Study||200
8441122|NCT00805545|20800791|P1|STARTED|Overall Study||200
8441123|NCT00805532|20800799|P2|NOT COMPLETED|Overall Study||1
8441124|NCT00805532|20800800|P1|NOT COMPLETED|Overall Study||0
8441125|NCT00805532|20800799|P2|COMPLETED|Overall Study||38
8441126|NCT00805532|20800800|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
8441127|NCT00805532|20800799|P2|STARTED|Overall Study||39
8441128|NCT00805532|20800800|P1|STARTED|Overall Study||42
8441129|NCT00805493|20800817|P3|NOT COMPLETED|Overall Study||1
8441130|NCT00805493|20800818|P2|NOT COMPLETED|Overall Study||0
8441131|NCT00805493|20800819|P1|NOT COMPLETED|Overall Study||2
8441132|NCT00805493|20800817|P3|COMPLETED|Overall Study||0
8441133|NCT00805493|20800818|P2|COMPLETED|Overall Study||2
8441134|NCT00805493|20800819|P1|COMPLETED|Overall Study||1
8441135|NCT00805493|20800817|P3|STARTED|Overall Study||1
8441136|NCT00805493|20800818|P2|STARTED|Overall Study||2
8441137|NCT00805493|20800819|P1|STARTED|Overall Study||3
8441138|NCT00805480|20800834|P4|NOT COMPLETED|Overall Study||5
8441139|NCT00805480|20800835|P3|NOT COMPLETED|Overall Study||12
8441140|NCT00805480|20800836|P2|NOT COMPLETED|Overall Study||7
8441141|NCT00805480|20800837|P1|NOT COMPLETED|Overall Study||14
8441142|NCT00805480|20800834|P4|COMPLETED|Overall Study||5
8441143|NCT00805480|20800835|P3|COMPLETED|Overall Study||19
8441144|NCT00805480|20800836|P2|COMPLETED|Overall Study||22
8441145|NCT00805480|20800837|P1|COMPLETED|Overall Study||16
8441146|NCT00805480|20800834|P4|Pharmacodynamic Analysis Set|Overall Study||10
8441147|NCT00805480|20800835|P3|Pharmacodynamic Analysis Set|Overall Study||29
8441148|NCT00805480|20800836|P2|Pharmacodynamic Analysis Set|Overall Study||25
8441149|NCT00805480|20800837|P1|Pharmacodynamic Analysis Set|Overall Study||30
8441150|NCT00805480|20800834|P4|STARTED|Overall Study||10
8441151|NCT00805480|20800835|P3|STARTED|Overall Study||31
8441152|NCT00805480|20800836|P2|STARTED|Overall Study||29
8441153|NCT00805480|20800837|P1|STARTED|Overall Study||30
8441154|NCT00805467|20800866|P4|NOT COMPLETED|Overall Study||237
8441155|NCT00805467|20800867|P3|NOT COMPLETED|Overall Study||103
8441156|NCT00805467|20800868|P2|NOT COMPLETED|Overall Study||34
8441157|NCT00805467|20800869|P1|NOT COMPLETED|Overall Study||0
8441158|NCT00805467|20800866|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
8441159|NCT00805467|20800867|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
8441160|NCT00805467|20800868|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
8441161|NCT00805467|20800869|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
8441162|NCT00805467|20800866|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
8441163|NCT00805467|20800867|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
8441164|NCT00805467|20800868|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
8441165|NCT00805467|20800869|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
8441166|NCT00805467|20800866|P4|STARTED|Overall Study|Patients who received treatment|381
8441167|NCT00805467|20800867|P3|STARTED|Overall Study|Patients who received treatment|183
8441168|NCT00805467|20800868|P2|STARTED|Overall Study|Patients who received treatment|59
8441169|NCT00805467|20800869|P1|STARTED|Overall Study|Patients who received treatment|1
8441170|NCT00805441|20800889|P2|NOT COMPLETED|Overall Study||36
8441171|NCT00805441|20800890|P1|NOT COMPLETED|Overall Study||34
8441172|NCT00805441|20800889|P2|COMPLETED|Overall Study||60
8441173|NCT00805441|20800890|P1|COMPLETED|Overall Study||60
8441174|NCT00805441|20800889|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
8441175|NCT00805441|20800890|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
8441176|NCT00805441|20800889|P2|STARTED|Overall Study||96
8441177|NCT00805441|20800890|P1|STARTED|Overall Study||94
8441178|NCT00805389|20800925|P5|NOT COMPLETED|Overall Study||13
8441179|NCT00805389|20800926|P4|NOT COMPLETED|Overall Study||17
8441180|NCT00805389|20800927|P3|NOT COMPLETED|Overall Study||12
8441181|NCT00805389|20800928|P2|NOT COMPLETED|Overall Study||5
8441182|NCT00805389|20800929|P1|NOT COMPLETED|Overall Study||7
8441183|NCT00805389|20800925|P5|COMPLETED|Overall Study||129
8441184|NCT00805389|20800926|P4|COMPLETED|Overall Study||128
8441185|NCT00805389|20800927|P3|COMPLETED|Overall Study||129
8441186|NCT00805389|20800928|P2|COMPLETED|Overall Study||137
8441187|NCT00805389|20800929|P1|COMPLETED|Overall Study||136
8441188|NCT00805389|20800925|P5|STARTED|Overall Study||142
8441189|NCT00805389|20800926|P4|STARTED|Overall Study||145
8441190|NCT00805389|20800927|P3|STARTED|Overall Study||141
8441191|NCT00805389|20800928|P2|STARTED|Overall Study||142
8441192|NCT00805389|20800929|P1|STARTED|Overall Study||143
8441193|NCT00805285|20801176|P1|NOT COMPLETED|Overall Study||1
8441194|NCT00805285|20801176|P1|COMPLETED|Overall Study||0
8441195|NCT00805285|20801176|P1|STARTED|Overall Study||1
8441196|NCT00805207|20801193|P9|NOT COMPLETED|Overall Study||0
8441197|NCT00805207|20801194|P8|NOT COMPLETED|Overall Study||0
8441198|NCT00805207|20801195|P7|NOT COMPLETED|Overall Study||0
8441199|NCT00805207|20801196|P6|NOT COMPLETED|Overall Study||3
8441200|NCT00805207|20801197|P5|NOT COMPLETED|Overall Study||1
8441201|NCT00805207|20801198|P4|NOT COMPLETED|Overall Study||0
8441202|NCT00805207|20801199|P3|NOT COMPLETED|Overall Study||1
8441203|NCT00805207|20801200|P2|NOT COMPLETED|Overall Study||2
8441204|NCT00805207|20801201|P1|NOT COMPLETED|Overall Study||0
8441205|NCT00805207|20801193|P9|COMPLETED|Overall Study||6
8441206|NCT00805207|20801194|P8|COMPLETED|Overall Study||6
8441207|NCT00805207|20801195|P7|COMPLETED|Overall Study||6
8441208|NCT00805207|20801196|P6|COMPLETED|Overall Study||9
8441209|NCT00805207|20801197|P5|COMPLETED|Overall Study||2
8441210|NCT00805207|20801198|P4|COMPLETED|Overall Study||6
8441211|NCT00805207|20801199|P3|COMPLETED|Overall Study||11
8441212|NCT00805207|20801200|P2|COMPLETED|Overall Study||7
8441213|NCT00805207|20801201|P1|COMPLETED|Overall Study||1
8441214|NCT00805207|20801193|P9|STARTED|Overall Study||6
8441215|NCT00805207|20801194|P8|STARTED|Overall Study||6
8441216|NCT00805207|20801195|P7|STARTED|Overall Study||6
8441217|NCT00805207|20801196|P6|STARTED|Overall Study||12
8441218|NCT00805207|20801197|P5|STARTED|Overall Study||3
8441219|NCT00805207|20801198|P4|STARTED|Overall Study||6
8441220|NCT00805207|20801199|P3|STARTED|Overall Study||12
8441221|NCT00805207|20801200|P2|STARTED|Overall Study||9
8441222|NCT00805207|20801201|P1|STARTED|Overall Study||1
8441223|NCT00805194|20801259|P2|NOT COMPLETED|Overall Study||654
8441224|NCT00805194|20801260|P1|NOT COMPLETED|Overall Study||649
8441225|NCT00805194|20801259|P2|COMPLETED|Overall Study||5
8441226|NCT00805194|20801260|P1|COMPLETED|Overall Study||6
8441227|NCT00805194|20801259|P2|STARTED|Overall Study|randomised patients|659
8441228|NCT00805194|20801260|P1|STARTED|Overall Study|randomised patients|655
8441229|NCT00805142|20801294|P2|NOT COMPLETED|Maintenance Period||2
8441230|NCT00805142|20801295|P1|NOT COMPLETED|Maintenance Period||0
8441231|NCT00805142|20801294|P2|COMPLETED|Maintenance Period||30
8441232|NCT00805142|20801295|P1|COMPLETED|Maintenance Period||30
8441233|NCT00805142|20801294|P2|STARTED|Maintenance Period||32
8441234|NCT00805142|20801295|P1|STARTED|Maintenance Period||30
8441235|NCT00805142|20801294|P2|NOT COMPLETED|Titration Period||10
8441236|NCT00805142|20801295|P1|NOT COMPLETED|Titration Period||6
8441237|NCT00805142|20801294|P2|COMPLETED|Titration Period||32
8441238|NCT00805142|20801295|P1|COMPLETED|Titration Period||30
8441239|NCT00805142|20801294|P2|STARTED|Titration Period||42
8441240|NCT00805142|20801295|P1|STARTED|Titration Period||36
8441241|NCT00805038|20801321|P2|NOT COMPLETED|Overall Study||0
8441242|NCT00805038|20801322|P1|NOT COMPLETED|Overall Study||0
8441243|NCT00805038|20801321|P2|COMPLETED|Overall Study||92
8441244|NCT00805038|20801322|P1|COMPLETED|Overall Study||75
8441245|NCT00805038|20801321|P2|STARTED|Overall Study||92
8441246|NCT00805038|20801322|P1|STARTED|Overall Study||75
8441247|NCT00805025|20801328|P1|NOT COMPLETED|Overall Study||49
8441248|NCT00805025|20801328|P1|COMPLETED|Overall Study||82
8441249|NCT00805025|20801328|P1|Enrolled and Treated|Overall Study||89
8441250|NCT00805025|20801328|P1|STARTED|Overall Study||131
8441251|NCT00804999|20801338|P4|NOT COMPLETED|Overall Study||0
8441252|NCT00804999|20801339|P3|NOT COMPLETED|Overall Study||0
8441253|NCT00804999|20801340|P2|NOT COMPLETED|Overall Study||0
8441254|NCT00804999|20801341|P1|NOT COMPLETED|Overall Study||0
8441255|NCT00804999|20801338|P4|COMPLETED|Overall Study||10
8441256|NCT00804999|20801339|P3|COMPLETED|Overall Study||14
8441257|NCT00804999|20801340|P2|COMPLETED|Overall Study||12
8441258|NCT00804999|20801341|P1|COMPLETED|Overall Study||15
8441259|NCT00804999|20801338|P4|STARTED|Overall Study||10
8441260|NCT00804999|20801339|P3|STARTED|Overall Study||14
8441261|NCT00804999|20801340|P2|STARTED|Overall Study||12
8441262|NCT00804999|20801341|P1|STARTED|Overall Study||15
8441263|NCT00804986|20801357|P6|NOT COMPLETED|Overall Study||10
8441264|NCT00804986|20801358|P5|NOT COMPLETED|Overall Study||9
8441265|NCT00804986|20801359|P4|NOT COMPLETED|Overall Study||8
8441266|NCT00804986|20801360|P3|NOT COMPLETED|Overall Study||2
8441267|NCT00804986|20801361|P2|NOT COMPLETED|Overall Study||8
8441268|NCT00804986|20801362|P1|NOT COMPLETED|Overall Study||1
8441269|NCT00804986|20801357|P6|COMPLETED|Overall Study||31
8441270|NCT00804986|20801358|P5|COMPLETED|Overall Study||34
8441271|NCT00804986|20801359|P4|COMPLETED|Overall Study||34
8441272|NCT00804986|20801360|P3|COMPLETED|Overall Study||40
8441273|NCT00804986|20801361|P2|COMPLETED|Overall Study||35
8441274|NCT00804986|20801362|P1|COMPLETED|Overall Study||35
8441275|NCT00804986|20801357|P6|STARTED|Overall Study||41
8441276|NCT00804986|20801358|P5|STARTED|Overall Study||43
8441277|NCT00804986|20801359|P4|STARTED|Overall Study||42
8441278|NCT00804986|20801360|P3|STARTED|Overall Study||42
8441279|NCT00804986|20801361|P2|STARTED|Overall Study||43
8441280|NCT00804986|20801362|P1|STARTED|Overall Study||36
8441281|NCT00804973|20801457|P3|NOT COMPLETED|Overall Study||0
8441282|NCT00804973|20801458|P2|NOT COMPLETED|Overall Study||0
8441283|NCT00804973|20801459|P1|NOT COMPLETED|Overall Study||0
8441284|NCT00804973|20801457|P3|COMPLETED|Overall Study||40
8441285|NCT00804973|20801458|P2|COMPLETED|Overall Study||40
8441286|NCT00804973|20801459|P1|COMPLETED|Overall Study||40
8441287|NCT00804973|20801457|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
8441288|NCT00804973|20801458|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
8441289|NCT00804973|20801459|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
8441290|NCT00804973|20801457|P3|STARTED|Overall Study||40
8441291|NCT00804973|20801458|P2|STARTED|Overall Study||40
8441292|NCT00804973|20801459|P1|STARTED|Overall Study||40
8441293|NCT00804908|20801497|P3|NOT COMPLETED|Overall Study||114
8441294|NCT00804908|20801498|P2|NOT COMPLETED|Overall Study||116
8441295|NCT00804908|20801499|P1|NOT COMPLETED|Overall Study||115
8441296|NCT00804908|20801497|P3|COMPLETED|Overall Study||1
8441297|NCT00804908|20801498|P2|COMPLETED|Overall Study||0
8441298|NCT00804908|20801499|P1|COMPLETED|Overall Study||0
8441299|NCT00804908|20801497|P3|STARTED|Overall Study||115
8441300|NCT00804908|20801498|P2|STARTED|Overall Study||116
8441301|NCT00804908|20801499|P1|STARTED|Overall Study||115
8441302|NCT00804843|20801530|P2|NOT COMPLETED|Overall Study||7
8441303|NCT00804843|20801531|P1|NOT COMPLETED|Overall Study||10
8441304|NCT00804843|20801530|P2|COMPLETED|Overall Study||43
8441305|NCT00804843|20801531|P1|COMPLETED|Overall Study||40
8441306|NCT00804843|20801530|P2|STARTED|Overall Study||50
8441307|NCT00804843|20801531|P1|STARTED|Overall Study||50
8441308|NCT00804713|20801541|P1|NOT COMPLETED|Overall Study||0
8441309|NCT00804713|20801541|P1|COMPLETED|Overall Study||1978
8441310|NCT00804713|20801541|P1|STARTED|Overall Study||1978
8441311|NCT00804687|20801549|P6|NOT COMPLETED|Period 5: Treatment Period||0
8441312|NCT00804687|20801550|P5|NOT COMPLETED|Period 5: Treatment Period||1
8441313|NCT00804687|20801551|P4|NOT COMPLETED|Period 5: Treatment Period||0
8441314|NCT00804687|20801552|P3|NOT COMPLETED|Period 5: Treatment Period||1
8441315|NCT00804687|20801553|P2|NOT COMPLETED|Period 5: Treatment Period||0
8441316|NCT00804687|20801554|P1|NOT COMPLETED|Period 5: Treatment Period||1
8441317|NCT00804687|20801549|P6|COMPLETED|Period 5: Treatment Period||8
8441318|NCT00804687|20801550|P5|COMPLETED|Period 5: Treatment Period||8
8441319|NCT00804687|20801551|P4|COMPLETED|Period 5: Treatment Period||8
8441320|NCT00804687|20801552|P3|COMPLETED|Period 5: Treatment Period||8
8441321|NCT00804687|20801553|P2|COMPLETED|Period 5: Treatment Period||9
8441322|NCT00804687|20801554|P1|COMPLETED|Period 5: Treatment Period||8
8441323|NCT00804687|20801549|P6|STARTED|Period 5: Treatment Period||8
8441324|NCT00804687|20801550|P5|STARTED|Period 5: Treatment Period||9
8441325|NCT00804687|20801551|P4|STARTED|Period 5: Treatment Period||8
8441326|NCT00804687|20801552|P3|STARTED|Period 5: Treatment Period||9
8441327|NCT00804687|20801553|P2|STARTED|Period 5: Treatment Period||9
8441328|NCT00804687|20801554|P1|STARTED|Period 5: Treatment Period||9
8441329|NCT00804687|20801549|P6|NOT COMPLETED|Period 4: Washout Period||0
8441330|NCT00804687|20801550|P5|NOT COMPLETED|Period 4: Washout Period||0
8441331|NCT00804687|20801551|P4|NOT COMPLETED|Period 4: Washout Period||0
8441332|NCT00804687|20801552|P3|NOT COMPLETED|Period 4: Washout Period||0
8441333|NCT00804687|20801553|P2|NOT COMPLETED|Period 4: Washout Period||0
8441334|NCT00804687|20801554|P1|NOT COMPLETED|Period 4: Washout Period||0
8441335|NCT00804687|20801549|P6|COMPLETED|Period 4: Washout Period||8
8441336|NCT00804687|20801550|P5|COMPLETED|Period 4: Washout Period||9
8441337|NCT00804687|20801551|P4|COMPLETED|Period 4: Washout Period||8
8441338|NCT00804687|20801552|P3|COMPLETED|Period 4: Washout Period||9
8441339|NCT00804687|20801553|P2|COMPLETED|Period 4: Washout Period||9
8441340|NCT00804687|20801554|P1|COMPLETED|Period 4: Washout Period||9
8441341|NCT00804687|20801549|P6|STARTED|Period 4: Washout Period||8
8441342|NCT00804687|20801550|P5|STARTED|Period 4: Washout Period||9
8441343|NCT00804687|20801551|P4|STARTED|Period 4: Washout Period||8
8441344|NCT00804687|20801552|P3|STARTED|Period 4: Washout Period||9
8441345|NCT00804687|20801553|P2|STARTED|Period 4: Washout Period||9
8441346|NCT00804687|20801554|P1|STARTED|Period 4: Washout Period||9
8441347|NCT00804687|20801549|P6|NOT COMPLETED|Period 3: Treatment Period||0
8441348|NCT00804687|20801550|P5|NOT COMPLETED|Period 3: Treatment Period||0
8441349|NCT00804687|20801551|P4|NOT COMPLETED|Period 3: Treatment Period||1
8441350|NCT00804687|20801552|P3|NOT COMPLETED|Period 3: Treatment Period||0
8441351|NCT00804687|20801553|P2|NOT COMPLETED|Period 3: Treatment Period||0
8441352|NCT00804687|20801554|P1|NOT COMPLETED|Period 3: Treatment Period||0
8441353|NCT00804687|20801549|P6|COMPLETED|Period 3: Treatment Period||8
8441354|NCT00804687|20801550|P5|COMPLETED|Period 3: Treatment Period||9
8441355|NCT00804687|20801551|P4|COMPLETED|Period 3: Treatment Period||8
8441356|NCT00804687|20801552|P3|COMPLETED|Period 3: Treatment Period||9
8441357|NCT00804687|20801553|P2|COMPLETED|Period 3: Treatment Period||9
8441358|NCT00804687|20801554|P1|COMPLETED|Period 3: Treatment Period||9
8441359|NCT00804687|20801549|P6|STARTED|Period 3: Treatment Period||8
8441360|NCT00804687|20801550|P5|STARTED|Period 3: Treatment Period||9
8441361|NCT00804687|20801551|P4|STARTED|Period 3: Treatment Period||9
8441362|NCT00804687|20801552|P3|STARTED|Period 3: Treatment Period||9
8441363|NCT00804687|20801553|P2|STARTED|Period 3: Treatment Period||9
8441364|NCT00804687|20801554|P1|STARTED|Period 3: Treatment Period||9
8441365|NCT00804687|20801549|P6|NOT COMPLETED|Period 2: Washout Period||0
8441366|NCT00804687|20801550|P5|NOT COMPLETED|Period 2: Washout Period||0
8441367|NCT00804687|20801551|P4|NOT COMPLETED|Period 2: Washout Period||0
8441368|NCT00804687|20801552|P3|NOT COMPLETED|Period 2: Washout Period||0
8441369|NCT00804687|20801553|P2|NOT COMPLETED|Period 2: Washout Period||0
8441370|NCT00804687|20801554|P1|NOT COMPLETED|Period 2: Washout Period||0
8441371|NCT00804687|20801549|P6|COMPLETED|Period 2: Washout Period||8
8441372|NCT00804687|20801550|P5|COMPLETED|Period 2: Washout Period||9
8441373|NCT00804687|20801551|P4|COMPLETED|Period 2: Washout Period||9
8441374|NCT00804687|20801552|P3|COMPLETED|Period 2: Washout Period||9
8441375|NCT00804687|20801553|P2|COMPLETED|Period 2: Washout Period||9
8441376|NCT00804687|20801554|P1|COMPLETED|Period 2: Washout Period||9
8441377|NCT00804687|20801549|P6|STARTED|Period 2: Washout Period||8
8441378|NCT00804687|20801550|P5|STARTED|Period 2: Washout Period||9
8441379|NCT00804687|20801551|P4|STARTED|Period 2: Washout Period||9
8441380|NCT00804687|20801552|P3|STARTED|Period 2: Washout Period||9
8441381|NCT00804687|20801553|P2|STARTED|Period 2: Washout Period||9
8441382|NCT00804687|20801554|P1|STARTED|Period 2: Washout Period||9
8441383|NCT00804687|20801549|P6|NOT COMPLETED|Period 1: Treatment Period||0
8441384|NCT00804687|20801550|P5|NOT COMPLETED|Period 1: Treatment Period||0
8441385|NCT00804687|20801551|P4|NOT COMPLETED|Period 1: Treatment Period||0
8441386|NCT00804687|20801552|P3|NOT COMPLETED|Period 1: Treatment Period||0
8441387|NCT00804687|20801553|P2|NOT COMPLETED|Period 1: Treatment Period||0
8441388|NCT00804687|20801554|P1|NOT COMPLETED|Period 1: Treatment Period||0
8441389|NCT00804687|20801549|P6|COMPLETED|Period 1: Treatment Period||8
8441390|NCT00804687|20801550|P5|COMPLETED|Period 1: Treatment Period||9
8441391|NCT00804687|20801551|P4|COMPLETED|Period 1: Treatment Period||9
8441392|NCT00804687|20801552|P3|COMPLETED|Period 1: Treatment Period||9
8441393|NCT00804687|20801553|P2|COMPLETED|Period 1: Treatment Period||9
8441394|NCT00804687|20801554|P1|COMPLETED|Period 1: Treatment Period||9
8441395|NCT00804687|20801549|P6|STARTED|Period 1: Treatment Period||8
8441396|NCT00804687|20801550|P5|STARTED|Period 1: Treatment Period||9
8441397|NCT00804687|20801551|P4|STARTED|Period 1: Treatment Period||9
8441398|NCT00804687|20801552|P3|STARTED|Period 1: Treatment Period||9
8441399|NCT00804687|20801553|P2|STARTED|Period 1: Treatment Period||9
8441400|NCT00804687|20801554|P1|STARTED|Period 1: Treatment Period||9
8441401|NCT00804648|20801571|P6|NOT COMPLETED|Third Invervention||0
8441402|NCT00804648|20801572|P5|NOT COMPLETED|Third Invervention||0
8441403|NCT00804648|20801573|P4|NOT COMPLETED|Third Invervention||0
8441404|NCT00804648|20801574|P3|NOT COMPLETED|Third Invervention||0
8441405|NCT00804648|20801575|P2|NOT COMPLETED|Third Invervention||0
8441406|NCT00804648|20801576|P1|NOT COMPLETED|Third Invervention||0
8441407|NCT00804648|20801571|P6|COMPLETED|Third Invervention||8
8441408|NCT00804648|20801572|P5|COMPLETED|Third Invervention||4
8441409|NCT00804648|20801573|P4|COMPLETED|Third Invervention||4
8441410|NCT00804648|20801574|P3|COMPLETED|Third Invervention||6
8441411|NCT00804648|20801575|P2|COMPLETED|Third Invervention||5
8441412|NCT00804648|20801576|P1|COMPLETED|Third Invervention||3
8441413|NCT00804648|20801571|P6|STARTED|Third Invervention||8
8441414|NCT00804648|20801572|P5|STARTED|Third Invervention||4
8441415|NCT00804648|20801573|P4|STARTED|Third Invervention||4
8441416|NCT00804648|20801574|P3|STARTED|Third Invervention||6
8441417|NCT00804648|20801575|P2|STARTED|Third Invervention||5
8441418|NCT00804648|20801576|P1|STARTED|Third Invervention||3
8441419|NCT00804648|20801571|P6|NOT COMPLETED|Second Intervention||0
8441420|NCT00804648|20801572|P5|NOT COMPLETED|Second Intervention||0
8441421|NCT00804648|20801573|P4|NOT COMPLETED|Second Intervention||0
8441422|NCT00804648|20801574|P3|NOT COMPLETED|Second Intervention||0
8441423|NCT00804648|20801575|P2|NOT COMPLETED|Second Intervention||0
8441424|NCT00804648|20801576|P1|NOT COMPLETED|Second Intervention||0
8441425|NCT00804648|20801571|P6|COMPLETED|Second Intervention||8
8441426|NCT00804648|20801572|P5|COMPLETED|Second Intervention||4
8441427|NCT00804648|20801573|P4|COMPLETED|Second Intervention||4
8441428|NCT00804648|20801574|P3|COMPLETED|Second Intervention||6
8441429|NCT00804648|20801575|P2|COMPLETED|Second Intervention||5
8441430|NCT00804648|20801576|P1|COMPLETED|Second Intervention||3
8441431|NCT00804648|20801571|P6|STARTED|Second Intervention||8
8441432|NCT00804648|20801572|P5|STARTED|Second Intervention||4
8441433|NCT00804648|20801573|P4|STARTED|Second Intervention||4
8441434|NCT00804648|20801574|P3|STARTED|Second Intervention||6
8441435|NCT00804648|20801575|P2|STARTED|Second Intervention||5
8441436|NCT00804648|20801576|P1|STARTED|Second Intervention||3
8441437|NCT00804648|20801571|P6|NOT COMPLETED|First Intervention||0
8441438|NCT00804648|20801572|P5|NOT COMPLETED|First Intervention||0
8441439|NCT00804648|20801573|P4|NOT COMPLETED|First Intervention||0
8441440|NCT00804648|20801574|P3|NOT COMPLETED|First Intervention||0
8441441|NCT00804648|20801575|P2|NOT COMPLETED|First Intervention||0
8441442|NCT00804648|20801576|P1|NOT COMPLETED|First Intervention||0
8441443|NCT00804648|20801571|P6|COMPLETED|First Intervention||8
8441444|NCT00804648|20801572|P5|COMPLETED|First Intervention||4
8441445|NCT00804648|20801573|P4|COMPLETED|First Intervention||4
8441446|NCT00804648|20801574|P3|COMPLETED|First Intervention||6
8441447|NCT00804648|20801575|P2|COMPLETED|First Intervention||5
8441448|NCT00804648|20801576|P1|COMPLETED|First Intervention||3
8441449|NCT00804648|20801571|P6|STARTED|First Intervention||8
8441450|NCT00804648|20801572|P5|STARTED|First Intervention||4
8441451|NCT00804648|20801573|P4|STARTED|First Intervention||4
8441452|NCT00804648|20801574|P3|STARTED|First Intervention||6
8441453|NCT00804648|20801575|P2|STARTED|First Intervention||5
8441454|NCT00804648|20801576|P1|STARTED|First Intervention||3
8441455|NCT00804609|20801619|P2|NOT COMPLETED|Overall Study||1
8441456|NCT00804609|20801620|P1|NOT COMPLETED|Overall Study||0
8441457|NCT00804609|20801619|P2|COMPLETED|Overall Study||14
8441458|NCT00804609|20801620|P1|COMPLETED|Overall Study||15
8441459|NCT00804609|20801619|P2|STARTED|Overall Study||15
8441460|NCT00804609|20801620|P1|STARTED|Overall Study||15
8441461|NCT00804596|20801626|P1|NOT COMPLETED|Overall Study||0
8441462|NCT00804596|20801626|P1|COMPLETED|Overall Study||74
8441463|NCT00804596|20801626|P1|STARTED|Overall Study||74
8441464|NCT00804570|20801633|P2|NOT COMPLETED|Overall Study||94
8441465|NCT00804570|20801634|P1|NOT COMPLETED|Overall Study||72
8441466|NCT00804570|20801633|P2|COMPLETED|Overall Study||94
8441467|NCT00804570|20801634|P1|COMPLETED|Overall Study||115
8441468|NCT00804570|20801633|P2|STARTED|Overall Study||188
8441469|NCT00804570|20801634|P1|STARTED|Overall Study||187
8441470|NCT00804349|20801692|P2|NOT COMPLETED|Overall Study||0
8441471|NCT00804349|20801693|P1|NOT COMPLETED|Overall Study||0
8441472|NCT00804349|20801692|P2|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
8441473|NCT00804349|20801693|P1|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
8441474|NCT00804349|20801692|P2|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
8441475|NCT00804349|20801693|P1|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
8441476|NCT00804193|20801708|P3|NOT COMPLETED|Overall Study||32
8441477|NCT00804193|20801709|P2|NOT COMPLETED|Overall Study||44
8441478|NCT00804193|20801710|P1|NOT COMPLETED|Overall Study||39
8441479|NCT00804193|20801708|P3|COMPLETED|Overall Study||77
8441480|NCT00804193|20801709|P2|COMPLETED|Overall Study||180
8441481|NCT00804193|20801710|P1|COMPLETED|Overall Study||181
8441482|NCT00804193|20801708|P3|STARTED|Overall Study||109
8441483|NCT00804193|20801709|P2|STARTED|Overall Study||224
8441484|NCT00804193|20801710|P1|STARTED|Overall Study||220
8441485|NCT00804141|20801724|P1|NOT COMPLETED|Overall Study||563
8441486|NCT00804141|20801724|P1|COMPLETED|Overall Study||477
8441487|NCT00804141|20801724|P1|Received at Least 1 Dose of Study Drug|Overall Study||1034
8441488|NCT00804141|20801724|P1|STARTED|Overall Study||1040
8441489|NCT00803959|20801731|P2|NOT COMPLETED|Overall Study||51
8441490|NCT00803959|20801732|P1|NOT COMPLETED|Overall Study||56
8441491|NCT00803959|20801731|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
8441492|NCT00803959|20801732|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
8441493|NCT00803959|20801731|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
8441494|NCT00803959|20801732|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
8441495|NCT00803959|20801731|P2|STARTED|Overall Study||315
8441496|NCT00803959|20801732|P1|STARTED|Overall Study||315
8441497|NCT00803790|20801764|P4|NOT COMPLETED|Period 2||1
8441498|NCT00803790|20801765|P3|NOT COMPLETED|Period 2||1
8441499|NCT00803790|20801766|P2|NOT COMPLETED|Period 2||0
8441500|NCT00803790|20801767|P1|NOT COMPLETED|Period 2||2
8441501|NCT00803790|20801764|P4|COMPLETED|Period 2||30
8441502|NCT00803790|20801765|P3|COMPLETED|Period 2||30
8441503|NCT00803790|20801766|P2|COMPLETED|Period 2||114
8441504|NCT00803790|20801767|P1|COMPLETED|Period 2||114
8441505|NCT00803790|20801764|P4|STARTED|Period 2||31
8441506|NCT00803790|20801765|P3|STARTED|Period 2||31
8441507|NCT00803790|20801766|P2|STARTED|Period 2||114
8441508|NCT00803790|20801767|P1|STARTED|Period 2||116
8441509|NCT00803790|20801764|P4|NOT COMPLETED|Period 1||4
8441510|NCT00803790|20801765|P3|NOT COMPLETED|Period 1||1
8441511|NCT00803790|20801766|P2|NOT COMPLETED|Period 1||12
8441512|NCT00803790|20801767|P1|NOT COMPLETED|Period 1||9
8441513|NCT00803790|20801764|P4|COMPLETED|Period 1||31
8441514|NCT00803790|20801765|P3|COMPLETED|Period 1||31
8441515|NCT00803790|20801766|P2|COMPLETED|Period 1||114
8441516|NCT00803790|20801767|P1|COMPLETED|Period 1||116
8441517|NCT00803790|20801764|P4|STARTED|Period 1||35
8441518|NCT00803790|20801765|P3|STARTED|Period 1||32
8441519|NCT00803790|20801766|P2|STARTED|Period 1||126
8441520|NCT00803790|20801767|P1|STARTED|Period 1||125
8441521|NCT00803777|20801778|P1|NOT COMPLETED|Overall Study||0
8441522|NCT00803777|20801778|P1|COMPLETED|Overall Study||147
8441523|NCT00803777|20801778|P1|STARTED|Overall Study||147
8441524|NCT00803751|20801788|P2|NOT COMPLETED|Overall Study||0
8441525|NCT00803751|20801789|P1|NOT COMPLETED|Overall Study||0
8441526|NCT00803751|20801788|P2|COMPLETED|Overall Study||23
8441527|NCT00803751|20801789|P1|COMPLETED|Overall Study||26
8441528|NCT00803751|20801788|P2|STARTED|Overall Study||23
8441529|NCT00803751|20801789|P1|STARTED|Overall Study||26
8441530|NCT00803738|20801807|P2|NOT COMPLETED|Overall Study||110
8441531|NCT00803738|20801808|P1|NOT COMPLETED|Overall Study||94
8441532|NCT00803738|20801807|P2|COMPLETED|Overall Study||176
8441533|NCT00803738|20801808|P1|COMPLETED|Overall Study||192
8441534|NCT00803738|20801807|P2|STARTED|Overall Study||286
8441535|NCT00803738|20801808|P1|STARTED|Overall Study||286
8441536|NCT00803712|20801820|P2|NOT COMPLETED|Overall Study||27
8441537|NCT00803712|20801821|P1|NOT COMPLETED|Overall Study||36
8441538|NCT00803712|20801820|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
8441539|NCT00803712|20801821|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
8441540|NCT00803712|20801820|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
8441541|NCT00803712|20801821|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
8441542|NCT00803712|20801820|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
8441543|NCT00803712|20801821|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
8441544|NCT00803712|20801820|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
8441545|NCT00803712|20801821|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
8441546|NCT00803686|20801889|P4|NOT COMPLETED|Part 2, Period 3||0
8441547|NCT00803686|20801890|P3|NOT COMPLETED|Part 2, Period 3||0
8441548|NCT00803686|20801891|P2|NOT COMPLETED|Part 2, Period 3||0
8441549|NCT00803686|20801892|P1|NOT COMPLETED|Part 2, Period 3||0
8441550|NCT00803686|20801889|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
8441551|NCT00803686|20801890|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
8441552|NCT00803686|20801891|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
8441553|NCT00803686|20801892|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
8441554|NCT00803686|20801889|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
8441555|NCT00803686|20801890|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
8441556|NCT00803686|20801891|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
8441557|NCT00803686|20801892|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
8441558|NCT00803686|20801889|P4|NOT COMPLETED|Part 1, Period 2||0
8441559|NCT00803686|20801890|P3|NOT COMPLETED|Part 1, Period 2||0
8441560|NCT00803686|20801891|P2|NOT COMPLETED|Part 1, Period 2||0
8441561|NCT00803686|20801892|P1|NOT COMPLETED|Part 1, Period 2||0
8441562|NCT00803686|20801889|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
8441563|NCT00803686|20801890|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
8441564|NCT00803686|20801891|P2|COMPLETED|Part 1, Period 2||6
8441565|NCT00803686|20801892|P1|COMPLETED|Part 1, Period 2||6
8441566|NCT00803686|20801889|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
8441567|NCT00803686|20801890|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
8441568|NCT00803686|20801891|P2|STARTED|Part 1, Period 2||6
8441569|NCT00803686|20801892|P1|STARTED|Part 1, Period 2||6
8441570|NCT00803686|20801889|P4|NOT COMPLETED|Part 1, Period 1||0
8441571|NCT00803686|20801890|P3|NOT COMPLETED|Part 1, Period 1||0
8441572|NCT00803686|20801891|P2|NOT COMPLETED|Part 1, Period 1||0
8441573|NCT00803686|20801892|P1|NOT COMPLETED|Part 1, Period 1||0
8441574|NCT00803686|20801889|P4|COMPLETED|Part 1, Period 1||0
8441575|NCT00803686|20801890|P3|COMPLETED|Part 1, Period 1||0
8441576|NCT00803686|20801891|P2|COMPLETED|Part 1, Period 1||6
8441577|NCT00803686|20801892|P1|COMPLETED|Part 1, Period 1||6
8441578|NCT00803686|20801889|P4|STARTED|Part 1, Period 1||0
8441579|NCT00803686|20801890|P3|STARTED|Part 1, Period 1||0
8441580|NCT00803686|20801891|P2|STARTED|Part 1, Period 1||6
8441581|NCT00803686|20801892|P1|STARTED|Part 1, Period 1||6
8441582|NCT00803647|20801910|P1|NOT COMPLETED|Overall Study||0
8441583|NCT00803647|20801910|P1|COMPLETED|Overall Study||20
8441584|NCT00803647|20801910|P1|STARTED|Overall Study||20
8441585|NCT00803634|20801920|P2|NOT COMPLETED|Overall Study||5
8441586|NCT00803634|20801921|P1|NOT COMPLETED|Overall Study||6
8441587|NCT00803634|20801920|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
8441588|NCT00803634|20801921|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
8441589|NCT00803634|20801920|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
8441590|NCT00803634|20801921|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
8441591|NCT00803634|20801920|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
8441592|NCT00803634|20801921|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
8441593|NCT00803595|20801950|P3|NOT COMPLETED|Overall Study||16
8441594|NCT00803595|20801951|P2|NOT COMPLETED|Overall Study||8
8441595|NCT00803595|20801952|P1|NOT COMPLETED|Overall Study||15
8441596|NCT00803595|20801950|P3|COMPLETED|Overall Study||322
8441597|NCT00803595|20801951|P2|COMPLETED|Overall Study||319
8441598|NCT00803595|20801952|P1|COMPLETED|Overall Study||322
8441599|NCT00803595|20801950|P3|STARTED|Overall Study||338
8441600|NCT00803595|20801951|P2|STARTED|Overall Study||327
8441601|NCT00803595|20801952|P1|STARTED|Overall Study||337
8441602|NCT00803569|20801963|P1|NOT COMPLETED|Overall Study||4
8441603|NCT00803569|20801963|P1|COMPLETED|Overall Study||9
8441604|NCT00803569|20801963|P1|STARTED|Overall Study||13
8441605|NCT00803543|20801973|P2|NOT COMPLETED|Overall Study||12
8441606|NCT00803543|20801974|P1|NOT COMPLETED|Overall Study||24
8441607|NCT00803543|20801973|P2|COMPLETED|Overall Study||22
8441608|NCT00803543|20801974|P1|COMPLETED|Overall Study||45
8441609|NCT00803543|20801973|P2|STARTED|Overall Study||34
8441610|NCT00803543|20801974|P1|STARTED|Overall Study||69
8441611|NCT00803517|20801988|P2|NOT COMPLETED|Overall Study||0
8441612|NCT00803517|20801989|P1|NOT COMPLETED|Overall Study||0
8441613|NCT00803517|20801988|P2|COMPLETED|Overall Study||12
8441614|NCT00803517|20801989|P1|COMPLETED|Overall Study||12
8441615|NCT00803517|20801988|P2|STARTED|Overall Study||12
8441616|NCT00803517|20801989|P1|STARTED|Overall Study||12
8441617|NCT00803452|20801997|P2|NOT COMPLETED|Overall Study||5
8441618|NCT00803452|20801998|P1|NOT COMPLETED|Overall Study||0
8441619|NCT00803452|20801997|P2|COMPLETED|Overall Study||17
8441620|NCT00803452|20801998|P1|COMPLETED|Overall Study||9
8441621|NCT00803452|20801997|P2|STARTED|Overall Study||22
8441622|NCT00803452|20801998|P1|STARTED|Overall Study||9
8441623|NCT00803413|20802008|P4|NOT COMPLETED|Overall Period||0
8441624|NCT00803413|20802009|P3|NOT COMPLETED|Overall Period||0
8441625|NCT00803413|20802010|P2|NOT COMPLETED|Overall Period||0
8441626|NCT00803413|20802011|P1|NOT COMPLETED|Overall Period||0
8441627|NCT00803413|20802008|P4|COMPLETED|Overall Period||30
8441628|NCT00803413|20802009|P3|COMPLETED|Overall Period||29
8441629|NCT00803413|20802010|P2|COMPLETED|Overall Period||32
8441630|NCT00803413|20802011|P1|COMPLETED|Overall Period||28
8441631|NCT00803413|20802008|P4|STARTED|Overall Period||30
8441632|NCT00803413|20802009|P3|STARTED|Overall Period||29
8441633|NCT00803413|20802010|P2|STARTED|Overall Period||32
8441634|NCT00803413|20802011|P1|STARTED|Overall Period||28
8441635|NCT00803400|20802023|P2|NOT COMPLETED|Overall Study||24
8441636|NCT00803400|20802024|P1|NOT COMPLETED|Overall Study||20
8441637|NCT00803400|20802023|P2|COMPLETED|Overall Study||51
8441638|NCT00803400|20802024|P1|COMPLETED|Overall Study||55
8441639|NCT00803400|20802023|P2|STARTED|Overall Study||75
8441640|NCT00803400|20802024|P1|STARTED|Overall Study||75
8441641|NCT00803361|20802036|P2|NOT COMPLETED|Overall Study||28
8441642|NCT00803361|20802037|P1|NOT COMPLETED|Overall Study||26
8441643|NCT00803361|20802036|P2|COMPLETED|Overall Study||74
8441644|NCT00803361|20802037|P1|COMPLETED|Overall Study||82
8441645|NCT00803361|20802036|P2|STARTED|Overall Study||102
8441646|NCT00803361|20802037|P1|STARTED|Overall Study||108
8441647|NCT00803283|20802057|P2|NOT COMPLETED|Overall Study||0
8441648|NCT00803283|20802058|P1|NOT COMPLETED|Overall Study||0
8441649|NCT00803283|20802057|P2|COMPLETED|Overall Study||1
8441650|NCT00803283|20802058|P1|COMPLETED|Overall Study||1
8441651|NCT00803283|20802057|P2|STARTED|Overall Study||1
8441652|NCT00803283|20802058|P1|STARTED|Overall Study||1
8441653|NCT00803270|20802084|P2|NOT COMPLETED|Overall Study||2
8441654|NCT00803270|20802085|P1|NOT COMPLETED|Overall Study||1
8441655|NCT00803270|20802084|P2|COMPLETED|Overall Study||12
8441656|NCT00803270|20802085|P1|COMPLETED|Overall Study||12
8441657|NCT00803270|20802084|P2|STARTED|Overall Study||14
8441658|NCT00803270|20802085|P1|STARTED|Overall Study||13
8441659|NCT00803244|20802095|P2|NOT COMPLETED|Overall Study||15
8441660|NCT00803244|20802096|P1|NOT COMPLETED|Overall Study||7
8441661|NCT00803244|20802095|P2|COMPLETED|Overall Study||178
8441662|NCT00803244|20802096|P1|COMPLETED|Overall Study||181
8441663|NCT00803244|20802095|P2|STARTED|Overall Study||193
8441664|NCT00803244|20802096|P1|STARTED|Overall Study||188
8441665|NCT00803205|20802106|P2|NOT COMPLETED|Overall Study||14
8441666|NCT00803205|20802107|P1|NOT COMPLETED|Overall Study||20
8441667|NCT00803205|20802106|P2|COMPLETED|Overall Study||104
8441668|NCT00803205|20802107|P1|COMPLETED|Overall Study||100
8441669|NCT00803205|20802106|P2|Per Protocol Population|Overall Study||103
8441670|NCT00803205|20802107|P1|Per Protocol Population|Overall Study||100
8441671|NCT00803205|20802106|P2|ITT Population|Overall Study||116
8441672|NCT00803205|20802107|P1|ITT Population|Overall Study||116
8441673|NCT00803205|20802106|P2|As-Treated Population*|Overall Study||118
8441674|NCT00803205|20802107|P1|As-Treated Population*|Overall Study||120
8441675|NCT00803205|20802106|P2|Completed Week 24|Overall Study||110
8441676|NCT00803205|20802107|P1|Completed Week 24|Overall Study||103
8441677|NCT00803205|20802106|P2|Completed Week 16|Overall Study||113
8441678|NCT00803205|20802107|P1|Completed Week 16|Overall Study||107
8441679|NCT00803205|20802106|P2|STARTED|Overall Study||118
8441680|NCT00803205|20802107|P1|STARTED|Overall Study||120
8441681|NCT00803179|20802150|P1|NOT COMPLETED|Overall Study||3
8441682|NCT00803179|20802150|P1|COMPLETED|Overall Study||2
8441683|NCT00803179|20802150|P1|STARTED|Overall Study||5
8441684|NCT00803114|20802156|P2|NOT COMPLETED|Overall Study||0
8441685|NCT00803114|20802157|P1|NOT COMPLETED|Overall Study||0
8441686|NCT00803114|20802156|P2|COMPLETED|Overall Study||115
8441687|NCT00803114|20802157|P1|COMPLETED|Overall Study||113
8441688|NCT00803114|20802156|P2|STARTED|Overall Study||115
8441689|NCT00803114|20802157|P1|STARTED|Overall Study||113
8441690|NCT00803101|20802169|P2|NOT COMPLETED|Overall Study||22
8441691|NCT00803101|20802170|P1|NOT COMPLETED|Overall Study||18
8441692|NCT00803101|20802169|P2|COMPLETED|Overall Study||66
8441693|NCT00803101|20802170|P1|COMPLETED|Overall Study||70
8441694|NCT00803101|20802169|P2|STARTED|Overall Study||88
8441695|NCT00803101|20802170|P1|STARTED|Overall Study||88
8441696|NCT00803062|20802192|P4|NOT COMPLETED|Overall Study||0
8441697|NCT00803062|20802193|P3|NOT COMPLETED|Overall Study||0
8441698|NCT00803062|20802194|P2|NOT COMPLETED|Overall Study||0
8441699|NCT00803062|20802195|P1|NOT COMPLETED|Overall Study||0
8441700|NCT00803062|20802192|P4|COMPLETED|Overall Study||112
8441701|NCT00803062|20802193|P3|COMPLETED|Overall Study||111
8441702|NCT00803062|20802194|P2|COMPLETED|Overall Study||115
8441703|NCT00803062|20802195|P1|COMPLETED|Overall Study||114
8441704|NCT00803062|20802192|P4|STARTED|Overall Study||112
8441705|NCT00803062|20802193|P3|STARTED|Overall Study||111
8441706|NCT00803062|20802194|P2|STARTED|Overall Study||115
8441707|NCT00803062|20802195|P1|STARTED|Overall Study||114
8441708|NCT00803049|20802221|P4|NOT COMPLETED|Overall Study||102
8441709|NCT00803049|20802222|P3|NOT COMPLETED|Overall Study||44
8441710|NCT00803049|20802223|P2|NOT COMPLETED|Overall Study||118
8441711|NCT00803049|20802224|P1|NOT COMPLETED|Overall Study||61
8441712|NCT00803049|20802221|P4|COMPLETED|Overall Study||151
8441713|NCT00803049|20802222|P3|COMPLETED|Overall Study||64
8441714|NCT00803049|20802223|P2|COMPLETED|Overall Study||134
8441715|NCT00803049|20802224|P1|COMPLETED|Overall Study||68
8441716|NCT00803049|20802221|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
8441717|NCT00803049|20802222|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
8441718|NCT00803049|20802223|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
8441719|NCT00803049|20802224|P1|Safety Population|Overall Study||129
8441720|NCT00803049|20802221|P4|Treated|Overall Study||251
8441721|NCT00803049|20802222|P3|Treated|Overall Study||108
8441722|NCT00803049|20802223|P2|Treated|Overall Study||252
8441723|NCT00803049|20802224|P1|Treated|Overall Study||129
8441724|NCT00803049|20802221|P4|STARTED|Overall Study|Randomized in extension study|253
8441725|NCT00803049|20802222|P3|STARTED|Overall Study|Randomized in extension study|108
8441726|NCT00803049|20802223|P2|STARTED|Overall Study|Randomized in extension study|252
8441727|NCT00803049|20802224|P1|STARTED|Overall Study|Randomized in extension study|129
8441728|NCT00803023|20802258|P4|NOT COMPLETED|Overall Study||8
8441729|NCT00803023|20802259|P3|NOT COMPLETED|Overall Study||11
8441730|NCT00803023|20802260|P2|NOT COMPLETED|Overall Study||8
8441731|NCT00803023|20802261|P1|NOT COMPLETED|Overall Study||5
8441732|NCT00803023|20802258|P4|COMPLETED|Overall Study||25
8441733|NCT00803023|20802259|P3|COMPLETED|Overall Study||20
8441734|NCT00803023|20802260|P2|COMPLETED|Overall Study||25
8441735|NCT00803023|20802261|P1|COMPLETED|Overall Study||27
8441736|NCT00803023|20802258|P4|STARTED|Overall Study||33
8441737|NCT00803023|20802259|P3|STARTED|Overall Study||31
8441738|NCT00803023|20802260|P2|STARTED|Overall Study||33
8441739|NCT00803023|20802261|P1|STARTED|Overall Study||32
8441740|NCT00803010|20802273|P2|NOT COMPLETED|Overall Study||0
8441741|NCT00803010|20802274|P1|NOT COMPLETED|Overall Study||0
8441742|NCT00803010|20802273|P2|COMPLETED|Overall Study||37
8441743|NCT00803010|20802274|P1|COMPLETED|Overall Study||37
8441744|NCT00803010|20802273|P2|STARTED|Overall Study||37
8441745|NCT00803010|20802274|P1|STARTED|Overall Study||37
8441746|NCT00802997|20802286|P2|NOT COMPLETED|6 Month to 9 Months||0
8441747|NCT00802997|20802287|P1|NOT COMPLETED|6 Month to 9 Months||2
8441748|NCT00802997|20802286|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441749|NCT00802997|20802287|P1|COMPLETED|6 Month to 9 Months||25
8441750|NCT00802997|20802286|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441751|NCT00802997|20802287|P1|STARTED|6 Month to 9 Months||27
8441752|NCT00802997|20802286|P2|NOT COMPLETED|3 Months to 6 Months||0
8441753|NCT00802997|20802287|P1|NOT COMPLETED|3 Months to 6 Months||7
8441754|NCT00802997|20802286|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441755|NCT00802997|20802287|P1|COMPLETED|3 Months to 6 Months||27
8441756|NCT00802997|20802286|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441757|NCT00802997|20802287|P1|STARTED|3 Months to 6 Months||34
8441758|NCT00802997|20802286|P2|NOT COMPLETED|Baseline to 3 Months||0
8441759|NCT00802997|20802287|P1|NOT COMPLETED|Baseline to 3 Months||0
8441760|NCT00802997|20802286|P2|COMPLETED|Baseline to 3 Months||17
8441761|NCT00802997|20802287|P1|COMPLETED|Baseline to 3 Months||34
8441762|NCT00802997|20802286|P2|STARTED|Baseline to 3 Months||17
8441763|NCT00802997|20802287|P1|STARTED|Baseline to 3 Months||34
8441764|NCT00802945|20802299|P2|NOT COMPLETED|Overall Study||35
8441765|NCT00802945|20802300|P1|NOT COMPLETED|Overall Study||35
8441766|NCT00802945|20802299|P2|COMPLETED|Overall Study||0
8441767|NCT00802945|20802300|P1|COMPLETED|Overall Study||0
8441768|NCT00802945|20802299|P2|STARTED|Overall Study||35
8441769|NCT00802945|20802300|P1|STARTED|Overall Study||35
8441770|NCT00802919|20802318|P2|NOT COMPLETED|Overall Study||1
8441771|NCT00802919|20802319|P1|NOT COMPLETED|Overall Study||3
8441772|NCT00802919|20802318|P2|COMPLETED|Overall Study||45
8441773|NCT00802919|20802319|P1|COMPLETED|Overall Study||42
8441774|NCT00802919|20802318|P2|STARTED|Overall Study||46
8441775|NCT00802919|20802319|P1|STARTED|Overall Study||45
8441776|NCT00802893|20802331|P1|NOT COMPLETED|Overall Study||3
8441777|NCT00802893|20802331|P1|COMPLETED|Overall Study||0
8441778|NCT00802893|20802331|P1|STARTED|Overall Study||3
8441779|NCT00802880|20802336|P1|NOT COMPLETED|Overall Study||0
8441780|NCT00802880|20802336|P1|COMPLETED|Overall Study||80
8441781|NCT00802880|20802336|P1|STARTED|Overall Study||80
8441782|NCT00802867|20802355|P1|NOT COMPLETED|Overall Study||13
8441783|NCT00802867|20802355|P1|COMPLETED|Overall Study||976
8441784|NCT00802867|20802355|P1|STARTED|Overall Study||989
8441785|NCT00802854|20802363|P1|NOT COMPLETED|Overall Study||0
8441786|NCT00802854|20802363|P1|COMPLETED|Overall Study||244
8441787|NCT00802854|20802363|P1|STARTED|Overall Study||244
8441788|NCT00802841|20802378|P2|NOT COMPLETED|Overall Study||95
8441789|NCT00802841|20802379|P1|NOT COMPLETED|Overall Study||96
8441790|NCT00802841|20802378|P2|COMPLETED|Overall Study||0
8441791|NCT00802841|20802379|P1|COMPLETED|Overall Study||0
8441792|NCT00802841|20802378|P2|Cross-over Set|Overall Study||56
8441793|NCT00802841|20802379|P1|Cross-over Set|Overall Study||13
8441794|NCT00802841|20802378|P2|Safety Set|Overall Study||93
8441795|NCT00802841|20802379|P1|Safety Set|Overall Study||96
8441796|NCT00802841|20802378|P2|Full Analysis Set|Overall Study||95
8441797|NCT00802841|20802379|P1|Full Analysis Set|Overall Study||96
8441798|NCT00802841|20802378|P2|STARTED|Overall Study||95
8441799|NCT00802841|20802379|P1|STARTED|Overall Study||96
8441800|NCT00802737|20802404|P3|NOT COMPLETED|Overall Study||1
8441801|NCT00802737|20802405|P2|NOT COMPLETED|Overall Study||11
8441802|NCT00802737|20802406|P1|NOT COMPLETED|Overall Study||17
8441803|NCT00802737|20802404|P3|COMPLETED|Overall Study||0
8441804|NCT00802737|20802405|P2|COMPLETED|Overall Study||0
8441805|NCT00802737|20802406|P1|COMPLETED|Overall Study||0
8441806|NCT00802737|20802404|P3|STARTED|Overall Study||1
8441807|NCT00802737|20802405|P2|STARTED|Overall Study||11
8441808|NCT00802737|20802406|P1|STARTED|Overall Study||17
8441809|NCT00802685|20802454|P2|NOT COMPLETED|Overall Study||0
8441810|NCT00802685|20802455|P1|NOT COMPLETED|Overall Study||0
8441811|NCT00802685|20802454|P2|COMPLETED|Overall Study||51
8441812|NCT00802685|20802455|P1|COMPLETED|Overall Study||54
8441813|NCT00802685|20802454|P2|STARTED|Overall Study||51
8441814|NCT00802685|20802455|P1|STARTED|Overall Study||54
8441815|NCT00802672|20802466|P3|NOT COMPLETED|Overall Study||34
8441816|NCT00802672|20802467|P2|NOT COMPLETED|Overall Study||52
8441817|NCT00802672|20802468|P1|NOT COMPLETED|Overall Study||68
8441818|NCT00802672|20802466|P3|COMPLETED|Overall Study||77
8441819|NCT00802672|20802467|P2|COMPLETED|Overall Study||174
8441820|NCT00802672|20802468|P1|COMPLETED|Overall Study||156
8441821|NCT00802672|20802466|P3|STARTED|Overall Study||111
8441822|NCT00802672|20802467|P2|STARTED|Overall Study||226
8441823|NCT00802672|20802468|P1|STARTED|Overall Study||224
8441824|NCT00802659|20802486|P4|NOT COMPLETED|Overall Study||0
8441825|NCT00802659|20802487|P3|NOT COMPLETED|Overall Study||0
8441826|NCT00802659|20802488|P2|NOT COMPLETED|Overall Study||1
8441827|NCT00802659|20802489|P1|NOT COMPLETED|Overall Study||0
8441828|NCT00802659|20802486|P4|COMPLETED|Overall Study||0
8441829|NCT00802659|20802487|P3|COMPLETED|Overall Study||0
8441830|NCT00802659|20802488|P2|COMPLETED|Overall Study||1
8441831|NCT00802659|20802489|P1|COMPLETED|Overall Study||0
8441832|NCT00802659|20802486|P4|STARTED|Overall Study||0
8441833|NCT00802659|20802487|P3|STARTED|Overall Study||0
8441834|NCT00802659|20802488|P2|STARTED|Overall Study||2
8441835|NCT00802659|20802489|P1|STARTED|Overall Study||0
8441836|NCT00802633|20802517|P2|NOT COMPLETED|Overall Study||0
8441837|NCT00802633|20802518|P1|NOT COMPLETED|Overall Study||0
8441838|NCT00802633|20802517|P2|COMPLETED|Overall Study||40
8441839|NCT00802633|20802518|P1|COMPLETED|Overall Study||40
8441840|NCT00802633|20802517|P2|STARTED|Overall Study||40
8441841|NCT00802633|20802518|P1|STARTED|Overall Study||40
8441842|NCT00802529|20802528|P2|NOT COMPLETED|Overall Study||1
8441843|NCT00802529|20802529|P1|NOT COMPLETED|Overall Study||0
8441844|NCT00802529|20802528|P2|COMPLETED|Overall Study||29
8441845|NCT00802529|20802529|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
8441846|NCT00802529|20802528|P2|STARTED|Overall Study||30
8441847|NCT00802529|20802529|P1|STARTED|Overall Study||30
8441848|NCT00802503|20802541|P2|NOT COMPLETED|Overall Study||20
8441849|NCT00802503|20802542|P1|NOT COMPLETED|Overall Study||10
8441850|NCT00802503|20802541|P2|COMPLETED|Overall Study||133
8441851|NCT00802503|20802542|P1|COMPLETED|Overall Study||142
8441852|NCT00802503|20802541|P2|STARTED|Overall Study||153
8441853|NCT00802503|20802542|P1|STARTED|Overall Study||152
8441854|NCT00802464|20802568|P4|NOT COMPLETED|Month 8 - Month 14||0
8441855|NCT00802464|20802569|P3|NOT COMPLETED|Month 8 - Month 14||1
8441856|NCT00802464|20802570|P2|NOT COMPLETED|Month 8 - Month 14||2
8441857|NCT00802464|20802571|P1|NOT COMPLETED|Month 8 - Month 14||1
8441858|NCT00802464|20802568|P4|COMPLETED|Month 8 - Month 14||126
8441859|NCT00802464|20802569|P3|COMPLETED|Month 8 - Month 14||129
8441860|NCT00802464|20802570|P2|COMPLETED|Month 8 - Month 14||63
8441861|NCT00802464|20802571|P1|COMPLETED|Month 8 - Month 14||33
8441862|NCT00802464|20802568|P4|STARTED|Month 8 - Month 14||126
8441863|NCT00802464|20802569|P3|STARTED|Month 8 - Month 14||130
8441864|NCT00802464|20802570|P2|STARTED|Month 8 - Month 14||65
8441865|NCT00802464|20802571|P1|STARTED|Month 8 - Month 14||34
8441866|NCT00802464|20802568|P4|NOT COMPLETED|Month 0 - Month 8||9
8441867|NCT00802464|20802569|P3|NOT COMPLETED|Month 0 - Month 8||7
8441868|NCT00802464|20802570|P2|NOT COMPLETED|Month 0 - Month 8||3
8441869|NCT00802464|20802571|P1|NOT COMPLETED|Month 0 - Month 8||0
8441870|NCT00802464|20802568|P4|COMPLETED|Month 0 - Month 8||141
8441871|NCT00802464|20802569|P3|COMPLETED|Month 0 - Month 8||142
8441872|NCT00802464|20802570|P2|COMPLETED|Month 0 - Month 8||70
8441873|NCT00802464|20802571|P1|COMPLETED|Month 0 - Month 8||38
8441874|NCT00802464|20802568|P4|STARTED|Month 0 - Month 8||150
8441875|NCT00802464|20802569|P3|STARTED|Month 0 - Month 8||149
8441876|NCT00802464|20802570|P2|STARTED|Month 0 - Month 8||73
8441877|NCT00802464|20802571|P1|STARTED|Month 0 - Month 8||38
8441878|NCT00802438|20802657|P1|NOT COMPLETED|Overall Study||28
8441879|NCT00802438|20802657|P1|COMPLETED|Overall Study||10
8441880|NCT00802438|20802657|P1|STARTED|Overall Study||38
8441881|NCT00802412|20802664|P2|NOT COMPLETED|Overall Study||1
8441882|NCT00802412|20802665|P1|NOT COMPLETED|Overall Study||2
8441883|NCT00802412|20802664|P2|COMPLETED|Overall Study||66
8441884|NCT00802412|20802665|P1|COMPLETED|Overall Study||63
8441885|NCT00802412|20802664|P2|STARTED|Overall Study||67
8441886|NCT00802412|20802665|P1|STARTED|Overall Study||65
8441887|NCT00802360|20802677|P4|NOT COMPLETED|Overall Study||22
8441888|NCT00802360|20802678|P3|NOT COMPLETED|Overall Study||25
8441889|NCT00802360|20802679|P2|NOT COMPLETED|Overall Study||26
8441890|NCT00802360|20802680|P1|NOT COMPLETED|Overall Study||24
8441891|NCT00802360|20802677|P4|COMPLETED|Overall Study||17
8441892|NCT00802360|20802678|P3|COMPLETED|Overall Study||17
8441893|NCT00802360|20802679|P2|COMPLETED|Overall Study||16
8441894|NCT00802360|20802680|P1|COMPLETED|Overall Study||18
8441895|NCT00802360|20802677|P4|STARTED|Overall Study||39
8441896|NCT00802360|20802678|P3|STARTED|Overall Study||42
8441897|NCT00802360|20802679|P2|STARTED|Overall Study||42
8441898|NCT00802360|20802680|P1|STARTED|Overall Study||42
8441899|NCT00802204|20802722|P2|NOT COMPLETED|Overall Study||1
8441900|NCT00802204|20802723|P1|NOT COMPLETED|Overall Study||1
8441901|NCT00802204|20802722|P2|COMPLETED|Overall Study||18
8441902|NCT00802204|20802723|P1|COMPLETED|Overall Study||8
8441903|NCT00802204|20802722|P2|STARTED|Overall Study||19
8441904|NCT00802204|20802723|P1|STARTED|Overall Study||9
8441905|NCT00802178|20802747|P1|NOT COMPLETED|Overall Study||113
8441906|NCT00802178|20802747|P1|COMPLETED|Overall Study||2335
8441907|NCT00802178|20802747|P1|STARTED|Overall Study||2448
8441908|NCT00802113|20802756|P2|NOT COMPLETED|Overall Study||0
8441909|NCT00802113|20802757|P1|NOT COMPLETED|Overall Study||0
8441910|NCT00802113|20802756|P2|COMPLETED|Overall Study||17
8441911|NCT00802113|20802757|P1|COMPLETED|Overall Study||6
8441912|NCT00802113|20802756|P2|STARTED|Overall Study||17
8441913|NCT00802113|20802757|P1|STARTED|Overall Study||6
8441914|NCT00802100|20802778|P3|NOT COMPLETED|Overall Study||4
8441915|NCT00802100|20802779|P2|NOT COMPLETED|Overall Study||7
8441916|NCT00802100|20802780|P1|NOT COMPLETED|Overall Study||6
8441917|NCT00802100|20802778|P3|COMPLETED|Overall Study||2
8441918|NCT00802100|20802779|P2|COMPLETED|Overall Study||2
8441919|NCT00802100|20802780|P1|COMPLETED|Overall Study||0
8441920|NCT00802100|20802778|P3|STARTED|Overall Study||6
8441921|NCT00802100|20802779|P2|STARTED|Overall Study||9
8441922|NCT00802100|20802780|P1|STARTED|Overall Study||6
8441923|NCT00802074|20802795|P6|NOT COMPLETED|Overall Study||0
8441924|NCT00802074|20802796|P5|NOT COMPLETED|Overall Study||0
8441925|NCT00802074|20802797|P4|NOT COMPLETED|Overall Study||0
8441926|NCT00802074|20802798|P3|NOT COMPLETED|Overall Study||1
8441927|NCT00802074|20802799|P2|NOT COMPLETED|Overall Study||1
8441928|NCT00802074|20802800|P1|NOT COMPLETED|Overall Study||2
8441929|NCT00802074|20802795|P6|COMPLETED|Overall Study||7
8441930|NCT00802074|20802796|P5|COMPLETED|Overall Study||7
8441931|NCT00802074|20802797|P4|COMPLETED|Overall Study||7
8441932|NCT00802074|20802798|P3|COMPLETED|Overall Study||6
8441933|NCT00802074|20802799|P2|COMPLETED|Overall Study||7
8441934|NCT00802074|20802800|P1|COMPLETED|Overall Study||7
8441935|NCT00802074|20802795|P6|STARTED|Overall Study||7
8441936|NCT00802074|20802796|P5|STARTED|Overall Study||7
8441937|NCT00802074|20802797|P4|STARTED|Overall Study||7
8441938|NCT00802074|20802798|P3|STARTED|Overall Study||7
8441939|NCT00802074|20802799|P2|STARTED|Overall Study||8
8441940|NCT00802074|20802800|P1|STARTED|Overall Study||9
8441941|NCT00801983|20802834|P2|NOT COMPLETED|Period 2||1
8441942|NCT00801983|20802835|P1|NOT COMPLETED|Period 2||2
8441943|NCT00801983|20802834|P2|COMPLETED|Period 2||32
8441944|NCT00801983|20802835|P1|COMPLETED|Period 2||38
8441945|NCT00801983|20802834|P2|STARTED|Period 2||33
8441946|NCT00801983|20802835|P1|STARTED|Period 2||40
8441947|NCT00801983|20802834|P2|NOT COMPLETED|Period 1||8
8441948|NCT00801983|20802835|P1|NOT COMPLETED|Period 1||4
8441949|NCT00801983|20802834|P2|COMPLETED|Period 1||33
8441950|NCT00801983|20802835|P1|COMPLETED|Period 1||40
8441951|NCT00801983|20802834|P2|STARTED|Period 1||41
8441952|NCT00801983|20802835|P1|STARTED|Period 1||44
8441953|NCT00801931|20802841|P1|NOT COMPLETED|Overall Study||0
8441954|NCT00801931|20802841|P1|COMPLETED|Overall Study||1
8441955|NCT00801931|20802841|P1|STARTED|Overall Study||1
8441956|NCT00801892|20802850|P2|NOT COMPLETED|Sham Crossover Period||2
8441957|NCT00801892|20802851|P1|NOT COMPLETED|Sham Crossover Period||0
8441958|NCT00801892|20802850|P2|COMPLETED|Sham Crossover Period||5
8441959|NCT00801892|20802851|P1|COMPLETED|Sham Crossover Period||0
8441960|NCT00801892|20802850|P2|STARTED|Sham Crossover Period||7
8441961|NCT00801892|20802851|P1|STARTED|Sham Crossover Period||0
8441962|NCT00801892|20802850|P2|NOT COMPLETED|Main Study Period||1
8441963|NCT00801892|20802851|P1|NOT COMPLETED|Main Study Period||0
8441964|NCT00801892|20802850|P2|COMPLETED|Main Study Period||10
8441965|NCT00801892|20802851|P1|COMPLETED|Main Study Period||12
8441966|NCT00801892|20802850|P2|STARTED|Main Study Period||11
8441967|NCT00801892|20802851|P1|STARTED|Main Study Period||12
8441968|NCT00801827|20802867|P1|NOT COMPLETED|Overall Study||0
8441969|NCT00801827|20802867|P1|COMPLETED|Overall Study||5
8441970|NCT00801827|20802867|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
8441971|NCT00801801|20802871|P1|NOT COMPLETED|Overall Study||0
8441972|NCT00801801|20802871|P1|COMPLETED|Overall Study||5
8441973|NCT00801801|20802871|P1|STARTED|Overall Study||5
8441974|NCT00801723|20802878|P2|NOT COMPLETED|Overall Study||35
8441975|NCT00801723|20802879|P1|NOT COMPLETED|Overall Study||36
8441976|NCT00801723|20802878|P2|COMPLETED|Overall Study||27
8441977|NCT00801723|20802879|P1|COMPLETED|Overall Study||25
8441978|NCT00801723|20802878|P2|STARTED|Overall Study||62
8441979|NCT00801723|20802879|P1|STARTED|Overall Study||61
8441980|NCT00801684|20802889|P1|NOT COMPLETED|Overall Study||0
8441981|NCT00801684|20802889|P1|COMPLETED|Overall Study||24
8441982|NCT00801684|20802889|P1|STARTED|Overall Study||24
8441983|NCT00801632|20802911|P1|NOT COMPLETED|Overall Study||1
8441984|NCT00801632|20802911|P1|COMPLETED|Overall Study||4
8441985|NCT00801632|20802911|P1|STARTED|Overall Study||5
8441986|NCT00801398|20802928|P6|NOT COMPLETED|Overall Study||3
8441987|NCT00801398|20802929|P5|NOT COMPLETED|Overall Study||7
8441988|NCT00801398|20802930|P4|NOT COMPLETED|Overall Study||6
8441989|NCT00801398|20802931|P3|NOT COMPLETED|Overall Study||7
8441990|NCT00801398|20802932|P2|NOT COMPLETED|Overall Study||9
8441991|NCT00801398|20802933|P1|NOT COMPLETED|Overall Study||6
8441992|NCT00801398|20802928|P6|COMPLETED|Overall Study||5
8441993|NCT00801398|20802929|P5|COMPLETED|Overall Study||1
8441994|NCT00801398|20802930|P4|COMPLETED|Overall Study||3
8441995|NCT00801398|20802931|P3|COMPLETED|Overall Study||4
8441996|NCT00801398|20802932|P2|COMPLETED|Overall Study||0
8441997|NCT00801398|20802933|P1|COMPLETED|Overall Study||7
8441998|NCT00801398|20802928|P6|STARTED|Overall Study||8
8441999|NCT00801398|20802929|P5|STARTED|Overall Study||8
8442000|NCT00801398|20802930|P4|STARTED|Overall Study||9
8442001|NCT00801398|20802931|P3|STARTED|Overall Study||11
8442002|NCT00801398|20802932|P2|STARTED|Overall Study||9
8442003|NCT00801398|20802933|P1|STARTED|Overall Study||13
8442004|NCT00801242|20802989|P1|NOT COMPLETED|Overall Study||52
8442005|NCT00801242|20802989|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
8442006|NCT00801242|20802989|P1|Started Cycle 3|Overall Study||2
8442007|NCT00801242|20802989|P1|Started Cycle 2|Overall Study||35
8442008|NCT00801242|20802989|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
8442009|NCT00801242|20802989|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
8442010|NCT00801242|20802989|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
8442011|NCT00801242|20802989|P1|STARTED|Overall Study|Randomized participants.|220
8442012|NCT00801229|20803002|P2|NOT COMPLETED|Received Study Drug/Placebo||4
8442013|NCT00801229|20803003|P1|NOT COMPLETED|Received Study Drug/Placebo||4
8442014|NCT00801229|20803002|P2|COMPLETED|Received Study Drug/Placebo||30
8442015|NCT00801229|20803003|P1|COMPLETED|Received Study Drug/Placebo||31
8442016|NCT00801229|20803002|P2|STARTED|Received Study Drug/Placebo||34
8442017|NCT00801229|20803003|P1|STARTED|Received Study Drug/Placebo||35
8442018|NCT00801229|20803002|P2|NOT COMPLETED|Signed Consent||3
8442019|NCT00801229|20803003|P1|NOT COMPLETED|Signed Consent||3
8442020|NCT00801229|20803002|P2|COMPLETED|Signed Consent||34
8442021|NCT00801229|20803003|P1|COMPLETED|Signed Consent||35
8442022|NCT00801229|20803002|P2|STARTED|Signed Consent||37
8442023|NCT00801229|20803003|P1|STARTED|Signed Consent||38
8442024|NCT00801138|20803013|P4|NOT COMPLETED|Overall Study||0
8442025|NCT00801138|20803014|P3|NOT COMPLETED|Overall Study||0
8442026|NCT00801138|20803015|P2|NOT COMPLETED|Overall Study||0
8442027|NCT00801138|20803016|P1|NOT COMPLETED|Overall Study||0
8442028|NCT00801138|20803013|P4|COMPLETED|Overall Study||54
8442029|NCT00801138|20803014|P3|COMPLETED|Overall Study||54
8442030|NCT00801138|20803015|P2|COMPLETED|Overall Study||56
8442031|NCT00801138|20803016|P1|COMPLETED|Overall Study||54
8442032|NCT00801138|20803013|P4|STARTED|Overall Study||54
8442033|NCT00801138|20803014|P3|STARTED|Overall Study||54
8442034|NCT00801138|20803015|P2|STARTED|Overall Study||56
8442035|NCT00801138|20803016|P1|STARTED|Overall Study||54
8442036|NCT00801099|20803038|P1|NOT COMPLETED|Overall Study||101
8442037|NCT00801099|20803038|P1|COMPLETED|Overall Study||175
8442038|NCT00801099|20803038|P1|STARTED|Overall Study||276
8442039|NCT00800982|20803044|P2|NOT COMPLETED|Overall Study||3
8442040|NCT00800982|20803045|P1|NOT COMPLETED|Overall Study||2
8442041|NCT00800982|20803044|P2|COMPLETED|Overall Study||12
8442042|NCT00800982|20803045|P1|COMPLETED|Overall Study||13
8442043|NCT00800982|20803044|P2|STARTED|Overall Study||15
8442044|NCT00800982|20803045|P1|STARTED|Overall Study||15
8442045|NCT00800865|20803053|P2|NOT COMPLETED|Overall Study||0
8442046|NCT00800865|20803054|P1|NOT COMPLETED|Overall Study||0
8442047|NCT00800865|20803053|P2|COMPLETED|Overall Study||16
8442048|NCT00800865|20803054|P1|COMPLETED|Overall Study||15
8442049|NCT00800865|20803053|P2|STARTED|Overall Study||16
8442050|NCT00800865|20803054|P1|STARTED|Overall Study||15
8442051|NCT00800839|20803062|P1|NOT COMPLETED|Overall Study||7
8442052|NCT00800839|20803062|P1|COMPLETED|Overall Study||49
8442053|NCT00800839|20803062|P1|STARTED|Overall Study||56
8442054|NCT00800735|20803071|P1|NOT COMPLETED|Overall Study||14
8442055|NCT00800735|20803071|P1|COMPLETED|Overall Study||16
8442056|NCT00800735|20803071|P1|STARTED|Overall Study||30
8442057|NCT00800683|20803077|P2|NOT COMPLETED|Overall Study||19
8442058|NCT00800683|20803078|P1|NOT COMPLETED|Overall Study||17
8442059|NCT00800683|20803077|P2|COMPLETED|Overall Study|Number who completed treatment|49
8442060|NCT00800683|20803078|P1|COMPLETED|Overall Study|Number who completed treatment|48
8442061|NCT00800683|20803077|P2|STARTED|Overall Study|Number who started treatment|68
8442062|NCT00800683|20803078|P1|STARTED|Overall Study|Number who started treatment|65
8442063|NCT00800540|20803124|P2|NOT COMPLETED|Period 2: 6 Weeks||1
8442064|NCT00800540|20803125|P1|NOT COMPLETED|Period 2: 6 Weeks||0
8442065|NCT00800540|20803124|P2|COMPLETED|Period 2: 6 Weeks||16
8442066|NCT00800540|20803125|P1|COMPLETED|Period 2: 6 Weeks||16
8442067|NCT00800540|20803124|P2|STARTED|Period 2: 6 Weeks||17
8442068|NCT00800540|20803125|P1|STARTED|Period 2: 6 Weeks||16
8442069|NCT00800540|20803124|P2|NOT COMPLETED|Washout: 4 Weeks||0
8442070|NCT00800540|20803125|P1|NOT COMPLETED|Washout: 4 Weeks||0
8442071|NCT00800540|20803124|P2|COMPLETED|Washout: 4 Weeks||17
8442072|NCT00800540|20803125|P1|COMPLETED|Washout: 4 Weeks||16
8442073|NCT00800540|20803124|P2|STARTED|Washout: 4 Weeks||17
8442074|NCT00800540|20803125|P1|STARTED|Washout: 4 Weeks||16
8442075|NCT00800540|20803124|P2|NOT COMPLETED|Period One: 6 Weeks||1
8442076|NCT00800540|20803125|P1|NOT COMPLETED|Period One: 6 Weeks||1
8442077|NCT00800540|20803124|P2|COMPLETED|Period One: 6 Weeks||17
8442078|NCT00800540|20803125|P1|COMPLETED|Period One: 6 Weeks||16
8442079|NCT00800540|20803124|P2|STARTED|Period One: 6 Weeks||18
8442080|NCT00800540|20803125|P1|STARTED|Period One: 6 Weeks||17
8442081|NCT00800436|20803160|P7|NOT COMPLETED|Overall Study||0
8442082|NCT00800436|20803161|P6|NOT COMPLETED|Overall Study||0
8442083|NCT00800436|20803162|P5|NOT COMPLETED|Overall Study||0
8442084|NCT00800436|20803163|P4|NOT COMPLETED|Overall Study||1
8442085|NCT00800436|20803164|P3|NOT COMPLETED|Overall Study||1
8442086|NCT00800436|20803165|P2|NOT COMPLETED|Overall Study||0
8442087|NCT00800436|20803166|P1|NOT COMPLETED|Overall Study||0
8442088|NCT00800436|20803160|P7|COMPLETED|Overall Study||20
8442089|NCT00800436|20803161|P6|COMPLETED|Overall Study||20
8442090|NCT00800436|20803162|P5|COMPLETED|Overall Study||6
8442091|NCT00800436|20803163|P4|COMPLETED|Overall Study||5
8442092|NCT00800436|20803164|P3|COMPLETED|Overall Study||5
8442093|NCT00800436|20803165|P2|COMPLETED|Overall Study||6
8442094|NCT00800436|20803166|P1|COMPLETED|Overall Study||6
8442095|NCT00800436|20803160|P7|STARTED|Overall Study||20
8442096|NCT00800436|20803161|P6|STARTED|Overall Study||20
8442097|NCT00800436|20803162|P5|STARTED|Overall Study||6
8442098|NCT00800436|20803163|P4|STARTED|Overall Study||6
8442099|NCT00800436|20803164|P3|STARTED|Overall Study||6
8442100|NCT00800436|20803165|P2|STARTED|Overall Study||6
8442101|NCT00800436|20803166|P1|STARTED|Overall Study||6
8442102|NCT00800384|20803212|P2|NOT COMPLETED|Overall Study||43
8442103|NCT00800384|20803213|P1|NOT COMPLETED|Overall Study||41
8442104|NCT00800384|20803212|P2|COMPLETED|Overall Study||1210
8442105|NCT00800384|20803213|P1|COMPLETED|Overall Study||1206
8442106|NCT00800384|20803212|P2|STARTED|Overall Study||1253
8442107|NCT00800384|20803213|P1|STARTED|Overall Study||1247
8442108|NCT00800345|20803221|P1|NOT COMPLETED|Overall Study||0
8442109|NCT00800345|20803221|P1|COMPLETED|Overall Study||33
8442110|NCT00800345|20803221|P1|STARTED|Overall Study||33
8442111|NCT00800254|20803228|P2|NOT COMPLETED|Overall Study||6
8442112|NCT00800254|20803229|P1|NOT COMPLETED|Overall Study||5
8442113|NCT00800254|20803228|P2|COMPLETED|Overall Study||25
8442114|NCT00800254|20803229|P1|COMPLETED|Overall Study||30
8442115|NCT00800254|20803228|P2|3.5 Weeks Post-operatively|Overall Study||31
8442116|NCT00800254|20803229|P1|3.5 Weeks Post-operatively|Overall Study||31
8442117|NCT00800254|20803228|P2|STARTED|Overall Study||31
8442118|NCT00800254|20803229|P1|STARTED|Overall Study||35
8442119|NCT00800202|20803251|P2|NOT COMPLETED|Overall Study||24
8442120|NCT00800202|20803252|P1|NOT COMPLETED|Overall Study||67
8442121|NCT00800202|20803251|P2|COMPLETED|Overall Study||0
8442122|NCT00800202|20803252|P1|COMPLETED|Overall Study||0
8442123|NCT00800202|20803251|P2|STARTED|Overall Study||24
8442124|NCT00800202|20803252|P1|STARTED|Overall Study||67
8442125|NCT00800176|20803276|P6|NOT COMPLETED|Overall Study||5
8442126|NCT00800176|20803277|P5|NOT COMPLETED|Overall Study||4
8442127|NCT00800176|20803278|P4|NOT COMPLETED|Overall Study||4
8442128|NCT00800176|20803279|P3|NOT COMPLETED|Overall Study||0
8442129|NCT00800176|20803280|P2|NOT COMPLETED|Overall Study||6
8442130|NCT00800176|20803281|P1|NOT COMPLETED|Overall Study||9
8442131|NCT00800176|20803276|P6|COMPLETED|Overall Study||62
8442132|NCT00800176|20803277|P5|COMPLETED|Overall Study||60
8442133|NCT00800176|20803278|P4|COMPLETED|Overall Study||62
8442134|NCT00800176|20803279|P3|COMPLETED|Overall Study||65
8442135|NCT00800176|20803280|P2|COMPLETED|Overall Study||60
8442136|NCT00800176|20803281|P1|COMPLETED|Overall Study||57
8442137|NCT00800176|20803276|P6|STARTED|Overall Study||67
8442138|NCT00800176|20803277|P5|STARTED|Overall Study||64
8442139|NCT00800176|20803278|P4|STARTED|Overall Study||66
8442140|NCT00800176|20803279|P3|STARTED|Overall Study||65
8442141|NCT00800176|20803280|P2|STARTED|Overall Study||66
8442142|NCT00800176|20803281|P1|STARTED|Overall Study||66
8442143|NCT00799903|20803357|P2|NOT COMPLETED|Overall Study||278
8442144|NCT00799903|20803358|P1|NOT COMPLETED|Overall Study||273
8442145|NCT00799903|20803357|P2|COMPLETED|Overall Study||7646
8442146|NCT00799903|20803358|P1|COMPLETED|Overall Study||7631
8442147|NCT00799903|20803357|P2|STARTED|Overall Study||7924
8442148|NCT00799903|20803358|P1|STARTED|Overall Study||7904
8442149|NCT00799825|20803378|P1|NOT COMPLETED|Overall Study||48
8442150|NCT00799825|20803378|P1|COMPLETED|Overall Study||296
8442151|NCT00799825|20803378|P1|STARTED|Overall Study||344
8442152|NCT00799773|20803386|P2|NOT COMPLETED|Overall Study||0
8442153|NCT00799773|20803387|P1|NOT COMPLETED|Overall Study||0
8442154|NCT00799773|20803386|P2|COMPLETED|Overall Study||1
8442155|NCT00799773|20803387|P1|COMPLETED|Overall Study||2
8442156|NCT00799773|20803386|P2|STARTED|Overall Study||1
8442157|NCT00799773|20803387|P1|STARTED|Overall Study||2
8442158|NCT00799708|20803418|P3|NOT COMPLETED|Overall Study||0
8442159|NCT00799708|20803419|P2|NOT COMPLETED|Overall Study||0
8442160|NCT00799708|20803420|P1|NOT COMPLETED|Overall Study||1
8442161|NCT00799708|20803418|P3|COMPLETED|Overall Study||11
8442162|NCT00799708|20803419|P2|COMPLETED|Overall Study||6
8442163|NCT00799708|20803420|P1|COMPLETED|Overall Study||9
8442164|NCT00799708|20803418|P3|STARTED|Overall Study||11
8442165|NCT00799708|20803419|P2|STARTED|Overall Study||6
8442166|NCT00799708|20803420|P1|STARTED|Overall Study||10
8442167|NCT00799643|20803432|P2|NOT COMPLETED|Overall Study||27
8442168|NCT00799643|20803433|P1|NOT COMPLETED|Overall Study||25
8442169|NCT00799643|20803432|P2|COMPLETED|Overall Study||119
8442170|NCT00799643|20803433|P1|COMPLETED|Overall Study||115
8442171|NCT00799643|20803432|P2|STARTED|Overall Study||146
8442172|NCT00799643|20803433|P1|STARTED|Overall Study||140
8442173|NCT00799617|20803443|P2|NOT COMPLETED|Anemia Trial||3
8442174|NCT00799617|20803444|P1|NOT COMPLETED|Anemia Trial||3
8442175|NCT00799617|20803443|P2|COMPLETED|Anemia Trial||32
8442176|NCT00799617|20803444|P1|COMPLETED|Anemia Trial||24
8442177|NCT00799617|20803443|P2|STARTED|Anemia Trial||35
8442178|NCT00799617|20803444|P1|STARTED|Anemia Trial||27
8442179|NCT00799617|20803443|P2|NOT COMPLETED|Cognitive Function Trial||1
8442180|NCT00799617|20803444|P1|NOT COMPLETED|Cognitive Function Trial||0
8442181|NCT00799617|20803443|P2|COMPLETED|Cognitive Function Trial||245
8442182|NCT00799617|20803444|P1|COMPLETED|Cognitive Function Trial||247
8442183|NCT00799617|20803443|P2|STARTED|Cognitive Function Trial||246
8442184|NCT00799617|20803444|P1|STARTED|Cognitive Function Trial||247
8442185|NCT00799617|20803443|P2|NOT COMPLETED|Bone Trial||16
8442186|NCT00799617|20803444|P1|NOT COMPLETED|Bone Trial||6
8442187|NCT00799617|20803443|P2|COMPLETED|Bone Trial||85
8442188|NCT00799617|20803444|P1|COMPLETED|Bone Trial||104
8442189|NCT00799617|20803443|P2|STARTED|Bone Trial||101
8442190|NCT00799617|20803444|P1|STARTED|Bone Trial||110
8442191|NCT00799617|20803443|P2|NOT COMPLETED|Cardiovascular Trial||17
8442192|NCT00799617|20803444|P1|NOT COMPLETED|Cardiovascular Trial||15
8442193|NCT00799617|20803443|P2|COMPLETED|Cardiovascular Trial||65
8442194|NCT00799617|20803444|P1|COMPLETED|Cardiovascular Trial||73
8442195|NCT00799617|20803443|P2|STARTED|Cardiovascular Trial||82
8442196|NCT00799617|20803444|P1|STARTED|Cardiovascular Trial||88
8442197|NCT00799617|20803443|P2|NOT COMPLETED|Vitality Trial||22
8442198|NCT00799617|20803444|P1|NOT COMPLETED|Vitality Trial||7
8442199|NCT00799617|20803443|P2|COMPLETED|Vitality Trial||216
8442200|NCT00799617|20803444|P1|COMPLETED|Vitality Trial||229
8442201|NCT00799617|20803443|P2|STARTED|Vitality Trial||238
8442202|NCT00799617|20803444|P1|STARTED|Vitality Trial||236
8442203|NCT00799617|20803443|P2|NOT COMPLETED|Physical Function Trial||11
8442204|NCT00799617|20803444|P1|NOT COMPLETED|Physical Function Trial||6
8442205|NCT00799617|20803443|P2|COMPLETED|Physical Function Trial||185
8442206|NCT00799617|20803444|P1|COMPLETED|Physical Function Trial||185
8442207|NCT00799617|20803443|P2|STARTED|Physical Function Trial||196
8442208|NCT00799617|20803444|P1|STARTED|Physical Function Trial||191
8442209|NCT00799617|20803443|P2|NOT COMPLETED|Sexual Funtion Trial||21
8442210|NCT00799617|20803444|P1|NOT COMPLETED|Sexual Funtion Trial||16
8442211|NCT00799617|20803443|P2|COMPLETED|Sexual Funtion Trial||215
8442212|NCT00799617|20803444|P1|COMPLETED|Sexual Funtion Trial||218
8442213|NCT00799617|20803443|P2|STARTED|Sexual Funtion Trial||236
8442214|NCT00799617|20803444|P1|STARTED|Sexual Funtion Trial||234
8442215|NCT00799617|20803443|P2|NOT COMPLETED|Main Testosterone Trial||21
8442216|NCT00799617|20803444|P1|NOT COMPLETED|Main Testosterone Trial||19
8442217|NCT00799617|20803443|P2|COMPLETED|Main Testosterone Trial||374
8442218|NCT00799617|20803444|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
8442219|NCT00799617|20803443|P2|STARTED|Main Testosterone Trial||395
8442220|NCT00799617|20803444|P1|STARTED|Main Testosterone Trial||395
8442221|NCT00799604|20803525|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8442222|NCT00799604|20803526|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8442223|NCT00799604|20803527|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8442224|NCT00799604|20803525|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
8442225|NCT00799604|20803526|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
8442226|NCT00799604|20803527|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
8442227|NCT00799604|20803525|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
8442228|NCT00799604|20803526|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
8442229|NCT00799604|20803527|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
8442230|NCT00799604|20803525|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8442231|NCT00799604|20803526|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8442232|NCT00799604|20803527|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8442233|NCT00799604|20803525|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8442234|NCT00799604|20803526|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8442235|NCT00799604|20803527|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8442236|NCT00799604|20803525|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
8442237|NCT00799604|20803526|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
8442238|NCT00799604|20803527|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
8442239|NCT00799591|20803551|P1|NOT COMPLETED|Overall Study||66
8442240|NCT00799591|20803551|P1|COMPLETED|Overall Study||90
8442241|NCT00799591|20803551|P1|STARTED|Overall Study||156
8442242|NCT00799578|20803562|P1|NOT COMPLETED|Overall Study||2
8442243|NCT00799578|20803562|P1|COMPLETED|Overall Study||11
8442244|NCT00799578|20803562|P1|STARTED|Overall Study||13
8442245|NCT00799487|20803569|P3|NOT COMPLETED|Double-Blind Assessment Period||2
8442246|NCT00799487|20803570|P2|NOT COMPLETED|Double-Blind Assessment Period||1
8442247|NCT00799487|20803571|P1|NOT COMPLETED|Double-Blind Assessment Period||0
8442248|NCT00799487|20803569|P3|COMPLETED|Double-Blind Assessment Period||32
8442249|NCT00799487|20803570|P2|COMPLETED|Double-Blind Assessment Period||33
8442250|NCT00799487|20803571|P1|COMPLETED|Double-Blind Assessment Period||0
8442251|NCT00799487|20803569|P3|STARTED|Double-Blind Assessment Period||34
8442252|NCT00799487|20803570|P2|STARTED|Double-Blind Assessment Period||34
8442253|NCT00799487|20803571|P1|STARTED|Double-Blind Assessment Period||0
8442254|NCT00799487|20803569|P3|NOT COMPLETED|Dose Adjustment Period||0
8442255|NCT00799487|20803570|P2|NOT COMPLETED|Dose Adjustment Period||0
8442256|NCT00799487|20803571|P1|NOT COMPLETED|Dose Adjustment Period||21
8442257|NCT00799487|20803569|P3|COMPLETED|Dose Adjustment Period||34
8442258|NCT00799487|20803570|P2|COMPLETED|Dose Adjustment Period||34
8442259|NCT00799487|20803571|P1|COMPLETED|Dose Adjustment Period||0
8442260|NCT00799487|20803569|P3|STARTED|Dose Adjustment Period||34
8442261|NCT00799487|20803570|P2|STARTED|Dose Adjustment Period||34
8442262|NCT00799487|20803571|P1|STARTED|Dose Adjustment Period||21
8442263|NCT00799474|20803651|P1|NOT COMPLETED|Overall Study||0
8442264|NCT00799474|20803651|P1|COMPLETED|Overall Study||609
8442265|NCT00799474|20803651|P1|STARTED|Overall Study||609
8442266|NCT00799435|20803659|P2|NOT COMPLETED|Overall Study||0
8442267|NCT00799435|20803660|P1|NOT COMPLETED|Overall Study||0
8442268|NCT00799435|20803659|P2|COMPLETED|Overall Study||1
8442269|NCT00799435|20803660|P1|COMPLETED|Overall Study||1
8442270|NCT00799435|20803659|P2|STARTED|Overall Study||1
8442271|NCT00799435|20803660|P1|STARTED|Overall Study||1
8442272|NCT00799422|20803668|P6|NOT COMPLETED|Third Week of Wear||0
8442273|NCT00799422|20803669|P5|NOT COMPLETED|Third Week of Wear||0
8442274|NCT00799422|20803670|P4|NOT COMPLETED|Third Week of Wear||0
8442275|NCT00799422|20803671|P3|NOT COMPLETED|Third Week of Wear||0
8442276|NCT00799422|20803672|P2|NOT COMPLETED|Third Week of Wear||0
8442277|NCT00799422|20803673|P1|NOT COMPLETED|Third Week of Wear||0
8442278|NCT00799422|20803668|P6|COMPLETED|Third Week of Wear||4
8442279|NCT00799422|20803669|P5|COMPLETED|Third Week of Wear||4
8442280|NCT00799422|20803670|P4|COMPLETED|Third Week of Wear||3
8442281|NCT00799422|20803671|P3|COMPLETED|Third Week of Wear||3
8442282|NCT00799422|20803672|P2|COMPLETED|Third Week of Wear||4
8442283|NCT00799422|20803673|P1|COMPLETED|Third Week of Wear||4
8442284|NCT00799422|20803668|P6|STARTED|Third Week of Wear||4
8442285|NCT00799422|20803669|P5|STARTED|Third Week of Wear||4
8442286|NCT00799422|20803670|P4|STARTED|Third Week of Wear||3
8442287|NCT00799422|20803671|P3|STARTED|Third Week of Wear||3
8442288|NCT00799422|20803672|P2|STARTED|Third Week of Wear||4
8442289|NCT00799422|20803673|P1|STARTED|Third Week of Wear||4
8442290|NCT00799422|20803668|P6|NOT COMPLETED|Second Week of Wear||0
8442291|NCT00799422|20803669|P5|NOT COMPLETED|Second Week of Wear||0
8442292|NCT00799422|20803670|P4|NOT COMPLETED|Second Week of Wear||0
8442293|NCT00799422|20803671|P3|NOT COMPLETED|Second Week of Wear||0
8442294|NCT00799422|20803672|P2|NOT COMPLETED|Second Week of Wear||0
8442295|NCT00799422|20803673|P1|NOT COMPLETED|Second Week of Wear||0
8442296|NCT00799422|20803668|P6|COMPLETED|Second Week of Wear||4
8442297|NCT00799422|20803669|P5|COMPLETED|Second Week of Wear||4
8442298|NCT00799422|20803670|P4|COMPLETED|Second Week of Wear||3
8442299|NCT00799422|20803671|P3|COMPLETED|Second Week of Wear||3
8442300|NCT00799422|20803672|P2|COMPLETED|Second Week of Wear||4
8442301|NCT00799422|20803673|P1|COMPLETED|Second Week of Wear||4
8442302|NCT00799422|20803668|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
8442303|NCT00799422|20803669|P5|STARTED|Second Week of Wear||4
8442304|NCT00799422|20803670|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
8442305|NCT00799422|20803671|P3|STARTED|Second Week of Wear||3
8442306|NCT00799422|20803672|P2|STARTED|Second Week of Wear||4
8442307|NCT00799422|20803673|P1|STARTED|Second Week of Wear||4
8442308|NCT00799422|20803668|P6|NOT COMPLETED|First Week of Wear||0
8442309|NCT00799422|20803669|P5|NOT COMPLETED|First Week of Wear||0
8442310|NCT00799422|20803670|P4|NOT COMPLETED|First Week of Wear||1
8442311|NCT00799422|20803671|P3|NOT COMPLETED|First Week of Wear||1
8442312|NCT00799422|20803672|P2|NOT COMPLETED|First Week of Wear||0
8442313|NCT00799422|20803673|P1|NOT COMPLETED|First Week of Wear||0
8442314|NCT00799422|20803668|P6|COMPLETED|First Week of Wear||5
8442315|NCT00799422|20803669|P5|COMPLETED|First Week of Wear||4
8442316|NCT00799422|20803670|P4|COMPLETED|First Week of Wear||4
8442317|NCT00799422|20803671|P3|COMPLETED|First Week of Wear||3
8442318|NCT00799422|20803672|P2|COMPLETED|First Week of Wear||4
8442319|NCT00799422|20803673|P1|COMPLETED|First Week of Wear||4
8442320|NCT00799422|20803668|P6|STARTED|First Week of Wear||5
8442321|NCT00799422|20803669|P5|STARTED|First Week of Wear||4
8442322|NCT00799422|20803670|P4|STARTED|First Week of Wear||5
8442323|NCT00799422|20803671|P3|STARTED|First Week of Wear||4
8442324|NCT00799422|20803672|P2|STARTED|First Week of Wear||4
8442325|NCT00799422|20803673|P1|STARTED|First Week of Wear||4
8442326|NCT00799409|20803690|P3|NOT COMPLETED|Overall Study||0
8442327|NCT00799409|20803691|P2|NOT COMPLETED|Overall Study||0
8442328|NCT00799409|20803692|P1|NOT COMPLETED|Overall Study||7
8442329|NCT00799409|20803690|P3|COMPLETED|Overall Study||35
8442330|NCT00799409|20803691|P2|COMPLETED|Overall Study||36
8442331|NCT00799409|20803692|P1|COMPLETED|Overall Study||0
8442332|NCT00799409|20803690|P3|STARTED|Overall Study||35
8442333|NCT00799409|20803691|P2|STARTED|Overall Study||36
8442334|NCT00799409|20803692|P1|STARTED|Overall Study||7
8442335|NCT00799396|20803772|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
8442336|NCT00799396|20803772|P1|COMPLETED|Clopidogrel Plus Aspirin||663
8442337|NCT00799396|20803772|P1|STARTED|Clopidogrel Plus Aspirin||669
8442338|NCT00799396|20803772|P1|NOT COMPLETED|Clopidogrel Treatment||13
8442339|NCT00799396|20803772|P1|COMPLETED|Clopidogrel Treatment||669
8442340|NCT00799396|20803772|P1|STARTED|Clopidogrel Treatment||682
8442341|NCT00799383|20803779|P2|NOT COMPLETED|Overall Study||6
8442342|NCT00799383|20803780|P1|NOT COMPLETED|Overall Study||3
8442343|NCT00799383|20803779|P2|COMPLETED|Overall Study||18
8442344|NCT00799383|20803780|P1|COMPLETED|Overall Study||20
8442345|NCT00799383|20803779|P2|STARTED|Overall Study||24
8442346|NCT00799383|20803780|P1|STARTED|Overall Study||23
8442347|NCT00799292|20803802|P2|NOT COMPLETED|Overall Study||0
8442348|NCT00799292|20803803|P1|NOT COMPLETED|Overall Study||0
8442349|NCT00799292|20803802|P2|COMPLETED|Overall Study||29
8442350|NCT00799292|20803803|P1|COMPLETED|Overall Study||29
8442351|NCT00799292|20803802|P2|STARTED|Overall Study||29
8442352|NCT00799292|20803803|P1|STARTED|Overall Study||29
8442353|NCT00799266|20803809|P2|NOT COMPLETED|Overall Study||1
8442354|NCT00799266|20803810|P1|NOT COMPLETED|Overall Study||3
8442355|NCT00799266|20803809|P2|COMPLETED|Overall Study||15
8442356|NCT00799266|20803810|P1|COMPLETED|Overall Study||15
8442357|NCT00799266|20803809|P2|Safety Set|Overall Study||16
8442358|NCT00799266|20803810|P1|Safety Set|Overall Study||18
8442359|NCT00799266|20803809|P2|Modified Intention-to-treat (MITT)|Overall Study||16
8442360|NCT00799266|20803810|P1|Modified Intention-to-treat (MITT)|Overall Study||17
8442361|NCT00799266|20803809|P2|STARTED|Overall Study||16
8442362|NCT00799266|20803810|P1|STARTED|Overall Study||18
8442363|NCT00799227|20803841|P1|NOT COMPLETED|Overall Study||3
8442364|NCT00799227|20803841|P1|COMPLETED|Overall Study||53
8442365|NCT00799227|20803841|P1|STARTED|Overall Study||56
8442366|NCT00798967|20803850|P2|NOT COMPLETED|Overall Study||4
8442367|NCT00798967|20803851|P1|NOT COMPLETED|Overall Study||4
8442368|NCT00798967|20803850|P2|COMPLETED|Overall Study||39
8442369|NCT00798967|20803851|P1|COMPLETED|Overall Study||39
8442370|NCT00798967|20803850|P2|Discontinued During Dosing Period|Overall Study||4
8442371|NCT00798967|20803851|P1|Discontinued During Dosing Period|Overall Study||4
8442372|NCT00798967|20803850|P2|STARTED|Overall Study||43
8442373|NCT00798967|20803851|P1|STARTED|Overall Study||43
8442374|NCT00798889|20803859|P1|NOT COMPLETED|Overall Study||314
8442375|NCT00798889|20803859|P1|COMPLETED|Overall Study||0
8442376|NCT00798889|20803859|P1|Treated|Overall Study||311
8442377|NCT00798889|20803859|P1|STARTED|Overall Study||314
8442378|NCT00798759|20803865|P2|NOT COMPLETED|Overall Study||13
8442379|NCT00798759|20803866|P1|NOT COMPLETED|Overall Study||8
8442380|NCT00798759|20803865|P2|COMPLETED|Overall Study||106
8442381|NCT00798759|20803866|P1|COMPLETED|Overall Study||109
8442382|NCT00798759|20803865|P2|STARTED|Overall Study||119
8442383|NCT00798759|20803866|P1|STARTED|Overall Study||117
8442384|NCT00798720|20803874|P1|NOT COMPLETED|Overall Study||0
8442385|NCT00798720|20803874|P1|COMPLETED|Overall Study||18
8442386|NCT00798720|20803874|P1|STARTED|Overall Study||18
8442387|NCT00798707|20803884|P3|NOT COMPLETED|Overall Study||22
8442388|NCT00798707|20803885|P2|NOT COMPLETED|Overall Study||33
8442389|NCT00798707|20803886|P1|NOT COMPLETED|Overall Study||26
8442390|NCT00798707|20803884|P3|COMPLETED|Overall Study||215
8442391|NCT00798707|20803885|P2|COMPLETED|Overall Study||204
8442392|NCT00798707|20803886|P1|COMPLETED|Overall Study||209
8442393|NCT00798707|20803884|P3|Treated|Overall Study||236
8442394|NCT00798707|20803885|P2|Treated|Overall Study||232
8442395|NCT00798707|20803886|P1|Treated|Overall Study||231
8442396|NCT00798707|20803884|P3|STARTED|Overall Study||237
8442397|NCT00798707|20803885|P2|STARTED|Overall Study||237
8442398|NCT00798707|20803886|P1|STARTED|Overall Study||235
8442399|NCT00798694|20803938|P2|NOT COMPLETED|Overall Study||1
8442400|NCT00798694|20803939|P1|NOT COMPLETED|Overall Study||2
8442401|NCT00798694|20803938|P2|COMPLETED|Overall Study||27
8442402|NCT00798694|20803939|P1|COMPLETED|Overall Study||28
8442403|NCT00798694|20803938|P2|STARTED|Overall Study||28
8442404|NCT00798694|20803939|P1|STARTED|Overall Study||30
8442405|NCT00798655|20803963|P1|NOT COMPLETED|Overall Study||2
8442406|NCT00798655|20803963|P1|COMPLETED|Overall Study||44
8442407|NCT00798655|20803963|P1|STARTED|Overall Study||46
8442408|NCT00798603|20803968|P1|NOT COMPLETED|Overall Study||35
8442409|NCT00798603|20803968|P1|COMPLETED|Overall Study||27
8442410|NCT00798603|20803968|P1|STARTED|Overall Study||62
8442411|NCT00798590|20803990|P2|NOT COMPLETED|Overall Study||8
8442412|NCT00798590|20803991|P1|NOT COMPLETED|Overall Study||11
8442413|NCT00798590|20803990|P2|COMPLETED|Overall Study||0
8442414|NCT00798590|20803991|P1|COMPLETED|Overall Study||0
8442415|NCT00798590|20803990|P2|STARTED|Overall Study||8
8442416|NCT00798590|20803991|P1|STARTED|Overall Study||11
8442417|NCT00798577|20804001|P2|NOT COMPLETED|Overall Study||0
8442418|NCT00798577|20804002|P1|NOT COMPLETED|Overall Study||0
8442419|NCT00798577|20804001|P2|COMPLETED|Overall Study||7
8442420|NCT00798577|20804002|P1|COMPLETED|Overall Study||17
8442421|NCT00798577|20804001|P2|STARTED|Overall Study||7
8442422|NCT00798577|20804002|P1|STARTED|Overall Study||17
8442423|NCT00798486|20804016|P1|NOT COMPLETED|Overall Study||0
8442424|NCT00798486|20804016|P1|COMPLETED|Overall Study||110
8442425|NCT00798486|20804016|P1|STARTED|Overall Study||110
8442426|NCT00798434|20804025|P2|NOT COMPLETED|Open-Label||32
8442427|NCT00798434|20804026|P1|NOT COMPLETED|Open-Label||42
8442428|NCT00798434|20804025|P2|COMPLETED|Open-Label||282
8442429|NCT00798434|20804026|P1|COMPLETED|Open-Label||299
8442430|NCT00798434|20804025|P2|Received Treatment|Open-Label||313
8442431|NCT00798434|20804026|P1|Received Treatment|Open-Label||341
8442432|NCT00798434|20804025|P2|STARTED|Open-Label||314
8442433|NCT00798434|20804026|P1|STARTED|Open-Label||341
8442434|NCT00798434|20804025|P2|NOT COMPLETED|Double-Blind||84
8442435|NCT00798434|20804026|P1|NOT COMPLETED|Double-Blind||55
8442436|NCT00798434|20804025|P2|COMPLETED|Double-Blind||314
8442437|NCT00798434|20804026|P1|COMPLETED|Double-Blind||341
8442438|NCT00798434|20804025|P2|Received Treatment|Double-Blind||392
8442439|NCT00798434|20804026|P1|Received Treatment|Double-Blind||393
8442440|NCT00798434|20804025|P2|STARTED|Double-Blind||398
8442441|NCT00798434|20804026|P1|STARTED|Double-Blind||396
8442442|NCT00798369|20804112|P6|NOT COMPLETED|Overall Study||3
8442443|NCT00798369|20804113|P5|NOT COMPLETED|Overall Study||1
8442444|NCT00798369|20804114|P4|NOT COMPLETED|Overall Study||1
8442445|NCT00798369|20804115|P3|NOT COMPLETED|Overall Study||2
8442446|NCT00798369|20804116|P2|NOT COMPLETED|Overall Study||1
8442447|NCT00798369|20804117|P1|NOT COMPLETED|Overall Study||1
8442448|NCT00798369|20804112|P6|COMPLETED|Overall Study||54
8442449|NCT00798369|20804113|P5|COMPLETED|Overall Study||27
8442450|NCT00798369|20804114|P4|COMPLETED|Overall Study||28
8442451|NCT00798369|20804115|P3|COMPLETED|Overall Study||27
8442452|NCT00798369|20804116|P2|COMPLETED|Overall Study||28
8442453|NCT00798369|20804117|P1|COMPLETED|Overall Study||27
8442454|NCT00798369|20804112|P6|STARTED|Overall Study||57
8442455|NCT00798369|20804113|P5|STARTED|Overall Study||28
8442456|NCT00798369|20804114|P4|STARTED|Overall Study||29
8442457|NCT00798369|20804115|P3|STARTED|Overall Study||29
8442458|NCT00798369|20804116|P2|STARTED|Overall Study||29
8442459|NCT00798369|20804117|P1|STARTED|Overall Study||28
8442460|NCT00798317|20804164|P2|NOT COMPLETED|Overall Study||7
8442461|NCT00798317|20804165|P1|NOT COMPLETED|Overall Study||10
8442462|NCT00798317|20804164|P2|COMPLETED|Overall Study||74
8442463|NCT00798317|20804165|P1|COMPLETED|Overall Study||235
8442464|NCT00798317|20804164|P2|STARTED|Overall Study||81
8442465|NCT00798317|20804165|P1|STARTED|Overall Study||245
8442466|NCT00798304|20804176|P3|NOT COMPLETED|Overall Study||10
8442467|NCT00798304|20804177|P2|NOT COMPLETED|Overall Study||22
8442468|NCT00798304|20804178|P1|NOT COMPLETED|Overall Study||14
8442469|NCT00798304|20804176|P3|COMPLETED|Overall Study||0
8442470|NCT00798304|20804177|P2|COMPLETED|Overall Study||0
8442471|NCT00798304|20804178|P1|COMPLETED|Overall Study||0
8442472|NCT00798304|20804176|P3|STARTED|Overall Study||10
8442473|NCT00798304|20804177|P2|STARTED|Overall Study||22
8442474|NCT00798304|20804178|P1|STARTED|Overall Study||14
8442475|NCT00798174|20804204|P2|NOT COMPLETED|Overall Study||3
8442476|NCT00798174|20804205|P1|NOT COMPLETED|Overall Study||4
8442477|NCT00798174|20804204|P2|COMPLETED|Overall Study||13
8442478|NCT00798174|20804205|P1|COMPLETED|Overall Study||12
8442479|NCT00798174|20804204|P2|STARTED|Overall Study||16
8442480|NCT00798174|20804205|P1|STARTED|Overall Study||16
8442481|NCT00798161|20804216|P7|NOT COMPLETED|Overall Study||10
8442482|NCT00798161|20804217|P6|NOT COMPLETED|Overall Study||11
8442483|NCT00798161|20804218|P5|NOT COMPLETED|Overall Study||16
8442484|NCT00798161|20804219|P4|NOT COMPLETED|Overall Study||21
8442485|NCT00798161|20804220|P3|NOT COMPLETED|Overall Study||21
8442486|NCT00798161|20804221|P2|NOT COMPLETED|Overall Study||17
8442487|NCT00798161|20804222|P1|NOT COMPLETED|Overall Study||18
8442488|NCT00798161|20804216|P7|COMPLETED|Overall Study||56
8442489|NCT00798161|20804217|P6|COMPLETED|Overall Study||132
8442490|NCT00798161|20804218|P5|COMPLETED|Overall Study||127
8442491|NCT00798161|20804219|P4|COMPLETED|Overall Study||121
8442492|NCT00798161|20804220|P3|COMPLETED|Overall Study||126
8442493|NCT00798161|20804221|P2|COMPLETED|Overall Study||127
8442494|NCT00798161|20804222|P1|COMPLETED|Overall Study||54
8442495|NCT00798161|20804216|P7|STARTED|Overall Study||66
8442496|NCT00798161|20804217|P6|STARTED|Overall Study||143
8442497|NCT00798161|20804218|P5|STARTED|Overall Study||143
8442498|NCT00798161|20804219|P4|STARTED|Overall Study||142
8442499|NCT00798161|20804220|P3|STARTED|Overall Study||147
8442500|NCT00798161|20804221|P2|STARTED|Overall Study||144
8442501|NCT00798161|20804222|P1|STARTED|Overall Study||72
8442502|NCT00798135|20804329|P1|NOT COMPLETED|Overall Study||13
8442503|NCT00798135|20804329|P1|COMPLETED|Overall Study||0
8442504|NCT00798135|20804329|P1|STARTED|Overall Study||13
8442505|NCT00798096|20804335|P1|NOT COMPLETED|Overall Study||2
8442506|NCT00798096|20804335|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
8442507|NCT00798096|20804335|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
8442508|NCT00798018|20804346|P4|NOT COMPLETED|Overall Study||0
8442509|NCT00798018|20804347|P3|NOT COMPLETED|Overall Study||0
8442510|NCT00798018|20804348|P2|NOT COMPLETED|Overall Study||0
8442511|NCT00798018|20804349|P1|NOT COMPLETED|Overall Study||0
8442512|NCT00798018|20804346|P4|COMPLETED|Overall Study||25
8442513|NCT00798018|20804347|P3|COMPLETED|Overall Study||25
8442514|NCT00798018|20804348|P2|COMPLETED|Overall Study||25
8442515|NCT00798018|20804349|P1|COMPLETED|Overall Study||25
8442516|NCT00798018|20804346|P4|STARTED|Overall Study||25
8442517|NCT00798018|20804347|P3|STARTED|Overall Study||25
8442518|NCT00798018|20804348|P2|STARTED|Overall Study||25
8442519|NCT00798018|20804349|P1|STARTED|Overall Study||25
8442520|NCT00797966|20804363|P6|NOT COMPLETED|Phase A+||28
8442521|NCT00797966|20804364|P5|NOT COMPLETED|Phase A+||0
8442522|NCT00797966|20804365|P4|NOT COMPLETED|Phase A+||0
8442523|NCT00797966|20804366|P3|NOT COMPLETED|Phase A+||0
8442524|NCT00797966|20804367|P2|NOT COMPLETED|Phase A+||0
8442525|NCT00797966|20804368|P1|NOT COMPLETED|Phase A+||0
8442526|NCT00797966|20804363|P6|COMPLETED|Phase A+||207
8442527|NCT00797966|20804364|P5|COMPLETED|Phase A+||0
8442528|NCT00797966|20804365|P4|COMPLETED|Phase A+||0
8442529|NCT00797966|20804366|P3|COMPLETED|Phase A+||0
8442530|NCT00797966|20804367|P2|COMPLETED|Phase A+||0
8442531|NCT00797966|20804368|P1|COMPLETED|Phase A+||0
8442532|NCT00797966|20804363|P6|STARTED|Phase A+||235
8442533|NCT00797966|20804364|P5|STARTED|Phase A+||0
8442534|NCT00797966|20804365|P4|STARTED|Phase A+||0
8442535|NCT00797966|20804366|P3|STARTED|Phase A+||0
8442536|NCT00797966|20804367|P2|STARTED|Phase A+||0
8442537|NCT00797966|20804368|P1|STARTED|Phase A+||0
8442538|NCT00797966|20804363|P6|NOT COMPLETED|Phase B||0
8442539|NCT00797966|20804364|P5|NOT COMPLETED|Phase B||0
8442540|NCT00797966|20804365|P4|NOT COMPLETED|Phase B||16
8442541|NCT00797966|20804366|P3|NOT COMPLETED|Phase B||21
8442542|NCT00797966|20804367|P2|NOT COMPLETED|Phase B||18
8442543|NCT00797966|20804368|P1|NOT COMPLETED|Phase B||11
8442544|NCT00797966|20804363|P6|COMPLETED|Phase B||0
8442545|NCT00797966|20804364|P5|COMPLETED|Phase B||0
8442546|NCT00797966|20804365|P4|COMPLETED|Phase B||110
8442547|NCT00797966|20804366|P3|COMPLETED|Phase B||100
8442548|NCT00797966|20804367|P2|COMPLETED|Phase B||102
8442549|NCT00797966|20804368|P1|COMPLETED|Phase B||51
8442550|NCT00797966|20804363|P6|STARTED|Phase B||0
8442551|NCT00797966|20804364|P5|STARTED|Phase B||0
8442552|NCT00797966|20804365|P4|STARTED|Phase B|Randomized participants.|126
8442553|NCT00797966|20804366|P3|STARTED|Phase B|Randomized participants.|121
8442554|NCT00797966|20804367|P2|STARTED|Phase B|Randomized participants.|120
8442555|NCT00797966|20804368|P1|STARTED|Phase B|Randomized participants.|62
8442556|NCT00797966|20804363|P6|NOT COMPLETED|Phase A||0
8442557|NCT00797966|20804364|P5|NOT COMPLETED|Phase A||185
8442558|NCT00797966|20804365|P4|NOT COMPLETED|Phase A||0
8442559|NCT00797966|20804366|P3|NOT COMPLETED|Phase A||0
8442560|NCT00797966|20804367|P2|NOT COMPLETED|Phase A||0
8442561|NCT00797966|20804368|P1|NOT COMPLETED|Phase A||0
8442562|NCT00797966|20804363|P6|COMPLETED|Phase A||0
8442563|NCT00797966|20804364|P5|COMPLETED|Phase A||664
8442564|NCT00797966|20804365|P4|COMPLETED|Phase A||0
8442565|NCT00797966|20804366|P3|COMPLETED|Phase A||0
8442566|NCT00797966|20804367|P2|COMPLETED|Phase A||0
8442567|NCT00797966|20804368|P1|COMPLETED|Phase A||0
8442568|NCT00797966|20804363|P6|STARTED|Phase A||0
8442569|NCT00797966|20804364|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
8442570|NCT00797966|20804365|P4|STARTED|Phase A||0
8442571|NCT00797966|20804366|P3|STARTED|Phase A||0
8442572|NCT00797966|20804367|P2|STARTED|Phase A||0
8442573|NCT00797966|20804368|P1|STARTED|Phase A||0
8442574|NCT00797862|20804433|P3|NOT COMPLETED|Overall Study||86
8442575|NCT00797862|20804434|P2|NOT COMPLETED|Overall Study||68
8442576|NCT00797862|20804435|P1|NOT COMPLETED|Overall Study||124
8442577|NCT00797862|20804433|P3|COMPLETED|Overall Study||230
8442578|NCT00797862|20804434|P2|COMPLETED|Overall Study||250
8442579|NCT00797862|20804435|P1|COMPLETED|Overall Study||496
8442580|NCT00797862|20804433|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
8442581|NCT00797862|20804434|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
8442582|NCT00797862|20804435|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
8442583|NCT00797862|20804433|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
8442584|NCT00797862|20804434|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
8442585|NCT00797862|20804435|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
8442586|NCT00797823|20804464|P3|NOT COMPLETED|Second Period (Crossover)||0
8442587|NCT00797823|20804465|P2|NOT COMPLETED|Second Period (Crossover)||0
8442588|NCT00797823|20804466|P1|NOT COMPLETED|Second Period (Crossover)||0
8442589|NCT00797823|20804464|P3|COMPLETED|Second Period (Crossover)||0
8442590|NCT00797823|20804465|P2|COMPLETED|Second Period (Crossover)||4
8442591|NCT00797823|20804466|P1|COMPLETED|Second Period (Crossover)||3
8442592|NCT00797823|20804464|P3|STARTED|Second Period (Crossover)||0
8442593|NCT00797823|20804465|P2|STARTED|Second Period (Crossover)||4
8442594|NCT00797823|20804466|P1|STARTED|Second Period (Crossover)||3
8442595|NCT00797823|20804464|P3|NOT COMPLETED|First Period (Initial Randomization)||0
8442596|NCT00797823|20804465|P2|NOT COMPLETED|First Period (Initial Randomization)||0
8442597|NCT00797823|20804466|P1|NOT COMPLETED|First Period (Initial Randomization)||1
8442598|NCT00797823|20804464|P3|COMPLETED|First Period (Initial Randomization)||0
8442599|NCT00797823|20804465|P2|COMPLETED|First Period (Initial Randomization)||4
8442600|NCT00797823|20804466|P1|COMPLETED|First Period (Initial Randomization)||3
8442601|NCT00797823|20804464|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
8442602|NCT00797823|20804465|P2|STARTED|First Period (Initial Randomization)||4
8442603|NCT00797823|20804466|P1|STARTED|First Period (Initial Randomization)||4
8442604|NCT00797823|20804464|P3|NOT COMPLETED|Pilot Studies||0
8442605|NCT00797823|20804465|P2|NOT COMPLETED|Pilot Studies||0
8442606|NCT00797823|20804466|P1|NOT COMPLETED|Pilot Studies||0
8442607|NCT00797823|20804464|P3|COMPLETED|Pilot Studies||6
8442608|NCT00797823|20804465|P2|COMPLETED|Pilot Studies||0
8442609|NCT00797823|20804466|P1|COMPLETED|Pilot Studies||0
8442610|NCT00797823|20804464|P3|STARTED|Pilot Studies||6
8442611|NCT00797823|20804465|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
8442612|NCT00797823|20804466|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
8442613|NCT00797797|20804477|P2|NOT COMPLETED|Overall Study||43
8442614|NCT00797797|20804478|P1|NOT COMPLETED|Overall Study||55
8442615|NCT00797797|20804477|P2|COMPLETED|Overall Study||141
8442616|NCT00797797|20804478|P1|COMPLETED|Overall Study||123
8442617|NCT00797797|20804477|P2|STARTED|Overall Study||184
8442618|NCT00797797|20804478|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
8442619|NCT00797732|20804488|P3|NOT COMPLETED|Overall Study||154
8442620|NCT00797732|20804489|P2|NOT COMPLETED|Overall Study||3
8442621|NCT00797732|20804490|P1|NOT COMPLETED|Overall Study||5
8442622|NCT00797732|20804488|P3|COMPLETED|Overall Study||0
8442623|NCT00797732|20804489|P2|COMPLETED|Overall Study||18
8442624|NCT00797732|20804490|P1|COMPLETED|Overall Study||16
8442625|NCT00797732|20804488|P3|Evaluable at 12 Months|Overall Study||0
8442626|NCT00797732|20804489|P2|Evaluable at 12 Months|Overall Study||18
8442627|NCT00797732|20804490|P1|Evaluable at 12 Months|Overall Study||17
8442628|NCT00797732|20804488|P3|Evaluable at 20 Weeks|Overall Study||0
8442629|NCT00797732|20804489|P2|Evaluable at 20 Weeks|Overall Study||18
8442630|NCT00797732|20804490|P1|Evaluable at 20 Weeks|Overall Study||17
8442631|NCT00797732|20804488|P3|Evaluable at Baseline|Overall Study||0
8442632|NCT00797732|20804489|P2|Evaluable at Baseline|Overall Study||18
8442633|NCT00797732|20804490|P1|Evaluable at Baseline|Overall Study||18
8442634|NCT00797732|20804488|P3|STARTED|Overall Study||154
8442635|NCT00797732|20804489|P2|STARTED|Overall Study||21
8442636|NCT00797732|20804490|P1|STARTED|Overall Study||21
8442637|NCT00797667|20804505|P3|NOT COMPLETED|Overall Study||127
8442638|NCT00797667|20804506|P2|NOT COMPLETED|Overall Study||259
8442639|NCT00797667|20804507|P1|NOT COMPLETED|Overall Study||260
8442640|NCT00797667|20804505|P3|COMPLETED|Overall Study||4
8442641|NCT00797667|20804506|P2|COMPLETED|Overall Study||5
8442642|NCT00797667|20804507|P1|COMPLETED|Overall Study||5
8442643|NCT00797667|20804505|P3|Treated|Overall Study||130
8442644|NCT00797667|20804506|P2|Treated|Overall Study||263
8442645|NCT00797667|20804507|P1|Treated|Overall Study||263
8442646|NCT00797667|20804505|P3|STARTED|Overall Study||131
8442647|NCT00797667|20804506|P2|STARTED|Overall Study||264
8442648|NCT00797667|20804507|P1|STARTED|Overall Study||265
8442649|NCT00797563|20804533|P1|NOT COMPLETED|Overall Study||1
8442650|NCT00797563|20804533|P1|COMPLETED|Overall Study||101
8442651|NCT00797563|20804533|P1|STARTED|Overall Study|number of subjects|102
8442652|NCT00797511|20804539|P1|NOT COMPLETED|Overall Study||1
8442653|NCT00797511|20804539|P1|COMPLETED|Overall Study||131
8442654|NCT00797511|20804539|P1|STARTED|Overall Study||132
8442655|NCT00797459|20804547|P1|NOT COMPLETED|Overall Study||0
8442656|NCT00797459|20804547|P1|COMPLETED|Overall Study||60
8442657|NCT00797459|20804547|P1|STARTED|Overall Study||60
8442658|NCT00797316|20804557|P2|NOT COMPLETED|Overall Study||32
8442659|NCT00797316|20804558|P1|NOT COMPLETED|Overall Study||23
8442660|NCT00797316|20804557|P2|COMPLETED|Overall Study||233
8442661|NCT00797316|20804558|P1|COMPLETED|Overall Study||244
8442662|NCT00797316|20804557|P2|STARTED|Overall Study||265
8442663|NCT00797316|20804558|P1|STARTED|Overall Study||267
8442664|NCT00797277|20804574|P2|NOT COMPLETED|Overall Study||0
8442665|NCT00797277|20804575|P1|NOT COMPLETED|Overall Study||0
8442666|NCT00797277|20804574|P2|COMPLETED|Overall Study||30
8442667|NCT00797277|20804575|P1|COMPLETED|Overall Study||37
8442668|NCT00797277|20804574|P2|STARTED|Overall Study||30
8442669|NCT00797277|20804575|P1|STARTED|Overall Study||37
8442670|NCT00797225|20804587|P8|NOT COMPLETED|Weeks 13 to 24||0
8442671|NCT00797225|20804588|P7|NOT COMPLETED|Weeks 13 to 24||2
8442672|NCT00797225|20804589|P6|NOT COMPLETED|Weeks 13 to 24||0
8442673|NCT00797225|20804590|P5|NOT COMPLETED|Weeks 13 to 24||1
8442674|NCT00797225|20804591|P4|NOT COMPLETED|Weeks 13 to 24||0
8442675|NCT00797225|20804592|P3|NOT COMPLETED|Weeks 13 to 24||2
8442676|NCT00797225|20804593|P2|NOT COMPLETED|Weeks 13 to 24||4
8442677|NCT00797225|20804594|P1|NOT COMPLETED|Weeks 13 to 24||0
8442678|NCT00797225|20804587|P8|COMPLETED|Weeks 13 to 24||22
8442679|NCT00797225|20804588|P7|COMPLETED|Weeks 13 to 24||20
8442680|NCT00797225|20804589|P6|COMPLETED|Weeks 13 to 24||21
8442681|NCT00797225|20804590|P5|COMPLETED|Weeks 13 to 24||19
8442682|NCT00797225|20804591|P4|COMPLETED|Weeks 13 to 24||0
8442683|NCT00797225|20804592|P3|COMPLETED|Weeks 13 to 24||41
8442684|NCT00797225|20804593|P2|COMPLETED|Weeks 13 to 24||38
8442685|NCT00797225|20804594|P1|COMPLETED|Weeks 13 to 24||0
8442686|NCT00797225|20804587|P8|STARTED|Weeks 13 to 24||22
8442687|NCT00797225|20804588|P7|STARTED|Weeks 13 to 24||22
8442688|NCT00797225|20804589|P6|STARTED|Weeks 13 to 24||21
8442689|NCT00797225|20804590|P5|STARTED|Weeks 13 to 24||20
8442690|NCT00797225|20804591|P4|STARTED|Weeks 13 to 24||0
8442691|NCT00797225|20804592|P3|STARTED|Weeks 13 to 24||43
8442692|NCT00797225|20804593|P2|STARTED|Weeks 13 to 24||42
8442693|NCT00797225|20804594|P1|STARTED|Weeks 13 to 24||0
8442694|NCT00797225|20804587|P8|NOT COMPLETED|Weeks 1 to 12||0
8442695|NCT00797225|20804588|P7|NOT COMPLETED|Weeks 1 to 12||0
8442696|NCT00797225|20804589|P6|NOT COMPLETED|Weeks 1 to 12||0
8442697|NCT00797225|20804590|P5|NOT COMPLETED|Weeks 1 to 12||0
8442698|NCT00797225|20804591|P4|NOT COMPLETED|Weeks 1 to 12||0
8442699|NCT00797225|20804592|P3|NOT COMPLETED|Weeks 1 to 12||1
8442700|NCT00797225|20804593|P2|NOT COMPLETED|Weeks 1 to 12||1
8442701|NCT00797225|20804594|P1|NOT COMPLETED|Weeks 1 to 12||2
8442702|NCT00797225|20804587|P8|COMPLETED|Weeks 1 to 12||0
8442703|NCT00797225|20804588|P7|COMPLETED|Weeks 1 to 12||0
8442704|NCT00797225|20804589|P6|COMPLETED|Weeks 1 to 12||0
8442705|NCT00797225|20804590|P5|COMPLETED|Weeks 1 to 12||0
8442706|NCT00797225|20804591|P4|COMPLETED|Weeks 1 to 12||44
8442707|NCT00797225|20804592|P3|COMPLETED|Weeks 1 to 12||43
8442708|NCT00797225|20804593|P2|COMPLETED|Weeks 1 to 12||42
8442709|NCT00797225|20804594|P1|COMPLETED|Weeks 1 to 12||41
8442710|NCT00797225|20804587|P8|Received Study Drug|Weeks 1 to 12||0
8442711|NCT00797225|20804588|P7|Received Study Drug|Weeks 1 to 12||0
8442712|NCT00797225|20804589|P6|Received Study Drug|Weeks 1 to 12||0
8442713|NCT00797225|20804590|P5|Received Study Drug|Weeks 1 to 12||0
8442714|NCT00797225|20804591|P4|Received Study Drug|Weeks 1 to 12||44
8442715|NCT00797225|20804592|P3|Received Study Drug|Weeks 1 to 12||44
8442716|NCT00797225|20804593|P2|Received Study Drug|Weeks 1 to 12||43
8442717|NCT00797225|20804594|P1|Received Study Drug|Weeks 1 to 12||43
8442718|NCT00797225|20804587|P8|STARTED|Weeks 1 to 12||0
8442719|NCT00797225|20804588|P7|STARTED|Weeks 1 to 12||0
8442720|NCT00797225|20804589|P6|STARTED|Weeks 1 to 12||0
8442721|NCT00797225|20804590|P5|STARTED|Weeks 1 to 12||0
8442722|NCT00797225|20804591|P4|STARTED|Weeks 1 to 12||44
8442723|NCT00797225|20804592|P3|STARTED|Weeks 1 to 12||44
8442724|NCT00797225|20804593|P2|STARTED|Weeks 1 to 12||43
8442725|NCT00797225|20804594|P1|STARTED|Weeks 1 to 12||43
8442726|NCT00797212|20804702|P1|NOT COMPLETED|Overall Study||0
8442727|NCT00797212|20804702|P1|COMPLETED|Overall Study||50
8442728|NCT00797212|20804702|P1|STARTED|Overall Study||50
8442729|NCT00797108|20804711|P3|NOT COMPLETED|Overall Study||6
8442730|NCT00797108|20804712|P2|NOT COMPLETED|Overall Study||2
8442731|NCT00797108|20804713|P1|NOT COMPLETED|Overall Study||4
8442732|NCT00797108|20804711|P3|COMPLETED|Overall Study||6
8442733|NCT00797108|20804712|P2|COMPLETED|Overall Study||9
8442734|NCT00797108|20804713|P1|COMPLETED|Overall Study||8
8442735|NCT00797108|20804711|P3|Treated|Overall Study||12
8442736|NCT00797108|20804712|P2|Treated|Overall Study||11
8442737|NCT00797108|20804713|P1|Treated|Overall Study||10
8442738|NCT00797108|20804711|P3|STARTED|Overall Study||12
8442739|NCT00797108|20804712|P2|STARTED|Overall Study||11
8442740|NCT00797108|20804713|P1|STARTED|Overall Study||12
8442741|NCT00796991|20804748|P3|NOT COMPLETED|Overall Study||14
8442742|NCT00796991|20804749|P2|NOT COMPLETED|Overall Study||12
8442743|NCT00796991|20804750|P1|NOT COMPLETED|Overall Study||15
8442744|NCT00796991|20804748|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
8442745|NCT00796991|20804749|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
8442746|NCT00796991|20804750|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
8442747|NCT00796991|20804748|P3|STARTED|Overall Study||20
8442748|NCT00796991|20804749|P2|STARTED|Overall Study||19
8442749|NCT00796991|20804750|P1|STARTED|Overall Study||20
8442750|NCT00796978|20804848|P1|NOT COMPLETED|Overall Study||12
8442751|NCT00796978|20804848|P1|COMPLETED|Overall Study||44
8442752|NCT00796978|20804848|P1|STARTED|Overall Study||56
8442753|NCT00796926|20804867|P2|NOT COMPLETED|Overall Study||0
8442754|NCT00796926|20804868|P1|NOT COMPLETED|Overall Study||1
8442755|NCT00796926|20804867|P2|COMPLETED|Overall Study||15
8442756|NCT00796926|20804868|P1|COMPLETED|Overall Study||14
8442757|NCT00796926|20804867|P2|STARTED|Overall Study||15
8442758|NCT00796926|20804868|P1|STARTED|Overall Study||15
8442759|NCT00796861|20804874|P1|NOT COMPLETED|Overall Study||4
8442760|NCT00796861|20804874|P1|COMPLETED|Overall Study||0
8442761|NCT00796861|20804874|P1|STARTED|Overall Study||4
8442762|NCT00796822|20804880|P2|NOT COMPLETED|Overall Study||0
8442763|NCT00796822|20804881|P1|NOT COMPLETED|Overall Study||3
8442764|NCT00796822|20804880|P2|COMPLETED|Overall Study||13
8442765|NCT00796822|20804881|P1|COMPLETED|Overall Study||10
8442766|NCT00796822|20804880|P2|STARTED|Overall Study||13
8442767|NCT00796822|20804881|P1|STARTED|Overall Study||13
8442768|NCT00796757|20804889|P1|NOT COMPLETED|Overall Study||86
8442769|NCT00796757|20804889|P1|COMPLETED|Overall Study||60
8442770|NCT00796757|20804889|P1|STARTED|Overall Study||146
8442771|NCT00796744|20804904|P3|NOT COMPLETED|Overall Study||1
8442772|NCT00796744|20804905|P2|NOT COMPLETED|Overall Study||0
8442773|NCT00796744|20804906|P1|NOT COMPLETED|Overall Study||0
8442774|NCT00796744|20804904|P3|COMPLETED|Overall Study||27
8442775|NCT00796744|20804905|P2|COMPLETED|Overall Study||26
8442776|NCT00796744|20804906|P1|COMPLETED|Overall Study||24
8442777|NCT00796744|20804904|P3|STARTED|Overall Study||28
8442778|NCT00796744|20804905|P2|STARTED|Overall Study||26
8442779|NCT00796744|20804906|P1|STARTED|Overall Study||24
8442780|NCT00796718|20804923|P1|NOT COMPLETED|Overall Study||9
8442781|NCT00796718|20804923|P1|COMPLETED|Overall Study||53
8442782|NCT00796718|20804923|P1|STARTED|Overall Study||62
8442783|NCT00796705|20804934|P4|NOT COMPLETED|Overall Study||0
8442784|NCT00796705|20804935|P3|NOT COMPLETED|Overall Study||0
8442785|NCT00796705|20804936|P2|NOT COMPLETED|Overall Study||0
8442786|NCT00796705|20804937|P1|NOT COMPLETED|Overall Study||0
8442787|NCT00796705|20804934|P4|COMPLETED|Overall Study||2
8442788|NCT00796705|20804935|P3|COMPLETED|Overall Study||4
8442789|NCT00796705|20804936|P2|COMPLETED|Overall Study||4
8442790|NCT00796705|20804937|P1|COMPLETED|Overall Study||3
8442791|NCT00796705|20804934|P4|STARTED|Overall Study||2
8442792|NCT00796705|20804935|P3|STARTED|Overall Study||4
8442793|NCT00796705|20804936|P2|STARTED|Overall Study||4
8442794|NCT00796705|20804937|P1|STARTED|Overall Study||3
8442795|NCT00796666|20804975|P2|NOT COMPLETED|Overall Study||64
8442796|NCT00796666|20804976|P1|NOT COMPLETED|Overall Study||67
8442797|NCT00796666|20804975|P2|COMPLETED|Overall Study||0
8442798|NCT00796666|20804976|P1|COMPLETED|Overall Study||0
8442799|NCT00796666|20804975|P2|Randomized and Not Treated|Overall Study||0
8442800|NCT00796666|20804976|P1|Randomized and Not Treated|Overall Study||1
8442801|NCT00796666|20804975|P2|Treated|Overall Study||64
8442802|NCT00796666|20804976|P1|Treated|Overall Study||66
8442803|NCT00796666|20804975|P2|STARTED|Overall Study||64
8442804|NCT00796666|20804976|P1|STARTED|Overall Study||67
8442805|NCT00796653|20805010|P4|NOT COMPLETED|Overall Study||40
8442806|NCT00796653|20805011|P3|NOT COMPLETED|Overall Study||36
8442807|NCT00796653|20805012|P2|NOT COMPLETED|Overall Study||37
8442808|NCT00796653|20805013|P1|NOT COMPLETED|Overall Study||51
8442809|NCT00796653|20805010|P4|COMPLETED|Overall Study||193
8442810|NCT00796653|20805011|P3|COMPLETED|Overall Study||198
8442811|NCT00796653|20805012|P2|COMPLETED|Overall Study||195
8442812|NCT00796653|20805013|P1|COMPLETED|Overall Study||184
8442813|NCT00796653|20805010|P4|STARTED|Overall Study||233
8442814|NCT00796653|20805011|P3|STARTED|Overall Study||234
8442815|NCT00796653|20805012|P2|STARTED|Overall Study||232
8442816|NCT00796653|20805013|P1|STARTED|Overall Study||235
8442817|NCT00796627|20805281|P2|NOT COMPLETED|Overall Study||0
8442818|NCT00796627|20805282|P1|NOT COMPLETED|Overall Study||0
8442819|NCT00796627|20805281|P2|COMPLETED|Overall Study||31
8442820|NCT00796627|20805282|P1|COMPLETED|Overall Study||10
8442821|NCT00796627|20805281|P2|STARTED|Overall Study||31
8442822|NCT00796627|20805282|P1|STARTED|Overall Study||10
8442823|NCT00796614|20805298|P4|NOT COMPLETED|Overall Study||1
8442824|NCT00796614|20805299|P3|NOT COMPLETED|Overall Study||3
8442825|NCT00796614|20805300|P2|NOT COMPLETED|Overall Study||4
8442826|NCT00796614|20805301|P1|NOT COMPLETED|Overall Study||5
8442827|NCT00796614|20805298|P4|COMPLETED|Overall Study||40
8442828|NCT00796614|20805299|P3|COMPLETED|Overall Study||36
8442829|NCT00796614|20805300|P2|COMPLETED|Overall Study||36
8442830|NCT00796614|20805301|P1|COMPLETED|Overall Study||36
8442831|NCT00796614|20805298|P4|Not Treated|Overall Study||0
8442832|NCT00796614|20805299|P3|Not Treated|Overall Study||1
8442833|NCT00796614|20805300|P2|Not Treated|Overall Study||0
8442834|NCT00796614|20805301|P1|Not Treated|Overall Study||0
8442835|NCT00796614|20805298|P4|STARTED|Overall Study||41
8442836|NCT00796614|20805299|P3|STARTED|Overall Study||39
8442837|NCT00796614|20805300|P2|STARTED|Overall Study||40
8442838|NCT00796614|20805301|P1|STARTED|Overall Study||41
8442839|NCT00796562|20805343|P1|NOT COMPLETED|Overall Study||49
8442840|NCT00796562|20805343|P1|COMPLETED|Overall Study||47
8442841|NCT00796562|20805343|P1|STARTED|Overall Study||96
8442842|NCT00796549|20805352|P1|NOT COMPLETED|Overall Study||218
8442843|NCT00796549|20805352|P1|COMPLETED|Overall Study||0
8442844|NCT00796549|20805352|P1|Entered|Overall Study|entered and treated|69
8442845|NCT00796549|20805352|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
8442846|NCT00796523|20805369|P2|NOT COMPLETED|Overall Study||7
8442847|NCT00796523|20805370|P1|NOT COMPLETED|Overall Study||9
8442848|NCT00796523|20805369|P2|COMPLETED|Overall Study||17
8442849|NCT00796523|20805370|P1|COMPLETED|Overall Study||18
8442850|NCT00796523|20805369|P2|STARTED|Overall Study||24
8442851|NCT00796523|20805370|P1|STARTED|Overall Study||27
8442852|NCT00796510|20805380|P2|NOT COMPLETED|Overall Study||0
8442853|NCT00796510|20805381|P1|NOT COMPLETED|Overall Study||3
8442854|NCT00796510|20805380|P2|COMPLETED|Overall Study||0
8442855|NCT00796510|20805381|P1|COMPLETED|Overall Study||0
8442856|NCT00796510|20805380|P2|STARTED|Overall Study||0
8442857|NCT00796510|20805381|P1|STARTED|Overall Study||3
8442858|NCT00796445|20805393|P2|NOT COMPLETED|Overall Study||292
8442859|NCT00796445|20805394|P1|NOT COMPLETED|Overall Study||584
8442860|NCT00796445|20805393|P2|COMPLETED|Overall Study||158
8442861|NCT00796445|20805394|P1|COMPLETED|Overall Study||310
8442862|NCT00796445|20805393|P2|STARTED|Overall Study||450
8442863|NCT00796445|20805394|P1|STARTED|Overall Study||894
8442864|NCT00796419|20805446|P2|NOT COMPLETED|Overall Study||1
8442865|NCT00796419|20805447|P1|NOT COMPLETED|Overall Study||0
8442866|NCT00796419|20805446|P2|COMPLETED|Overall Study||13
8442867|NCT00796419|20805447|P1|COMPLETED|Overall Study||13
8442868|NCT00796419|20805446|P2|STARTED|Overall Study||14
8442869|NCT00796419|20805447|P1|STARTED|Overall Study||13
8442870|NCT00796367|20805460|P3|NOT COMPLETED|Overall Study||47
8442871|NCT00796367|20805461|P2|NOT COMPLETED|Overall Study||25
8442872|NCT00796367|20805462|P1|NOT COMPLETED|Overall Study||30
8442873|NCT00796367|20805460|P3|COMPLETED|Overall Study||248
8442874|NCT00796367|20805461|P2|COMPLETED|Overall Study||129
8442875|NCT00796367|20805462|P1|COMPLETED|Overall Study||197
8442876|NCT00796367|20805460|P3|STARTED|Overall Study||295
8442877|NCT00796367|20805461|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
8442878|NCT00796367|20805462|P1|STARTED|Overall Study||227
8442879|NCT00796328|20805473|P1|NOT COMPLETED|Overall Study||6
8442880|NCT00796328|20805473|P1|COMPLETED|Overall Study||40
8442881|NCT00796328|20805473|P1|STARTED|Overall Study||46
8442882|NCT00796315|20805477|P3|NOT COMPLETED|Overall Study||0
8442883|NCT00796315|20805478|P2|NOT COMPLETED|Overall Study||1
8442884|NCT00796315|20805479|P1|NOT COMPLETED|Overall Study||0
8442885|NCT00796315|20805477|P3|COMPLETED|Overall Study||15
8442886|NCT00796315|20805478|P2|COMPLETED|Overall Study||16
8442887|NCT00796315|20805479|P1|COMPLETED|Overall Study||9
8442888|NCT00796315|20805477|P3|STARTED|Overall Study||15
8442889|NCT00796315|20805478|P2|STARTED|Overall Study||17
8442890|NCT00796315|20805479|P1|STARTED|Overall Study||9
8442891|NCT00796302|20805492|P2|NOT COMPLETED|Overall Study||18
8442892|NCT00796302|20805493|P1|NOT COMPLETED|Overall Study||13
8442893|NCT00796302|20805492|P2|COMPLETED|Overall Study||66
8442894|NCT00796302|20805493|P1|COMPLETED|Overall Study||71
8442895|NCT00796302|20805492|P2|STARTED|Overall Study||84
8442896|NCT00796302|20805493|P1|STARTED|Overall Study||84
8442897|NCT00796224|20805507|P2|NOT COMPLETED|Overall Study||1
8442898|NCT00796224|20805508|P1|NOT COMPLETED|Overall Study||1
8442899|NCT00796224|20805507|P2|COMPLETED|Overall Study||18
8442900|NCT00796224|20805508|P1|COMPLETED|Overall Study||18
8442901|NCT00796224|20805507|P2|STARTED|Overall Study||19
8442902|NCT00796224|20805508|P1|STARTED|Overall Study||19
8442903|NCT00796120|20805528|P2|NOT COMPLETED|Overall Study||60
8442904|NCT00796120|20805529|P1|NOT COMPLETED|Overall Study||61
8442905|NCT00796120|20805528|P2|COMPLETED|Overall Study||0
8442906|NCT00796120|20805529|P1|COMPLETED|Overall Study||0
8442907|NCT00796120|20805528|P2|Treated|Overall Study||57
8442908|NCT00796120|20805529|P1|Treated|Overall Study||61
8442909|NCT00796120|20805528|P2|STARTED|Overall Study||60
8442910|NCT00796120|20805529|P1|STARTED|Overall Study||61
8442911|NCT00796107|20805543|P1|NOT COMPLETED|Overall Study||6
8442912|NCT00796107|20805543|P1|COMPLETED|Overall Study||0
8442913|NCT00796107|20805543|P1|STARTED|Overall Study||6
8442914|NCT00796003|20805552|P2|NOT COMPLETED|Overall Study||29
8442915|NCT00796003|20805553|P1|NOT COMPLETED|Overall Study||3
8442916|NCT00796003|20805552|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
8442917|NCT00796003|20805553|P1|COMPLETED|Overall Study||0
8442918|NCT00796003|20805552|P2|Treated|Overall Study|Number of participants treated|34
8442919|NCT00796003|20805553|P1|Treated|Overall Study|Number of participants treated|3
8442920|NCT00796003|20805552|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
8442921|NCT00796003|20805553|P1|STARTED|Overall Study|Number of participants enrolled|3
8442922|NCT00795951|20805574|P1|NOT COMPLETED|Overall Study||2
8442923|NCT00795951|20805574|P1|COMPLETED|Overall Study||100
8442924|NCT00795951|20805574|P1|STARTED|Overall Study||102
8442925|NCT00795886|20805667|P1|NOT COMPLETED|Overall Study||10
8442926|NCT00795886|20805667|P1|COMPLETED|Overall Study||53
8442927|NCT00795886|20805667|P1|STARTED|Overall Study||63
8442928|NCT00795821|20805675|P2|NOT COMPLETED|Taper Phase||0
8442929|NCT00795821|20805676|P1|NOT COMPLETED|Taper Phase||9
8442930|NCT00795821|20805675|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
8442931|NCT00795821|20805676|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
8442932|NCT00795821|20805675|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
8442933|NCT00795821|20805676|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
8442934|NCT00795821|20805675|P2|NOT COMPLETED|Long-term Extension Phase||92
8442935|NCT00795821|20805676|P1|NOT COMPLETED|Long-term Extension Phase||90
8442936|NCT00795821|20805675|P2|COMPLETED|Long-term Extension Phase||115
8442937|NCT00795821|20805676|P1|COMPLETED|Long-term Extension Phase||100
8442938|NCT00795821|20805675|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
8442939|NCT00795821|20805676|P1|STARTED|Long-term Extension Phase||190
8442940|NCT00795821|20805675|P2|NOT COMPLETED|Acute Treatment Phase||31
8442941|NCT00795821|20805676|P1|NOT COMPLETED|Acute Treatment Phase||56
8442942|NCT00795821|20805675|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
8442943|NCT00795821|20805676|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
8442944|NCT00795821|20805675|P2|STARTED|Acute Treatment Phase||245
8442945|NCT00795821|20805676|P1|STARTED|Acute Treatment Phase||250
8442946|NCT00795769|20805745|P1|NOT COMPLETED|Overall Study||0
8442947|NCT00795769|20805745|P1|COMPLETED|Overall Study||49
8442948|NCT00795769|20805745|P1|STARTED|Overall Study||49
8442949|NCT00795717|20805751|P2|NOT COMPLETED|Phase II||1
8442950|NCT00795717|20805752|P1|NOT COMPLETED|Phase II||0
8442951|NCT00795717|20805751|P2|COMPLETED|Phase II||18
8442952|NCT00795717|20805752|P1|COMPLETED|Phase II||18
8442953|NCT00795717|20805751|P2|STARTED|Phase II||19
8442954|NCT00795717|20805752|P1|STARTED|Phase II||18
8442955|NCT00795717|20805751|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
8442956|NCT00795717|20805752|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
8442957|NCT00795717|20805751|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
8442958|NCT00795717|20805752|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
8442959|NCT00795717|20805751|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
8442960|NCT00795717|20805752|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
8442961|NCT00795704|20805764|P2|NOT COMPLETED|Overall Study||3
8442962|NCT00795704|20805765|P1|NOT COMPLETED|Overall Study||4
8442963|NCT00795704|20805764|P2|COMPLETED|Overall Study||9
8442964|NCT00795704|20805765|P1|COMPLETED|Overall Study||8
8442965|NCT00795704|20805764|P2|STARTED|Overall Study||12
8442966|NCT00795704|20805765|P1|STARTED|Overall Study||12
8442967|NCT00795665|20805775|P1|NOT COMPLETED|Overall Study||0
8442968|NCT00795665|20805775|P1|COMPLETED|Overall Study||7
8442969|NCT00795665|20805775|P1|STARTED|Overall Study||7
8442970|NCT00795639|20805785|P2|NOT COMPLETED|Overall Study||26
8442971|NCT00795639|20805786|P1|NOT COMPLETED|Overall Study||21
8442972|NCT00795639|20805785|P2|COMPLETED|Overall Study||66
8442973|NCT00795639|20805786|P1|COMPLETED|Overall Study||70
8442974|NCT00795639|20805785|P2|Randomized and Not Treated|Overall Study||1
8442975|NCT00795639|20805786|P1|Randomized and Not Treated|Overall Study||0
8442976|NCT00795639|20805785|P2|STARTED|Overall Study||92
8442977|NCT00795639|20805786|P1|STARTED|Overall Study||91
8442978|NCT00795600|20805798|P2|NOT COMPLETED|Overall Study||4
8442979|NCT00795600|20805799|P1|NOT COMPLETED|Overall Study||4
8442980|NCT00795600|20805798|P2|COMPLETED|Overall Study||31
8442981|NCT00795600|20805799|P1|COMPLETED|Overall Study||21
8442982|NCT00795600|20805798|P2|Exposed to Drug|Overall Study||35
8442983|NCT00795600|20805799|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
8442984|NCT00795600|20805798|P2|STARTED|Overall Study||35
8442985|NCT00795600|20805799|P1|STARTED|Overall Study||25
8442986|NCT00795535|20805919|P1|NOT COMPLETED|Overall Study||20
8442987|NCT00795535|20805919|P1|COMPLETED|Overall Study||75
8442988|NCT00795535|20805919|P1|STARTED|Overall Study||95
8442989|NCT00795509|20805926|P1|NOT COMPLETED|Overall Study||31
8442990|NCT00795509|20805926|P1|COMPLETED|Overall Study||343
8442991|NCT00795509|20805926|P1|STARTED|Overall Study||374
8442992|NCT00795366|20805933|P2|NOT COMPLETED|Overall Study||0
8442993|NCT00795366|20805934|P1|NOT COMPLETED|Overall Study||0
8442994|NCT00795366|20805933|P2|COMPLETED|Overall Study||54
8442995|NCT00795366|20805934|P1|COMPLETED|Overall Study||42
8442996|NCT00795366|20805933|P2|STARTED|Overall Study||54
8442997|NCT00795366|20805934|P1|STARTED|Overall Study||42
8442998|NCT00795340|20805942|P2|NOT COMPLETED|Overall Study||0
8442999|NCT00795340|20805943|P1|NOT COMPLETED|Overall Study||7
8443000|NCT00795340|20805942|P2|COMPLETED|Overall Study||153
8443001|NCT00795340|20805943|P1|COMPLETED|Overall Study||146
8443002|NCT00795340|20805942|P2|STARTED|Overall Study||153
8443003|NCT00795340|20805943|P1|STARTED|Overall Study||153
8443004|NCT00795288|20805955|P2|NOT COMPLETED|Overall Study||0
8443005|NCT00795288|20805956|P1|NOT COMPLETED|Overall Study||0
8443006|NCT00795288|20805955|P2|COMPLETED|Overall Study||21
8443007|NCT00795288|20805956|P1|COMPLETED|Overall Study||21
8443008|NCT00795288|20805955|P2|STARTED|Overall Study||21
8443009|NCT00795288|20805956|P1|STARTED|Overall Study||21
8443010|NCT00795236|20805968|P2|NOT COMPLETED|Overall Study||0
8443011|NCT00795236|20805969|P1|NOT COMPLETED|Overall Study||0
8443012|NCT00795236|20805968|P2|COMPLETED|Overall Study||0
8443013|NCT00795236|20805969|P1|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
8443014|NCT00795236|20805968|P2|STARTED|Overall Study||0
8443015|NCT00795236|20805969|P1|STARTED|Overall Study||0
8443016|NCT00795210|20805982|P3|NOT COMPLETED|Overall Study||2
8443017|NCT00795210|20805983|P2|NOT COMPLETED|Overall Study||1
8443018|NCT00795210|20805984|P1|NOT COMPLETED|Overall Study||0
8443019|NCT00795210|20805982|P3|COMPLETED|Overall Study||3
8443020|NCT00795210|20805983|P2|COMPLETED|Overall Study||11
8443021|NCT00795210|20805984|P1|COMPLETED|Overall Study||8
8443022|NCT00795210|20805982|P3|STARTED|Overall Study||5
8443023|NCT00795210|20805983|P2|STARTED|Overall Study||12
8443024|NCT00795210|20805984|P1|STARTED|Overall Study||8
8443025|NCT00795184|20805995|P2|NOT COMPLETED|Overall Study||13
8443026|NCT00795184|20805996|P1|NOT COMPLETED|Overall Study||8
8443027|NCT00795184|20805995|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
8443028|NCT00795184|20805996|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
8443029|NCT00795184|20805995|P2|STARTED|Overall Study||57
8443030|NCT00795184|20805996|P1|STARTED|Overall Study||65
8443031|NCT00795145|20806007|P7|NOT COMPLETED|Cohort 2||0
8443032|NCT00795145|20806008|P6|NOT COMPLETED|Cohort 2||0
8443033|NCT00795145|20806009|P5|NOT COMPLETED|Cohort 2||0
8443034|NCT00795145|20806010|P4|NOT COMPLETED|Cohort 2||0
8443035|NCT00795145|20806011|P3|NOT COMPLETED|Cohort 2||0
8443036|NCT00795145|20806012|P2|NOT COMPLETED|Cohort 2||0
8443037|NCT00795145|20806013|P1|NOT COMPLETED|Cohort 2||0
8443038|NCT00795145|20806007|P7|COMPLETED|Cohort 2||10
8443039|NCT00795145|20806008|P6|COMPLETED|Cohort 2||10
8443040|NCT00795145|20806009|P5|COMPLETED|Cohort 2||10
8443041|NCT00795145|20806010|P4|COMPLETED|Cohort 2||10
8443042|NCT00795145|20806011|P3|COMPLETED|Cohort 2||0
8443043|NCT00795145|20806012|P2|COMPLETED|Cohort 2||0
8443044|NCT00795145|20806013|P1|COMPLETED|Cohort 2||0
8443045|NCT00795145|20806007|P7|STARTED|Cohort 2||10
8443046|NCT00795145|20806008|P6|STARTED|Cohort 2||10
8443047|NCT00795145|20806009|P5|STARTED|Cohort 2||10
8443048|NCT00795145|20806010|P4|STARTED|Cohort 2||10
8443049|NCT00795145|20806011|P3|STARTED|Cohort 2||0
8443050|NCT00795145|20806012|P2|STARTED|Cohort 2||0
8443051|NCT00795145|20806013|P1|STARTED|Cohort 2||0
8443052|NCT00795145|20806007|P7|NOT COMPLETED|Cohort 1||0
8443053|NCT00795145|20806008|P6|NOT COMPLETED|Cohort 1||0
8443054|NCT00795145|20806009|P5|NOT COMPLETED|Cohort 1||0
8443055|NCT00795145|20806010|P4|NOT COMPLETED|Cohort 1||0
8443056|NCT00795145|20806011|P3|NOT COMPLETED|Cohort 1||0
8443057|NCT00795145|20806012|P2|NOT COMPLETED|Cohort 1||0
8443058|NCT00795145|20806013|P1|NOT COMPLETED|Cohort 1||0
8443059|NCT00795145|20806007|P7|COMPLETED|Cohort 1||0
8443060|NCT00795145|20806008|P6|COMPLETED|Cohort 1||0
8443061|NCT00795145|20806009|P5|COMPLETED|Cohort 1||0
8443062|NCT00795145|20806010|P4|COMPLETED|Cohort 1||0
8443063|NCT00795145|20806011|P3|COMPLETED|Cohort 1||3
8443064|NCT00795145|20806012|P2|COMPLETED|Cohort 1||3
8443065|NCT00795145|20806013|P1|COMPLETED|Cohort 1||3
8443066|NCT00795145|20806007|P7|STARTED|Cohort 1||0
8443067|NCT00795145|20806008|P6|STARTED|Cohort 1||0
8443068|NCT00795145|20806009|P5|STARTED|Cohort 1||0
8443069|NCT00795145|20806010|P4|STARTED|Cohort 1||0
8443070|NCT00795145|20806011|P3|STARTED|Cohort 1||3
8443071|NCT00795145|20806012|P2|STARTED|Cohort 1||3
8443072|NCT00795145|20806013|P1|STARTED|Cohort 1||3
8443073|NCT00795132|20806057|P1|NOT COMPLETED|Overall Study||3
8443074|NCT00795132|20806057|P1|COMPLETED|Overall Study||44
8443075|NCT00795132|20806057|P1|STARTED|Overall Study||47
8443076|NCT00795002|20806071|P2|NOT COMPLETED|Overall Study||0
8443077|NCT00795002|20806072|P1|NOT COMPLETED|Overall Study||0
8443078|NCT00795002|20806071|P2|COMPLETED|Overall Study||37
8443079|NCT00795002|20806072|P1|COMPLETED|Overall Study||37
8443080|NCT00795002|20806071|P2|STARTED|Overall Study||37
8443081|NCT00795002|20806072|P1|STARTED|Overall Study||37
8443082|NCT00794963|20806084|P2|NOT COMPLETED|Overall Study||4
8443083|NCT00794963|20806085|P1|NOT COMPLETED|Overall Study||1
8443084|NCT00794963|20806084|P2|COMPLETED|Overall Study||0
8443085|NCT00794963|20806085|P1|COMPLETED|Overall Study||3
8443086|NCT00794963|20806084|P2|STARTED|Overall Study||4
8443087|NCT00794963|20806085|P1|STARTED|Overall Study||4
8443088|NCT00794950|20806091|P1|NOT COMPLETED|Beginning Sunitinib Treatment||12
8443089|NCT00794950|20806091|P1|COMPLETED|Beginning Sunitinib Treatment||24
8443090|NCT00794950|20806091|P1|STARTED|Beginning Sunitinib Treatment||36
8443091|NCT00794950|20806091|P1|NOT COMPLETED|BCG Induction||7
8443092|NCT00794950|20806091|P1|COMPLETED|BCG Induction||36
8443093|NCT00794950|20806091|P1|STARTED|BCG Induction||43
8443094|NCT00794924|20806100|P2|NOT COMPLETED|Overall Study||70
8443095|NCT00794924|20806101|P1|NOT COMPLETED|Overall Study||60
8443096|NCT00794924|20806100|P2|COMPLETED|Overall Study||101
8443097|NCT00794924|20806101|P1|COMPLETED|Overall Study||114
8443098|NCT00794924|20806100|P2|STARTED|Overall Study|14 patients refused to start the study|171
8443099|NCT00794924|20806101|P1|STARTED|Overall Study|14 patients refused to start the study|174
8443100|NCT00794820|20806105|P1|NOT COMPLETED|Overall Study||16
8443101|NCT00794820|20806105|P1|COMPLETED|Overall Study||50
8443102|NCT00794820|20806105|P1|STARTED|Overall Study||66
8443115|NCT00794664|20806136|P2|NOT COMPLETED|Follow-up Period||5
8443116|NCT00794664|20806137|P1|NOT COMPLETED|Follow-up Period||1
8443117|NCT00794664|20806136|P2|COMPLETED|Follow-up Period||28
8443118|NCT00794664|20806137|P1|COMPLETED|Follow-up Period||15
8443119|NCT00794664|20806136|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
8443120|NCT00794664|20806137|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
8443121|NCT00794664|20806136|P2|NOT COMPLETED|Treatment Period||12
8443122|NCT00794664|20806137|P1|NOT COMPLETED|Treatment Period||1
8443123|NCT00794664|20806136|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
8443124|NCT00794664|20806137|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
8443125|NCT00794664|20806136|P2|STARTED|Treatment Period||39
8443126|NCT00794664|20806137|P1|STARTED|Treatment Period||19
8443127|NCT00794573|20806183|P2|NOT COMPLETED|Overall Study||45
8443128|NCT00794573|20806184|P1|NOT COMPLETED|Overall Study||38
8443129|NCT00794573|20806183|P2|COMPLETED|Overall Study||106
8443130|NCT00794573|20806184|P1|COMPLETED|Overall Study||113
8443131|NCT00794573|20806183|P2|STARTED|Overall Study||151
8443132|NCT00794573|20806184|P1|STARTED|Overall Study||151
8443133|NCT00794560|20806216|P4|NOT COMPLETED|Overall Study||4
8443134|NCT00794560|20806217|P3|NOT COMPLETED|Overall Study||4
8443135|NCT00794560|20806218|P2|NOT COMPLETED|Overall Study||4
8443136|NCT00794560|20806219|P1|NOT COMPLETED|Overall Study||3
8443137|NCT00794560|20806216|P4|COMPLETED|Overall Study||34
8443138|NCT00794560|20806217|P3|COMPLETED|Overall Study||40
8443139|NCT00794560|20806218|P2|COMPLETED|Overall Study||32
8443140|NCT00794560|20806219|P1|COMPLETED|Overall Study||33
8443141|NCT00794560|20806216|P4|STARTED|Overall Study||38
8443142|NCT00794560|20806217|P3|STARTED|Overall Study||44
8443143|NCT00794560|20806218|P2|STARTED|Overall Study||36
8443144|NCT00794560|20806219|P1|STARTED|Overall Study||36
8443145|NCT00794547|20806233|P2|NOT COMPLETED|Overall Study||0
8443146|NCT00794547|20806234|P1|NOT COMPLETED|Overall Study||0
8443147|NCT00794547|20806233|P2|COMPLETED|Overall Study||16
8443148|NCT00794547|20806234|P1|COMPLETED|Overall Study||18
8443149|NCT00794547|20806233|P2|STARTED|Overall Study||16
8443150|NCT00794547|20806234|P1|STARTED|Overall Study||18
8443151|NCT00794508|20806242|P1|NOT COMPLETED|Overall Study||0
8443152|NCT00794508|20806242|P1|COMPLETED|Overall Study||10
8443153|NCT00794508|20806242|P1|STARTED|Overall Study||10
8443154|NCT00794469|20806248|P1|NOT COMPLETED|Overall Study||0
8443155|NCT00794469|20806248|P1|COMPLETED|Overall Study||21
8443156|NCT00794469|20806248|P1|STARTED|Overall Study||21
8443157|NCT00794417|20806257|P4|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
8443158|NCT00794417|20806258|P3|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443159|NCT00794417|20806259|P2|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443160|NCT00794417|20806260|P1|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443161|NCT00794417|20806257|P4|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
8443162|NCT00794417|20806258|P3|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443163|NCT00794417|20806259|P2|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443164|NCT00794417|20806260|P1|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443165|NCT00794417|20806257|P4|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
8443166|NCT00794417|20806258|P3|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8443167|NCT00794417|20806259|P2|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8443168|NCT00794417|20806260|P1|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8443169|NCT00794417|20806257|P4|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
8443170|NCT00794417|20806258|P3|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8443171|NCT00794417|20806259|P2|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8443172|NCT00794417|20806260|P1|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8443173|NCT00794417|20806257|P4|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
8443174|NCT00794417|20806258|P3|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
8443175|NCT00794417|20806259|P2|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
8443176|NCT00794417|20806260|P1|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
8443177|NCT00794417|20806257|P4|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
8443178|NCT00794417|20806258|P3|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
8443179|NCT00794417|20806259|P2|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
8443180|NCT00794417|20806260|P1|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
8443181|NCT00794365|20806313|P1|NOT COMPLETED|Overall Study||79
8443182|NCT00794365|20806313|P1|COMPLETED|Overall Study||251
8443183|NCT00794365|20806313|P1|STARTED|Overall Study||330
8443184|NCT00794313|20806319|P3|NOT COMPLETED|Overall Study||0
8443185|NCT00794313|20806320|P2|NOT COMPLETED|Overall Study||0
8443186|NCT00794313|20806321|P1|NOT COMPLETED|Overall Study||0
8443187|NCT00794313|20806319|P3|COMPLETED|Overall Study||1
8443188|NCT00794313|20806320|P2|COMPLETED|Overall Study||1
8443189|NCT00794313|20806321|P1|COMPLETED|Overall Study||1
8443190|NCT00794313|20806319|P3|STARTED|Overall Study||1
8443191|NCT00794313|20806320|P2|STARTED|Overall Study||1
8443192|NCT00794313|20806321|P1|STARTED|Overall Study||1
8443193|NCT00794196|20806334|P2|NOT COMPLETED|Overall Study||23
8443194|NCT00794196|20806335|P1|NOT COMPLETED|Overall Study||5
8443195|NCT00794196|20806334|P2|COMPLETED|Overall Study||64
8443196|NCT00794196|20806335|P1|COMPLETED|Overall Study||87
8443197|NCT00794196|20806334|P2|STARTED|Overall Study||87
8443198|NCT00794196|20806335|P1|STARTED|Overall Study||92
8443199|NCT00794170|20806345|P2|NOT COMPLETED|Overall Study||3
8443200|NCT00794170|20806346|P1|NOT COMPLETED|Overall Study||7
8443201|NCT00794170|20806345|P2|COMPLETED|Overall Study||152
8443202|NCT00794170|20806346|P1|COMPLETED|Overall Study||150
8443203|NCT00794170|20806345|P2|STARTED|Overall Study||155
8443204|NCT00794170|20806346|P1|STARTED|Overall Study||157
8443205|NCT00794157|20806355|P3|NOT COMPLETED|Overall Study||19
8443206|NCT00794157|20806356|P2|NOT COMPLETED|Overall Study||10
8443207|NCT00794157|20806357|P1|NOT COMPLETED|Overall Study||10
8443208|NCT00794157|20806355|P3|COMPLETED|Overall Study||98
8443209|NCT00794157|20806356|P2|COMPLETED|Overall Study||106
8443210|NCT00794157|20806357|P1|COMPLETED|Overall Study||104
8443211|NCT00794157|20806355|P3|STARTED|Overall Study||117
8443212|NCT00794157|20806356|P2|STARTED|Overall Study||116
8443213|NCT00794157|20806357|P1|STARTED|Overall Study||114
8443214|NCT00794144|20806379|P2|NOT COMPLETED|Overall Study||3
8443215|NCT00794144|20806380|P1|NOT COMPLETED|Overall Study||3
8443216|NCT00794144|20806379|P2|COMPLETED|Overall Study||63
8443217|NCT00794144|20806380|P1|COMPLETED|Overall Study||63
8443218|NCT00794144|20806379|P2|STARTED|Overall Study||66
8443219|NCT00794144|20806380|P1|STARTED|Overall Study||66
8443220|NCT00794118|20806386|P1|NOT COMPLETED|Overall Study||27
8443221|NCT00794118|20806386|P1|COMPLETED|Overall Study||272
8443222|NCT00794118|20806386|P1|STARTED|Overall Study||299
8443223|NCT00794040|20806446|P2|NOT COMPLETED|Overall Study||5
8443224|NCT00794040|20806447|P1|NOT COMPLETED|Overall Study||3
8443225|NCT00794040|20806446|P2|COMPLETED|Overall Study||23
8443226|NCT00794040|20806447|P1|COMPLETED|Overall Study||22
8443227|NCT00794040|20806446|P2|STARTED|Overall Study||28
8443228|NCT00794040|20806447|P1|STARTED|Overall Study||25
8443229|NCT00793910|20806463|P2|NOT COMPLETED|Overall Study||7
8443230|NCT00793910|20806464|P1|NOT COMPLETED|Overall Study||5
8443231|NCT00793910|20806463|P2|COMPLETED|Overall Study||46
8443232|NCT00793910|20806464|P1|COMPLETED|Overall Study||48
8443233|NCT00793910|20806463|P2|STARTED|Overall Study||53
8443234|NCT00793910|20806464|P1|STARTED|Overall Study||53
8443235|NCT00793871|20806478|P1|NOT COMPLETED|Overall Study||60
8443236|NCT00793871|20806478|P1|COMPLETED|Overall Study||0
8443237|NCT00793871|20806478|P1|Received Treatment|Overall Study||59
8443238|NCT00793871|20806478|P1|STARTED|Overall Study||60
8443239|NCT00793819|20806492|P2|NOT COMPLETED|Overall Study||9
8443240|NCT00793819|20806493|P1|NOT COMPLETED|Overall Study||14
8443241|NCT00793819|20806492|P2|COMPLETED|Overall Study||89
8443242|NCT00793819|20806493|P1|COMPLETED|Overall Study||97
8443243|NCT00793819|20806492|P2|STARTED|Overall Study||98
8443244|NCT00793819|20806493|P1|STARTED|Overall Study||111
8443245|NCT00793793|20806511|P12|NOT COMPLETED|Overall Study||6
8443246|NCT00793793|20806512|P11|NOT COMPLETED|Overall Study||3
8443247|NCT00793793|20806513|P10|NOT COMPLETED|Overall Study||9
8443248|NCT00793793|20806514|P9|NOT COMPLETED|Overall Study||9
8443249|NCT00793793|20806515|P8|NOT COMPLETED|Overall Study||0
8443250|NCT00793793|20806516|P7|NOT COMPLETED|Overall Study||4
8443251|NCT00793793|20806517|P6|NOT COMPLETED|Overall Study||2
8443252|NCT00793793|20806518|P5|NOT COMPLETED|Overall Study||2
8443253|NCT00793793|20806519|P4|NOT COMPLETED|Overall Study||3
8443254|NCT00793793|20806520|P3|NOT COMPLETED|Overall Study||2
8443255|NCT00793793|20806521|P2|NOT COMPLETED|Overall Study||1
8443256|NCT00793793|20806522|P1|NOT COMPLETED|Overall Study||0
8443257|NCT00793793|20806511|P12|COMPLETED|Overall Study||1
8443258|NCT00793793|20806512|P11|COMPLETED|Overall Study||3
8443259|NCT00793793|20806513|P10|COMPLETED|Overall Study||6
8443260|NCT00793793|20806514|P9|COMPLETED|Overall Study||6
8443261|NCT00793793|20806515|P8|COMPLETED|Overall Study||6
8443262|NCT00793793|20806516|P7|COMPLETED|Overall Study||3
8443263|NCT00793793|20806517|P6|COMPLETED|Overall Study||4
8443264|NCT00793793|20806518|P5|COMPLETED|Overall Study||4
8443265|NCT00793793|20806519|P4|COMPLETED|Overall Study||4
8443266|NCT00793793|20806520|P3|COMPLETED|Overall Study||5
8443267|NCT00793793|20806521|P2|COMPLETED|Overall Study||5
8443268|NCT00793793|20806522|P1|COMPLETED|Overall Study||8
8443269|NCT00793793|20806511|P12|STARTED|Overall Study||7
8443270|NCT00793793|20806512|P11|STARTED|Overall Study||6
8443271|NCT00793793|20806513|P10|STARTED|Overall Study||15
8443272|NCT00793793|20806514|P9|STARTED|Overall Study||15
8443273|NCT00793793|20806515|P8|STARTED|Overall Study||6
8443274|NCT00793793|20806516|P7|STARTED|Overall Study||7
8443275|NCT00793793|20806517|P6|STARTED|Overall Study||6
8443276|NCT00793793|20806518|P5|STARTED|Overall Study||6
8443277|NCT00793793|20806519|P4|STARTED|Overall Study||7
8443278|NCT00793793|20806520|P3|STARTED|Overall Study||7
8443279|NCT00793793|20806521|P2|STARTED|Overall Study||6
8443280|NCT00793793|20806522|P1|STARTED|Overall Study||8
8443281|NCT00793780|20806897|P2|NOT COMPLETED|Overall Study||1
8443282|NCT00793780|20806898|P1|NOT COMPLETED|Overall Study||2
8443283|NCT00793780|20806897|P2|COMPLETED|Overall Study||11
8443284|NCT00793780|20806898|P1|COMPLETED|Overall Study||10
8443285|NCT00793780|20806897|P2|Collected Baseline Data|Overall Study||12
8443286|NCT00793780|20806898|P1|Collected Baseline Data|Overall Study||11
8443287|NCT00793780|20806897|P2|Randomization|Overall Study||12
8443288|NCT00793780|20806898|P1|Randomization|Overall Study||12
8443289|NCT00793780|20806897|P2|STARTED|Overall Study||12
8443290|NCT00793780|20806898|P1|STARTED|Overall Study||12
8443291|NCT00793650|20806916|P2|NOT COMPLETED|Overall Study||0
8443292|NCT00793650|20806917|P1|NOT COMPLETED|Overall Study||0
8443293|NCT00793650|20806916|P2|COMPLETED|Overall Study||20
8443294|NCT00793650|20806917|P1|COMPLETED|Overall Study||19
8443295|NCT00793650|20806916|P2|STARTED|Overall Study||20
8443296|NCT00793650|20806917|P1|STARTED|Overall Study||19
8443297|NCT00793624|20806929|P4|NOT COMPLETED|Overall Study||43
8443298|NCT00793624|20806930|P3|NOT COMPLETED|Overall Study||39
8443299|NCT00793624|20806931|P2|NOT COMPLETED|Overall Study||36
8443300|NCT00793624|20806932|P1|NOT COMPLETED|Overall Study||57
8443301|NCT00793624|20806929|P4|COMPLETED|Overall Study||184
8443302|NCT00793624|20806930|P3|COMPLETED|Overall Study||186
8443303|NCT00793624|20806931|P2|COMPLETED|Overall Study||191
8443304|NCT00793624|20806932|P1|COMPLETED|Overall Study||168
8443305|NCT00793624|20806929|P4|STARTED|Overall Study||227
8443306|NCT00793624|20806930|P3|STARTED|Overall Study||225
8443307|NCT00793624|20806931|P2|STARTED|Overall Study||227
8443308|NCT00793624|20806932|P1|STARTED|Overall Study||225
8443309|NCT00793611|20807200|P2|NOT COMPLETED|Overall Study||0
8443310|NCT00793611|20807201|P1|NOT COMPLETED|Overall Study||0
8443311|NCT00793611|20807200|P2|COMPLETED|Overall Study||10
8443312|NCT00793611|20807201|P1|COMPLETED|Overall Study||10
8443313|NCT00793611|20807200|P2|STARTED|Overall Study||10
8443314|NCT00793611|20807201|P1|STARTED|Overall Study||10
8443315|NCT00793585|20807213|P2|NOT COMPLETED|Overall Study||3
8443316|NCT00793585|20807214|P1|NOT COMPLETED|Overall Study||2
8443317|NCT00793585|20807213|P2|COMPLETED|Overall Study||18
8443318|NCT00793585|20807214|P1|COMPLETED|Overall Study||17
8443319|NCT00793585|20807213|P2|STARTED|Overall Study||21
8443320|NCT00793585|20807214|P1|STARTED|Overall Study||19
8443321|NCT00793572|20807222|P1|NOT COMPLETED|Overall Study||0
8443322|NCT00793572|20807222|P1|COMPLETED|Overall Study||32
8443323|NCT00793572|20807222|P1|STARTED|Overall Study||32
8443324|NCT00793546|20807233|P2|NOT COMPLETED|Overall Study||28
8443325|NCT00793546|20807234|P1|NOT COMPLETED|Overall Study||14
8443326|NCT00793546|20807233|P2|COMPLETED|Overall Study||0
8443327|NCT00793546|20807234|P1|COMPLETED|Overall Study||0
8443328|NCT00793546|20807233|P2|STARTED|Overall Study||28
8443329|NCT00793546|20807234|P1|STARTED|Overall Study||14
8443330|NCT00793520|20807264|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
8443331|NCT00793520|20807265|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
8443332|NCT00793520|20807264|P2|COMPLETED|Placebo Crossover to Milnacipran||0
8443333|NCT00793520|20807265|P1|COMPLETED|Placebo Crossover to Milnacipran||0
8443334|NCT00793520|20807264|P2|STARTED|Placebo Crossover to Milnacipran||1
8443335|NCT00793520|20807265|P1|STARTED|Placebo Crossover to Milnacipran||0
8443336|NCT00793520|20807264|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
8443337|NCT00793520|20807265|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
8443338|NCT00793520|20807264|P2|COMPLETED|Milnacipran Crossover to Placebo||0
8443339|NCT00793520|20807265|P1|COMPLETED|Milnacipran Crossover to Placebo||0
8443340|NCT00793520|20807264|P2|STARTED|Milnacipran Crossover to Placebo||0
8443341|NCT00793520|20807265|P1|STARTED|Milnacipran Crossover to Placebo||1
8443342|NCT00793455|20807275|P2|NOT COMPLETED|Overall Study||0
8443343|NCT00793455|20807276|P1|NOT COMPLETED|Overall Study||0
8443344|NCT00793455|20807275|P2|COMPLETED|Overall Study||314
8443345|NCT00793455|20807276|P1|COMPLETED|Overall Study||314
8443346|NCT00793455|20807275|P2|STARTED|Overall Study||314
8443347|NCT00793455|20807276|P1|STARTED|Overall Study||314
8443348|NCT00793403|20807284|P1|NOT COMPLETED|Overall Study||73
8443349|NCT00793403|20807284|P1|COMPLETED|Overall Study||220
8443350|NCT00793403|20807284|P1|STARTED|Overall Study||293
8443351|NCT00793325|20807331|P1|NOT COMPLETED|Overall Study||19
8443352|NCT00793325|20807331|P1|COMPLETED|Overall Study||890
8443353|NCT00793325|20807331|P1|STARTED|Overall Study||909
8443354|NCT00793182|20807357|P2|NOT COMPLETED|Overall Study||1
8443355|NCT00793182|20807358|P1|NOT COMPLETED|Overall Study||0
8443356|NCT00793182|20807357|P2|COMPLETED|Overall Study||3
8443357|NCT00793182|20807358|P1|COMPLETED|Overall Study||2
8443358|NCT00793182|20807357|P2|STARTED|Overall Study||4
8443359|NCT00793182|20807358|P1|STARTED|Overall Study||2
8443360|NCT00793169|20807364|P1|NOT COMPLETED|Overall Study||0
8443361|NCT00793169|20807364|P1|COMPLETED|Overall Study||19
8443362|NCT00793169|20807364|P1|STARTED|Overall Study||19
8443363|NCT00793104|20807368|P1|NOT COMPLETED|Overall Study||1
8443364|NCT00793104|20807368|P1|COMPLETED|Overall Study||9
8443365|NCT00793104|20807368|P1|STARTED|Overall Study||10
8443366|NCT00792948|20807376|P1|NOT COMPLETED|Overall Study||28
8443367|NCT00792948|20807376|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
8443368|NCT00792948|20807376|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
8443369|NCT00792935|20807387|P2|NOT COMPLETED|Overall Study||3
8443370|NCT00792935|20807388|P1|NOT COMPLETED|Overall Study||4
8443371|NCT00792935|20807387|P2|COMPLETED|Overall Study||68
8443372|NCT00792935|20807388|P1|COMPLETED|Overall Study||68
8443373|NCT00792935|20807387|P2|STARTED|Overall Study||71
8443374|NCT00792935|20807388|P1|STARTED|Overall Study||72
8443375|NCT00792922|20807400|P4|NOT COMPLETED|At 3 Years||0
8443376|NCT00792922|20807401|P3|NOT COMPLETED|At 3 Years||0
8443377|NCT00792922|20807402|P2|NOT COMPLETED|At 3 Years||0
8443378|NCT00792922|20807403|P1|NOT COMPLETED|At 3 Years||0
8443379|NCT00792922|20807400|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443380|NCT00792922|20807401|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443381|NCT00792922|20807402|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443382|NCT00792922|20807403|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443383|NCT00792922|20807400|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443384|NCT00792922|20807401|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443385|NCT00792922|20807402|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443386|NCT00792922|20807403|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443387|NCT00792922|20807400|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443388|NCT00792922|20807401|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443389|NCT00792922|20807402|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443390|NCT00792922|20807403|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443391|NCT00792922|20807400|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443392|NCT00792922|20807401|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443393|NCT00792922|20807402|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443394|NCT00792922|20807403|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443395|NCT00792922|20807400|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443396|NCT00792922|20807401|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443397|NCT00792922|20807402|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443472|NCT00792623|20807560|P1|NOT COMPLETED|Overall Study||7
8443398|NCT00792922|20807403|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443399|NCT00792922|20807400|P4|NOT COMPLETED|At Baseline||0
8443400|NCT00792922|20807401|P3|NOT COMPLETED|At Baseline||0
8443401|NCT00792922|20807402|P2|NOT COMPLETED|At Baseline||0
8443402|NCT00792922|20807403|P1|NOT COMPLETED|At Baseline||0
8443403|NCT00792922|20807400|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443404|NCT00792922|20807401|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443405|NCT00792922|20807402|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443406|NCT00792922|20807403|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443407|NCT00792922|20807400|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443408|NCT00792922|20807401|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443409|NCT00792922|20807402|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443410|NCT00792922|20807403|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443411|NCT00792922|20807400|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443412|NCT00792922|20807401|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443413|NCT00792922|20807402|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443414|NCT00792922|20807403|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443415|NCT00792922|20807400|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443416|NCT00792922|20807401|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443417|NCT00792922|20807402|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443418|NCT00792922|20807403|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443419|NCT00792922|20807400|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443420|NCT00792922|20807401|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443421|NCT00792922|20807402|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443422|NCT00792922|20807403|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443423|NCT00792909|20807420|P3|NOT COMPLETED|Overall Study||0
8443424|NCT00792909|20807421|P2|NOT COMPLETED|Overall Study||1
8443425|NCT00792909|20807422|P1|NOT COMPLETED|Overall Study||0
8443426|NCT00792909|20807420|P3|COMPLETED|Overall Study||62
8443427|NCT00792909|20807421|P2|COMPLETED|Overall Study||58
8443428|NCT00792909|20807422|P1|COMPLETED|Overall Study||51
8443429|NCT00792909|20807420|P3|STARTED|Overall Study||62
8443430|NCT00792909|20807421|P2|STARTED|Overall Study||59
8443431|NCT00792909|20807422|P1|STARTED|Overall Study||51
8443432|NCT00792805|20807478|P3|NOT COMPLETED|Overall Study||33
8443433|NCT00792805|20807479|P2|NOT COMPLETED|Overall Study||26
8443434|NCT00792805|20807480|P1|NOT COMPLETED|Overall Study||22
8443435|NCT00792805|20807478|P3|COMPLETED|Overall Study||154
8443436|NCT00792805|20807479|P2|COMPLETED|Overall Study||162
8443437|NCT00792805|20807480|P1|COMPLETED|Overall Study||166
8443438|NCT00792805|20807478|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
8443439|NCT00792805|20807479|P2|Exposed to Study Medication or Placebo|Overall Study||188
8443440|NCT00792805|20807480|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
8443441|NCT00792805|20807478|P3|STARTED|Overall Study||187
8443442|NCT00792805|20807479|P2|STARTED|Overall Study||188
8443443|NCT00792805|20807480|P1|STARTED|Overall Study||188
8443444|NCT00792701|20807490|P2|NOT COMPLETED|Overall Study||44
8443445|NCT00792701|20807491|P1|NOT COMPLETED|Overall Study||19
8443446|NCT00792701|20807490|P2|COMPLETED|Overall Study||22
8443447|NCT00792701|20807491|P1|COMPLETED|Overall Study||0
8443448|NCT00792701|20807490|P2|Eligible and Analyzable|Overall Study||44
8443449|NCT00792701|20807491|P1|Eligible and Analyzable|Overall Study||17
8443450|NCT00792701|20807490|P2|Eligible|Overall Study||63
8443451|NCT00792701|20807491|P1|Eligible|Overall Study||18
8443452|NCT00792701|20807490|P2|STARTED|Overall Study||66
8443453|NCT00792701|20807491|P1|STARTED|Overall Study||19
8443454|NCT00792688|20807505|P3|NOT COMPLETED|Overall Study||0
8443455|NCT00792688|20807506|P2|NOT COMPLETED|Overall Study||0
8443456|NCT00792688|20807507|P1|NOT COMPLETED|Overall Study||0
8443457|NCT00792688|20807505|P3|COMPLETED|Overall Study||9
8443458|NCT00792688|20807506|P2|COMPLETED|Overall Study||8
8443459|NCT00792688|20807507|P1|COMPLETED|Overall Study||9
8443460|NCT00792688|20807505|P3|STARTED|Overall Study||9
8443461|NCT00792688|20807506|P2|STARTED|Overall Study||8
8443462|NCT00792688|20807507|P1|STARTED|Overall Study||9
8443463|NCT00792636|20807521|P3|NOT COMPLETED|Overall Study||81
8443464|NCT00792636|20807522|P2|NOT COMPLETED|Overall Study||81
8443465|NCT00792636|20807523|P1|NOT COMPLETED|Overall Study||68
8443466|NCT00792636|20807521|P3|COMPLETED|Overall Study||55
8443467|NCT00792636|20807522|P2|COMPLETED|Overall Study||55
8443468|NCT00792636|20807523|P1|COMPLETED|Overall Study||67
8443469|NCT00792636|20807521|P3|STARTED|Overall Study||136
8443470|NCT00792636|20807522|P2|STARTED|Overall Study||136
8443471|NCT00792636|20807523|P1|STARTED|Overall Study||135
8443473|NCT00792623|20807560|P1|COMPLETED|Overall Study||22
8443474|NCT00792623|20807560|P1|STARTED|Overall Study||29
8443475|NCT00792610|20807573|P1|NOT COMPLETED|Overall Study||0
8443476|NCT00792610|20807573|P1|COMPLETED|Overall Study||127
8443477|NCT00792610|20807573|P1|Youths|Overall Study||127
8443478|NCT00792610|20807573|P1|STARTED|Overall Study||127
8443479|NCT00792571|20807577|P1|NOT COMPLETED|Overall Study||10
8443480|NCT00792571|20807577|P1|COMPLETED|Overall Study||8
8443481|NCT00792571|20807577|P1|STARTED|Overall Study||18
8443482|NCT00792428|20807588|P2|NOT COMPLETED|Overall Study||0
8443483|NCT00792428|20807589|P1|NOT COMPLETED|Overall Study||0
8443484|NCT00792428|20807588|P2|COMPLETED|Overall Study||10
8443485|NCT00792428|20807589|P1|COMPLETED|Overall Study||10
8443486|NCT00792428|20807588|P2|STARTED|Overall Study||10
8443487|NCT00792428|20807589|P1|STARTED|Overall Study||10
8443488|NCT00792298|20807597|P8|NOT COMPLETED|Treatment Period 2||2
8443489|NCT00792298|20807598|P7|NOT COMPLETED|Treatment Period 2||1
8443490|NCT00792298|20807599|P6|NOT COMPLETED|Treatment Period 2||0
8443491|NCT00792298|20807600|P5|NOT COMPLETED|Treatment Period 2||2
8443492|NCT00792298|20807601|P4|NOT COMPLETED|Treatment Period 2||2
8443493|NCT00792298|20807602|P3|NOT COMPLETED|Treatment Period 2||1
8443494|NCT00792298|20807603|P2|NOT COMPLETED|Treatment Period 2||1
8443495|NCT00792298|20807604|P1|NOT COMPLETED|Treatment Period 2||1
8443496|NCT00792298|20807597|P8|COMPLETED|Treatment Period 2||28
8443497|NCT00792298|20807598|P7|COMPLETED|Treatment Period 2||28
8443498|NCT00792298|20807599|P6|COMPLETED|Treatment Period 2||27
8443499|NCT00792298|20807600|P5|COMPLETED|Treatment Period 2||30
8443500|NCT00792298|20807601|P4|COMPLETED|Treatment Period 2||26
8443501|NCT00792298|20807602|P3|COMPLETED|Treatment Period 2||30
8443502|NCT00792298|20807603|P2|COMPLETED|Treatment Period 2||30
8443503|NCT00792298|20807604|P1|COMPLETED|Treatment Period 2||29
8443504|NCT00792298|20807597|P8|STARTED|Treatment Period 2||30
8443505|NCT00792298|20807598|P7|STARTED|Treatment Period 2||29
8443506|NCT00792298|20807599|P6|STARTED|Treatment Period 2||27
8443507|NCT00792298|20807600|P5|STARTED|Treatment Period 2||32
8443508|NCT00792298|20807601|P4|STARTED|Treatment Period 2||28
8443509|NCT00792298|20807602|P3|STARTED|Treatment Period 2||31
8443510|NCT00792298|20807603|P2|STARTED|Treatment Period 2||31
8443511|NCT00792298|20807604|P1|STARTED|Treatment Period 2||30
8443512|NCT00792298|20807597|P8|NOT COMPLETED|Washout||0
8443513|NCT00792298|20807598|P7|NOT COMPLETED|Washout||0
8443514|NCT00792298|20807599|P6|NOT COMPLETED|Washout||2
8443515|NCT00792298|20807600|P5|NOT COMPLETED|Washout||0
8443516|NCT00792298|20807601|P4|NOT COMPLETED|Washout||0
8443517|NCT00792298|20807602|P3|NOT COMPLETED|Washout||1
8443518|NCT00792298|20807603|P2|NOT COMPLETED|Washout||0
8443519|NCT00792298|20807604|P1|NOT COMPLETED|Washout||0
8443520|NCT00792298|20807597|P8|COMPLETED|Washout||30
8443521|NCT00792298|20807598|P7|COMPLETED|Washout||29
8443522|NCT00792298|20807599|P6|COMPLETED|Washout||27
8443523|NCT00792298|20807600|P5|COMPLETED|Washout||32
8443524|NCT00792298|20807601|P4|COMPLETED|Washout||28
8443525|NCT00792298|20807602|P3|COMPLETED|Washout||31
8443526|NCT00792298|20807603|P2|COMPLETED|Washout||31
8443527|NCT00792298|20807604|P1|COMPLETED|Washout||30
8443528|NCT00792298|20807597|P8|STARTED|Washout||30
8443529|NCT00792298|20807598|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
8443530|NCT00792298|20807599|P6|STARTED|Washout||29
8443531|NCT00792298|20807600|P5|STARTED|Washout||32
8443532|NCT00792298|20807601|P4|STARTED|Washout||28
8443533|NCT00792298|20807602|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
8443534|NCT00792298|20807603|P2|STARTED|Washout||31
8443535|NCT00792298|20807604|P1|STARTED|Washout||30
8443536|NCT00792298|20807597|P8|NOT COMPLETED|Treatment Period 1||1
8443537|NCT00792298|20807598|P7|NOT COMPLETED|Treatment Period 1||4
8443538|NCT00792298|20807599|P6|NOT COMPLETED|Treatment Period 1||3
8443539|NCT00792298|20807600|P5|NOT COMPLETED|Treatment Period 1||0
8443540|NCT00792298|20807601|P4|NOT COMPLETED|Treatment Period 1||4
8443541|NCT00792298|20807602|P3|NOT COMPLETED|Treatment Period 1||2
8443542|NCT00792298|20807603|P2|NOT COMPLETED|Treatment Period 1||1
8443543|NCT00792298|20807604|P1|NOT COMPLETED|Treatment Period 1||1
8443544|NCT00792298|20807597|P8|COMPLETED|Treatment Period 1||30
8443545|NCT00792298|20807598|P7|COMPLETED|Treatment Period 1||27
8443546|NCT00792298|20807599|P6|COMPLETED|Treatment Period 1||29
8443547|NCT00792298|20807600|P5|COMPLETED|Treatment Period 1||32
8443548|NCT00792298|20807601|P4|COMPLETED|Treatment Period 1||28
8443549|NCT00792298|20807602|P3|COMPLETED|Treatment Period 1||31
8443550|NCT00792298|20807603|P2|COMPLETED|Treatment Period 1||31
8443551|NCT00792298|20807604|P1|COMPLETED|Treatment Period 1||30
8443552|NCT00792298|20807597|P8|STARTED|Treatment Period 1||31
8443553|NCT00792298|20807598|P7|STARTED|Treatment Period 1||31
8443554|NCT00792298|20807599|P6|STARTED|Treatment Period 1||32
8443555|NCT00792298|20807600|P5|STARTED|Treatment Period 1||32
8443556|NCT00792298|20807601|P4|STARTED|Treatment Period 1||32
8443557|NCT00792298|20807602|P3|STARTED|Treatment Period 1||33
8443558|NCT00792298|20807603|P2|STARTED|Treatment Period 1||32
8443559|NCT00792298|20807604|P1|STARTED|Treatment Period 1||31
8443560|NCT00792259|20807634|P3|NOT COMPLETED|Overall Study||0
8443561|NCT00792259|20807635|P2|NOT COMPLETED|Overall Study||0
8443562|NCT00792259|20807636|P1|NOT COMPLETED|Overall Study||1
8443563|NCT00792259|20807634|P3|COMPLETED|Overall Study||13
8443564|NCT00792259|20807635|P2|COMPLETED|Overall Study||20
8443565|NCT00792259|20807636|P1|COMPLETED|Overall Study||14
8443566|NCT00792259|20807634|P3|STARTED|Overall Study||13
8443567|NCT00792259|20807635|P2|STARTED|Overall Study||20
8443568|NCT00792259|20807636|P1|STARTED|Overall Study||15
8443569|NCT00792142|20807644|P1|NOT COMPLETED|Overall Study||0
8443570|NCT00792142|20807644|P1|COMPLETED|Overall Study||45
8443571|NCT00792142|20807644|P1|STARTED|Overall Study||45
8443572|NCT00792116|20807653|P2|NOT COMPLETED|Overall Study||1
8443573|NCT00792116|20807654|P1|NOT COMPLETED|Overall Study||1
8443574|NCT00792116|20807653|P2|COMPLETED|Overall Study||54
8443575|NCT00792116|20807654|P1|COMPLETED|Overall Study||52
8443576|NCT00792116|20807653|P2|STARTED|Overall Study||55
8443577|NCT00792116|20807654|P1|STARTED|Overall Study||53
8443578|NCT00792103|20807664|P1|NOT COMPLETED|Overall Study||133
8443579|NCT00792103|20807664|P1|COMPLETED|Overall Study||65
8443580|NCT00792103|20807664|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
8443581|NCT00791999|20807676|P4|NOT COMPLETED|Overall Study||52
8443582|NCT00791999|20807677|P3|NOT COMPLETED|Overall Study||20
8443583|NCT00791999|20807678|P2|NOT COMPLETED|Overall Study||16
8443584|NCT00791999|20807679|P1|NOT COMPLETED|Overall Study||21
8443585|NCT00791999|20807676|P4|COMPLETED|Overall Study||25
8443586|NCT00791999|20807677|P3|COMPLETED|Overall Study||65
8443587|NCT00791999|20807678|P2|COMPLETED|Overall Study||66
8443588|NCT00791999|20807679|P1|COMPLETED|Overall Study||51
8443589|NCT00791999|20807676|P4|STARTED|Overall Study||77
8443590|NCT00791999|20807677|P3|STARTED|Overall Study||85
8443591|NCT00791999|20807678|P2|STARTED|Overall Study||82
8443592|NCT00791999|20807679|P1|STARTED|Overall Study||72
8443593|NCT00791973|20807695|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8443594|NCT00791973|20807696|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8443595|NCT00791973|20807695|P2|COMPLETED|Second Intervention (1 Week)||7
8443596|NCT00791973|20807696|P1|COMPLETED|Second Intervention (1 Week)||8
8443597|NCT00791973|20807695|P2|STARTED|Second Intervention (1 Week)||7
8443598|NCT00791973|20807696|P1|STARTED|Second Intervention (1 Week)||8
8443599|NCT00791973|20807695|P2|NOT COMPLETED|Washout (1 Week)||0
8443600|NCT00791973|20807696|P1|NOT COMPLETED|Washout (1 Week)||0
8443601|NCT00791973|20807695|P2|COMPLETED|Washout (1 Week)||7
8443602|NCT00791973|20807696|P1|COMPLETED|Washout (1 Week)||8
8443603|NCT00791973|20807695|P2|STARTED|Washout (1 Week)||7
8443604|NCT00791973|20807696|P1|STARTED|Washout (1 Week)||8
8443605|NCT00791973|20807695|P2|NOT COMPLETED|First Intervention (1 Week)||0
8443606|NCT00791973|20807696|P1|NOT COMPLETED|First Intervention (1 Week)||0
8443607|NCT00791973|20807695|P2|COMPLETED|First Intervention (1 Week)||7
8443608|NCT00791973|20807696|P1|COMPLETED|First Intervention (1 Week)||8
8443609|NCT00791973|20807695|P2|STARTED|First Intervention (1 Week)||7
8443610|NCT00791973|20807696|P1|STARTED|First Intervention (1 Week)||8
8443611|NCT00791934|20807704|P1|NOT COMPLETED|Overall Study||15
8443612|NCT00791934|20807704|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
8443613|NCT00791934|20807704|P1|STARTED|Overall Study||63
8443614|NCT00791921|20807714|P2|NOT COMPLETED|Overall Study||96
8443615|NCT00791921|20807715|P1|NOT COMPLETED|Overall Study||34
8443616|NCT00791921|20807714|P2|COMPLETED|Overall Study||18
8443617|NCT00791921|20807715|P1|COMPLETED|Overall Study||82
8443618|NCT00791921|20807714|P2|STARTED|Overall Study||114
8443619|NCT00791921|20807715|P1|STARTED|Overall Study||116
8443620|NCT00791908|20807723|P1|NOT COMPLETED|Overall Study||0
8443621|NCT00791908|20807723|P1|COMPLETED|Overall Study||15
8443622|NCT00791908|20807723|P1|STARTED|Overall Study||15
8443623|NCT00791843|20807731|P1|NOT COMPLETED|Overall Study||0
8443624|NCT00791843|20807731|P1|COMPLETED|Overall Study|Data unavailable for the study|0
8443625|NCT00791843|20807731|P1|STARTED|Overall Study|Data unavailable for the study|0
8443626|NCT00791817|20807737|P2|NOT COMPLETED|2: Single Dose||0
8443627|NCT00791817|20807738|P1|NOT COMPLETED|2: Single Dose||0
8443628|NCT00791817|20807737|P2|COMPLETED|2: Single Dose||5
8443629|NCT00791817|20807738|P1|COMPLETED|2: Single Dose||5
8443630|NCT00791817|20807737|P2|STARTED|2: Single Dose||5
8443631|NCT00791817|20807738|P1|STARTED|2: Single Dose||5
8443632|NCT00791817|20807737|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
8443633|NCT00791817|20807738|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
8443634|NCT00791817|20807737|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
8443635|NCT00791817|20807738|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
8443636|NCT00791817|20807737|P2|STARTED|1: Single Dose Followed by Week Washout||5
8443637|NCT00791817|20807738|P1|STARTED|1: Single Dose Followed by Week Washout||5
8443638|NCT00791778|20807746|P2|NOT COMPLETED|Follow-up||1
8443639|NCT00791778|20807747|P1|NOT COMPLETED|Follow-up||5
8443640|NCT00791778|20807746|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
8443641|NCT00791778|20807747|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
8443642|NCT00791778|20807746|P2|STARTED|Follow-up||91
8443643|NCT00791778|20807747|P1|STARTED|Follow-up||100
8443644|NCT00791778|20807746|P2|NOT COMPLETED|Double-blind Treatment||48
8443645|NCT00791778|20807747|P1|NOT COMPLETED|Double-blind Treatment||77
8443646|NCT00791778|20807746|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
8443647|NCT00791778|20807747|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
8443648|NCT00791778|20807746|P2|STARTED|Double-blind Treatment||123
8443649|NCT00791778|20807747|P1|STARTED|Double-blind Treatment||123
8443650|NCT00791765|20807801|P2|NOT COMPLETED|Weeks 13 to 24||8
8443651|NCT00791765|20807802|P1|NOT COMPLETED|Weeks 13 to 24||5
8443652|NCT00791765|20807801|P2|COMPLETED|Weeks 13 to 24||49
8443653|NCT00791765|20807802|P1|COMPLETED|Weeks 13 to 24||49
8443654|NCT00791765|20807801|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
8443655|NCT00791765|20807802|P1|STARTED|Weeks 13 to 24||54
8443656|NCT00791765|20807801|P2|NOT COMPLETED|Weeks 1 to 12||4
8443657|NCT00791765|20807802|P1|NOT COMPLETED|Weeks 1 to 12||8
8443658|NCT00791765|20807801|P2|COMPLETED|Weeks 1 to 12||58
8443659|NCT00791765|20807802|P1|COMPLETED|Weeks 1 to 12||54
8443660|NCT00791765|20807801|P2|Treated|Weeks 1 to 12||59
8443661|NCT00791765|20807802|P1|Treated|Weeks 1 to 12||62
8443662|NCT00791765|20807801|P2|STARTED|Weeks 1 to 12||62
8443663|NCT00791765|20807802|P1|STARTED|Weeks 1 to 12||62
8443664|NCT00791700|20807817|P4|NOT COMPLETED|Overall Study||30
8443665|NCT00791700|20807818|P3|NOT COMPLETED|Overall Study||6
8443666|NCT00791700|20807819|P2|NOT COMPLETED|Overall Study||11
8443667|NCT00791700|20807820|P1|NOT COMPLETED|Overall Study||6
8443668|NCT00791700|20807817|P4|COMPLETED|Overall Study||13
8443669|NCT00791700|20807818|P3|COMPLETED|Overall Study||7
8443670|NCT00791700|20807819|P2|COMPLETED|Overall Study||20
8443671|NCT00791700|20807820|P1|COMPLETED|Overall Study||10
8443672|NCT00791700|20807817|P4|STARTED|Overall Study||43
8443673|NCT00791700|20807818|P3|STARTED|Overall Study||13
8443674|NCT00791700|20807819|P2|STARTED|Overall Study||31
8443675|NCT00791700|20807820|P1|STARTED|Overall Study||16
8443676|NCT00791661|20807908|P3|NOT COMPLETED|Period 3||0
8443677|NCT00791661|20807909|P2|NOT COMPLETED|Period 3||0
8443678|NCT00791661|20807910|P1|NOT COMPLETED|Period 3||0
8443679|NCT00791661|20807908|P3|COMPLETED|Period 3||6
8443680|NCT00791661|20807909|P2|COMPLETED|Period 3||8
8443681|NCT00791661|20807910|P1|COMPLETED|Period 3||8
8443682|NCT00791661|20807908|P3|Received Matching Placebo to MK-1006|Period 3||1
8443683|NCT00791661|20807909|P2|Received Matching Placebo to MK-1006|Period 3||2
8443684|NCT00791661|20807910|P1|Received Matching Placebo to MK-1006|Period 3||2
8443685|NCT00791661|20807908|P3|Received MK-1006|Period 3||5
8443686|NCT00791661|20807909|P2|Received MK-1006|Period 3||6
8443687|NCT00791661|20807910|P1|Received MK-1006|Period 3||6
8443688|NCT00791661|20807908|P3|STARTED|Period 3||6
8443689|NCT00791661|20807909|P2|STARTED|Period 3||8
8443690|NCT00791661|20807910|P1|STARTED|Period 3||8
8443691|NCT00791661|20807908|P3|NOT COMPLETED|7 Day Wash-out||0
8443692|NCT00791661|20807909|P2|NOT COMPLETED|7 Day Wash-out||0
8443693|NCT00791661|20807910|P1|NOT COMPLETED|7 Day Wash-out||0
8443694|NCT00791661|20807908|P3|COMPLETED|7 Day Wash-out||6
8443695|NCT00791661|20807909|P2|COMPLETED|7 Day Wash-out||8
8443696|NCT00791661|20807910|P1|COMPLETED|7 Day Wash-out||8
8443697|NCT00791661|20807908|P3|STARTED|7 Day Wash-out||6
8443698|NCT00791661|20807909|P2|STARTED|7 Day Wash-out||8
8443699|NCT00791661|20807910|P1|STARTED|7 Day Wash-out||8
8443700|NCT00791661|20807908|P3|NOT COMPLETED|Period 2||0
8443701|NCT00791661|20807909|P2|NOT COMPLETED|Period 2||0
8443702|NCT00791661|20807910|P1|NOT COMPLETED|Period 2||0
8443703|NCT00791661|20807908|P3|COMPLETED|Period 2||6
8443704|NCT00791661|20807909|P2|COMPLETED|Period 2||8
8443705|NCT00791661|20807910|P1|COMPLETED|Period 2||8
8443706|NCT00791661|20807908|P3|Received Matching Placebo to MK-1006|Period 2||2
8443707|NCT00791661|20807909|P2|Received Matching Placebo to MK-1006|Period 2||2
8443708|NCT00791661|20807910|P1|Received Matching Placebo to MK-1006|Period 2||2
8443709|NCT00791661|20807908|P3|Received MK-1006|Period 2||4
8443710|NCT00791661|20807909|P2|Received MK-1006|Period 2||6
8443711|NCT00791661|20807910|P1|Received MK-1006|Period 2||6
8443712|NCT00791661|20807908|P3|STARTED|Period 2||6
8443713|NCT00791661|20807909|P2|STARTED|Period 2||8
8443714|NCT00791661|20807910|P1|STARTED|Period 2||8
8443715|NCT00791661|20807908|P3|NOT COMPLETED|7 Day Wash-out||2
8443716|NCT00791661|20807909|P2|NOT COMPLETED|7 Day Wash-out||0
8443717|NCT00791661|20807910|P1|NOT COMPLETED|7 Day Wash-out||0
8443718|NCT00791661|20807908|P3|COMPLETED|7 Day Wash-out||6
8443719|NCT00791661|20807909|P2|COMPLETED|7 Day Wash-out||8
8443720|NCT00791661|20807910|P1|COMPLETED|7 Day Wash-out||8
8443721|NCT00791661|20807908|P3|STARTED|7 Day Wash-out||8
8443722|NCT00791661|20807909|P2|STARTED|7 Day Wash-out||8
8443723|NCT00791661|20807910|P1|STARTED|7 Day Wash-out||8
8443724|NCT00791661|20807908|P3|NOT COMPLETED|Period 1||0
8443725|NCT00791661|20807909|P2|NOT COMPLETED|Period 1||0
8443726|NCT00791661|20807910|P1|NOT COMPLETED|Period 1||0
8443727|NCT00791661|20807908|P3|COMPLETED|Period 1||8
8443728|NCT00791661|20807909|P2|COMPLETED|Period 1||8
8443729|NCT00791661|20807910|P1|COMPLETED|Period 1||8
8443730|NCT00791661|20807908|P3|Received Matching Placebo to MK-1006|Period 1||2
8443731|NCT00791661|20807909|P2|Received Matching Placebo to MK-1006|Period 1||2
8443732|NCT00791661|20807910|P1|Received Matching Placebo to MK-1006|Period 1||2
8443733|NCT00791661|20807908|P3|Received MK-1006|Period 1||6
8443734|NCT00791661|20807909|P2|Received MK-1006|Period 1||6
8443735|NCT00791661|20807910|P1|Received MK-1006|Period 1||6
8443736|NCT00791661|20807908|P3|STARTED|Period 1||8
8443737|NCT00791661|20807909|P2|STARTED|Period 1||8
8443738|NCT00791661|20807910|P1|STARTED|Period 1||8
8443739|NCT00791648|20808003|P2|NOT COMPLETED|Overall Study||2
8443740|NCT00791648|20808004|P1|NOT COMPLETED|Overall Study||0
8443741|NCT00791648|20808003|P2|COMPLETED|Overall Study||307
8443742|NCT00791648|20808004|P1|COMPLETED|Overall Study||308
8443743|NCT00791648|20808003|P2|STARTED|Overall Study||309
8443744|NCT00791648|20808004|P1|STARTED|Overall Study||308
8443745|NCT00791557|20808040|P1|NOT COMPLETED|Overall Study||1
8443746|NCT00791557|20808040|P1|COMPLETED|Overall Study||1
8443747|NCT00791557|20808040|P1|STARTED|Overall Study||2
8443748|NCT00791518|20808044|P1|NOT COMPLETED|Overall Study||93
8443749|NCT00791518|20808044|P1|COMPLETED|Overall Study||991
8443750|NCT00791518|20808044|P1|STARTED|Overall Study||1084
8443751|NCT00791492|20808072|P2|NOT COMPLETED|Overall Study||3
8443752|NCT00791492|20808073|P1|NOT COMPLETED|Overall Study||6
8443753|NCT00791492|20808072|P2|COMPLETED|Overall Study||38
8443754|NCT00791492|20808073|P1|COMPLETED|Overall Study||39
8443755|NCT00791492|20808072|P2|TREATED|Overall Study||41
8443756|NCT00791492|20808073|P1|TREATED|Overall Study||44
8443757|NCT00791492|20808072|P2|STARTED|Overall Study||41
8443758|NCT00791492|20808073|P1|STARTED|Overall Study||45
8443759|NCT00791479|20808121|P6|NOT COMPLETED|Overall Study||3
8443760|NCT00791479|20808122|P5|NOT COMPLETED|Overall Study||3
8443761|NCT00791479|20808123|P4|NOT COMPLETED|Overall Study||4
8443762|NCT00791479|20808124|P3|NOT COMPLETED|Overall Study||0
8443763|NCT00791479|20808125|P2|NOT COMPLETED|Overall Study||3
8443764|NCT00791479|20808126|P1|NOT COMPLETED|Overall Study||2
8443765|NCT00791479|20808121|P6|COMPLETED|Overall Study||29
8443766|NCT00791479|20808122|P5|COMPLETED|Overall Study||0
8443767|NCT00791479|20808123|P4|COMPLETED|Overall Study||25
8443768|NCT00791479|20808124|P3|COMPLETED|Overall Study||34
8443769|NCT00791479|20808125|P2|COMPLETED|Overall Study||31
8443770|NCT00791479|20808126|P1|COMPLETED|Overall Study||33
8443771|NCT00791479|20808121|P6|Received at Least One Dose of Study Drug|Overall Study||32
8443772|NCT00791479|20808122|P5|Received at Least One Dose of Study Drug|Overall Study||3
8443773|NCT00791479|20808123|P4|Received at Least One Dose of Study Drug|Overall Study||29
8443774|NCT00791479|20808124|P3|Received at Least One Dose of Study Drug|Overall Study||34
8443775|NCT00791479|20808125|P2|Received at Least One Dose of Study Drug|Overall Study||34
8443776|NCT00791479|20808126|P1|Received at Least One Dose of Study Drug|Overall Study||35
8443777|NCT00791479|20808121|P6|STARTED|Overall Study||32
8443778|NCT00791479|20808122|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
8443779|NCT00791479|20808123|P4|STARTED|Overall Study||29
8443780|NCT00791479|20808124|P3|STARTED|Overall Study||34
8443781|NCT00791479|20808125|P2|STARTED|Overall Study||34
8443782|NCT00791479|20808126|P1|STARTED|Overall Study||35
8443783|NCT00791388|20808225|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
8443784|NCT00791388|20808226|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443785|NCT00791388|20808227|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443786|NCT00791388|20808228|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443787|NCT00791388|20808229|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443788|NCT00791388|20808225|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
8443789|NCT00791388|20808226|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
8443790|NCT00791388|20808227|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
8443791|NCT00791388|20808228|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
8443792|NCT00791388|20808229|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
8443793|NCT00791388|20808225|P5|STARTED|Period 4 - 400 mg Dose Group||8
8443794|NCT00791388|20808226|P4|STARTED|Period 4 - 400 mg Dose Group||0
8443795|NCT00791388|20808227|P3|STARTED|Period 4 - 400 mg Dose Group||0
8443796|NCT00791388|20808228|P2|STARTED|Period 4 - 400 mg Dose Group||0
8443797|NCT00791388|20808229|P1|STARTED|Period 4 - 400 mg Dose Group||4
8443798|NCT00791388|20808225|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443799|NCT00791388|20808226|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443800|NCT00791388|20808227|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443801|NCT00791388|20808228|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443802|NCT00791388|20808229|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443803|NCT00791388|20808225|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
8443804|NCT00791388|20808226|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
8443805|NCT00791388|20808227|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
8443806|NCT00791388|20808228|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
8443807|NCT00791388|20808229|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
8443808|NCT00791388|20808225|P5|STARTED|Period 3 - 200 mg Dose Group||0
8443809|NCT00791388|20808226|P4|STARTED|Period 3 - 200 mg Dose Group||8
8443810|NCT00791388|20808227|P3|STARTED|Period 3 - 200 mg Dose Group||0
8443811|NCT00791388|20808228|P2|STARTED|Period 3 - 200 mg Dose Group||0
8443812|NCT00791388|20808229|P1|STARTED|Period 3 - 200 mg Dose Group||3
8443813|NCT00791388|20808225|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443814|NCT00791388|20808226|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443815|NCT00791388|20808227|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443816|NCT00791388|20808228|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443817|NCT00791388|20808229|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
8443818|NCT00791388|20808225|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
8443819|NCT00791388|20808226|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
8443820|NCT00791388|20808227|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
8443821|NCT00791388|20808228|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
8443822|NCT00791388|20808229|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
8443823|NCT00791388|20808225|P5|STARTED|Period 2 - 100 mg Dose Group||0
8443824|NCT00791388|20808226|P4|STARTED|Period 2 - 100 mg Dose Group||0
8443825|NCT00791388|20808227|P3|STARTED|Period 2 - 100 mg Dose Group||8
8443826|NCT00791388|20808228|P2|STARTED|Period 2 - 100 mg Dose Group||0
8443827|NCT00791388|20808229|P1|STARTED|Period 2 - 100 mg Dose Group||3
8443828|NCT00791388|20808225|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443829|NCT00791388|20808226|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443830|NCT00791388|20808227|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443831|NCT00791388|20808228|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
8443832|NCT00791388|20808229|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443833|NCT00791388|20808225|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
8443834|NCT00791388|20808226|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
8443835|NCT00791388|20808227|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
8443836|NCT00791388|20808228|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
8443837|NCT00791388|20808229|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
8443838|NCT00791388|20808225|P5|STARTED|Period 1 - 50 mg Dose Group||0
8443839|NCT00791388|20808226|P4|STARTED|Period 1 - 50 mg Dose Group||0
8443840|NCT00791388|20808227|P3|STARTED|Period 1 - 50 mg Dose Group||0
8443841|NCT00791388|20808228|P2|STARTED|Period 1 - 50 mg Dose Group||8
8443842|NCT00791388|20808229|P1|STARTED|Period 1 - 50 mg Dose Group||3
8443843|NCT00791336|20808256|P1|NOT COMPLETED|Overall Study||0
8443844|NCT00791336|20808256|P1|COMPLETED|Overall Study||1
8443845|NCT00791336|20808256|P1|STARTED|Overall Study||1
8443846|NCT00791323|20808264|P2|NOT COMPLETED|Overall Study||0
8443847|NCT00791323|20808265|P1|NOT COMPLETED|Overall Study||0
8443848|NCT00791323|20808264|P2|COMPLETED|Overall Study||3
8443849|NCT00791323|20808265|P1|COMPLETED|Overall Study||6
8443850|NCT00791323|20808264|P2|STARTED|Overall Study||3
8443851|NCT00791323|20808265|P1|STARTED|Overall Study||6
8443852|NCT00791258|20808271|P1|NOT COMPLETED|Overall Study||263
8443853|NCT00791258|20808271|P1|COMPLETED|Overall Study||736
8443854|NCT00791258|20808271|P1|STARTED|Overall Study||999
8443855|NCT00791219|20808336|P3|NOT COMPLETED|Overall Study||14
8443856|NCT00791219|20808337|P2|NOT COMPLETED|Overall Study||16
8443857|NCT00791219|20808338|P1|NOT COMPLETED|Overall Study||5
8443858|NCT00791219|20808336|P3|COMPLETED|Overall Study||61
8443859|NCT00791219|20808337|P2|COMPLETED|Overall Study||60
8443860|NCT00791219|20808338|P1|COMPLETED|Overall Study||19
8443861|NCT00791219|20808336|P3|STARTED|Overall Study||75
8443862|NCT00791219|20808337|P2|STARTED|Overall Study||76
8443863|NCT00791219|20808338|P1|STARTED|Overall Study||24
8443864|NCT00791128|20808364|P1|NOT COMPLETED|Overall Study||9
8443865|NCT00791128|20808364|P1|COMPLETED|Overall Study||13
8443866|NCT00791128|20808364|P1|STARTED|Overall Study||22
8443867|NCT00791102|20808369|P2|NOT COMPLETED|Period 2||0
8443868|NCT00791102|20808370|P1|NOT COMPLETED|Period 2||0
8443869|NCT00791102|20808369|P2|COMPLETED|Period 2||10
8443870|NCT00791102|20808370|P1|COMPLETED|Period 2||10
8443871|NCT00791102|20808369|P2|STARTED|Period 2||10
8443872|NCT00791102|20808370|P1|STARTED|Period 2||10
8443873|NCT00791102|20808369|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8443874|NCT00791102|20808370|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8443875|NCT00791102|20808369|P2|COMPLETED|Washout Period of 2 Weeks||10
8443876|NCT00791102|20808370|P1|COMPLETED|Washout Period of 2 Weeks||10
8443877|NCT00791102|20808369|P2|STARTED|Washout Period of 2 Weeks||10
8443878|NCT00791102|20808370|P1|STARTED|Washout Period of 2 Weeks||10
8443879|NCT00791102|20808369|P2|NOT COMPLETED|Period 1||0
8443880|NCT00791102|20808370|P1|NOT COMPLETED|Period 1||0
8443881|NCT00791102|20808369|P2|COMPLETED|Period 1||10
8443882|NCT00791102|20808370|P1|COMPLETED|Period 1||10
8443883|NCT00791102|20808369|P2|STARTED|Period 1||10
8443884|NCT00791102|20808370|P1|STARTED|Period 1||10
8443885|NCT00791089|20808388|P2|NOT COMPLETED|Overall Study||6
8443886|NCT00791089|20808389|P1|NOT COMPLETED|Overall Study||6
8443887|NCT00791089|20808388|P2|COMPLETED|Overall Study||0
8443888|NCT00791089|20808389|P1|COMPLETED|Overall Study||0
8443889|NCT00791089|20808388|P2|Six-month Data Collected|Overall Study||5
8443890|NCT00791089|20808389|P1|Six-month Data Collected|Overall Study||6
8443891|NCT00791089|20808388|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
8443892|NCT00791089|20808389|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
8443893|NCT00791089|20808388|P2|STARTED|Overall Study||6
8443894|NCT00791089|20808389|P1|STARTED|Overall Study||6
8443895|NCT00791076|20808395|P1|NOT COMPLETED|Overall Study||8
8443896|NCT00791076|20808395|P1|COMPLETED|Overall Study||0
8443897|NCT00791076|20808395|P1|STARTED|Overall Study||8
8443898|NCT00791037|20808403|P1|NOT COMPLETED|Overall Study||0
8443899|NCT00791037|20808403|P1|COMPLETED|Overall Study||23
8443900|NCT00791037|20808403|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
8443901|NCT00791037|20808403|P1|Primary Outcome|Overall Study||19
8443902|NCT00791037|20808403|P1|STARTED|Overall Study||23
8443903|NCT00790933|20808415|P5|NOT COMPLETED|Overall Study||276
8443904|NCT00790933|20808416|P4|NOT COMPLETED|Overall Study||14
8443905|NCT00790933|20808417|P3|NOT COMPLETED|Overall Study||269
8443906|NCT00790933|20808418|P2|NOT COMPLETED|Overall Study||480
8443907|NCT00790933|20808419|P1|NOT COMPLETED|Overall Study||438
8443908|NCT00790933|20808415|P5|COMPLETED|Overall Study||145
8443909|NCT00790933|20808416|P4|COMPLETED|Overall Study||23
8443910|NCT00790933|20808417|P3|COMPLETED|Overall Study||115
8443911|NCT00790933|20808418|P2|COMPLETED|Overall Study||246
8443912|NCT00790933|20808419|P1|COMPLETED|Overall Study||237
8443913|NCT00790933|20808415|P5|STARTED|Overall Study||421
8443914|NCT00790933|20808416|P4|STARTED|Overall Study||37
8443915|NCT00790933|20808417|P3|STARTED|Overall Study||384
8443916|NCT00790933|20808418|P2|STARTED|Overall Study||726
8443917|NCT00790933|20808419|P1|STARTED|Overall Study||675
8443918|NCT00790907|20808950|P3|NOT COMPLETED|Overall Study||339
8443919|NCT00790907|20808951|P2|NOT COMPLETED|Overall Study||340
8443920|NCT00790907|20808952|P1|NOT COMPLETED|Overall Study||455
8443921|NCT00790907|20808950|P3|COMPLETED|Overall Study||663
8443922|NCT00790907|20808951|P2|COMPLETED|Overall Study||684
8443923|NCT00790907|20808952|P1|COMPLETED|Overall Study||754
8443924|NCT00790907|20808950|P3|STARTED|Overall Study||1002
8443925|NCT00790907|20808951|P2|STARTED|Overall Study||1024
8443926|NCT00790907|20808952|P1|STARTED|Overall Study||1209
8443927|NCT00790868|20808975|P2|NOT COMPLETED|Overall Study||17
8443928|NCT00790868|20808976|P1|NOT COMPLETED|Overall Study||6
8443929|NCT00790868|20808975|P2|COMPLETED|Overall Study||75
8443930|NCT00790868|20808976|P1|COMPLETED|Overall Study||82
8443931|NCT00790868|20808975|P2|STARTED|Overall Study||92
8443932|NCT00790868|20808976|P1|STARTED|Overall Study||88
8443933|NCT00790855|20808990|P1|NOT COMPLETED|Overall Study||0
8443934|NCT00790855|20808990|P1|COMPLETED|Overall Study||25
8443935|NCT00790855|20808990|P1|STARTED|Overall Study||25
8443936|NCT00790842|20808998|P11|NOT COMPLETED|Expansion Cohort||0
8443937|NCT00790842|20808999|P10|NOT COMPLETED|Expansion Cohort||0
8443938|NCT00790842|20809000|P9|NOT COMPLETED|Expansion Cohort||0
8443939|NCT00790842|20809001|P8|NOT COMPLETED|Expansion Cohort||0
8443940|NCT00790842|20809002|P7|NOT COMPLETED|Expansion Cohort||1
8443941|NCT00790842|20809003|P6|NOT COMPLETED|Expansion Cohort||0
8443942|NCT00790842|20809004|P5|NOT COMPLETED|Expansion Cohort||0
8443943|NCT00790842|20809005|P4|NOT COMPLETED|Expansion Cohort||0
8443944|NCT00790842|20809006|P3|NOT COMPLETED|Expansion Cohort||7
8443945|NCT00790842|20809007|P2|NOT COMPLETED|Expansion Cohort||0
8443946|NCT00790842|20809008|P1|NOT COMPLETED|Expansion Cohort||0
8443947|NCT00790842|20808998|P11|COMPLETED|Expansion Cohort||0
8443948|NCT00790842|20808999|P10|COMPLETED|Expansion Cohort||0
8443949|NCT00790842|20809000|P9|COMPLETED|Expansion Cohort||0
8443950|NCT00790842|20809001|P8|COMPLETED|Expansion Cohort||0
8443951|NCT00790842|20809002|P7|COMPLETED|Expansion Cohort||1
8443952|NCT00790842|20809003|P6|COMPLETED|Expansion Cohort||0
8443953|NCT00790842|20809004|P5|COMPLETED|Expansion Cohort||0
8443954|NCT00790842|20809005|P4|COMPLETED|Expansion Cohort||0
8443955|NCT00790842|20809006|P3|COMPLETED|Expansion Cohort||7
8443956|NCT00790842|20809007|P2|COMPLETED|Expansion Cohort||0
8443957|NCT00790842|20809008|P1|COMPLETED|Expansion Cohort||0
8443958|NCT00790842|20808998|P11|Began Treatment|Expansion Cohort||0
8443959|NCT00790842|20808999|P10|Began Treatment|Expansion Cohort||0
8443960|NCT00790842|20809000|P9|Began Treatment|Expansion Cohort||0
8443961|NCT00790842|20809001|P8|Began Treatment|Expansion Cohort||0
8443962|NCT00790842|20809002|P7|Began Treatment|Expansion Cohort||2
8443963|NCT00790842|20809003|P6|Began Treatment|Expansion Cohort||0
8443964|NCT00790842|20809004|P5|Began Treatment|Expansion Cohort||0
8443965|NCT00790842|20809005|P4|Began Treatment|Expansion Cohort||0
8443966|NCT00790842|20809006|P3|Began Treatment|Expansion Cohort||14
8443967|NCT00790842|20809007|P2|Began Treatment|Expansion Cohort||0
8443968|NCT00790842|20809008|P1|Began Treatment|Expansion Cohort||0
8443969|NCT00790842|20808998|P11|STARTED|Expansion Cohort||0
8443970|NCT00790842|20808999|P10|STARTED|Expansion Cohort||0
8443971|NCT00790842|20809000|P9|STARTED|Expansion Cohort||0
8443972|NCT00790842|20809001|P8|STARTED|Expansion Cohort||0
8443973|NCT00790842|20809002|P7|STARTED|Expansion Cohort||2
8443974|NCT00790842|20809003|P6|STARTED|Expansion Cohort||0
8443975|NCT00790842|20809004|P5|STARTED|Expansion Cohort||0
8443976|NCT00790842|20809005|P4|STARTED|Expansion Cohort||0
8443977|NCT00790842|20809006|P3|STARTED|Expansion Cohort||14
8443978|NCT00790842|20809007|P2|STARTED|Expansion Cohort||0
8443979|NCT00790842|20809008|P1|STARTED|Expansion Cohort||0
8443980|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 4||2
8443981|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 4||0
8443982|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 4||0
8443983|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 4||0
8443984|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 4||2
8443985|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 4||0
8443986|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 4||0
8443987|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 4||0
8443988|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 4||0
8443989|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 4||0
8443990|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 4||0
8443991|NCT00790842|20808998|P11|COMPLETED|Dose Level 4||3
8443992|NCT00790842|20808999|P10|COMPLETED|Dose Level 4||0
8443993|NCT00790842|20809000|P9|COMPLETED|Dose Level 4||0
8443994|NCT00790842|20809001|P8|COMPLETED|Dose Level 4||0
8443995|NCT00790842|20809002|P7|COMPLETED|Dose Level 4||6
8443996|NCT00790842|20809003|P6|COMPLETED|Dose Level 4||0
8443997|NCT00790842|20809004|P5|COMPLETED|Dose Level 4||0
8443998|NCT00790842|20809005|P4|COMPLETED|Dose Level 4||0
8443999|NCT00790842|20809006|P3|COMPLETED|Dose Level 4||0
8444000|NCT00790842|20809007|P2|COMPLETED|Dose Level 4||0
8444001|NCT00790842|20809008|P1|COMPLETED|Dose Level 4||0
8444002|NCT00790842|20808998|P11|Began Treatment|Dose Level 4||5
8444003|NCT00790842|20808999|P10|Began Treatment|Dose Level 4||0
8444004|NCT00790842|20809000|P9|Began Treatment|Dose Level 4||0
8444005|NCT00790842|20809001|P8|Began Treatment|Dose Level 4||0
8444006|NCT00790842|20809002|P7|Began Treatment|Dose Level 4||8
8444007|NCT00790842|20809003|P6|Began Treatment|Dose Level 4||0
8444008|NCT00790842|20809004|P5|Began Treatment|Dose Level 4||0
8444009|NCT00790842|20809005|P4|Began Treatment|Dose Level 4||0
8444010|NCT00790842|20809006|P3|Began Treatment|Dose Level 4||0
8444011|NCT00790842|20809007|P2|Began Treatment|Dose Level 4||0
8444012|NCT00790842|20809008|P1|Began Treatment|Dose Level 4||0
8444013|NCT00790842|20808998|P11|STARTED|Dose Level 4||5
8444014|NCT00790842|20808999|P10|STARTED|Dose Level 4||0
8444015|NCT00790842|20809000|P9|STARTED|Dose Level 4||0
8444016|NCT00790842|20809001|P8|STARTED|Dose Level 4||0
8444017|NCT00790842|20809002|P7|STARTED|Dose Level 4||8
8444018|NCT00790842|20809003|P6|STARTED|Dose Level 4||0
8444019|NCT00790842|20809004|P5|STARTED|Dose Level 4||0
8444020|NCT00790842|20809005|P4|STARTED|Dose Level 4||0
8444021|NCT00790842|20809006|P3|STARTED|Dose Level 4||0
8444022|NCT00790842|20809007|P2|STARTED|Dose Level 4||0
8444023|NCT00790842|20809008|P1|STARTED|Dose Level 4||0
8444024|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 3||0
8444025|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 3||2
8444026|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 3||0
8444027|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 3||0
8444028|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 3||0
8444029|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 3||1
8444030|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 3||0
8444031|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 3||0
8444032|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 3||5
8444033|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 3||0
8444034|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 3||0
8444035|NCT00790842|20808998|P11|COMPLETED|Dose Level 3||0
8444036|NCT00790842|20808999|P10|COMPLETED|Dose Level 3||1
8444037|NCT00790842|20809000|P9|COMPLETED|Dose Level 3||0
8444038|NCT00790842|20809001|P8|COMPLETED|Dose Level 3||0
8444039|NCT00790842|20809002|P7|COMPLETED|Dose Level 3||0
8444040|NCT00790842|20809003|P6|COMPLETED|Dose Level 3||2
8444041|NCT00790842|20809004|P5|COMPLETED|Dose Level 3||0
8444042|NCT00790842|20809005|P4|COMPLETED|Dose Level 3||0
8444043|NCT00790842|20809006|P3|COMPLETED|Dose Level 3||2
8444044|NCT00790842|20809007|P2|COMPLETED|Dose Level 3||0
8444045|NCT00790842|20809008|P1|COMPLETED|Dose Level 3||0
8444046|NCT00790842|20808998|P11|Began Treatment|Dose Level 3||0
8444047|NCT00790842|20808999|P10|Began Treatment|Dose Level 3||3
8444048|NCT00790842|20809000|P9|Began Treatment|Dose Level 3||0
8444049|NCT00790842|20809001|P8|Began Treatment|Dose Level 3||0
8444050|NCT00790842|20809002|P7|Began Treatment|Dose Level 3||0
8444051|NCT00790842|20809003|P6|Began Treatment|Dose Level 3||3
8444052|NCT00790842|20809004|P5|Began Treatment|Dose Level 3||0
8444053|NCT00790842|20809005|P4|Began Treatment|Dose Level 3||0
8444054|NCT00790842|20809006|P3|Began Treatment|Dose Level 3||6
8444055|NCT00790842|20809007|P2|Began Treatment|Dose Level 3||0
8444056|NCT00790842|20809008|P1|Began Treatment|Dose Level 3||0
8444057|NCT00790842|20808998|P11|STARTED|Dose Level 3||0
8444058|NCT00790842|20808999|P10|STARTED|Dose Level 3||3
8444059|NCT00790842|20809000|P9|STARTED|Dose Level 3||0
8444060|NCT00790842|20809001|P8|STARTED|Dose Level 3||0
8444061|NCT00790842|20809002|P7|STARTED|Dose Level 3||0
8444062|NCT00790842|20809003|P6|STARTED|Dose Level 3||3
8444063|NCT00790842|20809004|P5|STARTED|Dose Level 3||0
8444064|NCT00790842|20809005|P4|STARTED|Dose Level 3||0
8444065|NCT00790842|20809006|P3|STARTED|Dose Level 3||7
8444066|NCT00790842|20809007|P2|STARTED|Dose Level 3||0
8444067|NCT00790842|20809008|P1|STARTED|Dose Level 3||0
8444068|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 2||0
8444069|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 2||0
8444070|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 2||2
8444071|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 2||0
8444072|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 2||0
8444073|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 2||0
8444074|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 2||1
8444075|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 2||0
8444076|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 2||0
8444077|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 2||3
8444078|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 2||0
8444079|NCT00790842|20808998|P11|COMPLETED|Dose Level 2||0
8444080|NCT00790842|20808999|P10|COMPLETED|Dose Level 2||0
8444081|NCT00790842|20809000|P9|COMPLETED|Dose Level 2||1
8444082|NCT00790842|20809001|P8|COMPLETED|Dose Level 2||0
8444083|NCT00790842|20809002|P7|COMPLETED|Dose Level 2||0
8444084|NCT00790842|20809003|P6|COMPLETED|Dose Level 2||0
8444085|NCT00790842|20809004|P5|COMPLETED|Dose Level 2||2
8444086|NCT00790842|20809005|P4|COMPLETED|Dose Level 2||0
8444087|NCT00790842|20809006|P3|COMPLETED|Dose Level 2||0
8444088|NCT00790842|20809007|P2|COMPLETED|Dose Level 2||0
8444089|NCT00790842|20809008|P1|COMPLETED|Dose Level 2||0
8444090|NCT00790842|20808998|P11|Began Treatment|Dose Level 2||0
8444091|NCT00790842|20808999|P10|Began Treatment|Dose Level 2||0
8444092|NCT00790842|20809000|P9|Began Treatment|Dose Level 2||3
8444093|NCT00790842|20809001|P8|Began Treatment|Dose Level 2||0
8444094|NCT00790842|20809002|P7|Began Treatment|Dose Level 2||0
8444095|NCT00790842|20809003|P6|Began Treatment|Dose Level 2||0
8444096|NCT00790842|20809004|P5|Began Treatment|Dose Level 2||3
8444097|NCT00790842|20809005|P4|Began Treatment|Dose Level 2||0
8444098|NCT00790842|20809006|P3|Began Treatment|Dose Level 2||0
8444099|NCT00790842|20809007|P2|Began Treatment|Dose Level 2||3
8444100|NCT00790842|20809008|P1|Began Treatment|Dose Level 2||0
8444101|NCT00790842|20808998|P11|STARTED|Dose Level 2||0
8444102|NCT00790842|20808999|P10|STARTED|Dose Level 2||0
8444103|NCT00790842|20809000|P9|STARTED|Dose Level 2||3
8444104|NCT00790842|20809001|P8|STARTED|Dose Level 2||0
8444105|NCT00790842|20809002|P7|STARTED|Dose Level 2||0
8444106|NCT00790842|20809003|P6|STARTED|Dose Level 2||0
8444107|NCT00790842|20809004|P5|STARTED|Dose Level 2||3
8444108|NCT00790842|20809005|P4|STARTED|Dose Level 2||0
8444109|NCT00790842|20809006|P3|STARTED|Dose Level 2||0
8444110|NCT00790842|20809007|P2|STARTED|Dose Level 2||3
8444111|NCT00790842|20809008|P1|STARTED|Dose Level 2||0
8444112|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 1||0
8444113|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 1||0
8444114|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 1||0
8444115|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 1||2
8444116|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 1||0
8444117|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 1||0
8444118|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 1||0
8444119|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 1||2
8444120|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 1||0
8444121|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 1||0
8444122|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 1||3
8444123|NCT00790842|20808998|P11|COMPLETED|Dose Level 1||0
8444124|NCT00790842|20808999|P10|COMPLETED|Dose Level 1||0
8444125|NCT00790842|20809000|P9|COMPLETED|Dose Level 1||0
8444126|NCT00790842|20809001|P8|COMPLETED|Dose Level 1||1
8444127|NCT00790842|20809002|P7|COMPLETED|Dose Level 1||0
8444128|NCT00790842|20809003|P6|COMPLETED|Dose Level 1||0
8444129|NCT00790842|20809004|P5|COMPLETED|Dose Level 1||0
8444130|NCT00790842|20809005|P4|COMPLETED|Dose Level 1||1
8444131|NCT00790842|20809006|P3|COMPLETED|Dose Level 1||0
8444132|NCT00790842|20809007|P2|COMPLETED|Dose Level 1||0
8444133|NCT00790842|20809008|P1|COMPLETED|Dose Level 1||3
8444134|NCT00790842|20808998|P11|Began Treatment|Dose Level 1||0
8444135|NCT00790842|20808999|P10|Began Treatment|Dose Level 1||0
8444136|NCT00790842|20809000|P9|Began Treatment|Dose Level 1||0
8444137|NCT00790842|20809001|P8|Began Treatment|Dose Level 1||3
8444138|NCT00790842|20809002|P7|Began Treatment|Dose Level 1||0
8444139|NCT00790842|20809003|P6|Began Treatment|Dose Level 1||0
8444140|NCT00790842|20809004|P5|Began Treatment|Dose Level 1||0
8444141|NCT00790842|20809005|P4|Began Treatment|Dose Level 1||3
8444142|NCT00790842|20809006|P3|Began Treatment|Dose Level 1||0
8444143|NCT00790842|20809007|P2|Began Treatment|Dose Level 1||0
8444144|NCT00790842|20809008|P1|Began Treatment|Dose Level 1||6
8444145|NCT00790842|20808998|P11|STARTED|Dose Level 1||0
8444146|NCT00790842|20808999|P10|STARTED|Dose Level 1||0
8444147|NCT00790842|20809000|P9|STARTED|Dose Level 1||0
8444148|NCT00790842|20809001|P8|STARTED|Dose Level 1||3
8444149|NCT00790842|20809002|P7|STARTED|Dose Level 1||0
8444150|NCT00790842|20809003|P6|STARTED|Dose Level 1||0
8444151|NCT00790842|20809004|P5|STARTED|Dose Level 1||0
8444152|NCT00790842|20809005|P4|STARTED|Dose Level 1||3
8444153|NCT00790842|20809006|P3|STARTED|Dose Level 1||0
8444154|NCT00790842|20809007|P2|STARTED|Dose Level 1||0
8444155|NCT00790842|20809008|P1|STARTED|Dose Level 1||6
8444156|NCT00790803|20809065|P1|NOT COMPLETED|Overall Study||0
8444157|NCT00790803|20809065|P1|COMPLETED|Overall Study||5
8444158|NCT00790803|20809065|P1|STARTED|Overall Study||5
8444159|NCT00790790|20809076|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8444160|NCT00790790|20809077|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8444161|NCT00790790|20809078|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8444162|NCT00790790|20809076|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
8444163|NCT00790790|20809077|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
8444164|NCT00790790|20809078|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
8444165|NCT00790790|20809076|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
8444166|NCT00790790|20809077|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
8444167|NCT00790790|20809078|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
8444168|NCT00790790|20809076|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
8444169|NCT00790790|20809077|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
8444170|NCT00790790|20809078|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
8444171|NCT00790790|20809076|P3|COMPLETED|Study Period 2: Therapy Phase||27
8444172|NCT00790790|20809077|P2|COMPLETED|Study Period 2: Therapy Phase||32
8444173|NCT00790790|20809078|P1|COMPLETED|Study Period 2: Therapy Phase||37
8444174|NCT00790790|20809076|P3|STARTED|Study Period 2: Therapy Phase||48
8444175|NCT00790790|20809077|P2|STARTED|Study Period 2: Therapy Phase||50
8444176|NCT00790790|20809078|P1|STARTED|Study Period 2: Therapy Phase||49
8444177|NCT00790751|20809155|P4|NOT COMPLETED|Overall Study||21
8444178|NCT00790751|20809156|P3|NOT COMPLETED|Overall Study||20
8444179|NCT00790751|20809157|P2|NOT COMPLETED|Overall Study||30
8444180|NCT00790751|20809158|P1|NOT COMPLETED|Overall Study||25
8444181|NCT00790751|20809155|P4|COMPLETED|Overall Study||141
8444182|NCT00790751|20809156|P3|COMPLETED|Overall Study||141
8444183|NCT00790751|20809157|P2|COMPLETED|Overall Study||131
8444184|NCT00790751|20809158|P1|COMPLETED|Overall Study||137
8444185|NCT00790751|20809155|P4|STARTED|Overall Study||162
8444186|NCT00790751|20809156|P3|STARTED|Overall Study||161
8444187|NCT00790751|20809157|P2|STARTED|Overall Study||161
8444188|NCT00790751|20809158|P1|STARTED|Overall Study||162
8444189|NCT00790738|20809178|P2|NOT COMPLETED|Overall Study||3
8444190|NCT00790738|20809179|P1|NOT COMPLETED|Overall Study||2
8444191|NCT00790738|20809178|P2|COMPLETED|Overall Study||3
8444192|NCT00790738|20809179|P1|COMPLETED|Overall Study||3
8444193|NCT00790738|20809178|P2|STARTED|Overall Study||6
8444194|NCT00790738|20809179|P1|STARTED|Overall Study||5
8444195|NCT00790699|20809191|P2|NOT COMPLETED|Overall Study||0
8444196|NCT00790699|20809192|P1|NOT COMPLETED|Overall Study||1
8444197|NCT00790699|20809191|P2|COMPLETED|Overall Study||14
8444198|NCT00790699|20809192|P1|COMPLETED|Overall Study||16
8444199|NCT00790699|20809191|P2|STARTED|Overall Study||14
8444200|NCT00790699|20809192|P1|STARTED|Overall Study||17
8444201|NCT00790673|20809204|P4|NOT COMPLETED|Overall Study||0
8444202|NCT00790673|20809205|P3|NOT COMPLETED|Overall Study||0
8444203|NCT00790673|20809206|P2|NOT COMPLETED|Overall Study||0
8444204|NCT00790673|20809207|P1|NOT COMPLETED|Overall Study||0
8444205|NCT00790673|20809204|P4|COMPLETED|Overall Study||8
8444206|NCT00790673|20809205|P3|COMPLETED|Overall Study||12
8444207|NCT00790673|20809206|P2|COMPLETED|Overall Study||6
8444208|NCT00790673|20809207|P1|COMPLETED|Overall Study||6
8444209|NCT00790673|20809204|P4|STARTED|Overall Study||8
8444210|NCT00790673|20809205|P3|STARTED|Overall Study||12
8444211|NCT00790673|20809206|P2|STARTED|Overall Study||6
8444212|NCT00790673|20809207|P1|STARTED|Overall Study||6
8444213|NCT00790647|20809217|P1|NOT COMPLETED|Overall Study||1
8444214|NCT00790647|20809217|P1|COMPLETED|Overall Study||9
8444215|NCT00790647|20809217|P1|STARTED|Overall Study||10
8444216|NCT00790582|20809226|P2|NOT COMPLETED|Overall Study||87
8444217|NCT00790582|20809227|P1|NOT COMPLETED|Overall Study||31
8444218|NCT00790582|20809226|P2|COMPLETED|Overall Study||162
8444219|NCT00790582|20809227|P1|COMPLETED|Overall Study||78
8444220|NCT00790582|20809226|P2|STARTED|Overall Study||249
8444221|NCT00790582|20809227|P1|STARTED|Overall Study||109
8444222|NCT00790569|20809238|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
8444223|NCT00790569|20809239|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
8444224|NCT00790569|20809240|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
8444225|NCT00790569|20809238|P3|COMPLETED|End of Study (12 Month Interview)||83
8444226|NCT00790569|20809239|P2|COMPLETED|End of Study (12 Month Interview)||26
8444227|NCT00790569|20809240|P1|COMPLETED|End of Study (12 Month Interview)||71
8444228|NCT00790569|20809238|P3|STARTED|End of Study (12 Month Interview)||133
8444229|NCT00790569|20809239|P2|STARTED|End of Study (12 Month Interview)||45
8444230|NCT00790569|20809240|P1|STARTED|End of Study (12 Month Interview)||137
8444231|NCT00790569|20809238|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
8444232|NCT00790569|20809239|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
8444233|NCT00790569|20809240|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
8444234|NCT00790569|20809238|P3|COMPLETED|End of Treatment (6 Month Interview)||107
8444235|NCT00790569|20809239|P2|COMPLETED|End of Treatment (6 Month Interview)||35
8444236|NCT00790569|20809240|P1|COMPLETED|End of Treatment (6 Month Interview)||115
8444237|NCT00790569|20809238|P3|STARTED|End of Treatment (6 Month Interview)||133
8444238|NCT00790569|20809239|P2|STARTED|End of Treatment (6 Month Interview)||45
8444239|NCT00790569|20809240|P1|STARTED|End of Treatment (6 Month Interview)||137
8444240|NCT00790556|20809281|P2|NOT COMPLETED|Treatment Period 2||0
8444241|NCT00790556|20809282|P1|NOT COMPLETED|Treatment Period 2||0
8444242|NCT00790556|20809281|P2|COMPLETED|Treatment Period 2||6
8444243|NCT00790556|20809282|P1|COMPLETED|Treatment Period 2||6
8444244|NCT00790556|20809281|P2|STARTED|Treatment Period 2||6
8444245|NCT00790556|20809282|P1|STARTED|Treatment Period 2||6
8444246|NCT00790556|20809281|P2|NOT COMPLETED|Washout After Period 1||0
8444247|NCT00790556|20809282|P1|NOT COMPLETED|Washout After Period 1||0
8444248|NCT00790556|20809281|P2|COMPLETED|Washout After Period 1||6
8444249|NCT00790556|20809282|P1|COMPLETED|Washout After Period 1||6
8444250|NCT00790556|20809281|P2|STARTED|Washout After Period 1||6
8444251|NCT00790556|20809282|P1|STARTED|Washout After Period 1||6
8444252|NCT00790556|20809281|P2|NOT COMPLETED|Treatment Period 1||0
8444253|NCT00790556|20809282|P1|NOT COMPLETED|Treatment Period 1||2
8444254|NCT00790556|20809281|P2|COMPLETED|Treatment Period 1||6
8444255|NCT00790556|20809282|P1|COMPLETED|Treatment Period 1||6
8444256|NCT00790556|20809281|P2|STARTED|Treatment Period 1||6
8444257|NCT00790556|20809282|P1|STARTED|Treatment Period 1||8
8444258|NCT00790452|20809294|P2|NOT COMPLETED|Overall Study||0
8444259|NCT00790452|20809295|P1|NOT COMPLETED|Overall Study||1
8444260|NCT00790452|20809294|P2|COMPLETED|Overall Study||0
8444261|NCT00790452|20809295|P1|COMPLETED|Overall Study||0
8444262|NCT00790452|20809294|P2|STARTED|Overall Study||0
8444263|NCT00790452|20809295|P1|STARTED|Overall Study||1
8444264|NCT00790400|20809303|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
8444265|NCT00790400|20809304|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
8444266|NCT00790400|20809303|P2|COMPLETED|Everolimus Period (Core or Extension)||0
8444267|NCT00790400|20809304|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
8444268|NCT00790400|20809303|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
8444269|NCT00790400|20809304|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
8444270|NCT00790400|20809303|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
8444271|NCT00790400|20809304|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
8444272|NCT00790400|20809303|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
8444273|NCT00790400|20809304|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
8444274|NCT00790400|20809303|P2|STARTED|Double-blind Period (Core Phase)||39
8444275|NCT00790400|20809304|P1|STARTED|Double-blind Period (Core Phase)||79
8444276|NCT00790335|20809333|P2|NOT COMPLETED|Overall Study||112
8444277|NCT00790335|20809334|P1|NOT COMPLETED|Overall Study||80
8444278|NCT00790335|20809333|P2|COMPLETED|Overall Study||243
8444279|NCT00790335|20809334|P1|COMPLETED|Overall Study||257
8444280|NCT00790335|20809333|P2|STARTED|Overall Study||355
8444281|NCT00790335|20809334|P1|STARTED|Overall Study||337
8444282|NCT00790296|20809394|P2|NOT COMPLETED|Overall Study||2
8444283|NCT00790296|20809395|P1|NOT COMPLETED|Overall Study||1
8444284|NCT00790296|20809394|P2|COMPLETED|Overall Study||4
8444285|NCT00790296|20809395|P1|COMPLETED|Overall Study||4
8444286|NCT00790296|20809394|P2|STARTED|Overall Study||6
8444287|NCT00790296|20809395|P1|STARTED|Overall Study||5
8444288|NCT00790270|20809404|P3|NOT COMPLETED|Overall Study||0
8444289|NCT00790270|20809405|P2|NOT COMPLETED|Overall Study||0
8444290|NCT00790270|20809406|P1|NOT COMPLETED|Overall Study||0
8444291|NCT00790270|20809404|P3|COMPLETED|Overall Study||20
8444292|NCT00790270|20809405|P2|COMPLETED|Overall Study||20
8444293|NCT00790270|20809406|P1|COMPLETED|Overall Study||21
8444294|NCT00790270|20809404|P3|STARTED|Overall Study||20
8444295|NCT00790270|20809405|P2|STARTED|Overall Study||20
8444296|NCT00790270|20809406|P1|STARTED|Overall Study||21
8444297|NCT00790218|20809417|P3|NOT COMPLETED|Overall Study||0
8444298|NCT00790218|20809418|P2|NOT COMPLETED|Overall Study||0
8444299|NCT00790218|20809419|P1|NOT COMPLETED|Overall Study||1
8444300|NCT00790218|20809417|P3|COMPLETED|Overall Study||7
8444301|NCT00790218|20809418|P2|COMPLETED|Overall Study||6
8444302|NCT00790218|20809419|P1|COMPLETED|Overall Study||5
8444303|NCT00790218|20809417|P3|STARTED|Overall Study||7
8444304|NCT00790218|20809418|P2|STARTED|Overall Study||6
8444305|NCT00790218|20809419|P1|STARTED|Overall Study||6
8444306|NCT00790205|20809429|P2|NOT COMPLETED|Overall Study||434
8444307|NCT00790205|20809430|P1|NOT COMPLETED|Overall Study||360
8444308|NCT00790205|20809429|P2|COMPLETED|Overall Study||6905
8444309|NCT00790205|20809430|P1|COMPLETED|Overall Study||6972
8444310|NCT00790205|20809429|P2|Treated|Overall Study||7274
8444311|NCT00790205|20809430|P1|Treated|Overall Study||7266
8444312|NCT00790205|20809429|P2|STARTED|Overall Study||7339
8444313|NCT00790205|20809430|P1|STARTED|Overall Study||7332
8444314|NCT00790192|20809474|P4|NOT COMPLETED|Overall Study||48
8444315|NCT00790192|20809475|P3|NOT COMPLETED|Overall Study||23
8444316|NCT00790192|20809476|P2|NOT COMPLETED|Overall Study||28
8444317|NCT00790192|20809477|P1|NOT COMPLETED|Overall Study||36
8444318|NCT00790192|20809474|P4|COMPLETED|Overall Study||74
8444319|NCT00790192|20809475|P3|COMPLETED|Overall Study||97
8444320|NCT00790192|20809476|P2|COMPLETED|Overall Study||93
8444321|NCT00790192|20809477|P1|COMPLETED|Overall Study||89
8444322|NCT00790192|20809474|P4|STARTED|Overall Study||122
8444323|NCT00790192|20809475|P3|STARTED|Overall Study||120
8444324|NCT00790192|20809476|P2|STARTED|Overall Study||121
8444325|NCT00790192|20809477|P1|STARTED|Overall Study||125
8444326|NCT00790088|20809491|P1|NOT COMPLETED|Overall Study||39
8444327|NCT00790088|20809491|P1|COMPLETED|Overall Study||235
8444328|NCT00790088|20809491|P1|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
8444329|NCT00790088|20809491|P1|STARTED|Overall Study||274
8444330|NCT00790062|20809504|P3|NOT COMPLETED|Overall Study||0
8444331|NCT00790062|20809505|P2|NOT COMPLETED|Overall Study||0
8444332|NCT00790062|20809506|P1|NOT COMPLETED|Overall Study||0
8444333|NCT00790062|20809504|P3|COMPLETED|Overall Study||658
8444334|NCT00790062|20809505|P2|COMPLETED|Overall Study||481
8444335|NCT00790062|20809506|P1|COMPLETED|Overall Study||659
8444336|NCT00790062|20809504|P3|STARTED|Overall Study||658
8444337|NCT00790062|20809505|P2|STARTED|Overall Study||481
8444338|NCT00790062|20809506|P1|STARTED|Overall Study||659
8444339|NCT00790036|20809537|P2|NOT COMPLETED|Overall Study||121
8444340|NCT00790036|20809538|P1|NOT COMPLETED|Overall Study||195
8444341|NCT00790036|20809537|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
8444342|NCT00790036|20809538|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
8444343|NCT00790036|20809537|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
8444344|NCT00790036|20809538|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
8444345|NCT00790036|20809537|P2|STARTED|Overall Study||370
8444346|NCT00790036|20809538|P1|STARTED|Overall Study||372
8444347|NCT00790023|20809552|P3|NOT COMPLETED|Overall Study||21
8444348|NCT00790023|20809553|P2|NOT COMPLETED|Overall Study||10
8444349|NCT00790023|20809554|P1|NOT COMPLETED|Overall Study||11
8444350|NCT00790023|20809552|P3|COMPLETED|Overall Study||214
8444351|NCT00790023|20809553|P2|COMPLETED|Overall Study||225
8444352|NCT00790023|20809554|P1|COMPLETED|Overall Study||226
8444353|NCT00790023|20809552|P3|STARTED|Overall Study||235
8444354|NCT00790023|20809553|P2|STARTED|Overall Study||235
8444355|NCT00790023|20809554|P1|STARTED|Overall Study||237
8444356|NCT00789997|20809644|P2|NOT COMPLETED|Overall Study||2
8444357|NCT00789997|20809645|P1|NOT COMPLETED|Overall Study||1
8444358|NCT00789997|20809644|P2|COMPLETED|Overall Study||38
8444359|NCT00789997|20809645|P1|COMPLETED|Overall Study||40
8444360|NCT00789997|20809644|P2|STARTED|Overall Study||40
8444361|NCT00789997|20809645|P1|STARTED|Overall Study||41
8444362|NCT00789958|20809653|P1|NOT COMPLETED|Overall Study||37
8444363|NCT00789958|20809653|P1|COMPLETED|Overall Study||68
8444364|NCT00789958|20809653|P1|Eligible and Analyzable|Overall Study||79
8444365|NCT00789958|20809653|P1|STARTED|Overall Study||105
8444366|NCT00789880|20809672|P6|NOT COMPLETED|Overall Study||0
8444367|NCT00789880|20809673|P5|NOT COMPLETED|Overall Study||3
8444368|NCT00789880|20809674|P4|NOT COMPLETED|Overall Study||1
8444369|NCT00789880|20809675|P3|NOT COMPLETED|Overall Study||0
8444370|NCT00789880|20809676|P2|NOT COMPLETED|Overall Study||1
8444371|NCT00789880|20809677|P1|NOT COMPLETED|Overall Study||1
8444372|NCT00789880|20809672|P6|COMPLETED|Overall Study||8
8444373|NCT00789880|20809673|P5|COMPLETED|Overall Study||15
8444374|NCT00789880|20809674|P4|COMPLETED|Overall Study||15
8444375|NCT00789880|20809675|P3|COMPLETED|Overall Study||8
8444376|NCT00789880|20809676|P2|COMPLETED|Overall Study||15
8444377|NCT00789880|20809677|P1|COMPLETED|Overall Study||15
8444378|NCT00789880|20809672|P6|STARTED|Overall Study||8
8444379|NCT00789880|20809673|P5|STARTED|Overall Study||18
8444380|NCT00789880|20809674|P4|STARTED|Overall Study||16
8444381|NCT00789880|20809675|P3|STARTED|Overall Study||8
8444382|NCT00789880|20809676|P2|STARTED|Overall Study||16
8444383|NCT00789880|20809677|P1|STARTED|Overall Study||16
8444384|NCT00789867|20809706|P3|NOT COMPLETED|Overall Study||0
8444385|NCT00789867|20809707|P2|NOT COMPLETED|Overall Study||0
8444386|NCT00789867|20809708|P1|NOT COMPLETED|Overall Study||0
8444387|NCT00789867|20809706|P3|COMPLETED|Overall Study||8
8444388|NCT00789867|20809707|P2|COMPLETED|Overall Study||10
8444389|NCT00789867|20809708|P1|COMPLETED|Overall Study||17
8444390|NCT00789867|20809706|P3|STARTED|Overall Study||8
8444391|NCT00789867|20809707|P2|STARTED|Overall Study||10
8444392|NCT00789867|20809708|P1|STARTED|Overall Study||17
8444393|NCT00789854|20809734|P3|NOT COMPLETED|Overall Study||47
8444394|NCT00789854|20809735|P2|NOT COMPLETED|Overall Study||35
8444395|NCT00789854|20809736|P1|NOT COMPLETED|Overall Study||49
8444396|NCT00789854|20809734|P3|COMPLETED|Overall Study||182
8444397|NCT00789854|20809735|P2|COMPLETED|Overall Study||196
8444398|NCT00789854|20809736|P1|COMPLETED|Overall Study||179
8444399|NCT00789854|20809734|P3|STARTED|Overall Study||229
8444400|NCT00789854|20809735|P2|STARTED|Overall Study||231
8444401|NCT00789854|20809736|P1|STARTED|Overall Study||228
8444402|NCT00789828|20809833|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
8444403|NCT00789828|20809834|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
8444404|NCT00789828|20809833|P2|COMPLETED|Open-label Extension Period (4 Years)||0
8444405|NCT00789828|20809834|P1|COMPLETED|Open-label Extension Period (4 Years)||82
8444406|NCT00789828|20809833|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
8444407|NCT00789828|20809834|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
8444408|NCT00789828|20809833|P2|NOT COMPLETED|Core Period (48 Weeks)||6
8444409|NCT00789828|20809834|P1|NOT COMPLETED|Core Period (48 Weeks)||0
8444410|NCT00789828|20809833|P2|COMPLETED|Core Period (48 Weeks)||33
8444411|NCT00789828|20809834|P1|COMPLETED|Core Period (48 Weeks)||78
8444412|NCT00789828|20809833|P2|STARTED|Core Period (48 Weeks)||39
8444413|NCT00789828|20809834|P1|STARTED|Core Period (48 Weeks)||78
8444414|NCT00789815|20809868|P2|NOT COMPLETED|Overall Study||1
8444415|NCT00789815|20809869|P1|NOT COMPLETED|Overall Study||7
8444416|NCT00789815|20809868|P2|COMPLETED|Overall Study||249
8444417|NCT00789815|20809869|P1|COMPLETED|Overall Study||243
8444418|NCT00789815|20809868|P2|STARTED|Overall Study||250
8444419|NCT00789815|20809869|P1|STARTED|Overall Study||250
8444420|NCT00789802|20809892|P3|NOT COMPLETED|Overall Study||6
8444421|NCT00789802|20809893|P2|NOT COMPLETED|Overall Study||7
8444422|NCT00789802|20809894|P1|NOT COMPLETED|Overall Study||10
8444423|NCT00789802|20809892|P3|COMPLETED|Overall Study||37
8444424|NCT00789802|20809893|P2|COMPLETED|Overall Study||35
8444425|NCT00789802|20809894|P1|COMPLETED|Overall Study||34
8444426|NCT00789802|20809892|P3|STARTED|Overall Study||43
8444427|NCT00789802|20809893|P2|STARTED|Overall Study||42
8444428|NCT00789802|20809894|P1|STARTED|Overall Study||44
8444429|NCT00789776|20809913|P2|NOT COMPLETED|Overall Study||1
8444430|NCT00789776|20809914|P1|NOT COMPLETED|Overall Study||0
8444431|NCT00789776|20809913|P2|COMPLETED|Overall Study||35
8444432|NCT00789776|20809914|P1|COMPLETED|Overall Study||5
8444433|NCT00789776|20809913|P2|STARTED|Overall Study||36
8444434|NCT00789776|20809914|P1|STARTED|Overall Study||5
8444435|NCT00789750|20809934|P2|NOT COMPLETED|Overall Study||60
8444436|NCT00789750|20809935|P1|NOT COMPLETED|Overall Study||59
8444437|NCT00789750|20809934|P2|COMPLETED|Overall Study||222
8444438|NCT00789750|20809935|P1|COMPLETED|Overall Study||221
8444439|NCT00789750|20809934|P2|Intent to Treat Set|Overall Study||276
8444440|NCT00789750|20809935|P1|Intent to Treat Set|Overall Study||271
8444441|NCT00789750|20809934|P2|Safety Set|Overall Study||277
8444442|NCT00789750|20809935|P1|Safety Set|Overall Study||274
8444443|NCT00789750|20809934|P2|Dropped During run-in Period|Overall Study||5
8444444|NCT00789750|20809935|P1|Dropped During run-in Period|Overall Study||6
8444445|NCT00789750|20809934|P2|STARTED|Overall Study||282
8444446|NCT00789750|20809935|P1|STARTED|Overall Study||280
8444447|NCT00789737|20809979|P2|NOT COMPLETED|Overall Study||55
8444448|NCT00789737|20809980|P1|NOT COMPLETED|Overall Study||48
8444449|NCT00789737|20809979|P2|COMPLETED|Overall Study||126
8444450|NCT00789737|20809980|P1|COMPLETED|Overall Study||128
8444451|NCT00789737|20809979|P2|STARTED|Overall Study||181
8444452|NCT00789737|20809980|P1|STARTED|Overall Study||176
8444453|NCT00789724|20810012|P2|NOT COMPLETED|Overall Study||0
8444454|NCT00789724|20810013|P1|NOT COMPLETED|Overall Study||0
8444455|NCT00789724|20810012|P2|COMPLETED|Overall Study||5
8444456|NCT00789724|20810013|P1|COMPLETED|Overall Study||5
8444457|NCT00789724|20810012|P2|STARTED|Overall Study||5
8444458|NCT00789724|20810013|P1|STARTED|Overall Study||5
8444459|NCT00789698|20810023|P4|NOT COMPLETED|Overall Study||52
8444460|NCT00789698|20810024|P3|NOT COMPLETED|Overall Study||27
8444461|NCT00789698|20810025|P2|NOT COMPLETED|Overall Study||33
8444462|NCT00789698|20810026|P1|NOT COMPLETED|Overall Study||40
8444463|NCT00789698|20810023|P4|COMPLETED|Overall Study||33
8444464|NCT00789698|20810024|P3|COMPLETED|Overall Study||29
8444465|NCT00789698|20810025|P2|COMPLETED|Overall Study||46
8444466|NCT00789698|20810026|P1|COMPLETED|Overall Study||32
8444467|NCT00789698|20810023|P4|STARTED|Overall Study||85
8444468|NCT00789698|20810024|P3|STARTED|Overall Study||56
8444469|NCT00789698|20810025|P2|STARTED|Overall Study||79
8444470|NCT00789698|20810026|P1|STARTED|Overall Study||72
8444471|NCT00789685|20810040|P1|NOT COMPLETED|Overall Study||12
8444472|NCT00789685|20810040|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
8444473|NCT00789685|20810040|P1|STARTED|Overall Study||37
8444474|NCT00789672|20810048|P2|NOT COMPLETED|Overall Study||0
8444475|NCT00789672|20810049|P1|NOT COMPLETED|Overall Study||0
8444476|NCT00789672|20810048|P2|COMPLETED|Overall Study||17
8444477|NCT00789672|20810049|P1|COMPLETED|Overall Study||16
8444478|NCT00789672|20810048|P2|STARTED|Overall Study||17
8444479|NCT00789672|20810049|P1|STARTED|Overall Study||16
8444480|NCT00789581|20810081|P2|NOT COMPLETED|Adjuvant Therapy||57
8444481|NCT00789581|20810082|P1|NOT COMPLETED|Adjuvant Therapy||40
8444482|NCT00789581|20810081|P2|COMPLETED|Adjuvant Therapy||234
8444483|NCT00789581|20810082|P1|COMPLETED|Adjuvant Therapy||255
8444484|NCT00789581|20810081|P2|STARTED|Adjuvant Therapy||291
8444485|NCT00789581|20810082|P1|STARTED|Adjuvant Therapy||295
8444486|NCT00789581|20810081|P2|NOT COMPLETED|AC Therapy||17
8444487|NCT00789581|20810082|P1|NOT COMPLETED|AC Therapy||11
8444488|NCT00789581|20810081|P2|COMPLETED|AC Therapy||291
8444489|NCT00789581|20810082|P1|COMPLETED|AC Therapy||295
8444490|NCT00789581|20810081|P2|STARTED|AC Therapy||308
8444491|NCT00789581|20810082|P1|STARTED|AC Therapy||306
8444492|NCT00789555|20810093|P3|NOT COMPLETED|Overall Study||159
8444493|NCT00789555|20810094|P2|NOT COMPLETED|Overall Study||139
8444494|NCT00789555|20810095|P1|NOT COMPLETED|Overall Study||159
8444495|NCT00789555|20810093|P3|COMPLETED|Overall Study||263
8444496|NCT00789555|20810094|P2|COMPLETED|Overall Study||278
8444497|NCT00789555|20810095|P1|COMPLETED|Overall Study||262
8444498|NCT00789555|20810093|P3|STARTED|Overall Study||422
8444499|NCT00789555|20810094|P2|STARTED|Overall Study||417
8444500|NCT00789555|20810095|P1|STARTED|Overall Study||421
8444501|NCT00789529|20810120|P2|NOT COMPLETED|Overall Study||1
8444502|NCT00789529|20810121|P1|NOT COMPLETED|Overall Study||1
8444503|NCT00789529|20810120|P2|COMPLETED|Overall Study||15
8444504|NCT00789529|20810121|P1|COMPLETED|Overall Study||15
8444505|NCT00789529|20810120|P2|STARTED|Overall Study||16
8444506|NCT00789529|20810121|P1|STARTED|Overall Study||16
8444507|NCT00789477|20810134|P5|NOT COMPLETED|Overall Study||7
8444508|NCT00789477|20810135|P4|NOT COMPLETED|Overall Study||10
8444509|NCT00789477|20810136|P3|NOT COMPLETED|Overall Study||11
8444510|NCT00789477|20810137|P2|NOT COMPLETED|Overall Study||6
8444511|NCT00789477|20810138|P1|NOT COMPLETED|Overall Study||11
8444512|NCT00789477|20810134|P5|COMPLETED|Overall Study||38
8444513|NCT00789477|20810135|P4|COMPLETED|Overall Study||34
8444514|NCT00789477|20810136|P3|COMPLETED|Overall Study||33
8444515|NCT00789477|20810137|P2|COMPLETED|Overall Study||38
8444516|NCT00789477|20810138|P1|COMPLETED|Overall Study||33
8444517|NCT00789477|20810134|P5|Participants Received Treatment|Overall Study|SAF|45
8444518|NCT00789477|20810135|P4|Participants Received Treatment|Overall Study|SAF|42
8444519|NCT00789477|20810136|P3|Participants Received Treatment|Overall Study|SAF|44
8444520|NCT00789477|20810137|P2|Participants Received Treatment|Overall Study|SAF|44
8444521|NCT00789477|20810138|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
8444522|NCT00789477|20810134|P5|STARTED|Overall Study|randomized|45
8444523|NCT00789477|20810135|P4|STARTED|Overall Study|randomized|44
8444524|NCT00789477|20810136|P3|STARTED|Overall Study|randomized|44
8444525|NCT00789477|20810137|P2|STARTED|Overall Study|randomized|44
8444526|NCT00789477|20810138|P1|STARTED|Overall Study|randomized|44
8444527|NCT00789438|20810173|P3|NOT COMPLETED|Overall Study||0
8444528|NCT00789438|20810174|P2|NOT COMPLETED|Overall Study||0
8444529|NCT00789438|20810175|P1|NOT COMPLETED|Overall Study||0
8444530|NCT00789438|20810173|P3|COMPLETED|Overall Study||28
8444531|NCT00789438|20810174|P2|COMPLETED|Overall Study||20
8444532|NCT00789438|20810175|P1|COMPLETED|Overall Study||21
8444533|NCT00789438|20810173|P3|STARTED|Overall Study||28
8444534|NCT00789438|20810174|P2|STARTED|Overall Study||20
8444535|NCT00789438|20810175|P1|STARTED|Overall Study||21
8444536|NCT00789373|20810183|P3|NOT COMPLETED|Maintenance||180
8444537|NCT00789373|20810184|P2|NOT COMPLETED|Maintenance||359
8444538|NCT00789373|20810185|P1|NOT COMPLETED|Maintenance||0
8444539|NCT00789373|20810183|P3|COMPLETED|Maintenance||0
8444540|NCT00789373|20810184|P2|COMPLETED|Maintenance||0
8444541|NCT00789373|20810185|P1|COMPLETED|Maintenance||0
8444542|NCT00789373|20810183|P3|STARTED|Maintenance||180
8444543|NCT00789373|20810184|P2|STARTED|Maintenance||359
8444544|NCT00789373|20810185|P1|STARTED|Maintenance||0
8444545|NCT00789373|20810183|P3|NOT COMPLETED|Induction||0
8444546|NCT00789373|20810184|P2|NOT COMPLETED|Induction||0
8444547|NCT00789373|20810185|P1|NOT COMPLETED|Induction||399
8444548|NCT00789373|20810183|P3|COMPLETED|Induction||0
8444549|NCT00789373|20810184|P2|COMPLETED|Induction||0
8444550|NCT00789373|20810185|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
8444551|NCT00789373|20810183|P3|STARTED|Induction||0
8444552|NCT00789373|20810184|P2|STARTED|Induction||0
8444553|NCT00789373|20810185|P1|STARTED|Induction||939
8444554|NCT00789360|20810212|P2|NOT COMPLETED|Overall Study||1
8444555|NCT00789360|20810213|P1|NOT COMPLETED|Overall Study||3
8444556|NCT00789360|20810212|P2|COMPLETED|Overall Study||14
8444557|NCT00789360|20810213|P1|COMPLETED|Overall Study||12
8444558|NCT00789360|20810212|P2|STARTED|Overall Study||15
8444559|NCT00789360|20810213|P1|STARTED|Overall Study||15
8444560|NCT00789321|20810223|P2|NOT COMPLETED|Overall Study||1
8444561|NCT00789321|20810224|P1|NOT COMPLETED|Overall Study||0
8444562|NCT00789321|20810223|P2|COMPLETED|Overall Study||22
8444563|NCT00789321|20810224|P1|COMPLETED|Overall Study||24
8444564|NCT00789321|20810223|P2|STARTED|Overall Study||23
8444565|NCT00789321|20810224|P1|STARTED|Overall Study||24
8444566|NCT00789256|20810234|P2|NOT COMPLETED|Overall Study||0
8444567|NCT00789256|20810235|P1|NOT COMPLETED|Overall Study||0
8444568|NCT00789256|20810234|P2|COMPLETED|Overall Study||12
8444569|NCT00789256|20810235|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
8444570|NCT00789256|20810234|P2|STARTED|Overall Study||12
8444571|NCT00789256|20810235|P1|STARTED|Overall Study||14
8444572|NCT00789191|20810246|P2|NOT COMPLETED|Overall Study||19
8444573|NCT00789191|20810247|P1|NOT COMPLETED|Overall Study||14
8444574|NCT00789191|20810246|P2|COMPLETED|Overall Study||92
8444575|NCT00789191|20810247|P1|COMPLETED|Overall Study||97
8444576|NCT00789191|20810246|P2|Exposed|Overall Study|1 non-compliance|110
8444577|NCT00789191|20810247|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
8444578|NCT00789191|20810246|P2|STARTED|Overall Study||111
8444579|NCT00789191|20810247|P1|STARTED|Overall Study||111
8444580|NCT00789113|20810275|P1|NOT COMPLETED|Overall Study||0
8444581|NCT00789113|20810275|P1|COMPLETED|Overall Study||12
8444582|NCT00789113|20810275|P1|STARTED|Overall Study||12
8444583|NCT00789074|20810282|P2|NOT COMPLETED|Overall Study||13
8444584|NCT00789074|20810283|P1|NOT COMPLETED|Overall Study||11
8444585|NCT00789074|20810282|P2|COMPLETED|Overall Study||35
8444586|NCT00789074|20810283|P1|COMPLETED|Overall Study||42
8444587|NCT00789074|20810282|P2|STARTED|Overall Study||48
8444588|NCT00789074|20810283|P1|STARTED|Overall Study||53
8444589|NCT00789035|20810304|P5|NOT COMPLETED|Overall Study||6
8444590|NCT00789035|20810305|P4|NOT COMPLETED|Overall Study||1
8444591|NCT00789035|20810306|P3|NOT COMPLETED|Overall Study||1
8444592|NCT00789035|20810307|P2|NOT COMPLETED|Overall Study||7
8444593|NCT00789035|20810308|P1|NOT COMPLETED|Overall Study||6
8444594|NCT00789035|20810304|P5|COMPLETED|Overall Study||74
8444595|NCT00789035|20810305|P4|COMPLETED|Overall Study||81
8444596|NCT00789035|20810306|P3|COMPLETED|Overall Study||80
8444597|NCT00789035|20810307|P2|COMPLETED|Overall Study||74
8444598|NCT00789035|20810308|P1|COMPLETED|Overall Study||76
8444599|NCT00789035|20810304|P5|STARTED|Overall Study||80
8444600|NCT00789035|20810305|P4|STARTED|Overall Study||82
8444601|NCT00789035|20810306|P3|STARTED|Overall Study||81
8444602|NCT00789035|20810307|P2|STARTED|Overall Study||81
8444603|NCT00789035|20810308|P1|STARTED|Overall Study||82
8444604|NCT00788957|20810367|P6|NOT COMPLETED|Part 3||11
8444605|NCT00788957|20810368|P5|NOT COMPLETED|Part 3||9
8444606|NCT00788957|20810369|P4|NOT COMPLETED|Part 3||0
8444607|NCT00788957|20810370|P3|NOT COMPLETED|Part 3||0
8444608|NCT00788957|20810371|P2|NOT COMPLETED|Part 3||0
8444609|NCT00788957|20810372|P1|NOT COMPLETED|Part 3||0
8444610|NCT00788957|20810367|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
8444611|NCT00788957|20810368|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
8444612|NCT00788957|20810369|P4|COMPLETED|Part 3||0
8444613|NCT00788957|20810370|P3|COMPLETED|Part 3||0
8444614|NCT00788957|20810371|P2|COMPLETED|Part 3||0
8444615|NCT00788957|20810372|P1|COMPLETED|Part 3||0
8444616|NCT00788957|20810367|P6|STARTED|Part 3||12
8444617|NCT00788957|20810368|P5|STARTED|Part 3||13
8444618|NCT00788957|20810369|P4|STARTED|Part 3||0
8444619|NCT00788957|20810370|P3|STARTED|Part 3||0
8444620|NCT00788957|20810371|P2|STARTED|Part 3||0
8444621|NCT00788957|20810372|P1|STARTED|Part 3||0
8444622|NCT00788957|20810367|P6|NOT COMPLETED|Part 2||0
8444623|NCT00788957|20810368|P5|NOT COMPLETED|Part 2||0
8444624|NCT00788957|20810369|P4|NOT COMPLETED|Part 2||41
8444625|NCT00788957|20810370|P3|NOT COMPLETED|Part 2||44
8444626|NCT00788957|20810371|P2|NOT COMPLETED|Part 2||42
8444627|NCT00788957|20810372|P1|NOT COMPLETED|Part 2||0
8444628|NCT00788957|20810367|P6|COMPLETED|Part 2||0
8444629|NCT00788957|20810368|P5|COMPLETED|Part 2||0
8444630|NCT00788957|20810369|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
8444631|NCT00788957|20810370|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
8444632|NCT00788957|20810371|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
8444633|NCT00788957|20810372|P1|COMPLETED|Part 2||0
8444634|NCT00788957|20810367|P6|STARTED|Part 2||0
8444635|NCT00788957|20810368|P5|STARTED|Part 2||0
8444636|NCT00788957|20810369|P4|STARTED|Part 2||46
8444637|NCT00788957|20810370|P3|STARTED|Part 2||48
8444638|NCT00788957|20810371|P2|STARTED|Part 2||48
8444639|NCT00788957|20810372|P1|STARTED|Part 2||0
8444640|NCT00788957|20810367|P6|NOT COMPLETED|Part 1||0
8444641|NCT00788957|20810368|P5|NOT COMPLETED|Part 1||0
8444642|NCT00788957|20810369|P4|NOT COMPLETED|Part 1||0
8444643|NCT00788957|20810370|P3|NOT COMPLETED|Part 1||0
8444644|NCT00788957|20810371|P2|NOT COMPLETED|Part 1||0
8444645|NCT00788957|20810372|P1|NOT COMPLETED|Part 1||9
8444646|NCT00788957|20810367|P6|COMPLETED|Part 1||0
8444647|NCT00788957|20810368|P5|COMPLETED|Part 1||0
8444648|NCT00788957|20810369|P4|COMPLETED|Part 1||0
8444649|NCT00788957|20810370|P3|COMPLETED|Part 1||0
8444650|NCT00788957|20810371|P2|COMPLETED|Part 1||0
8444651|NCT00788957|20810372|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
8444652|NCT00788957|20810367|P6|STARTED|Part 1||0
8444653|NCT00788957|20810368|P5|STARTED|Part 1||0
8444654|NCT00788957|20810369|P4|STARTED|Part 1||0
8444655|NCT00788957|20810370|P3|STARTED|Part 1||0
8444656|NCT00788957|20810371|P2|STARTED|Part 1||0
8444657|NCT00788957|20810372|P1|STARTED|Part 1||11
8444658|NCT00788892|20810428|P2|NOT COMPLETED|Overall Study||23
8444659|NCT00788892|20810429|P1|NOT COMPLETED|Overall Study||49
8444660|NCT00788892|20810428|P2|COMPLETED|Overall Study||18
8444661|NCT00788892|20810429|P1|COMPLETED|Overall Study||36
8444662|NCT00788892|20810428|P2|STARTED|Overall Study||41
8444663|NCT00788892|20810429|P1|STARTED|Overall Study||85
8444664|NCT00788827|20810445|P1|NOT COMPLETED|Overall Study||2
8444665|NCT00788827|20810445|P1|COMPLETED|Overall Study||5
8444666|NCT00788827|20810445|P1|STARTED|Overall Study||7
8444667|NCT00788775|20810459|P2|NOT COMPLETED|Overall Study||8
8444668|NCT00788775|20810460|P1|NOT COMPLETED|Overall Study||10
8444669|NCT00788775|20810459|P2|COMPLETED|Overall Study||1
8444670|NCT00788775|20810460|P1|COMPLETED|Overall Study||1
8444671|NCT00788775|20810459|P2|Treated|Overall Study||8
8444672|NCT00788775|20810460|P1|Treated|Overall Study||11
8444673|NCT00788775|20810459|P2|STARTED|Overall Study||9
8444674|NCT00788775|20810460|P1|STARTED|Overall Study||11
8444675|NCT00788710|20810475|P3|NOT COMPLETED|Overall Study||6
8444676|NCT00788710|20810476|P2|NOT COMPLETED|Overall Study||8
8444677|NCT00788710|20810477|P1|NOT COMPLETED|Overall Study||5
8444678|NCT00788710|20810475|P3|COMPLETED|Overall Study||138
8444679|NCT00788710|20810476|P2|COMPLETED|Overall Study||134
8444680|NCT00788710|20810477|P1|COMPLETED|Overall Study||139
8444681|NCT00788710|20810475|P3|STARTED|Overall Study||144
8444682|NCT00788710|20810476|P2|STARTED|Overall Study||142
8444683|NCT00788710|20810477|P1|STARTED|Overall Study||144
8444684|NCT00788697|20810491|P1|NOT COMPLETED|Overall Study||109
8444685|NCT00788697|20810491|P1|COMPLETED|Overall Study||240
8444686|NCT00788697|20810491|P1|STARTED|Overall Study||349
8444687|NCT00788593|20810538|P3|NOT COMPLETED|Second Intervention Period||1
8444688|NCT00788593|20810539|P2|NOT COMPLETED|Second Intervention Period||1
8444689|NCT00788593|20810540|P1|NOT COMPLETED|Second Intervention Period||0
8444690|NCT00788593|20810538|P3|COMPLETED|Second Intervention Period||36
8444691|NCT00788593|20810539|P2|COMPLETED|Second Intervention Period||37
8444692|NCT00788593|20810540|P1|COMPLETED|Second Intervention Period||0
8444693|NCT00788593|20810538|P3|STARTED|Second Intervention Period||37
8444694|NCT00788593|20810539|P2|STARTED|Second Intervention Period||38
8444695|NCT00788593|20810540|P1|STARTED|Second Intervention Period||0
8444696|NCT00788593|20810538|P3|NOT COMPLETED|First Intervention Period||0
8444697|NCT00788593|20810539|P2|NOT COMPLETED|First Intervention Period||1
8444698|NCT00788593|20810540|P1|NOT COMPLETED|First Intervention Period||0
8444699|NCT00788593|20810538|P3|COMPLETED|First Intervention Period||37
8444700|NCT00788593|20810539|P2|COMPLETED|First Intervention Period||38
8444701|NCT00788593|20810540|P1|COMPLETED|First Intervention Period||0
8444702|NCT00788593|20810538|P3|STARTED|First Intervention Period||37
8444703|NCT00788593|20810539|P2|STARTED|First Intervention Period||39
8444704|NCT00788593|20810540|P1|STARTED|First Intervention Period||0
8444705|NCT00788593|20810538|P3|NOT COMPLETED|Placebo Run-in Phase||0
8444706|NCT00788593|20810539|P2|NOT COMPLETED|Placebo Run-in Phase||0
8444707|NCT00788593|20810540|P1|NOT COMPLETED|Placebo Run-in Phase||6
8444708|NCT00788593|20810538|P3|COMPLETED|Placebo Run-in Phase||0
8444709|NCT00788593|20810539|P2|COMPLETED|Placebo Run-in Phase||0
8444710|NCT00788593|20810540|P1|COMPLETED|Placebo Run-in Phase||76
8444711|NCT00788593|20810538|P3|STARTED|Placebo Run-in Phase||0
8444712|NCT00788593|20810539|P2|STARTED|Placebo Run-in Phase||0
8444713|NCT00788593|20810540|P1|STARTED|Placebo Run-in Phase||82
8444714|NCT00788372|20810557|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
8444715|NCT00788372|20810557|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
8444716|NCT00788372|20810557|P1|STARTED|Period 2 (Week 4 to Week 52)||111
8444717|NCT00788372|20810557|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
8444718|NCT00788372|20810557|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
8444719|NCT00788372|20810557|P1|STARTED|Period 1 (up to 4 Weeks)||142
8444720|NCT00788255|20810571|P1|NOT COMPLETED|Overall Study||0
8444721|NCT00788255|20810571|P1|COMPLETED|Overall Study||25
8444722|NCT00788255|20810571|P1|Oxytocin: 0 μU/mL|Overall Study||25
8444723|NCT00788255|20810571|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
8444724|NCT00788255|20810571|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
8444725|NCT00788255|20810571|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
8444726|NCT00788255|20810571|P1|STARTED|Overall Study||25
8444727|NCT00788151|20810586|P2|NOT COMPLETED|Overall Study||10
8444728|NCT00788151|20810587|P1|NOT COMPLETED|Overall Study||14
8444729|NCT00788151|20810586|P2|COMPLETED|Overall Study||90
8444730|NCT00788151|20810587|P1|COMPLETED|Overall Study||186
8444731|NCT00788151|20810586|P2|Received Vaccination 3|Overall Study||90
8444732|NCT00788151|20810587|P1|Received Vaccination 3|Overall Study||186
8444733|NCT00788151|20810586|P2|Received Vaccination 2|Overall Study||92
8444734|NCT00788151|20810587|P1|Received Vaccination 2|Overall Study||188
8444735|NCT00788151|20810586|P2|Received Vaccination 1|Overall Study||99
8444736|NCT00788151|20810587|P1|Received Vaccination 1|Overall Study||199
8444737|NCT00788151|20810586|P2|STARTED|Overall Study||100
8444738|NCT00788151|20810587|P1|STARTED|Overall Study||200
8444739|NCT00788073|20810631|P2|NOT COMPLETED|Placebo Then STX209||1
8444740|NCT00788073|20810632|P1|NOT COMPLETED|Placebo Then STX209||2
8444741|NCT00788073|20810631|P2|COMPLETED|Placebo Then STX209||29
8444742|NCT00788073|20810632|P1|COMPLETED|Placebo Then STX209||27
8444743|NCT00788073|20810631|P2|STARTED|Placebo Then STX209||30
8444744|NCT00788073|20810632|P1|STARTED|Placebo Then STX209||29
8444745|NCT00788073|20810631|P2|NOT COMPLETED|STX209 Then Placebo||3
8444746|NCT00788073|20810632|P1|NOT COMPLETED|STX209 Then Placebo||1
8444747|NCT00788073|20810631|P2|COMPLETED|STX209 Then Placebo||30
8444748|NCT00788073|20810632|P1|COMPLETED|STX209 Then Placebo||29
8444749|NCT00788073|20810631|P2|STARTED|STX209 Then Placebo||33
8444750|NCT00788073|20810632|P1|STARTED|STX209 Then Placebo||30
8444751|NCT00788008|20810642|P2|NOT COMPLETED|Overall Study||0
8444752|NCT00788008|20810643|P1|NOT COMPLETED|Overall Study||0
8444753|NCT00788008|20810642|P2|COMPLETED|Overall Study||101
8444754|NCT00788008|20810643|P1|COMPLETED|Overall Study||98
8444755|NCT00788008|20810642|P2|STARTED|Overall Study||101
8444756|NCT00788008|20810643|P1|STARTED|Overall Study||98
8444757|NCT00787943|20810649|P1|NOT COMPLETED|Overall Study||0
8444758|NCT00787943|20810649|P1|COMPLETED|Overall Study||10
8444759|NCT00787943|20810649|P1|STARTED|Overall Study||10
8444760|NCT00787930|20810657|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
8444761|NCT00787930|20810657|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
8444762|NCT00787930|20810657|P1|STARTED|Continuation Treatment -- up to 12 Month||19
8444763|NCT00787930|20810657|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
8444764|NCT00787930|20810657|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
8444765|NCT00787930|20810657|P1|STARTED|Acute Treatment -- 3 Weeks||19
8444766|NCT00787917|20810672|P2|NOT COMPLETED|Open Label||0
8444767|NCT00787917|20810673|P1|NOT COMPLETED|Open Label||4
8444768|NCT00787917|20810672|P2|COMPLETED|Open Label||0
8444769|NCT00787917|20810673|P1|COMPLETED|Open Label||3
8444770|NCT00787917|20810672|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
8444771|NCT00787917|20810673|P1|STARTED|Open Label||7
8444772|NCT00787917|20810672|P2|NOT COMPLETED|Blinded Treatment||2
8444773|NCT00787917|20810673|P1|NOT COMPLETED|Blinded Treatment||5
8444774|NCT00787917|20810672|P2|COMPLETED|Blinded Treatment||3
8444775|NCT00787917|20810673|P1|COMPLETED|Blinded Treatment||4
8444776|NCT00787917|20810672|P2|STARTED|Blinded Treatment||5
8444777|NCT00787917|20810673|P1|STARTED|Blinded Treatment||9
8444778|NCT00787904|20810692|P2|NOT COMPLETED|Overall Study||0
8444779|NCT00787904|20810693|P1|NOT COMPLETED|Overall Study||0
8444780|NCT00787904|20810692|P2|COMPLETED|Overall Study||13
8444781|NCT00787904|20810693|P1|COMPLETED|Overall Study||6
8444782|NCT00787904|20810692|P2|STARTED|Overall Study||13
8444783|NCT00787904|20810693|P1|STARTED|Overall Study||6
8444784|NCT00787891|20810703|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
8444785|NCT00787891|20810704|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
8444786|NCT00787891|20810703|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
8444787|NCT00787891|20810704|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
8444788|NCT00787891|20810703|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
8444789|NCT00787891|20810704|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
8444790|NCT00787891|20810703|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
8444791|NCT00787891|20810704|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
8444792|NCT00787891|20810703|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
8444793|NCT00787891|20810704|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
8444794|NCT00787891|20810703|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
8444795|NCT00787891|20810704|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
8444796|NCT00787852|20810724|P2|NOT COMPLETED|Overall Study||0
8444797|NCT00787852|20810725|P1|NOT COMPLETED|Overall Study||1
8444798|NCT00787852|20810724|P2|COMPLETED|Overall Study||5
8444799|NCT00787852|20810725|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
8444800|NCT00787852|20810724|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
8444801|NCT00787852|20810725|P1|STARTED|Overall Study||6
8444802|NCT00787839|20810731|P1|NOT COMPLETED|Overall Study||404
8444803|NCT00787839|20810731|P1|COMPLETED|Overall Study||1535
8444804|NCT00787839|20810731|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
8444805|NCT00787839|20810731|P1|Completed GCT Screening|Overall Study||1876
8444806|NCT00787839|20810731|P1|Consented|Overall Study|consented|1939
8444807|NCT00787839|20810731|P1|STARTED|Overall Study||1939
8444808|NCT00787800|20810754|P2|NOT COMPLETED|Overall Study||7
8444809|NCT00787800|20810755|P1|NOT COMPLETED|Overall Study||3
8444810|NCT00787800|20810754|P2|COMPLETED|Overall Study||43
8444811|NCT00787800|20810755|P1|COMPLETED|Overall Study||47
8444812|NCT00787800|20810754|P2|STARTED|Overall Study||50
8444813|NCT00787800|20810755|P1|STARTED|Overall Study||50
8444814|NCT00787787|20810771|P1|NOT COMPLETED|Overall Study||7
8444815|NCT00787787|20810771|P1|COMPLETED|Overall Study||0
8444816|NCT00787787|20810771|P1|STARTED|Overall Study||7
8444817|NCT00787761|20810777|P1|NOT COMPLETED|Overall Study||0
8444818|NCT00787761|20810777|P1|COMPLETED|Overall Study||24
8444819|NCT00787761|20810777|P1|STARTED|Overall Study||24
8444820|NCT00787722|20810788|P1|NOT COMPLETED|Overall Study||1
8444821|NCT00787722|20810788|P1|COMPLETED|Overall Study||12
8444822|NCT00787722|20810788|P1|STARTED|Overall Study||13
8444823|NCT00787644|20810799|P2|NOT COMPLETED|Overall Study||2
8444824|NCT00787644|20810800|P1|NOT COMPLETED|Overall Study||2
8444825|NCT00787644|20810799|P2|COMPLETED|Overall Study||9
8444826|NCT00787644|20810800|P1|COMPLETED|Overall Study||10
8444827|NCT00787644|20810799|P2|STARTED|Overall Study||11
8444828|NCT00787644|20810800|P1|STARTED|Overall Study||12
8444829|NCT00787618|20810809|P3|NOT COMPLETED|Overall Study||0
8444830|NCT00787618|20810810|P2|NOT COMPLETED|Overall Study||0
8444831|NCT00787618|20810811|P1|NOT COMPLETED|Overall Study||0
8444832|NCT00787618|20810809|P3|COMPLETED|Overall Study||3
8444833|NCT00787618|20810810|P2|COMPLETED|Overall Study||0
8444834|NCT00787618|20810811|P1|COMPLETED|Overall Study||3
8444835|NCT00787618|20810809|P3|STARTED|Overall Study||3
8444836|NCT00787618|20810810|P2|STARTED|Overall Study||0
8444837|NCT00787618|20810811|P1|STARTED|Overall Study||3
8444838|NCT00787605|20810821|P2|NOT COMPLETED|Overall Study||56
8444839|NCT00787605|20810822|P1|NOT COMPLETED|Overall Study||46
8444840|NCT00787605|20810821|P2|COMPLETED|Overall Study||376
8444841|NCT00787605|20810822|P1|COMPLETED|Overall Study||382
8444842|NCT00787605|20810821|P2|STARTED|Overall Study||432
8444843|NCT00787605|20810822|P1|STARTED|Overall Study||428
8444844|NCT00787566|20810841|P3|NOT COMPLETED|Overall Study||0
8444845|NCT00787566|20810842|P2|NOT COMPLETED|Overall Study||1
8444846|NCT00787566|20810843|P1|NOT COMPLETED|Overall Study||0
8444847|NCT00787566|20810841|P3|COMPLETED|Overall Study||22
8444848|NCT00787566|20810842|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
8444849|NCT00787566|20810843|P1|COMPLETED|Overall Study||21
8444850|NCT00787566|20810841|P3|STARTED|Overall Study||22
8444851|NCT00787566|20810842|P2|STARTED|Overall Study||25
8444852|NCT00787566|20810843|P1|STARTED|Overall Study||21
8444853|NCT00787527|20810851|P1|NOT COMPLETED|Overall Study||3
8444854|NCT00787527|20810851|P1|COMPLETED|Overall Study||11
8444855|NCT00787527|20810851|P1|STARTED|Overall Study||14
8444856|NCT00787332|20810861|P2|NOT COMPLETED|Overall Study||0
8444857|NCT00787332|20810862|P1|NOT COMPLETED|Overall Study||0
8444858|NCT00787332|20810861|P2|COMPLETED|Overall Study||8
8444859|NCT00787332|20810862|P1|COMPLETED|Overall Study||8
8444860|NCT00787332|20810861|P2|STARTED|Overall Study||8
8444861|NCT00787332|20810862|P1|STARTED|Overall Study||8
8444862|NCT00787319|20810868|P1|NOT COMPLETED|Overall Study||63
8444863|NCT00787319|20810868|P1|COMPLETED|Overall Study||45
8444864|NCT00787319|20810868|P1|STARTED|Overall Study||108
8444865|NCT00787267|20810880|P1|NOT COMPLETED|Overall Study||12
8444866|NCT00787267|20810880|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
8444867|NCT00787267|20810880|P1|STARTED|Overall Study|Signed a consent form|37
8444868|NCT00787254|20810890|P2|NOT COMPLETED|Overall Study||82
8444869|NCT00787254|20810891|P1|NOT COMPLETED|Overall Study||76
8444870|NCT00787254|20810890|P2|COMPLETED|Overall Study||99
8444871|NCT00787254|20810891|P1|COMPLETED|Overall Study||109
8444872|NCT00787254|20810890|P2|STARTED|Overall Study||181
8444873|NCT00787254|20810891|P1|STARTED|Overall Study||185
8444874|NCT00787241|20810994|P3|NOT COMPLETED|Overall Study||0
8444875|NCT00787241|20810995|P2|NOT COMPLETED|Overall Study||0
8444876|NCT00787241|20810996|P1|NOT COMPLETED|Overall Study||0
8444877|NCT00787241|20810994|P3|COMPLETED|Overall Study||41
8444878|NCT00787241|20810995|P2|COMPLETED|Overall Study||143
8444879|NCT00787241|20810996|P1|COMPLETED|Overall Study||261
8444880|NCT00787241|20810994|P3|STARTED|Overall Study||41
8444881|NCT00787241|20810995|P2|STARTED|Overall Study||143
8444882|NCT00787241|20810996|P1|STARTED|Overall Study||261
8444883|NCT00787202|20811015|P5|NOT COMPLETED|Overall Study||4
8444884|NCT00787202|20811016|P4|NOT COMPLETED|Overall Study||2
8444885|NCT00787202|20811017|P3|NOT COMPLETED|Overall Study||7
8444886|NCT00787202|20811018|P2|NOT COMPLETED|Overall Study||11
8444887|NCT00787202|20811019|P1|NOT COMPLETED|Overall Study||14
8444888|NCT00787202|20811015|P5|COMPLETED|Overall Study||45
8444889|NCT00787202|20811016|P4|COMPLETED|Overall Study||31
8444890|NCT00787202|20811017|P3|COMPLETED|Overall Study||26
8444891|NCT00787202|20811018|P2|COMPLETED|Overall Study||20
8444892|NCT00787202|20811019|P1|COMPLETED|Overall Study||35
8444893|NCT00787202|20811015|P5|Treated|Overall Study||49
8444894|NCT00787202|20811016|P4|Treated|Overall Study||33
8444895|NCT00787202|20811017|P3|Treated|Overall Study||33
8444896|NCT00787202|20811018|P2|Treated|Overall Study||31
8444897|NCT00787202|20811019|P1|Treated|Overall Study||48
8444898|NCT00787202|20811015|P5|STARTED|Overall Study||49
8444899|NCT00787202|20811016|P4|STARTED|Overall Study||33
8444900|NCT00787202|20811017|P3|STARTED|Overall Study||33
8444901|NCT00787202|20811018|P2|STARTED|Overall Study||31
8444902|NCT00787202|20811019|P1|STARTED|Overall Study||49
8444903|NCT00787189|20811072|P2|NOT COMPLETED|Overall Study||2
8444904|NCT00787189|20811073|P1|NOT COMPLETED|Overall Study||2
8444905|NCT00787189|20811072|P2|COMPLETED|Overall Study|To study end point.|30
8444906|NCT00787189|20811073|P1|COMPLETED|Overall Study|To study end point.|30
8444907|NCT00787189|20811072|P2|STARTED|Overall Study||32
8444908|NCT00787189|20811073|P1|STARTED|Overall Study||32
8444909|NCT00787150|20811082|P3|NOT COMPLETED|Overall Study||5
8444910|NCT00787150|20811083|P2|NOT COMPLETED|Overall Study||7
8444911|NCT00787150|20811084|P1|NOT COMPLETED|Overall Study||9
8444912|NCT00787150|20811082|P3|COMPLETED|Overall Study||66
8444913|NCT00787150|20811083|P2|COMPLETED|Overall Study||65
8444914|NCT00787150|20811084|P1|COMPLETED|Overall Study||66
8444915|NCT00787150|20811082|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
8444916|NCT00787150|20811083|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
8444917|NCT00787150|20811084|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
8444918|NCT00787137|20811129|P3|NOT COMPLETED|Overall Study||1
8444919|NCT00787137|20811130|P2|NOT COMPLETED|Overall Study||0
8444920|NCT00787137|20811131|P1|NOT COMPLETED|Overall Study||0
8444921|NCT00787137|20811129|P3|COMPLETED|Overall Study||4
8444922|NCT00787137|20811130|P2|COMPLETED|Overall Study||6
8444923|NCT00787137|20811131|P1|COMPLETED|Overall Study||6
8444924|NCT00787137|20811129|P3|STARTED|Overall Study||5
8444925|NCT00787137|20811130|P2|STARTED|Overall Study||6
8444926|NCT00787137|20811131|P1|STARTED|Overall Study||6
8444927|NCT00787124|20811153|P2|NOT COMPLETED|Overall Study||0
8444928|NCT00787124|20811154|P1|NOT COMPLETED|Overall Study||0
8444929|NCT00787124|20811153|P2|COMPLETED|Overall Study||4
8444930|NCT00787124|20811154|P1|COMPLETED|Overall Study||4
8444931|NCT00787124|20811153|P2|STARTED|Overall Study||4
8444932|NCT00787124|20811154|P1|STARTED|Overall Study||4
8444933|NCT00787020|20811164|P2|NOT COMPLETED|Overall Study||0
8444934|NCT00787020|20811165|P1|NOT COMPLETED|Overall Study||0
8444935|NCT00787020|20811164|P2|COMPLETED|Overall Study||13
8444936|NCT00787020|20811165|P1|COMPLETED|Overall Study||24
8444937|NCT00787020|20811164|P2|STARTED|Overall Study||13
8444938|NCT00787020|20811165|P1|STARTED|Overall Study||24
8444939|NCT00786994|20811179|P4|NOT COMPLETED|Overall Study||6
8444940|NCT00786994|20811180|P3|NOT COMPLETED|Overall Study||2
8444941|NCT00786994|20811181|P2|NOT COMPLETED|Overall Study||15
8444942|NCT00786994|20811182|P1|NOT COMPLETED|Overall Study||10
8444943|NCT00786994|20811179|P4|COMPLETED|Overall Study||22
8444944|NCT00786994|20811180|P3|COMPLETED|Overall Study||24
8444945|NCT00786994|20811181|P2|COMPLETED|Overall Study||39
8444946|NCT00786994|20811182|P1|COMPLETED|Overall Study||47
8444947|NCT00786994|20811179|P4|ITT|Overall Study||28
8444948|NCT00786994|20811180|P3|ITT|Overall Study||25
8444949|NCT00786994|20811181|P2|ITT|Overall Study||51
8444950|NCT00786994|20811182|P1|ITT|Overall Study||53
8444951|NCT00786994|20811179|P4|STARTED|Overall Study||28
8444952|NCT00786994|20811180|P3|STARTED|Overall Study||26
8444953|NCT00786994|20811181|P2|STARTED|Overall Study||54
8444954|NCT00786994|20811182|P1|STARTED|Overall Study||57
8444955|NCT00786916|20811194|P3|NOT COMPLETED|Overall Study||0
8444956|NCT00786916|20811195|P2|NOT COMPLETED|Overall Study||0
8444957|NCT00786916|20811196|P1|NOT COMPLETED|Overall Study||0
8444958|NCT00786916|20811194|P3|COMPLETED|Overall Study||34
8444959|NCT00786916|20811195|P2|COMPLETED|Overall Study||36
8444960|NCT00786916|20811196|P1|COMPLETED|Overall Study||39
8444961|NCT00786916|20811194|P3|STARTED|Overall Study||34
8444962|NCT00786916|20811195|P2|STARTED|Overall Study||36
8444963|NCT00786916|20811196|P1|STARTED|Overall Study||39
8444964|NCT00786864|20811206|P2|NOT COMPLETED|Overall Study||1
8444965|NCT00786864|20811207|P1|NOT COMPLETED|Overall Study||1
8444966|NCT00786864|20811206|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
8444967|NCT00786864|20811207|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
8444968|NCT00786864|20811206|P2|STARTED|Overall Study||33
8444969|NCT00786864|20811207|P1|STARTED|Overall Study||39
8444970|NCT00786838|20811219|P1|NOT COMPLETED|Overall Study||49
8444971|NCT00786838|20811219|P1|COMPLETED|Overall Study||26
8444972|NCT00786838|20811219|P1|STARTED|Overall Study||75
8444973|NCT00786825|20811246|P2|NOT COMPLETED|Overall Study||0
8444974|NCT00786825|20811247|P1|NOT COMPLETED|Overall Study||0
8444975|NCT00786825|20811246|P2|COMPLETED|Overall Study||5
8444976|NCT00786825|20811247|P1|COMPLETED|Overall Study||5
8444977|NCT00786825|20811246|P2|STARTED|Overall Study||5
8444978|NCT00786825|20811247|P1|STARTED|Overall Study||5
8444979|NCT00786799|20811255|P2|NOT COMPLETED|Overall Study||1
8444980|NCT00786799|20811256|P1|NOT COMPLETED|Overall Study||1
8444981|NCT00786799|20811255|P2|COMPLETED|Overall Study||12
8444982|NCT00786799|20811256|P1|COMPLETED|Overall Study||13
8444983|NCT00786799|20811255|P2|STARTED|Overall Study||13
8444984|NCT00786799|20811256|P1|STARTED|Overall Study||14
8444985|NCT00786682|20811267|P1|NOT COMPLETED|Overall Study||0
8444986|NCT00786682|20811267|P1|COMPLETED|Overall Study||11
8444987|NCT00786682|20811267|P1|STARTED|Overall Study||11
8444988|NCT00786643|20811275|P2|NOT COMPLETED|Overall Study||0
8444989|NCT00786643|20811276|P1|NOT COMPLETED|Overall Study||0
8444990|NCT00786643|20811275|P2|COMPLETED|Overall Study||28
8444991|NCT00786643|20811276|P1|COMPLETED|Overall Study||20
8444992|NCT00786643|20811275|P2|STARTED|Overall Study||28
8444993|NCT00786643|20811276|P1|STARTED|Overall Study||20
8444994|NCT00786565|20811286|P1|NOT COMPLETED|Post Surgery||2
8444995|NCT00786565|20811286|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
8444996|NCT00786565|20811286|P1|STARTED|Post Surgery||69
8444997|NCT00786565|20811286|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
8444998|NCT00786565|20811286|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
8444999|NCT00786565|20811286|P1|STARTED|Enrollment Prior to Surgery||75
8445000|NCT00786487|20811328|P4|NOT COMPLETED|Overall Study||0
8445001|NCT00786487|20811329|P3|NOT COMPLETED|Overall Study||0
8445002|NCT00786487|20811330|P2|NOT COMPLETED|Overall Study||0
8445003|NCT00786487|20811331|P1|NOT COMPLETED|Overall Study||0
8445004|NCT00786487|20811328|P4|COMPLETED|Overall Study||7
8445005|NCT00786487|20811329|P3|COMPLETED|Overall Study||9
8445006|NCT00786487|20811330|P2|COMPLETED|Overall Study||7
8445007|NCT00786487|20811331|P1|COMPLETED|Overall Study||10
8445008|NCT00786487|20811328|P4|STARTED|Overall Study||7
8445009|NCT00786487|20811329|P3|STARTED|Overall Study||9
8445010|NCT00786487|20811330|P2|STARTED|Overall Study||7
8445011|NCT00786487|20811331|P1|STARTED|Overall Study||10
8445012|NCT00786474|20811343|P2|NOT COMPLETED|Overall Study||43
8445013|NCT00786474|20811344|P1|NOT COMPLETED|Overall Study||37
8445014|NCT00786474|20811343|P2|COMPLETED|Overall Study||891
8445015|NCT00786474|20811344|P1|COMPLETED|Overall Study||913
8445016|NCT00786474|20811343|P2|STARTED|Overall Study||934
8445017|NCT00786474|20811344|P1|STARTED|Overall Study||950
8445018|NCT00786422|20811356|P1|NOT COMPLETED|Follow-up Period||3
8445019|NCT00786422|20811356|P1|COMPLETED|Follow-up Period||17
8445100|NCT00785785|20811608|P2|NOT COMPLETED|Optional Extension Phase||125
8445020|NCT00786422|20811356|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
8445021|NCT00786422|20811356|P1|NOT COMPLETED|Rivaroxaban Treatment||11
8445022|NCT00786422|20811356|P1|COMPLETED|Rivaroxaban Treatment||14
8445023|NCT00786422|20811356|P1|STARTED|Rivaroxaban Treatment||25
8445024|NCT00786409|20811372|P1|NOT COMPLETED|Overall Study||7
8445025|NCT00786409|20811372|P1|COMPLETED|Overall Study||20
8445026|NCT00786409|20811372|P1|STARTED|Overall Study||27
8445027|NCT00786188|20811389|P2|NOT COMPLETED|Overall Study||1
8445028|NCT00786188|20811390|P1|NOT COMPLETED|Overall Study||5
8445029|NCT00786188|20811389|P2|COMPLETED|Overall Study||51
8445030|NCT00786188|20811390|P1|COMPLETED|Overall Study||45
8445031|NCT00786188|20811389|P2|STARTED|Overall Study||52
8445032|NCT00786188|20811390|P1|STARTED|Overall Study||50
8445033|NCT00786032|20811416|P1|NOT COMPLETED|Overall Study||24
8445034|NCT00786032|20811416|P1|COMPLETED|Overall Study||3
8445035|NCT00786032|20811416|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
8445036|NCT00786032|20811416|P1|STARTED|Overall Study||27
8445037|NCT00786019|20811428|P2|NOT COMPLETED|Overall Study||10
8445038|NCT00786019|20811429|P1|NOT COMPLETED|Overall Study||5
8445039|NCT00786019|20811428|P2|COMPLETED|Overall Study||17
8445040|NCT00786019|20811429|P1|COMPLETED|Overall Study||15
8445041|NCT00786019|20811428|P2|STARTED|Overall Study||27
8445042|NCT00786019|20811429|P1|STARTED|Overall Study||20
8445043|NCT00785980|20811437|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
8445044|NCT00785980|20811437|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
8445045|NCT00785980|20811437|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
8445046|NCT00785980|20811437|P1|NOT COMPLETED|Ciprofloxacin Alone||0
8445047|NCT00785980|20811437|P1|COMPLETED|Ciprofloxacin Alone||21
8445048|NCT00785980|20811437|P1|STARTED|Ciprofloxacin Alone||21
8445049|NCT00785980|20811437|P1|NOT COMPLETED|7 Day Washout Period||3
8445050|NCT00785980|20811437|P1|COMPLETED|7 Day Washout Period||21
8445051|NCT00785980|20811437|P1|STARTED|7 Day Washout Period||24
8445052|NCT00785980|20811437|P1|NOT COMPLETED|Quinine Sulfate Alone||0
8445053|NCT00785980|20811437|P1|COMPLETED|Quinine Sulfate Alone||24
8445054|NCT00785980|20811437|P1|STARTED|Quinine Sulfate Alone||24
8445055|NCT00785928|20811455|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
8445056|NCT00785928|20811456|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
8445057|NCT00785928|20811457|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
8445058|NCT00785928|20811458|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
8445059|NCT00785928|20811459|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
8445060|NCT00785928|20811460|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
8445061|NCT00785928|20811461|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
8445062|NCT00785928|20811455|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
8445063|NCT00785928|20811456|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
8445064|NCT00785928|20811457|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8445065|NCT00785928|20811458|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8445066|NCT00785928|20811459|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8445067|NCT00785928|20811460|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
8445068|NCT00785928|20811461|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
8445069|NCT00785928|20811455|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
8445070|NCT00785928|20811456|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
8445071|NCT00785928|20811457|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
8445072|NCT00785928|20811458|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
8445073|NCT00785928|20811459|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
8445074|NCT00785928|20811460|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
8445075|NCT00785928|20811461|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
8445076|NCT00785928|20811455|P7|NOT COMPLETED|Treatment Phase||3
8445077|NCT00785928|20811456|P6|NOT COMPLETED|Treatment Phase||0
8445078|NCT00785928|20811457|P5|NOT COMPLETED|Treatment Phase||2
8445079|NCT00785928|20811458|P4|NOT COMPLETED|Treatment Phase||0
8445080|NCT00785928|20811459|P3|NOT COMPLETED|Treatment Phase||3
8445081|NCT00785928|20811460|P2|NOT COMPLETED|Treatment Phase||5
8445082|NCT00785928|20811461|P1|NOT COMPLETED|Treatment Phase||3
8445083|NCT00785928|20811455|P7|COMPLETED|Treatment Phase||23
8445084|NCT00785928|20811456|P6|COMPLETED|Treatment Phase||13
8445085|NCT00785928|20811457|P5|COMPLETED|Treatment Phase||16
8445086|NCT00785928|20811458|P4|COMPLETED|Treatment Phase||15
8445087|NCT00785928|20811459|P3|COMPLETED|Treatment Phase||17
8445088|NCT00785928|20811460|P2|COMPLETED|Treatment Phase||25
8445089|NCT00785928|20811461|P1|COMPLETED|Treatment Phase||33
8445090|NCT00785928|20811455|P7|STARTED|Treatment Phase||26
8445091|NCT00785928|20811456|P6|STARTED|Treatment Phase||13
8445092|NCT00785928|20811457|P5|STARTED|Treatment Phase||18
8445093|NCT00785928|20811458|P4|STARTED|Treatment Phase||15
8445094|NCT00785928|20811459|P3|STARTED|Treatment Phase||20
8445095|NCT00785928|20811460|P2|STARTED|Treatment Phase||30
8445096|NCT00785928|20811461|P1|STARTED|Treatment Phase||36
8445097|NCT00785798|20811601|P1|NOT COMPLETED|Overall Study||1
8445098|NCT00785798|20811601|P1|COMPLETED|Overall Study||16
8445099|NCT00785798|20811601|P1|STARTED|Overall Study||17
8445101|NCT00785785|20811609|P1|NOT COMPLETED|Optional Extension Phase||39
8445102|NCT00785785|20811608|P2|COMPLETED|Optional Extension Phase||0
8445103|NCT00785785|20811609|P1|COMPLETED|Optional Extension Phase||0
8445104|NCT00785785|20811608|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
8445105|NCT00785785|20811609|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
8445106|NCT00785785|20811608|P2|NOT COMPLETED|Core Phase up to 36 Months||320
8445107|NCT00785785|20811609|P1|NOT COMPLETED|Core Phase up to 36 Months||324
8445108|NCT00785785|20811608|P2|COMPLETED|Core Phase up to 36 Months||0
8445109|NCT00785785|20811609|P1|COMPLETED|Core Phase up to 36 Months||0
8445110|NCT00785785|20811608|P2|STARTED|Core Phase up to 36 Months||320
8445111|NCT00785785|20811609|P1|STARTED|Core Phase up to 36 Months||324
8445115|NCT00785707|20811623|P1|NOT COMPLETED|Overall Study||7
8445116|NCT00785707|20811623|P1|COMPLETED|Overall Study||24
8445117|NCT00785707|20811623|P1|STARTED|Overall Study||31
8445118|NCT00785629|20811632|P4|NOT COMPLETED|Overall Study||16
8445119|NCT00785629|20811633|P3|NOT COMPLETED|Overall Study||10
8445120|NCT00785629|20811634|P2|NOT COMPLETED|Overall Study||5
8445121|NCT00785629|20811635|P1|NOT COMPLETED|Overall Study||8
8445122|NCT00785629|20811632|P4|COMPLETED|Overall Study|16 not completed|41
8445123|NCT00785629|20811633|P3|COMPLETED|Overall Study|10 not completed|18
8445124|NCT00785629|20811634|P2|COMPLETED|Overall Study|5 not completed|25
8445125|NCT00785629|20811635|P1|COMPLETED|Overall Study|8 not completed|22
8445126|NCT00785629|20811632|P4|STARTED|Overall Study||57
8445127|NCT00785629|20811633|P3|STARTED|Overall Study||28
8445128|NCT00785629|20811634|P2|STARTED|Overall Study||30
8445129|NCT00785629|20811635|P1|STARTED|Overall Study||30
8445130|NCT00785577|20811648|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8445131|NCT00785577|20811649|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8445132|NCT00785577|20811650|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8445133|NCT00785577|20811651|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8445134|NCT00785577|20811652|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8445135|NCT00785577|20811648|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
8445136|NCT00785577|20811649|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
8445137|NCT00785577|20811650|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
8445138|NCT00785577|20811651|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
8445139|NCT00785577|20811652|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
8445140|NCT00785577|20811648|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
8445141|NCT00785577|20811649|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
8445142|NCT00785577|20811650|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
8445143|NCT00785577|20811651|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
8445144|NCT00785577|20811652|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
8445145|NCT00785577|20811648|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
8445146|NCT00785577|20811649|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
8445147|NCT00785577|20811650|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
8445148|NCT00785577|20811651|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
8445149|NCT00785577|20811652|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
8445150|NCT00785577|20811648|P5|COMPLETED|Study Period 2: Therapy Phase||27
8445151|NCT00785577|20811649|P4|COMPLETED|Study Period 2: Therapy Phase||36
8445152|NCT00785577|20811650|P3|COMPLETED|Study Period 2: Therapy Phase||25
8445153|NCT00785577|20811651|P2|COMPLETED|Study Period 2: Therapy Phase||36
8445154|NCT00785577|20811652|P1|COMPLETED|Study Period 2: Therapy Phase||78
8445155|NCT00785577|20811648|P5|STARTED|Study Period 2: Therapy Phase||47
8445156|NCT00785577|20811649|P4|STARTED|Study Period 2: Therapy Phase||49
8445157|NCT00785577|20811650|P3|STARTED|Study Period 2: Therapy Phase||43
8445158|NCT00785577|20811651|P2|STARTED|Study Period 2: Therapy Phase||45
8445159|NCT00785577|20811652|P1|STARTED|Study Period 2: Therapy Phase||89
8445160|NCT00785538|20811792|P4|NOT COMPLETED|Treatment Period||1
8445161|NCT00785538|20811793|P3|NOT COMPLETED|Treatment Period||2
8445162|NCT00785538|20811794|P2|NOT COMPLETED|Treatment Period||2
8445163|NCT00785538|20811795|P1|NOT COMPLETED|Treatment Period||1
8445164|NCT00785538|20811792|P4|COMPLETED|Treatment Period||1
8445165|NCT00785538|20811793|P3|COMPLETED|Treatment Period||4
8445166|NCT00785538|20811794|P2|COMPLETED|Treatment Period||7
8445167|NCT00785538|20811795|P1|COMPLETED|Treatment Period||6
8445168|NCT00785538|20811792|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
8445169|NCT00785538|20811793|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
8445170|NCT00785538|20811794|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
8445171|NCT00785538|20811795|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
8445172|NCT00785538|20811792|P4|STARTED|Treatment Period||2
8445173|NCT00785538|20811793|P3|STARTED|Treatment Period||6
8445174|NCT00785538|20811794|P2|STARTED|Treatment Period||9
8445175|NCT00785538|20811795|P1|STARTED|Treatment Period||7
8445176|NCT00785538|20811792|P4|NOT COMPLETED|PK Period||0
8445177|NCT00785538|20811793|P3|NOT COMPLETED|PK Period||0
8445178|NCT00785538|20811794|P2|NOT COMPLETED|PK Period||0
8445179|NCT00785538|20811795|P1|NOT COMPLETED|PK Period||0
8445180|NCT00785538|20811792|P4|COMPLETED|PK Period||0
8445181|NCT00785538|20811793|P3|COMPLETED|PK Period||1
8445182|NCT00785538|20811794|P2|COMPLETED|PK Period||1
8445183|NCT00785538|20811795|P1|COMPLETED|PK Period||7
8445184|NCT00785538|20811792|P4|STARTED|PK Period||0
8445185|NCT00785538|20811793|P3|STARTED|PK Period||1
8445186|NCT00785538|20811794|P2|STARTED|PK Period||1
8445187|NCT00785538|20811795|P1|STARTED|PK Period||7
8445188|NCT00785512|20811843|P2|NOT COMPLETED|Overall Study||4
8445189|NCT00785512|20811844|P1|NOT COMPLETED|Overall Study||3
8445190|NCT00785512|20811843|P2|COMPLETED|Overall Study||101
8445191|NCT00785512|20811844|P1|COMPLETED|Overall Study||99
8445192|NCT00785512|20811843|P2|STARTED|Overall Study||105
8445193|NCT00785512|20811844|P1|STARTED|Overall Study||102
8445194|NCT00785486|20811853|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
8445195|NCT00785486|20811853|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
8445196|NCT00785486|20811853|P1|STARTED|Midazolam With Qualaquin at Steady State||23
8445197|NCT00785486|20811853|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
8445198|NCT00785486|20811853|P1|COMPLETED|Qualaquin Alone at Steady State||23
8445199|NCT00785486|20811853|P1|STARTED|Qualaquin Alone at Steady State||23
8445200|NCT00785486|20811853|P1|NOT COMPLETED|3 Day Washout||0
8445201|NCT00785486|20811853|P1|COMPLETED|3 Day Washout||23
8445202|NCT00785486|20811853|P1|STARTED|3 Day Washout||23
8445203|NCT00785486|20811853|P1|NOT COMPLETED|Midazolam Alone||1
8445204|NCT00785486|20811853|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
8445205|NCT00785486|20811853|P1|STARTED|Midazolam Alone||24
8445206|NCT00785356|20811877|P1|NOT COMPLETED|Overall Study||8
8445207|NCT00785356|20811877|P1|COMPLETED|Overall Study||0
8445208|NCT00785356|20811877|P1|STARTED|Overall Study||8
8445218|NCT00785213|20811910|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
8445219|NCT00785213|20811910|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
8445220|NCT00785213|20811910|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
8445221|NCT00785213|20811910|P1|NOT COMPLETED|Quinine Sulfate Alone||4
8445222|NCT00785213|20811910|P1|COMPLETED|Quinine Sulfate Alone||19
8445223|NCT00785213|20811910|P1|STARTED|Quinine Sulfate Alone||23
8445224|NCT00785213|20811910|P1|NOT COMPLETED|2 Day Washout Period||0
8445225|NCT00785213|20811910|P1|COMPLETED|2 Day Washout Period||23
8445226|NCT00785213|20811910|P1|STARTED|2 Day Washout Period||23
8445227|NCT00785213|20811910|P1|NOT COMPLETED|Rosiglitazone Alone||0
8445228|NCT00785213|20811910|P1|COMPLETED|Rosiglitazone Alone||23
8445229|NCT00785213|20811910|P1|STARTED|Rosiglitazone Alone||23
8445230|NCT00785044|20811921|P1|NOT COMPLETED|Overall Study||496
8445231|NCT00785044|20811921|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
8445232|NCT00785044|20811921|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
8445233|NCT00785044|20811921|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
8445234|NCT00784979|20811926|P1|NOT COMPLETED|Overall Study||6
8445235|NCT00784979|20811926|P1|COMPLETED|Overall Study||20
8445236|NCT00784979|20811926|P1|STARTED|Overall Study||26
8445237|NCT00784927|20811930|P1|NOT COMPLETED|Overall Study||3
8445238|NCT00784927|20811930|P1|COMPLETED|Overall Study||33
8445239|NCT00784927|20811930|P1|STARTED|Overall Study||36
8445240|NCT00784875|20811942|P4|NOT COMPLETED|Period D||1
8445241|NCT00784875|20811943|P3|NOT COMPLETED|Period D||6
8445242|NCT00784875|20811944|P2|NOT COMPLETED|Period D||4
8445243|NCT00784875|20811945|P1|NOT COMPLETED|Period D||5
8445244|NCT00784875|20811942|P4|COMPLETED|Period D||87
8445245|NCT00784875|20811943|P3|COMPLETED|Period D||88
8445246|NCT00784875|20811944|P2|COMPLETED|Period D||85
8445247|NCT00784875|20811945|P1|COMPLETED|Period D||86
8445248|NCT00784875|20811942|P4|STARTED|Period D||88
8445249|NCT00784875|20811943|P3|STARTED|Period D||94
8445250|NCT00784875|20811944|P2|STARTED|Period D||89
8445251|NCT00784875|20811945|P1|STARTED|Period D||91
8445252|NCT00784875|20811942|P4|NOT COMPLETED|Period C||7
8445253|NCT00784875|20811943|P3|NOT COMPLETED|Period C||13
8445254|NCT00784875|20811944|P2|NOT COMPLETED|Period C||6
8445255|NCT00784875|20811945|P1|NOT COMPLETED|Period C||7
8445256|NCT00784875|20811942|P4|COMPLETED|Period C||91
8445257|NCT00784875|20811943|P3|COMPLETED|Period C||84
8445258|NCT00784875|20811944|P2|COMPLETED|Period C||91
8445259|NCT00784875|20811945|P1|COMPLETED|Period C||96
8445260|NCT00784875|20811942|P4|STARTED|Period C||98
8445261|NCT00784875|20811943|P3|STARTED|Period C||97
8445262|NCT00784875|20811944|P2|STARTED|Period C||97
8445263|NCT00784875|20811945|P1|STARTED|Period C||103
8445264|NCT00784875|20811942|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
8445265|NCT00784875|20811943|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
8445266|NCT00784875|20811944|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
8445267|NCT00784875|20811945|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
8445268|NCT00784875|20811942|P4|COMPLETED|Period B - Efficacy Endpoint||98
8445269|NCT00784875|20811943|P3|COMPLETED|Period B - Efficacy Endpoint||96
8445270|NCT00784875|20811944|P2|COMPLETED|Period B - Efficacy Endpoint||101
8445271|NCT00784875|20811945|P1|COMPLETED|Period B - Efficacy Endpoint||100
8445272|NCT00784875|20811942|P4|Cohort 2|Period B - Efficacy Endpoint||101
8445273|NCT00784875|20811943|P3|Cohort 2|Period B - Efficacy Endpoint||102
8445274|NCT00784875|20811944|P2|Cohort 2|Period B - Efficacy Endpoint||102
8445275|NCT00784875|20811945|P1|Cohort 2|Period B - Efficacy Endpoint||102
8445276|NCT00784875|20811942|P4|STARTED|Period B - Efficacy Endpoint||117
8445277|NCT00784875|20811943|P3|STARTED|Period B - Efficacy Endpoint||117
8445278|NCT00784875|20811944|P2|STARTED|Period B - Efficacy Endpoint||113
8445279|NCT00784875|20811945|P1|STARTED|Period B - Efficacy Endpoint||114
8445280|NCT00784875|20811942|P4|NOT COMPLETED|Period A - Baseline||182
8445281|NCT00784875|20811943|P3|NOT COMPLETED|Period A - Baseline||0
8445282|NCT00784875|20811944|P2|NOT COMPLETED|Period A - Baseline||0
8445283|NCT00784875|20811945|P1|NOT COMPLETED|Period A - Baseline||0
8445284|NCT00784875|20811942|P4|COMPLETED|Period A - Baseline||461
8445285|NCT00784875|20811943|P3|COMPLETED|Period A - Baseline||0
8445286|NCT00784875|20811944|P2|COMPLETED|Period A - Baseline||0
8445287|NCT00784875|20811945|P1|COMPLETED|Period A - Baseline||0
8445288|NCT00784875|20811942|P4|STARTED|Period A - Baseline||643
8445289|NCT00784875|20811943|P3|STARTED|Period A - Baseline||0
8445290|NCT00784875|20811944|P2|STARTED|Period A - Baseline||0
8445291|NCT00784875|20811945|P1|STARTED|Period A - Baseline||0
8445292|NCT00784849|20812059|P1|NOT COMPLETED|Overall Study||0
8445293|NCT00784849|20812059|P1|COMPLETED|Overall Study||62
8445294|NCT00784849|20812059|P1|STARTED|Overall Study||62
8445295|NCT00784836|20812065|P1|NOT COMPLETED|Overall Study||3
8445296|NCT00784836|20812065|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
8445297|NCT00784836|20812065|P1|STARTED|Overall Study||3
8445298|NCT00784810|20812072|P2|NOT COMPLETED|Overall Study||49
8445299|NCT00784810|20812073|P1|NOT COMPLETED|Overall Study||63
8445300|NCT00784810|20812072|P2|COMPLETED|Overall Study||74
8445301|NCT00784810|20812073|P1|COMPLETED|Overall Study||61
8445302|NCT00784810|20812072|P2|STARTED|Overall Study||123
8445303|NCT00784810|20812073|P1|STARTED|Overall Study||124
8445304|NCT00784784|20812083|P2|NOT COMPLETED|Overall Study||2
8445305|NCT00784784|20812084|P1|NOT COMPLETED|Overall Study||2
8445306|NCT00784784|20812083|P2|COMPLETED|Overall Study||40
8445307|NCT00784784|20812084|P1|COMPLETED|Overall Study||20
8445308|NCT00784784|20812083|P2|STARTED|Overall Study||42
8445309|NCT00784784|20812084|P1|STARTED|Overall Study||22
8445310|NCT00784758|20812094|P2|NOT COMPLETED|Overall Study||0
8445311|NCT00784758|20812095|P1|NOT COMPLETED|Overall Study||4
8445312|NCT00784758|20812094|P2|COMPLETED|Overall Study||39
8445313|NCT00784758|20812095|P1|COMPLETED|Overall Study||38
8445314|NCT00784758|20812094|P2|Completed Treatment|Overall Study||39
8445315|NCT00784758|20812095|P1|Completed Treatment|Overall Study||40
8445316|NCT00784758|20812094|P2|Began Treatment|Overall Study||39
8445317|NCT00784758|20812095|P1|Began Treatment|Overall Study||41
8445318|NCT00784758|20812094|P2|STARTED|Overall Study||39
8445319|NCT00784758|20812095|P1|STARTED|Overall Study||42
8445320|NCT00784719|20812144|P7|NOT COMPLETED|Overall Study||5
8445321|NCT00784719|20812145|P6|NOT COMPLETED|Overall Study||3
8445322|NCT00784719|20812146|P5|NOT COMPLETED|Overall Study||6
8445323|NCT00784719|20812147|P4|NOT COMPLETED|Overall Study||0
8445324|NCT00784719|20812148|P3|NOT COMPLETED|Overall Study||1
8445325|NCT00784719|20812149|P2|NOT COMPLETED|Overall Study||3
8445326|NCT00784719|20812150|P1|NOT COMPLETED|Overall Study||3
8445327|NCT00784719|20812144|P7|COMPLETED|Overall Study||42
8445328|NCT00784719|20812145|P6|COMPLETED|Overall Study||41
8445329|NCT00784719|20812146|P5|COMPLETED|Overall Study||42
8445330|NCT00784719|20812147|P4|COMPLETED|Overall Study||48
8445331|NCT00784719|20812148|P3|COMPLETED|Overall Study||46
8445332|NCT00784719|20812149|P2|COMPLETED|Overall Study||43
8445333|NCT00784719|20812150|P1|COMPLETED|Overall Study||44
8445334|NCT00784719|20812144|P7|STARTED|Overall Study||47
8445335|NCT00784719|20812145|P6|STARTED|Overall Study||44
8445336|NCT00784719|20812146|P5|STARTED|Overall Study||48
8445337|NCT00784719|20812147|P4|STARTED|Overall Study||48
8445338|NCT00784719|20812148|P3|STARTED|Overall Study||47
8445339|NCT00784719|20812149|P2|STARTED|Overall Study||46
8445340|NCT00784719|20812150|P1|STARTED|Overall Study||47
8445341|NCT00784654|20812320|P3|NOT COMPLETED|Randomized Withdrawal Period||63
8445342|NCT00784654|20812321|P2|NOT COMPLETED|Randomized Withdrawal Period||18
8445343|NCT00784654|20812322|P1|NOT COMPLETED|Randomized Withdrawal Period||0
8445344|NCT00784654|20812320|P3|COMPLETED|Randomized Withdrawal Period||16
8445345|NCT00784654|20812321|P2|COMPLETED|Randomized Withdrawal Period||60
8445346|NCT00784654|20812322|P1|COMPLETED|Randomized Withdrawal Period||0
8445347|NCT00784654|20812320|P3|STARTED|Randomized Withdrawal Period||79
8445348|NCT00784654|20812321|P2|STARTED|Randomized Withdrawal Period||78
8445349|NCT00784654|20812322|P1|STARTED|Randomized Withdrawal Period||0
8445350|NCT00784654|20812320|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
8445351|NCT00784654|20812321|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
8445352|NCT00784654|20812322|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
8445353|NCT00784654|20812320|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
8445354|NCT00784654|20812321|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
8445355|NCT00784654|20812322|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
8445356|NCT00784654|20812320|P3|STARTED|Open-Label Period (Non-Randomized)||0
8445357|NCT00784654|20812321|P2|STARTED|Open-Label Period (Non-Randomized)||0
8445358|NCT00784654|20812322|P1|STARTED|Open-Label Period (Non-Randomized)||276
8445359|NCT00784641|20812357|P3|NOT COMPLETED|Overall Study||2
8445360|NCT00784641|20812358|P2|NOT COMPLETED|Overall Study||3
8445361|NCT00784641|20812359|P1|NOT COMPLETED|Overall Study||6
8445362|NCT00784641|20812357|P3|COMPLETED|Overall Study||187
8445363|NCT00784641|20812358|P2|COMPLETED|Overall Study||186
8445364|NCT00784641|20812359|P1|COMPLETED|Overall Study||183
8445365|NCT00784641|20812357|P3|STARTED|Overall Study||189
8445366|NCT00784641|20812358|P2|STARTED|Overall Study||189
8445367|NCT00784641|20812359|P1|STARTED|Overall Study||189
8445368|NCT00784563|20812370|P3|NOT COMPLETED|Year 3||3
8445369|NCT00784563|20812371|P2|NOT COMPLETED|Year 3||0
8445370|NCT00784563|20812372|P1|NOT COMPLETED|Year 3||0
8445371|NCT00784563|20812370|P3|COMPLETED|Year 3||14
8445372|NCT00784563|20812371|P2|COMPLETED|Year 3||0
8445373|NCT00784563|20812372|P1|COMPLETED|Year 3||0
8445374|NCT00784563|20812370|P3|STARTED|Year 3||17
8445375|NCT00784563|20812371|P2|STARTED|Year 3||0
8445376|NCT00784563|20812372|P1|STARTED|Year 3||0
8445377|NCT00784563|20812370|P3|NOT COMPLETED|Years 1 & 2||0
8445378|NCT00784563|20812371|P2|NOT COMPLETED|Years 1 & 2||5
8445379|NCT00784563|20812372|P1|NOT COMPLETED|Years 1 & 2||3
8445380|NCT00784563|20812370|P3|COMPLETED|Years 1 & 2||0
8445381|NCT00784563|20812371|P2|COMPLETED|Years 1 & 2||17
8445382|NCT00784563|20812372|P1|COMPLETED|Years 1 & 2||18
8445383|NCT00784563|20812370|P3|STARTED|Years 1 & 2||0
8445384|NCT00784563|20812371|P2|STARTED|Years 1 & 2||22
8445385|NCT00784563|20812372|P1|STARTED|Years 1 & 2||21
8445386|NCT00784550|20812390|P2|NOT COMPLETED|Overall Study||42
8445387|NCT00784550|20812391|P1|NOT COMPLETED|Overall Study||36
8445388|NCT00784550|20812390|P2|COMPLETED|Overall Study||127
8445389|NCT00784550|20812391|P1|COMPLETED|Overall Study||137
8445390|NCT00784550|20812390|P2|STARTED|Overall Study||169
8445391|NCT00784550|20812391|P1|STARTED|Overall Study||173
8445392|NCT00784524|20812407|P1|NOT COMPLETED|Overall Study||0
8445393|NCT00784524|20812407|P1|COMPLETED|Overall Study||14
8445394|NCT00784524|20812407|P1|STARTED|Overall Study||14
8445395|NCT00784459|20812417|P2|NOT COMPLETED|Overall Study||2
8445396|NCT00784459|20812418|P1|NOT COMPLETED|Overall Study||0
8445397|NCT00784459|20812417|P2|COMPLETED|Overall Study||11
8445398|NCT00784459|20812418|P1|COMPLETED|Overall Study||11
8445399|NCT00784459|20812417|P2|STARTED|Overall Study||13
8445400|NCT00784459|20812418|P1|STARTED|Overall Study||11
8445401|NCT00784368|20812429|P3|NOT COMPLETED|Overall Study||11
8445402|NCT00784368|20812430|P2|NOT COMPLETED|Overall Study||11
8445403|NCT00784368|20812431|P1|NOT COMPLETED|Overall Study||8
8445404|NCT00784368|20812429|P3|COMPLETED|Overall Study||12
8445405|NCT00784368|20812430|P2|COMPLETED|Overall Study||5
8445406|NCT00784368|20812431|P1|COMPLETED|Overall Study||8
8445407|NCT00784368|20812429|P3|STARTED|Overall Study||23
8445408|NCT00784368|20812430|P2|STARTED|Overall Study||16
8445409|NCT00784368|20812431|P1|STARTED|Overall Study||16
8445410|NCT00784303|20812467|P2|NOT COMPLETED|Overall Study||0
8445411|NCT00784303|20812468|P1|NOT COMPLETED|Overall Study||0
8445412|NCT00784303|20812467|P2|COMPLETED|Overall Study||59
8445413|NCT00784303|20812468|P1|COMPLETED|Overall Study||58
8445414|NCT00784303|20812467|P2|STARTED|Overall Study||59
8445415|NCT00784303|20812468|P1|STARTED|Overall Study||58
8445416|NCT00784277|20812507|P7|NOT COMPLETED|ER Treatment||15
8445417|NCT00784277|20812508|P6|NOT COMPLETED|ER Treatment||24
8445418|NCT00784277|20812509|P5|NOT COMPLETED|ER Treatment||9
8445419|NCT00784277|20812510|P4|NOT COMPLETED|ER Treatment||0
8445420|NCT00784277|20812511|P3|NOT COMPLETED|ER Treatment||0
8445421|NCT00784277|20812512|P2|NOT COMPLETED|ER Treatment||0
8445422|NCT00784277|20812513|P1|NOT COMPLETED|ER Treatment||0
8445423|NCT00784277|20812507|P7|COMPLETED|ER Treatment||76
8445424|NCT00784277|20812508|P6|COMPLETED|ER Treatment||226
8445425|NCT00784277|20812509|P5|COMPLETED|ER Treatment||113
8445426|NCT00784277|20812510|P4|COMPLETED|ER Treatment||0
8445427|NCT00784277|20812511|P3|COMPLETED|ER Treatment||0
8445428|NCT00784277|20812512|P2|COMPLETED|ER Treatment||0
8445429|NCT00784277|20812513|P1|COMPLETED|ER Treatment||0
8445430|NCT00784277|20812507|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
8445431|NCT00784277|20812508|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
8445432|NCT00784277|20812509|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
8445433|NCT00784277|20812510|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445434|NCT00784277|20812511|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445435|NCT00784277|20812512|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445436|NCT00784277|20812513|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445437|NCT00784277|20812507|P7|NOT COMPLETED|IR Treatment||0
8445438|NCT00784277|20812508|P6|NOT COMPLETED|IR Treatment||0
8445439|NCT00784277|20812509|P5|NOT COMPLETED|IR Treatment||0
8445440|NCT00784277|20812510|P4|NOT COMPLETED|IR Treatment||43
8445441|NCT00784277|20812511|P3|NOT COMPLETED|IR Treatment||28
8445442|NCT00784277|20812512|P2|NOT COMPLETED|IR Treatment||17
8445443|NCT00784277|20812513|P1|NOT COMPLETED|IR Treatment||16
8445444|NCT00784277|20812507|P7|COMPLETED|IR Treatment||0
8445445|NCT00784277|20812508|P6|COMPLETED|IR Treatment||0
8445446|NCT00784277|20812509|P5|COMPLETED|IR Treatment||0
8445447|NCT00784277|20812510|P4|COMPLETED|IR Treatment||100
8445448|NCT00784277|20812511|P3|COMPLETED|IR Treatment||126
8445449|NCT00784277|20812512|P2|COMPLETED|IR Treatment||134
8445450|NCT00784277|20812513|P1|COMPLETED|IR Treatment||132
8445451|NCT00784277|20812507|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8445452|NCT00784277|20812508|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8445453|NCT00784277|20812509|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8445454|NCT00784277|20812510|P4|STARTED|IR Treatment||143
8445455|NCT00784277|20812511|P3|STARTED|IR Treatment||154
8445456|NCT00784277|20812512|P2|STARTED|IR Treatment||151
8445457|NCT00784277|20812513|P1|STARTED|IR Treatment||148
8445458|NCT00784238|20812530|P1|NOT COMPLETED|Overall Study||119
8445459|NCT00784238|20812530|P1|COMPLETED|Overall Study||170
8445460|NCT00784238|20812530|P1|STARTED|Overall Study||289
8445461|NCT00784225|20812575|P4|NOT COMPLETED|Overall Study||0
8445462|NCT00784225|20812576|P3|NOT COMPLETED|Overall Study||0
8445463|NCT00784225|20812577|P2|NOT COMPLETED|Overall Study||0
8445464|NCT00784225|20812578|P1|NOT COMPLETED|Overall Study||0
8445465|NCT00784225|20812575|P4|COMPLETED|Overall Study||3374
8445466|NCT00784225|20812576|P3|COMPLETED|Overall Study||3369
8445467|NCT00784225|20812577|P2|COMPLETED|Overall Study||3357
8445468|NCT00784225|20812578|P1|COMPLETED|Overall Study||3375
8445469|NCT00784225|20812575|P4|STARTED|Overall Study||3374
8445470|NCT00784225|20812576|P3|STARTED|Overall Study||3369
8445471|NCT00784225|20812577|P2|STARTED|Overall Study||3357
8445472|NCT00784225|20812578|P1|STARTED|Overall Study||3375
8445473|NCT00784147|20812602|P2|NOT COMPLETED|Overall Study||9
8445474|NCT00784147|20812603|P1|NOT COMPLETED|Overall Study||8
8445475|NCT00784147|20812602|P2|COMPLETED|Overall Study||45
8445476|NCT00784147|20812603|P1|COMPLETED|Overall Study||51
8445477|NCT00784147|20812602|P2|STARTED|Overall Study||54
8445478|NCT00784147|20812603|P1|STARTED|Overall Study||59
8445479|NCT00784134|20812623|P2|NOT COMPLETED|Overall Study||6
8445480|NCT00784134|20812624|P1|NOT COMPLETED|Overall Study||3
8445481|NCT00784134|20812623|P2|COMPLETED|Overall Study||245
8445482|NCT00784134|20812624|P1|COMPLETED|Overall Study||246
8445483|NCT00784134|20812623|P2|STARTED|Overall Study||251
8445484|NCT00784134|20812624|P1|STARTED|Overall Study||249
8445485|NCT00784095|20812723|P3|NOT COMPLETED|Overall Study||1
8445486|NCT00784095|20812724|P2|NOT COMPLETED|Overall Study||1
8445487|NCT00784095|20812725|P1|NOT COMPLETED|Overall Study||0
8445488|NCT00784095|20812723|P3|COMPLETED|Overall Study||11
8445489|NCT00784095|20812724|P2|COMPLETED|Overall Study||11
8445490|NCT00784095|20812725|P1|COMPLETED|Overall Study||12
8445491|NCT00784095|20812723|P3|STARTED|Overall Study||12
8445492|NCT00784095|20812724|P2|STARTED|Overall Study||12
8445493|NCT00784095|20812725|P1|STARTED|Overall Study||12
8445494|NCT00784043|20812747|P2|NOT COMPLETED|Overall Study||6
8445495|NCT00784043|20812748|P1|NOT COMPLETED|Overall Study||31
8445496|NCT00784043|20812747|P2|COMPLETED|Overall Study||0
8445497|NCT00784043|20812748|P1|COMPLETED|Overall Study||0
8445498|NCT00784043|20812747|P2|STARTED|Overall Study||6
8445499|NCT00784043|20812748|P1|STARTED|Overall Study||31
8445500|NCT00784030|20812760|P2|NOT COMPLETED|Overall Study||0
8445501|NCT00784030|20812761|P1|NOT COMPLETED|Overall Study||0
8445502|NCT00784030|20812760|P2|COMPLETED|Overall Study||10
8445503|NCT00784030|20812761|P1|COMPLETED|Overall Study||13
8445504|NCT00784030|20812760|P2|STARTED|Overall Study||10
8445505|NCT00784030|20812761|P1|STARTED|Overall Study||13
8445506|NCT00783965|20812769|P2|NOT COMPLETED|Second Intervention (24 Months)||9
8445507|NCT00783965|20812770|P1|NOT COMPLETED|Second Intervention (24 Months)||0
8445508|NCT00783965|20812769|P2|COMPLETED|Second Intervention (24 Months)||16
8445509|NCT00783965|20812770|P1|COMPLETED|Second Intervention (24 Months)||2
8445510|NCT00783965|20812769|P2|STARTED|Second Intervention (24 Months)||25
8445511|NCT00783965|20812770|P1|STARTED|Second Intervention (24 Months)||2
8445512|NCT00783965|20812769|P2|NOT COMPLETED|First Intervention (12 Months)||4
8445513|NCT00783965|20812770|P1|NOT COMPLETED|First Intervention (12 Months)||3
8445514|NCT00783965|20812769|P2|COMPLETED|First Intervention (12 Months)||25
8445515|NCT00783965|20812770|P1|COMPLETED|First Intervention (12 Months)||2
8445516|NCT00783965|20812769|P2|STARTED|First Intervention (12 Months)||29
8445517|NCT00783965|20812770|P1|STARTED|First Intervention (12 Months)||5
8445518|NCT00783952|20812778|P1|NOT COMPLETED|Overall Study||0
8445519|NCT00783952|20812778|P1|COMPLETED|Overall Study||8
8445520|NCT00783952|20812778|P1|STARTED|Overall Study||8
8445521|NCT00783835|20812783|P1|NOT COMPLETED|Overall Study||10
8445522|NCT00783835|20812783|P1|COMPLETED|Overall Study||50
8445523|NCT00783835|20812783|P1|STARTED|Overall Study||60
8445524|NCT00783796|20812795|P1|NOT COMPLETED|Overall Study||6
8445525|NCT00783796|20812795|P1|COMPLETED|Overall Study||144
8445526|NCT00783796|20812795|P1|STARTED|Overall Study||150
8445527|NCT00783718|20812900|P7|NOT COMPLETED|Maintenance Phase||195
8445528|NCT00783718|20812901|P6|NOT COMPLETED|Maintenance Phase||41
8445529|NCT00783718|20812902|P5|NOT COMPLETED|Maintenance Phase||45
8445530|NCT00783718|20812903|P4|NOT COMPLETED|Maintenance Phase||78
8445531|NCT00783718|20812904|P3|NOT COMPLETED|Maintenance Phase||0
8445532|NCT00783718|20812905|P2|NOT COMPLETED|Maintenance Phase||0
8445533|NCT00783718|20812906|P1|NOT COMPLETED|Maintenance Phase||105
8445534|NCT00783718|20812900|P7|COMPLETED|Maintenance Phase||135
8445535|NCT00783718|20812901|P6|COMPLETED|Maintenance Phase||84
8445536|NCT00783718|20812902|P5|COMPLETED|Maintenance Phase||77
8445537|NCT00783718|20812903|P4|COMPLETED|Maintenance Phase||48
8445538|NCT00783718|20812904|P3|COMPLETED|Maintenance Phase||0
8445539|NCT00783718|20812905|P2|COMPLETED|Maintenance Phase||0
8445540|NCT00783718|20812906|P1|COMPLETED|Maintenance Phase||30
8445541|NCT00783718|20812900|P7|STARTED|Maintenance Phase||330
8445542|NCT00783718|20812901|P6|STARTED|Maintenance Phase||125
8445543|NCT00783718|20812902|P5|STARTED|Maintenance Phase||122
8445544|NCT00783718|20812903|P4|STARTED|Maintenance Phase||126
8445545|NCT00783718|20812904|P3|STARTED|Maintenance Phase||0
8445546|NCT00783718|20812905|P2|STARTED|Maintenance Phase||0
8445547|NCT00783718|20812906|P1|STARTED|Maintenance Phase||135
8445548|NCT00783718|20812900|P7|NOT COMPLETED|Induction Phase||0
8445549|NCT00783718|20812901|P6|NOT COMPLETED|Induction Phase||0
8445550|NCT00783718|20812902|P5|NOT COMPLETED|Induction Phase||0
8445551|NCT00783718|20812903|P4|NOT COMPLETED|Induction Phase||0
8445552|NCT00783718|20812904|P3|NOT COMPLETED|Induction Phase||36
8445553|NCT00783718|20812905|P2|NOT COMPLETED|Induction Phase||7
8445554|NCT00783718|20812906|P1|NOT COMPLETED|Induction Phase||14
8445555|NCT00783718|20812900|P7|COMPLETED|Induction Phase||0
8445556|NCT00783718|20812901|P6|COMPLETED|Induction Phase||0
8445557|NCT00783718|20812902|P5|COMPLETED|Induction Phase||0
8445558|NCT00783718|20812903|P4|COMPLETED|Induction Phase||0
8445559|NCT00783718|20812904|P3|COMPLETED|Induction Phase||485
8445560|NCT00783718|20812905|P2|COMPLETED|Induction Phase||218
8445561|NCT00783718|20812906|P1|COMPLETED|Induction Phase||135
8445562|NCT00783718|20812900|P7|STARTED|Induction Phase||0
8445563|NCT00783718|20812901|P6|STARTED|Induction Phase||0
8445564|NCT00783718|20812902|P5|STARTED|Induction Phase||0
8445565|NCT00783718|20812903|P4|STARTED|Induction Phase||0
8445566|NCT00783718|20812904|P3|STARTED|Induction Phase||521
8445567|NCT00783718|20812905|P2|STARTED|Induction Phase||225
8445568|NCT00783718|20812906|P1|STARTED|Induction Phase||149
8445569|NCT00783705|20812934|P2|NOT COMPLETED|Overall Study||5
8445570|NCT00783705|20812935|P1|NOT COMPLETED|Overall Study||6
8445571|NCT00783705|20812934|P2|COMPLETED|Overall Study||36
8445572|NCT00783705|20812935|P1|COMPLETED|Overall Study||38
8445573|NCT00783705|20812934|P2|STARTED|Overall Study||41
8445574|NCT00783705|20812935|P1|STARTED|Overall Study||44
8445575|NCT00783692|20812982|P7|NOT COMPLETED|Maintenance Phase||249
8445576|NCT00783692|20812983|P6|NOT COMPLETED|Maintenance Phase||72
8445577|NCT00783692|20812984|P5|NOT COMPLETED|Maintenance Phase||81
8445578|NCT00783692|20812985|P4|NOT COMPLETED|Maintenance Phase||89
8445579|NCT00783692|20812986|P3|NOT COMPLETED|Maintenance Phase||0
8445580|NCT00783692|20812987|P2|NOT COMPLETED|Maintenance Phase||0
8445581|NCT00783692|20812988|P1|NOT COMPLETED|Maintenance Phase||95
8445582|NCT00783692|20812982|P7|COMPLETED|Maintenance Phase||163
8445583|NCT00783692|20812983|P6|COMPLETED|Maintenance Phase||82
8445584|NCT00783692|20812984|P5|COMPLETED|Maintenance Phase||73
8445585|NCT00783692|20812985|P4|COMPLETED|Maintenance Phase||64
8445586|NCT00783692|20812986|P3|COMPLETED|Maintenance Phase||0
8445587|NCT00783692|20812987|P2|COMPLETED|Maintenance Phase||0
8445588|NCT00783692|20812988|P1|COMPLETED|Maintenance Phase||42
8445589|NCT00783692|20812982|P7|STARTED|Maintenance Phase||412
8445590|NCT00783692|20812983|P6|STARTED|Maintenance Phase||154
8445591|NCT00783692|20812984|P5|STARTED|Maintenance Phase||154
8445592|NCT00783692|20812985|P4|STARTED|Maintenance Phase||153
8445593|NCT00783692|20812986|P3|STARTED|Maintenance Phase||0
8445594|NCT00783692|20812987|P2|STARTED|Maintenance Phase||0
8445595|NCT00783692|20812988|P1|STARTED|Maintenance Phase||137
8445596|NCT00783692|20812982|P7|NOT COMPLETED|Induction Phase||0
8445597|NCT00783692|20812983|P6|NOT COMPLETED|Induction Phase||0
8445598|NCT00783692|20812984|P5|NOT COMPLETED|Induction Phase||0
8445599|NCT00783692|20812985|P4|NOT COMPLETED|Induction Phase||0
8445600|NCT00783692|20812986|P3|NOT COMPLETED|Induction Phase||74
8445601|NCT00783692|20812987|P2|NOT COMPLETED|Induction Phase||21
8445602|NCT00783692|20812988|P1|NOT COMPLETED|Induction Phase||11
8445603|NCT00783692|20812982|P7|COMPLETED|Induction Phase||0
8445604|NCT00783692|20812983|P6|COMPLETED|Induction Phase||0
8445605|NCT00783692|20812984|P5|COMPLETED|Induction Phase||0
8445606|NCT00783692|20812985|P4|COMPLETED|Induction Phase||0
8445607|NCT00783692|20812986|P3|COMPLETED|Induction Phase||674
8445608|NCT00783692|20812987|P2|COMPLETED|Induction Phase||199
8445609|NCT00783692|20812988|P1|COMPLETED|Induction Phase||137
8445610|NCT00783692|20812982|P7|Treated|Induction Phase||0
8445611|NCT00783692|20812983|P6|Treated|Induction Phase||0
8445612|NCT00783692|20812984|P5|Treated|Induction Phase||0
8445613|NCT00783692|20812985|P4|Treated|Induction Phase||0
8445614|NCT00783692|20812986|P3|Treated|Induction Phase||747
8445615|NCT00783692|20812987|P2|Treated|Induction Phase||220
8445616|NCT00783692|20812988|P1|Treated|Induction Phase||148
8445617|NCT00783692|20812982|P7|STARTED|Induction Phase||0
8445618|NCT00783692|20812983|P6|STARTED|Induction Phase||0
8445619|NCT00783692|20812984|P5|STARTED|Induction Phase||0
8445620|NCT00783692|20812985|P4|STARTED|Induction Phase||0
8445621|NCT00783692|20812986|P3|STARTED|Induction Phase||748
8445622|NCT00783692|20812987|P2|STARTED|Induction Phase||220
8445623|NCT00783692|20812988|P1|STARTED|Induction Phase||148
8445624|NCT00783614|20813015|P4|NOT COMPLETED|Overall Study||0
8445625|NCT00783614|20813016|P3|NOT COMPLETED|Overall Study||0
8445626|NCT00783614|20813017|P2|NOT COMPLETED|Overall Study||0
8445627|NCT00783614|20813018|P1|NOT COMPLETED|Overall Study||0
8445628|NCT00783614|20813015|P4|COMPLETED|Overall Study||5
8445629|NCT00783614|20813016|P3|COMPLETED|Overall Study||5
8445630|NCT00783614|20813017|P2|COMPLETED|Overall Study||6
8445631|NCT00783614|20813018|P1|COMPLETED|Overall Study||6
8445632|NCT00783614|20813015|P4|STARTED|Overall Study||5
8445633|NCT00783614|20813016|P3|STARTED|Overall Study||5
8445634|NCT00783614|20813017|P2|STARTED|Overall Study||6
8445635|NCT00783614|20813018|P1|STARTED|Overall Study||6
8445636|NCT00783432|20813034|P2|NOT COMPLETED|Overall Study||78
8445637|NCT00783432|20813035|P1|NOT COMPLETED|Overall Study||85
8445638|NCT00783432|20813034|P2|COMPLETED|Overall Study||354
8445639|NCT00783432|20813035|P1|COMPLETED|Overall Study||345
8445640|NCT00783432|20813034|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
8445641|NCT00783432|20813035|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
8445642|NCT00783302|20813045|P1|NOT COMPLETED|Overall Study||35
8445643|NCT00783302|20813045|P1|COMPLETED|Overall Study||850
8445644|NCT00783302|20813045|P1|STARTED|Overall Study||885
8445645|NCT00783289|20813067|P4|NOT COMPLETED|Overall Study||0
8445646|NCT00783289|20813068|P3|NOT COMPLETED|Overall Study||0
8445647|NCT00783289|20813069|P2|NOT COMPLETED|Overall Study||1
8445648|NCT00783289|20813070|P1|NOT COMPLETED|Overall Study||0
8445649|NCT00783289|20813067|P4|COMPLETED|Overall Study||6
8445650|NCT00783289|20813068|P3|COMPLETED|Overall Study||6
8445651|NCT00783289|20813069|P2|COMPLETED|Overall Study||6
8445652|NCT00783289|20813070|P1|COMPLETED|Overall Study||6
8445653|NCT00783289|20813067|P4|STARTED|Overall Study||6
8445654|NCT00783289|20813068|P3|STARTED|Overall Study||6
8445655|NCT00783289|20813069|P2|STARTED|Overall Study||7
8445656|NCT00783289|20813070|P1|STARTED|Overall Study||6
8445657|NCT00783263|20813100|P4|NOT COMPLETED|Overall Study||3
8445658|NCT00783263|20813101|P3|NOT COMPLETED|Overall Study||3
8445659|NCT00783263|20813102|P2|NOT COMPLETED|Overall Study||2
8445660|NCT00783263|20813103|P1|NOT COMPLETED|Overall Study||4
8445661|NCT00783263|20813100|P4|COMPLETED|Overall Study||118
8445662|NCT00783263|20813101|P3|COMPLETED|Overall Study||119
8445663|NCT00783263|20813102|P2|COMPLETED|Overall Study||96
8445664|NCT00783263|20813103|P1|COMPLETED|Overall Study||95
8445665|NCT00783263|20813100|P4|STARTED|Overall Study||121
8445666|NCT00783263|20813101|P3|STARTED|Overall Study||122
8445667|NCT00783263|20813102|P2|STARTED|Overall Study||98
8445668|NCT00783263|20813103|P1|STARTED|Overall Study||99
8445669|NCT00783224|20813133|P4|NOT COMPLETED|Overall Study||2
8445670|NCT00783224|20813134|P3|NOT COMPLETED|Overall Study||1
8445671|NCT00783224|20813135|P2|NOT COMPLETED|Overall Study||0
8445672|NCT00783224|20813136|P1|NOT COMPLETED|Overall Study||0
8445673|NCT00783224|20813133|P4|COMPLETED|Overall Study||140
8445674|NCT00783224|20813134|P3|COMPLETED|Overall Study||142
8445675|NCT00783224|20813135|P2|COMPLETED|Overall Study||34
8445676|NCT00783224|20813136|P1|COMPLETED|Overall Study||32
8445677|NCT00783224|20813133|P4|STARTED|Overall Study||142
8445678|NCT00783224|20813134|P3|STARTED|Overall Study||143
8445679|NCT00783224|20813135|P2|STARTED|Overall Study||34
8445680|NCT00783224|20813136|P1|STARTED|Overall Study||32
8445681|NCT00783198|20813148|P3|NOT COMPLETED|Overall Study||42
8445682|NCT00783198|20813149|P2|NOT COMPLETED|Overall Study||43
8445683|NCT00783198|20813150|P1|NOT COMPLETED|Overall Study||57
8445684|NCT00783198|20813148|P3|COMPLETED|Overall Study||146
8445685|NCT00783198|20813149|P2|COMPLETED|Overall Study||144
8445686|NCT00783198|20813150|P1|COMPLETED|Overall Study||133
8445687|NCT00783198|20813148|P3|STARTED|Overall Study||188
8445688|NCT00783198|20813149|P2|STARTED|Overall Study||187
8445689|NCT00783198|20813150|P1|STARTED|Overall Study||190
8445690|NCT00783094|20813173|P3|NOT COMPLETED|Open-Label Extension Period||30
8445691|NCT00783094|20813174|P2|NOT COMPLETED|Open-Label Extension Period||19
8445692|NCT00783094|20813175|P1|NOT COMPLETED|Open-Label Extension Period||22
8445693|NCT00783094|20813173|P3|COMPLETED|Open-Label Extension Period||101
8445694|NCT00783094|20813174|P2|COMPLETED|Open-Label Extension Period||109
8445695|NCT00783094|20813175|P1|COMPLETED|Open-Label Extension Period||113
8445696|NCT00783094|20813173|P3|STARTED|Open-Label Extension Period||131
8445697|NCT00783094|20813174|P2|STARTED|Open-Label Extension Period||128
8445698|NCT00783094|20813175|P1|STARTED|Open-Label Extension Period||135
8445699|NCT00783094|20813173|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
8445700|NCT00783094|20813174|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
8445701|NCT00783094|20813175|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
8445702|NCT00783094|20813173|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
8445703|NCT00783094|20813174|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
8445704|NCT00783094|20813175|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
8445705|NCT00783094|20813173|P3|STARTED|Randomized Double-Blind Treatment Period||140
8445706|NCT00783094|20813174|P2|STARTED|Randomized Double-Blind Treatment Period||140
8445707|NCT00783094|20813175|P1|STARTED|Randomized Double-Blind Treatment Period||142
8445708|NCT00782834|20813251|P1|NOT COMPLETED|Treatment Phase||1
8445709|NCT00782834|20813251|P1|COMPLETED|Treatment Phase||13
8445710|NCT00782834|20813251|P1|STARTED|Treatment Phase||14
8445711|NCT00782834|20813251|P1|NOT COMPLETED|Screened Patients||1
8445712|NCT00782834|20813251|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
8445713|NCT00782834|20813251|P1|STARTED|Screened Patients||15
8445714|NCT00782821|20813260|P4|NOT COMPLETED|Overall Study||2
8445715|NCT00782821|20813261|P3|NOT COMPLETED|Overall Study||1
8445716|NCT00782821|20813262|P2|NOT COMPLETED|Overall Study||0
8445717|NCT00782821|20813263|P1|NOT COMPLETED|Overall Study||0
8445718|NCT00782821|20813260|P4|COMPLETED|Overall Study||8
8445719|NCT00782821|20813261|P3|COMPLETED|Overall Study||9
8445720|NCT00782821|20813262|P2|COMPLETED|Overall Study||10
8445721|NCT00782821|20813263|P1|COMPLETED|Overall Study||10
8445722|NCT00782821|20813260|P4|STARTED|Overall Study||10
8445723|NCT00782821|20813261|P3|STARTED|Overall Study||10
8445724|NCT00782821|20813262|P2|STARTED|Overall Study||10
8445725|NCT00782821|20813263|P1|STARTED|Overall Study||10
8445726|NCT00782795|20813291|P2|NOT COMPLETED|Overall Study||2
8445727|NCT00782795|20813292|P1|NOT COMPLETED|Overall Study||1
8445728|NCT00782795|20813291|P2|COMPLETED|Overall Study||6
8445729|NCT00782795|20813292|P1|COMPLETED|Overall Study||16
8445730|NCT00782795|20813291|P2|24 Week Appointment|Overall Study||7
8445731|NCT00782795|20813292|P1|24 Week Appointment|Overall Study||16
8445732|NCT00782795|20813291|P2|6 Weeks (1st Apptment)|Overall Study||7
8445733|NCT00782795|20813292|P1|6 Weeks (1st Apptment)|Overall Study||16
8445734|NCT00782795|20813291|P2|STARTED|Overall Study||8
8445735|NCT00782795|20813292|P1|STARTED|Overall Study||17
8445736|NCT00782756|20813324|P1|NOT COMPLETED|Overall Study||0
8445737|NCT00782756|20813324|P1|COMPLETED|Overall Study||40
8445738|NCT00782756|20813324|P1|STARTED|Overall Study||40
8445739|NCT00782717|20813332|P2|NOT COMPLETED|Overall Study||28
8445740|NCT00782717|20813333|P1|NOT COMPLETED|Overall Study||15
8445741|NCT00782717|20813332|P2|COMPLETED|Overall Study||102
8445742|NCT00782717|20813333|P1|COMPLETED|Overall Study||118
8445743|NCT00782717|20813332|P2|STARTED|Overall Study||130
8445744|NCT00782717|20813333|P1|STARTED|Overall Study||133
8445745|NCT00782639|20813343|P2|NOT COMPLETED|Overall Study||0
8445746|NCT00782639|20813344|P1|NOT COMPLETED|Overall Study||0
8445747|NCT00782639|20813343|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
8445748|NCT00782639|20813344|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
8445749|NCT00782639|20813343|P2|STARTED|Overall Study||11
8445750|NCT00782639|20813344|P1|STARTED|Overall Study||12
8445751|NCT00782626|20813360|P1|NOT COMPLETED|Overall Study||7
8445752|NCT00782626|20813360|P1|COMPLETED|Overall Study||16
8445753|NCT00782626|20813360|P1|STARTED|Overall Study||23
8445754|NCT00782509|20813367|P3|NOT COMPLETED|Overall Study||36
8445755|NCT00782509|20813368|P2|NOT COMPLETED|Overall Study||24
8445756|NCT00782509|20813369|P1|NOT COMPLETED|Overall Study||41
8445757|NCT00782509|20813367|P3|COMPLETED|Overall Study||181
8445758|NCT00782509|20813368|P2|COMPLETED|Overall Study||185
8445759|NCT00782509|20813369|P1|COMPLETED|Overall Study||175
8445760|NCT00782509|20813367|P3|STARTED|Overall Study||217
8445761|NCT00782509|20813368|P2|STARTED|Overall Study||209
8445762|NCT00782509|20813369|P1|STARTED|Overall Study||216
8445763|NCT00782496|20813562|P2|NOT COMPLETED|Overall Study||15
8445764|NCT00782496|20813563|P1|NOT COMPLETED|Overall Study||14
8445765|NCT00782496|20813562|P2|COMPLETED|Overall Study||90
8445766|NCT00782496|20813563|P1|COMPLETED|Overall Study||92
8445767|NCT00782496|20813562|P2|STARTED|Overall Study||105
8445768|NCT00782496|20813563|P1|STARTED|Overall Study||106
8445769|NCT00782483|20813570|P1|NOT COMPLETED|Overall Study||6
8445770|NCT00782483|20813570|P1|COMPLETED|Overall Study||0
8445771|NCT00782483|20813570|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
8445772|NCT00782418|20813574|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445773|NCT00782418|20813575|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445774|NCT00782418|20813576|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445775|NCT00782418|20813577|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445776|NCT00782418|20813578|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445777|NCT00782418|20813579|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445778|NCT00782418|20813580|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445779|NCT00782418|20813574|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445780|NCT00782418|20813575|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445781|NCT00782418|20813576|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
8445782|NCT00782418|20813577|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
8445783|NCT00782418|20813578|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445784|NCT00782418|20813579|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445785|NCT00782418|20813580|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
8445786|NCT00782418|20813574|P7|STARTED|Period 2 Procedure/Treatment Groups||4
8445787|NCT00782418|20813575|P6|STARTED|Period 2 Procedure/Treatment Groups||4
8445788|NCT00782418|20813576|P5|STARTED|Period 2 Procedure/Treatment Groups||3
8445789|NCT00782418|20813577|P4|STARTED|Period 2 Procedure/Treatment Groups||1
8445790|NCT00782418|20813578|P3|STARTED|Period 2 Procedure/Treatment Groups||4
8445791|NCT00782418|20813579|P2|STARTED|Period 2 Procedure/Treatment Groups||4
8445792|NCT00782418|20813580|P1|STARTED|Period 2 Procedure/Treatment Groups||3
8445793|NCT00782418|20813574|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445794|NCT00782418|20813575|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
8445795|NCT00782418|20813576|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
8445796|NCT00782418|20813577|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445797|NCT00782418|20813578|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445798|NCT00782418|20813579|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445799|NCT00782418|20813580|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
8445800|NCT00782418|20813574|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445801|NCT00782418|20813575|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445802|NCT00782418|20813576|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445803|NCT00782418|20813577|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
8445804|NCT00782418|20813578|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445805|NCT00782418|20813579|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445806|NCT00782418|20813580|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
8445807|NCT00782418|20813574|P7|STARTED|Period 1 Procedure/Treatment Groups||4
8445808|NCT00782418|20813575|P6|STARTED|Period 1 Procedure/Treatment Groups||5
8445809|NCT00782418|20813576|P5|STARTED|Period 1 Procedure/Treatment Groups||5
8445810|NCT00782418|20813577|P4|STARTED|Period 1 Procedure/Treatment Groups||2
8445811|NCT00782418|20813578|P3|STARTED|Period 1 Procedure/Treatment Groups||4
8445812|NCT00782418|20813579|P2|STARTED|Period 1 Procedure/Treatment Groups||4
8445813|NCT00782418|20813580|P1|STARTED|Period 1 Procedure/Treatment Groups||3
8445814|NCT00782379|20813600|P1|NOT COMPLETED|Overall Study||0
8445815|NCT00782379|20813600|P1|COMPLETED|Overall Study||20
8445816|NCT00782379|20813600|P1|STARTED|Overall Study||20
8445817|NCT00782340|20813617|P3|NOT COMPLETED|Randomized Double Blind||0
8445818|NCT00782340|20813618|P2|NOT COMPLETED|Randomized Double Blind||0
8445819|NCT00782340|20813619|P1|NOT COMPLETED|Randomized Double Blind||0
8445820|NCT00782340|20813617|P3|COMPLETED|Randomized Double Blind||80
8445821|NCT00782340|20813618|P2|COMPLETED|Randomized Double Blind||82
8445822|NCT00782340|20813619|P1|COMPLETED|Randomized Double Blind||0
8445823|NCT00782340|20813617|P3|STARTED|Randomized Double Blind||80
8445824|NCT00782340|20813618|P2|STARTED|Randomized Double Blind||82
8445825|NCT00782340|20813619|P1|STARTED|Randomized Double Blind||0
8445826|NCT00782340|20813617|P3|NOT COMPLETED|Open Label Titration||0
8445827|NCT00782340|20813618|P2|NOT COMPLETED|Open Label Titration||0
8445828|NCT00782340|20813619|P1|NOT COMPLETED|Open Label Titration||101
8445829|NCT00782340|20813617|P3|COMPLETED|Open Label Titration||0
8445830|NCT00782340|20813618|P2|COMPLETED|Open Label Titration||0
8445831|NCT00782340|20813619|P1|COMPLETED|Open Label Titration||162
8445832|NCT00782340|20813617|P3|STARTED|Open Label Titration||0
8445833|NCT00782340|20813618|P2|STARTED|Open Label Titration||0
8445834|NCT00782340|20813619|P1|STARTED|Open Label Titration||263
8445835|NCT00782288|20813645|P3|NOT COMPLETED|Overall Study||0
8445836|NCT00782288|20813646|P2|NOT COMPLETED|Overall Study||0
8445837|NCT00782288|20813647|P1|NOT COMPLETED|Overall Study||0
8445838|NCT00782288|20813645|P3|COMPLETED|Overall Study||8
8445839|NCT00782288|20813646|P2|COMPLETED|Overall Study||8
8445840|NCT00782288|20813647|P1|COMPLETED|Overall Study||8
8445841|NCT00782288|20813645|P3|STARTED|Overall Study||8
8445842|NCT00782288|20813646|P2|STARTED|Overall Study||8
8445843|NCT00782288|20813647|P1|STARTED|Overall Study||8
8445844|NCT00782275|20813689|P1|NOT COMPLETED|Overall Study||41
8445845|NCT00782275|20813689|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8445846|NCT00782275|20813689|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
8445847|NCT00782275|20813689|P1|Treated|Overall Study||40
8445848|NCT00782275|20813689|P1|STARTED|Overall Study||41
8445849|NCT00782210|20813698|P3|NOT COMPLETED|Overall Study||35
8445850|NCT00782210|20813699|P2|NOT COMPLETED|Overall Study||35
8445851|NCT00782210|20813700|P1|NOT COMPLETED|Overall Study||50
8445852|NCT00782210|20813698|P3|COMPLETED|Overall Study||172
8445853|NCT00782210|20813699|P2|COMPLETED|Overall Study||173
8445854|NCT00782210|20813700|P1|COMPLETED|Overall Study||159
8445855|NCT00782210|20813698|P3|STARTED|Overall Study||207
8445856|NCT00782210|20813699|P2|STARTED|Overall Study||208
8445857|NCT00782210|20813700|P1|STARTED|Overall Study||209
8445858|NCT00782184|20813893|P2|NOT COMPLETED|Overall Study||5
8445859|NCT00782184|20813894|P1|NOT COMPLETED|Overall Study||4
8445860|NCT00782184|20813893|P2|COMPLETED|Overall Study||125
8445861|NCT00782184|20813894|P1|COMPLETED|Overall Study||116
8445862|NCT00782184|20813893|P2|STARTED|Overall Study||130
8445863|NCT00782184|20813894|P1|STARTED|Overall Study||120
8445864|NCT00782171|20813931|P2|NOT COMPLETED|Overall Study||19
8445865|NCT00782171|20813932|P1|NOT COMPLETED|Overall Study||22
8445866|NCT00782171|20813931|P2|COMPLETED|Overall Study||115
8445867|NCT00782171|20813932|P1|COMPLETED|Overall Study||124
8445868|NCT00782171|20813931|P2|Surgery (Baseline)|Overall Study||128
8445869|NCT00782171|20813932|P1|Surgery (Baseline)|Overall Study||138
8445870|NCT00782171|20813931|P2|1 Year|Overall Study||120
8445871|NCT00782171|20813932|P1|1 Year|Overall Study||131
8445872|NCT00782171|20813931|P2|20-23 Weeks|Overall Study||124
8445873|NCT00782171|20813932|P1|20-23 Weeks|Overall Study||135
8445874|NCT00782171|20813931|P2|STARTED|Overall Study||134
8445875|NCT00782171|20813932|P1|STARTED|Overall Study||146
8445876|NCT00782067|20813964|P1|NOT COMPLETED|Overall Study||116
8445877|NCT00782067|20813964|P1|COMPLETED|Overall Study||0
8445878|NCT00782067|20813964|P1|Primary Efficacy Population (PEP)|Overall Study||89
8445879|NCT00782067|20813964|P1|Safety Set (SS)|Overall Study||116
8445880|NCT00782067|20813964|P1|STARTED|Overall Study||116
8445881|NCT00781963|20813976|P2|NOT COMPLETED|Overall Study||2
8445882|NCT00781963|20813977|P1|NOT COMPLETED|Overall Study||17
8445883|NCT00781963|20813976|P2|COMPLETED|Overall Study||51
8445884|NCT00781963|20813977|P1|COMPLETED|Overall Study||89
8445885|NCT00781963|20813976|P2|STARTED|Overall Study||53
8445886|NCT00781963|20813977|P1|STARTED|Overall Study||106
8445887|NCT00781950|20813995|P2|NOT COMPLETED|Overall Study||13
8445888|NCT00781950|20813996|P1|NOT COMPLETED|Overall Study||11
8445889|NCT00781950|20813995|P2|COMPLETED|Overall Study||45
8445890|NCT00781950|20813996|P1|COMPLETED|Overall Study||41
8445891|NCT00781950|20813995|P2|STARTED|Overall Study||58
8445892|NCT00781950|20813996|P1|STARTED|Overall Study||52
8445893|NCT00781937|20814006|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
8445894|NCT00781937|20814007|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
8445895|NCT00781937|20814006|P2|COMPLETED|Follow up Period (Week 56-68)||141
8445896|NCT00781937|20814007|P1|COMPLETED|Follow up Period (Week 56-68)||153
8445897|NCT00781937|20814006|P2|STARTED|Follow up Period (Week 56-68)||146
8445898|NCT00781937|20814007|P1|STARTED|Follow up Period (Week 56-68)||159
8445899|NCT00781937|20814006|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
8445900|NCT00781937|20814007|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
8445901|NCT00781937|20814006|P2|COMPLETED|Main Trial Period Through Week 56||146
8445902|NCT00781937|20814007|P1|COMPLETED|Main Trial Period Through Week 56||159
8445903|NCT00781937|20814006|P2|STARTED|Main Trial Period Through Week 56||210
8445904|NCT00781937|20814007|P1|STARTED|Main Trial Period Through Week 56||212
8445905|NCT00781911|20814065|P2|NOT COMPLETED|Overall Study||8
8445906|NCT00781911|20814066|P1|NOT COMPLETED|Overall Study||6
8445907|NCT00781911|20814065|P2|COMPLETED|Overall Study||4
8445908|NCT00781911|20814066|P1|COMPLETED|Overall Study||25
8445909|NCT00781911|20814065|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
8445910|NCT00781911|20814066|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8445911|NCT00781911|20814065|P2|STARTED|Overall Study||12
8445912|NCT00781911|20814066|P1|STARTED|Overall Study||31
8445913|NCT00781898|20814094|P2|NOT COMPLETED|Overall Study||29
8445914|NCT00781898|20814095|P1|NOT COMPLETED|Overall Study||34
8445915|NCT00781898|20814094|P2|COMPLETED|Overall Study||126
8445916|NCT00781898|20814095|P1|COMPLETED|Overall Study||119
8445917|NCT00781898|20814094|P2|STARTED|Overall Study||155
8445918|NCT00781898|20814095|P1|STARTED|Overall Study||153
8445919|NCT00781885|20814101|P1|NOT COMPLETED|Overall Study||1
8445920|NCT00781885|20814101|P1|COMPLETED|Overall Study||18
8445921|NCT00781885|20814101|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
8445922|NCT00781885|20814101|P1|STARTED|Overall Study||19
8445923|NCT00781859|20814118|P2|NOT COMPLETED|Overall Study||9
8445924|NCT00781859|20814119|P1|NOT COMPLETED|Overall Study||19
8445925|NCT00781859|20814118|P2|COMPLETED|Overall Study||98
8445926|NCT00781859|20814119|P1|COMPLETED|Overall Study||200
8445927|NCT00781859|20814118|P2|STARTED|Overall Study||107
8445928|NCT00781859|20814119|P1|STARTED|Overall Study||219
8445929|NCT00781768|20814129|P2|NOT COMPLETED|Overall Study||2
8445930|NCT00781768|20814130|P1|NOT COMPLETED|Overall Study||0
8445931|NCT00781768|20814129|P2|COMPLETED|Overall Study||90
8445932|NCT00781768|20814130|P1|COMPLETED|Overall Study||89
8445933|NCT00781768|20814129|P2|STARTED|Overall Study||92
8445934|NCT00781768|20814130|P1|STARTED|Overall Study||89
8445935|NCT00781599|20814138|P2|NOT COMPLETED|Overall Study||4
8445936|NCT00781599|20814139|P1|NOT COMPLETED|Overall Study||7
8445937|NCT00781599|20814138|P2|COMPLETED|Overall Study||32
8445938|NCT00781599|20814139|P1|COMPLETED|Overall Study||29
8445939|NCT00781599|20814138|P2|STARTED|Overall Study||36
8445940|NCT00781599|20814139|P1|STARTED|Overall Study||36
8445941|NCT00781508|20814153|P2|NOT COMPLETED|Overall Study||0
8445942|NCT00781508|20814154|P1|NOT COMPLETED|Overall Study||0
8445943|NCT00781508|20814153|P2|COMPLETED|Overall Study||5
8445944|NCT00781508|20814154|P1|COMPLETED|Overall Study||5
8445945|NCT00781508|20814153|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
8445946|NCT00781508|20814154|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
8445947|NCT00781456|20814164|P2|NOT COMPLETED|Overall Study||16
8445948|NCT00781456|20814165|P1|NOT COMPLETED|Overall Study||21
8445949|NCT00781456|20814164|P2|COMPLETED|Overall Study||35
8445950|NCT00781456|20814165|P1|COMPLETED|Overall Study||37
8445951|NCT00781456|20814164|P2|Received Study Drug|Overall Study||49
8445952|NCT00781456|20814165|P1|Received Study Drug|Overall Study||57
8445953|NCT00781456|20814164|P2|STARTED|Overall Study||51
8445954|NCT00781456|20814165|P1|STARTED|Overall Study||58
8445955|NCT00781391|20814188|P3|NOT COMPLETED|Overall Study||784
8445956|NCT00781391|20814189|P2|NOT COMPLETED|Overall Study||807
8445957|NCT00781391|20814190|P1|NOT COMPLETED|Overall Study||879
8445958|NCT00781391|20814188|P3|COMPLETED|Overall Study||6250
8445959|NCT00781391|20814189|P2|COMPLETED|Overall Study||6228
8445960|NCT00781391|20814190|P1|COMPLETED|Overall Study||6157
8445961|NCT00781391|20814188|P3|Per Protocol Analysis Set|Overall Study||6982
8445962|NCT00781391|20814189|P2|Per Protocol Analysis Set|Overall Study||6995
8445963|NCT00781391|20814190|P1|Per Protocol Analysis Set|Overall Study||6993
8445964|NCT00781391|20814188|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
8445965|NCT00781391|20814189|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
8445966|NCT00781391|20814190|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
8445967|NCT00781391|20814188|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
8445968|NCT00781391|20814189|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
8445969|NCT00781391|20814190|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
8445970|NCT00781391|20814188|P3|STARTED|Overall Study||7034
8445971|NCT00781391|20814189|P2|STARTED|Overall Study||7035
8445972|NCT00781391|20814190|P1|STARTED|Overall Study||7036
8445973|NCT00781365|20814224|P2|NOT COMPLETED|Overall Study||36
8445974|NCT00781365|20814225|P1|NOT COMPLETED|Overall Study||34
8445975|NCT00781365|20814224|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
8445976|NCT00781365|20814225|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
8445977|NCT00781365|20814224|P2|STARTED|Overall Study||222
8445978|NCT00781365|20814225|P1|STARTED|Overall Study||228
8445979|NCT00781326|20814235|P1|NOT COMPLETED|Phase 2||0
8445980|NCT00781326|20814235|P1|COMPLETED|Phase 2||0
8445981|NCT00781326|20814235|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
8445982|NCT00781326|20814235|P1|NOT COMPLETED|Phase I||4
8445983|NCT00781326|20814235|P1|COMPLETED|Phase I||2
8445984|NCT00781326|20814235|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
8445985|NCT00781274|20814239|P1|NOT COMPLETED|Overall Study||2
8445986|NCT00781274|20814239|P1|COMPLETED|Overall Study||30
8445987|NCT00781274|20814239|P1|STARTED|Overall Study||32
8445988|NCT00781079|20814245|P2|NOT COMPLETED|Overall Study||17
8445989|NCT00781079|20814246|P1|NOT COMPLETED|Overall Study||27
8445990|NCT00781079|20814245|P2|COMPLETED|Overall Study||116
8445991|NCT00781079|20814246|P1|COMPLETED|Overall Study||122
8445992|NCT00781079|20814245|P2|STARTED|Overall Study||133
8445993|NCT00781079|20814246|P1|STARTED|Overall Study||149
8445994|NCT00780975|20814262|P1|NOT COMPLETED|Overall Study||8
8445995|NCT00780975|20814262|P1|COMPLETED|Overall Study||0
8445996|NCT00780975|20814262|P1|STARTED|Overall Study||8
8445997|NCT00780962|20814273|P2|NOT COMPLETED|Overall Study||27
8445998|NCT00780962|20814274|P1|NOT COMPLETED|Overall Study||15
8445999|NCT00780962|20814273|P2|COMPLETED|Overall Study||172
8446000|NCT00780962|20814274|P1|COMPLETED|Overall Study||185
8446001|NCT00780962|20814273|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
8446002|NCT00780962|20814274|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
8446003|NCT00780962|20814273|P2|STARTED|Overall Study||199
8446004|NCT00780962|20814274|P1|STARTED|Overall Study||200
8446005|NCT00780910|20814280|P1|NOT COMPLETED|Overall Study||2
8446006|NCT00780910|20814280|P1|COMPLETED|Overall Study||107
8446007|NCT00780910|20814280|P1|STARTED|Overall Study||109
8446008|NCT00780741|20814286|P2|NOT COMPLETED|Overall Study||10
8446009|NCT00780741|20814287|P1|NOT COMPLETED|Overall Study||7
8446010|NCT00780741|20814286|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
8446011|NCT00780741|20814287|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
8446012|NCT00780741|20814286|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
8446013|NCT00780741|20814287|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
8446014|NCT00780741|20814286|P2|STARTED|Overall Study|randomized|81
8446015|NCT00780741|20814287|P1|STARTED|Overall Study|randomized|82
8446016|NCT00780715|20814303|P4|NOT COMPLETED|Overall Study||0
8446017|NCT00780715|20814304|P3|NOT COMPLETED|Overall Study||0
8446018|NCT00780715|20814305|P2|NOT COMPLETED|Overall Study||0
8446019|NCT00780715|20814306|P1|NOT COMPLETED|Overall Study||0
8446020|NCT00780715|20814303|P4|COMPLETED|Overall Study||11
8446021|NCT00780715|20814304|P3|COMPLETED|Overall Study||6
8446022|NCT00780715|20814305|P2|COMPLETED|Overall Study||6
8446023|NCT00780715|20814306|P1|COMPLETED|Overall Study||6
8446024|NCT00780715|20814303|P4|STARTED|Overall Study||11
8446025|NCT00780715|20814304|P3|STARTED|Overall Study||6
8446026|NCT00780715|20814305|P2|STARTED|Overall Study||6
8446027|NCT00780715|20814306|P1|STARTED|Overall Study||6
8446028|NCT00780676|20814321|P5|NOT COMPLETED|Overall Study||0
8446029|NCT00780676|20814322|P4|NOT COMPLETED|Overall Study||0
8446030|NCT00780676|20814323|P3|NOT COMPLETED|Overall Study||0
8446031|NCT00780676|20814324|P2|NOT COMPLETED|Overall Study||0
8446032|NCT00780676|20814325|P1|NOT COMPLETED|Overall Study||0
8446033|NCT00780676|20814321|P5|COMPLETED|Overall Study||0
8446034|NCT00780676|20814322|P4|COMPLETED|Overall Study||0
8446035|NCT00780676|20814323|P3|COMPLETED|Overall Study||13
8446036|NCT00780676|20814324|P2|COMPLETED|Overall Study||8
8446037|NCT00780676|20814325|P1|COMPLETED|Overall Study||9
8446038|NCT00780676|20814321|P5|STARTED|Overall Study||0
8446039|NCT00780676|20814322|P4|STARTED|Overall Study||0
8446040|NCT00780676|20814323|P3|STARTED|Overall Study||13
8446041|NCT00780676|20814324|P2|STARTED|Overall Study||8
8446042|NCT00780676|20814325|P1|STARTED|Overall Study||9
8446043|NCT00780572|20814333|P2|NOT COMPLETED|Overall Study||0
8446044|NCT00780572|20814334|P1|NOT COMPLETED|Overall Study||0
8446045|NCT00780572|20814333|P2|COMPLETED|Overall Study||298
8446046|NCT00780572|20814334|P1|COMPLETED|Overall Study||297
8446047|NCT00780572|20814333|P2|STARTED|Overall Study||298
8446048|NCT00780572|20814334|P1|STARTED|Overall Study||297
8446049|NCT00780559|20814342|P2|NOT COMPLETED|Overall Study||7
8446050|NCT00780559|20814343|P1|NOT COMPLETED|Overall Study||3
8446051|NCT00780559|20814342|P2|COMPLETED|Overall Study||33
8446052|NCT00780559|20814343|P1|COMPLETED|Overall Study||29
8446053|NCT00780559|20814342|P2|STARTED|Overall Study||40
8446054|NCT00780559|20814343|P1|STARTED|Overall Study||32
8446055|NCT00780494|20814357|P1|NOT COMPLETED|Overall Study||0
8446056|NCT00780494|20814357|P1|COMPLETED|Overall Study||35
8446057|NCT00780494|20814357|P1|STARTED|Overall Study||35
8446058|NCT00780481|20814366|P1|NOT COMPLETED|Overall Study||0
8446059|NCT00780481|20814366|P1|COMPLETED|Overall Study||13
8446060|NCT00780481|20814366|P1|STARTED|Overall Study||13
8446061|NCT00780455|20814375|P2|NOT COMPLETED|Overall Study||0
8446062|NCT00780455|20814376|P1|NOT COMPLETED|Overall Study||0
8446063|NCT00780455|20814375|P2|COMPLETED|Overall Study||2
8446064|NCT00780455|20814376|P1|COMPLETED|Overall Study||2
8446065|NCT00780455|20814375|P2|STARTED|Overall Study||2
8446066|NCT00780455|20814376|P1|STARTED|Overall Study||2
8446067|NCT00780442|20814402|P2|NOT COMPLETED|Overall Study||0
8446068|NCT00780442|20814403|P1|NOT COMPLETED|Overall Study||0
8446069|NCT00780442|20814402|P2|COMPLETED|Overall Study||15
8446070|NCT00780442|20814403|P1|COMPLETED|Overall Study||12
8446071|NCT00780442|20814402|P2|STARTED|Overall Study||15
8446072|NCT00780442|20814403|P1|STARTED|Overall Study||12
8446073|NCT00780416|20814411|P2|NOT COMPLETED|Overall Study||9
8446074|NCT00780416|20814412|P1|NOT COMPLETED|Overall Study||12
8446075|NCT00780416|20814411|P2|COMPLETED|Overall Study||54
8446076|NCT00780416|20814412|P1|COMPLETED|Overall Study||114
8446077|NCT00780416|20814411|P2|STARTED|Overall Study||63
8446078|NCT00780416|20814412|P1|STARTED|Overall Study||126
8446079|NCT00780403|20814418|P2|NOT COMPLETED|Second Intervention||0
8446080|NCT00780403|20814419|P1|NOT COMPLETED|Second Intervention||0
8446081|NCT00780403|20814418|P2|COMPLETED|Second Intervention||111
8446082|NCT00780403|20814419|P1|COMPLETED|Second Intervention||109
8446083|NCT00780403|20814418|P2|STARTED|Second Intervention||111
8446084|NCT00780403|20814419|P1|STARTED|Second Intervention||109
8446085|NCT00780403|20814418|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446086|NCT00780403|20814419|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446087|NCT00780403|20814418|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
8446088|NCT00780403|20814419|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
8446089|NCT00780403|20814418|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
8446090|NCT00780403|20814419|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
8446091|NCT00780403|20814418|P2|NOT COMPLETED|First Intervention||0
8446092|NCT00780403|20814419|P1|NOT COMPLETED|First Intervention||0
8446093|NCT00780403|20814418|P2|COMPLETED|First Intervention||111
8446094|NCT00780403|20814419|P1|COMPLETED|First Intervention||109
8446095|NCT00780403|20814418|P2|STARTED|First Intervention||111
8446096|NCT00780403|20814419|P1|STARTED|First Intervention||109
8446097|NCT00780338|20814428|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
8446098|NCT00780338|20814429|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
8446099|NCT00780338|20814428|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
8446100|NCT00780338|20814429|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
8446101|NCT00780338|20814428|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
8446102|NCT00780338|20814429|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
8446103|NCT00780338|20814428|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
8446104|NCT00780338|20814429|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
8446105|NCT00780338|20814428|P2|COMPLETED|Baseline to Mid (1 Year)||164
8446106|NCT00780338|20814429|P1|COMPLETED|Baseline to Mid (1 Year)||169
8446107|NCT00780338|20814428|P2|STARTED|Baseline to Mid (1 Year)||202
8446108|NCT00780338|20814429|P1|STARTED|Baseline to Mid (1 Year)||174
8446109|NCT00780273|20814457|P1|NOT COMPLETED|Overall Study||2
8446110|NCT00780273|20814457|P1|COMPLETED|Overall Study||17
8446111|NCT00780273|20814457|P1|STARTED|Overall Study||19
8446112|NCT00780234|20814468|P2|NOT COMPLETED|Overall Study||8
8446113|NCT00780234|20814469|P1|NOT COMPLETED|Overall Study||8
8446114|NCT00780234|20814468|P2|COMPLETED|Overall Study||37
8446115|NCT00780234|20814469|P1|COMPLETED|Overall Study||39
8446116|NCT00780234|20814468|P2|STARTED|Overall Study||45
8446117|NCT00780234|20814469|P1|STARTED|Overall Study||47
8446118|NCT00780208|20814475|P1|NOT COMPLETED|Overall Study||6
8446119|NCT00780208|20814475|P1|COMPLETED|Overall Study||8
8446120|NCT00780208|20814475|P1|STARTED|Overall Study||14
8446121|NCT00780143|20814480|P1|NOT COMPLETED|Overall Study||3
8446122|NCT00780143|20814480|P1|COMPLETED|Overall Study||0
8446123|NCT00780143|20814480|P1|STARTED|Overall Study||3
8446124|NCT00780026|20814488|P2|NOT COMPLETED|Overall Study||0
8446125|NCT00780026|20814489|P1|NOT COMPLETED|Overall Study||0
8446126|NCT00780026|20814488|P2|COMPLETED|Overall Study||50
8446127|NCT00780026|20814489|P1|COMPLETED|Overall Study||50
8446128|NCT00780026|20814488|P2|STARTED|Overall Study||50
8446129|NCT00780026|20814489|P1|STARTED|Overall Study||50
8446130|NCT00779909|20814511|P4|NOT COMPLETED|Overall Study||1
8446131|NCT00779909|20814512|P3|NOT COMPLETED|Overall Study||0
8446132|NCT00779909|20814513|P2|NOT COMPLETED|Overall Study||1
8446133|NCT00779909|20814514|P1|NOT COMPLETED|Overall Study||1
8446134|NCT00779909|20814511|P4|COMPLETED|Overall Study||7
8446135|NCT00779909|20814512|P3|COMPLETED|Overall Study||8
8446136|NCT00779909|20814513|P2|COMPLETED|Overall Study||8
8446137|NCT00779909|20814514|P1|COMPLETED|Overall Study||9
8446138|NCT00779909|20814511|P4|STARTED|Overall Study||8
8446139|NCT00779909|20814512|P3|STARTED|Overall Study||8
8446140|NCT00779909|20814513|P2|STARTED|Overall Study||9
8446141|NCT00779909|20814514|P1|STARTED|Overall Study||10
8446142|NCT00779870|20814559|P3|NOT COMPLETED|Overall Study||0
8446143|NCT00779870|20814560|P2|NOT COMPLETED|Overall Study||0
8446144|NCT00779870|20814561|P1|NOT COMPLETED|Overall Study||0
8446145|NCT00779870|20814559|P3|COMPLETED|Overall Study||7
8446146|NCT00779870|20814560|P2|COMPLETED|Overall Study||6
8446147|NCT00779870|20814561|P1|COMPLETED|Overall Study||5
8446148|NCT00779870|20814559|P3|STARTED|Overall Study||7
8446149|NCT00779870|20814560|P2|STARTED|Overall Study||6
8446150|NCT00779870|20814561|P1|STARTED|Overall Study||5
8446151|NCT00779857|20814578|P1|NOT COMPLETED|Overall Study||6
8446152|NCT00779857|20814578|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
8446153|NCT00779857|20814578|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
8446154|NCT00779857|20814578|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
8446155|NCT00779857|20814578|P1|STARTED|Overall Study|70 patients treated|70
8446156|NCT00779779|20814583|P1|NOT COMPLETED|Overall Study||24
8446157|NCT00779779|20814583|P1|COMPLETED|Overall Study||498
8446158|NCT00779779|20814583|P1|STARTED|Overall Study||522
8446159|NCT00779766|20814592|P2|NOT COMPLETED|Month 72||189
8446160|NCT00779766|20814593|P1|NOT COMPLETED|Month 72||185
8446161|NCT00779766|20814592|P2|COMPLETED|Month 72||2158
8446162|NCT00779766|20814593|P1|COMPLETED|Month 72||2134
8446163|NCT00779766|20814592|P2|STARTED|Month 72||2347
8446164|NCT00779766|20814593|P1|STARTED|Month 72||2319
8446165|NCT00779766|20814592|P2|NOT COMPLETED|Month 48||168
8446166|NCT00779766|20814593|P1|NOT COMPLETED|Month 48||174
8446167|NCT00779766|20814592|P2|COMPLETED|Month 48||2559
8446168|NCT00779766|20814593|P1|COMPLETED|Month 48||2529
8446169|NCT00779766|20814592|P2|STARTED|Month 48||2727
8446170|NCT00779766|20814593|P1|STARTED|Month 48||2703
8446171|NCT00779766|20814592|P2|NOT COMPLETED|Month 24||332
8446172|NCT00779766|20814593|P1|NOT COMPLETED|Month 24||332
8446173|NCT00779766|20814592|P2|COMPLETED|Month 24||2693
8446174|NCT00779766|20814593|P1|COMPLETED|Month 24||2694
8446175|NCT00779766|20814592|P2|STARTED|Month 24||3025
8446176|NCT00779766|20814593|P1|STARTED|Month 24||3026
8446177|NCT00779701|20814677|P1|NOT COMPLETED|Overall Study||0
8446178|NCT00779701|20814677|P1|COMPLETED|Overall Study||27
8446179|NCT00779701|20814677|P1|STARTED|Overall Study||27
8446180|NCT00779675|20814681|P1|NOT COMPLETED|Extended Treatment Period||46
8446181|NCT00779675|20814681|P1|COMPLETED|Extended Treatment Period||147
8446182|NCT00779675|20814681|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
8446183|NCT00779675|20814681|P1|NOT COMPLETED|Treatment Period||332
8446184|NCT00779675|20814681|P1|COMPLETED|Treatment Period||328
8446185|NCT00779675|20814681|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
8446186|NCT00779584|20814709|P9|NOT COMPLETED|Overall Study||2
8446187|NCT00779584|20814710|P8|NOT COMPLETED|Overall Study||3
8446188|NCT00779584|20814711|P7|NOT COMPLETED|Overall Study||8
8446189|NCT00779584|20814712|P6|NOT COMPLETED|Overall Study||6
8446190|NCT00779584|20814713|P5|NOT COMPLETED|Overall Study||7
8446191|NCT00779584|20814714|P4|NOT COMPLETED|Overall Study||6
8446192|NCT00779584|20814715|P3|NOT COMPLETED|Overall Study||7
8446193|NCT00779584|20814716|P2|NOT COMPLETED|Overall Study||3
8446194|NCT00779584|20814717|P1|NOT COMPLETED|Overall Study||3
8446195|NCT00779584|20814709|P9|COMPLETED|Overall Study||0
8446196|NCT00779584|20814710|P8|COMPLETED|Overall Study||0
8446197|NCT00779584|20814711|P7|COMPLETED|Overall Study||0
8446198|NCT00779584|20814712|P6|COMPLETED|Overall Study||0
8446199|NCT00779584|20814713|P5|COMPLETED|Overall Study||0
8446200|NCT00779584|20814714|P4|COMPLETED|Overall Study||0
8446201|NCT00779584|20814715|P3|COMPLETED|Overall Study||0
8446202|NCT00779584|20814716|P2|COMPLETED|Overall Study||0
8446203|NCT00779584|20814717|P1|COMPLETED|Overall Study||0
8446204|NCT00779584|20814709|P9|Treated|Overall Study||2
8446205|NCT00779584|20814710|P8|Treated|Overall Study||3
8446206|NCT00779584|20814711|P7|Treated|Overall Study||8
8446207|NCT00779584|20814712|P6|Treated|Overall Study||4
8446208|NCT00779584|20814713|P5|Treated|Overall Study||7
8446209|NCT00779584|20814714|P4|Treated|Overall Study||6
8446210|NCT00779584|20814715|P3|Treated|Overall Study||7
8446211|NCT00779584|20814716|P2|Treated|Overall Study||3
8446212|NCT00779584|20814717|P1|Treated|Overall Study||3
8446213|NCT00779584|20814709|P9|STARTED|Overall Study||2
8446214|NCT00779584|20814710|P8|STARTED|Overall Study||3
8446215|NCT00779584|20814711|P7|STARTED|Overall Study||8
8446216|NCT00779584|20814712|P6|STARTED|Overall Study||6
8446217|NCT00779584|20814713|P5|STARTED|Overall Study||7
8446218|NCT00779584|20814714|P4|STARTED|Overall Study||6
8446219|NCT00779584|20814715|P3|STARTED|Overall Study||7
8446220|NCT00779584|20814716|P2|STARTED|Overall Study||3
8446221|NCT00779584|20814717|P1|STARTED|Overall Study||3
8446222|NCT00779558|20814793|P2|NOT COMPLETED|Overall Study||7
8446223|NCT00779558|20814794|P1|NOT COMPLETED|Overall Study||4
8446224|NCT00779558|20814793|P2|COMPLETED|Overall Study||37
8446225|NCT00779558|20814794|P1|COMPLETED|Overall Study||53
8446226|NCT00779558|20814793|P2|STARTED|Overall Study||44
8446227|NCT00779558|20814794|P1|STARTED|Overall Study||57
8446228|NCT00779506|20814808|P1|NOT COMPLETED|Overall Study||29
8446229|NCT00779506|20814808|P1|COMPLETED|Overall Study||67
8446230|NCT00779506|20814808|P1|Withdrawal Treatment|Overall Study||27
8446231|NCT00779506|20814808|P1|Treatment Complete|Overall Study||67
8446232|NCT00779506|20814808|P1|MITT|Overall Study||89
8446233|NCT00779506|20814808|P1|Assigned|Overall Study||94
8446234|NCT00779506|20814808|P1|Screen Failed|Overall Study||2
8446235|NCT00779506|20814808|P1|Enrolled|Overall Study||96
8446236|NCT00779506|20814808|P1|STARTED|Overall Study||96
8446237|NCT00779467|20814822|P4|NOT COMPLETED|Overall Study||19
8446238|NCT00779467|20814823|P3|NOT COMPLETED|Overall Study||10
8446239|NCT00779467|20814824|P2|NOT COMPLETED|Overall Study||5
8446240|NCT00779467|20814825|P1|NOT COMPLETED|Overall Study||15
8446241|NCT00779467|20814822|P4|COMPLETED|Overall Study||35
8446242|NCT00779467|20814823|P3|COMPLETED|Overall Study||38
8446243|NCT00779467|20814824|P2|COMPLETED|Overall Study||40
8446244|NCT00779467|20814825|P1|COMPLETED|Overall Study||38
8446245|NCT00779467|20814822|P4|STARTED|Overall Study||54
8446246|NCT00779467|20814823|P3|STARTED|Overall Study||48
8446247|NCT00779467|20814824|P2|STARTED|Overall Study||45
8446248|NCT00779467|20814825|P1|STARTED|Overall Study||53
8446249|NCT00779402|20814865|P2|NOT COMPLETED|Long-term Follow-up||6
8446250|NCT00779402|20814866|P1|NOT COMPLETED|Long-term Follow-up||21
8446251|NCT00779402|20814865|P2|COMPLETED|Long-term Follow-up||7
8446252|NCT00779402|20814866|P1|COMPLETED|Long-term Follow-up||20
8446253|NCT00779402|20814865|P2|STARTED|Long-term Follow-up||13
8446254|NCT00779402|20814866|P1|STARTED|Long-term Follow-up||41
8446255|NCT00779402|20814865|P2|NOT COMPLETED|Surveillance Phase||31
8446256|NCT00779402|20814866|P1|NOT COMPLETED|Surveillance Phase||43
8446257|NCT00779402|20814865|P2|COMPLETED|Surveillance Phase||13
8446258|NCT00779402|20814866|P1|COMPLETED|Surveillance Phase||41
8446259|NCT00779402|20814865|P2|STARTED|Surveillance Phase||44
8446260|NCT00779402|20814866|P1|STARTED|Surveillance Phase||84
8446261|NCT00779402|20814865|P2|NOT COMPLETED|Treatment Phase 1||15
8446262|NCT00779402|20814866|P1|NOT COMPLETED|Treatment Phase 1||33
8446263|NCT00779402|20814865|P2|COMPLETED|Treatment Phase 1||44
8446264|NCT00779402|20814866|P1|COMPLETED|Treatment Phase 1||84
8446265|NCT00779402|20814865|P2|Received Booster Infusion|Treatment Phase 1||30
8446266|NCT00779402|20814866|P1|Received Booster Infusion|Treatment Phase 1||50
8446267|NCT00779402|20814865|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
8446268|NCT00779402|20814866|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
8446269|NCT00779402|20814865|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
8446355|NCT00778999|20815002|P2|COMPLETED|Overall Study||185
8446270|NCT00779402|20814866|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
8446271|NCT00779402|20814865|P2|STARTED|Treatment Phase 1||59
8446272|NCT00779402|20814866|P1|STARTED|Treatment Phase 1||117
8446273|NCT00779311|20814879|P5|NOT COMPLETED|Overall Study||0
8446274|NCT00779311|20814880|P4|NOT COMPLETED|Overall Study||0
8446275|NCT00779311|20814881|P3|NOT COMPLETED|Overall Study||0
8446276|NCT00779311|20814882|P2|NOT COMPLETED|Overall Study||0
8446277|NCT00779311|20814883|P1|NOT COMPLETED|Overall Study||0
8446278|NCT00779311|20814879|P5|COMPLETED|Overall Study||0
8446279|NCT00779311|20814880|P4|COMPLETED|Overall Study||0
8446280|NCT00779311|20814881|P3|COMPLETED|Overall Study||0
8446281|NCT00779311|20814882|P2|COMPLETED|Overall Study||0
8446282|NCT00779311|20814883|P1|COMPLETED|Overall Study||8
8446283|NCT00779311|20814879|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446284|NCT00779311|20814880|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446285|NCT00779311|20814881|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446286|NCT00779311|20814882|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446287|NCT00779311|20814883|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
8446288|NCT00779311|20814879|P5|STARTED|Overall Study||0
8446289|NCT00779311|20814880|P4|STARTED|Overall Study||0
8446290|NCT00779311|20814881|P3|STARTED|Overall Study||0
8446291|NCT00779311|20814882|P2|STARTED|Overall Study||0
8446292|NCT00779311|20814883|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
8446293|NCT00779285|20814905|P1|NOT COMPLETED|Overall Study||0
8446294|NCT00779285|20814905|P1|COMPLETED|Overall Study||1
8446295|NCT00779285|20814905|P1|STARTED|Overall Study||1
8446296|NCT00779259|20814909|P1|NOT COMPLETED|Theophylline With Quinine||0
8446297|NCT00779259|20814909|P1|COMPLETED|Theophylline With Quinine||22
8446298|NCT00779259|20814909|P1|STARTED|Theophylline With Quinine||22
8446299|NCT00779259|20814909|P1|NOT COMPLETED|Quinine Alone||2
8446300|NCT00779259|20814909|P1|COMPLETED|Quinine Alone||22
8446301|NCT00779259|20814909|P1|STARTED|Quinine Alone||24
8446302|NCT00779259|20814909|P1|NOT COMPLETED|4 Day Washout Period||0
8446303|NCT00779259|20814909|P1|COMPLETED|4 Day Washout Period||24
8446304|NCT00779259|20814909|P1|STARTED|4 Day Washout Period||24
8446305|NCT00779259|20814909|P1|NOT COMPLETED|Theophylline Alone||0
8446306|NCT00779259|20814909|P1|COMPLETED|Theophylline Alone||24
8446307|NCT00779259|20814909|P1|STARTED|Theophylline Alone||24
8446308|NCT00779246|20814930|P2|NOT COMPLETED|Overall Study||53
8446309|NCT00779246|20814931|P1|NOT COMPLETED|Overall Study||33
8446310|NCT00779246|20814930|P2|COMPLETED|Overall Study||715
8446311|NCT00779246|20814931|P1|COMPLETED|Overall Study||717
8446312|NCT00779246|20814930|P2|STARTED|Overall Study||768
8446313|NCT00779246|20814931|P1|STARTED|Overall Study||750
8446314|NCT00779155|20814943|P2|NOT COMPLETED|Overall Study||0
8446315|NCT00779155|20814944|P1|NOT COMPLETED|Overall Study||0
8446316|NCT00779155|20814943|P2|COMPLETED|Overall Study||6
8446317|NCT00779155|20814944|P1|COMPLETED|Overall Study||6
8446318|NCT00779155|20814943|P2|STARTED|Overall Study||6
8446319|NCT00779155|20814944|P1|STARTED|Overall Study||6
8446320|NCT00779142|20814950|P1|NOT COMPLETED|Overall Study||3
8446321|NCT00779142|20814950|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
8446322|NCT00779142|20814950|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
8446323|NCT00779116|20814956|P2|NOT COMPLETED|Second Intervention||0
8446324|NCT00779116|20814957|P1|NOT COMPLETED|Second Intervention||0
8446325|NCT00779116|20814956|P2|COMPLETED|Second Intervention||108
8446326|NCT00779116|20814957|P1|COMPLETED|Second Intervention||109
8446327|NCT00779116|20814956|P2|STARTED|Second Intervention||108
8446328|NCT00779116|20814957|P1|STARTED|Second Intervention||109
8446329|NCT00779116|20814956|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446330|NCT00779116|20814957|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446331|NCT00779116|20814956|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
8446332|NCT00779116|20814957|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
8446333|NCT00779116|20814956|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
8446334|NCT00779116|20814957|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
8446335|NCT00779116|20814956|P2|NOT COMPLETED|First Intervention||0
8446336|NCT00779116|20814957|P1|NOT COMPLETED|First Intervention||0
8446337|NCT00779116|20814956|P2|COMPLETED|First Intervention||108
8446338|NCT00779116|20814957|P1|COMPLETED|First Intervention||109
8446339|NCT00779116|20814956|P2|STARTED|First Intervention||108
8446340|NCT00779116|20814957|P1|STARTED|First Intervention||109
8446341|NCT00779103|20814964|P1|NOT COMPLETED|Overall Study||0
8446342|NCT00779103|20814964|P1|COMPLETED|Overall Study|Initial Phase (First Implant)|36
8446343|NCT00779103|20814964|P1|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
8446344|NCT00779103|20814964|P1|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
8446345|NCT00779103|20814964|P1|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
8446346|NCT00779103|20814964|P1|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
8446347|NCT00779038|20814982|P1|NOT COMPLETED|Overall Study||13
8446348|NCT00779038|20814982|P1|COMPLETED|Overall Study||0
8446349|NCT00779038|20814982|P1|STARTED|Overall Study||13
8446350|NCT00779025|20814991|P1|NOT COMPLETED|Overall Study||1
8446351|NCT00779025|20814991|P1|COMPLETED|Overall Study||81
8446352|NCT00779025|20814991|P1|STARTED|Overall Study||82
8446353|NCT00778999|20815002|P2|NOT COMPLETED|Overall Study||34
8446354|NCT00778999|20815003|P1|NOT COMPLETED|Overall Study||28
8446356|NCT00778999|20815003|P1|COMPLETED|Overall Study||195
8446357|NCT00778999|20815002|P2|STARTED|Overall Study||219
8446358|NCT00778999|20815003|P1|STARTED|Overall Study||223
8446359|NCT00778921|20815012|P3|NOT COMPLETED|Overall Study||28
8446360|NCT00778921|20815013|P2|NOT COMPLETED|Overall Study||19
8446361|NCT00778921|20815014|P1|NOT COMPLETED|Overall Study||18
8446362|NCT00778921|20815012|P3|COMPLETED|Overall Study||255
8446363|NCT00778921|20815013|P2|COMPLETED|Overall Study||266
8446364|NCT00778921|20815014|P1|COMPLETED|Overall Study||261
8446365|NCT00778921|20815012|P3|STARTED|Overall Study||283
8446366|NCT00778921|20815013|P2|STARTED|Overall Study||285
8446367|NCT00778921|20815014|P1|STARTED|Overall Study||279
8446368|NCT00778895|20815031|P3|NOT COMPLETED|ESFU Phase||2
8446369|NCT00778895|20815032|P2|NOT COMPLETED|ESFU Phase||12
8446370|NCT00778895|20815033|P1|NOT COMPLETED|ESFU Phase||11
8446371|NCT00778895|20815031|P3|COMPLETED|ESFU Phase||41
8446372|NCT00778895|20815032|P2|COMPLETED|ESFU Phase||155
8446373|NCT00778895|20815033|P1|COMPLETED|ESFU Phase||153
8446374|NCT00778895|20815031|P3|STARTED|ESFU Phase||43
8446375|NCT00778895|20815032|P2|STARTED|ESFU Phase||167
8446376|NCT00778895|20815033|P1|STARTED|ESFU Phase||164
8446377|NCT00778895|20815031|P3|NOT COMPLETED|Active Phase||0
8446378|NCT00778895|20815032|P2|NOT COMPLETED|Active Phase||6
8446379|NCT00778895|20815033|P1|NOT COMPLETED|Active Phase||7
8446380|NCT00778895|20815031|P3|COMPLETED|Active Phase||43
8446381|NCT00778895|20815032|P2|COMPLETED|Active Phase||161
8446382|NCT00778895|20815033|P1|COMPLETED|Active Phase||157
8446383|NCT00778895|20815031|P3|STARTED|Active Phase||43
8446384|NCT00778895|20815032|P2|STARTED|Active Phase||167
8446385|NCT00778895|20815033|P1|STARTED|Active Phase||164
8446386|NCT00778869|20815071|P1|NOT COMPLETED|Overall Study||0
8446387|NCT00778869|20815071|P1|COMPLETED|Overall Study||10
8446388|NCT00778869|20815071|P1|STARTED|Overall Study||10
8446389|NCT00778830|20815077|P2|NOT COMPLETED|Overall Study||1
8446390|NCT00778830|20815078|P1|NOT COMPLETED|Overall Study||0
8446391|NCT00778830|20815077|P2|COMPLETED|Overall Study||187
8446392|NCT00778830|20815078|P1|COMPLETED|Overall Study||101
8446393|NCT00778830|20815077|P2|STARTED|Overall Study||188
8446394|NCT00778830|20815078|P1|STARTED|Overall Study||101
8446395|NCT00778817|20815090|P1|NOT COMPLETED|Overall Study||4
8446396|NCT00778817|20815090|P1|COMPLETED|Overall Study||16
8446397|NCT00778817|20815090|P1|STARTED|Overall Study||20
8446398|NCT00778648|20815107|P2|NOT COMPLETED|Overall Study||5
8446399|NCT00778648|20815108|P1|NOT COMPLETED|Overall Study||9
8446400|NCT00778648|20815107|P2|COMPLETED|Overall Study||266
8446401|NCT00778648|20815108|P1|COMPLETED|Overall Study||263
8446402|NCT00778648|20815107|P2|STARTED|Overall Study||271
8446403|NCT00778648|20815108|P1|STARTED|Overall Study||272
8446404|NCT00778622|20815117|P3|NOT COMPLETED|Overall Study||15
8446405|NCT00778622|20815118|P2|NOT COMPLETED|Overall Study||15
8446406|NCT00778622|20815119|P1|NOT COMPLETED|Overall Study||16
8446407|NCT00778622|20815117|P3|COMPLETED|Overall Study||109
8446408|NCT00778622|20815118|P2|COMPLETED|Overall Study||107
8446409|NCT00778622|20815119|P1|COMPLETED|Overall Study||109
8446410|NCT00778622|20815117|P3|STARTED|Overall Study||124
8446411|NCT00778622|20815118|P2|STARTED|Overall Study||122
8446412|NCT00778622|20815119|P1|STARTED|Overall Study||125
8446413|NCT00778375|20815172|P1|NOT COMPLETED|Overall Study||3
8446414|NCT00778375|20815172|P1|COMPLETED|Overall Study||119
8446415|NCT00778375|20815172|P1|STARTED|Overall Study||122
8446416|NCT00778336|20815186|P4|NOT COMPLETED|3 Month Follow Up||0
8446417|NCT00778336|20815187|P3|NOT COMPLETED|3 Month Follow Up||5
8446418|NCT00778336|20815188|P2|NOT COMPLETED|3 Month Follow Up||23
8446419|NCT00778336|20815189|P1|NOT COMPLETED|3 Month Follow Up||23
8446420|NCT00778336|20815186|P4|COMPLETED|3 Month Follow Up||12
8446421|NCT00778336|20815187|P3|COMPLETED|3 Month Follow Up||65
8446422|NCT00778336|20815188|P2|COMPLETED|3 Month Follow Up||144
8446423|NCT00778336|20815189|P1|COMPLETED|3 Month Follow Up||169
8446424|NCT00778336|20815186|P4|STARTED|3 Month Follow Up||12
8446425|NCT00778336|20815187|P3|STARTED|3 Month Follow Up||70
8446426|NCT00778336|20815188|P2|STARTED|3 Month Follow Up||167
8446427|NCT00778336|20815189|P1|STARTED|3 Month Follow Up||192
8446428|NCT00778336|20815186|P4|NOT COMPLETED|Index Procedure-Discharge||0
8446429|NCT00778336|20815187|P3|NOT COMPLETED|Index Procedure-Discharge||2
8446430|NCT00778336|20815188|P2|NOT COMPLETED|Index Procedure-Discharge||3
8446431|NCT00778336|20815189|P1|NOT COMPLETED|Index Procedure-Discharge||6
8446432|NCT00778336|20815186|P4|COMPLETED|Index Procedure-Discharge||12
8446433|NCT00778336|20815187|P3|COMPLETED|Index Procedure-Discharge||70
8446434|NCT00778336|20815188|P2|COMPLETED|Index Procedure-Discharge||167
8446435|NCT00778336|20815189|P1|COMPLETED|Index Procedure-Discharge||192
8446436|NCT00778336|20815186|P4|STARTED|Index Procedure-Discharge||12
8446437|NCT00778336|20815187|P3|STARTED|Index Procedure-Discharge||72
8446438|NCT00778336|20815188|P2|STARTED|Index Procedure-Discharge||170
8446439|NCT00778336|20815189|P1|STARTED|Index Procedure-Discharge||198
8446440|NCT00778310|20815209|P2|NOT COMPLETED|Overall Study||0
8446441|NCT00778310|20815210|P1|NOT COMPLETED|Overall Study||0
8446442|NCT00778310|20815209|P2|COMPLETED|Overall Study||26
8446443|NCT00778310|20815210|P1|COMPLETED|Overall Study||17
8446444|NCT00778310|20815209|P2|Usable Data|Overall Study||21
8446445|NCT00778310|20815210|P1|Usable Data|Overall Study||14
8446446|NCT00778310|20815209|P2|STARTED|Overall Study||26
8446447|NCT00778310|20815210|P1|STARTED|Overall Study||17
8446448|NCT00778258|20815227|P9|NOT COMPLETED|Overall Study||4
8446449|NCT00778258|20815228|P8|NOT COMPLETED|Overall Study||15
8446450|NCT00778258|20815229|P7|NOT COMPLETED|Overall Study||15
8446451|NCT00778258|20815230|P6|NOT COMPLETED|Overall Study||10
8446452|NCT00778258|20815231|P5|NOT COMPLETED|Overall Study||0
8446453|NCT00778258|20815232|P4|NOT COMPLETED|Overall Study||3
8446454|NCT00778258|20815233|P3|NOT COMPLETED|Overall Study||10
8446455|NCT00778258|20815234|P2|NOT COMPLETED|Overall Study||2
8446456|NCT00778258|20815235|P1|NOT COMPLETED|Overall Study||7
8446457|NCT00778258|20815227|P9|COMPLETED|Overall Study||6
8446458|NCT00778258|20815228|P8|COMPLETED|Overall Study||26
8446459|NCT00778258|20815229|P7|COMPLETED|Overall Study||19
8446460|NCT00778258|20815230|P6|COMPLETED|Overall Study||13
8446461|NCT00778258|20815231|P5|COMPLETED|Overall Study||6
8446462|NCT00778258|20815232|P4|COMPLETED|Overall Study||12
8446463|NCT00778258|20815233|P3|COMPLETED|Overall Study||10
8446464|NCT00778258|20815234|P2|COMPLETED|Overall Study||3
8446465|NCT00778258|20815235|P1|COMPLETED|Overall Study||9
8446466|NCT00778258|20815227|P9|STARTED|Overall Study||10
8446467|NCT00778258|20815228|P8|STARTED|Overall Study||41
8446468|NCT00778258|20815229|P7|STARTED|Overall Study||34
8446469|NCT00778258|20815230|P6|STARTED|Overall Study||23
8446470|NCT00778258|20815231|P5|STARTED|Overall Study||6
8446471|NCT00778258|20815232|P4|STARTED|Overall Study||15
8446472|NCT00778258|20815233|P3|STARTED|Overall Study||20
8446473|NCT00778258|20815234|P2|STARTED|Overall Study||5
8446474|NCT00778258|20815235|P1|STARTED|Overall Study||16
8446475|NCT00778167|20815290|P3|NOT COMPLETED|Overall Study||0
8446476|NCT00778167|20815291|P2|NOT COMPLETED|Overall Study||0
8446477|NCT00778167|20815292|P1|NOT COMPLETED|Overall Study||0
8446478|NCT00778167|20815290|P3|COMPLETED|Overall Study||4
8446479|NCT00778167|20815291|P2|COMPLETED|Overall Study||8
8446480|NCT00778167|20815292|P1|COMPLETED|Overall Study||6
8446481|NCT00778167|20815290|P3|STARTED|Overall Study||4
8446482|NCT00778167|20815291|P2|STARTED|Overall Study||8
8446483|NCT00778167|20815292|P1|STARTED|Overall Study||6
8446484|NCT00778102|20815302|P2|NOT COMPLETED|Overall Study||22
8446485|NCT00778102|20815303|P1|NOT COMPLETED|Overall Study||21
8446486|NCT00778102|20815302|P2|COMPLETED|Overall Study||19
8446487|NCT00778102|20815303|P1|COMPLETED|Overall Study||18
8446488|NCT00778102|20815302|P2|STARTED|Overall Study||41
8446489|NCT00778102|20815303|P1|STARTED|Overall Study||39
8446490|NCT00777946|20815338|P3|NOT COMPLETED|Overall Study||16
8446491|NCT00777946|20815339|P2|NOT COMPLETED|Overall Study||6
8446492|NCT00777946|20815340|P1|NOT COMPLETED|Overall Study||21
8446493|NCT00777946|20815338|P3|COMPLETED|Overall Study||244
8446494|NCT00777946|20815339|P2|COMPLETED|Overall Study||271
8446495|NCT00777946|20815340|P1|COMPLETED|Overall Study||262
8446496|NCT00777946|20815338|P3|Safety & Full Analysis Sets|Overall Study||260
8446497|NCT00777946|20815339|P2|Safety & Full Analysis Sets|Overall Study||276
8446498|NCT00777946|20815340|P1|Safety & Full Analysis Sets|Overall Study||282
8446499|NCT00777946|20815338|P3|STARTED|Overall Study||260
8446500|NCT00777946|20815339|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
8446501|NCT00777946|20815340|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
8446502|NCT00777920|20815363|P1|NOT COMPLETED|Overall Study||50
8446503|NCT00777920|20815363|P1|COMPLETED|Overall Study||90
8446504|NCT00777920|20815363|P1|STARTED|Overall Study||140
8446505|NCT00777855|20815367|P2|NOT COMPLETED|Second Intervention||0
8446506|NCT00777855|20815368|P1|NOT COMPLETED|Second Intervention||0
8446507|NCT00777855|20815367|P2|COMPLETED|Second Intervention||5
8446508|NCT00777855|20815368|P1|COMPLETED|Second Intervention||5
8446509|NCT00777855|20815367|P2|STARTED|Second Intervention||5
8446510|NCT00777855|20815368|P1|STARTED|Second Intervention||5
8446511|NCT00777855|20815367|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
8446512|NCT00777855|20815368|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
8446513|NCT00777855|20815367|P2|COMPLETED|Washout Period (>= 14 Days)||5
8446514|NCT00777855|20815368|P1|COMPLETED|Washout Period (>= 14 Days)||5
8446515|NCT00777855|20815367|P2|STARTED|Washout Period (>= 14 Days)||5
8446516|NCT00777855|20815368|P1|STARTED|Washout Period (>= 14 Days)||5
8446517|NCT00777855|20815367|P2|NOT COMPLETED|First Intervention||0
8446518|NCT00777855|20815368|P1|NOT COMPLETED|First Intervention||0
8446519|NCT00777855|20815367|P2|COMPLETED|First Intervention||5
8446520|NCT00777855|20815368|P1|COMPLETED|First Intervention||5
8446521|NCT00777855|20815367|P2|STARTED|First Intervention||5
8446522|NCT00777855|20815368|P1|STARTED|First Intervention||5
8446523|NCT00777803|20815379|P2|NOT COMPLETED|Overall Study||7
8446524|NCT00777803|20815380|P1|NOT COMPLETED|Overall Study||15
8446525|NCT00777803|20815379|P2|COMPLETED|Overall Study||90
8446526|NCT00777803|20815380|P1|COMPLETED|Overall Study||269
8446527|NCT00777803|20815379|P2|STARTED|Overall Study||97
8446528|NCT00777803|20815380|P1|STARTED|Overall Study||284
8446529|NCT00777790|20815415|P3|NOT COMPLETED|Overall Study||0
8446530|NCT00777790|20815416|P2|NOT COMPLETED|Overall Study||0
8446531|NCT00777790|20815417|P1|NOT COMPLETED|Overall Study||0
8446532|NCT00777790|20815415|P3|COMPLETED|Overall Study||88
8446533|NCT00777790|20815416|P2|COMPLETED|Overall Study||77
8446534|NCT00777790|20815417|P1|COMPLETED|Overall Study||76
8446535|NCT00777790|20815415|P3|STARTED|Overall Study||88
8446536|NCT00777790|20815416|P2|STARTED|Overall Study||77
8446537|NCT00777790|20815417|P1|STARTED|Overall Study||76
8446538|NCT00777764|20815427|P2|NOT COMPLETED|Overall Study||1
8446539|NCT00777764|20815428|P1|NOT COMPLETED|Overall Study||0
8446540|NCT00777764|20815427|P2|COMPLETED|Overall Study||29
8446541|NCT00777764|20815428|P1|COMPLETED|Overall Study||30
8446542|NCT00777764|20815427|P2|STARTED|Overall Study||30
8446543|NCT00777764|20815428|P1|STARTED|Overall Study||30
8446544|NCT00777634|20815440|P2|NOT COMPLETED|Overall Study||1
8446545|NCT00777634|20815441|P1|NOT COMPLETED|Overall Study||5
8446546|NCT00777634|20815440|P2|COMPLETED|Overall Study||133
8446547|NCT00777634|20815441|P1|COMPLETED|Overall Study||129
8446548|NCT00777634|20815440|P2|STARTED|Overall Study||134
8446549|NCT00777634|20815441|P1|STARTED|Overall Study||134
8446550|NCT00777608|20815459|P2|NOT COMPLETED|Overall Study||6
8446551|NCT00777608|20815460|P1|NOT COMPLETED|Overall Study||4
8446552|NCT00777608|20815459|P2|COMPLETED|Overall Study||47
8446553|NCT00777608|20815460|P1|COMPLETED|Overall Study||49
8446554|NCT00777608|20815459|P2|STARTED|Overall Study||53
8446555|NCT00777608|20815460|P1|STARTED|Overall Study||53
8446556|NCT00777556|20815470|P1|NOT COMPLETED|Overall Study||66
8446557|NCT00777556|20815470|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
8446558|NCT00777556|20815470|P1|Used Product|Overall Study||297
8446559|NCT00777556|20815470|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
8446560|NCT00777556|20815470|P1|Dispensed Product|Overall Study||307
8446561|NCT00777556|20815470|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
8446584|NCT00777335|20815500|P2|NOT COMPLETED|Overall Study||0
8446585|NCT00777335|20815501|P1|NOT COMPLETED|Overall Study||0
8446586|NCT00777335|20815500|P2|COMPLETED|Overall Study||2
8446587|NCT00777335|20815501|P1|COMPLETED|Overall Study||2
8446588|NCT00777335|20815500|P2|STARTED|Overall Study||2
8446589|NCT00777335|20815501|P1|STARTED|Overall Study||2
8446590|NCT00777296|20815513|P4|NOT COMPLETED|Overall Study||1
8446591|NCT00777296|20815514|P3|NOT COMPLETED|Overall Study||2
8446592|NCT00777296|20815515|P2|NOT COMPLETED|Overall Study||1
8446593|NCT00777296|20815516|P1|NOT COMPLETED|Overall Study||1
8446594|NCT00777296|20815513|P4|COMPLETED|Overall Study||10
8446595|NCT00777296|20815514|P3|COMPLETED|Overall Study||21
8446596|NCT00777296|20815515|P2|COMPLETED|Overall Study||10
8446597|NCT00777296|20815516|P1|COMPLETED|Overall Study||20
8446598|NCT00777296|20815513|P4|STARTED|Overall Study||11
8446599|NCT00777296|20815514|P3|STARTED|Overall Study||23
8446600|NCT00777296|20815515|P2|STARTED|Overall Study||11
8446601|NCT00777296|20815516|P1|STARTED|Overall Study||21
8446602|NCT00777257|20815558|P3|NOT COMPLETED|Overall Study||9
8446603|NCT00777257|20815559|P2|NOT COMPLETED|Overall Study||12
8446604|NCT00777257|20815560|P1|NOT COMPLETED|Overall Study||11
8446605|NCT00777257|20815558|P3|COMPLETED|Overall Study||442
8446606|NCT00777257|20815559|P2|COMPLETED|Overall Study||438
8446607|NCT00777257|20815560|P1|COMPLETED|Overall Study||433
8446608|NCT00777257|20815558|P3|STARTED|Overall Study||451
8446609|NCT00777257|20815559|P2|STARTED|Overall Study||450
8446610|NCT00777257|20815560|P1|STARTED|Overall Study||444
8446611|NCT00777205|20815579|P2|NOT COMPLETED|Overall Study||71
8446612|NCT00777205|20815580|P1|NOT COMPLETED|Overall Study||31
8446613|NCT00777205|20815579|P2|COMPLETED|Overall Study||129
8446614|NCT00777205|20815580|P1|COMPLETED|Overall Study||212
8446615|NCT00777205|20815579|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
8446616|NCT00777205|20815580|P1|Intervention Interruption|Overall Study||0
8446617|NCT00777205|20815579|P2|STARTED|Overall Study||200
8446618|NCT00777205|20815580|P1|STARTED|Overall Study||243
8446619|NCT00777179|20815596|P2|NOT COMPLETED|Overall Study||0
8446620|NCT00777179|20815597|P1|NOT COMPLETED|Overall Study||0
8446621|NCT00777179|20815596|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
8446622|NCT00777179|20815597|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
8446623|NCT00777179|20815596|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
8446624|NCT00777179|20815597|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
8446625|NCT00777153|20815614|P3|NOT COMPLETED|Overall Study||37
8446626|NCT00777153|20815615|P2|NOT COMPLETED|Overall Study||83
8446627|NCT00777153|20815616|P1|NOT COMPLETED|Overall Study||90
8446628|NCT00777153|20815614|P3|COMPLETED|Overall Study||28
8446629|NCT00777153|20815615|P2|COMPLETED|Overall Study||46
8446630|NCT00777153|20815616|P1|COMPLETED|Overall Study||41
8446631|NCT00777153|20815614|P3|STARTED|Overall Study||65
8446632|NCT00777153|20815615|P2|STARTED|Overall Study||129
8446633|NCT00777153|20815616|P1|STARTED|Overall Study||131
8446634|NCT00777101|20815641|P2|NOT COMPLETED|Overall Study||51
8446635|NCT00777101|20815642|P1|NOT COMPLETED|Overall Study||62
8446636|NCT00777101|20815641|P2|COMPLETED|Overall Study||65
8446637|NCT00777101|20815642|P1|COMPLETED|Overall Study||55
8446638|NCT00777101|20815641|P2|Treated|Overall Study||115
8446639|NCT00777101|20815642|P1|Treated|Overall Study||116
8446640|NCT00777101|20815641|P2|STARTED|Overall Study||116
8446641|NCT00777101|20815642|P1|STARTED|Overall Study||117
8446642|NCT00777088|20815660|P1|NOT COMPLETED|Overall Study||1
8446643|NCT00777088|20815660|P1|COMPLETED|Overall Study||107
8446644|NCT00777088|20815660|P1|STARTED|Overall Study||108
8446645|NCT00777062|20815674|P2|NOT COMPLETED|Overall Study||5
8446646|NCT00777062|20815675|P1|NOT COMPLETED|Overall Study||3
8446647|NCT00777062|20815674|P2|COMPLETED|Overall Study||36
8446648|NCT00777062|20815675|P1|COMPLETED|Overall Study||36
8446649|NCT00777062|20815674|P2|STARTED|Overall Study||41
8446650|NCT00777062|20815675|P1|STARTED|Overall Study||39
8446651|NCT00777049|20815685|P2|NOT COMPLETED|Overall Study||1
8446652|NCT00777049|20815686|P1|NOT COMPLETED|Overall Study||1
8446653|NCT00777049|20815685|P2|COMPLETED|Overall Study||20
8446654|NCT00777049|20815686|P1|COMPLETED|Overall Study||32
8446655|NCT00777049|20815685|P2|STARTED|Overall Study||21
8446656|NCT00777049|20815686|P1|STARTED|Overall Study||33
8446657|NCT00777036|20815695|P3|NOT COMPLETED|Follow-Up||4
8446658|NCT00777036|20815696|P2|NOT COMPLETED|Follow-Up||8
8446659|NCT00777036|20815697|P1|NOT COMPLETED|Follow-Up||5
8446660|NCT00777036|20815695|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
8446661|NCT00777036|20815696|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
8446662|NCT00777036|20815697|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
8446663|NCT00777036|20815695|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
8446664|NCT00777036|20815696|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
8446665|NCT00777036|20815697|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
8446666|NCT00777036|20815695|P3|NOT COMPLETED|On Treatment||23
8446667|NCT00777036|20815696|P2|NOT COMPLETED|On Treatment||16
8446668|NCT00777036|20815697|P1|NOT COMPLETED|On Treatment||15
8446669|NCT00777036|20815695|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
8446670|NCT00777036|20815696|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
8446671|NCT00777036|20815697|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
8446672|NCT00777036|20815695|P3|STARTED|On Treatment||84
8446673|NCT00777036|20815696|P2|STARTED|On Treatment||17
8446674|NCT00777036|20815697|P1|STARTED|On Treatment||29
8446675|NCT00777023|20815793|P3|NOT COMPLETED|Overall Study||37
8446676|NCT00777023|20815794|P2|NOT COMPLETED|Overall Study||41
8446677|NCT00777023|20815795|P1|NOT COMPLETED|Overall Study||35
8446678|NCT00777023|20815793|P3|COMPLETED|Overall Study||146
8446679|NCT00777023|20815794|P2|COMPLETED|Overall Study||149
8446680|NCT00777023|20815795|P1|COMPLETED|Overall Study||151
8446681|NCT00777023|20815793|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
8446682|NCT00777023|20815794|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
8446683|NCT00777023|20815795|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
8446684|NCT00776997|20815812|P1|NOT COMPLETED|Overall Study||2
8446685|NCT00776997|20815812|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
8446686|NCT00776997|20815812|P1|STARTED|Overall Study||100
8446687|NCT00776984|20815821|P2|NOT COMPLETED|Overall Study||21
8446688|NCT00776984|20815822|P1|NOT COMPLETED|Overall Study||31
8446689|NCT00776984|20815821|P2|COMPLETED|Overall Study||198
8446690|NCT00776984|20815822|P1|COMPLETED|Overall Study||203
8446691|NCT00776984|20815821|P2|STARTED|Overall Study||219
8446692|NCT00776984|20815822|P1|STARTED|Overall Study||234
8446693|NCT00776919|20815896|P4|NOT COMPLETED|Overall Study||39
8446694|NCT00776919|20815897|P3|NOT COMPLETED|Overall Study||32
8446695|NCT00776919|20815898|P2|NOT COMPLETED|Overall Study||33
8446696|NCT00776919|20815899|P1|NOT COMPLETED|Overall Study||27
8446697|NCT00776919|20815896|P4|COMPLETED|Overall Study||293
8446698|NCT00776919|20815897|P3|COMPLETED|Overall Study||296
8446699|NCT00776919|20815898|P2|COMPLETED|Overall Study||295
8446700|NCT00776919|20815899|P1|COMPLETED|Overall Study||300
8446701|NCT00776919|20815896|P4|STARTED|Overall Study||332
8446702|NCT00776919|20815897|P3|STARTED|Overall Study||328
8446703|NCT00776919|20815898|P2|STARTED|Overall Study||328
8446704|NCT00776919|20815899|P1|STARTED|Overall Study||327
8446705|NCT00776789|20815963|P2|NOT COMPLETED|Overall Study||3
8446706|NCT00776789|20815964|P1|NOT COMPLETED|Overall Study||3
8446707|NCT00776789|20815963|P2|COMPLETED|Overall Study||18
8446708|NCT00776789|20815964|P1|COMPLETED|Overall Study||17
8446709|NCT00776789|20815963|P2|STARTED|Overall Study||21
8446710|NCT00776789|20815964|P1|STARTED|Overall Study||20
8446711|NCT00776659|20815976|P1|NOT COMPLETED|Overall Study||26
8446712|NCT00776659|20815976|P1|COMPLETED|Overall Study||13
8446713|NCT00776659|20815976|P1|STARTED|Overall Study||39
8446714|NCT00776594|20815988|P2|NOT COMPLETED|Overall Study||2
8446715|NCT00776594|20815989|P1|NOT COMPLETED|Overall Study||4
8446716|NCT00776594|20815988|P2|COMPLETED|Overall Study||34
8446717|NCT00776594|20815989|P1|COMPLETED|Overall Study||62
8446718|NCT00776594|20815988|P2|STARTED|Overall Study||36
8446719|NCT00776594|20815989|P1|STARTED|Overall Study||66
8446720|NCT00776555|20816003|P2|NOT COMPLETED|Overall Study||0
8446721|NCT00776555|20816004|P1|NOT COMPLETED|Overall Study||3
8446722|NCT00776555|20816003|P2|COMPLETED|Overall Study||0
8446723|NCT00776555|20816004|P1|COMPLETED|Overall Study||0
8446724|NCT00776555|20816003|P2|STARTED|Overall Study||0
8446725|NCT00776555|20816004|P1|STARTED|Overall Study||3
8446726|NCT00776295|20816014|P1|NOT COMPLETED|Overall Study||0
8446727|NCT00776295|20816014|P1|COMPLETED|Overall Study||2
8446728|NCT00776295|20816014|P1|STARTED|Overall Study||2
8446729|NCT00776230|20816022|P3|NOT COMPLETED|Overall Study||5
8446730|NCT00776230|20816023|P2|NOT COMPLETED|Overall Study||3
8446731|NCT00776230|20816024|P1|NOT COMPLETED|Overall Study||3
8446732|NCT00776230|20816022|P3|COMPLETED|Overall Study||97
8446733|NCT00776230|20816023|P2|COMPLETED|Overall Study||100
8446734|NCT00776230|20816024|P1|COMPLETED|Overall Study||96
8446735|NCT00776230|20816022|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
8446736|NCT00776230|20816023|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
8446737|NCT00776230|20816024|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
8446738|NCT00776230|20816022|P3|STARTED|Overall Study||102
8446739|NCT00776230|20816023|P2|STARTED|Overall Study||103
8446740|NCT00776230|20816024|P1|STARTED|Overall Study||99
8446741|NCT00776100|20816034|P2|NOT COMPLETED|Overall Study||0
8446742|NCT00776100|20816035|P1|NOT COMPLETED|Overall Study||1
8446743|NCT00776100|20816034|P2|COMPLETED|Overall Study||1
8446744|NCT00776100|20816035|P1|COMPLETED|Overall Study||0
8446745|NCT00776100|20816034|P2|STARTED|Overall Study||1
8446746|NCT00776100|20816035|P1|STARTED|Overall Study||1
8446747|NCT00776009|20816057|P6|NOT COMPLETED|Period 3: Third Intervention||0
8446748|NCT00776009|20816058|P5|NOT COMPLETED|Period 3: Third Intervention||0
8446749|NCT00776009|20816059|P4|NOT COMPLETED|Period 3: Third Intervention||0
8446750|NCT00776009|20816060|P3|NOT COMPLETED|Period 3: Third Intervention||0
8446751|NCT00776009|20816061|P2|NOT COMPLETED|Period 3: Third Intervention||0
8446752|NCT00776009|20816062|P1|NOT COMPLETED|Period 3: Third Intervention||1
8446753|NCT00776009|20816057|P6|COMPLETED|Period 3: Third Intervention||26
8446754|NCT00776009|20816058|P5|COMPLETED|Period 3: Third Intervention||26
8446755|NCT00776009|20816059|P4|COMPLETED|Period 3: Third Intervention||27
8446756|NCT00776009|20816060|P3|COMPLETED|Period 3: Third Intervention||27
8446757|NCT00776009|20816061|P2|COMPLETED|Period 3: Third Intervention||27
8446758|NCT00776009|20816062|P1|COMPLETED|Period 3: Third Intervention||24
8446759|NCT00776009|20816057|P6|STARTED|Period 3: Third Intervention||26
8446760|NCT00776009|20816058|P5|STARTED|Period 3: Third Intervention||26
8446761|NCT00776009|20816059|P4|STARTED|Period 3: Third Intervention||27
8446762|NCT00776009|20816060|P3|STARTED|Period 3: Third Intervention||27
8446763|NCT00776009|20816061|P2|STARTED|Period 3: Third Intervention||27
8446764|NCT00776009|20816062|P1|STARTED|Period 3: Third Intervention||25
8446765|NCT00776009|20816057|P6|NOT COMPLETED|Period 2: Second Intervention||1
8446766|NCT00776009|20816058|P5|NOT COMPLETED|Period 2: Second Intervention||0
8446767|NCT00776009|20816059|P4|NOT COMPLETED|Period 2: Second Intervention||0
8446768|NCT00776009|20816060|P3|NOT COMPLETED|Period 2: Second Intervention||1
8446769|NCT00776009|20816061|P2|NOT COMPLETED|Period 2: Second Intervention||0
8446770|NCT00776009|20816062|P1|NOT COMPLETED|Period 2: Second Intervention||1
8446771|NCT00776009|20816057|P6|COMPLETED|Period 2: Second Intervention||26
8446772|NCT00776009|20816058|P5|COMPLETED|Period 2: Second Intervention||26
8446773|NCT00776009|20816059|P4|COMPLETED|Period 2: Second Intervention||27
8446774|NCT00776009|20816060|P3|COMPLETED|Period 2: Second Intervention||27
8446775|NCT00776009|20816061|P2|COMPLETED|Period 2: Second Intervention||27
8446776|NCT00776009|20816062|P1|COMPLETED|Period 2: Second Intervention||25
8446777|NCT00776009|20816057|P6|STARTED|Period 2: Second Intervention||27
8446778|NCT00776009|20816058|P5|STARTED|Period 2: Second Intervention||26
8446779|NCT00776009|20816059|P4|STARTED|Period 2: Second Intervention||27
8446780|NCT00776009|20816060|P3|STARTED|Period 2: Second Intervention||28
8446781|NCT00776009|20816061|P2|STARTED|Period 2: Second Intervention||27
8446782|NCT00776009|20816062|P1|STARTED|Period 2: Second Intervention||26
8446783|NCT00776009|20816057|P6|NOT COMPLETED|Period 1: First Intervention||0
8446784|NCT00776009|20816058|P5|NOT COMPLETED|Period 1: First Intervention||2
8446785|NCT00776009|20816059|P4|NOT COMPLETED|Period 1: First Intervention||0
8446786|NCT00776009|20816060|P3|NOT COMPLETED|Period 1: First Intervention||1
8446787|NCT00776009|20816061|P2|NOT COMPLETED|Period 1: First Intervention||1
8446788|NCT00776009|20816062|P1|NOT COMPLETED|Period 1: First Intervention||0
8446789|NCT00776009|20816057|P6|COMPLETED|Period 1: First Intervention||27
8446790|NCT00776009|20816058|P5|COMPLETED|Period 1: First Intervention||26
8446791|NCT00776009|20816059|P4|COMPLETED|Period 1: First Intervention||27
8446792|NCT00776009|20816060|P3|COMPLETED|Period 1: First Intervention||28
8446793|NCT00776009|20816061|P2|COMPLETED|Period 1: First Intervention||27
8446794|NCT00776009|20816062|P1|COMPLETED|Period 1: First Intervention||26
8446795|NCT00776009|20816057|P6|STARTED|Period 1: First Intervention||27
8446796|NCT00776009|20816058|P5|STARTED|Period 1: First Intervention||28
8446797|NCT00776009|20816059|P4|STARTED|Period 1: First Intervention||27
8446798|NCT00776009|20816060|P3|STARTED|Period 1: First Intervention||29
8446799|NCT00776009|20816061|P2|STARTED|Period 1: First Intervention||28
8446800|NCT00776009|20816062|P1|STARTED|Period 1: First Intervention||26
8446801|NCT00775983|20816084|P2|NOT COMPLETED|Overall Study||2
8446802|NCT00775983|20816085|P1|NOT COMPLETED|Overall Study||1
8446803|NCT00775983|20816084|P2|COMPLETED|Overall Study||34
8446804|NCT00775983|20816085|P1|COMPLETED|Overall Study||35
8446805|NCT00775983|20816084|P2|STARTED|Overall Study||36
8446806|NCT00775983|20816085|P1|STARTED|Overall Study||36
8446807|NCT00775944|20816097|P4|NOT COMPLETED|Overall Study||16
8446808|NCT00775944|20816098|P3|NOT COMPLETED|Overall Study||16
8446809|NCT00775944|20816099|P2|NOT COMPLETED|Overall Study||9
8446810|NCT00775944|20816100|P1|NOT COMPLETED|Overall Study||15
8446811|NCT00775944|20816097|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
8446812|NCT00775944|20816098|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
8446813|NCT00775944|20816099|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
8446814|NCT00775944|20816100|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
8446815|NCT00775944|20816097|P4|STARTED|Overall Study||648
8446816|NCT00775944|20816098|P3|STARTED|Overall Study||648
8446817|NCT00775944|20816099|P2|STARTED|Overall Study||647
8446818|NCT00775944|20816100|P1|STARTED|Overall Study||648
8446819|NCT00775931|20816128|P2|NOT COMPLETED|Overall Study||0
8446820|NCT00775931|20816129|P1|NOT COMPLETED|Overall Study||0
8446821|NCT00775931|20816128|P2|COMPLETED|Overall Study||1
8446822|NCT00775931|20816129|P1|COMPLETED|Overall Study||6
8446823|NCT00775931|20816128|P2|STARTED|Overall Study||1
8446824|NCT00775931|20816129|P1|STARTED|Overall Study||6
8446825|NCT00775684|20816144|P3|NOT COMPLETED|Overall Study||3
8446826|NCT00775684|20816145|P2|NOT COMPLETED|Overall Study||1
8446827|NCT00775684|20816146|P1|NOT COMPLETED|Overall Study||3
8446828|NCT00775684|20816144|P3|COMPLETED|Overall Study||14
8446829|NCT00775684|20816145|P2|COMPLETED|Overall Study||12
8446830|NCT00775684|20816146|P1|COMPLETED|Overall Study||14
8446831|NCT00775684|20816144|P3|STARTED|Overall Study||17
8446832|NCT00775684|20816145|P2|STARTED|Overall Study||13
8446833|NCT00775684|20816146|P1|STARTED|Overall Study||17
8446834|NCT00775671|20816168|P2|NOT COMPLETED|Overall Study||0
8446835|NCT00775671|20816169|P1|NOT COMPLETED|Overall Study||0
8446836|NCT00775671|20816168|P2|COMPLETED|Overall Study||23
8446837|NCT00775671|20816169|P1|COMPLETED|Overall Study||23
8446838|NCT00775671|20816168|P2|STARTED|Overall Study||23
8446839|NCT00775671|20816169|P1|STARTED|Overall Study||23
8446840|NCT00775658|20816177|P2|NOT COMPLETED|Second Intervention||0
8446841|NCT00775658|20816178|P1|NOT COMPLETED|Second Intervention||0
8446842|NCT00775658|20816177|P2|COMPLETED|Second Intervention||11
8446843|NCT00775658|20816178|P1|COMPLETED|Second Intervention||10
8446844|NCT00775658|20816177|P2|STARTED|Second Intervention||11
8446845|NCT00775658|20816178|P1|STARTED|Second Intervention||10
8446846|NCT00775658|20816177|P2|NOT COMPLETED|First Intervention||0
8446847|NCT00775658|20816178|P1|NOT COMPLETED|First Intervention||0
8446848|NCT00775658|20816177|P2|COMPLETED|First Intervention||11
8446849|NCT00775658|20816178|P1|COMPLETED|First Intervention||10
8446850|NCT00775658|20816177|P2|STARTED|First Intervention||11
8446851|NCT00775658|20816178|P1|STARTED|First Intervention||10
8446852|NCT00775645|20816188|P2|NOT COMPLETED|Overall Study||20
8446853|NCT00775645|20816189|P1|NOT COMPLETED|Overall Study||17
8446854|NCT00775645|20816188|P2|COMPLETED|Overall Study||181
8446855|NCT00775645|20816189|P1|COMPLETED|Overall Study||191
8446856|NCT00775645|20816188|P2|STARTED|Overall Study||201
8446857|NCT00775645|20816189|P1|STARTED|Overall Study||208
8446858|NCT00775606|20816211|P2|NOT COMPLETED|Overall Study||0
8446859|NCT00775606|20816212|P1|NOT COMPLETED|Overall Study||3
8446860|NCT00775606|20816211|P2|COMPLETED|Overall Study||5
8446861|NCT00775606|20816212|P1|COMPLETED|Overall Study||5
8446862|NCT00775606|20816211|P2|STARTED|Overall Study||5
8446863|NCT00775606|20816212|P1|STARTED|Overall Study||8
8446864|NCT00775593|20816222|P1|NOT COMPLETED|Overall Study||7
8446865|NCT00775593|20816222|P1|COMPLETED|Overall Study||53
8446866|NCT00775593|20816222|P1|STARTED|Overall Study||60
8446867|NCT00775528|20816229|P1|NOT COMPLETED|Overall Study||1
8446868|NCT00775528|20816229|P1|COMPLETED|Overall Study||18
8446869|NCT00775528|20816229|P1|STARTED|Overall Study|Started means number of patients who consented|19
8446870|NCT00775463|20816238|P2|NOT COMPLETED|Overall Study||13
8446871|NCT00775463|20816239|P1|NOT COMPLETED|Overall Study||11
8446872|NCT00775463|20816238|P2|COMPLETED|Overall Study||59
8446873|NCT00775463|20816239|P1|COMPLETED|Overall Study||65
8446874|NCT00775463|20816238|P2|STARTED|Overall Study||72
8446875|NCT00775463|20816239|P1|STARTED|Overall Study||76
8446876|NCT00775450|20816276|P5|NOT COMPLETED|Overall Study||2
8446877|NCT00775450|20816277|P4|NOT COMPLETED|Overall Study||0
8446878|NCT00775450|20816278|P3|NOT COMPLETED|Overall Study||0
8446879|NCT00775450|20816279|P2|NOT COMPLETED|Overall Study||0
8446880|NCT00775450|20816280|P1|NOT COMPLETED|Overall Study||3
8446881|NCT00775450|20816276|P5|COMPLETED|Overall Study||199
8446882|NCT00775450|20816277|P4|COMPLETED|Overall Study||108
8446883|NCT00775450|20816278|P3|COMPLETED|Overall Study||105
8446884|NCT00775450|20816279|P2|COMPLETED|Overall Study||98
8446885|NCT00775450|20816280|P1|COMPLETED|Overall Study||292
8446886|NCT00775450|20816276|P5|STARTED|Overall Study||201
8446887|NCT00775450|20816277|P4|STARTED|Overall Study||108
8446888|NCT00775450|20816278|P3|STARTED|Overall Study||105
8446889|NCT00775450|20816279|P2|STARTED|Overall Study||98
8446890|NCT00775450|20816280|P1|STARTED|Overall Study||295
8446891|NCT00775437|20816307|P1|NOT COMPLETED|Overall Study||6
8446892|NCT00775437|20816307|P1|COMPLETED|Overall Study||26
8446893|NCT00775437|20816307|P1|STARTED|Overall Study||32
8446894|NCT00775411|20816357|P1|NOT COMPLETED|Overall Study||1
8446895|NCT00775411|20816357|P1|COMPLETED|Overall Study||43
8446896|NCT00775411|20816357|P1|STARTED|Overall Study||44
8446897|NCT00775346|20816363|P1|NOT COMPLETED|Overall Study||0
8446898|NCT00775346|20816363|P1|COMPLETED|Overall Study||92
8446899|NCT00775346|20816363|P1|STARTED|Overall Study||92
8446900|NCT00775229|20816369|P2|NOT COMPLETED|Overall Study||2
8446901|NCT00775229|20816370|P1|NOT COMPLETED|Overall Study||5
8446902|NCT00775229|20816369|P2|COMPLETED|Overall Study||24
8446903|NCT00775229|20816370|P1|COMPLETED|Overall Study||20
8446904|NCT00775229|20816369|P2|STARTED|Overall Study||26
8446905|NCT00775229|20816370|P1|STARTED|Overall Study||25
8446906|NCT00775203|20816382|P2|NOT COMPLETED|Overall Study||43
8446907|NCT00775203|20816383|P1|NOT COMPLETED|Overall Study||62
8446908|NCT00775203|20816382|P2|COMPLETED|Overall Study||163
8446909|NCT00775203|20816383|P1|COMPLETED|Overall Study||144
8446910|NCT00775203|20816382|P2|Received Study Medication|Overall Study||204
8446911|NCT00775203|20816383|P1|Received Study Medication|Overall Study||202
8446912|NCT00775203|20816382|P2|STARTED|Overall Study||206
8446913|NCT00775203|20816383|P1|STARTED|Overall Study||206
8446914|NCT00775190|20816417|P2|NOT COMPLETED|Overall Study||5
8446915|NCT00775190|20816418|P1|NOT COMPLETED|Overall Study||4
8446916|NCT00775190|20816417|P2|COMPLETED|Overall Study||0
8446917|NCT00775190|20816418|P1|COMPLETED|Overall Study||3
8446918|NCT00775190|20816417|P2|STARTED|Overall Study||5
8446919|NCT00775190|20816418|P1|STARTED|Overall Study||7
8446920|NCT00775138|20816444|P4|NOT COMPLETED|Overall Study||2
8446921|NCT00775138|20816445|P3|NOT COMPLETED|Overall Study||3
8446922|NCT00775138|20816446|P2|NOT COMPLETED|Overall Study||0
8446923|NCT00775138|20816447|P1|NOT COMPLETED|Overall Study||0
8446924|NCT00775138|20816444|P4|COMPLETED|Overall Study||8
8446925|NCT00775138|20816445|P3|COMPLETED|Overall Study||17
8446926|NCT00775138|20816446|P2|COMPLETED|Overall Study||10
8446927|NCT00775138|20816447|P1|COMPLETED|Overall Study||24
8446928|NCT00775138|20816444|P4|STARTED|Overall Study||10
8446929|NCT00775138|20816445|P3|STARTED|Overall Study||20
8446930|NCT00775138|20816446|P2|STARTED|Overall Study||10
8446931|NCT00775138|20816447|P1|STARTED|Overall Study||24
8446932|NCT00775021|20816493|P2|NOT COMPLETED|Second Intervention||1
8446933|NCT00775021|20816494|P1|NOT COMPLETED|Second Intervention||0
8446934|NCT00775021|20816493|P2|COMPLETED|Second Intervention||59
8446935|NCT00775021|20816494|P1|COMPLETED|Second Intervention||62
8446936|NCT00775021|20816493|P2|STARTED|Second Intervention||60
8446937|NCT00775021|20816494|P1|STARTED|Second Intervention||62
8446938|NCT00775021|20816493|P2|NOT COMPLETED|First Intervention||0
8446939|NCT00775021|20816494|P1|NOT COMPLETED|First Intervention||1
8446940|NCT00775021|20816493|P2|COMPLETED|First Intervention||60
8446941|NCT00775021|20816494|P1|COMPLETED|First Intervention||62
8446942|NCT00775021|20816493|P2|STARTED|First Intervention||60
8446943|NCT00775021|20816494|P1|STARTED|First Intervention||63
8446944|NCT00774995|20816512|P4|NOT COMPLETED|Overall Study||0
8446945|NCT00774995|20816513|P3|NOT COMPLETED|Overall Study||1
8446946|NCT00774995|20816514|P2|NOT COMPLETED|Overall Study||0
8446947|NCT00774995|20816515|P1|NOT COMPLETED|Overall Study||0
8446948|NCT00774995|20816512|P4|COMPLETED|Overall Study||16
8446949|NCT00774995|20816513|P3|COMPLETED|Overall Study||7
8446950|NCT00774995|20816514|P2|COMPLETED|Overall Study||16
8446951|NCT00774995|20816515|P1|COMPLETED|Overall Study||9
8446952|NCT00774995|20816512|P4|STARTED|Overall Study||16
8446953|NCT00774995|20816513|P3|STARTED|Overall Study||8
8446954|NCT00774995|20816514|P2|STARTED|Overall Study||16
8446955|NCT00774995|20816515|P1|STARTED|Overall Study||9
8446956|NCT00774930|20816555|P2|NOT COMPLETED|LTOLE Phase||17
8446957|NCT00774930|20816556|P1|NOT COMPLETED|LTOLE Phase||15
8446958|NCT00774930|20816555|P2|COMPLETED|LTOLE Phase||8
8446959|NCT00774930|20816556|P1|COMPLETED|LTOLE Phase||17
8446960|NCT00774930|20816555|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
8446961|NCT00774930|20816556|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
8446962|NCT00774930|20816555|P2|NOT COMPLETED|IOL Phase||9
8446963|NCT00774930|20816556|P1|NOT COMPLETED|IOL Phase||13
8446964|NCT00774930|20816555|P2|COMPLETED|IOL Phase||37
8446965|NCT00774930|20816556|P1|COMPLETED|IOL Phase||43
8446966|NCT00774930|20816555|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
8446967|NCT00774930|20816556|P1|STARTED|IOL Phase||56
8446968|NCT00774930|20816555|P2|NOT COMPLETED|DB Phase||22
8446969|NCT00774930|20816556|P1|NOT COMPLETED|DB Phase||14
8446970|NCT00774930|20816555|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
8446971|NCT00774930|20816556|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
8446972|NCT00774930|20816555|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
8446973|NCT00774930|20816556|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
8446974|NCT00774852|20816584|P2|NOT COMPLETED|Overall Study||41
8446975|NCT00774852|20816585|P1|NOT COMPLETED|Overall Study||45
8446976|NCT00774852|20816584|P2|COMPLETED|Overall Study||27
8446977|NCT00774852|20816585|P1|COMPLETED|Overall Study||24
8446978|NCT00774852|20816584|P2|STARTED|Overall Study||68
8446979|NCT00774852|20816585|P1|STARTED|Overall Study||69
8446980|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 4||1
8446981|NCT00774800|20816633|P1|COMPLETED|Intervention 4||21
8446982|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 4||21
8446983|NCT00774800|20816633|P1|STARTED|Intervention 4||22
8446984|NCT00774800|20816633|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
8446985|NCT00774800|20816633|P1|COMPLETED|Washout (3 to 10 Days)||22
8446986|NCT00774800|20816633|P1|STARTED|Washout (3 to 10 Days)||22
8446987|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 3||0
8446988|NCT00774800|20816633|P1|COMPLETED|Intervention 3||22
8446989|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 3||22
8446990|NCT00774800|20816633|P1|STARTED|Intervention 3||22
8446991|NCT00774800|20816633|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
8446992|NCT00774800|20816633|P1|COMPLETED|Washout (3 to 10 Days)||22
8446993|NCT00774800|20816633|P1|STARTED|Washout (3 to 10 Days)||22
8446994|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 2||0
8446995|NCT00774800|20816633|P1|COMPLETED|Intervention 2||22
8446996|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 2||22
8446997|NCT00774800|20816633|P1|STARTED|Intervention 2||22
8446998|NCT00774800|20816633|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
8446999|NCT00774800|20816633|P1|COMPLETED|Washout (3 to 10 Days)||22
8447000|NCT00774800|20816633|P1|STARTED|Washout (3 to 10 Days)||22
8447001|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 1||0
8447002|NCT00774800|20816633|P1|COMPLETED|Intervention 1||22
8447003|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 1||22
8447004|NCT00774800|20816633|P1|STARTED|Intervention 1||22
8447005|NCT00774787|20816655|P1|NOT COMPLETED|Overall Study||1
8447006|NCT00774787|20816655|P1|COMPLETED|Overall Study||26
8447007|NCT00774787|20816655|P1|STARTED|Overall Study||27
8447008|NCT00774748|20816662|P1|NOT COMPLETED|Overall Study||3
8447009|NCT00774748|20816662|P1|COMPLETED|Overall Study||18
8447010|NCT00774748|20816662|P1|STARTED|Overall Study||21
8447011|NCT00774579|20816672|P2|NOT COMPLETED|Overall Study||0
8447012|NCT00774579|20816673|P1|NOT COMPLETED|Overall Study||0
8447013|NCT00774579|20816672|P2|COMPLETED|Overall Study||9
8447014|NCT00774579|20816673|P1|COMPLETED|Overall Study||9
8447015|NCT00774579|20816672|P2|STARTED|Overall Study||9
8447016|NCT00774579|20816673|P1|STARTED|Overall Study||9
8447017|NCT00774397|20816688|P7|NOT COMPLETED|Overall Study||30
8447018|NCT00774397|20816689|P6|NOT COMPLETED|Overall Study||22
8447019|NCT00774397|20816690|P5|NOT COMPLETED|Overall Study||46
8447020|NCT00774397|20816691|P4|NOT COMPLETED|Overall Study||17
8447021|NCT00774397|20816692|P3|NOT COMPLETED|Overall Study||30
8447022|NCT00774397|20816693|P2|NOT COMPLETED|Overall Study||13
8447023|NCT00774397|20816694|P1|NOT COMPLETED|Overall Study||14
8447024|NCT00774397|20816688|P7|COMPLETED|Overall Study||41
8447025|NCT00774397|20816689|P6|COMPLETED|Overall Study||54
8447026|NCT00774397|20816690|P5|COMPLETED|Overall Study||97
8447027|NCT00774397|20816691|P4|COMPLETED|Overall Study||129
8447028|NCT00774397|20816692|P3|COMPLETED|Overall Study||113
8447029|NCT00774397|20816693|P2|COMPLETED|Overall Study||56
8447030|NCT00774397|20816694|P1|COMPLETED|Overall Study||57
8447031|NCT00774397|20816688|P7|STARTED|Overall Study||71
8447032|NCT00774397|20816689|P6|STARTED|Overall Study||76
8447033|NCT00774397|20816690|P5|STARTED|Overall Study||143
8447034|NCT00774397|20816691|P4|STARTED|Overall Study||146
8447035|NCT00774397|20816692|P3|STARTED|Overall Study||143
8447036|NCT00774397|20816693|P2|STARTED|Overall Study||69
8447037|NCT00774397|20816694|P1|STARTED|Overall Study||71
8447038|NCT00774306|20816930|P4|NOT COMPLETED|Overall Study||5
8447039|NCT00774306|20816931|P3|NOT COMPLETED|Overall Study||8
8447040|NCT00774306|20816932|P2|NOT COMPLETED|Overall Study||2
8447041|NCT00774306|20816933|P1|NOT COMPLETED|Overall Study||18
8447042|NCT00774306|20816930|P4|COMPLETED|Overall Study||2
8447043|NCT00774306|20816931|P3|COMPLETED|Overall Study||8
8447044|NCT00774306|20816932|P2|COMPLETED|Overall Study||3
8447045|NCT00774306|20816933|P1|COMPLETED|Overall Study||6
8447046|NCT00774306|20816930|P4|STARTED|Overall Study||7
8447047|NCT00774306|20816931|P3|STARTED|Overall Study||16
8447048|NCT00774306|20816932|P2|STARTED|Overall Study||5
8447049|NCT00774306|20816933|P1|STARTED|Overall Study||24
8447050|NCT00774267|20816947|P4|NOT COMPLETED|Overall Study||0
8447051|NCT00774267|20816948|P3|NOT COMPLETED|Overall Study||0
8447052|NCT00774267|20816949|P2|NOT COMPLETED|Overall Study||0
8447053|NCT00774267|20816950|P1|NOT COMPLETED|Overall Study||0
8447054|NCT00774267|20816947|P4|COMPLETED|Overall Study||135
8447055|NCT00774267|20816948|P3|COMPLETED|Overall Study||129
8447056|NCT00774267|20816949|P2|COMPLETED|Overall Study||111
8447057|NCT00774267|20816950|P1|COMPLETED|Overall Study||132
8447058|NCT00774267|20816947|P4|STARTED|Overall Study||135
8447059|NCT00774267|20816948|P3|STARTED|Overall Study||129
8447060|NCT00774267|20816949|P2|STARTED|Overall Study||111
8447061|NCT00774267|20816950|P1|STARTED|Overall Study||132
8447062|NCT00774202|20816962|P2|NOT COMPLETED|Overall Study||0
8447063|NCT00774202|20816963|P1|NOT COMPLETED|Overall Study||0
8447064|NCT00774202|20816962|P2|COMPLETED|Overall Study||8
8447065|NCT00774202|20816963|P1|COMPLETED|Overall Study||9
8447066|NCT00774202|20816962|P2|STARTED|Overall Study||8
8447067|NCT00774202|20816963|P1|STARTED|Overall Study||9
8447068|NCT00774163|20816975|P2|NOT COMPLETED|Overall Study||0
8447069|NCT00774163|20816976|P1|NOT COMPLETED|Overall Study||0
8447070|NCT00774163|20816975|P2|COMPLETED|Overall Study||15
8447071|NCT00774163|20816976|P1|COMPLETED|Overall Study||30
8447072|NCT00774163|20816975|P2|STARTED|Overall Study||15
8447073|NCT00774163|20816976|P1|STARTED|Overall Study||30
8447074|NCT00774046|20817014|P1|NOT COMPLETED|Autologous Transplant||0
8447075|NCT00774046|20817014|P1|COMPLETED|Autologous Transplant||4
8447076|NCT00774046|20817014|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
8447077|NCT00774046|20817014|P1|NOT COMPLETED|Stem Cell Mobilization||3
8447078|NCT00774046|20817014|P1|COMPLETED|Stem Cell Mobilization||7
8447079|NCT00774046|20817014|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
8447080|NCT00774046|20817014|P1|NOT COMPLETED|Induction Therapy||0
8447081|NCT00774046|20817014|P1|COMPLETED|Induction Therapy||32
8447082|NCT00774046|20817014|P1|STARTED|Induction Therapy||32
8447083|NCT00774046|20817014|P1|NOT COMPLETED|Enrollment||28
8447084|NCT00774046|20817014|P1|COMPLETED|Enrollment||32
8447085|NCT00774046|20817014|P1|STARTED|Enrollment||60
8447086|NCT00774046|20817014|P1|NOT COMPLETED|Screening||56
8447087|NCT00774046|20817014|P1|COMPLETED|Screening||60
8447088|NCT00774046|20817014|P1|STARTED|Screening||116
8447089|NCT00773968|20817024|P1|NOT COMPLETED|Overall Study||45
8447090|NCT00773968|20817024|P1|COMPLETED|Overall Study||95
8447091|NCT00773968|20817024|P1|Treated|Overall Study||111
8447092|NCT00773968|20817024|P1|STARTED|Overall Study||140
8447093|NCT00773955|20817033|P1|NOT COMPLETED|Overall Study||0
8447094|NCT00773955|20817033|P1|COMPLETED|Overall Study||15
8447095|NCT00773955|20817033|P1|STARTED|Overall Study||15
8447096|NCT00773786|20817040|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8447097|NCT00773786|20817041|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8447098|NCT00773786|20817040|P2|COMPLETED|Second Intervention (1 Week)||10
8447099|NCT00773786|20817041|P1|COMPLETED|Second Intervention (1 Week)||10
8447100|NCT00773786|20817040|P2|STARTED|Second Intervention (1 Week)||10
8447101|NCT00773786|20817041|P1|STARTED|Second Intervention (1 Week)||10
8447102|NCT00773786|20817040|P2|NOT COMPLETED|Washout (1 Week)||0
8447103|NCT00773786|20817041|P1|NOT COMPLETED|Washout (1 Week)||0
8447104|NCT00773786|20817040|P2|COMPLETED|Washout (1 Week)||10
8447105|NCT00773786|20817041|P1|COMPLETED|Washout (1 Week)||10
8447106|NCT00773786|20817040|P2|STARTED|Washout (1 Week)||10
8447107|NCT00773786|20817041|P1|STARTED|Washout (1 Week)||10
8447108|NCT00773786|20817040|P2|NOT COMPLETED|First Intervention (1 Week)||0
8447109|NCT00773786|20817041|P1|NOT COMPLETED|First Intervention (1 Week)||0
8447110|NCT00773786|20817040|P2|COMPLETED|First Intervention (1 Week)||10
8447111|NCT00773786|20817041|P1|COMPLETED|First Intervention (1 Week)||10
8447112|NCT00773786|20817040|P2|STARTED|First Intervention (1 Week)||10
8447113|NCT00773786|20817041|P1|STARTED|First Intervention (1 Week)||10
8447114|NCT00773734|20817055|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447115|NCT00773734|20817056|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447116|NCT00773734|20817057|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
8447117|NCT00773734|20817058|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
8447118|NCT00773734|20817059|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447119|NCT00773734|20817060|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447120|NCT00773734|20817055|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447121|NCT00773734|20817056|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447122|NCT00773734|20817057|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
8447123|NCT00773734|20817058|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
8447124|NCT00773734|20817059|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447125|NCT00773734|20817060|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447126|NCT00773734|20817055|P6|STARTED|LTE Period: Week 52 to 6 Years||0
8447127|NCT00773734|20817056|P5|STARTED|LTE Period: Week 52 to 6 Years||0
8447128|NCT00773734|20817057|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
8447129|NCT00773734|20817058|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
8447130|NCT00773734|20817059|P2|STARTED|LTE Period: Week 52 to 6 Years||0
8447131|NCT00773734|20817060|P1|STARTED|LTE Period: Week 52 to 6 Years||0
8447132|NCT00773734|20817055|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
8447133|NCT00773734|20817056|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
8447134|NCT00773734|20817057|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
8447135|NCT00773734|20817058|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
8447136|NCT00773734|20817059|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
8447137|NCT00773734|20817060|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
8447138|NCT00773734|20817055|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
8447139|NCT00773734|20817056|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
8447140|NCT00773734|20817057|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
8447141|NCT00773734|20817058|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
8447142|NCT00773734|20817059|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
8447143|NCT00773734|20817060|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
8447144|NCT00773734|20817055|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
8447145|NCT00773734|20817056|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
8447146|NCT00773734|20817057|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
8447147|NCT00773734|20817058|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
8447148|NCT00773734|20817059|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
8447149|NCT00773734|20817060|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
8447150|NCT00773734|20817055|P6|STARTED|Extension: Active Treatment Week 24-52||27
8447151|NCT00773734|20817056|P5|STARTED|Extension: Active Treatment Week 24-52||27
8447152|NCT00773734|20817057|P4|STARTED|Extension: Active Treatment Week 24-52||58
8447153|NCT00773734|20817058|P3|STARTED|Extension: Active Treatment Week 24-52||50
8447154|NCT00773734|20817059|P2|STARTED|Extension: Active Treatment Week 24-52||47
8447155|NCT00773734|20817060|P1|STARTED|Extension: Active Treatment Week 24-52||0
8447156|NCT00773734|20817055|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
8447157|NCT00773734|20817056|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
8447158|NCT00773734|20817057|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
8447159|NCT00773734|20817058|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
8447160|NCT00773734|20817059|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
8447161|NCT00773734|20817060|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
8447162|NCT00773734|20817055|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
8447163|NCT00773734|20817056|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
8447164|NCT00773734|20817057|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
8447165|NCT00773734|20817058|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
8447166|NCT00773734|20817059|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
8447167|NCT00773734|20817060|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
8447168|NCT00773734|20817055|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
8447169|NCT00773734|20817056|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
8447170|NCT00773734|20817057|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
8447171|NCT00773734|20817058|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
8447172|NCT00773734|20817059|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
8447173|NCT00773734|20817060|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
8447174|NCT00773734|20817055|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447175|NCT00773734|20817056|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447176|NCT00773734|20817057|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
8447177|NCT00773734|20817058|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
8447178|NCT00773734|20817059|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
8447179|NCT00773734|20817060|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
8447180|NCT00773734|20817055|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447181|NCT00773734|20817056|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447182|NCT00773734|20817057|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
8447183|NCT00773734|20817058|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
8447184|NCT00773734|20817059|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
8447185|NCT00773734|20817060|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
8447186|NCT00773734|20817055|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
8447187|NCT00773734|20817056|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
8447188|NCT00773734|20817057|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
8447189|NCT00773734|20817058|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
8447190|NCT00773734|20817059|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
8447191|NCT00773734|20817060|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
8447192|NCT00773604|20817622|P1|NOT COMPLETED|Overall Study||0
8447193|NCT00773604|20817622|P1|COMPLETED|Overall Study||9
8447194|NCT00773604|20817622|P1|STARTED|Overall Study||9
8447195|NCT00773513|20817628|P2|NOT COMPLETED|Overall Study||1109
8447196|NCT00773513|20817629|P1|NOT COMPLETED|Overall Study||1101
8447197|NCT00773513|20817628|P2|COMPLETED|Overall Study||303
8447198|NCT00773513|20817629|P1|COMPLETED|Overall Study||312
8447199|NCT00773513|20817628|P2|Received Study Treatment|Overall Study||1409
8447200|NCT00773513|20817629|P1|Received Study Treatment|Overall Study||1409
8447201|NCT00773513|20817628|P2|STARTED|Overall Study||1412
8447202|NCT00773513|20817629|P1|STARTED|Overall Study||1413
8447203|NCT00773474|20817649|P1|NOT COMPLETED|Overall Study||0
8447204|NCT00773474|20817649|P1|COMPLETED|Overall Study||29
8447205|NCT00773474|20817649|P1|STARTED|Overall Study||29
8447206|NCT00773461|20817658|P2|NOT COMPLETED|Overall Study||4
8447207|NCT00773461|20817659|P1|NOT COMPLETED|Overall Study||5
8447208|NCT00773461|20817658|P2|COMPLETED|Overall Study||135
8447209|NCT00773461|20817659|P1|COMPLETED|Overall Study||65
8447210|NCT00773461|20817658|P2|STARTED|Overall Study||139
8447211|NCT00773461|20817659|P1|STARTED|Overall Study||70
8447212|NCT00773422|20817700|P3|NOT COMPLETED|Overall Study||0
8447213|NCT00773422|20817701|P2|NOT COMPLETED|Overall Study||0
8447214|NCT00773422|20817702|P1|NOT COMPLETED|Overall Study||0
8447215|NCT00773422|20817700|P3|COMPLETED|Overall Study||10
8447216|NCT00773422|20817701|P2|COMPLETED|Overall Study||9
8447217|NCT00773422|20817702|P1|COMPLETED|Overall Study||11
8447218|NCT00773422|20817700|P3|STARTED|Overall Study||10
8447219|NCT00773422|20817701|P2|STARTED|Overall Study||9
8447220|NCT00773422|20817702|P1|STARTED|Overall Study||11
8447221|NCT00773383|20817713|P1|NOT COMPLETED|Overall Study||31
8447222|NCT00773383|20817713|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
8447223|NCT00773383|20817713|P1|Received Study Drug|Overall Study||34
8447224|NCT00773383|20817713|P1|STARTED|Overall Study||35
8447225|NCT00773370|20817735|P2|NOT COMPLETED|Overall Study||10
8447226|NCT00773370|20817736|P1|NOT COMPLETED|Overall Study||18
8447227|NCT00773370|20817735|P2|COMPLETED|Overall Study||23
8447228|NCT00773370|20817736|P1|COMPLETED|Overall Study||25
8447229|NCT00773370|20817735|P2|STARTED|Overall Study||33
8447230|NCT00773370|20817736|P1|STARTED|Overall Study||43
8447231|NCT00773279|20817748|P2|NOT COMPLETED|Period 2||6
8447232|NCT00773279|20817749|P1|NOT COMPLETED|Period 2||3
8447233|NCT00773279|20817748|P2|COMPLETED|Period 2||111
8447234|NCT00773279|20817749|P1|COMPLETED|Period 2||111
8447235|NCT00773279|20817748|P2|STARTED|Period 2||117
8447236|NCT00773279|20817749|P1|STARTED|Period 2||114
8447237|NCT00773279|20817748|P2|NOT COMPLETED|Period 1||4
8447238|NCT00773279|20817749|P1|NOT COMPLETED|Period 1||7
8447239|NCT00773279|20817748|P2|COMPLETED|Period 1||117
8447240|NCT00773279|20817749|P1|COMPLETED|Period 1||114
8447241|NCT00773279|20817748|P2|STARTED|Period 1||121
8447242|NCT00773279|20817749|P1|STARTED|Period 1||121
8447243|NCT00773253|20817770|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
8447244|NCT00773253|20817771|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
8447245|NCT00773253|20817770|P2|COMPLETED|Second Intervention (Week 24-48)||4
8447246|NCT00773253|20817771|P1|COMPLETED|Second Intervention (Week 24-48)||5
8447247|NCT00773253|20817770|P2|STARTED|Second Intervention (Week 24-48)||4
8447248|NCT00773253|20817771|P1|STARTED|Second Intervention (Week 24-48)||5
8447249|NCT00773253|20817770|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
8447250|NCT00773253|20817771|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
8447251|NCT00773253|20817770|P2|COMPLETED|First Intervention (Week 0-24)||4
8447252|NCT00773253|20817771|P1|COMPLETED|First Intervention (Week 0-24)||5
8447253|NCT00773253|20817770|P2|STARTED|First Intervention (Week 0-24)||5
8447254|NCT00773253|20817771|P1|STARTED|First Intervention (Week 0-24)||5
8447255|NCT00773175|20817781|P2|NOT COMPLETED|Overall Study||2
8447256|NCT00773175|20817782|P1|NOT COMPLETED|Overall Study||2
8447257|NCT00773175|20817781|P2|COMPLETED|Overall Study||73
8447258|NCT00773175|20817782|P1|COMPLETED|Overall Study||71
8447259|NCT00773175|20817781|P2|No Fluids Received|Overall Study||1
8447260|NCT00773175|20817782|P1|No Fluids Received|Overall Study||0
8447261|NCT00773175|20817781|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
8447262|NCT00773175|20817782|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
8447263|NCT00773175|20817781|P2|Initial Fluids Via Randomized Route|Overall Study||59
8447264|NCT00773175|20817782|P1|Initial Fluids Via Randomized Route|Overall Study||73
8447265|NCT00773175|20817781|P2|STARTED|Overall Study||75
8447266|NCT00773175|20817782|P1|STARTED|Overall Study||73
8447267|NCT00773136|20817874|P1|NOT COMPLETED|Overall Study||2
8447268|NCT00773136|20817874|P1|COMPLETED|Overall Study||19
8447269|NCT00773136|20817874|P1|STARTED|Overall Study||21
8447270|NCT00773097|20817879|P1|NOT COMPLETED|Overall Study||7
8447271|NCT00773097|20817879|P1|COMPLETED|Overall Study||39
8447272|NCT00773097|20817879|P1|STARTED|Overall Study||46
8447273|NCT00772967|20817885|P6|NOT COMPLETED|Crossover Treatment 3||0
8447274|NCT00772967|20817886|P5|NOT COMPLETED|Crossover Treatment 3||1
8447275|NCT00772967|20817887|P4|NOT COMPLETED|Crossover Treatment 3||0
8447276|NCT00772967|20817888|P3|NOT COMPLETED|Crossover Treatment 3||0
8447277|NCT00772967|20817889|P2|NOT COMPLETED|Crossover Treatment 3||0
8447278|NCT00772967|20817890|P1|NOT COMPLETED|Crossover Treatment 3||0
8447279|NCT00772967|20817885|P6|COMPLETED|Crossover Treatment 3||3
8447280|NCT00772967|20817886|P5|COMPLETED|Crossover Treatment 3||3
8447281|NCT00772967|20817887|P4|COMPLETED|Crossover Treatment 3||3
8447282|NCT00772967|20817888|P3|COMPLETED|Crossover Treatment 3||3
8447283|NCT00772967|20817889|P2|COMPLETED|Crossover Treatment 3||4
8447284|NCT00772967|20817890|P1|COMPLETED|Crossover Treatment 3||3
8447285|NCT00772967|20817885|P6|STARTED|Crossover Treatment 3||3
8447286|NCT00772967|20817886|P5|STARTED|Crossover Treatment 3||4
8447287|NCT00772967|20817887|P4|STARTED|Crossover Treatment 3||3
8447288|NCT00772967|20817888|P3|STARTED|Crossover Treatment 3||3
8447289|NCT00772967|20817889|P2|STARTED|Crossover Treatment 3||4
8447290|NCT00772967|20817890|P1|STARTED|Crossover Treatment 3||3
8447291|NCT00772967|20817885|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
8447292|NCT00772967|20817886|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
8447293|NCT00772967|20817887|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
8447294|NCT00772967|20817888|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
8447295|NCT00772967|20817889|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
8447296|NCT00772967|20817890|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
8447297|NCT00772967|20817885|P6|COMPLETED|Break 2 (4-7 Days)||3
8447298|NCT00772967|20817886|P5|COMPLETED|Break 2 (4-7 Days)||4
8447299|NCT00772967|20817887|P4|COMPLETED|Break 2 (4-7 Days)||3
8447300|NCT00772967|20817888|P3|COMPLETED|Break 2 (4-7 Days)||3
8447301|NCT00772967|20817889|P2|COMPLETED|Break 2 (4-7 Days)||4
8447302|NCT00772967|20817890|P1|COMPLETED|Break 2 (4-7 Days)||3
8447303|NCT00772967|20817885|P6|STARTED|Break 2 (4-7 Days)||3
8447304|NCT00772967|20817886|P5|STARTED|Break 2 (4-7 Days)||4
8447305|NCT00772967|20817887|P4|STARTED|Break 2 (4-7 Days)||3
8447306|NCT00772967|20817888|P3|STARTED|Break 2 (4-7 Days)||3
8447307|NCT00772967|20817889|P2|STARTED|Break 2 (4-7 Days)||4
8447308|NCT00772967|20817890|P1|STARTED|Break 2 (4-7 Days)||3
8447309|NCT00772967|20817885|P6|NOT COMPLETED|Crossover Treatment 2||0
8447310|NCT00772967|20817886|P5|NOT COMPLETED|Crossover Treatment 2||0
8447311|NCT00772967|20817887|P4|NOT COMPLETED|Crossover Treatment 2||0
8447312|NCT00772967|20817888|P3|NOT COMPLETED|Crossover Treatment 2||0
8447313|NCT00772967|20817889|P2|NOT COMPLETED|Crossover Treatment 2||0
8447314|NCT00772967|20817890|P1|NOT COMPLETED|Crossover Treatment 2||0
8447315|NCT00772967|20817885|P6|COMPLETED|Crossover Treatment 2||3
8447316|NCT00772967|20817886|P5|COMPLETED|Crossover Treatment 2||4
8447317|NCT00772967|20817887|P4|COMPLETED|Crossover Treatment 2||3
8447318|NCT00772967|20817888|P3|COMPLETED|Crossover Treatment 2||3
8447319|NCT00772967|20817889|P2|COMPLETED|Crossover Treatment 2||4
8447320|NCT00772967|20817890|P1|COMPLETED|Crossover Treatment 2||3
8447321|NCT00772967|20817885|P6|STARTED|Crossover Treatment 2||3
8447322|NCT00772967|20817886|P5|STARTED|Crossover Treatment 2||4
8447323|NCT00772967|20817887|P4|STARTED|Crossover Treatment 2||3
8447324|NCT00772967|20817888|P3|STARTED|Crossover Treatment 2||3
8447325|NCT00772967|20817889|P2|STARTED|Crossover Treatment 2||4
8447326|NCT00772967|20817890|P1|STARTED|Crossover Treatment 2||3
8447327|NCT00772967|20817885|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
8447328|NCT00772967|20817886|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
8447329|NCT00772967|20817887|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
8447330|NCT00772967|20817888|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
8447331|NCT00772967|20817889|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
8447332|NCT00772967|20817890|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
8447333|NCT00772967|20817885|P6|COMPLETED|Break 1 (4-7 Days)||3
8447334|NCT00772967|20817886|P5|COMPLETED|Break 1 (4-7 Days)||4
8447335|NCT00772967|20817887|P4|COMPLETED|Break 1 (4-7 Days)||3
8447336|NCT00772967|20817888|P3|COMPLETED|Break 1 (4-7 Days)||3
8447337|NCT00772967|20817889|P2|COMPLETED|Break 1 (4-7 Days)||4
8447338|NCT00772967|20817890|P1|COMPLETED|Break 1 (4-7 Days)||3
8447339|NCT00772967|20817885|P6|STARTED|Break 1 (4-7 Days)||3
8447340|NCT00772967|20817886|P5|STARTED|Break 1 (4-7 Days)||4
8447341|NCT00772967|20817887|P4|STARTED|Break 1 (4-7 Days)||3
8447342|NCT00772967|20817888|P3|STARTED|Break 1 (4-7 Days)||3
8447343|NCT00772967|20817889|P2|STARTED|Break 1 (4-7 Days)||5
8447344|NCT00772967|20817890|P1|STARTED|Break 1 (4-7 Days)||3
8447345|NCT00772967|20817885|P6|NOT COMPLETED|Crossover Treatment 1||0
8447346|NCT00772967|20817886|P5|NOT COMPLETED|Crossover Treatment 1||0
8447347|NCT00772967|20817887|P4|NOT COMPLETED|Crossover Treatment 1||1
8447348|NCT00772967|20817888|P3|NOT COMPLETED|Crossover Treatment 1||0
8447349|NCT00772967|20817889|P2|NOT COMPLETED|Crossover Treatment 1||0
8447350|NCT00772967|20817890|P1|NOT COMPLETED|Crossover Treatment 1||0
8447351|NCT00772967|20817885|P6|COMPLETED|Crossover Treatment 1||3
8447352|NCT00772967|20817886|P5|COMPLETED|Crossover Treatment 1||4
8447353|NCT00772967|20817887|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
8447354|NCT00772967|20817888|P3|COMPLETED|Crossover Treatment 1||3
8447355|NCT00772967|20817889|P2|COMPLETED|Crossover Treatment 1||5
8447356|NCT00772967|20817890|P1|COMPLETED|Crossover Treatment 1||3
8447357|NCT00772967|20817885|P6|STARTED|Crossover Treatment 1||3
8447358|NCT00772967|20817886|P5|STARTED|Crossover Treatment 1||4
8447359|NCT00772967|20817887|P4|STARTED|Crossover Treatment 1||4
8447360|NCT00772967|20817888|P3|STARTED|Crossover Treatment 1||3
8447361|NCT00772967|20817889|P2|STARTED|Crossover Treatment 1||5
8447362|NCT00772967|20817890|P1|STARTED|Crossover Treatment 1||3
8447363|NCT00772954|20817910|P3|NOT COMPLETED|Overall Study||1
8447364|NCT00772954|20817911|P2|NOT COMPLETED|Overall Study||0
8447365|NCT00772954|20817912|P1|NOT COMPLETED|Overall Study||0
8447366|NCT00772954|20817910|P3|COMPLETED|Overall Study||11
8447367|NCT00772954|20817911|P2|COMPLETED|Overall Study||12
8447368|NCT00772954|20817912|P1|COMPLETED|Overall Study||12
8447369|NCT00772954|20817910|P3|STARTED|Overall Study||12
8447370|NCT00772954|20817911|P2|STARTED|Overall Study||12
8447371|NCT00772954|20817912|P1|STARTED|Overall Study||12
8447372|NCT00772941|20817920|P1|NOT COMPLETED|Overall Study||682
8447373|NCT00772941|20817920|P1|COMPLETED|Overall Study||3257
8447374|NCT00772941|20817920|P1|STARTED|Overall Study||3939
8447375|NCT00772928|20817951|P2|NOT COMPLETED|Overall Study||41
8447376|NCT00772928|20817952|P1|NOT COMPLETED|Overall Study||44
8447377|NCT00772928|20817951|P2|COMPLETED|Overall Study||538
8447378|NCT00772928|20817952|P1|COMPLETED|Overall Study||543
8447379|NCT00772928|20817951|P2|STARTED|Overall Study||579
8447380|NCT00772928|20817952|P1|STARTED|Overall Study||587
8447381|NCT00772915|20817962|P1|NOT COMPLETED|Overall Study||15
8447382|NCT00772915|20817962|P1|COMPLETED|Overall Study||23
8447383|NCT00772915|20817962|P1|STARTED|Overall Study||38
8447384|NCT00772889|20817973|P3|NOT COMPLETED|Overall Study||16
8447385|NCT00772889|20817974|P2|NOT COMPLETED|Overall Study||18
8447386|NCT00772889|20817975|P1|NOT COMPLETED|Overall Study||22
8447387|NCT00772889|20817973|P3|COMPLETED|Overall Study||187
8447388|NCT00772889|20817974|P2|COMPLETED|Overall Study||375
8447389|NCT00772889|20817975|P1|COMPLETED|Overall Study||353
8447390|NCT00772889|20817973|P3|Completed at Day 21|Overall Study||203
8447391|NCT00772889|20817974|P2|Completed at Day 21|Overall Study||390
8447392|NCT00772889|20817975|P1|Completed at Day 21|Overall Study||374
8447393|NCT00772889|20817973|P3|STARTED|Overall Study||203
8447394|NCT00772889|20817974|P2|STARTED|Overall Study||393
8447395|NCT00772889|20817975|P1|STARTED|Overall Study||375
8447396|NCT00772772|20818028|P1|NOT COMPLETED|Overall Study||0
8447397|NCT00772772|20818028|P1|COMPLETED|Overall Study||12
8447398|NCT00772772|20818028|P1|STARTED|Overall Study||12
8447399|NCT00772707|20818033|P1|NOT COMPLETED|Overall Study||3
8447400|NCT00772707|20818033|P1|COMPLETED|Overall Study||111
8447401|NCT00772707|20818033|P1|STARTED|Overall Study||114
8447402|NCT00772668|20818038|P1|NOT COMPLETED|Overall Study||3
8447403|NCT00772668|20818038|P1|COMPLETED|Overall Study||0
8447404|NCT00772668|20818038|P1|STARTED|Overall Study||3
8447405|NCT00772629|20818047|P2|NOT COMPLETED|Overall Study||0
8447406|NCT00772629|20818048|P1|NOT COMPLETED|Overall Study||1
8447407|NCT00772629|20818047|P2|COMPLETED|Overall Study||1
8447408|NCT00772629|20818048|P1|COMPLETED|Overall Study||16
8447409|NCT00772629|20818047|P2|STARTED|Overall Study||1
8447410|NCT00772629|20818048|P1|STARTED|Overall Study||17
8447411|NCT00772603|20818057|P3|NOT COMPLETED|Overall Study||26
8447412|NCT00772603|20818058|P2|NOT COMPLETED|Overall Study||40
8447413|NCT00772603|20818059|P1|NOT COMPLETED|Overall Study||52
8447414|NCT00772603|20818057|P3|COMPLETED|Overall Study||95
8447415|NCT00772603|20818058|P2|COMPLETED|Overall Study||82
8447416|NCT00772603|20818059|P1|COMPLETED|Overall Study||71
8447417|NCT00772603|20818057|P3|STARTED|Overall Study||121
8447418|NCT00772603|20818058|P2|STARTED|Overall Study||122
8447419|NCT00772603|20818059|P1|STARTED|Overall Study||123
8447420|NCT00772590|20818083|P4|NOT COMPLETED|Overall Study||0
8447421|NCT00772590|20818084|P3|NOT COMPLETED|Overall Study||0
8447422|NCT00772590|20818085|P2|NOT COMPLETED|Overall Study||0
8447423|NCT00772590|20818086|P1|NOT COMPLETED|Overall Study||0
8447424|NCT00772590|20818083|P4|COMPLETED|Overall Study||17
8447425|NCT00772590|20818084|P3|COMPLETED|Overall Study||18
8447426|NCT00772590|20818085|P2|COMPLETED|Overall Study||19
8447427|NCT00772590|20818086|P1|COMPLETED|Overall Study||19
8447428|NCT00772590|20818083|P4|STARTED|Overall Study||17
8447429|NCT00772590|20818084|P3|STARTED|Overall Study||18
8447430|NCT00772590|20818085|P2|STARTED|Overall Study||19
8447431|NCT00772590|20818086|P1|STARTED|Overall Study||19
8447432|NCT00772577|20818098|P2|NOT COMPLETED|Overall Study||23
8447433|NCT00772577|20818099|P1|NOT COMPLETED|Overall Study||23
8447434|NCT00772577|20818098|P2|COMPLETED|Overall Study||170
8447435|NCT00772577|20818099|P1|COMPLETED|Overall Study||170
8447436|NCT00772577|20818098|P2|STARTED|Overall Study||193
8447437|NCT00772577|20818099|P1|STARTED|Overall Study||193
8447438|NCT00772538|20818115|P2|NOT COMPLETED|Overall Study||26
8447439|NCT00772538|20818116|P1|NOT COMPLETED|Overall Study||20
8447440|NCT00772538|20818115|P2|COMPLETED|Overall Study||211
8447441|NCT00772538|20818116|P1|COMPLETED|Overall Study||202
8447442|NCT00772538|20818115|P2|STARTED|Overall Study||237
8447443|NCT00772538|20818116|P1|STARTED|Overall Study||222
8447444|NCT00772447|20818188|P2|NOT COMPLETED|Overall Study||24
8447445|NCT00772447|20818189|P1|NOT COMPLETED|Overall Study||20
8447446|NCT00772447|20818188|P2|COMPLETED|Overall Study||110
8447447|NCT00772447|20818189|P1|COMPLETED|Overall Study||111
8447448|NCT00772447|20818188|P2|STARTED|Overall Study||134
8447449|NCT00772447|20818189|P1|STARTED|Overall Study||131
8447450|NCT00772382|20818217|P1|NOT COMPLETED|Overall Study||55
8447451|NCT00772382|20818217|P1|COMPLETED|Overall Study||61
8447452|NCT00772382|20818217|P1|STARTED|Overall Study||116
8447453|NCT00772369|20818222|P1|NOT COMPLETED|Overall Study||1
8447454|NCT00772369|20818222|P1|COMPLETED|Overall Study||3213
8447455|NCT00772369|20818222|P1|STARTED|Overall Study||3214
8447456|NCT00772304|20818227|P1|NOT COMPLETED|Overall Study||0
8447457|NCT00772304|20818227|P1|COMPLETED|Overall Study||102
8447458|NCT00772304|20818227|P1|STARTED|Overall Study||102
8447459|NCT00772148|20818233|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
8447460|NCT00772148|20818234|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
8447461|NCT00772148|20818233|P2|COMPLETED|Maintenance Phase (Week 52)||18
8447462|NCT00772148|20818234|P1|COMPLETED|Maintenance Phase (Week 52)||17
8447463|NCT00772148|20818233|P2|STARTED|Maintenance Phase (Week 52)||23
8447464|NCT00772148|20818234|P1|STARTED|Maintenance Phase (Week 52)||21
8447465|NCT00772148|20818233|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
8447466|NCT00772148|20818234|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
8447467|NCT00772148|20818233|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
8447468|NCT00772148|20818234|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
8447469|NCT00772148|20818233|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
8447470|NCT00772148|20818234|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
8447471|NCT00772109|20818254|P4|NOT COMPLETED|Overall Study||31
8447472|NCT00772109|20818255|P3|NOT COMPLETED|Overall Study||19
8447473|NCT00772109|20818256|P2|NOT COMPLETED|Overall Study||19
8447474|NCT00772109|20818257|P1|NOT COMPLETED|Overall Study||21
8447475|NCT00772109|20818254|P4|COMPLETED|Overall Study||1397
8447476|NCT00772109|20818255|P3|COMPLETED|Overall Study||936
8447477|NCT00772109|20818256|P2|COMPLETED|Overall Study||934
8447478|NCT00772109|20818257|P1|COMPLETED|Overall Study||935
8447479|NCT00772109|20818254|P4|STARTED|Overall Study||1428
8447480|NCT00772109|20818255|P3|STARTED|Overall Study||955
8447481|NCT00772109|20818256|P2|STARTED|Overall Study||953
8447482|NCT00772109|20818257|P1|STARTED|Overall Study||956
8447483|NCT00772070|20818281|P2|NOT COMPLETED|Overall Study||10
8447484|NCT00772070|20818282|P1|NOT COMPLETED|Overall Study||2
8447485|NCT00772070|20818281|P2|COMPLETED|Overall Study||61
8447486|NCT00772070|20818282|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
8447487|NCT00772070|20818281|P2|STARTED|Overall Study||71
8447488|NCT00772070|20818282|P1|STARTED|Overall Study||102
8447489|NCT00772031|20818294|P2|NOT COMPLETED|Overall Study||43
8447490|NCT00772031|20818295|P1|NOT COMPLETED|Overall Study||32
8447491|NCT00772031|20818294|P2|COMPLETED|Overall Study||52
8447492|NCT00772031|20818295|P1|COMPLETED|Overall Study||64
8447493|NCT00772031|20818294|P2|STARTED|Overall Study||95
8447494|NCT00772031|20818295|P1|STARTED|Overall Study||96
8447495|NCT00772005|20818321|P4|NOT COMPLETED|Overall Study||26
8447496|NCT00772005|20818322|P3|NOT COMPLETED|Overall Study||28
8447497|NCT00772005|20818323|P2|NOT COMPLETED|Overall Study||30
8447498|NCT00772005|20818324|P1|NOT COMPLETED|Overall Study||25
8447499|NCT00772005|20818321|P4|COMPLETED|Overall Study||46
8447500|NCT00772005|20818322|P3|COMPLETED|Overall Study||44
8447501|NCT00772005|20818323|P2|COMPLETED|Overall Study||40
8447502|NCT00772005|20818324|P1|COMPLETED|Overall Study||46
8447503|NCT00772005|20818321|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
8447504|NCT00772005|20818322|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
8447505|NCT00772005|20818323|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
8447506|NCT00772005|20818324|P1|STARTED|Overall Study||71
8447507|NCT00771953|20819012|P2|NOT COMPLETED|Overall Study||10
8447508|NCT00771953|20819013|P1|NOT COMPLETED|Overall Study||10
8447509|NCT00771953|20819012|P2|COMPLETED|Overall Study||26
8447510|NCT00771953|20819013|P1|COMPLETED|Overall Study||26
8447511|NCT00771953|20819012|P2|STARTED|Overall Study||36
8447512|NCT00771953|20819013|P1|STARTED|Overall Study||36
8447513|NCT00771927|20819023|P2|NOT COMPLETED|Overall Study||237
8447514|NCT00771927|20819024|P1|NOT COMPLETED|Overall Study||255
8447515|NCT00771927|20819023|P2|COMPLETED|Overall Study||256
8447516|NCT00771927|20819024|P1|COMPLETED|Overall Study||256
8447517|NCT00771927|20819023|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
8447518|NCT00771927|20819024|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
8447519|NCT00771914|20819036|P4|NOT COMPLETED|Overall Study||2
8447520|NCT00771914|20819037|P3|NOT COMPLETED|Overall Study||0
8447521|NCT00771914|20819038|P2|NOT COMPLETED|Overall Study||0
8447522|NCT00771914|20819039|P1|NOT COMPLETED|Overall Study||0
8447523|NCT00771914|20819036|P4|COMPLETED|Overall Study||6
8447524|NCT00771914|20819037|P3|COMPLETED|Overall Study||6
8447525|NCT00771914|20819038|P2|COMPLETED|Overall Study||6
8447526|NCT00771914|20819039|P1|COMPLETED|Overall Study||7
8447527|NCT00771914|20819036|P4|STARTED|Overall Study||8
8447528|NCT00771914|20819037|P3|STARTED|Overall Study||6
8447529|NCT00771914|20819038|P2|STARTED|Overall Study||6
8447530|NCT00771914|20819039|P1|STARTED|Overall Study||7
8447531|NCT00771901|20819052|P3|NOT COMPLETED|Overall Study||4
8447532|NCT00771901|20819053|P2|NOT COMPLETED|Overall Study||0
8447533|NCT00771901|20819054|P1|NOT COMPLETED|Overall Study||0
8447534|NCT00771901|20819052|P3|COMPLETED|Overall Study||6
8447535|NCT00771901|20819053|P2|COMPLETED|Overall Study||10
8447536|NCT00771901|20819054|P1|COMPLETED|Overall Study||10
8447537|NCT00771901|20819052|P3|STARTED|Overall Study||10
8447538|NCT00771901|20819053|P2|STARTED|Overall Study||10
8447539|NCT00771901|20819054|P1|STARTED|Overall Study||10
8447540|NCT00771875|20819071|P3|NOT COMPLETED|Overall Study||0
8447541|NCT00771875|20819072|P2|NOT COMPLETED|Overall Study||1
8447542|NCT00771875|20819073|P1|NOT COMPLETED|Overall Study||0
8447543|NCT00771875|20819071|P3|COMPLETED|Overall Study||10
8447544|NCT00771875|20819072|P2|COMPLETED|Overall Study||9
8447545|NCT00771875|20819073|P1|COMPLETED|Overall Study||10
8447546|NCT00771875|20819071|P3|STARTED|Overall Study||10
8447547|NCT00771875|20819072|P2|STARTED|Overall Study||10
8447548|NCT00771875|20819073|P1|STARTED|Overall Study||10
8447549|NCT00771849|20819101|P2|NOT COMPLETED|Overall Study||4
8447550|NCT00771849|20819102|P1|NOT COMPLETED|Overall Study||2
8447551|NCT00771849|20819101|P2|COMPLETED|Overall Study||47
8447552|NCT00771849|20819102|P1|COMPLETED|Overall Study||50
8447553|NCT00771849|20819101|P2|STARTED|Overall Study|One subject was not vaccinated|51
8447554|NCT00771849|20819102|P1|STARTED|Overall Study||52
8447555|NCT00771810|20819113|P3|NOT COMPLETED|Overall Study||7
8447556|NCT00771810|20819114|P2|NOT COMPLETED|Overall Study||5
8447557|NCT00771810|20819115|P1|NOT COMPLETED|Overall Study||5
8447558|NCT00771810|20819113|P3|COMPLETED|Overall Study||6
8447559|NCT00771810|20819114|P2|COMPLETED|Overall Study||6
8447560|NCT00771810|20819115|P1|COMPLETED|Overall Study||5
8447561|NCT00771810|20819113|P3|STARTED|Overall Study||13
8447562|NCT00771810|20819114|P2|STARTED|Overall Study||11
8447563|NCT00771810|20819115|P1|STARTED|Overall Study||10
8447564|NCT00771758|20819153|P3|NOT COMPLETED|Overall Study||2
8447565|NCT00771758|20819154|P2|NOT COMPLETED|Overall Study||12
8447566|NCT00771758|20819155|P1|NOT COMPLETED|Overall Study||8
8447567|NCT00771758|20819153|P3|COMPLETED|Overall Study||19
8447568|NCT00771758|20819154|P2|COMPLETED|Overall Study||31
8447569|NCT00771758|20819155|P1|COMPLETED|Overall Study||36
8447570|NCT00771758|20819153|P3|STARTED|Overall Study||21
8447571|NCT00771758|20819154|P2|STARTED|Overall Study||43
8447572|NCT00771758|20819155|P1|STARTED|Overall Study||44
8447573|NCT00771745|20819305|P2|NOT COMPLETED|Overall Study||0
8447574|NCT00771745|20819306|P1|NOT COMPLETED|Overall Study||0
8447575|NCT00771745|20819305|P2|COMPLETED|Overall Study||5
8447576|NCT00771745|20819306|P1|COMPLETED|Overall Study||6
8447577|NCT00771745|20819305|P2|STARTED|Overall Study||5
8447578|NCT00771745|20819306|P1|STARTED|Overall Study||6
8447579|NCT00771667|20819316|P10|NOT COMPLETED|Maintenance Phase||17
8447580|NCT00771667|20819317|P9|NOT COMPLETED|Maintenance Phase||22
8447581|NCT00771667|20819318|P8|NOT COMPLETED|Maintenance Phase||5
8447582|NCT00771667|20819319|P7|NOT COMPLETED|Maintenance Phase||10
8447583|NCT00771667|20819320|P6|NOT COMPLETED|Maintenance Phase||7
8447584|NCT00771667|20819321|P5|NOT COMPLETED|Maintenance Phase||2
8447585|NCT00771667|20819322|P4|NOT COMPLETED|Maintenance Phase||0
8447586|NCT00771667|20819323|P3|NOT COMPLETED|Maintenance Phase||0
8447587|NCT00771667|20819324|P2|NOT COMPLETED|Maintenance Phase||0
8447588|NCT00771667|20819325|P1|NOT COMPLETED|Maintenance Phase||0
8447589|NCT00771667|20819316|P10|COMPLETED|Maintenance Phase||92
8447590|NCT00771667|20819317|P9|COMPLETED|Maintenance Phase||88
8447591|NCT00771667|20819318|P8|COMPLETED|Maintenance Phase||67
8447592|NCT00771667|20819319|P7|COMPLETED|Maintenance Phase||63
8447593|NCT00771667|20819320|P6|COMPLETED|Maintenance Phase||78
8447594|NCT00771667|20819321|P5|COMPLETED|Maintenance Phase||26
8447595|NCT00771667|20819322|P4|COMPLETED|Maintenance Phase||0
8447596|NCT00771667|20819323|P3|COMPLETED|Maintenance Phase||0
8447597|NCT00771667|20819324|P2|COMPLETED|Maintenance Phase||0
8447598|NCT00771667|20819325|P1|COMPLETED|Maintenance Phase||0
8447599|NCT00771667|20819316|P10|STARTED|Maintenance Phase||109
8447600|NCT00771667|20819317|P9|STARTED|Maintenance Phase||110
8447601|NCT00771667|20819318|P8|STARTED|Maintenance Phase||72
8447602|NCT00771667|20819319|P7|STARTED|Maintenance Phase||73
8447603|NCT00771667|20819320|P6|STARTED|Maintenance Phase||85
8447604|NCT00771667|20819321|P5|STARTED|Maintenance Phase||28
8447605|NCT00771667|20819322|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447606|NCT00771667|20819323|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447607|NCT00771667|20819324|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447608|NCT00771667|20819325|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447609|NCT00771667|20819316|P10|NOT COMPLETED|Induction Phase||0
8447610|NCT00771667|20819317|P9|NOT COMPLETED|Induction Phase||0
8447611|NCT00771667|20819318|P8|NOT COMPLETED|Induction Phase||0
8447612|NCT00771667|20819319|P7|NOT COMPLETED|Induction Phase||0
8447613|NCT00771667|20819320|P6|NOT COMPLETED|Induction Phase||0
8447614|NCT00771667|20819321|P5|NOT COMPLETED|Induction Phase||0
8447615|NCT00771667|20819322|P4|NOT COMPLETED|Induction Phase||8
8447616|NCT00771667|20819323|P3|NOT COMPLETED|Induction Phase||12
8447617|NCT00771667|20819324|P2|NOT COMPLETED|Induction Phase||10
8447618|NCT00771667|20819325|P1|NOT COMPLETED|Induction Phase||19
8447619|NCT00771667|20819316|P10|COMPLETED|Induction Phase||0
8447620|NCT00771667|20819317|P9|COMPLETED|Induction Phase||0
8447621|NCT00771667|20819318|P8|COMPLETED|Induction Phase||0
8447622|NCT00771667|20819319|P7|COMPLETED|Induction Phase||0
8447623|NCT00771667|20819320|P6|COMPLETED|Induction Phase||0
8447624|NCT00771667|20819321|P5|COMPLETED|Induction Phase||0
8447625|NCT00771667|20819322|P4|COMPLETED|Induction Phase||123
8447626|NCT00771667|20819323|P3|COMPLETED|Induction Phase||120
8447627|NCT00771667|20819324|P2|COMPLETED|Induction Phase||121
8447628|NCT00771667|20819325|P1|COMPLETED|Induction Phase||113
8447629|NCT00771667|20819316|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447630|NCT00771667|20819317|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447631|NCT00771667|20819318|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447632|NCT00771667|20819319|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447633|NCT00771667|20819320|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447634|NCT00771667|20819321|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447635|NCT00771667|20819322|P4|STARTED|Induction Phase||131
8447636|NCT00771667|20819323|P3|STARTED|Induction Phase||132
8447637|NCT00771667|20819324|P2|STARTED|Induction Phase||131
8447638|NCT00771667|20819325|P1|STARTED|Induction Phase||132
8447639|NCT00771615|20819370|P9|NOT COMPLETED|Overall Study||0
8447640|NCT00771615|20819371|P8|NOT COMPLETED|Overall Study||1
8447641|NCT00771615|20819372|P7|NOT COMPLETED|Overall Study||1
8447642|NCT00771615|20819373|P6|NOT COMPLETED|Overall Study||1
8447643|NCT00771615|20819374|P5|NOT COMPLETED|Overall Study||0
8447644|NCT00771615|20819375|P4|NOT COMPLETED|Overall Study||1
8447645|NCT00771615|20819376|P3|NOT COMPLETED|Overall Study||1
8447646|NCT00771615|20819377|P2|NOT COMPLETED|Overall Study||2
8447647|NCT00771615|20819378|P1|NOT COMPLETED|Overall Study||1
8447648|NCT00771615|20819370|P9|COMPLETED|Overall Study|Up to Day 364|41
8447649|NCT00771615|20819371|P8|COMPLETED|Overall Study|Up to Day 364|58
8447650|NCT00771615|20819372|P7|COMPLETED|Overall Study|Up to Day 364|45
8447651|NCT00771615|20819373|P6|COMPLETED|Overall Study|Up to Day 364|60
8447652|NCT00771615|20819374|P5|COMPLETED|Overall Study|Up to Day 364|40
8447653|NCT00771615|20819375|P4|COMPLETED|Overall Study|Up to Day 364|59
8447654|NCT00771615|20819376|P3|COMPLETED|Overall Study|Up to Day 364|40
8447655|NCT00771615|20819377|P2|COMPLETED|Overall Study|Up to Day 364|70
8447656|NCT00771615|20819378|P1|COMPLETED|Overall Study|Up to Day 364|48
8447657|NCT00771615|20819370|P9|STARTED|Overall Study||41
8447658|NCT00771615|20819371|P8|STARTED|Overall Study||59
8447659|NCT00771615|20819372|P7|STARTED|Overall Study||46
8447660|NCT00771615|20819373|P6|STARTED|Overall Study||61
8447661|NCT00771615|20819374|P5|STARTED|Overall Study||40
8447662|NCT00771615|20819375|P4|STARTED|Overall Study||60
8447663|NCT00771615|20819376|P3|STARTED|Overall Study||41
8447664|NCT00771615|20819377|P2|STARTED|Overall Study||72
8447665|NCT00771615|20819378|P1|STARTED|Overall Study||49
8447666|NCT00771602|20819572|P3|NOT COMPLETED|Overall Study||0
8447667|NCT00771602|20819573|P2|NOT COMPLETED|Overall Study||0
8447668|NCT00771602|20819574|P1|NOT COMPLETED|Overall Study||0
8447669|NCT00771602|20819572|P3|COMPLETED|Overall Study||0
8447670|NCT00771602|20819573|P2|COMPLETED|Overall Study||0
8447671|NCT00771602|20819574|P1|COMPLETED|Overall Study||1
8447672|NCT00771602|20819572|P3|STARTED|Overall Study||0
8447673|NCT00771602|20819573|P2|STARTED|Overall Study||0
8447674|NCT00771602|20819574|P1|STARTED|Overall Study||1
8447675|NCT00771537|20819598|P16|NOT COMPLETED|Overall Study||0
8447676|NCT00771537|20819599|P15|NOT COMPLETED|Overall Study||0
8447677|NCT00771537|20819600|P14|NOT COMPLETED|Overall Study||0
8447678|NCT00771537|20819601|P13|NOT COMPLETED|Overall Study||0
8447679|NCT00771537|20819602|P12|NOT COMPLETED|Overall Study||0
8447680|NCT00771537|20819603|P11|NOT COMPLETED|Overall Study||0
8447681|NCT00771537|20819604|P10|NOT COMPLETED|Overall Study||0
8447682|NCT00771537|20819605|P9|NOT COMPLETED|Overall Study||0
8447683|NCT00771537|20819606|P8|NOT COMPLETED|Overall Study||0
8447684|NCT00771537|20819607|P7|NOT COMPLETED|Overall Study||0
8447685|NCT00771537|20819608|P6|NOT COMPLETED|Overall Study||0
8447686|NCT00771537|20819609|P5|NOT COMPLETED|Overall Study||0
8447687|NCT00771537|20819610|P4|NOT COMPLETED|Overall Study||0
8447688|NCT00771537|20819611|P3|NOT COMPLETED|Overall Study||0
8447689|NCT00771537|20819612|P2|NOT COMPLETED|Overall Study||0
8447690|NCT00771537|20819613|P1|NOT COMPLETED|Overall Study||0
8447691|NCT00771537|20819598|P16|COMPLETED|Overall Study||122
8447692|NCT00771537|20819599|P15|COMPLETED|Overall Study||124
8447693|NCT00771537|20819600|P14|COMPLETED|Overall Study||124
8447694|NCT00771537|20819601|P13|COMPLETED|Overall Study||128
8447695|NCT00771537|20819602|P12|COMPLETED|Overall Study||137
8447696|NCT00771537|20819603|P11|COMPLETED|Overall Study||133
8447697|NCT00771537|20819604|P10|COMPLETED|Overall Study||119
8447698|NCT00771537|20819605|P9|COMPLETED|Overall Study||115
8447699|NCT00771537|20819606|P8|COMPLETED|Overall Study||132
8447700|NCT00771537|20819607|P7|COMPLETED|Overall Study||128
8447701|NCT00771537|20819608|P6|COMPLETED|Overall Study||118
8447702|NCT00771537|20819609|P5|COMPLETED|Overall Study||127
8447703|NCT00771537|20819610|P4|COMPLETED|Overall Study||114
8447704|NCT00771537|20819611|P3|COMPLETED|Overall Study||151
8447705|NCT00771537|20819612|P2|COMPLETED|Overall Study||124
8447706|NCT00771537|20819613|P1|COMPLETED|Overall Study||135
8447707|NCT00771537|20819598|P16|STARTED|Overall Study||122
8447708|NCT00771537|20819599|P15|STARTED|Overall Study||124
8447709|NCT00771537|20819600|P14|STARTED|Overall Study||124
8447710|NCT00771537|20819601|P13|STARTED|Overall Study||128
8447711|NCT00771537|20819602|P12|STARTED|Overall Study||137
8447712|NCT00771537|20819603|P11|STARTED|Overall Study||133
8447713|NCT00771537|20819604|P10|STARTED|Overall Study||119
8447714|NCT00771537|20819605|P9|STARTED|Overall Study||115
8447715|NCT00771537|20819606|P8|STARTED|Overall Study||132
8447716|NCT00771537|20819607|P7|STARTED|Overall Study||128
8447717|NCT00771537|20819608|P6|STARTED|Overall Study||118
8447718|NCT00771537|20819609|P5|STARTED|Overall Study||127
8447719|NCT00771537|20819610|P4|STARTED|Overall Study||114
8447720|NCT00771537|20819611|P3|STARTED|Overall Study||151
8447721|NCT00771537|20819612|P2|STARTED|Overall Study||124
8447722|NCT00771537|20819613|P1|STARTED|Overall Study||135
8447723|NCT00771472|20819639|P2|NOT COMPLETED|Overall Study||4
8447724|NCT00771472|20819640|P1|NOT COMPLETED|Overall Study||6
8447725|NCT00771472|20819639|P2|COMPLETED|Overall Study||0
8447726|NCT00771472|20819640|P1|COMPLETED|Overall Study||0
8447727|NCT00771472|20819639|P2|STARTED|Overall Study||4
8447728|NCT00771472|20819640|P1|STARTED|Overall Study||6
8447729|NCT00771407|20819651|P2|NOT COMPLETED|Overall Study||25
8447730|NCT00771407|20819652|P1|NOT COMPLETED|Overall Study||20
8447731|NCT00771407|20819651|P2|COMPLETED|Overall Study||35
8447732|NCT00771407|20819652|P1|COMPLETED|Overall Study||40
8447733|NCT00771407|20819651|P2|STARTED|Overall Study||60
8447734|NCT00771407|20819652|P1|STARTED|Overall Study||60
8447735|NCT00771316|20819660|P2|NOT COMPLETED|Overall Study||1
8447736|NCT00771316|20819661|P1|NOT COMPLETED|Overall Study||2
8447737|NCT00771316|20819660|P2|COMPLETED|Overall Study||1
8447738|NCT00771316|20819661|P1|COMPLETED|Overall Study||2
8447739|NCT00771316|20819660|P2|STARTED|Overall Study||2
8447740|NCT00771316|20819661|P1|STARTED|Overall Study||4
8447741|NCT00771277|20819671|P1|NOT COMPLETED|Overall Study||0
8447742|NCT00771277|20819671|P1|COMPLETED|Overall Study||6
8447743|NCT00771277|20819671|P1|STARTED|Overall Study||6
8447744|NCT00771264|20819679|P2|NOT COMPLETED|Overall Study||5
8447745|NCT00771264|20819680|P1|NOT COMPLETED|Overall Study||7
8447746|NCT00771264|20819679|P2|COMPLETED|Overall Study||105
8447747|NCT00771264|20819680|P1|COMPLETED|Overall Study||103
8447748|NCT00771264|20819679|P2|STARTED|Overall Study||110
8447749|NCT00771264|20819680|P1|STARTED|Overall Study||110
8447750|NCT00771238|20819688|P2|NOT COMPLETED|Overall Study||0
8447751|NCT00771238|20819689|P1|NOT COMPLETED|Overall Study||0
8447752|NCT00771238|20819688|P2|COMPLETED|Overall Study||21
8447753|NCT00771238|20819689|P1|COMPLETED|Overall Study||31
8447754|NCT00771238|20819688|P2|STARTED|Overall Study||21
8447755|NCT00771238|20819689|P1|STARTED|Overall Study||31
8447756|NCT00771173|20819699|P2|NOT COMPLETED|Overall Study||17
8447757|NCT00771173|20819700|P1|NOT COMPLETED|Overall Study||22
8447758|NCT00771173|20819699|P2|COMPLETED|Overall Study||112
8447759|NCT00771173|20819700|P1|COMPLETED|Overall Study||107
8447760|NCT00771173|20819699|P2|STARTED|Overall Study||129
8447761|NCT00771173|20819700|P1|STARTED|Overall Study||129
8447762|NCT00771056|20819706|P1|NOT COMPLETED|Overall Study||5
8447763|NCT00771056|20819706|P1|COMPLETED|Overall Study||18
8447764|NCT00771056|20819706|P1|STARTED|Overall Study||23
8447765|NCT00770991|20819713|P2|NOT COMPLETED|Overall Study||5
8447766|NCT00770991|20819714|P1|NOT COMPLETED|Overall Study||5
8447767|NCT00770991|20819713|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
8447768|NCT00770991|20819714|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
8447769|NCT00770991|20819713|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
8447770|NCT00770991|20819714|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
8447771|NCT00770965|20819730|P4|NOT COMPLETED|Excluded Set||13
8447772|NCT00770965|20819731|P3|NOT COMPLETED|Excluded Set||14
8447773|NCT00770965|20819732|P2|NOT COMPLETED|Excluded Set||13
8447774|NCT00770965|20819733|P1|NOT COMPLETED|Excluded Set||15
8447775|NCT00770965|20819730|P4|COMPLETED|Excluded Set||2
8447776|NCT00770965|20819731|P3|COMPLETED|Excluded Set||2
8447777|NCT00770965|20819732|P2|COMPLETED|Excluded Set||3
8447778|NCT00770965|20819733|P1|COMPLETED|Excluded Set||3
8447779|NCT00770965|20819730|P4|STARTED|Excluded Set||15
8447780|NCT00770965|20819731|P3|STARTED|Excluded Set||16
8447781|NCT00770965|20819732|P2|STARTED|Excluded Set||16
8447782|NCT00770965|20819733|P1|STARTED|Excluded Set||18
8447783|NCT00770965|20819730|P4|NOT COMPLETED|Safety Set||1
8447784|NCT00770965|20819731|P3|NOT COMPLETED|Safety Set||1
8447785|NCT00770965|20819732|P2|NOT COMPLETED|Safety Set||0
8447786|NCT00770965|20819733|P1|NOT COMPLETED|Safety Set||0
8447787|NCT00770965|20819730|P4|COMPLETED|Safety Set||4
8447788|NCT00770965|20819731|P3|COMPLETED|Safety Set||3
8447789|NCT00770965|20819732|P2|COMPLETED|Safety Set||4
8447790|NCT00770965|20819733|P1|COMPLETED|Safety Set||2
8447791|NCT00770965|20819730|P4|STARTED|Safety Set||5
8447792|NCT00770965|20819731|P3|STARTED|Safety Set||4
8447793|NCT00770965|20819732|P2|STARTED|Safety Set||4
8447794|NCT00770965|20819733|P1|STARTED|Safety Set||2
8447795|NCT00770913|20819754|P3|NOT COMPLETED|Overall Study||13
8447796|NCT00770913|20819755|P2|NOT COMPLETED|Overall Study||8
8447797|NCT00770913|20819756|P1|NOT COMPLETED|Overall Study||11
8447798|NCT00770913|20819754|P3|COMPLETED|Overall Study||100
8447799|NCT00770913|20819755|P2|COMPLETED|Overall Study||103
8447800|NCT00770913|20819756|P1|COMPLETED|Overall Study||102
8447801|NCT00770913|20819754|P3|STARTED|Overall Study||113
8447802|NCT00770913|20819755|P2|STARTED|Overall Study||111
8447803|NCT00770913|20819756|P1|STARTED|Overall Study||113
8447804|NCT00770874|20819766|P2|NOT COMPLETED|Overall Study||0
8447805|NCT00770874|20819767|P1|NOT COMPLETED|Overall Study||0
8447806|NCT00770874|20819766|P2|COMPLETED|Overall Study||176
8447807|NCT00770874|20819767|P1|COMPLETED|Overall Study||188
8447808|NCT00770874|20819766|P2|STARTED|Overall Study||176
8447809|NCT00770874|20819767|P1|STARTED|Overall Study||188
8447810|NCT00770861|20819777|P2|NOT COMPLETED|Overall Study||16
8447811|NCT00770861|20819778|P1|NOT COMPLETED|Overall Study||10
8447812|NCT00770861|20819777|P2|COMPLETED|Overall Study||120
8447813|NCT00770861|20819778|P1|COMPLETED|Overall Study||131
8447814|NCT00770861|20819777|P2|STARTED|Overall Study||136
8447815|NCT00770861|20819778|P1|STARTED|Overall Study||141
8447816|NCT00770809|20819789|P3|NOT COMPLETED|Overall Study||23
8447817|NCT00770809|20819790|P2|NOT COMPLETED|Overall Study||10
8447818|NCT00770809|20819791|P1|NOT COMPLETED|Overall Study||17
8447819|NCT00770809|20819789|P3|COMPLETED|Overall Study||44
8447820|NCT00770809|20819790|P2|COMPLETED|Overall Study||110
8447821|NCT00770809|20819791|P1|COMPLETED|Overall Study||101
8447822|NCT00770809|20819789|P3|STARTED|Overall Study||67
8447823|NCT00770809|20819790|P2|STARTED|Overall Study||120
8447824|NCT00770809|20819791|P1|STARTED|Overall Study||118
8447825|NCT00770770|20819801|P2|NOT COMPLETED|Overall Study||1
8447826|NCT00770770|20819802|P1|NOT COMPLETED|Overall Study||10
8447827|NCT00770770|20819801|P2|COMPLETED|Overall Study||5
8447828|NCT00770770|20819802|P1|COMPLETED|Overall Study||4
8447829|NCT00770770|20819801|P2|STARTED|Overall Study||6
8447830|NCT00770770|20819802|P1|STARTED|Overall Study||14
8447831|NCT00770757|20819808|P1|NOT COMPLETED|Overall Study||0
8447832|NCT00770757|20819808|P1|COMPLETED|Overall Study||13
8447833|NCT00770757|20819808|P1|STARTED|Overall Study||13
8447834|NCT00770692|20819820|P4|NOT COMPLETED|Overall Study||11
8447835|NCT00770692|20819821|P3|NOT COMPLETED|Overall Study||14
8447836|NCT00770692|20819822|P2|NOT COMPLETED|Overall Study||9
8447837|NCT00770692|20819823|P1|NOT COMPLETED|Overall Study||12
8447838|NCT00770692|20819820|P4|COMPLETED|Overall Study||66
8447839|NCT00770692|20819821|P3|COMPLETED|Overall Study||70
8447840|NCT00770692|20819822|P2|COMPLETED|Overall Study||74
8447841|NCT00770692|20819823|P1|COMPLETED|Overall Study||69
8447842|NCT00770692|20819820|P4|STARTED|Overall Study||77
8447843|NCT00770692|20819821|P3|STARTED|Overall Study||84
8447844|NCT00770692|20819822|P2|STARTED|Overall Study||83
8447845|NCT00770692|20819823|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
8447846|NCT00770679|20819849|P1|NOT COMPLETED|Overall Study||6
8447847|NCT00770679|20819849|P1|COMPLETED|Overall Study||10
8447848|NCT00770679|20819849|P1|STARTED|Overall Study||16
8447849|NCT00770653|20819857|P2|NOT COMPLETED|Overall Study||29
8447850|NCT00770653|20819858|P1|NOT COMPLETED|Overall Study||32
8447851|NCT00770653|20819857|P2|COMPLETED|Overall Study||121
8447852|NCT00770653|20819858|P1|COMPLETED|Overall Study||123
8447853|NCT00770653|20819857|P2|STARTED|Overall Study||150
8447854|NCT00770653|20819858|P1|STARTED|Overall Study||155
8447855|NCT00770588|20819928|P2|NOT COMPLETED|Overall Study||95
8447856|NCT00770588|20819929|P1|NOT COMPLETED|Overall Study||81
8447857|NCT00770588|20819928|P2|COMPLETED|Overall Study||53
8447858|NCT00770588|20819929|P1|COMPLETED|Overall Study||67
8447859|NCT00770588|20819928|P2|STARTED|Overall Study||148
8447860|NCT00770588|20819929|P1|STARTED|Overall Study||148
8447861|NCT00770562|20819945|P2|NOT COMPLETED|Overall Study||1
8447862|NCT00770562|20819946|P1|NOT COMPLETED|Overall Study||1
8447863|NCT00770562|20819945|P2|COMPLETED|Overall Study||49
8447864|NCT00770562|20819946|P1|COMPLETED|Overall Study||52
8447865|NCT00770562|20819945|P2|STARTED|Overall Study||50
8447866|NCT00770562|20819946|P1|STARTED|Overall Study||53
8447867|NCT00770510|20819957|P1|NOT COMPLETED|Overall Study||5
8447868|NCT00770510|20819957|P1|COMPLETED|Overall Study||67
8447869|NCT00770510|20819957|P1|STARTED|Overall Study||72
8447870|NCT00770484|20819996|P2|NOT COMPLETED|Overall Study||0
8447871|NCT00770484|20819997|P1|NOT COMPLETED|Overall Study||1
8447872|NCT00770484|20819996|P2|COMPLETED|Overall Study||4
8447873|NCT00770484|20819997|P1|COMPLETED|Overall Study||7
8447874|NCT00770484|20819996|P2|STARTED|Overall Study||4
8447875|NCT00770484|20819997|P1|STARTED|Overall Study||8
8447876|NCT00770432|20820005|P2|NOT COMPLETED|Overall Study||7
8447877|NCT00770432|20820006|P1|NOT COMPLETED|Overall Study||4
8447878|NCT00770432|20820005|P2|COMPLETED|Overall Study||94
8447879|NCT00770432|20820006|P1|COMPLETED|Overall Study||98
8447880|NCT00770432|20820005|P2|STARTED|Overall Study||101
8447881|NCT00770432|20820006|P1|STARTED|Overall Study||102
8447882|NCT00770367|20820014|P2|NOT COMPLETED|Second Intervention||0
8447883|NCT00770367|20820015|P1|NOT COMPLETED|Second Intervention||2
8447884|NCT00770367|20820014|P2|COMPLETED|Second Intervention||15
8447885|NCT00770367|20820015|P1|COMPLETED|Second Intervention||16
8447886|NCT00770367|20820014|P2|STARTED|Second Intervention||15
8447887|NCT00770367|20820015|P1|STARTED|Second Intervention||18
8447888|NCT00770367|20820014|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
8447889|NCT00770367|20820015|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
8447890|NCT00770367|20820014|P2|COMPLETED|Washout Period of 4 Weeks||15
8447891|NCT00770367|20820015|P1|COMPLETED|Washout Period of 4 Weeks||18
8447892|NCT00770367|20820014|P2|STARTED|Washout Period of 4 Weeks||16
8447893|NCT00770367|20820015|P1|STARTED|Washout Period of 4 Weeks||18
8447894|NCT00770367|20820014|P2|NOT COMPLETED|First Intervention||2
8447895|NCT00770367|20820015|P1|NOT COMPLETED|First Intervention||0
8447896|NCT00770367|20820014|P2|COMPLETED|First Intervention||16
8447897|NCT00770367|20820015|P1|COMPLETED|First Intervention||18
8447898|NCT00770367|20820014|P2|STARTED|First Intervention||18
8447899|NCT00770367|20820015|P1|STARTED|First Intervention||18
8447900|NCT00770341|20820026|P3|NOT COMPLETED|Overall Study||3
8447901|NCT00770341|20820027|P2|NOT COMPLETED|Overall Study||5
8447902|NCT00770341|20820028|P1|NOT COMPLETED|Overall Study||12
8447903|NCT00770341|20820026|P3|COMPLETED|Overall Study||8
8447904|NCT00770341|20820027|P2|COMPLETED|Overall Study||17
8447905|NCT00770341|20820028|P1|COMPLETED|Overall Study||77
8447906|NCT00770341|20820026|P3|STARTED|Overall Study|Number randomized|11
8447907|NCT00770341|20820027|P2|STARTED|Overall Study|Number randomized|22
8447908|NCT00770341|20820028|P1|STARTED|Overall Study|Number randomized|89
8447909|NCT00770328|20820054|P2|NOT COMPLETED|Overall Study||4
8447910|NCT00770328|20820055|P1|NOT COMPLETED|Overall Study||13
8447911|NCT00770328|20820054|P2|COMPLETED|Overall Study||11
8447912|NCT00770328|20820055|P1|COMPLETED|Overall Study||9
8447913|NCT00770328|20820054|P2|STARTED|Overall Study||15
8447914|NCT00770328|20820055|P1|STARTED|Overall Study||22
8447915|NCT00770315|20820071|P4|NOT COMPLETED|Overall Study||38
8447916|NCT00770315|20820072|P3|NOT COMPLETED|Overall Study||57
8447917|NCT00770315|20820073|P2|NOT COMPLETED|Overall Study||43
8447918|NCT00770315|20820074|P1|NOT COMPLETED|Overall Study||40
8447919|NCT00770315|20820071|P4|COMPLETED|Overall Study||160
8447920|NCT00770315|20820072|P3|COMPLETED|Overall Study||137
8447921|NCT00770315|20820073|P2|COMPLETED|Overall Study||152
8447922|NCT00770315|20820074|P1|COMPLETED|Overall Study||157
8447923|NCT00770315|20820071|P4|STARTED|Overall Study||198
8447924|NCT00770315|20820072|P3|STARTED|Overall Study||194
8447925|NCT00770315|20820073|P2|STARTED|Overall Study||195
8447926|NCT00770315|20820074|P1|STARTED|Overall Study||197
8447927|NCT00770289|20820100|P1|NOT COMPLETED|Overall Study||6
8447928|NCT00770289|20820100|P1|COMPLETED|Overall Study||845
8447929|NCT00770289|20820100|P1|STARTED|Overall Study||851
8447930|NCT00770224|20820109|P2|NOT COMPLETED|Step 2: Maintenance||30
8447931|NCT00770224|20820110|P1|NOT COMPLETED|Step 2: Maintenance||0
8447932|NCT00770224|20820109|P2|COMPLETED|Step 2: Maintenance||41
8447933|NCT00770224|20820110|P1|COMPLETED|Step 2: Maintenance||0
8447934|NCT00770224|20820109|P2|Eligible and Evaluable|Step 2: Maintenance||69
8447935|NCT00770224|20820110|P1|Eligible and Evaluable|Step 2: Maintenance||0
8447936|NCT00770224|20820109|P2|STARTED|Step 2: Maintenance||71
8447937|NCT00770224|20820110|P1|STARTED|Step 2: Maintenance||0
8447938|NCT00770224|20820109|P2|NOT COMPLETED|Step 1: Induction||0
8447939|NCT00770224|20820110|P1|NOT COMPLETED|Step 1: Induction||14
8447940|NCT00770224|20820109|P2|COMPLETED|Step 1: Induction||0
8447941|NCT00770224|20820110|P1|COMPLETED|Step 1: Induction||73
8447942|NCT00770224|20820109|P2|Eligible and Evaluable|Step 1: Induction||0
8447943|NCT00770224|20820110|P1|Eligible and Evaluable|Step 1: Induction||84
8447944|NCT00770224|20820109|P2|STARTED|Step 1: Induction||0
8447945|NCT00770224|20820110|P1|STARTED|Step 1: Induction||87
8447946|NCT00770211|20820122|P2|NOT COMPLETED|Overall Study||2
8447947|NCT00770211|20820123|P1|NOT COMPLETED|Overall Study||1
8447948|NCT00770211|20820122|P2|COMPLETED|Overall Study||87
8447949|NCT00770211|20820123|P1|COMPLETED|Overall Study||181
8447950|NCT00770211|20820122|P2|STARTED|Overall Study||89
8447951|NCT00770211|20820123|P1|STARTED|Overall Study||182
8447952|NCT00770146|20820139|P2|NOT COMPLETED|Follow-up Period||20
8447953|NCT00770146|20820140|P1|NOT COMPLETED|Follow-up Period||11
8447954|NCT00770146|20820139|P2|COMPLETED|Follow-up Period||85
8447955|NCT00770146|20820140|P1|COMPLETED|Follow-up Period||42
8447956|NCT00770146|20820139|P2|STARTED|Follow-up Period||105
8447957|NCT00770146|20820140|P1|STARTED|Follow-up Period||53
8447958|NCT00770146|20820139|P2|NOT COMPLETED|Treatment Period||45
8447959|NCT00770146|20820140|P1|NOT COMPLETED|Treatment Period||9
8447960|NCT00770146|20820139|P2|COMPLETED|Treatment Period||60
8447961|NCT00770146|20820140|P1|COMPLETED|Treatment Period||44
8447962|NCT00770146|20820139|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
8447963|NCT00770146|20820140|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
8447964|NCT00770146|20820139|P2|Treated|Treatment Period||105
8447965|NCT00770146|20820140|P1|Treated|Treatment Period||52
8447966|NCT00770146|20820139|P2|STARTED|Treatment Period||105
8447967|NCT00770146|20820140|P1|STARTED|Treatment Period||53
8447968|NCT00770133|20820188|P4|NOT COMPLETED|Overall Study||3
8447969|NCT00770133|20820189|P3|NOT COMPLETED|Overall Study||3
8447970|NCT00770133|20820190|P2|NOT COMPLETED|Overall Study||1
8447971|NCT00770133|20820191|P1|NOT COMPLETED|Overall Study||3
8447972|NCT00770133|20820188|P4|COMPLETED|Overall Study||32
8447973|NCT00770133|20820189|P3|COMPLETED|Overall Study||32
8447974|NCT00770133|20820190|P2|COMPLETED|Overall Study||35
8447975|NCT00770133|20820191|P1|COMPLETED|Overall Study||32
8447976|NCT00770133|20820188|P4|STARTED|Overall Study||35
8447977|NCT00770133|20820189|P3|STARTED|Overall Study||35
8447978|NCT00770133|20820190|P2|STARTED|Overall Study||36
8447979|NCT00770133|20820191|P1|STARTED|Overall Study||35
8447980|NCT00770120|20820229|P1|NOT COMPLETED|Overall Study||61
8447981|NCT00770120|20820229|P1|COMPLETED|Overall Study||0
8447982|NCT00770120|20820229|P1|Not Analyzable|Overall Study||1
8447983|NCT00770120|20820229|P1|Eligible|Overall Study||60
8447984|NCT00770120|20820229|P1|STARTED|Overall Study||61
8447985|NCT00770029|20820238|P2|NOT COMPLETED|Overall Study||3
8447986|NCT00770029|20820239|P1|NOT COMPLETED|Overall Study||6
8447987|NCT00770029|20820238|P2|COMPLETED|Overall Study||89
8447988|NCT00770029|20820239|P1|COMPLETED|Overall Study||178
8447989|NCT00770029|20820238|P2|STARTED|Overall Study||92
8447990|NCT00770029|20820239|P1|STARTED|Overall Study||184
8447991|NCT00769886|20820257|P4|NOT COMPLETED|Overall Study||2
8447992|NCT00769886|20820258|P3|NOT COMPLETED|Overall Study||1
8447993|NCT00769886|20820259|P2|NOT COMPLETED|Overall Study||4
8447994|NCT00769886|20820260|P1|NOT COMPLETED|Overall Study||5
8447995|NCT00769886|20820257|P4|COMPLETED|Overall Study||35
8447996|NCT00769886|20820258|P3|COMPLETED|Overall Study||34
8447997|NCT00769886|20820259|P2|COMPLETED|Overall Study||32
8447998|NCT00769886|20820260|P1|COMPLETED|Overall Study||31
8447999|NCT00769886|20820257|P4|STARTED|Overall Study||37
8448000|NCT00769886|20820258|P3|STARTED|Overall Study||35
8448001|NCT00769886|20820259|P2|STARTED|Overall Study||36
8448002|NCT00769886|20820260|P1|STARTED|Overall Study||36
8448003|NCT00769860|20820300|P2|NOT COMPLETED|Overall Study||0
8448004|NCT00769860|20820301|P1|NOT COMPLETED|Overall Study||2
8448005|NCT00769860|20820300|P2|COMPLETED|Overall Study||8
8448006|NCT00769860|20820301|P1|COMPLETED|Overall Study||14
8448007|NCT00769860|20820300|P2|Month 8|Overall Study||8
8448008|NCT00769860|20820301|P1|Month 8|Overall Study||14
8448009|NCT00769860|20820300|P2|Month 4|Overall Study||8
8448010|NCT00769860|20820301|P1|Month 4|Overall Study||16
8448011|NCT00769860|20820300|P2|STARTED|Overall Study||8
8448012|NCT00769860|20820301|P1|STARTED|Overall Study||16
8448013|NCT00769808|20820327|P1|NOT COMPLETED|Overall Study||8
8448014|NCT00769808|20820327|P1|COMPLETED|Overall Study||64
8448015|NCT00769808|20820327|P1|STARTED|Overall Study||72
8448016|NCT00769704|20820339|P2|NOT COMPLETED|Overall Study||199
8448017|NCT00769704|20820340|P1|NOT COMPLETED|Overall Study||111
8448018|NCT00769704|20820339|P2|COMPLETED|Overall Study||97
8448019|NCT00769704|20820340|P1|COMPLETED|Overall Study||30
8448020|NCT00769704|20820339|P2|Received Treatment|Overall Study||292
8448021|NCT00769704|20820340|P1|Received Treatment|Overall Study||127
8448022|NCT00769704|20820339|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
8448023|NCT00769704|20820340|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
8448024|NCT00769704|20820339|P2|STARTED|Overall Study||296
8448025|NCT00769704|20820340|P1|STARTED|Overall Study||141
8448026|NCT00769652|20820360|P2|NOT COMPLETED|Overall Study||0
8448027|NCT00769652|20820361|P1|NOT COMPLETED|Overall Study||0
8448028|NCT00769652|20820360|P2|COMPLETED|Overall Study||1
8448029|NCT00769652|20820361|P1|COMPLETED|Overall Study||6
8448030|NCT00769652|20820360|P2|STARTED|Overall Study||1
8448031|NCT00769652|20820361|P1|STARTED|Overall Study||6
8448032|NCT00769600|20820373|P2|NOT COMPLETED|Overall Study||0
8448033|NCT00769600|20820374|P1|NOT COMPLETED|Overall Study||0
8448034|NCT00769600|20820373|P2|COMPLETED|Overall Study||8
8448035|NCT00769600|20820374|P1|COMPLETED|Overall Study||15
8448036|NCT00769600|20820373|P2|STARTED|Overall Study||8
8448037|NCT00769600|20820374|P1|STARTED|Overall Study||15
8448038|NCT00769561|20820390|P2|NOT COMPLETED|Overall Study||5
8448039|NCT00769561|20820391|P1|NOT COMPLETED|Overall Study||3
8448040|NCT00769561|20820390|P2|COMPLETED|Overall Study||24
8448041|NCT00769561|20820391|P1|COMPLETED|Overall Study||26
8448042|NCT00769561|20820390|P2|STARTED|Overall Study||29
8448043|NCT00769561|20820391|P1|STARTED|Overall Study||29
8448044|NCT00769483|20820417|P6|NOT COMPLETED|Overall Study||0
8448045|NCT00769483|20820418|P5|NOT COMPLETED|Overall Study||1
8448046|NCT00769483|20820419|P4|NOT COMPLETED|Overall Study||0
8448047|NCT00769483|20820420|P3|NOT COMPLETED|Overall Study||0
8448048|NCT00769483|20820421|P2|NOT COMPLETED|Overall Study||1
8448049|NCT00769483|20820422|P1|NOT COMPLETED|Overall Study||0
8448050|NCT00769483|20820417|P6|COMPLETED|Overall Study||9
8448051|NCT00769483|20820418|P5|COMPLETED|Overall Study||15
8448052|NCT00769483|20820419|P4|COMPLETED|Overall Study||15
8448053|NCT00769483|20820420|P3|COMPLETED|Overall Study||15
8448054|NCT00769483|20820421|P2|COMPLETED|Overall Study||12
8448055|NCT00769483|20820422|P1|COMPLETED|Overall Study||9
8448056|NCT00769483|20820417|P6|STARTED|Overall Study||9
8448057|NCT00769483|20820418|P5|STARTED|Overall Study||16
8448058|NCT00769483|20820419|P4|STARTED|Overall Study||15
8448059|NCT00769483|20820420|P3|STARTED|Overall Study||15
8448060|NCT00769483|20820421|P2|STARTED|Overall Study||13
8448061|NCT00769483|20820422|P1|STARTED|Overall Study||9
8448062|NCT00769392|20820460|P1|NOT COMPLETED|Overall Study||4
8448063|NCT00769392|20820460|P1|COMPLETED|Overall Study||24
8448064|NCT00769392|20820460|P1|STARTED|Overall Study||28
8448065|NCT00769314|20820467|P2|NOT COMPLETED|Overall Study||13
8448066|NCT00769314|20820468|P1|NOT COMPLETED|Overall Study||17
8448067|NCT00769314|20820467|P2|COMPLETED|Overall Study||384
8448068|NCT00769314|20820468|P1|COMPLETED|Overall Study||361
8448069|NCT00769314|20820467|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
8448070|NCT00769314|20820468|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
8448071|NCT00769184|20820494|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
8448072|NCT00769184|20820495|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
8448073|NCT00769184|20820494|P2|COMPLETED|No Treatment (6 Weeks)||6
8448074|NCT00769184|20820495|P1|COMPLETED|No Treatment (6 Weeks)||5
8448075|NCT00769184|20820494|P2|STARTED|No Treatment (6 Weeks)||7
8448076|NCT00769184|20820495|P1|STARTED|No Treatment (6 Weeks)||6
8448077|NCT00769184|20820494|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
8448078|NCT00769184|20820495|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
8448079|NCT00769184|20820494|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
8448080|NCT00769184|20820495|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
8448081|NCT00769184|20820494|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
8448082|NCT00769184|20820495|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
8448083|NCT00769184|20820494|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
8448084|NCT00769184|20820495|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
8448085|NCT00769184|20820494|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
8448086|NCT00769184|20820495|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
8448087|NCT00769184|20820494|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
8448088|NCT00769184|20820495|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
8448089|NCT00769132|20820503|P4|NOT COMPLETED|Period 4||0
8448090|NCT00769132|20820504|P3|NOT COMPLETED|Period 4||0
8448091|NCT00769132|20820505|P2|NOT COMPLETED|Period 4||1
8448092|NCT00769132|20820506|P1|NOT COMPLETED|Period 4||0
8448093|NCT00769132|20820503|P4|COMPLETED|Period 4||5
8448094|NCT00769132|20820504|P3|COMPLETED|Period 4||6
8448095|NCT00769132|20820505|P2|COMPLETED|Period 4||5
8448096|NCT00769132|20820506|P1|COMPLETED|Period 4||5
8448097|NCT00769132|20820503|P4|STARTED|Period 4||5
8448098|NCT00769132|20820504|P3|STARTED|Period 4||6
8448099|NCT00769132|20820505|P2|STARTED|Period 4||6
8448100|NCT00769132|20820506|P1|STARTED|Period 4||5
8448101|NCT00769132|20820503|P4|NOT COMPLETED|Period 3||0
8448102|NCT00769132|20820504|P3|NOT COMPLETED|Period 3||0
8448103|NCT00769132|20820505|P2|NOT COMPLETED|Period 3||0
8448104|NCT00769132|20820506|P1|NOT COMPLETED|Period 3||1
8448105|NCT00769132|20820503|P4|COMPLETED|Period 3||5
8448106|NCT00769132|20820504|P3|COMPLETED|Period 3||6
8448107|NCT00769132|20820505|P2|COMPLETED|Period 3||6
8448108|NCT00769132|20820506|P1|COMPLETED|Period 3||5
8448109|NCT00769132|20820503|P4|STARTED|Period 3||5
8448110|NCT00769132|20820504|P3|STARTED|Period 3||6
8448111|NCT00769132|20820505|P2|STARTED|Period 3||6
8448112|NCT00769132|20820506|P1|STARTED|Period 3||6
8448113|NCT00769132|20820503|P4|NOT COMPLETED|Period 2||1
8448114|NCT00769132|20820504|P3|NOT COMPLETED|Period 2||0
8448115|NCT00769132|20820505|P2|NOT COMPLETED|Period 2||0
8448116|NCT00769132|20820506|P1|NOT COMPLETED|Period 2||0
8448117|NCT00769132|20820503|P4|COMPLETED|Period 2||5
8448118|NCT00769132|20820504|P3|COMPLETED|Period 2||6
8448119|NCT00769132|20820505|P2|COMPLETED|Period 2||6
8448120|NCT00769132|20820506|P1|COMPLETED|Period 2||6
8448121|NCT00769132|20820503|P4|STARTED|Period 2||6
8448122|NCT00769132|20820504|P3|STARTED|Period 2||6
8448123|NCT00769132|20820505|P2|STARTED|Period 2||6
8448124|NCT00769132|20820506|P1|STARTED|Period 2||6
8448125|NCT00769132|20820503|P4|NOT COMPLETED|Period 1||1
8448126|NCT00769132|20820504|P3|NOT COMPLETED|Period 1||0
8448127|NCT00769132|20820505|P2|NOT COMPLETED|Period 1||0
8448128|NCT00769132|20820506|P1|NOT COMPLETED|Period 1||1
8448129|NCT00769132|20820503|P4|COMPLETED|Period 1||6
8448130|NCT00769132|20820504|P3|COMPLETED|Period 1||6
8448131|NCT00769132|20820505|P2|COMPLETED|Period 1||6
8448132|NCT00769132|20820506|P1|COMPLETED|Period 1||6
8448133|NCT00769132|20820503|P4|STARTED|Period 1||7
8448134|NCT00769132|20820504|P3|STARTED|Period 1||6
8448135|NCT00769132|20820505|P2|STARTED|Period 1||6
8448136|NCT00769132|20820506|P1|STARTED|Period 1||7
8448137|NCT00769119|20820522|P2|NOT COMPLETED|Overall Study||3
8448138|NCT00769119|20820523|P1|NOT COMPLETED|Overall Study||2
8448139|NCT00769119|20820522|P2|COMPLETED|Overall Study||13
8448140|NCT00769119|20820523|P1|COMPLETED|Overall Study||20
8448141|NCT00769119|20820522|P2|STARTED|Overall Study||16
8448142|NCT00769119|20820523|P1|STARTED|Overall Study||22
8448143|NCT00769067|20820569|P2|NOT COMPLETED|Overall Study||94
8448144|NCT00769067|20820570|P1|NOT COMPLETED|Overall Study||94
8448145|NCT00769067|20820569|P2|COMPLETED|Overall Study||0
8448146|NCT00769067|20820570|P1|COMPLETED|Overall Study||0
8448147|NCT00769067|20820569|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
8448148|NCT00769067|20820570|P1|Treated|Overall Study||94
8448149|NCT00769067|20820569|P2|STARTED|Overall Study||94
8448150|NCT00769067|20820570|P1|STARTED|Overall Study||94
8448151|NCT00769015|20820597|P2|NOT COMPLETED|Overall Study||16
8448152|NCT00769015|20820598|P1|NOT COMPLETED|Overall Study||9
8448153|NCT00769015|20820597|P2|COMPLETED|Overall Study||76
8448154|NCT00769015|20820598|P1|COMPLETED|Overall Study||87
8448155|NCT00769015|20820597|P2|STARTED|Overall Study||92
8448156|NCT00769015|20820598|P1|STARTED|Overall Study||96
8448157|NCT00769002|20820620|P2|NOT COMPLETED|Overall Study||9
8448158|NCT00769002|20820621|P1|NOT COMPLETED|Overall Study||9
8448159|NCT00769002|20820620|P2|COMPLETED|Overall Study||0
8448160|NCT00769002|20820621|P1|COMPLETED|Overall Study||0
8448161|NCT00769002|20820620|P2|STARTED|Overall Study||9
8448162|NCT00769002|20820621|P1|STARTED|Overall Study||9
8448163|NCT00768989|20820628|P2|NOT COMPLETED|On or After Week 36||27
8448164|NCT00768989|20820629|P1|NOT COMPLETED|On or After Week 36||51
8448165|NCT00768989|20820628|P2|COMPLETED|On or After Week 36||0
8448166|NCT00768989|20820629|P1|COMPLETED|On or After Week 36||0
8448167|NCT00768989|20820628|P2|STARTED|On or After Week 36||27
8448168|NCT00768989|20820629|P1|STARTED|On or After Week 36||51
8448169|NCT00768989|20820628|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
8448170|NCT00768989|20820629|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
8448171|NCT00768989|20820628|P2|COMPLETED|Week 24 to Prior to Week 36||27
8448172|NCT00768989|20820629|P1|COMPLETED|Week 24 to Prior to Week 36||51
8448173|NCT00768989|20820628|P2|STARTED|Week 24 to Prior to Week 36||27
8448174|NCT00768989|20820629|P1|STARTED|Week 24 to Prior to Week 36||59
8448175|NCT00768989|20820628|P2|NOT COMPLETED|Prior to Week 24||3
8448176|NCT00768989|20820629|P1|NOT COMPLETED|Prior to Week 24||4
8448177|NCT00768989|20820628|P2|COMPLETED|Prior to Week 24||27
8448178|NCT00768989|20820629|P1|COMPLETED|Prior to Week 24||59
8448179|NCT00768989|20820628|P2|STARTED|Prior to Week 24||30
8448180|NCT00768989|20820629|P1|STARTED|Prior to Week 24||63
8448181|NCT00768898|20820677|P1|NOT COMPLETED|Overall Study||2
8448182|NCT00768898|20820677|P1|COMPLETED|Overall Study||28
8448183|NCT00768898|20820677|P1|STARTED|Overall Study||30
8448184|NCT00768755|20820701|P4|NOT COMPLETED|Phase 2||57
8448185|NCT00768755|20820702|P3|NOT COMPLETED|Phase 2||58
8448186|NCT00768755|20820703|P2|NOT COMPLETED|Phase 2||55
8448187|NCT00768755|20820704|P1|NOT COMPLETED|Phase 2||0
8448188|NCT00768755|20820701|P4|COMPLETED|Phase 2||0
8448189|NCT00768755|20820702|P3|COMPLETED|Phase 2||0
8448190|NCT00768755|20820703|P2|COMPLETED|Phase 2||0
8448191|NCT00768755|20820704|P1|COMPLETED|Phase 2||0
8448192|NCT00768755|20820701|P4|Treated|Phase 2||55
8448193|NCT00768755|20820702|P3|Treated|Phase 2||58
8448194|NCT00768755|20820703|P2|Treated|Phase 2||55
8448195|NCT00768755|20820704|P1|Treated|Phase 2||0
8448196|NCT00768755|20820701|P4|STARTED|Phase 2||57
8448197|NCT00768755|20820702|P3|STARTED|Phase 2||58
8448198|NCT00768755|20820703|P2|STARTED|Phase 2||55
8448199|NCT00768755|20820704|P1|STARTED|Phase 2||0
8448200|NCT00768755|20820701|P4|NOT COMPLETED|Phase 1||0
8448201|NCT00768755|20820702|P3|NOT COMPLETED|Phase 1||0
8448202|NCT00768755|20820703|P2|NOT COMPLETED|Phase 1||0
8448203|NCT00768755|20820704|P1|NOT COMPLETED|Phase 1||10
8448204|NCT00768755|20820701|P4|COMPLETED|Phase 1||0
8448205|NCT00768755|20820702|P3|COMPLETED|Phase 1||0
8448206|NCT00768755|20820703|P2|COMPLETED|Phase 1||0
8448207|NCT00768755|20820704|P1|COMPLETED|Phase 1||0
8448208|NCT00768755|20820701|P4|STARTED|Phase 1||0
8448209|NCT00768755|20820702|P3|STARTED|Phase 1||0
8448210|NCT00768755|20820703|P2|STARTED|Phase 1||0
8448211|NCT00768755|20820704|P1|STARTED|Phase 1||10
8448212|NCT00768716|20820730|P2|NOT COMPLETED|Overall Study||0
8448213|NCT00768716|20820731|P1|NOT COMPLETED|Overall Study||0
8448214|NCT00768716|20820730|P2|COMPLETED|Overall Study||41
8448215|NCT00768716|20820731|P1|COMPLETED|Overall Study||54
8448216|NCT00768716|20820730|P2|STARTED|Overall Study||41
8448217|NCT00768716|20820731|P1|STARTED|Overall Study||54
8448218|NCT00768651|20820752|P1|NOT COMPLETED|Overall Study||1
8448219|NCT00768651|20820752|P1|COMPLETED|Overall Study||7
8448220|NCT00768651|20820752|P1|STARTED|Overall Study||8
8448221|NCT00768599|20820760|P3|NOT COMPLETED|Overall Study||12
8448222|NCT00768599|20820761|P2|NOT COMPLETED|Overall Study||16
8448223|NCT00768599|20820762|P1|NOT COMPLETED|Overall Study||11
8448224|NCT00768599|20820760|P3|COMPLETED|Overall Study||35
8448225|NCT00768599|20820761|P2|COMPLETED|Overall Study||27
8448226|NCT00768599|20820762|P1|COMPLETED|Overall Study||34
8448227|NCT00768599|20820760|P3|STARTED|Overall Study||47
8448228|NCT00768599|20820761|P2|STARTED|Overall Study||43
8448229|NCT00768599|20820762|P1|STARTED|Overall Study||45
8448230|NCT00768560|20820791|P6|NOT COMPLETED|Intervention Set 3||0
8448231|NCT00768560|20820792|P5|NOT COMPLETED|Intervention Set 3||0
8448232|NCT00768560|20820793|P4|NOT COMPLETED|Intervention Set 3||0
8448233|NCT00768560|20820794|P3|NOT COMPLETED|Intervention Set 3||0
8448234|NCT00768560|20820795|P2|NOT COMPLETED|Intervention Set 3||0
8448235|NCT00768560|20820796|P1|NOT COMPLETED|Intervention Set 3||0
8448236|NCT00768560|20820791|P6|COMPLETED|Intervention Set 3||6
8448237|NCT00768560|20820792|P5|COMPLETED|Intervention Set 3||6
8448238|NCT00768560|20820793|P4|COMPLETED|Intervention Set 3||6
8448239|NCT00768560|20820794|P3|COMPLETED|Intervention Set 3||6
8448240|NCT00768560|20820795|P2|COMPLETED|Intervention Set 3||5
8448241|NCT00768560|20820796|P1|COMPLETED|Intervention Set 3||5
8448242|NCT00768560|20820791|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
8448243|NCT00768560|20820792|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
8448244|NCT00768560|20820793|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
8448245|NCT00768560|20820794|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
8448246|NCT00768560|20820795|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
8448247|NCT00768560|20820796|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
8448248|NCT00768560|20820791|P6|NOT COMPLETED|Intervention Set 2||0
8448249|NCT00768560|20820792|P5|NOT COMPLETED|Intervention Set 2||0
8448250|NCT00768560|20820793|P4|NOT COMPLETED|Intervention Set 2||0
8448251|NCT00768560|20820794|P3|NOT COMPLETED|Intervention Set 2||0
8448252|NCT00768560|20820795|P2|NOT COMPLETED|Intervention Set 2||0
8448253|NCT00768560|20820796|P1|NOT COMPLETED|Intervention Set 2||0
8448254|NCT00768560|20820791|P6|COMPLETED|Intervention Set 2||6
8448255|NCT00768560|20820792|P5|COMPLETED|Intervention Set 2||6
8448256|NCT00768560|20820793|P4|COMPLETED|Intervention Set 2||6
8448257|NCT00768560|20820794|P3|COMPLETED|Intervention Set 2||6
8448258|NCT00768560|20820795|P2|COMPLETED|Intervention Set 2||5
8448259|NCT00768560|20820796|P1|COMPLETED|Intervention Set 2||5
8448260|NCT00768560|20820791|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
8448261|NCT00768560|20820792|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
8448262|NCT00768560|20820793|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
8448263|NCT00768560|20820794|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
8448264|NCT00768560|20820795|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
8448265|NCT00768560|20820796|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
8448266|NCT00768560|20820791|P6|NOT COMPLETED|Intervention Set 1||0
8448267|NCT00768560|20820792|P5|NOT COMPLETED|Intervention Set 1||0
8448268|NCT00768560|20820793|P4|NOT COMPLETED|Intervention Set 1||0
8448269|NCT00768560|20820794|P3|NOT COMPLETED|Intervention Set 1||0
8448270|NCT00768560|20820795|P2|NOT COMPLETED|Intervention Set 1||1
8448271|NCT00768560|20820796|P1|NOT COMPLETED|Intervention Set 1||0
8448272|NCT00768560|20820791|P6|COMPLETED|Intervention Set 1||6
8448273|NCT00768560|20820792|P5|COMPLETED|Intervention Set 1||6
8448274|NCT00768560|20820793|P4|COMPLETED|Intervention Set 1||6
8448275|NCT00768560|20820794|P3|COMPLETED|Intervention Set 1||6
8448276|NCT00768560|20820795|P2|COMPLETED|Intervention Set 1||5
8448277|NCT00768560|20820796|P1|COMPLETED|Intervention Set 1||5
8448278|NCT00768560|20820791|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
8448279|NCT00768560|20820792|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
8448280|NCT00768560|20820793|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
8448281|NCT00768560|20820794|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
8448282|NCT00768560|20820795|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
8448283|NCT00768560|20820796|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
8448284|NCT00768560|20820791|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448285|NCT00768560|20820792|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448286|NCT00768560|20820793|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448287|NCT00768560|20820794|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448288|NCT00768560|20820795|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448289|NCT00768560|20820796|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
8448290|NCT00768521|20820822|P2|NOT COMPLETED|Period 2||0
8448291|NCT00768521|20820823|P1|NOT COMPLETED|Period 2||0
8448292|NCT00768521|20820822|P2|COMPLETED|Period 2||11
8448293|NCT00768521|20820823|P1|COMPLETED|Period 2||9
8448294|NCT00768521|20820822|P2|STARTED|Period 2||11
8448295|NCT00768521|20820823|P1|STARTED|Period 2||9
8448296|NCT00768521|20820822|P2|NOT COMPLETED|Period 1||0
8448297|NCT00768521|20820823|P1|NOT COMPLETED|Period 1||0
8448298|NCT00768521|20820822|P2|COMPLETED|Period 1||11
8448299|NCT00768521|20820823|P1|COMPLETED|Period 1||9
8448300|NCT00768521|20820822|P2|STARTED|Period 1||11
8448301|NCT00768521|20820823|P1|STARTED|Period 1||9
8448302|NCT00768469|20820833|P2|NOT COMPLETED|Overall Study||7
8448303|NCT00768469|20820834|P1|NOT COMPLETED|Overall Study||3
8448304|NCT00768469|20820833|P2|COMPLETED|Overall Study||0
8448305|NCT00768469|20820834|P1|COMPLETED|Overall Study||0
8448306|NCT00768469|20820833|P2|STARTED|Overall Study||7
8448307|NCT00768469|20820834|P1|STARTED|Overall Study||3
8448308|NCT00768430|20820849|P2|NOT COMPLETED|7 Day Endpoint||3
8448309|NCT00768430|20820850|P1|NOT COMPLETED|7 Day Endpoint||2
8448310|NCT00768430|20820849|P2|COMPLETED|7 Day Endpoint||22
8448311|NCT00768430|20820850|P1|COMPLETED|7 Day Endpoint||45
8448312|NCT00768430|20820849|P2|STARTED|7 Day Endpoint||25
8448313|NCT00768430|20820850|P1|STARTED|7 Day Endpoint||47
8448314|NCT00768430|20820849|P2|NOT COMPLETED|24 Hour Endpoint||0
8448315|NCT00768430|20820850|P1|NOT COMPLETED|24 Hour Endpoint||1
8448316|NCT00768430|20820849|P2|COMPLETED|24 Hour Endpoint||25
8448317|NCT00768430|20820850|P1|COMPLETED|24 Hour Endpoint||47
8448318|NCT00768430|20820849|P2|STARTED|24 Hour Endpoint||25
8448319|NCT00768430|20820850|P1|STARTED|24 Hour Endpoint||48
8448320|NCT00768300|20820858|P2|NOT COMPLETED|Overall Study||163
8448321|NCT00768300|20820859|P1|NOT COMPLETED|Overall Study||329
8448322|NCT00768300|20820858|P2|COMPLETED|Overall Study||1
8448323|NCT00768300|20820859|P1|COMPLETED|Overall Study||1
8448324|NCT00768300|20820858|P2|Randomized and Treated|Overall Study||163
8448325|NCT00768300|20820859|P1|Randomized and Treated|Overall Study||329
8448326|NCT00768300|20820858|P2|STARTED|Overall Study||164
8448327|NCT00768300|20820859|P1|STARTED|Overall Study||330
8448328|NCT00768287|20820881|P6|NOT COMPLETED|Surgical Sub-study||0
8448329|NCT00768287|20820882|P5|NOT COMPLETED|Surgical Sub-study||0
8448330|NCT00768287|20820883|P4|NOT COMPLETED|Surgical Sub-study||0
8448331|NCT00768287|20820884|P3|NOT COMPLETED|Surgical Sub-study||0
8448332|NCT00768287|20820885|P2|NOT COMPLETED|Surgical Sub-study||0
8448333|NCT00768287|20820886|P1|NOT COMPLETED|Surgical Sub-study||0
8448334|NCT00768287|20820881|P6|COMPLETED|Surgical Sub-study||17
8448335|NCT00768287|20820882|P5|COMPLETED|Surgical Sub-study||0
8448336|NCT00768287|20820883|P4|COMPLETED|Surgical Sub-study||0
8448337|NCT00768287|20820884|P3|COMPLETED|Surgical Sub-study||0
8448338|NCT00768287|20820885|P2|COMPLETED|Surgical Sub-study||0
8448339|NCT00768287|20820886|P1|COMPLETED|Surgical Sub-study||0
8448340|NCT00768287|20820881|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
8448341|NCT00768287|20820882|P5|STARTED|Surgical Sub-study||0
8448342|NCT00768287|20820883|P4|STARTED|Surgical Sub-study||0
8448343|NCT00768287|20820884|P3|STARTED|Surgical Sub-study||0
8448344|NCT00768287|20820885|P2|STARTED|Surgical Sub-study||0
8448345|NCT00768287|20820886|P1|STARTED|Surgical Sub-study||0
8448346|NCT00768287|20820881|P6|NOT COMPLETED|Treatment Study||0
8448347|NCT00768287|20820882|P5|NOT COMPLETED|Treatment Study||0
8448348|NCT00768287|20820883|P4|NOT COMPLETED|Treatment Study||0
8448349|NCT00768287|20820884|P3|NOT COMPLETED|Treatment Study||0
8448350|NCT00768287|20820885|P2|NOT COMPLETED|Treatment Study||0
8448351|NCT00768287|20820886|P1|NOT COMPLETED|Treatment Study||0
8448352|NCT00768287|20820881|P6|COMPLETED|Treatment Study||0
8448353|NCT00768287|20820882|P5|COMPLETED|Treatment Study||9
8448354|NCT00768287|20820883|P4|COMPLETED|Treatment Study||58
8448355|NCT00768287|20820884|P3|COMPLETED|Treatment Study||0
8448356|NCT00768287|20820885|P2|COMPLETED|Treatment Study||0
8448357|NCT00768287|20820886|P1|COMPLETED|Treatment Study||0
8448358|NCT00768287|20820881|P6|Treated|Treatment Study||0
8448359|NCT00768287|20820882|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
8448360|NCT00768287|20820883|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
8448361|NCT00768287|20820884|P3|Treated|Treatment Study||0
8448362|NCT00768287|20820885|P2|Treated|Treatment Study||0
8448363|NCT00768287|20820886|P1|Treated|Treatment Study||0
8448364|NCT00768287|20820881|P6|STARTED|Treatment Study||0
8448365|NCT00768287|20820882|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
8448366|NCT00768287|20820883|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
8448367|NCT00768287|20820884|P3|STARTED|Treatment Study||0
8448368|NCT00768287|20820885|P2|STARTED|Treatment Study||0
8448369|NCT00768287|20820886|P1|STARTED|Treatment Study||0
8448370|NCT00768287|20820881|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8448371|NCT00768287|20820882|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8448372|NCT00768287|20820883|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8448373|NCT00768287|20820884|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8448374|NCT00768287|20820885|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8448375|NCT00768287|20820886|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8448376|NCT00768287|20820881|P6|COMPLETED|Repeat Pharmacokinetic Study||0
8448377|NCT00768287|20820882|P5|COMPLETED|Repeat Pharmacokinetic Study||0
8448378|NCT00768287|20820883|P4|COMPLETED|Repeat Pharmacokinetic Study||0
8448379|NCT00768287|20820884|P3|COMPLETED|Repeat Pharmacokinetic Study||14
8448380|NCT00768287|20820885|P2|COMPLETED|Repeat Pharmacokinetic Study||0
8448381|NCT00768287|20820886|P1|COMPLETED|Repeat Pharmacokinetic Study||0
8448382|NCT00768287|20820881|P6|STARTED|Repeat Pharmacokinetic Study||0
8448383|NCT00768287|20820882|P5|STARTED|Repeat Pharmacokinetic Study||0
8448384|NCT00768287|20820883|P4|STARTED|Repeat Pharmacokinetic Study||0
8448385|NCT00768287|20820884|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
8448386|NCT00768287|20820885|P2|STARTED|Repeat Pharmacokinetic Study||0
8448387|NCT00768287|20820886|P1|STARTED|Repeat Pharmacokinetic Study||0
8448388|NCT00768287|20820881|P6|NOT COMPLETED|Pharmacokinetic Study||0
8448389|NCT00768287|20820882|P5|NOT COMPLETED|Pharmacokinetic Study||0
8448390|NCT00768287|20820883|P4|NOT COMPLETED|Pharmacokinetic Study||0
8448391|NCT00768287|20820884|P3|NOT COMPLETED|Pharmacokinetic Study||0
8448392|NCT00768287|20820885|P2|NOT COMPLETED|Pharmacokinetic Study||0
8448393|NCT00768287|20820886|P1|NOT COMPLETED|Pharmacokinetic Study||0
8448394|NCT00768287|20820881|P6|COMPLETED|Pharmacokinetic Study||0
8448395|NCT00768287|20820882|P5|COMPLETED|Pharmacokinetic Study||0
8448396|NCT00768287|20820883|P4|COMPLETED|Pharmacokinetic Study||0
8448397|NCT00768287|20820884|P3|COMPLETED|Pharmacokinetic Study||0
8448398|NCT00768287|20820885|P2|COMPLETED|Pharmacokinetic Study||16
8448399|NCT00768287|20820886|P1|COMPLETED|Pharmacokinetic Study||16
8448400|NCT00768287|20820881|P6|STARTED|Pharmacokinetic Study||0
8448401|NCT00768287|20820882|P5|STARTED|Pharmacokinetic Study||0
8448402|NCT00768287|20820883|P4|STARTED|Pharmacokinetic Study||0
8448403|NCT00768287|20820884|P3|STARTED|Pharmacokinetic Study||0
8448404|NCT00768287|20820885|P2|STARTED|Pharmacokinetic Study||16
8448405|NCT00768287|20820886|P1|STARTED|Pharmacokinetic Study||16
8448406|NCT00768261|20820925|P4|NOT COMPLETED|Overall Study||0
8448407|NCT00768261|20820926|P3|NOT COMPLETED|Overall Study||25
8448408|NCT00768261|20820927|P2|NOT COMPLETED|Overall Study||0
8448409|NCT00768261|20820928|P1|NOT COMPLETED|Overall Study||0
8448410|NCT00768261|20820925|P4|COMPLETED|Overall Study||56
8448411|NCT00768261|20820926|P3|COMPLETED|Overall Study||14
8448412|NCT00768261|20820927|P2|COMPLETED|Overall Study||18
8448413|NCT00768261|20820928|P1|COMPLETED|Overall Study||14
8448414|NCT00768261|20820925|P4|STARTED|Overall Study||56
8448415|NCT00768261|20820926|P3|STARTED|Overall Study||39
8448416|NCT00768261|20820927|P2|STARTED|Overall Study||18
8448417|NCT00768261|20820928|P1|STARTED|Overall Study||14
8448418|NCT00768248|20820943|P2|NOT COMPLETED|Overall Study||1
8448419|NCT00768248|20820944|P1|NOT COMPLETED|Overall Study||1
8448420|NCT00768248|20820943|P2|COMPLETED|Overall Study||0
8448421|NCT00768248|20820944|P1|COMPLETED|Overall Study||0
8448422|NCT00768248|20820943|P2|STARTED|Overall Study||1
8448423|NCT00768248|20820944|P1|STARTED|Overall Study||1
8448424|NCT00768222|20820960|P2|NOT COMPLETED|Overall Study||4
8448425|NCT00768222|20820961|P1|NOT COMPLETED|Overall Study||4
8448426|NCT00768222|20820960|P2|COMPLETED|Overall Study||47
8448427|NCT00768222|20820961|P1|COMPLETED|Overall Study||46
8448428|NCT00768222|20820960|P2|STARTED|Overall Study||51
8448429|NCT00768222|20820961|P1|STARTED|Overall Study||50
8448430|NCT00768144|20820983|P1|NOT COMPLETED|Overall Study||36
8448431|NCT00768144|20820983|P1|COMPLETED|Overall Study||0
8448432|NCT00768144|20820983|P1|STARTED|Overall Study||36
8448433|NCT00768118|20820989|P1|NOT COMPLETED|Overall Study||0
8448434|NCT00768118|20820989|P1|COMPLETED|Overall Study||11
8448435|NCT00768118|20820989|P1|STARTED|Overall Study||11
8448436|NCT00768079|20820996|P3|NOT COMPLETED|Overall Study||4
8448437|NCT00768079|20820997|P2|NOT COMPLETED|Overall Study||1
8448438|NCT00768079|20820998|P1|NOT COMPLETED|Overall Study||2
8448439|NCT00768079|20820996|P3|COMPLETED|Overall Study||32
8448440|NCT00768079|20820997|P2|COMPLETED|Overall Study||35
8448441|NCT00768079|20820998|P1|COMPLETED|Overall Study||36
8448442|NCT00768079|20820996|P3|STARTED|Overall Study||36
8448443|NCT00768079|20820997|P2|STARTED|Overall Study||36
8448444|NCT00768079|20820998|P1|STARTED|Overall Study||38
8448445|NCT00768066|20821055|P3|NOT COMPLETED|Overall Study||0
8448446|NCT00768066|20821056|P2|NOT COMPLETED|Overall Study||3
8448447|NCT00768066|20821057|P1|NOT COMPLETED|Overall Study||3
8448448|NCT00768066|20821055|P3|COMPLETED|Overall Study||21
8448449|NCT00768066|20821056|P2|COMPLETED|Overall Study||19
8448450|NCT00768066|20821057|P1|COMPLETED|Overall Study||19
8448451|NCT00768066|20821055|P3|STARTED|Overall Study||21
8448452|NCT00768066|20821056|P2|STARTED|Overall Study||22
8448453|NCT00768066|20821057|P1|STARTED|Overall Study||22
8448454|NCT00768053|20821089|P1|NOT COMPLETED|Overall Study||11
8448455|NCT00768053|20821089|P1|COMPLETED|Overall Study||97
8448456|NCT00768053|20821089|P1|STARTED|Overall Study||108
8448457|NCT00768040|20821120|P2|NOT COMPLETED|Overall Study||3
8448458|NCT00768040|20821121|P1|NOT COMPLETED|Overall Study||4
8448459|NCT00768040|20821120|P2|COMPLETED|Overall Study||16
8448460|NCT00768040|20821121|P1|COMPLETED|Overall Study||16
8448461|NCT00768040|20821120|P2|STARTED|Overall Study||19
8448462|NCT00768040|20821121|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
8448463|NCT00767819|20821130|P3|NOT COMPLETED|Overall Study||0
8448464|NCT00767819|20821131|P2|NOT COMPLETED|Overall Study||19
8448465|NCT00767819|20821132|P1|NOT COMPLETED|Overall Study||25
8448466|NCT00767819|20821130|P3|COMPLETED|Overall Study||10
8448467|NCT00767819|20821131|P2|COMPLETED|Overall Study||5
8448468|NCT00767819|20821132|P1|COMPLETED|Overall Study||12
8448469|NCT00767819|20821130|P3|Safety Analysis Set (SAF)|Overall Study||10
8448470|NCT00767819|20821131|P2|Safety Analysis Set (SAF)|Overall Study||24
8448471|NCT00767819|20821132|P1|Safety Analysis Set (SAF)|Overall Study||37
8448472|NCT00767819|20821130|P3|Intent to Treat (ITT) Analysis Set|Overall Study||10
8448473|NCT00767819|20821131|P2|Intent to Treat (ITT) Analysis Set|Overall Study||24
8448474|NCT00767819|20821132|P1|Intent to Treat (ITT) Analysis Set|Overall Study||37
8448475|NCT00767819|20821130|P3|STARTED|Overall Study||10
8448476|NCT00767819|20821131|P2|STARTED|Overall Study||24
8448477|NCT00767819|20821132|P1|STARTED|Overall Study||37
8448478|NCT00767806|20821157|P2|NOT COMPLETED|Overall Study||47
8448479|NCT00767806|20821158|P1|NOT COMPLETED|Overall Study||51
8448480|NCT00767806|20821157|P2|COMPLETED|Overall Study||156
8448481|NCT00767806|20821158|P1|COMPLETED|Overall Study||147
8448482|NCT00767806|20821157|P2|STARTED|Overall Study||203
8448483|NCT00767806|20821158|P1|STARTED|Overall Study||198
8448484|NCT00767767|20821219|P5|NOT COMPLETED|Overall Study||0
8448485|NCT00767767|20821220|P4|NOT COMPLETED|Overall Study||0
8448486|NCT00767767|20821221|P3|NOT COMPLETED|Overall Study||0
8448487|NCT00767767|20821222|P2|NOT COMPLETED|Overall Study||0
8448488|NCT00767767|20821223|P1|NOT COMPLETED|Overall Study||0
8448489|NCT00767767|20821219|P5|COMPLETED|Overall Study||3
8448490|NCT00767767|20821220|P4|COMPLETED|Overall Study||3
8448491|NCT00767767|20821221|P3|COMPLETED|Overall Study||20
8448492|NCT00767767|20821222|P2|COMPLETED|Overall Study||20
8448493|NCT00767767|20821223|P1|COMPLETED|Overall Study||21
8448494|NCT00767767|20821219|P5|STARTED|Overall Study||3
8448495|NCT00767767|20821220|P4|STARTED|Overall Study||3
8448496|NCT00767767|20821221|P3|STARTED|Overall Study||20
8448497|NCT00767767|20821222|P2|STARTED|Overall Study||20
8448498|NCT00767767|20821223|P1|STARTED|Overall Study||21
8448499|NCT00767676|20821235|P1|NOT COMPLETED|Overall Study||54
8448500|NCT00767676|20821235|P1|COMPLETED|Overall Study||205
8448501|NCT00767676|20821235|P1|STARTED|Overall Study||259
8448502|NCT00767624|20821241|P2|NOT COMPLETED|Overall Study||17
8448503|NCT00767624|20821242|P1|NOT COMPLETED|Overall Study||24
8448504|NCT00767624|20821241|P2|COMPLETED|Overall Study||58
8448505|NCT00767624|20821242|P1|COMPLETED|Overall Study||51
8448506|NCT00767624|20821241|P2|STARTED|Overall Study||75
8448507|NCT00767624|20821242|P1|STARTED|Overall Study||75
8448508|NCT00767572|20821250|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8448509|NCT00767572|20821250|P1|COMPLETED|Second Intervention (12 Weeks)||12
8448510|NCT00767572|20821250|P1|STARTED|Second Intervention (12 Weeks)||12
8448511|NCT00767572|20821250|P1|NOT COMPLETED|Washout (4 Weeks)||0
8448512|NCT00767572|20821250|P1|COMPLETED|Washout (4 Weeks)||12
8448513|NCT00767572|20821250|P1|STARTED|Washout (4 Weeks)||12
8448514|NCT00767572|20821250|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8448515|NCT00767572|20821250|P1|COMPLETED|First Intervention (12 Weeks)||12
8448516|NCT00767572|20821250|P1|STARTED|First Intervention (12 Weeks)||12
8448517|NCT00767520|20821258|P2|NOT COMPLETED|Overall Study||17
8448518|NCT00767520|20821259|P1|NOT COMPLETED|Overall Study||11
8448519|NCT00767520|20821258|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
8448520|NCT00767520|20821259|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
8448521|NCT00767520|20821258|P2|STARTED|Overall Study||78
8448522|NCT00767520|20821259|P1|STARTED|Overall Study||79
8448523|NCT00767507|20821285|P4|NOT COMPLETED|Overall Study||3
8448524|NCT00767507|20821286|P3|NOT COMPLETED|Overall Study||0
8448525|NCT00767507|20821287|P2|NOT COMPLETED|Overall Study||0
8448526|NCT00767507|20821288|P1|NOT COMPLETED|Overall Study||0
8448527|NCT00767507|20821285|P4|COMPLETED|Overall Study||101
8448528|NCT00767507|20821286|P3|COMPLETED|Overall Study||106
8448529|NCT00767507|20821287|P2|COMPLETED|Overall Study||6
8448530|NCT00767507|20821288|P1|COMPLETED|Overall Study||5
8448531|NCT00767507|20821285|P4|STARTED|Overall Study||104
8448532|NCT00767507|20821286|P3|STARTED|Overall Study||106
8448533|NCT00767507|20821287|P2|STARTED|Overall Study||6
8448534|NCT00767507|20821288|P1|STARTED|Overall Study||5
8448535|NCT00767455|20821312|P1|NOT COMPLETED|Overall Study||19
8448536|NCT00767455|20821312|P1|COMPLETED|Overall Study||40
8448537|NCT00767455|20821312|P1|STARTED|Overall Study||59
8448538|NCT00767364|20821320|P2|NOT COMPLETED|Overall Study||0
8448539|NCT00767364|20821321|P1|NOT COMPLETED|Overall Study||0
8448540|NCT00767364|20821320|P2|COMPLETED|Overall Study||3
8448541|NCT00767364|20821321|P1|COMPLETED|Overall Study||5
8448542|NCT00767364|20821320|P2|STARTED|Overall Study||3
8448543|NCT00767364|20821321|P1|STARTED|Overall Study||5
8448544|NCT00767338|20821333|P4|NOT COMPLETED|Overall Study||0
8448545|NCT00767338|20821334|P3|NOT COMPLETED|Overall Study||0
8448546|NCT00767338|20821335|P2|NOT COMPLETED|Overall Study||2
8448547|NCT00767338|20821336|P1|NOT COMPLETED|Overall Study||1
8448548|NCT00767338|20821333|P4|COMPLETED|Overall Study||0
8448549|NCT00767338|20821334|P3|COMPLETED|Overall Study||0
8448550|NCT00767338|20821335|P2|COMPLETED|Overall Study||0
8448551|NCT00767338|20821336|P1|COMPLETED|Overall Study||0
8448552|NCT00767338|20821333|P4|STARTED|Overall Study||0
8448553|NCT00767338|20821334|P3|STARTED|Overall Study||0
8448554|NCT00767338|20821335|P2|STARTED|Overall Study||2
8448555|NCT00767338|20821336|P1|STARTED|Overall Study||1
8448556|NCT00767325|20821346|P1|NOT COMPLETED|Overall Study||15
8448557|NCT00767325|20821346|P1|COMPLETED|Overall Study||89
8448558|NCT00767325|20821346|P1|STARTED|Overall Study||104
8448559|NCT00767104|20821357|P2|NOT COMPLETED|Overall Study||2
8448560|NCT00767104|20821358|P1|NOT COMPLETED|Overall Study||1
8448561|NCT00767104|20821357|P2|COMPLETED|Overall Study||18
8448562|NCT00767104|20821358|P1|COMPLETED|Overall Study||19
8448563|NCT00767104|20821357|P2|STARTED|Overall Study||20
8448564|NCT00767104|20821358|P1|STARTED|Overall Study||20
8448565|NCT00767039|20821368|P2|NOT COMPLETED|Overall Study||2
8448566|NCT00767039|20821369|P1|NOT COMPLETED|Overall Study||5
8448567|NCT00767039|20821368|P2|COMPLETED|Overall Study||23
8448568|NCT00767039|20821369|P1|COMPLETED|Overall Study||22
8448569|NCT00767039|20821368|P2|STARTED|Overall Study||25
8448570|NCT00767039|20821369|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
8448571|NCT00767000|20821400|P5|NOT COMPLETED|Optional 104-week Extension||4
8448572|NCT00767000|20821401|P4|NOT COMPLETED|Optional 104-week Extension||2
8448573|NCT00767000|20821402|P3|NOT COMPLETED|Optional 104-week Extension||7
8448574|NCT00767000|20821403|P2|NOT COMPLETED|Optional 104-week Extension||3
8448575|NCT00767000|20821404|P1|NOT COMPLETED|Optional 104-week Extension||7
8448576|NCT00767000|20821400|P5|COMPLETED|Optional 104-week Extension||0
8448577|NCT00767000|20821401|P4|COMPLETED|Optional 104-week Extension||0
8448578|NCT00767000|20821402|P3|COMPLETED|Optional 104-week Extension||0
8448579|NCT00767000|20821403|P2|COMPLETED|Optional 104-week Extension||0
8448580|NCT00767000|20821404|P1|COMPLETED|Optional 104-week Extension||0
8448581|NCT00767000|20821400|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
8448582|NCT00767000|20821401|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
8448583|NCT00767000|20821402|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
8448584|NCT00767000|20821403|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
8448585|NCT00767000|20821404|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
8448586|NCT00767000|20821400|P5|NOT COMPLETED|54-week Study||224
8448587|NCT00767000|20821401|P4|NOT COMPLETED|54-week Study||225
8448588|NCT00767000|20821402|P3|NOT COMPLETED|54-week Study||109
8448589|NCT00767000|20821403|P2|NOT COMPLETED|54-week Study||113
8448590|NCT00767000|20821404|P1|NOT COMPLETED|54-week Study||108
8448591|NCT00767000|20821400|P5|COMPLETED|54-week Study||7
8448592|NCT00767000|20821401|P4|COMPLETED|54-week Study||4
8448593|NCT00767000|20821402|P3|COMPLETED|54-week Study||8
8448594|NCT00767000|20821403|P2|COMPLETED|54-week Study||4
8448595|NCT00767000|20821404|P1|COMPLETED|54-week Study||11
8448596|NCT00767000|20821400|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
8448597|NCT00767000|20821401|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
8448598|NCT00767000|20821402|P3|STARTED|54-week Study||117
8448599|NCT00767000|20821403|P2|STARTED|54-week Study||117
8448600|NCT00767000|20821404|P1|STARTED|54-week Study||119
8448601|NCT00766831|20821446|P1|NOT COMPLETED|Overall Study||115
8448602|NCT00766831|20821446|P1|COMPLETED|Overall Study||75
8448603|NCT00766831|20821446|P1|STARTED|Overall Study||190
8448604|NCT00766753|20821464|P2|NOT COMPLETED|Overall Study||0
8448605|NCT00766753|20821465|P1|NOT COMPLETED|Overall Study||0
8448606|NCT00766753|20821464|P2|COMPLETED|Overall Study||11
8448607|NCT00766753|20821465|P1|COMPLETED|Overall Study||11
8448608|NCT00766753|20821464|P2|Completed at Least Four Vaccines|Overall Study||9
8448609|NCT00766753|20821465|P1|Completed at Least Four Vaccines|Overall Study||10
8448610|NCT00766753|20821464|P2|Received at Least One Vaccine|Overall Study||11
8448611|NCT00766753|20821465|P1|Received at Least One Vaccine|Overall Study||11
8448612|NCT00766753|20821464|P2|STARTED|Overall Study||11
8448613|NCT00766753|20821465|P1|STARTED|Overall Study||11
8448614|NCT00766727|20821476|P1|NOT COMPLETED|Overall Study||3
8448615|NCT00766727|20821476|P1|COMPLETED|Overall Study||9
8448616|NCT00766727|20821476|P1|STARTED|Overall Study||12
8448617|NCT00766675|20821482|P1|NOT COMPLETED|Overall Study||40
8448618|NCT00766675|20821482|P1|COMPLETED|Overall Study||40
8448619|NCT00766675|20821482|P1|STARTED|Overall Study||80
8448620|NCT00766649|20821495|P1|NOT COMPLETED|Overall Study||10
8448621|NCT00766649|20821495|P1|COMPLETED|Overall Study||1
8448622|NCT00766649|20821495|P1|STARTED|Overall Study||11
8448623|NCT00766636|20821511|P2|NOT COMPLETED|Overall Study||2
8448624|NCT00766636|20821512|P1|NOT COMPLETED|Overall Study||3
8448625|NCT00766636|20821511|P2|COMPLETED|Overall Study||0
8448626|NCT00766636|20821512|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
8448627|NCT00766636|20821511|P2|STARTED|Overall Study||2
8448628|NCT00766636|20821512|P1|STARTED|Overall Study||3
8448629|NCT00766597|20821518|P1|NOT COMPLETED|Overall Study||9
8448630|NCT00766597|20821518|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
8448631|NCT00766597|20821518|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
8448632|NCT00766597|20821518|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
8448633|NCT00766597|20821518|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
8448634|NCT00766597|20821518|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
8448635|NCT00766597|20821518|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
8448636|NCT00766532|20821530|P1|NOT COMPLETED|Overall Study||2
8448637|NCT00766532|20821530|P1|COMPLETED|Overall Study||10
8448638|NCT00766532|20821530|P1|STARTED|Overall Study||12
8448639|NCT00766506|20821536|P2|NOT COMPLETED|Overall Study||2
8448640|NCT00766506|20821537|P1|NOT COMPLETED|Overall Study||5
8448641|NCT00766506|20821536|P2|COMPLETED|Overall Study||48
8448642|NCT00766506|20821537|P1|COMPLETED|Overall Study||53
8448643|NCT00766506|20821536|P2|STARTED|Overall Study||50
8448644|NCT00766506|20821537|P1|STARTED|Overall Study||58
8448645|NCT00766493|20821561|P1|NOT COMPLETED|30 Days Post-Procedure||12
8448646|NCT00766493|20821561|P1|COMPLETED|30 Days Post-Procedure||238
8448647|NCT00766493|20821561|P1|STARTED|30 Days Post-Procedure||250
8448648|NCT00766493|20821561|P1|NOT COMPLETED|Pre-Discharge||0
8448649|NCT00766493|20821561|P1|COMPLETED|Pre-Discharge||250
8448650|NCT00766493|20821561|P1|STARTED|Pre-Discharge||250
8448651|NCT00766467|20821571|P2|NOT COMPLETED|Overall Study||8
8448652|NCT00766467|20821572|P1|NOT COMPLETED|Overall Study||11
8448653|NCT00766467|20821571|P2|COMPLETED|Overall Study||31
8448654|NCT00766467|20821572|P1|COMPLETED|Overall Study||31
8448655|NCT00766467|20821571|P2|Initiated Treatment|Overall Study||38
8448656|NCT00766467|20821572|P1|Initiated Treatment|Overall Study||39
8448657|NCT00766467|20821571|P2|STARTED|Overall Study||39
8448658|NCT00766467|20821572|P1|STARTED|Overall Study||42
8448659|NCT00766415|20821584|P2|NOT COMPLETED|Overall Study||1
8448660|NCT00766415|20821585|P1|NOT COMPLETED|Overall Study||0
8448661|NCT00766415|20821584|P2|COMPLETED|Overall Study||26
8448662|NCT00766415|20821585|P1|COMPLETED|Overall Study||25
8448663|NCT00766415|20821584|P2|STARTED|Overall Study||27
8448664|NCT00766415|20821585|P1|STARTED|Overall Study||25
8448665|NCT00766376|20821633|P1|NOT COMPLETED|Overall Study||27
8448666|NCT00766376|20821633|P1|COMPLETED|Overall Study||124
8448667|NCT00766376|20821633|P1|STARTED|Overall Study||151
8448668|NCT00766363|20821642|P4|NOT COMPLETED|Overall Study||0
8448669|NCT00766363|20821643|P3|NOT COMPLETED|Overall Study||0
8448670|NCT00766363|20821644|P2|NOT COMPLETED|Overall Study||1
8448671|NCT00766363|20821645|P1|NOT COMPLETED|Overall Study||1
8448672|NCT00766363|20821642|P4|COMPLETED|Overall Study||12
8448673|NCT00766363|20821643|P3|COMPLETED|Overall Study||12
8448674|NCT00766363|20821644|P2|COMPLETED|Overall Study||12
8448675|NCT00766363|20821645|P1|COMPLETED|Overall Study||11
8448676|NCT00766363|20821642|P4|PK POPULATION|Overall Study||13
8448677|NCT00766363|20821643|P3|PK POPULATION|Overall Study||10
8448678|NCT00766363|20821644|P2|PK POPULATION|Overall Study||13
8448679|NCT00766363|20821645|P1|PK POPULATION|Overall Study||12
8448680|NCT00766363|20821642|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
8448681|NCT00766363|20821643|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
8448682|NCT00766363|20821644|P2|SAFETY POPULATION|Overall Study||13
8448683|NCT00766363|20821645|P1|SAFETY POPULATION|Overall Study||12
8448684|NCT00766363|20821642|P4|STARTED|Overall Study|Number randomized.|12
8448685|NCT00766363|20821643|P3|STARTED|Overall Study|Number randomized.|12
8448686|NCT00766363|20821644|P2|STARTED|Overall Study||13
8448687|NCT00766363|20821645|P1|STARTED|Overall Study||12
8448688|NCT00766142|20821682|P1|NOT COMPLETED|Overall Study||4
8448689|NCT00766142|20821682|P1|COMPLETED|Overall Study||14
8448690|NCT00766142|20821682|P1|STARTED|Overall Study||18
8448691|NCT00766116|20821689|P1|NOT COMPLETED|Overall Study||0
8448692|NCT00766116|20821689|P1|COMPLETED|Overall Study||50
8448693|NCT00766116|20821689|P1|STARTED|Overall Study||50
8448694|NCT00766090|20821698|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448695|NCT00766090|20821699|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448696|NCT00766090|20821700|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448697|NCT00766090|20821701|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448698|NCT00766090|20821702|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448699|NCT00766090|20821703|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448700|NCT00766090|20821704|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448701|NCT00766090|20821705|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448702|NCT00766090|20821706|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448703|NCT00766090|20821707|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448704|NCT00766090|20821708|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448705|NCT00766090|20821709|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448706|NCT00766090|20821698|P12|COMPLETED|Treatment Period 3 (28 Days)||6
8448707|NCT00766090|20821699|P11|COMPLETED|Treatment Period 3 (28 Days)||7
8448708|NCT00766090|20821700|P10|COMPLETED|Treatment Period 3 (28 Days)||8
8448709|NCT00766090|20821701|P9|COMPLETED|Treatment Period 3 (28 Days)||6
8448710|NCT00766090|20821702|P8|COMPLETED|Treatment Period 3 (28 Days)||8
8448711|NCT00766090|20821703|P7|COMPLETED|Treatment Period 3 (28 Days)||6
8448712|NCT00766090|20821704|P6|COMPLETED|Treatment Period 3 (28 Days)||22
8448713|NCT00766090|20821705|P5|COMPLETED|Treatment Period 3 (28 Days)||20
8448714|NCT00766090|20821706|P4|COMPLETED|Treatment Period 3 (28 Days)||24
8448715|NCT00766090|20821707|P3|COMPLETED|Treatment Period 3 (28 Days)||20
8448716|NCT00766090|20821708|P2|COMPLETED|Treatment Period 3 (28 Days)||26
8448717|NCT00766090|20821709|P1|COMPLETED|Treatment Period 3 (28 Days)||22
8448718|NCT00766090|20821698|P12|STARTED|Treatment Period 3 (28 Days)||7
8448719|NCT00766090|20821699|P11|STARTED|Treatment Period 3 (28 Days)||7
8448720|NCT00766090|20821700|P10|STARTED|Treatment Period 3 (28 Days)||8
8448721|NCT00766090|20821701|P9|STARTED|Treatment Period 3 (28 Days)||6
8448722|NCT00766090|20821702|P8|STARTED|Treatment Period 3 (28 Days)||8
8448723|NCT00766090|20821703|P7|STARTED|Treatment Period 3 (28 Days)||6
8448724|NCT00766090|20821704|P6|STARTED|Treatment Period 3 (28 Days)||23
8448725|NCT00766090|20821705|P5|STARTED|Treatment Period 3 (28 Days)||21
8448726|NCT00766090|20821706|P4|STARTED|Treatment Period 3 (28 Days)||25
8448727|NCT00766090|20821707|P3|STARTED|Treatment Period 3 (28 Days)||20
8448728|NCT00766090|20821708|P2|STARTED|Treatment Period 3 (28 Days)||27
8448729|NCT00766090|20821709|P1|STARTED|Treatment Period 3 (28 Days)||22
8448730|NCT00766090|20821698|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448731|NCT00766090|20821699|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448732|NCT00766090|20821700|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448733|NCT00766090|20821701|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448734|NCT00766090|20821702|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448735|NCT00766090|20821703|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448736|NCT00766090|20821704|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448737|NCT00766090|20821705|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448738|NCT00766090|20821706|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448739|NCT00766090|20821707|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
8448740|NCT00766090|20821708|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448741|NCT00766090|20821709|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448742|NCT00766090|20821698|P12|COMPLETED|Washout Period 2 (14 Days)||7
8448743|NCT00766090|20821699|P11|COMPLETED|Washout Period 2 (14 Days)||7
8448744|NCT00766090|20821700|P10|COMPLETED|Washout Period 2 (14 Days)||8
8448745|NCT00766090|20821701|P9|COMPLETED|Washout Period 2 (14 Days)||6
8448746|NCT00766090|20821702|P8|COMPLETED|Washout Period 2 (14 Days)||8
8448747|NCT00766090|20821703|P7|COMPLETED|Washout Period 2 (14 Days)||6
8448748|NCT00766090|20821704|P6|COMPLETED|Washout Period 2 (14 Days)||23
8448749|NCT00766090|20821705|P5|COMPLETED|Washout Period 2 (14 Days)||21
8448750|NCT00766090|20821706|P4|COMPLETED|Washout Period 2 (14 Days)||25
8448751|NCT00766090|20821707|P3|COMPLETED|Washout Period 2 (14 Days)||20
8448752|NCT00766090|20821708|P2|COMPLETED|Washout Period 2 (14 Days)||27
8448753|NCT00766090|20821709|P1|COMPLETED|Washout Period 2 (14 Days)||22
8448754|NCT00766090|20821698|P12|STARTED|Washout Period 2 (14 Days)||7
8448755|NCT00766090|20821699|P11|STARTED|Washout Period 2 (14 Days)||7
8448756|NCT00766090|20821700|P10|STARTED|Washout Period 2 (14 Days)||8
8448757|NCT00766090|20821701|P9|STARTED|Washout Period 2 (14 Days)||6
8448758|NCT00766090|20821702|P8|STARTED|Washout Period 2 (14 Days)||8
8448759|NCT00766090|20821703|P7|STARTED|Washout Period 2 (14 Days)||6
8448760|NCT00766090|20821704|P6|STARTED|Washout Period 2 (14 Days)||23
8448761|NCT00766090|20821705|P5|STARTED|Washout Period 2 (14 Days)||21
8448762|NCT00766090|20821706|P4|STARTED|Washout Period 2 (14 Days)||25
8448763|NCT00766090|20821707|P3|STARTED|Washout Period 2 (14 Days)||21
8448764|NCT00766090|20821708|P2|STARTED|Washout Period 2 (14 Days)||27
8448765|NCT00766090|20821709|P1|STARTED|Washout Period 2 (14 Days)||22
8448766|NCT00766090|20821698|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448767|NCT00766090|20821699|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448768|NCT00766090|20821700|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448769|NCT00766090|20821701|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448770|NCT00766090|20821702|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448771|NCT00766090|20821703|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448772|NCT00766090|20821704|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448773|NCT00766090|20821705|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
8448774|NCT00766090|20821706|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448775|NCT00766090|20821707|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8448776|NCT00766090|20821708|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448777|NCT00766090|20821709|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448778|NCT00766090|20821698|P12|COMPLETED|Treatment Period 2 (28 Days)||7
8448779|NCT00766090|20821699|P11|COMPLETED|Treatment Period 2 (28 Days)||7
8448780|NCT00766090|20821700|P10|COMPLETED|Treatment Period 2 (28 Days)||8
8448781|NCT00766090|20821701|P9|COMPLETED|Treatment Period 2 (28 Days)||6
8448782|NCT00766090|20821702|P8|COMPLETED|Treatment Period 2 (28 Days)||8
8448783|NCT00766090|20821703|P7|COMPLETED|Treatment Period 2 (28 Days)||6
8448784|NCT00766090|20821704|P6|COMPLETED|Treatment Period 2 (28 Days)||23
8448785|NCT00766090|20821705|P5|COMPLETED|Treatment Period 2 (28 Days)||21
8448786|NCT00766090|20821706|P4|COMPLETED|Treatment Period 2 (28 Days)||25
8448787|NCT00766090|20821707|P3|COMPLETED|Treatment Period 2 (28 Days)||21
8448788|NCT00766090|20821708|P2|COMPLETED|Treatment Period 2 (28 Days)||27
8448789|NCT00766090|20821709|P1|COMPLETED|Treatment Period 2 (28 Days)||22
8448790|NCT00766090|20821698|P12|STARTED|Treatment Period 2 (28 Days)||7
8448791|NCT00766090|20821699|P11|STARTED|Treatment Period 2 (28 Days)||7
8448792|NCT00766090|20821700|P10|STARTED|Treatment Period 2 (28 Days)||8
8448793|NCT00766090|20821701|P9|STARTED|Treatment Period 2 (28 Days)||6
8448794|NCT00766090|20821702|P8|STARTED|Treatment Period 2 (28 Days)||8
8448795|NCT00766090|20821703|P7|STARTED|Treatment Period 2 (28 Days)||6
8448796|NCT00766090|20821704|P6|STARTED|Treatment Period 2 (28 Days)||23
8448797|NCT00766090|20821705|P5|STARTED|Treatment Period 2 (28 Days)||23
8448798|NCT00766090|20821706|P4|STARTED|Treatment Period 2 (28 Days)||25
8448799|NCT00766090|20821707|P3|STARTED|Treatment Period 2 (28 Days)||22
8448800|NCT00766090|20821708|P2|STARTED|Treatment Period 2 (28 Days)||27
8448801|NCT00766090|20821709|P1|STARTED|Treatment Period 2 (28 Days)||22
8448802|NCT00766090|20821698|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448803|NCT00766090|20821699|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448804|NCT00766090|20821700|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448805|NCT00766090|20821701|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448806|NCT00766090|20821702|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448807|NCT00766090|20821703|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448808|NCT00766090|20821704|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448809|NCT00766090|20821705|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448810|NCT00766090|20821706|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448811|NCT00766090|20821707|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
8448812|NCT00766090|20821708|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448813|NCT00766090|20821709|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448814|NCT00766090|20821698|P12|COMPLETED|Washout Period 1 (14 Days)||7
8448815|NCT00766090|20821699|P11|COMPLETED|Washout Period 1 (14 Days)||7
8448816|NCT00766090|20821700|P10|COMPLETED|Washout Period 1 (14 Days)||8
8448817|NCT00766090|20821701|P9|COMPLETED|Washout Period 1 (14 Days)||6
8448818|NCT00766090|20821702|P8|COMPLETED|Washout Period 1 (14 Days)||8
8448819|NCT00766090|20821703|P7|COMPLETED|Washout Period 1 (14 Days)||6
8448820|NCT00766090|20821704|P6|COMPLETED|Washout Period 1 (14 Days)||23
8448821|NCT00766090|20821705|P5|COMPLETED|Washout Period 1 (14 Days)||23
8448822|NCT00766090|20821706|P4|COMPLETED|Washout Period 1 (14 Days)||25
8448823|NCT00766090|20821707|P3|COMPLETED|Washout Period 1 (14 Days)||22
8448824|NCT00766090|20821708|P2|COMPLETED|Washout Period 1 (14 Days)||27
8448825|NCT00766090|20821709|P1|COMPLETED|Washout Period 1 (14 Days)||22
8448826|NCT00766090|20821698|P12|STARTED|Washout Period 1 (14 Days)||7
8448827|NCT00766090|20821699|P11|STARTED|Washout Period 1 (14 Days)||7
8448828|NCT00766090|20821700|P10|STARTED|Washout Period 1 (14 Days)||8
8448829|NCT00766090|20821701|P9|STARTED|Washout Period 1 (14 Days)||6
8448830|NCT00766090|20821702|P8|STARTED|Washout Period 1 (14 Days)||8
8448831|NCT00766090|20821703|P7|STARTED|Washout Period 1 (14 Days)||6
8448832|NCT00766090|20821704|P6|STARTED|Washout Period 1 (14 Days)||23
8448833|NCT00766090|20821705|P5|STARTED|Washout Period 1 (14 Days)||23
8448834|NCT00766090|20821706|P4|STARTED|Washout Period 1 (14 Days)||25
8448835|NCT00766090|20821707|P3|STARTED|Washout Period 1 (14 Days)||23
8448836|NCT00766090|20821708|P2|STARTED|Washout Period 1 (14 Days)||27
8448837|NCT00766090|20821709|P1|STARTED|Washout Period 1 (14 Days)||22
8448838|NCT00766090|20821698|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448839|NCT00766090|20821699|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448840|NCT00766090|20821700|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448841|NCT00766090|20821701|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8448842|NCT00766090|20821702|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448843|NCT00766090|20821703|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448844|NCT00766090|20821704|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448845|NCT00766090|20821705|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448846|NCT00766090|20821706|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8448847|NCT00766090|20821707|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448848|NCT00766090|20821708|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448849|NCT00766090|20821709|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
8448850|NCT00766090|20821698|P12|COMPLETED|Treatment Period 1 (28 Days)||7
8448851|NCT00766090|20821699|P11|COMPLETED|Treatment Period 1 (28 Days)||7
8448852|NCT00766090|20821700|P10|COMPLETED|Treatment Period 1 (28 Days)||8
8448853|NCT00766090|20821701|P9|COMPLETED|Treatment Period 1 (28 Days)||6
8448854|NCT00766090|20821702|P8|COMPLETED|Treatment Period 1 (28 Days)||8
8448855|NCT00766090|20821703|P7|COMPLETED|Treatment Period 1 (28 Days)||6
8448856|NCT00766090|20821704|P6|COMPLETED|Treatment Period 1 (28 Days)||23
8448857|NCT00766090|20821705|P5|COMPLETED|Treatment Period 1 (28 Days)||23
8448858|NCT00766090|20821706|P4|COMPLETED|Treatment Period 1 (28 Days)||25
8448859|NCT00766090|20821707|P3|COMPLETED|Treatment Period 1 (28 Days)||23
8448860|NCT00766090|20821708|P2|COMPLETED|Treatment Period 1 (28 Days)||27
8448861|NCT00766090|20821709|P1|COMPLETED|Treatment Period 1 (28 Days)||22
8448862|NCT00766090|20821698|P12|STARTED|Treatment Period 1 (28 Days)||7
8448863|NCT00766090|20821699|P11|STARTED|Treatment Period 1 (28 Days)||7
8448864|NCT00766090|20821700|P10|STARTED|Treatment Period 1 (28 Days)||8
8448865|NCT00766090|20821701|P9|STARTED|Treatment Period 1 (28 Days)||7
8448866|NCT00766090|20821702|P8|STARTED|Treatment Period 1 (28 Days)||8
8448867|NCT00766090|20821703|P7|STARTED|Treatment Period 1 (28 Days)||6
8448868|NCT00766090|20821704|P6|STARTED|Treatment Period 1 (28 Days)||23
8448869|NCT00766090|20821705|P5|STARTED|Treatment Period 1 (28 Days)||23
8448870|NCT00766090|20821706|P4|STARTED|Treatment Period 1 (28 Days)||26
8448871|NCT00766090|20821707|P3|STARTED|Treatment Period 1 (28 Days)||23
8448872|NCT00766090|20821708|P2|STARTED|Treatment Period 1 (28 Days)||27
8448873|NCT00766090|20821709|P1|STARTED|Treatment Period 1 (28 Days)||25
8448874|NCT00766051|20821750|P2|NOT COMPLETED|Overall Study||0
8448875|NCT00766051|20821751|P1|NOT COMPLETED|Overall Study||2
8448876|NCT00766051|20821750|P2|COMPLETED|Overall Study||10
8448877|NCT00766051|20821751|P1|COMPLETED|Overall Study||10
8448878|NCT00766051|20821750|P2|STARTED|Overall Study||10
8448879|NCT00766051|20821751|P1|STARTED|Overall Study||12
8448880|NCT00766038|20821763|P2|NOT COMPLETED|Overall Study||14
8448881|NCT00766038|20821764|P1|NOT COMPLETED|Overall Study||15
8448882|NCT00766038|20821763|P2|COMPLETED|Overall Study||18
8448883|NCT00766038|20821764|P1|COMPLETED|Overall Study||16
8448884|NCT00766038|20821763|P2|STARTED|Overall Study||32
8448885|NCT00766038|20821764|P1|STARTED|Overall Study||31
8448886|NCT00765999|20821780|P1|NOT COMPLETED|Overall Study||784
8448887|NCT00765999|20821780|P1|COMPLETED|Overall Study||770
8448888|NCT00765999|20821780|P1|STARTED|Overall Study||1554
8448889|NCT00765947|20821786|P1|NOT COMPLETED|Overall Study||24
8448890|NCT00765947|20821786|P1|COMPLETED|Overall Study||232
8448891|NCT00765947|20821786|P1|STARTED|Overall Study||256
8448892|NCT00765895|20821797|P2|NOT COMPLETED|Overall Study||0
8448893|NCT00765895|20821798|P1|NOT COMPLETED|Overall Study||0
8448894|NCT00765895|20821797|P2|COMPLETED|Overall Study||65
8448895|NCT00765895|20821798|P1|COMPLETED|Overall Study||65
8448896|NCT00765895|20821797|P2|STARTED|Overall Study||65
8448897|NCT00765895|20821798|P1|STARTED|Overall Study||65
8448898|NCT00765882|20821807|P3|NOT COMPLETED|Overall Study||36
8448899|NCT00765882|20821808|P2|NOT COMPLETED|Overall Study||40
8448900|NCT00765882|20821809|P1|NOT COMPLETED|Overall Study||24
8448901|NCT00765882|20821807|P3|COMPLETED|Overall Study||169
8448902|NCT00765882|20821808|P2|COMPLETED|Overall Study||173
8448903|NCT00765882|20821809|P1|COMPLETED|Overall Study||191
8448904|NCT00765882|20821807|P3|STARTED|Overall Study||205
8448905|NCT00765882|20821808|P2|STARTED|Overall Study||213
8448906|NCT00765882|20821809|P1|STARTED|Overall Study||215
8448907|NCT00765856|20821838|P1|NOT COMPLETED|Maintenance Period||6
8448908|NCT00765856|20821838|P1|COMPLETED|Maintenance Period||18
8448909|NCT00765856|20821838|P1|STARTED|Maintenance Period||24
8448910|NCT00765856|20821838|P1|NOT COMPLETED|Titration Period||3
8448911|NCT00765856|20821838|P1|COMPLETED|Titration Period||24
8448912|NCT00765856|20821838|P1|STARTED|Titration Period||27
8448913|NCT00765843|20821855|P3|NOT COMPLETED|Overall Study||3
8448914|NCT00765843|20821856|P2|NOT COMPLETED|Overall Study||4
8448915|NCT00765843|20821857|P1|NOT COMPLETED|Overall Study||1
8448916|NCT00765843|20821855|P3|COMPLETED|Overall Study||23
8448917|NCT00765843|20821856|P2|COMPLETED|Overall Study||21
8448918|NCT00765843|20821857|P1|COMPLETED|Overall Study||25
8448919|NCT00765843|20821855|P3|STARTED|Overall Study||26
8448920|NCT00765843|20821856|P2|STARTED|Overall Study||25
8448921|NCT00765843|20821857|P1|STARTED|Overall Study||26
8448922|NCT00765817|20821867|P2|NOT COMPLETED|Overall Study||22
8448923|NCT00765817|20821868|P1|NOT COMPLETED|Overall Study||26
8448924|NCT00765817|20821867|P2|COMPLETED|Overall Study||101
8448925|NCT00765817|20821868|P1|COMPLETED|Overall Study||112
8448926|NCT00765817|20821867|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
8448927|NCT00765817|20821868|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
8448928|NCT00765765|20821906|P1|NOT COMPLETED|Overall Study||0
8448929|NCT00765765|20821906|P1|COMPLETED|Overall Study||6
8448930|NCT00765765|20821906|P1|STARTED|Overall Study||6
8448931|NCT00765726|20821916|P1|NOT COMPLETED|Overall Study||9
8448932|NCT00765726|20821916|P1|COMPLETED|Overall Study||3
8448933|NCT00765726|20821916|P1|STARTED|Overall Study||12
8448934|NCT00765674|20821924|P4|NOT COMPLETED|Overall Study||25
8448935|NCT00765674|20821925|P3|NOT COMPLETED|Overall Study||17
8448936|NCT00765674|20821926|P2|NOT COMPLETED|Overall Study||22
8448937|NCT00765674|20821927|P1|NOT COMPLETED|Overall Study||21
8448938|NCT00765674|20821924|P4|COMPLETED|Overall Study||285
8448939|NCT00765674|20821925|P3|COMPLETED|Overall Study||279
8448940|NCT00765674|20821926|P2|COMPLETED|Overall Study||276
8448941|NCT00765674|20821927|P1|COMPLETED|Overall Study||266
8448942|NCT00765674|20821924|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
8448943|NCT00765674|20821925|P3|STARTED|Overall Study||296
8448944|NCT00765674|20821926|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
8448945|NCT00765674|20821927|P1|STARTED|Overall Study||287
8448946|NCT00765661|20821951|P2|NOT COMPLETED|Overall Study||0
8448947|NCT00765661|20821952|P1|NOT COMPLETED|Overall Study||0
8448948|NCT00765661|20821951|P2|COMPLETED|Overall Study||31
8448949|NCT00765661|20821952|P1|COMPLETED|Overall Study||32
8448950|NCT00765661|20821951|P2|STARTED|Overall Study||31
8448951|NCT00765661|20821952|P1|STARTED|Overall Study||32
8448952|NCT00765648|20821966|P2|NOT COMPLETED|Overall Study||2
8448953|NCT00765648|20821967|P1|NOT COMPLETED|Overall Study||1
8448954|NCT00765648|20821966|P2|COMPLETED|Overall Study||114
8448955|NCT00765648|20821967|P1|COMPLETED|Overall Study||109
8448956|NCT00765648|20821966|P2|STARTED|Overall Study||116
8448957|NCT00765648|20821967|P1|STARTED|Overall Study||110
8448958|NCT00765570|20821985|P2|NOT COMPLETED|Overall Study||0
8448959|NCT00765570|20821986|P1|NOT COMPLETED|Overall Study||2
8448960|NCT00765570|20821985|P2|COMPLETED|Overall Study||3
8448961|NCT00765570|20821986|P1|COMPLETED|Overall Study||7
8448962|NCT00765570|20821985|P2|STARTED|Overall Study||3
8448963|NCT00765570|20821986|P1|STARTED|Overall Study||9
8448964|NCT00765388|20821994|P2|NOT COMPLETED|Period 2||0
8448965|NCT00765388|20821995|P1|NOT COMPLETED|Period 2||0
8448966|NCT00765388|20821994|P2|COMPLETED|Period 2||6
8448967|NCT00765388|20821995|P1|COMPLETED|Period 2||15
8448968|NCT00765388|20821994|P2|STARTED|Period 2||6
8448969|NCT00765388|20821995|P1|STARTED|Period 2||15
8448970|NCT00765388|20821994|P2|NOT COMPLETED|Period 1||5
8448971|NCT00765388|20821995|P1|NOT COMPLETED|Period 1||1
8448972|NCT00765388|20821994|P2|COMPLETED|Period 1||6
8448973|NCT00765388|20821995|P1|COMPLETED|Period 1||15
8448974|NCT00765388|20821994|P2|STARTED|Period 1||11
8448975|NCT00765388|20821995|P1|STARTED|Period 1|A cross-over study|16
8448976|NCT00765375|20822023|P1|NOT COMPLETED|Overall Study||0
8448977|NCT00765375|20822023|P1|COMPLETED|Overall Study||5
8448978|NCT00765375|20822023|P1|STARTED|Overall Study||5
8448979|NCT00765362|20822029|P1|NOT COMPLETED|Overall Study||137
8448980|NCT00765362|20822029|P1|COMPLETED|Overall Study||282
8448981|NCT00765362|20822029|P1|STARTED|Overall Study||419
8448982|NCT00765336|20822037|P2|NOT COMPLETED|Overall Study||16
8448983|NCT00765336|20822038|P1|NOT COMPLETED|Overall Study||19
8448984|NCT00765336|20822037|P2|COMPLETED|Overall Study||73
8448985|NCT00765336|20822038|P1|COMPLETED|Overall Study||72
8448986|NCT00765336|20822037|P2|STARTED|Overall Study||89
8448987|NCT00765336|20822038|P1|STARTED|Overall Study||91
8448988|NCT00765245|20822046|P2|NOT COMPLETED|Overall Study||2
8448989|NCT00765245|20822047|P1|NOT COMPLETED|Overall Study||13
8448990|NCT00765245|20822046|P2|COMPLETED|Overall Study||20
8448991|NCT00765245|20822047|P1|COMPLETED|Overall Study||9
8448992|NCT00765245|20822046|P2|STARTED|Overall Study||22
8448993|NCT00765245|20822047|P1|STARTED|Overall Study||22
8448994|NCT00765232|20822059|P2|NOT COMPLETED|Overall Study||0
8448995|NCT00765232|20822060|P1|NOT COMPLETED|Overall Study||0
8448996|NCT00765232|20822059|P2|COMPLETED|Overall Study||54
8448997|NCT00765232|20822060|P1|COMPLETED|Overall Study||57
8448998|NCT00765232|20822059|P2|STARTED|Overall Study||54
8448999|NCT00765232|20822060|P1|STARTED|Overall Study||57
8449000|NCT00765206|20822068|P4|NOT COMPLETED|Second Intervention||0
8449001|NCT00765206|20822069|P3|NOT COMPLETED|Second Intervention||0
8449002|NCT00765206|20822070|P2|NOT COMPLETED|Second Intervention||0
8449003|NCT00765206|20822071|P1|NOT COMPLETED|Second Intervention||0
8449004|NCT00765206|20822068|P4|COMPLETED|Second Intervention||15
8449005|NCT00765206|20822069|P3|COMPLETED|Second Intervention||15
8449006|NCT00765206|20822070|P2|COMPLETED|Second Intervention||15
8449007|NCT00765206|20822071|P1|COMPLETED|Second Intervention||15
8449008|NCT00765206|20822068|P4|STARTED|Second Intervention||15
8449009|NCT00765206|20822069|P3|STARTED|Second Intervention||15
8449010|NCT00765206|20822070|P2|STARTED|Second Intervention||15
8449011|NCT00765206|20822071|P1|STARTED|Second Intervention||15
8449012|NCT00765206|20822068|P4|NOT COMPLETED|Washout Period of 14 Days||0
8449013|NCT00765206|20822069|P3|NOT COMPLETED|Washout Period of 14 Days||0
8449014|NCT00765206|20822070|P2|NOT COMPLETED|Washout Period of 14 Days||0
8449015|NCT00765206|20822071|P1|NOT COMPLETED|Washout Period of 14 Days||0
8449016|NCT00765206|20822068|P4|COMPLETED|Washout Period of 14 Days||15
8449017|NCT00765206|20822069|P3|COMPLETED|Washout Period of 14 Days||15
8449018|NCT00765206|20822070|P2|COMPLETED|Washout Period of 14 Days||15
8449019|NCT00765206|20822071|P1|COMPLETED|Washout Period of 14 Days||15
8449020|NCT00765206|20822068|P4|STARTED|Washout Period of 14 Days||15
8449021|NCT00765206|20822069|P3|STARTED|Washout Period of 14 Days||15
8449022|NCT00765206|20822070|P2|STARTED|Washout Period of 14 Days||15
8449023|NCT00765206|20822071|P1|STARTED|Washout Period of 14 Days||15
8449024|NCT00765206|20822068|P4|NOT COMPLETED|First Intervention||0
8449025|NCT00765206|20822069|P3|NOT COMPLETED|First Intervention||0
8449026|NCT00765206|20822070|P2|NOT COMPLETED|First Intervention||0
8449027|NCT00765206|20822071|P1|NOT COMPLETED|First Intervention||0
8449028|NCT00765206|20822068|P4|COMPLETED|First Intervention||15
8449029|NCT00765206|20822069|P3|COMPLETED|First Intervention||15
8449030|NCT00765206|20822070|P2|COMPLETED|First Intervention||15
8449031|NCT00765206|20822071|P1|COMPLETED|First Intervention||15
8449032|NCT00765206|20822068|P4|STARTED|First Intervention||15
8449033|NCT00765206|20822069|P3|STARTED|First Intervention||15
8449034|NCT00765206|20822070|P2|STARTED|First Intervention||15
8449035|NCT00765206|20822071|P1|STARTED|First Intervention||15
8449036|NCT00765193|20822077|P1|NOT COMPLETED|Full Body Examination||0
8449037|NCT00765193|20822077|P1|COMPLETED|Full Body Examination||14381
8449038|NCT00765193|20822077|P1|STARTED|Full Body Examination||14381
8449039|NCT00765193|20822077|P1|NOT COMPLETED|Problem Area Examination||0
8449040|NCT00765193|20822077|P1|COMPLETED|Problem Area Examination||14381
8449041|NCT00765193|20822077|P1|STARTED|Problem Area Examination||14381
8449042|NCT00765128|20822084|P2|NOT COMPLETED|Overall Study||0
8449043|NCT00765128|20822085|P1|NOT COMPLETED|Overall Study||0
8449044|NCT00765128|20822084|P2|COMPLETED|Overall Study||9
8449045|NCT00765128|20822085|P1|COMPLETED|Overall Study||8
8449046|NCT00765128|20822084|P2|STARTED|Overall Study||9
8449047|NCT00765128|20822085|P1|STARTED|Overall Study||8
8449048|NCT00765102|20822093|P1|NOT COMPLETED|Overall Study||31
8449049|NCT00765102|20822093|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
8449050|NCT00765102|20822093|P1|STARTED|Overall Study||32
8449051|NCT00765076|20822118|P3|NOT COMPLETED|Overall Study||1
8449052|NCT00765076|20822119|P2|NOT COMPLETED|Overall Study||0
8449053|NCT00765076|20822120|P1|NOT COMPLETED|Overall Study||1
8449054|NCT00765076|20822118|P3|COMPLETED|Overall Study||49
8449055|NCT00765076|20822119|P2|COMPLETED|Overall Study||73
8449056|NCT00765076|20822120|P1|COMPLETED|Overall Study||68
8449057|NCT00765076|20822118|P3|STARTED|Overall Study||50
8449058|NCT00765076|20822119|P2|STARTED|Overall Study||73
8449059|NCT00765076|20822120|P1|STARTED|Overall Study||69
8449060|NCT00765063|20822173|P1|NOT COMPLETED|Overall Study||32
8449061|NCT00765063|20822173|P1|COMPLETED|Overall Study||30
8449062|NCT00765063|20822173|P1|STARTED|Overall Study||62
8449063|NCT00765037|20822189|P1|NOT COMPLETED|Overall Study||6
8449064|NCT00765037|20822189|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
8449065|NCT00765037|20822189|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
8449066|NCT00764946|20822196|P3|NOT COMPLETED|Overall Study||4
8449067|NCT00764946|20822197|P2|NOT COMPLETED|Overall Study||17
8449068|NCT00764946|20822198|P1|NOT COMPLETED|Overall Study||13
8449069|NCT00764946|20822196|P3|COMPLETED|Overall Study||18
8449070|NCT00764946|20822197|P2|COMPLETED|Overall Study||72
8449071|NCT00764946|20822198|P1|COMPLETED|Overall Study||85
8449072|NCT00764946|20822196|P3|TREATED|Overall Study||21
8449073|NCT00764946|20822197|P2|TREATED|Overall Study||88
8449074|NCT00764946|20822198|P1|TREATED|Overall Study||97
8449075|NCT00764946|20822196|P3|STARTED|Overall Study||22
8449076|NCT00764946|20822197|P2|STARTED|Overall Study||89
8449077|NCT00764946|20822198|P1|STARTED|Overall Study||98
8449078|NCT00764881|20822226|P2|NOT COMPLETED|Overall Study||10
8449079|NCT00764881|20822227|P1|NOT COMPLETED|Overall Study||16
8449080|NCT00764881|20822226|P2|COMPLETED|Overall Study||99
8449081|NCT00764881|20822227|P1|COMPLETED|Overall Study||92
8449082|NCT00764881|20822226|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
8449083|NCT00764881|20822227|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
8449084|NCT00764881|20822226|P2|STARTED|Overall Study||109
8449085|NCT00764881|20822227|P1|STARTED|Overall Study||108
8449086|NCT00764868|20822451|P1|NOT COMPLETED|Overall Study||113
8449087|NCT00764868|20822451|P1|COMPLETED|Overall Study||156
8449088|NCT00764868|20822451|P1|STARTED|Overall Study||269
8449089|NCT00764790|20822460|P3|NOT COMPLETED|Overall Study||30
8449090|NCT00764790|20822461|P2|NOT COMPLETED|Overall Study||41
8449091|NCT00764790|20822462|P1|NOT COMPLETED|Overall Study||38
8449092|NCT00764790|20822460|P3|COMPLETED|Overall Study||1074
8449093|NCT00764790|20822461|P2|COMPLETED|Overall Study||1065
8449094|NCT00764790|20822462|P1|COMPLETED|Overall Study||1069
8449095|NCT00764790|20822460|P3|STARTED|Overall Study||1104
8449096|NCT00764790|20822461|P2|STARTED|Overall Study||1106
8449097|NCT00764790|20822462|P1|STARTED|Overall Study||1107
8449098|NCT00764751|20822496|P2|NOT COMPLETED|Overall Study||1
8449099|NCT00764751|20822497|P1|NOT COMPLETED|Overall Study||2
8449100|NCT00764751|20822496|P2|COMPLETED|Overall Study||11
8449101|NCT00764751|20822497|P1|COMPLETED|Overall Study||37
8449102|NCT00764751|20822496|P2|STARTED|Overall Study||12
8449103|NCT00764751|20822497|P1|STARTED|Overall Study||39
8449104|NCT00764738|20822535|P4|NOT COMPLETED|Overall Study||6
8449105|NCT00764738|20822536|P3|NOT COMPLETED|Overall Study||3
8449106|NCT00764738|20822537|P2|NOT COMPLETED|Overall Study||3
8449107|NCT00764738|20822538|P1|NOT COMPLETED|Overall Study||2
8449108|NCT00764738|20822535|P4|COMPLETED|Overall Study||18
8449109|NCT00764738|20822536|P3|COMPLETED|Overall Study||12
8449110|NCT00764738|20822537|P2|COMPLETED|Overall Study||25
8449111|NCT00764738|20822538|P1|COMPLETED|Overall Study||22
8449112|NCT00764738|20822535|P4|STARTED|Overall Study||24
8449113|NCT00764738|20822536|P3|STARTED|Overall Study||15
8449114|NCT00764738|20822537|P2|STARTED|Overall Study||28
8449115|NCT00764738|20822538|P1|STARTED|Overall Study||24
8449116|NCT00764699|20822560|P1|NOT COMPLETED|Overall Study||3
8449117|NCT00764699|20822560|P1|COMPLETED|Overall Study||0
8449118|NCT00764699|20822560|P1|STARTED|Overall Study||3
8449119|NCT00764673|20822564|P1|NOT COMPLETED|Overall Study||12
8449120|NCT00764673|20822564|P1|COMPLETED|Overall Study||59
8449121|NCT00764673|20822564|P1|STARTED|Overall Study||71
8449122|NCT00764660|20822574|P2|NOT COMPLETED|Overall Study||11
8449123|NCT00764660|20822575|P1|NOT COMPLETED|Overall Study||22
8449124|NCT00764660|20822574|P2|COMPLETED|Overall Study||55
8449125|NCT00764660|20822575|P1|COMPLETED|Overall Study||53
8449126|NCT00764660|20822574|P2|STARTED|Overall Study||66
8449127|NCT00764660|20822575|P1|STARTED|Overall Study||75
8449128|NCT00764517|20822609|P2|NOT COMPLETED|Overall Study||14
8449129|NCT00764517|20822610|P1|NOT COMPLETED|Overall Study||15
8449130|NCT00764517|20822609|P2|COMPLETED|Overall Study||4
8449131|NCT00764517|20822610|P1|COMPLETED|Overall Study||24
8449132|NCT00764517|20822609|P2|STARTED|Overall Study||18
8449133|NCT00764517|20822610|P1|STARTED|Overall Study||39
8449134|NCT00764504|20822631|P3|NOT COMPLETED|Overall Study||103
8449135|NCT00764504|20822632|P2|NOT COMPLETED|Overall Study||70
8449136|NCT00764504|20822633|P1|NOT COMPLETED|Overall Study||66
8449137|NCT00764504|20822631|P3|COMPLETED|Overall Study||131
8449138|NCT00764504|20822632|P2|COMPLETED|Overall Study||71
8449139|NCT00764504|20822633|P1|COMPLETED|Overall Study||75
8449140|NCT00764504|20822631|P3|STARTED|Overall Study||234
8449141|NCT00764504|20822632|P2|STARTED|Overall Study||141
8449142|NCT00764504|20822633|P1|STARTED|Overall Study||141
8449143|NCT00764478|20822662|P3|NOT COMPLETED|Overall Study||8
8449144|NCT00764478|20822663|P2|NOT COMPLETED|Overall Study||22
8449145|NCT00764478|20822664|P1|NOT COMPLETED|Overall Study||15
8449146|NCT00764478|20822662|P3|COMPLETED|Overall Study||118
8449147|NCT00764478|20822663|P2|COMPLETED|Overall Study||97
8449148|NCT00764478|20822664|P1|COMPLETED|Overall Study||107
8449149|NCT00764478|20822662|P3|STARTED|Overall Study||126
8449150|NCT00764478|20822663|P2|STARTED|Overall Study||119
8449151|NCT00764478|20822664|P1|STARTED|Overall Study||122
8449152|NCT00764465|20822744|P6|NOT COMPLETED|Overall Study||1
8449153|NCT00764465|20822745|P5|NOT COMPLETED|Overall Study||1
8449154|NCT00764465|20822746|P4|NOT COMPLETED|Overall Study||1
8449155|NCT00764465|20822747|P3|NOT COMPLETED|Overall Study||1
8449156|NCT00764465|20822748|P2|NOT COMPLETED|Overall Study||1
8449157|NCT00764465|20822749|P1|NOT COMPLETED|Overall Study||2
8449158|NCT00764465|20822744|P6|COMPLETED|Overall Study||7
8449159|NCT00764465|20822745|P5|COMPLETED|Overall Study||6
8449160|NCT00764465|20822746|P4|COMPLETED|Overall Study||6
8449161|NCT00764465|20822747|P3|COMPLETED|Overall Study||6
8449162|NCT00764465|20822748|P2|COMPLETED|Overall Study||6
8449163|NCT00764465|20822749|P1|COMPLETED|Overall Study||7
8449164|NCT00764465|20822744|P6|STARTED|Overall Study||8
8449165|NCT00764465|20822745|P5|STARTED|Overall Study||7
8449166|NCT00764465|20822746|P4|STARTED|Overall Study||7
8449167|NCT00764465|20822747|P3|STARTED|Overall Study||7
8449168|NCT00764465|20822748|P2|STARTED|Overall Study||7
8449169|NCT00764465|20822749|P1|STARTED|Overall Study||9
8449170|NCT00764361|20822777|P2|NOT COMPLETED|Overall Study||4
8449171|NCT00764361|20822778|P1|NOT COMPLETED|Overall Study||2
8449172|NCT00764361|20822777|P2|COMPLETED|Overall Study||3
8449173|NCT00764361|20822778|P1|COMPLETED|Overall Study||6
8449174|NCT00764361|20822777|P2|STARTED|Overall Study||7
8449175|NCT00764361|20822778|P1|STARTED|Overall Study||8
8449176|NCT00764322|20822786|P1|NOT COMPLETED|Overall Study||20
8449177|NCT00764322|20822786|P1|COMPLETED|Overall Study||480
8449178|NCT00764322|20822786|P1|STARTED|Overall Study||500
8449179|NCT00764309|20822803|P1|NOT COMPLETED|Overall Study||0
8449180|NCT00764309|20822803|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
8449181|NCT00764309|20822803|P1|STARTED|Overall Study|Number of participants treated.|31
8449182|NCT00763971|20822813|P3|NOT COMPLETED|Overall Study||69
8449183|NCT00763971|20822814|P2|NOT COMPLETED|Overall Study||38
8449184|NCT00763971|20822815|P1|NOT COMPLETED|Overall Study||33
8449185|NCT00763971|20822813|P3|COMPLETED|Overall Study||42
8449186|NCT00763971|20822814|P2|COMPLETED|Overall Study||74
8449187|NCT00763971|20822815|P1|COMPLETED|Overall Study||80
8449188|NCT00763971|20822813|P3|STARTED|Overall Study||111
8449189|NCT00763971|20822814|P2|STARTED|Overall Study||112
8449190|NCT00763971|20822815|P1|STARTED|Overall Study||113
8449191|NCT00763958|20822846|P2|NOT COMPLETED|Overall Study||11
8449192|NCT00763958|20822847|P1|NOT COMPLETED|Overall Study||14
8449193|NCT00763958|20822846|P2|COMPLETED|Overall Study||5
8449194|NCT00763958|20822847|P1|COMPLETED|Overall Study||14
8449195|NCT00763958|20822846|P2|STARTED|Overall Study||16
8449196|NCT00763958|20822847|P1|STARTED|Overall Study||28
8449197|NCT00763919|20822857|P1|NOT COMPLETED|Overall Study||13
8449198|NCT00763919|20822857|P1|COMPLETED|Overall Study||30
8449199|NCT00763919|20822857|P1|STARTED|Overall Study||43
8449200|NCT00763867|20822885|P2|NOT COMPLETED|Overall Study||12
8449201|NCT00763867|20822886|P1|NOT COMPLETED|Overall Study||5
8449202|NCT00763867|20822885|P2|COMPLETED|Overall Study||101
8449203|NCT00763867|20822886|P1|COMPLETED|Overall Study||98
8449204|NCT00763867|20822885|P2|STARTED|Overall Study||113
8449205|NCT00763867|20822886|P1|STARTED|Overall Study||103
8449206|NCT00763815|20822982|P2|NOT COMPLETED|Overall Study||84
8449207|NCT00763815|20822983|P1|NOT COMPLETED|Overall Study||52
8449208|NCT00763815|20822982|P2|COMPLETED|Overall Study||239
8449209|NCT00763815|20822983|P1|COMPLETED|Overall Study||109
8449210|NCT00763815|20822982|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
8449211|NCT00763815|20822983|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
8449212|NCT00763815|20822982|P2|Treated/Safety Population|Overall Study||323
8449213|NCT00763815|20822983|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
8449214|NCT00763815|20822982|P2|STARTED|Overall Study||323
8449215|NCT00763815|20822983|P1|STARTED|Overall Study|Randomized.|161
8449216|NCT00763750|20823007|P1|NOT COMPLETED|Overall Study||0
8449217|NCT00763750|20823007|P1|COMPLETED|Overall Study||25
8449218|NCT00763750|20823007|P1|STARTED|Overall Study||25
8449219|NCT00763698|20823011|P1|NOT COMPLETED|Overall Study||10
8449220|NCT00763698|20823011|P1|COMPLETED|Overall Study||76
8449221|NCT00763698|20823011|P1|STARTED|Overall Study||86
8449222|NCT00763490|20823017|P1|NOT COMPLETED|Overall Study||0
8449223|NCT00763490|20823017|P1|COMPLETED|Overall Study||20
8449224|NCT00763490|20823017|P1|STARTED|Overall Study||20
8449225|NCT00763451|20823028|P4|NOT COMPLETED|Overall Study||30
8449226|NCT00763451|20823029|P3|NOT COMPLETED|Overall Study||40
8449227|NCT00763451|20823030|P2|NOT COMPLETED|Overall Study||22
8449228|NCT00763451|20823031|P1|NOT COMPLETED|Overall Study||13
8449229|NCT00763451|20823028|P4|COMPLETED|Overall Study||131
8449230|NCT00763451|20823029|P3|COMPLETED|Overall Study||121
8449231|NCT00763451|20823030|P2|COMPLETED|Overall Study||60
8449232|NCT00763451|20823031|P1|COMPLETED|Overall Study||67
8449233|NCT00763451|20823028|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
8449234|NCT00763451|20823029|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
8449235|NCT00763451|20823030|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
8449236|NCT00763451|20823031|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
8449237|NCT00763451|20823028|P4|Treated/Safety Population|Overall Study||161
8449238|NCT00763451|20823029|P3|Treated/Safety Population|Overall Study||161
8449239|NCT00763451|20823030|P2|Treated/Safety Population|Overall Study||81
8449240|NCT00763451|20823031|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
8449241|NCT00763451|20823028|P4|STARTED|Overall Study||161
8449242|NCT00763451|20823029|P3|STARTED|Overall Study||161
8449243|NCT00763451|20823030|P2|STARTED|Overall Study||82
8449244|NCT00763451|20823031|P1|STARTED|Overall Study|Randomized.|80
8449245|NCT00763412|20823065|P2|NOT COMPLETED|Overall Study||4
8449246|NCT00763412|20823066|P1|NOT COMPLETED|Overall Study||4
8449247|NCT00763412|20823065|P2|COMPLETED|Overall Study||4
8449248|NCT00763412|20823066|P1|COMPLETED|Overall Study||4
8449249|NCT00763412|20823065|P2|STARTED|Overall Study||8
8449250|NCT00763412|20823066|P1|STARTED|Overall Study||8
8449251|NCT00763386|20823090|P2|NOT COMPLETED|Overall Study||40
8449252|NCT00763386|20823091|P1|NOT COMPLETED|Overall Study||48
8449253|NCT00763386|20823090|P2|COMPLETED|Overall Study||127
8449254|NCT00763386|20823091|P1|COMPLETED|Overall Study||116
8449255|NCT00763386|20823090|P2|STARTED|Overall Study||167
8449256|NCT00763386|20823091|P1|STARTED|Overall Study||164
8449257|NCT00763360|20823102|P3|NOT COMPLETED|Overall Study||0
8449258|NCT00763360|20823103|P2|NOT COMPLETED|Overall Study||2
8449259|NCT00763360|20823104|P1|NOT COMPLETED|Overall Study||0
8449260|NCT00763360|20823102|P3|COMPLETED|Overall Study||63
8449261|NCT00763360|20823103|P2|COMPLETED|Overall Study||58
8449262|NCT00763360|20823104|P1|COMPLETED|Overall Study||61
8449263|NCT00763360|20823102|P3|STARTED|Overall Study||63
8449264|NCT00763360|20823103|P2|STARTED|Overall Study||60
8449265|NCT00763360|20823104|P1|STARTED|Overall Study||61
8449266|NCT00763321|20823124|P3|NOT COMPLETED|Double-blind Period||29
8449267|NCT00763321|20823125|P2|NOT COMPLETED|Double-blind Period||21
8449268|NCT00763321|20823126|P1|NOT COMPLETED|Double-blind Period||0
8449269|NCT00763321|20823124|P3|COMPLETED|Double-blind Period||84
8449270|NCT00763321|20823125|P2|COMPLETED|Double-blind Period||88
8449271|NCT00763321|20823126|P1|COMPLETED|Double-blind Period||0
8449272|NCT00763321|20823124|P3|STARTED|Double-blind Period||113
8449273|NCT00763321|20823125|P2|STARTED|Double-blind Period||109
8449274|NCT00763321|20823126|P1|STARTED|Double-blind Period||0
8449275|NCT00763321|20823124|P3|NOT COMPLETED|Open-label Period||0
8449276|NCT00763321|20823125|P2|NOT COMPLETED|Open-label Period||0
8449277|NCT00763321|20823126|P1|NOT COMPLETED|Open-label Period||63
8449278|NCT00763321|20823124|P3|COMPLETED|Open-label Period||0
8449279|NCT00763321|20823125|P2|COMPLETED|Open-label Period||0
8449280|NCT00763321|20823126|P1|COMPLETED|Open-label Period||222
8449281|NCT00763321|20823124|P3|STARTED|Open-label Period||0
8449282|NCT00763321|20823125|P2|STARTED|Open-label Period||0
8449283|NCT00763321|20823126|P1|STARTED|Open-label Period||285
8449284|NCT00763282|20823137|P2|NOT COMPLETED|Overall Study||34
8449285|NCT00763282|20823138|P1|NOT COMPLETED|Overall Study||32
8449286|NCT00763282|20823137|P2|COMPLETED|Overall Study||38
8449287|NCT00763282|20823138|P1|COMPLETED|Overall Study||40
8449288|NCT00763282|20823137|P2|STARTED|Overall Study||72
8449289|NCT00763282|20823138|P1|STARTED|Overall Study||72
8449290|NCT00763269|20823154|P2|NOT COMPLETED|Overall Study||13
8449291|NCT00763269|20823155|P1|NOT COMPLETED|Overall Study||12
8449292|NCT00763269|20823154|P2|COMPLETED|Overall Study||299
8449293|NCT00763269|20823155|P1|COMPLETED|Overall Study||302
8449294|NCT00763269|20823154|P2|STARTED|Overall Study||312
8449295|NCT00763269|20823155|P1|STARTED|Overall Study||314
8449296|NCT00763256|20823169|P2|NOT COMPLETED|Overall Study||10
8449297|NCT00763256|20823170|P1|NOT COMPLETED|Overall Study||7
8449298|NCT00763256|20823169|P2|COMPLETED|Overall Study||8
8449299|NCT00763256|20823170|P1|COMPLETED|Overall Study||8
8449300|NCT00763256|20823169|P2|STARTED|Overall Study||18
8449301|NCT00763256|20823170|P1|STARTED|Overall Study||15
8449302|NCT00763243|20823184|P1|NOT COMPLETED|6-Month Follow-Up Period||0
8449303|NCT00763243|20823184|P1|COMPLETED|6-Month Follow-Up Period||9
8449304|NCT00763243|20823184|P1|STARTED|6-Month Follow-Up Period||9
8449305|NCT00763243|20823184|P1|NOT COMPLETED|1-Month Follow-Up Period||0
8449306|NCT00763243|20823184|P1|COMPLETED|1-Month Follow-Up Period||9
8449307|NCT00763243|20823184|P1|STARTED|1-Month Follow-Up Period||9
8449308|NCT00763243|20823184|P1|NOT COMPLETED|Training Period||0
8449309|NCT00763243|20823184|P1|COMPLETED|Training Period||9
8449310|NCT00763243|20823184|P1|STARTED|Training Period||9
8449311|NCT00763243|20823184|P1|NOT COMPLETED|Waiting Period||0
8449312|NCT00763243|20823184|P1|COMPLETED|Waiting Period||9
8449313|NCT00763243|20823184|P1|STARTED|Waiting Period||9
8449314|NCT00763139|20823206|P2|NOT COMPLETED|Overall Study||3
8449315|NCT00763139|20823207|P1|NOT COMPLETED|Overall Study||5
8449316|NCT00763139|20823206|P2|COMPLETED|Overall Study||14
8449317|NCT00763139|20823207|P1|COMPLETED|Overall Study||12
8449318|NCT00763139|20823206|P2|STARTED|Overall Study||17
8449319|NCT00763139|20823207|P1|STARTED|Overall Study||17
8449320|NCT00763061|20823229|P2|NOT COMPLETED|Overall Study||13
8449321|NCT00763061|20823230|P1|NOT COMPLETED|Overall Study||5
8449322|NCT00763061|20823229|P2|COMPLETED|Overall Study||44
8449323|NCT00763061|20823230|P1|COMPLETED|Overall Study||49
8449324|NCT00763061|20823229|P2|STARTED|Overall Study||57
8449325|NCT00763061|20823230|P1|STARTED|Overall Study||54
8449326|NCT00763048|20823244|P2|NOT COMPLETED|Overall Study||0
8449327|NCT00763048|20823245|P1|NOT COMPLETED|Overall Study||0
8449328|NCT00763048|20823244|P2|COMPLETED|Overall Study||18
8449329|NCT00763048|20823245|P1|COMPLETED|Overall Study||21
8449330|NCT00763048|20823244|P2|STARTED|Overall Study||18
8449331|NCT00763048|20823245|P1|STARTED|Overall Study||21
8449332|NCT00763035|20823269|P2|NOT COMPLETED|Second Intervention||0
8449333|NCT00763035|20823270|P1|NOT COMPLETED|Second Intervention||3
8449334|NCT00763035|20823269|P2|COMPLETED|Second Intervention||3
8449335|NCT00763035|20823270|P1|COMPLETED|Second Intervention||6
8449336|NCT00763035|20823269|P2|STARTED|Second Intervention||3
8449337|NCT00763035|20823270|P1|STARTED|Second Intervention||9
8449338|NCT00763035|20823269|P2|NOT COMPLETED|First Intervention||1
8449339|NCT00763035|20823270|P1|NOT COMPLETED|First Intervention||1
8449340|NCT00763035|20823269|P2|COMPLETED|First Intervention||3
8449341|NCT00763035|20823270|P1|COMPLETED|First Intervention||9
8449342|NCT00763035|20823269|P2|STARTED|First Intervention||4
8449343|NCT00763035|20823270|P1|STARTED|First Intervention||10
8449344|NCT00763009|20823288|P1|NOT COMPLETED|Overall Study||1
8449345|NCT00763009|20823288|P1|COMPLETED|Overall Study||7
8449346|NCT00763009|20823288|P1|STARTED|Overall Study||8
8449347|NCT00762996|20823293|P4|NOT COMPLETED|Period Two||0
8449348|NCT00762996|20823294|P3|NOT COMPLETED|Period Two||0
8449349|NCT00762996|20823295|P2|NOT COMPLETED|Period Two||0
8449350|NCT00762996|20823296|P1|NOT COMPLETED|Period Two||0
8449351|NCT00762996|20823293|P4|COMPLETED|Period Two||16
8449352|NCT00762996|20823294|P3|COMPLETED|Period Two||13
8449353|NCT00762996|20823295|P2|COMPLETED|Period Two||16
8449354|NCT00762996|20823296|P1|COMPLETED|Period Two||15
8449355|NCT00762996|20823293|P4|STARTED|Period Two||16
8449356|NCT00762996|20823294|P3|STARTED|Period Two||13
8449357|NCT00762996|20823295|P2|STARTED|Period Two||16
8449358|NCT00762996|20823296|P1|STARTED|Period Two||15
8449359|NCT00762996|20823293|P4|NOT COMPLETED|Period One||1
8449360|NCT00762996|20823294|P3|NOT COMPLETED|Period One||4
8449361|NCT00762996|20823295|P2|NOT COMPLETED|Period One||0
8449362|NCT00762996|20823296|P1|NOT COMPLETED|Period One||0
8449363|NCT00762996|20823293|P4|COMPLETED|Period One||16
8449364|NCT00762996|20823294|P3|COMPLETED|Period One||13
8449365|NCT00762996|20823295|P2|COMPLETED|Period One||16
8449366|NCT00762996|20823296|P1|COMPLETED|Period One||15
8449367|NCT00762996|20823293|P4|STARTED|Period One||17
8449368|NCT00762996|20823294|P3|STARTED|Period One||17
8449369|NCT00762996|20823295|P2|STARTED|Period One||16
8449370|NCT00762996|20823296|P1|STARTED|Period One||15
8449371|NCT00762970|20823309|P3|NOT COMPLETED|Overall Study||1
8449372|NCT00762970|20823310|P2|NOT COMPLETED|Overall Study||9
8449373|NCT00762970|20823311|P1|NOT COMPLETED|Overall Study||12
8449374|NCT00762970|20823309|P3|COMPLETED|Overall Study||46
8449375|NCT00762970|20823310|P2|COMPLETED|Overall Study||35
8449376|NCT00762970|20823311|P1|COMPLETED|Overall Study||34
8449377|NCT00762970|20823309|P3|STARTED|Overall Study||47
8449378|NCT00762970|20823310|P2|STARTED|Overall Study||44
8449379|NCT00762970|20823311|P1|STARTED|Overall Study||46
8449380|NCT00762931|20823322|P1|NOT COMPLETED|Overall Study||2
8449381|NCT00762931|20823322|P1|COMPLETED|Overall Study||23
8449382|NCT00762931|20823322|P1|STARTED|Overall Study||25
8449383|NCT00762892|20823329|P2|NOT COMPLETED|Overall Study||6
8449384|NCT00762892|20823330|P1|NOT COMPLETED|Overall Study||5
8449385|NCT00762892|20823329|P2|COMPLETED|Overall Study||8
8449386|NCT00762892|20823330|P1|COMPLETED|Overall Study||9
8449387|NCT00762892|20823329|P2|STARTED|Overall Study||14
8449388|NCT00762892|20823330|P1|STARTED|Overall Study||14
8449389|NCT00762853|20823346|P2|NOT COMPLETED|Second Treatment Period||0
8449390|NCT00762853|20823347|P1|NOT COMPLETED|Second Treatment Period||0
8449391|NCT00762853|20823346|P2|COMPLETED|Second Treatment Period||10
8449392|NCT00762853|20823347|P1|COMPLETED|Second Treatment Period||10
8449393|NCT00762853|20823346|P2|STARTED|Second Treatment Period||10
8449394|NCT00762853|20823347|P1|STARTED|Second Treatment Period||10
8449395|NCT00762853|20823346|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
8449396|NCT00762853|20823347|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
8449397|NCT00762853|20823346|P2|COMPLETED|1 Week Washout After Treatment 1||10
8449398|NCT00762853|20823347|P1|COMPLETED|1 Week Washout After Treatment 1||10
8449399|NCT00762853|20823346|P2|STARTED|1 Week Washout After Treatment 1||10
8449400|NCT00762853|20823347|P1|STARTED|1 Week Washout After Treatment 1||10
8449401|NCT00762853|20823346|P2|NOT COMPLETED|First Treatment Period||0
8449402|NCT00762853|20823347|P1|NOT COMPLETED|First Treatment Period||0
8449403|NCT00762853|20823346|P2|COMPLETED|First Treatment Period||10
8449404|NCT00762853|20823347|P1|COMPLETED|First Treatment Period||10
8449405|NCT00762853|20823346|P2|STARTED|First Treatment Period||10
8449406|NCT00762853|20823347|P1|STARTED|First Treatment Period||10
8449407|NCT00762788|20823359|P6|NOT COMPLETED|Overall Study||21
8449408|NCT00762788|20823360|P5|NOT COMPLETED|Overall Study||13
8449409|NCT00762788|20823361|P4|NOT COMPLETED|Overall Study||26
8449410|NCT00762788|20823362|P3|NOT COMPLETED|Overall Study||21
8449411|NCT00762788|20823363|P2|NOT COMPLETED|Overall Study||37
8449412|NCT00762788|20823364|P1|NOT COMPLETED|Overall Study||26
8449413|NCT00762788|20823359|P6|COMPLETED|Overall Study||31
8449414|NCT00762788|20823360|P5|COMPLETED|Overall Study||30
8449415|NCT00762788|20823361|P4|COMPLETED|Overall Study||38
8449416|NCT00762788|20823362|P3|COMPLETED|Overall Study||21
8449417|NCT00762788|20823363|P2|COMPLETED|Overall Study||21
8449418|NCT00762788|20823364|P1|COMPLETED|Overall Study||29
8449419|NCT00762788|20823359|P6|STARTED|Overall Study||52
8449420|NCT00762788|20823360|P5|STARTED|Overall Study||43
8449421|NCT00762788|20823361|P4|STARTED|Overall Study||64
8449422|NCT00762788|20823362|P3|STARTED|Overall Study||42
8449423|NCT00762788|20823363|P2|STARTED|Overall Study||58
8449424|NCT00762788|20823364|P1|STARTED|Overall Study||55
8449425|NCT00762762|20823386|P2|NOT COMPLETED|Overall Study||10
8449426|NCT00762762|20823387|P1|NOT COMPLETED|Overall Study||8
8449427|NCT00762762|20823386|P2|COMPLETED|Overall Study||20
8449428|NCT00762762|20823387|P1|COMPLETED|Overall Study||22
8449429|NCT00762762|20823386|P2|STARTED|Overall Study||30
8449430|NCT00762762|20823387|P1|STARTED|Overall Study||30
8449431|NCT00762723|20823404|P3|NOT COMPLETED|Overall Study||3
8449432|NCT00762723|20823405|P2|NOT COMPLETED|Overall Study||5
8449433|NCT00762723|20823406|P1|NOT COMPLETED|Overall Study||5
8449434|NCT00762723|20823404|P3|COMPLETED|Overall Study||0
8449435|NCT00762723|20823405|P2|COMPLETED|Overall Study||6
8449436|NCT00762723|20823406|P1|COMPLETED|Overall Study||0
8449437|NCT00762723|20823404|P3|STARTED|Overall Study||3
8449438|NCT00762723|20823405|P2|STARTED|Overall Study||11
8449439|NCT00762723|20823406|P1|STARTED|Overall Study||5
8449440|NCT00762710|20823416|P2|NOT COMPLETED|Overall Study||15
8449441|NCT00762710|20823417|P1|NOT COMPLETED|Overall Study||21
8449442|NCT00762710|20823416|P2|COMPLETED|Overall Study||29
8449443|NCT00762710|20823417|P1|COMPLETED|Overall Study||27
8449444|NCT00762710|20823416|P2|STARTED|Overall Study||44
8449445|NCT00762710|20823417|P1|STARTED|Overall Study||48
8449446|NCT00762645|20823425|P2|NOT COMPLETED|Overall Study||2
8449447|NCT00762645|20823426|P1|NOT COMPLETED|Overall Study||4
8449448|NCT00762645|20823425|P2|COMPLETED|Overall Study||12
8449449|NCT00762645|20823426|P1|COMPLETED|Overall Study||12
8449450|NCT00762645|20823425|P2|STARTED|Overall Study||14
8449451|NCT00762645|20823426|P1|STARTED|Overall Study||16
8449452|NCT00762619|20823436|P2|NOT COMPLETED|Overall Study||0
8449453|NCT00762619|20823437|P1|NOT COMPLETED|Overall Study||0
8449454|NCT00762619|20823436|P2|COMPLETED|Overall Study||50
8449455|NCT00762619|20823437|P1|COMPLETED|Overall Study||55
8449456|NCT00762619|20823436|P2|STARTED|Overall Study||50
8449457|NCT00762619|20823437|P1|STARTED|Overall Study||55
8449458|NCT00762606|20823579|P2|NOT COMPLETED|Overall Study||13
8449459|NCT00762606|20823580|P1|NOT COMPLETED|Overall Study||18
8449460|NCT00762606|20823579|P2|COMPLETED|Overall Study||38
8449461|NCT00762606|20823580|P1|COMPLETED|Overall Study||37
8449462|NCT00762606|20823579|P2|STARTED|Overall Study||51
8449463|NCT00762606|20823580|P1|STARTED|Overall Study||55
8449464|NCT00762528|20823590|P2|NOT COMPLETED|Overall Study||0
8449465|NCT00762528|20823591|P1|NOT COMPLETED|Overall Study||0
8449466|NCT00762528|20823590|P2|COMPLETED|Overall Study||25
8449467|NCT00762528|20823591|P1|COMPLETED|Overall Study||24
8449468|NCT00762528|20823590|P2|STARTED|Overall Study||25
8449469|NCT00762528|20823591|P1|STARTED|Overall Study||24
8449470|NCT00762515|20823613|P2|NOT COMPLETED|Overall Study||0
8449471|NCT00762515|20823614|P1|NOT COMPLETED|Overall Study||0
8449472|NCT00762515|20823613|P2|COMPLETED|Overall Study||22
8449473|NCT00762515|20823614|P1|COMPLETED|Overall Study||22
8449474|NCT00762515|20823613|P2|STARTED|Overall Study||22
8449475|NCT00762515|20823614|P1|STARTED|Overall Study||22
8449476|NCT00762502|20823625|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
8449477|NCT00762502|20823626|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
8449478|NCT00762502|20823627|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
8449479|NCT00762502|20823625|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
8449480|NCT00762502|20823626|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
8449481|NCT00762502|20823627|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
8449482|NCT00762502|20823625|P3|STARTED|Month 3 to Month 6 (Period 2)||23
8449483|NCT00762502|20823626|P2|STARTED|Month 3 to Month 6 (Period 2)||5
8449484|NCT00762502|20823627|P1|STARTED|Month 3 to Month 6 (Period 2)||9
8449485|NCT00762502|20823625|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
8449486|NCT00762502|20823626|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
8449487|NCT00762502|20823627|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
8449488|NCT00762502|20823625|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
8449489|NCT00762502|20823626|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
8449490|NCT00762502|20823627|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
8449491|NCT00762502|20823625|P3|STARTED|Baseline to Month 3 (Period 1)||51
8449492|NCT00762502|20823626|P2|STARTED|Baseline to Month 3 (Period 1)||25
8449493|NCT00762502|20823627|P1|STARTED|Baseline to Month 3 (Period 1)||36
8449494|NCT00762476|20823641|P2|NOT COMPLETED|Overall Study||36
8449495|NCT00762476|20823642|P1|NOT COMPLETED|Overall Study||23
8449496|NCT00762476|20823641|P2|COMPLETED|Overall Study||169
8449497|NCT00762476|20823642|P1|COMPLETED|Overall Study||183
8449498|NCT00762476|20823641|P2|STARTED|Overall Study||205
8449499|NCT00762476|20823642|P1|STARTED|Overall Study||206
8449536|NCT00762450|20823742|P3|NOT COMPLETED|3rd Treatment Period||0
8449537|NCT00762450|20823743|P2|NOT COMPLETED|3rd Treatment Period||0
8449538|NCT00762450|20823744|P1|NOT COMPLETED|3rd Treatment Period||0
8449539|NCT00762450|20823742|P3|COMPLETED|3rd Treatment Period||2
8449540|NCT00762450|20823743|P2|COMPLETED|3rd Treatment Period||2
8449541|NCT00762450|20823744|P1|COMPLETED|3rd Treatment Period||2
8449542|NCT00762450|20823742|P3|STARTED|3rd Treatment Period||2
8449543|NCT00762450|20823743|P2|STARTED|3rd Treatment Period||2
8449544|NCT00762450|20823744|P1|STARTED|3rd Treatment Period||2
8449545|NCT00762450|20823742|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
8449546|NCT00762450|20823743|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
8449547|NCT00762450|20823744|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
8449548|NCT00762450|20823742|P3|COMPLETED|Washout After 2nd Treatment Period||2
8449549|NCT00762450|20823743|P2|COMPLETED|Washout After 2nd Treatment Period||2
8449550|NCT00762450|20823744|P1|COMPLETED|Washout After 2nd Treatment Period||2
8449551|NCT00762450|20823742|P3|STARTED|Washout After 2nd Treatment Period||2
8449552|NCT00762450|20823743|P2|STARTED|Washout After 2nd Treatment Period||2
8449553|NCT00762450|20823744|P1|STARTED|Washout After 2nd Treatment Period||2
8449554|NCT00762450|20823742|P3|NOT COMPLETED|2nd Treatment Period||0
8449555|NCT00762450|20823743|P2|NOT COMPLETED|2nd Treatment Period||0
8449556|NCT00762450|20823744|P1|NOT COMPLETED|2nd Treatment Period||0
8449557|NCT00762450|20823742|P3|COMPLETED|2nd Treatment Period||2
8449558|NCT00762450|20823743|P2|COMPLETED|2nd Treatment Period||2
8449559|NCT00762450|20823744|P1|COMPLETED|2nd Treatment Period||2
8449560|NCT00762450|20823742|P3|STARTED|2nd Treatment Period||2
8449561|NCT00762450|20823743|P2|STARTED|2nd Treatment Period||2
8449562|NCT00762450|20823744|P1|STARTED|2nd Treatment Period||2
8449563|NCT00762450|20823742|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
8449564|NCT00762450|20823743|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
8449565|NCT00762450|20823744|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
8449566|NCT00762450|20823742|P3|COMPLETED|Washout After 1st Treatment Period||2
8449567|NCT00762450|20823743|P2|COMPLETED|Washout After 1st Treatment Period||2
8449568|NCT00762450|20823744|P1|COMPLETED|Washout After 1st Treatment Period||2
8449569|NCT00762450|20823742|P3|STARTED|Washout After 1st Treatment Period||2
8449570|NCT00762450|20823743|P2|STARTED|Washout After 1st Treatment Period||2
8449571|NCT00762450|20823744|P1|STARTED|Washout After 1st Treatment Period||2
8449572|NCT00762450|20823742|P3|NOT COMPLETED|1st Treatment Period||0
8449573|NCT00762450|20823743|P2|NOT COMPLETED|1st Treatment Period||0
8449574|NCT00762450|20823744|P1|NOT COMPLETED|1st Treatment Period||0
8449575|NCT00762450|20823742|P3|COMPLETED|1st Treatment Period||2
8449576|NCT00762450|20823743|P2|COMPLETED|1st Treatment Period||2
8449577|NCT00762450|20823744|P1|COMPLETED|1st Treatment Period||2
8449578|NCT00762450|20823742|P3|STARTED|1st Treatment Period||2
8449579|NCT00762450|20823743|P2|STARTED|1st Treatment Period||2
8449580|NCT00762450|20823744|P1|STARTED|1st Treatment Period||2
8449581|NCT00762424|20823754|P2|NOT COMPLETED|Overall Study||0
8449582|NCT00762424|20823755|P1|NOT COMPLETED|Overall Study||0
8449583|NCT00762424|20823754|P2|COMPLETED|Overall Study||25
8449584|NCT00762424|20823755|P1|COMPLETED|Overall Study||28
8449585|NCT00762424|20823754|P2|STARTED|Overall Study||25
8449586|NCT00762424|20823755|P1|STARTED|Overall Study||28
8449587|NCT00762411|20823763|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
8449588|NCT00762411|20823764|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
8449589|NCT00762411|20823763|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
8449590|NCT00762411|20823764|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
8449591|NCT00762411|20823763|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
8449592|NCT00762411|20823764|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
8449593|NCT00762411|20823763|P2|NOT COMPLETED|Delayed Start||26
8449594|NCT00762411|20823764|P1|NOT COMPLETED|Delayed Start||17
8449595|NCT00762411|20823763|P2|COMPLETED|Delayed Start||8
8449596|NCT00762411|20823764|P1|COMPLETED|Delayed Start||5
8449597|NCT00762411|20823763|P2|STARTED|Delayed Start||34
8449598|NCT00762411|20823764|P1|STARTED|Delayed Start||22
8449599|NCT00762411|20823763|P2|NOT COMPLETED|Initial Treatment||521
8449600|NCT00762411|20823764|P1|NOT COMPLETED|Initial Treatment||534
8449601|NCT00762411|20823763|P2|COMPLETED|Initial Treatment||34
8449602|NCT00762411|20823764|P1|COMPLETED|Initial Treatment||22
8449603|NCT00762411|20823763|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
8449604|NCT00762411|20823764|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
8449605|NCT00762411|20823763|P2|STARTED|Initial Treatment||555
8449606|NCT00762411|20823764|P1|STARTED|Initial Treatment||556
8449607|NCT00762385|20823828|P2|NOT COMPLETED|Second Intervention||3
8449608|NCT00762385|20823829|P1|NOT COMPLETED|Second Intervention||3
8449609|NCT00762385|20823828|P2|COMPLETED|Second Intervention||39
8449610|NCT00762385|20823829|P1|COMPLETED|Second Intervention||46
8449611|NCT00762385|20823828|P2|STARTED|Second Intervention||42
8449612|NCT00762385|20823829|P1|STARTED|Second Intervention||49
8449613|NCT00762385|20823828|P2|NOT COMPLETED|First Intervention||4
8449614|NCT00762385|20823829|P1|NOT COMPLETED|First Intervention||2
8449615|NCT00762385|20823828|P2|COMPLETED|First Intervention||42
8449616|NCT00762385|20823829|P1|COMPLETED|First Intervention||49
8449617|NCT00762385|20823828|P2|STARTED|First Intervention||46
8449618|NCT00762385|20823829|P1|STARTED|First Intervention||51
8449619|NCT00762372|20823842|P3|NOT COMPLETED|Overall Study||0
8449620|NCT00762372|20823843|P2|NOT COMPLETED|Overall Study||0
8449621|NCT00762372|20823844|P1|NOT COMPLETED|Overall Study||1
8449622|NCT00762372|20823842|P3|COMPLETED|Overall Study||50
8449623|NCT00762372|20823843|P2|COMPLETED|Overall Study||55
8449624|NCT00762372|20823844|P1|COMPLETED|Overall Study||110
8449625|NCT00762372|20823842|P3|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
8449626|NCT00762372|20823843|P2|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
8449627|NCT00762372|20823844|P1|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
8449628|NCT00762359|20823920|P2|NOT COMPLETED|Overall Study||57
8449629|NCT00762359|20823921|P1|NOT COMPLETED|Overall Study||59
8449630|NCT00762359|20823920|P2|COMPLETED|Overall Study||178
8449631|NCT00762359|20823921|P1|COMPLETED|Overall Study||167
8449632|NCT00762359|20823920|P2|STARTED|Overall Study||235
8449633|NCT00762359|20823921|P1|STARTED|Overall Study||226
8449634|NCT00762320|20824021|P1|NOT COMPLETED|Overall Study||0
8449635|NCT00762320|20824021|P1|COMPLETED|Overall Study||8
8449636|NCT00762320|20824021|P1|STARTED|Overall Study||8
8449637|NCT00762268|20824038|P2|NOT COMPLETED|Overall Study||3
8449638|NCT00762268|20824039|P1|NOT COMPLETED|Overall Study||3
8449639|NCT00762268|20824038|P2|COMPLETED|Overall Study||8
8449640|NCT00762268|20824039|P1|COMPLETED|Overall Study||9
8449641|NCT00762268|20824038|P2|STARTED|Overall Study||11
8449642|NCT00762268|20824039|P1|STARTED|Overall Study||12
8449643|NCT00762229|20824051|P2|NOT COMPLETED|Overall Study||2
8449644|NCT00762229|20824052|P1|NOT COMPLETED|Overall Study||1
8449645|NCT00762229|20824051|P2|COMPLETED|Overall Study||22
8449646|NCT00762229|20824052|P1|COMPLETED|Overall Study||14
8449647|NCT00762229|20824051|P2|STARTED|Overall Study||24
8449648|NCT00762229|20824052|P1|STARTED|Overall Study||15
8449649|NCT00762216|20824060|P1|NOT COMPLETED|Overall Study||0
8449650|NCT00762216|20824060|P1|COMPLETED|Overall Study||71
8449651|NCT00762216|20824060|P1|STARTED|Overall Study||71
8449652|NCT00762177|20824068|P3|NOT COMPLETED|3rd Treatment Period||0
8449653|NCT00762177|20824069|P2|NOT COMPLETED|3rd Treatment Period||0
8449654|NCT00762177|20824070|P1|NOT COMPLETED|3rd Treatment Period||0
8449655|NCT00762177|20824068|P3|COMPLETED|3rd Treatment Period||8
8449656|NCT00762177|20824069|P2|COMPLETED|3rd Treatment Period||8
8449657|NCT00762177|20824070|P1|COMPLETED|3rd Treatment Period||8
8449658|NCT00762177|20824068|P3|STARTED|3rd Treatment Period||8
8449659|NCT00762177|20824069|P2|STARTED|3rd Treatment Period||8
8449660|NCT00762177|20824070|P1|STARTED|3rd Treatment Period||8
8449661|NCT00762177|20824068|P3|NOT COMPLETED|Washout After 2nd Treatment||0
8449662|NCT00762177|20824069|P2|NOT COMPLETED|Washout After 2nd Treatment||0
8449663|NCT00762177|20824070|P1|NOT COMPLETED|Washout After 2nd Treatment||0
8449664|NCT00762177|20824068|P3|COMPLETED|Washout After 2nd Treatment||8
8449665|NCT00762177|20824069|P2|COMPLETED|Washout After 2nd Treatment||8
8449666|NCT00762177|20824070|P1|COMPLETED|Washout After 2nd Treatment||8
8449667|NCT00762177|20824068|P3|STARTED|Washout After 2nd Treatment||8
8449668|NCT00762177|20824069|P2|STARTED|Washout After 2nd Treatment||8
8449669|NCT00762177|20824070|P1|STARTED|Washout After 2nd Treatment||8
8449670|NCT00762177|20824068|P3|NOT COMPLETED|2nd Treatment Period||0
8449671|NCT00762177|20824069|P2|NOT COMPLETED|2nd Treatment Period||0
8449672|NCT00762177|20824070|P1|NOT COMPLETED|2nd Treatment Period||0
8449673|NCT00762177|20824068|P3|COMPLETED|2nd Treatment Period||8
8449674|NCT00762177|20824069|P2|COMPLETED|2nd Treatment Period||8
8449675|NCT00762177|20824070|P1|COMPLETED|2nd Treatment Period||8
8449676|NCT00762177|20824068|P3|STARTED|2nd Treatment Period||8
8449677|NCT00762177|20824069|P2|STARTED|2nd Treatment Period||8
8449678|NCT00762177|20824070|P1|STARTED|2nd Treatment Period||8
8449679|NCT00762177|20824068|P3|NOT COMPLETED|Washout After 1st Treatment||0
8449680|NCT00762177|20824069|P2|NOT COMPLETED|Washout After 1st Treatment||0
8449681|NCT00762177|20824070|P1|NOT COMPLETED|Washout After 1st Treatment||0
8449682|NCT00762177|20824068|P3|COMPLETED|Washout After 1st Treatment||8
8449683|NCT00762177|20824069|P2|COMPLETED|Washout After 1st Treatment||8
8449684|NCT00762177|20824070|P1|COMPLETED|Washout After 1st Treatment||8
8449685|NCT00762177|20824068|P3|STARTED|Washout After 1st Treatment||8
8449686|NCT00762177|20824069|P2|STARTED|Washout After 1st Treatment||8
8449687|NCT00762177|20824070|P1|STARTED|Washout After 1st Treatment||8
8449688|NCT00762177|20824068|P3|NOT COMPLETED|1st Treatment Period||0
8449689|NCT00762177|20824069|P2|NOT COMPLETED|1st Treatment Period||0
8449690|NCT00762177|20824070|P1|NOT COMPLETED|1st Treatment Period||0
8449691|NCT00762177|20824068|P3|COMPLETED|1st Treatment Period||8
8449692|NCT00762177|20824069|P2|COMPLETED|1st Treatment Period||8
8449693|NCT00762177|20824070|P1|COMPLETED|1st Treatment Period||8
8449694|NCT00762177|20824068|P3|STARTED|1st Treatment Period||8
8449695|NCT00762177|20824069|P2|STARTED|1st Treatment Period||8
8449696|NCT00762177|20824070|P1|STARTED|1st Treatment Period||8
8449697|NCT00762164|20824149|P2|NOT COMPLETED|Overall Study||2
8449698|NCT00762164|20824150|P1|NOT COMPLETED|Overall Study||3
8449699|NCT00762164|20824149|P2|COMPLETED|Overall Study||15
8449700|NCT00762164|20824150|P1|COMPLETED|Overall Study||14
8449701|NCT00762164|20824149|P2|STARTED|Overall Study||17
8449702|NCT00762164|20824150|P1|STARTED|Overall Study||17
8449703|NCT00762086|20824160|P2|NOT COMPLETED|Overall Study||4
8449704|NCT00762086|20824161|P1|NOT COMPLETED|Overall Study||6
8449705|NCT00762086|20824160|P2|COMPLETED|Overall Study||24
8449706|NCT00762086|20824161|P1|COMPLETED|Overall Study||33
8449707|NCT00762086|20824160|P2|STARTED|Overall Study||28
8449708|NCT00762086|20824161|P1|STARTED|Overall Study||39
8449709|NCT00762073|20824171|P4|NOT COMPLETED|Overall Study||3
8449710|NCT00762073|20824172|P3|NOT COMPLETED|Overall Study||2
8449711|NCT00762073|20824173|P2|NOT COMPLETED|Overall Study||4
8449712|NCT00762073|20824174|P1|NOT COMPLETED|Overall Study||4
8449713|NCT00762073|20824171|P4|COMPLETED|Overall Study||17
8449714|NCT00762073|20824172|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
8449715|NCT00762073|20824173|P2|COMPLETED|Overall Study||17
8449716|NCT00762073|20824174|P1|COMPLETED|Overall Study||17
8449717|NCT00762073|20824171|P4|STARTED|Overall Study||20
8449718|NCT00762073|20824172|P3|STARTED|Overall Study||20
8449719|NCT00762073|20824173|P2|STARTED|Overall Study||21
8449720|NCT00762073|20824174|P1|STARTED|Overall Study||21
8449721|NCT00762034|20824238|P2|NOT COMPLETED|Maintenance Period||298
8449722|NCT00762034|20824239|P1|NOT COMPLETED|Maintenance Period||294
8449723|NCT00762034|20824238|P2|COMPLETED|Maintenance Period||0
8449724|NCT00762034|20824239|P1|COMPLETED|Maintenance Period||0
8449725|NCT00762034|20824238|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
8449726|NCT00762034|20824239|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
8449727|NCT00762034|20824238|P2|STARTED|Maintenance Period||298
8449728|NCT00762034|20824239|P1|STARTED|Maintenance Period||294
8449729|NCT00762034|20824238|P2|NOT COMPLETED|Induction Period||169
8449730|NCT00762034|20824239|P1|NOT COMPLETED|Induction Period||178
8449731|NCT00762034|20824238|P2|COMPLETED|Induction Period||298
8449732|NCT00762034|20824239|P1|COMPLETED|Induction Period||294
8449733|NCT00762034|20824238|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
8449734|NCT00762034|20824239|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
8449735|NCT00762034|20824238|P2|STARTED|Induction Period||467
8449736|NCT00762034|20824239|P1|STARTED|Induction Period||472
8449737|NCT00762021|20824298|P2|NOT COMPLETED|Overall Study||8
8449738|NCT00762021|20824299|P1|NOT COMPLETED|Overall Study||8
8449739|NCT00762021|20824298|P2|COMPLETED|Overall Study||44
8449740|NCT00762021|20824299|P1|COMPLETED|Overall Study||44
8449741|NCT00762021|20824298|P2|STARTED|Overall Study||52
8449742|NCT00762021|20824299|P1|STARTED|Overall Study||52
8449743|NCT00761969|20824311|P2|NOT COMPLETED|Overall Study||140
8449744|NCT00761969|20824312|P1|NOT COMPLETED|Overall Study||200
8449745|NCT00761969|20824311|P2|COMPLETED|Overall Study||573
8449746|NCT00761969|20824312|P1|COMPLETED|Overall Study||542
8449747|NCT00761969|20824311|P2|STARTED|Overall Study||713
8449748|NCT00761969|20824312|P1|STARTED|Overall Study||742
8449749|NCT00761956|20824322|P2|NOT COMPLETED|Overall Study||54
8449750|NCT00761956|20824323|P1|NOT COMPLETED|Overall Study||35
8449751|NCT00761956|20824322|P2|COMPLETED|Overall Study||48
8449752|NCT00761956|20824323|P1|COMPLETED|Overall Study||52
8449753|NCT00761956|20824322|P2|STARTED|Overall Study||102
8449754|NCT00761956|20824323|P1|STARTED|Overall Study||87
8449755|NCT00761930|20824334|P3|NOT COMPLETED|Overall Study||0
8449756|NCT00761930|20824335|P2|NOT COMPLETED|Overall Study||0
8449757|NCT00761930|20824336|P1|NOT COMPLETED|Overall Study||0
8449758|NCT00761930|20824334|P3|COMPLETED|Overall Study||35
8449759|NCT00761930|20824335|P2|COMPLETED|Overall Study||34
8449760|NCT00761930|20824336|P1|COMPLETED|Overall Study||34
8449761|NCT00761930|20824334|P3|STARTED|Overall Study||35
8449762|NCT00761930|20824335|P2|STARTED|Overall Study||34
8449763|NCT00761930|20824336|P1|STARTED|Overall Study||34
8449764|NCT00761891|20824350|P1|NOT COMPLETED|Overall Study||10
8449765|NCT00761891|20824350|P1|COMPLETED|Overall Study||54
8449766|NCT00761891|20824350|P1|STARTED|Overall Study||64
8449767|NCT00761865|20824357|P2|NOT COMPLETED|Overall Study||7
8449768|NCT00761865|20824358|P1|NOT COMPLETED|Overall Study||8
8449769|NCT00761865|20824357|P2|COMPLETED|Overall Study||11
8449770|NCT00761865|20824358|P1|COMPLETED|Overall Study||8
8449771|NCT00761865|20824357|P2|STARTED|Overall Study||18
8449772|NCT00761865|20824358|P1|STARTED|Overall Study||16
8449773|NCT00761813|20824368|P2|NOT COMPLETED|Overall Study||14
8449774|NCT00761813|20824369|P1|NOT COMPLETED|Overall Study||15
8449775|NCT00761813|20824368|P2|COMPLETED|Overall Study||537
8449776|NCT00761813|20824369|P1|COMPLETED|Overall Study||542
8449777|NCT00761813|20824368|P2|STARTED|Overall Study||551
8449778|NCT00761813|20824369|P1|STARTED|Overall Study||557
8449779|NCT00761774|20824379|P1|NOT COMPLETED|Overall Study||79
8449780|NCT00761774|20824379|P1|COMPLETED|Overall Study||29
8449781|NCT00761774|20824379|P1|STARTED|Overall Study||108
8449782|NCT00761761|20824390|P2|NOT COMPLETED|Overall Study||1
8449783|NCT00761761|20824391|P1|NOT COMPLETED|Overall Study||6
8449784|NCT00761761|20824390|P2|COMPLETED|Overall Study||29
8449785|NCT00761761|20824391|P1|COMPLETED|Overall Study||24
8449786|NCT00761761|20824390|P2|STARTED|Overall Study||30
8449787|NCT00761761|20824391|P1|STARTED|Overall Study||30
8449788|NCT00761748|20824403|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
8449789|NCT00761748|20824404|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
8449790|NCT00761748|20824403|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
8449791|NCT00761748|20824404|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
8449792|NCT00761748|20824403|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
8449793|NCT00761748|20824404|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
8449794|NCT00761748|20824403|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
8449795|NCT00761748|20824404|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
8449796|NCT00761748|20824403|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
8449797|NCT00761748|20824404|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
8449798|NCT00761748|20824403|P2|STARTED|First Intervention (21 +/- 3 Days)||10
8449799|NCT00761748|20824404|P1|STARTED|First Intervention (21 +/- 3 Days)||20
8449800|NCT00761735|20824410|P1|NOT COMPLETED|Overall Study||14
8449801|NCT00761735|20824410|P1|COMPLETED|Overall Study||80
8449802|NCT00761735|20824410|P1|STARTED|Overall Study||94
8449803|NCT00761631|20824426|P6|NOT COMPLETED|Overall Study||5
8449804|NCT00761631|20824427|P5|NOT COMPLETED|Overall Study||22
8449805|NCT00761631|20824428|P4|NOT COMPLETED|Overall Study||3
8449806|NCT00761631|20824429|P3|NOT COMPLETED|Overall Study||16
8449807|NCT00761631|20824430|P2|NOT COMPLETED|Overall Study||7
8449808|NCT00761631|20824431|P1|NOT COMPLETED|Overall Study||15
8449809|NCT00761631|20824426|P6|COMPLETED|Overall Study||294
8449810|NCT00761631|20824427|P5|COMPLETED|Overall Study||277
8449811|NCT00761631|20824428|P4|COMPLETED|Overall Study||116
8449812|NCT00761631|20824429|P3|COMPLETED|Overall Study||160
8449813|NCT00761631|20824430|P2|COMPLETED|Overall Study||174
8449814|NCT00761631|20824431|P1|COMPLETED|Overall Study||111
8449815|NCT00761631|20824426|P6|Vaccinated Dose 2|Overall Study||0
8449816|NCT00761631|20824427|P5|Vaccinated Dose 2|Overall Study||0
8449817|NCT00761631|20824428|P4|Vaccinated Dose 2|Overall Study||0
8449818|NCT00761631|20824429|P3|Vaccinated Dose 2|Overall Study||165
8449819|NCT00761631|20824430|P2|Vaccinated Dose 2|Overall Study||0
8449820|NCT00761631|20824431|P1|Vaccinated Dose 2|Overall Study||112
8449821|NCT00761631|20824426|P6|Vaccinated Dose 1|Overall Study||298
8449822|NCT00761631|20824427|P5|Vaccinated Dose 1|Overall Study||294
8449823|NCT00761631|20824428|P4|Vaccinated Dose 1|Overall Study||118
8449824|NCT00761631|20824429|P3|Vaccinated Dose 1|Overall Study||175
8449825|NCT00761631|20824430|P2|Vaccinated Dose 1|Overall Study||179
8449826|NCT00761631|20824431|P1|Vaccinated Dose 1|Overall Study||124
8449827|NCT00761631|20824426|P6|STARTED|Overall Study||299
8449828|NCT00761631|20824427|P5|STARTED|Overall Study||299
8449829|NCT00761631|20824428|P4|STARTED|Overall Study||119
8449830|NCT00761631|20824429|P3|STARTED|Overall Study||176
8449831|NCT00761631|20824430|P2|STARTED|Overall Study||181
8449832|NCT00761631|20824431|P1|STARTED|Overall Study||126
8449833|NCT00761605|20824466|P1|NOT COMPLETED|Overall Study||141
8449834|NCT00761605|20824466|P1|COMPLETED|Overall Study||246
8449835|NCT00761605|20824466|P1|STARTED|Overall Study||387
8449836|NCT00761592|20824495|P2|NOT COMPLETED|Overall Study||1
8449837|NCT00761592|20824496|P1|NOT COMPLETED|Overall Study||1
8449838|NCT00761592|20824495|P2|COMPLETED|Overall Study||32
8449839|NCT00761592|20824496|P1|COMPLETED|Overall Study||31
8449840|NCT00761592|20824495|P2|STARTED|Overall Study||33
8449841|NCT00761592|20824496|P1|STARTED|Overall Study||32
8449842|NCT00761579|20824510|P1|NOT COMPLETED|Overall Study||92
8449843|NCT00761579|20824510|P1|COMPLETED|Overall Study||98
8449844|NCT00761579|20824510|P1|STARTED|Overall Study||190
8449845|NCT00761527|20824543|P1|NOT COMPLETED|Overall Study||22
8449846|NCT00761527|20824543|P1|COMPLETED|Overall Study||2958
8449847|NCT00761527|20824543|P1|Received One Dose of Study Medication|Overall Study||2978
8449848|NCT00761527|20824543|P1|STARTED|Overall Study||2980
8449849|NCT00761514|20824550|P1|NOT COMPLETED|Overall Study||7
8449850|NCT00761514|20824550|P1|COMPLETED|Overall Study||7
8449851|NCT00761514|20824550|P1|STARTED|Overall Study||14
8449852|NCT00761462|20824557|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
8449853|NCT00761462|20824558|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
8449854|NCT00761462|20824557|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
8449855|NCT00761462|20824558|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
8449856|NCT00761462|20824557|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
8449857|NCT00761462|20824558|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
8449858|NCT00761462|20824557|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
8449859|NCT00761462|20824558|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
8449860|NCT00761462|20824557|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
8449861|NCT00761462|20824558|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
8449862|NCT00761462|20824557|P2|NOT COMPLETED|Treatment||12
8449863|NCT00761462|20824558|P1|NOT COMPLETED|Treatment||23
8449864|NCT00761462|20824557|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
8449865|NCT00761462|20824558|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
8449866|NCT00761462|20824557|P2|STARTED|Treatment|Patients enrolled in study group|519
8449867|NCT00761462|20824558|P1|STARTED|Treatment|Patients enrolled in study group|510
8449868|NCT00761345|20824566|P1|NOT COMPLETED|Overall Study||3
8449869|NCT00761345|20824566|P1|COMPLETED|Overall Study||24
8449870|NCT00761345|20824566|P1|STARTED|Overall Study||27
8449871|NCT00761319|20824572|P2|NOT COMPLETED|Overall Study||34
8449872|NCT00761319|20824573|P1|NOT COMPLETED|Overall Study||48
8449873|NCT00761319|20824572|P2|COMPLETED|Overall Study||318
8449874|NCT00761319|20824573|P1|COMPLETED|Overall Study||305
8449875|NCT00761319|20824572|P2|STARTED|Overall Study||352
8449876|NCT00761319|20824573|P1|STARTED|Overall Study||353
8449877|NCT00761306|20824581|P1|NOT COMPLETED|Overall Study||20
8449878|NCT00761306|20824581|P1|COMPLETED|Overall Study||54
8449879|NCT00761306|20824581|P1|STARTED|Overall Study||74
8449880|NCT00761280|20824592|P2|NOT COMPLETED|First Dose to End of Study||11
8449881|NCT00761280|20824593|P1|NOT COMPLETED|First Dose to End of Study||12
8449882|NCT00761280|20824592|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
8449883|NCT00761280|20824593|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
8449884|NCT00761280|20824592|P2|STARTED|First Dose to End of Study||11
8449885|NCT00761280|20824593|P1|STARTED|First Dose to End of Study||12
8449886|NCT00761280|20824592|P2|NOT COMPLETED|Randomization to First Dose||2
8449887|NCT00761280|20824593|P1|NOT COMPLETED|Randomization to First Dose||2
8449888|NCT00761280|20824592|P2|COMPLETED|Randomization to First Dose||11
8449889|NCT00761280|20824593|P1|COMPLETED|Randomization to First Dose||12
8449890|NCT00761280|20824592|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
8449891|NCT00761280|20824593|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
8449892|NCT00761280|20824592|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
8449893|NCT00761280|20824593|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
8449894|NCT00761280|20824592|P2|STARTED|Randomization to First Dose||13
8449895|NCT00761280|20824593|P1|STARTED|Randomization to First Dose||14
8449896|NCT00761267|20824624|P3|NOT COMPLETED|Overall Study||6
8449897|NCT00761267|20824625|P2|NOT COMPLETED|Overall Study||4
8449898|NCT00761267|20824626|P1|NOT COMPLETED|Overall Study||2
8449899|NCT00761267|20824624|P3|COMPLETED|Overall Study||24
8449900|NCT00761267|20824625|P2|COMPLETED|Overall Study||16
8449901|NCT00761267|20824626|P1|COMPLETED|Overall Study||18
8449902|NCT00761267|20824624|P3|Treated|Overall Study||30
8449903|NCT00761267|20824625|P2|Treated|Overall Study||19
8449904|NCT00761267|20824626|P1|Treated|Overall Study||19
8449905|NCT00761267|20824624|P3|STARTED|Overall Study||30
8449906|NCT00761267|20824625|P2|STARTED|Overall Study||20
8449907|NCT00761267|20824626|P1|STARTED|Overall Study||20
8449908|NCT00761215|20824677|P3|NOT COMPLETED|Overall Study||8
8449909|NCT00761215|20824678|P2|NOT COMPLETED|Overall Study||4
8449910|NCT00761215|20824679|P1|NOT COMPLETED|Overall Study||9
8449911|NCT00761215|20824677|P3|COMPLETED|Overall Study||56
8449912|NCT00761215|20824678|P2|COMPLETED|Overall Study||60
8449913|NCT00761215|20824679|P1|COMPLETED|Overall Study||55
8449914|NCT00761215|20824677|P3|STARTED|Overall Study||64
8449915|NCT00761215|20824678|P2|STARTED|Overall Study||64
8449916|NCT00761215|20824679|P1|STARTED|Overall Study||64
8449917|NCT00761202|20824704|P2|NOT COMPLETED|Overall Study||2
8449918|NCT00761202|20824705|P1|NOT COMPLETED|Overall Study||1
8449919|NCT00761202|20824704|P2|COMPLETED|Overall Study||26
8449920|NCT00761202|20824705|P1|COMPLETED|Overall Study||21
8449921|NCT00761202|20824704|P2|STARTED|Overall Study||28
8449922|NCT00761202|20824705|P1|STARTED|Overall Study||22
8449923|NCT00761189|20824721|P1|NOT COMPLETED|Overall Study||185
8449924|NCT00761189|20824721|P1|COMPLETED|Overall Study||306
8449925|NCT00761189|20824721|P1|STARTED|Overall Study||491
8449926|NCT00761176|20824738|P2|NOT COMPLETED|Overall Study||1
8449927|NCT00761176|20824739|P1|NOT COMPLETED|Overall Study||2
8449928|NCT00761176|20824738|P2|COMPLETED|Overall Study||3
8449929|NCT00761176|20824739|P1|COMPLETED|Overall Study||2
8449930|NCT00761176|20824738|P2|STARTED|Overall Study||4
8449931|NCT00761176|20824739|P1|STARTED|Overall Study||4
8449932|NCT00761150|20824748|P3|NOT COMPLETED|Double-blind Period||29
8449933|NCT00761150|20824749|P2|NOT COMPLETED|Double-blind Period||14
8449934|NCT00761150|20824750|P1|NOT COMPLETED|Double-blind Period||0
8449935|NCT00761150|20824748|P3|COMPLETED|Double-blind Period||89
8449936|NCT00761150|20824749|P2|COMPLETED|Double-blind Period||106
8449937|NCT00761150|20824750|P1|COMPLETED|Double-blind Period||0
8449938|NCT00761150|20824748|P3|STARTED|Double-blind Period||118
8449939|NCT00761150|20824749|P2|STARTED|Double-blind Period||120
8449940|NCT00761150|20824750|P1|STARTED|Double-blind Period||0
8449941|NCT00761150|20824748|P3|NOT COMPLETED|Open-label Period||0
8449942|NCT00761150|20824749|P2|NOT COMPLETED|Open-label Period||0
8449943|NCT00761150|20824750|P1|NOT COMPLETED|Open-label Period||70
8449944|NCT00761150|20824748|P3|COMPLETED|Open-label Period||0
8449945|NCT00761150|20824749|P2|COMPLETED|Open-label Period||0
8449946|NCT00761150|20824750|P1|COMPLETED|Open-label Period||238
8449947|NCT00761150|20824748|P3|STARTED|Open-label Period||0
8449948|NCT00761150|20824749|P2|STARTED|Open-label Period||0
8449949|NCT00761150|20824750|P1|STARTED|Open-label Period||308
8449950|NCT00761137|20824759|P1|NOT COMPLETED|Overall Study||0
8449951|NCT00761137|20824759|P1|COMPLETED|Overall Study||19
8449952|NCT00761137|20824759|P1|3 mg Tropicamide|Overall Study||19
8449953|NCT00761137|20824759|P1|1 mg Tropicamide|Overall Study||19
8449954|NCT00761137|20824759|P1|0.3 mg Tropicamide|Overall Study||19
8449955|NCT00761137|20824759|P1|Placebo|Overall Study||19
8449956|NCT00761137|20824759|P1|STARTED|Overall Study||19
8449957|NCT00761085|20824774|P4|NOT COMPLETED|Overall Study||4
8449958|NCT00761085|20824775|P3|NOT COMPLETED|Overall Study||0
8449959|NCT00761085|20824776|P2|NOT COMPLETED|Overall Study||6
8449960|NCT00761085|20824777|P1|NOT COMPLETED|Overall Study||0
8449961|NCT00761085|20824774|P4|COMPLETED|Overall Study||8
8449962|NCT00761085|20824775|P3|COMPLETED|Overall Study||11
8449963|NCT00761085|20824776|P2|COMPLETED|Overall Study||6
8449964|NCT00761085|20824777|P1|COMPLETED|Overall Study||12
8449965|NCT00761085|20824774|P4|STARTED|Overall Study||12
8449966|NCT00761085|20824775|P3|STARTED|Overall Study||11
8449967|NCT00761085|20824776|P2|STARTED|Overall Study||12
8449968|NCT00761085|20824777|P1|STARTED|Overall Study||12
8449969|NCT00761007|20824795|P4|NOT COMPLETED|Overall Study||7
8449970|NCT00761007|20824796|P3|NOT COMPLETED|Overall Study||18
8449971|NCT00761007|20824797|P2|NOT COMPLETED|Overall Study||11
8449972|NCT00761007|20824798|P1|NOT COMPLETED|Overall Study||13
8449973|NCT00761007|20824795|P4|COMPLETED|Overall Study||131
8449974|NCT00761007|20824796|P3|COMPLETED|Overall Study||121
8449975|NCT00761007|20824797|P2|COMPLETED|Overall Study||124
8449976|NCT00761007|20824798|P1|COMPLETED|Overall Study||129
8449977|NCT00761007|20824795|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
8449978|NCT00761007|20824796|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
8449979|NCT00761007|20824797|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
8449980|NCT00761007|20824798|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
8449981|NCT00761007|20824795|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
8449982|NCT00761007|20824796|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
8449983|NCT00761007|20824797|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
8449984|NCT00761007|20824798|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
8449985|NCT00761007|20824795|P4|STARTED|Overall Study||138
8449986|NCT00761007|20824796|P3|STARTED|Overall Study||139
8449987|NCT00761007|20824797|P2|STARTED|Overall Study||135
8449988|NCT00761007|20824798|P1|STARTED|Overall Study||142
8449989|NCT00760994|20824823|P3|NOT COMPLETED|Overall Study||3
8449990|NCT00760994|20824824|P2|NOT COMPLETED|Overall Study||4
8449991|NCT00760994|20824825|P1|NOT COMPLETED|Overall Study||4
8449992|NCT00760994|20824823|P3|COMPLETED|Overall Study||17
8449993|NCT00760994|20824824|P2|COMPLETED|Overall Study||27
8449994|NCT00760994|20824825|P1|COMPLETED|Overall Study||25
8449995|NCT00760994|20824823|P3|STARTED|Overall Study||20
8449996|NCT00760994|20824824|P2|STARTED|Overall Study||31
8449997|NCT00760994|20824825|P1|STARTED|Overall Study||29
8449998|NCT00760929|20824840|P4|NOT COMPLETED|Overall Study||55
8449999|NCT00760929|20824841|P3|NOT COMPLETED|Overall Study||58
8450000|NCT00760929|20824842|P2|NOT COMPLETED|Overall Study||28
8450001|NCT00760929|20824843|P1|NOT COMPLETED|Overall Study||26
8450002|NCT00760929|20824840|P4|COMPLETED|Overall Study||2
8450003|NCT00760929|20824841|P3|COMPLETED|Overall Study||1
8450004|NCT00760929|20824842|P2|COMPLETED|Overall Study||1
8450005|NCT00760929|20824843|P1|COMPLETED|Overall Study||0
8450006|NCT00760929|20824840|P4|STARTED|Overall Study||57
8450007|NCT00760929|20824841|P3|STARTED|Overall Study||59
8450008|NCT00760929|20824842|P2|STARTED|Overall Study||29
8450009|NCT00760929|20824843|P1|STARTED|Overall Study||26
8450010|NCT00760877|20824866|P2|NOT COMPLETED|Overall Study||26
8450011|NCT00760877|20824867|P1|NOT COMPLETED|Overall Study||45
8450012|NCT00760877|20824866|P2|COMPLETED|Overall Study||77
8450013|NCT00760877|20824867|P1|COMPLETED|Overall Study||59
8450014|NCT00760877|20824866|P2|Safety Set|Overall Study||103
8450015|NCT00760877|20824867|P1|Safety Set|Overall Study||101
8450016|NCT00760877|20824866|P2|Cross-over to Nilotinib|Overall Study||46
8450017|NCT00760877|20824867|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
8450018|NCT00760877|20824866|P2|STARTED|Overall Study||103
8450019|NCT00760877|20824867|P1|STARTED|Overall Study||104
8450020|NCT00760838|20824885|P2|NOT COMPLETED|Overall Study||2
8450021|NCT00760838|20824886|P1|NOT COMPLETED|Overall Study||5
8450022|NCT00760838|20824885|P2|COMPLETED|Overall Study||53
8450023|NCT00760838|20824886|P1|COMPLETED|Overall Study||49
8450024|NCT00760838|20824885|P2|STARTED|Overall Study||55
8450025|NCT00760838|20824886|P1|STARTED|Overall Study||54
8450026|NCT00760747|20824904|P2|NOT COMPLETED|Study Period III||3
8450027|NCT00760747|20824905|P1|NOT COMPLETED|Study Period III||3
8450028|NCT00760747|20824904|P2|COMPLETED|Study Period III||38
8450029|NCT00760747|20824905|P1|COMPLETED|Study Period III||41
8450030|NCT00760747|20824904|P2|STARTED|Study Period III||41
8450031|NCT00760747|20824905|P1|STARTED|Study Period III||44
8450032|NCT00760747|20824904|P2|NOT COMPLETED|Study Period II||14
8450033|NCT00760747|20824905|P1|NOT COMPLETED|Study Period II||13
8450034|NCT00760747|20824904|P2|COMPLETED|Study Period II||41
8450035|NCT00760747|20824905|P1|COMPLETED|Study Period II||44
8450036|NCT00760747|20824904|P2|Received at Least One Dose of Study Drug|Study Period II||54
8450037|NCT00760747|20824905|P1|Received at Least One Dose of Study Drug|Study Period II||57
8450038|NCT00760747|20824904|P2|STARTED|Study Period II||55
8450039|NCT00760747|20824905|P1|STARTED|Study Period II||57
8450040|NCT00760669|20824933|P1|NOT COMPLETED|Overall Study||30
8450041|NCT00760669|20824933|P1|COMPLETED|Overall Study||1031
8450042|NCT00760669|20824933|P1|STARTED|Overall Study||1061
8450043|NCT00760617|20824950|P3|NOT COMPLETED|Overall Study||5
8450044|NCT00760617|20824951|P2|NOT COMPLETED|Overall Study||2
8450045|NCT00760617|20824952|P1|NOT COMPLETED|Overall Study||5
8450046|NCT00760617|20824950|P3|COMPLETED|Overall Study||111
8450047|NCT00760617|20824951|P2|COMPLETED|Overall Study||142
8450048|NCT00760617|20824952|P1|COMPLETED|Overall Study||261
8450049|NCT00760617|20824950|P3|STARTED|Overall Study||116
8450050|NCT00760617|20824951|P2|STARTED|Overall Study||144
8450051|NCT00760617|20824952|P1|STARTED|Overall Study||266
8450052|NCT00760578|20825027|P4|NOT COMPLETED|Overall Study||4
8450053|NCT00760578|20825028|P3|NOT COMPLETED|Overall Study||5
8450054|NCT00760578|20825029|P2|NOT COMPLETED|Overall Study||2
8450055|NCT00760578|20825030|P1|NOT COMPLETED|Overall Study||3
8450056|NCT00760578|20825027|P4|COMPLETED|Overall Study||18
8450057|NCT00760578|20825028|P3|COMPLETED|Overall Study||16
8450058|NCT00760578|20825029|P2|COMPLETED|Overall Study||19
8450059|NCT00760578|20825030|P1|COMPLETED|Overall Study||19
8450060|NCT00760578|20825027|P4|Entered Drug Treatment Period|Overall Study||22
8450061|NCT00760578|20825028|P3|Entered Drug Treatment Period|Overall Study||19
8450062|NCT00760578|20825029|P2|Entered Drug Treatment Period|Overall Study||20
8450063|NCT00760578|20825030|P1|Entered Drug Treatment Period|Overall Study||21
8450064|NCT00760578|20825027|P4|STARTED|Overall Study||22
8450065|NCT00760578|20825028|P3|STARTED|Overall Study||21
8450066|NCT00760578|20825029|P2|STARTED|Overall Study||21
8450067|NCT00760578|20825030|P1|STARTED|Overall Study||22
8450068|NCT00760552|20825066|P2|NOT COMPLETED|Overall Study||10
8450069|NCT00760552|20825067|P1|NOT COMPLETED|Overall Study||13
8450070|NCT00760552|20825066|P2|COMPLETED|Overall Study||52
8450071|NCT00760552|20825067|P1|COMPLETED|Overall Study||48
8450072|NCT00760552|20825066|P2|STARTED|Overall Study||62
8450073|NCT00760552|20825067|P1|STARTED|Overall Study||61
8450074|NCT00760526|20825075|P2|NOT COMPLETED|Overall Study||4
8450075|NCT00760526|20825076|P1|NOT COMPLETED|Overall Study||5
8450076|NCT00760526|20825075|P2|COMPLETED|Overall Study||68
8450077|NCT00760526|20825076|P1|COMPLETED|Overall Study||69
8450078|NCT00760526|20825075|P2|STARTED|Overall Study||72
8450079|NCT00760526|20825076|P1|STARTED|Overall Study||74
8450080|NCT00760513|20825103|P2|NOT COMPLETED|Overall Study||7
8450081|NCT00760513|20825104|P1|NOT COMPLETED|Overall Study||5
8450082|NCT00760513|20825103|P2|COMPLETED|Overall Study||45
8450083|NCT00760513|20825104|P1|COMPLETED|Overall Study||46
8450084|NCT00760513|20825103|P2|STARTED|Overall Study||52
8450085|NCT00760513|20825104|P1|STARTED|Overall Study||51
8450086|NCT00760487|20825114|P1|NOT COMPLETED|Overall Study||3
8450087|NCT00760487|20825114|P1|COMPLETED|Overall Study||117
8450088|NCT00760487|20825114|P1|STARTED|Overall Study||120
8450089|NCT00760474|20825120|P2|NOT COMPLETED|Period 2 (P2)||1
8450090|NCT00760474|20825121|P1|NOT COMPLETED|Period 2 (P2)||1
8450091|NCT00760474|20825120|P2|COMPLETED|Period 2 (P2)||11
8450092|NCT00760474|20825121|P1|COMPLETED|Period 2 (P2)||11
8450093|NCT00760474|20825120|P2|STARTED|Period 2 (P2)||12
8450094|NCT00760474|20825121|P1|STARTED|Period 2 (P2)||12
8450095|NCT00760474|20825120|P2|NOT COMPLETED|Placebo Washout Period||1
8450096|NCT00760474|20825121|P1|NOT COMPLETED|Placebo Washout Period||0
8450097|NCT00760474|20825120|P2|COMPLETED|Placebo Washout Period||12
8450098|NCT00760474|20825121|P1|COMPLETED|Placebo Washout Period||12
8450099|NCT00760474|20825120|P2|STARTED|Placebo Washout Period||13
8450100|NCT00760474|20825121|P1|STARTED|Placebo Washout Period||12
8450101|NCT00760474|20825120|P2|NOT COMPLETED|Period 1 (P1)||1
8450102|NCT00760474|20825121|P1|NOT COMPLETED|Period 1 (P1)||1
8450103|NCT00760474|20825120|P2|COMPLETED|Period 1 (P1)||13
8450104|NCT00760474|20825121|P1|COMPLETED|Period 1 (P1)||12
8450105|NCT00760474|20825120|P2|Overall Number of Unique Participants|Period 1 (P1)||13
8450106|NCT00760474|20825121|P1|Overall Number of Unique Participants|Period 1 (P1)||12
8450107|NCT00760474|20825120|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
8450108|NCT00760474|20825121|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
8450109|NCT00760474|20825120|P2|STARTED|Period 1 (P1)||14
8450110|NCT00760474|20825121|P1|STARTED|Period 1 (P1)||13
8450111|NCT00760461|20825157|P1|NOT COMPLETED|Overall Study||44
8450112|NCT00760461|20825157|P1|COMPLETED|Overall Study||0
8450113|NCT00760461|20825157|P1|STARTED|Overall Study||44
8450114|NCT00760435|20825163|P2|NOT COMPLETED|Overall Study||5
8450115|NCT00760435|20825164|P1|NOT COMPLETED|Overall Study||4
8450116|NCT00760435|20825163|P2|COMPLETED|Overall Study||93
8450117|NCT00760435|20825164|P1|COMPLETED|Overall Study||94
8450118|NCT00760435|20825163|P2|STARTED|Overall Study||98
8450119|NCT00760435|20825164|P1|STARTED|Overall Study||98
8450120|NCT00760383|20825178|P2|NOT COMPLETED|Overall Study||7
8450121|NCT00760383|20825179|P1|NOT COMPLETED|Overall Study||5
8450122|NCT00760383|20825178|P2|COMPLETED|Overall Study||12
8450123|NCT00760383|20825179|P1|COMPLETED|Overall Study||16
8450124|NCT00760383|20825178|P2|STARTED|Overall Study||19
8450125|NCT00760383|20825179|P1|STARTED|Overall Study||21
8450126|NCT00760266|20825191|P2|NOT COMPLETED|Overall Study||18
8450127|NCT00760266|20825192|P1|NOT COMPLETED|Overall Study||24
8450128|NCT00760266|20825191|P2|COMPLETED|Overall Study||205
8450129|NCT00760266|20825192|P1|COMPLETED|Overall Study||204
8450130|NCT00760266|20825191|P2|STARTED|Overall Study||223
8450131|NCT00760266|20825192|P1|STARTED|Overall Study||228
8450132|NCT00760214|20825209|P3|NOT COMPLETED|Overall Study||41
8450133|NCT00760214|20825210|P2|NOT COMPLETED|Overall Study||30
8450134|NCT00760214|20825211|P1|NOT COMPLETED|Overall Study||30
8450135|NCT00760214|20825209|P3|COMPLETED|Overall Study||255
8450136|NCT00760214|20825210|P2|COMPLETED|Overall Study||264
8450137|NCT00760214|20825211|P1|COMPLETED|Overall Study||265
8450138|NCT00760214|20825209|P3|STARTED|Overall Study||296
8450139|NCT00760214|20825210|P2|STARTED|Overall Study||294
8450140|NCT00760214|20825211|P1|STARTED|Overall Study||295
8450141|NCT00760084|20825252|P1|NOT COMPLETED|Overall Study||10
8450142|NCT00760084|20825252|P1|COMPLETED|Overall Study||0
8450143|NCT00760084|20825252|P1|STARTED|Overall Study||10
8450144|NCT00760019|20825258|P4|NOT COMPLETED|Overall Study||0
8450145|NCT00760019|20825259|P3|NOT COMPLETED|Overall Study||0
8450146|NCT00760019|20825260|P2|NOT COMPLETED|Overall Study||0
8450147|NCT00760019|20825261|P1|NOT COMPLETED|Overall Study||0
8450148|NCT00760019|20825258|P4|COMPLETED|Overall Study||14
8450149|NCT00760019|20825259|P3|COMPLETED|Overall Study||14
8450150|NCT00760019|20825260|P2|COMPLETED|Overall Study||15
8450151|NCT00760019|20825261|P1|COMPLETED|Overall Study||15
8450152|NCT00760019|20825258|P4|STARTED|Overall Study||14
8450153|NCT00760019|20825259|P3|STARTED|Overall Study||14
8450154|NCT00760019|20825260|P2|STARTED|Overall Study||15
8450155|NCT00760019|20825261|P1|STARTED|Overall Study||15
8450156|NCT00760006|20825269|P2|NOT COMPLETED|Overall Study||0
8450157|NCT00760006|20825270|P1|NOT COMPLETED|Overall Study||0
8450158|NCT00760006|20825269|P2|COMPLETED|Overall Study||138
8450159|NCT00760006|20825270|P1|COMPLETED|Overall Study||86
8450160|NCT00760006|20825269|P2|STARTED|Overall Study||138
8450161|NCT00760006|20825270|P1|STARTED|Overall Study||86
8450162|NCT00759967|20825276|P2|NOT COMPLETED|Second Intervention||0
8450163|NCT00759967|20825277|P1|NOT COMPLETED|Second Intervention||2
8450164|NCT00759967|20825276|P2|COMPLETED|Second Intervention||9
8450165|NCT00759967|20825277|P1|COMPLETED|Second Intervention||8
8450166|NCT00759967|20825276|P2|STARTED|Second Intervention||9
8450167|NCT00759967|20825277|P1|STARTED|Second Intervention||10
8450168|NCT00759967|20825276|P2|NOT COMPLETED|First Intervention||0
8450169|NCT00759967|20825277|P1|NOT COMPLETED|First Intervention||0
8450170|NCT00759967|20825276|P2|COMPLETED|First Intervention||9
8450171|NCT00759967|20825277|P1|COMPLETED|First Intervention||10
8450172|NCT00759967|20825276|P2|STARTED|First Intervention||9
8450173|NCT00759967|20825277|P1|STARTED|First Intervention||10
8450174|NCT00759954|20825295|P2|NOT COMPLETED|Overall Study||2
8450175|NCT00759954|20825296|P1|NOT COMPLETED|Overall Study||2
8450176|NCT00759954|20825295|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
8450177|NCT00759954|20825296|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
8450178|NCT00759954|20825295|P2|STARTED|Overall Study|All assigned participants entered trial|18
8450179|NCT00759954|20825296|P1|STARTED|Overall Study|All assigned participants entered trial|18
8450180|NCT00759941|20825310|P2|NOT COMPLETED|Overall Study||1
8450181|NCT00759941|20825311|P1|NOT COMPLETED|Overall Study||3
8450182|NCT00759941|20825310|P2|COMPLETED|Overall Study||43
8450183|NCT00759941|20825311|P1|COMPLETED|Overall Study||39
8450184|NCT00759941|20825310|P2|STARTED|Overall Study||44
8450185|NCT00759941|20825311|P1|STARTED|Overall Study||42
8450186|NCT00759915|20825325|P2|NOT COMPLETED|Overall Study||1
8450187|NCT00759915|20825326|P1|NOT COMPLETED|Overall Study||1
8450188|NCT00759915|20825325|P2|COMPLETED|Overall Study||17
8450189|NCT00759915|20825326|P1|COMPLETED|Overall Study||17
8450190|NCT00759915|20825325|P2|STARTED|Overall Study||18
8450191|NCT00759915|20825326|P1|STARTED|Overall Study||18
8450192|NCT00759902|20825340|P2|NOT COMPLETED|Overall Study||1
8450193|NCT00759902|20825341|P1|NOT COMPLETED|Overall Study||0
8450194|NCT00759902|20825340|P2|COMPLETED|Overall Study||17
8450195|NCT00759902|20825341|P1|COMPLETED|Overall Study||18
8450196|NCT00759902|20825340|P2|STARTED|Overall Study||18
8450197|NCT00759902|20825341|P1|STARTED|Overall Study||18
8450198|NCT00759876|20825353|P1|NOT COMPLETED|Overall Study||36
8450199|NCT00759876|20825353|P1|COMPLETED|Overall Study||0
8450200|NCT00759876|20825353|P1|Ambulatory Evaluable Population|Overall Study||24
8450201|NCT00759876|20825353|P1|Evaluable Population|Overall Study||35
8450202|NCT00759876|20825353|P1|As-Treated Population|Overall Study||36
8450203|NCT00759876|20825353|P1|STARTED|Overall Study||36
8450204|NCT00759863|20825377|P2|NOT COMPLETED|Overall Study||18
8450205|NCT00759863|20825378|P1|NOT COMPLETED|Overall Study||20
8450206|NCT00759863|20825377|P2|COMPLETED|Overall Study||80
8450207|NCT00759863|20825378|P1|COMPLETED|Overall Study||124
8450208|NCT00759863|20825377|P2|STARTED|Overall Study||98
8450209|NCT00759863|20825378|P1|STARTED|Overall Study||144
8450210|NCT00759811|20825390|P2|NOT COMPLETED|Overall Study||1
8450211|NCT00759811|20825391|P1|NOT COMPLETED|Overall Study||2
8450212|NCT00759811|20825390|P2|COMPLETED|Overall Study||24
8450213|NCT00759811|20825391|P1|COMPLETED|Overall Study||23
8450214|NCT00759811|20825390|P2|STARTED|Overall Study||25
8450215|NCT00759811|20825391|P1|STARTED|Overall Study||25
8450216|NCT00759785|20825399|P2|NOT COMPLETED|Overall Study||5
8450217|NCT00759785|20825400|P1|NOT COMPLETED|Overall Study||12
8450218|NCT00759785|20825399|P2|COMPLETED|Overall Study||17
8450219|NCT00759785|20825400|P1|COMPLETED|Overall Study||14
8450220|NCT00759785|20825399|P2|Treated|Overall Study||20
8450221|NCT00759785|20825400|P1|Treated|Overall Study||25
8450222|NCT00759785|20825399|P2|STARTED|Overall Study||22
8450223|NCT00759785|20825400|P1|STARTED|Overall Study||26
8450224|NCT00759772|20825414|P2|NOT COMPLETED|Overall Study||0
8450225|NCT00759772|20825415|P1|NOT COMPLETED|Overall Study||0
8450226|NCT00759772|20825414|P2|COMPLETED|Overall Study||11
8450227|NCT00759772|20825415|P1|COMPLETED|Overall Study||12
8450228|NCT00759772|20825414|P2|STARTED|Overall Study||11
8450229|NCT00759772|20825415|P1|STARTED|Overall Study||12
8450230|NCT00759759|20825423|P2|NOT COMPLETED|Overall Study||1
8450231|NCT00759759|20825424|P1|NOT COMPLETED|Overall Study||4
8450232|NCT00759759|20825423|P2|COMPLETED|Overall Study||17
8450233|NCT00759759|20825424|P1|COMPLETED|Overall Study||14
8450234|NCT00759759|20825423|P2|STARTED|Overall Study||18
8450235|NCT00759759|20825424|P1|STARTED|Overall Study||18
8450236|NCT00759707|20825436|P1|NOT COMPLETED|Overall Study||0
8450237|NCT00759707|20825436|P1|COMPLETED|Overall Study||19
8450238|NCT00759707|20825436|P1|STARTED|Overall Study||19
8450239|NCT00759681|20825442|P2|NOT COMPLETED|Overall Study||10
8450240|NCT00759681|20825443|P1|NOT COMPLETED|Overall Study||10
8450241|NCT00759681|20825442|P2|COMPLETED|Overall Study||100
8450242|NCT00759681|20825443|P1|COMPLETED|Overall Study||97
8450243|NCT00759681|20825442|P2|STARTED|Overall Study||110
8450244|NCT00759681|20825443|P1|STARTED|Overall Study||107
8450245|NCT00759668|20825453|P2|NOT COMPLETED|Overall Study||3
8450246|NCT00759668|20825454|P1|NOT COMPLETED|Overall Study||1
8450247|NCT00759668|20825453|P2|COMPLETED|Overall Study||15
8450248|NCT00759668|20825454|P1|COMPLETED|Overall Study||16
8450249|NCT00759668|20825453|P2|STARTED|Overall Study||18
8450250|NCT00759668|20825454|P1|STARTED|Overall Study||17
8450251|NCT00759655|20825470|P1|NOT COMPLETED|Overall Study||1
8450252|NCT00759655|20825470|P1|COMPLETED|Overall Study||0
8450253|NCT00759655|20825470|P1|STARTED|Overall Study||1
8450254|NCT00759642|20825481|P1|NOT COMPLETED|Overall Study||0
8450255|NCT00759642|20825481|P1|COMPLETED|Overall Study||33
8450256|NCT00759642|20825481|P1|STARTED|Overall Study||33
8450257|NCT00759603|20825485|P1|NOT COMPLETED|Overall Study||0
8450258|NCT00759603|20825485|P1|COMPLETED|Overall Study||59
8450259|NCT00759603|20825485|P1|STARTED|Overall Study||59
8450260|NCT00759577|20825489|P1|NOT COMPLETED|Overall Study||0
8450261|NCT00759577|20825489|P1|COMPLETED|Overall Study||36
8450262|NCT00759577|20825489|P1|STARTED|Overall Study||36
8450263|NCT00759564|20825498|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450264|NCT00759564|20825499|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450265|NCT00759564|20825500|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450266|NCT00759564|20825501|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450267|NCT00759564|20825502|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450268|NCT00759564|20825498|P5|COMPLETED|Second Intervention Period (4 Days)||3
8450269|NCT00759564|20825499|P4|COMPLETED|Second Intervention Period (4 Days)||1
8450270|NCT00759564|20825500|P3|COMPLETED|Second Intervention Period (4 Days)||8
8450271|NCT00759564|20825501|P2|COMPLETED|Second Intervention Period (4 Days)||8
8450272|NCT00759564|20825502|P1|COMPLETED|Second Intervention Period (4 Days)||8
8450273|NCT00759564|20825498|P5|STARTED|Second Intervention Period (4 Days)||3
8450274|NCT00759564|20825499|P4|STARTED|Second Intervention Period (4 Days)||1
8450275|NCT00759564|20825500|P3|STARTED|Second Intervention Period (4 Days)||8
8450276|NCT00759564|20825501|P2|STARTED|Second Intervention Period (4 Days)||8
8450277|NCT00759564|20825502|P1|STARTED|Second Intervention Period (4 Days)||8
8450278|NCT00759564|20825498|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8450279|NCT00759564|20825499|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450280|NCT00759564|20825500|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450281|NCT00759564|20825501|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450282|NCT00759564|20825502|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450283|NCT00759564|20825498|P5|COMPLETED|Washout Period (at Least 14 Days)||3
8450284|NCT00759564|20825499|P4|COMPLETED|Washout Period (at Least 14 Days)||1
8450285|NCT00759564|20825500|P3|COMPLETED|Washout Period (at Least 14 Days)||8
8450286|NCT00759564|20825501|P2|COMPLETED|Washout Period (at Least 14 Days)||8
8450287|NCT00759564|20825502|P1|COMPLETED|Washout Period (at Least 14 Days)||8
8450288|NCT00759564|20825498|P5|STARTED|Washout Period (at Least 14 Days)||4
8450289|NCT00759564|20825499|P4|STARTED|Washout Period (at Least 14 Days)||1
8450290|NCT00759564|20825500|P3|STARTED|Washout Period (at Least 14 Days)||8
8450291|NCT00759564|20825501|P2|STARTED|Washout Period (at Least 14 Days)||8
8450292|NCT00759564|20825502|P1|STARTED|Washout Period (at Least 14 Days)||8
8450293|NCT00759564|20825498|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
8450294|NCT00759564|20825499|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
8450295|NCT00759564|20825500|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
8450296|NCT00759564|20825501|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
8450297|NCT00759564|20825502|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
8450298|NCT00759564|20825498|P5|COMPLETED|First Intervention Period (4 Days)||4
8450299|NCT00759564|20825499|P4|COMPLETED|First Intervention Period (4 Days)||1
8450300|NCT00759564|20825500|P3|COMPLETED|First Intervention Period (4 Days)||8
8450301|NCT00759564|20825501|P2|COMPLETED|First Intervention Period (4 Days)||8
8450302|NCT00759564|20825502|P1|COMPLETED|First Intervention Period (4 Days)||8
8450303|NCT00759564|20825498|P5|STARTED|First Intervention Period (4 Days)||4
8450304|NCT00759564|20825499|P4|STARTED|First Intervention Period (4 Days)||1
8450305|NCT00759564|20825500|P3|STARTED|First Intervention Period (4 Days)||8
8450306|NCT00759564|20825501|P2|STARTED|First Intervention Period (4 Days)||8
8450307|NCT00759564|20825502|P1|STARTED|First Intervention Period (4 Days)||8
8450308|NCT00759525|20825642|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8450309|NCT00759525|20825643|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8450310|NCT00759525|20825642|P2|COMPLETED|Second Intervention (14 Days)||8
8450311|NCT00759525|20825643|P1|COMPLETED|Second Intervention (14 Days)||7
8450312|NCT00759525|20825642|P2|STARTED|Second Intervention (14 Days)||8
8450313|NCT00759525|20825643|P1|STARTED|Second Intervention (14 Days)||7
8450314|NCT00759525|20825642|P2|NOT COMPLETED|Washout (14 Days)||0
8450315|NCT00759525|20825643|P1|NOT COMPLETED|Washout (14 Days)||0
8450316|NCT00759525|20825642|P2|COMPLETED|Washout (14 Days)||8
8450317|NCT00759525|20825643|P1|COMPLETED|Washout (14 Days)||7
8450318|NCT00759525|20825642|P2|STARTED|Washout (14 Days)||8
8450319|NCT00759525|20825643|P1|STARTED|Washout (14 Days)||7
8450320|NCT00759525|20825642|P2|NOT COMPLETED|First Intervention (14 Days)||0
8450321|NCT00759525|20825643|P1|NOT COMPLETED|First Intervention (14 Days)||0
8450322|NCT00759525|20825642|P2|COMPLETED|First Intervention (14 Days)||8
8450323|NCT00759525|20825643|P1|COMPLETED|First Intervention (14 Days)||7
8450324|NCT00759525|20825642|P2|STARTED|First Intervention (14 Days)||8
8450325|NCT00759525|20825643|P1|STARTED|First Intervention (14 Days)||7
8450326|NCT00759473|20825654|P5|NOT COMPLETED|Overall Study||0
8450327|NCT00759473|20825655|P4|NOT COMPLETED|Overall Study||0
8450328|NCT00759473|20825656|P3|NOT COMPLETED|Overall Study||0
8450329|NCT00759473|20825657|P2|NOT COMPLETED|Overall Study||0
8450330|NCT00759473|20825658|P1|NOT COMPLETED|Overall Study||0
8450331|NCT00759473|20825654|P5|COMPLETED|Overall Study||24
8450332|NCT00759473|20825655|P4|COMPLETED|Overall Study||23
8450333|NCT00759473|20825656|P3|COMPLETED|Overall Study||12
8450334|NCT00759473|20825657|P2|COMPLETED|Overall Study||10
8450335|NCT00759473|20825658|P1|COMPLETED|Overall Study||10
8450336|NCT00759473|20825654|P5|STARTED|Overall Study||24
8450337|NCT00759473|20825655|P4|STARTED|Overall Study||23
8450338|NCT00759473|20825656|P3|STARTED|Overall Study||12
8450339|NCT00759473|20825657|P2|STARTED|Overall Study||10
8450340|NCT00759473|20825658|P1|STARTED|Overall Study||10
8450341|NCT00759408|20825670|P1|NOT COMPLETED|Overall Study||19
8450342|NCT00759408|20825670|P1|COMPLETED|Overall Study||19
8450343|NCT00759408|20825670|P1|STARTED|Overall Study||38
8450344|NCT00759395|20825679|P2|NOT COMPLETED|Overall Study||2
8450345|NCT00759395|20825680|P1|NOT COMPLETED|Overall Study||2
8450346|NCT00759395|20825679|P2|COMPLETED|Overall Study||7
8450347|NCT00759395|20825680|P1|COMPLETED|Overall Study||11
8450348|NCT00759395|20825679|P2|STARTED|Overall Study||9
8450349|NCT00759395|20825680|P1|STARTED|Overall Study||13
8450350|NCT00759356|20825696|P2|NOT COMPLETED|Overall Study||3
8450351|NCT00759356|20825697|P1|NOT COMPLETED|Overall Study||1
8450352|NCT00759356|20825696|P2|COMPLETED|Overall Study||15
8450353|NCT00759356|20825697|P1|COMPLETED|Overall Study||17
8450354|NCT00759356|20825696|P2|STARTED|Overall Study||18
8450355|NCT00759356|20825697|P1|STARTED|Overall Study||18
8450356|NCT00759330|20825713|P4|NOT COMPLETED|Overall Study||2
8450357|NCT00759330|20825714|P3|NOT COMPLETED|Overall Study||0
8450358|NCT00759330|20825715|P2|NOT COMPLETED|Overall Study||1
8450359|NCT00759330|20825716|P1|NOT COMPLETED|Overall Study||1
8450360|NCT00759330|20825713|P4|COMPLETED|Overall Study||41
8450361|NCT00759330|20825714|P3|COMPLETED|Overall Study||22
8450362|NCT00759330|20825715|P2|COMPLETED|Overall Study||41
8450363|NCT00759330|20825716|P1|COMPLETED|Overall Study||19
8450364|NCT00759330|20825713|P4|STARTED|Overall Study||43
8450365|NCT00759330|20825714|P3|STARTED|Overall Study||22
8450366|NCT00759330|20825715|P2|STARTED|Overall Study||42
8450367|NCT00759330|20825716|P1|STARTED|Overall Study||20
8450368|NCT00759187|20825765|P3|NOT COMPLETED|Overall Study||0
8450369|NCT00759187|20825766|P2|NOT COMPLETED|Overall Study||0
8450370|NCT00759187|20825767|P1|NOT COMPLETED|Overall Study||0
8450371|NCT00759187|20825765|P3|COMPLETED|Overall Study||9
8450372|NCT00759187|20825766|P2|COMPLETED|Overall Study||8
8450373|NCT00759187|20825767|P1|COMPLETED|Overall Study||8
8450374|NCT00759187|20825765|P3|STARTED|Overall Study||9
8450375|NCT00759187|20825766|P2|STARTED|Overall Study||8
8450376|NCT00759187|20825767|P1|STARTED|Overall Study||8
8450383|NCT00759161|20825787|P1|NOT COMPLETED|Overall Study||0
8450384|NCT00759161|20825787|P1|COMPLETED|Overall Study||35
8450385|NCT00759161|20825787|P1|STARTED|Overall Study||35
8450386|NCT00759148|20825802|P2|NOT COMPLETED|Overall Study||32
8450387|NCT00759148|20825803|P1|NOT COMPLETED|Overall Study||14
8450388|NCT00759148|20825802|P2|COMPLETED|Overall Study||554
8450389|NCT00759148|20825803|P1|COMPLETED|Overall Study||579
8450390|NCT00759148|20825802|P2|STARTED|Overall Study||586
8450391|NCT00759148|20825803|P1|STARTED|Overall Study||593
8450392|NCT00759109|20825813|P2|NOT COMPLETED|Overall Study||35
8450393|NCT00759109|20825814|P1|NOT COMPLETED|Overall Study||39
8450394|NCT00759109|20825813|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
8450395|NCT00759109|20825814|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
8450396|NCT00759109|20825813|P2|STARTED|Overall Study||76
8450397|NCT00759109|20825814|P1|STARTED|Overall Study||74
8450398|NCT00759096|20825830|P1|NOT COMPLETED|Overall Study||0
8450399|NCT00759096|20825830|P1|COMPLETED|Overall Study||30
8450400|NCT00759096|20825830|P1|STARTED|Overall Study||30
8450401|NCT00759031|20825836|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8450402|NCT00759031|20825837|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8450403|NCT00759031|20825836|P2|COMPLETED|Second Intervention (1 Day)||8
8450404|NCT00759031|20825837|P1|COMPLETED|Second Intervention (1 Day)||8
8450405|NCT00759031|20825836|P2|STARTED|Second Intervention (1 Day)||8
8450406|NCT00759031|20825837|P1|STARTED|Second Intervention (1 Day)||8
8450407|NCT00759031|20825836|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
8450408|NCT00759031|20825837|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
8450409|NCT00759031|20825836|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
8450410|NCT00759031|20825837|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
8450411|NCT00759031|20825836|P2|STARTED|Washout After 1st Intervention (1 Week)||8
8450412|NCT00759031|20825837|P1|STARTED|Washout After 1st Intervention (1 Week)||8
8450413|NCT00759031|20825836|P2|NOT COMPLETED|First Intervention (1 Day)||1
8450414|NCT00759031|20825837|P1|NOT COMPLETED|First Intervention (1 Day)||2
8450415|NCT00759031|20825836|P2|COMPLETED|First Intervention (1 Day)||8
8450416|NCT00759031|20825837|P1|COMPLETED|First Intervention (1 Day)||8
8450417|NCT00759031|20825836|P2|STARTED|First Intervention (1 Day)||9
8450418|NCT00759031|20825837|P1|STARTED|First Intervention (1 Day)||10
8450419|NCT00758862|20825843|P1|NOT COMPLETED|Overall Study||1
8450420|NCT00758862|20825843|P1|COMPLETED|Overall Study||19
8450421|NCT00758862|20825843|P1|STARTED|Overall Study||20
8450422|NCT00758836|20825863|P4|NOT COMPLETED|Overall Study||32
8450423|NCT00758836|20825864|P3|NOT COMPLETED|Overall Study||38
8450424|NCT00758836|20825865|P2|NOT COMPLETED|Overall Study||26
8450425|NCT00758836|20825866|P1|NOT COMPLETED|Overall Study||24
8450426|NCT00758836|20825863|P4|COMPLETED|Overall Study||138
8450427|NCT00758836|20825864|P3|COMPLETED|Overall Study||133
8450428|NCT00758836|20825865|P2|COMPLETED|Overall Study||145
8450429|NCT00758836|20825866|P1|COMPLETED|Overall Study||147
8450430|NCT00758836|20825863|P4|Treated|Overall Study||138
8450431|NCT00758836|20825864|P3|Treated|Overall Study||133
8450432|NCT00758836|20825865|P2|Treated|Overall Study||145
8450433|NCT00758836|20825866|P1|Treated|Overall Study||147
8450434|NCT00758836|20825863|P4|STARTED|Overall Study||170
8450435|NCT00758836|20825864|P3|STARTED|Overall Study||171
8450436|NCT00758836|20825865|P2|STARTED|Overall Study||171
8450437|NCT00758836|20825866|P1|STARTED|Overall Study||171
8450438|NCT00758784|20825888|P1|NOT COMPLETED|Overall Study||2
8450439|NCT00758784|20825888|P1|COMPLETED|Overall Study||36
8450440|NCT00758784|20825888|P1|STARTED|Overall Study||38
8450441|NCT00758771|20825896|P2|NOT COMPLETED|Overall Study||5
8450442|NCT00758771|20825897|P1|NOT COMPLETED|Overall Study||3
8450443|NCT00758771|20825896|P2|COMPLETED|Overall Study||15
8450444|NCT00758771|20825897|P1|COMPLETED|Overall Study||15
8450445|NCT00758771|20825896|P2|STARTED|Overall Study||20
8450446|NCT00758771|20825897|P1|STARTED|Overall Study||18
8450447|NCT00758758|20825911|P8|NOT COMPLETED|Overall Study||0
8450448|NCT00758758|20825912|P7|NOT COMPLETED|Overall Study||14
8450449|NCT00758758|20825913|P6|NOT COMPLETED|Overall Study||14
8450450|NCT00758758|20825914|P5|NOT COMPLETED|Overall Study||2
8450451|NCT00758758|20825915|P4|NOT COMPLETED|Overall Study||2
8450452|NCT00758758|20825916|P3|NOT COMPLETED|Overall Study||18
8450453|NCT00758758|20825917|P2|NOT COMPLETED|Overall Study||25
8450454|NCT00758758|20825918|P1|NOT COMPLETED|Overall Study||3
8450455|NCT00758758|20825911|P8|COMPLETED|Overall Study||0
8450456|NCT00758758|20825912|P7|COMPLETED|Overall Study||17
8450457|NCT00758758|20825913|P6|COMPLETED|Overall Study||36
8450458|NCT00758758|20825914|P5|COMPLETED|Overall Study||1
8450459|NCT00758758|20825915|P4|COMPLETED|Overall Study||4
8450460|NCT00758758|20825916|P3|COMPLETED|Overall Study||35
8450461|NCT00758758|20825917|P2|COMPLETED|Overall Study||49
8450462|NCT00758758|20825918|P1|COMPLETED|Overall Study||11
8450463|NCT00758758|20825911|P8|STARTED|Overall Study||0
8450464|NCT00758758|20825912|P7|STARTED|Overall Study||31
8450465|NCT00758758|20825913|P6|STARTED|Overall Study||50
8450466|NCT00758758|20825914|P5|STARTED|Overall Study||3
8450467|NCT00758758|20825915|P4|STARTED|Overall Study||6
8450468|NCT00758758|20825916|P3|STARTED|Overall Study||53
8450469|NCT00758758|20825917|P2|STARTED|Overall Study||74
8450470|NCT00758758|20825918|P1|STARTED|Overall Study||14
8450471|NCT00758745|20825946|P2|NOT COMPLETED|Overall Study||21
8450472|NCT00758745|20825947|P1|NOT COMPLETED|Overall Study||21
8450473|NCT00758745|20825946|P2|COMPLETED|Overall Study||60
8450474|NCT00758745|20825947|P1|COMPLETED|Overall Study||60
8450475|NCT00758745|20825946|P2|STARTED|Overall Study||81
8450476|NCT00758745|20825947|P1|STARTED|Overall Study||81
8450477|NCT00758706|20825955|P2|NOT COMPLETED|Overall Study||4
8450478|NCT00758706|20825956|P1|NOT COMPLETED|Overall Study||4
8450479|NCT00758706|20825955|P2|COMPLETED|Overall Study||25
8450480|NCT00758706|20825956|P1|COMPLETED|Overall Study||22
8450481|NCT00758706|20825955|P2|STARTED|Overall Study||29
8450482|NCT00758706|20825956|P1|STARTED|Overall Study||26
8450483|NCT00758680|20825992|P10|NOT COMPLETED|Overall Study||1
8450484|NCT00758680|20825993|P9|NOT COMPLETED|Overall Study||2
8450485|NCT00758680|20825994|P8|NOT COMPLETED|Overall Study||1
8450486|NCT00758680|20825995|P7|NOT COMPLETED|Overall Study||1
8450487|NCT00758680|20825996|P6|NOT COMPLETED|Overall Study||0
8450488|NCT00758680|20825997|P5|NOT COMPLETED|Overall Study||0
8450489|NCT00758680|20825998|P4|NOT COMPLETED|Overall Study||0
8450490|NCT00758680|20825999|P3|NOT COMPLETED|Overall Study||0
8450491|NCT00758680|20826000|P2|NOT COMPLETED|Overall Study||0
8450492|NCT00758680|20826001|P1|NOT COMPLETED|Overall Study||0
8450493|NCT00758680|20825992|P10|COMPLETED|Overall Study||28
8450494|NCT00758680|20825993|P9|COMPLETED|Overall Study||18
8450495|NCT00758680|20825994|P8|COMPLETED|Overall Study||19
8450496|NCT00758680|20825995|P7|COMPLETED|Overall Study||6
8450497|NCT00758680|20825996|P6|COMPLETED|Overall Study||6
8450498|NCT00758680|20825997|P5|COMPLETED|Overall Study||6
8450499|NCT00758680|20825998|P4|COMPLETED|Overall Study||6
8450500|NCT00758680|20825999|P3|COMPLETED|Overall Study||6
8450501|NCT00758680|20826000|P2|COMPLETED|Overall Study||6
8450502|NCT00758680|20826001|P1|COMPLETED|Overall Study||6
8450503|NCT00758680|20825992|P10|STARTED|Overall Study||29
8450504|NCT00758680|20825993|P9|STARTED|Overall Study||20
8450505|NCT00758680|20825994|P8|STARTED|Overall Study||20
8450506|NCT00758680|20825995|P7|STARTED|Overall Study||7
8450507|NCT00758680|20825996|P6|STARTED|Overall Study||6
8450508|NCT00758680|20825997|P5|STARTED|Overall Study||6
8450509|NCT00758680|20825998|P4|STARTED|Overall Study||6
8450510|NCT00758680|20825999|P3|STARTED|Overall Study||6
8450511|NCT00758680|20826000|P2|STARTED|Overall Study||6
8450512|NCT00758680|20826001|P1|STARTED|Overall Study||6
8450513|NCT00758667|20826043|P2|NOT COMPLETED|Overall Study||0
8450514|NCT00758667|20826044|P1|NOT COMPLETED|Overall Study||0
8450515|NCT00758667|20826043|P2|COMPLETED|Overall Study||11
8450516|NCT00758667|20826044|P1|COMPLETED|Overall Study||9
8450517|NCT00758667|20826043|P2|STARTED|Overall Study||11
8450518|NCT00758667|20826044|P1|STARTED|Overall Study||9
8450519|NCT00758602|20826054|P2|NOT COMPLETED|Overall Study||22
8450520|NCT00758602|20826055|P1|NOT COMPLETED|Overall Study||19
8450521|NCT00758602|20826054|P2|COMPLETED|Overall Study||84
8450522|NCT00758602|20826055|P1|COMPLETED|Overall Study||85
8450523|NCT00758602|20826054|P2|STARTED|Overall Study||106
8450524|NCT00758602|20826055|P1|STARTED|Overall Study||104
8450525|NCT00758589|20826081|P4|NOT COMPLETED|Overall Study||6
8450526|NCT00758589|20826082|P3|NOT COMPLETED|Overall Study||6
8450527|NCT00758589|20826083|P2|NOT COMPLETED|Overall Study||3
8450528|NCT00758589|20826084|P1|NOT COMPLETED|Overall Study||3
8450529|NCT00758589|20826081|P4|COMPLETED|Overall Study||85
8450530|NCT00758589|20826082|P3|COMPLETED|Overall Study||86
8450531|NCT00758589|20826083|P2|COMPLETED|Overall Study||87
8450532|NCT00758589|20826084|P1|COMPLETED|Overall Study||92
8450533|NCT00758589|20826081|P4|STARTED|Overall Study||91
8450534|NCT00758589|20826082|P3|STARTED|Overall Study||92
8450535|NCT00758589|20826083|P2|STARTED|Overall Study||90
8450536|NCT00758589|20826084|P1|STARTED|Overall Study||95
8450537|NCT00758576|20826150|P1|NOT COMPLETED|Overall Study||1
8450538|NCT00758576|20826150|P1|COMPLETED|Overall Study||63
8450539|NCT00758576|20826150|P1|STARTED|Overall Study||64
8450540|NCT00758563|20826158|P2|NOT COMPLETED|Overall Study||0
8450541|NCT00758563|20826159|P1|NOT COMPLETED|Overall Study||0
8450542|NCT00758563|20826158|P2|COMPLETED|Overall Study||8
8450543|NCT00758563|20826159|P1|COMPLETED|Overall Study||7
8450544|NCT00758563|20826158|P2|STARTED|Overall Study||8
8450545|NCT00758563|20826159|P1|STARTED|Overall Study||7
8450546|NCT00758550|20826165|P2|NOT COMPLETED|Overall Study||0
8450547|NCT00758550|20826166|P1|NOT COMPLETED|Overall Study||0
8450548|NCT00758550|20826165|P2|COMPLETED|Overall Study||30
8450549|NCT00758550|20826166|P1|COMPLETED|Overall Study||30
8450550|NCT00758550|20826165|P2|STARTED|Overall Study||30
8450551|NCT00758550|20826166|P1|STARTED|Overall Study||30
8450552|NCT00758498|20826177|P3|NOT COMPLETED|Overall Study||5
8450553|NCT00758498|20826178|P2|NOT COMPLETED|Overall Study||2
8450554|NCT00758498|20826179|P1|NOT COMPLETED|Overall Study||3
8450555|NCT00758498|20826177|P3|COMPLETED|Overall Study||137
8450556|NCT00758498|20826178|P2|COMPLETED|Overall Study||141
8450557|NCT00758498|20826179|P1|COMPLETED|Overall Study||139
8450558|NCT00758498|20826177|P3|STARTED|Overall Study||142
8450559|NCT00758498|20826178|P2|STARTED|Overall Study||143
8450560|NCT00758498|20826179|P1|STARTED|Overall Study||142
8450561|NCT00758485|20826264|P2|NOT COMPLETED|Overall Study||3
8450562|NCT00758485|20826265|P1|NOT COMPLETED|Overall Study||1
8450563|NCT00758485|20826264|P2|COMPLETED|Overall Study||67
8450564|NCT00758485|20826265|P1|COMPLETED|Overall Study||69
8450565|NCT00758485|20826264|P2|TREATED|Overall Study||68
8450566|NCT00758485|20826265|P1|TREATED|Overall Study||69
8450567|NCT00758485|20826264|P2|STARTED|Overall Study||70
8450568|NCT00758485|20826265|P1|STARTED|Overall Study||70
8450569|NCT00758459|20826277|P2|NOT COMPLETED|Overall Study||4
8450570|NCT00758459|20826278|P1|NOT COMPLETED|Overall Study||3
8450571|NCT00758459|20826277|P2|COMPLETED|Overall Study||35
8450572|NCT00758459|20826278|P1|COMPLETED|Overall Study||32
8450573|NCT00758459|20826277|P2|STARTED|Overall Study||39
8450574|NCT00758459|20826278|P1|STARTED|Overall Study||35
8450575|NCT00758420|20826312|P2|NOT COMPLETED|Overall Study||0
8450576|NCT00758420|20826313|P1|NOT COMPLETED|Overall Study||0
8450577|NCT00758420|20826312|P2|COMPLETED|Overall Study||38
8450578|NCT00758420|20826313|P1|COMPLETED|Overall Study||39
8450579|NCT00758420|20826312|P2|STARTED|Overall Study||38
8450580|NCT00758420|20826313|P1|STARTED|Overall Study||39
8450581|NCT00758394|20826323|P4|NOT COMPLETED|4th Intervention||0
8450582|NCT00758394|20826324|P3|NOT COMPLETED|4th Intervention||0
8450583|NCT00758394|20826325|P2|NOT COMPLETED|4th Intervention||0
8450584|NCT00758394|20826326|P1|NOT COMPLETED|4th Intervention||0
8450585|NCT00758394|20826323|P4|COMPLETED|4th Intervention||7
8450586|NCT00758394|20826324|P3|COMPLETED|4th Intervention||6
8450587|NCT00758394|20826325|P2|COMPLETED|4th Intervention||6
8450588|NCT00758394|20826326|P1|COMPLETED|4th Intervention||7
8450589|NCT00758394|20826323|P4|STARTED|4th Intervention||7
8450590|NCT00758394|20826324|P3|STARTED|4th Intervention||6
8450591|NCT00758394|20826325|P2|STARTED|4th Intervention||6
8450592|NCT00758394|20826326|P1|STARTED|4th Intervention||7
8450593|NCT00758394|20826323|P4|NOT COMPLETED|Washout After 3rd Intervention||0
8450594|NCT00758394|20826324|P3|NOT COMPLETED|Washout After 3rd Intervention||0
8450595|NCT00758394|20826325|P2|NOT COMPLETED|Washout After 3rd Intervention||0
8450596|NCT00758394|20826326|P1|NOT COMPLETED|Washout After 3rd Intervention||0
8450597|NCT00758394|20826323|P4|COMPLETED|Washout After 3rd Intervention||7
8450598|NCT00758394|20826324|P3|COMPLETED|Washout After 3rd Intervention||6
8450599|NCT00758394|20826325|P2|COMPLETED|Washout After 3rd Intervention||6
8450600|NCT00758394|20826326|P1|COMPLETED|Washout After 3rd Intervention||7
8450601|NCT00758394|20826323|P4|STARTED|Washout After 3rd Intervention||7
8450602|NCT00758394|20826324|P3|STARTED|Washout After 3rd Intervention||6
8450603|NCT00758394|20826325|P2|STARTED|Washout After 3rd Intervention||6
8450604|NCT00758394|20826326|P1|STARTED|Washout After 3rd Intervention||7
8450605|NCT00758394|20826323|P4|NOT COMPLETED|3rd Intervention||1
8450606|NCT00758394|20826324|P3|NOT COMPLETED|3rd Intervention||0
8450607|NCT00758394|20826325|P2|NOT COMPLETED|3rd Intervention||0
8450608|NCT00758394|20826326|P1|NOT COMPLETED|3rd Intervention||1
8450609|NCT00758394|20826323|P4|COMPLETED|3rd Intervention||7
8450610|NCT00758394|20826324|P3|COMPLETED|3rd Intervention||6
8450611|NCT00758394|20826325|P2|COMPLETED|3rd Intervention||6
8450612|NCT00758394|20826326|P1|COMPLETED|3rd Intervention||7
8450613|NCT00758394|20826323|P4|STARTED|3rd Intervention||8
8450614|NCT00758394|20826324|P3|STARTED|3rd Intervention||6
8450615|NCT00758394|20826325|P2|STARTED|3rd Intervention||6
8450616|NCT00758394|20826326|P1|STARTED|3rd Intervention||8
8450617|NCT00758394|20826323|P4|NOT COMPLETED|Washout After 2nd Intervention||0
8450618|NCT00758394|20826324|P3|NOT COMPLETED|Washout After 2nd Intervention||0
8450619|NCT00758394|20826325|P2|NOT COMPLETED|Washout After 2nd Intervention||0
8450620|NCT00758394|20826326|P1|NOT COMPLETED|Washout After 2nd Intervention||0
8450621|NCT00758394|20826323|P4|COMPLETED|Washout After 2nd Intervention||8
8450622|NCT00758394|20826324|P3|COMPLETED|Washout After 2nd Intervention||6
8450623|NCT00758394|20826325|P2|COMPLETED|Washout After 2nd Intervention||6
8450624|NCT00758394|20826326|P1|COMPLETED|Washout After 2nd Intervention||8
8450625|NCT00758394|20826323|P4|STARTED|Washout After 2nd Intervention||8
8450626|NCT00758394|20826324|P3|STARTED|Washout After 2nd Intervention||6
8450627|NCT00758394|20826325|P2|STARTED|Washout After 2nd Intervention||6
8450628|NCT00758394|20826326|P1|STARTED|Washout After 2nd Intervention||8
8450629|NCT00758394|20826323|P4|NOT COMPLETED|2nd Intervention Order||0
8450630|NCT00758394|20826324|P3|NOT COMPLETED|2nd Intervention Order||0
8450631|NCT00758394|20826325|P2|NOT COMPLETED|2nd Intervention Order||1
8450632|NCT00758394|20826326|P1|NOT COMPLETED|2nd Intervention Order||0
8450633|NCT00758394|20826323|P4|COMPLETED|2nd Intervention Order||8
8450634|NCT00758394|20826324|P3|COMPLETED|2nd Intervention Order||6
8450635|NCT00758394|20826325|P2|COMPLETED|2nd Intervention Order||6
8450636|NCT00758394|20826326|P1|COMPLETED|2nd Intervention Order||8
8450637|NCT00758394|20826323|P4|STARTED|2nd Intervention Order||8
8450638|NCT00758394|20826324|P3|STARTED|2nd Intervention Order||6
8450639|NCT00758394|20826325|P2|STARTED|2nd Intervention Order||7
8450640|NCT00758394|20826326|P1|STARTED|2nd Intervention Order||8
8450641|NCT00758394|20826323|P4|NOT COMPLETED|Washout After 1st Intervention||0
8450642|NCT00758394|20826324|P3|NOT COMPLETED|Washout After 1st Intervention||0
8450643|NCT00758394|20826325|P2|NOT COMPLETED|Washout After 1st Intervention||0
8450644|NCT00758394|20826326|P1|NOT COMPLETED|Washout After 1st Intervention||0
8450645|NCT00758394|20826323|P4|COMPLETED|Washout After 1st Intervention||8
8450646|NCT00758394|20826324|P3|COMPLETED|Washout After 1st Intervention||6
8450647|NCT00758394|20826325|P2|COMPLETED|Washout After 1st Intervention||7
8450648|NCT00758394|20826326|P1|COMPLETED|Washout After 1st Intervention||8
8450649|NCT00758394|20826323|P4|STARTED|Washout After 1st Intervention||8
8450650|NCT00758394|20826324|P3|STARTED|Washout After 1st Intervention||6
8450651|NCT00758394|20826325|P2|STARTED|Washout After 1st Intervention||7
8450652|NCT00758394|20826326|P1|STARTED|Washout After 1st Intervention||8
8450653|NCT00758394|20826323|P4|NOT COMPLETED|1st Intervention||0
8450654|NCT00758394|20826324|P3|NOT COMPLETED|1st Intervention||0
8450655|NCT00758394|20826325|P2|NOT COMPLETED|1st Intervention||0
8450656|NCT00758394|20826326|P1|NOT COMPLETED|1st Intervention||0
8450657|NCT00758394|20826323|P4|COMPLETED|1st Intervention||8
8450658|NCT00758394|20826324|P3|COMPLETED|1st Intervention||6
8450659|NCT00758394|20826325|P2|COMPLETED|1st Intervention||7
8450660|NCT00758394|20826326|P1|COMPLETED|1st Intervention||8
8450661|NCT00758394|20826323|P4|STARTED|1st Intervention||8
8450662|NCT00758394|20826324|P3|STARTED|1st Intervention||6
8450663|NCT00758394|20826325|P2|STARTED|1st Intervention||7
8450664|NCT00758394|20826326|P1|STARTED|1st Intervention||8
8450665|NCT00758342|20826338|P2|NOT COMPLETED|Overall Study||1
8450666|NCT00758342|20826339|P1|NOT COMPLETED|Overall Study||4
8450667|NCT00758342|20826338|P2|COMPLETED|Overall Study||17
8450668|NCT00758342|20826339|P1|COMPLETED|Overall Study||15
8450669|NCT00758342|20826338|P2|STARTED|Overall Study||18
8450670|NCT00758342|20826339|P1|STARTED|Overall Study||19
8450671|NCT00758290|20826347|P2|NOT COMPLETED|Overall Study||0
8450672|NCT00758290|20826348|P1|NOT COMPLETED|Overall Study||0
8450673|NCT00758290|20826347|P2|COMPLETED|Overall Study||12
8450674|NCT00758290|20826348|P1|COMPLETED|Overall Study||11
8450675|NCT00758290|20826347|P2|STARTED|Overall Study||12
8450676|NCT00758290|20826348|P1|STARTED|Overall Study||11
8450677|NCT00758264|20826355|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8450678|NCT00758264|20826356|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8450679|NCT00758264|20826357|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8450680|NCT00758264|20826355|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
8450681|NCT00758264|20826356|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
8450682|NCT00758264|20826357|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
8450683|NCT00758264|20826355|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
8450684|NCT00758264|20826356|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
8450685|NCT00758264|20826357|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
8450686|NCT00758264|20826355|P3|NOT COMPLETED|Active Phase||5
8450687|NCT00758264|20826356|P2|NOT COMPLETED|Active Phase||0
8450688|NCT00758264|20826357|P1|NOT COMPLETED|Active Phase||1
8450689|NCT00758264|20826355|P3|COMPLETED|Active Phase||85
8450690|NCT00758264|20826356|P2|COMPLETED|Active Phase||91
8450691|NCT00758264|20826357|P1|COMPLETED|Active Phase||181
8450692|NCT00758264|20826355|P3|STARTED|Active Phase||90
8450693|NCT00758264|20826356|P2|STARTED|Active Phase||91
8450694|NCT00758264|20826357|P1|STARTED|Active Phase||182
8450695|NCT00758160|20826416|P1|NOT COMPLETED|Overall Study||66
8450696|NCT00758160|20826416|P1|COMPLETED|Overall Study||230
8450697|NCT00758160|20826416|P1|STARTED|Overall Study||296
8450698|NCT00758069|20826437|P3|NOT COMPLETED|Overall Study||1
8450699|NCT00758069|20826438|P2|NOT COMPLETED|Overall Study||0
8450700|NCT00758069|20826439|P1|NOT COMPLETED|Overall Study||1
8450701|NCT00758069|20826437|P3|COMPLETED|Overall Study||27
8450702|NCT00758069|20826438|P2|COMPLETED|Overall Study||25
8450703|NCT00758069|20826439|P1|COMPLETED|Overall Study||26
8450704|NCT00758069|20826437|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
8450705|NCT00758069|20826438|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
8450706|NCT00758069|20826439|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
8450707|NCT00758043|20826454|P4|NOT COMPLETED|Overall Study||100
8450708|NCT00758043|20826455|P3|NOT COMPLETED|Overall Study||39
8450709|NCT00758043|20826456|P2|NOT COMPLETED|Overall Study||41
8450710|NCT00758043|20826457|P1|NOT COMPLETED|Overall Study||1
8450711|NCT00758043|20826454|P4|COMPLETED|Overall Study||0
8450712|NCT00758043|20826455|P3|COMPLETED|Overall Study||79
8450713|NCT00758043|20826456|P2|COMPLETED|Overall Study||119
8450714|NCT00758043|20826457|P1|COMPLETED|Overall Study||161
8450715|NCT00758043|20826454|P4|STARTED|Overall Study||100
8450716|NCT00758043|20826455|P3|STARTED|Overall Study||118
8450717|NCT00758043|20826456|P2|STARTED|Overall Study||160
8450718|NCT00758043|20826457|P1|STARTED|Overall Study||162
8450719|NCT00757848|20826485|P2|NOT COMPLETED|Overall Study||2
8450720|NCT00757848|20826486|P1|NOT COMPLETED|Overall Study||3
8450721|NCT00757848|20826485|P2|COMPLETED|Overall Study||27
8450722|NCT00757848|20826486|P1|COMPLETED|Overall Study||24
8450723|NCT00757848|20826485|P2|STARTED|Overall Study||29
8450724|NCT00757848|20826486|P1|STARTED|Overall Study||27
8450725|NCT00757822|20826532|P2|NOT COMPLETED|Overall Study||31
8450726|NCT00757822|20826533|P1|NOT COMPLETED|Overall Study||28
8450727|NCT00757822|20826532|P2|COMPLETED|Overall Study||57
8450728|NCT00757822|20826533|P1|COMPLETED|Overall Study||64
8450729|NCT00757822|20826532|P2|Data Lock, Unblinding Analysis|Overall Study||57
8450730|NCT00757822|20826533|P1|Data Lock, Unblinding Analysis|Overall Study||64
8450731|NCT00757822|20826532|P2|Withdrawn-protocol Deviation|Overall Study||8
8450732|NCT00757822|20826533|P1|Withdrawn-protocol Deviation|Overall Study||9
8450733|NCT00757822|20826532|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
8450734|NCT00757822|20826533|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
8450735|NCT00757822|20826532|P2|Data Entry, QC Assessment|Overall Study||74
8450736|NCT00757822|20826533|P1|Data Entry, QC Assessment|Overall Study||85
8450737|NCT00757822|20826532|P2|2-6 wk Post-op Assessment|Overall Study||74
8450738|NCT00757822|20826533|P1|2-6 wk Post-op Assessment|Overall Study||85
8450739|NCT00757822|20826532|P2|24-48 hr Telephone Assessment|Overall Study||74
8450740|NCT00757822|20826533|P1|24-48 hr Telephone Assessment|Overall Study||85
8450741|NCT00757822|20826532|P2|DOS: Post-operative Assessments|Overall Study||74
8450742|NCT00757822|20826533|P1|DOS: Post-operative Assessments|Overall Study||85
8450743|NCT00757822|20826532|P2|Received Study Intervention|Overall Study||74
8450744|NCT00757822|20826533|P1|Received Study Intervention|Overall Study||85
8450745|NCT00757822|20826532|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
8450746|NCT00757822|20826533|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
8450747|NCT00757822|20826532|P2|Withdrawal by Subject-no Intervention|Overall Study||3
8450748|NCT00757822|20826533|P1|Withdrawal by Subject-no Intervention|Overall Study||1
8450749|NCT00757822|20826532|P2|Day of Surgery (DOS) Assessment|Overall Study||88
8450750|NCT00757822|20826533|P1|Day of Surgery (DOS) Assessment|Overall Study||92
8450751|NCT00757822|20826532|P2|STARTED|Overall Study||88
8450752|NCT00757822|20826533|P1|STARTED|Overall Study||92
8450753|NCT00757783|20826555|P2|NOT COMPLETED|Overall Study||6
8450754|NCT00757783|20826556|P1|NOT COMPLETED|Overall Study||5
8450755|NCT00757783|20826555|P2|COMPLETED|Overall Study||25
8450756|NCT00757783|20826556|P1|COMPLETED|Overall Study||29
8450757|NCT00757783|20826555|P2|STARTED|Overall Study||31
8450758|NCT00757783|20826556|P1|STARTED|Overall Study||34
8450759|NCT00757705|20826592|P1|NOT COMPLETED|Overall Study||121
8450760|NCT00757705|20826592|P1|COMPLETED|Overall Study||178
8450761|NCT00757705|20826592|P1|STARTED|Overall Study||299
8450762|NCT00757666|20826606|P2|NOT COMPLETED|Overall Study||23
8450763|NCT00757666|20826607|P1|NOT COMPLETED|Overall Study||22
8450764|NCT00757666|20826606|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
8450765|NCT00757666|20826607|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
8450766|NCT00757666|20826606|P2|STARTED|Overall Study||34
8450767|NCT00757666|20826607|P1|STARTED|Overall Study||34
8450768|NCT00757627|20826621|P1|NOT COMPLETED|Overall Study||81
8450769|NCT00757627|20826621|P1|COMPLETED|Overall Study||419
8450770|NCT00757627|20826621|P1|STARTED|Overall Study||500
8450771|NCT00757601|20826634|P12|NOT COMPLETED|Period 5||0
8450772|NCT00757601|20826635|P11|NOT COMPLETED|Period 5||0
8450773|NCT00757601|20826636|P10|NOT COMPLETED|Period 5||0
8450774|NCT00757601|20826637|P9|NOT COMPLETED|Period 5||0
8450775|NCT00757601|20826638|P8|NOT COMPLETED|Period 5||0
8450776|NCT00757601|20826639|P7|NOT COMPLETED|Period 5||0
8450777|NCT00757601|20826640|P6|NOT COMPLETED|Period 5||0
8450778|NCT00757601|20826641|P5|NOT COMPLETED|Period 5||0
8450779|NCT00757601|20826642|P4|NOT COMPLETED|Period 5||0
8450780|NCT00757601|20826643|P3|NOT COMPLETED|Period 5||0
8450781|NCT00757601|20826644|P2|NOT COMPLETED|Period 5||0
8450782|NCT00757601|20826645|P1|NOT COMPLETED|Period 5||0
8450783|NCT00757601|20826634|P12|COMPLETED|Period 5||1
8450784|NCT00757601|20826635|P11|COMPLETED|Period 5||2
8450785|NCT00757601|20826636|P10|COMPLETED|Period 5||1
8450786|NCT00757601|20826637|P9|COMPLETED|Period 5||2
8450787|NCT00757601|20826638|P8|COMPLETED|Period 5||2
8450788|NCT00757601|20826639|P7|COMPLETED|Period 5||2
8450789|NCT00757601|20826640|P6|COMPLETED|Period 5||2
8450790|NCT00757601|20826641|P5|COMPLETED|Period 5||2
8450791|NCT00757601|20826642|P4|COMPLETED|Period 5||2
8450792|NCT00757601|20826643|P3|COMPLETED|Period 5||2
8450793|NCT00757601|20826644|P2|COMPLETED|Period 5||2
8450794|NCT00757601|20826645|P1|COMPLETED|Period 5||2
8450795|NCT00757601|20826634|P12|STARTED|Period 5||1
8450796|NCT00757601|20826635|P11|STARTED|Period 5||2
8450797|NCT00757601|20826636|P10|STARTED|Period 5||1
8450798|NCT00757601|20826637|P9|STARTED|Period 5||2
8450799|NCT00757601|20826638|P8|STARTED|Period 5||2
8450800|NCT00757601|20826639|P7|STARTED|Period 5||2
8450801|NCT00757601|20826640|P6|STARTED|Period 5||2
8450802|NCT00757601|20826641|P5|STARTED|Period 5||2
8450803|NCT00757601|20826642|P4|STARTED|Period 5||2
8450804|NCT00757601|20826643|P3|STARTED|Period 5||2
8450805|NCT00757601|20826644|P2|STARTED|Period 5||2
8450806|NCT00757601|20826645|P1|STARTED|Period 5||2
8450807|NCT00757601|20826634|P12|NOT COMPLETED|Period 4||1
8450808|NCT00757601|20826635|P11|NOT COMPLETED|Period 4||0
8450809|NCT00757601|20826636|P10|NOT COMPLETED|Period 4||1
8450810|NCT00757601|20826637|P9|NOT COMPLETED|Period 4||0
8450811|NCT00757601|20826638|P8|NOT COMPLETED|Period 4||0
8450812|NCT00757601|20826639|P7|NOT COMPLETED|Period 4||0
8450813|NCT00757601|20826640|P6|NOT COMPLETED|Period 4||0
8450814|NCT00757601|20826641|P5|NOT COMPLETED|Period 4||0
8450815|NCT00757601|20826642|P4|NOT COMPLETED|Period 4||0
8450816|NCT00757601|20826643|P3|NOT COMPLETED|Period 4||0
8450817|NCT00757601|20826644|P2|NOT COMPLETED|Period 4||0
8450818|NCT00757601|20826645|P1|NOT COMPLETED|Period 4||0
8450819|NCT00757601|20826634|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
8450820|NCT00757601|20826635|P11|COMPLETED|Period 4||2
8450821|NCT00757601|20826636|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
8450822|NCT00757601|20826637|P9|COMPLETED|Period 4||2
8450823|NCT00757601|20826638|P8|COMPLETED|Period 4||2
8450824|NCT00757601|20826639|P7|COMPLETED|Period 4||2
8450825|NCT00757601|20826640|P6|COMPLETED|Period 4||2
8450826|NCT00757601|20826641|P5|COMPLETED|Period 4||2
8450827|NCT00757601|20826642|P4|COMPLETED|Period 4||2
8450828|NCT00757601|20826643|P3|COMPLETED|Period 4||2
8450829|NCT00757601|20826644|P2|COMPLETED|Period 4||2
8450830|NCT00757601|20826645|P1|COMPLETED|Period 4||2
8450831|NCT00757601|20826634|P12|STARTED|Period 4||2
8450832|NCT00757601|20826635|P11|STARTED|Period 4||2
8450833|NCT00757601|20826636|P10|STARTED|Period 4||2
8450834|NCT00757601|20826637|P9|STARTED|Period 4||2
8450835|NCT00757601|20826638|P8|STARTED|Period 4||2
8450836|NCT00757601|20826639|P7|STARTED|Period 4||2
8450837|NCT00757601|20826640|P6|STARTED|Period 4||2
8450838|NCT00757601|20826641|P5|STARTED|Period 4||2
8450839|NCT00757601|20826642|P4|STARTED|Period 4||2
8450840|NCT00757601|20826643|P3|STARTED|Period 4||2
8450841|NCT00757601|20826644|P2|STARTED|Period 4||2
8450842|NCT00757601|20826645|P1|STARTED|Period 4||2
8450843|NCT00757601|20826634|P12|NOT COMPLETED|Period 3||0
8450844|NCT00757601|20826635|P11|NOT COMPLETED|Period 3||0
8450845|NCT00757601|20826636|P10|NOT COMPLETED|Period 3||0
8450846|NCT00757601|20826637|P9|NOT COMPLETED|Period 3||0
8450847|NCT00757601|20826638|P8|NOT COMPLETED|Period 3||0
8450848|NCT00757601|20826639|P7|NOT COMPLETED|Period 3||0
8450849|NCT00757601|20826640|P6|NOT COMPLETED|Period 3||0
8450850|NCT00757601|20826641|P5|NOT COMPLETED|Period 3||0
8450851|NCT00757601|20826642|P4|NOT COMPLETED|Period 3||0
8450852|NCT00757601|20826643|P3|NOT COMPLETED|Period 3||0
8450853|NCT00757601|20826644|P2|NOT COMPLETED|Period 3||0
8450854|NCT00757601|20826645|P1|NOT COMPLETED|Period 3||0
8450855|NCT00757601|20826634|P12|COMPLETED|Period 3||2
8450856|NCT00757601|20826635|P11|COMPLETED|Period 3||2
8450857|NCT00757601|20826636|P10|COMPLETED|Period 3||2
8450858|NCT00757601|20826637|P9|COMPLETED|Period 3||2
8450859|NCT00757601|20826638|P8|COMPLETED|Period 3||2
8450860|NCT00757601|20826639|P7|COMPLETED|Period 3||2
8450861|NCT00757601|20826640|P6|COMPLETED|Period 3||2
8450862|NCT00757601|20826641|P5|COMPLETED|Period 3||2
8450863|NCT00757601|20826642|P4|COMPLETED|Period 3||2
8450864|NCT00757601|20826643|P3|COMPLETED|Period 3||2
8450865|NCT00757601|20826644|P2|COMPLETED|Period 3||2
8450866|NCT00757601|20826645|P1|COMPLETED|Period 3||2
8450867|NCT00757601|20826634|P12|STARTED|Period 3||2
8450868|NCT00757601|20826635|P11|STARTED|Period 3||2
8450869|NCT00757601|20826636|P10|STARTED|Period 3||2
8450870|NCT00757601|20826637|P9|STARTED|Period 3||2
8450871|NCT00757601|20826638|P8|STARTED|Period 3||2
8450872|NCT00757601|20826639|P7|STARTED|Period 3||2
8450873|NCT00757601|20826640|P6|STARTED|Period 3||2
8450874|NCT00757601|20826641|P5|STARTED|Period 3||2
8450875|NCT00757601|20826642|P4|STARTED|Period 3||2
8450876|NCT00757601|20826643|P3|STARTED|Period 3||2
8450877|NCT00757601|20826644|P2|STARTED|Period 3||2
8450878|NCT00757601|20826645|P1|STARTED|Period 3||2
8450879|NCT00757601|20826634|P12|NOT COMPLETED|Period 2||1
8450880|NCT00757601|20826635|P11|NOT COMPLETED|Period 2||0
8450881|NCT00757601|20826636|P10|NOT COMPLETED|Period 2||0
8450882|NCT00757601|20826637|P9|NOT COMPLETED|Period 2||0
8450883|NCT00757601|20826638|P8|NOT COMPLETED|Period 2||0
8450884|NCT00757601|20826639|P7|NOT COMPLETED|Period 2||0
8450885|NCT00757601|20826640|P6|NOT COMPLETED|Period 2||0
8450886|NCT00757601|20826641|P5|NOT COMPLETED|Period 2||0
8450887|NCT00757601|20826642|P4|NOT COMPLETED|Period 2||0
8450888|NCT00757601|20826643|P3|NOT COMPLETED|Period 2||0
8450889|NCT00757601|20826644|P2|NOT COMPLETED|Period 2||0
8450890|NCT00757601|20826645|P1|NOT COMPLETED|Period 2||0
8450891|NCT00757601|20826634|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
8450892|NCT00757601|20826635|P11|COMPLETED|Period 2||2
8450893|NCT00757601|20826636|P10|COMPLETED|Period 2||2
8450894|NCT00757601|20826637|P9|COMPLETED|Period 2||2
8450895|NCT00757601|20826638|P8|COMPLETED|Period 2||2
8450896|NCT00757601|20826639|P7|COMPLETED|Period 2||2
8450897|NCT00757601|20826640|P6|COMPLETED|Period 2||2
8450898|NCT00757601|20826641|P5|COMPLETED|Period 2||2
8450899|NCT00757601|20826642|P4|COMPLETED|Period 2||2
8450900|NCT00757601|20826643|P3|COMPLETED|Period 2||2
8450901|NCT00757601|20826644|P2|COMPLETED|Period 2||2
8450902|NCT00757601|20826645|P1|COMPLETED|Period 2||2
8450903|NCT00757601|20826634|P12|STARTED|Period 2||3
8450904|NCT00757601|20826635|P11|STARTED|Period 2||2
8450905|NCT00757601|20826636|P10|STARTED|Period 2||2
8450906|NCT00757601|20826637|P9|STARTED|Period 2||2
8450907|NCT00757601|20826638|P8|STARTED|Period 2||2
8450908|NCT00757601|20826639|P7|STARTED|Period 2||2
8450909|NCT00757601|20826640|P6|STARTED|Period 2||2
8450910|NCT00757601|20826641|P5|STARTED|Period 2||2
8450911|NCT00757601|20826642|P4|STARTED|Period 2||2
8450912|NCT00757601|20826643|P3|STARTED|Period 2||2
8450913|NCT00757601|20826644|P2|STARTED|Period 2||2
8450914|NCT00757601|20826645|P1|STARTED|Period 2||2
8450915|NCT00757601|20826634|P12|NOT COMPLETED|Period 1||0
8450916|NCT00757601|20826635|P11|NOT COMPLETED|Period 1||0
8450917|NCT00757601|20826636|P10|NOT COMPLETED|Period 1||0
8450918|NCT00757601|20826637|P9|NOT COMPLETED|Period 1||0
8450919|NCT00757601|20826638|P8|NOT COMPLETED|Period 1||0
8450920|NCT00757601|20826639|P7|NOT COMPLETED|Period 1||0
8450921|NCT00757601|20826640|P6|NOT COMPLETED|Period 1||0
8450922|NCT00757601|20826641|P5|NOT COMPLETED|Period 1||0
8450923|NCT00757601|20826642|P4|NOT COMPLETED|Period 1||0
8450924|NCT00757601|20826643|P3|NOT COMPLETED|Period 1||0
8450925|NCT00757601|20826644|P2|NOT COMPLETED|Period 1||0
8450926|NCT00757601|20826645|P1|NOT COMPLETED|Period 1||0
8450927|NCT00757601|20826634|P12|COMPLETED|Period 1||3
8450928|NCT00757601|20826635|P11|COMPLETED|Period 1||2
8450929|NCT00757601|20826636|P10|COMPLETED|Period 1||2
8450930|NCT00757601|20826637|P9|COMPLETED|Period 1||2
8450931|NCT00757601|20826638|P8|COMPLETED|Period 1||2
8450932|NCT00757601|20826639|P7|COMPLETED|Period 1||2
8450933|NCT00757601|20826640|P6|COMPLETED|Period 1||2
8450934|NCT00757601|20826641|P5|COMPLETED|Period 1||2
8450935|NCT00757601|20826642|P4|COMPLETED|Period 1||2
8450936|NCT00757601|20826643|P3|COMPLETED|Period 1||2
8450937|NCT00757601|20826644|P2|COMPLETED|Period 1||2
8450938|NCT00757601|20826645|P1|COMPLETED|Period 1||2
8450939|NCT00757601|20826634|P12|STARTED|Period 1||3
8450940|NCT00757601|20826635|P11|STARTED|Period 1||2
8450941|NCT00757601|20826636|P10|STARTED|Period 1||2
8450942|NCT00757601|20826637|P9|STARTED|Period 1||2
8450943|NCT00757601|20826638|P8|STARTED|Period 1||2
8450944|NCT00757601|20826639|P7|STARTED|Period 1||2
8450945|NCT00757601|20826640|P6|STARTED|Period 1||2
8450946|NCT00757601|20826641|P5|STARTED|Period 1||2
8450947|NCT00757601|20826642|P4|STARTED|Period 1||2
8450948|NCT00757601|20826643|P3|STARTED|Period 1||2
8450949|NCT00757601|20826644|P2|STARTED|Period 1||2
8450950|NCT00757601|20826645|P1|STARTED|Period 1||2
8450951|NCT00757588|20826756|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
8450952|NCT00757588|20826757|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
8450953|NCT00757588|20826756|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
8450954|NCT00757588|20826757|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
8450955|NCT00757588|20826756|P2|STARTED|Period 2: Long-term (52-week) Phase||134
8450956|NCT00757588|20826757|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
8450957|NCT00757588|20826756|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
8450958|NCT00757588|20826757|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
8450959|NCT00757588|20826756|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
8450960|NCT00757588|20826757|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
8450961|NCT00757588|20826756|P2|STARTED|Period 1: Short-term (24-week) Phase||151
8450962|NCT00757588|20826757|P1|STARTED|Period 1: Short-term (24-week) Phase||304
8450963|NCT00757484|20826789|P1|NOT COMPLETED|Overall Study||0
8450964|NCT00757484|20826789|P1|COMPLETED|Overall Study||491
8450965|NCT00757484|20826789|P1|STARTED|Overall Study||491
8450966|NCT00757237|20826798|P2|NOT COMPLETED|Overall Study||25
8450967|NCT00757237|20826799|P1|NOT COMPLETED|Overall Study||13
8450968|NCT00757237|20826798|P2|COMPLETED|Overall Study||111
8450969|NCT00757237|20826799|P1|COMPLETED|Overall Study||124
8450970|NCT00757237|20826798|P2|Treated|Overall Study||132
8450971|NCT00757237|20826799|P1|Treated|Overall Study||136
8450972|NCT00757237|20826798|P2|STARTED|Overall Study||136
8450973|NCT00757237|20826799|P1|STARTED|Overall Study||137
8450974|NCT00757172|20826827|P1|NOT COMPLETED|Overall Study||11
8450975|NCT00757172|20826827|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
8450976|NCT00757172|20826827|P1|STARTED|Overall Study||65
8450977|NCT00757003|20826835|P1|NOT COMPLETED|Overall Study||49
8450978|NCT00757003|20826835|P1|COMPLETED|Overall Study||51
8450979|NCT00757003|20826835|P1|STARTED|Overall Study||100
8450980|NCT00756977|20826843|P2|NOT COMPLETED|Overall Study||11
8450981|NCT00756977|20826844|P1|NOT COMPLETED|Overall Study||21
8450982|NCT00756977|20826843|P2|COMPLETED|Overall Study||187
8450983|NCT00756977|20826844|P1|COMPLETED|Overall Study||175
8450984|NCT00756977|20826843|P2|STARTED|Overall Study||198
8450985|NCT00756977|20826844|P1|STARTED|Overall Study||196
8450986|NCT00756964|20826872|P2|NOT COMPLETED|Overall Study||0
8450987|NCT00756964|20826873|P1|NOT COMPLETED|Overall Study||0
8450988|NCT00756964|20826872|P2|COMPLETED|Overall Study||13
8450989|NCT00756964|20826873|P1|COMPLETED|Overall Study||13
8450990|NCT00756964|20826872|P2|STARTED|Overall Study||13
8450991|NCT00756964|20826873|P1|STARTED|Overall Study||13
8450992|NCT00756938|20826882|P4|NOT COMPLETED|Optional Extension||37
8450993|NCT00756938|20826883|P3|NOT COMPLETED|Optional Extension||0
8450994|NCT00756938|20826884|P2|NOT COMPLETED|Optional Extension||0
8450995|NCT00756938|20826885|P1|NOT COMPLETED|Optional Extension||0
8450996|NCT00756938|20826882|P4|COMPLETED|Optional Extension||53
8450997|NCT00756938|20826883|P3|COMPLETED|Optional Extension||0
8450998|NCT00756938|20826884|P2|COMPLETED|Optional Extension||0
8450999|NCT00756938|20826885|P1|COMPLETED|Optional Extension||0
8451000|NCT00756938|20826882|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
8451001|NCT00756938|20826883|P3|STARTED|Optional Extension||0
8451002|NCT00756938|20826884|P2|STARTED|Optional Extension||0
8451003|NCT00756938|20826885|P1|STARTED|Optional Extension||0
8451004|NCT00756938|20826882|P4|NOT COMPLETED|12-week Base Study||0
8451005|NCT00756938|20826883|P3|NOT COMPLETED|12-week Base Study||2
8451006|NCT00756938|20826884|P2|NOT COMPLETED|12-week Base Study||0
8451007|NCT00756938|20826885|P1|NOT COMPLETED|12-week Base Study||2
8451008|NCT00756938|20826882|P4|COMPLETED|12-week Base Study||0
8451009|NCT00756938|20826883|P3|COMPLETED|12-week Base Study||32
8451010|NCT00756938|20826884|P2|COMPLETED|12-week Base Study||34
8451011|NCT00756938|20826885|P1|COMPLETED|12-week Base Study||31
8451012|NCT00756938|20826882|P4|STARTED|12-week Base Study||0
8451013|NCT00756938|20826883|P3|STARTED|12-week Base Study||34
8451014|NCT00756938|20826884|P2|STARTED|12-week Base Study||34
8451015|NCT00756938|20826885|P1|STARTED|12-week Base Study||33
8451016|NCT00756886|20826913|P2|NOT COMPLETED|Overall Study||7
8451017|NCT00756886|20826914|P1|NOT COMPLETED|Overall Study||11
8451018|NCT00756886|20826913|P2|COMPLETED|Overall Study||25
8451019|NCT00756886|20826914|P1|COMPLETED|Overall Study||30
8451020|NCT00756886|20826913|P2|STARTED|Overall Study||32
8451021|NCT00756886|20826914|P1|STARTED|Overall Study||41
8451022|NCT00756730|20826922|P2|NOT COMPLETED|Overall Study||2
8451023|NCT00756730|20826923|P1|NOT COMPLETED|Overall Study||0
8451024|NCT00756730|20826922|P2|COMPLETED|Overall Study||22
8451025|NCT00756730|20826923|P1|COMPLETED|Overall Study||25
8451026|NCT00756730|20826922|P2|STARTED|Overall Study||24
8451027|NCT00756730|20826923|P1|STARTED|Overall Study||25
8451028|NCT00756717|20826943|P1|NOT COMPLETED|Overall Study||2
8451029|NCT00756717|20826943|P1|COMPLETED|Overall Study||20
8451030|NCT00756717|20826943|P1|STARTED|Overall Study||22
8451031|NCT00756678|20826947|P1|NOT COMPLETED|Overall Study||1
8451032|NCT00756678|20826947|P1|COMPLETED|Overall Study||50
8451033|NCT00756678|20826947|P1|STARTED|Overall Study||51
8451034|NCT00756652|20826960|P2|NOT COMPLETED|Re-Op Phase||0
8451035|NCT00756652|20826961|P1|NOT COMPLETED|Re-Op Phase||2876
8451036|NCT00756652|20826960|P2|COMPLETED|Re-Op Phase||0
8451037|NCT00756652|20826961|P1|COMPLETED|Re-Op Phase||8225
8451038|NCT00756652|20826960|P2|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
8451039|NCT00756652|20826961|P1|STARTED|Re-Op Phase||11101
8451040|NCT00756652|20826960|P2|NOT COMPLETED|Original Phase||921
8451041|NCT00756652|20826961|P1|NOT COMPLETED|Original Phase||35389
8451042|NCT00756652|20826960|P2|COMPLETED|Original Phase||118
8451043|NCT00756652|20826961|P1|COMPLETED|Original Phase|At Year 7|6063
8451044|NCT00756652|20826960|P2|STARTED|Original Phase||1039
8451045|NCT00756652|20826961|P1|STARTED|Original Phase||41452
8451046|NCT00756613|20826969|P2|NOT COMPLETED|Overall Study||70
8451047|NCT00756613|20826970|P1|NOT COMPLETED|Overall Study||86
8451048|NCT00756613|20826969|P2|COMPLETED|Overall Study||462
8451049|NCT00756613|20826970|P1|COMPLETED|Overall Study||426
8451050|NCT00756613|20826969|P2|STARTED|Overall Study||532
8451051|NCT00756613|20826970|P1|STARTED|Overall Study||512
8451052|NCT00756600|20826985|P2|NOT COMPLETED|Overall Study||0
8451053|NCT00756600|20826986|P1|NOT COMPLETED|Overall Study||0
8451054|NCT00756600|20826985|P2|COMPLETED|Overall Study||356
8451055|NCT00756600|20826986|P1|COMPLETED|Overall Study||287
8451056|NCT00756600|20826985|P2|STARTED|Overall Study||356
8451057|NCT00756600|20826986|P1|STARTED|Overall Study||287
8451058|NCT00756574|20827072|P2|NOT COMPLETED|Overall Study||11
8451059|NCT00756574|20827073|P1|NOT COMPLETED|Overall Study||13
8451060|NCT00756574|20827072|P2|COMPLETED|Overall Study||210
8451061|NCT00756574|20827073|P1|COMPLETED|Overall Study||212
8451062|NCT00756574|20827072|P2|STARTED|Overall Study||221
8451063|NCT00756574|20827073|P1|STARTED|Overall Study||225
8451064|NCT00756561|20827083|P1|NOT COMPLETED|Overall Study||0
8451065|NCT00756561|20827083|P1|COMPLETED|Overall Study||10
8451066|NCT00756561|20827083|P1|STARTED|Overall Study||10
8451067|NCT00756548|20827090|P2|NOT COMPLETED|Overall Study||0
8451068|NCT00756548|20827091|P1|NOT COMPLETED|Overall Study||2
8451069|NCT00756548|20827090|P2|COMPLETED|Overall Study||185
8451070|NCT00756548|20827091|P1|COMPLETED|Overall Study||184
8451071|NCT00756548|20827090|P2|STARTED|Overall Study||185
8451072|NCT00756548|20827091|P1|STARTED|Overall Study||186
8451073|NCT00756496|20827117|P1|NOT COMPLETED|Overall Study||0
8451074|NCT00756496|20827117|P1|COMPLETED|Overall Study||442
8451075|NCT00756496|20827117|P1|STARTED|Overall Study||442
8451076|NCT00756470|20827122|P1|NOT COMPLETED|Overall Study||5
8451077|NCT00756470|20827122|P1|COMPLETED|Overall Study||10
8451078|NCT00756470|20827122|P1|STARTED|Overall Study||15
8451079|NCT00756457|20827129|P2|NOT COMPLETED|Overall Study||2
8451080|NCT00756457|20827130|P1|NOT COMPLETED|Overall Study||1
8451081|NCT00756457|20827129|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
8451082|NCT00756457|20827130|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
8451083|NCT00756457|20827129|P2|STARTED|Overall Study||19
8451084|NCT00756457|20827130|P1|STARTED|Overall Study||20
8451085|NCT00756444|20827160|P2|NOT COMPLETED|Overall Study||21
8451086|NCT00756444|20827161|P1|NOT COMPLETED|Overall Study||15
8451087|NCT00756444|20827160|P2|COMPLETED|Overall Study||13
8451088|NCT00756444|20827161|P1|COMPLETED|Overall Study||18
8451089|NCT00756444|20827160|P2|STARTED|Overall Study||34
8451090|NCT00756444|20827161|P1|STARTED|Overall Study||33
8451091|NCT00756314|20827172|P2|NOT COMPLETED|Overall Study||59
8451092|NCT00756314|20827173|P1|NOT COMPLETED|Overall Study||2
8451093|NCT00756314|20827172|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
8451094|NCT00756314|20827173|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
8451095|NCT00756314|20827172|P2|STARTED|Overall Study||123
8451096|NCT00756314|20827173|P1|STARTED|Overall Study||123
8451097|NCT00756275|20827189|P2|NOT COMPLETED|Overall Study||28
8451098|NCT00756275|20827190|P1|NOT COMPLETED|Overall Study||29
8451099|NCT00756275|20827189|P2|COMPLETED|Overall Study||49
8451100|NCT00756275|20827190|P1|COMPLETED|Overall Study||31
8451101|NCT00756275|20827189|P2|STARTED|Overall Study||77
8451102|NCT00756275|20827190|P1|STARTED|Overall Study||60
8451103|NCT00756236|20827217|P3|NOT COMPLETED|Overall Study||0
8451104|NCT00756236|20827218|P2|NOT COMPLETED|Overall Study||0
8451105|NCT00756236|20827219|P1|NOT COMPLETED|Overall Study||0
8451106|NCT00756236|20827217|P3|COMPLETED|Overall Study||20
8451107|NCT00756236|20827218|P2|COMPLETED|Overall Study||20
8451108|NCT00756236|20827219|P1|COMPLETED|Overall Study||20
8451109|NCT00756236|20827217|P3|STARTED|Overall Study||20
8451110|NCT00756236|20827218|P2|STARTED|Overall Study||20
8451111|NCT00756236|20827219|P1|STARTED|Overall Study||20
8451112|NCT00756106|20827227|P1|NOT COMPLETED|Overall Study||12
8451113|NCT00756106|20827227|P1|COMPLETED|Overall Study||3
8451114|NCT00756106|20827227|P1|STARTED|Overall Study||15
8451115|NCT00756093|20827239|P4|NOT COMPLETED|Fourth Intervention||0
8451116|NCT00756093|20827240|P3|NOT COMPLETED|Fourth Intervention||0
8451117|NCT00756093|20827241|P2|NOT COMPLETED|Fourth Intervention||0
8451118|NCT00756093|20827242|P1|NOT COMPLETED|Fourth Intervention||0
8451119|NCT00756093|20827239|P4|COMPLETED|Fourth Intervention||5
8451120|NCT00756093|20827240|P3|COMPLETED|Fourth Intervention||5
8451121|NCT00756093|20827241|P2|COMPLETED|Fourth Intervention||5
8451122|NCT00756093|20827242|P1|COMPLETED|Fourth Intervention||5
8451123|NCT00756093|20827239|P4|STARTED|Fourth Intervention||5
8451124|NCT00756093|20827240|P3|STARTED|Fourth Intervention||5
8451125|NCT00756093|20827241|P2|STARTED|Fourth Intervention||5
8451126|NCT00756093|20827242|P1|STARTED|Fourth Intervention||5
8451127|NCT00756093|20827239|P4|NOT COMPLETED|Third Intervention||0
8451128|NCT00756093|20827240|P3|NOT COMPLETED|Third Intervention||0
8451129|NCT00756093|20827241|P2|NOT COMPLETED|Third Intervention||0
8451130|NCT00756093|20827242|P1|NOT COMPLETED|Third Intervention||0
8451131|NCT00756093|20827239|P4|COMPLETED|Third Intervention||5
8451132|NCT00756093|20827240|P3|COMPLETED|Third Intervention||5
8451133|NCT00756093|20827241|P2|COMPLETED|Third Intervention||5
8451134|NCT00756093|20827242|P1|COMPLETED|Third Intervention||5
8451135|NCT00756093|20827239|P4|STARTED|Third Intervention||5
8451136|NCT00756093|20827240|P3|STARTED|Third Intervention||5
8451137|NCT00756093|20827241|P2|STARTED|Third Intervention||5
8451138|NCT00756093|20827242|P1|STARTED|Third Intervention||5
8451139|NCT00756093|20827239|P4|NOT COMPLETED|Second Intervention||0
8451140|NCT00756093|20827240|P3|NOT COMPLETED|Second Intervention||0
8451141|NCT00756093|20827241|P2|NOT COMPLETED|Second Intervention||0
8451142|NCT00756093|20827242|P1|NOT COMPLETED|Second Intervention||0
8451143|NCT00756093|20827239|P4|COMPLETED|Second Intervention||5
8451144|NCT00756093|20827240|P3|COMPLETED|Second Intervention||5
8451145|NCT00756093|20827241|P2|COMPLETED|Second Intervention||5
8451146|NCT00756093|20827242|P1|COMPLETED|Second Intervention||5
8451147|NCT00756093|20827239|P4|STARTED|Second Intervention||5
8451148|NCT00756093|20827240|P3|STARTED|Second Intervention||5
8451149|NCT00756093|20827241|P2|STARTED|Second Intervention||5
8451150|NCT00756093|20827242|P1|STARTED|Second Intervention||5
8451151|NCT00756093|20827239|P4|NOT COMPLETED|First Intervention||0
8451152|NCT00756093|20827240|P3|NOT COMPLETED|First Intervention||0
8451153|NCT00756093|20827241|P2|NOT COMPLETED|First Intervention||0
8451154|NCT00756093|20827242|P1|NOT COMPLETED|First Intervention||0
8451155|NCT00756093|20827239|P4|COMPLETED|First Intervention||5
8451156|NCT00756093|20827240|P3|COMPLETED|First Intervention||5
8451157|NCT00756093|20827241|P2|COMPLETED|First Intervention||5
8451158|NCT00756093|20827242|P1|COMPLETED|First Intervention||5
8451159|NCT00756093|20827239|P4|STARTED|First Intervention||5
8451160|NCT00756093|20827240|P3|STARTED|First Intervention||5
8451161|NCT00756093|20827241|P2|STARTED|First Intervention||5
8451162|NCT00756093|20827242|P1|STARTED|First Intervention||5
8451163|NCT00756002|20827254|P2|NOT COMPLETED|Placebo Run-out||0
8451164|NCT00756002|20827255|P1|NOT COMPLETED|Placebo Run-out||0
8451165|NCT00756002|20827254|P2|COMPLETED|Placebo Run-out||0
8451166|NCT00756002|20827255|P1|COMPLETED|Placebo Run-out||114
8451167|NCT00756002|20827254|P2|STARTED|Placebo Run-out||0
8451168|NCT00756002|20827255|P1|STARTED|Placebo Run-out||114
8451169|NCT00756002|20827254|P2|NOT COMPLETED|Double-Blind Treatment Period||15
8451170|NCT00756002|20827255|P1|NOT COMPLETED|Double-Blind Treatment Period||15
8451171|NCT00756002|20827254|P2|COMPLETED|Double-Blind Treatment Period||115
8451172|NCT00756002|20827255|P1|COMPLETED|Double-Blind Treatment Period||114
8451173|NCT00756002|20827254|P2|STARTED|Double-Blind Treatment Period||130
8451174|NCT00756002|20827255|P1|STARTED|Double-Blind Treatment Period||129
8451175|NCT00756002|20827254|P2|NOT COMPLETED|Placebo Run-in||0
8451176|NCT00756002|20827255|P1|NOT COMPLETED|Placebo Run-in||229
8451177|NCT00756002|20827254|P2|COMPLETED|Placebo Run-in||0
8451178|NCT00756002|20827255|P1|COMPLETED|Placebo Run-in||259
8451179|NCT00756002|20827254|P2|STARTED|Placebo Run-in||0
8451180|NCT00756002|20827255|P1|STARTED|Placebo Run-in||488
8451181|NCT00755937|20827349|P1|NOT COMPLETED|Observational Follow-up||148
8451182|NCT00755937|20827349|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
8451183|NCT00755937|20827349|P1|STARTED|Observational Follow-up||392
8451184|NCT00755937|20827349|P1|NOT COMPLETED|Recruitment||164
8451185|NCT00755937|20827349|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
8451186|NCT00755937|20827349|P1|STARTED|Recruitment|Subjects registered in the program|556
8451187|NCT00755911|20827361|P2|NOT COMPLETED|Overall Study||0
8451188|NCT00755911|20827362|P1|NOT COMPLETED|Overall Study||0
8451189|NCT00755911|20827361|P2|COMPLETED|Overall Study||12
8451190|NCT00755911|20827362|P1|COMPLETED|Overall Study||12
8451191|NCT00755911|20827361|P2|STARTED|Overall Study||12
8451192|NCT00755911|20827362|P1|STARTED|Overall Study||12
8451193|NCT00755846|20827376|P6|NOT COMPLETED|Overall Study||14
8451194|NCT00755846|20827377|P5|NOT COMPLETED|Overall Study||17
8451195|NCT00755846|20827378|P4|NOT COMPLETED|Overall Study||13
8451196|NCT00755846|20827379|P3|NOT COMPLETED|Overall Study||12
8451197|NCT00755846|20827380|P2|NOT COMPLETED|Overall Study||17
8451198|NCT00755846|20827381|P1|NOT COMPLETED|Overall Study||25
8451199|NCT00755846|20827376|P6|COMPLETED|Overall Study||31
8451200|NCT00755846|20827377|P5|COMPLETED|Overall Study||27
8451201|NCT00755846|20827378|P4|COMPLETED|Overall Study||32
8451202|NCT00755846|20827379|P3|COMPLETED|Overall Study||32
8451203|NCT00755846|20827380|P2|COMPLETED|Overall Study||27
8451204|NCT00755846|20827381|P1|COMPLETED|Overall Study||18
8451205|NCT00755846|20827376|P6|STARTED|Overall Study||45
8451206|NCT00755846|20827377|P5|STARTED|Overall Study||44
8451207|NCT00755846|20827378|P4|STARTED|Overall Study||45
8451208|NCT00755846|20827379|P3|STARTED|Overall Study||44
8451209|NCT00755846|20827380|P2|STARTED|Overall Study||44
8451210|NCT00755846|20827381|P1|STARTED|Overall Study||43
8451211|NCT00755807|20827481|P2|NOT COMPLETED|Open-label Extension Phase||16
8451212|NCT00755807|20827482|P1|NOT COMPLETED|Open-label Extension Phase||18
8451213|NCT00755807|20827481|P2|COMPLETED|Open-label Extension Phase||93
8451214|NCT00755807|20827482|P1|COMPLETED|Open-label Extension Phase||82
8451215|NCT00755807|20827481|P2|STARTED|Open-label Extension Phase||109
8451216|NCT00755807|20827482|P1|STARTED|Open-label Extension Phase||100
8451217|NCT00755807|20827481|P2|NOT COMPLETED|Acute Phase||12
8451218|NCT00755807|20827482|P1|NOT COMPLETED|Acute Phase||18
8451219|NCT00755807|20827481|P2|COMPLETED|Acute Phase||109
8451220|NCT00755807|20827482|P1|COMPLETED|Acute Phase||100
8451221|NCT00755807|20827481|P2|STARTED|Acute Phase||121
8451222|NCT00755807|20827482|P1|STARTED|Acute Phase||118
8451223|NCT00755755|20827546|P3|NOT COMPLETED|Overall Study||3
8451224|NCT00755755|20827547|P2|NOT COMPLETED|Overall Study||8
8451225|NCT00755755|20827548|P1|NOT COMPLETED|Overall Study||6
8451226|NCT00755755|20827546|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
8451227|NCT00755755|20827547|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
8451228|NCT00755755|20827548|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
8451229|NCT00755755|20827546|P3|STARTED|Overall Study|Safety population|48
8451230|NCT00755755|20827547|P2|STARTED|Overall Study|Safety population|98
8451231|NCT00755755|20827548|P1|STARTED|Overall Study|Safety population|95
8451232|NCT00755716|20827562|P3|NOT COMPLETED|Overall Study||3
8451233|NCT00755716|20827563|P2|NOT COMPLETED|Overall Study||8
8451234|NCT00755716|20827564|P1|NOT COMPLETED|Overall Study||8
8451235|NCT00755716|20827562|P3|COMPLETED|Overall Study||16
8451236|NCT00755716|20827563|P2|COMPLETED|Overall Study||11
8451237|NCT00755716|20827564|P1|COMPLETED|Overall Study||11
8451238|NCT00755716|20827562|P3|STARTED|Overall Study||19
8451239|NCT00755716|20827563|P2|STARTED|Overall Study||19
8451240|NCT00755716|20827564|P1|STARTED|Overall Study||19
8451241|NCT00755417|20827578|P3|NOT COMPLETED|Overall Study||42
8451242|NCT00755417|20827579|P2|NOT COMPLETED|Overall Study||55
8451243|NCT00755417|20827580|P1|NOT COMPLETED|Overall Study||62
8451244|NCT00755417|20827578|P3|COMPLETED|Overall Study||135
8451245|NCT00755417|20827579|P2|COMPLETED|Overall Study||126
8451246|NCT00755417|20827580|P1|COMPLETED|Overall Study||112
8451247|NCT00755417|20827578|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
8451248|NCT00755417|20827579|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
8451249|NCT00755417|20827580|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
8451250|NCT00755326|20827599|P2|NOT COMPLETED|Overall Study||3
8451251|NCT00755326|20827600|P1|NOT COMPLETED|Overall Study||2
8451252|NCT00755326|20827599|P2|COMPLETED|Overall Study||42
8451253|NCT00755326|20827600|P1|COMPLETED|Overall Study||45
8451254|NCT00755326|20827599|P2|STARTED|Overall Study||45
8451255|NCT00755326|20827600|P1|STARTED|Overall Study||47
8451256|NCT00755274|20827612|P2|NOT COMPLETED|Overall Study||0
8451257|NCT00755274|20827613|P1|NOT COMPLETED|Overall Study||0
8451258|NCT00755274|20827612|P2|COMPLETED|Overall Study||8
8451259|NCT00755274|20827613|P1|COMPLETED|Overall Study||24
8451260|NCT00755274|20827612|P2|STARTED|Overall Study||8
8451261|NCT00755274|20827613|P1|STARTED|Overall Study||24
8451262|NCT00755261|20827633|P1|NOT COMPLETED|Overall Study||2
8451263|NCT00755261|20827633|P1|COMPLETED|Overall Study||4
8451264|NCT00755261|20827633|P1|STARTED|Overall Study||6
8451265|NCT00755235|20827639|P2|NOT COMPLETED|Overall Study||9
8451266|NCT00755235|20827640|P1|NOT COMPLETED|Overall Study||2
8451267|NCT00755235|20827639|P2|COMPLETED|Overall Study||93
8451268|NCT00755235|20827640|P1|COMPLETED|Overall Study||104
8451269|NCT00755235|20827639|P2|STARTED|Overall Study||102
8451270|NCT00755235|20827640|P1|STARTED|Overall Study||106
8451271|NCT00755222|20827650|P2|NOT COMPLETED|Overall Study||2
8451272|NCT00755222|20827651|P1|NOT COMPLETED|Overall Study||8
8451273|NCT00755222|20827650|P2|COMPLETED|Overall Study||34
8451274|NCT00755222|20827651|P1|COMPLETED|Overall Study||103
8451275|NCT00755222|20827650|P2|STARTED|Overall Study||36
8451276|NCT00755222|20827651|P1|STARTED|Overall Study||111
8451277|NCT00755196|20827665|P1|NOT COMPLETED|Overall Study||2
8451278|NCT00755196|20827665|P1|COMPLETED|Overall Study||28
8451279|NCT00755196|20827665|P1|STARTED|Overall Study||30
8451280|NCT00755183|20827672|P2|NOT COMPLETED|Overall Study||6
8451281|NCT00755183|20827673|P1|NOT COMPLETED|Overall Study||7
8451282|NCT00755183|20827672|P2|COMPLETED|Overall Study||24
8451283|NCT00755183|20827673|P1|COMPLETED|Overall Study||23
8451284|NCT00755183|20827672|P2|STARTED|Overall Study||30
8451285|NCT00755183|20827673|P1|STARTED|Overall Study||30
8451286|NCT00755131|20827683|P2|NOT COMPLETED|Overall Study||0
8451287|NCT00755131|20827684|P1|NOT COMPLETED|Overall Study||0
8451288|NCT00755131|20827683|P2|COMPLETED|Overall Study||38
8451289|NCT00755131|20827684|P1|COMPLETED|Overall Study||37
8451290|NCT00755131|20827683|P2|STARTED|Overall Study||38
8451291|NCT00755131|20827684|P1|STARTED|Overall Study||37
8451292|NCT00755105|20827697|P3|NOT COMPLETED|Overall Study||4
8451293|NCT00755105|20827698|P2|NOT COMPLETED|Overall Study||11
8451294|NCT00755105|20827699|P1|NOT COMPLETED|Overall Study||9
8451295|NCT00755105|20827697|P3|COMPLETED|Overall Study||5
8451296|NCT00755105|20827698|P2|COMPLETED|Overall Study||19
8451297|NCT00755105|20827699|P1|COMPLETED|Overall Study||29
8451298|NCT00755105|20827697|P3|STARTED|Overall Study||9
8451299|NCT00755105|20827698|P2|STARTED|Overall Study||30
8451300|NCT00755105|20827699|P1|STARTED|Overall Study||38
8451301|NCT00755079|20827709|P2|NOT COMPLETED|Overall Study||6
8451302|NCT00755079|20827710|P1|NOT COMPLETED|Overall Study||1
8451303|NCT00755079|20827709|P2|COMPLETED|Overall Study||16
8451304|NCT00755079|20827710|P1|COMPLETED|Overall Study||17
8451305|NCT00755079|20827709|P2|STARTED|Overall Study||22
8451306|NCT00755079|20827710|P1|STARTED|Overall Study||18
8451307|NCT00755040|20827720|P2|NOT COMPLETED|Overall Study||34
8451308|NCT00755040|20827721|P1|NOT COMPLETED|Overall Study||43
8451309|NCT00755040|20827720|P2|COMPLETED|Overall Study||47
8451310|NCT00755040|20827721|P1|COMPLETED|Overall Study||40
8451311|NCT00755040|20827720|P2|STARTED|Overall Study||81
8451312|NCT00755040|20827721|P1|STARTED|Overall Study||83
8451313|NCT00754936|20827729|P1|NOT COMPLETED|Overall Study||12
8451314|NCT00754936|20827729|P1|COMPLETED|Overall Study||59
8451315|NCT00754936|20827729|P1|STARTED|Overall Study||71
8451316|NCT00754923|20827734|P1|NOT COMPLETED|Overall Study||0
8451317|NCT00754923|20827734|P1|COMPLETED|Overall Study||11
8451318|NCT00754923|20827734|P1|STARTED|Overall Study||11
8451319|NCT00754845|20827743|P2|NOT COMPLETED|Overall Study||0
8451320|NCT00754845|20827744|P1|NOT COMPLETED|Overall Study||0
8451321|NCT00754845|20827743|P2|COMPLETED|Overall Study||959
8451322|NCT00754845|20827744|P1|COMPLETED|Overall Study||959
8451323|NCT00754845|20827743|P2|STARTED|Overall Study||959
8451324|NCT00754845|20827744|P1|STARTED|Overall Study||959
8451325|NCT00754832|20827756|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
8451326|NCT00754832|20827757|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
8451327|NCT00754832|20827756|P2|COMPLETED|Second 6 Weeks Intervention||24
8451328|NCT00754832|20827757|P1|COMPLETED|Second 6 Weeks Intervention||17
8451329|NCT00754832|20827756|P2|STARTED|Second 6 Weeks Intervention||26
8451330|NCT00754832|20827757|P1|STARTED|Second 6 Weeks Intervention||17
8451331|NCT00754832|20827756|P2|NOT COMPLETED|2 Weeks Washout||2
8451332|NCT00754832|20827757|P1|NOT COMPLETED|2 Weeks Washout||1
8451333|NCT00754832|20827756|P2|COMPLETED|2 Weeks Washout||26
8451334|NCT00754832|20827757|P1|COMPLETED|2 Weeks Washout||17
8451335|NCT00754832|20827756|P2|STARTED|2 Weeks Washout||28
8451336|NCT00754832|20827757|P1|STARTED|2 Weeks Washout||18
8451337|NCT00754832|20827756|P2|NOT COMPLETED|First 6 Weeks Intervention||2
8451338|NCT00754832|20827757|P1|NOT COMPLETED|First 6 Weeks Intervention||8
8451339|NCT00754832|20827756|P2|COMPLETED|First 6 Weeks Intervention||28
8451340|NCT00754832|20827757|P1|COMPLETED|First 6 Weeks Intervention||18
8451341|NCT00754832|20827756|P2|STARTED|First 6 Weeks Intervention||30
8451342|NCT00754832|20827757|P1|STARTED|First 6 Weeks Intervention||26
8451343|NCT00754793|20827769|P2|NOT COMPLETED|Overall Study||1
8451344|NCT00754793|20827770|P1|NOT COMPLETED|Overall Study||0
8451345|NCT00754793|20827769|P2|COMPLETED|Overall Study||1
8451346|NCT00754793|20827770|P1|COMPLETED|Overall Study||1
8451347|NCT00754793|20827769|P2|STARTED|Overall Study||2
8451348|NCT00754793|20827770|P1|STARTED|Overall Study||1
8451349|NCT00754767|20827778|P2|NOT COMPLETED|Overall Study||0
8451350|NCT00754767|20827779|P1|NOT COMPLETED|Overall Study||0
8451351|NCT00754767|20827778|P2|COMPLETED|Overall Study||0
8451352|NCT00754767|20827779|P1|COMPLETED|Overall Study||2
8451353|NCT00754767|20827778|P2|STARTED|Overall Study||0
8451354|NCT00754767|20827779|P1|STARTED|Overall Study||2
8451355|NCT00754741|20827788|P3|NOT COMPLETED|Overall Study||54
8451356|NCT00754741|20827789|P2|NOT COMPLETED|Overall Study||69
8451357|NCT00754741|20827790|P1|NOT COMPLETED|Overall Study||57
8451358|NCT00754741|20827788|P3|COMPLETED|Overall Study||502
8451359|NCT00754741|20827789|P2|COMPLETED|Overall Study||500
8451360|NCT00754741|20827790|P1|COMPLETED|Overall Study||510
8451361|NCT00754741|20827788|P3|STARTED|Overall Study||556
8451362|NCT00754741|20827789|P2|STARTED|Overall Study||569
8451363|NCT00754741|20827790|P1|STARTED|Overall Study||567
8451364|NCT00754650|20827837|P1|NOT COMPLETED|Overall Study||2
8451365|NCT00754650|20827837|P1|COMPLETED|Overall Study||0
8451366|NCT00754650|20827837|P1|STARTED|Overall Study||2
8451367|NCT00754624|20827842|P1|NOT COMPLETED|Overall Study||69
8451368|NCT00754624|20827842|P1|COMPLETED|Overall Study||160
8451369|NCT00754624|20827842|P1|STARTED|Overall Study||229
8451370|NCT00754572|20827852|P1|NOT COMPLETED|Overall Study||71
8451371|NCT00754572|20827852|P1|COMPLETED|Overall Study||347
8451372|NCT00754572|20827852|P1|STARTED|Overall Study||418
8451373|NCT00754559|20827879|P1|NOT COMPLETED|Overall Study||47
8451374|NCT00754559|20827879|P1|COMPLETED|Overall Study||239
8451375|NCT00754559|20827879|P1|STARTED|Overall Study||286
8451376|NCT00754546|20827903|P1|NOT COMPLETED|Overall Study||0
8451377|NCT00754546|20827903|P1|COMPLETED|Overall Study||20
8451378|NCT00754546|20827903|P1|STARTED|Overall Study||20
8451379|NCT00754494|20827920|P3|NOT COMPLETED|Overall Study||1
8451380|NCT00754494|20827921|P2|NOT COMPLETED|Overall Study||0
8451381|NCT00754494|20827922|P1|NOT COMPLETED|Overall Study||2
8451382|NCT00754494|20827920|P3|COMPLETED|Overall Study||14
8451383|NCT00754494|20827921|P2|COMPLETED|Overall Study||15
8451384|NCT00754494|20827922|P1|COMPLETED|Overall Study||13
8451385|NCT00754494|20827920|P3|STARTED|Overall Study||15
8451386|NCT00754494|20827921|P2|STARTED|Overall Study||15
8451387|NCT00754494|20827922|P1|STARTED|Overall Study||15
8451388|NCT00754468|20827968|P2|NOT COMPLETED|Overall Study||0
8451389|NCT00754468|20827969|P1|NOT COMPLETED|Overall Study||0
8451390|NCT00754468|20827968|P2|COMPLETED|Overall Study||3
8451391|NCT00754468|20827969|P1|COMPLETED|Overall Study||4
8451392|NCT00754468|20827968|P2|STARTED|Overall Study||3
8451393|NCT00754468|20827969|P1|STARTED|Overall Study||4
8451394|NCT00754442|20827979|P2|NOT COMPLETED|Overall Study||3
8451395|NCT00754442|20827980|P1|NOT COMPLETED|Overall Study||5
8451396|NCT00754442|20827979|P2|COMPLETED|Overall Study||6
8451397|NCT00754442|20827980|P1|COMPLETED|Overall Study||6
8451398|NCT00754442|20827979|P2|STARTED|Overall Study|patients 9|9
8451399|NCT00754442|20827980|P1|STARTED|Overall Study|controls 11|11
8451400|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
8451401|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
8451402|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
8451403|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
8451404|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
8451405|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
8451406|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
8451407|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
8451408|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
8451409|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
8451410|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
8451411|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
8451412|NCT00754377|20827996|P2|NOT COMPLETED|Overall Study||0
8451413|NCT00754377|20827997|P1|NOT COMPLETED|Overall Study||0
8451414|NCT00754377|20827996|P2|COMPLETED|Overall Study||42
8451415|NCT00754377|20827997|P1|COMPLETED|Overall Study||50
8451416|NCT00754377|20827996|P2|STARTED|Overall Study||42
8451417|NCT00754377|20827997|P1|STARTED|Overall Study||50
8451418|NCT00754338|20828009|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
8451419|NCT00754338|20828010|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
8451420|NCT00754338|20828011|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
8451421|NCT00754338|20828012|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
8451422|NCT00754338|20828009|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
8451423|NCT00754338|20828010|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
8451424|NCT00754338|20828011|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
8451425|NCT00754338|20828012|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
8451426|NCT00754338|20828009|P4|STARTED|Second Intervention for Phase1&Phase2||19
8451427|NCT00754338|20828010|P3|STARTED|Second Intervention for Phase1&Phase2||16
8451428|NCT00754338|20828011|P2|STARTED|Second Intervention for Phase1&Phase2||18
8451429|NCT00754338|20828012|P1|STARTED|Second Intervention for Phase1&Phase2||17
8451430|NCT00754338|20828009|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
8451431|NCT00754338|20828010|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
8451432|NCT00754338|20828011|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
8451433|NCT00754338|20828012|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
8451434|NCT00754338|20828009|P4|COMPLETED|First Intervention for Phase1&Phase2||19
8451435|NCT00754338|20828010|P3|COMPLETED|First Intervention for Phase1&Phase2||16
8451436|NCT00754338|20828011|P2|COMPLETED|First Intervention for Phase1&Phase2||18
8451437|NCT00754338|20828012|P1|COMPLETED|First Intervention for Phase1&Phase2||17
8451438|NCT00754338|20828009|P4|STARTED|First Intervention for Phase1&Phase2||19
8451439|NCT00754338|20828010|P3|STARTED|First Intervention for Phase1&Phase2||19
8451440|NCT00754338|20828011|P2|STARTED|First Intervention for Phase1&Phase2||21
8451441|NCT00754338|20828012|P1|STARTED|First Intervention for Phase1&Phase2||17
8451442|NCT00754325|20828044|P2|NOT COMPLETED|Progression and Cross-over||21
8451443|NCT00754325|20828045|P1|NOT COMPLETED|Progression and Cross-over||0
8451444|NCT00754325|20828044|P2|COMPLETED|Progression and Cross-over||0
8451445|NCT00754325|20828045|P1|COMPLETED|Progression and Cross-over||0
8451446|NCT00754325|20828044|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
8451447|NCT00754325|20828045|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
8451448|NCT00754325|20828044|P2|NOT COMPLETED|Initial Treatment||49
8451449|NCT00754325|20828045|P1|NOT COMPLETED|Initial Treatment||50
8451450|NCT00754325|20828044|P2|COMPLETED|Initial Treatment||0
8451451|NCT00754325|20828045|P1|COMPLETED|Initial Treatment||0
8451452|NCT00754325|20828044|P2|STARTED|Initial Treatment||49
8451453|NCT00754325|20828045|P1|STARTED|Initial Treatment||50
8451454|NCT00754247|20828067|P3|NOT COMPLETED|Overall Study||5
8451455|NCT00754247|20828068|P2|NOT COMPLETED|Overall Study||5
8451456|NCT00754247|20828069|P1|NOT COMPLETED|Overall Study||5
8451457|NCT00754247|20828067|P3|COMPLETED|Overall Study||5
8451458|NCT00754247|20828068|P2|COMPLETED|Overall Study||5
8451459|NCT00754247|20828069|P1|COMPLETED|Overall Study||5
8451460|NCT00754247|20828067|P3|STARTED|Overall Study||10
8451461|NCT00754247|20828068|P2|STARTED|Overall Study||10
8451462|NCT00754247|20828069|P1|STARTED|Overall Study||10
8451463|NCT00754234|20828098|P1|NOT COMPLETED|Overall Study||3
8451464|NCT00754234|20828098|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
8451465|NCT00754234|20828098|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
8451466|NCT00754208|20828102|P1|NOT COMPLETED|Overall Study||0
8451467|NCT00754208|20828102|P1|COMPLETED|Overall Study||7
8451468|NCT00754208|20828102|P1|STARTED|Overall Study||7
8451469|NCT00754156|20828111|P2|NOT COMPLETED|Overall Study||0
8451470|NCT00754156|20828112|P1|NOT COMPLETED|Overall Study||0
8451471|NCT00754156|20828111|P2|COMPLETED|Overall Study||6
8451472|NCT00754156|20828112|P1|COMPLETED|Overall Study||8
8451473|NCT00754156|20828111|P2|STARTED|Overall Study||6
8451474|NCT00754156|20828112|P1|STARTED|Overall Study||8
8451475|NCT00754130|20828136|P6|NOT COMPLETED|Period 2 (5 Days)||0
8451476|NCT00754130|20828137|P5|NOT COMPLETED|Period 2 (5 Days)||0
8451477|NCT00754130|20828138|P4|NOT COMPLETED|Period 2 (5 Days)||0
8451478|NCT00754130|20828139|P3|NOT COMPLETED|Period 2 (5 Days)||0
8451479|NCT00754130|20828140|P2|NOT COMPLETED|Period 2 (5 Days)||0
8451480|NCT00754130|20828141|P1|NOT COMPLETED|Period 2 (5 Days)||0
8451481|NCT00754130|20828136|P6|COMPLETED|Period 2 (5 Days)||4
8451482|NCT00754130|20828137|P5|COMPLETED|Period 2 (5 Days)||2
8451483|NCT00754130|20828138|P4|COMPLETED|Period 2 (5 Days)||2
8451484|NCT00754130|20828139|P3|COMPLETED|Period 2 (5 Days)||4
8451485|NCT00754130|20828140|P2|COMPLETED|Period 2 (5 Days)||2
8451486|NCT00754130|20828141|P1|COMPLETED|Period 2 (5 Days)||2
8451487|NCT00754130|20828136|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
8451488|NCT00754130|20828137|P5|STARTED|Period 2 (5 Days)||2
8451489|NCT00754130|20828138|P4|STARTED|Period 2 (5 Days)||2
8451490|NCT00754130|20828139|P3|STARTED|Period 2 (5 Days)||4
8451491|NCT00754130|20828140|P2|STARTED|Period 2 (5 Days)||2
8451492|NCT00754130|20828141|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
8451493|NCT00754130|20828136|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
8451494|NCT00754130|20828137|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
8451495|NCT00754130|20828138|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
8451496|NCT00754130|20828139|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
8451497|NCT00754130|20828140|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
8451498|NCT00754130|20828141|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
8451499|NCT00754130|20828136|P6|COMPLETED|Washout Period (>=8 Days)||4
8451500|NCT00754130|20828137|P5|COMPLETED|Washout Period (>=8 Days)||2
8451501|NCT00754130|20828138|P4|COMPLETED|Washout Period (>=8 Days)||2
8451502|NCT00754130|20828139|P3|COMPLETED|Washout Period (>=8 Days)||4
8451503|NCT00754130|20828140|P2|COMPLETED|Washout Period (>=8 Days)||2
8451504|NCT00754130|20828141|P1|COMPLETED|Washout Period (>=8 Days)||2
8451505|NCT00754130|20828136|P6|STARTED|Washout Period (>=8 Days)||4
8451506|NCT00754130|20828137|P5|STARTED|Washout Period (>=8 Days)||2
8451507|NCT00754130|20828138|P4|STARTED|Washout Period (>=8 Days)||2
8451508|NCT00754130|20828139|P3|STARTED|Washout Period (>=8 Days)||4
8451509|NCT00754130|20828140|P2|STARTED|Washout Period (>=8 Days)||2
8451510|NCT00754130|20828141|P1|STARTED|Washout Period (>=8 Days)||2
8451511|NCT00754130|20828136|P6|NOT COMPLETED|Period 1 (5 Days)||0
8451512|NCT00754130|20828137|P5|NOT COMPLETED|Period 1 (5 Days)||0
8451513|NCT00754130|20828138|P4|NOT COMPLETED|Period 1 (5 Days)||0
8451514|NCT00754130|20828139|P3|NOT COMPLETED|Period 1 (5 Days)||0
8451515|NCT00754130|20828140|P2|NOT COMPLETED|Period 1 (5 Days)||0
8451516|NCT00754130|20828141|P1|NOT COMPLETED|Period 1 (5 Days)||0
8451517|NCT00754130|20828136|P6|COMPLETED|Period 1 (5 Days)||4
8451518|NCT00754130|20828137|P5|COMPLETED|Period 1 (5 Days)||2
8451519|NCT00754130|20828138|P4|COMPLETED|Period 1 (5 Days)||2
8451520|NCT00754130|20828139|P3|COMPLETED|Period 1 (5 Days)||4
8451521|NCT00754130|20828140|P2|COMPLETED|Period 1 (5 Days)||2
8451522|NCT00754130|20828141|P1|COMPLETED|Period 1 (5 Days)||2
8451523|NCT00754130|20828136|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
8451524|NCT00754130|20828137|P5|STARTED|Period 1 (5 Days)||2
8451525|NCT00754130|20828138|P4|STARTED|Period 1 (5 Days)||2
8451526|NCT00754130|20828139|P3|STARTED|Period 1 (5 Days)||4
8451527|NCT00754130|20828140|P2|STARTED|Period 1 (5 Days)||2
8451528|NCT00754130|20828141|P1|STARTED|Period 1 (5 Days)||2
8451529|NCT00754065|20828184|P2|NOT COMPLETED|Overall Study||80
8451530|NCT00754065|20828185|P1|NOT COMPLETED|Overall Study||81
8451531|NCT00754065|20828184|P2|COMPLETED|Overall Study||126
8451532|NCT00754065|20828185|P1|COMPLETED|Overall Study||122
8451533|NCT00754065|20828184|P2|Cycle 6|Overall Study||153
8451534|NCT00754065|20828185|P1|Cycle 6|Overall Study||141
8451535|NCT00754065|20828184|P2|Participants Received Treatment|Overall Study||204
8451536|NCT00754065|20828185|P1|Participants Received Treatment|Overall Study||191
8451537|NCT00754065|20828184|P2|STARTED|Overall Study||206
8451538|NCT00754065|20828185|P1|STARTED|Overall Study||203
8451539|NCT00754052|20828425|P2|NOT COMPLETED|Overall Study||3
8451540|NCT00754052|20828426|P1|NOT COMPLETED|Overall Study||5
8451541|NCT00754052|20828425|P2|COMPLETED|Overall Study||0
8451542|NCT00754052|20828426|P1|COMPLETED|Overall Study||0
8451543|NCT00754052|20828425|P2|STARTED|Overall Study||3
8451544|NCT00754052|20828426|P1|STARTED|Overall Study||5
8451545|NCT00754013|20828440|P2|NOT COMPLETED|Overall Study||5
8451546|NCT00754013|20828441|P1|NOT COMPLETED|Overall Study||4
8451547|NCT00754013|20828440|P2|COMPLETED|Overall Study||0
8451548|NCT00754013|20828441|P1|COMPLETED|Overall Study||0
8451549|NCT00754013|20828440|P2|STARTED|Overall Study||5
8451550|NCT00754013|20828441|P1|STARTED|Overall Study||4
8451551|NCT00753948|20828452|P3|NOT COMPLETED|Overall Study||0
8451552|NCT00753948|20828453|P2|NOT COMPLETED|Overall Study||0
8451553|NCT00753948|20828454|P1|NOT COMPLETED|Overall Study||0
8451554|NCT00753948|20828452|P3|COMPLETED|Overall Study||7
8451555|NCT00753948|20828453|P2|COMPLETED|Overall Study||7
8451556|NCT00753948|20828454|P1|COMPLETED|Overall Study||9
8451557|NCT00753948|20828452|P3|STARTED|Overall Study||7
8451558|NCT00753948|20828453|P2|STARTED|Overall Study||7
8451559|NCT00753948|20828454|P1|STARTED|Overall Study||9
8451560|NCT00753935|20828467|P2|NOT COMPLETED|Overall Study||0
8451561|NCT00753935|20828468|P1|NOT COMPLETED|Overall Study||0
8451562|NCT00753935|20828467|P2|COMPLETED|Overall Study||47
8451563|NCT00753935|20828468|P1|COMPLETED|Overall Study||45
8451564|NCT00753935|20828467|P2|STARTED|Overall Study||47
8451565|NCT00753935|20828468|P1|STARTED|Overall Study||45
8451566|NCT00753922|20828478|P4|NOT COMPLETED|Overall Study||23
8451567|NCT00753922|20828479|P3|NOT COMPLETED|Overall Study||63
8451568|NCT00753922|20828480|P2|NOT COMPLETED|Overall Study||94
8451569|NCT00753922|20828481|P1|NOT COMPLETED|Overall Study||246
8451570|NCT00753922|20828478|P4|COMPLETED|Overall Study||37
8451571|NCT00753922|20828479|P3|COMPLETED|Overall Study||82
8451572|NCT00753922|20828480|P2|COMPLETED|Overall Study||157
8451573|NCT00753922|20828481|P1|COMPLETED|Overall Study||306
8451574|NCT00753922|20828478|P4|STARTED|Overall Study||60
8451575|NCT00753922|20828479|P3|STARTED|Overall Study||145
8451576|NCT00753922|20828480|P2|STARTED|Overall Study||251
8451577|NCT00753922|20828481|P1|STARTED|Overall Study||552
8451578|NCT00753896|20828511|P1|NOT COMPLETED|Overall Study||16
8451579|NCT00753896|20828511|P1|COMPLETED|Overall Study||118
8451580|NCT00753896|20828511|P1|STARTED|Overall Study||134
8451581|NCT00753766|20828527|P2|NOT COMPLETED|Overall Study||0
8451582|NCT00753766|20828528|P1|NOT COMPLETED|Overall Study||1
8451583|NCT00753766|20828527|P2|COMPLETED|Overall Study||0
8451584|NCT00753766|20828528|P1|COMPLETED|Overall Study||0
8451585|NCT00753766|20828527|P2|STARTED|Overall Study||0
8451586|NCT00753766|20828528|P1|STARTED|Overall Study||1
8451587|NCT00753714|20828550|P2|NOT COMPLETED|Overall Study||62
8451588|NCT00753714|20828551|P1|NOT COMPLETED|Overall Study||60
8451589|NCT00753714|20828550|P2|COMPLETED|Overall Study||1
8451590|NCT00753714|20828551|P1|COMPLETED|Overall Study||1
8451591|NCT00753714|20828550|P2|STARTED|Overall Study||63
8451592|NCT00753714|20828551|P1|STARTED|Overall Study||61
8451593|NCT00753688|20828567|P2|NOT COMPLETED|Overall Study||246
8451594|NCT00753688|20828568|P1|NOT COMPLETED|Overall Study||123
8451595|NCT00753688|20828567|P2|COMPLETED|Overall Study||0
8451596|NCT00753688|20828568|P1|COMPLETED|Overall Study||0
8451597|NCT00753688|20828567|P2|Ongoing - in Follow-up|Overall Study||31
8451598|NCT00753688|20828568|P1|Ongoing - in Follow-up|Overall Study||15
8451599|NCT00753688|20828567|P2|STARTED|Overall Study||246
8451600|NCT00753688|20828568|P1|STARTED|Overall Study||123
8451601|NCT00753675|20828597|P3|NOT COMPLETED|Overall Study||56
8451602|NCT00753675|20828598|P2|NOT COMPLETED|Overall Study||59
8451603|NCT00753675|20828599|P1|NOT COMPLETED|Overall Study||59
8451604|NCT00753675|20828597|P3|COMPLETED|Overall Study||0
8451605|NCT00753675|20828598|P2|COMPLETED|Overall Study||0
8451606|NCT00753675|20828599|P1|COMPLETED|Overall Study||0
8451607|NCT00753675|20828597|P3|STARTED|Overall Study||56
8451608|NCT00753675|20828598|P2|STARTED|Overall Study||59
8451609|NCT00753675|20828599|P1|STARTED|Overall Study||59
8451610|NCT00753649|20828621|P2|NOT COMPLETED|Overall Study||0
8451611|NCT00753649|20828622|P1|NOT COMPLETED|Overall Study||7
8451612|NCT00753649|20828621|P2|COMPLETED|Overall Study||112
8451613|NCT00753649|20828622|P1|COMPLETED|Overall Study||105
8451614|NCT00753649|20828621|P2|STARTED|Overall Study||112
8451615|NCT00753649|20828622|P1|STARTED|Overall Study||112
8451616|NCT00753636|20828642|P1|NOT COMPLETED|Overall Study||6
8451617|NCT00753636|20828642|P1|COMPLETED|Overall Study||25
8451618|NCT00753636|20828642|P1|STARTED|Overall Study||31
8451619|NCT00753623|20828654|P2|NOT COMPLETED|Phase II (14 Days)||1
8451620|NCT00753623|20828655|P1|NOT COMPLETED|Phase II (14 Days)||0
8451621|NCT00753623|20828654|P2|COMPLETED|Phase II (14 Days)||7
8451622|NCT00753623|20828655|P1|COMPLETED|Phase II (14 Days)||8
8451623|NCT00753623|20828654|P2|STARTED|Phase II (14 Days)||8
8451624|NCT00753623|20828655|P1|STARTED|Phase II (14 Days)||8
8451625|NCT00753623|20828654|P2|NOT COMPLETED|Washout (7 Days)||0
8451626|NCT00753623|20828655|P1|NOT COMPLETED|Washout (7 Days)||1
8451627|NCT00753623|20828654|P2|COMPLETED|Washout (7 Days)||8
8451628|NCT00753623|20828655|P1|COMPLETED|Washout (7 Days)||8
8451629|NCT00753623|20828654|P2|STARTED|Washout (7 Days)||8
8451630|NCT00753623|20828655|P1|STARTED|Washout (7 Days)||9
8451631|NCT00753623|20828654|P2|NOT COMPLETED|Phase I (14 Days)||4
8451632|NCT00753623|20828655|P1|NOT COMPLETED|Phase I (14 Days)||2
8451633|NCT00753623|20828654|P2|COMPLETED|Phase I (14 Days)||8
8451634|NCT00753623|20828655|P1|COMPLETED|Phase I (14 Days)||9
8451635|NCT00753623|20828654|P2|STARTED|Phase I (14 Days)||12
8451636|NCT00753623|20828655|P1|STARTED|Phase I (14 Days)||11
8451637|NCT00753545|20828663|P2|NOT COMPLETED|Overall Study||118
8451638|NCT00753545|20828664|P1|NOT COMPLETED|Overall Study||108
8451639|NCT00753545|20828663|P2|COMPLETED|Overall Study|Patients completing the Study|11
8451640|NCT00753545|20828664|P1|COMPLETED|Overall Study|Patients completing the Study|28
8451641|NCT00753545|20828663|P2|STARTED|Overall Study|Patients randomized|129
8451642|NCT00753545|20828664|P1|STARTED|Overall Study|Patients randomized|136
8451643|NCT00753519|20828702|P2|NOT COMPLETED|Overall Study||2
8451644|NCT00753519|20828703|P1|NOT COMPLETED|Overall Study||0
8451645|NCT00753519|20828702|P2|COMPLETED|Overall Study||13
8451646|NCT00753519|20828703|P1|COMPLETED|Overall Study||13
8451647|NCT00753519|20828702|P2|STARTED|Overall Study||15
8451648|NCT00753519|20828703|P1|STARTED|Overall Study||13
8451649|NCT00753506|20828725|P2|NOT COMPLETED|Overall Study||2
8451650|NCT00753506|20828726|P1|NOT COMPLETED|Overall Study||7
8451651|NCT00753506|20828725|P2|COMPLETED|Overall Study||31
8451652|NCT00753506|20828726|P1|COMPLETED|Overall Study||26
8451653|NCT00753506|20828725|P2|STARTED|Overall Study||33
8451654|NCT00753506|20828726|P1|STARTED|Overall Study||33
8451655|NCT00753454|20828732|P1|NOT COMPLETED|Overall Study||14
8451656|NCT00753454|20828732|P1|COMPLETED|Overall Study||154
8451657|NCT00753454|20828732|P1|STARTED|Overall Study||168
8451658|NCT00753415|20828766|P10|NOT COMPLETED|Part B||1
8451659|NCT00753415|20828767|P9|NOT COMPLETED|Part B||3
8451660|NCT00753415|20828768|P8|NOT COMPLETED|Part B||1
8451661|NCT00753415|20828769|P7|NOT COMPLETED|Part B||0
8451662|NCT00753415|20828770|P6|NOT COMPLETED|Part B||0
8451663|NCT00753415|20828771|P5|NOT COMPLETED|Part B||0
8451664|NCT00753415|20828772|P4|NOT COMPLETED|Part B||0
8451665|NCT00753415|20828773|P3|NOT COMPLETED|Part B||0
8451666|NCT00753415|20828774|P2|NOT COMPLETED|Part B||0
8451667|NCT00753415|20828775|P1|NOT COMPLETED|Part B||0
8451668|NCT00753415|20828766|P10|COMPLETED|Part B||8
8451669|NCT00753415|20828767|P9|COMPLETED|Part B||6
8451670|NCT00753415|20828768|P8|COMPLETED|Part B||6
8451671|NCT00753415|20828769|P7|COMPLETED|Part B||2
8451672|NCT00753415|20828770|P6|COMPLETED|Part B||1
8451673|NCT00753415|20828771|P5|COMPLETED|Part B||0
8451674|NCT00753415|20828772|P4|COMPLETED|Part B||0
8451675|NCT00753415|20828773|P3|COMPLETED|Part B||0
8451676|NCT00753415|20828774|P2|COMPLETED|Part B||0
8451677|NCT00753415|20828775|P1|COMPLETED|Part B||0
8451678|NCT00753415|20828766|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
8451679|NCT00753415|20828767|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
8451680|NCT00753415|20828768|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
8451681|NCT00753415|20828769|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
8451682|NCT00753415|20828770|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
8451683|NCT00753415|20828771|P5|STARTED|Part B||0
8451684|NCT00753415|20828772|P4|STARTED|Part B||0
8451685|NCT00753415|20828773|P3|STARTED|Part B||0
8451686|NCT00753415|20828774|P2|STARTED|Part B||0
8451687|NCT00753415|20828775|P1|STARTED|Part B||0
8451688|NCT00753415|20828766|P10|NOT COMPLETED|Part A||0
8451689|NCT00753415|20828767|P9|NOT COMPLETED|Part A||0
8451690|NCT00753415|20828768|P8|NOT COMPLETED|Part A||0
8451691|NCT00753415|20828769|P7|NOT COMPLETED|Part A||0
8451692|NCT00753415|20828770|P6|NOT COMPLETED|Part A||0
8451693|NCT00753415|20828771|P5|NOT COMPLETED|Part A||0
8451694|NCT00753415|20828772|P4|NOT COMPLETED|Part A||2
8451695|NCT00753415|20828773|P3|NOT COMPLETED|Part A||2
8451696|NCT00753415|20828774|P2|NOT COMPLETED|Part A||0
8451697|NCT00753415|20828775|P1|NOT COMPLETED|Part A||1
8451698|NCT00753415|20828766|P10|COMPLETED|Part A||0
8451699|NCT00753415|20828767|P9|COMPLETED|Part A||0
8451700|NCT00753415|20828768|P8|COMPLETED|Part A||0
8451701|NCT00753415|20828769|P7|COMPLETED|Part A||0
8451702|NCT00753415|20828770|P6|COMPLETED|Part A||0
8451703|NCT00753415|20828771|P5|COMPLETED|Part A||10
8451704|NCT00753415|20828772|P4|COMPLETED|Part A||9
8451705|NCT00753415|20828773|P3|COMPLETED|Part A||8
8451706|NCT00753415|20828774|P2|COMPLETED|Part A||3
8451707|NCT00753415|20828775|P1|COMPLETED|Part A||2
8451708|NCT00753415|20828766|P10|STARTED|Part A||0
8451709|NCT00753415|20828767|P9|STARTED|Part A||0
8451710|NCT00753415|20828768|P8|STARTED|Part A||0
8451711|NCT00753415|20828769|P7|STARTED|Part A||0
8451712|NCT00753415|20828770|P6|STARTED|Part A||0
8451713|NCT00753415|20828771|P5|STARTED|Part A||10
8451714|NCT00753415|20828772|P4|STARTED|Part A||11
8451715|NCT00753415|20828773|P3|STARTED|Part A||10
8451716|NCT00753415|20828774|P2|STARTED|Part A||3
8451717|NCT00753415|20828775|P1|STARTED|Part A||3
8451718|NCT00753363|20828819|P2|NOT COMPLETED|Overall Study||39
8451719|NCT00753363|20828820|P1|NOT COMPLETED|Overall Study||40
8451720|NCT00753363|20828819|P2|COMPLETED|Overall Study||21
8451721|NCT00753363|20828820|P1|COMPLETED|Overall Study||19
8451722|NCT00753363|20828819|P2|STARTED|Overall Study||60
8451723|NCT00753363|20828820|P1|STARTED|Overall Study||59
8451724|NCT00753337|20828830|P1|NOT COMPLETED|Overall Study||0
8451725|NCT00753337|20828830|P1|COMPLETED|Overall Study||123
8451726|NCT00753337|20828830|P1|STARTED|Overall Study||123
8451727|NCT00753298|20828846|P2|NOT COMPLETED|Overall Study||4
8451728|NCT00753298|20828847|P1|NOT COMPLETED|Overall Study||8
8451729|NCT00753298|20828846|P2|COMPLETED|Overall Study||94
8451730|NCT00753298|20828847|P1|COMPLETED|Overall Study||89
8451731|NCT00753298|20828846|P2|STARTED|Overall Study||98
8451732|NCT00753298|20828847|P1|STARTED|Overall Study||97
8451733|NCT00753272|20828865|P2|NOT COMPLETED|Overall Study||4907
8451734|NCT00753272|20828866|P1|NOT COMPLETED|Overall Study||4982
8451735|NCT00753272|20828865|P2|COMPLETED|Overall Study||16895
8451736|NCT00753272|20828866|P1|COMPLETED|Overall Study||16911
8451737|NCT00753272|20828865|P2|STARTED|Overall Study||21802
8451738|NCT00753272|20828866|P1|STARTED|Overall Study||21893
8451739|NCT00753220|20828928|P1|NOT COMPLETED|Overall Study||5
8451740|NCT00753220|20828928|P1|COMPLETED|Overall Study||2
8451741|NCT00753220|20828928|P1|STARTED|Overall Study||7
8451742|NCT00753142|20828935|P3|NOT COMPLETED|Overall Study||0
8451743|NCT00753142|20828936|P2|NOT COMPLETED|Overall Study||0
8451744|NCT00753142|20828937|P1|NOT COMPLETED|Overall Study||0
8451745|NCT00753142|20828935|P3|COMPLETED|Overall Study||13
8451746|NCT00753142|20828936|P2|COMPLETED|Overall Study||7
8451747|NCT00753142|20828937|P1|COMPLETED|Overall Study||8
8451748|NCT00753142|20828935|P3|STARTED|Overall Study||13
8451749|NCT00753142|20828936|P2|STARTED|Overall Study||7
8451750|NCT00753142|20828937|P1|STARTED|Overall Study||8
8451751|NCT00753012|20828950|P2|NOT COMPLETED|Overall Study||1
8451752|NCT00753012|20828951|P1|NOT COMPLETED|Overall Study||8
8451753|NCT00753012|20828950|P2|COMPLETED|Overall Study||8
8451754|NCT00753012|20828951|P1|COMPLETED|Overall Study||7
8451755|NCT00753012|20828950|P2|STARTED|Overall Study||9
8451756|NCT00753012|20828951|P1|STARTED|Overall Study||15
8451757|NCT00752986|20828964|P3|NOT COMPLETED|Overall Study||2
8451758|NCT00752986|20828965|P2|NOT COMPLETED|Overall Study||1
8451759|NCT00752986|20828966|P1|NOT COMPLETED|Overall Study||5
8451760|NCT00752986|20828964|P3|COMPLETED|Overall Study||9
8451761|NCT00752986|20828965|P2|COMPLETED|Overall Study||11
8451762|NCT00752986|20828966|P1|COMPLETED|Overall Study||11
8451763|NCT00752986|20828964|P3|STARTED|Overall Study||11
8451764|NCT00752986|20828965|P2|STARTED|Overall Study||12
8451765|NCT00752986|20828966|P1|STARTED|Overall Study||16
8451766|NCT00752973|20828983|P1|NOT COMPLETED|Overall Study||0
8451767|NCT00752973|20828983|P1|COMPLETED|Overall Study||12
8451768|NCT00752973|20828983|P1|STARTED|Overall Study||12
8451769|NCT00752908|20828995|P2|NOT COMPLETED|Overall Study||0
8451770|NCT00752908|20828996|P1|NOT COMPLETED|Overall Study||0
8451771|NCT00752908|20828995|P2|COMPLETED|Overall Study||13
8451772|NCT00752908|20828996|P1|COMPLETED|Overall Study||14
8451773|NCT00752908|20828995|P2|STARTED|Overall Study||13
8451774|NCT00752908|20828996|P1|STARTED|Overall Study||14
8451775|NCT00752895|20829006|P2|NOT COMPLETED|Overall Study||3
8451776|NCT00752895|20829007|P1|NOT COMPLETED|Overall Study||8
8451777|NCT00752895|20829006|P2|COMPLETED|Overall Study||143
8451778|NCT00752895|20829007|P1|COMPLETED|Overall Study||139
8451779|NCT00752895|20829006|P2|STARTED|Overall Study||146
8451780|NCT00752895|20829007|P1|STARTED|Overall Study||147
8451781|NCT00752856|20829017|P2|NOT COMPLETED|Overall Study||1
8451782|NCT00752856|20829018|P1|NOT COMPLETED|Overall Study||0
8451783|NCT00752856|20829017|P2|COMPLETED|Overall Study||24
8451784|NCT00752856|20829018|P1|COMPLETED|Overall Study||26
8451785|NCT00752856|20829017|P2|STARTED|Overall Study||25
8451786|NCT00752856|20829018|P1|STARTED|Overall Study||26
8451787|NCT00752791|20829030|P1|NOT COMPLETED|Overall Study||16
8451788|NCT00752791|20829030|P1|COMPLETED|Overall Study||43
8451789|NCT00752791|20829030|P1|STARTED|Overall Study||59
8451790|NCT00752726|20829042|P2|NOT COMPLETED|Overall Study||13
8451791|NCT00752726|20829043|P1|NOT COMPLETED|Overall Study||11
8451792|NCT00752726|20829042|P2|COMPLETED|Overall Study||53
8451793|NCT00752726|20829043|P1|COMPLETED|Overall Study||54
8451794|NCT00752726|20829042|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
8451795|NCT00752726|20829043|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
8451796|NCT00752726|20829042|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
8451797|NCT00752726|20829043|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
8451798|NCT00752726|20829042|P2|STARTED|Overall Study||66
8451799|NCT00752726|20829043|P1|STARTED|Overall Study||65
8451800|NCT00752622|20829068|P1|NOT COMPLETED|Interventional Phase||8
8451801|NCT00752622|20829068|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
8451802|NCT00752622|20829068|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
8451803|NCT00752622|20829068|P1|NOT COMPLETED|Observational Phase||43
8451804|NCT00752622|20829068|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
8451805|NCT00752622|20829068|P1|STARTED|Observational Phase||65
8451806|NCT00752622|20829068|P1|NOT COMPLETED|Induction Phase||35
8451807|NCT00752622|20829068|P1|COMPLETED|Induction Phase||65
8451808|NCT00752622|20829068|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
8451809|NCT00752609|20829081|P2|NOT COMPLETED|Overall Study||2
8451810|NCT00752609|20829082|P1|NOT COMPLETED|Overall Study||9
8451811|NCT00752609|20829081|P2|COMPLETED|Overall Study||47
8451812|NCT00752609|20829082|P1|COMPLETED|Overall Study||44
8451813|NCT00752609|20829081|P2|Full Analysis Set|Overall Study||49
8451814|NCT00752609|20829082|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
8451815|NCT00752609|20829081|P2|STARTED|Overall Study||49
8451816|NCT00752609|20829082|P1|STARTED|Overall Study||53
8451817|NCT00752557|20829104|P3|NOT COMPLETED|Overall Study||6
8451818|NCT00752557|20829105|P2|NOT COMPLETED|Overall Study||5
8451819|NCT00752557|20829106|P1|NOT COMPLETED|Overall Study||5
8451820|NCT00752557|20829104|P3|COMPLETED|Overall Study||11
8451821|NCT00752557|20829105|P2|COMPLETED|Overall Study||11
8451822|NCT00752557|20829106|P1|COMPLETED|Overall Study||12
8451823|NCT00752557|20829104|P3|STARTED|Overall Study||17
8451824|NCT00752557|20829105|P2|STARTED|Overall Study||16
8451825|NCT00752557|20829106|P1|STARTED|Overall Study||17
8451826|NCT00752232|20829138|P7|NOT COMPLETED|Overall Study||0
8451827|NCT00752232|20829139|P6|NOT COMPLETED|Overall Study||1
8451828|NCT00752232|20829140|P5|NOT COMPLETED|Overall Study||3
8451829|NCT00752232|20829141|P4|NOT COMPLETED|Overall Study||1
8451830|NCT00752232|20829142|P3|NOT COMPLETED|Overall Study||1
8451831|NCT00752232|20829143|P2|NOT COMPLETED|Overall Study||0
8451832|NCT00752232|20829144|P1|NOT COMPLETED|Overall Study||2
8451833|NCT00752232|20829138|P7|COMPLETED|Overall Study||4
8451834|NCT00752232|20829139|P6|COMPLETED|Overall Study||5
8451835|NCT00752232|20829140|P5|COMPLETED|Overall Study||3
8451836|NCT00752232|20829141|P4|COMPLETED|Overall Study||5
8451837|NCT00752232|20829142|P3|COMPLETED|Overall Study||5
8451838|NCT00752232|20829143|P2|COMPLETED|Overall Study||6
8451839|NCT00752232|20829144|P1|COMPLETED|Overall Study||4
8451840|NCT00752232|20829138|P7|STARTED|Overall Study||4
8451841|NCT00752232|20829139|P6|STARTED|Overall Study||6
8451842|NCT00752232|20829140|P5|STARTED|Overall Study||6
8451843|NCT00752232|20829141|P4|STARTED|Overall Study||6
8451844|NCT00752232|20829142|P3|STARTED|Overall Study||6
8451845|NCT00752232|20829143|P2|STARTED|Overall Study||6
8451846|NCT00752232|20829144|P1|STARTED|Overall Study||6
8451847|NCT00752219|20829218|P2|NOT COMPLETED|Overall Study||6
8451848|NCT00752219|20829219|P1|NOT COMPLETED|Overall Study||11
8451849|NCT00752219|20829218|P2|COMPLETED|Overall Study||96
8451850|NCT00752219|20829219|P1|COMPLETED|Overall Study||91
8451851|NCT00752219|20829218|P2|Treated|Overall Study||102
8451852|NCT00752219|20829219|P1|Treated|Overall Study||101
8451853|NCT00752219|20829218|P2|STARTED|Overall Study||102
8451854|NCT00752219|20829219|P1|STARTED|Overall Study||102
8451855|NCT00752206|20829245|P2|NOT COMPLETED|Overall Study||11
8451856|NCT00752206|20829246|P1|NOT COMPLETED|Overall Study||9
8451857|NCT00752206|20829245|P2|COMPLETED|Overall Study||8
8451858|NCT00752206|20829246|P1|COMPLETED|Overall Study||10
8451859|NCT00752206|20829245|P2|STARTED|Overall Study||19
8451860|NCT00752206|20829246|P1|STARTED|Overall Study||19
8451861|NCT00752128|20829264|P1|NOT COMPLETED|Overall Study||4
8451862|NCT00752128|20829264|P1|COMPLETED|Overall Study||2345
8451863|NCT00752128|20829264|P1|STARTED|Overall Study||2349
8451864|NCT00752102|20829271|P2|NOT COMPLETED|Overall Study||1
8451865|NCT00752102|20829272|P1|NOT COMPLETED|Overall Study||3
8451866|NCT00752102|20829271|P2|COMPLETED|Overall Study||21
8451867|NCT00752102|20829272|P1|COMPLETED|Overall Study||19
8451868|NCT00752102|20829271|P2|STARTED|Overall Study||22
8451869|NCT00752102|20829272|P1|STARTED|Overall Study||22
8451870|NCT00752089|20829278|P1|NOT COMPLETED|Overall Study||6
8451871|NCT00752089|20829278|P1|COMPLETED|Overall Study||14
8451872|NCT00752089|20829278|P1|Received Placebo|Overall Study||18
8451873|NCT00752089|20829278|P1|Received NaF|Overall Study||18
8451874|NCT00752089|20829278|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
8451875|NCT00752089|20829278|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
8451876|NCT00752089|20829278|P1|STARTED|Overall Study||20
8451877|NCT00751998|20829292|P1|NOT COMPLETED|Overall Study||20
8451878|NCT00751998|20829292|P1|COMPLETED|Overall Study||277
8451879|NCT00751998|20829292|P1|STARTED|Overall Study||297
8451880|NCT00751972|20829298|P2|NOT COMPLETED|Overall Study||0
8451881|NCT00751972|20829299|P1|NOT COMPLETED|Overall Study||0
8451882|NCT00751972|20829298|P2|COMPLETED|Overall Study||499
8451883|NCT00751972|20829299|P1|COMPLETED|Overall Study||140
8451884|NCT00751972|20829298|P2|STARTED|Overall Study||499
8451885|NCT00751972|20829299|P1|STARTED|Overall Study||140
8451886|NCT00751933|20829311|P4|NOT COMPLETED|Overall Study||1
8451887|NCT00751933|20829312|P3|NOT COMPLETED|Overall Study||1
8451888|NCT00751933|20829313|P2|NOT COMPLETED|Overall Study||1
8451889|NCT00751933|20829314|P1|NOT COMPLETED|Overall Study||0
8451890|NCT00751933|20829311|P4|COMPLETED|Overall Study||0
8451891|NCT00751933|20829312|P3|COMPLETED|Overall Study||0
8451892|NCT00751933|20829313|P2|COMPLETED|Overall Study||0
8451893|NCT00751933|20829314|P1|COMPLETED|Overall Study||0
8451894|NCT00751933|20829311|P4|STARTED|Overall Study||1
8451895|NCT00751933|20829312|P3|STARTED|Overall Study||1
8451896|NCT00751933|20829313|P2|STARTED|Overall Study||1
8451897|NCT00751933|20829314|P1|STARTED|Overall Study||0
8451898|NCT00751881|20829322|P3|NOT COMPLETED|Extension Study Period||66
8451899|NCT00751881|20829323|P2|NOT COMPLETED|Extension Study Period||71
8451900|NCT00751881|20829324|P1|NOT COMPLETED|Extension Study Period||65
8451901|NCT00751881|20829322|P3|COMPLETED|Extension Study Period||167
8451902|NCT00751881|20829323|P2|COMPLETED|Extension Study Period||194
8451903|NCT00751881|20829324|P1|COMPLETED|Extension Study Period||188
8451904|NCT00751881|20829322|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
8451905|NCT00751881|20829323|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
8451906|NCT00751881|20829324|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
8451907|NCT00751881|20829322|P3|NOT COMPLETED|Core Treatment Period||128
8451908|NCT00751881|20829323|P2|NOT COMPLETED|Core Treatment Period||135
8451909|NCT00751881|20829324|P1|NOT COMPLETED|Core Treatment Period||126
8451910|NCT00751881|20829322|P3|COMPLETED|Core Treatment Period||244
8451911|NCT00751881|20829323|P2|COMPLETED|Core Treatment Period||273
8451912|NCT00751881|20829324|P1|COMPLETED|Core Treatment Period||263
8451913|NCT00751881|20829322|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
8451914|NCT00751881|20829323|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
8451915|NCT00751881|20829324|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
8451916|NCT00751881|20829322|P3|STARTED|Core Treatment Period|Randomized|372
8451917|NCT00751881|20829323|P2|STARTED|Core Treatment Period|Randomized|408
8451918|NCT00751881|20829324|P1|STARTED|Core Treatment Period|Randomized|389
8451919|NCT00751790|20829371|P1|NOT COMPLETED|Overall Study||5
8451920|NCT00751790|20829371|P1|COMPLETED|Overall Study||115
8451921|NCT00751790|20829371|P1|STARTED|Overall Study||120
8451922|NCT00751777|20829377|P2|NOT COMPLETED|Overall Study||3
8451923|NCT00751777|20829378|P1|NOT COMPLETED|Overall Study||11
8451924|NCT00751777|20829377|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
8452014|NCT00750815|20829656|P2|COMPLETED|Overall Study||46
8451925|NCT00751777|20829378|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
8451926|NCT00751777|20829377|P2|STARTED|Overall Study||39
8451927|NCT00751777|20829378|P1|STARTED|Overall Study||81
8451928|NCT00751634|20829394|P1|NOT COMPLETED|Overall Study||0
8451929|NCT00751634|20829394|P1|COMPLETED|Overall Study||20
8451930|NCT00751634|20829394|P1|STARTED|Overall Study||20
8451931|NCT00751621|20829402|P1|NOT COMPLETED|Overall Study||4
8451932|NCT00751621|20829402|P1|COMPLETED|Overall Study||36
8451933|NCT00751621|20829402|P1|STARTED|Overall Study||40
8451934|NCT00751530|20829421|P2|NOT COMPLETED|Overall Study||0
8451935|NCT00751530|20829422|P1|NOT COMPLETED|Overall Study||0
8451936|NCT00751530|20829421|P2|COMPLETED|Overall Study||110
8451937|NCT00751530|20829422|P1|COMPLETED|Overall Study||332
8451938|NCT00751530|20829421|P2|STARTED|Overall Study||110
8451939|NCT00751530|20829422|P1|STARTED|Overall Study||332
8451940|NCT00751400|20829436|P1|NOT COMPLETED|Overall Study||10
8451941|NCT00751400|20829436|P1|COMPLETED|Overall Study||487
8451942|NCT00751400|20829436|P1|Subjects Provided Detailed Use Data|Overall Study||467
8451943|NCT00751400|20829436|P1|Subjects Consumed Drug|Overall Study||485
8451944|NCT00751400|20829436|P1|Subjects Provided Drug|Overall Study||497
8451945|NCT00751400|20829436|P1|STARTED|Overall Study||497
8451946|NCT00751348|20829451|P2|NOT COMPLETED|Overall Study||2
8451947|NCT00751348|20829452|P1|NOT COMPLETED|Overall Study||6
8451948|NCT00751348|20829451|P2|COMPLETED|Overall Study||159
8451949|NCT00751348|20829452|P1|COMPLETED|Overall Study||307
8451950|NCT00751348|20829451|P2|STARTED|Overall Study||161
8451951|NCT00751348|20829452|P1|STARTED|Overall Study||313
8451952|NCT00751335|20829476|P2|NOT COMPLETED|Overall Study||0
8451953|NCT00751335|20829477|P1|NOT COMPLETED|Overall Study||0
8451954|NCT00751335|20829476|P2|COMPLETED|Overall Study||0
8451955|NCT00751335|20829477|P1|COMPLETED|Overall Study||0
8451956|NCT00751335|20829476|P2|STARTED|Overall Study||0
8451957|NCT00751335|20829477|P1|STARTED|Overall Study||0
8451958|NCT00751296|20829485|P1|NOT COMPLETED|Overall Study||2
8451959|NCT00751296|20829485|P1|COMPLETED|Overall Study||25
8451960|NCT00751296|20829485|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
8451961|NCT00751179|20829492|P2|NOT COMPLETED|Overall Study||15
8451962|NCT00751179|20829493|P1|NOT COMPLETED|Overall Study||14
8451963|NCT00751179|20829492|P2|COMPLETED|Overall Study||70
8451964|NCT00751179|20829493|P1|COMPLETED|Overall Study||62
8451965|NCT00751179|20829492|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
8451966|NCT00751179|20829493|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
8451967|NCT00751140|20829513|P1|NOT COMPLETED|Overall Study||1
8451968|NCT00751140|20829513|P1|COMPLETED|Overall Study||19
8451969|NCT00751140|20829513|P1|STARTED|Overall Study||20
8451970|NCT00751114|20829523|P2|NOT COMPLETED|Overall Study||32
8451971|NCT00751114|20829524|P1|NOT COMPLETED|Overall Study||38
8451972|NCT00751114|20829523|P2|COMPLETED|Overall Study||233
8451973|NCT00751114|20829524|P1|COMPLETED|Overall Study||212
8451974|NCT00751114|20829523|P2|mITT Population|Overall Study||253
8451975|NCT00751114|20829524|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
8451976|NCT00751114|20829523|P2|TREATED = Safety Population|Overall Study||264
8451977|NCT00751114|20829524|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
8451978|NCT00751114|20829523|P2|STARTED|Overall Study||265
8451979|NCT00751114|20829524|P1|STARTED|Overall Study|randomized|250
8451980|NCT00751101|20829549|P2|NOT COMPLETED|Overall Study||5
8451981|NCT00751101|20829550|P1|NOT COMPLETED|Overall Study||2
8451982|NCT00751101|20829549|P2|COMPLETED|Overall Study||7
8451983|NCT00751101|20829550|P1|COMPLETED|Overall Study||10
8451984|NCT00751101|20829549|P2|Started Capecitabine|Overall Study||11
8451985|NCT00751101|20829550|P1|Started Capecitabine|Overall Study||11
8451986|NCT00751101|20829549|P2|STARTED|Overall Study||12
8451987|NCT00751101|20829550|P1|STARTED|Overall Study||12
8451988|NCT00751036|20829570|P2|NOT COMPLETED|Overall Study||46
8451989|NCT00751036|20829571|P1|NOT COMPLETED|Overall Study||48
8451990|NCT00751036|20829570|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
8451991|NCT00751036|20829571|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
8451992|NCT00751036|20829570|P2|STARTED|Overall Study|Started = Treated|46
8451993|NCT00751036|20829571|P1|STARTED|Overall Study|Started = Treated|48
8451994|NCT00751023|20829585|P2|NOT COMPLETED|Overall Study||7
8451995|NCT00751023|20829586|P1|NOT COMPLETED|Overall Study||11
8451996|NCT00751023|20829585|P2|COMPLETED|Overall Study||13
8451997|NCT00751023|20829586|P1|COMPLETED|Overall Study||9
8451998|NCT00751023|20829585|P2|STARTED|Overall Study||20
8451999|NCT00751023|20829586|P1|STARTED|Overall Study||20
8452003|NCT00750893|20829614|P1|NOT COMPLETED|Overall Study||542
8452004|NCT00750893|20829614|P1|COMPLETED|Overall Study||2569
8452005|NCT00750893|20829614|P1|STARTED|Overall Study||3111
8452006|NCT00750880|20829626|P1|NOT COMPLETED|Overall Study||215
8452007|NCT00750880|20829626|P1|COMPLETED|Overall Study||1466
8452008|NCT00750880|20829626|P1|STARTED|Overall Study||1681
8452009|NCT00750867|20829649|P1|NOT COMPLETED|Overall Study||2
8452010|NCT00750867|20829649|P1|COMPLETED|Overall Study||7
8452011|NCT00750867|20829649|P1|STARTED|Overall Study||9
8452012|NCT00750815|20829656|P2|NOT COMPLETED|Overall Study||0
8452013|NCT00750815|20829657|P1|NOT COMPLETED|Overall Study||0
8452015|NCT00750815|20829657|P1|COMPLETED|Overall Study||12
8452016|NCT00750815|20829656|P2|STARTED|Overall Study||46
8452017|NCT00750815|20829657|P1|STARTED|Overall Study||12
8452018|NCT00750737|20829670|P2|NOT COMPLETED|Overall Study||3
8452019|NCT00750737|20829671|P1|NOT COMPLETED|Overall Study||3
8452020|NCT00750737|20829670|P2|COMPLETED|Overall Study||19
8452021|NCT00750737|20829671|P1|COMPLETED|Overall Study||21
8452022|NCT00750737|20829670|P2|STARTED|Overall Study||22
8452023|NCT00750737|20829671|P1|STARTED|Overall Study||24
8452024|NCT00750555|20829679|P1|NOT COMPLETED|Overall Study||0
8452025|NCT00750555|20829679|P1|COMPLETED|Overall Study||0
8452026|NCT00750555|20829679|P1|STARTED|Overall Study||0
8452027|NCT00750438|20829686|P2|NOT COMPLETED|Overall Study||4
8452028|NCT00750438|20829687|P1|NOT COMPLETED|Overall Study||7
8452029|NCT00750438|20829686|P2|COMPLETED|Overall Study||25
8452030|NCT00750438|20829687|P1|COMPLETED|Overall Study||24
8452031|NCT00750438|20829686|P2|STARTED|Overall Study||29
8452032|NCT00750438|20829687|P1|STARTED|Overall Study||31
8452033|NCT00750373|20829703|P2|NOT COMPLETED|Overall Study||0
8452034|NCT00750373|20829704|P1|NOT COMPLETED|Overall Study||0
8452035|NCT00750373|20829703|P2|COMPLETED|Overall Study||37
8452036|NCT00750373|20829704|P1|COMPLETED|Overall Study||39
8452037|NCT00750373|20829703|P2|STARTED|Overall Study||37
8452038|NCT00750373|20829704|P1|STARTED|Overall Study||39
8452039|NCT00750360|20829716|P6|NOT COMPLETED|Overall Study||0
8452040|NCT00750360|20829717|P5|NOT COMPLETED|Overall Study||0
8452041|NCT00750360|20829718|P4|NOT COMPLETED|Overall Study||0
8452042|NCT00750360|20829719|P3|NOT COMPLETED|Overall Study||0
8452043|NCT00750360|20829720|P2|NOT COMPLETED|Overall Study||0
8452044|NCT00750360|20829721|P1|NOT COMPLETED|Overall Study||0
8452045|NCT00750360|20829716|P6|COMPLETED|Overall Study||71
8452046|NCT00750360|20829717|P5|COMPLETED|Overall Study||46
8452047|NCT00750360|20829718|P4|COMPLETED|Overall Study||79
8452048|NCT00750360|20829719|P3|COMPLETED|Overall Study||384
8452049|NCT00750360|20829720|P2|COMPLETED|Overall Study||1
8452050|NCT00750360|20829721|P1|COMPLETED|Overall Study||294
8452051|NCT00750360|20829716|P6|STARTED|Overall Study||71
8452052|NCT00750360|20829717|P5|STARTED|Overall Study||46
8452053|NCT00750360|20829718|P4|STARTED|Overall Study||79
8452054|NCT00750360|20829719|P3|STARTED|Overall Study||384
8452055|NCT00750360|20829720|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
8452056|NCT00750360|20829721|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
8452057|NCT00750308|20829753|P12|NOT COMPLETED|Fourth Treatment||0
8452058|NCT00750308|20829754|P11|NOT COMPLETED|Fourth Treatment||0
8452059|NCT00750308|20829755|P10|NOT COMPLETED|Fourth Treatment||0
8452060|NCT00750308|20829756|P9|NOT COMPLETED|Fourth Treatment||0
8452061|NCT00750308|20829757|P8|NOT COMPLETED|Fourth Treatment||0
8452062|NCT00750308|20829758|P7|NOT COMPLETED|Fourth Treatment||0
8452063|NCT00750308|20829759|P6|NOT COMPLETED|Fourth Treatment||0
8452064|NCT00750308|20829760|P5|NOT COMPLETED|Fourth Treatment||0
8452065|NCT00750308|20829761|P4|NOT COMPLETED|Fourth Treatment||0
8452066|NCT00750308|20829762|P3|NOT COMPLETED|Fourth Treatment||0
8452067|NCT00750308|20829763|P2|NOT COMPLETED|Fourth Treatment||0
8452068|NCT00750308|20829764|P1|NOT COMPLETED|Fourth Treatment||0
8452069|NCT00750308|20829753|P12|COMPLETED|Fourth Treatment||1
8452070|NCT00750308|20829754|P11|COMPLETED|Fourth Treatment||1
8452071|NCT00750308|20829755|P10|COMPLETED|Fourth Treatment||2
8452072|NCT00750308|20829756|P9|COMPLETED|Fourth Treatment||1
8452073|NCT00750308|20829757|P8|COMPLETED|Fourth Treatment||2
8452074|NCT00750308|20829758|P7|COMPLETED|Fourth Treatment||2
8452075|NCT00750308|20829759|P6|COMPLETED|Fourth Treatment||2
8452076|NCT00750308|20829760|P5|COMPLETED|Fourth Treatment||1
8452077|NCT00750308|20829761|P4|COMPLETED|Fourth Treatment||1
8452078|NCT00750308|20829762|P3|COMPLETED|Fourth Treatment||2
8452079|NCT00750308|20829763|P2|COMPLETED|Fourth Treatment||1
8452080|NCT00750308|20829764|P1|COMPLETED|Fourth Treatment||2
8452081|NCT00750308|20829753|P12|STARTED|Fourth Treatment||1
8452082|NCT00750308|20829754|P11|STARTED|Fourth Treatment||1
8452083|NCT00750308|20829755|P10|STARTED|Fourth Treatment||2
8452084|NCT00750308|20829756|P9|STARTED|Fourth Treatment||1
8452085|NCT00750308|20829757|P8|STARTED|Fourth Treatment||2
8452086|NCT00750308|20829758|P7|STARTED|Fourth Treatment||2
8452087|NCT00750308|20829759|P6|STARTED|Fourth Treatment||2
8452088|NCT00750308|20829760|P5|STARTED|Fourth Treatment||1
8452089|NCT00750308|20829761|P4|STARTED|Fourth Treatment||1
8452090|NCT00750308|20829762|P3|STARTED|Fourth Treatment||2
8452091|NCT00750308|20829763|P2|STARTED|Fourth Treatment||1
8452092|NCT00750308|20829764|P1|STARTED|Fourth Treatment||2
8452093|NCT00750308|20829753|P12|NOT COMPLETED|Washout||0
8452094|NCT00750308|20829754|P11|NOT COMPLETED|Washout||0
8452095|NCT00750308|20829755|P10|NOT COMPLETED|Washout||0
8452096|NCT00750308|20829756|P9|NOT COMPLETED|Washout||0
8452097|NCT00750308|20829757|P8|NOT COMPLETED|Washout||0
8452098|NCT00750308|20829758|P7|NOT COMPLETED|Washout||0
8452099|NCT00750308|20829759|P6|NOT COMPLETED|Washout||0
8452100|NCT00750308|20829760|P5|NOT COMPLETED|Washout||0
8452101|NCT00750308|20829761|P4|NOT COMPLETED|Washout||0
8452102|NCT00750308|20829762|P3|NOT COMPLETED|Washout||0
8452103|NCT00750308|20829763|P2|NOT COMPLETED|Washout||0
8452104|NCT00750308|20829764|P1|NOT COMPLETED|Washout||0
8452105|NCT00750308|20829753|P12|COMPLETED|Washout||1
8452106|NCT00750308|20829754|P11|COMPLETED|Washout||1
8452107|NCT00750308|20829755|P10|COMPLETED|Washout||2
8452108|NCT00750308|20829756|P9|COMPLETED|Washout||1
8452109|NCT00750308|20829757|P8|COMPLETED|Washout||2
8452110|NCT00750308|20829758|P7|COMPLETED|Washout||2
8452111|NCT00750308|20829759|P6|COMPLETED|Washout||2
8452112|NCT00750308|20829760|P5|COMPLETED|Washout||1
8452113|NCT00750308|20829761|P4|COMPLETED|Washout||1
8452114|NCT00750308|20829762|P3|COMPLETED|Washout||2
8452115|NCT00750308|20829763|P2|COMPLETED|Washout||1
8452116|NCT00750308|20829764|P1|COMPLETED|Washout||2
8452117|NCT00750308|20829753|P12|STARTED|Washout||1
8452118|NCT00750308|20829754|P11|STARTED|Washout||1
8452119|NCT00750308|20829755|P10|STARTED|Washout||2
8452120|NCT00750308|20829756|P9|STARTED|Washout||1
8452121|NCT00750308|20829757|P8|STARTED|Washout||2
8452122|NCT00750308|20829758|P7|STARTED|Washout||2
8452123|NCT00750308|20829759|P6|STARTED|Washout||2
8452124|NCT00750308|20829760|P5|STARTED|Washout||1
8452125|NCT00750308|20829761|P4|STARTED|Washout||1
8452126|NCT00750308|20829762|P3|STARTED|Washout||2
8452127|NCT00750308|20829763|P2|STARTED|Washout||1
8452128|NCT00750308|20829764|P1|STARTED|Washout||2
8452129|NCT00750308|20829753|P12|NOT COMPLETED|Third Treatment||0
8452130|NCT00750308|20829754|P11|NOT COMPLETED|Third Treatment||0
8452131|NCT00750308|20829755|P10|NOT COMPLETED|Third Treatment||0
8452132|NCT00750308|20829756|P9|NOT COMPLETED|Third Treatment||0
8452133|NCT00750308|20829757|P8|NOT COMPLETED|Third Treatment||0
8452134|NCT00750308|20829758|P7|NOT COMPLETED|Third Treatment||0
8452135|NCT00750308|20829759|P6|NOT COMPLETED|Third Treatment||0
8452136|NCT00750308|20829760|P5|NOT COMPLETED|Third Treatment||0
8452137|NCT00750308|20829761|P4|NOT COMPLETED|Third Treatment||0
8452138|NCT00750308|20829762|P3|NOT COMPLETED|Third Treatment||0
8452139|NCT00750308|20829763|P2|NOT COMPLETED|Third Treatment||1
8452140|NCT00750308|20829764|P1|NOT COMPLETED|Third Treatment||0
8452141|NCT00750308|20829753|P12|COMPLETED|Third Treatment||1
8452142|NCT00750308|20829754|P11|COMPLETED|Third Treatment||1
8452143|NCT00750308|20829755|P10|COMPLETED|Third Treatment||2
8452144|NCT00750308|20829756|P9|COMPLETED|Third Treatment||1
8452145|NCT00750308|20829757|P8|COMPLETED|Third Treatment||2
8452146|NCT00750308|20829758|P7|COMPLETED|Third Treatment||2
8452147|NCT00750308|20829759|P6|COMPLETED|Third Treatment||2
8452148|NCT00750308|20829760|P5|COMPLETED|Third Treatment||1
8452149|NCT00750308|20829761|P4|COMPLETED|Third Treatment||1
8452150|NCT00750308|20829762|P3|COMPLETED|Third Treatment||2
8452151|NCT00750308|20829763|P2|COMPLETED|Third Treatment||1
8452152|NCT00750308|20829764|P1|COMPLETED|Third Treatment||2
8452153|NCT00750308|20829753|P12|STARTED|Third Treatment||1
8452154|NCT00750308|20829754|P11|STARTED|Third Treatment||1
8452155|NCT00750308|20829755|P10|STARTED|Third Treatment||2
8452156|NCT00750308|20829756|P9|STARTED|Third Treatment||1
8452157|NCT00750308|20829757|P8|STARTED|Third Treatment||2
8452158|NCT00750308|20829758|P7|STARTED|Third Treatment||2
8452159|NCT00750308|20829759|P6|STARTED|Third Treatment||2
8452160|NCT00750308|20829760|P5|STARTED|Third Treatment||1
8452161|NCT00750308|20829761|P4|STARTED|Third Treatment||1
8452162|NCT00750308|20829762|P3|STARTED|Third Treatment||2
8452163|NCT00750308|20829763|P2|STARTED|Third Treatment||2
8452164|NCT00750308|20829764|P1|STARTED|Third Treatment||2
8452165|NCT00750308|20829753|P12|NOT COMPLETED|Washout||0
8452166|NCT00750308|20829754|P11|NOT COMPLETED|Washout||0
8452167|NCT00750308|20829755|P10|NOT COMPLETED|Washout||0
8452168|NCT00750308|20829756|P9|NOT COMPLETED|Washout||0
8452169|NCT00750308|20829757|P8|NOT COMPLETED|Washout||0
8452170|NCT00750308|20829758|P7|NOT COMPLETED|Washout||0
8452171|NCT00750308|20829759|P6|NOT COMPLETED|Washout||0
8452172|NCT00750308|20829760|P5|NOT COMPLETED|Washout||0
8452173|NCT00750308|20829761|P4|NOT COMPLETED|Washout||0
8452174|NCT00750308|20829762|P3|NOT COMPLETED|Washout||0
8452175|NCT00750308|20829763|P2|NOT COMPLETED|Washout||0
8452176|NCT00750308|20829764|P1|NOT COMPLETED|Washout||0
8452177|NCT00750308|20829753|P12|COMPLETED|Washout||1
8452178|NCT00750308|20829754|P11|COMPLETED|Washout||1
8452179|NCT00750308|20829755|P10|COMPLETED|Washout||2
8452180|NCT00750308|20829756|P9|COMPLETED|Washout||1
8452181|NCT00750308|20829757|P8|COMPLETED|Washout||2
8452182|NCT00750308|20829758|P7|COMPLETED|Washout||2
8452183|NCT00750308|20829759|P6|COMPLETED|Washout||2
8452184|NCT00750308|20829760|P5|COMPLETED|Washout||1
8452185|NCT00750308|20829761|P4|COMPLETED|Washout||1
8452186|NCT00750308|20829762|P3|COMPLETED|Washout||2
8452187|NCT00750308|20829763|P2|COMPLETED|Washout||2
8452188|NCT00750308|20829764|P1|COMPLETED|Washout||2
8452189|NCT00750308|20829753|P12|STARTED|Washout||1
8452190|NCT00750308|20829754|P11|STARTED|Washout||1
8452191|NCT00750308|20829755|P10|STARTED|Washout||2
8452192|NCT00750308|20829756|P9|STARTED|Washout||1
8452193|NCT00750308|20829757|P8|STARTED|Washout||2
8452194|NCT00750308|20829758|P7|STARTED|Washout||2
8452195|NCT00750308|20829759|P6|STARTED|Washout||2
8452196|NCT00750308|20829760|P5|STARTED|Washout||1
8452197|NCT00750308|20829761|P4|STARTED|Washout||1
8452198|NCT00750308|20829762|P3|STARTED|Washout||2
8452199|NCT00750308|20829763|P2|STARTED|Washout||2
8452200|NCT00750308|20829764|P1|STARTED|Washout||2
8452201|NCT00750308|20829753|P12|NOT COMPLETED|Second Treatment||0
8452202|NCT00750308|20829754|P11|NOT COMPLETED|Second Treatment||0
8452203|NCT00750308|20829755|P10|NOT COMPLETED|Second Treatment||0
8452204|NCT00750308|20829756|P9|NOT COMPLETED|Second Treatment||1
8452205|NCT00750308|20829757|P8|NOT COMPLETED|Second Treatment||0
8452206|NCT00750308|20829758|P7|NOT COMPLETED|Second Treatment||0
8452207|NCT00750308|20829759|P6|NOT COMPLETED|Second Treatment||1
8452208|NCT00750308|20829760|P5|NOT COMPLETED|Second Treatment||1
8452209|NCT00750308|20829761|P4|NOT COMPLETED|Second Treatment||0
8452210|NCT00750308|20829762|P3|NOT COMPLETED|Second Treatment||0
8452211|NCT00750308|20829763|P2|NOT COMPLETED|Second Treatment||0
8452212|NCT00750308|20829764|P1|NOT COMPLETED|Second Treatment||0
8452213|NCT00750308|20829753|P12|COMPLETED|Second Treatment||1
8452214|NCT00750308|20829754|P11|COMPLETED|Second Treatment||1
8452215|NCT00750308|20829755|P10|COMPLETED|Second Treatment||2
8452216|NCT00750308|20829756|P9|COMPLETED|Second Treatment||1
8452217|NCT00750308|20829757|P8|COMPLETED|Second Treatment||2
8452218|NCT00750308|20829758|P7|COMPLETED|Second Treatment||2
8452219|NCT00750308|20829759|P6|COMPLETED|Second Treatment||2
8452220|NCT00750308|20829760|P5|COMPLETED|Second Treatment||1
8452221|NCT00750308|20829761|P4|COMPLETED|Second Treatment||1
8452222|NCT00750308|20829762|P3|COMPLETED|Second Treatment||2
8452223|NCT00750308|20829763|P2|COMPLETED|Second Treatment||2
8452224|NCT00750308|20829764|P1|COMPLETED|Second Treatment||2
8452225|NCT00750308|20829753|P12|STARTED|Second Treatment||1
8452226|NCT00750308|20829754|P11|STARTED|Second Treatment||1
8452227|NCT00750308|20829755|P10|STARTED|Second Treatment||2
8452228|NCT00750308|20829756|P9|STARTED|Second Treatment||2
8452229|NCT00750308|20829757|P8|STARTED|Second Treatment||2
8452230|NCT00750308|20829758|P7|STARTED|Second Treatment||2
8452231|NCT00750308|20829759|P6|STARTED|Second Treatment||3
8452232|NCT00750308|20829760|P5|STARTED|Second Treatment||2
8452233|NCT00750308|20829761|P4|STARTED|Second Treatment||1
8452234|NCT00750308|20829762|P3|STARTED|Second Treatment||2
8452235|NCT00750308|20829763|P2|STARTED|Second Treatment||2
8452236|NCT00750308|20829764|P1|STARTED|Second Treatment||2
8452237|NCT00750308|20829753|P12|NOT COMPLETED|Washout||0
8452238|NCT00750308|20829754|P11|NOT COMPLETED|Washout||0
8452239|NCT00750308|20829755|P10|NOT COMPLETED|Washout||0
8452240|NCT00750308|20829756|P9|NOT COMPLETED|Washout||0
8452241|NCT00750308|20829757|P8|NOT COMPLETED|Washout||0
8452242|NCT00750308|20829758|P7|NOT COMPLETED|Washout||0
8452243|NCT00750308|20829759|P6|NOT COMPLETED|Washout||0
8452244|NCT00750308|20829760|P5|NOT COMPLETED|Washout||0
8452245|NCT00750308|20829761|P4|NOT COMPLETED|Washout||0
8452246|NCT00750308|20829762|P3|NOT COMPLETED|Washout||0
8452247|NCT00750308|20829763|P2|NOT COMPLETED|Washout||0
8452248|NCT00750308|20829764|P1|NOT COMPLETED|Washout||0
8452249|NCT00750308|20829753|P12|COMPLETED|Washout||1
8452250|NCT00750308|20829754|P11|COMPLETED|Washout||1
8452251|NCT00750308|20829755|P10|COMPLETED|Washout||2
8452252|NCT00750308|20829756|P9|COMPLETED|Washout||2
8452253|NCT00750308|20829757|P8|COMPLETED|Washout||2
8452254|NCT00750308|20829758|P7|COMPLETED|Washout||2
8452255|NCT00750308|20829759|P6|COMPLETED|Washout||3
8452256|NCT00750308|20829760|P5|COMPLETED|Washout||2
8452257|NCT00750308|20829761|P4|COMPLETED|Washout||1
8452258|NCT00750308|20829762|P3|COMPLETED|Washout||2
8452259|NCT00750308|20829763|P2|COMPLETED|Washout||2
8452260|NCT00750308|20829764|P1|COMPLETED|Washout||2
8452261|NCT00750308|20829753|P12|STARTED|Washout||1
8452262|NCT00750308|20829754|P11|STARTED|Washout||1
8452263|NCT00750308|20829755|P10|STARTED|Washout||2
8452264|NCT00750308|20829756|P9|STARTED|Washout||2
8452265|NCT00750308|20829757|P8|STARTED|Washout||2
8452266|NCT00750308|20829758|P7|STARTED|Washout||2
8452267|NCT00750308|20829759|P6|STARTED|Washout||3
8452268|NCT00750308|20829760|P5|STARTED|Washout||2
8452269|NCT00750308|20829761|P4|STARTED|Washout||1
8452270|NCT00750308|20829762|P3|STARTED|Washout||2
8452271|NCT00750308|20829763|P2|STARTED|Washout||2
8452272|NCT00750308|20829764|P1|STARTED|Washout||2
8452273|NCT00750308|20829753|P12|NOT COMPLETED|First Treatment||1
8452274|NCT00750308|20829754|P11|NOT COMPLETED|First Treatment||1
8452275|NCT00750308|20829755|P10|NOT COMPLETED|First Treatment||0
8452276|NCT00750308|20829756|P9|NOT COMPLETED|First Treatment||0
8452277|NCT00750308|20829757|P8|NOT COMPLETED|First Treatment||1
8452278|NCT00750308|20829758|P7|NOT COMPLETED|First Treatment||0
8452279|NCT00750308|20829759|P6|NOT COMPLETED|First Treatment||0
8452280|NCT00750308|20829760|P5|NOT COMPLETED|First Treatment||0
8452281|NCT00750308|20829761|P4|NOT COMPLETED|First Treatment||1
8452282|NCT00750308|20829762|P3|NOT COMPLETED|First Treatment||0
8452283|NCT00750308|20829763|P2|NOT COMPLETED|First Treatment||1
8452284|NCT00750308|20829764|P1|NOT COMPLETED|First Treatment||0
8452285|NCT00750308|20829753|P12|COMPLETED|First Treatment||1
8452286|NCT00750308|20829754|P11|COMPLETED|First Treatment||1
8452287|NCT00750308|20829755|P10|COMPLETED|First Treatment||2
8452288|NCT00750308|20829756|P9|COMPLETED|First Treatment||2
8452289|NCT00750308|20829757|P8|COMPLETED|First Treatment||2
8452290|NCT00750308|20829758|P7|COMPLETED|First Treatment||2
8452291|NCT00750308|20829759|P6|COMPLETED|First Treatment||3
8452292|NCT00750308|20829760|P5|COMPLETED|First Treatment||2
8452293|NCT00750308|20829761|P4|COMPLETED|First Treatment||1
8452294|NCT00750308|20829762|P3|COMPLETED|First Treatment||2
8452295|NCT00750308|20829763|P2|COMPLETED|First Treatment||2
8452296|NCT00750308|20829764|P1|COMPLETED|First Treatment||2
8452297|NCT00750308|20829753|P12|STARTED|First Treatment||2
8452298|NCT00750308|20829754|P11|STARTED|First Treatment||2
8452299|NCT00750308|20829755|P10|STARTED|First Treatment||2
8452300|NCT00750308|20829756|P9|STARTED|First Treatment||2
8452301|NCT00750308|20829757|P8|STARTED|First Treatment||3
8452302|NCT00750308|20829758|P7|STARTED|First Treatment||2
8452303|NCT00750308|20829759|P6|STARTED|First Treatment||3
8452304|NCT00750308|20829760|P5|STARTED|First Treatment||2
8452305|NCT00750308|20829761|P4|STARTED|First Treatment||2
8452306|NCT00750308|20829762|P3|STARTED|First Treatment||2
8452307|NCT00750308|20829763|P2|STARTED|First Treatment||3
8452308|NCT00750308|20829764|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
8452309|NCT00750282|20829782|P4|NOT COMPLETED|Overall Study||1
8452310|NCT00750282|20829783|P3|NOT COMPLETED|Overall Study||1
8452311|NCT00750282|20829784|P2|NOT COMPLETED|Overall Study||1
8452312|NCT00750282|20829785|P1|NOT COMPLETED|Overall Study||0
8452313|NCT00750282|20829782|P4|COMPLETED|Overall Study||147
8452314|NCT00750282|20829783|P3|COMPLETED|Overall Study||125
8452315|NCT00750282|20829784|P2|COMPLETED|Overall Study||81
8452316|NCT00750282|20829785|P1|COMPLETED|Overall Study||69
8452317|NCT00750282|20829782|P4|STARTED|Overall Study||148
8452318|NCT00750282|20829783|P3|STARTED|Overall Study||126
8452319|NCT00750282|20829784|P2|STARTED|Overall Study||82
8452320|NCT00750282|20829785|P1|STARTED|Overall Study||69
8452321|NCT00750269|20829814|P5|NOT COMPLETED|Overall Study||10
8452322|NCT00750269|20829815|P4|NOT COMPLETED|Overall Study||5
8452323|NCT00750269|20829816|P3|NOT COMPLETED|Overall Study||4
8452324|NCT00750269|20829817|P2|NOT COMPLETED|Overall Study||1
8452325|NCT00750269|20829818|P1|NOT COMPLETED|Overall Study||0
8452326|NCT00750269|20829814|P5|COMPLETED|Overall Study||33
8452327|NCT00750269|20829815|P4|COMPLETED|Overall Study||38
8452328|NCT00750269|20829816|P3|COMPLETED|Overall Study||14
8452329|NCT00750269|20829817|P2|COMPLETED|Overall Study||7
8452330|NCT00750269|20829818|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
8452331|NCT00750269|20829814|P5|STARTED|Overall Study||43
8452332|NCT00750269|20829815|P4|STARTED|Overall Study||43
8452333|NCT00750269|20829816|P3|STARTED|Overall Study||18
8452334|NCT00750269|20829817|P2|STARTED|Overall Study||8
8452335|NCT00750269|20829818|P1|STARTED|Overall Study||8
8452336|NCT00750204|20829865|P2|NOT COMPLETED|Overall Study||1
8452337|NCT00750204|20829866|P1|NOT COMPLETED|Overall Study||1
8452338|NCT00750204|20829865|P2|COMPLETED|Overall Study||0
8452339|NCT00750204|20829866|P1|COMPLETED|Overall Study||0
8452340|NCT00750204|20829865|P2|STARTED|Overall Study||1
8452341|NCT00750204|20829866|P1|STARTED|Overall Study||1
8452342|NCT00750191|20829874|P2|NOT COMPLETED|Overall Study||10
8452343|NCT00750191|20829875|P1|NOT COMPLETED|Overall Study||5
8452344|NCT00750191|20829874|P2|COMPLETED|Overall Study||20
8452345|NCT00750191|20829875|P1|COMPLETED|Overall Study||22
8452346|NCT00750191|20829874|P2|STARTED|Overall Study||30
8452347|NCT00750191|20829875|P1|STARTED|Overall Study||27
8452348|NCT00750165|20829887|P1|NOT COMPLETED|Overall Study||11
8452349|NCT00750165|20829887|P1|COMPLETED|Overall Study||21
8452350|NCT00750165|20829887|P1|STARTED|Overall Study||32
8452351|NCT00750152|20829896|P2|NOT COMPLETED|Overall Study||27
8452352|NCT00750152|20829897|P1|NOT COMPLETED|Overall Study||22
8452353|NCT00750152|20829896|P2|COMPLETED|Overall Study||141
8452354|NCT00750152|20829897|P1|COMPLETED|Overall Study||144
8452355|NCT00750152|20829896|P2|STARTED|Overall Study||168
8452356|NCT00750152|20829897|P1|STARTED|Overall Study||166
8452357|NCT00750139|20829909|P4|NOT COMPLETED|Overall Study||46
8452358|NCT00750139|20829910|P3|NOT COMPLETED|Overall Study||101
8452359|NCT00750139|20829911|P2|NOT COMPLETED|Overall Study||59
8452360|NCT00750139|20829912|P1|NOT COMPLETED|Overall Study||89
8452361|NCT00750139|20829909|P4|COMPLETED|Overall Study||73
8452362|NCT00750139|20829910|P3|COMPLETED|Overall Study||135
8452363|NCT00750139|20829911|P2|COMPLETED|Overall Study||59
8452364|NCT00750139|20829912|P1|COMPLETED|Overall Study||145
8452365|NCT00750139|20829909|P4|STARTED|Overall Study||119
8452366|NCT00750139|20829910|P3|STARTED|Overall Study||236
8452367|NCT00750139|20829911|P2|STARTED|Overall Study||118
8452368|NCT00750139|20829912|P1|STARTED|Overall Study||234
8452369|NCT00750061|20829928|P2|NOT COMPLETED|Overall Study||2
8452370|NCT00750061|20829929|P1|NOT COMPLETED|Overall Study||2
8452371|NCT00750061|20829928|P2|COMPLETED|Overall Study||18
8452372|NCT00750061|20829929|P1|COMPLETED|Overall Study||18
8452373|NCT00750061|20829928|P2|STARTED|Overall Study||20
8452374|NCT00750061|20829929|P1|STARTED|Overall Study||20
8452375|NCT00749996|20829939|P2|NOT COMPLETED|Overall Study||13
8452376|NCT00749996|20829940|P1|NOT COMPLETED|Overall Study||18
8452377|NCT00749996|20829939|P2|COMPLETED|Overall Study||58
8452378|NCT00749996|20829940|P1|COMPLETED|Overall Study||57
8452379|NCT00749996|20829939|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
8452380|NCT00749996|20829940|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
8452381|NCT00749996|20829939|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
8452382|NCT00749996|20829940|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
8452383|NCT00749996|20829939|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
8452384|NCT00749996|20829940|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
8452385|NCT00749996|20829939|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
8452386|NCT00749996|20829940|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
8452387|NCT00749996|20829939|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
8452388|NCT00749996|20829940|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
8452389|NCT00749996|20829939|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
8452390|NCT00749996|20829940|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
8452391|NCT00749957|20829950|P2|NOT COMPLETED|Overall Study||0
8452392|NCT00749957|20829951|P1|NOT COMPLETED|Overall Study||0
8452393|NCT00749957|20829950|P2|COMPLETED|Overall Study||6
8452394|NCT00749957|20829951|P1|COMPLETED|Overall Study||6
8452395|NCT00749957|20829950|P2|STARTED|Overall Study||6
8452396|NCT00749957|20829951|P1|STARTED|Overall Study||6
8452397|NCT00749944|20829963|P2|NOT COMPLETED|Overall Study||1
8452398|NCT00749944|20829964|P1|NOT COMPLETED|Overall Study||5
8452399|NCT00749944|20829963|P2|COMPLETED|Overall Study||54
8452400|NCT00749944|20829964|P1|COMPLETED|Overall Study||50
8452401|NCT00749944|20829963|P2|STARTED|Overall Study||55
8452402|NCT00749944|20829964|P1|STARTED|Overall Study||55
8452403|NCT00749931|20830032|P3|NOT COMPLETED|Overall Study||0
8452404|NCT00749931|20830033|P2|NOT COMPLETED|Overall Study||0
8452405|NCT00749931|20830034|P1|NOT COMPLETED|Overall Study||0
8452406|NCT00749931|20830032|P3|COMPLETED|Overall Study||68
8452407|NCT00749931|20830033|P2|COMPLETED|Overall Study||298
8452408|NCT00749931|20830034|P1|COMPLETED|Overall Study||298
8452409|NCT00749931|20830032|P3|STARTED|Overall Study||68
8452410|NCT00749931|20830033|P2|STARTED|Overall Study||298
8452411|NCT00749931|20830034|P1|STARTED|Overall Study||298
8452412|NCT00749892|20830043|P1|NOT COMPLETED|Overall Study||3
8452413|NCT00749892|20830043|P1|COMPLETED|Overall Study||31
8452414|NCT00749892|20830043|P1|STARTED|Overall Study||34
8452415|NCT00749879|20830047|P1|NOT COMPLETED|Overall Study||0
8452416|NCT00749879|20830047|P1|COMPLETED|Overall Study||12
8452417|NCT00749879|20830047|P1|STARTED|Overall Study||12
8452418|NCT00749775|20830079|P1|NOT COMPLETED|Overall Study||107
8452419|NCT00749775|20830079|P1|COMPLETED|Overall Study||3210
8452420|NCT00749775|20830079|P1|STARTED|Overall Study||3317
8452421|NCT00749749|20830097|P2|NOT COMPLETED|Overall Study||0
8452422|NCT00749749|20830098|P1|NOT COMPLETED|Overall Study||0
8452423|NCT00749749|20830097|P2|COMPLETED|Overall Study||13
8452424|NCT00749749|20830098|P1|COMPLETED|Overall Study||14
8452425|NCT00749749|20830097|P2|STARTED|Overall Study||13
8452426|NCT00749749|20830098|P1|STARTED|Overall Study||14
8452427|NCT00749684|20830116|P1|NOT COMPLETED|Overall Study||82
8452428|NCT00749684|20830116|P1|COMPLETED|Overall Study||56
8452429|NCT00749684|20830116|P1|STARTED|Overall Study||138
8452430|NCT00749671|20830123|P2|NOT COMPLETED|Overall Study||0
8452431|NCT00749671|20830124|P1|NOT COMPLETED|Overall Study||0
8452432|NCT00749671|20830123|P2|COMPLETED|Overall Study||9
8452433|NCT00749671|20830124|P1|COMPLETED|Overall Study||11
8452434|NCT00749671|20830123|P2|STARTED|Overall Study||9
8452435|NCT00749671|20830124|P1|STARTED|Overall Study||11
8452436|NCT00749658|20830134|P2|NOT COMPLETED|Overall Study||0
8452437|NCT00749658|20830135|P1|NOT COMPLETED|Overall Study||0
8452438|NCT00749658|20830134|P2|COMPLETED|Overall Study||61
8452439|NCT00749658|20830135|P1|COMPLETED|Overall Study||60
8452440|NCT00749658|20830134|P2|STARTED|Overall Study||61
8452441|NCT00749658|20830135|P1|STARTED|Overall Study||60
8452442|NCT00749606|20830143|P2|NOT COMPLETED|Year 3 (Observation)||3
8452443|NCT00749606|20830144|P1|NOT COMPLETED|Year 3 (Observation)||0
8452444|NCT00749606|20830143|P2|COMPLETED|Year 3 (Observation)||69
8452445|NCT00749606|20830144|P1|COMPLETED|Year 3 (Observation)||63
8452446|NCT00749606|20830143|P2|STARTED|Year 3 (Observation)||72
8452447|NCT00749606|20830144|P1|STARTED|Year 3 (Observation)||63
8452448|NCT00749606|20830143|P2|NOT COMPLETED|Year 2||8
8452449|NCT00749606|20830144|P1|NOT COMPLETED|Year 2||11
8452450|NCT00749606|20830143|P2|COMPLETED|Year 2||72
8452451|NCT00749606|20830144|P1|COMPLETED|Year 2||63
8452452|NCT00749606|20830143|P2|STARTED|Year 2||80
8452453|NCT00749606|20830144|P1|STARTED|Year 2||74
8452454|NCT00749606|20830143|P2|NOT COMPLETED|Year 1||48
8452455|NCT00749606|20830144|P1|NOT COMPLETED|Year 1||55
8452456|NCT00749606|20830143|P2|COMPLETED|Year 1||80
8452457|NCT00749606|20830144|P1|COMPLETED|Year 1||74
8452458|NCT00749606|20830143|P2|STARTED|Year 1||128
8452459|NCT00749606|20830144|P1|STARTED|Year 1||129
8452460|NCT00749580|20830164|P2|NOT COMPLETED|Overall Study||9
8452461|NCT00749580|20830165|P1|NOT COMPLETED|Overall Study||4
8452462|NCT00749580|20830164|P2|COMPLETED|Overall Study||16
8452463|NCT00749580|20830165|P1|COMPLETED|Overall Study|December 2010|17
8452464|NCT00749580|20830164|P2|STARTED|Overall Study||25
8452465|NCT00749580|20830165|P1|STARTED|Overall Study|September 2008|21
8452466|NCT00749515|20830175|P2|NOT COMPLETED|Overall Study||0
8452467|NCT00749515|20830176|P1|NOT COMPLETED|Overall Study||0
8452468|NCT00749515|20830175|P2|COMPLETED|Overall Study||5
8452469|NCT00749515|20830176|P1|COMPLETED|Overall Study||10
8452470|NCT00749515|20830175|P2|STARTED|Overall Study||5
8452471|NCT00749515|20830176|P1|STARTED|Overall Study||10
8452472|NCT00749476|20830192|P1|NOT COMPLETED|Overall Study||0
8452473|NCT00749476|20830192|P1|COMPLETED|Overall Study||1
8452474|NCT00749476|20830192|P1|STARTED|Overall Study||1
8452475|NCT00749463|20830199|P3|NOT COMPLETED|Overall Study||1
8452476|NCT00749463|20830200|P2|NOT COMPLETED|Overall Study||4
8452477|NCT00749463|20830201|P1|NOT COMPLETED|Overall Study||1
8452478|NCT00749463|20830199|P3|COMPLETED|Overall Study||149
8452479|NCT00749463|20830200|P2|COMPLETED|Overall Study||60
8452480|NCT00749463|20830201|P1|COMPLETED|Overall Study||85
8452481|NCT00749463|20830199|P3|STARTED|Overall Study||150
8452482|NCT00749463|20830200|P2|STARTED|Overall Study||64
8452483|NCT00749463|20830201|P1|STARTED|Overall Study||86
8452484|NCT00749411|20830229|P2|NOT COMPLETED|Overall Study||5
8452485|NCT00749411|20830230|P1|NOT COMPLETED|Overall Study||1
8452486|NCT00749411|20830229|P2|COMPLETED|Overall Study||35
8452487|NCT00749411|20830230|P1|COMPLETED|Overall Study||20
8452488|NCT00749411|20830229|P2|STARTED|Overall Study||40
8452489|NCT00749411|20830230|P1|STARTED|Overall Study||21
8452490|NCT00749398|20830238|P1|NOT COMPLETED|Overall Study||53
8452491|NCT00749398|20830238|P1|COMPLETED|Overall Study||71
8452492|NCT00749398|20830238|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
8452493|NCT00749268|20830256|P2|NOT COMPLETED|Overall Study||36
8452494|NCT00749268|20830257|P1|NOT COMPLETED|Overall Study||34
8452495|NCT00749268|20830256|P2|COMPLETED|Overall Study||74
8452496|NCT00749268|20830257|P1|COMPLETED|Overall Study||72
8452497|NCT00749268|20830256|P2|STARTED|Overall Study||110
8452498|NCT00749268|20830257|P1|STARTED|Overall Study||106
8452499|NCT00749203|20830281|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
8452500|NCT00749203|20830282|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
8452501|NCT00749203|20830281|P2|COMPLETED|Second Infusion at 2 Weeks||13
8452502|NCT00749203|20830282|P1|COMPLETED|Second Infusion at 2 Weeks||16
8452503|NCT00749203|20830281|P2|STARTED|Second Infusion at 2 Weeks||15
8452504|NCT00749203|20830282|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
8452505|NCT00749203|20830281|P2|NOT COMPLETED|no Infusion at Week 1||4
8452506|NCT00749203|20830282|P1|NOT COMPLETED|no Infusion at Week 1||0
8452507|NCT00749203|20830281|P2|COMPLETED|no Infusion at Week 1||15
8452508|NCT00749203|20830282|P1|COMPLETED|no Infusion at Week 1||22
8452509|NCT00749203|20830281|P2|STARTED|no Infusion at Week 1||19
8452510|NCT00749203|20830282|P1|STARTED|no Infusion at Week 1||22
8452511|NCT00749203|20830281|P2|NOT COMPLETED|First Infusion Day 1||0
8452512|NCT00749203|20830282|P1|NOT COMPLETED|First Infusion Day 1||0
8452513|NCT00749203|20830281|P2|COMPLETED|First Infusion Day 1||19
8452514|NCT00749203|20830282|P1|COMPLETED|First Infusion Day 1||22
8452515|NCT00749203|20830281|P2|STARTED|First Infusion Day 1||19
8452516|NCT00749203|20830282|P1|STARTED|First Infusion Day 1||22
8452517|NCT00749190|20830303|P7|NOT COMPLETED|Overall Study||1
8452518|NCT00749190|20830304|P6|NOT COMPLETED|Overall Study||5
8452519|NCT00749190|20830305|P5|NOT COMPLETED|Overall Study||0
8452520|NCT00749190|20830306|P4|NOT COMPLETED|Overall Study||5
8452521|NCT00749190|20830307|P3|NOT COMPLETED|Overall Study||1
8452522|NCT00749190|20830308|P2|NOT COMPLETED|Overall Study||5
8452523|NCT00749190|20830309|P1|NOT COMPLETED|Overall Study||5
8452524|NCT00749190|20830303|P7|COMPLETED|Overall Study||70
8452525|NCT00749190|20830304|P6|COMPLETED|Overall Study||65
8452526|NCT00749190|20830305|P5|COMPLETED|Overall Study||70
8452527|NCT00749190|20830306|P4|COMPLETED|Overall Study||66
8452528|NCT00749190|20830307|P3|COMPLETED|Overall Study||70
8452529|NCT00749190|20830308|P2|COMPLETED|Overall Study||66
8452530|NCT00749190|20830309|P1|COMPLETED|Overall Study||66
8452531|NCT00749190|20830303|P7|STARTED|Overall Study||71
8452532|NCT00749190|20830304|P6|STARTED|Overall Study||70
8452533|NCT00749190|20830305|P5|STARTED|Overall Study||70
8452534|NCT00749190|20830306|P4|STARTED|Overall Study||71
8452535|NCT00749190|20830307|P3|STARTED|Overall Study||71
8452536|NCT00749190|20830308|P2|STARTED|Overall Study||71
8452537|NCT00749190|20830309|P1|STARTED|Overall Study||71
8452538|NCT00749125|20830388|P2|NOT COMPLETED|Overall Study||18
8452539|NCT00749125|20830389|P1|NOT COMPLETED|Overall Study||11
8452540|NCT00749125|20830388|P2|COMPLETED|Overall Study||34
8452541|NCT00749125|20830389|P1|COMPLETED|Overall Study||36
8452542|NCT00749125|20830388|P2|STARTED|Overall Study||52
8452543|NCT00749125|20830389|P1|STARTED|Overall Study||47
8452544|NCT00749073|20830395|P1|NOT COMPLETED|Overall Study||0
8452545|NCT00749073|20830395|P1|COMPLETED|Overall Study||10
8452546|NCT00749073|20830395|P1|STARTED|Overall Study||10
8452547|NCT00748982|20830403|P2|NOT COMPLETED|Overall Study||0
8452548|NCT00748982|20830404|P1|NOT COMPLETED|Overall Study||0
8452549|NCT00748982|20830403|P2|COMPLETED|Overall Study||4
8452550|NCT00748982|20830404|P1|COMPLETED|Overall Study||12
8452551|NCT00748982|20830403|P2|STARTED|Overall Study||4
8452552|NCT00748982|20830404|P1|STARTED|Overall Study||12
8452553|NCT00748969|20830418|P2|NOT COMPLETED|Overall Study||1
8452554|NCT00748969|20830419|P1|NOT COMPLETED|Overall Study||1
8452555|NCT00748969|20830418|P2|COMPLETED|Overall Study||0
8452556|NCT00748969|20830419|P1|COMPLETED|Overall Study||0
8452557|NCT00748969|20830418|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
8452558|NCT00748969|20830419|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
8452559|NCT00748956|20830430|P3|NOT COMPLETED|Overall Study||0
8452560|NCT00748956|20830431|P2|NOT COMPLETED|Overall Study||0
8452561|NCT00748956|20830432|P1|NOT COMPLETED|Overall Study||0
8452562|NCT00748956|20830430|P3|COMPLETED|Overall Study||5
8452563|NCT00748956|20830431|P2|COMPLETED|Overall Study||5
8452564|NCT00748956|20830432|P1|COMPLETED|Overall Study||0
8452565|NCT00748956|20830430|P3|STARTED|Overall Study||5
8452566|NCT00748956|20830431|P2|STARTED|Overall Study||5
8452567|NCT00748956|20830432|P1|STARTED|Overall Study||0
8452568|NCT00748865|20830455|P2|NOT COMPLETED|Overall Study||0
8452569|NCT00748865|20830456|P1|NOT COMPLETED|Overall Study||0
8452570|NCT00748865|20830455|P2|COMPLETED|Overall Study||10
8452571|NCT00748865|20830456|P1|COMPLETED|Overall Study||10
8452572|NCT00748865|20830455|P2|STARTED|Overall Study||10
8452573|NCT00748865|20830456|P1|STARTED|Overall Study||10
8452574|NCT00748826|20830462|P1|NOT COMPLETED|Overall Study||301
8452575|NCT00748826|20830462|P1|COMPLETED|Overall Study||207
8452576|NCT00748826|20830462|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
8452577|NCT00748709|20830469|P1|NOT COMPLETED|Overall Study||20
8452578|NCT00748709|20830469|P1|COMPLETED|Overall Study||0
8452579|NCT00748709|20830469|P1|STARTED|Overall Study|Treated|20
8452580|NCT00748657|20830481|P1|NOT COMPLETED|Overall Study||0
8452581|NCT00748657|20830481|P1|COMPLETED|Overall Study||36
8452582|NCT00748657|20830481|P1|STARTED|Overall Study||36
8452583|NCT00748579|20830495|P2|NOT COMPLETED|Overall Study||0
8452584|NCT00748579|20830496|P1|NOT COMPLETED|Overall Study||0
8452585|NCT00748579|20830495|P2|COMPLETED|Overall Study||0
8452586|NCT00748579|20830496|P1|COMPLETED|Overall Study||2
8452587|NCT00748579|20830495|P2|STARTED|Overall Study||0
8452588|NCT00748579|20830496|P1|STARTED|Overall Study||2
8452589|NCT00748566|20830512|P1|NOT COMPLETED|Overall Study||112
8452590|NCT00748566|20830512|P1|COMPLETED|Overall Study||60
8452591|NCT00748566|20830512|P1|STARTED|Overall Study||172
8452592|NCT00748553|20830542|P2|NOT COMPLETED|Overall Study||1
8452593|NCT00748553|20830543|P1|NOT COMPLETED|Overall Study||3
8452594|NCT00748553|20830542|P2|COMPLETED|Overall Study||13
8452595|NCT00748553|20830543|P1|COMPLETED|Overall Study||13
8452596|NCT00748553|20830542|P2|STARTED|Overall Study||14
8452597|NCT00748553|20830543|P1|STARTED|Overall Study||16
8452598|NCT00748540|20830550|P1|NOT COMPLETED|Overall Study||1
8452599|NCT00748540|20830550|P1|COMPLETED|Overall Study||49
8452600|NCT00748540|20830550|P1|STARTED|Overall Study||50
8452601|NCT00748410|20830559|P2|NOT COMPLETED|Overall Study||0
8452602|NCT00748410|20830560|P1|NOT COMPLETED|Overall Study||0
8452603|NCT00748410|20830559|P2|COMPLETED|Overall Study||2
8452604|NCT00748410|20830560|P1|COMPLETED|Overall Study||1
8452605|NCT00748410|20830559|P2|STARTED|Overall Study||2
8452606|NCT00748410|20830560|P1|STARTED|Overall Study||1
8452607|NCT00748241|20830576|P1|NOT COMPLETED|Overall Study||8
8452608|NCT00748241|20830576|P1|COMPLETED|Overall Study||11
8452609|NCT00748241|20830576|P1|STARTED|Overall Study||19
8452610|NCT00748215|20830586|P2|NOT COMPLETED|Overall Study||18
8452611|NCT00748215|20830587|P1|NOT COMPLETED|Overall Study||9
8452612|NCT00748215|20830586|P2|COMPLETED|Overall Study||32
8452613|NCT00748215|20830587|P1|COMPLETED|Overall Study||41
8452614|NCT00748215|20830586|P2|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
8452615|NCT00748215|20830587|P1|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
8452616|NCT00748215|20830586|P2|STARTED|Overall Study||50
8452617|NCT00748215|20830587|P1|STARTED|Overall Study||50
8452618|NCT00748189|20830595|P2|NOT COMPLETED|Overall Study||212
8452619|NCT00748189|20830596|P1|NOT COMPLETED|Overall Study||216
8452620|NCT00748189|20830595|P2|COMPLETED|Overall Study||9
8452621|NCT00748189|20830596|P1|COMPLETED|Overall Study||10
8452622|NCT00748189|20830595|P2|STARTED|Overall Study||221
8452623|NCT00748189|20830596|P1|STARTED|Overall Study||226
8452624|NCT00748098|20830651|P2|NOT COMPLETED|Second Taper Period||0
8452625|NCT00748098|20830652|P1|NOT COMPLETED|Second Taper Period||0
8452626|NCT00748098|20830651|P2|COMPLETED|Second Taper Period||61
8452627|NCT00748098|20830652|P1|COMPLETED|Second Taper Period||53
8452628|NCT00748098|20830651|P2|STARTED|Second Taper Period||61
8452629|NCT00748098|20830652|P1|STARTED|Second Taper Period||53
8452630|NCT00748098|20830651|P2|NOT COMPLETED|Second Treatment Intervention Period||3
8452631|NCT00748098|20830652|P1|NOT COMPLETED|Second Treatment Intervention Period||6
8452632|NCT00748098|20830651|P2|COMPLETED|Second Treatment Intervention Period||61
8452633|NCT00748098|20830652|P1|COMPLETED|Second Treatment Intervention Period||53
8452634|NCT00748098|20830651|P2|STARTED|Second Treatment Intervention Period||64
8452635|NCT00748098|20830652|P1|STARTED|Second Treatment Intervention Period||59
8452636|NCT00748098|20830651|P2|NOT COMPLETED|1-Week Washout Period||1
8452637|NCT00748098|20830652|P1|NOT COMPLETED|1-Week Washout Period||2
8452638|NCT00748098|20830651|P2|COMPLETED|1-Week Washout Period||64
8452639|NCT00748098|20830652|P1|COMPLETED|1-Week Washout Period||59
8452640|NCT00748098|20830651|P2|STARTED|1-Week Washout Period||65
8452641|NCT00748098|20830652|P1|STARTED|1-Week Washout Period||61
8452642|NCT00748098|20830651|P2|NOT COMPLETED|First Taper Period||1
8452643|NCT00748098|20830652|P1|NOT COMPLETED|First Taper Period||3
8452644|NCT00748098|20830651|P2|COMPLETED|First Taper Period||65
8452645|NCT00748098|20830652|P1|COMPLETED|First Taper Period||61
8452646|NCT00748098|20830651|P2|STARTED|First Taper Period||66
8452647|NCT00748098|20830652|P1|STARTED|First Taper Period||64
8452648|NCT00748098|20830651|P2|NOT COMPLETED|First Treatment Intervention Period||1
8452649|NCT00748098|20830652|P1|NOT COMPLETED|First Treatment Intervention Period||5
8452650|NCT00748098|20830651|P2|COMPLETED|First Treatment Intervention Period||66
8452651|NCT00748098|20830652|P1|COMPLETED|First Treatment Intervention Period||64
8452652|NCT00748098|20830651|P2|STARTED|First Treatment Intervention Period||67
8452653|NCT00748098|20830652|P1|STARTED|First Treatment Intervention Period||69
8452654|NCT00748085|20830712|P1|NOT COMPLETED|Overall Study||0
8452655|NCT00748085|20830712|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
8452656|NCT00748085|20830712|P1|STARTED|Overall Study||5
8452657|NCT00748072|20830719|P2|NOT COMPLETED|Overall Study||0
8452658|NCT00748072|20830720|P1|NOT COMPLETED|Overall Study||0
8452659|NCT00748072|20830719|P2|COMPLETED|Overall Study||80
8452660|NCT00748072|20830720|P1|COMPLETED|Overall Study||82
8452661|NCT00748072|20830719|P2|STARTED|Overall Study||80
8452662|NCT00748072|20830720|P1|STARTED|Overall Study||82
8452663|NCT00747916|20830726|P1|NOT COMPLETED|Overall Study||0
8452664|NCT00747916|20830726|P1|COMPLETED|Overall Study||3
8452665|NCT00747916|20830726|P1|STARTED|Overall Study||3
8452666|NCT00747812|20830733|P2|NOT COMPLETED|Overall Study||3
8452667|NCT00747812|20830734|P1|NOT COMPLETED|Overall Study||5
8452668|NCT00747812|20830733|P2|COMPLETED|Overall Study||0
8452669|NCT00747812|20830734|P1|COMPLETED|Overall Study||0
8452670|NCT00747812|20830733|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
8452671|NCT00747812|20830734|P1|STARTED|Overall Study||5
8452672|NCT00747747|20830745|P3|NOT COMPLETED|Overall Study||0
8452673|NCT00747747|20830746|P2|NOT COMPLETED|Overall Study||0
8452674|NCT00747747|20830747|P1|NOT COMPLETED|Overall Study||0
8452675|NCT00747747|20830745|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
8452676|NCT00747747|20830746|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
8452677|NCT00747747|20830747|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
8452678|NCT00747747|20830745|P3|STARTED|Overall Study||21
8452679|NCT00747747|20830746|P2|STARTED|Overall Study||14
8452680|NCT00747747|20830747|P1|STARTED|Overall Study||14
8452681|NCT00747643|20830772|P2|NOT COMPLETED|Overall Study||27
8452682|NCT00747643|20830773|P1|NOT COMPLETED|Overall Study||36
8452683|NCT00747643|20830772|P2|COMPLETED|Overall Study||54
8452684|NCT00747643|20830773|P1|COMPLETED|Overall Study||46
8452685|NCT00747643|20830772|P2|STARTED|Overall Study||81
8452686|NCT00747643|20830773|P1|STARTED|Overall Study||82
8452687|NCT00747617|20830787|P2|NOT COMPLETED|Overall Study||1
8452688|NCT00747617|20830788|P1|NOT COMPLETED|Overall Study||3
8452689|NCT00747617|20830787|P2|COMPLETED|Overall Study||11
8452690|NCT00747617|20830788|P1|COMPLETED|Overall Study||10
8452691|NCT00747617|20830787|P2|STARTED|Overall Study||12
8452692|NCT00747617|20830788|P1|STARTED|Overall Study||13
8452693|NCT00747565|20830798|P2|NOT COMPLETED|Overall Study||7
8452694|NCT00747565|20830799|P1|NOT COMPLETED|Overall Study||14
8452695|NCT00747565|20830798|P2|COMPLETED|Overall Study||116
8452696|NCT00747565|20830799|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
8452697|NCT00747565|20830798|P2|STARTED|Overall Study||123
8452698|NCT00747565|20830799|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
8452699|NCT00747552|20830807|P1|NOT COMPLETED|Overall Study||0
8452700|NCT00747552|20830807|P1|COMPLETED|Overall Study||30
8452701|NCT00747552|20830807|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
8452702|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452703|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452704|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452705|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452706|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452707|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452708|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452709|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452710|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452711|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452712|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452713|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452714|NCT00747474|20830812|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
8452715|NCT00747474|20830813|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452716|NCT00747474|20830814|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452717|NCT00747474|20830815|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452718|NCT00747474|20830816|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452719|NCT00747474|20830817|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452720|NCT00747474|20830818|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452721|NCT00747474|20830819|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452722|NCT00747474|20830820|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452723|NCT00747474|20830821|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452724|NCT00747474|20830822|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452725|NCT00747474|20830823|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452726|NCT00747474|20830812|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
8452727|NCT00747474|20830813|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452728|NCT00747474|20830814|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452729|NCT00747474|20830815|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452730|NCT00747474|20830816|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452731|NCT00747474|20830817|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452732|NCT00747474|20830818|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452733|NCT00747474|20830819|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452734|NCT00747474|20830820|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452735|NCT00747474|20830821|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452736|NCT00747474|20830822|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452737|NCT00747474|20830823|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452738|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452739|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452740|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452741|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452742|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452743|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452744|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452745|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452746|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452747|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452748|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452749|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452750|NCT00747474|20830812|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452751|NCT00747474|20830813|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
8452752|NCT00747474|20830814|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452753|NCT00747474|20830815|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452754|NCT00747474|20830816|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452755|NCT00747474|20830817|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452756|NCT00747474|20830818|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452757|NCT00747474|20830819|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452758|NCT00747474|20830820|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452759|NCT00747474|20830821|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452760|NCT00747474|20830822|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452761|NCT00747474|20830823|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452762|NCT00747474|20830812|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452763|NCT00747474|20830813|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
8452764|NCT00747474|20830814|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452765|NCT00747474|20830815|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452766|NCT00747474|20830816|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452767|NCT00747474|20830817|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452768|NCT00747474|20830818|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452769|NCT00747474|20830819|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452770|NCT00747474|20830820|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452771|NCT00747474|20830821|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452772|NCT00747474|20830822|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452773|NCT00747474|20830823|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452774|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452775|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452776|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452777|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452778|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452779|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452780|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452781|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452782|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452783|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452784|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452785|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452786|NCT00747474|20830812|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452787|NCT00747474|20830813|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452788|NCT00747474|20830814|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
8452789|NCT00747474|20830815|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452790|NCT00747474|20830816|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452791|NCT00747474|20830817|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452792|NCT00747474|20830818|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452793|NCT00747474|20830819|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452794|NCT00747474|20830820|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452795|NCT00747474|20830821|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452796|NCT00747474|20830822|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452797|NCT00747474|20830823|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452798|NCT00747474|20830812|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452799|NCT00747474|20830813|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452800|NCT00747474|20830814|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
8452801|NCT00747474|20830815|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452802|NCT00747474|20830816|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452803|NCT00747474|20830817|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452804|NCT00747474|20830818|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452805|NCT00747474|20830819|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452806|NCT00747474|20830820|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452807|NCT00747474|20830821|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452808|NCT00747474|20830822|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452809|NCT00747474|20830823|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452810|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452811|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452812|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452813|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452814|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452815|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452816|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452817|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452818|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452819|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452820|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452821|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452822|NCT00747474|20830812|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452823|NCT00747474|20830813|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452824|NCT00747474|20830814|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452825|NCT00747474|20830815|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
8452826|NCT00747474|20830816|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452827|NCT00747474|20830817|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452828|NCT00747474|20830818|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452829|NCT00747474|20830819|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452830|NCT00747474|20830820|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452831|NCT00747474|20830821|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452832|NCT00747474|20830822|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452833|NCT00747474|20830823|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452834|NCT00747474|20830812|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452835|NCT00747474|20830813|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452836|NCT00747474|20830814|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452837|NCT00747474|20830815|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
8452838|NCT00747474|20830816|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452839|NCT00747474|20830817|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452840|NCT00747474|20830818|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452841|NCT00747474|20830819|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452842|NCT00747474|20830820|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452843|NCT00747474|20830821|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452844|NCT00747474|20830822|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452845|NCT00747474|20830823|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452846|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452847|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452848|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452849|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452850|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
8452851|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452852|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452853|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452854|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452855|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452856|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452857|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452858|NCT00747474|20830812|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452859|NCT00747474|20830813|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452860|NCT00747474|20830814|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452861|NCT00747474|20830815|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452862|NCT00747474|20830816|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
8452863|NCT00747474|20830817|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452864|NCT00747474|20830818|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452865|NCT00747474|20830819|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452866|NCT00747474|20830820|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452867|NCT00747474|20830821|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452868|NCT00747474|20830822|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452869|NCT00747474|20830823|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452870|NCT00747474|20830812|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452871|NCT00747474|20830813|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452872|NCT00747474|20830814|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452873|NCT00747474|20830815|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452874|NCT00747474|20830816|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
8452875|NCT00747474|20830817|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452876|NCT00747474|20830818|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452877|NCT00747474|20830819|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452878|NCT00747474|20830820|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452879|NCT00747474|20830821|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452880|NCT00747474|20830822|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452881|NCT00747474|20830823|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452882|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452883|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452884|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452885|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452886|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452887|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452888|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452889|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452890|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452891|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452892|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452893|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452894|NCT00747474|20830812|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452895|NCT00747474|20830813|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452896|NCT00747474|20830814|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452897|NCT00747474|20830815|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452898|NCT00747474|20830816|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452899|NCT00747474|20830817|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
8452900|NCT00747474|20830818|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452901|NCT00747474|20830819|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452902|NCT00747474|20830820|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452903|NCT00747474|20830821|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452904|NCT00747474|20830822|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452905|NCT00747474|20830823|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452906|NCT00747474|20830812|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452907|NCT00747474|20830813|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452908|NCT00747474|20830814|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452909|NCT00747474|20830815|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452910|NCT00747474|20830816|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452911|NCT00747474|20830817|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
8452912|NCT00747474|20830818|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452913|NCT00747474|20830819|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452914|NCT00747474|20830820|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452915|NCT00747474|20830821|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452916|NCT00747474|20830822|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452917|NCT00747474|20830823|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452918|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452919|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452920|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452921|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452922|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452923|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452924|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452925|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452926|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452927|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452928|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452929|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452930|NCT00747474|20830812|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452931|NCT00747474|20830813|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452932|NCT00747474|20830814|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452933|NCT00747474|20830815|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452934|NCT00747474|20830816|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452935|NCT00747474|20830817|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452936|NCT00747474|20830818|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
8452937|NCT00747474|20830819|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452938|NCT00747474|20830820|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452939|NCT00747474|20830821|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452940|NCT00747474|20830822|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452941|NCT00747474|20830823|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452942|NCT00747474|20830812|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452943|NCT00747474|20830813|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452944|NCT00747474|20830814|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452945|NCT00747474|20830815|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452946|NCT00747474|20830816|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452947|NCT00747474|20830817|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452948|NCT00747474|20830818|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
8452949|NCT00747474|20830819|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452950|NCT00747474|20830820|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452951|NCT00747474|20830821|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452952|NCT00747474|20830822|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452953|NCT00747474|20830823|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452954|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452955|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452956|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452957|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452958|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452959|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452960|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452961|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452962|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452963|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452964|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452965|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452966|NCT00747474|20830812|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452967|NCT00747474|20830813|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452968|NCT00747474|20830814|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452969|NCT00747474|20830815|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452970|NCT00747474|20830816|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452971|NCT00747474|20830817|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452972|NCT00747474|20830818|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452973|NCT00747474|20830819|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
8452974|NCT00747474|20830820|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452975|NCT00747474|20830821|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452976|NCT00747474|20830822|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452977|NCT00747474|20830823|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452978|NCT00747474|20830812|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452979|NCT00747474|20830813|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452980|NCT00747474|20830814|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452981|NCT00747474|20830815|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452982|NCT00747474|20830816|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452983|NCT00747474|20830817|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452984|NCT00747474|20830818|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452985|NCT00747474|20830819|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
8452986|NCT00747474|20830820|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452987|NCT00747474|20830821|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452988|NCT00747474|20830822|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452989|NCT00747474|20830823|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452990|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452991|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452992|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452993|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452994|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452995|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452996|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452997|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452998|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452999|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453000|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453001|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453002|NCT00747474|20830812|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453003|NCT00747474|20830813|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453004|NCT00747474|20830814|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453005|NCT00747474|20830815|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453006|NCT00747474|20830816|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453007|NCT00747474|20830817|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453008|NCT00747474|20830818|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453009|NCT00747474|20830819|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453010|NCT00747474|20830820|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
8453011|NCT00747474|20830821|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453012|NCT00747474|20830822|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453013|NCT00747474|20830823|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453014|NCT00747474|20830812|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453015|NCT00747474|20830813|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453016|NCT00747474|20830814|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453017|NCT00747474|20830815|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453018|NCT00747474|20830816|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453019|NCT00747474|20830817|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453020|NCT00747474|20830818|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453021|NCT00747474|20830819|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453022|NCT00747474|20830820|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
8453023|NCT00747474|20830821|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453024|NCT00747474|20830822|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453025|NCT00747474|20830823|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453026|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453027|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453028|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453029|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453030|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453031|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453032|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453033|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453034|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453035|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453036|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453037|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453038|NCT00747474|20830812|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453039|NCT00747474|20830813|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453040|NCT00747474|20830814|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453041|NCT00747474|20830815|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453042|NCT00747474|20830816|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453043|NCT00747474|20830817|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453044|NCT00747474|20830818|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453045|NCT00747474|20830819|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453046|NCT00747474|20830820|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453047|NCT00747474|20830821|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
8453048|NCT00747474|20830822|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453049|NCT00747474|20830823|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453050|NCT00747474|20830812|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453051|NCT00747474|20830813|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453052|NCT00747474|20830814|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453053|NCT00747474|20830815|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453054|NCT00747474|20830816|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453055|NCT00747474|20830817|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453056|NCT00747474|20830818|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453057|NCT00747474|20830819|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453058|NCT00747474|20830820|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453059|NCT00747474|20830821|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
8453060|NCT00747474|20830822|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453061|NCT00747474|20830823|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453062|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453063|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453064|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453065|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453066|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453067|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453068|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453069|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453070|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453071|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453072|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453073|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453074|NCT00747474|20830812|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453075|NCT00747474|20830813|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453076|NCT00747474|20830814|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453077|NCT00747474|20830815|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453078|NCT00747474|20830816|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453079|NCT00747474|20830817|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453080|NCT00747474|20830818|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453081|NCT00747474|20830819|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453082|NCT00747474|20830820|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453083|NCT00747474|20830821|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453084|NCT00747474|20830822|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
8453085|NCT00747474|20830823|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453086|NCT00747474|20830812|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453087|NCT00747474|20830813|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453088|NCT00747474|20830814|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453089|NCT00747474|20830815|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453090|NCT00747474|20830816|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453091|NCT00747474|20830817|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453092|NCT00747474|20830818|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453093|NCT00747474|20830819|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453094|NCT00747474|20830820|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453095|NCT00747474|20830821|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453096|NCT00747474|20830822|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
8453097|NCT00747474|20830823|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453098|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453099|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453100|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453101|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453102|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453103|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453104|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453105|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453106|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453107|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453108|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453109|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453110|NCT00747474|20830812|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453111|NCT00747474|20830813|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453112|NCT00747474|20830814|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453113|NCT00747474|20830815|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453114|NCT00747474|20830816|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453115|NCT00747474|20830817|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453116|NCT00747474|20830818|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453117|NCT00747474|20830819|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453118|NCT00747474|20830820|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453119|NCT00747474|20830821|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453120|NCT00747474|20830822|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453121|NCT00747474|20830823|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
8453122|NCT00747474|20830812|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453123|NCT00747474|20830813|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453124|NCT00747474|20830814|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453125|NCT00747474|20830815|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453126|NCT00747474|20830816|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453127|NCT00747474|20830817|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453128|NCT00747474|20830818|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453129|NCT00747474|20830819|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453130|NCT00747474|20830820|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453131|NCT00747474|20830821|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453132|NCT00747474|20830822|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453133|NCT00747474|20830823|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
8453134|NCT00747461|20830849|P1|NOT COMPLETED|Overall Study||5
8453135|NCT00747461|20830849|P1|COMPLETED|Overall Study||0
8453136|NCT00747461|20830849|P1|STARTED|Overall Study||5
8453137|NCT00747435|20830854|P1|NOT COMPLETED|Overall Study||6
8453138|NCT00747435|20830854|P1|COMPLETED|Overall Study||67
8453139|NCT00747435|20830854|P1|STARTED|Overall Study||73
8453140|NCT00747344|20830864|P4|NOT COMPLETED|After Controlled Period||1
8453141|NCT00747344|20830865|P3|NOT COMPLETED|After Controlled Period||0
8453142|NCT00747344|20830866|P2|NOT COMPLETED|After Controlled Period||0
8453143|NCT00747344|20830867|P1|NOT COMPLETED|After Controlled Period||0
8453144|NCT00747344|20830864|P4|COMPLETED|After Controlled Period||56
8453145|NCT00747344|20830865|P3|COMPLETED|After Controlled Period||55
8453146|NCT00747344|20830866|P2|COMPLETED|After Controlled Period||0
8453147|NCT00747344|20830867|P1|COMPLETED|After Controlled Period||0
8453148|NCT00747344|20830864|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
8453149|NCT00747344|20830865|P3|STARTED|After Controlled Period||55
8453150|NCT00747344|20830866|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8453151|NCT00747344|20830867|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8453152|NCT00747344|20830864|P4|NOT COMPLETED|Controlled Period||0
8453153|NCT00747344|20830865|P3|NOT COMPLETED|Controlled Period||0
8453154|NCT00747344|20830866|P2|NOT COMPLETED|Controlled Period||4
8453155|NCT00747344|20830867|P1|NOT COMPLETED|Controlled Period||5
8453156|NCT00747344|20830864|P4|COMPLETED|Controlled Period||0
8453157|NCT00747344|20830865|P3|COMPLETED|Controlled Period||0
8453158|NCT00747344|20830866|P2|COMPLETED|Controlled Period||57
8453159|NCT00747344|20830867|P1|COMPLETED|Controlled Period||55
8453160|NCT00747344|20830864|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8453161|NCT00747344|20830865|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8453162|NCT00747344|20830866|P2|STARTED|Controlled Period||61
8453163|NCT00747344|20830867|P1|STARTED|Controlled Period||60
8453164|NCT00747227|20830881|P2|NOT COMPLETED|Overall Study||4
8453165|NCT00747227|20830882|P1|NOT COMPLETED|Overall Study||6
8453166|NCT00747227|20830881|P2|COMPLETED|Overall Study||120
8453167|NCT00747227|20830882|P1|COMPLETED|Overall Study||120
8453168|NCT00747227|20830881|P2|STARTED|Overall Study||124
8453169|NCT00747227|20830882|P1|STARTED|Overall Study||126
8453170|NCT00747214|20830896|P2|NOT COMPLETED|Overall Study||3
8453171|NCT00747214|20830897|P1|NOT COMPLETED|Overall Study||8
8453172|NCT00747214|20830896|P2|COMPLETED|Overall Study||29
8453173|NCT00747214|20830897|P1|COMPLETED|Overall Study||19
8453174|NCT00747214|20830896|P2|STARTED|Overall Study||32
8453175|NCT00747214|20830897|P1|STARTED|Overall Study||27
8453176|NCT00747149|20830911|P2|NOT COMPLETED|Overall Study||43
8453177|NCT00747149|20830912|P1|NOT COMPLETED|Overall Study||1
8453178|NCT00747149|20830911|P2|COMPLETED|Overall Study||401
8453179|NCT00747149|20830912|P1|COMPLETED|Overall Study||153
8453180|NCT00747149|20830911|P2|STARTED|Overall Study||444
8453181|NCT00747149|20830912|P1|STARTED|Overall Study||154
8453182|NCT00747006|20830927|P3|NOT COMPLETED|Overall Study||1
8453183|NCT00747006|20830928|P2|NOT COMPLETED|Overall Study||1
8453184|NCT00747006|20830929|P1|NOT COMPLETED|Overall Study||3
8453185|NCT00747006|20830927|P3|COMPLETED|Overall Study||2
8453186|NCT00747006|20830928|P2|COMPLETED|Overall Study||7
8453187|NCT00747006|20830929|P1|COMPLETED|Overall Study||4
8453188|NCT00747006|20830927|P3|STARTED|Overall Study||3
8453189|NCT00747006|20830928|P2|STARTED|Overall Study||8
8453190|NCT00747006|20830929|P1|STARTED|Overall Study||7
8453191|NCT00746954|20830995|P3|NOT COMPLETED|Overall Study||0
8453192|NCT00746954|20830996|P2|NOT COMPLETED|Overall Study||0
8453193|NCT00746954|20830997|P1|NOT COMPLETED|Overall Study||0
8453194|NCT00746954|20830995|P3|COMPLETED|Overall Study||2
8453195|NCT00746954|20830996|P2|COMPLETED|Overall Study||3
8453196|NCT00746954|20830997|P1|COMPLETED|Overall Study||3
8453197|NCT00746954|20830995|P3|STARTED|Overall Study||2
8453198|NCT00746954|20830996|P2|STARTED|Overall Study||3
8453199|NCT00746954|20830997|P1|STARTED|Overall Study||3
8453200|NCT00746941|20831007|P4|NOT COMPLETED|Overall Study||13
8453201|NCT00746941|20831008|P3|NOT COMPLETED|Overall Study||2
8453202|NCT00746941|20831009|P2|NOT COMPLETED|Overall Study||4
8453203|NCT00746941|20831010|P1|NOT COMPLETED|Overall Study||7
8453204|NCT00746941|20831007|P4|COMPLETED|Overall Study||7
8453205|NCT00746941|20831008|P3|COMPLETED|Overall Study||3
8453206|NCT00746941|20831009|P2|COMPLETED|Overall Study||1
8453207|NCT00746941|20831010|P1|COMPLETED|Overall Study||0
8453208|NCT00746941|20831007|P4|STARTED|Overall Study||20
8453209|NCT00746941|20831008|P3|STARTED|Overall Study||5
8453210|NCT00746941|20831009|P2|STARTED|Overall Study||5
8453211|NCT00746941|20831010|P1|STARTED|Overall Study||7
8453212|NCT00746889|20831038|P2|NOT COMPLETED|Overall Study||4
8453213|NCT00746889|20831039|P1|NOT COMPLETED|Overall Study||4
8453214|NCT00746889|20831038|P2|COMPLETED|Overall Study||35
8453215|NCT00746889|20831039|P1|COMPLETED|Overall Study||36
8453216|NCT00746889|20831038|P2|STARTED|Overall Study||39
8453217|NCT00746889|20831039|P1|STARTED|Overall Study||40
8453218|NCT00746863|20831049|P2|NOT COMPLETED|Overall Study||0
8453219|NCT00746863|20831050|P1|NOT COMPLETED|Overall Study||0
8453220|NCT00746863|20831049|P2|COMPLETED|Overall Study||21
8453221|NCT00746863|20831050|P1|COMPLETED|Overall Study||21
8453222|NCT00746863|20831049|P2|STARTED|Overall Study||21
8453223|NCT00746863|20831050|P1|STARTED|Overall Study||21
8453224|NCT00746798|20831068|P4|NOT COMPLETED|Overall Study||0
8453225|NCT00746798|20831069|P3|NOT COMPLETED|Overall Study||3
8453226|NCT00746798|20831070|P2|NOT COMPLETED|Overall Study||2
8453227|NCT00746798|20831071|P1|NOT COMPLETED|Overall Study||1
8453228|NCT00746798|20831068|P4|COMPLETED|Overall Study||120
8453229|NCT00746798|20831069|P3|COMPLETED|Overall Study||110
8453230|NCT00746798|20831070|P2|COMPLETED|Overall Study||122
8453231|NCT00746798|20831071|P1|COMPLETED|Overall Study||121
8453232|NCT00746798|20831068|P4|STARTED|Overall Study||120
8453233|NCT00746798|20831069|P3|STARTED|Overall Study||113
8453234|NCT00746798|20831070|P2|STARTED|Overall Study||124
8453235|NCT00746798|20831071|P1|STARTED|Overall Study||122
8453236|NCT00746785|20831096|P3|NOT COMPLETED|Overall Study||27
8453237|NCT00746785|20831097|P2|NOT COMPLETED|Overall Study||25
8453238|NCT00746785|20831098|P1|NOT COMPLETED|Overall Study||29
8453239|NCT00746785|20831096|P3|COMPLETED|Overall Study||13
8453240|NCT00746785|20831097|P2|COMPLETED|Overall Study||21
8453241|NCT00746785|20831098|P1|COMPLETED|Overall Study||14
8453242|NCT00746785|20831096|P3|STARTED|Overall Study||40
8453243|NCT00746785|20831097|P2|STARTED|Overall Study||46
8453244|NCT00746785|20831098|P1|STARTED|Overall Study||43
8453245|NCT00746733|20831106|P2|NOT COMPLETED|Fourth Intervention||0
8453246|NCT00746733|20831107|P1|NOT COMPLETED|Fourth Intervention||0
8453247|NCT00746733|20831106|P2|COMPLETED|Fourth Intervention||11
8453248|NCT00746733|20831107|P1|COMPLETED|Fourth Intervention||10
8453249|NCT00746733|20831106|P2|STARTED|Fourth Intervention||11
8453250|NCT00746733|20831107|P1|STARTED|Fourth Intervention||10
8453251|NCT00746733|20831106|P2|NOT COMPLETED|Third Intervention||1
8453252|NCT00746733|20831107|P1|NOT COMPLETED|Third Intervention||1
8453253|NCT00746733|20831106|P2|COMPLETED|Third Intervention||11
8453254|NCT00746733|20831107|P1|COMPLETED|Third Intervention||10
8453255|NCT00746733|20831106|P2|STARTED|Third Intervention||12
8453256|NCT00746733|20831107|P1|STARTED|Third Intervention||11
8453257|NCT00746733|20831106|P2|NOT COMPLETED|Second Intervention||0
8453258|NCT00746733|20831107|P1|NOT COMPLETED|Second Intervention||1
8453259|NCT00746733|20831106|P2|COMPLETED|Second Intervention||12
8453260|NCT00746733|20831107|P1|COMPLETED|Second Intervention||11
8453261|NCT00746733|20831106|P2|STARTED|Second Intervention||12
8453262|NCT00746733|20831107|P1|STARTED|Second Intervention||12
8453263|NCT00746733|20831106|P2|NOT COMPLETED|First Intervention||0
8453264|NCT00746733|20831107|P1|NOT COMPLETED|First Intervention||0
8453265|NCT00746733|20831106|P2|COMPLETED|First Intervention||12
8453266|NCT00746733|20831107|P1|COMPLETED|First Intervention||12
8453267|NCT00746733|20831106|P2|STARTED|First Intervention||12
8453268|NCT00746733|20831107|P1|STARTED|First Intervention||12
8453269|NCT00746694|20831167|P1|NOT COMPLETED|Overall Study||0
8453270|NCT00746694|20831167|P1|COMPLETED|Overall Study||154
8453271|NCT00746694|20831167|P1|STARTED|Overall Study||154
8453272|NCT00746668|20831172|P7|NOT COMPLETED|Overall Study||0
8453273|NCT00746668|20831173|P6|NOT COMPLETED|Overall Study||0
8453274|NCT00746668|20831174|P5|NOT COMPLETED|Overall Study||0
8453275|NCT00746668|20831175|P4|NOT COMPLETED|Overall Study||0
8453276|NCT00746668|20831176|P3|NOT COMPLETED|Overall Study||0
8453277|NCT00746668|20831177|P2|NOT COMPLETED|Overall Study||0
8453278|NCT00746668|20831178|P1|NOT COMPLETED|Overall Study||0
8453279|NCT00746668|20831172|P7|COMPLETED|Overall Study||5
8453280|NCT00746668|20831173|P6|COMPLETED|Overall Study||5
8453281|NCT00746668|20831174|P5|COMPLETED|Overall Study||5
8453282|NCT00746668|20831175|P4|COMPLETED|Overall Study||5
8453283|NCT00746668|20831176|P3|COMPLETED|Overall Study||5
8453284|NCT00746668|20831177|P2|COMPLETED|Overall Study||5
8453285|NCT00746668|20831178|P1|COMPLETED|Overall Study||6
8453286|NCT00746668|20831172|P7|STARTED|Overall Study||5
8453287|NCT00746668|20831173|P6|STARTED|Overall Study||5
8453288|NCT00746668|20831174|P5|STARTED|Overall Study||5
8453289|NCT00746668|20831175|P4|STARTED|Overall Study||5
8453290|NCT00746668|20831176|P3|STARTED|Overall Study||5
8453291|NCT00746668|20831177|P2|STARTED|Overall Study||5
8453292|NCT00746668|20831178|P1|STARTED|Overall Study||6
8453293|NCT00746590|20831191|P1|NOT COMPLETED|Overall Study||1
8453294|NCT00746590|20831191|P1|COMPLETED|Overall Study||0
8453295|NCT00746590|20831191|P1|STARTED|Overall Study||1
8453296|NCT00746564|20831195|P1|NOT COMPLETED|Overall Study||2
8453297|NCT00746564|20831195|P1|COMPLETED|Overall Study||73
8453298|NCT00746564|20831195|P1|STARTED|Overall Study||75
8453299|NCT00746551|20831210|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
8453300|NCT00746551|20831211|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
8453301|NCT00746551|20831210|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
8453302|NCT00746551|20831211|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
8453303|NCT00746551|20831210|P2|STARTED|At Delivery (GA of 39 Weeks)||40
8453304|NCT00746551|20831211|P1|STARTED|At Delivery (GA of 39 Weeks)||40
8453305|NCT00746551|20831210|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
8453306|NCT00746551|20831211|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
8453307|NCT00746551|20831210|P2|COMPLETED|At Gestational Age of 36 Weeks||36
8453308|NCT00746551|20831211|P1|COMPLETED|At Gestational Age of 36 Weeks||38
8453309|NCT00746551|20831210|P2|STARTED|At Gestational Age of 36 Weeks||40
8453310|NCT00746551|20831211|P1|STARTED|At Gestational Age of 36 Weeks||40
8453311|NCT00746512|20831223|P4|NOT COMPLETED|Overall Study||0
8453312|NCT00746512|20831224|P3|NOT COMPLETED|Overall Study||0
8453313|NCT00746512|20831225|P2|NOT COMPLETED|Overall Study||0
8453314|NCT00746512|20831226|P1|NOT COMPLETED|Overall Study||0
8453315|NCT00746512|20831223|P4|COMPLETED|Overall Study||9
8453316|NCT00746512|20831224|P3|COMPLETED|Overall Study||18
8453317|NCT00746512|20831225|P2|COMPLETED|Overall Study||10
8453318|NCT00746512|20831226|P1|COMPLETED|Overall Study||8
8453319|NCT00746512|20831223|P4|STARTED|Overall Study||9
8453320|NCT00746512|20831224|P3|STARTED|Overall Study||18
8453321|NCT00746512|20831225|P2|STARTED|Overall Study||10
8453322|NCT00746512|20831226|P1|STARTED|Overall Study||8
8453323|NCT00746421|20831242|P2|NOT COMPLETED|Overall Study||2
8453324|NCT00746421|20831243|P1|NOT COMPLETED|Overall Study||7
8453325|NCT00746421|20831242|P2|COMPLETED|Overall Study||9
8453326|NCT00746421|20831243|P1|COMPLETED|Overall Study||5
8453327|NCT00746421|20831242|P2|STARTED|Overall Study||11
8453328|NCT00746421|20831243|P1|STARTED|Overall Study||12
8453329|NCT00746395|20831253|P2|NOT COMPLETED|Overall Study||0
8453330|NCT00746395|20831254|P1|NOT COMPLETED|Overall Study||0
8453331|NCT00746395|20831253|P2|COMPLETED|Overall Study||20
8453332|NCT00746395|20831254|P1|COMPLETED|Overall Study||20
8453333|NCT00746395|20831253|P2|STARTED|Overall Study||20
8453334|NCT00746395|20831254|P1|STARTED|Overall Study||20
8453335|NCT00746356|20831262|P2|NOT COMPLETED|Overall Study||7
8453336|NCT00746356|20831263|P1|NOT COMPLETED|Overall Study||11
8453337|NCT00746356|20831262|P2|COMPLETED|Overall Study||40
8453338|NCT00746356|20831263|P1|COMPLETED|Overall Study||70
8453339|NCT00746356|20831262|P2|STARTED|Overall Study||47
8453340|NCT00746356|20831263|P1|STARTED|Overall Study||81
8453341|NCT00746330|20831275|P4|NOT COMPLETED|Period 4||0
8453342|NCT00746330|20831276|P3|NOT COMPLETED|Period 4||0
8453343|NCT00746330|20831277|P2|NOT COMPLETED|Period 4||0
8453344|NCT00746330|20831278|P1|NOT COMPLETED|Period 4||0
8453345|NCT00746330|20831275|P4|COMPLETED|Period 4||7
8453346|NCT00746330|20831276|P3|COMPLETED|Period 4||8
8453347|NCT00746330|20831277|P2|COMPLETED|Period 4||9
8453348|NCT00746330|20831278|P1|COMPLETED|Period 4||7
8453349|NCT00746330|20831275|P4|STARTED|Period 4||7
8453350|NCT00746330|20831276|P3|STARTED|Period 4||8
8453351|NCT00746330|20831277|P2|STARTED|Period 4||9
8453352|NCT00746330|20831278|P1|STARTED|Period 4||7
8453353|NCT00746330|20831275|P4|NOT COMPLETED|Period 3||0
8453354|NCT00746330|20831276|P3|NOT COMPLETED|Period 3||0
8453355|NCT00746330|20831277|P2|NOT COMPLETED|Period 3||0
8453356|NCT00746330|20831278|P1|NOT COMPLETED|Period 3||0
8453357|NCT00746330|20831275|P4|COMPLETED|Period 3||7
8453358|NCT00746330|20831276|P3|COMPLETED|Period 3||8
8453359|NCT00746330|20831277|P2|COMPLETED|Period 3||9
8453360|NCT00746330|20831278|P1|COMPLETED|Period 3||7
8453361|NCT00746330|20831275|P4|STARTED|Period 3||7
8453362|NCT00746330|20831276|P3|STARTED|Period 3||8
8453363|NCT00746330|20831277|P2|STARTED|Period 3||9
8453364|NCT00746330|20831278|P1|STARTED|Period 3||7
8453365|NCT00746330|20831275|P4|NOT COMPLETED|Period 2||0
8453366|NCT00746330|20831276|P3|NOT COMPLETED|Period 2||0
8453367|NCT00746330|20831277|P2|NOT COMPLETED|Period 2||0
8453368|NCT00746330|20831278|P1|NOT COMPLETED|Period 2||0
8453369|NCT00746330|20831275|P4|COMPLETED|Period 2||7
8453370|NCT00746330|20831276|P3|COMPLETED|Period 2||8
8453371|NCT00746330|20831277|P2|COMPLETED|Period 2||9
8453372|NCT00746330|20831278|P1|COMPLETED|Period 2||7
8453373|NCT00746330|20831275|P4|STARTED|Period 2||7
8453374|NCT00746330|20831276|P3|STARTED|Period 2||8
8453375|NCT00746330|20831277|P2|STARTED|Period 2||9
8453376|NCT00746330|20831278|P1|STARTED|Period 2||7
8453377|NCT00746330|20831275|P4|NOT COMPLETED|Period 1||0
8453378|NCT00746330|20831276|P3|NOT COMPLETED|Period 1||1
8453379|NCT00746330|20831277|P2|NOT COMPLETED|Period 1||0
8453380|NCT00746330|20831278|P1|NOT COMPLETED|Period 1||0
8453381|NCT00746330|20831275|P4|COMPLETED|Period 1||7
8453382|NCT00746330|20831276|P3|COMPLETED|Period 1||8
8453383|NCT00746330|20831277|P2|COMPLETED|Period 1||9
8453384|NCT00746330|20831278|P1|COMPLETED|Period 1||7
8453385|NCT00746330|20831275|P4|STARTED|Period 1||7
8453386|NCT00746330|20831276|P3|STARTED|Period 1||9
8453387|NCT00746330|20831277|P2|STARTED|Period 1||9
8453388|NCT00746330|20831278|P1|STARTED|Period 1||7
8453389|NCT00746252|20831308|P2|NOT COMPLETED|Overall Study||2
8453390|NCT00746252|20831309|P1|NOT COMPLETED|Overall Study||1
8453391|NCT00746252|20831308|P2|COMPLETED|Overall Study||0
8453392|NCT00746252|20831309|P1|COMPLETED|Overall Study||0
8453393|NCT00746252|20831308|P2|STARTED|Overall Study||2
8453394|NCT00746252|20831309|P1|STARTED|Overall Study||1
8453395|NCT00746239|20831315|P1|NOT COMPLETED|Overall Study||6
8453396|NCT00746239|20831315|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
8453397|NCT00746239|20831315|P1|STARTED|Overall Study||11
8453398|NCT00746187|20831322|P2|NOT COMPLETED|Overall Study||2
8453399|NCT00746187|20831323|P1|NOT COMPLETED|Overall Study||3
8453400|NCT00746187|20831322|P2|COMPLETED|Overall Study||16
8453401|NCT00746187|20831323|P1|COMPLETED|Overall Study||15
8453402|NCT00746187|20831322|P2|STARTED|Overall Study||18
8453403|NCT00746187|20831323|P1|STARTED|Overall Study||18
8453404|NCT00746122|20831331|P2|NOT COMPLETED|Overall Study||0
8453405|NCT00746122|20831332|P1|NOT COMPLETED|Overall Study||0
8453406|NCT00746122|20831331|P2|COMPLETED|Overall Study||316
8453407|NCT00746122|20831332|P1|COMPLETED|Overall Study||297
8453408|NCT00746122|20831331|P2|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
8453409|NCT00746122|20831332|P1|STARTED|Overall Study||297
8453410|NCT00746096|20831344|P2|NOT COMPLETED|Overall Study||3
8453411|NCT00746096|20831345|P1|NOT COMPLETED|Overall Study||10
8453412|NCT00746096|20831344|P2|COMPLETED|Overall Study||54
8453413|NCT00746096|20831345|P1|COMPLETED|Overall Study||48
8453414|NCT00746096|20831344|P2|STARTED|Overall Study||57
8453415|NCT00746096|20831345|P1|STARTED|Overall Study||58
8453416|NCT00746018|20831353|P1|NOT COMPLETED|Overall Study||0
8453417|NCT00746018|20831353|P1|COMPLETED|Overall Study||39
8453418|NCT00746018|20831353|P1|STARTED|Overall Study||39
8453419|NCT00745940|20831359|P2|NOT COMPLETED|Overall Study||10
8453420|NCT00745940|20831360|P1|NOT COMPLETED|Overall Study||19
8453421|NCT00745940|20831359|P2|COMPLETED|Overall Study||38
8453422|NCT00745940|20831360|P1|COMPLETED|Overall Study||38
8453423|NCT00745940|20831359|P2|STARTED|Overall Study||48
8453424|NCT00745940|20831360|P1|STARTED|Overall Study||57
8453425|NCT00745901|20831376|P2|NOT COMPLETED|Overall Study||21
8453426|NCT00745901|20831377|P1|NOT COMPLETED|Overall Study||24
8453427|NCT00745901|20831376|P2|COMPLETED|Overall Study||156
8453428|NCT00745901|20831377|P1|COMPLETED|Overall Study||154
8453429|NCT00745901|20831376|P2|STARTED|Overall Study|Number of Patients Randomized|177
8453430|NCT00745901|20831377|P1|STARTED|Overall Study|Number of Patients Randomized|178
8453431|NCT00745875|20831423|P2|NOT COMPLETED|Overall Study||4
8453432|NCT00745875|20831424|P1|NOT COMPLETED|Overall Study||4
8453433|NCT00745875|20831423|P2|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
8453434|NCT00745875|20831424|P1|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
8453435|NCT00745875|20831423|P2|STARTED|Overall Study|Started - Number of patients randomised|30
8453436|NCT00745875|20831424|P1|STARTED|Overall Study|Started - Number of patients randomised|36
8453437|NCT00745849|20831432|P2|NOT COMPLETED|Second Intervention||1
8453438|NCT00745849|20831433|P1|NOT COMPLETED|Second Intervention||2
8453439|NCT00745849|20831432|P2|COMPLETED|Second Intervention||19
8453440|NCT00745849|20831433|P1|COMPLETED|Second Intervention||18
8453441|NCT00745849|20831432|P2|STARTED|Second Intervention||20
8453442|NCT00745849|20831433|P1|STARTED|Second Intervention||20
8453443|NCT00745849|20831432|P2|NOT COMPLETED|Washout Period||0
8453444|NCT00745849|20831433|P1|NOT COMPLETED|Washout Period||0
8453445|NCT00745849|20831432|P2|COMPLETED|Washout Period||20
8453446|NCT00745849|20831433|P1|COMPLETED|Washout Period||20
8453447|NCT00745849|20831432|P2|STARTED|Washout Period||20
8453448|NCT00745849|20831433|P1|STARTED|Washout Period||20
8453449|NCT00745849|20831432|P2|NOT COMPLETED|First Intervention||2
8453450|NCT00745849|20831433|P1|NOT COMPLETED|First Intervention||1
8453451|NCT00745849|20831432|P2|COMPLETED|First Intervention||20
8453452|NCT00745849|20831433|P1|COMPLETED|First Intervention||20
8453453|NCT00745849|20831432|P2|STARTED|First Intervention||22
8453454|NCT00745849|20831433|P1|STARTED|First Intervention||21
8453455|NCT00745823|20831441|P2|NOT COMPLETED|Overall Study||386
8453456|NCT00745823|20831442|P1|NOT COMPLETED|Overall Study||385
8453457|NCT00745823|20831441|P2|COMPLETED|Overall Study||3
8453458|NCT00745823|20831442|P1|COMPLETED|Overall Study||1
8453459|NCT00745823|20831441|P2|TREATED Week 0 - 96|Overall Study||388
8453460|NCT00745823|20831442|P1|TREATED Week 0 - 96|Overall Study||382
8453461|NCT00745823|20831441|P2|STARTED|Overall Study||389
8453462|NCT00745823|20831442|P1|STARTED|Overall Study||386
8453463|NCT00745615|20831470|P6|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
8453464|NCT00745615|20831471|P5|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
8453465|NCT00745615|20831472|P4|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453466|NCT00745615|20831473|P3|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453467|NCT00745615|20831474|P2|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453468|NCT00745615|20831475|P1|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453469|NCT00745615|20831470|P6|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
8453470|NCT00745615|20831471|P5|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
8453471|NCT00745615|20831472|P4|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453472|NCT00745615|20831473|P3|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453473|NCT00745615|20831474|P2|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453474|NCT00745615|20831475|P1|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453475|NCT00745615|20831470|P6|STARTED|Open-Label (up to Approx 10.5 Years)||113
8453476|NCT00745615|20831471|P5|STARTED|Open-Label (up to Approx 10.5 Years)||96
8453477|NCT00745615|20831472|P4|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453478|NCT00745615|20831473|P3|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453479|NCT00745615|20831474|P2|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453480|NCT00745615|20831475|P1|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453481|NCT00745615|20831470|P6|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
8453482|NCT00745615|20831471|P5|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
8453483|NCT00745615|20831472|P4|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
8453484|NCT00745615|20831473|P3|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
8453485|NCT00745615|20831474|P2|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
8453486|NCT00745615|20831475|P1|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
8453487|NCT00745615|20831470|P6|COMPLETED|Double-Blind Extension (36 Weeks)||0
8453488|NCT00745615|20831471|P5|COMPLETED|Double-Blind Extension (36 Weeks)||0
8453489|NCT00745615|20831472|P4|COMPLETED|Double-Blind Extension (36 Weeks)||39
8453490|NCT00745615|20831473|P3|COMPLETED|Double-Blind Extension (36 Weeks)||38
8453491|NCT00745615|20831474|P2|COMPLETED|Double-Blind Extension (36 Weeks)||87
8453492|NCT00745615|20831475|P1|COMPLETED|Double-Blind Extension (36 Weeks)||75
8453493|NCT00745615|20831470|P6|STARTED|Double-Blind Extension (36 Weeks)||0
8453494|NCT00745615|20831471|P5|STARTED|Double-Blind Extension (36 Weeks)||0
8453495|NCT00745615|20831472|P4|STARTED|Double-Blind Extension (36 Weeks)||44
8453496|NCT00745615|20831473|P3|STARTED|Double-Blind Extension (36 Weeks)||39
8453497|NCT00745615|20831474|P2|STARTED|Double-Blind Extension (36 Weeks)||94
8453498|NCT00745615|20831475|P1|STARTED|Double-Blind Extension (36 Weeks)||80
8453499|NCT00745498|20831524|P3|NOT COMPLETED|Overall Study||8
8453500|NCT00745498|20831525|P2|NOT COMPLETED|Overall Study||6
8453501|NCT00745498|20831526|P1|NOT COMPLETED|Overall Study||5
8453502|NCT00745498|20831524|P3|COMPLETED|Overall Study||34
8453503|NCT00745498|20831525|P2|COMPLETED|Overall Study||37
8453504|NCT00745498|20831526|P1|COMPLETED|Overall Study||36
8453505|NCT00745498|20831524|P3|STARTED|Overall Study||42
8453506|NCT00745498|20831525|P2|STARTED|Overall Study||43
8453507|NCT00745498|20831526|P1|STARTED|Overall Study||41
8453508|NCT00745420|20831540|P1|NOT COMPLETED|Overall Study||1
8453509|NCT00745420|20831540|P1|COMPLETED|Overall Study||29
8453510|NCT00745420|20831540|P1|STARTED|Overall Study||30
8453511|NCT00745368|20831557|P1|NOT COMPLETED|Overall Study||3
8453512|NCT00745368|20831557|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
8453513|NCT00745368|20831557|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
8453514|NCT00745290|20831570|P2|NOT COMPLETED|Overall Study||0
8453515|NCT00745290|20831571|P1|NOT COMPLETED|Overall Study||0
8453516|NCT00745290|20831570|P2|COMPLETED|Overall Study||122
8453517|NCT00745290|20831571|P1|COMPLETED|Overall Study||123
8453518|NCT00745290|20831570|P2|STARTED|Overall Study||122
8453519|NCT00745290|20831571|P1|STARTED|Overall Study||123
8453520|NCT00745251|20831579|P2|NOT COMPLETED|Overall Study||3
8453521|NCT00745251|20831580|P1|NOT COMPLETED|Overall Study||2
8453522|NCT00745251|20831579|P2|COMPLETED|Overall Study||19
8453523|NCT00745251|20831580|P1|COMPLETED|Overall Study||21
8453524|NCT00745251|20831579|P2|STARTED|Overall Study||22
8453525|NCT00745251|20831580|P1|STARTED|Overall Study||23
8453526|NCT00745121|20831590|P2|NOT COMPLETED|Overall Study||2
8453527|NCT00745121|20831591|P1|NOT COMPLETED|Overall Study||9
8453528|NCT00745121|20831590|P2|COMPLETED|Overall Study||26
8453529|NCT00745121|20831591|P1|COMPLETED|Overall Study||11
8453530|NCT00745121|20831590|P2|STARTED|Overall Study||28
8453531|NCT00745121|20831591|P1|STARTED|Overall Study||20
8453532|NCT00745095|20831603|P6|NOT COMPLETED|Overall Study||123
8453533|NCT00745095|20831604|P5|NOT COMPLETED|Overall Study||122
8453534|NCT00745095|20831605|P4|NOT COMPLETED|Overall Study||3
8453535|NCT00745095|20831606|P3|NOT COMPLETED|Overall Study||3
8453536|NCT00745095|20831607|P2|NOT COMPLETED|Overall Study||2
8453537|NCT00745095|20831608|P1|NOT COMPLETED|Overall Study||1
8453538|NCT00745095|20831603|P6|COMPLETED|Overall Study||27
8453539|NCT00745095|20831604|P5|COMPLETED|Overall Study||28
8453540|NCT00745095|20831605|P4|COMPLETED|Overall Study||12
8453541|NCT00745095|20831606|P3|COMPLETED|Overall Study||12
8453542|NCT00745095|20831607|P2|COMPLETED|Overall Study||13
8453543|NCT00745095|20831608|P1|COMPLETED|Overall Study||14
8453544|NCT00745095|20831603|P6|STARTED|Overall Study||150
8453545|NCT00745095|20831604|P5|STARTED|Overall Study||150
8453546|NCT00745095|20831605|P4|STARTED|Overall Study||15
8453547|NCT00745095|20831606|P3|STARTED|Overall Study||15
8453548|NCT00745095|20831607|P2|STARTED|Overall Study||15
8453549|NCT00745095|20831608|P1|STARTED|Overall Study||15
8453550|NCT00745030|20831630|P2|NOT COMPLETED|Overall Study||0
8453551|NCT00745030|20831631|P1|NOT COMPLETED|Overall Study||0
8453552|NCT00745030|20831630|P2|COMPLETED|Overall Study||2
8453553|NCT00745030|20831631|P1|COMPLETED|Overall Study||1
8453554|NCT00745030|20831630|P2|STARTED|Overall Study||2
8453555|NCT00745030|20831631|P1|STARTED|Overall Study||1
8453556|NCT00744991|20831637|P1|NOT COMPLETED|Overall Study||25
8453557|NCT00744991|20831637|P1|COMPLETED|Overall Study||0
8453558|NCT00744991|20831637|P1|Received at Least 1 Dose|Overall Study||25
8453559|NCT00744991|20831637|P1|STARTED|Overall Study||25
8453560|NCT00744978|20831654|P2|NOT COMPLETED|Period 2||1
8453561|NCT00744978|20831655|P1|NOT COMPLETED|Period 2||0
8453562|NCT00744978|20831654|P2|COMPLETED|Period 2||28
8453563|NCT00744978|20831655|P1|COMPLETED|Period 2||26
8453564|NCT00744978|20831654|P2|STARTED|Period 2||29
8453565|NCT00744978|20831655|P1|STARTED|Period 2||26
8453566|NCT00744978|20831654|P2|NOT COMPLETED|Placebo Washout||0
8453567|NCT00744978|20831655|P1|NOT COMPLETED|Placebo Washout||0
8453568|NCT00744978|20831654|P2|COMPLETED|Placebo Washout||29
8453569|NCT00744978|20831655|P1|COMPLETED|Placebo Washout||26
8453570|NCT00744978|20831654|P2|STARTED|Placebo Washout||29
8453571|NCT00744978|20831655|P1|STARTED|Placebo Washout||26
8453572|NCT00744978|20831654|P2|NOT COMPLETED|Period 1||5
8453573|NCT00744978|20831655|P1|NOT COMPLETED|Period 1||6
8453574|NCT00744978|20831654|P2|COMPLETED|Period 1||29
8453575|NCT00744978|20831655|P1|COMPLETED|Period 1||26
8453576|NCT00744978|20831654|P2|Treated|Period 1||33
8453577|NCT00744978|20831655|P1|Treated|Period 1||31
8453578|NCT00744978|20831654|P2|STARTED|Period 1||34
8453579|NCT00744978|20831655|P1|STARTED|Period 1||32
8453580|NCT00744965|20831705|P2|NOT COMPLETED|Overall Study||9
8453581|NCT00744965|20831706|P1|NOT COMPLETED|Overall Study||11
8453582|NCT00744965|20831705|P2|COMPLETED|Overall Study||189
8453583|NCT00744965|20831706|P1|COMPLETED|Overall Study||186
8453584|NCT00744965|20831705|P2|STARTED|Overall Study||198
8453585|NCT00744965|20831706|P1|STARTED|Overall Study||197
8453586|NCT00744939|20831736|P1|NOT COMPLETED|Overall Study||91
8453587|NCT00744939|20831736|P1|COMPLETED|Overall Study||77
8453588|NCT00744939|20831736|P1|Treatment Received|Overall Study||141
8453589|NCT00744939|20831736|P1|STARTED|Overall Study||168
8453590|NCT00744874|20831772|P1|NOT COMPLETED|Overall Study||4
8453591|NCT00744874|20831772|P1|COMPLETED|Overall Study||51
8453592|NCT00744874|20831772|P1|STARTED|Overall Study||55
8453593|NCT00744848|20831790|P2|NOT COMPLETED|Overall Study||0
8453594|NCT00744848|20831791|P1|NOT COMPLETED|Overall Study||0
8453595|NCT00744848|20831790|P2|COMPLETED|Overall Study||101
8453596|NCT00744848|20831791|P1|COMPLETED|Overall Study||103
8453597|NCT00744848|20831790|P2|STARTED|Overall Study||101
8453598|NCT00744848|20831791|P1|STARTED|Overall Study||103
8453599|NCT00744796|20831797|P1|NOT COMPLETED|Post-Operative 6-9 Months||12
8453600|NCT00744796|20831797|P1|COMPLETED|Post-Operative 6-9 Months||9
8453601|NCT00744796|20831797|P1|STARTED|Post-Operative 6-9 Months||21
8453602|NCT00744796|20831797|P1|NOT COMPLETED|Post-Operative 3-6 Months||0
8453603|NCT00744796|20831797|P1|COMPLETED|Post-Operative 3-6 Months||21
8453604|NCT00744796|20831797|P1|STARTED|Post-Operative 3-6 Months||21
8453605|NCT00744796|20831797|P1|NOT COMPLETED|Post-Operative Day 1||0
8453606|NCT00744796|20831797|P1|COMPLETED|Post-Operative Day 1||21
8453607|NCT00744796|20831797|P1|STARTED|Post-Operative Day 1||21
8453608|NCT00744796|20831797|P1|NOT COMPLETED|Pre-operative||0
8453609|NCT00744796|20831797|P1|COMPLETED|Pre-operative||21
8453610|NCT00744796|20831797|P1|STARTED|Pre-operative||21
8453611|NCT00744757|20831803|P1|NOT COMPLETED|Overall Study||21
8453612|NCT00744757|20831803|P1|COMPLETED|Overall Study||16
8453613|NCT00744757|20831803|P1|STARTED|Overall Study||37
8453614|NCT00744692|20831816|P1|NOT COMPLETED|Overall Study||0
8453615|NCT00744692|20831816|P1|COMPLETED|Overall Study||22
8453616|NCT00744692|20831816|P1|STARTED|Overall Study||22
8453617|NCT00744653|20831828|P1|NOT COMPLETED|Overall Study||16
8453618|NCT00744653|20831828|P1|COMPLETED|Overall Study||1
8453619|NCT00744653|20831828|P1|STARTED|Overall Study||17
8453620|NCT00744627|20831836|P2|NOT COMPLETED|Overall Study||22
8453621|NCT00744627|20831837|P1|NOT COMPLETED|Overall Study||25
8453622|NCT00744627|20831836|P2|COMPLETED|Overall Study||128
8453623|NCT00744627|20831837|P1|COMPLETED|Overall Study||126
8453624|NCT00744627|20831836|P2|Treated|Overall Study||150
8453625|NCT00744627|20831837|P1|Treated|Overall Study||150
8453626|NCT00744627|20831836|P2|STARTED|Overall Study||150
8453627|NCT00744627|20831837|P1|STARTED|Overall Study||151
8453628|NCT00744523|20831893|P2|NOT COMPLETED|30 Days After the Procedure||5
8453629|NCT00744523|20831894|P1|NOT COMPLETED|30 Days After the Procedure||0
8453630|NCT00744523|20831893|P2|COMPLETED|30 Days After the Procedure||220
8453631|NCT00744523|20831894|P1|COMPLETED|30 Days After the Procedure||37
8453632|NCT00744523|20831893|P2|STARTED|30 Days After the Procedure||225
8453633|NCT00744523|20831894|P1|STARTED|30 Days After the Procedure||37
8453634|NCT00744523|20831893|P2|NOT COMPLETED|Procedure||0
8453635|NCT00744523|20831894|P1|NOT COMPLETED|Procedure||0
8453636|NCT00744523|20831893|P2|COMPLETED|Procedure||225
8453637|NCT00744523|20831894|P1|COMPLETED|Procedure||37
8453638|NCT00744523|20831893|P2|STARTED|Procedure||225
8453639|NCT00744523|20831894|P1|STARTED|Procedure||37
8453640|NCT00744497|20831914|P2|NOT COMPLETED|Overall Study||762
8453641|NCT00744497|20831915|P1|NOT COMPLETED|Overall Study||760
8453642|NCT00744497|20831914|P2|COMPLETED|Overall Study||0
8453643|NCT00744497|20831915|P1|COMPLETED|Overall Study||0
8453644|NCT00744497|20831914|P2|Received Treatment|Overall Study||761
8453645|NCT00744497|20831915|P1|Received Treatment|Overall Study||757
8453646|NCT00744497|20831914|P2|STARTED|Overall Study|Randomized|762
8453647|NCT00744497|20831915|P1|STARTED|Overall Study|Randomized|760
8453648|NCT00744380|20831951|P2|NOT COMPLETED|Overall Study||0
8453649|NCT00744380|20831952|P1|NOT COMPLETED|Overall Study||0
8453650|NCT00744380|20831951|P2|COMPLETED|Overall Study||11
8453651|NCT00744380|20831952|P1|COMPLETED|Overall Study||12
8453652|NCT00744380|20831951|P2|STARTED|Overall Study||11
8453653|NCT00744380|20831952|P1|STARTED|Overall Study||12
8453654|NCT00744328|20831975|P3|NOT COMPLETED|Overall Study||8
8453655|NCT00744328|20831976|P2|NOT COMPLETED|Overall Study||8
8453656|NCT00744328|20831977|P1|NOT COMPLETED|Overall Study||7
8453657|NCT00744328|20831975|P3|COMPLETED|Overall Study||21
8453658|NCT00744328|20831976|P2|COMPLETED|Overall Study||22
8453659|NCT00744328|20831977|P1|COMPLETED|Overall Study||19
8453660|NCT00744328|20831975|P3|STARTED|Overall Study||29
8453661|NCT00744328|20831976|P2|STARTED|Overall Study||30
8453662|NCT00744328|20831977|P1|STARTED|Overall Study||26
8453663|NCT00744263|20831990|P2|NOT COMPLETED|Overall Study||5320
8453664|NCT00744263|20831991|P1|NOT COMPLETED|Overall Study||5236
8453665|NCT00744263|20831990|P2|COMPLETED|Overall Study||36936
8453666|NCT00744263|20831991|P1|COMPLETED|Overall Study||37004
8453667|NCT00744263|20831990|P2|STARTED|Overall Study||42256
8453668|NCT00744263|20831991|P1|STARTED|Overall Study||42240
8453669|NCT00744237|20832014|P3|NOT COMPLETED|Overall Study||15
8453670|NCT00744237|20832015|P2|NOT COMPLETED|Overall Study||27
8453671|NCT00744237|20832016|P1|NOT COMPLETED|Overall Study||27
8453672|NCT00744237|20832014|P3|COMPLETED|Overall Study||59
8453673|NCT00744237|20832015|P2|COMPLETED|Overall Study||46
8453674|NCT00744237|20832016|P1|COMPLETED|Overall Study||56
8453675|NCT00744237|20832014|P3|STARTED|Overall Study||74
8453676|NCT00744237|20832015|P2|STARTED|Overall Study||73
8453677|NCT00744237|20832016|P1|STARTED|Overall Study||83
8453678|NCT00744211|20832030|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8453679|NCT00744211|20832031|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8453680|NCT00744211|20832032|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8453681|NCT00744211|20832030|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
8453682|NCT00744211|20832031|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
8453683|NCT00744211|20832032|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
8453684|NCT00744211|20832030|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
8453685|NCT00744211|20832031|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
8453686|NCT00744211|20832032|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
8453687|NCT00744211|20832030|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8453688|NCT00744211|20832031|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8453689|NCT00744211|20832032|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8453690|NCT00744211|20832030|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
8453691|NCT00744211|20832031|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
8453692|NCT00744211|20832032|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
8453693|NCT00744211|20832030|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
8453694|NCT00744211|20832031|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
8453695|NCT00744211|20832032|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
8453696|NCT00744211|20832030|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8453697|NCT00744211|20832031|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8453698|NCT00744211|20832032|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8453699|NCT00744211|20832030|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
8453700|NCT00744211|20832031|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
8453701|NCT00744211|20832032|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
8453702|NCT00744211|20832030|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
8453703|NCT00744211|20832031|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
8453704|NCT00744211|20832032|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
8453705|NCT00744211|20832030|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8453706|NCT00744211|20832031|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8453707|NCT00744211|20832032|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8453708|NCT00744211|20832030|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
8453709|NCT00744211|20832031|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
8453710|NCT00744211|20832032|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
8453711|NCT00744211|20832030|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
8453712|NCT00744211|20832031|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
8453713|NCT00744211|20832032|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
8453714|NCT00744211|20832030|P3|NOT COMPLETED|Baseline||0
8453715|NCT00744211|20832031|P2|NOT COMPLETED|Baseline||0
8453716|NCT00744211|20832032|P1|NOT COMPLETED|Baseline||0
8453717|NCT00744211|20832030|P3|COMPLETED|Baseline||10
8453718|NCT00744211|20832031|P2|COMPLETED|Baseline||9
8453719|NCT00744211|20832032|P1|COMPLETED|Baseline||10
8453720|NCT00744211|20832030|P3|STARTED|Baseline||10
8453721|NCT00744211|20832031|P2|STARTED|Baseline||9
8453722|NCT00744211|20832032|P1|STARTED|Baseline||10
8453723|NCT00744055|20832050|P2|NOT COMPLETED|Overall Study||14
8453724|NCT00744055|20832051|P1|NOT COMPLETED|Overall Study||7
8453725|NCT00744055|20832050|P2|COMPLETED|Overall Study||32
8453726|NCT00744055|20832051|P1|COMPLETED|Overall Study||43
8453727|NCT00744055|20832050|P2|STARTED|Overall Study||46
8453728|NCT00744055|20832051|P1|STARTED|Overall Study||50
8453729|NCT00744042|20832059|P1|NOT COMPLETED|Overall Study||1
8453730|NCT00744042|20832059|P1|COMPLETED|Overall Study||10
8453731|NCT00744042|20832059|P1|STARTED|Overall Study||11
8453732|NCT00743730|20832075|P3|NOT COMPLETED|Overall Study||5
8453733|NCT00743730|20832076|P2|NOT COMPLETED|Overall Study||4
8453734|NCT00743730|20832077|P1|NOT COMPLETED|Overall Study||5
8453735|NCT00743730|20832075|P3|COMPLETED|Overall Study||28
8453736|NCT00743730|20832076|P2|COMPLETED|Overall Study||30
8453737|NCT00743730|20832077|P1|COMPLETED|Overall Study||22
8453738|NCT00743730|20832075|P3|STARTED|Overall Study||33
8453739|NCT00743730|20832076|P2|STARTED|Overall Study||34
8453740|NCT00743730|20832077|P1|STARTED|Overall Study||27
8453741|NCT00743717|20832093|P2|NOT COMPLETED|Overall Study||0
8453742|NCT00743717|20832094|P1|NOT COMPLETED|Overall Study||0
8453743|NCT00743717|20832093|P2|COMPLETED|Overall Study||2
8453744|NCT00743717|20832094|P1|COMPLETED|Overall Study||2
8453745|NCT00743717|20832093|P2|STARTED|Overall Study||2
8453746|NCT00743717|20832094|P1|STARTED|Overall Study||2
8453747|NCT00743652|20832105|P5|NOT COMPLETED|Overall Study||0
8453748|NCT00743652|20832106|P4|NOT COMPLETED|Overall Study||4
8453749|NCT00743652|20832107|P3|NOT COMPLETED|Overall Study||2
8453750|NCT00743652|20832108|P2|NOT COMPLETED|Overall Study||3
8453751|NCT00743652|20832109|P1|NOT COMPLETED|Overall Study||10
8453752|NCT00743652|20832105|P5|COMPLETED|Overall Study||79
8453753|NCT00743652|20832106|P4|COMPLETED|Overall Study||63
8453754|NCT00743652|20832107|P3|COMPLETED|Overall Study||23
8453755|NCT00743652|20832108|P2|COMPLETED|Overall Study||48
8453756|NCT00743652|20832109|P1|COMPLETED|Overall Study||141
8453757|NCT00743652|20832105|P5|Toddler Dose|Overall Study||0
8453758|NCT00743652|20832106|P4|Toddler Dose|Overall Study||0
8453759|NCT00743652|20832107|P3|Toddler Dose|Overall Study||16
8453760|NCT00743652|20832108|P2|Toddler Dose|Overall Study||23
8453761|NCT00743652|20832109|P1|Toddler Dose|Overall Study||15
8453762|NCT00743652|20832105|P5|Vaccinated Dose 3|Overall Study||0
8453763|NCT00743652|20832106|P4|Vaccinated Dose 3|Overall Study||0
8453764|NCT00743652|20832107|P3|Vaccinated Dose 3|Overall Study||0
8453765|NCT00743652|20832108|P2|Vaccinated Dose 3|Overall Study||0
8453766|NCT00743652|20832109|P1|Vaccinated Dose 3|Overall Study||74
8453767|NCT00743652|20832105|P5|Vaccinated Dose 2|Overall Study||0
8453768|NCT00743652|20832106|P4|Vaccinated Dose 2|Overall Study||49
8453769|NCT00743652|20832107|P3|Vaccinated Dose 2|Overall Study||0
8453770|NCT00743652|20832108|P2|Vaccinated Dose 2|Overall Study||41
8453771|NCT00743652|20832109|P1|Vaccinated Dose 2|Overall Study||112
8453772|NCT00743652|20832105|P5|Vaccinated Dose 1|Overall Study||79
8453773|NCT00743652|20832106|P4|Vaccinated Dose 1|Overall Study||66
8453774|NCT00743652|20832107|P3|Vaccinated Dose 1|Overall Study||25
8453775|NCT00743652|20832108|P2|Vaccinated Dose 1|Overall Study||51
8453776|NCT00743652|20832109|P1|Vaccinated Dose 1|Overall Study||151
8453777|NCT00743652|20832105|P5|STARTED|Overall Study||79
8453778|NCT00743652|20832106|P4|STARTED|Overall Study||67
8453779|NCT00743652|20832107|P3|STARTED|Overall Study||25
8453780|NCT00743652|20832108|P2|STARTED|Overall Study||51
8453781|NCT00743652|20832109|P1|STARTED|Overall Study||151
8453782|NCT00743574|20832184|P1|NOT COMPLETED|Overall Study||24
8453783|NCT00743574|20832184|P1|COMPLETED|Overall Study||12
8453784|NCT00743574|20832184|P1|Dropped Out After Initiating Trial|Overall Study||3
8453785|NCT00743574|20832184|P1|Further Exclusions|Overall Study||8
8453786|NCT00743574|20832184|P1|Dropped Out Before Eligibility Testing|Overall Study||13
8453787|NCT00743574|20832184|P1|STARTED|Overall Study||36
8453788|NCT00743509|20832193|P1|NOT COMPLETED|Overall Study||2
8453789|NCT00743509|20832193|P1|COMPLETED|Overall Study||47
8453790|NCT00743509|20832193|P1|STARTED|Overall Study||49
8453791|NCT00743483|20832198|P1|NOT COMPLETED|Treatment Period||1
8453792|NCT00743483|20832198|P1|COMPLETED|Treatment Period||13
8453793|NCT00743483|20832198|P1|STARTED|Treatment Period||14
8453794|NCT00743483|20832198|P1|NOT COMPLETED|Baseline Period||1
8453795|NCT00743483|20832198|P1|COMPLETED|Baseline Period||14
8453796|NCT00743483|20832198|P1|STARTED|Baseline Period||15
8453797|NCT00743444|20832202|P2|NOT COMPLETED|Second Intervention||0
8453798|NCT00743444|20832203|P1|NOT COMPLETED|Second Intervention||0
8453799|NCT00743444|20832202|P2|COMPLETED|Second Intervention||11
8453800|NCT00743444|20832203|P1|COMPLETED|Second Intervention||14
8453801|NCT00743444|20832202|P2|STARTED|Second Intervention||11
8453802|NCT00743444|20832203|P1|STARTED|Second Intervention||14
8453803|NCT00743444|20832202|P2|NOT COMPLETED|Washout Period||1
8453804|NCT00743444|20832203|P1|NOT COMPLETED|Washout Period||0
8453805|NCT00743444|20832202|P2|COMPLETED|Washout Period||11
8453806|NCT00743444|20832203|P1|COMPLETED|Washout Period||14
8453807|NCT00743444|20832202|P2|STARTED|Washout Period||12
8453808|NCT00743444|20832203|P1|STARTED|Washout Period||14
8453809|NCT00743444|20832202|P2|NOT COMPLETED|First Intervention||1
8453810|NCT00743444|20832203|P1|NOT COMPLETED|First Intervention||0
8453811|NCT00743444|20832202|P2|COMPLETED|First Intervention||12
8453812|NCT00743444|20832203|P1|COMPLETED|First Intervention||14
8453813|NCT00743444|20832202|P2|STARTED|First Intervention||13
8453814|NCT00743444|20832203|P1|STARTED|First Intervention||14
8453815|NCT00743431|20832212|P1|NOT COMPLETED|Overall Study||126
8453816|NCT00743431|20832212|P1|COMPLETED|Overall Study||98
8453817|NCT00743431|20832212|P1|STARTED|Overall Study||224
8453818|NCT00743366|20832216|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
8453819|NCT00743366|20832217|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
8453820|NCT00743366|20832216|P2|COMPLETED|Intervention 2 (8 Days)||7
8453821|NCT00743366|20832217|P1|COMPLETED|Intervention 2 (8 Days)||7
8453822|NCT00743366|20832216|P2|STARTED|Intervention 2 (8 Days)||7
8453823|NCT00743366|20832217|P1|STARTED|Intervention 2 (8 Days)||7
8453824|NCT00743366|20832216|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
8453825|NCT00743366|20832217|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
8453826|NCT00743366|20832216|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
8453827|NCT00743366|20832217|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
8453828|NCT00743366|20832216|P2|STARTED|Intervention 1 (8 Days)||10
8453829|NCT00743366|20832217|P1|STARTED|Intervention 1 (8 Days)||10
8453830|NCT00743340|20832223|P1|NOT COMPLETED|Overall Study||41
8453831|NCT00743340|20832223|P1|COMPLETED|Overall Study||9
8453832|NCT00743340|20832223|P1|STARTED|Overall Study||50
8453833|NCT00743288|20832227|P7|NOT COMPLETED|Overall Study||9
8453834|NCT00743288|20832228|P6|NOT COMPLETED|Overall Study||5
8453835|NCT00743288|20832229|P5|NOT COMPLETED|Overall Study||6
8453836|NCT00743288|20832230|P4|NOT COMPLETED|Overall Study||7
8453837|NCT00743288|20832231|P3|NOT COMPLETED|Overall Study||5
8453838|NCT00743288|20832232|P2|NOT COMPLETED|Overall Study||3
8453839|NCT00743288|20832233|P1|NOT COMPLETED|Overall Study||3
8453840|NCT00743288|20832227|P7|COMPLETED|Overall Study||0
8453841|NCT00743288|20832228|P6|COMPLETED|Overall Study||1
8453842|NCT00743288|20832229|P5|COMPLETED|Overall Study||0
8453843|NCT00743288|20832230|P4|COMPLETED|Overall Study||0
8453844|NCT00743288|20832231|P3|COMPLETED|Overall Study||1
8453845|NCT00743288|20832232|P2|COMPLETED|Overall Study||0
8453846|NCT00743288|20832233|P1|COMPLETED|Overall Study||0
8453847|NCT00743288|20832227|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
8453848|NCT00743288|20832228|P6|STARTED|Overall Study||6
8453849|NCT00743288|20832229|P5|STARTED|Overall Study||6
8453850|NCT00743288|20832230|P4|STARTED|Overall Study||7
8453851|NCT00743288|20832231|P3|STARTED|Overall Study||6
8453852|NCT00743288|20832232|P2|STARTED|Overall Study||3
8453853|NCT00743288|20832233|P1|STARTED|Overall Study||3
8453854|NCT00743275|20832247|P2|NOT COMPLETED|Overall Study||1
8453855|NCT00743275|20832248|P1|NOT COMPLETED|Overall Study||0
8453856|NCT00743275|20832247|P2|COMPLETED|Overall Study||60
8453857|NCT00743275|20832248|P1|COMPLETED|Overall Study||59
8453858|NCT00743275|20832247|P2|STARTED|Overall Study||61
8453859|NCT00743275|20832248|P1|STARTED|Overall Study||59
8453860|NCT00743262|20832260|P1|NOT COMPLETED|Overall Study||0
8453861|NCT00743262|20832260|P1|COMPLETED|Overall Study||15
8453862|NCT00743262|20832260|P1|STARTED|Overall Study||15
8453863|NCT00743249|20832268|P2|NOT COMPLETED|Overall Study||6
8453864|NCT00743249|20832269|P1|NOT COMPLETED|Overall Study||2
8453865|NCT00743249|20832268|P2|COMPLETED|Overall Study||24
8453866|NCT00743249|20832269|P1|COMPLETED|Overall Study||28
8453867|NCT00743249|20832268|P2|STARTED|Overall Study||30
8453868|NCT00743249|20832269|P1|STARTED|Overall Study||30
8453869|NCT00743197|20832279|P2|NOT COMPLETED|Overall Study||2
8453870|NCT00743197|20832280|P1|NOT COMPLETED|Overall Study||1
8453871|NCT00743197|20832279|P2|COMPLETED|Overall Study||0
8453872|NCT00743197|20832280|P1|COMPLETED|Overall Study||0
8453873|NCT00743197|20832279|P2|STARTED|Overall Study||2
8453874|NCT00743197|20832280|P1|STARTED|Overall Study||1
8453875|NCT00743145|20832286|P1|NOT COMPLETED|Overall Study||4
8453876|NCT00743145|20832286|P1|COMPLETED|Overall Study||19
8453877|NCT00743145|20832286|P1|STARTED|Overall Study||23
8453878|NCT00743119|20832300|P1|NOT COMPLETED|Overall Study||4
8453879|NCT00743119|20832300|P1|COMPLETED|Overall Study||30
8453880|NCT00743119|20832300|P1|STARTED|Overall Study||34
8453881|NCT00743106|20832314|P2|NOT COMPLETED|Overall Study||5
8453882|NCT00743106|20832315|P1|NOT COMPLETED|Overall Study||8
8453883|NCT00743106|20832314|P2|COMPLETED|Overall Study||43
8453884|NCT00743106|20832315|P1|COMPLETED|Overall Study||34
8453885|NCT00743106|20832314|P2|STARTED|Overall Study||48
8453886|NCT00743106|20832315|P1|STARTED|Overall Study||42
8453887|NCT00743093|20832325|P2|NOT COMPLETED|Extended Dosing Period||0
8453888|NCT00743093|20832326|P1|NOT COMPLETED|Extended Dosing Period||3
8453889|NCT00743093|20832325|P2|COMPLETED|Extended Dosing Period||1
8453890|NCT00743093|20832326|P1|COMPLETED|Extended Dosing Period||48
8453891|NCT00743093|20832325|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
8453984|NCT00742508|20832547|P1|COMPLETED|8-Week Primary Evaluation Period||11
8453892|NCT00743093|20832326|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
8453893|NCT00743093|20832325|P2|NOT COMPLETED|Base Study Period||5
8453894|NCT00743093|20832326|P1|NOT COMPLETED|Base Study Period||19
8453895|NCT00743093|20832325|P2|COMPLETED|Base Study Period||47
8453896|NCT00743093|20832326|P1|COMPLETED|Base Study Period||205
8453897|NCT00743093|20832325|P2|STARTED|Base Study Period||52
8453898|NCT00743093|20832326|P1|STARTED|Base Study Period||224
8453899|NCT00742963|20832334|P1|NOT COMPLETED|Overall Study||33
8453900|NCT00742963|20832334|P1|COMPLETED|Overall Study||68
8453901|NCT00742963|20832334|P1|Completed All Treatment Cycles|Overall Study||68
8453902|NCT00742963|20832334|P1|STARTED|Overall Study||101
8453903|NCT00742924|20832342|P4|NOT COMPLETED|Overall Study||6
8453904|NCT00742924|20832343|P3|NOT COMPLETED|Overall Study||4
8453905|NCT00742924|20832344|P2|NOT COMPLETED|Overall Study||2
8453906|NCT00742924|20832345|P1|NOT COMPLETED|Overall Study||5
8453907|NCT00742924|20832342|P4|COMPLETED|Overall Study||0
8453908|NCT00742924|20832343|P3|COMPLETED|Overall Study||2
8453909|NCT00742924|20832344|P2|COMPLETED|Overall Study||4
8453910|NCT00742924|20832345|P1|COMPLETED|Overall Study||1
8453911|NCT00742924|20832342|P4|STARTED|Overall Study||6
8453912|NCT00742924|20832343|P3|STARTED|Overall Study||6
8453913|NCT00742924|20832344|P2|STARTED|Overall Study||6
8453914|NCT00742924|20832345|P1|STARTED|Overall Study||6
8453915|NCT00742885|20832357|P2|NOT COMPLETED|Overall Study||0
8453916|NCT00742885|20832358|P1|NOT COMPLETED|Overall Study||1
8453917|NCT00742885|20832357|P2|COMPLETED|Overall Study|to Day 182|50
8453918|NCT00742885|20832358|P1|COMPLETED|Overall Study|to Day 182|49
8453919|NCT00742885|20832357|P2|STARTED|Overall Study||50
8453920|NCT00742885|20832358|P1|STARTED|Overall Study||50
8453921|NCT00742872|20832406|P2|NOT COMPLETED|Overall Study||8
8453922|NCT00742872|20832407|P1|NOT COMPLETED|Overall Study||12
8453923|NCT00742872|20832406|P2|COMPLETED|Overall Study||12
8453924|NCT00742872|20832407|P1|COMPLETED|Overall Study||9
8453925|NCT00742872|20832406|P2|STARTED|Overall Study||20
8453926|NCT00742872|20832407|P1|STARTED|Overall Study||21
8453927|NCT00742859|20832417|P4|NOT COMPLETED|Overall Study||8
8453928|NCT00742859|20832418|P3|NOT COMPLETED|Overall Study||11
8453929|NCT00742859|20832419|P2|NOT COMPLETED|Overall Study||12
8453930|NCT00742859|20832420|P1|NOT COMPLETED|Overall Study||11
8453931|NCT00742859|20832417|P4|COMPLETED|Overall Study||119
8453932|NCT00742859|20832418|P3|COMPLETED|Overall Study||116
8453933|NCT00742859|20832419|P2|COMPLETED|Overall Study||115
8453934|NCT00742859|20832420|P1|COMPLETED|Overall Study||116
8453935|NCT00742859|20832417|P4|STARTED|Overall Study||127
8453936|NCT00742859|20832418|P3|STARTED|Overall Study||127
8453937|NCT00742859|20832419|P2|STARTED|Overall Study||127
8453938|NCT00742859|20832420|P1|STARTED|Overall Study||127
8453939|NCT00742781|20832434|P1|NOT COMPLETED|Overall Study||3
8453940|NCT00742781|20832434|P1|COMPLETED|Overall Study||18
8453941|NCT00742781|20832434|P1|STARTED|Overall Study||21
8453942|NCT00742625|20832443|P1|NOT COMPLETED|Consolidation||21
8453943|NCT00742625|20832443|P1|COMPLETED|Consolidation||20
8453944|NCT00742625|20832443|P1|STARTED|Consolidation||41
8453945|NCT00742625|20832443|P1|NOT COMPLETED|Remission Induction||54
8453946|NCT00742625|20832443|P1|COMPLETED|Remission Induction||41
8453947|NCT00742625|20832443|P1|STARTED|Remission Induction||95
8453948|NCT00742573|20832454|P2|NOT COMPLETED|Overall Study||62
8453949|NCT00742573|20832455|P1|NOT COMPLETED|Overall Study||57
8453950|NCT00742573|20832454|P2|COMPLETED|Overall Study||25
8453951|NCT00742573|20832455|P1|COMPLETED|Overall Study||26
8453952|NCT00742573|20832454|P2|Week 52|Overall Study||25
8453953|NCT00742573|20832455|P1|Week 52|Overall Study||26
8453954|NCT00742573|20832454|P2|Week 24|Overall Study||37
8453955|NCT00742573|20832455|P1|Week 24|Overall Study||39
8453956|NCT00742573|20832454|P2|Week 12|Overall Study||51
8453957|NCT00742573|20832455|P1|Week 12|Overall Study||46
8453958|NCT00742573|20832454|P2|STARTED|Overall Study||87
8453959|NCT00742573|20832455|P1|STARTED|Overall Study||83
8453960|NCT00742560|20832468|P5|NOT COMPLETED|Overall Study||37
8453961|NCT00742560|20832469|P4|NOT COMPLETED|Overall Study||36
8453962|NCT00742560|20832470|P3|NOT COMPLETED|Overall Study||22
8453963|NCT00742560|20832471|P2|NOT COMPLETED|Overall Study||3
8453964|NCT00742560|20832472|P1|NOT COMPLETED|Overall Study||3
8453965|NCT00742560|20832468|P5|COMPLETED|Overall Study||0
8453966|NCT00742560|20832469|P4|COMPLETED|Overall Study||0
8453967|NCT00742560|20832470|P3|COMPLETED|Overall Study||0
8453968|NCT00742560|20832471|P2|COMPLETED|Overall Study||0
8453969|NCT00742560|20832472|P1|COMPLETED|Overall Study||0
8453970|NCT00742560|20832468|P5|STARTED|Overall Study||37
8453971|NCT00742560|20832469|P4|STARTED|Overall Study||36
8453972|NCT00742560|20832470|P3|STARTED|Overall Study||22
8453973|NCT00742560|20832471|P2|STARTED|Overall Study||3
8453974|NCT00742560|20832472|P1|STARTED|Overall Study||3
8453975|NCT00742508|20832546|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
8453976|NCT00742508|20832547|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
8453977|NCT00742508|20832546|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
8453978|NCT00742508|20832547|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
8453979|NCT00742508|20832546|P2|STARTED|4-Week Exploratory Evaluation Period||8
8453980|NCT00742508|20832547|P1|STARTED|4-Week Exploratory Evaluation Period||0
8453981|NCT00742508|20832546|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
8453982|NCT00742508|20832547|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
8453983|NCT00742508|20832546|P2|COMPLETED|8-Week Primary Evaluation Period||8
8453985|NCT00742508|20832546|P2|STARTED|8-Week Primary Evaluation Period||19
8453986|NCT00742508|20832547|P1|STARTED|8-Week Primary Evaluation Period||22
8453987|NCT00742469|20832611|P2|NOT COMPLETED|Overall Study||35
8453988|NCT00742469|20832612|P1|NOT COMPLETED|Overall Study||18
8453989|NCT00742469|20832611|P2|COMPLETED|Overall Study||69
8453990|NCT00742469|20832612|P1|COMPLETED|Overall Study||88
8453991|NCT00742469|20832611|P2|STARTED|Overall Study||104
8453992|NCT00742469|20832612|P1|STARTED|Overall Study||106
8453993|NCT00742417|20832620|P2|NOT COMPLETED|Maintenance II||0
8453994|NCT00742417|20832621|P1|NOT COMPLETED|Maintenance II||0
8453995|NCT00742417|20832620|P2|COMPLETED|Maintenance II||19
8453996|NCT00742417|20832621|P1|COMPLETED|Maintenance II||16
8453997|NCT00742417|20832620|P2|STARTED|Maintenance II||19
8453998|NCT00742417|20832621|P1|STARTED|Maintenance II||16
8453999|NCT00742417|20832620|P2|NOT COMPLETED|Maintenance I||0
8454000|NCT00742417|20832621|P1|NOT COMPLETED|Maintenance I||0
8454001|NCT00742417|20832620|P2|COMPLETED|Maintenance I||19
8454002|NCT00742417|20832621|P1|COMPLETED|Maintenance I||16
8454003|NCT00742417|20832620|P2|STARTED|Maintenance I||19
8454004|NCT00742417|20832621|P1|STARTED|Maintenance I||16
8454005|NCT00742417|20832620|P2|NOT COMPLETED|Intensive Period||1
8454006|NCT00742417|20832621|P1|NOT COMPLETED|Intensive Period||3
8454007|NCT00742417|20832620|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
8454008|NCT00742417|20832621|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
8454009|NCT00742417|20832620|P2|STARTED|Intensive Period||20
8454010|NCT00742417|20832621|P1|STARTED|Intensive Period||19
8454011|NCT00742417|20832620|P2|NOT COMPLETED|Randomized||1
8454012|NCT00742417|20832621|P1|NOT COMPLETED|Randomized||2
8454013|NCT00742417|20832620|P2|COMPLETED|Randomized||20
8454014|NCT00742417|20832621|P1|COMPLETED|Randomized||19
8454015|NCT00742417|20832620|P2|STARTED|Randomized||21
8454016|NCT00742417|20832621|P1|STARTED|Randomized||21
8454017|NCT00742391|20832645|P2|NOT COMPLETED|Overall Study||1
8454018|NCT00742391|20832646|P1|NOT COMPLETED|Overall Study||4
8454019|NCT00742391|20832645|P2|COMPLETED|Overall Study||128
8454020|NCT00742391|20832646|P1|COMPLETED|Overall Study||122
8454021|NCT00742391|20832645|P2|STARTED|Overall Study||129
8454022|NCT00742391|20832646|P1|STARTED|Overall Study||126
8454023|NCT00742326|20832656|P2|NOT COMPLETED|Overall Study||1
8454024|NCT00742326|20832657|P1|NOT COMPLETED|Overall Study||0
8454025|NCT00742326|20832656|P2|COMPLETED|Overall Study||6
8454026|NCT00742326|20832657|P1|COMPLETED|Overall Study||6
8454027|NCT00742326|20832656|P2|STARTED|Overall Study||7
8454028|NCT00742326|20832657|P1|STARTED|Overall Study||6
8454029|NCT00742313|20832667|P2|NOT COMPLETED|Overall Study||0
8454030|NCT00742313|20832668|P1|NOT COMPLETED|Overall Study||1
8454031|NCT00742313|20832667|P2|COMPLETED|Overall Study||19
8454032|NCT00742313|20832668|P1|COMPLETED|Overall Study||24
8454033|NCT00742313|20832667|P2|STARTED|Overall Study||19
8454034|NCT00742313|20832668|P1|STARTED|Overall Study||25
8454035|NCT00742274|20832676|P2|NOT COMPLETED|Overall Study||3
8454036|NCT00742274|20832677|P1|NOT COMPLETED|Overall Study||3
8454037|NCT00742274|20832676|P2|COMPLETED|Overall Study||28
8454038|NCT00742274|20832677|P1|COMPLETED|Overall Study||27
8454039|NCT00742274|20832676|P2|STARTED|Overall Study||31
8454040|NCT00742274|20832677|P1|STARTED|Overall Study||30
8454041|NCT00742235|20832685|P2|NOT COMPLETED|Overall Study||31
8454042|NCT00742235|20832686|P1|NOT COMPLETED|Overall Study||0
8454043|NCT00742235|20832685|P2|COMPLETED|Overall Study||36
8454044|NCT00742235|20832686|P1|COMPLETED|Overall Study||32
8454045|NCT00742235|20832685|P2|STARTED|Overall Study||67
8454046|NCT00742235|20832686|P1|STARTED|Overall Study||32
8454047|NCT00742209|20832699|P5|NOT COMPLETED|Overall Study||25
8454048|NCT00742209|20832700|P4|NOT COMPLETED|Overall Study||37
8454049|NCT00742209|20832701|P3|NOT COMPLETED|Overall Study||46
8454050|NCT00742209|20832702|P2|NOT COMPLETED|Overall Study||18
8454051|NCT00742209|20832703|P1|NOT COMPLETED|Overall Study||34
8454052|NCT00742209|20832699|P5|COMPLETED|Overall Study||37
8454053|NCT00742209|20832700|P4|COMPLETED|Overall Study||97
8454054|NCT00742209|20832701|P3|COMPLETED|Overall Study||88
8454055|NCT00742209|20832702|P2|COMPLETED|Overall Study||49
8454056|NCT00742209|20832703|P1|COMPLETED|Overall Study||95
8454057|NCT00742209|20832699|P5|STARTED|Overall Study||62
8454058|NCT00742209|20832700|P4|STARTED|Overall Study||134
8454059|NCT00742209|20832701|P3|STARTED|Overall Study||134
8454060|NCT00742209|20832702|P2|STARTED|Overall Study||67
8454061|NCT00742209|20832703|P1|STARTED|Overall Study||129
8454062|NCT00742183|20832806|P2|NOT COMPLETED|Overall Study||12
8454063|NCT00742183|20832807|P1|NOT COMPLETED|Overall Study||9
8454064|NCT00742183|20832806|P2|COMPLETED|Overall Study||39
8454065|NCT00742183|20832807|P1|COMPLETED|Overall Study||40
8454066|NCT00742183|20832806|P2|STARTED|Overall Study||51
8454067|NCT00742183|20832807|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
8454068|NCT00742170|20832815|P2|NOT COMPLETED|Overall Study||5
8454069|NCT00742170|20832816|P1|NOT COMPLETED|Overall Study||2
8454070|NCT00742170|20832815|P2|COMPLETED|Overall Study||24
8454071|NCT00742170|20832816|P1|COMPLETED|Overall Study||24
8454072|NCT00742170|20832815|P2|STARTED|Overall Study||29
8454073|NCT00742170|20832816|P1|STARTED|Overall Study||26
8454074|NCT00742079|20832826|P2|NOT COMPLETED|Overall Study||1
8454075|NCT00742079|20832827|P1|NOT COMPLETED|Overall Study||0
8454076|NCT00742079|20832826|P2|COMPLETED|Overall Study||9
8454077|NCT00742079|20832827|P1|COMPLETED|Overall Study||11
8454078|NCT00742079|20832826|P2|Week 2 (Received Dose 2)|Overall Study||9
8454079|NCT00742079|20832827|P1|Week 2 (Received Dose 2)|Overall Study||11
8454080|NCT00742079|20832826|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
8454081|NCT00742079|20832827|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
8454082|NCT00742079|20832826|P2|STARTED|Overall Study||10
8454083|NCT00742079|20832827|P1|STARTED|Overall Study||11
8454084|NCT00742053|20832841|P1|NOT COMPLETED|Overall Study||0
8454085|NCT00742053|20832841|P1|COMPLETED|Overall Study||7
8454086|NCT00742053|20832841|P1|STARTED|Overall Study||7
8454087|NCT00742001|20832848|P3|NOT COMPLETED|Overall Study||1
8454088|NCT00742001|20832849|P2|NOT COMPLETED|Overall Study||0
8454089|NCT00742001|20832850|P1|NOT COMPLETED|Overall Study||0
8454090|NCT00742001|20832848|P3|COMPLETED|Overall Study||3
8454091|NCT00742001|20832849|P2|COMPLETED|Overall Study||4
8454092|NCT00742001|20832850|P1|COMPLETED|Overall Study||4
8454093|NCT00742001|20832848|P3|STARTED|Overall Study||4
8454094|NCT00742001|20832849|P2|STARTED|Overall Study||4
8454095|NCT00742001|20832850|P1|STARTED|Overall Study||4
8454096|NCT00741988|20832866|P2|NOT COMPLETED|Overall Study||4
8454097|NCT00741988|20832867|P1|NOT COMPLETED|Overall Study||4
8454098|NCT00741988|20832866|P2|COMPLETED|Overall Study||36
8454099|NCT00741988|20832867|P1|COMPLETED|Overall Study||38
8454100|NCT00741988|20832866|P2|STARTED|Overall Study||40
8454101|NCT00741988|20832867|P1|STARTED|Overall Study||42
8454102|NCT00741936|20832879|P2|NOT COMPLETED|Overall Study||8
8454103|NCT00741936|20832880|P1|NOT COMPLETED|Overall Study||9
8454104|NCT00741936|20832879|P2|COMPLETED|Overall Study||52
8454105|NCT00741936|20832880|P1|COMPLETED|Overall Study||51
8454106|NCT00741936|20832879|P2|STARTED|Overall Study||60
8454107|NCT00741936|20832880|P1|STARTED|Overall Study||60
8454108|NCT00741858|20832908|P2|NOT COMPLETED|Overall Study||0
8454109|NCT00741858|20832909|P1|NOT COMPLETED|Overall Study||0
8454110|NCT00741858|20832908|P2|COMPLETED|Overall Study||18
8454111|NCT00741858|20832909|P1|COMPLETED|Overall Study||16
8454112|NCT00741858|20832908|P2|STARTED|Overall Study||18
8454113|NCT00741858|20832909|P1|STARTED|Overall Study||16
8454114|NCT00741819|20832915|P1|NOT COMPLETED|Overall Study||8
8454115|NCT00741819|20832915|P1|COMPLETED|Overall Study||65
8454116|NCT00741819|20832915|P1|STARTED|Overall Study||73
8454117|NCT00741611|20832929|P3|NOT COMPLETED|Overall Study||3
8454118|NCT00741611|20832930|P2|NOT COMPLETED|Overall Study||2
8454119|NCT00741611|20832931|P1|NOT COMPLETED|Overall Study||0
8454120|NCT00741611|20832929|P3|COMPLETED|Overall Study||26
8454121|NCT00741611|20832930|P2|COMPLETED|Overall Study||1
8454122|NCT00741611|20832931|P1|COMPLETED|Overall Study||4
8454123|NCT00741611|20832929|P3|STARTED|Overall Study||29
8454124|NCT00741611|20832930|P2|STARTED|Overall Study||3
8454125|NCT00741611|20832931|P1|STARTED|Overall Study||4
8454126|NCT00741598|20832950|P2|NOT COMPLETED|Overall Study||9
8454127|NCT00741598|20832951|P1|NOT COMPLETED|Overall Study||9
8454128|NCT00741598|20832950|P2|COMPLETED|Overall Study||30
8454129|NCT00741598|20832951|P1|COMPLETED|Overall Study||24
8454130|NCT00741598|20832950|P2|STARTED|Overall Study||39
8454131|NCT00741598|20832951|P1|STARTED|Overall Study||33
8454132|NCT00741468|20832965|P1|NOT COMPLETED|Overall Study||0
8454133|NCT00741468|20832965|P1|COMPLETED|Overall Study||18
8454134|NCT00741468|20832965|P1|STARTED|Overall Study||18
8454135|NCT00741455|20832973|P1|NOT COMPLETED|Overall Study||1
8454136|NCT00741455|20832973|P1|COMPLETED|Overall Study||17
8454137|NCT00741455|20832973|P1|STARTED|Overall Study||18
8454138|NCT00741390|20832982|P4|NOT COMPLETED|Visit 2||1
8454139|NCT00741390|20832983|P3|NOT COMPLETED|Visit 2||1
8454140|NCT00741390|20832984|P2|NOT COMPLETED|Visit 2||0
8454141|NCT00741390|20832985|P1|NOT COMPLETED|Visit 2||0
8454142|NCT00741390|20832982|P4|COMPLETED|Visit 2||60
8454143|NCT00741390|20832983|P3|COMPLETED|Visit 2||54
8454144|NCT00741390|20832984|P2|COMPLETED|Visit 2||61
8454145|NCT00741390|20832985|P1|COMPLETED|Visit 2||59
8454146|NCT00741390|20832982|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
8454147|NCT00741390|20832983|P3|STARTED|Visit 2||55
8454148|NCT00741390|20832984|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
8454149|NCT00741390|20832985|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
8454150|NCT00741390|20832982|P4|NOT COMPLETED|Visit 1||1
8454151|NCT00741390|20832983|P3|NOT COMPLETED|Visit 1||7
8454152|NCT00741390|20832984|P2|NOT COMPLETED|Visit 1||0
8454153|NCT00741390|20832985|P1|NOT COMPLETED|Visit 1||2
8454154|NCT00741390|20832982|P4|COMPLETED|Visit 1||62
8454155|NCT00741390|20832983|P3|COMPLETED|Visit 1||55
8454156|NCT00741390|20832984|P2|COMPLETED|Visit 1||63
8454157|NCT00741390|20832985|P1|COMPLETED|Visit 1||60
8454158|NCT00741390|20832982|P4|STARTED|Visit 1||63
8454159|NCT00741390|20832983|P3|STARTED|Visit 1||62
8454160|NCT00741390|20832984|P2|STARTED|Visit 1||63
8454161|NCT00741390|20832985|P1|STARTED|Visit 1||62
8454162|NCT00741338|20833006|P2|NOT COMPLETED|Overall Study||1
8454163|NCT00741338|20833007|P1|NOT COMPLETED|Overall Study||0
8454164|NCT00741338|20833006|P2|COMPLETED|Overall Study||2
8454165|NCT00741338|20833007|P1|COMPLETED|Overall Study||3
8454166|NCT00741338|20833006|P2|STARTED|Overall Study||3
8454167|NCT00741338|20833007|P1|STARTED|Overall Study||3
8454168|NCT00741286|20833017|P2|NOT COMPLETED|Overall Study||19
8454169|NCT00741286|20833018|P1|NOT COMPLETED|Overall Study||20
8454170|NCT00741286|20833017|P2|COMPLETED|Overall Study||81
8454171|NCT00741286|20833018|P1|COMPLETED|Overall Study||83
8454172|NCT00741286|20833017|P2|STARTED|Overall Study||100
8454173|NCT00741286|20833018|P1|STARTED|Overall Study||103
8454174|NCT00741273|20833028|P2|NOT COMPLETED|Overall Study||0
8454175|NCT00741273|20833029|P1|NOT COMPLETED|Overall Study||0
8454176|NCT00741273|20833028|P2|COMPLETED|Overall Study||8
8454177|NCT00741273|20833029|P1|COMPLETED|Overall Study||8
8454178|NCT00741273|20833028|P2|STARTED|Overall Study||8
8454179|NCT00741273|20833029|P1|STARTED|Overall Study||8
8454180|NCT00741260|20833052|P7|NOT COMPLETED|Overall Study||7
8454181|NCT00741260|20833053|P6|NOT COMPLETED|Overall Study||45
8454182|NCT00741260|20833054|P5|NOT COMPLETED|Overall Study||9
8454183|NCT00741260|20833055|P4|NOT COMPLETED|Overall Study||6
8454184|NCT00741260|20833056|P3|NOT COMPLETED|Overall Study||4
8454185|NCT00741260|20833057|P2|NOT COMPLETED|Overall Study||8
8454186|NCT00741260|20833058|P1|NOT COMPLETED|Overall Study||6
8454187|NCT00741260|20833052|P7|COMPLETED|Overall Study||0
8454188|NCT00741260|20833053|P6|COMPLETED|Overall Study||20
8454189|NCT00741260|20833054|P5|COMPLETED|Overall Study||0
8454190|NCT00741260|20833055|P4|COMPLETED|Overall Study||0
8454191|NCT00741260|20833056|P3|COMPLETED|Overall Study||0
8454192|NCT00741260|20833057|P2|COMPLETED|Overall Study||0
8454193|NCT00741260|20833058|P1|COMPLETED|Overall Study||0
8454194|NCT00741260|20833052|P7|STARTED|Overall Study||7
8454195|NCT00741260|20833053|P6|STARTED|Overall Study||65
8454196|NCT00741260|20833054|P5|STARTED|Overall Study||9
8454197|NCT00741260|20833055|P4|STARTED|Overall Study||6
8454198|NCT00741260|20833056|P3|STARTED|Overall Study||4
8454199|NCT00741260|20833057|P2|STARTED|Overall Study||8
8454200|NCT00741260|20833058|P1|STARTED|Overall Study||6
8454201|NCT00741156|20833085|P1|NOT COMPLETED|Overall Study||0
8454202|NCT00741156|20833085|P1|COMPLETED|Overall Study||12
8454203|NCT00741156|20833085|P1|STARTED|Overall Study||12
8454204|NCT00741104|20833100|P1|NOT COMPLETED|Overall Study||0
8454205|NCT00741104|20833100|P1|COMPLETED|Overall Study||363
8454206|NCT00741104|20833100|P1|STARTED|Overall Study||363
8454207|NCT00741091|20833107|P1|NOT COMPLETED|Overall Study||57
8454208|NCT00741091|20833107|P1|COMPLETED|Overall Study||1040
8454209|NCT00741091|20833107|P1|STARTED|Overall Study||1097
8454210|NCT00741039|20833117|P2|NOT COMPLETED|Overall Study||0
8454211|NCT00741039|20833118|P1|NOT COMPLETED|Overall Study||2
8454212|NCT00741039|20833117|P2|COMPLETED|Overall Study||25
8454213|NCT00741039|20833118|P1|COMPLETED|Overall Study||100
8454214|NCT00741039|20833117|P2|STARTED|Overall Study||25
8454215|NCT00741039|20833118|P1|STARTED|Overall Study||102
8454216|NCT00741026|20833124|P1|NOT COMPLETED|Overall Study||0
8454217|NCT00741026|20833124|P1|COMPLETED|Overall Study||15
8454218|NCT00741026|20833124|P1|STARTED|Overall Study||15
8454219|NCT00741013|20833155|P3|NOT COMPLETED|Overall Study||1
8454220|NCT00741013|20833156|P2|NOT COMPLETED|Overall Study||2
8454221|NCT00741013|20833157|P1|NOT COMPLETED|Overall Study||1
8454222|NCT00741013|20833155|P3|COMPLETED|Overall Study||6
8454223|NCT00741013|20833156|P2|COMPLETED|Overall Study||6
8454224|NCT00741013|20833157|P1|COMPLETED|Overall Study||6
8454225|NCT00741013|20833155|P3|STARTED|Overall Study||7
8454226|NCT00741013|20833156|P2|STARTED|Overall Study||8
8454227|NCT00741013|20833157|P1|STARTED|Overall Study||7
8454228|NCT00740870|20833168|P1|NOT COMPLETED|Overall Study||21
8454229|NCT00740870|20833168|P1|COMPLETED|Overall Study||150
8454230|NCT00740870|20833168|P1|STARTED|Overall Study||171
8454231|NCT00740857|20833183|P3|NOT COMPLETED|Overall Study||0
8454232|NCT00740857|20833184|P2|NOT COMPLETED|Overall Study||0
8454233|NCT00740857|20833185|P1|NOT COMPLETED|Overall Study||1
8454234|NCT00740857|20833183|P3|COMPLETED|Overall Study||90
8454235|NCT00740857|20833184|P2|COMPLETED|Overall Study||88
8454236|NCT00740857|20833185|P1|COMPLETED|Overall Study||32
8454237|NCT00740857|20833183|P3|STARTED|Overall Study||90
8454238|NCT00740857|20833184|P2|STARTED|Overall Study||88
8454239|NCT00740857|20833185|P1|STARTED|Overall Study||33
8454240|NCT00740831|20833217|P3|NOT COMPLETED|Overall Study||6
8454241|NCT00740831|20833218|P2|NOT COMPLETED|Overall Study||3
8454242|NCT00740831|20833219|P1|NOT COMPLETED|Overall Study||4
8454243|NCT00740831|20833217|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
8454244|NCT00740831|20833218|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
8454245|NCT00740831|20833219|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
8454246|NCT00740831|20833217|P3|STARTED|Overall Study|Safety population|101
8454247|NCT00740831|20833218|P2|STARTED|Overall Study|Safety population|103
8454248|NCT00740831|20833219|P1|STARTED|Overall Study|Safety population|97
8454249|NCT00740792|20833240|P4|NOT COMPLETED|Overall Study||10
8454250|NCT00740792|20833241|P3|NOT COMPLETED|Overall Study||9
8454251|NCT00740792|20833242|P2|NOT COMPLETED|Overall Study||8
8454252|NCT00740792|20833243|P1|NOT COMPLETED|Overall Study||10
8454253|NCT00740792|20833240|P4|COMPLETED|Overall Study||190
8454254|NCT00740792|20833241|P3|COMPLETED|Overall Study||180
8454255|NCT00740792|20833242|P2|COMPLETED|Overall Study||186
8454256|NCT00740792|20833243|P1|COMPLETED|Overall Study||183
8454257|NCT00740792|20833240|P4|STARTED|Overall Study||200
8454258|NCT00740792|20833241|P3|STARTED|Overall Study||189
8454259|NCT00740792|20833242|P2|STARTED|Overall Study||194
8454260|NCT00740792|20833243|P1|STARTED|Overall Study||193
8454261|NCT00740779|20833264|P3|NOT COMPLETED|Overall Study||13
8454262|NCT00740779|20833265|P2|NOT COMPLETED|Overall Study||14
8454263|NCT00740779|20833266|P1|NOT COMPLETED|Overall Study||9
8454264|NCT00740779|20833264|P3|COMPLETED|Overall Study||41
8454265|NCT00740779|20833265|P2|COMPLETED|Overall Study||31
8454266|NCT00740779|20833266|P1|COMPLETED|Overall Study||43
8454267|NCT00740779|20833264|P3|STARTED|Overall Study||54
8454268|NCT00740779|20833265|P2|STARTED|Overall Study||45
8454269|NCT00740779|20833266|P1|STARTED|Overall Study||52
8454270|NCT00740727|20833274|P1|NOT COMPLETED|Overall Study||0
8454271|NCT00740727|20833274|P1|COMPLETED|Overall Study||18
8454272|NCT00740727|20833274|P1|STARTED|Overall Study||18
8454273|NCT00740714|20833283|P3|NOT COMPLETED|Overall Study||29
8454274|NCT00740714|20833284|P2|NOT COMPLETED|Overall Study||19
8454275|NCT00740714|20833285|P1|NOT COMPLETED|Overall Study||17
8454276|NCT00740714|20833283|P3|COMPLETED|Overall Study||174
8454277|NCT00740714|20833284|P2|COMPLETED|Overall Study||182
8454278|NCT00740714|20833285|P1|COMPLETED|Overall Study||179
8454279|NCT00740714|20833283|P3|Active Patients at Study Termination|Overall Study||33
8454280|NCT00740714|20833284|P2|Active Patients at Study Termination|Overall Study||12
8454281|NCT00740714|20833285|P1|Active Patients at Study Termination|Overall Study||24
8454282|NCT00740714|20833283|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
8454283|NCT00740714|20833284|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
8454284|NCT00740714|20833285|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
8454285|NCT00740714|20833283|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
8454286|NCT00740714|20833284|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
8454287|NCT00740714|20833285|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
8454288|NCT00740636|20833361|P2|NOT COMPLETED|Overall Study||4
8454289|NCT00740636|20833362|P1|NOT COMPLETED|Overall Study||2
8454290|NCT00740636|20833361|P2|COMPLETED|Overall Study||63
8454291|NCT00740636|20833362|P1|COMPLETED|Overall Study||23
8454292|NCT00740636|20833361|P2|STARTED|Overall Study||67
8454293|NCT00740636|20833362|P1|STARTED|Overall Study||25
8454294|NCT00740597|20833368|P1|NOT COMPLETED|Overall Study||1
8454295|NCT00740597|20833368|P1|COMPLETED|Overall Study||0
8454296|NCT00740597|20833368|P1|STARTED|Overall Study||1
8454297|NCT00740584|20833372|P1|NOT COMPLETED|Overall Study||1
8454298|NCT00740584|20833372|P1|COMPLETED|Overall Study||11
8454299|NCT00740584|20833372|P1|STARTED|Overall Study||12
8454300|NCT00740480|20833377|P1|NOT COMPLETED|Overall Study||2
8454301|NCT00740480|20833377|P1|COMPLETED|Overall Study||23
8454302|NCT00740480|20833377|P1|STARTED|Overall Study||25
8454303|NCT00740376|20833383|P2|NOT COMPLETED|Overall Study||3
8454304|NCT00740376|20833384|P1|NOT COMPLETED|Overall Study||3
8454305|NCT00740376|20833383|P2|COMPLETED|Overall Study||12
8454306|NCT00740376|20833384|P1|COMPLETED|Overall Study||19
8454307|NCT00740376|20833383|P2|STARTED|Overall Study||15
8454308|NCT00740376|20833384|P1|STARTED|Overall Study||22
8454309|NCT00740220|20833402|P1|NOT COMPLETED|Overall Study||9
8454310|NCT00740220|20833402|P1|COMPLETED|Overall Study||88
8454311|NCT00740220|20833402|P1|STARTED|Overall Study||97
8454312|NCT00740207|20833408|P2|NOT COMPLETED|Overall Study||0
8454313|NCT00740207|20833409|P1|NOT COMPLETED|Overall Study||0
8454314|NCT00740207|20833408|P2|COMPLETED|Overall Study||16
8454315|NCT00740207|20833409|P1|COMPLETED|Overall Study||17
8454316|NCT00740207|20833408|P2|STARTED|Overall Study||16
8454317|NCT00740207|20833409|P1|STARTED|Overall Study||17
8454318|NCT00740181|20833421|P1|NOT COMPLETED|Overall Study||0
8454319|NCT00740181|20833421|P1|COMPLETED|Overall Study||9
8454320|NCT00740181|20833421|P1|STARTED|Overall Study||9
8454321|NCT00740051|20833427|P2|NOT COMPLETED|Overall Study||32
8454322|NCT00740051|20833428|P1|NOT COMPLETED|Overall Study||18
8454323|NCT00740051|20833427|P2|COMPLETED|Overall Study||119
8454324|NCT00740051|20833428|P1|COMPLETED|Overall Study||58
8454325|NCT00740051|20833427|P2|STARTED|Overall Study||151
8454326|NCT00740051|20833428|P1|STARTED|Overall Study||76
8454327|NCT00739999|20833450|P2|NOT COMPLETED|Overall Study||0
8454328|NCT00739999|20833451|P1|NOT COMPLETED|Overall Study||0
8454329|NCT00739999|20833450|P2|COMPLETED|Overall Study||24
8454330|NCT00739999|20833451|P1|COMPLETED|Overall Study||15
8454331|NCT00739999|20833450|P2|STARTED|Overall Study||24
8454332|NCT00739999|20833451|P1|STARTED|Overall Study||15
8454333|NCT00739973|20833531|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
8454334|NCT00739973|20833532|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
8454335|NCT00739973|20833533|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
8454336|NCT00739973|20833534|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
8454337|NCT00739973|20833535|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
8454338|NCT00739973|20833536|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
8454339|NCT00739973|20833537|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
8454340|NCT00739973|20833538|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
8454341|NCT00739973|20833539|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
8454342|NCT00739973|20833531|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
8454343|NCT00739973|20833532|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
8454344|NCT00739973|20833533|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
8454345|NCT00739973|20833534|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
8454346|NCT00739973|20833535|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
8454347|NCT00739973|20833536|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
8454348|NCT00739973|20833537|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
8454349|NCT00739973|20833538|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
8454350|NCT00739973|20833539|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
8454351|NCT00739973|20833531|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
8454352|NCT00739973|20833532|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
8454353|NCT00739973|20833533|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
8454354|NCT00739973|20833534|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
8454355|NCT00739973|20833535|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
8454356|NCT00739973|20833536|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
8454357|NCT00739973|20833537|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
8454358|NCT00739973|20833538|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
8454359|NCT00739973|20833539|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
8454360|NCT00739973|20833531|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454361|NCT00739973|20833532|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454362|NCT00739973|20833533|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454363|NCT00739973|20833534|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454364|NCT00739973|20833535|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454365|NCT00739973|20833536|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454366|NCT00739973|20833537|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454367|NCT00739973|20833538|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454368|NCT00739973|20833539|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
8454369|NCT00739973|20833531|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454370|NCT00739973|20833532|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454371|NCT00739973|20833533|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454372|NCT00739973|20833534|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454373|NCT00739973|20833535|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454374|NCT00739973|20833536|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454375|NCT00739973|20833537|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454376|NCT00739973|20833538|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454377|NCT00739973|20833539|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
8454378|NCT00739973|20833531|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454379|NCT00739973|20833532|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454380|NCT00739973|20833533|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454381|NCT00739973|20833534|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454382|NCT00739973|20833535|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454383|NCT00739973|20833536|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454384|NCT00739973|20833537|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454385|NCT00739973|20833538|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454386|NCT00739973|20833539|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
8454387|NCT00739960|20833625|P1|NOT COMPLETED|Overall Study||0
8454388|NCT00739960|20833625|P1|COMPLETED|Overall Study||1
8454389|NCT00739960|20833625|P1|STARTED|Overall Study||1
8454390|NCT00739934|20833630|P1|NOT COMPLETED|Voriconazole Oral||3
8454391|NCT00739934|20833630|P1|COMPLETED|Voriconazole Oral||31
8454392|NCT00739934|20833630|P1|STARTED|Voriconazole Oral||34
8454393|NCT00739934|20833630|P1|NOT COMPLETED|Voriconazole IV||6
8454394|NCT00739934|20833630|P1|COMPLETED|Voriconazole IV||34
8454395|NCT00739934|20833630|P1|STARTED|Voriconazole IV||40
8454396|NCT00739908|20833652|P2|NOT COMPLETED|Overall Study||25
8454397|NCT00739908|20833653|P1|NOT COMPLETED|Overall Study||25
8454398|NCT00739908|20833652|P2|COMPLETED|Overall Study||118
8454399|NCT00739908|20833653|P1|COMPLETED|Overall Study||117
8454400|NCT00739908|20833652|P2|STARTED|Overall Study||143
8454401|NCT00739908|20833653|P1|STARTED|Overall Study||142
8454402|NCT00739882|20833673|P2|NOT COMPLETED|Open-label Period||5
8454403|NCT00739882|20833674|P1|NOT COMPLETED|Open-label Period||10
8454404|NCT00739882|20833673|P2|COMPLETED|Open-label Period||9
8454405|NCT00739882|20833674|P1|COMPLETED|Open-label Period||7
8454406|NCT00739882|20833673|P2|STARTED|Open-label Period||14
8454407|NCT00739882|20833674|P1|STARTED|Open-label Period||17
8454408|NCT00739882|20833673|P2|NOT COMPLETED|Double-blind Period||11
8454409|NCT00739882|20833674|P1|NOT COMPLETED|Double-blind Period||19
8454410|NCT00739882|20833673|P2|COMPLETED|Double-blind Period||14
8454411|NCT00739882|20833674|P1|COMPLETED|Double-blind Period||32
8454412|NCT00739882|20833673|P2|STARTED|Double-blind Period||25
8454413|NCT00739882|20833674|P1|STARTED|Double-blind Period||51
8454414|NCT00739765|20833695|P3|NOT COMPLETED|Overall Study||11
8454415|NCT00739765|20833696|P2|NOT COMPLETED|Overall Study||11
8454416|NCT00739765|20833697|P1|NOT COMPLETED|Overall Study||6
8454417|NCT00739765|20833695|P3|COMPLETED|Overall Study||21
8454418|NCT00739765|20833696|P2|COMPLETED|Overall Study||27
8454419|NCT00739765|20833697|P1|COMPLETED|Overall Study||34
8454420|NCT00739765|20833695|P3|STARTED|Overall Study||32
8454421|NCT00739765|20833696|P2|STARTED|Overall Study||38
8454422|NCT00739765|20833697|P1|STARTED|Overall Study||40
8454423|NCT00739752|20833714|P6|NOT COMPLETED|Overall Study||0
8454424|NCT00739752|20833715|P5|NOT COMPLETED|Overall Study||0
8454425|NCT00739752|20833716|P4|NOT COMPLETED|Overall Study||0
8454426|NCT00739752|20833717|P3|NOT COMPLETED|Overall Study||0
8454427|NCT00739752|20833718|P2|NOT COMPLETED|Overall Study||0
8454428|NCT00739752|20833719|P1|NOT COMPLETED|Overall Study||0
8454429|NCT00739752|20833714|P6|COMPLETED|Overall Study||293
8454430|NCT00739752|20833715|P5|COMPLETED|Overall Study||291
8454431|NCT00739752|20833716|P4|COMPLETED|Overall Study||288
8454432|NCT00739752|20833717|P3|COMPLETED|Overall Study||292
8454433|NCT00739752|20833718|P2|COMPLETED|Overall Study||284
8454434|NCT00739752|20833719|P1|COMPLETED|Overall Study||299
8454435|NCT00739752|20833714|P6|STARTED|Overall Study||293
8454436|NCT00739752|20833715|P5|STARTED|Overall Study||291
8454437|NCT00739752|20833716|P4|STARTED|Overall Study||288
8454438|NCT00739752|20833717|P3|STARTED|Overall Study||292
8454439|NCT00739752|20833718|P2|STARTED|Overall Study||284
8454440|NCT00739752|20833719|P1|STARTED|Overall Study||299
8454441|NCT00739674|20833735|P2|NOT COMPLETED|Overall Study||122
8454442|NCT00739674|20833736|P1|NOT COMPLETED|Overall Study||181
8454443|NCT00739674|20833735|P2|COMPLETED|Overall Study||335
8454444|NCT00739674|20833736|P1|COMPLETED|Overall Study||354
8454445|NCT00739674|20833735|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
8454446|NCT00739674|20833736|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
8454447|NCT00739674|20833735|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
8454448|NCT00739674|20833736|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
8454449|NCT00739674|20833735|P2|No Follow-up Data|Overall Study||18
8454450|NCT00739674|20833736|P1|No Follow-up Data|Overall Study||33
8454451|NCT00739674|20833735|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
8454452|NCT00739674|20833736|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
8454453|NCT00739674|20833735|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
8454454|NCT00739674|20833736|P1|Screening Failures|Overall Study||19
8454455|NCT00739674|20833735|P2|STARTED|Overall Study||457
8454456|NCT00739674|20833736|P1|STARTED|Overall Study||535
8454457|NCT00739661|20833764|P2|NOT COMPLETED|Overall Study||42
8454458|NCT00739661|20833765|P1|NOT COMPLETED|Overall Study||46
8454459|NCT00739661|20833764|P2|COMPLETED|Overall Study||10
8454460|NCT00739661|20833765|P1|COMPLETED|Overall Study||6
8454461|NCT00739661|20833764|P2|STARTED|Overall Study||52
8454462|NCT00739661|20833765|P1|STARTED|Overall Study||52
8454463|NCT00739648|20833777|P2|NOT COMPLETED|Overall Study||53
8454464|NCT00739648|20833778|P1|NOT COMPLETED|Overall Study||26
8454465|NCT00739648|20833777|P2|COMPLETED|Overall Study||161
8454466|NCT00739648|20833778|P1|COMPLETED|Overall Study||82
8454467|NCT00739648|20833777|P2|STARTED|Overall Study||214
8454468|NCT00739648|20833778|P1|STARTED|Overall Study||108
8454469|NCT00739596|20833792|P2|NOT COMPLETED|Overall Study||17
8454470|NCT00739596|20833793|P1|NOT COMPLETED|Overall Study||25
8454471|NCT00739596|20833792|P2|COMPLETED|Overall Study||149
8454472|NCT00739596|20833793|P1|COMPLETED|Overall Study||141
8454473|NCT00739596|20833792|P2|STARTED|Overall Study||166
8454474|NCT00739596|20833793|P1|STARTED|Overall Study||166
8454475|NCT00739583|20833809|P2|NOT COMPLETED|Overall Study||0
8454476|NCT00739583|20833810|P1|NOT COMPLETED|Overall Study||0
8454477|NCT00739583|20833809|P2|COMPLETED|Overall Study||10
8454478|NCT00739583|20833810|P1|COMPLETED|Overall Study||10
8454479|NCT00739583|20833809|P2|STARTED|Overall Study||10
8454480|NCT00739583|20833810|P1|STARTED|Overall Study||10
8454481|NCT00739336|20833822|P2|NOT COMPLETED|Overall Study||0
8454482|NCT00739336|20833823|P1|NOT COMPLETED|Overall Study||4
8454483|NCT00739336|20833822|P2|COMPLETED|Overall Study||24
8454484|NCT00739336|20833823|P1|COMPLETED|Overall Study||17
8454485|NCT00739336|20833822|P2|STARTED|Overall Study||24
8454486|NCT00739336|20833823|P1|STARTED|Overall Study||21
8454487|NCT00739310|20833835|P1|NOT COMPLETED|Overall Study||7
8454488|NCT00739310|20833835|P1|COMPLETED|Overall Study||22
8454489|NCT00739310|20833835|P1|STARTED|Overall Study||29
8454490|NCT00739297|20833840|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
8454491|NCT00739297|20833841|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
8454492|NCT00739297|20833842|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454493|NCT00739297|20833843|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454494|NCT00739297|20833844|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454495|NCT00739297|20833845|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454496|NCT00739297|20833846|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454497|NCT00739297|20833840|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
8454498|NCT00739297|20833841|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
8454499|NCT00739297|20833842|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
8454500|NCT00739297|20833843|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
8454501|NCT00739297|20833844|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
8454502|NCT00739297|20833845|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
8454503|NCT00739297|20833846|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
8454504|NCT00739297|20833840|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
8454505|NCT00739297|20833841|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
8454506|NCT00739297|20833842|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
8454507|NCT00739297|20833843|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
8454508|NCT00739297|20833844|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
8454509|NCT00739297|20833845|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
8454510|NCT00739297|20833846|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
8454511|NCT00739297|20833840|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454512|NCT00739297|20833841|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454513|NCT00739297|20833842|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454514|NCT00739297|20833843|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454515|NCT00739297|20833844|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454516|NCT00739297|20833845|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454517|NCT00739297|20833846|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454518|NCT00739297|20833840|P7|COMPLETED|Third Washout Period of 4-7 Days||66
8454519|NCT00739297|20833841|P6|COMPLETED|Third Washout Period of 4-7 Days||8
8454520|NCT00739297|20833842|P5|COMPLETED|Third Washout Period of 4-7 Days||6
8454521|NCT00739297|20833843|P4|COMPLETED|Third Washout Period of 4-7 Days||18
8454522|NCT00739297|20833844|P3|COMPLETED|Third Washout Period of 4-7 Days||6
8454523|NCT00739297|20833845|P2|COMPLETED|Third Washout Period of 4-7 Days||12
8454524|NCT00739297|20833846|P1|COMPLETED|Third Washout Period of 4-7 Days||16
8454525|NCT00739297|20833840|P7|STARTED|Third Washout Period of 4-7 Days||66
8454526|NCT00739297|20833841|P6|STARTED|Third Washout Period of 4-7 Days||8
8454527|NCT00739297|20833842|P5|STARTED|Third Washout Period of 4-7 Days||6
8454528|NCT00739297|20833843|P4|STARTED|Third Washout Period of 4-7 Days||18
8454529|NCT00739297|20833844|P3|STARTED|Third Washout Period of 4-7 Days||6
8454530|NCT00739297|20833845|P2|STARTED|Third Washout Period of 4-7 Days||12
8454531|NCT00739297|20833846|P1|STARTED|Third Washout Period of 4-7 Days||16
8454532|NCT00739297|20833840|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454533|NCT00739297|20833841|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454534|NCT00739297|20833842|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454535|NCT00739297|20833843|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454536|NCT00739297|20833844|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454537|NCT00739297|20833845|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454538|NCT00739297|20833846|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454539|NCT00739297|20833840|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
8454540|NCT00739297|20833841|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
8454541|NCT00739297|20833842|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
8454542|NCT00739297|20833843|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
8454543|NCT00739297|20833844|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
8454544|NCT00739297|20833845|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
8454545|NCT00739297|20833846|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
8454546|NCT00739297|20833840|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
8454547|NCT00739297|20833841|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
8454548|NCT00739297|20833842|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
8454549|NCT00739297|20833843|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
8454550|NCT00739297|20833844|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
8454551|NCT00739297|20833845|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
8454552|NCT00739297|20833846|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
8454553|NCT00739297|20833840|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454554|NCT00739297|20833841|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454555|NCT00739297|20833842|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454556|NCT00739297|20833843|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454557|NCT00739297|20833844|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454558|NCT00739297|20833845|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454559|NCT00739297|20833846|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454560|NCT00739297|20833840|P7|COMPLETED|Second Washout Period of 4-7 Days||66
8454561|NCT00739297|20833841|P6|COMPLETED|Second Washout Period of 4-7 Days||10
8454562|NCT00739297|20833842|P5|COMPLETED|Second Washout Period of 4-7 Days||6
8454563|NCT00739297|20833843|P4|COMPLETED|Second Washout Period of 4-7 Days||14
8454564|NCT00739297|20833844|P3|COMPLETED|Second Washout Period of 4-7 Days||10
8454565|NCT00739297|20833845|P2|COMPLETED|Second Washout Period of 4-7 Days||8
8454566|NCT00739297|20833846|P1|COMPLETED|Second Washout Period of 4-7 Days||18
8454567|NCT00739297|20833840|P7|STARTED|Second Washout Period of 4-7 Days||66
8454568|NCT00739297|20833841|P6|STARTED|Second Washout Period of 4-7 Days||10
8454569|NCT00739297|20833842|P5|STARTED|Second Washout Period of 4-7 Days||6
8454570|NCT00739297|20833843|P4|STARTED|Second Washout Period of 4-7 Days||14
8454571|NCT00739297|20833844|P3|STARTED|Second Washout Period of 4-7 Days||10
8454572|NCT00739297|20833845|P2|STARTED|Second Washout Period of 4-7 Days||8
8454573|NCT00739297|20833846|P1|STARTED|Second Washout Period of 4-7 Days||18
8454574|NCT00739297|20833840|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454575|NCT00739297|20833841|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454576|NCT00739297|20833842|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454577|NCT00739297|20833843|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454578|NCT00739297|20833844|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454579|NCT00739297|20833845|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454580|NCT00739297|20833846|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454581|NCT00739297|20833840|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
8454582|NCT00739297|20833841|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
8454583|NCT00739297|20833842|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
8454584|NCT00739297|20833843|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
8454585|NCT00739297|20833844|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
8454586|NCT00739297|20833845|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
8454587|NCT00739297|20833846|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
8454588|NCT00739297|20833840|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
8454589|NCT00739297|20833841|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
8454590|NCT00739297|20833842|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
8454591|NCT00739297|20833843|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
8454592|NCT00739297|20833844|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
8454593|NCT00739297|20833845|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
8454594|NCT00739297|20833846|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
8454595|NCT00739297|20833840|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
8454596|NCT00739297|20833841|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454597|NCT00739297|20833842|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454598|NCT00739297|20833843|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
8454599|NCT00739297|20833844|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454600|NCT00739297|20833845|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454601|NCT00739297|20833846|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454602|NCT00739297|20833840|P7|COMPLETED|First Washout Period of 4-7 Days||66
8454603|NCT00739297|20833841|P6|COMPLETED|First Washout Period of 4-7 Days||9
8454604|NCT00739297|20833842|P5|COMPLETED|First Washout Period of 4-7 Days||6
8454605|NCT00739297|20833843|P4|COMPLETED|First Washout Period of 4-7 Days||17
8454606|NCT00739297|20833844|P3|COMPLETED|First Washout Period of 4-7 Days||6
8454607|NCT00739297|20833845|P2|COMPLETED|First Washout Period of 4-7 Days||11
8454608|NCT00739297|20833846|P1|COMPLETED|First Washout Period of 4-7 Days||17
8454609|NCT00739297|20833840|P7|STARTED|First Washout Period of 4-7 Days||68
8454610|NCT00739297|20833841|P6|STARTED|First Washout Period of 4-7 Days||9
8454611|NCT00739297|20833842|P5|STARTED|First Washout Period of 4-7 Days||6
8454612|NCT00739297|20833843|P4|STARTED|First Washout Period of 4-7 Days||19
8454613|NCT00739297|20833844|P3|STARTED|First Washout Period of 4-7 Days||6
8454614|NCT00739297|20833845|P2|STARTED|First Washout Period of 4-7 Days||11
8454615|NCT00739297|20833846|P1|STARTED|First Washout Period of 4-7 Days||17
8454616|NCT00739297|20833840|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454617|NCT00739297|20833841|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454618|NCT00739297|20833842|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454619|NCT00739297|20833843|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454620|NCT00739297|20833844|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454621|NCT00739297|20833845|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454622|NCT00739297|20833846|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454623|NCT00739297|20833840|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
8454624|NCT00739297|20833841|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
8454625|NCT00739297|20833842|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
8454626|NCT00739297|20833843|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
8454627|NCT00739297|20833844|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
8454628|NCT00739297|20833845|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
8454629|NCT00739297|20833846|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
8454630|NCT00739297|20833840|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
8454631|NCT00739297|20833841|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
8454632|NCT00739297|20833842|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
8454633|NCT00739297|20833843|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
8454634|NCT00739297|20833844|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
8454635|NCT00739297|20833845|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
8454636|NCT00739297|20833846|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
8454637|NCT00739102|20833874|P1|NOT COMPLETED|Overall Study||15
8454638|NCT00739102|20833874|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
8454639|NCT00739102|20833874|P1|STARTED|Overall Study||250
8454640|NCT00739063|20833890|P1|NOT COMPLETED|Overall Study||8
8454641|NCT00739063|20833890|P1|COMPLETED|Overall Study||3
8454642|NCT00739063|20833890|P1|STARTED|Overall Study||11
8454643|NCT00739050|20833894|P2|NOT COMPLETED|Overall Study||0
8454644|NCT00739050|20833895|P1|NOT COMPLETED|Overall Study||1
8454645|NCT00739050|20833894|P2|COMPLETED|Overall Study||0
8454646|NCT00739050|20833895|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
8454647|NCT00739050|20833894|P2|STARTED|Overall Study||0
8454648|NCT00739050|20833895|P1|STARTED|Overall Study||4
8454649|NCT00739024|20833909|P2|NOT COMPLETED|Overall Study||0
8454650|NCT00739024|20833910|P1|NOT COMPLETED|Overall Study||0
8454651|NCT00739024|20833909|P2|COMPLETED|Overall Study||6
8454652|NCT00739024|20833910|P1|COMPLETED|Overall Study||7
8454653|NCT00739024|20833909|P2|STARTED|Overall Study||6
8454654|NCT00739024|20833910|P1|STARTED|Overall Study||7
8454655|NCT00738972|20833920|P4|NOT COMPLETED|Overall Study||1
8454656|NCT00738972|20833921|P3|NOT COMPLETED|Overall Study||0
8454657|NCT00738972|20833922|P2|NOT COMPLETED|Overall Study||0
8454658|NCT00738972|20833923|P1|NOT COMPLETED|Overall Study||0
8454659|NCT00738972|20833920|P4|COMPLETED|Overall Study||2
8454660|NCT00738972|20833921|P3|COMPLETED|Overall Study||3
8454661|NCT00738972|20833922|P2|COMPLETED|Overall Study||3
8454662|NCT00738972|20833923|P1|COMPLETED|Overall Study||3
8454663|NCT00738972|20833920|P4|STARTED|Overall Study||3
8454664|NCT00738972|20833921|P3|STARTED|Overall Study||3
8454665|NCT00738972|20833922|P2|STARTED|Overall Study||3
8454666|NCT00738972|20833923|P1|STARTED|Overall Study||3
8454667|NCT00738894|20833935|P2|NOT COMPLETED|Overall Study||33
8454668|NCT00738894|20833936|P1|NOT COMPLETED|Overall Study||39
8454669|NCT00738894|20833935|P2|COMPLETED|Overall Study||190
8454670|NCT00738894|20833936|P1|COMPLETED|Overall Study||402
8454671|NCT00738894|20833935|P2|STARTED|Overall Study||223
8454672|NCT00738894|20833936|P1|STARTED|Overall Study||441
8454673|NCT00738881|20833949|P2|NOT COMPLETED|Overall Study||2
8454674|NCT00738881|20833950|P1|NOT COMPLETED|Overall Study||0
8454675|NCT00738881|20833949|P2|COMPLETED|Overall Study||10
8454676|NCT00738881|20833950|P1|COMPLETED|Overall Study||11
8454677|NCT00738881|20833949|P2|STARTED|Overall Study||12
8454678|NCT00738881|20833950|P1|STARTED|Overall Study||11
8454679|NCT00738699|20833964|P2|NOT COMPLETED|Overall Study||140
8454680|NCT00738699|20833965|P1|NOT COMPLETED|Overall Study||275
8454681|NCT00738699|20833964|P2|COMPLETED|Overall Study||0
8454682|NCT00738699|20833965|P1|COMPLETED|Overall Study||0
8454683|NCT00738699|20833964|P2|Participants Treated|Overall Study||139
8454684|NCT00738699|20833965|P1|Participants Treated|Overall Study||273
8454685|NCT00738699|20833964|P2|Participants Not Treated|Overall Study||1
8454686|NCT00738699|20833965|P1|Participants Not Treated|Overall Study||2
8454687|NCT00738699|20833964|P2|STARTED|Overall Study||140
8454688|NCT00738699|20833965|P1|STARTED|Overall Study||275
8454689|NCT00738673|20833983|P2|NOT COMPLETED|Overall Study||11
8454690|NCT00738673|20833984|P1|NOT COMPLETED|Overall Study||24
8454691|NCT00738673|20833983|P2|COMPLETED|Overall Study||1
8454692|NCT00738673|20833984|P1|COMPLETED|Overall Study||1
8454693|NCT00738673|20833983|P2|Intent to Treat Population|Overall Study||12
8454694|NCT00738673|20833984|P1|Intent to Treat Population|Overall Study||24
8454695|NCT00738673|20833983|P2|STARTED|Overall Study||12
8454696|NCT00738673|20833984|P1|STARTED|Overall Study||25
8454697|NCT00738543|20834012|P1|NOT COMPLETED|Control||0
8454698|NCT00738543|20834012|P1|COMPLETED|Control||48
8454699|NCT00738543|20834012|P1|STARTED|Control||48
8454700|NCT00738543|20834012|P1|NOT COMPLETED|Sodium Hypochlorite||0
8454701|NCT00738543|20834012|P1|COMPLETED|Sodium Hypochlorite||48
8454702|NCT00738543|20834012|P1|STARTED|Sodium Hypochlorite||48
8454703|NCT00738543|20834012|P1|NOT COMPLETED|Povidone Iodine||0
8454704|NCT00738543|20834012|P1|COMPLETED|Povidone Iodine||48
8454705|NCT00738543|20834012|P1|STARTED|Povidone Iodine||48
8454706|NCT00738530|20834022|P2|NOT COMPLETED|Overall Study||238
8454707|NCT00738530|20834023|P1|NOT COMPLETED|Overall Study||234
8454708|NCT00738530|20834022|P2|COMPLETED|Overall Study||84
8454709|NCT00738530|20834023|P1|COMPLETED|Overall Study||93
8454710|NCT00738530|20834022|P2|Treated|Overall Study||316
8454711|NCT00738530|20834023|P1|Treated|Overall Study||325
8454712|NCT00738530|20834022|P2|STARTED|Overall Study||322
8454713|NCT00738530|20834023|P1|STARTED|Overall Study||327
8454714|NCT00738426|20834049|P2|NOT COMPLETED|Overall Study||3
8454715|NCT00738426|20834050|P1|NOT COMPLETED|Overall Study||2
8454716|NCT00738426|20834049|P2|COMPLETED|Overall Study||32
8454717|NCT00738426|20834050|P1|COMPLETED|Overall Study||35
8454718|NCT00738426|20834049|P2|STARTED|Overall Study||35
8454719|NCT00738426|20834050|P1|STARTED|Overall Study||37
8454720|NCT00738400|20834058|P2|NOT COMPLETED|Overall Study||7
8454721|NCT00738400|20834059|P1|NOT COMPLETED|Overall Study||4
8454722|NCT00738400|20834058|P2|COMPLETED|Overall Study||67
8454723|NCT00738400|20834059|P1|COMPLETED|Overall Study||72
8454724|NCT00738400|20834058|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
8454725|NCT00738400|20834059|P1|ITT (Intent To Treatment) Population|Overall Study||75
8454726|NCT00738400|20834058|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
8454727|NCT00738400|20834059|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
8454728|NCT00738400|20834058|P2|STARTED|Overall Study||74
8454729|NCT00738400|20834059|P1|STARTED|Overall Study||76
8454730|NCT00738374|20834080|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
8454731|NCT00738374|20834081|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
8454732|NCT00738374|20834082|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
8454733|NCT00738374|20834083|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
8454734|NCT00738374|20834080|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
8454735|NCT00738374|20834081|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
8454736|NCT00738374|20834082|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
8454737|NCT00738374|20834083|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
8454738|NCT00738374|20834080|P4|STARTED|Maintenance Treatment/Observation Phase||32
8454739|NCT00738374|20834081|P3|STARTED|Maintenance Treatment/Observation Phase||34
8454740|NCT00738374|20834082|P2|STARTED|Maintenance Treatment/Observation Phase||7
8454741|NCT00738374|20834083|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
8454742|NCT00738374|20834080|P4|NOT COMPLETED|Induction Treatment Phase||0
8454743|NCT00738374|20834081|P3|NOT COMPLETED|Induction Treatment Phase||0
8454744|NCT00738374|20834082|P2|NOT COMPLETED|Induction Treatment Phase||0
8454745|NCT00738374|20834083|P1|NOT COMPLETED|Induction Treatment Phase||24
8454746|NCT00738374|20834080|P4|COMPLETED|Induction Treatment Phase||0
8454747|NCT00738374|20834081|P3|COMPLETED|Induction Treatment Phase||0
8454748|NCT00738374|20834082|P2|COMPLETED|Induction Treatment Phase||0
8454749|NCT00738374|20834083|P1|COMPLETED|Induction Treatment Phase||73
8454750|NCT00738374|20834080|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
8454751|NCT00738374|20834081|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
8454752|NCT00738374|20834082|P2|STARTED|Induction Treatment Phase||0
8454753|NCT00738374|20834083|P1|STARTED|Induction Treatment Phase||97
8454754|NCT00738361|20834115|P1|NOT COMPLETED|Overall Study||0
8454755|NCT00738361|20834115|P1|COMPLETED|Overall Study||4
8454756|NCT00738361|20834115|P1|STARTED|Overall Study||4
8454757|NCT00738283|20834121|P1|NOT COMPLETED|Overall Study||4
8454758|NCT00738283|20834121|P1|COMPLETED|Overall Study||13
8454759|NCT00738283|20834121|P1|STARTED|Overall Study||17
8454760|NCT00738101|20834125|P1|NOT COMPLETED|Overall Study||7
8454761|NCT00738101|20834125|P1|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
8454762|NCT00738101|20834125|P1|STARTED|Overall Study||293
8454763|NCT00738062|20834140|P3|NOT COMPLETED|Open-Label Extension||0
8454764|NCT00738062|20834141|P2|NOT COMPLETED|Open-Label Extension||0
8454765|NCT00738062|20834142|P1|NOT COMPLETED|Open-Label Extension||17
8454766|NCT00738062|20834140|P3|COMPLETED|Open-Label Extension||0
8454767|NCT00738062|20834141|P2|COMPLETED|Open-Label Extension||0
8454768|NCT00738062|20834142|P1|COMPLETED|Open-Label Extension||57
8454769|NCT00738062|20834140|P3|STARTED|Open-Label Extension||0
8454770|NCT00738062|20834141|P2|STARTED|Open-Label Extension||0
8454771|NCT00738062|20834142|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
8454772|NCT00738062|20834140|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
8454773|NCT00738062|20834141|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
8454774|NCT00738062|20834142|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
8454775|NCT00738062|20834140|P3|COMPLETED|2 Week Randomized Withdrawal||37
8454776|NCT00738062|20834141|P2|COMPLETED|2 Week Randomized Withdrawal||38
8454777|NCT00738062|20834142|P1|COMPLETED|2 Week Randomized Withdrawal||0
8454778|NCT00738062|20834140|P3|STARTED|2 Week Randomized Withdrawal||37
8454779|NCT00738062|20834141|P2|STARTED|2 Week Randomized Withdrawal||38
8454780|NCT00738062|20834142|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
8454781|NCT00738062|20834140|P3|NOT COMPLETED|Open Label Treatment||0
8454782|NCT00738062|20834141|P2|NOT COMPLETED|Open Label Treatment||0
8454783|NCT00738062|20834142|P1|NOT COMPLETED|Open Label Treatment||28
8454784|NCT00738062|20834140|P3|COMPLETED|Open Label Treatment||0
8454785|NCT00738062|20834141|P2|COMPLETED|Open Label Treatment||0
8454786|NCT00738062|20834142|P1|COMPLETED|Open Label Treatment||75
8454787|NCT00738062|20834140|P3|STARTED|Open Label Treatment||0
8454788|NCT00738062|20834141|P2|STARTED|Open Label Treatment||0
8454789|NCT00738062|20834142|P1|STARTED|Open Label Treatment||103
8454790|NCT00738049|20834169|P2|NOT COMPLETED|Washout||0
8454791|NCT00738049|20834170|P1|NOT COMPLETED|Washout||0
8454792|NCT00738049|20834169|P2|COMPLETED|Washout||7
8454793|NCT00738049|20834170|P1|COMPLETED|Washout||13
8454794|NCT00738049|20834169|P2|STARTED|Washout||7
8454795|NCT00738049|20834170|P1|STARTED|Washout||13
8454796|NCT00738049|20834169|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
8454797|NCT00738049|20834170|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
8454798|NCT00738049|20834169|P2|COMPLETED|2nd Intervention(14 Days)||7
8454799|NCT00738049|20834170|P1|COMPLETED|2nd Intervention(14 Days)||13
8454800|NCT00738049|20834169|P2|STARTED|2nd Intervention(14 Days)||7
8454801|NCT00738049|20834170|P1|STARTED|2nd Intervention(14 Days)||13
8454802|NCT00738049|20834169|P2|NOT COMPLETED|1st Intervention(14 Days)||0
8454803|NCT00738049|20834170|P1|NOT COMPLETED|1st Intervention(14 Days)||0
8454804|NCT00738049|20834169|P2|COMPLETED|1st Intervention(14 Days)||7
8454805|NCT00738049|20834170|P1|COMPLETED|1st Intervention(14 Days)||13
8454806|NCT00738049|20834169|P2|STARTED|1st Intervention(14 Days)||7
8454807|NCT00738049|20834170|P1|STARTED|1st Intervention(14 Days)||13
8454808|NCT00738023|20834184|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454809|NCT00738023|20834185|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454810|NCT00738023|20834184|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454811|NCT00738023|20834185|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
8454812|NCT00738023|20834184|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454813|NCT00738023|20834185|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
8454814|NCT00738023|20834184|P2|NOT COMPLETED|Saline Infusion||0
8454815|NCT00738023|20834185|P1|NOT COMPLETED|Saline Infusion||0
8454816|NCT00738023|20834184|P2|COMPLETED|Saline Infusion||0
8454817|NCT00738023|20834185|P1|COMPLETED|Saline Infusion||19
8454818|NCT00738023|20834184|P2|STARTED|Saline Infusion||0
8454819|NCT00738023|20834185|P1|STARTED|Saline Infusion||19
8454820|NCT00738023|20834184|P2|NOT COMPLETED|Intralipid Infusion||0
8454821|NCT00738023|20834185|P1|NOT COMPLETED|Intralipid Infusion||0
8454822|NCT00738023|20834184|P2|COMPLETED|Intralipid Infusion||13
8454823|NCT00738023|20834185|P1|COMPLETED|Intralipid Infusion||19
8454824|NCT00738023|20834184|P2|STARTED|Intralipid Infusion||13
8454825|NCT00738023|20834185|P1|STARTED|Intralipid Infusion||19
8454826|NCT00737893|20834195|P2|NOT COMPLETED|Overall Study||0
8454827|NCT00737893|20834196|P1|NOT COMPLETED|Overall Study||0
8454828|NCT00737893|20834195|P2|COMPLETED|Overall Study||27
8454829|NCT00737893|20834196|P1|COMPLETED|Overall Study||29
8454830|NCT00737893|20834195|P2|STARTED|Overall Study||27
8454831|NCT00737893|20834196|P1|STARTED|Overall Study||29
8454832|NCT00737737|20834246|P2|NOT COMPLETED|Overall Study||0
8454833|NCT00737737|20834247|P1|NOT COMPLETED|Overall Study||0
8454834|NCT00737737|20834246|P2|COMPLETED|Overall Study||2
8454835|NCT00737737|20834247|P1|COMPLETED|Overall Study||2
8454836|NCT00737737|20834246|P2|STARTED|Overall Study||2
8454837|NCT00737737|20834247|P1|STARTED|Overall Study||2
8454838|NCT00737711|20834255|P1|NOT COMPLETED|Overall Study||31
8454839|NCT00737711|20834255|P1|COMPLETED|Overall Study||158
8454840|NCT00737711|20834255|P1|STARTED|Overall Study||189
8454841|NCT00737698|20834289|P3|NOT COMPLETED|Overall Study||4
8454842|NCT00737698|20834290|P2|NOT COMPLETED|Overall Study||5
8454843|NCT00737698|20834291|P1|NOT COMPLETED|Overall Study||6
8454844|NCT00737698|20834289|P3|COMPLETED|Overall Study||17
8454845|NCT00737698|20834290|P2|COMPLETED|Overall Study||37
8454846|NCT00737698|20834291|P1|COMPLETED|Overall Study||17
8454847|NCT00737698|20834289|P3|STARTED|Overall Study||21
8454848|NCT00737698|20834290|P2|STARTED|Overall Study||42
8454849|NCT00737698|20834291|P1|STARTED|Overall Study||23
8454850|NCT00737672|20834301|P2|NOT COMPLETED|Overall Study||83
8454851|NCT00737672|20834302|P1|NOT COMPLETED|Overall Study||80
8454852|NCT00737672|20834301|P2|COMPLETED|Overall Study||65
8454853|NCT00737672|20834302|P1|COMPLETED|Overall Study||65
8454854|NCT00737672|20834301|P2|Per Protocol Population|Overall Study||138
8454855|NCT00737672|20834302|P1|Per Protocol Population|Overall Study||131
8454856|NCT00737672|20834301|P2|Exclusions Due to Protocol Deviations|Overall Study||10
8454857|NCT00737672|20834302|P1|Exclusions Due to Protocol Deviations|Overall Study||14
8454858|NCT00737672|20834301|P2|STARTED|Overall Study||148
8454859|NCT00737672|20834302|P1|STARTED|Overall Study||145
8454860|NCT00737633|20834340|P2|NOT COMPLETED|Overall Study||57
8454861|NCT00737633|20834341|P1|NOT COMPLETED|Overall Study||44
8454862|NCT00737633|20834340|P2|COMPLETED|Overall Study||0
8454863|NCT00737633|20834341|P1|COMPLETED|Overall Study||0
8454864|NCT00737633|20834340|P2|STARTED|Overall Study||57
8454865|NCT00737633|20834341|P1|STARTED|Overall Study||44
8454866|NCT00737594|20834352|P3|NOT COMPLETED|Overall Study||0
8454867|NCT00737594|20834353|P2|NOT COMPLETED|Overall Study||0
8454868|NCT00737594|20834354|P1|NOT COMPLETED|Overall Study||0
8454869|NCT00737594|20834352|P3|COMPLETED|Overall Study||0
8454870|NCT00737594|20834353|P2|COMPLETED|Overall Study||0
8454871|NCT00737594|20834354|P1|COMPLETED|Overall Study||0
8454872|NCT00737594|20834352|P3|STARTED|Overall Study||0
8454873|NCT00737594|20834353|P2|STARTED|Overall Study||0
8454874|NCT00737594|20834354|P1|STARTED|Overall Study||0
8454875|NCT00737568|20834364|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
8454876|NCT00737568|20834365|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
8454877|NCT00737568|20834364|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
8454878|NCT00737568|20834365|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
8454879|NCT00737568|20834364|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
8454880|NCT00737568|20834365|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
8454881|NCT00737568|20834364|P2|NOT COMPLETED|Treatment Period Through Week 240||21
8454882|NCT00737568|20834365|P1|NOT COMPLETED|Treatment Period Through Week 240||20
8454883|NCT00737568|20834364|P2|COMPLETED|Treatment Period Through Week 240||118
8454884|NCT00737568|20834365|P1|COMPLETED|Treatment Period Through Week 240||121
8454885|NCT00737568|20834364|P2|STARTED|Treatment Period Through Week 240||139
8454886|NCT00737568|20834365|P1|STARTED|Treatment Period Through Week 240||141
8454887|NCT00737529|20834395|P1|NOT COMPLETED|Overall Study||133
8454888|NCT00737529|20834395|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
8454889|NCT00737529|20834395|P1|STARTED|Overall Study||134
8454890|NCT00737477|20834409|P1|NOT COMPLETED|Overall Study||34
8454891|NCT00737477|20834409|P1|COMPLETED|Overall Study||62
8454892|NCT00737477|20834409|P1|STARTED|Overall Study||96
8454893|NCT00737464|20834425|P1|NOT COMPLETED|Overall Study||18
8454894|NCT00737464|20834425|P1|COMPLETED|Overall Study||114
8454895|NCT00737464|20834425|P1|STARTED|Overall Study||132
8454896|NCT00737438|20834446|P1|NOT COMPLETED|Overall Study||3
8454897|NCT00737438|20834446|P1|COMPLETED|Overall Study||20
8454898|NCT00737438|20834446|P1|STARTED|Overall Study||23
8454899|NCT00737360|20834450|P1|NOT COMPLETED|Overall Study||0
8454900|NCT00737360|20834450|P1|COMPLETED|Overall Study||27
8454901|NCT00737360|20834450|P1|STARTED|Overall Study||27
8454902|NCT00737282|20834459|P1|NOT COMPLETED|Overall Study||175
8454903|NCT00737282|20834459|P1|COMPLETED|Overall Study||0
8454904|NCT00737282|20834459|P1|STARTED|Overall Study||175
8454905|NCT00737243|20834465|P1|NOT COMPLETED|Overall Study||95
8454906|NCT00737243|20834465|P1|COMPLETED|Overall Study||194
8454907|NCT00737243|20834465|P1|Empiric CUP Therapy|Overall Study||29
8454908|NCT00737243|20834465|P1|Site Specific Therapy Less Responsive|Overall Study||79
8454909|NCT00737243|20834465|P1|Site Specific Therapy More Responsive|Overall Study||115
8454910|NCT00737243|20834465|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
8454911|NCT00737243|20834465|P1|Treated|Overall Study||223
8454912|NCT00737243|20834465|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
8454913|NCT00737243|20834465|P1|Successful Assay Performed|Overall Study||252
8454914|NCT00737243|20834465|P1|STARTED|Overall Study||289
8454915|NCT00737204|20834473|P2|NOT COMPLETED|Overall Study||6
8454916|NCT00737204|20834474|P1|NOT COMPLETED|Overall Study||0
8454917|NCT00737204|20834473|P2|COMPLETED|Overall Study||28
8454918|NCT00737204|20834474|P1|COMPLETED|Overall Study||36
8454919|NCT00737204|20834473|P2|STARTED|Overall Study||34
8454920|NCT00737204|20834474|P1|STARTED|Overall Study||36
8454921|NCT00737178|20834488|P2|NOT COMPLETED|Overall Study||9
8454922|NCT00737178|20834489|P1|NOT COMPLETED|Overall Study||5
8454923|NCT00737178|20834488|P2|COMPLETED|Overall Study||76
8454924|NCT00737178|20834489|P1|COMPLETED|Overall Study||66
8454925|NCT00737178|20834488|P2|STARTED|Overall Study||85
8454926|NCT00737178|20834489|P1|STARTED|Overall Study||71
8454927|NCT00737100|20834502|P3|NOT COMPLETED|Overall Study||7
8454928|NCT00737100|20834503|P2|NOT COMPLETED|Overall Study||7
8454929|NCT00737100|20834504|P1|NOT COMPLETED|Overall Study||7
8454930|NCT00737100|20834502|P3|COMPLETED|Overall Study||169
8454931|NCT00737100|20834503|P2|COMPLETED|Overall Study||159
8454932|NCT00737100|20834504|P1|COMPLETED|Overall Study||161
8454933|NCT00737100|20834502|P3|STARTED|Overall Study||176
8454934|NCT00737100|20834503|P2|STARTED|Overall Study||166
8454935|NCT00737100|20834504|P1|STARTED|Overall Study||168
8454936|NCT00737061|20834548|P1|NOT COMPLETED|1 Year Wearing Period||17
8454937|NCT00737061|20834548|P1|COMPLETED|1 Year Wearing Period||553
8454938|NCT00737061|20834548|P1|STARTED|1 Year Wearing Period||570
8454939|NCT00737061|20834548|P1|NOT COMPLETED|Waiting Period||75
8454940|NCT00737061|20834548|P1|COMPLETED|Waiting Period||570
8454941|NCT00737061|20834548|P1|STARTED|Waiting Period||645
8454942|NCT00737048|20834565|P3|NOT COMPLETED|Overall Study||4
8454943|NCT00737048|20834566|P2|NOT COMPLETED|Overall Study||6
8454944|NCT00737048|20834567|P1|NOT COMPLETED|Overall Study||3
8454945|NCT00737048|20834565|P3|COMPLETED|Overall Study||126
8454946|NCT00737048|20834566|P2|COMPLETED|Overall Study||60
8454947|NCT00737048|20834567|P1|COMPLETED|Overall Study||129
8454948|NCT00737048|20834565|P3|STARTED|Overall Study||130
8454949|NCT00737048|20834566|P2|STARTED|Overall Study||66
8454950|NCT00737048|20834567|P1|STARTED|Overall Study||132
8454951|NCT00736996|20834611|P3|NOT COMPLETED|Overall Study||2
8454952|NCT00736996|20834612|P2|NOT COMPLETED|Overall Study||9
8454953|NCT00736996|20834613|P1|NOT COMPLETED|Overall Study||1
8454954|NCT00736996|20834611|P3|COMPLETED|Overall Study||25
8454955|NCT00736996|20834612|P2|COMPLETED|Overall Study||17
8454956|NCT00736996|20834613|P1|COMPLETED|Overall Study||24
8454957|NCT00736996|20834611|P3|STARTED|Overall Study||27
8454958|NCT00736996|20834612|P2|STARTED|Overall Study||26
8454959|NCT00736996|20834613|P1|STARTED|Overall Study||25
8454960|NCT00736957|20834627|P1|NOT COMPLETED|Overall Study||122
8454961|NCT00736957|20834627|P1|COMPLETED|Overall Study||97
8454962|NCT00736957|20834627|P1|Treated|Overall Study||190
8454963|NCT00736957|20834627|P1|STARTED|Overall Study||219
8454964|NCT00736944|20834637|P1|NOT COMPLETED|Definitive Treatment||1
8454965|NCT00736944|20834637|P1|COMPLETED|Definitive Treatment||28
8454966|NCT00736944|20834637|P1|STARTED|Definitive Treatment||29
8454967|NCT00736944|20834637|P1|NOT COMPLETED|Induction||1
8454968|NCT00736944|20834637|P1|COMPLETED|Induction||29
8454969|NCT00736944|20834637|P1|STARTED|Induction||30
8454970|NCT00736879|20834671|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
8454971|NCT00736879|20834672|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
8454972|NCT00736879|20834673|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
8454973|NCT00736879|20834674|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
8454974|NCT00736879|20834671|P4|COMPLETED|Follow up Period - No Drug Treatment||62
8454975|NCT00736879|20834672|P3|COMPLETED|Follow up Period - No Drug Treatment||66
8454976|NCT00736879|20834673|P2|COMPLETED|Follow up Period - No Drug Treatment||67
8454977|NCT00736879|20834674|P1|COMPLETED|Follow up Period - No Drug Treatment||65
8454978|NCT00736879|20834671|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
8454979|NCT00736879|20834672|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
8454980|NCT00736879|20834673|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
8454981|NCT00736879|20834674|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
8454982|NCT00736879|20834671|P4|NOT COMPLETED|Double Blind Treatment Period||5
8454983|NCT00736879|20834672|P3|NOT COMPLETED|Double Blind Treatment Period||7
8454984|NCT00736879|20834673|P2|NOT COMPLETED|Double Blind Treatment Period||4
8454985|NCT00736879|20834674|P1|NOT COMPLETED|Double Blind Treatment Period||3
8454986|NCT00736879|20834671|P4|COMPLETED|Double Blind Treatment Period||63
8454987|NCT00736879|20834672|P3|COMPLETED|Double Blind Treatment Period||67
8454988|NCT00736879|20834673|P2|COMPLETED|Double Blind Treatment Period||68
8454989|NCT00736879|20834674|P1|COMPLETED|Double Blind Treatment Period||65
8454990|NCT00736879|20834671|P4|STARTED|Double Blind Treatment Period||68
8454991|NCT00736879|20834672|P3|STARTED|Double Blind Treatment Period||74
8454992|NCT00736879|20834673|P2|STARTED|Double Blind Treatment Period||72
8454993|NCT00736879|20834674|P1|STARTED|Double Blind Treatment Period||68
8454994|NCT00736853|20834728|P3|NOT COMPLETED|Double-Blind Period||48
8454995|NCT00736853|20834729|P2|NOT COMPLETED|Double-Blind Period||24
8454996|NCT00736853|20834730|P1|NOT COMPLETED|Double-Blind Period||0
8454997|NCT00736853|20834728|P3|COMPLETED|Double-Blind Period||45
8454998|NCT00736853|20834729|P2|COMPLETED|Double-Blind Period||70
8454999|NCT00736853|20834730|P1|COMPLETED|Double-Blind Period||0
8455000|NCT00736853|20834728|P3|STARTED|Double-Blind Period||93
8455001|NCT00736853|20834729|P2|STARTED|Double-Blind Period||94
8455002|NCT00736853|20834730|P1|STARTED|Double-Blind Period||0
8455003|NCT00736853|20834728|P3|NOT COMPLETED|Open-Label Period||0
8455004|NCT00736853|20834729|P2|NOT COMPLETED|Open-Label Period||0
8455005|NCT00736853|20834730|P1|NOT COMPLETED|Open-Label Period||132
8455006|NCT00736853|20834728|P3|COMPLETED|Open-Label Period||0
8455007|NCT00736853|20834729|P2|COMPLETED|Open-Label Period||0
8455008|NCT00736853|20834730|P1|COMPLETED|Open-Label Period||187
8455009|NCT00736853|20834728|P3|Treated|Open-Label Period||0
8455010|NCT00736853|20834729|P2|Treated|Open-Label Period||0
8455011|NCT00736853|20834730|P1|Treated|Open-Label Period||277
8455012|NCT00736853|20834728|P3|STARTED|Open-Label Period||0
8455013|NCT00736853|20834729|P2|STARTED|Open-Label Period||0
8455014|NCT00736853|20834730|P1|STARTED|Open-Label Period||319
8455015|NCT00736840|20834770|P1|NOT COMPLETED|Overall Study||13
8455016|NCT00736840|20834770|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
8455017|NCT00736840|20834770|P1|STARTED|Overall Study||414
8455018|NCT00736723|20834777|P2|NOT COMPLETED|Overall Study||3
8455019|NCT00736723|20834778|P1|NOT COMPLETED|Overall Study||4
8455020|NCT00736723|20834777|P2|COMPLETED|Overall Study||18
8455021|NCT00736723|20834778|P1|COMPLETED|Overall Study||26
8455022|NCT00736723|20834777|P2|STARTED|Overall Study||21
8455023|NCT00736723|20834778|P1|STARTED|Overall Study||30
8455024|NCT00736645|20834788|P4|NOT COMPLETED|Overall Study||0
8455025|NCT00736645|20834789|P3|NOT COMPLETED|Overall Study||0
8455026|NCT00736645|20834790|P2|NOT COMPLETED|Overall Study||2
8455027|NCT00736645|20834791|P1|NOT COMPLETED|Overall Study||0
8455028|NCT00736645|20834788|P4|COMPLETED|Overall Study||13
8455029|NCT00736645|20834789|P3|COMPLETED|Overall Study||14
8455030|NCT00736645|20834790|P2|COMPLETED|Overall Study||13
8455031|NCT00736645|20834791|P1|COMPLETED|Overall Study||13
8455032|NCT00736645|20834788|P4|STARTED|Overall Study||13
8455033|NCT00736645|20834789|P3|STARTED|Overall Study||14
8455034|NCT00736645|20834790|P2|STARTED|Overall Study||15
8455035|NCT00736645|20834791|P1|STARTED|Overall Study||13
8455036|NCT00736632|20834808|P3|NOT COMPLETED|Overall Study||0
8455037|NCT00736632|20834809|P2|NOT COMPLETED|Overall Study||0
8455038|NCT00736632|20834810|P1|NOT COMPLETED|Overall Study||0
8455039|NCT00736632|20834808|P3|COMPLETED|Overall Study||31
8455040|NCT00736632|20834809|P2|COMPLETED|Overall Study||50
8455041|NCT00736632|20834810|P1|COMPLETED|Overall Study||44
8455042|NCT00736632|20834808|P3|STARTED|Overall Study||31
8455043|NCT00736632|20834809|P2|STARTED|Overall Study||50
8455044|NCT00736632|20834810|P1|STARTED|Overall Study||44
8455045|NCT00736580|20834834|P2|NOT COMPLETED|Overall Study||0
8455046|NCT00736580|20834835|P1|NOT COMPLETED|Overall Study||0
8455047|NCT00736580|20834834|P2|COMPLETED|Overall Study||123
8455048|NCT00736580|20834835|P1|COMPLETED|Overall Study||117
8455049|NCT00736580|20834834|P2|STARTED|Overall Study||123
8455050|NCT00736580|20834835|P1|STARTED|Overall Study||117
8455051|NCT00736502|20834841|P1|NOT COMPLETED|Overall Study||65
8455052|NCT00736502|20834841|P1|COMPLETED|Overall Study||213
8455053|NCT00736502|20834841|P1|STARTED|Overall Study|Entered and treated.|278
8455054|NCT00736489|20834847|P6|NOT COMPLETED|Period 6||0
8455055|NCT00736489|20834848|P5|NOT COMPLETED|Period 6||0
8455056|NCT00736489|20834849|P4|NOT COMPLETED|Period 6||0
8455057|NCT00736489|20834850|P3|NOT COMPLETED|Period 6||0
8455058|NCT00736489|20834851|P2|NOT COMPLETED|Period 6||0
8455059|NCT00736489|20834852|P1|NOT COMPLETED|Period 6||0
8455060|NCT00736489|20834847|P6|COMPLETED|Period 6||5
8455061|NCT00736489|20834848|P5|COMPLETED|Period 6||7
8455062|NCT00736489|20834849|P4|COMPLETED|Period 6||7
8455063|NCT00736489|20834850|P3|COMPLETED|Period 6||6
8455064|NCT00736489|20834851|P2|COMPLETED|Period 6||5
8455065|NCT00736489|20834852|P1|COMPLETED|Period 6||5
8455066|NCT00736489|20834847|P6|STARTED|Period 6||5
8455067|NCT00736489|20834848|P5|STARTED|Period 6||7
8455068|NCT00736489|20834849|P4|STARTED|Period 6||7
8455069|NCT00736489|20834850|P3|STARTED|Period 6||6
8455070|NCT00736489|20834851|P2|STARTED|Period 6||5
8455071|NCT00736489|20834852|P1|STARTED|Period 6||5
8455072|NCT00736489|20834847|P6|NOT COMPLETED|Period 5||0
8455073|NCT00736489|20834848|P5|NOT COMPLETED|Period 5||0
8455074|NCT00736489|20834849|P4|NOT COMPLETED|Period 5||0
8455075|NCT00736489|20834850|P3|NOT COMPLETED|Period 5||0
8455076|NCT00736489|20834851|P2|NOT COMPLETED|Period 5||0
8455077|NCT00736489|20834852|P1|NOT COMPLETED|Period 5||0
8455078|NCT00736489|20834847|P6|COMPLETED|Period 5||5
8455079|NCT00736489|20834848|P5|COMPLETED|Period 5||7
8455080|NCT00736489|20834849|P4|COMPLETED|Period 5||7
8455081|NCT00736489|20834850|P3|COMPLETED|Period 5||6
8455082|NCT00736489|20834851|P2|COMPLETED|Period 5||5
8455083|NCT00736489|20834852|P1|COMPLETED|Period 5||5
8455084|NCT00736489|20834847|P6|STARTED|Period 5||5
8455085|NCT00736489|20834848|P5|STARTED|Period 5||7
8455086|NCT00736489|20834849|P4|STARTED|Period 5||7
8455087|NCT00736489|20834850|P3|STARTED|Period 5||6
8455088|NCT00736489|20834851|P2|STARTED|Period 5||5
8455089|NCT00736489|20834852|P1|STARTED|Period 5||5
8455090|NCT00736489|20834847|P6|NOT COMPLETED|Period 4||0
8455091|NCT00736489|20834848|P5|NOT COMPLETED|Period 4||0
8455092|NCT00736489|20834849|P4|NOT COMPLETED|Period 4||0
8455093|NCT00736489|20834850|P3|NOT COMPLETED|Period 4||0
8455094|NCT00736489|20834851|P2|NOT COMPLETED|Period 4||0
8455095|NCT00736489|20834852|P1|NOT COMPLETED|Period 4||0
8455096|NCT00736489|20834847|P6|COMPLETED|Period 4||5
8455097|NCT00736489|20834848|P5|COMPLETED|Period 4||7
8455098|NCT00736489|20834849|P4|COMPLETED|Period 4||7
8455099|NCT00736489|20834850|P3|COMPLETED|Period 4||6
8455100|NCT00736489|20834851|P2|COMPLETED|Period 4||5
8455101|NCT00736489|20834852|P1|COMPLETED|Period 4||5
8455102|NCT00736489|20834847|P6|STARTED|Period 4||5
8455103|NCT00736489|20834848|P5|STARTED|Period 4||7
8455104|NCT00736489|20834849|P4|STARTED|Period 4||7
8455105|NCT00736489|20834850|P3|STARTED|Period 4||6
8455106|NCT00736489|20834851|P2|STARTED|Period 4||5
8455107|NCT00736489|20834852|P1|STARTED|Period 4||5
8455108|NCT00736489|20834847|P6|NOT COMPLETED|Period 3||0
8455109|NCT00736489|20834848|P5|NOT COMPLETED|Period 3||0
8455110|NCT00736489|20834849|P4|NOT COMPLETED|Period 3||0
8455111|NCT00736489|20834850|P3|NOT COMPLETED|Period 3||0
8455112|NCT00736489|20834851|P2|NOT COMPLETED|Period 3||0
8455113|NCT00736489|20834852|P1|NOT COMPLETED|Period 3||0
8455114|NCT00736489|20834847|P6|COMPLETED|Period 3||5
8455115|NCT00736489|20834848|P5|COMPLETED|Period 3||7
8455116|NCT00736489|20834849|P4|COMPLETED|Period 3||7
8455117|NCT00736489|20834850|P3|COMPLETED|Period 3||6
8455118|NCT00736489|20834851|P2|COMPLETED|Period 3||5
8455119|NCT00736489|20834852|P1|COMPLETED|Period 3||5
8455120|NCT00736489|20834847|P6|STARTED|Period 3||5
8455121|NCT00736489|20834848|P5|STARTED|Period 3||7
8455122|NCT00736489|20834849|P4|STARTED|Period 3||7
8455123|NCT00736489|20834850|P3|STARTED|Period 3||6
8455124|NCT00736489|20834851|P2|STARTED|Period 3||5
8455125|NCT00736489|20834852|P1|STARTED|Period 3||5
8455126|NCT00736489|20834847|P6|NOT COMPLETED|Period 2||0
8455127|NCT00736489|20834848|P5|NOT COMPLETED|Period 2||0
8455128|NCT00736489|20834849|P4|NOT COMPLETED|Period 2||0
8455129|NCT00736489|20834850|P3|NOT COMPLETED|Period 2||0
8455130|NCT00736489|20834851|P2|NOT COMPLETED|Period 2||0
8455131|NCT00736489|20834852|P1|NOT COMPLETED|Period 2||0
8455132|NCT00736489|20834847|P6|COMPLETED|Period 2||5
8455133|NCT00736489|20834848|P5|COMPLETED|Period 2||7
8455134|NCT00736489|20834849|P4|COMPLETED|Period 2||7
8455135|NCT00736489|20834850|P3|COMPLETED|Period 2||6
8455136|NCT00736489|20834851|P2|COMPLETED|Period 2||5
8455137|NCT00736489|20834852|P1|COMPLETED|Period 2||5
8455138|NCT00736489|20834847|P6|STARTED|Period 2||5
8455139|NCT00736489|20834848|P5|STARTED|Period 2||7
8455140|NCT00736489|20834849|P4|STARTED|Period 2||7
8455141|NCT00736489|20834850|P3|STARTED|Period 2||6
8455142|NCT00736489|20834851|P2|STARTED|Period 2||5
8455143|NCT00736489|20834852|P1|STARTED|Period 2||5
8455144|NCT00736489|20834847|P6|NOT COMPLETED|Period 1||1
8455145|NCT00736489|20834848|P5|NOT COMPLETED|Period 1||0
8455146|NCT00736489|20834849|P4|NOT COMPLETED|Period 1||0
8455147|NCT00736489|20834850|P3|NOT COMPLETED|Period 1||0
8455148|NCT00736489|20834851|P2|NOT COMPLETED|Period 1||0
8455149|NCT00736489|20834852|P1|NOT COMPLETED|Period 1||1
8455150|NCT00736489|20834847|P6|COMPLETED|Period 1||5
8455151|NCT00736489|20834848|P5|COMPLETED|Period 1||7
8455152|NCT00736489|20834849|P4|COMPLETED|Period 1||7
8455153|NCT00736489|20834850|P3|COMPLETED|Period 1||6
8455154|NCT00736489|20834851|P2|COMPLETED|Period 1||5
8455155|NCT00736489|20834852|P1|COMPLETED|Period 1||5
8455156|NCT00736489|20834847|P6|STARTED|Period 1||6
8455157|NCT00736489|20834848|P5|STARTED|Period 1||7
8455158|NCT00736489|20834849|P4|STARTED|Period 1||7
8455159|NCT00736489|20834850|P3|STARTED|Period 1||6
8455160|NCT00736489|20834851|P2|STARTED|Period 1||5
8455161|NCT00736489|20834852|P1|STARTED|Period 1|Cross-over study|6
8455162|NCT00736476|20835006|P2|NOT COMPLETED|Overall Study||0
8455163|NCT00736476|20835007|P1|NOT COMPLETED|Overall Study||1
8455164|NCT00736476|20835006|P2|COMPLETED|Overall Study||27
8455165|NCT00736476|20835007|P1|COMPLETED|Overall Study||35
8455166|NCT00736476|20835006|P2|STARTED|Overall Study||27
8455167|NCT00736476|20835007|P1|STARTED|Overall Study||36
8455168|NCT00736450|20835027|P1|NOT COMPLETED|Overall Study||25
8455169|NCT00736450|20835027|P1|COMPLETED|Overall Study||12
8455170|NCT00736450|20835027|P1|STARTED|Overall Study||37
8455171|NCT00736385|20835035|P2|NOT COMPLETED|Overall Study||3
8455172|NCT00736385|20835036|P1|NOT COMPLETED|Overall Study||2
8455173|NCT00736385|20835035|P2|COMPLETED|Overall Study||2
8455174|NCT00736385|20835036|P1|COMPLETED|Overall Study||2
8455175|NCT00736385|20835035|P2|STARTED|Overall Study||5
8455176|NCT00736385|20835036|P1|STARTED|Overall Study||4
8455177|NCT00736333|20835048|P1|NOT COMPLETED|Overall Study||111
8455178|NCT00736333|20835048|P1|COMPLETED|Overall Study||56
8455179|NCT00736333|20835048|P1|STARTED|Overall Study||167
8455180|NCT00736255|20835059|P2|NOT COMPLETED|Overall Study||1
8455181|NCT00736255|20835060|P1|NOT COMPLETED|Overall Study||3
8455182|NCT00736255|20835059|P2|COMPLETED|Overall Study||14
8455183|NCT00736255|20835060|P1|COMPLETED|Overall Study||14
8455184|NCT00736255|20835059|P2|STARTED|Overall Study||15
8455185|NCT00736255|20835060|P1|STARTED|Overall Study||17
8455186|NCT00736242|20835078|P1|NOT COMPLETED|Overall Study||125
8455187|NCT00736242|20835078|P1|COMPLETED|Overall Study||107
8455188|NCT00736242|20835078|P1|Participants in Safety Analysis Set|Overall Study||229
8455189|NCT00736242|20835078|P1|STARTED|Overall Study||232
8455190|NCT00736229|20835092|P3|NOT COMPLETED|Overall Study||0
8455191|NCT00736229|20835093|P2|NOT COMPLETED|Overall Study||0
8455192|NCT00736229|20835094|P1|NOT COMPLETED|Overall Study||0
8455193|NCT00736229|20835092|P3|COMPLETED|Overall Study||84
8455194|NCT00736229|20835093|P2|COMPLETED|Overall Study||71
8455195|NCT00736229|20835094|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
8455196|NCT00736229|20835092|P3|STARTED|Overall Study|Historic Control|84
8455197|NCT00736229|20835093|P2|STARTED|Overall Study|Historic control|71
8455198|NCT00736229|20835094|P1|STARTED|Overall Study|Actively Enrolled|40
8455199|NCT00736190|20835107|P1|NOT COMPLETED|Overall Study||3
8455200|NCT00736190|20835107|P1|COMPLETED|Overall Study||87
8455201|NCT00736190|20835107|P1|STARTED|Overall Study||90
8455202|NCT00736125|20835122|P2|NOT COMPLETED|Overall Study||2
8455203|NCT00736125|20835123|P1|NOT COMPLETED|Overall Study||1
8455204|NCT00736125|20835122|P2|COMPLETED|Overall Study||8
8455205|NCT00736125|20835123|P1|COMPLETED|Overall Study||9
8455206|NCT00736125|20835122|P2|STARTED|Overall Study||10
8455207|NCT00736125|20835123|P1|STARTED|Overall Study||10
8455208|NCT00736099|20835137|P2|NOT COMPLETED|Overall Study||58
8455209|NCT00736099|20835138|P1|NOT COMPLETED|Overall Study||183
8455210|NCT00736099|20835137|P2|COMPLETED|Overall Study|Number who completed treatment.|531
8455211|NCT00736099|20835138|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
8455212|NCT00736099|20835137|P2|STARTED|Overall Study|Number who started treatment.|589
8455213|NCT00736099|20835138|P1|STARTED|Overall Study|Number who started treatment.|1532
8455214|NCT00736073|20835236|P2|NOT COMPLETED|Overall Study||0
8455215|NCT00736073|20835237|P1|NOT COMPLETED|Overall Study||0
8455216|NCT00736073|20835236|P2|COMPLETED|Overall Study||39
8455217|NCT00736073|20835237|P1|COMPLETED|Overall Study||34
8455218|NCT00736073|20835236|P2|STARTED|Overall Study||39
8455219|NCT00736073|20835237|P1|STARTED|Overall Study||34
8455220|NCT00736034|20835247|P1|NOT COMPLETED|Overall Study||2
8455221|NCT00736034|20835247|P1|COMPLETED|Overall Study||16
8455222|NCT00736034|20835247|P1|STARTED|Overall Study||18
8455223|NCT00735969|20835251|P1|NOT COMPLETED|Overall Study||0
8455224|NCT00735969|20835251|P1|COMPLETED|Overall Study||21
8455225|NCT00735969|20835251|P1|STARTED|Overall Study||21
8455226|NCT00735943|20835255|P1|NOT COMPLETED|Overall Study||2
8455227|NCT00735943|20835255|P1|COMPLETED|Overall Study||20
8455228|NCT00735943|20835255|P1|STARTED|Overall Study||22
8455229|NCT00735917|20835272|P1|NOT COMPLETED|Overall Study||0
8455230|NCT00735917|20835272|P1|COMPLETED|Overall Study||19
8455231|NCT00735917|20835272|P1|STARTED|Overall Study||19
8455232|NCT00735904|20835280|P1|NOT COMPLETED|Overall Study||38
8455233|NCT00735904|20835280|P1|COMPLETED|Overall Study||0
8455234|NCT00735904|20835280|P1|STARTED|Overall Study||38
8455235|NCT00735878|20835290|P3|NOT COMPLETED|Phase II- Determined Dose||0
8455236|NCT00735878|20835291|P2|NOT COMPLETED|Phase II- Determined Dose||0
8455237|NCT00735878|20835292|P1|NOT COMPLETED|Phase II- Determined Dose||0
8455238|NCT00735878|20835290|P3|COMPLETED|Phase II- Determined Dose||0
8455239|NCT00735878|20835291|P2|COMPLETED|Phase II- Determined Dose||7
8455240|NCT00735878|20835292|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
8455241|NCT00735878|20835290|P3|STARTED|Phase II- Determined Dose||0
8455242|NCT00735878|20835291|P2|STARTED|Phase II- Determined Dose||7
8455243|NCT00735878|20835292|P1|STARTED|Phase II- Determined Dose||0
8455244|NCT00735878|20835290|P3|NOT COMPLETED|Phase I- Dose Determination||1
8455245|NCT00735878|20835291|P2|NOT COMPLETED|Phase I- Dose Determination||0
8455246|NCT00735878|20835292|P1|NOT COMPLETED|Phase I- Dose Determination||0
8455247|NCT00735878|20835290|P3|COMPLETED|Phase I- Dose Determination||4
8455248|NCT00735878|20835291|P2|COMPLETED|Phase I- Dose Determination||7
8455249|NCT00735878|20835292|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
8455250|NCT00735878|20835290|P3|STARTED|Phase I- Dose Determination||5
8455251|NCT00735878|20835291|P2|STARTED|Phase I- Dose Determination||7
8455252|NCT00735878|20835292|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
8455253|NCT00735839|20835305|P2|NOT COMPLETED|Overall Study||0
8455254|NCT00735839|20835306|P1|NOT COMPLETED|Overall Study||0
8455255|NCT00735839|20835305|P2|COMPLETED|Overall Study||10
8455256|NCT00735839|20835306|P1|COMPLETED|Overall Study||30
8455257|NCT00735839|20835305|P2|STARTED|Overall Study||10
8455258|NCT00735839|20835306|P1|STARTED|Overall Study||30
8455259|NCT00735826|20835314|P1|NOT COMPLETED|Overall Study||0
8455260|NCT00735826|20835314|P1|COMPLETED|Overall Study||10
8455261|NCT00735826|20835314|P1|STARTED|Overall Study||10
8455262|NCT00735787|20835322|P2|NOT COMPLETED|Period 2||1
8455263|NCT00735787|20835323|P1|NOT COMPLETED|Period 2||5
8455264|NCT00735787|20835322|P2|COMPLETED|Period 2||40
8455265|NCT00735787|20835323|P1|COMPLETED|Period 2||13
8455266|NCT00735787|20835322|P2|STARTED|Period 2||41
8455267|NCT00735787|20835323|P1|STARTED|Period 2||18
8455268|NCT00735787|20835322|P2|NOT COMPLETED|Period 1||8
8455269|NCT00735787|20835323|P1|NOT COMPLETED|Period 1||6
8455270|NCT00735787|20835322|P2|COMPLETED|Period 1||41
8455271|NCT00735787|20835323|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
8455272|NCT00735787|20835322|P2|STARTED|Period 1||49
8455273|NCT00735787|20835323|P1|STARTED|Period 1||23
8455274|NCT00735709|20835371|P4|NOT COMPLETED|Overall Study||18
8455275|NCT00735709|20835372|P3|NOT COMPLETED|Overall Study||11
8455276|NCT00735709|20835373|P2|NOT COMPLETED|Overall Study||13
8455277|NCT00735709|20835374|P1|NOT COMPLETED|Overall Study||13
8455278|NCT00735709|20835371|P4|COMPLETED|Overall Study||122
8455279|NCT00735709|20835372|P3|COMPLETED|Overall Study||129
8455280|NCT00735709|20835373|P2|COMPLETED|Overall Study||127
8455281|NCT00735709|20835374|P1|COMPLETED|Overall Study||127
8455282|NCT00735709|20835371|P4|Treated|Overall Study||139
8455283|NCT00735709|20835372|P3|Treated|Overall Study||140
8455284|NCT00735709|20835373|P2|Treated|Overall Study||140
8455285|NCT00735709|20835374|P1|Treated|Overall Study||140
8455286|NCT00735709|20835371|P4|STARTED|Overall Study||140
8455287|NCT00735709|20835372|P3|STARTED|Overall Study||140
8455288|NCT00735709|20835373|P2|STARTED|Overall Study||140
8455289|NCT00735709|20835374|P1|STARTED|Overall Study||140
8455290|NCT00735696|20835484|P1|NOT COMPLETED|Overall Study||2
8455291|NCT00735696|20835484|P1|COMPLETED|Overall Study||39
8455292|NCT00735696|20835484|P1|Received Any Quantity of Study Drug|Overall Study||40
8455293|NCT00735696|20835484|P1|STARTED|Overall Study||41
8455294|NCT00735670|20835498|P2|NOT COMPLETED|Overall Study||5
8455295|NCT00735670|20835499|P1|NOT COMPLETED|Overall Study||4
8455296|NCT00735670|20835498|P2|COMPLETED|Overall Study||6
8455297|NCT00735670|20835499|P1|COMPLETED|Overall Study||6
8455298|NCT00735670|20835498|P2|STARTED|Overall Study||11
8455299|NCT00735670|20835499|P1|STARTED|Overall Study||10
8455300|NCT00735644|20835512|P5|NOT COMPLETED|Overall Study||0
8455301|NCT00735644|20835513|P4|NOT COMPLETED|Overall Study||1
8455302|NCT00735644|20835514|P3|NOT COMPLETED|Overall Study||1
8455303|NCT00735644|20835515|P2|NOT COMPLETED|Overall Study||2
8455304|NCT00735644|20835516|P1|NOT COMPLETED|Overall Study||0
8455305|NCT00735644|20835512|P5|COMPLETED|Overall Study||102
8455306|NCT00735644|20835513|P4|COMPLETED|Overall Study||198
8455307|NCT00735644|20835514|P3|COMPLETED|Overall Study||295
8455308|NCT00735644|20835515|P2|COMPLETED|Overall Study||298
8455309|NCT00735644|20835516|P1|COMPLETED|Overall Study||303
8455310|NCT00735644|20835512|P5|STARTED|Overall Study||102
8455311|NCT00735644|20835513|P4|STARTED|Overall Study||199
8455312|NCT00735644|20835514|P3|STARTED|Overall Study||296
8455313|NCT00735644|20835515|P2|STARTED|Overall Study||300
8455314|NCT00735644|20835516|P1|STARTED|Overall Study||303
8455315|NCT00735618|20835553|P1|NOT COMPLETED|Overall Study||0
8455316|NCT00735618|20835553|P1|COMPLETED|Overall Study||19
8455317|NCT00735618|20835553|P1|STARTED|Overall Study||19
8455318|NCT00735553|20835560|P1|NOT COMPLETED|Overall Study||77
8455319|NCT00735553|20835560|P1|COMPLETED|Overall Study||0
8455320|NCT00735553|20835560|P1|STARTED|Overall Study||77
8455321|NCT00735475|20835570|P2|NOT COMPLETED|Overall Study||11
8455322|NCT00735475|20835571|P1|NOT COMPLETED|Overall Study||8
8455323|NCT00735475|20835570|P2|COMPLETED|Overall Study||626
8455324|NCT00735475|20835571|P1|COMPLETED|Overall Study||623
8455325|NCT00735475|20835570|P2|STARTED|Overall Study||637
8455326|NCT00735475|20835571|P1|STARTED|Overall Study||631
8455327|NCT00735462|20835592|P3|NOT COMPLETED|Overall Study||28
8455328|NCT00735462|20835593|P2|NOT COMPLETED|Overall Study||55
8455329|NCT00735462|20835594|P1|NOT COMPLETED|Overall Study||63
8455330|NCT00735462|20835592|P3|COMPLETED|Overall Study||77
8455331|NCT00735462|20835593|P2|COMPLETED|Overall Study||149
8455332|NCT00735462|20835594|P1|COMPLETED|Overall Study||139
8455333|NCT00735462|20835592|P3|STARTED|Overall Study||105
8455334|NCT00735462|20835593|P2|STARTED|Overall Study||204
8455335|NCT00735462|20835594|P1|STARTED|Overall Study||202
8455336|NCT00735449|20835607|P2|NOT COMPLETED|Overall Study||6
8455337|NCT00735449|20835608|P1|NOT COMPLETED|Overall Study||7
8455338|NCT00735449|20835607|P2|COMPLETED|Overall Study||96
8455339|NCT00735449|20835608|P1|COMPLETED|Overall Study||95
8455340|NCT00735449|20835607|P2|STARTED|Overall Study||102
8455341|NCT00735449|20835608|P1|STARTED|Overall Study||102
8455342|NCT00735436|20835622|P1|NOT COMPLETED|Overall Study||0
8455343|NCT00735436|20835622|P1|COMPLETED|Overall Study||18
8455344|NCT00735436|20835622|P1|STARTED|Overall Study||18
8455345|NCT00735397|20835631|P1|NOT COMPLETED|Overall Study||1183
8455346|NCT00735397|20835631|P1|COMPLETED|Overall Study||35
8455347|NCT00735397|20835631|P1|STARTED|Overall Study||1218
8455348|NCT00735371|20835645|P4|NOT COMPLETED|Overall Study||10
8455349|NCT00735371|20835646|P3|NOT COMPLETED|Overall Study||11
8455350|NCT00735371|20835647|P2|NOT COMPLETED|Overall Study||13
8455351|NCT00735371|20835648|P1|NOT COMPLETED|Overall Study||15
8455352|NCT00735371|20835645|P4|COMPLETED|Overall Study||69
8455353|NCT00735371|20835646|P3|COMPLETED|Overall Study||67
8455354|NCT00735371|20835647|P2|COMPLETED|Overall Study||66
8455355|NCT00735371|20835648|P1|COMPLETED|Overall Study||63
8455356|NCT00735371|20835645|P4|STARTED|Overall Study||79
8455357|NCT00735371|20835646|P3|STARTED|Overall Study||78
8455358|NCT00735371|20835647|P2|STARTED|Overall Study||79
8455359|NCT00735371|20835648|P1|STARTED|Overall Study||78
8455360|NCT00735306|20835666|P1|NOT COMPLETED|Overall Study||0
8455361|NCT00735306|20835666|P1|COMPLETED|Overall Study||12
8455362|NCT00735306|20835666|P1|STARTED|Overall Study||12
8455363|NCT00735254|20835676|P4|NOT COMPLETED|Overall Study||0
8455364|NCT00735254|20835677|P3|NOT COMPLETED|Overall Study||1
8455365|NCT00735254|20835678|P2|NOT COMPLETED|Overall Study||1
8455366|NCT00735254|20835679|P1|NOT COMPLETED|Overall Study||1
8455367|NCT00735254|20835676|P4|COMPLETED|Overall Study||0
8455368|NCT00735254|20835677|P3|COMPLETED|Overall Study||0
8455369|NCT00735254|20835678|P2|COMPLETED|Overall Study||0
8455370|NCT00735254|20835679|P1|COMPLETED|Overall Study||0
8455371|NCT00735254|20835676|P4|STARTED|Overall Study||0
8455372|NCT00735254|20835677|P3|STARTED|Overall Study||1
8455373|NCT00735254|20835678|P2|STARTED|Overall Study||1
8455374|NCT00735254|20835679|P1|STARTED|Overall Study||1
8455375|NCT00735072|20835691|P2|NOT COMPLETED|Overall Study||1
8455376|NCT00735072|20835692|P1|NOT COMPLETED|Overall Study||1
8455377|NCT00735072|20835691|P2|COMPLETED|Overall Study||21
8455378|NCT00735072|20835692|P1|COMPLETED|Overall Study||22
8455379|NCT00735072|20835691|P2|STARTED|Overall Study||22
8455380|NCT00735072|20835692|P1|STARTED|Overall Study||23
8455381|NCT00735007|20835706|P1|NOT COMPLETED|Overall Study||5
8455382|NCT00735007|20835706|P1|COMPLETED|Overall Study||101
8455383|NCT00735007|20835706|P1|STARTED|Overall Study||106
8455384|NCT00734994|20835731|P1|NOT COMPLETED|Overall Study||1
8455385|NCT00734994|20835731|P1|COMPLETED|Overall Study||14
8455386|NCT00734994|20835731|P1|STARTED|Overall Study||15
8455387|NCT00734968|20835738|P2|NOT COMPLETED|Overall Study||1
8455388|NCT00734968|20835739|P1|NOT COMPLETED|Overall Study||1
8455389|NCT00734968|20835738|P2|COMPLETED|Overall Study||75
8455390|NCT00734968|20835739|P1|COMPLETED|Overall Study||76
8455391|NCT00734968|20835738|P2|STARTED|Overall Study||76
8455392|NCT00734968|20835739|P1|STARTED|Overall Study||77
8455393|NCT00734929|20835751|P2|NOT COMPLETED|Overall Study||5
8455394|NCT00734929|20835752|P1|NOT COMPLETED|Overall Study||6
8455395|NCT00734929|20835751|P2|COMPLETED|Overall Study||53
8455396|NCT00734929|20835752|P1|COMPLETED|Overall Study||51
8455397|NCT00734929|20835751|P2|STARTED|Overall Study||58
8455398|NCT00734929|20835752|P1|STARTED|Overall Study||57
8455399|NCT00734903|20835782|P2|NOT COMPLETED|Overall Study||1
8455400|NCT00734903|20835783|P1|NOT COMPLETED|Overall Study||3
8455401|NCT00734903|20835782|P2|COMPLETED|Overall Study||32
8455402|NCT00734903|20835783|P1|COMPLETED|Overall Study||30
8455403|NCT00734903|20835782|P2|Completed 3-month Followup|Overall Study||15
8455404|NCT00734903|20835783|P1|Completed 3-month Followup|Overall Study||14
8455405|NCT00734903|20835782|P2|Completed End of Treatment Assessment|Overall Study||23
8455406|NCT00734903|20835783|P1|Completed End of Treatment Assessment|Overall Study||21
8455407|NCT00734903|20835782|P2|STARTED|Overall Study||33
8455408|NCT00734903|20835783|P1|STARTED|Overall Study||33
8455409|NCT00734851|20835809|P1|NOT COMPLETED|Overall Study||21
8455410|NCT00734851|20835809|P1|COMPLETED|Overall Study||13
8455411|NCT00734851|20835809|P1|STARTED|Overall Study||34
8455412|NCT00734799|20835821|P2|NOT COMPLETED|Overall Study||4
8455413|NCT00734799|20835822|P1|NOT COMPLETED|Overall Study||0
8455414|NCT00734799|20835821|P2|COMPLETED|Overall Study||9
8455415|NCT00734799|20835822|P1|COMPLETED|Overall Study||9
8455416|NCT00734799|20835821|P2|STARTED|Overall Study||13
8455417|NCT00734799|20835822|P1|STARTED|Overall Study||9
8455418|NCT00734747|20835830|P1|NOT COMPLETED|6 Month Follow-up||3
8455419|NCT00734747|20835830|P1|COMPLETED|6 Month Follow-up||66
8455420|NCT00734747|20835830|P1|STARTED|6 Month Follow-up||69
8455421|NCT00734747|20835830|P1|NOT COMPLETED|SRS Procedure||3
8455422|NCT00734747|20835830|P1|COMPLETED|SRS Procedure||69
8455423|NCT00734747|20835830|P1|STARTED|SRS Procedure||72
8455424|NCT00734734|20835837|P1|NOT COMPLETED|Overall Study||0
8455425|NCT00734734|20835837|P1|COMPLETED|Overall Study||64
8455426|NCT00734734|20835837|P1|STARTED|Overall Study||64
8455427|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 4||1
8455428|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 4||0
8455429|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 4||0
8455430|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 4||0
8455431|NCT00734656|20835844|P4|COMPLETED|Lab Session 4||19
8455432|NCT00734656|20835845|P3|COMPLETED|Lab Session 4||16
8455433|NCT00734656|20835846|P2|COMPLETED|Lab Session 4||18
8455434|NCT00734656|20835847|P1|COMPLETED|Lab Session 4||20
8455435|NCT00734656|20835844|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455436|NCT00734656|20835845|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
8455437|NCT00734656|20835846|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
8455438|NCT00734656|20835847|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455439|NCT00734656|20835844|P4|NOT COMPLETED|Washout 3||1
8455440|NCT00734656|20835845|P3|NOT COMPLETED|Washout 3||0
8455441|NCT00734656|20835846|P2|NOT COMPLETED|Washout 3||0
8455442|NCT00734656|20835847|P1|NOT COMPLETED|Washout 3||1
8455443|NCT00734656|20835844|P4|COMPLETED|Washout 3||18
8455444|NCT00734656|20835845|P3|COMPLETED|Washout 3||20
8455445|NCT00734656|20835846|P2|COMPLETED|Washout 3||19
8455446|NCT00734656|20835847|P1|COMPLETED|Washout 3||17
8455447|NCT00734656|20835844|P4|STARTED|Washout 3||19
8455448|NCT00734656|20835845|P3|STARTED|Washout 3||20
8455449|NCT00734656|20835846|P2|STARTED|Washout 3||19
8455450|NCT00734656|20835847|P1|STARTED|Washout 3||18
8455451|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 3||0
8455452|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 3||0
8455453|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 3||0
8455454|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 3||0
8455455|NCT00734656|20835844|P4|COMPLETED|Lab Session 3||19
8455456|NCT00734656|20835845|P3|COMPLETED|Lab Session 3||20
8455457|NCT00734656|20835846|P2|COMPLETED|Lab Session 3||19
8455458|NCT00734656|20835847|P1|COMPLETED|Lab Session 3||18
8455459|NCT00734656|20835844|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8455460|NCT00734656|20835845|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455461|NCT00734656|20835846|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8455462|NCT00734656|20835847|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
8455463|NCT00734656|20835844|P4|NOT COMPLETED|Washout 2||0
8455464|NCT00734656|20835845|P3|NOT COMPLETED|Washout 2||1
8455465|NCT00734656|20835846|P2|NOT COMPLETED|Washout 2||1
8455466|NCT00734656|20835847|P1|NOT COMPLETED|Washout 2||1
8455467|NCT00734656|20835844|P4|COMPLETED|Washout 2||19
8455468|NCT00734656|20835845|P3|COMPLETED|Washout 2||20
8455469|NCT00734656|20835846|P2|COMPLETED|Washout 2||20
8455470|NCT00734656|20835847|P1|COMPLETED|Washout 2||17
8455471|NCT00734656|20835844|P4|STARTED|Washout 2||19
8455472|NCT00734656|20835845|P3|STARTED|Washout 2||21
8455473|NCT00734656|20835846|P2|STARTED|Washout 2||21
8455474|NCT00734656|20835847|P1|STARTED|Washout 2||18
8455475|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 2||1
8455476|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 2||0
8455477|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 2||0
8455478|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 2||1
8455479|NCT00734656|20835844|P4|COMPLETED|Lab Session 2||19
8455480|NCT00734656|20835845|P3|COMPLETED|Lab Session 2||21
8455481|NCT00734656|20835846|P2|COMPLETED|Lab Session 2||21
8455482|NCT00734656|20835847|P1|COMPLETED|Lab Session 2||18
8455483|NCT00734656|20835844|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455484|NCT00734656|20835845|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
8455485|NCT00734656|20835846|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
8455486|NCT00734656|20835847|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8455487|NCT00734656|20835844|P4|NOT COMPLETED|Washout 1||3
8455488|NCT00734656|20835845|P3|NOT COMPLETED|Washout 1||2
8455489|NCT00734656|20835846|P2|NOT COMPLETED|Washout 1||5
8455490|NCT00734656|20835847|P1|NOT COMPLETED|Washout 1||1
8455491|NCT00734656|20835844|P4|COMPLETED|Washout 1||18
8455492|NCT00734656|20835845|P3|COMPLETED|Washout 1||24
8455493|NCT00734656|20835846|P2|COMPLETED|Washout 1||18
8455494|NCT00734656|20835847|P1|COMPLETED|Washout 1||21
8455495|NCT00734656|20835844|P4|STARTED|Washout 1||21
8455496|NCT00734656|20835845|P3|STARTED|Washout 1||26
8455497|NCT00734656|20835846|P2|STARTED|Washout 1||23
8455498|NCT00734656|20835847|P1|STARTED|Washout 1||22
8455499|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 1||0
8455500|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 1||0
8455501|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 1||0
8455502|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 1||2
8455503|NCT00734656|20835844|P4|COMPLETED|Lab Session 1||21
8455504|NCT00734656|20835845|P3|COMPLETED|Lab Session 1||26
8455505|NCT00734656|20835846|P2|COMPLETED|Lab Session 1||23
8455506|NCT00734656|20835847|P1|COMPLETED|Lab Session 1||22
8455507|NCT00734656|20835844|P4|STARTED|Lab Session 1||21
8455508|NCT00734656|20835845|P3|STARTED|Lab Session 1||26
8455509|NCT00734656|20835846|P2|STARTED|Lab Session 1||23
8455510|NCT00734656|20835847|P1|STARTED|Lab Session 1||24
8455511|NCT00734630|20835871|P2|NOT COMPLETED|Overall Study||33
8455512|NCT00734630|20835872|P1|NOT COMPLETED|Overall Study||29
8455513|NCT00734630|20835871|P2|COMPLETED|Overall Study||200
8455514|NCT00734630|20835872|P1|COMPLETED|Overall Study||229
8455515|NCT00734630|20835871|P2|STARTED|Overall Study||233
8455516|NCT00734630|20835872|P1|STARTED|Overall Study||258
8455517|NCT00734617|20835882|P2|NOT COMPLETED|Overall Study||102
8455518|NCT00734617|20835883|P1|NOT COMPLETED|Overall Study||107
8455519|NCT00734617|20835882|P2|COMPLETED|Overall Study||128
8455520|NCT00734617|20835883|P1|COMPLETED|Overall Study||142
8455521|NCT00734617|20835882|P2|STARTED|Overall Study||230
8455522|NCT00734617|20835883|P1|STARTED|Overall Study||249
8455523|NCT00734604|20835895|P6|NOT COMPLETED|Overall Study||6
8455524|NCT00734604|20835896|P5|NOT COMPLETED|Overall Study||8
8455525|NCT00734604|20835897|P4|NOT COMPLETED|Overall Study||9
8455526|NCT00734604|20835898|P3|NOT COMPLETED|Overall Study||6
8455527|NCT00734604|20835899|P2|NOT COMPLETED|Overall Study||12
8455528|NCT00734604|20835900|P1|NOT COMPLETED|Overall Study||3
8455529|NCT00734604|20835895|P6|COMPLETED|Overall Study||58
8455530|NCT00734604|20835896|P5|COMPLETED|Overall Study||55
8455531|NCT00734604|20835897|P4|COMPLETED|Overall Study||54
8455532|NCT00734604|20835898|P3|COMPLETED|Overall Study||57
8455533|NCT00734604|20835899|P2|COMPLETED|Overall Study||51
8455534|NCT00734604|20835900|P1|COMPLETED|Overall Study||59
8455535|NCT00734604|20835895|P6|STARTED|Overall Study||64
8455536|NCT00734604|20835896|P5|STARTED|Overall Study||63
8455537|NCT00734604|20835897|P4|STARTED|Overall Study||63
8455538|NCT00734604|20835898|P3|STARTED|Overall Study||63
8455539|NCT00734604|20835899|P2|STARTED|Overall Study||63
8455540|NCT00734604|20835900|P1|STARTED|Overall Study||62
8455541|NCT00734591|20835950|P2|NOT COMPLETED|Prospective Period||44
8455542|NCT00734591|20835951|P1|NOT COMPLETED|Prospective Period||51
8455543|NCT00734591|20835950|P2|COMPLETED|Prospective Period||1229
8455544|NCT00734591|20835951|P1|COMPLETED|Prospective Period||1307
8455545|NCT00734591|20835950|P2|STARTED|Prospective Period||1273
8455546|NCT00734591|20835951|P1|STARTED|Prospective Period||1358
8455547|NCT00734591|20835950|P2|NOT COMPLETED|Screening for Prospective Period||2291
8455548|NCT00734591|20835951|P1|NOT COMPLETED|Screening for Prospective Period||2517
8455549|NCT00734591|20835950|P2|COMPLETED|Screening for Prospective Period||1273
8455550|NCT00734591|20835951|P1|COMPLETED|Screening for Prospective Period||1358
8455551|NCT00734591|20835950|P2|STARTED|Screening for Prospective Period||3564
8455552|NCT00734591|20835951|P1|STARTED|Screening for Prospective Period||3875
8455553|NCT00734591|20835950|P2|NOT COMPLETED|Retrospective Period||0
8455554|NCT00734591|20835951|P1|NOT COMPLETED|Retrospective Period||0
8455555|NCT00734591|20835950|P2|COMPLETED|Retrospective Period||3564
8455556|NCT00734591|20835951|P1|COMPLETED|Retrospective Period||3875
8455557|NCT00734591|20835950|P2|STARTED|Retrospective Period||3564
8455558|NCT00734591|20835951|P1|STARTED|Retrospective Period||3875
8455559|NCT00734578|20835966|P3|NOT COMPLETED|Overall Study||25
8455560|NCT00734578|20835967|P2|NOT COMPLETED|Overall Study||25
8455561|NCT00734578|20835968|P1|NOT COMPLETED|Overall Study||33
8455562|NCT00734578|20835966|P3|COMPLETED|Overall Study||129
8455563|NCT00734578|20835967|P2|COMPLETED|Overall Study||128
8455564|NCT00734578|20835968|P1|COMPLETED|Overall Study||121
8455565|NCT00734578|20835966|P3|STARTED|Overall Study||154
8455566|NCT00734578|20835967|P2|STARTED|Overall Study||153
8455567|NCT00734578|20835968|P1|STARTED|Overall Study||154
8455568|NCT00734539|20836002|P2|NOT COMPLETED|Long Term Follow up||31
8455569|NCT00734539|20836003|P1|NOT COMPLETED|Long Term Follow up||34
8455570|NCT00734539|20836002|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
8455571|NCT00734539|20836003|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
8455572|NCT00734539|20836002|P2|STARTED|Long Term Follow up||138
8455573|NCT00734539|20836003|P1|STARTED|Long Term Follow up||152
8455574|NCT00734539|20836002|P2|NOT COMPLETED|Main Study||35
8455575|NCT00734539|20836003|P1|NOT COMPLETED|Main Study||37
8455576|NCT00734539|20836002|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
8455577|NCT00734539|20836003|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
8455578|NCT00734539|20836002|P2|STARTED|Main Study||173
8455579|NCT00734539|20836003|P1|STARTED|Main Study||189
8455580|NCT00734500|20836031|P1|NOT COMPLETED|Overall Study||1
8455581|NCT00734500|20836031|P1|COMPLETED|Overall Study||14
8455582|NCT00734500|20836031|P1|STARTED|Overall Study||15
8455583|NCT00734474|20836045|P9|NOT COMPLETED|Overall Study||82
8455584|NCT00734474|20836046|P8|NOT COMPLETED|Overall Study||129
8455585|NCT00734474|20836047|P7|NOT COMPLETED|Overall Study||24
8455586|NCT00734474|20836048|P6|NOT COMPLETED|Overall Study||25
8455587|NCT00734474|20836049|P5|NOT COMPLETED|Overall Study||118
8455588|NCT00734474|20836050|P4|NOT COMPLETED|Overall Study||10
8455589|NCT00734474|20836051|P3|NOT COMPLETED|Overall Study||112
8455590|NCT00734474|20836052|P2|NOT COMPLETED|Overall Study||30
8455591|NCT00734474|20836053|P1|NOT COMPLETED|Overall Study||15
8455592|NCT00734474|20836045|P9|COMPLETED|Overall Study||95
8455593|NCT00734474|20836046|P8|COMPLETED|Overall Study||186
8455594|NCT00734474|20836047|P7|COMPLETED|Overall Study||0
8455595|NCT00734474|20836048|P6|COMPLETED|Overall Study||0
8455596|NCT00734474|20836049|P5|COMPLETED|Overall Study||184
8455597|NCT00734474|20836050|P4|COMPLETED|Overall Study||0
8455598|NCT00734474|20836051|P3|COMPLETED|Overall Study||192
8455599|NCT00734474|20836052|P2|COMPLETED|Overall Study||0
8455600|NCT00734474|20836053|P1|COMPLETED|Overall Study||0
8455601|NCT00734474|20836045|P9|Completed 52-Week Visit|Overall Study||112
8455602|NCT00734474|20836046|P8|Completed 52-Week Visit|Overall Study||238
8455603|NCT00734474|20836047|P7|Completed 52-Week Visit|Overall Study||0
8455604|NCT00734474|20836048|P6|Completed 52-Week Visit|Overall Study||0
8455605|NCT00734474|20836049|P5|Completed 52-Week Visit|Overall Study||243
8455606|NCT00734474|20836050|P4|Completed 52-Week Visit|Overall Study||0
8455607|NCT00734474|20836051|P3|Completed 52-Week Visit|Overall Study||238
8455608|NCT00734474|20836052|P2|Completed 52-Week Visit|Overall Study||0
8455609|NCT00734474|20836053|P1|Completed 52-Week Visit|Overall Study||0
8455610|NCT00734474|20836045|P9|Completed 26-Week Visit|Overall Study||124
8455611|NCT00734474|20836046|P8|Completed 26-Week Visit|Overall Study||270
8455612|NCT00734474|20836047|P7|Completed 26-Week Visit|Overall Study||2
8455613|NCT00734474|20836048|P6|Completed 26-Week Visit|Overall Study||2
8455614|NCT00734474|20836049|P5|Completed 26-Week Visit|Overall Study||268
8455615|NCT00734474|20836050|P4|Completed 26-Week Visit|Overall Study||2
8455616|NCT00734474|20836051|P3|Completed 26-Week Visit|Overall Study||258
8455617|NCT00734474|20836052|P2|Completed 26-Week Visit|Overall Study||0
8455618|NCT00734474|20836053|P1|Completed 26-Week Visit|Overall Study||0
8455619|NCT00734474|20836045|P9|Entered Study After Dose Decision Point|Overall Study||139
8455620|NCT00734474|20836046|P8|Entered Study After Dose Decision Point|Overall Study||273
8455621|NCT00734474|20836047|P7|Entered Study After Dose Decision Point|Overall Study||0
8455622|NCT00734474|20836048|P6|Entered Study After Dose Decision Point|Overall Study||0
8455623|NCT00734474|20836049|P5|Entered Study After Dose Decision Point|Overall Study||281
8455624|NCT00734474|20836050|P4|Entered Study After Dose Decision Point|Overall Study||0
8455625|NCT00734474|20836051|P3|Entered Study After Dose Decision Point|Overall Study||279
8455626|NCT00734474|20836052|P2|Entered Study After Dose Decision Point|Overall Study||0
8455627|NCT00734474|20836053|P1|Entered Study After Dose Decision Point|Overall Study||0
8455628|NCT00734474|20836045|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
8455629|NCT00734474|20836046|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
8455630|NCT00734474|20836047|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
8455631|NCT00734474|20836048|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
8455632|NCT00734474|20836049|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
8455633|NCT00734474|20836050|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
8455634|NCT00734474|20836051|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
8455635|NCT00734474|20836052|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
8455636|NCT00734474|20836053|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
8455637|NCT00734474|20836045|P9|Entered Study Before Dose Decision Point|Overall Study||38
8455638|NCT00734474|20836046|P8|Entered Study Before Dose Decision Point|Overall Study||42
8455639|NCT00734474|20836047|P7|Entered Study Before Dose Decision Point|Overall Study||24
8455640|NCT00734474|20836048|P6|Entered Study Before Dose Decision Point|Overall Study||25
8455641|NCT00734474|20836049|P5|Entered Study Before Dose Decision Point|Overall Study||21
8455642|NCT00734474|20836050|P4|Entered Study Before Dose Decision Point|Overall Study||10
8455643|NCT00734474|20836051|P3|Entered Study Before Dose Decision Point|Overall Study||25
8455644|NCT00734474|20836052|P2|Entered Study Before Dose Decision Point|Overall Study||30
8455645|NCT00734474|20836053|P1|Entered Study Before Dose Decision Point|Overall Study||15
8455646|NCT00734474|20836045|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
8455647|NCT00734474|20836046|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
8455648|NCT00734474|20836047|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
8455649|NCT00734474|20836048|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
8455650|NCT00734474|20836049|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
8455651|NCT00734474|20836050|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
8455652|NCT00734474|20836051|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
8455653|NCT00734474|20836052|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
8455654|NCT00734474|20836053|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8455655|NCT00734474|20836045|P9|STARTED|Overall Study||177
8455656|NCT00734474|20836046|P8|STARTED|Overall Study||315
8455657|NCT00734474|20836047|P7|STARTED|Overall Study||24
8455658|NCT00734474|20836048|P6|STARTED|Overall Study||25
8455659|NCT00734474|20836049|P5|STARTED|Overall Study||302
8455660|NCT00734474|20836050|P4|STARTED|Overall Study||10
8455661|NCT00734474|20836051|P3|STARTED|Overall Study||304
8455662|NCT00734474|20836052|P2|STARTED|Overall Study||30
8455663|NCT00734474|20836053|P1|STARTED|Overall Study||15
8455664|NCT00734409|20836222|P2|NOT COMPLETED|Overall Study||0
8455665|NCT00734409|20836223|P1|NOT COMPLETED|Overall Study||0
8455666|NCT00734409|20836222|P2|COMPLETED|Overall Study||145
8455667|NCT00734409|20836223|P1|COMPLETED|Overall Study||155
8455668|NCT00734409|20836222|P2|STARTED|Overall Study||145
8455669|NCT00734409|20836223|P1|STARTED|Overall Study||155
8455670|NCT00734344|20836235|P2|NOT COMPLETED|Overall Study||0
8455671|NCT00734344|20836236|P1|NOT COMPLETED|Overall Study||0
8455672|NCT00734344|20836235|P2|COMPLETED|Overall Study||9
8455673|NCT00734344|20836236|P1|COMPLETED|Overall Study||9
8455674|NCT00734344|20836235|P2|STARTED|Overall Study||9
8455675|NCT00734344|20836236|P1|STARTED|Overall Study||9
8455676|NCT00734305|20836306|P7|NOT COMPLETED|Overall Study||0
8455677|NCT00734305|20836307|P6|NOT COMPLETED|Overall Study||0
8455678|NCT00734305|20836308|P5|NOT COMPLETED|Overall Study||0
8455679|NCT00734305|20836309|P4|NOT COMPLETED|Overall Study||0
8455680|NCT00734305|20836310|P3|NOT COMPLETED|Overall Study||0
8455681|NCT00734305|20836311|P2|NOT COMPLETED|Overall Study||0
8455682|NCT00734305|20836312|P1|NOT COMPLETED|Overall Study||1
8455683|NCT00734305|20836306|P7|COMPLETED|Overall Study||18
8455684|NCT00734305|20836307|P6|COMPLETED|Overall Study||4
8455685|NCT00734305|20836308|P5|COMPLETED|Overall Study||5
8455686|NCT00734305|20836309|P4|COMPLETED|Overall Study||3
8455687|NCT00734305|20836310|P3|COMPLETED|Overall Study||4
8455688|NCT00734305|20836311|P2|COMPLETED|Overall Study||3
8455689|NCT00734305|20836312|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
8455690|NCT00734305|20836306|P7|STARTED|Overall Study||18
8455691|NCT00734305|20836307|P6|STARTED|Overall Study||4
8455692|NCT00734305|20836308|P5|STARTED|Overall Study||5
8455693|NCT00734305|20836309|P4|STARTED|Overall Study||3
8455694|NCT00734305|20836310|P3|STARTED|Overall Study||4
8455695|NCT00734305|20836311|P2|STARTED|Overall Study||3
8455696|NCT00734305|20836312|P1|STARTED|Overall Study||7
8455697|NCT00734214|20836343|P2|NOT COMPLETED|Overall Study||4
8455698|NCT00734214|20836344|P1|NOT COMPLETED|Overall Study||4
8455699|NCT00734214|20836343|P2|COMPLETED|Overall Study||126
8455700|NCT00734214|20836344|P1|COMPLETED|Overall Study||124
8455701|NCT00734214|20836343|P2|STARTED|Overall Study||130
8455702|NCT00734214|20836344|P1|STARTED|Overall Study||128
8455703|NCT00734162|20836354|P4|NOT COMPLETED|Open-Label Phase||3
8455704|NCT00734162|20836355|P3|NOT COMPLETED|Open-Label Phase||1
8455705|NCT00734162|20836356|P2|NOT COMPLETED|Open-Label Phase||2
8455706|NCT00734162|20836357|P1|NOT COMPLETED|Open-Label Phase||3
8455707|NCT00734162|20836354|P4|COMPLETED|Open-Label Phase||36
8455708|NCT00734162|20836355|P3|COMPLETED|Open-Label Phase||12
8455709|NCT00734162|20836356|P2|COMPLETED|Open-Label Phase||39
8455710|NCT00734162|20836357|P1|COMPLETED|Open-Label Phase||7
8455711|NCT00734162|20836354|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
8455712|NCT00734162|20836355|P3|STARTED|Open-Label Phase||13
8455713|NCT00734162|20836356|P2|STARTED|Open-Label Phase||41
8455714|NCT00734162|20836357|P1|STARTED|Open-Label Phase||10
8455715|NCT00734162|20836354|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
8455716|NCT00734162|20836355|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
8455717|NCT00734162|20836356|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
8455718|NCT00734162|20836357|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
8455719|NCT00734162|20836354|P4|COMPLETED|Randomized Phase (Through Week 72)||37
8455720|NCT00734162|20836355|P3|COMPLETED|Randomized Phase (Through Week 72)||13
8455721|NCT00734162|20836356|P2|COMPLETED|Randomized Phase (Through Week 72)||41
8455722|NCT00734162|20836357|P1|COMPLETED|Randomized Phase (Through Week 72)||10
8455723|NCT00734162|20836354|P4|STARTED|Randomized Phase (Through Week 72)||41
8455724|NCT00734162|20836355|P3|STARTED|Randomized Phase (Through Week 72)||13
8455725|NCT00734162|20836356|P2|STARTED|Randomized Phase (Through Week 72)||42
8455726|NCT00734162|20836357|P1|STARTED|Randomized Phase (Through Week 72)||10
8455727|NCT00734149|20836581|P1|NOT COMPLETED|Overall Study||1
8455728|NCT00734149|20836581|P1|COMPLETED|Overall Study||44
8455729|NCT00734149|20836581|P1|STARTED|Overall Study||45
8455730|NCT00734097|20836588|P1|NOT COMPLETED|Open Label||16
8455731|NCT00734097|20836588|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
8455732|NCT00734097|20836588|P1|Per Protocol|Open Label||301
8455733|NCT00734097|20836588|P1|Full Analysis|Open Label||311
8455734|NCT00734097|20836588|P1|Safety Analysis|Open Label||317
8455735|NCT00734097|20836588|P1|STARTED|Open Label|Full analysis performed in 311|317
8455736|NCT00734097|20836588|P1|NOT COMPLETED|Screening||20
8455737|NCT00734097|20836588|P1|COMPLETED|Screening|20 participants were screening failure.|317
8455738|NCT00734097|20836588|P1|STARTED|Screening||337
8455739|NCT00734071|20836605|P2|NOT COMPLETED|Overall Study||27
8455740|NCT00734071|20836606|P1|NOT COMPLETED|Overall Study||38
8455741|NCT00734071|20836605|P2|COMPLETED|Overall Study||125
8455742|NCT00734071|20836606|P1|COMPLETED|Overall Study||114
8455743|NCT00734071|20836605|P2|Treated|Overall Study||148
8455744|NCT00734071|20836606|P1|Treated|Overall Study||151
8455745|NCT00734071|20836605|P2|STARTED|Overall Study||152
8455746|NCT00734071|20836606|P1|STARTED|Overall Study||152
8455747|NCT00734032|20836664|P4|NOT COMPLETED|Overall Study||0
8455748|NCT00734032|20836665|P3|NOT COMPLETED|Overall Study||0
8455749|NCT00734032|20836666|P2|NOT COMPLETED|Overall Study||1
8455750|NCT00734032|20836667|P1|NOT COMPLETED|Overall Study||0
8455751|NCT00734032|20836664|P4|COMPLETED|Overall Study||26
8455752|NCT00734032|20836665|P3|COMPLETED|Overall Study||28
8455753|NCT00734032|20836666|P2|COMPLETED|Overall Study||27
8455754|NCT00734032|20836667|P1|COMPLETED|Overall Study||25
8455755|NCT00734032|20836664|P4|STARTED|Overall Study||26
8455756|NCT00734032|20836665|P3|STARTED|Overall Study||28
8455757|NCT00734032|20836666|P2|STARTED|Overall Study||28
8455758|NCT00734032|20836667|P1|STARTED|Overall Study||25
8455759|NCT00733993|20836687|P2|NOT COMPLETED|Overall Study||0
8455760|NCT00733993|20836688|P1|NOT COMPLETED|Overall Study||0
8455761|NCT00733993|20836687|P2|COMPLETED|Overall Study||10
8455762|NCT00733993|20836688|P1|COMPLETED|Overall Study||13
8455763|NCT00733993|20836687|P2|STARTED|Overall Study||10
8455764|NCT00733993|20836688|P1|STARTED|Overall Study||13
8455765|NCT00733980|20836723|P2|NOT COMPLETED|Overall Study||21
8455766|NCT00733980|20836724|P1|NOT COMPLETED|Overall Study||22
8455767|NCT00733980|20836723|P2|COMPLETED|Overall Study||55
8455768|NCT00733980|20836724|P1|COMPLETED|Overall Study||52
8455769|NCT00733980|20836723|P2|STARTED|Overall Study||76
8455770|NCT00733980|20836724|P1|STARTED|Overall Study||74
8455771|NCT00733954|20836768|P2|NOT COMPLETED|Overall Study||2
8455772|NCT00733954|20836769|P1|NOT COMPLETED|Overall Study||8
8455773|NCT00733954|20836768|P2|COMPLETED|Overall Study||123
8455774|NCT00733954|20836769|P1|COMPLETED|Overall Study||116
8455775|NCT00733954|20836768|P2|STARTED|Overall Study||125
8455776|NCT00733954|20836769|P1|STARTED|Overall Study||124
8455777|NCT00733824|20836816|P5|NOT COMPLETED|Phase II||0
8455778|NCT00733824|20836817|P4|NOT COMPLETED|Phase II||0
8455779|NCT00733824|20836818|P3|NOT COMPLETED|Phase II||0
8455780|NCT00733824|20836819|P2|NOT COMPLETED|Phase II||0
8455781|NCT00733824|20836820|P1|NOT COMPLETED|Phase II||0
8455782|NCT00733824|20836816|P5|COMPLETED|Phase II||36
8455783|NCT00733824|20836817|P4|COMPLETED|Phase II||0
8455784|NCT00733824|20836818|P3|COMPLETED|Phase II||0
8455785|NCT00733824|20836819|P2|COMPLETED|Phase II||0
8455786|NCT00733824|20836820|P1|COMPLETED|Phase II||0
8455787|NCT00733824|20836816|P5|STARTED|Phase II||36
8455788|NCT00733824|20836817|P4|STARTED|Phase II||0
8455789|NCT00733824|20836818|P3|STARTED|Phase II||0
8455790|NCT00733824|20836819|P2|STARTED|Phase II||0
8455791|NCT00733824|20836820|P1|STARTED|Phase II||0
8455792|NCT00733824|20836816|P5|NOT COMPLETED|Phase I||0
8455793|NCT00733824|20836817|P4|NOT COMPLETED|Phase I||0
8455794|NCT00733824|20836818|P3|NOT COMPLETED|Phase I||0
8455795|NCT00733824|20836819|P2|NOT COMPLETED|Phase I||0
8455796|NCT00733824|20836820|P1|NOT COMPLETED|Phase I||1
8455797|NCT00733824|20836816|P5|COMPLETED|Phase I||0
8455798|NCT00733824|20836817|P4|COMPLETED|Phase I||6
8455799|NCT00733824|20836818|P3|COMPLETED|Phase I||6
8455800|NCT00733824|20836819|P2|COMPLETED|Phase I||3
8455801|NCT00733824|20836820|P1|COMPLETED|Phase I||9
8455802|NCT00733824|20836816|P5|STARTED|Phase I||0
8455803|NCT00733824|20836817|P4|STARTED|Phase I||6
8455804|NCT00733824|20836818|P3|STARTED|Phase I||6
8455805|NCT00733824|20836819|P2|STARTED|Phase I||3
8455806|NCT00733824|20836820|P1|STARTED|Phase I||10
8455807|NCT00733746|20836839|P1|NOT COMPLETED|Overall Study||5
8455808|NCT00733746|20836839|P1|COMPLETED|Overall Study||114
8455809|NCT00733746|20836839|P1|STARTED|Overall Study||119
8455810|NCT00733512|20836847|P1|NOT COMPLETED|Overall Study||0
8455811|NCT00733512|20836847|P1|COMPLETED|Overall Study||146
8455812|NCT00733512|20836847|P1|STARTED|Overall Study||146
8455813|NCT00733499|20836854|P2|NOT COMPLETED|10 Year Followup||19
8455814|NCT00733499|20836855|P1|NOT COMPLETED|10 Year Followup||20
8455815|NCT00733499|20836854|P2|COMPLETED|10 Year Followup||13
8455816|NCT00733499|20836855|P1|COMPLETED|10 Year Followup||26
8455817|NCT00733499|20836854|P2|STARTED|10 Year Followup||32
8455818|NCT00733499|20836855|P1|STARTED|10 Year Followup||46
8455819|NCT00733499|20836854|P2|NOT COMPLETED|5 Year Followup||25
8455820|NCT00733499|20836855|P1|NOT COMPLETED|5 Year Followup||21
8455821|NCT00733499|20836854|P2|COMPLETED|5 Year Followup||53
8455822|NCT00733499|20836855|P1|COMPLETED|5 Year Followup||70
8455823|NCT00733499|20836854|P2|STARTED|5 Year Followup||78
8455824|NCT00733499|20836855|P1|STARTED|5 Year Followup||91
8455825|NCT00733499|20836854|P2|NOT COMPLETED|24 Months Follow-up||1
8455826|NCT00733499|20836855|P1|NOT COMPLETED|24 Months Follow-up||0
8455827|NCT00733499|20836854|P2|COMPLETED|24 Months Follow-up||95
8455828|NCT00733499|20836855|P1|COMPLETED|24 Months Follow-up||99
8455829|NCT00733499|20836854|P2|STARTED|24 Months Follow-up||96
8455830|NCT00733499|20836855|P1|STARTED|24 Months Follow-up||99
8455831|NCT00733499|20836854|P2|NOT COMPLETED|12 Months Follow-up||1
8455832|NCT00733499|20836855|P1|NOT COMPLETED|12 Months Follow-up||2
8455833|NCT00733499|20836854|P2|COMPLETED|12 Months Follow-up||96
8455834|NCT00733499|20836855|P1|COMPLETED|12 Months Follow-up||99
8455835|NCT00733499|20836854|P2|STARTED|12 Months Follow-up||97
8455836|NCT00733499|20836855|P1|STARTED|12 Months Follow-up||101
8455837|NCT00733499|20836854|P2|NOT COMPLETED|6 Months Follow-up||3
8455838|NCT00733499|20836855|P1|NOT COMPLETED|6 Months Follow-up||0
8455839|NCT00733499|20836854|P2|COMPLETED|6 Months Follow-up||97
8455840|NCT00733499|20836855|P1|COMPLETED|6 Months Follow-up||101
8455841|NCT00733499|20836854|P2|STARTED|6 Months Follow-up||100
8455842|NCT00733499|20836855|P1|STARTED|6 Months Follow-up||101
8455843|NCT00733499|20836854|P2|NOT COMPLETED|3 Months Follow-up||2
8455844|NCT00733499|20836855|P1|NOT COMPLETED|3 Months Follow-up||1
8455845|NCT00733499|20836854|P2|COMPLETED|3 Months Follow-up||100
8455846|NCT00733499|20836855|P1|COMPLETED|3 Months Follow-up||101
8455847|NCT00733499|20836854|P2|STARTED|3 Months Follow-up||102
8455848|NCT00733499|20836855|P1|STARTED|3 Months Follow-up||102
8455849|NCT00733499|20836854|P2|NOT COMPLETED|Pre-operative||1
8455850|NCT00733499|20836855|P1|NOT COMPLETED|Pre-operative||0
8455851|NCT00733499|20836854|P2|COMPLETED|Pre-operative||102
8455852|NCT00733499|20836855|P1|COMPLETED|Pre-operative||102
8455853|NCT00733499|20836854|P2|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
8455854|NCT00733499|20836855|P1|STARTED|Pre-operative||102
8455855|NCT00733421|20836915|P2|NOT COMPLETED|Overall Study||1
8455856|NCT00733421|20836916|P1|NOT COMPLETED|Overall Study||1
8455857|NCT00733421|20836915|P2|COMPLETED|Overall Study|All but one randomised patient|49
8455858|NCT00733421|20836916|P1|COMPLETED|Overall Study|All but one randomsied patient|49
8455859|NCT00733421|20836915|P2|STARTED|Overall Study|November 2008|50
8455860|NCT00733421|20836916|P1|STARTED|Overall Study|November 2008|50
8455861|NCT00733408|20836938|P1|NOT COMPLETED|Overall Study||4
8455862|NCT00733408|20836938|P1|COMPLETED|Overall Study||55
8455863|NCT00733408|20836938|P1|STARTED|Overall Study||59
8455864|NCT00733369|20836950|P2|NOT COMPLETED|Overall Study||9
8455865|NCT00733369|20836951|P1|NOT COMPLETED|Overall Study||10
8455866|NCT00733369|20836950|P2|COMPLETED|Overall Study||47
8455867|NCT00733369|20836951|P1|COMPLETED|Overall Study||40
8455868|NCT00733369|20836950|P2|STARTED|Overall Study||56
8455869|NCT00733369|20836951|P1|STARTED|Overall Study||50
8455870|NCT00733356|20837067|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
8455871|NCT00733356|20837067|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
8455872|NCT00733356|20837067|P1|STARTED|Modified Lab School, Reading Evaluation||26
8455873|NCT00733356|20837067|P1|NOT COMPLETED|Vyvanse Dose Titration||2
8455874|NCT00733356|20837067|P1|COMPLETED|Vyvanse Dose Titration||26
8455875|NCT00733356|20837067|P1|STARTED|Vyvanse Dose Titration||28
8455876|NCT00733343|20837073|P2|NOT COMPLETED|Overall Study||81
8455877|NCT00733343|20837074|P1|NOT COMPLETED|Overall Study||83
8455878|NCT00733343|20837073|P2|COMPLETED|Overall Study||578
8455879|NCT00733343|20837074|P1|COMPLETED|Overall Study||583
8455880|NCT00733343|20837073|P2|STARTED|Overall Study||659
8455881|NCT00733343|20837074|P1|STARTED|Overall Study||666
8455882|NCT00733330|20837164|P2|NOT COMPLETED|Overall Study||4
8455883|NCT00733330|20837165|P1|NOT COMPLETED|Overall Study||2
8455884|NCT00733330|20837164|P2|COMPLETED|Overall Study||48
8455885|NCT00733330|20837165|P1|COMPLETED|Overall Study||30
8455886|NCT00733330|20837164|P2|STARTED|Overall Study||52
8455887|NCT00733330|20837165|P1|STARTED|Overall Study||32
8455888|NCT00733304|20837250|P3|NOT COMPLETED|Overall Study||5
8455889|NCT00733304|20837251|P2|NOT COMPLETED|Overall Study||3
8455890|NCT00733304|20837252|P1|NOT COMPLETED|Overall Study||7
8455891|NCT00733304|20837250|P3|COMPLETED|Overall Study||3
8455892|NCT00733304|20837251|P2|COMPLETED|Overall Study||12
8455893|NCT00733304|20837252|P1|COMPLETED|Overall Study||12
8455894|NCT00733304|20837250|P3|STARTED|Overall Study||8
8455895|NCT00733304|20837251|P2|STARTED|Overall Study||15
8455896|NCT00733304|20837252|P1|STARTED|Overall Study||19
8455897|NCT00733291|20837334|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455898|NCT00733291|20837335|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455899|NCT00733291|20837336|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455900|NCT00733291|20837337|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455901|NCT00733291|20837334|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455902|NCT00733291|20837335|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455903|NCT00733291|20837336|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455904|NCT00733291|20837337|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
8455905|NCT00733291|20837334|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455906|NCT00733291|20837335|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455907|NCT00733291|20837336|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455908|NCT00733291|20837337|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
8455909|NCT00733291|20837334|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8455910|NCT00733291|20837335|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8455911|NCT00733291|20837336|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8455912|NCT00733291|20837337|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
8455913|NCT00733291|20837334|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8455914|NCT00733291|20837335|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8455915|NCT00733291|20837336|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8455916|NCT00733291|20837337|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
8455917|NCT00733291|20837334|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8455918|NCT00733291|20837335|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8455919|NCT00733291|20837336|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8455920|NCT00733291|20837337|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
8455921|NCT00733291|20837334|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455922|NCT00733291|20837335|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455923|NCT00733291|20837336|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455924|NCT00733291|20837337|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455925|NCT00733291|20837334|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455926|NCT00733291|20837335|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455927|NCT00733291|20837336|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455928|NCT00733291|20837337|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
8455929|NCT00733291|20837334|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455930|NCT00733291|20837335|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455931|NCT00733291|20837336|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455932|NCT00733291|20837337|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
8455933|NCT00733278|20837359|P1|NOT COMPLETED|Overall Study||0
8455934|NCT00733278|20837359|P1|COMPLETED|Overall Study||7
8455935|NCT00733278|20837359|P1|STARTED|Overall Study||7
8455936|NCT00733226|20837366|P2|NOT COMPLETED|Overall Study||0
8455937|NCT00733226|20837367|P1|NOT COMPLETED|Overall Study||5
8455938|NCT00733226|20837366|P2|COMPLETED|Overall Study||40
8455939|NCT00733226|20837367|P1|COMPLETED|Overall Study||35
8455940|NCT00733226|20837366|P2|STARTED|Overall Study||40
8455941|NCT00733226|20837367|P1|STARTED|Overall Study||40
8455942|NCT00733135|20837383|P1|NOT COMPLETED|Overall Study||2
8455943|NCT00733135|20837383|P1|COMPLETED|Overall Study||131
8455944|NCT00733135|20837383|P1|STARTED|Overall Study||133
8455945|NCT00733096|20837395|P3|NOT COMPLETED|Overall Study||0
8455946|NCT00733096|20837396|P2|NOT COMPLETED|Overall Study||0
8455947|NCT00733096|20837397|P1|NOT COMPLETED|Overall Study||0
8455948|NCT00733096|20837395|P3|COMPLETED|Overall Study||30
8455949|NCT00733096|20837396|P2|COMPLETED|Overall Study||26
8455950|NCT00733096|20837397|P1|COMPLETED|Overall Study||28
8455951|NCT00733096|20837395|P3|STARTED|Overall Study||30
8455952|NCT00733096|20837396|P2|STARTED|Overall Study||26
8455953|NCT00733096|20837397|P1|STARTED|Overall Study||28
8455954|NCT00733005|20837416|P2|NOT COMPLETED|Overall Study||3
8455955|NCT00733005|20837417|P1|NOT COMPLETED|Overall Study||2
8455956|NCT00733005|20837416|P2|COMPLETED|Overall Study||159
8455957|NCT00733005|20837417|P1|COMPLETED|Overall Study||160
8455958|NCT00733005|20837416|P2|STARTED|Overall Study||162
8455959|NCT00733005|20837417|P1|STARTED|Overall Study||162
8455960|NCT00732992|20837427|P2|NOT COMPLETED|Overall Study||6
8455961|NCT00732992|20837428|P1|NOT COMPLETED|Overall Study||6
8455962|NCT00732992|20837427|P2|COMPLETED|Overall Study||0
8455963|NCT00732992|20837428|P1|COMPLETED|Overall Study||0
8455964|NCT00732992|20837427|P2|STARTED|Overall Study||6
8455965|NCT00732992|20837428|P1|STARTED|Overall Study||6
8455966|NCT00732940|20837447|P2|NOT COMPLETED|Overall Study||3
8455967|NCT00732940|20837448|P1|NOT COMPLETED|Overall Study||2
8455968|NCT00732940|20837447|P2|COMPLETED|Overall Study||25
8455969|NCT00732940|20837448|P1|COMPLETED|Overall Study||26
8455970|NCT00732940|20837447|P2|STARTED|Overall Study||28
8455971|NCT00732940|20837448|P1|STARTED|Overall Study||28
8455972|NCT00732901|20837518|P2|NOT COMPLETED|Overall Study||0
8455973|NCT00732901|20837519|P1|NOT COMPLETED|Overall Study||0
8455974|NCT00732901|20837518|P2|COMPLETED|Overall Study||12
8455975|NCT00732901|20837519|P1|COMPLETED|Overall Study||11
8455976|NCT00732901|20837518|P2|STARTED|Overall Study||12
8455977|NCT00732901|20837519|P1|STARTED|Overall Study||11
8455978|NCT00732875|20837529|P1|NOT COMPLETED|Overall Study||35
8455979|NCT00732875|20837529|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
8455980|NCT00732875|20837529|P1|STARTED|Overall Study||92
8455981|NCT00732758|20837537|P2|NOT COMPLETED|Overall Study||16
8455982|NCT00732758|20837538|P1|NOT COMPLETED|Overall Study||8
8455983|NCT00732758|20837537|P2|COMPLETED|Overall Study||63
8455984|NCT00732758|20837538|P1|COMPLETED|Overall Study||70
8455985|NCT00732758|20837537|P2|STARTED|Overall Study||79
8455986|NCT00732758|20837538|P1|STARTED|Overall Study||78
8455987|NCT00732680|20837550|P1|NOT COMPLETED|Overall Study||0
8455988|NCT00732680|20837550|P1|COMPLETED|Overall Study||9
8455989|NCT00732680|20837550|P1|STARTED|Overall Study||9
8455990|NCT00732654|20837557|P3|NOT COMPLETED|Overall Study||0
8455991|NCT00732654|20837558|P2|NOT COMPLETED|Overall Study||1
8455992|NCT00732654|20837559|P1|NOT COMPLETED|Overall Study||0
8455993|NCT00732654|20837557|P3|COMPLETED|Overall Study||10
8455994|NCT00732654|20837558|P2|COMPLETED|Overall Study||9
8455995|NCT00732654|20837559|P1|COMPLETED|Overall Study||10
8455996|NCT00732654|20837557|P3|STARTED|Overall Study||10
8455997|NCT00732654|20837558|P2|STARTED|Overall Study||10
8455998|NCT00732654|20837559|P1|STARTED|Overall Study||10
8455999|NCT00732641|20837578|P2|NOT COMPLETED|Overall Study||112
8456000|NCT00732641|20837579|P1|NOT COMPLETED|Overall Study||106
8456001|NCT00732641|20837578|P2|COMPLETED|Overall Study||9
8456002|NCT00732641|20837579|P1|COMPLETED|Overall Study||17
8456003|NCT00732641|20837578|P2|STARTED|Overall Study||121
8456004|NCT00732641|20837579|P1|STARTED|Overall Study||123
8456005|NCT00732615|20837599|P2|NOT COMPLETED|Overall Study||5
8456006|NCT00732615|20837600|P1|NOT COMPLETED|Overall Study||7
8456007|NCT00732615|20837599|P2|COMPLETED|Overall Study||79
8456008|NCT00732615|20837600|P1|COMPLETED|Overall Study||33
8456009|NCT00732615|20837599|P2|STARTED|Overall Study||84
8456010|NCT00732615|20837600|P1|STARTED|Overall Study||40
8456011|NCT00732498|20837612|P1|NOT COMPLETED|Overall Study||6
8456012|NCT00732498|20837612|P1|COMPLETED|Overall Study||22
8456013|NCT00732498|20837612|P1|STARTED|Overall Study||28
8456014|NCT00732472|20837623|P4|NOT COMPLETED|Overall Study||3
8456015|NCT00732472|20837624|P3|NOT COMPLETED|Overall Study||1
8456016|NCT00732472|20837625|P2|NOT COMPLETED|Overall Study||3
8456017|NCT00732472|20837626|P1|NOT COMPLETED|Overall Study||0
8456018|NCT00732472|20837623|P4|COMPLETED|Overall Study||6
8456019|NCT00732472|20837624|P3|COMPLETED|Overall Study||9
8456020|NCT00732472|20837625|P2|COMPLETED|Overall Study||7
8456021|NCT00732472|20837626|P1|COMPLETED|Overall Study||9
8456022|NCT00732472|20837623|P4|STARTED|Overall Study||9
8456023|NCT00732472|20837624|P3|STARTED|Overall Study||10
8456024|NCT00732472|20837625|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
8456025|NCT00732472|20837626|P1|STARTED|Overall Study||9
8456026|NCT00732381|20837726|P2|NOT COMPLETED|Overall Study||1
8456027|NCT00732381|20837727|P1|NOT COMPLETED|Overall Study||2
8456028|NCT00732381|20837726|P2|COMPLETED|Overall Study||174
8456029|NCT00732381|20837727|P1|COMPLETED|Overall Study||174
8456030|NCT00732381|20837726|P2|STARTED|Overall Study||175
8456031|NCT00732381|20837727|P1|STARTED|Overall Study||176
8456032|NCT00732303|20837735|P1|NOT COMPLETED|Overall Study||2
8456033|NCT00732303|20837735|P1|COMPLETED|Overall Study||6
8456034|NCT00732303|20837735|P1|STARTED|Overall Study||8
8456035|NCT00732251|20837741|P1|NOT COMPLETED|Overall Study||7
8456036|NCT00732251|20837741|P1|COMPLETED|Overall Study||1
8456037|NCT00732251|20837741|P1|STARTED|Overall Study||8
8456038|NCT00732238|20837749|P2|NOT COMPLETED|Overall Study||1
8456039|NCT00732238|20837750|P1|NOT COMPLETED|Overall Study||5
8456040|NCT00732238|20837749|P2|COMPLETED|Overall Study||27
8456041|NCT00732238|20837750|P1|COMPLETED|Overall Study||28
8456042|NCT00732238|20837749|P2|STARTED|Overall Study||28
8456043|NCT00732238|20837750|P1|STARTED|Overall Study||33
8456044|NCT00732225|20837763|P5|NOT COMPLETED|Overall Study||6
8456045|NCT00732225|20837764|P4|NOT COMPLETED|Overall Study||4
8456046|NCT00732225|20837765|P3|NOT COMPLETED|Overall Study||3
8456047|NCT00732225|20837766|P2|NOT COMPLETED|Overall Study||8
8456048|NCT00732225|20837767|P1|NOT COMPLETED|Overall Study||11
8456049|NCT00732225|20837763|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
8456050|NCT00732225|20837764|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
8456051|NCT00732225|20837765|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
8456052|NCT00732225|20837766|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
8456053|NCT00732225|20837767|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
8456054|NCT00732225|20837763|P5|STARTED|Overall Study|55 eyes of 54 patients|54
8456055|NCT00732225|20837764|P4|STARTED|Overall Study|33 eyes of 33 patients|33
8456056|NCT00732225|20837765|P3|STARTED|Overall Study|26 eyes of 26 patients|26
8456057|NCT00732225|20837766|P2|STARTED|Overall Study|41 eyes of 40 patients|40
8456058|NCT00732225|20837767|P1|STARTED|Overall Study|76 eyes of 71 patients|71
8456059|NCT00732212|20837818|P2|NOT COMPLETED|Overall Study||0
8456060|NCT00732212|20837819|P1|NOT COMPLETED|Overall Study||0
8456061|NCT00732212|20837818|P2|COMPLETED|Overall Study||123
8456062|NCT00732212|20837819|P1|COMPLETED|Overall Study||112
8456063|NCT00732212|20837818|P2|Temporarily Suspended|Overall Study||50
8456064|NCT00732212|20837819|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
8456065|NCT00732212|20837818|P2|STARTED|Overall Study||123
8456066|NCT00732212|20837819|P1|STARTED|Overall Study||112
8456067|NCT00732199|20837851|P2|NOT COMPLETED|Overall Study||26
8456068|NCT00732199|20837852|P1|NOT COMPLETED|Overall Study||34
8456069|NCT00732199|20837851|P2|COMPLETED|Overall Study||16
8456070|NCT00732199|20837852|P1|COMPLETED|Overall Study||16
8456071|NCT00732199|20837851|P2|STARTED|Overall Study||42
8456072|NCT00732199|20837852|P1|STARTED|Overall Study||50
8456073|NCT00732160|20837867|P4|NOT COMPLETED|Overall Study||2
8456074|NCT00732160|20837868|P3|NOT COMPLETED|Overall Study||3
8456075|NCT00732160|20837869|P2|NOT COMPLETED|Overall Study||4
8456076|NCT00732160|20837870|P1|NOT COMPLETED|Overall Study||5
8456077|NCT00732160|20837867|P4|COMPLETED|Overall Study||3
8456078|NCT00732160|20837868|P3|COMPLETED|Overall Study||3
8456079|NCT00732160|20837869|P2|COMPLETED|Overall Study||1
8456080|NCT00732160|20837870|P1|COMPLETED|Overall Study||2
8456081|NCT00732160|20837867|P4|LS Aldosterone|Overall Study||5
8456082|NCT00732160|20837868|P3|LS Aldosterone|Overall Study||6
8456083|NCT00732160|20837869|P2|LS Aldosterone|Overall Study||1
8456084|NCT00732160|20837870|P1|LS Aldosterone|Overall Study||2
8456085|NCT00732160|20837867|P4|LS Vehicle|Overall Study||5
8456086|NCT00732160|20837868|P3|LS Vehicle|Overall Study||6
8456087|NCT00732160|20837869|P2|LS Vehicle|Overall Study||1
8456088|NCT00732160|20837870|P1|LS Vehicle|Overall Study||2
8456089|NCT00732160|20837867|P4|HS Aldosterone|Overall Study||3
8456090|NCT00732160|20837868|P3|HS Aldosterone|Overall Study||3
8456091|NCT00732160|20837869|P2|HS Aldosterone|Overall Study||5
8456092|NCT00732160|20837870|P1|HS Aldosterone|Overall Study||7
8456093|NCT00732160|20837867|P4|HS Vehicle|Overall Study||3
8456094|NCT00732160|20837868|P3|HS Vehicle|Overall Study||3
8456095|NCT00732160|20837869|P2|HS Vehicle|Overall Study||5
8456096|NCT00732160|20837870|P1|HS Vehicle|Overall Study||7
8456097|NCT00732160|20837867|P4|STARTED|Overall Study||5
8456098|NCT00732160|20837868|P3|STARTED|Overall Study||6
8456099|NCT00732160|20837869|P2|STARTED|Overall Study||5
8456100|NCT00732160|20837870|P1|STARTED|Overall Study||7
8456101|NCT00732069|20837884|P6|NOT COMPLETED|Third Study Drug||0
8456102|NCT00732069|20837885|P5|NOT COMPLETED|Third Study Drug||0
8456103|NCT00732069|20837886|P4|NOT COMPLETED|Third Study Drug||0
8456104|NCT00732069|20837887|P3|NOT COMPLETED|Third Study Drug||0
8456105|NCT00732069|20837888|P2|NOT COMPLETED|Third Study Drug||0
8456106|NCT00732069|20837889|P1|NOT COMPLETED|Third Study Drug||0
8456107|NCT00732069|20837884|P6|COMPLETED|Third Study Drug||2
8456108|NCT00732069|20837885|P5|COMPLETED|Third Study Drug||3
8456109|NCT00732069|20837886|P4|COMPLETED|Third Study Drug||2
8456110|NCT00732069|20837887|P3|COMPLETED|Third Study Drug||3
8456111|NCT00732069|20837888|P2|COMPLETED|Third Study Drug||3
8456112|NCT00732069|20837889|P1|COMPLETED|Third Study Drug||2
8456113|NCT00732069|20837884|P6|STARTED|Third Study Drug||2
8456114|NCT00732069|20837885|P5|STARTED|Third Study Drug||3
8456115|NCT00732069|20837886|P4|STARTED|Third Study Drug||2
8456116|NCT00732069|20837887|P3|STARTED|Third Study Drug||3
8456117|NCT00732069|20837888|P2|STARTED|Third Study Drug||3
8456118|NCT00732069|20837889|P1|STARTED|Third Study Drug||2
8456119|NCT00732069|20837884|P6|NOT COMPLETED|Washout After Second Study Drug||0
8456120|NCT00732069|20837885|P5|NOT COMPLETED|Washout After Second Study Drug||0
8456121|NCT00732069|20837886|P4|NOT COMPLETED|Washout After Second Study Drug||0
8456122|NCT00732069|20837887|P3|NOT COMPLETED|Washout After Second Study Drug||0
8456123|NCT00732069|20837888|P2|NOT COMPLETED|Washout After Second Study Drug||0
8456124|NCT00732069|20837889|P1|NOT COMPLETED|Washout After Second Study Drug||0
8456125|NCT00732069|20837884|P6|COMPLETED|Washout After Second Study Drug||2
8456126|NCT00732069|20837885|P5|COMPLETED|Washout After Second Study Drug||3
8456127|NCT00732069|20837886|P4|COMPLETED|Washout After Second Study Drug||2
8456128|NCT00732069|20837887|P3|COMPLETED|Washout After Second Study Drug||3
8456129|NCT00732069|20837888|P2|COMPLETED|Washout After Second Study Drug||3
8456130|NCT00732069|20837889|P1|COMPLETED|Washout After Second Study Drug||2
8456131|NCT00732069|20837884|P6|STARTED|Washout After Second Study Drug||2
8456132|NCT00732069|20837885|P5|STARTED|Washout After Second Study Drug||3
8456133|NCT00732069|20837886|P4|STARTED|Washout After Second Study Drug||2
8456134|NCT00732069|20837887|P3|STARTED|Washout After Second Study Drug||3
8456135|NCT00732069|20837888|P2|STARTED|Washout After Second Study Drug||3
8456136|NCT00732069|20837889|P1|STARTED|Washout After Second Study Drug||2
8456137|NCT00732069|20837884|P6|NOT COMPLETED|Second Study Drug||0
8456138|NCT00732069|20837885|P5|NOT COMPLETED|Second Study Drug||0
8456139|NCT00732069|20837886|P4|NOT COMPLETED|Second Study Drug||0
8456140|NCT00732069|20837887|P3|NOT COMPLETED|Second Study Drug||0
8456141|NCT00732069|20837888|P2|NOT COMPLETED|Second Study Drug||0
8456142|NCT00732069|20837889|P1|NOT COMPLETED|Second Study Drug||0
8456143|NCT00732069|20837884|P6|COMPLETED|Second Study Drug||2
8456144|NCT00732069|20837885|P5|COMPLETED|Second Study Drug||3
8456145|NCT00732069|20837886|P4|COMPLETED|Second Study Drug||2
8456146|NCT00732069|20837887|P3|COMPLETED|Second Study Drug||3
8456147|NCT00732069|20837888|P2|COMPLETED|Second Study Drug||3
8456148|NCT00732069|20837889|P1|COMPLETED|Second Study Drug||2
8456149|NCT00732069|20837884|P6|STARTED|Second Study Drug||2
8456150|NCT00732069|20837885|P5|STARTED|Second Study Drug||3
8456151|NCT00732069|20837886|P4|STARTED|Second Study Drug||2
8456152|NCT00732069|20837887|P3|STARTED|Second Study Drug||3
8456153|NCT00732069|20837888|P2|STARTED|Second Study Drug||3
8456154|NCT00732069|20837889|P1|STARTED|Second Study Drug||2
8456155|NCT00732069|20837884|P6|NOT COMPLETED|Washout After First Study Drug||0
8456156|NCT00732069|20837885|P5|NOT COMPLETED|Washout After First Study Drug||0
8456157|NCT00732069|20837886|P4|NOT COMPLETED|Washout After First Study Drug||0
8456158|NCT00732069|20837887|P3|NOT COMPLETED|Washout After First Study Drug||0
8456159|NCT00732069|20837888|P2|NOT COMPLETED|Washout After First Study Drug||0
8456160|NCT00732069|20837889|P1|NOT COMPLETED|Washout After First Study Drug||1
8456161|NCT00732069|20837884|P6|COMPLETED|Washout After First Study Drug||2
8456162|NCT00732069|20837885|P5|COMPLETED|Washout After First Study Drug||3
8456163|NCT00732069|20837886|P4|COMPLETED|Washout After First Study Drug||2
8456164|NCT00732069|20837887|P3|COMPLETED|Washout After First Study Drug||3
8456165|NCT00732069|20837888|P2|COMPLETED|Washout After First Study Drug||3
8456166|NCT00732069|20837889|P1|COMPLETED|Washout After First Study Drug||2
8456167|NCT00732069|20837884|P6|STARTED|Washout After First Study Drug||2
8456168|NCT00732069|20837885|P5|STARTED|Washout After First Study Drug||3
8456169|NCT00732069|20837886|P4|STARTED|Washout After First Study Drug||2
8456170|NCT00732069|20837887|P3|STARTED|Washout After First Study Drug||3
8456171|NCT00732069|20837888|P2|STARTED|Washout After First Study Drug||3
8456172|NCT00732069|20837889|P1|STARTED|Washout After First Study Drug||3
8456173|NCT00732069|20837884|P6|NOT COMPLETED|First Study Drug||0
8456174|NCT00732069|20837885|P5|NOT COMPLETED|First Study Drug||0
8456175|NCT00732069|20837886|P4|NOT COMPLETED|First Study Drug||0
8456176|NCT00732069|20837887|P3|NOT COMPLETED|First Study Drug||0
8456177|NCT00732069|20837888|P2|NOT COMPLETED|First Study Drug||0
8456178|NCT00732069|20837889|P1|NOT COMPLETED|First Study Drug||0
8456179|NCT00732069|20837884|P6|COMPLETED|First Study Drug||2
8456180|NCT00732069|20837885|P5|COMPLETED|First Study Drug||3
8456181|NCT00732069|20837886|P4|COMPLETED|First Study Drug||2
8456182|NCT00732069|20837887|P3|COMPLETED|First Study Drug||3
8456183|NCT00732069|20837888|P2|COMPLETED|First Study Drug||3
8456184|NCT00732069|20837889|P1|COMPLETED|First Study Drug||3
8456185|NCT00732069|20837884|P6|STARTED|First Study Drug||2
8456186|NCT00732069|20837885|P5|STARTED|First Study Drug||3
8456187|NCT00732069|20837886|P4|STARTED|First Study Drug||2
8456188|NCT00732069|20837887|P3|STARTED|First Study Drug||3
8456189|NCT00732069|20837888|P2|STARTED|First Study Drug||3
8456190|NCT00732069|20837889|P1|STARTED|First Study Drug||3
8456191|NCT00732030|20837900|P1|NOT COMPLETED|Overall Study||2
8456192|NCT00732030|20837900|P1|COMPLETED|Overall Study||24
8456193|NCT00732030|20837900|P1|STARTED|Overall Study||26
8456194|NCT00731939|20837907|P1|NOT COMPLETED|Overall Study||34
8456195|NCT00731939|20837907|P1|COMPLETED|Overall Study||90
8456196|NCT00731939|20837907|P1|STARTED|Overall Study||124
8456197|NCT00731874|20837957|P2|NOT COMPLETED|Overall Study||0
8456198|NCT00731874|20837958|P1|NOT COMPLETED|Overall Study||0
8456199|NCT00731874|20837957|P2|COMPLETED|Overall Study||13
8456200|NCT00731874|20837958|P1|COMPLETED|Overall Study||10
8456201|NCT00731874|20837957|P2|STARTED|Overall Study||13
8456202|NCT00731874|20837958|P1|STARTED|Overall Study||10
8456203|NCT00731822|20837984|P2|NOT COMPLETED|Overall Study||1
8456204|NCT00731822|20837985|P1|NOT COMPLETED|Overall Study||4
8456205|NCT00731822|20837984|P2|COMPLETED|Overall Study||39
8456206|NCT00731822|20837985|P1|COMPLETED|Overall Study||16
8456207|NCT00731822|20837984|P2|STARTED|Overall Study||40
8456208|NCT00731822|20837985|P1|STARTED|Overall Study||20
8456209|NCT00731783|20837999|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
8456210|NCT00731783|20838000|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
8456211|NCT00731783|20837999|P2|COMPLETED|12 Month Follow-Up Visit||58
8456212|NCT00731783|20838000|P1|COMPLETED|12 Month Follow-Up Visit||68
8456213|NCT00731783|20837999|P2|STARTED|12 Month Follow-Up Visit||65
8456214|NCT00731783|20838000|P1|STARTED|12 Month Follow-Up Visit||74
8456215|NCT00731783|20837999|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
8456216|NCT00731783|20838000|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
8456217|NCT00731783|20837999|P2|COMPLETED|Six Month Follow-Up Visit||64
8456218|NCT00731783|20838000|P1|COMPLETED|Six Month Follow-Up Visit||71
8456219|NCT00731783|20837999|P2|STARTED|Six Month Follow-Up Visit||67
8456220|NCT00731783|20838000|P1|STARTED|Six Month Follow-Up Visit||77
8456221|NCT00731783|20837999|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
8456222|NCT00731783|20838000|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
8456223|NCT00731783|20837999|P2|COMPLETED|Three Month Follow-Up Visit||57
8456224|NCT00731783|20838000|P1|COMPLETED|Three Month Follow-Up Visit||72
8456225|NCT00731783|20837999|P2|STARTED|Three Month Follow-Up Visit||73
8456226|NCT00731783|20838000|P1|STARTED|Three Month Follow-Up Visit||79
8456227|NCT00731783|20837999|P2|NOT COMPLETED|One Month Follow-Up Visit||22
8456228|NCT00731783|20838000|P1|NOT COMPLETED|One Month Follow-Up Visit||14
8456229|NCT00731783|20837999|P2|COMPLETED|One Month Follow-Up Visit||69
8456230|NCT00731783|20838000|P1|COMPLETED|One Month Follow-Up Visit||78
8456231|NCT00731783|20837999|P2|STARTED|One Month Follow-Up Visit||91
8456232|NCT00731783|20838000|P1|STARTED|One Month Follow-Up Visit||92
8456233|NCT00731770|20838022|P2|NOT COMPLETED|Overall Study||0
8456234|NCT00731770|20838023|P1|NOT COMPLETED|Overall Study||0
8456235|NCT00731770|20838022|P2|COMPLETED|Overall Study||5
8456236|NCT00731770|20838023|P1|COMPLETED|Overall Study||5
8456237|NCT00731770|20838022|P2|STARTED|Overall Study||5
8456238|NCT00731770|20838023|P1|STARTED|Overall Study||5
8456239|NCT00731731|20838034|P3|NOT COMPLETED|Overall Study||3
8456240|NCT00731731|20838035|P2|NOT COMPLETED|Overall Study||0
8456241|NCT00731731|20838036|P1|NOT COMPLETED|Overall Study||0
8456242|NCT00731731|20838034|P3|COMPLETED|Overall Study||107
8456243|NCT00731731|20838035|P2|COMPLETED|Overall Study||3
8456244|NCT00731731|20838036|P1|COMPLETED|Overall Study||12
8456245|NCT00731731|20838034|P3|STARTED|Overall Study||110
8456246|NCT00731731|20838035|P2|STARTED|Overall Study||3
8456247|NCT00731731|20838036|P1|STARTED|Overall Study||12
8456248|NCT00731692|20838054|P3|NOT COMPLETED|Extension Phase||301
8456249|NCT00731692|20838055|P2|NOT COMPLETED|Extension Phase||196
8456250|NCT00731692|20838056|P1|NOT COMPLETED|Extension Phase||74
8456251|NCT00731692|20838054|P3|COMPLETED|Extension Phase||0
8456252|NCT00731692|20838055|P2|COMPLETED|Extension Phase||0
8456253|NCT00731692|20838056|P1|COMPLETED|Extension Phase||0
8456254|NCT00731692|20838054|P3|STARTED|Extension Phase||301
8456255|NCT00731692|20838055|P2|STARTED|Extension Phase||196
8456256|NCT00731692|20838056|P1|STARTED|Extension Phase||74
8456257|NCT00731692|20838054|P3|NOT COMPLETED|Core Study (36 Months)||170
8456258|NCT00731692|20838055|P2|NOT COMPLETED|Core Study (36 Months)||116
8456259|NCT00731692|20838056|P1|NOT COMPLETED|Core Study (36 Months)||68
8456260|NCT00731692|20838054|P3|COMPLETED|Core Study (36 Months)||317
8456261|NCT00731692|20838055|P2|COMPLETED|Core Study (36 Months)||220
8456262|NCT00731692|20838056|P1|COMPLETED|Core Study (36 Months)||79
8456263|NCT00731692|20838054|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
8456264|NCT00731692|20838055|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
8456265|NCT00731692|20838056|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
8456266|NCT00731692|20838054|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
8456267|NCT00731692|20838055|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
8456268|NCT00731692|20838056|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
8456269|NCT00731692|20838054|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
8456270|NCT00731692|20838055|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
8456271|NCT00731692|20838056|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
8456272|NCT00731692|20838054|P3|Safety Set (SAF)|Core Study (36 Months)||487
8456273|NCT00731692|20838055|P2|Safety Set (SAF)|Core Study (36 Months)||336
8456274|NCT00731692|20838056|P1|Safety Set (SAF)|Core Study (36 Months)||0
8456275|NCT00731692|20838054|P3|STARTED|Core Study (36 Months)||487
8456276|NCT00731692|20838055|P2|STARTED|Core Study (36 Months)||336
8456277|NCT00731692|20838056|P1|STARTED|Core Study (36 Months)||147
8456278|NCT00731679|20838102|P2|NOT COMPLETED|Overall Study||26
8456279|NCT00731679|20838103|P1|NOT COMPLETED|Overall Study||22
8456280|NCT00731679|20838102|P2|COMPLETED|Overall Study||283
8456281|NCT00731679|20838103|P1|COMPLETED|Overall Study||292
8456282|NCT00731679|20838102|P2|STARTED|Overall Study||309
8456283|NCT00731679|20838103|P1|STARTED|Overall Study||314
8456284|NCT00731666|20838111|P1|NOT COMPLETED|Overall Study||12
8456285|NCT00731666|20838111|P1|COMPLETED|Overall Study||28
8456286|NCT00731666|20838111|P1|STARTED|Overall Study||40
8456287|NCT00731653|20838117|P1|NOT COMPLETED|Overall Study||9
8456288|NCT00731653|20838117|P1|COMPLETED|Overall Study||72
8456289|NCT00731653|20838117|P1|STARTED|Overall Study||81
8456290|NCT00731640|20838123|P2|NOT COMPLETED|Overall Study||0
8456291|NCT00731640|20838124|P1|NOT COMPLETED|Overall Study||0
8456292|NCT00731640|20838123|P2|COMPLETED|Overall Study||32
8456293|NCT00731640|20838124|P1|COMPLETED|Overall Study||20
8456294|NCT00731640|20838123|P2|STARTED|Overall Study||32
8456295|NCT00731640|20838124|P1|STARTED|Overall Study||20
8456296|NCT00731614|20838138|P2|NOT COMPLETED|Overall Study||13
8456297|NCT00731614|20838139|P1|NOT COMPLETED|Overall Study||7
8456298|NCT00731614|20838138|P2|COMPLETED|Overall Study||18
8456299|NCT00731614|20838139|P1|COMPLETED|Overall Study||16
8456300|NCT00731614|20838138|P2|12 Weeks Posttreatment|Overall Study||23
8456301|NCT00731614|20838139|P1|12 Weeks Posttreatment|Overall Study||18
8456302|NCT00731614|20838138|P2|End of Treatment|Overall Study||24
8456303|NCT00731614|20838139|P1|End of Treatment|Overall Study||16
8456304|NCT00731614|20838138|P2|STARTED|Overall Study||31
8456305|NCT00731614|20838139|P1|STARTED|Overall Study||23
8456306|NCT00731549|20838147|P1|NOT COMPLETED|Overall Study||223
8456307|NCT00731549|20838147|P1|COMPLETED|Overall Study||858
8456308|NCT00731549|20838147|P1|STARTED|Overall Study||1081
8456309|NCT00731484|20838160|P1|NOT COMPLETED|Overall Study||0
8456310|NCT00731484|20838160|P1|COMPLETED|Overall Study||233
8456311|NCT00731484|20838160|P1|STARTED|Overall Study||233
8456312|NCT00731341|20838164|P1|NOT COMPLETED|Overall Study||0
8456313|NCT00731341|20838164|P1|COMPLETED|Overall Study||3
8456314|NCT00731341|20838164|P1|STARTED|Overall Study||3
8456315|NCT00731211|20838173|P1|NOT COMPLETED|Overall Study||0
8456316|NCT00731211|20838173|P1|COMPLETED|Overall Study||55
8456317|NCT00731211|20838173|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
8456318|NCT00731198|20838180|P2|NOT COMPLETED|Overall Study||6
8456319|NCT00731198|20838181|P1|NOT COMPLETED|Overall Study||6
8456320|NCT00731198|20838180|P2|COMPLETED|Overall Study||319
8456321|NCT00731198|20838181|P1|COMPLETED|Overall Study||319
8456322|NCT00731198|20838180|P2|STARTED|Overall Study||325
8456323|NCT00731198|20838181|P1|STARTED|Overall Study||325
8456324|NCT00731133|20838187|P1|NOT COMPLETED|Overall Study||10
8456325|NCT00731133|20838187|P1|COMPLETED|Overall Study||5
8456326|NCT00731133|20838187|P1|STARTED|Overall Study||15
8456327|NCT00731120|20838195|P3|NOT COMPLETED|Overall Study||36
8456328|NCT00731120|20838196|P2|NOT COMPLETED|Overall Study||43
8456329|NCT00731120|20838197|P1|NOT COMPLETED|Overall Study||42
8456330|NCT00731120|20838195|P3|COMPLETED|Overall Study||116
8456331|NCT00731120|20838196|P2|COMPLETED|Overall Study||109
8456332|NCT00731120|20838197|P1|COMPLETED|Overall Study||111
8456333|NCT00731120|20838195|P3|Treated|Overall Study||152
8456334|NCT00731120|20838196|P2|Treated|Overall Study||151
8456335|NCT00731120|20838197|P1|Treated|Overall Study||153
8456336|NCT00731120|20838195|P3|STARTED|Overall Study||152
8456337|NCT00731120|20838196|P2|STARTED|Overall Study||152
8456338|NCT00731120|20838197|P1|STARTED|Overall Study||153
8456339|NCT00731094|20838234|P2|NOT COMPLETED|Overall Study||11
8456340|NCT00731094|20838235|P1|NOT COMPLETED|Overall Study||18
8456341|NCT00731094|20838234|P2|COMPLETED|Overall Study||105
8456342|NCT00731094|20838235|P1|COMPLETED|Overall Study||98
8456343|NCT00731094|20838234|P2|Month 6|Overall Study||107
8456344|NCT00731094|20838235|P1|Month 6|Overall Study||101
8456345|NCT00731094|20838234|P2|STARTED|Overall Study||116
8456346|NCT00731094|20838235|P1|STARTED|Overall Study||116
8456347|NCT00731055|20838305|P1|NOT COMPLETED|Overall Study||0
8456348|NCT00731055|20838305|P1|COMPLETED|Overall Study||16
8456349|NCT00731055|20838305|P1|Received Varenicline 2.0 mg|Overall Study||16
8456350|NCT00731055|20838305|P1|Received Varenicline 1.0 mg|Overall Study||16
8456351|NCT00731055|20838305|P1|Received Varenicline 0.5 mg|Overall Study||16
8456352|NCT00731055|20838305|P1|Received Placebo|Overall Study||16
8456353|NCT00731055|20838305|P1|STARTED|Overall Study|This is a within-subjects study design.|16
8456354|NCT00731042|20838314|P2|NOT COMPLETED|Second Intervention||2
8456355|NCT00731042|20838315|P1|NOT COMPLETED|Second Intervention||0
8456356|NCT00731042|20838314|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
8456357|NCT00731042|20838315|P1|COMPLETED|Second Intervention||16
8456358|NCT00731042|20838314|P2|STARTED|Second Intervention||17
8456359|NCT00731042|20838315|P1|STARTED|Second Intervention||16
8456360|NCT00731042|20838314|P2|NOT COMPLETED|Wash-out||0
8456361|NCT00731042|20838315|P1|NOT COMPLETED|Wash-out||0
8456362|NCT00731042|20838314|P2|COMPLETED|Wash-out||17
8456363|NCT00731042|20838315|P1|COMPLETED|Wash-out||16
8456364|NCT00731042|20838314|P2|STARTED|Wash-out||17
8456365|NCT00731042|20838315|P1|STARTED|Wash-out||16
8456366|NCT00731042|20838314|P2|NOT COMPLETED|First Intervention||0
8456367|NCT00731042|20838315|P1|NOT COMPLETED|First Intervention||0
8456368|NCT00731042|20838314|P2|COMPLETED|First Intervention||17
8456369|NCT00731042|20838315|P1|COMPLETED|First Intervention||16
8456370|NCT00731042|20838314|P2|STARTED|First Intervention||17
8456371|NCT00731042|20838315|P1|STARTED|First Intervention||16
8456372|NCT00730964|20838321|P1|NOT COMPLETED|Overall Study||0
8456373|NCT00730964|20838321|P1|COMPLETED|Overall Study||1039
8456374|NCT00730964|20838321|P1|STARTED|Overall Study||1039
8456375|NCT00730925|20838326|P1|NOT COMPLETED|Overall Study||41
8456376|NCT00730925|20838326|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
8456377|NCT00730925|20838326|P1|STARTED|Overall Study||41
8456378|NCT00730912|20838336|P3|NOT COMPLETED|Overall Study||1
8456379|NCT00730912|20838337|P2|NOT COMPLETED|Overall Study||0
8456380|NCT00730912|20838338|P1|NOT COMPLETED|Overall Study||0
8456381|NCT00730912|20838336|P3|COMPLETED|Overall Study||103
8456382|NCT00730912|20838337|P2|COMPLETED|Overall Study||104
8456383|NCT00730912|20838338|P1|COMPLETED|Overall Study||53
8456384|NCT00730912|20838336|P3|STARTED|Overall Study||104
8456385|NCT00730912|20838337|P2|STARTED|Overall Study||104
8456386|NCT00730912|20838338|P1|STARTED|Overall Study||53
8456387|NCT00730886|20838351|P2|NOT COMPLETED|Overall Study||0
8456388|NCT00730886|20838352|P1|NOT COMPLETED|Overall Study||2
8456389|NCT00730886|20838351|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
8456390|NCT00730886|20838352|P1|COMPLETED|Overall Study||0
8456391|NCT00730886|20838351|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
8456392|NCT00730886|20838352|P1|STARTED|Overall Study||2
8456393|NCT00730847|20838376|P1|NOT COMPLETED|Overall Study||131
8456394|NCT00730847|20838376|P1|COMPLETED|Overall Study||465
8456395|NCT00730847|20838376|P1|STARTED|Overall Study||596
8456396|NCT00730756|20838385|P2|NOT COMPLETED|Overall Study||5
8456397|NCT00730756|20838386|P1|NOT COMPLETED|Overall Study||4
8456398|NCT00730756|20838385|P2|COMPLETED|Overall Study||48
8456399|NCT00730756|20838386|P1|COMPLETED|Overall Study||45
8456400|NCT00730756|20838385|P2|STARTED|Overall Study||53
8456401|NCT00730756|20838386|P1|STARTED|Overall Study||49
8456402|NCT00730730|20838408|P1|NOT COMPLETED|Overall Study||0
8456403|NCT00730730|20838408|P1|COMPLETED|Overall Study||50
8456404|NCT00730730|20838408|P1|STARTED|Overall Study||50
8456405|NCT00730691|20838420|P5|NOT COMPLETED|Overall Study||50
8456406|NCT00730691|20838421|P4|NOT COMPLETED|Overall Study||45
8456407|NCT00730691|20838422|P3|NOT COMPLETED|Overall Study||39
8456408|NCT00730691|20838423|P2|NOT COMPLETED|Overall Study||36
8456409|NCT00730691|20838424|P1|NOT COMPLETED|Overall Study||36
8456410|NCT00730691|20838420|P5|COMPLETED|Overall Study||106
8456411|NCT00730691|20838421|P4|COMPLETED|Overall Study||111
8456412|NCT00730691|20838422|P3|COMPLETED|Overall Study||117
8456413|NCT00730691|20838423|P2|COMPLETED|Overall Study||120
8456414|NCT00730691|20838424|P1|COMPLETED|Overall Study||121
8456415|NCT00730691|20838420|P5|STARTED|Overall Study||156
8456416|NCT00730691|20838421|P4|STARTED|Overall Study||156
8456417|NCT00730691|20838422|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
8456418|NCT00730691|20838423|P2|STARTED|Overall Study||156
8456419|NCT00730691|20838424|P1|STARTED|Overall Study||157
8456420|NCT00730639|20838516|P5|NOT COMPLETED|Overall Study||131
8456421|NCT00730639|20838517|P4|NOT COMPLETED|Overall Study||54
8456422|NCT00730639|20838518|P3|NOT COMPLETED|Overall Study||86
8456423|NCT00730639|20838519|P2|NOT COMPLETED|Overall Study||18
8456424|NCT00730639|20838520|P1|NOT COMPLETED|Overall Study||17
8456425|NCT00730639|20838516|P5|COMPLETED|Overall Study||0
8456426|NCT00730639|20838517|P4|COMPLETED|Overall Study||0
8456427|NCT00730639|20838518|P3|COMPLETED|Overall Study||0
8456428|NCT00730639|20838519|P2|COMPLETED|Overall Study||0
8456429|NCT00730639|20838520|P1|COMPLETED|Overall Study||0
8456430|NCT00730639|20838516|P5|STARTED|Overall Study||131
8456431|NCT00730639|20838517|P4|STARTED|Overall Study||54
8456432|NCT00730639|20838518|P3|STARTED|Overall Study||86
8456433|NCT00730639|20838519|P2|STARTED|Overall Study||18
8456434|NCT00730639|20838520|P1|STARTED|Overall Study||17
8456435|NCT00730522|20838586|P2|NOT COMPLETED|Overall Study||0
8456436|NCT00730522|20838587|P1|NOT COMPLETED|Overall Study||0
8456437|NCT00730522|20838586|P2|COMPLETED|Overall Study||27
8456438|NCT00730522|20838587|P1|COMPLETED|Overall Study||28
8456439|NCT00730522|20838586|P2|STARTED|Overall Study||27
8456440|NCT00730522|20838587|P1|STARTED|Overall Study||28
8456441|NCT00730483|20838595|P1|NOT COMPLETED|Overall Study||7
8456442|NCT00730483|20838595|P1|COMPLETED|Overall Study||6
8456443|NCT00730483|20838595|P1|6 Months After First DEB-TACE|Overall Study||10
8456444|NCT00730483|20838595|P1|1 Month After First DEB-TACE|Overall Study||13
8456445|NCT00730483|20838595|P1|STARTED|Overall Study||13
8456446|NCT00730405|20838608|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
8456447|NCT00730405|20838609|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
8456448|NCT00730405|20838610|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
8456449|NCT00730405|20838611|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
8456450|NCT00730405|20838612|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
8456451|NCT00730405|20838608|P5|COMPLETED|Overall Study-follow-up Phase||93
8456452|NCT00730405|20838609|P4|COMPLETED|Overall Study-follow-up Phase||100
8456453|NCT00730405|20838610|P3|COMPLETED|Overall Study-follow-up Phase||94
8456454|NCT00730405|20838611|P2|COMPLETED|Overall Study-follow-up Phase||96
8456455|NCT00730405|20838612|P1|COMPLETED|Overall Study-follow-up Phase||95
8456456|NCT00730405|20838608|P5|STARTED|Overall Study-follow-up Phase||115
8456457|NCT00730405|20838609|P4|STARTED|Overall Study-follow-up Phase||117
8456458|NCT00730405|20838610|P3|STARTED|Overall Study-follow-up Phase||117
8456459|NCT00730405|20838611|P2|STARTED|Overall Study-follow-up Phase||117
8456460|NCT00730405|20838612|P1|STARTED|Overall Study-follow-up Phase||116
8456461|NCT00730405|20838608|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
8456462|NCT00730405|20838609|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
8456463|NCT00730405|20838610|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
8456464|NCT00730405|20838611|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
8456465|NCT00730405|20838612|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
8456466|NCT00730405|20838608|P5|COMPLETED|Overall Study-Treatment Phase||95
8456467|NCT00730405|20838609|P4|COMPLETED|Overall Study-Treatment Phase||98
8456468|NCT00730405|20838610|P3|COMPLETED|Overall Study-Treatment Phase||96
8456469|NCT00730405|20838611|P2|COMPLETED|Overall Study-Treatment Phase||96
8456470|NCT00730405|20838612|P1|COMPLETED|Overall Study-Treatment Phase||97
8456471|NCT00730405|20838608|P5|STARTED|Overall Study-Treatment Phase||115
8456472|NCT00730405|20838609|P4|STARTED|Overall Study-Treatment Phase||117
8456473|NCT00730405|20838610|P3|STARTED|Overall Study-Treatment Phase||117
8456474|NCT00730405|20838611|P2|STARTED|Overall Study-Treatment Phase||117
8456475|NCT00730405|20838612|P1|STARTED|Overall Study-Treatment Phase||116
8456476|NCT00730353|20838649|P1|NOT COMPLETED|Overall Study||0
8456477|NCT00730353|20838649|P1|COMPLETED|Overall Study||28
8456478|NCT00730353|20838649|P1|STARTED|Overall Study||28
8456479|NCT00730327|20838659|P2|NOT COMPLETED|Overall Study||37
8456480|NCT00730327|20838660|P1|NOT COMPLETED|Overall Study||27
8456481|NCT00730327|20838659|P2|COMPLETED|Overall Study||93
8456482|NCT00730327|20838660|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
8456483|NCT00730327|20838659|P2|Completed Week 26|Overall Study||99
8456484|NCT00730327|20838660|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
8456485|NCT00730327|20838659|P2|STARTED|Overall Study||130
8456486|NCT00730327|20838660|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
8456487|NCT00730275|20838685|P4|NOT COMPLETED|Overall Study||1
8456488|NCT00730275|20838686|P3|NOT COMPLETED|Overall Study||0
8456489|NCT00730275|20838687|P2|NOT COMPLETED|Overall Study||0
8456490|NCT00730275|20838688|P1|NOT COMPLETED|Overall Study||0
8456491|NCT00730275|20838685|P4|COMPLETED|Overall Study||8
8456492|NCT00730275|20838686|P3|COMPLETED|Overall Study||8
8456493|NCT00730275|20838687|P2|COMPLETED|Overall Study||9
8456494|NCT00730275|20838688|P1|COMPLETED|Overall Study||9
8456495|NCT00730275|20838685|P4|STARTED|Overall Study||9
8456496|NCT00730275|20838686|P3|STARTED|Overall Study||8
8456497|NCT00730275|20838687|P2|STARTED|Overall Study||9
8456498|NCT00730275|20838688|P1|STARTED|Overall Study||9
8456499|NCT00730236|20838714|P1|NOT COMPLETED|Overall Study||6
8456500|NCT00730236|20838714|P1|COMPLETED|Overall Study||23
8456501|NCT00730236|20838714|P1|STARTED|Overall Study||29
8456502|NCT00730171|20838729|P1|NOT COMPLETED|Overall Study||771
8456503|NCT00730171|20838729|P1|COMPLETED|Overall Study||954
8456504|NCT00730171|20838729|P1|IBS-C Safety Population|Overall Study||1119
8456505|NCT00730171|20838729|P1|CC Safety Population|Overall Study||607
8456506|NCT00730171|20838729|P1|STARTED|Overall Study||1725
8456507|NCT00730158|20838739|P2|NOT COMPLETED|Overall Study||1
8456508|NCT00730158|20838740|P1|NOT COMPLETED|Overall Study||1
8456509|NCT00730158|20838739|P2|COMPLETED|Overall Study||15
8456510|NCT00730158|20838740|P1|COMPLETED|Overall Study||16
8456511|NCT00730158|20838739|P2|STARTED|Overall Study||16
8456512|NCT00730158|20838740|P1|STARTED|Overall Study||17
8456513|NCT00730132|20838778|P1|NOT COMPLETED|Overall Study||155
8456514|NCT00730132|20838778|P1|COMPLETED|Overall Study||557
8456515|NCT00730132|20838778|P1|STARTED|Overall Study||712
8456516|NCT00730041|20838796|P2|NOT COMPLETED|Overall Study||2
8456517|NCT00730041|20838797|P1|NOT COMPLETED|Overall Study||0
8456518|NCT00730041|20838796|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
8456519|NCT00730041|20838797|P1|COMPLETED|Overall Study||26
8456520|NCT00730041|20838796|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
8456521|NCT00730041|20838797|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
8456522|NCT00730028|20838820|P5|NOT COMPLETED|Overall Study||82
8456523|NCT00730028|20838821|P4|NOT COMPLETED|Overall Study||56
8456524|NCT00730028|20838822|P3|NOT COMPLETED|Overall Study||45
8456525|NCT00730028|20838823|P2|NOT COMPLETED|Overall Study||66
8456526|NCT00730028|20838824|P1|NOT COMPLETED|Overall Study||60
8456527|NCT00730028|20838820|P5|COMPLETED|Overall Study||175
8456528|NCT00730028|20838821|P4|COMPLETED|Overall Study||207
8456529|NCT00730028|20838822|P3|COMPLETED|Overall Study||221
8456530|NCT00730028|20838823|P2|COMPLETED|Overall Study||194
8456531|NCT00730028|20838824|P1|COMPLETED|Overall Study||204
8456532|NCT00730028|20838820|P5|STARTED|Overall Study||257
8456533|NCT00730028|20838821|P4|STARTED|Overall Study||263
8456534|NCT00730028|20838822|P3|STARTED|Overall Study||266
8456535|NCT00730028|20838823|P2|STARTED|Overall Study||260
8456536|NCT00730028|20838824|P1|STARTED|Overall Study||264
8456537|NCT00730015|20838874|P3|NOT COMPLETED|Overall Study||32
8456538|NCT00730015|20838875|P2|NOT COMPLETED|Overall Study||40
8456539|NCT00730015|20838876|P1|NOT COMPLETED|Overall Study||31
8456540|NCT00730015|20838874|P3|COMPLETED|Overall Study||177
8456541|NCT00730015|20838875|P2|COMPLETED|Overall Study||177
8456542|NCT00730015|20838876|P1|COMPLETED|Overall Study||186
8456543|NCT00730015|20838874|P3|STARTED|Overall Study||209
8456544|NCT00730015|20838875|P2|STARTED|Overall Study||217
8456545|NCT00730015|20838876|P1|STARTED|Overall Study||217
8456546|NCT00729937|20838916|P6|NOT COMPLETED|Overall Study||37
8456547|NCT00729937|20838917|P5|NOT COMPLETED|Overall Study||28
8456548|NCT00729937|20838918|P4|NOT COMPLETED|Overall Study||34
8456549|NCT00729937|20838919|P3|NOT COMPLETED|Overall Study||29
8456550|NCT00729937|20838920|P2|NOT COMPLETED|Overall Study||88
8456551|NCT00729937|20838921|P1|NOT COMPLETED|Overall Study||74
8456552|NCT00729937|20838916|P6|COMPLETED|Overall Study||214
8456553|NCT00729937|20838917|P5|COMPLETED|Overall Study||221
8456554|NCT00729937|20838918|P4|COMPLETED|Overall Study||215
8456555|NCT00729937|20838919|P3|COMPLETED|Overall Study||222
8456556|NCT00729937|20838920|P2|COMPLETED|Overall Study||548
8456557|NCT00729937|20838921|P1|COMPLETED|Overall Study||555
8456558|NCT00729937|20838916|P6|STARTED|Overall Study||251
8456559|NCT00729937|20838917|P5|STARTED|Overall Study||249
8456560|NCT00729937|20838918|P4|STARTED|Overall Study||249
8456561|NCT00729937|20838919|P3|STARTED|Overall Study||251
8456562|NCT00729937|20838920|P2|STARTED|Overall Study||636
8456563|NCT00729937|20838921|P1|STARTED|Overall Study||629
8456564|NCT00729924|20839115|P1|NOT COMPLETED|Overall Study||0
8456565|NCT00729924|20839115|P1|COMPLETED|Overall Study||40
8456566|NCT00729924|20839115|P1|STARTED|Overall Study||40
8456567|NCT00729859|20839125|P3|NOT COMPLETED|Overall Study||0
8456568|NCT00729859|20839126|P2|NOT COMPLETED|Overall Study||2
8456569|NCT00729859|20839127|P1|NOT COMPLETED|Overall Study||0
8456570|NCT00729859|20839125|P3|COMPLETED|Overall Study||8
8456571|NCT00729859|20839126|P2|COMPLETED|Overall Study||6
8456572|NCT00729859|20839127|P1|COMPLETED|Overall Study||8
8456573|NCT00729859|20839125|P3|STARTED|Overall Study||8
8456574|NCT00729859|20839126|P2|STARTED|Overall Study||8
8456575|NCT00729859|20839127|P1|STARTED|Overall Study||8
8456576|NCT00729846|20839164|P2|NOT COMPLETED|Overall Study||0
8456577|NCT00729846|20839165|P1|NOT COMPLETED|Overall Study||0
8456578|NCT00729846|20839164|P2|COMPLETED|Overall Study||11
8456579|NCT00729846|20839165|P1|COMPLETED|Overall Study||11
8456580|NCT00729846|20839164|P2|STARTED|Overall Study||11
8456581|NCT00729846|20839165|P1|STARTED|Overall Study||11
8456582|NCT00729833|20839171|P4|NOT COMPLETED|Overall Study||6
8456583|NCT00729833|20839172|P3|NOT COMPLETED|Overall Study||12
8456584|NCT00729833|20839173|P2|NOT COMPLETED|Overall Study||7
8456585|NCT00729833|20839174|P1|NOT COMPLETED|Overall Study||20
8456586|NCT00729833|20839171|P4|COMPLETED|Overall Study||0
8456587|NCT00729833|20839172|P3|COMPLETED|Overall Study||0
8456588|NCT00729833|20839173|P2|COMPLETED|Overall Study||0
8456589|NCT00729833|20839174|P1|COMPLETED|Overall Study||0
8456590|NCT00729833|20839171|P4|STARTED|Overall Study||6
8456591|NCT00729833|20839172|P3|STARTED|Overall Study||12
8456592|NCT00729833|20839173|P2|STARTED|Overall Study||7
8456593|NCT00729833|20839174|P1|STARTED|Overall Study||20
8456594|NCT00729807|20839213|P1|NOT COMPLETED|Overall Study||0
8456595|NCT00729807|20839213|P1|COMPLETED|Overall Study||6
8456596|NCT00729807|20839213|P1|STARTED|Overall Study||6
8456597|NCT00729781|20839223|P1|NOT COMPLETED|Long-term Follow-up Study||0
8456598|NCT00729781|20839223|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
8456599|NCT00729781|20839223|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
8456600|NCT00729781|20839223|P1|NOT COMPLETED|Original Study||0
8456601|NCT00729781|20839223|P1|COMPLETED|Original Study||45
8456602|NCT00729781|20839223|P1|STARTED|Original Study||45
8456603|NCT00729690|20839232|P3|NOT COMPLETED|Overall Study||2
8456604|NCT00729690|20839233|P2|NOT COMPLETED|Overall Study||2
8456605|NCT00729690|20839234|P1|NOT COMPLETED|Overall Study||0
8456606|NCT00729690|20839232|P3|COMPLETED|Overall Study||14
8456607|NCT00729690|20839233|P2|COMPLETED|Overall Study||14
8456608|NCT00729690|20839234|P1|COMPLETED|Overall Study||16
8456609|NCT00729690|20839232|P3|STARTED|Overall Study||16
8456610|NCT00729690|20839233|P2|STARTED|Overall Study||16
8456611|NCT00729690|20839234|P1|STARTED|Overall Study||16
8456612|NCT00729677|20839251|P1|NOT COMPLETED|Overall Study||0
8456613|NCT00729677|20839251|P1|COMPLETED|Overall Study||64
8456614|NCT00729677|20839251|P1|STARTED|Overall Study||64
8456615|NCT00729651|20839264|P2|NOT COMPLETED|Overall Study||18
8456616|NCT00729651|20839265|P1|NOT COMPLETED|Overall Study||19
8456617|NCT00729651|20839264|P2|COMPLETED|Overall Study||152
8456618|NCT00729651|20839265|P1|COMPLETED|Overall Study||154
8456619|NCT00729651|20839264|P2|STARTED|Overall Study||170
8456620|NCT00729651|20839265|P1|STARTED|Overall Study||173
8456621|NCT00729612|20839277|P1|NOT COMPLETED|Overall Study||10
8456622|NCT00729612|20839277|P1|COMPLETED|Overall Study||53
8456623|NCT00729612|20839277|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
8456624|NCT00729612|20839277|P1|Received Cycle 2|Overall Study||54
8456625|NCT00729612|20839277|P1|Did Not Receive Cycle 2|Overall Study||7
8456626|NCT00729612|20839277|P1|Received Cycle 1|Overall Study||62
8456627|NCT00729612|20839277|P1|Died Before Cycle 1|Overall Study||1
8456628|NCT00729612|20839277|P1|STARTED|Overall Study||63
8456629|NCT00729586|20839286|P2|NOT COMPLETED|Overall Study||1
8456630|NCT00729586|20839287|P1|NOT COMPLETED|Overall Study||1
8456631|NCT00729586|20839286|P2|COMPLETED|Overall Study|Eligible and treated patients|21
8456632|NCT00729586|20839287|P1|COMPLETED|Overall Study|Eligible and treated patients|50
8456633|NCT00729586|20839286|P2|STARTED|Overall Study||22
8456634|NCT00729586|20839287|P1|STARTED|Overall Study||51
8456635|NCT00729560|20839300|P1|NOT COMPLETED|Overall Study||3
8456636|NCT00729560|20839300|P1|COMPLETED|Overall Study||5
8456637|NCT00729560|20839300|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
8456638|NCT00729521|20839307|P3|NOT COMPLETED|Overall Study||0
8456639|NCT00729521|20839308|P2|NOT COMPLETED|Overall Study||0
8456640|NCT00729521|20839309|P1|NOT COMPLETED|Overall Study||0
8456641|NCT00729521|20839307|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
8456904|NCT00727909|20840031|P1|NOT COMPLETED|Overall Study||5
8456642|NCT00729521|20839308|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
8456643|NCT00729521|20839309|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
8456644|NCT00729521|20839307|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
8456645|NCT00729521|20839308|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
8456646|NCT00729521|20839309|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
8456647|NCT00729482|20839317|P1|NOT COMPLETED|Overall Study||0
8456648|NCT00729482|20839317|P1|COMPLETED|Overall Study||54
8456649|NCT00729482|20839317|P1|STARTED|Overall Study||54
8456650|NCT00729469|20839326|P2|NOT COMPLETED|Overall Study||47
8456651|NCT00729469|20839327|P1|NOT COMPLETED|Overall Study||53
8456652|NCT00729469|20839326|P2|COMPLETED|Overall Study||416
8456653|NCT00729469|20839327|P1|COMPLETED|Overall Study||403
8456654|NCT00729469|20839326|P2|STARTED|Overall Study||463
8456655|NCT00729469|20839327|P1|STARTED|Overall Study||456
8456656|NCT00729430|20839365|P2|NOT COMPLETED|Overall Study||50
8456657|NCT00729430|20839366|P1|NOT COMPLETED|Overall Study||47
8456658|NCT00729430|20839365|P2|COMPLETED|Overall Study||128
8456659|NCT00729430|20839366|P1|COMPLETED|Overall Study||133
8456660|NCT00729430|20839365|P2|STARTED|Overall Study||178
8456661|NCT00729430|20839366|P1|STARTED|Overall Study||180
8456662|NCT00729378|20839380|P2|NOT COMPLETED|36-months||6
8456663|NCT00729378|20839381|P1|NOT COMPLETED|36-months||15
8456664|NCT00729378|20839380|P2|COMPLETED|36-months||95
8456665|NCT00729378|20839381|P1|COMPLETED|36-months||105
8456666|NCT00729378|20839380|P2|STARTED|36-months||101
8456667|NCT00729378|20839381|P1|STARTED|36-months||120
8456668|NCT00729378|20839380|P2|NOT COMPLETED|24-months||51
8456669|NCT00729378|20839381|P1|NOT COMPLETED|24-months||72
8456670|NCT00729378|20839380|P2|COMPLETED|24-months||101
8456671|NCT00729378|20839381|P1|COMPLETED|24-months||120
8456672|NCT00729378|20839380|P2|STARTED|24-months||152
8456673|NCT00729378|20839381|P1|STARTED|24-months||192
8456674|NCT00729378|20839380|P2|NOT COMPLETED|12-months||65
8456675|NCT00729378|20839381|P1|NOT COMPLETED|12-months||100
8456676|NCT00729378|20839380|P2|COMPLETED|12-months||152
8456677|NCT00729378|20839381|P1|COMPLETED|12-months||192
8456678|NCT00729378|20839380|P2|STARTED|12-months||217
8456679|NCT00729378|20839381|P1|STARTED|12-months||292
8456680|NCT00729378|20839380|P2|NOT COMPLETED|Baseline||92
8456681|NCT00729378|20839381|P1|NOT COMPLETED|Baseline||138
8456682|NCT00729378|20839380|P2|COMPLETED|Baseline||217
8456683|NCT00729378|20839381|P1|COMPLETED|Baseline||292
8456684|NCT00729378|20839380|P2|STARTED|Baseline||309
8456685|NCT00729378|20839381|P1|STARTED|Baseline||430
8456686|NCT00729365|20839580|P3|NOT COMPLETED|Overall Study||7
8456687|NCT00729365|20839581|P2|NOT COMPLETED|Overall Study||6
8456688|NCT00729365|20839582|P1|NOT COMPLETED|Overall Study||33
8456689|NCT00729365|20839580|P3|COMPLETED|Overall Study|Study terminated|0
8456690|NCT00729365|20839581|P2|COMPLETED|Overall Study|Study Terminated|0
8456691|NCT00729365|20839582|P1|COMPLETED|Overall Study|Study terminated|0
8456692|NCT00729365|20839580|P3|STARTED|Overall Study||7
8456693|NCT00729365|20839581|P2|STARTED|Overall Study||6
8456694|NCT00729365|20839582|P1|STARTED|Overall Study||33
8456695|NCT00729326|20839595|P2|NOT COMPLETED|Overall Study||9
8456696|NCT00729326|20839596|P1|NOT COMPLETED|Overall Study||10
8456697|NCT00729326|20839595|P2|COMPLETED|Overall Study||33
8456698|NCT00729326|20839596|P1|COMPLETED|Overall Study||31
8456699|NCT00729326|20839595|P2|STARTED|Overall Study||42
8456700|NCT00729326|20839596|P1|STARTED|Overall Study||41
8456701|NCT00729248|20839638|P1|NOT COMPLETED|Overall Study||2
8456702|NCT00729248|20839638|P1|COMPLETED|Overall Study||10
8456703|NCT00729248|20839638|P1|STARTED|Overall Study||12
8456704|NCT00729183|20839645|P2|NOT COMPLETED|Overall Study||15
8456705|NCT00729183|20839646|P1|NOT COMPLETED|Overall Study||25
8456706|NCT00729183|20839645|P2|COMPLETED|Overall Study|Completed 24 month visit|90
8456707|NCT00729183|20839646|P1|COMPLETED|Overall Study|Completed 24 month visit|84
8456708|NCT00729183|20839645|P2|STARTED|Overall Study||105
8456709|NCT00729183|20839646|P1|STARTED|Overall Study||109
8456710|NCT00729157|20839678|P1|NOT COMPLETED|Overall Study||1
8456711|NCT00729157|20839678|P1|COMPLETED|Overall Study||40
8456712|NCT00729157|20839678|P1|STARTED|Overall Study||41
8456713|NCT00729053|20839690|P4|NOT COMPLETED|Overall Study||0
8456714|NCT00729053|20839691|P3|NOT COMPLETED|Overall Study||0
8456715|NCT00729053|20839692|P2|NOT COMPLETED|Overall Study||0
8456716|NCT00729053|20839693|P1|NOT COMPLETED|Overall Study||0
8456717|NCT00729053|20839690|P4|COMPLETED|Overall Study||23
8456718|NCT00729053|20839691|P3|COMPLETED|Overall Study||23
8456719|NCT00729053|20839692|P2|COMPLETED|Overall Study||23
8456720|NCT00729053|20839693|P1|COMPLETED|Overall Study||23
8456721|NCT00729053|20839690|P4|STARTED|Overall Study||23
8456722|NCT00729053|20839691|P3|STARTED|Overall Study||23
8456723|NCT00729053|20839692|P2|STARTED|Overall Study||23
8456724|NCT00729053|20839693|P1|STARTED|Overall Study||23
8456735|NCT00728962|20839740|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
8456736|NCT00728962|20839740|P1|COMPLETED|Two Year Post Placement Follow-up||59
8456737|NCT00728962|20839740|P1|STARTED|Two Year Post Placement Follow-up||62
8456738|NCT00728962|20839740|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
8456739|NCT00728962|20839740|P1|COMPLETED|One Year Post Placement Follow-up||62
8456740|NCT00728962|20839740|P1|STARTED|One Year Post Placement Follow-up||62
8456741|NCT00728962|20839740|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
8456742|NCT00728962|20839740|P1|COMPLETED|Permanent Prosthesis Placement||62
8456743|NCT00728962|20839740|P1|STARTED|Permanent Prosthesis Placement||65
8456744|NCT00728962|20839740|P1|NOT COMPLETED|Implant Placement Surgery||10
8456745|NCT00728962|20839740|P1|COMPLETED|Implant Placement Surgery||65
8456746|NCT00728962|20839740|P1|STARTED|Implant Placement Surgery||75
8456747|NCT00728949|20839746|P2|NOT COMPLETED|Overall Study||4
8456748|NCT00728949|20839747|P1|NOT COMPLETED|Overall Study||11
8456749|NCT00728949|20839746|P2|COMPLETED|Overall Study||27
8456750|NCT00728949|20839747|P1|COMPLETED|Overall Study||51
8456751|NCT00728949|20839746|P2|STARTED|Overall Study||31
8456752|NCT00728949|20839747|P1|STARTED|Overall Study||62
8456753|NCT00728936|20839772|P7|NOT COMPLETED|Overall Study||0
8456754|NCT00728936|20839773|P6|NOT COMPLETED|Overall Study||1
8456755|NCT00728936|20839774|P5|NOT COMPLETED|Overall Study||0
8456756|NCT00728936|20839775|P4|NOT COMPLETED|Overall Study||0
8456757|NCT00728936|20839776|P3|NOT COMPLETED|Overall Study||0
8456758|NCT00728936|20839777|P2|NOT COMPLETED|Overall Study||0
8456759|NCT00728936|20839778|P1|NOT COMPLETED|Overall Study||0
8456760|NCT00728936|20839772|P7|COMPLETED|Overall Study||7
8456761|NCT00728936|20839773|P6|COMPLETED|Overall Study||7
8456762|NCT00728936|20839774|P5|COMPLETED|Overall Study||8
8456763|NCT00728936|20839775|P4|COMPLETED|Overall Study||8
8456764|NCT00728936|20839776|P3|COMPLETED|Overall Study||9
8456765|NCT00728936|20839777|P2|COMPLETED|Overall Study||8
8456766|NCT00728936|20839778|P1|COMPLETED|Overall Study||10
8456767|NCT00728936|20839772|P7|STARTED|Overall Study||7
8456768|NCT00728936|20839773|P6|STARTED|Overall Study||8
8456769|NCT00728936|20839774|P5|STARTED|Overall Study||8
8456770|NCT00728936|20839775|P4|STARTED|Overall Study||8
8456771|NCT00728936|20839776|P3|STARTED|Overall Study||9
8456772|NCT00728936|20839777|P2|STARTED|Overall Study||8
8456773|NCT00728936|20839778|P1|STARTED|Overall Study||10
8456774|NCT00728923|20839794|P1|NOT COMPLETED|Overall Study||0
8456775|NCT00728923|20839794|P1|COMPLETED|Overall Study||9
8456776|NCT00728923|20839794|P1|STARTED|Overall Study||9
8456777|NCT00728910|20839799|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
8456778|NCT00728910|20839799|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
8456779|NCT00728910|20839799|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
8456780|NCT00728910|20839799|P1|NOT COMPLETED|Atorvastatin+ABT335||0
8456781|NCT00728910|20839799|P1|COMPLETED|Atorvastatin+ABT335||22
8456782|NCT00728910|20839799|P1|STARTED|Atorvastatin+ABT335||22
8456783|NCT00728910|20839799|P1|NOT COMPLETED|Atorvastatin||3
8456784|NCT00728910|20839799|P1|COMPLETED|Atorvastatin||22
8456785|NCT00728910|20839799|P1|STARTED|Atorvastatin||25
8456786|NCT00728884|20839811|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
8456787|NCT00728884|20839811|P1|COMPLETED|Two Year Post Placement Follow-up||145
8456788|NCT00728884|20839811|P1|STARTED|Two Year Post Placement Follow-up||145
8456789|NCT00728884|20839811|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
8456790|NCT00728884|20839811|P1|COMPLETED|One Year Post Placement Follow-up||145
8456791|NCT00728884|20839811|P1|STARTED|One Year Post Placement Follow-up||149
8456792|NCT00728884|20839811|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
8456793|NCT00728884|20839811|P1|COMPLETED|Permanent Prosthesis Placement||149
8456794|NCT00728884|20839811|P1|STARTED|Permanent Prosthesis Placement||162
8456795|NCT00728884|20839811|P1|NOT COMPLETED|Implant Placement Surgery||0
8456796|NCT00728884|20839811|P1|COMPLETED|Implant Placement Surgery||162
8456797|NCT00728884|20839811|P1|STARTED|Implant Placement Surgery||162
8456798|NCT00728845|20839817|P2|NOT COMPLETED|Overall Study||0
8456799|NCT00728845|20839818|P1|NOT COMPLETED|Overall Study||0
8456800|NCT00728845|20839817|P2|COMPLETED|Overall Study||0
8456801|NCT00728845|20839818|P1|COMPLETED|Overall Study||8
8456802|NCT00728845|20839817|P2|STARTED|Overall Study||0
8456803|NCT00728845|20839818|P1|STARTED|Overall Study||8
8456804|NCT00728819|20839834|P2|NOT COMPLETED|Overall Study||29
8456805|NCT00728819|20839835|P1|NOT COMPLETED|Overall Study||36
8456806|NCT00728819|20839834|P2|COMPLETED|Overall Study||139
8456807|NCT00728819|20839835|P1|COMPLETED|Overall Study||135
8456808|NCT00728819|20839834|P2|STARTED|Overall Study||168
8456809|NCT00728819|20839835|P1|STARTED|Overall Study||171
8456810|NCT00728754|20839847|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
8456811|NCT00728754|20839848|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
8456812|NCT00728754|20839847|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
8456813|NCT00728754|20839848|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
8456814|NCT00728754|20839847|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
8456815|NCT00728754|20839848|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
8456816|NCT00728754|20839847|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
8456817|NCT00728754|20839848|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
8456818|NCT00728754|20839847|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
8456819|NCT00728754|20839848|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
8456905|NCT00727909|20840028|P4|COMPLETED|Overall Study||70
8456820|NCT00728754|20839847|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
8456821|NCT00728754|20839848|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
8456822|NCT00728754|20839847|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
8456823|NCT00728754|20839848|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
8456824|NCT00728754|20839847|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
8456825|NCT00728754|20839848|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
8456826|NCT00728754|20839847|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
8456827|NCT00728754|20839848|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
8456828|NCT00728754|20839847|P2|NOT COMPLETED|Implant Placement Surgery||0
8456829|NCT00728754|20839848|P1|NOT COMPLETED|Implant Placement Surgery||0
8456830|NCT00728754|20839847|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
8456831|NCT00728754|20839848|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
8456832|NCT00728754|20839847|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
8456833|NCT00728754|20839848|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
8456834|NCT00728728|20839856|P2|NOT COMPLETED|Overall Study||12
8456835|NCT00728728|20839857|P1|NOT COMPLETED|Overall Study||4
8456836|NCT00728728|20839856|P2|COMPLETED|Overall Study||34
8456837|NCT00728728|20839857|P1|COMPLETED|Overall Study||38
8456838|NCT00728728|20839856|P2|STARTED|Overall Study||46
8456839|NCT00728728|20839857|P1|STARTED|Overall Study||42
8456840|NCT00728689|20839877|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
8456841|NCT00728689|20839878|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
8456842|NCT00728689|20839877|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
8456843|NCT00728689|20839878|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
8456844|NCT00728689|20839877|P2|STARTED|Second Intervention (Days 11 - 13)||6
8456845|NCT00728689|20839878|P1|STARTED|Second Intervention (Days 11 - 13)||5
8456846|NCT00728689|20839877|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
8456847|NCT00728689|20839878|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
8456848|NCT00728689|20839877|P2|COMPLETED|Washout Period (Days 4 - 10)||6
8456849|NCT00728689|20839878|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
8456850|NCT00728689|20839877|P2|STARTED|Washout Period (Days 4 - 10)||6
8456851|NCT00728689|20839878|P1|STARTED|Washout Period (Days 4 - 10)||6
8456852|NCT00728689|20839877|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
8456853|NCT00728689|20839878|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
8456854|NCT00728689|20839877|P2|COMPLETED|First Intervention (Days 1 - 3)||6
8456855|NCT00728689|20839878|P1|COMPLETED|First Intervention (Days 1 - 3)||6
8456856|NCT00728689|20839877|P2|STARTED|First Intervention (Days 1 - 3)||6
8456857|NCT00728689|20839878|P1|STARTED|First Intervention (Days 1 - 3)||6
8456858|NCT00728507|20839896|P2|NOT COMPLETED|Overall Study||8
8456859|NCT00728507|20839897|P1|NOT COMPLETED|Overall Study||2
8456860|NCT00728507|20839896|P2|COMPLETED|Overall Study||51
8456861|NCT00728507|20839897|P1|COMPLETED|Overall Study||60
8456862|NCT00728507|20839896|P2|STARTED|Overall Study||59
8456863|NCT00728507|20839897|P1|STARTED|Overall Study||62
8456864|NCT00728494|20839907|P2|NOT COMPLETED|Overall Study||7
8456865|NCT00728494|20839908|P1|NOT COMPLETED|Overall Study||9
8456866|NCT00728494|20839907|P2|COMPLETED|Overall Study||32
8456867|NCT00728494|20839908|P1|COMPLETED|Overall Study||51
8456868|NCT00728494|20839907|P2|STARTED|Overall Study||39
8456869|NCT00728494|20839908|P1|STARTED|Overall Study||60
8456870|NCT00728481|20839926|P2|NOT COMPLETED|Overall Study||4
8456871|NCT00728481|20839927|P1|NOT COMPLETED|Overall Study||1
8456872|NCT00728481|20839926|P2|COMPLETED|Overall Study||28
8456873|NCT00728481|20839927|P1|COMPLETED|Overall Study||18
8456874|NCT00728481|20839926|P2|STARTED|Overall Study||32
8456875|NCT00728481|20839927|P1|STARTED|Overall Study||19
8456876|NCT00728468|20839943|P1|NOT COMPLETED|Overall Study||16
8456877|NCT00728468|20839943|P1|COMPLETED|Overall Study||0
8456878|NCT00728468|20839943|P1|Treated|Overall Study||15
8456879|NCT00728468|20839943|P1|STARTED|Overall Study||16
8456880|NCT00728416|20839967|P2|NOT COMPLETED|Overall Study||2
8456881|NCT00728416|20839968|P1|NOT COMPLETED|Overall Study||2
8456882|NCT00728416|20839967|P2|COMPLETED|Overall Study||163
8456883|NCT00728416|20839968|P1|COMPLETED|Overall Study||166
8456884|NCT00728416|20839967|P2|STARTED|Overall Study||165
8456885|NCT00728416|20839968|P1|STARTED|Overall Study||168
8456886|NCT00728260|20839976|P1|NOT COMPLETED|Overall Study||0
8456887|NCT00728260|20839976|P1|COMPLETED|Overall Study||1421
8456888|NCT00728260|20839976|P1|STARTED|Overall Study||1421
8456889|NCT00728182|20839984|P2|NOT COMPLETED|Overall Study||3
8456890|NCT00728182|20839985|P1|NOT COMPLETED|Overall Study||3
8456891|NCT00728182|20839984|P2|COMPLETED|Overall Study||90
8456892|NCT00728182|20839985|P1|COMPLETED|Overall Study||89
8456893|NCT00728182|20839984|P2|STARTED|Overall Study||93
8456894|NCT00728182|20839985|P1|STARTED|Overall Study||92
8456895|NCT00728130|20840013|P1|NOT COMPLETED|Overall Study||3
8456896|NCT00728130|20840013|P1|COMPLETED|Overall Study||19
8456897|NCT00728130|20840013|P1|STARTED|Overall Study||22
8456898|NCT00727961|20840018|P1|NOT COMPLETED|Overall Study||37
8456899|NCT00727961|20840018|P1|COMPLETED|Overall Study||21
8456900|NCT00727961|20840018|P1|STARTED|Overall Study||58
8456901|NCT00727909|20840028|P4|NOT COMPLETED|Overall Study||5
8456902|NCT00727909|20840029|P3|NOT COMPLETED|Overall Study||9
8456903|NCT00727909|20840030|P2|NOT COMPLETED|Overall Study||11
8456906|NCT00727909|20840029|P3|COMPLETED|Overall Study||58
8456907|NCT00727909|20840030|P2|COMPLETED|Overall Study||61
8456908|NCT00727909|20840031|P1|COMPLETED|Overall Study||60
8456909|NCT00727909|20840028|P4|STARTED|Overall Study||75
8456910|NCT00727909|20840029|P3|STARTED|Overall Study||67
8456911|NCT00727909|20840030|P2|STARTED|Overall Study||72
8456912|NCT00727909|20840031|P1|STARTED|Overall Study||65
8456913|NCT00727857|20840038|P3|NOT COMPLETED|Overall Study||68
8456914|NCT00727857|20840039|P2|NOT COMPLETED|Overall Study||64
8456915|NCT00727857|20840040|P1|NOT COMPLETED|Overall Study||44
8456916|NCT00727857|20840038|P3|COMPLETED|Overall Study||142
8456917|NCT00727857|20840039|P2|COMPLETED|Overall Study||125
8456918|NCT00727857|20840040|P1|COMPLETED|Overall Study||157
8456919|NCT00727857|20840038|P3|STARTED|Overall Study||210
8456920|NCT00727857|20840039|P2|STARTED|Overall Study||189
8456921|NCT00727857|20840040|P1|STARTED|Overall Study||201
8456922|NCT00727844|20840128|P4|NOT COMPLETED|Second Randomization||0
8456923|NCT00727844|20840129|P3|NOT COMPLETED|Second Randomization||0
8456924|NCT00727844|20840130|P2|NOT COMPLETED|Second Randomization||0
8456925|NCT00727844|20840131|P1|NOT COMPLETED|Second Randomization||0
8456926|NCT00727844|20840128|P4|COMPLETED|Second Randomization||16
8456927|NCT00727844|20840129|P3|COMPLETED|Second Randomization||17
8456928|NCT00727844|20840130|P2|COMPLETED|Second Randomization||0
8456929|NCT00727844|20840131|P1|COMPLETED|Second Randomization||0
8456930|NCT00727844|20840128|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
8456931|NCT00727844|20840129|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
8456932|NCT00727844|20840130|P2|STARTED|Second Randomization||0
8456933|NCT00727844|20840131|P1|STARTED|Second Randomization||0
8456934|NCT00727844|20840128|P4|NOT COMPLETED|Initial Randomization||0
8456935|NCT00727844|20840129|P3|NOT COMPLETED|Initial Randomization||0
8456936|NCT00727844|20840130|P2|NOT COMPLETED|Initial Randomization||0
8456937|NCT00727844|20840131|P1|NOT COMPLETED|Initial Randomization||2
8456938|NCT00727844|20840128|P4|COMPLETED|Initial Randomization||0
8456939|NCT00727844|20840129|P3|COMPLETED|Initial Randomization||0
8456940|NCT00727844|20840130|P2|COMPLETED|Initial Randomization||20
8456941|NCT00727844|20840131|P1|COMPLETED|Initial Randomization||19
8456942|NCT00727844|20840128|P4|Included in MITT Analysis|Initial Randomization||0
8456943|NCT00727844|20840129|P3|Included in MITT Analysis|Initial Randomization||0
8456944|NCT00727844|20840130|P2|Included in MITT Analysis|Initial Randomization||20
8456945|NCT00727844|20840131|P1|Included in MITT Analysis|Initial Randomization||19
8456946|NCT00727844|20840128|P4|STARTED|Initial Randomization||0
8456947|NCT00727844|20840129|P3|STARTED|Initial Randomization||0
8456948|NCT00727844|20840130|P2|STARTED|Initial Randomization||20
8456949|NCT00727844|20840131|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
8456950|NCT00727740|20840138|P2|NOT COMPLETED|Overall Study||0
8456951|NCT00727740|20840139|P1|NOT COMPLETED|Overall Study||0
8456952|NCT00727740|20840138|P2|COMPLETED|Overall Study||61
8456953|NCT00727740|20840139|P1|COMPLETED|Overall Study||56
8456954|NCT00727740|20840138|P2|STARTED|Overall Study||61
8456955|NCT00727740|20840139|P1|STARTED|Overall Study||56
8456956|NCT00727714|20840145|P1|NOT COMPLETED|Overall Study||2
8456957|NCT00727714|20840145|P1|COMPLETED|Overall Study||93
8456958|NCT00727714|20840145|P1|STARTED|Overall Study||95
8456959|NCT00727649|20840155|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
8456960|NCT00727649|20840156|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
8456961|NCT00727649|20840155|P2|COMPLETED|Second Intervention (4-weeks)||34
8456962|NCT00727649|20840156|P1|COMPLETED|Second Intervention (4-weeks)||29
8456963|NCT00727649|20840155|P2|STARTED|Second Intervention (4-weeks)||37
8456964|NCT00727649|20840156|P1|STARTED|Second Intervention (4-weeks)||30
8456965|NCT00727649|20840155|P2|NOT COMPLETED|Wash-out (2-weeks)||3
8456966|NCT00727649|20840156|P1|NOT COMPLETED|Wash-out (2-weeks)||4
8456967|NCT00727649|20840155|P2|COMPLETED|Wash-out (2-weeks)||37
8456968|NCT00727649|20840156|P1|COMPLETED|Wash-out (2-weeks)||30
8456969|NCT00727649|20840155|P2|STARTED|Wash-out (2-weeks)||40
8456970|NCT00727649|20840156|P1|STARTED|Wash-out (2-weeks)||34
8456971|NCT00727649|20840155|P2|NOT COMPLETED|First Intervention (4-weeks)||3
8456972|NCT00727649|20840156|P1|NOT COMPLETED|First Intervention (4-weeks)||3
8456973|NCT00727649|20840155|P2|COMPLETED|First Intervention (4-weeks)||40
8456974|NCT00727649|20840156|P1|COMPLETED|First Intervention (4-weeks)||34
8456975|NCT00727649|20840155|P2|STARTED|First Intervention (4-weeks)||43
8456976|NCT00727649|20840156|P1|STARTED|First Intervention (4-weeks)||37
8456977|NCT00727636|20840170|P2|NOT COMPLETED|Overall Study||0
8456978|NCT00727636|20840171|P1|NOT COMPLETED|Overall Study||4
8456979|NCT00727636|20840170|P2|COMPLETED|Overall Study||15
8456980|NCT00727636|20840171|P1|COMPLETED|Overall Study||33
8456981|NCT00727636|20840170|P2|STARTED|Overall Study||15
8456982|NCT00727636|20840171|P1|STARTED|Overall Study||37
8456983|NCT00727597|20840185|P2|NOT COMPLETED|Overall Study||0
8456984|NCT00727597|20840186|P1|NOT COMPLETED|Overall Study||0
8456985|NCT00727597|20840185|P2|COMPLETED|Overall Study||50
8456986|NCT00727597|20840186|P1|COMPLETED|Overall Study||51
8456987|NCT00727597|20840185|P2|STARTED|Overall Study||50
8456988|NCT00727597|20840186|P1|STARTED|Overall Study||51
8456989|NCT00727571|20840198|P4|NOT COMPLETED|Overall Study||6
8456990|NCT00727571|20840199|P3|NOT COMPLETED|Overall Study||30
8456991|NCT00727571|20840200|P2|NOT COMPLETED|Overall Study||55
8456992|NCT00727571|20840201|P1|NOT COMPLETED|Overall Study||1
8456993|NCT00727571|20840198|P4|COMPLETED|Overall Study||163
8456994|NCT00727571|20840199|P3|COMPLETED|Overall Study||135
8456995|NCT00727571|20840200|P2|COMPLETED|Overall Study||173
8456996|NCT00727571|20840201|P1|COMPLETED|Overall Study||231
8456997|NCT00727571|20840198|P4|STARTED|Overall Study||169
8456998|NCT00727571|20840199|P3|STARTED|Overall Study||165
8456999|NCT00727571|20840200|P2|STARTED|Overall Study||228
8457000|NCT00727571|20840201|P1|STARTED|Overall Study||232
8457001|NCT00727558|20840228|P2|NOT COMPLETED|Overall Study||3
8457002|NCT00727558|20840229|P1|NOT COMPLETED|Overall Study||2
8457003|NCT00727558|20840228|P2|COMPLETED|Overall Study||118
8457004|NCT00727558|20840229|P1|COMPLETED|Overall Study||125
8457005|NCT00727558|20840228|P2|STARTED|Overall Study||121
8457006|NCT00727558|20840229|P1|STARTED|Overall Study||127
8457007|NCT00727532|20840247|P1|NOT COMPLETED|Overall Study||2
8457008|NCT00727532|20840247|P1|COMPLETED|Overall Study||7
8457009|NCT00727532|20840247|P1|STARTED|Overall Study||9
8457010|NCT00727506|20840259|P6|NOT COMPLETED|Overall Study||39
8457011|NCT00727506|20840260|P5|NOT COMPLETED|Overall Study||41
8457012|NCT00727506|20840261|P4|NOT COMPLETED|Overall Study||39
8457013|NCT00727506|20840262|P3|NOT COMPLETED|Overall Study||18
8457014|NCT00727506|20840263|P2|NOT COMPLETED|Overall Study||8
8457015|NCT00727506|20840264|P1|NOT COMPLETED|Overall Study||6
8457016|NCT00727506|20840259|P6|COMPLETED|Overall Study||0
8457017|NCT00727506|20840260|P5|COMPLETED|Overall Study||0
8457018|NCT00727506|20840261|P4|COMPLETED|Overall Study||0
8457019|NCT00727506|20840262|P3|COMPLETED|Overall Study||0
8457020|NCT00727506|20840263|P2|COMPLETED|Overall Study||0
8457021|NCT00727506|20840264|P1|COMPLETED|Overall Study||0
8457022|NCT00727506|20840259|P6|STARTED|Overall Study|Randomized|39
8457023|NCT00727506|20840260|P5|STARTED|Overall Study|Randomized|41
8457024|NCT00727506|20840261|P4|STARTED|Overall Study|Randomized|39
8457025|NCT00727506|20840262|P3|STARTED|Overall Study|Entered|18
8457026|NCT00727506|20840263|P2|STARTED|Overall Study|Entered|8
8457027|NCT00727506|20840264|P1|STARTED|Overall Study|Entered|6
8457028|NCT00727441|20840360|P3|NOT COMPLETED|Overall Study||25
8457029|NCT00727441|20840361|P2|NOT COMPLETED|Overall Study||22
8457030|NCT00727441|20840362|P1|NOT COMPLETED|Overall Study||18
8457031|NCT00727441|20840360|P3|COMPLETED|Overall Study||5
8457032|NCT00727441|20840361|P2|COMPLETED|Overall Study||6
8457033|NCT00727441|20840362|P1|COMPLETED|Overall Study||11
8457034|NCT00727441|20840360|P3|STARTED|Overall Study||30
8457035|NCT00727441|20840361|P2|STARTED|Overall Study||28
8457036|NCT00727441|20840362|P1|STARTED|Overall Study||29
8457037|NCT00727415|20840382|P1|NOT COMPLETED|Phase II||0
8457038|NCT00727415|20840382|P1|COMPLETED|Phase II||33
8457039|NCT00727415|20840382|P1|STARTED|Phase II||33
8457040|NCT00727415|20840382|P1|NOT COMPLETED|Phase I||2
8457041|NCT00727415|20840382|P1|COMPLETED|Phase I||7
8457042|NCT00727415|20840382|P1|STARTED|Phase I||9
8457043|NCT00727402|20840391|P1|NOT COMPLETED|Overall Study||116
8457044|NCT00727402|20840391|P1|COMPLETED|Overall Study||89
8457045|NCT00727402|20840391|P1|STARTED|Overall Study||205
8457046|NCT00727337|20840399|P4|NOT COMPLETED|Overall Study||9
8457047|NCT00727337|20840400|P3|NOT COMPLETED|Overall Study||10
8457048|NCT00727337|20840401|P2|NOT COMPLETED|Overall Study||10
8457049|NCT00727337|20840402|P1|NOT COMPLETED|Overall Study||7
8457050|NCT00727337|20840399|P4|COMPLETED|Overall Study||64
8457051|NCT00727337|20840400|P3|COMPLETED|Overall Study||63
8457052|NCT00727337|20840401|P2|COMPLETED|Overall Study||55
8457053|NCT00727337|20840402|P1|COMPLETED|Overall Study||61
8457054|NCT00727337|20840399|P4|STARTED|Overall Study||73
8457055|NCT00727337|20840400|P3|STARTED|Overall Study||73
8457056|NCT00727337|20840401|P2|STARTED|Overall Study||65
8457057|NCT00727337|20840402|P1|STARTED|Overall Study||68
8457058|NCT00727311|20840420|P1|NOT COMPLETED|Overall Study||1107
8457059|NCT00727311|20840420|P1|COMPLETED|Overall Study||1195
8457060|NCT00727311|20840420|P1|STARTED|Overall Study||2302
8457061|NCT00727298|20840427|P1|NOT COMPLETED|Overall Study||1257
8457062|NCT00727298|20840427|P1|COMPLETED|Overall Study||3228
8457063|NCT00727298|20840427|P1|STARTED|Overall Study||4485
8457064|NCT00727272|20840433|P3|NOT COMPLETED|Period III||0
8457065|NCT00727272|20840434|P2|NOT COMPLETED|Period III||0
8457066|NCT00727272|20840435|P1|NOT COMPLETED|Period III||0
8457067|NCT00727272|20840433|P3|COMPLETED|Period III||7
8457068|NCT00727272|20840434|P2|COMPLETED|Period III||9
8457069|NCT00727272|20840435|P1|COMPLETED|Period III||9
8457070|NCT00727272|20840433|P3|STARTED|Period III||7
8457071|NCT00727272|20840434|P2|STARTED|Period III||9
8457072|NCT00727272|20840435|P1|STARTED|Period III||9
8457073|NCT00727272|20840433|P3|NOT COMPLETED|Washout Period B||1
8457074|NCT00727272|20840434|P2|NOT COMPLETED|Washout Period B||0
8457075|NCT00727272|20840435|P1|NOT COMPLETED|Washout Period B||0
8457076|NCT00727272|20840433|P3|COMPLETED|Washout Period B|personal reasons|7
8457077|NCT00727272|20840434|P2|COMPLETED|Washout Period B||9
8457078|NCT00727272|20840435|P1|COMPLETED|Washout Period B||9
8457079|NCT00727272|20840433|P3|STARTED|Washout Period B||8
8457080|NCT00727272|20840434|P2|STARTED|Washout Period B||9
8457081|NCT00727272|20840435|P1|STARTED|Washout Period B||9
8457082|NCT00727272|20840433|P3|NOT COMPLETED|Period II||0
8457083|NCT00727272|20840434|P2|NOT COMPLETED|Period II||0
8457084|NCT00727272|20840435|P1|NOT COMPLETED|Period II||0
8457085|NCT00727272|20840433|P3|COMPLETED|Period II||8
8457086|NCT00727272|20840434|P2|COMPLETED|Period II||9
8457087|NCT00727272|20840435|P1|COMPLETED|Period II||9
8457088|NCT00727272|20840433|P3|STARTED|Period II||8
8457089|NCT00727272|20840434|P2|STARTED|Period II||9
8457090|NCT00727272|20840435|P1|STARTED|Period II||9
8457091|NCT00727272|20840433|P3|NOT COMPLETED|Washout Period A||1
8457092|NCT00727272|20840434|P2|NOT COMPLETED|Washout Period A||0
8457093|NCT00727272|20840435|P1|NOT COMPLETED|Washout Period A||0
8457094|NCT00727272|20840433|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
8457095|NCT00727272|20840434|P2|COMPLETED|Washout Period A||9
8457096|NCT00727272|20840435|P1|COMPLETED|Washout Period A||9
8457097|NCT00727272|20840433|P3|STARTED|Washout Period A||9
8457098|NCT00727272|20840434|P2|STARTED|Washout Period A||9
8457099|NCT00727272|20840435|P1|STARTED|Washout Period A||9
8457100|NCT00727272|20840433|P3|NOT COMPLETED|Period I||0
8457101|NCT00727272|20840434|P2|NOT COMPLETED|Period I||0
8457102|NCT00727272|20840435|P1|NOT COMPLETED|Period I||0
8457103|NCT00727272|20840433|P3|COMPLETED|Period I||9
8457104|NCT00727272|20840434|P2|COMPLETED|Period I||9
8457105|NCT00727272|20840435|P1|COMPLETED|Period I||9
8457106|NCT00727272|20840433|P3|STARTED|Period I||9
8457107|NCT00727272|20840434|P2|STARTED|Period I||9
8457108|NCT00727272|20840435|P1|STARTED|Period I||9
8457109|NCT00727259|20840452|P1|NOT COMPLETED|Overall Study||1055
8457110|NCT00727259|20840452|P1|COMPLETED|Overall Study||940
8457111|NCT00727259|20840452|P1|STARTED|Overall Study||1995
8457112|NCT00727246|20840461|P4|NOT COMPLETED|Overall Study||2
8457113|NCT00727246|20840462|P3|NOT COMPLETED|Overall Study||1
8457114|NCT00727246|20840463|P2|NOT COMPLETED|Overall Study||1
8457115|NCT00727246|20840464|P1|NOT COMPLETED|Overall Study||0
8457116|NCT00727246|20840461|P4|COMPLETED|Overall Study||3
8457117|NCT00727246|20840462|P3|COMPLETED|Overall Study||7
8457118|NCT00727246|20840463|P2|COMPLETED|Overall Study||2
8457119|NCT00727246|20840464|P1|COMPLETED|Overall Study||3
8457120|NCT00727246|20840461|P4|STARTED|Overall Study||5
8457121|NCT00727246|20840462|P3|STARTED|Overall Study||8
8457122|NCT00727246|20840463|P2|STARTED|Overall Study||3
8457123|NCT00727246|20840464|P1|STARTED|Overall Study||3
8457124|NCT00727220|20840480|P2|NOT COMPLETED|Overall Study||4
8457125|NCT00727220|20840481|P1|NOT COMPLETED|Overall Study||1
8457126|NCT00727220|20840480|P2|COMPLETED|Overall Study||17
8457127|NCT00727220|20840481|P1|COMPLETED|Overall Study||20
8457128|NCT00727220|20840480|P2|STARTED|Overall Study||21
8457129|NCT00727220|20840481|P1|STARTED|Overall Study||21
8457130|NCT00727194|20840487|P3|NOT COMPLETED|Treatment Period 2||0
8457131|NCT00727194|20840488|P2|NOT COMPLETED|Treatment Period 2||1
8457132|NCT00727194|20840489|P1|NOT COMPLETED|Treatment Period 2||0
8457133|NCT00727194|20840487|P3|COMPLETED|Treatment Period 2||0
8457134|NCT00727194|20840488|P2|COMPLETED|Treatment Period 2||5
8457135|NCT00727194|20840489|P1|COMPLETED|Treatment Period 2||6
8457136|NCT00727194|20840487|P3|STARTED|Treatment Period 2||0
8457137|NCT00727194|20840488|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
8457138|NCT00727194|20840489|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
8457139|NCT00727194|20840487|P3|NOT COMPLETED|Washout Period||0
8457140|NCT00727194|20840488|P2|NOT COMPLETED|Washout Period||0
8457141|NCT00727194|20840489|P1|NOT COMPLETED|Washout Period||0
8457142|NCT00727194|20840487|P3|COMPLETED|Washout Period||0
8457143|NCT00727194|20840488|P2|COMPLETED|Washout Period||7
8457144|NCT00727194|20840489|P1|COMPLETED|Washout Period||7
8457145|NCT00727194|20840487|P3|STARTED|Washout Period||0
8457146|NCT00727194|20840488|P2|STARTED|Washout Period||7
8457147|NCT00727194|20840489|P1|STARTED|Washout Period||7
8457148|NCT00727194|20840487|P3|NOT COMPLETED|Treatment Period 1||0
8457149|NCT00727194|20840488|P2|NOT COMPLETED|Treatment Period 1||0
8457150|NCT00727194|20840489|P1|NOT COMPLETED|Treatment Period 1||0
8457151|NCT00727194|20840487|P3|COMPLETED|Treatment Period 1||0
8457152|NCT00727194|20840488|P2|COMPLETED|Treatment Period 1||7
8457153|NCT00727194|20840489|P1|COMPLETED|Treatment Period 1||7
8457154|NCT00727194|20840487|P3|STARTED|Treatment Period 1||0
8457155|NCT00727194|20840488|P2|STARTED|Treatment Period 1||7
8457156|NCT00727194|20840489|P1|STARTED|Treatment Period 1||7
8457157|NCT00727194|20840487|P3|NOT COMPLETED|Screening Period||16
8457158|NCT00727194|20840488|P2|NOT COMPLETED|Screening Period||0
8457159|NCT00727194|20840489|P1|NOT COMPLETED|Screening Period||0
8457160|NCT00727194|20840487|P3|COMPLETED|Screening Period||0
8457161|NCT00727194|20840488|P2|COMPLETED|Screening Period||7
8457162|NCT00727194|20840489|P1|COMPLETED|Screening Period||7
8457163|NCT00727194|20840487|P3|STARTED|Screening Period||16
8457164|NCT00727194|20840488|P2|STARTED|Screening Period||7
8457165|NCT00727194|20840489|P1|STARTED|Screening Period||7
8457166|NCT00727090|20840525|P2|NOT COMPLETED|Overall Study||0
8457167|NCT00727090|20840526|P1|NOT COMPLETED|Overall Study||0
8457168|NCT00727090|20840525|P2|COMPLETED|Overall Study||3
8457169|NCT00727090|20840526|P1|COMPLETED|Overall Study||3
8457170|NCT00727090|20840525|P2|STARTED|Overall Study||3
8457171|NCT00727090|20840526|P1|STARTED|Overall Study||3
8457172|NCT00727064|20840544|P2|NOT COMPLETED|Overall Study||0
8457173|NCT00727064|20840545|P1|NOT COMPLETED|Overall Study||0
8457174|NCT00727064|20840544|P2|COMPLETED|Overall Study||7
8457175|NCT00727064|20840545|P1|COMPLETED|Overall Study||7
8457176|NCT00727064|20840544|P2|STARTED|Overall Study||7
8457177|NCT00727064|20840545|P1|STARTED|Overall Study||7
8457178|NCT00727025|20840561|P1|NOT COMPLETED|Overall Study||23
8457179|NCT00727025|20840561|P1|COMPLETED|Overall Study||51
8457180|NCT00727025|20840561|P1|STARTED|Overall Study||74
8457181|NCT00726999|20840573|P2|NOT COMPLETED|Overall Study||1
8457182|NCT00726999|20840574|P1|NOT COMPLETED|Overall Study||3
8457183|NCT00726999|20840573|P2|COMPLETED|Overall Study||30
8457184|NCT00726999|20840574|P1|COMPLETED|Overall Study||29
8457185|NCT00726999|20840573|P2|STARTED|Overall Study||31
8457186|NCT00726999|20840574|P1|STARTED|Overall Study||32
8457187|NCT00726986|20840586|P1|NOT COMPLETED|Maintenance Phase||3
8457188|NCT00726986|20840586|P1|COMPLETED|Maintenance Phase||0
8457189|NCT00726986|20840586|P1|STARTED|Maintenance Phase||3
8457190|NCT00726986|20840586|P1|NOT COMPLETED|Induction Phase||15
8457191|NCT00726986|20840586|P1|COMPLETED|Induction Phase||3
8457192|NCT00726986|20840586|P1|Maintance|Induction Phase||3
8457193|NCT00726986|20840586|P1|STARTED|Induction Phase||18
8457194|NCT00726895|20840593|P2|NOT COMPLETED|Second Intervention||0
8457195|NCT00726895|20840594|P1|NOT COMPLETED|Second Intervention||0
8457196|NCT00726895|20840593|P2|COMPLETED|Second Intervention||11
8457197|NCT00726895|20840594|P1|COMPLETED|Second Intervention||12
8457198|NCT00726895|20840593|P2|STARTED|Second Intervention||11
8457199|NCT00726895|20840594|P1|STARTED|Second Intervention||12
8457200|NCT00726895|20840593|P2|NOT COMPLETED|Washout Period of 7 Days||1
8457201|NCT00726895|20840594|P1|NOT COMPLETED|Washout Period of 7 Days||0
8457202|NCT00726895|20840593|P2|COMPLETED|Washout Period of 7 Days||11
8457203|NCT00726895|20840594|P1|COMPLETED|Washout Period of 7 Days||12
8457204|NCT00726895|20840593|P2|STARTED|Washout Period of 7 Days||12
8457205|NCT00726895|20840594|P1|STARTED|Washout Period of 7 Days||12
8457206|NCT00726895|20840593|P2|NOT COMPLETED|First Intervention||0
8457207|NCT00726895|20840594|P1|NOT COMPLETED|First Intervention||0
8457208|NCT00726895|20840593|P2|COMPLETED|First Intervention||12
8457209|NCT00726895|20840594|P1|COMPLETED|First Intervention||12
8457210|NCT00726895|20840593|P2|STARTED|First Intervention||12
8457211|NCT00726895|20840594|P1|STARTED|First Intervention||12
8457212|NCT00726882|20840607|P1|NOT COMPLETED|Overall Study||22
8457213|NCT00726882|20840607|P1|COMPLETED|Overall Study||13
8457214|NCT00726882|20840607|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
8457215|NCT00726882|20840607|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
8457216|NCT00726882|20840607|P1|STARTED|Overall Study||35
8457217|NCT00726830|20840615|P2|NOT COMPLETED|Overall Study||0
8457218|NCT00726830|20840616|P1|NOT COMPLETED|Overall Study||0
8457219|NCT00726830|20840615|P2|COMPLETED|Overall Study||0
8457220|NCT00726830|20840616|P1|COMPLETED|Overall Study||1
8457221|NCT00726830|20840615|P2|STARTED|Overall Study||0
8457222|NCT00726830|20840616|P1|STARTED|Overall Study||1
8457223|NCT00726752|20840622|P1|NOT COMPLETED|Overall Study||6
8457224|NCT00726752|20840622|P1|COMPLETED|Overall Study||0
8457225|NCT00726752|20840622|P1|STARTED|Overall Study||6
8457226|NCT00726739|20840638|P2|NOT COMPLETED|Overall Study||0
8457227|NCT00726739|20840639|P1|NOT COMPLETED|Overall Study||1
8457228|NCT00726739|20840638|P2|COMPLETED|Overall Study||10
8457229|NCT00726739|20840639|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
8457230|NCT00726739|20840638|P2|STARTED|Overall Study||10
8457231|NCT00726739|20840639|P1|STARTED|Overall Study||11
8457232|NCT00726713|20840655|P2|NOT COMPLETED|Overall Study||7
8457233|NCT00726713|20840656|P1|NOT COMPLETED|Overall Study||7
8457234|NCT00726713|20840655|P2|COMPLETED|Overall Study||101
8457235|NCT00726713|20840656|P1|COMPLETED|Overall Study||99
8457236|NCT00726713|20840655|P2|STARTED|Overall Study||108
8457237|NCT00726713|20840656|P1|STARTED|Overall Study||106
8457238|NCT00726661|20840684|P2|NOT COMPLETED|Overall Study||418
8457239|NCT00726661|20840685|P1|NOT COMPLETED|Overall Study||814
8457240|NCT00726661|20840684|P2|COMPLETED|Overall Study||17
8457241|NCT00726661|20840685|P1|COMPLETED|Overall Study||18
8457242|NCT00726661|20840684|P2|STARTED|Overall Study||435
8457243|NCT00726661|20840685|P1|STARTED|Overall Study||832
8457244|NCT00726622|20840702|P2|NOT COMPLETED|Overall Study||3
8457245|NCT00726622|20840703|P1|NOT COMPLETED|Overall Study||18
8457246|NCT00726622|20840702|P2|COMPLETED|Overall Study||240
8457247|NCT00726622|20840703|P1|COMPLETED|Overall Study||225
8457248|NCT00726622|20840702|P2|STARTED|Overall Study||243
8457249|NCT00726622|20840703|P1|STARTED|Overall Study||243
8457250|NCT00726609|20840721|P1|NOT COMPLETED|Overall Study||98
8457251|NCT00726609|20840721|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
8457252|NCT00726609|20840721|P1|STARTED|Overall Study||214
8457253|NCT00726557|20840725|P1|NOT COMPLETED|Overall Study||128
8457254|NCT00726557|20840725|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
8457255|NCT00726557|20840725|P1|STARTED|Overall Study||246
8457256|NCT00726453|20840732|P2|NOT COMPLETED|38 mm Length Group||3
8457257|NCT00726453|20840733|P1|NOT COMPLETED|38 mm Length Group||0
8457258|NCT00726453|20840732|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
8457259|NCT00726453|20840733|P1|COMPLETED|38 mm Length Group||0
8457260|NCT00726453|20840732|P2|STARTED|38 mm Length Group||114
8457261|NCT00726453|20840733|P1|STARTED|38 mm Length Group||0
8457262|NCT00726453|20840732|P2|NOT COMPLETED|Primary Enrollment Group||0
8457263|NCT00726453|20840733|P1|NOT COMPLETED|Primary Enrollment Group||31
8457264|NCT00726453|20840732|P2|COMPLETED|Primary Enrollment Group||0
8457265|NCT00726453|20840733|P1|COMPLETED|Primary Enrollment Group||1371
8457266|NCT00726453|20840732|P2|STARTED|Primary Enrollment Group||0
8457267|NCT00726453|20840733|P1|STARTED|Primary Enrollment Group||1402
8457268|NCT00726414|20840743|P2|NOT COMPLETED|Second Intervention||0
8457269|NCT00726414|20840744|P1|NOT COMPLETED|Second Intervention||0
8457270|NCT00726414|20840743|P2|COMPLETED|Second Intervention||11
8457271|NCT00726414|20840744|P1|COMPLETED|Second Intervention||11
8457272|NCT00726414|20840743|P2|STARTED|Second Intervention||11
8457273|NCT00726414|20840744|P1|STARTED|Second Intervention||11
8457274|NCT00726414|20840743|P2|NOT COMPLETED|Washout Period of 7 Days||0
8457275|NCT00726414|20840744|P1|NOT COMPLETED|Washout Period of 7 Days||0
8457276|NCT00726414|20840743|P2|COMPLETED|Washout Period of 7 Days||11
8457277|NCT00726414|20840744|P1|COMPLETED|Washout Period of 7 Days||11
8457278|NCT00726414|20840743|P2|STARTED|Washout Period of 7 Days||11
8457279|NCT00726414|20840744|P1|STARTED|Washout Period of 7 Days||11
8457280|NCT00726414|20840743|P2|NOT COMPLETED|First Intervention||0
8457281|NCT00726414|20840744|P1|NOT COMPLETED|First Intervention||0
8457282|NCT00726414|20840743|P2|COMPLETED|First Intervention||11
8457283|NCT00726414|20840744|P1|COMPLETED|First Intervention||11
8457284|NCT00726414|20840743|P2|STARTED|First Intervention||11
8457285|NCT00726414|20840744|P1|STARTED|First Intervention||11
8457286|NCT00726375|20840754|P1|NOT COMPLETED|Overall Study||0
8457287|NCT00726375|20840754|P1|COMPLETED|Overall Study||34
8457288|NCT00726375|20840754|P1|STARTED|Overall Study||34
8457289|NCT00726323|20840761|P2|NOT COMPLETED|Overall Study||31
8457290|NCT00726323|20840762|P1|NOT COMPLETED|Overall Study||37
8457291|NCT00726323|20840761|P2|COMPLETED|Overall Study||6
8457292|NCT00726323|20840762|P1|COMPLETED|Overall Study||0
8457293|NCT00726323|20840761|P2|STARTED|Overall Study||37
8457294|NCT00726323|20840762|P1|STARTED|Overall Study||37
8457295|NCT00726232|20840792|P8|NOT COMPLETED|Expansion Phase||38
8457296|NCT00726232|20840793|P7|NOT COMPLETED|Expansion Phase||24
8457297|NCT00726232|20840794|P6|NOT COMPLETED|Expansion Phase||0
8457298|NCT00726232|20840795|P5|NOT COMPLETED|Expansion Phase||0
8457299|NCT00726232|20840796|P4|NOT COMPLETED|Expansion Phase||0
8457300|NCT00726232|20840797|P3|NOT COMPLETED|Expansion Phase||0
8457301|NCT00726232|20840798|P2|NOT COMPLETED|Expansion Phase||0
8457302|NCT00726232|20840799|P1|NOT COMPLETED|Expansion Phase||0
8457303|NCT00726232|20840792|P8|COMPLETED|Expansion Phase||1
8457304|NCT00726232|20840793|P7|COMPLETED|Expansion Phase||10
8457305|NCT00726232|20840794|P6|COMPLETED|Expansion Phase||0
8457306|NCT00726232|20840795|P5|COMPLETED|Expansion Phase||0
8457307|NCT00726232|20840796|P4|COMPLETED|Expansion Phase||0
8457308|NCT00726232|20840797|P3|COMPLETED|Expansion Phase||0
8457309|NCT00726232|20840798|P2|COMPLETED|Expansion Phase||0
8457310|NCT00726232|20840799|P1|COMPLETED|Expansion Phase||0
8457311|NCT00726232|20840792|P8|ITT Participants|Expansion Phase||39
8457312|NCT00726232|20840793|P7|ITT Participants|Expansion Phase||34
8457313|NCT00726232|20840794|P6|ITT Participants|Expansion Phase||0
8457314|NCT00726232|20840795|P5|ITT Participants|Expansion Phase||0
8457315|NCT00726232|20840796|P4|ITT Participants|Expansion Phase||0
8457316|NCT00726232|20840797|P3|ITT Participants|Expansion Phase||0
8457317|NCT00726232|20840798|P2|ITT Participants|Expansion Phase||0
8457318|NCT00726232|20840799|P1|ITT Participants|Expansion Phase||0
8457319|NCT00726232|20840792|P8|Safety Evaluable Participants|Expansion Phase||39
8457320|NCT00726232|20840793|P7|Safety Evaluable Participants|Expansion Phase||34
8457321|NCT00726232|20840794|P6|Safety Evaluable Participants|Expansion Phase||0
8457322|NCT00726232|20840795|P5|Safety Evaluable Participants|Expansion Phase||0
8457323|NCT00726232|20840796|P4|Safety Evaluable Participants|Expansion Phase||0
8457324|NCT00726232|20840797|P3|Safety Evaluable Participants|Expansion Phase||0
8457325|NCT00726232|20840798|P2|Safety Evaluable Participants|Expansion Phase||0
8457326|NCT00726232|20840799|P1|Safety Evaluable Participants|Expansion Phase||0
8457327|NCT00726232|20840792|P8|STARTED|Expansion Phase||39
8457328|NCT00726232|20840793|P7|STARTED|Expansion Phase||34
8457329|NCT00726232|20840794|P6|STARTED|Expansion Phase||0
8457330|NCT00726232|20840795|P5|STARTED|Expansion Phase||0
8457331|NCT00726232|20840796|P4|STARTED|Expansion Phase||0
8457332|NCT00726232|20840797|P3|STARTED|Expansion Phase||0
8457333|NCT00726232|20840798|P2|STARTED|Expansion Phase||0
8457334|NCT00726232|20840799|P1|STARTED|Expansion Phase||0
8457335|NCT00726232|20840792|P8|NOT COMPLETED|Initial Phase (Dose-finding)||0
8457336|NCT00726232|20840793|P7|NOT COMPLETED|Initial Phase (Dose-finding)||0
8457337|NCT00726232|20840794|P6|NOT COMPLETED|Initial Phase (Dose-finding)||9
8457338|NCT00726232|20840795|P5|NOT COMPLETED|Initial Phase (Dose-finding)||21
8457339|NCT00726232|20840796|P4|NOT COMPLETED|Initial Phase (Dose-finding)||8
8457340|NCT00726232|20840797|P3|NOT COMPLETED|Initial Phase (Dose-finding)||5
8457341|NCT00726232|20840798|P2|NOT COMPLETED|Initial Phase (Dose-finding)||6
8457342|NCT00726232|20840799|P1|NOT COMPLETED|Initial Phase (Dose-finding)||13
8457343|NCT00726232|20840792|P8|COMPLETED|Initial Phase (Dose-finding)||0
8457344|NCT00726232|20840793|P7|COMPLETED|Initial Phase (Dose-finding)||0
8457345|NCT00726232|20840794|P6|COMPLETED|Initial Phase (Dose-finding)||0
8457346|NCT00726232|20840795|P5|COMPLETED|Initial Phase (Dose-finding)||1
8457347|NCT00726232|20840796|P4|COMPLETED|Initial Phase (Dose-finding)||0
8457348|NCT00726232|20840797|P3|COMPLETED|Initial Phase (Dose-finding)||2
8457349|NCT00726232|20840798|P2|COMPLETED|Initial Phase (Dose-finding)||2
8457350|NCT00726232|20840799|P1|COMPLETED|Initial Phase (Dose-finding)||6
8457351|NCT00726232|20840792|P8|ITT Participants|Initial Phase (Dose-finding)||0
8457352|NCT00726232|20840793|P7|ITT Participants|Initial Phase (Dose-finding)||0
8457353|NCT00726232|20840794|P6|ITT Participants|Initial Phase (Dose-finding)||9
8457354|NCT00726232|20840795|P5|ITT Participants|Initial Phase (Dose-finding)||22
8457355|NCT00726232|20840796|P4|ITT Participants|Initial Phase (Dose-finding)||8
8457356|NCT00726232|20840797|P3|ITT Participants|Initial Phase (Dose-finding)||7
8457357|NCT00726232|20840798|P2|ITT Participants|Initial Phase (Dose-finding)||8
8457358|NCT00726232|20840799|P1|ITT Participants|Initial Phase (Dose-finding)||19
8457359|NCT00726232|20840792|P8|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
8457360|NCT00726232|20840793|P7|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
8457361|NCT00726232|20840794|P6|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
8457362|NCT00726232|20840795|P5|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
8457363|NCT00726232|20840796|P4|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
8457364|NCT00726232|20840797|P3|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
8457365|NCT00726232|20840798|P2|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
8457366|NCT00726232|20840799|P1|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
8457367|NCT00726232|20840792|P8|STARTED|Initial Phase (Dose-finding)||0
8457368|NCT00726232|20840793|P7|STARTED|Initial Phase (Dose-finding)||0
8457369|NCT00726232|20840794|P6|STARTED|Initial Phase (Dose-finding)||9
8457370|NCT00726232|20840795|P5|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
8457371|NCT00726232|20840796|P4|STARTED|Initial Phase (Dose-finding)||8
8457372|NCT00726232|20840797|P3|STARTED|Initial Phase (Dose-finding)||7
8457373|NCT00726232|20840798|P2|STARTED|Initial Phase (Dose-finding)||8
8457374|NCT00726232|20840799|P1|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
8457375|NCT00726180|20840845|P1|NOT COMPLETED|Overall Study||0
8457376|NCT00726180|20840845|P1|COMPLETED|Overall Study||1
8457377|NCT00726180|20840845|P1|STARTED|Overall Study||1
8457378|NCT00726063|20840851|P2|NOT COMPLETED|Overall Study||7
8457379|NCT00726063|20840852|P1|NOT COMPLETED|Overall Study||9
8457380|NCT00726063|20840851|P2|COMPLETED|Overall Study|Number of implants = 239|112
8457381|NCT00726063|20840852|P1|COMPLETED|Overall Study|Number of implants =230|113
8457382|NCT00726063|20840851|P2|STARTED|Overall Study|Number of implants= 246|119
8457383|NCT00726063|20840852|P1|STARTED|Overall Study|Number of implants= 239|122
8457384|NCT00726037|20840858|P1|NOT COMPLETED|Overall Study||0
8457385|NCT00726037|20840858|P1|COMPLETED|Overall Study||7
8457386|NCT00726037|20840858|P1|STARTED|Overall Study||7
8457387|NCT00725985|20840866|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
8457388|NCT00725985|20840867|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
8457389|NCT00725985|20840868|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
8457390|NCT00725985|20840869|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457391|NCT00725985|20840870|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457392|NCT00725985|20840871|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457393|NCT00725985|20840872|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457394|NCT00725985|20840873|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457395|NCT00725985|20840874|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457396|NCT00725985|20840875|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457397|NCT00725985|20840876|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457398|NCT00725985|20840877|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
8457399|NCT00725985|20840866|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
8457400|NCT00725985|20840867|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
8457401|NCT00725985|20840868|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
8457402|NCT00725985|20840869|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
8457403|NCT00725985|20840870|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
8457404|NCT00725985|20840871|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
8457405|NCT00725985|20840872|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
8457406|NCT00725985|20840873|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
8457407|NCT00725985|20840874|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
8457408|NCT00725985|20840875|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
8457409|NCT00725985|20840876|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
8457410|NCT00725985|20840877|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
8457411|NCT00725985|20840866|P12|STARTED|LTFU (No Cladribine Treatment)||14
8457412|NCT00725985|20840867|P11|STARTED|LTFU (No Cladribine Treatment)||36
8457413|NCT00725985|20840868|P10|STARTED|LTFU (No Cladribine Treatment)||34
8457414|NCT00725985|20840869|P9|STARTED|LTFU (No Cladribine Treatment)||0
8457415|NCT00725985|20840870|P8|STARTED|LTFU (No Cladribine Treatment)||0
8457416|NCT00725985|20840871|P7|STARTED|LTFU (No Cladribine Treatment)||0
8457417|NCT00725985|20840872|P6|STARTED|LTFU (No Cladribine Treatment)||0
8457418|NCT00725985|20840873|P5|STARTED|LTFU (No Cladribine Treatment)||0
8457419|NCT00725985|20840874|P4|STARTED|LTFU (No Cladribine Treatment)||0
8457420|NCT00725985|20840875|P3|STARTED|LTFU (No Cladribine Treatment)||0
8457421|NCT00725985|20840876|P2|STARTED|LTFU (No Cladribine Treatment)||0
8457422|NCT00725985|20840877|P1|STARTED|LTFU (No Cladribine Treatment)||0
8457423|NCT00725985|20840866|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457424|NCT00725985|20840867|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457425|NCT00725985|20840868|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457426|NCT00725985|20840869|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
8457427|NCT00725985|20840870|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
8457428|NCT00725985|20840871|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
8457429|NCT00725985|20840872|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457430|NCT00725985|20840873|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457431|NCT00725985|20840874|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457432|NCT00725985|20840875|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457433|NCT00725985|20840876|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457434|NCT00725985|20840877|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
8457435|NCT00725985|20840866|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
8457436|NCT00725985|20840867|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
8457437|NCT00725985|20840868|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
8457438|NCT00725985|20840869|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
8457439|NCT00725985|20840870|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
8457440|NCT00725985|20840871|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
8457441|NCT00725985|20840872|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
8457442|NCT00725985|20840873|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
8457443|NCT00725985|20840874|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
8457444|NCT00725985|20840875|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
8457445|NCT00725985|20840876|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
8457446|NCT00725985|20840877|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
8457447|NCT00725985|20840866|P12|STARTED|LTFU (With Cladribine Treatment)||0
8457448|NCT00725985|20840867|P11|STARTED|LTFU (With Cladribine Treatment)||0
8457449|NCT00725985|20840868|P10|STARTED|LTFU (With Cladribine Treatment)||0
8457450|NCT00725985|20840869|P9|STARTED|LTFU (With Cladribine Treatment)||17
8457451|NCT00725985|20840870|P8|STARTED|LTFU (With Cladribine Treatment)||9
8457452|NCT00725985|20840871|P7|STARTED|LTFU (With Cladribine Treatment)||9
8457453|NCT00725985|20840872|P6|STARTED|LTFU (With Cladribine Treatment)||0
8457454|NCT00725985|20840873|P5|STARTED|LTFU (With Cladribine Treatment)||0
8457455|NCT00725985|20840874|P4|STARTED|LTFU (With Cladribine Treatment)||0
8457456|NCT00725985|20840875|P3|STARTED|LTFU (With Cladribine Treatment)||0
8457457|NCT00725985|20840876|P2|STARTED|LTFU (With Cladribine Treatment)||0
8457458|NCT00725985|20840877|P1|STARTED|LTFU (With Cladribine Treatment)||0
8457459|NCT00725985|20840866|P12|NOT COMPLETED|OLMP||0
8457460|NCT00725985|20840867|P11|NOT COMPLETED|OLMP||0
8457461|NCT00725985|20840868|P10|NOT COMPLETED|OLMP||0
8457462|NCT00725985|20840869|P9|NOT COMPLETED|OLMP||0
8457463|NCT00725985|20840870|P8|NOT COMPLETED|OLMP||0
8457464|NCT00725985|20840871|P7|NOT COMPLETED|OLMP||0
8457465|NCT00725985|20840872|P6|NOT COMPLETED|OLMP||53
8457466|NCT00725985|20840873|P5|NOT COMPLETED|OLMP||23
8457467|NCT00725985|20840874|P4|NOT COMPLETED|OLMP||18
8457468|NCT00725985|20840875|P3|NOT COMPLETED|OLMP||0
8457469|NCT00725985|20840876|P2|NOT COMPLETED|OLMP||0
8457470|NCT00725985|20840877|P1|NOT COMPLETED|OLMP||0
8457471|NCT00725985|20840866|P12|COMPLETED|OLMP||0
8457472|NCT00725985|20840867|P11|COMPLETED|OLMP||0
8457473|NCT00725985|20840868|P10|COMPLETED|OLMP||0
8457474|NCT00725985|20840869|P9|COMPLETED|OLMP||0
8457475|NCT00725985|20840870|P8|COMPLETED|OLMP||0
8457476|NCT00725985|20840871|P7|COMPLETED|OLMP||0
8457477|NCT00725985|20840872|P6|COMPLETED|OLMP||7
8457478|NCT00725985|20840873|P5|COMPLETED|OLMP||2
8457479|NCT00725985|20840874|P4|COMPLETED|OLMP||6
8457480|NCT00725985|20840875|P3|COMPLETED|OLMP||0
8457481|NCT00725985|20840876|P2|COMPLETED|OLMP||0
8457482|NCT00725985|20840877|P1|COMPLETED|OLMP||0
8457483|NCT00725985|20840866|P12|STARTED|OLMP||0
8457484|NCT00725985|20840867|P11|STARTED|OLMP||0
8457485|NCT00725985|20840868|P10|STARTED|OLMP||0
8457486|NCT00725985|20840869|P9|STARTED|OLMP||0
8457487|NCT00725985|20840870|P8|STARTED|OLMP||0
8457488|NCT00725985|20840871|P7|STARTED|OLMP||0
8457489|NCT00725985|20840872|P6|STARTED|OLMP||60
8457490|NCT00725985|20840873|P5|STARTED|OLMP||25
8457491|NCT00725985|20840874|P4|STARTED|OLMP||24
8457492|NCT00725985|20840875|P3|STARTED|OLMP||0
8457493|NCT00725985|20840876|P2|STARTED|OLMP||0
8457494|NCT00725985|20840877|P1|STARTED|OLMP||0
8457495|NCT00725985|20840866|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457496|NCT00725985|20840867|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457497|NCT00725985|20840868|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457498|NCT00725985|20840869|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457499|NCT00725985|20840870|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457500|NCT00725985|20840871|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457501|NCT00725985|20840872|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457502|NCT00725985|20840873|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457503|NCT00725985|20840874|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
8457504|NCT00725985|20840875|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
8457505|NCT00725985|20840876|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
8457506|NCT00725985|20840877|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
8457507|NCT00725985|20840866|P12|COMPLETED|ITP (Up to 96 Weeks)||0
8457508|NCT00725985|20840867|P11|COMPLETED|ITP (Up to 96 Weeks)||0
8457509|NCT00725985|20840868|P10|COMPLETED|ITP (Up to 96 Weeks)||0
8457510|NCT00725985|20840869|P9|COMPLETED|ITP (Up to 96 Weeks)||0
8457511|NCT00725985|20840870|P8|COMPLETED|ITP (Up to 96 Weeks)||0
8457512|NCT00725985|20840871|P7|COMPLETED|ITP (Up to 96 Weeks)||0
8457513|NCT00725985|20840872|P6|COMPLETED|ITP (Up to 96 Weeks)||0
8457514|NCT00725985|20840873|P5|COMPLETED|ITP (Up to 96 Weeks)||0
8457515|NCT00725985|20840874|P4|COMPLETED|ITP (Up to 96 Weeks)||0
8457516|NCT00725985|20840875|P3|COMPLETED|ITP (Up to 96 Weeks)||104
8457517|NCT00725985|20840876|P2|COMPLETED|ITP (Up to 96 Weeks)||131
8457518|NCT00725985|20840877|P1|COMPLETED|ITP (Up to 96 Weeks)||104
8457519|NCT00725985|20840866|P12|Treated|ITP (Up to 96 Weeks)||0
8457520|NCT00725985|20840867|P11|Treated|ITP (Up to 96 Weeks)||0
8457521|NCT00725985|20840868|P10|Treated|ITP (Up to 96 Weeks)||0
8457522|NCT00725985|20840869|P9|Treated|ITP (Up to 96 Weeks)||0
8457523|NCT00725985|20840870|P8|Treated|ITP (Up to 96 Weeks)||0
8457524|NCT00725985|20840871|P7|Treated|ITP (Up to 96 Weeks)||0
8457525|NCT00725985|20840872|P6|Treated|ITP (Up to 96 Weeks)||0
8457526|NCT00725985|20840873|P5|Treated|ITP (Up to 96 Weeks)||0
8457527|NCT00725985|20840874|P4|Treated|ITP (Up to 96 Weeks)||0
8457528|NCT00725985|20840875|P3|Treated|ITP (Up to 96 Weeks)||206
8457529|NCT00725985|20840876|P2|Treated|ITP (Up to 96 Weeks)||206
8457530|NCT00725985|20840877|P1|Treated|ITP (Up to 96 Weeks)||204
8457531|NCT00725985|20840866|P12|STARTED|ITP (Up to 96 Weeks)||0
8457532|NCT00725985|20840867|P11|STARTED|ITP (Up to 96 Weeks)||0
8457533|NCT00725985|20840868|P10|STARTED|ITP (Up to 96 Weeks)||0
8457534|NCT00725985|20840869|P9|STARTED|ITP (Up to 96 Weeks)||0
8457535|NCT00725985|20840870|P8|STARTED|ITP (Up to 96 Weeks)||0
8457536|NCT00725985|20840871|P7|STARTED|ITP (Up to 96 Weeks)||0
8457537|NCT00725985|20840872|P6|STARTED|ITP (Up to 96 Weeks)||0
8457538|NCT00725985|20840873|P5|STARTED|ITP (Up to 96 Weeks)||0
8457539|NCT00725985|20840874|P4|STARTED|ITP (Up to 96 Weeks)||0
8457540|NCT00725985|20840875|P3|STARTED|ITP (Up to 96 Weeks)||206
8457541|NCT00725985|20840876|P2|STARTED|ITP (Up to 96 Weeks)||206
8457542|NCT00725985|20840877|P1|STARTED|ITP (Up to 96 Weeks)||205
8457543|NCT00725959|20840905|P2|NOT COMPLETED|Overall Study||197
8457544|NCT00725959|20840906|P1|NOT COMPLETED|Overall Study||289
8457545|NCT00725959|20840905|P2|COMPLETED|Overall Study||439
8457546|NCT00725959|20840906|P1|COMPLETED|Overall Study||653
8457547|NCT00725959|20840905|P2|STARTED|Overall Study||636
8457548|NCT00725959|20840906|P1|STARTED|Overall Study||942
8457549|NCT00725920|20840914|P2|NOT COMPLETED|Overall Study||6
8457550|NCT00725920|20840915|P1|NOT COMPLETED|Overall Study||3
8457551|NCT00725920|20840914|P2|COMPLETED|Overall Study||12
8457552|NCT00725920|20840915|P1|COMPLETED|Overall Study||14
8457553|NCT00725920|20840914|P2|STARTED|Overall Study||18
8457554|NCT00725920|20840915|P1|STARTED|Overall Study||17
8457555|NCT00725842|20840921|P1|NOT COMPLETED|Overall Study||40
8457556|NCT00725842|20840921|P1|COMPLETED|Overall Study||57
8457557|NCT00725842|20840921|P1|Participants Eligible for Analysis|Overall Study||90
8457558|NCT00725842|20840921|P1|STARTED|Overall Study||97
8457559|NCT00725764|20840928|P1|NOT COMPLETED|Overall Study||14
8457560|NCT00725764|20840928|P1|COMPLETED|Overall Study||0
8457561|NCT00725764|20840928|P1|STARTED|Overall Study||14
8457562|NCT00725751|20840948|P2|NOT COMPLETED|Overall Study||108
8457563|NCT00725751|20840949|P1|NOT COMPLETED|Overall Study||34
8457564|NCT00725751|20840948|P2|COMPLETED|Overall Study||150
8457565|NCT00725751|20840949|P1|COMPLETED|Overall Study||56
8457566|NCT00725751|20840948|P2|STARTED|Overall Study||258
8457567|NCT00725751|20840949|P1|STARTED|Overall Study||90
8457568|NCT00725725|20840961|P3|NOT COMPLETED|Overall Study||5
8457569|NCT00725725|20840962|P2|NOT COMPLETED|Overall Study||4
8457570|NCT00725725|20840963|P1|NOT COMPLETED|Overall Study||4
8457571|NCT00725725|20840961|P3|COMPLETED|Overall Study||12
8457572|NCT00725725|20840962|P2|COMPLETED|Overall Study||11
8457573|NCT00725725|20840963|P1|COMPLETED|Overall Study||10
8457574|NCT00725725|20840961|P3|Treated|Overall Study||14
8457575|NCT00725725|20840962|P2|Treated|Overall Study||15
8457576|NCT00725725|20840963|P1|Treated|Overall Study||11
8457577|NCT00725725|20840961|P3|STARTED|Overall Study||17
8457578|NCT00725725|20840962|P2|STARTED|Overall Study||15
8457579|NCT00725725|20840963|P1|STARTED|Overall Study||14
8457580|NCT00725712|20841006|P2|NOT COMPLETED|Overall Study||26
8457581|NCT00725712|20841007|P1|NOT COMPLETED|Overall Study||48
8457582|NCT00725712|20841006|P2|COMPLETED|Overall Study||0
8457583|NCT00725712|20841007|P1|COMPLETED|Overall Study||0
8457584|NCT00725712|20841006|P2|STARTED|Overall Study||26
8457585|NCT00725712|20841007|P1|STARTED|Overall Study||48
8457586|NCT00725621|20841043|P1|NOT COMPLETED|Overall Study||271
8457587|NCT00725621|20841043|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
8457588|NCT00725621|20841043|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
8457589|NCT00725608|20841066|P1|NOT COMPLETED|Overall Study||167
8457590|NCT00725608|20841066|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
8457591|NCT00725608|20841066|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
8457592|NCT00725543|20841072|P1|NOT COMPLETED|Overall Study||153
8457593|NCT00725543|20841072|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
8457594|NCT00725543|20841072|P1|STARTED|Overall Study||358
8457595|NCT00725530|20841081|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
8457596|NCT00725530|20841082|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
8457597|NCT00725530|20841081|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
8457598|NCT00725530|20841082|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
8457599|NCT00725530|20841081|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
8457600|NCT00725530|20841082|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
8457601|NCT00725530|20841081|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
8457602|NCT00725530|20841082|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
8457603|NCT00725530|20841081|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
8457604|NCT00725530|20841082|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
8457605|NCT00725530|20841081|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
8457606|NCT00725530|20841082|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
8457607|NCT00725504|20841088|P1|NOT COMPLETED|Overall Study||0
8457608|NCT00725504|20841088|P1|COMPLETED|Overall Study||71
8457609|NCT00725504|20841088|P1|STARTED|Overall Study||71
8457610|NCT00725491|20841097|P2|NOT COMPLETED|Overall Study||18
8457611|NCT00725491|20841098|P1|NOT COMPLETED|Overall Study||9
8457612|NCT00725491|20841097|P2|COMPLETED|Overall Study||102
8457613|NCT00725491|20841098|P1|COMPLETED|Overall Study||104
8457614|NCT00725491|20841097|P2|STARTED|Overall Study|Intent-to-Treat Group|120
8457615|NCT00725491|20841098|P1|STARTED|Overall Study|Intent-to-Treat Group|113
8457616|NCT00725452|20841104|P1|NOT COMPLETED|Overall Study||11
8457617|NCT00725452|20841104|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
8457618|NCT00725452|20841104|P1|STARTED|Overall Study||26
8457619|NCT00725361|20841113|P1|NOT COMPLETED|Overall Study||4
8457620|NCT00725361|20841113|P1|COMPLETED|Overall Study||16
8457621|NCT00725361|20841113|P1|STARTED|Overall Study||20
8457622|NCT00725322|20841123|P2|NOT COMPLETED|Second Injection Visit||0
8457623|NCT00725322|20841124|P1|NOT COMPLETED|Second Injection Visit||0
8457624|NCT00725322|20841123|P2|COMPLETED|Second Injection Visit||14
8457625|NCT00725322|20841124|P1|COMPLETED|Second Injection Visit||13
8457626|NCT00725322|20841123|P2|STARTED|Second Injection Visit||14
8457627|NCT00725322|20841124|P1|STARTED|Second Injection Visit||13
8457628|NCT00725322|20841123|P2|NOT COMPLETED|Washout (28 Days)||1
8457629|NCT00725322|20841124|P1|NOT COMPLETED|Washout (28 Days)||2
8457630|NCT00725322|20841123|P2|COMPLETED|Washout (28 Days)||14
8457631|NCT00725322|20841124|P1|COMPLETED|Washout (28 Days)||13
8457632|NCT00725322|20841123|P2|STARTED|Washout (28 Days)||15
8457633|NCT00725322|20841124|P1|STARTED|Washout (28 Days)||15
8457634|NCT00725322|20841123|P2|NOT COMPLETED|First Injection Visit||0
8457635|NCT00725322|20841124|P1|NOT COMPLETED|First Injection Visit||0
8457636|NCT00725322|20841123|P2|COMPLETED|First Injection Visit||15
8457637|NCT00725322|20841124|P1|COMPLETED|First Injection Visit||15
8457638|NCT00725322|20841123|P2|STARTED|First Injection Visit||15
8457639|NCT00725322|20841124|P1|STARTED|First Injection Visit||15
8457640|NCT00725296|20841132|P1|NOT COMPLETED|Overall Study||62
8457641|NCT00725296|20841132|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
8457642|NCT00725296|20841132|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
8457643|NCT00725283|20841141|P1|NOT COMPLETED|Overall Study||24
8457644|NCT00725283|20841141|P1|COMPLETED|Overall Study||10
8457645|NCT00725283|20841141|P1|STARTED|Overall Study||34
8457646|NCT00725270|20841153|P2|NOT COMPLETED|Overall Study||0
8457647|NCT00725270|20841154|P1|NOT COMPLETED|Overall Study||0
8457648|NCT00725270|20841153|P2|COMPLETED|Overall Study||7
8457649|NCT00725270|20841154|P1|COMPLETED|Overall Study||5
8457650|NCT00725270|20841153|P2|STARTED|Overall Study||7
8457651|NCT00725270|20841154|P1|STARTED|Overall Study||5
8457652|NCT00725205|20841162|P1|NOT COMPLETED|Overall Study||87
8457653|NCT00725205|20841162|P1|COMPLETED|Overall Study||207
8457654|NCT00725205|20841162|P1|STARTED|Overall Study||294
8457655|NCT00725153|20841168|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
8457656|NCT00725153|20841169|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
8457657|NCT00725153|20841168|P2|COMPLETED|Period Two, 10 Hours of Wear||28
8457658|NCT00725153|20841169|P1|COMPLETED|Period Two, 10 Hours of Wear||27
8457659|NCT00725153|20841168|P2|STARTED|Period Two, 10 Hours of Wear||28
8457660|NCT00725153|20841169|P1|STARTED|Period Two, 10 Hours of Wear||27
8457661|NCT00725153|20841168|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
8457662|NCT00725153|20841169|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
8457663|NCT00725153|20841168|P2|COMPLETED|Period One, 10 Hours of Wear||28
8457664|NCT00725153|20841169|P1|COMPLETED|Period One, 10 Hours of Wear||27
8457665|NCT00725153|20841168|P2|STARTED|Period One, 10 Hours of Wear||28
8457666|NCT00725153|20841169|P1|STARTED|Period One, 10 Hours of Wear||27
8457667|NCT00725101|20841175|P1|NOT COMPLETED|Overall Study||495
8457668|NCT00725101|20841175|P1|COMPLETED|Overall Study||1205
8457669|NCT00725101|20841175|P1|STARTED|Overall Study||1700
8457670|NCT00725075|20841198|P3|NOT COMPLETED|Overall Study||9
8457671|NCT00725075|20841199|P2|NOT COMPLETED|Overall Study||8
8457672|NCT00725075|20841200|P1|NOT COMPLETED|Overall Study||11
8457673|NCT00725075|20841198|P3|COMPLETED|Overall Study||61
8457674|NCT00725075|20841199|P2|COMPLETED|Overall Study||65
8457675|NCT00725075|20841200|P1|COMPLETED|Overall Study||61
8457676|NCT00725075|20841198|P3|Treated|Overall Study||70
8457677|NCT00725075|20841199|P2|Treated|Overall Study||73
8457678|NCT00725075|20841200|P1|Treated|Overall Study||71
8457679|NCT00725075|20841198|P3|STARTED|Overall Study||70
8457680|NCT00725075|20841199|P2|STARTED|Overall Study||73
8457681|NCT00725075|20841200|P1|STARTED|Overall Study||72
8457682|NCT00725049|20841246|P2|NOT COMPLETED|Overall Study||0
8457683|NCT00725049|20841247|P1|NOT COMPLETED|Overall Study||0
8457684|NCT00725049|20841246|P2|COMPLETED|Overall Study||20
8457685|NCT00725049|20841247|P1|COMPLETED|Overall Study||17
8457686|NCT00725049|20841246|P2|STARTED|Overall Study||20
8457687|NCT00725049|20841247|P1|STARTED|Overall Study||17
8457688|NCT00725010|20841253|P1|NOT COMPLETED|Overall Study||25
8457689|NCT00725010|20841253|P1|COMPLETED|Overall Study||25
8457690|NCT00725010|20841253|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
8457691|NCT00724984|20841267|P6|NOT COMPLETED|Overall Study||5
8457692|NCT00724984|20841268|P5|NOT COMPLETED|Overall Study||4
8457693|NCT00724984|20841269|P4|NOT COMPLETED|Overall Study||2
8457694|NCT00724984|20841270|P3|NOT COMPLETED|Overall Study||0
8457695|NCT00724984|20841271|P2|NOT COMPLETED|Overall Study||1
8457696|NCT00724984|20841272|P1|NOT COMPLETED|Overall Study||1
8457697|NCT00724984|20841267|P6|COMPLETED|Overall Study||9
8457698|NCT00724984|20841268|P5|COMPLETED|Overall Study||12
8457699|NCT00724984|20841269|P4|COMPLETED|Overall Study||7
8457700|NCT00724984|20841270|P3|COMPLETED|Overall Study||3
8457701|NCT00724984|20841271|P2|COMPLETED|Overall Study||7
8457702|NCT00724984|20841272|P1|COMPLETED|Overall Study||4
8457703|NCT00724984|20841267|P6|STARTED|Overall Study||14
8457704|NCT00724984|20841268|P5|STARTED|Overall Study||16
8457705|NCT00724984|20841269|P4|STARTED|Overall Study||9
8457706|NCT00724984|20841270|P3|STARTED|Overall Study||3
8457707|NCT00724984|20841271|P2|STARTED|Overall Study||8
8457708|NCT00724984|20841272|P1|STARTED|Overall Study||5
8457709|NCT00724971|20841286|P1|NOT COMPLETED|Overall Study||6
8457710|NCT00724971|20841286|P1|COMPLETED|Overall Study||4
8457711|NCT00724971|20841286|P1|STARTED|Overall Study||10
8457712|NCT00724958|20841301|P1|NOT COMPLETED|Overall Study||182
8457713|NCT00724958|20841301|P1|COMPLETED|Overall Study||166
8457714|NCT00724958|20841301|P1|STARTED|Overall Study||348
8457715|NCT00724945|20841310|P2|NOT COMPLETED|Period 2||0
8457716|NCT00724945|20841311|P1|NOT COMPLETED|Period 2||4
8457717|NCT00724945|20841310|P2|COMPLETED|Period 2||54
8457718|NCT00724945|20841311|P1|COMPLETED|Period 2||51
8457719|NCT00724945|20841310|P2|STARTED|Period 2||54
8457720|NCT00724945|20841311|P1|STARTED|Period 2||55
8457721|NCT00724945|20841310|P2|NOT COMPLETED|Period 1||1
8457722|NCT00724945|20841311|P1|NOT COMPLETED|Period 1||3
8457723|NCT00724945|20841310|P2|COMPLETED|Period 1||54
8457724|NCT00724945|20841311|P1|COMPLETED|Period 1||55
8457725|NCT00724945|20841310|P2|STARTED|Period 1||55
8457726|NCT00724945|20841311|P1|STARTED|Period 1||58
8457727|NCT00724932|20841323|P2|NOT COMPLETED|Overall Study||3
8457728|NCT00724932|20841324|P1|NOT COMPLETED|Overall Study||5
8457729|NCT00724932|20841323|P2|COMPLETED|Overall Study||67
8457730|NCT00724932|20841324|P1|COMPLETED|Overall Study||65
8457731|NCT00724932|20841323|P2|STARTED|Overall Study||70
8457732|NCT00724932|20841324|P1|STARTED|Overall Study||70
8457733|NCT00724893|20841395|P2|NOT COMPLETED|Overall Study||458
8457734|NCT00724893|20841396|P1|NOT COMPLETED|Overall Study||364
8457735|NCT00724893|20841395|P2|COMPLETED|Overall Study||670
8457736|NCT00724893|20841396|P1|COMPLETED|Overall Study||938
8457737|NCT00724893|20841395|P2|STARTED|Overall Study||1128
8457738|NCT00724893|20841396|P1|STARTED|Overall Study||1302
8457739|NCT00724867|20841464|P1|NOT COMPLETED|Overall Study||128
8457740|NCT00724867|20841464|P1|COMPLETED|Overall Study||140
8457741|NCT00724867|20841464|P1|STARTED|Overall Study||268
8457742|NCT00724854|20841504|P2|NOT COMPLETED|Overall Study||31
8457743|NCT00724854|20841505|P1|NOT COMPLETED|Overall Study||403
8457744|NCT00724854|20841504|P2|COMPLETED|Overall Study||41
8457745|NCT00724854|20841505|P1|COMPLETED|Overall Study||607
8457746|NCT00724854|20841504|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
8457747|NCT00724854|20841505|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
8457748|NCT00724815|20841522|P2|NOT COMPLETED|Overall Study||39
8457749|NCT00724815|20841523|P1|NOT COMPLETED|Overall Study||43
8457750|NCT00724815|20841522|P2|COMPLETED|Overall Study||226
8457751|NCT00724815|20841523|P1|COMPLETED|Overall Study||222
8457752|NCT00724815|20841522|P2|STARTED|Overall Study|subjects randomized|265
8457753|NCT00724815|20841523|P1|STARTED|Overall Study|subjects randomized|265
8457754|NCT00724750|20841537|P2|NOT COMPLETED|Overall Study||0
8457755|NCT00724750|20841538|P1|NOT COMPLETED|Overall Study||0
8457756|NCT00724750|20841537|P2|COMPLETED|Overall Study||42
8457757|NCT00724750|20841538|P1|COMPLETED|Overall Study||45
8457758|NCT00724750|20841537|P2|STARTED|Overall Study||42
8457759|NCT00724750|20841538|P1|STARTED|Overall Study||45
8457760|NCT00724711|20841556|P2|NOT COMPLETED|Overall Study||17
8457761|NCT00724711|20841557|P1|NOT COMPLETED|Overall Study||17
8457762|NCT00724711|20841556|P2|COMPLETED|Overall Study||139
8457763|NCT00724711|20841557|P1|COMPLETED|Overall Study||138
8457764|NCT00724711|20841556|P2|STARTED|Overall Study||156
8457765|NCT00724711|20841557|P1|STARTED|Overall Study||155
8457766|NCT00724698|20841589|P1|NOT COMPLETED|Overall Study||90
8457767|NCT00724698|20841589|P1|COMPLETED|Overall Study||2921
8457768|NCT00724698|20841589|P1|STARTED|Overall Study||3011
8457769|NCT00724594|20841596|P4|NOT COMPLETED|Overall Study||1
8457770|NCT00724594|20841597|P3|NOT COMPLETED|Overall Study||0
8457771|NCT00724594|20841598|P2|NOT COMPLETED|Overall Study||0
8457772|NCT00724594|20841599|P1|NOT COMPLETED|Overall Study||0
8457773|NCT00724594|20841596|P4|COMPLETED|Overall Study||10
8457774|NCT00724594|20841597|P3|COMPLETED|Overall Study||11
8457775|NCT00724594|20841598|P2|COMPLETED|Overall Study||12
8457776|NCT00724594|20841599|P1|COMPLETED|Overall Study||12
8457777|NCT00724594|20841596|P4|STARTED|Overall Study||11
8457778|NCT00724594|20841597|P3|STARTED|Overall Study||11
8457779|NCT00724594|20841598|P2|STARTED|Overall Study||12
8457780|NCT00724594|20841599|P1|STARTED|Overall Study||12
8457781|NCT00724568|20841634|P2|NOT COMPLETED|Overall Study||0
8457782|NCT00724568|20841635|P1|NOT COMPLETED|Overall Study||0
8457783|NCT00724568|20841634|P2|COMPLETED|Overall Study||32
8457784|NCT00724568|20841635|P1|COMPLETED|Overall Study||42
8457785|NCT00724568|20841634|P2|STARTED|Overall Study||32
8457786|NCT00724568|20841635|P1|STARTED|Overall Study||42
8457787|NCT00724503|20841642|P2|NOT COMPLETED|Overall Study||220
8457788|NCT00724503|20841643|P1|NOT COMPLETED|Overall Study||210
8457789|NCT00724503|20841642|P2|COMPLETED|Overall Study||43
8457790|NCT00724503|20841643|P1|COMPLETED|Overall Study||57
8457791|NCT00724503|20841642|P2|STARTED|Overall Study||263
8457792|NCT00724503|20841643|P1|STARTED|Overall Study||267
8457793|NCT00724477|20841651|P1|NOT COMPLETED|Overall Study||0
8457794|NCT00724477|20841651|P1|COMPLETED|Overall Study||1663
8457795|NCT00724477|20841651|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
8457796|NCT00724464|20841655|P1|NOT COMPLETED|Overall Study||23
8457797|NCT00724464|20841655|P1|COMPLETED|Overall Study||309
8457798|NCT00724464|20841655|P1|STARTED|Overall Study||332
8457799|NCT00724451|20841667|P1|NOT COMPLETED|Overall Study||802
8457800|NCT00724451|20841667|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
8457801|NCT00724451|20841667|P1|Received Antiviral Treatment|Overall Study||500
8457802|NCT00724451|20841667|P1|STARTED|Overall Study||1128
8457803|NCT00724373|20841673|P1|NOT COMPLETED|Overall Study||171
8457804|NCT00724373|20841673|P1|COMPLETED|Overall Study||271
8457805|NCT00724373|20841673|P1|STARTED|Overall Study||442
8457806|NCT00724347|20841677|P1|NOT COMPLETED|Overall Study||2
8457807|NCT00724347|20841677|P1|COMPLETED|Overall Study||16
8457808|NCT00724347|20841677|P1|Baseline Testing|Overall Study||18
8457809|NCT00724347|20841677|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
8457810|NCT00724308|20841683|P2|NOT COMPLETED|Overall Study||97
8457811|NCT00724308|20841684|P1|NOT COMPLETED|Overall Study||80
8457812|NCT00724308|20841683|P2|COMPLETED|Overall Study||210
8457813|NCT00724308|20841684|P1|COMPLETED|Overall Study||190
8457814|NCT00724308|20841683|P2|STARTED|Overall Study||307
8457815|NCT00724308|20841684|P1|STARTED|Overall Study||270
8457816|NCT00724282|20841698|P1|NOT COMPLETED|Overall Study||4
8457817|NCT00724282|20841698|P1|COMPLETED|Overall Study||16
8457818|NCT00724282|20841698|P1|STARTED|Overall Study||20
8457819|NCT00724243|20841702|P1|NOT COMPLETED|Overall Study||15
8457820|NCT00724243|20841702|P1|COMPLETED|Overall Study||18
8457821|NCT00724243|20841702|P1|STARTED|Overall Study||33
8457822|NCT00724152|20841712|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
8457823|NCT00724152|20841713|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
8457824|NCT00724152|20841714|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
8457825|NCT00724152|20841712|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
8457826|NCT00724152|20841713|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
8457827|NCT00724152|20841714|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
8457828|NCT00724152|20841712|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
8457829|NCT00724152|20841713|P2|STARTED|Three-arm Study Period (+Standard Care)||2
8457830|NCT00724152|20841714|P1|STARTED|Three-arm Study Period (+Standard Care)||4
8457831|NCT00724152|20841712|P3|NOT COMPLETED|Two-arm Study Period||0
8457832|NCT00724152|20841713|P2|NOT COMPLETED|Two-arm Study Period||2
8457833|NCT00724152|20841714|P1|NOT COMPLETED|Two-arm Study Period||3
8457834|NCT00724152|20841712|P3|COMPLETED|Two-arm Study Period||0
8457835|NCT00724152|20841713|P2|COMPLETED|Two-arm Study Period||9
8457836|NCT00724152|20841714|P1|COMPLETED|Two-arm Study Period||11
8457837|NCT00724152|20841712|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
8457838|NCT00724152|20841713|P2|STARTED|Two-arm Study Period||11
8457839|NCT00724152|20841714|P1|STARTED|Two-arm Study Period||14
8457840|NCT00724126|20841731|P2|NOT COMPLETED|Overall Study||15
8457841|NCT00724126|20841732|P1|NOT COMPLETED|Overall Study||19
8457842|NCT00724126|20841731|P2|COMPLETED|Overall Study||301
8457843|NCT00724126|20841732|P1|COMPLETED|Overall Study||302
8457844|NCT00724126|20841731|P2|STARTED|Overall Study||316
8457845|NCT00724126|20841732|P1|STARTED|Overall Study||321
8457846|NCT00724061|20841740|P1|NOT COMPLETED|Maintenance Therapy||0
8457847|NCT00724061|20841740|P1|COMPLETED|Maintenance Therapy||2
8457848|NCT00724061|20841740|P1|STARTED|Maintenance Therapy||2
8457849|NCT00724061|20841740|P1|NOT COMPLETED|Dose Escalation Phase||5
8457850|NCT00724061|20841740|P1|COMPLETED|Dose Escalation Phase||2
8457851|NCT00724061|20841740|P1|STARTED|Dose Escalation Phase||7
8457852|NCT00724009|20841747|P1|NOT COMPLETED|Overall Study||0
8457853|NCT00724009|20841747|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
8457854|NCT00724009|20841747|P1|STARTED|Overall Study||29
8457855|NCT00723957|20841760|P2|NOT COMPLETED|Overall Study||53
8457856|NCT00723957|20841761|P1|NOT COMPLETED|Overall Study||51
8457857|NCT00723957|20841760|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
8457858|NCT00723957|20841761|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
8457859|NCT00723957|20841760|P2|STARTED|Overall Study|Randomized|99
8457860|NCT00723957|20841761|P1|STARTED|Overall Study|Randomized|98
8457861|NCT00723944|20841785|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
8457862|NCT00723944|20841786|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
8457863|NCT00723944|20841785|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
8457864|NCT00723944|20841786|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
8457865|NCT00723944|20841785|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
8457866|NCT00723944|20841786|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
8457867|NCT00723944|20841785|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
8457868|NCT00723944|20841786|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
8457869|NCT00723944|20841785|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
8457870|NCT00723944|20841786|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
8457871|NCT00723944|20841785|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
8457872|NCT00723944|20841786|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
8458038|NCT00723255|20842168|P1|STARTED|Overall Study||53
8457873|NCT00723944|20841785|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
8457874|NCT00723944|20841786|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
8457875|NCT00723944|20841785|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
8457876|NCT00723944|20841786|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
8457877|NCT00723944|20841785|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
8457878|NCT00723944|20841786|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
8457879|NCT00723944|20841785|P2|NOT COMPLETED|Implant Placement Surgery||0
8457880|NCT00723944|20841786|P1|NOT COMPLETED|Implant Placement Surgery||0
8457881|NCT00723944|20841785|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
8457882|NCT00723944|20841786|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
8457883|NCT00723944|20841785|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
8457884|NCT00723944|20841786|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
8457885|NCT00723931|20841792|P1|NOT COMPLETED|Overall Study||0
8457886|NCT00723931|20841792|P1|COMPLETED|Overall Study||1267
8457887|NCT00723931|20841792|P1|STARTED|Overall Study||1267
8457888|NCT00723892|20841799|P2|NOT COMPLETED|Overall Study||87
8457889|NCT00723892|20841800|P1|NOT COMPLETED|Overall Study||107
8457890|NCT00723892|20841799|P2|COMPLETED|Overall Study||168
8457891|NCT00723892|20841800|P1|COMPLETED|Overall Study||206
8457892|NCT00723892|20841799|P2|STARTED|Overall Study||255
8457893|NCT00723892|20841800|P1|STARTED|Overall Study||313
8457894|NCT00723840|20841807|P1|NOT COMPLETED|Overall Study||82
8457895|NCT00723840|20841807|P1|COMPLETED|Overall Study||163
8457896|NCT00723840|20841807|P1|STARTED|Overall Study||245
8457897|NCT00723827|20841818|P1|NOT COMPLETED|Overall Study||0
8457898|NCT00723827|20841818|P1|COMPLETED|Overall Study||682
8457899|NCT00723827|20841818|P1|STARTED|Overall Study||682
8457900|NCT00723801|20841828|P2|NOT COMPLETED|Overall Study||3
8457901|NCT00723801|20841829|P1|NOT COMPLETED|Overall Study||3
8457902|NCT00723801|20841828|P2|COMPLETED|Overall Study||17
8457903|NCT00723801|20841829|P1|COMPLETED|Overall Study||17
8457904|NCT00723801|20841828|P2|STARTED|Overall Study||20
8457905|NCT00723801|20841829|P1|STARTED|Overall Study||20
8457906|NCT00723788|20841837|P1|NOT COMPLETED|Overall Study||0
8457907|NCT00723788|20841837|P1|COMPLETED|Overall Study||21
8457908|NCT00723788|20841837|P1|STARTED|Overall Study||21
8457909|NCT00723749|20841843|P1|NOT COMPLETED|Overall Study||163
8457910|NCT00723749|20841843|P1|COMPLETED|Overall Study||182
8457911|NCT00723749|20841843|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
8457912|NCT00723736|20841850|P1|NOT COMPLETED|Overall Study||1
8457913|NCT00723736|20841850|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
8457914|NCT00723736|20841850|P1|STARTED|Overall Study||100
8457915|NCT00723710|20841854|P1|NOT COMPLETED|Overall Study||174
8457916|NCT00723710|20841854|P1|COMPLETED|Overall Study||120
8457917|NCT00723710|20841854|P1|STARTED|Overall Study||294
8457918|NCT00723697|20841858|P1|NOT COMPLETED|Overall Study||18
8457919|NCT00723697|20841858|P1|COMPLETED|Overall Study||1289
8457920|NCT00723697|20841858|P1|STARTED|Overall Study||1307
8457921|NCT00723645|20841866|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
8457922|NCT00723645|20841866|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
8457923|NCT00723645|20841866|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
8457924|NCT00723645|20841866|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
8457925|NCT00723645|20841866|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
8457926|NCT00723645|20841866|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
8457927|NCT00723645|20841866|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
8457928|NCT00723645|20841866|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
8457929|NCT00723645|20841866|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
8457930|NCT00723632|20841871|P1|NOT COMPLETED|Overall Study||203
8457931|NCT00723632|20841871|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
8457932|NCT00723632|20841871|P1|STARTED|Overall Study||901
8457933|NCT00723606|20841879|P2|NOT COMPLETED|Overall Study||7
8457934|NCT00723606|20841880|P1|NOT COMPLETED|Overall Study||4
8457935|NCT00723606|20841879|P2|COMPLETED|Overall Study||180
8457936|NCT00723606|20841880|P1|COMPLETED|Overall Study||185
8457937|NCT00723606|20841879|P2|STARTED|Overall Study||187
8457938|NCT00723606|20841880|P1|STARTED|Overall Study||189
8457939|NCT00723580|20841896|P1|NOT COMPLETED|Overall Study||0
8457940|NCT00723580|20841896|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
8457941|NCT00723580|20841896|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
8457942|NCT00723580|20841896|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
8457943|NCT00723554|20841900|P1|NOT COMPLETED|Overall Study||29
8457944|NCT00723554|20841900|P1|COMPLETED|Overall Study||34
8457945|NCT00723554|20841900|P1|STARTED|Overall Study||63
8457946|NCT00723528|20841950|P7|NOT COMPLETED|Period 2: After Controlled Period||4
8457947|NCT00723528|20841951|P6|NOT COMPLETED|Period 2: After Controlled Period||6
8457948|NCT00723528|20841952|P5|NOT COMPLETED|Period 2: After Controlled Period||2
8457949|NCT00723528|20841953|P4|NOT COMPLETED|Period 2: After Controlled Period||1
8457950|NCT00723528|20841954|P3|NOT COMPLETED|Period 2: After Controlled Period||0
8457951|NCT00723528|20841955|P2|NOT COMPLETED|Period 2: After Controlled Period||0
8457952|NCT00723528|20841956|P1|NOT COMPLETED|Period 2: After Controlled Period||0
8457953|NCT00723528|20841950|P7|COMPLETED|Period 2: After Controlled Period||54
8457954|NCT00723528|20841951|P6|COMPLETED|Period 2: After Controlled Period||58
8457955|NCT00723528|20841952|P5|COMPLETED|Period 2: After Controlled Period||11
8457956|NCT00723528|20841953|P4|COMPLETED|Period 2: After Controlled Period||14
8457957|NCT00723528|20841954|P3|COMPLETED|Period 2: After Controlled Period||0
8457958|NCT00723528|20841955|P2|COMPLETED|Period 2: After Controlled Period||0
8457959|NCT00723528|20841956|P1|COMPLETED|Period 2: After Controlled Period||0
8457960|NCT00723528|20841950|P7|STARTED|Period 2: After Controlled Period||58
8457961|NCT00723528|20841951|P6|STARTED|Period 2: After Controlled Period||64
8457962|NCT00723528|20841952|P5|STARTED|Period 2: After Controlled Period||13
8457963|NCT00723528|20841953|P4|STARTED|Period 2: After Controlled Period||15
8457964|NCT00723528|20841954|P3|STARTED|Period 2: After Controlled Period||0
8457965|NCT00723528|20841955|P2|STARTED|Period 2: After Controlled Period||0
8457966|NCT00723528|20841956|P1|STARTED|Period 2: After Controlled Period||0
8457967|NCT00723528|20841950|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457968|NCT00723528|20841951|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457969|NCT00723528|20841952|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457970|NCT00723528|20841953|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457971|NCT00723528|20841954|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
8457972|NCT00723528|20841955|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457973|NCT00723528|20841956|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
8457974|NCT00723528|20841950|P7|COMPLETED|Period 1: Controlled Period (CP)||0
8457975|NCT00723528|20841951|P6|COMPLETED|Period 1: Controlled Period (CP)||0
8457976|NCT00723528|20841952|P5|COMPLETED|Period 1: Controlled Period (CP)||0
8457977|NCT00723528|20841953|P4|COMPLETED|Period 1: Controlled Period (CP)||0
8457978|NCT00723528|20841954|P3|COMPLETED|Period 1: Controlled Period (CP)||58
8457979|NCT00723528|20841955|P2|COMPLETED|Period 1: Controlled Period (CP)||64
8457980|NCT00723528|20841956|P1|COMPLETED|Period 1: Controlled Period (CP)||28
8457981|NCT00723528|20841950|P7|STARTED|Period 1: Controlled Period (CP)||0
8457982|NCT00723528|20841951|P6|STARTED|Period 1: Controlled Period (CP)||0
8457983|NCT00723528|20841952|P5|STARTED|Period 1: Controlled Period (CP)||0
8457984|NCT00723528|20841953|P4|STARTED|Period 1: Controlled Period (CP)||0
8457985|NCT00723528|20841954|P3|STARTED|Period 1: Controlled Period (CP)||62
8457986|NCT00723528|20841955|P2|STARTED|Period 1: Controlled Period (CP)||64
8457987|NCT00723528|20841956|P1|STARTED|Period 1: Controlled Period (CP)||32
8457988|NCT00723489|20842018|P4|NOT COMPLETED|Overall Study||3
8457989|NCT00723489|20842019|P3|NOT COMPLETED|Overall Study||0
8457990|NCT00723489|20842020|P2|NOT COMPLETED|Overall Study||4
8457991|NCT00723489|20842021|P1|NOT COMPLETED|Overall Study||1
8457992|NCT00723489|20842018|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
8457993|NCT00723489|20842019|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
8457994|NCT00723489|20842020|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
8457995|NCT00723489|20842021|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
8457996|NCT00723489|20842018|P4|STARTED|Overall Study||23
8457997|NCT00723489|20842019|P3|STARTED|Overall Study||19
8457998|NCT00723489|20842020|P2|STARTED|Overall Study||19
8457999|NCT00723489|20842021|P1|STARTED|Overall Study||21
8458000|NCT00723450|20842049|P3|NOT COMPLETED|Randomized Phase||67
8458001|NCT00723450|20842050|P2|NOT COMPLETED|Randomized Phase||65
8458002|NCT00723450|20842051|P1|NOT COMPLETED|Randomized Phase||0
8458003|NCT00723450|20842049|P3|COMPLETED|Randomized Phase||20
8458004|NCT00723450|20842050|P2|COMPLETED|Randomized Phase||21
8458005|NCT00723450|20842051|P1|COMPLETED|Randomized Phase||0
8458006|NCT00723450|20842049|P3|STARTED|Randomized Phase||87
8458007|NCT00723450|20842050|P2|STARTED|Randomized Phase||86
8458008|NCT00723450|20842051|P1|STARTED|Randomized Phase||0
8458009|NCT00723450|20842049|P3|NOT COMPLETED|Open-Label Phase||0
8458010|NCT00723450|20842050|P2|NOT COMPLETED|Open-Label Phase||0
8458011|NCT00723450|20842051|P1|NOT COMPLETED|Open-Label Phase||125
8458012|NCT00723450|20842049|P3|COMPLETED|Open-Label Phase||0
8458013|NCT00723450|20842050|P2|COMPLETED|Open-Label Phase||0
8458014|NCT00723450|20842051|P1|COMPLETED|Open-Label Phase||173
8458015|NCT00723450|20842049|P3|STARTED|Open-Label Phase||0
8458016|NCT00723450|20842050|P2|STARTED|Open-Label Phase||0
8458017|NCT00723450|20842051|P1|STARTED|Open-Label Phase||298
8458018|NCT00723398|20842097|P5|NOT COMPLETED|Overall Study||9
8458019|NCT00723398|20842098|P4|NOT COMPLETED|Overall Study||5
8458020|NCT00723398|20842099|P3|NOT COMPLETED|Overall Study||17
8458021|NCT00723398|20842100|P2|NOT COMPLETED|Overall Study||15
8458022|NCT00723398|20842101|P1|NOT COMPLETED|Overall Study||6
8458023|NCT00723398|20842097|P5|COMPLETED|Overall Study||44
8458024|NCT00723398|20842098|P4|COMPLETED|Overall Study||49
8458025|NCT00723398|20842099|P3|COMPLETED|Overall Study||36
8458026|NCT00723398|20842100|P2|COMPLETED|Overall Study||38
8458027|NCT00723398|20842101|P1|COMPLETED|Overall Study||47
8458028|NCT00723398|20842097|P5|STARTED|Overall Study||53
8458029|NCT00723398|20842098|P4|STARTED|Overall Study||54
8458030|NCT00723398|20842099|P3|STARTED|Overall Study||53
8458031|NCT00723398|20842100|P2|STARTED|Overall Study||53
8458032|NCT00723398|20842101|P1|STARTED|Overall Study||53
8458033|NCT00723294|20842163|P1|NOT COMPLETED|Overall Study||13
8458034|NCT00723294|20842163|P1|COMPLETED|Overall Study||86
8458035|NCT00723294|20842163|P1|STARTED|Overall Study||99
8458036|NCT00723255|20842168|P1|NOT COMPLETED|Overall Study||4
8458037|NCT00723255|20842168|P1|COMPLETED|Overall Study|Eligible and treated patients|49
8458039|NCT00723229|20842195|P2|NOT COMPLETED|Second Intervention||0
8458040|NCT00723229|20842196|P1|NOT COMPLETED|Second Intervention||0
8458041|NCT00723229|20842195|P2|COMPLETED|Second Intervention||20
8458042|NCT00723229|20842196|P1|COMPLETED|Second Intervention||18
8458043|NCT00723229|20842195|P2|STARTED|Second Intervention||20
8458044|NCT00723229|20842196|P1|STARTED|Second Intervention||18
8458045|NCT00723229|20842195|P2|NOT COMPLETED|First Intervention||3
8458046|NCT00723229|20842196|P1|NOT COMPLETED|First Intervention||7
8458047|NCT00723229|20842195|P2|COMPLETED|First Intervention||20
8458048|NCT00723229|20842196|P1|COMPLETED|First Intervention||18
8458049|NCT00723229|20842195|P2|STARTED|First Intervention||23
8458050|NCT00723229|20842196|P1|STARTED|First Intervention||25
8458051|NCT00723203|20842208|P1|NOT COMPLETED|Overall Study||3
8458052|NCT00723203|20842208|P1|COMPLETED|Overall Study||13
8458053|NCT00723203|20842208|P1|STARTED|Overall Study||16
8458054|NCT00723190|20842212|P1|NOT COMPLETED|Overall Study||142
8458055|NCT00723190|20842212|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
8458056|NCT00723190|20842212|P1|SAFETY POPULATION|Overall Study||301
8458057|NCT00723190|20842212|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
8458058|NCT00723177|20842230|P3|NOT COMPLETED|Overall Study||5
8458059|NCT00723177|20842231|P2|NOT COMPLETED|Overall Study||4
8458060|NCT00723177|20842232|P1|NOT COMPLETED|Overall Study||5
8458061|NCT00723177|20842230|P3|COMPLETED|Overall Study||10
8458062|NCT00723177|20842231|P2|COMPLETED|Overall Study||10
8458063|NCT00723177|20842232|P1|COMPLETED|Overall Study||10
8458064|NCT00723177|20842230|P3|STARTED|Overall Study||15
8458065|NCT00723177|20842231|P2|STARTED|Overall Study||14
8458066|NCT00723177|20842232|P1|STARTED|Overall Study||15
8458067|NCT00723125|20842245|P2|NOT COMPLETED|Overall Study||6
8458068|NCT00723125|20842246|P1|NOT COMPLETED|Overall Study||18
8458069|NCT00723125|20842245|P2|COMPLETED|Overall Study||21
8458070|NCT00723125|20842246|P1|COMPLETED|Overall Study||15
8458071|NCT00723125|20842245|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
8458072|NCT00723125|20842246|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
8458073|NCT00723099|20842256|P1|NOT COMPLETED|Overall Study||1
8458074|NCT00723099|20842256|P1|COMPLETED|Overall Study||72
8458075|NCT00723099|20842256|P1|STARTED|Overall Study||73
8458076|NCT00723073|20842270|P2|NOT COMPLETED|Overall Study||0
8458077|NCT00723073|20842271|P1|NOT COMPLETED|Overall Study||0
8458078|NCT00723073|20842270|P2|COMPLETED|Overall Study||174
8458079|NCT00723073|20842271|P1|COMPLETED|Overall Study||149
8458080|NCT00723073|20842270|P2|STARTED|Overall Study||174
8458081|NCT00723073|20842271|P1|STARTED|Overall Study||149
8458082|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 5||0
8458083|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 5||0
8458084|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 5||0
8458085|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 5||0
8458086|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 5||0
8458087|NCT00723021|20842295|P5|COMPLETED|Intervention Period 5||2
8458088|NCT00723021|20842296|P4|COMPLETED|Intervention Period 5||3
8458089|NCT00723021|20842297|P3|COMPLETED|Intervention Period 5||3
8458090|NCT00723021|20842298|P2|COMPLETED|Intervention Period 5||3
8458091|NCT00723021|20842299|P1|COMPLETED|Intervention Period 5||3
8458092|NCT00723021|20842295|P5|STARTED|Intervention Period 5||2
8458093|NCT00723021|20842296|P4|STARTED|Intervention Period 5||3
8458094|NCT00723021|20842297|P3|STARTED|Intervention Period 5||3
8458095|NCT00723021|20842298|P2|STARTED|Intervention Period 5||3
8458096|NCT00723021|20842299|P1|STARTED|Intervention Period 5||3
8458097|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 4||1
8458098|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 4||0
8458099|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 4||0
8458100|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 4||0
8458101|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 4||0
8458102|NCT00723021|20842295|P5|COMPLETED|Intervention Period 4||2
8458103|NCT00723021|20842296|P4|COMPLETED|Intervention Period 4||3
8458104|NCT00723021|20842297|P3|COMPLETED|Intervention Period 4||3
8458105|NCT00723021|20842298|P2|COMPLETED|Intervention Period 4||3
8458106|NCT00723021|20842299|P1|COMPLETED|Intervention Period 4||3
8458107|NCT00723021|20842295|P5|STARTED|Intervention Period 4||3
8458108|NCT00723021|20842296|P4|STARTED|Intervention Period 4||3
8458109|NCT00723021|20842297|P3|STARTED|Intervention Period 4||3
8458110|NCT00723021|20842298|P2|STARTED|Intervention Period 4||3
8458111|NCT00723021|20842299|P1|STARTED|Intervention Period 4||3
8458112|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 3||0
8458113|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 3||0
8458114|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 3||0
8458115|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 3||0
8458116|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 3||0
8458117|NCT00723021|20842295|P5|COMPLETED|Intervention Period 3||3
8458118|NCT00723021|20842296|P4|COMPLETED|Intervention Period 3||3
8458119|NCT00723021|20842297|P3|COMPLETED|Intervention Period 3||3
8458120|NCT00723021|20842298|P2|COMPLETED|Intervention Period 3||3
8458121|NCT00723021|20842299|P1|COMPLETED|Intervention Period 3||3
8458122|NCT00723021|20842295|P5|STARTED|Intervention Period 3||3
8458123|NCT00723021|20842296|P4|STARTED|Intervention Period 3||3
8458124|NCT00723021|20842297|P3|STARTED|Intervention Period 3||3
8458125|NCT00723021|20842298|P2|STARTED|Intervention Period 3||3
8458126|NCT00723021|20842299|P1|STARTED|Intervention Period 3||3
8458127|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 2||0
8458128|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 2||0
8458129|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 2||0
8458130|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 2||0
8458131|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 2||0
8458132|NCT00723021|20842295|P5|COMPLETED|Intervention Period 2||3
8458133|NCT00723021|20842296|P4|COMPLETED|Intervention Period 2||3
8458134|NCT00723021|20842297|P3|COMPLETED|Intervention Period 2||3
8458135|NCT00723021|20842298|P2|COMPLETED|Intervention Period 2||3
8458136|NCT00723021|20842299|P1|COMPLETED|Intervention Period 2||3
8458137|NCT00723021|20842295|P5|STARTED|Intervention Period 2||3
8458138|NCT00723021|20842296|P4|STARTED|Intervention Period 2||3
8458139|NCT00723021|20842297|P3|STARTED|Intervention Period 2||3
8458140|NCT00723021|20842298|P2|STARTED|Intervention Period 2||3
8458141|NCT00723021|20842299|P1|STARTED|Intervention Period 2||3
8458142|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 1||0
8458143|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 1||0
8458144|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 1||0
8458145|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 1||0
8458146|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 1||0
8458147|NCT00723021|20842295|P5|COMPLETED|Intervention Period 1||3
8458148|NCT00723021|20842296|P4|COMPLETED|Intervention Period 1||3
8458149|NCT00723021|20842297|P3|COMPLETED|Intervention Period 1||3
8458150|NCT00723021|20842298|P2|COMPLETED|Intervention Period 1||3
8458151|NCT00723021|20842299|P1|COMPLETED|Intervention Period 1||3
8458152|NCT00723021|20842295|P5|STARTED|Intervention Period 1||3
8458153|NCT00723021|20842296|P4|STARTED|Intervention Period 1||3
8458154|NCT00723021|20842297|P3|STARTED|Intervention Period 1||3
8458155|NCT00723021|20842298|P2|STARTED|Intervention Period 1||3
8458156|NCT00723021|20842299|P1|STARTED|Intervention Period 1||3
8458157|NCT00723008|20842353|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
8458158|NCT00723008|20842354|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
8458159|NCT00723008|20842353|P2|COMPLETED|4-Week Unblinded Treatment||3
8458160|NCT00723008|20842354|P1|COMPLETED|4-Week Unblinded Treatment||4
8458161|NCT00723008|20842353|P2|STARTED|4-Week Unblinded Treatment||4
8458162|NCT00723008|20842354|P1|STARTED|4-Week Unblinded Treatment||5
8458163|NCT00723008|20842353|P2|NOT COMPLETED|4-Week Double Blinded||5
8458164|NCT00723008|20842354|P1|NOT COMPLETED|4-Week Double Blinded||5
8458165|NCT00723008|20842353|P2|COMPLETED|4-Week Double Blinded||4
8458166|NCT00723008|20842354|P1|COMPLETED|4-Week Double Blinded||5
8458167|NCT00723008|20842353|P2|STARTED|4-Week Double Blinded||9
8458168|NCT00723008|20842354|P1|STARTED|4-Week Double Blinded||10
8458169|NCT00723008|20842353|P2|NOT COMPLETED|Enrollment||0
8458170|NCT00723008|20842354|P1|NOT COMPLETED|Enrollment||1
8458171|NCT00723008|20842353|P2|COMPLETED|Enrollment||9
8458172|NCT00723008|20842354|P1|COMPLETED|Enrollment||10
8458173|NCT00723008|20842353|P2|STARTED|Enrollment||9
8458174|NCT00723008|20842354|P1|STARTED|Enrollment||11
8458175|NCT00722865|20842376|P1|NOT COMPLETED|Overall Study||2
8458176|NCT00722865|20842376|P1|COMPLETED|Overall Study||23
8458177|NCT00722865|20842376|P1|STARTED|Overall Study||25
8458178|NCT00722800|20842386|P2|NOT COMPLETED|Overall Study||0
8458179|NCT00722800|20842387|P1|NOT COMPLETED|Overall Study||2
8458180|NCT00722800|20842386|P2|COMPLETED|Overall Study||2
8458181|NCT00722800|20842387|P1|COMPLETED|Overall Study||0
8458182|NCT00722800|20842386|P2|STARTED|Overall Study||2
8458183|NCT00722800|20842387|P1|STARTED|Overall Study||2
8458184|NCT00722761|20842399|P2|NOT COMPLETED|Overall Study||6
8458185|NCT00722761|20842400|P1|NOT COMPLETED|Overall Study||6
8458186|NCT00722761|20842399|P2|COMPLETED|Overall Study||8
8458187|NCT00722761|20842400|P1|COMPLETED|Overall Study||10
8458188|NCT00722761|20842399|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
8458189|NCT00722761|20842400|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
8458190|NCT00722761|20842399|P2|STARTED|Overall Study||14
8458191|NCT00722761|20842400|P1|STARTED|Overall Study||16
8458192|NCT00722722|20842411|P3|NOT COMPLETED|Overall Study||0
8458193|NCT00722722|20842412|P2|NOT COMPLETED|Overall Study||0
8458194|NCT00722722|20842413|P1|NOT COMPLETED|Overall Study||0
8458195|NCT00722722|20842411|P3|COMPLETED|Overall Study||10
8458196|NCT00722722|20842412|P2|COMPLETED|Overall Study||5
8458197|NCT00722722|20842413|P1|COMPLETED|Overall Study||3
8458198|NCT00722722|20842411|P3|STARTED|Overall Study||10
8458199|NCT00722722|20842412|P2|STARTED|Overall Study||5
8458200|NCT00722722|20842413|P1|STARTED|Overall Study||3
8458201|NCT00722566|20842423|P2|NOT COMPLETED|Overall Study||35
8458202|NCT00722566|20842424|P1|NOT COMPLETED|Overall Study||67
8458203|NCT00722566|20842423|P2|COMPLETED|Overall Study|Completed 8 cycles|39
8458204|NCT00722566|20842424|P1|COMPLETED|Overall Study|Completed 8 cycles|81
8458205|NCT00722566|20842423|P2|STARTED|Overall Study||74
8458206|NCT00722566|20842424|P1|STARTED|Overall Study|One patient randomized and not dosed|148
8458207|NCT00722553|20842432|P1|NOT COMPLETED|Overall Study||0
8458208|NCT00722553|20842432|P1|COMPLETED|Overall Study||30
8458209|NCT00722553|20842432|P1|STARTED|Overall Study||30
8458210|NCT00722436|20842442|P2|NOT COMPLETED|Overall Study||0
8458211|NCT00722436|20842443|P1|NOT COMPLETED|Overall Study||0
8458212|NCT00722436|20842442|P2|COMPLETED|Overall Study||11
8458213|NCT00722436|20842443|P1|COMPLETED|Overall Study||9
8458214|NCT00722436|20842442|P2|STARTED|Overall Study||11
8458215|NCT00722436|20842443|P1|STARTED|Overall Study||9
8458216|NCT00722423|20842457|P2|NOT COMPLETED|Overall Study||1
8458217|NCT00722423|20842458|P1|NOT COMPLETED|Overall Study||0
8458218|NCT00722423|20842457|P2|COMPLETED|Overall Study||181
8458219|NCT00722423|20842458|P1|COMPLETED|Overall Study||182
8458220|NCT00722423|20842457|P2|STARTED|Overall Study||182
8458221|NCT00722423|20842458|P1|STARTED|Overall Study||182
8458222|NCT00722371|20842473|P7|NOT COMPLETED|Overall Study||51
8458223|NCT00722371|20842474|P6|NOT COMPLETED|Overall Study||53
8458224|NCT00722371|20842475|P5|NOT COMPLETED|Overall Study||48
8458225|NCT00722371|20842476|P4|NOT COMPLETED|Overall Study||63
8458226|NCT00722371|20842477|P3|NOT COMPLETED|Overall Study||65
8458227|NCT00722371|20842478|P2|NOT COMPLETED|Overall Study||72
8458228|NCT00722371|20842479|P1|NOT COMPLETED|Overall Study||56
8458229|NCT00722371|20842473|P7|COMPLETED|Overall Study||179
8458230|NCT00722371|20842474|P6|COMPLETED|Overall Study||178
8458231|NCT00722371|20842475|P5|COMPLETED|Overall Study||182
8458232|NCT00722371|20842476|P4|COMPLETED|Overall Study||167
8458233|NCT00722371|20842477|P3|COMPLETED|Overall Study||168
8458234|NCT00722371|20842478|P2|COMPLETED|Overall Study||158
8458235|NCT00722371|20842479|P1|COMPLETED|Overall Study||175
8458236|NCT00722371|20842473|P7|STARTED|Overall Study||230
8458237|NCT00722371|20842474|P6|STARTED|Overall Study||231
8458238|NCT00722371|20842475|P5|STARTED|Overall Study||230
8458239|NCT00722371|20842476|P4|STARTED|Overall Study||230
8458240|NCT00722371|20842477|P3|STARTED|Overall Study||233
8458241|NCT00722371|20842478|P2|STARTED|Overall Study||230
8458242|NCT00722371|20842479|P1|STARTED|Overall Study||231
8458243|NCT00722137|20842532|P2|NOT COMPLETED|Overall Study||48
8458244|NCT00722137|20842533|P1|NOT COMPLETED|Overall Study||45
8458245|NCT00722137|20842532|P2|COMPLETED|Overall Study||195
8458246|NCT00722137|20842533|P1|COMPLETED|Overall Study||199
8458247|NCT00722137|20842532|P2|STARTED|Overall Study||243
8458248|NCT00722137|20842533|P1|STARTED|Overall Study||244
8458249|NCT00722124|20842562|P3|NOT COMPLETED|Overall Study||20
8458250|NCT00722124|20842563|P2|NOT COMPLETED|Overall Study||14
8458251|NCT00722124|20842564|P1|NOT COMPLETED|Overall Study||17
8458252|NCT00722124|20842562|P3|COMPLETED|Overall Study||20
8458253|NCT00722124|20842563|P2|COMPLETED|Overall Study||26
8458254|NCT00722124|20842564|P1|COMPLETED|Overall Study||23
8458255|NCT00722124|20842562|P3|STARTED|Overall Study||40
8458256|NCT00722124|20842563|P2|STARTED|Overall Study||40
8458257|NCT00722124|20842564|P1|STARTED|Overall Study||40
8458258|NCT00722111|20842574|P2|NOT COMPLETED|Overall Study||0
8458259|NCT00722111|20842575|P1|NOT COMPLETED|Overall Study||0
8458260|NCT00722111|20842574|P2|COMPLETED|Overall Study||72
8458261|NCT00722111|20842575|P1|COMPLETED|Overall Study||11
8458262|NCT00722111|20842574|P2|STARTED|Overall Study||72
8458263|NCT00722111|20842575|P1|STARTED|Overall Study||11
8458264|NCT00722072|20842582|P1|NOT COMPLETED|Overall Study||3
8458265|NCT00722072|20842582|P1|COMPLETED|Overall Study||9
8458266|NCT00722072|20842582|P1|STARTED|Overall Study||12
8458267|NCT00722020|20842592|P2|NOT COMPLETED|Overall Study||0
8458268|NCT00722020|20842593|P1|NOT COMPLETED|Overall Study||0
8458269|NCT00722020|20842592|P2|COMPLETED|Overall Study||24
8458270|NCT00722020|20842593|P1|COMPLETED|Overall Study||19
8458271|NCT00722020|20842592|P2|STARTED|Overall Study||24
8458272|NCT00722020|20842593|P1|STARTED|Overall Study||19
8458273|NCT00722007|20842601|P1|NOT COMPLETED|Overall Study||30
8458274|NCT00722007|20842601|P1|COMPLETED|Overall Study||117
8458275|NCT00722007|20842601|P1|STARTED|Overall Study||147
8458276|NCT00721968|20842611|P2|NOT COMPLETED|Overall Study||0
8458277|NCT00721968|20842612|P1|NOT COMPLETED|Overall Study||2
8458278|NCT00721968|20842611|P2|COMPLETED|Overall Study||17
8458279|NCT00721968|20842612|P1|COMPLETED|Overall Study||25
8458280|NCT00721968|20842611|P2|STARTED|Overall Study||17
8458281|NCT00721968|20842612|P1|STARTED|Overall Study||27
8458282|NCT00721955|20842623|P3|NOT COMPLETED|Overall Study||2
8458283|NCT00721955|20842624|P2|NOT COMPLETED|Overall Study||0
8458284|NCT00721955|20842625|P1|NOT COMPLETED|Overall Study||0
8458285|NCT00721955|20842623|P3|COMPLETED|Overall Study||103
8458286|NCT00721955|20842624|P2|COMPLETED|Overall Study||104
8458287|NCT00721955|20842625|P1|COMPLETED|Overall Study||105
8458288|NCT00721955|20842623|P3|STARTED|Overall Study||105
8458289|NCT00721955|20842624|P2|STARTED|Overall Study||104
8458290|NCT00721955|20842625|P1|STARTED|Overall Study||105
8458291|NCT00721799|20842639|P1|NOT COMPLETED|Overall Study||8
8458292|NCT00721799|20842639|P1|COMPLETED|Overall Study||25
8458293|NCT00721799|20842639|P1|Received FLT PET Scan #2|Overall Study||25
8458294|NCT00721799|20842639|P1|Recieved FLT PET Scan 1|Overall Study||26
8458295|NCT00721799|20842639|P1|STARTED|Overall Study||33
8458296|NCT00721734|20842679|P5|NOT COMPLETED|Overall Study||6
8458297|NCT00721734|20842680|P4|NOT COMPLETED|Overall Study||6
8458298|NCT00721734|20842681|P3|NOT COMPLETED|Overall Study||8
8458299|NCT00721734|20842682|P2|NOT COMPLETED|Overall Study||12
8458300|NCT00721734|20842683|P1|NOT COMPLETED|Overall Study||8
8458301|NCT00721734|20842679|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8458302|NCT00721734|20842680|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8458303|NCT00721734|20842681|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8458304|NCT00721734|20842682|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
8458305|NCT00721734|20842683|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
8458306|NCT00721734|20842679|P5|STARTED|Overall Study||8
8458307|NCT00721734|20842680|P4|STARTED|Overall Study||8
8458308|NCT00721734|20842681|P3|STARTED|Overall Study||10
8458309|NCT00721734|20842682|P2|STARTED|Overall Study||12
8458310|NCT00721734|20842683|P1|STARTED|Overall Study||12
8458311|NCT00721630|20842795|P1|NOT COMPLETED|Overall Study||1
8458312|NCT00721630|20842795|P1|COMPLETED|Overall Study||23
8458313|NCT00721630|20842795|P1|STARTED|Overall Study||24
8458314|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
8458315|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
8458316|NCT00721617|20842800|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
8458317|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
8458318|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
8458319|NCT00721617|20842800|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
8458320|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
8458321|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
8458322|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
8458323|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
8458324|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
8458325|NCT00721617|20842800|P1|STARTED|8 Hours Into Dextrose Infusion||12
8458326|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
8458327|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
8458328|NCT00721617|20842800|P1|STARTED|4 Hours Into Dextrose Infusion||12
8458329|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
8458330|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
8458331|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
8458332|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
8458333|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
8458334|NCT00721617|20842800|P1|STARTED|8 Hours Into Intralipid Infusion||12
8458335|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
8458336|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
8458337|NCT00721617|20842800|P1|STARTED|4 Hours Into Intralipid Infusion||12
8458338|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
8458339|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
8458340|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
8458341|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
8458342|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Saline Infusion||12
8458343|NCT00721617|20842800|P1|STARTED|8 Hours Into Saline Infusion||12
8458344|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
8458345|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Saline Infusion||12
8458346|NCT00721617|20842800|P1|STARTED|4 Hours Into Saline Infusion||12
8458347|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
8458348|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
8458349|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
8458350|NCT00721578|20842824|P2|NOT COMPLETED|Overall Study||2
8458351|NCT00721578|20842825|P1|NOT COMPLETED|Overall Study||2
8458352|NCT00721578|20842824|P2|COMPLETED|Overall Study||9
8458353|NCT00721578|20842825|P1|COMPLETED|Overall Study||10
8458354|NCT00721578|20842824|P2|STARTED|Overall Study||11
8458355|NCT00721578|20842825|P1|STARTED|Overall Study||12
8458356|NCT00721539|20842837|P1|NOT COMPLETED|Overall Study||0
8458357|NCT00721539|20842837|P1|COMPLETED|Overall Study||9
8458358|NCT00721539|20842837|P1|STARTED|Overall Study||9
8458359|NCT00721513|20842844|P1|NOT COMPLETED|Overall Study||0
8458360|NCT00721513|20842844|P1|COMPLETED|Overall Study||20
8458361|NCT00721513|20842844|P1|STARTED|Overall Study||20
8458362|NCT00721500|20842856|P4|NOT COMPLETED|Period Three||0
8458363|NCT00721500|20842857|P3|NOT COMPLETED|Period Three||0
8458364|NCT00721500|20842858|P2|NOT COMPLETED|Period Three||0
8458365|NCT00721500|20842859|P1|NOT COMPLETED|Period Three||0
8458366|NCT00721500|20842856|P4|COMPLETED|Period Three||6
8458367|NCT00721500|20842857|P3|COMPLETED|Period Three||6
8458368|NCT00721500|20842858|P2|COMPLETED|Period Three||7
8458369|NCT00721500|20842859|P1|COMPLETED|Period Three||6
8458370|NCT00721500|20842856|P4|STARTED|Period Three||6
8458371|NCT00721500|20842857|P3|STARTED|Period Three||6
8458372|NCT00721500|20842858|P2|STARTED|Period Three||7
8458373|NCT00721500|20842859|P1|STARTED|Period Three||6
8458374|NCT00721500|20842856|P4|NOT COMPLETED|Period Two||0
8458375|NCT00721500|20842857|P3|NOT COMPLETED|Period Two||0
8458376|NCT00721500|20842858|P2|NOT COMPLETED|Period Two||0
8458377|NCT00721500|20842859|P1|NOT COMPLETED|Period Two||0
8458378|NCT00721500|20842856|P4|COMPLETED|Period Two||6
8458379|NCT00721500|20842857|P3|COMPLETED|Period Two||6
8458380|NCT00721500|20842858|P2|COMPLETED|Period Two||7
8458381|NCT00721500|20842859|P1|COMPLETED|Period Two||6
8458382|NCT00721500|20842856|P4|STARTED|Period Two||6
8458383|NCT00721500|20842857|P3|STARTED|Period Two||6
8458384|NCT00721500|20842858|P2|STARTED|Period Two||7
8458385|NCT00721500|20842859|P1|STARTED|Period Two||6
8458386|NCT00721500|20842856|P4|NOT COMPLETED|Period One||0
8458387|NCT00721500|20842857|P3|NOT COMPLETED|Period One||0
8458388|NCT00721500|20842858|P2|NOT COMPLETED|Period One||0
8458389|NCT00721500|20842859|P1|NOT COMPLETED|Period One||0
8458390|NCT00721500|20842856|P4|COMPLETED|Period One||6
8458391|NCT00721500|20842857|P3|COMPLETED|Period One||6
8458392|NCT00721500|20842858|P2|COMPLETED|Period One||7
8458393|NCT00721500|20842859|P1|COMPLETED|Period One||6
8458394|NCT00721500|20842856|P4|STARTED|Period One||6
8458395|NCT00721500|20842857|P3|STARTED|Period One||6
8458396|NCT00721500|20842858|P2|STARTED|Period One||7
8458397|NCT00721500|20842859|P1|STARTED|Period One||6
8458398|NCT00721409|20842880|P3|NOT COMPLETED|Overall Study||79
8458399|NCT00721409|20842881|P2|NOT COMPLETED|Overall Study||82
8458400|NCT00721409|20842882|P1|NOT COMPLETED|Overall Study||12
8458401|NCT00721409|20842880|P3|COMPLETED|Overall Study||2
8458402|NCT00721409|20842881|P2|COMPLETED|Overall Study||2
8458403|NCT00721409|20842882|P1|COMPLETED|Overall Study||0
8458404|NCT00721409|20842880|P3|Treated|Overall Study||77
8458405|NCT00721409|20842881|P2|Treated|Overall Study||83
8458406|NCT00721409|20842882|P1|Treated|Overall Study||12
8458407|NCT00721409|20842880|P3|STARTED|Overall Study||81
8458408|NCT00721409|20842881|P2|STARTED|Overall Study||84
8458409|NCT00721409|20842882|P1|STARTED|Overall Study||12
8458410|NCT00721396|20843009|P4|NOT COMPLETED|Overall Study||10
8458411|NCT00721396|20843010|P3|NOT COMPLETED|Overall Study||10
8458412|NCT00721396|20843011|P2|NOT COMPLETED|Overall Study||36
8458413|NCT00721396|20843012|P1|NOT COMPLETED|Overall Study||30
8458414|NCT00721396|20843009|P4|COMPLETED|Overall Study||302
8458415|NCT00721396|20843010|P3|COMPLETED|Overall Study||308
8458416|NCT00721396|20843011|P2|COMPLETED|Overall Study||592
8458417|NCT00721396|20843012|P1|COMPLETED|Overall Study||597
8458418|NCT00721396|20843009|P4|STARTED|Overall Study||312
8458419|NCT00721396|20843010|P3|STARTED|Overall Study||318
8458420|NCT00721396|20843011|P2|STARTED|Overall Study||628
8458421|NCT00721396|20843012|P1|STARTED|Overall Study||627
8458422|NCT00721357|20843050|P2|NOT COMPLETED|Overall Study||0
8458423|NCT00721357|20843051|P1|NOT COMPLETED|Overall Study||0
8458424|NCT00721357|20843050|P2|COMPLETED|Overall Study||15
8458425|NCT00721357|20843051|P1|COMPLETED|Overall Study||15
8458426|NCT00721357|20843050|P2|STARTED|Overall Study||15
8458427|NCT00721357|20843051|P1|STARTED|Overall Study||15
8458428|NCT00721279|20843063|P2|NOT COMPLETED|Overall Study||24
8458429|NCT00721279|20843064|P1|NOT COMPLETED|Overall Study||36
8458430|NCT00721279|20843063|P2|COMPLETED|Overall Study||73
8458431|NCT00721279|20843064|P1|COMPLETED|Overall Study||416
8458432|NCT00721279|20843063|P2|STARTED|Overall Study||97
8458433|NCT00721279|20843064|P1|STARTED|Overall Study||452
8458434|NCT00721253|20843078|P3|NOT COMPLETED|Overall Study||0
8458435|NCT00721253|20843079|P2|NOT COMPLETED|Overall Study||0
8458436|NCT00721253|20843080|P1|NOT COMPLETED|Overall Study||0
8458437|NCT00721253|20843078|P3|COMPLETED|Overall Study||0
8458438|NCT00721253|20843079|P2|COMPLETED|Overall Study||22
8458439|NCT00721253|20843080|P1|COMPLETED|Overall Study||20
8458440|NCT00721253|20843078|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
8458441|NCT00721253|20843079|P2|STARTED|Overall Study||22
8458442|NCT00721253|20843080|P1|STARTED|Overall Study||20
8458443|NCT00721227|20843092|P2|NOT COMPLETED|Overall Study||0
8458444|NCT00721227|20843093|P1|NOT COMPLETED|Overall Study||4
8458445|NCT00721227|20843092|P2|COMPLETED|Overall Study||6
8458446|NCT00721227|20843093|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
8458447|NCT00721227|20843092|P2|STARTED|Overall Study||6
8458448|NCT00721227|20843093|P1|STARTED|Overall Study||9
8458449|NCT00721214|20843103|P1|NOT COMPLETED|Overall Study||4
8458450|NCT00721214|20843103|P1|COMPLETED|Overall Study||12
8458451|NCT00721214|20843103|P1|STARTED|Overall Study||16
8458452|NCT00721188|20843114|P1|NOT COMPLETED|Overall Study||0
8458453|NCT00721188|20843114|P1|COMPLETED|Overall Study||11
8458454|NCT00721188|20843114|P1|STARTED|Overall Study||11
8458455|NCT00721175|20843131|P2|NOT COMPLETED|Overall Study||0
8458456|NCT00721175|20843132|P1|NOT COMPLETED|Overall Study||0
8458457|NCT00721175|20843131|P2|COMPLETED|Overall Study||54
8458458|NCT00721175|20843132|P1|COMPLETED|Overall Study||54
8458459|NCT00721175|20843131|P2|STARTED|Overall Study||54
8458460|NCT00721175|20843132|P1|STARTED|Overall Study||54
8458461|NCT00721162|20843144|P1|NOT COMPLETED|Overall Study||0
8458462|NCT00721162|20843144|P1|COMPLETED|Overall Study||60
8458463|NCT00721162|20843144|P1|Received Any Amount of Study Drug|Overall Study||60
8458464|NCT00721162|20843144|P1|STARTED|Overall Study||60
8458465|NCT00721149|20843153|P1|NOT COMPLETED|Overall Study||1
8458466|NCT00721149|20843153|P1|COMPLETED|Overall Study||9
8458467|NCT00721149|20843153|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
8458468|NCT00721136|20843166|P4|NOT COMPLETED|Overall Study||0
8458469|NCT00721136|20843167|P3|NOT COMPLETED|Overall Study||0
8458470|NCT00721136|20843168|P2|NOT COMPLETED|Overall Study||0
8458471|NCT00721136|20843169|P1|NOT COMPLETED|Overall Study||0
8458472|NCT00721136|20843166|P4|COMPLETED|Overall Study||8
8458473|NCT00721136|20843167|P3|COMPLETED|Overall Study||8
8458474|NCT00721136|20843168|P2|COMPLETED|Overall Study||42
8458475|NCT00721136|20843169|P1|COMPLETED|Overall Study||42
8458476|NCT00721136|20843166|P4|STARTED|Overall Study||8
8458477|NCT00721136|20843167|P3|STARTED|Overall Study||8
8458478|NCT00721136|20843168|P2|STARTED|Overall Study||42
8458479|NCT00721136|20843169|P1|STARTED|Overall Study||42
8458480|NCT00721123|20843187|P1|NOT COMPLETED|Overall Study||183
8458481|NCT00721123|20843187|P1|COMPLETED|Overall Study||355
8458482|NCT00721123|20843187|P1|STARTED|Overall Study||538
8458483|NCT00721110|20843265|P4|NOT COMPLETED|Overall Study||0
8458484|NCT00721110|20843266|P3|NOT COMPLETED|Overall Study||1
8458485|NCT00721110|20843267|P2|NOT COMPLETED|Overall Study||0
8458486|NCT00721110|20843268|P1|NOT COMPLETED|Overall Study||1
8458487|NCT00721110|20843265|P4|COMPLETED|Overall Study||16
8458488|NCT00721110|20843266|P3|COMPLETED|Overall Study||15
8458489|NCT00721110|20843267|P2|COMPLETED|Overall Study||16
8458490|NCT00721110|20843268|P1|COMPLETED|Overall Study||15
8458491|NCT00721110|20843265|P4|STARTED|Overall Study||16
8458492|NCT00721110|20843266|P3|STARTED|Overall Study||16
8458493|NCT00721110|20843267|P2|STARTED|Overall Study||16
8458494|NCT00721110|20843268|P1|STARTED|Overall Study||16
8458495|NCT00720941|20843296|P2|NOT COMPLETED|Overall Study||415
8458496|NCT00720941|20843297|P1|NOT COMPLETED|Overall Study||413
8458497|NCT00720941|20843296|P2|COMPLETED|Overall Study||138
8458498|NCT00720941|20843297|P1|COMPLETED|Overall Study||144
8458499|NCT00720941|20843296|P2|Ongoing|Overall Study||23
8458500|NCT00720941|20843297|P1|Ongoing|Overall Study||34
8458501|NCT00720941|20843296|P2|STARTED|Overall Study||553
8458502|NCT00720941|20843297|P1|STARTED|Overall Study||557
8458503|NCT00720876|20843337|P1|NOT COMPLETED|Overall Study||2
8458504|NCT00720876|20843337|P1|COMPLETED|Overall Study||28
8458505|NCT00720876|20843337|P1|STARTED|Overall Study||30
8458506|NCT00720798|20843343|P1|NOT COMPLETED|Overall Study||756
8458507|NCT00720798|20843343|P1|COMPLETED|Overall Study||1311
8458508|NCT00720798|20843343|P1|STARTED|Overall Study||2067
8458509|NCT00720759|20843366|P4|NOT COMPLETED|Overall Study||0
8458510|NCT00720759|20843367|P3|NOT COMPLETED|Overall Study||1
8458511|NCT00720759|20843368|P2|NOT COMPLETED|Overall Study||1
8458512|NCT00720759|20843369|P1|NOT COMPLETED|Overall Study||0
8458513|NCT00720759|20843366|P4|COMPLETED|Overall Study||6
8458514|NCT00720759|20843367|P3|COMPLETED|Overall Study||5
8458515|NCT00720759|20843368|P2|COMPLETED|Overall Study||5
8458516|NCT00720759|20843369|P1|COMPLETED|Overall Study||6
8458517|NCT00720759|20843366|P4|STARTED|Overall Study||6
8458518|NCT00720759|20843367|P3|STARTED|Overall Study||6
8458519|NCT00720759|20843368|P2|STARTED|Overall Study||6
8458520|NCT00720759|20843369|P1|STARTED|Overall Study||6
8458521|NCT00720629|20843379|P1|NOT COMPLETED|Overall Study||0
8458522|NCT00720629|20843379|P1|COMPLETED|Overall Study||8
8458523|NCT00720629|20843379|P1|STARTED|Overall Study||8
8458524|NCT00720499|20843389|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
8458525|NCT00720499|20843390|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
8458526|NCT00720499|20843389|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
8458527|NCT00720499|20843390|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
8458528|NCT00720499|20843389|P2|STARTED|Treatment Period 2 (4 Weeks)||70
8458529|NCT00720499|20843390|P1|STARTED|Treatment Period 2 (4 Weeks)||66
8458530|NCT00720499|20843389|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8458531|NCT00720499|20843390|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8458532|NCT00720499|20843389|P2|COMPLETED|Washout Period (2 Weeks)||70
8458533|NCT00720499|20843390|P1|COMPLETED|Washout Period (2 Weeks)||66
8458534|NCT00720499|20843389|P2|STARTED|Washout Period (2 Weeks)||70
8458535|NCT00720499|20843390|P1|STARTED|Washout Period (2 Weeks)||66
8458536|NCT00720499|20843389|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
8458537|NCT00720499|20843390|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
8458538|NCT00720499|20843389|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
8458539|NCT00720499|20843390|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
8458540|NCT00720499|20843389|P2|STARTED|Treatment Period 1 (4 Weeks)||72
8458541|NCT00720499|20843390|P1|STARTED|Treatment Period 1 (4 Weeks)||69
8458542|NCT00720473|20843454|P2|NOT COMPLETED|Overall Study||8
8458543|NCT00720473|20843455|P1|NOT COMPLETED|Overall Study||30
8458544|NCT00720473|20843454|P2|COMPLETED|Overall Study||16
8458545|NCT00720473|20843455|P1|COMPLETED|Overall Study||15
8458546|NCT00720473|20843454|P2|STARTED|Overall Study||24
8458547|NCT00720473|20843455|P1|STARTED|Overall Study||45
8458548|NCT00720434|20843483|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
8458549|NCT00720434|20843484|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
8458550|NCT00720434|20843485|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
8458551|NCT00720434|20843486|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
8458552|NCT00720434|20843483|P4|COMPLETED|Open-Label Period (Week 5-72)||4
8458553|NCT00720434|20843484|P3|COMPLETED|Open-Label Period (Week 5-72)||4
8458554|NCT00720434|20843485|P2|COMPLETED|Open-Label Period (Week 5-72)||5
8458555|NCT00720434|20843486|P1|COMPLETED|Open-Label Period (Week 5-72)||4
8458556|NCT00720434|20843483|P4|STARTED|Open-Label Period (Week 5-72)||8
8458557|NCT00720434|20843484|P3|STARTED|Open-Label Period (Week 5-72)||8
8458558|NCT00720434|20843485|P2|STARTED|Open-Label Period (Week 5-72)||8
8458559|NCT00720434|20843486|P1|STARTED|Open-Label Period (Week 5-72)||10
8458560|NCT00720434|20843483|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8458561|NCT00720434|20843484|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8458562|NCT00720434|20843485|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
8458563|NCT00720434|20843486|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8458564|NCT00720434|20843483|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
8458565|NCT00720434|20843484|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
8458566|NCT00720434|20843485|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
8458567|NCT00720434|20843486|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
8458568|NCT00720434|20843483|P4|STARTED|Double-Blind Period (Week 1-4)||8
8458569|NCT00720434|20843484|P3|STARTED|Double-Blind Period (Week 1-4)||8
8458570|NCT00720434|20843485|P2|STARTED|Double-Blind Period (Week 1-4)||9
8458571|NCT00720434|20843486|P1|STARTED|Double-Blind Period (Week 1-4)||10
8458572|NCT00720382|20843510|P2|NOT COMPLETED|Overall Study||59
8458573|NCT00720382|20843511|P1|NOT COMPLETED|Overall Study||176
8458574|NCT00720382|20843510|P2|COMPLETED|Overall Study||178
8458575|NCT00720382|20843511|P1|COMPLETED|Overall Study||290
8458576|NCT00720382|20843510|P2|STARTED|Overall Study||237
8458577|NCT00720382|20843511|P1|STARTED|Overall Study||466
8458578|NCT00720369|20843521|P2|NOT COMPLETED|Overall Study||0
8458579|NCT00720369|20843522|P1|NOT COMPLETED|Overall Study||1
8458580|NCT00720369|20843521|P2|COMPLETED|Overall Study||8
8458581|NCT00720369|20843522|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
8458582|NCT00720369|20843521|P2|STARTED|Overall Study||8
8458583|NCT00720369|20843522|P1|STARTED|Overall Study||11
8458584|NCT00720356|20843530|P1|NOT COMPLETED|Follow up Until Death||5
8458585|NCT00720356|20843530|P1|COMPLETED|Follow up Until Death||43
8458586|NCT00720356|20843530|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
8458587|NCT00720356|20843530|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
8458588|NCT00720356|20843530|P1|COMPLETED|Went on to be Treated Cycle 3||44
8458589|NCT00720356|20843530|P1|STARTED|Went on to be Treated Cycle 3||46
8458590|NCT00720356|20843530|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8458591|NCT00720356|20843530|P1|COMPLETED|Reached 1st Response/2 Cycles||46
8458592|NCT00720356|20843530|P1|STARTED|Reached 1st Response/2 Cycles||48
8458593|NCT00720356|20843530|P1|NOT COMPLETED|Registration to Study||67
8458594|NCT00720356|20843530|P1|COMPLETED|Registration to Study||48
8458595|NCT00720356|20843530|P1|Completed Registration Step 2|Registration to Study||48
8458596|NCT00720356|20843530|P1|Completed Registration Step 1|Registration to Study||115
8458597|NCT00720356|20843530|P1|STARTED|Registration to Study||115
8458598|NCT00720343|20843544|P1|NOT COMPLETED|Overall Study||6
8458599|NCT00720343|20843544|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
8458600|NCT00720343|20843544|P1|STARTED|Overall Study||54
8458601|NCT00720330|20843553|P3|NOT COMPLETED|Overall Study||0
8458602|NCT00720330|20843554|P2|NOT COMPLETED|Overall Study||0
8458603|NCT00720330|20843555|P1|NOT COMPLETED|Overall Study||0
8458604|NCT00720330|20843553|P3|COMPLETED|Overall Study||3
8458605|NCT00720330|20843554|P2|COMPLETED|Overall Study||4
8458606|NCT00720330|20843555|P1|COMPLETED|Overall Study||5
8458607|NCT00720330|20843553|P3|STARTED|Overall Study||3
8458608|NCT00720330|20843554|P2|STARTED|Overall Study||4
8458609|NCT00720330|20843555|P1|STARTED|Overall Study||5
8458610|NCT00720278|20843578|P3|NOT COMPLETED|Overall Study||6
8458611|NCT00720278|20843579|P2|NOT COMPLETED|Overall Study||4
8458612|NCT00720278|20843580|P1|NOT COMPLETED|Overall Study||7
8458613|NCT00720278|20843578|P3|COMPLETED|Overall Study||172
8458614|NCT00720278|20843579|P2|COMPLETED|Overall Study||166
8458615|NCT00720278|20843580|P1|COMPLETED|Overall Study||171
8458616|NCT00720278|20843578|P3|STARTED|Overall Study|1 subject was randomized in error|178
8458617|NCT00720278|20843579|P2|STARTED|Overall Study|1 subject was randomized in error|170
8458618|NCT00720278|20843580|P1|STARTED|Overall Study|1 subject was randomized in error|178
8458619|NCT00720226|20843602|P2|NOT COMPLETED|Overall Study||4
8458620|NCT00720226|20843603|P1|NOT COMPLETED|Overall Study||7
8458621|NCT00720226|20843602|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
8458622|NCT00720226|20843603|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
8458623|NCT00720226|20843602|P2|STARTED|Overall Study||52
8458624|NCT00720226|20843603|P1|STARTED|Overall Study||54
8458625|NCT00720213|20843611|P3|NOT COMPLETED|Treatment Period||0
8458626|NCT00720213|20843612|P2|NOT COMPLETED|Treatment Period||0
8458627|NCT00720213|20843613|P1|NOT COMPLETED|Treatment Period||0
8458628|NCT00720213|20843611|P3|COMPLETED|Treatment Period||17
8458629|NCT00720213|20843612|P2|COMPLETED|Treatment Period||20
8458630|NCT00720213|20843613|P1|COMPLETED|Treatment Period||0
8458631|NCT00720213|20843611|P3|STARTED|Treatment Period||17
8458632|NCT00720213|20843612|P2|STARTED|Treatment Period||20
8458633|NCT00720213|20843613|P1|STARTED|Treatment Period||0
8458634|NCT00720213|20843611|P3|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
8458635|NCT00720213|20843612|P2|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
8458636|NCT00720213|20843613|P1|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
8458637|NCT00720213|20843611|P3|COMPLETED|Screening Phase With Diagnostic PSG||0
8458638|NCT00720213|20843612|P2|COMPLETED|Screening Phase With Diagnostic PSG||0
8458639|NCT00720213|20843613|P1|COMPLETED|Screening Phase With Diagnostic PSG||37
8458640|NCT00720213|20843611|P3|STARTED|Screening Phase With Diagnostic PSG||0
8458641|NCT00720213|20843612|P2|STARTED|Screening Phase With Diagnostic PSG||0
8458642|NCT00720213|20843613|P1|STARTED|Screening Phase With Diagnostic PSG||44
8458643|NCT00720122|20843651|P1|NOT COMPLETED|Overall Study||9
8458644|NCT00720122|20843651|P1|COMPLETED|Overall Study||19
8458645|NCT00720122|20843651|P1|STARTED|Overall Study||28
8458646|NCT00720109|20843655|P3|NOT COMPLETED|Risk Stratification Period||8
8458647|NCT00720109|20843656|P2|NOT COMPLETED|Risk Stratification Period||15
8458648|NCT00720109|20843657|P1|NOT COMPLETED|Risk Stratification Period||0
8458649|NCT00720109|20843655|P3|COMPLETED|Risk Stratification Period||1
8458650|NCT00720109|20843656|P2|COMPLETED|Risk Stratification Period||33
8458651|NCT00720109|20843657|P1|COMPLETED|Risk Stratification Period||0
8458652|NCT00720109|20843655|P3|STARTED|Risk Stratification Period||9
8458653|NCT00720109|20843656|P2|STARTED|Risk Stratification Period||48
8458654|NCT00720109|20843657|P1|STARTED|Risk Stratification Period||0
8458655|NCT00720109|20843655|P3|NOT COMPLETED|Induction Period||0
8458656|NCT00720109|20843656|P2|NOT COMPLETED|Induction Period||0
8458657|NCT00720109|20843657|P1|NOT COMPLETED|Induction Period||6
8458658|NCT00720109|20843655|P3|COMPLETED|Induction Period||0
8458659|NCT00720109|20843656|P2|COMPLETED|Induction Period||0
8458660|NCT00720109|20843657|P1|COMPLETED|Induction Period||57
8458661|NCT00720109|20843655|P3|STARTED|Induction Period||0
8458662|NCT00720109|20843656|P2|STARTED|Induction Period||0
8458663|NCT00720109|20843657|P1|STARTED|Induction Period||63
8458664|NCT00720096|20843677|P2|NOT COMPLETED|Overall Study||2
8458665|NCT00720096|20843678|P1|NOT COMPLETED|Overall Study||0
8458666|NCT00720096|20843677|P2|COMPLETED|Overall Study||0
8458667|NCT00720096|20843678|P1|COMPLETED|Overall Study||2
8458668|NCT00720096|20843677|P2|STARTED|Overall Study||2
8458669|NCT00720096|20843678|P1|STARTED|Overall Study||2
8458670|NCT00720083|20843690|P2|NOT COMPLETED|Overall Study||2
8458671|NCT00720083|20843691|P1|NOT COMPLETED|Overall Study||1
8458672|NCT00720083|20843690|P2|COMPLETED|Overall Study||13
8458673|NCT00720083|20843691|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
8458674|NCT00720083|20843690|P2|STARTED|Overall Study||15
8458675|NCT00720083|20843691|P1|STARTED|Overall Study||17
8458676|NCT00720057|20843699|P2|NOT COMPLETED|Overall Study||3
8458677|NCT00720057|20843700|P1|NOT COMPLETED|Overall Study||1
8458678|NCT00720057|20843699|P2|COMPLETED|Overall Study||156
8458679|NCT00720057|20843700|P1|COMPLETED|Overall Study||152
8458680|NCT00720057|20843699|P2|STARTED|Overall Study||159
8458681|NCT00720057|20843700|P1|STARTED|Overall Study||153
8458682|NCT00719953|20843716|P1|NOT COMPLETED|Overall Study||4
8458683|NCT00719953|20843716|P1|COMPLETED|Overall Study||26
8458684|NCT00719953|20843716|P1|STARTED|Overall Study||30
8458685|NCT00719914|20843722|P2|NOT COMPLETED|Overall Study||0
8458686|NCT00719914|20843723|P1|NOT COMPLETED|Overall Study||0
8458687|NCT00719914|20843722|P2|COMPLETED|Overall Study||7
8458688|NCT00719914|20843723|P1|COMPLETED|Overall Study||10
8458689|NCT00719914|20843722|P2|STARTED|Overall Study||7
8458690|NCT00719914|20843723|P1|STARTED|Overall Study||10
8458691|NCT00719901|20843729|P1|NOT COMPLETED|Overall Study||11
8458692|NCT00719901|20843729|P1|COMPLETED|Overall Study||0
8458693|NCT00719901|20843729|P1|STARTED|Overall Study||11
8458694|NCT00719862|20843741|P2|NOT COMPLETED|Overall Study||6
8458695|NCT00719862|20843742|P1|NOT COMPLETED|Overall Study||8
8458696|NCT00719862|20843741|P2|COMPLETED|Overall Study||233
8458697|NCT00719862|20843742|P1|COMPLETED|Overall Study||234
8458698|NCT00719862|20843741|P2|STARTED|Overall Study|1 subject was randomized in error|239
8458699|NCT00719862|20843742|P1|STARTED|Overall Study||242
8458700|NCT00719849|20843760|P2|NOT COMPLETED|Overall Study||1
8458701|NCT00719849|20843761|P1|NOT COMPLETED|Overall Study||0
8458702|NCT00719849|20843760|P2|COMPLETED|Overall Study||8
8458703|NCT00719849|20843761|P1|COMPLETED|Overall Study||4
8458704|NCT00719849|20843760|P2|STARTED|Overall Study||9
8458705|NCT00719849|20843761|P1|STARTED|Overall Study||4
8458706|NCT00719810|20843800|P3|NOT COMPLETED|Overall Study||8
8458707|NCT00719810|20843801|P2|NOT COMPLETED|Overall Study||4
8458708|NCT00719810|20843802|P1|NOT COMPLETED|Overall Study||3
8458709|NCT00719810|20843800|P3|COMPLETED|Overall Study||42
8458710|NCT00719810|20843801|P2|COMPLETED|Overall Study||47
8458711|NCT00719810|20843802|P1|COMPLETED|Overall Study||46
8458712|NCT00719810|20843800|P3|STARTED|Overall Study||50
8458713|NCT00719810|20843801|P2|STARTED|Overall Study||51
8458714|NCT00719810|20843802|P1|STARTED|Overall Study||49
8458715|NCT00719732|20843813|P1|NOT COMPLETED|Overall Study||22
8458716|NCT00719732|20843813|P1|COMPLETED|Overall Study||196
8458717|NCT00719732|20843813|P1|STARTED|Overall Study||218
8458718|NCT00719706|20843819|P2|NOT COMPLETED|Overall Study||6
8458719|NCT00719706|20843820|P1|NOT COMPLETED|Overall Study||9
8458720|NCT00719706|20843819|P2|COMPLETED|Overall Study||14
8458721|NCT00719706|20843820|P1|COMPLETED|Overall Study||11
8458722|NCT00719706|20843819|P2|STARTED|Overall Study||20
8458723|NCT00719706|20843820|P1|STARTED|Overall Study||20
8458724|NCT00719680|20843834|P1|NOT COMPLETED|Overall Study||5
8458725|NCT00719680|20843834|P1|COMPLETED|Overall Study||16
8458726|NCT00719680|20843834|P1|STARTED|Overall Study||21
8458727|NCT00719615|20843857|P3|NOT COMPLETED|Overall Study||0
8458728|NCT00719615|20843858|P2|NOT COMPLETED|Overall Study||0
8458729|NCT00719615|20843859|P1|NOT COMPLETED|Overall Study||0
8458730|NCT00719615|20843857|P3|COMPLETED|Overall Study||24
8458731|NCT00719615|20843858|P2|COMPLETED|Overall Study||45
8458732|NCT00719615|20843859|P1|COMPLETED|Overall Study||42
8458733|NCT00719615|20843857|P3|STARTED|Overall Study||24
8458734|NCT00719615|20843858|P2|STARTED|Overall Study||45
8458735|NCT00719615|20843859|P1|STARTED|Overall Study||42
8458736|NCT00719576|20843869|P2|NOT COMPLETED|Overall Study||5
8458737|NCT00719576|20843870|P1|NOT COMPLETED|Overall Study||2
8458738|NCT00719576|20843869|P2|COMPLETED|Overall Study||67
8458739|NCT00719576|20843870|P1|COMPLETED|Overall Study||70
8458740|NCT00719576|20843869|P2|STARTED|Overall Study||72
8458741|NCT00719576|20843870|P1|STARTED|Overall Study||72
8458742|NCT00719563|20843890|P2|NOT COMPLETED|Overall Study||42
8458743|NCT00719563|20843891|P1|NOT COMPLETED|Overall Study||38
8458744|NCT00719563|20843890|P2|COMPLETED|Overall Study||128
8458745|NCT00719563|20843891|P1|COMPLETED|Overall Study||133
8458746|NCT00719563|20843890|P2|STARTED|Overall Study||170
8458747|NCT00719563|20843891|P1|STARTED|Overall Study||171
8458748|NCT00719537|20843923|P2|NOT COMPLETED|Overall Study||1
8458749|NCT00719537|20843924|P1|NOT COMPLETED|Overall Study||1
8458750|NCT00719537|20843923|P2|COMPLETED|Overall Study||0
8458751|NCT00719537|20843924|P1|COMPLETED|Overall Study||1
8458752|NCT00719537|20843923|P2|STARTED|Overall Study||1
8458753|NCT00719537|20843924|P1|STARTED|Overall Study||2
8458754|NCT00719472|20843930|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
8458755|NCT00719472|20843930|P1|COMPLETED|Received Cycle 2 Treatment||304
8458756|NCT00719472|20843930|P1|STARTED|Received Cycle 2 Treatment||372
8458757|NCT00719472|20843930|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
8458758|NCT00719472|20843930|P1|COMPLETED|Received Cycle 1 Treatment||372
8458759|NCT00719472|20843930|P1|STARTED|Received Cycle 1 Treatment||425
8458760|NCT00719472|20843930|P1|NOT COMPLETED|Enrolled in Study||26
8458761|NCT00719472|20843930|P1|COMPLETED|Enrolled in Study||425
8458762|NCT00719472|20843930|P1|STARTED|Enrolled in Study||451
8458763|NCT00719355|20843941|P2|NOT COMPLETED|Overall Study||13
8458764|NCT00719355|20843942|P1|NOT COMPLETED|Overall Study||18
8458765|NCT00719355|20843941|P2|COMPLETED|Overall Study||39
8458766|NCT00719355|20843942|P1|COMPLETED|Overall Study||33
8458767|NCT00719355|20843941|P2|Completed 32 Weeks|Overall Study||39
8458768|NCT00719355|20843942|P1|Completed 32 Weeks|Overall Study||33
8458769|NCT00719355|20843941|P2|Completed 24 Weeks|Overall Study||43
8458770|NCT00719355|20843942|P1|Completed 24 Weeks|Overall Study||34
8458771|NCT00719355|20843941|P2|Completed 12 Weeks|Overall Study||46
8458772|NCT00719355|20843942|P1|Completed 12 Weeks|Overall Study||43
8458773|NCT00719355|20843941|P2|Completed 6 Weeks|Overall Study||48
8458774|NCT00719355|20843942|P1|Completed 6 Weeks|Overall Study||49
8458775|NCT00719355|20843941|P2|STARTED|Overall Study||52
8458776|NCT00719355|20843942|P1|STARTED|Overall Study||51
8458777|NCT00719329|20843953|P3|NOT COMPLETED|Overall Study||1
8458778|NCT00719329|20843954|P2|NOT COMPLETED|Overall Study||2
8458779|NCT00719329|20843955|P1|NOT COMPLETED|Overall Study||0
8458780|NCT00719329|20843953|P3|COMPLETED|Overall Study||646
8458781|NCT00719329|20843954|P2|COMPLETED|Overall Study||569
8458782|NCT00719329|20843955|P1|COMPLETED|Overall Study||705
8458783|NCT00719329|20843953|P3|Day 7 Swab|Overall Study||561
8458784|NCT00719329|20843954|P2|Day 7 Swab|Overall Study||467
8458785|NCT00719329|20843955|P1|Day 7 Swab|Overall Study||593
8458786|NCT00719329|20843953|P3|Day 3 Swab|Overall Study||578
8458787|NCT00719329|20843954|P2|Day 3 Swab|Overall Study||501
8458788|NCT00719329|20843955|P1|Day 3 Swab|Overall Study||614
8458789|NCT00719329|20843953|P3|Day 1 Swab|Overall Study||646
8458790|NCT00719329|20843954|P2|Day 1 Swab|Overall Study||569
8458791|NCT00719329|20843955|P1|Day 1 Swab|Overall Study||705
8458792|NCT00719329|20843953|P3|STARTED|Overall Study||647
8458793|NCT00719329|20843954|P2|STARTED|Overall Study||571
8458794|NCT00719329|20843955|P1|STARTED|Overall Study||705
8458795|NCT00719264|20843971|P2|NOT COMPLETED|Overall Study||183
8458796|NCT00719264|20843972|P1|NOT COMPLETED|Overall Study||182
8458797|NCT00719264|20843971|P2|COMPLETED|Overall Study||0
8458798|NCT00719264|20843972|P1|COMPLETED|Overall Study||0
8458799|NCT00719264|20843971|P2|Safety Set|Overall Study||181
8458800|NCT00719264|20843972|P1|Safety Set|Overall Study||180
8458801|NCT00719264|20843971|P2|Full Analysis Set|Overall Study||183
8458802|NCT00719264|20843972|P1|Full Analysis Set|Overall Study||182
8458803|NCT00719264|20843971|P2|STARTED|Overall Study||183
8458804|NCT00719264|20843972|P1|STARTED|Overall Study||182
8458805|NCT00719212|20843991|P1|NOT COMPLETED|Overall Study||44
8458806|NCT00719212|20843991|P1|COMPLETED|Overall Study||17
8458807|NCT00719212|20843991|P1|STARTED|Overall Study||61
8458808|NCT00719186|20844003|P2|NOT COMPLETED|Overall Study||0
8458809|NCT00719186|20844004|P1|NOT COMPLETED|Overall Study||0
8458810|NCT00719186|20844003|P2|COMPLETED|Overall Study||374
8458811|NCT00719186|20844004|P1|COMPLETED|Overall Study||376
8458812|NCT00719186|20844003|P2|STARTED|Overall Study||374
8458813|NCT00719186|20844004|P1|STARTED|Overall Study||376
8458814|NCT00719160|20844018|P2|NOT COMPLETED|Overall Study||0
8458815|NCT00719160|20844019|P1|NOT COMPLETED|Overall Study||0
8458816|NCT00719160|20844018|P2|COMPLETED|Overall Study||6
8458817|NCT00719160|20844019|P1|COMPLETED|Overall Study||6
8458818|NCT00719160|20844018|P2|STARTED|Overall Study||6
8458819|NCT00719160|20844019|P1|STARTED|Overall Study||6
8458820|NCT00719134|20844026|P1|NOT COMPLETED|Overall Study||10
8458821|NCT00719134|20844026|P1|COMPLETED|Overall Study||66
8458822|NCT00719134|20844026|P1|STARTED|Overall Study||76
8458823|NCT00719043|20844039|P7|NOT COMPLETED|Overall Study||28
8458824|NCT00719043|20844040|P6|NOT COMPLETED|Overall Study||34
8458825|NCT00719043|20844041|P5|NOT COMPLETED|Overall Study||27
8458826|NCT00719043|20844042|P4|NOT COMPLETED|Overall Study||23
8458827|NCT00719043|20844043|P3|NOT COMPLETED|Overall Study||20
8458828|NCT00719043|20844044|P2|NOT COMPLETED|Overall Study||25
8458829|NCT00719043|20844045|P1|NOT COMPLETED|Overall Study||32
8458830|NCT00719043|20844039|P7|COMPLETED|Overall Study|Up to Day 909|92
8458831|NCT00719043|20844040|P6|COMPLETED|Overall Study|Up to Day 909|86
8458832|NCT00719043|20844041|P5|COMPLETED|Overall Study|Up to Day 909|95
8458833|NCT00719043|20844042|P4|COMPLETED|Overall Study|Up to Day 909|96
8458834|NCT00719043|20844043|P3|COMPLETED|Overall Study|Up to Day 909|99
8458835|NCT00719043|20844044|P2|COMPLETED|Overall Study|Up to Day 909|96
8458836|NCT00719043|20844045|P1|COMPLETED|Overall Study|Up to Day 909|88
8458837|NCT00719043|20844039|P7|STARTED|Overall Study||120
8458838|NCT00719043|20844040|P6|STARTED|Overall Study||120
8458839|NCT00719043|20844041|P5|STARTED|Overall Study||122
8458840|NCT00719043|20844042|P4|STARTED|Overall Study||119
8458841|NCT00719043|20844043|P3|STARTED|Overall Study||119
8458842|NCT00719043|20844044|P2|STARTED|Overall Study||121
8458843|NCT00719043|20844045|P1|STARTED|Overall Study||120
8458844|NCT00718887|20844169|P2|NOT COMPLETED|Overall Study||9
8458845|NCT00718887|20844170|P1|NOT COMPLETED|Overall Study||5
8458846|NCT00718887|20844169|P2|COMPLETED|Overall Study||68
8458847|NCT00718887|20844170|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
8458848|NCT00718887|20844169|P2|STARTED|Overall Study|Participants who received treatment.|77
8458849|NCT00718887|20844170|P1|STARTED|Overall Study|Participants who received treatment.|89
8458850|NCT00718861|20844194|P2|NOT COMPLETED|Overall Study||18
8458851|NCT00718861|20844195|P1|NOT COMPLETED|Overall Study||21
8458852|NCT00718861|20844194|P2|COMPLETED|Overall Study||77
8458853|NCT00718861|20844195|P1|COMPLETED|Overall Study||74
8458854|NCT00718861|20844194|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
8458855|NCT00718861|20844195|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
8458856|NCT00718861|20844194|P2|Safety Set|Overall Study||95
8458857|NCT00718861|20844195|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
8458858|NCT00718861|20844194|P2|STARTED|Overall Study||95
8458859|NCT00718861|20844195|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
8458860|NCT00718809|20844223|P2|NOT COMPLETED|Overall Study||9
8458861|NCT00718809|20844224|P1|NOT COMPLETED|Overall Study||12
8458862|NCT00718809|20844223|P2|COMPLETED|Overall Study||0
8458863|NCT00718809|20844224|P1|COMPLETED|Overall Study||0
8458864|NCT00718809|20844223|P2|STARTED|Overall Study||9
8458865|NCT00718809|20844224|P1|STARTED|Overall Study||12
8458866|NCT00718770|20844238|P1|NOT COMPLETED|Overall Study||8
8458867|NCT00718770|20844238|P1|COMPLETED|Overall Study||2
8458868|NCT00718770|20844238|P1|STARTED|Overall Study||10
8458869|NCT00718718|20844249|P10|NOT COMPLETED|Week 12 to End of Study||0
8458870|NCT00718718|20844250|P9|NOT COMPLETED|Week 12 to End of Study||1
8458871|NCT00718718|20844251|P8|NOT COMPLETED|Week 12 to End of Study||1
8458872|NCT00718718|20844252|P7|NOT COMPLETED|Week 12 to End of Study||2
8458873|NCT00718718|20844253|P6|NOT COMPLETED|Week 12 to End of Study||3
8458874|NCT00718718|20844254|P5|NOT COMPLETED|Week 12 to End of Study||0
8458875|NCT00718718|20844255|P4|NOT COMPLETED|Week 12 to End of Study||1
8458876|NCT00718718|20844256|P3|NOT COMPLETED|Week 12 to End of Study||0
8458877|NCT00718718|20844257|P2|NOT COMPLETED|Week 12 to End of Study||1
8458878|NCT00718718|20844258|P1|NOT COMPLETED|Week 12 to End of Study||0
8458879|NCT00718718|20844249|P10|COMPLETED|Week 12 to End of Study||31
8458880|NCT00718718|20844250|P9|COMPLETED|Week 12 to End of Study||27
8458881|NCT00718718|20844251|P8|COMPLETED|Week 12 to End of Study||27
8458882|NCT00718718|20844252|P7|COMPLETED|Week 12 to End of Study||27
8458883|NCT00718718|20844253|P6|COMPLETED|Week 12 to End of Study||24
8458884|NCT00718718|20844254|P5|COMPLETED|Week 12 to End of Study||0
8458885|NCT00718718|20844255|P4|COMPLETED|Week 12 to End of Study||15
8458886|NCT00718718|20844256|P3|COMPLETED|Week 12 to End of Study||0
8458887|NCT00718718|20844257|P2|COMPLETED|Week 12 to End of Study||17
8458888|NCT00718718|20844258|P1|COMPLETED|Week 12 to End of Study||0
8458889|NCT00718718|20844249|P10|Treated|Week 12 to End of Study||31
8458890|NCT00718718|20844250|P9|Treated|Week 12 to End of Study||28
8458891|NCT00718718|20844251|P8|Treated|Week 12 to End of Study||28
8458892|NCT00718718|20844252|P7|Treated|Week 12 to End of Study||29
8458893|NCT00718718|20844253|P6|Treated|Week 12 to End of Study||26
8458894|NCT00718718|20844254|P5|Treated|Week 12 to End of Study||0
8458895|NCT00718718|20844255|P4|Treated|Week 12 to End of Study||16
8458896|NCT00718718|20844256|P3|Treated|Week 12 to End of Study||0
8458897|NCT00718718|20844257|P2|Treated|Week 12 to End of Study||18
8458898|NCT00718718|20844258|P1|Treated|Week 12 to End of Study||0
8458899|NCT00718718|20844249|P10|STARTED|Week 12 to End of Study||31
8458900|NCT00718718|20844250|P9|STARTED|Week 12 to End of Study||28
8458901|NCT00718718|20844251|P8|STARTED|Week 12 to End of Study||28
8458902|NCT00718718|20844252|P7|STARTED|Week 12 to End of Study||29
8458903|NCT00718718|20844253|P6|STARTED|Week 12 to End of Study||27
8458904|NCT00718718|20844254|P5|STARTED|Week 12 to End of Study||0
8458905|NCT00718718|20844255|P4|STARTED|Week 12 to End of Study||16
8458906|NCT00718718|20844256|P3|STARTED|Week 12 to End of Study||0
8458907|NCT00718718|20844257|P2|STARTED|Week 12 to End of Study||18
8458908|NCT00718718|20844258|P1|STARTED|Week 12 to End of Study||0
8458909|NCT00718718|20844249|P10|NOT COMPLETED|Prior to Week 12||0
8458910|NCT00718718|20844250|P9|NOT COMPLETED|Prior to Week 12||2
8458911|NCT00718718|20844251|P8|NOT COMPLETED|Prior to Week 12||2
8458912|NCT00718718|20844252|P7|NOT COMPLETED|Prior to Week 12||1
8458913|NCT00718718|20844253|P6|NOT COMPLETED|Prior to Week 12||0
8458914|NCT00718718|20844254|P5|NOT COMPLETED|Prior to Week 12||3
8458915|NCT00718718|20844255|P4|NOT COMPLETED|Prior to Week 12||0
8458916|NCT00718718|20844256|P3|NOT COMPLETED|Prior to Week 12||1
8458917|NCT00718718|20844257|P2|NOT COMPLETED|Prior to Week 12||0
8458918|NCT00718718|20844258|P1|NOT COMPLETED|Prior to Week 12||1
8458919|NCT00718718|20844249|P10|COMPLETED|Prior to Week 12||31
8458920|NCT00718718|20844250|P9|COMPLETED|Prior to Week 12||28
8458921|NCT00718718|20844251|P8|COMPLETED|Prior to Week 12||28
8458922|NCT00718718|20844252|P7|COMPLETED|Prior to Week 12||29
8458923|NCT00718718|20844253|P6|COMPLETED|Prior to Week 12||0
8458924|NCT00718718|20844254|P5|COMPLETED|Prior to Week 12||27
8458925|NCT00718718|20844255|P4|COMPLETED|Prior to Week 12||0
8458926|NCT00718718|20844256|P3|COMPLETED|Prior to Week 12||16
8458927|NCT00718718|20844257|P2|COMPLETED|Prior to Week 12||0
8458928|NCT00718718|20844258|P1|COMPLETED|Prior to Week 12||18
8458929|NCT00718718|20844249|P10|STARTED|Prior to Week 12||31
8458930|NCT00718718|20844250|P9|STARTED|Prior to Week 12||30
8458931|NCT00718718|20844251|P8|STARTED|Prior to Week 12||30
8458932|NCT00718718|20844252|P7|STARTED|Prior to Week 12||30
8458933|NCT00718718|20844253|P6|STARTED|Prior to Week 12||0
8458934|NCT00718718|20844254|P5|STARTED|Prior to Week 12||30
8458935|NCT00718718|20844255|P4|STARTED|Prior to Week 12||0
8458936|NCT00718718|20844256|P3|STARTED|Prior to Week 12||17
8458937|NCT00718718|20844257|P2|STARTED|Prior to Week 12||0
8458938|NCT00718718|20844258|P1|STARTED|Prior to Week 12||19
8458939|NCT00718666|20844301|P3|NOT COMPLETED|Booster Phase Year 5||6
8458940|NCT00718666|20844302|P2|NOT COMPLETED|Booster Phase Year 5||0
8458941|NCT00718666|20844303|P1|NOT COMPLETED|Booster Phase Year 5||2
8458942|NCT00718666|20844301|P3|COMPLETED|Booster Phase Year 5||94
8458943|NCT00718666|20844302|P2|COMPLETED|Booster Phase Year 5||46
8458944|NCT00718666|20844303|P1|COMPLETED|Booster Phase Year 5||36
8458945|NCT00718666|20844301|P3|STARTED|Booster Phase Year 5||100
8458946|NCT00718666|20844302|P2|STARTED|Booster Phase Year 5||46
8458947|NCT00718666|20844303|P1|STARTED|Booster Phase Year 5||38
8458948|NCT00718666|20844301|P3|NOT COMPLETED|Persistence Phase Year 5||0
8458949|NCT00718666|20844302|P2|NOT COMPLETED|Persistence Phase Year 5||0
8458950|NCT00718666|20844303|P1|NOT COMPLETED|Persistence Phase Year 5||0
8458951|NCT00718666|20844301|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8458952|NCT00718666|20844302|P2|COMPLETED|Persistence Phase Year 5||82
8458953|NCT00718666|20844303|P1|COMPLETED|Persistence Phase Year 5||70
8458954|NCT00718666|20844301|P3|STARTED|Persistence Phase Year 5||0
8458955|NCT00718666|20844302|P2|STARTED|Persistence Phase Year 5||82
8458956|NCT00718666|20844303|P1|STARTED|Persistence Phase Year 5||70
8458957|NCT00718666|20844301|P3|NOT COMPLETED|Persistence Phase Year 3||0
8458958|NCT00718666|20844302|P2|NOT COMPLETED|Persistence Phase Year 3||0
8458959|NCT00718666|20844303|P1|NOT COMPLETED|Persistence Phase Year 3||0
8458960|NCT00718666|20844301|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8458961|NCT00718666|20844302|P2|COMPLETED|Persistence Phase Year 3||104
8458962|NCT00718666|20844303|P1|COMPLETED|Persistence Phase Year 3||98
8458963|NCT00718666|20844301|P3|STARTED|Persistence Phase Year 3||0
8458964|NCT00718666|20844302|P2|STARTED|Persistence Phase Year 3||104
8458965|NCT00718666|20844303|P1|STARTED|Persistence Phase Year 3||98
8458966|NCT00718666|20844301|P3|NOT COMPLETED|Persistence Phase Year 1||0
8458967|NCT00718666|20844302|P2|NOT COMPLETED|Persistence Phase Year 1||0
8458968|NCT00718666|20844303|P1|NOT COMPLETED|Persistence Phase Year 1||0
8458969|NCT00718666|20844301|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8458970|NCT00718666|20844302|P2|COMPLETED|Persistence Phase Year 1||130
8458971|NCT00718666|20844303|P1|COMPLETED|Persistence Phase Year 1||118
8458972|NCT00718666|20844301|P3|STARTED|Persistence Phase Year 1||0
8458973|NCT00718666|20844302|P2|STARTED|Persistence Phase Year 1||130
8458974|NCT00718666|20844303|P1|STARTED|Persistence Phase Year 1||118
8458975|NCT00718640|20844387|P1|NOT COMPLETED|Overall Study||7
8458976|NCT00718640|20844387|P1|COMPLETED|Overall Study||3
8458977|NCT00718640|20844387|P1|STARTED|Overall Study||10
8458978|NCT00718549|20844399|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
8458979|NCT00718549|20844400|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
8458980|NCT00718549|20844401|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
8458981|NCT00718549|20844399|P3|COMPLETED|Maintenance/ Observation Phase||3
8458982|NCT00718549|20844400|P2|COMPLETED|Maintenance/ Observation Phase||5
8458983|NCT00718549|20844401|P1|COMPLETED|Maintenance/ Observation Phase||0
8458984|NCT00718549|20844399|P3|STARTED|Maintenance/ Observation Phase||33
8458985|NCT00718549|20844400|P2|STARTED|Maintenance/ Observation Phase||33
8458986|NCT00718549|20844401|P1|STARTED|Maintenance/ Observation Phase||0
8458987|NCT00718549|20844399|P3|NOT COMPLETED|Induction Phase||0
8458988|NCT00718549|20844400|P2|NOT COMPLETED|Induction Phase||0
8458989|NCT00718549|20844401|P1|NOT COMPLETED|Induction Phase||62
8458990|NCT00718549|20844399|P3|COMPLETED|Induction Phase||0
8458991|NCT00718549|20844400|P2|COMPLETED|Induction Phase||0
8458992|NCT00718549|20844401|P1|COMPLETED|Induction Phase||66
8458993|NCT00718549|20844399|P3|STARTED|Induction Phase||0
8458994|NCT00718549|20844400|P2|STARTED|Induction Phase||0
8458995|NCT00718549|20844401|P1|STARTED|Induction Phase||128
8458996|NCT00718523|20844426|P2|NOT COMPLETED|Overall Study||24
8458997|NCT00718523|20844427|P1|NOT COMPLETED|Overall Study||18
8458998|NCT00718523|20844426|P2|COMPLETED|Overall Study||62
8458999|NCT00718523|20844427|P1|COMPLETED|Overall Study||66
8459000|NCT00718523|20844426|P2|STARTED|Overall Study||86
8459001|NCT00718523|20844427|P1|STARTED|Overall Study||84
8459002|NCT00718510|20844439|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8459003|NCT00718510|20844440|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
8459004|NCT00718510|20844439|P2|COMPLETED|Second Intervention (3 Weeks)||7
8459005|NCT00718510|20844440|P1|COMPLETED|Second Intervention (3 Weeks)||6
8459006|NCT00718510|20844439|P2|STARTED|Second Intervention (3 Weeks)||7
8459007|NCT00718510|20844440|P1|STARTED|Second Intervention (3 Weeks)||7
8459008|NCT00718510|20844439|P2|NOT COMPLETED|Washout (5 Days)||0
8459009|NCT00718510|20844440|P1|NOT COMPLETED|Washout (5 Days)||0
8459010|NCT00718510|20844439|P2|COMPLETED|Washout (5 Days)||7
8459011|NCT00718510|20844440|P1|COMPLETED|Washout (5 Days)||7
8459012|NCT00718510|20844439|P2|STARTED|Washout (5 Days)||7
8459013|NCT00718510|20844440|P1|STARTED|Washout (5 Days)||7
8459014|NCT00718510|20844439|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
8459015|NCT00718510|20844440|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8459016|NCT00718510|20844439|P2|COMPLETED|First Intervention (3 Weeks)||7
8459017|NCT00718510|20844440|P1|COMPLETED|First Intervention (3 Weeks)||7
8459018|NCT00718510|20844439|P2|Received Intervention|First Intervention (3 Weeks)||7
8459019|NCT00718510|20844440|P1|Received Intervention|First Intervention (3 Weeks)||7
8459020|NCT00718510|20844439|P2|STARTED|First Intervention (3 Weeks)||8
8459021|NCT00718510|20844440|P1|STARTED|First Intervention (3 Weeks)||7
8459022|NCT00718419|20844452|P2|NOT COMPLETED|Overall Study||39
8459023|NCT00718419|20844453|P1|NOT COMPLETED|Overall Study||13
8459024|NCT00718419|20844452|P2|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
8459025|NCT00718419|20844453|P1|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
8459026|NCT00718419|20844452|P2|Received at Least One Dose of Study Drug|Overall Study||42
8459027|NCT00718419|20844453|P1|Received at Least One Dose of Study Drug|Overall Study||14
8459028|NCT00718419|20844452|P2|STARTED|Overall Study||42
8459029|NCT00718419|20844453|P1|STARTED|Overall Study||14
8459030|NCT00718328|20844469|P2|NOT COMPLETED|Overall Study||0
8459031|NCT00718328|20844470|P1|NOT COMPLETED|Overall Study||1
8459032|NCT00718328|20844469|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
8459033|NCT00718328|20844470|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
8459034|NCT00718328|20844469|P2|STARTED|Overall Study||0
8459035|NCT00718328|20844470|P1|STARTED|Overall Study||1
8459036|NCT00718315|20844479|P3|NOT COMPLETED|Overall Study||21
8459037|NCT00718315|20844480|P2|NOT COMPLETED|Overall Study||22
8459038|NCT00718315|20844481|P1|NOT COMPLETED|Overall Study||19
8459039|NCT00718315|20844479|P3|COMPLETED|Overall Study||46
8459040|NCT00718315|20844480|P2|COMPLETED|Overall Study||45
8459041|NCT00718315|20844481|P1|COMPLETED|Overall Study||48
8459042|NCT00718315|20844479|P3|STARTED|Overall Study||67
8459043|NCT00718315|20844480|P2|STARTED|Overall Study||67
8459044|NCT00718315|20844481|P1|STARTED|Overall Study||67
8459045|NCT00718302|20844515|P2|NOT COMPLETED|Overall Study||0
8459046|NCT00718302|20844516|P1|NOT COMPLETED|Overall Study||0
8459047|NCT00718302|20844515|P2|COMPLETED|Overall Study||114
8459048|NCT00718302|20844516|P1|COMPLETED|Overall Study||119
8459049|NCT00718302|20844515|P2|STARTED|Overall Study||114
8459050|NCT00718302|20844516|P1|STARTED|Overall Study||119
8459051|NCT00718237|20844532|P2|NOT COMPLETED|Overall Study||15
8459052|NCT00718237|20844533|P1|NOT COMPLETED|Overall Study||13
8459053|NCT00718237|20844532|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
8459054|NCT00718237|20844533|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
8459055|NCT00718237|20844532|P2|Vaccinated at Visit 3|Overall Study||369
8459056|NCT00718237|20844533|P1|Vaccinated at Visit 3|Overall Study||371
8459057|NCT00718237|20844532|P2|Vaccinated at Visit 2|Overall Study||374
8459058|NCT00718237|20844533|P1|Vaccinated at Visit 2|Overall Study||373
8459059|NCT00718237|20844532|P2|Vaccinated at Visit 1|Overall Study||381
8459060|NCT00718237|20844533|P1|Vaccinated at Visit 1|Overall Study||380
8459061|NCT00718237|20844532|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
8459062|NCT00718237|20844533|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
8459063|NCT00718159|20844550|P7|NOT COMPLETED|Overall Study||1
8459064|NCT00718159|20844551|P6|NOT COMPLETED|Overall Study||1
8459065|NCT00718159|20844552|P5|NOT COMPLETED|Overall Study||8
8459066|NCT00718159|20844553|P4|NOT COMPLETED|Overall Study||4
8459067|NCT00718159|20844554|P3|NOT COMPLETED|Overall Study||3
8459068|NCT00718159|20844555|P2|NOT COMPLETED|Overall Study||3
8459069|NCT00718159|20844556|P1|NOT COMPLETED|Overall Study||3
8459070|NCT00718159|20844550|P7|COMPLETED|Overall Study||0
8459071|NCT00718159|20844551|P6|COMPLETED|Overall Study||0
8459072|NCT00718159|20844552|P5|COMPLETED|Overall Study||0
8459073|NCT00718159|20844553|P4|COMPLETED|Overall Study||0
8459074|NCT00718159|20844554|P3|COMPLETED|Overall Study||0
8459075|NCT00718159|20844555|P2|COMPLETED|Overall Study||0
8459076|NCT00718159|20844556|P1|COMPLETED|Overall Study||0
8459077|NCT00718159|20844550|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
8459078|NCT00718159|20844551|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
8459079|NCT00718159|20844552|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
8459080|NCT00718159|20844553|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8459081|NCT00718159|20844554|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8459082|NCT00718159|20844555|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8459083|NCT00718159|20844556|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8459084|NCT00718159|20844550|P7|STARTED|Overall Study||1
8459085|NCT00718159|20844551|P6|STARTED|Overall Study||1
8459086|NCT00718159|20844552|P5|STARTED|Overall Study||8
8459087|NCT00718159|20844553|P4|STARTED|Overall Study||4
8459088|NCT00718159|20844554|P3|STARTED|Overall Study||3
8459089|NCT00718159|20844555|P2|STARTED|Overall Study||3
8459090|NCT00718159|20844556|P1|STARTED|Overall Study||3
8459091|NCT00718120|20844582|P2|NOT COMPLETED|Overall Study||0
8459092|NCT00718120|20844583|P1|NOT COMPLETED|Overall Study||0
8459093|NCT00718120|20844582|P2|COMPLETED|Overall Study||55
8459094|NCT00718120|20844583|P1|COMPLETED|Overall Study||55
8459095|NCT00718120|20844582|P2|STARTED|Overall Study||55
8459096|NCT00718120|20844583|P1|STARTED|Overall Study||55
8459097|NCT00718094|20844603|P2|NOT COMPLETED|Overall Study||0
8459098|NCT00718094|20844604|P1|NOT COMPLETED|Overall Study||0
8459099|NCT00718094|20844603|P2|COMPLETED|Overall Study||5
8459100|NCT00718094|20844604|P1|COMPLETED|Overall Study||15
8459101|NCT00718094|20844603|P2|STARTED|Overall Study||5
8459102|NCT00718094|20844604|P1|STARTED|Overall Study||15
8459103|NCT00718081|20844613|P3|NOT COMPLETED|Overall Study||21
8459104|NCT00718081|20844614|P2|NOT COMPLETED|Overall Study||4
8459105|NCT00718081|20844615|P1|NOT COMPLETED|Overall Study||7
8459106|NCT00718081|20844613|P3|COMPLETED|Overall Study||9
8459107|NCT00718081|20844614|P2|COMPLETED|Overall Study||25
8459108|NCT00718081|20844615|P1|COMPLETED|Overall Study||22
8459109|NCT00718081|20844613|P3|STARTED|Overall Study||30
8459110|NCT00718081|20844614|P2|STARTED|Overall Study||29
8459111|NCT00718081|20844615|P1|STARTED|Overall Study||29
8459112|NCT00718042|20844632|P6|NOT COMPLETED|Donor Follow-up||0
8459113|NCT00718042|20844633|P5|NOT COMPLETED|Donor Follow-up||19
8459114|NCT00718042|20844634|P4|NOT COMPLETED|Donor Follow-up||0
8459115|NCT00718042|20844635|P3|NOT COMPLETED|Donor Follow-up||0
8459116|NCT00718042|20844636|P2|NOT COMPLETED|Donor Follow-up||0
8459117|NCT00718042|20844637|P1|NOT COMPLETED|Donor Follow-up||13
8459118|NCT00718042|20844632|P6|COMPLETED|Donor Follow-up||0
8459119|NCT00718042|20844633|P5|COMPLETED|Donor Follow-up||24
8459120|NCT00718042|20844634|P4|COMPLETED|Donor Follow-up||0
8459121|NCT00718042|20844635|P3|COMPLETED|Donor Follow-up||0
8459122|NCT00718042|20844636|P2|COMPLETED|Donor Follow-up||0
8459123|NCT00718042|20844637|P1|COMPLETED|Donor Follow-up||23
8459124|NCT00718042|20844632|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459125|NCT00718042|20844633|P5|STARTED|Donor Follow-up||43
8459126|NCT00718042|20844634|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459127|NCT00718042|20844635|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459128|NCT00718042|20844636|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459129|NCT00718042|20844637|P1|STARTED|Donor Follow-up||36
8459130|NCT00718042|20844632|P6|NOT COMPLETED|ESA Chagas Testing||0
8459131|NCT00718042|20844633|P5|NOT COMPLETED|ESA Chagas Testing||0
8459132|NCT00718042|20844634|P4|NOT COMPLETED|ESA Chagas Testing||0
8459133|NCT00718042|20844635|P3|NOT COMPLETED|ESA Chagas Testing||0
8459134|NCT00718042|20844636|P2|NOT COMPLETED|ESA Chagas Testing||0
8459135|NCT00718042|20844637|P1|NOT COMPLETED|ESA Chagas Testing||0
8459136|NCT00718042|20844632|P6|COMPLETED|ESA Chagas Testing||330
8459137|NCT00718042|20844633|P5|COMPLETED|ESA Chagas Testing||43
8459138|NCT00718042|20844634|P4|COMPLETED|ESA Chagas Testing||110
8459139|NCT00718042|20844635|P3|COMPLETED|ESA Chagas Testing||524
8459140|NCT00718042|20844636|P2|COMPLETED|ESA Chagas Testing||287
8459141|NCT00718042|20844637|P1|COMPLETED|ESA Chagas Testing||36
8459142|NCT00718042|20844632|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
8459143|NCT00718042|20844633|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
8459144|NCT00718042|20844634|P4|STARTED|ESA Chagas Testing||110
8459145|NCT00718042|20844635|P3|STARTED|ESA Chagas Testing||524
8459146|NCT00718042|20844636|P2|STARTED|ESA Chagas Testing||287
8459147|NCT00718042|20844637|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
8459148|NCT00718042|20844632|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
8459149|NCT00718042|20844633|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
8459150|NCT00718042|20844634|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
8459151|NCT00718042|20844635|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
8459152|NCT00718042|20844636|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
8459153|NCT00718042|20844637|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
8459154|NCT00718042|20844632|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
8459155|NCT00718042|20844633|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
8459156|NCT00718042|20844634|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
8459157|NCT00718042|20844635|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
8459158|NCT00718042|20844636|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
8459159|NCT00718042|20844637|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
8459160|NCT00718042|20844632|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
8459161|NCT00718042|20844633|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
8459162|NCT00718042|20844634|P4|STARTED|ABBOTT PRISM Chagas Testing||110
8459163|NCT00718042|20844635|P3|STARTED|ABBOTT PRISM Chagas Testing||525
8459164|NCT00718042|20844636|P2|STARTED|ABBOTT PRISM Chagas Testing||289
8459165|NCT00718042|20844637|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
8459166|NCT00717977|20844649|P1|NOT COMPLETED|Overall Study||0
8459167|NCT00717977|20844649|P1|COMPLETED|Overall Study||74
8459168|NCT00717977|20844649|P1|STARTED|Overall Study||74
8459169|NCT00717912|20844677|P6|NOT COMPLETED|Overall Study||0
8459170|NCT00717912|20844678|P5|NOT COMPLETED|Overall Study||0
8459171|NCT00717912|20844679|P4|NOT COMPLETED|Overall Study||0
8459172|NCT00717912|20844680|P3|NOT COMPLETED|Overall Study||0
8459173|NCT00717912|20844681|P2|NOT COMPLETED|Overall Study||0
8459174|NCT00717912|20844682|P1|NOT COMPLETED|Overall Study||0
8459175|NCT00717912|20844677|P6|COMPLETED|Overall Study||1
8459176|NCT00717912|20844678|P5|COMPLETED|Overall Study||1
8459177|NCT00717912|20844679|P4|COMPLETED|Overall Study||1
8459178|NCT00717912|20844680|P3|COMPLETED|Overall Study||1
8459179|NCT00717912|20844681|P2|COMPLETED|Overall Study||1
8459180|NCT00717912|20844682|P1|COMPLETED|Overall Study||1
8459181|NCT00717912|20844677|P6|STARTED|Overall Study||1
8459182|NCT00717912|20844678|P5|STARTED|Overall Study||1
8459183|NCT00717912|20844679|P4|STARTED|Overall Study||1
8459184|NCT00717912|20844680|P3|STARTED|Overall Study||1
8459185|NCT00717912|20844681|P2|STARTED|Overall Study||1
8459186|NCT00717912|20844682|P1|STARTED|Overall Study||1
8459187|NCT00717886|20844693|P1|NOT COMPLETED|Overall Study||4
8459188|NCT00717886|20844693|P1|COMPLETED|Overall Study||9
8459189|NCT00717886|20844693|P1|STARTED|Overall Study||13
8459190|NCT00717873|20844699|P2|NOT COMPLETED|Overall Study||0
8459191|NCT00717873|20844700|P1|NOT COMPLETED|Overall Study||0
8459192|NCT00717873|20844699|P2|COMPLETED|Overall Study||59
8459193|NCT00717873|20844700|P1|COMPLETED|Overall Study||46
8459194|NCT00717873|20844699|P2|STARTED|Overall Study||59
8459195|NCT00717873|20844700|P1|STARTED|Overall Study||46
8459196|NCT00717860|20844708|P2|NOT COMPLETED|Overall Study||28
8459197|NCT00717860|20844709|P1|NOT COMPLETED|Overall Study||27
8459198|NCT00717860|20844708|P2|COMPLETED|Overall Study||32
8459199|NCT00717860|20844709|P1|COMPLETED|Overall Study||34
8459200|NCT00717860|20844708|P2|STARTED|Overall Study||60
8459201|NCT00717860|20844709|P1|STARTED|Overall Study||61
8459202|NCT00717756|20844719|P1|NOT COMPLETED|Overall Study||1
8459203|NCT00717756|20844719|P1|COMPLETED|Overall Study||40
8459204|NCT00717756|20844719|P1|STARTED|Overall Study||41
8459205|NCT00717626|20844723|P1|NOT COMPLETED|Overall Study||0
8459206|NCT00717626|20844723|P1|COMPLETED|Overall Study||14
8459207|NCT00717626|20844723|P1|STARTED|Overall Study||14
8459208|NCT00717574|20844735|P2|NOT COMPLETED|Overall Study||2
8459209|NCT00717574|20844736|P1|NOT COMPLETED|Overall Study||2
8459210|NCT00717574|20844735|P2|COMPLETED|Overall Study||14
8459211|NCT00717574|20844736|P1|COMPLETED|Overall Study||14
8459212|NCT00717574|20844735|P2|STARTED|Overall Study||16
8459213|NCT00717574|20844736|P1|STARTED|Overall Study||16
8459214|NCT00717522|20844742|P1|NOT COMPLETED|Overall Study||7
8459215|NCT00717522|20844742|P1|COMPLETED|Overall Study||0
8459216|NCT00717522|20844742|P1|STARTED|Overall Study||7
8459217|NCT00717418|20844751|P4|NOT COMPLETED|1-Year Follow-Up||4
8459218|NCT00717418|20844752|P3|NOT COMPLETED|1-Year Follow-Up||434
8459219|NCT00717418|20844753|P2|NOT COMPLETED|1-Year Follow-Up||51
8459220|NCT00717418|20844754|P1|NOT COMPLETED|1-Year Follow-Up||147
8459221|NCT00717418|20844751|P4|COMPLETED|1-Year Follow-Up||0
8459222|NCT00717418|20844752|P3|COMPLETED|1-Year Follow-Up||74
8459223|NCT00717418|20844753|P2|COMPLETED|1-Year Follow-Up||23
8459224|NCT00717418|20844754|P1|COMPLETED|1-Year Follow-Up||33
8459225|NCT00717418|20844751|P4|STARTED|1-Year Follow-Up||4
8459226|NCT00717418|20844752|P3|STARTED|1-Year Follow-Up||508
8459227|NCT00717418|20844753|P2|STARTED|1-Year Follow-Up||74
8459228|NCT00717418|20844754|P1|STARTED|1-Year Follow-Up||180
8459229|NCT00717418|20844751|P4|NOT COMPLETED|Baseline||15
8459230|NCT00717418|20844752|P3|NOT COMPLETED|Baseline||0
8459231|NCT00717418|20844753|P2|NOT COMPLETED|Baseline||0
8459232|NCT00717418|20844754|P1|NOT COMPLETED|Baseline||0
8459233|NCT00717418|20844751|P4|COMPLETED|Baseline||4
8459234|NCT00717418|20844752|P3|COMPLETED|Baseline||508
8459235|NCT00717418|20844753|P2|COMPLETED|Baseline||74
8459236|NCT00717418|20844754|P1|COMPLETED|Baseline||180
8459237|NCT00717418|20844751|P4|STARTED|Baseline||19
8459238|NCT00717418|20844752|P3|STARTED|Baseline||508
8459239|NCT00717418|20844753|P2|STARTED|Baseline||74
8459240|NCT00717418|20844754|P1|STARTED|Baseline||180
8459241|NCT00717405|20844759|P1|NOT COMPLETED|Overall Study||0
8459242|NCT00717405|20844759|P1|COMPLETED|Overall Study||52
8459243|NCT00717405|20844759|P1|STARTED|Overall Study||52
8459244|NCT00717366|20844778|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
8459245|NCT00717366|20844779|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
8459246|NCT00717366|20844778|P2|COMPLETED|Extension Period (52 Weeks)||12
8459247|NCT00717366|20844779|P1|COMPLETED|Extension Period (52 Weeks)||5
8459248|NCT00717366|20844778|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
8459249|NCT00717366|20844779|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
8459250|NCT00717366|20844778|P2|STARTED|Extension Period (52 Weeks)||28
8459251|NCT00717366|20844779|P1|STARTED|Extension Period (52 Weeks)||9
8459252|NCT00717366|20844778|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
8459253|NCT00717366|20844779|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
8459254|NCT00717366|20844778|P2|COMPLETED|Core Study Period (20 Weeks)||35
8459255|NCT00717366|20844779|P1|COMPLETED|Core Study Period (20 Weeks)||12
8459256|NCT00717366|20844778|P2|STARTED|Core Study Period (20 Weeks)||48
8459257|NCT00717366|20844779|P1|STARTED|Core Study Period (20 Weeks)||16
8459258|NCT00717314|20844803|P2|NOT COMPLETED|Overall Study||10
8459259|NCT00717314|20844804|P1|NOT COMPLETED|Overall Study||6
8459260|NCT00717314|20844803|P2|COMPLETED|Overall Study||34
8459261|NCT00717314|20844804|P1|COMPLETED|Overall Study||37
8459262|NCT00717314|20844803|P2|STARTED|Overall Study||44
8459263|NCT00717314|20844804|P1|STARTED|Overall Study||43
8459264|NCT00717288|20844825|P3|NOT COMPLETED|Overall Study||0
8459265|NCT00717288|20844826|P2|NOT COMPLETED|Overall Study||0
8459266|NCT00717288|20844827|P1|NOT COMPLETED|Overall Study||0
8459267|NCT00717288|20844825|P3|COMPLETED|Overall Study||25
8459268|NCT00717288|20844826|P2|COMPLETED|Overall Study||29
8459269|NCT00717288|20844827|P1|COMPLETED|Overall Study||28
8459270|NCT00717288|20844825|P3|STARTED|Overall Study||25
8459271|NCT00717288|20844826|P2|STARTED|Overall Study||29
8459272|NCT00717288|20844827|P1|STARTED|Overall Study||28
8459273|NCT00717275|20844841|P1|NOT COMPLETED|Overall Study||3
8459274|NCT00717275|20844841|P1|COMPLETED|Overall Study||0
8459275|NCT00717275|20844841|P1|STARTED|Overall Study||3
8459276|NCT00717249|20844847|P2|NOT COMPLETED|Overall Study||15
8459277|NCT00717249|20844848|P1|NOT COMPLETED|Overall Study||22
8459278|NCT00717249|20844847|P2|COMPLETED|Overall Study||150
8459279|NCT00717249|20844848|P1|COMPLETED|Overall Study||304
8459280|NCT00717249|20844847|P2|STARTED|Overall Study||165
8459281|NCT00717249|20844848|P1|STARTED|Overall Study||326
8459282|NCT00717236|20844862|P2|NOT COMPLETED|Open-Label Period||21
8459283|NCT00717236|20844863|P1|NOT COMPLETED|Open-Label Period||125
8459284|NCT00717236|20844862|P2|COMPLETED|Open-Label Period||163
8459285|NCT00717236|20844863|P1|COMPLETED|Open-Label Period||646
8459286|NCT00717236|20844862|P2|STARTED|Open-Label Period||184
8459287|NCT00717236|20844863|P1|STARTED|Open-Label Period||771
8459288|NCT00717236|20844862|P2|NOT COMPLETED|Double-Blind Period||28
8459289|NCT00717236|20844863|P1|NOT COMPLETED|Double-Blind Period||80
8459290|NCT00717236|20844862|P2|COMPLETED|Double-Blind Period||184
8459291|NCT00717236|20844863|P1|COMPLETED|Double-Blind Period||771
8459292|NCT00717236|20844862|P2|STARTED|Double-Blind Period||212
8459293|NCT00717236|20844863|P1|STARTED|Double-Blind Period||851
8459294|NCT00717197|20844932|P1|NOT COMPLETED|Overall Study||7
8459295|NCT00717197|20844932|P1|COMPLETED|Overall Study||23
8459296|NCT00717197|20844932|P1|STARTED|Overall Study||30
8459297|NCT00717093|20844938|P2|NOT COMPLETED|Overall Study||48
8459298|NCT00717093|20844939|P1|NOT COMPLETED|Overall Study||44
8459299|NCT00717093|20844938|P2|COMPLETED|Overall Study||170
8459300|NCT00717093|20844939|P1|COMPLETED|Overall Study||170
8459301|NCT00717093|20844938|P2|Received Treatment|Overall Study||218
8459302|NCT00717093|20844939|P1|Received Treatment|Overall Study||213
8459303|NCT00717093|20844938|P2|STARTED|Overall Study||218
8459304|NCT00717093|20844939|P1|STARTED|Overall Study||214
8459305|NCT00717067|20844956|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459306|NCT00717067|20844957|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459307|NCT00717067|20844958|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459308|NCT00717067|20844959|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459309|NCT00717067|20844960|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459310|NCT00717067|20844956|P5|COMPLETED|Part 2: End Stage Renal Disease||6
8459311|NCT00717067|20844957|P4|COMPLETED|Part 2: End Stage Renal Disease||0
8459312|NCT00717067|20844958|P3|COMPLETED|Part 2: End Stage Renal Disease||0
8459313|NCT00717067|20844959|P2|COMPLETED|Part 2: End Stage Renal Disease||0
8459314|NCT00717067|20844960|P1|COMPLETED|Part 2: End Stage Renal Disease||0
8459315|NCT00717067|20844956|P5|STARTED|Part 2: End Stage Renal Disease||6
8459316|NCT00717067|20844957|P4|STARTED|Part 2: End Stage Renal Disease||0
8459317|NCT00717067|20844958|P3|STARTED|Part 2: End Stage Renal Disease||0
8459318|NCT00717067|20844959|P2|STARTED|Part 2: End Stage Renal Disease||0
8459319|NCT00717067|20844960|P1|STARTED|Part 2: End Stage Renal Disease||0
8459320|NCT00717067|20844956|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459321|NCT00717067|20844957|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459322|NCT00717067|20844958|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459323|NCT00717067|20844959|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459324|NCT00717067|20844960|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459325|NCT00717067|20844956|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
8459326|NCT00717067|20844957|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
8459327|NCT00717067|20844958|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
8459328|NCT00717067|20844959|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
8459329|NCT00717067|20844960|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
8459330|NCT00717067|20844956|P5|STARTED|Part 1b: Severe Renal Impairment||0
8459331|NCT00717067|20844957|P4|STARTED|Part 1b: Severe Renal Impairment||6
8459332|NCT00717067|20844958|P3|STARTED|Part 1b: Severe Renal Impairment||0
8459333|NCT00717067|20844959|P2|STARTED|Part 1b: Severe Renal Impairment||0
8459334|NCT00717067|20844960|P1|STARTED|Part 1b: Severe Renal Impairment||0
8459335|NCT00717067|20844956|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459336|NCT00717067|20844957|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459337|NCT00717067|20844958|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
8459338|NCT00717067|20844959|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459339|NCT00717067|20844960|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459340|NCT00717067|20844956|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459341|NCT00717067|20844957|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459342|NCT00717067|20844958|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
8459343|NCT00717067|20844959|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
8459344|NCT00717067|20844960|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
8459345|NCT00717067|20844956|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
8459346|NCT00717067|20844957|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
8459347|NCT00717067|20844958|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8459348|NCT00717067|20844959|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8459349|NCT00717067|20844960|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8459350|NCT00717054|20845044|P2|NOT COMPLETED|Overall Study||0
8459351|NCT00717054|20845045|P1|NOT COMPLETED|Overall Study||0
8459352|NCT00717054|20845044|P2|COMPLETED|Overall Study||57
8459353|NCT00717054|20845045|P1|COMPLETED|Overall Study||58
8459354|NCT00717054|20845044|P2|STARTED|Overall Study||57
8459355|NCT00717054|20845045|P1|STARTED|Overall Study||58
8459356|NCT00717041|20845057|P1|NOT COMPLETED|Overall Study||0
8459357|NCT00717041|20845057|P1|COMPLETED|Overall Study||1206
8459358|NCT00717041|20845057|P1|STARTED|Overall Study||1206
8459359|NCT00716976|20845067|P2|NOT COMPLETED|Overall Study||9
8459360|NCT00716976|20845068|P1|NOT COMPLETED|Overall Study||20
8459361|NCT00716976|20845067|P2|COMPLETED|Overall Study||57
8459362|NCT00716976|20845068|P1|COMPLETED|Overall Study||45
8459363|NCT00716976|20845067|P2|STARTED|Overall Study||66
8459364|NCT00716976|20845068|P1|STARTED|Overall Study||65
8459365|NCT00716963|20845090|P6|NOT COMPLETED|Overall Study||0
8459366|NCT00716963|20845091|P5|NOT COMPLETED|Overall Study||0
8459367|NCT00716963|20845092|P4|NOT COMPLETED|Overall Study||0
8459368|NCT00716963|20845093|P3|NOT COMPLETED|Overall Study||0
8459369|NCT00716963|20845094|P2|NOT COMPLETED|Overall Study||0
8459370|NCT00716963|20845095|P1|NOT COMPLETED|Overall Study||1
8459371|NCT00716963|20845090|P6|COMPLETED|Overall Study||1
8459372|NCT00716963|20845091|P5|COMPLETED|Overall Study||1
8459373|NCT00716963|20845092|P4|COMPLETED|Overall Study||1
8459374|NCT00716963|20845093|P3|COMPLETED|Overall Study||1
8459375|NCT00716963|20845094|P2|COMPLETED|Overall Study||1
8459376|NCT00716963|20845095|P1|COMPLETED|Overall Study||1
8459377|NCT00716963|20845090|P6|STARTED|Overall Study||1
8459378|NCT00716963|20845091|P5|STARTED|Overall Study||1
8459379|NCT00716963|20845092|P4|STARTED|Overall Study||1
8459380|NCT00716963|20845093|P3|STARTED|Overall Study||1
8459381|NCT00716963|20845094|P2|STARTED|Overall Study||1
8459382|NCT00716963|20845095|P1|STARTED|Overall Study||2
8459391|NCT00716820|20845133|P1|NOT COMPLETED|Overall Study||0
8459392|NCT00716820|20845133|P1|COMPLETED|Overall Study||472
8459393|NCT00716820|20845133|P1|STARTED|Overall Study||472
8459394|NCT00716807|20845168|P4|NOT COMPLETED|Overall Study||0
8459395|NCT00716807|20845169|P3|NOT COMPLETED|Overall Study||0
8459396|NCT00716807|20845170|P2|NOT COMPLETED|Overall Study||0
8459397|NCT00716807|20845171|P1|NOT COMPLETED|Overall Study||0
8459398|NCT00716807|20845168|P4|COMPLETED|Overall Study||15
8459399|NCT00716807|20845169|P3|COMPLETED|Overall Study||18
8459400|NCT00716807|20845170|P2|COMPLETED|Overall Study||5
8459401|NCT00716807|20845171|P1|COMPLETED|Overall Study||8
8459402|NCT00716807|20845168|P4|STARTED|Overall Study||15
8459403|NCT00716807|20845169|P3|STARTED|Overall Study||18
8459404|NCT00716807|20845170|P2|STARTED|Overall Study||5
8459405|NCT00716807|20845171|P1|STARTED|Overall Study||8
8459406|NCT00716742|20845184|P3|NOT COMPLETED|3 Year Follow-up||21
8459407|NCT00716742|20845185|P2|NOT COMPLETED|3 Year Follow-up||32
8459408|NCT00716742|20845186|P1|NOT COMPLETED|3 Year Follow-up||30
8459409|NCT00716742|20845184|P3|COMPLETED|3 Year Follow-up||29
8459410|NCT00716742|20845185|P2|COMPLETED|3 Year Follow-up||35
8459411|NCT00716742|20845186|P1|COMPLETED|3 Year Follow-up||26
8459412|NCT00716742|20845184|P3|STARTED|3 Year Follow-up||50
8459413|NCT00716742|20845185|P2|STARTED|3 Year Follow-up||67
8459414|NCT00716742|20845186|P1|STARTED|3 Year Follow-up||56
8459415|NCT00716742|20845184|P3|NOT COMPLETED|2 Year Follow-up||102
8459416|NCT00716742|20845185|P2|NOT COMPLETED|2 Year Follow-up||96
8459417|NCT00716742|20845186|P1|NOT COMPLETED|2 Year Follow-up||104
8459418|NCT00716742|20845184|P3|COMPLETED|2 Year Follow-up||50
8459419|NCT00716742|20845185|P2|COMPLETED|2 Year Follow-up||67
8459420|NCT00716742|20845186|P1|COMPLETED|2 Year Follow-up||56
8459421|NCT00716742|20845184|P3|STARTED|2 Year Follow-up||152
8459422|NCT00716742|20845185|P2|STARTED|2 Year Follow-up||163
8459423|NCT00716742|20845186|P1|STARTED|2 Year Follow-up||160
8459424|NCT00716742|20845184|P3|NOT COMPLETED|1 Year Follow-up||200
8459425|NCT00716742|20845185|P2|NOT COMPLETED|1 Year Follow-up||193
8459426|NCT00716742|20845186|P1|NOT COMPLETED|1 Year Follow-up||187
8459427|NCT00716742|20845184|P3|COMPLETED|1 Year Follow-up||152
8459428|NCT00716742|20845185|P2|COMPLETED|1 Year Follow-up||163
8459429|NCT00716742|20845186|P1|COMPLETED|1 Year Follow-up||160
8459430|NCT00716742|20845184|P3|STARTED|1 Year Follow-up||352
8459431|NCT00716742|20845185|P2|STARTED|1 Year Follow-up||356
8459432|NCT00716742|20845186|P1|STARTED|1 Year Follow-up||347
8459433|NCT00716742|20845184|P3|NOT COMPLETED|Baseline||13
8459434|NCT00716742|20845185|P2|NOT COMPLETED|Baseline||14
8459435|NCT00716742|20845186|P1|NOT COMPLETED|Baseline||17
8459436|NCT00716742|20845184|P3|COMPLETED|Baseline||352
8459437|NCT00716742|20845185|P2|COMPLETED|Baseline||356
8459438|NCT00716742|20845186|P1|COMPLETED|Baseline||347
8459439|NCT00716742|20845184|P3|STARTED|Baseline||365
8459440|NCT00716742|20845185|P2|STARTED|Baseline||370
8459441|NCT00716742|20845186|P1|STARTED|Baseline||364
8459442|NCT00716625|20845194|P1|NOT COMPLETED|Overall Study||1
8459443|NCT00716625|20845194|P1|COMPLETED|Overall Study||1673
8459444|NCT00716625|20845194|P1|STARTED|Overall Study||1674
8459445|NCT00716482|20845219|P1|NOT COMPLETED|Overall Study||119
8459446|NCT00716482|20845219|P1|COMPLETED|Overall Study||1562
8459447|NCT00716482|20845219|P1|STARTED|Overall Study||1681
8459448|NCT00716456|20845232|P3|NOT COMPLETED|Overall Study||0
8459449|NCT00716456|20845233|P2|NOT COMPLETED|Overall Study||2
8459450|NCT00716456|20845234|P1|NOT COMPLETED|Overall Study||0
8459451|NCT00716456|20845232|P3|COMPLETED|Overall Study||13
8459452|NCT00716456|20845233|P2|COMPLETED|Overall Study||3
8459453|NCT00716456|20845234|P1|COMPLETED|Overall Study||3
8459454|NCT00716456|20845232|P3|STARTED|Overall Study||13
8459455|NCT00716456|20845233|P2|STARTED|Overall Study||5
8459456|NCT00716456|20845234|P1|STARTED|Overall Study||3
8459457|NCT00716443|20845242|P1|NOT COMPLETED|Overall Study||0
8459458|NCT00716443|20845242|P1|COMPLETED|Overall Study||51
8459459|NCT00716443|20845242|P1|STARTED|Overall Study||51
8459460|NCT00716417|20845285|P10|NOT COMPLETED|Overall Study||3
8459461|NCT00716417|20845286|P9|NOT COMPLETED|Overall Study||5
8459462|NCT00716417|20845287|P8|NOT COMPLETED|Overall Study||3
8459463|NCT00716417|20845288|P7|NOT COMPLETED|Overall Study||7
8459464|NCT00716417|20845289|P6|NOT COMPLETED|Overall Study||3
8459465|NCT00716417|20845290|P5|NOT COMPLETED|Overall Study||1
8459466|NCT00716417|20845291|P4|NOT COMPLETED|Overall Study||11
8459467|NCT00716417|20845292|P3|NOT COMPLETED|Overall Study||5
8459468|NCT00716417|20845293|P2|NOT COMPLETED|Overall Study||6
8459469|NCT00716417|20845294|P1|NOT COMPLETED|Overall Study||3
8459470|NCT00716417|20845285|P10|COMPLETED|Overall Study||0
8459471|NCT00716417|20845286|P9|COMPLETED|Overall Study||0
8459472|NCT00716417|20845287|P8|COMPLETED|Overall Study||0
8459473|NCT00716417|20845288|P7|COMPLETED|Overall Study||0
8459474|NCT00716417|20845289|P6|COMPLETED|Overall Study||0
8459475|NCT00716417|20845290|P5|COMPLETED|Overall Study||0
8459476|NCT00716417|20845291|P4|COMPLETED|Overall Study||0
8459477|NCT00716417|20845292|P3|COMPLETED|Overall Study||0
8459478|NCT00716417|20845293|P2|COMPLETED|Overall Study||0
8459479|NCT00716417|20845294|P1|COMPLETED|Overall Study||0
8459480|NCT00716417|20845285|P10|STARTED|Overall Study||3
8459481|NCT00716417|20845286|P9|STARTED|Overall Study||5
8459482|NCT00716417|20845287|P8|STARTED|Overall Study||3
8459483|NCT00716417|20845288|P7|STARTED|Overall Study||7
8459484|NCT00716417|20845289|P6|STARTED|Overall Study||3
8459485|NCT00716417|20845290|P5|STARTED|Overall Study||1
8459486|NCT00716417|20845291|P4|STARTED|Overall Study||11
8459487|NCT00716417|20845292|P3|STARTED|Overall Study||5
8459488|NCT00716417|20845293|P2|STARTED|Overall Study||6
8459489|NCT00716417|20845294|P1|STARTED|Overall Study||3
8459490|NCT00716274|20845341|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
8459491|NCT00716274|20845342|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
8459492|NCT00716274|20845343|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
8459493|NCT00716274|20845344|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
8459494|NCT00716274|20845345|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
8459495|NCT00716274|20845346|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
8459496|NCT00716274|20845341|P6|COMPLETED|Study Period III (16-Weeks)||19
8459497|NCT00716274|20845342|P5|COMPLETED|Study Period III (16-Weeks)||32
8459498|NCT00716274|20845343|P4|COMPLETED|Study Period III (16-Weeks)||17
8459499|NCT00716274|20845344|P3|COMPLETED|Study Period III (16-Weeks)||16
8459500|NCT00716274|20845345|P2|COMPLETED|Study Period III (16-Weeks)||0
8459501|NCT00716274|20845346|P1|COMPLETED|Study Period III (16-Weeks)||0
8459502|NCT00716274|20845341|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
8459503|NCT00716274|20845342|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
8459504|NCT00716274|20845343|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
8459505|NCT00716274|20845344|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
8459506|NCT00716274|20845345|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
8459507|NCT00716274|20845346|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
8459508|NCT00716274|20845341|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
8459509|NCT00716274|20845342|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
8459510|NCT00716274|20845343|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
8459511|NCT00716274|20845344|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
8459512|NCT00716274|20845345|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
8459513|NCT00716274|20845346|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
8459514|NCT00716274|20845341|P6|COMPLETED|Study Period II (16-Weeks)||19
8459515|NCT00716274|20845342|P5|COMPLETED|Study Period II (16-Weeks)||0
8459516|NCT00716274|20845343|P4|COMPLETED|Study Period II (16-Weeks)||0
8459517|NCT00716274|20845344|P3|COMPLETED|Study Period II (16-Weeks)||0
8459518|NCT00716274|20845345|P2|COMPLETED|Study Period II (16-Weeks)||35
8459519|NCT00716274|20845346|P1|COMPLETED|Study Period II (16-Weeks)||36
8459520|NCT00716274|20845341|P6|STARTED|Study Period II (16-Weeks)||21
8459521|NCT00716274|20845342|P5|STARTED|Study Period II (16-Weeks)||0
8459522|NCT00716274|20845343|P4|STARTED|Study Period II (16-Weeks)||0
8459523|NCT00716274|20845344|P3|STARTED|Study Period II (16-Weeks)||0
8459524|NCT00716274|20845345|P2|STARTED|Study Period II (16-Weeks)||44
8459525|NCT00716274|20845346|P1|STARTED|Study Period II (16-Weeks)||45
8459526|NCT00716144|20845480|P4|NOT COMPLETED|Overall Study||12
8459527|NCT00716144|20845481|P3|NOT COMPLETED|Overall Study||12
8459528|NCT00716144|20845482|P2|NOT COMPLETED|Overall Study||7
8459529|NCT00716144|20845483|P1|NOT COMPLETED|Overall Study||9
8459530|NCT00716144|20845480|P4|COMPLETED|Overall Study||33
8459531|NCT00716144|20845481|P3|COMPLETED|Overall Study||33
8459532|NCT00716144|20845482|P2|COMPLETED|Overall Study||38
8459533|NCT00716144|20845483|P1|COMPLETED|Overall Study||32
8459534|NCT00716144|20845480|P4|STARTED|Overall Study||45
8459535|NCT00716144|20845481|P3|STARTED|Overall Study||45
8459536|NCT00716144|20845482|P2|STARTED|Overall Study||45
8459537|NCT00716144|20845483|P1|STARTED|Overall Study||41
8459538|NCT00716092|20845508|P3|NOT COMPLETED|Overall Study||0
8459539|NCT00716092|20845509|P2|NOT COMPLETED|Overall Study||1
8459540|NCT00716092|20845510|P1|NOT COMPLETED|Overall Study||2
8459541|NCT00716092|20845508|P3|COMPLETED|Overall Study||41
8459542|NCT00716092|20845509|P2|COMPLETED|Overall Study||39
8459543|NCT00716092|20845510|P1|COMPLETED|Overall Study||38
8459544|NCT00716092|20845508|P3|STARTED|Overall Study||41
8459545|NCT00716092|20845509|P2|STARTED|Overall Study||40
8459546|NCT00716092|20845510|P1|STARTED|Overall Study||40
8459547|NCT00716079|20845541|P2|NOT COMPLETED|Overall Study||15
8459548|NCT00716079|20845542|P1|NOT COMPLETED|Overall Study||9
8459549|NCT00716079|20845541|P2|COMPLETED|Overall Study||1421
8459550|NCT00716079|20845542|P1|COMPLETED|Overall Study||1394
8459551|NCT00716079|20845541|P2|STARTED|Overall Study||1436
8459552|NCT00716079|20845542|P1|STARTED|Overall Study||1403
8459553|NCT00715962|20845552|P2|NOT COMPLETED|Overall Study||2
8459554|NCT00715962|20845553|P1|NOT COMPLETED|Overall Study||6
8459555|NCT00715962|20845552|P2|COMPLETED|Overall Study||48
8459556|NCT00715962|20845553|P1|COMPLETED|Overall Study||44
8459557|NCT00715962|20845552|P2|STARTED|Overall Study||50
8459558|NCT00715962|20845553|P1|STARTED|Overall Study||50
8459559|NCT00715949|20845563|P1|NOT COMPLETED|Overall Study||4
8459560|NCT00715949|20845563|P1|COMPLETED|Overall Study|116 patients completed first test|116
8459561|NCT00715949|20845563|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
8459562|NCT00715910|20845571|P6|NOT COMPLETED|Booster and ESFU Phase||13
8459563|NCT00715910|20845572|P5|NOT COMPLETED|Booster and ESFU Phase||2
8459564|NCT00715910|20845573|P4|NOT COMPLETED|Booster and ESFU Phase||11
8459565|NCT00715910|20845574|P3|NOT COMPLETED|Booster and ESFU Phase||0
8459566|NCT00715910|20845575|P2|NOT COMPLETED|Booster and ESFU Phase||0
8459567|NCT00715910|20845576|P1|NOT COMPLETED|Booster and ESFU Phase||0
8459568|NCT00715910|20845571|P6|COMPLETED|Booster and ESFU Phase||88
8459569|NCT00715910|20845572|P5|COMPLETED|Booster and ESFU Phase||36
8459570|NCT00715910|20845573|P4|COMPLETED|Booster and ESFU Phase||172
8459571|NCT00715910|20845574|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459572|NCT00715910|20845575|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459573|NCT00715910|20845576|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459574|NCT00715910|20845571|P6|STARTED|Booster and ESFU Phase||101
8459575|NCT00715910|20845572|P5|STARTED|Booster and ESFU Phase||38
8459576|NCT00715910|20845573|P4|STARTED|Booster and ESFU Phase||183
8459577|NCT00715910|20845574|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459578|NCT00715910|20845575|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459579|NCT00715910|20845576|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459580|NCT00715910|20845571|P6|NOT COMPLETED|Year 5||0
8459581|NCT00715910|20845572|P5|NOT COMPLETED|Year 5||0
8459582|NCT00715910|20845573|P4|NOT COMPLETED|Year 5||0
8459583|NCT00715910|20845574|P3|NOT COMPLETED|Year 5||0
8459584|NCT00715910|20845575|P2|NOT COMPLETED|Year 5||0
8459585|NCT00715910|20845576|P1|NOT COMPLETED|Year 5||0
8459586|NCT00715910|20845571|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459587|NCT00715910|20845572|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459588|NCT00715910|20845573|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459589|NCT00715910|20845574|P3|COMPLETED|Year 5||38
8459590|NCT00715910|20845575|P2|COMPLETED|Year 5||56
8459591|NCT00715910|20845576|P1|COMPLETED|Year 5||218
8459592|NCT00715910|20845571|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459593|NCT00715910|20845572|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459594|NCT00715910|20845573|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459595|NCT00715910|20845574|P3|STARTED|Year 5||38
8459596|NCT00715910|20845575|P2|STARTED|Year 5||56
8459597|NCT00715910|20845576|P1|STARTED|Year 5||218
8459598|NCT00715910|20845571|P6|NOT COMPLETED|Year 3||0
8459599|NCT00715910|20845572|P5|NOT COMPLETED|Year 3||0
8459600|NCT00715910|20845573|P4|NOT COMPLETED|Year 3||0
8459601|NCT00715910|20845574|P3|NOT COMPLETED|Year 3||0
8459602|NCT00715910|20845575|P2|NOT COMPLETED|Year 3||0
8459603|NCT00715910|20845576|P1|NOT COMPLETED|Year 3||0
8459604|NCT00715910|20845571|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459605|NCT00715910|20845572|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459606|NCT00715910|20845573|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459607|NCT00715910|20845574|P3|COMPLETED|Year 3||56
8459608|NCT00715910|20845575|P2|COMPLETED|Year 3||86
8459609|NCT00715910|20845576|P1|COMPLETED|Year 3||345
8459610|NCT00715910|20845571|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459611|NCT00715910|20845572|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459612|NCT00715910|20845573|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459613|NCT00715910|20845574|P3|STARTED|Year 3||56
8459614|NCT00715910|20845575|P2|STARTED|Year 3||86
8459615|NCT00715910|20845576|P1|STARTED|Year 3||345
8459616|NCT00715910|20845571|P6|NOT COMPLETED|Year 1||0
8459617|NCT00715910|20845572|P5|NOT COMPLETED|Year 1||0
8459618|NCT00715910|20845573|P4|NOT COMPLETED|Year 1||0
8459619|NCT00715910|20845574|P3|NOT COMPLETED|Year 1||0
8459620|NCT00715910|20845575|P2|NOT COMPLETED|Year 1||0
8459621|NCT00715910|20845576|P1|NOT COMPLETED|Year 1||0
8459622|NCT00715910|20845571|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459623|NCT00715910|20845572|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459624|NCT00715910|20845573|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459625|NCT00715910|20845574|P3|COMPLETED|Year 1||68
8459626|NCT00715910|20845575|P2|COMPLETED|Year 1||147
8459627|NCT00715910|20845576|P1|COMPLETED|Year 1||433
8459628|NCT00715910|20845571|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459629|NCT00715910|20845572|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459630|NCT00715910|20845573|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459631|NCT00715910|20845574|P3|STARTED|Year 1||68
8459632|NCT00715910|20845575|P2|STARTED|Year 1||147
8459633|NCT00715910|20845576|P1|STARTED|Year 1||433
8459634|NCT00715884|20845652|P2|NOT COMPLETED|Overall Study||1
8459635|NCT00715884|20845653|P1|NOT COMPLETED|Overall Study||8
8459636|NCT00715884|20845652|P2|COMPLETED|Overall Study||225
8459637|NCT00715884|20845653|P1|COMPLETED|Overall Study||444
8459638|NCT00715884|20845652|P2|STARTED|Overall Study||226
8459639|NCT00715884|20845653|P1|STARTED|Overall Study||452
8459640|NCT00715793|20845695|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
8459641|NCT00715793|20845696|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8459642|NCT00715793|20845695|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
8459643|NCT00715793|20845696|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8459644|NCT00715793|20845695|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
8459645|NCT00715793|20845696|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8459646|NCT00715793|20845695|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
8459647|NCT00715793|20845696|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
8459648|NCT00715793|20845695|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
8459649|NCT00715793|20845696|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
8459650|NCT00715793|20845695|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
8459651|NCT00715793|20845696|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
8459652|NCT00715754|20845708|P1|NOT COMPLETED|Overall Study||0
8459653|NCT00715754|20845708|P1|COMPLETED|Overall Study||47
8459654|NCT00715754|20845708|P1|STARTED|Overall Study||47
8459655|NCT00715741|20845718|P4|NOT COMPLETED|Overall Study||0
8459656|NCT00715741|20845719|P3|NOT COMPLETED|Overall Study||0
8459657|NCT00715741|20845720|P2|NOT COMPLETED|Overall Study||0
8459658|NCT00715741|20845721|P1|NOT COMPLETED|Overall Study||0
8459659|NCT00715741|20845718|P4|COMPLETED|Overall Study||25
8459660|NCT00715741|20845719|P3|COMPLETED|Overall Study||25
8459661|NCT00715741|20845720|P2|COMPLETED|Overall Study||25
8459662|NCT00715741|20845721|P1|COMPLETED|Overall Study||25
8459663|NCT00715741|20845718|P4|STARTED|Overall Study||25
8459664|NCT00715741|20845719|P3|STARTED|Overall Study||25
8459665|NCT00715741|20845720|P2|STARTED|Overall Study||25
8459666|NCT00715741|20845721|P1|STARTED|Overall Study||25
8459667|NCT00715728|20845745|P2|NOT COMPLETED|Overall Study||0
8459668|NCT00715728|20845746|P1|NOT COMPLETED|Overall Study||0
8459669|NCT00715728|20845745|P2|COMPLETED|Overall Study||14
8459670|NCT00715728|20845746|P1|COMPLETED|Overall Study||14
8459671|NCT00715728|20845745|P2|STARTED|Overall Study||14
8459672|NCT00715728|20845746|P1|STARTED|Overall Study||14
8459673|NCT00715676|20845757|P3|NOT COMPLETED|Overall Study||32
8459674|NCT00715676|20845758|P2|NOT COMPLETED|Overall Study||11
8459675|NCT00715676|20845759|P1|NOT COMPLETED|Overall Study||6
8459676|NCT00715676|20845757|P3|COMPLETED|Overall Study||21
8459677|NCT00715676|20845758|P2|COMPLETED|Overall Study||43
8459678|NCT00715676|20845759|P1|COMPLETED|Overall Study||43
8459679|NCT00715676|20845757|P3|STARTED|Overall Study||53
8459680|NCT00715676|20845758|P2|STARTED|Overall Study||54
8459681|NCT00715676|20845759|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
8459682|NCT00715650|20845787|P2|NOT COMPLETED|Follow-up||5
8459683|NCT00715650|20845788|P1|NOT COMPLETED|Follow-up||13
8459684|NCT00715650|20845787|P2|COMPLETED|Follow-up||37
8459685|NCT00715650|20845788|P1|COMPLETED|Follow-up||29
8459686|NCT00715650|20845787|P2|Completed Month 6 Follow-up|Follow-up||37
8459687|NCT00715650|20845788|P1|Completed Month 6 Follow-up|Follow-up||29
8459688|NCT00715650|20845787|P2|Completed Month 3 Follow-up|Follow-up||40
8459689|NCT00715650|20845788|P1|Completed Month 3 Follow-up|Follow-up||35
8459690|NCT00715650|20845787|P2|Completed Month 1 Follow-up|Follow-up||38
8459691|NCT00715650|20845788|P1|Completed Month 1 Follow-up|Follow-up||40
8459692|NCT00715650|20845787|P2|STARTED|Follow-up||42
8459693|NCT00715650|20845788|P1|STARTED|Follow-up||42
8459694|NCT00715650|20845787|P2|NOT COMPLETED|Intervention||3
8459695|NCT00715650|20845788|P1|NOT COMPLETED|Intervention||5
8459696|NCT00715650|20845787|P2|COMPLETED|Intervention||42
8459697|NCT00715650|20845788|P1|COMPLETED|Intervention||42
8459698|NCT00715650|20845787|P2|Attended ≥ 3 Sessions|Intervention||17
8459699|NCT00715650|20845788|P1|Attended ≥ 3 Sessions|Intervention||23
8459700|NCT00715650|20845787|P2|Attended ≥ 2 Sessions|Intervention||33
8459701|NCT00715650|20845788|P1|Attended ≥ 2 Sessions|Intervention||36
8459702|NCT00715650|20845787|P2|Received Any Session|Intervention||38
8459703|NCT00715650|20845788|P1|Received Any Session|Intervention||39
8459704|NCT00715650|20845787|P2|STARTED|Intervention||45
8459705|NCT00715650|20845788|P1|STARTED|Intervention||47
8459706|NCT00715624|20845802|P2|NOT COMPLETED|Overall Study||116
8459707|NCT00715624|20845803|P1|NOT COMPLETED|Overall Study||52
8459708|NCT00715624|20845802|P2|COMPLETED|Overall Study||213
8459709|NCT00715624|20845803|P1|COMPLETED|Overall Study||115
8459710|NCT00715624|20845802|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
8459711|NCT00715624|20845803|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
8459712|NCT00715624|20845802|P2|Treated/Safety Population|Overall Study||328
8459713|NCT00715624|20845803|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
8459714|NCT00715624|20845802|P2|STARTED|Overall Study||329
8459715|NCT00715624|20845803|P1|STARTED|Overall Study|Randomized|167
8459716|NCT00715559|20845831|P1|NOT COMPLETED|Overall Study||1
8459717|NCT00715559|20845831|P1|COMPLETED|Overall Study||2
8459718|NCT00715559|20845831|P1|STARTED|Overall Study||3
8459719|NCT00715520|20845841|P3|NOT COMPLETED|Overall Study||2
8459720|NCT00715520|20845842|P2|NOT COMPLETED|Overall Study||1
8459721|NCT00715520|20845843|P1|NOT COMPLETED|Overall Study||10
8459722|NCT00715520|20845841|P3|COMPLETED|Overall Study||1
8459723|NCT00715520|20845842|P2|COMPLETED|Overall Study||9
8459724|NCT00715520|20845843|P1|COMPLETED|Overall Study||10
8459725|NCT00715520|20845841|P3|STARTED|Overall Study||3
8459726|NCT00715520|20845842|P2|STARTED|Overall Study||10
8459727|NCT00715520|20845843|P1|STARTED|Overall Study||20
8459728|NCT00715429|20845858|P2|NOT COMPLETED|Overall Study||1
8459729|NCT00715429|20845859|P1|NOT COMPLETED|Overall Study||0
8459730|NCT00715429|20845858|P2|COMPLETED|Overall Study||6
8459731|NCT00715429|20845859|P1|COMPLETED|Overall Study||7
8459732|NCT00715429|20845858|P2|STARTED|Overall Study||7
8459733|NCT00715429|20845859|P1|STARTED|Overall Study||7
8459734|NCT00715403|20845874|P7|NOT COMPLETED|Overall Study||1
8459735|NCT00715403|20845875|P6|NOT COMPLETED|Overall Study||19
8459736|NCT00715403|20845876|P5|NOT COMPLETED|Overall Study||6
8459737|NCT00715403|20845877|P4|NOT COMPLETED|Overall Study||9
8459738|NCT00715403|20845878|P3|NOT COMPLETED|Overall Study||4
8459739|NCT00715403|20845879|P2|NOT COMPLETED|Overall Study||1
8459740|NCT00715403|20845880|P1|NOT COMPLETED|Overall Study||1
8459741|NCT00715403|20845874|P7|COMPLETED|Overall Study||0
8459742|NCT00715403|20845875|P6|COMPLETED|Overall Study||0
8459743|NCT00715403|20845876|P5|COMPLETED|Overall Study||0
8459744|NCT00715403|20845877|P4|COMPLETED|Overall Study||0
8459745|NCT00715403|20845878|P3|COMPLETED|Overall Study||0
8459746|NCT00715403|20845879|P2|COMPLETED|Overall Study||0
8459747|NCT00715403|20845880|P1|COMPLETED|Overall Study||0
8459748|NCT00715403|20845874|P7|STARTED|Overall Study||1
8459749|NCT00715403|20845875|P6|STARTED|Overall Study||19
8459750|NCT00715403|20845876|P5|STARTED|Overall Study||6
8459751|NCT00715403|20845877|P4|STARTED|Overall Study||9
8459752|NCT00715403|20845878|P3|STARTED|Overall Study||4
8459753|NCT00715403|20845879|P2|STARTED|Overall Study||1
8459754|NCT00715403|20845880|P1|STARTED|Overall Study||1
8459755|NCT00715390|20846015|P1|NOT COMPLETED|Overall Study||0
8459756|NCT00715390|20846015|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
8459757|NCT00715390|20846015|P1|Eligible|Overall Study||234
8459758|NCT00715390|20846015|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
8459759|NCT00715299|20846019|P1|NOT COMPLETED|Overall Study||6
8459760|NCT00715299|20846019|P1|COMPLETED|Overall Study||30
8459761|NCT00715299|20846019|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
8459762|NCT00715208|20846025|P2|NOT COMPLETED|Overall Study||9
8459763|NCT00715208|20846026|P1|NOT COMPLETED|Overall Study||1
8459764|NCT00715208|20846025|P2|COMPLETED|Overall Study||39
8459765|NCT00715208|20846026|P1|COMPLETED|Overall Study||6
8459766|NCT00715208|20846025|P2|STARTED|Overall Study||48
8459767|NCT00715208|20846026|P1|STARTED|Overall Study||7
8459768|NCT00715117|20846042|P2|NOT COMPLETED|Overall Study||1
8459769|NCT00715117|20846043|P1|NOT COMPLETED|Overall Study||0
8459770|NCT00715117|20846042|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
8459771|NCT00715117|20846043|P1|COMPLETED|Overall Study||6
8459772|NCT00715117|20846042|P2|Completion fo 8 Week Study|Overall Study||6
8459773|NCT00715117|20846043|P1|Completion fo 8 Week Study|Overall Study||6
8459774|NCT00715117|20846042|P2|STARTED|Overall Study||6
8459775|NCT00715117|20846043|P1|STARTED|Overall Study||6
8459776|NCT00715104|20846057|P3|NOT COMPLETED|Overall Study||0
8459777|NCT00715104|20846058|P2|NOT COMPLETED|Overall Study||0
8459778|NCT00715104|20846059|P1|NOT COMPLETED|Overall Study||0
8459779|NCT00715104|20846057|P3|COMPLETED|Overall Study||8
8459780|NCT00715104|20846058|P2|COMPLETED|Overall Study||16
8459781|NCT00715104|20846059|P1|COMPLETED|Overall Study||18
8459782|NCT00715104|20846057|P3|STARTED|Overall Study||8
8459783|NCT00715104|20846058|P2|STARTED|Overall Study||16
8459784|NCT00715104|20846059|P1|STARTED|Overall Study||18
8459785|NCT00715078|20846111|P3|NOT COMPLETED|Overall Study||38
8459786|NCT00715078|20846112|P2|NOT COMPLETED|Overall Study||36
8459787|NCT00715078|20846113|P1|NOT COMPLETED|Overall Study||30
8459788|NCT00715078|20846111|P3|COMPLETED|Overall Study||3
8459789|NCT00715078|20846112|P2|COMPLETED|Overall Study||4
8459790|NCT00715078|20846113|P1|COMPLETED|Overall Study||11
8459791|NCT00715078|20846111|P3|Received ≥ 1 Leukapheresis|Overall Study||40
8459792|NCT00715078|20846112|P2|Received ≥ 1 Leukapheresis|Overall Study||40
8459793|NCT00715078|20846113|P1|Received ≥ 1 Leukapheresis|Overall Study||40
8459794|NCT00715078|20846111|P3|Received ≥ 1 Study Infusion|Overall Study||39
8459795|NCT00715078|20846112|P2|Received ≥ 1 Study Infusion|Overall Study||40
8459796|NCT00715078|20846113|P1|Received ≥ 1 Study Infusion|Overall Study||40
8459797|NCT00715078|20846111|P3|STARTED|Overall Study||41
8459798|NCT00715078|20846112|P2|STARTED|Overall Study||40
8459799|NCT00715078|20846113|P1|STARTED|Overall Study||41
8459800|NCT00715026|20846121|P1|NOT COMPLETED|Overall Study||10
8459801|NCT00715026|20846121|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
8459802|NCT00715026|20846121|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
8459803|NCT00715026|20846121|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
8459804|NCT00714948|20846126|P1|NOT COMPLETED|Overall Study||2
8459805|NCT00714948|20846126|P1|COMPLETED|Overall Study||0
8459806|NCT00714948|20846126|P1|STARTED|Overall Study||2
8459807|NCT00714870|20846132|P2|NOT COMPLETED|Overall Study||5
8459808|NCT00714870|20846133|P1|NOT COMPLETED|Overall Study||27
8459809|NCT00714870|20846132|P2|COMPLETED|Overall Study||22
8459810|NCT00714870|20846133|P1|COMPLETED|Overall Study||22
8459811|NCT00714870|20846132|P2|STARTED|Overall Study||27
8459812|NCT00714870|20846133|P1|STARTED|Overall Study||49
8459813|NCT00714792|20846141|P2|NOT COMPLETED|Overall Study||0
8459814|NCT00714792|20846142|P1|NOT COMPLETED|Overall Study||0
8459815|NCT00714792|20846141|P2|COMPLETED|Overall Study||8
8459816|NCT00714792|20846142|P1|COMPLETED|Overall Study||10
8459817|NCT00714792|20846141|P2|STARTED|Overall Study||8
8459818|NCT00714792|20846142|P1|STARTED|Overall Study||10
8459819|NCT00714753|20846148|P1|NOT COMPLETED|Overall Study||0
8459820|NCT00714753|20846148|P1|COMPLETED|Overall Study||5
8459821|NCT00714753|20846148|P1|External Beam Radiotherapy (EBRT)|Overall Study||1
8459822|NCT00714753|20846148|P1|HDR Brachytherapy|Overall Study||5
8459823|NCT00714753|20846148|P1|STARTED|Overall Study||5
8459824|NCT00714714|20846157|P1|NOT COMPLETED|Overall Study||1
8459825|NCT00714714|20846157|P1|COMPLETED|Overall Study||24
8459826|NCT00714714|20846157|P1|STARTED|Overall Study||25
8459827|NCT00714688|20846166|P3|NOT COMPLETED|Overall Study||37
8459828|NCT00714688|20846167|P2|NOT COMPLETED|Overall Study||35
8459829|NCT00714688|20846168|P1|NOT COMPLETED|Overall Study||29
8459830|NCT00714688|20846166|P3|COMPLETED|Overall Study||55
8459831|NCT00714688|20846167|P2|COMPLETED|Overall Study||55
8459832|NCT00714688|20846168|P1|COMPLETED|Overall Study||68
8459833|NCT00714688|20846166|P3|STARTED|Overall Study||92
8459834|NCT00714688|20846167|P2|STARTED|Overall Study||90
8459835|NCT00714688|20846168|P1|STARTED|Overall Study||97
8459836|NCT00714571|20846191|P6|NOT COMPLETED|Stage 2||0
8459837|NCT00714571|20846192|P5|NOT COMPLETED|Stage 2||0
8459838|NCT00714571|20846193|P4|NOT COMPLETED|Stage 2||0
8459839|NCT00714571|20846194|P3|NOT COMPLETED|Stage 2||0
8459840|NCT00714571|20846195|P2|NOT COMPLETED|Stage 2||0
8459841|NCT00714571|20846196|P1|NOT COMPLETED|Stage 2||0
8459842|NCT00714571|20846191|P6|COMPLETED|Stage 2||15
8459843|NCT00714571|20846192|P5|COMPLETED|Stage 2||15
8459844|NCT00714571|20846193|P4|COMPLETED|Stage 2||0
8459845|NCT00714571|20846194|P3|COMPLETED|Stage 2||0
8459846|NCT00714571|20846195|P2|COMPLETED|Stage 2||0
8459847|NCT00714571|20846196|P1|COMPLETED|Stage 2||0
8459848|NCT00714571|20846191|P6|STARTED|Stage 2||15
8459849|NCT00714571|20846192|P5|STARTED|Stage 2||15
8459850|NCT00714571|20846193|P4|STARTED|Stage 2||0
8459851|NCT00714571|20846194|P3|STARTED|Stage 2||0
8459852|NCT00714571|20846195|P2|STARTED|Stage 2||0
8459853|NCT00714571|20846196|P1|STARTED|Stage 2||0
8459854|NCT00714571|20846191|P6|NOT COMPLETED|Stage 1||0
8459855|NCT00714571|20846192|P5|NOT COMPLETED|Stage 1||0
8459856|NCT00714571|20846193|P4|NOT COMPLETED|Stage 1||0
8459857|NCT00714571|20846194|P3|NOT COMPLETED|Stage 1||1
8459858|NCT00714571|20846195|P2|NOT COMPLETED|Stage 1||0
8459859|NCT00714571|20846196|P1|NOT COMPLETED|Stage 1||0
8459860|NCT00714571|20846191|P6|COMPLETED|Stage 1||0
8459861|NCT00714571|20846192|P5|COMPLETED|Stage 1||0
8459862|NCT00714571|20846193|P4|COMPLETED|Stage 1||14
8459863|NCT00714571|20846194|P3|COMPLETED|Stage 1||10
8459864|NCT00714571|20846195|P2|COMPLETED|Stage 1||15
8459865|NCT00714571|20846196|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
8459866|NCT00714571|20846191|P6|STARTED|Stage 1||0
8459867|NCT00714571|20846192|P5|STARTED|Stage 1||0
8459868|NCT00714571|20846193|P4|STARTED|Stage 1||14
8459869|NCT00714571|20846194|P3|STARTED|Stage 1||11
8459870|NCT00714571|20846195|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
8459871|NCT00714571|20846196|P1|STARTED|Stage 1||12
8459872|NCT00714493|20846210|P1|NOT COMPLETED|Overall Study||49
8459873|NCT00714493|20846210|P1|COMPLETED|Overall Study||154
8459874|NCT00714493|20846210|P1|STARTED|Overall Study||203
8459875|NCT00714415|20846222|P2|NOT COMPLETED|Overall Study||0
8459876|NCT00714415|20846223|P1|NOT COMPLETED|Overall Study||2
8459877|NCT00714415|20846222|P2|COMPLETED|Overall Study||55
8459878|NCT00714415|20846223|P1|COMPLETED|Overall Study||23
8459879|NCT00714415|20846222|P2|STARTED|Overall Study||55
8459880|NCT00714415|20846223|P1|STARTED|Overall Study||25
8459881|NCT00714389|20846255|P1|NOT COMPLETED|Overall Study||0
8459882|NCT00714389|20846255|P1|COMPLETED|Overall Study||12
8459883|NCT00714389|20846255|P1|STARTED|Overall Study||12
8459884|NCT00714311|20846262|P2|NOT COMPLETED|Overall Study||22
8459885|NCT00714311|20846263|P1|NOT COMPLETED|Overall Study||13
8459886|NCT00714311|20846262|P2|COMPLETED|Overall Study||30
8459887|NCT00714311|20846263|P1|COMPLETED|Overall Study||39
8459888|NCT00714311|20846262|P2|STARTED|Overall Study||52
8459889|NCT00714311|20846263|P1|STARTED|Overall Study||52
8459890|NCT00714285|20846273|P4|NOT COMPLETED|Overall Study||1
8459891|NCT00714285|20846274|P3|NOT COMPLETED|Overall Study||0
8459892|NCT00714285|20846275|P2|NOT COMPLETED|Overall Study||3
8459893|NCT00714285|20846276|P1|NOT COMPLETED|Overall Study||0
8459894|NCT00714285|20846273|P4|COMPLETED|Overall Study|Completed upto Day 180|104
8459895|NCT00714285|20846274|P3|COMPLETED|Overall Study|Completed upto Day 180|105
8459896|NCT00714285|20846275|P2|COMPLETED|Overall Study|Completed upto Day 180|102
8459897|NCT00714285|20846276|P1|COMPLETED|Overall Study|Completed upto Day 180|105
8459898|NCT00714285|20846273|P4|STARTED|Overall Study||105
8459899|NCT00714285|20846274|P3|STARTED|Overall Study||105
8459900|NCT00714285|20846275|P2|STARTED|Overall Study||105
8459901|NCT00714285|20846276|P1|STARTED|Overall Study||105
8459902|NCT00714272|20846328|P2|NOT COMPLETED|Overall Study||0
8459903|NCT00714272|20846329|P1|NOT COMPLETED|Overall Study||0
8459904|NCT00714272|20846328|P2|COMPLETED|Overall Study||2
8459905|NCT00714272|20846329|P1|COMPLETED|Overall Study||2
8459906|NCT00714272|20846328|P2|STARTED|Overall Study||2
8459907|NCT00714272|20846329|P1|STARTED|Overall Study||2
8459908|NCT00714259|20846337|P1|NOT COMPLETED|Overall Study||2
8459909|NCT00714259|20846337|P1|COMPLETED|Overall Study||3
8459910|NCT00714259|20846337|P1|STARTED|Overall Study||5
8459911|NCT00714233|20846351|P4|NOT COMPLETED|Overall Study||4
8459912|NCT00714233|20846352|P3|NOT COMPLETED|Overall Study||1
8459913|NCT00714233|20846353|P2|NOT COMPLETED|Overall Study||1
8459914|NCT00714233|20846354|P1|NOT COMPLETED|Overall Study||4
8459915|NCT00714233|20846351|P4|COMPLETED|Overall Study||6
8459916|NCT00714233|20846352|P3|COMPLETED|Overall Study||10
8459917|NCT00714233|20846353|P2|COMPLETED|Overall Study||10
8459918|NCT00714233|20846354|P1|COMPLETED|Overall Study||6
8459919|NCT00714233|20846351|P4|STARTED|Overall Study||10
8459920|NCT00714233|20846352|P3|STARTED|Overall Study||11
8459921|NCT00714233|20846353|P2|STARTED|Overall Study||11
8459922|NCT00714233|20846354|P1|STARTED|Overall Study||10
8459923|NCT00714168|20846383|P2|NOT COMPLETED|Overall Study||59
8459924|NCT00714168|20846384|P1|NOT COMPLETED|Overall Study||44
8459925|NCT00714168|20846383|P2|COMPLETED|Overall Study||139
8459926|NCT00714168|20846384|P1|COMPLETED|Overall Study||121
8459927|NCT00714168|20846383|P2|STARTED|Overall Study||198
8459928|NCT00714168|20846384|P1|STARTED|Overall Study||165
8459929|NCT00714051|20846400|P2|NOT COMPLETED|Overall Study||1
8459930|NCT00714051|20846401|P1|NOT COMPLETED|Overall Study||1
8459931|NCT00714051|20846400|P2|COMPLETED|Overall Study||27
8459932|NCT00714051|20846401|P1|COMPLETED|Overall Study||26
8459933|NCT00714051|20846400|P2|STARTED|Overall Study||28
8459934|NCT00714051|20846401|P1|STARTED|Overall Study||27
8459935|NCT00713830|20846409|P2|NOT COMPLETED|Overall Study||177
8459936|NCT00713830|20846410|P1|NOT COMPLETED|Overall Study||82
8459937|NCT00713830|20846409|P2|COMPLETED|Overall Study||396
8459938|NCT00713830|20846410|P1|COMPLETED|Overall Study||204
8459939|NCT00713830|20846409|P2|Subgroup for Standardized Meal Test|Overall Study||313
8459940|NCT00713830|20846410|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
8459941|NCT00713830|20846409|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
8459942|NCT00713830|20846410|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
8459943|NCT00713830|20846409|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
8459944|NCT00713830|20846410|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
8459945|NCT00713830|20846409|P2|STARTED|Overall Study||573
8459946|NCT00713830|20846410|P1|STARTED|Overall Study|Randomized.|286
8459947|NCT00713817|20846448|P2|NOT COMPLETED|Overall Study||0
8459948|NCT00713817|20846449|P1|NOT COMPLETED|Overall Study||0
8459949|NCT00713817|20846448|P2|COMPLETED|Overall Study||9
8459950|NCT00713817|20846449|P1|COMPLETED|Overall Study||10
8459951|NCT00713817|20846448|P2|STARTED|Overall Study||9
8459952|NCT00713817|20846449|P1|STARTED|Overall Study||10
8459953|NCT00713700|20846467|P1|NOT COMPLETED|Overall Study||4
8459954|NCT00713700|20846467|P1|COMPLETED|Overall Study||188
8459955|NCT00713700|20846467|P1|STARTED|Overall Study||192
8459956|NCT00713661|20846476|P4|NOT COMPLETED|Overall Study||0
8459957|NCT00713661|20846477|P3|NOT COMPLETED|Overall Study||0
8459958|NCT00713661|20846478|P2|NOT COMPLETED|Overall Study||0
8459959|NCT00713661|20846479|P1|NOT COMPLETED|Overall Study||0
8459960|NCT00713661|20846476|P4|COMPLETED|Overall Study||5
8459961|NCT00713661|20846477|P3|COMPLETED|Overall Study||4
8459962|NCT00713661|20846478|P2|COMPLETED|Overall Study||9
8459963|NCT00713661|20846479|P1|COMPLETED|Overall Study||7
8459964|NCT00713661|20846476|P4|STARTED|Overall Study||5
8459965|NCT00713661|20846477|P3|STARTED|Overall Study||4
8459966|NCT00713661|20846478|P2|STARTED|Overall Study||9
8459967|NCT00713661|20846479|P1|STARTED|Overall Study||7
8459968|NCT00713648|20846493|P1|NOT COMPLETED|Overall Study||8
8459969|NCT00713648|20846493|P1|COMPLETED|Overall Study||33
8459970|NCT00713648|20846493|P1|STARTED|Overall Study||41
8459971|NCT00713609|20846506|P6|NOT COMPLETED|Overall Study||8
8459972|NCT00713609|20846507|P5|NOT COMPLETED|Overall Study||19
8459973|NCT00713609|20846508|P4|NOT COMPLETED|Overall Study||9
8459974|NCT00713609|20846509|P3|NOT COMPLETED|Overall Study||15
8459975|NCT00713609|20846510|P2|NOT COMPLETED|Overall Study||15
8459976|NCT00713609|20846511|P1|NOT COMPLETED|Overall Study||21
8459977|NCT00713609|20846506|P6|COMPLETED|Overall Study||47
8459978|NCT00713609|20846507|P5|COMPLETED|Overall Study||87
8459979|NCT00713609|20846508|P4|COMPLETED|Overall Study||99
8459980|NCT00713609|20846509|P3|COMPLETED|Overall Study||92
8459981|NCT00713609|20846510|P2|COMPLETED|Overall Study||90
8459982|NCT00713609|20846511|P1|COMPLETED|Overall Study||85
8459983|NCT00713609|20846506|P6|STARTED|Overall Study||55
8459984|NCT00713609|20846507|P5|STARTED|Overall Study||106
8459985|NCT00713609|20846508|P4|STARTED|Overall Study||108
8459986|NCT00713609|20846509|P3|STARTED|Overall Study||107
8459987|NCT00713609|20846510|P2|STARTED|Overall Study||105
8459988|NCT00713609|20846511|P1|STARTED|Overall Study||106
8459989|NCT00713596|20846546|P3|NOT COMPLETED|Overall Study||2
8459990|NCT00713596|20846547|P2|NOT COMPLETED|Overall Study||3
8459991|NCT00713596|20846548|P1|NOT COMPLETED|Overall Study||2
8459992|NCT00713596|20846546|P3|COMPLETED|Overall Study||6
8459993|NCT00713596|20846547|P2|COMPLETED|Overall Study||5
8459994|NCT00713596|20846548|P1|COMPLETED|Overall Study||7
8459995|NCT00713596|20846546|P3|STARTED|Overall Study||8
8459996|NCT00713596|20846547|P2|STARTED|Overall Study||8
8459997|NCT00713596|20846548|P1|STARTED|Overall Study||9
8459998|NCT00713583|20846561|P2|NOT COMPLETED|Overall Study||0
8459999|NCT00713583|20846562|P1|NOT COMPLETED|Overall Study||0
8460000|NCT00713583|20846561|P2|COMPLETED|Overall Study||40
8460001|NCT00713583|20846562|P1|COMPLETED|Overall Study||45
8460002|NCT00713583|20846561|P2|STARTED|Overall Study||40
8460003|NCT00713583|20846562|P1|STARTED|Overall Study||45
8460004|NCT00713544|20846574|P6|NOT COMPLETED|Overall Study||9
8460005|NCT00713544|20846575|P5|NOT COMPLETED|Overall Study||8
8460006|NCT00713544|20846576|P4|NOT COMPLETED|Overall Study||10
8460007|NCT00713544|20846577|P3|NOT COMPLETED|Overall Study||11
8460008|NCT00713544|20846578|P2|NOT COMPLETED|Overall Study||6
8460009|NCT00713544|20846579|P1|NOT COMPLETED|Overall Study||7
8460010|NCT00713544|20846574|P6|COMPLETED|Overall Study||67
8460011|NCT00713544|20846575|P5|COMPLETED|Overall Study||57
8460012|NCT00713544|20846576|P4|COMPLETED|Overall Study||66
8460013|NCT00713544|20846577|P3|COMPLETED|Overall Study||41
8460014|NCT00713544|20846578|P2|COMPLETED|Overall Study||46
8460015|NCT00713544|20846579|P1|COMPLETED|Overall Study||45
8460016|NCT00713544|20846574|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
8460017|NCT00713544|20846575|P5|STARTED|Overall Study||65
8460018|NCT00713544|20846576|P4|STARTED|Overall Study||76
8460019|NCT00713544|20846577|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
8460020|NCT00713544|20846578|P2|STARTED|Overall Study||52
8460021|NCT00713544|20846579|P1|STARTED|Overall Study||52
8460022|NCT00713479|20846617|P2|NOT COMPLETED|Next Medication Condition||0
8460023|NCT00713479|20846618|P1|NOT COMPLETED|Next Medication Condition||0
8460024|NCT00713479|20846617|P2|COMPLETED|Next Medication Condition||6
8460025|NCT00713479|20846618|P1|COMPLETED|Next Medication Condition||2
8460026|NCT00713479|20846617|P2|STARTED|Next Medication Condition||6
8460027|NCT00713479|20846618|P1|STARTED|Next Medication Condition||2
8460028|NCT00713479|20846617|P2|NOT COMPLETED|Washout||0
8460029|NCT00713479|20846618|P1|NOT COMPLETED|Washout||0
8460030|NCT00713479|20846617|P2|COMPLETED|Washout||6
8460031|NCT00713479|20846618|P1|COMPLETED|Washout||2
8460032|NCT00713479|20846617|P2|STARTED|Washout||6
8460033|NCT00713479|20846618|P1|STARTED|Washout||2
8460034|NCT00713479|20846617|P2|NOT COMPLETED|First Medication Condition||0
8460035|NCT00713479|20846618|P1|NOT COMPLETED|First Medication Condition||4
8460036|NCT00713479|20846617|P2|COMPLETED|First Medication Condition||6
8460037|NCT00713479|20846618|P1|COMPLETED|First Medication Condition||2
8460038|NCT00713479|20846617|P2|STARTED|First Medication Condition||6
8460039|NCT00713479|20846618|P1|STARTED|First Medication Condition||6
8460040|NCT00713349|20846630|P1|NOT COMPLETED|Overall Study||1
8460041|NCT00713349|20846630|P1|COMPLETED|Overall Study||24
8460042|NCT00713349|20846630|P1|STARTED|Overall Study||25
8460043|NCT00713323|20846636|P1|NOT COMPLETED|Overall Study||146
8460044|NCT00713323|20846636|P1|COMPLETED|Overall Study||234
8460045|NCT00713323|20846636|P1|STARTED|Overall Study||380
8460046|NCT00713310|20846649|P2|NOT COMPLETED|Overall Study||6
8460047|NCT00713310|20846650|P1|NOT COMPLETED|Overall Study||5
8460048|NCT00713310|20846649|P2|COMPLETED|Overall Study||36
8460049|NCT00713310|20846650|P1|COMPLETED|Overall Study||36
8460050|NCT00713310|20846649|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
8460051|NCT00713310|20846650|P1|mITT Population|Overall Study||41
8460052|NCT00713310|20846649|P2|STARTED|Overall Study||42
8460053|NCT00713310|20846650|P1|STARTED|Overall Study||41
8460054|NCT00713284|20846658|P1|NOT COMPLETED|Overall Study||16
8460055|NCT00713284|20846658|P1|COMPLETED|Overall Study||13
8460056|NCT00713284|20846658|P1|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
8460057|NCT00713258|20846664|P2|NOT COMPLETED|Overall Study||6
8460058|NCT00713258|20846665|P1|NOT COMPLETED|Overall Study||5
8460059|NCT00713258|20846664|P2|COMPLETED|Overall Study||28
8460060|NCT00713258|20846665|P1|COMPLETED|Overall Study||36
8460061|NCT00713258|20846664|P2|STARTED|Overall Study||34
8460062|NCT00713258|20846665|P1|STARTED|Overall Study||41
8460063|NCT00713219|20846673|P1|NOT COMPLETED|Overall Study||2
8460064|NCT00713219|20846673|P1|COMPLETED|Overall Study||12
8460065|NCT00713219|20846673|P1|STARTED|Overall Study||14
8460066|NCT00713206|20846679|P2|NOT COMPLETED|Overall Study||3
8460067|NCT00713206|20846680|P1|NOT COMPLETED|Overall Study||7
8460068|NCT00713206|20846679|P2|COMPLETED|Overall Study||27
8460069|NCT00713206|20846680|P1|COMPLETED|Overall Study||55
8460070|NCT00713206|20846679|P2|STARTED|Overall Study||30
8460071|NCT00713206|20846680|P1|STARTED|Overall Study||62
8460072|NCT00712985|20846686|P1|NOT COMPLETED|Overall Study||5
8460073|NCT00712985|20846686|P1|COMPLETED|Overall Study||13
8460074|NCT00712985|20846686|P1|STARTED|Overall Study||18
8460075|NCT00712959|20846692|P2|NOT COMPLETED|Overall Study||3
8460076|NCT00712959|20846693|P1|NOT COMPLETED|Overall Study||19
8460077|NCT00712959|20846692|P2|COMPLETED|Overall Study||404
8460078|NCT00712959|20846693|P1|COMPLETED|Overall Study||342
8460079|NCT00712959|20846692|P2|STARTED|Overall Study||407
8460080|NCT00712959|20846693|P1|STARTED|Overall Study||361
8460081|NCT00712933|20846711|P1|NOT COMPLETED|Overall Study||367
8460082|NCT00712933|20846711|P1|COMPLETED|Overall Study||368
8460083|NCT00712933|20846711|P1|STARTED|Overall Study||735
8460084|NCT00712920|20846741|P3|NOT COMPLETED|Overall Study||12
8460085|NCT00712920|20846742|P2|NOT COMPLETED|Overall Study||17
8460086|NCT00712920|20846743|P1|NOT COMPLETED|Overall Study||17
8460087|NCT00712920|20846741|P3|COMPLETED|Overall Study||180
8460088|NCT00712920|20846742|P2|COMPLETED|Overall Study||180
8460089|NCT00712920|20846743|P1|COMPLETED|Overall Study||175
8460090|NCT00712920|20846741|P3|STARTED|Overall Study||192
8460091|NCT00712920|20846742|P2|STARTED|Overall Study|3 subjects were randomized in error|197
8460092|NCT00712920|20846743|P1|STARTED|Overall Study||192
8460093|NCT00712725|20846771|P8|NOT COMPLETED|Overall Study||11
8460094|NCT00712725|20846772|P7|NOT COMPLETED|Overall Study||22
8460095|NCT00712725|20846773|P6|NOT COMPLETED|Overall Study||16
8460096|NCT00712725|20846774|P5|NOT COMPLETED|Overall Study||19
8460097|NCT00712725|20846775|P4|NOT COMPLETED|Overall Study||17
8460098|NCT00712725|20846776|P3|NOT COMPLETED|Overall Study||10
8460099|NCT00712725|20846777|P2|NOT COMPLETED|Overall Study||6
8460100|NCT00712725|20846778|P1|NOT COMPLETED|Overall Study||29
8460101|NCT00712725|20846771|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
8460102|NCT00712725|20846772|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
8460103|NCT00712725|20846773|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
8460104|NCT00712725|20846774|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
8460105|NCT00712725|20846775|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
8460106|NCT00712725|20846776|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
8460107|NCT00712725|20846777|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
8460108|NCT00712725|20846778|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
8460109|NCT00712725|20846771|P8|STARTED|Overall Study||74
8460110|NCT00712725|20846772|P7|STARTED|Overall Study||83
8460111|NCT00712725|20846773|P6|STARTED|Overall Study||84
8460112|NCT00712725|20846774|P5|STARTED|Overall Study||86
8460113|NCT00712725|20846775|P4|STARTED|Overall Study||84
8460114|NCT00712725|20846776|P3|STARTED|Overall Study||57
8460115|NCT00712725|20846777|P2|STARTED|Overall Study||39
8460116|NCT00712725|20846778|P1|STARTED|Overall Study||169
8460117|NCT00712673|20846839|P4|NOT COMPLETED|Overall Study||70
8460118|NCT00712673|20846840|P3|NOT COMPLETED|Overall Study||57
8460119|NCT00712673|20846841|P2|NOT COMPLETED|Overall Study||21
8460120|NCT00712673|20846842|P1|NOT COMPLETED|Overall Study||21
8460121|NCT00712673|20846839|P4|COMPLETED|Overall Study||185
8460122|NCT00712673|20846840|P3|COMPLETED|Overall Study||198
8460123|NCT00712673|20846841|P2|COMPLETED|Overall Study||64
8460124|NCT00712673|20846842|P1|COMPLETED|Overall Study||64
8460125|NCT00712673|20846839|P4|Subgroup for Standardized Meal Test|Overall Study||0
8460126|NCT00712673|20846840|P3|Subgroup for Standardized Meal Test|Overall Study||255
8460127|NCT00712673|20846841|P2|Subgroup for Standardized Meal Test|Overall Study||0
8460128|NCT00712673|20846842|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
8460129|NCT00712673|20846839|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
8460130|NCT00712673|20846840|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
8460131|NCT00712673|20846841|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
8460132|NCT00712673|20846842|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
8460133|NCT00712673|20846839|P4|Safety Population|Overall Study||255
8460134|NCT00712673|20846840|P3|Safety Population|Overall Study||255
8460135|NCT00712673|20846841|P2|Safety Population|Overall Study||85
8460136|NCT00712673|20846842|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
8460137|NCT00712673|20846839|P4|STARTED|Overall Study||255
8460138|NCT00712673|20846840|P3|STARTED|Overall Study||255
8460139|NCT00712673|20846841|P2|STARTED|Overall Study||85
8460140|NCT00712673|20846842|P1|STARTED|Overall Study|Randomized.|85
8460141|NCT00712543|20846906|P2|NOT COMPLETED|Day 8-14||2
8460142|NCT00712543|20846907|P1|NOT COMPLETED|Day 8-14||0
8460143|NCT00712543|20846906|P2|COMPLETED|Day 8-14||25
8460144|NCT00712543|20846907|P1|COMPLETED|Day 8-14||23
8460145|NCT00712543|20846906|P2|STARTED|Day 8-14||27
8460146|NCT00712543|20846907|P1|STARTED|Day 8-14||23
8460147|NCT00712543|20846906|P2|NOT COMPLETED|Day 1-7||0
8460148|NCT00712543|20846907|P1|NOT COMPLETED|Day 1-7||0
8460149|NCT00712543|20846906|P2|COMPLETED|Day 1-7||27
8460150|NCT00712543|20846907|P1|COMPLETED|Day 1-7||23
8460151|NCT00712543|20846906|P2|STARTED|Day 1-7||27
8460152|NCT00712543|20846907|P1|STARTED|Day 1-7||23
8460153|NCT00712530|20846916|P3|NOT COMPLETED|Overall Study||0
8460154|NCT00712530|20846917|P2|NOT COMPLETED|Overall Study||0
8460155|NCT00712530|20846918|P1|NOT COMPLETED|Overall Study||0
8460156|NCT00712530|20846916|P3|COMPLETED|Overall Study||3
8460157|NCT00712530|20846917|P2|COMPLETED|Overall Study||3
8460158|NCT00712530|20846918|P1|COMPLETED|Overall Study||3
8460159|NCT00712530|20846916|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
8460160|NCT00712530|20846917|P2|STARTED|Overall Study||3
8460161|NCT00712530|20846918|P1|STARTED|Overall Study||3
8460162|NCT00712348|20846941|P1|NOT COMPLETED|Overall Study||1
8460163|NCT00712348|20846941|P1|COMPLETED|Overall Study||30
8460164|NCT00712348|20846941|P1|STARTED|Overall Study||31
8460165|NCT00712335|20846953|P5|NOT COMPLETED|Overall Study||0
8460166|NCT00712335|20846954|P4|NOT COMPLETED|Overall Study||5
8460167|NCT00712335|20846955|P3|NOT COMPLETED|Overall Study||5
8460168|NCT00712335|20846956|P2|NOT COMPLETED|Overall Study||17
8460169|NCT00712335|20846957|P1|NOT COMPLETED|Overall Study||3
8460170|NCT00712335|20846953|P5|COMPLETED|Overall Study||30
8460171|NCT00712335|20846954|P4|COMPLETED|Overall Study||19
8460172|NCT00712335|20846955|P3|COMPLETED|Overall Study||6
8460173|NCT00712335|20846956|P2|COMPLETED|Overall Study||15
8460174|NCT00712335|20846957|P1|COMPLETED|Overall Study||5
8460175|NCT00712335|20846953|P5|STARTED|Overall Study||30
8460176|NCT00712335|20846954|P4|STARTED|Overall Study||24
8460177|NCT00712335|20846955|P3|STARTED|Overall Study||11
8460178|NCT00712335|20846956|P2|STARTED|Overall Study||32
8460179|NCT00712335|20846957|P1|STARTED|Overall Study||8
8460180|NCT00712296|20847004|P5|NOT COMPLETED|Phase II (28 Weeks)||12
8460181|NCT00712296|20847005|P4|NOT COMPLETED|Phase II (28 Weeks)||15
8460182|NCT00712296|20847006|P3|NOT COMPLETED|Phase II (28 Weeks)||13
8460183|NCT00712296|20847007|P2|NOT COMPLETED|Phase II (28 Weeks)||0
8460184|NCT00712296|20847008|P1|NOT COMPLETED|Phase II (28 Weeks)||0
8460185|NCT00712296|20847004|P5|COMPLETED|Phase II (28 Weeks)||3
8460186|NCT00712296|20847005|P4|COMPLETED|Phase II (28 Weeks)||1
8460187|NCT00712296|20847006|P3|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
8460188|NCT00712296|20847007|P2|COMPLETED|Phase II (28 Weeks)||0
8460189|NCT00712296|20847008|P1|COMPLETED|Phase II (28 Weeks)||0
8460190|NCT00712296|20847004|P5|STARTED|Phase II (28 Weeks)||15
8460191|NCT00712296|20847005|P4|STARTED|Phase II (28 Weeks)||16
8460192|NCT00712296|20847006|P3|STARTED|Phase II (28 Weeks)||15
8460193|NCT00712296|20847007|P2|STARTED|Phase II (28 Weeks)||0
8460194|NCT00712296|20847008|P1|STARTED|Phase II (28 Weeks)||0
8460195|NCT00712296|20847004|P5|NOT COMPLETED|Phase I ( 1 Week)||0
8460196|NCT00712296|20847005|P4|NOT COMPLETED|Phase I ( 1 Week)||0
8460197|NCT00712296|20847006|P3|NOT COMPLETED|Phase I ( 1 Week)||0
8460198|NCT00712296|20847007|P2|NOT COMPLETED|Phase I ( 1 Week)||0
8460199|NCT00712296|20847008|P1|NOT COMPLETED|Phase I ( 1 Week)||0
8460200|NCT00712296|20847004|P5|COMPLETED|Phase I ( 1 Week)||0
8460201|NCT00712296|20847005|P4|COMPLETED|Phase I ( 1 Week)||0
8460202|NCT00712296|20847006|P3|COMPLETED|Phase I ( 1 Week)||0
8460203|NCT00712296|20847007|P2|COMPLETED|Phase I ( 1 Week)||8
8460204|NCT00712296|20847008|P1|COMPLETED|Phase I ( 1 Week)||12
8460205|NCT00712296|20847004|P5|STARTED|Phase I ( 1 Week)||0
8460206|NCT00712296|20847005|P4|STARTED|Phase I ( 1 Week)||0
8460207|NCT00712296|20847006|P3|STARTED|Phase I ( 1 Week)||0
8460208|NCT00712296|20847007|P2|STARTED|Phase I ( 1 Week)||8
8460209|NCT00712296|20847008|P1|STARTED|Phase I ( 1 Week)||12
8460210|NCT00712270|20847087|P1|NOT COMPLETED|Overall Study||14
8460211|NCT00712270|20847087|P1|COMPLETED|Overall Study||7
8460212|NCT00712270|20847087|P1|STARTED|Overall Study||21
8460213|NCT00712244|20847100|P4|NOT COMPLETED|Overall Study||1
8460214|NCT00712244|20847101|P3|NOT COMPLETED|Overall Study||2
8460215|NCT00712244|20847102|P2|NOT COMPLETED|Overall Study||1
8460216|NCT00712244|20847103|P1|NOT COMPLETED|Overall Study||4
8460217|NCT00712244|20847100|P4|COMPLETED|Overall Study||26
8460218|NCT00712244|20847101|P3|COMPLETED|Overall Study||25
8460219|NCT00712244|20847102|P2|COMPLETED|Overall Study||28
8460220|NCT00712244|20847103|P1|COMPLETED|Overall Study||25
8460221|NCT00712244|20847100|P4|STARTED|Overall Study||27
8460222|NCT00712244|20847101|P3|STARTED|Overall Study||27
8460223|NCT00712244|20847102|P2|STARTED|Overall Study||29
8460224|NCT00712244|20847103|P1|STARTED|Overall Study||29
8460225|NCT00712179|20847145|P1|NOT COMPLETED|Overall Study||12
8460226|NCT00712179|20847145|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
8460227|NCT00712179|20847145|P1|STARTED|Overall Study||49
8460228|NCT00712166|20847151|P2|NOT COMPLETED|Overall Study||1
8460229|NCT00712166|20847152|P1|NOT COMPLETED|Overall Study||0
8460230|NCT00712166|20847151|P2|COMPLETED|Overall Study||75
8460231|NCT00712166|20847152|P1|COMPLETED|Overall Study||81
8460232|NCT00712166|20847151|P2|STARTED|Overall Study||76
8460233|NCT00712166|20847152|P1|STARTED|Overall Study||81
8460234|NCT00712075|20847179|P3|NOT COMPLETED|Overall Study||11
8460235|NCT00712075|20847180|P2|NOT COMPLETED|Overall Study||4
8460236|NCT00712075|20847181|P1|NOT COMPLETED|Overall Study||5
8460237|NCT00712075|20847179|P3|COMPLETED|Overall Study||14
8460238|NCT00712075|20847180|P2|COMPLETED|Overall Study||26
8460239|NCT00712075|20847181|P1|COMPLETED|Overall Study||17
8460240|NCT00712075|20847179|P3|STARTED|Overall Study||25
8460241|NCT00712075|20847180|P2|STARTED|Overall Study||30
8460242|NCT00712075|20847181|P1|STARTED|Overall Study||22
8460243|NCT00712010|20847195|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
8460244|NCT00712010|20847195|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
8460245|NCT00712010|20847195|P1|STARTED|7th and Last Protein Testing (1 Day)||23
8460246|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460247|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||23
8460248|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||23
8460249|NCT00712010|20847195|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
8460250|NCT00712010|20847195|P1|COMPLETED|6th Protein Testing (1 Day)||23
8460251|NCT00712010|20847195|P1|STARTED|6th Protein Testing (1 Day)||23
8460252|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460253|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||23
8460254|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||23
8460255|NCT00712010|20847195|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
8460256|NCT00712010|20847195|P1|COMPLETED|5th Protein Testing (1 Day)||23
8460257|NCT00712010|20847195|P1|STARTED|5th Protein Testing (1 Day)||23
8460258|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||1
8460259|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||23
8460260|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460261|NCT00712010|20847195|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
8460262|NCT00712010|20847195|P1|COMPLETED|4th Protein Testing (1 Day)||24
8460263|NCT00712010|20847195|P1|STARTED|4th Protein Testing (1 Day)||24
8460264|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460265|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||24
8460266|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460267|NCT00712010|20847195|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
8460268|NCT00712010|20847195|P1|COMPLETED|3rd Protein Testing (1 Day)||24
8460269|NCT00712010|20847195|P1|STARTED|3rd Protein Testing (1 Day)||24
8460270|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460271|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||24
8460272|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460273|NCT00712010|20847195|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
8460274|NCT00712010|20847195|P1|COMPLETED|2nd Protein Testing (1 Day)||24
8460275|NCT00712010|20847195|P1|STARTED|2nd Protein Testing (1 Day)||24
8460276|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460277|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||24
8460278|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460279|NCT00712010|20847195|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
8460280|NCT00712010|20847195|P1|COMPLETED|1st Protein Testing (1 Day)||24
8460281|NCT00712010|20847195|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
8460282|NCT00711997|20847220|P2|NOT COMPLETED|Overall Study||0
8460283|NCT00711997|20847221|P1|NOT COMPLETED|Overall Study||0
8460284|NCT00711997|20847220|P2|COMPLETED|Overall Study||6
8460285|NCT00711997|20847221|P1|COMPLETED|Overall Study||3
8460286|NCT00711997|20847220|P2|STARTED|Overall Study||6
8460287|NCT00711997|20847221|P1|STARTED|Overall Study||3
8460288|NCT00711971|20847234|P3|NOT COMPLETED|Overall Study||1
8460289|NCT00711971|20847235|P2|NOT COMPLETED|Overall Study||4
8460290|NCT00711971|20847236|P1|NOT COMPLETED|Overall Study||3
8460291|NCT00711971|20847234|P3|COMPLETED|Overall Study||41
8460292|NCT00711971|20847235|P2|COMPLETED|Overall Study||38
8460293|NCT00711971|20847236|P1|COMPLETED|Overall Study||39
8460294|NCT00711971|20847234|P3|STARTED|Overall Study||42
8460295|NCT00711971|20847235|P2|STARTED|Overall Study||42
8460296|NCT00711971|20847236|P1|STARTED|Overall Study||42
8460297|NCT00711958|20847270|P2|NOT COMPLETED|Overall Study||23
8460298|NCT00711958|20847271|P1|NOT COMPLETED|Overall Study||33
8460299|NCT00711958|20847270|P2|COMPLETED|Overall Study||17
8460300|NCT00711958|20847271|P1|COMPLETED|Overall Study||41
8460301|NCT00711958|20847270|P2|STARTED|Overall Study||40
8460302|NCT00711958|20847271|P1|STARTED|Overall Study||74
8460309|NCT00711867|20847318|P2|NOT COMPLETED|Overall Study||4
8460310|NCT00711867|20847319|P1|NOT COMPLETED|Overall Study||5
8460311|NCT00711867|20847318|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
8460312|NCT00711867|20847319|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
8460313|NCT00711867|20847318|P2|STARTED|Overall Study||25
8460314|NCT00711867|20847319|P1|STARTED|Overall Study||30
8460315|NCT00711828|20847325|P1|NOT COMPLETED|Overall Study||0
8460316|NCT00711828|20847325|P1|COMPLETED|Overall Study||21
8460317|NCT00711828|20847325|P1|STARTED|Overall Study||21
8460318|NCT00711802|20847342|P8|NOT COMPLETED|Overall Study||2
8460319|NCT00711802|20847343|P7|NOT COMPLETED|Overall Study||5
8460320|NCT00711802|20847344|P6|NOT COMPLETED|Overall Study||8
8460321|NCT00711802|20847345|P5|NOT COMPLETED|Overall Study||14
8460322|NCT00711802|20847346|P4|NOT COMPLETED|Overall Study||3
8460323|NCT00711802|20847347|P3|NOT COMPLETED|Overall Study||6
8460324|NCT00711802|20847348|P2|NOT COMPLETED|Overall Study||6
8460325|NCT00711802|20847349|P1|NOT COMPLETED|Overall Study||2
8460326|NCT00711802|20847342|P8|COMPLETED|Overall Study||13
8460327|NCT00711802|20847343|P7|COMPLETED|Overall Study||25
8460328|NCT00711802|20847344|P6|COMPLETED|Overall Study||34
8460329|NCT00711802|20847345|P5|COMPLETED|Overall Study||69
8460330|NCT00711802|20847346|P4|COMPLETED|Overall Study||35
8460331|NCT00711802|20847347|P3|COMPLETED|Overall Study||69
8460332|NCT00711802|20847348|P2|COMPLETED|Overall Study||32
8460333|NCT00711802|20847349|P1|COMPLETED|Overall Study||73
8460334|NCT00711802|20847342|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
8460335|NCT00711802|20847343|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
8460336|NCT00711802|20847344|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
8460337|NCT00711802|20847345|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
8460338|NCT00711802|20847346|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
8460339|NCT00711802|20847347|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
8460340|NCT00711802|20847348|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
8460341|NCT00711802|20847349|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
8460342|NCT00711802|20847342|P8|STARTED|Overall Study||15
8460343|NCT00711802|20847343|P7|STARTED|Overall Study||30
8460344|NCT00711802|20847344|P6|STARTED|Overall Study||42
8460345|NCT00711802|20847345|P5|STARTED|Overall Study||83
8460346|NCT00711802|20847346|P4|STARTED|Overall Study||38
8460347|NCT00711802|20847347|P3|STARTED|Overall Study||75
8460348|NCT00711802|20847348|P2|STARTED|Overall Study||38
8460349|NCT00711802|20847349|P1|STARTED|Overall Study||75
8460350|NCT00711711|20847381|P2|NOT COMPLETED|Overall Study||6
8460351|NCT00711711|20847382|P1|NOT COMPLETED|Overall Study||1
8460352|NCT00711711|20847381|P2|COMPLETED|Overall Study||24
8460353|NCT00711711|20847382|P1|COMPLETED|Overall Study||29
8460354|NCT00711711|20847381|P2|Seventh Postsurgical Day|Overall Study||27
8460355|NCT00711711|20847382|P1|Seventh Postsurgical Day|Overall Study||29
8460356|NCT00711711|20847381|P2|Second Postsurgical Day|Overall Study||30
8460357|NCT00711711|20847382|P1|Second Postsurgical Day|Overall Study||30
8460358|NCT00711711|20847381|P2|STARTED|Overall Study||30
8460359|NCT00711711|20847382|P1|STARTED|Overall Study||30
8460360|NCT00711646|20847392|P2|NOT COMPLETED|Overall Study||3
8460361|NCT00711646|20847393|P1|NOT COMPLETED|Overall Study||12
8460362|NCT00711646|20847392|P2|COMPLETED|Overall Study||62
8460363|NCT00711646|20847393|P1|COMPLETED|Overall Study||112
8460364|NCT00711646|20847392|P2|STARTED|Overall Study||65
8460365|NCT00711646|20847393|P1|STARTED|Overall Study||124
8460366|NCT00711594|20847415|P4|NOT COMPLETED|Overall Study||62
8460367|NCT00711594|20847416|P3|NOT COMPLETED|Overall Study||6
8460368|NCT00711594|20847417|P2|NOT COMPLETED|Overall Study||3
8460369|NCT00711594|20847418|P1|NOT COMPLETED|Overall Study||3
8460370|NCT00711594|20847415|P4|COMPLETED|Overall Study||0
8460371|NCT00711594|20847416|P3|COMPLETED|Overall Study||0
8460372|NCT00711594|20847417|P2|COMPLETED|Overall Study||0
8460373|NCT00711594|20847418|P1|COMPLETED|Overall Study||0
8460374|NCT00711594|20847415|P4|STARTED|Overall Study||62
8460375|NCT00711594|20847416|P3|STARTED|Overall Study||6
8460376|NCT00711594|20847417|P2|STARTED|Overall Study||3
8460377|NCT00711594|20847418|P1|STARTED|Overall Study||3
8460378|NCT00711555|20847455|P1|NOT COMPLETED|Overall Study||3
8460379|NCT00711555|20847455|P1|COMPLETED|Overall Study||19
8460380|NCT00711555|20847455|P1|STARTED|Overall Study||22
8460381|NCT00711529|20847464|P2|NOT COMPLETED|Overall Study||6
8460382|NCT00711529|20847465|P1|NOT COMPLETED|Overall Study||4
8460383|NCT00711529|20847464|P2|COMPLETED|Overall Study||8
8460384|NCT00711529|20847465|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
8460385|NCT00711529|20847464|P2|STARTED|Overall Study||14
8460386|NCT00711529|20847465|P1|STARTED|Overall Study||13
8460387|NCT00711516|20847489|P2|NOT COMPLETED|Overall Study||3
8460388|NCT00711516|20847490|P1|NOT COMPLETED|Overall Study||1
8460389|NCT00711516|20847489|P2|COMPLETED|Overall Study||16
8460390|NCT00711516|20847490|P1|COMPLETED|Overall Study||20
8460391|NCT00711516|20847489|P2|STARTED|Overall Study||19
8460392|NCT00711516|20847490|P1|STARTED|Overall Study||21
8460393|NCT00711490|20847584|P1|NOT COMPLETED|Overall Study||0
8460394|NCT00711490|20847584|P1|COMPLETED|Overall Study||5
8460395|NCT00711490|20847584|P1|STARTED|Overall Study||5
8460396|NCT00711477|20847597|P2|NOT COMPLETED|Overall Study||3
8460397|NCT00711477|20847598|P1|NOT COMPLETED|Overall Study||3
8460398|NCT00711477|20847597|P2|COMPLETED|Overall Study||20
8460399|NCT00711477|20847598|P1|COMPLETED|Overall Study||20
8460400|NCT00711477|20847597|P2|STARTED|Overall Study||23
8460401|NCT00711477|20847598|P1|STARTED|Overall Study||23
8460402|NCT00711464|20847626|P1|NOT COMPLETED|Overall Study||0
8460403|NCT00711464|20847626|P1|COMPLETED|Overall Study||29
8460404|NCT00711464|20847626|P1|STARTED|Overall Study||29
8460405|NCT00711425|20847644|P1|NOT COMPLETED|Overall Study||4
8460406|NCT00711425|20847644|P1|COMPLETED|Overall Study||41
8460407|NCT00711425|20847644|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
8460408|NCT00711412|20847650|P1|NOT COMPLETED|Survival Follow up Until Death||12
8460409|NCT00711412|20847650|P1|COMPLETED|Survival Follow up Until Death||26
8460410|NCT00711412|20847650|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
8460411|NCT00711412|20847650|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
8460412|NCT00711412|20847650|P1|COMPLETED|Evaluation for Response and Surgery||28
8460413|NCT00711412|20847650|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
8460414|NCT00711412|20847650|P1|NOT COMPLETED|Combination Treatment||1
8460415|NCT00711412|20847650|P1|COMPLETED|Combination Treatment||33
8460416|NCT00711412|20847650|P1|STARTED|Combination Treatment||34
8460417|NCT00711412|20847650|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
8460418|NCT00711412|20847650|P1|COMPLETED|Evaluated for Combination Treatment||34
8460419|NCT00711412|20847650|P1|STARTED|Evaluated for Combination Treatment||40
8460420|NCT00711412|20847650|P1|NOT COMPLETED|Induction Treatment||4
8460421|NCT00711412|20847650|P1|COMPLETED|Induction Treatment||40
8460422|NCT00711412|20847650|P1|Started Induction Treatment|Induction Treatment||43
8460423|NCT00711412|20847650|P1|Registered to Study|Induction Treatment||44
8460424|NCT00711412|20847650|P1|STARTED|Induction Treatment||44
8460425|NCT00711347|20847664|P2|NOT COMPLETED|Overall Study||0
8460426|NCT00711347|20847665|P1|NOT COMPLETED|Overall Study||0
8460427|NCT00711347|20847664|P2|COMPLETED|Overall Study||14
8460428|NCT00711347|20847665|P1|COMPLETED|Overall Study||14
8460429|NCT00711347|20847664|P2|STARTED|Overall Study||14
8460430|NCT00711347|20847665|P1|STARTED|Overall Study||14
8460431|NCT00711269|20847685|P4|NOT COMPLETED|Overall Study||14
8460432|NCT00711269|20847686|P3|NOT COMPLETED|Overall Study||50
8460433|NCT00711269|20847687|P2|NOT COMPLETED|Overall Study||48
8460434|NCT00711269|20847688|P1|NOT COMPLETED|Overall Study||44
8460435|NCT00711269|20847685|P4|COMPLETED|Overall Study||51
8460436|NCT00711269|20847686|P3|COMPLETED|Overall Study||83
8460437|NCT00711269|20847687|P2|COMPLETED|Overall Study||83
8460438|NCT00711269|20847688|P1|COMPLETED|Overall Study||87
8460439|NCT00711269|20847685|P4|STARTED|Overall Study||65
8460440|NCT00711269|20847686|P3|STARTED|Overall Study||133
8460441|NCT00711269|20847687|P2|STARTED|Overall Study||131
8460442|NCT00711269|20847688|P1|STARTED|Overall Study||131
8460443|NCT00711243|20847728|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
8460444|NCT00711243|20847729|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460445|NCT00711243|20847730|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460446|NCT00711243|20847731|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460447|NCT00711243|20847732|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460448|NCT00711243|20847733|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460449|NCT00711243|20847728|P6|COMPLETED|Follow up Every 3 Months Until Death||37
8460450|NCT00711243|20847729|P5|COMPLETED|Follow up Every 3 Months Until Death||3
8460451|NCT00711243|20847730|P4|COMPLETED|Follow up Every 3 Months Until Death||3
8460452|NCT00711243|20847731|P3|COMPLETED|Follow up Every 3 Months Until Death||3
8460453|NCT00711243|20847732|P2|COMPLETED|Follow up Every 3 Months Until Death||3
8460454|NCT00711243|20847733|P1|COMPLETED|Follow up Every 3 Months Until Death||3
8460455|NCT00711243|20847728|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
8460456|NCT00711243|20847729|P5|STARTED|Follow up Every 3 Months Until Death||3
8460457|NCT00711243|20847730|P4|STARTED|Follow up Every 3 Months Until Death||3
8460458|NCT00711243|20847731|P3|STARTED|Follow up Every 3 Months Until Death||3
8460459|NCT00711243|20847732|P2|STARTED|Follow up Every 3 Months Until Death||3
8460460|NCT00711243|20847733|P1|STARTED|Follow up Every 3 Months Until Death||3
8460461|NCT00711243|20847728|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
8460462|NCT00711243|20847729|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
8460463|NCT00711243|20847730|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
8460464|NCT00711243|20847731|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
8460465|NCT00711243|20847732|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
8460466|NCT00711243|20847733|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
8460467|NCT00711243|20847728|P6|COMPLETED|Treated Cycle 5 After First Response||37
8460468|NCT00711243|20847729|P5|COMPLETED|Treated Cycle 5 After First Response||2
8460469|NCT00711243|20847730|P4|COMPLETED|Treated Cycle 5 After First Response||2
8460470|NCT00711243|20847731|P3|COMPLETED|Treated Cycle 5 After First Response||3
8460471|NCT00711243|20847732|P2|COMPLETED|Treated Cycle 5 After First Response||1
8460472|NCT00711243|20847733|P1|COMPLETED|Treated Cycle 5 After First Response||2
8460473|NCT00711243|20847728|P6|STARTED|Treated Cycle 5 After First Response||41
8460474|NCT00711243|20847729|P5|STARTED|Treated Cycle 5 After First Response||3
8460475|NCT00711243|20847730|P4|STARTED|Treated Cycle 5 After First Response||2
8460476|NCT00711243|20847731|P3|STARTED|Treated Cycle 5 After First Response||3
8460477|NCT00711243|20847732|P2|STARTED|Treated Cycle 5 After First Response||3
8460478|NCT00711243|20847733|P1|STARTED|Treated Cycle 5 After First Response||3
8460479|NCT00711243|20847728|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
8460480|NCT00711243|20847729|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
8460481|NCT00711243|20847730|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
8460482|NCT00711243|20847731|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
8460483|NCT00711243|20847732|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
8460484|NCT00711243|20847733|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
8460485|NCT00711243|20847728|P6|COMPLETED|Reached First Response/4 Cycles||41
8460486|NCT00711243|20847729|P5|COMPLETED|Reached First Response/4 Cycles||3
8460487|NCT00711243|20847730|P4|COMPLETED|Reached First Response/4 Cycles||2
8460488|NCT00711243|20847731|P3|COMPLETED|Reached First Response/4 Cycles||3
8460489|NCT00711243|20847732|P2|COMPLETED|Reached First Response/4 Cycles||3
8460490|NCT00711243|20847733|P1|COMPLETED|Reached First Response/4 Cycles||3
8460491|NCT00711243|20847728|P6|STARTED|Reached First Response/4 Cycles||43
8460492|NCT00711243|20847729|P5|STARTED|Reached First Response/4 Cycles||3
8460493|NCT00711243|20847730|P4|STARTED|Reached First Response/4 Cycles||3
8460494|NCT00711243|20847731|P3|STARTED|Reached First Response/4 Cycles||3
8460495|NCT00711243|20847732|P2|STARTED|Reached First Response/4 Cycles||3
8460496|NCT00711243|20847733|P1|STARTED|Reached First Response/4 Cycles||3
8460497|NCT00711243|20847728|P6|NOT COMPLETED|Registed and Started Treatment||1
8460498|NCT00711243|20847729|P5|NOT COMPLETED|Registed and Started Treatment||0
8460499|NCT00711243|20847730|P4|NOT COMPLETED|Registed and Started Treatment||0
8460500|NCT00711243|20847731|P3|NOT COMPLETED|Registed and Started Treatment||0
8460501|NCT00711243|20847732|P2|NOT COMPLETED|Registed and Started Treatment||0
8460502|NCT00711243|20847733|P1|NOT COMPLETED|Registed and Started Treatment||0
8460503|NCT00711243|20847728|P6|COMPLETED|Registed and Started Treatment||43
8460504|NCT00711243|20847729|P5|COMPLETED|Registed and Started Treatment||3
8460505|NCT00711243|20847730|P4|COMPLETED|Registed and Started Treatment||3
8460506|NCT00711243|20847731|P3|COMPLETED|Registed and Started Treatment||3
8460507|NCT00711243|20847732|P2|COMPLETED|Registed and Started Treatment||3
8460508|NCT00711243|20847733|P1|COMPLETED|Registed and Started Treatment||3
8460509|NCT00711243|20847728|P6|Started Treatment|Registed and Started Treatment||43
8460510|NCT00711243|20847729|P5|Started Treatment|Registed and Started Treatment||3
8460511|NCT00711243|20847730|P4|Started Treatment|Registed and Started Treatment||3
8460512|NCT00711243|20847731|P3|Started Treatment|Registed and Started Treatment||3
8460513|NCT00711243|20847732|P2|Started Treatment|Registed and Started Treatment||3
8460514|NCT00711243|20847733|P1|Started Treatment|Registed and Started Treatment||3
8460515|NCT00711243|20847728|P6|Registered to Study|Registed and Started Treatment||44
8460516|NCT00711243|20847729|P5|Registered to Study|Registed and Started Treatment||3
8460517|NCT00711243|20847730|P4|Registered to Study|Registed and Started Treatment||3
8460518|NCT00711243|20847731|P3|Registered to Study|Registed and Started Treatment||3
8460519|NCT00711243|20847732|P2|Registered to Study|Registed and Started Treatment||3
8460520|NCT00711243|20847733|P1|Registered to Study|Registed and Started Treatment||3
8460521|NCT00711243|20847728|P6|STARTED|Registed and Started Treatment||44
8460522|NCT00711243|20847729|P5|STARTED|Registed and Started Treatment||3
8460523|NCT00711243|20847730|P4|STARTED|Registed and Started Treatment||3
8460524|NCT00711243|20847731|P3|STARTED|Registed and Started Treatment||3
8460525|NCT00711243|20847732|P2|STARTED|Registed and Started Treatment||3
8460526|NCT00711243|20847733|P1|STARTED|Registed and Started Treatment||3
8460527|NCT00711191|20847756|P3|NOT COMPLETED|Overall Study||12
8460528|NCT00711191|20847757|P2|NOT COMPLETED|Overall Study||5
8460529|NCT00711191|20847758|P1|NOT COMPLETED|Overall Study||3
8460530|NCT00711191|20847756|P3|COMPLETED|Overall Study||1
8460531|NCT00711191|20847757|P2|COMPLETED|Overall Study||1
8460532|NCT00711191|20847758|P1|COMPLETED|Overall Study||0
8460533|NCT00711191|20847756|P3|STARTED|Overall Study||13
8460534|NCT00711191|20847757|P2|STARTED|Overall Study||6
8460535|NCT00711191|20847758|P1|STARTED|Overall Study||3
8460536|NCT00711113|20847795|P1|NOT COMPLETED|Overall Study||11
8460537|NCT00711113|20847795|P1|COMPLETED|Overall Study||36
8460538|NCT00711113|20847795|P1|STARTED|Overall Study||47
8460539|NCT00711100|20847801|P1|NOT COMPLETED|Overall Study||13
8460540|NCT00711100|20847801|P1|COMPLETED|Overall Study||91
8460541|NCT00711100|20847801|P1|STARTED|Overall Study||104
8460542|NCT00711087|20847819|P2|NOT COMPLETED|Overall Study||0
8460543|NCT00711087|20847820|P1|NOT COMPLETED|Overall Study||1
8460544|NCT00711087|20847819|P2|COMPLETED|Overall Study||0
8460545|NCT00711087|20847820|P1|COMPLETED|Overall Study||0
8460546|NCT00711087|20847819|P2|STARTED|Overall Study||0
8460547|NCT00711087|20847820|P1|STARTED|Overall Study||1
8460548|NCT00711022|20847826|P1|NOT COMPLETED|Overall Study||11
8460549|NCT00711022|20847826|P1|COMPLETED|Overall Study||40
8460550|NCT00711022|20847826|P1|STARTED|Overall Study||51
8460551|NCT00711009|20847832|P2|NOT COMPLETED|Overall Study||19
8460552|NCT00711009|20847833|P1|NOT COMPLETED|Overall Study||15
8460553|NCT00711009|20847832|P2|COMPLETED|Overall Study||82
8460554|NCT00711009|20847833|P1|COMPLETED|Overall Study||90
8460555|NCT00711009|20847832|P2|STARTED|Overall Study||101
8460556|NCT00711009|20847833|P1|STARTED|Overall Study||105
8460557|NCT00710996|20848004|P3|NOT COMPLETED|Overall Study||0
8460558|NCT00710996|20848005|P2|NOT COMPLETED|Overall Study||4
8460559|NCT00710996|20848006|P1|NOT COMPLETED|Overall Study||1
8460560|NCT00710996|20848004|P3|COMPLETED|Overall Study||21
8460561|NCT00710996|20848005|P2|COMPLETED|Overall Study||16
8460562|NCT00710996|20848006|P1|COMPLETED|Overall Study||16
8460563|NCT00710996|20848004|P3|STARTED|Overall Study||21
8460564|NCT00710996|20848005|P2|STARTED|Overall Study||20
8460565|NCT00710996|20848006|P1|STARTED|Overall Study||17
8460566|NCT00710970|20848014|P1|NOT COMPLETED|Overall Study||10
8460567|NCT00710970|20848014|P1|COMPLETED|Overall Study||18
8460568|NCT00710970|20848014|P1|STARTED|Overall Study||28
8460569|NCT00710944|20848021|P3|NOT COMPLETED|Overall Study||2
8460570|NCT00710944|20848022|P2|NOT COMPLETED|Overall Study||9
8460571|NCT00710944|20848023|P1|NOT COMPLETED|Overall Study||10
8460572|NCT00710944|20848021|P3|COMPLETED|Overall Study||17
8460573|NCT00710944|20848022|P2|COMPLETED|Overall Study||49
8460574|NCT00710944|20848023|P1|COMPLETED|Overall Study||45
8460575|NCT00710944|20848021|P3|STARTED|Overall Study||19
8460576|NCT00710944|20848022|P2|STARTED|Overall Study||58
8460577|NCT00710944|20848023|P1|STARTED|Overall Study||55
8460578|NCT00710931|20848031|P1|NOT COMPLETED|Overall Study||5
8460579|NCT00710931|20848031|P1|COMPLETED|Overall Study||29
8460580|NCT00710931|20848031|P1|STARTED|Overall Study||34
8460581|NCT00710905|20848035|P1|NOT COMPLETED|Overall Study||16
8460582|NCT00710905|20848035|P1|COMPLETED|Overall Study||34
8460583|NCT00710905|20848035|P1|STARTED|Overall Study||50
8460584|NCT00710879|20848041|P2|NOT COMPLETED|Overall Study||4
8460585|NCT00710879|20848042|P1|NOT COMPLETED|Overall Study||2
8460586|NCT00710879|20848041|P2|COMPLETED|Overall Study||113
8460587|NCT00710879|20848042|P1|COMPLETED|Overall Study||58
8460588|NCT00710879|20848041|P2|STARTED|Overall Study||117
8460589|NCT00710879|20848042|P1|STARTED|Overall Study||60
8460590|NCT00710866|20848054|P2|NOT COMPLETED|Overall Study||6
8460591|NCT00710866|20848055|P1|NOT COMPLETED|Overall Study||9
8460592|NCT00710866|20848054|P2|COMPLETED|Overall Study||128
8460593|NCT00710866|20848055|P1|COMPLETED|Overall Study||124
8460594|NCT00710866|20848054|P2|STARTED|Overall Study||134
8460595|NCT00710866|20848055|P1|STARTED|Overall Study||133
8460596|NCT00710840|20848077|P2|NOT COMPLETED|Overall Study||3
8460597|NCT00710840|20848078|P1|NOT COMPLETED|Overall Study||0
8460598|NCT00710840|20848077|P2|COMPLETED|Overall Study||19
8460599|NCT00710840|20848078|P1|COMPLETED|Overall Study||22
8460600|NCT00710840|20848077|P2|STARTED|Overall Study||22
8460601|NCT00710840|20848078|P1|STARTED|Overall Study||22
8460602|NCT00710814|20848092|P2|NOT COMPLETED|Overall Study||3
8460603|NCT00710814|20848093|P1|NOT COMPLETED|Overall Study||1
8460604|NCT00710814|20848092|P2|COMPLETED|Overall Study||13
8460605|NCT00710814|20848093|P1|COMPLETED|Overall Study||14
8460606|NCT00710814|20848092|P2|STARTED|Overall Study||16
8460607|NCT00710814|20848093|P1|STARTED|Overall Study||15
8460608|NCT00710762|20848101|P2|NOT COMPLETED|Overall Study||40
8460609|NCT00710762|20848102|P1|NOT COMPLETED|Overall Study||39
8460610|NCT00710762|20848101|P2|COMPLETED|Overall Study||0
8460611|NCT00710762|20848102|P1|COMPLETED|Overall Study||5
8460612|NCT00710762|20848101|P2|STARTED|Overall Study||40
8460613|NCT00710762|20848102|P1|STARTED|Overall Study||44
8460614|NCT00710749|20848118|P2|NOT COMPLETED|Second Intervention||0
8460615|NCT00710749|20848119|P1|NOT COMPLETED|Second Intervention||0
8460616|NCT00710749|20848118|P2|COMPLETED|Second Intervention||30
8460617|NCT00710749|20848119|P1|COMPLETED|Second Intervention||29
8460618|NCT00710749|20848118|P2|STARTED|Second Intervention||30
8460619|NCT00710749|20848119|P1|STARTED|Second Intervention||29
8460620|NCT00710749|20848118|P2|NOT COMPLETED|First Intervention||0
8460621|NCT00710749|20848119|P1|NOT COMPLETED|First Intervention||1
8460622|NCT00710749|20848118|P2|COMPLETED|First Intervention||30
8460623|NCT00710749|20848119|P1|COMPLETED|First Intervention||29
8460624|NCT00710749|20848118|P2|STARTED|First Intervention||30
8460625|NCT00710749|20848119|P1|STARTED|First Intervention||30
8460626|NCT00710749|20848118|P2|NOT COMPLETED|Clinic Baseline Recording||0
8460627|NCT00710749|20848119|P1|NOT COMPLETED|Clinic Baseline Recording||0
8460628|NCT00710749|20848118|P2|COMPLETED|Clinic Baseline Recording||30
8460629|NCT00710749|20848119|P1|COMPLETED|Clinic Baseline Recording||30
8460630|NCT00710749|20848118|P2|STARTED|Clinic Baseline Recording||30
8460631|NCT00710749|20848119|P1|STARTED|Clinic Baseline Recording||30
8460632|NCT00710684|20848130|P3|NOT COMPLETED|Overall Study||64
8460633|NCT00710684|20848131|P2|NOT COMPLETED|Overall Study||74
8460634|NCT00710684|20848132|P1|NOT COMPLETED|Overall Study||74
8460635|NCT00710684|20848130|P3|COMPLETED|Overall Study||172
8460636|NCT00710684|20848131|P2|COMPLETED|Overall Study||147
8460637|NCT00710684|20848132|P1|COMPLETED|Overall Study||151
8460638|NCT00710684|20848130|P3|STARTED|Overall Study||236
8460639|NCT00710684|20848131|P2|STARTED|Overall Study||221
8460640|NCT00710684|20848132|P1|STARTED|Overall Study||225
8460641|NCT00710606|20848189|P2|NOT COMPLETED|Overall Study||2
8460642|NCT00710606|20848190|P1|NOT COMPLETED|Overall Study||0
8460643|NCT00710606|20848189|P2|COMPLETED|Overall Study||18
8460644|NCT00710606|20848190|P1|COMPLETED|Overall Study||20
8460645|NCT00710606|20848189|P2|STARTED|Overall Study||20
8460646|NCT00710606|20848190|P1|STARTED|Overall Study||20
8460647|NCT00710593|20848202|P2|NOT COMPLETED|Overall Study||5
8460648|NCT00710593|20848203|P1|NOT COMPLETED|Overall Study||15
8460649|NCT00710593|20848202|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
8460650|NCT00710593|20848203|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
8460651|NCT00710593|20848202|P2|STARTED|Overall Study||30
8460652|NCT00710593|20848203|P1|STARTED|Overall Study||69
8460653|NCT00710554|20848246|P2|NOT COMPLETED|Overall Study||24
8460654|NCT00710554|20848247|P1|NOT COMPLETED|Overall Study||49
8460655|NCT00710554|20848246|P2|COMPLETED|Overall Study||94
8460656|NCT00710554|20848247|P1|COMPLETED|Overall Study||79
8460657|NCT00710554|20848246|P2|STARTED|Overall Study||118
8460658|NCT00710554|20848247|P1|STARTED|Overall Study||128
8460659|NCT00710424|20848275|P2|NOT COMPLETED|Overall Study||23
8460660|NCT00710424|20848276|P1|NOT COMPLETED|Overall Study||44
8460661|NCT00710424|20848275|P2|COMPLETED|Overall Study||125
8460662|NCT00710424|20848276|P1|COMPLETED|Overall Study||105
8460663|NCT00710424|20848275|P2|STARTED|Overall Study||148
8460664|NCT00710424|20848276|P1|STARTED|Overall Study||149
8460665|NCT00710385|20848300|P1|NOT COMPLETED|Overall Study||5
8460666|NCT00710385|20848300|P1|COMPLETED|Overall Study||12
8460667|NCT00710385|20848300|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
8460668|NCT00710203|20848317|P1|NOT COMPLETED|Overall Study||0
8460669|NCT00710203|20848317|P1|COMPLETED|Overall Study||10
8460670|NCT00710203|20848317|P1|STARTED|Overall Study||10
8460671|NCT00710034|20848345|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
8460672|NCT00710034|20848346|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
8460673|NCT00710034|20848345|P2|COMPLETED|Completed 12 Weeks of Treatment||138
8460674|NCT00710034|20848346|P1|COMPLETED|Completed 12 Weeks of Treatment||141
8460675|NCT00710034|20848345|P2|STARTED|Completed 12 Weeks of Treatment||149
8460676|NCT00710034|20848346|P1|STARTED|Completed 12 Weeks of Treatment||154
8460677|NCT00710034|20848345|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
8460678|NCT00710034|20848346|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
8460679|NCT00710034|20848345|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
8460680|NCT00710034|20848346|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
8460681|NCT00710034|20848345|P2|STARTED|Completed 6 Weeks of Treatment||196
8460682|NCT00710034|20848346|P1|STARTED|Completed 6 Weeks of Treatment||195
8460683|NCT00710021|20848363|P3|NOT COMPLETED|Overall Study||1
8460684|NCT00710021|20848364|P2|NOT COMPLETED|Overall Study||3
8460685|NCT00710021|20848365|P1|NOT COMPLETED|Overall Study||1
8460686|NCT00710021|20848363|P3|COMPLETED|Overall Study||18
8460687|NCT00710021|20848364|P2|COMPLETED|Overall Study||16
8460688|NCT00710021|20848365|P1|COMPLETED|Overall Study||18
8460689|NCT00710021|20848363|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
8460690|NCT00710021|20848364|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
8460691|NCT00710021|20848365|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
8460692|NCT00710021|20848363|P3|STARTED|Overall Study||19
8460693|NCT00710021|20848364|P2|STARTED|Overall Study||19
8460694|NCT00710021|20848365|P1|STARTED|Overall Study||19
8460695|NCT00709995|20848480|P2|NOT COMPLETED|Overall Study||5
8460696|NCT00709995|20848481|P1|NOT COMPLETED|Overall Study||5
8460697|NCT00709995|20848480|P2|COMPLETED|Overall Study||1
8460698|NCT00709995|20848481|P1|COMPLETED|Overall Study||6
8460699|NCT00709995|20848480|P2|Progressive Disease|Overall Study||1
8460700|NCT00709995|20848481|P1|Progressive Disease|Overall Study||6
8460701|NCT00709995|20848480|P2|STARTED|Overall Study||6
8460702|NCT00709995|20848481|P1|STARTED|Overall Study||11
8460703|NCT00709956|20848499|P2|NOT COMPLETED|Overall Study||4
8460704|NCT00709956|20848500|P1|NOT COMPLETED|Overall Study||3
8460705|NCT00709956|20848499|P2|COMPLETED|Overall Study||33
8460706|NCT00709956|20848500|P1|COMPLETED|Overall Study||30
8460707|NCT00709956|20848499|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
8460708|NCT00709956|20848500|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
8460709|NCT00709956|20848499|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
8460710|NCT00709956|20848500|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
8460711|NCT00709891|20848508|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
8460712|NCT00709891|20848508|P1|COMPLETED|Longitudinal Follow-up Phase||5020
8460713|NCT00709891|20848508|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
8460714|NCT00709891|20848508|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
8460715|NCT00709891|20848508|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
8460716|NCT00709891|20848508|P1|STARTED|Baseline, Cross-sectional Phase||47208
8460717|NCT00709878|20848517|P4|NOT COMPLETED|Overall Study||0
8460718|NCT00709878|20848518|P3|NOT COMPLETED|Overall Study||0
8460719|NCT00709878|20848519|P2|NOT COMPLETED|Overall Study||0
8460720|NCT00709878|20848520|P1|NOT COMPLETED|Overall Study||0
8460721|NCT00709878|20848517|P4|COMPLETED|Overall Study||8
8460722|NCT00709878|20848518|P3|COMPLETED|Overall Study||8
8460723|NCT00709878|20848519|P2|COMPLETED|Overall Study||8
8460724|NCT00709878|20848520|P1|COMPLETED|Overall Study||8
8460725|NCT00709878|20848517|P4|STARTED|Overall Study||8
8460726|NCT00709878|20848518|P3|STARTED|Overall Study||8
8460727|NCT00709878|20848519|P2|STARTED|Overall Study||8
8460728|NCT00709878|20848520|P1|STARTED|Overall Study||8
8460729|NCT00709852|20848530|P2|NOT COMPLETED|Period 2||2
8460730|NCT00709852|20848531|P1|NOT COMPLETED|Period 2||9
8460731|NCT00709852|20848530|P2|COMPLETED|Period 2||169
8460732|NCT00709852|20848531|P1|COMPLETED|Period 2||211
8460733|NCT00709852|20848530|P2|STARTED|Period 2||171
8460734|NCT00709852|20848531|P1|STARTED|Period 2||220
8460735|NCT00709852|20848530|P2|NOT COMPLETED|Period 1||3
8460736|NCT00709852|20848531|P1|NOT COMPLETED|Period 1||8
8460737|NCT00709852|20848530|P2|COMPLETED|Period 1||171
8460738|NCT00709852|20848531|P1|COMPLETED|Period 1||220
8460739|NCT00709852|20848530|P2|STARTED|Period 1||174
8460740|NCT00709852|20848531|P1|STARTED|Period 1||228
8460741|NCT00709826|20848686|P2|NOT COMPLETED|Overall Study||1
8460742|NCT00709826|20848687|P1|NOT COMPLETED|Overall Study||2
8460743|NCT00709826|20848686|P2|COMPLETED|Overall Study||38
8460744|NCT00709826|20848687|P1|COMPLETED|Overall Study||68
8460745|NCT00709826|20848686|P2|STARTED|Overall Study||39
8460746|NCT00709826|20848687|P1|STARTED|Overall Study||70
8460747|NCT00709761|20848695|P1|NOT COMPLETED|Overall Study||27
8460748|NCT00709761|20848695|P1|COMPLETED|Overall Study||33
8460749|NCT00709761|20848695|P1|STARTED|Overall Study||60
8460750|NCT00709735|20848706|P2|NOT COMPLETED|Overall Study||2
8460751|NCT00709735|20848707|P1|NOT COMPLETED|Overall Study||3
8460752|NCT00709735|20848706|P2|COMPLETED|Overall Study||10
8460753|NCT00709735|20848707|P1|COMPLETED|Overall Study||8
8460754|NCT00709735|20848706|P2|STARTED|Overall Study||12
8460755|NCT00709735|20848707|P1|STARTED|Overall Study||11
8460756|NCT00709722|20848715|P1|NOT COMPLETED|Overall Study||1
8460757|NCT00709722|20848715|P1|COMPLETED|Overall Study||20
8460758|NCT00709722|20848715|P1|STARTED|Overall Study||21
8460759|NCT00709696|20848723|P2|NOT COMPLETED|Overall Study||0
8460760|NCT00709696|20848724|P1|NOT COMPLETED|Overall Study||0
8460761|NCT00709696|20848723|P2|COMPLETED|Overall Study||3
8460762|NCT00709696|20848724|P1|COMPLETED|Overall Study||4
8460763|NCT00709696|20848723|P2|STARTED|Overall Study||3
8460764|NCT00709696|20848724|P1|STARTED|Overall Study||4
8460765|NCT00709618|20848730|P1|NOT COMPLETED|Overall Study||30
8460766|NCT00709618|20848730|P1|COMPLETED|Overall Study||14
8460767|NCT00709618|20848730|P1|STARTED|Overall Study||44
8460768|NCT00709592|20848742|P2|NOT COMPLETED|Overall Study||1
8460769|NCT00709592|20848743|P1|NOT COMPLETED|Overall Study||0
8460770|NCT00709592|20848742|P2|COMPLETED|Overall Study||22
8460771|NCT00709592|20848743|P1|COMPLETED|Overall Study||19
8460772|NCT00709592|20848742|P2|STARTED|Overall Study||23
8460773|NCT00709592|20848743|P1|STARTED|Overall Study||19
8460774|NCT00709319|20848765|P1|NOT COMPLETED|Overall Study||6
8460775|NCT00709319|20848765|P1|COMPLETED|Overall Study||81
8460776|NCT00709319|20848765|P1|STARTED|Overall Study||87
8460777|NCT00709306|20848777|P4|NOT COMPLETED|Overall Study||10
8460778|NCT00709306|20848778|P3|NOT COMPLETED|Overall Study||10
8460779|NCT00709306|20848779|P2|NOT COMPLETED|Overall Study||14
8460780|NCT00709306|20848780|P1|NOT COMPLETED|Overall Study||9
8460781|NCT00709306|20848777|P4|COMPLETED|Overall Study||37
8460782|NCT00709306|20848778|P3|COMPLETED|Overall Study||48
8460783|NCT00709306|20848779|P2|COMPLETED|Overall Study||30
8460784|NCT00709306|20848780|P1|COMPLETED|Overall Study||39
8460785|NCT00709306|20848777|P4|STARTED|Overall Study||47
8460786|NCT00709306|20848778|P3|STARTED|Overall Study||58
8460787|NCT00709306|20848779|P2|STARTED|Overall Study||44
8460788|NCT00709306|20848780|P1|STARTED|Overall Study||48
8460789|NCT00709228|20848794|P1|NOT COMPLETED|Overall Study||332
8460790|NCT00709228|20848794|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
8460791|NCT00709228|20848794|P1|STARTED|Overall Study||496
8460792|NCT00709202|20848800|P2|NOT COMPLETED|Overall Study||6
8460793|NCT00709202|20848801|P1|NOT COMPLETED|Overall Study||6
8460794|NCT00709202|20848800|P2|COMPLETED|Overall Study||15
8460795|NCT00709202|20848801|P1|COMPLETED|Overall Study||13
8460796|NCT00709202|20848800|P2|STARTED|Overall Study||21
8460797|NCT00709202|20848801|P1|STARTED|Overall Study||19
8460798|NCT00709124|20848829|P2|NOT COMPLETED|Overall Study||1
8460799|NCT00709124|20848830|P1|NOT COMPLETED|Overall Study||4
8460800|NCT00709124|20848829|P2|COMPLETED|Overall Study||17
8460801|NCT00709124|20848830|P1|COMPLETED|Overall Study||12
8460802|NCT00709124|20848829|P2|STARTED|Overall Study||18
8460803|NCT00709124|20848830|P1|STARTED|Overall Study||16
8460804|NCT00709111|20848864|P1|NOT COMPLETED|Overall Study||2
8460805|NCT00709111|20848864|P1|COMPLETED|Overall Study||32
8460806|NCT00709111|20848864|P1|Week 22/24|Overall Study||33
8460807|NCT00709111|20848864|P1|STARTED|Overall Study||34
8460808|NCT00709098|20848905|P3|NOT COMPLETED|Open-label Period||14
8460809|NCT00709098|20848906|P2|NOT COMPLETED|Open-label Period||0
8460810|NCT00709098|20848907|P1|NOT COMPLETED|Open-label Period||0
8460811|NCT00709098|20848905|P3|COMPLETED|Open-label Period||18
8460812|NCT00709098|20848906|P2|COMPLETED|Open-label Period||0
8460813|NCT00709098|20848907|P1|COMPLETED|Open-label Period||0
8460814|NCT00709098|20848905|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
8460815|NCT00709098|20848906|P2|STARTED|Open-label Period||0
8460816|NCT00709098|20848907|P1|STARTED|Open-label Period||0
8460817|NCT00709098|20848905|P3|NOT COMPLETED|Double-blind Period||0
8460818|NCT00709098|20848906|P2|NOT COMPLETED|Double-blind Period||8
8460819|NCT00709098|20848907|P1|NOT COMPLETED|Double-blind Period||6
8460820|NCT00709098|20848905|P3|COMPLETED|Double-blind Period||0
8460821|NCT00709098|20848906|P2|COMPLETED|Double-blind Period||16
8460822|NCT00709098|20848907|P1|COMPLETED|Double-blind Period||19
8460823|NCT00709098|20848905|P3|STARTED|Double-blind Period||0
8460824|NCT00709098|20848906|P2|STARTED|Double-blind Period||24
8460825|NCT00709098|20848907|P1|STARTED|Double-blind Period||25
8460826|NCT00709059|20848926|P1|NOT COMPLETED|Overall Study||94
8460827|NCT00709059|20848926|P1|COMPLETED|Overall Study||444
8460828|NCT00709059|20848926|P1|STARTED|Overall Study||538
8460829|NCT00708942|20848935|P5|NOT COMPLETED|Overall Study||1
8460830|NCT00708942|20848936|P4|NOT COMPLETED|Overall Study||0
8460831|NCT00708942|20848937|P3|NOT COMPLETED|Overall Study||2
8460832|NCT00708942|20848938|P2|NOT COMPLETED|Overall Study||1
8460833|NCT00708942|20848939|P1|NOT COMPLETED|Overall Study||7
8460834|NCT00708942|20848935|P5|COMPLETED|Overall Study||2
8460835|NCT00708942|20848936|P4|COMPLETED|Overall Study||10
8460836|NCT00708942|20848937|P3|COMPLETED|Overall Study||9
8460837|NCT00708942|20848938|P2|COMPLETED|Overall Study||11
8460838|NCT00708942|20848939|P1|COMPLETED|Overall Study||40
8460839|NCT00708942|20848935|P5|STARTED|Overall Study||3
8460840|NCT00708942|20848936|P4|STARTED|Overall Study||10
8460841|NCT00708942|20848937|P3|STARTED|Overall Study||11
8460842|NCT00708942|20848938|P2|STARTED|Overall Study||12
8460843|NCT00708942|20848939|P1|STARTED|Overall Study||47
8460844|NCT00708877|20848961|P1|NOT COMPLETED|Overall Study||0
8460845|NCT00708877|20848961|P1|COMPLETED|Overall Study||5
8460846|NCT00708877|20848961|P1|STARTED|Overall Study||5
8460847|NCT00708851|20848965|P1|NOT COMPLETED|Overall Study||0
8460848|NCT00708851|20848965|P1|COMPLETED|Overall Study||12
8460849|NCT00708851|20848965|P1|STARTED|Overall Study||12
8460850|NCT00708734|20848973|P1|NOT COMPLETED|Overall Study||7
8460851|NCT00708734|20848973|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
8460852|NCT00708734|20848973|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
8460853|NCT00708721|20848977|P4|NOT COMPLETED|Overall Study||0
8460854|NCT00708721|20848978|P3|NOT COMPLETED|Overall Study||0
8460855|NCT00708721|20848979|P2|NOT COMPLETED|Overall Study||0
8460856|NCT00708721|20848980|P1|NOT COMPLETED|Overall Study||0
8460857|NCT00708721|20848977|P4|COMPLETED|Overall Study||2
8460858|NCT00708721|20848978|P3|COMPLETED|Overall Study||3
8460859|NCT00708721|20848979|P2|COMPLETED|Overall Study||4
8460860|NCT00708721|20848980|P1|COMPLETED|Overall Study||2
8460861|NCT00708721|20848977|P4|STARTED|Overall Study||2
8460862|NCT00708721|20848978|P3|STARTED|Overall Study||3
8460863|NCT00708721|20848979|P2|STARTED|Overall Study||4
8460864|NCT00708721|20848980|P1|STARTED|Overall Study||2
8460865|NCT00708708|20848993|P1|NOT COMPLETED|Overall Study||742
8460866|NCT00708708|20848993|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
8460867|NCT00708708|20848993|P1|STARTED|Overall Study||955
8460868|NCT00708682|20849041|P1|NOT COMPLETED|Toddler Dose||8
8460869|NCT00708682|20849041|P1|COMPLETED|Toddler Dose||183
8460870|NCT00708682|20849041|P1|STARTED|Toddler Dose||191
8460871|NCT00708682|20849041|P1|NOT COMPLETED|After Infant Series||1
8460872|NCT00708682|20849041|P1|COMPLETED|After Infant Series||191
8460873|NCT00708682|20849041|P1|STARTED|After Infant Series||192
8460874|NCT00708682|20849041|P1|NOT COMPLETED|Infant Series||33
8460875|NCT00708682|20849041|P1|COMPLETED|Infant Series||192
8460876|NCT00708682|20849041|P1|Vaccinated Dose 3|Infant Series||194
8460877|NCT00708682|20849041|P1|Vaccinated Dose 2|Infant Series||214
8460878|NCT00708682|20849041|P1|Vaccinated Dose 1|Infant Series||223
8460879|NCT00708682|20849041|P1|STARTED|Infant Series||225
8460880|NCT00708643|20849062|P2|NOT COMPLETED|Overall Study||1
8460881|NCT00708643|20849063|P1|NOT COMPLETED|Overall Study||0
8460882|NCT00708643|20849062|P2|COMPLETED|Overall Study||39
8460883|NCT00708643|20849063|P1|COMPLETED|Overall Study||40
8460884|NCT00708643|20849062|P2|STARTED|Overall Study||40
8460885|NCT00708643|20849063|P1|STARTED|Overall Study||40
8460886|NCT00708552|20849083|P4|NOT COMPLETED|Overall Study||21
8460887|NCT00708552|20849084|P3|NOT COMPLETED|Overall Study||15
8460888|NCT00708552|20849085|P2|NOT COMPLETED|Overall Study||18
8460889|NCT00708552|20849086|P1|NOT COMPLETED|Overall Study||27
8460890|NCT00708552|20849083|P4|COMPLETED|Overall Study||130
8460891|NCT00708552|20849084|P3|COMPLETED|Overall Study||118
8460892|NCT00708552|20849085|P2|COMPLETED|Overall Study||127
8460893|NCT00708552|20849086|P1|COMPLETED|Overall Study||118
8460894|NCT00708552|20849083|P4|STARTED|Overall Study||151
8460895|NCT00708552|20849084|P3|STARTED|Overall Study||133
8460896|NCT00708552|20849085|P2|STARTED|Overall Study||145
8460897|NCT00708552|20849086|P1|STARTED|Overall Study||145
8460898|NCT00708526|20849236|P2|NOT COMPLETED|Return of Cognitive Function||0
8460899|NCT00708526|20849237|P1|NOT COMPLETED|Return of Cognitive Function||0
8460900|NCT00708526|20849236|P2|COMPLETED|Return of Cognitive Function||11
8460901|NCT00708526|20849237|P1|COMPLETED|Return of Cognitive Function||11
8460902|NCT00708526|20849236|P2|STARTED|Return of Cognitive Function||11
8460903|NCT00708526|20849237|P1|STARTED|Return of Cognitive Function||11
8460904|NCT00708526|20849236|P2|NOT COMPLETED|Wake up After Anesthesia||0
8460905|NCT00708526|20849237|P1|NOT COMPLETED|Wake up After Anesthesia||0
8460906|NCT00708526|20849236|P2|COMPLETED|Wake up After Anesthesia||11
8460907|NCT00708526|20849237|P1|COMPLETED|Wake up After Anesthesia||11
8460908|NCT00708526|20849236|P2|STARTED|Wake up After Anesthesia||11
8460909|NCT00708526|20849237|P1|STARTED|Wake up After Anesthesia||11
8460910|NCT00708500|20849248|P3|NOT COMPLETED|FOLLOWUP||15
8460911|NCT00708500|20849249|P2|NOT COMPLETED|FOLLOWUP||15
8460912|NCT00708500|20849250|P1|NOT COMPLETED|FOLLOWUP||40
8460913|NCT00708500|20849248|P3|COMPLETED|FOLLOWUP||143
8460914|NCT00708500|20849249|P2|COMPLETED|FOLLOWUP||136
8460915|NCT00708500|20849250|P1|COMPLETED|FOLLOWUP||37
8460916|NCT00708500|20849248|P3|STARTED|FOLLOWUP||158
8460917|NCT00708500|20849249|P2|STARTED|FOLLOWUP||151
8460918|NCT00708500|20849250|P1|STARTED|FOLLOWUP||77
8460919|NCT00708500|20849248|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
8460920|NCT00708500|20849249|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
8460921|NCT00708500|20849250|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
8460922|NCT00708500|20849248|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
8460923|NCT00708500|20849249|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
8460924|NCT00708500|20849250|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
8460925|NCT00708500|20849248|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
8460926|NCT00708500|20849249|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
8460927|NCT00708500|20849250|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
8460928|NCT00708500|20849248|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
8460929|NCT00708500|20849249|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
8460930|NCT00708500|20849250|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
8460931|NCT00708500|20849248|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
8460932|NCT00708500|20849249|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
8460933|NCT00708500|20849250|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
8460934|NCT00708500|20849248|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
8460935|NCT00708500|20849249|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8460936|NCT00708500|20849250|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
8460937|NCT00708500|20849248|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8460938|NCT00708500|20849249|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8460939|NCT00708500|20849250|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
8460940|NCT00708461|20849269|P2|NOT COMPLETED|Overall Study||200
8460941|NCT00708461|20849270|P1|NOT COMPLETED|Overall Study||141
8460942|NCT00708461|20849269|P2|COMPLETED|Overall Study||795
8460943|NCT00708461|20849270|P1|COMPLETED|Overall Study||611
8460944|NCT00708461|20849269|P2|STARTED|Overall Study||995
8460945|NCT00708461|20849270|P1|STARTED|Overall Study||752
8460946|NCT00708435|20849278|P2|NOT COMPLETED|Overall Study||17
8460947|NCT00708435|20849279|P1|NOT COMPLETED|Overall Study||25
8460948|NCT00708435|20849278|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
8460949|NCT00708435|20849279|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
8460950|NCT00708435|20849278|P2|STARTED|Overall Study||109
8460951|NCT00708435|20849279|P1|STARTED|Overall Study||107
8460952|NCT00708422|20849306|P2|NOT COMPLETED|Overall Study||1
8460953|NCT00708422|20849307|P1|NOT COMPLETED|Overall Study||4
8460954|NCT00708422|20849306|P2|COMPLETED|Overall Study||114
8460955|NCT00708422|20849307|P1|COMPLETED|Overall Study||112
8460956|NCT00708422|20849306|P2|STARTED|Overall Study||115
8460957|NCT00708422|20849307|P1|STARTED|Overall Study||116
8460958|NCT00708305|20849315|P4|NOT COMPLETED|Period 4||0
8460959|NCT00708305|20849316|P3|NOT COMPLETED|Period 4||0
8460960|NCT00708305|20849317|P2|NOT COMPLETED|Period 4||0
8460961|NCT00708305|20849318|P1|NOT COMPLETED|Period 4||0
8460962|NCT00708305|20849315|P4|COMPLETED|Period 4||14
8460963|NCT00708305|20849316|P3|COMPLETED|Period 4||14
8460964|NCT00708305|20849317|P2|COMPLETED|Period 4||14
8460965|NCT00708305|20849318|P1|COMPLETED|Period 4||12
8460966|NCT00708305|20849315|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8460967|NCT00708305|20849316|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8460968|NCT00708305|20849317|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8460969|NCT00708305|20849318|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
8460970|NCT00708305|20849315|P4|NOT COMPLETED|Period 3||0
8460971|NCT00708305|20849316|P3|NOT COMPLETED|Period 3||0
8460972|NCT00708305|20849317|P2|NOT COMPLETED|Period 3||2
8460973|NCT00708305|20849318|P1|NOT COMPLETED|Period 3||1
8460974|NCT00708305|20849315|P4|COMPLETED|Period 3||14
8460975|NCT00708305|20849316|P3|COMPLETED|Period 3||14
8460976|NCT00708305|20849317|P2|COMPLETED|Period 3||12
8460977|NCT00708305|20849318|P1|COMPLETED|Period 3||14
8460978|NCT00708305|20849315|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8460979|NCT00708305|20849316|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8460980|NCT00708305|20849317|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8460981|NCT00708305|20849318|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
8460982|NCT00708305|20849315|P4|NOT COMPLETED|Period 2||1
8460983|NCT00708305|20849316|P3|NOT COMPLETED|Period 2||0
8460984|NCT00708305|20849317|P2|NOT COMPLETED|Period 2||2
8460985|NCT00708305|20849318|P1|NOT COMPLETED|Period 2||1
8460986|NCT00708305|20849315|P4|COMPLETED|Period 2||14
8460987|NCT00708305|20849316|P3|COMPLETED|Period 2||16
8460988|NCT00708305|20849317|P2|COMPLETED|Period 2||13
8460989|NCT00708305|20849318|P1|COMPLETED|Period 2||14
8460990|NCT00708305|20849315|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8460991|NCT00708305|20849316|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
8460992|NCT00708305|20849317|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8460993|NCT00708305|20849318|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8460994|NCT00708305|20849315|P4|NOT COMPLETED|Period 1||2
8460995|NCT00708305|20849316|P3|NOT COMPLETED|Period 1||1
8460996|NCT00708305|20849317|P2|NOT COMPLETED|Period 1||0
8460997|NCT00708305|20849318|P1|NOT COMPLETED|Period 1||1
8460998|NCT00708305|20849315|P4|COMPLETED|Period 1||14
8460999|NCT00708305|20849316|P3|COMPLETED|Period 1||16
8461000|NCT00708305|20849317|P2|COMPLETED|Period 1||16
8461001|NCT00708305|20849318|P1|COMPLETED|Period 1||15
8461002|NCT00708305|20849315|P4|STARTED|Period 1||16
8461003|NCT00708305|20849316|P3|STARTED|Period 1||17
8461004|NCT00708305|20849317|P2|STARTED|Period 1||16
8461005|NCT00708305|20849318|P1|STARTED|Period 1||16
8461006|NCT00708227|20849354|P4|NOT COMPLETED|Overall Study||3
8461007|NCT00708227|20849355|P3|NOT COMPLETED|Overall Study||1
8461008|NCT00708227|20849356|P2|NOT COMPLETED|Overall Study||5
8461009|NCT00708227|20849357|P1|NOT COMPLETED|Overall Study||1
8461010|NCT00708227|20849354|P4|COMPLETED|Overall Study||22
8461011|NCT00708227|20849355|P3|COMPLETED|Overall Study||17
8461012|NCT00708227|20849356|P2|COMPLETED|Overall Study||21
8461013|NCT00708227|20849357|P1|COMPLETED|Overall Study||18
8461014|NCT00708227|20849354|P4|STARTED|Overall Study||25
8461015|NCT00708227|20849355|P3|STARTED|Overall Study||18
8461016|NCT00708227|20849356|P2|STARTED|Overall Study||26
8461017|NCT00708227|20849357|P1|STARTED|Overall Study||19
8461018|NCT00708214|20849390|P3|NOT COMPLETED|Overall Study||8
8461019|NCT00708214|20849391|P2|NOT COMPLETED|Overall Study||13
8461020|NCT00708214|20849392|P1|NOT COMPLETED|Overall Study||7
8461021|NCT00708214|20849390|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8461022|NCT00708214|20849391|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8461023|NCT00708214|20849392|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8461024|NCT00708214|20849390|P3|STARTED|Overall Study||8
8461025|NCT00708214|20849391|P2|STARTED|Overall Study||13
8461026|NCT00708214|20849392|P1|STARTED|Overall Study||7
8461027|NCT00708201|20849435|P2|NOT COMPLETED|Overall Study||6
8461028|NCT00708201|20849436|P1|NOT COMPLETED|Overall Study||7
8461029|NCT00708201|20849435|P2|COMPLETED|Overall Study||137
8461030|NCT00708201|20849436|P1|COMPLETED|Overall Study||130
8461031|NCT00708201|20849435|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
8461032|NCT00708201|20849436|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
8461033|NCT00708201|20849435|P2|STARTED|Overall Study||143
8461034|NCT00708201|20849436|P1|STARTED|Overall Study||137
8461035|NCT00708175|20849460|P2|NOT COMPLETED|Overall Study||21
8461036|NCT00708175|20849461|P1|NOT COMPLETED|Overall Study||18
8461037|NCT00708175|20849460|P2|COMPLETED|Overall Study||57
8461038|NCT00708175|20849461|P1|COMPLETED|Overall Study||60
8461039|NCT00708175|20849460|P2|STARTED|Overall Study||78
8461040|NCT00708175|20849461|P1|STARTED|Overall Study||78
8461041|NCT00708162|20849477|P2|NOT COMPLETED|Open-Label Phase||30
8461042|NCT00708162|20849478|P1|NOT COMPLETED|Open-Label Phase||44
8461043|NCT00708162|20849477|P2|COMPLETED|Open-Label Phase||121
8461044|NCT00708162|20849478|P1|COMPLETED|Open-Label Phase||152
8461045|NCT00708162|20849477|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
8461046|NCT00708162|20849478|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
8461047|NCT00708162|20849477|P2|NOT COMPLETED|Randomized Phase||154
8461048|NCT00708162|20849478|P1|NOT COMPLETED|Randomized Phase||156
8461049|NCT00708162|20849477|P2|COMPLETED|Randomized Phase||209
8461050|NCT00708162|20849478|P1|COMPLETED|Randomized Phase||205
8461051|NCT00708162|20849477|P2|Randomized and Treated|Randomized Phase||358
8461052|NCT00708162|20849478|P1|Randomized and Treated|Randomized Phase||354
8461053|NCT00708162|20849477|P2|STARTED|Randomized Phase||363
8461054|NCT00708162|20849478|P1|STARTED|Randomized Phase||361
8461055|NCT00708123|20849519|P5|NOT COMPLETED|Period 5||0
8461056|NCT00708123|20849520|P4|NOT COMPLETED|Period 5||0
8461057|NCT00708123|20849521|P3|NOT COMPLETED|Period 5||0
8461058|NCT00708123|20849522|P2|NOT COMPLETED|Period 5||0
8461059|NCT00708123|20849523|P1|NOT COMPLETED|Period 5||0
8461060|NCT00708123|20849519|P5|COMPLETED|Period 5||10
8461061|NCT00708123|20849520|P4|COMPLETED|Period 5||11
8461062|NCT00708123|20849521|P3|COMPLETED|Period 5||11
8461063|NCT00708123|20849522|P2|COMPLETED|Period 5||10
8461064|NCT00708123|20849523|P1|COMPLETED|Period 5||10
8461065|NCT00708123|20849519|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8461066|NCT00708123|20849520|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
8461067|NCT00708123|20849521|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
8461068|NCT00708123|20849522|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8461069|NCT00708123|20849523|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8461070|NCT00708123|20849519|P5|NOT COMPLETED|Period 4||0
8461071|NCT00708123|20849520|P4|NOT COMPLETED|Period 4||0
8461072|NCT00708123|20849521|P3|NOT COMPLETED|Period 4||0
8461073|NCT00708123|20849522|P2|NOT COMPLETED|Period 4||1
8461074|NCT00708123|20849523|P1|NOT COMPLETED|Period 4||0
8461075|NCT00708123|20849519|P5|COMPLETED|Period 4||11
8461076|NCT00708123|20849520|P4|COMPLETED|Period 4||10
8461077|NCT00708123|20849521|P3|COMPLETED|Period 4||10
8461078|NCT00708123|20849522|P2|COMPLETED|Period 4||11
8461079|NCT00708123|20849523|P1|COMPLETED|Period 4||10
8461080|NCT00708123|20849519|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
8461081|NCT00708123|20849520|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8461082|NCT00708123|20849521|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8461083|NCT00708123|20849522|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
8461084|NCT00708123|20849523|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8461085|NCT00708123|20849519|P5|NOT COMPLETED|Period 3||0
8461086|NCT00708123|20849520|P4|NOT COMPLETED|Period 3||1
8461087|NCT00708123|20849521|P3|NOT COMPLETED|Period 3||1
8461088|NCT00708123|20849522|P2|NOT COMPLETED|Period 3||0
8461089|NCT00708123|20849523|P1|NOT COMPLETED|Period 3||0
8461090|NCT00708123|20849519|P5|COMPLETED|Period 3||10
8461091|NCT00708123|20849520|P4|COMPLETED|Period 3||11
8461092|NCT00708123|20849521|P3|COMPLETED|Period 3||10
8461093|NCT00708123|20849522|P2|COMPLETED|Period 3||10
8461094|NCT00708123|20849523|P1|COMPLETED|Period 3||12
8461095|NCT00708123|20849519|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
8461096|NCT00708123|20849520|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
8461097|NCT00708123|20849521|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
8461098|NCT00708123|20849522|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
8461099|NCT00708123|20849523|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
8461100|NCT00708123|20849519|P5|NOT COMPLETED|Period 2||0
8461101|NCT00708123|20849520|P4|NOT COMPLETED|Period 2||1
8461102|NCT00708123|20849521|P3|NOT COMPLETED|Period 2||0
8461103|NCT00708123|20849522|P2|NOT COMPLETED|Period 2||0
8461104|NCT00708123|20849523|P1|NOT COMPLETED|Period 2||1
8461105|NCT00708123|20849519|P5|COMPLETED|Period 2||11
8461106|NCT00708123|20849520|P4|COMPLETED|Period 2||10
8461107|NCT00708123|20849521|P3|COMPLETED|Period 2||12
8461108|NCT00708123|20849522|P2|COMPLETED|Period 2||12
8461109|NCT00708123|20849523|P1|COMPLETED|Period 2||10
8461110|NCT00708123|20849519|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8461111|NCT00708123|20849520|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8461112|NCT00708123|20849521|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
8461113|NCT00708123|20849522|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
8461114|NCT00708123|20849523|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8461115|NCT00708123|20849519|P5|NOT COMPLETED|Period 1||0
8461116|NCT00708123|20849520|P4|NOT COMPLETED|Period 1||1
8461117|NCT00708123|20849521|P3|NOT COMPLETED|Period 1||1
8461118|NCT00708123|20849522|P2|NOT COMPLETED|Period 1||1
8461119|NCT00708123|20849523|P1|NOT COMPLETED|Period 1||0
8461120|NCT00708123|20849519|P5|COMPLETED|Period 1||12
8461121|NCT00708123|20849520|P4|COMPLETED|Period 1||11
8461122|NCT00708123|20849521|P3|COMPLETED|Period 1||11
8461123|NCT00708123|20849522|P2|COMPLETED|Period 1||11
8461124|NCT00708123|20849523|P1|COMPLETED|Period 1||12
8461125|NCT00708123|20849519|P5|STARTED|Period 1||12
8461126|NCT00708123|20849520|P4|STARTED|Period 1||12
8461127|NCT00708123|20849521|P3|STARTED|Period 1||12
8461128|NCT00708123|20849522|P2|STARTED|Period 1||12
8461129|NCT00708123|20849523|P1|STARTED|Period 1||12
8461130|NCT00708110|20849547|P4|NOT COMPLETED|Overall Study||0
8461131|NCT00708110|20849548|P3|NOT COMPLETED|Overall Study||0
8461132|NCT00708110|20849549|P2|NOT COMPLETED|Overall Study||0
8461133|NCT00708110|20849550|P1|NOT COMPLETED|Overall Study||0
8461134|NCT00708110|20849547|P4|COMPLETED|Overall Study||10
8461135|NCT00708110|20849548|P3|COMPLETED|Overall Study||9
8461136|NCT00708110|20849549|P2|COMPLETED|Overall Study||9
8461137|NCT00708110|20849550|P1|COMPLETED|Overall Study||7
8461138|NCT00708110|20849547|P4|STARTED|Overall Study||10
8461139|NCT00708110|20849548|P3|STARTED|Overall Study||9
8461140|NCT00708110|20849549|P2|STARTED|Overall Study||9
8461141|NCT00708110|20849550|P1|STARTED|Overall Study||7
8461142|NCT00708097|20849656|P5|NOT COMPLETED|Period 5||0
8461143|NCT00708097|20849657|P4|NOT COMPLETED|Period 5||0
8461144|NCT00708097|20849658|P3|NOT COMPLETED|Period 5||0
8461145|NCT00708097|20849659|P2|NOT COMPLETED|Period 5||0
8461146|NCT00708097|20849660|P1|NOT COMPLETED|Period 5||0
8461147|NCT00708097|20849656|P5|COMPLETED|Period 5||12
8461148|NCT00708097|20849657|P4|COMPLETED|Period 5||10
8461149|NCT00708097|20849658|P3|COMPLETED|Period 5||11
8461150|NCT00708097|20849659|P2|COMPLETED|Period 5||9
8461151|NCT00708097|20849660|P1|COMPLETED|Period 5||8
8461152|NCT00708097|20849656|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
8461153|NCT00708097|20849657|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
8461154|NCT00708097|20849658|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
8461155|NCT00708097|20849659|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
8461156|NCT00708097|20849660|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
8461157|NCT00708097|20849656|P5|NOT COMPLETED|Period 4||0
8461158|NCT00708097|20849657|P4|NOT COMPLETED|Period 4||0
8461159|NCT00708097|20849658|P3|NOT COMPLETED|Period 4||0
8461160|NCT00708097|20849659|P2|NOT COMPLETED|Period 4||0
8461161|NCT00708097|20849660|P1|NOT COMPLETED|Period 4||0
8461162|NCT00708097|20849656|P5|COMPLETED|Period 4||8
8461163|NCT00708097|20849657|P4|COMPLETED|Period 4||11
8461164|NCT00708097|20849658|P3|COMPLETED|Period 4||10
8461165|NCT00708097|20849659|P2|COMPLETED|Period 4||9
8461166|NCT00708097|20849660|P1|COMPLETED|Period 4||12
8461167|NCT00708097|20849656|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
8461168|NCT00708097|20849657|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
8461169|NCT00708097|20849658|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
8461170|NCT00708097|20849659|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
8461171|NCT00708097|20849660|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
8461172|NCT00708097|20849656|P5|NOT COMPLETED|Period 3||0
8461173|NCT00708097|20849657|P4|NOT COMPLETED|Period 3||0
8461174|NCT00708097|20849658|P3|NOT COMPLETED|Period 3||0
8461175|NCT00708097|20849659|P2|NOT COMPLETED|Period 3||0
8461176|NCT00708097|20849660|P1|NOT COMPLETED|Period 3||0
8461177|NCT00708097|20849656|P5|COMPLETED|Period 3||10
8461178|NCT00708097|20849657|P4|COMPLETED|Period 3||10
8461179|NCT00708097|20849658|P3|COMPLETED|Period 3||10
8461180|NCT00708097|20849659|P2|COMPLETED|Period 3||11
8461181|NCT00708097|20849660|P1|COMPLETED|Period 3||9
8461182|NCT00708097|20849656|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8461183|NCT00708097|20849657|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8461184|NCT00708097|20849658|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8461185|NCT00708097|20849659|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
8461186|NCT00708097|20849660|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
8461187|NCT00708097|20849656|P5|NOT COMPLETED|Period 2||0
8461188|NCT00708097|20849657|P4|NOT COMPLETED|Period 2||1
8461189|NCT00708097|20849658|P3|NOT COMPLETED|Period 2||1
8461190|NCT00708097|20849659|P2|NOT COMPLETED|Period 2||1
8461191|NCT00708097|20849660|P1|NOT COMPLETED|Period 2||0
8461192|NCT00708097|20849656|P5|COMPLETED|Period 2||10
8461193|NCT00708097|20849657|P4|COMPLETED|Period 2||10
8461194|NCT00708097|20849658|P3|COMPLETED|Period 2||9
8461195|NCT00708097|20849659|P2|COMPLETED|Period 2||11
8461196|NCT00708097|20849660|P1|COMPLETED|Period 2||10
8461197|NCT00708097|20849656|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8461198|NCT00708097|20849657|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
8461199|NCT00708097|20849658|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8461200|NCT00708097|20849659|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
8461201|NCT00708097|20849660|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8461202|NCT00708097|20849656|P5|NOT COMPLETED|Period 1||1
8461203|NCT00708097|20849657|P4|NOT COMPLETED|Period 1||2
8461204|NCT00708097|20849658|P3|NOT COMPLETED|Period 1||0
8461205|NCT00708097|20849659|P2|NOT COMPLETED|Period 1||1
8461206|NCT00708097|20849660|P1|NOT COMPLETED|Period 1||0
8461207|NCT00708097|20849656|P5|COMPLETED|Period 1||10
8461208|NCT00708097|20849657|P4|COMPLETED|Period 1||9
8461209|NCT00708097|20849658|P3|COMPLETED|Period 1||12
8461210|NCT00708097|20849659|P2|COMPLETED|Period 1||11
8461211|NCT00708097|20849660|P1|COMPLETED|Period 1||11
8461212|NCT00708097|20849656|P5|STARTED|Period 1||11
8461213|NCT00708097|20849657|P4|STARTED|Period 1||11
8461214|NCT00708097|20849658|P3|STARTED|Period 1||12
8461215|NCT00708097|20849659|P2|STARTED|Period 1||12
8461216|NCT00708097|20849660|P1|STARTED|Period 1||11
8461217|NCT00708071|20849690|P1|NOT COMPLETED|Overall Study||0
8461218|NCT00708071|20849690|P1|COMPLETED|Overall Study||45
8461219|NCT00708071|20849690|P1|STARTED|Overall Study|Randomized and treated|45
8461220|NCT00708032|20849770|P2|NOT COMPLETED|Overall Study||16
8461221|NCT00708032|20849771|P1|NOT COMPLETED|Overall Study||10
8461222|NCT00708032|20849770|P2|COMPLETED|Overall Study||22
8461223|NCT00708032|20849771|P1|COMPLETED|Overall Study||26
8461224|NCT00708032|20849770|P2|STARTED|Overall Study||38
8461225|NCT00708032|20849771|P1|STARTED|Overall Study||36
8461226|NCT00708019|20849787|P2|NOT COMPLETED|Overall Study||15
8461227|NCT00708019|20849788|P1|NOT COMPLETED|Overall Study||15
8461228|NCT00708019|20849787|P2|COMPLETED|Overall Study||78
8461229|NCT00708019|20849788|P1|COMPLETED|Overall Study||77
8461230|NCT00708019|20849787|P2|STARTED|Overall Study||93
8461231|NCT00708019|20849788|P1|STARTED|Overall Study||92
8461232|NCT00707993|20849798|P2|NOT COMPLETED|Overall Study||94
8461233|NCT00707993|20849799|P1|NOT COMPLETED|Overall Study||89
8461234|NCT00707993|20849798|P2|COMPLETED|Overall Study||125
8461235|NCT00707993|20849799|P1|COMPLETED|Overall Study||133
8461236|NCT00707993|20849798|P2|STARTED|Overall Study||219
8461237|NCT00707993|20849799|P1|STARTED|Overall Study||222
8461238|NCT00707980|20849841|P1|NOT COMPLETED|Overall Study||310
8461239|NCT00707980|20849841|P1|COMPLETED|Overall Study||526
8461240|NCT00707980|20849841|P1|Received Treatment|Overall Study||834
8461241|NCT00707980|20849841|P1|STARTED|Overall Study||836
8461242|NCT00707967|20849859|P3|NOT COMPLETED|Overall Study||0
8461243|NCT00707967|20849860|P2|NOT COMPLETED|Overall Study||0
8461244|NCT00707967|20849861|P1|NOT COMPLETED|Overall Study||0
8461245|NCT00707967|20849859|P3|COMPLETED|Overall Study||7
8461246|NCT00707967|20849860|P2|COMPLETED|Overall Study||8
8461247|NCT00707967|20849861|P1|COMPLETED|Overall Study||22
8461248|NCT00707967|20849859|P3|STARTED|Overall Study||7
8461249|NCT00707967|20849860|P2|STARTED|Overall Study||8
8461250|NCT00707967|20849861|P1|STARTED|Overall Study||22
8461251|NCT00707954|20849925|P5|NOT COMPLETED|Overall Study||1
8461252|NCT00707954|20849926|P4|NOT COMPLETED|Overall Study||0
8461253|NCT00707954|20849927|P3|NOT COMPLETED|Overall Study||0
8461254|NCT00707954|20849928|P2|NOT COMPLETED|Overall Study||0
8461255|NCT00707954|20849929|P1|NOT COMPLETED|Overall Study||0
8461256|NCT00707954|20849925|P5|COMPLETED|Overall Study||9
8461257|NCT00707954|20849926|P4|COMPLETED|Overall Study||13
8461258|NCT00707954|20849927|P3|COMPLETED|Overall Study||14
8461259|NCT00707954|20849928|P2|COMPLETED|Overall Study||12
8461260|NCT00707954|20849929|P1|COMPLETED|Overall Study||12
8461261|NCT00707954|20849925|P5|STARTED|Overall Study||10
8461262|NCT00707954|20849926|P4|STARTED|Overall Study||13
8461263|NCT00707954|20849927|P3|STARTED|Overall Study||14
8461264|NCT00707954|20849928|P2|STARTED|Overall Study||12
8461265|NCT00707954|20849929|P1|STARTED|Overall Study||12
8461266|NCT00707915|20849941|P1|NOT COMPLETED|Overall Study||0
8461267|NCT00707915|20849941|P1|COMPLETED|Overall Study||30
8461268|NCT00707915|20849941|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
8461269|NCT00707915|20849941|P1|STARTED|Overall Study||30
8461270|NCT00707863|20849952|P2|NOT COMPLETED|Overall Study||3
8461271|NCT00707863|20849953|P1|NOT COMPLETED|Overall Study||0
8461272|NCT00707863|20849952|P2|COMPLETED|Overall Study||8
8461273|NCT00707863|20849953|P1|COMPLETED|Overall Study||6
8461274|NCT00707863|20849952|P2|STARTED|Overall Study||11
8461275|NCT00707863|20849953|P1|STARTED|Overall Study||6
8461276|NCT00707759|20849961|P2|NOT COMPLETED|Overall Study||2
8461277|NCT00707759|20849962|P1|NOT COMPLETED|Overall Study||2
8461278|NCT00707759|20849961|P2|COMPLETED|Overall Study||12
8461279|NCT00707759|20849962|P1|COMPLETED|Overall Study||12
8461280|NCT00707759|20849961|P2|STARTED|Overall Study||14
8461281|NCT00707759|20849962|P1|STARTED|Overall Study||14
8461282|NCT00707746|20849970|P2|NOT COMPLETED|Follow-up Period||0
8461283|NCT00707746|20849971|P1|NOT COMPLETED|Follow-up Period||0
8461284|NCT00707746|20849970|P2|COMPLETED|Follow-up Period||21
8461285|NCT00707746|20849971|P1|COMPLETED|Follow-up Period||12
8461286|NCT00707746|20849970|P2|STARTED|Follow-up Period||21
8461287|NCT00707746|20849971|P1|STARTED|Follow-up Period||12
8461288|NCT00707746|20849970|P2|NOT COMPLETED|Treatment Period||5
8461289|NCT00707746|20849971|P1|NOT COMPLETED|Treatment Period||2
8461290|NCT00707746|20849970|P2|COMPLETED|Treatment Period||17
8461291|NCT00707746|20849971|P1|COMPLETED|Treatment Period||10
8461292|NCT00707746|20849970|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
8461293|NCT00707746|20849971|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
8461294|NCT00707746|20849970|P2|STARTED|Treatment Period||22
8461295|NCT00707746|20849971|P1|STARTED|Treatment Period||12
8461296|NCT00707655|20850019|P2|NOT COMPLETED|Overall Study||2
8461297|NCT00707655|20850020|P1|NOT COMPLETED|Overall Study||0
8461298|NCT00707655|20850019|P2|COMPLETED|Overall Study||3
8461299|NCT00707655|20850020|P1|COMPLETED|Overall Study||3
8461300|NCT00707655|20850019|P2|STARTED|Overall Study||5
8461301|NCT00707655|20850020|P1|STARTED|Overall Study||3
8461302|NCT00707577|20850032|P2|NOT COMPLETED|Overall Study||38
8461303|NCT00707577|20850033|P1|NOT COMPLETED|Overall Study||54
8461304|NCT00707577|20850032|P2|COMPLETED|Overall Study||118
8461305|NCT00707577|20850033|P1|COMPLETED|Overall Study||120
8461306|NCT00707577|20850032|P2|STARTED|Overall Study||156
8461307|NCT00707577|20850033|P1|STARTED|Overall Study||174
8461308|NCT00707486|20850039|P1|NOT COMPLETED|Overall Study||1
8461309|NCT00707486|20850039|P1|COMPLETED|Overall Study||71
8461310|NCT00707486|20850039|P1|STARTED|Overall Study||72
8461311|NCT00707447|20850050|P2|NOT COMPLETED|Overall Study||8
8461312|NCT00707447|20850051|P1|NOT COMPLETED|Overall Study||8
8461313|NCT00707447|20850050|P2|COMPLETED|Overall Study||85
8461314|NCT00707447|20850051|P1|COMPLETED|Overall Study||81
8461315|NCT00707447|20850050|P2|STARTED|Overall Study||93
8461316|NCT00707447|20850051|P1|STARTED|Overall Study||89
8461317|NCT00707434|20850075|P1|NOT COMPLETED|Overall Study||1
8461318|NCT00707434|20850075|P1|COMPLETED|Overall Study||5
8461319|NCT00707434|20850075|P1|STARTED|Overall Study||6
8461320|NCT00707343|20850079|P1|NOT COMPLETED|Overall Study||0
8461321|NCT00707343|20850079|P1|COMPLETED|Overall Study||15
8461322|NCT00707343|20850079|P1|STARTED|Overall Study||15
8461323|NCT00707239|20850086|P3|NOT COMPLETED|Overall Study||14
8461324|NCT00707239|20850087|P2|NOT COMPLETED|Overall Study||11
8461325|NCT00707239|20850088|P1|NOT COMPLETED|Overall Study||19
8461326|NCT00707239|20850086|P3|COMPLETED|Overall Study||21
8461327|NCT00707239|20850087|P2|COMPLETED|Overall Study||25
8461328|NCT00707239|20850088|P1|COMPLETED|Overall Study||18
8461329|NCT00707239|20850086|P3|Treated|Overall Study||34
8461330|NCT00707239|20850087|P2|Treated|Overall Study||35
8461331|NCT00707239|20850088|P1|Treated|Overall Study||36
8461332|NCT00707239|20850086|P3|STARTED|Overall Study||35
8461333|NCT00707239|20850087|P2|STARTED|Overall Study||36
8461334|NCT00707239|20850088|P1|STARTED|Overall Study||37
8461335|NCT00707174|20850136|P2|NOT COMPLETED|Overall Study||7
8461336|NCT00707174|20850137|P1|NOT COMPLETED|Overall Study||5
8461337|NCT00707174|20850136|P2|COMPLETED|Overall Study||37
8461338|NCT00707174|20850137|P1|COMPLETED|Overall Study||41
8461339|NCT00707174|20850136|P2|STARTED|Overall Study||44
8461340|NCT00707174|20850137|P1|STARTED|Overall Study||46
8461341|NCT00707161|20850143|P1|NOT COMPLETED|Overall Study||6
8461342|NCT00707161|20850143|P1|COMPLETED|Overall Study||0
8461343|NCT00707161|20850143|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
8461344|NCT00707057|20850149|P2|NOT COMPLETED|Overall Study||4
8461345|NCT00707057|20850150|P1|NOT COMPLETED|Overall Study||8
8461346|NCT00707057|20850149|P2|COMPLETED|Overall Study||83
8461347|NCT00707057|20850150|P1|COMPLETED|Overall Study||161
8461348|NCT00707057|20850149|P2|STARTED|Overall Study||87
8461349|NCT00707057|20850150|P1|STARTED|Overall Study||169
8461350|NCT00707031|20850184|P2|NOT COMPLETED|Overall Study||99
8461351|NCT00707031|20850185|P1|NOT COMPLETED|Overall Study||104
8461352|NCT00707031|20850184|P2|COMPLETED|Overall Study||220
8461353|NCT00707031|20850185|P1|COMPLETED|Overall Study||216
8461354|NCT00707031|20850184|P2|Modified Intent-to-Treat Population|Overall Study||315
8461355|NCT00707031|20850185|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
8461356|NCT00707031|20850184|P2|Treated/Safety Population|Overall Study||316
8461357|NCT00707031|20850185|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
8461358|NCT00707031|20850184|P2|STARTED|Overall Study||319
8461359|NCT00707031|20850185|P1|STARTED|Overall Study|Randomized|320
8461360|NCT00706992|20850214|P7|NOT COMPLETED|Overall Study||3
8461361|NCT00706992|20850215|P6|NOT COMPLETED|Overall Study||2
8461362|NCT00706992|20850216|P5|NOT COMPLETED|Overall Study||4
8461363|NCT00706992|20850217|P4|NOT COMPLETED|Overall Study||2
8461364|NCT00706992|20850218|P3|NOT COMPLETED|Overall Study||6
8461365|NCT00706992|20850219|P2|NOT COMPLETED|Overall Study||5
8461366|NCT00706992|20850220|P1|NOT COMPLETED|Overall Study||5
8461367|NCT00706992|20850214|P7|COMPLETED|Overall Study||3
8461368|NCT00706992|20850215|P6|COMPLETED|Overall Study||3
8461369|NCT00706992|20850216|P5|COMPLETED|Overall Study||2
8461370|NCT00706992|20850217|P4|COMPLETED|Overall Study||6
8461371|NCT00706992|20850218|P3|COMPLETED|Overall Study||3
8461372|NCT00706992|20850219|P2|COMPLETED|Overall Study||3
8461373|NCT00706992|20850220|P1|COMPLETED|Overall Study||3
8461374|NCT00706992|20850214|P7|STARTED|Overall Study||6
8461375|NCT00706992|20850215|P6|STARTED|Overall Study||5
8461376|NCT00706992|20850216|P5|STARTED|Overall Study||6
8461377|NCT00706992|20850217|P4|STARTED|Overall Study||8
8461378|NCT00706992|20850218|P3|STARTED|Overall Study||9
8461379|NCT00706992|20850219|P2|STARTED|Overall Study||8
8461380|NCT00706992|20850220|P1|STARTED|Overall Study||8
8461381|NCT00706979|20850239|P2|NOT COMPLETED|Overall Study||0
8461382|NCT00706979|20850240|P1|NOT COMPLETED|Overall Study||0
8461383|NCT00706979|20850239|P2|COMPLETED|Overall Study||423
8461384|NCT00706979|20850240|P1|COMPLETED|Overall Study||426
8461385|NCT00706979|20850239|P2|STARTED|Overall Study||423
8461386|NCT00706979|20850240|P1|STARTED|Overall Study||426
8461387|NCT00706966|20850252|P1|NOT COMPLETED|Overall Study||1
8461388|NCT00706966|20850252|P1|COMPLETED|Overall Study||9
8461389|NCT00706966|20850252|P1|STARTED|Overall Study||10
8461390|NCT00706914|20850288|P3|NOT COMPLETED|Overall Study||1
8461391|NCT00706914|20850289|P2|NOT COMPLETED|Overall Study||4
8461392|NCT00706914|20850290|P1|NOT COMPLETED|Overall Study||6
8461393|NCT00706914|20850288|P3|COMPLETED|Overall Study||30
8461394|NCT00706914|20850289|P2|COMPLETED|Overall Study||58
8461395|NCT00706914|20850290|P1|COMPLETED|Overall Study||57
8461396|NCT00706914|20850288|P3|STARTED|Overall Study||31
8461397|NCT00706914|20850289|P2|STARTED|Overall Study||62
8461398|NCT00706914|20850290|P1|STARTED|Overall Study||63
8461399|NCT00706901|20850313|P3|NOT COMPLETED|Overall Study||8
8461400|NCT00706901|20850314|P2|NOT COMPLETED|Overall Study||5
8461401|NCT00706901|20850315|P1|NOT COMPLETED|Overall Study||8
8461402|NCT00706901|20850313|P3|COMPLETED|Overall Study||51
8461403|NCT00706901|20850314|P2|COMPLETED|Overall Study||57
8461404|NCT00706901|20850315|P1|COMPLETED|Overall Study||51
8461405|NCT00706901|20850313|P3|STARTED|Overall Study||59
8461406|NCT00706901|20850314|P2|STARTED|Overall Study||62
8461407|NCT00706901|20850315|P1|STARTED|Overall Study||59
8461408|NCT00706849|20850340|P2|NOT COMPLETED|Follow-up Period||3
8461409|NCT00706849|20850341|P1|NOT COMPLETED|Follow-up Period||0
8461410|NCT00706849|20850340|P2|COMPLETED|Follow-up Period||25
8461411|NCT00706849|20850341|P1|COMPLETED|Follow-up Period||3
8461412|NCT00706849|20850340|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
8461413|NCT00706849|20850341|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
8461414|NCT00706849|20850340|P2|NOT COMPLETED|Treatment Period||10
8461415|NCT00706849|20850341|P1|NOT COMPLETED|Treatment Period||0
8461416|NCT00706849|20850340|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
8461417|NCT00706849|20850341|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
8461418|NCT00706849|20850340|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
8461419|NCT00706849|20850341|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
8461420|NCT00706849|20850340|P2|STARTED|Treatment Period||83
8461421|NCT00706849|20850341|P1|STARTED|Treatment Period||41
8461422|NCT00706836|20850385|P1|NOT COMPLETED|Overall Study||0
8461423|NCT00706836|20850385|P1|COMPLETED|Overall Study||16
8461424|NCT00706836|20850385|P1|STARTED|Overall Study||16
8461425|NCT00706823|20850395|P2|NOT COMPLETED|Overall Study||0
8461426|NCT00706823|20850396|P1|NOT COMPLETED|Overall Study||0
8461427|NCT00706823|20850395|P2|COMPLETED|Overall Study||25
8461428|NCT00706823|20850396|P1|COMPLETED|Overall Study||25
8461429|NCT00706823|20850395|P2|STARTED|Overall Study||25
8461430|NCT00706823|20850396|P1|STARTED|Overall Study||25
8461431|NCT00706810|20850412|P1|NOT COMPLETED|Overall Study||1
8461432|NCT00706810|20850412|P1|COMPLETED|Overall Study||7
8461433|NCT00706810|20850412|P1|STARTED|Overall Study||8
8461434|NCT00706797|20850419|P2|NOT COMPLETED|Overall Study||71
8461435|NCT00706797|20850420|P1|NOT COMPLETED|Overall Study||69
8461436|NCT00706797|20850419|P2|COMPLETED|Overall Study||0
8461437|NCT00706797|20850420|P1|COMPLETED|Overall Study||1
8461438|NCT00706797|20850419|P2|Safety Population|Overall Study||71
8461439|NCT00706797|20850420|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
8461440|NCT00706797|20850419|P2|STARTED|Overall Study||71
8461441|NCT00706797|20850420|P1|STARTED|Overall Study||70
8461442|NCT00706784|20850462|P2|NOT COMPLETED|Overall Study||0
8461443|NCT00706784|20850463|P1|NOT COMPLETED|Overall Study||0
8461444|NCT00706784|20850462|P2|COMPLETED|Overall Study||3
8461445|NCT00706784|20850463|P1|COMPLETED|Overall Study||3
8461446|NCT00706784|20850462|P2|STARTED|Overall Study||3
8461447|NCT00706784|20850463|P1|STARTED|Overall Study||3
8461448|NCT00706719|20850472|P3|NOT COMPLETED|Overall Study||4
8461449|NCT00706719|20850473|P2|NOT COMPLETED|Overall Study||1
8461450|NCT00706719|20850474|P1|NOT COMPLETED|Overall Study||0
8461451|NCT00706719|20850472|P3|COMPLETED|Overall Study||1
8461452|NCT00706719|20850473|P2|COMPLETED|Overall Study||6
8461453|NCT00706719|20850474|P1|COMPLETED|Overall Study||5
8461454|NCT00706719|20850472|P3|STARTED|Overall Study||5
8461455|NCT00706719|20850473|P2|STARTED|Overall Study||7
8461456|NCT00706719|20850474|P1|STARTED|Overall Study||5
8461457|NCT00706706|20850489|P1|NOT COMPLETED|Overall Study||105
8461458|NCT00706706|20850489|P1|COMPLETED|Overall Study||0
8461459|NCT00706706|20850489|P1|STARTED|Overall Study||105
8461460|NCT00706654|20850499|P4|NOT COMPLETED|Depot Maintenance Phase||70
8461461|NCT00706654|20850500|P3|NOT COMPLETED|Depot Maintenance Phase||88
8461462|NCT00706654|20850501|P2|NOT COMPLETED|Depot Maintenance Phase||69
8461463|NCT00706654|20850502|P1|NOT COMPLETED|Depot Maintenance Phase||0
8461464|NCT00706654|20850499|P4|COMPLETED|Depot Maintenance Phase||61
8461465|NCT00706654|20850500|P3|COMPLETED|Depot Maintenance Phase||178
8461466|NCT00706654|20850501|P2|COMPLETED|Depot Maintenance Phase||196
8461467|NCT00706654|20850502|P1|COMPLETED|Depot Maintenance Phase||0
8461468|NCT00706654|20850499|P4|STARTED|Depot Maintenance Phase||131
8461469|NCT00706654|20850500|P3|STARTED|Depot Maintenance Phase||266
8461470|NCT00706654|20850501|P2|STARTED|Depot Maintenance Phase||265
8461471|NCT00706654|20850502|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
8461472|NCT00706654|20850499|P4|NOT COMPLETED|Oral Stabilization Phase||0
8461473|NCT00706654|20850500|P3|NOT COMPLETED|Oral Stabilization Phase||0
8461474|NCT00706654|20850501|P2|NOT COMPLETED|Oral Stabilization Phase||0
8461475|NCT00706654|20850502|P1|NOT COMPLETED|Oral Stabilization Phase||180
8461476|NCT00706654|20850499|P4|COMPLETED|Oral Stabilization Phase||0
8461477|NCT00706654|20850500|P3|COMPLETED|Oral Stabilization Phase||0
8461478|NCT00706654|20850501|P2|COMPLETED|Oral Stabilization Phase||0
8461479|NCT00706654|20850502|P1|COMPLETED|Oral Stabilization Phase||662
8461480|NCT00706654|20850499|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461481|NCT00706654|20850500|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461482|NCT00706654|20850501|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461575|NCT00706433|20850738|P3|STARTED|Overall Study||67
8461483|NCT00706654|20850502|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
8461484|NCT00706654|20850499|P4|NOT COMPLETED|Conversion Phase||0
8461485|NCT00706654|20850500|P3|NOT COMPLETED|Conversion Phase||0
8461486|NCT00706654|20850501|P2|NOT COMPLETED|Conversion Phase||0
8461487|NCT00706654|20850502|P1|NOT COMPLETED|Conversion Phase||95
8461488|NCT00706654|20850499|P4|COMPLETED|Conversion Phase||0
8461489|NCT00706654|20850500|P3|COMPLETED|Conversion Phase||0
8461490|NCT00706654|20850501|P2|COMPLETED|Conversion Phase||0
8461491|NCT00706654|20850502|P1|COMPLETED|Conversion Phase||614
8461492|NCT00706654|20850499|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461493|NCT00706654|20850500|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461494|NCT00706654|20850501|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461495|NCT00706654|20850502|P1|STARTED|Conversion Phase||709
8461496|NCT00706641|20850521|P1|NOT COMPLETED|Radical Cystectomy||1
8461497|NCT00706641|20850521|P1|COMPLETED|Radical Cystectomy||22
8461498|NCT00706641|20850521|P1|STARTED|Radical Cystectomy||23
8461499|NCT00706641|20850521|P1|NOT COMPLETED|Dasatinib Administration||2
8461500|NCT00706641|20850521|P1|COMPLETED|Dasatinib Administration||23
8461501|NCT00706641|20850521|P1|Toxicity Evaluation|Dasatinib Administration||24
8461502|NCT00706641|20850521|P1|STARTED|Dasatinib Administration||25
8461503|NCT00706628|20850535|P4|NOT COMPLETED|Overall Study||3
8461504|NCT00706628|20850536|P3|NOT COMPLETED|Overall Study||16
8461505|NCT00706628|20850537|P2|NOT COMPLETED|Overall Study||21
8461506|NCT00706628|20850538|P1|NOT COMPLETED|Overall Study||47
8461507|NCT00706628|20850535|P4|COMPLETED|Overall Study||0
8461508|NCT00706628|20850536|P3|COMPLETED|Overall Study||0
8461509|NCT00706628|20850537|P2|COMPLETED|Overall Study||0
8461510|NCT00706628|20850538|P1|COMPLETED|Overall Study||0
8461511|NCT00706628|20850535|P4|STARTED|Overall Study||3
8461512|NCT00706628|20850536|P3|STARTED|Overall Study||16
8461513|NCT00706628|20850537|P2|STARTED|Overall Study||21
8461514|NCT00706628|20850538|P1|STARTED|Overall Study||47
8461515|NCT00706589|20850588|P2|NOT COMPLETED|Overall Study||4
8461516|NCT00706589|20850589|P1|NOT COMPLETED|Overall Study||3
8461517|NCT00706589|20850588|P2|COMPLETED|Overall Study||25
8461518|NCT00706589|20850589|P1|COMPLETED|Overall Study||29
8461519|NCT00706589|20850588|P2|STARTED|Overall Study||29
8461520|NCT00706589|20850589|P1|STARTED|Overall Study||32
8461521|NCT00706563|20850597|P2|NOT COMPLETED|Overall Study||0
8461522|NCT00706563|20850598|P1|NOT COMPLETED|Overall Study||0
8461523|NCT00706563|20850597|P2|COMPLETED|Overall Study||59
8461524|NCT00706563|20850598|P1|COMPLETED|Overall Study||61
8461525|NCT00706563|20850597|P2|STARTED|Overall Study||59
8461526|NCT00706563|20850598|P1|STARTED|Overall Study||61
8461527|NCT00706550|20850622|P2|NOT COMPLETED|Overall Study||28
8461528|NCT00706550|20850623|P1|NOT COMPLETED|Overall Study||7
8461529|NCT00706550|20850622|P2|COMPLETED|Overall Study||36
8461530|NCT00706550|20850623|P1|COMPLETED|Overall Study||36
8461531|NCT00706550|20850622|P2|STARTED|Overall Study||64
8461532|NCT00706550|20850623|P1|STARTED|Overall Study||43
8461533|NCT00706511|20850643|P4|NOT COMPLETED|Overall Study||0
8461534|NCT00706511|20850644|P3|NOT COMPLETED|Overall Study||0
8461535|NCT00706511|20850645|P2|NOT COMPLETED|Overall Study||0
8461536|NCT00706511|20850646|P1|NOT COMPLETED|Overall Study||1
8461537|NCT00706511|20850643|P4|COMPLETED|Overall Study||10
8461538|NCT00706511|20850644|P3|COMPLETED|Overall Study||3
8461539|NCT00706511|20850645|P2|COMPLETED|Overall Study||4
8461540|NCT00706511|20850646|P1|COMPLETED|Overall Study||9
8461541|NCT00706511|20850643|P4|STARTED|Overall Study||10
8461542|NCT00706511|20850644|P3|STARTED|Overall Study||3
8461543|NCT00706511|20850645|P2|STARTED|Overall Study||4
8461544|NCT00706511|20850646|P1|STARTED|Overall Study||10
8461545|NCT00706485|20850678|P1|NOT COMPLETED|Overall Study||0
8461546|NCT00706485|20850678|P1|COMPLETED|Overall Study||5
8461547|NCT00706485|20850678|P1|STARTED|Overall Study||5
8461548|NCT00706446|20850690|P6|NOT COMPLETED|Overall Study||38
8461549|NCT00706446|20850691|P5|NOT COMPLETED|Overall Study||44
8461550|NCT00706446|20850692|P4|NOT COMPLETED|Overall Study||22
8461551|NCT00706446|20850693|P3|NOT COMPLETED|Overall Study||37
8461552|NCT00706446|20850694|P2|NOT COMPLETED|Overall Study||49
8461553|NCT00706446|20850695|P1|NOT COMPLETED|Overall Study||26
8461554|NCT00706446|20850690|P6|COMPLETED|Overall Study||7
8461555|NCT00706446|20850691|P5|COMPLETED|Overall Study||10
8461556|NCT00706446|20850692|P4|COMPLETED|Overall Study||4
8461557|NCT00706446|20850693|P3|COMPLETED|Overall Study||7
8461558|NCT00706446|20850694|P2|COMPLETED|Overall Study||8
8461559|NCT00706446|20850695|P1|COMPLETED|Overall Study||3
8461560|NCT00706446|20850690|P6|STARTED|Overall Study||45
8461561|NCT00706446|20850691|P5|STARTED|Overall Study||54
8461562|NCT00706446|20850692|P4|STARTED|Overall Study||26
8461563|NCT00706446|20850693|P3|STARTED|Overall Study||44
8461564|NCT00706446|20850694|P2|STARTED|Overall Study||57
8461565|NCT00706446|20850695|P1|STARTED|Overall Study||29
8461566|NCT00706433|20850737|P4|NOT COMPLETED|Overall Study||2
8461567|NCT00706433|20850738|P3|NOT COMPLETED|Overall Study||10
8461568|NCT00706433|20850739|P2|NOT COMPLETED|Overall Study||3
8461569|NCT00706433|20850740|P1|NOT COMPLETED|Overall Study||5
8461570|NCT00706433|20850737|P4|COMPLETED|Overall Study||64
8461571|NCT00706433|20850738|P3|COMPLETED|Overall Study||57
8461572|NCT00706433|20850739|P2|COMPLETED|Overall Study||62
8461573|NCT00706433|20850740|P1|COMPLETED|Overall Study||63
8461574|NCT00706433|20850737|P4|STARTED|Overall Study||66
8461576|NCT00706433|20850739|P2|STARTED|Overall Study||65
8461577|NCT00706433|20850740|P1|STARTED|Overall Study||68
8461578|NCT00706407|20851056|P1|NOT COMPLETED|Overall Study||9
8461579|NCT00706407|20851056|P1|COMPLETED|Overall Study||33
8461580|NCT00706407|20851056|P1|STARTED|Overall Study||42
8461581|NCT00706381|20851067|P4|NOT COMPLETED|Overall Study||0
8461582|NCT00706381|20851068|P3|NOT COMPLETED|Overall Study||1
8461583|NCT00706381|20851069|P2|NOT COMPLETED|Overall Study||1
8461584|NCT00706381|20851070|P1|NOT COMPLETED|Overall Study||0
8461585|NCT00706381|20851067|P4|COMPLETED|Overall Study||9
8461586|NCT00706381|20851068|P3|COMPLETED|Overall Study||5
8461587|NCT00706381|20851069|P2|COMPLETED|Overall Study||5
8461588|NCT00706381|20851070|P1|COMPLETED|Overall Study||10
8461589|NCT00706381|20851067|P4|Intervention 5 (1 Day)|Overall Study||9
8461590|NCT00706381|20851068|P3|Intervention 5 (1 Day)|Overall Study||5
8461591|NCT00706381|20851069|P2|Intervention 5 (1 Day)|Overall Study||5
8461592|NCT00706381|20851070|P1|Intervention 5 (1 Day)|Overall Study||10
8461593|NCT00706381|20851067|P4|Intervention 4 (1 Day)|Overall Study||9
8461594|NCT00706381|20851068|P3|Intervention 4 (1 Day)|Overall Study||6
8461595|NCT00706381|20851069|P2|Intervention 4 (1 Day)|Overall Study||5
8461596|NCT00706381|20851070|P1|Intervention 4 (1 Day)|Overall Study||10
8461597|NCT00706381|20851067|P4|Intervention 3 (1 Day)|Overall Study||9
8461598|NCT00706381|20851068|P3|Intervention 3 (1 Day)|Overall Study||6
8461599|NCT00706381|20851069|P2|Intervention 3 (1 Day)|Overall Study||6
8461600|NCT00706381|20851070|P1|Intervention 3 (1 Day)|Overall Study||10
8461601|NCT00706381|20851067|P4|Intervention 2 (1 Day)|Overall Study||9
8461602|NCT00706381|20851068|P3|Intervention 2 (1 Day)|Overall Study||6
8461603|NCT00706381|20851069|P2|Intervention 2 (1 Day)|Overall Study||6
8461604|NCT00706381|20851070|P1|Intervention 2 (1 Day)|Overall Study||10
8461605|NCT00706381|20851067|P4|Intervention 1 (1 Day)|Overall Study||9
8461606|NCT00706381|20851068|P3|Intervention 1 (1 Day)|Overall Study||6
8461607|NCT00706381|20851069|P2|Intervention 1 (1 Day)|Overall Study||6
8461608|NCT00706381|20851070|P1|Intervention 1 (1 Day)|Overall Study||10
8461609|NCT00706381|20851067|P4|STARTED|Overall Study||9
8461610|NCT00706381|20851068|P3|STARTED|Overall Study||6
8461611|NCT00706381|20851069|P2|STARTED|Overall Study||6
8461612|NCT00706381|20851070|P1|STARTED|Overall Study||10
8461613|NCT00706355|20851091|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
8461614|NCT00706355|20851092|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8461615|NCT00706355|20851093|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8461616|NCT00706355|20851094|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8461617|NCT00706355|20851091|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
8461618|NCT00706355|20851092|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
8461619|NCT00706355|20851093|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
8461620|NCT00706355|20851094|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
8461621|NCT00706355|20851091|P4|STARTED|Period 4: PF-04217903 150 mg||4
8461622|NCT00706355|20851092|P3|STARTED|Period 4: PF-04217903 150 mg||0
8461623|NCT00706355|20851093|P2|STARTED|Period 4: PF-04217903 150 mg||0
8461624|NCT00706355|20851094|P1|STARTED|Period 4: PF-04217903 150 mg||0
8461625|NCT00706355|20851091|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8461626|NCT00706355|20851092|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
8461627|NCT00706355|20851093|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8461628|NCT00706355|20851094|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8461629|NCT00706355|20851091|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
8461630|NCT00706355|20851092|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
8461631|NCT00706355|20851093|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
8461632|NCT00706355|20851094|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
8461633|NCT00706355|20851091|P4|STARTED|Period 3: PF-04217903 200 mg||0
8461634|NCT00706355|20851092|P3|STARTED|Period 3: PF-04217903 200 mg||2
8461635|NCT00706355|20851093|P2|STARTED|Period 3: PF-04217903 200 mg||0
8461636|NCT00706355|20851094|P1|STARTED|Period 3: PF-04217903 200 mg||0
8461637|NCT00706355|20851091|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8461638|NCT00706355|20851092|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8461639|NCT00706355|20851093|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
8461640|NCT00706355|20851094|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8461641|NCT00706355|20851091|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
8461642|NCT00706355|20851092|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
8461643|NCT00706355|20851093|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
8461644|NCT00706355|20851094|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
8461645|NCT00706355|20851091|P4|STARTED|Period 2: PF-04217903 100 mg||0
8461646|NCT00706355|20851092|P3|STARTED|Period 2: PF-04217903 100 mg||0
8461647|NCT00706355|20851093|P2|STARTED|Period 2: PF-04217903 100 mg||7
8461648|NCT00706355|20851094|P1|STARTED|Period 2: PF-04217903 100 mg||0
8461649|NCT00706355|20851091|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8461650|NCT00706355|20851092|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8461651|NCT00706355|20851093|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8461652|NCT00706355|20851094|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
8461653|NCT00706355|20851091|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
8461654|NCT00706355|20851092|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
8461655|NCT00706355|20851093|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
8461656|NCT00706355|20851094|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
8461657|NCT00706355|20851091|P4|STARTED|Period 1: PF-04217903 50 mg||0
8461658|NCT00706355|20851092|P3|STARTED|Period 1: PF-04217903 50 mg||0
8461659|NCT00706355|20851093|P2|STARTED|Period 1: PF-04217903 50 mg||0
8461660|NCT00706355|20851094|P1|STARTED|Period 1: PF-04217903 50 mg||3
8461661|NCT00706342|20851146|P1|NOT COMPLETED|Overall Study||18
8461662|NCT00706342|20851146|P1|COMPLETED|Overall Study||0
8461663|NCT00706342|20851146|P1|STARTED|Overall Study||18
8461664|NCT00706329|20851155|P1|NOT COMPLETED|Overall Study||0
8461665|NCT00706329|20851155|P1|COMPLETED|Overall Study||25
8461666|NCT00706329|20851155|P1|STARTED|Overall Study||25
8461667|NCT00706238|20851159|P1|NOT COMPLETED|Overall Study||5
8461668|NCT00706238|20851159|P1|COMPLETED|Overall Study||0
8461669|NCT00706238|20851159|P1|STARTED|Overall Study||5
8461670|NCT00706134|20851176|P4|NOT COMPLETED|Overall Study||11
8461671|NCT00706134|20851177|P3|NOT COMPLETED|Overall Study||6
8461672|NCT00706134|20851178|P2|NOT COMPLETED|Overall Study||19
8461673|NCT00706134|20851179|P1|NOT COMPLETED|Overall Study||20
8461674|NCT00706134|20851176|P4|COMPLETED|Overall Study||175
8461675|NCT00706134|20851177|P3|COMPLETED|Overall Study||183
8461676|NCT00706134|20851178|P2|COMPLETED|Overall Study||173
8461677|NCT00706134|20851179|P1|COMPLETED|Overall Study||169
8461678|NCT00706134|20851176|P4|Entered Double-blind Period|Overall Study||186
8461679|NCT00706134|20851177|P3|Entered Double-blind Period|Overall Study||189
8461680|NCT00706134|20851178|P2|Entered Double-blind Period|Overall Study||192
8461681|NCT00706134|20851179|P1|Entered Double-blind Period|Overall Study||187
8461682|NCT00706134|20851176|P4|STARTED|Overall Study||186
8461683|NCT00706134|20851177|P3|STARTED|Overall Study||189
8461684|NCT00706134|20851178|P2|STARTED|Overall Study||192
8461685|NCT00706134|20851179|P1|STARTED|Overall Study||189
8461686|NCT00706121|20851213|P4|NOT COMPLETED|Overall Study||352
8461687|NCT00706121|20851214|P3|NOT COMPLETED|Overall Study||404
8461688|NCT00706121|20851215|P2|NOT COMPLETED|Overall Study||396
8461689|NCT00706121|20851216|P1|NOT COMPLETED|Overall Study||396
8461690|NCT00706121|20851213|P4|COMPLETED|Overall Study||1577
8461691|NCT00706121|20851214|P3|COMPLETED|Overall Study||1626
8461692|NCT00706121|20851215|P2|COMPLETED|Overall Study||1700
8461693|NCT00706121|20851216|P1|COMPLETED|Overall Study||1643
8461694|NCT00706121|20851213|P4|STARTED|Overall Study||1929
8461695|NCT00706121|20851214|P3|STARTED|Overall Study||2030
8461696|NCT00706121|20851215|P2|STARTED|Overall Study||2096
8461697|NCT00706121|20851216|P1|STARTED|Overall Study||2039
8461698|NCT00706095|20851245|P3|NOT COMPLETED|Overall Study||5
8461699|NCT00706095|20851246|P2|NOT COMPLETED|Overall Study||7
8461700|NCT00706095|20851247|P1|NOT COMPLETED|Overall Study||6
8461701|NCT00706095|20851245|P3|COMPLETED|Overall Study||0
8461702|NCT00706095|20851246|P2|COMPLETED|Overall Study||0
8461703|NCT00706095|20851247|P1|COMPLETED|Overall Study||0
8461704|NCT00706095|20851245|P3|STARTED|Overall Study||5
8461705|NCT00706095|20851246|P2|STARTED|Overall Study||7
8461706|NCT00706095|20851247|P1|STARTED|Overall Study||6
8461707|NCT00706030|20851265|P4|NOT COMPLETED|Overall Study||16
8461708|NCT00706030|20851266|P3|NOT COMPLETED|Overall Study||60
8461709|NCT00706030|20851267|P2|NOT COMPLETED|Overall Study||6
8461710|NCT00706030|20851268|P1|NOT COMPLETED|Overall Study||6
8461711|NCT00706030|20851265|P4|COMPLETED|Overall Study||0
8461712|NCT00706030|20851266|P3|COMPLETED|Overall Study||4
8461713|NCT00706030|20851267|P2|COMPLETED|Overall Study||0
8461714|NCT00706030|20851268|P1|COMPLETED|Overall Study||0
8461715|NCT00706030|20851265|P4|Treated|Overall Study||15
8461716|NCT00706030|20851266|P3|Treated|Overall Study||64
8461717|NCT00706030|20851267|P2|Treated|Overall Study||6
8461718|NCT00706030|20851268|P1|Treated|Overall Study||6
8461719|NCT00706030|20851265|P4|STARTED|Overall Study||16
8461720|NCT00706030|20851266|P3|STARTED|Overall Study||64
8461721|NCT00706030|20851267|P2|STARTED|Overall Study||6
8461722|NCT00706030|20851268|P1|STARTED|Overall Study||6
8461723|NCT00706004|20851283|P1|NOT COMPLETED|Overall Study||2
8461724|NCT00706004|20851283|P1|COMPLETED|Overall Study||7
8461725|NCT00706004|20851283|P1|STARTED|Overall Study||9
8461726|NCT00705939|20851311|P3|NOT COMPLETED|Overall Study||4
8461727|NCT00705939|20851312|P2|NOT COMPLETED|Overall Study||2
8461728|NCT00705939|20851313|P1|NOT COMPLETED|Overall Study||0
8461729|NCT00705939|20851311|P3|COMPLETED|Overall Study||14
8461730|NCT00705939|20851312|P2|COMPLETED|Overall Study||12
8461731|NCT00705939|20851313|P1|COMPLETED|Overall Study||12
8461732|NCT00705939|20851311|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
8461733|NCT00705939|20851312|P2|STARTED|Overall Study||14
8461734|NCT00705939|20851313|P1|STARTED|Overall Study||12
8461735|NCT00705874|20851343|P7|NOT COMPLETED|Overall Study||0
8461736|NCT00705874|20851344|P6|NOT COMPLETED|Overall Study||4
8461737|NCT00705874|20851345|P5|NOT COMPLETED|Overall Study||12
8461738|NCT00705874|20851346|P4|NOT COMPLETED|Overall Study||1
8461739|NCT00705874|20851347|P3|NOT COMPLETED|Overall Study||2
8461740|NCT00705874|20851348|P2|NOT COMPLETED|Overall Study||1
8461741|NCT00705874|20851349|P1|NOT COMPLETED|Overall Study||2
8461742|NCT00705874|20851343|P7|COMPLETED|Overall Study||3
8461743|NCT00705874|20851344|P6|COMPLETED|Overall Study||28
8461744|NCT00705874|20851345|P5|COMPLETED|Overall Study||36
8461745|NCT00705874|20851346|P4|COMPLETED|Overall Study||33
8461746|NCT00705874|20851347|P3|COMPLETED|Overall Study||32
8461747|NCT00705874|20851348|P2|COMPLETED|Overall Study||8
8461748|NCT00705874|20851349|P1|COMPLETED|Overall Study||10
8461749|NCT00705874|20851343|P7|STARTED|Overall Study||3
8461750|NCT00705874|20851344|P6|STARTED|Overall Study||32
8461751|NCT00705874|20851345|P5|STARTED|Overall Study||48
8461752|NCT00705874|20851346|P4|STARTED|Overall Study||34
8461753|NCT00705874|20851347|P3|STARTED|Overall Study||34
8461754|NCT00705874|20851348|P2|STARTED|Overall Study||9
8461755|NCT00705874|20851349|P1|STARTED|Overall Study||12
8461756|NCT00705783|20851367|P3|NOT COMPLETED|Depot Maintenance Phase||131
8461757|NCT00705783|20851368|P2|NOT COMPLETED|Depot Maintenance Phase||246
8461758|NCT00705783|20851369|P1|NOT COMPLETED|Depot Maintenance Phase||0
8461759|NCT00705783|20851367|P3|COMPLETED|Depot Maintenance Phase||3
8461760|NCT00705783|20851368|P2|COMPLETED|Depot Maintenance Phase||23
8461761|NCT00705783|20851369|P1|COMPLETED|Depot Maintenance Phase||0
8461762|NCT00705783|20851367|P3|STARTED|Depot Maintenance Phase||134
8461763|NCT00705783|20851368|P2|STARTED|Depot Maintenance Phase||269
8461764|NCT00705783|20851369|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
8461765|NCT00705783|20851367|P3|NOT COMPLETED|Depot Stabilization Phase||0
8461766|NCT00705783|20851368|P2|NOT COMPLETED|Depot Stabilization Phase||0
8461767|NCT00705783|20851369|P1|NOT COMPLETED|Depot Stabilization Phase||173
8461768|NCT00705783|20851367|P3|COMPLETED|Depot Stabilization Phase||0
8461769|NCT00705783|20851368|P2|COMPLETED|Depot Stabilization Phase||0
8461770|NCT00705783|20851369|P1|COMPLETED|Depot Stabilization Phase||403
8461771|NCT00705783|20851367|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461772|NCT00705783|20851368|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461773|NCT00705783|20851369|P1|STARTED|Depot Stabilization Phase||576
8461774|NCT00705783|20851367|P3|NOT COMPLETED|Oral Stabilization Phase||0
8461775|NCT00705783|20851368|P2|NOT COMPLETED|Oral Stabilization Phase||0
8461776|NCT00705783|20851369|P1|NOT COMPLETED|Oral Stabilization Phase||134
8461777|NCT00705783|20851367|P3|COMPLETED|Oral Stabilization Phase||0
8461778|NCT00705783|20851368|P2|COMPLETED|Oral Stabilization Phase||0
8461779|NCT00705783|20851369|P1|COMPLETED|Oral Stabilization Phase||576
8461780|NCT00705783|20851367|P3|Received Study Medication|Oral Stabilization Phase||0
8461781|NCT00705783|20851368|P2|Received Study Medication|Oral Stabilization Phase||0
8461782|NCT00705783|20851369|P1|Received Study Medication|Oral Stabilization Phase||709
8461783|NCT00705783|20851367|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461784|NCT00705783|20851368|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461785|NCT00705783|20851369|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
8461786|NCT00705783|20851367|P3|NOT COMPLETED|Conversion Phase||0
8461787|NCT00705783|20851368|P2|NOT COMPLETED|Conversion Phase||0
8461788|NCT00705783|20851369|P1|NOT COMPLETED|Conversion Phase||133
8461789|NCT00705783|20851367|P3|COMPLETED|Conversion Phase||0
8461790|NCT00705783|20851368|P2|COMPLETED|Conversion Phase||0
8461791|NCT00705783|20851369|P1|COMPLETED|Conversion Phase||500
8461792|NCT00705783|20851367|P3|Received Study Medication|Conversion Phase||0
8461793|NCT00705783|20851368|P2|Received Study Medication|Conversion Phase||0
8461794|NCT00705783|20851369|P1|Received Study Medication|Conversion Phase||632
8461795|NCT00705783|20851367|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461796|NCT00705783|20851368|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461797|NCT00705783|20851369|P1|STARTED|Conversion Phase||633
8461798|NCT00705757|20851399|P3|NOT COMPLETED|Overall Study||11
8461799|NCT00705757|20851400|P2|NOT COMPLETED|Overall Study||8
8461800|NCT00705757|20851401|P1|NOT COMPLETED|Overall Study||13
8461801|NCT00705757|20851399|P3|COMPLETED|Overall Study||17
8461802|NCT00705757|20851400|P2|COMPLETED|Overall Study||21
8461803|NCT00705757|20851401|P1|COMPLETED|Overall Study||19
8461804|NCT00705757|20851399|P3|STARTED|Overall Study||28
8461805|NCT00705757|20851400|P2|STARTED|Overall Study||29
8461806|NCT00705757|20851401|P1|STARTED|Overall Study||32
8461807|NCT00705718|20851411|P2|NOT COMPLETED|Overall Study||22
8461808|NCT00705718|20851412|P1|NOT COMPLETED|Overall Study||7
8461809|NCT00705718|20851411|P2|COMPLETED|Overall Study||128
8461810|NCT00705718|20851412|P1|COMPLETED|Overall Study||37
8461811|NCT00705718|20851411|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
8461812|NCT00705718|20851412|P1|12 Month Follow up|Overall Study|2 Deaths|37
8461813|NCT00705718|20851411|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
8461814|NCT00705718|20851412|P1|6 Month Follow up|Overall Study|3 Deaths|40
8461815|NCT00705718|20851411|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
8461816|NCT00705718|20851412|P1|1 Month Follow up|Overall Study|1 Death|43
8461817|NCT00705718|20851411|P2|STARTED|Overall Study||150
8461818|NCT00705718|20851412|P1|STARTED|Overall Study||44
8461819|NCT00705679|20851433|P5|NOT COMPLETED|Overall Study||69
8461820|NCT00705679|20851434|P4|NOT COMPLETED|Overall Study||80
8461821|NCT00705679|20851435|P3|NOT COMPLETED|Overall Study||115
8461822|NCT00705679|20851436|P2|NOT COMPLETED|Overall Study||139
8461823|NCT00705679|20851437|P1|NOT COMPLETED|Overall Study||65
8461824|NCT00705679|20851433|P5|COMPLETED|Overall Study||934
8461825|NCT00705679|20851434|P4|COMPLETED|Overall Study||927
8461826|NCT00705679|20851435|P3|COMPLETED|Overall Study||894
8461827|NCT00705679|20851436|P2|COMPLETED|Overall Study||864
8461828|NCT00705679|20851437|P1|COMPLETED|Overall Study||942
8461829|NCT00705679|20851433|P5|STARTED|Overall Study||1003
8461830|NCT00705679|20851434|P4|STARTED|Overall Study||1007
8461831|NCT00705679|20851435|P3|STARTED|Overall Study||1009
8461832|NCT00705679|20851436|P2|STARTED|Overall Study||1003
8461833|NCT00705679|20851437|P1|STARTED|Overall Study||1007
8461834|NCT00705666|20851472|P1|NOT COMPLETED|Overall Study||339
8461835|NCT00705666|20851472|P1|COMPLETED|Overall Study||450
8461836|NCT00705666|20851472|P1|STARTED|Overall Study||789
8461837|NCT00705653|20851476|P1|NOT COMPLETED|Overall Study||0
8461838|NCT00705653|20851476|P1|COMPLETED|Overall Study||46
8461839|NCT00705653|20851476|P1|STARTED|Overall Study||46
8461840|NCT00705614|20851483|P2|NOT COMPLETED|Switch to Remicade||49
8461841|NCT00705614|20851484|P1|NOT COMPLETED|Switch to Remicade||0
8461842|NCT00705614|20851483|P2|COMPLETED|Switch to Remicade||249
8461843|NCT00705614|20851484|P1|COMPLETED|Switch to Remicade||0
8461844|NCT00705614|20851483|P2|STARTED|Switch to Remicade||298
8461845|NCT00705614|20851484|P1|STARTED|Switch to Remicade||0
8461846|NCT00705614|20851483|P2|NOT COMPLETED|Initial Intervention||321
8461847|NCT00705614|20851484|P1|NOT COMPLETED|Initial Intervention||518
8461848|NCT00705614|20851483|P2|COMPLETED|Initial Intervention||800
8461849|NCT00705614|20851484|P1|COMPLETED|Initial Intervention||1023
8461850|NCT00705614|20851483|P2|STARTED|Initial Intervention||1121
8461851|NCT00705614|20851484|P1|STARTED|Initial Intervention||1541
8461852|NCT00705575|20851533|P2|NOT COMPLETED|Overall Study||46
8461853|NCT00705575|20851534|P1|NOT COMPLETED|Overall Study||23
8461854|NCT00705575|20851533|P2|COMPLETED|Overall Study||293
8461855|NCT00705575|20851534|P1|COMPLETED|Overall Study||326
8461856|NCT00705575|20851533|P2|STARTED|Overall Study||339
8461857|NCT00705575|20851534|P1|STARTED|Overall Study||349
8461858|NCT00705536|20851548|P4|NOT COMPLETED|Completed Study||0
8461859|NCT00705536|20851549|P3|NOT COMPLETED|Completed Study||0
8461860|NCT00705536|20851550|P2|NOT COMPLETED|Completed Study||0
8461861|NCT00705536|20851551|P1|NOT COMPLETED|Completed Study||0
8461862|NCT00705536|20851548|P4|COMPLETED|Completed Study||6
8461863|NCT00705536|20851549|P3|COMPLETED|Completed Study||7
8461864|NCT00705536|20851550|P2|COMPLETED|Completed Study||6
8461865|NCT00705536|20851551|P1|COMPLETED|Completed Study||6
8461866|NCT00705536|20851548|P4|STARTED|Completed Study||6
8461867|NCT00705536|20851549|P3|STARTED|Completed Study||7
8461868|NCT00705536|20851550|P2|STARTED|Completed Study||6
8461869|NCT00705536|20851551|P1|STARTED|Completed Study||6
8461870|NCT00705536|20851548|P4|NOT COMPLETED|Start Period 2||0
8461871|NCT00705536|20851549|P3|NOT COMPLETED|Start Period 2||0
8461872|NCT00705536|20851550|P2|NOT COMPLETED|Start Period 2||0
8461873|NCT00705536|20851551|P1|NOT COMPLETED|Start Period 2||0
8461874|NCT00705536|20851548|P4|COMPLETED|Start Period 2||6
8461875|NCT00705536|20851549|P3|COMPLETED|Start Period 2||7
8461876|NCT00705536|20851550|P2|COMPLETED|Start Period 2||6
8461877|NCT00705536|20851551|P1|COMPLETED|Start Period 2||6
8461878|NCT00705536|20851548|P4|STARTED|Start Period 2||6
8461879|NCT00705536|20851549|P3|STARTED|Start Period 2||7
8461880|NCT00705536|20851550|P2|STARTED|Start Period 2||6
8461881|NCT00705536|20851551|P1|STARTED|Start Period 2||6
8461882|NCT00705536|20851548|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461883|NCT00705536|20851549|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461884|NCT00705536|20851550|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461885|NCT00705536|20851551|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461886|NCT00705536|20851548|P4|COMPLETED|Washout Period of at Least 6 Days||6
8461887|NCT00705536|20851549|P3|COMPLETED|Washout Period of at Least 6 Days||7
8461888|NCT00705536|20851550|P2|COMPLETED|Washout Period of at Least 6 Days||6
8461889|NCT00705536|20851551|P1|COMPLETED|Washout Period of at Least 6 Days||6
8461890|NCT00705536|20851548|P4|STARTED|Washout Period of at Least 6 Days||6
8461891|NCT00705536|20851549|P3|STARTED|Washout Period of at Least 6 Days||7
8461892|NCT00705536|20851550|P2|STARTED|Washout Period of at Least 6 Days||6
8461893|NCT00705536|20851551|P1|STARTED|Washout Period of at Least 6 Days||6
8461894|NCT00705536|20851548|P4|NOT COMPLETED|Start Period 1||1
8461895|NCT00705536|20851549|P3|NOT COMPLETED|Start Period 1||0
8461896|NCT00705536|20851550|P2|NOT COMPLETED|Start Period 1||0
8461897|NCT00705536|20851551|P1|NOT COMPLETED|Start Period 1||0
8461898|NCT00705536|20851548|P4|COMPLETED|Start Period 1||6
8461899|NCT00705536|20851549|P3|COMPLETED|Start Period 1||7
8461900|NCT00705536|20851550|P2|COMPLETED|Start Period 1||6
8461901|NCT00705536|20851551|P1|COMPLETED|Start Period 1||6
8461902|NCT00705536|20851548|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
8461903|NCT00705536|20851549|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
8461904|NCT00705536|20851550|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
8461905|NCT00705536|20851551|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
8461906|NCT00705536|20851548|P4|STARTED|Start Period 1||7
8461907|NCT00705536|20851549|P3|STARTED|Start Period 1||7
8461908|NCT00705536|20851550|P2|STARTED|Start Period 1||6
8461909|NCT00705536|20851551|P1|STARTED|Start Period 1||6
8461910|NCT00705523|20851612|P2|NOT COMPLETED|Overall Study||3
8461911|NCT00705523|20851613|P1|NOT COMPLETED|Overall Study||2
8461912|NCT00705523|20851612|P2|COMPLETED|Overall Study||18
8461913|NCT00705523|20851613|P1|COMPLETED|Overall Study||17
8461914|NCT00705523|20851612|P2|STARTED|Overall Study||21
8461915|NCT00705523|20851613|P1|STARTED|Overall Study||19
8461916|NCT00705484|20851623|P2|NOT COMPLETED|Overall Study||408
8461917|NCT00705484|20851624|P1|NOT COMPLETED|Overall Study||382
8461918|NCT00705484|20851623|P2|COMPLETED|Overall Study||772
8461919|NCT00705484|20851624|P1|COMPLETED|Overall Study||677
8461920|NCT00705484|20851623|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
8461921|NCT00705484|20851624|P1|Follow-up Period|Overall Study||1059
8461922|NCT00705484|20851623|P2|STARTED|Overall Study|Number Enrolled|1180
8461923|NCT00705484|20851624|P1|STARTED|Overall Study|Number Enrolled|1059
8461924|NCT00705432|20851638|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
8461925|NCT00705432|20851639|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
8461926|NCT00705432|20851640|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
8461927|NCT00705432|20851641|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
8461928|NCT00705432|20851642|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
8461929|NCT00705432|20851643|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
8461930|NCT00705432|20851638|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
8461931|NCT00705432|20851639|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
8461932|NCT00705432|20851640|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
8461933|NCT00705432|20851641|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
8461934|NCT00705432|20851642|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
8461935|NCT00705432|20851643|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
8461936|NCT00705432|20851638|P6|STARTED|Follow-up Period (Upto Week 72)||53
8461937|NCT00705432|20851639|P5|STARTED|Follow-up Period (Upto Week 72)||44
8461938|NCT00705432|20851640|P4|STARTED|Follow-up Period (Upto Week 72)||42
8461939|NCT00705432|20851641|P3|STARTED|Follow-up Period (Upto Week 72)||291
8461940|NCT00705432|20851642|P2|STARTED|Follow-up Period (Upto Week 72)||295
8461941|NCT00705432|20851643|P1|STARTED|Follow-up Period (Upto Week 72)||278
8461942|NCT00705432|20851638|P6|NOT COMPLETED|Treatment Period||30
8461943|NCT00705432|20851639|P5|NOT COMPLETED|Treatment Period||28
8461944|NCT00705432|20851640|P4|NOT COMPLETED|Treatment Period||41
8461945|NCT00705432|20851641|P3|NOT COMPLETED|Treatment Period||121
8461946|NCT00705432|20851642|P2|NOT COMPLETED|Treatment Period||111
8461947|NCT00705432|20851643|P1|NOT COMPLETED|Treatment Period||163
8461948|NCT00705432|20851638|P6|COMPLETED|Treatment Period||25
8461949|NCT00705432|20851639|P5|COMPLETED|Treatment Period||24
8461950|NCT00705432|20851640|P4|COMPLETED|Treatment Period||11
8461951|NCT00705432|20851641|P3|COMPLETED|Treatment Period||190
8461952|NCT00705432|20851642|P2|COMPLETED|Treatment Period||205
8461953|NCT00705432|20851643|P1|COMPLETED|Treatment Period||148
8461954|NCT00705432|20851638|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
8461955|NCT00705432|20851639|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
8461956|NCT00705432|20851640|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
8461957|NCT00705432|20851641|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
8461958|NCT00705432|20851642|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
8461959|NCT00705432|20851643|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
8461960|NCT00705432|20851638|P6|STARTED|Treatment Period||55
8461961|NCT00705432|20851639|P5|STARTED|Treatment Period||52
8461962|NCT00705432|20851640|P4|STARTED|Treatment Period||52
8461963|NCT00705432|20851641|P3|STARTED|Treatment Period||311
8461964|NCT00705432|20851642|P2|STARTED|Treatment Period||316
8461965|NCT00705432|20851643|P1|STARTED|Treatment Period||311
8461966|NCT00705406|20851680|P2|NOT COMPLETED|Overall Study||5
8461967|NCT00705406|20851681|P1|NOT COMPLETED|Overall Study||4
8461968|NCT00705406|20851680|P2|COMPLETED|Overall Study||197
8461969|NCT00705406|20851681|P1|COMPLETED|Overall Study||199
8461970|NCT00705406|20851680|P2|STARTED|Overall Study||202
8461971|NCT00705406|20851681|P1|STARTED|Overall Study||203
8461972|NCT00705367|20851705|P2|NOT COMPLETED|Long-term Extension Period||0
8461973|NCT00705367|20851706|P1|NOT COMPLETED|Long-term Extension Period||9
8461974|NCT00705367|20851705|P2|COMPLETED|Long-term Extension Period||0
8461975|NCT00705367|20851706|P1|COMPLETED|Long-term Extension Period||0
8461976|NCT00705367|20851705|P2|STARTED|Long-term Extension Period||0
8461977|NCT00705367|20851706|P1|STARTED|Long-term Extension Period||9
8461978|NCT00705367|20851705|P2|NOT COMPLETED|Short-term Period||0
8461979|NCT00705367|20851706|P1|NOT COMPLETED|Short-term Period||0
8461980|NCT00705367|20851705|P2|COMPLETED|Short-term Period||3
8461981|NCT00705367|20851706|P1|COMPLETED|Short-term Period||6
8461982|NCT00705367|20851705|P2|STARTED|Short-term Period||3
8461983|NCT00705367|20851706|P1|STARTED|Short-term Period||6
8461984|NCT00705341|20851733|P4|NOT COMPLETED|Phase 2: Trial||4
8461985|NCT00705341|20851734|P3|NOT COMPLETED|Phase 2: Trial||7
8461986|NCT00705341|20851735|P2|NOT COMPLETED|Phase 2: Trial||0
8461987|NCT00705341|20851736|P1|NOT COMPLETED|Phase 2: Trial||0
8461988|NCT00705341|20851733|P4|COMPLETED|Phase 2: Trial||28
8461989|NCT00705341|20851734|P3|COMPLETED|Phase 2: Trial||23
8461990|NCT00705341|20851735|P2|COMPLETED|Phase 2: Trial||0
8461991|NCT00705341|20851736|P1|COMPLETED|Phase 2: Trial||0
8461992|NCT00705341|20851733|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
8461993|NCT00705341|20851734|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
8461994|NCT00705341|20851735|P2|STARTED|Phase 2: Trial||0
8461995|NCT00705341|20851736|P1|STARTED|Phase 2: Trial||0
8461996|NCT00705341|20851733|P4|NOT COMPLETED|Phase 1:Control Challenge||0
8461997|NCT00705341|20851734|P3|NOT COMPLETED|Phase 1:Control Challenge||0
8461998|NCT00705341|20851735|P2|NOT COMPLETED|Phase 1:Control Challenge||0
8461999|NCT00705341|20851736|P1|NOT COMPLETED|Phase 1:Control Challenge||0
8462000|NCT00705341|20851733|P4|COMPLETED|Phase 1:Control Challenge||0
8462001|NCT00705341|20851734|P3|COMPLETED|Phase 1:Control Challenge||0
8462002|NCT00705341|20851735|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
8462003|NCT00705341|20851736|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
8462004|NCT00705341|20851733|P4|STARTED|Phase 1:Control Challenge||0
8462005|NCT00705341|20851734|P3|STARTED|Phase 1:Control Challenge||0
8462006|NCT00705341|20851735|P2|STARTED|Phase 1:Control Challenge||93
8462007|NCT00705341|20851736|P1|STARTED|Phase 1:Control Challenge||126
8462008|NCT00705289|20851744|P1|NOT COMPLETED|Overall Study||131
8462009|NCT00705289|20851744|P1|COMPLETED|Overall Study||597
8462010|NCT00705289|20851744|P1|STARTED|Overall Study||728
8462011|NCT00705263|20851768|P1|NOT COMPLETED|Overall Study||2
8462012|NCT00705263|20851768|P1|COMPLETED|Overall Study||108
8462013|NCT00705263|20851768|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
8462014|NCT00705250|20851772|P1|NOT COMPLETED|Overall Study||2
8462015|NCT00705250|20851772|P1|COMPLETED|Overall Study||34
8462016|NCT00705250|20851772|P1|STARTED|Overall Study||36
8462017|NCT00705224|20851776|P1|NOT COMPLETED|Overall Study||11
8462018|NCT00705224|20851776|P1|COMPLETED|Overall Study||239
8462019|NCT00705224|20851776|P1|STARTED|Overall Study||250
8462020|NCT00705159|20851792|P4|NOT COMPLETED|Overall Study||4
8462021|NCT00705159|20851793|P3|NOT COMPLETED|Overall Study||5
8462022|NCT00705159|20851794|P2|NOT COMPLETED|Overall Study||2
8462023|NCT00705159|20851795|P1|NOT COMPLETED|Overall Study||0
8462024|NCT00705159|20851792|P4|COMPLETED|Overall Study||30
8462025|NCT00705159|20851793|P3|COMPLETED|Overall Study||29
8462026|NCT00705159|20851794|P2|COMPLETED|Overall Study||33
8462027|NCT00705159|20851795|P1|COMPLETED|Overall Study||34
8462028|NCT00705159|20851792|P4|STARTED|Overall Study||34
8462029|NCT00705159|20851793|P3|STARTED|Overall Study||34
8462030|NCT00705159|20851794|P2|STARTED|Overall Study||35
8462031|NCT00705159|20851795|P1|STARTED|Overall Study||34
8462032|NCT00705146|20851815|P2|NOT COMPLETED|Overall Study||1
8462033|NCT00705146|20851816|P1|NOT COMPLETED|Overall Study||1
8462034|NCT00705146|20851815|P2|COMPLETED|Overall Study||23
8462035|NCT00705146|20851816|P1|COMPLETED|Overall Study||31
8462036|NCT00705146|20851815|P2|STARTED|Overall Study||24
8462037|NCT00705146|20851816|P1|STARTED|Overall Study||32
8462038|NCT00705133|20851824|P1|NOT COMPLETED|Overall Study||0
8462039|NCT00705133|20851824|P1|COMPLETED|Overall Study||15
8462040|NCT00705133|20851824|P1|STARTED|Overall Study||15
8462041|NCT00705107|20851831|P1|NOT COMPLETED|Overall Study||49
8462042|NCT00705107|20851831|P1|COMPLETED|Overall Study||218
8462043|NCT00705107|20851831|P1|STARTED|Overall Study||267
8462044|NCT00705081|20851838|P2|NOT COMPLETED|Overall Study||0
8462045|NCT00705081|20851839|P1|NOT COMPLETED|Overall Study||0
8462046|NCT00705081|20851838|P2|COMPLETED|Overall Study||198
8462047|NCT00705081|20851839|P1|COMPLETED|Overall Study||255
8462048|NCT00705081|20851838|P2|STARTED|Overall Study||198
8462049|NCT00705081|20851839|P1|STARTED|Overall Study||255
8462050|NCT00705016|20851852|P3|NOT COMPLETED|Overall Study||58
8462051|NCT00705016|20851853|P2|NOT COMPLETED|Overall Study||58
8462052|NCT00705016|20851854|P1|NOT COMPLETED|Overall Study||60
8462053|NCT00705016|20851852|P3|COMPLETED|Overall Study||4
8462054|NCT00705016|20851853|P2|COMPLETED|Overall Study||2
8462055|NCT00705016|20851854|P1|COMPLETED|Overall Study||2
8462056|NCT00705016|20851852|P3|STARTED|Overall Study||62
8462057|NCT00705016|20851853|P2|STARTED|Overall Study||60
8462058|NCT00705016|20851854|P1|STARTED|Overall Study||62
8462059|NCT00705003|20851883|P3|NOT COMPLETED|Treated||3
8462060|NCT00705003|20851884|P2|NOT COMPLETED|Treated||6
8462061|NCT00705003|20851885|P1|NOT COMPLETED|Treated||13
8462062|NCT00705003|20851883|P3|COMPLETED|Treated||30
8462063|NCT00705003|20851884|P2|COMPLETED|Treated||28
8462064|NCT00705003|20851885|P1|COMPLETED|Treated||54
8462065|NCT00705003|20851883|P3|STARTED|Treated||33
8462066|NCT00705003|20851884|P2|STARTED|Treated||34
8462067|NCT00705003|20851885|P1|STARTED|Treated||67
8462068|NCT00705003|20851883|P3|NOT COMPLETED|Enrolled||1
8462069|NCT00705003|20851884|P2|NOT COMPLETED|Enrolled||3
8462070|NCT00705003|20851885|P1|NOT COMPLETED|Enrolled||4
8462071|NCT00705003|20851883|P3|COMPLETED|Enrolled||33
8462072|NCT00705003|20851884|P2|COMPLETED|Enrolled||34
8462073|NCT00705003|20851885|P1|COMPLETED|Enrolled||67
8462074|NCT00705003|20851883|P3|STARTED|Enrolled||34
8462075|NCT00705003|20851884|P2|STARTED|Enrolled||37
8462076|NCT00705003|20851885|P1|STARTED|Enrolled||71
8462077|NCT00704964|20851905|P1|NOT COMPLETED|Overall Study||328
8462078|NCT00704964|20851905|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
8462079|NCT00704964|20851905|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
8462080|NCT00704938|20851912|P2|NOT COMPLETED|Overall Study||0
8462081|NCT00704938|20851913|P1|NOT COMPLETED|Overall Study||0
8462082|NCT00704938|20851912|P2|COMPLETED|Overall Study||1
8462083|NCT00704938|20851913|P1|COMPLETED|Overall Study||2
8462084|NCT00704938|20851912|P2|STARTED|Overall Study||1
8462085|NCT00704938|20851913|P1|STARTED|Overall Study||2
8462086|NCT00704912|20851924|P3|NOT COMPLETED|Overall Study||7
8462087|NCT00704912|20851925|P2|NOT COMPLETED|Overall Study||4
8462088|NCT00704912|20851926|P1|NOT COMPLETED|Overall Study||6
8462089|NCT00704912|20851924|P3|COMPLETED|Overall Study||43
8462090|NCT00704912|20851925|P2|COMPLETED|Overall Study||45
8462091|NCT00704912|20851926|P1|COMPLETED|Overall Study||44
8462092|NCT00704912|20851924|P3|STARTED|Overall Study||50
8462093|NCT00704912|20851925|P2|STARTED|Overall Study||49
8462094|NCT00704912|20851926|P1|STARTED|Overall Study||50
8462095|NCT00704847|20851945|P2|NOT COMPLETED|Overall Study||170
8462096|NCT00704847|20851946|P1|NOT COMPLETED|Overall Study||221
8462097|NCT00704847|20851945|P2|COMPLETED|Overall Study||339
8462098|NCT00704847|20851946|P1|COMPLETED|Overall Study||300
8462099|NCT00704847|20851945|P2|STARTED|Overall Study||509
8462100|NCT00704847|20851946|P1|STARTED|Overall Study||521
8462101|NCT00704808|20851966|P1|NOT COMPLETED|Overall Study||131
8462102|NCT00704808|20851966|P1|COMPLETED|Overall Study||49
8462103|NCT00704808|20851966|P1|STARTED|Overall Study||180
8462104|NCT00704769|20851970|P1|NOT COMPLETED|Overall Study||0
8462105|NCT00704769|20851970|P1|COMPLETED|Overall Study||591
8462106|NCT00704769|20851970|P1|STARTED|Overall Study||591
8462107|NCT00704730|20851977|P2|NOT COMPLETED|Overall Study||96
8462108|NCT00704730|20851978|P1|NOT COMPLETED|Overall Study||121
8462109|NCT00704730|20851977|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
8462110|NCT00704730|20851978|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
8462111|NCT00704730|20851977|P2|STARTED|Overall Study|Randomized|111
8462112|NCT00704730|20851978|P1|STARTED|Overall Study|Randomized|219
8462113|NCT00704717|20851994|P1|NOT COMPLETED|Overall Study||0
8462114|NCT00704717|20851994|P1|COMPLETED|Overall Study||185
8462115|NCT00704717|20851994|P1|STARTED|Overall Study||185
8462116|NCT00704535|20851998|P1|NOT COMPLETED|Overall Study||146
8462117|NCT00704535|20851998|P1|COMPLETED|Overall Study||3959
8462118|NCT00704535|20851998|P1|STARTED|Overall Study||4105
8462119|NCT00704522|20852011|P2|NOT COMPLETED|Overall Study||45
8462120|NCT00704522|20852012|P1|NOT COMPLETED|Overall Study||183
8462121|NCT00704522|20852011|P2|COMPLETED|Overall Study||75
8462122|NCT00704522|20852012|P1|COMPLETED|Overall Study||298
8462123|NCT00704522|20852011|P2|STARTED|Overall Study||120
8462124|NCT00704522|20852012|P1|STARTED|Overall Study||481
8462125|NCT00704496|20852021|P2|NOT COMPLETED|Overall Study||0
8462126|NCT00704496|20852022|P1|NOT COMPLETED|Overall Study||0
8462127|NCT00704496|20852021|P2|COMPLETED|Overall Study||0
8462128|NCT00704496|20852022|P1|COMPLETED|Overall Study||0
8462129|NCT00704496|20852021|P2|STARTED|Overall Study||0
8462130|NCT00704496|20852022|P1|STARTED|Overall Study||0
8462131|NCT00704418|20852032|P2|NOT COMPLETED|Overall Study||6
8462132|NCT00704418|20852033|P1|NOT COMPLETED|Overall Study||5
8462133|NCT00704418|20852032|P2|COMPLETED|Overall Study||72
8462134|NCT00704418|20852033|P1|COMPLETED|Overall Study||73
8462135|NCT00704418|20852032|P2|STARTED|Overall Study||78
8462136|NCT00704418|20852033|P1|STARTED|Overall Study||78
8462137|NCT00704405|20852046|P5|NOT COMPLETED|Overall Study (C Population)||0
8462138|NCT00704405|20852047|P4|NOT COMPLETED|Overall Study (C Population)||1
8462139|NCT00704405|20852048|P3|NOT COMPLETED|Overall Study (C Population)||1
8462140|NCT00704405|20852049|P2|NOT COMPLETED|Overall Study (C Population)||3
8462141|NCT00704405|20852050|P1|NOT COMPLETED|Overall Study (C Population)||1
8462142|NCT00704405|20852046|P5|COMPLETED|Overall Study (C Population)||14
8462143|NCT00704405|20852047|P4|COMPLETED|Overall Study (C Population)||14
8462144|NCT00704405|20852048|P3|COMPLETED|Overall Study (C Population)||14
8462145|NCT00704405|20852049|P2|COMPLETED|Overall Study (C Population)||11
8462146|NCT00704405|20852050|P1|COMPLETED|Overall Study (C Population)||15
8462147|NCT00704405|20852046|P5|STARTED|Overall Study (C Population)||14
8462148|NCT00704405|20852047|P4|STARTED|Overall Study (C Population)||15
8462149|NCT00704405|20852048|P3|STARTED|Overall Study (C Population)||15
8462150|NCT00704405|20852049|P2|STARTED|Overall Study (C Population)||14
8462151|NCT00704405|20852050|P1|STARTED|Overall Study (C Population)||16
8462152|NCT00704405|20852046|P5|NOT COMPLETED|Overall Study (NC Population)||5
8462153|NCT00704405|20852047|P4|NOT COMPLETED|Overall Study (NC Population)||4
8462154|NCT00704405|20852048|P3|NOT COMPLETED|Overall Study (NC Population)||3
8462155|NCT00704405|20852049|P2|NOT COMPLETED|Overall Study (NC Population)||4
8462156|NCT00704405|20852050|P1|NOT COMPLETED|Overall Study (NC Population)||5
8462157|NCT00704405|20852046|P5|COMPLETED|Overall Study (NC Population)||37
8462158|NCT00704405|20852047|P4|COMPLETED|Overall Study (NC Population)||38
8462159|NCT00704405|20852048|P3|COMPLETED|Overall Study (NC Population)||38
8462160|NCT00704405|20852049|P2|COMPLETED|Overall Study (NC Population)||40
8462161|NCT00704405|20852050|P1|COMPLETED|Overall Study (NC Population)||37
8462162|NCT00704405|20852046|P5|STARTED|Overall Study (NC Population)||42
8462163|NCT00704405|20852047|P4|STARTED|Overall Study (NC Population)||42
8462164|NCT00704405|20852048|P3|STARTED|Overall Study (NC Population)||41
8462165|NCT00704405|20852049|P2|STARTED|Overall Study (NC Population)||44
8462166|NCT00704405|20852050|P1|STARTED|Overall Study (NC Population)||42
8462167|NCT00704379|20852080|P2|NOT COMPLETED|Overall Study||7
8462168|NCT00704379|20852081|P1|NOT COMPLETED|Overall Study||7
8462169|NCT00704379|20852080|P2|COMPLETED|Overall Study||41
8462170|NCT00704379|20852081|P1|COMPLETED|Overall Study||39
8462171|NCT00704379|20852080|P2|STARTED|Overall Study||48
8462172|NCT00704379|20852081|P1|STARTED|Overall Study||46
8462173|NCT00704353|20852099|P2|NOT COMPLETED|Overall Study||114
8462174|NCT00704353|20852100|P1|NOT COMPLETED|Overall Study||98
8462175|NCT00704353|20852099|P2|COMPLETED|Overall Study||255
8462176|NCT00704353|20852100|P1|COMPLETED|Overall Study||268
8462177|NCT00704353|20852099|P2|STARTED|Overall Study||369
8462178|NCT00704353|20852100|P1|STARTED|Overall Study||366
8462179|NCT00704340|20852108|P2|NOT COMPLETED|Overall Study||2
8462180|NCT00704340|20852109|P1|NOT COMPLETED|Overall Study||2
8462181|NCT00704340|20852108|P2|COMPLETED|Overall Study||115
8462182|NCT00704340|20852109|P1|COMPLETED|Overall Study||118
8462183|NCT00704340|20852108|P2|STARTED|Overall Study||117
8462184|NCT00704340|20852109|P1|STARTED|Overall Study||120
8462185|NCT00704262|20852119|P1|NOT COMPLETED|Overall Study||2
8462186|NCT00704262|20852119|P1|COMPLETED|Overall Study||31
8462187|NCT00704262|20852119|P1|STARTED|Overall Study||33
8462188|NCT00704184|20852140|P5|NOT COMPLETED|Open-Label Treatment||3
8462189|NCT00704184|20852141|P4|NOT COMPLETED|Open-Label Treatment||5
8462190|NCT00704184|20852142|P3|NOT COMPLETED|Open-Label Treatment||4
8462191|NCT00704184|20852143|P2|NOT COMPLETED|Open-Label Treatment||2
8462192|NCT00704184|20852144|P1|NOT COMPLETED|Open-Label Treatment||1
8462193|NCT00704184|20852140|P5|COMPLETED|Open-Label Treatment||16
8462194|NCT00704184|20852141|P4|COMPLETED|Open-Label Treatment||13
8462195|NCT00704184|20852142|P3|COMPLETED|Open-Label Treatment||16
8462196|NCT00704184|20852143|P2|COMPLETED|Open-Label Treatment||16
8462197|NCT00704184|20852144|P1|COMPLETED|Open-Label Treatment||18
8462198|NCT00704184|20852140|P5|STARTED|Open-Label Treatment||19
8462199|NCT00704184|20852141|P4|STARTED|Open-Label Treatment||18
8462200|NCT00704184|20852142|P3|STARTED|Open-Label Treatment||20
8462201|NCT00704184|20852143|P2|STARTED|Open-Label Treatment||18
8462202|NCT00704184|20852144|P1|STARTED|Open-Label Treatment||19
8462203|NCT00704184|20852140|P5|NOT COMPLETED|Double-Blind Treatment||0
8462204|NCT00704184|20852141|P4|NOT COMPLETED|Double-Blind Treatment||0
8462205|NCT00704184|20852142|P3|NOT COMPLETED|Double-Blind Treatment||0
8462206|NCT00704184|20852143|P2|NOT COMPLETED|Double-Blind Treatment||0
8462207|NCT00704184|20852144|P1|NOT COMPLETED|Double-Blind Treatment||1
8462208|NCT00704184|20852140|P5|COMPLETED|Double-Blind Treatment||19
8462209|NCT00704184|20852141|P4|COMPLETED|Double-Blind Treatment||18
8462210|NCT00704184|20852142|P3|COMPLETED|Double-Blind Treatment||20
8462211|NCT00704184|20852143|P2|COMPLETED|Double-Blind Treatment||18
8462212|NCT00704184|20852144|P1|COMPLETED|Double-Blind Treatment||19
8462213|NCT00704184|20852140|P5|Treated|Double-Blind Treatment||19
8462214|NCT00704184|20852141|P4|Treated|Double-Blind Treatment||18
8462215|NCT00704184|20852142|P3|Treated|Double-Blind Treatment||20
8462216|NCT00704184|20852143|P2|Treated|Double-Blind Treatment||18
8462217|NCT00704184|20852144|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
8462218|NCT00704184|20852140|P5|STARTED|Double-Blind Treatment||19
8462219|NCT00704184|20852141|P4|STARTED|Double-Blind Treatment||18
8462220|NCT00704184|20852142|P3|STARTED|Double-Blind Treatment||20
8462221|NCT00704184|20852143|P2|STARTED|Double-Blind Treatment||18
8462222|NCT00704184|20852144|P1|STARTED|Double-Blind Treatment||20
8462223|NCT00704171|20852183|P2|NOT COMPLETED|Overall Study||0
8462224|NCT00704171|20852184|P1|NOT COMPLETED|Overall Study||1
8462225|NCT00704171|20852183|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
8462226|NCT00704171|20852184|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
8462227|NCT00704171|20852183|P2|STARTED|Overall Study||59
8462228|NCT00704171|20852184|P1|STARTED|Overall Study||62
8462229|NCT00704132|20852202|P2|NOT COMPLETED|Overall Study||2
8462230|NCT00704132|20852203|P1|NOT COMPLETED|Overall Study||1
8462231|NCT00704132|20852202|P2|COMPLETED|Overall Study||22
8462232|NCT00704132|20852203|P1|COMPLETED|Overall Study||25
8462233|NCT00704132|20852202|P2|STARTED|Overall Study||24
8462234|NCT00704132|20852203|P1|STARTED|Overall Study||26
8462235|NCT00704028|20852211|P2|NOT COMPLETED|Overall Study||21
8462236|NCT00704028|20852212|P1|NOT COMPLETED|Overall Study||12
8462237|NCT00704028|20852211|P2|COMPLETED|Overall Study||57
8462238|NCT00704028|20852212|P1|COMPLETED|Overall Study||70
8462239|NCT00704028|20852211|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
8462240|NCT00704028|20852212|P1|STARTED|Overall Study||82
8462241|NCT00703976|20852220|P2|NOT COMPLETED|Overall Study||0
8462242|NCT00703976|20852221|P1|NOT COMPLETED|Overall Study||0
8462243|NCT00703976|20852220|P2|COMPLETED|Overall Study||41
8462244|NCT00703976|20852221|P1|COMPLETED|Overall Study||37
8462245|NCT00703976|20852220|P2|STARTED|Overall Study||41
8462246|NCT00703976|20852221|P1|STARTED|Overall Study||37
8462247|NCT00703963|20852231|P2|NOT COMPLETED|Overall Study||14
8462248|NCT00703963|20852232|P1|NOT COMPLETED|Overall Study||7
8462249|NCT00703963|20852231|P2|COMPLETED|Overall Study||86
8462250|NCT00703963|20852232|P1|COMPLETED|Overall Study||93
8462251|NCT00703963|20852231|P2|STARTED|Overall Study||100
8462252|NCT00703963|20852232|P1|STARTED|Overall Study||100
8462253|NCT00703937|20852244|P2|NOT COMPLETED|Overall Study||93
8462254|NCT00703937|20852245|P1|NOT COMPLETED|Overall Study||65
8462255|NCT00703937|20852244|P2|COMPLETED|Overall Study||267
8462256|NCT00703937|20852245|P1|COMPLETED|Overall Study||278
8462257|NCT00703937|20852244|P2|STARTED|Overall Study||360
8462258|NCT00703937|20852245|P1|STARTED|Overall Study||343
8462259|NCT00703924|20852253|P2|NOT COMPLETED|Overall Study||1
8462260|NCT00703924|20852254|P1|NOT COMPLETED|Overall Study||1
8462261|NCT00703924|20852253|P2|COMPLETED|Overall Study||41
8462262|NCT00703924|20852254|P1|COMPLETED|Overall Study||49
8462263|NCT00703924|20852253|P2|STARTED|Overall Study||42
8462264|NCT00703924|20852254|P1|STARTED|Overall Study||50
8462265|NCT00703911|20852270|P1|NOT COMPLETED|Overall Study||10
8462266|NCT00703911|20852270|P1|COMPLETED|Overall Study||92
8462267|NCT00703911|20852270|P1|STARTED|Overall Study||102
8462268|NCT00703885|20852298|P1|NOT COMPLETED|Overall Study||0
8462269|NCT00703885|20852298|P1|COMPLETED|Overall Study||16
8462270|NCT00703885|20852298|P1|STARTED|Overall Study||16
8462271|NCT00703846|20852303|P1|NOT COMPLETED|Overall Study||137
8462272|NCT00703846|20852303|P1|COMPLETED|Overall Study||363
8462273|NCT00703846|20852303|P1|STARTED|Overall Study||500
8462274|NCT00703820|20852319|P2|NOT COMPLETED|Overall Study||34
8462275|NCT00703820|20852320|P1|NOT COMPLETED|Overall Study||35
8462276|NCT00703820|20852319|P2|COMPLETED|Overall Study||95
8462277|NCT00703820|20852320|P1|COMPLETED|Overall Study||98
8462278|NCT00703820|20852319|P2|STARTED|Overall Study||129
8462279|NCT00703820|20852320|P1|STARTED|Overall Study||133
8462280|NCT00703781|20852329|P2|NOT COMPLETED|Overall Study||2
8462281|NCT00703781|20852330|P1|NOT COMPLETED|Overall Study||2
8462282|NCT00703781|20852329|P2|COMPLETED|Overall Study||61
8462283|NCT00703781|20852330|P1|COMPLETED|Overall Study||61
8462284|NCT00703781|20852329|P2|STARTED|Overall Study||63
8462285|NCT00703781|20852330|P1|STARTED|Overall Study||63
8462286|NCT00703729|20852340|P2|NOT COMPLETED|Overall Study||3
8462287|NCT00703729|20852341|P1|NOT COMPLETED|Overall Study||0
8462288|NCT00703729|20852340|P2|COMPLETED|Overall Study||21
8462289|NCT00703729|20852341|P1|COMPLETED|Overall Study||25
8462290|NCT00703729|20852340|P2|STARTED|Overall Study||24
8462291|NCT00703729|20852341|P1|STARTED|Overall Study||25
8462292|NCT00703677|20852375|P1|NOT COMPLETED|Overall Study||3
8462293|NCT00703677|20852375|P1|COMPLETED|Overall Study||14
8462294|NCT00703677|20852375|P1|STARTED|Overall Study||17
8462295|NCT00703664|20852391|P3|NOT COMPLETED|Overall Study||0
8462296|NCT00703664|20852392|P2|NOT COMPLETED|Overall Study||0
8462297|NCT00703664|20852393|P1|NOT COMPLETED|Overall Study||0
8462298|NCT00703664|20852391|P3|COMPLETED|Overall Study||39
8462299|NCT00703664|20852392|P2|COMPLETED|Overall Study||4
8462300|NCT00703664|20852393|P1|COMPLETED|Overall Study||22
8462301|NCT00703664|20852391|P3|STARTED|Overall Study||39
8462302|NCT00703664|20852392|P2|STARTED|Overall Study||4
8462303|NCT00703664|20852393|P1|STARTED|Overall Study||22
8462304|NCT00703534|20852415|P2|NOT COMPLETED|Overall Study||25
8462305|NCT00703534|20852416|P1|NOT COMPLETED|Overall Study||30
8462306|NCT00703534|20852415|P2|COMPLETED|Overall Study||218
8462307|NCT00703534|20852416|P1|COMPLETED|Overall Study||205
8462308|NCT00703534|20852415|P2|STARTED|Overall Study||243
8462309|NCT00703534|20852416|P1|STARTED|Overall Study||235
8462310|NCT00703508|20852422|P1|NOT COMPLETED|Overall Study||0
8462311|NCT00703508|20852422|P1|COMPLETED|Overall Study||26
8462312|NCT00703508|20852422|P1|STARTED|Overall Study||26
8462313|NCT00703391|20852436|P2|NOT COMPLETED|Overall Study||0
8462314|NCT00703391|20852437|P1|NOT COMPLETED|Overall Study||0
8462315|NCT00703391|20852436|P2|COMPLETED|Overall Study||6
8462316|NCT00703391|20852437|P1|COMPLETED|Overall Study||12
8462317|NCT00703391|20852436|P2|STARTED|Overall Study||6
8462318|NCT00703391|20852437|P1|STARTED|Overall Study||12
8462319|NCT00703339|20852481|P1|NOT COMPLETED|Overall Study||0
8462320|NCT00703339|20852481|P1|COMPLETED|Overall Study||1
8462321|NCT00703339|20852481|P1|STARTED|Overall Study||1
8462322|NCT00703326|20852488|P2|NOT COMPLETED|Overall Study||225
8462323|NCT00703326|20852489|P1|NOT COMPLETED|Overall Study||447
8462324|NCT00703326|20852488|P2|COMPLETED|Overall Study||160
8462325|NCT00703326|20852489|P1|COMPLETED|Overall Study||312
8462326|NCT00703326|20852488|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
8462327|NCT00703326|20852489|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
8462328|NCT00703326|20852488|P2|STARTED|Overall Study||385
8462329|NCT00703326|20852489|P1|STARTED|Overall Study||759
8462330|NCT00703261|20852511|P2|NOT COMPLETED|Overall Study||6
8462331|NCT00703261|20852512|P1|NOT COMPLETED|Overall Study||6
8462332|NCT00703261|20852511|P2|COMPLETED|Overall Study||35
8462333|NCT00703261|20852512|P1|COMPLETED|Overall Study||36
8462334|NCT00703261|20852511|P2|STARTED|Overall Study||41
8462335|NCT00703261|20852512|P1|STARTED|Overall Study||42
8462336|NCT00703157|20852521|P2|NOT COMPLETED|Overall Study||2
8462337|NCT00703157|20852522|P1|NOT COMPLETED|Overall Study||4
8462338|NCT00703157|20852521|P2|COMPLETED|Overall Study||24
8462339|NCT00703157|20852522|P1|COMPLETED|Overall Study||22
8462340|NCT00703157|20852521|P2|24 Months FU|Overall Study||24
8462341|NCT00703157|20852522|P1|24 Months FU|Overall Study||22
8462342|NCT00703157|20852521|P2|6 Months FU|Overall Study||25
8462343|NCT00703157|20852522|P1|6 Months FU|Overall Study||25
8462344|NCT00703157|20852521|P2|STARTED|Overall Study||26
8462345|NCT00703157|20852522|P1|STARTED|Overall Study||26
8462346|NCT00703118|20852556|P3|NOT COMPLETED|Overall Study||22
8462347|NCT00703118|20852557|P2|NOT COMPLETED|Overall Study||16
8462348|NCT00703118|20852558|P1|NOT COMPLETED|Overall Study||21
8462349|NCT00703118|20852556|P3|COMPLETED|Overall Study||110
8462350|NCT00703118|20852557|P2|COMPLETED|Overall Study||248
8462351|NCT00703118|20852558|P1|COMPLETED|Overall Study||245
8462352|NCT00703118|20852556|P3|STARTED|Overall Study||132
8462353|NCT00703118|20852557|P2|STARTED|Overall Study||264
8462354|NCT00703118|20852558|P1|STARTED|Overall Study||266
8462355|NCT00703092|20852589|P1|NOT COMPLETED|Overall Study||2
8462356|NCT00703092|20852589|P1|COMPLETED|Overall Study||0
8462357|NCT00703092|20852589|P1|STARTED|Overall Study||2
8462358|NCT00703053|20852603|P9|NOT COMPLETED|Overall Study||1
8462359|NCT00703053|20852604|P8|NOT COMPLETED|Overall Study||6
8462360|NCT00703053|20852605|P7|NOT COMPLETED|Overall Study||7
8462361|NCT00703053|20852606|P6|NOT COMPLETED|Overall Study||6
8462362|NCT00703053|20852607|P5|NOT COMPLETED|Overall Study||1
8462363|NCT00703053|20852608|P4|NOT COMPLETED|Overall Study||3
8462364|NCT00703053|20852609|P3|NOT COMPLETED|Overall Study||3
8462365|NCT00703053|20852610|P2|NOT COMPLETED|Overall Study||2
8462366|NCT00703053|20852611|P1|NOT COMPLETED|Overall Study||1
8462367|NCT00703053|20852603|P9|COMPLETED|Overall Study||102
8462368|NCT00703053|20852604|P8|COMPLETED|Overall Study||91
8462369|NCT00703053|20852605|P7|COMPLETED|Overall Study||45
8462370|NCT00703053|20852606|P6|COMPLETED|Overall Study||43
8462371|NCT00703053|20852607|P5|COMPLETED|Overall Study||50
8462372|NCT00703053|20852608|P4|COMPLETED|Overall Study||46
8462373|NCT00703053|20852609|P3|COMPLETED|Overall Study||48
8462374|NCT00703053|20852610|P2|COMPLETED|Overall Study||24
8462375|NCT00703053|20852611|P1|COMPLETED|Overall Study||26
8462376|NCT00703053|20852603|P9|STARTED|Overall Study||103
8462377|NCT00703053|20852604|P8|STARTED|Overall Study||97
8462378|NCT00703053|20852605|P7|STARTED|Overall Study||52
8462379|NCT00703053|20852606|P6|STARTED|Overall Study||49
8462380|NCT00703053|20852607|P5|STARTED|Overall Study||51
8462381|NCT00703053|20852608|P4|STARTED|Overall Study||49
8462382|NCT00703053|20852609|P3|STARTED|Overall Study||51
8462383|NCT00703053|20852610|P2|STARTED|Overall Study||26
8462384|NCT00703053|20852611|P1|STARTED|Overall Study||27
8462385|NCT00703014|20852797|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
8462386|NCT00703014|20852798|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
8462387|NCT00703014|20852799|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462388|NCT00703014|20852800|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462389|NCT00703014|20852797|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
8462390|NCT00703014|20852798|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
8462391|NCT00703014|20852799|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462392|NCT00703014|20852800|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462393|NCT00703014|20852797|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
8462394|NCT00703014|20852798|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
8462395|NCT00703014|20852799|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
8462396|NCT00703014|20852800|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
8462397|NCT00703014|20852797|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
8462398|NCT00703014|20852798|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
8462399|NCT00703014|20852799|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
8462400|NCT00703014|20852800|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
8462401|NCT00703014|20852797|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
8462402|NCT00703014|20852798|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
8462403|NCT00703014|20852799|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
8462404|NCT00703014|20852800|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
8462405|NCT00703014|20852797|P4|COMPLETED|Mothers Follow Up Trial P05712||0
8462406|NCT00703014|20852798|P3|COMPLETED|Mothers Follow Up Trial P05712||0
8462407|NCT00703014|20852799|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
8462408|NCT00703014|20852800|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
8462409|NCT00703014|20852797|P4|STARTED|Mothers Follow Up Trial P05712||0
8462410|NCT00703014|20852798|P3|STARTED|Mothers Follow Up Trial P05712||0
8462411|NCT00703014|20852799|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
8462412|NCT00703014|20852800|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
8462413|NCT00703014|20852797|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462414|NCT00703014|20852798|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462415|NCT00703014|20852799|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
8462416|NCT00703014|20852800|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
8462417|NCT00703014|20852797|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462418|NCT00703014|20852798|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462419|NCT00703014|20852799|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
8462420|NCT00703014|20852800|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
8462421|NCT00703014|20852797|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
8462422|NCT00703014|20852798|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
8462423|NCT00703014|20852799|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
8462424|NCT00703014|20852800|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
8462425|NCT00703014|20852797|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
8462426|NCT00703014|20852798|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
8462427|NCT00703014|20852799|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
8462428|NCT00703014|20852800|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
8462429|NCT00703014|20852797|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
8462430|NCT00703014|20852798|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
8462431|NCT00703014|20852799|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
8462432|NCT00703014|20852800|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
8462433|NCT00702962|20852820|P2|NOT COMPLETED|Overall Study||1
8462434|NCT00702962|20852821|P1|NOT COMPLETED|Overall Study||1
8462435|NCT00702962|20852820|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
8462436|NCT00702962|20852821|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
8462437|NCT00702962|20852820|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
8462438|NCT00702962|20852821|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
8462439|NCT00702949|20852832|P3|NOT COMPLETED|Overall Study||8
8462440|NCT00702949|20852833|P2|NOT COMPLETED|Overall Study||9
8462441|NCT00702949|20852834|P1|NOT COMPLETED|Overall Study||5
8462442|NCT00702949|20852832|P3|COMPLETED|Overall Study||54
8462443|NCT00702949|20852833|P2|COMPLETED|Overall Study||57
8462444|NCT00702949|20852834|P1|COMPLETED|Overall Study||58
8462445|NCT00702949|20852832|P3|Evaluable for Primary Endpoint|Overall Study||51
8462446|NCT00702949|20852833|P2|Evaluable for Primary Endpoint|Overall Study||56
8462447|NCT00702949|20852834|P1|Evaluable for Primary Endpoint|Overall Study||56
8462448|NCT00702949|20852832|P3|STARTED|Overall Study||62
8462449|NCT00702949|20852833|P2|STARTED|Overall Study||66
8462450|NCT00702949|20852834|P1|STARTED|Overall Study||63
8462451|NCT00702923|20852859|P1|NOT COMPLETED|Overall Study||1
8462452|NCT00702923|20852859|P1|COMPLETED|Overall Study||11
8462453|NCT00702923|20852859|P1|STARTED|Overall Study||12
8462454|NCT00702884|20852868|P1|NOT COMPLETED|Overall Study||0
8462455|NCT00702884|20852868|P1|COMPLETED|Overall Study||25
8462456|NCT00702884|20852868|P1|STARTED|Overall Study||25
8462457|NCT00702845|20852882|P2|NOT COMPLETED|Overall Study||8
8462458|NCT00702845|20852883|P1|NOT COMPLETED|Overall Study||22
8462459|NCT00702845|20852882|P2|COMPLETED|Overall Study||121
8462460|NCT00702845|20852883|P1|COMPLETED|Overall Study||246
8462461|NCT00702845|20852882|P2|Randomized|Overall Study||128
8462462|NCT00702845|20852883|P1|Randomized|Overall Study||268
8462463|NCT00702845|20852882|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
8462464|NCT00702845|20852883|P1|STARTED|Overall Study||268
8462465|NCT00702780|20852923|P2|NOT COMPLETED|Overall Study||8
8462466|NCT00702780|20852924|P1|NOT COMPLETED|Overall Study||9
8462467|NCT00702780|20852923|P2|COMPLETED|Overall Study||29
8462468|NCT00702780|20852924|P1|COMPLETED|Overall Study||28
8462469|NCT00702780|20852923|P2|STARTED|Overall Study||37
8462470|NCT00702780|20852924|P1|STARTED|Overall Study||37
8462471|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
8462472|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
8462473|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
8462474|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
8462475|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
8462476|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
8462477|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
8462478|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
8462479|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
8462480|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
8462481|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
8462482|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
8462483|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
8462484|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
8462485|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
8462486|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
8462487|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
8462488|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
8462489|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
8462490|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
8462491|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
8462492|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
8462493|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
8462494|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
8462495|NCT00702715|20852945|P2|NOT COMPLETED|Overall Study||0
8462496|NCT00702715|20852946|P1|NOT COMPLETED|Overall Study||1
8462497|NCT00702715|20852945|P2|COMPLETED|Overall Study||33
8462498|NCT00702715|20852946|P1|COMPLETED|Overall Study||34
8462499|NCT00702715|20852945|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
8462500|NCT00702715|20852946|P1|STARTED|Overall Study||35
8462501|NCT00702702|20852959|P1|NOT COMPLETED|Overall Study||56
8462502|NCT00702702|20852959|P1|COMPLETED|Overall Study||0
8462503|NCT00702702|20852959|P1|STARTED|Overall Study||56
8462504|NCT00702689|20852967|P1|NOT COMPLETED|Overall Study||6
8462505|NCT00702689|20852967|P1|COMPLETED|Overall Study||14
8462506|NCT00702689|20852967|P1|STARTED|Overall Study||20
8462507|NCT00702650|20852978|P1|NOT COMPLETED|Overall Study||20
8462508|NCT00702650|20852978|P1|COMPLETED|Overall Study||135
8462509|NCT00702650|20852978|P1|STARTED|Overall Study||155
8462510|NCT00702624|20852998|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
8462511|NCT00702624|20852999|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
8462512|NCT00702624|20853000|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
8462513|NCT00702624|20853001|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
8462514|NCT00702624|20852998|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
8462515|NCT00702624|20852999|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
8462516|NCT00702624|20853000|P2|COMPLETED|Fetuses/Infant Follow-up||0
8462517|NCT00702624|20853001|P1|COMPLETED|Fetuses/Infant Follow-up||0
8462518|NCT00702624|20852998|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
8462519|NCT00702624|20852999|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
8462520|NCT00702624|20853000|P2|Live Born Infants|Fetuses/Infant Follow-up||0
8462521|NCT00702624|20853001|P1|Live Born Infants|Fetuses/Infant Follow-up||0
8462522|NCT00702624|20852998|P4|STARTED|Fetuses/Infant Follow-up||55
8462523|NCT00702624|20852999|P3|STARTED|Fetuses/Infant Follow-up||88
8462524|NCT00702624|20853000|P2|STARTED|Fetuses/Infant Follow-up||0
8462525|NCT00702624|20853001|P1|STARTED|Fetuses/Infant Follow-up||0
8462526|NCT00702624|20852998|P4|NOT COMPLETED|Expectant Mother Follow-up||0
8462527|NCT00702624|20852999|P3|NOT COMPLETED|Expectant Mother Follow-up||0
8462528|NCT00702624|20853000|P2|NOT COMPLETED|Expectant Mother Follow-up||0
8462529|NCT00702624|20853001|P1|NOT COMPLETED|Expectant Mother Follow-up||7
8462530|NCT00702624|20852998|P4|COMPLETED|Expectant Mother Follow-up||0
8462531|NCT00702624|20852999|P3|COMPLETED|Expectant Mother Follow-up||0
8462532|NCT00702624|20853000|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
8462533|NCT00702624|20853001|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
8462534|NCT00702624|20852998|P4|STARTED|Expectant Mother Follow-up||0
8462535|NCT00702624|20852999|P3|STARTED|Expectant Mother Follow-up||0
8462536|NCT00702624|20853000|P2|STARTED|Expectant Mother Follow-up||45
8462537|NCT00702624|20853001|P1|STARTED|Expectant Mother Follow-up||68
8462538|NCT00702624|20852998|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
8462539|NCT00702624|20852999|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
8462540|NCT00702624|20853000|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
8462541|NCT00702624|20853001|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
8462542|NCT00702624|20852998|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
8462543|NCT00702624|20852999|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
8462544|NCT00702624|20853000|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
8462545|NCT00702624|20853001|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
8462546|NCT00702624|20852998|P4|STARTED|Base Study P05690 (NCT00702845)||0
8462547|NCT00702624|20852999|P3|STARTED|Base Study P05690 (NCT00702845)||0
8462548|NCT00702624|20853000|P2|STARTED|Base Study P05690 (NCT00702845)||128
8462549|NCT00702624|20853001|P1|STARTED|Base Study P05690 (NCT00702845)||268
8462550|NCT00702546|20853019|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
8462551|NCT00702546|20853020|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
8462552|NCT00702546|20853019|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
8462553|NCT00702546|20853020|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
8462554|NCT00702546|20853019|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
8462555|NCT00702546|20853020|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
8462556|NCT00702546|20853019|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
8462557|NCT00702546|20853020|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
8462558|NCT00702546|20853019|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
8462559|NCT00702546|20853020|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
8462560|NCT00702546|20853019|P2|STARTED|Base Study P05690 (NCT00702845)||128
8462561|NCT00702546|20853020|P1|STARTED|Base Study P05690 (NCT00702845)||268
8462562|NCT00702520|20853040|P4|NOT COMPLETED|Follow-up Study P05783||0
8462563|NCT00702520|20853041|P3|NOT COMPLETED|Follow-up Study P05783||0
8462564|NCT00702520|20853042|P2|NOT COMPLETED|Follow-up Study P05783||0
8462565|NCT00702520|20853043|P1|NOT COMPLETED|Follow-up Study P05783||0
8462566|NCT00702520|20853040|P4|COMPLETED|Follow-up Study P05783||11
8462567|NCT00702520|20853041|P3|COMPLETED|Follow-up Study P05783||8
8462568|NCT00702520|20853042|P2|COMPLETED|Follow-up Study P05783||8
8462569|NCT00702520|20853043|P1|COMPLETED|Follow-up Study P05783||7
8462570|NCT00702520|20853040|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
8462571|NCT00702520|20853041|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
8462572|NCT00702520|20853042|P2|STARTED|Follow-up Study P05783||8
8462573|NCT00702520|20853043|P1|STARTED|Follow-up Study P05783||7
8462574|NCT00702520|20853040|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
8462575|NCT00702520|20853041|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
8462576|NCT00702520|20853042|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
8462577|NCT00702520|20853043|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
8462578|NCT00702520|20853040|P4|COMPLETED|Base Study P05788 - Follow-Up||0
8462579|NCT00702520|20853041|P3|COMPLETED|Base Study P05788 - Follow-Up||0
8462580|NCT00702520|20853042|P2|COMPLETED|Base Study P05788 - Follow-Up||8
8462581|NCT00702520|20853043|P1|COMPLETED|Base Study P05788 - Follow-Up||7
8462582|NCT00702520|20853040|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
8462583|NCT00702520|20853041|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
8462584|NCT00702520|20853042|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
8462585|NCT00702520|20853043|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
8462586|NCT00702520|20853040|P4|STARTED|Base Study P05788 - Follow-Up||0
8462587|NCT00702520|20853041|P3|STARTED|Base Study P05788 - Follow-Up||0
8462588|NCT00702520|20853042|P2|STARTED|Base Study P05788 - Follow-Up||18
8462589|NCT00702520|20853043|P1|STARTED|Base Study P05788 - Follow-Up||22
8462590|NCT00702520|20853040|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
8462591|NCT00702520|20853041|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
8462592|NCT00702520|20853042|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
8462593|NCT00702520|20853043|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
8462594|NCT00702520|20853040|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
8462595|NCT00702520|20853041|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
8462596|NCT00702520|20853042|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
8462597|NCT00702520|20853043|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
8462598|NCT00702520|20853040|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
8462599|NCT00702520|20853041|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
8462600|NCT00702520|20853042|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
8462601|NCT00702520|20853043|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
8462602|NCT00702520|20853040|P4|STARTED|Base Study P05788 - Embryo Transfer||0
8462603|NCT00702520|20853041|P3|STARTED|Base Study P05788 - Embryo Transfer||0
8462604|NCT00702520|20853042|P2|STARTED|Base Study P05788 - Embryo Transfer||24
8462605|NCT00702520|20853043|P1|STARTED|Base Study P05788 - Embryo Transfer||25
8462606|NCT00702520|20853040|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8462607|NCT00702520|20853041|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8462608|NCT00702520|20853042|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
8462609|NCT00702520|20853043|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8462610|NCT00702520|20853040|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
8462611|NCT00702520|20853041|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
8462612|NCT00702520|20853042|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
8462613|NCT00702520|20853043|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
8462614|NCT00702520|20853040|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
8462615|NCT00702520|20853041|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
8462616|NCT00702520|20853042|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
8462617|NCT00702520|20853043|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
8462618|NCT00702520|20853040|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
8462619|NCT00702520|20853041|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
8462620|NCT00702520|20853042|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
8462621|NCT00702520|20853043|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
8462622|NCT00702520|20853040|P4|STARTED|Base Study P05788 - Assigned Treatment||0
8462623|NCT00702520|20853041|P3|STARTED|Base Study P05788 - Assigned Treatment||0
8462624|NCT00702520|20853042|P2|STARTED|Base Study P05788 - Assigned Treatment||25
8462625|NCT00702520|20853043|P1|STARTED|Base Study P05788 - Assigned Treatment||25
8462626|NCT00702507|20853059|P1|NOT COMPLETED|Follow-up Phase||27
8462627|NCT00702507|20853059|P1|COMPLETED|Follow-up Phase||132
8462628|NCT00702507|20853059|P1|STARTED|Follow-up Phase||159
8462629|NCT00702507|20853059|P1|NOT COMPLETED|Initial Treatment Phase||41
8462630|NCT00702507|20853059|P1|COMPLETED|Initial Treatment Phase||159
8462631|NCT00702507|20853059|P1|STARTED|Initial Treatment Phase||200
8462632|NCT00702468|20853073|P2|NOT COMPLETED|Overall Study||16
8462633|NCT00702468|20853074|P1|NOT COMPLETED|Overall Study||3
8462634|NCT00702468|20853073|P2|COMPLETED|Overall Study||2
8462635|NCT00702468|20853074|P1|COMPLETED|Overall Study||15
8462636|NCT00702468|20853073|P2|STARTED|Overall Study||18
8462637|NCT00702468|20853074|P1|STARTED|Overall Study||18
8462638|NCT00702403|20853096|P1|NOT COMPLETED|From Engraftment to Study Completion||27
8462639|NCT00702403|20853096|P1|COMPLETED|From Engraftment to Study Completion||13
8462640|NCT00702403|20853096|P1|Patient Drop-outs|From Engraftment to Study Completion||27
8462641|NCT00702403|20853096|P1|STARTED|From Engraftment to Study Completion||40
8462642|NCT00702403|20853096|P1|NOT COMPLETED|From Consent to Engraftment||17
8462643|NCT00702403|20853096|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
8462644|NCT00702403|20853096|P1|Ineligible for Study Drug|From Consent to Engraftment||17
8462645|NCT00702403|20853096|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
8462646|NCT00702377|20853106|P2|NOT COMPLETED|Overall Study||3
8462647|NCT00702377|20853107|P1|NOT COMPLETED|Overall Study||1
8462648|NCT00702377|20853106|P2|COMPLETED|Overall Study||53
8462649|NCT00702377|20853107|P1|COMPLETED|Overall Study||52
8462650|NCT00702377|20853106|P2|STARTED|Overall Study||56
8462651|NCT00702377|20853107|P1|STARTED|Overall Study||53
8462652|NCT00702364|20853119|P2|NOT COMPLETED|Overall Study||4
8462653|NCT00702364|20853120|P1|NOT COMPLETED|Overall Study||2
8462654|NCT00702364|20853119|P2|COMPLETED|Overall Study||25
8462655|NCT00702364|20853120|P1|COMPLETED|Overall Study||24
8462656|NCT00702364|20853119|P2|STARTED|Overall Study||29
8462657|NCT00702364|20853120|P1|STARTED|Overall Study||26
8462658|NCT00702338|20853132|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
8462659|NCT00702338|20853133|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
8462660|NCT00702338|20853134|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
8462661|NCT00702338|20853132|P3|COMPLETED|Follow-up Study: Infant FU||0
8462662|NCT00702338|20853133|P2|COMPLETED|Follow-up Study: Infant FU||0
8462663|NCT00702338|20853134|P1|COMPLETED|Follow-up Study: Infant FU||0
8462664|NCT00702338|20853132|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
8462665|NCT00702338|20853133|P2|STARTED|Follow-up Study: Infant FU||0
8462666|NCT00702338|20853134|P1|STARTED|Follow-up Study: Infant FU||0
8462667|NCT00702338|20853132|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462668|NCT00702338|20853133|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
8462669|NCT00702338|20853134|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462670|NCT00702338|20853132|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462737|NCT00702143|20853263|P3|NOT COMPLETED|Overall Study||1
8462738|NCT00702143|20853264|P2|NOT COMPLETED|Overall Study||0
8462671|NCT00702338|20853133|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
8462672|NCT00702338|20853134|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462673|NCT00702338|20853132|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
8462674|NCT00702338|20853133|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
8462675|NCT00702338|20853134|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
8462676|NCT00702338|20853132|P3|NOT COMPLETED|Base Study (NCT00697255)||0
8462677|NCT00702338|20853133|P2|NOT COMPLETED|Base Study (NCT00697255)||2
8462678|NCT00702338|20853134|P1|NOT COMPLETED|Base Study (NCT00697255)||3
8462679|NCT00702338|20853132|P3|COMPLETED|Base Study (NCT00697255)||0
8462680|NCT00702338|20853133|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
8462681|NCT00702338|20853134|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
8462682|NCT00702338|20853132|P3|STARTED|Base Study (NCT00697255)||0
8462683|NCT00702338|20853133|P2|STARTED|Base Study (NCT00697255)||3
8462684|NCT00702338|20853134|P1|STARTED|Base Study (NCT00697255)||5
8462685|NCT00702325|20853150|P2|NOT COMPLETED|Overall Study||53
8462686|NCT00702325|20853151|P1|NOT COMPLETED|Overall Study||38
8462687|NCT00702325|20853150|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
8462688|NCT00702325|20853151|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
8462689|NCT00702325|20853150|P2|STARTED|Overall Study|Randomized|155
8462690|NCT00702325|20853151|P1|STARTED|Overall Study|Randomized|156
8462691|NCT00702299|20853203|P1|NOT COMPLETED|Overall Study||0
8462692|NCT00702299|20853203|P1|COMPLETED|Overall Study||15
8462693|NCT00702299|20853203|P1|STARTED|Overall Study||15
8462694|NCT00702273|20853216|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
8462695|NCT00702273|20853217|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
8462696|NCT00702273|20853216|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
8462697|NCT00702273|20853217|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
8462698|NCT00702273|20853216|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
8462699|NCT00702273|20853217|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
8462700|NCT00702273|20853216|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
8462701|NCT00702273|20853217|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
8462702|NCT00702273|20853216|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
8462703|NCT00702273|20853217|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
8462704|NCT00702273|20853216|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
8462705|NCT00702273|20853217|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
8462706|NCT00702273|20853216|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
8462707|NCT00702273|20853217|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
8462708|NCT00702234|20853235|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
8462709|NCT00702234|20853236|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
8462710|NCT00702234|20853235|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
8462711|NCT00702234|20853236|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
8462712|NCT00702234|20853235|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
8462713|NCT00702234|20853236|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
8462714|NCT00702234|20853235|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
8462715|NCT00702234|20853236|P1|STARTED|Follow-up Study: Fetuses/Infants||0
8462716|NCT00702234|20853235|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
8462717|NCT00702234|20853236|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
8462718|NCT00702234|20853235|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
8462719|NCT00702234|20853236|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
8462720|NCT00702234|20853235|P2|STARTED|Follow-up Study: Expectant Mothers||0
8462721|NCT00702234|20853236|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
8462722|NCT00702234|20853235|P2|NOT COMPLETED|Base Study (NCT00696878)||0
8462723|NCT00702234|20853236|P1|NOT COMPLETED|Base Study (NCT00696878)||504
8462724|NCT00702234|20853235|P2|COMPLETED|Base Study (NCT00696878)||0
8462725|NCT00702234|20853236|P1|COMPLETED|Base Study (NCT00696878)||178
8462726|NCT00702234|20853235|P2|STARTED|Base Study (NCT00696878)||0
8462727|NCT00702234|20853236|P1|STARTED|Base Study (NCT00696878)||682
8462728|NCT00702221|20853247|P2|NOT COMPLETED|Overall Study||3
8462729|NCT00702221|20853248|P1|NOT COMPLETED|Overall Study||4
8462730|NCT00702221|20853247|P2|COMPLETED|Overall Study||7
8462731|NCT00702221|20853248|P1|COMPLETED|Overall Study||6
8462732|NCT00702221|20853247|P2|STARTED|Overall Study||10
8462733|NCT00702221|20853248|P1|STARTED|Overall Study||10
8462734|NCT00702208|20853254|P1|NOT COMPLETED|Overall Study||31
8462735|NCT00702208|20853254|P1|COMPLETED|Overall Study||167
8462736|NCT00702208|20853254|P1|STARTED|Overall Study||198
8462739|NCT00702143|20853265|P1|NOT COMPLETED|Overall Study||0
8462740|NCT00702143|20853263|P3|COMPLETED|Overall Study||78
8462741|NCT00702143|20853264|P2|COMPLETED|Overall Study||60
8462742|NCT00702143|20853265|P1|COMPLETED|Overall Study||45
8462743|NCT00702143|20853263|P3|STARTED|Overall Study||79
8462744|NCT00702143|20853264|P2|STARTED|Overall Study||60
8462745|NCT00702143|20853265|P1|STARTED|Overall Study||45
8462746|NCT00701935|20853279|P2|NOT COMPLETED|Overall Study||11
8462747|NCT00701935|20853280|P1|NOT COMPLETED|Overall Study||16
8462748|NCT00701935|20853279|P2|COMPLETED|Overall Study||26
8462749|NCT00701935|20853280|P1|COMPLETED|Overall Study||27
8462750|NCT00701935|20853279|P2|STARTED|Overall Study||37
8462751|NCT00701935|20853280|P1|STARTED|Overall Study||43
8462752|NCT00701896|20853312|P2|NOT COMPLETED|Overall Study||33
8462753|NCT00701896|20853313|P1|NOT COMPLETED|Overall Study||33
8462754|NCT00701896|20853312|P2|COMPLETED|Overall Study||118
8462755|NCT00701896|20853313|P1|COMPLETED|Overall Study||110
8462756|NCT00701896|20853312|P2|STARTED|Overall Study|Includes those eligible but declined to participate|151
8462757|NCT00701896|20853313|P1|STARTED|Overall Study|Includes those eligible but declined to participate|143
8462758|NCT00701805|20853325|P4|NOT COMPLETED|Overall Study||4
8462759|NCT00701805|20853326|P3|NOT COMPLETED|Overall Study||7
8462760|NCT00701805|20853327|P2|NOT COMPLETED|Overall Study||4
8462761|NCT00701805|20853328|P1|NOT COMPLETED|Overall Study||3
8462762|NCT00701805|20853325|P4|COMPLETED|Overall Study||22
8462763|NCT00701805|20853326|P3|COMPLETED|Overall Study||16
8462764|NCT00701805|20853327|P2|COMPLETED|Overall Study||25
8462765|NCT00701805|20853328|P1|COMPLETED|Overall Study||23
8462766|NCT00701805|20853325|P4|STARTED|Overall Study||26
8462767|NCT00701805|20853326|P3|STARTED|Overall Study||23
8462768|NCT00701805|20853327|P2|STARTED|Overall Study||29
8462769|NCT00701805|20853328|P1|STARTED|Overall Study||26
8462770|NCT00701779|20853378|P1|NOT COMPLETED|Overall Study||9
8462771|NCT00701779|20853378|P1|COMPLETED|Overall Study||54
8462772|NCT00701779|20853378|P1|12 Month|Overall Study||54
8462773|NCT00701779|20853378|P1|9 Month|Overall Study||56
8462774|NCT00701779|20853378|P1|6 Month|Overall Study||58
8462775|NCT00701779|20853378|P1|3 Month|Overall Study||60
8462776|NCT00701779|20853378|P1|STARTED|Overall Study||63
8462777|NCT00701727|20853390|P2|NOT COMPLETED|Second Treatment Period||0
8462778|NCT00701727|20853391|P1|NOT COMPLETED|Second Treatment Period||2
8462779|NCT00701727|20853390|P2|COMPLETED|Second Treatment Period||13
8462780|NCT00701727|20853391|P1|COMPLETED|Second Treatment Period||13
8462781|NCT00701727|20853390|P2|STARTED|Second Treatment Period||13
8462782|NCT00701727|20853391|P1|STARTED|Second Treatment Period||15
8462783|NCT00701727|20853390|P2|NOT COMPLETED|First Treatment Period||2
8462784|NCT00701727|20853391|P1|NOT COMPLETED|First Treatment Period||1
8462785|NCT00701727|20853390|P2|COMPLETED|First Treatment Period||13
8462786|NCT00701727|20853391|P1|COMPLETED|First Treatment Period||15
8462787|NCT00701727|20853390|P2|STARTED|First Treatment Period||15
8462788|NCT00701727|20853391|P1|STARTED|First Treatment Period||16
8462789|NCT00701714|20853411|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
8462790|NCT00701714|20853412|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
8462791|NCT00701714|20853411|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
8462792|NCT00701714|20853412|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
8462793|NCT00701714|20853411|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
8462794|NCT00701714|20853412|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
8462795|NCT00701714|20853411|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
8462796|NCT00701714|20853412|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
8462797|NCT00701714|20853411|P2|COMPLETED|Treatment Period (up to 1 Year)||29
8462798|NCT00701714|20853412|P1|COMPLETED|Treatment Period (up to 1 Year)||37
8462799|NCT00701714|20853411|P2|STARTED|Treatment Period (up to 1 Year)||163
8462800|NCT00701714|20853412|P1|STARTED|Treatment Period (up to 1 Year)||174
8462801|NCT00701701|20853426|P2|NOT COMPLETED|Overall Study||2
8462802|NCT00701701|20853427|P1|NOT COMPLETED|Overall Study||0
8462803|NCT00701701|20853426|P2|COMPLETED|Overall Study||1
8462804|NCT00701701|20853427|P1|COMPLETED|Overall Study||1
8462805|NCT00701701|20853426|P2|STARTED|Overall Study||3
8462806|NCT00701701|20853427|P1|STARTED|Overall Study||1
8462807|NCT00701675|20853452|P3|NOT COMPLETED|Overall Study||7
8462808|NCT00701675|20853453|P2|NOT COMPLETED|Overall Study||8
8462809|NCT00701675|20853454|P1|NOT COMPLETED|Overall Study||4
8462810|NCT00701675|20853452|P3|COMPLETED|Overall Study||7
8462811|NCT00701675|20853453|P2|COMPLETED|Overall Study||6
8462812|NCT00701675|20853454|P1|COMPLETED|Overall Study||10
8462813|NCT00701675|20853452|P3|STARTED|Overall Study||14
8462814|NCT00701675|20853453|P2|STARTED|Overall Study||14
8462815|NCT00701675|20853454|P1|STARTED|Overall Study||14
8462816|NCT00701662|20853462|P1|NOT COMPLETED|Overall Study||1
8462817|NCT00701662|20853462|P1|COMPLETED|Overall Study||7
8462818|NCT00701662|20853462|P1|STARTED|Overall Study||8
8462819|NCT00701636|20853481|P2|NOT COMPLETED|Overall Study||0
8462820|NCT00701636|20853482|P1|NOT COMPLETED|Overall Study||0
8462821|NCT00701636|20853481|P2|COMPLETED|Overall Study||15
8462822|NCT00701636|20853482|P1|COMPLETED|Overall Study||15
8462823|NCT00701636|20853481|P2|STARTED|Overall Study||15
8462824|NCT00701636|20853482|P1|STARTED|Overall Study||15
8462825|NCT00701558|20853487|P1|NOT COMPLETED|Overall Study||15
8462826|NCT00701558|20853487|P1|COMPLETED|Overall Study||4
8462827|NCT00701558|20853487|P1|STARTED|Overall Study||19
8462828|NCT00701441|20853495|P2|NOT COMPLETED|Overall Study||4
8462829|NCT00701441|20853496|P1|NOT COMPLETED|Overall Study||0
8462830|NCT00701441|20853495|P2|COMPLETED|Overall Study||12
8462831|NCT00701441|20853496|P1|COMPLETED|Overall Study||9
8462832|NCT00701441|20853495|P2|STARTED|Overall Study||16
8462833|NCT00701441|20853496|P1|STARTED|Overall Study||9
8462834|NCT00701415|20853508|P2|NOT COMPLETED|Overall Study||1
8462835|NCT00701415|20853509|P1|NOT COMPLETED|Overall Study||1
8462836|NCT00701415|20853508|P2|COMPLETED|Overall Study||14
8462837|NCT00701415|20853509|P1|COMPLETED|Overall Study||15
8462838|NCT00701415|20853508|P2|STARTED|Overall Study||15
8462839|NCT00701415|20853509|P1|STARTED|Overall Study||16
8462840|NCT00701389|20853519|P4|NOT COMPLETED|Period 4||0
8462841|NCT00701389|20853520|P3|NOT COMPLETED|Period 4||0
8462842|NCT00701389|20853521|P2|NOT COMPLETED|Period 4||0
8462843|NCT00701389|20853522|P1|NOT COMPLETED|Period 4||0
8462844|NCT00701389|20853519|P4|COMPLETED|Period 4||6
8462845|NCT00701389|20853520|P3|COMPLETED|Period 4||6
8462846|NCT00701389|20853521|P2|COMPLETED|Period 4||6
8462847|NCT00701389|20853522|P1|COMPLETED|Period 4||6
8462848|NCT00701389|20853519|P4|STARTED|Period 4||6
8462849|NCT00701389|20853520|P3|STARTED|Period 4||6
8462850|NCT00701389|20853521|P2|STARTED|Period 4||6
8462851|NCT00701389|20853522|P1|STARTED|Period 4||6
8462852|NCT00701389|20853519|P4|NOT COMPLETED|Period 3||0
8462853|NCT00701389|20853520|P3|NOT COMPLETED|Period 3||0
8462854|NCT00701389|20853521|P2|NOT COMPLETED|Period 3||0
8462855|NCT00701389|20853522|P1|NOT COMPLETED|Period 3||0
8462856|NCT00701389|20853519|P4|COMPLETED|Period 3||6
8462857|NCT00701389|20853520|P3|COMPLETED|Period 3||6
8462858|NCT00701389|20853521|P2|COMPLETED|Period 3||6
8462859|NCT00701389|20853522|P1|COMPLETED|Period 3||6
8462860|NCT00701389|20853519|P4|STARTED|Period 3||6
8462861|NCT00701389|20853520|P3|STARTED|Period 3||6
8462862|NCT00701389|20853521|P2|STARTED|Period 3||6
8462863|NCT00701389|20853522|P1|STARTED|Period 3||6
8462864|NCT00701389|20853519|P4|NOT COMPLETED|Period 2||0
8462865|NCT00701389|20853520|P3|NOT COMPLETED|Period 2||0
8462866|NCT00701389|20853521|P2|NOT COMPLETED|Period 2||0
8462867|NCT00701389|20853522|P1|NOT COMPLETED|Period 2||0
8462868|NCT00701389|20853519|P4|COMPLETED|Period 2||6
8462869|NCT00701389|20853520|P3|COMPLETED|Period 2||6
8462870|NCT00701389|20853521|P2|COMPLETED|Period 2||6
8462871|NCT00701389|20853522|P1|COMPLETED|Period 2||6
8462872|NCT00701389|20853519|P4|STARTED|Period 2||6
8462873|NCT00701389|20853520|P3|STARTED|Period 2||6
8462874|NCT00701389|20853521|P2|STARTED|Period 2||6
8462875|NCT00701389|20853522|P1|STARTED|Period 2||6
8462876|NCT00701389|20853519|P4|NOT COMPLETED|Period 1||0
8462877|NCT00701389|20853520|P3|NOT COMPLETED|Period 1||0
8462878|NCT00701389|20853521|P2|NOT COMPLETED|Period 1||0
8462879|NCT00701389|20853522|P1|NOT COMPLETED|Period 1||0
8462880|NCT00701389|20853519|P4|COMPLETED|Period 1||6
8462881|NCT00701389|20853520|P3|COMPLETED|Period 1||6
8462882|NCT00701389|20853521|P2|COMPLETED|Period 1||6
8462883|NCT00701389|20853522|P1|COMPLETED|Period 1||6
8462884|NCT00701389|20853519|P4|STARTED|Period 1||6
8462885|NCT00701389|20853520|P3|STARTED|Period 1||6
8462886|NCT00701389|20853521|P2|STARTED|Period 1||6
8462887|NCT00701389|20853522|P1|STARTED|Period 1||6
8462888|NCT00701376|20853540|P1|NOT COMPLETED|Overall Study||1
8462889|NCT00701376|20853540|P1|COMPLETED|Overall Study||105
8462890|NCT00701376|20853540|P1|STARTED|Overall Study||106
8462891|NCT00701363|20853568|P4|NOT COMPLETED|Treatment Phase 2||0
8462892|NCT00701363|20853569|P3|NOT COMPLETED|Treatment Phase 2||2
8462893|NCT00701363|20853570|P2|NOT COMPLETED|Treatment Phase 2||0
8462894|NCT00701363|20853571|P1|NOT COMPLETED|Treatment Phase 2||0
8462895|NCT00701363|20853568|P4|COMPLETED|Treatment Phase 2||26
8462896|NCT00701363|20853569|P3|COMPLETED|Treatment Phase 2||68
8462897|NCT00701363|20853570|P2|COMPLETED|Treatment Phase 2||13
8462898|NCT00701363|20853571|P1|COMPLETED|Treatment Phase 2||0
8462899|NCT00701363|20853568|P4|STARTED|Treatment Phase 2||26
8462900|NCT00701363|20853569|P3|STARTED|Treatment Phase 2||70
8462901|NCT00701363|20853570|P2|STARTED|Treatment Phase 2||13
8462902|NCT00701363|20853571|P1|STARTED|Treatment Phase 2||0
8462903|NCT00701363|20853568|P4|NOT COMPLETED|Treatment Phase 1||0
8462904|NCT00701363|20853569|P3|NOT COMPLETED|Treatment Phase 1||0
8462905|NCT00701363|20853570|P2|NOT COMPLETED|Treatment Phase 1||0
8462906|NCT00701363|20853571|P1|NOT COMPLETED|Treatment Phase 1||15
8462907|NCT00701363|20853568|P4|COMPLETED|Treatment Phase 1||0
8462908|NCT00701363|20853569|P3|COMPLETED|Treatment Phase 1||0
8462909|NCT00701363|20853570|P2|COMPLETED|Treatment Phase 1||0
8462910|NCT00701363|20853571|P1|COMPLETED|Treatment Phase 1||109
8462911|NCT00701363|20853568|P4|STARTED|Treatment Phase 1||0
8462912|NCT00701363|20853569|P3|STARTED|Treatment Phase 1||0
8462913|NCT00701363|20853570|P2|STARTED|Treatment Phase 1||0
8462914|NCT00701363|20853571|P1|STARTED|Treatment Phase 1||124
8462915|NCT00701363|20853568|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8462916|NCT00701363|20853569|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8462917|NCT00701363|20853570|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8462918|NCT00701363|20853571|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
8462919|NCT00701363|20853568|P4|COMPLETED|Screening (Pre-assignment) Phase||0
8462920|NCT00701363|20853569|P3|COMPLETED|Screening (Pre-assignment) Phase||0
8462921|NCT00701363|20853570|P2|COMPLETED|Screening (Pre-assignment) Phase||0
8462922|NCT00701363|20853571|P1|COMPLETED|Screening (Pre-assignment) Phase||124
8462923|NCT00701363|20853568|P4|STARTED|Screening (Pre-assignment) Phase||0
8462924|NCT00701363|20853569|P3|STARTED|Screening (Pre-assignment) Phase||0
8462925|NCT00701363|20853570|P2|STARTED|Screening (Pre-assignment) Phase||0
8462926|NCT00701363|20853571|P1|STARTED|Screening (Pre-assignment) Phase||128
8462927|NCT00701311|20853611|P1|NOT COMPLETED|Overall Study||8
8462928|NCT00701311|20853611|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
8462929|NCT00701311|20853611|P1|STARTED|Overall Study||17
8462930|NCT00701129|20853615|P1|NOT COMPLETED|Overall Study||2
8462931|NCT00701129|20853615|P1|COMPLETED|Overall Study||2
8462932|NCT00701129|20853615|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
8462933|NCT00701129|20853615|P1|STARTED|Overall Study||4
8462934|NCT00701103|20853637|P11|NOT COMPLETED|Overall Study||11
8462935|NCT00701103|20853638|P10|NOT COMPLETED|Overall Study||11
8462936|NCT00701103|20853639|P9|NOT COMPLETED|Overall Study||9
8462937|NCT00701103|20853640|P8|NOT COMPLETED|Overall Study||7
8462938|NCT00701103|20853641|P7|NOT COMPLETED|Overall Study||8
8462939|NCT00701103|20853642|P6|NOT COMPLETED|Overall Study||6
8462940|NCT00701103|20853643|P5|NOT COMPLETED|Overall Study||6
8462941|NCT00701103|20853644|P4|NOT COMPLETED|Overall Study||6
8462942|NCT00701103|20853645|P3|NOT COMPLETED|Overall Study||8
8462943|NCT00701103|20853646|P2|NOT COMPLETED|Overall Study||3
8462944|NCT00701103|20853647|P1|NOT COMPLETED|Overall Study||5
8462945|NCT00701103|20853637|P11|COMPLETED|Overall Study||0
8462946|NCT00701103|20853638|P10|COMPLETED|Overall Study||0
8462947|NCT00701103|20853639|P9|COMPLETED|Overall Study||0
8462948|NCT00701103|20853640|P8|COMPLETED|Overall Study||0
8462949|NCT00701103|20853641|P7|COMPLETED|Overall Study||0
8462950|NCT00701103|20853642|P6|COMPLETED|Overall Study||0
8462951|NCT00701103|20853643|P5|COMPLETED|Overall Study||0
8462952|NCT00701103|20853644|P4|COMPLETED|Overall Study||0
8462953|NCT00701103|20853645|P3|COMPLETED|Overall Study||0
8462954|NCT00701103|20853646|P2|COMPLETED|Overall Study||0
8462955|NCT00701103|20853647|P1|COMPLETED|Overall Study||0
8462956|NCT00701103|20853637|P11|STARTED|Overall Study||11
8462957|NCT00701103|20853638|P10|STARTED|Overall Study||11
8462958|NCT00701103|20853639|P9|STARTED|Overall Study||9
8462959|NCT00701103|20853640|P8|STARTED|Overall Study||7
8462960|NCT00701103|20853641|P7|STARTED|Overall Study||8
8462961|NCT00701103|20853642|P6|STARTED|Overall Study||6
8462962|NCT00701103|20853643|P5|STARTED|Overall Study||6
8462963|NCT00701103|20853644|P4|STARTED|Overall Study||6
8462964|NCT00701103|20853645|P3|STARTED|Overall Study||8
8462965|NCT00701103|20853646|P2|STARTED|Overall Study||3
8462966|NCT00701103|20853647|P1|STARTED|Overall Study||5
8462967|NCT00701090|20853753|P2|NOT COMPLETED|Overall Study||51
8462968|NCT00701090|20853754|P1|NOT COMPLETED|Overall Study||48
8462969|NCT00701090|20853753|P2|COMPLETED|Overall Study||468
8462970|NCT00701090|20853754|P1|COMPLETED|Overall Study||468
8462971|NCT00701090|20853753|P2|STARTED|Overall Study||519
8462972|NCT00701090|20853754|P1|STARTED|Overall Study||516
8462973|NCT00701064|20853772|P2|NOT COMPLETED|Overall Study||4
8462974|NCT00701064|20853773|P1|NOT COMPLETED|Overall Study||4
8462975|NCT00701064|20853772|P2|COMPLETED|Overall Study||32
8462976|NCT00701064|20853773|P1|COMPLETED|Overall Study||31
8462977|NCT00701064|20853772|P2|STARTED|Overall Study||36
8462978|NCT00701064|20853773|P1|STARTED|Overall Study||35
8462979|NCT00701051|20853785|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
8462980|NCT00701051|20853786|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
8462981|NCT00701051|20853787|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
8462982|NCT00701051|20853785|P3|COMPLETED|Detraining Intervention (Optional)||6
8462983|NCT00701051|20853786|P2|COMPLETED|Detraining Intervention (Optional)||6
8462984|NCT00701051|20853787|P1|COMPLETED|Detraining Intervention (Optional)||0
8462985|NCT00701051|20853785|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
8462986|NCT00701051|20853786|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
8462987|NCT00701051|20853787|P1|STARTED|Detraining Intervention (Optional)||0
8462988|NCT00701051|20853785|P3|NOT COMPLETED|Exercise Intervention||3
8462989|NCT00701051|20853786|P2|NOT COMPLETED|Exercise Intervention||5
8462990|NCT00701051|20853787|P1|NOT COMPLETED|Exercise Intervention||0
8462991|NCT00701051|20853785|P3|COMPLETED|Exercise Intervention||9
8462992|NCT00701051|20853786|P2|COMPLETED|Exercise Intervention||14
8462993|NCT00701051|20853787|P1|COMPLETED|Exercise Intervention||0
8462994|NCT00701051|20853785|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
8462995|NCT00701051|20853786|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
8462996|NCT00701051|20853787|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
8462997|NCT00701051|20853785|P3|NOT COMPLETED|Screening||0
8462998|NCT00701051|20853786|P2|NOT COMPLETED|Screening||0
8462999|NCT00701051|20853787|P1|NOT COMPLETED|Screening||59
8463000|NCT00701051|20853785|P3|COMPLETED|Screening||0
8463001|NCT00701051|20853786|P2|COMPLETED|Screening||0
8463002|NCT00701051|20853787|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
8463003|NCT00701051|20853785|P3|STARTED|Screening||0
8463004|NCT00701051|20853786|P2|STARTED|Screening||0
8463005|NCT00701051|20853787|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
8463006|NCT00701038|20853805|P2|NOT COMPLETED|Overall Study||4
8463007|NCT00701038|20853806|P1|NOT COMPLETED|Overall Study||4
8463008|NCT00701038|20853805|P2|COMPLETED|Overall Study||23
8463009|NCT00701038|20853806|P1|COMPLETED|Overall Study||23
8463010|NCT00701038|20853805|P2|STARTED|Overall Study||27
8463011|NCT00701038|20853806|P1|STARTED|Overall Study||27
8463012|NCT00700999|20853814|P2|NOT COMPLETED|Overall Study||9
8463013|NCT00700999|20853815|P1|NOT COMPLETED|Overall Study||15
8463014|NCT00700999|20853814|P2|COMPLETED|Overall Study||20
8463015|NCT00700999|20853815|P1|COMPLETED|Overall Study||21
8463016|NCT00700999|20853814|P2|Second MRI Scan|Overall Study||18
8463017|NCT00700999|20853815|P1|Second MRI Scan|Overall Study||19
8463018|NCT00700999|20853814|P2|First MRI Scan|Overall Study||22
8463019|NCT00700999|20853815|P1|First MRI Scan|Overall Study||29
8463020|NCT00700999|20853814|P2|STARTED|Overall Study||29
8463021|NCT00700999|20853815|P1|STARTED|Overall Study||36
8463022|NCT00700973|20853823|P2|NOT COMPLETED|Overall Study||7
8463023|NCT00700973|20853824|P1|NOT COMPLETED|Overall Study||8
8463024|NCT00700973|20853823|P2|COMPLETED|Overall Study||63
8463025|NCT00700973|20853824|P1|COMPLETED|Overall Study||63
8463026|NCT00700973|20853823|P2|STARTED|Overall Study||70
8463027|NCT00700973|20853824|P1|STARTED|Overall Study||71
8463028|NCT00700882|20853830|P1|NOT COMPLETED|Overall Study||59
8463029|NCT00700882|20853830|P1|COMPLETED|Overall Study||22
8463030|NCT00700882|20853830|P1|Eligible, Treated and KIT+ Patients|Overall Study||22
8463031|NCT00700882|20853830|P1|Eligible and Treated Patients|Overall Study||73
8463032|NCT00700882|20853830|P1|Received Protocol Therapy|Overall Study||75
8463033|NCT00700882|20853830|P1|STARTED|Overall Study||81
8463034|NCT00700817|20853839|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
8463035|NCT00700817|20853840|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
8463036|NCT00700817|20853841|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
8463037|NCT00700817|20853842|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
8463038|NCT00700817|20853843|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
8463039|NCT00700817|20853839|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
8463040|NCT00700817|20853840|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
8463041|NCT00700817|20853841|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
8463042|NCT00700817|20853842|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
8463043|NCT00700817|20853843|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
8463044|NCT00700817|20853839|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
8463045|NCT00700817|20853840|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
8463046|NCT00700817|20853841|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
8463047|NCT00700817|20853842|P2|STARTED|Week 52-78 (Extension Period 2)||150
8463048|NCT00700817|20853843|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
8463049|NCT00700817|20853839|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
8463050|NCT00700817|20853840|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
8463051|NCT00700817|20853841|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
8463052|NCT00700817|20853842|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
8463053|NCT00700817|20853843|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
8463054|NCT00700817|20853839|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
8463055|NCT00700817|20853840|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
8463056|NCT00700817|20853841|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
8463057|NCT00700817|20853842|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
8463058|NCT00700817|20853843|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
8463059|NCT00700817|20853839|P5|STARTED|Week 26-52 (Extension Period 1)||0
8463060|NCT00700817|20853840|P4|STARTED|Week 26-52 (Extension Period 1)||0
8463061|NCT00700817|20853841|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
8463062|NCT00700817|20853842|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
8463063|NCT00700817|20853843|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
8463064|NCT00700817|20853839|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
8463065|NCT00700817|20853840|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
8463066|NCT00700817|20853841|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
8463067|NCT00700817|20853842|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
8463068|NCT00700817|20853843|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
8463069|NCT00700817|20853839|P5|COMPLETED|Week 0-26 (Main Period)||0
8463070|NCT00700817|20853840|P4|COMPLETED|Week 0-26 (Main Period)||0
8463071|NCT00700817|20853841|P3|COMPLETED|Week 0-26 (Main Period)||194
8463072|NCT00700817|20853842|P2|COMPLETED|Week 0-26 (Main Period)||191
8463073|NCT00700817|20853843|P1|COMPLETED|Week 0-26 (Main Period)||169
8463074|NCT00700817|20853839|P5|Exposed|Week 0-26 (Main Period)||0
8463075|NCT00700817|20853840|P4|Exposed|Week 0-26 (Main Period)||0
8463076|NCT00700817|20853841|P3|Exposed|Week 0-26 (Main Period)||219
8463077|NCT00700817|20853842|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
8463078|NCT00700817|20853843|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
8463079|NCT00700817|20853839|P5|STARTED|Week 0-26 (Main Period)||0
8463080|NCT00700817|20853840|P4|STARTED|Week 0-26 (Main Period)||0
8463081|NCT00700817|20853841|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
8463082|NCT00700817|20853842|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
8463083|NCT00700817|20853843|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
8463084|NCT00700804|20854225|P2|NOT COMPLETED|Overall Study||4
8463085|NCT00700804|20854226|P1|NOT COMPLETED|Overall Study||3
8463086|NCT00700804|20854225|P2|COMPLETED|Overall Study||13
8463087|NCT00700804|20854226|P1|COMPLETED|Overall Study||14
8463088|NCT00700804|20854225|P2|STARTED|Overall Study||17
8463089|NCT00700804|20854226|P1|STARTED|Overall Study||17
8463090|NCT00700778|20854234|P1|NOT COMPLETED|Overall Study||2
8463091|NCT00700778|20854234|P1|COMPLETED|Overall Study||0
8463092|NCT00700778|20854234|P1|STARTED|Overall Study||2
8463093|NCT00700752|20854238|P2|NOT COMPLETED|Second Intervention||0
8463094|NCT00700752|20854239|P1|NOT COMPLETED|Second Intervention||0
8463095|NCT00700752|20854238|P2|COMPLETED|Second Intervention||18
8463096|NCT00700752|20854239|P1|COMPLETED|Second Intervention||20
8463097|NCT00700752|20854238|P2|STARTED|Second Intervention||18
8463098|NCT00700752|20854239|P1|STARTED|Second Intervention||20
8463099|NCT00700752|20854238|P2|NOT COMPLETED|First Intervention||2
8463100|NCT00700752|20854239|P1|NOT COMPLETED|First Intervention||0
8463101|NCT00700752|20854238|P2|COMPLETED|First Intervention||18
8463102|NCT00700752|20854239|P1|COMPLETED|First Intervention||20
8463103|NCT00700752|20854238|P2|STARTED|First Intervention||20
8463104|NCT00700752|20854239|P1|STARTED|First Intervention||20
8463105|NCT00700739|20854247|P2|NOT COMPLETED|Overall Study||4
8463106|NCT00700739|20854248|P1|NOT COMPLETED|Overall Study||4
8463107|NCT00700739|20854247|P2|COMPLETED|Overall Study||12
8463108|NCT00700739|20854248|P1|COMPLETED|Overall Study||18
8463109|NCT00700739|20854247|P2|STARTED|Overall Study||16
8463110|NCT00700739|20854248|P1|STARTED|Overall Study||22
8463111|NCT00700713|20854287|P3|NOT COMPLETED|Overall Study||2
8463112|NCT00700713|20854288|P2|NOT COMPLETED|Overall Study||0
8463113|NCT00700713|20854289|P1|NOT COMPLETED|Overall Study||1
8463114|NCT00700713|20854287|P3|COMPLETED|Overall Study||65
8463115|NCT00700713|20854288|P2|COMPLETED|Overall Study||66
8463116|NCT00700713|20854289|P1|COMPLETED|Overall Study||47
8463117|NCT00700713|20854287|P3|STARTED|Overall Study||67
8463118|NCT00700713|20854288|P2|STARTED|Overall Study||66
8463119|NCT00700713|20854289|P1|STARTED|Overall Study||48
8463120|NCT00700635|20854306|P3|NOT COMPLETED|Overall Study||1
8463121|NCT00700635|20854307|P2|NOT COMPLETED|Overall Study||8
8463122|NCT00700635|20854308|P1|NOT COMPLETED|Overall Study||11
8463123|NCT00700635|20854306|P3|COMPLETED|Overall Study||110
8463124|NCT00700635|20854307|P2|COMPLETED|Overall Study||103
8463125|NCT00700635|20854308|P1|COMPLETED|Overall Study||100
8463126|NCT00700635|20854306|P3|STARTED|Overall Study||111
8463127|NCT00700635|20854307|P2|STARTED|Overall Study||111
8463128|NCT00700635|20854308|P1|STARTED|Overall Study||111
8463129|NCT00700622|20854330|P2|NOT COMPLETED|Overall Study||5
8463130|NCT00700622|20854331|P1|NOT COMPLETED|Overall Study||13
8463131|NCT00700622|20854330|P2|COMPLETED|Overall Study||60
8463132|NCT00700622|20854331|P1|COMPLETED|Overall Study||52
8463133|NCT00700622|20854330|P2|STARTED|Overall Study||65
8463134|NCT00700622|20854331|P1|STARTED|Overall Study||65
8463135|NCT00700570|20854339|P2|NOT COMPLETED|Overall Study||26
8463136|NCT00700570|20854340|P1|NOT COMPLETED|Overall Study||11
8463137|NCT00700570|20854339|P2|COMPLETED|Overall Study||0
8463138|NCT00700570|20854340|P1|COMPLETED|Overall Study||8
8463139|NCT00700570|20854339|P2|STARTED|Overall Study||26
8463140|NCT00700570|20854340|P1|STARTED|Overall Study||19
8463141|NCT00700440|20854352|P1|NOT COMPLETED|Overall Study||0
8463142|NCT00700440|20854352|P1|COMPLETED|Overall Study||100
8463143|NCT00700440|20854352|P1|STARTED|Overall Study||100
8463144|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
8463145|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463146|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463147|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463148|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463149|NCT00700427|20854356|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
8463150|NCT00700427|20854357|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463151|NCT00700427|20854358|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463152|NCT00700427|20854359|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463153|NCT00700427|20854360|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463154|NCT00700427|20854356|P5|STARTED|Study Period 4 (Open-Label Extension)||180
8463155|NCT00700427|20854357|P4|STARTED|Study Period 4 (Open-Label Extension)||0
8463156|NCT00700427|20854358|P3|STARTED|Study Period 4 (Open-Label Extension)||0
8463157|NCT00700427|20854359|P2|STARTED|Study Period 4 (Open-Label Extension)||0
8463158|NCT00700427|20854360|P1|STARTED|Study Period 4 (Open-Label Extension)||0
8463159|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463160|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
8463161|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
8463162|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463163|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463164|NCT00700427|20854356|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463165|NCT00700427|20854357|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
8463166|NCT00700427|20854358|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
8463167|NCT00700427|20854359|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463168|NCT00700427|20854360|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463169|NCT00700427|20854356|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
8463170|NCT00700427|20854357|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
8463171|NCT00700427|20854358|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
8463172|NCT00700427|20854359|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
8463173|NCT00700427|20854360|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
8463174|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463175|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463176|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463177|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
8463178|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463179|NCT00700427|20854356|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463180|NCT00700427|20854357|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463181|NCT00700427|20854358|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463182|NCT00700427|20854359|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
8463183|NCT00700427|20854360|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463184|NCT00700427|20854356|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
8463185|NCT00700427|20854357|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
8463186|NCT00700427|20854358|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
8463187|NCT00700427|20854359|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
8463188|NCT00700427|20854360|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
8463189|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463190|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463191|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463192|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463193|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
8463194|NCT00700427|20854356|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463195|NCT00700427|20854357|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463196|NCT00700427|20854358|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463197|NCT00700427|20854359|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463198|NCT00700427|20854360|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
8463199|NCT00700427|20854356|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463200|NCT00700427|20854357|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463201|NCT00700427|20854358|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463202|NCT00700427|20854359|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463203|NCT00700427|20854360|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
8463204|NCT00700427|20854356|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463205|NCT00700427|20854357|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463206|NCT00700427|20854358|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463207|NCT00700427|20854359|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463208|NCT00700427|20854360|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
8463209|NCT00700401|20854382|P1|NOT COMPLETED|Overall Study||94
8463210|NCT00700401|20854382|P1|COMPLETED|Overall Study||168
8463211|NCT00700401|20854382|P1|STARTED|Overall Study||262
8463212|NCT00700375|20854395|P2|NOT COMPLETED|Overall Study||0
8463213|NCT00700375|20854396|P1|NOT COMPLETED|Overall Study||0
8463214|NCT00700375|20854395|P2|COMPLETED|Overall Study||29
8463215|NCT00700375|20854396|P1|COMPLETED|Overall Study||30
8463216|NCT00700375|20854395|P2|2 Days After Creatinine Mesurement|Overall Study||29
8463217|NCT00700375|20854396|P1|2 Days After Creatinine Mesurement|Overall Study||30
8463218|NCT00700375|20854395|P2|STARTED|Overall Study||29
8463219|NCT00700375|20854396|P1|STARTED|Overall Study||30
8463220|NCT00700310|20854406|P4|NOT COMPLETED|Overall Study||26
8463221|NCT00700310|20854407|P3|NOT COMPLETED|Overall Study||16
8463222|NCT00700310|20854408|P2|NOT COMPLETED|Overall Study||26
8463223|NCT00700310|20854409|P1|NOT COMPLETED|Overall Study||21
8463224|NCT00700310|20854406|P4|COMPLETED|Overall Study||145
8463225|NCT00700310|20854407|P3|COMPLETED|Overall Study||158
8463226|NCT00700310|20854408|P2|COMPLETED|Overall Study||154
8463227|NCT00700310|20854409|P1|COMPLETED|Overall Study||166
8463228|NCT00700310|20854406|P4|STARTED|Overall Study||171
8463229|NCT00700310|20854407|P3|STARTED|Overall Study||174
8463230|NCT00700310|20854408|P2|STARTED|Overall Study||180
8463231|NCT00700310|20854409|P1|STARTED|Overall Study||187
8463232|NCT00700271|20854429|P2|NOT COMPLETED|Overall Study||12
8463233|NCT00700271|20854430|P1|NOT COMPLETED|Overall Study||14
8463234|NCT00700271|20854429|P2|COMPLETED|Overall Study||256
8463235|NCT00700271|20854430|P1|COMPLETED|Overall Study||264
8463236|NCT00700271|20854429|P2|STARTED|Overall Study||268
8463237|NCT00700271|20854430|P1|STARTED|Overall Study||278
8463238|NCT00700180|20854458|P2|NOT COMPLETED|Overall Study||149
8463239|NCT00700180|20854459|P1|NOT COMPLETED|Overall Study||154
8463240|NCT00700180|20854458|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
8463241|NCT00700180|20854459|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
8463242|NCT00700180|20854458|P2|STARTED|Overall Study||149
8463243|NCT00700180|20854459|P1|STARTED|Overall Study||154
8463244|NCT00700141|20854481|P1|NOT COMPLETED|Overall Study||0
8463245|NCT00700141|20854481|P1|COMPLETED|Overall Study||482
8463246|NCT00700141|20854481|P1|STARTED|Overall Study||482
8463247|NCT00700115|20854488|P2|NOT COMPLETED|Overall Study||1
8463248|NCT00700115|20854489|P1|NOT COMPLETED|Overall Study||1
8463249|NCT00700115|20854488|P2|COMPLETED|Overall Study||19
8463250|NCT00700115|20854489|P1|COMPLETED|Overall Study||39
8463251|NCT00700115|20854488|P2|STARTED|Overall Study||20
8463252|NCT00700115|20854489|P1|STARTED|Overall Study||40
8463253|NCT00700102|20854499|P2|NOT COMPLETED|Overall Study||395
8463254|NCT00700102|20854500|P1|NOT COMPLETED|Overall Study||402
8463255|NCT00700102|20854499|P2|COMPLETED|Overall Study||14
8463256|NCT00700102|20854500|P1|COMPLETED|Overall Study||9
8463257|NCT00700102|20854499|P2|Received at Least One Dose|Overall Study||403
8463258|NCT00700102|20854500|P1|Received at Least One Dose|Overall Study||407
8463259|NCT00700102|20854499|P2|Intention to Treat|Overall Study||409
8463260|NCT00700102|20854500|P1|Intention to Treat|Overall Study||410
8463261|NCT00700102|20854499|P2|STARTED|Overall Study||409
8463262|NCT00700102|20854500|P1|STARTED|Overall Study||411
8463263|NCT00700063|20854524|P8|NOT COMPLETED|Overall Study||0
8463264|NCT00700063|20854525|P7|NOT COMPLETED|Overall Study||0
8463265|NCT00700063|20854526|P6|NOT COMPLETED|Overall Study||0
8463266|NCT00700063|20854527|P5|NOT COMPLETED|Overall Study||2
8463267|NCT00700063|20854528|P4|NOT COMPLETED|Overall Study||2
8463268|NCT00700063|20854529|P3|NOT COMPLETED|Overall Study||0
8463269|NCT00700063|20854530|P2|NOT COMPLETED|Overall Study||0
8463270|NCT00700063|20854531|P1|NOT COMPLETED|Overall Study||1
8463271|NCT00700063|20854524|P8|COMPLETED|Overall Study||33
8463272|NCT00700063|20854525|P7|COMPLETED|Overall Study||32
8463273|NCT00700063|20854526|P6|COMPLETED|Overall Study||34
8463274|NCT00700063|20854527|P5|COMPLETED|Overall Study||31
8463275|NCT00700063|20854528|P4|COMPLETED|Overall Study||31
8463276|NCT00700063|20854529|P3|COMPLETED|Overall Study||33
8463277|NCT00700063|20854530|P2|COMPLETED|Overall Study||34
8463278|NCT00700063|20854531|P1|COMPLETED|Overall Study||32
8463279|NCT00700063|20854524|P8|STARTED|Overall Study||33
8463280|NCT00700063|20854525|P7|STARTED|Overall Study||32
8463281|NCT00700063|20854526|P6|STARTED|Overall Study||34
8463282|NCT00700063|20854527|P5|STARTED|Overall Study||33
8463283|NCT00700063|20854528|P4|STARTED|Overall Study||33
8463284|NCT00700063|20854529|P3|STARTED|Overall Study||33
8463285|NCT00700063|20854530|P2|STARTED|Overall Study||34
8463286|NCT00700063|20854531|P1|STARTED|Overall Study||33
8463287|NCT00700011|20854639|P2|NOT COMPLETED|Overall Study||1
8463288|NCT00700011|20854640|P1|NOT COMPLETED|Overall Study||0
8463289|NCT00700011|20854639|P2|COMPLETED|Overall Study||1
8463290|NCT00700011|20854640|P1|COMPLETED|Overall Study||8
8463291|NCT00700011|20854639|P2|STARTED|Overall Study||2
8463292|NCT00700011|20854640|P1|STARTED|Overall Study||8
8463293|NCT00699998|20854656|P4|NOT COMPLETED|Overall Study||82
8463294|NCT00699998|20854657|P3|NOT COMPLETED|Overall Study||206
8463295|NCT00699998|20854658|P2|NOT COMPLETED|Overall Study||86
8463296|NCT00699998|20854659|P1|NOT COMPLETED|Overall Study||199
8463297|NCT00699998|20854656|P4|COMPLETED|Overall Study||958
8463298|NCT00699998|20854657|P3|COMPLETED|Overall Study||3417
8463299|NCT00699998|20854658|P2|COMPLETED|Overall Study||957
8463300|NCT00699998|20854659|P1|COMPLETED|Overall Study||3421
8463301|NCT00699998|20854656|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
8463302|NCT00699998|20854657|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
8463303|NCT00699998|20854658|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
8463304|NCT00699998|20854659|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
8463305|NCT00699998|20854656|P4|STARTED|Overall Study||1040
8463306|NCT00699998|20854657|P3|STARTED|Overall Study||3623
8463307|NCT00699998|20854658|P2|STARTED|Overall Study||1043
8463308|NCT00699998|20854659|P1|STARTED|Overall Study||3620
8463309|NCT00699972|20854704|P3|NOT COMPLETED|Overall Study||35
8463310|NCT00699972|20854705|P2|NOT COMPLETED|Overall Study||19
8463311|NCT00699972|20854706|P1|NOT COMPLETED|Overall Study||16
8463312|NCT00699972|20854704|P3|COMPLETED|Overall Study||100
8463313|NCT00699972|20854705|P2|COMPLETED|Overall Study||114
8463314|NCT00699972|20854706|P1|COMPLETED|Overall Study||106
8463315|NCT00699972|20854704|P3|STARTED|Overall Study||135
8463316|NCT00699972|20854705|P2|STARTED|Overall Study||133
8463317|NCT00699972|20854706|P1|STARTED|Overall Study||122
8463318|NCT00699907|20854723|P3|NOT COMPLETED|Overall Study||8
8463319|NCT00699907|20854724|P2|NOT COMPLETED|Overall Study||10
8463320|NCT00699907|20854725|P1|NOT COMPLETED|Overall Study||2
8463321|NCT00699907|20854723|P3|COMPLETED|Overall Study||48
8463322|NCT00699907|20854724|P2|COMPLETED|Overall Study||47
8463323|NCT00699907|20854725|P1|COMPLETED|Overall Study||12
8463324|NCT00699907|20854723|P3|STARTED|Overall Study||56
8463325|NCT00699907|20854724|P2|STARTED|Overall Study||57
8463326|NCT00699907|20854725|P1|STARTED|Overall Study||14
8463327|NCT00699842|20854760|P3|NOT COMPLETED|Overall Study||0
8463328|NCT00699842|20854761|P2|NOT COMPLETED|Overall Study||1
8463329|NCT00699842|20854762|P1|NOT COMPLETED|Overall Study||0
8463330|NCT00699842|20854760|P3|COMPLETED|Overall Study||0
8463331|NCT00699842|20854761|P2|COMPLETED|Overall Study||4
8463332|NCT00699842|20854762|P1|COMPLETED|Overall Study||3
8463333|NCT00699842|20854760|P3|STARTED|Overall Study||0
8463334|NCT00699842|20854761|P2|STARTED|Overall Study||5
8463335|NCT00699842|20854762|P1|STARTED|Overall Study||3
8463336|NCT00699816|20854775|P2|NOT COMPLETED|Overall Study||3
8463337|NCT00699816|20854776|P1|NOT COMPLETED|Overall Study||1
8463338|NCT00699816|20854775|P2|COMPLETED|Overall Study||112
8463339|NCT00699816|20854776|P1|COMPLETED|Overall Study||114
8463340|NCT00699816|20854775|P2|STARTED|Overall Study||115
8463341|NCT00699816|20854776|P1|STARTED|Overall Study||115
8463342|NCT00699803|20854794|P2|NOT COMPLETED|Overall Study||6
8463343|NCT00699803|20854795|P1|NOT COMPLETED|Overall Study||2
8463344|NCT00699803|20854794|P2|COMPLETED|Overall Study||26
8463345|NCT00699803|20854795|P1|COMPLETED|Overall Study||30
8463346|NCT00699803|20854794|P2|STARTED|Overall Study||32
8463347|NCT00699803|20854795|P1|STARTED|Overall Study||32
8463348|NCT00699751|20854803|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
8463349|NCT00699751|20854804|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
8463350|NCT00699751|20854803|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
8463351|NCT00699751|20854804|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
8463352|NCT00699751|20854803|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8463353|NCT00699751|20854804|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8463354|NCT00699751|20854803|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
8463355|NCT00699751|20854804|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8463356|NCT00699751|20854803|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
8463357|NCT00699751|20854804|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
8463358|NCT00699751|20854803|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
8463359|NCT00699751|20854804|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
8463360|NCT00699751|20854803|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
8463361|NCT00699751|20854804|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
8463362|NCT00699751|20854803|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
8463363|NCT00699751|20854804|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
8463364|NCT00699751|20854803|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
8463365|NCT00699751|20854804|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
8463366|NCT00699751|20854803|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
8463367|NCT00699751|20854804|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
8463368|NCT00699751|20854803|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
8463369|NCT00699751|20854804|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
8463370|NCT00699751|20854803|P2|STARTED|Period 1: Without/Before Drug Switch||307
8463371|NCT00699751|20854804|P1|STARTED|Period 1: Without/Before Drug Switch||614
8463372|NCT00699699|20854889|P1|NOT COMPLETED|Overall Study||57
8463373|NCT00699699|20854889|P1|COMPLETED|Overall Study||1223
8463374|NCT00699699|20854889|P1|STARTED|Overall Study||1280
8463375|NCT00699660|20854898|P2|NOT COMPLETED|Overall Study||8
8463376|NCT00699660|20854899|P1|NOT COMPLETED|Overall Study||14
8463377|NCT00699660|20854898|P2|COMPLETED|Overall Study||208
8463378|NCT00699660|20854899|P1|COMPLETED|Overall Study||176
8463379|NCT00699660|20854898|P2|STARTED|Overall Study||216
8463380|NCT00699660|20854899|P1|STARTED|Overall Study||190
8463381|NCT00699608|20854911|P6|NOT COMPLETED|Third Intervention||0
8463382|NCT00699608|20854912|P5|NOT COMPLETED|Third Intervention||0
8463383|NCT00699608|20854913|P4|NOT COMPLETED|Third Intervention||0
8463384|NCT00699608|20854914|P3|NOT COMPLETED|Third Intervention||0
8463385|NCT00699608|20854915|P2|NOT COMPLETED|Third Intervention||0
8463386|NCT00699608|20854916|P1|NOT COMPLETED|Third Intervention||0
8463387|NCT00699608|20854911|P6|COMPLETED|Third Intervention||15
8463388|NCT00699608|20854912|P5|COMPLETED|Third Intervention||14
8463389|NCT00699608|20854913|P4|COMPLETED|Third Intervention||14
8463390|NCT00699608|20854914|P3|COMPLETED|Third Intervention||13
8463391|NCT00699608|20854915|P2|COMPLETED|Third Intervention||15
8463392|NCT00699608|20854916|P1|COMPLETED|Third Intervention||16
8463393|NCT00699608|20854911|P6|STARTED|Third Intervention||15
8463394|NCT00699608|20854912|P5|STARTED|Third Intervention||14
8463395|NCT00699608|20854913|P4|STARTED|Third Intervention||14
8463396|NCT00699608|20854914|P3|STARTED|Third Intervention||13
8463397|NCT00699608|20854915|P2|STARTED|Third Intervention||15
8463398|NCT00699608|20854916|P1|STARTED|Third Intervention||16
8463399|NCT00699608|20854911|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463400|NCT00699608|20854912|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463401|NCT00699608|20854913|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463402|NCT00699608|20854914|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463403|NCT00699608|20854915|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463404|NCT00699608|20854916|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463405|NCT00699608|20854911|P6|COMPLETED|Second 4-14 Day Washout Period||15
8463406|NCT00699608|20854912|P5|COMPLETED|Second 4-14 Day Washout Period||14
8463407|NCT00699608|20854913|P4|COMPLETED|Second 4-14 Day Washout Period||14
8463408|NCT00699608|20854914|P3|COMPLETED|Second 4-14 Day Washout Period||13
8463409|NCT00699608|20854915|P2|COMPLETED|Second 4-14 Day Washout Period||15
8463410|NCT00699608|20854916|P1|COMPLETED|Second 4-14 Day Washout Period||16
8463411|NCT00699608|20854911|P6|STARTED|Second 4-14 Day Washout Period||15
8463412|NCT00699608|20854912|P5|STARTED|Second 4-14 Day Washout Period||14
8463413|NCT00699608|20854913|P4|STARTED|Second 4-14 Day Washout Period||14
8463414|NCT00699608|20854914|P3|STARTED|Second 4-14 Day Washout Period||13
8463415|NCT00699608|20854915|P2|STARTED|Second 4-14 Day Washout Period||15
8463416|NCT00699608|20854916|P1|STARTED|Second 4-14 Day Washout Period||16
8463417|NCT00699608|20854911|P6|NOT COMPLETED|Second Intervention||0
8463418|NCT00699608|20854912|P5|NOT COMPLETED|Second Intervention||0
8463419|NCT00699608|20854913|P4|NOT COMPLETED|Second Intervention||1
8463420|NCT00699608|20854914|P3|NOT COMPLETED|Second Intervention||1
8463421|NCT00699608|20854915|P2|NOT COMPLETED|Second Intervention||0
8463422|NCT00699608|20854916|P1|NOT COMPLETED|Second Intervention||0
8463423|NCT00699608|20854911|P6|COMPLETED|Second Intervention||15
8463424|NCT00699608|20854912|P5|COMPLETED|Second Intervention||14
8463425|NCT00699608|20854913|P4|COMPLETED|Second Intervention||14
8463426|NCT00699608|20854914|P3|COMPLETED|Second Intervention||13
8463427|NCT00699608|20854915|P2|COMPLETED|Second Intervention||15
8463428|NCT00699608|20854916|P1|COMPLETED|Second Intervention||16
8463429|NCT00699608|20854911|P6|STARTED|Second Intervention||15
8463430|NCT00699608|20854912|P5|STARTED|Second Intervention||14
8463431|NCT00699608|20854913|P4|STARTED|Second Intervention||15
8463432|NCT00699608|20854914|P3|STARTED|Second Intervention||14
8463433|NCT00699608|20854915|P2|STARTED|Second Intervention||15
8463434|NCT00699608|20854916|P1|STARTED|Second Intervention||16
8463435|NCT00699608|20854911|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
8463436|NCT00699608|20854912|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
8463437|NCT00699608|20854913|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
8463438|NCT00699608|20854914|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
8463439|NCT00699608|20854915|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
8463440|NCT00699608|20854916|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
8463441|NCT00699608|20854911|P6|COMPLETED|First 4-14 Day Washout Period||15
8463442|NCT00699608|20854912|P5|COMPLETED|First 4-14 Day Washout Period||14
8463443|NCT00699608|20854913|P4|COMPLETED|First 4-14 Day Washout Period||15
8463444|NCT00699608|20854914|P3|COMPLETED|First 4-14 Day Washout Period||14
8463445|NCT00699608|20854915|P2|COMPLETED|First 4-14 Day Washout Period||15
8463446|NCT00699608|20854916|P1|COMPLETED|First 4-14 Day Washout Period||16
8463447|NCT00699608|20854911|P6|STARTED|First 4-14 Day Washout Period||15
8463448|NCT00699608|20854912|P5|STARTED|First 4-14 Day Washout Period||14
8463449|NCT00699608|20854913|P4|STARTED|First 4-14 Day Washout Period||15
8463450|NCT00699608|20854914|P3|STARTED|First 4-14 Day Washout Period||14
8463451|NCT00699608|20854915|P2|STARTED|First 4-14 Day Washout Period||15
8463452|NCT00699608|20854916|P1|STARTED|First 4-14 Day Washout Period||16
8463453|NCT00699608|20854911|P6|NOT COMPLETED|First Intervention||0
8463454|NCT00699608|20854912|P5|NOT COMPLETED|First Intervention||1
8463455|NCT00699608|20854913|P4|NOT COMPLETED|First Intervention||0
8463456|NCT00699608|20854914|P3|NOT COMPLETED|First Intervention||1
8463457|NCT00699608|20854915|P2|NOT COMPLETED|First Intervention||0
8463458|NCT00699608|20854916|P1|NOT COMPLETED|First Intervention||0
8463459|NCT00699608|20854911|P6|COMPLETED|First Intervention||15
8463460|NCT00699608|20854912|P5|COMPLETED|First Intervention||14
8463461|NCT00699608|20854913|P4|COMPLETED|First Intervention||15
8463462|NCT00699608|20854914|P3|COMPLETED|First Intervention||14
8463463|NCT00699608|20854915|P2|COMPLETED|First Intervention||15
8463464|NCT00699608|20854916|P1|COMPLETED|First Intervention||16
8463465|NCT00699608|20854911|P6|STARTED|First Intervention||15
8463466|NCT00699608|20854912|P5|STARTED|First Intervention||15
8463467|NCT00699608|20854913|P4|STARTED|First Intervention||15
8463468|NCT00699608|20854914|P3|STARTED|First Intervention||15
8463469|NCT00699608|20854915|P2|STARTED|First Intervention||15
8463470|NCT00699608|20854916|P1|STARTED|First Intervention||16
8463471|NCT00699582|20854969|P3|NOT COMPLETED|Overall Study||28
8463472|NCT00699582|20854970|P2|NOT COMPLETED|Overall Study||22
8463473|NCT00699582|20854971|P1|NOT COMPLETED|Overall Study||18
8463474|NCT00699582|20854969|P3|COMPLETED|Overall Study||93
8463475|NCT00699582|20854970|P2|COMPLETED|Overall Study||108
8463476|NCT00699582|20854971|P1|COMPLETED|Overall Study||120
8463477|NCT00699582|20854969|P3|STARTED|Overall Study||121
8463478|NCT00699582|20854970|P2|STARTED|Overall Study||130
8463479|NCT00699582|20854971|P1|STARTED|Overall Study||138
8463480|NCT00699556|20854985|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8463481|NCT00699556|20854986|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8463482|NCT00699556|20854985|P2|COMPLETED|Second Intervention (1 Day)||11
8463483|NCT00699556|20854986|P1|COMPLETED|Second Intervention (1 Day)||11
8463484|NCT00699556|20854985|P2|STARTED|Second Intervention (1 Day)||11
8463485|NCT00699556|20854986|P1|STARTED|Second Intervention (1 Day)||11
8463486|NCT00699556|20854985|P2|NOT COMPLETED|First Intervention (1 Day)||0
8463487|NCT00699556|20854986|P1|NOT COMPLETED|First Intervention (1 Day)||0
8463488|NCT00699556|20854985|P2|COMPLETED|First Intervention (1 Day)||11
8463489|NCT00699556|20854986|P1|COMPLETED|First Intervention (1 Day)||11
8463490|NCT00699556|20854985|P2|STARTED|First Intervention (1 Day)||11
8463491|NCT00699556|20854986|P1|STARTED|First Intervention (1 Day)||11
8463492|NCT00699491|20855000|P6|NOT COMPLETED|Overall Study||0
8463493|NCT00699491|20855001|P5|NOT COMPLETED|Overall Study||0
8463494|NCT00699491|20855002|P4|NOT COMPLETED|Overall Study||0
8463495|NCT00699491|20855003|P3|NOT COMPLETED|Overall Study||0
8463496|NCT00699491|20855004|P2|NOT COMPLETED|Overall Study||0
8463497|NCT00699491|20855005|P1|NOT COMPLETED|Overall Study||0
8463498|NCT00699491|20855000|P6|COMPLETED|Overall Study||22
8463499|NCT00699491|20855001|P5|COMPLETED|Overall Study||8
8463500|NCT00699491|20855002|P4|COMPLETED|Overall Study||6
8463501|NCT00699491|20855003|P3|COMPLETED|Overall Study||7
8463502|NCT00699491|20855004|P2|COMPLETED|Overall Study||2
8463503|NCT00699491|20855005|P1|COMPLETED|Overall Study||3
8463504|NCT00699491|20855000|P6|STARTED|Overall Study||22
8463505|NCT00699491|20855001|P5|STARTED|Overall Study||8
8463506|NCT00699491|20855002|P4|STARTED|Overall Study||6
8463507|NCT00699491|20855003|P3|STARTED|Overall Study||7
8463508|NCT00699491|20855004|P2|STARTED|Overall Study||2
8463509|NCT00699491|20855005|P1|STARTED|Overall Study||3
8463510|NCT00699413|20855026|P2|NOT COMPLETED|Overall Study||4
8463511|NCT00699413|20855027|P1|NOT COMPLETED|Overall Study||4
8463512|NCT00699413|20855026|P2|COMPLETED|Overall Study||0
8463513|NCT00699413|20855027|P1|COMPLETED|Overall Study||0
8463514|NCT00699413|20855026|P2|STARTED|Overall Study||4
8463515|NCT00699413|20855027|P1|STARTED|Overall Study||4
8463516|NCT00699400|20855042|P6|NOT COMPLETED|Overall Study||11
8463517|NCT00699400|20855043|P5|NOT COMPLETED|Overall Study||0
8463518|NCT00699400|20855044|P4|NOT COMPLETED|Overall Study||0
8463519|NCT00699400|20855045|P3|NOT COMPLETED|Overall Study||0
8463520|NCT00699400|20855046|P2|NOT COMPLETED|Overall Study||0
8463521|NCT00699400|20855047|P1|NOT COMPLETED|Overall Study||0
8463522|NCT00699400|20855042|P6|COMPLETED|Overall Study||0
8463523|NCT00699400|20855043|P5|COMPLETED|Overall Study||4
8463524|NCT00699400|20855044|P4|COMPLETED|Overall Study||6
8463525|NCT00699400|20855045|P3|COMPLETED|Overall Study||138
8463526|NCT00699400|20855046|P2|COMPLETED|Overall Study||3
8463527|NCT00699400|20855047|P1|COMPLETED|Overall Study||42
8463528|NCT00699400|20855042|P6|STARTED|Overall Study||11
8463529|NCT00699400|20855043|P5|STARTED|Overall Study||4
8463530|NCT00699400|20855044|P4|STARTED|Overall Study||6
8463531|NCT00699400|20855045|P3|STARTED|Overall Study||138
8463532|NCT00699400|20855046|P2|STARTED|Overall Study||3
8463533|NCT00699400|20855047|P1|STARTED|Overall Study||42
8463534|NCT00699374|20855081|P2|NOT COMPLETED|Overall Study||544
8463535|NCT00699374|20855082|P1|NOT COMPLETED|Overall Study||530
8463536|NCT00699374|20855081|P2|COMPLETED|Overall Study||0
8463537|NCT00699374|20855082|P1|COMPLETED|Overall Study||0
8463538|NCT00699374|20855081|P2|Treated|Overall Study||542
8463539|NCT00699374|20855082|P1|Treated|Overall Study||526
8463540|NCT00699374|20855081|P2|STARTED|Overall Study||544
8463541|NCT00699374|20855082|P1|STARTED|Overall Study||530
8463542|NCT00699348|20855094|P1|NOT COMPLETED|Overall Study||90
8463543|NCT00699348|20855094|P1|COMPLETED|Overall Study||261
8463544|NCT00699348|20855094|P1|STARTED|Overall Study||351
8463545|NCT00699335|20855103|P1|NOT COMPLETED|Overall Study||228
8463546|NCT00699335|20855103|P1|COMPLETED|Overall Study||5080
8463547|NCT00699335|20855103|P1|STARTED|Overall Study||5308
8463548|NCT00699283|20855136|P2|NOT COMPLETED|Overall Study||8
8463549|NCT00699283|20855137|P1|NOT COMPLETED|Overall Study||33
8463550|NCT00699283|20855136|P2|COMPLETED|Overall Study||7
8463551|NCT00699283|20855137|P1|COMPLETED|Overall Study||14
8463552|NCT00699283|20855136|P2|STARTED|Overall Study||15
8463553|NCT00699283|20855137|P1|STARTED|Overall Study||47
8463554|NCT00699218|20855142|P1|NOT COMPLETED|Overall Study||0
8463555|NCT00699218|20855142|P1|COMPLETED|Overall Study||15
8463556|NCT00699218|20855142|P1|STARTED|Overall Study||15
8463557|NCT00699192|20855150|P3|NOT COMPLETED|Overall Study||11
8463558|NCT00699192|20855151|P2|NOT COMPLETED|Overall Study||12
8463559|NCT00699192|20855152|P1|NOT COMPLETED|Overall Study||16
8463560|NCT00699192|20855150|P3|COMPLETED|Overall Study||261
8463561|NCT00699192|20855151|P2|COMPLETED|Overall Study||260
8463562|NCT00699192|20855152|P1|COMPLETED|Overall Study||259
8463563|NCT00699192|20855150|P3|STARTED|Overall Study||272
8463564|NCT00699192|20855151|P2|STARTED|Overall Study||272
8463565|NCT00699192|20855152|P1|STARTED|Overall Study||275
8463566|NCT00699153|20855174|P2|NOT COMPLETED|Overall Study||2
8463567|NCT00699153|20855175|P1|NOT COMPLETED|Overall Study||3
8463568|NCT00699153|20855174|P2|COMPLETED|Overall Study||200
8463569|NCT00699153|20855175|P1|COMPLETED|Overall Study||200
8463570|NCT00699153|20855174|P2|STARTED|Overall Study|Intent to treat population|202
8463571|NCT00699153|20855175|P1|STARTED|Overall Study|Intent to treat population|203
8463572|NCT00699140|20855187|P1|NOT COMPLETED|Overall Study||0
8463573|NCT00699140|20855187|P1|COMPLETED|Overall Study||18
8463574|NCT00699140|20855187|P1|STARTED|Overall Study||18
8463575|NCT00699010|20855201|P2|NOT COMPLETED|Overall Study||0
8463576|NCT00699010|20855202|P1|NOT COMPLETED|Overall Study||0
8463577|NCT00699010|20855201|P2|COMPLETED|Overall Study||15
8463578|NCT00699010|20855202|P1|COMPLETED|Overall Study||15
8463579|NCT00699010|20855201|P2|STARTED|Overall Study||15
8463580|NCT00699010|20855202|P1|STARTED|Overall Study||15
8463581|NCT00698997|20855210|P2|NOT COMPLETED|Overall Study||27
8463582|NCT00698997|20855211|P1|NOT COMPLETED|Overall Study||10
8463583|NCT00698997|20855210|P2|COMPLETED|Overall Study|36 - final assessment completed|36
8463584|NCT00698997|20855211|P1|COMPLETED|Overall Study|45 - final participant assessment completed|45
8463585|NCT00698997|20855210|P2|STARTED|Overall Study|1 enrollment|63
8463586|NCT00698997|20855211|P1|STARTED|Overall Study|1 enrollment|55
8463587|NCT00698932|20855225|P2|NOT COMPLETED|Overall Study||36
8463588|NCT00698932|20855226|P1|NOT COMPLETED|Overall Study||22
8463589|NCT00698932|20855225|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
8463590|NCT00698932|20855226|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
8463591|NCT00698932|20855225|P2|STARTED|Overall Study|Randomized and treated|284
8463592|NCT00698932|20855226|P1|STARTED|Overall Study|Randomized and treated|284
8463593|NCT00698867|20855242|P1|NOT COMPLETED|Overall Study||91
8463594|NCT00698867|20855242|P1|COMPLETED|Overall Study||27
8463595|NCT00698867|20855242|P1|Subjects With 4 Year Data|Overall Study||34
8463596|NCT00698867|20855242|P1|Subjects With 3 Year Data|Overall Study||35
8463597|NCT00698867|20855242|P1|Subjects With 2 Year Data|Overall Study||55
8463598|NCT00698867|20855242|P1|Subjects With 1 Year Data|Overall Study||68
8463599|NCT00698867|20855242|P1|STARTED|Overall Study||118
8463600|NCT00698841|20855252|P1|NOT COMPLETED|Overall Study||18
8463601|NCT00698841|20855252|P1|COMPLETED|Overall Study||33
8463602|NCT00698841|20855252|P1|STARTED|Overall Study||51
8463603|NCT00698815|20855266|P3|NOT COMPLETED|Overall Study||10
8463604|NCT00698815|20855267|P2|NOT COMPLETED|Overall Study||14
8463605|NCT00698815|20855268|P1|NOT COMPLETED|Overall Study||10
8463606|NCT00698815|20855266|P3|COMPLETED|Overall Study||31
8463607|NCT00698815|20855267|P2|COMPLETED|Overall Study||33
8463608|NCT00698815|20855268|P1|COMPLETED|Overall Study||32
8463609|NCT00698815|20855266|P3|STARTED|Overall Study||41
8463610|NCT00698815|20855267|P2|STARTED|Overall Study||47
8463611|NCT00698815|20855268|P1|STARTED|Overall Study||42
8463612|NCT00698685|20855285|P1|NOT COMPLETED|Overall Study||2
8463613|NCT00698685|20855285|P1|COMPLETED|Overall Study||12
8463614|NCT00698685|20855285|P1|STARTED|Overall Study||14
8463615|NCT00698646|20855293|P3|NOT COMPLETED|Overall Study||29
8463616|NCT00698646|20855294|P2|NOT COMPLETED|Overall Study||31
8463617|NCT00698646|20855295|P1|NOT COMPLETED|Overall Study||36
8463618|NCT00698646|20855293|P3|COMPLETED|Overall Study||99
8463619|NCT00698646|20855294|P2|COMPLETED|Overall Study||97
8463620|NCT00698646|20855295|P1|COMPLETED|Overall Study||92
8463621|NCT00698646|20855293|P3|STARTED|Overall Study||128
8463622|NCT00698646|20855294|P2|STARTED|Overall Study||128
8463623|NCT00698646|20855295|P1|STARTED|Overall Study||128
8463624|NCT00698581|20855320|P2|NOT COMPLETED|Overall Study||12
8463625|NCT00698581|20855321|P1|NOT COMPLETED|Overall Study||45
8463626|NCT00698581|20855320|P2|COMPLETED|Overall Study||8
8463627|NCT00698581|20855321|P1|COMPLETED|Overall Study||23
8463628|NCT00698581|20855320|P2|STARTED|Overall Study||20
8463629|NCT00698581|20855321|P1|STARTED|Overall Study||68
8463630|NCT00698516|20855332|P1|NOT COMPLETED|Overall Study||5
8463631|NCT00698516|20855332|P1|COMPLETED|Overall Study||45
8463632|NCT00698516|20855332|P1|STARTED|Overall Study||50
8463633|NCT00698451|20855350|P1|NOT COMPLETED|Overall Study||39
8463634|NCT00698451|20855350|P1|COMPLETED|Overall Study||15
8463635|NCT00698451|20855350|P1|STARTED|Overall Study||54
8463636|NCT00698204|20855357|P2|NOT COMPLETED|Overall Study||0
8463637|NCT00698204|20855358|P1|NOT COMPLETED|Overall Study||1
8463638|NCT00698204|20855357|P2|COMPLETED|Overall Study||20
8463639|NCT00698204|20855358|P1|COMPLETED|Overall Study||19
8463640|NCT00698204|20855357|P2|STARTED|Overall Study||20
8463641|NCT00698204|20855358|P1|STARTED|Overall Study||20
8463642|NCT00698139|20855369|P3|NOT COMPLETED|Overall Study||0
8463643|NCT00698139|20855370|P2|NOT COMPLETED|Overall Study||0
8463644|NCT00698139|20855371|P1|NOT COMPLETED|Overall Study||0
8463645|NCT00698139|20855369|P3|COMPLETED|Overall Study||1
8463646|NCT00698139|20855370|P2|COMPLETED|Overall Study||1
8463647|NCT00698139|20855371|P1|COMPLETED|Overall Study||1
8463648|NCT00698139|20855369|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
8463649|NCT00698139|20855370|P2|2nd Visit|Overall Study||1
8463650|NCT00698139|20855371|P1|2nd Visit|Overall Study||1
8463651|NCT00698139|20855369|P3|STARTED|Overall Study||1
8463652|NCT00698139|20855370|P2|STARTED|Overall Study||1
8463653|NCT00698139|20855371|P1|STARTED|Overall Study||1
8463654|NCT00698035|20855387|P2|NOT COMPLETED|Overall Study||2
8463655|NCT00698035|20855388|P1|NOT COMPLETED|Overall Study||4
8463656|NCT00698035|20855387|P2|COMPLETED|Overall Study||34
8463657|NCT00698035|20855388|P1|COMPLETED|Overall Study||35
8463658|NCT00698035|20855387|P2|STARTED|Overall Study||36
8463659|NCT00698035|20855388|P1|STARTED|Overall Study||39
8463660|NCT00698022|20855408|P3|NOT COMPLETED|Overall Study||2
8463661|NCT00698022|20855409|P2|NOT COMPLETED|Overall Study||10
8463662|NCT00698022|20855410|P1|NOT COMPLETED|Overall Study||16
8463663|NCT00698022|20855408|P3|COMPLETED|Overall Study||14
8463664|NCT00698022|20855409|P2|COMPLETED|Overall Study||20
8463665|NCT00698022|20855410|P1|COMPLETED|Overall Study||14
8463666|NCT00698022|20855408|P3|STARTED|Overall Study||16
8463667|NCT00698022|20855409|P2|STARTED|Overall Study||30
8463668|NCT00698022|20855410|P1|STARTED|Overall Study||30
8463669|NCT00698009|20855418|P1|NOT COMPLETED|Overall Study||1
8463670|NCT00698009|20855418|P1|COMPLETED|Overall Study||0
8463671|NCT00698009|20855418|P1|STARTED|Overall Study||1
8463672|NCT00697827|20855424|P2|NOT COMPLETED|Overall Study||1
8463673|NCT00697827|20855425|P1|NOT COMPLETED|Overall Study||2
8463674|NCT00697827|20855424|P2|COMPLETED|Overall Study||15
8463675|NCT00697827|20855425|P1|COMPLETED|Overall Study||26
8463676|NCT00697827|20855424|P2|STARTED|Overall Study||16
8463677|NCT00697827|20855425|P1|STARTED|Overall Study||28
8463678|NCT00697801|20855436|P3|NOT COMPLETED|Overall Study||24
8463679|NCT00697801|20855437|P2|NOT COMPLETED|Overall Study||12
8463680|NCT00697801|20855438|P1|NOT COMPLETED|Overall Study||12
8463681|NCT00697801|20855436|P3|COMPLETED|Overall Study||45
8463682|NCT00697801|20855437|P2|COMPLETED|Overall Study||58
8463683|NCT00697801|20855438|P1|COMPLETED|Overall Study||57
8463684|NCT00697801|20855436|P3|STARTED|Overall Study||69
8463685|NCT00697801|20855437|P2|STARTED|Overall Study||70
8463686|NCT00697801|20855438|P1|STARTED|Overall Study||69
8463687|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463688|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463689|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463690|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463691|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463692|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463693|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463694|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463695|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
8463696|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463697|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463698|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463699|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463700|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463701|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463702|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463703|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
8463704|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463705|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463706|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463707|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463708|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463709|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463710|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463711|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463712|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463713|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463714|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463715|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463716|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463717|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463718|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463719|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463720|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
8463721|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463722|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463723|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463724|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463725|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463726|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463727|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463728|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
8463729|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463730|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463731|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463732|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463733|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463734|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463735|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463736|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463737|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463738|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463739|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463740|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463741|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463742|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463743|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463744|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463745|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
8463746|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463747|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463748|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463749|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463750|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463751|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463752|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463753|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
8463754|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463755|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463756|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463757|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463758|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463759|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463760|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463761|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463762|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
8463763|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463764|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463765|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463766|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463767|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463768|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463769|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463770|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
8463771|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463772|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463773|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463774|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463775|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463776|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463777|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463778|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
8463779|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463780|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463781|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463782|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463783|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463784|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463785|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463786|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463787|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463788|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463789|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463790|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463791|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463792|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463793|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463794|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463795|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
8463796|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463797|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463798|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463799|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463800|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463801|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463802|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463803|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
8463804|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463805|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463806|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463807|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463808|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463809|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463810|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463811|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463812|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463813|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463814|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463815|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463816|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463817|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463818|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463819|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463820|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
8463821|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463822|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463823|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463824|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463825|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463826|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463827|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463828|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
8463829|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463830|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463831|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463832|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463833|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463834|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463835|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463836|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463837|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
8463838|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463839|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463840|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463841|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463842|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463843|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463844|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463845|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
8463846|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463847|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463848|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463849|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463850|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463851|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463852|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463853|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
8463854|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463855|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463856|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463857|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463858|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463859|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463860|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463861|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463862|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463863|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463864|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463865|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463866|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463867|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463868|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463869|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463870|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
8463871|NCT00697788|20855452|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463872|NCT00697788|20855453|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463873|NCT00697788|20855454|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463874|NCT00697788|20855455|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463875|NCT00697788|20855456|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463876|NCT00697788|20855457|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
8463877|NCT00697788|20855458|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
8463878|NCT00697788|20855459|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
8463879|NCT00697697|20855503|P2|NOT COMPLETED|Overall Study||54
8463880|NCT00697697|20855504|P1|NOT COMPLETED|Overall Study||49
8463881|NCT00697697|20855503|P2|COMPLETED|Overall Study||44
8463882|NCT00697697|20855504|P1|COMPLETED|Overall Study||45
8463883|NCT00697697|20855503|P2|STARTED|Overall Study||98
8463884|NCT00697697|20855504|P1|STARTED|Overall Study||94
8463885|NCT00697619|20855514|P2|NOT COMPLETED|Overall Study||8
8463886|NCT00697619|20855515|P1|NOT COMPLETED|Overall Study||6
8463887|NCT00697619|20855514|P2|COMPLETED|Overall Study||22
8463888|NCT00697619|20855515|P1|COMPLETED|Overall Study||24
8463889|NCT00697619|20855514|P2|STARTED|Overall Study||30
8463890|NCT00697619|20855515|P1|STARTED|Overall Study||30
8463891|NCT00697593|20855521|P1|NOT COMPLETED|Overall Study||19
8463892|NCT00697593|20855521|P1|COMPLETED|Overall Study||51
8463893|NCT00697593|20855521|P1|STARTED|Overall Study||70
8463900|NCT00697515|20855565|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
8463901|NCT00697515|20855566|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
8463902|NCT00697515|20855565|P2|COMPLETED|Second Intervention (Crossover Period)||51
8463903|NCT00697515|20855566|P1|COMPLETED|Second Intervention (Crossover Period)||52
8463904|NCT00697515|20855565|P2|STARTED|Second Intervention (Crossover Period)||52
8463905|NCT00697515|20855566|P1|STARTED|Second Intervention (Crossover Period)||53
8463906|NCT00697515|20855565|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
8463907|NCT00697515|20855566|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
8463908|NCT00697515|20855565|P2|COMPLETED|First Intervention (Crossover Period)||52
8463909|NCT00697515|20855566|P1|COMPLETED|First Intervention (Crossover Period)||53
8463910|NCT00697515|20855565|P2|STARTED|First Intervention (Crossover Period)||64
8463911|NCT00697515|20855566|P1|STARTED|First Intervention (Crossover Period)||63
8463912|NCT00697515|20855565|P2|NOT COMPLETED|Dose Optimization Period||0
8463913|NCT00697515|20855566|P1|NOT COMPLETED|Dose Optimization Period||15
8463914|NCT00697515|20855565|P2|COMPLETED|Dose Optimization Period||0
8463915|NCT00697515|20855566|P1|COMPLETED|Dose Optimization Period||127
8463916|NCT00697515|20855565|P2|STARTED|Dose Optimization Period||0
8463917|NCT00697515|20855566|P1|STARTED|Dose Optimization Period||142
8463918|NCT00697463|20855594|P1|NOT COMPLETED|Overall Study||1
8463919|NCT00697463|20855594|P1|COMPLETED|Overall Study||21
8463920|NCT00697463|20855594|P1|STARTED|Overall Study||22
8463921|NCT00697346|20855601|P3|NOT COMPLETED|Overall Study||1
8463922|NCT00697346|20855602|P2|NOT COMPLETED|Overall Study||26
8463923|NCT00697346|20855603|P1|NOT COMPLETED|Overall Study||28
8463924|NCT00697346|20855601|P3|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
8463925|NCT00697346|20855602|P2|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
8463926|NCT00697346|20855603|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
8463927|NCT00697346|20855601|P3|STARTED|Overall Study||2
8463928|NCT00697346|20855602|P2|STARTED|Overall Study||28
8463929|NCT00697346|20855603|P1|STARTED|Overall Study||28
8463930|NCT00697255|20855711|P2|NOT COMPLETED|Stage 1b||2
8463931|NCT00697255|20855712|P1|NOT COMPLETED|Stage 1b||0
8463932|NCT00697255|20855711|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
8463933|NCT00697255|20855712|P1|COMPLETED|Stage 1b||0
8463934|NCT00697255|20855711|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
8463935|NCT00697255|20855712|P1|STARTED|Stage 1b||0
8463936|NCT00697255|20855711|P2|NOT COMPLETED|Stage 1a||0
8463937|NCT00697255|20855712|P1|NOT COMPLETED|Stage 1a||3
8463938|NCT00697255|20855711|P2|COMPLETED|Stage 1a||0
8463939|NCT00697255|20855712|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
8463940|NCT00697255|20855711|P2|STARTED|Stage 1a||0
8463941|NCT00697255|20855712|P1|STARTED|Stage 1a||5
8463942|NCT00697203|20855732|P4|NOT COMPLETED|Overall Study||7
8463943|NCT00697203|20855733|P3|NOT COMPLETED|Overall Study||8
8463944|NCT00697203|20855734|P2|NOT COMPLETED|Overall Study||6
8463945|NCT00697203|20855735|P1|NOT COMPLETED|Overall Study||9
8463946|NCT00697203|20855732|P4|COMPLETED|Overall Study||67
8463947|NCT00697203|20855733|P3|COMPLETED|Overall Study||66
8463948|NCT00697203|20855734|P2|COMPLETED|Overall Study||62
8463949|NCT00697203|20855735|P1|COMPLETED|Overall Study||67
8463950|NCT00697203|20855732|P4|STARTED|Overall Study||74
8463951|NCT00697203|20855733|P3|STARTED|Overall Study||74
8463952|NCT00697203|20855734|P2|STARTED|Overall Study||68
8463953|NCT00697203|20855735|P1|STARTED|Overall Study||76
8463954|NCT00697190|20855765|P2|NOT COMPLETED|Second Intervention||0
8463955|NCT00697190|20855766|P1|NOT COMPLETED|Second Intervention||0
8463956|NCT00697190|20855765|P2|COMPLETED|Second Intervention||20
8463957|NCT00697190|20855766|P1|COMPLETED|Second Intervention||18
8463958|NCT00697190|20855765|P2|STARTED|Second Intervention||20
8463959|NCT00697190|20855766|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
8463960|NCT00697190|20855765|P2|NOT COMPLETED|First Intervention||0
8463961|NCT00697190|20855766|P1|NOT COMPLETED|First Intervention||0
8463962|NCT00697190|20855765|P2|COMPLETED|First Intervention||20
8463963|NCT00697190|20855766|P1|COMPLETED|First Intervention||19
8463964|NCT00697190|20855765|P2|STARTED|First Intervention||20
8463965|NCT00697190|20855766|P1|STARTED|First Intervention||19
8463966|NCT00697112|20855800|P1|NOT COMPLETED|Overall Study||10
8463967|NCT00697112|20855800|P1|COMPLETED|Overall Study||43
8463968|NCT00697112|20855800|P1|Met the Inclusion Criteria|Overall Study||52
8463969|NCT00697112|20855800|P1|STARTED|Overall Study||53
8463970|NCT00697073|20855824|P1|NOT COMPLETED|Overall Study||9
8463971|NCT00697073|20855824|P1|COMPLETED|Overall Study||59
8463972|NCT00697073|20855824|P1|STARTED|Overall Study||68
8463973|NCT00696878|20855828|P1|NOT COMPLETED|Overall Study||504
8463974|NCT00696878|20855828|P1|COMPLETED|Overall Study||178
8463975|NCT00696878|20855828|P1|STARTED|Overall Study||682
8463976|NCT00696800|20855902|P2|NOT COMPLETED|Overall Study||48
8463977|NCT00696800|20855903|P1|NOT COMPLETED|Overall Study||85
8463978|NCT00696800|20855902|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
8463979|NCT00696800|20855903|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
8463980|NCT00696800|20855902|P2|Treated (ITT)|Overall Study|The ITT group|750
8463981|NCT00696800|20855903|P1|Treated (ITT)|Overall Study|The ITT group|756
8463982|NCT00696800|20855902|P2|STARTED|Overall Study||752
8463983|NCT00696800|20855903|P1|STARTED|Overall Study||757
8463984|NCT00696787|20855956|P3|NOT COMPLETED|Overall Study||26
8463985|NCT00696787|20855957|P2|NOT COMPLETED|Overall Study||20
8463986|NCT00696787|20855958|P1|NOT COMPLETED|Overall Study||15
8463987|NCT00696787|20855956|P3|COMPLETED|Overall Study||17
8463988|NCT00696787|20855957|P2|COMPLETED|Overall Study||22
8463989|NCT00696787|20855958|P1|COMPLETED|Overall Study||25
8463990|NCT00696787|20855956|P3|STARTED|Overall Study||43
8463991|NCT00696787|20855957|P2|STARTED|Overall Study||42
8463992|NCT00696787|20855958|P1|STARTED|Overall Study||40
8463993|NCT00696774|20855972|P3|NOT COMPLETED|Period III||0
8463994|NCT00696774|20855973|P2|NOT COMPLETED|Period III||7
8463995|NCT00696774|20855974|P1|NOT COMPLETED|Period III||7
8463996|NCT00696774|20855972|P3|COMPLETED|Period III||0
8463997|NCT00696774|20855973|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
8463998|NCT00696774|20855974|P1|COMPLETED|Period III||106
8463999|NCT00696774|20855972|P3|STARTED|Period III||0
8464000|NCT00696774|20855973|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
8464001|NCT00696774|20855974|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
8464002|NCT00696774|20855972|P3|NOT COMPLETED|Period II||36
8464003|NCT00696774|20855973|P2|NOT COMPLETED|Period II||0
8464004|NCT00696774|20855974|P1|NOT COMPLETED|Period II||0
8464005|NCT00696774|20855972|P3|COMPLETED|Period II||0
8464006|NCT00696774|20855973|P2|COMPLETED|Period II||91
8464007|NCT00696774|20855974|P1|COMPLETED|Period II||115
8464008|NCT00696774|20855972|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
8464009|NCT00696774|20855973|P2|STARTED|Period II||91
8464010|NCT00696774|20855974|P1|STARTED|Period II||115
8464023|NCT00696709|20856034|P5|NOT COMPLETED|Overall Study||3
8464024|NCT00696709|20856035|P4|NOT COMPLETED|Overall Study||5
8464025|NCT00696709|20856036|P3|NOT COMPLETED|Overall Study||1
8464026|NCT00696709|20856037|P2|NOT COMPLETED|Overall Study||3
8464027|NCT00696709|20856038|P1|NOT COMPLETED|Overall Study||3
8464028|NCT00696709|20856034|P5|COMPLETED|Overall Study||62
8464029|NCT00696709|20856035|P4|COMPLETED|Overall Study||59
8464030|NCT00696709|20856036|P3|COMPLETED|Overall Study||32
8464031|NCT00696709|20856037|P2|COMPLETED|Overall Study||60
8464032|NCT00696709|20856038|P1|COMPLETED|Overall Study||62
8464033|NCT00696709|20856034|P5|Vaccination 4 (~Day 90)|Overall Study||63
8464034|NCT00696709|20856035|P4|Vaccination 4 (~Day 90)|Overall Study||59
8464035|NCT00696709|20856036|P3|Vaccination 4 (~Day 90)|Overall Study||32
8464036|NCT00696709|20856037|P2|Vaccination 4 (~Day 90)|Overall Study||60
8464037|NCT00696709|20856038|P1|Vaccination 4 (~Day 90)|Overall Study||62
8464038|NCT00696709|20856034|P5|Vaccination 3 (~Day 60)|Overall Study||63
8464039|NCT00696709|20856035|P4|Vaccination 3 (~Day 60)|Overall Study||59
8464040|NCT00696709|20856036|P3|Vaccination 3 (~Day 60)|Overall Study||32
8464041|NCT00696709|20856037|P2|Vaccination 3 (~Day 60)|Overall Study||60
8464042|NCT00696709|20856038|P1|Vaccination 3 (~Day 60)|Overall Study||64
8464043|NCT00696709|20856034|P5|Vaccination 2 (~Day 30)|Overall Study||64
8464044|NCT00696709|20856035|P4|Vaccination 2 (~Day 30)|Overall Study||61
8464045|NCT00696709|20856036|P3|Vaccination 2 (~Day 30)|Overall Study||32
8464046|NCT00696709|20856037|P2|Vaccination 2 (~Day 30)|Overall Study||60
8464047|NCT00696709|20856038|P1|Vaccination 2 (~Day 30)|Overall Study||64
8464048|NCT00696709|20856034|P5|Vaccination 1 (Day 1)|Overall Study||65
8464049|NCT00696709|20856035|P4|Vaccination 1 (Day 1)|Overall Study||64
8464050|NCT00696709|20856036|P3|Vaccination 1 (Day 1)|Overall Study||32
8464051|NCT00696709|20856037|P2|Vaccination 1 (Day 1)|Overall Study||63
8464052|NCT00696709|20856038|P1|Vaccination 1 (Day 1)|Overall Study||65
8464053|NCT00696709|20856034|P5|STARTED|Overall Study||65
8464054|NCT00696709|20856035|P4|STARTED|Overall Study||64
8464055|NCT00696709|20856036|P3|STARTED|Overall Study||33
8464056|NCT00696709|20856037|P2|STARTED|Overall Study||63
8464057|NCT00696709|20856038|P1|STARTED|Overall Study||65
8464058|NCT00696696|20856074|P1|NOT COMPLETED|Overall Study||18
8464059|NCT00696696|20856074|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
8464060|NCT00696696|20856074|P1|STARTED|Overall Study||44
8464061|NCT00696657|20856089|P9|NOT COMPLETED|Overall Study||9
8464062|NCT00696657|20856090|P8|NOT COMPLETED|Overall Study||3
8464063|NCT00696657|20856091|P7|NOT COMPLETED|Overall Study||15
8464064|NCT00696657|20856092|P6|NOT COMPLETED|Overall Study||12
8464065|NCT00696657|20856093|P5|NOT COMPLETED|Overall Study||10
8464066|NCT00696657|20856094|P4|NOT COMPLETED|Overall Study||11
8464067|NCT00696657|20856095|P3|NOT COMPLETED|Overall Study||8
8464068|NCT00696657|20856096|P2|NOT COMPLETED|Overall Study||5
8464069|NCT00696657|20856097|P1|NOT COMPLETED|Overall Study||1
8464070|NCT00696657|20856089|P9|COMPLETED|Overall Study||41
8464071|NCT00696657|20856090|P8|COMPLETED|Overall Study||42
8464072|NCT00696657|20856091|P7|COMPLETED|Overall Study||30
8464073|NCT00696657|20856092|P6|COMPLETED|Overall Study||33
8464074|NCT00696657|20856093|P5|COMPLETED|Overall Study||34
8464075|NCT00696657|20856094|P4|COMPLETED|Overall Study||38
8464076|NCT00696657|20856095|P3|COMPLETED|Overall Study||36
8464077|NCT00696657|20856096|P2|COMPLETED|Overall Study||42
8464078|NCT00696657|20856097|P1|COMPLETED|Overall Study||45
8464079|NCT00696657|20856089|P9|EXPOSED|Overall Study||50
8464080|NCT00696657|20856090|P8|EXPOSED|Overall Study||45
8464081|NCT00696657|20856091|P7|EXPOSED|Overall Study||45
8464082|NCT00696657|20856092|P6|EXPOSED|Overall Study||43
8464083|NCT00696657|20856093|P5|EXPOSED|Overall Study||44
8464084|NCT00696657|20856094|P4|EXPOSED|Overall Study||48
8464085|NCT00696657|20856095|P3|EXPOSED|Overall Study||43
8464086|NCT00696657|20856096|P2|EXPOSED|Overall Study||47
8464087|NCT00696657|20856097|P1|EXPOSED|Overall Study||46
8464088|NCT00696657|20856089|P9|STARTED|Overall Study||50
8464089|NCT00696657|20856090|P8|STARTED|Overall Study||45
8464090|NCT00696657|20856091|P7|STARTED|Overall Study||45
8464091|NCT00696657|20856092|P6|STARTED|Overall Study||45
8464092|NCT00696657|20856093|P5|STARTED|Overall Study||44
8464093|NCT00696657|20856094|P4|STARTED|Overall Study||49
8464094|NCT00696657|20856095|P3|STARTED|Overall Study||44
8464095|NCT00696657|20856096|P2|STARTED|Overall Study||47
8464096|NCT00696657|20856097|P1|STARTED|Overall Study||46
8464097|NCT00696618|20856424|P3|NOT COMPLETED|Overall Study||0
8464098|NCT00696618|20856425|P2|NOT COMPLETED|Overall Study||0
8464099|NCT00696618|20856426|P1|NOT COMPLETED|Overall Study||0
8464100|NCT00696618|20856424|P3|COMPLETED|Overall Study||3
8464101|NCT00696618|20856425|P2|COMPLETED|Overall Study||3
8464102|NCT00696618|20856426|P1|COMPLETED|Overall Study||3
8464103|NCT00696618|20856424|P3|STARTED|Overall Study||3
8464104|NCT00696618|20856425|P2|STARTED|Overall Study||3
8464105|NCT00696618|20856426|P1|STARTED|Overall Study||3
8464106|NCT00696488|20856440|P1|NOT COMPLETED|Overall Study||0
8464107|NCT00696488|20856440|P1|COMPLETED|Overall Study||20
8464108|NCT00696488|20856440|P1|STARTED|Overall Study||20
8464109|NCT00696449|20856448|P4|NOT COMPLETED|Overall Study||3
8464110|NCT00696449|20856449|P3|NOT COMPLETED|Overall Study||1
8464111|NCT00696449|20856450|P2|NOT COMPLETED|Overall Study||6
8464112|NCT00696449|20856451|P1|NOT COMPLETED|Overall Study||3
8464113|NCT00696449|20856448|P4|COMPLETED|Overall Study||13
8464114|NCT00696449|20856449|P3|COMPLETED|Overall Study||14
8464115|NCT00696449|20856450|P2|COMPLETED|Overall Study||9
8464116|NCT00696449|20856451|P1|COMPLETED|Overall Study||12
8464117|NCT00696449|20856448|P4|STARTED|Overall Study||16
8464118|NCT00696449|20856449|P3|STARTED|Overall Study||15
8464119|NCT00696449|20856450|P2|STARTED|Overall Study||15
8464120|NCT00696449|20856451|P1|STARTED|Overall Study||15
8464121|NCT00696436|20856466|P5|NOT COMPLETED|Overall Study||13
8464122|NCT00696436|20856467|P4|NOT COMPLETED|Overall Study||22
8464123|NCT00696436|20856468|P3|NOT COMPLETED|Overall Study||28
8464124|NCT00696436|20856469|P2|NOT COMPLETED|Overall Study||30
8464125|NCT00696436|20856470|P1|NOT COMPLETED|Overall Study||23
8464126|NCT00696436|20856466|P5|COMPLETED|Overall Study||141
8464127|NCT00696436|20856467|P4|COMPLETED|Overall Study||268
8464128|NCT00696436|20856468|P3|COMPLETED|Overall Study||254
8464129|NCT00696436|20856469|P2|COMPLETED|Overall Study||255
8464130|NCT00696436|20856470|P1|COMPLETED|Overall Study||257
8464131|NCT00696436|20856466|P5|STARTED|Overall Study|Randomized participants only.|154
8464132|NCT00696436|20856467|P4|STARTED|Overall Study|Randomized participants only.|290
8464133|NCT00696436|20856468|P3|STARTED|Overall Study|Randomized participants only.|282
8464134|NCT00696436|20856469|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
8464135|NCT00696436|20856470|P1|STARTED|Overall Study|Randomized participants only.|280
8464136|NCT00696423|20856554|P2|NOT COMPLETED|Overall Study||5
8464137|NCT00696423|20856555|P1|NOT COMPLETED|Overall Study||0
8464138|NCT00696423|20856554|P2|COMPLETED|Overall Study||218
8464139|NCT00696423|20856555|P1|COMPLETED|Overall Study||244
8464140|NCT00696423|20856554|P2|STARTED|Overall Study||223
8464141|NCT00696423|20856555|P1|STARTED|Overall Study||244
8464142|NCT00696410|20856587|P2|NOT COMPLETED|Overall Study||0
8464143|NCT00696410|20856588|P1|NOT COMPLETED|Overall Study||13
8464144|NCT00696410|20856587|P2|COMPLETED|Overall Study||10
8464145|NCT00696410|20856588|P1|COMPLETED|Overall Study||25
8464146|NCT00696410|20856587|P2|STARTED|Overall Study||10
8464147|NCT00696410|20856588|P1|STARTED|Overall Study||38
8464148|NCT00696384|20856602|P3|NOT COMPLETED|Double Blind Phase||6
8464149|NCT00696384|20856603|P2|NOT COMPLETED|Double Blind Phase||11
8464150|NCT00696384|20856604|P1|NOT COMPLETED|Double Blind Phase||0
8464151|NCT00696384|20856602|P3|COMPLETED|Double Blind Phase||145
8464152|NCT00696384|20856603|P2|COMPLETED|Double Blind Phase||137
8464153|NCT00696384|20856604|P1|COMPLETED|Double Blind Phase||0
8464154|NCT00696384|20856602|P3|STARTED|Double Blind Phase||151
8464155|NCT00696384|20856603|P2|STARTED|Double Blind Phase||148
8464156|NCT00696384|20856604|P1|STARTED|Double Blind Phase||0
8464157|NCT00696384|20856602|P3|NOT COMPLETED|Open Label Phase||0
8464158|NCT00696384|20856603|P2|NOT COMPLETED|Open Label Phase||0
8464159|NCT00696384|20856604|P1|NOT COMPLETED|Open Label Phase||119
8464160|NCT00696384|20856602|P3|COMPLETED|Open Label Phase||0
8464161|NCT00696384|20856603|P2|COMPLETED|Open Label Phase||0
8464162|NCT00696384|20856604|P1|COMPLETED|Open Label Phase||299
8464163|NCT00696384|20856602|P3|STARTED|Open Label Phase||0
8464164|NCT00696384|20856603|P2|STARTED|Open Label Phase||0
8464165|NCT00696384|20856604|P1|STARTED|Open Label Phase||418
8464166|NCT00696293|20856618|P1|NOT COMPLETED|Overall Study||2
8464167|NCT00696293|20856618|P1|COMPLETED|Overall Study||28
8464168|NCT00696293|20856618|P1|STARTED|Overall Study||30
8464169|NCT00696241|20856628|P5|NOT COMPLETED|Overall Study||12
8464170|NCT00696241|20856629|P4|NOT COMPLETED|Overall Study||14
8464171|NCT00696241|20856630|P3|NOT COMPLETED|Overall Study||24
8464172|NCT00696241|20856631|P2|NOT COMPLETED|Overall Study||22
8464173|NCT00696241|20856632|P1|NOT COMPLETED|Overall Study||24
8464174|NCT00696241|20856628|P5|COMPLETED|Overall Study||130
8464175|NCT00696241|20856629|P4|COMPLETED|Overall Study||268
8464176|NCT00696241|20856630|P3|COMPLETED|Overall Study||261
8464177|NCT00696241|20856631|P2|COMPLETED|Overall Study||261
8464178|NCT00696241|20856632|P1|COMPLETED|Overall Study||259
8464179|NCT00696241|20856628|P5|STARTED|Overall Study||142
8464180|NCT00696241|20856629|P4|STARTED|Overall Study||282
8464181|NCT00696241|20856630|P3|STARTED|Overall Study||285
8464182|NCT00696241|20856631|P2|STARTED|Overall Study||283
8464183|NCT00696241|20856632|P1|STARTED|Overall Study||283
8464184|NCT00696137|20856714|P1|NOT COMPLETED|Overall Study||2
8464185|NCT00696137|20856714|P1|COMPLETED|Overall Study||3
8464186|NCT00696137|20856714|P1|STARTED|Overall Study||5
8464187|NCT00696072|20856720|P2|NOT COMPLETED|Overall Study||63
8464188|NCT00696072|20856721|P1|NOT COMPLETED|Overall Study||57
8464189|NCT00696072|20856720|P2|COMPLETED|Overall Study||0
8464190|NCT00696072|20856721|P1|COMPLETED|Overall Study||0
8464191|NCT00696072|20856720|P2|STARTED|Overall Study||63
8464192|NCT00696072|20856721|P1|STARTED|Overall Study||57
8464193|NCT00696020|20856742|P4|NOT COMPLETED|Overall Study||4
8464194|NCT00696020|20856743|P3|NOT COMPLETED|Overall Study||3
8464195|NCT00696020|20856744|P2|NOT COMPLETED|Overall Study||2
8464196|NCT00696020|20856745|P1|NOT COMPLETED|Overall Study||4
8464197|NCT00696020|20856742|P4|COMPLETED|Overall Study||84
8464198|NCT00696020|20856743|P3|COMPLETED|Overall Study||90
8464199|NCT00696020|20856744|P2|COMPLETED|Overall Study||87
8464200|NCT00696020|20856745|P1|COMPLETED|Overall Study||86
8464201|NCT00696020|20856742|P4|STARTED|Overall Study||88
8464202|NCT00696020|20856743|P3|STARTED|Overall Study||93
8464203|NCT00696020|20856744|P2|STARTED|Overall Study||89
8464204|NCT00696020|20856745|P1|STARTED|Overall Study||90
8464205|NCT00695955|20856853|P1|NOT COMPLETED|Cohort 2||104
8464206|NCT00695955|20856853|P1|COMPLETED|Cohort 2||203
8464207|NCT00695955|20856853|P1|STARTED|Cohort 2||307
8464208|NCT00695955|20856853|P1|NOT COMPLETED|Cohort 1||102
8464209|NCT00695955|20856853|P1|COMPLETED|Cohort 1||260
8464210|NCT00695955|20856853|P1|STARTED|Cohort 1||362
8464211|NCT00695903|20856865|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
8464212|NCT00695903|20856866|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
8464213|NCT00695903|20856865|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
8464214|NCT00695903|20856866|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
8464215|NCT00695903|20856865|P2|STARTED|Had Test of Cure (TOC) Assessment||4
8464216|NCT00695903|20856866|P1|STARTED|Had Test of Cure (TOC) Assessment||7
8464217|NCT00695903|20856865|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
8464218|NCT00695903|20856866|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
8464219|NCT00695903|20856865|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
8464220|NCT00695903|20856866|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
8464221|NCT00695903|20856865|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
8464222|NCT00695903|20856866|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
8464223|NCT00695903|20856865|P2|STARTED|Had End of Therapy (EOT) Assessment||19
8464224|NCT00695903|20856866|P1|STARTED|Had End of Therapy (EOT) Assessment||19
8464225|NCT00695864|20856878|P1|NOT COMPLETED|Ondansetron||5
8464226|NCT00695864|20856878|P1|COMPLETED|Ondansetron||9
8464227|NCT00695864|20856878|P1|STARTED|Ondansetron||14
8464228|NCT00695864|20856878|P1|NOT COMPLETED|Placebo||5
8464229|NCT00695864|20856878|P1|COMPLETED|Placebo||9
8464230|NCT00695864|20856878|P1|STARTED|Placebo||14
8464231|NCT00695669|20856888|P4|NOT COMPLETED|Overall Study||4
8464232|NCT00695669|20856889|P3|NOT COMPLETED|Overall Study||3
8464233|NCT00695669|20856890|P2|NOT COMPLETED|Overall Study||4
8464234|NCT00695669|20856891|P1|NOT COMPLETED|Overall Study||4
8464235|NCT00695669|20856888|P4|COMPLETED|Overall Study||74
8464236|NCT00695669|20856889|P3|COMPLETED|Overall Study||75
8464237|NCT00695669|20856890|P2|COMPLETED|Overall Study||74
8464238|NCT00695669|20856891|P1|COMPLETED|Overall Study||74
8464239|NCT00695669|20856888|P4|STARTED|Overall Study||78
8464240|NCT00695669|20856889|P3|STARTED|Overall Study||78
8464241|NCT00695669|20856890|P2|STARTED|Overall Study||78
8464242|NCT00695669|20856891|P1|STARTED|Overall Study||78
8464243|NCT00695578|20856967|P2|NOT COMPLETED|Overall Study||0
8464244|NCT00695578|20856968|P1|NOT COMPLETED|Overall Study||0
8464245|NCT00695578|20856967|P2|COMPLETED|Overall Study||10
8464246|NCT00695578|20856968|P1|COMPLETED|Overall Study||10
8464247|NCT00695578|20856967|P2|STARTED|Overall Study||10
8464248|NCT00695578|20856968|P1|STARTED|Overall Study||10
8464249|NCT00695565|20856976|P2|NOT COMPLETED|Overall Study||9
8464250|NCT00695565|20856977|P1|NOT COMPLETED|Overall Study||13
8464251|NCT00695565|20856976|P2|COMPLETED|Overall Study||81
8464252|NCT00695565|20856977|P1|COMPLETED|Overall Study||77
8464253|NCT00695565|20856976|P2|STARTED|Overall Study||90
8464254|NCT00695565|20856977|P1|STARTED|Overall Study||90
8464255|NCT00695500|20857011|P2|NOT COMPLETED|Overall Study||5
8464256|NCT00695500|20857012|P1|NOT COMPLETED|Overall Study||3
8464257|NCT00695500|20857011|P2|COMPLETED|Overall Study||17
8464258|NCT00695500|20857012|P1|COMPLETED|Overall Study||21
8464259|NCT00695500|20857011|P2|STARTED|Overall Study||22
8464260|NCT00695500|20857012|P1|STARTED|Overall Study||24
8464261|NCT00695435|20857022|P3|NOT COMPLETED|Overall Study||0
8464262|NCT00695435|20857023|P2|NOT COMPLETED|Overall Study||0
8464263|NCT00695435|20857024|P1|NOT COMPLETED|Overall Study||0
8464264|NCT00695435|20857022|P3|COMPLETED|Overall Study||7
8464265|NCT00695435|20857023|P2|COMPLETED|Overall Study||7
8464266|NCT00695435|20857024|P1|COMPLETED|Overall Study||7
8464267|NCT00695435|20857022|P3|STARTED|Overall Study||7
8464268|NCT00695435|20857023|P2|STARTED|Overall Study||7
8464269|NCT00695435|20857024|P1|STARTED|Overall Study||7
8464270|NCT00695409|20857035|P1|NOT COMPLETED|Overall Study||0
8464271|NCT00695409|20857035|P1|COMPLETED|Overall Study||122
8464272|NCT00695409|20857035|P1|STARTED|Overall Study||122
8464273|NCT00695396|20857050|P3|NOT COMPLETED|Overall Study||8
8464274|NCT00695396|20857051|P2|NOT COMPLETED|Overall Study||8
8464275|NCT00695396|20857052|P1|NOT COMPLETED|Overall Study||7
8464276|NCT00695396|20857050|P3|COMPLETED|Overall Study||1
8464277|NCT00695396|20857051|P2|COMPLETED|Overall Study||0
8464278|NCT00695396|20857052|P1|COMPLETED|Overall Study||1
8464279|NCT00695396|20857050|P3|STARTED|Overall Study||9
8464280|NCT00695396|20857051|P2|STARTED|Overall Study||8
8464281|NCT00695396|20857052|P1|STARTED|Overall Study||8
8464282|NCT00695318|20857068|P2|NOT COMPLETED|Overall Study||1
8464283|NCT00695318|20857069|P1|NOT COMPLETED|Overall Study||5
8464284|NCT00695318|20857068|P2|COMPLETED|Overall Study||6
8464285|NCT00695318|20857069|P1|COMPLETED|Overall Study||5
8464286|NCT00695318|20857068|P2|STARTED|Overall Study||7
8464287|NCT00695318|20857069|P1|STARTED|Overall Study||10
8464288|NCT00695292|20857080|P1|NOT COMPLETED|Overall Study||0
8464289|NCT00695292|20857080|P1|COMPLETED|Overall Study||37
8464290|NCT00695292|20857080|P1|STARTED|Overall Study||37
8464291|NCT00695188|20857087|P2|NOT COMPLETED|Overall Study||0
8464292|NCT00695188|20857088|P1|NOT COMPLETED|Overall Study||0
8464293|NCT00695188|20857087|P2|COMPLETED|Overall Study||9
8464294|NCT00695188|20857088|P1|COMPLETED|Overall Study||10
8464295|NCT00695188|20857087|P2|STARTED|Overall Study||9
8464296|NCT00695188|20857088|P1|STARTED|Overall Study||10
8464297|NCT00695136|20857094|P1|NOT COMPLETED|Overall Study||2
8464298|NCT00695136|20857094|P1|COMPLETED|Overall Study||5
8464299|NCT00695136|20857094|P1|STARTED|Overall Study|7|7
8464300|NCT00695097|20857100|P2|NOT COMPLETED|Overall Study||0
8464301|NCT00695097|20857101|P1|NOT COMPLETED|Overall Study||1
8464302|NCT00695097|20857100|P2|COMPLETED|Overall Study||5
8464303|NCT00695097|20857101|P1|COMPLETED|Overall Study||9
8464304|NCT00695097|20857100|P2|STARTED|Overall Study||5
8464305|NCT00695097|20857101|P1|STARTED|Overall Study||10
8464306|NCT00695019|20857110|P3|NOT COMPLETED|Overall Study||10
8464307|NCT00695019|20857111|P2|NOT COMPLETED|Overall Study||14
8464308|NCT00695019|20857112|P1|NOT COMPLETED|Overall Study||13
8464309|NCT00695019|20857110|P3|COMPLETED|Overall Study||47
8464310|NCT00695019|20857111|P2|COMPLETED|Overall Study||39
8464311|NCT00695019|20857112|P1|COMPLETED|Overall Study||46
8464312|NCT00695019|20857110|P3|STARTED|Overall Study||57
8464313|NCT00695019|20857111|P2|STARTED|Overall Study||53
8464314|NCT00695019|20857112|P1|STARTED|Overall Study||59
8464315|NCT00694707|20857146|P5|NOT COMPLETED|Overall Study||40
8464316|NCT00694707|20857147|P4|NOT COMPLETED|Overall Study||50
8464317|NCT00694707|20857148|P3|NOT COMPLETED|Overall Study||51
8464318|NCT00694707|20857149|P2|NOT COMPLETED|Overall Study||55
8464319|NCT00694707|20857150|P1|NOT COMPLETED|Overall Study||72
8464320|NCT00694707|20857146|P5|COMPLETED|Overall Study||101
8464321|NCT00694707|20857147|P4|COMPLETED|Overall Study||98
8464322|NCT00694707|20857148|P3|COMPLETED|Overall Study||96
8464323|NCT00694707|20857149|P2|COMPLETED|Overall Study||90
8464324|NCT00694707|20857150|P1|COMPLETED|Overall Study||79
8464325|NCT00694707|20857146|P5|STARTED|Overall Study||141
8464326|NCT00694707|20857147|P4|STARTED|Overall Study||148
8464327|NCT00694707|20857148|P3|STARTED|Overall Study||147
8464328|NCT00694707|20857149|P2|STARTED|Overall Study||145
8464329|NCT00694707|20857150|P1|STARTED|Overall Study||151
8464330|NCT00694603|20857167|P1|NOT COMPLETED|Overall Study||0
8464331|NCT00694603|20857167|P1|COMPLETED|Overall Study||18
8464332|NCT00694603|20857167|P1|STARTED|Overall Study||18
8464333|NCT00694564|20857172|P1|NOT COMPLETED|Overall Study||2
8464334|NCT00694564|20857172|P1|COMPLETED|Overall Study||6
8464335|NCT00694564|20857172|P1|STARTED|Overall Study||8
8464336|NCT00694551|20857179|P3|NOT COMPLETED|Overall Study||1
8464337|NCT00694551|20857180|P2|NOT COMPLETED|Overall Study||0
8464338|NCT00694551|20857181|P1|NOT COMPLETED|Overall Study||1
8464339|NCT00694551|20857179|P3|COMPLETED|Overall Study||8
8464340|NCT00694551|20857180|P2|COMPLETED|Overall Study||10
8464341|NCT00694551|20857181|P1|COMPLETED|Overall Study||9
8464342|NCT00694551|20857179|P3|STARTED|Overall Study||9
8464343|NCT00694551|20857180|P2|STARTED|Overall Study||10
8464344|NCT00694551|20857181|P1|STARTED|Overall Study||10
8464345|NCT00694473|20857195|P1|NOT COMPLETED|Overall Study||7
8464346|NCT00694473|20857195|P1|COMPLETED|Overall Study|Dec 2010|69
8464347|NCT00694473|20857195|P1|STARTED|Overall Study|Aug 2008|76
8464348|NCT00694369|20857210|P5|NOT COMPLETED|Overall Study||6
8464349|NCT00694369|20857211|P4|NOT COMPLETED|Overall Study||3
8464350|NCT00694369|20857212|P3|NOT COMPLETED|Overall Study||2
8464351|NCT00694369|20857213|P2|NOT COMPLETED|Overall Study||3
8464352|NCT00694369|20857214|P1|NOT COMPLETED|Overall Study||1
8464353|NCT00694369|20857210|P5|COMPLETED|Overall Study||56
8464354|NCT00694369|20857211|P4|COMPLETED|Overall Study||189
8464355|NCT00694369|20857212|P3|COMPLETED|Overall Study||95
8464356|NCT00694369|20857213|P2|COMPLETED|Overall Study||188
8464357|NCT00694369|20857214|P1|COMPLETED|Overall Study||45
8464358|NCT00694369|20857210|P5|STARTED|Overall Study||62
8464359|NCT00694369|20857211|P4|STARTED|Overall Study||192
8464360|NCT00694369|20857212|P3|STARTED|Overall Study||97
8464361|NCT00694369|20857213|P2|STARTED|Overall Study||191
8464362|NCT00694369|20857214|P1|STARTED|Overall Study||46
8464363|NCT00694356|20857234|P3|NOT COMPLETED|Overall Study||6
8464364|NCT00694356|20857235|P2|NOT COMPLETED|Overall Study||6
8464365|NCT00694356|20857236|P1|NOT COMPLETED|Overall Study||3
8464366|NCT00694356|20857234|P3|COMPLETED|Overall Study||0
8464367|NCT00694356|20857235|P2|COMPLETED|Overall Study||0
8464368|NCT00694356|20857236|P1|COMPLETED|Overall Study||0
8464369|NCT00694356|20857234|P3|STARTED|Overall Study||6
8464370|NCT00694356|20857235|P2|STARTED|Overall Study||6
8464371|NCT00694356|20857236|P1|STARTED|Overall Study||3
8464372|NCT00694304|20857271|P1|NOT COMPLETED|Overall Study||207
8464373|NCT00694304|20857271|P1|COMPLETED|Overall Study||328
8464374|NCT00694304|20857271|P1|STARTED|Overall Study||535
8464375|NCT00694161|20857284|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
8464376|NCT00694161|20857284|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
8464377|NCT00694161|20857284|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
8464378|NCT00694161|20857284|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
8464379|NCT00694161|20857284|P1|COMPLETED|Part 1 (up to Week 6)||35
8464380|NCT00694161|20857284|P1|STARTED|Part 1 (up to Week 6)||35
8464381|NCT00694122|20857323|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
8464382|NCT00694122|20857324|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
8464383|NCT00694122|20857323|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
8464384|NCT00694122|20857324|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
8464385|NCT00694122|20857323|P2|STARTED|Second Intervention (3-4 Weeks)||5
8464386|NCT00694122|20857324|P1|STARTED|Second Intervention (3-4 Weeks)||10
8464387|NCT00694122|20857323|P2|NOT COMPLETED|Washout (1 Day)||0
8464388|NCT00694122|20857324|P1|NOT COMPLETED|Washout (1 Day)||0
8464389|NCT00694122|20857323|P2|COMPLETED|Washout (1 Day)||5
8464390|NCT00694122|20857324|P1|COMPLETED|Washout (1 Day)||10
8464391|NCT00694122|20857323|P2|STARTED|Washout (1 Day)||5
8464392|NCT00694122|20857324|P1|STARTED|Washout (1 Day)||10
8464393|NCT00694122|20857323|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
8464394|NCT00694122|20857324|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
8464395|NCT00694122|20857323|P2|COMPLETED|First Intervention (3-4 Weeks)||5
8464396|NCT00694122|20857324|P1|COMPLETED|First Intervention (3-4 Weeks)||10
8464397|NCT00694122|20857323|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
8464398|NCT00694122|20857324|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
8464399|NCT00694109|20857340|P1|NOT COMPLETED|Overall Study||117
8464400|NCT00694109|20857340|P1|COMPLETED|Overall Study||25
8464401|NCT00694109|20857340|P1|Completed Consented Length of Treatment|Overall Study||60
8464402|NCT00694109|20857340|P1|Consented 2 Years Additional Treatment|Overall Study||42
8464403|NCT00694109|20857340|P1|Treated|Overall Study||141
8464404|NCT00694109|20857340|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
8464405|NCT00694096|20857364|P1|NOT COMPLETED|Overall Study||5
8464406|NCT00694096|20857364|P1|COMPLETED|Overall Study||20
8464407|NCT00694096|20857364|P1|STARTED|Overall Study||25
8464408|NCT00694070|20857370|P1|NOT COMPLETED|Overall Study||0
8464409|NCT00694070|20857370|P1|COMPLETED|Overall Study||51
8464410|NCT00694070|20857370|P1|STARTED|Overall Study||51
8464411|NCT00694018|20857378|P2|NOT COMPLETED|Overall Study||9
8464412|NCT00694018|20857379|P1|NOT COMPLETED|Overall Study||13
8464413|NCT00694018|20857378|P2|COMPLETED|Overall Study||102
8464414|NCT00694018|20857379|P1|COMPLETED|Overall Study||105
8464415|NCT00694018|20857378|P2|6 Months|Overall Study||101
8464416|NCT00694018|20857379|P1|6 Months|Overall Study||106
8464417|NCT00694018|20857378|P2|STARTED|Overall Study||111
8464418|NCT00694018|20857379|P1|STARTED|Overall Study||118
8464419|NCT00693992|20857387|P2|NOT COMPLETED|Overall Study||0
8464420|NCT00693992|20857388|P1|NOT COMPLETED|Overall Study||0
8464421|NCT00693992|20857387|P2|COMPLETED|Overall Study||104
8464422|NCT00693992|20857388|P1|COMPLETED|Overall Study||106
8464423|NCT00693992|20857387|P2|STARTED|Overall Study||104
8464424|NCT00693992|20857388|P1|STARTED|Overall Study||106
8464425|NCT00693784|20857404|P1|NOT COMPLETED|Overall Study||4
8464426|NCT00693784|20857404|P1|COMPLETED|Overall Study||11
8464427|NCT00693784|20857404|P1|104-week Extended Follow-up|Overall Study||11
8464428|NCT00693784|20857404|P1|52-week Extended Follow-up|Overall Study||13
8464429|NCT00693784|20857404|P1|26-Week Primary Endpoint|Overall Study||15
8464430|NCT00693784|20857404|P1|STARTED|Overall Study||15
8464431|NCT00693719|20857410|P1|NOT COMPLETED|Overall Study||0
8464432|NCT00693719|20857410|P1|COMPLETED|Overall Study||31
8464433|NCT00693719|20857410|P1|STARTED|Overall Study||31
8464434|NCT00693706|20857417|P2|NOT COMPLETED|Overall Study||1
8464435|NCT00693706|20857418|P1|NOT COMPLETED|Overall Study||0
8464436|NCT00693706|20857417|P2|COMPLETED|Overall Study||98
8464437|NCT00693706|20857418|P1|COMPLETED|Overall Study||101
8464438|NCT00693706|20857417|P2|STARTED|Overall Study||99
8464439|NCT00693706|20857418|P1|STARTED|Overall Study||101
8464440|NCT00693693|20857445|P3|NOT COMPLETED|Overall Study||2
8464441|NCT00693693|20857446|P2|NOT COMPLETED|Overall Study||1
8464442|NCT00693693|20857447|P1|NOT COMPLETED|Overall Study||1
8464443|NCT00693693|20857445|P3|COMPLETED|Overall Study||7
8464444|NCT00693693|20857446|P2|COMPLETED|Overall Study||8
8464445|NCT00693693|20857447|P1|COMPLETED|Overall Study||6
8464446|NCT00693693|20857445|P3|STARTED|Overall Study||9
8464447|NCT00693693|20857446|P2|STARTED|Overall Study||9
8464448|NCT00693693|20857447|P1|STARTED|Overall Study||7
8464449|NCT00693654|20857457|P2|NOT COMPLETED|Overall Study||0
8464450|NCT00693654|20857458|P1|NOT COMPLETED|Overall Study||0
8464451|NCT00693654|20857457|P2|COMPLETED|Overall Study||14
8464452|NCT00693654|20857458|P1|COMPLETED|Overall Study||14
8464453|NCT00693654|20857457|P2|STARTED|Overall Study||14
8464454|NCT00693654|20857458|P1|STARTED|Overall Study||14
8464455|NCT00693628|20857468|P2|NOT COMPLETED|Overall Study||0
8464456|NCT00693628|20857469|P1|NOT COMPLETED|Overall Study||0
8464457|NCT00693628|20857468|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
8464458|NCT00693628|20857469|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
8464459|NCT00693628|20857468|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
8464460|NCT00693628|20857469|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
8464461|NCT00693498|20857477|P2|NOT COMPLETED|Overall Study||0
8464462|NCT00693498|20857478|P1|NOT COMPLETED|Overall Study||0
8464463|NCT00693498|20857477|P2|COMPLETED|Overall Study||81
8464464|NCT00693498|20857478|P1|COMPLETED|Overall Study||81
8464465|NCT00693498|20857477|P2|STARTED|Overall Study||81
8464466|NCT00693498|20857478|P1|STARTED|Overall Study||81
8464467|NCT00693485|20857489|P3|NOT COMPLETED|Overall Study||0
8464468|NCT00693485|20857490|P2|NOT COMPLETED|Overall Study||2
8464469|NCT00693485|20857491|P1|NOT COMPLETED|Overall Study||0
8464470|NCT00693485|20857489|P3|COMPLETED|Overall Study||24
8464471|NCT00693485|20857490|P2|COMPLETED|Overall Study||19
8464472|NCT00693485|20857491|P1|COMPLETED|Overall Study||25
8464473|NCT00693485|20857489|P3|STARTED|Overall Study||24
8464474|NCT00693485|20857490|P2|STARTED|Overall Study||21
8464475|NCT00693485|20857491|P1|STARTED|Overall Study||25
8464476|NCT00693472|20857506|P4|NOT COMPLETED|Part 2||2
8464477|NCT00693472|20857507|P3|NOT COMPLETED|Part 2||2
8464478|NCT00693472|20857508|P2|NOT COMPLETED|Part 2||0
8464479|NCT00693472|20857509|P1|NOT COMPLETED|Part 2||0
8464480|NCT00693472|20857506|P4|COMPLETED|Part 2||4
8464481|NCT00693472|20857507|P3|COMPLETED|Part 2||6
8464482|NCT00693472|20857508|P2|COMPLETED|Part 2||0
8464483|NCT00693472|20857509|P1|COMPLETED|Part 2||0
8464484|NCT00693472|20857506|P4|STARTED|Part 2||6
8464485|NCT00693472|20857507|P3|STARTED|Part 2||8
8464486|NCT00693472|20857508|P2|STARTED|Part 2||0
8464487|NCT00693472|20857509|P1|STARTED|Part 2||0
8464488|NCT00693472|20857506|P4|NOT COMPLETED|Part 1||0
8464489|NCT00693472|20857507|P3|NOT COMPLETED|Part 1||0
8464490|NCT00693472|20857508|P2|NOT COMPLETED|Part 1||4
8464491|NCT00693472|20857509|P1|NOT COMPLETED|Part 1||6
8464492|NCT00693472|20857506|P4|COMPLETED|Part 1||0
8464493|NCT00693472|20857507|P3|COMPLETED|Part 1||0
8464494|NCT00693472|20857508|P2|COMPLETED|Part 1||9
8464495|NCT00693472|20857509|P1|COMPLETED|Part 1||13
8464496|NCT00693472|20857506|P4|STARTED|Part 1||0
8464497|NCT00693472|20857507|P3|STARTED|Part 1||0
8464498|NCT00693472|20857508|P2|STARTED|Part 1||13
8464499|NCT00693472|20857509|P1|STARTED|Part 1||19
8464500|NCT00693420|20857529|P2|NOT COMPLETED|Overall Study||15
8464501|NCT00693420|20857530|P1|NOT COMPLETED|Overall Study||6
8464502|NCT00693420|20857529|P2|COMPLETED|Overall Study||126
8464503|NCT00693420|20857530|P1|COMPLETED|Overall Study||131
8464504|NCT00693420|20857529|P2|STARTED|Overall Study||141
8464505|NCT00693420|20857530|P1|STARTED|Overall Study||137
8464506|NCT00693303|20857554|P1|NOT COMPLETED|Overall Study||0
8464507|NCT00693303|20857554|P1|COMPLETED|Overall Study||21
8464508|NCT00693303|20857554|P1|STARTED|Overall Study||21
8464509|NCT00693238|20857560|P2|NOT COMPLETED|Overall Study||0
8464510|NCT00693238|20857561|P1|NOT COMPLETED|Overall Study||0
8464511|NCT00693238|20857560|P2|COMPLETED|Overall Study||106
8464512|NCT00693238|20857561|P1|COMPLETED|Overall Study||122
8464513|NCT00693238|20857560|P2|STARTED|Overall Study||106
8464514|NCT00693238|20857561|P1|STARTED|Overall Study||122
8464515|NCT00693225|20857569|P2|NOT COMPLETED|Overall Study||5
8464516|NCT00693225|20857570|P1|NOT COMPLETED|Overall Study||2
8464517|NCT00693225|20857569|P2|COMPLETED|Overall Study||43
8464518|NCT00693225|20857570|P1|COMPLETED|Overall Study||41
8464519|NCT00693225|20857569|P2|STARTED|Overall Study||48
8464520|NCT00693225|20857570|P1|STARTED|Overall Study||43
8464521|NCT00693160|20857582|P2|NOT COMPLETED|Overall Study||0
8464522|NCT00693160|20857583|P1|NOT COMPLETED|Overall Study||0
8464523|NCT00693160|20857582|P2|COMPLETED|Overall Study||16
8464524|NCT00693160|20857583|P1|COMPLETED|Overall Study||14
8464525|NCT00693160|20857582|P2|STARTED|Overall Study||16
8464526|NCT00693160|20857583|P1|STARTED|Overall Study||14
8464527|NCT00693017|20857593|P2|NOT COMPLETED|Overall Study||2
8464528|NCT00693017|20857594|P1|NOT COMPLETED|Overall Study||2
8464529|NCT00693017|20857593|P2|COMPLETED|Overall Study||0
8464530|NCT00693017|20857594|P1|COMPLETED|Overall Study||0
8464531|NCT00693017|20857593|P2|STARTED|Overall Study||2
8464532|NCT00693017|20857594|P1|STARTED|Overall Study||2
8464533|NCT00692978|20857604|P2|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
8464534|NCT00692978|20857605|P1|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
8464535|NCT00692978|20857604|P2|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
8464536|NCT00692978|20857605|P1|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
8464537|NCT00692978|20857604|P2|STARTED|FP 6 Microns Size With MDI Inhaler||15
8464538|NCT00692978|20857605|P1|STARTED|FP 6 Microns Size With MDI Inhaler||15
8464539|NCT00692978|20857604|P2|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
8464540|NCT00692978|20857605|P1|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
8464541|NCT00692978|20857604|P2|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
8464542|NCT00692978|20857605|P1|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
8464543|NCT00692978|20857604|P2|STARTED|FP 3 Microns Size With MDI Inhaler||15
8464544|NCT00692978|20857605|P1|STARTED|FP 3 Microns Size With MDI Inhaler||15
8464545|NCT00692978|20857604|P2|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
8464546|NCT00692978|20857605|P1|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
8464547|NCT00692978|20857604|P2|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
8464548|NCT00692978|20857605|P1|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
8464549|NCT00692978|20857604|P2|STARTED|FP1.5 Microns Size With MDI Inhaler||15
8464550|NCT00692978|20857605|P1|STARTED|FP1.5 Microns Size With MDI Inhaler||15
8464551|NCT00692978|20857604|P2|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
8464552|NCT00692978|20857605|P1|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
8464553|NCT00692978|20857604|P2|COMPLETED|FP From Active 250 ug MDI Inhaler||15
8464554|NCT00692978|20857605|P1|COMPLETED|FP From Active 250 ug MDI Inhaler||15
8464555|NCT00692978|20857604|P2|STARTED|FP From Active 250 ug MDI Inhaler||15
8464556|NCT00692978|20857605|P1|STARTED|FP From Active 250 ug MDI Inhaler||15
8464557|NCT00692913|20857625|P2|NOT COMPLETED|Overall Study||30
8464558|NCT00692913|20857626|P1|NOT COMPLETED|Overall Study||29
8464559|NCT00692913|20857625|P2|COMPLETED|Overall Study||228
8464560|NCT00692913|20857626|P1|COMPLETED|Overall Study||228
8464561|NCT00692913|20857625|P2|STARTED|Overall Study||258
8464562|NCT00692913|20857626|P1|STARTED|Overall Study||257
8464563|NCT00692770|20857648|P2|NOT COMPLETED|Overall Study||558
8464564|NCT00692770|20857649|P1|NOT COMPLETED|Overall Study||556
8464565|NCT00692770|20857648|P2|COMPLETED|Overall Study||0
8464566|NCT00692770|20857649|P1|COMPLETED|Overall Study||0
8464567|NCT00692770|20857648|P2|Participants Received Treatment|Overall Study||554
8464568|NCT00692770|20857649|P1|Participants Received Treatment|Overall Study||553
8464569|NCT00692770|20857648|P2|STARTED|Overall Study||558
8464570|NCT00692770|20857649|P1|STARTED|Overall Study||556
8464571|NCT00692692|20857673|P2|NOT COMPLETED|Overall Study||0
8464572|NCT00692692|20857674|P1|NOT COMPLETED|Overall Study||0
8464573|NCT00692692|20857673|P2|COMPLETED|Overall Study||16
8464574|NCT00692692|20857674|P1|COMPLETED|Overall Study||20
8464575|NCT00692692|20857673|P2|STARTED|Overall Study||16
8464576|NCT00692692|20857674|P1|STARTED|Overall Study||20
8464577|NCT00692419|20857684|P2|NOT COMPLETED|Overall Study||18
8464578|NCT00692419|20857685|P1|NOT COMPLETED|Overall Study||16
8464579|NCT00692419|20857684|P2|COMPLETED|Overall Study||102
8464580|NCT00692419|20857685|P1|COMPLETED|Overall Study||84
8464581|NCT00692419|20857684|P2|STARTED|Overall Study||120
8464582|NCT00692419|20857685|P1|STARTED|Overall Study||100
8464583|NCT00692406|20857695|P1|NOT COMPLETED|Overall Study||57
8464584|NCT00692406|20857695|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
8464585|NCT00692406|20857695|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
8464586|NCT00692341|20857709|P3|NOT COMPLETED|Overall Study||0
8464587|NCT00692341|20857710|P2|NOT COMPLETED|Overall Study||0
8464588|NCT00692341|20857711|P1|NOT COMPLETED|Overall Study||0
8464589|NCT00692341|20857709|P3|COMPLETED|Overall Study||8
8464590|NCT00692341|20857710|P2|COMPLETED|Overall Study||8
8464591|NCT00692341|20857711|P1|COMPLETED|Overall Study||8
8464592|NCT00692341|20857709|P3|STARTED|Overall Study||8
8464593|NCT00692341|20857710|P2|STARTED|Overall Study||8
8464594|NCT00692341|20857711|P1|STARTED|Overall Study||8
8464595|NCT00692276|20857757|P2|NOT COMPLETED|Completed 24 Months||14
8464596|NCT00692276|20857758|P1|NOT COMPLETED|Completed 24 Months||7
8464597|NCT00692276|20857757|P2|COMPLETED|Completed 24 Months||187
8464598|NCT00692276|20857758|P1|COMPLETED|Completed 24 Months||183
8464599|NCT00692276|20857757|P2|STARTED|Completed 24 Months||201
8464600|NCT00692276|20857758|P1|STARTED|Completed 24 Months||190
8464601|NCT00692276|20857757|P2|NOT COMPLETED|Randomized Population||0
8464602|NCT00692276|20857758|P1|NOT COMPLETED|Randomized Population||0
8464603|NCT00692276|20857757|P2|COMPLETED|Randomized Population||201
8464604|NCT00692276|20857758|P1|COMPLETED|Randomized Population||190
8464605|NCT00692276|20857757|P2|STARTED|Randomized Population||201
8464606|NCT00692276|20857758|P1|STARTED|Randomized Population||190
8464607|NCT00692237|20857766|P2|NOT COMPLETED|Overall Study||4
8464608|NCT00692237|20857767|P1|NOT COMPLETED|Overall Study||1
8464609|NCT00692237|20857766|P2|COMPLETED|Overall Study||25
8464610|NCT00692237|20857767|P1|COMPLETED|Overall Study||29
8464611|NCT00692237|20857766|P2|STARTED|Overall Study||29
8464612|NCT00692237|20857767|P1|STARTED|Overall Study||30
8464613|NCT00692211|20857777|P2|NOT COMPLETED|Overall Study||0
8464614|NCT00692211|20857778|P1|NOT COMPLETED|Overall Study||0
8464615|NCT00692211|20857777|P2|COMPLETED|Overall Study||202
8464616|NCT00692211|20857778|P1|COMPLETED|Overall Study||202
8464617|NCT00692211|20857777|P2|STARTED|Overall Study||202
8464618|NCT00692211|20857778|P1|STARTED|Overall Study||202
8464619|NCT00692198|20857786|P2|NOT COMPLETED|Overall Study||0
8464620|NCT00692198|20857787|P1|NOT COMPLETED|Overall Study||0
8464621|NCT00692198|20857786|P2|COMPLETED|Overall Study||370
8464622|NCT00692198|20857787|P1|COMPLETED|Overall Study||368
8464623|NCT00692198|20857786|P2|STARTED|Overall Study||370
8464624|NCT00692198|20857787|P1|STARTED|Overall Study||368
8464625|NCT00692185|20857822|P2|NOT COMPLETED|Overall Study||3
8464626|NCT00692185|20857823|P1|NOT COMPLETED|Overall Study||3
8464627|NCT00692185|20857822|P2|COMPLETED|Overall Study||9
8464628|NCT00692185|20857823|P1|COMPLETED|Overall Study||8
8464629|NCT00692185|20857822|P2|STARTED|Overall Study||12
8464630|NCT00692185|20857823|P1|STARTED|Overall Study||11
8464631|NCT00692094|20857835|P4|NOT COMPLETED|Overall Study||0
8464632|NCT00692094|20857836|P3|NOT COMPLETED|Overall Study||0
8464633|NCT00692094|20857837|P2|NOT COMPLETED|Overall Study||0
8464634|NCT00692094|20857838|P1|NOT COMPLETED|Overall Study||0
8464635|NCT00692094|20857835|P4|COMPLETED|Overall Study||0
8464636|NCT00692094|20857836|P3|COMPLETED|Overall Study||0
8464637|NCT00692094|20857837|P2|COMPLETED|Overall Study||0
8464638|NCT00692094|20857838|P1|COMPLETED|Overall Study||0
8464639|NCT00692094|20857835|P4|STARTED|Overall Study||0
8464640|NCT00692094|20857836|P3|STARTED|Overall Study||0
8464641|NCT00692094|20857837|P2|STARTED|Overall Study||0
8464642|NCT00692094|20857838|P1|STARTED|Overall Study||0
8464643|NCT00692003|20857854|P2|NOT COMPLETED|Overall Study||1
8464644|NCT00692003|20857855|P1|NOT COMPLETED|Overall Study||5
8464645|NCT00692003|20857854|P2|COMPLETED|Overall Study||0
8464646|NCT00692003|20857855|P1|COMPLETED|Overall Study||0
8464647|NCT00692003|20857854|P2|STARTED|Overall Study||1
8464648|NCT00692003|20857855|P1|STARTED|Overall Study||5
8464649|NCT00691938|20857870|P7|NOT COMPLETED|Overall Study||0
8464650|NCT00691938|20857871|P6|NOT COMPLETED|Overall Study||0
8464651|NCT00691938|20857872|P5|NOT COMPLETED|Overall Study||0
8464652|NCT00691938|20857873|P4|NOT COMPLETED|Overall Study||0
8464653|NCT00691938|20857874|P3|NOT COMPLETED|Overall Study||0
8464654|NCT00691938|20857875|P2|NOT COMPLETED|Overall Study||0
8464655|NCT00691938|20857876|P1|NOT COMPLETED|Overall Study||1
8464656|NCT00691938|20857870|P7|COMPLETED|Overall Study||14
8464657|NCT00691938|20857871|P6|COMPLETED|Overall Study||6
8464658|NCT00691938|20857872|P5|COMPLETED|Overall Study||10
8464659|NCT00691938|20857873|P4|COMPLETED|Overall Study||8
8464660|NCT00691938|20857874|P3|COMPLETED|Overall Study||6
8464661|NCT00691938|20857875|P2|COMPLETED|Overall Study||3
8464662|NCT00691938|20857876|P1|COMPLETED|Overall Study||4
8464663|NCT00691938|20857870|P7|STARTED|Overall Study||14
8464664|NCT00691938|20857871|P6|STARTED|Overall Study||6
8464665|NCT00691938|20857872|P5|STARTED|Overall Study||10
8464666|NCT00691938|20857873|P4|STARTED|Overall Study||8
8464667|NCT00691938|20857874|P3|STARTED|Overall Study||6
8464668|NCT00691938|20857875|P2|STARTED|Overall Study||3
8464669|NCT00691938|20857876|P1|STARTED|Overall Study||5
8464670|NCT00691808|20857900|P3|NOT COMPLETED|Overall Study||0
8464671|NCT00691808|20857901|P2|NOT COMPLETED|Overall Study||1
8464672|NCT00691808|20857902|P1|NOT COMPLETED|Overall Study||0
8464673|NCT00691808|20857900|P3|COMPLETED|Overall Study||32
8464674|NCT00691808|20857901|P2|COMPLETED|Overall Study||35
8464675|NCT00691808|20857902|P1|COMPLETED|Overall Study||35
8464676|NCT00691808|20857900|P3|STARTED|Overall Study||32
8464677|NCT00691808|20857901|P2|STARTED|Overall Study||36
8464678|NCT00691808|20857902|P1|STARTED|Overall Study||35
8464679|NCT00691704|20857943|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
8464680|NCT00691704|20857943|P1|COMPLETED|Two Years of Maintenance Therapy||3
8464681|NCT00691704|20857943|P1|STARTED|Two Years of Maintenance Therapy||16
8464682|NCT00691704|20857943|P1|NOT COMPLETED|Induction Therapy||2
8464683|NCT00691704|20857943|P1|COMPLETED|Induction Therapy||16
8464684|NCT00691704|20857943|P1|STARTED|Induction Therapy||18
8464685|NCT00691665|20857953|P2|NOT COMPLETED|Overall Study||0
8464686|NCT00691665|20857954|P1|NOT COMPLETED|Overall Study||0
8464687|NCT00691665|20857953|P2|COMPLETED|Overall Study||65
8464688|NCT00691665|20857954|P1|COMPLETED|Overall Study||65
8464689|NCT00691665|20857953|P2|STARTED|Overall Study||65
8464690|NCT00691665|20857954|P1|STARTED|Overall Study||65
8464691|NCT00691652|20857966|P1|NOT COMPLETED|Overall Study||1
8464692|NCT00691652|20857966|P1|COMPLETED|Overall Study||1
8464693|NCT00691652|20857966|P1|STARTED|Overall Study||2
8464694|NCT00691600|20857978|P2|NOT COMPLETED|Overall Study||0
8464695|NCT00691600|20857979|P1|NOT COMPLETED|Overall Study||0
8464696|NCT00691600|20857978|P2|COMPLETED|Overall Study||11
8464697|NCT00691600|20857979|P1|COMPLETED|Overall Study||12
8464698|NCT00691600|20857978|P2|STARTED|Overall Study||11
8464699|NCT00691600|20857979|P1|STARTED|Overall Study||12
8464700|NCT00691574|20857991|P2|NOT COMPLETED|Overall Study||0
8464701|NCT00691574|20857992|P1|NOT COMPLETED|Overall Study||0
8464702|NCT00691574|20857991|P2|COMPLETED|Overall Study||0
8464703|NCT00691574|20857992|P1|COMPLETED|Overall Study||0
8464704|NCT00691574|20857991|P2|STARTED|Overall Study||0
8464705|NCT00691574|20857992|P1|STARTED|Overall Study||0
8464706|NCT00691483|20858004|P2|NOT COMPLETED|Overall Study||25
8464707|NCT00691483|20858005|P1|NOT COMPLETED|Overall Study||68
8464708|NCT00691483|20858004|P2|COMPLETED|Overall Study||141
8464709|NCT00691483|20858005|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
8464710|NCT00691483|20858004|P2|Received Treatment|Overall Study||165
8464711|NCT00691483|20858005|P1|Received Treatment|Overall Study||486
8464712|NCT00691483|20858004|P2|STARTED|Overall Study||166
8464713|NCT00691483|20858005|P1|STARTED|Overall Study||493
8464714|NCT00691444|20858024|P3|NOT COMPLETED|Overall Study||0
8464715|NCT00691444|20858025|P2|NOT COMPLETED|Overall Study||0
8464716|NCT00691444|20858026|P1|NOT COMPLETED|Overall Study||0
8464717|NCT00691444|20858024|P3|COMPLETED|Overall Study||0
8464718|NCT00691444|20858025|P2|COMPLETED|Overall Study||0
8464719|NCT00691444|20858026|P1|COMPLETED|Overall Study||0
8464720|NCT00691444|20858024|P3|STARTED|Overall Study||0
8464721|NCT00691444|20858025|P2|STARTED|Overall Study||0
8464722|NCT00691444|20858026|P1|STARTED|Overall Study||0
8464723|NCT00691327|20858039|P2|NOT COMPLETED|Overall Study||2508
8464724|NCT00691327|20858040|P1|NOT COMPLETED|Overall Study||2841
8464725|NCT00691327|20858039|P2|COMPLETED|Overall Study||36766
8464726|NCT00691327|20858040|P1|COMPLETED|Overall Study||42214
8464727|NCT00691327|20858039|P2|STARTED|Overall Study||39274
8464728|NCT00691327|20858040|P1|STARTED|Overall Study||45055
8464729|NCT00691301|20858048|P1|NOT COMPLETED|Overall Study||54
8464730|NCT00691301|20858048|P1|COMPLETED|Overall Study||1
8464731|NCT00691301|20858048|P1|STARTED|Overall Study||55
8464732|NCT00691210|20858068|P8|NOT COMPLETED|Overall Study||0
8464733|NCT00691210|20858069|P7|NOT COMPLETED|Overall Study||0
8464734|NCT00691210|20858070|P6|NOT COMPLETED|Overall Study||1
8464735|NCT00691210|20858071|P5|NOT COMPLETED|Overall Study||0
8464736|NCT00691210|20858072|P4|NOT COMPLETED|Overall Study||3
8464737|NCT00691210|20858073|P3|NOT COMPLETED|Overall Study||0
8464738|NCT00691210|20858074|P2|NOT COMPLETED|Overall Study||0
8464739|NCT00691210|20858075|P1|NOT COMPLETED|Overall Study||0
8464740|NCT00691210|20858068|P8|COMPLETED|Overall Study||0
8464741|NCT00691210|20858069|P7|COMPLETED|Overall Study||6
8464742|NCT00691210|20858070|P6|COMPLETED|Overall Study||6
8464743|NCT00691210|20858071|P5|COMPLETED|Overall Study||5
8464744|NCT00691210|20858072|P4|COMPLETED|Overall Study||6
8464745|NCT00691210|20858073|P3|COMPLETED|Overall Study||3
8464746|NCT00691210|20858074|P2|COMPLETED|Overall Study||5
8464747|NCT00691210|20858075|P1|COMPLETED|Overall Study||3
8464748|NCT00691210|20858068|P8|STARTED|Overall Study||0
8464749|NCT00691210|20858069|P7|STARTED|Overall Study||6
8464750|NCT00691210|20858070|P6|STARTED|Overall Study||7
8464751|NCT00691210|20858071|P5|STARTED|Overall Study||5
8464752|NCT00691210|20858072|P4|STARTED|Overall Study||9
8464753|NCT00691210|20858073|P3|STARTED|Overall Study||3
8464754|NCT00691210|20858074|P2|STARTED|Overall Study||5
8464755|NCT00691210|20858075|P1|STARTED|Overall Study||3
8464756|NCT00691197|20858095|P2|NOT COMPLETED|Overall Study||5
8464757|NCT00691197|20858096|P1|NOT COMPLETED|Overall Study||11
8464758|NCT00691197|20858095|P2|COMPLETED|Overall Study||75
8464759|NCT00691197|20858096|P1|COMPLETED|Overall Study||155
8464760|NCT00691197|20858095|P2|STARTED|Overall Study||80
8464761|NCT00691197|20858096|P1|STARTED|Overall Study||166
8464762|NCT00691132|20858110|P2|NOT COMPLETED|Overall Study||13
8464763|NCT00691132|20858111|P1|NOT COMPLETED|Overall Study||12
8464764|NCT00691132|20858110|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
8464765|NCT00691132|20858111|P1|COMPLETED|Overall Study||41
8464766|NCT00691132|20858110|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
8464767|NCT00691132|20858111|P1|STARTED|Overall Study||53
8464768|NCT00691093|20858130|P1|NOT COMPLETED|Overall Study||7
8464769|NCT00691093|20858130|P1|COMPLETED|Overall Study||816
8464770|NCT00691093|20858130|P1|STARTED|Overall Study||823
8464771|NCT00691054|20858164|P1|NOT COMPLETED|Overall Study||1
8464772|NCT00691054|20858164|P1|COMPLETED|Overall Study||19
8464773|NCT00691054|20858164|P1|STARTED|Overall Study||20
8464774|NCT00691028|20858176|P4|NOT COMPLETED|Double-blind Period||0
8464775|NCT00691028|20858177|P3|NOT COMPLETED|Double-blind Period||9
8464776|NCT00691028|20858178|P2|NOT COMPLETED|Double-blind Period||13
8464777|NCT00691028|20858179|P1|NOT COMPLETED|Double-blind Period||13
8464778|NCT00691028|20858176|P4|COMPLETED|Double-blind Period||0
8464779|NCT00691028|20858177|P3|COMPLETED|Double-blind Period||95
8464780|NCT00691028|20858178|P2|COMPLETED|Double-blind Period||91
8464781|NCT00691028|20858179|P1|COMPLETED|Double-blind Period||86
8464782|NCT00691028|20858176|P4|STARTED|Double-blind Period||0
8464783|NCT00691028|20858177|P3|STARTED|Double-blind Period||104
8464784|NCT00691028|20858178|P2|STARTED|Double-blind Period||104
8464785|NCT00691028|20858179|P1|STARTED|Double-blind Period||99
8464786|NCT00691028|20858176|P4|NOT COMPLETED|Open-label Period||20
8464787|NCT00691028|20858177|P3|NOT COMPLETED|Open-label Period||0
8464788|NCT00691028|20858178|P2|NOT COMPLETED|Open-label Period||0
8464789|NCT00691028|20858179|P1|NOT COMPLETED|Open-label Period||0
8464790|NCT00691028|20858176|P4|COMPLETED|Open-label Period||307
8464791|NCT00691028|20858177|P3|COMPLETED|Open-label Period||0
8464792|NCT00691028|20858178|P2|COMPLETED|Open-label Period||0
8464793|NCT00691028|20858179|P1|COMPLETED|Open-label Period||0
8464794|NCT00691028|20858176|P4|STARTED|Open-label Period||327
8464795|NCT00691028|20858177|P3|STARTED|Open-label Period||0
8464796|NCT00691028|20858178|P2|STARTED|Open-label Period||0
8464797|NCT00691028|20858179|P1|STARTED|Open-label Period||0
8464798|NCT00691015|20858212|P1|NOT COMPLETED|Overall Study||1
8464799|NCT00691015|20858212|P1|COMPLETED|Overall Study||47
8464800|NCT00691015|20858212|P1|STARTED|Overall Study||48
8464801|NCT00690924|20858223|P1|NOT COMPLETED|Overall Study||0
8464802|NCT00690924|20858223|P1|COMPLETED|Overall Study||16
8464803|NCT00690924|20858223|P1|STARTED|Overall Study||16
8464804|NCT00690898|20858227|P1|NOT COMPLETED|TREATMENT||26
8464805|NCT00690898|20858227|P1|COMPLETED|TREATMENT||64
8464806|NCT00690898|20858227|P1|STARTED|TREATMENT|Total number of patients treated.|90
8464807|NCT00690898|20858227|P1|NOT COMPLETED|SCREENING||18
8464808|NCT00690898|20858227|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
8464809|NCT00690898|20858227|P1|STARTED|SCREENING|Total of patients screened for the study.|108
8464810|NCT00690833|20858241|P1|NOT COMPLETED|Overall Study||2
8464811|NCT00690833|20858241|P1|COMPLETED|Overall Study||39
8464812|NCT00690833|20858241|P1|STARTED|Overall Study||41
8464813|NCT00690820|20858247|P2|NOT COMPLETED|Period 2||0
8464814|NCT00690820|20858248|P1|NOT COMPLETED|Period 2||0
8464815|NCT00690820|20858247|P2|COMPLETED|Period 2||8
8464816|NCT00690820|20858248|P1|COMPLETED|Period 2||8
8464817|NCT00690820|20858247|P2|STARTED|Period 2||8
8464818|NCT00690820|20858248|P1|STARTED|Period 2||8
8464819|NCT00690820|20858247|P2|NOT COMPLETED|Period 1||1
8464820|NCT00690820|20858248|P1|NOT COMPLETED|Period 1||0
8464821|NCT00690820|20858247|P2|COMPLETED|Period 1||8
8464822|NCT00690820|20858248|P1|COMPLETED|Period 1||8
8464823|NCT00690820|20858247|P2|STARTED|Period 1||9
8464824|NCT00690820|20858248|P1|STARTED|Period 1||8
8464825|NCT00690794|20858270|P2|NOT COMPLETED|Overall Study||35
8464826|NCT00690794|20858271|P1|NOT COMPLETED|Overall Study||21
8464827|NCT00690794|20858270|P2|COMPLETED|Overall Study||328
8464828|NCT00690794|20858271|P1|COMPLETED|Overall Study||342
8464829|NCT00690794|20858270|P2|STARTED|Overall Study||363
8464830|NCT00690794|20858271|P1|STARTED|Overall Study||363
8464831|NCT00690755|20858286|P7|NOT COMPLETED|Overall Study||0
8464832|NCT00690755|20858287|P6|NOT COMPLETED|Overall Study||4
8464833|NCT00690755|20858288|P5|NOT COMPLETED|Overall Study||0
8464834|NCT00690755|20858289|P4|NOT COMPLETED|Overall Study||5
8464835|NCT00690755|20858290|P3|NOT COMPLETED|Overall Study||46
8464836|NCT00690755|20858291|P2|NOT COMPLETED|Overall Study||0
8464837|NCT00690755|20858292|P1|NOT COMPLETED|Overall Study||2
8464838|NCT00690755|20858286|P7|COMPLETED|Overall Study||0
8464839|NCT00690755|20858287|P6|COMPLETED|Overall Study||6
8464840|NCT00690755|20858288|P5|COMPLETED|Overall Study||0
8464841|NCT00690755|20858289|P4|COMPLETED|Overall Study||15
8464842|NCT00690755|20858290|P3|COMPLETED|Overall Study||51
8464843|NCT00690755|20858291|P2|COMPLETED|Overall Study||0
8464844|NCT00690755|20858292|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
8464845|NCT00690755|20858286|P7|STARTED|Overall Study||0
8464846|NCT00690755|20858287|P6|STARTED|Overall Study||10
8464847|NCT00690755|20858288|P5|STARTED|Overall Study||0
8464848|NCT00690755|20858289|P4|STARTED|Overall Study||20
8464849|NCT00690755|20858290|P3|STARTED|Overall Study||97
8464850|NCT00690755|20858291|P2|STARTED|Overall Study||0
8464851|NCT00690755|20858292|P1|STARTED|Overall Study||30
8464852|NCT00690612|20858308|P1|NOT COMPLETED|Overall Study||3
8464853|NCT00690612|20858308|P1|COMPLETED|Overall Study||32
8464854|NCT00690612|20858308|P1|STARTED|Overall Study||35
8464855|NCT00690573|20858313|P1|NOT COMPLETED|Overall Study||9
8464856|NCT00690573|20858313|P1|COMPLETED|Overall Study||16
8464857|NCT00690573|20858313|P1|STARTED|Overall Study||25
8464858|NCT00690495|20858323|P2|NOT COMPLETED|Overall Study||0
8464859|NCT00690495|20858324|P1|NOT COMPLETED|Overall Study||0
8464860|NCT00690495|20858323|P2|COMPLETED|Overall Study||50
8464861|NCT00690495|20858324|P1|COMPLETED|Overall Study||50
8464862|NCT00690495|20858323|P2|Primary Endpoint|Overall Study||50
8464863|NCT00690495|20858324|P1|Primary Endpoint|Overall Study||50
8464864|NCT00690495|20858323|P2|STARTED|Overall Study||50
8464865|NCT00690495|20858324|P1|STARTED|Overall Study||50
8464866|NCT00690482|20858332|P2|NOT COMPLETED|Overall Study||3
8464867|NCT00690482|20858333|P1|NOT COMPLETED|Overall Study||4
8464868|NCT00690482|20858332|P2|COMPLETED|Overall Study||54
8464869|NCT00690482|20858333|P1|COMPLETED|Overall Study||57
8464870|NCT00690482|20858332|P2|STARTED|Overall Study||57
8464871|NCT00690482|20858333|P1|STARTED|Overall Study||61
8464872|NCT00690443|20858367|P2|NOT COMPLETED|Overall Study||2
8464873|NCT00690443|20858368|P1|NOT COMPLETED|Overall Study||1
8464874|NCT00690443|20858367|P2|COMPLETED|Overall Study||19
8464875|NCT00690443|20858368|P1|COMPLETED|Overall Study||22
8464876|NCT00690443|20858367|P2|STARTED|Overall Study||21
8464877|NCT00690443|20858368|P1|STARTED|Overall Study||23
8464878|NCT00690430|20858378|P3|NOT COMPLETED|Extension Phase||13
8464879|NCT00690430|20858379|P2|NOT COMPLETED|Extension Phase||5
8464880|NCT00690430|20858380|P1|NOT COMPLETED|Extension Phase||18
8464881|NCT00690430|20858378|P3|COMPLETED|Extension Phase||2
8464882|NCT00690430|20858379|P2|COMPLETED|Extension Phase||1
8464883|NCT00690430|20858380|P1|COMPLETED|Extension Phase||2
8464884|NCT00690430|20858378|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
8464885|NCT00690430|20858379|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
8464886|NCT00690430|20858380|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
8464887|NCT00690430|20858378|P3|NOT COMPLETED|Core Phase||0
8464888|NCT00690430|20858379|P2|NOT COMPLETED|Core Phase||23
8464889|NCT00690430|20858380|P1|NOT COMPLETED|Core Phase||18
8464890|NCT00690430|20858378|P3|COMPLETED|Core Phase||0
8464891|NCT00690430|20858379|P2|COMPLETED|Core Phase||34
8464892|NCT00690430|20858380|P1|COMPLETED|Core Phase||35
8464893|NCT00690430|20858378|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
8464894|NCT00690430|20858379|P2|STARTED|Core Phase||57
8464895|NCT00690430|20858380|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
8464896|NCT00690378|20858409|P2|NOT COMPLETED|Overall Study||14
8464897|NCT00690378|20858410|P1|NOT COMPLETED|Overall Study||20
8464898|NCT00690378|20858409|P2|COMPLETED|Overall Study|Up to LFU visit|54
8464899|NCT00690378|20858410|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
8464900|NCT00690378|20858409|P2|Treated|Overall Study||67
8464901|NCT00690378|20858410|P1|Treated|Overall Study||68
8464902|NCT00690378|20858409|P2|STARTED|Overall Study|Randomized|68
8464903|NCT00690378|20858410|P1|STARTED|Overall Study|Randomized|69
8464904|NCT00690339|20858458|P4|NOT COMPLETED|Overall Study||25
8464905|NCT00690339|20858459|P3|NOT COMPLETED|Overall Study||57
8464906|NCT00690339|20858460|P2|NOT COMPLETED|Overall Study||81
8464907|NCT00690339|20858461|P1|NOT COMPLETED|Overall Study||117
8464908|NCT00690339|20858458|P4|COMPLETED|Overall Study||43
8464909|NCT00690339|20858459|P3|COMPLETED|Overall Study||99
8464910|NCT00690339|20858460|P2|COMPLETED|Overall Study||144
8464911|NCT00690339|20858461|P1|COMPLETED|Overall Study||375
8464912|NCT00690339|20858458|P4|STARTED|Overall Study||68
8464913|NCT00690339|20858459|P3|STARTED|Overall Study||156
8464914|NCT00690339|20858460|P2|STARTED|Overall Study||225
8464915|NCT00690339|20858461|P1|STARTED|Overall Study||492
8464916|NCT00690274|20858477|P2|NOT COMPLETED|Overall Study||8
8464917|NCT00690274|20858478|P1|NOT COMPLETED|Overall Study||6
8464918|NCT00690274|20858477|P2|COMPLETED|Overall Study||15
8464919|NCT00690274|20858478|P1|COMPLETED|Overall Study||23
8464920|NCT00690274|20858477|P2|STARTED|Overall Study||23
8464921|NCT00690274|20858478|P1|STARTED|Overall Study||29
8464922|NCT00690235|20858488|P2|NOT COMPLETED|Overall Study||4
8464923|NCT00690235|20858489|P1|NOT COMPLETED|Overall Study||5
8464924|NCT00690235|20858488|P2|COMPLETED|Overall Study||12
8464925|NCT00690235|20858489|P1|COMPLETED|Overall Study||12
8464926|NCT00690235|20858488|P2|STARTED|Overall Study||16
8464927|NCT00690235|20858489|P1|STARTED|Overall Study||17
8464928|NCT00690040|20858497|P2|NOT COMPLETED|Overall Study||0
8464929|NCT00690040|20858498|P1|NOT COMPLETED|Overall Study||0
8464930|NCT00690040|20858497|P2|COMPLETED|Overall Study||148
8464931|NCT00690040|20858498|P1|COMPLETED|Overall Study||145
8464932|NCT00690040|20858497|P2|STARTED|Overall Study||148
8464933|NCT00690040|20858498|P1|STARTED|Overall Study||145
8464934|NCT00689936|20858507|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
8464935|NCT00689936|20858508|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
8464936|NCT00689936|20858509|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
8464937|NCT00689936|20858507|P3|COMPLETED|Long-Term Follow Up Phase||315
8464938|NCT00689936|20858508|P2|COMPLETED|Long-Term Follow Up Phase||275
8464939|NCT00689936|20858509|P1|COMPLETED|Long-Term Follow Up Phase||255
8464940|NCT00689936|20858507|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
8464941|NCT00689936|20858508|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
8464942|NCT00689936|20858509|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
8464943|NCT00689936|20858507|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8464944|NCT00689936|20858508|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8464945|NCT00689936|20858509|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8464946|NCT00689936|20858507|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
8464947|NCT00689936|20858508|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
8464948|NCT00689936|20858509|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
8464949|NCT00689936|20858507|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
8464950|NCT00689936|20858508|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
8464951|NCT00689936|20858509|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
8464952|NCT00689936|20858507|P3|NOT COMPLETED|Active Treatment Phase||547
8464953|NCT00689936|20858508|P2|NOT COMPLETED|Active Treatment Phase||541
8464954|NCT00689936|20858509|P1|NOT COMPLETED|Active Treatment Phase||535
8464955|NCT00689936|20858507|P3|COMPLETED|Active Treatment Phase||0
8464956|NCT00689936|20858508|P2|COMPLETED|Active Treatment Phase||0
8464957|NCT00689936|20858509|P1|COMPLETED|Active Treatment Phase||0
8464958|NCT00689936|20858507|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
8464959|NCT00689936|20858508|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
8464960|NCT00689936|20858509|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
8464961|NCT00689936|20858507|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
8464962|NCT00689936|20858508|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
8464963|NCT00689936|20858509|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
8464964|NCT00689936|20858507|P3|STARTED|Active Treatment Phase||547
8464965|NCT00689936|20858508|P2|STARTED|Active Treatment Phase||541
8464966|NCT00689936|20858509|P1|STARTED|Active Treatment Phase||535
8464967|NCT00689884|20858649|P1|NOT COMPLETED|Overall Study||0
8464968|NCT00689884|20858649|P1|COMPLETED|Overall Study||7
8464969|NCT00689884|20858649|P1|STARTED|Overall Study||7
8464970|NCT00689871|20858658|P4|NOT COMPLETED|Overall Study||7
8464971|NCT00689871|20858659|P3|NOT COMPLETED|Overall Study||73
8464972|NCT00689871|20858660|P2|NOT COMPLETED|Overall Study||52
8464973|NCT00689871|20858661|P1|NOT COMPLETED|Overall Study||175
8464974|NCT00689871|20858658|P4|COMPLETED|Overall Study|4 Patients discontinued|8
8464975|NCT00689871|20858659|P3|COMPLETED|Overall Study|28 Patients discontinued|74
8464976|NCT00689871|20858660|P2|COMPLETED|Overall Study|35 Patients discontinued|46
8464977|NCT00689871|20858661|P1|COMPLETED|Overall Study|35 Patients discontinued|280
8464978|NCT00689871|20858658|P4|STARTED|Overall Study|25 Implants|15
8464979|NCT00689871|20858659|P3|STARTED|Overall Study|288 Implants|147
8464980|NCT00689871|20858660|P2|STARTED|Overall Study|127 Implants|98
8464981|NCT00689871|20858661|P1|STARTED|Overall Study|908 Implants|455
8464982|NCT00689819|20858677|P2|NOT COMPLETED|Overall Study||15
8464983|NCT00689819|20858678|P1|NOT COMPLETED|Overall Study||20
8464984|NCT00689819|20858677|P2|COMPLETED|Overall Study||43
8464985|NCT00689819|20858678|P1|COMPLETED|Overall Study||45
8464986|NCT00689819|20858677|P2|STARTED|Overall Study||58
8464987|NCT00689819|20858678|P1|STARTED|Overall Study||65
8464988|NCT00689793|20858688|P2|NOT COMPLETED|Overall Study||5
8464989|NCT00689793|20858689|P1|NOT COMPLETED|Overall Study||4
8464990|NCT00689793|20858688|P2|COMPLETED|Overall Study||71
8464991|NCT00689793|20858689|P1|COMPLETED|Overall Study||74
8464992|NCT00689793|20858688|P2|STARTED|Overall Study||76
8464993|NCT00689793|20858689|P1|STARTED|Overall Study||78
8464994|NCT00689728|20858708|P3|NOT COMPLETED|Optional Follow-Up||6
8464995|NCT00689728|20858709|P2|NOT COMPLETED|Optional Follow-Up||6
8464996|NCT00689728|20858710|P1|NOT COMPLETED|Optional Follow-Up||3
8464997|NCT00689728|20858708|P3|COMPLETED|Optional Follow-Up||4
8464998|NCT00689728|20858709|P2|COMPLETED|Optional Follow-Up||5
8464999|NCT00689728|20858710|P1|COMPLETED|Optional Follow-Up||6
8465000|NCT00689728|20858708|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
8465001|NCT00689728|20858709|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
8465002|NCT00689728|20858710|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
8465003|NCT00689728|20858708|P3|NOT COMPLETED|Rescue||1
8465004|NCT00689728|20858709|P2|NOT COMPLETED|Rescue||2
8465005|NCT00689728|20858710|P1|NOT COMPLETED|Rescue||1
8465006|NCT00689728|20858708|P3|COMPLETED|Rescue||29
8465007|NCT00689728|20858709|P2|COMPLETED|Rescue||24
8465008|NCT00689728|20858710|P1|COMPLETED|Rescue||30
8465009|NCT00689728|20858708|P3|STARTED|Rescue||30
8465010|NCT00689728|20858709|P2|STARTED|Rescue||26
8465011|NCT00689728|20858710|P1|STARTED|Rescue||31
8465012|NCT00689728|20858708|P3|NOT COMPLETED|Double-Blind Treatment||5
8465013|NCT00689728|20858709|P2|NOT COMPLETED|Double-Blind Treatment||4
8465014|NCT00689728|20858710|P1|NOT COMPLETED|Double-Blind Treatment||4
8465015|NCT00689728|20858708|P3|COMPLETED|Double-Blind Treatment||30
8465016|NCT00689728|20858709|P2|COMPLETED|Double-Blind Treatment||26
8465017|NCT00689728|20858710|P1|COMPLETED|Double-Blind Treatment||31
8465018|NCT00689728|20858708|P3|STARTED|Double-Blind Treatment||35
8465019|NCT00689728|20858709|P2|STARTED|Double-Blind Treatment||30
8465020|NCT00689728|20858710|P1|STARTED|Double-Blind Treatment||35
8465021|NCT00689611|20858793|P2|NOT COMPLETED|Overall Study||46
8465022|NCT00689611|20858794|P1|NOT COMPLETED|Overall Study||41
8465023|NCT00689611|20858793|P2|COMPLETED|Overall Study||146
8465024|NCT00689611|20858794|P1|COMPLETED|Overall Study||159
8465025|NCT00689611|20858793|P2|STARTED|Overall Study||192
8465026|NCT00689611|20858794|P1|STARTED|Overall Study||200
8465027|NCT00689481|20858804|P2|NOT COMPLETED|Overall Study||14
8465028|NCT00689481|20858805|P1|NOT COMPLETED|Overall Study||24
8465029|NCT00689481|20858804|P2|COMPLETED|Overall Study||95
8465030|NCT00689481|20858805|P1|COMPLETED|Overall Study||190
8465031|NCT00689481|20858804|P2|STARTED|Overall Study||109
8465032|NCT00689481|20858805|P1|STARTED|Overall Study||214
8465033|NCT00689390|20858823|P2|NOT COMPLETED|Overall Study||10
8465034|NCT00689390|20858824|P1|NOT COMPLETED|Overall Study||426
8465035|NCT00689390|20858823|P2|COMPLETED|Overall Study||37
8465036|NCT00689390|20858824|P1|COMPLETED|Overall Study||1481
8465037|NCT00689390|20858823|P2|STARTED|Overall Study||47
8465038|NCT00689390|20858824|P1|STARTED|Overall Study||1907
8465039|NCT00689351|20858842|P2|NOT COMPLETED|Toddler Dose||0
8465040|NCT00689351|20858843|P1|NOT COMPLETED|Toddler Dose||0
8465041|NCT00689351|20858842|P2|COMPLETED|Toddler Dose||88
8465042|NCT00689351|20858843|P1|COMPLETED|Toddler Dose||84
8465043|NCT00689351|20858842|P2|STARTED|Toddler Dose||88
8465044|NCT00689351|20858843|P1|STARTED|Toddler Dose||84
8465045|NCT00689351|20858842|P2|NOT COMPLETED|After Infant Series||0
8465046|NCT00689351|20858843|P1|NOT COMPLETED|After Infant Series||1
8465047|NCT00689351|20858842|P2|COMPLETED|After Infant Series||88
8465048|NCT00689351|20858843|P1|COMPLETED|After Infant Series||84
8465049|NCT00689351|20858842|P2|STARTED|After Infant Series||88
8465050|NCT00689351|20858843|P1|STARTED|After Infant Series||85
8465051|NCT00689351|20858842|P2|NOT COMPLETED|Infant Series of Dosing||1
8465052|NCT00689351|20858843|P1|NOT COMPLETED|Infant Series of Dosing||6
8465053|NCT00689351|20858842|P2|COMPLETED|Infant Series of Dosing||88
8465054|NCT00689351|20858843|P1|COMPLETED|Infant Series of Dosing||85
8465055|NCT00689351|20858842|P2|Vaccinated Dose 3|Infant Series of Dosing||88
8465056|NCT00689351|20858843|P1|Vaccinated Dose 3|Infant Series of Dosing||85
8465057|NCT00689351|20858842|P2|Vaccinated Dose 2|Infant Series of Dosing||88
8465058|NCT00689351|20858843|P1|Vaccinated Dose 2|Infant Series of Dosing||86
8465059|NCT00689351|20858842|P2|Vaccinated Dose 1|Infant Series of Dosing||89
8465060|NCT00689351|20858843|P1|Vaccinated Dose 1|Infant Series of Dosing||88
8465061|NCT00689351|20858842|P2|STARTED|Infant Series of Dosing||89
8465062|NCT00689351|20858843|P1|STARTED|Infant Series of Dosing||91
8465063|NCT00689338|20858875|P1|NOT COMPLETED|Overall Study||143
8465064|NCT00689338|20858875|P1|COMPLETED|Overall Study||73
8465065|NCT00689338|20858875|P1|STARTED|Overall Study||216
8465066|NCT00689299|20858888|P3|NOT COMPLETED|Overall Study||5
8465067|NCT00689299|20858889|P2|NOT COMPLETED|Overall Study||3
8465068|NCT00689299|20858890|P1|NOT COMPLETED|Overall Study||7
8465069|NCT00689299|20858888|P3|COMPLETED|Overall Study||49
8465070|NCT00689299|20858889|P2|COMPLETED|Overall Study||54
8465071|NCT00689299|20858890|P1|COMPLETED|Overall Study||51
8465072|NCT00689299|20858888|P3|STARTED|Overall Study||54
8465073|NCT00689299|20858889|P2|STARTED|Overall Study||57
8465074|NCT00689299|20858890|P1|STARTED|Overall Study||58
8465075|NCT00689260|20858900|P2|NOT COMPLETED|Overall Study||0
8465076|NCT00689260|20858901|P1|NOT COMPLETED|Overall Study||2
8465077|NCT00689260|20858900|P2|COMPLETED|Overall Study||21
8465078|NCT00689260|20858901|P1|COMPLETED|Overall Study||19
8465079|NCT00689260|20858900|P2|STARTED|Overall Study||21
8465080|NCT00689260|20858901|P1|STARTED|Overall Study||21
8465081|NCT00689221|20858919|P2|NOT COMPLETED|Overall Study||36
8465082|NCT00689221|20858920|P1|NOT COMPLETED|Overall Study||39
8465083|NCT00689221|20858919|P2|COMPLETED|Overall Study||237
8465084|NCT00689221|20858920|P1|COMPLETED|Overall Study||233
8465085|NCT00689221|20858919|P2|STARTED|Overall Study||273
8465086|NCT00689221|20858920|P1|STARTED|Overall Study||272
8465087|NCT00689117|20858949|P4|NOT COMPLETED|Overall Study||31
8465088|NCT00689117|20858950|P3|NOT COMPLETED|Overall Study||59
8465089|NCT00689117|20858951|P2|NOT COMPLETED|Overall Study||51
8465090|NCT00689117|20858952|P1|NOT COMPLETED|Overall Study||62
8465091|NCT00689117|20858949|P4|COMPLETED|Overall Study||211
8465092|NCT00689117|20858950|P3|COMPLETED|Overall Study||405
8465093|NCT00689117|20858951|P2|COMPLETED|Overall Study||416
8465094|NCT00689117|20858952|P1|COMPLETED|Overall Study||414
8465095|NCT00689117|20858949|P4|STARTED|Overall Study||242
8465096|NCT00689117|20858950|P3|STARTED|Overall Study||464
8465097|NCT00689117|20858951|P2|STARTED|Overall Study||467
8465098|NCT00689117|20858952|P1|STARTED|Overall Study||476
8465099|NCT00689104|20858982|P4|NOT COMPLETED|Overall Study||50
8465100|NCT00689104|20858983|P3|NOT COMPLETED|Overall Study||45
8465101|NCT00689104|20858984|P2|NOT COMPLETED|Overall Study||57
8465102|NCT00689104|20858985|P1|NOT COMPLETED|Overall Study||44
8465103|NCT00689104|20858982|P4|COMPLETED|Overall Study||445
8465104|NCT00689104|20858983|P3|COMPLETED|Overall Study||453
8465105|NCT00689104|20858984|P2|COMPLETED|Overall Study||440
8465106|NCT00689104|20858985|P1|COMPLETED|Overall Study||453
8465107|NCT00689104|20858982|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
8465108|NCT00689104|20858983|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
8465193|NCT00688740|20859293|P1|COMPLETED|Overall Study||679
8465109|NCT00689104|20858984|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
8465110|NCT00689104|20858985|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
8465111|NCT00689104|20858982|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
8465112|NCT00689104|20858983|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
8465113|NCT00689104|20858984|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
8465114|NCT00689104|20858985|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
8465115|NCT00689104|20858982|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
8465116|NCT00689104|20858983|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
8465117|NCT00689104|20858984|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
8465118|NCT00689104|20858985|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
8465119|NCT00689104|20858982|P4|STARTED|Overall Study||495
8465120|NCT00689104|20858983|P3|STARTED|Overall Study||498
8465121|NCT00689104|20858984|P2|STARTED|Overall Study||497
8465122|NCT00689104|20858985|P1|STARTED|Overall Study||497
8465123|NCT00689091|20859117|P2|NOT COMPLETED|Overall Study||1394
8465124|NCT00689091|20859118|P1|NOT COMPLETED|Overall Study||1371
8465125|NCT00689091|20859117|P2|COMPLETED|Overall Study||9376
8465126|NCT00689091|20859118|P1|COMPLETED|Overall Study||9460
8465127|NCT00689091|20859117|P2|STARTED|Overall Study||10770
8465128|NCT00689091|20859118|P1|STARTED|Overall Study||10831
8465129|NCT00689078|20859140|P4|NOT COMPLETED|Overall Study||1
8465130|NCT00689078|20859141|P3|NOT COMPLETED|Overall Study||1
8465131|NCT00689078|20859142|P2|NOT COMPLETED|Overall Study||2
8465132|NCT00689078|20859143|P1|NOT COMPLETED|Overall Study||0
8465133|NCT00689078|20859140|P4|COMPLETED|Overall Study||8
8465134|NCT00689078|20859141|P3|COMPLETED|Overall Study||8
8465135|NCT00689078|20859142|P2|COMPLETED|Overall Study||7
8465136|NCT00689078|20859143|P1|COMPLETED|Overall Study||9
8465137|NCT00689078|20859140|P4|Intent to Treat|Overall Study||8
8465138|NCT00689078|20859141|P3|Intent to Treat|Overall Study||8
8465139|NCT00689078|20859142|P2|Intent to Treat|Overall Study||7
8465140|NCT00689078|20859143|P1|Intent to Treat|Overall Study||9
8465141|NCT00689078|20859140|P4|STARTED|Overall Study||9
8465142|NCT00689078|20859141|P3|STARTED|Overall Study||9
8465143|NCT00689078|20859142|P2|STARTED|Overall Study||9
8465144|NCT00689078|20859143|P1|STARTED|Overall Study||9
8465145|NCT00689052|20859191|P2|NOT COMPLETED|Overall Study||30
8465146|NCT00689052|20859192|P1|NOT COMPLETED|Overall Study||31
8465147|NCT00689052|20859191|P2|COMPLETED|Overall Study||0
8465148|NCT00689052|20859192|P1|COMPLETED|Overall Study||0
8465149|NCT00689052|20859191|P2|STARTED|Overall Study||30
8465150|NCT00689052|20859192|P1|STARTED|Overall Study||31
8465151|NCT00689026|20859224|P2|NOT COMPLETED|Overall Study||6
8465152|NCT00689026|20859225|P1|NOT COMPLETED|Overall Study||13
8465153|NCT00689026|20859224|P2|COMPLETED|Overall Study||24
8465154|NCT00689026|20859225|P1|COMPLETED|Overall Study||17
8465155|NCT00689026|20859224|P2|STARTED|Overall Study||30
8465156|NCT00689026|20859225|P1|STARTED|Overall Study||30
8465157|NCT00688935|20859231|P1|NOT COMPLETED|Overall Study||0
8465158|NCT00688935|20859231|P1|COMPLETED|Overall Study||0
8465159|NCT00688935|20859231|P1|STARTED|Overall Study||0
8465160|NCT00688870|20859238|P2|NOT COMPLETED|Toddler Dose||0
8465161|NCT00688870|20859239|P1|NOT COMPLETED|Toddler Dose||0
8465162|NCT00688870|20859238|P2|COMPLETED|Toddler Dose||84
8465163|NCT00688870|20859239|P1|COMPLETED|Toddler Dose||80
8465164|NCT00688870|20859238|P2|STARTED|Toddler Dose||84
8465165|NCT00688870|20859239|P1|STARTED|Toddler Dose||80
8465166|NCT00688870|20859238|P2|NOT COMPLETED|After Infant Series||0
8465167|NCT00688870|20859239|P1|NOT COMPLETED|After Infant Series||0
8465168|NCT00688870|20859238|P2|COMPLETED|After Infant Series||84
8465169|NCT00688870|20859239|P1|COMPLETED|After Infant Series||80
8465170|NCT00688870|20859238|P2|STARTED|After Infant Series||84
8465171|NCT00688870|20859239|P1|STARTED|After Infant Series||80
8465172|NCT00688870|20859238|P2|NOT COMPLETED|Infant Series||0
8465173|NCT00688870|20859239|P1|NOT COMPLETED|Infant Series||4
8465174|NCT00688870|20859238|P2|COMPLETED|Infant Series||84
8465175|NCT00688870|20859239|P1|COMPLETED|Infant Series||80
8465176|NCT00688870|20859238|P2|Vaccinated Dose 3|Infant Series||84
8465177|NCT00688870|20859239|P1|Vaccinated Dose 3|Infant Series||80
8465178|NCT00688870|20859238|P2|Vaccinated Dose 2|Infant Series||84
8465179|NCT00688870|20859239|P1|Vaccinated Dose 2|Infant Series||80
8465180|NCT00688870|20859238|P2|Vaccinated Dose 1|Infant Series||84
8465181|NCT00688870|20859239|P1|Vaccinated Dose 1|Infant Series||83
8465182|NCT00688870|20859238|P2|STARTED|Infant Series||84
8465183|NCT00688870|20859239|P1|STARTED|Infant Series||84
8465184|NCT00688844|20859271|P1|NOT COMPLETED|Overall Study||10
8465185|NCT00688844|20859271|P1|COMPLETED|Overall Study||48
8465186|NCT00688844|20859271|P1|STARTED|Overall Study||58
8465187|NCT00688753|20859281|P1|NOT COMPLETED|Overall Study||92
8465188|NCT00688753|20859281|P1|COMPLETED|Overall Study||0
8465189|NCT00688753|20859281|P1|STARTED|Overall Study||92
8465190|NCT00688740|20859292|P2|NOT COMPLETED|Overall Study||35
8465191|NCT00688740|20859293|P1|NOT COMPLETED|Overall Study||66
8465192|NCT00688740|20859292|P2|COMPLETED|Overall Study||711
8465194|NCT00688740|20859292|P2|STARTED|Overall Study||746
8465195|NCT00688740|20859293|P1|STARTED|Overall Study||745
8465196|NCT00688701|20859306|P4|NOT COMPLETED|Overall Study||11
8465197|NCT00688701|20859307|P3|NOT COMPLETED|Overall Study||10
8465198|NCT00688701|20859308|P2|NOT COMPLETED|Overall Study||5
8465199|NCT00688701|20859309|P1|NOT COMPLETED|Overall Study||4
8465200|NCT00688701|20859306|P4|COMPLETED|Overall Study||108
8465201|NCT00688701|20859307|P3|COMPLETED|Overall Study||110
8465202|NCT00688701|20859308|P2|COMPLETED|Overall Study||56
8465203|NCT00688701|20859309|P1|COMPLETED|Overall Study||57
8465204|NCT00688701|20859306|P4|Subgroup for Standardized Meal Test|Overall Study||65
8465205|NCT00688701|20859307|P3|Subgroup for Standardized Meal Test|Overall Study||60
8465206|NCT00688701|20859308|P2|Subgroup for Standardized Meal Test|Overall Study||35
8465207|NCT00688701|20859309|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
8465208|NCT00688701|20859306|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
8465209|NCT00688701|20859307|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
8465210|NCT00688701|20859308|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
8465211|NCT00688701|20859309|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
8465212|NCT00688701|20859306|P4|Treated/Safety Population|Overall Study||119
8465213|NCT00688701|20859307|P3|Treated/Safety Population|Overall Study||120
8465214|NCT00688701|20859308|P2|Treated/Safety Population|Overall Study||61
8465215|NCT00688701|20859309|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
8465216|NCT00688701|20859306|P4|STARTED|Overall Study||119
8465217|NCT00688701|20859307|P3|STARTED|Overall Study||120
8465218|NCT00688701|20859308|P2|STARTED|Overall Study||61
8465219|NCT00688701|20859309|P1|STARTED|Overall Study|Randomized|61
8465220|NCT00688688|20859350|P3|NOT COMPLETED|Overall Study||192
8465221|NCT00688688|20859351|P2|NOT COMPLETED|Overall Study||179
8465222|NCT00688688|20859352|P1|NOT COMPLETED|Overall Study||186
8465223|NCT00688688|20859350|P3|COMPLETED|Overall Study||621
8465224|NCT00688688|20859351|P2|COMPLETED|Overall Study||645
8465225|NCT00688688|20859352|P1|COMPLETED|Overall Study||629
8465226|NCT00688688|20859350|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
8465227|NCT00688688|20859351|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
8465228|NCT00688688|20859352|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
8465229|NCT00688688|20859350|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
8465230|NCT00688688|20859351|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
8465231|NCT00688688|20859352|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
8465232|NCT00688688|20859350|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
8465233|NCT00688688|20859351|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
8465234|NCT00688688|20859352|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
8465235|NCT00688688|20859350|P3|STARTED|Overall Study||813
8465236|NCT00688688|20859351|P2|STARTED|Overall Study||824
8465237|NCT00688688|20859352|P1|STARTED|Overall Study||815
8465238|NCT00688662|20859443|P2|NOT COMPLETED|Overall Study||18
8465239|NCT00688662|20859444|P1|NOT COMPLETED|Overall Study||23
8465240|NCT00688662|20859443|P2|COMPLETED|Overall Study||55
8465241|NCT00688662|20859444|P1|COMPLETED|Overall Study||118
8465242|NCT00688662|20859443|P2|STARTED|Overall Study||73
8465243|NCT00688662|20859444|P1|STARTED|Overall Study||141
8465244|NCT00688636|20859454|P2|NOT COMPLETED|Overall Study||1
8465245|NCT00688636|20859455|P1|NOT COMPLETED|Overall Study||2
8465246|NCT00688636|20859454|P2|COMPLETED|Overall Study||12
8465247|NCT00688636|20859455|P1|COMPLETED|Overall Study||9
8465248|NCT00688636|20859454|P2|STARTED|Overall Study||13
8465249|NCT00688636|20859455|P1|STARTED|Overall Study||11
8465250|NCT00688623|20859469|P1|NOT COMPLETED|Overall Study||55
8465251|NCT00688623|20859469|P1|COMPLETED|Overall Study||18
8465252|NCT00688623|20859469|P1|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
8465253|NCT00688623|20859469|P1|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
8465254|NCT00688623|20859469|P1|STARTED|Overall Study|Intent to treat (ITT)|73
8465255|NCT00688597|20859483|P3|NOT COMPLETED|Overall Study||0
8465256|NCT00688597|20859484|P2|NOT COMPLETED|Overall Study||0
8465257|NCT00688597|20859485|P1|NOT COMPLETED|Overall Study||3
8465258|NCT00688597|20859483|P3|COMPLETED|Overall Study||0
8465259|NCT00688597|20859484|P2|COMPLETED|Overall Study||0
8465260|NCT00688597|20859485|P1|COMPLETED|Overall Study||0
8465261|NCT00688597|20859483|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
8465262|NCT00688597|20859484|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
8465263|NCT00688597|20859485|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8465264|NCT00688597|20859483|P3|STARTED|Overall Study||0
8465265|NCT00688597|20859484|P2|STARTED|Overall Study||0
8465266|NCT00688597|20859485|P1|STARTED|Overall Study||3
8465275|NCT00688519|20859509|P2|NOT COMPLETED|Overall Study||15
8465276|NCT00688519|20859510|P1|NOT COMPLETED|Overall Study||19
8465277|NCT00688519|20859509|P2|COMPLETED|Overall Study||98
8465278|NCT00688519|20859510|P1|COMPLETED|Overall Study||204
8465279|NCT00688519|20859509|P2|STARTED|Overall Study||113
8465280|NCT00688519|20859510|P1|STARTED|Overall Study||223
8465281|NCT00688467|20859528|P2|NOT COMPLETED|Treatment Period 2||2
8465282|NCT00688467|20859529|P1|NOT COMPLETED|Treatment Period 2||0
8465283|NCT00688467|20859528|P2|COMPLETED|Treatment Period 2||6
8465284|NCT00688467|20859529|P1|COMPLETED|Treatment Period 2||7
8465285|NCT00688467|20859528|P2|STARTED|Treatment Period 2||8
8465286|NCT00688467|20859529|P1|STARTED|Treatment Period 2||7
8465287|NCT00688467|20859528|P2|NOT COMPLETED|Treatment Period 1||2
8465288|NCT00688467|20859529|P1|NOT COMPLETED|Treatment Period 1||2
8465289|NCT00688467|20859528|P2|COMPLETED|Treatment Period 1||8
8465290|NCT00688467|20859529|P1|COMPLETED|Treatment Period 1||7
8465291|NCT00688467|20859528|P2|STARTED|Treatment Period 1||10
8465292|NCT00688467|20859529|P1|STARTED|Treatment Period 1||9
8465293|NCT00688376|20859561|P2|NOT COMPLETED|Blinded Extension Phase||5
8465294|NCT00688376|20859562|P1|NOT COMPLETED|Blinded Extension Phase||5
8465295|NCT00688376|20859561|P2|COMPLETED|Blinded Extension Phase||20
8465296|NCT00688376|20859562|P1|COMPLETED|Blinded Extension Phase||29
8465297|NCT00688376|20859561|P2|STARTED|Blinded Extension Phase||25
8465298|NCT00688376|20859562|P1|STARTED|Blinded Extension Phase||34
8465299|NCT00688376|20859561|P2|NOT COMPLETED|Double-Blind Phase||7
8465300|NCT00688376|20859562|P1|NOT COMPLETED|Double-Blind Phase||6
8465301|NCT00688376|20859561|P2|COMPLETED|Double-Blind Phase||25
8465302|NCT00688376|20859562|P1|COMPLETED|Double-Blind Phase||34
8465303|NCT00688376|20859561|P2|Safety Population|Double-Blind Phase||31
8465304|NCT00688376|20859562|P1|Safety Population|Double-Blind Phase||40
8465305|NCT00688376|20859561|P2|STARTED|Double-Blind Phase||32
8465306|NCT00688376|20859562|P1|STARTED|Double-Blind Phase||40
8465307|NCT00688324|20859576|P1|NOT COMPLETED|Overall Study||8
8465308|NCT00688324|20859576|P1|COMPLETED|Overall Study||28
8465309|NCT00688324|20859576|P1|STARTED|Overall Study||36
8465310|NCT00688259|20859621|P2|NOT COMPLETED|Overall Study||8
8465311|NCT00688259|20859622|P1|NOT COMPLETED|Overall Study||7
8465312|NCT00688259|20859621|P2|COMPLETED|Overall Study||36
8465313|NCT00688259|20859622|P1|COMPLETED|Overall Study||37
8465314|NCT00688259|20859621|P2|End to Active Treatment,|Overall Study||37
8465315|NCT00688259|20859622|P1|End to Active Treatment,|Overall Study||37
8465316|NCT00688259|20859621|P2|STARTED|Overall Study||44
8465317|NCT00688259|20859622|P1|STARTED|Overall Study||44
8465318|NCT00688155|20859642|P4|NOT COMPLETED|Overall Study||1
8465319|NCT00688155|20859643|P3|NOT COMPLETED|Overall Study||1
8465320|NCT00688155|20859644|P2|NOT COMPLETED|Overall Study||2
8465321|NCT00688155|20859645|P1|NOT COMPLETED|Overall Study||2
8465322|NCT00688155|20859642|P4|COMPLETED|Overall Study||17
8465323|NCT00688155|20859643|P3|COMPLETED|Overall Study||18
8465324|NCT00688155|20859644|P2|COMPLETED|Overall Study||16
8465325|NCT00688155|20859645|P1|COMPLETED|Overall Study||16
8465326|NCT00688155|20859642|P4|STARTED|Overall Study||18
8465327|NCT00688155|20859643|P3|STARTED|Overall Study||19
8465328|NCT00688155|20859644|P2|STARTED|Overall Study||18
8465329|NCT00688155|20859645|P1|STARTED|Overall Study||18
8465330|NCT00688103|20859665|P2|NOT COMPLETED|Overall Study||13
8465331|NCT00688103|20859666|P1|NOT COMPLETED|Overall Study||30
8465332|NCT00688103|20859665|P2|COMPLETED|Overall Study||64
8465333|NCT00688103|20859666|P1|COMPLETED|Overall Study||44
8465334|NCT00688103|20859665|P2|Actually Treated|Overall Study||76
8465335|NCT00688103|20859666|P1|Actually Treated|Overall Study||71
8465336|NCT00688103|20859665|P2|STARTED|Overall Study||77
8465337|NCT00688103|20859666|P1|STARTED|Overall Study||74
8465344|NCT00687973|20859695|P2|NOT COMPLETED|Overall Study||38
8465345|NCT00687973|20859696|P1|NOT COMPLETED|Overall Study||24
8465346|NCT00687973|20859695|P2|COMPLETED|Overall Study||162
8465347|NCT00687973|20859696|P1|COMPLETED|Overall Study||169
8465348|NCT00687973|20859695|P2|STARTED|Overall Study||200
8465349|NCT00687973|20859696|P1|STARTED|Overall Study||193
8465356|NCT00687856|20859740|P1|NOT COMPLETED|Overall Study||0
8465357|NCT00687856|20859740|P1|COMPLETED|Overall Study||211
8465358|NCT00687856|20859740|P1|STARTED|Overall Study||211
8465359|NCT00687830|20859746|P2|NOT COMPLETED|Overall Study||0
8465360|NCT00687830|20859747|P1|NOT COMPLETED|Overall Study||0
8465361|NCT00687830|20859746|P2|COMPLETED|Overall Study||68
8465362|NCT00687830|20859747|P1|COMPLETED|Overall Study||68
8465363|NCT00687830|20859746|P2|STARTED|Overall Study||68
8465364|NCT00687830|20859747|P1|STARTED|Overall Study||68
8465365|NCT00687804|20859758|P3|NOT COMPLETED|Open-Label Extension Study||11
8465366|NCT00687804|20859759|P2|NOT COMPLETED|Open-Label Extension Study||11
8465367|NCT00687804|20859760|P1|NOT COMPLETED|Open-Label Extension Study||10
8465368|NCT00687804|20859758|P3|COMPLETED|Open-Label Extension Study||63
8465369|NCT00687804|20859759|P2|COMPLETED|Open-Label Extension Study||72
8465370|NCT00687804|20859760|P1|COMPLETED|Open-Label Extension Study||73
8465371|NCT00687804|20859758|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
8465372|NCT00687804|20859759|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
8465373|NCT00687804|20859760|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
8465374|NCT00687804|20859758|P3|STARTED|Open-Label Extension Study||74
8465375|NCT00687804|20859759|P2|STARTED|Open-Label Extension Study||83
8465376|NCT00687804|20859760|P1|STARTED|Open-Label Extension Study||83
8465377|NCT00687804|20859758|P3|NOT COMPLETED|Core Study||13
8465378|NCT00687804|20859759|P2|NOT COMPLETED|Core Study||15
8465379|NCT00687804|20859760|P1|NOT COMPLETED|Core Study||14
8465380|NCT00687804|20859758|P3|COMPLETED|Core Study||98
8465381|NCT00687804|20859759|P2|COMPLETED|Core Study||103
8465382|NCT00687804|20859760|P1|COMPLETED|Core Study||102
8465383|NCT00687804|20859758|P3|STARTED|Core Study||111
8465384|NCT00687804|20859759|P2|STARTED|Core Study||118
8465385|NCT00687804|20859760|P1|STARTED|Core Study||116
8465386|NCT00687739|20859807|P4|NOT COMPLETED|Overall Study||2
8465387|NCT00687739|20859808|P3|NOT COMPLETED|Overall Study||2
8465388|NCT00687739|20859809|P2|NOT COMPLETED|Overall Study||3
8465389|NCT00687739|20859810|P1|NOT COMPLETED|Overall Study||2
8465390|NCT00687739|20859807|P4|COMPLETED|Overall Study||12
8465391|NCT00687739|20859808|P3|COMPLETED|Overall Study||23
8465392|NCT00687739|20859809|P2|COMPLETED|Overall Study||12
8465393|NCT00687739|20859810|P1|COMPLETED|Overall Study||23
8465394|NCT00687739|20859807|P4|STARTED|Overall Study||14
8465395|NCT00687739|20859808|P3|STARTED|Overall Study||25
8465396|NCT00687739|20859809|P2|STARTED|Overall Study||15
8465397|NCT00687739|20859810|P1|STARTED|Overall Study||25
8465398|NCT00687713|20859836|P2|NOT COMPLETED|Overall Study||40
8465399|NCT00687713|20859837|P1|NOT COMPLETED|Overall Study||32
8465400|NCT00687713|20859836|P2|COMPLETED|Overall Study||64
8465401|NCT00687713|20859837|P1|COMPLETED|Overall Study||68
8465402|NCT00687713|20859836|P2|STARTED|Overall Study||104
8465403|NCT00687713|20859837|P1|STARTED|Overall Study||100
8465404|NCT00687674|20859845|P1|NOT COMPLETED|Overall Study||2
8465405|NCT00687674|20859845|P1|COMPLETED|Overall Study||11
8465406|NCT00687674|20859845|P1|STARTED|Overall Study||13
8465407|NCT00687609|20859852|P1|NOT COMPLETED|Overall Study||3
8465408|NCT00687609|20859852|P1|COMPLETED|Overall Study||4
8465409|NCT00687609|20859852|P1|STARTED|Overall Study||7
8465410|NCT00687544|20859866|P1|NOT COMPLETED|Overall Study||11
8465411|NCT00687544|20859866|P1|COMPLETED|Overall Study||0
8465412|NCT00687544|20859866|P1|STARTED|Overall Study||11
8465413|NCT00687531|20859875|P1|NOT COMPLETED|Overall Study||135
8465414|NCT00687531|20859875|P1|COMPLETED|Overall Study||250
8465415|NCT00687531|20859875|P1|RECEIVED TREATMENT|Overall Study||281
8465416|NCT00687531|20859875|P1|STARTED|Overall Study|Completed screening procedures|385
8465417|NCT00687453|20859891|P2|NOT COMPLETED|Overall Study||6
8465418|NCT00687453|20859892|P1|NOT COMPLETED|Overall Study||3
8465419|NCT00687453|20859891|P2|COMPLETED|Overall Study||7
8465420|NCT00687453|20859892|P1|COMPLETED|Overall Study||8
8465421|NCT00687453|20859891|P2|STARTED|Overall Study||13
8465422|NCT00687453|20859892|P1|STARTED|Overall Study||11
8465423|NCT00687440|20859898|P1|NOT COMPLETED|Overall Study||12
8465424|NCT00687440|20859898|P1|COMPLETED|Overall Study||15
8465425|NCT00687440|20859898|P1|STARTED|Overall Study|Number of screened participants|27
8465426|NCT00687401|20859902|P1|NOT COMPLETED|Overall Study||30
8465427|NCT00687401|20859902|P1|COMPLETED|Overall Study||129
8465428|NCT00687401|20859902|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
8465429|NCT00687362|20859907|P1|NOT COMPLETED|Overall Study||3
8465430|NCT00687362|20859907|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
8465431|NCT00687362|20859907|P1|STARTED|Overall Study||22
8465432|NCT00687323|20859911|P1|NOT COMPLETED|Overall Study||180
8465433|NCT00687323|20859911|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
8465434|NCT00687323|20859911|P1|Received Treatment|Overall Study||47
8465435|NCT00687323|20859911|P1|STARTED|Overall Study|Number of screened participants|195
8465436|NCT00687297|20859927|P2|NOT COMPLETED|Maintenance||1
8465437|NCT00687297|20859928|P1|NOT COMPLETED|Maintenance||3
8465438|NCT00687297|20859927|P2|COMPLETED|Maintenance||25
8465439|NCT00687297|20859928|P1|COMPLETED|Maintenance||29
8465440|NCT00687297|20859927|P2|STARTED|Maintenance||26
8465441|NCT00687297|20859928|P1|STARTED|Maintenance||32
8465442|NCT00687297|20859927|P2|NOT COMPLETED|Induction||55
8465443|NCT00687297|20859928|P1|NOT COMPLETED|Induction||45
8465444|NCT00687297|20859927|P2|COMPLETED|Induction||26
8465445|NCT00687297|20859928|P1|COMPLETED|Induction||32
8465446|NCT00687297|20859927|P2|STARTED|Induction||81
8465447|NCT00687297|20859928|P1|STARTED|Induction||77
8465448|NCT00687297|20859927|P2|NOT COMPLETED|Randomization||1
8465449|NCT00687297|20859928|P1|NOT COMPLETED|Randomization||3
8465450|NCT00687297|20859927|P2|COMPLETED|Randomization||81
8465451|NCT00687297|20859928|P1|COMPLETED|Randomization||77
8465452|NCT00687297|20859927|P2|STARTED|Randomization||82
8465453|NCT00687297|20859928|P1|STARTED|Randomization||80
8465454|NCT00687271|20859942|P4|NOT COMPLETED|Overall Study||0
8465455|NCT00687271|20859943|P3|NOT COMPLETED|Overall Study||5
8465456|NCT00687271|20859944|P2|NOT COMPLETED|Overall Study||6
8465457|NCT00687271|20859945|P1|NOT COMPLETED|Overall Study||3
8465458|NCT00687271|20859942|P4|COMPLETED|Overall Study||48
8465459|NCT00687271|20859943|P3|COMPLETED|Overall Study||91
8465460|NCT00687271|20859944|P2|COMPLETED|Overall Study||90
8465461|NCT00687271|20859945|P1|COMPLETED|Overall Study||91
8465462|NCT00687271|20859942|P4|Treated|Overall Study||48
8465463|NCT00687271|20859943|P3|Treated|Overall Study||96
8465464|NCT00687271|20859944|P2|Treated|Overall Study||95
8465465|NCT00687271|20859945|P1|Treated|Overall Study||94
8465466|NCT00687271|20859942|P4|STARTED|Overall Study||48
8465467|NCT00687271|20859943|P3|STARTED|Overall Study||96
8465468|NCT00687271|20859944|P2|STARTED|Overall Study||96
8465469|NCT00687271|20859945|P1|STARTED|Overall Study||94
8465470|NCT00687219|20859983|P1|NOT COMPLETED|Overall Study||51
8465471|NCT00687219|20859983|P1|COMPLETED|Overall Study||51
8465472|NCT00687219|20859983|P1|STARTED|Overall Study||102
8465473|NCT00687193|20859995|P6|NOT COMPLETED|Overall Study||4
8465474|NCT00687193|20859996|P5|NOT COMPLETED|Overall Study||2
8465475|NCT00687193|20859997|P4|NOT COMPLETED|Overall Study||4
8465476|NCT00687193|20859998|P3|NOT COMPLETED|Overall Study||2
8465477|NCT00687193|20859999|P2|NOT COMPLETED|Overall Study||4
8465478|NCT00687193|20860000|P1|NOT COMPLETED|Overall Study||2
8465479|NCT00687193|20859995|P6|COMPLETED|Overall Study||48
8465480|NCT00687193|20859996|P5|COMPLETED|Overall Study||52
8465481|NCT00687193|20859997|P4|COMPLETED|Overall Study||49
8465482|NCT00687193|20859998|P3|COMPLETED|Overall Study||50
8465483|NCT00687193|20859999|P2|COMPLETED|Overall Study||49
8465484|NCT00687193|20860000|P1|COMPLETED|Overall Study||51
8465485|NCT00687193|20859995|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
8465486|NCT00687193|20859996|P5|STARTED|Overall Study||54
8465487|NCT00687193|20859997|P4|STARTED|Overall Study||53
8465488|NCT00687193|20859998|P3|STARTED|Overall Study||52
8465489|NCT00687193|20859999|P2|STARTED|Overall Study||53
8465490|NCT00687193|20860000|P1|STARTED|Overall Study||53
8465491|NCT00687167|20860164|P2|NOT COMPLETED|Second Intervention||0
8465492|NCT00687167|20860165|P1|NOT COMPLETED|Second Intervention||0
8465493|NCT00687167|20860164|P2|COMPLETED|Second Intervention||17
8465494|NCT00687167|20860165|P1|COMPLETED|Second Intervention||17
8465495|NCT00687167|20860164|P2|STARTED|Second Intervention||17
8465496|NCT00687167|20860165|P1|STARTED|Second Intervention||17
8465497|NCT00687167|20860164|P2|NOT COMPLETED|Washout Period of 28 Days||0
8465498|NCT00687167|20860165|P1|NOT COMPLETED|Washout Period of 28 Days||0
8465499|NCT00687167|20860164|P2|COMPLETED|Washout Period of 28 Days||17
8465500|NCT00687167|20860165|P1|COMPLETED|Washout Period of 28 Days||17
8465501|NCT00687167|20860164|P2|STARTED|Washout Period of 28 Days||17
8465502|NCT00687167|20860165|P1|STARTED|Washout Period of 28 Days||17
8465503|NCT00687167|20860164|P2|NOT COMPLETED|First Intervention||0
8465504|NCT00687167|20860165|P1|NOT COMPLETED|First Intervention||0
8465505|NCT00687167|20860164|P2|COMPLETED|First Intervention||17
8465506|NCT00687167|20860165|P1|COMPLETED|First Intervention||17
8465507|NCT00687167|20860164|P2|STARTED|First Intervention||17
8465508|NCT00687167|20860165|P1|STARTED|First Intervention||17
8465509|NCT00687102|20860175|P2|NOT COMPLETED|Overall Study||0
8465510|NCT00687102|20860176|P1|NOT COMPLETED|Overall Study||0
8465511|NCT00687102|20860175|P2|COMPLETED|Overall Study||765
8465512|NCT00687102|20860176|P1|COMPLETED|Overall Study||733
8465513|NCT00687102|20860175|P2|STARTED|Overall Study||765
8465514|NCT00687102|20860176|P1|STARTED|Overall Study||733
8465515|NCT00687076|20860198|P2|NOT COMPLETED|Overall Study||30
8465516|NCT00687076|20860199|P1|NOT COMPLETED|Overall Study||32
8465517|NCT00687076|20860198|P2|COMPLETED|Overall Study||21
8465518|NCT00687076|20860199|P1|COMPLETED|Overall Study||19
8465519|NCT00687076|20860198|P2|STARTED|Overall Study||51
8465520|NCT00687076|20860199|P1|STARTED|Overall Study||51
8465521|NCT00686998|20860210|P3|NOT COMPLETED|Overall Study||4
8465522|NCT00686998|20860211|P2|NOT COMPLETED|Overall Study||8
8465523|NCT00686998|20860212|P1|NOT COMPLETED|Overall Study||13
8465524|NCT00686998|20860210|P3|COMPLETED|Overall Study||18
8465525|NCT00686998|20860211|P2|COMPLETED|Overall Study||33
8465526|NCT00686998|20860212|P1|COMPLETED|Overall Study||30
8465527|NCT00686998|20860210|P3|Completed Scheduled Treatment|Overall Study||18
8465528|NCT00686998|20860211|P2|Completed Scheduled Treatment|Overall Study||33
8465529|NCT00686998|20860212|P1|Completed Scheduled Treatment|Overall Study||30
8465530|NCT00686998|20860210|P3|Eligible for Efficacy Analysis|Overall Study||21
8465531|NCT00686998|20860211|P2|Eligible for Efficacy Analysis|Overall Study||39
8465532|NCT00686998|20860212|P1|Eligible for Efficacy Analysis|Overall Study||42
8465533|NCT00686998|20860210|P3|Received Treatment|Overall Study||22
8465534|NCT00686998|20860211|P2|Received Treatment|Overall Study||41
8465535|NCT00686998|20860212|P1|Received Treatment|Overall Study||43
8465536|NCT00686998|20860210|P3|Randomized|Overall Study||22
8465537|NCT00686998|20860211|P2|Randomized|Overall Study||41
8465538|NCT00686998|20860212|P1|Randomized|Overall Study||43
8465539|NCT00686998|20860210|P3|STARTED|Overall Study|Randomized & received study medication|22
8465540|NCT00686998|20860211|P2|STARTED|Overall Study|Randomized & received study medication|41
8465541|NCT00686998|20860212|P1|STARTED|Overall Study|Randomized & received study medication|43
8465542|NCT00686972|20860220|P1|NOT COMPLETED|Overall Study||51
8465543|NCT00686972|20860220|P1|COMPLETED|Overall Study||0
8465544|NCT00686972|20860220|P1|STARTED|Overall Study||51
8465545|NCT00686959|20860226|P2|NOT COMPLETED|Overall Study||117
8465546|NCT00686959|20860227|P1|NOT COMPLETED|Overall Study||124
8465547|NCT00686959|20860226|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
8465548|NCT00686959|20860227|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
8465549|NCT00686959|20860226|P2|Entered Consolidation Phase|Overall Study||202
8465550|NCT00686959|20860227|P1|Entered Consolidation Phase|Overall Study||229
8465551|NCT00686959|20860226|P2|Received at Least One Dose of Study Drug|Overall Study||272
8465552|NCT00686959|20860227|P1|Received at Least One Dose of Study Drug|Overall Study||283
8465553|NCT00686959|20860226|P2|STARTED|Overall Study||297
8465554|NCT00686959|20860227|P1|STARTED|Overall Study||301
8465555|NCT00686920|20860247|P2|NOT COMPLETED|Overall Study||36
8465556|NCT00686920|20860248|P1|NOT COMPLETED|Overall Study||132
8465557|NCT00686920|20860247|P2|COMPLETED|Overall Study||34
8465558|NCT00686920|20860248|P1|COMPLETED|Overall Study||120
8465559|NCT00686920|20860247|P2|Received At Least 1 Dose Of Study Drug|Overall Study||70
8465560|NCT00686920|20860248|P1|Received At Least 1 Dose Of Study Drug|Overall Study||252
8465561|NCT00686920|20860247|P2|STARTED|Overall Study||70
8465562|NCT00686920|20860248|P1|STARTED|Overall Study||252
8465563|NCT00686894|20860260|P1|NOT COMPLETED|Overall Study||6
8465564|NCT00686894|20860260|P1|COMPLETED|Overall Study||1
8465565|NCT00686894|20860260|P1|STARTED|Overall Study||7
8465566|NCT00686881|20860266|P2|NOT COMPLETED|Overall Study||81
8465567|NCT00686881|20860267|P1|NOT COMPLETED|Overall Study||82
8465568|NCT00686881|20860266|P2|COMPLETED|Overall Study||53
8465569|NCT00686881|20860267|P1|COMPLETED|Overall Study||45
8465570|NCT00686881|20860266|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
8465571|NCT00686881|20860267|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
8465572|NCT00686855|20860279|P2|NOT COMPLETED|Overall Study||1
8465573|NCT00686855|20860280|P1|NOT COMPLETED|Overall Study||1
8465574|NCT00686855|20860279|P2|COMPLETED|Overall Study||17
8465575|NCT00686855|20860280|P1|COMPLETED|Overall Study||27
8465576|NCT00686855|20860279|P2|STARTED|Overall Study||18
8465577|NCT00686855|20860280|P1|STARTED|Overall Study||28
8465578|NCT00686842|20860286|P1|NOT COMPLETED|Overall Study||0
8465579|NCT00686842|20860286|P1|COMPLETED|Overall Study||17
8465580|NCT00686842|20860286|P1|STARTED|Overall Study||17
8465581|NCT00686829|20860290|P1|NOT COMPLETED|Overall Study||79
8465582|NCT00686829|20860290|P1|COMPLETED|Overall Study||0
8465583|NCT00686829|20860290|P1|STARTED|Overall Study||79
8465584|NCT00686803|20860307|P3|NOT COMPLETED|Overall Study||0
8465585|NCT00686803|20860308|P2|NOT COMPLETED|Overall Study||0
8465586|NCT00686803|20860309|P1|NOT COMPLETED|Overall Study||0
8465587|NCT00686803|20860307|P3|COMPLETED|Overall Study||3
8465588|NCT00686803|20860308|P2|COMPLETED|Overall Study||12
8465589|NCT00686803|20860309|P1|COMPLETED|Overall Study||6
8465590|NCT00686803|20860307|P3|STARTED|Overall Study||3
8465591|NCT00686803|20860308|P2|STARTED|Overall Study||12
8465592|NCT00686803|20860309|P1|STARTED|Overall Study||6
8465593|NCT00686790|20860320|P1|NOT COMPLETED|Overall Study||16
8465594|NCT00686790|20860320|P1|COMPLETED|Overall Study||32
8465595|NCT00686790|20860320|P1|STARTED|Overall Study||48
8465596|NCT00686777|20860328|P1|NOT COMPLETED|Overall Study||10
8465597|NCT00686777|20860328|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
8465598|NCT00686777|20860328|P1|Completed 24 Weeks of Follow-up|Overall Study||70
8465599|NCT00686777|20860328|P1|Included in Follow-up (All Treated)|Overall Study||75
8465600|NCT00686777|20860328|P1|Completed 48 Weeks of Treatment|Overall Study||65
8465601|NCT00686777|20860328|P1|Completed 24 Weeks of Treatment|Overall Study||69
8465602|NCT00686777|20860328|P1|STARTED|Overall Study||75
8465603|NCT00686725|20860336|P2|NOT COMPLETED|Overall Study||42
8465604|NCT00686725|20860337|P1|NOT COMPLETED|Overall Study||46
8465605|NCT00686725|20860336|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
8465606|NCT00686725|20860337|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
8465607|NCT00686725|20860336|P2|STARTED|Overall Study||52
8465608|NCT00686725|20860337|P1|STARTED|Overall Study||47
8465609|NCT00686712|20860362|P3|NOT COMPLETED|Overall Study||13
8465610|NCT00686712|20860363|P2|NOT COMPLETED|Overall Study||11
8465611|NCT00686712|20860364|P1|NOT COMPLETED|Overall Study||10
8465612|NCT00686712|20860362|P3|COMPLETED|Overall Study||17
8465613|NCT00686712|20860363|P2|COMPLETED|Overall Study||14
8465614|NCT00686712|20860364|P1|COMPLETED|Overall Study||20
8465615|NCT00686712|20860362|P3|STARTED|Overall Study||30
8465616|NCT00686712|20860363|P2|STARTED|Overall Study||25
8465617|NCT00686712|20860364|P1|STARTED|Overall Study||30
8465618|NCT00686699|20860392|P2|NOT COMPLETED|Treatment Period 2||0
8465619|NCT00686699|20860393|P1|NOT COMPLETED|Treatment Period 2||0
8465620|NCT00686699|20860392|P2|COMPLETED|Treatment Period 2||5
8465621|NCT00686699|20860393|P1|COMPLETED|Treatment Period 2||4
8465622|NCT00686699|20860392|P2|STARTED|Treatment Period 2||5
8465623|NCT00686699|20860393|P1|STARTED|Treatment Period 2||4
8465624|NCT00686699|20860392|P2|NOT COMPLETED|Treatment Period 1||2
8465625|NCT00686699|20860393|P1|NOT COMPLETED|Treatment Period 1||0
8465626|NCT00686699|20860392|P2|COMPLETED|Treatment Period 1||5
8465627|NCT00686699|20860393|P1|COMPLETED|Treatment Period 1||4
8465628|NCT00686699|20860392|P2|STARTED|Treatment Period 1||7
8465629|NCT00686699|20860393|P1|STARTED|Treatment Period 1||4
8465630|NCT00686686|20860417|P1|NOT COMPLETED|Overall Study||6
8465631|NCT00686686|20860417|P1|COMPLETED|Overall Study||17
8465632|NCT00686686|20860417|P1|STARTED|Overall Study||23
8465633|NCT00686647|20860425|P1|NOT COMPLETED|Overall Study||2
8465634|NCT00686647|20860425|P1|COMPLETED|Overall Study||91
8465635|NCT00686647|20860425|P1|STARTED|Overall Study||93
8465636|NCT00686634|20860431|P1|NOT COMPLETED|Overall Study||6
8465637|NCT00686634|20860431|P1|COMPLETED|Overall Study||102
8465638|NCT00686634|20860431|P1|STARTED|Overall Study||108
8465639|NCT00686595|20860438|P1|NOT COMPLETED|Overall Study||7
8465640|NCT00686595|20860438|P1|COMPLETED|Overall Study||31
8465641|NCT00686595|20860438|P1|STARTED|Overall Study||38
8465642|NCT00686582|20860466|P3|NOT COMPLETED|Overall Study||0
8465643|NCT00686582|20860467|P2|NOT COMPLETED|Overall Study||14
8465644|NCT00686582|20860468|P1|NOT COMPLETED|Overall Study||18
8465645|NCT00686582|20860466|P3|COMPLETED|Overall Study||121
8465646|NCT00686582|20860467|P2|COMPLETED|Overall Study||77
8465647|NCT00686582|20860468|P1|COMPLETED|Overall Study||74
8465648|NCT00686582|20860466|P3|Booster Vaccination|Overall Study||0
8465649|NCT00686582|20860467|P2|Booster Vaccination|Overall Study||77
8465650|NCT00686582|20860468|P1|Booster Vaccination|Overall Study||75
8465651|NCT00686582|20860466|P3|STARTED|Overall Study||121
8465652|NCT00686582|20860467|P2|STARTED|Overall Study||91
8465653|NCT00686582|20860468|P1|STARTED|Overall Study||92
8465654|NCT00686543|20860498|P4|NOT COMPLETED|Overall Study||3
8465655|NCT00686543|20860499|P3|NOT COMPLETED|Overall Study||5
8465656|NCT00686543|20860500|P2|NOT COMPLETED|Overall Study||1
8465657|NCT00686543|20860501|P1|NOT COMPLETED|Overall Study||14
8465658|NCT00686543|20860498|P4|COMPLETED|Overall Study||17
8465659|NCT00686543|20860499|P3|COMPLETED|Overall Study||15
8465660|NCT00686543|20860500|P2|COMPLETED|Overall Study||20
8465661|NCT00686543|20860501|P1|COMPLETED|Overall Study||0
8465662|NCT00686543|20860498|P4|STARTED|Overall Study||20
8465663|NCT00686543|20860499|P3|STARTED|Overall Study||20
8465664|NCT00686543|20860500|P2|STARTED|Overall Study||21
8465665|NCT00686543|20860501|P1|STARTED|Overall Study||14
8465666|NCT00686517|20860522|P3|NOT COMPLETED|Follow-up||10
8465667|NCT00686517|20860523|P2|NOT COMPLETED|Follow-up||10
8465668|NCT00686517|20860524|P1|NOT COMPLETED|Follow-up||8
8465669|NCT00686517|20860522|P3|COMPLETED|Follow-up||29
8465670|NCT00686517|20860523|P2|COMPLETED|Follow-up||28
8465671|NCT00686517|20860524|P1|COMPLETED|Follow-up||29
8465672|NCT00686517|20860522|P3|STARTED|Follow-up||39
8465673|NCT00686517|20860523|P2|STARTED|Follow-up||38
8465674|NCT00686517|20860524|P1|STARTED|Follow-up||37
8465675|NCT00686517|20860522|P3|NOT COMPLETED|Treatment||1
8465676|NCT00686517|20860523|P2|NOT COMPLETED|Treatment||3
8465677|NCT00686517|20860524|P1|NOT COMPLETED|Treatment||6
8465678|NCT00686517|20860522|P3|COMPLETED|Treatment||42
8465679|NCT00686517|20860523|P2|COMPLETED|Treatment||40
8465680|NCT00686517|20860524|P1|COMPLETED|Treatment||38
8465681|NCT00686517|20860522|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
8465682|NCT00686517|20860523|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
8465683|NCT00686517|20860524|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
8465684|NCT00686517|20860522|P3|STARTED|Treatment||43
8465685|NCT00686517|20860523|P2|STARTED|Treatment||43
8465686|NCT00686517|20860524|P1|STARTED|Treatment||44
8465687|NCT00686374|20860547|P1|NOT COMPLETED|Overall Study||61
8465688|NCT00686374|20860547|P1|COMPLETED|Overall Study||39
8465689|NCT00686374|20860547|P1|STARTED|Overall Study||100
8465690|NCT00686335|20860558|P1|NOT COMPLETED|Treatment Period||0
8465691|NCT00686335|20860558|P1|COMPLETED|Treatment Period||7
8465692|NCT00686335|20860558|P1|STARTED|Treatment Period||7
8465693|NCT00686335|20860558|P1|NOT COMPLETED|Run-in Period||5
8465694|NCT00686335|20860558|P1|COMPLETED|Run-in Period||7
8465695|NCT00686335|20860558|P1|STARTED|Run-in Period||12
8465696|NCT00686257|20860566|P2|NOT COMPLETED|Overall Study||0
8465697|NCT00686257|20860567|P1|NOT COMPLETED|Overall Study||0
8465698|NCT00686257|20860566|P2|COMPLETED|Overall Study||31
8465699|NCT00686257|20860567|P1|COMPLETED|Overall Study||29
8465700|NCT00686257|20860566|P2|STARTED|Overall Study||31
8465701|NCT00686257|20860567|P1|STARTED|Overall Study||29
8465702|NCT00686231|20860587|P4|NOT COMPLETED|Combination Test - Visit 2||0
8465703|NCT00686231|20860588|P3|NOT COMPLETED|Combination Test - Visit 2||0
8465704|NCT00686231|20860589|P2|NOT COMPLETED|Combination Test - Visit 2||0
8465705|NCT00686231|20860590|P1|NOT COMPLETED|Combination Test - Visit 2||0
8465706|NCT00686231|20860587|P4|COMPLETED|Combination Test - Visit 2||9
8465707|NCT00686231|20860588|P3|COMPLETED|Combination Test - Visit 2||10
8465708|NCT00686231|20860589|P2|COMPLETED|Combination Test - Visit 2||0
8465709|NCT00686231|20860590|P1|COMPLETED|Combination Test - Visit 2||0
8465710|NCT00686231|20860587|P4|STARTED|Combination Test - Visit 2||9
8465711|NCT00686231|20860588|P3|STARTED|Combination Test - Visit 2||10
8465712|NCT00686231|20860589|P2|STARTED|Combination Test - Visit 2||0
8465713|NCT00686231|20860590|P1|STARTED|Combination Test - Visit 2||0
8465714|NCT00686231|20860587|P4|NOT COMPLETED|Dose Test - Visit 1||0
8465715|NCT00686231|20860588|P3|NOT COMPLETED|Dose Test - Visit 1||0
8465716|NCT00686231|20860589|P2|NOT COMPLETED|Dose Test - Visit 1||0
8465717|NCT00686231|20860590|P1|NOT COMPLETED|Dose Test - Visit 1||0
8465718|NCT00686231|20860587|P4|COMPLETED|Dose Test - Visit 1||0
8465719|NCT00686231|20860588|P3|COMPLETED|Dose Test - Visit 1||0
8465720|NCT00686231|20860589|P2|COMPLETED|Dose Test - Visit 1||7
8465721|NCT00686231|20860590|P1|COMPLETED|Dose Test - Visit 1||12
8465722|NCT00686231|20860587|P4|STARTED|Dose Test - Visit 1||0
8465723|NCT00686231|20860588|P3|STARTED|Dose Test - Visit 1||0
8465724|NCT00686231|20860589|P2|STARTED|Dose Test - Visit 1||7
8465725|NCT00686231|20860590|P1|STARTED|Dose Test - Visit 1||12
8465726|NCT00686205|20860602|P2|NOT COMPLETED|Overall Study||981
8465727|NCT00686205|20860603|P1|NOT COMPLETED|Overall Study||6007
8465728|NCT00686205|20860602|P2|COMPLETED|Overall Study||1524
8465729|NCT00686205|20860603|P1|COMPLETED|Overall Study||15599
8465730|NCT00686205|20860602|P2|STARTED|Overall Study||2505
8465731|NCT00686205|20860603|P1|STARTED|Overall Study||21606
8465732|NCT00686166|20860609|P1|NOT COMPLETED|Overall Study||20
8465733|NCT00686166|20860609|P1|COMPLETED|Overall Study||63
8465734|NCT00686166|20860609|P1|Eligible and Began Protocol Therapy|Overall Study||74
8465735|NCT00686166|20860609|P1|Eligible|Overall Study||78
8465736|NCT00686166|20860609|P1|STARTED|Overall Study||83
8465737|NCT00686127|20860621|P2|NOT COMPLETED|Overall Study||6
8465738|NCT00686127|20860622|P1|NOT COMPLETED|Overall Study||14
8465739|NCT00686127|20860621|P2|COMPLETED|Overall Study||1
8465740|NCT00686127|20860622|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
8465741|NCT00686127|20860621|P2|STARTED|Overall Study||7
8465742|NCT00686127|20860622|P1|STARTED|Overall Study||14
8465743|NCT00686075|20860638|P10|NOT COMPLETED|Overall Study||10
8465744|NCT00686075|20860639|P9|NOT COMPLETED|Overall Study||6
8465745|NCT00686075|20860640|P8|NOT COMPLETED|Overall Study||2
8465746|NCT00686075|20860641|P7|NOT COMPLETED|Overall Study||0
8465747|NCT00686075|20860642|P6|NOT COMPLETED|Overall Study||3
8465748|NCT00686075|20860643|P5|NOT COMPLETED|Overall Study||4
8465749|NCT00686075|20860644|P4|NOT COMPLETED|Overall Study||9
8465750|NCT00686075|20860645|P3|NOT COMPLETED|Overall Study||6
8465751|NCT00686075|20860646|P2|NOT COMPLETED|Overall Study||10
8465752|NCT00686075|20860647|P1|NOT COMPLETED|Overall Study||8
8465753|NCT00686075|20860638|P10|COMPLETED|Overall Study||69
8465754|NCT00686075|20860639|P9|COMPLETED|Overall Study||75
8465755|NCT00686075|20860640|P8|COMPLETED|Overall Study||76
8465756|NCT00686075|20860641|P7|COMPLETED|Overall Study||82
8465757|NCT00686075|20860642|P6|COMPLETED|Overall Study||37
8465758|NCT00686075|20860643|P5|COMPLETED|Overall Study||36
8465759|NCT00686075|20860644|P4|COMPLETED|Overall Study||71
8465760|NCT00686075|20860645|P3|COMPLETED|Overall Study||74
8465761|NCT00686075|20860646|P2|COMPLETED|Overall Study||71
8465762|NCT00686075|20860647|P1|COMPLETED|Overall Study||71
8465763|NCT00686075|20860638|P10|Treated|Overall Study||78
8465764|NCT00686075|20860639|P9|Treated|Overall Study||80
8465765|NCT00686075|20860640|P8|Treated|Overall Study||77
8465766|NCT00686075|20860641|P7|Treated|Overall Study||82
8465767|NCT00686075|20860642|P6|Treated|Overall Study||40
8465768|NCT00686075|20860643|P5|Treated|Overall Study||40
8465769|NCT00686075|20860644|P4|Treated|Overall Study||80
8465770|NCT00686075|20860645|P3|Treated|Overall Study||80
8465771|NCT00686075|20860646|P2|Treated|Overall Study||79
8465772|NCT00686075|20860647|P1|Treated|Overall Study||78
8465773|NCT00686075|20860638|P10|STARTED|Overall Study||79
8465774|NCT00686075|20860639|P9|STARTED|Overall Study||81
8465775|NCT00686075|20860640|P8|STARTED|Overall Study||78
8465776|NCT00686075|20860641|P7|STARTED|Overall Study||82
8465777|NCT00686075|20860642|P6|STARTED|Overall Study||40
8465778|NCT00686075|20860643|P5|STARTED|Overall Study||40
8465779|NCT00686075|20860644|P4|STARTED|Overall Study||80
8465780|NCT00686075|20860645|P3|STARTED|Overall Study||80
8465781|NCT00686075|20860646|P2|STARTED|Overall Study||81
8465782|NCT00686075|20860647|P1|STARTED|Overall Study||79
8465783|NCT00686036|20860841|P2|NOT COMPLETED|Overall Study||6
8465784|NCT00686036|20860842|P1|NOT COMPLETED|Overall Study||9
8465785|NCT00686036|20860841|P2|COMPLETED|Overall Study||2
8465786|NCT00686036|20860842|P1|COMPLETED|Overall Study||0
8465787|NCT00686036|20860841|P2|STARTED|Overall Study||8
8465788|NCT00686036|20860842|P1|STARTED|Overall Study||9
8465789|NCT00685945|20860854|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
8465790|NCT00685945|20860854|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
8465791|NCT00685945|20860854|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
8465792|NCT00685945|20860854|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
8465793|NCT00685945|20860854|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
8465794|NCT00685945|20860854|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
8465795|NCT00685945|20860854|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
8465796|NCT00685945|20860854|P1|COMPLETED|L-NMMA + Bradykinin||23
8465797|NCT00685945|20860854|P1|STARTED|L-NMMA + Bradykinin||24
8465798|NCT00685945|20860854|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
8465799|NCT00685945|20860854|P1|COMPLETED|Control (Bradykinin Infusion)||24
8465800|NCT00685945|20860854|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
8465801|NCT00685932|20860871|P2|NOT COMPLETED|Overall Study||20
8465802|NCT00685932|20860872|P1|NOT COMPLETED|Overall Study||21
8465803|NCT00685932|20860871|P2|COMPLETED|Overall Study||58
8465804|NCT00685932|20860872|P1|COMPLETED|Overall Study||55
8465805|NCT00685932|20860871|P2|STARTED|Overall Study||78
8465806|NCT00685932|20860872|P1|STARTED|Overall Study||76
8465807|NCT00685880|20860882|P2|NOT COMPLETED|Overall Study||0
8465808|NCT00685880|20860883|P1|NOT COMPLETED|Overall Study||0
8465809|NCT00685880|20860882|P2|COMPLETED|Overall Study||2
8465810|NCT00685880|20860883|P1|COMPLETED|Overall Study||0
8465811|NCT00685880|20860882|P2|STARTED|Overall Study||2
8465812|NCT00685880|20860883|P1|STARTED|Overall Study||0
8465813|NCT00685802|20860889|P2|NOT COMPLETED|Second Intervention||0
8465814|NCT00685802|20860890|P1|NOT COMPLETED|Second Intervention||0
8465815|NCT00685802|20860889|P2|COMPLETED|Second Intervention||15
8465816|NCT00685802|20860890|P1|COMPLETED|Second Intervention||14
8465817|NCT00685802|20860889|P2|STARTED|Second Intervention||15
8465818|NCT00685802|20860890|P1|STARTED|Second Intervention||14
8465819|NCT00685802|20860889|P2|NOT COMPLETED|Washout Period of 7 Days||1
8465820|NCT00685802|20860890|P1|NOT COMPLETED|Washout Period of 7 Days||2
8465821|NCT00685802|20860889|P2|COMPLETED|Washout Period of 7 Days||15
8465822|NCT00685802|20860890|P1|COMPLETED|Washout Period of 7 Days||14
8465823|NCT00685802|20860889|P2|STARTED|Washout Period of 7 Days||16
8465824|NCT00685802|20860890|P1|STARTED|Washout Period of 7 Days||16
8465825|NCT00685802|20860889|P2|NOT COMPLETED|First Intervention||0
8465826|NCT00685802|20860890|P1|NOT COMPLETED|First Intervention||0
8465827|NCT00685802|20860889|P2|COMPLETED|First Intervention||16
8465828|NCT00685802|20860890|P1|COMPLETED|First Intervention||16
8465829|NCT00685802|20860889|P2|STARTED|First Intervention||16
8465830|NCT00685802|20860890|P1|STARTED|First Intervention||16
8465831|NCT00685763|20860900|P1|NOT COMPLETED|Overall Study||2
8465832|NCT00685763|20860900|P1|COMPLETED|Overall Study||11
8465833|NCT00685763|20860900|P1|STARTED|Overall Study||13
8465834|NCT00685750|20860911|P7|NOT COMPLETED|Overall Study||1
8465835|NCT00685750|20860912|P6|NOT COMPLETED|Overall Study||0
8465836|NCT00685750|20860913|P5|NOT COMPLETED|Overall Study||0
8465837|NCT00685750|20860914|P4|NOT COMPLETED|Overall Study||0
8465838|NCT00685750|20860915|P3|NOT COMPLETED|Overall Study||2
8465839|NCT00685750|20860916|P2|NOT COMPLETED|Overall Study||0
8465840|NCT00685750|20860917|P1|NOT COMPLETED|Overall Study||0
8465841|NCT00685750|20860911|P7|COMPLETED|Overall Study||9
8465842|NCT00685750|20860912|P6|COMPLETED|Overall Study||20
8465843|NCT00685750|20860913|P5|COMPLETED|Overall Study||15
8465844|NCT00685750|20860914|P4|COMPLETED|Overall Study||2
8465845|NCT00685750|20860915|P3|COMPLETED|Overall Study||19
8465846|NCT00685750|20860916|P2|COMPLETED|Overall Study||3
8465847|NCT00685750|20860917|P1|COMPLETED|Overall Study||17
8465848|NCT00685750|20860911|P7|STARTED|Overall Study||10
8465849|NCT00685750|20860912|P6|STARTED|Overall Study||20
8465850|NCT00685750|20860913|P5|STARTED|Overall Study||15
8465851|NCT00685750|20860914|P4|STARTED|Overall Study||2
8465852|NCT00685750|20860915|P3|STARTED|Overall Study||21
8465853|NCT00685750|20860916|P2|STARTED|Overall Study||3
8465854|NCT00685750|20860917|P1|STARTED|Overall Study||17
8465855|NCT00685698|20860945|P1|NOT COMPLETED|Overall Study||13
8465856|NCT00685698|20860945|P1|COMPLETED|Overall Study||25
8465857|NCT00685698|20860945|P1|STARTED|Overall Study||38
8465858|NCT00685685|20860980|P2|NOT COMPLETED|Second Intervention||0
8465859|NCT00685685|20860981|P1|NOT COMPLETED|Second Intervention||0
8465860|NCT00685685|20860980|P2|COMPLETED|Second Intervention||26
8465861|NCT00685685|20860981|P1|COMPLETED|Second Intervention||25
8465862|NCT00685685|20860980|P2|STARTED|Second Intervention||26
8465863|NCT00685685|20860981|P1|STARTED|Second Intervention||25
8465864|NCT00685685|20860980|P2|NOT COMPLETED|Washout Period of 7 Days||1
8465865|NCT00685685|20860981|P1|NOT COMPLETED|Washout Period of 7 Days||2
8465866|NCT00685685|20860980|P2|COMPLETED|Washout Period of 7 Days||26
8465867|NCT00685685|20860981|P1|COMPLETED|Washout Period of 7 Days||25
8465868|NCT00685685|20860980|P2|STARTED|Washout Period of 7 Days||27
8465869|NCT00685685|20860981|P1|STARTED|Washout Period of 7 Days||27
8465870|NCT00685685|20860980|P2|NOT COMPLETED|First Intervention||0
8465871|NCT00685685|20860981|P1|NOT COMPLETED|First Intervention||0
8465872|NCT00685685|20860980|P2|COMPLETED|First Intervention||27
8465873|NCT00685685|20860981|P1|COMPLETED|First Intervention||27
8465874|NCT00685685|20860980|P2|STARTED|First Intervention||27
8465875|NCT00685685|20860981|P1|STARTED|First Intervention||27
8465876|NCT00685659|20860994|P3|NOT COMPLETED|Overall Study||15
8465877|NCT00685659|20860995|P2|NOT COMPLETED|Overall Study||25
8465878|NCT00685659|20860996|P1|NOT COMPLETED|Overall Study||31
8465879|NCT00685659|20860994|P3|COMPLETED|Overall Study||92
8465880|NCT00685659|20860995|P2|COMPLETED|Overall Study||81
8465881|NCT00685659|20860996|P1|COMPLETED|Overall Study||77
8465882|NCT00685659|20860994|P3|STARTED|Overall Study||107
8465883|NCT00685659|20860995|P2|STARTED|Overall Study||106
8465884|NCT00685659|20860996|P1|STARTED|Overall Study||108
8465885|NCT00685516|20861094|P3|NOT COMPLETED|Overall Study||7
8465886|NCT00685516|20861095|P2|NOT COMPLETED|Overall Study||5
8465887|NCT00685516|20861096|P1|NOT COMPLETED|Overall Study||8
8465888|NCT00685516|20861094|P3|COMPLETED|Overall Study||26
8465889|NCT00685516|20861095|P2|COMPLETED|Overall Study||33
8465890|NCT00685516|20861096|P1|COMPLETED|Overall Study||34
8465891|NCT00685516|20861094|P3|STARTED|Overall Study||33
8465892|NCT00685516|20861095|P2|STARTED|Overall Study||38
8465893|NCT00685516|20861096|P1|STARTED|Overall Study||42
8465894|NCT00685477|20861113|P6|NOT COMPLETED|Overall Study||0
8465895|NCT00685477|20861114|P5|NOT COMPLETED|Overall Study||0
8465896|NCT00685477|20861115|P4|NOT COMPLETED|Overall Study||0
8465897|NCT00685477|20861116|P3|NOT COMPLETED|Overall Study||0
8465898|NCT00685477|20861117|P2|NOT COMPLETED|Overall Study||0
8465899|NCT00685477|20861118|P1|NOT COMPLETED|Overall Study||0
8465900|NCT00685477|20861113|P6|COMPLETED|Overall Study||10
8465901|NCT00685477|20861114|P5|COMPLETED|Overall Study||10
8465902|NCT00685477|20861115|P4|COMPLETED|Overall Study||10
8465903|NCT00685477|20861116|P3|COMPLETED|Overall Study||10
8465904|NCT00685477|20861117|P2|COMPLETED|Overall Study||10
8465905|NCT00685477|20861118|P1|COMPLETED|Overall Study||10
8465906|NCT00685477|20861113|P6|STARTED|Overall Study||10
8465907|NCT00685477|20861114|P5|STARTED|Overall Study||10
8465908|NCT00685477|20861115|P4|STARTED|Overall Study||10
8465909|NCT00685477|20861116|P3|STARTED|Overall Study||10
8465910|NCT00685477|20861117|P2|STARTED|Overall Study||10
8465911|NCT00685477|20861118|P1|STARTED|Overall Study||10
8465912|NCT00685399|20861134|P8|NOT COMPLETED|Extension||0
8465913|NCT00685399|20861135|P7|NOT COMPLETED|Extension||0
8465914|NCT00685399|20861136|P6|NOT COMPLETED|Extension||0
8465915|NCT00685399|20861137|P5|NOT COMPLETED|Extension||0
8465916|NCT00685399|20861138|P4|NOT COMPLETED|Extension||7
8465917|NCT00685399|20861139|P3|NOT COMPLETED|Extension||0
8465918|NCT00685399|20861140|P2|NOT COMPLETED|Extension||0
8465919|NCT00685399|20861141|P1|NOT COMPLETED|Extension||0
8465920|NCT00685399|20861134|P8|COMPLETED|Extension||0
8465921|NCT00685399|20861135|P7|COMPLETED|Extension||0
8465922|NCT00685399|20861136|P6|COMPLETED|Extension||0
8465923|NCT00685399|20861137|P5|COMPLETED|Extension||0
8465924|NCT00685399|20861138|P4|COMPLETED|Extension||21
8465925|NCT00685399|20861139|P3|COMPLETED|Extension||0
8465926|NCT00685399|20861140|P2|COMPLETED|Extension||0
8465927|NCT00685399|20861141|P1|COMPLETED|Extension||0
8465928|NCT00685399|20861134|P8|STARTED|Extension||0
8465929|NCT00685399|20861135|P7|STARTED|Extension||0
8465930|NCT00685399|20861136|P6|STARTED|Extension||0
8465931|NCT00685399|20861137|P5|STARTED|Extension||0
8465932|NCT00685399|20861138|P4|STARTED|Extension||28
8465933|NCT00685399|20861139|P3|STARTED|Extension||0
8465934|NCT00685399|20861140|P2|STARTED|Extension||0
8465935|NCT00685399|20861141|P1|STARTED|Extension||0
8465936|NCT00685399|20861134|P8|NOT COMPLETED|Treatment Period 2||2
8465937|NCT00685399|20861135|P7|NOT COMPLETED|Treatment Period 2||0
8465938|NCT00685399|20861136|P6|NOT COMPLETED|Treatment Period 2||2
8465939|NCT00685399|20861137|P5|NOT COMPLETED|Treatment Period 2||0
8465940|NCT00685399|20861138|P4|NOT COMPLETED|Treatment Period 2||0
8465941|NCT00685399|20861139|P3|NOT COMPLETED|Treatment Period 2||3
8465942|NCT00685399|20861140|P2|NOT COMPLETED|Treatment Period 2||12
8465943|NCT00685399|20861141|P1|NOT COMPLETED|Treatment Period 2||0
8465944|NCT00685399|20861134|P8|COMPLETED|Treatment Period 2||10
8465945|NCT00685399|20861135|P7|COMPLETED|Treatment Period 2||13
8465946|NCT00685399|20861136|P6|COMPLETED|Treatment Period 2||10
8465947|NCT00685399|20861137|P5|COMPLETED|Treatment Period 2||4
8465948|NCT00685399|20861138|P4|COMPLETED|Treatment Period 2|in extension period only|0
8465949|NCT00685399|20861139|P3|COMPLETED|Treatment Period 2||2
8465950|NCT00685399|20861140|P2|COMPLETED|Treatment Period 2||2
8465951|NCT00685399|20861141|P1|COMPLETED|Treatment Period 2||0
8465952|NCT00685399|20861134|P8|STARTED|Treatment Period 2||12
8465953|NCT00685399|20861135|P7|STARTED|Treatment Period 2||13
8465954|NCT00685399|20861136|P6|STARTED|Treatment Period 2||12
8465955|NCT00685399|20861137|P5|STARTED|Treatment Period 2||4
8465956|NCT00685399|20861138|P4|STARTED|Treatment Period 2|in extension period only|0
8465957|NCT00685399|20861139|P3|STARTED|Treatment Period 2||5
8465958|NCT00685399|20861140|P2|STARTED|Treatment Period 2||14
8465959|NCT00685399|20861141|P1|STARTED|Treatment Period 2||0
8465960|NCT00685399|20861134|P8|NOT COMPLETED|Treatment Period 1||0
8465961|NCT00685399|20861135|P7|NOT COMPLETED|Treatment Period 1||0
8465962|NCT00685399|20861136|P6|NOT COMPLETED|Treatment Period 1||0
8465963|NCT00685399|20861137|P5|NOT COMPLETED|Treatment Period 1||0
8465964|NCT00685399|20861138|P4|NOT COMPLETED|Treatment Period 1||0
8465965|NCT00685399|20861139|P3|NOT COMPLETED|Treatment Period 1||0
8465966|NCT00685399|20861140|P2|NOT COMPLETED|Treatment Period 1||0
8465967|NCT00685399|20861141|P1|NOT COMPLETED|Treatment Period 1||6
8465968|NCT00685399|20861134|P8|COMPLETED|Treatment Period 1||0
8465969|NCT00685399|20861135|P7|COMPLETED|Treatment Period 1||0
8465970|NCT00685399|20861136|P6|COMPLETED|Treatment Period 1||0
8465971|NCT00685399|20861137|P5|COMPLETED|Treatment Period 1||0
8465972|NCT00685399|20861138|P4|COMPLETED|Treatment Period 1||0
8465973|NCT00685399|20861139|P3|COMPLETED|Treatment Period 1||0
8465974|NCT00685399|20861140|P2|COMPLETED|Treatment Period 1||0
8465975|NCT00685399|20861141|P1|COMPLETED|Treatment Period 1||10
8465976|NCT00685399|20861134|P8|STARTED|Treatment Period 1||0
8465977|NCT00685399|20861135|P7|STARTED|Treatment Period 1||0
8465978|NCT00685399|20861136|P6|STARTED|Treatment Period 1||0
8465979|NCT00685399|20861137|P5|STARTED|Treatment Period 1||0
8465980|NCT00685399|20861138|P4|STARTED|Treatment Period 1||0
8465981|NCT00685399|20861139|P3|STARTED|Treatment Period 1||0
8465982|NCT00685399|20861140|P2|STARTED|Treatment Period 1||0
8465983|NCT00685399|20861141|P1|STARTED|Treatment Period 1||16
8465984|NCT00685373|20861174|P1|NOT COMPLETED|Overall Study||15
8465985|NCT00685373|20861174|P1|COMPLETED|Overall Study||151
8465986|NCT00685373|20861174|P1|STARTED|Overall Study||166
8465987|NCT00685334|20861183|P2|NOT COMPLETED|Overall Study||7
8465988|NCT00685334|20861184|P1|NOT COMPLETED|Overall Study||10
8465989|NCT00685334|20861183|P2|COMPLETED|Overall Study||3
8465990|NCT00685334|20861184|P1|COMPLETED|Overall Study||2
8465991|NCT00685334|20861183|P2|STARTED|Overall Study||10
8465992|NCT00685334|20861184|P1|STARTED|Overall Study||12
8465993|NCT00685295|20861194|P2|NOT COMPLETED|Overall Study||0
8465994|NCT00685295|20861195|P1|NOT COMPLETED|Overall Study||0
8465995|NCT00685295|20861194|P2|COMPLETED|Overall Study||30
8465996|NCT00685295|20861195|P1|COMPLETED|Overall Study||30
8465997|NCT00685295|20861194|P2|STARTED|Overall Study||30
8465998|NCT00685295|20861195|P1|STARTED|Overall Study||30
8465999|NCT00685178|20861209|P4|NOT COMPLETED|Overall Study||14
8466000|NCT00685178|20861210|P3|NOT COMPLETED|Overall Study||12
8466001|NCT00685178|20861211|P2|NOT COMPLETED|Overall Study||19
8466002|NCT00685178|20861212|P1|NOT COMPLETED|Overall Study||13
8466003|NCT00685178|20861209|P4|COMPLETED|Overall Study||33
8466004|NCT00685178|20861210|P3|COMPLETED|Overall Study||27
8466005|NCT00685178|20861211|P2|COMPLETED|Overall Study||26
8466006|NCT00685178|20861212|P1|COMPLETED|Overall Study||27
8466007|NCT00685178|20861209|P4|STARTED|Overall Study||47
8466008|NCT00685178|20861210|P3|STARTED|Overall Study||39
8466009|NCT00685178|20861211|P2|STARTED|Overall Study||45
8466010|NCT00685178|20861212|P1|STARTED|Overall Study||40
8466011|NCT00685165|20861226|P2|NOT COMPLETED|Second Intervention||0
8466012|NCT00685165|20861227|P1|NOT COMPLETED|Second Intervention||0
8466013|NCT00685165|20861226|P2|COMPLETED|Second Intervention||11
8466014|NCT00685165|20861227|P1|COMPLETED|Second Intervention||10
8466015|NCT00685165|20861226|P2|STARTED|Second Intervention||11
8466016|NCT00685165|20861227|P1|STARTED|Second Intervention||10
8466017|NCT00685165|20861226|P2|NOT COMPLETED|Washout Period of 14 Days||0
8466018|NCT00685165|20861227|P1|NOT COMPLETED|Washout Period of 14 Days||1
8466019|NCT00685165|20861226|P2|COMPLETED|Washout Period of 14 Days||11
8466020|NCT00685165|20861227|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
8466021|NCT00685165|20861226|P2|STARTED|Washout Period of 14 Days||11
8466022|NCT00685165|20861227|P1|STARTED|Washout Period of 14 Days||11
8466023|NCT00685165|20861226|P2|NOT COMPLETED|First Intervention||0
8466024|NCT00685165|20861227|P1|NOT COMPLETED|First Intervention||0
8466025|NCT00685165|20861226|P2|COMPLETED|First Intervention||11
8466026|NCT00685165|20861227|P1|COMPLETED|First Intervention||11
8466027|NCT00685165|20861226|P2|STARTED|First Intervention||11
8466028|NCT00685165|20861227|P1|STARTED|First Intervention||11
8466029|NCT00685139|20861237|P2|NOT COMPLETED|Second Intervention||0
8466030|NCT00685139|20861238|P1|NOT COMPLETED|Second Intervention||0
8466031|NCT00685139|20861237|P2|COMPLETED|Second Intervention||17
8466032|NCT00685139|20861238|P1|COMPLETED|Second Intervention||17
8466033|NCT00685139|20861237|P2|STARTED|Second Intervention||17
8466034|NCT00685139|20861238|P1|STARTED|Second Intervention||17
8466035|NCT00685139|20861237|P2|NOT COMPLETED|Washout Period of 28 Days||0
8466036|NCT00685139|20861238|P1|NOT COMPLETED|Washout Period of 28 Days||0
8466037|NCT00685139|20861237|P2|COMPLETED|Washout Period of 28 Days||17
8466038|NCT00685139|20861238|P1|COMPLETED|Washout Period of 28 Days||17
8466039|NCT00685139|20861237|P2|STARTED|Washout Period of 28 Days||17
8466040|NCT00685139|20861238|P1|STARTED|Washout Period of 28 Days||17
8466041|NCT00685139|20861237|P2|NOT COMPLETED|First Intervention||0
8466042|NCT00685139|20861238|P1|NOT COMPLETED|First Intervention||0
8466043|NCT00685139|20861237|P2|COMPLETED|First Intervention||17
8466044|NCT00685139|20861238|P1|COMPLETED|First Intervention||17
8466045|NCT00685139|20861237|P2|STARTED|First Intervention||17
8466046|NCT00685139|20861238|P1|STARTED|First Intervention||17
8466047|NCT00685035|20861246|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
8466048|NCT00685035|20861247|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
8466049|NCT00685035|20861246|P2|COMPLETED|Period 3: 2nd Intervention||8
8466050|NCT00685035|20861247|P1|COMPLETED|Period 3: 2nd Intervention||8
8466051|NCT00685035|20861246|P2|STARTED|Period 3: 2nd Intervention||8
8466052|NCT00685035|20861247|P1|STARTED|Period 3: 2nd Intervention||8
8466053|NCT00685035|20861246|P2|NOT COMPLETED|Period 2: 2-day Washout||0
8466054|NCT00685035|20861247|P1|NOT COMPLETED|Period 2: 2-day Washout||0
8466055|NCT00685035|20861246|P2|COMPLETED|Period 2: 2-day Washout||8
8466056|NCT00685035|20861247|P1|COMPLETED|Period 2: 2-day Washout||8
8466057|NCT00685035|20861246|P2|STARTED|Period 2: 2-day Washout||8
8466058|NCT00685035|20861247|P1|STARTED|Period 2: 2-day Washout||8
8466059|NCT00685035|20861246|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
8466060|NCT00685035|20861247|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
8466061|NCT00685035|20861246|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
8466062|NCT00685035|20861247|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
8466063|NCT00685035|20861246|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
8466064|NCT00685035|20861247|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
8466065|NCT00684996|20861271|P1|NOT COMPLETED|Overall Study||5
8466066|NCT00684996|20861271|P1|COMPLETED|Overall Study||0
8466067|NCT00684996|20861271|P1|Eligible|Overall Study||5
8466068|NCT00684996|20861271|P1|STARTED|Overall Study||5
8466069|NCT00684983|20861286|P2|NOT COMPLETED|Overall Study||0
8466070|NCT00684983|20861287|P1|NOT COMPLETED|Overall Study||0
8466071|NCT00684983|20861286|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
8466072|NCT00684983|20861287|P1|COMPLETED|Overall Study||19
8466073|NCT00684983|20861286|P2|STARTED|Overall Study||45
8466074|NCT00684983|20861287|P1|STARTED|Overall Study||19
8466075|NCT00684814|20861303|P2|NOT COMPLETED|Second Intervention||0
8466076|NCT00684814|20861304|P1|NOT COMPLETED|Second Intervention||1
8466077|NCT00684814|20861303|P2|COMPLETED|Second Intervention||15
8466078|NCT00684814|20861304|P1|COMPLETED|Second Intervention||16
8466079|NCT00684814|20861303|P2|STARTED|Second Intervention||15
8466080|NCT00684814|20861304|P1|STARTED|Second Intervention||17
8466081|NCT00684814|20861303|P2|NOT COMPLETED|Washout Period of 7 Days||4
8466082|NCT00684814|20861304|P1|NOT COMPLETED|Washout Period of 7 Days||2
8466083|NCT00684814|20861303|P2|COMPLETED|Washout Period of 7 Days||15
8466084|NCT00684814|20861304|P1|COMPLETED|Washout Period of 7 Days||17
8466085|NCT00684814|20861303|P2|STARTED|Washout Period of 7 Days||19
8466086|NCT00684814|20861304|P1|STARTED|Washout Period of 7 Days||19
8466087|NCT00684814|20861303|P2|NOT COMPLETED|First Intervention||0
8466088|NCT00684814|20861304|P1|NOT COMPLETED|First Intervention||0
8466089|NCT00684814|20861303|P2|COMPLETED|First Intervention||19
8466090|NCT00684814|20861304|P1|COMPLETED|First Intervention||19
8466091|NCT00684814|20861303|P2|STARTED|First Intervention||19
8466092|NCT00684814|20861304|P1|STARTED|First Intervention||19
8466093|NCT00684788|20861316|P2|NOT COMPLETED|Overall Study||0
8466094|NCT00684788|20861317|P1|NOT COMPLETED|Overall Study||0
8466095|NCT00684788|20861316|P2|COMPLETED|Overall Study||18
8466096|NCT00684788|20861317|P1|COMPLETED|Overall Study||17
8466097|NCT00684788|20861316|P2|STARTED|Overall Study||18
8466098|NCT00684788|20861317|P1|STARTED|Overall Study||17
8466099|NCT00684775|20861337|P2|NOT COMPLETED|Overall Study||0
8466100|NCT00684775|20861338|P1|NOT COMPLETED|Overall Study||0
8466101|NCT00684775|20861337|P2|COMPLETED|Overall Study||19
8466102|NCT00684775|20861338|P1|COMPLETED|Overall Study||19
8466103|NCT00684775|20861337|P2|STARTED|Overall Study||19
8466104|NCT00684775|20861338|P1|STARTED|Overall Study||19
8466105|NCT00684762|20861356|P2|NOT COMPLETED|Second Intervention||0
8466106|NCT00684762|20861357|P1|NOT COMPLETED|Second Intervention||0
8466107|NCT00684762|20861356|P2|COMPLETED|Second Intervention||14
8466108|NCT00684762|20861357|P1|COMPLETED|Second Intervention||14
8466109|NCT00684762|20861356|P2|STARTED|Second Intervention||14
8466110|NCT00684762|20861357|P1|STARTED|Second Intervention||14
8466111|NCT00684762|20861356|P2|NOT COMPLETED|Washout Period of 7 Days||2
8466112|NCT00684762|20861357|P1|NOT COMPLETED|Washout Period of 7 Days||2
8466113|NCT00684762|20861356|P2|COMPLETED|Washout Period of 7 Days||14
8466114|NCT00684762|20861357|P1|COMPLETED|Washout Period of 7 Days||14
8466115|NCT00684762|20861356|P2|STARTED|Washout Period of 7 Days||16
8466116|NCT00684762|20861357|P1|STARTED|Washout Period of 7 Days||16
8466117|NCT00684762|20861356|P2|NOT COMPLETED|First Intervention||0
8466118|NCT00684762|20861357|P1|NOT COMPLETED|First Intervention||0
8466119|NCT00684762|20861356|P2|COMPLETED|First Intervention||16
8466120|NCT00684762|20861357|P1|COMPLETED|First Intervention||16
8466121|NCT00684762|20861356|P2|STARTED|First Intervention||16
8466122|NCT00684762|20861357|P1|STARTED|First Intervention||16
8466123|NCT00684749|20861367|P1|NOT COMPLETED|Overall Study||0
8466124|NCT00684749|20861367|P1|COMPLETED|Overall Study||142
8466125|NCT00684749|20861367|P1|STARTED|Overall Study||142
8466126|NCT00684723|20861371|P2|NOT COMPLETED|Second Intervention||0
8466127|NCT00684723|20861372|P1|NOT COMPLETED|Second Intervention||0
8466128|NCT00684723|20861371|P2|COMPLETED|Second Intervention||27
8466129|NCT00684723|20861372|P1|COMPLETED|Second Intervention||27
8466130|NCT00684723|20861371|P2|STARTED|Second Intervention||27
8466131|NCT00684723|20861372|P1|STARTED|Second Intervention||27
8466132|NCT00684723|20861371|P2|NOT COMPLETED|Washout Period of 7 Days||0
8466133|NCT00684723|20861372|P1|NOT COMPLETED|Washout Period of 7 Days||0
8466134|NCT00684723|20861371|P2|COMPLETED|Washout Period of 7 Days||27
8466135|NCT00684723|20861372|P1|COMPLETED|Washout Period of 7 Days||27
8466136|NCT00684723|20861371|P2|STARTED|Washout Period of 7 Days||27
8466137|NCT00684723|20861372|P1|STARTED|Washout Period of 7 Days||27
8466138|NCT00684723|20861371|P2|NOT COMPLETED|First Intervention||0
8466139|NCT00684723|20861372|P1|NOT COMPLETED|First Intervention||0
8466140|NCT00684723|20861371|P2|COMPLETED|First Intervention||27
8466141|NCT00684723|20861372|P1|COMPLETED|First Intervention||27
8466142|NCT00684723|20861371|P2|STARTED|First Intervention||27
8466143|NCT00684723|20861372|P1|STARTED|First Intervention||27
8466144|NCT00684671|20861385|P3|NOT COMPLETED|Overall Study||0
8466145|NCT00684671|20861386|P2|NOT COMPLETED|Overall Study||0
8466146|NCT00684671|20861387|P1|NOT COMPLETED|Overall Study||3
8466147|NCT00684671|20861385|P3|COMPLETED|Overall Study||164
8466148|NCT00684671|20861386|P2|COMPLETED|Overall Study||170
8466149|NCT00684671|20861387|P1|COMPLETED|Overall Study||169
8466150|NCT00684671|20861385|P3|STARTED|Overall Study||164
8466151|NCT00684671|20861386|P2|STARTED|Overall Study||170
8466152|NCT00684671|20861387|P1|STARTED|Overall Study||172
8466153|NCT00684645|20861416|P1|NOT COMPLETED|Overall Study||114
8466154|NCT00684645|20861416|P1|COMPLETED|Overall Study||72
8466155|NCT00684645|20861416|P1|STARTED|Overall Study||186
8466156|NCT00684593|20861436|P2|NOT COMPLETED|Overall Study||2
8466157|NCT00684593|20861437|P1|NOT COMPLETED|Overall Study||0
8466158|NCT00684593|20861436|P2|COMPLETED|Overall Study||8
8466159|NCT00684593|20861437|P1|COMPLETED|Overall Study||21
8466160|NCT00684593|20861436|P2|STARTED|Overall Study||10
8466161|NCT00684593|20861437|P1|STARTED|Overall Study||21
8466162|NCT00684567|20861449|P1|NOT COMPLETED|Monotherapy Period||14
8466163|NCT00684567|20861449|P1|COMPLETED|Monotherapy Period||9
8466164|NCT00684567|20861449|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
8466165|NCT00684567|20861449|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
8466166|NCT00684567|20861449|P1|COMPLETED|Concomitant Radiotherapy Period||28
8466167|NCT00684567|20861449|P1|STARTED|Concomitant Radiotherapy Period||30
8466168|NCT00684554|20861459|P2|NOT COMPLETED|Overall Study||0
8466169|NCT00684554|20861460|P1|NOT COMPLETED|Overall Study||0
8466170|NCT00684554|20861459|P2|COMPLETED|Overall Study||10
8466171|NCT00684554|20861460|P1|COMPLETED|Overall Study||10
8466172|NCT00684554|20861459|P2|STARTED|Overall Study||10
8466173|NCT00684554|20861460|P1|STARTED|Overall Study||10
8466174|NCT00684541|20861470|P2|NOT COMPLETED|Overall Study||3
8466175|NCT00684541|20861471|P1|NOT COMPLETED|Overall Study||3
8466176|NCT00684541|20861470|P2|COMPLETED|Overall Study||23
8466177|NCT00684541|20861471|P1|COMPLETED|Overall Study||20
8466178|NCT00684541|20861470|P2|STARTED|Overall Study||26
8466179|NCT00684541|20861471|P1|STARTED|Overall Study||23
8466180|NCT00684515|20861482|P3|NOT COMPLETED|Overall Study||1
8466181|NCT00684515|20861483|P2|NOT COMPLETED|Overall Study||3
8466182|NCT00684515|20861484|P1|NOT COMPLETED|Overall Study||4
8466183|NCT00684515|20861482|P3|COMPLETED|Overall Study||27
8466184|NCT00684515|20861483|P2|COMPLETED|Overall Study||26
8466185|NCT00684515|20861484|P1|COMPLETED|Overall Study||29
8466186|NCT00684515|20861482|P3|STARTED|Overall Study||28
8466187|NCT00684515|20861483|P2|STARTED|Overall Study||29
8466188|NCT00684515|20861484|P1|STARTED|Overall Study||33
8466192|NCT00684411|20861522|P1|NOT COMPLETED|Overall Study||12
8466193|NCT00684411|20861522|P1|COMPLETED|Overall Study||0
8466194|NCT00684411|20861522|P1|Disease Evaluable|Overall Study||11
8466195|NCT00684411|20861522|P1|STARTED|Overall Study||12
8466196|NCT00684320|20861530|P2|NOT COMPLETED|Overall Study||0
8466197|NCT00684320|20861531|P1|NOT COMPLETED|Overall Study||4
8466198|NCT00684320|20861530|P2|COMPLETED|Overall Study||22
8466199|NCT00684320|20861531|P1|COMPLETED|Overall Study||22
8466200|NCT00684320|20861530|P2|STARTED|Overall Study||22
8466201|NCT00684320|20861531|P1|STARTED|Overall Study||26
8466202|NCT00684307|20861544|P5|NOT COMPLETED|Overall Study||25
8466203|NCT00684307|20861545|P4|NOT COMPLETED|Overall Study||32
8466204|NCT00684307|20861546|P3|NOT COMPLETED|Overall Study||28
8466205|NCT00684307|20861547|P2|NOT COMPLETED|Overall Study||22
8466206|NCT00684307|20861548|P1|NOT COMPLETED|Overall Study||24
8466207|NCT00684307|20861544|P5|COMPLETED|Overall Study||293
8466208|NCT00684307|20861545|P4|COMPLETED|Overall Study||128
8466209|NCT00684307|20861546|P3|COMPLETED|Overall Study||128
8466210|NCT00684307|20861547|P2|COMPLETED|Overall Study||129
8466211|NCT00684307|20861548|P1|COMPLETED|Overall Study||140
8466212|NCT00684307|20861544|P5|On Treatment Period Completed|Overall Study||293
8466213|NCT00684307|20861545|P4|On Treatment Period Completed|Overall Study||128
8466214|NCT00684307|20861546|P3|On Treatment Period Completed|Overall Study||128
8466215|NCT00684307|20861547|P2|On Treatment Period Completed|Overall Study||129
8466216|NCT00684307|20861548|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
8466217|NCT00684307|20861544|P5|On Treatment Period Started|Overall Study||318
8466218|NCT00684307|20861545|P4|On Treatment Period Started|Overall Study||160
8466219|NCT00684307|20861546|P3|On Treatment Period Started|Overall Study||156
8466220|NCT00684307|20861547|P2|On Treatment Period Started|Overall Study||151
8466221|NCT00684307|20861548|P1|On Treatment Period Started|Overall Study||164
8466222|NCT00684307|20861544|P5|STARTED|Overall Study||318
8466223|NCT00684307|20861545|P4|STARTED|Overall Study||160
8466224|NCT00684307|20861546|P3|STARTED|Overall Study||156
8466225|NCT00684307|20861547|P2|STARTED|Overall Study||151
8466226|NCT00684307|20861548|P1|STARTED|Overall Study|Patients who received treatment|164
8466227|NCT00684255|20861615|P1|NOT COMPLETED|Overall Study||0
8466228|NCT00684255|20861615|P1|COMPLETED|Overall Study||1
8466229|NCT00684255|20861615|P1|STARTED|Overall Study||1
8466230|NCT00684242|20861620|P1|NOT COMPLETED|Overall Study||0
8466231|NCT00684242|20861620|P1|COMPLETED|Overall Study||3
8466232|NCT00684242|20861620|P1|STARTED|Overall Study||3
8466233|NCT00684203|20861630|P6|NOT COMPLETED|Overall Study||0
8466234|NCT00684203|20861631|P5|NOT COMPLETED|Overall Study||0
8466235|NCT00684203|20861632|P4|NOT COMPLETED|Overall Study||0
8466236|NCT00684203|20861633|P3|NOT COMPLETED|Overall Study||9
8466237|NCT00684203|20861634|P2|NOT COMPLETED|Overall Study||8
8466238|NCT00684203|20861635|P1|NOT COMPLETED|Overall Study||9
8466239|NCT00684203|20861630|P6|COMPLETED|Overall Study||2
8466240|NCT00684203|20861631|P5|COMPLETED|Overall Study||17
8466241|NCT00684203|20861632|P4|COMPLETED|Overall Study||6
8466242|NCT00684203|20861633|P3|COMPLETED|Overall Study||12
8466243|NCT00684203|20861634|P2|COMPLETED|Overall Study||23
8466244|NCT00684203|20861635|P1|COMPLETED|Overall Study||31
8466245|NCT00684203|20861630|P6|STARTED|Overall Study||2
8466246|NCT00684203|20861631|P5|STARTED|Overall Study||17
8466247|NCT00684203|20861632|P4|STARTED|Overall Study||6
8466248|NCT00684203|20861633|P3|STARTED|Overall Study||21
8466249|NCT00684203|20861634|P2|STARTED|Overall Study||31
8466250|NCT00684203|20861635|P1|STARTED|Overall Study||40
8466251|NCT00684177|20861696|P2|NOT COMPLETED|Overall Study||23
8466252|NCT00684177|20861697|P1|NOT COMPLETED|Overall Study||21
8466253|NCT00684177|20861696|P2|COMPLETED|Overall Study||141
8466254|NCT00684177|20861697|P1|COMPLETED|Overall Study||322
8466255|NCT00684177|20861696|P2|STARTED|Overall Study||164
8466256|NCT00684177|20861697|P1|STARTED|Overall Study||343
8466257|NCT00684138|20861715|P2|NOT COMPLETED|Overall Study||8
8466258|NCT00684138|20861716|P1|NOT COMPLETED|Overall Study||3
8466259|NCT00684138|20861715|P2|COMPLETED|Overall Study||131
8466260|NCT00684138|20861716|P1|COMPLETED|Overall Study||138
8466261|NCT00684138|20861715|P2|STARTED|Overall Study||139
8466262|NCT00684138|20861716|P1|STARTED|Overall Study||141
8466263|NCT00684073|20861732|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
8466264|NCT00684073|20861732|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
8466265|NCT00684073|20861732|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
8466266|NCT00684073|20861732|P1|NOT COMPLETED|Selection||7
8466267|NCT00684073|20861732|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
8466268|NCT00684073|20861732|P1|STARTED|Selection||60
8466269|NCT00684060|20861742|P2|NOT COMPLETED|Overall Study||3
8466270|NCT00684060|20861743|P1|NOT COMPLETED|Overall Study||3
8466271|NCT00684060|20861742|P2|COMPLETED|Overall Study||26
8466272|NCT00684060|20861743|P1|COMPLETED|Overall Study||55
8466273|NCT00684060|20861742|P2|STARTED|Overall Study||29
8466274|NCT00684060|20861743|P1|STARTED|Overall Study||58
8466275|NCT00684047|20861766|P3|NOT COMPLETED|Overall Study||5
8466276|NCT00684047|20861767|P2|NOT COMPLETED|Overall Study||16
8466277|NCT00684047|20861768|P1|NOT COMPLETED|Overall Study||13
8466278|NCT00684047|20861766|P3|COMPLETED|Overall Study||52
8466279|NCT00684047|20861767|P2|COMPLETED|Overall Study||94
8466280|NCT00684047|20861768|P1|COMPLETED|Overall Study||59
8466281|NCT00684047|20861766|P3|STARTED|Overall Study||57
8466282|NCT00684047|20861767|P2|STARTED|Overall Study||110
8466283|NCT00684047|20861768|P1|STARTED|Overall Study||72
8466284|NCT00684021|20861782|P4|NOT COMPLETED|Overall Study||2
8466285|NCT00684021|20861783|P3|NOT COMPLETED|Overall Study||2
8466286|NCT00684021|20861784|P2|NOT COMPLETED|Overall Study||2
8466287|NCT00684021|20861785|P1|NOT COMPLETED|Overall Study||2
8466288|NCT00684021|20861782|P4|COMPLETED|Overall Study||15
8466289|NCT00684021|20861783|P3|COMPLETED|Overall Study||34
8466290|NCT00684021|20861784|P2|COMPLETED|Overall Study||22
8466291|NCT00684021|20861785|P1|COMPLETED|Overall Study||41
8466292|NCT00684021|20861782|P4|STARTED|Overall Study||17
8466293|NCT00684021|20861783|P3|STARTED|Overall Study||36
8466294|NCT00684021|20861784|P2|STARTED|Overall Study||24
8466295|NCT00684021|20861785|P1|STARTED|Overall Study||43
8466296|NCT00683930|20861826|P3|NOT COMPLETED|Overall Study||9
8466297|NCT00683930|20861827|P2|NOT COMPLETED|Overall Study||3
8466298|NCT00683930|20861828|P1|NOT COMPLETED|Overall Study||7
8466299|NCT00683930|20861826|P3|COMPLETED|Overall Study||28
8466300|NCT00683930|20861827|P2|COMPLETED|Overall Study||18
8466301|NCT00683930|20861828|P1|COMPLETED|Overall Study||29
8466302|NCT00683930|20861826|P3|STARTED|Overall Study||37
8466303|NCT00683930|20861827|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
8466304|NCT00683930|20861828|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
8466305|NCT00683917|20861846|P1|NOT COMPLETED|Overall Study||10
8466306|NCT00683917|20861846|P1|COMPLETED|Overall Study||0
8466307|NCT00683917|20861846|P1|STARTED|Overall Study||10
8466308|NCT00683904|20861856|P2|NOT COMPLETED|Dose Level 2||2
8466309|NCT00683904|20861857|P1|NOT COMPLETED|Dose Level 2||0
8466310|NCT00683904|20861856|P2|COMPLETED|Dose Level 2||4
8466311|NCT00683904|20861857|P1|COMPLETED|Dose Level 2||0
8466312|NCT00683904|20861856|P2|STARTED|Dose Level 2||6
8466313|NCT00683904|20861857|P1|STARTED|Dose Level 2||0
8466314|NCT00683904|20861856|P2|NOT COMPLETED|Dose Level 1||0
8466315|NCT00683904|20861857|P1|NOT COMPLETED|Dose Level 1||3
8466316|NCT00683904|20861856|P2|COMPLETED|Dose Level 1||0
8466317|NCT00683904|20861857|P1|COMPLETED|Dose Level 1||3
8466318|NCT00683904|20861856|P2|STARTED|Dose Level 1||0
8466319|NCT00683904|20861857|P1|STARTED|Dose Level 1||6
8466320|NCT00683878|20861893|P3|NOT COMPLETED|Overall Study||14
8466321|NCT00683878|20861894|P2|NOT COMPLETED|Overall Study||16
8466322|NCT00683878|20861895|P1|NOT COMPLETED|Overall Study||23
8466323|NCT00683878|20861893|P3|COMPLETED|Overall Study||126
8466324|NCT00683878|20861894|P2|COMPLETED|Overall Study||125
8466325|NCT00683878|20861895|P1|COMPLETED|Overall Study||116
8466326|NCT00683878|20861893|P3|STARTED|Overall Study||140
8466327|NCT00683878|20861894|P2|STARTED|Overall Study||141
8466328|NCT00683878|20861895|P1|STARTED|Overall Study||139
8466329|NCT00683852|20861923|P3|NOT COMPLETED|30-Day Phase 2 Period||9
8466330|NCT00683852|20861924|P2|NOT COMPLETED|30-Day Phase 2 Period||5
8466331|NCT00683852|20861925|P1|NOT COMPLETED|30-Day Phase 2 Period||6
8466332|NCT00683852|20861923|P3|COMPLETED|30-Day Phase 2 Period||75
8466333|NCT00683852|20861924|P2|COMPLETED|30-Day Phase 2 Period||78
8466334|NCT00683852|20861925|P1|COMPLETED|30-Day Phase 2 Period||48
8466335|NCT00683852|20861923|P3|STARTED|30-Day Phase 2 Period||84
8466336|NCT00683852|20861924|P2|STARTED|30-Day Phase 2 Period||83
8466337|NCT00683852|20861925|P1|STARTED|30-Day Phase 2 Period||54
8466338|NCT00683852|20861923|P3|NOT COMPLETED|30-Day Phase 1 Period||1
8466339|NCT00683852|20861924|P2|NOT COMPLETED|30-Day Phase 1 Period||1
8466340|NCT00683852|20861925|P1|NOT COMPLETED|30-Day Phase 1 Period||2
8466341|NCT00683852|20861923|P3|COMPLETED|30-Day Phase 1 Period||84
8466342|NCT00683852|20861924|P2|COMPLETED|30-Day Phase 1 Period||83
8466343|NCT00683852|20861925|P1|COMPLETED|30-Day Phase 1 Period||54
8466344|NCT00683852|20861923|P3|STARTED|30-Day Phase 1 Period||85
8466345|NCT00683852|20861924|P2|STARTED|30-Day Phase 1 Period||84
8466346|NCT00683852|20861925|P1|STARTED|30-Day Phase 1 Period||56
8466347|NCT00683826|20861959|P1|NOT COMPLETED|Overall Study||1
8466348|NCT00683826|20861959|P1|COMPLETED|Overall Study||7
8466349|NCT00683826|20861959|P1|4g Leucine|Overall Study||7
8466350|NCT00683826|20861959|P1|8g Leucine|Overall Study||8
8466351|NCT00683826|20861959|P1|0g Leucine|Overall Study||8
8466352|NCT00683826|20861959|P1|STARTED|Overall Study||8
8466353|NCT00683800|20861969|P2|NOT COMPLETED|Overall Study||366
8466354|NCT00683800|20861970|P1|NOT COMPLETED|Overall Study||432
8466355|NCT00683800|20861969|P2|COMPLETED|Overall Study||719
8466356|NCT00683800|20861970|P1|COMPLETED|Overall Study||669
8466357|NCT00683800|20861969|P2|Treated|Overall Study||1052
8466358|NCT00683800|20861970|P1|Treated|Overall Study||1066
8466359|NCT00683800|20861969|P2|STARTED|Overall Study||1085
8466360|NCT00683800|20861970|P1|STARTED|Overall Study||1101
8466361|NCT00683787|20862037|P3|NOT COMPLETED|Overall Study||2
8466362|NCT00683787|20862038|P2|NOT COMPLETED|Overall Study||3
8466363|NCT00683787|20862039|P1|NOT COMPLETED|Overall Study||3
8466364|NCT00683787|20862037|P3|COMPLETED|Overall Study||0
8466365|NCT00683787|20862038|P2|COMPLETED|Overall Study||0
8466366|NCT00683787|20862039|P1|COMPLETED|Overall Study||0
8466367|NCT00683787|20862037|P3|STARTED|Overall Study||2
8466368|NCT00683787|20862038|P2|STARTED|Overall Study||3
8466369|NCT00683787|20862039|P1|STARTED|Overall Study||3
8466370|NCT00683774|20862058|P2|NOT COMPLETED|Overall Study||1
8466371|NCT00683774|20862059|P1|NOT COMPLETED|Overall Study||3
8466372|NCT00683774|20862058|P2|COMPLETED|Overall Study||9
8466373|NCT00683774|20862059|P1|COMPLETED|Overall Study||8
8466374|NCT00683774|20862058|P2|STARTED|Overall Study||10
8466375|NCT00683774|20862059|P1|STARTED|Overall Study||11
8466376|NCT00683696|20862069|P2|NOT COMPLETED|Overall Study||405
8466377|NCT00683696|20862070|P1|NOT COMPLETED|Overall Study||404
8466378|NCT00683696|20862069|P2|COMPLETED|Overall Study||0
8466379|NCT00683696|20862070|P1|COMPLETED|Overall Study||0
8466380|NCT00683696|20862069|P2|STARTED|Overall Study||405
8466381|NCT00683696|20862070|P1|STARTED|Overall Study||404
8466382|NCT00683657|20862089|P2|NOT COMPLETED|Overall Study||1
8466383|NCT00683657|20862090|P1|NOT COMPLETED|Overall Study||1
8466384|NCT00683657|20862089|P2|COMPLETED|Overall Study||46
8466385|NCT00683657|20862090|P1|COMPLETED|Overall Study||45
8466386|NCT00683657|20862089|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
8466387|NCT00683657|20862090|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
8466388|NCT00683657|20862089|P2|STARTED|Overall Study||47
8466389|NCT00683657|20862090|P1|STARTED|Overall Study||46
8466390|NCT00683644|20862106|P2|NOT COMPLETED|Overall Study||14
8466391|NCT00683644|20862107|P1|NOT COMPLETED|Overall Study||13
8466392|NCT00683644|20862106|P2|COMPLETED|Overall Study||44
8466393|NCT00683644|20862107|P1|COMPLETED|Overall Study||45
8466394|NCT00683644|20862106|P2|STARTED|Overall Study||58
8466395|NCT00683644|20862107|P1|STARTED|Overall Study||58
8466396|NCT00683618|20862120|P3|NOT COMPLETED|Extension Treatment Period||0
8466397|NCT00683618|20862121|P2|NOT COMPLETED|Extension Treatment Period||0
8466398|NCT00683618|20862122|P1|NOT COMPLETED|Extension Treatment Period||3
8466399|NCT00683618|20862120|P3|COMPLETED|Extension Treatment Period||0
8466400|NCT00683618|20862121|P2|COMPLETED|Extension Treatment Period||23
8466401|NCT00683618|20862122|P1|COMPLETED|Extension Treatment Period||33
8466402|NCT00683618|20862120|P3|STARTED|Extension Treatment Period||0
8466403|NCT00683618|20862121|P2|STARTED|Extension Treatment Period||23
8466404|NCT00683618|20862122|P1|STARTED|Extension Treatment Period||36
8466405|NCT00683618|20862120|P3|NOT COMPLETED|Randomised Treatment Period||6
8466406|NCT00683618|20862121|P2|NOT COMPLETED|Randomised Treatment Period||2
8466407|NCT00683618|20862122|P1|NOT COMPLETED|Randomised Treatment Period||6
8466408|NCT00683618|20862120|P3|COMPLETED|Randomised Treatment Period||140
8466409|NCT00683618|20862121|P2|COMPLETED|Randomised Treatment Period||143
8466410|NCT00683618|20862122|P1|COMPLETED|Randomised Treatment Period||139
8466411|NCT00683618|20862120|P3|STARTED|Randomised Treatment Period||146
8466412|NCT00683618|20862121|P2|STARTED|Randomised Treatment Period||145
8466413|NCT00683618|20862122|P1|STARTED|Randomised Treatment Period||145
8466414|NCT00683592|20862172|P2|NOT COMPLETED|Overall Study||46
8466415|NCT00683592|20862173|P1|NOT COMPLETED|Overall Study||47
8466416|NCT00683592|20862172|P2|COMPLETED|Overall Study||195
8466417|NCT00683592|20862173|P1|COMPLETED|Overall Study||193
8466418|NCT00683592|20862172|P2|Safety Population|Overall Study||233
8466419|NCT00683592|20862173|P1|Safety Population|Overall Study||235
8466420|NCT00683592|20862172|P2|Intent to Treat Population|Overall Study||232
8466421|NCT00683592|20862173|P1|Intent to Treat Population|Overall Study||231
8466422|NCT00683592|20862172|P2|STARTED|Overall Study||241
8466423|NCT00683592|20862173|P1|STARTED|Overall Study||240
8466424|NCT00683475|20862191|P2|NOT COMPLETED|Overall Study||3
8466425|NCT00683475|20862192|P1|NOT COMPLETED|Overall Study||4
8466426|NCT00683475|20862191|P2|COMPLETED|Overall Study||66
8466427|NCT00683475|20862192|P1|COMPLETED|Overall Study||65
8466428|NCT00683475|20862191|P2|Received Any Quantity of Study Drug|Overall Study||66
8466429|NCT00683475|20862192|P1|Received Any Quantity of Study Drug|Overall Study||66
8466430|NCT00683475|20862191|P2|STARTED|Overall Study||69
8466431|NCT00683475|20862192|P1|STARTED|Overall Study||69
8466432|NCT00683449|20862227|P5|NOT COMPLETED|Overall Study||0
8466433|NCT00683449|20862228|P4|NOT COMPLETED|Overall Study||0
8466434|NCT00683449|20862229|P3|NOT COMPLETED|Overall Study||0
8466435|NCT00683449|20862230|P2|NOT COMPLETED|Overall Study||1
8466436|NCT00683449|20862231|P1|NOT COMPLETED|Overall Study||0
8466437|NCT00683449|20862227|P5|COMPLETED|Overall Study||2
8466438|NCT00683449|20862228|P4|COMPLETED|Overall Study||6
8466439|NCT00683449|20862229|P3|COMPLETED|Overall Study||3
8466440|NCT00683449|20862230|P2|COMPLETED|Overall Study||12
8466441|NCT00683449|20862231|P1|COMPLETED|Overall Study||5
8466442|NCT00683449|20862227|P5|STARTED|Overall Study||2
8466443|NCT00683449|20862228|P4|STARTED|Overall Study||6
8466444|NCT00683449|20862229|P3|STARTED|Overall Study||3
8466445|NCT00683449|20862230|P2|STARTED|Overall Study||13
8466446|NCT00683449|20862231|P1|STARTED|Overall Study||5
8466447|NCT00683410|20862253|P1|NOT COMPLETED|Overall Study||0
8466448|NCT00683410|20862253|P1|COMPLETED|Overall Study||3366
8466449|NCT00683410|20862253|P1|Vaccinated Dose 4|Overall Study||175
8466450|NCT00683410|20862253|P1|Vaccinated Dose 3|Overall Study||817
8466451|NCT00683410|20862253|P1|Vaccinated Dose 2|Overall Study||1623
8466452|NCT00683410|20862253|P1|Vaccinated Dose 1|Overall Study||3240
8466453|NCT00683410|20862253|P1|STARTED|Overall Study||3366
8466454|NCT00683384|20862257|P1|NOT COMPLETED|Overall Study||2
8466455|NCT00683384|20862257|P1|COMPLETED|Overall Study||91
8466456|NCT00683384|20862257|P1|STARTED|Overall Study||93
8466457|NCT00683332|20862261|P1|NOT COMPLETED|Overall Study||0
8466458|NCT00683332|20862261|P1|COMPLETED|Overall Study||621
8466459|NCT00683332|20862261|P1|STARTED|Overall Study||621
8466460|NCT00683293|20862267|P2|NOT COMPLETED|Overall Study||3
8466461|NCT00683293|20862268|P1|NOT COMPLETED|Overall Study||2
8466462|NCT00683293|20862267|P2|COMPLETED|Overall Study||47
8466463|NCT00683293|20862268|P1|COMPLETED|Overall Study||48
8466464|NCT00683293|20862267|P2|STARTED|Overall Study||50
8466465|NCT00683293|20862268|P1|STARTED|Overall Study||50
8466466|NCT00683163|20862278|P2|NOT COMPLETED|Overall Study||0
8466467|NCT00683163|20862279|P1|NOT COMPLETED|Overall Study||0
8466468|NCT00683163|20862278|P2|COMPLETED|Overall Study||22
8466469|NCT00683163|20862279|P1|COMPLETED|Overall Study||22
8466470|NCT00683163|20862278|P2|STARTED|Overall Study||22
8466471|NCT00683163|20862279|P1|STARTED|Overall Study||22
8466472|NCT00683085|20862287|P1|NOT COMPLETED|Overall Study||0
8466473|NCT00683085|20862287|P1|COMPLETED|Overall Study||2
8466474|NCT00683085|20862287|P1|STARTED|Overall Study||2
8466475|NCT00683046|20862292|P1|NOT COMPLETED|Overall Study||0
8466476|NCT00683046|20862292|P1|COMPLETED|Overall Study||204
8466477|NCT00683046|20862292|P1|STARTED|Overall Study||204
8466478|NCT00683020|20862299|P2|NOT COMPLETED|Overall Study||55
8466479|NCT00683020|20862300|P1|NOT COMPLETED|Overall Study||55
8466480|NCT00683020|20862299|P2|COMPLETED|Overall Study||125
8466481|NCT00683020|20862300|P1|COMPLETED|Overall Study||127
8466482|NCT00683020|20862299|P2|STARTED|Overall Study||180
8466483|NCT00683020|20862300|P1|STARTED|Overall Study||182
8466484|NCT00682929|20862331|P3|NOT COMPLETED|Overall Study||2
8466485|NCT00682929|20862332|P2|NOT COMPLETED|Overall Study||5
8466486|NCT00682929|20862333|P1|NOT COMPLETED|Overall Study||6
8466487|NCT00682929|20862331|P3|COMPLETED|Overall Study||12
8466488|NCT00682929|20862332|P2|COMPLETED|Overall Study||9
8466489|NCT00682929|20862333|P1|COMPLETED|Overall Study||7
8466490|NCT00682929|20862331|P3|STARTED|Overall Study||14
8466491|NCT00682929|20862332|P2|STARTED|Overall Study||14
8466492|NCT00682929|20862333|P1|STARTED|Overall Study||13
8466493|NCT00682890|20862502|P2|NOT COMPLETED|Overall Study||2
8466494|NCT00682890|20862503|P1|NOT COMPLETED|Overall Study||2
8466495|NCT00682890|20862502|P2|COMPLETED|Overall Study||9
8466496|NCT00682890|20862503|P1|COMPLETED|Overall Study||10
8466497|NCT00682890|20862502|P2|STARTED|Overall Study||11
8466498|NCT00682890|20862503|P1|STARTED|Overall Study||12
8466499|NCT00682851|20862513|P2|NOT COMPLETED|Overall Study||0
8466500|NCT00682851|20862514|P1|NOT COMPLETED|Overall Study||0
8466501|NCT00682851|20862513|P2|COMPLETED|Overall Study||268
8466502|NCT00682851|20862514|P1|COMPLETED|Overall Study||251
8466503|NCT00682851|20862513|P2|STARTED|Overall Study||268
8466504|NCT00682851|20862514|P1|STARTED|Overall Study||251
8466505|NCT00682838|20862530|P4|NOT COMPLETED|Overall Study||0
8466506|NCT00682838|20862531|P3|NOT COMPLETED|Overall Study||0
8466507|NCT00682838|20862532|P2|NOT COMPLETED|Overall Study||0
8466508|NCT00682838|20862533|P1|NOT COMPLETED|Overall Study||0
8466509|NCT00682838|20862530|P4|COMPLETED|Overall Study||73
8466510|NCT00682838|20862531|P3|COMPLETED|Overall Study||75
8466511|NCT00682838|20862532|P2|COMPLETED|Overall Study||67
8466512|NCT00682838|20862533|P1|COMPLETED|Overall Study||65
8466513|NCT00682838|20862530|P4|STARTED|Overall Study||73
8466514|NCT00682838|20862531|P3|STARTED|Overall Study||75
8466515|NCT00682838|20862532|P2|STARTED|Overall Study||67
8466516|NCT00682838|20862533|P1|STARTED|Overall Study||65
8466517|NCT00682786|20862545|P2|NOT COMPLETED|Overall Study||3
8466518|NCT00682786|20862546|P1|NOT COMPLETED|Overall Study||2
8466519|NCT00682786|20862545|P2|COMPLETED|Overall Study||34
8466520|NCT00682786|20862546|P1|COMPLETED|Overall Study||96
8466521|NCT00682786|20862545|P2|STARTED|Overall Study||37
8466522|NCT00682786|20862546|P1|STARTED|Overall Study||98
8466523|NCT00682734|20862583|P3|NOT COMPLETED|48 Hour Follow-up||11
8466524|NCT00682734|20862584|P2|NOT COMPLETED|48 Hour Follow-up||6
8466525|NCT00682734|20862585|P1|NOT COMPLETED|48 Hour Follow-up||6
8466526|NCT00682734|20862583|P3|COMPLETED|48 Hour Follow-up||106
8466527|NCT00682734|20862584|P2|COMPLETED|48 Hour Follow-up||111
8466528|NCT00682734|20862585|P1|COMPLETED|48 Hour Follow-up||107
8466529|NCT00682734|20862583|P3|STARTED|48 Hour Follow-up||117
8466530|NCT00682734|20862584|P2|STARTED|48 Hour Follow-up||117
8466531|NCT00682734|20862585|P1|STARTED|48 Hour Follow-up||113
8466532|NCT00682734|20862583|P3|NOT COMPLETED|Emergency Department Portion||1
8466533|NCT00682734|20862584|P2|NOT COMPLETED|Emergency Department Portion||1
8466534|NCT00682734|20862585|P1|NOT COMPLETED|Emergency Department Portion||0
8466535|NCT00682734|20862583|P3|COMPLETED|Emergency Department Portion||117
8466536|NCT00682734|20862584|P2|COMPLETED|Emergency Department Portion||117
8466537|NCT00682734|20862585|P1|COMPLETED|Emergency Department Portion||113
8466538|NCT00682734|20862583|P3|STARTED|Emergency Department Portion||118
8466539|NCT00682734|20862584|P2|STARTED|Emergency Department Portion||118
8466540|NCT00682734|20862585|P1|STARTED|Emergency Department Portion||113
8466541|NCT00682643|20862595|P2|NOT COMPLETED|Overall Study||169
8466542|NCT00682643|20862596|P1|NOT COMPLETED|Overall Study||78
8466543|NCT00682643|20862595|P2|COMPLETED|Overall Study||199
8466544|NCT00682643|20862596|P1|COMPLETED|Overall Study||104
8466545|NCT00682643|20862595|P2|STARTED|Overall Study||368
8466546|NCT00682643|20862596|P1|STARTED|Overall Study||182
8466547|NCT00682617|20862630|P2|NOT COMPLETED|Overall Study||7
8466548|NCT00682617|20862631|P1|NOT COMPLETED|Overall Study||3
8466549|NCT00682617|20862630|P2|COMPLETED|Overall Study||21
8466550|NCT00682617|20862631|P1|COMPLETED|Overall Study||10
8466551|NCT00682617|20862630|P2|STARTED|Overall Study||28
8466552|NCT00682617|20862631|P1|STARTED|Overall Study||13
8466553|NCT00682565|20862644|P3|NOT COMPLETED|Overall Study||0
8466554|NCT00682565|20862645|P2|NOT COMPLETED|Overall Study||3
8466555|NCT00682565|20862646|P1|NOT COMPLETED|Overall Study||1
8466556|NCT00682565|20862644|P3|COMPLETED|Overall Study||29
8466557|NCT00682565|20862645|P2|COMPLETED|Overall Study||32
8466558|NCT00682565|20862646|P1|COMPLETED|Overall Study||30
8466559|NCT00682565|20862644|P3|STARTED|Overall Study||29
8466560|NCT00682565|20862645|P2|STARTED|Overall Study||35
8466561|NCT00682565|20862646|P1|STARTED|Overall Study||31
8466562|NCT00682539|20862670|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
8466563|NCT00682539|20862671|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
8466564|NCT00682539|20862672|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
8466565|NCT00682539|20862670|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
8466566|NCT00682539|20862671|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
8466567|NCT00682539|20862672|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
8466568|NCT00682539|20862670|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
8466569|NCT00682539|20862671|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
8466570|NCT00682539|20862672|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
8466571|NCT00682539|20862670|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
8466572|NCT00682539|20862671|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
8466573|NCT00682539|20862672|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
8466574|NCT00682539|20862670|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
8466575|NCT00682539|20862671|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
8466576|NCT00682539|20862672|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
8466577|NCT00682539|20862670|P3|STARTED|Bevacizumab vs Triamcinolone||0
8466578|NCT00682539|20862671|P2|STARTED|Bevacizumab vs Triamcinolone||16
8466579|NCT00682539|20862672|P1|STARTED|Bevacizumab vs Triamcinolone||18
8466580|NCT00682461|20862685|P2|NOT COMPLETED|Overall Study||31
8466581|NCT00682461|20862686|P1|NOT COMPLETED|Overall Study||25
8466582|NCT00682461|20862685|P2|COMPLETED|Overall Study||69
8466583|NCT00682461|20862686|P1|COMPLETED|Overall Study||75
8466584|NCT00682461|20862685|P2|STARTED|Overall Study||100
8466585|NCT00682461|20862686|P1|STARTED|Overall Study||100
8466586|NCT00682435|20862700|P1|NOT COMPLETED|Overall Study||7
8466587|NCT00682435|20862700|P1|COMPLETED|Overall Study||223
8466588|NCT00682435|20862700|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
8466589|NCT00682435|20862700|P1|Ensured Enrolled Only Once|Overall Study||228
8466590|NCT00682435|20862700|P1|STARTED|Overall Study||230
8466591|NCT00682357|20862710|P3|NOT COMPLETED|Overall Study||0
8466592|NCT00682357|20862711|P2|NOT COMPLETED|Overall Study||0
8466593|NCT00682357|20862712|P1|NOT COMPLETED|Overall Study||0
8466594|NCT00682357|20862710|P3|COMPLETED|Overall Study||5
8466595|NCT00682357|20862711|P2|COMPLETED|Overall Study||10
8466596|NCT00682357|20862712|P1|COMPLETED|Overall Study||10
8466597|NCT00682357|20862710|P3|STARTED|Overall Study||5
8466598|NCT00682357|20862711|P2|STARTED|Overall Study||10
8466599|NCT00682357|20862712|P1|STARTED|Overall Study||10
8466600|NCT00681889|20862729|P1|NOT COMPLETED|Overall Study||0
8466601|NCT00681889|20862729|P1|COMPLETED|Overall Study||9
8466602|NCT00681889|20862729|P1|STARTED|Overall Study||9
8466603|NCT00681863|20862733|P1|NOT COMPLETED|Overall Study||23
8466604|NCT00681863|20862733|P1|COMPLETED|Overall Study||22
8466605|NCT00681863|20862733|P1|STARTED|Overall Study||45
8466606|NCT00681824|20862781|P3|NOT COMPLETED|Overall Study||1
8466607|NCT00681824|20862782|P2|NOT COMPLETED|Overall Study||1
8466608|NCT00681824|20862783|P1|NOT COMPLETED|Overall Study||1
8466609|NCT00681824|20862781|P3|COMPLETED|Overall Study||33
8466610|NCT00681824|20862782|P2|COMPLETED|Overall Study||12
8466611|NCT00681824|20862783|P1|COMPLETED|Overall Study||27
8466612|NCT00681824|20862781|P3|STARTED|Overall Study||34
8466613|NCT00681824|20862782|P2|STARTED|Overall Study||13
8466614|NCT00681824|20862783|P1|STARTED|Overall Study||28
8466615|NCT00681811|20862801|P2|NOT COMPLETED|Overall Study||4
8466616|NCT00681811|20862802|P1|NOT COMPLETED|Overall Study||3
8466617|NCT00681811|20862801|P2|COMPLETED|Overall Study||1
8466618|NCT00681811|20862802|P1|COMPLETED|Overall Study||3
8466619|NCT00681811|20862801|P2|STARTED|Overall Study||5
8466620|NCT00681811|20862802|P1|STARTED|Overall Study||6
8466621|NCT00681668|20862830|P1|NOT COMPLETED|Overall Study||2
8466622|NCT00681668|20862830|P1|COMPLETED|Overall Study||3
8466623|NCT00681668|20862830|P1|STARTED|Overall Study||5
8466624|NCT00681629|20862839|P2|NOT COMPLETED|Overall Study||2
8466625|NCT00681629|20862840|P1|NOT COMPLETED|Overall Study||5
8466626|NCT00681629|20862839|P2|COMPLETED|Overall Study||0
8466627|NCT00681629|20862840|P1|COMPLETED|Overall Study||0
8466628|NCT00681629|20862839|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
8466629|NCT00681629|20862840|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
8466630|NCT00681590|20862886|P2|NOT COMPLETED|Overall Study||12
8466631|NCT00681590|20862887|P1|NOT COMPLETED|Overall Study||2
8466632|NCT00681590|20862886|P2|COMPLETED|Overall Study||59
8466633|NCT00681590|20862887|P1|COMPLETED|Overall Study||32
8466634|NCT00681590|20862886|P2|STARTED|Overall Study||71
8466635|NCT00681590|20862887|P1|STARTED|Overall Study||34
8466636|NCT00681564|20862897|P2|NOT COMPLETED|Overall Study||8
8466637|NCT00681564|20862898|P1|NOT COMPLETED|Overall Study||6
8466638|NCT00681564|20862897|P2|COMPLETED|Overall Study||47
8466639|NCT00681564|20862898|P1|COMPLETED|Overall Study||41
8466640|NCT00681564|20862897|P2|STARTED|Overall Study||55
8466641|NCT00681564|20862898|P1|STARTED|Overall Study||47
8466642|NCT00681538|20862928|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
8466643|NCT00681538|20862929|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
8466644|NCT00681538|20862928|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
8466645|NCT00681538|20862929|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
8466646|NCT00681538|20862928|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
8466647|NCT00681538|20862929|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
8466648|NCT00681538|20862928|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
8466649|NCT00681538|20862929|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
8466650|NCT00681538|20862928|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
8466651|NCT00681538|20862929|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
8466652|NCT00681538|20862928|P2|STARTED|Phase A- 4 Weeks Single Blind||0
8466653|NCT00681538|20862929|P1|STARTED|Phase A- 4 Weeks Single Blind||572
8466654|NCT00681473|20862959|P1|NOT COMPLETED|Overall Study||0
8466655|NCT00681473|20862959|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
8466656|NCT00681473|20862959|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
8466657|NCT00681291|20862967|P2|NOT COMPLETED|Overall Study||27
8466658|NCT00681291|20862968|P1|NOT COMPLETED|Overall Study||13
8466659|NCT00681291|20862967|P2|COMPLETED|Overall Study||57
8466660|NCT00681291|20862968|P1|COMPLETED|Overall Study||75
8466661|NCT00681291|20862967|P2|STARTED|Overall Study||84
8466662|NCT00681291|20862968|P1|STARTED|Overall Study||88
8466663|NCT00681265|20862980|P1|NOT COMPLETED|Overall Study||0
8466664|NCT00681265|20862980|P1|COMPLETED|Overall Study||16
8466665|NCT00681265|20862980|P1|STARTED|Overall Study||16
8466666|NCT00681187|20862990|P2|NOT COMPLETED|Overall Study||2
8466667|NCT00681187|20862991|P1|NOT COMPLETED|Overall Study||1
8466668|NCT00681187|20862990|P2|COMPLETED|Overall Study||13
8466669|NCT00681187|20862991|P1|COMPLETED|Overall Study||10
8466670|NCT00681187|20862990|P2|STARTED|Overall Study||15
8466671|NCT00681187|20862991|P1|STARTED|Overall Study||11
8466672|NCT00681109|20863026|P3|NOT COMPLETED|Overall Study||0
8466673|NCT00681109|20863027|P2|NOT COMPLETED|Overall Study||6
8466674|NCT00681109|20863028|P1|NOT COMPLETED|Overall Study||2
8466675|NCT00681109|20863026|P3|COMPLETED|Overall Study||15
8466676|NCT00681109|20863027|P2|COMPLETED|Overall Study||24
8466677|NCT00681109|20863028|P1|COMPLETED|Overall Study||28
8466678|NCT00681109|20863026|P3|STARTED|Overall Study||15
8466679|NCT00681109|20863027|P2|STARTED|Overall Study||30
8466680|NCT00681109|20863028|P1|STARTED|Overall Study||30
8466681|NCT00681083|20863045|P2|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
8466682|NCT00681083|20863046|P1|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
8466683|NCT00681083|20863045|P2|COMPLETED|Night 2 (Crossover of Night 1)||10
8466684|NCT00681083|20863046|P1|COMPLETED|Night 2 (Crossover of Night 1)||10
8466685|NCT00681083|20863045|P2|STARTED|Night 2 (Crossover of Night 1)||10
8466686|NCT00681083|20863046|P1|STARTED|Night 2 (Crossover of Night 1)||10
8466687|NCT00681083|20863045|P2|NOT COMPLETED|Night 1||3
8466688|NCT00681083|20863046|P1|NOT COMPLETED|Night 1||3
8466689|NCT00681083|20863045|P2|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
8466690|NCT00681083|20863046|P1|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
8466691|NCT00681083|20863045|P2|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
8466692|NCT00681083|20863046|P1|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
8466693|NCT00681044|20863054|P1|NOT COMPLETED|Overall Study||0
8466694|NCT00681044|20863054|P1|COMPLETED|Overall Study||4
8466695|NCT00681044|20863054|P1|STARTED|Overall Study||4
8466696|NCT00681031|20863062|P1|NOT COMPLETED|Overall Study||0
8466697|NCT00681031|20863062|P1|COMPLETED|Overall Study||96
8466698|NCT00681031|20863062|P1|STARTED|Overall Study||96
8466699|NCT00680992|20863069|P3|NOT COMPLETED|Overall Study||12
8466700|NCT00680992|20863070|P2|NOT COMPLETED|Overall Study||252
8466701|NCT00680992|20863071|P1|NOT COMPLETED|Overall Study||268
8466702|NCT00680992|20863069|P3|COMPLETED|Overall Study||0
8466703|NCT00680992|20863070|P2|COMPLETED|Overall Study||0
8466704|NCT00680992|20863071|P1|COMPLETED|Overall Study||0
8466705|NCT00680992|20863069|P3|Efficacy Analysis Set|Overall Study||11
8466706|NCT00680992|20863070|P2|Efficacy Analysis Set|Overall Study||242
8466707|NCT00680992|20863071|P1|Efficacy Analysis Set|Overall Study||260
8466708|NCT00680992|20863069|P3|Safety Analysis Set|Overall Study||12
8466709|NCT00680992|20863070|P2|Safety Analysis Set|Overall Study||249
8466710|NCT00680992|20863071|P1|Safety Analysis Set|Overall Study||265
8466711|NCT00680992|20863069|P3|STARTED|Overall Study||12
8466712|NCT00680992|20863070|P2|STARTED|Overall Study||252
8466713|NCT00680992|20863071|P1|STARTED|Overall Study||268
8466714|NCT00680953|20863087|P3|NOT COMPLETED|Overall Study||47
8466715|NCT00680953|20863088|P2|NOT COMPLETED|Overall Study||95
8466716|NCT00680953|20863089|P1|NOT COMPLETED|Overall Study||86
8466717|NCT00680953|20863087|P3|COMPLETED|Overall Study||204
8466718|NCT00680953|20863088|P2|COMPLETED|Overall Study||416
8466719|NCT00680953|20863089|P1|COMPLETED|Overall Study||414
8466720|NCT00680953|20863087|P3|STARTED|Overall Study||251
8466721|NCT00680953|20863088|P2|STARTED|Overall Study||511
8466722|NCT00680953|20863089|P1|STARTED|Overall Study||500
8466723|NCT00680914|20863105|P2|NOT COMPLETED|Overall Study||4
8466724|NCT00680914|20863106|P1|NOT COMPLETED|Overall Study||10
8466725|NCT00680914|20863105|P2|COMPLETED|Overall Study||125
8466726|NCT00680914|20863106|P1|COMPLETED|Overall Study||364
8466727|NCT00680914|20863105|P2|STARTED|Overall Study||129
8466728|NCT00680914|20863106|P1|STARTED|Overall Study||374
8466729|NCT00680901|20863140|P2|NOT COMPLETED|Overall Study||76
8466730|NCT00680901|20863141|P1|NOT COMPLETED|Overall Study||73
8466731|NCT00680901|20863140|P2|COMPLETED|Overall Study||197
8466732|NCT00680901|20863141|P1|COMPLETED|Overall Study||199
8466733|NCT00680901|20863140|P2|Ongoing: In Follow Up|Overall Study||41
8466734|NCT00680901|20863141|P1|Ongoing: In Follow Up|Overall Study||45
8466735|NCT00680901|20863140|P2|Ongoing: On Study Treatment|Overall Study||13
8466736|NCT00680901|20863141|P1|Ongoing: On Study Treatment|Overall Study||16
8466737|NCT00680901|20863140|P2|STARTED|Overall Study||273
8466738|NCT00680901|20863141|P1|STARTED|Overall Study||272
8466739|NCT00680862|20863173|P1|NOT COMPLETED|Overall Study||0
8466740|NCT00680862|20863173|P1|COMPLETED|Overall Study||25
8466741|NCT00680862|20863173|P1|STARTED|Overall Study||25
8466742|NCT00680836|20863179|P2|NOT COMPLETED|Overall Study||2
8466743|NCT00680836|20863180|P1|NOT COMPLETED|Overall Study||8
8466744|NCT00680836|20863179|P2|COMPLETED|Overall Study||25
8466745|NCT00680836|20863180|P1|COMPLETED|Overall Study||19
8466746|NCT00680836|20863179|P2|STARTED|Overall Study||27
8466747|NCT00680836|20863180|P1|STARTED|Overall Study||27
8466748|NCT00680823|20863199|P3|NOT COMPLETED|Overall Study||0
8466749|NCT00680823|20863200|P2|NOT COMPLETED|Overall Study||0
8466750|NCT00680823|20863201|P1|NOT COMPLETED|Overall Study||0
8466751|NCT00680823|20863199|P3|COMPLETED|Overall Study||50
8466752|NCT00680823|20863200|P2|COMPLETED|Overall Study||50
8466753|NCT00680823|20863201|P1|COMPLETED|Overall Study||50
8466754|NCT00680823|20863199|P3|STARTED|Overall Study||50
8466755|NCT00680823|20863200|P2|STARTED|Overall Study||50
8466756|NCT00680823|20863201|P1|STARTED|Overall Study||50
8466757|NCT00680797|20863219|P4|NOT COMPLETED|Overall Study||0
8466758|NCT00680797|20863220|P3|NOT COMPLETED|Overall Study||0
8466759|NCT00680797|20863221|P2|NOT COMPLETED|Overall Study||0
8466760|NCT00680797|20863222|P1|NOT COMPLETED|Overall Study||0
8466761|NCT00680797|20863219|P4|COMPLETED|Overall Study||8
8466762|NCT00680797|20863220|P3|COMPLETED|Overall Study||8
8466763|NCT00680797|20863221|P2|COMPLETED|Overall Study||8
8466764|NCT00680797|20863222|P1|COMPLETED|Overall Study||9
8466765|NCT00680797|20863219|P4|STARTED|Overall Study||8
8466766|NCT00680797|20863220|P3|STARTED|Overall Study||8
8466767|NCT00680797|20863221|P2|STARTED|Overall Study||8
8466768|NCT00680797|20863222|P1|STARTED|Overall Study||9
8466769|NCT00680771|20863234|P2|NOT COMPLETED|Overall Study||2
8466770|NCT00680771|20863235|P1|NOT COMPLETED|Overall Study||6
8466771|NCT00680771|20863234|P2|COMPLETED|Overall Study||11
8466772|NCT00680771|20863235|P1|COMPLETED|Overall Study||9
8466773|NCT00680771|20863234|P2|STARTED|Overall Study||13
8466774|NCT00680771|20863235|P1|STARTED|Overall Study||15
8466775|NCT00680745|20863245|P4|NOT COMPLETED|Overall Study||13
8466776|NCT00680745|20863246|P3|NOT COMPLETED|Overall Study||10
8466777|NCT00680745|20863247|P2|NOT COMPLETED|Overall Study||13
8466778|NCT00680745|20863248|P1|NOT COMPLETED|Overall Study||14
8466779|NCT00680745|20863245|P4|COMPLETED|Overall Study||133
8466780|NCT00680745|20863246|P3|COMPLETED|Overall Study||141
8466781|NCT00680745|20863247|P2|COMPLETED|Overall Study||132
8466782|NCT00680745|20863248|P1|COMPLETED|Overall Study||140
8466783|NCT00680745|20863245|P4|STARTED|Overall Study|Safety Analysis Set|146
8466784|NCT00680745|20863246|P3|STARTED|Overall Study|Safety Analysis Set|151
8466785|NCT00680745|20863247|P2|STARTED|Overall Study|Safety Analysis Set|145
8466786|NCT00680745|20863248|P1|STARTED|Overall Study|Safety Analysis Set|154
8466787|NCT00680706|20863280|P2|NOT COMPLETED|Overall Study||5
8466788|NCT00680706|20863281|P1|NOT COMPLETED|Overall Study||7
8466789|NCT00680706|20863280|P2|COMPLETED|Overall Study||55
8466790|NCT00680706|20863281|P1|COMPLETED|Overall Study||63
8466791|NCT00680706|20863280|P2|STARTED|Overall Study||60
8466792|NCT00680706|20863281|P1|STARTED|Overall Study||70
8466793|NCT00680628|20863291|P2|NOT COMPLETED|Overall Study||0
8466794|NCT00680628|20863292|P1|NOT COMPLETED|Overall Study||0
8466795|NCT00680628|20863291|P2|COMPLETED|Overall Study||40
8466796|NCT00680628|20863292|P1|COMPLETED|Overall Study||43
8466797|NCT00680628|20863291|P2|STARTED|Overall Study||40
8466798|NCT00680628|20863292|P1|STARTED|Overall Study||43
8466799|NCT00680524|20863302|P1|NOT COMPLETED|Overall Study||3
8466800|NCT00680524|20863302|P1|COMPLETED|Overall Study||17
8466801|NCT00680524|20863302|P1|STARTED|Overall Study||20
8466802|NCT00680459|20863308|P2|NOT COMPLETED|Overall Study||0
8466803|NCT00680459|20863309|P1|NOT COMPLETED|Overall Study||0
8466804|NCT00680459|20863308|P2|COMPLETED|Overall Study||6
8466805|NCT00680459|20863309|P1|COMPLETED|Overall Study||7
8466806|NCT00680459|20863308|P2|STARTED|Overall Study||6
8466807|NCT00680459|20863309|P1|STARTED|Overall Study||7
8466808|NCT00680407|20863322|P3|NOT COMPLETED|Overall Study||3
8466809|NCT00680407|20863323|P2|NOT COMPLETED|Overall Study||5
8466810|NCT00680407|20863324|P1|NOT COMPLETED|Overall Study||8
8466811|NCT00680407|20863322|P3|COMPLETED|Overall Study||22
8466812|NCT00680407|20863323|P2|COMPLETED|Overall Study||22
8466813|NCT00680407|20863324|P1|COMPLETED|Overall Study||18
8466814|NCT00680407|20863322|P3|STARTED|Overall Study||25
8466815|NCT00680407|20863323|P2|STARTED|Overall Study||27
8466816|NCT00680407|20863324|P1|STARTED|Overall Study||26
8466817|NCT00680368|20863338|P1|NOT COMPLETED|Overall Study||15
8466818|NCT00680368|20863338|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
8466819|NCT00680368|20863338|P1|STARTED|Overall Study||112
8466820|NCT00680316|20863346|P2|NOT COMPLETED|Overall Study||0
8466821|NCT00680316|20863347|P1|NOT COMPLETED|Overall Study||0
8466822|NCT00680316|20863346|P2|COMPLETED|Overall Study||2
8466823|NCT00680316|20863347|P1|COMPLETED|Overall Study||1
8466824|NCT00680316|20863346|P2|STARTED|Overall Study||2
8466825|NCT00680316|20863347|P1|STARTED|Overall Study||1
8466826|NCT00680225|20863359|P1|NOT COMPLETED|Overall Study||2
8466827|NCT00680225|20863359|P1|COMPLETED|Overall Study||8
8466828|NCT00680225|20863359|P1|STARTED|Overall Study||10
8466829|NCT00680186|20863366|P2|NOT COMPLETED|Overall Study||116
8466830|NCT00680186|20863367|P1|NOT COMPLETED|Overall Study||125
8466831|NCT00680186|20863366|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
8466832|NCT00680186|20863367|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
8466833|NCT00680186|20863366|P2|STARTED|Overall Study|Started treatment.|1288
8466834|NCT00680186|20863367|P1|STARTED|Overall Study|Started treatment.|1280
8466835|NCT00680121|20863393|P2|NOT COMPLETED|Overall Study||23
8466836|NCT00680121|20863394|P1|NOT COMPLETED|Overall Study||27
8466837|NCT00680121|20863393|P2|COMPLETED|Overall Study||37
8466838|NCT00680121|20863394|P1|COMPLETED|Overall Study||33
8466839|NCT00680121|20863393|P2|STARTED|Overall Study||60
8466840|NCT00680121|20863394|P1|STARTED|Overall Study||60
8466841|NCT00680056|20863408|P2|NOT COMPLETED|Second Intervention||1
8466842|NCT00680056|20863409|P1|NOT COMPLETED|Second Intervention||3
8466843|NCT00680056|20863408|P2|COMPLETED|Second Intervention||14
8466844|NCT00680056|20863409|P1|COMPLETED|Second Intervention||12
8466845|NCT00680056|20863408|P2|STARTED|Second Intervention||15
8466846|NCT00680056|20863409|P1|STARTED|Second Intervention||15
8466847|NCT00680056|20863408|P2|NOT COMPLETED|Washout Period of One Week||0
8466848|NCT00680056|20863409|P1|NOT COMPLETED|Washout Period of One Week||0
8466849|NCT00680056|20863408|P2|COMPLETED|Washout Period of One Week||15
8466850|NCT00680056|20863409|P1|COMPLETED|Washout Period of One Week||15
8466851|NCT00680056|20863408|P2|STARTED|Washout Period of One Week||15
8466852|NCT00680056|20863409|P1|STARTED|Washout Period of One Week||15
8466853|NCT00680056|20863408|P2|NOT COMPLETED|First Intervention||2
8466854|NCT00680056|20863409|P1|NOT COMPLETED|First Intervention||1
8466855|NCT00680056|20863408|P2|COMPLETED|First Intervention||15
8466856|NCT00680056|20863409|P1|COMPLETED|First Intervention||15
8466857|NCT00680056|20863408|P2|STARTED|First Intervention||17
8466858|NCT00680056|20863409|P1|STARTED|First Intervention||16
8466859|NCT00680043|20863420|P3|NOT COMPLETED|Overall Study||4
8466860|NCT00680043|20863421|P2|NOT COMPLETED|Overall Study||1
8466861|NCT00680043|20863422|P1|NOT COMPLETED|Overall Study||2
8466862|NCT00680043|20863420|P3|COMPLETED|Overall Study||34
8466863|NCT00680043|20863421|P2|COMPLETED|Overall Study||36
8466864|NCT00680043|20863422|P1|COMPLETED|Overall Study||37
8466865|NCT00680043|20863420|P3|STARTED|Overall Study||38
8466866|NCT00680043|20863421|P2|STARTED|Overall Study||37
8466867|NCT00680043|20863422|P1|STARTED|Overall Study||39
8466868|NCT00680017|20863438|P2|NOT COMPLETED|Overall Study||12
8466869|NCT00680017|20863439|P1|NOT COMPLETED|Overall Study||17
8466870|NCT00680017|20863438|P2|COMPLETED|Overall Study||128
8466871|NCT00680017|20863439|P1|COMPLETED|Overall Study||123
8466872|NCT00680017|20863438|P2|STARTED|Overall Study||140
8466873|NCT00680017|20863439|P1|STARTED|Overall Study||140
8466874|NCT00679952|20863449|P2|NOT COMPLETED|Overall Study||0
8466875|NCT00679952|20863450|P1|NOT COMPLETED|Overall Study||0
8466876|NCT00679952|20863449|P2|COMPLETED|Overall Study||82
8466877|NCT00679952|20863450|P1|COMPLETED|Overall Study||86
8466878|NCT00679952|20863449|P2|STARTED|Overall Study||82
8466879|NCT00679952|20863450|P1|STARTED|Overall Study||86
8466880|NCT00679939|20863458|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
8466881|NCT00679939|20863459|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
8466882|NCT00679939|20863458|P2|COMPLETED|24-Week Open-Label (OL) Period||80
8466883|NCT00679939|20863459|P1|COMPLETED|24-Week Open-Label (OL) Period||69
8466884|NCT00679939|20863458|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
8466885|NCT00679939|20863459|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
8466886|NCT00679939|20863458|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
8466887|NCT00679939|20863459|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
8466888|NCT00679939|20863458|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
8466889|NCT00679939|20863459|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
8466890|NCT00679939|20863458|P2|STARTED|52-Week Double-Blind (DB) Period||112
8466891|NCT00679939|20863459|P1|STARTED|52-Week Double-Blind (DB) Period||114
8466892|NCT00679926|20863608|P1|NOT COMPLETED|Overall Study||13
8466893|NCT00679926|20863608|P1|COMPLETED|Overall Study||2
8466894|NCT00679926|20863608|P1|STARTED|Overall Study||15
8466895|NCT00679913|20863625|P2|NOT COMPLETED|Overall Study||13
8466896|NCT00679913|20863626|P1|NOT COMPLETED|Overall Study||18
8466897|NCT00679913|20863625|P2|COMPLETED|Overall Study||86
8466898|NCT00679913|20863626|P1|COMPLETED|Overall Study||83
8466899|NCT00679913|20863625|P2|STARTED|Overall Study||99
8466900|NCT00679913|20863626|P1|STARTED|Overall Study||101
8466901|NCT00679783|20863641|P7|NOT COMPLETED|Overall Study||1
8466902|NCT00679783|20863642|P6|NOT COMPLETED|Overall Study||0
8466903|NCT00679783|20863643|P5|NOT COMPLETED|Overall Study||1
8466904|NCT00679783|20863644|P4|NOT COMPLETED|Overall Study||20
8466905|NCT00679783|20863645|P3|NOT COMPLETED|Overall Study||1
8466906|NCT00679783|20863646|P2|NOT COMPLETED|Overall Study||3
8466907|NCT00679783|20863647|P1|NOT COMPLETED|Overall Study||2
8466908|NCT00679783|20863641|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
8466909|NCT00679783|20863642|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
8466910|NCT00679783|20863643|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
8466911|NCT00679783|20863644|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
8466912|NCT00679783|20863645|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
8466913|NCT00679783|20863646|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
8466914|NCT00679783|20863647|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
8466915|NCT00679783|20863641|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
8466916|NCT00679783|20863642|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
8466917|NCT00679783|20863643|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
8466918|NCT00679783|20863644|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
8466919|NCT00679783|20863645|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
8466920|NCT00679783|20863646|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
8466921|NCT00679783|20863647|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
8466922|NCT00679627|20863700|P2|NOT COMPLETED|Overall Study||685
8466923|NCT00679627|20863701|P1|NOT COMPLETED|Overall Study||699
8466924|NCT00679627|20863700|P2|COMPLETED|Overall Study||339
8466925|NCT00679627|20863701|P1|COMPLETED|Overall Study||322
8466926|NCT00679627|20863700|P2|STARTED|Overall Study||1024
8466927|NCT00679627|20863701|P1|STARTED|Overall Study||1021
8466928|NCT00679549|20863725|P2|NOT COMPLETED|Overall Study||9
8466929|NCT00679549|20863726|P1|NOT COMPLETED|Overall Study||6
8466930|NCT00679549|20863725|P2|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
8466931|NCT00679549|20863726|P1|COMPLETED|Overall Study||69
8466932|NCT00679549|20863725|P2|STARTED|Overall Study||75
8466933|NCT00679549|20863726|P1|STARTED|Overall Study||75
8466934|NCT00679432|20863736|P4|NOT COMPLETED|Overall Study||32
8466935|NCT00679432|20863737|P3|NOT COMPLETED|Overall Study||53
8466936|NCT00679432|20863738|P2|NOT COMPLETED|Overall Study||38
8466937|NCT00679432|20863739|P1|NOT COMPLETED|Overall Study||37
8466938|NCT00679432|20863736|P4|COMPLETED|Overall Study||95
8466939|NCT00679432|20863737|P3|COMPLETED|Overall Study||76
8466940|NCT00679432|20863738|P2|COMPLETED|Overall Study||89
8466941|NCT00679432|20863739|P1|COMPLETED|Overall Study||89
8466942|NCT00679432|20863736|P4|STARTED|Overall Study||127
8466943|NCT00679432|20863737|P3|STARTED|Overall Study||129
8466944|NCT00679432|20863738|P2|STARTED|Overall Study||127
8466945|NCT00679432|20863739|P1|STARTED|Overall Study||126
8466946|NCT00679380|20863761|P4|NOT COMPLETED|Overall Study||28
8466947|NCT00679380|20863762|P3|NOT COMPLETED|Overall Study||35
8466948|NCT00679380|20863763|P2|NOT COMPLETED|Overall Study||33
8466949|NCT00679380|20863764|P1|NOT COMPLETED|Overall Study||42
8466950|NCT00679380|20863761|P4|COMPLETED|Overall Study||61
8466951|NCT00679380|20863762|P3|COMPLETED|Overall Study||68
8466952|NCT00679380|20863763|P2|COMPLETED|Overall Study||76
8466953|NCT00679380|20863764|P1|COMPLETED|Overall Study||67
8466954|NCT00679380|20863761|P4|STARTED|Overall Study||89
8466955|NCT00679380|20863762|P3|STARTED|Overall Study||103
8466956|NCT00679380|20863763|P2|STARTED|Overall Study||109
8466957|NCT00679380|20863764|P1|STARTED|Overall Study||109
8466958|NCT00679367|20863782|P1|NOT COMPLETED|Overall Study||12
8466959|NCT00679367|20863782|P1|COMPLETED|Overall Study||4
8466960|NCT00679367|20863782|P1|STARTED|Overall Study||16
8466961|NCT00679354|20863788|P1|NOT COMPLETED|Overall Study||30
8466962|NCT00679354|20863788|P1|COMPLETED|Overall Study||0
8466963|NCT00679354|20863788|P1|STARTED|Overall Study||30
8466964|NCT00679341|20863806|P2|NOT COMPLETED|Overall Study||51
8466965|NCT00679341|20863807|P1|NOT COMPLETED|Overall Study||53
8466966|NCT00679341|20863806|P2|COMPLETED|Overall Study||19
8466967|NCT00679341|20863807|P1|COMPLETED|Overall Study||14
8466968|NCT00679341|20863806|P2|STARTED|Overall Study||70
8466969|NCT00679341|20863807|P1|STARTED|Overall Study||67
8466970|NCT00679302|20863827|P2|NOT COMPLETED|Overall Study||4
8466971|NCT00679302|20863828|P1|NOT COMPLETED|Overall Study||8
8466972|NCT00679302|20863827|P2|COMPLETED|Overall Study||73
8466973|NCT00679302|20863828|P1|COMPLETED|Overall Study||76
8466974|NCT00679302|20863827|P2|STARTED|Overall Study||77
8466975|NCT00679302|20863828|P1|STARTED|Overall Study||84
8466976|NCT00679289|20863839|P3|NOT COMPLETED|Overall Study||23
8466977|NCT00679289|20863840|P2|NOT COMPLETED|Overall Study||6
8466978|NCT00679289|20863841|P1|NOT COMPLETED|Overall Study||5
8466979|NCT00679289|20863839|P3|COMPLETED|Overall Study||1
8466980|NCT00679289|20863840|P2|COMPLETED|Overall Study||0
8466981|NCT00679289|20863841|P1|COMPLETED|Overall Study||1
8466982|NCT00679289|20863839|P3|STARTED|Overall Study||24
8466983|NCT00679289|20863840|P2|STARTED|Overall Study||6
8466984|NCT00679289|20863841|P1|STARTED|Overall Study||6
8466985|NCT00679263|20863863|P3|NOT COMPLETED|Visit 2/Dose 1||0
8466986|NCT00679263|20863864|P2|NOT COMPLETED|Visit 2/Dose 1||1
8466987|NCT00679263|20863865|P1|NOT COMPLETED|Visit 2/Dose 1||2
8466988|NCT00679263|20863863|P3|COMPLETED|Visit 2/Dose 1||11
8466989|NCT00679263|20863864|P2|COMPLETED|Visit 2/Dose 1||5
8466990|NCT00679263|20863865|P1|COMPLETED|Visit 2/Dose 1||9
8466991|NCT00679263|20863863|P3|STARTED|Visit 2/Dose 1||11
8466992|NCT00679263|20863864|P2|STARTED|Visit 2/Dose 1||6
8466993|NCT00679263|20863865|P1|STARTED|Visit 2/Dose 1||11
8466994|NCT00679263|20863863|P3|NOT COMPLETED|Visit 3/Dose 2||0
8466995|NCT00679263|20863864|P2|NOT COMPLETED|Visit 3/Dose 2||5
8466996|NCT00679263|20863865|P1|NOT COMPLETED|Visit 3/Dose 2||1
8466997|NCT00679263|20863863|P3|COMPLETED|Visit 3/Dose 2||11
8466998|NCT00679263|20863864|P2|COMPLETED|Visit 3/Dose 2||6
8466999|NCT00679263|20863865|P1|COMPLETED|Visit 3/Dose 2||9
8467000|NCT00679263|20863863|P3|STARTED|Visit 3/Dose 2||11
8467001|NCT00679263|20863864|P2|STARTED|Visit 3/Dose 2||11
8467002|NCT00679263|20863865|P1|STARTED|Visit 3/Dose 2||10
8467003|NCT00679211|20863876|P1|NOT COMPLETED|Overall Study||110
8467004|NCT00679211|20863876|P1|COMPLETED|Overall Study||0
8467005|NCT00679211|20863876|P1|STARTED|Overall Study||110
8467006|NCT00679172|20863893|P5|NOT COMPLETED|Overall Study||0
8467007|NCT00679172|20863894|P4|NOT COMPLETED|Overall Study||1
8467008|NCT00679172|20863895|P3|NOT COMPLETED|Overall Study||1
8467009|NCT00679172|20863896|P2|NOT COMPLETED|Overall Study||1
8467010|NCT00679172|20863897|P1|NOT COMPLETED|Overall Study||1
8467011|NCT00679172|20863893|P5|COMPLETED|Overall Study||37
8467012|NCT00679172|20863894|P4|COMPLETED|Overall Study||38
8467013|NCT00679172|20863895|P3|COMPLETED|Overall Study||35
8467014|NCT00679172|20863896|P2|COMPLETED|Overall Study||37
8467015|NCT00679172|20863897|P1|COMPLETED|Overall Study||36
8467016|NCT00679172|20863893|P5|STARTED|Overall Study||37
8467017|NCT00679172|20863894|P4|STARTED|Overall Study||39
8467018|NCT00679172|20863895|P3|STARTED|Overall Study||36
8467019|NCT00679172|20863896|P2|STARTED|Overall Study||38
8467020|NCT00679172|20863897|P1|STARTED|Overall Study||37
8467021|NCT00679081|20863960|P1|NOT COMPLETED|Overall Study||1
8467022|NCT00679081|20863960|P1|COMPLETED|Overall Study||14
8467023|NCT00679081|20863960|P1|STARTED|Overall Study|Study design was within-subject control.|15
8467024|NCT00679055|20863970|P2|NOT COMPLETED|Overall Study||5
8467025|NCT00679055|20863971|P1|NOT COMPLETED|Overall Study||2
8467026|NCT00679055|20863970|P2|COMPLETED|Overall Study||1
8467027|NCT00679055|20863971|P1|COMPLETED|Overall Study||6
8467028|NCT00679055|20863970|P2|STARTED|Overall Study||6
8467029|NCT00679055|20863971|P1|STARTED|Overall Study||8
8467030|NCT00679029|20863981|P1|NOT COMPLETED|Overall Study||5
8467031|NCT00679029|20863981|P1|COMPLETED|Overall Study||10
8467032|NCT00679029|20863981|P1|STARTED|Overall Study||15
8467033|NCT00678899|20863988|P1|NOT COMPLETED|Overall Study||1
8467034|NCT00678899|20863988|P1|COMPLETED|Overall Study||49
8467035|NCT00678899|20863988|P1|STARTED|Overall Study||50
8467036|NCT00678886|20863997|P4|NOT COMPLETED|Overall Study||9
8467037|NCT00678886|20863998|P3|NOT COMPLETED|Overall Study||9
8467038|NCT00678886|20863999|P2|NOT COMPLETED|Overall Study||0
8467039|NCT00678886|20864000|P1|NOT COMPLETED|Overall Study||0
8467040|NCT00678886|20863997|P4|COMPLETED|Overall Study||153
8467041|NCT00678886|20863998|P3|COMPLETED|Overall Study||72
8467042|NCT00678886|20863999|P2|COMPLETED|Overall Study||19
8467043|NCT00678886|20864000|P1|COMPLETED|Overall Study||10
8467044|NCT00678886|20863997|P4|STARTED|Overall Study||162
8467045|NCT00678886|20863998|P3|STARTED|Overall Study||81
8467046|NCT00678886|20863999|P2|STARTED|Overall Study||19
8467047|NCT00678886|20864000|P1|STARTED|Overall Study||10
8467048|NCT00678834|20864047|P3|NOT COMPLETED|Overall Study||9
8467049|NCT00678834|20864048|P2|NOT COMPLETED|Overall Study||0
8467050|NCT00678834|20864049|P1|NOT COMPLETED|Overall Study||16
8467051|NCT00678834|20864047|P3|COMPLETED|Overall Study||16
8467052|NCT00678834|20864048|P2|COMPLETED|Overall Study||15
8467053|NCT00678834|20864049|P1|COMPLETED|Overall Study||24
8467054|NCT00678834|20864047|P3|STARTED|Overall Study||25
8467055|NCT00678834|20864048|P2|STARTED|Overall Study||15
8467056|NCT00678834|20864049|P1|STARTED|Overall Study||40
8467057|NCT00678795|20864069|P2|NOT COMPLETED|Overall Study||6
8467058|NCT00678795|20864070|P1|NOT COMPLETED|Overall Study||11
8467059|NCT00678795|20864069|P2|COMPLETED|Overall Study||62
8467060|NCT00678795|20864070|P1|COMPLETED|Overall Study||56
8467061|NCT00678795|20864069|P2|STARTED|Overall Study||68
8467062|NCT00678795|20864070|P1|STARTED|Overall Study||67
8467063|NCT00678691|20864092|P2|NOT COMPLETED|Overall Study||4
8467064|NCT00678691|20864093|P1|NOT COMPLETED|Overall Study||6
8467065|NCT00678691|20864092|P2|COMPLETED|Overall Study||24
8467066|NCT00678691|20864093|P1|COMPLETED|Overall Study||21
8467067|NCT00678691|20864092|P2|STARTED|Overall Study||28
8467068|NCT00678691|20864093|P1|STARTED|Overall Study||27
8467069|NCT00678652|20864103|P4|NOT COMPLETED|Overall Study||0
8467070|NCT00678652|20864104|P3|NOT COMPLETED|Overall Study||1
8467071|NCT00678652|20864105|P2|NOT COMPLETED|Overall Study||0
8467072|NCT00678652|20864106|P1|NOT COMPLETED|Overall Study||3
8467073|NCT00678652|20864103|P4|COMPLETED|Overall Study||9
8467074|NCT00678652|20864104|P3|COMPLETED|Overall Study||8
8467075|NCT00678652|20864105|P2|COMPLETED|Overall Study||9
8467076|NCT00678652|20864106|P1|COMPLETED|Overall Study||6
8467077|NCT00678652|20864103|P4|STARTED|Overall Study||9
8467078|NCT00678652|20864104|P3|STARTED|Overall Study||9
8467079|NCT00678652|20864105|P2|STARTED|Overall Study||9
8467080|NCT00678652|20864106|P1|STARTED|Overall Study||9
8467081|NCT00678639|20864130|P2|NOT COMPLETED|Overall Study||0
8467082|NCT00678639|20864131|P1|NOT COMPLETED|Overall Study||2
8467083|NCT00678639|20864130|P2|COMPLETED|Overall Study||57
8467084|NCT00678639|20864131|P1|COMPLETED|Overall Study||51
8467085|NCT00678639|20864130|P2|Hospital Discharge|Overall Study||57
8467086|NCT00678639|20864131|P1|Hospital Discharge|Overall Study||53
8467087|NCT00678639|20864130|P2|STARTED|Overall Study||57
8467088|NCT00678639|20864131|P1|STARTED|Overall Study||53
8467089|NCT00678587|20864146|P2|NOT COMPLETED|Overall Study||18
8467090|NCT00678587|20864147|P1|NOT COMPLETED|Overall Study||20
8467091|NCT00678587|20864146|P2|COMPLETED|Overall Study||127
8467092|NCT00678587|20864147|P1|COMPLETED|Overall Study||127
8467093|NCT00678587|20864146|P2|STARTED|Overall Study||145
8467094|NCT00678587|20864147|P1|STARTED|Overall Study||147
8467095|NCT00678574|20864181|P2|NOT COMPLETED|Overall Study||0
8467096|NCT00678574|20864182|P1|NOT COMPLETED|Overall Study||0
8467097|NCT00678574|20864181|P2|COMPLETED|Overall Study||27
8467098|NCT00678574|20864182|P1|COMPLETED|Overall Study||18
8467099|NCT00678574|20864181|P2|STARTED|Overall Study||27
8467100|NCT00678574|20864182|P1|STARTED|Overall Study||18
8467101|NCT00678561|20864196|P8|NOT COMPLETED|Overall Study||1
8467102|NCT00678561|20864197|P7|NOT COMPLETED|Overall Study||0
8467103|NCT00678561|20864198|P6|NOT COMPLETED|Overall Study||1
8467104|NCT00678561|20864199|P5|NOT COMPLETED|Overall Study||2
8467105|NCT00678561|20864200|P4|NOT COMPLETED|Overall Study||0
8467106|NCT00678561|20864201|P3|NOT COMPLETED|Overall Study||1
8467107|NCT00678561|20864202|P2|NOT COMPLETED|Overall Study||1
8467108|NCT00678561|20864203|P1|NOT COMPLETED|Overall Study||0
8467109|NCT00678561|20864196|P8|COMPLETED|Overall Study||7
8467110|NCT00678561|20864197|P7|COMPLETED|Overall Study||15
8467111|NCT00678561|20864198|P6|COMPLETED|Overall Study||16
8467112|NCT00678561|20864199|P5|COMPLETED|Overall Study||15
8467113|NCT00678561|20864200|P4|COMPLETED|Overall Study||4
8467114|NCT00678561|20864201|P3|COMPLETED|Overall Study||7
8467115|NCT00678561|20864202|P2|COMPLETED|Overall Study||5
8467116|NCT00678561|20864203|P1|COMPLETED|Overall Study||6
8467117|NCT00678561|20864196|P8|STARTED|Overall Study||8
8467118|NCT00678561|20864197|P7|STARTED|Overall Study||15
8467119|NCT00678561|20864198|P6|STARTED|Overall Study||17
8467120|NCT00678561|20864199|P5|STARTED|Overall Study||17
8467121|NCT00678561|20864200|P4|STARTED|Overall Study||4
8467122|NCT00678561|20864201|P3|STARTED|Overall Study||8
8467123|NCT00678561|20864202|P2|STARTED|Overall Study||6
8467124|NCT00678561|20864203|P1|STARTED|Overall Study||6
8467125|NCT00678535|20864258|P2|NOT COMPLETED|Overall Study||98
8467126|NCT00678535|20864259|P1|NOT COMPLETED|Overall Study||93
8467127|NCT00678535|20864258|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
8467128|NCT00678535|20864259|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
8467129|NCT00678535|20864258|P2|STARTED|Overall Study|ITT population|449
8467130|NCT00678535|20864259|P1|STARTED|Overall Study|ITT population|455
8467131|NCT00678470|20864275|P1|NOT COMPLETED|Overall Study||4
8467132|NCT00678470|20864275|P1|COMPLETED|Overall Study||14
8467133|NCT00678470|20864275|P1|STARTED|Overall Study||18
8467134|NCT00678444|20864281|P2|NOT COMPLETED|Overall Study||0
8467135|NCT00678444|20864282|P1|NOT COMPLETED|Overall Study||0
8467136|NCT00678444|20864281|P2|COMPLETED|Overall Study||99
8467137|NCT00678444|20864282|P1|COMPLETED|Overall Study||100
8467138|NCT00678444|20864281|P2|STARTED|Overall Study||99
8467139|NCT00678444|20864282|P1|STARTED|Overall Study||100
8467140|NCT00678418|20864292|P2|NOT COMPLETED|Part B (Open Label)||0
8467141|NCT00678418|20864293|P1|NOT COMPLETED|Part B (Open Label)||43
8467142|NCT00678418|20864292|P2|COMPLETED|Part B (Open Label)||0
8467143|NCT00678418|20864293|P1|COMPLETED|Part B (Open Label)||71
8467144|NCT00678418|20864292|P2|STARTED|Part B (Open Label)||0
8467145|NCT00678418|20864293|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
8467146|NCT00678418|20864292|P2|NOT COMPLETED|Part A (Double Blind)||77
8467147|NCT00678418|20864293|P1|NOT COMPLETED|Part A (Double Blind)||59
8467148|NCT00678418|20864292|P2|COMPLETED|Part A (Double Blind)||47
8467149|NCT00678418|20864293|P1|COMPLETED|Part A (Double Blind)||67
8467150|NCT00678418|20864292|P2|STARTED|Part A (Double Blind)||124
8467151|NCT00678418|20864293|P1|STARTED|Part A (Double Blind)||126
8467152|NCT00678392|20864309|P2|NOT COMPLETED|Overall Study||362
8467153|NCT00678392|20864310|P1|NOT COMPLETED|Overall Study||361
8467154|NCT00678392|20864309|P2|COMPLETED|Overall Study||0
8467155|NCT00678392|20864310|P1|COMPLETED|Overall Study||0
8467156|NCT00678392|20864309|P2|Treated|Overall Study||355
8467157|NCT00678392|20864310|P1|Treated|Overall Study||359
8467158|NCT00678392|20864309|P2|STARTED|Overall Study||362
8467159|NCT00678392|20864310|P1|STARTED|Overall Study||361
8467160|NCT00678379|20864345|P3|NOT COMPLETED|Overall Study||4
8467161|NCT00678379|20864346|P2|NOT COMPLETED|Overall Study||3
8467162|NCT00678379|20864347|P1|NOT COMPLETED|Overall Study||6
8467163|NCT00678379|20864345|P3|COMPLETED|Overall Study||36
8467164|NCT00678379|20864346|P2|COMPLETED|Overall Study||37
8467165|NCT00678379|20864347|P1|COMPLETED|Overall Study||34
8467166|NCT00678379|20864345|P3|STARTED|Overall Study||40
8467167|NCT00678379|20864346|P2|STARTED|Overall Study||40
8467168|NCT00678379|20864347|P1|STARTED|Overall Study||40
8467169|NCT00678301|20864375|P2|NOT COMPLETED|Overall Study||2
8467170|NCT00678301|20864376|P1|NOT COMPLETED|Overall Study||8
8467171|NCT00678301|20864375|P2|COMPLETED|Overall Study||116
8467172|NCT00678301|20864376|P1|COMPLETED|Overall Study||231
8467173|NCT00678301|20864375|P2|STARTED|Overall Study||118
8467174|NCT00678301|20864376|P1|STARTED|Overall Study||239
8467175|NCT00678288|20864434|P2|NOT COMPLETED|Overall Study||6
8467176|NCT00678288|20864435|P1|NOT COMPLETED|Overall Study||10
8467177|NCT00678288|20864434|P2|COMPLETED|Overall Study||0
8467178|NCT00678288|20864435|P1|COMPLETED|Overall Study||0
8467179|NCT00678288|20864434|P2|STARTED|Overall Study||6
8467180|NCT00678288|20864435|P1|STARTED|Overall Study||10
8467181|NCT00678249|20864452|P3|NOT COMPLETED|Overall Study||0
8467182|NCT00678249|20864453|P2|NOT COMPLETED|Overall Study||0
8467183|NCT00678249|20864454|P1|NOT COMPLETED|Overall Study||0
8467184|NCT00678249|20864452|P3|COMPLETED|Overall Study||37
8467185|NCT00678249|20864453|P2|COMPLETED|Overall Study||93
8467186|NCT00678249|20864454|P1|COMPLETED|Overall Study||97
8467187|NCT00678249|20864452|P3|STARTED|Overall Study||37
8467188|NCT00678249|20864453|P2|STARTED|Overall Study||93
8467189|NCT00678249|20864454|P1|STARTED|Overall Study||97
8467190|NCT00678210|20864490|P4|NOT COMPLETED|Overall Study||20
8467191|NCT00678210|20864491|P3|NOT COMPLETED|Overall Study||6
8467192|NCT00678210|20864492|P2|NOT COMPLETED|Overall Study||11
8467193|NCT00678210|20864493|P1|NOT COMPLETED|Overall Study||11
8467194|NCT00678210|20864490|P4|COMPLETED|Overall Study||30
8467195|NCT00678210|20864491|P3|COMPLETED|Overall Study||43
8467196|NCT00678210|20864492|P2|COMPLETED|Overall Study||38
8467197|NCT00678210|20864493|P1|COMPLETED|Overall Study||38
8467198|NCT00678210|20864490|P4|STARTED|Overall Study||50
8467199|NCT00678210|20864491|P3|STARTED|Overall Study||49
8467200|NCT00678210|20864492|P2|STARTED|Overall Study||49
8467201|NCT00678210|20864493|P1|STARTED|Overall Study||49
8467202|NCT00678080|20864529|P2|NOT COMPLETED|Overall Study||1
8467203|NCT00678080|20864530|P1|NOT COMPLETED|Overall Study||3
8467204|NCT00678080|20864529|P2|COMPLETED|Overall Study||13
8467205|NCT00678080|20864530|P1|COMPLETED|Overall Study||8
8467206|NCT00678080|20864529|P2|STARTED|Overall Study||14
8467207|NCT00678080|20864530|P1|STARTED|Overall Study||11
8467208|NCT00678041|20864556|P2|NOT COMPLETED|Overall Study||5
8467209|NCT00678041|20864557|P1|NOT COMPLETED|Overall Study||5
8467210|NCT00678041|20864556|P2|COMPLETED|Overall Study||0
8467211|NCT00678041|20864557|P1|COMPLETED|Overall Study||0
8467212|NCT00678041|20864556|P2|STARTED|Overall Study||5
8467213|NCT00678041|20864557|P1|STARTED|Overall Study||5
8467214|NCT00678015|20864569|P1|NOT COMPLETED|Overall Study||0
8467215|NCT00678015|20864569|P1|COMPLETED|Overall Study||12
8467216|NCT00678015|20864569|P1|STARTED|Overall Study||12
8467217|NCT00677924|20864578|P2|NOT COMPLETED|Overall Study||0
8467218|NCT00677924|20864579|P1|NOT COMPLETED|Overall Study||0
8467219|NCT00677924|20864578|P2|COMPLETED|Overall Study||6
8467220|NCT00677924|20864579|P1|COMPLETED|Overall Study||3
8467221|NCT00677924|20864578|P2|STARTED|Overall Study||6
8467222|NCT00677924|20864579|P1|STARTED|Overall Study||3
8467223|NCT00677898|20864589|P2|NOT COMPLETED|Overall Study||18
8467224|NCT00677898|20864590|P1|NOT COMPLETED|Overall Study||20
8467225|NCT00677898|20864589|P2|COMPLETED|Overall Study||102
8467226|NCT00677898|20864590|P1|COMPLETED|Overall Study||99
8467227|NCT00677898|20864589|P2|STARTED|Overall Study||120
8467228|NCT00677898|20864590|P1|STARTED|Overall Study||119
8467229|NCT00677833|20864610|P4|NOT COMPLETED|Overall Study||3
8467230|NCT00677833|20864611|P3|NOT COMPLETED|Overall Study||2
8467231|NCT00677833|20864612|P2|NOT COMPLETED|Overall Study||0
8467232|NCT00677833|20864613|P1|NOT COMPLETED|Overall Study||4
8467233|NCT00677833|20864610|P4|COMPLETED|Overall Study||128
8467234|NCT00677833|20864611|P3|COMPLETED|Overall Study||122
8467235|NCT00677833|20864612|P2|COMPLETED|Overall Study||51
8467236|NCT00677833|20864613|P1|COMPLETED|Overall Study||51
8467237|NCT00677833|20864610|P4|STARTED|Overall Study||131
8467238|NCT00677833|20864611|P3|STARTED|Overall Study||124
8467239|NCT00677833|20864612|P2|STARTED|Overall Study||51
8467240|NCT00677833|20864613|P1|STARTED|Overall Study||55
8467241|NCT00677820|20864663|P2|NOT COMPLETED|Overall Study||0
8467242|NCT00677820|20864664|P1|NOT COMPLETED|Overall Study||1
8467243|NCT00677820|20864663|P2|COMPLETED|Overall Study||60
8467244|NCT00677820|20864664|P1|COMPLETED|Overall Study||239
8467245|NCT00677820|20864663|P2|STARTED|Overall Study||60
8467246|NCT00677820|20864664|P1|STARTED|Overall Study||240
8467247|NCT00677807|20864685|P3|NOT COMPLETED|Overall Study||20
8467248|NCT00677807|20864686|P2|NOT COMPLETED|Overall Study||11
8467249|NCT00677807|20864687|P1|NOT COMPLETED|Overall Study||18
8467250|NCT00677807|20864685|P3|COMPLETED|Overall Study||105
8467251|NCT00677807|20864686|P2|COMPLETED|Overall Study||135
8467252|NCT00677807|20864687|P1|COMPLETED|Overall Study||126
8467253|NCT00677807|20864685|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
8467254|NCT00677807|20864686|P2|Safety/ITT: Received Study Drug|Overall Study||146
8467255|NCT00677807|20864687|P1|Safety/ITT: Received Study Drug|Overall Study||144
8467256|NCT00677807|20864685|P3|STARTED|Overall Study||125
8467257|NCT00677807|20864686|P2|STARTED|Overall Study||146
8467258|NCT00677807|20864687|P1|STARTED|Overall Study||144
8467259|NCT00677690|20864718|P2|NOT COMPLETED|Overall Study||0
8467260|NCT00677690|20864719|P1|NOT COMPLETED|Overall Study||0
8467261|NCT00677690|20864718|P2|COMPLETED|Overall Study||41
8467262|NCT00677690|20864719|P1|COMPLETED|Overall Study||42
8467263|NCT00677690|20864718|P2|STARTED|Overall Study||41
8467264|NCT00677690|20864719|P1|STARTED|Overall Study||42
8467265|NCT00677534|20864733|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
8467266|NCT00677534|20864733|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
8467267|NCT00677534|20864733|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
8467268|NCT00677534|20864733|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
8467269|NCT00677534|20864733|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
8467270|NCT00677534|20864733|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
8467271|NCT00677534|20864733|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
8467272|NCT00677534|20864733|P1|COMPLETED|Washout (Weeks 1-4)||7
8467273|NCT00677534|20864733|P1|STARTED|Washout (Weeks 1-4)||10
8467274|NCT00677365|20864741|P4|NOT COMPLETED|Overall Study||3
8467275|NCT00677365|20864742|P3|NOT COMPLETED|Overall Study||2
8467276|NCT00677365|20864743|P2|NOT COMPLETED|Overall Study||1
8467277|NCT00677365|20864744|P1|NOT COMPLETED|Overall Study||2
8467278|NCT00677365|20864741|P4|COMPLETED|Overall Study||36
8467279|NCT00677365|20864742|P3|COMPLETED|Overall Study||35
8467280|NCT00677365|20864743|P2|COMPLETED|Overall Study||37
8467281|NCT00677365|20864744|P1|COMPLETED|Overall Study||35
8467282|NCT00677365|20864741|P4|STARTED|Overall Study||39
8467283|NCT00677365|20864742|P3|STARTED|Overall Study||37
8467284|NCT00677365|20864743|P2|STARTED|Overall Study||38
8467285|NCT00677365|20864744|P1|STARTED|Overall Study||37
8467286|NCT00677352|20864776|P2|NOT COMPLETED|Tapering Phase||10
8467287|NCT00677352|20864777|P1|NOT COMPLETED|Tapering Phase||6
8467288|NCT00677352|20864776|P2|COMPLETED|Tapering Phase||112
8467289|NCT00677352|20864777|P1|COMPLETED|Tapering Phase||126
8467290|NCT00677352|20864776|P2|STARTED|Tapering Phase||122
8467291|NCT00677352|20864777|P1|STARTED|Tapering Phase||132
8467292|NCT00677352|20864776|P2|NOT COMPLETED|Treatment Phase||42
8467293|NCT00677352|20864777|P1|NOT COMPLETED|Treatment Phase||25
8467294|NCT00677352|20864776|P2|COMPLETED|Treatment Phase||122
8467295|NCT00677352|20864777|P1|COMPLETED|Treatment Phase||132
8467296|NCT00677352|20864776|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
8467297|NCT00677352|20864777|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
8467298|NCT00677235|20864797|P2|NOT COMPLETED|Overall Study||38
8467299|NCT00677235|20864798|P1|NOT COMPLETED|Overall Study||41
8467300|NCT00677235|20864797|P2|COMPLETED|Overall Study||94
8467301|NCT00677235|20864798|P1|COMPLETED|Overall Study||97
8467302|NCT00677235|20864797|P2|STARTED|Overall Study||132
8467303|NCT00677235|20864798|P1|STARTED|Overall Study||138
8467304|NCT00677092|20864838|P1|NOT COMPLETED|Overall Study||6
8467305|NCT00677092|20864838|P1|COMPLETED|Overall Study||6
8467306|NCT00677092|20864838|P1|Received Study Treatment|Overall Study||11
8467307|NCT00677092|20864838|P1|STARTED|Overall Study||12
8467308|NCT00677040|20864847|P1|NOT COMPLETED|Overall Study||0
8467309|NCT00677040|20864847|P1|COMPLETED|Overall Study||20
8467310|NCT00677040|20864847|P1|STARTED|Overall Study||20
8467311|NCT00677014|20864855|P3|NOT COMPLETED|Overall Study||49
8467312|NCT00677014|20864856|P2|NOT COMPLETED|Overall Study||41
8467313|NCT00677014|20864857|P1|NOT COMPLETED|Overall Study||44
8467314|NCT00677014|20864855|P3|COMPLETED|Overall Study||283
8467315|NCT00677014|20864856|P2|COMPLETED|Overall Study||282
8467316|NCT00677014|20864857|P1|COMPLETED|Overall Study||281
8467317|NCT00677014|20864855|P3|STARTED|Overall Study||332
8467318|NCT00677014|20864856|P2|STARTED|Overall Study||323
8467319|NCT00677014|20864857|P1|STARTED|Overall Study||325
8467320|NCT00676897|20864867|P2|NOT COMPLETED|Overall Study||0
8467321|NCT00676897|20864868|P1|NOT COMPLETED|Overall Study||0
8467322|NCT00676897|20864867|P2|COMPLETED|Overall Study||10
8467323|NCT00676897|20864868|P1|COMPLETED|Overall Study||8
8467324|NCT00676897|20864867|P2|STARTED|Overall Study||10
8467325|NCT00676897|20864868|P1|STARTED|Overall Study||8
8467326|NCT00676806|20864878|P2|NOT COMPLETED|Overall Study||0
8467327|NCT00676806|20864879|P1|NOT COMPLETED|Overall Study||0
8467328|NCT00676806|20864878|P2|COMPLETED|Overall Study||3
8467329|NCT00676806|20864879|P1|COMPLETED|Overall Study||3
8467330|NCT00676806|20864878|P2|STARTED|Overall Study||3
8467331|NCT00676806|20864879|P1|STARTED|Overall Study||3
8467332|NCT00676793|20864895|P1|NOT COMPLETED|Overall Study||13
8467333|NCT00676793|20864895|P1|COMPLETED|Overall Study||19
8467334|NCT00676793|20864895|P1|STARTED|Overall Study||32
8467335|NCT00676780|20864900|P1|NOT COMPLETED|Overall Study||7
8467336|NCT00676780|20864900|P1|COMPLETED|Overall Study||26
8467337|NCT00676780|20864900|P1|STARTED|Overall Study||33
8467338|NCT00676715|20864910|P4|NOT COMPLETED|Overall Study||40
8467339|NCT00676715|20864911|P3|NOT COMPLETED|Overall Study||41
8467340|NCT00676715|20864912|P2|NOT COMPLETED|Overall Study||47
8467341|NCT00676715|20864913|P1|NOT COMPLETED|Overall Study||40
8467342|NCT00676715|20864910|P4|COMPLETED|Overall Study||14
8467343|NCT00676715|20864911|P3|COMPLETED|Overall Study||14
8467344|NCT00676715|20864912|P2|COMPLETED|Overall Study||8
8467345|NCT00676715|20864913|P1|COMPLETED|Overall Study||14
8467346|NCT00676715|20864910|P4|STARTED|Overall Study||54
8467347|NCT00676715|20864911|P3|STARTED|Overall Study||55
8467348|NCT00676715|20864912|P2|STARTED|Overall Study||55
8467349|NCT00676715|20864913|P1|STARTED|Overall Study||54
8467350|NCT00676689|20864943|P1|NOT COMPLETED|Overall Study||61
8467351|NCT00676689|20864943|P1|COMPLETED|Overall Study||20
8467352|NCT00676689|20864943|P1|1 Year Follow-up|Overall Study||64
8467353|NCT00676689|20864943|P1|30 Day Follow-up|Overall Study||78
8467354|NCT00676689|20864943|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
8467355|NCT00676689|20864943|P1|STARTED|Overall Study||81
8467356|NCT00676676|20864949|P1|NOT COMPLETED|Overall Study||0
8467357|NCT00676676|20864949|P1|COMPLETED|Overall Study||9
8467358|NCT00676676|20864949|P1|STARTED|Overall Study||9
8467359|NCT00676663|20864955|P2|NOT COMPLETED|Overall Study||38
8467360|NCT00676663|20864956|P1|NOT COMPLETED|Overall Study||45
8467361|NCT00676663|20864955|P2|COMPLETED|Overall Study||26
8467362|NCT00676663|20864956|P1|COMPLETED|Overall Study||21
8467363|NCT00676663|20864955|P2|STARTED|Overall Study||64
8467364|NCT00676663|20864956|P1|STARTED|Overall Study||66
8467365|NCT00676650|20864972|P2|NOT COMPLETED|Overall Study||289
8467366|NCT00676650|20864973|P1|NOT COMPLETED|Overall Study||584
8467367|NCT00676650|20864972|P2|COMPLETED|Overall Study||0
8467368|NCT00676650|20864973|P1|COMPLETED|Overall Study||0
8467369|NCT00676650|20864972|P2|Treated|Overall Study||285
8467370|NCT00676650|20864973|P1|Treated|Overall Study||581
8467371|NCT00676650|20864972|P2|STARTED|Overall Study||289
8467372|NCT00676650|20864973|P1|STARTED|Overall Study||584
8467373|NCT00676585|20864993|P2|NOT COMPLETED|Overall Study||0
8467374|NCT00676585|20864994|P1|NOT COMPLETED|Overall Study||0
8467375|NCT00676585|20864993|P2|COMPLETED|Overall Study||25
8467376|NCT00676585|20864994|P1|COMPLETED|Overall Study||25
8467377|NCT00676585|20864993|P2|STARTED|Overall Study||25
8467378|NCT00676585|20864994|P1|STARTED|Overall Study||25
8467379|NCT00676572|20865006|P2|NOT COMPLETED|Overall Study||0
8467380|NCT00676572|20865007|P1|NOT COMPLETED|Overall Study||0
8467381|NCT00676572|20865006|P2|COMPLETED|Overall Study||6
8467382|NCT00676572|20865007|P1|COMPLETED|Overall Study||6
8467383|NCT00676572|20865006|P2|STARTED|Overall Study||6
8467384|NCT00676572|20865007|P1|STARTED|Overall Study||6
8467385|NCT00676520|20865015|P1|NOT COMPLETED|Overall Study||731
8467386|NCT00676520|20865015|P1|COMPLETED|Overall Study||7309
8467387|NCT00676520|20865015|P1|STARTED|Overall Study||8040
8467388|NCT00676494|20865072|P1|NOT COMPLETED|Overall Study||14
8467389|NCT00676494|20865072|P1|COMPLETED|Overall Study||158
8467390|NCT00676494|20865072|P1|STARTED|Overall Study||172
8467391|NCT00676455|20865078|P1|NOT COMPLETED|Overall Study||0
8467392|NCT00676455|20865078|P1|COMPLETED|Overall Study||14
8467393|NCT00676455|20865078|P1|STARTED|Overall Study||14
8467412|NCT00676364|20865224|P2|NOT COMPLETED|Overall Study||0
8467413|NCT00676364|20865225|P1|NOT COMPLETED|Overall Study||0
8467414|NCT00676364|20865224|P2|COMPLETED|Overall Study||57
8467415|NCT00676364|20865225|P1|COMPLETED|Overall Study||57
8467416|NCT00676364|20865224|P2|STARTED|Overall Study||57
8467417|NCT00676364|20865225|P1|STARTED|Overall Study||57
8467418|NCT00676338|20865237|P4|NOT COMPLETED|Overall Study||23
8467419|NCT00676338|20865238|P3|NOT COMPLETED|Overall Study||30
8467420|NCT00676338|20865239|P2|NOT COMPLETED|Overall Study||33
8467421|NCT00676338|20865240|P1|NOT COMPLETED|Overall Study||38
8467422|NCT00676338|20865237|P4|COMPLETED|Overall Study||140
8467423|NCT00676338|20865238|P3|COMPLETED|Overall Study||133
8467424|NCT00676338|20865239|P2|COMPLETED|Overall Study||213
8467425|NCT00676338|20865240|P1|COMPLETED|Overall Study||210
8467426|NCT00676338|20865237|P4|STARTED|Overall Study||163
8467427|NCT00676338|20865238|P3|STARTED|Overall Study||163
8467428|NCT00676338|20865239|P2|STARTED|Overall Study||246
8467429|NCT00676338|20865240|P1|STARTED|Overall Study||248
8467430|NCT00676208|20865292|P2|NOT COMPLETED|Overall Study||6
8467431|NCT00676208|20865293|P1|NOT COMPLETED|Overall Study||2
8467432|NCT00676208|20865292|P2|COMPLETED|Overall Study||13
8467433|NCT00676208|20865293|P1|COMPLETED|Overall Study||12
8467434|NCT00676208|20865292|P2|STARTED|Overall Study||19
8467435|NCT00676208|20865293|P1|STARTED|Overall Study||14
8467436|NCT00676195|20865301|P1|NOT COMPLETED|Overall Study||3
8467437|NCT00676195|20865301|P1|COMPLETED|Overall Study||21
8467438|NCT00676195|20865301|P1|STARTED|Overall Study||24
8467439|NCT00676182|20865311|P1|NOT COMPLETED|Overall Study||0
8467440|NCT00676182|20865311|P1|COMPLETED|Overall Study||75
8467441|NCT00676182|20865311|P1|STARTED|Overall Study||75
8467442|NCT00676143|20865326|P2|NOT COMPLETED|Overall Study||260
8467443|NCT00676143|20865327|P1|NOT COMPLETED|Overall Study||156
8467444|NCT00676143|20865326|P2|COMPLETED|Overall Study||398
8467445|NCT00676143|20865327|P1|COMPLETED|Overall Study||285
8467446|NCT00676143|20865326|P2|Treated|Overall Study||654
8467447|NCT00676143|20865327|P1|Treated|Overall Study||439
8467448|NCT00676143|20865326|P2|STARTED|Overall Study||658
8467449|NCT00676143|20865327|P1|STARTED|Overall Study||441
8467450|NCT00676130|20865367|P2|NOT COMPLETED|Overall Study||4
8467451|NCT00676130|20865368|P1|NOT COMPLETED|Overall Study||3
8467452|NCT00676130|20865367|P2|COMPLETED|Overall Study||73
8467453|NCT00676130|20865368|P1|COMPLETED|Overall Study||73
8467454|NCT00676130|20865367|P2|STARTED|Overall Study||77
8467455|NCT00676130|20865368|P1|STARTED|Overall Study||76
8467456|NCT00676091|20865378|P2|NOT COMPLETED|Toddler Dose||0
8467457|NCT00676091|20865379|P1|NOT COMPLETED|Toddler Dose||3
8467458|NCT00676091|20865378|P2|COMPLETED|Toddler Dose||156
8467459|NCT00676091|20865379|P1|COMPLETED|Toddler Dose||153
8467460|NCT00676091|20865378|P2|STARTED|Toddler Dose||156
8467461|NCT00676091|20865379|P1|STARTED|Toddler Dose||156
8467462|NCT00676091|20865378|P2|NOT COMPLETED|After Infant Series||3
8467463|NCT00676091|20865379|P1|NOT COMPLETED|After Infant Series||1
8467464|NCT00676091|20865378|P2|COMPLETED|After Infant Series||156
8467465|NCT00676091|20865379|P1|COMPLETED|After Infant Series||156
8467466|NCT00676091|20865378|P2|STARTED|After Infant Series||159
8467467|NCT00676091|20865379|P1|STARTED|After Infant Series||157
8467468|NCT00676091|20865378|P2|NOT COMPLETED|Infant Series||18
8467469|NCT00676091|20865379|P1|NOT COMPLETED|Infant Series||20
8467470|NCT00676091|20865378|P2|COMPLETED|Infant Series||159
8467471|NCT00676091|20865379|P1|COMPLETED|Infant Series||157
8467472|NCT00676091|20865378|P2|Vaccinated Dose 3|Infant Series||161
8467473|NCT00676091|20865379|P1|Vaccinated Dose 3|Infant Series||158
8467474|NCT00676091|20865378|P2|Vaccinated Dose 2|Infant Series||162
8467475|NCT00676091|20865379|P1|Vaccinated Dose 2|Infant Series||159
8467476|NCT00676091|20865378|P2|Vaccinated Dose 1|Infant Series||162
8467477|NCT00676091|20865379|P1|Vaccinated Dose 1|Infant Series||163
8467478|NCT00676091|20865378|P2|STARTED|Infant Series||177
8467479|NCT00676091|20865379|P1|STARTED|Infant Series||177
8467480|NCT00676065|20865414|P3|NOT COMPLETED|Overall Study||0
8467481|NCT00676065|20865415|P2|NOT COMPLETED|Overall Study||0
8467482|NCT00676065|20865416|P1|NOT COMPLETED|Overall Study||0
8467483|NCT00676065|20865414|P3|COMPLETED|Overall Study||26341
8467484|NCT00676065|20865415|P2|COMPLETED|Overall Study||15428
8467485|NCT00676065|20865416|P1|COMPLETED|Overall Study||16534
8467486|NCT00676065|20865414|P3|STARTED|Overall Study||26341
8467487|NCT00676065|20865415|P2|STARTED|Overall Study||15428
8467488|NCT00676065|20865416|P1|STARTED|Overall Study||16534
8467489|NCT00676052|20865436|P6|NOT COMPLETED|Overall Study||6
8467490|NCT00676052|20865437|P5|NOT COMPLETED|Overall Study||6
8467491|NCT00676052|20865438|P4|NOT COMPLETED|Overall Study||5
8467492|NCT00676052|20865439|P3|NOT COMPLETED|Overall Study||6
8467493|NCT00676052|20865440|P2|NOT COMPLETED|Overall Study||7
8467494|NCT00676052|20865441|P1|NOT COMPLETED|Overall Study||9
8467495|NCT00676052|20865436|P6|COMPLETED|Overall Study||91
8467496|NCT00676052|20865437|P5|COMPLETED|Overall Study||89
8467497|NCT00676052|20865438|P4|COMPLETED|Overall Study||92
8467498|NCT00676052|20865439|P3|COMPLETED|Overall Study||90
8467499|NCT00676052|20865440|P2|COMPLETED|Overall Study||88
8467500|NCT00676052|20865441|P1|COMPLETED|Overall Study||87
8467501|NCT00676052|20865436|P6|STARTED|Overall Study||97
8467502|NCT00676052|20865437|P5|STARTED|Overall Study||95
8467503|NCT00676052|20865438|P4|STARTED|Overall Study||97
8467504|NCT00676052|20865439|P3|STARTED|Overall Study||96
8467505|NCT00676052|20865440|P2|STARTED|Overall Study||95
8467506|NCT00676052|20865441|P1|STARTED|Overall Study||96
8467507|NCT00676026|20865473|P1|NOT COMPLETED|Overall Study||0
8467508|NCT00676026|20865473|P1|COMPLETED|Overall Study||8
8467509|NCT00676026|20865473|P1|STARTED|Overall Study||8
8467510|NCT00676013|20865477|P1|NOT COMPLETED|Overall Study||1
8467511|NCT00676013|20865477|P1|COMPLETED|Overall Study||157
8467512|NCT00676013|20865477|P1|STARTED|Overall Study||158
8467513|NCT00675987|20865486|P2|NOT COMPLETED|Overall Study||0
8467514|NCT00675987|20865487|P1|NOT COMPLETED|Overall Study||0
8467515|NCT00675987|20865486|P2|COMPLETED|Overall Study||27
8467516|NCT00675987|20865487|P1|COMPLETED|Overall Study||26
8467517|NCT00675987|20865486|P2|STARTED|Overall Study||27
8467518|NCT00675987|20865487|P1|STARTED|Overall Study||26
8467519|NCT00675948|20865511|P2|NOT COMPLETED|Overall Study||3
8467520|NCT00675948|20865512|P1|NOT COMPLETED|Overall Study||39
8467521|NCT00675948|20865511|P2|COMPLETED|Overall Study||1
8467522|NCT00675948|20865512|P1|COMPLETED|Overall Study||0
8467523|NCT00675948|20865511|P2|STARTED|Overall Study||4
8467524|NCT00675948|20865512|P1|STARTED|Overall Study||39
8467525|NCT00675922|20865522|P1|NOT COMPLETED|Overall Study||0
8467526|NCT00675922|20865522|P1|COMPLETED|Overall Study||98
8467527|NCT00675922|20865522|P1|STARTED|Overall Study||98
8467528|NCT00675909|20865530|P3|NOT COMPLETED|Overall Study||0
8467529|NCT00675909|20865531|P2|NOT COMPLETED|Overall Study||0
8467530|NCT00675909|20865532|P1|NOT COMPLETED|Overall Study||0
8467531|NCT00675909|20865530|P3|COMPLETED|Overall Study||60
8467532|NCT00675909|20865531|P2|COMPLETED|Overall Study||60
8467533|NCT00675909|20865532|P1|COMPLETED|Overall Study||60
8467534|NCT00675909|20865530|P3|STARTED|Overall Study||60
8467535|NCT00675909|20865531|P2|STARTED|Overall Study||60
8467536|NCT00675909|20865532|P1|STARTED|Overall Study||60
8467537|NCT00675792|20865554|P2|NOT COMPLETED|Overall Study||0
8467538|NCT00675792|20865555|P1|NOT COMPLETED|Overall Study||0
8467539|NCT00675792|20865554|P2|COMPLETED|Overall Study||49
8467540|NCT00675792|20865555|P1|COMPLETED|Overall Study||51
8467541|NCT00675792|20865554|P2|STARTED|Overall Study||49
8467542|NCT00675792|20865555|P1|STARTED|Overall Study||51
8467543|NCT00675766|20865575|P4|NOT COMPLETED|Overall Study||26
8467544|NCT00675766|20865576|P3|NOT COMPLETED|Overall Study||21
8467545|NCT00675766|20865577|P2|NOT COMPLETED|Overall Study||5
8467546|NCT00675766|20865578|P1|NOT COMPLETED|Overall Study||6
8467547|NCT00675766|20865575|P4|COMPLETED|Overall Study||11
8467548|NCT00675766|20865576|P3|COMPLETED|Overall Study||29
8467549|NCT00675766|20865577|P2|COMPLETED|Overall Study||25
8467550|NCT00675766|20865578|P1|COMPLETED|Overall Study||100
8467551|NCT00675766|20865575|P4|Year 3|Overall Study||11
8467552|NCT00675766|20865576|P3|Year 3|Overall Study||29
8467553|NCT00675766|20865577|P2|Year 3|Overall Study||25
8467554|NCT00675766|20865578|P1|Year 3|Overall Study||100
8467555|NCT00675766|20865575|P4|Year 2|Overall Study||20
8467556|NCT00675766|20865576|P3|Year 2|Overall Study||34
8467557|NCT00675766|20865577|P2|Year 2|Overall Study||28
8467558|NCT00675766|20865578|P1|Year 2|Overall Study||105
8467559|NCT00675766|20865575|P4|STARTED|Overall Study||37
8467560|NCT00675766|20865576|P3|STARTED|Overall Study||50
8467561|NCT00675766|20865577|P2|STARTED|Overall Study||30
8467562|NCT00675766|20865578|P1|STARTED|Overall Study||106
8467563|NCT00675597|20865588|P1|NOT COMPLETED|Overall Study||3
8467564|NCT00675597|20865588|P1|COMPLETED|Overall Study||23
8467565|NCT00675597|20865588|P1|STARTED|Overall Study||26
8467566|NCT00675584|20865594|P2|NOT COMPLETED|Overall Study||26
8467567|NCT00675584|20865595|P1|NOT COMPLETED|Overall Study||39
8467568|NCT00675584|20865594|P2|COMPLETED|Overall Study||113
8467569|NCT00675584|20865595|P1|COMPLETED|Overall Study||100
8467570|NCT00675584|20865594|P2|STARTED|Overall Study||139
8467571|NCT00675584|20865595|P1|STARTED|Overall Study||139
8467572|NCT00675558|20865624|P3|NOT COMPLETED|Second Operation||0
8467573|NCT00675558|20865625|P2|NOT COMPLETED|Second Operation||0
8467574|NCT00675558|20865626|P1|NOT COMPLETED|Second Operation||0
8467575|NCT00675558|20865624|P3|COMPLETED|Second Operation||10
8467576|NCT00675558|20865625|P2|COMPLETED|Second Operation||0
8467577|NCT00675558|20865626|P1|COMPLETED|Second Operation||0
8467578|NCT00675558|20865624|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
8467579|NCT00675558|20865625|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
8467580|NCT00675558|20865626|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
8467581|NCT00675558|20865624|P3|NOT COMPLETED|Surgery||0
8467582|NCT00675558|20865625|P2|NOT COMPLETED|Surgery||0
8467583|NCT00675558|20865626|P1|NOT COMPLETED|Surgery||0
8467584|NCT00675558|20865624|P3|COMPLETED|Surgery||30
8467585|NCT00675558|20865625|P2|COMPLETED|Surgery||10
8467586|NCT00675558|20865626|P1|COMPLETED|Surgery||10
8467587|NCT00675558|20865624|P3|STARTED|Surgery||30
8467588|NCT00675558|20865625|P2|STARTED|Surgery||10
8467589|NCT00675558|20865626|P1|STARTED|Surgery||10
8467590|NCT00675506|20865642|P2|NOT COMPLETED|Overall Study||12
8467591|NCT00675506|20865643|P1|NOT COMPLETED|Overall Study||12
8467592|NCT00675506|20865642|P2|COMPLETED|Overall Study||17
8467593|NCT00675506|20865643|P1|COMPLETED|Overall Study||19
8467594|NCT00675506|20865642|P2|Received Intervention|Overall Study||29
8467595|NCT00675506|20865643|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
8467596|NCT00675506|20865642|P2|STARTED|Overall Study||29
8467597|NCT00675506|20865643|P1|STARTED|Overall Study||31
8467598|NCT00675441|20865659|P1|NOT COMPLETED|Overall Study||3
8467599|NCT00675441|20865659|P1|COMPLETED|Overall Study||2
8467600|NCT00675441|20865659|P1|STARTED|Overall Study||5
8467601|NCT00675428|20865665|P2|NOT COMPLETED|Overall Study||3
8467602|NCT00675428|20865666|P1|NOT COMPLETED|Overall Study||3
8467603|NCT00675428|20865665|P2|COMPLETED|Overall Study||0
8467604|NCT00675428|20865666|P1|COMPLETED|Overall Study||0
8467605|NCT00675428|20865665|P2|STARTED|Overall Study||3
8467606|NCT00675428|20865666|P1|STARTED|Overall Study||3
8467607|NCT00675415|20865686|P2|NOT COMPLETED|Overall Study||8
8467608|NCT00675415|20865687|P1|NOT COMPLETED|Overall Study||8
8467609|NCT00675415|20865686|P2|COMPLETED|Overall Study||123
8467610|NCT00675415|20865687|P1|COMPLETED|Overall Study||124
8467611|NCT00675415|20865686|P2|STARTED|Overall Study||131
8467612|NCT00675415|20865687|P1|STARTED|Overall Study||132
8467613|NCT00675259|20865699|P1|NOT COMPLETED|Overall Study||14
8467614|NCT00675259|20865699|P1|COMPLETED|Overall Study||19
8467615|NCT00675259|20865699|P1|STARTED|Overall Study||33
8467616|NCT00675103|20865708|P1|NOT COMPLETED|Overall Study||3
8467617|NCT00675103|20865708|P1|COMPLETED|Overall Study||4
8467618|NCT00675103|20865708|P1|STARTED|Overall Study||7
8467619|NCT00674986|20865715|P2|NOT COMPLETED|Overall Study||81
8467620|NCT00674986|20865716|P1|NOT COMPLETED|Overall Study||43
8467621|NCT00674986|20865715|P2|COMPLETED|Overall Study||188
8467622|NCT00674986|20865716|P1|COMPLETED|Overall Study||187
8467623|NCT00674986|20865715|P2|Intent to Treat Population|Overall Study||256
8467624|NCT00674986|20865716|P1|Intent to Treat Population|Overall Study||227
8467625|NCT00674986|20865715|P2|STARTED|Overall Study||269
8467626|NCT00674986|20865716|P1|STARTED|Overall Study||230
8467627|NCT00674973|20865737|P2|NOT COMPLETED|Overall Study||102
8467628|NCT00674973|20865738|P1|NOT COMPLETED|Overall Study||100
8467629|NCT00674973|20865737|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
8467630|NCT00674973|20865738|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
8467631|NCT00674973|20865737|P2|Switch to Open-Label Erlotinib|Overall Study||0
8467632|NCT00674973|20865738|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
8467633|NCT00674973|20865737|P2|STARTED|Overall Study||104
8467634|NCT00674973|20865738|P1|STARTED|Overall Study||103
8467635|NCT00674817|20865752|P1|NOT COMPLETED|Period 6||0
8467636|NCT00674817|20865752|P1|COMPLETED|Period 6||38
8467637|NCT00674817|20865752|P1|STARTED|Period 6||38
8467638|NCT00674817|20865752|P1|NOT COMPLETED|Period 5||0
8467639|NCT00674817|20865752|P1|COMPLETED|Period 5||38
8467640|NCT00674817|20865752|P1|STARTED|Period 5||38
8467641|NCT00674817|20865752|P1|NOT COMPLETED|Period 4||1
8467642|NCT00674817|20865752|P1|COMPLETED|Period 4||38
8467643|NCT00674817|20865752|P1|STARTED|Period 4||39
8467644|NCT00674817|20865752|P1|NOT COMPLETED|Period 3||2
8467645|NCT00674817|20865752|P1|COMPLETED|Period 3||39
8467646|NCT00674817|20865752|P1|STARTED|Period 3||41
8467647|NCT00674817|20865752|P1|NOT COMPLETED|Period 2||0
8467648|NCT00674817|20865752|P1|COMPLETED|Period 2||41
8467649|NCT00674817|20865752|P1|STARTED|Period 2||41
8467650|NCT00674817|20865752|P1|NOT COMPLETED|Period 1||3
8467651|NCT00674817|20865752|P1|COMPLETED|Period 1||41
8467652|NCT00674817|20865752|P1|STARTED|Period 1||44
8467653|NCT00674765|20865900|P2|NOT COMPLETED|Overall Study||29
8467654|NCT00674765|20865901|P1|NOT COMPLETED|Overall Study||36
8467655|NCT00674765|20865900|P2|COMPLETED|Overall Study||46
8467656|NCT00674765|20865901|P1|COMPLETED|Overall Study||45
8467657|NCT00674765|20865900|P2|STARTED|Overall Study||75
8467658|NCT00674765|20865901|P1|STARTED|Overall Study||81
8467659|NCT00674739|20865910|P3|NOT COMPLETED|Overall Study||32
8467660|NCT00674739|20865911|P2|NOT COMPLETED|Overall Study||59
8467661|NCT00674739|20865912|P1|NOT COMPLETED|Overall Study||57
8467662|NCT00674739|20865910|P3|COMPLETED|Overall Study||65
8467663|NCT00674739|20865911|P2|COMPLETED|Overall Study||136
8467664|NCT00674739|20865912|P1|COMPLETED|Overall Study||121
8467665|NCT00674739|20865910|P3|STARTED|Overall Study||97
8467666|NCT00674739|20865911|P2|STARTED|Overall Study||195
8467667|NCT00674739|20865912|P1|STARTED|Overall Study||178
8467668|NCT00674700|20865929|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
8467669|NCT00674700|20865930|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
8467670|NCT00674700|20865931|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
8467671|NCT00674700|20865929|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
8467672|NCT00674700|20865930|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
8467673|NCT00674700|20865931|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
8467674|NCT00674700|20865929|P3|STARTED|Year 2 Follow-up Without Treatment||153
8467675|NCT00674700|20865930|P2|STARTED|Year 2 Follow-up Without Treatment||135
8467676|NCT00674700|20865931|P1|STARTED|Year 2 Follow-up Without Treatment||139
8467677|NCT00674700|20865929|P3|NOT COMPLETED|Year 1||17
8467678|NCT00674700|20865930|P2|NOT COMPLETED|Year 1||34
8467679|NCT00674700|20865931|P1|NOT COMPLETED|Year 1||31
8467680|NCT00674700|20865929|P3|COMPLETED|Year 1||153
8467681|NCT00674700|20865930|P2|COMPLETED|Year 1||135
8467682|NCT00674700|20865931|P1|COMPLETED|Year 1||139
8467683|NCT00674700|20865929|P3|STARTED|Year 1||170
8467684|NCT00674700|20865930|P2|STARTED|Year 1||169
8467685|NCT00674700|20865931|P1|STARTED|Year 1||170
8467686|NCT00674661|20865944|P2|NOT COMPLETED|Overall Study||15
8467687|NCT00674661|20865945|P1|NOT COMPLETED|Overall Study||11
8467688|NCT00674661|20865944|P2|COMPLETED|Overall Study||48
8467689|NCT00674661|20865945|P1|COMPLETED|Overall Study||56
8467690|NCT00674661|20865944|P2|STARTED|Overall Study||63
8467691|NCT00674661|20865945|P1|STARTED|Overall Study||67
8467692|NCT00674622|20865954|P3|NOT COMPLETED|Overall Study||0
8467693|NCT00674622|20865955|P2|NOT COMPLETED|Overall Study||4
8467694|NCT00674622|20865956|P1|NOT COMPLETED|Overall Study||1
8467695|NCT00674622|20865954|P3|COMPLETED|Overall Study||22
8467696|NCT00674622|20865955|P2|COMPLETED|Overall Study||18
8467697|NCT00674622|20865956|P1|COMPLETED|Overall Study||21
8467698|NCT00674622|20865954|P3|STARTED|Overall Study||22
8467699|NCT00674622|20865955|P2|STARTED|Overall Study||22
8467700|NCT00674622|20865956|P1|STARTED|Overall Study||22
8467701|NCT00674609|20865979|P3|NOT COMPLETED|Overall Study||8
8467702|NCT00674609|20865980|P2|NOT COMPLETED|Overall Study||13
8467703|NCT00674609|20865981|P1|NOT COMPLETED|Overall Study||12
8467704|NCT00674609|20865979|P3|COMPLETED|Overall Study||51
8467705|NCT00674609|20865980|P2|COMPLETED|Overall Study||45
8467706|NCT00674609|20865981|P1|COMPLETED|Overall Study||48
8467707|NCT00674609|20865979|P3|STARTED|Overall Study||59
8467708|NCT00674609|20865980|P2|STARTED|Overall Study||58
8467709|NCT00674609|20865981|P1|STARTED|Overall Study||60
8467710|NCT00674583|20866015|P2|NOT COMPLETED|Overall Study||0
8467711|NCT00674583|20866016|P1|NOT COMPLETED|Overall Study||0
8467712|NCT00674583|20866015|P2|COMPLETED|Overall Study||103
8467713|NCT00674583|20866016|P1|COMPLETED|Overall Study||311
8467714|NCT00674583|20866015|P2|STARTED|Overall Study||103
8467715|NCT00674583|20866016|P1|STARTED|Overall Study||311
8467716|NCT00674570|20866043|P3|NOT COMPLETED|Overall Study||0
8467717|NCT00674570|20866044|P2|NOT COMPLETED|Overall Study||2
8467718|NCT00674570|20866045|P1|NOT COMPLETED|Overall Study||0
8467719|NCT00674570|20866043|P3|COMPLETED|Overall Study||35
8467720|NCT00674570|20866044|P2|COMPLETED|Overall Study||32
8467721|NCT00674570|20866045|P1|COMPLETED|Overall Study||37
8467722|NCT00674570|20866043|P3|STARTED|Overall Study||35
8467723|NCT00674570|20866044|P2|STARTED|Overall Study||34
8467724|NCT00674570|20866045|P1|STARTED|Overall Study||37
8467725|NCT00674492|20866053|P1|NOT COMPLETED|Overall Study||0
8467726|NCT00674492|20866053|P1|COMPLETED|Overall Study||21
8467727|NCT00674492|20866053|P1|STARTED|Overall Study||21
8467728|NCT00674479|20866057|P1|NOT COMPLETED|Overall Study||0
8467729|NCT00674479|20866057|P1|COMPLETED|Overall Study||51
8467730|NCT00674479|20866057|P1|STARTED|Overall Study||51
8467731|NCT00674466|20866066|P3|NOT COMPLETED|Overall Study||9
8467732|NCT00674466|20866067|P2|NOT COMPLETED|Overall Study||8
8467733|NCT00674466|20866068|P1|NOT COMPLETED|Overall Study||7
8467734|NCT00674466|20866066|P3|COMPLETED|Overall Study||21
8467735|NCT00674466|20866067|P2|COMPLETED|Overall Study||22
8467736|NCT00674466|20866068|P1|COMPLETED|Overall Study||23
8467737|NCT00674466|20866066|P3|STARTED|Overall Study||30
8467738|NCT00674466|20866067|P2|STARTED|Overall Study||30
8467739|NCT00674466|20866068|P1|STARTED|Overall Study||30
8467740|NCT00674362|20866084|P2|NOT COMPLETED|Open Label||0
8467741|NCT00674362|20866085|P1|NOT COMPLETED|Open Label||2
8467742|NCT00674362|20866084|P2|COMPLETED|Open Label||7
8467743|NCT00674362|20866085|P1|COMPLETED|Open Label||18
8467744|NCT00674362|20866084|P2|STARTED|Open Label||7
8467745|NCT00674362|20866085|P1|STARTED|Open Label||20
8467746|NCT00674362|20866084|P2|NOT COMPLETED|Double Blind||18
8467747|NCT00674362|20866085|P1|NOT COMPLETED|Double Blind||12
8467748|NCT00674362|20866084|P2|COMPLETED|Double Blind||80
8467749|NCT00674362|20866085|P1|COMPLETED|Double Blind||84
8467750|NCT00674362|20866084|P2|STARTED|Double Blind||98
8467751|NCT00674362|20866085|P1|STARTED|Double Blind||96
8467752|NCT00674323|20866153|P3|NOT COMPLETED|Overall Study||0
8467753|NCT00674323|20866154|P2|NOT COMPLETED|Overall Study||1
8467754|NCT00674323|20866155|P1|NOT COMPLETED|Overall Study||1
8467755|NCT00674323|20866153|P3|COMPLETED|Overall Study||21
8467756|NCT00674323|20866154|P2|COMPLETED|Overall Study||20
8467757|NCT00674323|20866155|P1|COMPLETED|Overall Study||18
8467758|NCT00674323|20866153|P3|STARTED|Overall Study||21
8467759|NCT00674323|20866154|P2|STARTED|Overall Study||21
8467760|NCT00674323|20866155|P1|STARTED|Overall Study||19
8467761|NCT00674297|20866172|P4|NOT COMPLETED|Overall Study||3
8467762|NCT00674297|20866173|P3|NOT COMPLETED|Overall Study||4
8467763|NCT00674297|20866174|P2|NOT COMPLETED|Overall Study||0
8467764|NCT00674297|20866175|P1|NOT COMPLETED|Overall Study||10
8467765|NCT00674297|20866172|P4|COMPLETED|Overall Study||4
8467766|NCT00674297|20866173|P3|COMPLETED|Overall Study||5
8467767|NCT00674297|20866174|P2|COMPLETED|Overall Study||7
8467768|NCT00674297|20866175|P1|COMPLETED|Overall Study||8
8467769|NCT00674297|20866172|P4|STARTED|Overall Study||7
8467770|NCT00674297|20866173|P3|STARTED|Overall Study||9
8467771|NCT00674297|20866174|P2|STARTED|Overall Study||7
8467772|NCT00674297|20866175|P1|STARTED|Overall Study||18
8467773|NCT00674219|20866192|P2|NOT COMPLETED|Overall Study||0
8467774|NCT00674219|20866193|P1|NOT COMPLETED|Overall Study||0
8467775|NCT00674219|20866192|P2|COMPLETED|Overall Study||7
8467776|NCT00674219|20866193|P1|COMPLETED|Overall Study||10
8467777|NCT00674219|20866192|P2|STARTED|Overall Study||7
8467778|NCT00674219|20866193|P1|STARTED|Overall Study||10
8467779|NCT00674206|20866199|P1|NOT COMPLETED|Overall Study||0
8467780|NCT00674206|20866199|P1|COMPLETED|Overall Study||6
8467781|NCT00674206|20866199|P1|STARTED|Overall Study||6
8467782|NCT00674154|20866206|P2|NOT COMPLETED|Overall Study||3
8467783|NCT00674154|20866207|P1|NOT COMPLETED|Overall Study||3
8467784|NCT00674154|20866206|P2|COMPLETED|Overall Study||20
8467785|NCT00674154|20866207|P1|COMPLETED|Overall Study||20
8467786|NCT00674154|20866206|P2|STARTED|Overall Study||23
8467787|NCT00674154|20866207|P1|STARTED|Overall Study||23
8467788|NCT00674128|20866215|P2|NOT COMPLETED|Overall Study||23
8467789|NCT00674128|20866216|P1|NOT COMPLETED|Overall Study||25
8467790|NCT00674128|20866215|P2|COMPLETED|Overall Study||21
8467791|NCT00674128|20866216|P1|COMPLETED|Overall Study||25
8467792|NCT00674128|20866215|P2|STARTED|Overall Study||44
8467793|NCT00674128|20866216|P1|STARTED|Overall Study||50
8467794|NCT00674115|20866222|P4|NOT COMPLETED|Third Intervention||0
8467795|NCT00674115|20866223|P3|NOT COMPLETED|Third Intervention||0
8467796|NCT00674115|20866224|P2|NOT COMPLETED|Third Intervention||0
8467797|NCT00674115|20866225|P1|NOT COMPLETED|Third Intervention||0
8467798|NCT00674115|20866222|P4|COMPLETED|Third Intervention||0
8467799|NCT00674115|20866223|P3|COMPLETED|Third Intervention||0
8467800|NCT00674115|20866224|P2|COMPLETED|Third Intervention||16
8467801|NCT00674115|20866225|P1|COMPLETED|Third Intervention||14
8467802|NCT00674115|20866222|P4|STARTED|Third Intervention||0
8467803|NCT00674115|20866223|P3|STARTED|Third Intervention||0
8467804|NCT00674115|20866224|P2|STARTED|Third Intervention||16
8467805|NCT00674115|20866225|P1|STARTED|Third Intervention||14
8467806|NCT00674115|20866222|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8467807|NCT00674115|20866223|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8467808|NCT00674115|20866224|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8467809|NCT00674115|20866225|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8467810|NCT00674115|20866222|P4|COMPLETED|Washout Period of 2 Weeks||0
8467811|NCT00674115|20866223|P3|COMPLETED|Washout Period of 2 Weeks||0
8467812|NCT00674115|20866224|P2|COMPLETED|Washout Period of 2 Weeks||16
8467813|NCT00674115|20866225|P1|COMPLETED|Washout Period of 2 Weeks||14
8467814|NCT00674115|20866222|P4|STARTED|Washout Period of 2 Weeks||0
8467815|NCT00674115|20866223|P3|STARTED|Washout Period of 2 Weeks||0
8467816|NCT00674115|20866224|P2|STARTED|Washout Period of 2 Weeks||16
8467817|NCT00674115|20866225|P1|STARTED|Washout Period of 2 Weeks||14
8467818|NCT00674115|20866222|P4|NOT COMPLETED|Second Intervention||0
8467819|NCT00674115|20866223|P3|NOT COMPLETED|Second Intervention||0
8467820|NCT00674115|20866224|P2|NOT COMPLETED|Second Intervention||0
8467821|NCT00674115|20866225|P1|NOT COMPLETED|Second Intervention||0
8467822|NCT00674115|20866222|P4|COMPLETED|Second Intervention||16
8467823|NCT00674115|20866223|P3|COMPLETED|Second Intervention||14
8467824|NCT00674115|20866224|P2|COMPLETED|Second Intervention||16
8467825|NCT00674115|20866225|P1|COMPLETED|Second Intervention||14
8467826|NCT00674115|20866222|P4|STARTED|Second Intervention||16
8467827|NCT00674115|20866223|P3|STARTED|Second Intervention||14
8467828|NCT00674115|20866224|P2|STARTED|Second Intervention||16
8467829|NCT00674115|20866225|P1|STARTED|Second Intervention||14
8467830|NCT00674115|20866222|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8467831|NCT00674115|20866223|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8467832|NCT00674115|20866224|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8467833|NCT00674115|20866225|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8467834|NCT00674115|20866222|P4|COMPLETED|Washout Period of 2 Weeks||16
8467835|NCT00674115|20866223|P3|COMPLETED|Washout Period of 2 Weeks||14
8467836|NCT00674115|20866224|P2|COMPLETED|Washout Period of 2 Weeks||16
8467837|NCT00674115|20866225|P1|COMPLETED|Washout Period of 2 Weeks||14
8467838|NCT00674115|20866222|P4|STARTED|Washout Period of 2 Weeks||16
8467839|NCT00674115|20866223|P3|STARTED|Washout Period of 2 Weeks||14
8467840|NCT00674115|20866224|P2|STARTED|Washout Period of 2 Weeks||16
8467841|NCT00674115|20866225|P1|STARTED|Washout Period of 2 Weeks||14
8467842|NCT00674115|20866222|P4|NOT COMPLETED|First Intervention||0
8467843|NCT00674115|20866223|P3|NOT COMPLETED|First Intervention||0
8467844|NCT00674115|20866224|P2|NOT COMPLETED|First Intervention||0
8467845|NCT00674115|20866225|P1|NOT COMPLETED|First Intervention||0
8467846|NCT00674115|20866222|P4|COMPLETED|First Intervention||16
8467847|NCT00674115|20866223|P3|COMPLETED|First Intervention||14
8467848|NCT00674115|20866224|P2|COMPLETED|First Intervention||16
8467849|NCT00674115|20866225|P1|COMPLETED|First Intervention||14
8467850|NCT00674115|20866222|P4|STARTED|First Intervention||16
8467851|NCT00674115|20866223|P3|STARTED|First Intervention||14
8467852|NCT00674115|20866224|P2|STARTED|First Intervention||16
8467853|NCT00674115|20866225|P1|STARTED|First Intervention||14
8467854|NCT00673959|20866234|P2|NOT COMPLETED|Overall Study||0
8467855|NCT00673959|20866235|P1|NOT COMPLETED|Overall Study||0
8467856|NCT00673959|20866234|P2|COMPLETED|Overall Study||10
8467857|NCT00673959|20866235|P1|COMPLETED|Overall Study||10
8467858|NCT00673959|20866234|P2|STARTED|Overall Study||10
8467859|NCT00673959|20866235|P1|STARTED|Overall Study||10
8467860|NCT00673933|20866241|P1|NOT COMPLETED|Overall Study||3
8467861|NCT00673933|20866241|P1|COMPLETED|Overall Study||17
8467862|NCT00673933|20866241|P1|STARTED|Overall Study||20
8467863|NCT00673920|20866265|P8|NOT COMPLETED|Week 24 to Week 48||0
8467864|NCT00673920|20866266|P7|NOT COMPLETED|Week 24 to Week 48||1
8467865|NCT00673920|20866267|P6|NOT COMPLETED|Week 24 to Week 48||3
8467866|NCT00673920|20866268|P5|NOT COMPLETED|Week 24 to Week 48||0
8467867|NCT00673920|20866269|P4|NOT COMPLETED|Week 24 to Week 48||1
8467868|NCT00673920|20866270|P3|NOT COMPLETED|Week 24 to Week 48||0
8467869|NCT00673920|20866271|P2|NOT COMPLETED|Week 24 to Week 48||0
8467870|NCT00673920|20866272|P1|NOT COMPLETED|Week 24 to Week 48||0
8467871|NCT00673920|20866265|P8|COMPLETED|Week 24 to Week 48||28
8467872|NCT00673920|20866266|P7|COMPLETED|Week 24 to Week 48||28
8467873|NCT00673920|20866267|P6|COMPLETED|Week 24 to Week 48||106
8467874|NCT00673920|20866268|P5|COMPLETED|Week 24 to Week 48||61
8467875|NCT00673920|20866269|P4|COMPLETED|Week 24 to Week 48||60
8467876|NCT00673920|20866270|P3|COMPLETED|Week 24 to Week 48||0
8467877|NCT00673920|20866271|P2|COMPLETED|Week 24 to Week 48||0
8467878|NCT00673920|20866272|P1|COMPLETED|Week 24 to Week 48||0
8467879|NCT00673920|20866265|P8|STARTED|Week 24 to Week 48||28
8467880|NCT00673920|20866266|P7|STARTED|Week 24 to Week 48||29
8467881|NCT00673920|20866267|P6|STARTED|Week 24 to Week 48||109
8467882|NCT00673920|20866268|P5|STARTED|Week 24 to Week 48||61
8467883|NCT00673920|20866269|P4|STARTED|Week 24 to Week 48||61
8467884|NCT00673920|20866270|P3|STARTED|Week 24 to Week 48||0
8467885|NCT00673920|20866271|P2|STARTED|Week 24 to Week 48||0
8467886|NCT00673920|20866272|P1|STARTED|Week 24 to Week 48||0
8467887|NCT00673920|20866265|P8|NOT COMPLETED|Baseline up to Week 48||0
8467888|NCT00673920|20866266|P7|NOT COMPLETED|Baseline up to Week 48||0
8467889|NCT00673920|20866267|P6|NOT COMPLETED|Baseline up to Week 48||0
8467890|NCT00673920|20866268|P5|NOT COMPLETED|Baseline up to Week 48||0
8467891|NCT00673920|20866269|P4|NOT COMPLETED|Baseline up to Week 48||0
8467892|NCT00673920|20866270|P3|NOT COMPLETED|Baseline up to Week 48||7
8467893|NCT00673920|20866271|P2|NOT COMPLETED|Baseline up to Week 48||3
8467894|NCT00673920|20866272|P1|NOT COMPLETED|Baseline up to Week 48||4
8467895|NCT00673920|20866265|P8|COMPLETED|Baseline up to Week 48||0
8467896|NCT00673920|20866266|P7|COMPLETED|Baseline up to Week 48||0
8467897|NCT00673920|20866267|P6|COMPLETED|Baseline up to Week 48||0
8467898|NCT00673920|20866268|P5|COMPLETED|Baseline up to Week 48||0
8467899|NCT00673920|20866269|P4|COMPLETED|Baseline up to Week 48||0
8467900|NCT00673920|20866270|P3|COMPLETED|Baseline up to Week 48||126
8467901|NCT00673920|20866271|P2|COMPLETED|Baseline up to Week 48||114
8467902|NCT00673920|20866272|P1|COMPLETED|Baseline up to Week 48||60
8467903|NCT00673920|20866265|P8|STARTED|Baseline up to Week 48||0
8467904|NCT00673920|20866266|P7|STARTED|Baseline up to Week 48||0
8467905|NCT00673920|20866267|P6|STARTED|Baseline up to Week 48||0
8467906|NCT00673920|20866268|P5|STARTED|Baseline up to Week 48||0
8467907|NCT00673920|20866269|P4|STARTED|Baseline up to Week 48||0
8467908|NCT00673920|20866270|P3|STARTED|Baseline up to Week 48||133
8467909|NCT00673920|20866271|P2|STARTED|Baseline up to Week 48||117
8467910|NCT00673920|20866272|P1|STARTED|Baseline up to Week 48||64
8467911|NCT00673894|20866418|P2|NOT COMPLETED|Second Intervention 4 Weeks||0
8467912|NCT00673894|20866419|P1|NOT COMPLETED|Second Intervention 4 Weeks||0
8467913|NCT00673894|20866418|P2|COMPLETED|Second Intervention 4 Weeks||7
8467914|NCT00673894|20866419|P1|COMPLETED|Second Intervention 4 Weeks||6
8467915|NCT00673894|20866418|P2|STARTED|Second Intervention 4 Weeks||7
8467916|NCT00673894|20866419|P1|STARTED|Second Intervention 4 Weeks||6
8467917|NCT00673894|20866418|P2|NOT COMPLETED|Washout 4-6 Weeks||0
8467918|NCT00673894|20866419|P1|NOT COMPLETED|Washout 4-6 Weeks||0
8467919|NCT00673894|20866418|P2|COMPLETED|Washout 4-6 Weeks||7
8467920|NCT00673894|20866419|P1|COMPLETED|Washout 4-6 Weeks||6
8467921|NCT00673894|20866418|P2|STARTED|Washout 4-6 Weeks||7
8467922|NCT00673894|20866419|P1|STARTED|Washout 4-6 Weeks||6
8467923|NCT00673894|20866418|P2|NOT COMPLETED|First Intervention 4 Weeks||0
8467924|NCT00673894|20866419|P1|NOT COMPLETED|First Intervention 4 Weeks||2
8467925|NCT00673894|20866418|P2|COMPLETED|First Intervention 4 Weeks||7
8467926|NCT00673894|20866419|P1|COMPLETED|First Intervention 4 Weeks||6
8467927|NCT00673894|20866418|P2|STARTED|First Intervention 4 Weeks||7
8467928|NCT00673894|20866419|P1|STARTED|First Intervention 4 Weeks||8
8467929|NCT00673881|20866427|P1|NOT COMPLETED|Overall Study||1
8467930|NCT00673881|20866427|P1|COMPLETED|Overall Study||24
8467931|NCT00673881|20866427|P1|STARTED|Overall Study||25
8467932|NCT00673855|20866434|P2|NOT COMPLETED|Second Intervention||0
8467933|NCT00673855|20866435|P1|NOT COMPLETED|Second Intervention||0
8467934|NCT00673855|20866434|P2|COMPLETED|Second Intervention||10
8467935|NCT00673855|20866435|P1|COMPLETED|Second Intervention||10
8467936|NCT00673855|20866434|P2|STARTED|Second Intervention||10
8467937|NCT00673855|20866435|P1|STARTED|Second Intervention||10
8467938|NCT00673855|20866434|P2|NOT COMPLETED|First Intervention||0
8467939|NCT00673855|20866435|P1|NOT COMPLETED|First Intervention||0
8467940|NCT00673855|20866434|P2|COMPLETED|First Intervention||10
8467941|NCT00673855|20866435|P1|COMPLETED|First Intervention||10
8467942|NCT00673855|20866434|P2|STARTED|First Intervention||10
8467943|NCT00673855|20866435|P1|STARTED|First Intervention||10
8467944|NCT00673816|20866441|P1|NOT COMPLETED|Overall Study||2
8467945|NCT00673816|20866441|P1|COMPLETED|Overall Study||0
8467946|NCT00673816|20866441|P1|STARTED|Overall Study||2
8467947|NCT00673790|20866451|P3|NOT COMPLETED|Overall Study||12
8467948|NCT00673790|20866452|P2|NOT COMPLETED|Overall Study||38
8467949|NCT00673790|20866453|P1|NOT COMPLETED|Overall Study||45
8467950|NCT00673790|20866451|P3|COMPLETED|Overall Study||90
8467951|NCT00673790|20866452|P2|COMPLETED|Overall Study||174
8467952|NCT00673790|20866453|P1|COMPLETED|Overall Study||178
8467953|NCT00673790|20866451|P3|STARTED|Overall Study||102
8467954|NCT00673790|20866452|P2|STARTED|Overall Study||212
8467955|NCT00673790|20866453|P1|STARTED|Overall Study||223
8467956|NCT00673764|20866463|P2|NOT COMPLETED|Overall Study||0
8467957|NCT00673764|20866464|P1|NOT COMPLETED|Overall Study||0
8467958|NCT00673764|20866463|P2|COMPLETED|Overall Study||24
8467959|NCT00673764|20866464|P1|COMPLETED|Overall Study||24
8467960|NCT00673764|20866463|P2|STARTED|Overall Study||24
8467961|NCT00673764|20866464|P1|STARTED|Overall Study||24
8467962|NCT00673738|20866472|P1|NOT COMPLETED|Overall Study||0
8467963|NCT00673738|20866472|P1|COMPLETED|Overall Study||27
8467964|NCT00673738|20866472|P1|STARTED|Overall Study||27
8467965|NCT00673712|20866480|P2|NOT COMPLETED|Overall Study||0
8467966|NCT00673712|20866481|P1|NOT COMPLETED|Overall Study||0
8467967|NCT00673712|20866480|P2|COMPLETED|Overall Study||326
8467968|NCT00673712|20866481|P1|COMPLETED|Overall Study||321
8467969|NCT00673712|20866480|P2|STARTED|Overall Study||326
8467970|NCT00673712|20866481|P1|STARTED|Overall Study||321
8467971|NCT00673673|20866491|P1|NOT COMPLETED|Overall Study||36
8467972|NCT00673673|20866491|P1|COMPLETED|Overall Study||3
8467973|NCT00673673|20866491|P1|STARTED|Overall Study||39
8467977|NCT00673595|20866510|P2|NOT COMPLETED|Overall Study||0
8467978|NCT00673595|20866511|P1|NOT COMPLETED|Overall Study||0
8467979|NCT00673595|20866510|P2|COMPLETED|Overall Study||11
8467980|NCT00673595|20866511|P1|COMPLETED|Overall Study||8
8467981|NCT00673595|20866510|P2|STARTED|Overall Study||11
8467982|NCT00673595|20866511|P1|STARTED|Overall Study||8
8467983|NCT00673465|20866519|P12|NOT COMPLETED|Part 2 (India)||0
8467984|NCT00673465|20866520|P11|NOT COMPLETED|Part 2 (India)||0
8467985|NCT00673465|20866521|P10|NOT COMPLETED|Part 2 (India)||0
8467986|NCT00673465|20866522|P9|NOT COMPLETED|Part 2 (India)||0
8467987|NCT00673465|20866523|P8|NOT COMPLETED|Part 2 (India)||0
8467988|NCT00673465|20866524|P7|NOT COMPLETED|Part 2 (India)||0
8467989|NCT00673465|20866525|P6|NOT COMPLETED|Part 2 (India)||0
8467990|NCT00673465|20866526|P5|NOT COMPLETED|Part 2 (India)||0
8467991|NCT00673465|20866527|P4|NOT COMPLETED|Part 2 (India)||0
8467992|NCT00673465|20866528|P3|NOT COMPLETED|Part 2 (India)||0
8467993|NCT00673465|20866529|P2|NOT COMPLETED|Part 2 (India)||0
8467994|NCT00673465|20866530|P1|NOT COMPLETED|Part 2 (India)||0
8467995|NCT00673465|20866519|P12|COMPLETED|Part 2 (India)||0
8467996|NCT00673465|20866520|P11|COMPLETED|Part 2 (India)||0
8467997|NCT00673465|20866521|P10|COMPLETED|Part 2 (India)||0
8467998|NCT00673465|20866522|P9|COMPLETED|Part 2 (India)||0
8467999|NCT00673465|20866523|P8|COMPLETED|Part 2 (India)||0
8468000|NCT00673465|20866524|P7|COMPLETED|Part 2 (India)||0
8468001|NCT00673465|20866525|P6|COMPLETED|Part 2 (India)||0
8468002|NCT00673465|20866526|P5|COMPLETED|Part 2 (India)||0
8468003|NCT00673465|20866527|P4|COMPLETED|Part 2 (India)||0
8468004|NCT00673465|20866528|P3|COMPLETED|Part 2 (India)||0
8468005|NCT00673465|20866529|P2|COMPLETED|Part 2 (India)||0
8468006|NCT00673465|20866530|P1|COMPLETED|Part 2 (India)||0
8468007|NCT00673465|20866519|P12|STARTED|Part 2 (India)||0
8468008|NCT00673465|20866520|P11|STARTED|Part 2 (India)||0
8468009|NCT00673465|20866521|P10|STARTED|Part 2 (India)||0
8468010|NCT00673465|20866522|P9|STARTED|Part 2 (India)||0
8468011|NCT00673465|20866523|P8|STARTED|Part 2 (India)||0
8468012|NCT00673465|20866524|P7|STARTED|Part 2 (India)||0
8468013|NCT00673465|20866525|P6|STARTED|Part 2 (India)||0
8468014|NCT00673465|20866526|P5|STARTED|Part 2 (India)||0
8468015|NCT00673465|20866527|P4|STARTED|Part 2 (India)||0
8468016|NCT00673465|20866528|P3|STARTED|Part 2 (India)||0
8468017|NCT00673465|20866529|P2|STARTED|Part 2 (India)||0
8468018|NCT00673465|20866530|P1|STARTED|Part 2 (India)||0
8468019|NCT00673465|20866519|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468020|NCT00673465|20866520|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468021|NCT00673465|20866521|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468022|NCT00673465|20866522|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468023|NCT00673465|20866523|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468024|NCT00673465|20866524|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468025|NCT00673465|20866525|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468026|NCT00673465|20866526|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468027|NCT00673465|20866527|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468028|NCT00673465|20866528|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468029|NCT00673465|20866529|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468030|NCT00673465|20866530|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468031|NCT00673465|20866519|P12|COMPLETED|Part 1/Period 3 (United States)||0
8468032|NCT00673465|20866520|P11|COMPLETED|Part 1/Period 3 (United States)||0
8468033|NCT00673465|20866521|P10|COMPLETED|Part 1/Period 3 (United States)||0
8468034|NCT00673465|20866522|P9|COMPLETED|Part 1/Period 3 (United States)||0
8468035|NCT00673465|20866523|P8|COMPLETED|Part 1/Period 3 (United States)||0
8468036|NCT00673465|20866524|P7|COMPLETED|Part 1/Period 3 (United States)||0
8468037|NCT00673465|20866525|P6|COMPLETED|Part 1/Period 3 (United States)||1
8468038|NCT00673465|20866526|P5|COMPLETED|Part 1/Period 3 (United States)||1
8468039|NCT00673465|20866527|P4|COMPLETED|Part 1/Period 3 (United States)||3
8468040|NCT00673465|20866528|P3|COMPLETED|Part 1/Period 3 (United States)||3
8468041|NCT00673465|20866529|P2|COMPLETED|Part 1/Period 3 (United States)||3
8468042|NCT00673465|20866530|P1|COMPLETED|Part 1/Period 3 (United States)||3
8468043|NCT00673465|20866519|P12|STARTED|Part 1/Period 3 (United States)||0
8468044|NCT00673465|20866520|P11|STARTED|Part 1/Period 3 (United States)||0
8468045|NCT00673465|20866521|P10|STARTED|Part 1/Period 3 (United States)||0
8468046|NCT00673465|20866522|P9|STARTED|Part 1/Period 3 (United States)||0
8468047|NCT00673465|20866523|P8|STARTED|Part 1/Period 3 (United States)||0
8468048|NCT00673465|20866524|P7|STARTED|Part 1/Period 3 (United States)||0
8468049|NCT00673465|20866525|P6|STARTED|Part 1/Period 3 (United States)||1
8468050|NCT00673465|20866526|P5|STARTED|Part 1/Period 3 (United States)||1
8468051|NCT00673465|20866527|P4|STARTED|Part 1/Period 3 (United States)||3
8468052|NCT00673465|20866528|P3|STARTED|Part 1/Period 3 (United States)||3
8468053|NCT00673465|20866529|P2|STARTED|Part 1/Period 3 (United States)||3
8468054|NCT00673465|20866530|P1|STARTED|Part 1/Period 3 (United States)||3
8468055|NCT00673465|20866519|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468056|NCT00673465|20866520|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468057|NCT00673465|20866521|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468058|NCT00673465|20866522|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468059|NCT00673465|20866523|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468060|NCT00673465|20866524|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468061|NCT00673465|20866525|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468062|NCT00673465|20866526|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
8468063|NCT00673465|20866527|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468064|NCT00673465|20866528|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468065|NCT00673465|20866529|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468066|NCT00673465|20866530|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468067|NCT00673465|20866519|P12|COMPLETED|Part 1/Period 2 (United States)||0
8468068|NCT00673465|20866520|P11|COMPLETED|Part 1/Period 2 (United States)||0
8468069|NCT00673465|20866521|P10|COMPLETED|Part 1/Period 2 (United States)||0
8468070|NCT00673465|20866522|P9|COMPLETED|Part 1/Period 2 (United States)||0
8468071|NCT00673465|20866523|P8|COMPLETED|Part 1/Period 2 (United States)||0
8468072|NCT00673465|20866524|P7|COMPLETED|Part 1/Period 2 (United States)||0
8468073|NCT00673465|20866525|P6|COMPLETED|Part 1/Period 2 (United States)||1
8468074|NCT00673465|20866526|P5|COMPLETED|Part 1/Period 2 (United States)||1
8468075|NCT00673465|20866527|P4|COMPLETED|Part 1/Period 2 (United States)||3
8468076|NCT00673465|20866528|P3|COMPLETED|Part 1/Period 2 (United States)||3
8468077|NCT00673465|20866529|P2|COMPLETED|Part 1/Period 2 (United States)||3
8468078|NCT00673465|20866530|P1|COMPLETED|Part 1/Period 2 (United States)||3
8468079|NCT00673465|20866519|P12|STARTED|Part 1/Period 2 (United States)||0
8468080|NCT00673465|20866520|P11|STARTED|Part 1/Period 2 (United States)||0
8468081|NCT00673465|20866521|P10|STARTED|Part 1/Period 2 (United States)||0
8468082|NCT00673465|20866522|P9|STARTED|Part 1/Period 2 (United States)||0
8468083|NCT00673465|20866523|P8|STARTED|Part 1/Period 2 (United States)||0
8468084|NCT00673465|20866524|P7|STARTED|Part 1/Period 2 (United States)||0
8468085|NCT00673465|20866525|P6|STARTED|Part 1/Period 2 (United States)||1
8468086|NCT00673465|20866526|P5|STARTED|Part 1/Period 2 (United States)||2
8468087|NCT00673465|20866527|P4|STARTED|Part 1/Period 2 (United States)||3
8468088|NCT00673465|20866528|P3|STARTED|Part 1/Period 2 (United States)||3
8468089|NCT00673465|20866529|P2|STARTED|Part 1/Period 2 (United States)||3
8468090|NCT00673465|20866530|P1|STARTED|Part 1/Period 2 (United States)||3
8468091|NCT00673465|20866519|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468092|NCT00673465|20866520|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468093|NCT00673465|20866521|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468094|NCT00673465|20866522|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468095|NCT00673465|20866523|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468096|NCT00673465|20866524|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468097|NCT00673465|20866525|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
8468098|NCT00673465|20866526|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
8468099|NCT00673465|20866527|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468100|NCT00673465|20866528|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468101|NCT00673465|20866529|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468102|NCT00673465|20866530|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468103|NCT00673465|20866519|P12|COMPLETED|Part 1/Period 1 (United States)||0
8468104|NCT00673465|20866520|P11|COMPLETED|Part 1/Period 1 (United States)||0
8468105|NCT00673465|20866521|P10|COMPLETED|Part 1/Period 1 (United States)||0
8468106|NCT00673465|20866522|P9|COMPLETED|Part 1/Period 1 (United States)||0
8468107|NCT00673465|20866523|P8|COMPLETED|Part 1/Period 1 (United States)||0
8468108|NCT00673465|20866524|P7|COMPLETED|Part 1/Period 1 (United States)||0
8468109|NCT00673465|20866525|P6|COMPLETED|Part 1/Period 1 (United States)||1
8468110|NCT00673465|20866526|P5|COMPLETED|Part 1/Period 1 (United States)||2
8468111|NCT00673465|20866527|P4|COMPLETED|Part 1/Period 1 (United States)||3
8468112|NCT00673465|20866528|P3|COMPLETED|Part 1/Period 1 (United States)||3
8468113|NCT00673465|20866529|P2|COMPLETED|Part 1/Period 1 (United States)||3
8468114|NCT00673465|20866530|P1|COMPLETED|Part 1/Period 1 (United States)||3
8468115|NCT00673465|20866519|P12|STARTED|Part 1/Period 1 (United States)||0
8468116|NCT00673465|20866520|P11|STARTED|Part 1/Period 1 (United States)||0
8468117|NCT00673465|20866521|P10|STARTED|Part 1/Period 1 (United States)||0
8468118|NCT00673465|20866522|P9|STARTED|Part 1/Period 1 (United States)||0
8468119|NCT00673465|20866523|P8|STARTED|Part 1/Period 1 (United States)||0
8468120|NCT00673465|20866524|P7|STARTED|Part 1/Period 1 (United States)||0
8468121|NCT00673465|20866525|P6|STARTED|Part 1/Period 1 (United States)||2
8468122|NCT00673465|20866526|P5|STARTED|Part 1/Period 1 (United States)||3
8468123|NCT00673465|20866527|P4|STARTED|Part 1/Period 1 (United States)||3
8468124|NCT00673465|20866528|P3|STARTED|Part 1/Period 1 (United States)||3
8468125|NCT00673465|20866529|P2|STARTED|Part 1/Period 1 (United States)||3
8468126|NCT00673465|20866530|P1|STARTED|Part 1/Period 1 (United States)||3
8468127|NCT00673452|20866579|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
8468128|NCT00673452|20866580|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
8468129|NCT00673452|20866579|P2|COMPLETED|Continuation Double-Blind Phase||153
8468130|NCT00673452|20866580|P1|COMPLETED|Continuation Double-Blind Phase||151
8468131|NCT00673452|20866579|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
8468132|NCT00673452|20866580|P1|STARTED|Continuation Double-Blind Phase||176
8468133|NCT00673452|20866579|P2|NOT COMPLETED|Acute Double-Blind Phase||80
8468134|NCT00673452|20866580|P1|NOT COMPLETED|Acute Double-Blind Phase||87
8468135|NCT00673452|20866579|P2|COMPLETED|Acute Double-Blind Phase||187
8468136|NCT00673452|20866580|P1|COMPLETED|Acute Double-Blind Phase||176
8468137|NCT00673452|20866579|P2|STARTED|Acute Double-Blind Phase||267
8468138|NCT00673452|20866580|P1|STARTED|Acute Double-Blind Phase||263
8468139|NCT00673439|20866614|P1|NOT COMPLETED|Overall Study||0
8468140|NCT00673439|20866614|P1|COMPLETED|Overall Study||3
8468141|NCT00673439|20866614|P1|STARTED|Overall Study||3
8468142|NCT00673400|20866619|P1|NOT COMPLETED|Overall Study||0
8468143|NCT00673400|20866619|P1|COMPLETED|Overall Study||52
8468144|NCT00673400|20866619|P1|STARTED|Overall Study||52
8468145|NCT00673387|20866644|P8|NOT COMPLETED|Overall Study||35
8468146|NCT00673387|20866645|P7|NOT COMPLETED|Overall Study||30
8468147|NCT00673387|20866646|P6|NOT COMPLETED|Overall Study||34
8468148|NCT00673387|20866647|P5|NOT COMPLETED|Overall Study||30
8468149|NCT00673387|20866648|P4|NOT COMPLETED|Overall Study||26
8468150|NCT00673387|20866649|P3|NOT COMPLETED|Overall Study||31
8468151|NCT00673387|20866650|P2|NOT COMPLETED|Overall Study||23
8468152|NCT00673387|20866651|P1|NOT COMPLETED|Overall Study||29
8468153|NCT00673387|20866644|P8|COMPLETED|Overall Study||40
8468154|NCT00673387|20866645|P7|COMPLETED|Overall Study||48
8468155|NCT00673387|20866646|P6|COMPLETED|Overall Study||44
8468156|NCT00673387|20866647|P5|COMPLETED|Overall Study||48
8468157|NCT00673387|20866648|P4|COMPLETED|Overall Study||49
8468158|NCT00673387|20866649|P3|COMPLETED|Overall Study||41
8468159|NCT00673387|20866650|P2|COMPLETED|Overall Study||54
8468160|NCT00673387|20866651|P1|COMPLETED|Overall Study||46
8468161|NCT00673387|20866644|P8|STARTED|Overall Study||75
8468162|NCT00673387|20866645|P7|STARTED|Overall Study||78
8468163|NCT00673387|20866646|P6|STARTED|Overall Study||78
8468164|NCT00673387|20866647|P5|STARTED|Overall Study||78
8468165|NCT00673387|20866648|P4|STARTED|Overall Study||75
8468166|NCT00673387|20866649|P3|STARTED|Overall Study||72
8468167|NCT00673387|20866650|P2|STARTED|Overall Study||77
8468168|NCT00673387|20866651|P1|STARTED|Overall Study||75
8468169|NCT00673361|20866867|P1|NOT COMPLETED|Overall Study||2
8468170|NCT00673361|20866867|P1|COMPLETED|Overall Study||7
8468171|NCT00673361|20866867|P1|STARTED|Overall Study||9
8468172|NCT00673309|20866881|P10|NOT COMPLETED|Overall Study||0
8468173|NCT00673309|20866882|P9|NOT COMPLETED|Overall Study||0
8468174|NCT00673309|20866883|P8|NOT COMPLETED|Overall Study||0
8468175|NCT00673309|20866884|P7|NOT COMPLETED|Overall Study||0
8468176|NCT00673309|20866885|P6|NOT COMPLETED|Overall Study||0
8468177|NCT00673309|20866886|P5|NOT COMPLETED|Overall Study||0
8468178|NCT00673309|20866887|P4|NOT COMPLETED|Overall Study||0
8468179|NCT00673309|20866888|P3|NOT COMPLETED|Overall Study||0
8468180|NCT00673309|20866889|P2|NOT COMPLETED|Overall Study||0
8468181|NCT00673309|20866890|P1|NOT COMPLETED|Overall Study||0
8468182|NCT00673309|20866881|P10|COMPLETED|Overall Study||30
8468183|NCT00673309|20866882|P9|COMPLETED|Overall Study||17
8468184|NCT00673309|20866883|P8|COMPLETED|Overall Study||13
8468185|NCT00673309|20866884|P7|COMPLETED|Overall Study||14
8468186|NCT00673309|20866885|P6|COMPLETED|Overall Study||35
8468187|NCT00673309|20866886|P5|COMPLETED|Overall Study||18
8468188|NCT00673309|20866887|P4|COMPLETED|Overall Study||25
8468189|NCT00673309|20866888|P3|COMPLETED|Overall Study||14
8468190|NCT00673309|20866889|P2|COMPLETED|Overall Study||14
8468191|NCT00673309|20866890|P1|COMPLETED|Overall Study||64
8468192|NCT00673309|20866881|P10|STARTED|Overall Study||30
8468193|NCT00673309|20866882|P9|STARTED|Overall Study||17
8468194|NCT00673309|20866883|P8|STARTED|Overall Study||13
8468195|NCT00673309|20866884|P7|STARTED|Overall Study||14
8468196|NCT00673309|20866885|P6|STARTED|Overall Study||35
8468197|NCT00673309|20866886|P5|STARTED|Overall Study||18
8468198|NCT00673309|20866887|P4|STARTED|Overall Study||25
8468199|NCT00673309|20866888|P3|STARTED|Overall Study||14
8468200|NCT00673309|20866889|P2|STARTED|Overall Study||14
8468201|NCT00673309|20866890|P1|STARTED|Overall Study||64
8468202|NCT00673257|20866903|P1|NOT COMPLETED|Overall Study||5
8468203|NCT00673257|20866903|P1|COMPLETED|Overall Study||102
8468204|NCT00673257|20866903|P1|STARTED|Overall Study||107
8468205|NCT00673244|20866910|P2|NOT COMPLETED|Overall Study||0
8468206|NCT00673244|20866911|P1|NOT COMPLETED|Overall Study||0
8468207|NCT00673244|20866910|P2|COMPLETED|Overall Study||25
8468208|NCT00673244|20866911|P1|COMPLETED|Overall Study||52
8468209|NCT00673244|20866910|P2|STARTED|Overall Study||25
8468210|NCT00673244|20866911|P1|STARTED|Overall Study||52
8468211|NCT00673231|20866921|P4|NOT COMPLETED|Overall Study||18
8468212|NCT00673231|20866922|P3|NOT COMPLETED|Overall Study||26
8468213|NCT00673231|20866923|P2|NOT COMPLETED|Overall Study||22
8468214|NCT00673231|20866924|P1|NOT COMPLETED|Overall Study||29
8468215|NCT00673231|20866921|P4|COMPLETED|Overall Study||178
8468216|NCT00673231|20866922|P3|COMPLETED|Overall Study||186
8468217|NCT00673231|20866923|P2|COMPLETED|Overall Study||180
8468218|NCT00673231|20866924|P1|COMPLETED|Overall Study||168
8468219|NCT00673231|20866921|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
8468220|NCT00673231|20866922|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
8468221|NCT00673231|20866923|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
8468222|NCT00673231|20866924|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
8468223|NCT00673179|20866956|P2|NOT COMPLETED|Overall Study||0
8468224|NCT00673179|20866957|P1|NOT COMPLETED|Overall Study||3
8468225|NCT00673179|20866956|P2|COMPLETED|Overall Study||0
8468226|NCT00673179|20866957|P1|COMPLETED|Overall Study||4
8468227|NCT00673179|20866956|P2|STARTED|Overall Study||0
8468228|NCT00673179|20866957|P1|STARTED|Overall Study||7
8468229|NCT00673153|20866963|P1|NOT COMPLETED|Overall Study||1
8468230|NCT00673153|20866963|P1|COMPLETED|Overall Study||30
8468231|NCT00673153|20866963|P1|STARTED|Overall Study||31
8468232|NCT00673127|20866971|P1|NOT COMPLETED|Overall Study||0
8468233|NCT00673127|20866971|P1|COMPLETED|Overall Study||57
8468234|NCT00673127|20866971|P1|STARTED|Overall Study||57
8468235|NCT00673114|20866976|P1|NOT COMPLETED|Overall Study||0
8468236|NCT00673114|20866976|P1|COMPLETED|Overall Study||3
8468237|NCT00673114|20866976|P1|STARTED|Overall Study||3
8468238|NCT00673075|20866989|P2|NOT COMPLETED|Overall Study||7
8468239|NCT00673075|20866990|P1|NOT COMPLETED|Overall Study||9
8468240|NCT00673075|20866989|P2|COMPLETED|Overall Study||11
8468241|NCT00673075|20866990|P1|COMPLETED|Overall Study||12
8468242|NCT00673075|20866989|P2|STARTED|Overall Study||18
8468243|NCT00673075|20866990|P1|STARTED|Overall Study||21
8468244|NCT00673049|20867006|P4|NOT COMPLETED|After Progression on Erlotinib||83
8468245|NCT00673049|20867007|P3|NOT COMPLETED|After Progression on Erlotinib||0
8468246|NCT00673049|20867008|P2|NOT COMPLETED|After Progression on Erlotinib||0
8468247|NCT00673049|20867009|P1|NOT COMPLETED|After Progression on Erlotinib||0
8468248|NCT00673049|20867006|P4|COMPLETED|After Progression on Erlotinib||0
8468249|NCT00673049|20867007|P3|COMPLETED|After Progression on Erlotinib||0
8468250|NCT00673049|20867008|P2|COMPLETED|After Progression on Erlotinib||0
8468251|NCT00673049|20867009|P1|COMPLETED|After Progression on Erlotinib||0
8468252|NCT00673049|20867006|P4|STARTED|After Progression on Erlotinib||83
8468253|NCT00673049|20867007|P3|STARTED|After Progression on Erlotinib||0
8468254|NCT00673049|20867008|P2|STARTED|After Progression on Erlotinib||0
8468255|NCT00673049|20867009|P1|STARTED|After Progression on Erlotinib||0
8468256|NCT00673049|20867006|P4|NOT COMPLETED|Before Progression on Erlotinib||0
8468257|NCT00673049|20867007|P3|NOT COMPLETED|Before Progression on Erlotinib||1
8468258|NCT00673049|20867008|P2|NOT COMPLETED|Before Progression on Erlotinib||290
8468259|NCT00673049|20867009|P1|NOT COMPLETED|Before Progression on Erlotinib||292
8468260|NCT00673049|20867006|P4|COMPLETED|Before Progression on Erlotinib||0
8468261|NCT00673049|20867007|P3|COMPLETED|Before Progression on Erlotinib||0
8468262|NCT00673049|20867008|P2|COMPLETED|Before Progression on Erlotinib||0
8468263|NCT00673049|20867009|P1|COMPLETED|Before Progression on Erlotinib||0
8468264|NCT00673049|20867006|P4|Treated|Before Progression on Erlotinib||0
8468265|NCT00673049|20867007|P3|Treated|Before Progression on Erlotinib||1
8468266|NCT00673049|20867008|P2|Treated|Before Progression on Erlotinib||289
8468267|NCT00673049|20867009|P1|Treated|Before Progression on Erlotinib||289
8468268|NCT00673049|20867006|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
8468269|NCT00673049|20867007|P3|STARTED|Before Progression on Erlotinib||1
8468270|NCT00673049|20867008|P2|STARTED|Before Progression on Erlotinib||290
8468271|NCT00673049|20867009|P1|STARTED|Before Progression on Erlotinib||292
8468272|NCT00672984|20867033|P3|NOT COMPLETED|Third Intervention||1
8468273|NCT00672984|20867034|P2|NOT COMPLETED|Third Intervention||0
8468274|NCT00672984|20867035|P1|NOT COMPLETED|Third Intervention||1
8468275|NCT00672984|20867033|P3|COMPLETED|Third Intervention||23
8468276|NCT00672984|20867034|P2|COMPLETED|Third Intervention||17
8468277|NCT00672984|20867035|P1|COMPLETED|Third Intervention||21
8468278|NCT00672984|20867033|P3|STARTED|Third Intervention||24
8468279|NCT00672984|20867034|P2|STARTED|Third Intervention||17
8468280|NCT00672984|20867035|P1|STARTED|Third Intervention||22
8468281|NCT00672984|20867033|P3|NOT COMPLETED|Second Intervention||1
8468282|NCT00672984|20867034|P2|NOT COMPLETED|Second Intervention||6
8468283|NCT00672984|20867035|P1|NOT COMPLETED|Second Intervention||0
8468284|NCT00672984|20867033|P3|COMPLETED|Second Intervention||24
8468285|NCT00672984|20867034|P2|COMPLETED|Second Intervention||17
8468286|NCT00672984|20867035|P1|COMPLETED|Second Intervention||22
8468287|NCT00672984|20867033|P3|STARTED|Second Intervention||25
8468288|NCT00672984|20867034|P2|STARTED|Second Intervention||23
8468289|NCT00672984|20867035|P1|STARTED|Second Intervention||22
8468290|NCT00672984|20867033|P3|NOT COMPLETED|First Intervention||2
8468291|NCT00672984|20867034|P2|NOT COMPLETED|First Intervention||2
8468292|NCT00672984|20867035|P1|NOT COMPLETED|First Intervention||9
8468293|NCT00672984|20867033|P3|COMPLETED|First Intervention||25
8468294|NCT00672984|20867034|P2|COMPLETED|First Intervention||23
8468295|NCT00672984|20867035|P1|COMPLETED|First Intervention||22
8468296|NCT00672984|20867033|P3|STARTED|First Intervention||27
8468297|NCT00672984|20867034|P2|STARTED|First Intervention||25
8468298|NCT00672984|20867035|P1|STARTED|First Intervention||31
8468299|NCT00672958|20867086|P2|NOT COMPLETED|Overall Study||56
8468300|NCT00672958|20867087|P1|NOT COMPLETED|Overall Study||64
8468301|NCT00672958|20867086|P2|COMPLETED|Overall Study||244
8468302|NCT00672958|20867087|P1|COMPLETED|Overall Study||236
8468303|NCT00672958|20867086|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
8468304|NCT00672958|20867087|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
8468305|NCT00672958|20867086|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
8468306|NCT00672958|20867087|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
8468307|NCT00672958|20867086|P2|STARTED|Overall Study||300
8468308|NCT00672958|20867087|P1|STARTED|Overall Study||300
8468309|NCT00672932|20867119|P2|NOT COMPLETED|Overall Study||0
8468310|NCT00672932|20867120|P1|NOT COMPLETED|Overall Study||0
8468311|NCT00672932|20867119|P2|COMPLETED|Overall Study||9
8468312|NCT00672932|20867120|P1|COMPLETED|Overall Study||9
8468313|NCT00672932|20867119|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
8468314|NCT00672932|20867120|P1|Rolled Over to Raltegravir|Overall Study||0
8468315|NCT00672932|20867119|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
8468316|NCT00672932|20867120|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
8468317|NCT00672932|20867119|P2|Completed Initial 12-week Assignment|Overall Study||9
8468318|NCT00672932|20867120|P1|Completed Initial 12-week Assignment|Overall Study||9
8468319|NCT00672932|20867119|P2|STARTED|Overall Study||9
8468320|NCT00672932|20867120|P1|STARTED|Overall Study||9
8468321|NCT00672854|20867130|P2|NOT COMPLETED|Overall Study||0
8468322|NCT00672854|20867131|P1|NOT COMPLETED|Overall Study||0
8468323|NCT00672854|20867130|P2|COMPLETED|Overall Study||51
8468324|NCT00672854|20867131|P1|COMPLETED|Overall Study||49
8468325|NCT00672854|20867130|P2|STARTED|Overall Study||51
8468326|NCT00672854|20867131|P1|STARTED|Overall Study||49
8468327|NCT00672841|20867153|P2|NOT COMPLETED|Overall Study||15
8468328|NCT00672841|20867154|P1|NOT COMPLETED|Overall Study||1
8468329|NCT00672841|20867153|P2|COMPLETED|Overall Study||32
8468330|NCT00672841|20867154|P1|COMPLETED|Overall Study||16
8468331|NCT00672841|20867153|P2|STARTED|Overall Study||47
8468332|NCT00672841|20867154|P1|STARTED|Overall Study||17
8468333|NCT00672737|20867166|P1|NOT COMPLETED|Overall Study||8
8468334|NCT00672737|20867166|P1|COMPLETED|Overall Study||48
8468335|NCT00672737|20867166|P1|STARTED|Overall Study||56
8468336|NCT00672646|20867176|P3|NOT COMPLETED|Overall Study||3
8468337|NCT00672646|20867177|P2|NOT COMPLETED|Overall Study||1
8468338|NCT00672646|20867178|P1|NOT COMPLETED|Overall Study||0
8468339|NCT00672646|20867176|P3|COMPLETED|Overall Study||37
8468340|NCT00672646|20867177|P2|COMPLETED|Overall Study||22
8468341|NCT00672646|20867178|P1|COMPLETED|Overall Study||40
8468342|NCT00672646|20867176|P3|STARTED|Overall Study||40
8468343|NCT00672646|20867177|P2|STARTED|Overall Study||23
8468344|NCT00672646|20867178|P1|STARTED|Overall Study||40
8468345|NCT00672633|20867203|P2|NOT COMPLETED|Overall Study||1
8468346|NCT00672633|20867204|P1|NOT COMPLETED|Overall Study||0
8468347|NCT00672633|20867203|P2|COMPLETED|Overall Study||12
8468348|NCT00672633|20867204|P1|COMPLETED|Overall Study||12
8468349|NCT00672633|20867203|P2|STARTED|Overall Study||13
8468350|NCT00672633|20867204|P1|STARTED|Overall Study||12
8468351|NCT00672620|20867218|P4|NOT COMPLETED|Overall Study||42
8468352|NCT00672620|20867219|P3|NOT COMPLETED|Overall Study||31
8468353|NCT00672620|20867220|P2|NOT COMPLETED|Overall Study||54
8468354|NCT00672620|20867221|P1|NOT COMPLETED|Overall Study||33
8468355|NCT00672620|20867218|P4|COMPLETED|Overall Study||110
8468356|NCT00672620|20867219|P3|COMPLETED|Overall Study||122
8468357|NCT00672620|20867220|P2|COMPLETED|Overall Study||99
8468358|NCT00672620|20867221|P1|COMPLETED|Overall Study||120
8468359|NCT00672620|20867218|P4|Treated|Overall Study||150
8468360|NCT00672620|20867219|P3|Treated|Overall Study||153
8468361|NCT00672620|20867220|P2|Treated|Overall Study||149
8468362|NCT00672620|20867221|P1|Treated|Overall Study||151
8468363|NCT00672620|20867218|P4|STARTED|Overall Study||152
8468364|NCT00672620|20867219|P3|STARTED|Overall Study||153
8468365|NCT00672620|20867220|P2|STARTED|Overall Study||153
8468366|NCT00672620|20867221|P1|STARTED|Overall Study||153
8468367|NCT00672594|20867275|P1|NOT COMPLETED|Overall Study||3
8468368|NCT00672594|20867275|P1|COMPLETED|Overall Study||27
8468369|NCT00672594|20867275|P1|STARTED|Overall Study||30
8468370|NCT00672555|20867286|P1|NOT COMPLETED|Overall Study||6
8468371|NCT00672555|20867286|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
8468372|NCT00672555|20867286|P1|STARTED|Overall Study||70
8468373|NCT00672490|20867297|P2|NOT COMPLETED|Overall Study||32
8468374|NCT00672490|20867298|P1|NOT COMPLETED|Overall Study||24
8468375|NCT00672490|20867297|P2|COMPLETED|Overall Study||157
8468376|NCT00672490|20867298|P1|COMPLETED|Overall Study||163
8468377|NCT00672490|20867297|P2|STARTED|Overall Study||189
8468378|NCT00672490|20867298|P1|STARTED|Overall Study||187
8468379|NCT00672477|20867322|P2|NOT COMPLETED|Overall Study||26
8468380|NCT00672477|20867323|P1|NOT COMPLETED|Overall Study||27
8468381|NCT00672477|20867322|P2|COMPLETED|Overall Study||88
8468382|NCT00672477|20867323|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
8468383|NCT00672477|20867322|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
8468384|NCT00672477|20867323|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
8468385|NCT00672451|20867333|P2|NOT COMPLETED|Overall Study||0
8468386|NCT00672451|20867334|P1|NOT COMPLETED|Overall Study||0
8468387|NCT00672451|20867333|P2|COMPLETED|Overall Study||2
8468388|NCT00672451|20867334|P1|COMPLETED|Overall Study||1
8468389|NCT00672451|20867333|P2|STARTED|Overall Study||2
8468390|NCT00672451|20867334|P1|STARTED|Overall Study||1
8468391|NCT00672438|20867344|P2|NOT COMPLETED|Infusion 2||0
8468392|NCT00672438|20867345|P1|NOT COMPLETED|Infusion 2||0
8468393|NCT00672438|20867344|P2|COMPLETED|Infusion 2||118
8468394|NCT00672438|20867345|P1|COMPLETED|Infusion 2||119
8468395|NCT00672438|20867344|P2|STARTED|Infusion 2||118
8468396|NCT00672438|20867345|P1|STARTED|Infusion 2||119
8468397|NCT00672438|20867344|P2|NOT COMPLETED|Washout||0
8468398|NCT00672438|20867345|P1|NOT COMPLETED|Washout||0
8468399|NCT00672438|20867344|P2|COMPLETED|Washout||118
8468400|NCT00672438|20867345|P1|COMPLETED|Washout||119
8468401|NCT00672438|20867344|P2|STARTED|Washout||118
8468402|NCT00672438|20867345|P1|STARTED|Washout||119
8468403|NCT00672438|20867344|P2|NOT COMPLETED|Infusion 1||0
8468404|NCT00672438|20867345|P1|NOT COMPLETED|Infusion 1||0
8468405|NCT00672438|20867344|P2|COMPLETED|Infusion 1||118
8468406|NCT00672438|20867345|P1|COMPLETED|Infusion 1||119
8468407|NCT00672438|20867344|P2|STARTED|Infusion 1||118
8468408|NCT00672438|20867345|P1|STARTED|Infusion 1||119
8468409|NCT00672256|20867376|P1|NOT COMPLETED|Overall Study||44
8468410|NCT00672256|20867376|P1|COMPLETED|Overall Study||18
8468411|NCT00672256|20867376|P1|STARTED|Overall Study|January 2007|62
8468412|NCT00672243|20867383|P1|NOT COMPLETED|Overall Study||0
8468413|NCT00672243|20867383|P1|COMPLETED|Overall Study||32
8468414|NCT00672243|20867383|P1|STARTED|Overall Study||32
8468415|NCT00672204|20867391|P1|NOT COMPLETED|Overall Study||20
8468416|NCT00672204|20867391|P1|COMPLETED|Overall Study||3
8468417|NCT00672204|20867391|P1|STARTED|Overall Study||23
8468418|NCT00672178|20867395|P1|NOT COMPLETED|Overall Study||0
8468419|NCT00672178|20867395|P1|COMPLETED|Overall Study||1
8468420|NCT00672178|20867395|P1|STARTED|Overall Study||1
8468421|NCT00672139|20867401|P2|NOT COMPLETED|Overall Study||45
8468422|NCT00672139|20867402|P1|NOT COMPLETED|Overall Study||30
8468423|NCT00672139|20867401|P2|COMPLETED|Overall Study||47
8468424|NCT00672139|20867402|P1|COMPLETED|Overall Study||27
8468425|NCT00672139|20867401|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
8468426|NCT00672139|20867402|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
8468427|NCT00672100|20867411|P3|NOT COMPLETED|Overall Study||0
8468428|NCT00672100|20867412|P2|NOT COMPLETED|Overall Study||0
8468429|NCT00672100|20867413|P1|NOT COMPLETED|Overall Study||0
8468430|NCT00672100|20867411|P3|COMPLETED|Overall Study||12
8468431|NCT00672100|20867412|P2|COMPLETED|Overall Study||12
8468432|NCT00672100|20867413|P1|COMPLETED|Overall Study||12
8468433|NCT00672100|20867411|P3|PACU (Within 8 Hours)|Overall Study||12
8468434|NCT00672100|20867412|P2|PACU (Within 8 Hours)|Overall Study||12
8468435|NCT00672100|20867413|P1|PACU (Within 8 Hours)|Overall Study||12
8468436|NCT00672100|20867411|P3|STARTED|Overall Study||12
8468437|NCT00672100|20867412|P2|STARTED|Overall Study||12
8468438|NCT00672100|20867413|P1|STARTED|Overall Study||12
8468439|NCT00671970|20867430|P2|NOT COMPLETED|Overall Study||0
8468440|NCT00671970|20867431|P1|NOT COMPLETED|Overall Study||0
8468441|NCT00671970|20867430|P2|COMPLETED|Overall Study||25
8468442|NCT00671970|20867431|P1|COMPLETED|Overall Study||32
8468443|NCT00671970|20867430|P2|STARTED|Overall Study||25
8468444|NCT00671970|20867431|P1|STARTED|Overall Study||32
8468445|NCT00671931|20867459|P5|NOT COMPLETED|Overall Study||1
8468446|NCT00671931|20867460|P4|NOT COMPLETED|Overall Study||2
8468447|NCT00671931|20867461|P3|NOT COMPLETED|Overall Study||0
8468448|NCT00671931|20867462|P2|NOT COMPLETED|Overall Study||0
8468449|NCT00671931|20867463|P1|NOT COMPLETED|Overall Study||1
8468450|NCT00671931|20867459|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
8468451|NCT00671931|20867460|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
8468452|NCT00671931|20867461|P3|COMPLETED|Overall Study|all completed|9
8468453|NCT00671931|20867462|P2|COMPLETED|Overall Study|All completed|8
8468454|NCT00671931|20867463|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
8468455|NCT00671931|20867459|P5|STARTED|Overall Study||8
8468456|NCT00671931|20867460|P4|STARTED|Overall Study||10
8468457|NCT00671931|20867461|P3|STARTED|Overall Study||9
8468458|NCT00671931|20867462|P2|STARTED|Overall Study||8
8468459|NCT00671931|20867463|P1|STARTED|Overall Study||9
8468460|NCT00671918|20867475|P1|NOT COMPLETED|Overall Study||17
8468461|NCT00671918|20867475|P1|COMPLETED|Overall Study||169
8468462|NCT00671918|20867475|P1|STARTED|Overall Study||186
8468463|NCT00671879|20867483|P3|NOT COMPLETED|Overall Study||6
8468464|NCT00671879|20867484|P2|NOT COMPLETED|Overall Study||4
8468465|NCT00671879|20867485|P1|NOT COMPLETED|Overall Study||0
8468466|NCT00671879|20867483|P3|COMPLETED|Overall Study||274
8468467|NCT00671879|20867484|P2|COMPLETED|Overall Study||275
8468468|NCT00671879|20867485|P1|COMPLETED|Overall Study||281
8468469|NCT00671879|20867483|P3|STARTED|Overall Study||280
8468470|NCT00671879|20867484|P2|STARTED|Overall Study||279
8468471|NCT00671879|20867485|P1|STARTED|Overall Study||281
8468472|NCT00671853|20867498|P2|NOT COMPLETED|Overall Study||27
8468473|NCT00671853|20867499|P1|NOT COMPLETED|Overall Study||20
8468474|NCT00671853|20867498|P2|COMPLETED|Overall Study||18
8468475|NCT00671853|20867499|P1|COMPLETED|Overall Study||26
8468476|NCT00671853|20867498|P2|STARTED|Overall Study||45
8468477|NCT00671853|20867499|P1|STARTED|Overall Study||46
8468478|NCT00671788|20867515|P1|NOT COMPLETED|Overall Study||14
8468479|NCT00671788|20867515|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
8468480|NCT00671788|20867515|P1|STARTED|Overall Study||35
8468481|NCT00671749|20867522|P1|NOT COMPLETED|Overall Study||8
8468482|NCT00671749|20867522|P1|COMPLETED|Overall Study||92
8468483|NCT00671749|20867522|P1|STARTED|Overall Study||100
8468484|NCT00671723|20867535|P3|NOT COMPLETED|Overall Study||0
8468485|NCT00671723|20867536|P2|NOT COMPLETED|Overall Study||0
8468486|NCT00671723|20867537|P1|NOT COMPLETED|Overall Study||0
8468487|NCT00671723|20867535|P3|COMPLETED|Overall Study||11
8468488|NCT00671723|20867536|P2|COMPLETED|Overall Study||11
8468489|NCT00671723|20867537|P1|COMPLETED|Overall Study||11
8468490|NCT00671723|20867535|P3|STARTED|Overall Study||11
8468491|NCT00671723|20867536|P2|STARTED|Overall Study||11
8468492|NCT00671723|20867537|P1|STARTED|Overall Study||11
8468493|NCT00671671|20867550|P2|NOT COMPLETED|Overall Study||0
8468494|NCT00671671|20867551|P1|NOT COMPLETED|Overall Study||0
8468495|NCT00671671|20867550|P2|COMPLETED|Overall Study||10
8468496|NCT00671671|20867551|P1|COMPLETED|Overall Study||10
8468497|NCT00671671|20867550|P2|STARTED|Overall Study||10
8468498|NCT00671671|20867551|P1|STARTED|Overall Study||10
8468499|NCT00671658|20867577|P1|NOT COMPLETED|Overall Study||5
8468500|NCT00671658|20867577|P1|COMPLETED|Overall Study||215
8468501|NCT00671658|20867577|P1|STARTED|Overall Study||220
8468502|NCT00671606|20867581|P1|NOT COMPLETED|Overall Study||0
8468503|NCT00671606|20867581|P1|COMPLETED|Overall Study||5
8468504|NCT00671606|20867581|P1|STARTED|Overall Study||5
8468505|NCT00671554|20867585|P1|NOT COMPLETED|Overall Study||3
8468506|NCT00671554|20867585|P1|COMPLETED|Overall Study||0
8468507|NCT00671554|20867585|P1|STARTED|Overall Study||3
8468508|NCT00671528|20867593|P3|NOT COMPLETED|Overall Study||0
8468509|NCT00671528|20867594|P2|NOT COMPLETED|Overall Study||0
8468510|NCT00671528|20867595|P1|NOT COMPLETED|Overall Study||0
8468511|NCT00671528|20867593|P3|COMPLETED|Overall Study||1
8468512|NCT00671528|20867594|P2|COMPLETED|Overall Study||1
8468513|NCT00671528|20867595|P1|COMPLETED|Overall Study||1
8468514|NCT00671528|20867593|P3|STARTED|Overall Study||1
8468515|NCT00671528|20867594|P2|STARTED|Overall Study||1
8468516|NCT00671528|20867595|P1|STARTED|Overall Study||1
8468517|NCT00671515|20867606|P1|NOT COMPLETED|Phase 2||4
8468518|NCT00671515|20867606|P1|COMPLETED|Phase 2||9
8468519|NCT00671515|20867606|P1|STARTED|Phase 2||13
8468520|NCT00671515|20867606|P1|NOT COMPLETED|Phase 1||3
8468521|NCT00671515|20867606|P1|COMPLETED|Phase 1||20
8468522|NCT00671515|20867606|P1|STARTED|Phase 1||23
8468523|NCT00671502|20867614|P3|NOT COMPLETED|Overall Study||27
8468524|NCT00671502|20867615|P2|NOT COMPLETED|Overall Study||39
8468525|NCT00671502|20867616|P1|NOT COMPLETED|Overall Study||39
8468526|NCT00671502|20867614|P3|COMPLETED|Overall Study||252
8468527|NCT00671502|20867615|P2|COMPLETED|Overall Study||241
8468528|NCT00671502|20867616|P1|COMPLETED|Overall Study||242
8468529|NCT00671502|20867614|P3|STARTED|Overall Study||279
8468530|NCT00671502|20867615|P2|STARTED|Overall Study||280
8468531|NCT00671502|20867616|P1|STARTED|Overall Study||281
8468532|NCT00671437|20867624|P1|NOT COMPLETED|Overall Study||15
8468533|NCT00671437|20867624|P1|COMPLETED|Overall Study||27
8468534|NCT00671437|20867624|P1|STARTED|Overall Study||42
8468535|NCT00671177|20867645|P2|NOT COMPLETED|Overall Study||1
8468536|NCT00671177|20867646|P1|NOT COMPLETED|Overall Study||2
8468537|NCT00671177|20867645|P2|COMPLETED|Overall Study||114
8468538|NCT00671177|20867646|P1|COMPLETED|Overall Study||112
8468539|NCT00671177|20867645|P2|STARTED|Overall Study||115
8468540|NCT00671177|20867646|P1|STARTED|Overall Study||114
8468541|NCT00671060|20867658|P2|NOT COMPLETED|Overall Study||1
8468542|NCT00671060|20867659|P1|NOT COMPLETED|Overall Study||1
8468543|NCT00671060|20867658|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
8468544|NCT00671060|20867659|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
8468545|NCT00671060|20867658|P2|STARTED|Overall Study||76
8468546|NCT00671060|20867659|P1|STARTED|Overall Study||77
8468547|NCT00671034|20867668|P3|NOT COMPLETED|Overall Study||24
8468548|NCT00671034|20867669|P2|NOT COMPLETED|Overall Study||20
8468549|NCT00671034|20867670|P1|NOT COMPLETED|Overall Study||39
8468550|NCT00671034|20867668|P3|COMPLETED|Overall Study||31
8468551|NCT00671034|20867669|P2|COMPLETED|Overall Study||22
8468552|NCT00671034|20867670|P1|COMPLETED|Overall Study||30
8468553|NCT00671034|20867668|P3|STARTED|Overall Study||55
8468554|NCT00671034|20867669|P2|STARTED|Overall Study||42
8468555|NCT00671034|20867670|P1|STARTED|Overall Study||69
8468556|NCT00670982|20867707|P2|NOT COMPLETED|Overall Study||0
8468557|NCT00670982|20867708|P1|NOT COMPLETED|Overall Study||0
8468558|NCT00670982|20867707|P2|COMPLETED|Overall Study||7
8468559|NCT00670982|20867708|P1|COMPLETED|Overall Study||22
8468560|NCT00670982|20867707|P2|STARTED|Overall Study||7
8468561|NCT00670982|20867708|P1|STARTED|Overall Study||22
8468562|NCT00670956|20867717|P1|NOT COMPLETED|Overall Study||0
8468563|NCT00670956|20867717|P1|COMPLETED|Overall Study||1
8468564|NCT00670956|20867717|P1|STARTED|Overall Study||1
8468565|NCT00670930|20867725|P2|NOT COMPLETED|Overall Study||1
8468566|NCT00670930|20867726|P1|NOT COMPLETED|Overall Study||1
8468567|NCT00670930|20867725|P2|COMPLETED|Overall Study||12
8468568|NCT00670930|20867726|P1|COMPLETED|Overall Study||22
8468569|NCT00670930|20867725|P2|Intent to Treat (ITT) Population|Overall Study||12
8468570|NCT00670930|20867726|P1|Intent to Treat (ITT) Population|Overall Study||23
8468571|NCT00670930|20867725|P2|STARTED|Overall Study||13
8468572|NCT00670930|20867726|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
8468573|NCT00670800|20867742|P2|NOT COMPLETED|Overall Study||2
8468574|NCT00670800|20867743|P1|NOT COMPLETED|Overall Study||0
8468575|NCT00670800|20867742|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
8468576|NCT00670800|20867743|P1|COMPLETED|Overall Study||7
8468577|NCT00670800|20867742|P2|STARTED|Overall Study||7
8468578|NCT00670800|20867743|P1|STARTED|Overall Study||7
8468579|NCT00670774|20867759|P1|NOT COMPLETED|Overall Study||0
8468580|NCT00670774|20867759|P1|COMPLETED|Overall Study||26
8468581|NCT00670774|20867759|P1|STARTED|Overall Study||26
8468582|NCT00670748|20867774|P4|NOT COMPLETED|Overall Study||1
8468583|NCT00670748|20867775|P3|NOT COMPLETED|Overall Study||2
8468584|NCT00670748|20867776|P2|NOT COMPLETED|Overall Study||2
8468585|NCT00670748|20867777|P1|NOT COMPLETED|Overall Study||3
8468586|NCT00670748|20867774|P4|COMPLETED|Overall Study||4
8468587|NCT00670748|20867775|P3|COMPLETED|Overall Study||5
8468588|NCT00670748|20867776|P2|COMPLETED|Overall Study||14
8468589|NCT00670748|20867777|P1|COMPLETED|Overall Study||14
8468590|NCT00670748|20867774|P4|STARTED|Overall Study||5
8468591|NCT00670748|20867775|P3|STARTED|Overall Study||7
8468592|NCT00670748|20867776|P2|STARTED|Overall Study||16
8468593|NCT00670748|20867777|P1|STARTED|Overall Study||17
8468594|NCT00670709|20867797|P2|NOT COMPLETED|Overall Study||0
8468595|NCT00670709|20867798|P1|NOT COMPLETED|Overall Study||0
8468596|NCT00670709|20867797|P2|COMPLETED|Overall Study||15
8468597|NCT00670709|20867798|P1|COMPLETED|Overall Study||27
8468598|NCT00670709|20867797|P2|STARTED|Overall Study||15
8468599|NCT00670709|20867798|P1|STARTED|Overall Study||27
8468600|NCT00670631|20867806|P1|NOT COMPLETED|Overall Study||0
8468601|NCT00670631|20867806|P1|COMPLETED|Overall Study||0
8468602|NCT00670631|20867806|P1|STARTED|Overall Study||0
8468603|NCT00670540|20867812|P1|NOT COMPLETED|Overall Study||3325
8468604|NCT00670540|20867812|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
8468605|NCT00670540|20867812|P1|STARTED|Overall Study||8256
8468606|NCT00670488|20867832|P10|NOT COMPLETED|Overall Study||2
8468607|NCT00670488|20867833|P9|NOT COMPLETED|Overall Study||3
8468608|NCT00670488|20867834|P8|NOT COMPLETED|Overall Study||3
8468609|NCT00670488|20867835|P7|NOT COMPLETED|Overall Study||17
8468610|NCT00670488|20867836|P6|NOT COMPLETED|Overall Study||5
8468611|NCT00670488|20867837|P5|NOT COMPLETED|Overall Study||3
8468612|NCT00670488|20867838|P4|NOT COMPLETED|Overall Study||7
8468613|NCT00670488|20867839|P3|NOT COMPLETED|Overall Study||3
8468614|NCT00670488|20867840|P2|NOT COMPLETED|Overall Study||58
8468615|NCT00670488|20867841|P1|NOT COMPLETED|Overall Study||3
8468616|NCT00670488|20867832|P10|COMPLETED|Overall Study||0
8468617|NCT00670488|20867833|P9|COMPLETED|Overall Study||0
8468618|NCT00670488|20867834|P8|COMPLETED|Overall Study||0
8468619|NCT00670488|20867835|P7|COMPLETED|Overall Study||0
8468620|NCT00670488|20867836|P6|COMPLETED|Overall Study||0
8468621|NCT00670488|20867837|P5|COMPLETED|Overall Study||0
8468622|NCT00670488|20867838|P4|COMPLETED|Overall Study||0
8468623|NCT00670488|20867839|P3|COMPLETED|Overall Study||0
8468624|NCT00670488|20867840|P2|COMPLETED|Overall Study||0
8468625|NCT00670488|20867841|P1|COMPLETED|Overall Study||0
8468626|NCT00670488|20867832|P10|STARTED|Overall Study||2
8468627|NCT00670488|20867833|P9|STARTED|Overall Study||3
8468628|NCT00670488|20867834|P8|STARTED|Overall Study||3
8468629|NCT00670488|20867835|P7|STARTED|Overall Study||17
8468630|NCT00670488|20867836|P6|STARTED|Overall Study||5
8468631|NCT00670488|20867837|P5|STARTED|Overall Study||3
8468632|NCT00670488|20867838|P4|STARTED|Overall Study||7
8468633|NCT00670488|20867839|P3|STARTED|Overall Study||3
8468634|NCT00670488|20867840|P2|STARTED|Overall Study||58
8468635|NCT00670488|20867841|P1|STARTED|Overall Study||3
8468636|NCT00670462|20867995|P2|NOT COMPLETED|Overall Study||31
8468637|NCT00670462|20867996|P1|NOT COMPLETED|Overall Study||30
8468638|NCT00670462|20867995|P2|COMPLETED|Overall Study||76
8468639|NCT00670462|20867996|P1|COMPLETED|Overall Study||76
8468640|NCT00670462|20867995|P2|STARTED|Overall Study||107
8468641|NCT00670462|20867996|P1|STARTED|Overall Study||106
8468642|NCT00670449|20868028|P4|NOT COMPLETED|Overall Study||8
8468643|NCT00670449|20868029|P3|NOT COMPLETED|Overall Study||9
8468644|NCT00670449|20868030|P2|NOT COMPLETED|Overall Study||10
8468645|NCT00670449|20868031|P1|NOT COMPLETED|Overall Study||9
8468646|NCT00670449|20868028|P4|COMPLETED|Overall Study||15
8468647|NCT00670449|20868029|P3|COMPLETED|Overall Study||18
8468648|NCT00670449|20868030|P2|COMPLETED|Overall Study||36
8468649|NCT00670449|20868031|P1|COMPLETED|Overall Study||38
8468650|NCT00670449|20868028|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
8468651|NCT00670449|20868029|P3|Switched to 0.5mg (Open Label)|Overall Study||23
8468652|NCT00670449|20868030|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
8468653|NCT00670449|20868031|P1|Switched to 0.5mg (Open Label)|Overall Study||45
8468654|NCT00670449|20868028|P4|STARTED|Overall Study||23
8468655|NCT00670449|20868029|P3|STARTED|Overall Study||27
8468656|NCT00670449|20868030|P2|STARTED|Overall Study||46
8468657|NCT00670449|20868031|P1|STARTED|Overall Study||47
8468658|NCT00670306|20868055|P1|NOT COMPLETED|Overall Study||55
8468659|NCT00670306|20868055|P1|COMPLETED|Overall Study||473
8468660|NCT00670306|20868055|P1|STARTED|Overall Study||528
8468661|NCT00670267|20868059|P1|NOT COMPLETED|Overall Study||1
8468662|NCT00670267|20868059|P1|COMPLETED|Overall Study||9
8468663|NCT00670267|20868059|P1|STARTED|Overall Study||10
8468664|NCT00670241|20868070|P3|NOT COMPLETED|Overall Study||27
8468665|NCT00670241|20868071|P2|NOT COMPLETED|Overall Study||21
8468666|NCT00670241|20868072|P1|NOT COMPLETED|Overall Study||12
8468667|NCT00670241|20868070|P3|COMPLETED|Overall Study||64
8468668|NCT00670241|20868071|P2|COMPLETED|Overall Study||163
8468669|NCT00670241|20868072|P1|COMPLETED|Overall Study||171
8468670|NCT00670241|20868070|P3|STARTED|Overall Study||91
8468671|NCT00670241|20868071|P2|STARTED|Overall Study||184
8468672|NCT00670241|20868072|P1|STARTED|Overall Study||183
8468673|NCT00670228|20868094|P2|NOT COMPLETED|Overall Study||3
8468674|NCT00670228|20868095|P1|NOT COMPLETED|Overall Study||5
8468675|NCT00670228|20868094|P2|COMPLETED|Overall Study||12
8468676|NCT00670228|20868095|P1|COMPLETED|Overall Study||13
8468677|NCT00670228|20868094|P2|STARTED|Overall Study||15
8468678|NCT00670228|20868095|P1|STARTED|Overall Study||18
8468679|NCT00670202|20868109|P2|NOT COMPLETED|Overall Study||0
8468680|NCT00670202|20868110|P1|NOT COMPLETED|Overall Study||0
8468681|NCT00670202|20868109|P2|COMPLETED|Overall Study||0
8468682|NCT00670202|20868110|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
8468683|NCT00670202|20868109|P2|STARTED|Overall Study||0
8468684|NCT00670202|20868110|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
8468685|NCT00670111|20868119|P3|NOT COMPLETED|Six Months to Twelve Months||0
8468686|NCT00670111|20868120|P2|NOT COMPLETED|Six Months to Twelve Months||0
8468687|NCT00670111|20868121|P1|NOT COMPLETED|Six Months to Twelve Months||0
8468688|NCT00670111|20868119|P3|COMPLETED|Six Months to Twelve Months||0
8468689|NCT00670111|20868120|P2|COMPLETED|Six Months to Twelve Months||8
8468690|NCT00670111|20868121|P1|COMPLETED|Six Months to Twelve Months||4
8468691|NCT00670111|20868119|P3|STARTED|Six Months to Twelve Months||0
8468692|NCT00670111|20868120|P2|STARTED|Six Months to Twelve Months||8
8468693|NCT00670111|20868121|P1|STARTED|Six Months to Twelve Months||4
8468694|NCT00670111|20868119|P3|NOT COMPLETED|One Month to Six Months||0
8468695|NCT00670111|20868120|P2|NOT COMPLETED|One Month to Six Months||0
8468696|NCT00670111|20868121|P1|NOT COMPLETED|One Month to Six Months||0
8468697|NCT00670111|20868119|P3|COMPLETED|One Month to Six Months||0
8468698|NCT00670111|20868120|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
8468699|NCT00670111|20868121|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
8468700|NCT00670111|20868119|P3|STARTED|One Month to Six Months||0
8468701|NCT00670111|20868120|P2|STARTED|One Month to Six Months||8
8468702|NCT00670111|20868121|P1|STARTED|One Month to Six Months||4
8468703|NCT00670111|20868119|P3|NOT COMPLETED|One Month Period B||0
8468704|NCT00670111|20868120|P2|NOT COMPLETED|One Month Period B||0
8468705|NCT00670111|20868121|P1|NOT COMPLETED|One Month Period B||0
8468706|NCT00670111|20868119|P3|COMPLETED|One Month Period B||0
8468707|NCT00670111|20868120|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
8468708|NCT00670111|20868121|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
8468709|NCT00670111|20868119|P3|STARTED|One Month Period B||0
8468710|NCT00670111|20868120|P2|STARTED|One Month Period B||8
8468711|NCT00670111|20868121|P1|STARTED|One Month Period B||4
8468712|NCT00670111|20868119|P3|NOT COMPLETED|One Month Period A||0
8468713|NCT00670111|20868120|P2|NOT COMPLETED|One Month Period A||0
8468714|NCT00670111|20868121|P1|NOT COMPLETED|One Month Period A||0
8468715|NCT00670111|20868119|P3|COMPLETED|One Month Period A||0
8468716|NCT00670111|20868120|P2|COMPLETED|One Month Period A||8
8468717|NCT00670111|20868121|P1|COMPLETED|One Month Period A||4
8468718|NCT00670111|20868119|P3|STARTED|One Month Period A||0
8468719|NCT00670111|20868120|P2|STARTED|One Month Period A||8
8468720|NCT00670111|20868121|P1|STARTED|One Month Period A||4
8468721|NCT00670111|20868119|P3|NOT COMPLETED|Enrollment to One Month||19
8468722|NCT00670111|20868120|P2|NOT COMPLETED|Enrollment to One Month||0
8468723|NCT00670111|20868121|P1|NOT COMPLETED|Enrollment to One Month||1
8468724|NCT00670111|20868119|P3|COMPLETED|Enrollment to One Month||0
8468725|NCT00670111|20868120|P2|COMPLETED|Enrollment to One Month||8
8468726|NCT00670111|20868121|P1|COMPLETED|Enrollment to One Month||4
8468727|NCT00670111|20868119|P3|STARTED|Enrollment to One Month||19
8468728|NCT00670111|20868120|P2|STARTED|Enrollment to One Month||8
8468729|NCT00670111|20868121|P1|STARTED|Enrollment to One Month||5
8468730|NCT00670046|20868131|P2|NOT COMPLETED|Overall Study||2
8468731|NCT00670046|20868132|P1|NOT COMPLETED|Overall Study||1
8468732|NCT00670046|20868131|P2|COMPLETED|Overall Study||6
8468733|NCT00670046|20868132|P1|COMPLETED|Overall Study||6
8468734|NCT00670046|20868131|P2|STARTED|Overall Study||8
8468735|NCT00670046|20868132|P1|STARTED|Overall Study||7
8468736|NCT00670007|20868146|P1|NOT COMPLETED|Overall Study||9
8468737|NCT00670007|20868146|P1|COMPLETED|Overall Study||131
8468738|NCT00670007|20868146|P1|STARTED|Overall Study||140
8468739|NCT00669955|20868173|P2|NOT COMPLETED|Overall Study||27
8468740|NCT00669955|20868174|P1|NOT COMPLETED|Overall Study||14
8468741|NCT00669955|20868173|P2|COMPLETED|Overall Study||195
8468742|NCT00669955|20868174|P1|COMPLETED|Overall Study||204
8468743|NCT00669955|20868173|P2|STARTED|Overall Study||222
8468744|NCT00669955|20868174|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
8468745|NCT00669942|20868204|P12|NOT COMPLETED|Healthy Volunteers||0
8468746|NCT00669942|20868205|P11|NOT COMPLETED|Healthy Volunteers||1
8468747|NCT00669942|20868206|P10|NOT COMPLETED|Healthy Volunteers||0
8468748|NCT00669942|20868207|P9|NOT COMPLETED|Healthy Volunteers||0
8468749|NCT00669942|20868208|P8|NOT COMPLETED|Healthy Volunteers||0
8468750|NCT00669942|20868209|P7|NOT COMPLETED|Healthy Volunteers||0
8468751|NCT00669942|20868210|P6|NOT COMPLETED|Healthy Volunteers||0
8468752|NCT00669942|20868211|P5|NOT COMPLETED|Healthy Volunteers||0
8468753|NCT00669942|20868212|P4|NOT COMPLETED|Healthy Volunteers||0
8468754|NCT00669942|20868213|P3|NOT COMPLETED|Healthy Volunteers||0
8468755|NCT00669942|20868214|P2|NOT COMPLETED|Healthy Volunteers||0
8468756|NCT00669942|20868215|P1|NOT COMPLETED|Healthy Volunteers||0
8468757|NCT00669942|20868204|P12|COMPLETED|Healthy Volunteers||2
8468758|NCT00669942|20868205|P11|COMPLETED|Healthy Volunteers||2
8468759|NCT00669942|20868206|P10|COMPLETED|Healthy Volunteers||3
8468760|NCT00669942|20868207|P9|COMPLETED|Healthy Volunteers||0
8468761|NCT00669942|20868208|P8|COMPLETED|Healthy Volunteers||0
8468762|NCT00669942|20868209|P7|COMPLETED|Healthy Volunteers||0
8468763|NCT00669942|20868210|P6|COMPLETED|Healthy Volunteers||0
8468764|NCT00669942|20868211|P5|COMPLETED|Healthy Volunteers||0
8468765|NCT00669942|20868212|P4|COMPLETED|Healthy Volunteers||0
8468766|NCT00669942|20868213|P3|COMPLETED|Healthy Volunteers||0
8468767|NCT00669942|20868214|P2|COMPLETED|Healthy Volunteers||0
8468768|NCT00669942|20868215|P1|COMPLETED|Healthy Volunteers||0
8468769|NCT00669942|20868204|P12|STARTED|Healthy Volunteers||2
8468770|NCT00669942|20868205|P11|STARTED|Healthy Volunteers||3
8468771|NCT00669942|20868206|P10|STARTED|Healthy Volunteers||3
8468772|NCT00669942|20868207|P9|STARTED|Healthy Volunteers||0
8468773|NCT00669942|20868208|P8|STARTED|Healthy Volunteers||0
8468774|NCT00669942|20868209|P7|STARTED|Healthy Volunteers||0
8468775|NCT00669942|20868210|P6|STARTED|Healthy Volunteers||0
8468776|NCT00669942|20868211|P5|STARTED|Healthy Volunteers||0
8468777|NCT00669942|20868212|P4|STARTED|Healthy Volunteers||0
8468778|NCT00669942|20868213|P3|STARTED|Healthy Volunteers||0
8468779|NCT00669942|20868214|P2|STARTED|Healthy Volunteers||0
8468780|NCT00669942|20868215|P1|STARTED|Healthy Volunteers||0
8468781|NCT00669942|20868204|P12|NOT COMPLETED|Parts 2 and 3||0
8468782|NCT00669942|20868205|P11|NOT COMPLETED|Parts 2 and 3||0
8468783|NCT00669942|20868206|P10|NOT COMPLETED|Parts 2 and 3||0
8468784|NCT00669942|20868207|P9|NOT COMPLETED|Parts 2 and 3||3
8468785|NCT00669942|20868208|P8|NOT COMPLETED|Parts 2 and 3||2
8468786|NCT00669942|20868209|P7|NOT COMPLETED|Parts 2 and 3||0
8468787|NCT00669942|20868210|P6|NOT COMPLETED|Parts 2 and 3||2
8468788|NCT00669942|20868211|P5|NOT COMPLETED|Parts 2 and 3||0
8468789|NCT00669942|20868212|P4|NOT COMPLETED|Parts 2 and 3||0
8468790|NCT00669942|20868213|P3|NOT COMPLETED|Parts 2 and 3||0
8468791|NCT00669942|20868214|P2|NOT COMPLETED|Parts 2 and 3||0
8468792|NCT00669942|20868215|P1|NOT COMPLETED|Parts 2 and 3||0
8468793|NCT00669942|20868204|P12|COMPLETED|Parts 2 and 3||0
8468794|NCT00669942|20868205|P11|COMPLETED|Parts 2 and 3||0
8468795|NCT00669942|20868206|P10|COMPLETED|Parts 2 and 3||0
8468796|NCT00669942|20868207|P9|COMPLETED|Parts 2 and 3||23
8468797|NCT00669942|20868208|P8|COMPLETED|Parts 2 and 3||24
8468798|NCT00669942|20868209|P7|COMPLETED|Parts 2 and 3||6
8468799|NCT00669942|20868210|P6|COMPLETED|Parts 2 and 3||4
8468800|NCT00669942|20868211|P5|COMPLETED|Parts 2 and 3||0
8468801|NCT00669942|20868212|P4|COMPLETED|Parts 2 and 3||0
8468802|NCT00669942|20868213|P3|COMPLETED|Parts 2 and 3||0
8468803|NCT00669942|20868214|P2|COMPLETED|Parts 2 and 3||0
8468804|NCT00669942|20868215|P1|COMPLETED|Parts 2 and 3||0
8468805|NCT00669942|20868204|P12|STARTED|Parts 2 and 3||0
8468806|NCT00669942|20868205|P11|STARTED|Parts 2 and 3||0
8468807|NCT00669942|20868206|P10|STARTED|Parts 2 and 3||0
8468808|NCT00669942|20868207|P9|STARTED|Parts 2 and 3||26
8468809|NCT00669942|20868208|P8|STARTED|Parts 2 and 3||26
8468810|NCT00669942|20868209|P7|STARTED|Parts 2 and 3||6
8468811|NCT00669942|20868210|P6|STARTED|Parts 2 and 3||6
8468812|NCT00669942|20868211|P5|STARTED|Parts 2 and 3||0
8468813|NCT00669942|20868212|P4|STARTED|Parts 2 and 3||0
8468814|NCT00669942|20868213|P3|STARTED|Parts 2 and 3||0
8468815|NCT00669942|20868214|P2|STARTED|Parts 2 and 3||0
8468816|NCT00669942|20868215|P1|STARTED|Parts 2 and 3||0
8468817|NCT00669942|20868204|P12|NOT COMPLETED|Part 1||0
8468818|NCT00669942|20868205|P11|NOT COMPLETED|Part 1||0
8468819|NCT00669942|20868206|P10|NOT COMPLETED|Part 1||0
8468820|NCT00669942|20868207|P9|NOT COMPLETED|Part 1||0
8468821|NCT00669942|20868208|P8|NOT COMPLETED|Part 1||0
8468822|NCT00669942|20868209|P7|NOT COMPLETED|Part 1||0
8468823|NCT00669942|20868210|P6|NOT COMPLETED|Part 1||0
8468824|NCT00669942|20868211|P5|NOT COMPLETED|Part 1||0
8468825|NCT00669942|20868212|P4|NOT COMPLETED|Part 1||0
8468826|NCT00669942|20868213|P3|NOT COMPLETED|Part 1||0
8468827|NCT00669942|20868214|P2|NOT COMPLETED|Part 1||0
8468828|NCT00669942|20868215|P1|NOT COMPLETED|Part 1||0
8468829|NCT00669942|20868204|P12|COMPLETED|Part 1||0
8468830|NCT00669942|20868205|P11|COMPLETED|Part 1||0
8468831|NCT00669942|20868206|P10|COMPLETED|Part 1||0
8468832|NCT00669942|20868207|P9|COMPLETED|Part 1||0
8468833|NCT00669942|20868208|P8|COMPLETED|Part 1||0
8468834|NCT00669942|20868209|P7|COMPLETED|Part 1||0
8468835|NCT00669942|20868210|P6|COMPLETED|Part 1||0
8468836|NCT00669942|20868211|P5|COMPLETED|Part 1||8
8468837|NCT00669942|20868212|P4|COMPLETED|Part 1||6
8468838|NCT00669942|20868213|P3|COMPLETED|Part 1||6
8468839|NCT00669942|20868214|P2|COMPLETED|Part 1||6
8468840|NCT00669942|20868215|P1|COMPLETED|Part 1||6
8468841|NCT00669942|20868204|P12|STARTED|Part 1||0
8468842|NCT00669942|20868205|P11|STARTED|Part 1||0
8468843|NCT00669942|20868206|P10|STARTED|Part 1||0
8468844|NCT00669942|20868207|P9|STARTED|Part 1||0
8468845|NCT00669942|20868208|P8|STARTED|Part 1||0
8468846|NCT00669942|20868209|P7|STARTED|Part 1||0
8468847|NCT00669942|20868210|P6|STARTED|Part 1||0
8468848|NCT00669942|20868211|P5|STARTED|Part 1||8
8468849|NCT00669942|20868212|P4|STARTED|Part 1||6
8468850|NCT00669942|20868213|P3|STARTED|Part 1||6
8468851|NCT00669942|20868214|P2|STARTED|Part 1||6
8468852|NCT00669942|20868215|P1|STARTED|Part 1||6
8468853|NCT00669916|20868279|P2|NOT COMPLETED|Overall Study||0
8468854|NCT00669916|20868280|P1|NOT COMPLETED|Overall Study||0
8468855|NCT00669916|20868279|P2|COMPLETED|Overall Study||18
8468856|NCT00669916|20868280|P1|COMPLETED|Overall Study||18
8468857|NCT00669916|20868279|P2|STARTED|Overall Study||18
8468858|NCT00669916|20868280|P1|STARTED|Overall Study||18
8468859|NCT00669903|20868298|P4|NOT COMPLETED|Overall Study||4
8468860|NCT00669903|20868299|P3|NOT COMPLETED|Overall Study||5
8468861|NCT00669903|20868300|P2|NOT COMPLETED|Overall Study||5
8468862|NCT00669903|20868301|P1|NOT COMPLETED|Overall Study||1
8468863|NCT00669903|20868298|P4|COMPLETED|Overall Study||18
8468864|NCT00669903|20868299|P3|COMPLETED|Overall Study||13
8468865|NCT00669903|20868300|P2|COMPLETED|Overall Study||32
8468866|NCT00669903|20868301|P1|COMPLETED|Overall Study||22
8468867|NCT00669903|20868298|P4|Completed Treatment Period|Overall Study||19
8468868|NCT00669903|20868299|P3|Completed Treatment Period|Overall Study||13
8468869|NCT00669903|20868300|P2|Completed Treatment Period|Overall Study||33
8468870|NCT00669903|20868301|P1|Completed Treatment Period|Overall Study||23
8468871|NCT00669903|20868298|P4|STARTED|Overall Study||22
8468872|NCT00669903|20868299|P3|STARTED|Overall Study||18
8468873|NCT00669903|20868300|P2|STARTED|Overall Study||37
8468874|NCT00669903|20868301|P1|STARTED|Overall Study||23
8468875|NCT00669877|20868331|P1|NOT COMPLETED|Overall Study||4
8468876|NCT00669877|20868331|P1|COMPLETED|Overall Study||52
8468877|NCT00669877|20868331|P1|STARTED|Overall Study||56
8468878|NCT00669864|20868336|P1|NOT COMPLETED|Overall Study||9
8468879|NCT00669864|20868336|P1|COMPLETED|Overall Study||284
8468880|NCT00669864|20868336|P1|STARTED|Overall Study||293
8468881|NCT00669682|20868345|P1|NOT COMPLETED|Overall Study||0
8468882|NCT00669682|20868345|P1|COMPLETED|Overall Study||9
8468883|NCT00669682|20868345|P1|STARTED|Overall Study||9
8468884|NCT00669669|20868350|P1|NOT COMPLETED|Overall Study||1
8468885|NCT00669669|20868350|P1|COMPLETED|Overall Study||11
8468886|NCT00669669|20868350|P1|STARTED|Overall Study||12
8468887|NCT00669617|20868355|P5|NOT COMPLETED|Period 5||0
8468888|NCT00669617|20868356|P4|NOT COMPLETED|Period 5||0
8468889|NCT00669617|20868357|P3|NOT COMPLETED|Period 5||0
8468890|NCT00669617|20868358|P2|NOT COMPLETED|Period 5||0
8468891|NCT00669617|20868359|P1|NOT COMPLETED|Period 5||0
8468892|NCT00669617|20868355|P5|COMPLETED|Period 5||17
8468893|NCT00669617|20868356|P4|COMPLETED|Period 5||18
8468894|NCT00669617|20868357|P3|COMPLETED|Period 5||17
8468895|NCT00669617|20868358|P2|COMPLETED|Period 5||17
8468896|NCT00669617|20868359|P1|COMPLETED|Period 5||17
8468897|NCT00669617|20868355|P5|STARTED|Period 5||17
8468898|NCT00669617|20868356|P4|STARTED|Period 5||18
8468899|NCT00669617|20868357|P3|STARTED|Period 5||17
8468900|NCT00669617|20868358|P2|STARTED|Period 5||17
8468901|NCT00669617|20868359|P1|STARTED|Period 5||17
8468902|NCT00669617|20868355|P5|NOT COMPLETED|Period 4||0
8468903|NCT00669617|20868356|P4|NOT COMPLETED|Period 4||0
8468904|NCT00669617|20868357|P3|NOT COMPLETED|Period 4||0
8468905|NCT00669617|20868358|P2|NOT COMPLETED|Period 4||0
8468906|NCT00669617|20868359|P1|NOT COMPLETED|Period 4||0
8468907|NCT00669617|20868355|P5|COMPLETED|Period 4||17
8468908|NCT00669617|20868356|P4|COMPLETED|Period 4||18
8468909|NCT00669617|20868357|P3|COMPLETED|Period 4||17
8468910|NCT00669617|20868358|P2|COMPLETED|Period 4||17
8468911|NCT00669617|20868359|P1|COMPLETED|Period 4||17
8468912|NCT00669617|20868355|P5|STARTED|Period 4||17
8468913|NCT00669617|20868356|P4|STARTED|Period 4||18
8468914|NCT00669617|20868357|P3|STARTED|Period 4||17
8468915|NCT00669617|20868358|P2|STARTED|Period 4||17
8468916|NCT00669617|20868359|P1|STARTED|Period 4||17
8468917|NCT00669617|20868355|P5|NOT COMPLETED|Period 3||0
8468918|NCT00669617|20868356|P4|NOT COMPLETED|Period 3||0
8468919|NCT00669617|20868357|P3|NOT COMPLETED|Period 3||0
8468920|NCT00669617|20868358|P2|NOT COMPLETED|Period 3||0
8468921|NCT00669617|20868359|P1|NOT COMPLETED|Period 3||1
8468922|NCT00669617|20868355|P5|COMPLETED|Period 3||17
8468923|NCT00669617|20868356|P4|COMPLETED|Period 3||18
8468924|NCT00669617|20868357|P3|COMPLETED|Period 3||17
8468925|NCT00669617|20868358|P2|COMPLETED|Period 3||17
8468926|NCT00669617|20868359|P1|COMPLETED|Period 3||17
8468927|NCT00669617|20868355|P5|STARTED|Period 3||17
8468928|NCT00669617|20868356|P4|STARTED|Period 3||18
8468929|NCT00669617|20868357|P3|STARTED|Period 3||17
8468930|NCT00669617|20868358|P2|STARTED|Period 3||17
8468931|NCT00669617|20868359|P1|STARTED|Period 3||18
8468932|NCT00669617|20868355|P5|NOT COMPLETED|Period 2||0
8468933|NCT00669617|20868356|P4|NOT COMPLETED|Period 2||0
8468934|NCT00669617|20868357|P3|NOT COMPLETED|Period 2||0
8468935|NCT00669617|20868358|P2|NOT COMPLETED|Period 2||0
8468936|NCT00669617|20868359|P1|NOT COMPLETED|Period 2||0
8468937|NCT00669617|20868355|P5|COMPLETED|Period 2||17
8468938|NCT00669617|20868356|P4|COMPLETED|Period 2||18
8468939|NCT00669617|20868357|P3|COMPLETED|Period 2||17
8468940|NCT00669617|20868358|P2|COMPLETED|Period 2||17
8468941|NCT00669617|20868359|P1|COMPLETED|Period 2||18
8468942|NCT00669617|20868355|P5|STARTED|Period 2||17
8468943|NCT00669617|20868356|P4|STARTED|Period 2||18
8468944|NCT00669617|20868357|P3|STARTED|Period 2||17
8468945|NCT00669617|20868358|P2|STARTED|Period 2||17
8468946|NCT00669617|20868359|P1|STARTED|Period 2||18
8468947|NCT00669617|20868355|P5|NOT COMPLETED|Period 1||1
8468948|NCT00669617|20868356|P4|NOT COMPLETED|Period 1||0
8468949|NCT00669617|20868357|P3|NOT COMPLETED|Period 1||1
8468950|NCT00669617|20868358|P2|NOT COMPLETED|Period 1||0
8468951|NCT00669617|20868359|P1|NOT COMPLETED|Period 1||0
8468952|NCT00669617|20868355|P5|COMPLETED|Period 1||17
8468953|NCT00669617|20868356|P4|COMPLETED|Period 1||18
8468954|NCT00669617|20868357|P3|COMPLETED|Period 1||17
8468955|NCT00669617|20868358|P2|COMPLETED|Period 1||17
8468956|NCT00669617|20868359|P1|COMPLETED|Period 1||18
8468957|NCT00669617|20868355|P5|STARTED|Period 1||18
8468958|NCT00669617|20868356|P4|STARTED|Period 1||18
8468959|NCT00669617|20868357|P3|STARTED|Period 1||18
8468960|NCT00669617|20868358|P2|STARTED|Period 1||17
8468961|NCT00669617|20868359|P1|STARTED|Period 1||18
8468962|NCT00669578|20868373|P2|NOT COMPLETED|Overall Study||0
8468963|NCT00669578|20868374|P1|NOT COMPLETED|Overall Study||0
8468964|NCT00669578|20868373|P2|COMPLETED|Overall Study||65
8468965|NCT00669578|20868374|P1|COMPLETED|Overall Study||12
8468966|NCT00669578|20868373|P2|STARTED|Overall Study||65
8468967|NCT00669578|20868374|P1|STARTED|Overall Study||12
8468968|NCT00669552|20868387|P1|NOT COMPLETED|Overall Study||0
8468969|NCT00669552|20868387|P1|COMPLETED|Overall Study||11
8468970|NCT00669552|20868387|P1|STARTED|Overall Study||11
8468971|NCT00669539|20868393|P2|NOT COMPLETED|Overall Study||9
8468972|NCT00669539|20868394|P1|NOT COMPLETED|Overall Study||8
8468973|NCT00669539|20868393|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
8468974|NCT00669539|20868394|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
8468975|NCT00669539|20868393|P2|STARTED|Overall Study||52
8468976|NCT00669539|20868394|P1|STARTED|Overall Study||94
8468977|NCT00669461|20868400|P1|NOT COMPLETED|Overall Study||0
8468978|NCT00669461|20868400|P1|COMPLETED|Overall Study||1
8468979|NCT00669461|20868400|P1|STARTED|Overall Study||1
8468980|NCT00669396|20868407|P2|NOT COMPLETED|Overall Study||12
8468981|NCT00669396|20868408|P1|NOT COMPLETED|Overall Study||10
8468982|NCT00669396|20868407|P2|COMPLETED|Overall Study||22
8468983|NCT00669396|20868408|P1|COMPLETED|Overall Study||13
8468984|NCT00669396|20868407|P2|STARTED|Overall Study||34
8468985|NCT00669396|20868408|P1|STARTED|Overall Study||23
8468986|NCT00669383|20868422|P2|NOT COMPLETED|Overall Study||0
8468987|NCT00669383|20868423|P1|NOT COMPLETED|Overall Study||0
8468988|NCT00669383|20868422|P2|COMPLETED|Overall Study||41
8468989|NCT00669383|20868423|P1|COMPLETED|Overall Study||44
8468990|NCT00669383|20868422|P2|STARTED|Overall Study||41
8468991|NCT00669383|20868423|P1|STARTED|Overall Study||44
8468992|NCT00669331|20868435|P2|NOT COMPLETED|Blinded Treatment Period||39
8468993|NCT00669331|20868436|P1|NOT COMPLETED|Blinded Treatment Period||42
8468994|NCT00669331|20868435|P2|COMPLETED|Blinded Treatment Period||189
8468995|NCT00669331|20868436|P1|COMPLETED|Blinded Treatment Period||191
8468996|NCT00669331|20868435|P2|STARTED|Blinded Treatment Period||228
8468997|NCT00669331|20868436|P1|STARTED|Blinded Treatment Period||233
8468998|NCT00669331|20868435|P2|NOT COMPLETED|Randomisation to First Dose||13
8468999|NCT00669331|20868436|P1|NOT COMPLETED|Randomisation to First Dose||11
8469000|NCT00669331|20868435|P2|COMPLETED|Randomisation to First Dose||228
8469001|NCT00669331|20868436|P1|COMPLETED|Randomisation to First Dose||233
8469002|NCT00669331|20868435|P2|STARTED|Randomisation to First Dose||241
8469003|NCT00669331|20868436|P1|STARTED|Randomisation to First Dose||244
8469004|NCT00669318|20868478|P1|NOT COMPLETED|Overall Study||2
8469005|NCT00669318|20868478|P1|COMPLETED|Overall Study||39
8469006|NCT00669318|20868478|P1|STARTED|Overall Study||41
8469007|NCT00669279|20868488|P2|NOT COMPLETED|Overall Study||0
8469008|NCT00669279|20868489|P1|NOT COMPLETED|Overall Study||0
8469009|NCT00669279|20868488|P2|COMPLETED|Overall Study||19
8469010|NCT00669279|20868489|P1|COMPLETED|Overall Study||22
8469011|NCT00669279|20868488|P2|STARTED|Overall Study||19
8469012|NCT00669279|20868489|P1|STARTED|Overall Study||22
8469013|NCT00669240|20868495|P1|NOT COMPLETED|Overall Study||165
8469014|NCT00669240|20868495|P1|COMPLETED|Overall Study||402
8469015|NCT00669240|20868495|P1|Received Treatment|Overall Study||551
8469016|NCT00669240|20868495|P1|Assigned to Treatment|Overall Study||566
8469017|NCT00669240|20868495|P1|STARTED|Overall Study||567
8469018|NCT00669214|20868511|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
8469019|NCT00669214|20868512|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
8469020|NCT00669214|20868511|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
8469021|NCT00669214|20868512|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
8469022|NCT00669214|20868511|P2|STARTED|Open-Label Treatment Period (Week 24)||55
8469023|NCT00669214|20868512|P1|STARTED|Open-Label Treatment Period (Week 24)||22
8469024|NCT00669214|20868511|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
8469025|NCT00669214|20868512|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
8469026|NCT00669214|20868511|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
8469027|NCT00669214|20868512|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
8469028|NCT00669214|20868511|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
8469029|NCT00669214|20868512|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
8469030|NCT00669162|20868544|P1|NOT COMPLETED|Overall Study||1
8469031|NCT00669162|20868544|P1|COMPLETED|Overall Study||26
8469032|NCT00669162|20868544|P1|STARTED|Overall Study||27
8469033|NCT00669110|20868550|P2|NOT COMPLETED|Overall Study||13
8469034|NCT00669110|20868551|P1|NOT COMPLETED|Overall Study||8
8469035|NCT00669110|20868550|P2|COMPLETED|Overall Study||7
8469036|NCT00669110|20868551|P1|COMPLETED|Overall Study||12
8469037|NCT00669110|20868550|P2|STARTED|Overall Study||20
8469038|NCT00669110|20868551|P1|STARTED|Overall Study||20
8469039|NCT00669071|20868587|P1|NOT COMPLETED|Overall Study||4
8469040|NCT00669071|20868587|P1|COMPLETED|Overall Study||52
8469041|NCT00669071|20868587|P1|STARTED|Overall Study||56
8469042|NCT00669032|20868608|P2|NOT COMPLETED|Overall Study||59
8469043|NCT00669032|20868609|P1|NOT COMPLETED|Overall Study||44
8469044|NCT00669032|20868608|P2|COMPLETED|Overall Study||94
8469045|NCT00669032|20868609|P1|COMPLETED|Overall Study||109
8469046|NCT00669032|20868608|P2|STARTED|Overall Study||153
8469047|NCT00669032|20868609|P1|STARTED|Overall Study||153
8469048|NCT00669019|20868637|P1|NOT COMPLETED|Overall Study||0
8469049|NCT00669019|20868637|P1|COMPLETED|Overall Study||23
8469050|NCT00669019|20868637|P1|STARTED|Overall Study||23
8469051|NCT00668902|20868645|P3|NOT COMPLETED|Overall Study||0
8469052|NCT00668902|20868646|P2|NOT COMPLETED|Overall Study||0
8469053|NCT00668902|20868647|P1|NOT COMPLETED|Overall Study||0
8469054|NCT00668902|20868645|P3|COMPLETED|Overall Study||5
8469055|NCT00668902|20868646|P2|COMPLETED|Overall Study||10
8469056|NCT00668902|20868647|P1|COMPLETED|Overall Study||10
8469057|NCT00668902|20868645|P3|STARTED|Overall Study||5
8469058|NCT00668902|20868646|P2|STARTED|Overall Study||10
8469059|NCT00668902|20868647|P1|STARTED|Overall Study||10
8469060|NCT00668863|20868655|P1|NOT COMPLETED|Overall Study||71
8469061|NCT00668863|20868655|P1|COMPLETED|Overall Study||0
8469062|NCT00668863|20868655|P1|STARTED|Overall Study||71
8469063|NCT00668811|20868674|P1|NOT COMPLETED|Overall Study||0
8469064|NCT00668811|20868674|P1|COMPLETED|Overall Study||23
8469065|NCT00668811|20868674|P1|STARTED|Overall Study||23
8469066|NCT00668785|20868679|P1|NOT COMPLETED|Overall Study||0
8469067|NCT00668785|20868679|P1|COMPLETED|Overall Study||6
8469068|NCT00668785|20868679|P1|STARTED|Overall Study||6
8469069|NCT00668746|20868687|P2|NOT COMPLETED|Overall Study||1
8469070|NCT00668746|20868688|P1|NOT COMPLETED|Overall Study||2
8469071|NCT00668746|20868687|P2|COMPLETED|Overall Study||11
8469072|NCT00668746|20868688|P1|COMPLETED|Overall Study||21
8469073|NCT00668746|20868687|P2|STARTED|Overall Study||12
8469074|NCT00668746|20868688|P1|STARTED|Overall Study||23
8469075|NCT00668733|20868708|P2|NOT COMPLETED|Overall Study||7
8469076|NCT00668733|20868709|P1|NOT COMPLETED|Overall Study||2
8469077|NCT00668733|20868708|P2|COMPLETED|Overall Study||83
8469078|NCT00668733|20868709|P1|COMPLETED|Overall Study||87
8469079|NCT00668733|20868708|P2|STARTED|Overall Study||90
8469080|NCT00668733|20868709|P1|STARTED|Overall Study||89
8469081|NCT00668564|20868715|P1|NOT COMPLETED|Overall Study||0
8469082|NCT00668564|20868715|P1|COMPLETED|Overall Study||18
8469083|NCT00668564|20868715|P1|STARTED|Overall Study||18
8469084|NCT00668525|20868723|P3|NOT COMPLETED|Overall Study||53
8469085|NCT00668525|20868724|P2|NOT COMPLETED|Overall Study||93
8469086|NCT00668525|20868725|P1|NOT COMPLETED|Overall Study||77
8469087|NCT00668525|20868723|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
8469088|NCT00668525|20868724|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
8469089|NCT00668525|20868725|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
8469090|NCT00668525|20868723|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
8469091|NCT00668525|20868724|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
8469092|NCT00668525|20868725|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
8469093|NCT00668434|20868738|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
8469094|NCT00668434|20868739|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
8469095|NCT00668434|20868738|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
8469096|NCT00668434|20868739|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
8469097|NCT00668434|20868738|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
8469098|NCT00668434|20868739|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
8469099|NCT00668434|20868738|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
8469100|NCT00668434|20868739|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
8469101|NCT00668434|20868738|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
8469102|NCT00668434|20868739|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
8469103|NCT00668434|20868738|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
8469104|NCT00668434|20868739|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
8469105|NCT00668395|20868754|P3|NOT COMPLETED|Overall Study||1
8469106|NCT00668395|20868755|P2|NOT COMPLETED|Overall Study||6
8469107|NCT00668395|20868756|P1|NOT COMPLETED|Overall Study||6
8469108|NCT00668395|20868754|P3|COMPLETED|Overall Study||5
8469109|NCT00668395|20868755|P2|COMPLETED|Overall Study||16
8469110|NCT00668395|20868756|P1|COMPLETED|Overall Study||39
8469111|NCT00668395|20868754|P3|STARTED|Overall Study||6
8469112|NCT00668395|20868755|P2|STARTED|Overall Study||22
8469113|NCT00668395|20868756|P1|STARTED|Overall Study||45
8469114|NCT00668382|20868764|P1|NOT COMPLETED|Overall Study||0
8469115|NCT00668382|20868764|P1|COMPLETED|Overall Study||11
8469116|NCT00668382|20868764|P1|STARTED|Overall Study|beginning of trial|11
8469117|NCT00668317|20868768|P1|NOT COMPLETED|Overall Study||2
8469118|NCT00668317|20868768|P1|COMPLETED|Overall Study||3
8469119|NCT00668317|20868768|P1|STARTED|Overall Study||5
8469120|NCT00668265|20868774|P2|NOT COMPLETED|Overall Study||5
8469121|NCT00668265|20868775|P1|NOT COMPLETED|Overall Study||9
8469122|NCT00668265|20868774|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
8469123|NCT00668265|20868775|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
8469124|NCT00668265|20868774|P2|STARTED|Overall Study||5
8469125|NCT00668265|20868775|P1|STARTED|Overall Study||9
8469126|NCT00668200|20868783|P1|NOT COMPLETED|Overall Study||3
8469127|NCT00668200|20868783|P1|COMPLETED|Overall Study||77
8469128|NCT00668200|20868783|P1|Intent to Treat (ITT)|Overall Study||80
8469129|NCT00668200|20868783|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
8469130|NCT00668200|20868783|P1|STARTED|Overall Study||80
8469131|NCT00668148|20868789|P1|NOT COMPLETED|Overall Study||10
8469132|NCT00668148|20868789|P1|COMPLETED|Overall Study||103
8469133|NCT00668148|20868789|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
8469134|NCT00668148|20868789|P1|STARTED|Overall Study||113
8469135|NCT00667992|20868828|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
8469136|NCT00667992|20868829|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
8469137|NCT00667992|20868828|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
8469138|NCT00667992|20868829|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
8469139|NCT00667992|20868828|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
8469140|NCT00667992|20868829|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
8469141|NCT00667992|20868828|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
8469142|NCT00667992|20868829|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
8469143|NCT00667992|20868828|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
8469144|NCT00667992|20868829|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
8469145|NCT00667992|20868828|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
8469146|NCT00667992|20868829|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
8469147|NCT00667992|20868828|P2|NOT COMPLETED|Wash-out||5
8469148|NCT00667992|20868829|P1|NOT COMPLETED|Wash-out||7
8469149|NCT00667992|20868828|P2|COMPLETED|Wash-out||36
8469150|NCT00667992|20868829|P1|COMPLETED|Wash-out||34
8469151|NCT00667992|20868828|P2|STARTED|Wash-out||41
8469152|NCT00667992|20868829|P1|STARTED|Wash-out||41
8469153|NCT00667992|20868828|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
8469154|NCT00667992|20868829|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
8469155|NCT00667992|20868828|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
8469156|NCT00667992|20868829|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
8469157|NCT00667992|20868828|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
8469158|NCT00667992|20868829|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
8469159|NCT00667992|20868828|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
8469160|NCT00667992|20868829|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
8469161|NCT00667992|20868828|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
8469162|NCT00667992|20868829|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
8469163|NCT00667992|20868828|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
8469164|NCT00667992|20868829|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
8469165|NCT00667888|20868885|P2|NOT COMPLETED|Overall Study||9
8469166|NCT00667888|20868886|P1|NOT COMPLETED|Overall Study||10
8469167|NCT00667888|20868885|P2|COMPLETED|Overall Study||102
8469168|NCT00667888|20868886|P1|COMPLETED|Overall Study||101
8469169|NCT00667888|20868885|P2|STARTED|Overall Study||111
8469170|NCT00667888|20868886|P1|STARTED|Overall Study||111
8469171|NCT00667875|20868895|P3|NOT COMPLETED|Overall Study||13
8469172|NCT00667875|20868896|P2|NOT COMPLETED|Overall Study||11
8469173|NCT00667875|20868897|P1|NOT COMPLETED|Overall Study||10
8469174|NCT00667875|20868895|P3|COMPLETED|Overall Study||8
8469175|NCT00667875|20868896|P2|COMPLETED|Overall Study||10
8469176|NCT00667875|20868897|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
8469177|NCT00667875|20868895|P3|Subjects Included in Analysisd|Overall Study||19
8469178|NCT00667875|20868896|P2|Subjects Included in Analysisd|Overall Study||21
8469179|NCT00667875|20868897|P1|Subjects Included in Analysisd|Overall Study||20
8469180|NCT00667875|20868895|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
8469181|NCT00667875|20868896|P2|STARTED|Overall Study||21
8469182|NCT00667875|20868897|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
8469183|NCT00667849|20868916|P2|NOT COMPLETED|Overall Study||121
8469184|NCT00667849|20868917|P1|NOT COMPLETED|Overall Study||108
8469185|NCT00667849|20868916|P2|COMPLETED|Overall Study||130
8469186|NCT00667849|20868917|P1|COMPLETED|Overall Study||142
8469187|NCT00667849|20868916|P2|STARTED|Overall Study||251
8469188|NCT00667849|20868917|P1|STARTED|Overall Study||250
8469189|NCT00667810|20868931|P4|NOT COMPLETED|Overall Study||2
8469190|NCT00667810|20868932|P3|NOT COMPLETED|Overall Study||222
8469191|NCT00667810|20868933|P2|NOT COMPLETED|Overall Study||170
8469192|NCT00667810|20868934|P1|NOT COMPLETED|Overall Study||167
8469193|NCT00667810|20868931|P4|COMPLETED|Overall Study||9
8469194|NCT00667810|20868932|P3|COMPLETED|Overall Study||124
8469195|NCT00667810|20868933|P2|COMPLETED|Overall Study||94
8469196|NCT00667810|20868934|P1|COMPLETED|Overall Study||102
8469197|NCT00667810|20868931|P4|Treated|Overall Study||11
8469198|NCT00667810|20868932|P3|Treated|Overall Study||344
8469199|NCT00667810|20868933|P2|Treated|Overall Study||263
8469200|NCT00667810|20868934|P1|Treated|Overall Study||267
8469201|NCT00667810|20868931|P4|STARTED|Overall Study||11
8469202|NCT00667810|20868932|P3|STARTED|Overall Study||346
8469203|NCT00667810|20868933|P2|STARTED|Overall Study||264
8469204|NCT00667810|20868934|P1|STARTED|Overall Study||269
8469205|NCT00667745|20868993|P2|NOT COMPLETED|Overall Study||21
8469206|NCT00667745|20868994|P1|NOT COMPLETED|Overall Study||25
8469207|NCT00667745|20868993|P2|COMPLETED|Overall Study||121
8469208|NCT00667745|20868994|P1|COMPLETED|Overall Study||116
8469209|NCT00667745|20868993|P2|STARTED|Overall Study||142
8469210|NCT00667745|20868994|P1|STARTED|Overall Study||141
8469211|NCT00667732|20869010|P3|NOT COMPLETED|Extension (26 Weeks)||0
8469212|NCT00667732|20869011|P2|NOT COMPLETED|Extension (26 Weeks)||0
8469213|NCT00667732|20869012|P1|NOT COMPLETED|Extension (26 Weeks)||0
8469214|NCT00667732|20869010|P3|COMPLETED|Extension (26 Weeks)||17
8469215|NCT00667732|20869011|P2|COMPLETED|Extension (26 Weeks)||14
8469216|NCT00667732|20869012|P1|COMPLETED|Extension (26 Weeks)||0
8469217|NCT00667732|20869010|P3|STARTED|Extension (26 Weeks)||17
8469218|NCT00667732|20869011|P2|STARTED|Extension (26 Weeks)||14
8469219|NCT00667732|20869012|P1|STARTED|Extension (26 Weeks)||0
8469220|NCT00667732|20869010|P3|NOT COMPLETED|Randomization (24 Weeks)||0
8469221|NCT00667732|20869011|P2|NOT COMPLETED|Randomization (24 Weeks)||1
8469222|NCT00667732|20869012|P1|NOT COMPLETED|Randomization (24 Weeks)||0
8469223|NCT00667732|20869010|P3|COMPLETED|Randomization (24 Weeks)||17
8469224|NCT00667732|20869011|P2|COMPLETED|Randomization (24 Weeks)||16
8469225|NCT00667732|20869012|P1|COMPLETED|Randomization (24 Weeks)||0
8469226|NCT00667732|20869010|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
8469227|NCT00667732|20869011|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
8469228|NCT00667732|20869012|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
8469229|NCT00667732|20869010|P3|STARTED|Randomization (24 Weeks)||17
8469230|NCT00667732|20869011|P2|STARTED|Randomization (24 Weeks)||17
8469231|NCT00667732|20869012|P1|STARTED|Randomization (24 Weeks)||0
8469232|NCT00667732|20869010|P3|NOT COMPLETED|Run -In (8 Weeks)||0
8469233|NCT00667732|20869011|P2|NOT COMPLETED|Run -In (8 Weeks)||0
8469234|NCT00667732|20869012|P1|NOT COMPLETED|Run -In (8 Weeks)||7
8469235|NCT00667732|20869010|P3|COMPLETED|Run -In (8 Weeks)||0
8469236|NCT00667732|20869011|P2|COMPLETED|Run -In (8 Weeks)||0
8469237|NCT00667732|20869012|P1|COMPLETED|Run -In (8 Weeks)||34
8469238|NCT00667732|20869010|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
8469239|NCT00667732|20869011|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
8469240|NCT00667732|20869012|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
8469241|NCT00667732|20869010|P3|STARTED|Run -In (8 Weeks)||0
8469242|NCT00667732|20869011|P2|STARTED|Run -In (8 Weeks)||0
8469243|NCT00667732|20869012|P1|STARTED|Run -In (8 Weeks)||41
8469244|NCT00667693|20869025|P2|NOT COMPLETED|Overall Study||2
8469245|NCT00667693|20869026|P1|NOT COMPLETED|Overall Study||0
8469246|NCT00667693|20869025|P2|COMPLETED|Overall Study||50
8469247|NCT00667693|20869026|P1|COMPLETED|Overall Study||49
8469248|NCT00667693|20869025|P2|STARTED|Overall Study||52
8469249|NCT00667693|20869026|P1|STARTED|Overall Study||49
8469250|NCT00667615|20869040|P1|NOT COMPLETED|Overall Study||0
8469251|NCT00667615|20869040|P1|COMPLETED|Overall Study||30
8469252|NCT00667615|20869040|P1|STARTED|Overall Study||30
8469253|NCT00667602|20869048|P3|NOT COMPLETED|Overall Study||18
8469254|NCT00667602|20869049|P2|NOT COMPLETED|Overall Study||15
8469255|NCT00667602|20869050|P1|NOT COMPLETED|Overall Study||8
8469256|NCT00667602|20869048|P3|COMPLETED|Overall Study||197
8469257|NCT00667602|20869049|P2|COMPLETED|Overall Study||213
8469258|NCT00667602|20869050|P1|COMPLETED|Overall Study||211
8469259|NCT00667602|20869048|P3|STARTED|Overall Study||215
8469260|NCT00667602|20869049|P2|STARTED|Overall Study||228
8469261|NCT00667602|20869050|P1|STARTED|Overall Study||219
8469262|NCT00667589|20869100|P4|NOT COMPLETED|Overall Study||1
8469263|NCT00667589|20869101|P3|NOT COMPLETED|Overall Study||3
8469264|NCT00667589|20869102|P2|NOT COMPLETED|Overall Study||0
8469265|NCT00667589|20869103|P1|NOT COMPLETED|Overall Study||1
8469266|NCT00667589|20869100|P4|COMPLETED|Overall Study||1
8469267|NCT00667589|20869101|P3|COMPLETED|Overall Study||0
8469268|NCT00667589|20869102|P2|COMPLETED|Overall Study||0
8469269|NCT00667589|20869103|P1|COMPLETED|Overall Study||0
8469270|NCT00667589|20869100|P4|STARTED|Overall Study||2
8469271|NCT00667589|20869101|P3|STARTED|Overall Study||3
8469272|NCT00667589|20869102|P2|STARTED|Overall Study||0
8469273|NCT00667589|20869103|P1|STARTED|Overall Study||1
8469274|NCT00667576|20869118|P5|NOT COMPLETED|Overall Study||1
8469275|NCT00667576|20869119|P4|NOT COMPLETED|Overall Study||4
8469276|NCT00667576|20869120|P3|NOT COMPLETED|Overall Study||2
8469277|NCT00667576|20869121|P2|NOT COMPLETED|Overall Study||1
8469278|NCT00667576|20869122|P1|NOT COMPLETED|Overall Study||2
8469279|NCT00667576|20869118|P5|COMPLETED|Overall Study||29
8469280|NCT00667576|20869119|P4|COMPLETED|Overall Study||27
8469281|NCT00667576|20869120|P3|COMPLETED|Overall Study||29
8469282|NCT00667576|20869121|P2|COMPLETED|Overall Study||30
8469283|NCT00667576|20869122|P1|COMPLETED|Overall Study||28
8469284|NCT00667576|20869118|P5|STARTED|Overall Study||30
8469285|NCT00667576|20869119|P4|STARTED|Overall Study||31
8469286|NCT00667576|20869120|P3|STARTED|Overall Study||31
8469287|NCT00667576|20869121|P2|STARTED|Overall Study||31
8469288|NCT00667576|20869122|P1|STARTED|Overall Study||30
8469289|NCT00667563|20869169|P1|NOT COMPLETED|Overall Study||24
8469290|NCT00667563|20869169|P1|COMPLETED|Overall Study||126
8469291|NCT00667563|20869169|P1|STARTED|Overall Study||150
8469292|NCT00667511|20869179|P1|NOT COMPLETED|Intervention 2: Home NHD||4
8469293|NCT00667511|20869179|P1|COMPLETED|Intervention 2: Home NHD||39
8469294|NCT00667511|20869179|P1|STARTED|Intervention 2: Home NHD||43
8469295|NCT00667511|20869179|P1|NOT COMPLETED|Training/Transition Period||8
8469296|NCT00667511|20869179|P1|COMPLETED|Training/Transition Period||43
8469297|NCT00667511|20869179|P1|STARTED|Training/Transition Period||51
8469298|NCT00667511|20869179|P1|NOT COMPLETED|Intervention 1: Home DHD||7
8469299|NCT00667511|20869179|P1|COMPLETED|Intervention 1: Home DHD||51
8469300|NCT00667511|20869179|P1|STARTED|Intervention 1: Home DHD||58
8469301|NCT00667459|20869189|P2|NOT COMPLETED|Overall Study||45
8469302|NCT00667459|20869190|P1|NOT COMPLETED|Overall Study||8
8469303|NCT00667459|20869189|P2|COMPLETED|Overall Study||220
8469304|NCT00667459|20869190|P1|COMPLETED|Overall Study||272
8469305|NCT00667459|20869189|P2|STARTED|Overall Study||265
8469306|NCT00667459|20869190|P1|STARTED|Overall Study||280
8469307|NCT00667446|20869232|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
8469308|NCT00667446|20869233|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
8469309|NCT00667446|20869232|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
8469310|NCT00667446|20869233|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
8469311|NCT00667446|20869232|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
8469312|NCT00667446|20869233|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
8469313|NCT00667446|20869232|P2|NOT COMPLETED|Treatment Period (36 Months)||25
8469314|NCT00667446|20869233|P1|NOT COMPLETED|Treatment Period (36 Months)||23
8469315|NCT00667446|20869232|P2|COMPLETED|Treatment Period (36 Months)||13
8469316|NCT00667446|20869233|P1|COMPLETED|Treatment Period (36 Months)||11
8469317|NCT00667446|20869232|P2|STARTED|Treatment Period (36 Months)||38
8469318|NCT00667446|20869233|P1|STARTED|Treatment Period (36 Months)||34
8469319|NCT00667420|20869255|P1|NOT COMPLETED|Overall Study||10
8469320|NCT00667420|20869255|P1|COMPLETED|Overall Study||7
8469321|NCT00667420|20869255|P1|Completion of Surgery/Re-staging|Overall Study||11
8469322|NCT00667420|20869255|P1|Completion of Pre-operative EOX-P|Overall Study||15
8469323|NCT00667420|20869255|P1|STARTED|Overall Study||17
8469324|NCT00667394|20869265|P2|NOT COMPLETED|Overall Study||0
8469325|NCT00667394|20869266|P1|NOT COMPLETED|Overall Study||4
8469326|NCT00667394|20869265|P2|COMPLETED|Overall Study||1
8469327|NCT00667394|20869266|P1|COMPLETED|Overall Study||37
8469328|NCT00667394|20869265|P2|STARTED|Overall Study||1
8469329|NCT00667394|20869266|P1|STARTED|Overall Study||41
8469330|NCT00667381|20869276|P2|NOT COMPLETED|Overall Study||0
8469331|NCT00667381|20869277|P1|NOT COMPLETED|Overall Study||0
8469332|NCT00667381|20869276|P2|COMPLETED|Overall Study||503
8469333|NCT00667381|20869277|P1|COMPLETED|Overall Study||501
8469334|NCT00667381|20869276|P2|STARTED|Overall Study||503
8469335|NCT00667381|20869277|P1|STARTED|Overall Study||501
8469336|NCT00667368|20869293|P2|NOT COMPLETED|Overall Study||172
8469337|NCT00667368|20869294|P1|NOT COMPLETED|Overall Study||200
8469338|NCT00667368|20869293|P2|COMPLETED|Overall Study||511
8469339|NCT00667368|20869294|P1|COMPLETED|Overall Study||482
8469340|NCT00667368|20869293|P2|STARTED|Overall Study||683
8469341|NCT00667368|20869294|P1|STARTED|Overall Study||682
8469342|NCT00667355|20869302|P1|NOT COMPLETED|Overall Study||11
8469343|NCT00667355|20869302|P1|COMPLETED|Overall Study||30
8469344|NCT00667355|20869302|P1|STARTED|Overall Study||41
8469345|NCT00667342|20869327|P3|NOT COMPLETED|Overall Study||9
8469346|NCT00667342|20869328|P2|NOT COMPLETED|Overall Study||0
8469347|NCT00667342|20869329|P1|NOT COMPLETED|Overall Study||14
8469348|NCT00667342|20869327|P3|COMPLETED|Overall Study||3
8469349|NCT00667342|20869328|P2|COMPLETED|Overall Study||0
8469350|NCT00667342|20869329|P1|COMPLETED|Overall Study||17
8469351|NCT00667342|20869327|P3|STARTED|Overall Study||12
8469352|NCT00667342|20869328|P2|STARTED|Overall Study||0
8469353|NCT00667342|20869329|P1|STARTED|Overall Study||31
8469354|NCT00667277|20869367|P1|NOT COMPLETED|Overall Study||2
8469355|NCT00667277|20869367|P1|COMPLETED|Overall Study||11
8469356|NCT00667277|20869367|P1|STARTED|Overall Study||13
8469357|NCT00667251|20869374|P2|NOT COMPLETED|Overall Study||95
8469358|NCT00667251|20869375|P1|NOT COMPLETED|Overall Study||70
8469359|NCT00667251|20869374|P2|COMPLETED|Overall Study||231
8469360|NCT00667251|20869375|P1|COMPLETED|Overall Study||256
8469361|NCT00667251|20869374|P2|Not Started|Overall Study||1
8469362|NCT00667251|20869375|P1|Not Started|Overall Study||4
8469363|NCT00667251|20869374|P2|Monotherapy|Overall Study||232
8469364|NCT00667251|20869375|P1|Monotherapy|Overall Study||225
8469365|NCT00667251|20869374|P2|Combination Rx|Overall Study||325
8469366|NCT00667251|20869375|P1|Combination Rx|Overall Study||322
8469367|NCT00667251|20869374|P2|STARTED|Overall Study||326
8469368|NCT00667251|20869375|P1|STARTED|Overall Study||326
8469369|NCT00667225|20869401|P2|NOT COMPLETED|Overall Study||1
8469370|NCT00667225|20869402|P1|NOT COMPLETED|Overall Study||1
8469371|NCT00667225|20869401|P2|COMPLETED|Overall Study||12
8469372|NCT00667225|20869402|P1|COMPLETED|Overall Study||15
8469373|NCT00667225|20869401|P2|STARTED|Overall Study||13
8469374|NCT00667225|20869402|P1|STARTED|Overall Study||16
8469375|NCT00667186|20869412|P2|NOT COMPLETED|Overall Study||0
8469376|NCT00667186|20869413|P1|NOT COMPLETED|Overall Study||0
8469377|NCT00667186|20869412|P2|COMPLETED|Overall Study||4880
8469378|NCT00667186|20869413|P1|COMPLETED|Overall Study||4692
8469379|NCT00667186|20869412|P2|STARTED|Overall Study||4880
8469380|NCT00667186|20869413|P1|STARTED|Overall Study||4692
8469381|NCT00667095|20869423|P2|NOT COMPLETED|Overall Study||1
8469382|NCT00667095|20869424|P1|NOT COMPLETED|Overall Study||0
8469383|NCT00667095|20869423|P2|COMPLETED|Overall Study||9
8469384|NCT00667095|20869424|P1|COMPLETED|Overall Study||11
8469385|NCT00667095|20869423|P2|STARTED|Overall Study||10
8469386|NCT00667095|20869424|P1|STARTED|Overall Study||11
8469387|NCT00667017|20869440|P1|NOT COMPLETED|Overall Study||1
8469388|NCT00667017|20869440|P1|COMPLETED|Overall Study||0
8469389|NCT00667017|20869440|P1|STARTED|Overall Study||1
8469390|NCT00667004|20869446|P2|NOT COMPLETED|Overall Study||3
8469391|NCT00667004|20869447|P1|NOT COMPLETED|Overall Study||2
8469392|NCT00667004|20869446|P2|COMPLETED|Overall Study||85
8469393|NCT00667004|20869447|P1|COMPLETED|Overall Study||93
8469394|NCT00667004|20869446|P2|STARTED|Overall Study||88
8469395|NCT00667004|20869447|P1|STARTED|Overall Study||95
8469396|NCT00666978|20869455|P2|NOT COMPLETED|Overall Study||83
8469397|NCT00666978|20869456|P1|NOT COMPLETED|Overall Study||78
8469398|NCT00666978|20869455|P2|COMPLETED|Overall Study||187
8469399|NCT00666978|20869456|P1|COMPLETED|Overall Study||192
8469400|NCT00666978|20869455|P2|STARTED|Overall Study||270
8469401|NCT00666978|20869456|P1|STARTED|Overall Study||270
8469402|NCT00666965|20869469|P4|NOT COMPLETED|Overall Study||15
8469403|NCT00666965|20869470|P3|NOT COMPLETED|Overall Study||2
8469404|NCT00666965|20869471|P2|NOT COMPLETED|Overall Study||4
8469405|NCT00666965|20869472|P1|NOT COMPLETED|Overall Study||3
8469406|NCT00666965|20869469|P4|COMPLETED|Overall Study||42
8469407|NCT00666965|20869470|P3|COMPLETED|Overall Study||56
8469408|NCT00666965|20869471|P2|COMPLETED|Overall Study||53
8469409|NCT00666965|20869472|P1|COMPLETED|Overall Study||55
8469410|NCT00666965|20869469|P4|STARTED|Overall Study||57
8469411|NCT00666965|20869470|P3|STARTED|Overall Study||58
8469412|NCT00666965|20869471|P2|STARTED|Overall Study||57
8469413|NCT00666965|20869472|P1|STARTED|Overall Study||58
8469414|NCT00666926|20869502|P16|NOT COMPLETED|Overall Study||8
8469415|NCT00666926|20869503|P15|NOT COMPLETED|Overall Study||7
8469416|NCT00666926|20869504|P14|NOT COMPLETED|Overall Study||4
8469417|NCT00666926|20869505|P13|NOT COMPLETED|Overall Study||3
8469418|NCT00666926|20869506|P12|NOT COMPLETED|Overall Study||33
8469419|NCT00666926|20869507|P11|NOT COMPLETED|Overall Study||6
8469420|NCT00666926|20869508|P10|NOT COMPLETED|Overall Study||10
8469421|NCT00666926|20869509|P9|NOT COMPLETED|Overall Study||3
8469422|NCT00666926|20869510|P8|NOT COMPLETED|Overall Study||1
8469423|NCT00666926|20869511|P7|NOT COMPLETED|Overall Study||4
8469424|NCT00666926|20869512|P6|NOT COMPLETED|Overall Study||4
8469425|NCT00666926|20869513|P5|NOT COMPLETED|Overall Study||3
8469426|NCT00666926|20869514|P4|NOT COMPLETED|Overall Study||4
8469427|NCT00666926|20869515|P3|NOT COMPLETED|Overall Study||3
8469428|NCT00666926|20869516|P2|NOT COMPLETED|Overall Study||4
8469429|NCT00666926|20869517|P1|NOT COMPLETED|Overall Study||2
8469430|NCT00666926|20869502|P16|COMPLETED|Overall Study||0
8469431|NCT00666926|20869503|P15|COMPLETED|Overall Study||0
8469432|NCT00666926|20869504|P14|COMPLETED|Overall Study||0
8469433|NCT00666926|20869505|P13|COMPLETED|Overall Study||0
8469434|NCT00666926|20869506|P12|COMPLETED|Overall Study||0
8469435|NCT00666926|20869507|P11|COMPLETED|Overall Study||0
8469436|NCT00666926|20869508|P10|COMPLETED|Overall Study||0
8469437|NCT00666926|20869509|P9|COMPLETED|Overall Study||0
8469438|NCT00666926|20869510|P8|COMPLETED|Overall Study||0
8469439|NCT00666926|20869511|P7|COMPLETED|Overall Study||0
8469440|NCT00666926|20869512|P6|COMPLETED|Overall Study||0
8469441|NCT00666926|20869513|P5|COMPLETED|Overall Study||0
8469442|NCT00666926|20869514|P4|COMPLETED|Overall Study||0
8469443|NCT00666926|20869515|P3|COMPLETED|Overall Study||0
8469444|NCT00666926|20869516|P2|COMPLETED|Overall Study||0
8469445|NCT00666926|20869517|P1|COMPLETED|Overall Study||0
8469446|NCT00666926|20869502|P16|STARTED|Overall Study||8
8469447|NCT00666926|20869503|P15|STARTED|Overall Study||7
8469448|NCT00666926|20869504|P14|STARTED|Overall Study||4
8469449|NCT00666926|20869505|P13|STARTED|Overall Study||3
8469450|NCT00666926|20869506|P12|STARTED|Overall Study||33
8469451|NCT00666926|20869507|P11|STARTED|Overall Study||6
8469452|NCT00666926|20869508|P10|STARTED|Overall Study||10
8469453|NCT00666926|20869509|P9|STARTED|Overall Study||3
8469454|NCT00666926|20869510|P8|STARTED|Overall Study||1
8469455|NCT00666926|20869511|P7|STARTED|Overall Study||4
8469456|NCT00666926|20869512|P6|STARTED|Overall Study||4
8469457|NCT00666926|20869513|P5|STARTED|Overall Study||3
8469458|NCT00666926|20869514|P4|STARTED|Overall Study||4
8469459|NCT00666926|20869515|P3|STARTED|Overall Study||3
8469460|NCT00666926|20869516|P2|STARTED|Overall Study||4
8469461|NCT00666926|20869517|P1|STARTED|Overall Study||2
8469462|NCT00666848|20869811|P3|NOT COMPLETED|Overall Study||0
8469463|NCT00666848|20869812|P2|NOT COMPLETED|Overall Study||0
8469464|NCT00666848|20869813|P1|NOT COMPLETED|Overall Study||0
8469465|NCT00666848|20869811|P3|COMPLETED|Overall Study|finished Aim 3|7
8469466|NCT00666848|20869812|P2|COMPLETED|Overall Study|finished Aim 1|9
8469467|NCT00666848|20869813|P1|COMPLETED|Overall Study|finished Aim 2|8
8469468|NCT00666848|20869811|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
8469469|NCT00666848|20869812|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
8469470|NCT00666848|20869813|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
8469471|NCT00666835|20869826|P2|NOT COMPLETED|Overall Study||22
8469472|NCT00666835|20869827|P1|NOT COMPLETED|Overall Study||53
8469473|NCT00666835|20869826|P2|COMPLETED|Overall Study||142
8469474|NCT00666835|20869827|P1|COMPLETED|Overall Study||261
8469475|NCT00666835|20869826|P2|STARTED|Overall Study||164
8469476|NCT00666835|20869827|P1|STARTED|Overall Study||314
8469477|NCT00666757|20869837|P2|NOT COMPLETED|Overall Study||97
8469478|NCT00666757|20869838|P1|NOT COMPLETED|Overall Study||100
8469479|NCT00666757|20869837|P2|COMPLETED|Overall Study||281
8469480|NCT00666757|20869838|P1|COMPLETED|Overall Study||272
8469481|NCT00666757|20869837|P2|STARTED|Overall Study||378
8469482|NCT00666757|20869838|P1|STARTED|Overall Study||372
8469483|NCT00666718|20869897|P2|NOT COMPLETED|Overall Study||18
8469484|NCT00666718|20869898|P1|NOT COMPLETED|Overall Study||12
8469485|NCT00666718|20869897|P2|COMPLETED|Overall Study||169
8469486|NCT00666718|20869898|P1|COMPLETED|Overall Study||175
8469487|NCT00666718|20869897|P2|STARTED|Overall Study||187
8469488|NCT00666718|20869898|P1|STARTED|Overall Study||187
8469489|NCT00666705|20869924|P1|NOT COMPLETED|Overall Study||1
8469490|NCT00666705|20869924|P1|COMPLETED|Overall Study||17
8469491|NCT00666705|20869924|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
8469492|NCT00666705|20869924|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
8469493|NCT00666705|20869924|P1|Washout (Days 4 - 5)|Overall Study||18
8469494|NCT00666705|20869924|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
8469495|NCT00666705|20869924|P1|STARTED|Overall Study||18
8469496|NCT00666679|20869943|P2|NOT COMPLETED|Second Intervention||1
8469497|NCT00666679|20869944|P1|NOT COMPLETED|Second Intervention||1
8469498|NCT00666679|20869943|P2|COMPLETED|Second Intervention||64
8469499|NCT00666679|20869944|P1|COMPLETED|Second Intervention||61
8469500|NCT00666679|20869943|P2|STARTED|Second Intervention||65
8469501|NCT00666679|20869944|P1|STARTED|Second Intervention||62
8469502|NCT00666679|20869943|P2|NOT COMPLETED|Washout Period of 1 Week||2
8469503|NCT00666679|20869944|P1|NOT COMPLETED|Washout Period of 1 Week||0
8469504|NCT00666679|20869943|P2|COMPLETED|Washout Period of 1 Week||65
8469505|NCT00666679|20869944|P1|COMPLETED|Washout Period of 1 Week||62
8469506|NCT00666679|20869943|P2|STARTED|Washout Period of 1 Week||67
8469507|NCT00666679|20869944|P1|STARTED|Washout Period of 1 Week||62
8469508|NCT00666679|20869943|P2|NOT COMPLETED|First Intervention||1
8469509|NCT00666679|20869944|P1|NOT COMPLETED|First Intervention||4
8469510|NCT00666679|20869943|P2|COMPLETED|First Intervention||67
8469511|NCT00666679|20869944|P1|COMPLETED|First Intervention||62
8469512|NCT00666679|20869943|P2|STARTED|First Intervention||68
8469513|NCT00666679|20869944|P1|STARTED|First Intervention||66
8469514|NCT00666666|20869964|P1|NOT COMPLETED|Overall Study||0
8469515|NCT00666666|20869964|P1|COMPLETED|Overall Study||55
8469516|NCT00666666|20869964|P1|STARTED|Overall Study||55
8469517|NCT00666588|20869974|P4|NOT COMPLETED|Overall Study||2
8469518|NCT00666588|20869975|P3|NOT COMPLETED|Overall Study||0
8469519|NCT00666588|20869976|P2|NOT COMPLETED|Overall Study||0
8469520|NCT00666588|20869977|P1|NOT COMPLETED|Overall Study||4
8469521|NCT00666588|20869974|P4|COMPLETED|Overall Study||20
8469522|NCT00666588|20869975|P3|COMPLETED|Overall Study||6
8469523|NCT00666588|20869976|P2|COMPLETED|Overall Study||6
8469524|NCT00666588|20869977|P1|COMPLETED|Overall Study||14
8469525|NCT00666588|20869974|P4|STARTED|Overall Study||22
8469526|NCT00666588|20869975|P3|STARTED|Overall Study||6
8469527|NCT00666588|20869976|P2|STARTED|Overall Study||6
8469528|NCT00666588|20869977|P1|STARTED|Overall Study||18
8469529|NCT00666562|20870010|P3|NOT COMPLETED|Overall Study||0
8469530|NCT00666562|20870011|P2|NOT COMPLETED|Overall Study||2
8469531|NCT00666562|20870012|P1|NOT COMPLETED|Overall Study||0
8469532|NCT00666562|20870010|P3|COMPLETED|Overall Study||10
8469533|NCT00666562|20870011|P2|COMPLETED|Overall Study||8
8469534|NCT00666562|20870012|P1|COMPLETED|Overall Study||11
8469535|NCT00666562|20870010|P3|STARTED|Overall Study||10
8469536|NCT00666562|20870011|P2|STARTED|Overall Study||10
8469537|NCT00666562|20870012|P1|STARTED|Overall Study||11
8469538|NCT00666536|20870059|P2|NOT COMPLETED|Overall Study||37
8469539|NCT00666536|20870060|P1|NOT COMPLETED|Overall Study||33
8469540|NCT00666536|20870059|P2|COMPLETED|Overall Study||322
8469541|NCT00666536|20870060|P1|COMPLETED|Overall Study||336
8469542|NCT00666536|20870059|P2|STARTED|Overall Study||359
8469543|NCT00666536|20870060|P1|STARTED|Overall Study||369
8469544|NCT00666458|20870078|P2|NOT COMPLETED|Overall Study||24
8469545|NCT00666458|20870079|P1|NOT COMPLETED|Overall Study||38
8469546|NCT00666458|20870078|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
8469547|NCT00666458|20870079|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
8469548|NCT00666458|20870078|P2|STARTED|Overall Study|Randomized and treated|398
8469549|NCT00666458|20870079|P1|STARTED|Overall Study|Randomized and treated|403
8469550|NCT00666406|20870091|P2|NOT COMPLETED|Second PK Infusion||0
8469551|NCT00666406|20870092|P1|NOT COMPLETED|Second PK Infusion||0
8469552|NCT00666406|20870091|P2|COMPLETED|Second PK Infusion||3
8469553|NCT00666406|20870092|P1|COMPLETED|Second PK Infusion||6
8469554|NCT00666406|20870091|P2|STARTED|Second PK Infusion||3
8469555|NCT00666406|20870092|P1|STARTED|Second PK Infusion||6
8469556|NCT00666406|20870091|P2|NOT COMPLETED|First PK Infusion||0
8469557|NCT00666406|20870092|P1|NOT COMPLETED|First PK Infusion||0
8469558|NCT00666406|20870091|P2|COMPLETED|First PK Infusion||3
8469559|NCT00666406|20870092|P1|COMPLETED|First PK Infusion||6
8469560|NCT00666406|20870091|P2|STARTED|First PK Infusion||3
8469561|NCT00666406|20870092|P1|STARTED|First PK Infusion||6
8469562|NCT00666328|20870167|P1|NOT COMPLETED|Overall Study||5
8469563|NCT00666328|20870167|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
8469564|NCT00666328|20870167|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
8469565|NCT00666328|20870167|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
8469566|NCT00666276|20870180|P1|NOT COMPLETED|Overall Study||34
8469567|NCT00666276|20870180|P1|COMPLETED|Overall Study||970
8469568|NCT00666276|20870180|P1|STARTED|Overall Study||1004
8469569|NCT00666263|20870204|P2|NOT COMPLETED|End of Study Visit||0
8469570|NCT00666263|20870205|P1|NOT COMPLETED|End of Study Visit||0
8469571|NCT00666263|20870204|P2|COMPLETED|End of Study Visit||22
8469572|NCT00666263|20870205|P1|COMPLETED|End of Study Visit||22
8469573|NCT00666263|20870204|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
8469574|NCT00666263|20870205|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
8469575|NCT00666263|20870204|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
8469576|NCT00666263|20870205|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
8469577|NCT00666263|20870204|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
8469578|NCT00666263|20870205|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
8469579|NCT00666263|20870204|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
8469580|NCT00666263|20870205|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
8469581|NCT00666263|20870204|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
8469582|NCT00666263|20870205|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
8469583|NCT00666263|20870204|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
8469584|NCT00666263|20870205|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
8469585|NCT00666263|20870204|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
8469586|NCT00666263|20870205|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
8469587|NCT00666263|20870204|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
8469588|NCT00666263|20870205|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
8469589|NCT00666263|20870204|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
8469590|NCT00666263|20870205|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
8469591|NCT00666263|20870204|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
8469592|NCT00666263|20870205|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
8469593|NCT00666263|20870204|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
8469594|NCT00666263|20870205|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
8469595|NCT00666263|20870204|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
8469596|NCT00666263|20870205|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
8469597|NCT00666263|20870204|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
8469598|NCT00666263|20870205|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
8469599|NCT00666263|20870204|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
8469600|NCT00666263|20870205|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
8469601|NCT00666263|20870204|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
8469602|NCT00666263|20870205|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
8469603|NCT00666263|20870204|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
8469604|NCT00666263|20870205|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
8469605|NCT00666224|20870349|P2|NOT COMPLETED|Open-Label||85
8469606|NCT00666224|20870350|P1|NOT COMPLETED|Open-Label||35
8469607|NCT00666224|20870349|P2|COMPLETED|Open-Label||126
8469608|NCT00666224|20870350|P1|COMPLETED|Open-Label||163
8469609|NCT00666224|20870349|P2|STARTED|Open-Label||211
8469610|NCT00666224|20870350|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
8469611|NCT00666224|20870349|P2|NOT COMPLETED|Double-Blind||27
8469612|NCT00666224|20870350|P1|NOT COMPLETED|Double-Blind||45
8469613|NCT00666224|20870349|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
8469614|NCT00666224|20870350|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
8469615|NCT00666224|20870349|P2|STARTED|Double-Blind||238
8469616|NCT00666224|20870350|P1|STARTED|Double-Blind||243
8469617|NCT00666211|20870369|P2|NOT COMPLETED|Overall Study||38
8469618|NCT00666211|20870370|P1|NOT COMPLETED|Overall Study||20
8469619|NCT00666211|20870369|P2|COMPLETED|Overall Study||18
8469620|NCT00666211|20870370|P1|COMPLETED|Overall Study||22
8469621|NCT00666211|20870369|P2|STARTED|Overall Study||56
8469622|NCT00666211|20870370|P1|STARTED|Overall Study||42
8469626|NCT00666029|20870403|P2|NOT COMPLETED|Overall Study||0
8469627|NCT00666029|20870404|P1|NOT COMPLETED|Overall Study||1
8469628|NCT00666029|20870403|P2|COMPLETED|Overall Study||20
8469629|NCT00666029|20870404|P1|COMPLETED|Overall Study||19
8469630|NCT00666029|20870403|P2|STARTED|Overall Study||20
8469631|NCT00666029|20870404|P1|STARTED|Overall Study||20
8469632|NCT00665925|20870416|P4|NOT COMPLETED|Overall Study||21
8469633|NCT00665925|20870417|P3|NOT COMPLETED|Overall Study||26
8469634|NCT00665925|20870418|P2|NOT COMPLETED|Overall Study||17
8469635|NCT00665925|20870419|P1|NOT COMPLETED|Overall Study||15
8469636|NCT00665925|20870416|P4|COMPLETED|Overall Study|Participants completed the study|131
8469637|NCT00665925|20870417|P3|COMPLETED|Overall Study|Participants completed the study|126
8469638|NCT00665925|20870418|P2|COMPLETED|Overall Study|Participants completed the study|59
8469639|NCT00665925|20870419|P1|COMPLETED|Overall Study|Participants completed the study|62
8469640|NCT00665925|20870416|P4|STARTED|Overall Study|Participants randomized|152
8469641|NCT00665925|20870417|P3|STARTED|Overall Study|Participants randomized|152
8469642|NCT00665925|20870418|P2|STARTED|Overall Study|Participants randomized|76
8469643|NCT00665925|20870419|P1|STARTED|Overall Study|Participants randomized|77
8469644|NCT00665847|20870830|P1|NOT COMPLETED|Overall Study||25
8469645|NCT00665847|20870830|P1|COMPLETED|Overall Study||76
8469646|NCT00665847|20870830|P1|STARTED|Overall Study||101
8469647|NCT00665704|20870842|P1|NOT COMPLETED|Overall Study||0
8469648|NCT00665704|20870842|P1|COMPLETED|Overall Study||9
8469649|NCT00665704|20870842|P1|STARTED|Overall Study||9
8469650|NCT00665652|20870847|P1|NOT COMPLETED|Overall Study||6
8469651|NCT00665652|20870847|P1|COMPLETED|Overall Study||2
8469652|NCT00665652|20870847|P1|STARTED|Overall Study||8
8469653|NCT00665626|20870853|P2|NOT COMPLETED|Overall Study||22
8469654|NCT00665626|20870854|P1|NOT COMPLETED|Overall Study||10
8469655|NCT00665626|20870853|P2|COMPLETED|Overall Study|Participants completed the study|124
8469656|NCT00665626|20870854|P1|COMPLETED|Overall Study|Participants completed the study|63
8469657|NCT00665626|20870853|P2|STARTED|Overall Study|Participants randomized|146
8469658|NCT00665626|20870854|P1|STARTED|Overall Study|Participants randomized|73
8469659|NCT00665561|20870922|P2|NOT COMPLETED|Overall Study||534
8469660|NCT00665561|20870923|P1|NOT COMPLETED|Overall Study||502
8469661|NCT00665561|20870922|P2|COMPLETED|Overall Study||596
8469662|NCT00665561|20870923|P1|COMPLETED|Overall Study||814
8469663|NCT00665561|20870922|P2|STARTED|Overall Study||1130
8469664|NCT00665561|20870923|P1|STARTED|Overall Study||1316
8469665|NCT00665470|20870959|P2|NOT COMPLETED|Overall Study||0
8469666|NCT00665470|20870960|P1|NOT COMPLETED|Overall Study||0
8469667|NCT00665470|20870959|P2|COMPLETED|Overall Study||0
8469668|NCT00665470|20870960|P1|COMPLETED|Overall Study||10
8469669|NCT00665470|20870959|P2|STARTED|Overall Study||0
8469670|NCT00665470|20870960|P1|STARTED|Overall Study||10
8469671|NCT00665457|20870968|P1|NOT COMPLETED|Overall Study||0
8469672|NCT00665457|20870968|P1|COMPLETED|Overall Study||3
8469673|NCT00665457|20870968|P1|STARTED|Overall Study||3
8469674|NCT00665444|20870973|P1|NOT COMPLETED|Overall Study||2
8469675|NCT00665444|20870973|P1|COMPLETED|Overall Study||1
8469676|NCT00665444|20870973|P1|STARTED|Overall Study||3
8469677|NCT00665431|20870985|P3|NOT COMPLETED|Overall Study||24
8469678|NCT00665431|20870986|P2|NOT COMPLETED|Overall Study||57
8469679|NCT00665431|20870987|P1|NOT COMPLETED|Overall Study||40
8469680|NCT00665431|20870985|P3|COMPLETED|Overall Study||98
8469681|NCT00665431|20870986|P2|COMPLETED|Overall Study||188
8469682|NCT00665431|20870987|P1|COMPLETED|Overall Study||203
8469683|NCT00665431|20870985|P3|STARTED|Overall Study|Safety population|122
8469684|NCT00665431|20870986|P2|STARTED|Overall Study|Safety population|245
8469685|NCT00665431|20870987|P1|STARTED|Overall Study|Safety population|243
8469686|NCT00665366|20871030|P2|NOT COMPLETED|Overall Study||59
8469687|NCT00665366|20871031|P1|NOT COMPLETED|Overall Study||58
8469688|NCT00665366|20871030|P2|COMPLETED|Overall Study||122
8469689|NCT00665366|20871031|P1|COMPLETED|Overall Study||131
8469690|NCT00665366|20871030|P2|STARTED|Overall Study|Participants randomized|181
8469691|NCT00665366|20871031|P1|STARTED|Overall Study|Participants randomized|189
8469692|NCT00665353|20871059|P1|NOT COMPLETED|Study Step 2||14
8469693|NCT00665353|20871059|P1|COMPLETED|Study Step 2||2
8469694|NCT00665353|20871059|P1|STARTED|Study Step 2||16
8469695|NCT00665353|20871059|P1|NOT COMPLETED|Study Step 1||3
8469696|NCT00665353|20871059|P1|COMPLETED|Study Step 1||16
8469697|NCT00665353|20871059|P1|STARTED|Study Step 1||19
8469698|NCT00665132|20871069|P1|NOT COMPLETED|Overall Study||0
8469699|NCT00665132|20871069|P1|COMPLETED|Overall Study||10
8469700|NCT00665132|20871069|P1|STARTED|Overall Study||10
8469701|NCT00665002|20871076|P1|NOT COMPLETED|Overall Study||12
8469702|NCT00665002|20871076|P1|COMPLETED|Overall Study||4
8469703|NCT00665002|20871076|P1|STARTED|Overall Study||16
8469704|NCT00664859|20871084|P3|NOT COMPLETED|Overall Study||21
8469705|NCT00664859|20871085|P2|NOT COMPLETED|Overall Study||10
8469706|NCT00664859|20871086|P1|NOT COMPLETED|Overall Study||17
8469707|NCT00664859|20871084|P3|COMPLETED|Overall Study||23
8469708|NCT00664859|20871085|P2|COMPLETED|Overall Study||35
8469709|NCT00664859|20871086|P1|COMPLETED|Overall Study||34
8469710|NCT00664859|20871084|P3|STARTED|Overall Study||44
8469711|NCT00664859|20871085|P2|STARTED|Overall Study||45
8469712|NCT00664859|20871086|P1|STARTED|Overall Study||51
8469713|NCT00664755|20871099|P2|NOT COMPLETED|Overall Study||0
8469714|NCT00664755|20871100|P1|NOT COMPLETED|Overall Study||0
8469715|NCT00664755|20871099|P2|COMPLETED|Overall Study||73
8469716|NCT00664755|20871100|P1|COMPLETED|Overall Study||67
8469717|NCT00664755|20871099|P2|STARTED|Overall Study||73
8469718|NCT00664755|20871100|P1|STARTED|Overall Study||67
8469719|NCT00664742|20871106|P1|NOT COMPLETED|Overall Study||126
8469720|NCT00664742|20871106|P1|COMPLETED|Overall Study||481
8469721|NCT00664742|20871106|P1|STARTED|Overall Study||607
8469722|NCT00664560|20871114|P3|NOT COMPLETED|Overall Study||19
8469723|NCT00664560|20871115|P2|NOT COMPLETED|Overall Study||35
8469724|NCT00664560|20871116|P1|NOT COMPLETED|Overall Study||39
8469725|NCT00664560|20871114|P3|COMPLETED|Overall Study||105
8469726|NCT00664560|20871115|P2|COMPLETED|Overall Study||208
8469727|NCT00664560|20871116|P1|COMPLETED|Overall Study||208
8469728|NCT00664560|20871114|P3|STARTED|Overall Study|Safety Population|124
8469729|NCT00664560|20871115|P2|STARTED|Overall Study|Safety Population|243
8469730|NCT00664560|20871116|P1|STARTED|Overall Study|Safety Population|247
8469731|NCT00664534|20871159|P2|NOT COMPLETED|Overall Study||33
8469732|NCT00664534|20871160|P1|NOT COMPLETED|Overall Study||41
8469733|NCT00664534|20871159|P2|COMPLETED|Overall Study||138
8469734|NCT00664534|20871160|P1|COMPLETED|Overall Study||132
8469735|NCT00664534|20871159|P2|STARTED|Overall Study||171
8469736|NCT00664534|20871160|P1|STARTED|Overall Study||173
8469737|NCT00664521|20871188|P2|NOT COMPLETED|Overall Study||1
8469738|NCT00664521|20871189|P1|NOT COMPLETED|Overall Study||6
8469739|NCT00664521|20871188|P2|COMPLETED|Overall Study||8
8469740|NCT00664521|20871189|P1|COMPLETED|Overall Study||12
8469741|NCT00664521|20871188|P2|STARTED|Overall Study||9
8469742|NCT00664521|20871189|P1|STARTED|Overall Study||18
8469743|NCT00664430|20871209|P1|NOT COMPLETED|Overall Study||13
8469744|NCT00664430|20871209|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
8469745|NCT00664430|20871209|P1|STARTED|Overall Study||13
8469746|NCT00664209|20871215|P1|NOT COMPLETED|Study Treatment Period||6
8469747|NCT00664209|20871215|P1|COMPLETED|Study Treatment Period||0
8469748|NCT00664209|20871215|P1|STARTED|Study Treatment Period||6
8469749|NCT00664209|20871215|P1|NOT COMPLETED|Motor Fluctuations Screen||7
8469750|NCT00664209|20871215|P1|COMPLETED|Motor Fluctuations Screen||6
8469751|NCT00664209|20871215|P1|STARTED|Motor Fluctuations Screen||13
8469752|NCT00664105|20871223|P1|NOT COMPLETED|Overall Study||24
8469753|NCT00664105|20871223|P1|COMPLETED|Overall Study||39
8469754|NCT00664105|20871223|P1|STARTED|Overall Study||63
8469755|NCT00664066|20871230|P1|NOT COMPLETED|Overall Study||3
8469756|NCT00664066|20871230|P1|COMPLETED|Overall Study||0
8469757|NCT00664066|20871230|P1|STARTED|Overall Study||3
8469758|NCT00663962|20871236|P2|NOT COMPLETED|Overall Study||0
8469759|NCT00663962|20871237|P1|NOT COMPLETED|Overall Study||1
8469760|NCT00663962|20871236|P2|COMPLETED|Overall Study||8
8469761|NCT00663962|20871237|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
8469762|NCT00663962|20871236|P2|STARTED|Overall Study||8
8469763|NCT00663962|20871237|P1|STARTED|Overall Study||7
8469764|NCT00663923|20871243|P1|NOT COMPLETED|Overall Study||2
8469765|NCT00663923|20871243|P1|COMPLETED|Overall Study||48
8469766|NCT00663923|20871243|P1|STARTED|Overall Study||50
8469767|NCT00663858|20871260|P3|NOT COMPLETED|Overall Study||20
8469768|NCT00663858|20871261|P2|NOT COMPLETED|Overall Study||10
8469769|NCT00663858|20871262|P1|NOT COMPLETED|Overall Study||34
8469770|NCT00663858|20871260|P3|COMPLETED|Overall Study||82
8469771|NCT00663858|20871261|P2|COMPLETED|Overall Study||96
8469772|NCT00663858|20871262|P1|COMPLETED|Overall Study||178
8469773|NCT00663858|20871260|P3|STARTED|Overall Study||102
8469774|NCT00663858|20871261|P2|STARTED|Overall Study||106
8469775|NCT00663858|20871262|P1|STARTED|Overall Study||212
8469776|NCT00663819|20871272|P2|NOT COMPLETED|Overall Study||0
8469777|NCT00663819|20871273|P1|NOT COMPLETED|Overall Study||0
8469778|NCT00663819|20871272|P2|COMPLETED|Overall Study||135
8469779|NCT00663819|20871273|P1|COMPLETED|Overall Study||123
8469780|NCT00663819|20871272|P2|STARTED|Overall Study||135
8469781|NCT00663819|20871273|P1|STARTED|Overall Study||123
8469782|NCT00663793|20871287|P2|NOT COMPLETED|Overall Study||0
8469783|NCT00663793|20871288|P1|NOT COMPLETED|Overall Study||0
8469784|NCT00663793|20871287|P2|COMPLETED|Overall Study||8
8469785|NCT00663793|20871288|P1|COMPLETED|Overall Study||8
8469786|NCT00663793|20871287|P2|STARTED|Overall Study||8
8469787|NCT00663793|20871288|P1|STARTED|Overall Study||8
8469788|NCT00663702|20871300|P2|NOT COMPLETED|Overall Study||10
8469789|NCT00663702|20871301|P1|NOT COMPLETED|Overall Study||18
8469790|NCT00663702|20871300|P2|COMPLETED|Overall Study||61
8469791|NCT00663702|20871301|P1|COMPLETED|Overall Study||34
8469792|NCT00663702|20871300|P2|STARTED|Overall Study||71
8469793|NCT00663702|20871301|P1|STARTED|Overall Study||52
8469794|NCT00663403|20871324|P1|NOT COMPLETED|Overall Study||0
8469795|NCT00663403|20871324|P1|COMPLETED|Overall Study||8
8469796|NCT00663403|20871324|P1|STARTED|Overall Study||8
8469797|NCT00663260|20871337|P3|NOT COMPLETED|Overall Study||16
8469798|NCT00663260|20871338|P2|NOT COMPLETED|Overall Study||11
8469799|NCT00663260|20871339|P1|NOT COMPLETED|Overall Study||21
8469800|NCT00663260|20871337|P3|COMPLETED|Overall Study||69
8469801|NCT00663260|20871338|P2|COMPLETED|Overall Study||72
8469802|NCT00663260|20871339|P1|COMPLETED|Overall Study||63
8469803|NCT00663260|20871337|P3|STARTED|Overall Study||85
8469804|NCT00663260|20871338|P2|STARTED|Overall Study||83
8469805|NCT00663260|20871339|P1|STARTED|Overall Study||84
8469806|NCT00663234|20871353|P1|NOT COMPLETED|Overall Study||1
8469807|NCT00663234|20871353|P1|COMPLETED|Overall Study||27
8469808|NCT00663234|20871353|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
8469809|NCT00663234|20871353|P1|STARTED|Overall Study||28
8469810|NCT00663208|20871386|P7|NOT COMPLETED|Follow-up Period||1
8469811|NCT00663208|20871387|P6|NOT COMPLETED|Follow-up Period||0
8469812|NCT00663208|20871388|P5|NOT COMPLETED|Follow-up Period||0
8469813|NCT00663208|20871389|P4|NOT COMPLETED|Follow-up Period||2
8469814|NCT00663208|20871390|P3|NOT COMPLETED|Follow-up Period||3
8469815|NCT00663208|20871391|P2|NOT COMPLETED|Follow-up Period||0
8469816|NCT00663208|20871392|P1|NOT COMPLETED|Follow-up Period||3
8469817|NCT00663208|20871386|P7|COMPLETED|Follow-up Period||5
8469818|NCT00663208|20871387|P6|COMPLETED|Follow-up Period||4
8469819|NCT00663208|20871388|P5|COMPLETED|Follow-up Period||4
8469820|NCT00663208|20871389|P4|COMPLETED|Follow-up Period||2
8469821|NCT00663208|20871390|P3|COMPLETED|Follow-up Period||1
8469822|NCT00663208|20871391|P2|COMPLETED|Follow-up Period||3
8469823|NCT00663208|20871392|P1|COMPLETED|Follow-up Period||1
8469824|NCT00663208|20871386|P7|STARTED|Follow-up Period||6
8469825|NCT00663208|20871387|P6|STARTED|Follow-up Period||4
8469826|NCT00663208|20871388|P5|STARTED|Follow-up Period||4
8469827|NCT00663208|20871389|P4|STARTED|Follow-up Period||4
8469828|NCT00663208|20871390|P3|STARTED|Follow-up Period||4
8469829|NCT00663208|20871391|P2|STARTED|Follow-up Period||3
8469830|NCT00663208|20871392|P1|STARTED|Follow-up Period||4
8469831|NCT00663208|20871386|P7|NOT COMPLETED|Treatment Period||0
8469832|NCT00663208|20871387|P6|NOT COMPLETED|Treatment Period||0
8469833|NCT00663208|20871388|P5|NOT COMPLETED|Treatment Period||0
8469834|NCT00663208|20871389|P4|NOT COMPLETED|Treatment Period||0
8469835|NCT00663208|20871390|P3|NOT COMPLETED|Treatment Period||0
8469836|NCT00663208|20871391|P2|NOT COMPLETED|Treatment Period||1
8469837|NCT00663208|20871392|P1|NOT COMPLETED|Treatment Period||0
8469838|NCT00663208|20871386|P7|COMPLETED|Treatment Period||6
8469839|NCT00663208|20871387|P6|COMPLETED|Treatment Period||4
8469840|NCT00663208|20871388|P5|COMPLETED|Treatment Period||4
8469841|NCT00663208|20871389|P4|COMPLETED|Treatment Period||4
8469842|NCT00663208|20871390|P3|COMPLETED|Treatment Period||4
8469843|NCT00663208|20871391|P2|COMPLETED|Treatment Period||3
8469844|NCT00663208|20871392|P1|COMPLETED|Treatment Period||4
8469845|NCT00663208|20871386|P7|STARTED|Treatment Period||6
8469846|NCT00663208|20871387|P6|STARTED|Treatment Period||4
8469847|NCT00663208|20871388|P5|STARTED|Treatment Period||4
8469848|NCT00663208|20871389|P4|STARTED|Treatment Period||4
8469849|NCT00663208|20871390|P3|STARTED|Treatment Period||4
8469850|NCT00663208|20871391|P2|STARTED|Treatment Period||4
8469851|NCT00663208|20871392|P1|STARTED|Treatment Period||4
8469852|NCT00663169|20871544|P2|NOT COMPLETED|Overall Study||0
8469853|NCT00663169|20871545|P1|NOT COMPLETED|Overall Study||0
8469854|NCT00663169|20871544|P2|COMPLETED|Overall Study||3
8469855|NCT00663169|20871545|P1|COMPLETED|Overall Study||3
8469856|NCT00663169|20871544|P2|STARTED|Overall Study||3
8469857|NCT00663169|20871545|P1|STARTED|Overall Study||3
8469858|NCT00663117|20871570|P2|NOT COMPLETED|Overall Study||0
8469859|NCT00663117|20871571|P1|NOT COMPLETED|Overall Study||1
8469860|NCT00663117|20871570|P2|COMPLETED|Overall Study||20
8469861|NCT00663117|20871571|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
8469862|NCT00663117|20871570|P2|STARTED|Overall Study||20
8469863|NCT00663117|20871571|P1|STARTED|Overall Study||20
8469864|NCT00663052|20871585|P2|NOT COMPLETED|Overall Study||10
8469865|NCT00663052|20871586|P1|NOT COMPLETED|Overall Study||12
8469866|NCT00663052|20871585|P2|COMPLETED|Overall Study||127
8469867|NCT00663052|20871586|P1|COMPLETED|Overall Study||124
8469868|NCT00663052|20871585|P2|STARTED|Overall Study||137
8469869|NCT00663052|20871586|P1|STARTED|Overall Study||136
8469870|NCT00663039|20871666|P2|NOT COMPLETED|Overall Study||4
8469871|NCT00663039|20871667|P1|NOT COMPLETED|Overall Study||4
8469872|NCT00663039|20871666|P2|COMPLETED|Overall Study||9
8469873|NCT00663039|20871667|P1|COMPLETED|Overall Study||10
8469874|NCT00663039|20871666|P2|STARTED|Overall Study||13
8469875|NCT00663039|20871667|P1|STARTED|Overall Study||14
8469876|NCT00663026|20871692|P3|NOT COMPLETED|Overall Study||4
8469877|NCT00663026|20871693|P2|NOT COMPLETED|Overall Study||6
8469878|NCT00663026|20871694|P1|NOT COMPLETED|Overall Study||2
8469879|NCT00663026|20871692|P3|COMPLETED|Overall Study||27
8469880|NCT00663026|20871693|P2|COMPLETED|Overall Study||23
8469881|NCT00663026|20871694|P1|COMPLETED|Overall Study||17
8469882|NCT00663026|20871692|P3|STARTED|Overall Study||31
8469883|NCT00663026|20871693|P2|STARTED|Overall Study||29
8469884|NCT00663026|20871694|P1|STARTED|Overall Study||19
8469885|NCT00662909|20871717|P3|NOT COMPLETED|Overall Study||53
8469886|NCT00662909|20871718|P2|NOT COMPLETED|Overall Study||59
8469887|NCT00662909|20871719|P1|NOT COMPLETED|Overall Study||69
8469888|NCT00662909|20871717|P3|COMPLETED|Overall Study||380
8469889|NCT00662909|20871718|P2|COMPLETED|Overall Study||383
8469890|NCT00662909|20871719|P1|COMPLETED|Overall Study||385
8469891|NCT00662909|20871717|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
8469892|NCT00662909|20871718|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
8469893|NCT00662909|20871719|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
8469894|NCT00662909|20871717|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
8469895|NCT00662909|20871718|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
8469896|NCT00662909|20871719|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
8469897|NCT00662909|20871717|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
8469898|NCT00662909|20871718|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
8469899|NCT00662909|20871719|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
8469900|NCT00662909|20871717|P3|STARTED|Overall Study||433
8469901|NCT00662909|20871718|P2|STARTED|Overall Study||442
8469902|NCT00662909|20871719|P1|STARTED|Overall Study||454
8469903|NCT00662857|20871817|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
8469904|NCT00662857|20871818|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
8469905|NCT00662857|20871817|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
8469906|NCT00662857|20871818|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
8469907|NCT00662857|20871817|P2|STARTED|Lispro Dosing Period (1 Day)||14
8469908|NCT00662857|20871818|P1|STARTED|Lispro Dosing Period (1 Day)||12
8469909|NCT00662857|20871817|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
8469910|NCT00662857|20871818|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
8469911|NCT00662857|20871817|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
8469912|NCT00662857|20871818|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
8469913|NCT00662857|20871817|P2|STARTED|Washout 2 (3 - 14 Days)||14
8469914|NCT00662857|20871818|P1|STARTED|Washout 2 (3 - 14 Days)||13
8469915|NCT00662857|20871817|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
8469916|NCT00662857|20871818|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
8469917|NCT00662857|20871817|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
8469918|NCT00662857|20871818|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
8469919|NCT00662857|20871817|P2|STARTED|TI Dosing Period 2 (1 Day)||14
8469920|NCT00662857|20871818|P1|STARTED|TI Dosing Period 2 (1 Day)||13
8469921|NCT00662857|20871817|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
8469922|NCT00662857|20871818|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
8469923|NCT00662857|20871817|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
8469924|NCT00662857|20871818|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
8469925|NCT00662857|20871817|P2|STARTED|Washout 1 (3 - 14 Days)||16
8469926|NCT00662857|20871818|P1|STARTED|Washout 1 (3 - 14 Days)||13
8469927|NCT00662857|20871817|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
8469928|NCT00662857|20871818|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
8469929|NCT00662857|20871817|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
8469930|NCT00662857|20871818|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
8469931|NCT00662857|20871817|P2|STARTED|TI Dosing Period 1 (1 Day)||16
8469932|NCT00662857|20871818|P1|STARTED|TI Dosing Period 1 (1 Day)||13
8469933|NCT00662831|20871833|P2|NOT COMPLETED|Overall Study||59
8469934|NCT00662831|20871834|P1|NOT COMPLETED|Overall Study||106
8469935|NCT00662831|20871833|P2|COMPLETED|Overall Study||33
8469936|NCT00662831|20871834|P1|COMPLETED|Overall Study||78
8469937|NCT00662831|20871833|P2|STARTED|Overall Study||92
8469938|NCT00662831|20871834|P1|STARTED|Overall Study||184
8469939|NCT00662818|20871874|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
8469940|NCT00662818|20871875|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
8469941|NCT00662818|20871874|P2|COMPLETED|Period 2 (6 Weeks)||41
8469942|NCT00662818|20871875|P1|COMPLETED|Period 2 (6 Weeks)||38
8469943|NCT00662818|20871874|P2|STARTED|Period 2 (6 Weeks)||53
8469944|NCT00662818|20871875|P1|STARTED|Period 2 (6 Weeks)||51
8469945|NCT00662818|20871874|P2|NOT COMPLETED|Wash-Out (14 Days)||5
8469946|NCT00662818|20871875|P1|NOT COMPLETED|Wash-Out (14 Days)||5
8469947|NCT00662818|20871874|P2|COMPLETED|Wash-Out (14 Days)||53
8469948|NCT00662818|20871875|P1|COMPLETED|Wash-Out (14 Days)||51
8469949|NCT00662818|20871874|P2|STARTED|Wash-Out (14 Days)||58
8469950|NCT00662818|20871875|P1|STARTED|Wash-Out (14 Days)||56
8469951|NCT00662818|20871874|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
8469952|NCT00662818|20871875|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
8469953|NCT00662818|20871874|P2|COMPLETED|Period 1 (6 Weeks)||58
8469954|NCT00662818|20871875|P1|COMPLETED|Period 1 (6 Weeks)||56
8469955|NCT00662818|20871874|P2|Treated|Period 1 (6 Weeks)||58
8469956|NCT00662818|20871875|P1|Treated|Period 1 (6 Weeks)||56
8469957|NCT00662818|20871874|P2|STARTED|Period 1 (6 Weeks)||81
8469958|NCT00662818|20871875|P1|STARTED|Period 1 (6 Weeks)||84
8469959|NCT00662675|20871899|P2|NOT COMPLETED|Overall Study||0
8469960|NCT00662675|20871900|P1|NOT COMPLETED|Overall Study||0
8469961|NCT00662675|20871899|P2|COMPLETED|Overall Study||20
8469962|NCT00662675|20871900|P1|COMPLETED|Overall Study||20
8469963|NCT00662675|20871899|P2|STARTED|Overall Study||20
8469964|NCT00662675|20871900|P1|STARTED|Overall Study||20
8469965|NCT00662649|20871914|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
8469966|NCT00662649|20871915|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
8469967|NCT00662649|20871916|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
8469968|NCT00662649|20871917|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
8469969|NCT00662649|20871918|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
8469970|NCT00662649|20871914|P5|COMPLETED|Extension Study (Month 24 to 60)||126
8469971|NCT00662649|20871915|P4|COMPLETED|Extension Study (Month 24 to 60)||112
8469972|NCT00662649|20871916|P3|COMPLETED|Extension Study (Month 24 to 60)||0
8469973|NCT00662649|20871917|P2|COMPLETED|Extension Study (Month 24 to 60)||290
8469974|NCT00662649|20871918|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
8469975|NCT00662649|20871914|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
8469976|NCT00662649|20871915|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
8469977|NCT00662649|20871916|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
8469978|NCT00662649|20871917|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
8469979|NCT00662649|20871918|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
8469980|NCT00662649|20871914|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
8469981|NCT00662649|20871915|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
8469982|NCT00662649|20871916|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
8469983|NCT00662649|20871917|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
8469984|NCT00662649|20871918|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
8469985|NCT00662649|20871914|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
8469986|NCT00662649|20871915|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
8469987|NCT00662649|20871916|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
8469988|NCT00662649|20871917|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
8469989|NCT00662649|20871918|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
8469990|NCT00662649|20871914|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
8469991|NCT00662649|20871915|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
8469992|NCT00662649|20871916|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
8469993|NCT00662649|20871917|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
8469994|NCT00662649|20871918|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
8469995|NCT00662649|20871914|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
8469996|NCT00662649|20871915|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
8469997|NCT00662649|20871916|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
8469998|NCT00662649|20871917|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
8469999|NCT00662649|20871918|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
8470000|NCT00662649|20871914|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
8470001|NCT00662649|20871915|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
8470002|NCT00662649|20871916|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
8470003|NCT00662649|20871917|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
8470004|NCT00662649|20871918|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
8470005|NCT00662649|20871914|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
8470006|NCT00662649|20871915|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
8470007|NCT00662649|20871916|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
8470008|NCT00662649|20871917|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
8470009|NCT00662649|20871918|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
8470010|NCT00662649|20871914|P5|STARTED|Extension Study (Month 24 to 60)||155
8470011|NCT00662649|20871915|P4|STARTED|Extension Study (Month 24 to 60)||145
8470012|NCT00662649|20871916|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
8470013|NCT00662649|20871917|P2|STARTED|Extension Study (Month 24 to 60)||331
8470014|NCT00662649|20871918|P1|STARTED|Extension Study (Month 24 to 60)||289
8470015|NCT00662649|20871914|P5|NOT COMPLETED|Core Study (24 Months)||0
8470016|NCT00662649|20871915|P4|NOT COMPLETED|Core Study (24 Months)||0
8470017|NCT00662649|20871916|P3|NOT COMPLETED|Core Study (24 Months)||86
8470018|NCT00662649|20871917|P2|NOT COMPLETED|Core Study (24 Months)||56
8470019|NCT00662649|20871918|P1|NOT COMPLETED|Core Study (24 Months)||97
8470020|NCT00662649|20871914|P5|COMPLETED|Core Study (24 Months)||0
8470021|NCT00662649|20871915|P4|COMPLETED|Core Study (24 Months)||0
8470022|NCT00662649|20871916|P3|COMPLETED|Core Study (24 Months)||332
8470023|NCT00662649|20871917|P2|COMPLETED|Core Study (24 Months)||369
8470024|NCT00662649|20871918|P1|COMPLETED|Core Study (24 Months)||332
8470025|NCT00662649|20871914|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
8470026|NCT00662649|20871915|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
8470027|NCT00662649|20871916|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
8470028|NCT00662649|20871917|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
8470029|NCT00662649|20871918|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
8470030|NCT00662649|20871914|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
8470031|NCT00662649|20871915|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
8470032|NCT00662649|20871916|P3|STARTED|Core Study (24 Months)||418
8470033|NCT00662649|20871917|P2|STARTED|Core Study (24 Months)||425
8470034|NCT00662649|20871918|P1|STARTED|Core Study (24 Months)||429
8470043|NCT00662545|20871993|P2|NOT COMPLETED|Overall Study||0
8470044|NCT00662545|20871994|P1|NOT COMPLETED|Overall Study||0
8470045|NCT00662545|20871993|P2|COMPLETED|Overall Study||5
8470046|NCT00662545|20871994|P1|COMPLETED|Overall Study||5
8470047|NCT00662545|20871993|P2|STARTED|Overall Study||5
8470048|NCT00662545|20871994|P1|STARTED|Overall Study||5
8470049|NCT00662532|20872010|P2|NOT COMPLETED|Overall Study||2
8470050|NCT00662532|20872011|P1|NOT COMPLETED|Overall Study||0
8470051|NCT00662532|20872010|P2|COMPLETED|Overall Study||20
8470052|NCT00662532|20872011|P1|COMPLETED|Overall Study||22
8470053|NCT00662532|20872010|P2|STARTED|Overall Study||22
8470054|NCT00662532|20872011|P1|STARTED|Overall Study||22
8470055|NCT00662389|20872021|P1|NOT COMPLETED|Overall Study||0
8470056|NCT00662389|20872021|P1|COMPLETED|Overall Study||4
8470057|NCT00662389|20872021|P1|STARTED|Overall Study||4
8470058|NCT00662363|20872026|P2|NOT COMPLETED|Overall Study||10
8470059|NCT00662363|20872027|P1|NOT COMPLETED|Overall Study||11
8470060|NCT00662363|20872026|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
8470061|NCT00662363|20872027|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
8470062|NCT00662363|20872026|P2|STARTED|Overall Study||32
8470063|NCT00662363|20872027|P1|STARTED|Overall Study||32
8470064|NCT00662311|20872038|P3|NOT COMPLETED|Overall Study||0
8470065|NCT00662311|20872039|P2|NOT COMPLETED|Overall Study||0
8470066|NCT00662311|20872040|P1|NOT COMPLETED|Overall Study||1
8470067|NCT00662311|20872038|P3|COMPLETED|Overall Study||0
8470068|NCT00662311|20872039|P2|COMPLETED|Overall Study||0
8470069|NCT00662311|20872040|P1|COMPLETED|Overall Study||4
8470070|NCT00662311|20872038|P3|STARTED|Overall Study||0
8470071|NCT00662311|20872039|P2|STARTED|Overall Study||0
8470072|NCT00662311|20872040|P1|STARTED|Overall Study||5
8470073|NCT00662298|20872063|P1|NOT COMPLETED|Overall Study||0
8470074|NCT00662298|20872063|P1|COMPLETED|Overall Study||5
8470075|NCT00662298|20872063|P1|STARTED|Overall Study||5
8470076|NCT00662259|20872075|P2|NOT COMPLETED|Overall Study||0
8470077|NCT00662259|20872076|P1|NOT COMPLETED|Overall Study||2
8470078|NCT00662259|20872075|P2|COMPLETED|Overall Study||11
8470079|NCT00662259|20872076|P1|COMPLETED|Overall Study||19
8470080|NCT00662259|20872075|P2|STARTED|Overall Study||11
8470081|NCT00662259|20872076|P1|STARTED|Overall Study||21
8470082|NCT00662207|20872090|P1|NOT COMPLETED|Overall Study||0
8470083|NCT00662207|20872090|P1|COMPLETED|Overall Study||3
8470084|NCT00662207|20872090|P1|STARTED|Overall Study||3
8470085|NCT00662155|20872101|P4|NOT COMPLETED|Overall Study||4
8470086|NCT00662155|20872102|P3|NOT COMPLETED|Overall Study||7
8470087|NCT00662155|20872103|P2|NOT COMPLETED|Overall Study||5
8470088|NCT00662155|20872104|P1|NOT COMPLETED|Overall Study||3
8470089|NCT00662155|20872101|P4|COMPLETED|Overall Study||14
8470090|NCT00662155|20872102|P3|COMPLETED|Overall Study||13
8470091|NCT00662155|20872103|P2|COMPLETED|Overall Study||15
8470092|NCT00662155|20872104|P1|COMPLETED|Overall Study||13
8470093|NCT00662155|20872101|P4|STARTED|Overall Study||18
8470094|NCT00662155|20872102|P3|STARTED|Overall Study||20
8470095|NCT00662155|20872103|P2|STARTED|Overall Study||20
8470096|NCT00662155|20872104|P1|STARTED|Overall Study||16
8470097|NCT00662129|20872118|P1|NOT COMPLETED|Overall Study||3
8470098|NCT00662129|20872118|P1|COMPLETED|Overall Study||47
8470099|NCT00662129|20872118|P1|STARTED|Overall Study||50
8470100|NCT00662038|20872128|P1|NOT COMPLETED|Overall Study||631
8470101|NCT00662038|20872128|P1|COMPLETED|Overall Study||427
8470102|NCT00662038|20872128|P1|STARTED|Overall Study||1058
8470103|NCT00662025|20872132|P1|NOT COMPLETED|Overall Study||63
8470104|NCT00662025|20872132|P1|COMPLETED|Overall Study||0
8470105|NCT00662025|20872132|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
8470109|NCT00661999|20872160|P3|NOT COMPLETED|Overall Study||57
8470110|NCT00661999|20872161|P2|NOT COMPLETED|Overall Study||50
8470111|NCT00661999|20872162|P1|NOT COMPLETED|Overall Study||59
8470112|NCT00661999|20872160|P3|COMPLETED|Overall Study||106
8470113|NCT00661999|20872161|P2|COMPLETED|Overall Study||113
8470114|NCT00661999|20872162|P1|COMPLETED|Overall Study||105
8470115|NCT00661999|20872160|P3|STARTED|Overall Study||163
8470116|NCT00661999|20872161|P2|STARTED|Overall Study||163
8470117|NCT00661999|20872162|P1|STARTED|Overall Study||164
8470118|NCT00661960|20872218|P3|NOT COMPLETED|Overall Study||1
8470119|NCT00661960|20872219|P2|NOT COMPLETED|Overall Study||3
8470120|NCT00661960|20872220|P1|NOT COMPLETED|Overall Study||0
8470121|NCT00661960|20872218|P3|COMPLETED|Overall Study||9
8470122|NCT00661960|20872219|P2|COMPLETED|Overall Study||7
8470123|NCT00661960|20872220|P1|COMPLETED|Overall Study||5
8470124|NCT00661960|20872218|P3|STARTED|Overall Study||10
8470125|NCT00661960|20872219|P2|STARTED|Overall Study||10
8470126|NCT00661960|20872220|P1|STARTED|Overall Study||5
8470127|NCT00661895|20872230|P2|NOT COMPLETED|Overall Study||0
8470128|NCT00661895|20872231|P1|NOT COMPLETED|Overall Study||0
8470129|NCT00661895|20872230|P2|COMPLETED|Overall Study||50
8470130|NCT00661895|20872231|P1|COMPLETED|Overall Study||49
8470131|NCT00661895|20872230|P2|STARTED|Overall Study||50
8470132|NCT00661895|20872231|P1|STARTED|Overall Study||49
8470133|NCT00661830|20872239|P2|NOT COMPLETED|Overall Study||42
8470134|NCT00661830|20872240|P1|NOT COMPLETED|Overall Study||40
8470135|NCT00661830|20872239|P2|COMPLETED|Overall Study||6
8470136|NCT00661830|20872240|P1|COMPLETED|Overall Study||9
8470137|NCT00661830|20872239|P2|STARTED|Overall Study||48
8470138|NCT00661830|20872240|P1|STARTED|Overall Study||49
8470139|NCT00661778|20872252|P1|NOT COMPLETED|Overall Study||50
8470140|NCT00661778|20872252|P1|COMPLETED|Overall Study||0
8470141|NCT00661778|20872252|P1|STARTED|Overall Study||50
8470142|NCT00661726|20872259|P1|NOT COMPLETED|Overall Study||1
8470143|NCT00661726|20872259|P1|COMPLETED|Overall Study||5
8470144|NCT00661726|20872259|P1|STARTED|Overall Study||6
8470145|NCT00661713|20872282|P8|NOT COMPLETED|Overall Study||11
8470146|NCT00661713|20872283|P7|NOT COMPLETED|Overall Study||64
8470147|NCT00661713|20872284|P6|NOT COMPLETED|Overall Study||37
8470148|NCT00661713|20872285|P5|NOT COMPLETED|Overall Study||20
8470149|NCT00661713|20872286|P4|NOT COMPLETED|Overall Study||28
8470150|NCT00661713|20872287|P3|NOT COMPLETED|Overall Study||17
8470151|NCT00661713|20872288|P2|NOT COMPLETED|Overall Study||39
8470152|NCT00661713|20872289|P1|NOT COMPLETED|Overall Study||16
8470153|NCT00661713|20872282|P8|COMPLETED|Overall Study||117
8470154|NCT00661713|20872283|P7|COMPLETED|Overall Study||309
8470155|NCT00661713|20872284|P6|COMPLETED|Overall Study||216
8470156|NCT00661713|20872285|P5|COMPLETED|Overall Study||107
8470157|NCT00661713|20872286|P4|COMPLETED|Overall Study||219
8470158|NCT00661713|20872287|P3|COMPLETED|Overall Study||111
8470159|NCT00661713|20872288|P2|COMPLETED|Overall Study||208
8470160|NCT00661713|20872289|P1|COMPLETED|Overall Study||112
8470161|NCT00661713|20872282|P8|STARTED|Overall Study||128
8470162|NCT00661713|20872283|P7|STARTED|Overall Study||373
8470163|NCT00661713|20872284|P6|STARTED|Overall Study||253
8470164|NCT00661713|20872285|P5|STARTED|Overall Study||127
8470165|NCT00661713|20872286|P4|STARTED|Overall Study||247
8470166|NCT00661713|20872287|P3|STARTED|Overall Study||128
8470167|NCT00661713|20872288|P2|STARTED|Overall Study||247
8470168|NCT00661713|20872289|P1|STARTED|Overall Study||128
8470169|NCT00661687|20872381|P1|NOT COMPLETED|Overall Study||15
8470170|NCT00661687|20872381|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
8470171|NCT00661687|20872381|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
8470172|NCT00661674|20872391|P6|NOT COMPLETED|Overall Study||0
8470173|NCT00661674|20872392|P5|NOT COMPLETED|Overall Study||0
8470174|NCT00661674|20872393|P4|NOT COMPLETED|Overall Study||0
8470175|NCT00661674|20872394|P3|NOT COMPLETED|Overall Study||0
8470176|NCT00661674|20872395|P2|NOT COMPLETED|Overall Study||0
8470177|NCT00661674|20872396|P1|NOT COMPLETED|Overall Study||0
8470178|NCT00661674|20872391|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
8470179|NCT00661674|20872392|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
8470180|NCT00661674|20872393|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
8470181|NCT00661674|20872394|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
8470182|NCT00661674|20872395|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
8470183|NCT00661674|20872396|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
8470184|NCT00661674|20872391|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
8470185|NCT00661674|20872392|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
8470186|NCT00661674|20872393|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
8470187|NCT00661674|20872394|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
8470188|NCT00661674|20872395|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
8470189|NCT00661674|20872396|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
8470190|NCT00661661|20872409|P2|NOT COMPLETED|Overall Study||39
8470191|NCT00661661|20872410|P1|NOT COMPLETED|Overall Study||140
8470192|NCT00661661|20872409|P2|COMPLETED|Overall Study||66
8470193|NCT00661661|20872410|P1|COMPLETED|Overall Study||242
8470194|NCT00661661|20872409|P2|STARTED|Overall Study||105
8470195|NCT00661661|20872410|P1|STARTED|Overall Study||382
8470196|NCT00661622|20872486|P2|NOT COMPLETED|Overall Study||0
8470197|NCT00661622|20872487|P1|NOT COMPLETED|Overall Study||1
8470198|NCT00661622|20872486|P2|COMPLETED|Overall Study||27
8470199|NCT00661622|20872487|P1|COMPLETED|Overall Study||25
8470200|NCT00661622|20872486|P2|STARTED|Overall Study||27
8470201|NCT00661622|20872487|P1|STARTED|Overall Study||26
8470202|NCT00661609|20872501|P1|NOT COMPLETED|Overall Study||41
8470203|NCT00661609|20872501|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8470204|NCT00661609|20872501|P1|STARTED|Overall Study|All dosed patients|41
8470205|NCT00661583|20872511|P3|NOT COMPLETED|Overall Study||0
8470206|NCT00661583|20872512|P2|NOT COMPLETED|Overall Study||0
8470207|NCT00661583|20872513|P1|NOT COMPLETED|Overall Study||0
8470208|NCT00661583|20872511|P3|COMPLETED|Overall Study||10
8470209|NCT00661583|20872512|P2|COMPLETED|Overall Study||10
8470210|NCT00661583|20872513|P1|COMPLETED|Overall Study||10
8470211|NCT00661583|20872511|P3|STARTED|Overall Study||10
8470212|NCT00661583|20872512|P2|STARTED|Overall Study||10
8470213|NCT00661583|20872513|P1|STARTED|Overall Study||10
8470214|NCT00661570|20872530|P1|NOT COMPLETED|Overall Study||0
8470215|NCT00661570|20872530|P1|COMPLETED|Overall Study||26
8470216|NCT00661570|20872530|P1|STARTED|Overall Study||26
8470217|NCT00661557|20872539|P2|NOT COMPLETED|Overall Study||0
8470218|NCT00661557|20872540|P1|NOT COMPLETED|Overall Study||9
8470219|NCT00661557|20872539|P2|COMPLETED|Overall Study||79
8470220|NCT00661557|20872540|P1|COMPLETED|Overall Study||183
8470221|NCT00661557|20872539|P2|STARTED|Overall Study||79
8470222|NCT00661557|20872540|P1|STARTED|Overall Study||192
8470223|NCT00661544|20872564|P1|NOT COMPLETED|Overall Study||0
8470224|NCT00661544|20872564|P1|COMPLETED|Overall Study||48
8470225|NCT00661544|20872564|P1|STARTED|Overall Study||48
8470226|NCT00661531|20872568|P1|NOT COMPLETED|Overall Study||3
8470227|NCT00661531|20872568|P1|COMPLETED|Overall Study||8
8470228|NCT00661531|20872568|P1|STARTED|Overall Study||11
8470229|NCT00661505|20872573|P1|NOT COMPLETED|Overall Study||30
8470230|NCT00661505|20872573|P1|COMPLETED|Overall Study||102
8470231|NCT00661505|20872573|P1|STARTED|Overall Study||132
8470232|NCT00661492|20872601|P2|NOT COMPLETED|Overall Study||29
8470233|NCT00661492|20872602|P1|NOT COMPLETED|Overall Study||68
8470234|NCT00661492|20872601|P2|COMPLETED|Overall Study||11
8470235|NCT00661492|20872602|P1|COMPLETED|Overall Study||7
8470236|NCT00661492|20872601|P2|STARTED|Overall Study||40
8470237|NCT00661492|20872602|P1|STARTED|Overall Study||75
8470238|NCT00661479|20872626|P4|NOT COMPLETED|Overall Study||0
8470239|NCT00661479|20872627|P3|NOT COMPLETED|Overall Study||0
8470240|NCT00661479|20872628|P2|NOT COMPLETED|Overall Study||0
8470241|NCT00661479|20872629|P1|NOT COMPLETED|Overall Study||0
8470242|NCT00661479|20872626|P4|COMPLETED|Overall Study||3
8470243|NCT00661479|20872627|P3|COMPLETED|Overall Study||3
8470244|NCT00661479|20872628|P2|COMPLETED|Overall Study||3
8470245|NCT00661479|20872629|P1|COMPLETED|Overall Study||12
8470246|NCT00661479|20872626|P4|STARTED|Overall Study||3
8470247|NCT00661479|20872627|P3|STARTED|Overall Study||3
8470248|NCT00661479|20872628|P2|STARTED|Overall Study||3
8470249|NCT00661479|20872629|P1|STARTED|Overall Study||12
8470250|NCT00661466|20872644|P2|NOT COMPLETED|Overall Study||0
8470251|NCT00661466|20872645|P1|NOT COMPLETED|Overall Study||0
8470252|NCT00661466|20872644|P2|COMPLETED|Overall Study|Participants|3
8470253|NCT00661466|20872645|P1|COMPLETED|Overall Study|Participants|4
8470254|NCT00661466|20872644|P2|STARTED|Overall Study|Participants|3
8470255|NCT00661466|20872645|P1|STARTED|Overall Study|Participants|4
8470256|NCT00661453|20872671|P1|NOT COMPLETED|Overall Study||13
8470257|NCT00661453|20872671|P1|COMPLETED|Overall Study||25
8470258|NCT00661453|20872671|P1|STARTED|Overall Study||38
8470259|NCT00661427|20872677|P2|NOT COMPLETED|Overall Study||7
8470260|NCT00661427|20872678|P1|NOT COMPLETED|Overall Study||5
8470261|NCT00661427|20872677|P2|COMPLETED|Overall Study||19
8470262|NCT00661427|20872678|P1|COMPLETED|Overall Study||30
8470263|NCT00661427|20872677|P2|STARTED|Overall Study||26
8470264|NCT00661427|20872678|P1|STARTED|Overall Study||35
8470265|NCT00661388|20872686|P1|NOT COMPLETED|Overall Study||24
8470266|NCT00661388|20872686|P1|COMPLETED|Overall Study||51
8470267|NCT00661388|20872686|P1|STARTED|Overall Study||75
8470268|NCT00661362|20872709|P2|NOT COMPLETED|Overall Study||40
8470269|NCT00661362|20872710|P1|NOT COMPLETED|Overall Study||29
8470270|NCT00661362|20872709|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
8470271|NCT00661362|20872710|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
8470272|NCT00661362|20872709|P2|STARTED|Overall Study|Randomized and treated|287
8470273|NCT00661362|20872710|P1|STARTED|Overall Study|Randomized and treated|283
8470274|NCT00661271|20872728|P2|NOT COMPLETED|Overall Study||25
8470275|NCT00661271|20872729|P1|NOT COMPLETED|Overall Study||28
8470276|NCT00661271|20872728|P2|COMPLETED|Overall Study||20
8470277|NCT00661271|20872729|P1|COMPLETED|Overall Study||20
8470278|NCT00661271|20872728|P2|STARTED|Overall Study||45
8470279|NCT00661271|20872729|P1|STARTED|Overall Study||48
8470280|NCT00661258|20872739|P2|NOT COMPLETED|Overall Study||1
8470281|NCT00661258|20872740|P1|NOT COMPLETED|Overall Study||3
8470282|NCT00661258|20872739|P2|COMPLETED|Overall Study||33
8470283|NCT00661258|20872740|P1|COMPLETED|Overall Study||31
8470284|NCT00661258|20872739|P2|STARTED|Overall Study||34
8470285|NCT00661258|20872740|P1|STARTED|Overall Study||34
8470286|NCT00661193|20872750|P2|NOT COMPLETED|Overall Study||26
8470287|NCT00661193|20872751|P1|NOT COMPLETED|Overall Study||33
8470288|NCT00661193|20872750|P2|COMPLETED|Overall Study||0
8470289|NCT00661193|20872751|P1|COMPLETED|Overall Study||0
8470290|NCT00661193|20872750|P2|STARTED|Overall Study||26
8470291|NCT00661193|20872751|P1|STARTED|Overall Study||33
8470292|NCT00661141|20872762|P6|NOT COMPLETED|Overall Study||0
8470293|NCT00661141|20872763|P5|NOT COMPLETED|Overall Study||0
8470294|NCT00661141|20872764|P4|NOT COMPLETED|Overall Study||0
8470295|NCT00661141|20872765|P3|NOT COMPLETED|Overall Study||0
8470296|NCT00661141|20872766|P2|NOT COMPLETED|Overall Study||0
8470297|NCT00661141|20872767|P1|NOT COMPLETED|Overall Study||0
8470298|NCT00661141|20872762|P6|COMPLETED|Overall Study||4
8470299|NCT00661141|20872763|P5|COMPLETED|Overall Study||4
8470300|NCT00661141|20872764|P4|COMPLETED|Overall Study||4
8470301|NCT00661141|20872765|P3|COMPLETED|Overall Study||4
8470302|NCT00661141|20872766|P2|COMPLETED|Overall Study||8
8470303|NCT00661141|20872767|P1|COMPLETED|Overall Study||8
8470304|NCT00661141|20872762|P6|Administered 30 Minutes After Ethanol|Overall Study||0
8470305|NCT00661141|20872763|P5|Administered 30 Minutes After Ethanol|Overall Study||0
8470306|NCT00661141|20872764|P4|Administered 30 Minutes After Ethanol|Overall Study||2
8470307|NCT00661141|20872765|P3|Administered 30 Minutes After Ethanol|Overall Study||2
8470308|NCT00661141|20872766|P2|Administered 30 Minutes After Ethanol|Overall Study||2
8470309|NCT00661141|20872767|P1|Administered 30 Minutes After Ethanol|Overall Study||2
8470310|NCT00661141|20872762|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
8470311|NCT00661141|20872763|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
8470312|NCT00661141|20872764|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
8470313|NCT00661141|20872765|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
8470314|NCT00661141|20872766|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
8470315|NCT00661141|20872767|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
8470316|NCT00661141|20872762|P6|STARTED|Overall Study||4
8470317|NCT00661141|20872763|P5|STARTED|Overall Study||4
8470318|NCT00661141|20872764|P4|STARTED|Overall Study||4
8470319|NCT00661141|20872765|P3|STARTED|Overall Study||4
8470320|NCT00661141|20872766|P2|STARTED|Overall Study||8
8470321|NCT00661141|20872767|P1|STARTED|Overall Study||8
8470322|NCT00661089|20872976|P2|NOT COMPLETED|Overall Study||2
8470323|NCT00661089|20872977|P1|NOT COMPLETED|Overall Study||0
8470324|NCT00661089|20872976|P2|COMPLETED|Overall Study||9
8470325|NCT00661089|20872977|P1|COMPLETED|Overall Study||10
8470326|NCT00661089|20872976|P2|STARTED|Overall Study||11
8470327|NCT00661089|20872977|P1|STARTED|Overall Study||10
8470328|NCT00661037|20872987|P2|NOT COMPLETED|Overall Study||257
8470329|NCT00661037|20872988|P1|NOT COMPLETED|Overall Study||154
8470330|NCT00661037|20872987|P2|COMPLETED|Overall Study||1027
8470331|NCT00661037|20872988|P1|COMPLETED|Overall Study||682
8470332|NCT00661037|20872987|P2|Deaths|Overall Study||188
8470333|NCT00661037|20872988|P1|Deaths|Overall Study||108
8470334|NCT00661037|20872987|P2|Witdrawn|Overall Study||68
8470335|NCT00661037|20872988|P1|Witdrawn|Overall Study||47
8470336|NCT00661037|20872987|P2|STARTED|Overall Study||1284
8470337|NCT00661037|20872988|P1|STARTED|Overall Study||836
8470344|NCT00660907|20873025|P2|NOT COMPLETED|Overall Study||94
8470345|NCT00660907|20873026|P1|NOT COMPLETED|Overall Study||84
8470346|NCT00660907|20873025|P2|COMPLETED|Overall Study||314
8470347|NCT00660907|20873026|P1|COMPLETED|Overall Study||322
8470348|NCT00660907|20873025|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
8470349|NCT00660907|20873026|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
8470350|NCT00660829|20873040|P2|NOT COMPLETED|Overall Study||19
8470351|NCT00660829|20873041|P1|NOT COMPLETED|Overall Study||18
8470352|NCT00660829|20873040|P2|COMPLETED|Overall Study||249
8470353|NCT00660829|20873041|P1|COMPLETED|Overall Study||250
8470354|NCT00660829|20873040|P2|STARTED|Overall Study|2 subjects were randomized in error|268
8470355|NCT00660829|20873041|P1|STARTED|Overall Study|2 subjects were randomized in error|268
8470356|NCT00660816|20873059|P2|NOT COMPLETED|Overall Study||19
8470357|NCT00660816|20873060|P1|NOT COMPLETED|Overall Study||20
8470358|NCT00660816|20873059|P2|COMPLETED|Overall Study||3
8470359|NCT00660816|20873060|P1|COMPLETED|Overall Study||4
8470360|NCT00660816|20873059|P2|STARTED|Overall Study||22
8470361|NCT00660816|20873060|P1|STARTED|Overall Study||24
8470362|NCT00660790|20873072|P1|NOT COMPLETED|3 Months to 2 Years||17
8470363|NCT00660790|20873072|P1|COMPLETED|3 Months to 2 Years||77
8470364|NCT00660790|20873072|P1|STARTED|3 Months to 2 Years||94
8470365|NCT00660790|20873072|P1|NOT COMPLETED|Baseline to 3 Months||3
8470366|NCT00660790|20873072|P1|COMPLETED|Baseline to 3 Months||94
8470367|NCT00660790|20873072|P1|STARTED|Baseline to 3 Months||97
8470368|NCT00660699|20873076|P1|NOT COMPLETED|Overall Study||2
8470369|NCT00660699|20873076|P1|COMPLETED|Overall Study||48
8470370|NCT00660699|20873076|P1|STARTED|Overall Study||50
8470371|NCT00660660|20873092|P2|NOT COMPLETED|Overall Study||9
8470372|NCT00660660|20873093|P1|NOT COMPLETED|Overall Study||5
8470373|NCT00660660|20873092|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
8470374|NCT00660660|20873093|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
8470375|NCT00660660|20873092|P2|Met Criteria for MITT Population|Overall Study||125
8470376|NCT00660660|20873093|P1|Met Criteria for MITT Population|Overall Study||137
8470377|NCT00660660|20873092|P2|STARTED|Overall Study|Randomized|133
8470378|NCT00660660|20873093|P1|STARTED|Overall Study|Randomized|143
8470379|NCT00660595|20873193|P2|NOT COMPLETED|Overall Study||9
8470380|NCT00660595|20873194|P1|NOT COMPLETED|Overall Study||18
8470381|NCT00660595|20873193|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
8470382|NCT00660595|20873194|P1|COMPLETED|Overall Study||1
8470383|NCT00660595|20873193|P2|STARTED|Overall Study||10
8470384|NCT00660595|20873194|P1|STARTED|Overall Study||19
8470385|NCT00660543|20873206|P1|NOT COMPLETED|Overall Study||0
8470386|NCT00660543|20873206|P1|COMPLETED|Overall Study||14
8470387|NCT00660543|20873206|P1|STARTED|Overall Study||14
8470388|NCT00660530|20873215|P1|NOT COMPLETED|Overall Study||0
8470389|NCT00660530|20873215|P1|COMPLETED|Overall Study||11
8470390|NCT00660530|20873215|P1|STARTED|Overall Study||11
8470391|NCT00660517|20873225|P4|NOT COMPLETED|Overall Study||7
8470392|NCT00660517|20873226|P3|NOT COMPLETED|Overall Study||7
8470393|NCT00660517|20873227|P2|NOT COMPLETED|Overall Study||8
8470394|NCT00660517|20873228|P1|NOT COMPLETED|Overall Study||8
8470395|NCT00660517|20873225|P4|COMPLETED|Overall Study||144
8470396|NCT00660517|20873226|P3|COMPLETED|Overall Study||144
8470397|NCT00660517|20873227|P2|COMPLETED|Overall Study||144
8470398|NCT00660517|20873228|P1|COMPLETED|Overall Study||145
8470399|NCT00660517|20873225|P4|STARTED|Overall Study||151
8470400|NCT00660517|20873226|P3|STARTED|Overall Study||151
8470401|NCT00660517|20873227|P2|STARTED|Overall Study||152
8470402|NCT00660517|20873228|P1|STARTED|Overall Study||153
8470403|NCT00660504|20873248|P2|NOT COMPLETED|Overall Study||1
8470404|NCT00660504|20873249|P1|NOT COMPLETED|Overall Study||0
8470405|NCT00660504|20873248|P2|COMPLETED|Overall Study||150
8470406|NCT00660504|20873249|P1|COMPLETED|Overall Study||149
8470407|NCT00660504|20873248|P2|STARTED|Overall Study||151
8470408|NCT00660504|20873249|P1|STARTED|Overall Study||149
8470409|NCT00660400|20873261|P1|NOT COMPLETED|Overall Study||4
8470410|NCT00660400|20873261|P1|COMPLETED|Overall Study||21
8470411|NCT00660400|20873261|P1|STARTED|Overall Study||25
8470412|NCT00660387|20873270|P2|NOT COMPLETED|Overall Study||3
8470413|NCT00660387|20873271|P1|NOT COMPLETED|Overall Study||2
8470414|NCT00660387|20873270|P2|COMPLETED|Overall Study||31
8470415|NCT00660387|20873271|P1|COMPLETED|Overall Study||35
8470416|NCT00660387|20873270|P2|STARTED|Overall Study||34
8470417|NCT00660387|20873271|P1|STARTED|Overall Study||37
8470418|NCT00660348|20873325|P2|NOT COMPLETED|Overall Study||0
8470419|NCT00660348|20873326|P1|NOT COMPLETED|Overall Study||1
8470420|NCT00660348|20873325|P2|COMPLETED|Overall Study||0
8470421|NCT00660348|20873326|P1|COMPLETED|Overall Study||0
8470422|NCT00660348|20873325|P2|STARTED|Overall Study||0
8470423|NCT00660348|20873326|P1|STARTED|Overall Study||1
8470424|NCT00660309|20873334|P2|NOT COMPLETED|Overall Study||3
8470425|NCT00660309|20873335|P1|NOT COMPLETED|Overall Study||2
8470426|NCT00660309|20873334|P2|COMPLETED|Overall Study||19
8470427|NCT00660309|20873335|P1|COMPLETED|Overall Study||21
8470428|NCT00660309|20873334|P2|Pharmacodynamic Analysis Set|Overall Study||20
8470429|NCT00660309|20873335|P1|Pharmacodynamic Analysis Set|Overall Study||22
8470430|NCT00660309|20873334|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
8470431|NCT00660309|20873335|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
8470432|NCT00660309|20873334|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
8470433|NCT00660309|20873335|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
8470434|NCT00660192|20873376|P2|NOT COMPLETED|Overall Study||3
8470435|NCT00660192|20873377|P1|NOT COMPLETED|Overall Study||2
8470436|NCT00660192|20873376|P2|COMPLETED|Overall Study||10
8470437|NCT00660192|20873377|P1|COMPLETED|Overall Study||10
8470438|NCT00660192|20873376|P2|STARTED|Overall Study||13
8470439|NCT00660192|20873377|P1|STARTED|Overall Study||12
8470440|NCT00660179|20873388|P3|NOT COMPLETED|Overall Study||41
8470441|NCT00660179|20873389|P2|NOT COMPLETED|Overall Study||58
8470442|NCT00660179|20873390|P1|NOT COMPLETED|Overall Study||56
8470443|NCT00660179|20873388|P3|COMPLETED|Overall Study||201
8470444|NCT00660179|20873389|P2|COMPLETED|Overall Study||192
8470445|NCT00660179|20873390|P1|COMPLETED|Overall Study||194
8470446|NCT00660179|20873388|P3|STARTED|Overall Study||242
8470447|NCT00660179|20873389|P2|STARTED|Overall Study||250
8470448|NCT00660179|20873390|P1|STARTED|Overall Study||250
8470449|NCT00660075|20873424|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
8470450|NCT00660075|20873425|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
8470451|NCT00660075|20873424|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
8470452|NCT00660075|20873425|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
8470453|NCT00660075|20873424|P2|STARTED|Second Intervention (Week 11 to Week 16||18
8470454|NCT00660075|20873425|P1|STARTED|Second Intervention (Week 11 to Week 16||18
8470455|NCT00660075|20873424|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
8470456|NCT00660075|20873425|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
8470457|NCT00660075|20873424|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
8470458|NCT00660075|20873425|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
8470459|NCT00660075|20873424|P2|STARTED|Washout Period (Week 7 to Week 10)||18
8470460|NCT00660075|20873425|P1|STARTED|Washout Period (Week 7 to Week 10)||18
8470461|NCT00660075|20873424|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
8470462|NCT00660075|20873425|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
8470463|NCT00660075|20873424|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
8470464|NCT00660075|20873425|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
8470465|NCT00660075|20873424|P2|STARTED|First Intervention (Week 1 to Week 6)||18
8470466|NCT00660075|20873425|P1|STARTED|First Intervention (Week 1 to Week 6)||18
8470467|NCT00660049|20873431|P1|NOT COMPLETED|Overall Study||6
8470468|NCT00660049|20873431|P1|COMPLETED|Overall Study||6
8470469|NCT00660049|20873431|P1|STARTED|Overall Study||12
8470470|NCT00660023|20873435|P1|NOT COMPLETED|Overall Study||29
8470471|NCT00660023|20873435|P1|COMPLETED|Overall Study||95
8470472|NCT00660023|20873435|P1|Treated|Overall Study||114
8470473|NCT00660023|20873435|P1|STARTED|Overall Study||124
8470474|NCT00660010|20873446|P1|NOT COMPLETED|Overall Study||9
8470475|NCT00660010|20873446|P1|COMPLETED|Overall Study||46
8470476|NCT00660010|20873446|P1|STARTED|Overall Study||55
8470477|NCT00659984|20873460|P1|NOT COMPLETED|Overall Study||1
8470478|NCT00659984|20873460|P1|COMPLETED|Overall Study||14
8470479|NCT00659984|20873460|P1|STARTED|Overall Study||15
8470480|NCT00659945|20873473|P2|NOT COMPLETED|Overall Study||0
8470481|NCT00659945|20873474|P1|NOT COMPLETED|Overall Study||0
8470482|NCT00659945|20873473|P2|COMPLETED|Overall Study||75
8470483|NCT00659945|20873474|P1|COMPLETED|Overall Study||75
8470484|NCT00659945|20873473|P2|STARTED|Overall Study||75
8470485|NCT00659945|20873474|P1|STARTED|Overall Study||75
8470486|NCT00659880|20873480|P1|NOT COMPLETED|Overall Study||5
8470487|NCT00659880|20873480|P1|COMPLETED|Overall Study|60 months|4
8470488|NCT00659880|20873480|P1|24 Months|Overall Study||6
8470489|NCT00659880|20873480|P1|12 Months|Overall Study||7
8470490|NCT00659880|20873480|P1|6 Months|Overall Study||9
8470491|NCT00659880|20873480|P1|6 Weeks|Overall Study||9
8470492|NCT00659880|20873480|P1|STARTED|Overall Study||9
8470493|NCT00659828|20873485|P1|NOT COMPLETED|Overall Study||0
8470494|NCT00659828|20873485|P1|COMPLETED|Overall Study||1
8470495|NCT00659828|20873485|P1|STARTED|Overall Study||1
8470496|NCT00659815|20873493|P2|NOT COMPLETED|Overall Study||4
8470497|NCT00659815|20873494|P1|NOT COMPLETED|Overall Study||4
8470498|NCT00659815|20873493|P2|COMPLETED|Overall Study||147
8470499|NCT00659815|20873494|P1|COMPLETED|Overall Study||153
8470500|NCT00659815|20873493|P2|STARTED|Overall Study||151
8470501|NCT00659815|20873494|P1|STARTED|Overall Study||157
8470502|NCT00659802|20873507|P3|NOT COMPLETED|Overall Study||11
8470503|NCT00659802|20873508|P2|NOT COMPLETED|Overall Study||18
8470504|NCT00659802|20873509|P1|NOT COMPLETED|Overall Study||15
8470505|NCT00659802|20873507|P3|COMPLETED|Overall Study||64
8470506|NCT00659802|20873508|P2|COMPLETED|Overall Study||57
8470507|NCT00659802|20873509|P1|COMPLETED|Overall Study||59
8470508|NCT00659802|20873507|P3|STARTED|Overall Study||75
8470509|NCT00659802|20873508|P2|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
8470510|NCT00659802|20873509|P1|STARTED|Overall Study||74
8470511|NCT00659789|20873525|P2|NOT COMPLETED|Overall Study||7
8470512|NCT00659789|20873526|P1|NOT COMPLETED|Overall Study||7
8470513|NCT00659789|20873525|P2|COMPLETED|Overall Study||36
8470514|NCT00659789|20873526|P1|COMPLETED|Overall Study||86
8470515|NCT00659789|20873525|P2|STARTED|Overall Study||43
8470516|NCT00659789|20873526|P1|STARTED|Overall Study||93
8470517|NCT00659737|20873544|P2|NOT COMPLETED|Overall Study||0
8470518|NCT00659737|20873545|P1|NOT COMPLETED|Overall Study||0
8470519|NCT00659737|20873544|P2|COMPLETED|Overall Study||58
8470520|NCT00659737|20873545|P1|COMPLETED|Overall Study||57
8470521|NCT00659737|20873544|P2|STARTED|Overall Study||58
8470522|NCT00659737|20873545|P1|STARTED|Overall Study||57
8470523|NCT00659724|20873551|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
8470524|NCT00659724|20873551|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
8470525|NCT00659724|20873551|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
8470526|NCT00659724|20873551|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
8470527|NCT00659724|20873551|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
8470528|NCT00659724|20873551|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
8470529|NCT00659633|20873569|P1|NOT COMPLETED|Overall Study||0
8470530|NCT00659633|20873569|P1|COMPLETED|Overall Study||10
8470531|NCT00659633|20873569|P1|STARTED|Overall Study||10
8470532|NCT00659607|20873573|P1|NOT COMPLETED|Overall Study||316
8470533|NCT00659607|20873573|P1|COMPLETED|Overall Study||3616
8470534|NCT00659607|20873573|P1|STARTED|Overall Study||3932
8470535|NCT00659581|20873591|P1|NOT COMPLETED|Overall Study||8582
8470536|NCT00659581|20873591|P1|COMPLETED|Overall Study||12412
8470537|NCT00659581|20873591|P1|STARTED|Overall Study||20994
8470538|NCT00659529|20873603|P1|NOT COMPLETED|Overall Study||16
8470539|NCT00659529|20873603|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
8470540|NCT00659529|20873603|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
8470541|NCT00659529|20873603|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
8470542|NCT00659490|20873610|P3|NOT COMPLETED|Overall Study||1
8470543|NCT00659490|20873611|P2|NOT COMPLETED|Overall Study||0
8470544|NCT00659490|20873612|P1|NOT COMPLETED|Overall Study||2
8470545|NCT00659490|20873610|P3|COMPLETED|Overall Study||30
8470546|NCT00659490|20873611|P2|COMPLETED|Overall Study||59
8470547|NCT00659490|20873612|P1|COMPLETED|Overall Study||59
8470548|NCT00659490|20873610|P3|STARTED|Overall Study||31
8470549|NCT00659490|20873611|P2|STARTED|Overall Study||59
8470550|NCT00659490|20873612|P1|STARTED|Overall Study||61
8470551|NCT00659438|20873685|P2|NOT COMPLETED|Overall Study||8
8470552|NCT00659438|20873686|P1|NOT COMPLETED|Overall Study||14
8470553|NCT00659438|20873685|P2|COMPLETED|Overall Study||40
8470554|NCT00659438|20873686|P1|COMPLETED|Overall Study||33
8470555|NCT00659438|20873685|P2|Safety Analysis Set|Overall Study||47
8470556|NCT00659438|20873686|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
8470557|NCT00659438|20873685|P2|Secondary Analysis Set|Overall Study||48
8470558|NCT00659438|20873686|P1|Secondary Analysis Set|Overall Study||47
8470559|NCT00659438|20873685|P2|Assessable Set : Primary Analysis|Overall Study||45
8470560|NCT00659438|20873686|P1|Assessable Set : Primary Analysis|Overall Study||44
8470561|NCT00659438|20873685|P2|STARTED|Overall Study||48
8470562|NCT00659438|20873686|P1|STARTED|Overall Study||47
8470563|NCT00659425|20873718|P10|NOT COMPLETED|Overall Study||13
8470564|NCT00659425|20873719|P9|NOT COMPLETED|Overall Study||6
8470565|NCT00659425|20873720|P8|NOT COMPLETED|Overall Study||11
8470566|NCT00659425|20873721|P7|NOT COMPLETED|Overall Study||8
8470567|NCT00659425|20873722|P6|NOT COMPLETED|Overall Study||4
8470568|NCT00659425|20873723|P5|NOT COMPLETED|Overall Study||4
8470569|NCT00659425|20873724|P4|NOT COMPLETED|Overall Study||4
8470570|NCT00659425|20873725|P3|NOT COMPLETED|Overall Study||1
8470571|NCT00659425|20873726|P2|NOT COMPLETED|Overall Study||1
8470572|NCT00659425|20873727|P1|NOT COMPLETED|Overall Study||1
8470573|NCT00659425|20873718|P10|COMPLETED|Overall Study||1
8470574|NCT00659425|20873719|P9|COMPLETED|Overall Study||0
8470575|NCT00659425|20873720|P8|COMPLETED|Overall Study||0
8470576|NCT00659425|20873721|P7|COMPLETED|Overall Study||0
8470577|NCT00659425|20873722|P6|COMPLETED|Overall Study||1
8470578|NCT00659425|20873723|P5|COMPLETED|Overall Study||0
8470579|NCT00659425|20873724|P4|COMPLETED|Overall Study||0
8470580|NCT00659425|20873725|P3|COMPLETED|Overall Study||0
8470581|NCT00659425|20873726|P2|COMPLETED|Overall Study||0
8470582|NCT00659425|20873727|P1|COMPLETED|Overall Study||0
8470583|NCT00659425|20873718|P10|STARTED|Overall Study||14
8470584|NCT00659425|20873719|P9|STARTED|Overall Study||6
8470585|NCT00659425|20873720|P8|STARTED|Overall Study||11
8470586|NCT00659425|20873721|P7|STARTED|Overall Study||8
8470587|NCT00659425|20873722|P6|STARTED|Overall Study||5
8470588|NCT00659425|20873723|P5|STARTED|Overall Study||4
8470589|NCT00659425|20873724|P4|STARTED|Overall Study||4
8470590|NCT00659425|20873725|P3|STARTED|Overall Study||1
8470591|NCT00659425|20873726|P2|STARTED|Overall Study||1
8470592|NCT00659425|20873727|P1|STARTED|Overall Study||1
8470593|NCT00659373|20873958|P2|NOT COMPLETED|Overall Study||7
8470594|NCT00659373|20873959|P1|NOT COMPLETED|Overall Study||5
8470595|NCT00659373|20873958|P2|COMPLETED|Overall Study||54
8470596|NCT00659373|20873959|P1|COMPLETED|Overall Study||20
8470597|NCT00659373|20873958|P2|STARTED|Overall Study||61
8470598|NCT00659373|20873959|P1|STARTED|Overall Study||25
8470599|NCT00659360|20873965|P1|NOT COMPLETED|Overall Study||0
8470600|NCT00659360|20873965|P1|COMPLETED|Overall Study||17
8470601|NCT00659360|20873965|P1|STARTED|Overall Study||17
8470602|NCT00659334|20873981|P7|NOT COMPLETED|Overall Study||1
8470603|NCT00659334|20873982|P6|NOT COMPLETED|Overall Study||0
8470604|NCT00659334|20873983|P5|NOT COMPLETED|Overall Study||0
8470605|NCT00659334|20873984|P4|NOT COMPLETED|Overall Study||0
8470606|NCT00659334|20873985|P3|NOT COMPLETED|Overall Study||0
8470607|NCT00659334|20873986|P2|NOT COMPLETED|Overall Study||5
8470608|NCT00659334|20873987|P1|NOT COMPLETED|Overall Study||8
8470609|NCT00659334|20873981|P7|COMPLETED|Overall Study|1 screen failure|20
8470610|NCT00659334|20873982|P6|COMPLETED|Overall Study||0
8470611|NCT00659334|20873983|P5|COMPLETED|Overall Study||1
8470612|NCT00659334|20873984|P4|COMPLETED|Overall Study||2
8470613|NCT00659334|20873985|P3|COMPLETED|Overall Study||5
8470614|NCT00659334|20873986|P2|COMPLETED|Overall Study|5 Screen failures|36
8470615|NCT00659334|20873987|P1|COMPLETED|Overall Study|8 Screen failures|38
8470616|NCT00659334|20873981|P7|STARTED|Overall Study||21
8470617|NCT00659334|20873982|P6|STARTED|Overall Study||0
8470618|NCT00659334|20873983|P5|STARTED|Overall Study||1
8470619|NCT00659334|20873984|P4|STARTED|Overall Study||2
8470620|NCT00659334|20873985|P3|STARTED|Overall Study||5
8470621|NCT00659334|20873986|P2|STARTED|Overall Study||41
8470622|NCT00659334|20873987|P1|STARTED|Overall Study||46
8470623|NCT00659295|20874005|P2|NOT COMPLETED|Overall Study||5603
8470624|NCT00659295|20874006|P1|NOT COMPLETED|Overall Study||2708
8470625|NCT00659295|20874005|P2|COMPLETED|Overall Study||32038
8470626|NCT00659295|20874006|P1|COMPLETED|Overall Study||10821
8470627|NCT00659295|20874005|P2|STARTED|Overall Study||37641
8470628|NCT00659295|20874006|P1|STARTED|Overall Study||13529
8470629|NCT00659269|20874014|P2|NOT COMPLETED|Overall Study||1
8470630|NCT00659269|20874015|P1|NOT COMPLETED|Overall Study||1
8470631|NCT00659269|20874014|P2|COMPLETED|Overall Study||161
8470632|NCT00659269|20874015|P1|COMPLETED|Overall Study||156
8470633|NCT00659269|20874014|P2|Group 3 (Taxanes)|Overall Study||97
8470634|NCT00659269|20874015|P1|Group 3 (Taxanes)|Overall Study||92
8470635|NCT00659269|20874014|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
8470636|NCT00659269|20874015|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
8470637|NCT00659269|20874014|P2|Group 1 (Heavy Metals)|Overall Study||52
8470638|NCT00659269|20874015|P1|Group 1 (Heavy Metals)|Overall Study||52
8470639|NCT00659269|20874014|P2|STARTED|Overall Study||162
8470640|NCT00659269|20874015|P1|STARTED|Overall Study||157
8470641|NCT00659230|20874045|P2|NOT COMPLETED|Overall Study||12
8470642|NCT00659230|20874046|P1|NOT COMPLETED|Overall Study||9
8470643|NCT00659230|20874045|P2|COMPLETED|Overall Study||37
8470644|NCT00659230|20874046|P1|COMPLETED|Overall Study||42
8470645|NCT00659230|20874045|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
8470646|NCT00659230|20874046|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
8470647|NCT00659165|20874060|P2|NOT COMPLETED|Overall Study||0
8470648|NCT00659165|20874061|P1|NOT COMPLETED|Overall Study||0
8470649|NCT00659165|20874060|P2|COMPLETED|Overall Study||5
8470650|NCT00659165|20874061|P1|COMPLETED|Overall Study||5
8470651|NCT00659165|20874060|P2|STARTED|Overall Study||5
8470652|NCT00659165|20874061|P1|STARTED|Overall Study||5
8470653|NCT00659061|20874069|P2|NOT COMPLETED|Overall Study||15
8470654|NCT00659061|20874070|P1|NOT COMPLETED|Overall Study||21
8470655|NCT00659061|20874069|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
8470656|NCT00659061|20874070|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
8470657|NCT00659061|20874069|P2|STARTED|Overall Study||302
8470658|NCT00659061|20874070|P1|STARTED|Overall Study||308
8470659|NCT00658996|20874088|P2|NOT COMPLETED|Second Intervention||1
8470660|NCT00658996|20874089|P1|NOT COMPLETED|Second Intervention||1
8470661|NCT00658996|20874088|P2|COMPLETED|Second Intervention||104
8470662|NCT00658996|20874089|P1|COMPLETED|Second Intervention||105
8470663|NCT00658996|20874088|P2|STARTED|Second Intervention||105
8470664|NCT00658996|20874089|P1|STARTED|Second Intervention||106
8470665|NCT00658996|20874088|P2|NOT COMPLETED|Crossover Period||1
8470666|NCT00658996|20874089|P1|NOT COMPLETED|Crossover Period||2
8470667|NCT00658996|20874088|P2|COMPLETED|Crossover Period||105
8470668|NCT00658996|20874089|P1|COMPLETED|Crossover Period||106
8470669|NCT00658996|20874088|P2|STARTED|Crossover Period||106
8470670|NCT00658996|20874089|P1|STARTED|Crossover Period||108
8470671|NCT00658996|20874088|P2|NOT COMPLETED|First Intervention||1
8470672|NCT00658996|20874089|P1|NOT COMPLETED|First Intervention||1
8470673|NCT00658996|20874088|P2|COMPLETED|First Intervention||106
8470674|NCT00658996|20874089|P1|COMPLETED|First Intervention||108
8470675|NCT00658996|20874088|P2|STARTED|First Intervention||107
8470676|NCT00658996|20874089|P1|STARTED|First Intervention||109
8470677|NCT00658879|20874099|P1|NOT COMPLETED|Overall Study||1
8470678|NCT00658879|20874099|P1|COMPLETED|Overall Study||250
8470679|NCT00658879|20874099|P1|STARTED|Overall Study||251
8470680|NCT00658814|20874116|P2|NOT COMPLETED|Maintenance Therapy||1
8470681|NCT00658814|20874117|P1|NOT COMPLETED|Maintenance Therapy||3
8470682|NCT00658814|20874116|P2|COMPLETED|Maintenance Therapy||7
8470683|NCT00658814|20874117|P1|COMPLETED|Maintenance Therapy||17
8470684|NCT00658814|20874116|P2|Eligible|Maintenance Therapy||8
8470685|NCT00658814|20874117|P1|Eligible|Maintenance Therapy||19
8470686|NCT00658814|20874116|P2|STARTED|Maintenance Therapy||8
8470687|NCT00658814|20874117|P1|STARTED|Maintenance Therapy||20
8470688|NCT00658814|20874116|P2|NOT COMPLETED|Consolidation Therapy||3
8470689|NCT00658814|20874117|P1|NOT COMPLETED|Consolidation Therapy||2
8470690|NCT00658814|20874116|P2|COMPLETED|Consolidation Therapy||10
8470691|NCT00658814|20874117|P1|COMPLETED|Consolidation Therapy||22
8470692|NCT00658814|20874116|P2|Eligible|Consolidation Therapy||11
8470693|NCT00658814|20874117|P1|Eligible|Consolidation Therapy||22
8470694|NCT00658814|20874116|P2|STARTED|Consolidation Therapy||13
8470695|NCT00658814|20874117|P1|STARTED|Consolidation Therapy||24
8470696|NCT00658814|20874116|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
8470697|NCT00658814|20874117|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
8470698|NCT00658814|20874116|P2|COMPLETED|Remission Induction Chemotherapy||41
8470699|NCT00658814|20874117|P1|COMPLETED|Remission Induction Chemotherapy||75
8470700|NCT00658814|20874116|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
8470701|NCT00658814|20874117|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
8470702|NCT00658814|20874116|P2|Eligible|Remission Induction Chemotherapy||57
8470703|NCT00658814|20874117|P1|Eligible|Remission Induction Chemotherapy||82
8470704|NCT00658814|20874116|P2|STARTED|Remission Induction Chemotherapy||59
8470705|NCT00658814|20874117|P1|STARTED|Remission Induction Chemotherapy||83
8470706|NCT00658788|20874131|P1|NOT COMPLETED|Overall Study||74
8470707|NCT00658788|20874131|P1|COMPLETED|Overall Study||231
8470708|NCT00658788|20874131|P1|STARTED|Overall Study||305
8470709|NCT00658775|20874186|P2|NOT COMPLETED|Overall Study||43
8470710|NCT00658775|20874187|P1|NOT COMPLETED|Overall Study||42
8470711|NCT00658775|20874186|P2|COMPLETED|Overall Study||485
8470712|NCT00658775|20874187|P1|COMPLETED|Overall Study||495
8470713|NCT00658775|20874186|P2|STARTED|Overall Study|Treated|528
8470714|NCT00658775|20874187|P1|STARTED|Overall Study|Treated|537
8470715|NCT00658736|20874199|P2|NOT COMPLETED|Overall Study||2
8470716|NCT00658736|20874200|P1|NOT COMPLETED|Overall Study||6
8470717|NCT00658736|20874199|P2|COMPLETED|Overall Study||19
8470718|NCT00658736|20874200|P1|COMPLETED|Overall Study||13
8470719|NCT00658736|20874199|P2|STARTED|Overall Study||21
8470720|NCT00658736|20874200|P1|STARTED|Overall Study||19
8470721|NCT00658723|20874210|P3|NOT COMPLETED|Overall Study||7
8470722|NCT00658723|20874211|P2|NOT COMPLETED|Overall Study||4
8470723|NCT00658723|20874212|P1|NOT COMPLETED|Overall Study||4
8470724|NCT00658723|20874210|P3|COMPLETED|Overall Study||44
8470725|NCT00658723|20874211|P2|COMPLETED|Overall Study||26
8470726|NCT00658723|20874212|P1|COMPLETED|Overall Study||56
8470727|NCT00658723|20874210|P3|STARTED|Overall Study||51
8470728|NCT00658723|20874211|P2|STARTED|Overall Study||30
8470729|NCT00658723|20874212|P1|STARTED|Overall Study||60
8470730|NCT00658697|20874239|P1|NOT COMPLETED|Overall Study||0
8470731|NCT00658697|20874239|P1|COMPLETED|Overall Study||41
8470732|NCT00658697|20874239|P1|STARTED|Overall Study||41
8470733|NCT00658684|20874250|P4|NOT COMPLETED|Overall Study||1
8470734|NCT00658684|20874251|P3|NOT COMPLETED|Overall Study||3
8470735|NCT00658684|20874252|P2|NOT COMPLETED|Overall Study||15
8470736|NCT00658684|20874253|P1|NOT COMPLETED|Overall Study||19
8470737|NCT00658684|20874250|P4|COMPLETED|Overall Study||27
8470738|NCT00658684|20874251|P3|COMPLETED|Overall Study||22
8470739|NCT00658684|20874252|P2|COMPLETED|Overall Study||84
8470740|NCT00658684|20874253|P1|COMPLETED|Overall Study||133
8470741|NCT00658684|20874250|P4|STARTED|Overall Study||28
8470742|NCT00658684|20874251|P3|STARTED|Overall Study||25
8470743|NCT00658684|20874252|P2|STARTED|Overall Study||99
8470744|NCT00658684|20874253|P1|STARTED|Overall Study||152
8470745|NCT00658658|20874308|P5|NOT COMPLETED|Overall Study||5
8470746|NCT00658658|20874309|P4|NOT COMPLETED|Overall Study||2
8470747|NCT00658658|20874310|P3|NOT COMPLETED|Overall Study||0
8470748|NCT00658658|20874311|P2|NOT COMPLETED|Overall Study||2
8470749|NCT00658658|20874312|P1|NOT COMPLETED|Overall Study||5
8470750|NCT00658658|20874308|P5|COMPLETED|Overall Study||3
8470751|NCT00658658|20874309|P4|COMPLETED|Overall Study||4
8470752|NCT00658658|20874310|P3|COMPLETED|Overall Study||4
8470753|NCT00658658|20874311|P2|COMPLETED|Overall Study||5
8470754|NCT00658658|20874312|P1|COMPLETED|Overall Study||1
8470755|NCT00658658|20874308|P5|STARTED|Overall Study||8
8470756|NCT00658658|20874309|P4|STARTED|Overall Study||6
8470757|NCT00658658|20874310|P3|STARTED|Overall Study||4
8470758|NCT00658658|20874311|P2|STARTED|Overall Study||7
8470759|NCT00658658|20874312|P1|STARTED|Overall Study||6
8470760|NCT00658632|20874371|P2|NOT COMPLETED|Overall Study||65
8470761|NCT00658632|20874372|P1|NOT COMPLETED|Overall Study||64
8470762|NCT00658632|20874371|P2|COMPLETED|Overall Study||633
8470763|NCT00658632|20874372|P1|COMPLETED|Overall Study||618
8470764|NCT00658632|20874371|P2|STARTED|Overall Study|Treated|698
8470765|NCT00658632|20874372|P1|STARTED|Overall Study|Treated|682
8470766|NCT00658619|20874387|P5|NOT COMPLETED|Overall Study||2
8470767|NCT00658619|20874388|P4|NOT COMPLETED|Overall Study||12
8470768|NCT00658619|20874389|P3|NOT COMPLETED|Overall Study||10
8470769|NCT00658619|20874390|P2|NOT COMPLETED|Overall Study||1
8470770|NCT00658619|20874391|P1|NOT COMPLETED|Overall Study||0
8470771|NCT00658619|20874387|P5|COMPLETED|Overall Study||21
8470772|NCT00658619|20874388|P4|COMPLETED|Overall Study||37
8470773|NCT00658619|20874389|P3|COMPLETED|Overall Study||31
8470774|NCT00658619|20874390|P2|COMPLETED|Overall Study||2
8470775|NCT00658619|20874391|P1|COMPLETED|Overall Study||3
8470776|NCT00658619|20874387|P5|STARTED|Overall Study||23
8470777|NCT00658619|20874388|P4|STARTED|Overall Study||49
8470778|NCT00658619|20874389|P3|STARTED|Overall Study||41
8470779|NCT00658619|20874390|P2|STARTED|Overall Study||3
8470780|NCT00658619|20874391|P1|STARTED|Overall Study||3
8470781|NCT00658606|20874413|P2|NOT COMPLETED|Overall Study||23
8470782|NCT00658606|20874414|P1|NOT COMPLETED|Overall Study||16
8470783|NCT00658606|20874413|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
8470784|NCT00658606|20874414|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
8470785|NCT00658606|20874413|P2|Completed Treatment|Overall Study||44
8470786|NCT00658606|20874414|P1|Completed Treatment|Overall Study||42
8470787|NCT00658606|20874413|P2|STARTED|Overall Study||49
8470788|NCT00658606|20874414|P1|STARTED|Overall Study||49
8470789|NCT00658567|20874443|P3|NOT COMPLETED|Overall Study||6
8470790|NCT00658567|20874444|P2|NOT COMPLETED|Overall Study||4
8470791|NCT00658567|20874445|P1|NOT COMPLETED|Overall Study||8
8470792|NCT00658567|20874443|P3|COMPLETED|Overall Study||35
8470793|NCT00658567|20874444|P2|COMPLETED|Overall Study||38
8470794|NCT00658567|20874445|P1|COMPLETED|Overall Study||32
8470795|NCT00658567|20874443|P3|STARTED|Overall Study||41
8470796|NCT00658567|20874444|P2|STARTED|Overall Study||42
8470797|NCT00658567|20874445|P1|STARTED|Overall Study||40
8470798|NCT00658541|20874456|P2|NOT COMPLETED|Second Intervention||0
8470799|NCT00658541|20874457|P1|NOT COMPLETED|Second Intervention||0
8470800|NCT00658541|20874456|P2|COMPLETED|Second Intervention||17
8470801|NCT00658541|20874457|P1|COMPLETED|Second Intervention||18
8470802|NCT00658541|20874456|P2|STARTED|Second Intervention||17
8470803|NCT00658541|20874457|P1|STARTED|Second Intervention||18
8470804|NCT00658541|20874456|P2|NOT COMPLETED|Washout Period of 7 Days||2
8470805|NCT00658541|20874457|P1|NOT COMPLETED|Washout Period of 7 Days||1
8470806|NCT00658541|20874456|P2|COMPLETED|Washout Period of 7 Days||17
8470807|NCT00658541|20874457|P1|COMPLETED|Washout Period of 7 Days||18
8470808|NCT00658541|20874456|P2|STARTED|Washout Period of 7 Days||19
8470809|NCT00658541|20874457|P1|STARTED|Washout Period of 7 Days||19
8470810|NCT00658541|20874456|P2|NOT COMPLETED|First Intervention||0
8470811|NCT00658541|20874457|P1|NOT COMPLETED|First Intervention||0
8470812|NCT00658541|20874456|P2|COMPLETED|First Intervention||19
8470813|NCT00658541|20874457|P1|COMPLETED|First Intervention||19
8470814|NCT00658541|20874456|P2|STARTED|First Intervention||19
8470815|NCT00658541|20874457|P1|STARTED|First Intervention||19
8470816|NCT00658528|20874469|P2|NOT COMPLETED|Overall Study||45
8470817|NCT00658528|20874470|P1|NOT COMPLETED|Overall Study||40
8470818|NCT00658528|20874469|P2|COMPLETED|Overall Study||479
8470819|NCT00658528|20874470|P1|COMPLETED|Overall Study||491
8470820|NCT00658528|20874469|P2|STARTED|Overall Study|Treated|524
8470821|NCT00658528|20874470|P1|STARTED|Overall Study|Treated|531
8470822|NCT00658515|20874482|P2|NOT COMPLETED|Overall Study||265
8470823|NCT00658515|20874483|P1|NOT COMPLETED|Overall Study||312
8470824|NCT00658515|20874482|P2|COMPLETED|Overall Study||7668
8470825|NCT00658515|20874483|P1|COMPLETED|Overall Study||7626
8470826|NCT00658515|20874482|P2|STARTED|Overall Study||7933
8470827|NCT00658515|20874483|P1|STARTED|Overall Study||7938
8470828|NCT00658411|20874495|P1|NOT COMPLETED|Overall Study||0
8470829|NCT00658411|20874495|P1|COMPLETED|Overall Study||5
8470830|NCT00658411|20874495|P1|STARTED|Overall Study||5
8470831|NCT00658385|20874503|P1|NOT COMPLETED|Overall Study||0
8470832|NCT00658385|20874503|P1|COMPLETED|Overall Study||5
8470833|NCT00658385|20874503|P1|STARTED|Overall Study||5
8470834|NCT00658359|20874510|P3|NOT COMPLETED|Overall Study||46
8470835|NCT00658359|20874511|P2|NOT COMPLETED|Overall Study||45
8470836|NCT00658359|20874512|P1|NOT COMPLETED|Overall Study||28
8470837|NCT00658359|20874510|P3|COMPLETED|Overall Study||8
8470838|NCT00658359|20874511|P2|COMPLETED|Overall Study||15
8470839|NCT00658359|20874512|P1|COMPLETED|Overall Study||36
8470840|NCT00658359|20874510|P3|STARTED|Overall Study||54
8470841|NCT00658359|20874511|P2|STARTED|Overall Study||60
8470842|NCT00658359|20874512|P1|STARTED|Overall Study||64
8470843|NCT00658333|20874600|P2|NOT COMPLETED|Overall Study||1
8470844|NCT00658333|20874601|P1|NOT COMPLETED|Overall Study||2
8470845|NCT00658333|20874600|P2|COMPLETED|Overall Study||14
8470846|NCT00658333|20874601|P1|COMPLETED|Overall Study||13
8470847|NCT00658333|20874600|P2|STARTED|Overall Study||15
8470848|NCT00658333|20874601|P1|STARTED|Overall Study||15
8470849|NCT00658320|20874611|P2|NOT COMPLETED|Extension Study: After Month 24||0
8470850|NCT00658320|20874612|P1|NOT COMPLETED|Extension Study: After Month 24||2
8470851|NCT00658320|20874611|P2|COMPLETED|Extension Study: After Month 24||0
8470852|NCT00658320|20874612|P1|COMPLETED|Extension Study: After Month 24||42
8470853|NCT00658320|20874611|P2|STARTED|Extension Study: After Month 24||0
8470854|NCT00658320|20874612|P1|STARTED|Extension Study: After Month 24||44
8470855|NCT00658320|20874611|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
8470856|NCT00658320|20874612|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
8470857|NCT00658320|20874611|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
8470858|NCT00658320|20874612|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
8470859|NCT00658320|20874611|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
8470860|NCT00658320|20874612|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
8470861|NCT00658320|20874611|P2|STARTED|Extension Study: Month 12 to Month 24||57
8470862|NCT00658320|20874612|P1|STARTED|Extension Study: Month 12 to Month 24||53
8470863|NCT00658320|20874611|P2|NOT COMPLETED|Core Study: 12 Months||3
8470864|NCT00658320|20874612|P1|NOT COMPLETED|Core Study: 12 Months||5
8470865|NCT00658320|20874611|P2|COMPLETED|Core Study: 12 Months||58
8470866|NCT00658320|20874612|P1|COMPLETED|Core Study: 12 Months||56
8470867|NCT00658320|20874611|P2|STARTED|Core Study: 12 Months||61
8470868|NCT00658320|20874612|P1|STARTED|Core Study: 12 Months||61
8470869|NCT00658138|20874635|P1|NOT COMPLETED|Overall Study||21
8470870|NCT00658138|20874635|P1|COMPLETED|Overall Study||40
8470871|NCT00658138|20874635|P1|STARTED|Overall Study||61
8470872|NCT00658112|20874640|P1|NOT COMPLETED|Overall Study||9
8470873|NCT00658112|20874640|P1|COMPLETED|Overall Study||11
8470874|NCT00658112|20874640|P1|STARTED|Overall Study||20
8470875|NCT00658021|20874647|P3|NOT COMPLETED|Long-term Safety Follow-up Period||0
8470876|NCT00658021|20874648|P2|NOT COMPLETED|Long-term Safety Follow-up Period||3
8470877|NCT00658021|20874649|P1|NOT COMPLETED|Long-term Safety Follow-up Period||0
8470878|NCT00658021|20874647|P3|COMPLETED|Long-term Safety Follow-up Period||7
8470879|NCT00658021|20874648|P2|COMPLETED|Long-term Safety Follow-up Period||2
8470880|NCT00658021|20874649|P1|COMPLETED|Long-term Safety Follow-up Period||7
8470881|NCT00658021|20874647|P3|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
8470882|NCT00658021|20874648|P2|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
8470883|NCT00658021|20874649|P1|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
8470884|NCT00658021|20874647|P3|NOT COMPLETED|28-Week Treatment Period||17
8470885|NCT00658021|20874648|P2|NOT COMPLETED|28-Week Treatment Period||13
8470886|NCT00658021|20874649|P1|NOT COMPLETED|28-Week Treatment Period||11
8470887|NCT00658021|20874647|P3|COMPLETED|28-Week Treatment Period||25
8470888|NCT00658021|20874648|P2|COMPLETED|28-Week Treatment Period||25
8470889|NCT00658021|20874649|P1|COMPLETED|28-Week Treatment Period||31
8470890|NCT00658021|20874647|P3|Received Treatment|28-Week Treatment Period||42
8470891|NCT00658021|20874648|P2|Received Treatment|28-Week Treatment Period||38
8470892|NCT00658021|20874649|P1|Received Treatment|28-Week Treatment Period||40
8470893|NCT00658021|20874647|P3|STARTED|28-Week Treatment Period||42
8470894|NCT00658021|20874648|P2|STARTED|28-Week Treatment Period||38
8470895|NCT00658021|20874649|P1|STARTED|28-Week Treatment Period||42
8470896|NCT00657917|20874673|P1|NOT COMPLETED|Overall Study||0
8470897|NCT00657917|20874673|P1|COMPLETED|Overall Study||1
8470898|NCT00657917|20874673|P1|STARTED|Overall Study||1
8470899|NCT00657709|20874684|P5|NOT COMPLETED|Overall Study||33
8470900|NCT00657709|20874685|P4|NOT COMPLETED|Overall Study||14
8470901|NCT00657709|20874686|P3|NOT COMPLETED|Overall Study||28
8470902|NCT00657709|20874687|P2|NOT COMPLETED|Overall Study||33
8470903|NCT00657709|20874688|P1|NOT COMPLETED|Overall Study||23
8470904|NCT00657709|20874684|P5|COMPLETED|Overall Study||457
8470905|NCT00657709|20874685|P4|COMPLETED|Overall Study||645
8470906|NCT00657709|20874686|P3|COMPLETED|Overall Study||792
8470907|NCT00657709|20874687|P2|COMPLETED|Overall Study||795
8470908|NCT00657709|20874688|P1|COMPLETED|Overall Study||810
8470909|NCT00657709|20874684|P5|STARTED|Overall Study||490
8470910|NCT00657709|20874685|P4|STARTED|Overall Study||659
8470911|NCT00657709|20874686|P3|STARTED|Overall Study||820
8470912|NCT00657709|20874687|P2|STARTED|Overall Study||828
8470913|NCT00657709|20874688|P1|STARTED|Overall Study||833
8470914|NCT00657657|20874729|P1|NOT COMPLETED|Overall Study||0
8470915|NCT00657657|20874729|P1|COMPLETED|Overall Study||29
8470916|NCT00657657|20874729|P1|STARTED|Overall Study||29
8470917|NCT00657618|20874737|P1|NOT COMPLETED|Overall Study||43
8470918|NCT00657618|20874737|P1|COMPLETED|Overall Study||34
8470919|NCT00657618|20874737|P1|STARTED|Overall Study||77
8470920|NCT00657605|20874742|P1|NOT COMPLETED|Overall Study||0
8470921|NCT00657605|20874742|P1|COMPLETED|Overall Study||3
8470922|NCT00657605|20874742|P1|STARTED|Overall Study||3
8470923|NCT00657553|20874749|P2|NOT COMPLETED|Overall Study||5
8470924|NCT00657553|20874750|P1|NOT COMPLETED|Overall Study||5
8470925|NCT00657553|20874749|P2|COMPLETED|Overall Study||0
8470926|NCT00657553|20874750|P1|COMPLETED|Overall Study||0
8470927|NCT00657553|20874749|P2|STARTED|Overall Study||5
8470928|NCT00657553|20874750|P1|STARTED|Overall Study||5
8470929|NCT00657540|20874758|P2|NOT COMPLETED|Overall Study||4
8470930|NCT00657540|20874759|P1|NOT COMPLETED|Overall Study||1
8470931|NCT00657540|20874758|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
8470932|NCT00657540|20874759|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
8470933|NCT00657540|20874758|P2|STARTED|Overall Study||31
8470934|NCT00657540|20874759|P1|STARTED|Overall Study||29
8470935|NCT00657371|20874773|P1|NOT COMPLETED|Overall Study||39
8470936|NCT00657371|20874773|P1|COMPLETED|Overall Study||249
8470937|NCT00657371|20874773|P1|STARTED|Overall Study||288
8470938|NCT00657358|20874778|P1|NOT COMPLETED|Overall Study||6
8470939|NCT00657358|20874778|P1|COMPLETED|Overall Study||16
8470940|NCT00657358|20874778|P1|STARTED|Overall Study||22
8470941|NCT00657280|20874786|P1|NOT COMPLETED|Overall Study||0
8470942|NCT00657280|20874786|P1|COMPLETED|Overall Study||16
8470943|NCT00657280|20874786|P1|STARTED|Overall Study||16
8470944|NCT00657267|20874790|P1|NOT COMPLETED|Overall Study||54
8470945|NCT00657267|20874790|P1|COMPLETED|Overall Study||4
8470946|NCT00657267|20874790|P1|STARTED|Overall Study||58
8470947|NCT00657150|20874800|P2|NOT COMPLETED|Treatment||97
8470948|NCT00657150|20874801|P1|NOT COMPLETED|Treatment||107
8470949|NCT00657150|20874800|P2|COMPLETED|Treatment||906
8470950|NCT00657150|20874801|P1|COMPLETED|Treatment||903
8470951|NCT00657150|20874800|P2|STARTED|Treatment||1003
8470952|NCT00657150|20874801|P1|STARTED|Treatment||1010
8470953|NCT00657150|20874800|P2|NOT COMPLETED|Overall Study||93
8470954|NCT00657150|20874801|P1|NOT COMPLETED|Overall Study||115
8470955|NCT00657150|20874800|P2|COMPLETED|Overall Study||910
8470956|NCT00657150|20874801|P1|COMPLETED|Overall Study||895
8470957|NCT00657150|20874800|P2|STARTED|Overall Study||1003
8470958|NCT00657150|20874801|P1|STARTED|Overall Study||1010
8470959|NCT00657046|20874832|P3|NOT COMPLETED|Overall Study||2
8470960|NCT00657046|20874833|P2|NOT COMPLETED|Overall Study||3
8470961|NCT00657046|20874834|P1|NOT COMPLETED|Overall Study||4
8470962|NCT00657046|20874832|P3|COMPLETED|Overall Study||21
8470963|NCT00657046|20874833|P2|COMPLETED|Overall Study||29
8470964|NCT00657046|20874834|P1|COMPLETED|Overall Study||26
8470965|NCT00657046|20874832|P3|Had Visits up to Visit 18|Overall Study||23
8470966|NCT00657046|20874833|P2|Had Visits up to Visit 18|Overall Study||30
8470967|NCT00657046|20874834|P1|Had Visits up to Visit 18|Overall Study||28
8470968|NCT00657046|20874832|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
8470969|NCT00657046|20874833|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
8470970|NCT00657046|20874834|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
8470971|NCT00657046|20874832|P3|STARTED|Overall Study||23
8470972|NCT00657046|20874833|P2|STARTED|Overall Study||32
8470973|NCT00657046|20874834|P1|STARTED|Overall Study||30
8470974|NCT00657020|20874866|P2|NOT COMPLETED|PERIOD 2||0
8470975|NCT00657020|20874867|P1|NOT COMPLETED|PERIOD 2||0
8470976|NCT00657020|20874866|P2|COMPLETED|PERIOD 2||11
8470977|NCT00657020|20874867|P1|COMPLETED|PERIOD 2||11
8470978|NCT00657020|20874866|P2|STARTED|PERIOD 2||11
8470979|NCT00657020|20874867|P1|STARTED|PERIOD 2||11
8470980|NCT00657020|20874866|P2|NOT COMPLETED|PERIOD 1||1
8470981|NCT00657020|20874867|P1|NOT COMPLETED|PERIOD 1||0
8470982|NCT00657020|20874866|P2|COMPLETED|PERIOD 1||11
8470983|NCT00657020|20874867|P1|COMPLETED|PERIOD 1||11
8470984|NCT00657020|20874866|P2|STARTED|PERIOD 1||12
8470985|NCT00657020|20874867|P1|STARTED|PERIOD 1||11
8470986|NCT00656968|20874897|P2|NOT COMPLETED|Overall Study||0
8470987|NCT00656968|20874898|P1|NOT COMPLETED|Overall Study||0
8470988|NCT00656968|20874897|P2|COMPLETED|Overall Study||117
8470989|NCT00656968|20874898|P1|COMPLETED|Overall Study||115
8470990|NCT00656968|20874897|P2|STARTED|Overall Study||117
8470991|NCT00656968|20874898|P1|STARTED|Overall Study||115
8470992|NCT00656916|20874908|P2|NOT COMPLETED|Overall Study||0
8470993|NCT00656916|20874909|P1|NOT COMPLETED|Overall Study||0
8470994|NCT00656916|20874908|P2|COMPLETED|Overall Study||0
8470995|NCT00656916|20874909|P1|COMPLETED|Overall Study||1
8470996|NCT00656916|20874908|P2|STARTED|Overall Study||0
8470997|NCT00656916|20874909|P1|STARTED|Overall Study||1
8470998|NCT00656851|20874917|P2|NOT COMPLETED|Overall Study||4
8470999|NCT00656851|20874918|P1|NOT COMPLETED|Overall Study||0
8471000|NCT00656851|20874917|P2|COMPLETED|Overall Study||8
8471001|NCT00656851|20874918|P1|COMPLETED|Overall Study||12
8471002|NCT00656851|20874917|P2|STARTED|Overall Study||12
8471003|NCT00656851|20874918|P1|STARTED|Overall Study||12
8471004|NCT00656799|20874940|P1|NOT COMPLETED|Overall Study||2
8471005|NCT00656799|20874940|P1|COMPLETED|Overall Study||4
8471006|NCT00656799|20874940|P1|STARTED|Overall Study||6
8471007|NCT00656669|20874962|P1|NOT COMPLETED|AC (Cycles 6-9)||2
8471008|NCT00656669|20874962|P1|COMPLETED|AC (Cycles 6-9)||15
8471009|NCT00656669|20874962|P1|STARTED|AC (Cycles 6-9)||17
8471010|NCT00656669|20874962|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
8471011|NCT00656669|20874962|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
8471012|NCT00656669|20874962|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
8471013|NCT00656669|20874962|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
8471014|NCT00656669|20874962|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
8471015|NCT00656669|20874962|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
8471016|NCT00656656|20874971|P1|NOT COMPLETED|Overall Study||0
8471017|NCT00656656|20874971|P1|COMPLETED|Overall Study||23
8471018|NCT00656656|20874971|P1|STARTED|Overall Study||23
8471019|NCT00656630|20874979|P3|NOT COMPLETED|Overall Study||2
8471020|NCT00656630|20874980|P2|NOT COMPLETED|Overall Study||2
8471021|NCT00656630|20874981|P1|NOT COMPLETED|Overall Study||2
8471022|NCT00656630|20874979|P3|COMPLETED|Overall Study||17
8471023|NCT00656630|20874980|P2|COMPLETED|Overall Study||25
8471024|NCT00656630|20874981|P1|COMPLETED|Overall Study||20
8471025|NCT00656630|20874979|P3|STARTED|Overall Study||19
8471026|NCT00656630|20874980|P2|STARTED|Overall Study||27
8471027|NCT00656630|20874981|P1|STARTED|Overall Study||22
8471028|NCT00656617|20875001|P1|NOT COMPLETED|Overall Study||7
8471029|NCT00656617|20875001|P1|COMPLETED|Overall Study||99
8471030|NCT00656617|20875001|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
8471031|NCT00656617|20875001|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
8471032|NCT00656617|20875001|P1|STARTED|Overall Study||106
8471033|NCT00656513|20875010|P3|NOT COMPLETED|Overall Study||22
8471034|NCT00656513|20875011|P2|NOT COMPLETED|Overall Study||30
8471035|NCT00656513|20875012|P1|NOT COMPLETED|Overall Study||4
8471036|NCT00656513|20875010|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
8471037|NCT00656513|20875011|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
8471038|NCT00656513|20875012|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
8471039|NCT00656513|20875010|P3|STARTED|Overall Study||75
8471040|NCT00656513|20875011|P2|STARTED|Overall Study||73
8471041|NCT00656513|20875012|P1|STARTED|Overall Study||48
8471042|NCT00656487|20875034|P3|NOT COMPLETED|Overall Study||0
8471043|NCT00656487|20875035|P2|NOT COMPLETED|Overall Study||4
8471044|NCT00656487|20875036|P1|NOT COMPLETED|Overall Study||2
8471045|NCT00656487|20875034|P3|COMPLETED|Overall Study||20
8471046|NCT00656487|20875035|P2|COMPLETED|Overall Study||19
8471047|NCT00656487|20875036|P1|COMPLETED|Overall Study||21
8471048|NCT00656487|20875034|P3|STARTED|Overall Study||20
8471049|NCT00656487|20875035|P2|STARTED|Overall Study||23
8471050|NCT00656487|20875036|P1|STARTED|Overall Study||23
8471051|NCT00656474|20875059|P1|NOT COMPLETED|Overall Study||1
8471052|NCT00656474|20875059|P1|COMPLETED|Overall Study||11
8471053|NCT00656474|20875059|P1|STARTED|Overall Study||12
8471054|NCT00656448|20875068|P2|NOT COMPLETED|Overall Study||0
8471055|NCT00656448|20875069|P1|NOT COMPLETED|Overall Study||0
8471056|NCT00656448|20875068|P2|COMPLETED|Overall Study||25
8471057|NCT00656448|20875069|P1|COMPLETED|Overall Study||25
8471058|NCT00656448|20875068|P2|STARTED|Overall Study||25
8471059|NCT00656448|20875069|P1|STARTED|Overall Study||25
8471060|NCT00656370|20875077|P1|NOT COMPLETED|Overall Study||10
8471061|NCT00656370|20875077|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
8471062|NCT00656370|20875077|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
8471063|NCT00656305|20875093|P2|NOT COMPLETED|Overall Study||7
8471064|NCT00656305|20875094|P1|NOT COMPLETED|Overall Study||22
8471065|NCT00656305|20875093|P2|COMPLETED|Overall Study||21
8471066|NCT00656305|20875094|P1|COMPLETED|Overall Study||65
8471067|NCT00656305|20875093|P2|STARTED|Overall Study||28
8471068|NCT00656305|20875094|P1|STARTED|Overall Study||87
8471069|NCT00656292|20875106|P2|NOT COMPLETED|Overall Study||5
8471070|NCT00656292|20875107|P1|NOT COMPLETED|Overall Study||3
8471071|NCT00656292|20875106|P2|COMPLETED|Overall Study||24
8471072|NCT00656292|20875107|P1|COMPLETED|Overall Study||29
8471073|NCT00656292|20875106|P2|STARTED|Overall Study||29
8471074|NCT00656292|20875107|P1|STARTED|Overall Study||32
8471075|NCT00656201|20875125|P2|NOT COMPLETED|Overall Study||32
8471076|NCT00656201|20875126|P1|NOT COMPLETED|Overall Study||29
8471077|NCT00656201|20875125|P2|COMPLETED|Overall Study||201
8471078|NCT00656201|20875126|P1|COMPLETED|Overall Study||206
8471079|NCT00656201|20875125|P2|STARTED|Overall Study||233
8471080|NCT00656201|20875126|P1|STARTED|Overall Study||235
8471081|NCT00656175|20875134|P2|NOT COMPLETED|Overall Study||1
8471082|NCT00656175|20875135|P1|NOT COMPLETED|Overall Study||1
8471083|NCT00656175|20875134|P2|COMPLETED|Overall Study||20
8471084|NCT00656175|20875135|P1|COMPLETED|Overall Study||17
8471085|NCT00656175|20875134|P2|STARTED|Overall Study||21
8471086|NCT00656175|20875135|P1|STARTED|Overall Study||18
8471087|NCT00656136|20875143|P2|NOT COMPLETED|Overall Study||390
8471088|NCT00656136|20875144|P1|NOT COMPLETED|Overall Study||195
8471089|NCT00656136|20875143|P2|COMPLETED|Overall Study||0
8471090|NCT00656136|20875144|P1|COMPLETED|Overall Study||0
8471091|NCT00656136|20875143|P2|STARTED|Overall Study|Randomised patients.|390
8471092|NCT00656136|20875144|P1|STARTED|Overall Study|Randomised patients.|195
8471093|NCT00656084|20875154|P1|NOT COMPLETED|Overall Study||7
8471094|NCT00656084|20875154|P1|COMPLETED|Overall Study||9
8471095|NCT00656084|20875154|P1|STARTED|Overall Study||16
8471096|NCT00656058|20875161|P1|NOT COMPLETED|Overall Study||6
8471097|NCT00656058|20875161|P1|COMPLETED|Overall Study||19
8471098|NCT00656058|20875161|P1|STARTED|Overall Study||25
8471099|NCT00656019|20875174|P4|NOT COMPLETED|Overall Study||0
8471100|NCT00656019|20875175|P3|NOT COMPLETED|Overall Study||0
8471101|NCT00656019|20875176|P2|NOT COMPLETED|Overall Study||1
8471102|NCT00656019|20875177|P1|NOT COMPLETED|Overall Study||14
8471103|NCT00656019|20875174|P4|COMPLETED|Overall Study||4
8471104|NCT00656019|20875175|P3|COMPLETED|Overall Study||11
8471105|NCT00656019|20875176|P2|COMPLETED|Overall Study||18
8471106|NCT00656019|20875177|P1|COMPLETED|Overall Study||15
8471107|NCT00656019|20875174|P4|STARTED|Overall Study||4
8471108|NCT00656019|20875175|P3|STARTED|Overall Study||11
8471109|NCT00656019|20875176|P2|STARTED|Overall Study||19
8471110|NCT00656019|20875177|P1|STARTED|Overall Study||29
8471111|NCT00655980|20875190|P3|NOT COMPLETED|Overall Study||5
8471112|NCT00655980|20875191|P2|NOT COMPLETED|Overall Study||31
8471113|NCT00655980|20875192|P1|NOT COMPLETED|Overall Study||26
8471114|NCT00655980|20875190|P3|COMPLETED|Overall Study||125
8471115|NCT00655980|20875191|P2|COMPLETED|Overall Study||250
8471116|NCT00655980|20875192|P1|COMPLETED|Overall Study||250
8471117|NCT00655980|20875190|P3|STARTED|Overall Study||130
8471118|NCT00655980|20875191|P2|STARTED|Overall Study||281
8471119|NCT00655980|20875192|P1|STARTED|Overall Study||276
8471120|NCT00655928|20875205|P2|NOT COMPLETED|Overall Study||2
8471121|NCT00655928|20875206|P1|NOT COMPLETED|Overall Study||3
8471122|NCT00655928|20875205|P2|COMPLETED|Overall Study||24
8471123|NCT00655928|20875206|P1|COMPLETED|Overall Study||23
8471124|NCT00655928|20875205|P2|STARTED|Overall Study||26
8471125|NCT00655928|20875206|P1|STARTED|Overall Study||26
8471126|NCT00655889|20875212|P1|NOT COMPLETED|Overall Study||2
8471127|NCT00655889|20875212|P1|COMPLETED|Overall Study||11
8471128|NCT00655889|20875212|P1|STARTED|Overall Study||13
8471129|NCT00655876|20875219|P2|NOT COMPLETED|Overall Study||7
8471130|NCT00655876|20875220|P1|NOT COMPLETED|Overall Study||9
8471131|NCT00655876|20875219|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
8471132|NCT00655876|20875220|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
8471133|NCT00655876|20875219|P2|STARTED|Overall Study||176
8471134|NCT00655876|20875220|P1|STARTED|Overall Study||168
8471135|NCT00655863|20875239|P3|NOT COMPLETED|Overall Study||1
8471136|NCT00655863|20875240|P2|NOT COMPLETED|Overall Study||0
8471137|NCT00655863|20875241|P1|NOT COMPLETED|Overall Study||0
8471138|NCT00655863|20875239|P3|COMPLETED|Overall Study||21
8471139|NCT00655863|20875240|P2|COMPLETED|Overall Study||25
8471140|NCT00655863|20875241|P1|COMPLETED|Overall Study||24
8471141|NCT00655863|20875239|P3|STARTED|Overall Study||22
8471142|NCT00655863|20875240|P2|STARTED|Overall Study||25
8471143|NCT00655863|20875241|P1|STARTED|Overall Study||24
8471144|NCT00655850|20875300|P1|NOT COMPLETED|Overall Study||3
8471145|NCT00655850|20875300|P1|COMPLETED|Overall Study||36
8471146|NCT00655850|20875300|P1|STARTED|Overall Study||39
8471147|NCT00655824|20875307|P1|NOT COMPLETED|Overall Study||84
8471148|NCT00655824|20875307|P1|COMPLETED|Overall Study||8
8471149|NCT00655824|20875307|P1|STARTED|Overall Study||92
8471150|NCT00655811|20875341|P1|NOT COMPLETED|Overall Study||0
8471151|NCT00655811|20875341|P1|COMPLETED|Overall Study||40
8471152|NCT00655811|20875341|P1|STARTED|Overall Study||40
8471153|NCT00655746|20875355|P1|NOT COMPLETED|Overall Study||1
8471154|NCT00655746|20875355|P1|COMPLETED|Overall Study||13
8471155|NCT00655746|20875355|P1|STARTED|Overall Study||14
8471156|NCT00655733|20875374|P2|NOT COMPLETED|Overall Study||8
8471157|NCT00655733|20875375|P1|NOT COMPLETED|Overall Study||7
8471158|NCT00655733|20875374|P2|COMPLETED|Overall Study||42
8471159|NCT00655733|20875375|P1|COMPLETED|Overall Study||44
8471160|NCT00655733|20875374|P2|STARTED|Overall Study||50
8471161|NCT00655733|20875375|P1|STARTED|Overall Study||51
8471162|NCT00655707|20875403|P1|NOT COMPLETED|Overall Study||0
8471163|NCT00655707|20875403|P1|COMPLETED|Overall Study||5
8471164|NCT00655707|20875403|P1|STARTED|Overall Study||5
8471165|NCT00655668|20875408|P1|NOT COMPLETED|Overall Study||54
8471166|NCT00655668|20875408|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
8471167|NCT00655668|20875408|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
8471168|NCT00655642|20875420|P4|NOT COMPLETED|Overall Study||2
8471169|NCT00655642|20875421|P3|NOT COMPLETED|Overall Study||2
8471170|NCT00655642|20875422|P2|NOT COMPLETED|Overall Study||3
8471171|NCT00655642|20875423|P1|NOT COMPLETED|Overall Study||1
8471172|NCT00655642|20875420|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
8471173|NCT00655642|20875421|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
8471174|NCT00655642|20875422|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
8471175|NCT00655642|20875423|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
8471176|NCT00655642|20875420|P4|STARTED|Overall Study||41
8471177|NCT00655642|20875421|P3|STARTED|Overall Study||45
8471178|NCT00655642|20875422|P2|STARTED|Overall Study||43
8471179|NCT00655642|20875423|P1|STARTED|Overall Study||42
8471180|NCT00655629|20875435|P2|NOT COMPLETED|Overall Study||23
8471181|NCT00655629|20875436|P1|NOT COMPLETED|Overall Study||21
8471182|NCT00655629|20875435|P2|COMPLETED|Overall Study||144
8471183|NCT00655629|20875436|P1|COMPLETED|Overall Study||151
8471184|NCT00655629|20875435|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
8471185|NCT00655629|20875436|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
8471186|NCT00655629|20875435|P2|STARTED|Overall Study||167
8471187|NCT00655629|20875436|P1|STARTED|Overall Study||172
8471188|NCT00655564|20875472|P1|NOT COMPLETED|Overall Study||3
8471189|NCT00655564|20875472|P1|COMPLETED|Overall Study||12
8471190|NCT00655564|20875472|P1|STARTED|Overall Study||15
8471191|NCT00655551|20875480|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
8471192|NCT00655551|20875481|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
8471193|NCT00655551|20875482|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
8471194|NCT00655551|20875480|P3|COMPLETED|Period 4 (up to 7 Days)||0
8471195|NCT00655551|20875481|P2|COMPLETED|Period 4 (up to 7 Days)||23
8471196|NCT00655551|20875482|P1|COMPLETED|Period 4 (up to 7 Days)||0
8471197|NCT00655551|20875480|P3|STARTED|Period 4 (up to 7 Days)||0
8471198|NCT00655551|20875481|P2|STARTED|Period 4 (up to 7 Days)||25
8471199|NCT00655551|20875482|P1|STARTED|Period 4 (up to 7 Days)||0
8471200|NCT00655551|20875480|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
8471201|NCT00655551|20875481|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
8471202|NCT00655551|20875482|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
8471203|NCT00655551|20875480|P3|COMPLETED|Period 3 (up to 7 Days)||21
8471204|NCT00655551|20875481|P2|COMPLETED|Period 3 (up to 7 Days)||0
8471205|NCT00655551|20875482|P1|COMPLETED|Period 3 (up to 7 Days)||0
8471206|NCT00655551|20875480|P3|STARTED|Period 3 (up to 7 Days)||25
8471207|NCT00655551|20875481|P2|STARTED|Period 3 (up to 7 Days)||0
8471208|NCT00655551|20875482|P1|STARTED|Period 3 (up to 7 Days)||0
8471209|NCT00655551|20875480|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
8471210|NCT00655551|20875481|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
8471211|NCT00655551|20875482|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
8471212|NCT00655551|20875480|P3|COMPLETED|Period 2 (up to 7 Days)||0
8471213|NCT00655551|20875481|P2|COMPLETED|Period 2 (up to 7 Days)||24
8471214|NCT00655551|20875482|P1|COMPLETED|Period 2 (up to 7 Days)||0
8471215|NCT00655551|20875480|P3|STARTED|Period 2 (up to 7 Days)||0
8471216|NCT00655551|20875481|P2|STARTED|Period 2 (up to 7 Days)||25
8471217|NCT00655551|20875482|P1|STARTED|Period 2 (up to 7 Days)||0
8471218|NCT00655551|20875480|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
8471219|NCT00655551|20875481|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
8471220|NCT00655551|20875482|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
8471221|NCT00655551|20875480|P3|COMPLETED|Period 1 (up to 7 Days)||0
8471222|NCT00655551|20875481|P2|COMPLETED|Period 1 (up to 7 Days)||0
8471223|NCT00655551|20875482|P1|COMPLETED|Period 1 (up to 7 Days)||25
8471224|NCT00655551|20875480|P3|STARTED|Period 1 (up to 7 Days)||0
8471225|NCT00655551|20875481|P2|STARTED|Period 1 (up to 7 Days)||0
8471226|NCT00655551|20875482|P1|STARTED|Period 1 (up to 7 Days)||25
8471227|NCT00655551|20875480|P3|NOT COMPLETED|All Periods Combined||4
8471228|NCT00655551|20875481|P2|NOT COMPLETED|All Periods Combined||3
8471229|NCT00655551|20875482|P1|NOT COMPLETED|All Periods Combined||0
8471230|NCT00655551|20875480|P3|COMPLETED|All Periods Combined||21
8471231|NCT00655551|20875481|P2|COMPLETED|All Periods Combined||47
8471232|NCT00655551|20875482|P1|COMPLETED|All Periods Combined||25
8471233|NCT00655551|20875480|P3|STARTED|All Periods Combined||25
8471234|NCT00655551|20875481|P2|STARTED|All Periods Combined||50
8471235|NCT00655551|20875482|P1|STARTED|All Periods Combined||25
8471236|NCT00655538|20875498|P2|NOT COMPLETED|Overall Study||27
8471237|NCT00655538|20875499|P1|NOT COMPLETED|Overall Study||24
8471238|NCT00655538|20875498|P2|COMPLETED|Overall Study||211
8471239|NCT00655538|20875499|P1|COMPLETED|Overall Study||214
8471240|NCT00655538|20875498|P2|STARTED|Overall Study||238
8471241|NCT00655538|20875499|P1|STARTED|Overall Study||238
8471242|NCT00655486|20875519|P1|NOT COMPLETED|Overall Study||28
8471243|NCT00655486|20875519|P1|COMPLETED|Overall Study||69
8471244|NCT00655486|20875519|P1|STARTED|Overall Study||97
8471245|NCT00655473|20875526|P2|NOT COMPLETED|Overall Study||15
8471246|NCT00655473|20875527|P1|NOT COMPLETED|Overall Study||11
8471247|NCT00655473|20875526|P2|COMPLETED|Overall Study||51
8471248|NCT00655473|20875527|P1|COMPLETED|Overall Study||53
8471249|NCT00655473|20875526|P2|STARTED|Overall Study||66
8471250|NCT00655473|20875527|P1|STARTED|Overall Study||64
8471251|NCT00655356|20875547|P2|NOT COMPLETED|Overall Study||10
8471252|NCT00655356|20875548|P1|NOT COMPLETED|Overall Study||17
8471253|NCT00655356|20875547|P2|COMPLETED|Overall Study||98
8471254|NCT00655356|20875548|P1|COMPLETED|Overall Study||93
8471255|NCT00655356|20875547|P2|STARTED|Overall Study||108
8471256|NCT00655356|20875548|P1|STARTED|Overall Study||110
8471257|NCT00655083|20875562|P2|NOT COMPLETED|Overall Study||0
8471258|NCT00655083|20875563|P1|NOT COMPLETED|Overall Study||0
8471259|NCT00655083|20875562|P2|COMPLETED|Overall Study||8
8471260|NCT00655083|20875563|P1|COMPLETED|Overall Study||12
8471261|NCT00655083|20875562|P2|STARTED|Overall Study||8
8471262|NCT00655083|20875563|P1|STARTED|Overall Study||12
8471263|NCT00655057|20875578|P3|NOT COMPLETED|Overall Study||0
8471264|NCT00655057|20875579|P2|NOT COMPLETED|Overall Study||0
8471265|NCT00655057|20875580|P1|NOT COMPLETED|Overall Study||0
8471266|NCT00655057|20875578|P3|COMPLETED|Overall Study||0
8471267|NCT00655057|20875579|P2|COMPLETED|Overall Study||0
8471268|NCT00655057|20875580|P1|COMPLETED|Overall Study||0
8471269|NCT00655057|20875578|P3|STARTED|Overall Study||0
8471270|NCT00655057|20875579|P2|STARTED|Overall Study||0
8471271|NCT00655057|20875580|P1|STARTED|Overall Study||0
8471272|NCT00654992|20875590|P2|NOT COMPLETED|Overall Study||0
8471273|NCT00654992|20875591|P1|NOT COMPLETED|Overall Study||0
8471274|NCT00654992|20875590|P2|COMPLETED|Overall Study||35
8471275|NCT00654992|20875591|P1|COMPLETED|Overall Study||36
8471276|NCT00654992|20875590|P2|STARTED|Overall Study||35
8471277|NCT00654992|20875591|P1|STARTED|Overall Study||36
8471278|NCT00654953|20875600|P3|NOT COMPLETED|Overall Study||22
8471279|NCT00654953|20875601|P2|NOT COMPLETED|Overall Study||28
8471280|NCT00654953|20875602|P1|NOT COMPLETED|Overall Study||30
8471281|NCT00654953|20875600|P3|COMPLETED|Overall Study||8
8471282|NCT00654953|20875601|P2|COMPLETED|Overall Study||8
8471283|NCT00654953|20875602|P1|COMPLETED|Overall Study||6
8471284|NCT00654953|20875600|P3|STARTED|Overall Study||30
8471285|NCT00654953|20875601|P2|STARTED|Overall Study||36
8471286|NCT00654953|20875602|P1|STARTED|Overall Study||36
8471307|NCT00654927|20875625|P1|NOT COMPLETED|Overall Study||107
8471308|NCT00654927|20875625|P1|COMPLETED|Overall Study||70
8471309|NCT00654927|20875625|P1|STARTED|Overall Study||177
8471310|NCT00654901|20875637|P4|NOT COMPLETED|Overall Study||0
8471311|NCT00654901|20875638|P3|NOT COMPLETED|Overall Study||2
8471312|NCT00654901|20875639|P2|NOT COMPLETED|Overall Study||0
8471313|NCT00654901|20875640|P1|NOT COMPLETED|Overall Study||4
8471314|NCT00654901|20875637|P4|COMPLETED|Overall Study||113
8471315|NCT00654901|20875638|P3|COMPLETED|Overall Study||250
8471316|NCT00654901|20875639|P2|COMPLETED|Overall Study||262
8471317|NCT00654901|20875640|P1|COMPLETED|Overall Study||250
8471318|NCT00654901|20875637|P4|STARTED|Overall Study||113
8471319|NCT00654901|20875638|P3|STARTED|Overall Study||252
8471320|NCT00654901|20875639|P2|STARTED|Overall Study||262
8471321|NCT00654901|20875640|P1|STARTED|Overall Study||254
8471322|NCT00654875|20875660|P2|NOT COMPLETED|Overall Study||17
8471323|NCT00654875|20875661|P1|NOT COMPLETED|Overall Study||17
8471324|NCT00654875|20875660|P2|COMPLETED|Overall Study||147
8471325|NCT00654875|20875661|P1|COMPLETED|Overall Study||147
8471326|NCT00654875|20875660|P2|STARTED|Overall Study||164
8471327|NCT00654875|20875661|P1|STARTED|Overall Study||164
8471328|NCT00654836|20875679|P1|NOT COMPLETED|Overall Study||0
8471329|NCT00654836|20875679|P1|COMPLETED|Overall Study||32
8471330|NCT00654836|20875679|P1|STARTED|Overall Study||32
8471331|NCT00654784|20875687|P2|NOT COMPLETED|Overall Study||0
8471332|NCT00654784|20875688|P1|NOT COMPLETED|Overall Study||0
8471333|NCT00654784|20875687|P2|COMPLETED|Overall Study||8
8471334|NCT00654784|20875688|P1|COMPLETED|Overall Study||13
8471335|NCT00654784|20875687|P2|STARTED|Overall Study||8
8471336|NCT00654784|20875688|P1|STARTED|Overall Study||13
8471337|NCT00654745|20875694|P1|NOT COMPLETED|Overall Study||43
8471338|NCT00654745|20875694|P1|COMPLETED|Overall Study||164
8471339|NCT00654745|20875694|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
8471340|NCT00654732|20875734|P2|NOT COMPLETED|Overall Study||6
8471341|NCT00654732|20875735|P1|NOT COMPLETED|Overall Study||4
8471342|NCT00654732|20875734|P2|COMPLETED|Overall Study||26
8471343|NCT00654732|20875735|P1|COMPLETED|Overall Study||22
8471344|NCT00654732|20875734|P2|STARTED|Overall Study||32
8471345|NCT00654732|20875735|P1|STARTED|Overall Study||26
8471346|NCT00654654|20875741|P1|NOT COMPLETED|Overall Study||7
8471347|NCT00654654|20875741|P1|COMPLETED|Overall Study||43
8471348|NCT00654654|20875741|P1|STARTED|Overall Study||50
8471349|NCT00654641|20875748|P2|NOT COMPLETED|Overall Study||3
8471350|NCT00654641|20875749|P1|NOT COMPLETED|Overall Study||2
8471351|NCT00654641|20875748|P2|COMPLETED|Overall Study||23
8471352|NCT00654641|20875749|P1|COMPLETED|Overall Study||26
8471353|NCT00654641|20875748|P2|STARTED|Overall Study||26
8471354|NCT00654641|20875749|P1|STARTED|Overall Study||28
8471355|NCT00654628|20875755|P1|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
8471356|NCT00654628|20875755|P1|COMPLETED|6 -Week Extension Period (Single Site)||55
8471357|NCT00654628|20875755|P1|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
8471358|NCT00654628|20875755|P1|NOT COMPLETED|6-week Active Treatment Period||21
8471359|NCT00654628|20875755|P1|COMPLETED|6-week Active Treatment Period||152
8471360|NCT00654628|20875755|P1|STARTED|6-week Active Treatment Period||173
8471361|NCT00654615|20875772|P2|NOT COMPLETED|Overall Study||7
8471362|NCT00654615|20875773|P1|NOT COMPLETED|Overall Study||8
8471363|NCT00654615|20875772|P2|COMPLETED|Overall Study||23
8471364|NCT00654615|20875773|P1|COMPLETED|Overall Study||22
8471365|NCT00654615|20875772|P2|STARTED|Overall Study||30
8471366|NCT00654615|20875773|P1|STARTED|Overall Study||30
8471367|NCT00654511|20875785|P4|NOT COMPLETED|Overall Study||0
8471368|NCT00654511|20875786|P3|NOT COMPLETED|Overall Study||0
8471369|NCT00654511|20875787|P2|NOT COMPLETED|Overall Study||0
8471370|NCT00654511|20875788|P1|NOT COMPLETED|Overall Study||0
8471371|NCT00654511|20875785|P4|COMPLETED|Overall Study||25
8471372|NCT00654511|20875786|P3|COMPLETED|Overall Study||25
8471373|NCT00654511|20875787|P2|COMPLETED|Overall Study||25
8471374|NCT00654511|20875788|P1|COMPLETED|Overall Study||26
8471375|NCT00654511|20875785|P4|STARTED|Overall Study||25
8471376|NCT00654511|20875786|P3|STARTED|Overall Study||25
8471377|NCT00654511|20875787|P2|STARTED|Overall Study||25
8471378|NCT00654511|20875788|P1|STARTED|Overall Study||26
8471379|NCT00654498|20875804|P2|NOT COMPLETED|Overall Study||12
8471380|NCT00654498|20875805|P1|NOT COMPLETED|Overall Study||14
8471381|NCT00654498|20875804|P2|COMPLETED|Overall Study||91
8471382|NCT00654498|20875805|P1|COMPLETED|Overall Study||189
8471383|NCT00654498|20875804|P2|STARTED|Overall Study||103
8471384|NCT00654498|20875805|P1|STARTED|Overall Study||203
8471385|NCT00654420|20875837|P4|NOT COMPLETED|Phase II||38
8471386|NCT00654420|20875838|P3|NOT COMPLETED|Phase II||37
8471387|NCT00654420|20875839|P2|NOT COMPLETED|Phase II||0
8471388|NCT00654420|20875840|P1|NOT COMPLETED|Phase II||0
8471389|NCT00654420|20875837|P4|COMPLETED|Phase II||0
8471390|NCT00654420|20875838|P3|COMPLETED|Phase II||0
8471391|NCT00654420|20875839|P2|COMPLETED|Phase II||0
8471392|NCT00654420|20875840|P1|COMPLETED|Phase II||0
8471393|NCT00654420|20875837|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
8471394|NCT00654420|20875838|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
8471395|NCT00654420|20875839|P2|STARTED|Phase II||0
8471396|NCT00654420|20875840|P1|STARTED|Phase II||0
8471397|NCT00654420|20875837|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
8471398|NCT00654420|20875838|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
8471399|NCT00654420|20875839|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
8471400|NCT00654420|20875840|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
8471401|NCT00654420|20875837|P4|COMPLETED|Phase I (Dose Escalation)||0
8471402|NCT00654420|20875838|P3|COMPLETED|Phase I (Dose Escalation)||0
8471403|NCT00654420|20875839|P2|COMPLETED|Phase I (Dose Escalation)||0
8471404|NCT00654420|20875840|P1|COMPLETED|Phase I (Dose Escalation)||0
8471405|NCT00654420|20875837|P4|STARTED|Phase I (Dose Escalation)||0
8471406|NCT00654420|20875838|P3|STARTED|Phase I (Dose Escalation)||0
8471407|NCT00654420|20875839|P2|STARTED|Phase I (Dose Escalation)||16
8471408|NCT00654420|20875840|P1|STARTED|Phase I (Dose Escalation)||4
8471409|NCT00654381|20875866|P6|NOT COMPLETED|Extension Stage||3
8471410|NCT00654381|20875867|P5|NOT COMPLETED|Extension Stage||3
8471411|NCT00654381|20875868|P4|NOT COMPLETED|Extension Stage||9
8471412|NCT00654381|20875869|P3|NOT COMPLETED|Extension Stage||11
8471413|NCT00654381|20875870|P2|NOT COMPLETED|Extension Stage||2
8471414|NCT00654381|20875871|P1|NOT COMPLETED|Extension Stage||1
8471415|NCT00654381|20875866|P6|COMPLETED|Extension Stage||73
8471416|NCT00654381|20875867|P5|COMPLETED|Extension Stage||68
8471417|NCT00654381|20875868|P4|COMPLETED|Extension Stage||142
8471418|NCT00654381|20875869|P3|COMPLETED|Extension Stage||142
8471419|NCT00654381|20875870|P2|COMPLETED|Extension Stage||36
8471420|NCT00654381|20875871|P1|COMPLETED|Extension Stage||33
8471421|NCT00654381|20875866|P6|STARTED|Extension Stage||76
8471422|NCT00654381|20875867|P5|STARTED|Extension Stage||71
8471423|NCT00654381|20875868|P4|STARTED|Extension Stage||151
8471424|NCT00654381|20875869|P3|STARTED|Extension Stage||153
8471425|NCT00654381|20875870|P2|STARTED|Extension Stage||38
8471426|NCT00654381|20875871|P1|STARTED|Extension Stage||34
8471427|NCT00654381|20875866|P6|NOT COMPLETED|2nd Stage||3
8471428|NCT00654381|20875867|P5|NOT COMPLETED|2nd Stage||8
8471429|NCT00654381|20875868|P4|NOT COMPLETED|2nd Stage||4
8471430|NCT00654381|20875869|P3|NOT COMPLETED|2nd Stage||3
8471431|NCT00654381|20875870|P2|NOT COMPLETED|2nd Stage||0
8471432|NCT00654381|20875871|P1|NOT COMPLETED|2nd Stage||2
8471433|NCT00654381|20875866|P6|COMPLETED|2nd Stage||76
8471434|NCT00654381|20875867|P5|COMPLETED|2nd Stage||71
8471435|NCT00654381|20875868|P4|COMPLETED|2nd Stage||151
8471436|NCT00654381|20875869|P3|COMPLETED|2nd Stage||153
8471437|NCT00654381|20875870|P2|COMPLETED|2nd Stage||38
8471438|NCT00654381|20875871|P1|COMPLETED|2nd Stage||34
8471439|NCT00654381|20875866|P6|STARTED|2nd Stage||79
8471440|NCT00654381|20875867|P5|STARTED|2nd Stage||79
8471441|NCT00654381|20875868|P4|STARTED|2nd Stage||155
8471442|NCT00654381|20875869|P3|STARTED|2nd Stage||156
8471443|NCT00654381|20875870|P2|STARTED|2nd Stage||38
8471444|NCT00654381|20875871|P1|STARTED|2nd Stage||36
8471445|NCT00654381|20875866|P6|NOT COMPLETED|1st Stage||2
8471446|NCT00654381|20875867|P5|NOT COMPLETED|1st Stage||2
8471447|NCT00654381|20875868|P4|NOT COMPLETED|1st Stage||5
8471448|NCT00654381|20875869|P3|NOT COMPLETED|1st Stage||3
8471449|NCT00654381|20875870|P2|NOT COMPLETED|1st Stage||3
8471450|NCT00654381|20875871|P1|NOT COMPLETED|1st Stage||3
8471451|NCT00654381|20875866|P6|COMPLETED|1st Stage||79
8471452|NCT00654381|20875867|P5|COMPLETED|1st Stage||79
8471453|NCT00654381|20875868|P4|COMPLETED|1st Stage||155
8471454|NCT00654381|20875869|P3|COMPLETED|1st Stage||156
8471455|NCT00654381|20875870|P2|COMPLETED|1st Stage||38
8471456|NCT00654381|20875871|P1|COMPLETED|1st Stage||36
8471457|NCT00654381|20875866|P6|STARTED|1st Stage||81
8471458|NCT00654381|20875867|P5|STARTED|1st Stage||81
8471459|NCT00654381|20875868|P4|STARTED|1st Stage||160
8471460|NCT00654381|20875869|P3|STARTED|1st Stage||159
8471461|NCT00654381|20875870|P2|STARTED|1st Stage||41
8471462|NCT00654381|20875871|P1|STARTED|1st Stage||39
8471463|NCT00654368|20875908|P3|NOT COMPLETED|Overall Study||32
8471464|NCT00654368|20875909|P2|NOT COMPLETED|Overall Study||48
8471465|NCT00654368|20875910|P1|NOT COMPLETED|Overall Study||53
8471466|NCT00654368|20875908|P3|COMPLETED|Overall Study||75
8471467|NCT00654368|20875909|P2|COMPLETED|Overall Study||50
8471468|NCT00654368|20875910|P1|COMPLETED|Overall Study||0
8471469|NCT00654368|20875908|P3|STARTED|Overall Study||107
8471470|NCT00654368|20875909|P2|STARTED|Overall Study||98
8471471|NCT00654368|20875910|P1|STARTED|Overall Study||53
8471472|NCT00654355|20875943|P2|NOT COMPLETED|Overall Study||2
8471473|NCT00654355|20875944|P1|NOT COMPLETED|Overall Study||2
8471474|NCT00654355|20875943|P2|COMPLETED|Overall Study||13
8471475|NCT00654355|20875944|P1|COMPLETED|Overall Study||13
8471476|NCT00654355|20875943|P2|STARTED|Overall Study||15
8471477|NCT00654355|20875944|P1|STARTED|Overall Study||15
8471478|NCT00654329|20875958|P4|NOT COMPLETED|Overall Study||0
8471479|NCT00654329|20875959|P3|NOT COMPLETED|Overall Study||0
8471480|NCT00654329|20875960|P2|NOT COMPLETED|Overall Study||0
8471481|NCT00654329|20875961|P1|NOT COMPLETED|Overall Study||0
8471482|NCT00654329|20875958|P4|COMPLETED|Overall Study||27
8471483|NCT00654329|20875959|P3|COMPLETED|Overall Study||23
8471484|NCT00654329|20875960|P2|COMPLETED|Overall Study||28
8471485|NCT00654329|20875961|P1|COMPLETED|Overall Study||23
8471486|NCT00654329|20875958|P4|STARTED|Overall Study||27
8471487|NCT00654329|20875959|P3|STARTED|Overall Study||23
8471488|NCT00654329|20875960|P2|STARTED|Overall Study||28
8471489|NCT00654329|20875961|P1|STARTED|Overall Study||23
8471490|NCT00654238|20875975|P1|NOT COMPLETED|Overall Study||4
8471491|NCT00654238|20875975|P1|COMPLETED|Overall Study||55
8471492|NCT00654238|20875975|P1|STARTED|Overall Study||59
8471493|NCT00654186|20875980|P1|NOT COMPLETED|Overall Study||5
8471494|NCT00654186|20875980|P1|COMPLETED|Overall Study||27
8471495|NCT00654186|20875980|P1|STARTED|Overall Study||32
8471496|NCT00654147|20875988|P2|NOT COMPLETED|Overall Study||4
8471497|NCT00654147|20875989|P1|NOT COMPLETED|Overall Study||2
8471498|NCT00654147|20875988|P2|COMPLETED|Overall Study||19
8471499|NCT00654147|20875989|P1|COMPLETED|Overall Study||19
8471500|NCT00654147|20875988|P2|STARTED|Overall Study||23
8471501|NCT00654147|20875989|P1|STARTED|Overall Study||21
8471502|NCT00654095|20876005|P1|NOT COMPLETED|Overall Study||32
8471503|NCT00654095|20876005|P1|COMPLETED|Overall Study||114
8471504|NCT00654095|20876005|P1|STARTED|Overall Study||146
8471505|NCT00654069|20876012|P3|NOT COMPLETED|Overall Study||18
8471506|NCT00654069|20876013|P2|NOT COMPLETED|Overall Study||11
8471507|NCT00654069|20876014|P1|NOT COMPLETED|Overall Study||17
8471508|NCT00654069|20876012|P3|COMPLETED|Overall Study||116
8471509|NCT00654069|20876013|P2|COMPLETED|Overall Study||124
8471510|NCT00654069|20876014|P1|COMPLETED|Overall Study||119
8471511|NCT00654069|20876012|P3|STARTED|Overall Study||134
8471512|NCT00654069|20876013|P2|STARTED|Overall Study||135
8471513|NCT00654069|20876014|P1|STARTED|Overall Study||136
8471514|NCT00654030|20876022|P1|NOT COMPLETED|Overall Study||1
8471515|NCT00654030|20876022|P1|COMPLETED|Overall Study||11
8471516|NCT00654030|20876022|P1|STARTED|Overall Study||12
8471517|NCT00654004|20876028|P2|NOT COMPLETED|Overall Study||0
8471518|NCT00654004|20876029|P1|NOT COMPLETED|Overall Study||1
8471519|NCT00654004|20876028|P2|COMPLETED|Overall Study||12
8471520|NCT00654004|20876029|P1|COMPLETED|Overall Study||13
8471521|NCT00654004|20876028|P2|STARTED|Overall Study||12
8471522|NCT00654004|20876029|P1|STARTED|Overall Study||14
8471523|NCT00653991|20876045|P2|NOT COMPLETED|6 Month Follow-up||141
8471524|NCT00653991|20876046|P1|NOT COMPLETED|6 Month Follow-up||133
8471525|NCT00653991|20876045|P2|COMPLETED|6 Month Follow-up||350
8471526|NCT00653991|20876046|P1|COMPLETED|6 Month Follow-up||311
8471527|NCT00653991|20876045|P2|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
8471528|NCT00653991|20876046|P1|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
8471529|NCT00653991|20876045|P2|NOT COMPLETED|3 Month Follow-up||157
8471530|NCT00653991|20876046|P1|NOT COMPLETED|3 Month Follow-up||150
8471531|NCT00653991|20876045|P2|COMPLETED|3 Month Follow-up||334
8471532|NCT00653991|20876046|P1|COMPLETED|3 Month Follow-up||294
8471533|NCT00653991|20876045|P2|STARTED|3 Month Follow-up||491
8471534|NCT00653991|20876046|P1|STARTED|3 Month Follow-up||444
8471535|NCT00653939|20876058|P2|NOT COMPLETED|Overall Study||15
8471536|NCT00653939|20876059|P1|NOT COMPLETED|Overall Study||12
8471537|NCT00653939|20876058|P2|COMPLETED|Overall Study||17
8471538|NCT00653939|20876059|P1|COMPLETED|Overall Study||19
8471539|NCT00653939|20876058|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
8471540|NCT00653939|20876059|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
8471541|NCT00653861|20876075|P1|NOT COMPLETED|Overall Study||0
8471542|NCT00653861|20876075|P1|COMPLETED|Overall Study||72
8471543|NCT00653861|20876075|P1|STARTED|Overall Study||72
8471544|NCT00653523|20876084|P1|NOT COMPLETED|Overall Study||19
8471545|NCT00653523|20876084|P1|COMPLETED|Overall Study||132
8471546|NCT00653523|20876084|P1|STARTED|Overall Study||151
8471547|NCT00653432|20876090|P2|NOT COMPLETED|Overall Study||16
8471548|NCT00653432|20876091|P1|NOT COMPLETED|Overall Study||22
8471549|NCT00653432|20876090|P2|COMPLETED|Overall Study||169
8471550|NCT00653432|20876091|P1|COMPLETED|Overall Study||162
8471551|NCT00653432|20876090|P2|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
8471552|NCT00653432|20876091|P1|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
8471553|NCT00653432|20876090|P2|STARTED|Overall Study||185
8471554|NCT00653432|20876091|P1|STARTED|Overall Study||184
8471555|NCT00653328|20876115|P1|NOT COMPLETED|Overall Study||15
8471556|NCT00653328|20876115|P1|COMPLETED|Overall Study||0
8471557|NCT00653328|20876115|P1|STARTED|Overall Study||15
8471558|NCT00653263|20876122|P1|NOT COMPLETED|Overall Study||2
8471559|NCT00653263|20876122|P1|COMPLETED|Overall Study||6
8471560|NCT00653263|20876122|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
8471561|NCT00653224|20876130|P2|NOT COMPLETED|Overall Study||7
8471562|NCT00653224|20876131|P1|NOT COMPLETED|Overall Study||7
8471563|NCT00653224|20876130|P2|COMPLETED|Overall Study||280
8471564|NCT00653224|20876131|P1|COMPLETED|Overall Study||286
8471565|NCT00653224|20876130|P2|STARTED|Overall Study||287
8471566|NCT00653224|20876131|P1|STARTED|Overall Study||293
8471567|NCT00653159|20876317|P2|NOT COMPLETED|Overall Study||3
8471568|NCT00653159|20876318|P1|NOT COMPLETED|Overall Study||5
8471569|NCT00653159|20876317|P2|COMPLETED|Overall Study||9
8471570|NCT00653159|20876318|P1|COMPLETED|Overall Study||6
8471571|NCT00653159|20876317|P2|STARTED|Overall Study||12
8471572|NCT00653159|20876318|P1|STARTED|Overall Study||11
8471573|NCT00653133|20876334|P2|NOT COMPLETED|Overall Study||0
8471574|NCT00653133|20876335|P1|NOT COMPLETED|Overall Study||0
8471575|NCT00653133|20876334|P2|COMPLETED|Overall Study||497
8471576|NCT00653133|20876335|P1|COMPLETED|Overall Study||1324
8471577|NCT00653133|20876334|P2|STARTED|Overall Study||497
8471578|NCT00653133|20876335|P1|STARTED|Overall Study||1324
8471582|NCT00652951|20876359|P3|NOT COMPLETED|Booster Phase||0
8471583|NCT00652951|20876360|P2|NOT COMPLETED|Booster Phase||1
8471584|NCT00652951|20876361|P1|NOT COMPLETED|Booster Phase||1
8471585|NCT00652951|20876359|P3|COMPLETED|Booster Phase||258
8471586|NCT00652951|20876360|P2|COMPLETED|Booster Phase||258
8471587|NCT00652951|20876361|P1|COMPLETED|Booster Phase||256
8471588|NCT00652951|20876359|P3|STARTED|Booster Phase||258
8471589|NCT00652951|20876360|P2|STARTED|Booster Phase||259
8471590|NCT00652951|20876361|P1|STARTED|Booster Phase||257
8471591|NCT00652951|20876359|P3|NOT COMPLETED|Primary Phase||0
8471592|NCT00652951|20876360|P2|NOT COMPLETED|Primary Phase||0
8471593|NCT00652951|20876361|P1|NOT COMPLETED|Primary Phase||0
8471594|NCT00652951|20876359|P3|COMPLETED|Primary Phase||260
8471595|NCT00652951|20876360|P2|COMPLETED|Primary Phase||260
8471596|NCT00652951|20876361|P1|COMPLETED|Primary Phase||260
8471597|NCT00652951|20876359|P3|STARTED|Primary Phase||260
8471598|NCT00652951|20876360|P2|STARTED|Primary Phase||260
8471599|NCT00652951|20876361|P1|STARTED|Primary Phase||260
8471600|NCT00652938|20876498|P3|NOT COMPLETED|Overall Study||5
8471601|NCT00652938|20876499|P2|NOT COMPLETED|Overall Study||7
8471602|NCT00652938|20876500|P1|NOT COMPLETED|Overall Study||1
8471603|NCT00652938|20876498|P3|COMPLETED|Overall Study||242
8471604|NCT00652938|20876499|P2|COMPLETED|Overall Study||240
8471605|NCT00652938|20876500|P1|COMPLETED|Overall Study||246
8471606|NCT00652938|20876498|P3|STARTED|Overall Study||247
8471607|NCT00652938|20876499|P2|STARTED|Overall Study||247
8471608|NCT00652938|20876500|P1|STARTED|Overall Study||247
8471609|NCT00652899|20876565|P1|NOT COMPLETED|Overall Study||2
8471610|NCT00652899|20876565|P1|COMPLETED|Overall Study||12
8471611|NCT00652899|20876565|P1|STARTED|Overall Study||14
8471612|NCT00652834|20876575|P1|NOT COMPLETED|Overall Study||5
8471613|NCT00652834|20876575|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
8471614|NCT00652834|20876575|P1|STARTED|Overall Study||23
8471615|NCT00652743|20876582|P3|NOT COMPLETED|Months 42-48||0
8471616|NCT00652743|20876583|P2|NOT COMPLETED|Months 42-48||0
8471617|NCT00652743|20876584|P1|NOT COMPLETED|Months 42-48||0
8471618|NCT00652743|20876582|P3|COMPLETED|Months 42-48||367
8471619|NCT00652743|20876583|P2|COMPLETED|Months 42-48||170
8471620|NCT00652743|20876584|P1|COMPLETED|Months 42-48||196
8471621|NCT00652743|20876582|P3|STARTED|Months 42-48||367
8471622|NCT00652743|20876583|P2|STARTED|Months 42-48||170
8471623|NCT00652743|20876584|P1|STARTED|Months 42-48||196
8471624|NCT00652743|20876582|P3|NOT COMPLETED|Months 36-42||9
8471625|NCT00652743|20876583|P2|NOT COMPLETED|Months 36-42||5
8471626|NCT00652743|20876584|P1|NOT COMPLETED|Months 36-42||6
8471627|NCT00652743|20876582|P3|COMPLETED|Months 36-42||381
8471628|NCT00652743|20876583|P2|COMPLETED|Months 36-42||180
8471629|NCT00652743|20876584|P1|COMPLETED|Months 36-42||210
8471630|NCT00652743|20876582|P3|STARTED|Months 36-42||390
8471631|NCT00652743|20876583|P2|STARTED|Months 36-42||185
8471632|NCT00652743|20876584|P1|STARTED|Months 36-42||216
8471633|NCT00652743|20876582|P3|NOT COMPLETED|Months 24-30||11
8471634|NCT00652743|20876583|P2|NOT COMPLETED|Months 24-30||1
8471635|NCT00652743|20876584|P1|NOT COMPLETED|Months 24-30||5
8471636|NCT00652743|20876582|P3|COMPLETED|Months 24-30||422
8471637|NCT00652743|20876583|P2|COMPLETED|Months 24-30||185
8471638|NCT00652743|20876584|P1|COMPLETED|Months 24-30||207
8471639|NCT00652743|20876582|P3|STARTED|Months 24-30||433
8471640|NCT00652743|20876583|P2|STARTED|Months 24-30||186
8471641|NCT00652743|20876584|P1|STARTED|Months 24-30||212
8471642|NCT00652743|20876582|P3|NOT COMPLETED|Months 12-18||7
8471643|NCT00652743|20876583|P2|NOT COMPLETED|Months 12-18||2
8471644|NCT00652743|20876584|P1|NOT COMPLETED|Months 12-18||1
8471645|NCT00652743|20876582|P3|COMPLETED|Months 12-18||430
8471646|NCT00652743|20876583|P2|COMPLETED|Months 12-18||186
8471647|NCT00652743|20876584|P1|COMPLETED|Months 12-18||218
8471648|NCT00652743|20876582|P3|STARTED|Months 12-18||437
8471649|NCT00652743|20876583|P2|STARTED|Months 12-18||188
8471650|NCT00652743|20876584|P1|STARTED|Months 12-18||219
8471651|NCT00652626|20876666|P7|NOT COMPLETED|Extension Phase||3
8471652|NCT00652626|20876667|P6|NOT COMPLETED|Extension Phase||12
8471653|NCT00652626|20876668|P5|NOT COMPLETED|Extension Phase||0
8471654|NCT00652626|20876669|P4|NOT COMPLETED|Extension Phase||0
8471655|NCT00652626|20876670|P3|NOT COMPLETED|Extension Phase||0
8471656|NCT00652626|20876671|P2|NOT COMPLETED|Extension Phase||0
8471657|NCT00652626|20876672|P1|NOT COMPLETED|Extension Phase||0
8471658|NCT00652626|20876666|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
8471659|NCT00652626|20876667|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
8471660|NCT00652626|20876668|P5|COMPLETED|Extension Phase||0
8471661|NCT00652626|20876669|P4|COMPLETED|Extension Phase||0
8471662|NCT00652626|20876670|P3|COMPLETED|Extension Phase||0
8471663|NCT00652626|20876671|P2|COMPLETED|Extension Phase||0
8471664|NCT00652626|20876672|P1|COMPLETED|Extension Phase||0
8471665|NCT00652626|20876666|P7|STARTED|Extension Phase||4
8471666|NCT00652626|20876667|P6|STARTED|Extension Phase||14
8471667|NCT00652626|20876668|P5|STARTED|Extension Phase||0
8471668|NCT00652626|20876669|P4|STARTED|Extension Phase||0
8471669|NCT00652626|20876670|P3|STARTED|Extension Phase||0
8471670|NCT00652626|20876671|P2|STARTED|Extension Phase||0
8471671|NCT00652626|20876672|P1|STARTED|Extension Phase||0
8471672|NCT00652626|20876666|P7|NOT COMPLETED|Initial Treatment Phase||0
8471673|NCT00652626|20876667|P6|NOT COMPLETED|Initial Treatment Phase||0
8471674|NCT00652626|20876668|P5|NOT COMPLETED|Initial Treatment Phase||3
8471675|NCT00652626|20876669|P4|NOT COMPLETED|Initial Treatment Phase||1
8471676|NCT00652626|20876670|P3|NOT COMPLETED|Initial Treatment Phase||1
8471677|NCT00652626|20876671|P2|NOT COMPLETED|Initial Treatment Phase||0
8471678|NCT00652626|20876672|P1|NOT COMPLETED|Initial Treatment Phase||0
8471679|NCT00652626|20876666|P7|COMPLETED|Initial Treatment Phase||0
8471680|NCT00652626|20876667|P6|COMPLETED|Initial Treatment Phase||0
8471681|NCT00652626|20876668|P5|COMPLETED|Initial Treatment Phase||5
8471682|NCT00652626|20876669|P4|COMPLETED|Initial Treatment Phase||5
8471683|NCT00652626|20876670|P3|COMPLETED|Initial Treatment Phase||6
8471684|NCT00652626|20876671|P2|COMPLETED|Initial Treatment Phase||5
8471685|NCT00652626|20876672|P1|COMPLETED|Initial Treatment Phase||5
8471686|NCT00652626|20876666|P7|Received Study Drug|Initial Treatment Phase||0
8471687|NCT00652626|20876667|P6|Received Study Drug|Initial Treatment Phase||0
8471688|NCT00652626|20876668|P5|Received Study Drug|Initial Treatment Phase||6
8471689|NCT00652626|20876669|P4|Received Study Drug|Initial Treatment Phase||5
8471690|NCT00652626|20876670|P3|Received Study Drug|Initial Treatment Phase||6
8471691|NCT00652626|20876671|P2|Received Study Drug|Initial Treatment Phase||5
8471692|NCT00652626|20876672|P1|Received Study Drug|Initial Treatment Phase||5
8471693|NCT00652626|20876666|P7|STARTED|Initial Treatment Phase||0
8471694|NCT00652626|20876667|P6|STARTED|Initial Treatment Phase||0
8471695|NCT00652626|20876668|P5|STARTED|Initial Treatment Phase||8
8471696|NCT00652626|20876669|P4|STARTED|Initial Treatment Phase||6
8471697|NCT00652626|20876670|P3|STARTED|Initial Treatment Phase||7
8471698|NCT00652626|20876671|P2|STARTED|Initial Treatment Phase||5
8471699|NCT00652626|20876672|P1|STARTED|Initial Treatment Phase||5
8471700|NCT00652457|20876736|P2|NOT COMPLETED|Overall Study||0
8471701|NCT00652457|20876737|P1|NOT COMPLETED|Overall Study||0
8471702|NCT00652457|20876736|P2|COMPLETED|Overall Study||27
8471703|NCT00652457|20876737|P1|COMPLETED|Overall Study||23
8471704|NCT00652457|20876736|P2|STARTED|Overall Study||27
8471705|NCT00652457|20876737|P1|STARTED|Overall Study||23
8471706|NCT00652366|20876750|P5|NOT COMPLETED|Overall Study||36
8471707|NCT00652366|20876751|P4|NOT COMPLETED|Overall Study||179
8471708|NCT00652366|20876752|P3|NOT COMPLETED|Overall Study||71
8471709|NCT00652366|20876753|P2|NOT COMPLETED|Overall Study||75
8471710|NCT00652366|20876754|P1|NOT COMPLETED|Overall Study||106
8471711|NCT00652366|20876750|P5|COMPLETED|Overall Study||0
8471712|NCT00652366|20876751|P4|COMPLETED|Overall Study||0
8471713|NCT00652366|20876752|P3|COMPLETED|Overall Study||0
8471714|NCT00652366|20876753|P2|COMPLETED|Overall Study||0
8471715|NCT00652366|20876754|P1|COMPLETED|Overall Study||0
8471716|NCT00652366|20876750|P5|STARTED|Overall Study||36
8471717|NCT00652366|20876751|P4|STARTED|Overall Study||179
8471718|NCT00652366|20876752|P3|STARTED|Overall Study||71
8471719|NCT00652366|20876753|P2|STARTED|Overall Study||75
8471720|NCT00652366|20876754|P1|STARTED|Overall Study||106
8471721|NCT00652340|20876789|P2|NOT COMPLETED|Overall Study||3
8471722|NCT00652340|20876790|P1|NOT COMPLETED|Overall Study||4
8471723|NCT00652340|20876789|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
8471724|NCT00652340|20876790|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
8471725|NCT00652340|20876789|P2|STARTED|Overall Study||42
8471726|NCT00652340|20876790|P1|STARTED|Overall Study||78
8471727|NCT00652327|20876800|P2|NOT COMPLETED|Overall Study||5
8471728|NCT00652327|20876801|P1|NOT COMPLETED|Overall Study||0
8471729|NCT00652327|20876800|P2|COMPLETED|Overall Study||36
8471730|NCT00652327|20876801|P1|COMPLETED|Overall Study||42
8471731|NCT00652327|20876800|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
8471732|NCT00652327|20876801|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
8471733|NCT00652314|20876809|P2|NOT COMPLETED|Overall Study||9
8471734|NCT00652314|20876810|P1|NOT COMPLETED|Overall Study||9
8471735|NCT00652314|20876809|P2|COMPLETED|Overall Study||26
8471736|NCT00652314|20876810|P1|COMPLETED|Overall Study||53
8471737|NCT00652314|20876809|P2|STARTED|Overall Study||35
8471738|NCT00652314|20876810|P1|STARTED|Overall Study||62
8471739|NCT00652145|20876826|P2|NOT COMPLETED|Overall Study||0
8471740|NCT00652145|20876827|P1|NOT COMPLETED|Overall Study||0
8471741|NCT00652145|20876826|P2|COMPLETED|Overall Study||26
8471742|NCT00652145|20876827|P1|COMPLETED|Overall Study||26
8471743|NCT00652145|20876826|P2|STARTED|Overall Study||26
8471744|NCT00652145|20876827|P1|STARTED|Overall Study||26
8471745|NCT00652093|20876843|P6|NOT COMPLETED|Overall Study||0
8471746|NCT00652093|20876844|P5|NOT COMPLETED|Overall Study||2
8471747|NCT00652093|20876845|P4|NOT COMPLETED|Overall Study||0
8471748|NCT00652093|20876846|P3|NOT COMPLETED|Overall Study||1
8471749|NCT00652093|20876847|P2|NOT COMPLETED|Overall Study||0
8471750|NCT00652093|20876848|P1|NOT COMPLETED|Overall Study||0
8471751|NCT00652093|20876843|P6|COMPLETED|Overall Study||4
8471752|NCT00652093|20876844|P5|COMPLETED|Overall Study||2
8471753|NCT00652093|20876845|P4|COMPLETED|Overall Study||4
8471754|NCT00652093|20876846|P3|COMPLETED|Overall Study||3
8471755|NCT00652093|20876847|P2|COMPLETED|Overall Study||4
8471756|NCT00652093|20876848|P1|COMPLETED|Overall Study||4
8471757|NCT00652093|20876843|P6|STARTED|Overall Study||4
8471758|NCT00652093|20876844|P5|STARTED|Overall Study||4
8471759|NCT00652093|20876845|P4|STARTED|Overall Study||4
8471760|NCT00652093|20876846|P3|STARTED|Overall Study||4
8471761|NCT00652093|20876847|P2|STARTED|Overall Study||4
8471762|NCT00652093|20876848|P1|STARTED|Overall Study||4
8471763|NCT00652080|20876928|P1|NOT COMPLETED|Overall Study||4
8471764|NCT00652080|20876928|P1|COMPLETED|Overall Study||31
8471765|NCT00652080|20876928|P1|STARTED|Overall Study||35
8471766|NCT00652028|20876938|P4|NOT COMPLETED|Overall Study||0
8471767|NCT00652028|20876939|P3|NOT COMPLETED|Overall Study||1
8471768|NCT00652028|20876940|P2|NOT COMPLETED|Overall Study||1
8471769|NCT00652028|20876941|P1|NOT COMPLETED|Overall Study||1
8471770|NCT00652028|20876938|P4|COMPLETED|Overall Study||14
8471771|NCT00652028|20876939|P3|COMPLETED|Overall Study||14
8471772|NCT00652028|20876940|P2|COMPLETED|Overall Study||13
8471773|NCT00652028|20876941|P1|COMPLETED|Overall Study||15
8471774|NCT00652028|20876938|P4|STARTED|Overall Study||14
8471775|NCT00652028|20876939|P3|STARTED|Overall Study||15
8471776|NCT00652028|20876940|P2|STARTED|Overall Study||14
8471777|NCT00652028|20876941|P1|STARTED|Overall Study||16
8471778|NCT00651937|20876985|P2|NOT COMPLETED|Overall Study||1
8471779|NCT00651937|20876986|P1|NOT COMPLETED|Overall Study||4
8471780|NCT00651937|20876985|P2|COMPLETED|Overall Study||40
8471781|NCT00651937|20876986|P1|COMPLETED|Overall Study||35
8471782|NCT00651937|20876985|P2|STARTED|Overall Study||41
8471783|NCT00651937|20876986|P1|STARTED|Overall Study||39
8471784|NCT00651924|20876996|P2|NOT COMPLETED|Overall Study||7
8471785|NCT00651924|20876997|P1|NOT COMPLETED|Overall Study||0
8471786|NCT00651924|20876996|P2|COMPLETED|Overall Study||2
8471787|NCT00651924|20876997|P1|COMPLETED|Overall Study||18
8471788|NCT00651924|20876996|P2|STARTED|Overall Study||9
8471789|NCT00651924|20876997|P1|STARTED|Overall Study||18
8471790|NCT00651820|20877003|P1|NOT COMPLETED|Overall Study||2
8471791|NCT00651820|20877003|P1|COMPLETED|Overall Study||26
8471792|NCT00651820|20877003|P1|STARTED|Overall Study||28
8471793|NCT00651794|20877013|P3|NOT COMPLETED|Overall Study||21
8471794|NCT00651794|20877014|P2|NOT COMPLETED|Overall Study||22
8471795|NCT00651794|20877015|P1|NOT COMPLETED|Overall Study||21
8471796|NCT00651794|20877013|P3|COMPLETED|Overall Study||10
8471797|NCT00651794|20877014|P2|COMPLETED|Overall Study||9
8471798|NCT00651794|20877015|P1|COMPLETED|Overall Study||15
8471799|NCT00651794|20877013|P3|STARTED|Overall Study||31
8471800|NCT00651794|20877014|P2|STARTED|Overall Study||31
8471801|NCT00651794|20877015|P1|STARTED|Overall Study||36
8471802|NCT00651755|20877035|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
8471803|NCT00651755|20877036|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
8471804|NCT00651755|20877035|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
8471805|NCT00651755|20877036|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
8471806|NCT00651755|20877035|P2|STARTED|Cycle 2 (Second 21 Days)||9
8471807|NCT00651755|20877036|P1|STARTED|Cycle 2 (Second 21 Days)||10
8471808|NCT00651755|20877035|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
8471809|NCT00651755|20877036|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
8471810|NCT00651755|20877035|P2|COMPLETED|Cycle 1 (First 21 Days)||9
8471811|NCT00651755|20877036|P1|COMPLETED|Cycle 1 (First 21 Days)||10
8471812|NCT00651755|20877035|P2|STARTED|Cycle 1 (First 21 Days)||9
8471813|NCT00651755|20877036|P1|STARTED|Cycle 1 (First 21 Days)||11
8471814|NCT00651664|20877062|P10|NOT COMPLETED|Overall Study||7
8471815|NCT00651664|20877063|P9|NOT COMPLETED|Overall Study||7
8471816|NCT00651664|20877064|P8|NOT COMPLETED|Overall Study||7
8471817|NCT00651664|20877065|P7|NOT COMPLETED|Overall Study||6
8471818|NCT00651664|20877066|P6|NOT COMPLETED|Overall Study||3
8471819|NCT00651664|20877067|P5|NOT COMPLETED|Overall Study||6
8471820|NCT00651664|20877068|P4|NOT COMPLETED|Overall Study||14
8471821|NCT00651664|20877069|P3|NOT COMPLETED|Overall Study||3
8471822|NCT00651664|20877070|P2|NOT COMPLETED|Overall Study||3
8471823|NCT00651664|20877071|P1|NOT COMPLETED|Overall Study||3
8471824|NCT00651664|20877062|P10|COMPLETED|Overall Study||0
8471825|NCT00651664|20877063|P9|COMPLETED|Overall Study||0
8471826|NCT00651664|20877064|P8|COMPLETED|Overall Study||0
8471827|NCT00651664|20877065|P7|COMPLETED|Overall Study||0
8471828|NCT00651664|20877066|P6|COMPLETED|Overall Study||0
8471829|NCT00651664|20877067|P5|COMPLETED|Overall Study||0
8471830|NCT00651664|20877068|P4|COMPLETED|Overall Study||0
8471831|NCT00651664|20877069|P3|COMPLETED|Overall Study||0
8471832|NCT00651664|20877070|P2|COMPLETED|Overall Study||0
8471833|NCT00651664|20877071|P1|COMPLETED|Overall Study||0
8471834|NCT00651664|20877062|P10|STARTED|Overall Study||7
8471835|NCT00651664|20877063|P9|STARTED|Overall Study||7
8471836|NCT00651664|20877064|P8|STARTED|Overall Study||7
8471837|NCT00651664|20877065|P7|STARTED|Overall Study||6
8471838|NCT00651664|20877066|P6|STARTED|Overall Study||3
8471839|NCT00651664|20877067|P5|STARTED|Overall Study||6
8471840|NCT00651664|20877068|P4|STARTED|Overall Study||14
8471841|NCT00651664|20877069|P3|STARTED|Overall Study||3
8471842|NCT00651664|20877070|P2|STARTED|Overall Study||3
8471843|NCT00651664|20877071|P1|STARTED|Overall Study||3
8471844|NCT00651625|20877197|P2|NOT COMPLETED|Overall Study||0
8471845|NCT00651625|20877198|P1|NOT COMPLETED|Overall Study||0
8471846|NCT00651625|20877197|P2|COMPLETED|Overall Study||218
8471847|NCT00651625|20877198|P1|COMPLETED|Overall Study||219
8471848|NCT00651625|20877197|P2|STARTED|Overall Study||218
8471849|NCT00651625|20877198|P1|STARTED|Overall Study||219
8471850|NCT00651573|20877212|P2|NOT COMPLETED|Overall Study||3
8471851|NCT00651573|20877213|P1|NOT COMPLETED|Overall Study||2
8471852|NCT00651573|20877212|P2|COMPLETED|Overall Study||354
8471853|NCT00651573|20877213|P1|COMPLETED|Overall Study||363
8471854|NCT00651573|20877212|P2|STARTED|Overall Study||357
8471855|NCT00651573|20877213|P1|STARTED|Overall Study||365
8471856|NCT00651482|20877229|P1|NOT COMPLETED|Overall Study||0
8471857|NCT00651482|20877229|P1|COMPLETED|Overall Study||10
8471858|NCT00651482|20877229|P1|STARTED|Overall Study||10
8471859|NCT00651313|20877243|P2|NOT COMPLETED|Overall Study||6
8471860|NCT00651313|20877244|P1|NOT COMPLETED|Overall Study||6
8471861|NCT00651313|20877243|P2|COMPLETED|Overall Study||37
8471862|NCT00651313|20877244|P1|COMPLETED|Overall Study||35
8471863|NCT00651313|20877243|P2|STARTED|Overall Study||43
8471864|NCT00651313|20877244|P1|STARTED|Overall Study||41
8471865|NCT00651261|20877252|P2|NOT COMPLETED|Overall Study||306
8471866|NCT00651261|20877253|P1|NOT COMPLETED|Overall Study||291
8471867|NCT00651261|20877252|P2|COMPLETED|Overall Study||51
8471868|NCT00651261|20877253|P1|COMPLETED|Overall Study||69
8471869|NCT00651261|20877252|P2|STARTED|Overall Study||357
8471870|NCT00651261|20877253|P1|STARTED|Overall Study||360
8471871|NCT00651183|20877269|P2|NOT COMPLETED|Overall Study||10
8471872|NCT00651183|20877270|P1|NOT COMPLETED|Overall Study||20
8471873|NCT00651183|20877269|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
8471874|NCT00651183|20877270|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
8471875|NCT00651183|20877269|P2|STARTED|Overall Study||97
8471876|NCT00651183|20877270|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
8471877|NCT00651157|20877282|P1|NOT COMPLETED|Overall Study||2
8471878|NCT00651157|20877282|P1|COMPLETED|Overall Study||21
8471879|NCT00651157|20877282|P1|STARTED|Overall Study||23
8471880|NCT00651118|20877292|P4|NOT COMPLETED|Overall Study||7
8471881|NCT00651118|20877293|P3|NOT COMPLETED|Overall Study||11
8471882|NCT00651118|20877294|P2|NOT COMPLETED|Overall Study||7
8471883|NCT00651118|20877295|P1|NOT COMPLETED|Overall Study||9
8471884|NCT00651118|20877292|P4|COMPLETED|Overall Study||203
8471885|NCT00651118|20877293|P3|COMPLETED|Overall Study||197
8471886|NCT00651118|20877294|P2|COMPLETED|Overall Study||200
8471887|NCT00651118|20877295|P1|COMPLETED|Overall Study||198
8471888|NCT00651118|20877292|P4|STARTED|Overall Study||210
8471889|NCT00651118|20877293|P3|STARTED|Overall Study||208
8471890|NCT00651118|20877294|P2|STARTED|Overall Study||207
8471891|NCT00651118|20877295|P1|STARTED|Overall Study||207
8471892|NCT00651040|20877315|P2|NOT COMPLETED|Overall Study||1
8471893|NCT00651040|20877316|P1|NOT COMPLETED|Overall Study||3
8471894|NCT00651040|20877315|P2|COMPLETED|Overall Study||14
8471895|NCT00651040|20877316|P1|COMPLETED|Overall Study||13
8471896|NCT00651040|20877315|P2|STARTED|Overall Study||15
8471897|NCT00651040|20877316|P1|STARTED|Overall Study||16
8471898|NCT00650936|20877322|P1|NOT COMPLETED|Overall Study||70
8471899|NCT00650936|20877322|P1|COMPLETED|Overall Study||930
8471900|NCT00650936|20877322|P1|STARTED|Overall Study||1000
8471901|NCT00650858|20877331|P3|NOT COMPLETED|Overall Study||0
8471902|NCT00650858|20877332|P2|NOT COMPLETED|Overall Study||0
8471903|NCT00650858|20877333|P1|NOT COMPLETED|Overall Study||0
8471904|NCT00650858|20877331|P3|COMPLETED|Overall Study||36
8471905|NCT00650858|20877332|P2|COMPLETED|Overall Study||8
8471906|NCT00650858|20877333|P1|COMPLETED|Overall Study||8
8471907|NCT00650858|20877331|P3|STARTED|Overall Study||36
8471908|NCT00650858|20877332|P2|STARTED|Overall Study||8
8471909|NCT00650858|20877333|P1|STARTED|Overall Study||8
8471910|NCT00650845|20877364|P2|NOT COMPLETED|Overall Study||13
8471911|NCT00650845|20877365|P1|NOT COMPLETED|Overall Study||5
8471912|NCT00650845|20877364|P2|COMPLETED|Overall Study||44
8471913|NCT00650845|20877365|P1|COMPLETED|Overall Study||70
8471914|NCT00650845|20877364|P2|STARTED|Overall Study||57
8471915|NCT00650845|20877365|P1|STARTED|Overall Study||75
8471916|NCT00650806|20877385|P4|NOT COMPLETED|Overall Study||26
8471917|NCT00650806|20877386|P3|NOT COMPLETED|Overall Study||29
8471918|NCT00650806|20877387|P2|NOT COMPLETED|Overall Study||21
8471919|NCT00650806|20877388|P1|NOT COMPLETED|Overall Study||18
8471920|NCT00650806|20877385|P4|COMPLETED|Overall Study||70
8471921|NCT00650806|20877386|P3|COMPLETED|Overall Study||64
8471922|NCT00650806|20877387|P2|COMPLETED|Overall Study||77
8471923|NCT00650806|20877388|P1|COMPLETED|Overall Study||71
8471924|NCT00650806|20877385|P4|STARTED|Overall Study||96
8471925|NCT00650806|20877386|P3|STARTED|Overall Study||93
8471926|NCT00650806|20877387|P2|STARTED|Overall Study||98
8471927|NCT00650806|20877388|P1|STARTED|Overall Study||89
8471928|NCT00650767|20877430|P4|NOT COMPLETED|Overall Study||11
8471929|NCT00650767|20877431|P3|NOT COMPLETED|Overall Study||14
8471930|NCT00650767|20877432|P2|NOT COMPLETED|Overall Study||9
8471931|NCT00650767|20877433|P1|NOT COMPLETED|Overall Study||5
8471932|NCT00650767|20877430|P4|COMPLETED|Overall Study||39
8471933|NCT00650767|20877431|P3|COMPLETED|Overall Study||36
8471934|NCT00650767|20877432|P2|COMPLETED|Overall Study||41
8471935|NCT00650767|20877433|P1|COMPLETED|Overall Study||46
8471936|NCT00650767|20877430|P4|STARTED|Overall Study||50
8471937|NCT00650767|20877431|P3|STARTED|Overall Study||50
8471938|NCT00650767|20877432|P2|STARTED|Overall Study||50
8471939|NCT00650767|20877433|P1|STARTED|Overall Study||51
8471940|NCT00650585|20877937|P2|NOT COMPLETED|Overall Study||1477
8471941|NCT00650585|20877938|P1|NOT COMPLETED|Overall Study||1797
8471942|NCT00650585|20877937|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
8471943|NCT00650585|20877938|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
8471944|NCT00650585|20877937|P2|STARTED|Overall Study||3990
8471945|NCT00650585|20877938|P1|STARTED|Overall Study||4348
8471946|NCT00650546|20877958|P1|NOT COMPLETED|Overall Study||0
8471947|NCT00650546|20877958|P1|COMPLETED|Overall Study||8
8471948|NCT00650546|20877958|P1|STARTED|Overall Study||8
8471949|NCT00650260|20877965|P2|NOT COMPLETED|Overall Study||0
8471950|NCT00650260|20877966|P1|NOT COMPLETED|Overall Study||0
8471951|NCT00650260|20877965|P2|COMPLETED|Overall Study||21
8471952|NCT00650260|20877966|P1|COMPLETED|Overall Study||21
8471953|NCT00650260|20877965|P2|STARTED|Overall Study||21
8471954|NCT00650260|20877966|P1|STARTED|Overall Study||21
8471955|NCT00650104|20877982|P1|NOT COMPLETED|Overall Study||41
8471956|NCT00650104|20877982|P1|COMPLETED|Overall Study||42
8471957|NCT00650104|20877982|P1|STARTED|Overall Study||83
8471958|NCT00650091|20877997|P3|NOT COMPLETED|Amended Study Design||0
8471959|NCT00650091|20877998|P2|NOT COMPLETED|Amended Study Design||20
8471960|NCT00650091|20877999|P1|NOT COMPLETED|Amended Study Design||23
8471961|NCT00650091|20877997|P3|COMPLETED|Amended Study Design||0
8471962|NCT00650091|20877998|P2|COMPLETED|Amended Study Design||111
8471963|NCT00650091|20877999|P1|COMPLETED|Amended Study Design||110
8471964|NCT00650091|20877997|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
8471965|NCT00650091|20877998|P2|STARTED|Amended Study Design||131
8471966|NCT00650091|20877999|P1|STARTED|Amended Study Design||133
8471967|NCT00650091|20877997|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8471968|NCT00650091|20877998|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8471969|NCT00650091|20877999|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8471970|NCT00650091|20877997|P3|COMPLETED|Initial Study Design - Interim Analysis||77
8471971|NCT00650091|20877998|P2|COMPLETED|Initial Study Design - Interim Analysis||78
8471972|NCT00650091|20877999|P1|COMPLETED|Initial Study Design - Interim Analysis||81
8471973|NCT00650091|20877997|P3|STARTED|Initial Study Design - Interim Analysis||77
8471974|NCT00650091|20877998|P2|STARTED|Initial Study Design - Interim Analysis||78
8471975|NCT00650091|20877999|P1|STARTED|Initial Study Design - Interim Analysis||81
8471976|NCT00650078|20878019|P2|NOT COMPLETED|Overall Study||13
8471977|NCT00650078|20878020|P1|NOT COMPLETED|Overall Study||14
8471978|NCT00650078|20878019|P2|COMPLETED|Overall Study||106
8471979|NCT00650078|20878020|P1|COMPLETED|Overall Study||217
8471980|NCT00650078|20878019|P2|STARTED|Overall Study||119
8471981|NCT00650078|20878020|P1|STARTED|Overall Study||231
8471982|NCT00649961|20878028|P1|NOT COMPLETED|Overall Study||0
8471983|NCT00649961|20878028|P1|COMPLETED|Overall Study||18
8471984|NCT00649961|20878028|P1|STARTED|Overall Study||18
8471985|NCT00649792|20878032|P1|NOT COMPLETED|Overall Study||68
8471986|NCT00649792|20878032|P1|COMPLETED|Overall Study||146
8471987|NCT00649792|20878032|P1|STARTED|Overall Study||214
8471988|NCT00649428|20878042|P2|NOT COMPLETED|Overall Study||15
8471989|NCT00649428|20878043|P1|NOT COMPLETED|Overall Study||20
8471990|NCT00649428|20878042|P2|COMPLETED|Overall Study||88
8471991|NCT00649428|20878043|P1|COMPLETED|Overall Study||80
8471992|NCT00649428|20878042|P2|STARTED|Overall Study||103
8471993|NCT00649428|20878043|P1|STARTED|Overall Study||100
8471994|NCT00649389|20878059|P4|NOT COMPLETED|Overall Study||111
8471995|NCT00649389|20878060|P3|NOT COMPLETED|Overall Study||88
8471996|NCT00649389|20878061|P2|NOT COMPLETED|Overall Study||106
8471997|NCT00649389|20878062|P1|NOT COMPLETED|Overall Study||71
8471998|NCT00649389|20878059|P4|COMPLETED|Overall Study||516
8471999|NCT00649389|20878060|P3|COMPLETED|Overall Study||512
8472000|NCT00649389|20878061|P2|COMPLETED|Overall Study||531
8472001|NCT00649389|20878062|P1|COMPLETED|Overall Study||557
8472002|NCT00649389|20878059|P4|STARTED|Overall Study||627
8472003|NCT00649389|20878060|P3|STARTED|Overall Study||600
8472004|NCT00649389|20878061|P2|STARTED|Overall Study||637
8472005|NCT00649389|20878062|P1|STARTED|Overall Study||628
8472006|NCT00649220|20878084|P1|NOT COMPLETED|Overall Study||3
8472007|NCT00649220|20878084|P1|COMPLETED|Overall Study||16
8472008|NCT00649220|20878084|P1|STARTED|Overall Study||19
8472009|NCT00648908|20878095|P1|NOT COMPLETED|Overall Study||115
8472010|NCT00648908|20878095|P1|COMPLETED|Overall Study||154
8472011|NCT00648908|20878095|P1|STARTED|Overall Study||269
8472012|NCT00648895|20878105|P2|NOT COMPLETED|Overall Study||1
8472013|NCT00648895|20878106|P1|NOT COMPLETED|Overall Study||0
8472014|NCT00648895|20878105|P2|COMPLETED|Overall Study||5
8472015|NCT00648895|20878106|P1|COMPLETED|Overall Study||6
8472016|NCT00648895|20878105|P2|STARTED|Overall Study||6
8472017|NCT00648895|20878106|P1|STARTED|Overall Study||6
8472018|NCT00648739|20878112|P7|NOT COMPLETED|Overall Study||1
8472019|NCT00648739|20878113|P6|NOT COMPLETED|Overall Study||5
8472020|NCT00648739|20878114|P5|NOT COMPLETED|Overall Study||2
8472021|NCT00648739|20878115|P4|NOT COMPLETED|Overall Study||2
8472022|NCT00648739|20878116|P3|NOT COMPLETED|Overall Study||3
8472023|NCT00648739|20878117|P2|NOT COMPLETED|Overall Study||2
8472024|NCT00648739|20878118|P1|NOT COMPLETED|Overall Study||2
8472025|NCT00648739|20878112|P7|COMPLETED|Overall Study||0
8472026|NCT00648739|20878113|P6|COMPLETED|Overall Study||2
8472027|NCT00648739|20878114|P5|COMPLETED|Overall Study||1
8472028|NCT00648739|20878115|P4|COMPLETED|Overall Study||1
8472029|NCT00648739|20878116|P3|COMPLETED|Overall Study||0
8472030|NCT00648739|20878117|P2|COMPLETED|Overall Study||3
8472031|NCT00648739|20878118|P1|COMPLETED|Overall Study||2
8472032|NCT00648739|20878112|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
8472033|NCT00648739|20878113|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
8472034|NCT00648739|20878114|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8472035|NCT00648739|20878115|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8472036|NCT00648739|20878116|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8472037|NCT00648739|20878117|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
8472038|NCT00648739|20878118|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8472039|NCT00648739|20878112|P7|STARTED|Overall Study||1
8472040|NCT00648739|20878113|P6|STARTED|Overall Study||7
8472041|NCT00648739|20878114|P5|STARTED|Overall Study||3
8472042|NCT00648739|20878115|P4|STARTED|Overall Study||3
8472043|NCT00648739|20878116|P3|STARTED|Overall Study||3
8472044|NCT00648739|20878117|P2|STARTED|Overall Study||5
8472045|NCT00648739|20878118|P1|STARTED|Overall Study||4
8472046|NCT00648648|20878184|P28|NOT COMPLETED|Overall Study||12
8472047|NCT00648648|20878185|P27|NOT COMPLETED|Overall Study||26
8472048|NCT00648648|20878186|P26|NOT COMPLETED|Overall Study||4
8472049|NCT00648648|20878187|P25|NOT COMPLETED|Overall Study||4
8472050|NCT00648648|20878188|P24|NOT COMPLETED|Overall Study||4
8472051|NCT00648648|20878189|P23|NOT COMPLETED|Overall Study||14
8472052|NCT00648648|20878190|P22|NOT COMPLETED|Overall Study||10
8472053|NCT00648648|20878191|P21|NOT COMPLETED|Overall Study||6
8472054|NCT00648648|20878192|P20|NOT COMPLETED|Overall Study||7
8472055|NCT00648648|20878193|P19|NOT COMPLETED|Overall Study||5
8472056|NCT00648648|20878194|P18|NOT COMPLETED|Overall Study||6
8472057|NCT00648648|20878195|P17|NOT COMPLETED|Overall Study||14
8472058|NCT00648648|20878196|P16|NOT COMPLETED|Overall Study||11
8472059|NCT00648648|20878197|P15|NOT COMPLETED|Overall Study||4
8472060|NCT00648648|20878198|P14|NOT COMPLETED|Overall Study||5
8472061|NCT00648648|20878199|P13|NOT COMPLETED|Overall Study||6
8472062|NCT00648648|20878200|P12|NOT COMPLETED|Overall Study||13
8472063|NCT00648648|20878201|P11|NOT COMPLETED|Overall Study||6
8472064|NCT00648648|20878202|P10|NOT COMPLETED|Overall Study||10
8472065|NCT00648648|20878203|P9|NOT COMPLETED|Overall Study||3
8472066|NCT00648648|20878204|P8|NOT COMPLETED|Overall Study||1
8472067|NCT00648648|20878205|P7|NOT COMPLETED|Overall Study||10
8472068|NCT00648648|20878206|P6|NOT COMPLETED|Overall Study||1
8472069|NCT00648648|20878207|P5|NOT COMPLETED|Overall Study||9
8472070|NCT00648648|20878208|P4|NOT COMPLETED|Overall Study||4
8472071|NCT00648648|20878209|P3|NOT COMPLETED|Overall Study||0
8472072|NCT00648648|20878210|P2|NOT COMPLETED|Overall Study||0
8472073|NCT00648648|20878211|P1|NOT COMPLETED|Overall Study||0
8472074|NCT00648648|20878184|P28|COMPLETED|Overall Study||0
8472075|NCT00648648|20878185|P27|COMPLETED|Overall Study||0
8472076|NCT00648648|20878186|P26|COMPLETED|Overall Study||0
8472077|NCT00648648|20878187|P25|COMPLETED|Overall Study||0
8472078|NCT00648648|20878188|P24|COMPLETED|Overall Study||0
8472079|NCT00648648|20878189|P23|COMPLETED|Overall Study||0
8472080|NCT00648648|20878190|P22|COMPLETED|Overall Study||0
8472081|NCT00648648|20878191|P21|COMPLETED|Overall Study||0
8472082|NCT00648648|20878192|P20|COMPLETED|Overall Study||0
8472083|NCT00648648|20878193|P19|COMPLETED|Overall Study||0
8472084|NCT00648648|20878194|P18|COMPLETED|Overall Study||0
8472085|NCT00648648|20878195|P17|COMPLETED|Overall Study||2
8472086|NCT00648648|20878196|P16|COMPLETED|Overall Study||0
8472087|NCT00648648|20878197|P15|COMPLETED|Overall Study||0
8472088|NCT00648648|20878198|P14|COMPLETED|Overall Study||0
8472089|NCT00648648|20878199|P13|COMPLETED|Overall Study||0
8472090|NCT00648648|20878200|P12|COMPLETED|Overall Study||0
8472091|NCT00648648|20878201|P11|COMPLETED|Overall Study||0
8472092|NCT00648648|20878202|P10|COMPLETED|Overall Study||0
8472093|NCT00648648|20878203|P9|COMPLETED|Overall Study||0
8472094|NCT00648648|20878204|P8|COMPLETED|Overall Study||0
8472095|NCT00648648|20878205|P7|COMPLETED|Overall Study||0
8472096|NCT00648648|20878206|P6|COMPLETED|Overall Study||0
8472097|NCT00648648|20878207|P5|COMPLETED|Overall Study||0
8472098|NCT00648648|20878208|P4|COMPLETED|Overall Study||0
8472099|NCT00648648|20878209|P3|COMPLETED|Overall Study||3
8472100|NCT00648648|20878210|P2|COMPLETED|Overall Study||3
8472101|NCT00648648|20878211|P1|COMPLETED|Overall Study||3
8472102|NCT00648648|20878184|P28|Treated|Overall Study||12
8472103|NCT00648648|20878185|P27|Treated|Overall Study||26
8472104|NCT00648648|20878186|P26|Treated|Overall Study||4
8472105|NCT00648648|20878187|P25|Treated|Overall Study||4
8472106|NCT00648648|20878188|P24|Treated|Overall Study||4
8472107|NCT00648648|20878189|P23|Treated|Overall Study||14
8472108|NCT00648648|20878190|P22|Treated|Overall Study||10
8472109|NCT00648648|20878191|P21|Treated|Overall Study||6
8472110|NCT00648648|20878192|P20|Treated|Overall Study||7
8472111|NCT00648648|20878193|P19|Treated|Overall Study||4
8472112|NCT00648648|20878194|P18|Treated|Overall Study||6
8472113|NCT00648648|20878195|P17|Treated|Overall Study||16
8472114|NCT00648648|20878196|P16|Treated|Overall Study||11
8472115|NCT00648648|20878197|P15|Treated|Overall Study||4
8472116|NCT00648648|20878198|P14|Treated|Overall Study||5
8472117|NCT00648648|20878199|P13|Treated|Overall Study||6
8472118|NCT00648648|20878200|P12|Treated|Overall Study||13
8472119|NCT00648648|20878201|P11|Treated|Overall Study||6
8472120|NCT00648648|20878202|P10|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
8472121|NCT00648648|20878203|P9|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
8472122|NCT00648648|20878204|P8|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
8472123|NCT00648648|20878205|P7|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
8472124|NCT00648648|20878206|P6|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
8472125|NCT00648648|20878207|P5|Treated|Overall Study||8
8472126|NCT00648648|20878208|P4|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
8472127|NCT00648648|20878209|P3|Treated|Overall Study||3
8472128|NCT00648648|20878210|P2|Treated|Overall Study||3
8472129|NCT00648648|20878211|P1|Treated|Overall Study||3
8472130|NCT00648648|20878184|P28|STARTED|Overall Study||12
8472131|NCT00648648|20878185|P27|STARTED|Overall Study||26
8472132|NCT00648648|20878186|P26|STARTED|Overall Study||4
8472133|NCT00648648|20878187|P25|STARTED|Overall Study||4
8472134|NCT00648648|20878188|P24|STARTED|Overall Study||4
8472135|NCT00648648|20878189|P23|STARTED|Overall Study||14
8472136|NCT00648648|20878190|P22|STARTED|Overall Study||10
8472137|NCT00648648|20878191|P21|STARTED|Overall Study||6
8472138|NCT00648648|20878192|P20|STARTED|Overall Study||7
8472139|NCT00648648|20878193|P19|STARTED|Overall Study||5
8472140|NCT00648648|20878194|P18|STARTED|Overall Study||6
8472141|NCT00648648|20878195|P17|STARTED|Overall Study||16
8472142|NCT00648648|20878196|P16|STARTED|Overall Study||11
8472143|NCT00648648|20878197|P15|STARTED|Overall Study||4
8472144|NCT00648648|20878198|P14|STARTED|Overall Study||5
8472145|NCT00648648|20878199|P13|STARTED|Overall Study||6
8472146|NCT00648648|20878200|P12|STARTED|Overall Study||13
8472147|NCT00648648|20878201|P11|STARTED|Overall Study||6
8472148|NCT00648648|20878202|P10|STARTED|Overall Study||10
8472149|NCT00648648|20878203|P9|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
8472150|NCT00648648|20878204|P8|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
8472325|NCT00646646|20878699|P3|STARTED|Overall Study||15
8472151|NCT00648648|20878205|P7|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
8472152|NCT00648648|20878206|P6|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
8472153|NCT00648648|20878207|P5|STARTED|Overall Study||9
8472154|NCT00648648|20878208|P4|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
8472155|NCT00648648|20878209|P3|STARTED|Overall Study||3
8472156|NCT00648648|20878210|P2|STARTED|Overall Study||3
8472157|NCT00648648|20878211|P1|STARTED|Overall Study||3
8472158|NCT00648375|20878439|P2|NOT COMPLETED|Overall Study||0
8472159|NCT00648375|20878440|P1|NOT COMPLETED|Overall Study||0
8472160|NCT00648375|20878439|P2|COMPLETED|Overall Study||2
8472161|NCT00648375|20878440|P1|COMPLETED|Overall Study||1
8472162|NCT00648375|20878439|P2|STARTED|Overall Study||2
8472163|NCT00648375|20878440|P1|STARTED|Overall Study||1
8472164|NCT00648167|20878452|P1|NOT COMPLETED|Overall Study||7
8472165|NCT00648167|20878452|P1|COMPLETED|Overall Study||48
8472166|NCT00648167|20878452|P1|Start Dose 6 g/Day|Overall Study||21
8472167|NCT00648167|20878452|P1|Start Dose 4.5 g/Day|Overall Study||34
8472168|NCT00648167|20878452|P1|STARTED|Overall Study||55
8472169|NCT00648115|20878459|P3|NOT COMPLETED|Overall Study||0
8472170|NCT00648115|20878460|P2|NOT COMPLETED|Overall Study||0
8472171|NCT00648115|20878461|P1|NOT COMPLETED|Overall Study||0
8472172|NCT00648115|20878459|P3|COMPLETED|Overall Study||27
8472173|NCT00648115|20878460|P2|COMPLETED|Overall Study||42
8472174|NCT00648115|20878461|P1|COMPLETED|Overall Study||42
8472175|NCT00648115|20878459|P3|STARTED|Overall Study||27
8472176|NCT00648115|20878460|P2|STARTED|Overall Study||42
8472177|NCT00648115|20878461|P1|STARTED|Overall Study||42
8472178|NCT00648037|20878472|P1|NOT COMPLETED|Overall Study||16
8472179|NCT00648037|20878472|P1|COMPLETED|Overall Study||10
8472180|NCT00648037|20878472|P1|STARTED|Overall Study||26
8472181|NCT00647998|20878478|P2|NOT COMPLETED|Overall Study||0
8472182|NCT00647998|20878479|P1|NOT COMPLETED|Overall Study||0
8472183|NCT00647998|20878478|P2|COMPLETED|Overall Study||9
8472184|NCT00647998|20878479|P1|COMPLETED|Overall Study||9
8472185|NCT00647998|20878478|P2|STARTED|Overall Study||9
8472186|NCT00647998|20878479|P1|STARTED|Overall Study||9
8472187|NCT00647699|20878491|P2|NOT COMPLETED|Overall Study||12
8472188|NCT00647699|20878492|P1|NOT COMPLETED|Overall Study||8
8472189|NCT00647699|20878491|P2|COMPLETED|Overall Study||62
8472190|NCT00647699|20878492|P1|COMPLETED|Overall Study||65
8472191|NCT00647699|20878491|P2|STARTED|Overall Study||74
8472192|NCT00647699|20878492|P1|STARTED|Overall Study||73
8472193|NCT00647556|20878500|P2|NOT COMPLETED|Overall Study||2
8472194|NCT00647556|20878501|P1|NOT COMPLETED|Overall Study||3
8472195|NCT00647556|20878500|P2|COMPLETED|Overall Study||13
8472196|NCT00647556|20878501|P1|COMPLETED|Overall Study||12
8472197|NCT00647556|20878500|P2|STARTED|Overall Study||15
8472198|NCT00647556|20878501|P1|STARTED|Overall Study||15
8472199|NCT00647426|20878515|P1|NOT COMPLETED|Overall Study||2
8472200|NCT00647426|20878515|P1|COMPLETED|Overall Study||5
8472201|NCT00647426|20878515|P1|STARTED|Overall Study||7
8472202|NCT00647400|20878524|P2|NOT COMPLETED|Overall Study||13
8472203|NCT00647400|20878525|P1|NOT COMPLETED|Overall Study||22
8472204|NCT00647400|20878524|P2|COMPLETED|Overall Study||45
8472205|NCT00647400|20878525|P1|COMPLETED|Overall Study||67
8472206|NCT00647400|20878524|P2|STARTED|Overall Study||58
8472207|NCT00647400|20878525|P1|STARTED|Overall Study||89
8472208|NCT00647348|20878537|P2|NOT COMPLETED|Overall Study||6
8472209|NCT00647348|20878538|P1|NOT COMPLETED|Overall Study||3
8472210|NCT00647348|20878537|P2|COMPLETED|Overall Study||64
8472211|NCT00647348|20878538|P1|COMPLETED|Overall Study||67
8472212|NCT00647348|20878537|P2|STARTED|Overall Study||70
8472213|NCT00647348|20878538|P1|STARTED|Overall Study||70
8472214|NCT00647270|20878563|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
8472215|NCT00647270|20878564|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
8472216|NCT00647270|20878565|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
8472217|NCT00647270|20878563|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
8472218|NCT00647270|20878564|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
8472219|NCT00647270|20878565|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
8472220|NCT00647270|20878563|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
8472221|NCT00647270|20878564|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
8472222|NCT00647270|20878565|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
8472223|NCT00647270|20878563|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
8472224|NCT00647270|20878564|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
8472225|NCT00647270|20878565|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
8472226|NCT00647270|20878563|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
8472227|NCT00647270|20878564|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
8472228|NCT00647270|20878565|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
8472229|NCT00647270|20878563|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
8472230|NCT00647270|20878564|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
8472231|NCT00647270|20878565|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
8472232|NCT00646958|20878591|P3|NOT COMPLETED|Overall Study||9
8472233|NCT00646958|20878592|P2|NOT COMPLETED|Overall Study||9
8472234|NCT00646958|20878593|P1|NOT COMPLETED|Overall Study||11
8472235|NCT00646958|20878591|P3|COMPLETED|Overall Study||40
8472236|NCT00646958|20878592|P2|COMPLETED|Overall Study||41
8472237|NCT00646958|20878593|P1|COMPLETED|Overall Study||40
8472238|NCT00646958|20878591|P3|STARTED|Overall Study|No. Participants Randomized|49
8472239|NCT00646958|20878592|P2|STARTED|Overall Study|No. Participants Randomized|50
8472240|NCT00646958|20878593|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
8472241|NCT00646906|20878608|P7|NOT COMPLETED|Crossover Period 2||1
8472242|NCT00646906|20878609|P6|NOT COMPLETED|Crossover Period 2||0
8472243|NCT00646906|20878610|P5|NOT COMPLETED|Crossover Period 2||0
8472244|NCT00646906|20878611|P4|NOT COMPLETED|Crossover Period 2||1
8472245|NCT00646906|20878612|P3|NOT COMPLETED|Crossover Period 2||2
8472246|NCT00646906|20878613|P2|NOT COMPLETED|Crossover Period 2||1
8472247|NCT00646906|20878614|P1|NOT COMPLETED|Crossover Period 2||0
8472248|NCT00646906|20878608|P7|COMPLETED|Crossover Period 2||4
8472249|NCT00646906|20878609|P6|COMPLETED|Crossover Period 2||4
8472250|NCT00646906|20878610|P5|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
8472251|NCT00646906|20878611|P4|COMPLETED|Crossover Period 2||8
8472252|NCT00646906|20878612|P3|COMPLETED|Crossover Period 2||8
8472253|NCT00646906|20878613|P2|COMPLETED|Crossover Period 2||8
8472254|NCT00646906|20878614|P1|COMPLETED|Crossover Period 2||8
8472255|NCT00646906|20878608|P7|STARTED|Crossover Period 2||5
8472256|NCT00646906|20878609|P6|STARTED|Crossover Period 2||4
8472257|NCT00646906|20878610|P5|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
8472258|NCT00646906|20878611|P4|STARTED|Crossover Period 2||9
8472259|NCT00646906|20878612|P3|STARTED|Crossover Period 2||10
8472260|NCT00646906|20878613|P2|STARTED|Crossover Period 2||9
8472261|NCT00646906|20878614|P1|STARTED|Crossover Period 2||8
8472262|NCT00646906|20878608|P7|NOT COMPLETED|Washout (>/= 14 Days)||0
8472263|NCT00646906|20878609|P6|NOT COMPLETED|Washout (>/= 14 Days)||0
8472264|NCT00646906|20878610|P5|NOT COMPLETED|Washout (>/= 14 Days)||0
8472265|NCT00646906|20878611|P4|NOT COMPLETED|Washout (>/= 14 Days)||0
8472266|NCT00646906|20878612|P3|NOT COMPLETED|Washout (>/= 14 Days)||0
8472267|NCT00646906|20878613|P2|NOT COMPLETED|Washout (>/= 14 Days)||0
8472268|NCT00646906|20878614|P1|NOT COMPLETED|Washout (>/= 14 Days)||0
8472269|NCT00646906|20878608|P7|COMPLETED|Washout (>/= 14 Days)||5
8472270|NCT00646906|20878609|P6|COMPLETED|Washout (>/= 14 Days)||4
8472271|NCT00646906|20878610|P5|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
8472272|NCT00646906|20878611|P4|COMPLETED|Washout (>/= 14 Days)||9
8472273|NCT00646906|20878612|P3|COMPLETED|Washout (>/= 14 Days)||10
8472274|NCT00646906|20878613|P2|COMPLETED|Washout (>/= 14 Days)||9
8472275|NCT00646906|20878614|P1|COMPLETED|Washout (>/= 14 Days)||8
8472276|NCT00646906|20878608|P7|STARTED|Washout (>/= 14 Days)||5
8472277|NCT00646906|20878609|P6|STARTED|Washout (>/= 14 Days)||4
8472278|NCT00646906|20878610|P5|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
8472279|NCT00646906|20878611|P4|STARTED|Washout (>/= 14 Days)||9
8472280|NCT00646906|20878612|P3|STARTED|Washout (>/= 14 Days)||10
8472281|NCT00646906|20878613|P2|STARTED|Washout (>/= 14 Days)||9
8472282|NCT00646906|20878614|P1|STARTED|Washout (>/= 14 Days)||8
8472283|NCT00646906|20878608|P7|NOT COMPLETED|Crossover Period 1||0
8472284|NCT00646906|20878609|P6|NOT COMPLETED|Crossover Period 1||1
8472285|NCT00646906|20878610|P5|NOT COMPLETED|Crossover Period 1||0
8472286|NCT00646906|20878611|P4|NOT COMPLETED|Crossover Period 1||0
8472287|NCT00646906|20878612|P3|NOT COMPLETED|Crossover Period 1||0
8472288|NCT00646906|20878613|P2|NOT COMPLETED|Crossover Period 1||0
8472289|NCT00646906|20878614|P1|NOT COMPLETED|Crossover Period 1||1
8472290|NCT00646906|20878608|P7|COMPLETED|Crossover Period 1||5
8472291|NCT00646906|20878609|P6|COMPLETED|Crossover Period 1||4
8472292|NCT00646906|20878610|P5|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
8472293|NCT00646906|20878611|P4|COMPLETED|Crossover Period 1||9
8472294|NCT00646906|20878612|P3|COMPLETED|Crossover Period 1||10
8472295|NCT00646906|20878613|P2|COMPLETED|Crossover Period 1||9
8472296|NCT00646906|20878614|P1|COMPLETED|Crossover Period 1||8
8472297|NCT00646906|20878608|P7|STARTED|Crossover Period 1||5
8472298|NCT00646906|20878609|P6|STARTED|Crossover Period 1||5
8472299|NCT00646906|20878610|P5|STARTED|Crossover Period 1||8
8472300|NCT00646906|20878611|P4|STARTED|Crossover Period 1||9
8472301|NCT00646906|20878612|P3|STARTED|Crossover Period 1||10
8472302|NCT00646906|20878613|P2|STARTED|Crossover Period 1||9
8472303|NCT00646906|20878614|P1|STARTED|Crossover Period 1||9
8472304|NCT00646776|20878633|P2|NOT COMPLETED|Overall Study||13
8472305|NCT00646776|20878634|P1|NOT COMPLETED|Overall Study||1
8472306|NCT00646776|20878633|P2|COMPLETED|Overall Study||5
8472307|NCT00646776|20878634|P1|COMPLETED|Overall Study||14
8472308|NCT00646776|20878633|P2|STARTED|Overall Study|Treated on Day 1|18
8472309|NCT00646776|20878634|P1|STARTED|Overall Study|Treated on Day 1|15
8472310|NCT00646763|20878683|P2|NOT COMPLETED|Overall Study||0
8472311|NCT00646763|20878684|P1|NOT COMPLETED|Overall Study||0
8472312|NCT00646763|20878683|P2|COMPLETED|Overall Study||17
8472313|NCT00646763|20878684|P1|COMPLETED|Overall Study||18
8472314|NCT00646763|20878683|P2|STARTED|Overall Study||17
8472315|NCT00646763|20878684|P1|STARTED|Overall Study||18
8472316|NCT00646646|20878698|P4|NOT COMPLETED|Overall Study||0
8472317|NCT00646646|20878699|P3|NOT COMPLETED|Overall Study||0
8472318|NCT00646646|20878700|P2|NOT COMPLETED|Overall Study||0
8472319|NCT00646646|20878701|P1|NOT COMPLETED|Overall Study||0
8472320|NCT00646646|20878698|P4|COMPLETED|Overall Study||20
8472321|NCT00646646|20878699|P3|COMPLETED|Overall Study||15
8472322|NCT00646646|20878700|P2|COMPLETED|Overall Study||15
8472323|NCT00646646|20878701|P1|COMPLETED|Overall Study||15
8472324|NCT00646646|20878698|P4|STARTED|Overall Study||20
8472326|NCT00646646|20878700|P2|STARTED|Overall Study||15
8472327|NCT00646646|20878701|P1|STARTED|Overall Study||15
8472328|NCT00646581|20878713|P2|NOT COMPLETED|Overall Study||0
8472329|NCT00646581|20878714|P1|NOT COMPLETED|Overall Study||0
8472330|NCT00646581|20878713|P2|COMPLETED|Overall Study||15
8472331|NCT00646581|20878714|P1|COMPLETED|Overall Study||15
8472332|NCT00646581|20878713|P2|STARTED|Overall Study||15
8472333|NCT00646581|20878714|P1|STARTED|Overall Study||15
8472334|NCT00646399|20878732|P2|NOT COMPLETED|Overall Study||74
8472335|NCT00646399|20878733|P1|NOT COMPLETED|Overall Study||83
8472336|NCT00646399|20878732|P2|COMPLETED|Overall Study||713
8472337|NCT00646399|20878733|P1|COMPLETED|Overall Study||709
8472338|NCT00646399|20878732|P2|STARTED|Overall Study||787
8472339|NCT00646399|20878733|P1|STARTED|Overall Study||792
8472340|NCT00646282|20878741|P2|NOT COMPLETED|Overall Study||4
8472341|NCT00646282|20878742|P1|NOT COMPLETED|Overall Study||4
8472342|NCT00646282|20878741|P2|COMPLETED|Overall Study||0
8472343|NCT00646282|20878742|P1|COMPLETED|Overall Study||0
8472344|NCT00646282|20878741|P2|STARTED|Overall Study||4
8472345|NCT00646282|20878742|P1|STARTED|Overall Study||4
8472346|NCT00646113|20878748|P1|NOT COMPLETED|Overall Study||8
8472347|NCT00646113|20878748|P1|COMPLETED|Overall Study||61
8472348|NCT00646113|20878748|P1|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
8472349|NCT00646048|20878752|P1|NOT COMPLETED|Overall Study||16
8472350|NCT00646048|20878752|P1|COMPLETED|Overall Study||27
8472351|NCT00646048|20878752|P1|STARTED|Overall Study||43
8472352|NCT00645970|20878760|P2|NOT COMPLETED|Overall Study||186
8472353|NCT00645970|20878761|P1|NOT COMPLETED|Overall Study||109
8472354|NCT00645970|20878760|P2|COMPLETED|Overall Study||32
8472355|NCT00645970|20878761|P1|COMPLETED|Overall Study||32
8472356|NCT00645970|20878760|P2|1 Year|Overall Study||42
8472357|NCT00645970|20878761|P1|1 Year|Overall Study||37
8472358|NCT00645970|20878760|P2|6 Months|Overall Study||97
8472359|NCT00645970|20878761|P1|6 Months|Overall Study||58
8472360|NCT00645970|20878760|P2|STARTED|Overall Study||218
8472361|NCT00645970|20878761|P1|STARTED|Overall Study||141
8472362|NCT00645944|20878769|P2|NOT COMPLETED|Received Medication||3
8472363|NCT00645944|20878770|P1|NOT COMPLETED|Received Medication||6
8472364|NCT00645944|20878769|P2|COMPLETED|Received Medication||14
8472365|NCT00645944|20878770|P1|COMPLETED|Received Medication||13
8472366|NCT00645944|20878769|P2|STARTED|Received Medication||17
8472367|NCT00645944|20878770|P1|STARTED|Received Medication||19
8472368|NCT00645944|20878769|P2|NOT COMPLETED|Randomized||2
8472369|NCT00645944|20878770|P1|NOT COMPLETED|Randomized||1
8472370|NCT00645944|20878769|P2|COMPLETED|Randomized||17
8472371|NCT00645944|20878770|P1|COMPLETED|Randomized||19
8472372|NCT00645944|20878769|P2|STARTED|Randomized||19
8472373|NCT00645944|20878770|P1|STARTED|Randomized||20
8472374|NCT00645853|20878778|P2|NOT COMPLETED|Overall Study||57
8472375|NCT00645853|20878779|P1|NOT COMPLETED|Overall Study||92
8472376|NCT00645853|20878778|P2|COMPLETED|Overall Study||178
8472377|NCT00645853|20878779|P1|COMPLETED|Overall Study||196
8472378|NCT00645853|20878778|P2|AZ Study Closure in Hungary|Overall Study||40
8472379|NCT00645853|20878779|P1|AZ Study Closure in Hungary|Overall Study||60
8472380|NCT00645853|20878778|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
8472381|NCT00645853|20878779|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
8472382|NCT00645853|20878778|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
8472383|NCT00645853|20878779|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
8472384|NCT00645853|20878778|P2|STARTED|Overall Study||235
8472385|NCT00645853|20878779|P1|STARTED|Overall Study||288
8472386|NCT00645840|20878797|P1|NOT COMPLETED|Overall Study||3
8472387|NCT00645840|20878797|P1|COMPLETED|Overall Study||12
8472388|NCT00645840|20878797|P1|STARTED|Overall Study||15
8472389|NCT00645827|20878804|P2|NOT COMPLETED|Overall Study||0
8472390|NCT00645827|20878805|P1|NOT COMPLETED|Overall Study||0
8472391|NCT00645827|20878804|P2|COMPLETED|Overall Study||17
8472392|NCT00645827|20878805|P1|COMPLETED|Overall Study||14
8472393|NCT00645827|20878804|P2|STARTED|Overall Study||17
8472394|NCT00645827|20878805|P1|STARTED|Overall Study||14
8472395|NCT00645788|20878815|P4|NOT COMPLETED|Overall Study||14
8472396|NCT00645788|20878816|P3|NOT COMPLETED|Overall Study||18
8472397|NCT00645788|20878817|P2|NOT COMPLETED|Overall Study||27
8472398|NCT00645788|20878818|P1|NOT COMPLETED|Overall Study||20
8472399|NCT00645788|20878815|P4|COMPLETED|Overall Study||21
8472400|NCT00645788|20878816|P3|COMPLETED|Overall Study||47
8472401|NCT00645788|20878817|P2|COMPLETED|Overall Study||67
8472402|NCT00645788|20878818|P1|COMPLETED|Overall Study||74
8472403|NCT00645788|20878815|P4|Participants Receive Treatment|Overall Study||35
8472404|NCT00645788|20878816|P3|Participants Receive Treatment|Overall Study||65
8472405|NCT00645788|20878817|P2|Participants Receive Treatment|Overall Study||93
8472406|NCT00645788|20878818|P1|Participants Receive Treatment|Overall Study||93
8472407|NCT00645788|20878815|P4|STARTED|Overall Study||35
8472408|NCT00645788|20878816|P3|STARTED|Overall Study||65
8472409|NCT00645788|20878817|P2|STARTED|Overall Study||94
8472410|NCT00645788|20878818|P1|STARTED|Overall Study||94
8472411|NCT00645762|20878868|P1|NOT COMPLETED|Overall Study||4
8472412|NCT00645762|20878868|P1|COMPLETED|Overall Study||67
8472413|NCT00645762|20878868|P1|STARTED|Overall Study||71
8472414|NCT00645710|20878877|P3|NOT COMPLETED|Overall Study||0
8472415|NCT00645710|20878878|P2|NOT COMPLETED|Overall Study||0
8472416|NCT00645710|20878879|P1|NOT COMPLETED|Overall Study||0
8472417|NCT00645710|20878877|P3|COMPLETED|Overall Study||10
8472418|NCT00645710|20878878|P2|COMPLETED|Overall Study||3
8472419|NCT00645710|20878879|P1|COMPLETED|Overall Study||3
8472420|NCT00645710|20878877|P3|STARTED|Overall Study||10
8472421|NCT00645710|20878878|P2|STARTED|Overall Study||3
8472422|NCT00645710|20878879|P1|STARTED|Overall Study||3
8472423|NCT00645671|20878896|P2|NOT COMPLETED|Overall Study||6
8472424|NCT00645671|20878897|P1|NOT COMPLETED|Overall Study||1
8472425|NCT00645671|20878896|P2|COMPLETED|Overall Study||193
8472426|NCT00645671|20878897|P1|COMPLETED|Overall Study||200
8472427|NCT00645671|20878896|P2|STARTED|Overall Study||199
8472428|NCT00645671|20878897|P1|STARTED|Overall Study||201
8472429|NCT00645593|20878911|P2|NOT COMPLETED|Overall Study||0
8472430|NCT00645593|20878912|P1|NOT COMPLETED|Overall Study||1
8472431|NCT00645593|20878911|P2|COMPLETED|Overall Study||60
8472432|NCT00645593|20878912|P1|COMPLETED|Overall Study||28
8472433|NCT00645593|20878911|P2|STARTED|Overall Study||60
8472434|NCT00645593|20878912|P1|STARTED|Overall Study||29
8472435|NCT00645567|20878924|P1|NOT COMPLETED|Overall Study||1
8472436|NCT00645567|20878924|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
8472437|NCT00645567|20878924|P1|STARTED|Overall Study||5
8472438|NCT00645528|20878932|P1|NOT COMPLETED|Overall Study||7
8472439|NCT00645528|20878932|P1|COMPLETED|Overall Study||32
8472440|NCT00645528|20878932|P1|STARTED|Overall Study||39
8472441|NCT00645450|20878943|P2|NOT COMPLETED|Overall Study||0
8472442|NCT00645450|20878944|P1|NOT COMPLETED|Overall Study||0
8472443|NCT00645450|20878943|P2|COMPLETED|Overall Study||4
8472444|NCT00645450|20878944|P1|COMPLETED|Overall Study||5
8472445|NCT00645450|20878943|P2|STARTED|Overall Study||4
8472446|NCT00645450|20878944|P1|STARTED|Overall Study||5
8472447|NCT00645411|20878954|P4|NOT COMPLETED|Overall Study||103
8472448|NCT00645411|20878955|P3|NOT COMPLETED|Overall Study||151
8472449|NCT00645411|20878956|P2|NOT COMPLETED|Overall Study||6
8472450|NCT00645411|20878957|P1|NOT COMPLETED|Overall Study||13
8472451|NCT00645411|20878954|P4|COMPLETED|Overall Study||919
8472452|NCT00645411|20878955|P3|COMPLETED|Overall Study||1457
8472453|NCT00645411|20878956|P2|COMPLETED|Overall Study||312
8472454|NCT00645411|20878957|P1|COMPLETED|Overall Study||643
8472455|NCT00645411|20878954|P4|STARTED|Overall Study||1022
8472456|NCT00645411|20878955|P3|STARTED|Overall Study||1608
8472457|NCT00645411|20878956|P2|STARTED|Overall Study||318
8472458|NCT00645411|20878957|P1|STARTED|Overall Study||656
8472459|NCT00645359|20878989|P1|NOT COMPLETED|Overall Study||0
8472460|NCT00645359|20878989|P1|COMPLETED|Overall Study||9
8472461|NCT00645359|20878989|P1|STARTED|Overall Study||9
8472462|NCT00645333|20878994|P1|NOT COMPLETED|Overall Study||0
8472463|NCT00645333|20878994|P1|COMPLETED|Overall Study||30
8472464|NCT00645333|20878994|P1|STARTED|Overall Study||30
8472465|NCT00645164|20878999|P1|NOT COMPLETED|Overall Study||7
8472466|NCT00645164|20878999|P1|COMPLETED|Overall Study||52
8472467|NCT00645164|20878999|P1|STARTED|Overall Study||59
8472468|NCT00645099|20879005|P2|NOT COMPLETED|Overall Study||42
8472469|NCT00645099|20879006|P1|NOT COMPLETED|Overall Study||71
8472470|NCT00645099|20879005|P2|COMPLETED|Overall Study||178
8472471|NCT00645099|20879006|P1|COMPLETED|Overall Study||168
8472472|NCT00645099|20879005|P2|STARTED|Overall Study||220
8472473|NCT00645099|20879006|P1|STARTED|Overall Study||239
8472474|NCT00645047|20879050|P2|NOT COMPLETED|Overall Study||39
8472475|NCT00645047|20879051|P1|NOT COMPLETED|Overall Study||43
8472476|NCT00645047|20879050|P2|COMPLETED|Overall Study||65
8472477|NCT00645047|20879051|P1|COMPLETED|Overall Study|6 month follow up|60
8472478|NCT00645047|20879050|P2|Post|Overall Study||80
8472479|NCT00645047|20879051|P1|Post|Overall Study||74
8472480|NCT00645047|20879050|P2|STARTED|Overall Study||104
8472481|NCT00645047|20879051|P1|STARTED|Overall Study||103
8472482|NCT00644995|20879075|P2|NOT COMPLETED|Overall Study||4
8472483|NCT00644995|20879076|P1|NOT COMPLETED|Overall Study||2
8472484|NCT00644995|20879075|P2|COMPLETED|Overall Study||23
8472485|NCT00644995|20879076|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
8472486|NCT00644995|20879075|P2|Completed 4 Month Assessment|Overall Study||24
8472487|NCT00644995|20879076|P1|Completed 4 Month Assessment|Overall Study||23
8472488|NCT00644995|20879075|P2|STARTED|Overall Study||27
8472489|NCT00644995|20879076|P1|STARTED|Overall Study||25
8472490|NCT00644969|20879096|P2|NOT COMPLETED|Post Treatment Phase||3
8472491|NCT00644969|20879097|P1|NOT COMPLETED|Post Treatment Phase||10
8472492|NCT00644969|20879096|P2|COMPLETED|Post Treatment Phase||37
8472493|NCT00644969|20879097|P1|COMPLETED|Post Treatment Phase||61
8472494|NCT00644969|20879096|P2|STARTED|Post Treatment Phase||40
8472495|NCT00644969|20879097|P1|STARTED|Post Treatment Phase||71
8472496|NCT00644969|20879096|P2|NOT COMPLETED|Treatment Phase||3
8472497|NCT00644969|20879097|P1|NOT COMPLETED|Treatment Phase||14
8472498|NCT00644969|20879096|P2|COMPLETED|Treatment Phase||40
8472499|NCT00644969|20879097|P1|COMPLETED|Treatment Phase||71
8472500|NCT00644969|20879096|P2|STARTED|Treatment Phase||43
8472501|NCT00644969|20879097|P1|STARTED|Treatment Phase||85
8472502|NCT00644917|20879143|P1|NOT COMPLETED|Overall Study||2
8472503|NCT00644917|20879143|P1|COMPLETED|Overall Study||36
8472504|NCT00644917|20879143|P1|STARTED|Overall Study||38
8472505|NCT00644787|20879151|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
8472506|NCT00644787|20879152|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
8472507|NCT00644787|20879153|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
8472508|NCT00644787|20879151|P3|COMPLETED|Period 2: Double Blind Phase||55
8472509|NCT00644787|20879152|P2|COMPLETED|Period 2: Double Blind Phase||49
8472510|NCT00644787|20879153|P1|COMPLETED|Period 2: Double Blind Phase||0
8472511|NCT00644787|20879151|P3|STARTED|Period 2: Double Blind Phase||62
8472512|NCT00644787|20879152|P2|STARTED|Period 2: Double Blind Phase||58
8472513|NCT00644787|20879153|P1|STARTED|Period 2: Double Blind Phase||0
8472514|NCT00644787|20879151|P3|NOT COMPLETED|Period 1: Titration Phase||0
8472515|NCT00644787|20879152|P2|NOT COMPLETED|Period 1: Titration Phase||0
8472516|NCT00644787|20879153|P1|NOT COMPLETED|Period 1: Titration Phase||27
8472517|NCT00644787|20879151|P3|COMPLETED|Period 1: Titration Phase||0
8472518|NCT00644787|20879152|P2|COMPLETED|Period 1: Titration Phase||0
8472519|NCT00644787|20879153|P1|COMPLETED|Period 1: Titration Phase||129
8472520|NCT00644787|20879151|P3|STARTED|Period 1: Titration Phase||0
8472521|NCT00644787|20879152|P2|STARTED|Period 1: Titration Phase||0
8472522|NCT00644787|20879153|P1|STARTED|Period 1: Titration Phase||156
8472523|NCT00644657|20879181|P1|NOT COMPLETED|Overall Study||0
8472524|NCT00644657|20879181|P1|COMPLETED|Overall Study||27
8472525|NCT00644657|20879181|P1|STARTED|Overall Study||27
8472526|NCT00644592|20879188|P2|NOT COMPLETED|Overall Study||0
8472527|NCT00644592|20879189|P1|NOT COMPLETED|Overall Study||0
8472528|NCT00644592|20879188|P2|COMPLETED|Overall Study||6
8472529|NCT00644592|20879189|P1|COMPLETED|Overall Study||5
8472530|NCT00644592|20879188|P2|STARTED|Overall Study||6
8472531|NCT00644592|20879189|P1|STARTED|Overall Study||5
8472532|NCT00644423|20879197|P2|NOT COMPLETED|Overall Study||1
8472533|NCT00644423|20879198|P1|NOT COMPLETED|Overall Study||1
8472534|NCT00644423|20879197|P2|COMPLETED|Overall Study||4
8472535|NCT00644423|20879198|P1|COMPLETED|Overall Study||5
8472536|NCT00644423|20879197|P2|STARTED|Overall Study||5
8472537|NCT00644423|20879198|P1|STARTED|Overall Study||6
8472538|NCT00644358|20879216|P1|NOT COMPLETED|Overall Study||362
8472539|NCT00644358|20879216|P1|COMPLETED|Overall Study||254
8472540|NCT00644358|20879216|P1|STARTED|Overall Study||616
8472541|NCT00644332|20879223|P1|NOT COMPLETED|Overall Study||21
8472542|NCT00644332|20879223|P1|COMPLETED|Overall Study||150
8472543|NCT00644332|20879223|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
8472544|NCT00644280|20879238|P2|NOT COMPLETED|Overall Study||0
8472545|NCT00644280|20879239|P1|NOT COMPLETED|Overall Study||0
8472546|NCT00644280|20879238|P2|COMPLETED|Overall Study||5
8472547|NCT00644280|20879239|P1|COMPLETED|Overall Study||6
8472548|NCT00644280|20879238|P2|STARTED|Overall Study||5
8472549|NCT00644280|20879239|P1|STARTED|Overall Study||6
8472550|NCT00644228|20879249|P2|NOT COMPLETED|Maintenance||135
8472551|NCT00644228|20879250|P1|NOT COMPLETED|Maintenance||143
8472552|NCT00644228|20879249|P2|COMPLETED|Maintenance||0
8472553|NCT00644228|20879250|P1|COMPLETED|Maintenance||0
8472554|NCT00644228|20879249|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
8472555|NCT00644228|20879250|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
8472556|NCT00644228|20879249|P2|NOT COMPLETED|Induction Therapy||105
8472557|NCT00644228|20879250|P1|NOT COMPLETED|Induction Therapy||83
8472558|NCT00644228|20879249|P2|COMPLETED|Induction Therapy||137
8472559|NCT00644228|20879250|P1|COMPLETED|Induction Therapy||146
8472560|NCT00644228|20879249|P2|STARTED|Induction Therapy||242
8472561|NCT00644228|20879250|P1|STARTED|Induction Therapy||229
8472562|NCT00644228|20879249|P2|NOT COMPLETED|Randomization & Eligibility||22
8472563|NCT00644228|20879250|P1|NOT COMPLETED|Randomization & Eligibility||32
8472564|NCT00644228|20879249|P2|COMPLETED|Randomization & Eligibility||242
8472565|NCT00644228|20879250|P1|COMPLETED|Randomization & Eligibility||229
8472566|NCT00644228|20879249|P2|Eligible and Analyzable|Randomization & Eligibility||242
8472567|NCT00644228|20879250|P1|Eligible and Analyzable|Randomization & Eligibility||229
8472568|NCT00644228|20879249|P2|STARTED|Randomization & Eligibility||264
8472569|NCT00644228|20879250|P1|STARTED|Randomization & Eligibility||261
8472598|NCT00644059|20879279|P3|NOT COMPLETED|Overall Study||65
8472599|NCT00644059|20879280|P2|NOT COMPLETED|Overall Study||123
8472600|NCT00644059|20879281|P1|NOT COMPLETED|Overall Study||124
8472601|NCT00644059|20879279|P3|COMPLETED|Overall Study||969
8472602|NCT00644059|20879280|P2|COMPLETED|Overall Study||1726
8472603|NCT00644059|20879281|P1|COMPLETED|Overall Study||1895
8472604|NCT00644059|20879279|P3|STARTED|Overall Study||1034
8472605|NCT00644059|20879280|P2|STARTED|Overall Study||1849
8472606|NCT00644059|20879281|P1|STARTED|Overall Study||2019
8472607|NCT00643916|20879371|P6|NOT COMPLETED|Overall Study||1
8472608|NCT00643916|20879372|P5|NOT COMPLETED|Overall Study||2
8472609|NCT00643916|20879373|P4|NOT COMPLETED|Overall Study||2
8472610|NCT00643916|20879374|P3|NOT COMPLETED|Overall Study||6
8472611|NCT00643916|20879375|P2|NOT COMPLETED|Overall Study||6
8472612|NCT00643916|20879376|P1|NOT COMPLETED|Overall Study||4
8472613|NCT00643916|20879371|P6|COMPLETED|Overall Study||66
8472614|NCT00643916|20879372|P5|COMPLETED|Overall Study||57
8472615|NCT00643916|20879373|P4|COMPLETED|Overall Study||60
8472616|NCT00643916|20879374|P3|COMPLETED|Overall Study||62
8472617|NCT00643916|20879375|P2|COMPLETED|Overall Study||61
8472618|NCT00643916|20879376|P1|COMPLETED|Overall Study||51
8472619|NCT00643916|20879371|P6|STARTED|Overall Study||67
8472620|NCT00643916|20879372|P5|STARTED|Overall Study||59
8472621|NCT00643916|20879373|P4|STARTED|Overall Study||62
8472622|NCT00643916|20879374|P3|STARTED|Overall Study||68
8472623|NCT00643916|20879375|P2|STARTED|Overall Study||67
8472624|NCT00643916|20879376|P1|STARTED|Overall Study||55
8472625|NCT00643864|20879396|P1|NOT COMPLETED|Post-test Assessment||0
8472626|NCT00643864|20879396|P1|COMPLETED|Post-test Assessment||3
8472627|NCT00643864|20879396|P1|STARTED|Post-test Assessment||3
8472628|NCT00643864|20879396|P1|NOT COMPLETED|Pre-test Assessment||0
8472629|NCT00643864|20879396|P1|COMPLETED|Pre-test Assessment||3
8472630|NCT00643864|20879396|P1|STARTED|Pre-test Assessment||3
8472631|NCT00643851|20879405|P3|NOT COMPLETED|Overall Study||30
8472632|NCT00643851|20879406|P2|NOT COMPLETED|Overall Study||33
8472633|NCT00643851|20879407|P1|NOT COMPLETED|Overall Study||17
8472634|NCT00643851|20879405|P3|COMPLETED|Overall Study||171
8472635|NCT00643851|20879406|P2|COMPLETED|Overall Study||170
8472636|NCT00643851|20879407|P1|COMPLETED|Overall Study||177
8472637|NCT00643851|20879405|P3|STARTED|Overall Study||201
8472638|NCT00643851|20879406|P2|STARTED|Overall Study||203
8472639|NCT00643851|20879407|P1|STARTED|Overall Study||194
8472640|NCT00643760|20879435|P5|NOT COMPLETED|Overall Study||19
8472641|NCT00643760|20879436|P4|NOT COMPLETED|Overall Study||38
8472642|NCT00643760|20879437|P3|NOT COMPLETED|Overall Study||19
8472643|NCT00643760|20879438|P2|NOT COMPLETED|Overall Study||15
8472644|NCT00643760|20879439|P1|NOT COMPLETED|Overall Study||30
8472645|NCT00643760|20879435|P5|COMPLETED|Overall Study||47
8472646|NCT00643760|20879436|P4|COMPLETED|Overall Study||79
8472647|NCT00643760|20879437|P3|COMPLETED|Overall Study||37
8472648|NCT00643760|20879438|P2|COMPLETED|Overall Study||47
8472649|NCT00643760|20879439|P1|COMPLETED|Overall Study||90
8472650|NCT00643760|20879435|P5|ITT Population|Overall Study||66
8472651|NCT00643760|20879436|P4|ITT Population|Overall Study||116
8472652|NCT00643760|20879437|P3|ITT Population|Overall Study||56
8472653|NCT00643760|20879438|P2|ITT Population|Overall Study||62
8472654|NCT00643760|20879439|P1|ITT Population|Overall Study||120
8472655|NCT00643760|20879435|P5|Safety Population/Treated With Drug|Overall Study||66
8472656|NCT00643760|20879436|P4|Safety Population/Treated With Drug|Overall Study||116
8472657|NCT00643760|20879437|P3|Safety Population/Treated With Drug|Overall Study||56
8472658|NCT00643760|20879438|P2|Safety Population/Treated With Drug|Overall Study||62
8472659|NCT00643760|20879439|P1|Safety Population/Treated With Drug|Overall Study||120
8472660|NCT00643760|20879435|P5|STARTED|Overall Study||66
8472661|NCT00643760|20879436|P4|STARTED|Overall Study||117
8472662|NCT00643760|20879437|P3|STARTED|Overall Study||56
8472663|NCT00643760|20879438|P2|STARTED|Overall Study||62
8472664|NCT00643760|20879439|P1|STARTED|Overall Study||120
8472665|NCT00643682|20879543|P2|NOT COMPLETED|Overall Study||509
8472666|NCT00643682|20879544|P1|NOT COMPLETED|Overall Study||522
8472667|NCT00643682|20879543|P2|COMPLETED|Overall Study||492
8472668|NCT00643682|20879544|P1|COMPLETED|Overall Study||477
8472669|NCT00643682|20879543|P2|STARTED|Overall Study||1001
8472670|NCT00643682|20879544|P1|STARTED|Overall Study||999
8472671|NCT00643604|20879556|P1|NOT COMPLETED|Overall Study||1
8472672|NCT00643604|20879556|P1|COMPLETED|Overall Study||6
8472673|NCT00643604|20879556|P1|STARTED|Overall Study||7
8472674|NCT00643578|20879573|P2|NOT COMPLETED|Overall Study||0
8472675|NCT00643578|20879574|P1|NOT COMPLETED|Overall Study||2
8472676|NCT00643578|20879573|P2|COMPLETED|Overall Study||6
8472677|NCT00643578|20879574|P1|COMPLETED|Overall Study||4
8472678|NCT00643578|20879573|P2|STARTED|Overall Study||6
8472679|NCT00643578|20879574|P1|STARTED|Overall Study||6
8472680|NCT00643565|20879584|P2|NOT COMPLETED|Overall Study||67
8472681|NCT00643565|20879585|P1|NOT COMPLETED|Overall Study||73
8472682|NCT00643565|20879584|P2|COMPLETED|Overall Study||7
8472683|NCT00643565|20879585|P1|COMPLETED|Overall Study||7
8472684|NCT00643565|20879584|P2|STARTED|Overall Study||74
8472685|NCT00643565|20879585|P1|STARTED|Overall Study||80
8472686|NCT00643487|20879607|P1|NOT COMPLETED|Overall Study||3
8472687|NCT00643487|20879607|P1|COMPLETED|Overall Study||5
8472688|NCT00643487|20879607|P1|STARTED|Overall Study||8
8472689|NCT00643448|20879614|P3|NOT COMPLETED|Overall Study||6
8472690|NCT00643448|20879615|P2|NOT COMPLETED|Overall Study||5
8472691|NCT00643448|20879616|P1|NOT COMPLETED|Overall Study||4
8472692|NCT00643448|20879614|P3|COMPLETED|Overall Study||16
8472693|NCT00643448|20879615|P2|COMPLETED|Overall Study||17
8472694|NCT00643448|20879616|P1|COMPLETED|Overall Study||17
8472695|NCT00643448|20879614|P3|STARTED|Overall Study||22
8472696|NCT00643448|20879615|P2|STARTED|Overall Study||22
8472697|NCT00643448|20879616|P1|STARTED|Overall Study||21
8472698|NCT00643279|20879633|P2|NOT COMPLETED|Overall Study||13
8472699|NCT00643279|20879634|P1|NOT COMPLETED|Overall Study||16
8472700|NCT00643279|20879633|P2|COMPLETED|Overall Study||127
8472701|NCT00643279|20879634|P1|COMPLETED|Overall Study||118
8472702|NCT00643279|20879633|P2|STARTED|Overall Study||140
8472703|NCT00643279|20879634|P1|STARTED|Overall Study||134
8472704|NCT00643201|20879656|P2|NOT COMPLETED|Completed Study Follow Up||79
8472705|NCT00643201|20879657|P1|NOT COMPLETED|Completed Study Follow Up||70
8472706|NCT00643201|20879656|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
8472707|NCT00643201|20879657|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
8472708|NCT00643201|20879656|P2|STARTED|Completed Study Follow Up||2639
8472709|NCT00643201|20879657|P1|STARTED|Completed Study Follow Up||2617
8472710|NCT00643201|20879656|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
8472711|NCT00643201|20879657|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
8472712|NCT00643201|20879656|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
8472713|NCT00643201|20879657|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
8472714|NCT00643201|20879656|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
8472715|NCT00643201|20879657|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
8472716|NCT00643162|20879705|P2|NOT COMPLETED|Overall Study||1
8472717|NCT00643162|20879706|P1|NOT COMPLETED|Overall Study||1
8472718|NCT00643162|20879705|P2|COMPLETED|Overall Study||4
8472719|NCT00643162|20879706|P1|COMPLETED|Overall Study||6
8472720|NCT00643162|20879705|P2|STARTED|Overall Study||5
8472721|NCT00643162|20879706|P1|STARTED|Overall Study||7
8472722|NCT00643123|20879718|P2|NOT COMPLETED|Overall Study||1
8472723|NCT00643123|20879719|P1|NOT COMPLETED|Overall Study||5
8472724|NCT00643123|20879718|P2|COMPLETED|Overall Study||11
8472725|NCT00643123|20879719|P1|COMPLETED|Overall Study||10
8472726|NCT00643123|20879718|P2|STARTED|Overall Study||12
8472727|NCT00643123|20879719|P1|STARTED|Overall Study||15
8472728|NCT00643097|20879730|P3|NOT COMPLETED|Overall Study||0
8472729|NCT00643097|20879731|P2|NOT COMPLETED|Overall Study||0
8472730|NCT00643097|20879732|P1|NOT COMPLETED|Overall Study||0
8472731|NCT00643097|20879730|P3|COMPLETED|Overall Study||10
8472732|NCT00643097|20879731|P2|COMPLETED|Overall Study||12
8472733|NCT00643097|20879732|P1|COMPLETED|Overall Study||18
8472734|NCT00643097|20879730|P3|STARTED|Overall Study||10
8472735|NCT00643097|20879731|P2|STARTED|Overall Study||12
8472736|NCT00643097|20879732|P1|STARTED|Overall Study||18
8472737|NCT00643006|20879751|P2|NOT COMPLETED|Overall Study||4
8472738|NCT00643006|20879752|P1|NOT COMPLETED|Overall Study||5
8472739|NCT00643006|20879751|P2|COMPLETED|Overall Study||29
8472740|NCT00643006|20879752|P1|COMPLETED|Overall Study||29
8472741|NCT00643006|20879751|P2|STARTED|Overall Study||33
8472742|NCT00643006|20879752|P1|STARTED|Overall Study||34
8472743|NCT00642993|20879762|P2|NOT COMPLETED|Overall Study||16
8472744|NCT00642993|20879763|P1|NOT COMPLETED|Overall Study||106
8472745|NCT00642993|20879762|P2|COMPLETED|Overall Study||118
8472746|NCT00642993|20879763|P1|COMPLETED|Overall Study||161
8472747|NCT00642993|20879762|P2|STARTED|Overall Study||134
8472748|NCT00642993|20879763|P1|STARTED|Overall Study||267
8472749|NCT00642954|20879782|P5|NOT COMPLETED|Overall Study||16
8472750|NCT00642954|20879783|P4|NOT COMPLETED|Overall Study||3
8472751|NCT00642954|20879784|P3|NOT COMPLETED|Overall Study||3
8472752|NCT00642954|20879785|P2|NOT COMPLETED|Overall Study||4
8472753|NCT00642954|20879786|P1|NOT COMPLETED|Overall Study||4
8472754|NCT00642954|20879782|P5|COMPLETED|Overall Study||1
8472755|NCT00642954|20879783|P4|COMPLETED|Overall Study||0
8472756|NCT00642954|20879784|P3|COMPLETED|Overall Study||0
8472757|NCT00642954|20879785|P2|COMPLETED|Overall Study||0
8472758|NCT00642954|20879786|P1|COMPLETED|Overall Study||0
8472759|NCT00642954|20879782|P5|STARTED|Overall Study||17
8472760|NCT00642954|20879783|P4|STARTED|Overall Study||3
8472761|NCT00642954|20879784|P3|STARTED|Overall Study||3
8472762|NCT00642954|20879785|P2|STARTED|Overall Study||4
8472763|NCT00642954|20879786|P1|STARTED|Overall Study||4
8472764|NCT00642902|20879812|P4|NOT COMPLETED|Overall Study||40
8472765|NCT00642902|20879813|P3|NOT COMPLETED|Overall Study||43
8472766|NCT00642902|20879814|P2|NOT COMPLETED|Overall Study||42
8472767|NCT00642902|20879815|P1|NOT COMPLETED|Overall Study||40
8472768|NCT00642902|20879812|P4|COMPLETED|Overall Study||25
8472769|NCT00642902|20879813|P3|COMPLETED|Overall Study||21
8472770|NCT00642902|20879814|P2|COMPLETED|Overall Study||21
8472771|NCT00642902|20879815|P1|COMPLETED|Overall Study||23
8472772|NCT00642902|20879812|P4|Treated|Overall Study||65
8472773|NCT00642902|20879813|P3|Treated|Overall Study||63
8472774|NCT00642902|20879814|P2|Treated|Overall Study||63
8472775|NCT00642902|20879815|P1|Treated|Overall Study||63
8472776|NCT00642902|20879812|P4|STARTED|Overall Study||65
8472777|NCT00642902|20879813|P3|STARTED|Overall Study||64
8472778|NCT00642902|20879814|P2|STARTED|Overall Study||63
8472779|NCT00642902|20879815|P1|STARTED|Overall Study||63
8472780|NCT00642850|20879837|P1|NOT COMPLETED|Overall Study||33
8472781|NCT00642850|20879837|P1|COMPLETED|Overall Study||155
8472782|NCT00642850|20879837|P1|STARTED|Overall Study||188
8472783|NCT00642811|20879853|P6|NOT COMPLETED|Overall Study||1
8472784|NCT00642811|20879854|P5|NOT COMPLETED|Overall Study||1
8472785|NCT00642811|20879855|P4|NOT COMPLETED|Overall Study||1
8472786|NCT00642811|20879856|P3|NOT COMPLETED|Overall Study||0
8472787|NCT00642811|20879857|P2|NOT COMPLETED|Overall Study||4
8472788|NCT00642811|20879858|P1|NOT COMPLETED|Overall Study||3
8472789|NCT00642811|20879853|P6|COMPLETED|Overall Study||13
8472790|NCT00642811|20879854|P5|COMPLETED|Overall Study||13
8472791|NCT00642811|20879855|P4|COMPLETED|Overall Study||15
8472792|NCT00642811|20879856|P3|COMPLETED|Overall Study||13
8472793|NCT00642811|20879857|P2|COMPLETED|Overall Study||17
8472794|NCT00642811|20879858|P1|COMPLETED|Overall Study||17
8472795|NCT00642811|20879853|P6|STARTED|Overall Study||14
8472796|NCT00642811|20879854|P5|STARTED|Overall Study||14
8472797|NCT00642811|20879855|P4|STARTED|Overall Study||16
8472798|NCT00642811|20879856|P3|STARTED|Overall Study||13
8472799|NCT00642811|20879857|P2|STARTED|Overall Study||21
8472800|NCT00642811|20879858|P1|STARTED|Overall Study||20
8472801|NCT00642772|20879880|P1|NOT COMPLETED|Overall Study||10
8472802|NCT00642772|20879880|P1|COMPLETED|Overall Study||14
8472803|NCT00642772|20879880|P1|STARTED|Overall Study||24
8472804|NCT00642759|20879884|P1|NOT COMPLETED|Overall Study||1
8472805|NCT00642759|20879884|P1|COMPLETED|Overall Study||35
8472806|NCT00642759|20879884|P1|STARTED|Overall Study||36
8472807|NCT00642746|20879893|P2|NOT COMPLETED|Overall Study||0
8472808|NCT00642746|20879894|P1|NOT COMPLETED|Overall Study||1
8472809|NCT00642746|20879893|P2|COMPLETED|Overall Study||1
8472810|NCT00642746|20879894|P1|COMPLETED|Overall Study||9
8472811|NCT00642746|20879893|P2|STARTED|Overall Study||1
8472812|NCT00642746|20879894|P1|STARTED|Overall Study||10
8472813|NCT00642707|20879908|P4|NOT COMPLETED|Overall Study||2
8472814|NCT00642707|20879909|P3|NOT COMPLETED|Overall Study||0
8472815|NCT00642707|20879910|P2|NOT COMPLETED|Overall Study||0
8472816|NCT00642707|20879911|P1|NOT COMPLETED|Overall Study||1
8472817|NCT00642707|20879908|P4|COMPLETED|Overall Study||8
8472818|NCT00642707|20879909|P3|COMPLETED|Overall Study||12
8472819|NCT00642707|20879910|P2|COMPLETED|Overall Study||11
8472820|NCT00642707|20879911|P1|COMPLETED|Overall Study||10
8472821|NCT00642707|20879908|P4|STARTED|Overall Study||10
8472822|NCT00642707|20879909|P3|STARTED|Overall Study||12
8472823|NCT00642707|20879910|P2|STARTED|Overall Study||11
8472824|NCT00642707|20879911|P1|STARTED|Overall Study||11
8472825|NCT00642694|20879923|P2|NOT COMPLETED|Overall Study||4
8472826|NCT00642694|20879924|P1|NOT COMPLETED|Overall Study||6
8472827|NCT00642694|20879923|P2|COMPLETED|Overall Study||11
8472828|NCT00642694|20879924|P1|COMPLETED|Overall Study||8
8472829|NCT00642694|20879923|P2|STARTED|Overall Study||15
8472830|NCT00642694|20879924|P1|STARTED|Overall Study||14
8472831|NCT00642668|20879946|P1|NOT COMPLETED|Overall Study||14
8472832|NCT00642668|20879946|P1|COMPLETED|Overall Study||21
8472833|NCT00642668|20879946|P1|STARTED|Overall Study||35
8472834|NCT00642642|20879954|P1|NOT COMPLETED|Treatment & Follow Up||17
8472835|NCT00642642|20879954|P1|COMPLETED|Treatment & Follow Up||92
8472836|NCT00642642|20879954|P1|STARTED|Treatment & Follow Up||109
8472837|NCT00642642|20879954|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
8472838|NCT00642642|20879954|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
8472839|NCT00642642|20879954|P1|STARTED|Biopsy & Product Manufacture||122
8472840|NCT00642616|20879971|P4|NOT COMPLETED|Overall Study||7
8472841|NCT00642616|20879972|P3|NOT COMPLETED|Overall Study||9
8472842|NCT00642616|20879973|P2|NOT COMPLETED|Overall Study||7
8472843|NCT00642616|20879974|P1|NOT COMPLETED|Overall Study||9
8472844|NCT00642616|20879971|P4|COMPLETED|Overall Study||1
8472845|NCT00642616|20879972|P3|COMPLETED|Overall Study||0
8472846|NCT00642616|20879973|P2|COMPLETED|Overall Study||1
8472847|NCT00642616|20879974|P1|COMPLETED|Overall Study||0
8472848|NCT00642616|20879971|P4|STARTED|Overall Study||8
8472849|NCT00642616|20879972|P3|STARTED|Overall Study||9
8472850|NCT00642616|20879973|P2|STARTED|Overall Study||8
8472851|NCT00642616|20879974|P1|STARTED|Overall Study||9
8472852|NCT00642603|20879998|P2|NOT COMPLETED|Overall Study||18
8472853|NCT00642603|20879999|P1|NOT COMPLETED|Overall Study||21
8472854|NCT00642603|20879998|P2|COMPLETED|Overall Study||2
8472855|NCT00642603|20879999|P1|COMPLETED|Overall Study||0
8472856|NCT00642603|20879998|P2|Safety Population|Overall Study||20
8472857|NCT00642603|20879999|P1|Safety Population|Overall Study||19
8472858|NCT00642603|20879998|P2|STARTED|Overall Study||20
8472859|NCT00642603|20879999|P1|STARTED|Overall Study||21
8472860|NCT00642473|20880007|P2|NOT COMPLETED|Overall Study||11
8472861|NCT00642473|20880008|P1|NOT COMPLETED|Overall Study||4
8472862|NCT00642473|20880007|P2|COMPLETED|Overall Study||5
8472863|NCT00642473|20880008|P1|COMPLETED|Overall Study||14
8472864|NCT00642473|20880007|P2|STARTED|Overall Study||16
8472865|NCT00642473|20880008|P1|STARTED|Overall Study||18
8472866|NCT00642460|20880022|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
8472867|NCT00642460|20880023|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
8472868|NCT00642460|20880024|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472869|NCT00642460|20880025|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472870|NCT00642460|20880026|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472871|NCT00642460|20880027|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472872|NCT00642460|20880022|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
8472873|NCT00642460|20880023|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
8472874|NCT00642460|20880024|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
8472875|NCT00642460|20880025|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
8472876|NCT00642460|20880026|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
8472877|NCT00642460|20880027|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
8472878|NCT00642460|20880022|P6|STARTED|Part III: Open-Label Up to Week 260||59
8472879|NCT00642460|20880023|P5|STARTED|Part III: Open-Label Up to Week 260||53
8472880|NCT00642460|20880024|P4|STARTED|Part III: Open-Label Up to Week 260||0
8472881|NCT00642460|20880025|P3|STARTED|Part III: Open-Label Up to Week 260||0
8472882|NCT00642460|20880026|P2|STARTED|Part III: Open-Label Up to Week 260||0
8472883|NCT00642460|20880027|P1|STARTED|Part III: Open-Label Up to Week 260||0
8472884|NCT00642460|20880022|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8472885|NCT00642460|20880023|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8472886|NCT00642460|20880024|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
8472887|NCT00642460|20880025|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8472888|NCT00642460|20880026|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
8472889|NCT00642460|20880027|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
8472890|NCT00642460|20880022|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
8472891|NCT00642460|20880023|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
8472892|NCT00642460|20880024|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
8472893|NCT00642460|20880025|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
8472894|NCT00642460|20880026|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
8472895|NCT00642460|20880027|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
8472896|NCT00642460|20880022|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8472897|NCT00642460|20880023|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8472898|NCT00642460|20880024|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
8472899|NCT00642460|20880025|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8472900|NCT00642460|20880026|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
8472901|NCT00642460|20880027|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
8472902|NCT00642460|20880022|P6|STARTED|Part II: Open-Label Up to Week 92||0
8472903|NCT00642460|20880023|P5|STARTED|Part II: Open-Label Up to Week 92||0
8472904|NCT00642460|20880024|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
8472905|NCT00642460|20880025|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
8472906|NCT00642460|20880026|P2|STARTED|Part II: Open-Label Up to Week 92||40
8472907|NCT00642460|20880027|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
8472908|NCT00642460|20880022|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8472909|NCT00642460|20880023|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8472910|NCT00642460|20880024|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8472911|NCT00642460|20880025|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8472912|NCT00642460|20880026|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8472913|NCT00642460|20880027|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8472914|NCT00642460|20880022|P6|COMPLETED|Part I: 12 Week Double-Blind||0
8472915|NCT00642460|20880023|P5|COMPLETED|Part I: 12 Week Double-Blind||0
8472916|NCT00642460|20880024|P4|COMPLETED|Part I: 12 Week Double-Blind||0
8472917|NCT00642460|20880025|P3|COMPLETED|Part I: 12 Week Double-Blind||36
8472918|NCT00642460|20880026|P2|COMPLETED|Part I: 12 Week Double-Blind||37
8472919|NCT00642460|20880027|P1|COMPLETED|Part I: 12 Week Double-Blind||36
8472920|NCT00642460|20880022|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8472921|NCT00642460|20880023|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8472922|NCT00642460|20880024|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8472923|NCT00642460|20880025|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
8472924|NCT00642460|20880026|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
8472925|NCT00642460|20880027|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
8472926|NCT00642460|20880022|P6|STARTED|Part I: 12 Week Double-Blind||0
8472927|NCT00642460|20880023|P5|STARTED|Part I: 12 Week Double-Blind||0
8472928|NCT00642460|20880024|P4|STARTED|Part I: 12 Week Double-Blind||0
8472929|NCT00642460|20880025|P3|STARTED|Part I: 12 Week Double-Blind||37
8472930|NCT00642460|20880026|P2|STARTED|Part I: 12 Week Double-Blind||38
8472931|NCT00642460|20880027|P1|STARTED|Part I: 12 Week Double-Blind||37
8472932|NCT00642382|20880093|P2|NOT COMPLETED|Overall Study||0
8472933|NCT00642382|20880094|P1|NOT COMPLETED|Overall Study||0
8472934|NCT00642382|20880093|P2|COMPLETED|Overall Study||0
8472935|NCT00642382|20880094|P1|COMPLETED|Overall Study||0
8472936|NCT00642382|20880093|P2|STARTED|Overall Study||0
8472937|NCT00642382|20880094|P1|STARTED|Overall Study||0
8472938|NCT00642369|20880102|P2|NOT COMPLETED|Overall Study||6
8472939|NCT00642369|20880103|P1|NOT COMPLETED|Overall Study||5
8472940|NCT00642369|20880102|P2|COMPLETED|Overall Study||24
8472941|NCT00642369|20880103|P1|COMPLETED|Overall Study||25
8472942|NCT00642369|20880102|P2|STARTED|Overall Study||30
8472943|NCT00642369|20880103|P1|STARTED|Overall Study||30
8472944|NCT00642356|20880113|P2|NOT COMPLETED|Overall Study||3
8472945|NCT00642356|20880114|P1|NOT COMPLETED|Overall Study||2
8472946|NCT00642356|20880113|P2|COMPLETED|Overall Study||4
8472947|NCT00642356|20880114|P1|COMPLETED|Overall Study||5
8472948|NCT00642356|20880113|P2|STARTED|Overall Study||7
8472949|NCT00642356|20880114|P1|STARTED|Overall Study||7
8472950|NCT00642304|20880122|P1|NOT COMPLETED|Overall Study||6
8472951|NCT00642304|20880122|P1|COMPLETED|Overall Study||14
8472952|NCT00642304|20880122|P1|STARTED|Overall Study||20
8472953|NCT00642278|20880138|P7|NOT COMPLETED|Overall Study||5
8472954|NCT00642278|20880139|P6|NOT COMPLETED|Overall Study||7
8472955|NCT00642278|20880140|P5|NOT COMPLETED|Overall Study||8
8472956|NCT00642278|20880141|P4|NOT COMPLETED|Overall Study||9
8472957|NCT00642278|20880142|P3|NOT COMPLETED|Overall Study||5
8472958|NCT00642278|20880143|P2|NOT COMPLETED|Overall Study||5
8472959|NCT00642278|20880144|P1|NOT COMPLETED|Overall Study||10
8472960|NCT00642278|20880138|P7|COMPLETED|Overall Study||60
8472961|NCT00642278|20880139|P6|COMPLETED|Overall Study||57
8472962|NCT00642278|20880140|P5|COMPLETED|Overall Study||56
8472963|NCT00642278|20880141|P4|COMPLETED|Overall Study||56
8472964|NCT00642278|20880142|P3|COMPLETED|Overall Study||59
8472965|NCT00642278|20880143|P2|COMPLETED|Overall Study||59
8472966|NCT00642278|20880144|P1|COMPLETED|Overall Study||55
8472967|NCT00642278|20880138|P7|STARTED|Overall Study||65
8472968|NCT00642278|20880139|P6|STARTED|Overall Study||64
8472969|NCT00642278|20880140|P5|STARTED|Overall Study||64
8472970|NCT00642278|20880141|P4|STARTED|Overall Study||65
8472971|NCT00642278|20880142|P3|STARTED|Overall Study||64
8472972|NCT00642278|20880143|P2|STARTED|Overall Study||64
8472973|NCT00642278|20880144|P1|STARTED|Overall Study||65
8472974|NCT00642174|20880197|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
8472975|NCT00642174|20880198|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
8472976|NCT00642174|20880197|P2|COMPLETED|Period 2 - Crossover Drug||16
8472977|NCT00642174|20880198|P1|COMPLETED|Period 2 - Crossover Drug||18
8472978|NCT00642174|20880197|P2|STARTED|Period 2 - Crossover Drug||16
8472979|NCT00642174|20880198|P1|STARTED|Period 2 - Crossover Drug||18
8472980|NCT00642174|20880197|P2|NOT COMPLETED|Period 1 - Initial Drug||1
8472981|NCT00642174|20880198|P1|NOT COMPLETED|Period 1 - Initial Drug||0
8472982|NCT00642174|20880197|P2|COMPLETED|Period 1 - Initial Drug||16
8472983|NCT00642174|20880198|P1|COMPLETED|Period 1 - Initial Drug||18
8472984|NCT00642174|20880197|P2|STARTED|Period 1 - Initial Drug||17
8472985|NCT00642174|20880198|P1|STARTED|Period 1 - Initial Drug||18
8472986|NCT00642018|20880214|P2|NOT COMPLETED|Overall Study||79
8472987|NCT00642018|20880215|P1|NOT COMPLETED|Overall Study||28
8472988|NCT00642018|20880214|P2|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
8472989|NCT00642018|20880215|P1|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
8472990|NCT00642018|20880214|P2|Received at Least One Dose of Study Drug|Overall Study||98
8472991|NCT00642018|20880215|P1|Received at Least One Dose of Study Drug|Overall Study||51
8472992|NCT00642018|20880214|P2|STARTED|Overall Study||102
8472993|NCT00642018|20880215|P1|STARTED|Overall Study||52
8472994|NCT00641862|20880245|P2|NOT COMPLETED|Overall Study||38
8472995|NCT00641862|20880246|P1|NOT COMPLETED|Overall Study||44
8472996|NCT00641862|20880245|P2|COMPLETED|Overall Study||145
8472997|NCT00641862|20880246|P1|COMPLETED|Overall Study||139
8472998|NCT00641862|20880245|P2|STARTED|Overall Study||183
8472999|NCT00641862|20880246|P1|STARTED|Overall Study||183
8473000|NCT00641797|20880264|P2|NOT COMPLETED|Overall Study||0
8473001|NCT00641797|20880265|P1|NOT COMPLETED|Overall Study||0
8473002|NCT00641797|20880264|P2|COMPLETED|Overall Study||15
8473003|NCT00641797|20880265|P1|COMPLETED|Overall Study||11
8473004|NCT00641797|20880264|P2|STARTED|Overall Study||15
8473005|NCT00641797|20880265|P1|STARTED|Overall Study||11
8473006|NCT00641745|20880273|P2|NOT COMPLETED|Overall Study||113
8473007|NCT00641745|20880274|P1|NOT COMPLETED|Overall Study||280
8473008|NCT00641745|20880273|P2|COMPLETED|Overall Study||89
8473009|NCT00641745|20880274|P1|COMPLETED|Overall Study||147
8473010|NCT00641745|20880273|P2|STARTED|Overall Study||202
8473011|NCT00641745|20880274|P1|STARTED|Overall Study||427
8473012|NCT00641719|20880282|P2|NOT COMPLETED|Overall Study||37
8473013|NCT00641719|20880283|P1|NOT COMPLETED|Overall Study||30
8473014|NCT00641719|20880282|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
8473015|NCT00641719|20880283|P1|COMPLETED|Overall Study||99
8473016|NCT00641719|20880282|P2|STARTED|Overall Study||129
8473017|NCT00641719|20880283|P1|STARTED|Overall Study||129
8473018|NCT00641706|20880307|P2|NOT COMPLETED|Overall Study||3
8473019|NCT00641706|20880308|P1|NOT COMPLETED|Overall Study||9
8473020|NCT00641706|20880307|P2|COMPLETED|Overall Study||4
8473021|NCT00641706|20880308|P1|COMPLETED|Overall Study||28
8473022|NCT00641706|20880307|P2|STARTED|Overall Study||7
8473023|NCT00641706|20880308|P1|STARTED|Overall Study||37
8473024|NCT00641667|20880320|P1|NOT COMPLETED|Overall Study||6
8473025|NCT00641667|20880320|P1|COMPLETED|Overall Study||60
8473026|NCT00641667|20880320|P1|STARTED|Overall Study||66
8473027|NCT00641641|20880330|P1|NOT COMPLETED|Overall Study||0
8473028|NCT00641641|20880330|P1|COMPLETED|Overall Study||16
8473029|NCT00641641|20880330|P1|STARTED|Overall Study||16
8473030|NCT00641563|20880334|P2|NOT COMPLETED|Infusion 2||0
8473031|NCT00641563|20880335|P1|NOT COMPLETED|Infusion 2||0
8473032|NCT00641563|20880334|P2|COMPLETED|Infusion 2||5
8473033|NCT00641563|20880335|P1|COMPLETED|Infusion 2||5
8473034|NCT00641563|20880334|P2|STARTED|Infusion 2||5
8473035|NCT00641563|20880335|P1|STARTED|Infusion 2||5
8473036|NCT00641563|20880334|P2|NOT COMPLETED|Infusion 1||0
8473037|NCT00641563|20880335|P1|NOT COMPLETED|Infusion 1||0
8473038|NCT00641563|20880334|P2|COMPLETED|Infusion 1||5
8473039|NCT00641563|20880335|P1|COMPLETED|Infusion 1||5
8473040|NCT00641563|20880334|P2|STARTED|Infusion 1||5
8473041|NCT00641563|20880335|P1|STARTED|Infusion 1||5
8473042|NCT00641537|20880348|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
8473043|NCT00641537|20880349|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
8473044|NCT00641537|20880350|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
8473045|NCT00641537|20880351|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
8473046|NCT00641537|20880352|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
8473047|NCT00641537|20880353|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
8473048|NCT00641537|20880354|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
8473049|NCT00641537|20880355|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
8473050|NCT00641537|20880348|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
8473051|NCT00641537|20880349|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
8473052|NCT00641537|20880350|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
8473053|NCT00641537|20880351|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
8473054|NCT00641537|20880352|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
8473055|NCT00641537|20880353|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
8473056|NCT00641537|20880354|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
8473057|NCT00641537|20880355|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
8473058|NCT00641537|20880348|P8|STARTED|24-Week Supplemental Follow-up Period||11
8473059|NCT00641537|20880349|P7|STARTED|24-Week Supplemental Follow-up Period||9
8473060|NCT00641537|20880350|P6|STARTED|24-Week Supplemental Follow-up Period||15
8473061|NCT00641537|20880351|P5|STARTED|24-Week Supplemental Follow-up Period||198
8473062|NCT00641537|20880352|P4|STARTED|24-Week Supplemental Follow-up Period||151
8473063|NCT00641537|20880353|P3|STARTED|24-Week Supplemental Follow-up Period||143
8473064|NCT00641537|20880354|P2|STARTED|24-Week Supplemental Follow-up Period||69
8473065|NCT00641537|20880355|P1|STARTED|24-Week Supplemental Follow-up Period||75
8473066|NCT00641537|20880348|P8|NOT COMPLETED|96-week Period||6
8473067|NCT00641537|20880349|P7|NOT COMPLETED|96-week Period||5
8473068|NCT00641537|20880350|P6|NOT COMPLETED|96-week Period||7
8473069|NCT00641537|20880351|P5|NOT COMPLETED|96-week Period||17
8473070|NCT00641537|20880352|P4|NOT COMPLETED|96-week Period||12
8473071|NCT00641537|20880353|P3|NOT COMPLETED|96-week Period||20
8473072|NCT00641537|20880354|P2|NOT COMPLETED|96-week Period||10
8473073|NCT00641537|20880355|P1|NOT COMPLETED|96-week Period||9
8473074|NCT00641537|20880348|P8|COMPLETED|96-week Period||16
8473075|NCT00641537|20880349|P7|COMPLETED|96-week Period||12
8473076|NCT00641537|20880350|P6|COMPLETED|96-week Period||15
8473077|NCT00641537|20880351|P5|COMPLETED|96-week Period||227
8473078|NCT00641537|20880352|P4|COMPLETED|96-week Period||174
8473079|NCT00641537|20880353|P3|COMPLETED|96-week Period||166
8473080|NCT00641537|20880354|P2|COMPLETED|96-week Period||82
8473081|NCT00641537|20880355|P1|COMPLETED|96-week Period||89
8473082|NCT00641537|20880348|P8|STARTED|96-week Period||22
8473083|NCT00641537|20880349|P7|STARTED|96-week Period||17
8473084|NCT00641537|20880350|P6|STARTED|96-week Period||22
8473085|NCT00641537|20880351|P5|STARTED|96-week Period||244
8473086|NCT00641537|20880352|P4|STARTED|96-week Period||186
8473087|NCT00641537|20880353|P3|STARTED|96-week Period||186
8473088|NCT00641537|20880354|P2|STARTED|96-week Period||92
8473089|NCT00641537|20880355|P1|STARTED|96-week Period||98
8473090|NCT00641147|20880443|P2|NOT COMPLETED|Completed 16 Months.||0
8473091|NCT00641147|20880444|P1|NOT COMPLETED|Completed 16 Months.||2
8473092|NCT00641147|20880443|P2|COMPLETED|Completed 16 Months.||19
8473093|NCT00641147|20880444|P1|COMPLETED|Completed 16 Months.||13
8473094|NCT00641147|20880443|P2|STARTED|Completed 16 Months.||19
8473095|NCT00641147|20880444|P1|STARTED|Completed 16 Months.||15
8473096|NCT00641147|20880443|P2|NOT COMPLETED|Completed 12 Months.||2
8473097|NCT00641147|20880444|P1|NOT COMPLETED|Completed 12 Months.||1
8473098|NCT00641147|20880443|P2|COMPLETED|Completed 12 Months.||19
8473099|NCT00641147|20880444|P1|COMPLETED|Completed 12 Months.||15
8473100|NCT00641147|20880443|P2|STARTED|Completed 12 Months.||21
8473101|NCT00641147|20880444|P1|STARTED|Completed 12 Months.||16
8473102|NCT00641147|20880443|P2|NOT COMPLETED|Completed 8 Months.||2
8473103|NCT00641147|20880444|P1|NOT COMPLETED|Completed 8 Months.||3
8473104|NCT00641147|20880443|P2|COMPLETED|Completed 8 Months.||21
8473105|NCT00641147|20880444|P1|COMPLETED|Completed 8 Months.||16
8473106|NCT00641147|20880443|P2|STARTED|Completed 8 Months.||23
8473107|NCT00641147|20880444|P1|STARTED|Completed 8 Months.||19
8473108|NCT00641147|20880443|P2|NOT COMPLETED|Completed 4 Months.||0
8473109|NCT00641147|20880444|P1|NOT COMPLETED|Completed 4 Months.||2
8473110|NCT00641147|20880443|P2|COMPLETED|Completed 4 Months.||23
8473111|NCT00641147|20880444|P1|COMPLETED|Completed 4 Months.||19
8473112|NCT00641147|20880443|P2|STARTED|Completed 4 Months.||23
8473113|NCT00641147|20880444|P1|STARTED|Completed 4 Months.||21
8473114|NCT00641108|20880488|P2|NOT COMPLETED|Overall Study||0
8473115|NCT00641108|20880489|P1|NOT COMPLETED|Overall Study||0
8473116|NCT00641108|20880488|P2|COMPLETED|Overall Study||0
8473117|NCT00641108|20880489|P1|COMPLETED|Overall Study||0
8473118|NCT00641108|20880488|P2|STARTED|Overall Study||0
8473119|NCT00641108|20880489|P1|STARTED|Overall Study||0
8473120|NCT00641056|20880497|P2|NOT COMPLETED|Overall Study||25
8473121|NCT00641056|20880498|P1|NOT COMPLETED|Overall Study||29
8473122|NCT00641056|20880497|P2|COMPLETED|Overall Study||209
8473123|NCT00641056|20880498|P1|COMPLETED|Overall Study||204
8473124|NCT00641056|20880497|P2|Intent to Treat (ITT)|Overall Study||223
8473125|NCT00641056|20880498|P1|Intent to Treat (ITT)|Overall Study||233
8473126|NCT00641056|20880497|P2|STARTED|Overall Study||234
8473127|NCT00641056|20880498|P1|STARTED|Overall Study||233
8473128|NCT00641043|20880526|P2|NOT COMPLETED|Overall Study||15
8473129|NCT00641043|20880527|P1|NOT COMPLETED|Overall Study||19
8473130|NCT00641043|20880526|P2|COMPLETED|Overall Study|number who completed treatment|244
8473131|NCT00641043|20880527|P1|COMPLETED|Overall Study|number who completed treatment|111
8473132|NCT00641043|20880526|P2|STARTED|Overall Study|number who started treatment|259
8473133|NCT00641043|20880527|P1|STARTED|Overall Study|number who started treatment|130
8473134|NCT00640978|20880557|P1|NOT COMPLETED|Overall Study||0
8473135|NCT00640978|20880557|P1|COMPLETED|Overall Study||15
8473136|NCT00640978|20880557|P1|STARTED|Overall Study||15
8473137|NCT00640926|20880564|P3|NOT COMPLETED|Overall Study||8
8473138|NCT00640926|20880565|P2|NOT COMPLETED|Overall Study||6
8473139|NCT00640926|20880566|P1|NOT COMPLETED|Overall Study||8
8473140|NCT00640926|20880564|P3|COMPLETED|Overall Study||45
8473141|NCT00640926|20880565|P2|COMPLETED|Overall Study||46
8473142|NCT00640926|20880566|P1|COMPLETED|Overall Study||45
8473143|NCT00640926|20880564|P3|STARTED|Overall Study||53
8473144|NCT00640926|20880565|P2|STARTED|Overall Study||52
8473145|NCT00640926|20880566|P1|STARTED|Overall Study||53
8473146|NCT00640835|20880579|P2|NOT COMPLETED|Overall Study||57
8473147|NCT00640835|20880580|P1|NOT COMPLETED|Overall Study||76
8473148|NCT00640835|20880579|P2|COMPLETED|Overall Study||131
8473149|NCT00640835|20880580|P1|COMPLETED|Overall Study||118
8473150|NCT00640835|20880579|P2|STARTED|Overall Study||188
8473151|NCT00640835|20880580|P1|STARTED|Overall Study||194
8473152|NCT00640822|20880591|P3|NOT COMPLETED|Overall Study||25
8473153|NCT00640822|20880592|P2|NOT COMPLETED|Overall Study||59
8473154|NCT00640822|20880593|P1|NOT COMPLETED|Overall Study||43
8473155|NCT00640822|20880591|P3|COMPLETED|Overall Study||77
8473156|NCT00640822|20880592|P2|COMPLETED|Overall Study||258
8473157|NCT00640822|20880593|P1|COMPLETED|Overall Study||279
8473158|NCT00640822|20880591|P3|STARTED|Overall Study||102
8473159|NCT00640822|20880592|P2|STARTED|Overall Study||317
8473160|NCT00640822|20880593|P1|STARTED|Overall Study||322
8473161|NCT00640653|20880606|P5|NOT COMPLETED|Overall Study||5
8473162|NCT00640653|20880607|P4|NOT COMPLETED|Overall Study||2
8473163|NCT00640653|20880608|P3|NOT COMPLETED|Overall Study||0
8473164|NCT00640653|20880609|P2|NOT COMPLETED|Overall Study||3
8473165|NCT00640653|20880610|P1|NOT COMPLETED|Overall Study||3
8473166|NCT00640653|20880606|P5|COMPLETED|Overall Study||129
8473167|NCT00640653|20880607|P4|COMPLETED|Overall Study||132
8473168|NCT00640653|20880608|P3|COMPLETED|Overall Study||129
8473169|NCT00640653|20880609|P2|COMPLETED|Overall Study||131
8473170|NCT00640653|20880610|P1|COMPLETED|Overall Study||128
8473171|NCT00640653|20880606|P5|Followed-up at 24 mo|Overall Study||112
8473172|NCT00640653|20880607|P4|Followed-up at 24 mo|Overall Study||112
8473173|NCT00640653|20880608|P3|Followed-up at 24 mo|Overall Study||105
8473174|NCT00640653|20880609|P2|Followed-up at 24 mo|Overall Study||116
8473175|NCT00640653|20880610|P1|Followed-up at 24 mo|Overall Study||114
8473176|NCT00640653|20880606|P5|Followed-up at 18 mo|Overall Study||117
8473177|NCT00640653|20880607|P4|Followed-up at 18 mo|Overall Study||117
8473178|NCT00640653|20880608|P3|Followed-up at 18 mo|Overall Study||113
8473179|NCT00640653|20880609|P2|Followed-up at 18 mo|Overall Study||112
8473180|NCT00640653|20880610|P1|Followed-up at 18 mo|Overall Study||118
8473181|NCT00640653|20880606|P5|Followed-up at 12 mo|Overall Study||116
8473182|NCT00640653|20880607|P4|Followed-up at 12 mo|Overall Study||122
8473183|NCT00640653|20880608|P3|Followed-up at 12 mo|Overall Study||115
8473184|NCT00640653|20880609|P2|Followed-up at 12 mo|Overall Study||121
8473185|NCT00640653|20880610|P1|Followed-up at 12 mo|Overall Study||124
8473186|NCT00640653|20880606|P5|Followed-up at 6 mo|Overall Study||125
8473187|NCT00640653|20880607|P4|Followed-up at 6 mo|Overall Study||130
8473188|NCT00640653|20880608|P3|Followed-up at 6 mo|Overall Study||124
8473189|NCT00640653|20880609|P2|Followed-up at 6 mo|Overall Study||130
8473190|NCT00640653|20880610|P1|Followed-up at 6 mo|Overall Study||127
8473191|NCT00640653|20880606|P5|Followed-up at 3 mo|Overall Study||126
8473192|NCT00640653|20880607|P4|Followed-up at 3 mo|Overall Study||129
8473193|NCT00640653|20880608|P3|Followed-up at 3 mo|Overall Study||125
8473194|NCT00640653|20880609|P2|Followed-up at 3 mo|Overall Study||127
8473195|NCT00640653|20880610|P1|Followed-up at 3 mo|Overall Study||126
8473196|NCT00640653|20880606|P5|STARTED|Overall Study||134
8473197|NCT00640653|20880607|P4|STARTED|Overall Study||134
8473198|NCT00640653|20880608|P3|STARTED|Overall Study||129
8473199|NCT00640653|20880609|P2|STARTED|Overall Study||134
8473200|NCT00640653|20880610|P1|STARTED|Overall Study||131
8473201|NCT00640614|20880644|P2|NOT COMPLETED|Overall Study||0
8473202|NCT00640614|20880645|P1|NOT COMPLETED|Overall Study||1
8473203|NCT00640614|20880644|P2|COMPLETED|Overall Study||110
8473204|NCT00640614|20880645|P1|COMPLETED|Overall Study||124
8473205|NCT00640614|20880644|P2|STARTED|Overall Study||110
8473206|NCT00640614|20880645|P1|STARTED|Overall Study||125
8473207|NCT00640601|20880687|P1|NOT COMPLETED|Overall Study||112
8473208|NCT00640601|20880687|P1|COMPLETED|Overall Study||183
8473209|NCT00640601|20880687|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
8473210|NCT00640562|20880703|P2|NOT COMPLETED|Overall Study||26
8473211|NCT00640562|20880704|P1|NOT COMPLETED|Overall Study||18
8473212|NCT00640562|20880703|P2|COMPLETED|Overall Study||81
8473213|NCT00640562|20880704|P1|COMPLETED|Overall Study||91
8473214|NCT00640562|20880703|P2|STARTED|Overall Study||107
8473215|NCT00640562|20880704|P1|STARTED|Overall Study||109
8473216|NCT00640510|20880732|P2|NOT COMPLETED|Overall Study||2
8473217|NCT00640510|20880733|P1|NOT COMPLETED|Overall Study||1
8473218|NCT00640510|20880732|P2|COMPLETED|Overall Study||15
8473219|NCT00640510|20880733|P1|COMPLETED|Overall Study||16
8473220|NCT00640510|20880732|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
8473221|NCT00640510|20880733|P1|STARTED|Overall Study||17
8473222|NCT00640393|20880745|P3|NOT COMPLETED|Part 2||3
8473223|NCT00640393|20880746|P2|NOT COMPLETED|Part 2||10
8473224|NCT00640393|20880747|P1|NOT COMPLETED|Part 2||0
8473225|NCT00640393|20880745|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
8473226|NCT00640393|20880746|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
8473227|NCT00640393|20880747|P1|COMPLETED|Part 2||0
8473228|NCT00640393|20880745|P3|STARTED|Part 2||38
8473229|NCT00640393|20880746|P2|STARTED|Part 2||37
8473230|NCT00640393|20880747|P1|STARTED|Part 2||0
8473231|NCT00640393|20880745|P3|NOT COMPLETED|Randomization||0
8473232|NCT00640393|20880746|P2|NOT COMPLETED|Randomization||0
8473233|NCT00640393|20880747|P1|NOT COMPLETED|Randomization||19
8473234|NCT00640393|20880745|P3|COMPLETED|Randomization||0
8473235|NCT00640393|20880746|P2|COMPLETED|Randomization||0
8473236|NCT00640393|20880747|P1|COMPLETED|Randomization||75
8473237|NCT00640393|20880745|P3|STARTED|Randomization||0
8473238|NCT00640393|20880746|P2|STARTED|Randomization||0
8473239|NCT00640393|20880747|P1|STARTED|Randomization||94
8473240|NCT00640393|20880745|P3|NOT COMPLETED|Part 1||0
8473241|NCT00640393|20880746|P2|NOT COMPLETED|Part 1||0
8473242|NCT00640393|20880747|P1|NOT COMPLETED|Part 1||5
8473243|NCT00640393|20880745|P3|COMPLETED|Part 1||0
8473244|NCT00640393|20880746|P2|COMPLETED|Part 1||0
8473245|NCT00640393|20880747|P1|COMPLETED|Part 1||94
8473246|NCT00640393|20880745|P3|STARTED|Part 1||0
8473247|NCT00640393|20880746|P2|STARTED|Part 1||0
8473248|NCT00640393|20880747|P1|STARTED|Part 1||99
8473249|NCT00640341|20880812|P3|NOT COMPLETED|Overall Study||7
8473250|NCT00640341|20880813|P2|NOT COMPLETED|Overall Study||5
8473251|NCT00640341|20880814|P1|NOT COMPLETED|Overall Study||21
8473252|NCT00640341|20880812|P3|COMPLETED|Overall Study||163
8473253|NCT00640341|20880813|P2|COMPLETED|Overall Study||165
8473254|NCT00640341|20880814|P1|COMPLETED|Overall Study||149
8473255|NCT00640341|20880812|P3|Eligible Participants at Baseline|Overall Study||168
8473256|NCT00640341|20880813|P2|Eligible Participants at Baseline|Overall Study||167
8473257|NCT00640341|20880814|P1|Eligible Participants at Baseline|Overall Study||165
8473258|NCT00640341|20880812|P3|STARTED|Overall Study||170
8473259|NCT00640341|20880813|P2|STARTED|Overall Study||170
8473260|NCT00640341|20880814|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
8473261|NCT00640328|20880834|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8473262|NCT00640328|20880835|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8473263|NCT00640328|20880836|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8473264|NCT00640328|20880837|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8473265|NCT00640328|20880838|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8473266|NCT00640328|20880839|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8473267|NCT00640328|20880834|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
8473268|NCT00640328|20880835|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
8473269|NCT00640328|20880836|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
8473270|NCT00640328|20880837|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
8473271|NCT00640328|20880838|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
8473272|NCT00640328|20880839|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
8473273|NCT00640328|20880834|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
8473274|NCT00640328|20880835|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
8473275|NCT00640328|20880836|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
8473276|NCT00640328|20880837|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
8473277|NCT00640328|20880838|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
8473278|NCT00640328|20880839|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
8473279|NCT00640328|20880834|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473280|NCT00640328|20880835|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
8473281|NCT00640328|20880836|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473282|NCT00640328|20880837|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473283|NCT00640328|20880838|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473284|NCT00640328|20880839|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473285|NCT00640328|20880834|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
8473286|NCT00640328|20880835|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
8473287|NCT00640328|20880836|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
8473288|NCT00640328|20880837|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
8473289|NCT00640328|20880838|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
8473290|NCT00640328|20880839|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
8473291|NCT00640328|20880834|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
8473292|NCT00640328|20880835|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
8473293|NCT00640328|20880836|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
8473294|NCT00640328|20880837|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
8473295|NCT00640328|20880838|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
8473296|NCT00640328|20880839|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
8473297|NCT00640328|20880834|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473298|NCT00640328|20880835|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473299|NCT00640328|20880836|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473300|NCT00640328|20880837|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473301|NCT00640328|20880838|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
8473302|NCT00640328|20880839|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473303|NCT00640328|20880834|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
8473304|NCT00640328|20880835|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
8473305|NCT00640328|20880836|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
8473306|NCT00640328|20880837|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
8473307|NCT00640328|20880838|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
8473308|NCT00640328|20880839|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
8473309|NCT00640328|20880834|P6|STARTED|First Treatment Period (Weeks 0-24)||4
8473310|NCT00640328|20880835|P5|STARTED|First Treatment Period (Weeks 0-24)||4
8473311|NCT00640328|20880836|P4|STARTED|First Treatment Period (Weeks 0-24)||4
8473312|NCT00640328|20880837|P3|STARTED|First Treatment Period (Weeks 0-24)||7
8473313|NCT00640328|20880838|P2|STARTED|First Treatment Period (Weeks 0-24)||11
8473314|NCT00640328|20880839|P1|STARTED|First Treatment Period (Weeks 0-24)||8
8473315|NCT00640315|20881005|P2|NOT COMPLETED|Overall Study||1
8473316|NCT00640315|20881006|P1|NOT COMPLETED|Overall Study||0
8473317|NCT00640315|20881005|P2|COMPLETED|Overall Study||12
8473318|NCT00640315|20881006|P1|COMPLETED|Overall Study||10
8473319|NCT00640315|20881005|P2|Participants Received Treatment|Overall Study||13
8473320|NCT00640315|20881006|P1|Participants Received Treatment|Overall Study||10
8473321|NCT00640315|20881005|P2|STARTED|Overall Study||13
8473322|NCT00640315|20881006|P1|STARTED|Overall Study||10
8473323|NCT00640289|20881132|P1|NOT COMPLETED|Overall Study||13
8473324|NCT00640289|20881132|P1|COMPLETED|Overall Study||59
8473325|NCT00640289|20881132|P1|STARTED|Overall Study||72
8473326|NCT00640250|20881137|P1|NOT COMPLETED|Overall Study||0
8473327|NCT00640250|20881137|P1|COMPLETED|Overall Study||48
8473328|NCT00640250|20881137|P1|STARTED|Overall Study||48
8473329|NCT00640224|20881244|P4|NOT COMPLETED|Overall Study||0
8473330|NCT00640224|20881245|P3|NOT COMPLETED|Overall Study||0
8473331|NCT00640224|20881246|P2|NOT COMPLETED|Overall Study||3
8473332|NCT00640224|20881247|P1|NOT COMPLETED|Overall Study||6
8473333|NCT00640224|20881244|P4|COMPLETED|Overall Study||0
8473334|NCT00640224|20881245|P3|COMPLETED|Overall Study||0
8473335|NCT00640224|20881246|P2|COMPLETED|Overall Study||20
8473336|NCT00640224|20881247|P1|COMPLETED|Overall Study||17
8473337|NCT00640224|20881244|P4|STARTED|Overall Study||0
8473338|NCT00640224|20881245|P3|STARTED|Overall Study||0
8473339|NCT00640224|20881246|P2|STARTED|Overall Study||23
8473340|NCT00640224|20881247|P1|STARTED|Overall Study||23
8473341|NCT00640146|20881347|P2|NOT COMPLETED|Overall Study||6
8473342|NCT00640146|20881348|P1|NOT COMPLETED|Overall Study||4
8473343|NCT00640146|20881347|P2|COMPLETED|Overall Study||12
8473344|NCT00640146|20881348|P1|COMPLETED|Overall Study||15
8473345|NCT00640146|20881347|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
8473346|NCT00640146|20881348|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8473347|NCT00640146|20881347|P2|STARTED|Overall Study||18
8473348|NCT00640146|20881348|P1|STARTED|Overall Study||19
8473349|NCT00640133|20881360|P2|NOT COMPLETED|Open Label Phase (Month 4-12)||0
8473350|NCT00640133|20881361|P1|NOT COMPLETED|Open Label Phase (Month 4-12)||3
8473351|NCT00640133|20881360|P2|COMPLETED|Open Label Phase (Month 4-12)||0
8473352|NCT00640133|20881361|P1|COMPLETED|Open Label Phase (Month 4-12)||24
8473353|NCT00640133|20881360|P2|STARTED|Open Label Phase (Month 4-12)||0
8473354|NCT00640133|20881361|P1|STARTED|Open Label Phase (Month 4-12)||27
8473355|NCT00640133|20881360|P2|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
8473356|NCT00640133|20881361|P1|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
8473357|NCT00640133|20881360|P2|COMPLETED|Randomization Phase (Baseline-Month 3)||12
8473358|NCT00640133|20881361|P1|COMPLETED|Randomization Phase (Baseline-Month 3)||15
8473359|NCT00640133|20881360|P2|STARTED|Randomization Phase (Baseline-Month 3)||12
8473360|NCT00640133|20881361|P1|STARTED|Randomization Phase (Baseline-Month 3)||15
8473361|NCT00640042|20881381|P1|NOT COMPLETED|Treatment||926
8473362|NCT00640042|20881381|P1|COMPLETED|Treatment||561
8473363|NCT00640042|20881381|P1|STARTED|Treatment||1487
8473364|NCT00640042|20881381|P1|NOT COMPLETED|Enrollment||83
8473365|NCT00640042|20881381|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
8473366|NCT00640042|20881381|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
8473367|NCT00640016|20881397|P4|NOT COMPLETED|Overall Study||3
8473368|NCT00640016|20881398|P3|NOT COMPLETED|Overall Study||3
8473369|NCT00640016|20881399|P2|NOT COMPLETED|Overall Study||2
8473370|NCT00640016|20881400|P1|NOT COMPLETED|Overall Study||2
8473371|NCT00640016|20881397|P4|COMPLETED|Overall Study||1
8473372|NCT00640016|20881398|P3|COMPLETED|Overall Study||1
8473373|NCT00640016|20881399|P2|COMPLETED|Overall Study||1
8473374|NCT00640016|20881400|P1|COMPLETED|Overall Study||1
8473375|NCT00640016|20881397|P4|Treated|Overall Study||4
8473376|NCT00640016|20881398|P3|Treated|Overall Study||4
8473377|NCT00640016|20881399|P2|Treated|Overall Study||2
8473378|NCT00640016|20881400|P1|Treated|Overall Study||3
8473379|NCT00640016|20881397|P4|STARTED|Overall Study||4
8473380|NCT00640016|20881398|P3|STARTED|Overall Study||4
8473381|NCT00640016|20881399|P2|STARTED|Overall Study||3
8473382|NCT00640016|20881400|P1|STARTED|Overall Study||3
8473383|NCT00639860|20881444|P1|NOT COMPLETED|Overall Study||0
8473384|NCT00639860|20881444|P1|COMPLETED|Overall Study||10
8473385|NCT00639860|20881444|P1|STARTED|Overall Study||10
8473386|NCT00639769|20881452|P1|NOT COMPLETED|Overall Study||40
8473387|NCT00639769|20881452|P1|COMPLETED|Overall Study||0
8473388|NCT00639769|20881452|P1|STARTED|Overall Study||40
8473389|NCT00639717|20881457|P1|NOT COMPLETED|Overall Study||0
8473390|NCT00639717|20881457|P1|COMPLETED|Overall Study||48
8473391|NCT00639717|20881457|P1|STARTED|Overall Study||48
8473392|NCT00639678|20881469|P4|NOT COMPLETED|Overall Study||0
8473393|NCT00639678|20881470|P3|NOT COMPLETED|Overall Study||11
8473394|NCT00639678|20881471|P2|NOT COMPLETED|Overall Study||1
8473395|NCT00639678|20881472|P1|NOT COMPLETED|Overall Study||4
8473396|NCT00639678|20881469|P4|COMPLETED|Overall Study||23
8473397|NCT00639678|20881470|P3|COMPLETED|Overall Study||206
8473398|NCT00639678|20881471|P2|COMPLETED|Overall Study||5
8473399|NCT00639678|20881472|P1|COMPLETED|Overall Study||70
8473400|NCT00639678|20881469|P4|STARTED|Overall Study||23
8473401|NCT00639678|20881470|P3|STARTED|Overall Study||217
8473402|NCT00639678|20881471|P2|STARTED|Overall Study||6
8473403|NCT00639678|20881472|P1|STARTED|Overall Study||74
8473404|NCT00639626|20881532|P1|NOT COMPLETED|Overall Study||0
8473405|NCT00639626|20881532|P1|COMPLETED|Overall Study||0
8473406|NCT00639626|20881532|P1|STARTED|Overall Study||0
8473407|NCT00639509|20881537|P1|NOT COMPLETED|Overall Study||1
8473408|NCT00639509|20881537|P1|COMPLETED|Overall Study||23
8473409|NCT00639509|20881537|P1|STARTED|Overall Study||24
8473410|NCT00639457|20881545|P2|NOT COMPLETED|Overall Study||3
8473411|NCT00639457|20881546|P1|NOT COMPLETED|Overall Study||2
8473412|NCT00639457|20881545|P2|COMPLETED|Overall Study||19
8473413|NCT00639457|20881546|P1|COMPLETED|Overall Study||20
8473414|NCT00639457|20881545|P2|STARTED|Overall Study||22
8473415|NCT00639457|20881546|P1|STARTED|Overall Study||22
8473416|NCT00639418|20881584|P4|NOT COMPLETED|Overall Study||0
8473417|NCT00639418|20881585|P3|NOT COMPLETED|Overall Study||0
8473418|NCT00639418|20881586|P2|NOT COMPLETED|Overall Study||0
8473419|NCT00639418|20881587|P1|NOT COMPLETED|Overall Study||0
8473420|NCT00639418|20881584|P4|COMPLETED|Overall Study||46930
8473421|NCT00639418|20881585|P3|COMPLETED|Overall Study||36496
8473422|NCT00639418|20881586|P2|COMPLETED|Overall Study||35967
8473423|NCT00639418|20881587|P1|COMPLETED|Overall Study||28101
8473424|NCT00639418|20881584|P4|STARTED|Overall Study||46930
8473425|NCT00639418|20881585|P3|STARTED|Overall Study||36496
8473426|NCT00639418|20881586|P2|STARTED|Overall Study||35967
8473427|NCT00639418|20881587|P1|STARTED|Overall Study||28101
8473428|NCT00639379|20881605|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
8473429|NCT00639379|20881606|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
8473430|NCT00639379|20881605|P2|COMPLETED|Period 2 - 2 Weeks||45
8473431|NCT00639379|20881606|P1|COMPLETED|Period 2 - 2 Weeks||39
8473432|NCT00639379|20881605|P2|STARTED|Period 2 - 2 Weeks||45
8473433|NCT00639379|20881606|P1|STARTED|Period 2 - 2 Weeks||39
8473434|NCT00639379|20881605|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
8473435|NCT00639379|20881606|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
8473436|NCT00639379|20881605|P2|COMPLETED|Period 1 - 2 Weeks||45
8473437|NCT00639379|20881606|P1|COMPLETED|Period 1 - 2 Weeks||39
8473438|NCT00639379|20881605|P2|STARTED|Period 1 - 2 Weeks||45
8473439|NCT00639379|20881606|P1|STARTED|Period 1 - 2 Weeks||44
8473440|NCT00639223|20881622|P2|NOT COMPLETED|Overall Study||2
8473441|NCT00639223|20881623|P1|NOT COMPLETED|Overall Study||0
8473442|NCT00639223|20881622|P2|COMPLETED|Overall Study||19
8473443|NCT00639223|20881623|P1|COMPLETED|Overall Study||22
8473444|NCT00639223|20881622|P2|STARTED|Overall Study||21
8473445|NCT00639223|20881623|P1|STARTED|Overall Study||22
8473446|NCT00639158|20881633|P2|NOT COMPLETED|Overall Study||30
8473447|NCT00639158|20881634|P1|NOT COMPLETED|Overall Study||26
8473448|NCT00639158|20881633|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
8473449|NCT00639158|20881634|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
8473450|NCT00639158|20881633|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
8473451|NCT00639158|20881634|P1|STARTED|Overall Study|All randomized subjects were treated.|272
8473452|NCT00639093|20881656|P2|NOT COMPLETED|Overall Study||0
8473453|NCT00639093|20881657|P1|NOT COMPLETED|Overall Study||0
8473454|NCT00639093|20881656|P2|COMPLETED|Overall Study|46|46
8473455|NCT00639093|20881657|P1|COMPLETED|Overall Study|45|45
8473456|NCT00639093|20881656|P2|STARTED|Overall Study|46|46
8473457|NCT00639093|20881657|P1|STARTED|Overall Study|45|45
8473458|NCT00639002|20881663|P1|NOT COMPLETED|Overall Study||13
8473459|NCT00639002|20881663|P1|COMPLETED|Overall Study||0
8473460|NCT00639002|20881663|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
8473461|NCT00639002|20881663|P1|Received Ruxolitinib|Overall Study||13
8473462|NCT00639002|20881663|P1|STARTED|Overall Study||13
8473463|NCT00638989|20881672|P3|NOT COMPLETED|Overall Study||1
8473464|NCT00638989|20881673|P2|NOT COMPLETED|Overall Study||0
8473465|NCT00638989|20881674|P1|NOT COMPLETED|Overall Study||0
8473466|NCT00638989|20881672|P3|COMPLETED|Overall Study||9
8473467|NCT00638989|20881673|P2|COMPLETED|Overall Study||10
8473468|NCT00638989|20881674|P1|COMPLETED|Overall Study||10
8473469|NCT00638989|20881672|P3|STARTED|Overall Study||10
8473470|NCT00638989|20881673|P2|STARTED|Overall Study||10
8473471|NCT00638989|20881674|P1|STARTED|Overall Study||10
8473472|NCT00638963|20881714|P2|NOT COMPLETED|Overall Study||0
8473473|NCT00638963|20881715|P1|NOT COMPLETED|Overall Study||1
8473474|NCT00638963|20881714|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
8473475|NCT00638963|20881715|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
8473476|NCT00638963|20881714|P2|STARTED|Overall Study|Received randomized treatment assignment|3
8473477|NCT00638963|20881715|P1|STARTED|Overall Study|Received randomized treatment assignment|3
8473478|NCT00638937|20881734|P1|NOT COMPLETED|Overall Study||0
8473479|NCT00638937|20881734|P1|COMPLETED|Overall Study||37
8473480|NCT00638937|20881734|P1|STARTED|Overall Study||37
8473481|NCT00638924|20881745|P1|NOT COMPLETED|Overall Study||0
8473482|NCT00638924|20881745|P1|COMPLETED|Overall Study||40
8473483|NCT00638924|20881745|P1|2 Months|Overall Study||40
8473484|NCT00638924|20881745|P1|STARTED|Overall Study||40
8473485|NCT00638885|20881750|P1|NOT COMPLETED|Overall Study||0
8473486|NCT00638885|20881750|P1|COMPLETED|Overall Study||142
8473487|NCT00638885|20881750|P1|STARTED|Overall Study||142
8473488|NCT00638846|20881756|P2|NOT COMPLETED|Overall Study||6
8473489|NCT00638846|20881757|P1|NOT COMPLETED|Overall Study||4
8473490|NCT00638846|20881756|P2|COMPLETED|Overall Study||133
8473491|NCT00638846|20881757|P1|COMPLETED|Overall Study||133
8473492|NCT00638846|20881756|P2|STARTED|Overall Study||139
8473493|NCT00638846|20881757|P1|STARTED|Overall Study||137
8473494|NCT00638820|20881773|P1|NOT COMPLETED|Overall Study||0
8473495|NCT00638820|20881773|P1|COMPLETED|Overall Study||3
8473496|NCT00638820|20881773|P1|STARTED|Overall Study||3
8473497|NCT00638716|20881783|P3|NOT COMPLETED|Overall Study||12
8473498|NCT00638716|20881784|P2|NOT COMPLETED|Overall Study||15
8473499|NCT00638716|20881785|P1|NOT COMPLETED|Overall Study||7
8473500|NCT00638716|20881783|P3|COMPLETED|Overall Study||46
8473501|NCT00638716|20881784|P2|COMPLETED|Overall Study||37
8473502|NCT00638716|20881785|P1|COMPLETED|Overall Study||43
8473503|NCT00638716|20881783|P3|STARTED|Overall Study||58
8473504|NCT00638716|20881784|P2|STARTED|Overall Study||52
8473505|NCT00638716|20881785|P1|STARTED|Overall Study||50
8473506|NCT00638690|20881801|P2|NOT COMPLETED|Overall Study||342
8473507|NCT00638690|20881802|P1|NOT COMPLETED|Overall Study||681
8473508|NCT00638690|20881801|P2|COMPLETED|Overall Study||56
8473509|NCT00638690|20881802|P1|COMPLETED|Overall Study||116
8473510|NCT00638690|20881801|P2|STARTED|Overall Study||398
8473511|NCT00638690|20881802|P1|STARTED|Overall Study||797
8473512|NCT00638651|20881815|P1|NOT COMPLETED|Overall Study||0
8473513|NCT00638651|20881815|P1|COMPLETED|Overall Study||3
8473514|NCT00638651|20881815|P1|STARTED|Overall Study||3
8473515|NCT00638508|20881822|P2|NOT COMPLETED|Overall Study||2
8473516|NCT00638508|20881823|P1|NOT COMPLETED|Overall Study||5
8473517|NCT00638508|20881822|P2|COMPLETED|Overall Study||30
8473518|NCT00638508|20881823|P1|COMPLETED|Overall Study||30
8473519|NCT00638508|20881822|P2|STARTED|Overall Study||32
8473520|NCT00638508|20881823|P1|STARTED|Overall Study||35
8473521|NCT00638456|20881869|P2|NOT COMPLETED|Overall Study||2
8473522|NCT00638456|20881870|P1|NOT COMPLETED|Overall Study||6
8473523|NCT00638456|20881869|P2|COMPLETED|Overall Study||9
8473524|NCT00638456|20881870|P1|COMPLETED|Overall Study||15
8473525|NCT00638456|20881869|P2|STARTED|Overall Study||11
8473526|NCT00638456|20881870|P1|STARTED|Overall Study||21
8473527|NCT00638443|20881880|P2|NOT COMPLETED|Second Intervention||0
8473528|NCT00638443|20881881|P1|NOT COMPLETED|Second Intervention||0
8473529|NCT00638443|20881880|P2|COMPLETED|Second Intervention||14
8473530|NCT00638443|20881881|P1|COMPLETED|Second Intervention||12
8473531|NCT00638443|20881880|P2|STARTED|Second Intervention||14
8473532|NCT00638443|20881881|P1|STARTED|Second Intervention||12
8473533|NCT00638443|20881880|P2|NOT COMPLETED|Washout||0
8473534|NCT00638443|20881881|P1|NOT COMPLETED|Washout||0
8473535|NCT00638443|20881880|P2|COMPLETED|Washout||14
8473536|NCT00638443|20881881|P1|COMPLETED|Washout||12
8473537|NCT00638443|20881880|P2|STARTED|Washout||14
8473538|NCT00638443|20881881|P1|STARTED|Washout||12
8473539|NCT00638443|20881880|P2|NOT COMPLETED|First Intervention||1
8473540|NCT00638443|20881881|P1|NOT COMPLETED|First Intervention||2
8473541|NCT00638443|20881880|P2|COMPLETED|First Intervention||14
8473542|NCT00638443|20881881|P1|COMPLETED|First Intervention||12
8473543|NCT00638443|20881880|P2|STARTED|First Intervention||15
8473544|NCT00638443|20881881|P1|STARTED|First Intervention||14
8473545|NCT00638404|20881911|P2|NOT COMPLETED|Overall Study||0
8473546|NCT00638404|20881912|P1|NOT COMPLETED|Overall Study||8
8473547|NCT00638404|20881911|P2|COMPLETED|Overall Study||100
8473548|NCT00638404|20881912|P1|COMPLETED|Overall Study||192
8473549|NCT00638404|20881911|P2|STARTED|Overall Study||100
8473550|NCT00638404|20881912|P1|STARTED|Overall Study||200
8473551|NCT00638378|20881924|P1|NOT COMPLETED|Overall Study||22
8473552|NCT00638378|20881924|P1|COMPLETED|Overall Study||0
8473553|NCT00638378|20881924|P1|STARTED|Overall Study||22
8473554|NCT00638365|20881934|P3|NOT COMPLETED|Overall Study||0
8473555|NCT00638365|20881935|P2|NOT COMPLETED|Overall Study||0
8473556|NCT00638365|20881936|P1|NOT COMPLETED|Overall Study||0
8473557|NCT00638365|20881934|P3|COMPLETED|Overall Study||8
8473558|NCT00638365|20881935|P2|COMPLETED|Overall Study||10
8473559|NCT00638365|20881936|P1|COMPLETED|Overall Study||9
8473560|NCT00638365|20881934|P3|STARTED|Overall Study||8
8473561|NCT00638365|20881935|P2|STARTED|Overall Study||10
8473562|NCT00638365|20881936|P1|STARTED|Overall Study||9
8473563|NCT00638274|20881946|P2|NOT COMPLETED|Overall Study||5
8473564|NCT00638274|20881947|P1|NOT COMPLETED|Overall Study||6
8473565|NCT00638274|20881946|P2|COMPLETED|Overall Study||172
8473566|NCT00638274|20881947|P1|COMPLETED|Overall Study||173
8473567|NCT00638274|20881946|P2|STARTED|Overall Study||177
8473568|NCT00638274|20881947|P1|STARTED|Overall Study||179
8473569|NCT00638235|20881964|P9|NOT COMPLETED|Overall Study||18
8473570|NCT00638235|20881965|P8|NOT COMPLETED|Overall Study||1
8473571|NCT00638235|20881966|P7|NOT COMPLETED|Overall Study||0
8473572|NCT00638235|20881967|P6|NOT COMPLETED|Overall Study||26
8473573|NCT00638235|20881968|P5|NOT COMPLETED|Overall Study||13
8473574|NCT00638235|20881969|P4|NOT COMPLETED|Overall Study||10
8473575|NCT00638235|20881970|P3|NOT COMPLETED|Overall Study||18
8473576|NCT00638235|20881971|P2|NOT COMPLETED|Overall Study||3
8473577|NCT00638235|20881972|P1|NOT COMPLETED|Overall Study||31
8473578|NCT00638235|20881964|P9|COMPLETED|Overall Study||124
8473579|NCT00638235|20881965|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
8473580|NCT00638235|20881966|P7|COMPLETED|Overall Study||23
8473581|NCT00638235|20881967|P6|COMPLETED|Overall Study||113
8473582|NCT00638235|20881968|P5|COMPLETED|Overall Study||42
8473583|NCT00638235|20881969|P4|COMPLETED|Overall Study||46
8473584|NCT00638235|20881970|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
8473585|NCT00638235|20881971|P2|COMPLETED|Overall Study||23
8473586|NCT00638235|20881972|P1|COMPLETED|Overall Study||110
8473587|NCT00638235|20881964|P9|STARTED|Overall Study||142
8473588|NCT00638235|20881965|P8|STARTED|Overall Study||35
8473589|NCT00638235|20881966|P7|STARTED|Overall Study||23
8473590|NCT00638235|20881967|P6|STARTED|Overall Study||139
8473591|NCT00638235|20881968|P5|STARTED|Overall Study||55
8473592|NCT00638235|20881969|P4|STARTED|Overall Study||56
8473593|NCT00638235|20881970|P3|STARTED|Overall Study||81
8473594|NCT00638235|20881971|P2|STARTED|Overall Study||26
8473595|NCT00638235|20881972|P1|STARTED|Overall Study||141
8473596|NCT00638222|20882373|P3|NOT COMPLETED|Overall Study||0
8473597|NCT00638222|20882374|P2|NOT COMPLETED|Overall Study||0
8473598|NCT00638222|20882375|P1|NOT COMPLETED|Overall Study||0
8473599|NCT00638222|20882373|P3|COMPLETED|Overall Study||6
8473600|NCT00638222|20882374|P2|COMPLETED|Overall Study||0
8473601|NCT00638222|20882375|P1|COMPLETED|Overall Study||0
8473602|NCT00638222|20882373|P3|STARTED|Overall Study||6
8473603|NCT00638222|20882374|P2|STARTED|Overall Study||0
8473604|NCT00638222|20882375|P1|STARTED|Overall Study||0
8473605|NCT00638183|20882382|P1|NOT COMPLETED|Overall Study||119
8473606|NCT00638183|20882382|P1|COMPLETED|Overall Study||266
8473607|NCT00638183|20882382|P1|STARTED|Overall Study||385
8473616|NCT00638027|20882402|P2|NOT COMPLETED|Overall Study||2
8473617|NCT00638027|20882403|P1|NOT COMPLETED|Overall Study||0
8473618|NCT00638027|20882402|P2|COMPLETED|Overall Study|all 10 included in analyses|8
8473619|NCT00638027|20882403|P1|COMPLETED|Overall Study||11
8473620|NCT00638027|20882402|P2|STARTED|Overall Study||10
8473621|NCT00638027|20882403|P1|STARTED|Overall Study||11
8473622|NCT00638014|20882415|P2|NOT COMPLETED|Overall Study||0
8473623|NCT00638014|20882416|P1|NOT COMPLETED|Overall Study||0
8473624|NCT00638014|20882415|P2|COMPLETED|Overall Study||28
8473625|NCT00638014|20882416|P1|COMPLETED|Overall Study||23
8473626|NCT00638014|20882415|P2|STARTED|Overall Study||28
8473627|NCT00638014|20882416|P1|STARTED|Overall Study||23
8473628|NCT00637923|20882426|P2|NOT COMPLETED|Overall Study||19
8473629|NCT00637923|20882427|P1|NOT COMPLETED|Overall Study||30
8473630|NCT00637923|20882426|P2|COMPLETED|Overall Study||18
8473631|NCT00637923|20882427|P1|COMPLETED|Overall Study||45
8473632|NCT00637923|20882426|P2|STARTED|Overall Study||37
8473633|NCT00637923|20882427|P1|STARTED|Overall Study||75
8473634|NCT00637806|20882450|P4|NOT COMPLETED|Extension Phase||1
8473635|NCT00637806|20882451|P3|NOT COMPLETED|Extension Phase||0
8473636|NCT00637806|20882452|P2|NOT COMPLETED|Extension Phase||0
8473637|NCT00637806|20882453|P1|NOT COMPLETED|Extension Phase||0
8473638|NCT00637806|20882450|P4|COMPLETED|Extension Phase||0
8473639|NCT00637806|20882451|P3|COMPLETED|Extension Phase||0
8473640|NCT00637806|20882452|P2|COMPLETED|Extension Phase||0
8473641|NCT00637806|20882453|P1|COMPLETED|Extension Phase||0
8473642|NCT00637806|20882450|P4|STARTED|Extension Phase||1
8473643|NCT00637806|20882451|P3|STARTED|Extension Phase||0
8473644|NCT00637806|20882452|P2|STARTED|Extension Phase||0
8473645|NCT00637806|20882453|P1|STARTED|Extension Phase||0
8473646|NCT00637806|20882450|P4|NOT COMPLETED|Double-blind Phase||0
8473647|NCT00637806|20882451|P3|NOT COMPLETED|Double-blind Phase||1
8473648|NCT00637806|20882452|P2|NOT COMPLETED|Double-blind Phase||0
8473649|NCT00637806|20882453|P1|NOT COMPLETED|Double-blind Phase||2
8473650|NCT00637806|20882450|P4|COMPLETED|Double-blind Phase||0
8473651|NCT00637806|20882451|P3|COMPLETED|Double-blind Phase||1
8473652|NCT00637806|20882452|P2|COMPLETED|Double-blind Phase||0
8473653|NCT00637806|20882453|P1|COMPLETED|Double-blind Phase||0
8473654|NCT00637806|20882450|P4|STARTED|Double-blind Phase||0
8473655|NCT00637806|20882451|P3|STARTED|Double-blind Phase||2
8473656|NCT00637806|20882452|P2|STARTED|Double-blind Phase||0
8473657|NCT00637806|20882453|P1|STARTED|Double-blind Phase||2
8473658|NCT00637780|20882471|P1|NOT COMPLETED|Overall Study||0
8473659|NCT00637780|20882471|P1|COMPLETED|Overall Study||2
8473660|NCT00637780|20882471|P1|STARTED|Overall Study||2
8473661|NCT00637728|20882488|P3|NOT COMPLETED|Extension Phase||0
8473662|NCT00637728|20882489|P2|NOT COMPLETED|Extension Phase||0
8473663|NCT00637728|20882490|P1|NOT COMPLETED|Extension Phase||0
8473664|NCT00637728|20882488|P3|COMPLETED|Extension Phase||0
8473665|NCT00637728|20882489|P2|COMPLETED|Extension Phase||0
8473666|NCT00637728|20882490|P1|COMPLETED|Extension Phase||0
8473667|NCT00637728|20882488|P3|STARTED|Extension Phase||0
8473668|NCT00637728|20882489|P2|STARTED|Extension Phase||0
8473669|NCT00637728|20882490|P1|STARTED|Extension Phase||0
8473670|NCT00637728|20882488|P3|NOT COMPLETED|Double-blind Phase||0
8473671|NCT00637728|20882489|P2|NOT COMPLETED|Double-blind Phase||1
8473672|NCT00637728|20882490|P1|NOT COMPLETED|Double-blind Phase||4
8473673|NCT00637728|20882488|P3|COMPLETED|Double-blind Phase||0
8473674|NCT00637728|20882489|P2|COMPLETED|Double-blind Phase||0
8473675|NCT00637728|20882490|P1|COMPLETED|Double-blind Phase||0
8473676|NCT00637728|20882488|P3|STARTED|Double-blind Phase||0
8473677|NCT00637728|20882489|P2|STARTED|Double-blind Phase||1
8473678|NCT00637728|20882490|P1|STARTED|Double-blind Phase||4
8473679|NCT00637572|20882505|P2|NOT COMPLETED|Overall Study||7
8473680|NCT00637572|20882506|P1|NOT COMPLETED|Overall Study||3
8473681|NCT00637572|20882505|P2|COMPLETED|Overall Study||24
8473682|NCT00637572|20882506|P1|COMPLETED|Overall Study||29
8473683|NCT00637572|20882505|P2|STARTED|Overall Study||31
8473684|NCT00637572|20882506|P1|STARTED|Overall Study||32
8473685|NCT00637494|20882534|P2|NOT COMPLETED|Overall Study||43
8473686|NCT00637494|20882535|P1|NOT COMPLETED|Overall Study||32
8473687|NCT00637494|20882534|P2|COMPLETED|Overall Study||108
8473688|NCT00637494|20882535|P1|COMPLETED|Overall Study||109
8473689|NCT00637494|20882534|P2|STARTED|Overall Study||151
8473690|NCT00637494|20882535|P1|STARTED|Overall Study||141
8473691|NCT00637416|20882545|P2|NOT COMPLETED|Overall Study||2
8473692|NCT00637416|20882546|P1|NOT COMPLETED|Overall Study||1
8473693|NCT00637416|20882545|P2|COMPLETED|Overall Study||3
8473694|NCT00637416|20882546|P1|COMPLETED|Overall Study||3
8473695|NCT00637416|20882545|P2|STARTED|Overall Study||5
8473696|NCT00637416|20882546|P1|STARTED|Overall Study||4
8473697|NCT00637377|20882556|P4|NOT COMPLETED|Overall Study||29
8473698|NCT00637377|20882557|P3|NOT COMPLETED|Overall Study||37
8473699|NCT00637377|20882558|P2|NOT COMPLETED|Overall Study||32
8473700|NCT00637377|20882559|P1|NOT COMPLETED|Overall Study||27
8473701|NCT00637377|20882556|P4|COMPLETED|Overall Study||284
8473702|NCT00637377|20882557|P3|COMPLETED|Overall Study||274
8473703|NCT00637377|20882558|P2|COMPLETED|Overall Study||281
8473704|NCT00637377|20882559|P1|COMPLETED|Overall Study||276
8473705|NCT00637377|20882556|P4|Participants Treated (FAS)|Overall Study||306
8473706|NCT00637377|20882557|P3|Participants Treated (FAS)|Overall Study||296
8473707|NCT00637377|20882558|P2|Participants Treated (FAS)|Overall Study||309
8473708|NCT00637377|20882559|P1|Participants Treated (FAS)|Overall Study||291
8473709|NCT00637377|20882556|P4|Participants Received Treatment|Overall Study|safety population|307
8473710|NCT00637377|20882557|P3|Participants Received Treatment|Overall Study|safety population|297
8473711|NCT00637377|20882558|P2|Participants Received Treatment|Overall Study|safety population|309
8473712|NCT00637377|20882559|P1|Participants Received Treatment|Overall Study|safety population|291
8473713|NCT00637377|20882556|P4|STARTED|Overall Study||313
8473714|NCT00637377|20882557|P3|STARTED|Overall Study||311
8473715|NCT00637377|20882558|P2|STARTED|Overall Study||313
8473716|NCT00637377|20882559|P1|STARTED|Overall Study||303
8473717|NCT00637312|20882587|P2|NOT COMPLETED|Overall Study||17
8473718|NCT00637312|20882588|P1|NOT COMPLETED|Overall Study||42
8473719|NCT00637312|20882587|P2|COMPLETED|Overall Study||19
8473720|NCT00637312|20882588|P1|COMPLETED|Overall Study||30
8473721|NCT00637312|20882587|P2|STARTED|Overall Study||36
8473722|NCT00637312|20882588|P1|STARTED|Overall Study||72
8473723|NCT00637299|20882596|P2|NOT COMPLETED|Overall Study||0
8473724|NCT00637299|20882597|P1|NOT COMPLETED|Overall Study||0
8473725|NCT00637299|20882596|P2|COMPLETED|Overall Study||10
8473726|NCT00637299|20882597|P1|COMPLETED|Overall Study||10
8473727|NCT00637299|20882596|P2|STARTED|Overall Study||10
8473728|NCT00637299|20882597|P1|STARTED|Overall Study||10
8473729|NCT00637273|20882608|P3|NOT COMPLETED|Overall Study||41
8473730|NCT00637273|20882609|P2|NOT COMPLETED|Overall Study||28
8473731|NCT00637273|20882610|P1|NOT COMPLETED|Overall Study||43
8473732|NCT00637273|20882608|P3|COMPLETED|Overall Study||131
8473733|NCT00637273|20882609|P2|COMPLETED|Overall Study||144
8473734|NCT00637273|20882610|P1|COMPLETED|Overall Study||127
8473735|NCT00637273|20882608|P3|Intent to Treat (ITT)|Overall Study||165
8473736|NCT00637273|20882609|P2|Intent to Treat (ITT)|Overall Study||166
8473737|NCT00637273|20882610|P1|Intent to Treat (ITT)|Overall Study||160
8473738|NCT00637273|20882608|P3|STARTED|Overall Study||172
8473739|NCT00637273|20882609|P2|STARTED|Overall Study||172
8473740|NCT00637273|20882610|P1|STARTED|Overall Study||170
8473741|NCT00637247|20882653|P2|NOT COMPLETED|Overall Study||0
8473742|NCT00637247|20882654|P1|NOT COMPLETED|Overall Study||0
8473743|NCT00637247|20882653|P2|COMPLETED|Overall Study||70
8473744|NCT00637247|20882654|P1|COMPLETED|Overall Study||72
8473745|NCT00637247|20882653|P2|STARTED|Overall Study||70
8473746|NCT00637247|20882654|P1|STARTED|Overall Study||72
8473747|NCT00637195|20882668|P2|NOT COMPLETED|Overall Study||1
8473748|NCT00637195|20882669|P1|NOT COMPLETED|Overall Study||3
8473749|NCT00637195|20882668|P2|COMPLETED|Overall Study||75
8473750|NCT00637195|20882669|P1|COMPLETED|Overall Study||73
8473751|NCT00637195|20882668|P2|STARTED|Overall Study||76
8473752|NCT00637195|20882669|P1|STARTED|Overall Study||76
8473753|NCT00637156|20882705|P2|NOT COMPLETED|Overall Study||24
8473754|NCT00637156|20882706|P1|NOT COMPLETED|Overall Study||10
8473755|NCT00637156|20882705|P2|COMPLETED|Overall Study||164
8473756|NCT00637156|20882706|P1|COMPLETED|Overall Study||199
8473757|NCT00637156|20882705|P2|STARTED|Overall Study||188
8473758|NCT00637156|20882706|P1|STARTED|Overall Study||209
8473759|NCT00637000|20882748|P2|NOT COMPLETED|Overall Study||3
8473760|NCT00637000|20882749|P1|NOT COMPLETED|Overall Study||4
8473761|NCT00637000|20882748|P2|COMPLETED|Overall Study||15
8473762|NCT00637000|20882749|P1|COMPLETED|Overall Study||16
8473763|NCT00637000|20882748|P2|Evaluable|Overall Study||16
8473764|NCT00637000|20882749|P1|Evaluable|Overall Study||18
8473765|NCT00637000|20882748|P2|STARTED|Overall Study|Randomized and treated|18
8473766|NCT00637000|20882749|P1|STARTED|Overall Study|Randomized and treated|20
8473767|NCT00636987|20882789|P1|NOT COMPLETED|Overall Study||189
8473768|NCT00636987|20882789|P1|COMPLETED|Overall Study||108
8473769|NCT00636987|20882789|P1|STARTED|Overall Study||297
8473770|NCT00636961|20882799|P2|NOT COMPLETED|Period 2||0
8473771|NCT00636961|20882800|P1|NOT COMPLETED|Period 2||1
8473772|NCT00636961|20882799|P2|COMPLETED|Period 2||12
8473773|NCT00636961|20882800|P1|COMPLETED|Period 2||12
8473774|NCT00636961|20882799|P2|STARTED|Period 2||12
8473775|NCT00636961|20882800|P1|STARTED|Period 2||13
8473776|NCT00636961|20882799|P2|NOT COMPLETED|Period 1||1
8473777|NCT00636961|20882800|P1|NOT COMPLETED|Period 1||1
8473778|NCT00636961|20882799|P2|COMPLETED|Period 1||12
8473779|NCT00636961|20882800|P1|COMPLETED|Period 1||13
8473780|NCT00636961|20882799|P2|STARTED|Period 1||13
8473781|NCT00636961|20882800|P1|STARTED|Period 1||14
8473782|NCT00636818|20882814|P1|NOT COMPLETED|Overall Study||11
8473783|NCT00636818|20882814|P1|COMPLETED|Overall Study||34
8473784|NCT00636818|20882814|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
8473785|NCT00636818|20882814|P1|STARTED|Overall Study||45
8473786|NCT00636805|20882829|P1|NOT COMPLETED|Overall Study||0
8473787|NCT00636805|20882829|P1|COMPLETED|Overall Study||63
8473788|NCT00636805|20882829|P1|STARTED|Overall Study||63
8473789|NCT00636792|20882839|P1|NOT COMPLETED|Overall Study||33
8473790|NCT00636792|20882839|P1|COMPLETED|Overall Study||40
8473791|NCT00636792|20882839|P1|STARTED|Overall Study||73
8473792|NCT00636701|20882846|P2|NOT COMPLETED|Overall Study||0
8473793|NCT00636701|20882847|P1|NOT COMPLETED|Overall Study||0
8473794|NCT00636701|20882846|P2|COMPLETED|Overall Study||2
8473795|NCT00636701|20882847|P1|COMPLETED|Overall Study||2
8473796|NCT00636701|20882846|P2|STARTED|Overall Study||2
8473797|NCT00636701|20882847|P1|STARTED|Overall Study||2
8473798|NCT00636675|20882855|P2|NOT COMPLETED|Overall Study||41
8473799|NCT00636675|20882856|P1|NOT COMPLETED|Overall Study||140
8473800|NCT00636675|20882855|P2|COMPLETED|Overall Study||734
8473801|NCT00636675|20882856|P1|COMPLETED|Overall Study||811
8473802|NCT00636675|20882855|P2|STARTED|Overall Study||775
8473803|NCT00636675|20882856|P1|STARTED|Overall Study||951
8473804|NCT00636649|20882868|P2|NOT COMPLETED|Overall Study||0
8473805|NCT00636649|20882869|P1|NOT COMPLETED|Overall Study||0
8473806|NCT00636649|20882868|P2|COMPLETED|Overall Study||20
8473807|NCT00636649|20882869|P1|COMPLETED|Overall Study||20
8473808|NCT00636649|20882868|P2|STARTED|Overall Study||20
8473809|NCT00636649|20882869|P1|STARTED|Overall Study||20
8473810|NCT00636636|20882899|P2|NOT COMPLETED|Overall Study||39
8473811|NCT00636636|20882900|P1|NOT COMPLETED|Overall Study||36
8473812|NCT00636636|20882899|P2|COMPLETED|Overall Study||192
8473813|NCT00636636|20882900|P1|COMPLETED|Overall Study||185
8473814|NCT00636636|20882899|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
8473815|NCT00636636|20882900|P1|379|Overall Study||186
8473816|NCT00636636|20882899|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
8473817|NCT00636636|20882900|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
8473818|NCT00636636|20882899|P2|STARTED|Overall Study||231
8473819|NCT00636636|20882900|P1|STARTED|Overall Study||221
8473820|NCT00636610|20882916|P2|NOT COMPLETED|Overall Study||83
8473821|NCT00636610|20882917|P1|NOT COMPLETED|Overall Study||92
8473822|NCT00636610|20882916|P2|COMPLETED|Overall Study||18
8473823|NCT00636610|20882917|P1|COMPLETED|Overall Study||6
8473824|NCT00636610|20882916|P2|STARTED|Overall Study||101
8473825|NCT00636610|20882917|P1|STARTED|Overall Study||98
8473826|NCT00636506|20882927|P1|NOT COMPLETED|Overall Study||16
8473827|NCT00636506|20882927|P1|COMPLETED|Overall Study||60
8473828|NCT00636506|20882927|P1|STARTED|Overall Study||76
8473829|NCT00636441|20882974|P7|NOT COMPLETED|Overall Study||18
8473830|NCT00636441|20882975|P6|NOT COMPLETED|Overall Study||1
8473831|NCT00636441|20882976|P5|NOT COMPLETED|Overall Study||0
8473832|NCT00636441|20882977|P4|NOT COMPLETED|Overall Study||0
8473833|NCT00636441|20882978|P3|NOT COMPLETED|Overall Study||1
8473834|NCT00636441|20882979|P2|NOT COMPLETED|Overall Study||1
8473835|NCT00636441|20882980|P1|NOT COMPLETED|Overall Study||0
8473836|NCT00636441|20882974|P7|COMPLETED|Overall Study||0
8473837|NCT00636441|20882975|P6|COMPLETED|Overall Study||6
8473838|NCT00636441|20882976|P5|COMPLETED|Overall Study||6
8473839|NCT00636441|20882977|P4|COMPLETED|Overall Study||6
8473840|NCT00636441|20882978|P3|COMPLETED|Overall Study||5
8473841|NCT00636441|20882979|P2|COMPLETED|Overall Study||6
8473842|NCT00636441|20882980|P1|COMPLETED|Overall Study||6
8473843|NCT00636441|20882974|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
8473844|NCT00636441|20882975|P6|Assigned Treatment|Overall Study||7
8473845|NCT00636441|20882976|P5|Assigned Treatment|Overall Study||6
8473846|NCT00636441|20882977|P4|Assigned Treatment|Overall Study||6
8473847|NCT00636441|20882978|P3|Assigned Treatment|Overall Study||6
8473848|NCT00636441|20882979|P2|Assigned Treatment|Overall Study||7
8473849|NCT00636441|20882980|P1|Assigned Treatment|Overall Study||6
8473850|NCT00636441|20882974|P7|STARTED|Overall Study||18
8473851|NCT00636441|20882975|P6|STARTED|Overall Study||7
8473852|NCT00636441|20882976|P5|STARTED|Overall Study||6
8473853|NCT00636441|20882977|P4|STARTED|Overall Study||6
8473854|NCT00636441|20882978|P3|STARTED|Overall Study||6
8473855|NCT00636441|20882979|P2|STARTED|Overall Study||7
8473856|NCT00636441|20882980|P1|STARTED|Overall Study||6
8473857|NCT00636389|20883009|P2|NOT COMPLETED|Period 2 - 1 Week||0
8473858|NCT00636389|20883010|P1|NOT COMPLETED|Period 2 - 1 Week||0
8473859|NCT00636389|20883009|P2|COMPLETED|Period 2 - 1 Week||5
8473860|NCT00636389|20883010|P1|COMPLETED|Period 2 - 1 Week||7
8473861|NCT00636389|20883009|P2|STARTED|Period 2 - 1 Week||5
8473862|NCT00636389|20883010|P1|STARTED|Period 2 - 1 Week||7
8473863|NCT00636389|20883009|P2|NOT COMPLETED|Period 1 - 1 Week||0
8473864|NCT00636389|20883010|P1|NOT COMPLETED|Period 1 - 1 Week||0
8473865|NCT00636389|20883009|P2|COMPLETED|Period 1 - 1 Week||5
8473866|NCT00636389|20883010|P1|COMPLETED|Period 1 - 1 Week||7
8473867|NCT00636389|20883009|P2|STARTED|Period 1 - 1 Week||5
8473868|NCT00636389|20883010|P1|STARTED|Period 1 - 1 Week||7
8473869|NCT00636363|20883023|P3|NOT COMPLETED|Overall Study||18
8473870|NCT00636363|20883024|P2|NOT COMPLETED|Overall Study||20
8473871|NCT00636363|20883025|P1|NOT COMPLETED|Overall Study||13
8473872|NCT00636363|20883023|P3|COMPLETED|Overall Study||163
8473873|NCT00636363|20883024|P2|COMPLETED|Overall Study||156
8473874|NCT00636363|20883025|P1|COMPLETED|Overall Study||165
8473875|NCT00636363|20883023|P3|STARTED|Overall Study||181
8473876|NCT00636363|20883024|P2|STARTED|Overall Study||176
8473877|NCT00636363|20883025|P1|STARTED|Overall Study||178
8473878|NCT00636220|20883039|P1|NOT COMPLETED|Overall Study||0
8473879|NCT00636220|20883039|P1|COMPLETED|Overall Study||101
8473880|NCT00636220|20883039|P1|STARTED|Overall Study||101
8473881|NCT00636207|20883046|P7|NOT COMPLETED|Overall Study||0
8473882|NCT00636207|20883047|P6|NOT COMPLETED|Overall Study||0
8473883|NCT00636207|20883048|P5|NOT COMPLETED|Overall Study||1
8473884|NCT00636207|20883049|P4|NOT COMPLETED|Overall Study||0
8473885|NCT00636207|20883050|P3|NOT COMPLETED|Overall Study||0
8473886|NCT00636207|20883051|P2|NOT COMPLETED|Overall Study||1
8473887|NCT00636207|20883052|P1|NOT COMPLETED|Overall Study||1
8473888|NCT00636207|20883046|P7|COMPLETED|Overall Study||3
8473889|NCT00636207|20883047|P6|COMPLETED|Overall Study||1
8473890|NCT00636207|20883048|P5|COMPLETED|Overall Study||8
8473891|NCT00636207|20883049|P4|COMPLETED|Overall Study||6
8473892|NCT00636207|20883050|P3|COMPLETED|Overall Study||18
8473893|NCT00636207|20883051|P2|COMPLETED|Overall Study||7
8473894|NCT00636207|20883052|P1|COMPLETED|Overall Study||0
8473895|NCT00636207|20883046|P7|STARTED|Overall Study||3
8473896|NCT00636207|20883047|P6|STARTED|Overall Study||1
8473897|NCT00636207|20883048|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
8473898|NCT00636207|20883049|P4|STARTED|Overall Study||6
8473899|NCT00636207|20883050|P3|STARTED|Overall Study||18
8473900|NCT00636207|20883051|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
8473901|NCT00636207|20883052|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
8473902|NCT00636194|20883116|P2|NOT COMPLETED|Overall Study||0
8473903|NCT00636194|20883117|P1|NOT COMPLETED|Overall Study||3
8473904|NCT00636194|20883116|P2|COMPLETED|Overall Study||175
8473905|NCT00636194|20883117|P1|COMPLETED|Overall Study||172
8473906|NCT00636194|20883116|P2|STARTED|Overall Study||175
8473907|NCT00636194|20883117|P1|STARTED|Overall Study||175
8473908|NCT00636181|20883130|P3|NOT COMPLETED|Overall Study||10
8473909|NCT00636181|20883131|P2|NOT COMPLETED|Overall Study||6
8473910|NCT00636181|20883132|P1|NOT COMPLETED|Overall Study||8
8473911|NCT00636181|20883130|P3|COMPLETED|Overall Study||47
8473912|NCT00636181|20883131|P2|COMPLETED|Overall Study||47
8473913|NCT00636181|20883132|P1|COMPLETED|Overall Study||46
8473914|NCT00636181|20883130|P3|STARTED|Overall Study||57
8473915|NCT00636181|20883131|P2|STARTED|Overall Study||53
8473916|NCT00636181|20883132|P1|STARTED|Overall Study||54
8473917|NCT00636168|20883160|P2|NOT COMPLETED|Long Term Follow-Up||14
8473918|NCT00636168|20883161|P1|NOT COMPLETED|Long Term Follow-Up||11
8473919|NCT00636168|20883160|P2|COMPLETED|Long Term Follow-Up||129
8473920|NCT00636168|20883161|P1|COMPLETED|Long Term Follow-Up||130
8473921|NCT00636168|20883160|P2|STARTED|Long Term Follow-Up||143
8473922|NCT00636168|20883161|P1|STARTED|Long Term Follow-Up||141
8473923|NCT00636168|20883160|P2|NOT COMPLETED|Treated With Study Drug||331
8473924|NCT00636168|20883161|P1|NOT COMPLETED|Treated With Study Drug||408
8473925|NCT00636168|20883160|P2|COMPLETED|Treated With Study Drug||143
8473926|NCT00636168|20883161|P1|COMPLETED|Treated With Study Drug||63
8473927|NCT00636168|20883160|P2|STARTED|Treated With Study Drug||474
8473928|NCT00636168|20883161|P1|STARTED|Treated With Study Drug||471
8473929|NCT00636168|20883160|P2|NOT COMPLETED|Randomized to Study Drug||2
8473930|NCT00636168|20883161|P1|NOT COMPLETED|Randomized to Study Drug||4
8473931|NCT00636168|20883160|P2|COMPLETED|Randomized to Study Drug||474
8473932|NCT00636168|20883161|P1|COMPLETED|Randomized to Study Drug||471
8473933|NCT00636168|20883160|P2|STARTED|Randomized to Study Drug||476
8473934|NCT00636168|20883161|P1|STARTED|Randomized to Study Drug||475
8473935|NCT00636155|20883189|P1|NOT COMPLETED|Overall Study||18
8473936|NCT00636155|20883189|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
8473937|NCT00636155|20883189|P1|STARTED|Overall Study||20
8473938|NCT00636077|20883195|P4|NOT COMPLETED|Week 4||0
8473939|NCT00636077|20883196|P3|NOT COMPLETED|Week 4||0
8473940|NCT00636077|20883197|P2|NOT COMPLETED|Week 4||0
8473941|NCT00636077|20883198|P1|NOT COMPLETED|Week 4||0
8473942|NCT00636077|20883195|P4|COMPLETED|Week 4||3
8473943|NCT00636077|20883196|P3|COMPLETED|Week 4||3
8473944|NCT00636077|20883197|P2|COMPLETED|Week 4||3
8473945|NCT00636077|20883198|P1|COMPLETED|Week 4||3
8473946|NCT00636077|20883195|P4|STARTED|Week 4||3
8473947|NCT00636077|20883196|P3|STARTED|Week 4||3
8473948|NCT00636077|20883197|P2|STARTED|Week 4||3
8473949|NCT00636077|20883198|P1|STARTED|Week 4||3
8473950|NCT00636077|20883195|P4|NOT COMPLETED|Week 3||0
8473951|NCT00636077|20883196|P3|NOT COMPLETED|Week 3||0
8473952|NCT00636077|20883197|P2|NOT COMPLETED|Week 3||0
8473953|NCT00636077|20883198|P1|NOT COMPLETED|Week 3||0
8473954|NCT00636077|20883195|P4|COMPLETED|Week 3||3
8473955|NCT00636077|20883196|P3|COMPLETED|Week 3||3
8473956|NCT00636077|20883197|P2|COMPLETED|Week 3||3
8473957|NCT00636077|20883198|P1|COMPLETED|Week 3||3
8473958|NCT00636077|20883195|P4|STARTED|Week 3||3
8473959|NCT00636077|20883196|P3|STARTED|Week 3||3
8473960|NCT00636077|20883197|P2|STARTED|Week 3||3
8473961|NCT00636077|20883198|P1|STARTED|Week 3||3
8473962|NCT00636077|20883195|P4|NOT COMPLETED|Week 2||0
8473963|NCT00636077|20883196|P3|NOT COMPLETED|Week 2||0
8473964|NCT00636077|20883197|P2|NOT COMPLETED|Week 2||0
8473965|NCT00636077|20883198|P1|NOT COMPLETED|Week 2||0
8473966|NCT00636077|20883195|P4|COMPLETED|Week 2||3
8473967|NCT00636077|20883196|P3|COMPLETED|Week 2||3
8473968|NCT00636077|20883197|P2|COMPLETED|Week 2||3
8473969|NCT00636077|20883198|P1|COMPLETED|Week 2||3
8473970|NCT00636077|20883195|P4|STARTED|Week 2||3
8473971|NCT00636077|20883196|P3|STARTED|Week 2||3
8473972|NCT00636077|20883197|P2|STARTED|Week 2||3
8473973|NCT00636077|20883198|P1|STARTED|Week 2||3
8473974|NCT00636077|20883195|P4|NOT COMPLETED|Week 1||0
8473975|NCT00636077|20883196|P3|NOT COMPLETED|Week 1||0
8473976|NCT00636077|20883197|P2|NOT COMPLETED|Week 1||0
8473977|NCT00636077|20883198|P1|NOT COMPLETED|Week 1||0
8473978|NCT00636077|20883195|P4|COMPLETED|Week 1||3
8473979|NCT00636077|20883196|P3|COMPLETED|Week 1||3
8473980|NCT00636077|20883197|P2|COMPLETED|Week 1||3
8473981|NCT00636077|20883198|P1|COMPLETED|Week 1||3
8473982|NCT00636077|20883195|P4|STARTED|Week 1||3
8473983|NCT00636077|20883196|P3|STARTED|Week 1||3
8473984|NCT00636077|20883197|P2|STARTED|Week 1||3
8473985|NCT00636077|20883198|P1|STARTED|Week 1||3
8473986|NCT00635999|20883231|P3|NOT COMPLETED|Overall Study||1
8473987|NCT00635999|20883232|P2|NOT COMPLETED|Overall Study||2
8473988|NCT00635999|20883233|P1|NOT COMPLETED|Overall Study||4
8473989|NCT00635999|20883231|P3|COMPLETED|Overall Study||23
8473990|NCT00635999|20883232|P2|COMPLETED|Overall Study||23
8473991|NCT00635999|20883233|P1|COMPLETED|Overall Study||23
8473992|NCT00635999|20883231|P3|STARTED|Overall Study||24
8473993|NCT00635999|20883232|P2|STARTED|Overall Study||25
8473994|NCT00635999|20883233|P1|STARTED|Overall Study||27
8473995|NCT00635882|20883250|P6|NOT COMPLETED|Overall Study||0
8473996|NCT00635882|20883251|P5|NOT COMPLETED|Overall Study||0
8473997|NCT00635882|20883252|P4|NOT COMPLETED|Overall Study||0
8473998|NCT00635882|20883253|P3|NOT COMPLETED|Overall Study||0
8473999|NCT00635882|20883254|P2|NOT COMPLETED|Overall Study||0
8474000|NCT00635882|20883255|P1|NOT COMPLETED|Overall Study||1
8474001|NCT00635882|20883250|P6|COMPLETED|Overall Study||13
8474002|NCT00635882|20883251|P5|COMPLETED|Overall Study||16
8474003|NCT00635882|20883252|P4|COMPLETED|Overall Study||15
8474004|NCT00635882|20883253|P3|COMPLETED|Overall Study||12
8474005|NCT00635882|20883254|P2|COMPLETED|Overall Study||17
8474006|NCT00635882|20883255|P1|COMPLETED|Overall Study||19
8474007|NCT00635882|20883250|P6|STARTED|Overall Study||13
8474008|NCT00635882|20883251|P5|STARTED|Overall Study||16
8474009|NCT00635882|20883252|P4|STARTED|Overall Study||15
8474010|NCT00635882|20883253|P3|STARTED|Overall Study||12
8474011|NCT00635882|20883254|P2|STARTED|Overall Study||17
8474012|NCT00635882|20883255|P1|STARTED|Overall Study||20
8474013|NCT00635830|20883319|P2|NOT COMPLETED|Overall Study||0
8474014|NCT00635830|20883320|P1|NOT COMPLETED|Overall Study||0
8474015|NCT00635830|20883319|P2|COMPLETED|Overall Study||20
8474016|NCT00635830|20883320|P1|COMPLETED|Overall Study||20
8474017|NCT00635830|20883319|P2|STARTED|Overall Study||20
8474018|NCT00635830|20883320|P1|STARTED|Overall Study||20
8474019|NCT00635817|20883330|P4|NOT COMPLETED|Overall Study||0
8474020|NCT00635817|20883331|P3|NOT COMPLETED|Overall Study||2
8474021|NCT00635817|20883332|P2|NOT COMPLETED|Overall Study||2
8474022|NCT00635817|20883333|P1|NOT COMPLETED|Overall Study||6
8474023|NCT00635817|20883330|P4|COMPLETED|Overall Study||21
8474024|NCT00635817|20883331|P3|COMPLETED|Overall Study||19
8474025|NCT00635817|20883332|P2|COMPLETED|Overall Study||19
8474026|NCT00635817|20883333|P1|COMPLETED|Overall Study||15
8474027|NCT00635817|20883330|P4|STARTED|Overall Study||21
8474028|NCT00635817|20883331|P3|STARTED|Overall Study||21
8474029|NCT00635817|20883332|P2|STARTED|Overall Study||21
8474030|NCT00635817|20883333|P1|STARTED|Overall Study||21
8474031|NCT00635804|20883385|P8|NOT COMPLETED|Overall Study||0
8474032|NCT00635804|20883386|P7|NOT COMPLETED|Overall Study||0
8474033|NCT00635804|20883387|P6|NOT COMPLETED|Overall Study||1
8474034|NCT00635804|20883388|P5|NOT COMPLETED|Overall Study||0
8474035|NCT00635804|20883389|P4|NOT COMPLETED|Overall Study||0
8474036|NCT00635804|20883390|P3|NOT COMPLETED|Overall Study||0
8474037|NCT00635804|20883391|P2|NOT COMPLETED|Overall Study||0
8474038|NCT00635804|20883392|P1|NOT COMPLETED|Overall Study||1
8474039|NCT00635804|20883385|P8|COMPLETED|Overall Study||14
8474040|NCT00635804|20883386|P7|COMPLETED|Overall Study||3
8474041|NCT00635804|20883387|P6|COMPLETED|Overall Study||11
8474042|NCT00635804|20883388|P5|COMPLETED|Overall Study||6
8474043|NCT00635804|20883389|P4|COMPLETED|Overall Study||6
8474044|NCT00635804|20883390|P3|COMPLETED|Overall Study||6
8474045|NCT00635804|20883391|P2|COMPLETED|Overall Study||6
8474046|NCT00635804|20883392|P1|COMPLETED|Overall Study||6
8474047|NCT00635804|20883385|P8|STARTED|Overall Study||14
8474048|NCT00635804|20883386|P7|STARTED|Overall Study||3
8474049|NCT00635804|20883387|P6|STARTED|Overall Study||12
8474050|NCT00635804|20883388|P5|STARTED|Overall Study||6
8474051|NCT00635804|20883389|P4|STARTED|Overall Study||6
8474052|NCT00635804|20883390|P3|STARTED|Overall Study||6
8474053|NCT00635804|20883391|P2|STARTED|Overall Study||6
8474054|NCT00635804|20883392|P1|STARTED|Overall Study||7
8474055|NCT00635778|20883496|P7|NOT COMPLETED|Overall Study||6
8474056|NCT00635778|20883497|P6|NOT COMPLETED|Overall Study||21
8474057|NCT00635778|20883498|P5|NOT COMPLETED|Overall Study||8
8474058|NCT00635778|20883499|P4|NOT COMPLETED|Overall Study||8
8474059|NCT00635778|20883500|P3|NOT COMPLETED|Overall Study||3
8474060|NCT00635778|20883501|P2|NOT COMPLETED|Overall Study||3
8474061|NCT00635778|20883502|P1|NOT COMPLETED|Overall Study||1
8474062|NCT00635778|20883496|P7|COMPLETED|Overall Study||0
8474063|NCT00635778|20883497|P6|COMPLETED|Overall Study||0
8474064|NCT00635778|20883498|P5|COMPLETED|Overall Study||0
8474065|NCT00635778|20883499|P4|COMPLETED|Overall Study||0
8474066|NCT00635778|20883500|P3|COMPLETED|Overall Study||0
8474067|NCT00635778|20883501|P2|COMPLETED|Overall Study||0
8474068|NCT00635778|20883502|P1|COMPLETED|Overall Study||0
8474069|NCT00635778|20883496|P7|STARTED|Overall Study||6
8474070|NCT00635778|20883497|P6|STARTED|Overall Study||21
8474071|NCT00635778|20883498|P5|STARTED|Overall Study||8
8474072|NCT00635778|20883499|P4|STARTED|Overall Study||8
8474073|NCT00635778|20883500|P3|STARTED|Overall Study||3
8474074|NCT00635778|20883501|P2|STARTED|Overall Study||3
8474075|NCT00635778|20883502|P1|STARTED|Overall Study||1
8474076|NCT00635739|20883555|P2|NOT COMPLETED|Overall Study||2
8474077|NCT00635739|20883556|P1|NOT COMPLETED|Overall Study||3
8474078|NCT00635739|20883555|P2|COMPLETED|Overall Study||36
8474079|NCT00635739|20883556|P1|COMPLETED|Overall Study||39
8474080|NCT00635739|20883555|P2|STARTED|Overall Study||38
8474081|NCT00635739|20883556|P1|STARTED|Overall Study||42
8474082|NCT00635700|20883566|P2|NOT COMPLETED|Overall Study||14
8474083|NCT00635700|20883567|P1|NOT COMPLETED|Overall Study||15
8474084|NCT00635700|20883566|P2|COMPLETED|Overall Study||13
8474085|NCT00635700|20883567|P1|COMPLETED|Overall Study||9
8474086|NCT00635700|20883566|P2|STARTED|Overall Study||27
8474087|NCT00635700|20883567|P1|STARTED|Overall Study||24
8474088|NCT00635661|20883573|P1|NOT COMPLETED|Overall Study||4
8474089|NCT00635661|20883573|P1|COMPLETED|Overall Study||30
8474090|NCT00635661|20883573|P1|STARTED|Overall Study||34
8474091|NCT00635648|20883577|P1|NOT COMPLETED|Overall Study||37
8474092|NCT00635648|20883577|P1|COMPLETED|Overall Study||26
8474093|NCT00635648|20883577|P1|STARTED|Overall Study||63
8474094|NCT00635609|20883586|P2|NOT COMPLETED|Overall Study||3
8474095|NCT00635609|20883587|P1|NOT COMPLETED|Overall Study||7
8474096|NCT00635609|20883586|P2|COMPLETED|Overall Study||42
8474097|NCT00635609|20883587|P1|COMPLETED|Overall Study||41
8474098|NCT00635609|20883586|P2|STARTED|Overall Study||45
8474099|NCT00635609|20883587|P1|STARTED|Overall Study||48
8474106|NCT00635492|20883614|P2|NOT COMPLETED|Overall Study||282
8474107|NCT00635492|20883615|P1|NOT COMPLETED|Overall Study||279
8474108|NCT00635492|20883614|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
8474109|NCT00635492|20883615|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
8474110|NCT00635492|20883614|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
8474111|NCT00635492|20883615|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
8474112|NCT00635479|20883661|P2|NOT COMPLETED|Overall Study||18
8474113|NCT00635479|20883662|P1|NOT COMPLETED|Overall Study||6
8474114|NCT00635479|20883661|P2|COMPLETED|Overall Study||42
8474115|NCT00635479|20883662|P1|COMPLETED|Overall Study||49
8474116|NCT00635479|20883661|P2|STARTED|Overall Study||60
8474117|NCT00635479|20883662|P1|STARTED|Overall Study||55
8474118|NCT00635453|20883670|P2|NOT COMPLETED|Overall Study||174
8474119|NCT00635453|20883671|P1|NOT COMPLETED|Overall Study||154
8474120|NCT00635453|20883670|P2|COMPLETED|Overall Study||181
8474121|NCT00635453|20883671|P1|COMPLETED|Overall Study||206
8474122|NCT00635453|20883670|P2|3 Years Assessment|Overall Study||204
8474123|NCT00635453|20883671|P1|3 Years Assessment|Overall Study||246
8474124|NCT00635453|20883670|P2|12 Months Assessment|Overall Study||260
8474125|NCT00635453|20883671|P1|12 Months Assessment|Overall Study||285
8474126|NCT00635453|20883670|P2|6 Months Assessment|Overall Study||311
8474127|NCT00635453|20883671|P1|6 Months Assessment|Overall Study||322
8474128|NCT00635453|20883670|P2|STARTED|Overall Study||355
8474129|NCT00635453|20883671|P1|STARTED|Overall Study||360
8474130|NCT00635427|20883688|P5|NOT COMPLETED|Overall Study||8
8474131|NCT00635427|20883689|P4|NOT COMPLETED|Overall Study||9
8474132|NCT00635427|20883690|P3|NOT COMPLETED|Overall Study||11
8474133|NCT00635427|20883691|P2|NOT COMPLETED|Overall Study||6
8474134|NCT00635427|20883692|P1|NOT COMPLETED|Overall Study||12
8474135|NCT00635427|20883688|P5|COMPLETED|Overall Study||30
8474136|NCT00635427|20883689|P4|COMPLETED|Overall Study||7
8474137|NCT00635427|20883690|P3|COMPLETED|Overall Study||5
8474138|NCT00635427|20883691|P2|COMPLETED|Overall Study||6
8474139|NCT00635427|20883692|P1|COMPLETED|Overall Study||1
8474140|NCT00635427|20883688|P5|STARTED|Overall Study||38
8474141|NCT00635427|20883689|P4|STARTED|Overall Study||16
8474142|NCT00635427|20883690|P3|STARTED|Overall Study||16
8474143|NCT00635427|20883691|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
8474144|NCT00635427|20883692|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
8474145|NCT00635362|20883714|P2|NOT COMPLETED|Overall Study||8
8474146|NCT00635362|20883715|P1|NOT COMPLETED|Overall Study||13
8474147|NCT00635362|20883714|P2|COMPLETED|Overall Study||12
8474148|NCT00635362|20883715|P1|COMPLETED|Overall Study||9
8474149|NCT00635362|20883714|P2|STARTED|Overall Study||20
8474150|NCT00635362|20883715|P1|STARTED|Overall Study||22
8474151|NCT00635349|20883731|P2|NOT COMPLETED|Overall Study||48
8474152|NCT00635349|20883732|P1|NOT COMPLETED|Overall Study||44
8474153|NCT00635349|20883731|P2|COMPLETED|Overall Study||19
8474154|NCT00635349|20883732|P1|COMPLETED|Overall Study||29
8474155|NCT00635349|20883731|P2|STARTED|Overall Study||67
8474156|NCT00635349|20883732|P1|STARTED|Overall Study||73
8474157|NCT00635232|20883755|P5|NOT COMPLETED|Overall Study||8
8474158|NCT00635232|20883756|P4|NOT COMPLETED|Overall Study||10
8474159|NCT00635232|20883757|P3|NOT COMPLETED|Overall Study||3
8474160|NCT00635232|20883758|P2|NOT COMPLETED|Overall Study||20
8474161|NCT00635232|20883759|P1|NOT COMPLETED|Overall Study||14
8474162|NCT00635232|20883755|P5|COMPLETED|Overall Study||20
8474163|NCT00635232|20883756|P4|COMPLETED|Overall Study||48
8474164|NCT00635232|20883757|P3|COMPLETED|Overall Study||55
8474165|NCT00635232|20883758|P2|COMPLETED|Overall Study||39
8474166|NCT00635232|20883759|P1|COMPLETED|Overall Study||44
8474167|NCT00635232|20883755|P5|STARTED|Overall Study||28
8474168|NCT00635232|20883756|P4|STARTED|Overall Study||58
8474169|NCT00635232|20883757|P3|STARTED|Overall Study||58
8474170|NCT00635232|20883758|P2|STARTED|Overall Study||59
8474171|NCT00635232|20883759|P1|STARTED|Overall Study||58
8474172|NCT00635219|20883786|P5|NOT COMPLETED|Overall Study||42
8474173|NCT00635219|20883787|P4|NOT COMPLETED|Overall Study||34
8474174|NCT00635219|20883788|P3|NOT COMPLETED|Overall Study||35
8474175|NCT00635219|20883789|P2|NOT COMPLETED|Overall Study||25
8474176|NCT00635219|20883790|P1|NOT COMPLETED|Overall Study||25
8474177|NCT00635219|20883786|P5|COMPLETED|Overall Study||113
8474178|NCT00635219|20883787|P4|COMPLETED|Overall Study||117
8474179|NCT00635219|20883788|P3|COMPLETED|Overall Study||122
8474180|NCT00635219|20883789|P2|COMPLETED|Overall Study||130
8474181|NCT00635219|20883790|P1|COMPLETED|Overall Study||123
8474182|NCT00635219|20883786|P5|STARTED|Overall Study||155
8474183|NCT00635219|20883787|P4|STARTED|Overall Study||151
8474184|NCT00635219|20883788|P3|STARTED|Overall Study||157
8474185|NCT00635219|20883789|P2|STARTED|Overall Study||155
8474186|NCT00635219|20883790|P1|STARTED|Overall Study||148
8474187|NCT00635167|20883847|P1|NOT COMPLETED|Overall Study||0
8474188|NCT00635167|20883847|P1|COMPLETED|Overall Study||1
8474189|NCT00635167|20883847|P1|STARTED|Overall Study||1
8474190|NCT00635154|20883853|P1|NOT COMPLETED|Overall Study||33
8474191|NCT00635154|20883853|P1|COMPLETED|Overall Study||21
8474192|NCT00635154|20883853|P1|STARTED|Overall Study||54
8474193|NCT00635128|20883865|P2|NOT COMPLETED|Overall Study||0
8474194|NCT00635128|20883866|P1|NOT COMPLETED|Overall Study||0
8474195|NCT00635128|20883865|P2|COMPLETED|Overall Study||64
8474196|NCT00635128|20883866|P1|COMPLETED|Overall Study||351
8474197|NCT00635128|20883865|P2|STARTED|Overall Study||64
8474198|NCT00635128|20883866|P1|STARTED|Overall Study||351
8474199|NCT00635102|20883896|P2|NOT COMPLETED|Overall Study||8
8474200|NCT00635102|20883897|P1|NOT COMPLETED|Overall Study||7
8474201|NCT00635102|20883896|P2|COMPLETED|Overall Study||22
8474202|NCT00635102|20883897|P1|COMPLETED|Overall Study||20
8474203|NCT00635102|20883896|P2|STARTED|Overall Study||30
8474204|NCT00635102|20883897|P1|STARTED|Overall Study||27
8474205|NCT00635089|20883991|P1|NOT COMPLETED|Overall Study||78
8474206|NCT00635089|20883991|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
8474207|NCT00635089|20883991|P1|Completed >/= 16 Weeks of Study|Overall Study||181
8474208|NCT00635089|20883991|P1|STARTED|Overall Study||190
8474209|NCT00635050|20884018|P1|NOT COMPLETED|Overall Study||1
8474210|NCT00635050|20884018|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
8474211|NCT00635050|20884018|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
8474212|NCT00635024|20884025|P1|NOT COMPLETED|Overall Study||1
8474213|NCT00635024|20884025|P1|COMPLETED|Overall Study||0
8474214|NCT00635024|20884025|P1|STARTED|Overall Study||1
8474215|NCT00634972|20884035|P2|NOT COMPLETED|Overall Study||0
8474216|NCT00634972|20884036|P1|NOT COMPLETED|Overall Study||0
8474217|NCT00634972|20884035|P2|COMPLETED|Overall Study||43
8474218|NCT00634972|20884036|P1|COMPLETED|Overall Study||40
8474219|NCT00634972|20884035|P2|STARTED|Overall Study||43
8474220|NCT00634972|20884036|P1|STARTED|Overall Study||40
8474221|NCT00634933|20884045|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
8474222|NCT00634933|20884046|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
8474223|NCT00634933|20884047|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
8474224|NCT00634933|20884048|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
8474225|NCT00634933|20884049|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
8474226|NCT00634933|20884045|P5|COMPLETED|Part B: Week 24 to Week 52||22
8474227|NCT00634933|20884046|P4|COMPLETED|Part B: Week 24 to Week 52||25
8474228|NCT00634933|20884047|P3|COMPLETED|Part B: Week 24 to Week 52||33
8474229|NCT00634933|20884048|P2|COMPLETED|Part B: Week 24 to Week 52||42
8474230|NCT00634933|20884049|P1|COMPLETED|Part B: Week 24 to Week 52||0
8474231|NCT00634933|20884045|P5|STARTED|Part B: Week 24 to Week 52||32
8474232|NCT00634933|20884046|P4|STARTED|Part B: Week 24 to Week 52||31
8474233|NCT00634933|20884047|P3|STARTED|Part B: Week 24 to Week 52||55
8474234|NCT00634933|20884048|P2|STARTED|Part B: Week 24 to Week 52||56
8474235|NCT00634933|20884049|P1|STARTED|Part B: Week 24 to Week 52||0
8474236|NCT00634933|20884045|P5|NOT COMPLETED|Between Part A and Part B||0
8474237|NCT00634933|20884046|P4|NOT COMPLETED|Between Part A and Part B||0
8474238|NCT00634933|20884047|P3|NOT COMPLETED|Between Part A and Part B||0
8474239|NCT00634933|20884048|P2|NOT COMPLETED|Between Part A and Part B||1
8474240|NCT00634933|20884049|P1|NOT COMPLETED|Between Part A and Part B||0
8474241|NCT00634933|20884045|P5|COMPLETED|Between Part A and Part B||32
8474242|NCT00634933|20884046|P4|COMPLETED|Between Part A and Part B||31
8474243|NCT00634933|20884047|P3|COMPLETED|Between Part A and Part B||55
8474244|NCT00634933|20884048|P2|COMPLETED|Between Part A and Part B||56
8474245|NCT00634933|20884049|P1|COMPLETED|Between Part A and Part B||0
8474246|NCT00634933|20884045|P5|STARTED|Between Part A and Part B||32
8474247|NCT00634933|20884046|P4|STARTED|Between Part A and Part B||31
8474248|NCT00634933|20884047|P3|STARTED|Between Part A and Part B||55
8474249|NCT00634933|20884048|P2|STARTED|Between Part A and Part B||57
8474250|NCT00634933|20884049|P1|STARTED|Between Part A and Part B||0
8474251|NCT00634933|20884045|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
8474252|NCT00634933|20884046|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
8474253|NCT00634933|20884047|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
8474254|NCT00634933|20884048|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
8474255|NCT00634933|20884049|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
8474256|NCT00634933|20884045|P5|COMPLETED|Part A: Baseline to Week 24||0
8474257|NCT00634933|20884046|P4|COMPLETED|Part A: Baseline to Week 24||0
8474258|NCT00634933|20884047|P3|COMPLETED|Part A: Baseline to Week 24||55
8474259|NCT00634933|20884048|P2|COMPLETED|Part A: Baseline to Week 24||57
8474260|NCT00634933|20884049|P1|COMPLETED|Part A: Baseline to Week 24||63
8474261|NCT00634933|20884045|P5|STARTED|Part A: Baseline to Week 24||0
8474262|NCT00634933|20884046|P4|STARTED|Part A: Baseline to Week 24||0
8474263|NCT00634933|20884047|P3|STARTED|Part A: Baseline to Week 24||73
8474264|NCT00634933|20884048|P2|STARTED|Part A: Baseline to Week 24||75
8474265|NCT00634933|20884049|P1|STARTED|Part A: Baseline to Week 24||74
8474266|NCT00634920|20884118|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
8474267|NCT00634920|20884119|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
8474268|NCT00634920|20884120|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
8474269|NCT00634920|20884118|P3|COMPLETED|Period 2 - Post-Randomization||0
8474270|NCT00634920|20884119|P2|COMPLETED|Period 2 - Post-Randomization||68
8474271|NCT00634920|20884120|P1|COMPLETED|Period 2 - Post-Randomization||43
8474272|NCT00634920|20884118|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
8474273|NCT00634920|20884119|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
8474274|NCT00634920|20884120|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
8474275|NCT00634920|20884118|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
8474276|NCT00634920|20884119|P2|STARTED|Period 2 - Post-Randomization||100
8474277|NCT00634920|20884120|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
8474278|NCT00634920|20884118|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
8474279|NCT00634920|20884119|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
8474280|NCT00634920|20884120|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
8474281|NCT00634920|20884118|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
8474282|NCT00634920|20884119|P2|COMPLETED|Period 1 - Pre-Randomization||0
8474283|NCT00634920|20884120|P1|COMPLETED|Period 1 - Pre-Randomization||0
8474284|NCT00634920|20884118|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
8474285|NCT00634920|20884119|P2|STARTED|Period 1 - Pre-Randomization||0
8474286|NCT00634920|20884120|P1|STARTED|Period 1 - Pre-Randomization||0
8474287|NCT00634907|20884164|P2|NOT COMPLETED|Overall Study||17
8474288|NCT00634907|20884165|P1|NOT COMPLETED|Overall Study||17
8474289|NCT00634907|20884164|P2|COMPLETED|Overall Study||115
8474290|NCT00634907|20884165|P1|COMPLETED|Overall Study||114
8474291|NCT00634907|20884164|P2|STARTED|Overall Study||132
8474292|NCT00634907|20884165|P1|STARTED|Overall Study||131
8474293|NCT00634842|20884189|P2|NOT COMPLETED|Overall Study||18
8474294|NCT00634842|20884190|P1|NOT COMPLETED|Overall Study||15
8474295|NCT00634842|20884189|P2|COMPLETED|Overall Study||104
8474296|NCT00634842|20884190|P1|COMPLETED|Overall Study||107
8474297|NCT00634842|20884189|P2|STARTED|Overall Study||122
8474298|NCT00634842|20884190|P1|STARTED|Overall Study||122
8474299|NCT00634803|20884205|P3|NOT COMPLETED|Overall Study||7
8474300|NCT00634803|20884206|P2|NOT COMPLETED|Overall Study||7
8474301|NCT00634803|20884207|P1|NOT COMPLETED|Overall Study||6
8474302|NCT00634803|20884205|P3|COMPLETED|Overall Study||23
8474303|NCT00634803|20884206|P2|COMPLETED|Overall Study||23
8474304|NCT00634803|20884207|P1|COMPLETED|Overall Study||24
8474305|NCT00634803|20884205|P3|Month 3|Overall Study||26
8474306|NCT00634803|20884206|P2|Month 3|Overall Study||23
8474307|NCT00634803|20884207|P1|Month 3|Overall Study||25
8474308|NCT00634803|20884205|P3|Month 2|Overall Study||28
8474309|NCT00634803|20884206|P2|Month 2|Overall Study||26
8474310|NCT00634803|20884207|P1|Month 2|Overall Study||26
8474311|NCT00634803|20884205|P3|Month 1|Overall Study||29
8474312|NCT00634803|20884206|P2|Month 1|Overall Study||29
8474313|NCT00634803|20884207|P1|Month 1|Overall Study||29
8474314|NCT00634803|20884205|P3|STARTED|Overall Study||30
8474315|NCT00634803|20884206|P2|STARTED|Overall Study||30
8474316|NCT00634803|20884207|P1|STARTED|Overall Study||30
8474317|NCT00634751|20884225|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
8474318|NCT00634751|20884226|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
8474319|NCT00634751|20884227|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474320|NCT00634751|20884228|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474321|NCT00634751|20884225|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
8474322|NCT00634751|20884226|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
8474323|NCT00634751|20884227|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474324|NCT00634751|20884228|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474325|NCT00634751|20884225|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
8474326|NCT00634751|20884226|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
8474327|NCT00634751|20884227|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
8474328|NCT00634751|20884228|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
8474329|NCT00634751|20884225|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474330|NCT00634751|20884226|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474331|NCT00634751|20884227|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
8474332|NCT00634751|20884228|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474333|NCT00634751|20884225|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474334|NCT00634751|20884226|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474335|NCT00634751|20884227|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
8474336|NCT00634751|20884228|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474337|NCT00634751|20884225|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8474338|NCT00634751|20884226|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8474339|NCT00634751|20884227|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
8474340|NCT00634751|20884228|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8474341|NCT00634751|20884225|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474342|NCT00634751|20884226|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474343|NCT00634751|20884227|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474344|NCT00634751|20884228|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
8474345|NCT00634751|20884225|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474346|NCT00634751|20884226|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474347|NCT00634751|20884227|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474348|NCT00634751|20884228|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
8474349|NCT00634751|20884225|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8474350|NCT00634751|20884226|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8474351|NCT00634751|20884227|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8474352|NCT00634751|20884228|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
8474353|NCT00634647|20884246|P1|NOT COMPLETED|Overall Study||7
8474354|NCT00634647|20884246|P1|COMPLETED|Overall Study||17
8474355|NCT00634647|20884246|P1|STARTED|Overall Study||24
8474356|NCT00634621|20884252|P1|NOT COMPLETED|Overall Study||0
8474357|NCT00634621|20884252|P1|COMPLETED|Overall Study||283
8474358|NCT00634621|20884252|P1|STARTED|Overall Study||283
8474359|NCT00634582|20884260|P1|NOT COMPLETED|Overall Study||0
8474360|NCT00634582|20884260|P1|COMPLETED|Overall Study||2
8474361|NCT00634582|20884260|P1|STARTED|Overall Study||2
8474362|NCT00634569|20884266|P2|NOT COMPLETED|Overall Study||5
8474363|NCT00634569|20884267|P1|NOT COMPLETED|Overall Study||0
8474364|NCT00634569|20884266|P2|COMPLETED|Overall Study||5
8474365|NCT00634569|20884267|P1|COMPLETED|Overall Study||14
8474366|NCT00634569|20884266|P2|STARTED|Overall Study||10
8474367|NCT00634569|20884267|P1|STARTED|Overall Study||14
8474368|NCT00634543|20884281|P2|NOT COMPLETED|Overall Study||21
8474369|NCT00634543|20884282|P1|NOT COMPLETED|Overall Study||19
8474370|NCT00634543|20884281|P2|COMPLETED|Overall Study||63
8474371|NCT00634543|20884282|P1|COMPLETED|Overall Study||59
8474372|NCT00634543|20884281|P2|Treated|Overall Study||80
8474373|NCT00634543|20884282|P1|Treated|Overall Study||76
8474374|NCT00634543|20884281|P2|STARTED|Overall Study||84
8474375|NCT00634543|20884282|P1|STARTED|Overall Study||78
8474376|NCT00634504|20884300|P2|NOT COMPLETED|Overall Study||0
8474377|NCT00634504|20884301|P1|NOT COMPLETED|Overall Study||1
8474378|NCT00634504|20884300|P2|COMPLETED|Overall Study||9
8474379|NCT00634504|20884301|P1|COMPLETED|Overall Study||10
8474380|NCT00634504|20884300|P2|STARTED|Overall Study||9
8474381|NCT00634504|20884301|P1|STARTED|Overall Study||11
8474382|NCT00634322|20884310|P3|NOT COMPLETED|Overall Study||0
8474383|NCT00634322|20884311|P2|NOT COMPLETED|Overall Study||0
8474384|NCT00634322|20884312|P1|NOT COMPLETED|Overall Study||0
8474385|NCT00634322|20884310|P3|COMPLETED|Overall Study||5
8474386|NCT00634322|20884311|P2|COMPLETED|Overall Study||1
8474387|NCT00634322|20884312|P1|COMPLETED|Overall Study||1
8474388|NCT00634322|20884310|P3|STARTED|Overall Study||5
8474389|NCT00634322|20884311|P2|STARTED|Overall Study||1
8474390|NCT00634322|20884312|P1|STARTED|Overall Study||1
8474391|NCT00634283|20884320|P1|NOT COMPLETED|Overall Study||0
8474392|NCT00634283|20884320|P1|COMPLETED|Overall Study||6
8474393|NCT00634283|20884320|P1|STARTED|Overall Study||6
8474394|NCT00634270|20884330|P2|NOT COMPLETED|Overall Study||1
8474395|NCT00634270|20884331|P1|NOT COMPLETED|Overall Study||3
8474396|NCT00634270|20884330|P2|COMPLETED|Overall Study||12
8474397|NCT00634270|20884331|P1|COMPLETED|Overall Study||46
8474398|NCT00634270|20884330|P2|STARTED|Overall Study||13
8474399|NCT00634270|20884331|P1|STARTED|Overall Study|February 12, 2008|49
8474400|NCT00634244|20884360|P3|NOT COMPLETED|Overall Study||0
8474401|NCT00634244|20884361|P2|NOT COMPLETED|Overall Study||13
8474402|NCT00634244|20884362|P1|NOT COMPLETED|Overall Study||1
8474403|NCT00634244|20884360|P3|COMPLETED|Overall Study||20
8474404|NCT00634244|20884361|P2|COMPLETED|Overall Study||24
8474405|NCT00634244|20884362|P1|COMPLETED|Overall Study||34
8474406|NCT00634244|20884360|P3|Eligible and Treated|Overall Study||20
8474407|NCT00634244|20884361|P2|Eligible and Treated|Overall Study||36
8474408|NCT00634244|20884362|P1|Eligible and Treated|Overall Study||35
8474409|NCT00634244|20884360|P3|STARTED|Overall Study||20
8474410|NCT00634244|20884361|P2|STARTED|Overall Study||37
8474411|NCT00634244|20884362|P1|STARTED|Overall Study||35
8474412|NCT00634179|20884373|P1|NOT COMPLETED|Phase II: Maintenance||1
8474413|NCT00634179|20884373|P1|COMPLETED|Phase II: Maintenance||29
8474414|NCT00634179|20884373|P1|STARTED|Phase II: Maintenance||30
8474415|NCT00634179|20884373|P1|NOT COMPLETED|Phase I: Induction||0
8474416|NCT00634179|20884373|P1|COMPLETED|Phase I: Induction||19
8474417|NCT00634179|20884373|P1|STARTED|Phase I: Induction||19
8474418|NCT00634166|20884382|P2|NOT COMPLETED|Overall Study||60
8474419|NCT00634166|20884383|P1|NOT COMPLETED|Overall Study||60
8474420|NCT00634166|20884382|P2|COMPLETED|Overall Study||78
8474421|NCT00634166|20884383|P1|COMPLETED|Overall Study||22
8474422|NCT00634166|20884382|P2|STARTED|Overall Study||138
8474423|NCT00634166|20884383|P1|STARTED|Overall Study||82
8474424|NCT00634114|20884392|P3|NOT COMPLETED|Overall Study||39
8474425|NCT00634114|20884393|P2|NOT COMPLETED|Overall Study||35
8474426|NCT00634114|20884394|P1|NOT COMPLETED|Overall Study||28
8474427|NCT00634114|20884392|P3|COMPLETED|Overall Study|Completed|148
8474428|NCT00634114|20884393|P2|COMPLETED|Overall Study|Completed|154
8474429|NCT00634114|20884394|P1|COMPLETED|Overall Study|Completed|160
8474430|NCT00634114|20884392|P3|STARTED|Overall Study|Randomised|187
8474431|NCT00634114|20884393|P2|STARTED|Overall Study|Randomised|189
8474432|NCT00634114|20884394|P1|STARTED|Overall Study|Randomised|188
8474433|NCT00634101|20884410|P2|NOT COMPLETED|Overall Study||3
8474434|NCT00634101|20884411|P1|NOT COMPLETED|Overall Study||5
8474435|NCT00634101|20884410|P2|COMPLETED|Overall Study||56
8474436|NCT00634101|20884411|P1|COMPLETED|Overall Study||61
8474437|NCT00634101|20884410|P2|STARTED|Overall Study||59
8474438|NCT00634101|20884411|P1|STARTED|Overall Study||66
8474439|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474440|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474441|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474442|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474443|NCT00634088|20884445|P4|COMPLETED|Time Period 4: Triplet Combination||0
8474444|NCT00634088|20884446|P3|COMPLETED|Time Period 4: Triplet Combination||0
8474445|NCT00634088|20884447|P2|COMPLETED|Time Period 4: Triplet Combination||0
8474446|NCT00634088|20884448|P1|COMPLETED|Time Period 4: Triplet Combination||0
8474447|NCT00634088|20884445|P4|STARTED|Time Period 4: Triplet Combination||0
8474448|NCT00634088|20884446|P3|STARTED|Time Period 4: Triplet Combination||0
8474449|NCT00634088|20884447|P2|STARTED|Time Period 4: Triplet Combination||0
8474450|NCT00634088|20884448|P1|STARTED|Time Period 4: Triplet Combination||0
8474451|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
8474452|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
8474453|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
8474454|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
8474455|NCT00634088|20884445|P4|COMPLETED|Time Period 3: Dose Level 3||0
8474456|NCT00634088|20884446|P3|COMPLETED|Time Period 3: Dose Level 3||0
8474457|NCT00634088|20884447|P2|COMPLETED|Time Period 3: Dose Level 3||0
8474458|NCT00634088|20884448|P1|COMPLETED|Time Period 3: Dose Level 3||0
8474459|NCT00634088|20884445|P4|STARTED|Time Period 3: Dose Level 3||0
8474460|NCT00634088|20884446|P3|STARTED|Time Period 3: Dose Level 3||1
8474461|NCT00634088|20884447|P2|STARTED|Time Period 3: Dose Level 3||0
8474462|NCT00634088|20884448|P1|STARTED|Time Period 3: Dose Level 3||0
8474463|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
8474464|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
8474465|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
8474466|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
8474467|NCT00634088|20884445|P4|COMPLETED|Time Period 2: Dose Level 2||0
8474468|NCT00634088|20884446|P3|COMPLETED|Time Period 2: Dose Level 2||0
8474469|NCT00634088|20884447|P2|COMPLETED|Time Period 2: Dose Level 2||0
8474470|NCT00634088|20884448|P1|COMPLETED|Time Period 2: Dose Level 2||0
8474471|NCT00634088|20884445|P4|STARTED|Time Period 2: Dose Level 2||0
8474472|NCT00634088|20884446|P3|STARTED|Time Period 2: Dose Level 2||0
8474473|NCT00634088|20884447|P2|STARTED|Time Period 2: Dose Level 2||3
8474474|NCT00634088|20884448|P1|STARTED|Time Period 2: Dose Level 2||0
8474475|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
8474476|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
8474477|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
8474478|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
8474479|NCT00634088|20884445|P4|COMPLETED|Time Period 1: Dose Level 1||0
8474480|NCT00634088|20884446|P3|COMPLETED|Time Period 1: Dose Level 1||0
8474481|NCT00634088|20884447|P2|COMPLETED|Time Period 1: Dose Level 1||0
8474482|NCT00634088|20884448|P1|COMPLETED|Time Period 1: Dose Level 1||0
8474483|NCT00634088|20884445|P4|STARTED|Time Period 1: Dose Level 1||0
8474484|NCT00634088|20884446|P3|STARTED|Time Period 1: Dose Level 1||0
8474485|NCT00634088|20884447|P2|STARTED|Time Period 1: Dose Level 1||0
8474486|NCT00634088|20884448|P1|STARTED|Time Period 1: Dose Level 1||6
8474487|NCT00634049|20884499|P1|NOT COMPLETED|Overall Study||3
8474488|NCT00634049|20884499|P1|COMPLETED|Overall Study||146
8474489|NCT00634049|20884499|P1|STARTED|Overall Study||149
8474490|NCT00634036|20884578|P2|NOT COMPLETED|Overall Study||2
8474491|NCT00634036|20884579|P1|NOT COMPLETED|Overall Study||2
8474492|NCT00634036|20884578|P2|COMPLETED|Overall Study||9
8474493|NCT00634036|20884579|P1|COMPLETED|Overall Study||10
8474494|NCT00634036|20884578|P2|STARTED|Overall Study||11
8474495|NCT00634036|20884579|P1|STARTED|Overall Study||12
8474496|NCT00634010|20884593|P2|NOT COMPLETED|Overall Study||14
8474497|NCT00634010|20884594|P1|NOT COMPLETED|Overall Study||10
8474498|NCT00634010|20884593|P2|COMPLETED|Overall Study||4
8474499|NCT00634010|20884594|P1|COMPLETED|Overall Study||8
8474500|NCT00634010|20884593|P2|STARTED|Overall Study||18
8474501|NCT00634010|20884594|P1|STARTED|Overall Study||18
8474502|NCT00633984|20884602|P2|NOT COMPLETED|Overall Study||13
8474503|NCT00633984|20884603|P1|NOT COMPLETED|Overall Study||9
8474504|NCT00633984|20884602|P2|COMPLETED|Overall Study||69
8474505|NCT00633984|20884603|P1|COMPLETED|Overall Study||78
8474506|NCT00633984|20884602|P2|STARTED|Overall Study||82
8474507|NCT00633984|20884603|P1|STARTED|Overall Study||87
8474508|NCT00633945|20884611|P1|NOT COMPLETED|Overall Study||2
8474509|NCT00633945|20884611|P1|COMPLETED|Overall Study||3
8474510|NCT00633945|20884611|P1|STARTED|Overall Study||5
8474511|NCT00633932|20884627|P3|NOT COMPLETED|Overall Study||11
8474512|NCT00633932|20884628|P2|NOT COMPLETED|Overall Study||14
8474513|NCT00633932|20884629|P1|NOT COMPLETED|Overall Study||12
8474514|NCT00633932|20884627|P3|COMPLETED|Overall Study||180
8474515|NCT00633932|20884628|P2|COMPLETED|Overall Study||176
8474516|NCT00633932|20884629|P1|COMPLETED|Overall Study||179
8474517|NCT00633932|20884627|P3|STARTED|Overall Study|Randomised|191
8474518|NCT00633932|20884628|P2|STARTED|Overall Study|Randomised|190
8474519|NCT00633932|20884629|P1|STARTED|Overall Study|Randomised|191
8474520|NCT00633919|20884642|P2|NOT COMPLETED|Overall Study||22
8474521|NCT00633919|20884643|P1|NOT COMPLETED|Overall Study||27
8474522|NCT00633919|20884642|P2|COMPLETED|Overall Study||39
8474523|NCT00633919|20884643|P1|COMPLETED|Overall Study||36
8474524|NCT00633919|20884642|P2|STARTED|Overall Study||61
8474525|NCT00633919|20884643|P1|STARTED|Overall Study||63
8474526|NCT00633893|20884660|P3|NOT COMPLETED|Overall Study||188
8474527|NCT00633893|20884661|P2|NOT COMPLETED|Overall Study||129
8474528|NCT00633893|20884662|P1|NOT COMPLETED|Overall Study||114
8474529|NCT00633893|20884660|P3|COMPLETED|Overall Study||641
8474530|NCT00633893|20884661|P2|COMPLETED|Overall Study||684
8474531|NCT00633893|20884662|P1|COMPLETED|Overall Study||726
8474532|NCT00633893|20884660|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
8474533|NCT00633893|20884661|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
8474534|NCT00633893|20884662|P1|STARTED|Overall Study||840
8474535|NCT00633880|20884736|P3|NOT COMPLETED|Randomized Double Blind||0
8474536|NCT00633880|20884737|P2|NOT COMPLETED|Randomized Double Blind||0
8474537|NCT00633880|20884738|P1|NOT COMPLETED|Randomized Double Blind||0
8474538|NCT00633880|20884736|P3|COMPLETED|Randomized Double Blind||51
8474539|NCT00633880|20884737|P2|COMPLETED|Randomized Double Blind||50
8474540|NCT00633880|20884738|P1|COMPLETED|Randomized Double Blind||0
8474541|NCT00633880|20884736|P3|STARTED|Randomized Double Blind||51
8474542|NCT00633880|20884737|P2|STARTED|Randomized Double Blind||50
8474543|NCT00633880|20884738|P1|STARTED|Randomized Double Blind||0
8474544|NCT00633880|20884736|P3|NOT COMPLETED|Open Label Titration||0
8474545|NCT00633880|20884737|P2|NOT COMPLETED|Open Label Titration||0
8474546|NCT00633880|20884738|P1|NOT COMPLETED|Open Label Titration||80
8474547|NCT00633880|20884736|P3|COMPLETED|Open Label Titration||0
8474548|NCT00633880|20884737|P2|COMPLETED|Open Label Titration||0
8474549|NCT00633880|20884738|P1|COMPLETED|Open Label Titration||101
8474550|NCT00633880|20884736|P3|STARTED|Open Label Titration||0
8474551|NCT00633880|20884737|P2|STARTED|Open Label Titration||0
8474552|NCT00633880|20884738|P1|STARTED|Open Label Titration||181
8474553|NCT00633867|20884767|P2|NOT COMPLETED|Overall Study||0
8474554|NCT00633867|20884768|P1|NOT COMPLETED|Overall Study||0
8474555|NCT00633867|20884767|P2|COMPLETED|Overall Study||60
8474556|NCT00633867|20884768|P1|COMPLETED|Overall Study||60
8474557|NCT00633867|20884767|P2|STARTED|Overall Study||60
8474558|NCT00633867|20884768|P1|STARTED|Overall Study||60
8474559|NCT00633750|20884774|P1|NOT COMPLETED|Overall Study||5
8474560|NCT00633750|20884774|P1|COMPLETED|Overall Study||42
8474561|NCT00633750|20884774|P1|STARTED|Overall Study||47
8474562|NCT00633594|20884783|P3|NOT COMPLETED|Overall Study||10
8474563|NCT00633594|20884784|P2|NOT COMPLETED|Overall Study||5
8474564|NCT00633594|20884785|P1|NOT COMPLETED|Overall Study||0
8474565|NCT00633594|20884783|P3|COMPLETED|Overall Study||16
8474566|NCT00633594|20884784|P2|COMPLETED|Overall Study||3
8474567|NCT00633594|20884785|P1|COMPLETED|Overall Study||5
8474568|NCT00633594|20884783|P3|STARTED|Overall Study||26
8474569|NCT00633594|20884784|P2|STARTED|Overall Study||8
8474570|NCT00633594|20884785|P1|STARTED|Overall Study||5
8474571|NCT00633477|20884814|P2|NOT COMPLETED|Overall Study||0
8474572|NCT00633477|20884815|P1|NOT COMPLETED|Overall Study||2
8474573|NCT00633477|20884814|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
8474574|NCT00633477|20884815|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
8474575|NCT00633477|20884814|P2|Completed Study Through Day 28|Overall Study||8
8474576|NCT00633477|20884815|P1|Completed Study Through Day 28|Overall Study||4
8474577|NCT00633477|20884814|P2|Prematurely Discontinued Study Drug|Overall Study||0
8474578|NCT00633477|20884815|P1|Prematurely Discontinued Study Drug|Overall Study||1
8474579|NCT00633477|20884814|P2|Randomized But Not Treated|Overall Study||0
8474580|NCT00633477|20884815|P1|Randomized But Not Treated|Overall Study||1
8474581|NCT00633477|20884814|P2|STARTED|Overall Study||11
8474582|NCT00633477|20884815|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
8474583|NCT00633464|20884831|P2|NOT COMPLETED|Overall Study||2
8474584|NCT00633464|20884832|P1|NOT COMPLETED|Overall Study||0
8474585|NCT00633464|20884831|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
8474586|NCT00633464|20884832|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
8474587|NCT00633464|20884831|P2|Treated|Overall Study||37
8474588|NCT00633464|20884832|P1|Treated|Overall Study||40
8474589|NCT00633464|20884831|P2|STARTED|Overall Study||39
8474590|NCT00633464|20884832|P1|STARTED|Overall Study||40
8474591|NCT00633399|20884854|P2|NOT COMPLETED|Overall Study||15
8474592|NCT00633399|20884855|P1|NOT COMPLETED|Overall Study||22
8474593|NCT00633399|20884854|P2|COMPLETED|Overall Study||53
8474594|NCT00633399|20884855|P1|COMPLETED|Overall Study||49
8474595|NCT00633399|20884854|P2|STARTED|Overall Study||68
8474596|NCT00633399|20884855|P1|STARTED|Overall Study||71
8474597|NCT00633360|20884867|P2|NOT COMPLETED|Overall Study||3
8474598|NCT00633360|20884868|P1|NOT COMPLETED|Overall Study||4
8474599|NCT00633360|20884867|P2|COMPLETED|Overall Study||13
8474600|NCT00633360|20884868|P1|COMPLETED|Overall Study||12
8474601|NCT00633360|20884867|P2|STARTED|Overall Study||16
8474602|NCT00633360|20884868|P1|STARTED|Overall Study||16
8474603|NCT00633256|20884878|P2|NOT COMPLETED|Overall Study||3
8474604|NCT00633256|20884879|P1|NOT COMPLETED|Overall Study||4
8474605|NCT00633256|20884878|P2|COMPLETED|Overall Study||10
8474606|NCT00633256|20884879|P1|COMPLETED|Overall Study||8
8474607|NCT00633256|20884878|P2|STARTED|Overall Study||13
8474608|NCT00633256|20884879|P1|STARTED|Overall Study||12
8474609|NCT00633243|20884891|P2|NOT COMPLETED|Overall Study||7
8474610|NCT00633243|20884892|P1|NOT COMPLETED|Overall Study||1
8474611|NCT00633243|20884891|P2|COMPLETED|Overall Study||2
8474612|NCT00633243|20884892|P1|COMPLETED|Overall Study||11
8474613|NCT00633243|20884891|P2|STARTED|Overall Study||9
8474614|NCT00633243|20884892|P1|STARTED|Overall Study||12
8474615|NCT00633217|20884900|P2|NOT COMPLETED|Overall Study||23
8474616|NCT00633217|20884901|P1|NOT COMPLETED|Overall Study||15
8474617|NCT00633217|20884900|P2|COMPLETED|Overall Study||103
8474618|NCT00633217|20884901|P1|COMPLETED|Overall Study||106
8474619|NCT00633217|20884900|P2|STARTED|Overall Study||126
8474620|NCT00633217|20884901|P1|STARTED|Overall Study||121
8474621|NCT00633152|20884913|P2|NOT COMPLETED|Overall Study||6
8474622|NCT00633152|20884914|P1|NOT COMPLETED|Overall Study||14
8474623|NCT00633152|20884913|P2|COMPLETED|Overall Study||41
8474624|NCT00633152|20884914|P1|COMPLETED|Overall Study||89
8474625|NCT00633152|20884913|P2|Clinically Evaluable Population|Overall Study||39
8474626|NCT00633152|20884914|P1|Clinically Evaluable Population|Overall Study||86
8474627|NCT00633152|20884913|P2|MITT and Safety Population|Overall Study||45
8474628|NCT00633152|20884914|P1|MITT and Safety Population|Overall Study||98
8474629|NCT00633152|20884913|P2|STARTED|Overall Study||47
8474630|NCT00633152|20884914|P1|STARTED|Overall Study||103
8474631|NCT00633139|20884925|P3|NOT COMPLETED|Overall Study||1
8474632|NCT00633139|20884926|P2|NOT COMPLETED|Overall Study||1
8474633|NCT00633139|20884927|P1|NOT COMPLETED|Overall Study||0
8474634|NCT00633139|20884925|P3|COMPLETED|Overall Study||3
8474635|NCT00633139|20884926|P2|COMPLETED|Overall Study||4
8474636|NCT00633139|20884927|P1|COMPLETED|Overall Study||4
8474637|NCT00633139|20884925|P3|STARTED|Overall Study||4
8474638|NCT00633139|20884926|P2|STARTED|Overall Study||5
8474639|NCT00633139|20884927|P1|STARTED|Overall Study||4
8474640|NCT00633126|20884941|P1|NOT COMPLETED|Overall Study||1
8474641|NCT00633126|20884941|P1|COMPLETED|Overall Study||8
8474642|NCT00633126|20884941|P1|STARTED|Overall Study||9
8474643|NCT00633087|20884946|P1|NOT COMPLETED|Overall Study||0
8474644|NCT00633087|20884946|P1|COMPLETED|Overall Study||12
8474645|NCT00633087|20884946|P1|STARTED|Overall Study||12
8474646|NCT00633074|20884955|P2|NOT COMPLETED|Overall Study||0
8474647|NCT00633074|20884956|P1|NOT COMPLETED|Overall Study||1
8474648|NCT00633074|20884955|P2|COMPLETED|Overall Study||360
8474649|NCT00633074|20884956|P1|COMPLETED|Overall Study||359
8474650|NCT00633074|20884955|P2|STARTED|Overall Study||360
8474651|NCT00633074|20884956|P1|STARTED|Overall Study||360
8474652|NCT00633061|20884986|P2|NOT COMPLETED|Overall Study||0
8474653|NCT00633061|20884987|P1|NOT COMPLETED|Overall Study||86
8474654|NCT00633061|20884986|P2|COMPLETED|Overall Study||0
8474655|NCT00633061|20884987|P1|COMPLETED|Overall Study||50
8474656|NCT00633061|20884986|P2|Had Prior Thrombosis Identified|Overall Study||0
8474657|NCT00633061|20884987|P1|Had Prior Thrombosis Identified|Overall Study||25
8474658|NCT00633061|20884986|P2|Met Criteria for Imaging|Overall Study||0
8474659|NCT00633061|20884987|P1|Met Criteria for Imaging|Overall Study||25
8474660|NCT00633061|20884986|P2|STARTED|Overall Study||0
8474661|NCT00633061|20884987|P1|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
8474662|NCT00633022|20884998|P3|NOT COMPLETED|Overall Study||5
8474663|NCT00633022|20884999|P2|NOT COMPLETED|Overall Study||1
8474664|NCT00633022|20885000|P1|NOT COMPLETED|Overall Study||1
8474665|NCT00633022|20884998|P3|COMPLETED|Overall Study||27
8474666|NCT00633022|20884999|P2|COMPLETED|Overall Study||32
8474667|NCT00633022|20885000|P1|COMPLETED|Overall Study||33
8474668|NCT00633022|20884998|P3|STARTED|Overall Study||32
8474669|NCT00633022|20884999|P2|STARTED|Overall Study||33
8474670|NCT00633022|20885000|P1|STARTED|Overall Study||34
8474671|NCT00633009|20885038|P3|NOT COMPLETED|Overall Study||1
8474672|NCT00633009|20885039|P2|NOT COMPLETED|Overall Study||4
8474673|NCT00633009|20885040|P1|NOT COMPLETED|Overall Study||4
8474674|NCT00633009|20885038|P3|COMPLETED|Overall Study||10
8474675|NCT00633009|20885039|P2|COMPLETED|Overall Study||23
8474676|NCT00633009|20885040|P1|COMPLETED|Overall Study||8
8474677|NCT00633009|20885038|P3|STARTED|Overall Study||11
8474678|NCT00633009|20885039|P2|STARTED|Overall Study||27
8474679|NCT00633009|20885040|P1|STARTED|Overall Study||12
8474680|NCT00632970|20885053|P2|NOT COMPLETED|Overall Study||0
8474681|NCT00632970|20885054|P1|NOT COMPLETED|Overall Study||0
8474682|NCT00632970|20885053|P2|COMPLETED|Overall Study||3
8474683|NCT00632970|20885054|P1|COMPLETED|Overall Study||3
8474684|NCT00632970|20885053|P2|STARTED|Overall Study||3
8474685|NCT00632970|20885054|P1|STARTED|Overall Study||3
8474686|NCT00632931|20885062|P3|NOT COMPLETED|Part 2||24
8474687|NCT00632931|20885063|P2|NOT COMPLETED|Part 2||0
8474688|NCT00632931|20885064|P1|NOT COMPLETED|Part 2||0
8474689|NCT00632931|20885062|P3|COMPLETED|Part 2||0
8474690|NCT00632931|20885063|P2|COMPLETED|Part 2||0
8474691|NCT00632931|20885064|P1|COMPLETED|Part 2||0
8474692|NCT00632931|20885062|P3|STARTED|Part 2||24
8474693|NCT00632931|20885063|P2|STARTED|Part 2||0
8474694|NCT00632931|20885064|P1|STARTED|Part 2||0
8474695|NCT00632931|20885062|P3|NOT COMPLETED|Post-Part 1 Washout||0
8474696|NCT00632931|20885063|P2|NOT COMPLETED|Post-Part 1 Washout||0
8474697|NCT00632931|20885064|P1|NOT COMPLETED|Post-Part 1 Washout||0
8474698|NCT00632931|20885062|P3|COMPLETED|Post-Part 1 Washout||0
8474699|NCT00632931|20885063|P2|COMPLETED|Post-Part 1 Washout||12
8474700|NCT00632931|20885064|P1|COMPLETED|Post-Part 1 Washout||12
8474701|NCT00632931|20885062|P3|STARTED|Post-Part 1 Washout||0
8474702|NCT00632931|20885063|P2|STARTED|Post-Part 1 Washout||12
8474703|NCT00632931|20885064|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
8474704|NCT00632931|20885062|P3|NOT COMPLETED|Part 1, Period 2||0
8474705|NCT00632931|20885063|P2|NOT COMPLETED|Part 1, Period 2||0
8474706|NCT00632931|20885064|P1|NOT COMPLETED|Part 1, Period 2||0
8474707|NCT00632931|20885062|P3|COMPLETED|Part 1, Period 2||0
8474708|NCT00632931|20885063|P2|COMPLETED|Part 1, Period 2||12
8474709|NCT00632931|20885064|P1|COMPLETED|Part 1, Period 2||11
8474710|NCT00632931|20885062|P3|STARTED|Part 1, Period 2||0
8474711|NCT00632931|20885063|P2|STARTED|Part 1, Period 2||12
8474712|NCT00632931|20885064|P1|STARTED|Part 1, Period 2||11
8474713|NCT00632931|20885062|P3|NOT COMPLETED|Part 1, Washout||0
8474714|NCT00632931|20885063|P2|NOT COMPLETED|Part 1, Washout||0
8474715|NCT00632931|20885064|P1|NOT COMPLETED|Part 1, Washout||0
8474716|NCT00632931|20885062|P3|COMPLETED|Part 1, Washout||0
8474717|NCT00632931|20885063|P2|COMPLETED|Part 1, Washout||12
8474718|NCT00632931|20885064|P1|COMPLETED|Part 1, Washout||11
8474719|NCT00632931|20885062|P3|STARTED|Part 1, Washout||0
8474720|NCT00632931|20885063|P2|STARTED|Part 1, Washout||12
8474721|NCT00632931|20885064|P1|STARTED|Part 1, Washout||11
8474722|NCT00632931|20885062|P3|NOT COMPLETED|Part 1, Period 1||0
8474723|NCT00632931|20885063|P2|NOT COMPLETED|Part 1, Period 1||0
8474724|NCT00632931|20885064|P1|NOT COMPLETED|Part 1, Period 1||2
8474725|NCT00632931|20885062|P3|COMPLETED|Part 1, Period 1||0
8474726|NCT00632931|20885063|P2|COMPLETED|Part 1, Period 1||12
8474727|NCT00632931|20885064|P1|COMPLETED|Part 1, Period 1||11
8474728|NCT00632931|20885062|P3|STARTED|Part 1, Period 1||0
8474729|NCT00632931|20885063|P2|STARTED|Part 1, Period 1||12
8474730|NCT00632931|20885064|P1|STARTED|Part 1, Period 1||13
8474731|NCT00632827|20885083|P1|NOT COMPLETED|Overall Study||10
8474732|NCT00632827|20885083|P1|COMPLETED|Overall Study||11
8474733|NCT00632827|20885083|P1|Evaluated Post Stem Cell Transplant|Overall Study||16
8474734|NCT00632827|20885083|P1|Received M-CHOP|Overall Study||18
8474735|NCT00632827|20885083|P1|Received GVD|Overall Study||21
8474736|NCT00632827|20885083|P1|STARTED|Overall Study||21
8474737|NCT00632814|20885093|P3|NOT COMPLETED|Overall Study||0
8474738|NCT00632814|20885094|P2|NOT COMPLETED|Overall Study||0
8474739|NCT00632814|20885095|P1|NOT COMPLETED|Overall Study||0
8474740|NCT00632814|20885093|P3|COMPLETED|Overall Study||8
8474741|NCT00632814|20885094|P2|COMPLETED|Overall Study||13
8474742|NCT00632814|20885095|P1|COMPLETED|Overall Study||11
8474743|NCT00632814|20885093|P3|STARTED|Overall Study||8
8474744|NCT00632814|20885094|P2|STARTED|Overall Study||13
8474745|NCT00632814|20885095|P1|STARTED|Overall Study||11
8474746|NCT00632749|20885141|P14|NOT COMPLETED|Overall Study||6
8474747|NCT00632749|20885142|P13|NOT COMPLETED|Overall Study||3
8474748|NCT00632749|20885143|P12|NOT COMPLETED|Overall Study||4
8474749|NCT00632749|20885144|P11|NOT COMPLETED|Overall Study||7
8474750|NCT00632749|20885145|P10|NOT COMPLETED|Overall Study||3
8474751|NCT00632749|20885146|P9|NOT COMPLETED|Overall Study||5
8474752|NCT00632749|20885147|P8|NOT COMPLETED|Overall Study||4
8474753|NCT00632749|20885148|P7|NOT COMPLETED|Overall Study||5
8474754|NCT00632749|20885149|P6|NOT COMPLETED|Overall Study||8
8474755|NCT00632749|20885150|P5|NOT COMPLETED|Overall Study||7
8474756|NCT00632749|20885151|P4|NOT COMPLETED|Overall Study||4
8474757|NCT00632749|20885152|P3|NOT COMPLETED|Overall Study||3
8474758|NCT00632749|20885153|P2|NOT COMPLETED|Overall Study||5
8474759|NCT00632749|20885154|P1|NOT COMPLETED|Overall Study||4
8474760|NCT00632749|20885141|P14|COMPLETED|Overall Study||0
8474761|NCT00632749|20885142|P13|COMPLETED|Overall Study||0
8474762|NCT00632749|20885143|P12|COMPLETED|Overall Study||0
8474763|NCT00632749|20885144|P11|COMPLETED|Overall Study||0
8474764|NCT00632749|20885145|P10|COMPLETED|Overall Study||0
8474765|NCT00632749|20885146|P9|COMPLETED|Overall Study||0
8474766|NCT00632749|20885147|P8|COMPLETED|Overall Study||0
8474767|NCT00632749|20885148|P7|COMPLETED|Overall Study||0
8474768|NCT00632749|20885149|P6|COMPLETED|Overall Study||0
8474769|NCT00632749|20885150|P5|COMPLETED|Overall Study||0
8474770|NCT00632749|20885151|P4|COMPLETED|Overall Study||0
8474771|NCT00632749|20885152|P3|COMPLETED|Overall Study||0
8474772|NCT00632749|20885153|P2|COMPLETED|Overall Study||0
8474773|NCT00632749|20885154|P1|COMPLETED|Overall Study||0
8474774|NCT00632749|20885141|P14|Not Treated|Overall Study||0
8474775|NCT00632749|20885142|P13|Not Treated|Overall Study||0
8474776|NCT00632749|20885143|P12|Not Treated|Overall Study||0
8474777|NCT00632749|20885144|P11|Not Treated|Overall Study||0
8474778|NCT00632749|20885145|P10|Not Treated|Overall Study||0
8474779|NCT00632749|20885146|P9|Not Treated|Overall Study||0
8474780|NCT00632749|20885147|P8|Not Treated|Overall Study||0
8474781|NCT00632749|20885148|P7|Not Treated|Overall Study||1
8474782|NCT00632749|20885149|P6|Not Treated|Overall Study||1
8474783|NCT00632749|20885150|P5|Not Treated|Overall Study||0
8474784|NCT00632749|20885151|P4|Not Treated|Overall Study||0
8474785|NCT00632749|20885152|P3|Not Treated|Overall Study||0
8474786|NCT00632749|20885153|P2|Not Treated|Overall Study||2
8474787|NCT00632749|20885154|P1|Not Treated|Overall Study||0
8474788|NCT00632749|20885141|P14|Treated|Overall Study||6
8474789|NCT00632749|20885142|P13|Treated|Overall Study||3
8474790|NCT00632749|20885143|P12|Treated|Overall Study||4
8474791|NCT00632749|20885144|P11|Treated|Overall Study||7
8474792|NCT00632749|20885145|P10|Treated|Overall Study||3
8474793|NCT00632749|20885146|P9|Treated|Overall Study||5
8474794|NCT00632749|20885147|P8|Treated|Overall Study||4
8474795|NCT00632749|20885148|P7|Treated|Overall Study||4
8474796|NCT00632749|20885149|P6|Treated|Overall Study||7
8474797|NCT00632749|20885150|P5|Treated|Overall Study||7
8474798|NCT00632749|20885151|P4|Treated|Overall Study||4
8474799|NCT00632749|20885152|P3|Treated|Overall Study||3
8474800|NCT00632749|20885153|P2|Treated|Overall Study||3
8474801|NCT00632749|20885154|P1|Treated|Overall Study||4
8474802|NCT00632749|20885141|P14|STARTED|Overall Study||6
8474803|NCT00632749|20885142|P13|STARTED|Overall Study||3
8474804|NCT00632749|20885143|P12|STARTED|Overall Study||4
8474805|NCT00632749|20885144|P11|STARTED|Overall Study||7
8474806|NCT00632749|20885145|P10|STARTED|Overall Study||3
8474807|NCT00632749|20885146|P9|STARTED|Overall Study||5
8474808|NCT00632749|20885147|P8|STARTED|Overall Study||4
8474809|NCT00632749|20885148|P7|STARTED|Overall Study||5
8474810|NCT00632749|20885149|P6|STARTED|Overall Study||8
8474811|NCT00632749|20885150|P5|STARTED|Overall Study||7
8474812|NCT00632749|20885151|P4|STARTED|Overall Study||4
8474813|NCT00632749|20885152|P3|STARTED|Overall Study||3
8474814|NCT00632749|20885153|P2|STARTED|Overall Study||5
8474815|NCT00632749|20885154|P1|STARTED|Overall Study||4
8474816|NCT00632736|20885448|P1|NOT COMPLETED|Overall Study||268
8474817|NCT00632736|20885448|P1|COMPLETED|Overall Study||151
8474818|NCT00632736|20885448|P1|STARTED|Overall Study||419
8474819|NCT00632632|20885455|P2|NOT COMPLETED|Overall Study||3
8474820|NCT00632632|20885456|P1|NOT COMPLETED|Overall Study||0
8474821|NCT00632632|20885455|P2|COMPLETED|Overall Study||9
8474822|NCT00632632|20885456|P1|COMPLETED|Overall Study||13
8474823|NCT00632632|20885455|P2|STARTED|Overall Study||12
8474824|NCT00632632|20885456|P1|STARTED|Overall Study||13
8474825|NCT00632619|20885468|P2|NOT COMPLETED|Overall Study||4
8474826|NCT00632619|20885469|P1|NOT COMPLETED|Overall Study||8
8474827|NCT00632619|20885468|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|31
8474828|NCT00632619|20885469|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|25
8474829|NCT00632619|20885468|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
8474830|NCT00632619|20885469|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
8474831|NCT00632541|20885483|P1|NOT COMPLETED|Overall Study||7
8474832|NCT00632541|20885483|P1|COMPLETED|Overall Study||11
8474833|NCT00632541|20885483|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
8474834|NCT00632502|20885492|P2|NOT COMPLETED|Overall Study||1
8474835|NCT00632502|20885493|P1|NOT COMPLETED|Overall Study||3
8474836|NCT00632502|20885492|P2|COMPLETED|Overall Study||11
8474837|NCT00632502|20885493|P1|COMPLETED|Overall Study||22
8474838|NCT00632502|20885492|P2|Completed Treatment|Overall Study||9
8474839|NCT00632502|20885493|P1|Completed Treatment|Overall Study||19
8474840|NCT00632502|20885492|P2|Treated|Overall Study||12
8474841|NCT00632502|20885493|P1|Treated|Overall Study||22
8474842|NCT00632502|20885492|P2|STARTED|Overall Study||12
8474843|NCT00632502|20885493|P1|STARTED|Overall Study||25
8474844|NCT00632489|20885521|P3|NOT COMPLETED|Overall Study||0
8474845|NCT00632489|20885522|P2|NOT COMPLETED|Overall Study||5
8474846|NCT00632489|20885523|P1|NOT COMPLETED|Overall Study||15
8474847|NCT00632489|20885521|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8474848|NCT00632489|20885522|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8474849|NCT00632489|20885523|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8474850|NCT00632489|20885521|P3|STARTED|Overall Study||0
8474851|NCT00632489|20885522|P2|STARTED|Overall Study||5
8474852|NCT00632489|20885523|P1|STARTED|Overall Study||15
8474853|NCT00632463|20885537|P3|NOT COMPLETED|Overall Study||0
8474854|NCT00632463|20885538|P2|NOT COMPLETED|Overall Study||1
8474855|NCT00632463|20885539|P1|NOT COMPLETED|Overall Study||0
8474856|NCT00632463|20885537|P3|COMPLETED|Overall Study||7
8474857|NCT00632463|20885538|P2|COMPLETED|Overall Study||6
8474858|NCT00632463|20885539|P1|COMPLETED|Overall Study||7
8474859|NCT00632463|20885537|P3|STARTED|Overall Study||7
8474860|NCT00632463|20885538|P2|STARTED|Overall Study||7
8474861|NCT00632463|20885539|P1|STARTED|Overall Study||7
8474862|NCT00632424|20885556|P1|NOT COMPLETED|Overall Study||18
8474863|NCT00632424|20885556|P1|COMPLETED|Overall Study||0
8474864|NCT00632424|20885556|P1|STARTED|Overall Study||18
8474865|NCT00632411|20885580|P2|NOT COMPLETED|Overall Study||176
8474866|NCT00632411|20885581|P1|NOT COMPLETED|Overall Study||160
8474867|NCT00632411|20885580|P2|COMPLETED|Overall Study||473
8474868|NCT00632411|20885581|P1|COMPLETED|Overall Study||489
8474869|NCT00632411|20885580|P2|STARTED|Overall Study||649
8474870|NCT00632411|20885581|P1|STARTED|Overall Study||649
8474871|NCT00632359|20885587|P1|NOT COMPLETED|Overall Study||2
8474872|NCT00632359|20885587|P1|COMPLETED|Overall Study||31
8474873|NCT00632359|20885587|P1|STARTED|Overall Study||33
8474874|NCT00632281|20885593|P1|NOT COMPLETED|Overall Study||0
8474875|NCT00632281|20885593|P1|COMPLETED|Overall Study||38
8474876|NCT00632281|20885593|P1|STARTED|Overall Study||38
8474877|NCT00632229|20885600|P2|NOT COMPLETED|Overall Study||6
8474878|NCT00632229|20885601|P1|NOT COMPLETED|Overall Study||6
8474879|NCT00632229|20885600|P2|COMPLETED|Overall Study||11
8474880|NCT00632229|20885601|P1|COMPLETED|Overall Study||11
8474881|NCT00632229|20885600|P2|STARTED|Overall Study||17
8474882|NCT00632229|20885601|P1|STARTED|Overall Study||17
8474883|NCT00632203|20885611|P2|NOT COMPLETED|Overall Study||0
8474884|NCT00632203|20885612|P1|NOT COMPLETED|Overall Study||1
8474885|NCT00632203|20885611|P2|COMPLETED|Overall Study||27
8474886|NCT00632203|20885612|P1|COMPLETED|Overall Study||25
8474887|NCT00632203|20885611|P2|STARTED|Overall Study||27
8474888|NCT00632203|20885612|P1|STARTED|Overall Study||26
8474889|NCT00632125|20885630|P1|NOT COMPLETED|Overall Study||302
8474890|NCT00632125|20885630|P1|COMPLETED|Overall Study||1393
8474891|NCT00632125|20885630|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
8474892|NCT00632099|20885636|P2|NOT COMPLETED|Overall Study||3
8474893|NCT00632099|20885637|P1|NOT COMPLETED|Overall Study||3
8474894|NCT00632099|20885636|P2|COMPLETED|Overall Study||8
8474895|NCT00632099|20885637|P1|COMPLETED|Overall Study||7
8474896|NCT00632099|20885636|P2|STARTED|Overall Study||11
8474897|NCT00632099|20885637|P1|STARTED|Overall Study||10
8474898|NCT00632021|20885645|P2|NOT COMPLETED|Overall Study||7
8474899|NCT00632021|20885646|P1|NOT COMPLETED|Overall Study||4
8474900|NCT00632021|20885645|P2|COMPLETED|Overall Study||423
8474901|NCT00632021|20885646|P1|COMPLETED|Overall Study||428
8474902|NCT00632021|20885645|P2|STARTED|Overall Study||430
8474903|NCT00632021|20885646|P1|STARTED|Overall Study||432
8474904|NCT00631969|20885656|P2|NOT COMPLETED|Overall Study||21
8474905|NCT00631969|20885657|P1|NOT COMPLETED|Overall Study||15
8474906|NCT00631969|20885656|P2|COMPLETED|Overall Study||155
8474907|NCT00631969|20885657|P1|COMPLETED|Overall Study||171
8474908|NCT00631969|20885656|P2|Received Treatment|Overall Study|safety population|174
8474909|NCT00631969|20885657|P1|Received Treatment|Overall Study|safety population|184
8474910|NCT00631969|20885656|P2|STARTED|Overall Study||176
8474911|NCT00631969|20885657|P1|STARTED|Overall Study||186
8474912|NCT00631917|20885703|P2|NOT COMPLETED|Overall Study||108
8474913|NCT00631917|20885704|P1|NOT COMPLETED|Overall Study||88
8474914|NCT00631917|20885703|P2|COMPLETED|Overall Study||291
8474915|NCT00631917|20885704|P1|COMPLETED|Overall Study||287
8474916|NCT00631917|20885703|P2|STARTED|Overall Study||399
8474917|NCT00631917|20885704|P1|STARTED|Overall Study||375
8474918|NCT00631748|20885720|P2|NOT COMPLETED|Overall Study||22
8474919|NCT00631748|20885721|P1|NOT COMPLETED|Overall Study||18
8474920|NCT00631748|20885720|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
8474921|NCT00631748|20885721|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
8474922|NCT00631748|20885720|P2|STARTED|Overall Study||31
8474923|NCT00631748|20885721|P1|STARTED|Overall Study||29
8474924|NCT00631696|20885731|P2|NOT COMPLETED|Overall Study||40
8474925|NCT00631696|20885732|P1|NOT COMPLETED|Overall Study||37
8474926|NCT00631696|20885731|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
8474927|NCT00631696|20885732|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
8474928|NCT00631696|20885731|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
8474929|NCT00631696|20885732|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
8474930|NCT00631696|20885731|P2|Received Study Treatment (Tx)|Overall Study||109
8474931|NCT00631696|20885732|P1|Received Study Treatment (Tx)|Overall Study||111
8474932|NCT00631696|20885731|P2|STARTED|Overall Study||110
8474933|NCT00631696|20885732|P1|STARTED|Overall Study||112
8474934|NCT00631670|20885758|P2|NOT COMPLETED|Overall Study||0
8474935|NCT00631670|20885759|P1|NOT COMPLETED|Overall Study||0
8474936|NCT00631670|20885758|P2|COMPLETED|Overall Study||0
8474937|NCT00631670|20885759|P1|COMPLETED|Overall Study||21
8474938|NCT00631670|20885758|P2|STARTED|Overall Study||0
8474939|NCT00631670|20885759|P1|STARTED|Overall Study||21
8474940|NCT00631657|20885775|P3|NOT COMPLETED|7-Day Discontinuation Period||1
8474941|NCT00631657|20885776|P2|NOT COMPLETED|7-Day Discontinuation Period||1
8474942|NCT00631657|20885777|P1|NOT COMPLETED|7-Day Discontinuation Period||2
8474943|NCT00631657|20885775|P3|COMPLETED|7-Day Discontinuation Period||65
8474944|NCT00631657|20885776|P2|COMPLETED|7-Day Discontinuation Period||136
8474945|NCT00631657|20885777|P1|COMPLETED|7-Day Discontinuation Period||65
8474946|NCT00631657|20885775|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
8474947|NCT00631657|20885776|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
8474948|NCT00631657|20885777|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
8474949|NCT00631657|20885775|P3|STARTED|7-Day Discontinuation Period||66
8474950|NCT00631657|20885776|P2|STARTED|7-Day Discontinuation Period||137
8474951|NCT00631657|20885777|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
8474952|NCT00631657|20885775|P3|NOT COMPLETED|6-Month Treatment Period||50
8474953|NCT00631657|20885776|P2|NOT COMPLETED|6-Month Treatment Period||0
8474954|NCT00631657|20885777|P1|NOT COMPLETED|6-Month Treatment Period||141
8474955|NCT00631657|20885775|P3|COMPLETED|6-Month Treatment Period||66
8474956|NCT00631657|20885776|P2|COMPLETED|6-Month Treatment Period||0
8474957|NCT00631657|20885777|P1|COMPLETED|6-Month Treatment Period||203
8474958|NCT00631657|20885775|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
8474959|NCT00631657|20885776|P2|Treated|6-Month Treatment Period||0
8474960|NCT00631657|20885777|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
8474961|NCT00631657|20885775|P3|STARTED|6-Month Treatment Period||116
8474962|NCT00631657|20885776|P2|STARTED|6-Month Treatment Period||0
8474963|NCT00631657|20885777|P1|STARTED|6-Month Treatment Period||344
8474964|NCT00631566|20885807|P3|NOT COMPLETED|Overall Study||0
8474965|NCT00631566|20885808|P2|NOT COMPLETED|Overall Study||4
8474966|NCT00631566|20885809|P1|NOT COMPLETED|Overall Study||2
8474967|NCT00631566|20885807|P3|COMPLETED|Overall Study||501
8474968|NCT00631566|20885808|P2|COMPLETED|Overall Study||24
8474969|NCT00631566|20885809|P1|COMPLETED|Overall Study||19
8474970|NCT00631566|20885807|P3|STARTED|Overall Study||501
8474971|NCT00631566|20885808|P2|STARTED|Overall Study||28
8474972|NCT00631566|20885809|P1|STARTED|Overall Study||21
8474973|NCT00631540|20885826|P1|NOT COMPLETED|Overall Study||14
8474974|NCT00631540|20885826|P1|COMPLETED|Overall Study||86
8474975|NCT00631540|20885826|P1|STARTED|Overall Study||100
8474976|NCT00631488|20885838|P3|NOT COMPLETED|Overall Study||2
8474977|NCT00631488|20885839|P2|NOT COMPLETED|Overall Study||2
8474978|NCT00631488|20885840|P1|NOT COMPLETED|Overall Study||4
8474979|NCT00631488|20885838|P3|COMPLETED|Overall Study||47
8474980|NCT00631488|20885839|P2|COMPLETED|Overall Study||47
8474981|NCT00631488|20885840|P1|COMPLETED|Overall Study||44
8474982|NCT00631488|20885838|P3|Completed Post-Treatment Period|Overall Study||47
8474983|NCT00631488|20885839|P2|Completed Post-Treatment Period|Overall Study||47
8474984|NCT00631488|20885840|P1|Completed Post-Treatment Period|Overall Study||44
8474985|NCT00631488|20885838|P3|STARTED|Overall Study||49
8474986|NCT00631488|20885839|P2|STARTED|Overall Study||49
8474987|NCT00631488|20885840|P1|STARTED|Overall Study||48
8474988|NCT00631475|20885860|P1|NOT COMPLETED|Overall Study||45
8474989|NCT00631475|20885860|P1|COMPLETED|Overall Study||83
8474990|NCT00631475|20885860|P1|STARTED|Overall Study||128
8474991|NCT00631449|20885870|P2|NOT COMPLETED|Overall Study||0
8474992|NCT00631449|20885871|P1|NOT COMPLETED|Overall Study||0
8474993|NCT00631449|20885870|P2|COMPLETED|Overall Study||15
8474994|NCT00631449|20885871|P1|COMPLETED|Overall Study||15
8474995|NCT00631449|20885870|P2|STARTED|Overall Study||15
8474996|NCT00631449|20885871|P1|STARTED|Overall Study||15
8474997|NCT00631410|20885881|P2|NOT COMPLETED|Overall Study||6
8474998|NCT00631410|20885882|P1|NOT COMPLETED|Overall Study||6
8474999|NCT00631410|20885881|P2|COMPLETED|Overall Study||0
8475000|NCT00631410|20885882|P1|COMPLETED|Overall Study||0
8475001|NCT00631410|20885881|P2|STARTED|Overall Study||6
8475002|NCT00631410|20885882|P1|STARTED|Overall Study||6
8475003|NCT00631371|20885901|P2|NOT COMPLETED|Overall Study||391
8475004|NCT00631371|20885902|P1|NOT COMPLETED|Overall Study||400
8475005|NCT00631371|20885901|P2|COMPLETED|Overall Study||0
8475006|NCT00631371|20885902|P1|COMPLETED|Overall Study||0
8475007|NCT00631371|20885901|P2|Treated|Overall Study||391
8475008|NCT00631371|20885902|P1|Treated|Overall Study||393
8475009|NCT00631371|20885901|P2|STARTED|Overall Study||391
8475010|NCT00631371|20885902|P1|STARTED|Overall Study||400
8475011|NCT00631358|20885916|P2|NOT COMPLETED|Overall Study||2
8475012|NCT00631358|20885917|P1|NOT COMPLETED|Overall Study||6
8475013|NCT00631358|20885916|P2|COMPLETED|Overall Study||45
8475014|NCT00631358|20885917|P1|COMPLETED|Overall Study||44
8475015|NCT00631358|20885916|P2|STARTED|Overall Study||47
8475016|NCT00631358|20885917|P1|STARTED|Overall Study||50
8475017|NCT00631319|20885933|P2|NOT COMPLETED|Double-blind Phase||35
8475018|NCT00631319|20885934|P1|NOT COMPLETED|Double-blind Phase||40
8475019|NCT00631319|20885933|P2|COMPLETED|Double-blind Phase||65
8475020|NCT00631319|20885934|P1|COMPLETED|Double-blind Phase||60
8475021|NCT00631319|20885933|P2|STARTED|Double-blind Phase||100
8475022|NCT00631319|20885934|P1|STARTED|Double-blind Phase||100
8475023|NCT00631319|20885933|P2|NOT COMPLETED|Conversion and Titration Phase||0
8475024|NCT00631319|20885934|P1|NOT COMPLETED|Conversion and Titration Phase||143
8475025|NCT00631319|20885933|P2|COMPLETED|Conversion and Titration Phase||0
8475026|NCT00631319|20885934|P1|COMPLETED|Conversion and Titration Phase||200
8475027|NCT00631319|20885933|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8475028|NCT00631319|20885934|P1|STARTED|Conversion and Titration Phase||343
8475029|NCT00631189|20885945|P4|NOT COMPLETED|Treatment Phase||7
8475030|NCT00631189|20885946|P3|NOT COMPLETED|Treatment Phase||11
8475031|NCT00631189|20885947|P2|NOT COMPLETED|Treatment Phase||7
8475032|NCT00631189|20885948|P1|NOT COMPLETED|Treatment Phase||0
8475033|NCT00631189|20885945|P4|COMPLETED|Treatment Phase||103
8475034|NCT00631189|20885946|P3|COMPLETED|Treatment Phase||92
8475035|NCT00631189|20885947|P2|COMPLETED|Treatment Phase||97
8475036|NCT00631189|20885948|P1|COMPLETED|Treatment Phase||0
8475037|NCT00631189|20885945|P4|STARTED|Treatment Phase||110
8475038|NCT00631189|20885946|P3|STARTED|Treatment Phase||103
8475039|NCT00631189|20885947|P2|STARTED|Treatment Phase||104
8475040|NCT00631189|20885948|P1|STARTED|Treatment Phase||0
8475041|NCT00631189|20885945|P4|NOT COMPLETED|Initial Phase||0
8475042|NCT00631189|20885946|P3|NOT COMPLETED|Initial Phase||0
8475043|NCT00631189|20885947|P2|NOT COMPLETED|Initial Phase||0
8475044|NCT00631189|20885948|P1|NOT COMPLETED|Initial Phase||351
8475045|NCT00631189|20885945|P4|COMPLETED|Initial Phase||0
8475046|NCT00631189|20885946|P3|COMPLETED|Initial Phase||0
8475047|NCT00631189|20885947|P2|COMPLETED|Initial Phase||0
8475048|NCT00631189|20885948|P1|COMPLETED|Initial Phase||317
8475049|NCT00631189|20885945|P4|STARTED|Initial Phase||0
8475050|NCT00631189|20885946|P3|STARTED|Initial Phase||0
8475051|NCT00631189|20885947|P2|STARTED|Initial Phase||0
8475052|NCT00631189|20885948|P1|STARTED|Initial Phase||668
8475053|NCT00631137|20885992|P2|NOT COMPLETED|Overall Study||0
8475054|NCT00631137|20885993|P1|NOT COMPLETED|Overall Study||1
8475055|NCT00631137|20885992|P2|COMPLETED|Overall Study||0
8475056|NCT00631137|20885993|P1|COMPLETED|Overall Study||0
8475057|NCT00631137|20885992|P2|STARTED|Overall Study||0
8475058|NCT00631137|20885993|P1|STARTED|Overall Study||1
8475059|NCT00631020|20886011|P1|NOT COMPLETED|Overall Study||8
8475060|NCT00631020|20886011|P1|COMPLETED|Overall Study||26
8475061|NCT00631020|20886011|P1|STARTED|Overall Study||34
8475062|NCT00631007|20886026|P6|NOT COMPLETED|Overall Study||15
8475063|NCT00631007|20886027|P5|NOT COMPLETED|Overall Study||12
8475064|NCT00631007|20886028|P4|NOT COMPLETED|Overall Study||9
8475065|NCT00631007|20886029|P3|NOT COMPLETED|Overall Study||10
8475066|NCT00631007|20886030|P2|NOT COMPLETED|Overall Study||11
8475067|NCT00631007|20886031|P1|NOT COMPLETED|Overall Study||11
8475068|NCT00631007|20886026|P6|COMPLETED|Overall Study||46
8475069|NCT00631007|20886027|P5|COMPLETED|Overall Study||48
8475070|NCT00631007|20886028|P4|COMPLETED|Overall Study||53
8475071|NCT00631007|20886029|P3|COMPLETED|Overall Study||53
8475072|NCT00631007|20886030|P2|COMPLETED|Overall Study||50
8475073|NCT00631007|20886031|P1|COMPLETED|Overall Study||49
8475074|NCT00631007|20886026|P6|STARTED|Overall Study||61
8475075|NCT00631007|20886027|P5|STARTED|Overall Study||60
8475076|NCT00631007|20886028|P4|STARTED|Overall Study||62
8475077|NCT00631007|20886029|P3|STARTED|Overall Study||63
8475078|NCT00631007|20886030|P2|STARTED|Overall Study||61
8475079|NCT00631007|20886031|P1|STARTED|Overall Study||60
8475080|NCT00630994|20886051|P1|NOT COMPLETED|Overall Study||4
8475081|NCT00630994|20886051|P1|COMPLETED|Overall Study||0
8475082|NCT00630994|20886051|P1|STARTED|Overall Study||4
8475083|NCT00630955|20886062|P3|NOT COMPLETED|Overall Study||12
8475084|NCT00630955|20886063|P2|NOT COMPLETED|Overall Study||6
8475085|NCT00630955|20886064|P1|NOT COMPLETED|Overall Study||3
8475086|NCT00630955|20886062|P3|COMPLETED|Overall Study||28
8475087|NCT00630955|20886063|P2|COMPLETED|Overall Study||31
8475088|NCT00630955|20886064|P1|COMPLETED|Overall Study||31
8475089|NCT00630955|20886062|P3|STARTED|Overall Study||40
8475090|NCT00630955|20886063|P2|STARTED|Overall Study||37
8475091|NCT00630955|20886064|P1|STARTED|Overall Study||34
8475092|NCT00630916|20886081|P1|NOT COMPLETED|Overall Study||210
8475093|NCT00630916|20886081|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
8475094|NCT00630916|20886081|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
8475095|NCT00630916|20886081|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
8475096|NCT00630877|20886091|P3|NOT COMPLETED|Overall Study||10
8475097|NCT00630877|20886092|P2|NOT COMPLETED|Overall Study||15
8475098|NCT00630877|20886093|P1|NOT COMPLETED|Overall Study||19
8475099|NCT00630877|20886091|P3|COMPLETED|Overall Study||80
8475100|NCT00630877|20886092|P2|COMPLETED|Overall Study||75
8475101|NCT00630877|20886093|P1|COMPLETED|Overall Study||72
8475102|NCT00630877|20886091|P3|STARTED|Overall Study||90
8475103|NCT00630877|20886092|P2|STARTED|Overall Study||90
8475104|NCT00630877|20886093|P1|STARTED|Overall Study|For all arms, started means treated.|91
8475105|NCT00630864|20886111|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
8475106|NCT00630864|20886111|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
8475107|NCT00630864|20886111|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
8475108|NCT00630864|20886111|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
8475109|NCT00630864|20886111|P1|COMPLETED|Part 1 (up to Week 6)||20
8475110|NCT00630864|20886111|P1|STARTED|Part 1 (up to Week 6)||21
8475111|NCT00630838|20886150|P2|NOT COMPLETED|Overall Study||2
8475112|NCT00630838|20886151|P1|NOT COMPLETED|Overall Study||0
8475113|NCT00630838|20886150|P2|COMPLETED|Overall Study||28
8475114|NCT00630838|20886151|P1|COMPLETED|Overall Study||32
8475115|NCT00630838|20886150|P2|STARTED|Overall Study||30
8475116|NCT00630838|20886151|P1|STARTED|Overall Study||32
8475117|NCT00630825|20886163|P4|NOT COMPLETED|Overall Study||6
8475118|NCT00630825|20886164|P3|NOT COMPLETED|Overall Study||8
8475119|NCT00630825|20886165|P2|NOT COMPLETED|Overall Study||7
8475120|NCT00630825|20886166|P1|NOT COMPLETED|Overall Study||9
8475121|NCT00630825|20886163|P4|COMPLETED|Overall Study||60
8475122|NCT00630825|20886164|P3|COMPLETED|Overall Study||58
8475123|NCT00630825|20886165|P2|COMPLETED|Overall Study||58
8475124|NCT00630825|20886166|P1|COMPLETED|Overall Study||56
8475125|NCT00630825|20886163|P4|Received at Least One Dose of Study Drug|Overall Study||66
8475126|NCT00630825|20886164|P3|Received at Least One Dose of Study Drug|Overall Study||66
8475127|NCT00630825|20886165|P2|Received at Least One Dose of Study Drug|Overall Study||65
8475128|NCT00630825|20886166|P1|Received at Least One Dose of Study Drug|Overall Study||65
8475129|NCT00630825|20886163|P4|STARTED|Overall Study||66
8475130|NCT00630825|20886164|P3|STARTED|Overall Study||66
8475131|NCT00630825|20886165|P2|STARTED|Overall Study||65
8475132|NCT00630825|20886166|P1|STARTED|Overall Study||65
8475133|NCT00630812|20886237|P2|NOT COMPLETED|Double Blind Treatment Period||14
8475134|NCT00630812|20886238|P1|NOT COMPLETED|Double Blind Treatment Period||31
8475135|NCT00630812|20886237|P2|COMPLETED|Double Blind Treatment Period||107
8475136|NCT00630812|20886238|P1|COMPLETED|Double Blind Treatment Period||153
8475137|NCT00630812|20886237|P2|STARTED|Double Blind Treatment Period||121
8475138|NCT00630812|20886238|P1|STARTED|Double Blind Treatment Period||184
8475139|NCT00630812|20886237|P2|NOT COMPLETED|Randomisation to First Dose||5
8475140|NCT00630812|20886238|P1|NOT COMPLETED|Randomisation to First Dose||8
8475141|NCT00630812|20886237|P2|COMPLETED|Randomisation to First Dose||121
8475142|NCT00630812|20886238|P1|COMPLETED|Randomisation to First Dose||184
8475143|NCT00630812|20886237|P2|STARTED|Randomisation to First Dose||126
8475144|NCT00630812|20886238|P1|STARTED|Randomisation to First Dose||192
8475145|NCT00630786|20886263|P3|NOT COMPLETED|Overall Study||2
8475146|NCT00630786|20886264|P2|NOT COMPLETED|Overall Study||2
8475147|NCT00630786|20886265|P1|NOT COMPLETED|Overall Study||1
8475148|NCT00630786|20886263|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
8475149|NCT00630786|20886264|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
8475150|NCT00630786|20886265|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
8475151|NCT00630786|20886263|P3|Received Study Medication|Overall Study||8
8475152|NCT00630786|20886264|P2|Received Study Medication|Overall Study||25
8475153|NCT00630786|20886265|P1|Received Study Medication|Overall Study||19
8475154|NCT00630786|20886263|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
8475155|NCT00630786|20886264|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
8475156|NCT00630786|20886265|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
8475157|NCT00630747|20886284|P1|NOT COMPLETED|Overall Study||9
8475158|NCT00630747|20886284|P1|COMPLETED|Overall Study||85
8475159|NCT00630747|20886284|P1|Participants Treated in Phase I of Study|Overall Study||94
8475160|NCT00630747|20886284|P1|STARTED|Overall Study||94
8475161|NCT00630734|20886296|P3|NOT COMPLETED|Overall Study||1
8475162|NCT00630734|20886297|P2|NOT COMPLETED|Overall Study||1
8475163|NCT00630734|20886298|P1|NOT COMPLETED|Overall Study||2
8475164|NCT00630734|20886296|P3|COMPLETED|Overall Study||7
8475165|NCT00630734|20886297|P2|COMPLETED|Overall Study||12
8475166|NCT00630734|20886298|P1|COMPLETED|Overall Study||9
8475167|NCT00630734|20886296|P3|STARTED|Overall Study||8
8475168|NCT00630734|20886297|P2|STARTED|Overall Study||13
8475169|NCT00630734|20886298|P1|STARTED|Overall Study||11
8475170|NCT00630539|20886337|P4|NOT COMPLETED|Overall Study||3
8475171|NCT00630539|20886338|P3|NOT COMPLETED|Overall Study||1
8475172|NCT00630539|20886339|P2|NOT COMPLETED|Overall Study||4
8475173|NCT00630539|20886340|P1|NOT COMPLETED|Overall Study||1
8475174|NCT00630539|20886337|P4|COMPLETED|Overall Study||27
8475175|NCT00630539|20886338|P3|COMPLETED|Overall Study||28
8475176|NCT00630539|20886339|P2|COMPLETED|Overall Study||29
8475177|NCT00630539|20886340|P1|COMPLETED|Overall Study||33
8475178|NCT00630539|20886337|P4|STARTED|Overall Study||30
8475179|NCT00630539|20886338|P3|STARTED|Overall Study||29
8475180|NCT00630539|20886339|P2|STARTED|Overall Study||33
8475181|NCT00630539|20886340|P1|STARTED|Overall Study||34
8475182|NCT00630487|20886396|P2|NOT COMPLETED|Overall Study||0
8475183|NCT00630487|20886397|P1|NOT COMPLETED|Overall Study||0
8475184|NCT00630487|20886396|P2|COMPLETED|Overall Study||0
8475185|NCT00630487|20886397|P1|COMPLETED|Overall Study||0
8475186|NCT00630487|20886396|P2|STARTED|Overall Study||0
8475187|NCT00630487|20886397|P1|STARTED|Overall Study||0
8475188|NCT00630409|20886431|P1|NOT COMPLETED|Overall Study||1
8475189|NCT00630409|20886431|P1|COMPLETED|Overall Study||4
8475190|NCT00630409|20886431|P1|STARTED|Overall Study||5
8475191|NCT00630396|20886436|P1|NOT COMPLETED|Overall Study||7
8475192|NCT00630396|20886436|P1|COMPLETED|Overall Study||53
8475193|NCT00630396|20886436|P1|STARTED|Overall Study||60
8475194|NCT00630344|20886442|P1|NOT COMPLETED|Overall Study||36
8475195|NCT00630344|20886442|P1|COMPLETED|Overall Study||0
8475196|NCT00630344|20886442|P1|STARTED|Overall Study||36
8475197|NCT00630331|20886454|P3|NOT COMPLETED|Overall Study||188
8475198|NCT00630331|20886455|P2|NOT COMPLETED|Overall Study||166
8475199|NCT00630331|20886456|P1|NOT COMPLETED|Overall Study||206
8475200|NCT00630331|20886454|P3|COMPLETED|Overall Study||3712
8475201|NCT00630331|20886455|P2|COMPLETED|Overall Study||3510
8475202|NCT00630331|20886456|P1|COMPLETED|Overall Study||3622
8475203|NCT00630331|20886454|P3|STARTED|Overall Study||3900
8475204|NCT00630331|20886455|P2|STARTED|Overall Study||3676
8475205|NCT00630331|20886456|P1|STARTED|Overall Study||3828
8475206|NCT00630305|20886497|P1|NOT COMPLETED|Overall Study||2
8475207|NCT00630305|20886497|P1|COMPLETED|Overall Study||35
8475208|NCT00630305|20886497|P1|STARTED|Overall Study||37
8475209|NCT00630292|20886519|P1|NOT COMPLETED|Overall Study||1
8475210|NCT00630292|20886519|P1|COMPLETED|Overall Study||5
8475211|NCT00630292|20886519|P1|STARTED|Overall Study||6
8475212|NCT00630058|20886525|P2|NOT COMPLETED|Overall Study||4
8475213|NCT00630058|20886526|P1|NOT COMPLETED|Overall Study||4
8475214|NCT00630058|20886525|P2|COMPLETED|Overall Study||6
8475215|NCT00630058|20886526|P1|COMPLETED|Overall Study||6
8475216|NCT00630058|20886525|P2|STARTED|Overall Study||10
8475217|NCT00630058|20886526|P1|STARTED|Overall Study||10
8475218|NCT00629850|20886544|P2|NOT COMPLETED|Overall Study||0
8475219|NCT00629850|20886545|P1|NOT COMPLETED|Overall Study||0
8475220|NCT00629850|20886544|P2|COMPLETED|Overall Study||0
8475221|NCT00629850|20886545|P1|COMPLETED|Overall Study||1
8475222|NCT00629850|20886544|P2|STARTED|Overall Study||0
8475223|NCT00629850|20886545|P1|STARTED|Overall Study||1
8475224|NCT00629772|20886557|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
8475225|NCT00629772|20886558|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
8475226|NCT00629772|20886557|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
8475227|NCT00629772|20886558|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
8475228|NCT00629772|20886557|P2|STARTED|Second Intervention Week 14 - Week 26||12
8475229|NCT00629772|20886558|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
8475230|NCT00629772|20886557|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
8475231|NCT00629772|20886558|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
8475232|NCT00629772|20886557|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
8475233|NCT00629772|20886558|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
8475234|NCT00629772|20886557|P2|STARTED|First Intervention - Day 0 - Week 14||12
8475235|NCT00629772|20886558|P1|STARTED|First Intervention - Day 0 - Week 14||12
8475236|NCT00629707|20886578|P2|NOT COMPLETED|Overall Study||2
8475237|NCT00629707|20886579|P1|NOT COMPLETED|Overall Study||0
8475238|NCT00629707|20886578|P2|COMPLETED|Overall Study||8
8475239|NCT00629707|20886579|P1|COMPLETED|Overall Study||10
8475240|NCT00629707|20886578|P2|STARTED|Overall Study||10
8475241|NCT00629707|20886579|P1|STARTED|Overall Study||10
8475242|NCT00629525|20886585|P1|NOT COMPLETED|Overall Study||3
8475243|NCT00629525|20886585|P1|COMPLETED|Overall Study||32
8475244|NCT00629525|20886585|P1|STARTED|Overall Study||35
8475245|NCT00629499|20886593|P1|NOT COMPLETED|Overall Study||0
8475246|NCT00629499|20886593|P1|COMPLETED|Overall Study||63
8475247|NCT00629499|20886593|P1|STARTED|Overall Study||63
8475248|NCT00629265|20886599|P2|NOT COMPLETED|Overall Study||20
8475249|NCT00629265|20886600|P1|NOT COMPLETED|Overall Study||32
8475250|NCT00629265|20886599|P2|COMPLETED|Overall Study||34
8475251|NCT00629265|20886600|P1|COMPLETED|Overall Study||84
8475252|NCT00629265|20886599|P2|STARTED|Overall Study||54
8475253|NCT00629265|20886600|P1|STARTED|Overall Study||116
8475254|NCT00629239|20886610|P2|NOT COMPLETED|Overall Study||4
8475255|NCT00629239|20886611|P1|NOT COMPLETED|Overall Study||8
8475256|NCT00629239|20886610|P2|COMPLETED|Overall Study||28
8475257|NCT00629239|20886611|P1|COMPLETED|Overall Study||26
8475258|NCT00629239|20886610|P2|STARTED|Overall Study||32
8475259|NCT00629239|20886611|P1|STARTED|Overall Study||34
8475260|NCT00629122|20886645|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
8475261|NCT00629122|20886646|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
8475262|NCT00629122|20886645|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
8475263|NCT00629122|20886646|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
8475264|NCT00629122|20886645|P2|STARTED|Third Period: Day 6-8 (Oral)||3
8475265|NCT00629122|20886646|P1|STARTED|Third Period: Day 6-8 (Oral)||2
8475266|NCT00629122|20886645|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
8475267|NCT00629122|20886646|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
8475268|NCT00629122|20886645|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
8475269|NCT00629122|20886646|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
8475270|NCT00629122|20886645|P2|STARTED|Second Period: Day 3-5 (Washout)||3
8475271|NCT00629122|20886646|P1|STARTED|Second Period: Day 3-5 (Washout)||2
8475272|NCT00629122|20886645|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
8475273|NCT00629122|20886646|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
8475274|NCT00629122|20886645|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
8475275|NCT00629122|20886646|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
8475276|NCT00629122|20886645|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
8475277|NCT00629122|20886646|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
8475278|NCT00629083|20886664|P2|NOT COMPLETED|Overall Study||14
8475279|NCT00629083|20886665|P1|NOT COMPLETED|Overall Study||28
8475280|NCT00629083|20886664|P2|COMPLETED|Overall Study||103
8475281|NCT00629083|20886665|P1|COMPLETED|Overall Study||200
8475282|NCT00629083|20886664|P2|STARTED|Overall Study||117
8475283|NCT00629083|20886665|P1|STARTED|Overall Study||228
8475284|NCT00629018|20886685|P2|NOT COMPLETED|Overall Study||0
8475285|NCT00629018|20886686|P1|NOT COMPLETED|Overall Study||0
8475286|NCT00629018|20886685|P2|COMPLETED|Overall Study||55
8475287|NCT00629018|20886686|P1|COMPLETED|Overall Study||55
8475288|NCT00629018|20886685|P2|STARTED|Overall Study||55
8475289|NCT00629018|20886686|P1|STARTED|Overall Study||55
8475290|NCT00628927|20886696|P2|NOT COMPLETED|Overall Study||0
8475291|NCT00628927|20886697|P1|NOT COMPLETED|Overall Study||8
8475292|NCT00628927|20886696|P2|COMPLETED|Overall Study||30
8475293|NCT00628927|20886697|P1|COMPLETED|Overall Study||175
8475294|NCT00628927|20886696|P2|STARTED|Overall Study||30
8475295|NCT00628927|20886697|P1|STARTED|Overall Study||183
8475296|NCT00628901|20886710|P2|NOT COMPLETED|Overall Study||1
8475297|NCT00628901|20886711|P1|NOT COMPLETED|Overall Study||3
8475298|NCT00628901|20886710|P2|COMPLETED|Overall Study||29
8475299|NCT00628901|20886711|P1|COMPLETED|Overall Study||27
8475300|NCT00628901|20886710|P2|STARTED|Overall Study||30
8475301|NCT00628901|20886711|P1|STARTED|Overall Study||30
8475302|NCT00628862|20886742|P3|NOT COMPLETED|Overall Study||22
8475303|NCT00628862|20886743|P2|NOT COMPLETED|Overall Study||17
8475304|NCT00628862|20886744|P1|NOT COMPLETED|Overall Study||11
8475305|NCT00628862|20886742|P3|COMPLETED|Overall Study|randomised patients|186
8475306|NCT00628862|20886743|P2|COMPLETED|Overall Study|randomised patients|182
8475307|NCT00628862|20886744|P1|COMPLETED|Overall Study|randomised patients|195
8475308|NCT00628862|20886742|P3|STARTED|Overall Study|randomised patients|208
8475309|NCT00628862|20886743|P2|STARTED|Overall Study|randomised patients|199
8475310|NCT00628862|20886744|P1|STARTED|Overall Study|randomised patients|206
8475311|NCT00628758|20886790|P2|NOT COMPLETED|Overall Study||42
8475312|NCT00628758|20886791|P1|NOT COMPLETED|Overall Study||44
8475313|NCT00628758|20886790|P2|COMPLETED|Overall Study||179
8475314|NCT00628758|20886791|P1|COMPLETED|Overall Study||165
8475315|NCT00628758|20886790|P2|STARTED|Overall Study||221
8475316|NCT00628758|20886791|P1|STARTED|Overall Study||209
8475317|NCT00628628|20886805|P2|NOT COMPLETED|Overall Study||0
8475318|NCT00628628|20886806|P1|NOT COMPLETED|Overall Study||0
8475319|NCT00628628|20886805|P2|COMPLETED|Overall Study||40
8475320|NCT00628628|20886806|P1|COMPLETED|Overall Study||40
8475321|NCT00628628|20886805|P2|STARTED|Overall Study||40
8475322|NCT00628628|20886806|P1|STARTED|Overall Study||40
8475323|NCT00628589|20886815|P3|NOT COMPLETED|Overall Study||3
8475324|NCT00628589|20886816|P2|NOT COMPLETED|Overall Study||2
8475325|NCT00628589|20886817|P1|NOT COMPLETED|Overall Study||1
8475326|NCT00628589|20886815|P3|COMPLETED|Overall Study||110
8475327|NCT00628589|20886816|P2|COMPLETED|Overall Study||114
8475328|NCT00628589|20886817|P1|COMPLETED|Overall Study||114
8475329|NCT00628589|20886815|P3|STARTED|Overall Study||113
8475330|NCT00628589|20886816|P2|STARTED|Overall Study||116
8475331|NCT00628589|20886817|P1|STARTED|Overall Study||115
8475332|NCT00628498|20886831|P1|NOT COMPLETED|Overall Study||52
8475333|NCT00628498|20886831|P1|COMPLETED|Overall Study||1154
8475334|NCT00628498|20886831|P1|STARTED|Overall Study||1206
8475335|NCT00628446|20886835|P1|NOT COMPLETED|Overall Study||7
8475336|NCT00628446|20886835|P1|COMPLETED|Overall Study||38
8475337|NCT00628446|20886835|P1|STARTED|Overall Study||45
8475338|NCT00628407|20886840|P1|NOT COMPLETED|Overall Study||0
8475339|NCT00628407|20886840|P1|COMPLETED|Overall Study||13
8475340|NCT00628407|20886840|P1|STARTED|Overall Study||13
8475341|NCT00628394|20886848|P4|NOT COMPLETED|Overall Study||3
8475342|NCT00628394|20886849|P3|NOT COMPLETED|Overall Study||2
8475343|NCT00628394|20886850|P2|NOT COMPLETED|Overall Study||4
8475344|NCT00628394|20886851|P1|NOT COMPLETED|Overall Study||4
8475345|NCT00628394|20886848|P4|COMPLETED|Overall Study||10
8475346|NCT00628394|20886849|P3|COMPLETED|Overall Study||11
8475347|NCT00628394|20886850|P2|COMPLETED|Overall Study||9
8475348|NCT00628394|20886851|P1|COMPLETED|Overall Study||10
8475349|NCT00628394|20886848|P4|STARTED|Overall Study||13
8475350|NCT00628394|20886849|P3|STARTED|Overall Study||13
8475351|NCT00628394|20886850|P2|STARTED|Overall Study||13
8475352|NCT00628394|20886851|P1|STARTED|Overall Study||14
8475353|NCT00628355|20886867|P2|NOT COMPLETED|Overall Study||1
8475354|NCT00628355|20886868|P1|NOT COMPLETED|Overall Study||1
8475355|NCT00628355|20886867|P2|COMPLETED|Overall Study||14
8475356|NCT00628355|20886868|P1|COMPLETED|Overall Study||14
8475357|NCT00628355|20886867|P2|STARTED|Overall Study||15
8475358|NCT00628355|20886868|P1|STARTED|Overall Study||15
8475359|NCT00628251|20886879|P3|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
8475360|NCT00628251|20886880|P2|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
8475361|NCT00628251|20886881|P1|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
8475362|NCT00628251|20886879|P3|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
8475363|NCT00628251|20886880|P2|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
8475364|NCT00628251|20886881|P1|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
8475365|NCT00628251|20886879|P3|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
8475366|NCT00628251|20886880|P2|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
8475367|NCT00628251|20886881|P1|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
8475368|NCT00628251|20886879|P3|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
8475369|NCT00628251|20886880|P2|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
8475370|NCT00628251|20886881|P1|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
8475371|NCT00628251|20886879|P3|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
8475372|NCT00628251|20886880|P2|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
8475373|NCT00628251|20886881|P1|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
8475374|NCT00628251|20886879|P3|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
8475375|NCT00628251|20886880|P2|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
8475376|NCT00628251|20886881|P1|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
8475377|NCT00628251|20886879|P3|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
8475378|NCT00628251|20886880|P2|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
8475379|NCT00628251|20886881|P1|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
8475380|NCT00628251|20886879|P3|NOT COMPLETED|Randomised Part||1
8475381|NCT00628251|20886880|P2|NOT COMPLETED|Randomised Part||0
8475382|NCT00628251|20886881|P1|NOT COMPLETED|Randomised Part||0
8475383|NCT00628251|20886879|P3|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
8475384|NCT00628251|20886880|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
8475385|NCT00628251|20886881|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
8475386|NCT00628251|20886879|P3|STARTED|Randomised Part|Patients randomised|33
8475387|NCT00628251|20886880|P2|STARTED|Randomised Part|Patients randomised|32
8475388|NCT00628251|20886881|P1|STARTED|Randomised Part|Patients randomised|32
8475389|NCT00628212|20886927|P4|NOT COMPLETED|Overall Study||5
8475390|NCT00628212|20886928|P3|NOT COMPLETED|Overall Study||3
8475391|NCT00628212|20886929|P2|NOT COMPLETED|Overall Study||1
8475392|NCT00628212|20886930|P1|NOT COMPLETED|Overall Study||3
8475393|NCT00628212|20886927|P4|COMPLETED|Overall Study||76
8475394|NCT00628212|20886928|P3|COMPLETED|Overall Study||76
8475395|NCT00628212|20886929|P2|COMPLETED|Overall Study||83
8475396|NCT00628212|20886930|P1|COMPLETED|Overall Study||77
8475397|NCT00628212|20886927|P4|STARTED|Overall Study||81
8475398|NCT00628212|20886928|P3|STARTED|Overall Study||79
8475399|NCT00628212|20886929|P2|STARTED|Overall Study||84
8475400|NCT00628212|20886930|P1|STARTED|Overall Study||80
8475401|NCT00628147|20886954|P2|NOT COMPLETED|Overall Study||1
8475402|NCT00628147|20886955|P1|NOT COMPLETED|Overall Study||7
8475403|NCT00628147|20886954|P2|COMPLETED|Overall Study||141
8475404|NCT00628147|20886955|P1|COMPLETED|Overall Study||135
8475405|NCT00628147|20886954|P2|STARTED|Overall Study||142
8475406|NCT00628147|20886955|P1|STARTED|Overall Study||142
8475407|NCT00628134|20886967|P2|NOT COMPLETED|Overall Study||0
8475408|NCT00628134|20886968|P1|NOT COMPLETED|Overall Study||0
8475409|NCT00628134|20886967|P2|COMPLETED|Overall Study||4
8475410|NCT00628134|20886968|P1|COMPLETED|Overall Study||4
8475411|NCT00628134|20886967|P2|STARTED|Overall Study||4
8475412|NCT00628134|20886968|P1|STARTED|Overall Study||4
8475413|NCT00628108|20886978|P2|NOT COMPLETED|Overall Study||3
8475414|NCT00628108|20886979|P1|NOT COMPLETED|Overall Study||1
8475415|NCT00628108|20886978|P2|COMPLETED|Overall Study||43
8475416|NCT00628108|20886979|P1|COMPLETED|Overall Study||22
8475417|NCT00628108|20886978|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
8475418|NCT00628108|20886979|P1|Safety Population|Overall Study||24
8475419|NCT00628108|20886978|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
8475420|NCT00628108|20886979|P1|STARTED|Overall Study||23
8475421|NCT00628030|20887011|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
8475422|NCT00628030|20887012|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
8475423|NCT00628030|20887011|P2|COMPLETED|Post to 6 Month Follow-up||33
8475424|NCT00628030|20887012|P1|COMPLETED|Post to 6 Month Follow-up||27
8475425|NCT00628030|20887011|P2|STARTED|Post to 6 Month Follow-up||63
8475426|NCT00628030|20887012|P1|STARTED|Post to 6 Month Follow-up||59
8475427|NCT00628030|20887011|P2|NOT COMPLETED|Baseline to Post-Assessment||29
8475428|NCT00628030|20887012|P1|NOT COMPLETED|Baseline to Post-Assessment||33
8475429|NCT00628030|20887011|P2|COMPLETED|Baseline to Post-Assessment||63
8475430|NCT00628030|20887012|P1|COMPLETED|Baseline to Post-Assessment||59
8475431|NCT00628030|20887011|P2|STARTED|Baseline to Post-Assessment||92
8475432|NCT00628030|20887012|P1|STARTED|Baseline to Post-Assessment||92
8475433|NCT00627978|20887028|P2|NOT COMPLETED|Overall Study||0
8475434|NCT00627978|20887029|P1|NOT COMPLETED|Overall Study||0
8475435|NCT00627978|20887028|P2|COMPLETED|Overall Study||5
8475436|NCT00627978|20887029|P1|COMPLETED|Overall Study||10
8475437|NCT00627978|20887028|P2|STARTED|Overall Study||5
8475438|NCT00627978|20887029|P1|STARTED|Overall Study||10
8475439|NCT00627926|20887038|P3|NOT COMPLETED|Overall Study||95
8475440|NCT00627926|20887039|P2|NOT COMPLETED|Overall Study||104
8475441|NCT00627926|20887040|P1|NOT COMPLETED|Overall Study||159
8475442|NCT00627926|20887038|P3|COMPLETED|Overall Study||268
8475443|NCT00627926|20887039|P2|COMPLETED|Overall Study||260
8475444|NCT00627926|20887040|P1|COMPLETED|Overall Study||202
8475445|NCT00627926|20887038|P3|STARTED|Overall Study||363
8475446|NCT00627926|20887039|P2|STARTED|Overall Study||364
8475447|NCT00627926|20887040|P1|STARTED|Overall Study||361
8475448|NCT00627861|20887084|P1|NOT COMPLETED|Overall Study||0
8475449|NCT00627861|20887084|P1|COMPLETED|Overall Study||1
8475450|NCT00627861|20887084|P1|STARTED|Overall Study||1
8475451|NCT00627705|20887092|P2|NOT COMPLETED|Overall Study||6
8475452|NCT00627705|20887093|P1|NOT COMPLETED|Overall Study||2
8475453|NCT00627705|20887092|P2|COMPLETED|Overall Study||12
8475454|NCT00627705|20887093|P1|COMPLETED|Overall Study||13
8475455|NCT00627705|20887092|P2|STARTED|Overall Study||18
8475456|NCT00627705|20887093|P1|STARTED|Overall Study||15
8475457|NCT00627679|20887113|P4|NOT COMPLETED|Overall Study||0
8475458|NCT00627679|20887114|P3|NOT COMPLETED|Overall Study||0
8475459|NCT00627679|20887115|P2|NOT COMPLETED|Overall Study||0
8475460|NCT00627679|20887116|P1|NOT COMPLETED|Overall Study||0
8475461|NCT00627679|20887113|P4|COMPLETED|Overall Study||4
8475462|NCT00627679|20887114|P3|COMPLETED|Overall Study||4
8475463|NCT00627679|20887115|P2|COMPLETED|Overall Study||4
8475464|NCT00627679|20887116|P1|COMPLETED|Overall Study||4
8475465|NCT00627679|20887113|P4|STARTED|Overall Study||4
8475466|NCT00627679|20887114|P3|STARTED|Overall Study||4
8475467|NCT00627679|20887115|P2|STARTED|Overall Study||4
8475468|NCT00627679|20887116|P1|STARTED|Overall Study||4
8475469|NCT00627523|20887144|P2|NOT COMPLETED|Overall Study||2
8475470|NCT00627523|20887145|P1|NOT COMPLETED|Overall Study||2
8475471|NCT00627523|20887144|P2|COMPLETED|Overall Study||20
8475472|NCT00627523|20887145|P1|COMPLETED|Overall Study||19
8475473|NCT00627523|20887144|P2|STARTED|Overall Study||22
8475474|NCT00627523|20887145|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
8475475|NCT00627497|20887173|P4|NOT COMPLETED|Overall Study||0
8475476|NCT00627497|20887174|P3|NOT COMPLETED|Overall Study||0
8475477|NCT00627497|20887175|P2|NOT COMPLETED|Overall Study||1
8475478|NCT00627497|20887176|P1|NOT COMPLETED|Overall Study||1
8475479|NCT00627497|20887173|P4|COMPLETED|Overall Study||2
8475480|NCT00627497|20887174|P3|COMPLETED|Overall Study||4
8475481|NCT00627497|20887175|P2|COMPLETED|Overall Study||11
8475482|NCT00627497|20887176|P1|COMPLETED|Overall Study||13
8475483|NCT00627497|20887173|P4|STARTED|Overall Study||2
8475484|NCT00627497|20887174|P3|STARTED|Overall Study||4
8475485|NCT00627497|20887175|P2|STARTED|Overall Study||12
8475486|NCT00627497|20887176|P1|STARTED|Overall Study||14
8475487|NCT00627458|20887237|P3|NOT COMPLETED|Overall Study||6
8475488|NCT00627458|20887238|P2|NOT COMPLETED|Overall Study||7
8475489|NCT00627458|20887239|P1|NOT COMPLETED|Overall Study||4
8475490|NCT00627458|20887237|P3|COMPLETED|Overall Study||133
8475491|NCT00627458|20887238|P2|COMPLETED|Overall Study||130
8475492|NCT00627458|20887239|P1|COMPLETED|Overall Study||123
8475493|NCT00627458|20887237|P3|STARTED|Overall Study||139
8475494|NCT00627458|20887238|P2|STARTED|Overall Study||137
8475495|NCT00627458|20887239|P1|STARTED|Overall Study||127
8475496|NCT00627445|20887314|P2|NOT COMPLETED|Overall Study||12
8475497|NCT00627445|20887315|P1|NOT COMPLETED|Overall Study||9
8475498|NCT00627445|20887314|P2|COMPLETED|Overall Study||210
8475499|NCT00627445|20887315|P1|COMPLETED|Overall Study||210
8475500|NCT00627445|20887314|P2|Exposed to Study Drug|Overall Study||222
8475501|NCT00627445|20887315|P1|Exposed to Study Drug|Overall Study||219
8475502|NCT00627445|20887314|P2|STARTED|Overall Study||222
8475503|NCT00627445|20887315|P1|STARTED|Overall Study||219
8475504|NCT00627406|20887339|P4|NOT COMPLETED|Overall Study||0
8475505|NCT00627406|20887340|P3|NOT COMPLETED|Overall Study||0
8475506|NCT00627406|20887341|P2|NOT COMPLETED|Overall Study||0
8475507|NCT00627406|20887342|P1|NOT COMPLETED|Overall Study||0
8475508|NCT00627406|20887339|P4|COMPLETED|Overall Study||141
8475509|NCT00627406|20887340|P3|COMPLETED|Overall Study||125
8475510|NCT00627406|20887341|P2|COMPLETED|Overall Study||58
8475511|NCT00627406|20887342|P1|COMPLETED|Overall Study||60
8475512|NCT00627406|20887339|P4|STARTED|Overall Study||141
8475513|NCT00627406|20887340|P3|STARTED|Overall Study||125
8475514|NCT00627406|20887341|P2|STARTED|Overall Study||58
8475515|NCT00627406|20887342|P1|STARTED|Overall Study||60
8475516|NCT00627393|20887358|P2|NOT COMPLETED|Per-Protocol Analysis||13
8475517|NCT00627393|20887359|P1|NOT COMPLETED|Per-Protocol Analysis||10
8475518|NCT00627393|20887358|P2|COMPLETED|Per-Protocol Analysis||35
8475519|NCT00627393|20887359|P1|COMPLETED|Per-Protocol Analysis||39
8475520|NCT00627393|20887358|P2|STARTED|Per-Protocol Analysis||48
8475521|NCT00627393|20887359|P1|STARTED|Per-Protocol Analysis||49
8475522|NCT00627393|20887358|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
8475523|NCT00627393|20887359|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
8475524|NCT00627393|20887358|P2|COMPLETED|Intention-To-Treat Analysis||48
8475525|NCT00627393|20887359|P1|COMPLETED|Intention-To-Treat Analysis||49
8475526|NCT00627393|20887358|P2|STARTED|Intention-To-Treat Analysis||56
8475527|NCT00627393|20887359|P1|STARTED|Intention-To-Treat Analysis||58
8475528|NCT00627367|20887380|P2|NOT COMPLETED|Overall Study||0
8475529|NCT00627367|20887381|P1|NOT COMPLETED|Overall Study||0
8475530|NCT00627367|20887380|P2|COMPLETED|Overall Study||112
8475531|NCT00627367|20887381|P1|COMPLETED|Overall Study||112
8475532|NCT00627367|20887380|P2|STARTED|Overall Study||112
8475533|NCT00627367|20887381|P1|STARTED|Overall Study||112
8475534|NCT00627094|20887395|P2|NOT COMPLETED|Overall Study||15
8475535|NCT00627094|20887396|P1|NOT COMPLETED|Overall Study||12
8475536|NCT00627094|20887395|P2|COMPLETED|Overall Study||45
8475537|NCT00627094|20887396|P1|COMPLETED|Overall Study||48
8475538|NCT00627094|20887395|P2|STARTED|Overall Study||60
8475539|NCT00627094|20887396|P1|STARTED|Overall Study||60
8475540|NCT00627042|20887408|P1|NOT COMPLETED|Overall Study||2
8475541|NCT00627042|20887408|P1|COMPLETED|Overall Study||40
8475542|NCT00627042|20887408|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
8475543|NCT00627042|20887408|P1|STARTED|Overall Study||42
8475544|NCT00627016|20887420|P2|NOT COMPLETED|Overall Study||6
8475545|NCT00627016|20887421|P1|NOT COMPLETED|Overall Study||6
8475546|NCT00627016|20887420|P2|COMPLETED|Overall Study||146
8475547|NCT00627016|20887421|P1|COMPLETED|Overall Study||147
8475548|NCT00627016|20887420|P2|STARTED|Overall Study||152
8475549|NCT00627016|20887421|P1|STARTED|Overall Study||153
8475550|NCT00626925|20887433|P2|NOT COMPLETED|Overall Study||9
8475551|NCT00626925|20887434|P1|NOT COMPLETED|Overall Study||12
8475552|NCT00626925|20887433|P2|COMPLETED|Overall Study||62
8475553|NCT00626925|20887434|P1|COMPLETED|Overall Study||55
8475554|NCT00626925|20887433|P2|STARTED|Overall Study||71
8475555|NCT00626925|20887434|P1|STARTED|Overall Study||67
8475556|NCT00626912|20887468|P2|NOT COMPLETED|Overall Study||10
8475557|NCT00626912|20887469|P1|NOT COMPLETED|Overall Study||2
8475558|NCT00626912|20887468|P2|COMPLETED|Overall Study||215
8475559|NCT00626912|20887469|P1|COMPLETED|Overall Study||220
8475560|NCT00626912|20887468|P2|STARTED|Overall Study||225
8475561|NCT00626912|20887469|P1|STARTED|Overall Study||222
8475562|NCT00626886|20887483|P2|NOT COMPLETED|Overall Study||0
8475563|NCT00626886|20887484|P1|NOT COMPLETED|Overall Study||0
8475564|NCT00626886|20887483|P2|COMPLETED|Overall Study||29
8475565|NCT00626886|20887484|P1|COMPLETED|Overall Study||24
8475566|NCT00626886|20887483|P2|STARTED|Overall Study||29
8475567|NCT00626886|20887484|P1|STARTED|Overall Study||24
8475568|NCT00626821|20887508|P1|NOT COMPLETED|Overall Study||221
8475569|NCT00626821|20887508|P1|COMPLETED|Overall Study||2796
8475570|NCT00626821|20887508|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
8475571|NCT00626821|20887508|P1|STARTED|Overall Study||3017
8475572|NCT00626808|20887516|P4|NOT COMPLETED|Overall Study||0
8475573|NCT00626808|20887517|P3|NOT COMPLETED|Overall Study||0
8475574|NCT00626808|20887518|P2|NOT COMPLETED|Overall Study||0
8475575|NCT00626808|20887519|P1|NOT COMPLETED|Overall Study||0
8475576|NCT00626808|20887516|P4|COMPLETED|Overall Study||2906
8475577|NCT00626808|20887517|P3|COMPLETED|Overall Study||30011
8475578|NCT00626808|20887518|P2|COMPLETED|Overall Study||34316
8475579|NCT00626808|20887519|P1|COMPLETED|Overall Study||254464
8475580|NCT00626808|20887516|P4|STARTED|Overall Study||2906
8475581|NCT00626808|20887517|P3|STARTED|Overall Study||30011
8475582|NCT00626808|20887518|P2|STARTED|Overall Study||34316
8475583|NCT00626808|20887519|P1|STARTED|Overall Study||254464
8475584|NCT00626795|20887588|P3|NOT COMPLETED|Blinded Treatment||9
8475585|NCT00626795|20887589|P2|NOT COMPLETED|Blinded Treatment||5
8475586|NCT00626795|20887590|P1|NOT COMPLETED|Blinded Treatment||10
8475587|NCT00626795|20887588|P3|COMPLETED|Blinded Treatment||196
8475588|NCT00626795|20887589|P2|COMPLETED|Blinded Treatment||200
8475589|NCT00626795|20887590|P1|COMPLETED|Blinded Treatment||194
8475590|NCT00626795|20887588|P3|STARTED|Blinded Treatment||205
8475591|NCT00626795|20887589|P2|STARTED|Blinded Treatment||205
8475592|NCT00626795|20887590|P1|STARTED|Blinded Treatment||204
8475593|NCT00626795|20887588|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475594|NCT00626795|20887589|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
8475595|NCT00626795|20887590|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475596|NCT00626795|20887588|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475597|NCT00626795|20887589|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
8475598|NCT00626795|20887590|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475599|NCT00626795|20887588|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
8475600|NCT00626795|20887589|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
8475601|NCT00626795|20887590|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
8475602|NCT00626782|20887619|P2|NOT COMPLETED|Overall Study||0
8475603|NCT00626782|20887620|P1|NOT COMPLETED|Overall Study||0
8475604|NCT00626782|20887619|P2|COMPLETED|Overall Study||12
8475605|NCT00626782|20887620|P1|COMPLETED|Overall Study||12
8475606|NCT00626782|20887619|P2|STARTED|Overall Study||12
8475607|NCT00626782|20887620|P1|STARTED|Overall Study||12
8475608|NCT00626743|20887630|P2|NOT COMPLETED|Treatment Period 2||0
8475609|NCT00626743|20887631|P1|NOT COMPLETED|Treatment Period 2||0
8475610|NCT00626743|20887630|P2|COMPLETED|Treatment Period 2||6
8475611|NCT00626743|20887631|P1|COMPLETED|Treatment Period 2||6
8475612|NCT00626743|20887630|P2|STARTED|Treatment Period 2||6
8475613|NCT00626743|20887631|P1|STARTED|Treatment Period 2||6
8475614|NCT00626743|20887630|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
8475615|NCT00626743|20887631|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
8475616|NCT00626743|20887630|P2|COMPLETED|Wash-out Period of 6 Days||6
8475617|NCT00626743|20887631|P1|COMPLETED|Wash-out Period of 6 Days||6
8475618|NCT00626743|20887630|P2|STARTED|Wash-out Period of 6 Days||6
8475619|NCT00626743|20887631|P1|STARTED|Wash-out Period of 6 Days||6
8475620|NCT00626743|20887630|P2|NOT COMPLETED|Treatment Period 1||1
8475621|NCT00626743|20887631|P1|NOT COMPLETED|Treatment Period 1||0
8475622|NCT00626743|20887630|P2|COMPLETED|Treatment Period 1||6
8475623|NCT00626743|20887631|P1|COMPLETED|Treatment Period 1||6
8475624|NCT00626743|20887630|P2|STARTED|Treatment Period 1||7
8475625|NCT00626743|20887631|P1|STARTED|Treatment Period 1||6
8475626|NCT00626639|20887641|P2|NOT COMPLETED|Overall Study||2
8475627|NCT00626639|20887642|P1|NOT COMPLETED|Overall Study||2
8475628|NCT00626639|20887641|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
8475629|NCT00626639|20887642|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
8475630|NCT00626639|20887641|P2|STARTED|Overall Study||3
8475631|NCT00626639|20887642|P1|STARTED|Overall Study||2
8475632|NCT00626626|20887662|P2|NOT COMPLETED|Overall Study||0
8475633|NCT00626626|20887663|P1|NOT COMPLETED|Overall Study||0
8475634|NCT00626626|20887662|P2|COMPLETED|Overall Study||3
8475635|NCT00626626|20887663|P1|COMPLETED|Overall Study||5
8475636|NCT00626626|20887662|P2|STARTED|Overall Study||3
8475637|NCT00626626|20887663|P1|STARTED|Overall Study||5
8475638|NCT00626574|20887675|P2|NOT COMPLETED|Overall Study||0
8475639|NCT00626574|20887676|P1|NOT COMPLETED|Overall Study||0
8475640|NCT00626574|20887675|P2|COMPLETED|Overall Study||1
8475641|NCT00626574|20887676|P1|COMPLETED|Overall Study||2
8475642|NCT00626574|20887675|P2|STARTED|Overall Study||1
8475643|NCT00626574|20887676|P1|STARTED|Overall Study||2
8475644|NCT00626561|20887688|P1|NOT COMPLETED|Overall Study||4
8475645|NCT00626561|20887688|P1|COMPLETED|Overall Study||0
8475646|NCT00626561|20887688|P1|STARTED|Overall Study||4
8475647|NCT00626548|20887694|P2|NOT COMPLETED|Overall Study||716
8475648|NCT00626548|20887695|P1|NOT COMPLETED|Overall Study||705
8475649|NCT00626548|20887694|P2|COMPLETED|Overall Study||0
8475650|NCT00626548|20887695|P1|COMPLETED|Overall Study||0
8475651|NCT00626548|20887694|P2|Patients Received Treatment|Overall Study||712
8475652|NCT00626548|20887695|P1|Patients Received Treatment|Overall Study||703
8475653|NCT00626548|20887694|P2|STARTED|Overall Study||716
8475654|NCT00626548|20887695|P1|STARTED|Overall Study||705
8475655|NCT00626522|20887709|P6|NOT COMPLETED|Overall Study||2
8475656|NCT00626522|20887710|P5|NOT COMPLETED|Overall Study||7
8475657|NCT00626522|20887711|P4|NOT COMPLETED|Overall Study||2
8475658|NCT00626522|20887712|P3|NOT COMPLETED|Overall Study||8
8475659|NCT00626522|20887713|P2|NOT COMPLETED|Overall Study||7
8475660|NCT00626522|20887714|P1|NOT COMPLETED|Overall Study||6
8475661|NCT00626522|20887709|P6|COMPLETED|Overall Study||57
8475662|NCT00626522|20887710|P5|COMPLETED|Overall Study||58
8475663|NCT00626522|20887711|P4|COMPLETED|Overall Study||74
8475664|NCT00626522|20887712|P3|COMPLETED|Overall Study||117
8475665|NCT00626522|20887713|P2|COMPLETED|Overall Study||113
8475666|NCT00626522|20887714|P1|COMPLETED|Overall Study||115
8475667|NCT00626522|20887709|P6|STARTED|Overall Study||59
8475668|NCT00626522|20887710|P5|STARTED|Overall Study||65
8475669|NCT00626522|20887711|P4|STARTED|Overall Study||76
8475670|NCT00626522|20887712|P3|STARTED|Overall Study||125
8475671|NCT00626522|20887713|P2|STARTED|Overall Study||120
8475672|NCT00626522|20887714|P1|STARTED|Overall Study||121
8475673|NCT00626444|20887752|P1|NOT COMPLETED|Overall Study||0
8475674|NCT00626444|20887752|P1|COMPLETED|Overall Study||2
8475675|NCT00626444|20887752|P1|STARTED|Overall Study||2
8475676|NCT00626431|20887759|P2|NOT COMPLETED|Overall Study||45
8475677|NCT00626431|20887760|P1|NOT COMPLETED|Overall Study||17
8475678|NCT00626431|20887759|P2|COMPLETED|Overall Study||114
8475679|NCT00626431|20887760|P1|COMPLETED|Overall Study||134
8475680|NCT00626431|20887759|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
8475681|NCT00626431|20887760|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
8475682|NCT00626405|20887777|P2|NOT COMPLETED|Overall Study||1
8475683|NCT00626405|20887778|P1|NOT COMPLETED|Overall Study||1
8475684|NCT00626405|20887777|P2|COMPLETED|Overall Study||51
8475685|NCT00626405|20887778|P1|COMPLETED|Overall Study||42
8475686|NCT00626405|20887777|P2|STARTED|Overall Study||52
8475687|NCT00626405|20887778|P1|STARTED|Overall Study||43
8475688|NCT00626392|20887794|P6|NOT COMPLETED|Coadministration Period||6
8475689|NCT00626392|20887795|P5|NOT COMPLETED|Coadministration Period||5
8475690|NCT00626392|20887796|P4|NOT COMPLETED|Coadministration Period||7
8475691|NCT00626392|20887797|P3|NOT COMPLETED|Coadministration Period||10
8475692|NCT00626392|20887798|P2|NOT COMPLETED|Coadministration Period||5
8475693|NCT00626392|20887799|P1|NOT COMPLETED|Coadministration Period||4
8475694|NCT00626392|20887794|P6|COMPLETED|Coadministration Period||38
8475695|NCT00626392|20887795|P5|COMPLETED|Coadministration Period||36
8475696|NCT00626392|20887796|P4|COMPLETED|Coadministration Period||36
8475697|NCT00626392|20887797|P3|COMPLETED|Coadministration Period||31
8475698|NCT00626392|20887798|P2|COMPLETED|Coadministration Period||38
8475699|NCT00626392|20887799|P1|COMPLETED|Coadministration Period||40
8475700|NCT00626392|20887794|P6|STARTED|Coadministration Period||44
8475701|NCT00626392|20887795|P5|STARTED|Coadministration Period||41
8475702|NCT00626392|20887796|P4|STARTED|Coadministration Period||43
8475703|NCT00626392|20887797|P3|STARTED|Coadministration Period||41
8475704|NCT00626392|20887798|P2|STARTED|Coadministration Period||43
8475705|NCT00626392|20887799|P1|STARTED|Coadministration Period||44
8475706|NCT00626392|20887794|P6|NOT COMPLETED|Run-in Period||1
8475707|NCT00626392|20887795|P5|NOT COMPLETED|Run-in Period||4
8475708|NCT00626392|20887796|P4|NOT COMPLETED|Run-in Period||1
8475709|NCT00626392|20887797|P3|NOT COMPLETED|Run-in Period||3
8475710|NCT00626392|20887798|P2|NOT COMPLETED|Run-in Period||1
8475711|NCT00626392|20887799|P1|NOT COMPLETED|Run-in Period||1
8475712|NCT00626392|20887794|P6|COMPLETED|Run-in Period||44
8475713|NCT00626392|20887795|P5|COMPLETED|Run-in Period||41
8475714|NCT00626392|20887796|P4|COMPLETED|Run-in Period||43
8475715|NCT00626392|20887797|P3|COMPLETED|Run-in Period||41
8475716|NCT00626392|20887798|P2|COMPLETED|Run-in Period||43
8475717|NCT00626392|20887799|P1|COMPLETED|Run-in Period||44
8475718|NCT00626392|20887794|P6|STARTED|Run-in Period||45
8475719|NCT00626392|20887795|P5|STARTED|Run-in Period||45
8475720|NCT00626392|20887796|P4|STARTED|Run-in Period||44
8475721|NCT00626392|20887797|P3|STARTED|Run-in Period||44
8475722|NCT00626392|20887798|P2|STARTED|Run-in Period||44
8475723|NCT00626392|20887799|P1|STARTED|Run-in Period||45
8475724|NCT00626366|20887813|P2|NOT COMPLETED|Overall Study||0
8475725|NCT00626366|20887814|P1|NOT COMPLETED|Overall Study||0
8475726|NCT00626366|20887813|P2|COMPLETED|Overall Study||9
8475727|NCT00626366|20887814|P1|COMPLETED|Overall Study||9
8475728|NCT00626366|20887813|P2|STARTED|Overall Study||9
8475729|NCT00626366|20887814|P1|STARTED|Overall Study||9
8475730|NCT00626340|20887820|P1|NOT COMPLETED|Overall Study||0
8475731|NCT00626340|20887820|P1|COMPLETED|Overall Study||18
8475732|NCT00626340|20887820|P1|STARTED|Overall Study||18
8475733|NCT00626327|20887827|P3|NOT COMPLETED|Overall Study||88
8475734|NCT00626327|20887828|P2|NOT COMPLETED|Overall Study||59
8475735|NCT00626327|20887829|P1|NOT COMPLETED|Overall Study||78
8475736|NCT00626327|20887827|P3|COMPLETED|Overall Study||422
8475737|NCT00626327|20887828|P2|COMPLETED|Overall Study||557
8475738|NCT00626327|20887829|P1|COMPLETED|Overall Study||426
8475739|NCT00626327|20887827|P3|STARTED|Overall Study||510
8475740|NCT00626327|20887828|P2|STARTED|Overall Study||616
8475741|NCT00626327|20887829|P1|STARTED|Overall Study||504
8475742|NCT00626275|20887855|P8|NOT COMPLETED|Part B||1
8475743|NCT00626275|20887856|P7|NOT COMPLETED|Part B||1
8475744|NCT00626275|20887857|P6|NOT COMPLETED|Part B||0
8475745|NCT00626275|20887858|P5|NOT COMPLETED|Part B||0
8475746|NCT00626275|20887859|P4|NOT COMPLETED|Part B||0
8475747|NCT00626275|20887860|P3|NOT COMPLETED|Part B||0
8475748|NCT00626275|20887861|P2|NOT COMPLETED|Part B||0
8475749|NCT00626275|20887862|P1|NOT COMPLETED|Part B||0
8475750|NCT00626275|20887855|P8|COMPLETED|Part B||23
8475751|NCT00626275|20887856|P7|COMPLETED|Part B||19
8475752|NCT00626275|20887857|P6|COMPLETED|Part B||0
8475753|NCT00626275|20887858|P5|COMPLETED|Part B||0
8475754|NCT00626275|20887859|P4|COMPLETED|Part B||0
8475755|NCT00626275|20887860|P3|COMPLETED|Part B||0
8475756|NCT00626275|20887861|P2|COMPLETED|Part B||0
8475757|NCT00626275|20887862|P1|COMPLETED|Part B||0
8475758|NCT00626275|20887855|P8|STARTED|Part B||24
8475759|NCT00626275|20887856|P7|STARTED|Part B||20
8475760|NCT00626275|20887857|P6|STARTED|Part B||0
8475761|NCT00626275|20887858|P5|STARTED|Part B||0
8475762|NCT00626275|20887859|P4|STARTED|Part B||0
8475763|NCT00626275|20887860|P3|STARTED|Part B||0
8475764|NCT00626275|20887861|P2|STARTED|Part B||0
8475765|NCT00626275|20887862|P1|STARTED|Part B||0
8475766|NCT00626275|20887855|P8|NOT COMPLETED|Re-randomization Period for Part B||0
8475767|NCT00626275|20887856|P7|NOT COMPLETED|Re-randomization Period for Part B||0
8475768|NCT00626275|20887857|P6|NOT COMPLETED|Re-randomization Period for Part B||0
8475769|NCT00626275|20887858|P5|NOT COMPLETED|Re-randomization Period for Part B||0
8475770|NCT00626275|20887859|P4|NOT COMPLETED|Re-randomization Period for Part B||0
8475771|NCT00626275|20887860|P3|NOT COMPLETED|Re-randomization Period for Part B||0
8475772|NCT00626275|20887861|P2|NOT COMPLETED|Re-randomization Period for Part B||0
8475773|NCT00626275|20887862|P1|NOT COMPLETED|Re-randomization Period for Part B||0
8475774|NCT00626275|20887855|P8|COMPLETED|Re-randomization Period for Part B||24
8475775|NCT00626275|20887856|P7|COMPLETED|Re-randomization Period for Part B||20
8475776|NCT00626275|20887857|P6|COMPLETED|Re-randomization Period for Part B||0
8475777|NCT00626275|20887858|P5|COMPLETED|Re-randomization Period for Part B||0
8475778|NCT00626275|20887859|P4|COMPLETED|Re-randomization Period for Part B||0
8475779|NCT00626275|20887860|P3|COMPLETED|Re-randomization Period for Part B||0
8475780|NCT00626275|20887861|P2|COMPLETED|Re-randomization Period for Part B||0
8475781|NCT00626275|20887862|P1|COMPLETED|Re-randomization Period for Part B||0
8475782|NCT00626275|20887855|P8|STARTED|Re-randomization Period for Part B||24
8475783|NCT00626275|20887856|P7|STARTED|Re-randomization Period for Part B||20
8475784|NCT00626275|20887857|P6|STARTED|Re-randomization Period for Part B||0
8475785|NCT00626275|20887858|P5|STARTED|Re-randomization Period for Part B||0
8475786|NCT00626275|20887859|P4|STARTED|Re-randomization Period for Part B||0
8475787|NCT00626275|20887860|P3|STARTED|Re-randomization Period for Part B||0
8475788|NCT00626275|20887861|P2|STARTED|Re-randomization Period for Part B||0
8475789|NCT00626275|20887862|P1|STARTED|Re-randomization Period for Part B||0
8475790|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Treatment Period 3||0
8475791|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Treatment Period 3||0
8475792|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Treatment Period 3||0
8475793|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Treatment Period 3||0
8475794|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Treatment Period 3||0
8475795|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Treatment Period 3||0
8475796|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Treatment Period 3||0
8475797|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Treatment Period 3||0
8475798|NCT00626275|20887855|P8|COMPLETED|Part A - Treatment Period 3||0
8475799|NCT00626275|20887856|P7|COMPLETED|Part A - Treatment Period 3||0
8475800|NCT00626275|20887857|P6|COMPLETED|Part A - Treatment Period 3||8
8475801|NCT00626275|20887858|P5|COMPLETED|Part A - Treatment Period 3||9
8475802|NCT00626275|20887859|P4|COMPLETED|Part A - Treatment Period 3||8
8475803|NCT00626275|20887860|P3|COMPLETED|Part A - Treatment Period 3||6
8475804|NCT00626275|20887861|P2|COMPLETED|Part A - Treatment Period 3||7
8475805|NCT00626275|20887862|P1|COMPLETED|Part A - Treatment Period 3||6
8475806|NCT00626275|20887855|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
8475807|NCT00626275|20887856|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
8475808|NCT00626275|20887857|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
8475809|NCT00626275|20887858|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
8475810|NCT00626275|20887859|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
8475811|NCT00626275|20887860|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
8475812|NCT00626275|20887861|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
8475813|NCT00626275|20887862|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
8475814|NCT00626275|20887855|P8|STARTED|Part A - Treatment Period 3||0
8475815|NCT00626275|20887856|P7|STARTED|Part A - Treatment Period 3||0
8475816|NCT00626275|20887857|P6|STARTED|Part A - Treatment Period 3||8
8475817|NCT00626275|20887858|P5|STARTED|Part A - Treatment Period 3||9
8475818|NCT00626275|20887859|P4|STARTED|Part A - Treatment Period 3||8
8475819|NCT00626275|20887860|P3|STARTED|Part A - Treatment Period 3||6
8475820|NCT00626275|20887861|P2|STARTED|Part A - Treatment Period 3||7
8475821|NCT00626275|20887862|P1|STARTED|Part A - Treatment Period 3||6
8475822|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Washout Period 2||0
8475823|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Washout Period 2||0
8475824|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Washout Period 2||0
8475825|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Washout Period 2||0
8475826|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Washout Period 2||0
8475827|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Washout Period 2||0
8475828|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Washout Period 2||0
8475829|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Washout Period 2||0
8475830|NCT00626275|20887855|P8|COMPLETED|Part A - Washout Period 2||0
8475831|NCT00626275|20887856|P7|COMPLETED|Part A - Washout Period 2||0
8475832|NCT00626275|20887857|P6|COMPLETED|Part A - Washout Period 2||8
8475833|NCT00626275|20887858|P5|COMPLETED|Part A - Washout Period 2||9
8475834|NCT00626275|20887859|P4|COMPLETED|Part A - Washout Period 2||8
8475835|NCT00626275|20887860|P3|COMPLETED|Part A - Washout Period 2||6
8475836|NCT00626275|20887861|P2|COMPLETED|Part A - Washout Period 2||7
8475837|NCT00626275|20887862|P1|COMPLETED|Part A - Washout Period 2||6
8475838|NCT00626275|20887855|P8|STARTED|Part A - Washout Period 2||0
8475839|NCT00626275|20887856|P7|STARTED|Part A - Washout Period 2||0
8475840|NCT00626275|20887857|P6|STARTED|Part A - Washout Period 2||8
8475841|NCT00626275|20887858|P5|STARTED|Part A - Washout Period 2||9
8475842|NCT00626275|20887859|P4|STARTED|Part A - Washout Period 2||8
8475843|NCT00626275|20887860|P3|STARTED|Part A - Washout Period 2||6
8475844|NCT00626275|20887861|P2|STARTED|Part A - Washout Period 2||7
8475845|NCT00626275|20887862|P1|STARTED|Part A - Washout Period 2||6
8475846|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Treatment Period 2||0
8475847|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Treatment Period 2||0
8475848|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Treatment Period 2||0
8475849|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Treatment Period 2||0
8475850|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Treatment Period 2||0
8475851|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Treatment Period 2||0
8475852|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Treatment Period 2||0
8475853|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Treatment Period 2||0
8475854|NCT00626275|20887855|P8|COMPLETED|Part A - Treatment Period 2||0
8475855|NCT00626275|20887856|P7|COMPLETED|Part A - Treatment Period 2||0
8475856|NCT00626275|20887857|P6|COMPLETED|Part A - Treatment Period 2||8
8475857|NCT00626275|20887858|P5|COMPLETED|Part A - Treatment Period 2||9
8475858|NCT00626275|20887859|P4|COMPLETED|Part A - Treatment Period 2||8
8475859|NCT00626275|20887860|P3|COMPLETED|Part A - Treatment Period 2||6
8475860|NCT00626275|20887861|P2|COMPLETED|Part A - Treatment Period 2||7
8475861|NCT00626275|20887862|P1|COMPLETED|Part A - Treatment Period 2||6
8475862|NCT00626275|20887855|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
8475863|NCT00626275|20887856|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
8475864|NCT00626275|20887857|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
8475865|NCT00626275|20887858|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
8475866|NCT00626275|20887859|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
8475867|NCT00626275|20887860|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
8475868|NCT00626275|20887861|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
8475869|NCT00626275|20887862|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
8475870|NCT00626275|20887855|P8|STARTED|Part A - Treatment Period 2||0
8475871|NCT00626275|20887856|P7|STARTED|Part A - Treatment Period 2||0
8475872|NCT00626275|20887857|P6|STARTED|Part A - Treatment Period 2||8
8475873|NCT00626275|20887858|P5|STARTED|Part A - Treatment Period 2||9
8475874|NCT00626275|20887859|P4|STARTED|Part A - Treatment Period 2||8
8475875|NCT00626275|20887860|P3|STARTED|Part A - Treatment Period 2||6
8475876|NCT00626275|20887861|P2|STARTED|Part A - Treatment Period 2||7
8475877|NCT00626275|20887862|P1|STARTED|Part A - Treatment Period 2||6
8475878|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Washout Period 1||0
8475879|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Washout Period 1||0
8475880|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Washout Period 1||0
8475881|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Washout Period 1||0
8475882|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Washout Period 1||0
8475883|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Washout Period 1||0
8475884|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Washout Period 1||0
8475885|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Washout Period 1||0
8475886|NCT00626275|20887855|P8|COMPLETED|Part A - Washout Period 1||0
8475887|NCT00626275|20887856|P7|COMPLETED|Part A - Washout Period 1||0
8475888|NCT00626275|20887857|P6|COMPLETED|Part A - Washout Period 1||8
8475889|NCT00626275|20887858|P5|COMPLETED|Part A - Washout Period 1||9
8475890|NCT00626275|20887859|P4|COMPLETED|Part A - Washout Period 1||8
8475891|NCT00626275|20887860|P3|COMPLETED|Part A - Washout Period 1||6
8475892|NCT00626275|20887861|P2|COMPLETED|Part A - Washout Period 1||7
8475893|NCT00626275|20887862|P1|COMPLETED|Part A - Washout Period 1||6
8475894|NCT00626275|20887855|P8|STARTED|Part A - Washout Period 1||0
8475895|NCT00626275|20887856|P7|STARTED|Part A - Washout Period 1||0
8475896|NCT00626275|20887857|P6|STARTED|Part A - Washout Period 1||8
8475897|NCT00626275|20887858|P5|STARTED|Part A - Washout Period 1||9
8475898|NCT00626275|20887859|P4|STARTED|Part A - Washout Period 1||8
8475899|NCT00626275|20887860|P3|STARTED|Part A - Washout Period 1||6
8475900|NCT00626275|20887861|P2|STARTED|Part A - Washout Period 1||7
8475901|NCT00626275|20887862|P1|STARTED|Part A - Washout Period 1||6
8475902|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Treatment Period 1||0
8475903|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Treatment Period 1||0
8475904|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Treatment Period 1||0
8475905|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Treatment Period 1||0
8475906|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Treatment Period 1||0
8475907|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Treatment Period 1||1
8475908|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Treatment Period 1||0
8475909|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Treatment Period 1||1
8475910|NCT00626275|20887855|P8|COMPLETED|Part A - Treatment Period 1||0
8475911|NCT00626275|20887856|P7|COMPLETED|Part A - Treatment Period 1||0
8475912|NCT00626275|20887857|P6|COMPLETED|Part A - Treatment Period 1||8
8475913|NCT00626275|20887858|P5|COMPLETED|Part A - Treatment Period 1||9
8475914|NCT00626275|20887859|P4|COMPLETED|Part A - Treatment Period 1||8
8475915|NCT00626275|20887860|P3|COMPLETED|Part A - Treatment Period 1||6
8475916|NCT00626275|20887861|P2|COMPLETED|Part A - Treatment Period 1||7
8475917|NCT00626275|20887862|P1|COMPLETED|Part A - Treatment Period 1||6
8475918|NCT00626275|20887855|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
8475919|NCT00626275|20887856|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
8475920|NCT00626275|20887857|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
8475921|NCT00626275|20887858|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
8475922|NCT00626275|20887859|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
8475923|NCT00626275|20887860|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8475924|NCT00626275|20887861|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8475925|NCT00626275|20887862|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8475926|NCT00626275|20887855|P8|STARTED|Part A - Treatment Period 1||0
8475927|NCT00626275|20887856|P7|STARTED|Part A - Treatment Period 1||0
8475928|NCT00626275|20887857|P6|STARTED|Part A - Treatment Period 1||8
8475929|NCT00626275|20887858|P5|STARTED|Part A - Treatment Period 1||9
8475930|NCT00626275|20887859|P4|STARTED|Part A - Treatment Period 1||8
8475931|NCT00626275|20887860|P3|STARTED|Part A - Treatment Period 1||7
8475932|NCT00626275|20887861|P2|STARTED|Part A - Treatment Period 1||7
8475933|NCT00626275|20887862|P1|STARTED|Part A - Treatment Period 1||7
8475934|NCT00626210|20887902|P1|NOT COMPLETED|Overall Study||0
8475935|NCT00626210|20887902|P1|COMPLETED|Overall Study||2
8475936|NCT00626210|20887902|P1|STARTED|Overall Study||2
8475937|NCT00626197|20887909|P3|NOT COMPLETED|Overall Study||77
8475938|NCT00626197|20887910|P2|NOT COMPLETED|Overall Study||54
8475939|NCT00626197|20887911|P1|NOT COMPLETED|Overall Study||44
8475940|NCT00626197|20887909|P3|COMPLETED|Overall Study||49
8475941|NCT00626197|20887910|P2|COMPLETED|Overall Study||74
8475942|NCT00626197|20887911|P1|COMPLETED|Overall Study||83
8475943|NCT00626197|20887909|P3|STARTED|Overall Study||126
8475944|NCT00626197|20887910|P2|STARTED|Overall Study||128
8475945|NCT00626197|20887911|P1|STARTED|Overall Study||127
8475946|NCT00626093|20887988|P1|NOT COMPLETED|Overall Study||23
8475947|NCT00626093|20887988|P1|COMPLETED|Overall Study||54
8475948|NCT00626093|20887988|P1|STARTED|Overall Study||77
8475949|NCT00626028|20887995|P2|NOT COMPLETED|Overall Study||9
8475950|NCT00626028|20887996|P1|NOT COMPLETED|Overall Study||6
8475951|NCT00626028|20887995|P2|COMPLETED|Overall Study||59
8475952|NCT00626028|20887996|P1|COMPLETED|Overall Study||62
8475953|NCT00626028|20887995|P2|STARTED|Overall Study||68
8475954|NCT00626028|20887996|P1|STARTED|Overall Study||68
8475955|NCT00625989|20888010|P2|NOT COMPLETED|Overall Study||0
8475956|NCT00625989|20888011|P1|NOT COMPLETED|Overall Study||0
8475957|NCT00625989|20888010|P2|COMPLETED|Overall Study||6
8475958|NCT00625989|20888011|P1|COMPLETED|Overall Study||6
8475959|NCT00625989|20888010|P2|STARTED|Overall Study||6
8475960|NCT00625989|20888011|P1|STARTED|Overall Study||6
8475961|NCT00625872|20888020|P2|NOT COMPLETED|Overall Study||6
8475962|NCT00625872|20888021|P1|NOT COMPLETED|Overall Study||4
8475963|NCT00625872|20888020|P2|COMPLETED|Overall Study||5
8475964|NCT00625872|20888021|P1|COMPLETED|Overall Study||8
8475965|NCT00625872|20888020|P2|Treated|Overall Study||10
8475966|NCT00625872|20888021|P1|Treated|Overall Study||12
8475967|NCT00625872|20888020|P2|STARTED|Overall Study||11
8475968|NCT00625872|20888021|P1|STARTED|Overall Study||12
8475969|NCT00625846|20888135|P4|NOT COMPLETED|Overall Study||2
8475970|NCT00625846|20888136|P3|NOT COMPLETED|Overall Study||1
8475971|NCT00625846|20888137|P2|NOT COMPLETED|Overall Study||0
8475972|NCT00625846|20888138|P1|NOT COMPLETED|Overall Study||2
8475973|NCT00625846|20888135|P4|COMPLETED|Overall Study||60
8475974|NCT00625846|20888136|P3|COMPLETED|Overall Study||15
8475975|NCT00625846|20888137|P2|COMPLETED|Overall Study||35
8475976|NCT00625846|20888138|P1|COMPLETED|Overall Study||37
8475977|NCT00625846|20888135|P4|STARTED|Overall Study||62
8475978|NCT00625846|20888136|P3|STARTED|Overall Study||16
8475979|NCT00625846|20888137|P2|STARTED|Overall Study||35
8475980|NCT00625846|20888138|P1|STARTED|Overall Study||39
8475981|NCT00625820|20888164|P1|NOT COMPLETED|Overall Study||1
8475982|NCT00625820|20888164|P1|COMPLETED|Overall Study||16
8475983|NCT00625820|20888164|P1|STARTED|Overall Study||17
8475984|NCT00625807|20888172|P2|NOT COMPLETED|Overall Study||8
8475985|NCT00625807|20888173|P1|NOT COMPLETED|Overall Study||2
8475986|NCT00625807|20888172|P2|COMPLETED|Overall Study||20
8475987|NCT00625807|20888173|P1|COMPLETED|Overall Study||20
8475988|NCT00625807|20888172|P2|STARTED|Overall Study||28
8475989|NCT00625807|20888173|P1|STARTED|Overall Study||22
8475990|NCT00625742|20888189|P1|NOT COMPLETED|Overall Study||12
8475991|NCT00625742|20888189|P1|COMPLETED|Overall Study||3
8475992|NCT00625742|20888189|P1|STARTED|Overall Study||15
8475993|NCT00625729|20888194|P1|NOT COMPLETED|Overall Study||0
8475994|NCT00625729|20888194|P1|COMPLETED|Overall Study||6
8475995|NCT00625729|20888194|P1|STARTED|Overall Study||6
8475996|NCT00625703|20888203|P1|NOT COMPLETED|Overall Study||0
8475997|NCT00625703|20888203|P1|COMPLETED|Overall Study||0
8475998|NCT00625703|20888203|P1|STARTED|Overall Study||0
8475999|NCT00625586|20888208|P1|NOT COMPLETED|Overall Study||1
8476000|NCT00625586|20888208|P1|COMPLETED|Overall Study||1
8476001|NCT00625586|20888208|P1|STARTED|Overall Study||2
8476002|NCT00625443|20888221|P3|NOT COMPLETED|Overall Study||5
8476003|NCT00625443|20888222|P2|NOT COMPLETED|Overall Study||11
8476004|NCT00625443|20888223|P1|NOT COMPLETED|Overall Study||2
8476005|NCT00625443|20888221|P3|COMPLETED|Overall Study||10
8476006|NCT00625443|20888222|P2|COMPLETED|Overall Study||15
8476007|NCT00625443|20888223|P1|COMPLETED|Overall Study||10
8476008|NCT00625443|20888221|P3|STARTED|Overall Study||15
8476009|NCT00625443|20888222|P2|STARTED|Overall Study||26
8476010|NCT00625443|20888223|P1|STARTED|Overall Study||12
8476011|NCT00625404|20888253|P2|NOT COMPLETED|Overall Study||173
8476012|NCT00625404|20888254|P1|NOT COMPLETED|Overall Study||207
8476013|NCT00625404|20888253|P2|COMPLETED|Overall Study||885
8476014|NCT00625404|20888254|P1|COMPLETED|Overall Study||855
8476015|NCT00625404|20888253|P2|STARTED|Overall Study||1058
8476016|NCT00625404|20888254|P1|STARTED|Overall Study||1062
8476017|NCT00625391|20888286|P4|NOT COMPLETED|Overall Study||1
8476018|NCT00625391|20888287|P3|NOT COMPLETED|Overall Study||5
8476019|NCT00625391|20888288|P2|NOT COMPLETED|Overall Study||8
8476020|NCT00625391|20888289|P1|NOT COMPLETED|Overall Study||7
8476021|NCT00625391|20888286|P4|COMPLETED|Overall Study||37
8476022|NCT00625391|20888287|P3|COMPLETED|Overall Study||37
8476023|NCT00625391|20888288|P2|COMPLETED|Overall Study||39
8476024|NCT00625391|20888289|P1|COMPLETED|Overall Study||37
8476025|NCT00625391|20888286|P4|STARTED|Overall Study||38
8476026|NCT00625391|20888287|P3|STARTED|Overall Study||42
8476027|NCT00625391|20888288|P2|STARTED|Overall Study||47
8476028|NCT00625391|20888289|P1|STARTED|Overall Study||44
8476029|NCT00625365|20888303|P1|NOT COMPLETED|Overall Study||7
8476030|NCT00625365|20888303|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
8476031|NCT00625365|20888303|P1|STARTED|Overall Study||1060
8476032|NCT00625183|20888309|P1|NOT COMPLETED|Overall Study||1
8476033|NCT00625183|20888309|P1|COMPLETED|Overall Study||4
8476034|NCT00625183|20888309|P1|STARTED|Overall Study||5
8476035|NCT00625131|20888320|P3|NOT COMPLETED|Overall Study||5
8476036|NCT00625131|20888321|P2|NOT COMPLETED|Overall Study||2
8476037|NCT00625131|20888322|P1|NOT COMPLETED|Overall Study||4
8476038|NCT00625131|20888320|P3|COMPLETED|Overall Study||0
8476039|NCT00625131|20888321|P2|COMPLETED|Overall Study||42
8476040|NCT00625131|20888322|P1|COMPLETED|Overall Study||34
8476041|NCT00625131|20888320|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
8476042|NCT00625131|20888321|P2|STARTED|Overall Study||44
8476043|NCT00625131|20888322|P1|STARTED|Overall Study||38
8476044|NCT00624923|20888334|P2|NOT COMPLETED|Overall Study||23
8476045|NCT00624923|20888335|P1|NOT COMPLETED|Overall Study||38
8476046|NCT00624923|20888334|P2|COMPLETED|Overall Study||101
8476047|NCT00624923|20888335|P1|COMPLETED|Overall Study||89
8476048|NCT00624923|20888334|P2|STARTED|Overall Study||124
8476049|NCT00624923|20888335|P1|STARTED|Overall Study||127
8476050|NCT00624910|20888350|P3|NOT COMPLETED|Overall Study||0
8476051|NCT00624910|20888351|P2|NOT COMPLETED|Overall Study||0
8476052|NCT00624910|20888352|P1|NOT COMPLETED|Overall Study||0
8476053|NCT00624910|20888350|P3|COMPLETED|Overall Study||11
8476054|NCT00624910|20888351|P2|COMPLETED|Overall Study||15
8476055|NCT00624910|20888352|P1|COMPLETED|Overall Study||28
8476056|NCT00624910|20888350|P3|STARTED|Overall Study||11
8476057|NCT00624910|20888351|P2|STARTED|Overall Study||15
8476058|NCT00624910|20888352|P1|STARTED|Overall Study||28
8476059|NCT00624832|20888385|P4|NOT COMPLETED|Overall Study||1
8476060|NCT00624832|20888386|P3|NOT COMPLETED|Overall Study||0
8476061|NCT00624832|20888387|P2|NOT COMPLETED|Overall Study||1
8476062|NCT00624832|20888388|P1|NOT COMPLETED|Overall Study||2
8476063|NCT00624832|20888385|P4|COMPLETED|Overall Study||15
8476064|NCT00624832|20888386|P3|COMPLETED|Overall Study||10
8476065|NCT00624832|20888387|P2|COMPLETED|Overall Study||15
8476066|NCT00624832|20888388|P1|COMPLETED|Overall Study||16
8476067|NCT00624832|20888385|P4|STARTED|Overall Study||16
8476068|NCT00624832|20888386|P3|STARTED|Overall Study||10
8476069|NCT00624832|20888387|P2|STARTED|Overall Study||16
8476070|NCT00624832|20888388|P1|STARTED|Overall Study||18
8476071|NCT00624819|20888404|P4|NOT COMPLETED|Follow-up Period: Year 4||0
8476072|NCT00624819|20888405|P3|NOT COMPLETED|Follow-up Period: Year 4||1
8476073|NCT00624819|20888406|P2|NOT COMPLETED|Follow-up Period: Year 4||1
8476074|NCT00624819|20888407|P1|NOT COMPLETED|Follow-up Period: Year 4||1
8476075|NCT00624819|20888404|P4|COMPLETED|Follow-up Period: Year 4||100
8476076|NCT00624819|20888405|P3|COMPLETED|Follow-up Period: Year 4||64
8476077|NCT00624819|20888406|P2|COMPLETED|Follow-up Period: Year 4||19
8476078|NCT00624819|20888407|P1|COMPLETED|Follow-up Period: Year 4||263
8476079|NCT00624819|20888404|P4|STARTED|Follow-up Period: Year 4||100
8476080|NCT00624819|20888405|P3|STARTED|Follow-up Period: Year 4||65
8476081|NCT00624819|20888406|P2|STARTED|Follow-up Period: Year 4||20
8476082|NCT00624819|20888407|P1|STARTED|Follow-up Period: Year 4||264
8476083|NCT00624819|20888404|P4|NOT COMPLETED|Follow-up Period: Year 2||0
8476084|NCT00624819|20888405|P3|NOT COMPLETED|Follow-up Period: Year 2||0
8476085|NCT00624819|20888406|P2|NOT COMPLETED|Follow-up Period: Year 2||0
8476086|NCT00624819|20888407|P1|NOT COMPLETED|Follow-up Period: Year 2||0
8476087|NCT00624819|20888404|P4|COMPLETED|Follow-up Period: Year 2||0
8476088|NCT00624819|20888405|P3|COMPLETED|Follow-up Period: Year 2||96
8476089|NCT00624819|20888406|P2|COMPLETED|Follow-up Period: Year 2||31
8476090|NCT00624819|20888407|P1|COMPLETED|Follow-up Period: Year 2||370
8476091|NCT00624819|20888404|P4|STARTED|Follow-up Period: Year 2||0
8476092|NCT00624819|20888405|P3|STARTED|Follow-up Period: Year 2||96
8476093|NCT00624819|20888406|P2|STARTED|Follow-up Period: Year 2||31
8476094|NCT00624819|20888407|P1|STARTED|Follow-up Period: Year 2||370
8476095|NCT00624819|20888404|P4|NOT COMPLETED|Follow-up Period: Year 1||0
8476096|NCT00624819|20888405|P3|NOT COMPLETED|Follow-up Period: Year 1||0
8476097|NCT00624819|20888406|P2|NOT COMPLETED|Follow-up Period: Year 1||0
8476098|NCT00624819|20888407|P1|NOT COMPLETED|Follow-up Period: Year 1||0
8476099|NCT00624819|20888404|P4|COMPLETED|Follow-up Period: Year 1||0
8476100|NCT00624819|20888405|P3|COMPLETED|Follow-up Period: Year 1||102
8476101|NCT00624819|20888406|P2|COMPLETED|Follow-up Period: Year 1||31
8476102|NCT00624819|20888407|P1|COMPLETED|Follow-up Period: Year 1||391
8476103|NCT00624819|20888404|P4|STARTED|Follow-up Period: Year 1||0
8476104|NCT00624819|20888405|P3|STARTED|Follow-up Period: Year 1||102
8476105|NCT00624819|20888406|P2|STARTED|Follow-up Period: Year 1||31
8476106|NCT00624819|20888407|P1|STARTED|Follow-up Period: Year 1||391
8476107|NCT00624806|20888567|P2|NOT COMPLETED|Overall Study||0
8476108|NCT00624806|20888568|P1|NOT COMPLETED|Overall Study||0
8476109|NCT00624806|20888567|P2|COMPLETED|Overall Study||8
8476110|NCT00624806|20888568|P1|COMPLETED|Overall Study||10
8476111|NCT00624806|20888567|P2|STARTED|Overall Study||8
8476112|NCT00624806|20888568|P1|STARTED|Overall Study||10
8476113|NCT00624650|20888580|P2|NOT COMPLETED|Overall Study||1
8476114|NCT00624650|20888581|P1|NOT COMPLETED|Overall Study||1
8476115|NCT00624650|20888580|P2|COMPLETED|Overall Study||15
8476116|NCT00624650|20888581|P1|COMPLETED|Overall Study||16
8476117|NCT00624650|20888580|P2|STARTED|Overall Study||16
8476118|NCT00624650|20888581|P1|STARTED|Overall Study||17
8476119|NCT00624585|20888587|P1|NOT COMPLETED|Overall Study||12
8476120|NCT00624585|20888587|P1|COMPLETED|Overall Study||6
8476121|NCT00624585|20888587|P1|STARTED|Overall Study||18
8476122|NCT00624559|20888598|P4|NOT COMPLETED|Overall Study||0
8476123|NCT00624559|20888599|P3|NOT COMPLETED|Overall Study||0
8476124|NCT00624559|20888600|P2|NOT COMPLETED|Overall Study||0
8476125|NCT00624559|20888601|P1|NOT COMPLETED|Overall Study||0
8476126|NCT00624559|20888598|P4|COMPLETED|Overall Study||3
8476127|NCT00624559|20888599|P3|COMPLETED|Overall Study||3
8476128|NCT00624559|20888600|P2|COMPLETED|Overall Study||3
8476129|NCT00624559|20888601|P1|COMPLETED|Overall Study||3
8476130|NCT00624559|20888598|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
8476131|NCT00624559|20888599|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
8476132|NCT00624559|20888600|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
8476133|NCT00624559|20888601|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
8476134|NCT00624520|20888617|P2|NOT COMPLETED|Overall Study||8
8476135|NCT00624520|20888618|P1|NOT COMPLETED|Overall Study||12
8476136|NCT00624520|20888617|P2|COMPLETED|Overall Study||39
8476137|NCT00624520|20888618|P1|COMPLETED|Overall Study||44
8476138|NCT00624520|20888617|P2|STARTED|Overall Study||47
8476139|NCT00624520|20888618|P1|STARTED|Overall Study||56
8476140|NCT00624468|20888645|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
8476141|NCT00624468|20888646|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
8476142|NCT00624468|20888647|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
8476143|NCT00624468|20888648|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
8476144|NCT00624468|20888645|P4|COMPLETED|Safety Follow-up (SFU) Period||11
8476145|NCT00624468|20888646|P3|COMPLETED|Safety Follow-up (SFU) Period||11
8476146|NCT00624468|20888647|P2|COMPLETED|Safety Follow-up (SFU) Period||0
8476147|NCT00624468|20888648|P1|COMPLETED|Safety Follow-up (SFU) Period||0
8476148|NCT00624468|20888645|P4|STARTED|Safety Follow-up (SFU) Period||14
8476149|NCT00624468|20888646|P3|STARTED|Safety Follow-up (SFU) Period||13
8476150|NCT00624468|20888647|P2|STARTED|Safety Follow-up (SFU) Period||0
8476151|NCT00624468|20888648|P1|STARTED|Safety Follow-up (SFU) Period||0
8476152|NCT00624468|20888645|P4|NOT COMPLETED|Double-blind Period||0
8476153|NCT00624468|20888646|P3|NOT COMPLETED|Double-blind Period||0
8476154|NCT00624468|20888647|P2|NOT COMPLETED|Double-blind Period||13
8476155|NCT00624468|20888648|P1|NOT COMPLETED|Double-blind Period||14
8476156|NCT00624468|20888645|P4|COMPLETED|Double-blind Period||0
8476157|NCT00624468|20888646|P3|COMPLETED|Double-blind Period||0
8476158|NCT00624468|20888647|P2|COMPLETED|Double-blind Period||4
8476159|NCT00624468|20888648|P1|COMPLETED|Double-blind Period||3
8476160|NCT00624468|20888645|P4|STARTED|Double-blind Period||0
8476161|NCT00624468|20888646|P3|STARTED|Double-blind Period||0
8476162|NCT00624468|20888647|P2|STARTED|Double-blind Period||17
8476163|NCT00624468|20888648|P1|STARTED|Double-blind Period||17
8476164|NCT00624442|20888679|P5|NOT COMPLETED|Overall Study||2
8476165|NCT00624442|20888680|P4|NOT COMPLETED|Overall Study||0
8476166|NCT00624442|20888681|P3|NOT COMPLETED|Overall Study||2
8476167|NCT00624442|20888682|P2|NOT COMPLETED|Overall Study||1
8476168|NCT00624442|20888683|P1|NOT COMPLETED|Overall Study||0
8476169|NCT00624442|20888679|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
8476170|NCT00624442|20888680|P4|COMPLETED|Overall Study||8
8476171|NCT00624442|20888681|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
8476172|NCT00624442|20888682|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
8476173|NCT00624442|20888683|P1|COMPLETED|Overall Study||8
8476174|NCT00624442|20888679|P5|STARTED|Overall Study||10
8476175|NCT00624442|20888680|P4|STARTED|Overall Study||8
8476176|NCT00624442|20888681|P3|STARTED|Overall Study||10
8476177|NCT00624442|20888682|P2|STARTED|Overall Study||9
8476178|NCT00624442|20888683|P1|STARTED|Overall Study||8
8476179|NCT00624416|20888709|P1|NOT COMPLETED|Overall Study||0
8476180|NCT00624416|20888709|P1|COMPLETED|Overall Study||10
8476181|NCT00624416|20888709|P1|STARTED|Overall Study||10
8476182|NCT00624377|20888715|P1|NOT COMPLETED|Overall Study||644
8476183|NCT00624377|20888715|P1|COMPLETED|Overall Study||1387
8476184|NCT00624377|20888715|P1|STARTED|Overall Study||2031
8476185|NCT00624338|20888729|P3|NOT COMPLETED|Overall Study||46
8476186|NCT00624338|20888730|P2|NOT COMPLETED|Overall Study||83
8476187|NCT00624338|20888731|P1|NOT COMPLETED|Overall Study||47
8476188|NCT00624338|20888729|P3|COMPLETED|Overall Study||111
8476189|NCT00624338|20888730|P2|COMPLETED|Overall Study||62
8476190|NCT00624338|20888731|P1|COMPLETED|Overall Study||112
8476191|NCT00624338|20888729|P3|Treated|Overall Study||154
8476192|NCT00624338|20888730|P2|Treated|Overall Study||144
8476193|NCT00624338|20888731|P1|Treated|Overall Study||157
8476194|NCT00624338|20888729|P3|STARTED|Overall Study||157
8476195|NCT00624338|20888730|P2|STARTED|Overall Study||145
8476196|NCT00624338|20888731|P1|STARTED|Overall Study||159
8476197|NCT00624286|20888753|P2|NOT COMPLETED|Overall Study||27
8476198|NCT00624286|20888754|P1|NOT COMPLETED|Overall Study||25
8476199|NCT00624286|20888753|P2|COMPLETED|Overall Study||178
8476200|NCT00624286|20888754|P1|COMPLETED|Overall Study||186
8476201|NCT00624286|20888753|P2|STARTED|Overall Study||205
8476202|NCT00624286|20888754|P1|STARTED|Overall Study||211
8476203|NCT00624221|20888764|P2|NOT COMPLETED|Overall Study||0
8476204|NCT00624221|20888765|P1|NOT COMPLETED|Overall Study||0
8476205|NCT00624221|20888764|P2|COMPLETED|Overall Study||20
8476206|NCT00624221|20888765|P1|COMPLETED|Overall Study||20
8476207|NCT00624221|20888764|P2|STARTED|Overall Study||20
8476208|NCT00624221|20888765|P1|STARTED|Overall Study||20
8476209|NCT00624195|20888773|P2|NOT COMPLETED|Overall Study||7
8476210|NCT00624195|20888774|P1|NOT COMPLETED|Overall Study||3
8476211|NCT00624195|20888773|P2|COMPLETED|Overall Study||23
8476212|NCT00624195|20888774|P1|COMPLETED|Overall Study||26
8476213|NCT00624195|20888773|P2|STARTED|Overall Study||30
8476214|NCT00624195|20888774|P1|STARTED|Overall Study||29
8476215|NCT00624065|20888782|P2|NOT COMPLETED|Overall Study||24
8476216|NCT00624065|20888783|P1|NOT COMPLETED|Overall Study||19
8476217|NCT00624065|20888782|P2|COMPLETED|Overall Study||192
8476218|NCT00624065|20888783|P1|COMPLETED|Overall Study||197
8476219|NCT00624065|20888782|P2|STARTED|Overall Study||216
8476220|NCT00624065|20888783|P1|STARTED|Overall Study||216
8476221|NCT00624052|20888795|P4|NOT COMPLETED|Overall Study||4
8476222|NCT00624052|20888796|P3|NOT COMPLETED|Overall Study||3
8476223|NCT00624052|20888797|P2|NOT COMPLETED|Overall Study||14
8476224|NCT00624052|20888798|P1|NOT COMPLETED|Overall Study||15
8476225|NCT00624052|20888795|P4|COMPLETED|Overall Study||88
8476226|NCT00624052|20888796|P3|COMPLETED|Overall Study||88
8476227|NCT00624052|20888797|P2|COMPLETED|Overall Study||422
8476228|NCT00624052|20888798|P1|COMPLETED|Overall Study||204
8476229|NCT00624052|20888795|P4|STARTED|Overall Study||92
8476230|NCT00624052|20888796|P3|STARTED|Overall Study||91
8476231|NCT00624052|20888797|P2|STARTED|Overall Study||436
8476232|NCT00624052|20888798|P1|STARTED|Overall Study||219
8476233|NCT00624013|20888849|P2|NOT COMPLETED|Overall Study||6
8476234|NCT00624013|20888850|P1|NOT COMPLETED|Overall Study||8
8476235|NCT00624013|20888849|P2|COMPLETED|Overall Study||39
8476236|NCT00624013|20888850|P1|COMPLETED|Overall Study||36
8476237|NCT00624013|20888849|P2|STARTED|Overall Study||45
8476238|NCT00624013|20888850|P1|STARTED|Overall Study||44
8476239|NCT00623974|20888862|P4|NOT COMPLETED|Overall Study||0
8476240|NCT00623974|20888863|P3|NOT COMPLETED|Overall Study||0
8476241|NCT00623974|20888864|P2|NOT COMPLETED|Overall Study||0
8476242|NCT00623974|20888865|P1|NOT COMPLETED|Overall Study||0
8476243|NCT00623974|20888862|P4|COMPLETED|Overall Study||0
8476244|NCT00623974|20888863|P3|COMPLETED|Overall Study||0
8476245|NCT00623974|20888864|P2|COMPLETED|Overall Study||0
8476246|NCT00623974|20888865|P1|COMPLETED|Overall Study||0
8476247|NCT00623974|20888862|P4|STARTED|Overall Study||0
8476248|NCT00623974|20888863|P3|STARTED|Overall Study||0
8476249|NCT00623974|20888864|P2|STARTED|Overall Study||0
8476250|NCT00623974|20888865|P1|STARTED|Overall Study||0
8476251|NCT00623935|20888875|P1|NOT COMPLETED|Overall Study||2
8476252|NCT00623935|20888875|P1|COMPLETED|Overall Study||54
8476253|NCT00623935|20888875|P1|STARTED|Overall Study||56
8476254|NCT00623831|20888882|P2|NOT COMPLETED|Overall Study||1
8476255|NCT00623831|20888883|P1|NOT COMPLETED|Overall Study||1
8476256|NCT00623831|20888882|P2|COMPLETED|Overall Study||3
8476257|NCT00623831|20888883|P1|COMPLETED|Overall Study||12
8476258|NCT00623831|20888882|P2|STARTED|Overall Study||4
8476259|NCT00623831|20888883|P1|STARTED|Overall Study||13
8476260|NCT00623805|20888895|P2|NOT COMPLETED|Overall Study||22
8476261|NCT00623805|20888896|P1|NOT COMPLETED|Overall Study||20
8476262|NCT00623805|20888895|P2|COMPLETED|Overall Study||39
8476263|NCT00623805|20888896|P1|COMPLETED|Overall Study||42
8476264|NCT00623805|20888895|P2|STARTED|Overall Study||61
8476265|NCT00623805|20888896|P1|STARTED|Overall Study||62
8476266|NCT00623779|20888913|P3|NOT COMPLETED|Overall Study||1
8476267|NCT00623779|20888914|P2|NOT COMPLETED|Overall Study||3
8476268|NCT00623779|20888915|P1|NOT COMPLETED|Overall Study||3
8476269|NCT00623779|20888913|P3|COMPLETED|Overall Study||44
8476270|NCT00623779|20888914|P2|COMPLETED|Overall Study||39
8476271|NCT00623779|20888915|P1|COMPLETED|Overall Study||38
8476272|NCT00623779|20888913|P3|STARTED|Overall Study||45
8476273|NCT00623779|20888914|P2|STARTED|Overall Study||42
8476274|NCT00623779|20888915|P1|STARTED|Overall Study||41
8476275|NCT00623766|20888964|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
8476276|NCT00623766|20888965|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
8476277|NCT00623766|20888964|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
8476278|NCT00623766|20888965|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
8476279|NCT00623766|20888964|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
8476280|NCT00623766|20888965|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
8476281|NCT00623766|20888964|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
8476282|NCT00623766|20888965|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
8476283|NCT00623766|20888964|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
8476284|NCT00623766|20888965|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
8476285|NCT00623766|20888964|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
8476286|NCT00623766|20888965|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
8476287|NCT00623727|20888989|P2|NOT COMPLETED|Open Label Extension Period||0
8476288|NCT00623727|20888990|P1|NOT COMPLETED|Open Label Extension Period||0
8476289|NCT00623727|20888989|P2|COMPLETED|Open Label Extension Period||0
8476290|NCT00623727|20888990|P1|COMPLETED|Open Label Extension Period||20
8476291|NCT00623727|20888989|P2|STARTED|Open Label Extension Period||0
8476292|NCT00623727|20888990|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
8476293|NCT00623727|20888989|P2|NOT COMPLETED|Open Label Follow-up||8
8476294|NCT00623727|20888990|P1|NOT COMPLETED|Open Label Follow-up||0
8476295|NCT00623727|20888989|P2|COMPLETED|Open Label Follow-up||18
8476296|NCT00623727|20888990|P1|COMPLETED|Open Label Follow-up||0
8476297|NCT00623727|20888989|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
8476298|NCT00623727|20888990|P1|STARTED|Open Label Follow-up||0
8476299|NCT00623727|20888989|P2|NOT COMPLETED|Double Blind (DB)||32
8476300|NCT00623727|20888990|P1|NOT COMPLETED|Double Blind (DB)||36
8476301|NCT00623727|20888989|P2|COMPLETED|Double Blind (DB)||41
8476302|NCT00623727|20888990|P1|COMPLETED|Double Blind (DB)||34
8476303|NCT00623727|20888989|P2|Participants Received Treatment|Double Blind (DB)||72
8476304|NCT00623727|20888990|P1|Participants Received Treatment|Double Blind (DB)||67
8476305|NCT00623727|20888989|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
8476306|NCT00623727|20888990|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
8476307|NCT00623714|20889010|P2|NOT COMPLETED|Period 2||0
8476308|NCT00623714|20889011|P1|NOT COMPLETED|Period 2||0
8476309|NCT00623714|20889010|P2|COMPLETED|Period 2||7
8476310|NCT00623714|20889011|P1|COMPLETED|Period 2||6
8476311|NCT00623714|20889010|P2|STARTED|Period 2||7
8476312|NCT00623714|20889011|P1|STARTED|Period 2||6
8476313|NCT00623714|20889010|P2|NOT COMPLETED|Period 1||0
8476314|NCT00623714|20889011|P1|NOT COMPLETED|Period 1||0
8476315|NCT00623714|20889010|P2|COMPLETED|Period 1||7
8476316|NCT00623714|20889011|P1|COMPLETED|Period 1||6
8476317|NCT00623714|20889010|P2|STARTED|Period 1||7
8476318|NCT00623714|20889011|P1|STARTED|Period 1||6
8476319|NCT00623636|20889021|P2|NOT COMPLETED|Open Label||412
8476320|NCT00623636|20889022|P1|NOT COMPLETED|Open Label||0
8476321|NCT00623636|20889021|P2|COMPLETED|Open Label||263
8476322|NCT00623636|20889022|P1|COMPLETED|Open Label||0
8476323|NCT00623636|20889021|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
8476324|NCT00623636|20889022|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
8476325|NCT00623636|20889021|P2|NOT COMPLETED|Double Blind||28
8476326|NCT00623636|20889022|P1|NOT COMPLETED|Double Blind||33
8476327|NCT00623636|20889021|P2|COMPLETED|Double Blind||422
8476328|NCT00623636|20889022|P1|COMPLETED|Double Blind||419
8476329|NCT00623636|20889021|P2|STARTED|Double Blind||450
8476330|NCT00623636|20889022|P1|STARTED|Double Blind||452
8476331|NCT00623623|20889045|P2|NOT COMPLETED|Overall Study||1
8476332|NCT00623623|20889046|P1|NOT COMPLETED|Overall Study||1
8476333|NCT00623623|20889045|P2|COMPLETED|Overall Study||948
8476334|NCT00623623|20889046|P1|COMPLETED|Overall Study||949
8476335|NCT00623623|20889045|P2|STARTED|Overall Study||949
8476336|NCT00623623|20889046|P1|STARTED|Overall Study||950
8476337|NCT00623597|20889102|P2|NOT COMPLETED|Overall Study||0
8476338|NCT00623597|20889103|P1|NOT COMPLETED|Overall Study||1
8476339|NCT00623597|20889102|P2|COMPLETED|Overall Study||13
8476340|NCT00623597|20889103|P1|COMPLETED|Overall Study||4
8476341|NCT00623597|20889102|P2|STARTED|Overall Study||13
8476342|NCT00623597|20889103|P1|STARTED|Overall Study||5
8476343|NCT00623545|20889166|P1|NOT COMPLETED|Overall Study||10
8476344|NCT00623545|20889166|P1|COMPLETED|Overall Study||18
8476345|NCT00623545|20889166|P1|STARTED|Overall Study||28
8476346|NCT00623506|20889173|P2|NOT COMPLETED|Overall Study||4
8476347|NCT00623506|20889174|P1|NOT COMPLETED|Overall Study||4
8476348|NCT00623506|20889173|P2|COMPLETED|Overall Study||11
8476349|NCT00623506|20889174|P1|COMPLETED|Overall Study||11
8476350|NCT00623506|20889173|P2|Week 4|Overall Study||11
8476351|NCT00623506|20889174|P1|Week 4|Overall Study||11
8476352|NCT00623506|20889173|P2|STARTED|Overall Study||15
8476353|NCT00623506|20889174|P1|STARTED|Overall Study||15
8476354|NCT00623480|20889186|P2|NOT COMPLETED|Overall Study||7
8476355|NCT00623480|20889187|P1|NOT COMPLETED|Overall Study||7
8476356|NCT00623480|20889186|P2|COMPLETED|Overall Study||35
8476357|NCT00623480|20889187|P1|COMPLETED|Overall Study||35
8476358|NCT00623480|20889186|P2|STARTED|Overall Study||42
8476359|NCT00623480|20889187|P1|STARTED|Overall Study||42
8476360|NCT00623467|20889199|P1|NOT COMPLETED|Overall Study||7
8476361|NCT00623467|20889199|P1|COMPLETED|Overall Study||336
8476362|NCT00623467|20889199|P1|STARTED|Overall Study||343
8476363|NCT00623441|20889263|P1|NOT COMPLETED|Overall Study||0
8476364|NCT00623441|20889263|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
8476365|NCT00623441|20889263|P1|STARTED|Overall Study||8314
8476366|NCT00623428|20889269|P2|NOT COMPLETED|Follow-up Period||15
8476367|NCT00623428|20889270|P1|NOT COMPLETED|Follow-up Period||29
8476368|NCT00623428|20889269|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
8476369|NCT00623428|20889270|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
8476370|NCT00623428|20889269|P2|STARTED|Follow-up Period||93
8476371|NCT00623428|20889270|P1|STARTED|Follow-up Period||95
8476372|NCT00623428|20889269|P2|NOT COMPLETED|Treatment Period||27
8476373|NCT00623428|20889270|P1|NOT COMPLETED|Treatment Period||0
8476374|NCT00623428|20889269|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
8476375|NCT00623428|20889270|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
8476376|NCT00623428|20889269|P2|STARTED|Treatment Period||93
8476377|NCT00623428|20889270|P1|STARTED|Treatment Period||95
8476378|NCT00623233|20889288|P1|NOT COMPLETED|Overall Study||24
8476379|NCT00623233|20889288|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
8476380|NCT00623233|20889288|P1|STARTED|Overall Study||52
8476381|NCT00623194|20889295|P1|NOT COMPLETED|Overall Study||5
8476382|NCT00623194|20889295|P1|COMPLETED|Overall Study||141
8476383|NCT00623194|20889295|P1|STARTED|Overall Study||146
8476384|NCT00623181|20889317|P2|NOT COMPLETED|Overall Study||0
8476385|NCT00623181|20889318|P1|NOT COMPLETED|Overall Study||0
8476386|NCT00623181|20889317|P2|COMPLETED|Overall Study||54
8476387|NCT00623181|20889318|P1|COMPLETED|Overall Study||56
8476388|NCT00623181|20889317|P2|STARTED|Overall Study||54
8476389|NCT00623181|20889318|P1|STARTED|Overall Study||56
8476390|NCT00623103|20889332|P2|NOT COMPLETED|Overall Study||113
8476391|NCT00623103|20889333|P1|NOT COMPLETED|Overall Study||111
8476392|NCT00623103|20889332|P2|COMPLETED|Overall Study||175
8476393|NCT00623103|20889333|P1|COMPLETED|Overall Study||184
8476394|NCT00623103|20889332|P2|Safety Set: Received Study Drug|Overall Study||288
8476395|NCT00623103|20889333|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
8476396|NCT00623103|20889332|P2|STARTED|Overall Study||288
8476397|NCT00623103|20889333|P1|STARTED|Overall Study||295
8476398|NCT00623012|20889353|P1|NOT COMPLETED|Overall Study||0
8476399|NCT00623012|20889353|P1|COMPLETED|Overall Study||2
8476400|NCT00623012|20889353|P1|STARTED|Overall Study||2
8476401|NCT00622908|20889361|P2|NOT COMPLETED|Overall Study||10
8476402|NCT00622908|20889362|P1|NOT COMPLETED|Overall Study||3
8476403|NCT00622908|20889361|P2|COMPLETED|Overall Study||122
8476404|NCT00622908|20889362|P1|COMPLETED|Overall Study||134
8476405|NCT00622908|20889361|P2|STARTED|Overall Study|Intent to treat population|132
8476406|NCT00622908|20889362|P1|STARTED|Overall Study|Intent to treat population|137
8476407|NCT00622895|20889374|P1|NOT COMPLETED|Overall Study||0
8476408|NCT00622895|20889374|P1|COMPLETED|Overall Study||3
8476409|NCT00622895|20889374|P1|STARTED|Overall Study||3
8476410|NCT00622869|20889392|P3|NOT COMPLETED|Overall Study||39
8476411|NCT00622869|20889393|P2|NOT COMPLETED|Overall Study||57
8476412|NCT00622869|20889394|P1|NOT COMPLETED|Overall Study||43
8476413|NCT00622869|20889392|P3|COMPLETED|Overall Study||204
8476414|NCT00622869|20889393|P2|COMPLETED|Overall Study||174
8476415|NCT00622869|20889394|P1|COMPLETED|Overall Study||202
8476416|NCT00622869|20889392|P3|STARTED|Overall Study||243
8476417|NCT00622869|20889393|P2|STARTED|Overall Study||231
8476418|NCT00622869|20889394|P1|STARTED|Overall Study||245
8476419|NCT00622739|20889413|P2|NOT COMPLETED|Overall Study||6
8476420|NCT00622739|20889414|P1|NOT COMPLETED|Overall Study||2
8476421|NCT00622739|20889413|P2|COMPLETED|Overall Study||9
8476422|NCT00622739|20889414|P1|COMPLETED|Overall Study||11
8476423|NCT00622739|20889413|P2|STARTED|Overall Study||15
8476424|NCT00622739|20889414|P1|STARTED|Overall Study||13
8476425|NCT00622726|20889432|P2|NOT COMPLETED|August, 2010 to April, 2013||5
8476426|NCT00622726|20889433|P1|NOT COMPLETED|August, 2010 to April, 2013||1
8476427|NCT00622726|20889432|P2|COMPLETED|August, 2010 to April, 2013||68
8476428|NCT00622726|20889433|P1|COMPLETED|August, 2010 to April, 2013||69
8476429|NCT00622726|20889432|P2|STARTED|August, 2010 to April, 2013||73
8476430|NCT00622726|20889433|P1|STARTED|August, 2010 to April, 2013||70
8476431|NCT00622726|20889432|P2|NOT COMPLETED|March, 2008 to August, 2010||2
8476432|NCT00622726|20889433|P1|NOT COMPLETED|March, 2008 to August, 2010||5
8476433|NCT00622726|20889432|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
8476434|NCT00622726|20889433|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
8476435|NCT00622726|20889432|P2|STARTED|March, 2008 to August, 2010||75
8476436|NCT00622726|20889433|P1|STARTED|March, 2008 to August, 2010||75
8476437|NCT00622713|20889443|P1|NOT COMPLETED|Overall Study||59
8476438|NCT00622713|20889443|P1|COMPLETED|Overall Study||169
8476439|NCT00622713|20889443|P1|Intent to Treat (ITT) Population|Overall Study||218
8476440|NCT00622713|20889443|P1|Exposed to Study Drug|Overall Study||226
8476441|NCT00622713|20889443|P1|STARTED|Overall Study||228
8476442|NCT00622700|20889454|P7|NOT COMPLETED|Extension Treatment Period||30
8476443|NCT00622700|20889455|P6|NOT COMPLETED|Extension Treatment Period||17
8476444|NCT00622700|20889456|P5|NOT COMPLETED|Extension Treatment Period||39
8476445|NCT00622700|20889457|P4|NOT COMPLETED|Extension Treatment Period||21
8476446|NCT00622700|20889458|P3|NOT COMPLETED|Extension Treatment Period||0
8476447|NCT00622700|20889459|P2|NOT COMPLETED|Extension Treatment Period||0
8476448|NCT00622700|20889460|P1|NOT COMPLETED|Extension Treatment Period||0
8476449|NCT00622700|20889454|P7|COMPLETED|Extension Treatment Period||120
8476450|NCT00622700|20889455|P6|COMPLETED|Extension Treatment Period||50
8476451|NCT00622700|20889456|P5|COMPLETED|Extension Treatment Period||103
8476452|NCT00622700|20889457|P4|COMPLETED|Extension Treatment Period||43
8476453|NCT00622700|20889458|P3|COMPLETED|Extension Treatment Period||0
8476454|NCT00622700|20889459|P2|COMPLETED|Extension Treatment Period||0
8476455|NCT00622700|20889460|P1|COMPLETED|Extension Treatment Period||0
8476456|NCT00622700|20889454|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
8476457|NCT00622700|20889455|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
8476458|NCT00622700|20889456|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
8476459|NCT00622700|20889457|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
8476460|NCT00622700|20889458|P3|STARTED|Extension Treatment Period||0
8476461|NCT00622700|20889459|P2|STARTED|Extension Treatment Period||0
8476462|NCT00622700|20889460|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
8476463|NCT00622700|20889454|P7|NOT COMPLETED|Core Treatment Period||0
8476464|NCT00622700|20889455|P6|NOT COMPLETED|Core Treatment Period||0
8476465|NCT00622700|20889456|P5|NOT COMPLETED|Core Treatment Period||0
8476466|NCT00622700|20889457|P4|NOT COMPLETED|Core Treatment Period||0
8476467|NCT00622700|20889458|P3|NOT COMPLETED|Core Treatment Period||53
8476468|NCT00622700|20889459|P2|NOT COMPLETED|Core Treatment Period||55
8476469|NCT00622700|20889460|P1|NOT COMPLETED|Core Treatment Period||56
8476470|NCT00622700|20889454|P7|COMPLETED|Core Treatment Period||0
8476471|NCT00622700|20889455|P6|COMPLETED|Core Treatment Period||0
8476472|NCT00622700|20889456|P5|COMPLETED|Core Treatment Period||0
8476473|NCT00622700|20889457|P4|COMPLETED|Core Treatment Period||0
8476474|NCT00622700|20889458|P3|COMPLETED|Core Treatment Period||163
8476475|NCT00622700|20889459|P2|COMPLETED|Core Treatment Period||150
8476476|NCT00622700|20889460|P1|COMPLETED|Core Treatment Period||141
8476477|NCT00622700|20889454|P7|Treated|Core Treatment Period||0
8476478|NCT00622700|20889455|P6|Treated|Core Treatment Period||0
8476479|NCT00622700|20889456|P5|Treated|Core Treatment Period||0
8476480|NCT00622700|20889457|P4|Treated|Core Treatment Period||0
8476481|NCT00622700|20889458|P3|Treated|Core Treatment Period||214
8476482|NCT00622700|20889459|P2|Treated|Core Treatment Period||203
8476483|NCT00622700|20889460|P1|Treated|Core Treatment Period||197
8476484|NCT00622700|20889454|P7|STARTED|Core Treatment Period||0
8476485|NCT00622700|20889455|P6|STARTED|Core Treatment Period||0
8476486|NCT00622700|20889456|P5|STARTED|Core Treatment Period||0
8476487|NCT00622700|20889457|P4|STARTED|Core Treatment Period||0
8476488|NCT00622700|20889458|P3|STARTED|Core Treatment Period||216
8476489|NCT00622700|20889459|P2|STARTED|Core Treatment Period||205
8476490|NCT00622700|20889460|P1|STARTED|Core Treatment Period||197
8476491|NCT00622635|20889519|P6|NOT COMPLETED|Treatment Period 3||0
8476492|NCT00622635|20889520|P5|NOT COMPLETED|Treatment Period 3||0
8476493|NCT00622635|20889521|P4|NOT COMPLETED|Treatment Period 3||3
8476494|NCT00622635|20889522|P3|NOT COMPLETED|Treatment Period 3||0
8476495|NCT00622635|20889523|P2|NOT COMPLETED|Treatment Period 3||0
8476496|NCT00622635|20889524|P1|NOT COMPLETED|Treatment Period 3||0
8476497|NCT00622635|20889519|P6|COMPLETED|Treatment Period 3||10
8476498|NCT00622635|20889520|P5|COMPLETED|Treatment Period 3||9
8476499|NCT00622635|20889521|P4|COMPLETED|Treatment Period 3||10
8476500|NCT00622635|20889522|P3|COMPLETED|Treatment Period 3||10
8476501|NCT00622635|20889523|P2|COMPLETED|Treatment Period 3||10
8476502|NCT00622635|20889524|P1|COMPLETED|Treatment Period 3||12
8476503|NCT00622635|20889519|P6|STARTED|Treatment Period 3||10
8476504|NCT00622635|20889520|P5|STARTED|Treatment Period 3||9
8476505|NCT00622635|20889521|P4|STARTED|Treatment Period 3||13
8476506|NCT00622635|20889522|P3|STARTED|Treatment Period 3||10
8476507|NCT00622635|20889523|P2|STARTED|Treatment Period 3||10
8476508|NCT00622635|20889524|P1|STARTED|Treatment Period 3||12
8476509|NCT00622635|20889519|P6|NOT COMPLETED|Treatment Period 2||0
8476510|NCT00622635|20889520|P5|NOT COMPLETED|Treatment Period 2||0
8476511|NCT00622635|20889521|P4|NOT COMPLETED|Treatment Period 2||0
8476512|NCT00622635|20889522|P3|NOT COMPLETED|Treatment Period 2||0
8476513|NCT00622635|20889523|P2|NOT COMPLETED|Treatment Period 2||0
8476514|NCT00622635|20889524|P1|NOT COMPLETED|Treatment Period 2||1
8476515|NCT00622635|20889519|P6|COMPLETED|Treatment Period 2||10
8476516|NCT00622635|20889520|P5|COMPLETED|Treatment Period 2||9
8476517|NCT00622635|20889521|P4|COMPLETED|Treatment Period 2||13
8476518|NCT00622635|20889522|P3|COMPLETED|Treatment Period 2||10
8476519|NCT00622635|20889523|P2|COMPLETED|Treatment Period 2||10
8476520|NCT00622635|20889524|P1|COMPLETED|Treatment Period 2||12
8476521|NCT00622635|20889519|P6|STARTED|Treatment Period 2||10
8476522|NCT00622635|20889520|P5|STARTED|Treatment Period 2||9
8476523|NCT00622635|20889521|P4|STARTED|Treatment Period 2||13
8476524|NCT00622635|20889522|P3|STARTED|Treatment Period 2||10
8476525|NCT00622635|20889523|P2|STARTED|Treatment Period 2||10
8476526|NCT00622635|20889524|P1|STARTED|Treatment Period 2||13
8476527|NCT00622635|20889519|P6|NOT COMPLETED|Treatment Period 1||0
8476528|NCT00622635|20889520|P5|NOT COMPLETED|Treatment Period 1||1
8476529|NCT00622635|20889521|P4|NOT COMPLETED|Treatment Period 1||0
8476530|NCT00622635|20889522|P3|NOT COMPLETED|Treatment Period 1||1
8476531|NCT00622635|20889523|P2|NOT COMPLETED|Treatment Period 1||1
8476532|NCT00622635|20889524|P1|NOT COMPLETED|Treatment Period 1||0
8476533|NCT00622635|20889519|P6|COMPLETED|Treatment Period 1||10
8476534|NCT00622635|20889520|P5|COMPLETED|Treatment Period 1||9
8476535|NCT00622635|20889521|P4|COMPLETED|Treatment Period 1||13
8476536|NCT00622635|20889522|P3|COMPLETED|Treatment Period 1||10
8476537|NCT00622635|20889523|P2|COMPLETED|Treatment Period 1||10
8476538|NCT00622635|20889524|P1|COMPLETED|Treatment Period 1||13
8476539|NCT00622635|20889519|P6|STARTED|Treatment Period 1||10
8476540|NCT00622635|20889520|P5|STARTED|Treatment Period 1||10
8476541|NCT00622635|20889521|P4|STARTED|Treatment Period 1||13
8476542|NCT00622635|20889522|P3|STARTED|Treatment Period 1||11
8476543|NCT00622635|20889523|P2|STARTED|Treatment Period 1||11
8476544|NCT00622635|20889524|P1|STARTED|Treatment Period 1||13
8476545|NCT00622544|20889589|P1|NOT COMPLETED|Overall Study||9
8476546|NCT00622544|20889589|P1|COMPLETED|Overall Study|35|35
8476547|NCT00622544|20889589|P1|STARTED|Overall Study||44
8476548|NCT00622518|20889596|P2|NOT COMPLETED|Overall Study||0
8476549|NCT00622518|20889597|P1|NOT COMPLETED|Overall Study||0
8476550|NCT00622518|20889596|P2|COMPLETED|Overall Study||60
8476551|NCT00622518|20889597|P1|COMPLETED|Overall Study||59
8476552|NCT00622518|20889596|P2|STARTED|Overall Study||60
8476553|NCT00622518|20889597|P1|STARTED|Overall Study||59
8476554|NCT00622466|20889605|P1|NOT COMPLETED|Overall Study||4
8476555|NCT00622466|20889605|P1|COMPLETED|Overall Study||16
8476556|NCT00622466|20889605|P1|STARTED|Overall Study||20
8476557|NCT00622440|20889618|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
8476558|NCT00622440|20889619|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
8476559|NCT00622440|20889618|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
8476560|NCT00622440|20889619|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
8476561|NCT00622440|20889618|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
8476562|NCT00622440|20889619|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
8476563|NCT00622440|20889618|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
8476564|NCT00622440|20889619|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
8476565|NCT00622440|20889618|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
8476566|NCT00622440|20889619|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
8476567|NCT00622440|20889618|P2|STARTED|Week 12 - Week 48 (Treatment)||34
8476568|NCT00622440|20889619|P1|STARTED|Week 12 - Week 48 (Treatment)||31
8476569|NCT00622440|20889618|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
8476570|NCT00622440|20889619|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
8476571|NCT00622440|20889618|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
8476572|NCT00622440|20889619|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
8476573|NCT00622440|20889618|P2|STARTED|Baseline - Week 12 (Treatment)||35
8476574|NCT00622440|20889619|P1|STARTED|Baseline - Week 12 (Treatment)||35
8476575|NCT00622427|20889633|P2|NOT COMPLETED|Overall Study||0
8476576|NCT00622427|20889634|P1|NOT COMPLETED|Overall Study||0
8476577|NCT00622427|20889633|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
8476578|NCT00622427|20889634|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
8476579|NCT00622427|20889633|P2|STARTED|Overall Study||16
8476580|NCT00622427|20889634|P1|STARTED|Overall Study||16
8476581|NCT00622401|20889645|P3|NOT COMPLETED|Overall Study||0
8476582|NCT00622401|20889646|P2|NOT COMPLETED|Overall Study||2
8476583|NCT00622401|20889647|P1|NOT COMPLETED|Overall Study||3
8476584|NCT00622401|20889645|P3|COMPLETED|Overall Study||0
8476585|NCT00622401|20889646|P2|COMPLETED|Overall Study||0
8476586|NCT00622401|20889647|P1|COMPLETED|Overall Study||3
8476587|NCT00622401|20889645|P3|STARTED|Overall Study|Never Opened|0
8476588|NCT00622401|20889646|P2|STARTED|Overall Study||2
8476589|NCT00622401|20889647|P1|STARTED|Overall Study||6
8476590|NCT00622388|20889654|P1|NOT COMPLETED|Overall Study||72
8476591|NCT00622388|20889654|P1|COMPLETED|Overall Study||9
8476592|NCT00622388|20889654|P1|STARTED|Overall Study||81
8476593|NCT00622336|20889672|P1|NOT COMPLETED|Extension Phase||21
8476594|NCT00622336|20889672|P1|COMPLETED|Extension Phase||0
8476595|NCT00622336|20889672|P1|STARTED|Extension Phase||21
8476596|NCT00622336|20889672|P1|NOT COMPLETED|Treatment Phase||309
8476597|NCT00622336|20889672|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
8476598|NCT00622336|20889672|P1|Safety Population|Treatment Phase||330
8476599|NCT00622336|20889672|P1|STARTED|Treatment Phase||330
8476600|NCT00622284|20889683|P2|NOT COMPLETED|Overall Study||171
8476601|NCT00622284|20889684|P1|NOT COMPLETED|Overall Study||189
8476602|NCT00622284|20889683|P2|COMPLETED|Overall Study|Number who completed treatment.|604
8476603|NCT00622284|20889684|P1|COMPLETED|Overall Study|Number who completed treatment.|587
8476604|NCT00622284|20889683|P2|STARTED|Overall Study|Number who started treatment.|775
8476605|NCT00622284|20889684|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
8476606|NCT00622180|20889746|P2|NOT COMPLETED|Overall Study||2
8476607|NCT00622180|20889747|P1|NOT COMPLETED|Overall Study||1
8476608|NCT00622180|20889746|P2|COMPLETED|Overall Study||5
8476609|NCT00622180|20889747|P1|COMPLETED|Overall Study||5
8476610|NCT00622180|20889746|P2|STARTED|Overall Study||7
8476611|NCT00622180|20889747|P1|STARTED|Overall Study||6
8476612|NCT00622167|20889753|P1|NOT COMPLETED|Overall Study||20
8476613|NCT00622167|20889753|P1|COMPLETED|Overall Study||4
8476614|NCT00622167|20889753|P1|STARTED|Overall Study||24
8476615|NCT00621985|20889757|P1|NOT COMPLETED|Dexamethasone Admission||1
8476616|NCT00621985|20889757|P1|COMPLETED|Dexamethasone Admission||4
8476617|NCT00621985|20889757|P1|STARTED|Dexamethasone Admission||5
8476618|NCT00621985|20889757|P1|NOT COMPLETED|Hydrocortisone Admission||0
8476619|NCT00621985|20889757|P1|COMPLETED|Hydrocortisone Admission||5
8476620|NCT00621985|20889757|P1|STARTED|Hydrocortisone Admission||5
8476621|NCT00621959|20889765|P2|NOT COMPLETED|Overall Study||9
8476622|NCT00621959|20889766|P1|NOT COMPLETED|Overall Study||7
8476623|NCT00621959|20889765|P2|COMPLETED|Overall Study||292
8476624|NCT00621959|20889766|P1|COMPLETED|Overall Study||288
8476625|NCT00621959|20889765|P2|STARTED|Overall Study||301
8476626|NCT00621959|20889766|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
8476627|NCT00621946|20889776|P2|NOT COMPLETED|Overall Study||1
8476628|NCT00621946|20889777|P1|NOT COMPLETED|Overall Study||0
8476629|NCT00621946|20889776|P2|COMPLETED|Overall Study||12
8476630|NCT00621946|20889777|P1|COMPLETED|Overall Study||13
8476631|NCT00621946|20889776|P2|STARTED|Overall Study||13
8476632|NCT00621946|20889777|P1|STARTED|Overall Study||13
8476633|NCT00621933|20889793|P1|NOT COMPLETED|Overall Study||0
8476634|NCT00621933|20889793|P1|COMPLETED|Overall Study||399
8476635|NCT00621933|20889793|P1|STARTED|Overall Study||399
8476636|NCT00621855|20889805|P5|NOT COMPLETED|Overall Study||55
8476637|NCT00621855|20889806|P4|NOT COMPLETED|Overall Study||67
8476638|NCT00621855|20889807|P3|NOT COMPLETED|Overall Study||81
8476639|NCT00621855|20889808|P2|NOT COMPLETED|Overall Study||61
8476640|NCT00621855|20889809|P1|NOT COMPLETED|Overall Study||76
8476641|NCT00621855|20889805|P5|COMPLETED|Overall Study|Completed means completed treatment|318
8476642|NCT00621855|20889806|P4|COMPLETED|Overall Study|Completed means completed treatment|284
8476643|NCT00621855|20889807|P3|COMPLETED|Overall Study|Completed means completed treatment|330
8476644|NCT00621855|20889808|P2|COMPLETED|Overall Study|Completed means completed treatment|310
8476645|NCT00621855|20889809|P1|COMPLETED|Overall Study|Completed means completed treatment|296
8476646|NCT00621855|20889805|P5|STARTED|Overall Study|Started means randomised to treatment|373
8476647|NCT00621855|20889806|P4|STARTED|Overall Study|Started means randomised to treatment|351
8476648|NCT00621855|20889807|P3|STARTED|Overall Study|Started means randomised to treatment|411
8476649|NCT00621855|20889808|P2|STARTED|Overall Study|Started means randomised to treatment|371
8476650|NCT00621855|20889809|P1|STARTED|Overall Study|Started means randomised to treatment|372
8476651|NCT00621842|20889851|P1|NOT COMPLETED|Overall Study||19
8476652|NCT00621842|20889851|P1|COMPLETED|Overall Study||38
8476653|NCT00621842|20889851|P1|STARTED|Overall Study||57
8476654|NCT00621777|20889868|P2|NOT COMPLETED|Randomized Phase||19
8476655|NCT00621777|20889869|P1|NOT COMPLETED|Randomized Phase||7
8476656|NCT00621777|20889868|P2|COMPLETED|Randomized Phase||28
8476657|NCT00621777|20889869|P1|COMPLETED|Randomized Phase||33
8476658|NCT00621777|20889868|P2|STARTED|Randomized Phase||47
8476659|NCT00621777|20889869|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
8476660|NCT00621777|20889868|P2|NOT COMPLETED|Open Phase||0
8476661|NCT00621777|20889869|P1|NOT COMPLETED|Open Phase||116
8476662|NCT00621777|20889868|P2|COMPLETED|Open Phase||0
8476663|NCT00621777|20889869|P1|COMPLETED|Open Phase||87
8476664|NCT00621777|20889868|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
8476665|NCT00621777|20889869|P1|STARTED|Open Phase||203
8476666|NCT00621764|20889884|P4|NOT COMPLETED|Overall Study||1
8476667|NCT00621764|20889885|P3|NOT COMPLETED|Overall Study||0
8476668|NCT00621764|20889886|P2|NOT COMPLETED|Overall Study||0
8476669|NCT00621764|20889887|P1|NOT COMPLETED|Overall Study||0
8476670|NCT00621764|20889884|P4|COMPLETED|Overall Study||98
8476671|NCT00621764|20889885|P3|COMPLETED|Overall Study||101
8476672|NCT00621764|20889886|P2|COMPLETED|Overall Study||50
8476673|NCT00621764|20889887|P1|COMPLETED|Overall Study||50
8476674|NCT00621764|20889884|P4|STARTED|Overall Study||99
8476675|NCT00621764|20889885|P3|STARTED|Overall Study||101
8476676|NCT00621764|20889886|P2|STARTED|Overall Study||50
8476677|NCT00621764|20889887|P1|STARTED|Overall Study||50
8476678|NCT00621686|20889919|P2|NOT COMPLETED|Overall Study||0
8476679|NCT00621686|20889920|P1|NOT COMPLETED|Overall Study||0
8476680|NCT00621686|20889919|P2|COMPLETED|Overall Study||35
8476681|NCT00621686|20889920|P1|COMPLETED|Overall Study||19
8476682|NCT00621686|20889919|P2|STARTED|Overall Study||35
8476683|NCT00621686|20889920|P1|STARTED|Overall Study||19
8476684|NCT00621621|20889933|P2|NOT COMPLETED|Overall Study||0
8476685|NCT00621621|20889934|P1|NOT COMPLETED|Overall Study||30
8476686|NCT00621621|20889933|P2|COMPLETED|Overall Study||705
8476687|NCT00621621|20889934|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
8476688|NCT00621621|20889933|P2|STARTED|Overall Study||705
8476689|NCT00621621|20889934|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
8476690|NCT00621582|20889942|P1|NOT COMPLETED|Overall Study||106
8476691|NCT00621582|20889942|P1|COMPLETED|Overall Study||4812
8476692|NCT00621582|20889942|P1|STARTED|Overall Study||4918
8476693|NCT00621543|20889949|P1|NOT COMPLETED|Overall Study||23
8476694|NCT00621543|20889949|P1|COMPLETED|Overall Study||97
8476695|NCT00621543|20889949|P1|STARTED|Overall Study||120
8476696|NCT00621530|20889956|P2|NOT COMPLETED|Overall Study||3
8476697|NCT00621530|20889957|P1|NOT COMPLETED|Overall Study||2
8476698|NCT00621530|20889956|P2|COMPLETED|Overall Study||29
8476699|NCT00621530|20889957|P1|COMPLETED|Overall Study||28
8476700|NCT00621530|20889956|P2|STARTED|Overall Study||32
8476701|NCT00621530|20889957|P1|STARTED|Overall Study||30
8476702|NCT00621517|20889973|P2|NOT COMPLETED|Overall Study||7
8476703|NCT00621517|20889974|P1|NOT COMPLETED|Overall Study||7
8476704|NCT00621517|20889973|P2|COMPLETED|Overall Study||24
8476705|NCT00621517|20889974|P1|COMPLETED|Overall Study||22
8476706|NCT00621517|20889973|P2|STARTED|Overall Study||31
8476707|NCT00621517|20889974|P1|STARTED|Overall Study||29
8476708|NCT00621504|20889986|P2|NOT COMPLETED|Overall Study||25
8476709|NCT00621504|20889987|P1|NOT COMPLETED|Overall Study||26
8476710|NCT00621504|20889986|P2|COMPLETED|Overall Study||282
8476711|NCT00621504|20889987|P1|COMPLETED|Overall Study||273
8476712|NCT00621504|20889986|P2|STARTED|Overall Study||307
8476713|NCT00621504|20889987|P1|STARTED|Overall Study||299
8476714|NCT00621348|20889996|P3|NOT COMPLETED|Overall Study||0
8476715|NCT00621348|20889997|P2|NOT COMPLETED|Overall Study||0
8476716|NCT00621348|20889998|P1|NOT COMPLETED|Overall Study||0
8476717|NCT00621348|20889996|P3|COMPLETED|Overall Study||56
8476718|NCT00621348|20889997|P2|COMPLETED|Overall Study||53
8476719|NCT00621348|20889998|P1|COMPLETED|Overall Study||58
8476720|NCT00621348|20889996|P3|STARTED|Overall Study||56
8476721|NCT00621348|20889997|P2|STARTED|Overall Study||53
8476722|NCT00621348|20889998|P1|STARTED|Overall Study||58
8476723|NCT00621322|20890021|P6|NOT COMPLETED|Overall Study||4
8476724|NCT00621322|20890022|P5|NOT COMPLETED|Overall Study||1
8476725|NCT00621322|20890023|P4|NOT COMPLETED|Overall Study||3
8476726|NCT00621322|20890024|P3|NOT COMPLETED|Overall Study||2
8476727|NCT00621322|20890025|P2|NOT COMPLETED|Overall Study||0
8476728|NCT00621322|20890026|P1|NOT COMPLETED|Overall Study||1
8476729|NCT00621322|20890021|P6|COMPLETED|Overall Study||36
8476730|NCT00621322|20890022|P5|COMPLETED|Overall Study||39
8476731|NCT00621322|20890023|P4|COMPLETED|Overall Study||37
8476732|NCT00621322|20890024|P3|COMPLETED|Overall Study||38
8476733|NCT00621322|20890025|P2|COMPLETED|Overall Study||10
8476734|NCT00621322|20890026|P1|COMPLETED|Overall Study||9
8476735|NCT00621322|20890021|P6|STARTED|Overall Study||40
8476736|NCT00621322|20890022|P5|STARTED|Overall Study||40
8476737|NCT00621322|20890023|P4|STARTED|Overall Study||40
8476738|NCT00621322|20890024|P3|STARTED|Overall Study||40
8476739|NCT00621322|20890025|P2|STARTED|Overall Study||10
8476740|NCT00621322|20890026|P1|STARTED|Overall Study||10
8476741|NCT00621309|20890106|P6|NOT COMPLETED|Overall Study||1
8476742|NCT00621309|20890107|P5|NOT COMPLETED|Overall Study||1
8476743|NCT00621309|20890108|P4|NOT COMPLETED|Overall Study||1
8476744|NCT00621309|20890109|P3|NOT COMPLETED|Overall Study||1
8476745|NCT00621309|20890110|P2|NOT COMPLETED|Overall Study||0
8476746|NCT00621309|20890111|P1|NOT COMPLETED|Overall Study||2
8476747|NCT00621309|20890106|P6|COMPLETED|Overall Study||3
8476748|NCT00621309|20890107|P5|COMPLETED|Overall Study||3
8476749|NCT00621309|20890108|P4|COMPLETED|Overall Study||5
8476750|NCT00621309|20890109|P3|COMPLETED|Overall Study||4
8476751|NCT00621309|20890110|P2|COMPLETED|Overall Study||4
8476752|NCT00621309|20890111|P1|COMPLETED|Overall Study||4
8476753|NCT00621309|20890106|P6|STARTED|Overall Study||4
8476754|NCT00621309|20890107|P5|STARTED|Overall Study||4
8476755|NCT00621309|20890108|P4|STARTED|Overall Study||6
8476756|NCT00621309|20890109|P3|STARTED|Overall Study||5
8476757|NCT00621309|20890110|P2|STARTED|Overall Study||4
8476758|NCT00621309|20890111|P1|STARTED|Overall Study||6
8476759|NCT00621296|20890117|P1|NOT COMPLETED|Overall Study||14
8476760|NCT00621296|20890117|P1|COMPLETED|Overall Study||1
8476761|NCT00621296|20890117|P1|STARTED|Overall Study||15
8476762|NCT00621257|20890126|P5|NOT COMPLETED|Overall Study||9
8476763|NCT00621257|20890127|P4|NOT COMPLETED|Overall Study||6
8476764|NCT00621257|20890128|P3|NOT COMPLETED|Overall Study||3
8476765|NCT00621257|20890129|P2|NOT COMPLETED|Overall Study||3
8476766|NCT00621257|20890130|P1|NOT COMPLETED|Overall Study||4
8476767|NCT00621257|20890126|P5|COMPLETED|Overall Study||22
8476768|NCT00621257|20890127|P4|COMPLETED|Overall Study||26
8476769|NCT00621257|20890128|P3|COMPLETED|Overall Study||20
8476770|NCT00621257|20890129|P2|COMPLETED|Overall Study||21
8476771|NCT00621257|20890130|P1|COMPLETED|Overall Study||20
8476772|NCT00621257|20890126|P5|STARTED|Overall Study||31
8476773|NCT00621257|20890127|P4|STARTED|Overall Study||32
8476774|NCT00621257|20890128|P3|STARTED|Overall Study||23
8476775|NCT00621257|20890129|P2|STARTED|Overall Study||24
8476776|NCT00621257|20890130|P1|STARTED|Overall Study||24
8476777|NCT00621244|20890146|P4|NOT COMPLETED|Overall Study||23
8476778|NCT00621244|20890147|P3|NOT COMPLETED|Overall Study||33
8476779|NCT00621244|20890148|P2|NOT COMPLETED|Overall Study||34
8476780|NCT00621244|20890149|P1|NOT COMPLETED|Overall Study||86
8476781|NCT00621244|20890146|P4|COMPLETED|Overall Study||0
8476782|NCT00621244|20890147|P3|COMPLETED|Overall Study||0
8476783|NCT00621244|20890148|P2|COMPLETED|Overall Study||0
8476784|NCT00621244|20890149|P1|COMPLETED|Overall Study||0
8476785|NCT00621244|20890146|P4|STARTED|Overall Study||23
8476786|NCT00621244|20890147|P3|STARTED|Overall Study||33
8476787|NCT00621244|20890148|P2|STARTED|Overall Study||34
8476788|NCT00621244|20890149|P1|STARTED|Overall Study||86
8476789|NCT00621192|20890253|P4|NOT COMPLETED|Overall Study||3
8476790|NCT00621192|20890254|P3|NOT COMPLETED|Overall Study||5
8476791|NCT00621192|20890255|P2|NOT COMPLETED|Overall Study||9
8476792|NCT00621192|20890256|P1|NOT COMPLETED|Overall Study||4
8476793|NCT00621192|20890253|P4|COMPLETED|Overall Study||24
8476794|NCT00621192|20890254|P3|COMPLETED|Overall Study||26
8476795|NCT00621192|20890255|P2|COMPLETED|Overall Study||94
8476796|NCT00621192|20890256|P1|COMPLETED|Overall Study||35
8476797|NCT00621192|20890253|P4|Efficacy Population|Overall Study||27
8476798|NCT00621192|20890254|P3|Efficacy Population|Overall Study||28
8476799|NCT00621192|20890255|P2|Efficacy Population|Overall Study||101
8476800|NCT00621192|20890256|P1|Efficacy Population|Overall Study||39
8476801|NCT00621192|20890253|P4|Safety Population|Overall Study||27
8476802|NCT00621192|20890254|P3|Safety Population|Overall Study||31
8476803|NCT00621192|20890255|P2|Safety Population|Overall Study||103
8476804|NCT00621192|20890256|P1|Safety Population|Overall Study||39
8476805|NCT00621192|20890253|P4|STARTED|Overall Study||27
8476806|NCT00621192|20890254|P3|STARTED|Overall Study||31
8476807|NCT00621192|20890255|P2|STARTED|Overall Study||103
8476808|NCT00621192|20890256|P1|STARTED|Overall Study||39
8476809|NCT00621179|20890282|P4|NOT COMPLETED|Overall Study||1
8476810|NCT00621179|20890283|P3|NOT COMPLETED|Overall Study||1
8476811|NCT00621179|20890284|P2|NOT COMPLETED|Overall Study||0
8476812|NCT00621179|20890285|P1|NOT COMPLETED|Overall Study||0
8476813|NCT00621179|20890282|P4|COMPLETED|Overall Study||9
8476814|NCT00621179|20890283|P3|COMPLETED|Overall Study||6
8476815|NCT00621179|20890284|P2|COMPLETED|Overall Study||8
8476816|NCT00621179|20890285|P1|COMPLETED|Overall Study||12
8476817|NCT00621179|20890282|P4|STARTED|Overall Study||10
8476818|NCT00621179|20890283|P3|STARTED|Overall Study||7
8476819|NCT00621179|20890284|P2|STARTED|Overall Study||8
8476820|NCT00621179|20890285|P1|STARTED|Overall Study||12
8476821|NCT00621153|20890297|P2|NOT COMPLETED|Overall Study||15
8476822|NCT00621153|20890298|P1|NOT COMPLETED|Overall Study||20
8476823|NCT00621153|20890297|P2|COMPLETED|Overall Study|completed|101
8476824|NCT00621153|20890298|P1|COMPLETED|Overall Study|completed|97
8476825|NCT00621153|20890297|P2|Discontinued|Overall Study||15
8476826|NCT00621153|20890298|P1|Discontinued|Overall Study||20
8476827|NCT00621153|20890297|P2|STARTED|Overall Study|randomised|116
8476828|NCT00621153|20890298|P1|STARTED|Overall Study|randomised|117
8476829|NCT00621140|20890306|P2|NOT COMPLETED|Overall Study||18
8476830|NCT00621140|20890307|P1|NOT COMPLETED|Overall Study||15
8476831|NCT00621140|20890306|P2|COMPLETED|Overall Study|number who completed treatment|318
8476832|NCT00621140|20890307|P1|COMPLETED|Overall Study|number who completed treatment|152
8476833|NCT00621140|20890306|P2|STARTED|Overall Study|number who started treatment|336
8476834|NCT00621140|20890307|P1|STARTED|Overall Study|number who started treatment|167
8476835|NCT00621049|20890341|P2|NOT COMPLETED|Maintenance Treatment||0
8476836|NCT00621049|20890342|P1|NOT COMPLETED|Maintenance Treatment||15
8476837|NCT00621049|20890341|P2|COMPLETED|Maintenance Treatment||0
8476838|NCT00621049|20890342|P1|COMPLETED|Maintenance Treatment||34
8476839|NCT00621049|20890341|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
8476840|NCT00621049|20890342|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
8476841|NCT00621049|20890341|P2|NOT COMPLETED|Adjuvant Treatment||10
8476842|NCT00621049|20890342|P1|NOT COMPLETED|Adjuvant Treatment||3
8476843|NCT00621049|20890341|P2|COMPLETED|Adjuvant Treatment||47
8476844|NCT00621049|20890342|P1|COMPLETED|Adjuvant Treatment||52
8476845|NCT00621049|20890341|P2|STARTED|Adjuvant Treatment||57
8476846|NCT00621049|20890342|P1|STARTED|Adjuvant Treatment||55
8476847|NCT00621023|20890354|P1|NOT COMPLETED|Overall Study||6
8476848|NCT00621023|20890354|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
8476849|NCT00621023|20890354|P1|STARTED|Overall Study||6
8476850|NCT00620945|20890360|P1|NOT COMPLETED|Overall Study||0
8476851|NCT00620945|20890360|P1|COMPLETED|Overall Study||87
8476852|NCT00620945|20890360|P1|STARTED|Overall Study|Total number in the study|87
8476853|NCT00620854|20890371|P6|NOT COMPLETED|Period 3||0
8476854|NCT00620854|20890372|P5|NOT COMPLETED|Period 3||0
8476855|NCT00620854|20890373|P4|NOT COMPLETED|Period 3||0
8476856|NCT00620854|20890374|P3|NOT COMPLETED|Period 3||0
8476857|NCT00620854|20890375|P2|NOT COMPLETED|Period 3||0
8476858|NCT00620854|20890376|P1|NOT COMPLETED|Period 3||0
8476859|NCT00620854|20890371|P6|COMPLETED|Period 3||4
8476860|NCT00620854|20890372|P5|COMPLETED|Period 3||4
8476861|NCT00620854|20890373|P4|COMPLETED|Period 3||3
8476862|NCT00620854|20890374|P3|COMPLETED|Period 3||3
8476863|NCT00620854|20890375|P2|COMPLETED|Period 3||4
8476864|NCT00620854|20890376|P1|COMPLETED|Period 3||4
8476865|NCT00620854|20890371|P6|STARTED|Period 3||4
8476866|NCT00620854|20890372|P5|STARTED|Period 3||4
8476867|NCT00620854|20890373|P4|STARTED|Period 3||3
8476868|NCT00620854|20890374|P3|STARTED|Period 3||3
8476869|NCT00620854|20890375|P2|STARTED|Period 3||4
8476870|NCT00620854|20890376|P1|STARTED|Period 3||4
8476871|NCT00620854|20890371|P6|NOT COMPLETED|Washout 2||0
8476872|NCT00620854|20890372|P5|NOT COMPLETED|Washout 2||0
8476873|NCT00620854|20890373|P4|NOT COMPLETED|Washout 2||0
8476874|NCT00620854|20890374|P3|NOT COMPLETED|Washout 2||0
8476875|NCT00620854|20890375|P2|NOT COMPLETED|Washout 2||0
8476876|NCT00620854|20890376|P1|NOT COMPLETED|Washout 2||0
8476877|NCT00620854|20890371|P6|COMPLETED|Washout 2||4
8476878|NCT00620854|20890372|P5|COMPLETED|Washout 2||4
8476879|NCT00620854|20890373|P4|COMPLETED|Washout 2||3
8476880|NCT00620854|20890374|P3|COMPLETED|Washout 2||3
8476881|NCT00620854|20890375|P2|COMPLETED|Washout 2||4
8476882|NCT00620854|20890376|P1|COMPLETED|Washout 2||4
8476883|NCT00620854|20890371|P6|STARTED|Washout 2||4
8476884|NCT00620854|20890372|P5|STARTED|Washout 2||4
8476885|NCT00620854|20890373|P4|STARTED|Washout 2||3
8476886|NCT00620854|20890374|P3|STARTED|Washout 2||3
8476887|NCT00620854|20890375|P2|STARTED|Washout 2||4
8476888|NCT00620854|20890376|P1|STARTED|Washout 2||4
8476889|NCT00620854|20890371|P6|NOT COMPLETED|Period 2||0
8476890|NCT00620854|20890372|P5|NOT COMPLETED|Period 2||0
8476891|NCT00620854|20890373|P4|NOT COMPLETED|Period 2||0
8476892|NCT00620854|20890374|P3|NOT COMPLETED|Period 2||0
8476893|NCT00620854|20890375|P2|NOT COMPLETED|Period 2||0
8476894|NCT00620854|20890376|P1|NOT COMPLETED|Period 2||0
8476895|NCT00620854|20890371|P6|COMPLETED|Period 2||4
8476896|NCT00620854|20890372|P5|COMPLETED|Period 2||4
8476897|NCT00620854|20890373|P4|COMPLETED|Period 2||3
8476898|NCT00620854|20890374|P3|COMPLETED|Period 2||3
8476899|NCT00620854|20890375|P2|COMPLETED|Period 2||4
8476900|NCT00620854|20890376|P1|COMPLETED|Period 2||4
8476901|NCT00620854|20890371|P6|STARTED|Period 2||4
8476902|NCT00620854|20890372|P5|STARTED|Period 2||4
8476903|NCT00620854|20890373|P4|STARTED|Period 2||3
8476904|NCT00620854|20890374|P3|STARTED|Period 2||3
8476905|NCT00620854|20890375|P2|STARTED|Period 2||4
8476906|NCT00620854|20890376|P1|STARTED|Period 2||4
8476907|NCT00620854|20890371|P6|NOT COMPLETED|Washout 1||0
8476908|NCT00620854|20890372|P5|NOT COMPLETED|Washout 1||0
8476909|NCT00620854|20890373|P4|NOT COMPLETED|Washout 1||1
8476910|NCT00620854|20890374|P3|NOT COMPLETED|Washout 1||1
8476911|NCT00620854|20890375|P2|NOT COMPLETED|Washout 1||0
8476912|NCT00620854|20890376|P1|NOT COMPLETED|Washout 1||0
8476913|NCT00620854|20890371|P6|COMPLETED|Washout 1||4
8476914|NCT00620854|20890372|P5|COMPLETED|Washout 1||4
8476915|NCT00620854|20890373|P4|COMPLETED|Washout 1||3
8476916|NCT00620854|20890374|P3|COMPLETED|Washout 1||3
8476917|NCT00620854|20890375|P2|COMPLETED|Washout 1||4
8476918|NCT00620854|20890376|P1|COMPLETED|Washout 1||4
8476919|NCT00620854|20890371|P6|STARTED|Washout 1||4
8476920|NCT00620854|20890372|P5|STARTED|Washout 1||4
8476921|NCT00620854|20890373|P4|STARTED|Washout 1||4
8476922|NCT00620854|20890374|P3|STARTED|Washout 1||4
8476923|NCT00620854|20890375|P2|STARTED|Washout 1||4
8476924|NCT00620854|20890376|P1|STARTED|Washout 1||4
8476925|NCT00620854|20890371|P6|NOT COMPLETED|Period 1||0
8476926|NCT00620854|20890372|P5|NOT COMPLETED|Period 1||0
8476927|NCT00620854|20890373|P4|NOT COMPLETED|Period 1||0
8476928|NCT00620854|20890374|P3|NOT COMPLETED|Period 1||0
8476929|NCT00620854|20890375|P2|NOT COMPLETED|Period 1||0
8476930|NCT00620854|20890376|P1|NOT COMPLETED|Period 1||0
8476931|NCT00620854|20890371|P6|COMPLETED|Period 1||4
8476932|NCT00620854|20890372|P5|COMPLETED|Period 1||4
8476933|NCT00620854|20890373|P4|COMPLETED|Period 1||4
8476934|NCT00620854|20890374|P3|COMPLETED|Period 1||4
8476935|NCT00620854|20890375|P2|COMPLETED|Period 1||4
8476936|NCT00620854|20890376|P1|COMPLETED|Period 1||4
8476937|NCT00620854|20890371|P6|STARTED|Period 1||4
8476938|NCT00620854|20890372|P5|STARTED|Period 1||4
8476939|NCT00620854|20890373|P4|STARTED|Period 1||4
8476940|NCT00620854|20890374|P3|STARTED|Period 1||4
8476941|NCT00620854|20890375|P2|STARTED|Period 1||4
8476942|NCT00620854|20890376|P1|STARTED|Period 1||4
8476943|NCT00620828|20890389|P2|NOT COMPLETED|Overall Study||0
8476944|NCT00620828|20890390|P1|NOT COMPLETED|Overall Study||0
8476945|NCT00620828|20890389|P2|COMPLETED|Overall Study||35
8476946|NCT00620828|20890390|P1|COMPLETED|Overall Study||32
8476947|NCT00620828|20890389|P2|Number of Subjects Enrolled = 67|Overall Study||35
8476948|NCT00620828|20890390|P1|Number of Subjects Enrolled = 67|Overall Study||32
8476949|NCT00620828|20890389|P2|STARTED|Overall Study||35
8476950|NCT00620828|20890390|P1|STARTED|Overall Study||32
8476951|NCT00620815|20890407|P3|NOT COMPLETED|Overall Study||7
8476952|NCT00620815|20890408|P2|NOT COMPLETED|Overall Study||11
8476953|NCT00620815|20890409|P1|NOT COMPLETED|Overall Study||4
8476954|NCT00620815|20890407|P3|COMPLETED|Overall Study||192
8476955|NCT00620815|20890408|P2|COMPLETED|Overall Study||192
8476956|NCT00620815|20890409|P1|COMPLETED|Overall Study||195
8476957|NCT00620815|20890407|P3|STARTED|Overall Study||199
8476958|NCT00620815|20890408|P2|STARTED|Overall Study||203
8476959|NCT00620815|20890409|P1|STARTED|Overall Study||199
8476960|NCT00620776|20890449|P2|NOT COMPLETED|Overall Study||16
8476961|NCT00620776|20890450|P1|NOT COMPLETED|Overall Study||12
8476962|NCT00620776|20890449|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
8476963|NCT00620776|20890450|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
8476964|NCT00620776|20890449|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
8476965|NCT00620776|20890450|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
8476966|NCT00620776|20890449|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
8476967|NCT00620776|20890450|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
8476968|NCT00620763|20890478|P2|NOT COMPLETED|Period: Second Intervention||0
8476969|NCT00620763|20890479|P1|NOT COMPLETED|Period: Second Intervention||1
8476970|NCT00620763|20890478|P2|COMPLETED|Period: Second Intervention||7
8476971|NCT00620763|20890479|P1|COMPLETED|Period: Second Intervention||9
8476972|NCT00620763|20890478|P2|STARTED|Period: Second Intervention||7
8476973|NCT00620763|20890479|P1|STARTED|Period: Second Intervention||10
8476974|NCT00620763|20890478|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
8476975|NCT00620763|20890479|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
8476976|NCT00620763|20890478|P2|COMPLETED|Period: Washout Period of 1 Week||7
8476977|NCT00620763|20890479|P1|COMPLETED|Period: Washout Period of 1 Week||10
8476978|NCT00620763|20890478|P2|STARTED|Period: Washout Period of 1 Week||7
8476979|NCT00620763|20890479|P1|STARTED|Period: Washout Period of 1 Week||10
8476980|NCT00620763|20890478|P2|NOT COMPLETED|Period: First Intervention||5
8476981|NCT00620763|20890479|P1|NOT COMPLETED|Period: First Intervention||0
8476982|NCT00620763|20890478|P2|COMPLETED|Period: First Intervention||7
8476983|NCT00620763|20890479|P1|COMPLETED|Period: First Intervention||10
8476984|NCT00620763|20890478|P2|STARTED|Period: First Intervention||12
8476985|NCT00620763|20890479|P1|STARTED|Period: First Intervention||10
8476986|NCT00620750|20890485|P1|NOT COMPLETED|Overall Study||25
8476987|NCT00620750|20890485|P1|COMPLETED|Overall Study||40
8476988|NCT00620750|20890485|P1|STARTED|Overall Study||65
8476989|NCT00620711|20890489|P1|NOT COMPLETED|Overall Study||0
8476990|NCT00620711|20890489|P1|COMPLETED|Overall Study||4
8476991|NCT00620711|20890489|P1|STARTED|Overall Study||4
8476992|NCT00620698|20890494|P1|NOT COMPLETED|Overall Study||29
8476993|NCT00620698|20890494|P1|COMPLETED|Overall Study||60
8476994|NCT00620698|20890494|P1|STARTED|Overall Study||89
8476995|NCT00620659|20890500|P6|NOT COMPLETED|Treatment Period 3||0
8476996|NCT00620659|20890501|P5|NOT COMPLETED|Treatment Period 3||0
8476997|NCT00620659|20890502|P4|NOT COMPLETED|Treatment Period 3||1
8476998|NCT00620659|20890503|P3|NOT COMPLETED|Treatment Period 3||0
8476999|NCT00620659|20890504|P2|NOT COMPLETED|Treatment Period 3||2
8477000|NCT00620659|20890505|P1|NOT COMPLETED|Treatment Period 3||0
8477001|NCT00620659|20890500|P6|COMPLETED|Treatment Period 3||20
8477002|NCT00620659|20890501|P5|COMPLETED|Treatment Period 3||15
8477003|NCT00620659|20890502|P4|COMPLETED|Treatment Period 3||17
8477004|NCT00620659|20890503|P3|COMPLETED|Treatment Period 3||19
8477005|NCT00620659|20890504|P2|COMPLETED|Treatment Period 3||16
8477006|NCT00620659|20890505|P1|COMPLETED|Treatment Period 3||16
8477007|NCT00620659|20890500|P6|STARTED|Treatment Period 3||20
8477008|NCT00620659|20890501|P5|STARTED|Treatment Period 3||15
8477009|NCT00620659|20890502|P4|STARTED|Treatment Period 3||18
8477010|NCT00620659|20890503|P3|STARTED|Treatment Period 3||19
8477011|NCT00620659|20890504|P2|STARTED|Treatment Period 3||18
8477012|NCT00620659|20890505|P1|STARTED|Treatment Period 3||16
8477013|NCT00620659|20890500|P6|NOT COMPLETED|Placebo Washout Period 2||0
8477014|NCT00620659|20890501|P5|NOT COMPLETED|Placebo Washout Period 2||0
8477015|NCT00620659|20890502|P4|NOT COMPLETED|Placebo Washout Period 2||0
8477016|NCT00620659|20890503|P3|NOT COMPLETED|Placebo Washout Period 2||0
8477017|NCT00620659|20890504|P2|NOT COMPLETED|Placebo Washout Period 2||0
8477018|NCT00620659|20890505|P1|NOT COMPLETED|Placebo Washout Period 2||2
8477019|NCT00620659|20890500|P6|COMPLETED|Placebo Washout Period 2||20
8477020|NCT00620659|20890501|P5|COMPLETED|Placebo Washout Period 2||15
8477021|NCT00620659|20890502|P4|COMPLETED|Placebo Washout Period 2||18
8477022|NCT00620659|20890503|P3|COMPLETED|Placebo Washout Period 2||19
8477023|NCT00620659|20890504|P2|COMPLETED|Placebo Washout Period 2||18
8477024|NCT00620659|20890505|P1|COMPLETED|Placebo Washout Period 2||16
8477025|NCT00620659|20890500|P6|STARTED|Placebo Washout Period 2||20
8477026|NCT00620659|20890501|P5|STARTED|Placebo Washout Period 2||15
8477027|NCT00620659|20890502|P4|STARTED|Placebo Washout Period 2||18
8477028|NCT00620659|20890503|P3|STARTED|Placebo Washout Period 2||19
8477029|NCT00620659|20890504|P2|STARTED|Placebo Washout Period 2||18
8477030|NCT00620659|20890505|P1|STARTED|Placebo Washout Period 2||18
8477031|NCT00620659|20890500|P6|NOT COMPLETED|Treatment Period 2||0
8477032|NCT00620659|20890501|P5|NOT COMPLETED|Treatment Period 2||5
8477033|NCT00620659|20890502|P4|NOT COMPLETED|Treatment Period 2||0
8477034|NCT00620659|20890503|P3|NOT COMPLETED|Treatment Period 2||1
8477035|NCT00620659|20890504|P2|NOT COMPLETED|Treatment Period 2||3
8477036|NCT00620659|20890505|P1|NOT COMPLETED|Treatment Period 2||0
8477037|NCT00620659|20890500|P6|COMPLETED|Treatment Period 2||20
8477038|NCT00620659|20890501|P5|COMPLETED|Treatment Period 2||15
8477039|NCT00620659|20890502|P4|COMPLETED|Treatment Period 2||18
8477040|NCT00620659|20890503|P3|COMPLETED|Treatment Period 2||19
8477041|NCT00620659|20890504|P2|COMPLETED|Treatment Period 2||18
8477042|NCT00620659|20890505|P1|COMPLETED|Treatment Period 2||18
8477043|NCT00620659|20890500|P6|STARTED|Treatment Period 2||20
8477044|NCT00620659|20890501|P5|STARTED|Treatment Period 2||20
8477045|NCT00620659|20890502|P4|STARTED|Treatment Period 2||18
8477046|NCT00620659|20890503|P3|STARTED|Treatment Period 2||20
8477047|NCT00620659|20890504|P2|STARTED|Treatment Period 2||21
8477048|NCT00620659|20890505|P1|STARTED|Treatment Period 2||18
8477049|NCT00620659|20890500|P6|NOT COMPLETED|Placebo Washout Period 1||0
8477050|NCT00620659|20890501|P5|NOT COMPLETED|Placebo Washout Period 1||0
8477051|NCT00620659|20890502|P4|NOT COMPLETED|Placebo Washout Period 1||1
8477052|NCT00620659|20890503|P3|NOT COMPLETED|Placebo Washout Period 1||0
8477053|NCT00620659|20890504|P2|NOT COMPLETED|Placebo Washout Period 1||0
8477054|NCT00620659|20890505|P1|NOT COMPLETED|Placebo Washout Period 1||0
8477055|NCT00620659|20890500|P6|COMPLETED|Placebo Washout Period 1||20
8477056|NCT00620659|20890501|P5|COMPLETED|Placebo Washout Period 1||20
8477057|NCT00620659|20890502|P4|COMPLETED|Placebo Washout Period 1||18
8477058|NCT00620659|20890503|P3|COMPLETED|Placebo Washout Period 1||20
8477059|NCT00620659|20890504|P2|COMPLETED|Placebo Washout Period 1||21
8477060|NCT00620659|20890505|P1|COMPLETED|Placebo Washout Period 1||18
8477061|NCT00620659|20890500|P6|STARTED|Placebo Washout Period 1||20
8477062|NCT00620659|20890501|P5|STARTED|Placebo Washout Period 1||20
8477063|NCT00620659|20890502|P4|STARTED|Placebo Washout Period 1||19
8477064|NCT00620659|20890503|P3|STARTED|Placebo Washout Period 1||20
8477065|NCT00620659|20890504|P2|STARTED|Placebo Washout Period 1||21
8477066|NCT00620659|20890505|P1|STARTED|Placebo Washout Period 1||18
8477067|NCT00620659|20890500|P6|NOT COMPLETED|Treatment Period 1||0
8477068|NCT00620659|20890501|P5|NOT COMPLETED|Treatment Period 1||1
8477069|NCT00620659|20890502|P4|NOT COMPLETED|Treatment Period 1||3
8477070|NCT00620659|20890503|P3|NOT COMPLETED|Treatment Period 1||1
8477071|NCT00620659|20890504|P2|NOT COMPLETED|Treatment Period 1||0
8477072|NCT00620659|20890505|P1|NOT COMPLETED|Treatment Period 1||3
8477073|NCT00620659|20890500|P6|COMPLETED|Treatment Period 1||20
8477074|NCT00620659|20890501|P5|COMPLETED|Treatment Period 1||20
8477075|NCT00620659|20890502|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
8477076|NCT00620659|20890503|P3|COMPLETED|Treatment Period 1||20
8477077|NCT00620659|20890504|P2|COMPLETED|Treatment Period 1||21
8477078|NCT00620659|20890505|P1|COMPLETED|Treatment Period 1||18
8477079|NCT00620659|20890500|P6|STARTED|Treatment Period 1||20
8477080|NCT00620659|20890501|P5|STARTED|Treatment Period 1||21
8477081|NCT00620659|20890502|P4|STARTED|Treatment Period 1||21
8477082|NCT00620659|20890503|P3|STARTED|Treatment Period 1||21
8477083|NCT00620659|20890504|P2|STARTED|Treatment Period 1||21
8477084|NCT00620659|20890505|P1|STARTED|Treatment Period 1||21
8477088|NCT00620542|20890532|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
8477089|NCT00620542|20890533|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
8477090|NCT00620542|20890534|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
8477091|NCT00620542|20890535|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
8477092|NCT00620542|20890532|P4|COMPLETED|Part B (2 Year Core Study)||547
8477093|NCT00620542|20890533|P3|COMPLETED|Part B (2 Year Core Study)||546
8477094|NCT00620542|20890534|P2|COMPLETED|Part B (2 Year Core Study)||0
8477095|NCT00620542|20890535|P1|COMPLETED|Part B (2 Year Core Study)||0
8477096|NCT00620542|20890532|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
8477097|NCT00620542|20890533|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
8477098|NCT00620542|20890534|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
8477099|NCT00620542|20890535|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
8477100|NCT00620542|20890532|P4|Received Treatment|Part B (2 Year Core Study)||689
8477101|NCT00620542|20890533|P3|Received Treatment|Part B (2 Year Core Study)||691
8477102|NCT00620542|20890534|P2|Received Treatment|Part B (2 Year Core Study)||0
8477103|NCT00620542|20890535|P1|Received Treatment|Part B (2 Year Core Study)||0
8477104|NCT00620542|20890532|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
8477105|NCT00620542|20890533|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
8477106|NCT00620542|20890534|P2|STARTED|Part B (2 Year Core Study)||0
8477107|NCT00620542|20890535|P1|STARTED|Part B (2 Year Core Study)||0
8477108|NCT00620542|20890532|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
8477109|NCT00620542|20890533|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
8477110|NCT00620542|20890534|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
8477111|NCT00620542|20890535|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
8477112|NCT00620542|20890532|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
8477113|NCT00620542|20890533|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
8477114|NCT00620542|20890534|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
8477115|NCT00620542|20890535|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
8477116|NCT00620542|20890532|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
8477117|NCT00620542|20890533|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
8477118|NCT00620542|20890534|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
8477119|NCT00620542|20890535|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
8477120|NCT00620542|20890532|P4|STARTED|Part A (Run-in - 2 Weeks)||0
8477121|NCT00620542|20890533|P3|STARTED|Part A (Run-in - 2 Weeks)||0
8477122|NCT00620542|20890534|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
8477123|NCT00620542|20890535|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
8477124|NCT00620503|20890573|P6|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477125|NCT00620503|20890574|P5|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477126|NCT00620503|20890575|P4|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477127|NCT00620503|20890576|P3|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477128|NCT00620503|20890577|P2|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477129|NCT00620503|20890578|P1|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477130|NCT00620503|20890573|P6|COMPLETED|Follow-up (up to 14 Days)||2
8477131|NCT00620503|20890574|P5|COMPLETED|Follow-up (up to 14 Days)||2
8477132|NCT00620503|20890575|P4|COMPLETED|Follow-up (up to 14 Days)||2
8477133|NCT00620503|20890576|P3|COMPLETED|Follow-up (up to 14 Days)||2
8477134|NCT00620503|20890577|P2|COMPLETED|Follow-up (up to 14 Days)||2
8477135|NCT00620503|20890578|P1|COMPLETED|Follow-up (up to 14 Days)||2
8477136|NCT00620503|20890573|P6|STARTED|Follow-up (up to 14 Days)||2
8477137|NCT00620503|20890574|P5|STARTED|Follow-up (up to 14 Days)||2
8477138|NCT00620503|20890575|P4|STARTED|Follow-up (up to 14 Days)||2
8477139|NCT00620503|20890576|P3|STARTED|Follow-up (up to 14 Days)||2
8477140|NCT00620503|20890577|P2|STARTED|Follow-up (up to 14 Days)||2
8477141|NCT00620503|20890578|P1|STARTED|Follow-up (up to 14 Days)||2
8477142|NCT00620503|20890573|P6|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477143|NCT00620503|20890574|P5|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477144|NCT00620503|20890575|P4|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477145|NCT00620503|20890576|P3|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477146|NCT00620503|20890577|P2|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477147|NCT00620503|20890578|P1|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477148|NCT00620503|20890573|P6|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477149|NCT00620503|20890574|P5|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477150|NCT00620503|20890575|P4|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477151|NCT00620503|20890576|P3|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477152|NCT00620503|20890577|P2|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477153|NCT00620503|20890578|P1|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477154|NCT00620503|20890573|P6|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477155|NCT00620503|20890574|P5|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477156|NCT00620503|20890575|P4|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477157|NCT00620503|20890576|P3|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477158|NCT00620503|20890577|P2|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477159|NCT00620503|20890578|P1|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477160|NCT00620503|20890573|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
8477161|NCT00620503|20890574|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
8477162|NCT00620503|20890575|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
8477163|NCT00620503|20890576|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
8477164|NCT00620503|20890577|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
8477165|NCT00620503|20890578|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
8477166|NCT00620503|20890573|P6|COMPLETED|Washout (at Least 1 Day)||2
8477167|NCT00620503|20890574|P5|COMPLETED|Washout (at Least 1 Day)||2
8477168|NCT00620503|20890575|P4|COMPLETED|Washout (at Least 1 Day)||2
8477169|NCT00620503|20890576|P3|COMPLETED|Washout (at Least 1 Day)||2
8477170|NCT00620503|20890577|P2|COMPLETED|Washout (at Least 1 Day)||2
8477171|NCT00620503|20890578|P1|COMPLETED|Washout (at Least 1 Day)||2
8477172|NCT00620503|20890573|P6|STARTED|Washout (at Least 1 Day)||2
8477173|NCT00620503|20890574|P5|STARTED|Washout (at Least 1 Day)||2
8477174|NCT00620503|20890575|P4|STARTED|Washout (at Least 1 Day)||2
8477175|NCT00620503|20890576|P3|STARTED|Washout (at Least 1 Day)||2
8477176|NCT00620503|20890577|P2|STARTED|Washout (at Least 1 Day)||2
8477177|NCT00620503|20890578|P1|STARTED|Washout (at Least 1 Day)||2
8477178|NCT00620503|20890573|P6|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477179|NCT00620503|20890574|P5|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477180|NCT00620503|20890575|P4|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477181|NCT00620503|20890576|P3|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477182|NCT00620503|20890577|P2|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477183|NCT00620503|20890578|P1|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477184|NCT00620503|20890573|P6|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477185|NCT00620503|20890574|P5|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477186|NCT00620503|20890575|P4|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477187|NCT00620503|20890576|P3|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477188|NCT00620503|20890577|P2|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477189|NCT00620503|20890578|P1|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477190|NCT00620503|20890573|P6|STARTED|Treatment Period 2 (TP2) (7days)||2
8477191|NCT00620503|20890574|P5|STARTED|Treatment Period 2 (TP2) (7days)||2
8477192|NCT00620503|20890575|P4|STARTED|Treatment Period 2 (TP2) (7days)||2
8477193|NCT00620503|20890576|P3|STARTED|Treatment Period 2 (TP2) (7days)||2
8477194|NCT00620503|20890577|P2|STARTED|Treatment Period 2 (TP2) (7days)||2
8477195|NCT00620503|20890578|P1|STARTED|Treatment Period 2 (TP2) (7days)||2
8477196|NCT00620503|20890573|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
8477197|NCT00620503|20890574|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
8477198|NCT00620503|20890575|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
8477199|NCT00620503|20890576|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
8477200|NCT00620503|20890577|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
8477201|NCT00620503|20890578|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
8477202|NCT00620503|20890573|P6|COMPLETED|Washout (at Least 1 Day)||2
8477203|NCT00620503|20890574|P5|COMPLETED|Washout (at Least 1 Day)||2
8477204|NCT00620503|20890575|P4|COMPLETED|Washout (at Least 1 Day)||2
8477205|NCT00620503|20890576|P3|COMPLETED|Washout (at Least 1 Day)||2
8477206|NCT00620503|20890577|P2|COMPLETED|Washout (at Least 1 Day)||2
8477207|NCT00620503|20890578|P1|COMPLETED|Washout (at Least 1 Day)||2
8477208|NCT00620503|20890573|P6|STARTED|Washout (at Least 1 Day)||2
8477209|NCT00620503|20890574|P5|STARTED|Washout (at Least 1 Day)||2
8477210|NCT00620503|20890575|P4|STARTED|Washout (at Least 1 Day)||2
8477211|NCT00620503|20890576|P3|STARTED|Washout (at Least 1 Day)||2
8477212|NCT00620503|20890577|P2|STARTED|Washout (at Least 1 Day)||2
8477213|NCT00620503|20890578|P1|STARTED|Washout (at Least 1 Day)||2
8477214|NCT00620503|20890573|P6|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477215|NCT00620503|20890574|P5|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477216|NCT00620503|20890575|P4|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477217|NCT00620503|20890576|P3|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477218|NCT00620503|20890577|P2|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477219|NCT00620503|20890578|P1|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477220|NCT00620503|20890573|P6|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477221|NCT00620503|20890574|P5|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477222|NCT00620503|20890575|P4|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477223|NCT00620503|20890576|P3|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477224|NCT00620503|20890577|P2|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477225|NCT00620503|20890578|P1|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477226|NCT00620503|20890573|P6|STARTED|Treatment Period 1 (TP1) (7days)||2
8477227|NCT00620503|20890574|P5|STARTED|Treatment Period 1 (TP1) (7days)||2
8477228|NCT00620503|20890575|P4|STARTED|Treatment Period 1 (TP1) (7days)||2
8477229|NCT00620503|20890576|P3|STARTED|Treatment Period 1 (TP1) (7days)||2
8477230|NCT00620503|20890577|P2|STARTED|Treatment Period 1 (TP1) (7days)||2
8477231|NCT00620503|20890578|P1|STARTED|Treatment Period 1 (TP1) (7days)||2
8477232|NCT00620503|20890573|P6|NOT COMPLETED|Screening (up to 21 Days)||0
8477233|NCT00620503|20890574|P5|NOT COMPLETED|Screening (up to 21 Days)||0
8477234|NCT00620503|20890575|P4|NOT COMPLETED|Screening (up to 21 Days)||0
8477235|NCT00620503|20890576|P3|NOT COMPLETED|Screening (up to 21 Days)||0
8477236|NCT00620503|20890577|P2|NOT COMPLETED|Screening (up to 21 Days)||0
8477237|NCT00620503|20890578|P1|NOT COMPLETED|Screening (up to 21 Days)||0
8477238|NCT00620503|20890573|P6|COMPLETED|Screening (up to 21 Days)||2
8477239|NCT00620503|20890574|P5|COMPLETED|Screening (up to 21 Days)||2
8477240|NCT00620503|20890575|P4|COMPLETED|Screening (up to 21 Days)||2
8477241|NCT00620503|20890576|P3|COMPLETED|Screening (up to 21 Days)||2
8477242|NCT00620503|20890577|P2|COMPLETED|Screening (up to 21 Days)||2
8477243|NCT00620503|20890578|P1|COMPLETED|Screening (up to 21 Days)||2
8477244|NCT00620503|20890573|P6|STARTED|Screening (up to 21 Days)||2
8477245|NCT00620503|20890574|P5|STARTED|Screening (up to 21 Days)||2
8477246|NCT00620503|20890575|P4|STARTED|Screening (up to 21 Days)||2
8477247|NCT00620503|20890576|P3|STARTED|Screening (up to 21 Days)||2
8477248|NCT00620503|20890577|P2|STARTED|Screening (up to 21 Days)||2
8477249|NCT00620503|20890578|P1|STARTED|Screening (up to 21 Days)||2
8477250|NCT00620464|20890600|P2|NOT COMPLETED|Overall Study||24
8477251|NCT00620464|20890601|P1|NOT COMPLETED|Overall Study||20
8477252|NCT00620464|20890600|P2|COMPLETED|Overall Study||32
8477253|NCT00620464|20890601|P1|COMPLETED|Overall Study||32
8477254|NCT00620464|20890600|P2|STARTED|Overall Study||56
8477255|NCT00620464|20890601|P1|STARTED|Overall Study||52
8477256|NCT00620425|20890609|P1|NOT COMPLETED|Overall Study||0
8477257|NCT00620425|20890609|P1|COMPLETED|Overall Study||18
8477258|NCT00620425|20890609|P1|STARTED|Overall Study||18
8477259|NCT00620373|20890620|P1|NOT COMPLETED|Overall Study||33
8477260|NCT00620373|20890620|P1|COMPLETED|Overall Study||936
8477261|NCT00620373|20890620|P1|STARTED|Overall Study||969
8477262|NCT00620321|20890638|P2|NOT COMPLETED|Overall Study||16
8477263|NCT00620321|20890639|P1|NOT COMPLETED|Overall Study||8
8477264|NCT00620321|20890638|P2|COMPLETED|Overall Study||0
8477265|NCT00620321|20890639|P1|COMPLETED|Overall Study||0
8477266|NCT00620321|20890638|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8477267|NCT00620321|20890639|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8477268|NCT00620321|20890638|P2|STARTED|Overall Study||16
8477269|NCT00620321|20890639|P1|STARTED|Overall Study||8
8477270|NCT00620282|20890658|P3|NOT COMPLETED|Overall Study||1
8477271|NCT00620282|20890659|P2|NOT COMPLETED|Overall Study||2
8477272|NCT00620282|20890660|P1|NOT COMPLETED|Overall Study||0
8477273|NCT00620282|20890658|P3|COMPLETED|Overall Study||16
8477274|NCT00620282|20890659|P2|COMPLETED|Overall Study||14
8477275|NCT00620282|20890660|P1|COMPLETED|Overall Study||16
8477276|NCT00620282|20890658|P3|STARTED|Overall Study||17
8477277|NCT00620282|20890659|P2|STARTED|Overall Study||16
8477278|NCT00620282|20890660|P1|STARTED|Overall Study||16
8477279|NCT00620191|20890709|P2|NOT COMPLETED|Overall Study||8
8477280|NCT00620191|20890710|P1|NOT COMPLETED|Overall Study||7
8477281|NCT00620191|20890709|P2|COMPLETED|Overall Study|12 month follow-up|32
8477282|NCT00620191|20890710|P1|COMPLETED|Overall Study|12 month follow-up|33
8477283|NCT00620191|20890709|P2|9 Month Follow-up|Overall Study||34
8477284|NCT00620191|20890710|P1|9 Month Follow-up|Overall Study||37
8477285|NCT00620191|20890709|P2|6 Month Follow-up|Overall Study||36
8477286|NCT00620191|20890710|P1|6 Month Follow-up|Overall Study||38
8477287|NCT00620191|20890709|P2|3 Month Follow-up|Overall Study||39
8477288|NCT00620191|20890710|P1|3 Month Follow-up|Overall Study||39
8477289|NCT00620191|20890709|P2|STARTED|Overall Study||40
8477290|NCT00620191|20890710|P1|STARTED|Overall Study||40
8477291|NCT00620126|20890724|P2|NOT COMPLETED|Overall Study||5
8477292|NCT00620126|20890725|P1|NOT COMPLETED|Overall Study||11
8477293|NCT00620126|20890724|P2|COMPLETED|Overall Study||17
8477294|NCT00620126|20890725|P1|COMPLETED|Overall Study||14
8477295|NCT00620126|20890724|P2|STARTED|Overall Study||22
8477296|NCT00620126|20890725|P1|STARTED|Overall Study||25
8477297|NCT00620113|20890739|P4|NOT COMPLETED|Overall Study||10
8477298|NCT00620113|20890740|P3|NOT COMPLETED|Overall Study||5
8477299|NCT00620113|20890741|P2|NOT COMPLETED|Overall Study||7
8477300|NCT00620113|20890742|P1|NOT COMPLETED|Overall Study||13
8477301|NCT00620113|20890739|P4|COMPLETED|Overall Study||59
8477302|NCT00620113|20890740|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
8477303|NCT00620113|20890741|P2|COMPLETED|Overall Study||67
8477304|NCT00620113|20890742|P1|COMPLETED|Overall Study||60
8477305|NCT00620113|20890739|P4|Efficacy/Safety Population|Overall Study||69
8477306|NCT00620113|20890740|P3|Efficacy/Safety Population|Overall Study||70
8477307|NCT00620113|20890741|P2|Efficacy/Safety Population|Overall Study||74
8477308|NCT00620113|20890742|P1|Efficacy/Safety Population|Overall Study||73
8477309|NCT00620113|20890739|P4|STARTED|Overall Study||69
8477310|NCT00620113|20890740|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
8477311|NCT00620113|20890741|P2|STARTED|Overall Study||74
8477312|NCT00620113|20890742|P1|STARTED|Overall Study||73
8477313|NCT00620074|20890792|P1|NOT COMPLETED|Overall Study||1
8477314|NCT00620074|20890792|P1|COMPLETED|Overall Study||5
8477315|NCT00620074|20890792|P1|STARTED|Overall Study||6
8477316|NCT00620061|20890800|P1|NOT COMPLETED|Overall Study||153
8477317|NCT00620061|20890800|P1|COMPLETED|Overall Study||286
8477318|NCT00620061|20890800|P1|STARTED|Overall Study||439
8477319|NCT00620035|20890815|P1|NOT COMPLETED|Overall Study||145
8477320|NCT00620035|20890815|P1|COMPLETED|Overall Study||156
8477321|NCT00620035|20890815|P1|STARTED|Overall Study||301
8477322|NCT00620022|20890825|P2|NOT COMPLETED|Treatment Period 2||2
8477323|NCT00620022|20890826|P1|NOT COMPLETED|Treatment Period 2||2
8477324|NCT00620022|20890825|P2|COMPLETED|Treatment Period 2||35
8477325|NCT00620022|20890826|P1|COMPLETED|Treatment Period 2||39
8477326|NCT00620022|20890825|P2|STARTED|Treatment Period 2||37
8477327|NCT00620022|20890826|P1|STARTED|Treatment Period 2||41
8477328|NCT00620022|20890825|P2|NOT COMPLETED|Treatment Period 1||6
8477329|NCT00620022|20890826|P1|NOT COMPLETED|Treatment Period 1||5
8477330|NCT00620022|20890825|P2|COMPLETED|Treatment Period 1||37
8477331|NCT00620022|20890826|P1|COMPLETED|Treatment Period 1||41
8477332|NCT00620022|20890825|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
8477333|NCT00620022|20890826|P1|STARTED|Treatment Period 1||46
8477334|NCT00619983|20890838|P4|NOT COMPLETED|Gabapentin Alone||0
8477335|NCT00619983|20890839|P3|NOT COMPLETED|Gabapentin Alone||0
8477336|NCT00619983|20890840|P2|NOT COMPLETED|Gabapentin Alone||0
8477337|NCT00619983|20890841|P1|NOT COMPLETED|Gabapentin Alone||0
8477338|NCT00619983|20890838|P4|COMPLETED|Gabapentin Alone||3
8477339|NCT00619983|20890839|P3|COMPLETED|Gabapentin Alone||4
8477340|NCT00619983|20890840|P2|COMPLETED|Gabapentin Alone||4
8477341|NCT00619983|20890841|P1|COMPLETED|Gabapentin Alone||3
8477342|NCT00619983|20890838|P4|STARTED|Gabapentin Alone||3
8477343|NCT00619983|20890839|P3|STARTED|Gabapentin Alone||4
8477344|NCT00619983|20890840|P2|STARTED|Gabapentin Alone||4
8477345|NCT00619983|20890841|P1|STARTED|Gabapentin Alone||3
8477346|NCT00619983|20890838|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477347|NCT00619983|20890839|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477348|NCT00619983|20890840|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477349|NCT00619983|20890841|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477350|NCT00619983|20890838|P4|COMPLETED|Test Drug Plus Gabapentin||3
8477351|NCT00619983|20890839|P3|COMPLETED|Test Drug Plus Gabapentin||4
8477352|NCT00619983|20890840|P2|COMPLETED|Test Drug Plus Gabapentin||4
8477353|NCT00619983|20890841|P1|COMPLETED|Test Drug Plus Gabapentin||3
8477354|NCT00619983|20890838|P4|STARTED|Test Drug Plus Gabapentin||3
8477355|NCT00619983|20890839|P3|STARTED|Test Drug Plus Gabapentin||4
8477356|NCT00619983|20890840|P2|STARTED|Test Drug Plus Gabapentin||4
8477357|NCT00619983|20890841|P1|STARTED|Test Drug Plus Gabapentin||3
8477358|NCT00619983|20890838|P4|NOT COMPLETED|Test Drug Alone||3
8477359|NCT00619983|20890839|P3|NOT COMPLETED|Test Drug Alone||2
8477360|NCT00619983|20890840|P2|NOT COMPLETED|Test Drug Alone||1
8477361|NCT00619983|20890841|P1|NOT COMPLETED|Test Drug Alone||2
8477362|NCT00619983|20890838|P4|COMPLETED|Test Drug Alone||3
8477363|NCT00619983|20890839|P3|COMPLETED|Test Drug Alone||4
8477364|NCT00619983|20890840|P2|COMPLETED|Test Drug Alone||4
8477365|NCT00619983|20890841|P1|COMPLETED|Test Drug Alone||3
8477366|NCT00619983|20890838|P4|STARTED|Test Drug Alone||6
8477367|NCT00619983|20890839|P3|STARTED|Test Drug Alone||6
8477368|NCT00619983|20890840|P2|STARTED|Test Drug Alone||5
8477369|NCT00619983|20890841|P1|STARTED|Test Drug Alone||5
8477370|NCT00619970|20890854|P3|NOT COMPLETED|Overall Study||2
8477371|NCT00619970|20890855|P2|NOT COMPLETED|Overall Study||3
8477372|NCT00619970|20890856|P1|NOT COMPLETED|Overall Study||0
8477373|NCT00619970|20890854|P3|COMPLETED|Overall Study||24
8477374|NCT00619970|20890855|P2|COMPLETED|Overall Study||46
8477375|NCT00619970|20890856|P1|COMPLETED|Overall Study||40
8477376|NCT00619970|20890854|P3|STARTED|Overall Study||26
8477377|NCT00619970|20890855|P2|STARTED|Overall Study||49
8477378|NCT00619970|20890856|P1|STARTED|Overall Study||40
8477379|NCT00619957|20890868|P2|NOT COMPLETED|Month 48 Open-Label||17
8477380|NCT00619957|20890869|P1|NOT COMPLETED|Month 48 Open-Label||12
8477381|NCT00619957|20890868|P2|COMPLETED|Month 48 Open-Label||134
8477382|NCT00619957|20890869|P1|COMPLETED|Month 48 Open-Label||55
8477383|NCT00619957|20890868|P2|STARTED|Month 48 Open-Label||151
8477384|NCT00619957|20890869|P1|STARTED|Month 48 Open-Label||67
8477385|NCT00619957|20890868|P2|NOT COMPLETED|Month 24 Double-Blind||17
8477386|NCT00619957|20890869|P1|NOT COMPLETED|Month 24 Double-Blind||18
8477387|NCT00619957|20890868|P2|COMPLETED|Month 24 Double-Blind||175
8477388|NCT00619957|20890869|P1|COMPLETED|Month 24 Double-Blind||75
8477389|NCT00619957|20890868|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
8477390|NCT00619957|20890869|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
8477391|NCT00619957|20890868|P2|STARTED|Month 24 Double-Blind||192
8477392|NCT00619957|20890869|P1|STARTED|Month 24 Double-Blind||93
8477393|NCT00619918|20890951|P2|NOT COMPLETED|Overall Study||22
8477394|NCT00619918|20890952|P1|NOT COMPLETED|Overall Study||20
8477395|NCT00619918|20890951|P2|COMPLETED|Overall Study||195
8477396|NCT00619918|20890952|P1|COMPLETED|Overall Study||210
8477397|NCT00619918|20890951|P2|STARTED|Overall Study||217
8477398|NCT00619918|20890952|P1|STARTED|Overall Study||230
8477399|NCT00619892|20890962|P2|NOT COMPLETED|Overall Study||2
8477400|NCT00619892|20890963|P1|NOT COMPLETED|Overall Study||3
8477401|NCT00619892|20890962|P2|COMPLETED|Overall Study||11
8477402|NCT00619892|20890963|P1|COMPLETED|Overall Study||10
8477403|NCT00619892|20890962|P2|STARTED|Overall Study||13
8477404|NCT00619892|20890963|P1|STARTED|Overall Study||13
8477405|NCT00619866|20890974|P5|NOT COMPLETED|Weeks 13 - 24||2
8477406|NCT00619866|20890975|P4|NOT COMPLETED|Weeks 13 - 24||4
8477407|NCT00619866|20890976|P3|NOT COMPLETED|Weeks 13 - 24||5
8477408|NCT00619866|20890977|P2|NOT COMPLETED|Weeks 13 - 24||7
8477409|NCT00619866|20890978|P1|NOT COMPLETED|Weeks 13 - 24||0
8477410|NCT00619866|20890974|P5|COMPLETED|Weeks 13 - 24||18
8477411|NCT00619866|20890975|P4|COMPLETED|Weeks 13 - 24||14
8477412|NCT00619866|20890976|P3|COMPLETED|Weeks 13 - 24||37
8477413|NCT00619866|20890977|P2|COMPLETED|Weeks 13 - 24||38
8477414|NCT00619866|20890978|P1|COMPLETED|Weeks 13 - 24||0
8477415|NCT00619866|20890974|P5|STARTED|Weeks 13 - 24||20
8477416|NCT00619866|20890975|P4|STARTED|Weeks 13 - 24||18
8477417|NCT00619866|20890976|P3|STARTED|Weeks 13 - 24||42
8477418|NCT00619866|20890977|P2|STARTED|Weeks 13 - 24||45
8477419|NCT00619866|20890978|P1|STARTED|Weeks 13 - 24||0
8477420|NCT00619866|20890974|P5|NOT COMPLETED|Weeks 1 - 12||0
8477421|NCT00619866|20890975|P4|NOT COMPLETED|Weeks 1 - 12||0
8477422|NCT00619866|20890976|P3|NOT COMPLETED|Weeks 1 - 12||10
8477423|NCT00619866|20890977|P2|NOT COMPLETED|Weeks 1 - 12||6
8477424|NCT00619866|20890978|P1|NOT COMPLETED|Weeks 1 - 12||14
8477425|NCT00619866|20890974|P5|COMPLETED|Weeks 1 - 12||0
8477426|NCT00619866|20890975|P4|COMPLETED|Weeks 1 - 12||0
8477427|NCT00619866|20890976|P3|COMPLETED|Weeks 1 - 12||42
8477428|NCT00619866|20890977|P2|COMPLETED|Weeks 1 - 12||45
8477429|NCT00619866|20890978|P1|COMPLETED|Weeks 1 - 12||38
8477430|NCT00619866|20890974|P5|STARTED|Weeks 1 - 12||0
8477431|NCT00619866|20890975|P4|STARTED|Weeks 1 - 12||0
8477432|NCT00619866|20890976|P3|STARTED|Weeks 1 - 12||52
8477433|NCT00619866|20890977|P2|STARTED|Weeks 1 - 12||51
8477434|NCT00619866|20890978|P1|STARTED|Weeks 1 - 12||52
8477435|NCT00619827|20891065|P2|NOT COMPLETED|Overall Study||4
8477436|NCT00619827|20891066|P1|NOT COMPLETED|Overall Study||3
8477437|NCT00619827|20891065|P2|COMPLETED|Overall Study||40
8477438|NCT00619827|20891066|P1|COMPLETED|Overall Study||42
8477439|NCT00619827|20891065|P2|STARTED|Overall Study||44
8477440|NCT00619827|20891066|P1|STARTED|Overall Study||45
8477441|NCT00619801|20891074|P2|NOT COMPLETED|Overall Study||3
8477442|NCT00619801|20891075|P1|NOT COMPLETED|Overall Study||1
8477443|NCT00619801|20891074|P2|COMPLETED|Overall Study||111
8477444|NCT00619801|20891075|P1|COMPLETED|Overall Study||58
8477445|NCT00619801|20891074|P2|Safety Population|Overall Study||114
8477446|NCT00619801|20891075|P1|Safety Population|Overall Study||59
8477447|NCT00619801|20891074|P2|STARTED|Overall Study||114
8477448|NCT00619801|20891075|P1|STARTED|Overall Study||59
8477449|NCT00619762|20891105|P1|NOT COMPLETED|Overall Study||3
8477450|NCT00619762|20891105|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
8477451|NCT00619762|20891105|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
8477452|NCT00619723|20891112|P2|NOT COMPLETED|Overall Study||6
8477453|NCT00619723|20891113|P1|NOT COMPLETED|Overall Study||2
8477454|NCT00619723|20891112|P2|COMPLETED|Overall Study||61
8477455|NCT00619723|20891113|P1|COMPLETED|Overall Study||61
8477456|NCT00619723|20891112|P2|STARTED|Overall Study||67
8477457|NCT00619723|20891113|P1|STARTED|Overall Study||63
8477458|NCT00619684|20891123|P1|NOT COMPLETED|Overall Study||0
8477459|NCT00619684|20891123|P1|COMPLETED|Overall Study||18
8477460|NCT00619684|20891123|P1|STARTED|Overall Study||18
8477461|NCT00619645|20891132|P1|NOT COMPLETED|Overall Study||1
8477462|NCT00619645|20891132|P1|COMPLETED|Overall Study||7
8477463|NCT00619645|20891132|P1|STARTED|Overall Study||8
8477464|NCT00619619|20891146|P8|NOT COMPLETED|Overall Study||3
8477465|NCT00619619|20891147|P7|NOT COMPLETED|Overall Study||1
8477466|NCT00619619|20891148|P6|NOT COMPLETED|Overall Study||0
8477467|NCT00619619|20891149|P5|NOT COMPLETED|Overall Study||2
8477468|NCT00619619|20891150|P4|NOT COMPLETED|Overall Study||1
8477469|NCT00619619|20891151|P3|NOT COMPLETED|Overall Study||1
8477470|NCT00619619|20891152|P2|NOT COMPLETED|Overall Study||0
8477471|NCT00619619|20891153|P1|NOT COMPLETED|Overall Study||0
8477472|NCT00619619|20891146|P8|COMPLETED|Overall Study||5
8477473|NCT00619619|20891147|P7|COMPLETED|Overall Study||7
8477474|NCT00619619|20891148|P6|COMPLETED|Overall Study||7
8477475|NCT00619619|20891149|P5|COMPLETED|Overall Study||5
8477476|NCT00619619|20891150|P4|COMPLETED|Overall Study||6
8477477|NCT00619619|20891151|P3|COMPLETED|Overall Study||8
8477478|NCT00619619|20891152|P2|COMPLETED|Overall Study||7
8477479|NCT00619619|20891153|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
8477480|NCT00619619|20891146|P8|Entered the Extension Study|Overall Study||7
8477481|NCT00619619|20891147|P7|Entered the Extension Study|Overall Study||6
8477482|NCT00619619|20891148|P6|Entered the Extension Study|Overall Study||6
8477483|NCT00619619|20891149|P5|Entered the Extension Study|Overall Study||7
8477484|NCT00619619|20891150|P4|Entered the Extension Study|Overall Study||3
8477485|NCT00619619|20891151|P3|Entered the Extension Study|Overall Study||8
8477486|NCT00619619|20891152|P2|Entered the Extension Study|Overall Study||5
8477487|NCT00619619|20891153|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
8477488|NCT00619619|20891146|P8|STARTED|Overall Study||8
8477489|NCT00619619|20891147|P7|STARTED|Overall Study||8
8477490|NCT00619619|20891148|P6|STARTED|Overall Study||7
8477491|NCT00619619|20891149|P5|STARTED|Overall Study||7
8477492|NCT00619619|20891150|P4|STARTED|Overall Study||7
8477493|NCT00619619|20891151|P3|STARTED|Overall Study||9
8477494|NCT00619619|20891152|P2|STARTED|Overall Study||7
8477495|NCT00619619|20891153|P1|STARTED|Overall Study||6
8477496|NCT00619515|20891238|P1|NOT COMPLETED|Overall Study||73
8477497|NCT00619515|20891238|P1|COMPLETED|Overall Study||0
8477498|NCT00619515|20891238|P1|STARTED|Overall Study||73
8477499|NCT00619502|20891252|P2|NOT COMPLETED|Overall Study||10
8477500|NCT00619502|20891253|P1|NOT COMPLETED|Overall Study||8
8477501|NCT00619502|20891252|P2|COMPLETED|Overall Study||114
8477502|NCT00619502|20891253|P1|COMPLETED|Overall Study||122
8477503|NCT00619502|20891252|P2|STARTED|Overall Study||124
8477504|NCT00619502|20891253|P1|STARTED|Overall Study||130
8477505|NCT00619489|20891265|P2|NOT COMPLETED|Overall Study||34
8477506|NCT00619489|20891266|P1|NOT COMPLETED|Overall Study||23
8477507|NCT00619489|20891265|P2|COMPLETED|Overall Study||1
8477508|NCT00619489|20891266|P1|COMPLETED|Overall Study||14
8477509|NCT00619489|20891265|P2|STARTED|Overall Study||35
8477510|NCT00619489|20891266|P1|STARTED|Overall Study||37
8477511|NCT00619476|20891288|P4|NOT COMPLETED|Overall Study||34
8477512|NCT00619476|20891289|P3|NOT COMPLETED|Overall Study||24
8477513|NCT00619476|20891290|P2|NOT COMPLETED|Overall Study||22
8477514|NCT00619476|20891291|P1|NOT COMPLETED|Overall Study||31
8477515|NCT00619476|20891288|P4|COMPLETED|Overall Study||56
8477516|NCT00619476|20891289|P3|COMPLETED|Overall Study||60
8477517|NCT00619476|20891290|P2|COMPLETED|Overall Study||85
8477518|NCT00619476|20891291|P1|COMPLETED|Overall Study||64
8477519|NCT00619476|20891288|P4|Safety Population|Overall Study||87
8477520|NCT00619476|20891289|P3|Safety Population|Overall Study||82
8477521|NCT00619476|20891290|P2|Safety Population|Overall Study||107
8477522|NCT00619476|20891291|P1|Safety Population|Overall Study||95
8477523|NCT00619476|20891288|P4|Intent-to-Treat Population|Overall Study||87
8477524|NCT00619476|20891289|P3|Intent-to-Treat Population|Overall Study||82
8477525|NCT00619476|20891290|P2|Intent-to-Treat Population|Overall Study||107
8477526|NCT00619476|20891291|P1|Intent-to-Treat Population|Overall Study||95
8477527|NCT00619476|20891288|P4|STARTED|Overall Study||90
8477528|NCT00619476|20891289|P3|STARTED|Overall Study||84
8477529|NCT00619476|20891290|P2|STARTED|Overall Study||107
8477530|NCT00619476|20891291|P1|STARTED|Overall Study||95
8477531|NCT00619385|20891376|P3|NOT COMPLETED|Overall Study||4
8477532|NCT00619385|20891377|P2|NOT COMPLETED|Overall Study||2
8477533|NCT00619385|20891378|P1|NOT COMPLETED|Overall Study||1
8477534|NCT00619385|20891376|P3|COMPLETED|Overall Study||6
8477535|NCT00619385|20891377|P2|COMPLETED|Overall Study||6
8477536|NCT00619385|20891378|P1|COMPLETED|Overall Study||6
8477537|NCT00619385|20891376|P3|STARTED|Overall Study||10
8477538|NCT00619385|20891377|P2|STARTED|Overall Study||8
8477539|NCT00619385|20891378|P1|STARTED|Overall Study||7
8477540|NCT00619359|20891393|P2|NOT COMPLETED|Overall Study||81
8477541|NCT00619359|20891394|P1|NOT COMPLETED|Overall Study||67
8477542|NCT00619359|20891393|P2|COMPLETED|Overall Study||1094
8477543|NCT00619359|20891394|P1|COMPLETED|Overall Study||1080
8477544|NCT00619359|20891393|P2|STARTED|Overall Study||1175
8477545|NCT00619359|20891394|P1|STARTED|Overall Study||1147
8477546|NCT00619307|20891406|P2|NOT COMPLETED|Overall Study||4
8477547|NCT00619307|20891407|P1|NOT COMPLETED|Overall Study||4
8477548|NCT00619307|20891406|P2|COMPLETED|Overall Study||53
8477549|NCT00619307|20891407|P1|COMPLETED|Overall Study||56
8477550|NCT00619307|20891406|P2|STARTED|Overall Study||57
8477551|NCT00619307|20891407|P1|STARTED|Overall Study||60
8477552|NCT00619255|20891423|P2|NOT COMPLETED|Overall Study||0
8477553|NCT00619255|20891424|P1|NOT COMPLETED|Overall Study||2
8477554|NCT00619255|20891423|P2|COMPLETED|Overall Study||61
8477555|NCT00619255|20891424|P1|COMPLETED|Overall Study||57
8477556|NCT00619255|20891423|P2|STARTED|Overall Study||61
8477557|NCT00619255|20891424|P1|STARTED|Overall Study||59
8477558|NCT00619242|20891438|P1|NOT COMPLETED|Overall Study||0
8477559|NCT00619242|20891438|P1|COMPLETED|Overall Study||3
8477560|NCT00619242|20891438|P1|STARTED|Overall Study||3
8477561|NCT00619229|20891444|P2|NOT COMPLETED|Overall Study||2
8477562|NCT00619229|20891445|P1|NOT COMPLETED|Overall Study||4
8477563|NCT00619229|20891444|P2|COMPLETED|Overall Study||16
8477564|NCT00619229|20891445|P1|COMPLETED|Overall Study||14
8477565|NCT00619229|20891444|P2|Full Analysis Set (FAS)|Overall Study||17
8477566|NCT00619229|20891445|P1|Full Analysis Set (FAS)|Overall Study||16
8477567|NCT00619229|20891444|P2|STARTED|Overall Study||18
8477568|NCT00619229|20891445|P1|STARTED|Overall Study||18
8477569|NCT00619190|20891473|P2|NOT COMPLETED|Overall Study||0
8477570|NCT00619190|20891474|P1|NOT COMPLETED|Overall Study||1
8477571|NCT00619190|20891473|P2|COMPLETED|Overall Study||9
8477572|NCT00619190|20891474|P1|COMPLETED|Overall Study||20
8477573|NCT00619190|20891473|P2|STARTED|Overall Study||9
8477574|NCT00619190|20891474|P1|STARTED|Overall Study||21
8477575|NCT00619177|20891484|P1|NOT COMPLETED|Overall Study||508
8477576|NCT00619177|20891484|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
8477577|NCT00619177|20891484|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
8477578|NCT00619151|20891494|P2|NOT COMPLETED|Overall Study||0
8477579|NCT00619151|20891495|P1|NOT COMPLETED|Overall Study||1
8477580|NCT00619151|20891494|P2|COMPLETED|Overall Study||0
8477581|NCT00619151|20891495|P1|COMPLETED|Overall Study||1
8477582|NCT00619151|20891494|P2|STARTED|Overall Study||0
8477583|NCT00619151|20891495|P1|STARTED|Overall Study||2
8477584|NCT00619112|20891505|P2|NOT COMPLETED|Overall Study||2
8477585|NCT00619112|20891506|P1|NOT COMPLETED|Overall Study||1
8477586|NCT00619112|20891505|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
8477587|NCT00619112|20891506|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
8477588|NCT00619112|20891505|P2|STARTED|Overall Study||20
8477589|NCT00619112|20891506|P1|STARTED|Overall Study||40
8477590|NCT00619099|20891527|P2|NOT COMPLETED|Overall Study||19
8477591|NCT00619099|20891528|P1|NOT COMPLETED|Overall Study||33
8477592|NCT00619099|20891527|P2|COMPLETED|Overall Study||4
8477593|NCT00619099|20891528|P1|COMPLETED|Overall Study||11
8477776|NCT00618410|20891867|P1|COMPLETED|Second Intervention||7
8477594|NCT00619099|20891527|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
8477595|NCT00619099|20891528|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
8477596|NCT00619099|20891527|P2|STARTED|Overall Study|All randomized subjects|23
8477597|NCT00619099|20891528|P1|STARTED|Overall Study|All randomized subjects|44
8477598|NCT00619073|20891534|P2|NOT COMPLETED|Second Intervention - 60 Days||0
8477599|NCT00619073|20891535|P1|NOT COMPLETED|Second Intervention - 60 Days||0
8477600|NCT00619073|20891534|P2|COMPLETED|Second Intervention - 60 Days||8
8477601|NCT00619073|20891535|P1|COMPLETED|Second Intervention - 60 Days||8
8477602|NCT00619073|20891534|P2|STARTED|Second Intervention - 60 Days||8
8477603|NCT00619073|20891535|P1|STARTED|Second Intervention - 60 Days||8
8477604|NCT00619073|20891534|P2|NOT COMPLETED|Washout Period (30 Days)||0
8477605|NCT00619073|20891535|P1|NOT COMPLETED|Washout Period (30 Days)||0
8477606|NCT00619073|20891534|P2|COMPLETED|Washout Period (30 Days)||8
8477607|NCT00619073|20891535|P1|COMPLETED|Washout Period (30 Days)||8
8477608|NCT00619073|20891534|P2|STARTED|Washout Period (30 Days)||8
8477609|NCT00619073|20891535|P1|STARTED|Washout Period (30 Days)||8
8477610|NCT00619073|20891534|P2|NOT COMPLETED|First Intervention - 60 Days||0
8477611|NCT00619073|20891535|P1|NOT COMPLETED|First Intervention - 60 Days||0
8477612|NCT00619073|20891534|P2|COMPLETED|First Intervention - 60 Days||8
8477613|NCT00619073|20891535|P1|COMPLETED|First Intervention - 60 Days||8
8477614|NCT00619073|20891534|P2|STARTED|First Intervention - 60 Days||8
8477615|NCT00619073|20891535|P1|STARTED|First Intervention - 60 Days||8
8477616|NCT00619060|20891541|P2|NOT COMPLETED|Overall Study||0
8477617|NCT00619060|20891542|P1|NOT COMPLETED|Overall Study||0
8477618|NCT00619060|20891541|P2|COMPLETED|Overall Study||12
8477619|NCT00619060|20891542|P1|COMPLETED|Overall Study||10
8477620|NCT00619060|20891541|P2|STARTED|Overall Study||12
8477621|NCT00619060|20891542|P1|STARTED|Overall Study||10
8477622|NCT00618995|20891550|P4|NOT COMPLETED|Period 4||0
8477623|NCT00618995|20891551|P3|NOT COMPLETED|Period 4||0
8477624|NCT00618995|20891552|P2|NOT COMPLETED|Period 4||0
8477625|NCT00618995|20891553|P1|NOT COMPLETED|Period 4||1
8477626|NCT00618995|20891550|P4|COMPLETED|Period 4||6
8477627|NCT00618995|20891551|P3|COMPLETED|Period 4||4
8477628|NCT00618995|20891552|P2|COMPLETED|Period 4||6
8477629|NCT00618995|20891553|P1|COMPLETED|Period 4||5
8477630|NCT00618995|20891550|P4|STARTED|Period 4||6
8477631|NCT00618995|20891551|P3|STARTED|Period 4||4
8477632|NCT00618995|20891552|P2|STARTED|Period 4||6
8477633|NCT00618995|20891553|P1|STARTED|Period 4||6
8477634|NCT00618995|20891550|P4|NOT COMPLETED|Period 3||0
8477635|NCT00618995|20891551|P3|NOT COMPLETED|Period 3||0
8477636|NCT00618995|20891552|P2|NOT COMPLETED|Period 3||0
8477637|NCT00618995|20891553|P1|NOT COMPLETED|Period 3||0
8477638|NCT00618995|20891550|P4|COMPLETED|Period 3||6
8477639|NCT00618995|20891551|P3|COMPLETED|Period 3||4
8477640|NCT00618995|20891552|P2|COMPLETED|Period 3||6
8477641|NCT00618995|20891553|P1|COMPLETED|Period 3||6
8477642|NCT00618995|20891550|P4|STARTED|Period 3||6
8477643|NCT00618995|20891551|P3|STARTED|Period 3||4
8477644|NCT00618995|20891552|P2|STARTED|Period 3||6
8477645|NCT00618995|20891553|P1|STARTED|Period 3||6
8477646|NCT00618995|20891550|P4|NOT COMPLETED|Period 2||0
8477647|NCT00618995|20891551|P3|NOT COMPLETED|Period 2||1
8477648|NCT00618995|20891552|P2|NOT COMPLETED|Period 2||0
8477649|NCT00618995|20891553|P1|NOT COMPLETED|Period 2||0
8477650|NCT00618995|20891550|P4|COMPLETED|Period 2||6
8477651|NCT00618995|20891551|P3|COMPLETED|Period 2||4
8477652|NCT00618995|20891552|P2|COMPLETED|Period 2||6
8477653|NCT00618995|20891553|P1|COMPLETED|Period 2||6
8477654|NCT00618995|20891550|P4|STARTED|Period 2||6
8477655|NCT00618995|20891551|P3|STARTED|Period 2||5
8477656|NCT00618995|20891552|P2|STARTED|Period 2||6
8477657|NCT00618995|20891553|P1|STARTED|Period 2||6
8477658|NCT00618995|20891550|P4|NOT COMPLETED|Period 1||0
8477659|NCT00618995|20891551|P3|NOT COMPLETED|Period 1||2
8477660|NCT00618995|20891552|P2|NOT COMPLETED|Period 1||1
8477661|NCT00618995|20891553|P1|NOT COMPLETED|Period 1||0
8477662|NCT00618995|20891550|P4|COMPLETED|Period 1||6
8477663|NCT00618995|20891551|P3|COMPLETED|Period 1||5
8477664|NCT00618995|20891552|P2|COMPLETED|Period 1||6
8477665|NCT00618995|20891553|P1|COMPLETED|Period 1||6
8477666|NCT00618995|20891550|P4|STARTED|Period 1||6
8477667|NCT00618995|20891551|P3|STARTED|Period 1||7
8477668|NCT00618995|20891552|P2|STARTED|Period 1||7
8477669|NCT00618995|20891553|P1|STARTED|Period 1||6
8477670|NCT00618982|20891567|P1|NOT COMPLETED|Overall Study||50
8477671|NCT00618982|20891567|P1|COMPLETED|Overall Study||33
8477672|NCT00618982|20891567|P1|STARTED|Overall Study||83
8477673|NCT00618956|20891590|P2|NOT COMPLETED|Overall Study||50
8477674|NCT00618956|20891591|P1|NOT COMPLETED|Overall Study||25
8477675|NCT00618956|20891590|P2|COMPLETED|Overall Study||160
8477676|NCT00618956|20891591|P1|COMPLETED|Overall Study||86
8477677|NCT00618956|20891590|P2|STARTED|Overall Study||210
8477678|NCT00618956|20891591|P1|STARTED|Overall Study||111
8477679|NCT00618839|20891607|P1|NOT COMPLETED|Overall Study||0
8477680|NCT00618839|20891607|P1|COMPLETED|Overall Study||15
8477681|NCT00618839|20891607|P1|STARTED|Overall Study||15
8477682|NCT00618826|20891616|P1|NOT COMPLETED|Overall Study||1
8477683|NCT00618826|20891616|P1|COMPLETED|Overall Study||13
8477684|NCT00618826|20891616|P1|STARTED|Overall Study||14
8477685|NCT00618813|20891621|P1|NOT COMPLETED|Overall Study||4
8477686|NCT00618813|20891621|P1|COMPLETED|Overall Study||31
8477777|NCT00618410|20891866|P2|STARTED|Second Intervention||5
8477687|NCT00618813|20891621|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
8477688|NCT00618813|20891621|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
8477689|NCT00618813|20891621|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
8477690|NCT00618813|20891621|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
8477691|NCT00618813|20891621|P1|STARTED|Overall Study||35
8477692|NCT00618787|20891631|P2|NOT COMPLETED|Overall Study||2
8477693|NCT00618787|20891632|P1|NOT COMPLETED|Overall Study||3
8477694|NCT00618787|20891631|P2|COMPLETED|Overall Study||21
8477695|NCT00618787|20891632|P1|COMPLETED|Overall Study||19
8477696|NCT00618787|20891631|P2|STARTED|Overall Study||23
8477697|NCT00618787|20891632|P1|STARTED|Overall Study||22
8477698|NCT00618774|20891640|P2|NOT COMPLETED|Overall Study||3
8477699|NCT00618774|20891641|P1|NOT COMPLETED|Overall Study||6
8477700|NCT00618774|20891640|P2|COMPLETED|Overall Study||45
8477701|NCT00618774|20891641|P1|COMPLETED|Overall Study||205
8477702|NCT00618774|20891640|P2|STARTED|Overall Study||48
8477703|NCT00618774|20891641|P1|STARTED|Overall Study||211
8477704|NCT00618748|20891674|P3|NOT COMPLETED|Overall Study||14
8477705|NCT00618748|20891675|P2|NOT COMPLETED|Overall Study||5
8477706|NCT00618748|20891676|P1|NOT COMPLETED|Overall Study||11
8477707|NCT00618748|20891674|P3|COMPLETED|Overall Study||6
8477708|NCT00618748|20891675|P2|COMPLETED|Overall Study||20
8477709|NCT00618748|20891676|P1|COMPLETED|Overall Study||45
8477710|NCT00618748|20891674|P3|STARTED|Overall Study||20
8477711|NCT00618748|20891675|P2|STARTED|Overall Study||25
8477712|NCT00618748|20891676|P1|STARTED|Overall Study||56
8477713|NCT00618722|20891721|P4|NOT COMPLETED|Overall Study||4
8477714|NCT00618722|20891722|P3|NOT COMPLETED|Overall Study||3
8477715|NCT00618722|20891723|P2|NOT COMPLETED|Overall Study||2
8477716|NCT00618722|20891724|P1|NOT COMPLETED|Overall Study||3
8477717|NCT00618722|20891721|P4|COMPLETED|Overall Study||18
8477718|NCT00618722|20891722|P3|COMPLETED|Overall Study||19
8477719|NCT00618722|20891723|P2|COMPLETED|Overall Study||18
8477720|NCT00618722|20891724|P1|COMPLETED|Overall Study||18
8477721|NCT00618722|20891721|P4|Received Treatment|Overall Study||22
8477722|NCT00618722|20891722|P3|Received Treatment|Overall Study||22
8477723|NCT00618722|20891723|P2|Received Treatment|Overall Study||20
8477724|NCT00618722|20891724|P1|Received Treatment|Overall Study||20
8477725|NCT00618722|20891721|P4|STARTED|Overall Study||22
8477726|NCT00618722|20891722|P3|STARTED|Overall Study||22
8477727|NCT00618722|20891723|P2|STARTED|Overall Study||20
8477728|NCT00618722|20891724|P1|STARTED|Overall Study||21
8477729|NCT00618618|20891762|P4|NOT COMPLETED|Overall Study||1
8477730|NCT00618618|20891763|P3|NOT COMPLETED|Overall Study||3
8477731|NCT00618618|20891764|P2|NOT COMPLETED|Overall Study||3
8477732|NCT00618618|20891765|P1|NOT COMPLETED|Overall Study||4
8477733|NCT00618618|20891762|P4|COMPLETED|Overall Study||13
8477734|NCT00618618|20891763|P3|COMPLETED|Overall Study||18
8477735|NCT00618618|20891764|P2|COMPLETED|Overall Study||11
8477736|NCT00618618|20891765|P1|COMPLETED|Overall Study||20
8477737|NCT00618618|20891762|P4|Received Treatment|Overall Study||14
8477738|NCT00618618|20891763|P3|Received Treatment|Overall Study||20
8477739|NCT00618618|20891764|P2|Received Treatment|Overall Study||13
8477740|NCT00618618|20891765|P1|Received Treatment|Overall Study||24
8477741|NCT00618618|20891762|P4|STARTED|Overall Study||14
8477742|NCT00618618|20891763|P3|STARTED|Overall Study||21
8477743|NCT00618618|20891764|P2|STARTED|Overall Study||14
8477744|NCT00618618|20891765|P1|STARTED|Overall Study||24
8477745|NCT00618540|20891811|P1|NOT COMPLETED|Overall Study||0
8477746|NCT00618540|20891811|P1|COMPLETED|Overall Study||1
8477747|NCT00618540|20891811|P1|STARTED|Overall Study||1
8477748|NCT00618514|20891824|P3|NOT COMPLETED|Overall Study||4
8477749|NCT00618514|20891825|P2|NOT COMPLETED|Overall Study||12
8477750|NCT00618514|20891826|P1|NOT COMPLETED|Overall Study||11
8477751|NCT00618514|20891824|P3|COMPLETED|Overall Study||12
8477752|NCT00618514|20891825|P2|COMPLETED|Overall Study||26
8477753|NCT00618514|20891826|P1|COMPLETED|Overall Study||25
8477754|NCT00618514|20891824|P3|STARTED|Overall Study||16
8477755|NCT00618514|20891825|P2|STARTED|Overall Study||38
8477756|NCT00618514|20891826|P1|STARTED|Overall Study||36
8477757|NCT00618449|20891846|P2|NOT COMPLETED|Overall Study||110
8477758|NCT00618449|20891847|P1|NOT COMPLETED|Overall Study||98
8477759|NCT00618449|20891846|P2|COMPLETED|Overall Study||558
8477760|NCT00618449|20891847|P1|COMPLETED|Overall Study||581
8477761|NCT00618449|20891846|P2|1-year, Post-treatment|Overall Study||558
8477762|NCT00618449|20891847|P1|1-year, Post-treatment|Overall Study||581
8477763|NCT00618449|20891846|P2|1-month, Post-treatment|Overall Study||656
8477764|NCT00618449|20891847|P1|1-month, Post-treatment|Overall Study||666
8477765|NCT00618449|20891846|P2|STARTED|Overall Study||668
8477766|NCT00618449|20891847|P1|STARTED|Overall Study||679
8477767|NCT00618436|20891855|P2|NOT COMPLETED|Overall Study||0
8477768|NCT00618436|20891856|P1|NOT COMPLETED|Overall Study||0
8477769|NCT00618436|20891855|P2|COMPLETED|Overall Study||18
8477770|NCT00618436|20891856|P1|COMPLETED|Overall Study||34
8477771|NCT00618436|20891855|P2|STARTED|Overall Study||18
8477772|NCT00618436|20891856|P1|STARTED|Overall Study||34
8477773|NCT00618410|20891866|P2|NOT COMPLETED|Second Intervention||0
8477774|NCT00618410|20891867|P1|NOT COMPLETED|Second Intervention||0
8477775|NCT00618410|20891866|P2|COMPLETED|Second Intervention||5
8477778|NCT00618410|20891867|P1|STARTED|Second Intervention||7
8477779|NCT00618410|20891866|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
8477780|NCT00618410|20891867|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8477781|NCT00618410|20891866|P2|COMPLETED|Washout Period (2 Weeks)||5
8477782|NCT00618410|20891867|P1|COMPLETED|Washout Period (2 Weeks)||7
8477783|NCT00618410|20891866|P2|STARTED|Washout Period (2 Weeks)||6
8477784|NCT00618410|20891867|P1|STARTED|Washout Period (2 Weeks)||7
8477785|NCT00618410|20891866|P2|NOT COMPLETED|First Intervention||0
8477786|NCT00618410|20891867|P1|NOT COMPLETED|First Intervention||0
8477787|NCT00618410|20891866|P2|COMPLETED|First Intervention||6
8477788|NCT00618410|20891867|P1|COMPLETED|First Intervention||7
8477789|NCT00618410|20891866|P2|STARTED|First Intervention||6
8477790|NCT00618410|20891867|P1|STARTED|First Intervention||7
8477791|NCT00618371|20891883|P1|NOT COMPLETED|Overall Study||2
8477792|NCT00618371|20891883|P1|COMPLETED|Overall Study||10
8477793|NCT00618371|20891883|P1|STARTED|Overall Study||12
8477794|NCT00618332|20891890|P2|NOT COMPLETED|Overall Study||0
8477795|NCT00618332|20891891|P1|NOT COMPLETED|Overall Study||0
8477796|NCT00618332|20891890|P2|COMPLETED|Overall Study||20
8477797|NCT00618332|20891891|P1|COMPLETED|Overall Study||20
8477798|NCT00618332|20891890|P2|STARTED|Overall Study||20
8477799|NCT00618332|20891891|P1|STARTED|Overall Study||20
8477800|NCT00618072|20891916|P3|NOT COMPLETED|Overall Study||4
8477801|NCT00618072|20891917|P2|NOT COMPLETED|Overall Study||1
8477802|NCT00618072|20891918|P1|NOT COMPLETED|Overall Study||2
8477803|NCT00618072|20891916|P3|COMPLETED|Overall Study||11
8477804|NCT00618072|20891917|P2|COMPLETED|Overall Study||14
8477805|NCT00618072|20891918|P1|COMPLETED|Overall Study||14
8477806|NCT00618072|20891916|P3|STARTED|Overall Study||15
8477807|NCT00618072|20891917|P2|STARTED|Overall Study||15
8477808|NCT00618072|20891918|P1|STARTED|Overall Study||16
8477809|NCT00617981|20891952|P2|NOT COMPLETED|Overall Study||102
8477810|NCT00617981|20891953|P1|NOT COMPLETED|Overall Study||110
8477811|NCT00617981|20891952|P2|COMPLETED|Overall Study||245
8477812|NCT00617981|20891953|P1|COMPLETED|Overall Study||244
8477813|NCT00617981|20891952|P2|STARTED|Overall Study||347
8477814|NCT00617981|20891953|P1|STARTED|Overall Study||354
8477815|NCT00617942|20891961|P2|NOT COMPLETED|Overall Study||4
8477816|NCT00617942|20891962|P1|NOT COMPLETED|Overall Study||8
8477817|NCT00617942|20891961|P2|COMPLETED|Overall Study||19
8477818|NCT00617942|20891962|P1|COMPLETED|Overall Study||29
8477819|NCT00617942|20891961|P2|STARTED|Overall Study||23
8477820|NCT00617942|20891962|P1|STARTED|Overall Study||37
8477821|NCT00617929|20891974|P1|NOT COMPLETED|Overall Study||1
8477822|NCT00617929|20891974|P1|COMPLETED|Overall Study||11
8477823|NCT00617929|20891974|P1|STARTED|Overall Study||12
8477824|NCT00617903|20891986|P2|NOT COMPLETED|Overall Study||7
8477825|NCT00617903|20891987|P1|NOT COMPLETED|Overall Study||3
8477826|NCT00617903|20891986|P2|COMPLETED|Overall Study||35
8477827|NCT00617903|20891987|P1|COMPLETED|Overall Study||38
8477828|NCT00617903|20891986|P2|STARTED|Overall Study||42
8477829|NCT00617903|20891987|P1|STARTED|Overall Study||41
8477830|NCT00617890|20892033|P4|NOT COMPLETED|Overall Study||115
8477831|NCT00617890|20892034|P3|NOT COMPLETED|Overall Study||35
8477832|NCT00617890|20892035|P2|NOT COMPLETED|Overall Study||28
8477833|NCT00617890|20892036|P1|NOT COMPLETED|Overall Study||31
8477834|NCT00617890|20892033|P4|COMPLETED|Overall Study||1
8477835|NCT00617890|20892034|P3|COMPLETED|Overall Study||0
8477836|NCT00617890|20892035|P2|COMPLETED|Overall Study||5
8477837|NCT00617890|20892036|P1|COMPLETED|Overall Study||4
8477838|NCT00617890|20892033|P4|Received Treatment|Overall Study||115
8477839|NCT00617890|20892034|P3|Received Treatment|Overall Study||34
8477840|NCT00617890|20892035|P2|Received Treatment|Overall Study||33
8477841|NCT00617890|20892036|P1|Received Treatment|Overall Study||34
8477842|NCT00617890|20892033|P4|STARTED|Overall Study||116
8477843|NCT00617890|20892034|P3|STARTED|Overall Study||35
8477844|NCT00617890|20892035|P2|STARTED|Overall Study||33
8477845|NCT00617890|20892036|P1|STARTED|Overall Study||35
8477846|NCT00617851|20892072|P4|NOT COMPLETED|Overall Study||25
8477847|NCT00617851|20892073|P3|NOT COMPLETED|Overall Study||45
8477848|NCT00617851|20892074|P2|NOT COMPLETED|Overall Study||40
8477849|NCT00617851|20892075|P1|NOT COMPLETED|Overall Study||47
8477850|NCT00617851|20892072|P4|COMPLETED|Overall Study||192
8477851|NCT00617851|20892073|P3|COMPLETED|Overall Study||384
8477852|NCT00617851|20892074|P2|COMPLETED|Overall Study||391
8477853|NCT00617851|20892075|P1|COMPLETED|Overall Study||383
8477854|NCT00617851|20892072|P4|STARTED|Overall Study||217
8477855|NCT00617851|20892073|P3|STARTED|Overall Study||429
8477856|NCT00617851|20892074|P2|STARTED|Overall Study||431
8477857|NCT00617851|20892075|P1|STARTED|Overall Study||430
8477858|NCT00617773|20892113|P1|NOT COMPLETED|Overall Study||24
8477859|NCT00617773|20892113|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
8477860|NCT00617773|20892113|P1|STARTED|Overall Study||31
8477861|NCT00617734|20892130|P2|NOT COMPLETED|Overall Study||6
8477862|NCT00617734|20892131|P1|NOT COMPLETED|Overall Study||8
8477863|NCT00617734|20892130|P2|COMPLETED|Overall Study||42
8477864|NCT00617734|20892131|P1|COMPLETED|Overall Study||41
8477865|NCT00617734|20892130|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
8477866|NCT00617734|20892131|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
8477867|NCT00617734|20892130|P2|STARTED|Overall Study||48
8477868|NCT00617734|20892131|P1|STARTED|Overall Study||49
8477869|NCT00617708|20892152|P3|NOT COMPLETED|Overall Study||64
8477870|NCT00617708|20892153|P2|NOT COMPLETED|Overall Study||60
8477871|NCT00617708|20892154|P1|NOT COMPLETED|Overall Study||10
8477872|NCT00617708|20892152|P3|COMPLETED|Overall Study||0
8477873|NCT00617708|20892153|P2|COMPLETED|Overall Study||0
8477874|NCT00617708|20892154|P1|COMPLETED|Overall Study||0
8477875|NCT00617708|20892152|P3|Eligible and Began Protocol Therapy|Overall Study||59
8477876|NCT00617708|20892153|P2|Eligible and Began Protocol Therapy|Overall Study||57
8477877|NCT00617708|20892154|P1|Eligible and Began Protocol Therapy|Overall Study||9
8477878|NCT00617708|20892152|P3|STARTED|Overall Study||64
8477879|NCT00617708|20892153|P2|STARTED|Overall Study||60
8477880|NCT00617708|20892154|P1|STARTED|Overall Study||10
8477881|NCT00617669|20892171|P2|NOT COMPLETED|Overall Study||451
8477882|NCT00617669|20892172|P1|NOT COMPLETED|Overall Study||430
8477883|NCT00617669|20892171|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
8477884|NCT00617669|20892172|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
8477885|NCT00617669|20892171|P2|Patients Who Received IP|Overall Study||525
8477886|NCT00617669|20892172|P1|Patients Who Received IP|Overall Study||522
8477887|NCT00617669|20892171|P2|STARTED|Overall Study||528
8477888|NCT00617669|20892172|P1|STARTED|Overall Study||524
8477889|NCT00617604|20892194|P2|NOT COMPLETED|Overall Study||20
8477890|NCT00617604|20892195|P1|NOT COMPLETED|Overall Study||18
8477891|NCT00617604|20892194|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
8477892|NCT00617604|20892195|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
8477893|NCT00617604|20892194|P2|Completed 12 Weeks of Treatment|Overall Study||83
8477894|NCT00617604|20892195|P1|Completed 12 Weeks of Treatment|Overall Study||89
8477895|NCT00617604|20892194|P2|Received Treatment|Overall Study||105
8477896|NCT00617604|20892195|P1|Received Treatment|Overall Study||107
8477897|NCT00617604|20892194|P2|STARTED|Overall Study||108
8477898|NCT00617604|20892195|P1|STARTED|Overall Study||110
8477899|NCT00617591|20892239|P1|NOT COMPLETED|Overall Study||10
8477900|NCT00617591|20892239|P1|COMPLETED|Overall Study||47
8477901|NCT00617591|20892239|P1|STARTED|Overall Study||57
8477902|NCT00617539|20892247|P1|NOT COMPLETED|Overall Study||0
8477903|NCT00617539|20892247|P1|COMPLETED|Overall Study||30
8477904|NCT00617539|20892247|P1|STARTED|Overall Study||30
8477905|NCT00617461|20892255|P2|NOT COMPLETED|6-Day Down-Titration Period||2
8477906|NCT00617461|20892256|P1|NOT COMPLETED|6-Day Down-Titration Period||2
8477907|NCT00617461|20892255|P2|COMPLETED|6-Day Down-Titration Period||35
8477908|NCT00617461|20892256|P1|COMPLETED|6-Day Down-Titration Period||39
8477909|NCT00617461|20892255|P2|STARTED|6-Day Down-Titration Period||37
8477910|NCT00617461|20892256|P1|STARTED|6-Day Down-Titration Period||41
8477911|NCT00617461|20892255|P2|NOT COMPLETED|Second Treatment Intervention Period||4
8477912|NCT00617461|20892256|P1|NOT COMPLETED|Second Treatment Intervention Period||0
8477913|NCT00617461|20892255|P2|COMPLETED|Second Treatment Intervention Period||37
8477914|NCT00617461|20892256|P1|COMPLETED|Second Treatment Intervention Period||41
8477915|NCT00617461|20892255|P2|STARTED|Second Treatment Intervention Period||41
8477916|NCT00617461|20892256|P1|STARTED|Second Treatment Intervention Period||41
8477917|NCT00617461|20892255|P2|NOT COMPLETED|4-Day Crossover Period||0
8477918|NCT00617461|20892256|P1|NOT COMPLETED|4-Day Crossover Period||1
8477919|NCT00617461|20892255|P2|COMPLETED|4-Day Crossover Period||40
8477920|NCT00617461|20892256|P1|COMPLETED|4-Day Crossover Period||41
8477921|NCT00617461|20892255|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
8477922|NCT00617461|20892256|P1|STARTED|4-Day Crossover Period||42
8477923|NCT00617461|20892255|P2|NOT COMPLETED|First Treatment Intervention Period||3
8477924|NCT00617461|20892256|P1|NOT COMPLETED|First Treatment Intervention Period||10
8477925|NCT00617461|20892255|P2|COMPLETED|First Treatment Intervention Period||41
8477926|NCT00617461|20892256|P1|COMPLETED|First Treatment Intervention Period||42
8477927|NCT00617461|20892255|P2|STARTED|First Treatment Intervention Period||44
8477928|NCT00617461|20892256|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
8477929|NCT00617409|20892312|P3|NOT COMPLETED|Overall Study||27
8477930|NCT00617409|20892313|P2|NOT COMPLETED|Overall Study||18
8477931|NCT00617409|20892314|P1|NOT COMPLETED|Overall Study||16
8477932|NCT00617409|20892312|P3|COMPLETED|Overall Study||4
8477933|NCT00617409|20892313|P2|COMPLETED|Overall Study||2
8477934|NCT00617409|20892314|P1|COMPLETED|Overall Study||2
8477935|NCT00617409|20892312|P3|STARTED|Overall Study||31
8477936|NCT00617409|20892313|P2|STARTED|Overall Study||20
8477937|NCT00617409|20892314|P1|STARTED|Overall Study||18
8477938|NCT00617396|20892325|P1|NOT COMPLETED|Overall Study||0
8477939|NCT00617396|20892325|P1|COMPLETED|Overall Study||25
8477940|NCT00617396|20892325|P1|STARTED|Overall Study||25
8477941|NCT00617357|20892329|P1|NOT COMPLETED|Overall Study||16
8477942|NCT00617357|20892329|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
8477943|NCT00617357|20892329|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
8477944|NCT00617344|20892342|P3|NOT COMPLETED|Overall Study||8
8477945|NCT00617344|20892343|P2|NOT COMPLETED|Overall Study||22
8477946|NCT00617344|20892344|P1|NOT COMPLETED|Overall Study||25
8477947|NCT00617344|20892342|P3|COMPLETED|Overall Study||45
8477948|NCT00617344|20892343|P2|COMPLETED|Overall Study||81
8477949|NCT00617344|20892344|P1|COMPLETED|Overall Study||79
8477950|NCT00617344|20892342|P3|Received Vaccination 3|Overall Study||45
8477951|NCT00617344|20892343|P2|Received Vaccination 3|Overall Study||81
8477952|NCT00617344|20892344|P1|Received Vaccination 3|Overall Study||79
8477953|NCT00617344|20892342|P3|Received Vaccination 2|Overall Study||46
8477954|NCT00617344|20892343|P2|Received Vaccination 2|Overall Study||85
8477955|NCT00617344|20892344|P1|Received Vaccination 2|Overall Study||86
8477956|NCT00617344|20892342|P3|Received Vaccination 1|Overall Study||53
8477957|NCT00617344|20892343|P2|Received Vaccination 1|Overall Study||103
8477958|NCT00617344|20892344|P1|Received Vaccination 1|Overall Study||104
8477959|NCT00617344|20892342|P3|STARTED|Overall Study||53
8477960|NCT00617344|20892343|P2|STARTED|Overall Study||103
8477961|NCT00617344|20892344|P1|STARTED|Overall Study||104
8477962|NCT00617305|20892372|P3|NOT COMPLETED|Overall Study||1
8477963|NCT00617305|20892373|P2|NOT COMPLETED|Overall Study||0
8477964|NCT00617305|20892374|P1|NOT COMPLETED|Overall Study||8
8477965|NCT00617305|20892372|P3|COMPLETED|Overall Study||0
8477966|NCT00617305|20892373|P2|COMPLETED|Overall Study||4
8477967|NCT00617305|20892374|P1|COMPLETED|Overall Study||25
8477968|NCT00617305|20892372|P3|Completed 24-week Primary Analysis|Overall Study||0
8477969|NCT00617305|20892373|P2|Completed 24-week Primary Analysis|Overall Study||4
8477970|NCT00617305|20892374|P1|Completed 24-week Primary Analysis|Overall Study||31
8477971|NCT00617305|20892372|P3|STARTED|Overall Study||1
8477972|NCT00617305|20892373|P2|STARTED|Overall Study||4
8477973|NCT00617305|20892374|P1|STARTED|Overall Study||33
8477974|NCT00617279|20892430|P2|NOT COMPLETED|Overall Study||17
8477975|NCT00617279|20892431|P1|NOT COMPLETED|Overall Study||14
8477976|NCT00617279|20892430|P2|COMPLETED|Overall Study||0
8477977|NCT00617279|20892431|P1|COMPLETED|Overall Study||0
8477978|NCT00617279|20892430|P2|STARTED|Overall Study||17
8477979|NCT00617279|20892431|P1|STARTED|Overall Study||14
8477980|NCT00617240|20892487|P2|NOT COMPLETED|Overall Study||0
8477981|NCT00617240|20892488|P1|NOT COMPLETED|Overall Study||1
8477982|NCT00617240|20892487|P2|COMPLETED|Overall Study||4
8477983|NCT00617240|20892488|P1|COMPLETED|Overall Study||4
8477984|NCT00617240|20892487|P2|STARTED|Overall Study||4
8477985|NCT00617240|20892488|P1|STARTED|Overall Study||5
8477986|NCT00617201|20892508|P2|NOT COMPLETED|Overall Study||13
8477987|NCT00617201|20892509|P1|NOT COMPLETED|Overall Study||9
8477988|NCT00617201|20892508|P2|COMPLETED|Overall Study||12
8477989|NCT00617201|20892509|P1|COMPLETED|Overall Study||16
8477990|NCT00617201|20892508|P2|STARTED|Overall Study||25
8477991|NCT00617201|20892509|P1|STARTED|Overall Study||25
8477992|NCT00617188|20892517|P1|NOT COMPLETED|Overall Study||0
8477993|NCT00617188|20892517|P1|COMPLETED|Overall Study||26
8477994|NCT00617188|20892517|P1|STARTED|Overall Study||26
8477995|NCT00617175|20892528|P2|NOT COMPLETED|Overall Study||0
8477996|NCT00617175|20892529|P1|NOT COMPLETED|Overall Study||0
8477997|NCT00617175|20892528|P2|COMPLETED|Overall Study||948
8477998|NCT00617175|20892529|P1|COMPLETED|Overall Study||954
8477999|NCT00617175|20892528|P2|STARTED|Overall Study||948
8478000|NCT00617175|20892529|P1|STARTED|Overall Study||954
8478001|NCT00617123|20892537|P2|NOT COMPLETED|Study Treatment Period||16
8478002|NCT00617123|20892538|P1|NOT COMPLETED|Study Treatment Period||17
8478003|NCT00617123|20892537|P2|COMPLETED|Study Treatment Period||79
8478004|NCT00617123|20892538|P1|COMPLETED|Study Treatment Period||81
8478005|NCT00617123|20892537|P2|Treated|Study Treatment Period||95
8478006|NCT00617123|20892538|P1|Treated|Study Treatment Period|1 participant was not treated|97
8478007|NCT00617123|20892537|P2|STARTED|Study Treatment Period||95
8478008|NCT00617123|20892538|P1|STARTED|Study Treatment Period||98
8478009|NCT00617123|20892537|P2|NOT COMPLETED|Referral Screening Period||26
8478010|NCT00617123|20892538|P1|NOT COMPLETED|Referral Screening Period||39
8478011|NCT00617123|20892537|P2|COMPLETED|Referral Screening Period||95
8478012|NCT00617123|20892538|P1|COMPLETED|Referral Screening Period||98
8478013|NCT00617123|20892537|P2|STARTED|Referral Screening Period||121
8478014|NCT00617123|20892538|P1|STARTED|Referral Screening Period||137
8478015|NCT00617097|20892554|P2|NOT COMPLETED|Overall Study||0
8478016|NCT00617097|20892555|P1|NOT COMPLETED|Overall Study||0
8478017|NCT00617097|20892554|P2|COMPLETED|Overall Study||25
8478018|NCT00617097|20892555|P1|COMPLETED|Overall Study||25
8478019|NCT00617097|20892554|P2|STARTED|Overall Study||25
8478020|NCT00617097|20892555|P1|STARTED|Overall Study||25
8478021|NCT00617084|20892569|P2|NOT COMPLETED|Overall Study||26
8478022|NCT00617084|20892570|P1|NOT COMPLETED|Overall Study||21
8478023|NCT00617084|20892569|P2|COMPLETED|Overall Study||1126
8478024|NCT00617084|20892570|P1|COMPLETED|Overall Study||1119
8478025|NCT00617084|20892569|P2|STARTED|Overall Study||1152
8478026|NCT00617084|20892570|P1|STARTED|Overall Study||1140
8478027|NCT00617058|20892581|P3|NOT COMPLETED|Overall Study||0
8478028|NCT00617058|20892582|P2|NOT COMPLETED|Overall Study||0
8478029|NCT00617058|20892583|P1|NOT COMPLETED|Overall Study||0
8478030|NCT00617058|20892581|P3|COMPLETED|Overall Study||0
8478031|NCT00617058|20892582|P2|COMPLETED|Overall Study||0
8478032|NCT00617058|20892583|P1|COMPLETED|Overall Study||1
8478033|NCT00617058|20892581|P3|STARTED|Overall Study||0
8478034|NCT00617058|20892582|P2|STARTED|Overall Study||0
8478035|NCT00617058|20892583|P1|STARTED|Overall Study||1
8478045|NCT00616941|20892650|P3|NOT COMPLETED|Overall Study||6
8478046|NCT00616941|20892651|P2|NOT COMPLETED|Overall Study||5
8478047|NCT00616941|20892652|P1|NOT COMPLETED|Overall Study||1
8478048|NCT00616941|20892650|P3|COMPLETED|Overall Study||5
8478049|NCT00616941|20892651|P2|COMPLETED|Overall Study||8
8478050|NCT00616941|20892652|P1|COMPLETED|Overall Study||3
8478051|NCT00616941|20892650|P3|STARTED|Overall Study||11
8478052|NCT00616941|20892651|P2|STARTED|Overall Study||13
8478053|NCT00616941|20892652|P1|STARTED|Overall Study||4
8478054|NCT00616928|20892679|P4|NOT COMPLETED|Overall Study||7
8478055|NCT00616928|20892680|P3|NOT COMPLETED|Overall Study||17
8478056|NCT00616928|20892681|P2|NOT COMPLETED|Overall Study||18
8478057|NCT00616928|20892682|P1|NOT COMPLETED|Overall Study||62
8478058|NCT00616928|20892679|P4|COMPLETED|Overall Study||364
8478059|NCT00616928|20892680|P3|COMPLETED|Overall Study||1101
8478060|NCT00616928|20892681|P2|COMPLETED|Overall Study||750
8478061|NCT00616928|20892682|P1|COMPLETED|Overall Study||2242
8478062|NCT00616928|20892679|P4|STARTED|Overall Study||371
8478063|NCT00616928|20892680|P3|STARTED|Overall Study||1118
8478064|NCT00616928|20892681|P2|STARTED|Overall Study||768
8478065|NCT00616928|20892682|P1|STARTED|Overall Study||2304
8478066|NCT00616902|20892746|P2|NOT COMPLETED|Overall Study||6
8478067|NCT00616902|20892747|P1|NOT COMPLETED|Overall Study||6
8478068|NCT00616902|20892746|P2|COMPLETED|Overall Study||0
8478069|NCT00616902|20892747|P1|COMPLETED|Overall Study||0
8478070|NCT00616902|20892746|P2|STARTED|Overall Study||6
8478071|NCT00616902|20892747|P1|STARTED|Overall Study||6
8478072|NCT00616772|20892773|P2|NOT COMPLETED|Overall Study||102
8478073|NCT00616772|20892774|P1|NOT COMPLETED|Overall Study||115
8478074|NCT00616772|20892773|P2|COMPLETED|Overall Study||240
8478075|NCT00616772|20892774|P1|COMPLETED|Overall Study||225
8478076|NCT00616772|20892773|P2|Treated|Overall Study||339
8478077|NCT00616772|20892774|P1|Treated|Overall Study||337
8478078|NCT00616772|20892773|P2|STARTED|Overall Study||342
8478079|NCT00616772|20892774|P1|STARTED|Overall Study||340
8478080|NCT00616759|20892790|P2|NOT COMPLETED|Overall Study||2
8478081|NCT00616759|20892791|P1|NOT COMPLETED|Overall Study||3
8478082|NCT00616759|20892790|P2|COMPLETED|Overall Study||8
8478083|NCT00616759|20892791|P1|COMPLETED|Overall Study||7
8478084|NCT00616759|20892790|P2|STARTED|Overall Study||10
8478085|NCT00616759|20892791|P1|STARTED|Overall Study||10
8478086|NCT00616655|20892800|P3|NOT COMPLETED|Overall Study||48
8478087|NCT00616655|20892801|P2|NOT COMPLETED|Overall Study||41
8478088|NCT00616655|20892802|P1|NOT COMPLETED|Overall Study||35
8478089|NCT00616655|20892800|P3|COMPLETED|Overall Study||103
8478090|NCT00616655|20892801|P2|COMPLETED|Overall Study||112
8478091|NCT00616655|20892802|P1|COMPLETED|Overall Study||117
8478092|NCT00616655|20892800|P3|STARTED|Overall Study||151
8478093|NCT00616655|20892801|P2|STARTED|Overall Study||153
8478094|NCT00616655|20892802|P1|STARTED|Overall Study||152
8478095|NCT00616642|20892842|P2|NOT COMPLETED|Overall Study||1
8478096|NCT00616642|20892843|P1|NOT COMPLETED|Overall Study||0
8478097|NCT00616642|20892842|P2|COMPLETED|Overall Study||0
8478098|NCT00616642|20892843|P1|COMPLETED|Overall Study||0
8478099|NCT00616642|20892842|P2|STARTED|Overall Study||1
8478100|NCT00616642|20892843|P1|STARTED|Overall Study||0
8478101|NCT00616629|20892854|P5|NOT COMPLETED|Overall Study||0
8478102|NCT00616629|20892855|P4|NOT COMPLETED|Overall Study||0
8478103|NCT00616629|20892856|P3|NOT COMPLETED|Overall Study||1
8478104|NCT00616629|20892857|P2|NOT COMPLETED|Overall Study||2
8478105|NCT00616629|20892858|P1|NOT COMPLETED|Overall Study||2
8478106|NCT00616629|20892854|P5|COMPLETED|Overall Study||12
8478107|NCT00616629|20892855|P4|COMPLETED|Overall Study||2
8478108|NCT00616629|20892856|P3|COMPLETED|Overall Study||13
8478109|NCT00616629|20892857|P2|COMPLETED|Overall Study||12
8478110|NCT00616629|20892858|P1|COMPLETED|Overall Study||11
8478111|NCT00616629|20892854|P5|STARTED|Overall Study||12
8478112|NCT00616629|20892855|P4|STARTED|Overall Study||2
8478113|NCT00616629|20892856|P3|STARTED|Overall Study|One patient never received study drug|14
8478114|NCT00616629|20892857|P2|STARTED|Overall Study|Two patients never received study drug|14
8478115|NCT00616629|20892858|P1|STARTED|Overall Study|Two patients never received study drug|13
8478116|NCT00616603|20892903|P3|NOT COMPLETED|Overall Study||2
8478117|NCT00616603|20892904|P2|NOT COMPLETED|Overall Study||0
8478118|NCT00616603|20892905|P1|NOT COMPLETED|Overall Study||2
8478119|NCT00616603|20892903|P3|COMPLETED|Overall Study||13
8478120|NCT00616603|20892904|P2|COMPLETED|Overall Study||14
8478121|NCT00616603|20892905|P1|COMPLETED|Overall Study||12
8478122|NCT00616603|20892903|P3|STARTED|Overall Study||15
8478123|NCT00616603|20892904|P2|STARTED|Overall Study||14
8478124|NCT00616603|20892905|P1|STARTED|Overall Study||14
8478125|NCT00616577|20892916|P3|NOT COMPLETED|Overall Study||0
8478126|NCT00616577|20892917|P2|NOT COMPLETED|Overall Study||0
8478127|NCT00616577|20892918|P1|NOT COMPLETED|Overall Study||0
8478128|NCT00616577|20892916|P3|COMPLETED|Overall Study||7
8478129|NCT00616577|20892917|P2|COMPLETED|Overall Study||9
8478130|NCT00616577|20892918|P1|COMPLETED|Overall Study||6
8478131|NCT00616577|20892916|P3|STARTED|Overall Study||7
8478132|NCT00616577|20892917|P2|STARTED|Overall Study||9
8478133|NCT00616577|20892918|P1|STARTED|Overall Study||6
8478134|NCT00616434|20892928|P2|NOT COMPLETED|Overall Study||8
8478135|NCT00616434|20892929|P1|NOT COMPLETED|Overall Study||6
8478136|NCT00616434|20892928|P2|COMPLETED|Overall Study||53
8478137|NCT00616434|20892929|P1|COMPLETED|Overall Study||56
8478138|NCT00616434|20892928|P2|STARTED|Overall Study||61
8478139|NCT00616434|20892929|P1|STARTED|Overall Study||62
8478140|NCT00616421|20892942|P3|NOT COMPLETED|Overall Study||41
8478141|NCT00616421|20892943|P2|NOT COMPLETED|Overall Study||38
8478142|NCT00616421|20892944|P1|NOT COMPLETED|Overall Study||26
8478143|NCT00616421|20892942|P3|COMPLETED|Overall Study||1229
8478144|NCT00616421|20892943|P2|COMPLETED|Overall Study||1240
8478145|NCT00616421|20892944|P1|COMPLETED|Overall Study||333
8478146|NCT00616421|20892942|P3|STARTED|Overall Study||1270
8478147|NCT00616421|20892943|P2|STARTED|Overall Study||1278
8478148|NCT00616421|20892944|P1|STARTED|Overall Study||359
8478149|NCT00616343|20892981|P1|NOT COMPLETED|Overall Study||0
8478150|NCT00616343|20892981|P1|COMPLETED|Overall Study||9
8478151|NCT00616343|20892981|P1|STARTED|Overall Study||9
8478152|NCT00616239|20892985|P1|NOT COMPLETED|Overall Study||2
8478153|NCT00616239|20892985|P1|COMPLETED|Overall Study||18
8478154|NCT00616239|20892985|P1|STARTED|Overall Study||20
8478155|NCT00616200|20892989|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
8478156|NCT00616200|20892989|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
8478157|NCT00616200|20892989|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
8478158|NCT00616200|20892989|P1|NOT COMPLETED|Two Week Standard Diet||1
8478159|NCT00616200|20892989|P1|COMPLETED|Two Week Standard Diet||16
8478160|NCT00616200|20892989|P1|STARTED|Two Week Standard Diet||17
8478161|NCT00616122|20892995|P4|NOT COMPLETED|Overall Study||11
8478162|NCT00616122|20892996|P3|NOT COMPLETED|Overall Study||0
8478163|NCT00616122|20892997|P2|NOT COMPLETED|Overall Study||0
8478164|NCT00616122|20892998|P1|NOT COMPLETED|Overall Study||0
8478165|NCT00616122|20892995|P4|COMPLETED|Overall Study||0
8478166|NCT00616122|20892996|P3|COMPLETED|Overall Study||10
8478167|NCT00616122|20892997|P2|COMPLETED|Overall Study||7
8478168|NCT00616122|20892998|P1|COMPLETED|Overall Study||4
8478169|NCT00616122|20892995|P4|STARTED|Overall Study||11
8478170|NCT00616122|20892996|P3|STARTED|Overall Study||10
8478171|NCT00616122|20892997|P2|STARTED|Overall Study||7
8478172|NCT00616122|20892998|P1|STARTED|Overall Study||4
8478173|NCT00616109|20893008|P1|NOT COMPLETED|Overall Study||0
8478174|NCT00616109|20893008|P1|COMPLETED|Overall Study||16
8478175|NCT00616109|20893008|P1|STARTED|Overall Study||16
8478176|NCT00616018|20893015|P1|NOT COMPLETED|Overall Study||3
8478177|NCT00616018|20893015|P1|COMPLETED|Overall Study||24
8478178|NCT00616018|20893015|P1|STARTED|Overall Study||27
8478179|NCT00615992|20893020|P1|NOT COMPLETED|Overall Study||67
8478180|NCT00615992|20893020|P1|COMPLETED|Overall Study||687
8478181|NCT00615992|20893020|P1|STARTED|Overall Study||754
8478182|NCT00615927|20893031|P2|NOT COMPLETED|Overall Study||0
8478183|NCT00615927|20893032|P1|NOT COMPLETED|Overall Study||0
8478184|NCT00615927|20893031|P2|COMPLETED|Overall Study||32
8478185|NCT00615927|20893032|P1|COMPLETED|Overall Study||32
8478186|NCT00615927|20893031|P2|STARTED|Overall Study||32
8478187|NCT00615927|20893032|P1|STARTED|Overall Study||32
8478188|NCT00615914|20893046|P1|NOT COMPLETED|Overall Study||637
8478189|NCT00615914|20893046|P1|COMPLETED|Overall Study||1008
8478190|NCT00615914|20893046|P1|STARTED|Overall Study|The number of patients enrolled|1645
8478191|NCT00615901|20893053|P1|NOT COMPLETED|Overall Study||9
8478192|NCT00615901|20893053|P1|COMPLETED|Overall Study||29
8478193|NCT00615901|20893053|P1|STARTED|Overall Study||38
8478194|NCT00615836|20893061|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
8478195|NCT00615836|20893062|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
8478196|NCT00615836|20893063|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
8478197|NCT00615836|20893064|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
8478198|NCT00615836|20893065|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
8478199|NCT00615836|20893061|P5|COMPLETED|Extension Study (FE992026 CS31)||0
8478200|NCT00615836|20893062|P4|COMPLETED|Extension Study (FE992026 CS31)||53
8478201|NCT00615836|20893063|P3|COMPLETED|Extension Study (FE992026 CS31)||59
8478202|NCT00615836|20893064|P2|COMPLETED|Extension Study (FE992026 CS31)||58
8478203|NCT00615836|20893065|P1|COMPLETED|Extension Study (FE992026 CS31)||0
8478204|NCT00615836|20893061|P5|STARTED|Extension Study (FE992026 CS31)||0
8478205|NCT00615836|20893062|P4|STARTED|Extension Study (FE992026 CS31)||137
8478206|NCT00615836|20893063|P3|STARTED|Extension Study (FE992026 CS31)||132
8478207|NCT00615836|20893064|P2|STARTED|Extension Study (FE992026 CS31)||144
8478208|NCT00615836|20893065|P1|STARTED|Extension Study (FE992026 CS31)||141
8478209|NCT00615836|20893061|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
8478210|NCT00615836|20893062|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
8478211|NCT00615836|20893063|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
8478212|NCT00615836|20893064|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
8478213|NCT00615836|20893065|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
8478214|NCT00615836|20893061|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
8478215|NCT00615836|20893062|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
8478216|NCT00615836|20893063|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
8478217|NCT00615836|20893064|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
8478218|NCT00615836|20893065|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
8478219|NCT00615836|20893061|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
8478220|NCT00615836|20893062|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
8478221|NCT00615836|20893063|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
8478222|NCT00615836|20893064|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
8478223|NCT00615836|20893065|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
8478224|NCT00615836|20893061|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
8478225|NCT00615836|20893062|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
8478226|NCT00615836|20893063|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
8478227|NCT00615836|20893064|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
8478228|NCT00615836|20893065|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
8478229|NCT00615784|20893125|P1|NOT COMPLETED|Overall Study||0
8478230|NCT00615784|20893125|P1|COMPLETED|Overall Study||24
8478231|NCT00615784|20893125|P1|STARTED|Overall Study||24
8478232|NCT00615719|20893130|P1|NOT COMPLETED|Overall Study||5
8478233|NCT00615719|20893130|P1|COMPLETED|Overall Study||30
8478234|NCT00615719|20893130|P1|STARTED|Overall Study||35
8478235|NCT00615589|20893134|P1|NOT COMPLETED|Overall Study||0
8478236|NCT00615589|20893134|P1|COMPLETED|Overall Study||22
8478237|NCT00615589|20893134|P1|STARTED|Overall Study||22
8478238|NCT00615550|20893144|P2|NOT COMPLETED|Overall Study||1
8478239|NCT00615550|20893145|P1|NOT COMPLETED|Overall Study||6
8478240|NCT00615550|20893144|P2|COMPLETED|Overall Study||235
8478241|NCT00615550|20893145|P1|COMPLETED|Overall Study||223
8478242|NCT00615550|20893144|P2|STARTED|Overall Study||236
8478243|NCT00615550|20893145|P1|STARTED|Overall Study||229
8478244|NCT00615472|20893161|P2|NOT COMPLETED|Overall Study||0
8478245|NCT00615472|20893162|P1|NOT COMPLETED|Overall Study||0
8478246|NCT00615472|20893161|P2|COMPLETED|Overall Study||28
8478247|NCT00615472|20893162|P1|COMPLETED|Overall Study||30
8478248|NCT00615472|20893161|P2|STARTED|Overall Study||28
8478249|NCT00615472|20893162|P1|STARTED|Overall Study||30
8478250|NCT00615459|20893168|P4|NOT COMPLETED|Period III||0
8478251|NCT00615459|20893169|P3|NOT COMPLETED|Period III||1
8478252|NCT00615459|20893170|P2|NOT COMPLETED|Period III||3
8478253|NCT00615459|20893171|P1|NOT COMPLETED|Period III||0
8478254|NCT00615459|20893168|P4|COMPLETED|Period III||41
8478255|NCT00615459|20893169|P3|COMPLETED|Period III||39
8478256|NCT00615459|20893170|P2|COMPLETED|Period III||37
8478257|NCT00615459|20893171|P1|COMPLETED|Period III||36
8478258|NCT00615459|20893168|P4|STARTED|Period III||41
8478259|NCT00615459|20893169|P3|STARTED|Period III||40
8478260|NCT00615459|20893170|P2|STARTED|Period III||40
8478261|NCT00615459|20893171|P1|STARTED|Period III||36
8478262|NCT00615459|20893168|P4|NOT COMPLETED|Period II||1
8478263|NCT00615459|20893169|P3|NOT COMPLETED|Period II||0
8478264|NCT00615459|20893170|P2|NOT COMPLETED|Period II||0
8478265|NCT00615459|20893171|P1|NOT COMPLETED|Period II||1
8478266|NCT00615459|20893168|P4|COMPLETED|Period II||41
8478267|NCT00615459|20893169|P3|COMPLETED|Period II||40
8478268|NCT00615459|20893170|P2|COMPLETED|Period II||40
8478269|NCT00615459|20893171|P1|COMPLETED|Period II||36
8478270|NCT00615459|20893168|P4|STARTED|Period II||42
8478271|NCT00615459|20893169|P3|STARTED|Period II||40
8478272|NCT00615459|20893170|P2|STARTED|Period II||40
8478273|NCT00615459|20893171|P1|STARTED|Period II||37
8478274|NCT00615459|20893168|P4|NOT COMPLETED|Period I||1
8478275|NCT00615459|20893169|P3|NOT COMPLETED|Period I||2
8478276|NCT00615459|20893170|P2|NOT COMPLETED|Period I||1
8478277|NCT00615459|20893171|P1|NOT COMPLETED|Period I||4
8478278|NCT00615459|20893168|P4|COMPLETED|Period I||42
8478279|NCT00615459|20893169|P3|COMPLETED|Period I||40
8478280|NCT00615459|20893170|P2|COMPLETED|Period I||40
8478281|NCT00615459|20893171|P1|COMPLETED|Period I||37
8478282|NCT00615459|20893168|P4|STARTED|Period I||43
8478283|NCT00615459|20893169|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
8478284|NCT00615459|20893170|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
8478285|NCT00615459|20893171|P1|STARTED|Period I||41
8478286|NCT00615433|20893189|P4|NOT COMPLETED|Overall Study||45
8478287|NCT00615433|20893190|P3|NOT COMPLETED|Overall Study||39
8478288|NCT00615433|20893191|P2|NOT COMPLETED|Overall Study||53
8478289|NCT00615433|20893192|P1|NOT COMPLETED|Overall Study||43
8478290|NCT00615433|20893189|P4|COMPLETED|Overall Study||71
8478291|NCT00615433|20893190|P3|COMPLETED|Overall Study||84
8478292|NCT00615433|20893191|P2|COMPLETED|Overall Study||66
8478293|NCT00615433|20893192|P1|COMPLETED|Overall Study||77
8478294|NCT00615433|20893189|P4|STARTED|Overall Study||116
8478295|NCT00615433|20893190|P3|STARTED|Overall Study||123
8478296|NCT00615433|20893191|P2|STARTED|Overall Study||119
8478297|NCT00615433|20893192|P1|STARTED|Overall Study||120
8478298|NCT00615420|20893208|P2|NOT COMPLETED|Overall Study||27
8478299|NCT00615420|20893209|P1|NOT COMPLETED|Overall Study||31
8478300|NCT00615420|20893208|P2|COMPLETED|Overall Study||25
8478301|NCT00615420|20893209|P1|COMPLETED|Overall Study||23
8478302|NCT00615420|20893208|P2|STARTED|Overall Study||52
8478303|NCT00615420|20893209|P1|STARTED|Overall Study||54
8478304|NCT00615290|20893217|P1|NOT COMPLETED|Overall Study||8
8478305|NCT00615290|20893217|P1|COMPLETED|Overall Study||34
8478306|NCT00615290|20893217|P1|STARTED|Overall Study||42
8478307|NCT00615264|20893231|P2|NOT COMPLETED|Overall Study||52
8478308|NCT00615264|20893232|P1|NOT COMPLETED|Overall Study||50
8478309|NCT00615264|20893231|P2|COMPLETED|Overall Study||180
8478310|NCT00615264|20893232|P1|COMPLETED|Overall Study||175
8478311|NCT00615264|20893231|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
8478312|NCT00615264|20893232|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
8478313|NCT00615264|20893231|P2|Received at Least One Dose (ITT)|Overall Study||231
8478314|NCT00615264|20893232|P1|Received at Least One Dose (ITT)|Overall Study||225
8478315|NCT00615264|20893231|P2|STARTED|Overall Study||232
8478316|NCT00615264|20893232|P1|STARTED|Overall Study||225
8478317|NCT00615199|20893244|P4|NOT COMPLETED|Overall Study||2
8478318|NCT00615199|20893245|P3|NOT COMPLETED|Overall Study||1
8478319|NCT00615199|20893246|P2|NOT COMPLETED|Overall Study||2
8478320|NCT00615199|20893247|P1|NOT COMPLETED|Overall Study||8
8478321|NCT00615199|20893244|P4|COMPLETED|Overall Study||33
8478322|NCT00615199|20893245|P3|COMPLETED|Overall Study||33
8478323|NCT00615199|20893246|P2|COMPLETED|Overall Study||34
8478324|NCT00615199|20893247|P1|COMPLETED|Overall Study||26
8478325|NCT00615199|20893244|P4|STARTED|Overall Study||35
8478326|NCT00615199|20893245|P3|STARTED|Overall Study||34
8478327|NCT00615199|20893246|P2|STARTED|Overall Study||36
8478328|NCT00615199|20893247|P1|STARTED|Overall Study||34
8478329|NCT00615108|20893281|P1|NOT COMPLETED|Overall Study||507
8478330|NCT00615108|20893281|P1|COMPLETED|Overall Study||2641
8478331|NCT00615108|20893281|P1|STARTED|Overall Study||3148
8478332|NCT00615069|20893296|P1|NOT COMPLETED|Overall Study||16
8478333|NCT00615069|20893296|P1|COMPLETED|Overall Study||19
8478334|NCT00615069|20893296|P1|STARTED|Overall Study||35
8478335|NCT00615056|20893305|P4|NOT COMPLETED|Overall Study||35
8478336|NCT00615056|20893306|P3|NOT COMPLETED|Overall Study||36
8478337|NCT00615056|20893307|P2|NOT COMPLETED|Overall Study||51
8478338|NCT00615056|20893308|P1|NOT COMPLETED|Overall Study||49
8478339|NCT00615056|20893305|P4|COMPLETED|Overall Study||0
8478340|NCT00615056|20893306|P3|COMPLETED|Overall Study||0
8478341|NCT00615056|20893307|P2|COMPLETED|Overall Study||0
8478342|NCT00615056|20893308|P1|COMPLETED|Overall Study||0
8478343|NCT00615056|20893305|P4|Treated|Overall Study||35
8478344|NCT00615056|20893306|P3|Treated|Overall Study||36
8478345|NCT00615056|20893307|P2|Treated|Overall Study||51
8478346|NCT00615056|20893308|P1|Treated|Overall Study||46
8478347|NCT00615056|20893305|P4|STARTED|Overall Study||35
8478348|NCT00615056|20893306|P3|STARTED|Overall Study||36
8478349|NCT00615056|20893307|P2|STARTED|Overall Study||51
8478350|NCT00615056|20893308|P1|STARTED|Overall Study||49
8478351|NCT00615030|20893338|P12|NOT COMPLETED|Period III||0
8478352|NCT00615030|20893339|P11|NOT COMPLETED|Period III||0
8478353|NCT00615030|20893340|P10|NOT COMPLETED|Period III||0
8478354|NCT00615030|20893341|P9|NOT COMPLETED|Period III||0
8478355|NCT00615030|20893342|P8|NOT COMPLETED|Period III||0
8478356|NCT00615030|20893343|P7|NOT COMPLETED|Period III||0
8478357|NCT00615030|20893344|P6|NOT COMPLETED|Period III||0
8478358|NCT00615030|20893345|P5|NOT COMPLETED|Period III||0
8478359|NCT00615030|20893346|P4|NOT COMPLETED|Period III||1
8478360|NCT00615030|20893347|P3|NOT COMPLETED|Period III||0
8478361|NCT00615030|20893348|P2|NOT COMPLETED|Period III||0
8478362|NCT00615030|20893349|P1|NOT COMPLETED|Period III||1
8478363|NCT00615030|20893338|P12|COMPLETED|Period III||6
8478364|NCT00615030|20893339|P11|COMPLETED|Period III||7
8478365|NCT00615030|20893340|P10|COMPLETED|Period III||8
8478366|NCT00615030|20893341|P9|COMPLETED|Period III||7
8478367|NCT00615030|20893342|P8|COMPLETED|Period III||7
8478368|NCT00615030|20893343|P7|COMPLETED|Period III||6
8478369|NCT00615030|20893344|P6|COMPLETED|Period III||5
8478370|NCT00615030|20893345|P5|COMPLETED|Period III||8
8478371|NCT00615030|20893346|P4|COMPLETED|Period III||6
8478372|NCT00615030|20893347|P3|COMPLETED|Period III||8
8478373|NCT00615030|20893348|P2|COMPLETED|Period III||8
8478374|NCT00615030|20893349|P1|COMPLETED|Period III||7
8478375|NCT00615030|20893338|P12|STARTED|Period III||6
8478376|NCT00615030|20893339|P11|STARTED|Period III||7
8478377|NCT00615030|20893340|P10|STARTED|Period III||8
8478378|NCT00615030|20893341|P9|STARTED|Period III||7
8478379|NCT00615030|20893342|P8|STARTED|Period III||7
8478380|NCT00615030|20893343|P7|STARTED|Period III||6
8478381|NCT00615030|20893344|P6|STARTED|Period III||5
8478382|NCT00615030|20893345|P5|STARTED|Period III||8
8478383|NCT00615030|20893346|P4|STARTED|Period III||7
8478384|NCT00615030|20893347|P3|STARTED|Period III||8
8478385|NCT00615030|20893348|P2|STARTED|Period III||8
8478386|NCT00615030|20893349|P1|STARTED|Period III||8
8478387|NCT00615030|20893338|P12|NOT COMPLETED|Period II||0
8478388|NCT00615030|20893339|P11|NOT COMPLETED|Period II||0
8478389|NCT00615030|20893340|P10|NOT COMPLETED|Period II||0
8478390|NCT00615030|20893341|P9|NOT COMPLETED|Period II||1
8478391|NCT00615030|20893342|P8|NOT COMPLETED|Period II||0
8478392|NCT00615030|20893343|P7|NOT COMPLETED|Period II||1
8478393|NCT00615030|20893344|P6|NOT COMPLETED|Period II||0
8478394|NCT00615030|20893345|P5|NOT COMPLETED|Period II||0
8478395|NCT00615030|20893346|P4|NOT COMPLETED|Period II||1
8478396|NCT00615030|20893347|P3|NOT COMPLETED|Period II||1
8478397|NCT00615030|20893348|P2|NOT COMPLETED|Period II||0
8478398|NCT00615030|20893349|P1|NOT COMPLETED|Period II||0
8478399|NCT00615030|20893338|P12|COMPLETED|Period II||6
8478400|NCT00615030|20893339|P11|COMPLETED|Period II||7
8478401|NCT00615030|20893340|P10|COMPLETED|Period II||8
8478402|NCT00615030|20893341|P9|COMPLETED|Period II||7
8478403|NCT00615030|20893342|P8|COMPLETED|Period II||7
8478404|NCT00615030|20893343|P7|COMPLETED|Period II||6
8478405|NCT00615030|20893344|P6|COMPLETED|Period II||5
8478406|NCT00615030|20893345|P5|COMPLETED|Period II||8
8478407|NCT00615030|20893346|P4|COMPLETED|Period II||7
8478408|NCT00615030|20893347|P3|COMPLETED|Period II||8
8478409|NCT00615030|20893348|P2|COMPLETED|Period II||8
8478410|NCT00615030|20893349|P1|COMPLETED|Period II||8
8478411|NCT00615030|20893338|P12|STARTED|Period II||6
8478412|NCT00615030|20893339|P11|STARTED|Period II||7
8478413|NCT00615030|20893340|P10|STARTED|Period II||8
8478414|NCT00615030|20893341|P9|STARTED|Period II||8
8478415|NCT00615030|20893342|P8|STARTED|Period II||7
8478416|NCT00615030|20893343|P7|STARTED|Period II||7
8478417|NCT00615030|20893344|P6|STARTED|Period II||5
8478418|NCT00615030|20893345|P5|STARTED|Period II||8
8478419|NCT00615030|20893346|P4|STARTED|Period II||8
8478420|NCT00615030|20893347|P3|STARTED|Period II||9
8478421|NCT00615030|20893348|P2|STARTED|Period II||8
8478422|NCT00615030|20893349|P1|STARTED|Period II||8
8478423|NCT00615030|20893338|P12|NOT COMPLETED|Period I||1
8478424|NCT00615030|20893339|P11|NOT COMPLETED|Period I||1
8478425|NCT00615030|20893340|P10|NOT COMPLETED|Period I||0
8478426|NCT00615030|20893341|P9|NOT COMPLETED|Period I||1
8478427|NCT00615030|20893342|P8|NOT COMPLETED|Period I||0
8478428|NCT00615030|20893343|P7|NOT COMPLETED|Period I||0
8478429|NCT00615030|20893344|P6|NOT COMPLETED|Period I||1
8478430|NCT00615030|20893345|P5|NOT COMPLETED|Period I||1
8478431|NCT00615030|20893346|P4|NOT COMPLETED|Period I||0
8478432|NCT00615030|20893347|P3|NOT COMPLETED|Period I||0
8478433|NCT00615030|20893348|P2|NOT COMPLETED|Period I||0
8478434|NCT00615030|20893349|P1|NOT COMPLETED|Period I||1
8478435|NCT00615030|20893338|P12|COMPLETED|Period I||6
8478436|NCT00615030|20893339|P11|COMPLETED|Period I||7
8478437|NCT00615030|20893340|P10|COMPLETED|Period I||8
8478438|NCT00615030|20893341|P9|COMPLETED|Period I||8
8478439|NCT00615030|20893342|P8|COMPLETED|Period I||7
8478440|NCT00615030|20893343|P7|COMPLETED|Period I||7
8478441|NCT00615030|20893344|P6|COMPLETED|Period I||5
8478442|NCT00615030|20893345|P5|COMPLETED|Period I||8
8478443|NCT00615030|20893346|P4|COMPLETED|Period I||8
8478444|NCT00615030|20893347|P3|COMPLETED|Period I||9
8478445|NCT00615030|20893348|P2|COMPLETED|Period I||8
8478446|NCT00615030|20893349|P1|COMPLETED|Period I||8
8478447|NCT00615030|20893338|P12|STARTED|Period I||7
8478448|NCT00615030|20893339|P11|STARTED|Period I||8
8478449|NCT00615030|20893340|P10|STARTED|Period I||8
8478450|NCT00615030|20893341|P9|STARTED|Period I||9
8478451|NCT00615030|20893342|P8|STARTED|Period I||7
8478452|NCT00615030|20893343|P7|STARTED|Period I||7
8478453|NCT00615030|20893344|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
8478454|NCT00615030|20893345|P5|STARTED|Period I||9
8478455|NCT00615030|20893346|P4|STARTED|Period I||8
8478456|NCT00615030|20893347|P3|STARTED|Period I||9
8478457|NCT00615030|20893348|P2|STARTED|Period I||8
8478458|NCT00615030|20893349|P1|STARTED|Period I||9
8478459|NCT00615017|20893369|P6|NOT COMPLETED|Overall Study||3
8478460|NCT00615017|20893370|P5|NOT COMPLETED|Overall Study||1
8478461|NCT00615017|20893371|P4|NOT COMPLETED|Overall Study||1
8478462|NCT00615017|20893372|P3|NOT COMPLETED|Overall Study||5
8478463|NCT00615017|20893373|P2|NOT COMPLETED|Overall Study||1
8478464|NCT00615017|20893374|P1|NOT COMPLETED|Overall Study||0
8478465|NCT00615017|20893369|P6|COMPLETED|Overall Study|Patient completed the study drug|20
8478466|NCT00615017|20893370|P5|COMPLETED|Overall Study|Patient completed the study drug|7
8478467|NCT00615017|20893371|P4|COMPLETED|Overall Study|Patient completed the study drug|9
8478468|NCT00615017|20893372|P3|COMPLETED|Overall Study|Patient completed the study drug|7
8478469|NCT00615017|20893373|P2|COMPLETED|Overall Study|Patient completed the study drug|8
8478470|NCT00615017|20893374|P1|COMPLETED|Overall Study|Patient completed the study drug|8
8478471|NCT00615017|20893369|P6|STARTED|Overall Study|Patients received treatment|23
8478472|NCT00615017|20893370|P5|STARTED|Overall Study|Patients received treatment|8
8478473|NCT00615017|20893371|P4|STARTED|Overall Study|Patients received treatment|10
8478474|NCT00615017|20893372|P3|STARTED|Overall Study|Patients received treatment|12
8478475|NCT00615017|20893373|P2|STARTED|Overall Study|Patients received treatment|9
8478476|NCT00615017|20893374|P1|STARTED|Overall Study|Patients received treatment|8
8478477|NCT00614991|20893532|P6|NOT COMPLETED|Overall Study||0
8478478|NCT00614991|20893533|P5|NOT COMPLETED|Overall Study||1
8478479|NCT00614991|20893534|P4|NOT COMPLETED|Overall Study||0
8478480|NCT00614991|20893535|P3|NOT COMPLETED|Overall Study||0
8478481|NCT00614991|20893536|P2|NOT COMPLETED|Overall Study||3
8478482|NCT00614991|20893537|P1|NOT COMPLETED|Overall Study||3
8478483|NCT00614991|20893532|P6|COMPLETED|Overall Study||6
8478484|NCT00614991|20893533|P5|COMPLETED|Overall Study||6
8478485|NCT00614991|20893534|P4|COMPLETED|Overall Study||7
8478486|NCT00614991|20893535|P3|COMPLETED|Overall Study||7
8478487|NCT00614991|20893536|P2|COMPLETED|Overall Study||6
8478488|NCT00614991|20893537|P1|COMPLETED|Overall Study||5
8478489|NCT00614991|20893532|P6|STARTED|Overall Study||6
8478490|NCT00614991|20893533|P5|STARTED|Overall Study||7
8478491|NCT00614991|20893534|P4|STARTED|Overall Study||7
8478492|NCT00614991|20893535|P3|STARTED|Overall Study||7
8478493|NCT00614991|20893536|P2|STARTED|Overall Study||9
8478494|NCT00614991|20893537|P1|STARTED|Overall Study||8
8478495|NCT00614939|20893571|P2|NOT COMPLETED|Overall Study||43
8478496|NCT00614939|20893572|P1|NOT COMPLETED|Overall Study||35
8478497|NCT00614939|20893571|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
8478498|NCT00614939|20893572|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
8478499|NCT00614939|20893571|P2|STARTED|Overall Study|Randomized and treated|85
8478500|NCT00614939|20893572|P1|STARTED|Overall Study|Randomized and treated|85
8478501|NCT00614926|20893606|P2|NOT COMPLETED|Overall Study||0
8478502|NCT00614926|20893607|P1|NOT COMPLETED|Overall Study||4
8478503|NCT00614926|20893606|P2|COMPLETED|Overall Study||7
8478504|NCT00614926|20893607|P1|COMPLETED|Overall Study||21
8478505|NCT00614926|20893606|P2|STARTED|Overall Study||7
8478506|NCT00614926|20893607|P1|STARTED|Overall Study||25
8478507|NCT00614913|20893615|P1|NOT COMPLETED|Overall Study||0
8478508|NCT00614913|20893615|P1|COMPLETED|Overall Study||76
8478509|NCT00614913|20893615|P1|STARTED|Overall Study||76
8478510|NCT00614874|20893620|P1|NOT COMPLETED|Overall Study||2
8478511|NCT00614874|20893620|P1|COMPLETED|Overall Study||14
8478512|NCT00614874|20893620|P1|STARTED|Overall Study||16
8478513|NCT00614822|20893627|P1|NOT COMPLETED|Overall Study||3
8478514|NCT00614822|20893627|P1|COMPLETED|Overall Study||47
8478515|NCT00614822|20893627|P1|STARTED|Overall Study||50
8478516|NCT00614744|20893636|P2|NOT COMPLETED|Overall Study||6
8478517|NCT00614744|20893637|P1|NOT COMPLETED|Overall Study||5
8478518|NCT00614744|20893636|P2|COMPLETED|Overall Study||79
8478519|NCT00614744|20893637|P1|COMPLETED|Overall Study||78
8478520|NCT00614744|20893636|P2|STARTED|Overall Study||85
8478521|NCT00614744|20893637|P1|STARTED|Overall Study||83
8478522|NCT00614614|20893663|P5|NOT COMPLETED|Booster Vaccination Phase||13
8478523|NCT00614614|20893664|P4|NOT COMPLETED|Booster Vaccination Phase||19
8478524|NCT00614614|20893665|P3|NOT COMPLETED|Booster Vaccination Phase||27
8478525|NCT00614614|20893666|P2|NOT COMPLETED|Booster Vaccination Phase||6
8478526|NCT00614614|20893667|P1|NOT COMPLETED|Booster Vaccination Phase||0
8478527|NCT00614614|20893663|P5|COMPLETED|Booster Vaccination Phase||396
8478528|NCT00614614|20893664|P4|COMPLETED|Booster Vaccination Phase||210
8478529|NCT00614614|20893665|P3|COMPLETED|Booster Vaccination Phase||405
8478530|NCT00614614|20893666|P2|COMPLETED|Booster Vaccination Phase||227
8478531|NCT00614614|20893667|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
8478532|NCT00614614|20893663|P5|STARTED|Booster Vaccination Phase||409
8478533|NCT00614614|20893664|P4|STARTED|Booster Vaccination Phase||229
8478534|NCT00614614|20893665|P3|STARTED|Booster Vaccination Phase||432
8478535|NCT00614614|20893666|P2|STARTED|Booster Vaccination Phase||233
8478536|NCT00614614|20893667|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
8478537|NCT00614614|20893663|P5|NOT COMPLETED|Primary Vaccination Phase||0
8478538|NCT00614614|20893664|P4|NOT COMPLETED|Primary Vaccination Phase||0
8478539|NCT00614614|20893665|P3|NOT COMPLETED|Primary Vaccination Phase||0
8478540|NCT00614614|20893666|P2|NOT COMPLETED|Primary Vaccination Phase||17
8478541|NCT00614614|20893667|P1|NOT COMPLETED|Primary Vaccination Phase||90
8478542|NCT00614614|20893663|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478543|NCT00614614|20893664|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478544|NCT00614614|20893665|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478545|NCT00614614|20893666|P2|COMPLETED|Primary Vaccination Phase||265
8478546|NCT00614614|20893667|P1|COMPLETED|Primary Vaccination Phase||1182
8478547|NCT00614614|20893663|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478548|NCT00614614|20893664|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478549|NCT00614614|20893665|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478550|NCT00614614|20893666|P2|STARTED|Primary Vaccination Phase||282
8478551|NCT00614614|20893667|P1|STARTED|Primary Vaccination Phase||1272
8478552|NCT00614575|20893790|P1|NOT COMPLETED|Overall Study||228
8478553|NCT00614575|20893790|P1|COMPLETED|Overall Study||861
8478554|NCT00614575|20893790|P1|STARTED|Overall Study|The number of patients enrolled.|1089
8478555|NCT00614523|20893801|P2|NOT COMPLETED|Overall Study||131
8478556|NCT00614523|20893802|P1|NOT COMPLETED|Overall Study||63
8478557|NCT00614523|20893801|P2|COMPLETED|Overall Study||36
8478558|NCT00614523|20893802|P1|COMPLETED|Overall Study||20
8478559|NCT00614523|20893801|P2|STARTED|Overall Study||167
8478560|NCT00614523|20893802|P1|STARTED|Overall Study||83
8478561|NCT00614484|20893826|P1|NOT COMPLETED|Overall Study||0
8478562|NCT00614484|20893826|P1|COMPLETED|Overall Study||28
8478563|NCT00614484|20893826|P1|STARTED|Overall Study||28
8478564|NCT00614458|20893831|P1|NOT COMPLETED|Overall Study||0
8478565|NCT00614458|20893831|P1|COMPLETED|Overall Study||6
8478566|NCT00614458|20893831|P1|STARTED|Overall Study||6
8478567|NCT00614445|20893837|P2|NOT COMPLETED|Overall Study||49
8478568|NCT00614445|20893838|P1|NOT COMPLETED|Overall Study||28
8478569|NCT00614445|20893837|P2|COMPLETED|Overall Study||91
8478570|NCT00614445|20893838|P1|COMPLETED|Overall Study||112
8478571|NCT00614445|20893837|P2|STARTED|Overall Study||140
8478572|NCT00614445|20893838|P1|STARTED|Overall Study||140
8478573|NCT00614432|20893846|P2|NOT COMPLETED|Overall Study||0
8478574|NCT00614432|20893847|P1|NOT COMPLETED|Overall Study||0
8478575|NCT00614432|20893846|P2|COMPLETED|Overall Study||6
8478576|NCT00614432|20893847|P1|COMPLETED|Overall Study||4
8478577|NCT00614432|20893846|P2|STARTED|Overall Study||6
8478578|NCT00614432|20893847|P1|STARTED|Overall Study||4
8478579|NCT00614406|20893855|P2|NOT COMPLETED|Overall Study||0
8478580|NCT00614406|20893856|P1|NOT COMPLETED|Overall Study||0
8478581|NCT00614406|20893855|P2|COMPLETED|Overall Study||4
8478582|NCT00614406|20893856|P1|COMPLETED|Overall Study||7
8478583|NCT00614406|20893855|P2|STARTED|Overall Study||4
8478584|NCT00614406|20893856|P1|STARTED|Overall Study||7
8478585|NCT00614393|20893867|P5|NOT COMPLETED|Overall Study||180
8478586|NCT00614393|20893868|P4|NOT COMPLETED|Overall Study||180
8478587|NCT00614393|20893869|P3|NOT COMPLETED|Overall Study||10
8478588|NCT00614393|20893870|P2|NOT COMPLETED|Overall Study||8
8478589|NCT00614393|20893871|P1|NOT COMPLETED|Overall Study||180
8478590|NCT00614393|20893867|P5|COMPLETED|Overall Study||0
8478591|NCT00614393|20893868|P4|COMPLETED|Overall Study||0
8478592|NCT00614393|20893869|P3|COMPLETED|Overall Study||0
8478593|NCT00614393|20893870|P2|COMPLETED|Overall Study||0
8478594|NCT00614393|20893871|P1|COMPLETED|Overall Study||0
8478595|NCT00614393|20893867|P5|Treated|Overall Study||178
8478596|NCT00614393|20893868|P4|Treated|Overall Study||180
8478597|NCT00614393|20893869|P3|Treated|Overall Study||10
8478598|NCT00614393|20893870|P2|Treated|Overall Study||8
8478599|NCT00614393|20893871|P1|Treated|Overall Study||180
8478600|NCT00614393|20893867|P5|STARTED|Overall Study||180
8478601|NCT00614393|20893868|P4|STARTED|Overall Study||180
8478602|NCT00614393|20893869|P3|STARTED|Overall Study||10
8478603|NCT00614393|20893870|P2|STARTED|Overall Study||8
8478604|NCT00614393|20893871|P1|STARTED|Overall Study||180
8478605|NCT00614380|20893917|P4|NOT COMPLETED|Overall Study||2
8478606|NCT00614380|20893918|P3|NOT COMPLETED|Overall Study||1
8478607|NCT00614380|20893919|P2|NOT COMPLETED|Overall Study||8
8478608|NCT00614380|20893920|P1|NOT COMPLETED|Overall Study||35
8478609|NCT00614380|20893917|P4|COMPLETED|Overall Study||179
8478610|NCT00614380|20893918|P3|COMPLETED|Overall Study||24
8478611|NCT00614380|20893919|P2|COMPLETED|Overall Study||198
8478612|NCT00614380|20893920|P1|COMPLETED|Overall Study||529
8478613|NCT00614380|20893917|P4|STARTED|Overall Study||181
8478614|NCT00614380|20893918|P3|STARTED|Overall Study||25
8478615|NCT00614380|20893919|P2|STARTED|Overall Study||206
8478616|NCT00614380|20893920|P1|STARTED|Overall Study||564
8478617|NCT00614315|20893969|P1|NOT COMPLETED|Overall Study||0
8478618|NCT00614315|20893969|P1|COMPLETED|Overall Study||30
8478619|NCT00614315|20893969|P1|STARTED|Overall Study||30
8478620|NCT00614198|20893976|P2|NOT COMPLETED|Stage 2||12
8478621|NCT00614198|20893977|P1|NOT COMPLETED|Stage 2||8
8478622|NCT00614198|20893976|P2|COMPLETED|Stage 2||17
8478623|NCT00614198|20893977|P1|COMPLETED|Stage 2||18
8478624|NCT00614198|20893976|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
8478625|NCT00614198|20893977|P1|STARTED|Stage 2||26
8478626|NCT00614198|20893976|P2|NOT COMPLETED|Stage 1||5
8478627|NCT00614198|20893977|P1|NOT COMPLETED|Stage 1||12
8478628|NCT00614198|20893976|P2|COMPLETED|Stage 1||29
8478629|NCT00614198|20893977|P1|COMPLETED|Stage 1||26
8478630|NCT00614198|20893976|P2|STARTED|Stage 1||34
8478631|NCT00614198|20893977|P1|STARTED|Stage 1||38
8478632|NCT00614120|20893987|P4|NOT COMPLETED|Overall Study||16
8478633|NCT00614120|20893988|P3|NOT COMPLETED|Overall Study||59
8478634|NCT00614120|20893989|P2|NOT COMPLETED|Overall Study||46
8478635|NCT00614120|20893990|P1|NOT COMPLETED|Overall Study||29
8478636|NCT00614120|20893987|P4|COMPLETED|Overall Study||215
8478637|NCT00614120|20893988|P3|COMPLETED|Overall Study||175
8478638|NCT00614120|20893989|P2|COMPLETED|Overall Study||187
8478639|NCT00614120|20893990|P1|COMPLETED|Overall Study||202
8478640|NCT00614120|20893987|P4|Exposed to Study Drug|Overall Study||231
8478641|NCT00614120|20893988|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
8478642|NCT00614120|20893989|P2|Exposed to Study Drug|Overall Study||233
8478643|NCT00614120|20893990|P1|Exposed to Study Drug|Overall Study||231
8478644|NCT00614120|20893987|P4|STARTED|Overall Study|Randomised|231
8478645|NCT00614120|20893988|P3|STARTED|Overall Study|Randomised|234
8478646|NCT00614120|20893989|P2|STARTED|Overall Study|Randomised|233
8478647|NCT00614120|20893990|P1|STARTED|Overall Study|Randomised|231
8478648|NCT00614055|20894031|P3|NOT COMPLETED|Overall Study||5
8478649|NCT00614055|20894032|P2|NOT COMPLETED|Overall Study||6
8478650|NCT00614055|20894033|P1|NOT COMPLETED|Overall Study||4
8478651|NCT00614055|20894031|P3|COMPLETED|Overall Study||55
8478652|NCT00614055|20894032|P2|COMPLETED|Overall Study||53
8478653|NCT00614055|20894033|P1|COMPLETED|Overall Study||55
8478654|NCT00614055|20894031|P3|Exposed|Overall Study||60
8478655|NCT00614055|20894032|P2|Exposed|Overall Study||59
8478656|NCT00614055|20894033|P1|Exposed|Overall Study||59
8478657|NCT00614055|20894031|P3|STARTED|Overall Study||60
8478658|NCT00614055|20894032|P2|STARTED|Overall Study||59
8478659|NCT00614055|20894033|P1|STARTED|Overall Study||59
8478660|NCT00613951|20894080|P3|NOT COMPLETED|Overall Study||5
8478661|NCT00613951|20894081|P2|NOT COMPLETED|Overall Study||5
8478662|NCT00613951|20894082|P1|NOT COMPLETED|Overall Study||7
8478663|NCT00613951|20894080|P3|COMPLETED|Overall Study||57
8478664|NCT00613951|20894081|P2|COMPLETED|Overall Study||54
8478665|NCT00613951|20894082|P1|COMPLETED|Overall Study||54
8478666|NCT00613951|20894080|P3|Exposed|Overall Study||62
8478667|NCT00613951|20894081|P2|Exposed|Overall Study||59
8478668|NCT00613951|20894082|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
8478669|NCT00613951|20894080|P3|STARTED|Overall Study||62
8478670|NCT00613951|20894081|P2|STARTED|Overall Study||59
8478671|NCT00613951|20894082|P1|STARTED|Overall Study||61
8478672|NCT00613938|20894127|P4|NOT COMPLETED|Overall Study||26
8478673|NCT00613938|20894128|P3|NOT COMPLETED|Overall Study||23
8478674|NCT00613938|20894129|P2|NOT COMPLETED|Overall Study||28
8478675|NCT00613938|20894130|P1|NOT COMPLETED|Overall Study||20
8478676|NCT00613938|20894127|P4|COMPLETED|Overall Study||253
8478677|NCT00613938|20894128|P3|COMPLETED|Overall Study||255
8478678|NCT00613938|20894129|P2|COMPLETED|Overall Study||247
8478679|NCT00613938|20894130|P1|COMPLETED|Overall Study||49
8478680|NCT00613938|20894127|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
8478681|NCT00613938|20894128|P3|STARTED|Overall Study||278
8478682|NCT00613938|20894129|P2|STARTED|Overall Study||275
8478683|NCT00613938|20894130|P1|STARTED|Overall Study||69
8478684|NCT00613925|20894162|P2|NOT COMPLETED|Overall Study||1
8478685|NCT00613925|20894163|P1|NOT COMPLETED|Overall Study||0
8478686|NCT00613925|20894162|P2|COMPLETED|Overall Study||32
8478687|NCT00613925|20894163|P1|COMPLETED|Overall Study||37
8478688|NCT00613925|20894162|P2|STARTED|Overall Study||33
8478689|NCT00613925|20894163|P1|STARTED|Overall Study||37
8478690|NCT00613886|20894171|P1|NOT COMPLETED|Overall Study||24
8478691|NCT00613886|20894171|P1|COMPLETED|Overall Study||0
8478692|NCT00613886|20894171|P1|STARTED|Overall Study||24
8478693|NCT00613834|20894178|P2|NOT COMPLETED|Overall Study||3
8478694|NCT00613834|20894179|P1|NOT COMPLETED|Overall Study||0
8478695|NCT00613834|20894178|P2|COMPLETED|Overall Study||26
8478696|NCT00613834|20894179|P1|COMPLETED|Overall Study||29
8478697|NCT00613834|20894178|P2|STARTED|Overall Study||29
8478698|NCT00613834|20894179|P1|STARTED|Overall Study||29
8478699|NCT00613821|20894191|P2|NOT COMPLETED|Overall Study||1
8478700|NCT00613821|20894192|P1|NOT COMPLETED|Overall Study||2
8478701|NCT00613821|20894191|P2|COMPLETED|Overall Study||39
8478702|NCT00613821|20894192|P1|COMPLETED|Overall Study||38
8478703|NCT00613821|20894191|P2|STARTED|Overall Study||40
8478704|NCT00613821|20894192|P1|STARTED|Overall Study||40
8478705|NCT00613730|20894198|P1|NOT COMPLETED|Overall Study||3
8478706|NCT00613730|20894198|P1|COMPLETED|Overall Study||0
8478707|NCT00613730|20894198|P1|STARTED|Overall Study||3
8478708|NCT00613626|20894207|P3|NOT COMPLETED|Overall Study||0
8478709|NCT00613626|20894208|P2|NOT COMPLETED|Overall Study||1
8478710|NCT00613626|20894209|P1|NOT COMPLETED|Overall Study||0
8478711|NCT00613626|20894207|P3|COMPLETED|Overall Study||7
8478712|NCT00613626|20894208|P2|COMPLETED|Overall Study||33
8478713|NCT00613626|20894209|P1|COMPLETED|Overall Study||33
8478714|NCT00613626|20894207|P3|1st Dose ZD6474|Overall Study||7
8478715|NCT00613626|20894208|P2|1st Dose ZD6474|Overall Study||34
8478716|NCT00613626|20894209|P1|1st Dose ZD6474|Overall Study||33
8478717|NCT00613626|20894207|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
8478718|NCT00613626|20894208|P2|STARTED|Overall Study||34
8478719|NCT00613626|20894209|P1|STARTED|Overall Study||33
8478720|NCT00613574|20894225|P1|NOT COMPLETED|Overall Study||6
8478721|NCT00613574|20894225|P1|COMPLETED|Overall Study||401
8478722|NCT00613574|20894225|P1|STARTED|Overall Study||407
8478723|NCT00613509|20894237|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
8478724|NCT00613509|20894238|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
8478725|NCT00613509|20894237|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
8478726|NCT00613509|20894238|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
8478727|NCT00613509|20894237|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
8478728|NCT00613509|20894238|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
8478729|NCT00613509|20894237|P2|NOT COMPLETED|Cycle 1||8
8478730|NCT00613509|20894238|P1|NOT COMPLETED|Cycle 1||5
8478731|NCT00613509|20894237|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
8478732|NCT00613509|20894238|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
8478733|NCT00613509|20894237|P2|STARTED|Cycle 1||12
8478734|NCT00613509|20894238|P1|STARTED|Cycle 1||11
8478735|NCT00613405|20894262|P2|NOT COMPLETED|Overall Study||0
8478736|NCT00613405|20894263|P1|NOT COMPLETED|Overall Study||0
8478737|NCT00613405|20894262|P2|COMPLETED|Overall Study||42
8478738|NCT00613405|20894263|P1|COMPLETED|Overall Study||45
8478739|NCT00613405|20894262|P2|STARTED|Overall Study||42
8478740|NCT00613405|20894263|P1|STARTED|Overall Study||45
8478741|NCT00613379|20894272|P3|NOT COMPLETED|Overall Study||0
8478742|NCT00613379|20894273|P2|NOT COMPLETED|Overall Study||0
8478743|NCT00613379|20894274|P1|NOT COMPLETED|Overall Study||0
8478744|NCT00613379|20894272|P3|COMPLETED|Overall Study||11
8478745|NCT00613379|20894273|P2|COMPLETED|Overall Study||10
8478746|NCT00613379|20894274|P1|COMPLETED|Overall Study||10
8478747|NCT00613379|20894272|P3|STARTED|Overall Study||11
8478748|NCT00613379|20894273|P2|STARTED|Overall Study||10
8478749|NCT00613379|20894274|P1|STARTED|Overall Study||10
8478750|NCT00613366|20894284|P2|NOT COMPLETED|Overall Study||2
8478751|NCT00613366|20894285|P1|NOT COMPLETED|Overall Study||3
8478752|NCT00613366|20894284|P2|COMPLETED|Overall Study||18
8478753|NCT00613366|20894285|P1|COMPLETED|Overall Study||17
8478754|NCT00613366|20894284|P2|STARTED|Overall Study||20
8478755|NCT00613366|20894285|P1|STARTED|Overall Study||20
8478756|NCT00613327|20894293|P1|NOT COMPLETED|Overall Study||101
8478757|NCT00613327|20894293|P1|COMPLETED|Overall Study||244
8478758|NCT00613327|20894293|P1|STARTED|Overall Study||345
8478759|NCT00613314|20894312|P1|NOT COMPLETED|Overall Study||155
8478760|NCT00613314|20894312|P1|COMPLETED|Overall Study||15113
8478761|NCT00613314|20894312|P1|STARTED|Overall Study||15268
8478762|NCT00613301|20894320|P1|NOT COMPLETED|Overall Study||228
8478763|NCT00613301|20894320|P1|COMPLETED|Overall Study||188
8478764|NCT00613301|20894320|P1|STARTED|Overall Study||416
8478765|NCT00613106|20894329|P2|NOT COMPLETED|Overall Study||9
8478766|NCT00613106|20894330|P1|NOT COMPLETED|Overall Study||20
8478767|NCT00613106|20894329|P2|COMPLETED|Overall Study||38
8478768|NCT00613106|20894330|P1|COMPLETED|Overall Study||112
8478769|NCT00613106|20894329|P2|STARTED|Overall Study||47
8478770|NCT00613106|20894330|P1|STARTED|Overall Study||132
8478771|NCT00613080|20894336|P1|NOT COMPLETED|Overall Study||11
8478772|NCT00613080|20894336|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
8478773|NCT00613080|20894336|P1|STARTED|Overall Study||79
8478774|NCT00613028|20894350|P2|NOT COMPLETED|Overall Study||1
8478775|NCT00613028|20894351|P1|NOT COMPLETED|Overall Study||0
8478776|NCT00613028|20894350|P2|COMPLETED|Overall Study||12
8478777|NCT00613028|20894351|P1|COMPLETED|Overall Study||10
8478778|NCT00613028|20894350|P2|STARTED|Overall Study||13
8478779|NCT00613028|20894351|P1|STARTED|Overall Study||10
8478780|NCT00613015|20894371|P6|NOT COMPLETED|Overall Study||3
8478781|NCT00613015|20894372|P5|NOT COMPLETED|Overall Study||2
8478782|NCT00613015|20894373|P4|NOT COMPLETED|Overall Study||3
8478783|NCT00613015|20894374|P3|NOT COMPLETED|Overall Study||3
8478784|NCT00613015|20894375|P2|NOT COMPLETED|Overall Study||1
8478785|NCT00613015|20894376|P1|NOT COMPLETED|Overall Study||0
8478786|NCT00613015|20894371|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
8478787|NCT00613015|20894372|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
8478788|NCT00613015|20894373|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
8478789|NCT00613015|20894374|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
8478790|NCT00613015|20894375|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
8478791|NCT00613015|20894376|P1|COMPLETED|Overall Study||13
8478792|NCT00613015|20894371|P6|STARTED|Overall Study||19
8478793|NCT00613015|20894372|P5|STARTED|Overall Study||15
8478794|NCT00613015|20894373|P4|STARTED|Overall Study||24
8478795|NCT00613015|20894374|P3|STARTED|Overall Study||26
8478796|NCT00613015|20894375|P2|STARTED|Overall Study||12
8478797|NCT00613015|20894376|P1|STARTED|Overall Study||13
8478798|NCT00612924|20894398|P2|NOT COMPLETED|Overall Study||9
8478799|NCT00612924|20894399|P1|NOT COMPLETED|Overall Study||7
8478800|NCT00612924|20894398|P2|COMPLETED|Overall Study||85
8478801|NCT00612924|20894399|P1|COMPLETED|Overall Study||94
8478802|NCT00612924|20894398|P2|STARTED|Overall Study||94
8478803|NCT00612924|20894399|P1|STARTED|Overall Study||101
8478804|NCT00612807|20894412|P2|NOT COMPLETED|Overall Study||0
8478805|NCT00612807|20894413|P1|NOT COMPLETED|Overall Study||2
8478806|NCT00612807|20894412|P2|COMPLETED|Overall Study||28
8478807|NCT00612807|20894413|P1|COMPLETED|Overall Study||12
8478808|NCT00612807|20894412|P2|STARTED|Overall Study||28
8478809|NCT00612807|20894413|P1|STARTED|Overall Study||14
8478810|NCT00612768|20894421|P1|NOT COMPLETED|Overall Study||0
8478811|NCT00612768|20894421|P1|COMPLETED|Overall Study||50
8478812|NCT00612768|20894421|P1|STARTED|Overall Study||50
8478813|NCT00612716|20894446|P1|NOT COMPLETED|Overall Study||0
8478814|NCT00612716|20894446|P1|COMPLETED|Overall Study||6
8478815|NCT00612716|20894446|P1|STARTED|Overall Study||6
8478816|NCT00612690|20894460|P2|NOT COMPLETED|Overall Study||118
8478817|NCT00612690|20894461|P1|NOT COMPLETED|Overall Study||115
8478818|NCT00612690|20894460|P2|COMPLETED|Overall Study||89
8478819|NCT00612690|20894461|P1|COMPLETED|Overall Study||160
8478820|NCT00612690|20894460|P2|STARTED|Overall Study||207
8478821|NCT00612690|20894461|P1|STARTED|Overall Study||275
8478822|NCT00612677|20894469|P1|NOT COMPLETED|Overall Study||1
8478823|NCT00612677|20894469|P1|COMPLETED|Overall Study||0
8478824|NCT00612677|20894469|P1|STARTED|Overall Study||1
8478825|NCT00612586|20894477|P2|NOT COMPLETED|Overall Study||41
8478826|NCT00612586|20894478|P1|NOT COMPLETED|Overall Study||43
8478827|NCT00612586|20894477|P2|COMPLETED|Overall Study||18
8478828|NCT00612586|20894478|P1|COMPLETED|Overall Study||15
8478829|NCT00612586|20894477|P2|Received at Least 1 Dose|Overall Study||58
8478830|NCT00612586|20894478|P1|Received at Least 1 Dose|Overall Study||57
8478831|NCT00612586|20894477|P2|STARTED|Overall Study||59
8478832|NCT00612586|20894478|P1|STARTED|Overall Study||58
8478833|NCT00612573|20894496|P4|NOT COMPLETED|Overall Study||13
8478834|NCT00612573|20894497|P3|NOT COMPLETED|Overall Study||9
8478835|NCT00612573|20894498|P2|NOT COMPLETED|Overall Study||14
8478836|NCT00612573|20894499|P1|NOT COMPLETED|Overall Study||12
8478837|NCT00612573|20894496|P4|COMPLETED|Overall Study||54
8478838|NCT00612573|20894497|P3|COMPLETED|Overall Study||52
8478839|NCT00612573|20894498|P2|COMPLETED|Overall Study||51
8478840|NCT00612573|20894499|P1|COMPLETED|Overall Study||52
8478841|NCT00612573|20894496|P4|STARTED|Overall Study||67
8478842|NCT00612573|20894497|P3|STARTED|Overall Study||61
8478843|NCT00612573|20894498|P2|STARTED|Overall Study||65
8478844|NCT00612573|20894499|P1|STARTED|Overall Study||64
8478845|NCT00612560|20894525|P4|NOT COMPLETED|Overall Study||0
8478846|NCT00612560|20894526|P3|NOT COMPLETED|Overall Study||0
8478847|NCT00612560|20894527|P2|NOT COMPLETED|Overall Study||0
8478848|NCT00612560|20894528|P1|NOT COMPLETED|Overall Study||0
8478849|NCT00612560|20894525|P4|COMPLETED|Overall Study||6
8478850|NCT00612560|20894526|P3|COMPLETED|Overall Study||8
8478851|NCT00612560|20894527|P2|COMPLETED|Overall Study||7
8478852|NCT00612560|20894528|P1|COMPLETED|Overall Study||7
8478853|NCT00612560|20894525|P4|STARTED|Overall Study||6
8478854|NCT00612560|20894526|P3|STARTED|Overall Study||8
8478855|NCT00612560|20894527|P2|STARTED|Overall Study||7
8478856|NCT00612560|20894528|P1|STARTED|Overall Study||7
8478857|NCT00612534|20894554|P4|NOT COMPLETED|Overall Study||17
8478858|NCT00612534|20894555|P3|NOT COMPLETED|Overall Study||7
8478859|NCT00612534|20894556|P2|NOT COMPLETED|Overall Study||17
8478860|NCT00612534|20894557|P1|NOT COMPLETED|Overall Study||13
8478861|NCT00612534|20894554|P4|COMPLETED|Overall Study||7
8478862|NCT00612534|20894555|P3|COMPLETED|Overall Study||13
8478863|NCT00612534|20894556|P2|COMPLETED|Overall Study||9
8478864|NCT00612534|20894557|P1|COMPLETED|Overall Study||11
8478865|NCT00612534|20894554|P4|STARTED|Overall Study||24
8478866|NCT00612534|20894555|P3|STARTED|Overall Study||20
8478867|NCT00612534|20894556|P2|STARTED|Overall Study||26
8478868|NCT00612534|20894557|P1|STARTED|Overall Study||24
8478869|NCT00612508|20894569|P2|NOT COMPLETED|Overall Study||4
8478870|NCT00612508|20894570|P1|NOT COMPLETED|Overall Study||3
8478871|NCT00612508|20894569|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
8478872|NCT00612508|20894570|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
8478873|NCT00612508|20894569|P2|STARTED|Overall Study||7
8478874|NCT00612508|20894570|P1|STARTED|Overall Study||7
8478875|NCT00612456|20894581|P3|NOT COMPLETED|Overall Study||0
8478876|NCT00612456|20894582|P2|NOT COMPLETED|Overall Study||2
8478877|NCT00612456|20894583|P1|NOT COMPLETED|Overall Study||2
8478878|NCT00612456|20894581|P3|COMPLETED|Overall Study||16
8478879|NCT00612456|20894582|P2|COMPLETED|Overall Study||25
8478880|NCT00612456|20894583|P1|COMPLETED|Overall Study||25
8478881|NCT00612456|20894581|P3|STARTED|Overall Study||16
8478882|NCT00612456|20894582|P2|STARTED|Overall Study||27
8478883|NCT00612456|20894583|P1|STARTED|Overall Study||27
8478884|NCT00612430|20894629|P2|NOT COMPLETED|Overall Study||0
8478885|NCT00612430|20894630|P1|NOT COMPLETED|Overall Study||0
8478886|NCT00612430|20894629|P2|COMPLETED|Overall Study||27
8478887|NCT00612430|20894630|P1|COMPLETED|Overall Study||32
8478888|NCT00612430|20894629|P2|STARTED|Overall Study||27
8478889|NCT00612430|20894630|P1|STARTED|Overall Study||32
8478890|NCT00612352|20894646|P2|NOT COMPLETED|Overall Study||6
8478891|NCT00612352|20894647|P1|NOT COMPLETED|Overall Study||9
8478892|NCT00612352|20894646|P2|COMPLETED|Overall Study||109
8478893|NCT00612352|20894647|P1|COMPLETED|Overall Study||56
8478894|NCT00612352|20894646|P2|Placebo|Overall Study||4
8478895|NCT00612352|20894647|P1|Placebo|Overall Study||4
8478896|NCT00612352|20894646|P2|40%mg|Overall Study||0
8478897|NCT00612352|20894647|P1|40%mg|Overall Study||1
8478898|NCT00612352|20894646|P2|100%mg|Overall Study||1
8478899|NCT00612352|20894647|P1|100%mg|Overall Study||2
8478900|NCT00612352|20894646|P2|Placebo & 100%mg|Overall Study||0
8478901|NCT00612352|20894647|P1|Placebo & 100%mg|Overall Study||1
8478902|NCT00612352|20894646|P2|40%mg & 100%mg|Overall Study||1
8478903|NCT00612352|20894647|P1|40%mg & 100%mg|Overall Study||1
8478904|NCT00612352|20894646|P2|STARTED|Overall Study||115
8478905|NCT00612352|20894647|P1|STARTED|Overall Study||65
8478906|NCT00612339|20894761|P1|NOT COMPLETED|Overall Study||0
8478907|NCT00612339|20894761|P1|COMPLETED|Overall Study||41
8478908|NCT00612339|20894761|P1|STARTED|Overall Study||41
8478909|NCT00612313|20894767|P2|NOT COMPLETED|Overall Study||13
8478910|NCT00612313|20894768|P1|NOT COMPLETED|Overall Study||17
8478911|NCT00612313|20894767|P2|COMPLETED|Overall Study||62
8478912|NCT00612313|20894768|P1|COMPLETED|Overall Study||52
8478913|NCT00612313|20894767|P2|STARTED|Overall Study||75
8478914|NCT00612313|20894768|P1|STARTED|Overall Study||69
8478915|NCT00612235|20894788|P4|NOT COMPLETED|Overall Study||0
8478916|NCT00612235|20894789|P3|NOT COMPLETED|Overall Study||0
8478917|NCT00612235|20894790|P2|NOT COMPLETED|Overall Study||0
8478918|NCT00612235|20894791|P1|NOT COMPLETED|Overall Study||0
8478919|NCT00612235|20894788|P4|COMPLETED|Overall Study||20
8478920|NCT00612235|20894789|P3|COMPLETED|Overall Study||20
8478921|NCT00612235|20894790|P2|COMPLETED|Overall Study||20
8478922|NCT00612235|20894791|P1|COMPLETED|Overall Study||20
8478923|NCT00612235|20894788|P4|STARTED|Overall Study||20
8478924|NCT00612235|20894789|P3|STARTED|Overall Study||20
8478925|NCT00612235|20894790|P2|STARTED|Overall Study||20
8478926|NCT00612235|20894791|P1|STARTED|Overall Study||20
8478927|NCT00612222|20894802|P1|NOT COMPLETED|Overall Study||0
8478928|NCT00612222|20894802|P1|COMPLETED|Overall Study||4
8478929|NCT00612222|20894802|P1|STARTED|Overall Study||4
8478930|NCT00612105|20894810|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
8478931|NCT00612105|20894811|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
8478932|NCT00612105|20894810|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
8478933|NCT00612105|20894811|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
8478934|NCT00612105|20894810|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
8478935|NCT00612105|20894811|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
8478936|NCT00612105|20894810|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
8478937|NCT00612105|20894811|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
8478938|NCT00612105|20894810|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
8478939|NCT00612105|20894811|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
8478940|NCT00612105|20894810|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
8478941|NCT00612105|20894811|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
8478942|NCT00612105|20894810|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
8478943|NCT00612105|20894811|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
8478944|NCT00612105|20894810|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
8478945|NCT00612105|20894811|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
8478946|NCT00612105|20894810|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
8478947|NCT00612105|20894811|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
8478948|NCT00612066|20894861|P1|NOT COMPLETED|Overall Study||1
8478949|NCT00612066|20894861|P1|COMPLETED|Overall Study||1
8478950|NCT00612066|20894861|P1|STARTED|Overall Study||2
8478951|NCT00612040|20894868|P3|NOT COMPLETED|Overall Study||7
8478952|NCT00612040|20894869|P2|NOT COMPLETED|Overall Study||7
8478953|NCT00612040|20894870|P1|NOT COMPLETED|Overall Study||5
8478954|NCT00612040|20894868|P3|COMPLETED|Overall Study||52
8478955|NCT00612040|20894869|P2|COMPLETED|Overall Study||52
8478956|NCT00612040|20894870|P1|COMPLETED|Overall Study||55
8478957|NCT00612040|20894868|P3|Exposed|Overall Study||59
8478958|NCT00612040|20894869|P2|Exposed|Overall Study||59
8478959|NCT00612040|20894870|P1|Exposed|Overall Study||60
8478960|NCT00612040|20894868|P3|STARTED|Overall Study||59
8478961|NCT00612040|20894869|P2|STARTED|Overall Study||59
8478962|NCT00612040|20894870|P1|STARTED|Overall Study||60
8478963|NCT00611975|20894916|P2|NOT COMPLETED|Overall Study||8
8478964|NCT00611975|20894917|P1|NOT COMPLETED|Overall Study||5
8478965|NCT00611975|20894916|P2|COMPLETED|Overall Study||30
8478966|NCT00611975|20894917|P1|COMPLETED|Overall Study||40
8478967|NCT00611975|20894916|P2|STARTED|Overall Study||38
8478968|NCT00611975|20894917|P1|STARTED|Overall Study||45
8478969|NCT00611923|20894945|P2|NOT COMPLETED|Overall Study||2
8478970|NCT00611923|20894946|P1|NOT COMPLETED|Overall Study||2
8478971|NCT00611923|20894945|P2|COMPLETED|Overall Study||11
8478972|NCT00611923|20894946|P1|COMPLETED|Overall Study||10
8478973|NCT00611923|20894945|P2|STARTED|Overall Study||13
8478974|NCT00611923|20894946|P1|STARTED|Overall Study||12
8478975|NCT00611897|20894962|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
8478976|NCT00611897|20894963|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
8478977|NCT00611897|20894962|P2|COMPLETED|Day 2: Crossover Treatment||8
8478978|NCT00611897|20894963|P1|COMPLETED|Day 2: Crossover Treatment||8
8478979|NCT00611897|20894962|P2|STARTED|Day 2: Crossover Treatment||8
8478980|NCT00611897|20894963|P1|STARTED|Day 2: Crossover Treatment||8
8478981|NCT00611897|20894962|P2|NOT COMPLETED|Day 1: Initial Treatment||0
8478982|NCT00611897|20894963|P1|NOT COMPLETED|Day 1: Initial Treatment||0
8478983|NCT00611897|20894962|P2|COMPLETED|Day 1: Initial Treatment||8
8478984|NCT00611897|20894963|P1|COMPLETED|Day 1: Initial Treatment||8
8478985|NCT00611897|20894962|P2|STARTED|Day 1: Initial Treatment||8
8478986|NCT00611897|20894963|P1|STARTED|Day 1: Initial Treatment||8
8478987|NCT00611884|20894991|P4|NOT COMPLETED|Overall Study||6
8478988|NCT00611884|20894992|P3|NOT COMPLETED|Overall Study||4
8478989|NCT00611884|20894993|P2|NOT COMPLETED|Overall Study||9
8478990|NCT00611884|20894994|P1|NOT COMPLETED|Overall Study||9
8478991|NCT00611884|20894991|P4|COMPLETED|Overall Study||56
8478992|NCT00611884|20894992|P3|COMPLETED|Overall Study||58
8478993|NCT00611884|20894993|P2|COMPLETED|Overall Study||51
8478994|NCT00611884|20894994|P1|COMPLETED|Overall Study||52
8478995|NCT00611884|20894991|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
8478996|NCT00611884|20894992|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
8478997|NCT00611884|20894993|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
8478998|NCT00611884|20894994|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
8478999|NCT00611884|20894991|P4|STARTED|Overall Study||62
8479000|NCT00611884|20894992|P3|STARTED|Overall Study||62
8479001|NCT00611884|20894993|P2|STARTED|Overall Study||60
8479002|NCT00611884|20894994|P1|STARTED|Overall Study||61
8479003|NCT00611858|20895048|P1|NOT COMPLETED|Overall Study||4
8479004|NCT00611858|20895048|P1|COMPLETED|Overall Study||9
8479005|NCT00611858|20895048|P1|STARTED|Overall Study||13
8479006|NCT00611806|20895060|P2|NOT COMPLETED|Overall Study||3
8479007|NCT00611806|20895061|P1|NOT COMPLETED|Overall Study||16
8479008|NCT00611806|20895060|P2|COMPLETED|Overall Study||43
8479009|NCT00611806|20895061|P1|COMPLETED|Overall Study||78
8479010|NCT00611806|20895060|P2|STARTED|Overall Study||46
8479011|NCT00611806|20895061|P1|STARTED|Overall Study||94
8479012|NCT00611767|20895075|P2|NOT COMPLETED|Overall Study||2
8479013|NCT00611767|20895076|P1|NOT COMPLETED|Overall Study||9
8479014|NCT00611767|20895075|P2|COMPLETED|Overall Study||22
8479015|NCT00611767|20895076|P1|COMPLETED|Overall Study||40
8479016|NCT00611767|20895075|P2|Placebo Test Day|Overall Study||1
8479017|NCT00611767|20895076|P1|Placebo Test Day|Overall Study||6
8479018|NCT00611767|20895075|P2|Thiopental Test Day|Overall Study||1
8479019|NCT00611767|20895076|P1|Thiopental Test Day|Overall Study||3
8479020|NCT00611767|20895075|P2|STARTED|Overall Study||24
8479021|NCT00611767|20895076|P1|STARTED|Overall Study||49
8479022|NCT00611715|20895238|P2|NOT COMPLETED|Overall Study||6
8479023|NCT00611715|20895239|P1|NOT COMPLETED|Overall Study||41
8479024|NCT00611715|20895238|P2|COMPLETED|Overall Study||0
8479025|NCT00611715|20895239|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
8479026|NCT00611715|20895238|P2|STARTED|Overall Study||6
8479027|NCT00611715|20895239|P1|STARTED|Overall Study||42
8479028|NCT00611624|20895251|P1|NOT COMPLETED|Overall Study||0
8479029|NCT00611624|20895251|P1|COMPLETED|Overall Study||28
8479030|NCT00611624|20895251|P1|STARTED|Overall Study||28
8479031|NCT00611559|20895259|P3|NOT COMPLETED|Overall Study||1
8479032|NCT00611559|20895260|P2|NOT COMPLETED|Overall Study||1
8479033|NCT00611559|20895261|P1|NOT COMPLETED|Overall Study||1
8479034|NCT00611559|20895259|P3|COMPLETED|Overall Study||56
8479035|NCT00611559|20895260|P2|COMPLETED|Overall Study||114
8479036|NCT00611559|20895261|P1|COMPLETED|Overall Study||110
8479037|NCT00611559|20895259|P3|STARTED|Overall Study||57
8479038|NCT00611559|20895260|P2|STARTED|Overall Study||115
8479039|NCT00611559|20895261|P1|STARTED|Overall Study||111
8479040|NCT00611533|20895320|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
8479041|NCT00611533|20895321|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8479042|NCT00611533|20895320|P2|COMPLETED|Second Intervention (6 Weeks)||4
8479043|NCT00611533|20895321|P1|COMPLETED|Second Intervention (6 Weeks)||8
8479044|NCT00611533|20895320|P2|STARTED|Second Intervention (6 Weeks)||6
8479045|NCT00611533|20895321|P1|STARTED|Second Intervention (6 Weeks)||8
8479046|NCT00611533|20895320|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
8479047|NCT00611533|20895321|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8479048|NCT00611533|20895320|P2|COMPLETED|First Intervention (6 Weeks)||6
8479049|NCT00611533|20895321|P1|COMPLETED|First Intervention (6 Weeks)||8
8479050|NCT00611533|20895320|P2|STARTED|First Intervention (6 Weeks)||8
8479051|NCT00611533|20895321|P1|STARTED|First Intervention (6 Weeks)||8
8479052|NCT00611468|20895340|P4|NOT COMPLETED|Overall Study||0
8479053|NCT00611468|20895341|P3|NOT COMPLETED|Overall Study||0
8479054|NCT00611468|20895342|P2|NOT COMPLETED|Overall Study||1
8479055|NCT00611468|20895343|P1|NOT COMPLETED|Overall Study||0
8479056|NCT00611468|20895340|P4|COMPLETED|Overall Study||13
8479057|NCT00611468|20895341|P3|COMPLETED|Overall Study||6
8479058|NCT00611468|20895342|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
8479059|NCT00611468|20895343|P1|COMPLETED|Overall Study||3
8479060|NCT00611468|20895340|P4|STARTED|Overall Study||13
8479061|NCT00611468|20895341|P3|STARTED|Overall Study||6
8479062|NCT00611468|20895342|P2|STARTED|Overall Study||7
8479063|NCT00611468|20895343|P1|STARTED|Overall Study||3
8479064|NCT00611455|20895355|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
8479065|NCT00611455|20895356|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479066|NCT00611455|20895357|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479067|NCT00611455|20895355|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
8479068|NCT00611455|20895356|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479069|NCT00611455|20895357|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479070|NCT00611455|20895355|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
8479071|NCT00611455|20895356|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
8479072|NCT00611455|20895357|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
8479073|NCT00611455|20895355|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8479074|NCT00611455|20895356|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
8479075|NCT00611455|20895357|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8479076|NCT00611455|20895355|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
8479077|NCT00611455|20895356|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
8479078|NCT00611455|20895357|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
8479079|NCT00611455|20895355|P3|STARTED|OL Treatment Period (120 Weeks)||0
8479080|NCT00611455|20895356|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
8479081|NCT00611455|20895357|P1|STARTED|OL Treatment Period (120 Weeks)||0
8479082|NCT00611455|20895355|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
8479083|NCT00611455|20895356|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
8479084|NCT00611455|20895357|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
8479085|NCT00611455|20895355|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
8479086|NCT00611455|20895356|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
8479087|NCT00611455|20895357|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
8479088|NCT00611455|20895355|P3|STARTED|DB Treatment Period (24 Weeks)||0
8479089|NCT00611455|20895356|P2|STARTED|DB Treatment Period (24 Weeks)||131
8479090|NCT00611455|20895357|P1|STARTED|DB Treatment Period (24 Weeks)||134
8479091|NCT00611442|20895485|P2|NOT COMPLETED|Overall Study||2
8479092|NCT00611442|20895486|P1|NOT COMPLETED|Overall Study||1
8479093|NCT00611442|20895485|P2|COMPLETED|Overall Study||94
8479094|NCT00611442|20895486|P1|COMPLETED|Overall Study||94
8479095|NCT00611442|20895485|P2|STARTED|Overall Study||96
8479096|NCT00611442|20895486|P1|STARTED|Overall Study||95
8479097|NCT00611403|20895500|P2|NOT COMPLETED|Post Treatment Extension Phase||1
8479098|NCT00611403|20895501|P1|NOT COMPLETED|Post Treatment Extension Phase||4
8479099|NCT00611403|20895500|P2|COMPLETED|Post Treatment Extension Phase||24
8479100|NCT00611403|20895501|P1|COMPLETED|Post Treatment Extension Phase||22
8479101|NCT00611403|20895500|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
8479102|NCT00611403|20895501|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
8479103|NCT00611403|20895500|P2|NOT COMPLETED|Treatment Phase||11
8479104|NCT00611403|20895501|P1|NOT COMPLETED|Treatment Phase||6
8479105|NCT00611403|20895500|P2|COMPLETED|Treatment Phase||58
8479106|NCT00611403|20895501|P1|COMPLETED|Treatment Phase||62
8479107|NCT00611403|20895500|P2|STARTED|Treatment Phase||69
8479108|NCT00611403|20895501|P1|STARTED|Treatment Phase||68
8479109|NCT00611351|20895511|P1|NOT COMPLETED|Overall Study||2
8479110|NCT00611351|20895511|P1|COMPLETED|Overall Study||3
8479111|NCT00611351|20895511|P1|STARTED|Overall Study||5
8479112|NCT00611325|20895520|P2|NOT COMPLETED|Overall Study||0
8479113|NCT00611325|20895521|P1|NOT COMPLETED|Overall Study||0
8479114|NCT00611325|20895520|P2|COMPLETED|Overall Study||28
8479115|NCT00611325|20895521|P1|COMPLETED|Overall Study||28
8479116|NCT00611325|20895520|P2|STARTED|Overall Study||28
8479117|NCT00611325|20895521|P1|STARTED|Overall Study||28
8479118|NCT00611247|20895537|P2|NOT COMPLETED|Overall Study||21
8479119|NCT00611247|20895538|P1|NOT COMPLETED|Overall Study||2
8479120|NCT00611247|20895537|P2|COMPLETED|Overall Study||10
8479121|NCT00611247|20895538|P1|COMPLETED|Overall Study||3
8479122|NCT00611247|20895537|P2|STARTED|Overall Study||31
8479123|NCT00611247|20895538|P1|STARTED|Overall Study||5
8479124|NCT00611130|20895550|P2|NOT COMPLETED|Overall Study||47
8479125|NCT00611130|20895551|P1|NOT COMPLETED|Overall Study||49
8479126|NCT00611130|20895550|P2|COMPLETED|Overall Study||47
8479127|NCT00611130|20895551|P1|COMPLETED|Overall Study||43
8479128|NCT00611130|20895550|P2|Completed 12 Week Treatment Phase|Overall Study||64
8479129|NCT00611130|20895551|P1|Completed 12 Week Treatment Phase|Overall Study||61
8479130|NCT00611130|20895550|P2|STARTED|Overall Study||94
8479131|NCT00611130|20895551|P1|STARTED|Overall Study||92
8479132|NCT00611026|20895561|P3|NOT COMPLETED|Double-blind Treatment Period||98
8479133|NCT00611026|20895562|P2|NOT COMPLETED|Double-blind Treatment Period||88
8479134|NCT00611026|20895563|P1|NOT COMPLETED|Double-blind Treatment Period||47
8479135|NCT00611026|20895561|P3|COMPLETED|Double-blind Treatment Period||862
8479136|NCT00611026|20895562|P2|COMPLETED|Double-blind Treatment Period||885
8479137|NCT00611026|20895563|P1|COMPLETED|Double-blind Treatment Period||431
8479138|NCT00611026|20895561|P3|STARTED|Double-blind Treatment Period||960
8479139|NCT00611026|20895562|P2|STARTED|Double-blind Treatment Period||973
8479140|NCT00611026|20895563|P1|STARTED|Double-blind Treatment Period||478
8479141|NCT00611026|20895561|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
8479142|NCT00611026|20895562|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
8479143|NCT00611026|20895563|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
8479144|NCT00611026|20895561|P3|COMPLETED|Randomized to Double-blind Treatment||960
8479145|NCT00611026|20895562|P2|COMPLETED|Randomized to Double-blind Treatment||973
8479146|NCT00611026|20895563|P1|COMPLETED|Randomized to Double-blind Treatment||478
8479147|NCT00611026|20895561|P3|STARTED|Randomized to Double-blind Treatment||963
8479148|NCT00611026|20895562|P2|STARTED|Randomized to Double-blind Treatment||974
8479149|NCT00611026|20895563|P1|STARTED|Randomized to Double-blind Treatment||480
8479150|NCT00610987|20895629|P2|NOT COMPLETED|Overall Study||0
8479151|NCT00610987|20895630|P1|NOT COMPLETED|Overall Study||0
8479152|NCT00610987|20895629|P2|COMPLETED|Overall Study||71
8479153|NCT00610987|20895630|P1|COMPLETED|Overall Study||75
8479154|NCT00610987|20895629|P2|STARTED|Overall Study||71
8479155|NCT00610987|20895630|P1|STARTED|Overall Study||75
8479156|NCT00610883|20895636|P1|NOT COMPLETED|Overall Study||0
8479157|NCT00610883|20895636|P1|COMPLETED|Overall Study||17
8479158|NCT00610883|20895636|P1|STARTED|Overall Study||17
8479159|NCT00610857|20895640|P1|NOT COMPLETED|Overall Study||2
8479160|NCT00610857|20895640|P1|COMPLETED|Overall Study||35
8479161|NCT00610857|20895640|P1|STARTED|Overall Study||37
8479162|NCT00610740|20895647|P1|NOT COMPLETED|Overall Study||0
8479163|NCT00610740|20895647|P1|COMPLETED|Overall Study||18
8479164|NCT00610740|20895647|P1|STARTED|Overall Study||18
8479165|NCT00610727|20895659|P6|NOT COMPLETED|Overall Study||0
8479166|NCT00610727|20895660|P5|NOT COMPLETED|Overall Study||0
8479167|NCT00610727|20895661|P4|NOT COMPLETED|Overall Study||0
8479168|NCT00610727|20895662|P3|NOT COMPLETED|Overall Study||0
8479169|NCT00610727|20895663|P2|NOT COMPLETED|Overall Study||0
8479170|NCT00610727|20895664|P1|NOT COMPLETED|Overall Study||0
8479171|NCT00610727|20895659|P6|COMPLETED|Overall Study||8
8479172|NCT00610727|20895660|P5|COMPLETED|Overall Study||8
8479173|NCT00610727|20895661|P4|COMPLETED|Overall Study||8
8479174|NCT00610727|20895662|P3|COMPLETED|Overall Study||8
8479175|NCT00610727|20895663|P2|COMPLETED|Overall Study||8
8479176|NCT00610727|20895664|P1|COMPLETED|Overall Study||14
8479177|NCT00610727|20895659|P6|STARTED|Overall Study||8
8479178|NCT00610727|20895660|P5|STARTED|Overall Study||8
8479179|NCT00610727|20895661|P4|STARTED|Overall Study||8
8479180|NCT00610727|20895662|P3|STARTED|Overall Study||8
8479181|NCT00610727|20895663|P2|STARTED|Overall Study||8
8479182|NCT00610727|20895664|P1|STARTED|Overall Study||14
8479183|NCT00610714|20895684|P2|NOT COMPLETED|Overall Study||24
8479184|NCT00610714|20895685|P1|NOT COMPLETED|Overall Study||26
8479185|NCT00610714|20895684|P2|COMPLETED|Overall Study||82
8479186|NCT00610714|20895685|P1|COMPLETED|Overall Study||79
8479187|NCT00610714|20895684|P2|STARTED|Overall Study||106
8479188|NCT00610714|20895685|P1|STARTED|Overall Study||105
8479189|NCT00610701|20895697|P2|NOT COMPLETED|Overall Study||11
8479190|NCT00610701|20895698|P1|NOT COMPLETED|Overall Study||10
8479191|NCT00610701|20895697|P2|COMPLETED|Overall Study||9
8479192|NCT00610701|20895698|P1|COMPLETED|Overall Study||5
8479193|NCT00610701|20895697|P2|STARTED|Overall Study||20
8479194|NCT00610701|20895698|P1|STARTED|Overall Study||15
8479195|NCT00610688|20895707|P3|NOT COMPLETED|Overall Study||8
8479196|NCT00610688|20895708|P2|NOT COMPLETED|Overall Study||13
8479197|NCT00610688|20895709|P1|NOT COMPLETED|Overall Study||9
8479198|NCT00610688|20895707|P3|COMPLETED|Overall Study||55
8479199|NCT00610688|20895708|P2|COMPLETED|Overall Study||52
8479200|NCT00610688|20895709|P1|COMPLETED|Overall Study||55
8479201|NCT00610688|20895707|P3|STARTED|Overall Study||63
8479202|NCT00610688|20895708|P2|STARTED|Overall Study||65
8479203|NCT00610688|20895709|P1|STARTED|Overall Study||64
8479204|NCT00610675|20895723|P1|NOT COMPLETED|Overall Study||220
8479205|NCT00610675|20895723|P1|COMPLETED|Overall Study||126
8479206|NCT00610675|20895723|P1|Treated|Overall Study||342
8479207|NCT00610675|20895723|P1|STARTED|Overall Study||346
8479208|NCT00610649|20895745|P11|NOT COMPLETED|Overall Study||1
8479209|NCT00610649|20895746|P10|NOT COMPLETED|Overall Study||1
8479210|NCT00610649|20895747|P9|NOT COMPLETED|Overall Study||0
8479211|NCT00610649|20895748|P8|NOT COMPLETED|Overall Study||0
8479212|NCT00610649|20895749|P7|NOT COMPLETED|Overall Study||0
8479213|NCT00610649|20895750|P6|NOT COMPLETED|Overall Study||0
8479214|NCT00610649|20895751|P5|NOT COMPLETED|Overall Study||0
8479215|NCT00610649|20895752|P4|NOT COMPLETED|Overall Study||0
8479216|NCT00610649|20895753|P3|NOT COMPLETED|Overall Study||0
8479217|NCT00610649|20895754|P2|NOT COMPLETED|Overall Study||1
8479218|NCT00610649|20895755|P1|NOT COMPLETED|Overall Study||1
8479219|NCT00610649|20895745|P11|COMPLETED|Overall Study||9
8479220|NCT00610649|20895746|P10|COMPLETED|Overall Study||9
8479221|NCT00610649|20895747|P9|COMPLETED|Overall Study||10
8479222|NCT00610649|20895748|P8|COMPLETED|Overall Study||2
8479223|NCT00610649|20895749|P7|COMPLETED|Overall Study||4
8479224|NCT00610649|20895750|P6|COMPLETED|Overall Study||2
8479225|NCT00610649|20895751|P5|COMPLETED|Overall Study||4
8479226|NCT00610649|20895752|P4|COMPLETED|Overall Study||2
8479227|NCT00610649|20895753|P3|COMPLETED|Overall Study||4
8479228|NCT00610649|20895754|P2|COMPLETED|Overall Study||1
8479229|NCT00610649|20895755|P1|COMPLETED|Overall Study||3
8479230|NCT00610649|20895745|P11|STARTED|Overall Study||10
8479231|NCT00610649|20895746|P10|STARTED|Overall Study||10
8479232|NCT00610649|20895747|P9|STARTED|Overall Study||10
8479233|NCT00610649|20895748|P8|STARTED|Overall Study||2
8479234|NCT00610649|20895749|P7|STARTED|Overall Study||4
8479235|NCT00610649|20895750|P6|STARTED|Overall Study||2
8479236|NCT00610649|20895751|P5|STARTED|Overall Study||4
8479237|NCT00610649|20895752|P4|STARTED|Overall Study||2
8479238|NCT00610649|20895753|P3|STARTED|Overall Study||4
8479239|NCT00610649|20895754|P2|STARTED|Overall Study||2
8479240|NCT00610649|20895755|P1|STARTED|Overall Study||4
8479241|NCT00610558|20895812|P3|NOT COMPLETED|Overall Study||6
8479242|NCT00610558|20895813|P2|NOT COMPLETED|Overall Study||6
8479243|NCT00610558|20895814|P1|NOT COMPLETED|Overall Study||5
8479244|NCT00610558|20895812|P3|COMPLETED|Overall Study||14
8479245|NCT00610558|20895813|P2|COMPLETED|Overall Study||14
8479246|NCT00610558|20895814|P1|COMPLETED|Overall Study||15
8479247|NCT00610558|20895812|P3|STARTED|Overall Study||20
8479248|NCT00610558|20895813|P2|STARTED|Overall Study||20
8479249|NCT00610558|20895814|P1|STARTED|Overall Study||20
8479250|NCT00610532|20895822|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
8479251|NCT00610532|20895822|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
8479252|NCT00610532|20895822|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
8479253|NCT00610532|20895822|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
8479254|NCT00610532|20895822|P1|COMPLETED|Intravenous Phenytoin Alone||8
8479255|NCT00610532|20895822|P1|STARTED|Intravenous Phenytoin Alone||8
8479256|NCT00610480|20895830|P2|NOT COMPLETED|Overall Study||0
8479257|NCT00610480|20895831|P1|NOT COMPLETED|Overall Study||0
8479258|NCT00610480|20895830|P2|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
8479259|NCT00610480|20895831|P1|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
8479260|NCT00610480|20895830|P2|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
8479261|NCT00610480|20895831|P1|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
8479262|NCT00610467|20895839|P2|NOT COMPLETED|Overall Study||0
8479263|NCT00610467|20895840|P1|NOT COMPLETED|Overall Study||0
8479264|NCT00610467|20895839|P2|COMPLETED|Overall Study||1
8479265|NCT00610467|20895840|P1|COMPLETED|Overall Study||1
8479266|NCT00610467|20895839|P2|STARTED|Overall Study||1
8479267|NCT00610467|20895840|P1|STARTED|Overall Study||1
8479268|NCT00610441|20895850|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
8479269|NCT00610441|20895851|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
8479270|NCT00610441|20895852|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
8479271|NCT00610441|20895853|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
8479272|NCT00610441|20895850|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
8479273|NCT00610441|20895851|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
8479274|NCT00610441|20895852|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
8479275|NCT00610441|20895853|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
8479276|NCT00610441|20895850|P4|STARTED|Treatment Period 2 - 3 Weeks||16
8479277|NCT00610441|20895851|P3|STARTED|Treatment Period 2 - 3 Weeks||9
8479278|NCT00610441|20895852|P2|STARTED|Treatment Period 2 - 3 Weeks||13
8479279|NCT00610441|20895853|P1|STARTED|Treatment Period 2 - 3 Weeks||12
8479280|NCT00610441|20895850|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
8479281|NCT00610441|20895851|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
8479282|NCT00610441|20895852|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
8479283|NCT00610441|20895853|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
8479284|NCT00610441|20895850|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
8479285|NCT00610441|20895851|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
8479286|NCT00610441|20895852|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
8479287|NCT00610441|20895853|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
8479288|NCT00610441|20895850|P4|STARTED|Placebo Washout Period - 2 Weeks||16
8479289|NCT00610441|20895851|P3|STARTED|Placebo Washout Period - 2 Weeks||11
8479290|NCT00610441|20895852|P2|STARTED|Placebo Washout Period - 2 Weeks||14
8479291|NCT00610441|20895853|P1|STARTED|Placebo Washout Period - 2 Weeks||12
8479292|NCT00610441|20895850|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
8479293|NCT00610441|20895851|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
8479294|NCT00610441|20895852|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
8479295|NCT00610441|20895853|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
8479296|NCT00610441|20895850|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
8479297|NCT00610441|20895851|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
8479298|NCT00610441|20895852|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
8479299|NCT00610441|20895853|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
8479300|NCT00610441|20895850|P4|STARTED|Treatment Period 1 - 3 Weeks||18
8479301|NCT00610441|20895851|P3|STARTED|Treatment Period 1 - 3 Weeks||18
8479302|NCT00610441|20895852|P2|STARTED|Treatment Period 1 - 3 Weeks||16
8479303|NCT00610441|20895853|P1|STARTED|Treatment Period 1 - 3 Weeks||15
8479304|NCT00610428|20895947|P3|NOT COMPLETED|Overall Study||2
8479305|NCT00610428|20895948|P2|NOT COMPLETED|Overall Study||1
8479306|NCT00610428|20895949|P1|NOT COMPLETED|Overall Study||0
8479307|NCT00610428|20895947|P3|COMPLETED|Overall Study||25
8479308|NCT00610428|20895948|P2|COMPLETED|Overall Study||23
8479309|NCT00610428|20895949|P1|COMPLETED|Overall Study||24
8479310|NCT00610428|20895947|P3|STARTED|Overall Study||27
8479311|NCT00610428|20895948|P2|STARTED|Overall Study||24
8479312|NCT00610428|20895949|P1|STARTED|Overall Study||24
8479313|NCT00610363|20895962|P2|NOT COMPLETED|Overall Study||3
8479314|NCT00610363|20895963|P1|NOT COMPLETED|Overall Study||11
8479315|NCT00610363|20895962|P2|COMPLETED|Overall Study||38
8479316|NCT00610363|20895963|P1|COMPLETED|Overall Study||31
8479317|NCT00610363|20895962|P2|STARTED|Overall Study||41
8479318|NCT00610363|20895963|P1|STARTED|Overall Study||42
8479319|NCT00610311|20895981|P1|NOT COMPLETED|Overall Study||0
8479320|NCT00610311|20895981|P1|COMPLETED|Overall Study||3
8479321|NCT00610311|20895981|P1|STARTED|Overall Study||3
8479322|NCT00610207|20895988|P1|NOT COMPLETED|Overall Study||3
8479323|NCT00610207|20895988|P1|COMPLETED|Overall Study||18
8479324|NCT00610207|20895988|P1|STARTED|Overall Study||21
8479325|NCT00610168|20895995|P2|NOT COMPLETED|Overall Study||0
8479326|NCT00610168|20895996|P1|NOT COMPLETED|Overall Study||2
8479327|NCT00610168|20895995|P2|COMPLETED|Overall Study||7
8479328|NCT00610168|20895996|P1|COMPLETED|Overall Study||73
8479329|NCT00610168|20895995|P2|STARTED|Overall Study||7
8479330|NCT00610168|20895996|P1|STARTED|Overall Study||75
8479331|NCT00610155|20896015|P6|NOT COMPLETED|Period 3||0
8479332|NCT00610155|20896016|P5|NOT COMPLETED|Period 3||0
8479333|NCT00610155|20896017|P4|NOT COMPLETED|Period 3||0
8479334|NCT00610155|20896018|P3|NOT COMPLETED|Period 3||0
8479335|NCT00610155|20896019|P2|NOT COMPLETED|Period 3||0
8479336|NCT00610155|20896020|P1|NOT COMPLETED|Period 3||1
8479337|NCT00610155|20896015|P6|COMPLETED|Period 3||1
8479338|NCT00610155|20896016|P5|COMPLETED|Period 3||3
8479339|NCT00610155|20896017|P4|COMPLETED|Period 3||3
8479340|NCT00610155|20896018|P3|COMPLETED|Period 3||3
8479341|NCT00610155|20896019|P2|COMPLETED|Period 3||3
8479342|NCT00610155|20896020|P1|COMPLETED|Period 3||3
8479343|NCT00610155|20896015|P6|STARTED|Period 3||1
8479344|NCT00610155|20896016|P5|STARTED|Period 3||3
8479345|NCT00610155|20896017|P4|STARTED|Period 3||3
8479346|NCT00610155|20896018|P3|STARTED|Period 3||3
8479347|NCT00610155|20896019|P2|STARTED|Period 3||3
8479348|NCT00610155|20896020|P1|STARTED|Period 3||4
8479349|NCT00610155|20896015|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479350|NCT00610155|20896016|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479351|NCT00610155|20896017|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479352|NCT00610155|20896018|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479353|NCT00610155|20896019|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479354|NCT00610155|20896020|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479355|NCT00610155|20896015|P6|COMPLETED|Washout Period 2 (7 Days)||1
8479356|NCT00610155|20896016|P5|COMPLETED|Washout Period 2 (7 Days)||3
8479357|NCT00610155|20896017|P4|COMPLETED|Washout Period 2 (7 Days)||3
8479358|NCT00610155|20896018|P3|COMPLETED|Washout Period 2 (7 Days)||3
8479359|NCT00610155|20896019|P2|COMPLETED|Washout Period 2 (7 Days)||3
8479360|NCT00610155|20896020|P1|COMPLETED|Washout Period 2 (7 Days)||4
8479361|NCT00610155|20896015|P6|STARTED|Washout Period 2 (7 Days)||1
8479362|NCT00610155|20896016|P5|STARTED|Washout Period 2 (7 Days)||3
8479363|NCT00610155|20896017|P4|STARTED|Washout Period 2 (7 Days)||3
8479364|NCT00610155|20896018|P3|STARTED|Washout Period 2 (7 Days)||3
8479365|NCT00610155|20896019|P2|STARTED|Washout Period 2 (7 Days)||3
8479366|NCT00610155|20896020|P1|STARTED|Washout Period 2 (7 Days)||4
8479367|NCT00610155|20896015|P6|NOT COMPLETED|Period 2||0
8479368|NCT00610155|20896016|P5|NOT COMPLETED|Period 2||0
8479369|NCT00610155|20896017|P4|NOT COMPLETED|Period 2||0
8479370|NCT00610155|20896018|P3|NOT COMPLETED|Period 2||0
8479371|NCT00610155|20896019|P2|NOT COMPLETED|Period 2||0
8479372|NCT00610155|20896020|P1|NOT COMPLETED|Period 2||0
8479373|NCT00610155|20896015|P6|COMPLETED|Period 2||1
8479374|NCT00610155|20896016|P5|COMPLETED|Period 2||3
8479375|NCT00610155|20896017|P4|COMPLETED|Period 2||3
8479376|NCT00610155|20896018|P3|COMPLETED|Period 2||3
8479377|NCT00610155|20896019|P2|COMPLETED|Period 2||3
8479378|NCT00610155|20896020|P1|COMPLETED|Period 2||4
8479379|NCT00610155|20896015|P6|STARTED|Period 2||1
8479380|NCT00610155|20896016|P5|STARTED|Period 2||3
8479381|NCT00610155|20896017|P4|STARTED|Period 2||3
8479382|NCT00610155|20896018|P3|STARTED|Period 2||3
8479383|NCT00610155|20896019|P2|STARTED|Period 2||3
8479384|NCT00610155|20896020|P1|STARTED|Period 2||4
8479385|NCT00610155|20896015|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479386|NCT00610155|20896016|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479387|NCT00610155|20896017|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479388|NCT00610155|20896018|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479389|NCT00610155|20896019|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479390|NCT00610155|20896020|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479391|NCT00610155|20896015|P6|COMPLETED|Washout Period 1 (7 Days)||1
8479392|NCT00610155|20896016|P5|COMPLETED|Washout Period 1 (7 Days)||3
8479393|NCT00610155|20896017|P4|COMPLETED|Washout Period 1 (7 Days)||3
8479394|NCT00610155|20896018|P3|COMPLETED|Washout Period 1 (7 Days)||3
8479395|NCT00610155|20896019|P2|COMPLETED|Washout Period 1 (7 Days)||3
8479396|NCT00610155|20896020|P1|COMPLETED|Washout Period 1 (7 Days)||4
8479397|NCT00610155|20896015|P6|STARTED|Washout Period 1 (7 Days)||1
8479398|NCT00610155|20896016|P5|STARTED|Washout Period 1 (7 Days)||3
8479399|NCT00610155|20896017|P4|STARTED|Washout Period 1 (7 Days)||3
8479400|NCT00610155|20896018|P3|STARTED|Washout Period 1 (7 Days)||3
8479401|NCT00610155|20896019|P2|STARTED|Washout Period 1 (7 Days)||3
8479402|NCT00610155|20896020|P1|STARTED|Washout Period 1 (7 Days)||4
8479403|NCT00610155|20896015|P6|NOT COMPLETED|Period 1||0
8479404|NCT00610155|20896016|P5|NOT COMPLETED|Period 1||0
8479405|NCT00610155|20896017|P4|NOT COMPLETED|Period 1||0
8479406|NCT00610155|20896018|P3|NOT COMPLETED|Period 1||1
8479407|NCT00610155|20896019|P2|NOT COMPLETED|Period 1||0
8479408|NCT00610155|20896020|P1|NOT COMPLETED|Period 1||0
8479409|NCT00610155|20896015|P6|COMPLETED|Period 1||1
8479410|NCT00610155|20896016|P5|COMPLETED|Period 1||3
8479411|NCT00610155|20896017|P4|COMPLETED|Period 1||3
8479412|NCT00610155|20896018|P3|COMPLETED|Period 1||3
8479413|NCT00610155|20896019|P2|COMPLETED|Period 1||3
8479414|NCT00610155|20896020|P1|COMPLETED|Period 1||4
8479415|NCT00610155|20896015|P6|STARTED|Period 1||1
8479416|NCT00610155|20896016|P5|STARTED|Period 1||3
8479417|NCT00610155|20896017|P4|STARTED|Period 1||3
8479418|NCT00610155|20896018|P3|STARTED|Period 1||4
8479419|NCT00610155|20896019|P2|STARTED|Period 1||3
8479420|NCT00610155|20896020|P1|STARTED|Period 1||4
8479421|NCT00610129|20896067|P1|NOT COMPLETED|Overall Study||3
8479422|NCT00610129|20896067|P1|COMPLETED|Overall Study||25
8479423|NCT00610129|20896067|P1|STARTED|Overall Study||28
8479424|NCT00609986|20896073|P2|NOT COMPLETED|Overall Study||3
8479425|NCT00609986|20896074|P1|NOT COMPLETED|Overall Study||8
8479426|NCT00609986|20896073|P2|COMPLETED|Overall Study||49
8479427|NCT00609986|20896074|P1|COMPLETED|Overall Study||44
8479428|NCT00609986|20896073|P2|Received Transplant|Overall Study||49
8479429|NCT00609986|20896074|P1|Received Transplant|Overall Study||44
8479430|NCT00609986|20896073|P2|STARTED|Overall Study||52
8479431|NCT00609986|20896074|P1|STARTED|Overall Study||52
8479432|NCT00609973|20896088|P2|NOT COMPLETED|Overall Study||6
8479433|NCT00609973|20896089|P1|NOT COMPLETED|Overall Study||8
8479434|NCT00609973|20896088|P2|COMPLETED|Overall Study||10
8479435|NCT00609973|20896089|P1|COMPLETED|Overall Study||9
8479436|NCT00609973|20896088|P2|STARTED|Overall Study||16
8479437|NCT00609973|20896089|P1|STARTED|Overall Study||17
8479438|NCT00609947|20896097|P1|NOT COMPLETED|Overall Study||1
8479439|NCT00609947|20896097|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
8479440|NCT00609947|20896097|P1|STARTED|Overall Study||241
8479441|NCT00609869|20896102|P1|NOT COMPLETED|Overall Study||11
8479442|NCT00609869|20896102|P1|COMPLETED|Overall Study||18
8479443|NCT00609869|20896102|P1|STARTED|Overall Study||29
8479444|NCT00609804|20896110|P2|NOT COMPLETED|Overall Study||28
8479445|NCT00609804|20896111|P1|NOT COMPLETED|Overall Study||25
8479446|NCT00609804|20896110|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
8479447|NCT00609804|20896111|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
8479448|NCT00609804|20896110|P2|STARTED|Overall Study||28
8479449|NCT00609804|20896111|P1|STARTED|Overall Study||25
8479450|NCT00609765|20896121|P1|NOT COMPLETED|Overall Study||1
8479451|NCT00609765|20896121|P1|COMPLETED|Overall Study||0
8479452|NCT00609765|20896121|P1|STARTED|Overall Study||1
8479453|NCT00609739|20896126|P1|NOT COMPLETED|Overall Study||0
8479454|NCT00609739|20896126|P1|COMPLETED|Overall Study||1
8479455|NCT00609739|20896126|P1|STARTED|Overall Study||1
8479456|NCT00609674|20896135|P2|NOT COMPLETED|Overall Study||7
8479457|NCT00609674|20896136|P1|NOT COMPLETED|Overall Study||7
8479458|NCT00609674|20896135|P2|COMPLETED|Overall Study||153
8479459|NCT00609674|20896136|P1|COMPLETED|Overall Study||148
8479460|NCT00609674|20896135|P2|STARTED|Overall Study||160
8479461|NCT00609674|20896136|P1|STARTED|Overall Study||155
8479462|NCT00609622|20896172|P2|NOT COMPLETED|Overall Study||95
8479463|NCT00609622|20896173|P1|NOT COMPLETED|Overall Study||96
8479464|NCT00609622|20896172|P2|COMPLETED|Overall Study||0
8479465|NCT00609622|20896173|P1|COMPLETED|Overall Study||0
8479466|NCT00609622|20896172|P2|STARTED|Overall Study||95
8479467|NCT00609622|20896173|P1|STARTED|Overall Study||96
8479468|NCT00609609|20896195|P2|NOT COMPLETED|Overall Study||2
8479469|NCT00609609|20896196|P1|NOT COMPLETED|Overall Study||6
8479470|NCT00609609|20896195|P2|COMPLETED|Overall Study||49
8479471|NCT00609609|20896196|P1|COMPLETED|Overall Study||24
8479472|NCT00609609|20896195|P2|STARTED|Overall Study||51
8479473|NCT00609609|20896196|P1|STARTED|Overall Study||30
8479474|NCT00609518|20896208|P2|NOT COMPLETED|Overall Study||40
8479475|NCT00609518|20896209|P1|NOT COMPLETED|Overall Study||43
8479476|NCT00609518|20896208|P2|COMPLETED|Overall Study||17
8479477|NCT00609518|20896209|P1|COMPLETED|Overall Study||11
8479478|NCT00609518|20896208|P2|Completed 6 Treatment Cycles|Overall Study||22
8479479|NCT00609518|20896209|P1|Completed 6 Treatment Cycles|Overall Study||19
8479480|NCT00609518|20896208|P2|STARTED|Overall Study||57
8479481|NCT00609518|20896209|P1|STARTED|Overall Study||54
8479482|NCT00609492|20896224|P3|NOT COMPLETED|Overall Study||7
8479483|NCT00609492|20896225|P2|NOT COMPLETED|Overall Study||3
8479484|NCT00609492|20896226|P1|NOT COMPLETED|Overall Study||1
8479485|NCT00609492|20896224|P3|COMPLETED|Overall Study||122
8479486|NCT00609492|20896225|P2|COMPLETED|Overall Study||69
8479487|NCT00609492|20896226|P1|COMPLETED|Overall Study||43
8479488|NCT00609492|20896224|P3|STARTED|Overall Study||129
8479489|NCT00609492|20896225|P2|STARTED|Overall Study||72
8479490|NCT00609492|20896226|P1|STARTED|Overall Study||44
8479491|NCT00609466|20896311|P3|NOT COMPLETED|Overall Study||4
8479492|NCT00609466|20896312|P2|NOT COMPLETED|Overall Study||6
8479493|NCT00609466|20896313|P1|NOT COMPLETED|Overall Study||2
8479494|NCT00609466|20896311|P3|COMPLETED|Overall Study||95
8479495|NCT00609466|20896312|P2|COMPLETED|Overall Study||90
8479496|NCT00609466|20896313|P1|COMPLETED|Overall Study||94
8479497|NCT00609466|20896311|P3|STARTED|Overall Study||99
8479498|NCT00609466|20896312|P2|STARTED|Overall Study||96
8479499|NCT00609466|20896313|P1|STARTED|Overall Study||96
8479500|NCT00609362|20896341|P2|NOT COMPLETED|Overall Study||1
8479501|NCT00609362|20896342|P1|NOT COMPLETED|Overall Study||3
8479502|NCT00609362|20896341|P2|COMPLETED|Overall Study||27
8479503|NCT00609362|20896342|P1|COMPLETED|Overall Study||26
8479504|NCT00609362|20896341|P2|STARTED|Overall Study||28
8479505|NCT00609362|20896342|P1|STARTED|Overall Study||29
8479506|NCT00609336|20896352|P1|NOT COMPLETED|Overall Study||13
8479507|NCT00609336|20896352|P1|COMPLETED|Overall Study||22
8479508|NCT00609336|20896352|P1|Surgery|Overall Study||22
8479509|NCT00609336|20896352|P1|STARTED|Overall Study||35
8479510|NCT00609271|20896366|P2|NOT COMPLETED|Overall Study||13
8479511|NCT00609271|20896367|P1|NOT COMPLETED|Overall Study||16
8479512|NCT00609271|20896366|P2|COMPLETED|Overall Study||60
8479513|NCT00609271|20896367|P1|COMPLETED|Overall Study||59
8479514|NCT00609271|20896366|P2|STARTED|Overall Study||73
8479515|NCT00609271|20896367|P1|STARTED|Overall Study||75
8479516|NCT00609245|20896403|P1|NOT COMPLETED|Overall Study||1
8479517|NCT00609245|20896403|P1|COMPLETED|Overall Study||12
8479518|NCT00609245|20896403|P1|STARTED|Overall Study||13
8479519|NCT00609167|20896411|P2|NOT COMPLETED|Overall Study||7
8479520|NCT00609167|20896412|P1|NOT COMPLETED|Overall Study||8
8479521|NCT00609167|20896411|P2|COMPLETED|Overall Study||23
8479522|NCT00609167|20896412|P1|COMPLETED|Overall Study||25
8479523|NCT00609167|20896411|P2|STARTED|Overall Study||30
8479524|NCT00609167|20896412|P1|STARTED|Overall Study||33
8479525|NCT00609128|20896434|P1|NOT COMPLETED|Overall Study||0
8479526|NCT00609128|20896434|P1|COMPLETED|Overall Study||21
8479527|NCT00609128|20896434|P1|STARTED|Overall Study||21
8479528|NCT00608985|20896443|P4|NOT COMPLETED|Overall Study||9
8479529|NCT00608985|20896444|P3|NOT COMPLETED|Overall Study||6
8479530|NCT00608985|20896445|P2|NOT COMPLETED|Overall Study||13
8479531|NCT00608985|20896446|P1|NOT COMPLETED|Overall Study||16
8479532|NCT00608985|20896443|P4|COMPLETED|Overall Study|Completed follow-up|159
8479533|NCT00608985|20896444|P3|COMPLETED|Overall Study|Completed follow-up|170
8479534|NCT00608985|20896445|P2|COMPLETED|Overall Study|Completed follow-up|173
8479535|NCT00608985|20896446|P1|COMPLETED|Overall Study|Completed follow-up|161
8479536|NCT00608985|20896443|P4|Completed Double-blind Treatment|Overall Study||161
8479537|NCT00608985|20896444|P3|Completed Double-blind Treatment|Overall Study||171
8479538|NCT00608985|20896445|P2|Completed Double-blind Treatment|Overall Study||174
8479539|NCT00608985|20896446|P1|Completed Double-blind Treatment|Overall Study||163
8479540|NCT00608985|20896443|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
8479541|NCT00608985|20896444|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
8479542|NCT00608985|20896445|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
8479543|NCT00608985|20896446|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
8479544|NCT00608959|20896478|P1|NOT COMPLETED|Part 2||0
8479545|NCT00608959|20896478|P1|COMPLETED|Part 2||25
8479546|NCT00608959|20896478|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
8479547|NCT00608959|20896478|P1|NOT COMPLETED|Part 1||1
8479548|NCT00608959|20896478|P1|COMPLETED|Part 1||24
8479549|NCT00608959|20896478|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
8479550|NCT00608907|20896491|P3|NOT COMPLETED|Overall Study||1
8479551|NCT00608907|20896492|P2|NOT COMPLETED|Overall Study||0
8479552|NCT00608907|20896493|P1|NOT COMPLETED|Overall Study||12
8479553|NCT00608907|20896491|P3|COMPLETED|Overall Study||17
8479554|NCT00608907|20896492|P2|COMPLETED|Overall Study||13
8479555|NCT00608907|20896493|P1|COMPLETED|Overall Study||18
8479556|NCT00608907|20896491|P3|STARTED|Overall Study||18
8479557|NCT00608907|20896492|P2|STARTED|Overall Study||13
8479558|NCT00608907|20896493|P1|STARTED|Overall Study||30
8479559|NCT00608894|20896503|P2|NOT COMPLETED|Overall Study||2
8479560|NCT00608894|20896504|P1|NOT COMPLETED|Overall Study||0
8479561|NCT00608894|20896503|P2|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
8479562|NCT00608894|20896504|P1|COMPLETED|Overall Study||7
8479563|NCT00608894|20896503|P2|STARTED|Overall Study||6
8479564|NCT00608894|20896504|P1|STARTED|Overall Study||7
8479565|NCT00608881|20896516|P2|NOT COMPLETED|Overall Study||66
8479566|NCT00608881|20896517|P1|NOT COMPLETED|Overall Study||79
8479567|NCT00608881|20896516|P2|COMPLETED|Overall Study||240
8479568|NCT00608881|20896517|P1|COMPLETED|Overall Study||224
8479569|NCT00608881|20896516|P2|STARTED|Overall Study||306
8479570|NCT00608881|20896517|P1|STARTED|Overall Study||303
8479571|NCT00608868|20896551|P1|NOT COMPLETED|Overall Study||15
8479572|NCT00608868|20896551|P1|COMPLETED|Overall Study||141
8479573|NCT00608868|20896551|P1|Per Protocol (PP) Population|Overall Study||121
8479574|NCT00608868|20896551|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
8479575|NCT00608868|20896551|P1|Treatment Completed|Overall Study||141
8479576|NCT00608868|20896551|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
8479577|NCT00608868|20896551|P1|Enrolled|Overall Study||156
8479578|NCT00608868|20896551|P1|STARTED|Overall Study||156
8479579|NCT00608842|20896562|P4|NOT COMPLETED|Overall Study||1
8479580|NCT00608842|20896563|P3|NOT COMPLETED|Overall Study||2
8479581|NCT00608842|20896564|P2|NOT COMPLETED|Overall Study||1
8479582|NCT00608842|20896565|P1|NOT COMPLETED|Overall Study||1
8479583|NCT00608842|20896562|P4|COMPLETED|Overall Study||16
8479584|NCT00608842|20896563|P3|COMPLETED|Overall Study||13
8479585|NCT00608842|20896564|P2|COMPLETED|Overall Study||14
8479586|NCT00608842|20896565|P1|COMPLETED|Overall Study||14
8479587|NCT00608842|20896562|P4|STARTED|Overall Study||17
8479588|NCT00608842|20896563|P3|STARTED|Overall Study||15
8479589|NCT00608842|20896564|P2|STARTED|Overall Study||15
8479590|NCT00608842|20896565|P1|STARTED|Overall Study||15
8479591|NCT00608829|20896599|P1|NOT COMPLETED|Overall Study||15
8479592|NCT00608829|20896599|P1|COMPLETED|Overall Study||8
8479593|NCT00608829|20896599|P1|STARTED|Overall Study||23
8479594|NCT00608777|20896603|P1|NOT COMPLETED|Overall Study||0
8479595|NCT00608777|20896603|P1|COMPLETED|Overall Study||6
8479596|NCT00608777|20896603|P1|STARTED|Overall Study||6
8479597|NCT00608634|20896610|P3|NOT COMPLETED|Overall Study||1
8479598|NCT00608634|20896611|P2|NOT COMPLETED|Overall Study||1
8479599|NCT00608634|20896612|P1|NOT COMPLETED|Overall Study||2
8479600|NCT00608634|20896610|P3|COMPLETED|Overall Study||27
8479601|NCT00608634|20896611|P2|COMPLETED|Overall Study||26
8479602|NCT00608634|20896612|P1|COMPLETED|Overall Study||26
8479603|NCT00608634|20896610|P3|STARTED|Overall Study||28
8479604|NCT00608634|20896611|P2|STARTED|Overall Study||27
8479605|NCT00608634|20896612|P1|STARTED|Overall Study||28
8479606|NCT00608582|20896625|P2|NOT COMPLETED|Overall Study||4
8479607|NCT00608582|20896626|P1|NOT COMPLETED|Overall Study||4
8479608|NCT00608582|20896625|P2|COMPLETED|Overall Study||7
8479609|NCT00608582|20896626|P1|COMPLETED|Overall Study||10
8479610|NCT00608582|20896625|P2|STARTED|Overall Study||11
8479611|NCT00608582|20896626|P1|STARTED|Overall Study||14
8479612|NCT00608569|20896636|P2|NOT COMPLETED|Overall Study||9
8479613|NCT00608569|20896637|P1|NOT COMPLETED|Overall Study||10
8479614|NCT00608569|20896636|P2|COMPLETED|Overall Study||119
8479615|NCT00608569|20896637|P1|COMPLETED|Overall Study||119
8479616|NCT00608569|20896636|P2|STARTED|Overall Study||128
8479617|NCT00608569|20896637|P1|STARTED|Overall Study||129
8479618|NCT00608543|20896657|P1|NOT COMPLETED|Overall Study||4
8479619|NCT00608543|20896657|P1|COMPLETED|Overall Study||13
8479620|NCT00608543|20896657|P1|STARTED|Overall Study||17
8479621|NCT00608530|20896670|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
8479622|NCT00608530|20896671|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
8479623|NCT00608530|20896672|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
8479624|NCT00608530|20896673|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
8479625|NCT00608530|20896670|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
8479626|NCT00608530|20896671|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
8479627|NCT00608530|20896672|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
8479628|NCT00608530|20896673|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
8479629|NCT00608530|20896670|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
8479630|NCT00608530|20896671|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
8479631|NCT00608530|20896672|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
8479632|NCT00608530|20896673|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
8479633|NCT00608530|20896670|P4|STARTED|Study 2 Nurse-delivered Treatments||34
8479634|NCT00608530|20896671|P3|STARTED|Study 2 Nurse-delivered Treatments||33
8479635|NCT00608530|20896672|P2|STARTED|Study 2 Nurse-delivered Treatments||0
8479636|NCT00608530|20896673|P1|STARTED|Study 2 Nurse-delivered Treatments||0
8479637|NCT00608530|20896670|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479638|NCT00608530|20896671|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479639|NCT00608530|20896672|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
8479640|NCT00608530|20896673|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
8479641|NCT00608530|20896670|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479642|NCT00608530|20896671|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479643|NCT00608530|20896672|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
8479644|NCT00608530|20896673|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
8479645|NCT00608530|20896670|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
8479646|NCT00608530|20896671|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
8479647|NCT00608530|20896672|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
8479648|NCT00608530|20896673|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
8479649|NCT00608530|20896670|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
8479650|NCT00608530|20896671|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
8479651|NCT00608530|20896672|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
8479652|NCT00608530|20896673|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
8479653|NCT00608517|20896694|P3|NOT COMPLETED|Overall Study||0
8479654|NCT00608517|20896695|P2|NOT COMPLETED|Overall Study||0
8479655|NCT00608517|20896696|P1|NOT COMPLETED|Overall Study||1
8479656|NCT00608517|20896694|P3|COMPLETED|Overall Study||1
8479657|NCT00608517|20896695|P2|COMPLETED|Overall Study||3
8479658|NCT00608517|20896696|P1|COMPLETED|Overall Study||1
8479659|NCT00608517|20896694|P3|STARTED|Overall Study||1
8479660|NCT00608517|20896695|P2|STARTED|Overall Study||3
8479661|NCT00608517|20896696|P1|STARTED|Overall Study||2
8479662|NCT00608491|20896724|P2|NOT COMPLETED|Overall Study||22
8479663|NCT00608491|20896725|P1|NOT COMPLETED|Overall Study||21
8479664|NCT00608491|20896724|P2|COMPLETED|Overall Study||72
8479665|NCT00608491|20896725|P1|COMPLETED|Overall Study||73
8479666|NCT00608491|20896724|P2|STARTED|Overall Study||94
8479667|NCT00608491|20896725|P1|STARTED|Overall Study||94
8479668|NCT00608465|20896869|P1|NOT COMPLETED|Overall Study||0
8479669|NCT00608465|20896869|P1|COMPLETED|Overall Study||4
8479670|NCT00608465|20896869|P1|STARTED|Overall Study||4
8479671|NCT00608426|20896876|P2|NOT COMPLETED|Overall Study||905
8479672|NCT00608426|20896877|P1|NOT COMPLETED|Overall Study||836
8479673|NCT00608426|20896876|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
8479674|NCT00608426|20896877|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
8479675|NCT00608426|20896876|P2|STARTED|Overall Study||2519
8479676|NCT00608426|20896877|P1|STARTED|Overall Study||2604
8479677|NCT00608322|20896889|P2|NOT COMPLETED|Overall Study||1
8479678|NCT00608322|20896890|P1|NOT COMPLETED|Overall Study||2
8479679|NCT00608322|20896889|P2|COMPLETED|Overall Study||22
8479680|NCT00608322|20896890|P1|COMPLETED|Overall Study||24
8479681|NCT00608322|20896889|P2|STARTED|Overall Study||23
8479682|NCT00608322|20896890|P1|STARTED|Overall Study||26
8479683|NCT00608244|20896896|P1|NOT COMPLETED|Overall Study||2
8479684|NCT00608244|20896896|P1|COMPLETED|Overall Study||57
8479685|NCT00608244|20896896|P1|STARTED|Overall Study||59
8479686|NCT00608205|20896907|P2|NOT COMPLETED|Overall Study||3
8479687|NCT00608205|20896908|P1|NOT COMPLETED|Overall Study||3
8479688|NCT00608205|20896907|P2|COMPLETED|Overall Study||31
8479689|NCT00608205|20896908|P1|COMPLETED|Overall Study||32
8479690|NCT00608205|20896907|P2|STARTED|Overall Study||34
8479691|NCT00608205|20896908|P1|STARTED|Overall Study||35
8479692|NCT00608140|20896998|P2|NOT COMPLETED|Overall Study||1
8479693|NCT00608140|20896999|P1|NOT COMPLETED|Overall Study||1
8479694|NCT00608140|20896998|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
8479695|NCT00608140|20896999|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
8479696|NCT00608140|20896998|P2|STARTED|Overall Study||1
8479697|NCT00608140|20896999|P1|STARTED|Overall Study||1
8479698|NCT00608062|20897028|P6|NOT COMPLETED|Overall Study||0
8479699|NCT00608062|20897029|P5|NOT COMPLETED|Overall Study||0
8479700|NCT00608062|20897030|P4|NOT COMPLETED|Overall Study||0
8479701|NCT00608062|20897031|P3|NOT COMPLETED|Overall Study||0
8479702|NCT00608062|20897032|P2|NOT COMPLETED|Overall Study||0
8479703|NCT00608062|20897033|P1|NOT COMPLETED|Overall Study||0
8479704|NCT00608062|20897028|P6|COMPLETED|Overall Study||15
8479705|NCT00608062|20897029|P5|COMPLETED|Overall Study||13
8479706|NCT00608062|20897030|P4|COMPLETED|Overall Study||21
8479707|NCT00608062|20897031|P3|COMPLETED|Overall Study||19
8479708|NCT00608062|20897032|P2|COMPLETED|Overall Study||12
8479709|NCT00608062|20897033|P1|COMPLETED|Overall Study||12
8479710|NCT00608062|20897028|P6|STARTED|Overall Study||15
8479711|NCT00608062|20897029|P5|STARTED|Overall Study||13
8479712|NCT00608062|20897030|P4|STARTED|Overall Study||21
8479713|NCT00608062|20897031|P3|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
8479714|NCT00608062|20897032|P2|STARTED|Overall Study||12
8479715|NCT00608062|20897033|P1|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
8479716|NCT00608023|20897092|P3|NOT COMPLETED|Overall Study||14
8479717|NCT00608023|20897093|P2|NOT COMPLETED|Overall Study||22
8479718|NCT00608023|20897094|P1|NOT COMPLETED|Overall Study||12
8479719|NCT00608023|20897092|P3|COMPLETED|Overall Study||72
8479720|NCT00608023|20897093|P2|COMPLETED|Overall Study||63
8479721|NCT00608023|20897094|P1|COMPLETED|Overall Study||80
8479722|NCT00608023|20897092|P3|STARTED|Overall Study||86
8479723|NCT00608023|20897093|P2|STARTED|Overall Study||85
8479724|NCT00608023|20897094|P1|STARTED|Overall Study||92
8479725|NCT00607997|20897118|P4|NOT COMPLETED|Overall Study||16
8479726|NCT00607997|20897119|P3|NOT COMPLETED|Overall Study||24
8479727|NCT00607997|20897120|P2|NOT COMPLETED|Overall Study||27
8479728|NCT00607997|20897121|P1|NOT COMPLETED|Overall Study||27
8479729|NCT00607997|20897118|P4|COMPLETED|Overall Study||4
8479730|NCT00607997|20897119|P3|COMPLETED|Overall Study||5
8479731|NCT00607997|20897120|P2|COMPLETED|Overall Study||8
8479732|NCT00607997|20897121|P1|COMPLETED|Overall Study||2
8479733|NCT00607997|20897118|P4|STARTED|Overall Study||20
8479734|NCT00607997|20897119|P3|STARTED|Overall Study||29
8479735|NCT00607997|20897120|P2|STARTED|Overall Study||35
8479736|NCT00607997|20897121|P1|STARTED|Overall Study||29
8479737|NCT00607919|20897179|P2|NOT COMPLETED|Open-Label Phase||12
8479738|NCT00607919|20897180|P1|NOT COMPLETED|Open-Label Phase||10
8479739|NCT00607919|20897179|P2|COMPLETED|Open-Label Phase||59
8479740|NCT00607919|20897180|P1|COMPLETED|Open-Label Phase||74
8479741|NCT00607919|20897179|P2|STARTED|Open-Label Phase||71
8479742|NCT00607919|20897180|P1|STARTED|Open-Label Phase||84
8479743|NCT00607919|20897179|P2|NOT COMPLETED|Acute Phase||16
8479744|NCT00607919|20897180|P1|NOT COMPLETED|Acute Phase||34
8479745|NCT00607919|20897179|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
8479746|NCT00607919|20897180|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
8479747|NCT00607919|20897179|P2|STARTED|Acute Phase||89
8479748|NCT00607919|20897180|P1|STARTED|Acute Phase||120
8479749|NCT00607893|20897238|P2|NOT COMPLETED|Overall Study||4
8479750|NCT00607893|20897239|P1|NOT COMPLETED|Overall Study||6
8479751|NCT00607893|20897238|P2|COMPLETED|Overall Study||72
8479752|NCT00607893|20897239|P1|COMPLETED|Overall Study||71
8479753|NCT00607893|20897238|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
8479754|NCT00607893|20897239|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
8479755|NCT00607893|20897238|P2|Completed 8 Week Visit|Overall Study||72
8479756|NCT00607893|20897239|P1|Completed 8 Week Visit|Overall Study||71
8479757|NCT00607893|20897238|P2|Completed Baseline Visit|Overall Study||75
8479758|NCT00607893|20897239|P1|Completed Baseline Visit|Overall Study||74
8479759|NCT00607893|20897238|P2|STARTED|Overall Study||76
8479760|NCT00607893|20897239|P1|STARTED|Overall Study||77
8479761|NCT00607880|20897267|P2|NOT COMPLETED|Overall Study||0
8479762|NCT00607880|20897268|P1|NOT COMPLETED|Overall Study||1
8479763|NCT00607880|20897267|P2|COMPLETED|Overall Study||50
8479764|NCT00607880|20897268|P1|COMPLETED|Overall Study||49
8479765|NCT00607880|20897267|P2|STARTED|Overall Study||50
8479766|NCT00607880|20897268|P1|STARTED|Overall Study||50
8479767|NCT00607867|20897282|P2|NOT COMPLETED|Overall Study||0
8479768|NCT00607867|20897283|P1|NOT COMPLETED|Overall Study||0
8479769|NCT00607867|20897282|P2|COMPLETED|Overall Study||7
8479770|NCT00607867|20897283|P1|COMPLETED|Overall Study||7
8479771|NCT00607867|20897282|P2|STARTED|Overall Study||7
8479772|NCT00607867|20897283|P1|STARTED|Overall Study||7
8479773|NCT00607815|20897301|P2|NOT COMPLETED|Overall Study||11
8479774|NCT00607815|20897302|P1|NOT COMPLETED|Overall Study||23
8479775|NCT00607815|20897301|P2|COMPLETED|Overall Study||25
8479776|NCT00607815|20897302|P1|COMPLETED|Overall Study||20
8479777|NCT00607815|20897301|P2|STARTED|Overall Study||36
8479778|NCT00607815|20897302|P1|STARTED|Overall Study||43
8479779|NCT00607789|20897318|P2|NOT COMPLETED|Overall Study||6
8479780|NCT00607789|20897319|P1|NOT COMPLETED|Overall Study||7
8479781|NCT00607789|20897318|P2|COMPLETED|Overall Study||14
8479782|NCT00607789|20897319|P1|COMPLETED|Overall Study||13
8479783|NCT00607789|20897318|P2|STARTED|Overall Study||20
8479784|NCT00607789|20897319|P1|STARTED|Overall Study|20 participants were randomized in each group|20
8479785|NCT00607724|20897334|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
8479786|NCT00607724|20897335|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
8479787|NCT00607724|20897336|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
8479788|NCT00607724|20897337|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
8479789|NCT00607724|20897338|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
8479790|NCT00607724|20897339|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
8479791|NCT00607724|20897340|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
8479792|NCT00607724|20897334|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
8479793|NCT00607724|20897335|P6|COMPLETED|Stage 2: Expanded Cohort||0
8479794|NCT00607724|20897336|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
8479795|NCT00607724|20897337|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
8479796|NCT00607724|20897338|P3|COMPLETED|Stage 2: Expanded Cohort||0
8479797|NCT00607724|20897339|P2|COMPLETED|Stage 2: Expanded Cohort||0
8479798|NCT00607724|20897340|P1|COMPLETED|Stage 2: Expanded Cohort||0
8479799|NCT00607724|20897334|P7|STARTED|Stage 2: Expanded Cohort||16
8479800|NCT00607724|20897335|P6|STARTED|Stage 2: Expanded Cohort||12
8479801|NCT00607724|20897336|P5|STARTED|Stage 2: Expanded Cohort||14
8479802|NCT00607724|20897337|P4|STARTED|Stage 2: Expanded Cohort||6
8479803|NCT00607724|20897338|P3|STARTED|Stage 2: Expanded Cohort||0
8479804|NCT00607724|20897339|P2|STARTED|Stage 2: Expanded Cohort||0
8479805|NCT00607724|20897340|P1|STARTED|Stage 2: Expanded Cohort||0
8479806|NCT00607724|20897334|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
8479807|NCT00607724|20897335|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
8479808|NCT00607724|20897336|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
8479809|NCT00607724|20897337|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
8479810|NCT00607724|20897338|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
8479811|NCT00607724|20897339|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
8479812|NCT00607724|20897340|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
8479813|NCT00607724|20897334|P7|COMPLETED|Stage 1: Dose Escalation||0
8479814|NCT00607724|20897335|P6|COMPLETED|Stage 1: Dose Escalation||0
8479815|NCT00607724|20897336|P5|COMPLETED|Stage 1: Dose Escalation||0
8479816|NCT00607724|20897337|P4|COMPLETED|Stage 1: Dose Escalation||0
8479817|NCT00607724|20897338|P3|COMPLETED|Stage 1: Dose Escalation||0
8479818|NCT00607724|20897339|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
8479819|NCT00607724|20897340|P1|COMPLETED|Stage 1: Dose Escalation||0
8479820|NCT00607724|20897334|P7|STARTED|Stage 1: Dose Escalation||0
8479821|NCT00607724|20897335|P6|STARTED|Stage 1: Dose Escalation||0
8479822|NCT00607724|20897336|P5|STARTED|Stage 1: Dose Escalation||0
8479823|NCT00607724|20897337|P4|STARTED|Stage 1: Dose Escalation||0
8479824|NCT00607724|20897338|P3|STARTED|Stage 1: Dose Escalation||4
8479825|NCT00607724|20897339|P2|STARTED|Stage 1: Dose Escalation||9
8479826|NCT00607724|20897340|P1|STARTED|Stage 1: Dose Escalation||7
8479827|NCT00607672|20897419|P3|NOT COMPLETED|Overall Study||5
8479828|NCT00607672|20897420|P2|NOT COMPLETED|Overall Study||3
8479829|NCT00607672|20897421|P1|NOT COMPLETED|Overall Study||4
8479830|NCT00607672|20897419|P3|COMPLETED|Overall Study||22
8479831|NCT00607672|20897420|P2|COMPLETED|Overall Study||24
8479832|NCT00607672|20897421|P1|COMPLETED|Overall Study||28
8479833|NCT00607672|20897419|P3|STARTED|Overall Study||27
8479834|NCT00607672|20897420|P2|STARTED|Overall Study||27
8479835|NCT00607672|20897421|P1|STARTED|Overall Study||32
8479836|NCT00607620|20897467|P2|NOT COMPLETED|Overall Study||0
8479837|NCT00607620|20897468|P1|NOT COMPLETED|Overall Study||0
8479838|NCT00607620|20897467|P2|COMPLETED|Overall Study||469
8479839|NCT00607620|20897468|P1|COMPLETED|Overall Study||409
8479840|NCT00607620|20897467|P2|STARTED|Overall Study||469
8479841|NCT00607620|20897468|P1|STARTED|Overall Study||409
8479842|NCT00607594|20897482|P1|NOT COMPLETED|Overall Study||0
8479843|NCT00607594|20897482|P1|COMPLETED|Overall Study||21
8479844|NCT00607594|20897482|P1|STARTED|Overall Study||21
8479845|NCT00607477|20897496|P2|NOT COMPLETED|Overall Study||0
8479846|NCT00607477|20897497|P1|NOT COMPLETED|Overall Study||0
8479847|NCT00607477|20897496|P2|COMPLETED|Overall Study||2
8479848|NCT00607477|20897497|P1|COMPLETED|Overall Study||0
8479849|NCT00607477|20897496|P2|STARTED|Overall Study||2
8479850|NCT00607477|20897497|P1|STARTED|Overall Study||0
8479851|NCT00607386|20897503|P1|NOT COMPLETED|Overall Study||1
8479852|NCT00607386|20897503|P1|COMPLETED|Overall Study||27
8479853|NCT00607386|20897503|P1|STARTED|Overall Study||28
8479854|NCT00607373|20897518|P2|NOT COMPLETED|Follow-up Period||5
8479855|NCT00607373|20897519|P1|NOT COMPLETED|Follow-up Period||1
8479856|NCT00607373|20897518|P2|COMPLETED|Follow-up Period||6
8479857|NCT00607373|20897519|P1|COMPLETED|Follow-up Period||0
8479858|NCT00607373|20897518|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
8479859|NCT00607373|20897519|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
8479860|NCT00607373|20897518|P2|NOT COMPLETED|Treatment Period||6
8479861|NCT00607373|20897519|P1|NOT COMPLETED|Treatment Period||0
8479862|NCT00607373|20897518|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
8479863|NCT00607373|20897519|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
8479864|NCT00607373|20897518|P2|STARTED|Treatment Period||34
8479865|NCT00607373|20897519|P1|STARTED|Treatment Period||17
8479866|NCT00607321|20897563|P1|NOT COMPLETED|Overall Study||0
8479867|NCT00607321|20897563|P1|COMPLETED|Overall Study||60
8479868|NCT00607321|20897563|P1|STARTED|Overall Study||60
8479869|NCT00607269|20897573|P2|NOT COMPLETED|Overall Study||0
8479870|NCT00607269|20897574|P1|NOT COMPLETED|Overall Study||0
8479871|NCT00607269|20897573|P2|COMPLETED|Overall Study||64
8479872|NCT00607269|20897574|P1|COMPLETED|Overall Study||67
8479873|NCT00607269|20897573|P2|STARTED|Overall Study||64
8479874|NCT00607269|20897574|P1|STARTED|Overall Study||67
8479875|NCT00607243|20897588|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
8479876|NCT00607243|20897589|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
8479877|NCT00607243|20897588|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
8479878|NCT00607243|20897589|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
8479879|NCT00607243|20897588|P2|STARTED|Telephone Safety Assessment Period||41
8479880|NCT00607243|20897589|P1|STARTED|Telephone Safety Assessment Period||82
8479881|NCT00607243|20897588|P2|NOT COMPLETED|Initial Post-vaccination Period||0
8479882|NCT00607243|20897589|P1|NOT COMPLETED|Initial Post-vaccination Period||0
8479883|NCT00607243|20897588|P2|COMPLETED|Initial Post-vaccination Period||41
8479884|NCT00607243|20897589|P1|COMPLETED|Initial Post-vaccination Period||82
8479885|NCT00607243|20897588|P2|STARTED|Initial Post-vaccination Period||41
8479886|NCT00607243|20897589|P1|STARTED|Initial Post-vaccination Period||82
8479887|NCT00607126|20897597|P2|NOT COMPLETED|Overall Study||0
8479888|NCT00607126|20897598|P1|NOT COMPLETED|Overall Study||0
8479889|NCT00607126|20897597|P2|COMPLETED|Overall Study||19
8479890|NCT00607126|20897598|P1|COMPLETED|Overall Study||17
8479891|NCT00607126|20897597|P2|STARTED|Overall Study||19
8479892|NCT00607126|20897598|P1|STARTED|Overall Study||17
8479893|NCT00607113|20897612|P2|NOT COMPLETED|Overall Study||0
8479894|NCT00607113|20897613|P1|NOT COMPLETED|Overall Study||0
8479895|NCT00607113|20897612|P2|COMPLETED|Overall Study||20
8479896|NCT00607113|20897613|P1|COMPLETED|Overall Study||19
8479897|NCT00607113|20897612|P2|STARTED|Overall Study||20
8479898|NCT00607113|20897613|P1|STARTED|Overall Study||19
8479899|NCT00607087|20897621|P3|NOT COMPLETED|Period 3||0
8479900|NCT00607087|20897622|P2|NOT COMPLETED|Period 3||2
8479901|NCT00607087|20897623|P1|NOT COMPLETED|Period 3||2
8479902|NCT00607087|20897621|P3|COMPLETED|Period 3||84
8479903|NCT00607087|20897622|P2|COMPLETED|Period 3||84
8479904|NCT00607087|20897623|P1|COMPLETED|Period 3||84
8479905|NCT00607087|20897621|P3|STARTED|Period 3||84
8479906|NCT00607087|20897622|P2|STARTED|Period 3||86
8479907|NCT00607087|20897623|P1|STARTED|Period 3||86
8479908|NCT00607087|20897621|P3|NOT COMPLETED|Period 2||5
8479909|NCT00607087|20897622|P2|NOT COMPLETED|Period 2||3
8479910|NCT00607087|20897623|P1|NOT COMPLETED|Period 2||1
8479911|NCT00607087|20897621|P3|COMPLETED|Period 2||84
8479912|NCT00607087|20897622|P2|COMPLETED|Period 2||86
8479913|NCT00607087|20897623|P1|COMPLETED|Period 2||86
8479914|NCT00607087|20897621|P3|STARTED|Period 2||89
8479915|NCT00607087|20897622|P2|STARTED|Period 2||89
8479916|NCT00607087|20897623|P1|STARTED|Period 2||87
8479917|NCT00607087|20897621|P3|NOT COMPLETED|Period 1||5
8479918|NCT00607087|20897622|P2|NOT COMPLETED|Period 1||6
8479919|NCT00607087|20897623|P1|NOT COMPLETED|Period 1||12
8479920|NCT00607087|20897621|P3|COMPLETED|Period 1||89
8479921|NCT00607087|20897622|P2|COMPLETED|Period 1||89
8479922|NCT00607087|20897623|P1|COMPLETED|Period 1||87
8479923|NCT00607087|20897621|P3|STARTED|Period 1||94
8479924|NCT00607087|20897622|P2|STARTED|Period 1||95
8479925|NCT00607087|20897623|P1|STARTED|Period 1||99
8479926|NCT00607087|20897621|P3|NOT COMPLETED|Overall Study||10
8479927|NCT00607087|20897622|P2|NOT COMPLETED|Overall Study||11
8479928|NCT00607087|20897623|P1|NOT COMPLETED|Overall Study||15
8479929|NCT00607087|20897621|P3|COMPLETED|Overall Study||84
8479930|NCT00607087|20897622|P2|COMPLETED|Overall Study||84
8479931|NCT00607087|20897623|P1|COMPLETED|Overall Study||84
8479932|NCT00607087|20897621|P3|STARTED|Overall Study||94
8479933|NCT00607087|20897622|P2|STARTED|Overall Study||95
8479934|NCT00607087|20897623|P1|STARTED|Overall Study||99
8479935|NCT00607048|20897681|P6|NOT COMPLETED|Overall Study||5
8479936|NCT00607048|20897682|P5|NOT COMPLETED|Overall Study||6
8479937|NCT00607048|20897683|P4|NOT COMPLETED|Overall Study||3
8479938|NCT00607048|20897684|P3|NOT COMPLETED|Overall Study||4
8479939|NCT00607048|20897685|P2|NOT COMPLETED|Overall Study||4
8479940|NCT00607048|20897686|P1|NOT COMPLETED|Overall Study||3
8479941|NCT00607048|20897681|P6|COMPLETED|Overall Study||2
8479942|NCT00607048|20897682|P5|COMPLETED|Overall Study||0
8479943|NCT00607048|20897683|P4|COMPLETED|Overall Study||0
8479944|NCT00607048|20897684|P3|COMPLETED|Overall Study||3
8479945|NCT00607048|20897685|P2|COMPLETED|Overall Study||2
8479946|NCT00607048|20897686|P1|COMPLETED|Overall Study||0
8479947|NCT00607048|20897681|P6|STARTED|Overall Study||7
8479948|NCT00607048|20897682|P5|STARTED|Overall Study||6
8479949|NCT00607048|20897683|P4|STARTED|Overall Study||3
8479950|NCT00607048|20897684|P3|STARTED|Overall Study||7
8479951|NCT00607048|20897685|P2|STARTED|Overall Study||6
8479952|NCT00607048|20897686|P1|STARTED|Overall Study||3
8479953|NCT00607022|20897771|P3|NOT COMPLETED|Overall Study||0
8479954|NCT00607022|20897772|P2|NOT COMPLETED|Overall Study||0
8479955|NCT00607022|20897773|P1|NOT COMPLETED|Overall Study||1
8479956|NCT00607022|20897771|P3|COMPLETED|Overall Study||19
8479957|NCT00607022|20897772|P2|COMPLETED|Overall Study||15
8479958|NCT00607022|20897773|P1|COMPLETED|Overall Study||6
8479959|NCT00607022|20897771|P3|STARTED|Overall Study||19
8479960|NCT00607022|20897772|P2|STARTED|Overall Study||15
8479961|NCT00607022|20897773|P1|STARTED|Overall Study||7
8479962|NCT00606944|20897783|P2|NOT COMPLETED|Overall Study||0
8479963|NCT00606944|20897784|P1|NOT COMPLETED|Overall Study||0
8479964|NCT00606944|20897783|P2|COMPLETED|Overall Study||100
8479965|NCT00606944|20897784|P1|COMPLETED|Overall Study||98
8479966|NCT00606944|20897783|P2|STARTED|Overall Study||100
8479967|NCT00606944|20897784|P1|STARTED|Overall Study||98
8479968|NCT00606931|20897790|P1|NOT COMPLETED|Overall Study||3
8479969|NCT00606931|20897790|P1|COMPLETED|Overall Study||19
8479970|NCT00606931|20897790|P1|STARTED|Overall Study||22
8479971|NCT00606905|20897798|P2|NOT COMPLETED|Overall Study||15
8479972|NCT00606905|20897799|P1|NOT COMPLETED|Overall Study||15
8479973|NCT00606905|20897798|P2|COMPLETED|Overall Study||24
8479974|NCT00606905|20897799|P1|COMPLETED|Overall Study||23
8479975|NCT00606905|20897798|P2|Pregnancy|Overall Study||33
8479976|NCT00606905|20897799|P1|Pregnancy|Overall Study||29
8479977|NCT00606905|20897798|P2|STARTED|Overall Study||39
8479978|NCT00606905|20897799|P1|STARTED|Overall Study||38
8479979|NCT00606892|20897805|P2|NOT COMPLETED|Second Intervention||0
8479980|NCT00606892|20897806|P1|NOT COMPLETED|Second Intervention||0
8479981|NCT00606892|20897805|P2|COMPLETED|Second Intervention||4
8479982|NCT00606892|20897806|P1|COMPLETED|Second Intervention||8
8479983|NCT00606892|20897805|P2|STARTED|Second Intervention||4
8479984|NCT00606892|20897806|P1|STARTED|Second Intervention||8
8479985|NCT00606892|20897805|P2|NOT COMPLETED|Washout Period||0
8479986|NCT00606892|20897806|P1|NOT COMPLETED|Washout Period||0
8479987|NCT00606892|20897805|P2|COMPLETED|Washout Period||4
8479988|NCT00606892|20897806|P1|COMPLETED|Washout Period||8
8479989|NCT00606892|20897805|P2|STARTED|Washout Period||4
8479990|NCT00606892|20897806|P1|STARTED|Washout Period||8
8479991|NCT00606892|20897805|P2|NOT COMPLETED|First Intervention||4
8479992|NCT00606892|20897806|P1|NOT COMPLETED|First Intervention||1
8479993|NCT00606892|20897805|P2|COMPLETED|First Intervention||4
8479994|NCT00606892|20897806|P1|COMPLETED|First Intervention||8
8479995|NCT00606892|20897805|P2|STARTED|First Intervention||8
8479996|NCT00606892|20897806|P1|STARTED|First Intervention||9
8479997|NCT00606892|20897805|P2|NOT COMPLETED|Adaptation||0
8479998|NCT00606892|20897806|P1|NOT COMPLETED|Adaptation||0
8479999|NCT00606892|20897805|P2|COMPLETED|Adaptation||8
8480000|NCT00606892|20897806|P1|COMPLETED|Adaptation||9
8480001|NCT00606892|20897805|P2|STARTED|Adaptation||8
8480002|NCT00606892|20897806|P1|STARTED|Adaptation||9
8480003|NCT00606801|20897840|P2|NOT COMPLETED|Intervention||3
8480004|NCT00606801|20897841|P1|NOT COMPLETED|Intervention||3
8480005|NCT00606801|20897840|P2|COMPLETED|Intervention||14
8480006|NCT00606801|20897841|P1|COMPLETED|Intervention||14
8480007|NCT00606801|20897840|P2|STARTED|Intervention||17
8480008|NCT00606801|20897841|P1|STARTED|Intervention||17
8480009|NCT00606801|20897840|P2|NOT COMPLETED|Adaptation||0
8480010|NCT00606801|20897841|P1|NOT COMPLETED|Adaptation||0
8480011|NCT00606801|20897840|P2|COMPLETED|Adaptation||17
8480012|NCT00606801|20897841|P1|COMPLETED|Adaptation||17
8480013|NCT00606801|20897840|P2|STARTED|Adaptation||17
8480014|NCT00606801|20897841|P1|STARTED|Adaptation||17
8480015|NCT00606684|20897869|P7|NOT COMPLETED|Double-Blind Treatment Period||8
8480016|NCT00606684|20897870|P6|NOT COMPLETED|Double-Blind Treatment Period||9
8480017|NCT00606684|20897871|P5|NOT COMPLETED|Double-Blind Treatment Period||9
8480018|NCT00606684|20897872|P4|NOT COMPLETED|Double-Blind Treatment Period||10
8480019|NCT00606684|20897873|P3|NOT COMPLETED|Double-Blind Treatment Period||11
8480020|NCT00606684|20897874|P2|NOT COMPLETED|Double-Blind Treatment Period||16
8480021|NCT00606684|20897875|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8480022|NCT00606684|20897869|P7|COMPLETED|Double-Blind Treatment Period||91
8480023|NCT00606684|20897870|P6|COMPLETED|Double-Blind Treatment Period||92
8480024|NCT00606684|20897871|P5|COMPLETED|Double-Blind Treatment Period||92
8480025|NCT00606684|20897872|P4|COMPLETED|Double-Blind Treatment Period||91
8480026|NCT00606684|20897873|P3|COMPLETED|Double-Blind Treatment Period||88
8480027|NCT00606684|20897874|P2|COMPLETED|Double-Blind Treatment Period||85
8480028|NCT00606684|20897875|P1|COMPLETED|Double-Blind Treatment Period||0
8480029|NCT00606684|20897869|P7|STARTED|Double-Blind Treatment Period||99
8480030|NCT00606684|20897870|P6|STARTED|Double-Blind Treatment Period||101
8480031|NCT00606684|20897871|P5|STARTED|Double-Blind Treatment Period||101
8480032|NCT00606684|20897872|P4|STARTED|Double-Blind Treatment Period||101
8480033|NCT00606684|20897873|P3|STARTED|Double-Blind Treatment Period||99
8480034|NCT00606684|20897874|P2|STARTED|Double-Blind Treatment Period||101
8480035|NCT00606684|20897875|P1|STARTED|Double-Blind Treatment Period||0
8480036|NCT00606684|20897869|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480037|NCT00606684|20897870|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480038|NCT00606684|20897871|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480039|NCT00606684|20897872|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480040|NCT00606684|20897873|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480041|NCT00606684|20897874|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480042|NCT00606684|20897875|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
8480043|NCT00606684|20897869|P7|COMPLETED|2-week Single-Blind Run-in Period||0
8480044|NCT00606684|20897870|P6|COMPLETED|2-week Single-Blind Run-in Period||0
8480045|NCT00606684|20897871|P5|COMPLETED|2-week Single-Blind Run-in Period||0
8480046|NCT00606684|20897872|P4|COMPLETED|2-week Single-Blind Run-in Period||0
8480047|NCT00606684|20897873|P3|COMPLETED|2-week Single-Blind Run-in Period||0
8480048|NCT00606684|20897874|P2|COMPLETED|2-week Single-Blind Run-in Period||0
8480049|NCT00606684|20897875|P1|COMPLETED|2-week Single-Blind Run-in Period||605
8480050|NCT00606684|20897869|P7|STARTED|2-week Single-Blind Run-in Period||0
8480051|NCT00606684|20897870|P6|STARTED|2-week Single-Blind Run-in Period||0
8480052|NCT00606684|20897871|P5|STARTED|2-week Single-Blind Run-in Period||0
8480053|NCT00606684|20897872|P4|STARTED|2-week Single-Blind Run-in Period||0
8480054|NCT00606684|20897873|P3|STARTED|2-week Single-Blind Run-in Period||0
8480055|NCT00606684|20897874|P2|STARTED|2-week Single-Blind Run-in Period||0
8480056|NCT00606684|20897875|P1|STARTED|2-week Single-Blind Run-in Period||851
8480057|NCT00606632|20897907|P1|NOT COMPLETED|Overall Study||22
8480058|NCT00606632|20897907|P1|COMPLETED|Overall Study||204
8480059|NCT00606632|20897907|P1|STARTED|Overall Study||226
8480060|NCT00606593|20897920|P10|NOT COMPLETED|Overall Study||0
8480061|NCT00606593|20897921|P9|NOT COMPLETED|Overall Study||1
8480062|NCT00606593|20897922|P8|NOT COMPLETED|Overall Study||2
8480063|NCT00606593|20897923|P7|NOT COMPLETED|Overall Study||1
8480064|NCT00606593|20897924|P6|NOT COMPLETED|Overall Study||0
8480065|NCT00606593|20897925|P5|NOT COMPLETED|Overall Study||1
8480066|NCT00606593|20897926|P4|NOT COMPLETED|Overall Study||1
8480067|NCT00606593|20897927|P3|NOT COMPLETED|Overall Study||2
8480068|NCT00606593|20897928|P2|NOT COMPLETED|Overall Study||0
8480069|NCT00606593|20897929|P1|NOT COMPLETED|Overall Study||1
8480070|NCT00606593|20897920|P10|COMPLETED|Overall Study||11
8480071|NCT00606593|20897921|P9|COMPLETED|Overall Study||11
8480072|NCT00606593|20897922|P8|COMPLETED|Overall Study||9
8480073|NCT00606593|20897923|P7|COMPLETED|Overall Study||10
8480074|NCT00606593|20897924|P6|COMPLETED|Overall Study||11
8480075|NCT00606593|20897925|P5|COMPLETED|Overall Study||11
8480076|NCT00606593|20897926|P4|COMPLETED|Overall Study||10
8480077|NCT00606593|20897927|P3|COMPLETED|Overall Study||9
8480078|NCT00606593|20897928|P2|COMPLETED|Overall Study||11
8480079|NCT00606593|20897929|P1|COMPLETED|Overall Study||10
8480080|NCT00606593|20897920|P10|5th Double-blind Treatment|Overall Study||11
8480081|NCT00606593|20897921|P9|5th Double-blind Treatment|Overall Study||11
8480082|NCT00606593|20897922|P8|5th Double-blind Treatment|Overall Study||9
8480083|NCT00606593|20897923|P7|5th Double-blind Treatment|Overall Study||10
8480084|NCT00606593|20897924|P6|5th Double-blind Treatment|Overall Study||11
8480085|NCT00606593|20897925|P5|5th Double-blind Treatment|Overall Study||11
8480086|NCT00606593|20897926|P4|5th Double-blind Treatment|Overall Study||10
8480087|NCT00606593|20897927|P3|5th Double-blind Treatment|Overall Study||9
8480088|NCT00606593|20897928|P2|5th Double-blind Treatment|Overall Study||11
8480089|NCT00606593|20897929|P1|5th Double-blind Treatment|Overall Study||10
8480090|NCT00606593|20897920|P10|4th Double-blind Treatment|Overall Study||11
8480091|NCT00606593|20897921|P9|4th Double-blind Treatment|Overall Study||11
8480092|NCT00606593|20897922|P8|4th Double-blind Treatment|Overall Study||9
8480093|NCT00606593|20897923|P7|4th Double-blind Treatment|Overall Study||10
8480094|NCT00606593|20897924|P6|4th Double-blind Treatment|Overall Study||11
8480095|NCT00606593|20897925|P5|4th Double-blind Treatment|Overall Study||11
8480096|NCT00606593|20897926|P4|4th Double-blind Treatment|Overall Study||10
8480097|NCT00606593|20897927|P3|4th Double-blind Treatment|Overall Study||10
8480098|NCT00606593|20897928|P2|4th Double-blind Treatment|Overall Study||11
8480099|NCT00606593|20897929|P1|4th Double-blind Treatment|Overall Study||10
8480100|NCT00606593|20897920|P10|3rd Double-blind Treatment|Overall Study||11
8480101|NCT00606593|20897921|P9|3rd Double-blind Treatment|Overall Study||12
8480102|NCT00606593|20897922|P8|3rd Double-blind Treatment|Overall Study||9
8480103|NCT00606593|20897923|P7|3rd Double-blind Treatment|Overall Study||10
8480104|NCT00606593|20897924|P6|3rd Double-blind Treatment|Overall Study||11
8480105|NCT00606593|20897925|P5|3rd Double-blind Treatment|Overall Study||11
8480106|NCT00606593|20897926|P4|3rd Double-blind Treatment|Overall Study||10
8480107|NCT00606593|20897927|P3|3rd Double-blind Treatment|Overall Study||10
8480108|NCT00606593|20897928|P2|3rd Double-blind Treatment|Overall Study||11
8480109|NCT00606593|20897929|P1|3rd Double-blind Treatment|Overall Study||11
8480110|NCT00606593|20897920|P10|2nd Double-blind Treatment|Overall Study||11
8480111|NCT00606593|20897921|P9|2nd Double-blind Treatment|Overall Study||12
8480112|NCT00606593|20897922|P8|2nd Double-blind Treatment|Overall Study||9
8480113|NCT00606593|20897923|P7|2nd Double-blind Treatment|Overall Study||10
8480114|NCT00606593|20897924|P6|2nd Double-blind Treatment|Overall Study||11
8480115|NCT00606593|20897925|P5|2nd Double-blind Treatment|Overall Study||12
8480116|NCT00606593|20897926|P4|2nd Double-blind Treatment|Overall Study||10
8480117|NCT00606593|20897927|P3|2nd Double-blind Treatment|Overall Study||11
8480118|NCT00606593|20897928|P2|2nd Double-blind Treatment|Overall Study||11
8480119|NCT00606593|20897929|P1|2nd Double-blind Treatment|Overall Study||11
8480120|NCT00606593|20897920|P10|1st Double-blind Treatment|Overall Study||11
8480121|NCT00606593|20897921|P9|1st Double-blind Treatment|Overall Study||12
8480122|NCT00606593|20897922|P8|1st Double-blind Treatment|Overall Study||11
8480123|NCT00606593|20897923|P7|1st Double-blind Treatment|Overall Study||11
8480124|NCT00606593|20897924|P6|1st Double-blind Treatment|Overall Study||11
8480125|NCT00606593|20897925|P5|1st Double-blind Treatment|Overall Study||12
8480126|NCT00606593|20897926|P4|1st Double-blind Treatment|Overall Study||11
8480127|NCT00606593|20897927|P3|1st Double-blind Treatment|Overall Study||11
8480128|NCT00606593|20897928|P2|1st Double-blind Treatment|Overall Study||11
8480129|NCT00606593|20897929|P1|1st Double-blind Treatment|Overall Study||11
8480130|NCT00606593|20897920|P10|STARTED|Overall Study|Randomized participants|11
8480131|NCT00606593|20897921|P9|STARTED|Overall Study|Randomized participants|12
8480132|NCT00606593|20897922|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
8480133|NCT00606593|20897923|P7|STARTED|Overall Study|Randomized participants|11
8480134|NCT00606593|20897924|P6|STARTED|Overall Study|Randomized participants|11
8480135|NCT00606593|20897925|P5|STARTED|Overall Study|Randomized participants|12
8480136|NCT00606593|20897926|P4|STARTED|Overall Study|Randomized participants|11
8480137|NCT00606593|20897927|P3|STARTED|Overall Study|Randomized participants|11
8480138|NCT00606593|20897928|P2|STARTED|Overall Study|Randomized participants|11
8480139|NCT00606593|20897929|P1|STARTED|Overall Study|Randomized participants|11
8480140|NCT00606580|20897950|P3|NOT COMPLETED|Overall Study||22
8480141|NCT00606580|20897951|P2|NOT COMPLETED|Overall Study||3
8480142|NCT00606580|20897952|P1|NOT COMPLETED|Overall Study||2
8480143|NCT00606580|20897950|P3|COMPLETED|Overall Study||103
8480144|NCT00606580|20897951|P2|COMPLETED|Overall Study||122
8480145|NCT00606580|20897952|P1|COMPLETED|Overall Study||123
8480146|NCT00606580|20897950|P3|STARTED|Overall Study||125
8480147|NCT00606580|20897951|P2|STARTED|Overall Study||125
8480148|NCT00606580|20897952|P1|STARTED|Overall Study||125
8480149|NCT00606554|20897995|P2|NOT COMPLETED|Overall Study||0
8480150|NCT00606554|20897996|P1|NOT COMPLETED|Overall Study||0
8480151|NCT00606554|20897995|P2|COMPLETED|Overall Study||18
8480152|NCT00606554|20897996|P1|COMPLETED|Overall Study||15
8480153|NCT00606554|20897995|P2|STARTED|Overall Study||18
8480154|NCT00606554|20897996|P1|STARTED|Overall Study||15
8480155|NCT00606502|20898018|P2|NOT COMPLETED|Treatment||3
8480156|NCT00606502|20898019|P1|NOT COMPLETED|Treatment||0
8480157|NCT00606502|20898018|P2|COMPLETED|Treatment||98
8480158|NCT00606502|20898019|P1|COMPLETED|Treatment||97
8480159|NCT00606502|20898018|P2|STARTED|Treatment||101
8480160|NCT00606502|20898019|P1|STARTED|Treatment||97
8480161|NCT00606502|20898018|P2|NOT COMPLETED|Randomization||0
8480162|NCT00606502|20898019|P1|NOT COMPLETED|Randomization||3
8480163|NCT00606502|20898018|P2|COMPLETED|Randomization||101
8480164|NCT00606502|20898019|P1|COMPLETED|Randomization||97
8480165|NCT00606502|20898018|P2|STARTED|Randomization||101
8480166|NCT00606502|20898019|P1|STARTED|Randomization||100
8480167|NCT00606489|20898033|P2|NOT COMPLETED|Overall Study||0
8480168|NCT00606489|20898034|P1|NOT COMPLETED|Overall Study||0
8480169|NCT00606489|20898033|P2|COMPLETED|Overall Study||40
8480170|NCT00606489|20898034|P1|COMPLETED|Overall Study||21
8480171|NCT00606489|20898033|P2|STARTED|Overall Study||40
8480172|NCT00606489|20898034|P1|STARTED|Overall Study||21
8480173|NCT00606320|20898040|P1|NOT COMPLETED|Overall Study||37
8480174|NCT00606320|20898040|P1|COMPLETED|Overall Study||22
8480175|NCT00606320|20898040|P1|STARTED|Overall Study||59
8480176|NCT00606307|20898045|P1|NOT COMPLETED|Overall Study||11
8480177|NCT00606307|20898045|P1|COMPLETED|Overall Study||18
8480178|NCT00606307|20898045|P1|STARTED|Overall Study||29
8480179|NCT00606294|20898053|P2|NOT COMPLETED|Overall Study||0
8480180|NCT00606294|20898054|P1|NOT COMPLETED|Overall Study||36
8480181|NCT00606294|20898053|P2|COMPLETED|Overall Study||19
8480182|NCT00606294|20898054|P1|COMPLETED|Overall Study||161
8480183|NCT00606294|20898053|P2|STARTED|Overall Study||19
8480184|NCT00606294|20898054|P1|STARTED|Overall Study||197
8480185|NCT00606281|20898068|P2|NOT COMPLETED|Overall Study||66
8480186|NCT00606281|20898069|P1|NOT COMPLETED|Overall Study||56
8480187|NCT00606281|20898068|P2|COMPLETED|Overall Study||64
8480188|NCT00606281|20898069|P1|COMPLETED|Overall Study||72
8480189|NCT00606281|20898068|P2|STARTED|Overall Study||130
8480190|NCT00606281|20898069|P1|STARTED|Overall Study||128
8480191|NCT00606229|20898077|P1|NOT COMPLETED|Overall Study||22
8480192|NCT00606229|20898077|P1|COMPLETED|Overall Study||19
8480193|NCT00606229|20898077|P1|STARTED|Overall Study||41
8480194|NCT00606177|20898084|P2|NOT COMPLETED|Overall Study||25
8480195|NCT00606177|20898085|P1|NOT COMPLETED|Overall Study||27
8480196|NCT00606177|20898084|P2|COMPLETED|Overall Study||19
8480197|NCT00606177|20898085|P1|COMPLETED|Overall Study||28
8480198|NCT00606177|20898084|P2|STARTED|Overall Study||44
8480199|NCT00606177|20898085|P1|STARTED|Overall Study||55
8480200|NCT00606138|20898095|P2|NOT COMPLETED|Overall Study||0
8480201|NCT00606138|20898096|P1|NOT COMPLETED|Overall Study||0
8480202|NCT00606138|20898095|P2|COMPLETED|Overall Study||2
8480203|NCT00606138|20898096|P1|COMPLETED|Overall Study||6
8480204|NCT00606138|20898095|P2|STARTED|Overall Study||2
8480205|NCT00606138|20898096|P1|STARTED|Overall Study||6
8480206|NCT00606086|20898112|P2|NOT COMPLETED|Overall Study||15
8480207|NCT00606086|20898113|P1|NOT COMPLETED|Overall Study||12
8480208|NCT00606086|20898112|P2|COMPLETED|Overall Study||53
8480209|NCT00606086|20898113|P1|COMPLETED|Overall Study||60
8480210|NCT00606086|20898112|P2|STARTED|Overall Study||68
8480211|NCT00606086|20898113|P1|STARTED|Overall Study||72
8480212|NCT00606047|20898119|P1|NOT COMPLETED|Overall Study||0
8480213|NCT00606047|20898119|P1|COMPLETED|Overall Study||200
8480214|NCT00606047|20898119|P1|STARTED|Overall Study||200
8480215|NCT00606034|20898123|P1|NOT COMPLETED|Overall Study||1
8480216|NCT00606034|20898123|P1|COMPLETED|Overall Study||20
8480217|NCT00606034|20898123|P1|STARTED|Overall Study||21
8480218|NCT00606021|20898131|P3|NOT COMPLETED|Maintenance Phase||17
8480219|NCT00606021|20898132|P2|NOT COMPLETED|Maintenance Phase||23
8480220|NCT00606021|20898133|P1|NOT COMPLETED|Maintenance Phase||0
8480221|NCT00606021|20898131|P3|COMPLETED|Maintenance Phase||10
8480222|NCT00606021|20898132|P2|COMPLETED|Maintenance Phase||5
8480223|NCT00606021|20898133|P1|COMPLETED|Maintenance Phase||0
8480224|NCT00606021|20898131|P3|STARTED|Maintenance Phase||27
8480225|NCT00606021|20898132|P2|STARTED|Maintenance Phase||28
8480226|NCT00606021|20898133|P1|STARTED|Maintenance Phase||0
8480227|NCT00606021|20898131|P3|NOT COMPLETED|Induction Phase||0
8480228|NCT00606021|20898132|P2|NOT COMPLETED|Induction Phase||0
8480229|NCT00606021|20898133|P1|NOT COMPLETED|Induction Phase||87
8480230|NCT00606021|20898131|P3|COMPLETED|Induction Phase||0
8480231|NCT00606021|20898132|P2|COMPLETED|Induction Phase||0
8480232|NCT00606021|20898133|P1|COMPLETED|Induction Phase||19
8480233|NCT00606021|20898131|P3|STARTED|Induction Phase||0
8480234|NCT00606021|20898132|P2|STARTED|Induction Phase||0
8480235|NCT00606021|20898133|P1|STARTED|Induction Phase||106
8480236|NCT00606008|20898151|P1|NOT COMPLETED|Overall Study||5
8480237|NCT00606008|20898151|P1|COMPLETED|Overall Study||25
8480238|NCT00606008|20898151|P1|STARTED|Overall Study||30
8480239|NCT00605904|20898167|P2|NOT COMPLETED|Infusion Sessions||3
8480240|NCT00605904|20898168|P1|NOT COMPLETED|Infusion Sessions||1
8480241|NCT00605904|20898167|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
8480242|NCT00605904|20898168|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
8480243|NCT00605904|20898167|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
8480244|NCT00605904|20898168|P1|Yohimbine Infusion|Infusion Sessions||12
8480245|NCT00605904|20898167|P2|mCPP Infusion|Infusion Sessions||13
8480246|NCT00605904|20898168|P1|mCPP Infusion|Infusion Sessions||12
8480247|NCT00605904|20898167|P2|Saline Infusion|Infusion Sessions||14
8480248|NCT00605904|20898168|P1|Saline Infusion|Infusion Sessions||13
8480249|NCT00605904|20898167|P2|STARTED|Infusion Sessions||16
8480250|NCT00605904|20898168|P1|STARTED|Infusion Sessions||13
8480251|NCT00605904|20898167|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
8480252|NCT00605904|20898168|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
8480253|NCT00605904|20898167|P2|COMPLETED|Baseline Data Collection and Dosing||16
8480254|NCT00605904|20898168|P1|COMPLETED|Baseline Data Collection and Dosing||13
8480255|NCT00605904|20898167|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
8480256|NCT00605904|20898168|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
8480257|NCT00605839|20898181|P3|NOT COMPLETED|Overall Study||0
8480258|NCT00605839|20898182|P2|NOT COMPLETED|Overall Study||0
8480259|NCT00605839|20898183|P1|NOT COMPLETED|Overall Study||1
8480260|NCT00605839|20898181|P3|COMPLETED|Overall Study||28
8480261|NCT00605839|20898182|P2|COMPLETED|Overall Study||37
8480262|NCT00605839|20898183|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
8480263|NCT00605839|20898181|P3|STARTED|Overall Study||28
8480264|NCT00605839|20898182|P2|STARTED|Overall Study||37
8480265|NCT00605839|20898183|P1|STARTED|Overall Study||40
8480266|NCT00605826|20898193|P2|NOT COMPLETED|Overall Study||10
8480267|NCT00605826|20898194|P1|NOT COMPLETED|Overall Study||7
8480268|NCT00605826|20898193|P2|COMPLETED|Overall Study||60
8480269|NCT00605826|20898194|P1|COMPLETED|Overall Study||129
8480270|NCT00605826|20898193|P2|STARTED|Overall Study||70
8480271|NCT00605826|20898194|P1|STARTED|Overall Study||136
8480272|NCT00605722|20898206|P1|NOT COMPLETED|Overall Study||51
8480273|NCT00605722|20898206|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
8480274|NCT00605722|20898206|P1|STARTED|Overall Study||51
8480275|NCT00605696|20898218|P2|NOT COMPLETED|Overall Study||0
8480276|NCT00605696|20898219|P1|NOT COMPLETED|Overall Study||0
8480277|NCT00605696|20898218|P2|COMPLETED|Overall Study||11
8480278|NCT00605696|20898219|P1|COMPLETED|Overall Study||7
8480279|NCT00605696|20898218|P2|STARTED|Overall Study||11
8480280|NCT00605696|20898219|P1|STARTED|Overall Study||7
8480281|NCT00605657|20898227|P1|NOT COMPLETED|Overall Study||2
8480282|NCT00605657|20898227|P1|COMPLETED|Overall Study||3
8480283|NCT00605657|20898227|P1|STARTED|Overall Study||5
8480284|NCT00605644|20898237|P5|NOT COMPLETED|Overall Study||8
8480285|NCT00605644|20898238|P4|NOT COMPLETED|Overall Study||5
8480286|NCT00605644|20898239|P3|NOT COMPLETED|Overall Study||2
8480287|NCT00605644|20898240|P2|NOT COMPLETED|Overall Study||1
8480288|NCT00605644|20898241|P1|NOT COMPLETED|Overall Study||1
8480289|NCT00605644|20898237|P5|COMPLETED|Overall Study||22
8480290|NCT00605644|20898238|P4|COMPLETED|Overall Study||25
8480291|NCT00605644|20898239|P3|COMPLETED|Overall Study||18
8480292|NCT00605644|20898240|P2|COMPLETED|Overall Study||18
8480293|NCT00605644|20898241|P1|COMPLETED|Overall Study||28
8480294|NCT00605644|20898237|P5|STARTED|Overall Study||30
8480295|NCT00605644|20898238|P4|STARTED|Overall Study||30
8480296|NCT00605644|20898239|P3|STARTED|Overall Study||20
8480297|NCT00605644|20898240|P2|STARTED|Overall Study||19
8480298|NCT00605644|20898241|P1|STARTED|Overall Study||29
8480299|NCT00605566|20898253|P1|NOT COMPLETED|Overall Study||3
8480300|NCT00605566|20898253|P1|COMPLETED|Overall Study||19
8480301|NCT00605566|20898253|P1|STARTED|Overall Study||22
8480302|NCT00605540|20898261|P1|NOT COMPLETED|Overall Study||38
8480303|NCT00605540|20898261|P1|COMPLETED|Overall Study||95
8480304|NCT00605540|20898261|P1|STARTED|Overall Study||133
8480305|NCT00605475|20898279|P10|NOT COMPLETED|Overall Study||2
8480306|NCT00605475|20898280|P9|NOT COMPLETED|Overall Study||2
8480307|NCT00605475|20898281|P8|NOT COMPLETED|Overall Study||0
8480308|NCT00605475|20898282|P7|NOT COMPLETED|Overall Study||1
8480309|NCT00605475|20898283|P6|NOT COMPLETED|Overall Study||2
8480310|NCT00605475|20898284|P5|NOT COMPLETED|Overall Study||1
8480311|NCT00605475|20898285|P4|NOT COMPLETED|Overall Study||0
8480312|NCT00605475|20898286|P3|NOT COMPLETED|Overall Study||0
8480313|NCT00605475|20898287|P2|NOT COMPLETED|Overall Study||0
8480314|NCT00605475|20898288|P1|NOT COMPLETED|Overall Study||0
8480315|NCT00605475|20898279|P10|COMPLETED|Overall Study||8
8480316|NCT00605475|20898280|P9|COMPLETED|Overall Study||18
8480317|NCT00605475|20898281|P8|COMPLETED|Overall Study||24
8480318|NCT00605475|20898282|P7|COMPLETED|Overall Study||22
8480319|NCT00605475|20898283|P6|COMPLETED|Overall Study||22
8480320|NCT00605475|20898284|P5|COMPLETED|Overall Study||24
8480321|NCT00605475|20898285|P4|COMPLETED|Overall Study||45
8480322|NCT00605475|20898286|P3|COMPLETED|Overall Study||45
8480323|NCT00605475|20898287|P2|COMPLETED|Overall Study||5
8480324|NCT00605475|20898288|P1|COMPLETED|Overall Study||10
8480325|NCT00605475|20898279|P10|STARTED|Overall Study||10
8480326|NCT00605475|20898280|P9|STARTED|Overall Study||20
8480327|NCT00605475|20898281|P8|STARTED|Overall Study||24
8480328|NCT00605475|20898282|P7|STARTED|Overall Study||23
8480329|NCT00605475|20898283|P6|STARTED|Overall Study||24
8480330|NCT00605475|20898284|P5|STARTED|Overall Study||25
8480331|NCT00605475|20898285|P4|STARTED|Overall Study||45
8480332|NCT00605475|20898286|P3|STARTED|Overall Study||45
8480333|NCT00605475|20898287|P2|STARTED|Overall Study||5
8480334|NCT00605475|20898288|P1|STARTED|Overall Study||10
8480335|NCT00605423|20898412|P2|NOT COMPLETED|Overall Study||0
8480336|NCT00605423|20898413|P1|NOT COMPLETED|Overall Study||0
8480337|NCT00605423|20898412|P2|COMPLETED|Overall Study||2
8480338|NCT00605423|20898413|P1|COMPLETED|Overall Study||4
8480339|NCT00605423|20898412|P2|STARTED|Overall Study||2
8480340|NCT00605423|20898413|P1|STARTED|Overall Study||4
8480341|NCT00605384|20898425|P2|NOT COMPLETED|Overall Study||1
8480342|NCT00605384|20898426|P1|NOT COMPLETED|Overall Study||1
8480343|NCT00605384|20898425|P2|COMPLETED|Overall Study|study terminated early|0
8480344|NCT00605384|20898426|P1|COMPLETED|Overall Study|study terminated early|0
8480345|NCT00605384|20898425|P2|STARTED|Overall Study||1
8480346|NCT00605384|20898426|P1|STARTED|Overall Study||1
8480347|NCT00605358|20898456|P2|NOT COMPLETED|Overall Study||0
8480348|NCT00605358|20898457|P1|NOT COMPLETED|Overall Study||0
8480349|NCT00605358|20898456|P2|COMPLETED|Overall Study||80
8480350|NCT00605358|20898457|P1|COMPLETED|Overall Study||81
8480351|NCT00605358|20898456|P2|STARTED|Overall Study||80
8480352|NCT00605358|20898457|P1|STARTED|Overall Study||81
8480353|NCT00605345|20898465|P2|NOT COMPLETED|Overall Study||3
8480354|NCT00605345|20898466|P1|NOT COMPLETED|Overall Study||1
8480355|NCT00605345|20898465|P2|COMPLETED|Overall Study||22
8480356|NCT00605345|20898466|P1|COMPLETED|Overall Study||45
8480357|NCT00605345|20898465|P2|STARTED|Overall Study||25
8480358|NCT00605345|20898466|P1|STARTED|Overall Study||46
8480359|NCT00605319|20898482|P1|NOT COMPLETED|Overall Study||6
8480360|NCT00605319|20898482|P1|COMPLETED|Overall Study||11
8480361|NCT00605319|20898482|P1|STARTED|Overall Study||17
8480362|NCT00605306|20898494|P2|NOT COMPLETED|Overall Study||1
8480363|NCT00605306|20898495|P1|NOT COMPLETED|Overall Study||0
8480364|NCT00605306|20898494|P2|COMPLETED|Overall Study||13
8480365|NCT00605306|20898495|P1|COMPLETED|Overall Study||14
8480366|NCT00605306|20898494|P2|STARTED|Overall Study||14
8480367|NCT00605306|20898495|P1|STARTED|Overall Study||14
8480368|NCT00605293|20898509|P2|NOT COMPLETED|Overall Study||5
8480369|NCT00605293|20898510|P1|NOT COMPLETED|Overall Study||17
8480370|NCT00605293|20898509|P2|COMPLETED|Overall Study||31
8480371|NCT00605293|20898510|P1|COMPLETED|Overall Study||48
8480372|NCT00605293|20898509|P2|STARTED|Overall Study||36
8480373|NCT00605293|20898510|P1|STARTED|Overall Study||65
8480374|NCT00605280|20898530|P4|NOT COMPLETED|Year 3 Extension||9
8480375|NCT00605280|20898531|P3|NOT COMPLETED|Year 3 Extension||0
8480376|NCT00605280|20898532|P2|NOT COMPLETED|Year 3 Extension||0
8480377|NCT00605280|20898533|P1|NOT COMPLETED|Year 3 Extension||8
8480378|NCT00605280|20898530|P4|COMPLETED|Year 3 Extension||45
8480379|NCT00605280|20898531|P3|COMPLETED|Year 3 Extension||0
8480380|NCT00605280|20898532|P2|COMPLETED|Year 3 Extension||0
8480381|NCT00605280|20898533|P1|COMPLETED|Year 3 Extension||38
8480382|NCT00605280|20898530|P4|Received 0.3 mg Treatment|Year 3 Extension||54
8480383|NCT00605280|20898531|P3|Received 0.3 mg Treatment|Year 3 Extension||0
8480384|NCT00605280|20898532|P2|Received 0.3 mg Treatment|Year 3 Extension||0
8480385|NCT00605280|20898533|P1|Received 0.3 mg Treatment|Year 3 Extension||46
8480386|NCT00605280|20898530|P4|STARTED|Year 3 Extension||54
8480387|NCT00605280|20898531|P3|STARTED|Year 3 Extension||0
8480388|NCT00605280|20898532|P2|STARTED|Year 3 Extension||0
8480389|NCT00605280|20898533|P1|STARTED|Year 3 Extension||46
8480390|NCT00605280|20898530|P4|NOT COMPLETED|Year 2||22
8480391|NCT00605280|20898531|P3|NOT COMPLETED|Year 2||6
8480392|NCT00605280|20898532|P2|NOT COMPLETED|Year 2||6
8480393|NCT00605280|20898533|P1|NOT COMPLETED|Year 2||24
8480394|NCT00605280|20898530|P4|COMPLETED|Year 2||102
8480395|NCT00605280|20898531|P3|COMPLETED|Year 2||0
8480396|NCT00605280|20898532|P2|COMPLETED|Year 2||5
8480397|NCT00605280|20898533|P1|COMPLETED|Year 2||102
8480398|NCT00605280|20898530|P4|Received 0.3 mg Treatment|Year 2||0
8480399|NCT00605280|20898531|P3|Received 0.3 mg Treatment|Year 2||2
8480400|NCT00605280|20898532|P2|Received 0.3 mg Treatment|Year 2||3
8480401|NCT00605280|20898533|P1|Received 0.3 mg Treatment|Year 2||126
8480402|NCT00605280|20898530|P4|STARTED|Year 2||124
8480403|NCT00605280|20898531|P3|STARTED|Year 2||6
8480404|NCT00605280|20898532|P2|STARTED|Year 2||11
8480405|NCT00605280|20898533|P1|STARTED|Year 2||126
8480406|NCT00605280|20898530|P4|NOT COMPLETED|Year 1||19
8480407|NCT00605280|20898531|P3|NOT COMPLETED|Year 1||1
8480408|NCT00605280|20898532|P2|NOT COMPLETED|Year 1||11
8480409|NCT00605280|20898533|P1|NOT COMPLETED|Year 1||19
8480410|NCT00605280|20898530|P4|COMPLETED|Year 1||124
8480411|NCT00605280|20898531|P3|COMPLETED|Year 1||6
8480412|NCT00605280|20898532|P2|COMPLETED|Year 1||11
8480413|NCT00605280|20898533|P1|COMPLETED|Year 1||126
8480414|NCT00605280|20898530|P4|Received 0.3 mg Treatment|Year 1||0
8480415|NCT00605280|20898531|P3|Received 0.3 mg Treatment|Year 1||3
8480416|NCT00605280|20898532|P2|Received 0.3 mg Treatment|Year 1||13
8480417|NCT00605280|20898533|P1|Received 0.3 mg Treatment|Year 1||144
8480418|NCT00605280|20898530|P4|STARTED|Year 1||143
8480419|NCT00605280|20898531|P3|STARTED|Year 1||7
8480420|NCT00605280|20898532|P2|STARTED|Year 1||22
8480421|NCT00605280|20898533|P1|STARTED|Year 1||145
8480422|NCT00605267|20898567|P2|NOT COMPLETED|Overall Study||9
8480423|NCT00605267|20898568|P1|NOT COMPLETED|Overall Study||3
8480424|NCT00605267|20898567|P2|COMPLETED|Overall Study|Breast surgery performed|90
8480425|NCT00605267|20898568|P1|COMPLETED|Overall Study|Breast surgery performed|95
8480426|NCT00605267|20898567|P2|STARTED|Overall Study||99
8480427|NCT00605267|20898568|P1|STARTED|Overall Study||98
8480428|NCT00605202|20898606|P2|NOT COMPLETED|Second Intervention||0
8480429|NCT00605202|20898607|P1|NOT COMPLETED|Second Intervention||0
8480430|NCT00605202|20898606|P2|COMPLETED|Second Intervention||5
8480431|NCT00605202|20898607|P1|COMPLETED|Second Intervention||5
8480432|NCT00605202|20898606|P2|STARTED|Second Intervention||5
8480433|NCT00605202|20898607|P1|STARTED|Second Intervention||5
8480434|NCT00605202|20898606|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
8480435|NCT00605202|20898607|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
8480436|NCT00605202|20898606|P2|COMPLETED|Washout Period of 3 Weeks||5
8480437|NCT00605202|20898607|P1|COMPLETED|Washout Period of 3 Weeks||5
8480438|NCT00605202|20898606|P2|STARTED|Washout Period of 3 Weeks||5
8480439|NCT00605202|20898607|P1|STARTED|Washout Period of 3 Weeks||5
8480440|NCT00605202|20898606|P2|NOT COMPLETED|First Intervention||0
8480441|NCT00605202|20898607|P1|NOT COMPLETED|First Intervention||0
8480442|NCT00605202|20898606|P2|COMPLETED|First Intervention||5
8480443|NCT00605202|20898607|P1|COMPLETED|First Intervention||5
8480444|NCT00605202|20898606|P2|STARTED|First Intervention||5
8480445|NCT00605202|20898607|P1|STARTED|First Intervention||5
8480446|NCT00605189|20898616|P3|NOT COMPLETED|Overall Study||0
8480447|NCT00605189|20898617|P2|NOT COMPLETED|Overall Study||2
8480448|NCT00605189|20898618|P1|NOT COMPLETED|Overall Study||3
8480449|NCT00605189|20898616|P3|COMPLETED|Overall Study||9
8480450|NCT00605189|20898617|P2|COMPLETED|Overall Study||19
8480451|NCT00605189|20898618|P1|COMPLETED|Overall Study||17
8480452|NCT00605189|20898616|P3|STARTED|Overall Study||9
8480453|NCT00605189|20898617|P2|STARTED|Overall Study||21
8480454|NCT00605189|20898618|P1|STARTED|Overall Study||20
8480455|NCT00605176|20898629|P3|NOT COMPLETED|Overall Study||9
8480456|NCT00605176|20898630|P2|NOT COMPLETED|Overall Study||6
8480457|NCT00605176|20898631|P1|NOT COMPLETED|Overall Study||11
8480458|NCT00605176|20898629|P3|COMPLETED|Overall Study||150
8480459|NCT00605176|20898630|P2|COMPLETED|Overall Study||154
8480460|NCT00605176|20898631|P1|COMPLETED|Overall Study||149
8480461|NCT00605176|20898629|P3|STARTED|Overall Study||159
8480462|NCT00605176|20898630|P2|STARTED|Overall Study||160
8480463|NCT00605176|20898631|P1|STARTED|Overall Study||160
8480464|NCT00605150|20898648|P1|NOT COMPLETED|Overall Study||1
8480465|NCT00605150|20898648|P1|COMPLETED|Overall Study||10
8480466|NCT00605150|20898648|P1|STARTED|Overall Study|11 started|11
8480467|NCT00605085|20898655|P2|NOT COMPLETED|Overall Study||25
8480468|NCT00605085|20898656|P1|NOT COMPLETED|Overall Study||50
8480469|NCT00605085|20898655|P2|COMPLETED|Overall Study||638
8480470|NCT00605085|20898656|P1|COMPLETED|Overall Study||1962
8480471|NCT00605085|20898655|P2|STARTED|Overall Study||663
8480472|NCT00605085|20898656|P1|STARTED|Overall Study||2012
8480473|NCT00605072|20898665|P3|NOT COMPLETED|Overall Study||4
8480474|NCT00605072|20898666|P2|NOT COMPLETED|Overall Study||11
8480475|NCT00605072|20898667|P1|NOT COMPLETED|Overall Study||7
8480476|NCT00605072|20898665|P3|COMPLETED|Overall Study||11
8480477|NCT00605072|20898666|P2|COMPLETED|Overall Study||9
8480478|NCT00605072|20898667|P1|COMPLETED|Overall Study||11
8480479|NCT00605072|20898665|P3|STARTED|Overall Study||15
8480480|NCT00605072|20898666|P2|STARTED|Overall Study||20
8480481|NCT00605072|20898667|P1|STARTED|Overall Study||18
8480482|NCT00605033|20898689|P2|NOT COMPLETED|Overall Study||8
8480483|NCT00605033|20898690|P1|NOT COMPLETED|Overall Study||7
8480484|NCT00605033|20898689|P2|COMPLETED|Overall Study||90
8480485|NCT00605033|20898690|P1|COMPLETED|Overall Study||136
8480486|NCT00605033|20898689|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
8480487|NCT00605033|20898690|P1|STARTED|Overall Study||143
8480488|NCT00604968|20898696|P1|NOT COMPLETED|Overall Study||0
8480489|NCT00604968|20898696|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
8480490|NCT00604968|20898696|P1|STARTED|Overall Study||25
8480491|NCT00604890|20898713|P4|NOT COMPLETED|Overall Study||4
8480492|NCT00604890|20898714|P3|NOT COMPLETED|Overall Study||1
8480493|NCT00604890|20898715|P2|NOT COMPLETED|Overall Study||0
8480494|NCT00604890|20898716|P1|NOT COMPLETED|Overall Study||3
8480495|NCT00604890|20898713|P4|COMPLETED|Overall Study||42
8480496|NCT00604890|20898714|P3|COMPLETED|Overall Study||47
8480497|NCT00604890|20898715|P2|COMPLETED|Overall Study||45
8480498|NCT00604890|20898716|P1|COMPLETED|Overall Study||44
8480499|NCT00604890|20898713|P4|STARTED|Overall Study||46
8480500|NCT00604890|20898714|P3|STARTED|Overall Study||48
8480501|NCT00604890|20898715|P2|STARTED|Overall Study||45
8480502|NCT00604890|20898716|P1|STARTED|Overall Study||47
8480503|NCT00604825|20898734|P4|NOT COMPLETED|Overall Study||11
8480504|NCT00604825|20898735|P3|NOT COMPLETED|Overall Study||16
8480505|NCT00604825|20898736|P2|NOT COMPLETED|Overall Study||15
8480506|NCT00604825|20898737|P1|NOT COMPLETED|Overall Study||9
8480507|NCT00604825|20898734|P4|COMPLETED|Overall Study||79
8480508|NCT00604825|20898735|P3|COMPLETED|Overall Study||73
8480509|NCT00604825|20898736|P2|COMPLETED|Overall Study||72
8480510|NCT00604825|20898737|P1|COMPLETED|Overall Study||81
8480511|NCT00604825|20898734|P4|STARTED|Overall Study||90
8480512|NCT00604825|20898735|P3|STARTED|Overall Study||89
8480513|NCT00604825|20898736|P2|STARTED|Overall Study||87
8480514|NCT00604825|20898737|P1|STARTED|Overall Study||90
8480515|NCT00604812|20898938|P6|NOT COMPLETED|Overall Study||0
8480516|NCT00604812|20898939|P5|NOT COMPLETED|Overall Study||0
8480517|NCT00604812|20898940|P4|NOT COMPLETED|Overall Study||0
8480518|NCT00604812|20898941|P3|NOT COMPLETED|Overall Study||0
8480519|NCT00604812|20898942|P2|NOT COMPLETED|Overall Study||0
8480520|NCT00604812|20898943|P1|NOT COMPLETED|Overall Study||0
8480521|NCT00604812|20898938|P6|COMPLETED|Overall Study||1
8480522|NCT00604812|20898939|P5|COMPLETED|Overall Study||5
8480523|NCT00604812|20898940|P4|COMPLETED|Overall Study||3
8480524|NCT00604812|20898941|P3|COMPLETED|Overall Study||10
8480525|NCT00604812|20898942|P2|COMPLETED|Overall Study||3
8480526|NCT00604812|20898943|P1|COMPLETED|Overall Study||9
8480527|NCT00604812|20898938|P6|STARTED|Overall Study||1
8480528|NCT00604812|20898939|P5|STARTED|Overall Study||5
8480529|NCT00604812|20898940|P4|STARTED|Overall Study||3
8480530|NCT00604812|20898941|P3|STARTED|Overall Study||10
8480531|NCT00604812|20898942|P2|STARTED|Overall Study||3
8480532|NCT00604812|20898943|P1|STARTED|Overall Study||9
8480533|NCT00604786|20898965|P2|NOT COMPLETED|Overall Study||0
8480534|NCT00604786|20898966|P1|NOT COMPLETED|Overall Study||2
8480535|NCT00604786|20898965|P2|COMPLETED|Overall Study||4
8480536|NCT00604786|20898966|P1|COMPLETED|Overall Study||12
8480537|NCT00604786|20898965|P2|STARTED|Overall Study||4
8480538|NCT00604786|20898966|P1|STARTED|Overall Study||14
8480539|NCT00604721|20898972|P1|NOT COMPLETED|Overall Study||2
8480540|NCT00604721|20898972|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
8480541|NCT00604721|20898972|P1|STARTED|Overall Study||19
8480542|NCT00604708|20898980|P2|NOT COMPLETED|Overall Study||40
8480543|NCT00604708|20898981|P1|NOT COMPLETED|Overall Study||31
8480544|NCT00604708|20898980|P2|COMPLETED|Overall Study||397
8480545|NCT00604708|20898981|P1|COMPLETED|Overall Study||399
8480546|NCT00604708|20898980|P2|STARTED|Overall Study||437
8480547|NCT00604708|20898981|P1|STARTED|Overall Study||430
8480548|NCT00604695|20898991|P2|NOT COMPLETED|Overall Study||4
8480549|NCT00604695|20898992|P1|NOT COMPLETED|Overall Study||0
8480550|NCT00604695|20898991|P2|COMPLETED|Overall Study||16
8480551|NCT00604695|20898992|P1|COMPLETED|Overall Study||20
8480552|NCT00604695|20898991|P2|STARTED|Overall Study||20
8480553|NCT00604695|20898992|P1|STARTED|Overall Study||20
8480554|NCT00604669|20899014|P1|NOT COMPLETED|Overall Study||7
8480555|NCT00604669|20899014|P1|COMPLETED|Overall Study||163
8480556|NCT00604669|20899014|P1|STARTED|Overall Study||170
8480557|NCT00604565|20899020|P2|NOT COMPLETED|Overall Study||3
8480558|NCT00604565|20899021|P1|NOT COMPLETED|Overall Study||0
8480559|NCT00604565|20899020|P2|COMPLETED|Overall Study||4
8480560|NCT00604565|20899021|P1|COMPLETED|Overall Study||4
8480561|NCT00604565|20899020|P2|STARTED|Overall Study||7
8480562|NCT00604565|20899021|P1|STARTED|Overall Study||4
8480563|NCT00604552|20899031|P2|NOT COMPLETED|Overall Study||0
8480564|NCT00604552|20899032|P1|NOT COMPLETED|Overall Study||0
8480565|NCT00604552|20899031|P2|COMPLETED|Overall Study||160
8480566|NCT00604552|20899032|P1|COMPLETED|Overall Study||189
8480567|NCT00604552|20899031|P2|STARTED|Overall Study||160
8480568|NCT00604552|20899032|P1|STARTED|Overall Study||189
8480572|NCT00604461|20899047|P1|NOT COMPLETED|Overall Study||1
8480573|NCT00604461|20899047|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
8480574|NCT00604461|20899047|P1|STARTED|Overall Study||13
8480575|NCT00604383|20899054|P2|NOT COMPLETED|Overall Study||84
8480576|NCT00604383|20899055|P1|NOT COMPLETED|Overall Study||87
8480577|NCT00604383|20899054|P2|COMPLETED|Overall Study||256
8480578|NCT00604383|20899055|P1|COMPLETED|Overall Study||258
8480579|NCT00604383|20899054|P2|Received Extended Treatment|Overall Study||141
8480580|NCT00604383|20899055|P1|Received Extended Treatment|Overall Study||136
8480581|NCT00604383|20899054|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
8480582|NCT00604383|20899055|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
8480583|NCT00604383|20899054|P2|STARTED|Overall Study||340
8480584|NCT00604383|20899055|P1|STARTED|Overall Study||345
8480585|NCT00604279|20899071|P2|NOT COMPLETED|Overall Study||38
8480586|NCT00604279|20899072|P1|NOT COMPLETED|Overall Study||64
8480587|NCT00604279|20899071|P2|COMPLETED|Overall Study||185
8480588|NCT00604279|20899072|P1|COMPLETED|Overall Study||165
8480589|NCT00604279|20899071|P2|STARTED|Overall Study||223
8480590|NCT00604279|20899072|P1|STARTED|Overall Study||229
8480591|NCT00604214|20899088|P2|NOT COMPLETED|Day 91 to Day 180||32
8480592|NCT00604214|20899089|P1|NOT COMPLETED|Day 91 to Day 180||26
8480593|NCT00604214|20899088|P2|COMPLETED|Day 91 to Day 180||521
8480594|NCT00604214|20899089|P1|COMPLETED|Day 91 to Day 180||529
8480595|NCT00604214|20899088|P2|STARTED|Day 91 to Day 180||553
8480596|NCT00604214|20899089|P1|STARTED|Day 91 to Day 180||555
8480597|NCT00604214|20899088|P2|NOT COMPLETED|Day 29 to Day 90||79
8480598|NCT00604214|20899089|P1|NOT COMPLETED|Day 29 to Day 90||68
8480599|NCT00604214|20899088|P2|COMPLETED|Day 29 to Day 90||553
8480600|NCT00604214|20899089|P1|COMPLETED|Day 29 to Day 90||555
8480601|NCT00604214|20899088|P2|STARTED|Day 29 to Day 90||632
8480602|NCT00604214|20899089|P1|STARTED|Day 29 to Day 90||623
8480603|NCT00604214|20899088|P2|NOT COMPLETED|Baseline to Day 28||213
8480604|NCT00604214|20899089|P1|NOT COMPLETED|Baseline to Day 28||228
8480605|NCT00604214|20899088|P2|COMPLETED|Baseline to Day 28||632
8480606|NCT00604214|20899089|P1|COMPLETED|Baseline to Day 28||623
8480607|NCT00604214|20899088|P2|Received Study Drug|Baseline to Day 28||833
8480608|NCT00604214|20899089|P1|Received Study Drug|Baseline to Day 28||833
8480609|NCT00604214|20899088|P2|STARTED|Baseline to Day 28||845
8480610|NCT00604214|20899089|P1|STARTED|Baseline to Day 28||851
8480611|NCT00604201|20899119|P1|NOT COMPLETED|Overall Study||10
8480612|NCT00604201|20899119|P1|COMPLETED|Overall Study||21
8480613|NCT00604201|20899119|P1|STARTED|Overall Study||31
8480614|NCT00604188|20899137|P2|NOT COMPLETED|Overall Study||25
8480615|NCT00604188|20899138|P1|NOT COMPLETED|Overall Study||27
8480616|NCT00604188|20899137|P2|COMPLETED|Overall Study||70
8480617|NCT00604188|20899138|P1|COMPLETED|Overall Study||66
8480618|NCT00604188|20899137|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
8480619|NCT00604188|20899138|P1|STARTED|Overall Study||93
8480620|NCT00604175|20899161|P3|NOT COMPLETED|Week 29 Through Week 72||4
8480621|NCT00604175|20899162|P2|NOT COMPLETED|Week 29 Through Week 72||7
8480622|NCT00604175|20899163|P1|NOT COMPLETED|Week 29 Through Week 72||12
8480623|NCT00604175|20899161|P3|COMPLETED|Week 29 Through Week 72||89
8480624|NCT00604175|20899162|P2|COMPLETED|Week 29 Through Week 72||85
8480625|NCT00604175|20899163|P1|COMPLETED|Week 29 Through Week 72||108
8480626|NCT00604175|20899161|P3|STARTED|Week 29 Through Week 72||93
8480627|NCT00604175|20899162|P2|STARTED|Week 29 Through Week 72||92
8480628|NCT00604175|20899163|P1|STARTED|Week 29 Through Week 72||120
8480629|NCT00604175|20899161|P3|NOT COMPLETED|Entry Through Week 28||1
8480630|NCT00604175|20899162|P2|NOT COMPLETED|Entry Through Week 28||3
8480631|NCT00604175|20899163|P1|NOT COMPLETED|Entry Through Week 28||10
8480632|NCT00604175|20899161|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
8480633|NCT00604175|20899162|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
8480634|NCT00604175|20899163|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
8480635|NCT00604175|20899161|P3|STARTED|Entry Through Week 28||94
8480636|NCT00604175|20899162|P2|STARTED|Entry Through Week 28||95
8480637|NCT00604175|20899163|P1|STARTED|Entry Through Week 28||130
8480638|NCT00604162|20899216|P1|NOT COMPLETED|Overall Study||4
8480639|NCT00604162|20899216|P1|COMPLETED|Overall Study||328
8480640|NCT00604162|20899216|P1|STARTED|Overall Study||332
8480641|NCT00604045|20899229|P2|NOT COMPLETED|Overall Study||1
8480642|NCT00604045|20899230|P1|NOT COMPLETED|Overall Study||1
8480643|NCT00604045|20899229|P2|COMPLETED|Overall Study||9
8480644|NCT00604045|20899230|P1|COMPLETED|Overall Study||14
8480645|NCT00604045|20899229|P2|STARTED|Overall Study||10
8480646|NCT00604045|20899230|P1|STARTED|Overall Study||15
8480647|NCT00604019|20899238|P2|NOT COMPLETED|Overall Study||0
8480648|NCT00604019|20899239|P1|NOT COMPLETED|Overall Study||0
8480649|NCT00604019|20899238|P2|COMPLETED|Overall Study||118
8480650|NCT00604019|20899239|P1|COMPLETED|Overall Study||134
8480651|NCT00604019|20899238|P2|STARTED|Overall Study||118
8480652|NCT00604019|20899239|P1|STARTED|Overall Study||134
8480653|NCT00603993|20899245|P1|NOT COMPLETED|Overall Study||20
8480654|NCT00603993|20899245|P1|COMPLETED|Overall Study||68
8480655|NCT00603993|20899245|P1|STARTED|Overall Study||88
8480656|NCT00603980|20899258|P1|NOT COMPLETED|Main Study||1
8480657|NCT00603980|20899258|P1|COMPLETED|Main Study||14
8480658|NCT00603980|20899258|P1|STARTED|Main Study||15
8480659|NCT00603980|20899258|P1|NOT COMPLETED|Study Qualification||16
8480660|NCT00603980|20899258|P1|COMPLETED|Study Qualification||15
8480661|NCT00603980|20899258|P1|STARTED|Study Qualification||31
8480662|NCT00603941|20899377|P3|NOT COMPLETED|Overall Study||2
8480663|NCT00603941|20899378|P2|NOT COMPLETED|Overall Study||10
8480664|NCT00603941|20899379|P1|NOT COMPLETED|Overall Study||7
8480665|NCT00603941|20899377|P3|COMPLETED|Overall Study||0
8480666|NCT00603941|20899378|P2|COMPLETED|Overall Study||0
8480667|NCT00603941|20899379|P1|COMPLETED|Overall Study||0
8480668|NCT00603941|20899377|P3|STARTED|Overall Study||2
8480669|NCT00603941|20899378|P2|STARTED|Overall Study||10
8480670|NCT00603941|20899379|P1|STARTED|Overall Study||7
8480671|NCT00603915|20899390|P1|NOT COMPLETED|Overall Study||1
8480672|NCT00603915|20899390|P1|COMPLETED|Overall Study||19
8480673|NCT00603915|20899390|P1|STARTED|Overall Study||20
8480674|NCT00603902|20899398|P3|NOT COMPLETED|Overall Study||769
8480675|NCT00603902|20899399|P2|NOT COMPLETED|Overall Study||686
8480676|NCT00603902|20899400|P1|NOT COMPLETED|Overall Study||329
8480677|NCT00603902|20899398|P3|COMPLETED|Overall Study||834
8480678|NCT00603902|20899399|P2|COMPLETED|Overall Study||917
8480679|NCT00603902|20899400|P1|COMPLETED|Overall Study||473
8480680|NCT00603902|20899398|P3|STARTED|Overall Study||1603
8480681|NCT00603902|20899399|P2|STARTED|Overall Study||1603
8480682|NCT00603902|20899400|P1|STARTED|Overall Study||802
8480683|NCT00603889|20899411|P1|NOT COMPLETED|Overall Study||0
8480684|NCT00603889|20899411|P1|COMPLETED|Overall Study||12
8480685|NCT00603889|20899411|P1|STARTED|Overall Study||12
8480686|NCT00603837|20899420|P2|NOT COMPLETED|Overall Study||0
8480687|NCT00603837|20899421|P1|NOT COMPLETED|Overall Study||3
8480688|NCT00603837|20899420|P2|COMPLETED|Overall Study||19
8480689|NCT00603837|20899421|P1|COMPLETED|Overall Study||17
8480690|NCT00603837|20899420|P2|STARTED|Overall Study||19
8480691|NCT00603837|20899421|P1|STARTED|Overall Study||20
8480692|NCT00603798|20899430|P3|NOT COMPLETED|Overall Study||10
8480693|NCT00603798|20899431|P2|NOT COMPLETED|Overall Study||7
8480694|NCT00603798|20899432|P1|NOT COMPLETED|Overall Study||10
8480695|NCT00603798|20899430|P3|COMPLETED|Overall Study||154
8480696|NCT00603798|20899431|P2|COMPLETED|Overall Study||157
8480697|NCT00603798|20899432|P1|COMPLETED|Overall Study||152
8480698|NCT00603798|20899430|P3|STARTED|Overall Study||164
8480699|NCT00603798|20899431|P2|STARTED|Overall Study||164
8480700|NCT00603798|20899432|P1|STARTED|Overall Study||162
8480701|NCT00603746|20899455|P6|NOT COMPLETED|Overall Study||13
8480702|NCT00603746|20899456|P5|NOT COMPLETED|Overall Study||17
8480703|NCT00603746|20899457|P4|NOT COMPLETED|Overall Study||13
8480704|NCT00603746|20899458|P3|NOT COMPLETED|Overall Study||8
8480705|NCT00603746|20899459|P2|NOT COMPLETED|Overall Study||18
8480706|NCT00603746|20899460|P1|NOT COMPLETED|Overall Study||38
8480707|NCT00603746|20899455|P6|COMPLETED|Overall Study||97
8480708|NCT00603746|20899456|P5|COMPLETED|Overall Study||85
8480709|NCT00603746|20899457|P4|COMPLETED|Overall Study||94
8480710|NCT00603746|20899458|P3|COMPLETED|Overall Study||93
8480711|NCT00603746|20899459|P2|COMPLETED|Overall Study||81
8480712|NCT00603746|20899460|P1|COMPLETED|Overall Study||65
8480713|NCT00603746|20899455|P6|STARTED|Overall Study||110
8480714|NCT00603746|20899456|P5|STARTED|Overall Study||102
8480715|NCT00603746|20899457|P4|STARTED|Overall Study||107
8480716|NCT00603746|20899458|P3|STARTED|Overall Study||101
8480717|NCT00603746|20899459|P2|STARTED|Overall Study||99
8480718|NCT00603746|20899460|P1|STARTED|Overall Study||103
8480719|NCT00603733|20899608|P2|NOT COMPLETED|Maintenance Phase ITT||16
8480720|NCT00603733|20899609|P1|NOT COMPLETED|Maintenance Phase ITT||10
8480721|NCT00603733|20899608|P2|COMPLETED|Maintenance Phase ITT||66
8480722|NCT00603733|20899609|P1|COMPLETED|Maintenance Phase ITT||61
8480723|NCT00603733|20899608|P2|STARTED|Maintenance Phase ITT||82
8480724|NCT00603733|20899609|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
8480725|NCT00603733|20899608|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
8480726|NCT00603733|20899609|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
8480727|NCT00603733|20899608|P2|COMPLETED|Run-In Phase - 4 Weeks||36
8480728|NCT00603733|20899609|P1|COMPLETED|Run-In Phase - 4 Weeks||35
8480729|NCT00603733|20899608|P2|STARTED|Run-In Phase - 4 Weeks||49
8480730|NCT00603733|20899609|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
8480731|NCT00603733|20899608|P2|NOT COMPLETED|Active Phase ITT||17
8480732|NCT00603733|20899609|P1|NOT COMPLETED|Active Phase ITT||11
8480733|NCT00603733|20899608|P2|COMPLETED|Active Phase ITT||78
8480734|NCT00603733|20899609|P1|COMPLETED|Active Phase ITT||84
8480735|NCT00603733|20899608|P2|STARTED|Active Phase ITT||95
8480736|NCT00603733|20899609|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
8480737|NCT00603720|20899624|P5|NOT COMPLETED|Overall Study||0
8480738|NCT00603720|20899625|P4|NOT COMPLETED|Overall Study||0
8480739|NCT00603720|20899626|P3|NOT COMPLETED|Overall Study||0
8480740|NCT00603720|20899627|P2|NOT COMPLETED|Overall Study||0
8480741|NCT00603720|20899628|P1|NOT COMPLETED|Overall Study||0
8480742|NCT00603720|20899624|P5|COMPLETED|Overall Study||12
8480743|NCT00603720|20899625|P4|COMPLETED|Overall Study||10
8480744|NCT00603720|20899626|P3|COMPLETED|Overall Study||12
8480745|NCT00603720|20899627|P2|COMPLETED|Overall Study||10
8480746|NCT00603720|20899628|P1|COMPLETED|Overall Study||10
8480747|NCT00603720|20899624|P5|STARTED|Overall Study||12
8480748|NCT00603720|20899625|P4|STARTED|Overall Study||10
8480749|NCT00603720|20899626|P3|STARTED|Overall Study||12
8480750|NCT00603720|20899627|P2|STARTED|Overall Study||10
8480751|NCT00603720|20899628|P1|STARTED|Overall Study||10
8480752|NCT00603642|20899642|P2|NOT COMPLETED|Overall Study||0
8480753|NCT00603642|20899643|P1|NOT COMPLETED|Overall Study||0
8480754|NCT00603642|20899642|P2|COMPLETED|Overall Study||22
8480755|NCT00603642|20899643|P1|COMPLETED|Overall Study||12
8480756|NCT00603642|20899642|P2|STARTED|Overall Study||22
8480757|NCT00603642|20899643|P1|STARTED|Overall Study||12
8480758|NCT00603590|20899659|P2|NOT COMPLETED|Overall Study||51
8480759|NCT00603590|20899660|P1|NOT COMPLETED|Overall Study||76
8480760|NCT00603590|20899659|P2|COMPLETED|Overall Study||183
8480761|NCT00603590|20899660|P1|COMPLETED|Overall Study||165
8480762|NCT00603590|20899659|P2|Eight Months|Overall Study||194
8480763|NCT00603590|20899660|P1|Eight Months|Overall Study||178
8480764|NCT00603590|20899659|P2|Four Months|Overall Study||200
8480765|NCT00603590|20899660|P1|Four Months|Overall Study||187
8480766|NCT00603590|20899659|P2|One Month|Overall Study||212
8480767|NCT00603590|20899660|P1|One Month|Overall Study||204
8480768|NCT00603590|20899659|P2|STARTED|Overall Study||234
8480769|NCT00603590|20899660|P1|STARTED|Overall Study||241
8480770|NCT00603564|20899672|P2|NOT COMPLETED|Overall Study||0
8480771|NCT00603564|20899673|P1|NOT COMPLETED|Overall Study||0
8480772|NCT00603564|20899672|P2|COMPLETED|Overall Study|February 2008|27
8480773|NCT00603564|20899673|P1|COMPLETED|Overall Study|February 2008|20
8480774|NCT00603564|20899672|P2|STARTED|Overall Study|January 2006|27
8480775|NCT00603564|20899673|P1|STARTED|Overall Study|January 2006|20
8480776|NCT00603538|20899684|P3|NOT COMPLETED|Overall Study||2
8480777|NCT00603538|20899685|P2|NOT COMPLETED|Overall Study||4
8480778|NCT00603538|20899686|P1|NOT COMPLETED|Overall Study||3
8480779|NCT00603538|20899684|P3|COMPLETED|Overall Study||4
8480780|NCT00603538|20899685|P2|COMPLETED|Overall Study||3
8480781|NCT00603538|20899686|P1|COMPLETED|Overall Study||3
8480782|NCT00603538|20899684|P3|STARTED|Overall Study||6
8480783|NCT00603538|20899685|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
8480784|NCT00603538|20899686|P1|STARTED|Overall Study||6
8480785|NCT00603525|20899726|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
8480786|NCT00603525|20899727|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480787|NCT00603525|20899728|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480788|NCT00603525|20899726|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
8480789|NCT00603525|20899727|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480790|NCT00603525|20899728|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480791|NCT00603525|20899726|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
8480792|NCT00603525|20899727|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
8480793|NCT00603525|20899728|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
8480794|NCT00603525|20899726|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
8480795|NCT00603525|20899727|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
8480796|NCT00603525|20899728|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
8480797|NCT00603525|20899726|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8480798|NCT00603525|20899727|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
8480799|NCT00603525|20899728|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8480800|NCT00603525|20899726|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
8480801|NCT00603525|20899727|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
8480802|NCT00603525|20899728|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
8480803|NCT00603525|20899726|P3|STARTED|OL Treatment Period (120 Weeks)||0
8480804|NCT00603525|20899727|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
8480805|NCT00603525|20899728|P1|STARTED|OL Treatment Period (120 Weeks)||0
8480806|NCT00603525|20899726|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
8480807|NCT00603525|20899727|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
8480808|NCT00603525|20899728|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
8480809|NCT00603525|20899726|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
8480810|NCT00603525|20899727|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
8480811|NCT00603525|20899728|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
8480812|NCT00603525|20899726|P3|STARTED|DB Treatment Period (24 Weeks)||0
8480813|NCT00603525|20899727|P2|STARTED|DB Treatment Period (24 Weeks)||85
8480814|NCT00603525|20899728|P1|STARTED|DB Treatment Period (24 Weeks)||84
8480815|NCT00603512|20899860|P5|NOT COMPLETED|Overall Study||5
8480816|NCT00603512|20899861|P4|NOT COMPLETED|Overall Study||7
8480817|NCT00603512|20899862|P3|NOT COMPLETED|Overall Study||5
8480818|NCT00603512|20899863|P2|NOT COMPLETED|Overall Study||5
8480819|NCT00603512|20899864|P1|NOT COMPLETED|Overall Study||2
8480820|NCT00603512|20899860|P5|COMPLETED|Overall Study||23
8480821|NCT00603512|20899861|P4|COMPLETED|Overall Study||21
8480822|NCT00603512|20899862|P3|COMPLETED|Overall Study||23
8480823|NCT00603512|20899863|P2|COMPLETED|Overall Study||23
8480824|NCT00603512|20899864|P1|COMPLETED|Overall Study||26
8480825|NCT00603512|20899860|P5|Treated|Overall Study||28
8480826|NCT00603512|20899861|P4|Treated|Overall Study||26
8480827|NCT00603512|20899862|P3|Treated|Overall Study||27
8480828|NCT00603512|20899863|P2|Treated|Overall Study||27
8480829|NCT00603512|20899864|P1|Treated|Overall Study||28
8480830|NCT00603512|20899860|P5|STARTED|Overall Study||28
8480831|NCT00603512|20899861|P4|STARTED|Overall Study||28
8480832|NCT00603512|20899862|P3|STARTED|Overall Study||28
8480833|NCT00603512|20899863|P2|STARTED|Overall Study||28
8480834|NCT00603512|20899864|P1|STARTED|Overall Study||28
8480838|NCT00603447|20900019|P7|NOT COMPLETED|Overall Study||24
8480839|NCT00603447|20900020|P6|NOT COMPLETED|Overall Study||2
8480840|NCT00603447|20900021|P5|NOT COMPLETED|Overall Study||5
8480841|NCT00603447|20900022|P4|NOT COMPLETED|Overall Study||2
8480842|NCT00603447|20900023|P3|NOT COMPLETED|Overall Study||2
8480843|NCT00603447|20900024|P2|NOT COMPLETED|Overall Study||3
8480844|NCT00603447|20900025|P1|NOT COMPLETED|Overall Study||0
8480845|NCT00603447|20900019|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
8480846|NCT00603447|20900020|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8480847|NCT00603447|20900021|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
8480848|NCT00603447|20900022|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
8480849|NCT00603447|20900023|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8480850|NCT00603447|20900024|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
8480851|NCT00603447|20900025|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8480852|NCT00603447|20900019|P7|STARTED|Overall Study||44
8480853|NCT00603447|20900020|P6|STARTED|Overall Study||8
8480854|NCT00603447|20900021|P5|STARTED|Overall Study||6
8480855|NCT00603447|20900022|P4|STARTED|Overall Study||6
8480856|NCT00603447|20900023|P3|STARTED|Overall Study||8
8480857|NCT00603447|20900024|P2|STARTED|Overall Study||6
8480858|NCT00603447|20900025|P1|STARTED|Overall Study||6
8480859|NCT00603408|20900047|P1|NOT COMPLETED|Overall Study||0
8480860|NCT00603408|20900047|P1|COMPLETED|Overall Study||5
8480861|NCT00603408|20900047|P1|STARTED|Overall Study||5
8480862|NCT00603382|20900064|P6|NOT COMPLETED|Overall Study||18
8480863|NCT00603382|20900065|P5|NOT COMPLETED|Overall Study||9
8480864|NCT00603382|20900066|P4|NOT COMPLETED|Overall Study||12
8480865|NCT00603382|20900067|P3|NOT COMPLETED|Overall Study||9
8480866|NCT00603382|20900068|P2|NOT COMPLETED|Overall Study||14
8480867|NCT00603382|20900069|P1|NOT COMPLETED|Overall Study||18
8480868|NCT00603382|20900064|P6|COMPLETED|Overall Study||84
8480869|NCT00603382|20900065|P5|COMPLETED|Overall Study||86
8480870|NCT00603382|20900066|P4|COMPLETED|Overall Study||98
8480871|NCT00603382|20900067|P3|COMPLETED|Overall Study||91
8480872|NCT00603382|20900068|P2|COMPLETED|Overall Study||83
8480873|NCT00603382|20900069|P1|COMPLETED|Overall Study||76
8480874|NCT00603382|20900064|P6|STARTED|Overall Study||102
8480875|NCT00603382|20900065|P5|STARTED|Overall Study||95
8480876|NCT00603382|20900066|P4|STARTED|Overall Study||110
8480877|NCT00603382|20900067|P3|STARTED|Overall Study||100
8480878|NCT00603382|20900068|P2|STARTED|Overall Study||97
8480879|NCT00603382|20900069|P1|STARTED|Overall Study||94
8480880|NCT00603304|20900217|P2|NOT COMPLETED|Overall Study||31
8480881|NCT00603304|20900218|P1|NOT COMPLETED|Overall Study||32
8480882|NCT00603304|20900217|P2|COMPLETED|Overall Study||155
8480883|NCT00603304|20900218|P1|COMPLETED|Overall Study||151
8480884|NCT00603304|20900217|P2|STARTED|Overall Study||186
8480885|NCT00603304|20900218|P1|STARTED|Overall Study||183
8480886|NCT00603291|20900255|P3|NOT COMPLETED|Overall Study||96
8480887|NCT00603291|20900256|P2|NOT COMPLETED|Overall Study||87
8480888|NCT00603291|20900257|P1|NOT COMPLETED|Overall Study||20
8480889|NCT00603291|20900255|P3|COMPLETED|Overall Study||157
8480890|NCT00603291|20900256|P2|COMPLETED|Overall Study||169
8480891|NCT00603291|20900257|P1|COMPLETED|Overall Study||75
8480892|NCT00603291|20900255|P3|STARTED|Overall Study||253
8480893|NCT00603291|20900256|P2|STARTED|Overall Study||256
8480894|NCT00603291|20900257|P1|STARTED|Overall Study||95
8480895|NCT00603278|20900274|P6|NOT COMPLETED|Overall Study||19
8480896|NCT00603278|20900275|P5|NOT COMPLETED|Overall Study||13
8480897|NCT00603278|20900276|P4|NOT COMPLETED|Overall Study||11
8480898|NCT00603278|20900277|P3|NOT COMPLETED|Overall Study||14
8480899|NCT00603278|20900278|P2|NOT COMPLETED|Overall Study||17
8480900|NCT00603278|20900279|P1|NOT COMPLETED|Overall Study||41
8480901|NCT00603278|20900274|P6|COMPLETED|Overall Study||81
8480902|NCT00603278|20900275|P5|COMPLETED|Overall Study||86
8480903|NCT00603278|20900276|P4|COMPLETED|Overall Study||92
8480904|NCT00603278|20900277|P3|COMPLETED|Overall Study||87
8480905|NCT00603278|20900278|P2|COMPLETED|Overall Study||88
8480906|NCT00603278|20900279|P1|COMPLETED|Overall Study||66
8480907|NCT00603278|20900274|P6|STARTED|Overall Study||100
8480908|NCT00603278|20900275|P5|STARTED|Overall Study||99
8480909|NCT00603278|20900276|P4|STARTED|Overall Study||103
8480910|NCT00603278|20900277|P3|STARTED|Overall Study||101
8480911|NCT00603278|20900278|P2|STARTED|Overall Study||105
8480912|NCT00603278|20900279|P1|STARTED|Overall Study||107
8480913|NCT00603265|20900428|P3|NOT COMPLETED|Overall Study||5
8480914|NCT00603265|20900429|P2|NOT COMPLETED|Overall Study||16
8480915|NCT00603265|20900430|P1|NOT COMPLETED|Overall Study||7
8480916|NCT00603265|20900428|P3|COMPLETED|Overall Study||67
8480917|NCT00603265|20900429|P2|COMPLETED|Overall Study||62
8480918|NCT00603265|20900430|P1|COMPLETED|Overall Study||69
8480919|NCT00603265|20900428|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
8480920|NCT00603265|20900429|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
8480921|NCT00603265|20900430|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
8480922|NCT00603265|20900428|P3|STARTED|Overall Study||72
8480923|NCT00603265|20900429|P2|STARTED|Overall Study||78
8480924|NCT00603265|20900430|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
8480925|NCT00603239|20900458|P2|NOT COMPLETED|Overall Study||4
8480926|NCT00603239|20900459|P1|NOT COMPLETED|Overall Study||15
8480927|NCT00603239|20900458|P2|COMPLETED|Overall Study||50
8480928|NCT00603239|20900459|P1|COMPLETED|Overall Study||96
8480929|NCT00603239|20900458|P2|STARTED|Overall Study||54
8480930|NCT00603239|20900459|P1|STARTED|Overall Study||111
8480931|NCT00603187|20900485|P1|NOT COMPLETED|Overall Study||0
8480932|NCT00603187|20900485|P1|COMPLETED|Overall Study||4
8480933|NCT00603187|20900485|P1|STARTED|Overall Study||4
8480934|NCT00603044|20900493|P2|NOT COMPLETED|Overall Study||0
8480935|NCT00603044|20900494|P1|NOT COMPLETED|Overall Study||0
8480936|NCT00603044|20900493|P2|COMPLETED|Overall Study||13
8480937|NCT00603044|20900494|P1|COMPLETED|Overall Study||11
8480938|NCT00603044|20900493|P2|STARTED|Overall Study||13
8480939|NCT00603044|20900494|P1|STARTED|Overall Study||11
8480940|NCT00603018|20900510|P1|NOT COMPLETED|Overall Study||0
8480941|NCT00603018|20900510|P1|COMPLETED|Overall Study||23
8480942|NCT00603018|20900510|P1|STARTED|Overall Study||23
8480943|NCT00602979|20900520|P5|NOT COMPLETED|Overall Study||3
8480944|NCT00602979|20900521|P4|NOT COMPLETED|Overall Study||3
8480945|NCT00602979|20900522|P3|NOT COMPLETED|Overall Study||3
8480946|NCT00602979|20900523|P2|NOT COMPLETED|Overall Study||3
8480947|NCT00602979|20900524|P1|NOT COMPLETED|Overall Study||3
8480948|NCT00602979|20900520|P5|COMPLETED|Overall Study||45
8480949|NCT00602979|20900521|P4|COMPLETED|Overall Study||45
8480950|NCT00602979|20900522|P3|COMPLETED|Overall Study||45
8480951|NCT00602979|20900523|P2|COMPLETED|Overall Study||45
8480952|NCT00602979|20900524|P1|COMPLETED|Overall Study||45
8480953|NCT00602979|20900520|P5|STARTED|Overall Study||48
8480954|NCT00602979|20900521|P4|STARTED|Overall Study||48
8480955|NCT00602979|20900522|P3|STARTED|Overall Study||48
8480956|NCT00602979|20900523|P2|STARTED|Overall Study||48
8480957|NCT00602979|20900524|P1|STARTED|Overall Study||48
8480958|NCT00602953|20900541|P5|NOT COMPLETED|Overall Study||0
8480959|NCT00602953|20900542|P4|NOT COMPLETED|Overall Study||0
8480960|NCT00602953|20900543|P3|NOT COMPLETED|Overall Study||0
8480961|NCT00602953|20900544|P2|NOT COMPLETED|Overall Study||0
8480962|NCT00602953|20900545|P1|NOT COMPLETED|Overall Study||0
8480963|NCT00602953|20900541|P5|COMPLETED|Overall Study||0
8480964|NCT00602953|20900542|P4|COMPLETED|Overall Study||13
8480965|NCT00602953|20900543|P3|COMPLETED|Overall Study||47
8480966|NCT00602953|20900544|P2|COMPLETED|Overall Study||26
8480967|NCT00602953|20900545|P1|COMPLETED|Overall Study||15
8480968|NCT00602953|20900541|P5|STARTED|Overall Study||0
8480969|NCT00602953|20900542|P4|STARTED|Overall Study||13
8480970|NCT00602953|20900543|P3|STARTED|Overall Study||47
8480971|NCT00602953|20900544|P2|STARTED|Overall Study||26
8480972|NCT00602953|20900545|P1|STARTED|Overall Study||15
8480973|NCT00602927|20900574|P2|NOT COMPLETED|Period 3: 13 Days||3
8480974|NCT00602927|20900575|P1|NOT COMPLETED|Period 3: 13 Days||2
8480975|NCT00602927|20900574|P2|COMPLETED|Period 3: 13 Days||9
8480976|NCT00602927|20900575|P1|COMPLETED|Period 3: 13 Days||13
8480977|NCT00602927|20900574|P2|STARTED|Period 3: 13 Days||12
8480978|NCT00602927|20900575|P1|STARTED|Period 3: 13 Days||15
8480979|NCT00602927|20900574|P2|NOT COMPLETED|Period 2: 14 Days||2
8480980|NCT00602927|20900575|P1|NOT COMPLETED|Period 2: 14 Days||0
8480981|NCT00602927|20900574|P2|COMPLETED|Period 2: 14 Days||12
8480982|NCT00602927|20900575|P1|COMPLETED|Period 2: 14 Days||15
8480983|NCT00602927|20900574|P2|STARTED|Period 2: 14 Days||14
8480984|NCT00602927|20900575|P1|STARTED|Period 2: 14 Days||15
8480985|NCT00602927|20900574|P2|NOT COMPLETED|Period 1: 13 Days||5
8480986|NCT00602927|20900575|P1|NOT COMPLETED|Period 1: 13 Days||4
8480987|NCT00602927|20900574|P2|COMPLETED|Period 1: 13 Days||14
8480988|NCT00602927|20900575|P1|COMPLETED|Period 1: 13 Days||15
8480989|NCT00602927|20900574|P2|STARTED|Period 1: 13 Days||19
8480990|NCT00602927|20900575|P1|STARTED|Period 1: 13 Days||19
8480991|NCT00602836|20900583|P1|NOT COMPLETED|Overall Study||5
8480992|NCT00602836|20900583|P1|COMPLETED|Overall Study||39
8480993|NCT00602836|20900583|P1|STARTED|Overall Study||44
8480994|NCT00602797|20900592|P1|NOT COMPLETED|Overall Study||1
8480995|NCT00602797|20900592|P1|COMPLETED|Overall Study||19
8480996|NCT00602797|20900592|P1|STARTED|Overall Study||20
8480997|NCT00602771|20900600|P2|NOT COMPLETED|Overall Study||0
8480998|NCT00602771|20900601|P1|NOT COMPLETED|Overall Study||1
8480999|NCT00602771|20900600|P2|COMPLETED|Overall Study||21
8481000|NCT00602771|20900601|P1|COMPLETED|Overall Study||62
8481001|NCT00602771|20900600|P2|STARTED|Overall Study||21
8481002|NCT00602771|20900601|P1|STARTED|Overall Study||63
8481003|NCT00602667|20900610|P3|NOT COMPLETED|Overall Study||63
8481004|NCT00602667|20900611|P2|NOT COMPLETED|Overall Study||81
8481005|NCT00602667|20900612|P1|NOT COMPLETED|Overall Study||19
8481006|NCT00602667|20900610|P3|COMPLETED|Overall Study||14
8481007|NCT00602667|20900611|P2|COMPLETED|Overall Study||75
8481008|NCT00602667|20900612|P1|COMPLETED|Overall Study||38
8481009|NCT00602667|20900610|P3|STARTED|Overall Study||77
8481010|NCT00602667|20900611|P2|STARTED|Overall Study||156
8481011|NCT00602667|20900612|P1|STARTED|Overall Study||57
8481020|NCT00602537|20900806|P2|NOT COMPLETED|Follow Up Study Comparison||3
8481021|NCT00602537|20900807|P1|NOT COMPLETED|Follow Up Study Comparison||11
8481022|NCT00602537|20900806|P2|COMPLETED|Follow Up Study Comparison||14
8481023|NCT00602537|20900807|P1|COMPLETED|Follow Up Study Comparison||31
8481024|NCT00602537|20900806|P2|STARTED|Follow Up Study Comparison||17
8481025|NCT00602537|20900807|P1|STARTED|Follow Up Study Comparison||42
8481026|NCT00602537|20900806|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
8481027|NCT00602537|20900807|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
8481028|NCT00602537|20900806|P2|COMPLETED|12 Week Double Blind Comparison||17
8481029|NCT00602537|20900807|P1|COMPLETED|12 Week Double Blind Comparison||42
8481030|NCT00602537|20900806|P2|Responded|12 Week Double Blind Comparison||22
8481031|NCT00602537|20900807|P1|Responded|12 Week Double Blind Comparison||44
8481032|NCT00602537|20900806|P2|STARTED|12 Week Double Blind Comparison||64
8481033|NCT00602537|20900807|P1|STARTED|12 Week Double Blind Comparison||65
8481034|NCT00602472|20900817|P2|NOT COMPLETED|Overall Study||58
8481035|NCT00602472|20900818|P1|NOT COMPLETED|Overall Study||21
8481036|NCT00602472|20900817|P2|COMPLETED|Overall Study|number who completed treatment|734
8481037|NCT00602472|20900818|P1|COMPLETED|Overall Study|number who completed treatment|242
8481038|NCT00602472|20900817|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
8481039|NCT00602472|20900818|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
8481064|NCT00602446|20900876|P1|NOT COMPLETED|Overall Study||0
8481065|NCT00602446|20900876|P1|COMPLETED|Overall Study||3
8481066|NCT00602446|20900876|P1|STARTED|Overall Study||3
8481067|NCT00602420|20900883|P2|NOT COMPLETED|Overall Study||24
8481068|NCT00602420|20900884|P1|NOT COMPLETED|Overall Study||25
8481069|NCT00602420|20900883|P2|COMPLETED|Overall Study||229
8481070|NCT00602420|20900884|P1|COMPLETED|Overall Study||232
8481071|NCT00602420|20900883|P2|STARTED|Overall Study||253
8481072|NCT00602420|20900884|P1|STARTED|Overall Study||257
8481073|NCT00602355|20900893|P3|NOT COMPLETED|Overall Study||10
8481074|NCT00602355|20900894|P2|NOT COMPLETED|Overall Study||18
8481075|NCT00602355|20900895|P1|NOT COMPLETED|Overall Study||9
8481076|NCT00602355|20900893|P3|COMPLETED|Overall Study||43
8481077|NCT00602355|20900894|P2|COMPLETED|Overall Study||38
8481078|NCT00602355|20900895|P1|COMPLETED|Overall Study||44
8481079|NCT00602355|20900893|P3|STARTED|Overall Study||53
8481080|NCT00602355|20900894|P2|STARTED|Overall Study||56
8481081|NCT00602355|20900895|P1|STARTED|Overall Study||53
8481082|NCT00602290|20900918|P3|NOT COMPLETED|Overall Study||1
8481083|NCT00602290|20900919|P2|NOT COMPLETED|Overall Study||2
8481084|NCT00602290|20900920|P1|NOT COMPLETED|Overall Study||2
8481085|NCT00602290|20900918|P3|COMPLETED|Overall Study||46
8481086|NCT00602290|20900919|P2|COMPLETED|Overall Study||46
8481087|NCT00602290|20900920|P1|COMPLETED|Overall Study||46
8481088|NCT00602290|20900918|P3|STARTED|Overall Study||47
8481089|NCT00602290|20900919|P2|STARTED|Overall Study||48
8481090|NCT00602290|20900920|P1|STARTED|Overall Study||48
8481091|NCT00602225|20900931|P1|NOT COMPLETED|Overall Study||0
8481092|NCT00602225|20900931|P1|COMPLETED|Overall Study||50
8481093|NCT00602225|20900931|P1|STARTED|Overall Study||50
8481094|NCT00602043|20900944|P1|NOT COMPLETED|Overall Study||5
8481095|NCT00602043|20900944|P1|COMPLETED|Overall Study||15
8481096|NCT00602043|20900944|P1|STARTED|Overall Study||20
8481097|NCT00601965|20900958|P4|NOT COMPLETED|Overall Study||1
8481098|NCT00601965|20900959|P3|NOT COMPLETED|Overall Study||0
8481099|NCT00601965|20900960|P2|NOT COMPLETED|Overall Study||2
8481100|NCT00601965|20900961|P1|NOT COMPLETED|Overall Study||0
8481101|NCT00601965|20900958|P4|COMPLETED|Overall Study||17
8481102|NCT00601965|20900959|P3|COMPLETED|Overall Study||19
8481103|NCT00601965|20900960|P2|COMPLETED|Overall Study||16
8481104|NCT00601965|20900961|P1|COMPLETED|Overall Study||18
8481105|NCT00601965|20900958|P4|STARTED|Overall Study||18
8481106|NCT00601965|20900959|P3|STARTED|Overall Study||19
8481107|NCT00601965|20900960|P2|STARTED|Overall Study||18
8481108|NCT00601965|20900961|P1|STARTED|Overall Study||18
8481109|NCT00601952|20900977|P2|NOT COMPLETED|Overall Study||0
8481110|NCT00601952|20900978|P1|NOT COMPLETED|Overall Study||2
8481111|NCT00601952|20900977|P2|COMPLETED|Overall Study||17
8481112|NCT00601952|20900978|P1|COMPLETED|Overall Study||12
8481113|NCT00601952|20900977|P2|STARTED|Overall Study||17
8481114|NCT00601952|20900978|P1|STARTED|Overall Study||14
8481115|NCT00601926|20900984|P1|NOT COMPLETED|Overall Study||0
8481116|NCT00601926|20900984|P1|COMPLETED|Overall Study||5
8481117|NCT00601926|20900984|P1|STARTED|Overall Study||5
8481118|NCT00601900|20900992|P2|NOT COMPLETED|Overall Study||3
8481119|NCT00601900|20900993|P1|NOT COMPLETED|Overall Study||0
8481120|NCT00601900|20900992|P2|COMPLETED|Overall Study||196
8481121|NCT00601900|20900993|P1|COMPLETED|Overall Study||195
8481122|NCT00601900|20900992|P2|STARTED|Overall Study||199
8481123|NCT00601900|20900993|P1|STARTED|Overall Study||195
8481124|NCT00601848|20901007|P1|NOT COMPLETED|Overall Study||9
8481125|NCT00601848|20901007|P1|COMPLETED|Overall Study||0
8481126|NCT00601848|20901007|P1|STARTED|Overall Study||9
8481127|NCT00601835|20901017|P2|NOT COMPLETED|Overall Study||14
8481128|NCT00601835|20901018|P1|NOT COMPLETED|Overall Study||60
8481129|NCT00601835|20901017|P2|COMPLETED|Overall Study||686
8481130|NCT00601835|20901018|P1|COMPLETED|Overall Study||2890
8481131|NCT00601835|20901017|P2|STARTED|Overall Study||700
8481132|NCT00601835|20901018|P1|STARTED|Overall Study||2950
8481133|NCT00601796|20901028|P1|NOT COMPLETED|Overall Study||0
8481134|NCT00601796|20901028|P1|COMPLETED|Overall Study||24
8481135|NCT00601796|20901028|P1|STARTED|Overall Study||24
8481136|NCT00601731|20901047|P4|NOT COMPLETED|Overall Study||1
8481137|NCT00601731|20901048|P3|NOT COMPLETED|Overall Study||15
8481138|NCT00601731|20901049|P2|NOT COMPLETED|Overall Study||0
8481139|NCT00601731|20901050|P1|NOT COMPLETED|Overall Study||23
8481140|NCT00601731|20901047|P4|COMPLETED|Overall Study||29
8481141|NCT00601731|20901048|P3|COMPLETED|Overall Study||151
8481142|NCT00601731|20901049|P2|COMPLETED|Overall Study||43
8481143|NCT00601731|20901050|P1|COMPLETED|Overall Study||120
8481144|NCT00601731|20901047|P4|STARTED|Overall Study||30
8481145|NCT00601731|20901048|P3|STARTED|Overall Study||166
8481146|NCT00601731|20901049|P2|STARTED|Overall Study||43
8481147|NCT00601731|20901050|P1|STARTED|Overall Study||143
8481148|NCT00601718|20901100|P1|NOT COMPLETED|Overall Study||0
8481149|NCT00601718|20901100|P1|COMPLETED|Overall Study||29
8481150|NCT00601718|20901100|P1|STARTED|Overall Study||29
8481151|NCT00601705|20901107|P1|NOT COMPLETED|Overall Study||1
8481152|NCT00601705|20901107|P1|COMPLETED|Overall Study||60
8481153|NCT00601705|20901107|P1|STARTED|Overall Study||61
8481154|NCT00601640|20901119|P3|NOT COMPLETED|Overall Study||10
8481155|NCT00601640|20901120|P2|NOT COMPLETED|Overall Study||5
8481156|NCT00601640|20901121|P1|NOT COMPLETED|Overall Study||5
8481157|NCT00601640|20901119|P3|COMPLETED|Overall Study||42
8481158|NCT00601640|20901120|P2|COMPLETED|Overall Study||47
8481159|NCT00601640|20901121|P1|COMPLETED|Overall Study||47
8481160|NCT00601640|20901119|P3|STARTED|Overall Study||52
8481161|NCT00601640|20901120|P2|STARTED|Overall Study||52
8481162|NCT00601640|20901121|P1|STARTED|Overall Study||52
8481163|NCT00601627|20901135|P1|NOT COMPLETED|Overall Study||0
8481164|NCT00601627|20901135|P1|COMPLETED|Overall Study||51
8481165|NCT00601627|20901135|P1|STARTED|Overall Study||51
8481166|NCT00601523|20901146|P2|NOT COMPLETED|Overall Study||26
8481167|NCT00601523|20901147|P1|NOT COMPLETED|Overall Study||77
8481168|NCT00601523|20901146|P2|COMPLETED|Overall Study||117
8481169|NCT00601523|20901147|P1|COMPLETED|Overall Study||291
8481170|NCT00601523|20901146|P2|STARTED|Overall Study||143
8481171|NCT00601523|20901147|P1|STARTED|Overall Study||368
8481172|NCT00601458|20901182|P3|NOT COMPLETED|Overall Study||2
8481173|NCT00601458|20901183|P2|NOT COMPLETED|Overall Study||5
8481174|NCT00601458|20901184|P1|NOT COMPLETED|Overall Study||4
8481175|NCT00601458|20901182|P3|COMPLETED|Overall Study||28
8481176|NCT00601458|20901183|P2|COMPLETED|Overall Study||29
8481177|NCT00601458|20901184|P1|COMPLETED|Overall Study||32
8481178|NCT00601458|20901182|P3|STARTED|Overall Study||30
8481179|NCT00601458|20901183|P2|STARTED|Overall Study||34
8481180|NCT00601458|20901184|P1|STARTED|Overall Study||36
8481181|NCT00601419|20901195|P1|NOT COMPLETED|Overall Study||4
8481182|NCT00601419|20901195|P1|COMPLETED|Overall Study||226
8481183|NCT00601419|20901195|P1|STARTED|Overall Study||230
8481184|NCT00601367|20901219|P1|NOT COMPLETED|Overall Study||187
8481185|NCT00601367|20901219|P1|COMPLETED|Overall Study||293
8481186|NCT00601367|20901219|P1|STARTED|Overall Study||480
8481187|NCT00601354|20901225|P2|NOT COMPLETED|Overall Study||5
8481188|NCT00601354|20901226|P1|NOT COMPLETED|Overall Study||4
8481189|NCT00601354|20901225|P2|COMPLETED|Overall Study||4
8481190|NCT00601354|20901226|P1|COMPLETED|Overall Study||4
8481191|NCT00601354|20901225|P2|STARTED|Overall Study||9
8481192|NCT00601354|20901226|P1|STARTED|Overall Study||8
8481193|NCT00601250|20901238|P2|NOT COMPLETED|Overall Study||39
8481194|NCT00601250|20901239|P1|NOT COMPLETED|Overall Study||14
8481195|NCT00601250|20901238|P2|COMPLETED|Overall Study|number who completed treatment|484
8481196|NCT00601250|20901239|P1|COMPLETED|Overall Study|number who completed treatment|163
8481339|NCT00600704|20901621|P1|NOT COMPLETED|Overall Study||0
8481197|NCT00601250|20901238|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
8481198|NCT00601250|20901239|P1|STARTED|Overall Study|number who started treatment|177
8481199|NCT00601172|20901275|P2|NOT COMPLETED|Overall Study||127
8481200|NCT00601172|20901276|P1|NOT COMPLETED|Overall Study||141
8481201|NCT00601172|20901275|P2|COMPLETED|Overall Study||228
8481202|NCT00601172|20901276|P1|COMPLETED|Overall Study||214
8481203|NCT00601172|20901275|P2|STARTED|Overall Study||355
8481204|NCT00601172|20901276|P1|STARTED|Overall Study||355
8481205|NCT00601146|20901325|P1|NOT COMPLETED|Overall Study||0
8481206|NCT00601146|20901325|P1|COMPLETED|Overall Study||39
8481207|NCT00601146|20901325|P1|STARTED|Overall Study||39
8481208|NCT00601107|20901333|P4|NOT COMPLETED|Overall Study||12
8481209|NCT00601107|20901334|P3|NOT COMPLETED|Overall Study||12
8481210|NCT00601107|20901335|P2|NOT COMPLETED|Overall Study||9
8481211|NCT00601107|20901336|P1|NOT COMPLETED|Overall Study||13
8481212|NCT00601107|20901333|P4|COMPLETED|Overall Study||13
8481213|NCT00601107|20901334|P3|COMPLETED|Overall Study||16
8481214|NCT00601107|20901335|P2|COMPLETED|Overall Study||22
8481215|NCT00601107|20901336|P1|COMPLETED|Overall Study||14
8481216|NCT00601107|20901333|P4|Treated|Overall Study||25
8481217|NCT00601107|20901334|P3|Treated|Overall Study||28
8481218|NCT00601107|20901335|P2|Treated|Overall Study||31
8481219|NCT00601107|20901336|P1|Treated|Overall Study||27
8481220|NCT00601107|20901333|P4|STARTED|Overall Study||25
8481221|NCT00601107|20901334|P3|STARTED|Overall Study||28
8481222|NCT00601107|20901335|P2|STARTED|Overall Study||31
8481223|NCT00601107|20901336|P1|STARTED|Overall Study|Randomized.|27
8481224|NCT00600938|20901356|P4|NOT COMPLETED|Extension Study||1
8481225|NCT00600938|20901357|P3|NOT COMPLETED|Extension Study||9
8481226|NCT00600938|20901358|P2|NOT COMPLETED|Extension Study||5
8481227|NCT00600938|20901359|P1|NOT COMPLETED|Extension Study||9
8481228|NCT00600938|20901356|P4|COMPLETED|Extension Study||0
8481229|NCT00600938|20901357|P3|COMPLETED|Extension Study||33
8481230|NCT00600938|20901358|P2|COMPLETED|Extension Study||24
8481231|NCT00600938|20901359|P1|COMPLETED|Extension Study||65
8481232|NCT00600938|20901356|P4|Extension Safety Set|Extension Study||1
8481233|NCT00600938|20901357|P3|Extension Safety Set|Extension Study||42
8481234|NCT00600938|20901358|P2|Extension Safety Set|Extension Study||29
8481235|NCT00600938|20901359|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
8481236|NCT00600938|20901356|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
8481237|NCT00600938|20901357|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
8481238|NCT00600938|20901358|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
8481239|NCT00600938|20901359|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
8481240|NCT00600938|20901356|P4|NOT COMPLETED|Core Study||0
8481241|NCT00600938|20901357|P3|NOT COMPLETED|Core Study||0
8481242|NCT00600938|20901358|P2|NOT COMPLETED|Core Study||21
8481243|NCT00600938|20901359|P1|NOT COMPLETED|Core Study||16
8481244|NCT00600938|20901356|P4|COMPLETED|Core Study||0
8481245|NCT00600938|20901357|P3|COMPLETED|Core Study||0
8481246|NCT00600938|20901358|P2|COMPLETED|Core Study||78
8481247|NCT00600938|20901359|P1|COMPLETED|Core Study||82
8481248|NCT00600938|20901356|P4|Per Protocol Set (PPS)|Core Study||0
8481249|NCT00600938|20901357|P3|Per Protocol Set (PPS)|Core Study||0
8481250|NCT00600938|20901358|P2|Per Protocol Set (PPS)|Core Study||81
8481251|NCT00600938|20901359|P1|Per Protocol Set (PPS)|Core Study||91
8481252|NCT00600938|20901356|P4|Core Safety Set|Core Study||0
8481253|NCT00600938|20901357|P3|Core Safety Set|Core Study||0
8481254|NCT00600938|20901358|P2|Core Safety Set|Core Study||91
8481255|NCT00600938|20901359|P1|Core Safety Set|Core Study||96
8481256|NCT00600938|20901356|P4|STARTED|Core Study||0
8481257|NCT00600938|20901357|P3|STARTED|Core Study||0
8481258|NCT00600938|20901358|P2|STARTED|Core Study||99
8481259|NCT00600938|20901359|P1|STARTED|Core Study||98
8481260|NCT00600886|20901423|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
8481261|NCT00600886|20901424|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
8481262|NCT00600886|20901423|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
8481263|NCT00600886|20901424|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
8481264|NCT00600886|20901423|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
8481265|NCT00600886|20901424|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
8481266|NCT00600886|20901423|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
8481267|NCT00600886|20901424|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
8481268|NCT00600886|20901423|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
8481269|NCT00600886|20901424|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
8481270|NCT00600886|20901423|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
8481271|NCT00600886|20901424|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
8481272|NCT00600886|20901423|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
8481273|NCT00600886|20901424|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
8481274|NCT00600886|20901423|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
8481275|NCT00600886|20901424|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
8481276|NCT00600886|20901423|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
8481277|NCT00600886|20901424|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
8481278|NCT00600886|20901423|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
8481279|NCT00600886|20901424|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
8481280|NCT00600886|20901423|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
8481281|NCT00600886|20901424|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
8481282|NCT00600886|20901423|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
8481283|NCT00600886|20901424|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
8481284|NCT00600886|20901423|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
8481285|NCT00600886|20901424|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
8481286|NCT00600886|20901423|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
8481287|NCT00600886|20901424|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
8481288|NCT00600886|20901423|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
8481289|NCT00600886|20901424|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
8481290|NCT00600886|20901423|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
8481291|NCT00600886|20901424|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
8481292|NCT00600886|20901423|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
8481293|NCT00600886|20901424|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
8481294|NCT00600886|20901423|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
8481295|NCT00600886|20901424|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
8481296|NCT00600886|20901423|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
8481297|NCT00600886|20901424|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
8481298|NCT00600886|20901423|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
8481299|NCT00600886|20901424|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
8481300|NCT00600821|20901488|P2|NOT COMPLETED|Overall Study||60
8481301|NCT00600821|20901489|P1|NOT COMPLETED|Overall Study||58
8481302|NCT00600821|20901488|P2|COMPLETED|Overall Study||0
8481303|NCT00600821|20901489|P1|COMPLETED|Overall Study||0
8481304|NCT00600821|20901488|P2|Treated|Overall Study||59
8481305|NCT00600821|20901489|P1|Treated|Overall Study||58
8481306|NCT00600821|20901488|P2|STARTED|Overall Study||60
8481307|NCT00600821|20901489|P1|STARTED|Overall Study||58
8481308|NCT00600756|20901517|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
8481309|NCT00600756|20901518|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
8481310|NCT00600756|20901517|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
8481311|NCT00600756|20901518|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
8481312|NCT00600756|20901517|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
8481313|NCT00600756|20901518|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
8481314|NCT00600756|20901517|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
8481315|NCT00600756|20901518|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
8481316|NCT00600756|20901517|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
8481317|NCT00600756|20901518|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
8481318|NCT00600756|20901517|P2|STARTED|Overall Study Analysis After 12 Months||403
8481319|NCT00600756|20901518|P1|STARTED|Overall Study Analysis After 12 Months||395
8481320|NCT00600756|20901517|P2|NOT COMPLETED|Analysis After 6 Months||120
8481321|NCT00600756|20901518|P1|NOT COMPLETED|Analysis After 6 Months||131
8481322|NCT00600756|20901517|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
8481323|NCT00600756|20901518|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
8481324|NCT00600756|20901517|P2|STARTED|Analysis After 6 Months||403
8481325|NCT00600756|20901518|P1|STARTED|Analysis After 6 Months||395
8481326|NCT00600743|20901588|P4|NOT COMPLETED|Overall Study||0
8481327|NCT00600743|20901589|P3|NOT COMPLETED|Overall Study||0
8481328|NCT00600743|20901590|P2|NOT COMPLETED|Overall Study||0
8481329|NCT00600743|20901591|P1|NOT COMPLETED|Overall Study||0
8481330|NCT00600743|20901588|P4|COMPLETED|Overall Study||7
8481331|NCT00600743|20901589|P3|COMPLETED|Overall Study||8
8481332|NCT00600743|20901590|P2|COMPLETED|Overall Study||4
8481333|NCT00600743|20901591|P1|COMPLETED|Overall Study||4
8481334|NCT00600743|20901588|P4|STARTED|Overall Study||7
8481335|NCT00600743|20901589|P3|STARTED|Overall Study||8
8481336|NCT00600743|20901590|P2|STARTED|Overall Study||4
8481337|NCT00600743|20901591|P1|STARTED|Overall Study||4
8481338|NCT00600704|20901620|P2|NOT COMPLETED|Overall Study||0
8481340|NCT00600704|20901620|P2|COMPLETED|Overall Study||92
8481341|NCT00600704|20901621|P1|COMPLETED|Overall Study||100
8481342|NCT00600704|20901620|P2|STARTED|Overall Study||92
8481343|NCT00600704|20901621|P1|STARTED|Overall Study||100
8481344|NCT00600613|20901627|P1|NOT COMPLETED|Overall Study||1
8481345|NCT00600613|20901627|P1|COMPLETED|Overall Study||5
8481346|NCT00600613|20901627|P1|STARTED|Overall Study||6
8481347|NCT00600353|20901633|P2|NOT COMPLETED|Overall Study||1
8481348|NCT00600353|20901634|P1|NOT COMPLETED|Overall Study||1
8481349|NCT00600353|20901633|P2|COMPLETED|Overall Study||9
8481350|NCT00600353|20901634|P1|COMPLETED|Overall Study||9
8481351|NCT00600353|20901633|P2|STARTED|Overall Study||10
8481352|NCT00600353|20901634|P1|STARTED|Overall Study||10
8481353|NCT00600340|20901648|P2|NOT COMPLETED|Overall Study||0
8481354|NCT00600340|20901649|P1|NOT COMPLETED|Overall Study||0
8481355|NCT00600340|20901648|P2|COMPLETED|Overall Study||279
8481356|NCT00600340|20901649|P1|COMPLETED|Overall Study||285
8481357|NCT00600340|20901648|P2|STARTED|Overall Study||279
8481358|NCT00600340|20901649|P1|STARTED|Overall Study||285
8481359|NCT00600171|20901697|P6|NOT COMPLETED|Overall Study||5
8481360|NCT00600171|20901698|P5|NOT COMPLETED|Overall Study||8
8481361|NCT00600171|20901699|P4|NOT COMPLETED|Overall Study||12
8481362|NCT00600171|20901700|P3|NOT COMPLETED|Overall Study||10
8481363|NCT00600171|20901701|P2|NOT COMPLETED|Overall Study||17
8481364|NCT00600171|20901702|P1|NOT COMPLETED|Overall Study||16
8481365|NCT00600171|20901697|P6|COMPLETED|Overall Study||97
8481366|NCT00600171|20901698|P5|COMPLETED|Overall Study||93
8481367|NCT00600171|20901699|P4|COMPLETED|Overall Study||88
8481368|NCT00600171|20901700|P3|COMPLETED|Overall Study||91
8481369|NCT00600171|20901701|P2|COMPLETED|Overall Study||84
8481370|NCT00600171|20901702|P1|COMPLETED|Overall Study||86
8481371|NCT00600171|20901697|P6|STARTED|Overall Study||102
8481372|NCT00600171|20901698|P5|STARTED|Overall Study||101
8481373|NCT00600171|20901699|P4|STARTED|Overall Study||100
8481374|NCT00600171|20901700|P3|STARTED|Overall Study||101
8481375|NCT00600171|20901701|P2|STARTED|Overall Study||101
8481376|NCT00600171|20901702|P1|STARTED|Overall Study||102
8481377|NCT00600119|20901776|P6|NOT COMPLETED|Follow-up Period||1
8481378|NCT00600119|20901777|P5|NOT COMPLETED|Follow-up Period||0
8481379|NCT00600119|20901778|P4|NOT COMPLETED|Follow-up Period||0
8481380|NCT00600119|20901779|P3|NOT COMPLETED|Follow-up Period||0
8481381|NCT00600119|20901780|P2|NOT COMPLETED|Follow-up Period||0
8481382|NCT00600119|20901781|P1|NOT COMPLETED|Follow-up Period||1
8481383|NCT00600119|20901776|P6|COMPLETED|Follow-up Period||20
8481384|NCT00600119|20901777|P5|COMPLETED|Follow-up Period||31
8481385|NCT00600119|20901778|P4|COMPLETED|Follow-up Period||28
8481386|NCT00600119|20901779|P3|COMPLETED|Follow-up Period||27
8481387|NCT00600119|20901780|P2|COMPLETED|Follow-up Period||28
8481388|NCT00600119|20901781|P1|COMPLETED|Follow-up Period||26
8481389|NCT00600119|20901776|P6|STARTED|Follow-up Period||21
8481390|NCT00600119|20901777|P5|STARTED|Follow-up Period||31
8481391|NCT00600119|20901778|P4|STARTED|Follow-up Period||28
8481392|NCT00600119|20901779|P3|STARTED|Follow-up Period||27
8481393|NCT00600119|20901780|P2|STARTED|Follow-up Period||28
8481394|NCT00600119|20901781|P1|STARTED|Follow-up Period||27
8481395|NCT00600119|20901776|P6|NOT COMPLETED|Double-blind Treatment Period||14
8481396|NCT00600119|20901777|P5|NOT COMPLETED|Double-blind Treatment Period||6
8481397|NCT00600119|20901778|P4|NOT COMPLETED|Double-blind Treatment Period||2
8481398|NCT00600119|20901779|P3|NOT COMPLETED|Double-blind Treatment Period||0
8481399|NCT00600119|20901780|P2|NOT COMPLETED|Double-blind Treatment Period||5
8481400|NCT00600119|20901781|P1|NOT COMPLETED|Double-blind Treatment Period||5
8481401|NCT00600119|20901776|P6|COMPLETED|Double-blind Treatment Period||21
8481402|NCT00600119|20901777|P5|COMPLETED|Double-blind Treatment Period||31
8481403|NCT00600119|20901778|P4|COMPLETED|Double-blind Treatment Period||28
8481404|NCT00600119|20901779|P3|COMPLETED|Double-blind Treatment Period||27
8481405|NCT00600119|20901780|P2|COMPLETED|Double-blind Treatment Period||28
8481406|NCT00600119|20901781|P1|COMPLETED|Double-blind Treatment Period||27
8481407|NCT00600119|20901776|P6|STARTED|Double-blind Treatment Period||35
8481408|NCT00600119|20901777|P5|STARTED|Double-blind Treatment Period||37
8481409|NCT00600119|20901778|P4|STARTED|Double-blind Treatment Period||30
8481410|NCT00600119|20901779|P3|STARTED|Double-blind Treatment Period||27
8481411|NCT00600119|20901780|P2|STARTED|Double-blind Treatment Period||33
8481412|NCT00600119|20901781|P1|STARTED|Double-blind Treatment Period||32
8481413|NCT00600119|20901776|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481414|NCT00600119|20901777|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481415|NCT00600119|20901778|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
8481416|NCT00600119|20901779|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481417|NCT00600119|20901780|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481418|NCT00600119|20901781|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
8481419|NCT00600119|20901776|P6|COMPLETED|Single-blind Placebo run-in Period||35
8481420|NCT00600119|20901777|P5|COMPLETED|Single-blind Placebo run-in Period||37
8481421|NCT00600119|20901778|P4|COMPLETED|Single-blind Placebo run-in Period||30
8481422|NCT00600119|20901779|P3|COMPLETED|Single-blind Placebo run-in Period||27
8481423|NCT00600119|20901780|P2|COMPLETED|Single-blind Placebo run-in Period||33
8481424|NCT00600119|20901781|P1|COMPLETED|Single-blind Placebo run-in Period||32
8481425|NCT00600119|20901776|P6|STARTED|Single-blind Placebo run-in Period||37
8481426|NCT00600119|20901777|P5|STARTED|Single-blind Placebo run-in Period||39
8481427|NCT00600119|20901778|P4|STARTED|Single-blind Placebo run-in Period||31
8481428|NCT00600119|20901779|P3|STARTED|Single-blind Placebo run-in Period||29
8481429|NCT00600119|20901780|P2|STARTED|Single-blind Placebo run-in Period||35
8481430|NCT00600119|20901781|P1|STARTED|Single-blind Placebo run-in Period||36
8481431|NCT00600106|20901815|P2|NOT COMPLETED|Overall Study||1
8481432|NCT00600106|20901816|P1|NOT COMPLETED|Overall Study||1
8481433|NCT00600106|20901815|P2|COMPLETED|Overall Study||18
8481434|NCT00600106|20901816|P1|COMPLETED|Overall Study||17
8481435|NCT00600106|20901815|P2|STARTED|Overall Study||19
8481436|NCT00600106|20901816|P1|STARTED|Overall Study||18
8481437|NCT00600080|20901848|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
8481438|NCT00600080|20901849|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
8481439|NCT00600080|20901848|P2|COMPLETED|Period 2: One-week to Two-weeks||32
8481440|NCT00600080|20901849|P1|COMPLETED|Period 2: One-week to Two-weeks||28
8481441|NCT00600080|20901848|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
8481442|NCT00600080|20901849|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
8481443|NCT00600080|20901848|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
8481444|NCT00600080|20901849|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
8481445|NCT00600080|20901848|P2|COMPLETED|Period 1: Baseline to One-week||32
8481446|NCT00600080|20901849|P1|COMPLETED|Period 1: Baseline to One-week||28
8481447|NCT00600080|20901848|P2|STARTED|Period 1: Baseline to One-week||32
8481448|NCT00600080|20901849|P1|STARTED|Period 1: Baseline to One-week||28
8481449|NCT00600067|20901863|P2|NOT COMPLETED|Overall Study||7
8481450|NCT00600067|20901864|P1|NOT COMPLETED|Overall Study||3
8481451|NCT00600067|20901863|P2|COMPLETED|Overall Study||68
8481452|NCT00600067|20901864|P1|COMPLETED|Overall Study||52
8481453|NCT00600067|20901863|P2|STARTED|Overall Study||75
8481454|NCT00600067|20901864|P1|STARTED|Overall Study||55
8481455|NCT00600028|20901874|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
8481456|NCT00600028|20901875|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8481457|NCT00600028|20901874|P2|COMPLETED|Second Intervention (12 Weeks)||8
8481458|NCT00600028|20901875|P1|COMPLETED|Second Intervention (12 Weeks)||12
8481459|NCT00600028|20901874|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
8481460|NCT00600028|20901875|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
8481461|NCT00600028|20901874|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8481462|NCT00600028|20901875|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
8481463|NCT00600028|20901874|P2|COMPLETED|First Intervention (12 Weeks)||10
8481464|NCT00600028|20901875|P1|COMPLETED|First Intervention (12 Weeks)||12
8481465|NCT00600028|20901874|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
8481466|NCT00600028|20901875|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
8481467|NCT00600015|20901889|P2|NOT COMPLETED|Overall Study||35
8481468|NCT00600015|20901890|P1|NOT COMPLETED|Overall Study||60
8481469|NCT00600015|20901889|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
8481470|NCT00600015|20901890|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
8481471|NCT00600015|20901889|P2|STARTED|Overall Study||55
8481472|NCT00600015|20901890|P1|STARTED|Overall Study||111
8481473|NCT00599924|20901905|P7|NOT COMPLETED|Overall Study||5
8481474|NCT00599924|20901906|P6|NOT COMPLETED|Overall Study||4
8481475|NCT00599924|20901907|P5|NOT COMPLETED|Overall Study||6
8481476|NCT00599924|20901908|P4|NOT COMPLETED|Overall Study||8
8481477|NCT00599924|20901909|P3|NOT COMPLETED|Overall Study||2
8481478|NCT00599924|20901910|P2|NOT COMPLETED|Overall Study||5
8481479|NCT00599924|20901911|P1|NOT COMPLETED|Overall Study||3
8481480|NCT00599924|20901905|P7|COMPLETED|Overall Study||3
8481481|NCT00599924|20901906|P6|COMPLETED|Overall Study||2
8481482|NCT00599924|20901907|P5|COMPLETED|Overall Study||3
8481483|NCT00599924|20901908|P4|COMPLETED|Overall Study||4
8481484|NCT00599924|20901909|P3|COMPLETED|Overall Study||3
8481485|NCT00599924|20901910|P2|COMPLETED|Overall Study||4
8481486|NCT00599924|20901911|P1|COMPLETED|Overall Study||1
8481487|NCT00599924|20901905|P7|STARTED|Overall Study||8
8481488|NCT00599924|20901906|P6|STARTED|Overall Study||6
8481489|NCT00599924|20901907|P5|STARTED|Overall Study||9
8481490|NCT00599924|20901908|P4|STARTED|Overall Study||12
8481491|NCT00599924|20901909|P3|STARTED|Overall Study||5
8481492|NCT00599924|20901910|P2|STARTED|Overall Study||9
8481493|NCT00599924|20901911|P1|STARTED|Overall Study||4
8481494|NCT00599872|20901998|P2|NOT COMPLETED|Overall Study||33
8481495|NCT00599872|20901999|P1|NOT COMPLETED|Overall Study||49
8481496|NCT00599872|20901998|P2|COMPLETED|Overall Study||181
8481497|NCT00599872|20901999|P1|COMPLETED|Overall Study||167
8481498|NCT00599872|20901998|P2|STARTED|Overall Study||214
8481499|NCT00599872|20901999|P1|STARTED|Overall Study||216
8481500|NCT00599755|20902015|P1|NOT COMPLETED|Overall Study||19
8481501|NCT00599755|20902015|P1|COMPLETED|Overall Study||49
8481502|NCT00599755|20902015|P1|STARTED|Overall Study||68
8481509|NCT00599339|20902041|P1|NOT COMPLETED|Overall Study||664
8481510|NCT00599339|20902041|P1|COMPLETED|Overall Study||1531
8481511|NCT00599339|20902041|P1|Safety Set|Overall Study||2179
8481512|NCT00599339|20902041|P1|STARTED|Overall Study||2195
8481513|NCT00599326|20902143|P1|NOT COMPLETED|Overall Study||2
8481514|NCT00599326|20902143|P1|COMPLETED|Overall Study||8
8481515|NCT00599326|20902143|P1|STARTED|Overall Study||10
8481516|NCT00599313|20902148|P1|NOT COMPLETED|Overall Study||36
8481517|NCT00599313|20902148|P1|COMPLETED|Overall Study||0
8481518|NCT00599313|20902148|P1|STARTED|Overall Study||36
8481519|NCT00599248|20902159|P4|NOT COMPLETED|Overall Study||0
8481520|NCT00599248|20902160|P3|NOT COMPLETED|Overall Study||0
8481521|NCT00599248|20902161|P2|NOT COMPLETED|Overall Study||0
8481522|NCT00599248|20902162|P1|NOT COMPLETED|Overall Study||0
8481523|NCT00599248|20902159|P4|COMPLETED|Overall Study||3
8481524|NCT00599248|20902160|P3|COMPLETED|Overall Study||3
8481525|NCT00599248|20902161|P2|COMPLETED|Overall Study||3
8481526|NCT00599248|20902162|P1|COMPLETED|Overall Study||3
8481527|NCT00599248|20902159|P4|STARTED|Overall Study||3
8481528|NCT00599248|20902160|P3|STARTED|Overall Study||3
8481529|NCT00599248|20902161|P2|STARTED|Overall Study||3
8481530|NCT00599248|20902162|P1|STARTED|Overall Study||3
8481531|NCT00599196|20902190|P1|NOT COMPLETED|Overall Study||381
8481532|NCT00599196|20902190|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8481533|NCT00599196|20902190|P1|STARTED|Overall Study||381
8481534|NCT00599131|20902196|P1|NOT COMPLETED|Overall Study||0
8481535|NCT00599131|20902196|P1|COMPLETED|Overall Study||4
8481536|NCT00599131|20902196|P1|STARTED|Overall Study||4
8481537|NCT00599053|20902206|P2|NOT COMPLETED|Overall Study||0
8481538|NCT00599053|20902207|P1|NOT COMPLETED|Overall Study||0
8481539|NCT00599053|20902206|P2|COMPLETED|Overall Study||2
8481540|NCT00599053|20902207|P1|COMPLETED|Overall Study||5
8481541|NCT00599053|20902206|P2|STARTED|Overall Study||2
8481542|NCT00599053|20902207|P1|STARTED|Overall Study||5
8481543|NCT00599027|20902221|P2|NOT COMPLETED|Overall Study||3
8481544|NCT00599027|20902222|P1|NOT COMPLETED|Overall Study||1
8481545|NCT00599027|20902221|P2|COMPLETED|Overall Study||22
8481546|NCT00599027|20902222|P1|COMPLETED|Overall Study||25
8481547|NCT00599027|20902221|P2|STARTED|Overall Study||25
8481548|NCT00599027|20902222|P1|STARTED|Overall Study||26
8481549|NCT00599014|20902228|P1|NOT COMPLETED|Overall Study||0
8481550|NCT00599014|20902228|P1|COMPLETED|Overall Study||335
8481551|NCT00599014|20902228|P1|STARTED|Overall Study||335
8481552|NCT00598871|20902235|P2|NOT COMPLETED|Overall Study||1
8481553|NCT00598871|20902236|P1|NOT COMPLETED|Overall Study||0
8481554|NCT00598871|20902235|P2|COMPLETED|Overall Study||8
8481555|NCT00598871|20902236|P1|COMPLETED|Overall Study||3
8481556|NCT00598871|20902235|P2|STARTED|Overall Study||9
8481557|NCT00598871|20902236|P1|STARTED|Overall Study||3
8481564|NCT00598819|20902261|P1|NOT COMPLETED|Overall Study||0
8481565|NCT00598819|20902261|P1|COMPLETED|Overall Study||14
8481566|NCT00598819|20902261|P1|STARTED|Overall Study||14
8481567|NCT00598806|20902271|P2|NOT COMPLETED|Overall Study||64
8481568|NCT00598806|20902272|P1|NOT COMPLETED|Overall Study||73
8481569|NCT00598806|20902271|P2|COMPLETED|Overall Study||346
8481570|NCT00598806|20902272|P1|COMPLETED|Overall Study||329
8481571|NCT00598806|20902271|P2|STARTED|Overall Study||410
8481572|NCT00598806|20902272|P1|STARTED|Overall Study||402
8481573|NCT00598702|20902300|P8|NOT COMPLETED|Overall Study||0
8481574|NCT00598702|20902301|P7|NOT COMPLETED|Overall Study||1
8481575|NCT00598702|20902302|P6|NOT COMPLETED|Overall Study||12
8481576|NCT00598702|20902303|P5|NOT COMPLETED|Overall Study||3
8481577|NCT00598702|20902304|P4|NOT COMPLETED|Overall Study||8
8481578|NCT00598702|20902305|P3|NOT COMPLETED|Overall Study||2
8481579|NCT00598702|20902306|P2|NOT COMPLETED|Overall Study||2
8481580|NCT00598702|20902307|P1|NOT COMPLETED|Overall Study||0
8481581|NCT00598702|20902300|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
8481582|NCT00598702|20902301|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
8481583|NCT00598702|20902302|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
8481584|NCT00598702|20902303|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
8481585|NCT00598702|20902304|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
8481586|NCT00598702|20902305|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
8481587|NCT00598702|20902306|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
8481588|NCT00598702|20902307|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
8481589|NCT00598702|20902300|P8|STARTED|Overall Study||4
8481590|NCT00598702|20902301|P7|STARTED|Overall Study||1
8481591|NCT00598702|20902302|P6|STARTED|Overall Study||42
8481592|NCT00598702|20902303|P5|STARTED|Overall Study||9
8481593|NCT00598702|20902304|P4|STARTED|Overall Study||33
8481594|NCT00598702|20902305|P3|STARTED|Overall Study||7
8481595|NCT00598702|20902306|P2|STARTED|Overall Study||3
8481596|NCT00598702|20902307|P1|STARTED|Overall Study||1
8481597|NCT00598689|20902351|P2|NOT COMPLETED|Overall Study||0
8481598|NCT00598689|20902352|P1|NOT COMPLETED|Overall Study||0
8481599|NCT00598689|20902351|P2|COMPLETED|Overall Study||40
8481600|NCT00598689|20902352|P1|COMPLETED|Overall Study||40
8481601|NCT00598689|20902351|P2|STARTED|Overall Study||40
8481602|NCT00598689|20902352|P1|STARTED|Overall Study||40
8481603|NCT00598663|20902364|P2|NOT COMPLETED|Second Intervention (6 Months)||1
8481604|NCT00598663|20902365|P1|NOT COMPLETED|Second Intervention (6 Months)||4
8481605|NCT00598663|20902364|P2|COMPLETED|Second Intervention (6 Months)||69
8481606|NCT00598663|20902365|P1|COMPLETED|Second Intervention (6 Months)||69
8481607|NCT00598663|20902364|P2|STARTED|Second Intervention (6 Months)||70
8481608|NCT00598663|20902365|P1|STARTED|Second Intervention (6 Months)||73
8481609|NCT00598663|20902364|P2|NOT COMPLETED|Washout (4 Months)||1
8481610|NCT00598663|20902365|P1|NOT COMPLETED|Washout (4 Months)||0
8481611|NCT00598663|20902364|P2|COMPLETED|Washout (4 Months)||70
8481612|NCT00598663|20902365|P1|COMPLETED|Washout (4 Months)||73
8481613|NCT00598663|20902364|P2|STARTED|Washout (4 Months)||71
8481614|NCT00598663|20902365|P1|STARTED|Washout (4 Months)||73
8481615|NCT00598663|20902364|P2|NOT COMPLETED|First Intervention (6 Months)||6
8481616|NCT00598663|20902365|P1|NOT COMPLETED|First Intervention (6 Months)||3
8481617|NCT00598663|20902364|P2|COMPLETED|First Intervention (6 Months)||71
8481618|NCT00598663|20902365|P1|COMPLETED|First Intervention (6 Months)||73
8481619|NCT00598663|20902364|P2|STARTED|First Intervention (6 Months)||77
8481620|NCT00598663|20902365|P1|STARTED|First Intervention (6 Months)||76
8481621|NCT00598650|20902383|P1|NOT COMPLETED|Overall Study||27
8481622|NCT00598650|20902383|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
8481623|NCT00598650|20902383|P1|STARTED|Overall Study||108
8481624|NCT00598585|20902392|P2|NOT COMPLETED|Overall Study||0
8481625|NCT00598585|20902393|P1|NOT COMPLETED|Overall Study||1
8481626|NCT00598585|20902392|P2|COMPLETED|Overall Study||6
8481627|NCT00598585|20902393|P1|COMPLETED|Overall Study||5
8481628|NCT00598585|20902392|P2|STARTED|Overall Study||6
8481629|NCT00598585|20902393|P1|STARTED|Overall Study||6
8481630|NCT00598559|20902402|P3|NOT COMPLETED|Overall Study||3
8481631|NCT00598559|20902403|P2|NOT COMPLETED|Overall Study||28
8481632|NCT00598559|20902404|P1|NOT COMPLETED|Overall Study||27
8481633|NCT00598559|20902402|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
8481634|NCT00598559|20902403|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
8481635|NCT00598559|20902404|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
8481636|NCT00598559|20902402|P3|STARTED|Overall Study||30
8481637|NCT00598559|20902403|P2|STARTED|Overall Study||91
8481638|NCT00598559|20902404|P1|STARTED|Overall Study||92
8481639|NCT00598507|20902421|P1|NOT COMPLETED|Overall Study||0
8481640|NCT00598507|20902421|P1|COMPLETED|Overall Study||35
8481641|NCT00598507|20902421|P1|STARTED|Overall Study||35
8481642|NCT00598481|20902428|P1|NOT COMPLETED|Treatment||1
8481643|NCT00598481|20902428|P1|COMPLETED|Treatment||11
8481644|NCT00598481|20902428|P1|STARTED|Treatment||12
8481645|NCT00598481|20902428|P1|NOT COMPLETED|Baseline||0
8481646|NCT00598481|20902428|P1|COMPLETED|Baseline||12
8481647|NCT00598481|20902428|P1|STARTED|Baseline||12
8481648|NCT00598442|20902438|P3|NOT COMPLETED|Overall Study||24
8481649|NCT00598442|20902439|P2|NOT COMPLETED|Overall Study||39
8481650|NCT00598442|20902440|P1|NOT COMPLETED|Overall Study||43
8481651|NCT00598442|20902438|P3|COMPLETED|Overall Study||139
8481652|NCT00598442|20902439|P2|COMPLETED|Overall Study||124
8481653|NCT00598442|20902440|P1|COMPLETED|Overall Study||124
8481654|NCT00598442|20902438|P3|STARTED|Overall Study||163
8481655|NCT00598442|20902439|P2|STARTED|Overall Study||163
8481656|NCT00598442|20902440|P1|STARTED|Overall Study||167
8481657|NCT00598273|20902457|P3|NOT COMPLETED|Overall Study||39
8481658|NCT00598273|20902458|P2|NOT COMPLETED|Overall Study||38
8481659|NCT00598273|20902459|P1|NOT COMPLETED|Overall Study||41
8481660|NCT00598273|20902457|P3|COMPLETED|Overall Study||125
8481661|NCT00598273|20902458|P2|COMPLETED|Overall Study||127
8481662|NCT00598273|20902459|P1|COMPLETED|Overall Study||120
8481663|NCT00598273|20902457|P3|STARTED|Overall Study||164
8481664|NCT00598273|20902458|P2|STARTED|Overall Study||165
8481665|NCT00598273|20902459|P1|STARTED|Overall Study||161
8481666|NCT00598078|20902473|P2|NOT COMPLETED|Period 3 (Day 3)||0
8481667|NCT00598078|20902474|P1|NOT COMPLETED|Period 3 (Day 3)||0
8481668|NCT00598078|20902473|P2|COMPLETED|Period 3 (Day 3)||10
8481669|NCT00598078|20902474|P1|COMPLETED|Period 3 (Day 3)||9
8481670|NCT00598078|20902473|P2|STARTED|Period 3 (Day 3)||10
8481671|NCT00598078|20902474|P1|STARTED|Period 3 (Day 3)||9
8481672|NCT00598078|20902473|P2|NOT COMPLETED|Period 2 (Day 2)||0
8481673|NCT00598078|20902474|P1|NOT COMPLETED|Period 2 (Day 2)||1
8481674|NCT00598078|20902473|P2|COMPLETED|Period 2 (Day 2)||10
8481675|NCT00598078|20902474|P1|COMPLETED|Period 2 (Day 2)||9
8481676|NCT00598078|20902473|P2|STARTED|Period 2 (Day 2)||10
8481677|NCT00598078|20902474|P1|STARTED|Period 2 (Day 2)||10
8481678|NCT00598078|20902473|P2|NOT COMPLETED|Period 1 (Day 1)||0
8481679|NCT00598078|20902474|P1|NOT COMPLETED|Period 1 (Day 1)||0
8481680|NCT00598078|20902473|P2|COMPLETED|Period 1 (Day 1)||10
8481681|NCT00598078|20902474|P1|COMPLETED|Period 1 (Day 1)||10
8481682|NCT00598078|20902473|P2|STARTED|Period 1 (Day 1)||10
8481683|NCT00598078|20902474|P1|STARTED|Period 1 (Day 1)||10
8481684|NCT00597935|20902486|P4|NOT COMPLETED|6-Months to 24-Months||8
8481685|NCT00597935|20902487|P3|NOT COMPLETED|6-Months to 24-Months||10
8481686|NCT00597935|20902488|P2|NOT COMPLETED|6-Months to 24-Months||8
8481687|NCT00597935|20902489|P1|NOT COMPLETED|6-Months to 24-Months||17
8481688|NCT00597935|20902486|P4|COMPLETED|6-Months to 24-Months||85
8481689|NCT00597935|20902487|P3|COMPLETED|6-Months to 24-Months||77
8481690|NCT00597935|20902488|P2|COMPLETED|6-Months to 24-Months||79
8481691|NCT00597935|20902489|P1|COMPLETED|6-Months to 24-Months||76
8481692|NCT00597935|20902486|P4|STARTED|6-Months to 24-Months||93
8481693|NCT00597935|20902487|P3|STARTED|6-Months to 24-Months||87
8481694|NCT00597935|20902488|P2|STARTED|6-Months to 24-Months||87
8481695|NCT00597935|20902489|P1|STARTED|6-Months to 24-Months||93
8481696|NCT00597935|20902486|P4|NOT COMPLETED|Baseline to 6-Months||4
8481697|NCT00597935|20902487|P3|NOT COMPLETED|Baseline to 6-Months||4
8481698|NCT00597935|20902488|P2|NOT COMPLETED|Baseline to 6-Months||4
8481699|NCT00597935|20902489|P1|NOT COMPLETED|Baseline to 6-Months||2
8481700|NCT00597935|20902486|P4|COMPLETED|Baseline to 6-Months||93
8481701|NCT00597935|20902487|P3|COMPLETED|Baseline to 6-Months||87
8481702|NCT00597935|20902488|P2|COMPLETED|Baseline to 6-Months||87
8481703|NCT00597935|20902489|P1|COMPLETED|Baseline to 6-Months||93
8481704|NCT00597935|20902486|P4|STARTED|Baseline to 6-Months||97
8481705|NCT00597935|20902487|P3|STARTED|Baseline to 6-Months||91
8481706|NCT00597935|20902488|P2|STARTED|Baseline to 6-Months||91
8481707|NCT00597935|20902489|P1|STARTED|Baseline to 6-Months||95
8481708|NCT00597935|20902486|P4|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481709|NCT00597935|20902487|P3|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481710|NCT00597935|20902488|P2|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481711|NCT00597935|20902489|P1|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481712|NCT00597935|20902486|P4|COMPLETED|Randomized to Surgical and BPMT Arms||97
8481713|NCT00597935|20902487|P3|COMPLETED|Randomized to Surgical and BPMT Arms||91
8481714|NCT00597935|20902488|P2|COMPLETED|Randomized to Surgical and BPMT Arms||91
8481715|NCT00597935|20902489|P1|COMPLETED|Randomized to Surgical and BPMT Arms||95
8481716|NCT00597935|20902486|P4|STARTED|Randomized to Surgical and BPMT Arms||97
8481717|NCT00597935|20902487|P3|STARTED|Randomized to Surgical and BPMT Arms||91
8481718|NCT00597935|20902488|P2|STARTED|Randomized to Surgical and BPMT Arms||91
8481719|NCT00597935|20902489|P1|STARTED|Randomized to Surgical and BPMT Arms||95
8481720|NCT00597909|20902546|P3|NOT COMPLETED|Overall Study||0
8481721|NCT00597909|20902547|P2|NOT COMPLETED|Overall Study||0
8481722|NCT00597909|20902548|P1|NOT COMPLETED|Overall Study||0
8481723|NCT00597909|20902546|P3|COMPLETED|Overall Study||0
8481724|NCT00597909|20902547|P2|COMPLETED|Overall Study||0
8481725|NCT00597909|20902548|P1|COMPLETED|Overall Study||0
8481726|NCT00597909|20902546|P3|STARTED|Overall Study||0
8481727|NCT00597909|20902547|P2|STARTED|Overall Study||0
8481728|NCT00597909|20902548|P1|STARTED|Overall Study||0
8481729|NCT00597896|20902558|P2|NOT COMPLETED|Overall Study||2
8481730|NCT00597896|20902559|P1|NOT COMPLETED|Overall Study||3
8481731|NCT00597896|20902558|P2|COMPLETED|Overall Study||24
8481732|NCT00597896|20902559|P1|COMPLETED|Overall Study||21
8481733|NCT00597896|20902558|P2|STARTED|Overall Study||26
8481734|NCT00597896|20902559|P1|STARTED|Overall Study||24
8481735|NCT00597818|20902589|P4|NOT COMPLETED|Overall Study||10
8481736|NCT00597818|20902590|P3|NOT COMPLETED|Overall Study||19
8481737|NCT00597818|20902591|P2|NOT COMPLETED|Overall Study||16
8481738|NCT00597818|20902592|P1|NOT COMPLETED|Overall Study||18
8481739|NCT00597818|20902589|P4|COMPLETED|Overall Study||20
8481740|NCT00597818|20902590|P3|COMPLETED|Overall Study||12
8481741|NCT00597818|20902591|P2|COMPLETED|Overall Study||14
8481742|NCT00597818|20902592|P1|COMPLETED|Overall Study||12
8481743|NCT00597818|20902589|P4|STARTED|Overall Study||30
8481744|NCT00597818|20902590|P3|STARTED|Overall Study||31
8481745|NCT00597818|20902591|P2|STARTED|Overall Study||30
8481746|NCT00597818|20902592|P1|STARTED|Overall Study||30
8481747|NCT00597766|20902617|P3|NOT COMPLETED|Follow-up 3, Week 12||0
8481748|NCT00597766|20902618|P2|NOT COMPLETED|Follow-up 3, Week 12||0
8481749|NCT00597766|20902619|P1|NOT COMPLETED|Follow-up 3, Week 12||0
8481750|NCT00597766|20902617|P3|COMPLETED|Follow-up 3, Week 12||9
8481751|NCT00597766|20902618|P2|COMPLETED|Follow-up 3, Week 12||9
8481752|NCT00597766|20902619|P1|COMPLETED|Follow-up 3, Week 12||8
8481753|NCT00597766|20902617|P3|STARTED|Follow-up 3, Week 12||9
8481754|NCT00597766|20902618|P2|STARTED|Follow-up 3, Week 12||9
8481755|NCT00597766|20902619|P1|STARTED|Follow-up 3, Week 12||8
8481756|NCT00597766|20902617|P3|NOT COMPLETED|Follow-up 2, Week 8||1
8481757|NCT00597766|20902618|P2|NOT COMPLETED|Follow-up 2, Week 8||0
8481758|NCT00597766|20902619|P1|NOT COMPLETED|Follow-up 2, Week 8||0
8481759|NCT00597766|20902617|P3|COMPLETED|Follow-up 2, Week 8||9
8481760|NCT00597766|20902618|P2|COMPLETED|Follow-up 2, Week 8||9
8481761|NCT00597766|20902619|P1|COMPLETED|Follow-up 2, Week 8||8
8481762|NCT00597766|20902617|P3|STARTED|Follow-up 2, Week 8||10
8481763|NCT00597766|20902618|P2|STARTED|Follow-up 2, Week 8||9
8481764|NCT00597766|20902619|P1|STARTED|Follow-up 2, Week 8||8
8481765|NCT00597766|20902617|P3|NOT COMPLETED|Follow-up 1, Week 4||0
8481766|NCT00597766|20902618|P2|NOT COMPLETED|Follow-up 1, Week 4||0
8481767|NCT00597766|20902619|P1|NOT COMPLETED|Follow-up 1, Week 4||1
8481768|NCT00597766|20902617|P3|COMPLETED|Follow-up 1, Week 4||10
8481769|NCT00597766|20902618|P2|COMPLETED|Follow-up 1, Week 4||9
8481770|NCT00597766|20902619|P1|COMPLETED|Follow-up 1, Week 4||8
8481771|NCT00597766|20902617|P3|STARTED|Follow-up 1, Week 4||10
8481772|NCT00597766|20902618|P2|STARTED|Follow-up 1, Week 4||9
8481773|NCT00597766|20902619|P1|STARTED|Follow-up 1, Week 4||9
8481774|NCT00597766|20902617|P3|NOT COMPLETED|Enrolled||0
8481775|NCT00597766|20902618|P2|NOT COMPLETED|Enrolled||0
8481776|NCT00597766|20902619|P1|NOT COMPLETED|Enrolled||0
8481777|NCT00597766|20902617|P3|COMPLETED|Enrolled||10
8481778|NCT00597766|20902618|P2|COMPLETED|Enrolled||9
8481779|NCT00597766|20902619|P1|COMPLETED|Enrolled||9
8481780|NCT00597766|20902617|P3|STARTED|Enrolled||10
8481781|NCT00597766|20902618|P2|STARTED|Enrolled||9
8481782|NCT00597766|20902619|P1|STARTED|Enrolled||9
8481783|NCT00597753|20902638|P2|NOT COMPLETED|Overall Study||69
8481784|NCT00597753|20902639|P1|NOT COMPLETED|Overall Study||166
8481785|NCT00597753|20902638|P2|COMPLETED|Overall Study||202
8481786|NCT00597753|20902639|P1|COMPLETED|Overall Study||366
8481787|NCT00597753|20902638|P2|STARTED|Overall Study||271
8481788|NCT00597753|20902639|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
8481789|NCT00597727|20902653|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
8481790|NCT00597727|20902654|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
8481791|NCT00597727|20902655|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
8481792|NCT00597727|20902656|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
8481793|NCT00597727|20902657|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
8481794|NCT00597727|20902653|P5|COMPLETED|Open-label Extended Maintenance Phase||1
8481795|NCT00597727|20902654|P4|COMPLETED|Open-label Extended Maintenance Phase||14
8481796|NCT00597727|20902655|P3|COMPLETED|Open-label Extended Maintenance Phase||23
8481797|NCT00597727|20902656|P2|COMPLETED|Open-label Extended Maintenance Phase||0
8481798|NCT00597727|20902657|P1|COMPLETED|Open-label Extended Maintenance Phase||0
8481799|NCT00597727|20902653|P5|STARTED|Open-label Extended Maintenance Phase||3
8481800|NCT00597727|20902654|P4|STARTED|Open-label Extended Maintenance Phase||17
8481801|NCT00597727|20902655|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
8481802|NCT00597727|20902656|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
8481803|NCT00597727|20902657|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
8481804|NCT00597727|20902653|P5|NOT COMPLETED|12 Month Blinded Phase||1
8481805|NCT00597727|20902654|P4|NOT COMPLETED|12 Month Blinded Phase||10
8481806|NCT00597727|20902655|P3|NOT COMPLETED|12 Month Blinded Phase||0
8481807|NCT00597727|20902656|P2|NOT COMPLETED|12 Month Blinded Phase||0
8481808|NCT00597727|20902657|P1|NOT COMPLETED|12 Month Blinded Phase||0
8481809|NCT00597727|20902653|P5|COMPLETED|12 Month Blinded Phase||3
8481810|NCT00597727|20902654|P4|COMPLETED|12 Month Blinded Phase||17
8481811|NCT00597727|20902655|P3|COMPLETED|12 Month Blinded Phase||0
8481812|NCT00597727|20902656|P2|COMPLETED|12 Month Blinded Phase||15
8481813|NCT00597727|20902657|P1|COMPLETED|12 Month Blinded Phase||14
8481814|NCT00597727|20902653|P5|STARTED|12 Month Blinded Phase||4
8481815|NCT00597727|20902654|P4|STARTED|12 Month Blinded Phase||27
8481816|NCT00597727|20902655|P3|STARTED|12 Month Blinded Phase||0
8481817|NCT00597727|20902656|P2|STARTED|12 Month Blinded Phase||15
8481818|NCT00597727|20902657|P1|STARTED|12 Month Blinded Phase||14
8481819|NCT00597714|20902673|P3|NOT COMPLETED|Overall Study||10
8481820|NCT00597714|20902674|P2|NOT COMPLETED|Overall Study||46
8481821|NCT00597714|20902675|P1|NOT COMPLETED|Overall Study||56
8481822|NCT00597714|20902673|P3|COMPLETED|Overall Study||84
8481823|NCT00597714|20902674|P2|COMPLETED|Overall Study||11
8481824|NCT00597714|20902675|P1|COMPLETED|Overall Study||24
8481825|NCT00597714|20902673|P3|STARTED|Overall Study||94
8481826|NCT00597714|20902674|P2|STARTED|Overall Study||57
8481827|NCT00597714|20902675|P1|STARTED|Overall Study||80
8481828|NCT00597701|20902687|P2|NOT COMPLETED|Overall Study||8
8481829|NCT00597701|20902688|P1|NOT COMPLETED|Overall Study||7
8481830|NCT00597701|20902687|P2|COMPLETED|Overall Study||13
8481831|NCT00597701|20902688|P1|COMPLETED|Overall Study||18
8481832|NCT00597701|20902687|P2|STARTED|Overall Study||21
8481833|NCT00597701|20902688|P1|STARTED|Overall Study||25
8481834|NCT00597675|20902696|P2|NOT COMPLETED|Open Label Phase||0
8481835|NCT00597675|20902697|P1|NOT COMPLETED|Open Label Phase||0
8481836|NCT00597675|20902696|P2|COMPLETED|Open Label Phase||5
8481837|NCT00597675|20902697|P1|COMPLETED|Open Label Phase||2
8481838|NCT00597675|20902696|P2|STARTED|Open Label Phase||5
8481839|NCT00597675|20902697|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
8481840|NCT00597675|20902696|P2|NOT COMPLETED|Blinded Phase||1
8481841|NCT00597675|20902697|P1|NOT COMPLETED|Blinded Phase||2
8481842|NCT00597675|20902696|P2|COMPLETED|Blinded Phase||5
8481843|NCT00597675|20902697|P1|COMPLETED|Blinded Phase||2
8481844|NCT00597675|20902696|P2|STARTED|Blinded Phase||6
8481845|NCT00597675|20902697|P1|STARTED|Blinded Phase||4
8481846|NCT00597584|20902710|P2|NOT COMPLETED|Overall Study||63
8481847|NCT00597584|20902711|P1|NOT COMPLETED|Overall Study||128
8481848|NCT00597584|20902710|P2|COMPLETED|Overall Study||211
8481849|NCT00597584|20902711|P1|COMPLETED|Overall Study||421
8481850|NCT00597584|20902710|P2|STARTED|Overall Study||274
8481851|NCT00597584|20902711|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
8481852|NCT00597558|20902721|P1|NOT COMPLETED|Overall Study||4
8481853|NCT00597558|20902721|P1|COMPLETED|Overall Study||9
8481854|NCT00597558|20902721|P1|STARTED|Overall Study||13
8481855|NCT00597545|20902729|P2|NOT COMPLETED|Overall Study||0
8481856|NCT00597545|20902730|P1|NOT COMPLETED|Overall Study||0
8481857|NCT00597545|20902729|P2|COMPLETED|Overall Study||6
8481858|NCT00597545|20902730|P1|COMPLETED|Overall Study||4
8481859|NCT00597545|20902729|P2|STARTED|Overall Study||6
8481860|NCT00597545|20902730|P1|STARTED|Overall Study||4
8481861|NCT00597519|20902736|P1|NOT COMPLETED|Overall Study||1
8481862|NCT00597519|20902736|P1|COMPLETED|Overall Study||27
8481863|NCT00597519|20902736|P1|STARTED|Overall Study||28
8481864|NCT00597506|20902740|P1|NOT COMPLETED|Overall Study||1
8481865|NCT00597506|20902740|P1|COMPLETED|Overall Study||49
8481866|NCT00597506|20902740|P1|STARTED|Overall Study||50
8481867|NCT00597493|20902745|P1|NOT COMPLETED|Overall Study||0
8481868|NCT00597493|20902745|P1|COMPLETED|Overall Study||32
8481869|NCT00597493|20902745|P1|STARTED|Overall Study||32
8481870|NCT00597428|20902764|P2|NOT COMPLETED|Overall Study||71
8481871|NCT00597428|20902765|P1|NOT COMPLETED|Overall Study||61
8481872|NCT00597428|20902764|P2|COMPLETED|Overall Study||152
8481873|NCT00597428|20902765|P1|COMPLETED|Overall Study||153
8481874|NCT00597428|20902764|P2|STARTED|Overall Study||223
8481875|NCT00597428|20902765|P1|STARTED|Overall Study||214
8481876|NCT00597402|20902781|P1|NOT COMPLETED|Overall Study||0
8481877|NCT00597402|20902781|P1|COMPLETED|Overall Study||125
8481878|NCT00597402|20902781|P1|STARTED|Overall Study||125
8481879|NCT00597376|20902790|P2|NOT COMPLETED|Overall Study||4
8481880|NCT00597376|20902791|P1|NOT COMPLETED|Overall Study||8
8481881|NCT00597376|20902790|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
8481882|NCT00597376|20902791|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
8481883|NCT00597376|20902790|P2|STARTED|Overall Study||53
8481884|NCT00597376|20902791|P1|STARTED|Overall Study||51
8481885|NCT00597272|20902808|P7|NOT COMPLETED|Overall Study||0
8481886|NCT00597272|20902809|P6|NOT COMPLETED|Overall Study||0
8481887|NCT00597272|20902810|P5|NOT COMPLETED|Overall Study||0
8481888|NCT00597272|20902811|P4|NOT COMPLETED|Overall Study||0
8481889|NCT00597272|20902812|P3|NOT COMPLETED|Overall Study||0
8481890|NCT00597272|20902813|P2|NOT COMPLETED|Overall Study||0
8481891|NCT00597272|20902814|P1|NOT COMPLETED|Overall Study||0
8481892|NCT00597272|20902808|P7|COMPLETED|Overall Study||10
8481893|NCT00597272|20902809|P6|COMPLETED|Overall Study||10
8481894|NCT00597272|20902810|P5|COMPLETED|Overall Study||1
8481895|NCT00597272|20902811|P4|COMPLETED|Overall Study||1
8481896|NCT00597272|20902812|P3|COMPLETED|Overall Study||10
8481897|NCT00597272|20902813|P2|COMPLETED|Overall Study||1
8481898|NCT00597272|20902814|P1|COMPLETED|Overall Study||1
8481899|NCT00597272|20902808|P7|STARTED|Overall Study||10
8481900|NCT00597272|20902809|P6|STARTED|Overall Study||10
8481901|NCT00597272|20902810|P5|STARTED|Overall Study||1
8481902|NCT00597272|20902811|P4|STARTED|Overall Study||1
8481903|NCT00597272|20902812|P3|STARTED|Overall Study||10
8481904|NCT00597272|20902813|P2|STARTED|Overall Study||1
8481905|NCT00597272|20902814|P1|STARTED|Overall Study||1
8481906|NCT00597246|20902830|P1|NOT COMPLETED|Overall Study||0
8481907|NCT00597246|20902830|P1|COMPLETED|Overall Study||30
8481908|NCT00597246|20902830|P1|STARTED|Overall Study||30
8481909|NCT00597207|20902837|P2|NOT COMPLETED|Overall Study||7
8481910|NCT00597207|20902838|P1|NOT COMPLETED|Overall Study||5
8481911|NCT00597207|20902837|P2|COMPLETED|Overall Study||2125
8481912|NCT00597207|20902838|P1|COMPLETED|Overall Study||2094
8481913|NCT00597207|20902837|P2|STARTED|Overall Study||2132
8481914|NCT00597207|20902838|P1|STARTED|Overall Study||2099
8481915|NCT00597116|20902846|P2|NOT COMPLETED|Overall Study||11
8481916|NCT00597116|20902847|P1|NOT COMPLETED|Overall Study||14
8481917|NCT00597116|20902846|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
8481918|NCT00597116|20902847|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
8481919|NCT00597116|20902846|P2|STARTED|Overall Study||11
8481920|NCT00597116|20902847|P1|STARTED|Overall Study||14
8481921|NCT00597038|20902861|P2|NOT COMPLETED|Overall Study||4
8481922|NCT00597038|20902862|P1|NOT COMPLETED|Overall Study||2
8481923|NCT00597038|20902861|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
8481924|NCT00597038|20902862|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
8481925|NCT00597038|20902861|P2|STARTED|Overall Study||34
8481926|NCT00597038|20902862|P1|STARTED|Overall Study||16
8481927|NCT00597012|20902873|P2|NOT COMPLETED|Overall Study||8
8481928|NCT00597012|20902874|P1|NOT COMPLETED|Overall Study||13
8481929|NCT00597012|20902873|P2|COMPLETED|Overall Study||169
8481930|NCT00597012|20902874|P1|COMPLETED|Overall Study||161
8481931|NCT00597012|20902873|P2|STARTED|Overall Study||177
8481932|NCT00597012|20902874|P1|STARTED|Overall Study||174
8481933|NCT00596960|20902890|P2|NOT COMPLETED|Overall Study||9
8481934|NCT00596960|20902891|P1|NOT COMPLETED|Overall Study||11
8481935|NCT00596960|20902890|P2|COMPLETED|Overall Study||60
8481936|NCT00596960|20902891|P1|COMPLETED|Overall Study||59
8481937|NCT00596960|20902890|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
8481938|NCT00596960|20902891|P1|STARTED|Overall Study||70
8481939|NCT00596947|20902903|P2|NOT COMPLETED|Overall Study||3
8481940|NCT00596947|20902904|P1|NOT COMPLETED|Overall Study||6
8481941|NCT00596947|20902903|P2|COMPLETED|Overall Study||6
8481942|NCT00596947|20902904|P1|COMPLETED|Overall Study||3
8481943|NCT00596947|20902903|P2|STARTED|Overall Study||9
8481944|NCT00596947|20902904|P1|STARTED|Overall Study||9
8481945|NCT00596934|20902944|P1|NOT COMPLETED|Overall Study||2
8481946|NCT00596934|20902944|P1|COMPLETED|Overall Study||7
8481947|NCT00596934|20902944|P1|STARTED|Overall Study||9
8481948|NCT00596830|20902957|P2|NOT COMPLETED|Overall Study||339
8481949|NCT00596830|20902958|P1|NOT COMPLETED|Overall Study||342
8481950|NCT00596830|20902957|P2|COMPLETED|Overall Study||0
8481951|NCT00596830|20902958|P1|COMPLETED|Overall Study||0
8481952|NCT00596830|20902957|P2|Treated|Overall Study||332
8481953|NCT00596830|20902958|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
8481954|NCT00596830|20902957|P2|STARTED|Overall Study||339
8481955|NCT00596830|20902958|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
8481956|NCT00596817|20902984|P2|NOT COMPLETED|Double-blind Period||79
8481957|NCT00596817|20902985|P1|NOT COMPLETED|Double-blind Period||88
8481958|NCT00596817|20902984|P2|COMPLETED|Double-blind Period||125
8481959|NCT00596817|20902985|P1|COMPLETED|Double-blind Period||104
8481960|NCT00596817|20902984|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
8481961|NCT00596817|20902985|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
8481962|NCT00596817|20902984|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
8481963|NCT00596817|20902985|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
8481964|NCT00596817|20902984|P2|COMPLETED|Open-label Period to Double-blind Period||400
8481965|NCT00596817|20902985|P1|COMPLETED|Open-label Period to Double-blind Period||0
8481966|NCT00596817|20902984|P2|STARTED|Open-label Period to Double-blind Period||492
8481967|NCT00596817|20902985|P1|STARTED|Open-label Period to Double-blind Period||0
8481968|NCT00596817|20902984|P2|NOT COMPLETED|Open-label Period||147
8481969|NCT00596817|20902985|P1|NOT COMPLETED|Open-label Period||0
8481970|NCT00596817|20902984|P2|COMPLETED|Open-label Period||492
8481971|NCT00596817|20902985|P1|COMPLETED|Open-label Period||0
8481972|NCT00596817|20902984|P2|STARTED|Open-label Period||639
8481973|NCT00596817|20902985|P1|STARTED|Open-label Period||0
8481974|NCT00596752|20903010|P2|NOT COMPLETED|Overall Study||143
8481975|NCT00596752|20903011|P1|NOT COMPLETED|Overall Study||126
8481976|NCT00596752|20903010|P2|COMPLETED|Overall Study||282
8481977|NCT00596752|20903011|P1|COMPLETED|Overall Study||289
8481978|NCT00596752|20903010|P2|Randomized and Treated|Overall Study||424
8481979|NCT00596752|20903011|P1|Randomized and Treated|Overall Study||415
8481980|NCT00596752|20903010|P2|STARTED|Overall Study||425
8481981|NCT00596752|20903011|P1|STARTED|Overall Study||415
8481982|NCT00596687|20903041|P2|NOT COMPLETED|Overall Study||9
8481983|NCT00596687|20903042|P1|NOT COMPLETED|Overall Study||14
8481984|NCT00596687|20903041|P2|COMPLETED|Overall Study||107
8481985|NCT00596687|20903042|P1|COMPLETED|Overall Study||104
8481986|NCT00596687|20903041|P2|STARTED|Overall Study||116
8481987|NCT00596687|20903042|P1|STARTED|Overall Study||118
8481988|NCT00596635|20903053|P3|NOT COMPLETED|Overall Study||8
8481989|NCT00596635|20903054|P2|NOT COMPLETED|Overall Study||13
8481990|NCT00596635|20903055|P1|NOT COMPLETED|Overall Study||7
8481991|NCT00596635|20903053|P3|COMPLETED|Overall Study||11
8481992|NCT00596635|20903054|P2|COMPLETED|Overall Study||7
8481993|NCT00596635|20903055|P1|COMPLETED|Overall Study||10
8481994|NCT00596635|20903053|P3|STARTED|Overall Study||19
8481995|NCT00596635|20903054|P2|STARTED|Overall Study||20
8481996|NCT00596635|20903055|P1|STARTED|Overall Study||17
8481997|NCT00596622|20903072|P1|NOT COMPLETED|Overall Study||13
8481998|NCT00596622|20903072|P1|COMPLETED|Overall Study||33
8481999|NCT00596622|20903072|P1|STARTED|Overall Study||46
8482000|NCT00596466|20903081|P1|NOT COMPLETED|Overall Study||17
8482001|NCT00596466|20903081|P1|COMPLETED|Overall Study||58
8482002|NCT00596466|20903081|P1|Enrolled, Treated|Overall Study||73
8482003|NCT00596466|20903081|P1|STARTED|Overall Study||75
8482004|NCT00596453|20903089|P2|NOT COMPLETED|Overall Study||3
8482005|NCT00596453|20903090|P1|NOT COMPLETED|Overall Study||1
8482006|NCT00596453|20903089|P2|COMPLETED|Overall Study||12
8482007|NCT00596453|20903090|P1|COMPLETED|Overall Study||12
8482008|NCT00596453|20903089|P2|STARTED|Overall Study||15
8482009|NCT00596453|20903090|P1|STARTED|Overall Study||13
8482010|NCT00596440|20903098|P2|NOT COMPLETED|Overall Study||80
8482011|NCT00596440|20903099|P1|NOT COMPLETED|Overall Study||65
8482012|NCT00596440|20903098|P2|COMPLETED|Overall Study||41
8482013|NCT00596440|20903099|P1|COMPLETED|Overall Study||48
8482014|NCT00596440|20903098|P2|Showed to First Treatment Session|Overall Study||52
8482015|NCT00596440|20903099|P1|Showed to First Treatment Session|Overall Study||61
8482016|NCT00596440|20903098|P2|Showed to Eligibility Visit|Overall Study||72
8482017|NCT00596440|20903099|P1|Showed to Eligibility Visit|Overall Study||85
8482018|NCT00596440|20903098|P2|STARTED|Overall Study||121
8482019|NCT00596440|20903099|P1|STARTED|Overall Study||113
8482020|NCT00596427|20903111|P2|NOT COMPLETED|Overall Study||2
8482021|NCT00596427|20903112|P1|NOT COMPLETED|Overall Study||4
8482022|NCT00596427|20903111|P2|COMPLETED|Overall Study||28
8482023|NCT00596427|20903112|P1|COMPLETED|Overall Study||26
8482024|NCT00596427|20903111|P2|STARTED|Overall Study||30
8482025|NCT00596427|20903112|P1|STARTED|Overall Study||30
8482026|NCT00596362|20903140|P1|NOT COMPLETED|Overall Study||1
8482027|NCT00596362|20903140|P1|COMPLETED|Overall Study||0
8482028|NCT00596362|20903140|P1|STARTED|Overall Study||1
8482029|NCT00596271|20903147|P3|NOT COMPLETED|Overall Study||1
8482030|NCT00596271|20903148|P2|NOT COMPLETED|Overall Study||6
8482031|NCT00596271|20903149|P1|NOT COMPLETED|Overall Study||5
8482032|NCT00596271|20903147|P3|COMPLETED|Overall Study||61
8482033|NCT00596271|20903148|P2|COMPLETED|Overall Study||59
8482034|NCT00596271|20903149|P1|COMPLETED|Overall Study||60
8482035|NCT00596271|20903147|P3|STARTED|Overall Study||62
8482036|NCT00596271|20903148|P2|STARTED|Overall Study||65
8482037|NCT00596271|20903149|P1|STARTED|Overall Study||65
8482038|NCT00596167|20903158|P1|NOT COMPLETED|Overall Study||0
8482039|NCT00596167|20903158|P1|COMPLETED|Overall Study||6
8482040|NCT00596167|20903158|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
8482041|NCT00596102|20903165|P3|NOT COMPLETED|Up to Month 60||637
8482042|NCT00596102|20903166|P2|NOT COMPLETED|Up to Month 60||338
8482043|NCT00596102|20903167|P1|NOT COMPLETED|Up to Month 60||2181
8482044|NCT00596102|20903165|P3|COMPLETED|Up to Month 60||0
8482045|NCT00596102|20903166|P2|COMPLETED|Up to Month 60||0
8482046|NCT00596102|20903167|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
8482047|NCT00596102|20903165|P3|STARTED|Up to Month 60||637
8482048|NCT00596102|20903166|P2|STARTED|Up to Month 60||338
8482049|NCT00596102|20903167|P1|STARTED|Up to Month 60||2283
8482050|NCT00596102|20903165|P3|NOT COMPLETED|Up to Month 6||0
8482051|NCT00596102|20903166|P2|NOT COMPLETED|Up to Month 6||0
8482052|NCT00596102|20903167|P1|NOT COMPLETED|Up to Month 6||0
8482053|NCT00596102|20903165|P3|COMPLETED|Up to Month 6||637
8482054|NCT00596102|20903166|P2|COMPLETED|Up to Month 6||338
8482055|NCT00596102|20903167|P1|COMPLETED|Up to Month 6||2283
8482056|NCT00596102|20903165|P3|STARTED|Up to Month 6||637
8482057|NCT00596102|20903166|P2|STARTED|Up to Month 6||338
8482058|NCT00596102|20903167|P1|STARTED|Up to Month 6||2283
8482059|NCT00596011|20903176|P2|NOT COMPLETED|Overall Study||10
8482060|NCT00596011|20903177|P1|NOT COMPLETED|Overall Study||13
8482061|NCT00596011|20903176|P2|COMPLETED|Overall Study||38
8482062|NCT00596011|20903177|P1|COMPLETED|Overall Study||36
8482063|NCT00596011|20903176|P2|STARTED|Overall Study||48
8482064|NCT00596011|20903177|P1|STARTED|Overall Study||49
8482065|NCT00595959|20903193|P1|NOT COMPLETED|Overall Study||2
8482066|NCT00595959|20903193|P1|COMPLETED|Overall Study||63
8482067|NCT00595959|20903193|P1|STARTED|Overall Study||65
8482068|NCT00595946|20903210|P2|NOT COMPLETED|Overall Study||69
8482069|NCT00595946|20903211|P1|NOT COMPLETED|Overall Study||64
8482070|NCT00595946|20903210|P2|COMPLETED|Overall Study||152
8482071|NCT00595946|20903211|P1|COMPLETED|Overall Study||154
8482072|NCT00595946|20903210|P2|STARTED|Overall Study||221
8482073|NCT00595946|20903211|P1|STARTED|Overall Study||218
8482074|NCT00595920|20903227|P1|NOT COMPLETED|Overall Study||116
8482075|NCT00595920|20903227|P1|COMPLETED|Overall Study||0
8482076|NCT00595920|20903227|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
8482077|NCT00595920|20903227|P1|STARTED|Overall Study||116
8482078|NCT00595881|20903231|P1|NOT COMPLETED|Overall Study||0
8482079|NCT00595881|20903231|P1|COMPLETED|Overall Study||420
8482080|NCT00595881|20903231|P1|STARTED|Overall Study||420
8482081|NCT00595868|20903238|P2|NOT COMPLETED|Overall Study||50
8482082|NCT00595868|20903239|P1|NOT COMPLETED|Overall Study||45
8482083|NCT00595868|20903238|P2|COMPLETED|Overall Study||61
8482084|NCT00595868|20903239|P1|COMPLETED|Overall Study||62
8482085|NCT00595868|20903238|P2|STARTED|Overall Study||111
8482086|NCT00595868|20903239|P1|STARTED|Overall Study||107
8482087|NCT00595790|20903250|P3|NOT COMPLETED|Overall Study||3
8482088|NCT00595790|20903251|P2|NOT COMPLETED|Overall Study||1
8482089|NCT00595790|20903252|P1|NOT COMPLETED|Overall Study||2
8482090|NCT00595790|20903250|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
8482091|NCT00595790|20903251|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
8482092|NCT00595790|20903252|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
8482093|NCT00595790|20903250|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
8482094|NCT00595790|20903251|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
8482095|NCT00595790|20903252|P1|STARTED|Overall Study||125
8482096|NCT00595764|20903262|P2|NOT COMPLETED|Overall Study||43
8482097|NCT00595764|20903263|P1|NOT COMPLETED|Overall Study||39
8482098|NCT00595764|20903262|P2|COMPLETED|Overall Study||27
8482099|NCT00595764|20903263|P1|COMPLETED|Overall Study||32
8482100|NCT00595764|20903262|P2|STARTED|Overall Study||70
8482101|NCT00595764|20903263|P1|STARTED|Overall Study||71
8482102|NCT00595621|20903279|P2|NOT COMPLETED|Randomization and Study||1
8482103|NCT00595621|20903280|P1|NOT COMPLETED|Randomization and Study||2
8482104|NCT00595621|20903279|P2|COMPLETED|Randomization and Study||8
8482105|NCT00595621|20903280|P1|COMPLETED|Randomization and Study||8
8482106|NCT00595621|20903279|P2|STARTED|Randomization and Study||9
8482107|NCT00595621|20903280|P1|STARTED|Randomization and Study||10
8482108|NCT00595621|20903279|P2|NOT COMPLETED|Open Label Run in||0
8482109|NCT00595621|20903280|P1|NOT COMPLETED|Open Label Run in||3
8482110|NCT00595621|20903279|P2|COMPLETED|Open Label Run in||0
8482111|NCT00595621|20903280|P1|COMPLETED|Open Label Run in||19
8482112|NCT00595621|20903279|P2|STARTED|Open Label Run in||0
8482113|NCT00595621|20903280|P1|STARTED|Open Label Run in||22
8482114|NCT00595582|20903297|P1|NOT COMPLETED|Overall Study||10
8482115|NCT00595582|20903297|P1|COMPLETED|Overall Study||0
8482116|NCT00595582|20903297|P1|STARTED|Overall Study||10
8482117|NCT00595556|20903303|P2|NOT COMPLETED|Overall Study||1
8482118|NCT00595556|20903304|P1|NOT COMPLETED|Overall Study||3
8482119|NCT00595556|20903303|P2|COMPLETED|Overall Study||19
8482120|NCT00595556|20903304|P1|COMPLETED|Overall Study||17
8482121|NCT00595556|20903303|P2|STARTED|Overall Study||20
8482122|NCT00595556|20903304|P1|STARTED|Overall Study||20
8482123|NCT00595530|20903318|P1|NOT COMPLETED|Overall Study||0
8482124|NCT00595530|20903318|P1|COMPLETED|Overall Study||3
8482125|NCT00595530|20903318|P1|STARTED|Overall Study||3
8482126|NCT00595517|20903323|P1|NOT COMPLETED|Overall Study||19
8482127|NCT00595517|20903323|P1|COMPLETED|Overall Study||111
8482128|NCT00595517|20903323|P1|STARTED|Overall Study||130
8482129|NCT00595504|20903332|P2|NOT COMPLETED|Overall Study||3
8482130|NCT00595504|20903333|P1|NOT COMPLETED|Overall Study||2
8482131|NCT00595504|20903332|P2|COMPLETED|Overall Study||6
8482132|NCT00595504|20903333|P1|COMPLETED|Overall Study||14
8482133|NCT00595504|20903332|P2|STARTED|Overall Study||9
8482134|NCT00595504|20903333|P1|STARTED|Overall Study||16
8482135|NCT00595478|20903345|P2|NOT COMPLETED|36-week Follow-up Period||8
8482136|NCT00595478|20903346|P1|NOT COMPLETED|36-week Follow-up Period||9
8482137|NCT00595478|20903345|P2|COMPLETED|36-week Follow-up Period||30
8482138|NCT00595478|20903346|P1|COMPLETED|36-week Follow-up Period||28
8482139|NCT00595478|20903345|P2|STARTED|36-week Follow-up Period||38
8482140|NCT00595478|20903346|P1|STARTED|36-week Follow-up Period||37
8482141|NCT00595478|20903345|P2|NOT COMPLETED|Treatment||0
8482142|NCT00595478|20903346|P1|NOT COMPLETED|Treatment||0
8482143|NCT00595478|20903345|P2|COMPLETED|Treatment||38
8482144|NCT00595478|20903346|P1|COMPLETED|Treatment||37
8482145|NCT00595478|20903345|P2|STARTED|Treatment||38
8482146|NCT00595478|20903346|P1|STARTED|Treatment||37
8482147|NCT00595465|20903357|P3|NOT COMPLETED|Overall Study||7
8482148|NCT00595465|20903358|P2|NOT COMPLETED|Overall Study||4
8482149|NCT00595465|20903359|P1|NOT COMPLETED|Overall Study||6
8482150|NCT00595465|20903357|P3|COMPLETED|Overall Study||121
8482151|NCT00595465|20903358|P2|COMPLETED|Overall Study||125
8482152|NCT00595465|20903359|P1|COMPLETED|Overall Study||124
8482153|NCT00595465|20903357|P3|STARTED|Overall Study||128
8482154|NCT00595465|20903358|P2|STARTED|Overall Study||129
8482155|NCT00595465|20903359|P1|STARTED|Overall Study||130
8482156|NCT00595413|20903371|P4|NOT COMPLETED|Overall Study||4
8482157|NCT00595413|20903372|P3|NOT COMPLETED|Overall Study||8
8482158|NCT00595413|20903373|P2|NOT COMPLETED|Overall Study||5
8482159|NCT00595413|20903374|P1|NOT COMPLETED|Overall Study||7
8482160|NCT00595413|20903371|P4|COMPLETED|Overall Study||75
8482161|NCT00595413|20903372|P3|COMPLETED|Overall Study||70
8482162|NCT00595413|20903373|P2|COMPLETED|Overall Study||73
8482163|NCT00595413|20903374|P1|COMPLETED|Overall Study||69
8482164|NCT00595413|20903371|P4|STARTED|Overall Study||79
8482165|NCT00595413|20903372|P3|STARTED|Overall Study||78
8482166|NCT00595413|20903373|P2|STARTED|Overall Study||78
8482167|NCT00595413|20903374|P1|STARTED|Overall Study||76
8482168|NCT00595361|20903402|P2|NOT COMPLETED|Overall Study||0
8482169|NCT00595361|20903403|P1|NOT COMPLETED|Overall Study||0
8482170|NCT00595361|20903402|P2|COMPLETED|Overall Study||18
8482171|NCT00595361|20903403|P1|COMPLETED|Overall Study||12
8482172|NCT00595361|20903402|P2|STARTED|Overall Study||18
8482173|NCT00595361|20903403|P1|STARTED|Overall Study||12
8482174|NCT00595335|20903415|P2|NOT COMPLETED|Six Months to Twelve Months||1
8482175|NCT00595335|20903416|P1|NOT COMPLETED|Six Months to Twelve Months||1
8482176|NCT00595335|20903415|P2|COMPLETED|Six Months to Twelve Months||9
8482177|NCT00595335|20903416|P1|COMPLETED|Six Months to Twelve Months||10
8482178|NCT00595335|20903415|P2|STARTED|Six Months to Twelve Months||10
8482179|NCT00595335|20903416|P1|STARTED|Six Months to Twelve Months||11
8482180|NCT00595335|20903415|P2|NOT COMPLETED|Baseline to Six Months||2
8482181|NCT00595335|20903416|P1|NOT COMPLETED|Baseline to Six Months||2
8482182|NCT00595335|20903415|P2|COMPLETED|Baseline to Six Months||10
8482183|NCT00595335|20903416|P1|COMPLETED|Baseline to Six Months||11
8482184|NCT00595335|20903415|P2|STARTED|Baseline to Six Months||12
8482185|NCT00595335|20903416|P1|STARTED|Baseline to Six Months||13
8482186|NCT00595309|20903436|P1|NOT COMPLETED|Overall Study||4
8482187|NCT00595309|20903436|P1|COMPLETED|Overall Study||194
8482188|NCT00595309|20903436|P1|STARTED|Overall Study||198
8482189|NCT00595270|20903443|P3|NOT COMPLETED|Overall Study||8
8482190|NCT00595270|20903444|P2|NOT COMPLETED|Overall Study||10
8482191|NCT00595270|20903445|P1|NOT COMPLETED|Overall Study||6
8482192|NCT00595270|20903443|P3|COMPLETED|Overall Study||108
8482193|NCT00595270|20903444|P2|COMPLETED|Overall Study||107
8482194|NCT00595270|20903445|P1|COMPLETED|Overall Study||110
8482195|NCT00595270|20903443|P3|STARTED|Overall Study||116
8482196|NCT00595270|20903444|P2|STARTED|Overall Study||117
8482197|NCT00595270|20903445|P1|STARTED|Overall Study||116
8482198|NCT00595231|20903455|P2|NOT COMPLETED|Overall Study||5
8482199|NCT00595231|20903456|P1|NOT COMPLETED|Overall Study||5
8482200|NCT00595231|20903455|P2|COMPLETED|Overall Study||114
8482201|NCT00595231|20903456|P1|COMPLETED|Overall Study||115
8482202|NCT00595231|20903455|P2|STARTED|Overall Study||119
8482203|NCT00595231|20903456|P1|STARTED|Overall Study||120
8482204|NCT00595153|20903475|P3|NOT COMPLETED|Overall Study||25
8482205|NCT00595153|20903476|P2|NOT COMPLETED|Overall Study||16
8482206|NCT00595153|20903477|P1|NOT COMPLETED|Overall Study||4
8482207|NCT00595153|20903475|P3|COMPLETED|Overall Study||36
8482208|NCT00595153|20903476|P2|COMPLETED|Overall Study||26
8482209|NCT00595153|20903477|P1|COMPLETED|Overall Study||20
8482210|NCT00595153|20903475|P3|STARTED|Overall Study||61
8482211|NCT00595153|20903476|P2|STARTED|Overall Study||42
8482212|NCT00595153|20903477|P1|STARTED|Overall Study||24
8482213|NCT00595127|20903485|P1|NOT COMPLETED|Overall Study||10
8482214|NCT00595127|20903485|P1|COMPLETED|Overall Study||11
8482215|NCT00595127|20903485|P1|STARTED|Overall Study||21
8482216|NCT00595114|20903491|P2|NOT COMPLETED|Overall Study||0
8482217|NCT00595114|20903492|P1|NOT COMPLETED|Overall Study||0
8482218|NCT00595114|20903491|P2|COMPLETED|Overall Study||19
8482219|NCT00595114|20903492|P1|COMPLETED|Overall Study||24
8482220|NCT00595114|20903491|P2|STARTED|Overall Study||19
8482221|NCT00595114|20903492|P1|STARTED|Overall Study||24
8482222|NCT00595101|20903502|P4|NOT COMPLETED|Overall Study||0
8482223|NCT00595101|20903503|P3|NOT COMPLETED|Overall Study||0
8482224|NCT00595101|20903504|P2|NOT COMPLETED|Overall Study||1
8482225|NCT00595101|20903505|P1|NOT COMPLETED|Overall Study||0
8482226|NCT00595101|20903502|P4|COMPLETED|Overall Study||30
8482227|NCT00595101|20903503|P3|COMPLETED|Overall Study||29
8482228|NCT00595101|20903504|P2|COMPLETED|Overall Study||28
8482229|NCT00595101|20903505|P1|COMPLETED|Overall Study||29
8482230|NCT00595101|20903502|P4|STARTED|Overall Study||30
8482231|NCT00595101|20903503|P3|STARTED|Overall Study||29
8482232|NCT00595101|20903504|P2|STARTED|Overall Study||29
8482233|NCT00595101|20903505|P1|STARTED|Overall Study||29
8482234|NCT00595088|20903523|P1|NOT COMPLETED|Overall Study||40
8482235|NCT00595088|20903523|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
8482236|NCT00595088|20903523|P1|STARTED|Overall Study||47
8482237|NCT00595075|20903531|P2|NOT COMPLETED|Overall Study||0
8482238|NCT00595075|20903532|P1|NOT COMPLETED|Overall Study||1
8482239|NCT00595075|20903531|P2|COMPLETED|Overall Study||5
8482240|NCT00595075|20903532|P1|COMPLETED|Overall Study||5
8482241|NCT00595075|20903531|P2|STARTED|Overall Study||5
8482242|NCT00595075|20903532|P1|STARTED|Overall Study||6
8482243|NCT00594958|20903553|P3|NOT COMPLETED|Overall Study||10
8482244|NCT00594958|20903554|P2|NOT COMPLETED|Overall Study||3
8482245|NCT00594958|20903555|P1|NOT COMPLETED|Overall Study||14
8482246|NCT00594958|20903553|P3|COMPLETED|Overall Study||202
8482247|NCT00594958|20903554|P2|COMPLETED|Overall Study||210
8482248|NCT00594958|20903555|P1|COMPLETED|Overall Study||200
8482249|NCT00594958|20903553|P3|Randomized and at Least 1 Vaccination|Overall Study||211
8482250|NCT00594958|20903554|P2|Randomized and at Least 1 Vaccination|Overall Study||213
8482251|NCT00594958|20903555|P1|Randomized and at Least 1 Vaccination|Overall Study||212
8482252|NCT00594958|20903553|P3|STARTED|Overall Study||212
8482253|NCT00594958|20903554|P2|STARTED|Overall Study||213
8482254|NCT00594958|20903555|P1|STARTED|Overall Study||214
8482255|NCT00594945|20903566|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8482256|NCT00594945|20903567|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8482257|NCT00594945|20903568|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8482258|NCT00594945|20903566|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
8482259|NCT00594945|20903567|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
8482260|NCT00594945|20903568|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
8482261|NCT00594945|20903566|P3|STARTED|Cohort 2 / Treatment Period 2||2
8482262|NCT00594945|20903567|P2|STARTED|Cohort 2 / Treatment Period 2||3
8482263|NCT00594945|20903568|P1|STARTED|Cohort 2 / Treatment Period 2||0
8482264|NCT00594945|20903566|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8482265|NCT00594945|20903567|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8482266|NCT00594945|20903568|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8482267|NCT00594945|20903566|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
8482268|NCT00594945|20903567|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
8482269|NCT00594945|20903568|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
8482270|NCT00594945|20903566|P3|STARTED|Cohort 1 / Treatment Period 1||2
8482271|NCT00594945|20903567|P2|STARTED|Cohort 1 / Treatment Period 1||0
8482272|NCT00594945|20903568|P1|STARTED|Cohort 1 / Treatment Period 1||4
8482273|NCT00594932|20903576|P2|NOT COMPLETED|Final 3 Months||3
8482274|NCT00594932|20903577|P1|NOT COMPLETED|Final 3 Months||4
8482275|NCT00594932|20903576|P2|COMPLETED|Final 3 Months||8
8482276|NCT00594932|20903577|P1|COMPLETED|Final 3 Months||8
8482277|NCT00594932|20903576|P2|STARTED|Final 3 Months||11
8482278|NCT00594932|20903577|P1|STARTED|Final 3 Months||12
8482279|NCT00594932|20903576|P2|NOT COMPLETED|First 3 Months||3
8482280|NCT00594932|20903577|P1|NOT COMPLETED|First 3 Months||1
8482281|NCT00594932|20903576|P2|COMPLETED|First 3 Months||11
8482282|NCT00594932|20903577|P1|COMPLETED|First 3 Months||12
8482283|NCT00594932|20903576|P2|STARTED|First 3 Months||14
8482284|NCT00594932|20903577|P1|STARTED|First 3 Months||13
8482285|NCT00594906|20903589|P2|NOT COMPLETED|Overall Study||2
8482286|NCT00594906|20903590|P1|NOT COMPLETED|Overall Study||1
8482287|NCT00594906|20903589|P2|COMPLETED|Overall Study||1
8482288|NCT00594906|20903590|P1|COMPLETED|Overall Study||6
8482289|NCT00594906|20903589|P2|STARTED|Overall Study||3
8482290|NCT00594906|20903590|P1|STARTED|Overall Study||7
8482291|NCT00594880|20903598|P2|NOT COMPLETED|Overall Study||1
8482292|NCT00594880|20903599|P1|NOT COMPLETED|Overall Study||2
8482293|NCT00594880|20903598|P2|COMPLETED|Overall Study||10
8482294|NCT00594880|20903599|P1|COMPLETED|Overall Study||10
8482295|NCT00594880|20903598|P2|STARTED|Overall Study||11
8482296|NCT00594880|20903599|P1|STARTED|Overall Study||12
8482297|NCT00594854|20903611|P2|NOT COMPLETED|Overall Study||10
8482298|NCT00594854|20903612|P1|NOT COMPLETED|Overall Study||7
8482299|NCT00594854|20903611|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
8482300|NCT00594854|20903612|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
8482301|NCT00594854|20903611|P2|STARTED|Overall Study||11
8482302|NCT00594854|20903612|P1|STARTED|Overall Study||9
8482303|NCT00594815|20903622|P1|NOT COMPLETED|Overall Study||9
8482304|NCT00594815|20903622|P1|COMPLETED|Overall Study||43
8482305|NCT00594815|20903622|P1|STARTED|Overall Study||52
8482306|NCT00594685|20903627|P1|NOT COMPLETED|Overall Study||0
8482307|NCT00594685|20903627|P1|COMPLETED|Overall Study||10
8482308|NCT00594685|20903627|P1|STARTED|Overall Study||10
8482309|NCT00594659|20903647|P3|NOT COMPLETED|Overall Study||7
8482310|NCT00594659|20903648|P2|NOT COMPLETED|Overall Study||9
8482311|NCT00594659|20903649|P1|NOT COMPLETED|Overall Study||13
8482312|NCT00594659|20903647|P3|COMPLETED|Overall Study||9
8482313|NCT00594659|20903648|P2|COMPLETED|Overall Study||21
8482314|NCT00594659|20903649|P1|COMPLETED|Overall Study||16
8482315|NCT00594659|20903647|P3|STARTED|Overall Study||16
8482316|NCT00594659|20903648|P2|STARTED|Overall Study||30
8482317|NCT00594659|20903649|P1|STARTED|Overall Study||29
8482318|NCT00594646|20903660|P1|NOT COMPLETED|Overall Study||16
8482319|NCT00594646|20903660|P1|COMPLETED|Overall Study||84
8482320|NCT00594646|20903660|P1|STARTED|Overall Study||100
8482321|NCT00594568|20903668|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
8482322|NCT00594568|20903669|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
8482323|NCT00594568|20903670|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
8482324|NCT00594568|20903668|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
8482325|NCT00594568|20903669|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
8482326|NCT00594568|20903670|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
8482327|NCT00594568|20903668|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
8482328|NCT00594568|20903669|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
8482329|NCT00594568|20903670|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
8482330|NCT00594568|20903668|P3|NOT COMPLETED|Delayed Start||66
8482331|NCT00594568|20903669|P2|NOT COMPLETED|Delayed Start||77
8482332|NCT00594568|20903670|P1|NOT COMPLETED|Delayed Start||98
8482333|NCT00594568|20903668|P3|COMPLETED|Delayed Start||55
8482334|NCT00594568|20903669|P2|COMPLETED|Delayed Start||76
8482335|NCT00594568|20903670|P1|COMPLETED|Delayed Start||91
8482336|NCT00594568|20903668|P3|STARTED|Delayed Start||121
8482337|NCT00594568|20903669|P2|STARTED|Delayed Start||153
8482338|NCT00594568|20903670|P1|STARTED|Delayed Start||189
8482339|NCT00594568|20903668|P3|NOT COMPLETED|Initial Treatment||408
8482340|NCT00594568|20903669|P2|NOT COMPLETED|Initial Treatment||354
8482341|NCT00594568|20903670|P1|NOT COMPLETED|Initial Treatment||312
8482342|NCT00594568|20903668|P3|COMPLETED|Initial Treatment||121
8482343|NCT00594568|20903669|P2|COMPLETED|Initial Treatment||153
8482344|NCT00594568|20903670|P1|COMPLETED|Initial Treatment||189
8482345|NCT00594568|20903668|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
8482346|NCT00594568|20903669|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
8482347|NCT00594568|20903670|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
8482348|NCT00594568|20903668|P3|STARTED|Initial Treatment||529
8482349|NCT00594568|20903669|P2|STARTED|Initial Treatment||507
8482350|NCT00594568|20903670|P1|STARTED|Initial Treatment||501
8482351|NCT00594516|20903758|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
8482352|NCT00594516|20903759|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
8482353|NCT00594516|20903760|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
8482354|NCT00594516|20903758|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
8482355|NCT00594516|20903759|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
8482356|NCT00594516|20903760|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
8482357|NCT00594516|20903758|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
8482358|NCT00594516|20903759|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
8482359|NCT00594516|20903760|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
8482360|NCT00594516|20903758|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
8482361|NCT00594516|20903759|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
8482362|NCT00594516|20903760|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
8482363|NCT00594516|20903758|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
8482364|NCT00594516|20903759|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
8482365|NCT00594516|20903760|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
8482366|NCT00594516|20903758|P3|STARTED|Open Label (OL): Tapentadol IR||0
8482367|NCT00594516|20903759|P2|STARTED|Open Label (OL): Tapentadol IR||0
8482368|NCT00594516|20903760|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
8482369|NCT00594464|20903768|P1|NOT COMPLETED|Overall Study||3
8482370|NCT00594464|20903768|P1|COMPLETED|Overall Study||11
8482371|NCT00594464|20903768|P1|STARTED|Overall Study||14
8482372|NCT00594425|20903783|P3|NOT COMPLETED|Overall Study||10
8482373|NCT00594425|20903784|P2|NOT COMPLETED|Overall Study||14
8482374|NCT00594425|20903785|P1|NOT COMPLETED|Overall Study||7
8482375|NCT00594425|20903783|P3|COMPLETED|Overall Study||42
8482376|NCT00594425|20903784|P2|COMPLETED|Overall Study||34
8482377|NCT00594425|20903785|P1|COMPLETED|Overall Study||43
8482378|NCT00594425|20903783|P3|STARTED|Overall Study||52
8482379|NCT00594425|20903784|P2|STARTED|Overall Study||48
8482380|NCT00594425|20903785|P1|STARTED|Overall Study||50
8482381|NCT00594399|20903897|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
8482382|NCT00594399|20903898|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
8482383|NCT00594399|20903899|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
8482384|NCT00594399|20903897|P3|COMPLETED|Rerandomization Arm 1 Only||82
8482385|NCT00594399|20903898|P2|COMPLETED|Rerandomization Arm 1 Only||114
8482386|NCT00594399|20903899|P1|COMPLETED|Rerandomization Arm 1 Only||79
8482387|NCT00594399|20903897|P3|Rerandomization|Rerandomization Arm 1 Only||82
8482388|NCT00594399|20903898|P2|Rerandomization|Rerandomization Arm 1 Only||114
8482389|NCT00594399|20903899|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
8482390|NCT00594399|20903897|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
8482391|NCT00594399|20903898|P2|STARTED|Rerandomization Arm 1 Only||118
8482392|NCT00594399|20903899|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
8482393|NCT00594399|20903897|P3|NOT COMPLETED|Initial 3 Month Counseling||0
8482394|NCT00594399|20903898|P2|NOT COMPLETED|Initial 3 Month Counseling||4
8482395|NCT00594399|20903899|P1|NOT COMPLETED|Initial 3 Month Counseling||17
8482396|NCT00594399|20903897|P3|COMPLETED|Initial 3 Month Counseling||0
8482397|NCT00594399|20903898|P2|COMPLETED|Initial 3 Month Counseling||118
8482398|NCT00594399|20903899|P1|COMPLETED|Initial 3 Month Counseling||163
8482399|NCT00594399|20903897|P3|STARTED|Initial 3 Month Counseling||0
8482400|NCT00594399|20903898|P2|STARTED|Initial 3 Month Counseling||122
8482401|NCT00594399|20903899|P1|STARTED|Initial 3 Month Counseling||180
8482402|NCT00594386|20903921|P1|NOT COMPLETED|Overall Study||258
8482403|NCT00594386|20903921|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8482404|NCT00594386|20903921|P1|STARTED|Overall Study||258
8482405|NCT00594308|20903927|P1|NOT COMPLETED|Overall Study||0
8482406|NCT00594308|20903927|P1|COMPLETED|Overall Study||10
8482407|NCT00594308|20903927|P1|STARTED|Overall Study||10
8482408|NCT00594256|20903935|P1|NOT COMPLETED|Overall Study||0
8482409|NCT00594256|20903935|P1|COMPLETED|Overall Study||8
8482410|NCT00594256|20903935|P1|STARTED|Overall Study||8
8482411|NCT00594230|20903945|P2|NOT COMPLETED|Overall Study||9
8482412|NCT00594230|20903946|P1|NOT COMPLETED|Overall Study||15
8482413|NCT00594230|20903945|P2|COMPLETED|Overall Study||1
8482414|NCT00594230|20903946|P1|COMPLETED|Overall Study||1
8482415|NCT00594230|20903945|P2|STARTED|Overall Study||10
8482416|NCT00594230|20903946|P1|STARTED|Overall Study||16
8482417|NCT00594204|20903954|P2|NOT COMPLETED|Overall Study||45
8482418|NCT00594204|20903955|P1|NOT COMPLETED|Overall Study||58
8482419|NCT00594204|20903954|P2|COMPLETED|Overall Study||154
8482420|NCT00594204|20903955|P1|COMPLETED|Overall Study||336
8482421|NCT00594204|20903954|P2|Received Treatment|Overall Study||198
8482422|NCT00594204|20903955|P1|Received Treatment|Overall Study||390
8482423|NCT00594204|20903954|P2|STARTED|Overall Study||199
8482424|NCT00594204|20903955|P1|STARTED|Overall Study||394
8482425|NCT00594178|20903965|P1|NOT COMPLETED|Overall Study||5
8482426|NCT00594178|20903965|P1|COMPLETED|Overall Study||12
8482427|NCT00594178|20903965|P1|STARTED|Overall Study||17
8482428|NCT00594165|20903970|P1|NOT COMPLETED|Overall Study||217
8482429|NCT00594165|20903970|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8482430|NCT00594165|20903970|P1|STARTED|Overall Study||217
8482431|NCT00594100|20903976|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
8482432|NCT00594100|20903976|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
8482433|NCT00594100|20903976|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
8482434|NCT00594100|20903976|P1|NOT COMPLETED|Procedure||9
8482435|NCT00594100|20903976|P1|COMPLETED|Procedure||236
8482436|NCT00594100|20903976|P1|STARTED|Procedure||245
8482437|NCT00594061|20903985|P1|NOT COMPLETED|Overall Study||0
8482438|NCT00594061|20903985|P1|COMPLETED|Overall Study||9
8482439|NCT00594061|20903985|P1|STARTED|Overall Study||9
8482440|NCT00594035|20903992|P2|NOT COMPLETED|Overall Study||3
8482441|NCT00594035|20903993|P1|NOT COMPLETED|Overall Study||2
8482442|NCT00594035|20903992|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
8482443|NCT00594035|20903993|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
8482444|NCT00594035|20903992|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
8482445|NCT00594035|20903993|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
8482446|NCT00594022|20904001|P2|NOT COMPLETED|Overall Study||0
8482447|NCT00594022|20904002|P1|NOT COMPLETED|Overall Study||0
8482448|NCT00594022|20904001|P2|COMPLETED|Overall Study||173
8482449|NCT00594022|20904002|P1|COMPLETED|Overall Study||176
8482450|NCT00594022|20904001|P2|STARTED|Overall Study||173
8482451|NCT00594022|20904002|P1|STARTED|Overall Study||176
8482452|NCT00594009|20904016|P1|NOT COMPLETED|Overall Study||0
8482453|NCT00594009|20904016|P1|COMPLETED|Overall Study||1
8482454|NCT00594009|20904016|P1|STARTED|Overall Study||1
8482455|NCT00593957|20904023|P3|NOT COMPLETED|Overall Study||2
8482456|NCT00593957|20904024|P2|NOT COMPLETED|Overall Study||1
8482457|NCT00593957|20904025|P1|NOT COMPLETED|Overall Study||0
8482458|NCT00593957|20904023|P3|COMPLETED|Overall Study||10
8482459|NCT00593957|20904024|P2|COMPLETED|Overall Study||12
8482460|NCT00593957|20904025|P1|COMPLETED|Overall Study||13
8482461|NCT00593957|20904023|P3|STARTED|Overall Study||12
8482462|NCT00593957|20904024|P2|STARTED|Overall Study||13
8482463|NCT00593957|20904025|P1|STARTED|Overall Study||13
8482464|NCT00593918|20904049|P2|NOT COMPLETED|Overall Study||24
8482465|NCT00593918|20904050|P1|NOT COMPLETED|Overall Study||5
8482466|NCT00593918|20904049|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
8482467|NCT00593918|20904050|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
8482468|NCT00593918|20904049|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
8482469|NCT00593918|20904050|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
8482470|NCT00593866|20904058|P1|NOT COMPLETED|Overall Study||0
8482471|NCT00593866|20904058|P1|COMPLETED|Overall Study||50
8482472|NCT00593866|20904058|P1|STARTED|Overall Study||50
8482473|NCT00593840|20904063|P1|NOT COMPLETED|Overall Study||1
8482474|NCT00593840|20904063|P1|COMPLETED|Overall Study||72
8482475|NCT00593840|20904063|P1|STARTED|Overall Study||73
8482476|NCT00593827|20904075|P2|NOT COMPLETED|Overall Study||2
8482477|NCT00593827|20904076|P1|NOT COMPLETED|Overall Study||0
8482478|NCT00593827|20904075|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
8482479|NCT00593827|20904076|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
8482480|NCT00593827|20904075|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
8482481|NCT00593827|20904076|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
8482482|NCT00593827|20904075|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
8482483|NCT00593827|20904076|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
8482484|NCT00593827|20904075|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
8482485|NCT00593827|20904076|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
8482486|NCT00593814|20904100|P2|NOT COMPLETED|Overall Study||0
8482487|NCT00593814|20904101|P1|NOT COMPLETED|Overall Study||24
8482488|NCT00593814|20904100|P2|COMPLETED|Overall Study||120
8482489|NCT00593814|20904101|P1|COMPLETED|Overall Study||115
8482490|NCT00593814|20904100|P2|STARTED|Overall Study||120
8482491|NCT00593814|20904101|P1|STARTED|Overall Study||139
8482492|NCT00593736|20904113|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
8482493|NCT00593736|20904114|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
8482494|NCT00593736|20904115|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
8482495|NCT00593736|20904116|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
8482496|NCT00593736|20904113|P4|COMPLETED|Treatment Period and Placebo Run-out||28
8482497|NCT00593736|20904114|P3|COMPLETED|Treatment Period and Placebo Run-out||30
8482498|NCT00593736|20904115|P2|COMPLETED|Treatment Period and Placebo Run-out||31
8482499|NCT00593736|20904116|P1|COMPLETED|Treatment Period and Placebo Run-out||29
8482500|NCT00593736|20904113|P4|STARTED|Treatment Period and Placebo Run-out||32
8482501|NCT00593736|20904114|P3|STARTED|Treatment Period and Placebo Run-out||35
8482502|NCT00593736|20904115|P2|STARTED|Treatment Period and Placebo Run-out||33
8482503|NCT00593736|20904116|P1|STARTED|Treatment Period and Placebo Run-out||32
8482504|NCT00593736|20904113|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
8482505|NCT00593736|20904114|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
8482506|NCT00593736|20904115|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
8482507|NCT00593736|20904116|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
8482508|NCT00593736|20904113|P4|COMPLETED|Screening Period and Placebo Run-in||132
8482509|NCT00593736|20904114|P3|COMPLETED|Screening Period and Placebo Run-in||0
8482510|NCT00593736|20904115|P2|COMPLETED|Screening Period and Placebo Run-in||0
8482511|NCT00593736|20904116|P1|COMPLETED|Screening Period and Placebo Run-in||0
8482512|NCT00593736|20904113|P4|STARTED|Screening Period and Placebo Run-in||549
8482513|NCT00593736|20904114|P3|STARTED|Screening Period and Placebo Run-in||0
8482514|NCT00593736|20904115|P2|STARTED|Screening Period and Placebo Run-in||0
8482515|NCT00593736|20904116|P1|STARTED|Screening Period and Placebo Run-in||0
8482516|NCT00593684|20904364|P2|NOT COMPLETED|Overall Study||1
8482517|NCT00593684|20904365|P1|NOT COMPLETED|Overall Study||2
8482518|NCT00593684|20904364|P2|COMPLETED|Overall Study||24
8482519|NCT00593684|20904365|P1|COMPLETED|Overall Study||23
8482520|NCT00593684|20904364|P2|STARTED|Overall Study||25
8482521|NCT00593684|20904365|P1|STARTED|Overall Study||25
8482522|NCT00593645|20904377|P1|NOT COMPLETED|Overall Study||0
8482523|NCT00593645|20904377|P1|COMPLETED|Overall Study||7
8482524|NCT00593645|20904377|P1|STARTED|Overall Study||7
8482525|NCT00593606|20904391|P1|NOT COMPLETED|Overall Study||27
8482526|NCT00593606|20904391|P1|COMPLETED|Overall Study||97
8482527|NCT00593606|20904391|P1|Treatment Period Completed|Overall Study||99
8482528|NCT00593606|20904391|P1|Full Analysis Set|Overall Study||114
8482529|NCT00593606|20904391|P1|Start of Treatment - Safety Set|Overall Study||116
8482530|NCT00593606|20904391|P1|STARTED|Overall Study||124
8482531|NCT00593554|20904489|P2|NOT COMPLETED|Overall Study||5
8482532|NCT00593554|20904490|P1|NOT COMPLETED|Overall Study||3
8482533|NCT00593554|20904489|P2|COMPLETED|Overall Study||0
8482534|NCT00593554|20904490|P1|COMPLETED|Overall Study||0
8482535|NCT00593554|20904489|P2|STARTED|Overall Study||5
8482536|NCT00593554|20904490|P1|STARTED|Overall Study||3
8482537|NCT00593489|20904510|P2|NOT COMPLETED|Analysis||0
8482538|NCT00593489|20904511|P1|NOT COMPLETED|Analysis||0
8482539|NCT00593489|20904510|P2|COMPLETED|Analysis||78
8482540|NCT00593489|20904511|P1|COMPLETED|Analysis||73
8482541|NCT00593489|20904510|P2|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
8482542|NCT00593489|20904511|P1|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
8482543|NCT00593489|20904510|P2|NOT COMPLETED|Allocation||1
8482544|NCT00593489|20904511|P1|NOT COMPLETED|Allocation||2
8482545|NCT00593489|20904510|P2|COMPLETED|Allocation||78
8482546|NCT00593489|20904511|P1|COMPLETED|Allocation||73
8482547|NCT00593489|20904510|P2|STARTED|Allocation|allocated to usual care group|79
8482548|NCT00593489|20904511|P1|STARTED|Allocation|allocated to intervention group to receive the intervention|75
8482549|NCT00593450|20904541|P4|NOT COMPLETED|Overall Study||29
8482550|NCT00593450|20904542|P3|NOT COMPLETED|Overall Study||13
8482551|NCT00593450|20904543|P2|NOT COMPLETED|Overall Study||21
8482552|NCT00593450|20904544|P1|NOT COMPLETED|Overall Study||17
8482553|NCT00593450|20904541|P4|COMPLETED|Overall Study||271
8482554|NCT00593450|20904542|P3|COMPLETED|Overall Study||285
8482555|NCT00593450|20904543|P2|COMPLETED|Overall Study||265
8482556|NCT00593450|20904544|P1|COMPLETED|Overall Study||284
8482557|NCT00593450|20904541|P4|STARTED|Overall Study||300
8482558|NCT00593450|20904542|P3|STARTED|Overall Study||298
8482559|NCT00593450|20904543|P2|STARTED|Overall Study||286
8482560|NCT00593450|20904544|P1|STARTED|Overall Study||301
8482561|NCT00593385|20904614|P1|NOT COMPLETED|Overall Study||40
8482562|NCT00593385|20904614|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
8482563|NCT00593385|20904614|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
8482564|NCT00593385|20904614|P1|STARTED|Overall Study||165
8482565|NCT00593372|20904651|P2|NOT COMPLETED|Overall Study||0
8482566|NCT00593372|20904652|P1|NOT COMPLETED|Overall Study||0
8482567|NCT00593372|20904651|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
8482568|NCT00593372|20904652|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
8482569|NCT00593372|20904651|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
8482570|NCT00593372|20904652|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
8482571|NCT00593346|20904658|P1|NOT COMPLETED|Overall Study||0
8482572|NCT00593346|20904658|P1|COMPLETED|Overall Study||151
8482573|NCT00593346|20904658|P1|STARTED|Overall Study||151
8482574|NCT00593333|20904675|P2|NOT COMPLETED|Overall Study||11
8482575|NCT00593333|20904676|P1|NOT COMPLETED|Overall Study||10
8482576|NCT00593333|20904675|P2|COMPLETED|Overall Study||45
8482577|NCT00593333|20904676|P1|COMPLETED|Overall Study||44
8482578|NCT00593333|20904675|P2|STARTED|Overall Study||56
8482579|NCT00593333|20904676|P1|STARTED|Overall Study||54
8482580|NCT00593320|20904684|P2|NOT COMPLETED|Overall Study||0
8482581|NCT00593320|20904685|P1|NOT COMPLETED|Overall Study||0
8482582|NCT00593320|20904684|P2|COMPLETED|Overall Study||1
8482583|NCT00593320|20904685|P1|COMPLETED|Overall Study||1
8482584|NCT00593320|20904684|P2|STARTED|Overall Study||1
8482585|NCT00593320|20904685|P1|STARTED|Overall Study||1
8482586|NCT00593112|20904699|P2|NOT COMPLETED|Overall Study||0
8482587|NCT00593112|20904700|P1|NOT COMPLETED|Overall Study||10
8482588|NCT00593112|20904699|P2|COMPLETED|Overall Study||12
8482589|NCT00593112|20904700|P1|COMPLETED|Overall Study||17
8482590|NCT00593112|20904699|P2|STARTED|Overall Study||12
8482591|NCT00593112|20904700|P1|STARTED|Overall Study||27
8482592|NCT00592943|20904712|P2|NOT COMPLETED|Overall Study||0
8482593|NCT00592943|20904713|P1|NOT COMPLETED|Overall Study||0
8482594|NCT00592943|20904712|P2|COMPLETED|Overall Study||6
8482595|NCT00592943|20904713|P1|COMPLETED|Overall Study||6
8482596|NCT00592943|20904712|P2|STARTED|Overall Study||6
8482597|NCT00592943|20904713|P1|STARTED|Overall Study||6
8482598|NCT00592904|20904727|P4|NOT COMPLETED|Overall Study||11
8482599|NCT00592904|20904728|P3|NOT COMPLETED|Overall Study||17
8482600|NCT00592904|20904729|P2|NOT COMPLETED|Overall Study||55
8482601|NCT00592904|20904730|P1|NOT COMPLETED|Overall Study||25
8482602|NCT00592904|20904727|P4|COMPLETED|Overall Study||19
8482603|NCT00592904|20904728|P3|COMPLETED|Overall Study||10
8482604|NCT00592904|20904729|P2|COMPLETED|Overall Study||93
8482605|NCT00592904|20904730|P1|COMPLETED|Overall Study||32
8482606|NCT00592904|20904727|P4|STARTED|Overall Study||30
8482607|NCT00592904|20904728|P3|STARTED|Overall Study||27
8482608|NCT00592904|20904729|P2|STARTED|Overall Study||148
8482609|NCT00592904|20904730|P1|STARTED|Overall Study||57
8482610|NCT00592852|20904756|P1|NOT COMPLETED|Overall Study||6
8482611|NCT00592852|20904756|P1|COMPLETED|Overall Study||7
8482612|NCT00592852|20904756|P1|STARTED|Overall Study||13
8482613|NCT00592839|20904764|P3|NOT COMPLETED|Overall Study||6
8482614|NCT00592839|20904765|P2|NOT COMPLETED|Overall Study||4
8482615|NCT00592839|20904766|P1|NOT COMPLETED|Overall Study||2
8482616|NCT00592839|20904764|P3|COMPLETED|Overall Study||46
8482617|NCT00592839|20904765|P2|COMPLETED|Overall Study||48
8482618|NCT00592839|20904766|P1|COMPLETED|Overall Study||51
8482619|NCT00592839|20904764|P3|STARTED|Overall Study||52
8482620|NCT00592839|20904765|P2|STARTED|Overall Study||52
8482621|NCT00592839|20904766|P1|STARTED|Overall Study||53
8482622|NCT00592774|20904794|P5|NOT COMPLETED|Overall Study||14
8482623|NCT00592774|20904795|P4|NOT COMPLETED|Overall Study||14
8482624|NCT00592774|20904796|P3|NOT COMPLETED|Overall Study||4
8482625|NCT00592774|20904797|P2|NOT COMPLETED|Overall Study||32
8482626|NCT00592774|20904798|P1|NOT COMPLETED|Overall Study||11
8482627|NCT00592774|20904794|P5|COMPLETED|Overall Study||9
8482628|NCT00592774|20904795|P4|COMPLETED|Overall Study||8
8482629|NCT00592774|20904796|P3|COMPLETED|Overall Study||18
8482630|NCT00592774|20904797|P2|COMPLETED|Overall Study||21
8482631|NCT00592774|20904798|P1|COMPLETED|Overall Study||15
8482632|NCT00592774|20904794|P5|STARTED|Overall Study||23
8482633|NCT00592774|20904795|P4|STARTED|Overall Study||22
8482634|NCT00592774|20904796|P3|STARTED|Overall Study||22
8482635|NCT00592774|20904797|P2|STARTED|Overall Study||53
8482636|NCT00592774|20904798|P1|STARTED|Overall Study||26
8482637|NCT00592761|20904855|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8482638|NCT00592761|20904856|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8482639|NCT00592761|20904855|P2|COMPLETED|Second Intervention (2 Weeks)||9
8482640|NCT00592761|20904856|P1|COMPLETED|Second Intervention (2 Weeks)||9
8482641|NCT00592761|20904855|P2|STARTED|Second Intervention (2 Weeks)||9
8482642|NCT00592761|20904856|P1|STARTED|Second Intervention (2 Weeks)||9
8482643|NCT00592761|20904855|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8482644|NCT00592761|20904856|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8482645|NCT00592761|20904855|P2|COMPLETED|First Intervention (2 Weeks)||9
8482646|NCT00592761|20904856|P1|COMPLETED|First Intervention (2 Weeks)||9
8482647|NCT00592761|20904855|P2|STARTED|First Intervention (2 Weeks)||9
8482648|NCT00592761|20904856|P1|STARTED|First Intervention (2 Weeks)||9
8482649|NCT00592683|20904870|P2|NOT COMPLETED|Overall Study||4
8482650|NCT00592683|20904871|P1|NOT COMPLETED|Overall Study||4
8482651|NCT00592683|20904870|P2|COMPLETED|Overall Study||6
8482652|NCT00592683|20904871|P1|COMPLETED|Overall Study||6
8482653|NCT00592683|20904870|P2|STARTED|Overall Study||10
8482654|NCT00592683|20904871|P1|STARTED|Overall Study||10
8482655|NCT00592631|20904881|P2|NOT COMPLETED|Overall Study||2
8482656|NCT00592631|20904882|P1|NOT COMPLETED|Overall Study||0
8482657|NCT00592631|20904881|P2|COMPLETED|Overall Study||9
8482658|NCT00592631|20904882|P1|COMPLETED|Overall Study||16
8482659|NCT00592631|20904881|P2|STARTED|Overall Study||11
8482660|NCT00592631|20904882|P1|STARTED|Overall Study||16
8482661|NCT00592553|20904891|P3|NOT COMPLETED|Overall Study||0
8482662|NCT00592553|20904892|P2|NOT COMPLETED|Overall Study||0
8482663|NCT00592553|20904893|P1|NOT COMPLETED|Overall Study||1
8482664|NCT00592553|20904891|P3|COMPLETED|Overall Study||57
8482665|NCT00592553|20904892|P2|COMPLETED|Overall Study||57
8482666|NCT00592553|20904893|P1|COMPLETED|Overall Study||59
8482667|NCT00592553|20904891|P3|ITT Population|Overall Study||57
8482668|NCT00592553|20904892|P2|ITT Population|Overall Study||57
8482669|NCT00592553|20904893|P1|ITT Population|Overall Study||60
8482670|NCT00592553|20904891|P3|As-treated Population|Overall Study||57
8482671|NCT00592553|20904892|P2|As-treated Population|Overall Study||57
8482672|NCT00592553|20904893|P1|As-treated Population|Overall Study||60
8482673|NCT00592553|20904891|P3|STARTED|Overall Study||57
8482674|NCT00592553|20904892|P2|STARTED|Overall Study||57
8482675|NCT00592553|20904893|P1|STARTED|Overall Study||60
8482676|NCT00592488|20904969|P2|NOT COMPLETED|Overall Study||0
8482677|NCT00592488|20904970|P1|NOT COMPLETED|Overall Study||0
8482678|NCT00592488|20904969|P2|COMPLETED|Overall Study||7
8482679|NCT00592488|20904970|P1|COMPLETED|Overall Study||6
8482680|NCT00592488|20904969|P2|STARTED|Overall Study||7
8482681|NCT00592488|20904970|P1|STARTED|Overall Study||6
8482682|NCT00592475|20904983|P3|NOT COMPLETED|Overall Study||0
8482683|NCT00592475|20904984|P2|NOT COMPLETED|Overall Study||0
8482684|NCT00592475|20904985|P1|NOT COMPLETED|Overall Study||0
8482685|NCT00592475|20904983|P3|COMPLETED|Overall Study||5
8482686|NCT00592475|20904984|P2|COMPLETED|Overall Study||9
8482687|NCT00592475|20904985|P1|COMPLETED|Overall Study||6
8482688|NCT00592475|20904983|P3|STARTED|Overall Study||5
8482689|NCT00592475|20904984|P2|STARTED|Overall Study||9
8482690|NCT00592475|20904985|P1|STARTED|Overall Study||6
8482691|NCT00592384|20905010|P2|NOT COMPLETED|Overall Study||6
8482692|NCT00592384|20905011|P1|NOT COMPLETED|Overall Study||5
8482693|NCT00592384|20905010|P2|COMPLETED|Overall Study||63
8482694|NCT00592384|20905011|P1|COMPLETED|Overall Study||59
8482695|NCT00592384|20905010|P2|STARTED|Overall Study||69
8482696|NCT00592384|20905011|P1|STARTED|Overall Study||64
8482697|NCT00592358|20905019|P1|NOT COMPLETED|Overall Study||6
8482698|NCT00592358|20905019|P1|COMPLETED|Overall Study||11
8482699|NCT00592358|20905019|P1|STARTED|Overall Study||17
8482700|NCT00592319|20905026|P2|NOT COMPLETED|Overall Study||3
8482701|NCT00592319|20905027|P1|NOT COMPLETED|Overall Study||0
8482702|NCT00592319|20905026|P2|COMPLETED|Overall Study||5
8482703|NCT00592319|20905027|P1|COMPLETED|Overall Study||2
8482704|NCT00592319|20905026|P2|STARTED|Overall Study||8
8482705|NCT00592319|20905027|P1|STARTED|Overall Study||2
8482706|NCT00592176|20905035|P1|NOT COMPLETED|Overall Study||0
8482707|NCT00592176|20905035|P1|COMPLETED|Overall Study||5
8482708|NCT00592176|20905035|P1|STARTED|Overall Study||5
8482709|NCT00592124|20905046|P6|NOT COMPLETED|Overall Study||3
8482710|NCT00592124|20905047|P5|NOT COMPLETED|Overall Study||3
8482711|NCT00592124|20905048|P4|NOT COMPLETED|Overall Study||3
8482712|NCT00592124|20905049|P3|NOT COMPLETED|Overall Study||6
8482713|NCT00592124|20905050|P2|NOT COMPLETED|Overall Study||5
8482714|NCT00592124|20905051|P1|NOT COMPLETED|Overall Study||4
8482715|NCT00592124|20905046|P6|COMPLETED|Overall Study||24
8482716|NCT00592124|20905047|P5|COMPLETED|Overall Study||24
8482717|NCT00592124|20905048|P4|COMPLETED|Overall Study||24
8482718|NCT00592124|20905049|P3|COMPLETED|Overall Study||24
8482719|NCT00592124|20905050|P2|COMPLETED|Overall Study||24
8482720|NCT00592124|20905051|P1|COMPLETED|Overall Study||24
8482721|NCT00592124|20905046|P6|STARTED|Overall Study||27
8482722|NCT00592124|20905047|P5|STARTED|Overall Study||27
8482723|NCT00592124|20905048|P4|STARTED|Overall Study||27
8482724|NCT00592124|20905049|P3|STARTED|Overall Study||30
8482725|NCT00592124|20905050|P2|STARTED|Overall Study||29
8482726|NCT00592124|20905051|P1|STARTED|Overall Study||28
8482727|NCT00592072|20905102|P2|NOT COMPLETED|Second Sequence||0
8482728|NCT00592072|20905103|P1|NOT COMPLETED|Second Sequence||0
8482729|NCT00592072|20905102|P2|COMPLETED|Second Sequence||5
8482730|NCT00592072|20905103|P1|COMPLETED|Second Sequence||5
8482731|NCT00592072|20905102|P2|STARTED|Second Sequence||5
8482732|NCT00592072|20905103|P1|STARTED|Second Sequence||5
8482733|NCT00592072|20905102|P2|NOT COMPLETED|Wash Out Period||1
8482734|NCT00592072|20905103|P1|NOT COMPLETED|Wash Out Period||1
8482735|NCT00592072|20905102|P2|COMPLETED|Wash Out Period||5
8482736|NCT00592072|20905103|P1|COMPLETED|Wash Out Period||5
8482737|NCT00592072|20905102|P2|STARTED|Wash Out Period||6
8482738|NCT00592072|20905103|P1|STARTED|Wash Out Period||6
8482739|NCT00592072|20905102|P2|NOT COMPLETED|First Sequence||0
8482740|NCT00592072|20905103|P1|NOT COMPLETED|First Sequence||0
8482741|NCT00592072|20905102|P2|COMPLETED|First Sequence||6
8482742|NCT00592072|20905103|P1|COMPLETED|First Sequence||6
8482743|NCT00592072|20905102|P2|STARTED|First Sequence||6
8482744|NCT00592072|20905103|P1|STARTED|First Sequence||6
8482745|NCT00592007|20905125|P1|NOT COMPLETED|Overall Study||2
8482746|NCT00592007|20905125|P1|COMPLETED|Overall Study||5
8482747|NCT00592007|20905125|P1|STARTED|Overall Study||7
8482748|NCT00591942|20905130|P2|NOT COMPLETED|Overall Study||0
8482749|NCT00591942|20905131|P1|NOT COMPLETED|Overall Study||0
8482750|NCT00591942|20905130|P2|COMPLETED|Overall Study||36
8482751|NCT00591942|20905131|P1|COMPLETED|Overall Study||36
8482752|NCT00591942|20905130|P2|STARTED|Overall Study||36
8482753|NCT00591942|20905131|P1|STARTED|Overall Study||36
8482754|NCT00591864|20905137|P1|NOT COMPLETED|Overall Study||5
8482755|NCT00591864|20905137|P1|COMPLETED|Overall Study||84
8482756|NCT00591864|20905137|P1|STARTED|Overall Study||89
8482757|NCT00591851|20905143|P1|NOT COMPLETED|Overall Study||6
8482758|NCT00591851|20905143|P1|COMPLETED|Overall Study||64
8482759|NCT00591851|20905143|P1|STARTED|Overall Study||70
8482760|NCT00591838|20905152|P5|NOT COMPLETED|Overall Study||0
8482761|NCT00591838|20905153|P4|NOT COMPLETED|Overall Study||1
8482762|NCT00591838|20905154|P3|NOT COMPLETED|Overall Study||0
8482763|NCT00591838|20905155|P2|NOT COMPLETED|Overall Study||0
8482764|NCT00591838|20905156|P1|NOT COMPLETED|Overall Study||0
8482765|NCT00591838|20905152|P5|COMPLETED|Overall Study||51
8482766|NCT00591838|20905153|P4|COMPLETED|Overall Study||5
8482767|NCT00591838|20905154|P3|COMPLETED|Overall Study||6
8482768|NCT00591838|20905155|P2|COMPLETED|Overall Study||6
8482769|NCT00591838|20905156|P1|COMPLETED|Overall Study||5
8482770|NCT00591838|20905152|P5|STARTED|Overall Study||51
8482771|NCT00591838|20905153|P4|STARTED|Overall Study||6
8482772|NCT00591838|20905154|P3|STARTED|Overall Study||6
8482773|NCT00591838|20905155|P2|STARTED|Overall Study||6
8482774|NCT00591838|20905156|P1|STARTED|Overall Study||5
8482775|NCT00591825|20905181|P4|NOT COMPLETED|Overall Study||0
8482776|NCT00591825|20905182|P3|NOT COMPLETED|Overall Study||0
8482777|NCT00591825|20905183|P2|NOT COMPLETED|Overall Study||0
8482778|NCT00591825|20905184|P1|NOT COMPLETED|Overall Study||0
8482779|NCT00591825|20905181|P4|COMPLETED|Overall Study||14
8482780|NCT00591825|20905182|P3|COMPLETED|Overall Study||13
8482781|NCT00591825|20905183|P2|COMPLETED|Overall Study||13
8482782|NCT00591825|20905184|P1|COMPLETED|Overall Study||14
8482783|NCT00591825|20905181|P4|STARTED|Overall Study||14
8482784|NCT00591825|20905182|P3|STARTED|Overall Study||13
8482785|NCT00591825|20905183|P2|STARTED|Overall Study||13
8482786|NCT00591825|20905184|P1|STARTED|Overall Study||14
8482787|NCT00591786|20905220|P10|NOT COMPLETED|Overall Study||0
8482788|NCT00591786|20905221|P9|NOT COMPLETED|Overall Study||0
8482789|NCT00591786|20905222|P8|NOT COMPLETED|Overall Study||0
8482790|NCT00591786|20905223|P7|NOT COMPLETED|Overall Study||0
8482791|NCT00591786|20905224|P6|NOT COMPLETED|Overall Study||0
8482792|NCT00591786|20905225|P5|NOT COMPLETED|Overall Study||0
8482793|NCT00591786|20905226|P4|NOT COMPLETED|Overall Study||0
8482794|NCT00591786|20905227|P3|NOT COMPLETED|Overall Study||1
8482795|NCT00591786|20905228|P2|NOT COMPLETED|Overall Study||0
8482796|NCT00591786|20905229|P1|NOT COMPLETED|Overall Study||0
8482797|NCT00591786|20905220|P10|COMPLETED|Overall Study||10
8482798|NCT00591786|20905221|P9|COMPLETED|Overall Study||10
8482799|NCT00591786|20905222|P8|COMPLETED|Overall Study||10
8482800|NCT00591786|20905223|P7|COMPLETED|Overall Study||10
8482801|NCT00591786|20905224|P6|COMPLETED|Overall Study||10
8482802|NCT00591786|20905225|P5|COMPLETED|Overall Study||10
8482803|NCT00591786|20905226|P4|COMPLETED|Overall Study||11
8482804|NCT00591786|20905227|P3|COMPLETED|Overall Study||10
8482805|NCT00591786|20905228|P2|COMPLETED|Overall Study||9
8482806|NCT00591786|20905229|P1|COMPLETED|Overall Study||9
8482807|NCT00591786|20905220|P10|Treated Participants|Overall Study||10
8482808|NCT00591786|20905221|P9|Treated Participants|Overall Study||10
8482809|NCT00591786|20905222|P8|Treated Participants|Overall Study||10
8482810|NCT00591786|20905223|P7|Treated Participants|Overall Study||10
8482811|NCT00591786|20905224|P6|Treated Participants|Overall Study||10
8482812|NCT00591786|20905225|P5|Treated Participants|Overall Study||10
8482813|NCT00591786|20905226|P4|Treated Participants|Overall Study||11
8482814|NCT00591786|20905227|P3|Treated Participants|Overall Study||10
8482815|NCT00591786|20905228|P2|Treated Participants|Overall Study||9
8482816|NCT00591786|20905229|P1|Treated Participants|Overall Study||9
8482817|NCT00591786|20905220|P10|STARTED|Overall Study||10
8482818|NCT00591786|20905221|P9|STARTED|Overall Study||10
8482819|NCT00591786|20905222|P8|STARTED|Overall Study||10
8482820|NCT00591786|20905223|P7|STARTED|Overall Study||10
8482821|NCT00591786|20905224|P6|STARTED|Overall Study||10
8482822|NCT00591786|20905225|P5|STARTED|Overall Study||10
8482823|NCT00591786|20905226|P4|STARTED|Overall Study||11
8482824|NCT00591786|20905227|P3|STARTED|Overall Study||11
8482825|NCT00591786|20905228|P2|STARTED|Overall Study||9
8482826|NCT00591786|20905229|P1|STARTED|Overall Study||9
8482827|NCT00591773|20905274|P3|NOT COMPLETED|Overall Study||16
8482828|NCT00591773|20905275|P2|NOT COMPLETED|Overall Study||24
8482829|NCT00591773|20905276|P1|NOT COMPLETED|Overall Study||16
8482830|NCT00591773|20905274|P3|COMPLETED|Overall Study||168
8482831|NCT00591773|20905275|P2|COMPLETED|Overall Study||158
8482832|NCT00591773|20905276|P1|COMPLETED|Overall Study||169
8482833|NCT00591773|20905274|P3|STARTED|Overall Study||184
8482834|NCT00591773|20905275|P2|STARTED|Overall Study||182
8482835|NCT00591773|20905276|P1|STARTED|Overall Study||185
8482836|NCT00591760|20905328|P2|NOT COMPLETED|Overall Study||0
8482837|NCT00591760|20905329|P1|NOT COMPLETED|Overall Study||0
8482838|NCT00591760|20905328|P2|COMPLETED|Overall Study||28
8482839|NCT00591760|20905329|P1|COMPLETED|Overall Study||28
8482840|NCT00591760|20905328|P2|STARTED|Overall Study||28
8482841|NCT00591760|20905329|P1|STARTED|Overall Study||28
8482842|NCT00591734|20905335|P1|NOT COMPLETED|Overall Study||53
8482843|NCT00591734|20905335|P1|COMPLETED|Overall Study||4
8482844|NCT00591734|20905335|P1|STARTED|Overall Study||57
8482845|NCT00591721|20905341|P2|NOT COMPLETED|Overall Study||22
8482846|NCT00591721|20905342|P1|NOT COMPLETED|Overall Study||21
8482847|NCT00591721|20905341|P2|COMPLETED|Overall Study||70
8482848|NCT00591721|20905342|P1|COMPLETED|Overall Study||68
8482849|NCT00591721|20905341|P2|STARTED|Overall Study||92
8482850|NCT00591721|20905342|P1|STARTED|Overall Study||89
8482851|NCT00591591|20905350|P2|NOT COMPLETED|Overall Study||39
8482852|NCT00591591|20905351|P1|NOT COMPLETED|Overall Study||11
8482853|NCT00591591|20905350|P2|COMPLETED|Overall Study||94
8482854|NCT00591591|20905351|P1|COMPLETED|Overall Study||165
8482855|NCT00591591|20905350|P2|STARTED|Overall Study||133
8482856|NCT00591591|20905351|P1|STARTED|Overall Study||176
8482857|NCT00591578|20905368|P3|NOT COMPLETED|Open-Label Extension Phase||0
8482858|NCT00591578|20905369|P2|NOT COMPLETED|Open-Label Extension Phase||10
8482859|NCT00591578|20905370|P1|NOT COMPLETED|Open-Label Extension Phase||6
8482860|NCT00591578|20905368|P3|COMPLETED|Open-Label Extension Phase||0
8482861|NCT00591578|20905369|P2|COMPLETED|Open-Label Extension Phase||105
8482862|NCT00591578|20905370|P1|COMPLETED|Open-Label Extension Phase||49
8482863|NCT00591578|20905368|P3|STARTED|Open-Label Extension Phase||0
8482864|NCT00591578|20905369|P2|STARTED|Open-Label Extension Phase||115
8482865|NCT00591578|20905370|P1|STARTED|Open-Label Extension Phase||55
8482866|NCT00591578|20905368|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
8482867|NCT00591578|20905369|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
8482868|NCT00591578|20905370|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
8482869|NCT00591578|20905368|P3|COMPLETED|Double-Blind Treatment Phase||244
8482870|NCT00591578|20905369|P2|COMPLETED|Double-Blind Treatment Phase||249
8482871|NCT00591578|20905370|P1|COMPLETED|Double-Blind Treatment Phase||249
8482872|NCT00591578|20905368|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
8482873|NCT00591578|20905369|P2|STARTED|Double-Blind Treatment Phase||329
8482874|NCT00591578|20905370|P1|STARTED|Double-Blind Treatment Phase||327
8482875|NCT00591565|20905421|P1|NOT COMPLETED|Overall Study||5
8482876|NCT00591565|20905421|P1|COMPLETED|Overall Study||8
8482877|NCT00591565|20905421|P1|STARTED|Overall Study||13
8482878|NCT00591409|20905435|P10|NOT COMPLETED|Overall Study||1
8482879|NCT00591409|20905436|P9|NOT COMPLETED|Overall Study||0
8482880|NCT00591409|20905437|P8|NOT COMPLETED|Overall Study||0
8482881|NCT00591409|20905438|P7|NOT COMPLETED|Overall Study||0
8482882|NCT00591409|20905439|P6|NOT COMPLETED|Overall Study||0
8482883|NCT00591409|20905440|P5|NOT COMPLETED|Overall Study||1
8482884|NCT00591409|20905441|P4|NOT COMPLETED|Overall Study||0
8482885|NCT00591409|20905442|P3|NOT COMPLETED|Overall Study||0
8482886|NCT00591409|20905443|P2|NOT COMPLETED|Overall Study||0
8482887|NCT00591409|20905444|P1|NOT COMPLETED|Overall Study||0
8482888|NCT00591409|20905435|P10|COMPLETED|Overall Study||10
8482889|NCT00591409|20905436|P9|COMPLETED|Overall Study||9
8482890|NCT00591409|20905437|P8|COMPLETED|Overall Study||10
8482891|NCT00591409|20905438|P7|COMPLETED|Overall Study||10
8482892|NCT00591409|20905439|P6|COMPLETED|Overall Study||10
8482893|NCT00591409|20905440|P5|COMPLETED|Overall Study||9
8482894|NCT00591409|20905441|P4|COMPLETED|Overall Study||10
8482895|NCT00591409|20905442|P3|COMPLETED|Overall Study||10
8482896|NCT00591409|20905443|P2|COMPLETED|Overall Study||10
8482897|NCT00591409|20905444|P1|COMPLETED|Overall Study||10
8482898|NCT00591409|20905435|P10|Treated|Overall Study||10
8482899|NCT00591409|20905436|P9|Treated|Overall Study||9
8482900|NCT00591409|20905437|P8|Treated|Overall Study||10
8482901|NCT00591409|20905438|P7|Treated|Overall Study||10
8482902|NCT00591409|20905439|P6|Treated|Overall Study||10
8482903|NCT00591409|20905440|P5|Treated|Overall Study||9
8482904|NCT00591409|20905441|P4|Treated|Overall Study||10
8482905|NCT00591409|20905442|P3|Treated|Overall Study||10
8482906|NCT00591409|20905443|P2|Treated|Overall Study||10
8482907|NCT00591409|20905444|P1|Treated|Overall Study||10
8482908|NCT00591409|20905435|P10|STARTED|Overall Study||11
8482909|NCT00591409|20905436|P9|STARTED|Overall Study||9
8482910|NCT00591409|20905437|P8|STARTED|Overall Study||10
8482911|NCT00591409|20905438|P7|STARTED|Overall Study||10
8482912|NCT00591409|20905439|P6|STARTED|Overall Study||10
8482913|NCT00591409|20905440|P5|STARTED|Overall Study||10
8482914|NCT00591409|20905441|P4|STARTED|Overall Study||10
8482915|NCT00591409|20905442|P3|STARTED|Overall Study||10
8482916|NCT00591409|20905443|P2|STARTED|Overall Study||10
8482917|NCT00591409|20905444|P1|STARTED|Overall Study||10
8482918|NCT00591370|20905486|P1|NOT COMPLETED|Overall Study||2
8482919|NCT00591370|20905486|P1|COMPLETED|Overall Study||49
8482920|NCT00591370|20905486|P1|STARTED|Overall Study||51
8482921|NCT00591344|20905494|P2|NOT COMPLETED|Overall Study||8
8482922|NCT00591344|20905495|P1|NOT COMPLETED|Overall Study||5
8482923|NCT00591344|20905494|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
8482924|NCT00591344|20905495|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
8482925|NCT00591344|20905494|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
8482926|NCT00591344|20905495|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
8482927|NCT00591344|20905494|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
8482928|NCT00591344|20905495|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
8482929|NCT00591305|20905507|P2|NOT COMPLETED|Overall Study||0
8482930|NCT00591305|20905508|P1|NOT COMPLETED|Overall Study||0
8482931|NCT00591305|20905507|P2|COMPLETED|Overall Study||0
8482932|NCT00591305|20905508|P1|COMPLETED|Overall Study||1
8482933|NCT00591305|20905507|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
8482934|NCT00591305|20905508|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
8482935|NCT00591305|20905507|P2|STARTED|Overall Study||0
8482936|NCT00591305|20905508|P1|STARTED|Overall Study||1
8482937|NCT00591266|20905521|P3|NOT COMPLETED|Overall Study||14
8482938|NCT00591266|20905522|P2|NOT COMPLETED|Overall Study||11
8482939|NCT00591266|20905523|P1|NOT COMPLETED|Overall Study||9
8482940|NCT00591266|20905521|P3|COMPLETED|Overall Study||175
8482941|NCT00591266|20905522|P2|COMPLETED|Overall Study||177
8482942|NCT00591266|20905523|P1|COMPLETED|Overall Study||180
8482943|NCT00591266|20905521|P3|STARTED|Overall Study|Randomized only|189
8482944|NCT00591266|20905522|P2|STARTED|Overall Study|Randomized only|188
8482945|NCT00591266|20905523|P1|STARTED|Overall Study|Randomized only|189
8482946|NCT00591253|20905576|P3|NOT COMPLETED|Overall Study||15
8482947|NCT00591253|20905577|P2|NOT COMPLETED|Overall Study||21
8482948|NCT00591253|20905578|P1|NOT COMPLETED|Overall Study||14
8482949|NCT00591253|20905576|P3|COMPLETED|Overall Study||123
8482950|NCT00591253|20905577|P2|COMPLETED|Overall Study||116
8482951|NCT00591253|20905578|P1|COMPLETED|Overall Study||126
8482952|NCT00591253|20905576|P3|STARTED|Overall Study|Randomized or Treated|138
8482953|NCT00591253|20905577|P2|STARTED|Overall Study|Randomized or Treated|137
8482954|NCT00591253|20905578|P1|STARTED|Overall Study|Randomized or Treated|140
8482955|NCT00591240|20905630|P2|NOT COMPLETED|Overall Study||0
8482956|NCT00591240|20905631|P1|NOT COMPLETED|Overall Study||0
8482957|NCT00591240|20905630|P2|COMPLETED|Overall Study||222
8482958|NCT00591240|20905631|P1|COMPLETED|Overall Study||116
8482959|NCT00591240|20905630|P2|STARTED|Overall Study||222
8482960|NCT00591240|20905631|P1|STARTED|Overall Study||116
8482961|NCT00591227|20905639|P2|NOT COMPLETED|Overall Study||0
8482962|NCT00591227|20905640|P1|NOT COMPLETED|Overall Study||0
8482963|NCT00591227|20905639|P2|COMPLETED|Overall Study||87
8482964|NCT00591227|20905640|P1|COMPLETED|Overall Study||89
8482965|NCT00591227|20905639|P2|STARTED|Overall Study||87
8482966|NCT00591227|20905640|P1|STARTED|Overall Study||89
8482967|NCT00591214|20905646|P1|NOT COMPLETED|Overall Study||8
8482968|NCT00591214|20905646|P1|COMPLETED|Overall Study||2
8482969|NCT00591214|20905646|P1|STARTED|Overall Study||10
8482970|NCT00591149|20905655|P1|NOT COMPLETED|Overall Study||5
8482971|NCT00591149|20905655|P1|COMPLETED|Overall Study||11
8482972|NCT00591149|20905655|P1|STARTED|Overall Study||16
8482973|NCT00591019|20905659|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
8482974|NCT00591019|20905660|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
8482975|NCT00591019|20905659|P2|COMPLETED|Intevention 2 (14 Days)||3
8482976|NCT00591019|20905660|P1|COMPLETED|Intevention 2 (14 Days)||2
8482977|NCT00591019|20905659|P2|STARTED|Intevention 2 (14 Days)||3
8482978|NCT00591019|20905660|P1|STARTED|Intevention 2 (14 Days)||2
8482979|NCT00591019|20905659|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
8482980|NCT00591019|20905660|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
8482981|NCT00591019|20905659|P2|COMPLETED|Intervention 1 (14 Days)||3
8482982|NCT00591019|20905660|P1|COMPLETED|Intervention 1 (14 Days)||2
8482983|NCT00591019|20905659|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
8482984|NCT00591019|20905660|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
8482985|NCT00591019|20905659|P2|NOT COMPLETED|Baseline (1 Day)||0
8482986|NCT00591019|20905660|P1|NOT COMPLETED|Baseline (1 Day)||0
8482987|NCT00591019|20905659|P2|COMPLETED|Baseline (1 Day)||4
8482988|NCT00591019|20905660|P1|COMPLETED|Baseline (1 Day)||3
8482989|NCT00591019|20905659|P2|STARTED|Baseline (1 Day)||4
8482990|NCT00591019|20905660|P1|STARTED|Baseline (1 Day)||3
8482991|NCT00591006|20905671|P24|NOT COMPLETED|Overall Study||1
8482992|NCT00591006|20905672|P23|NOT COMPLETED|Overall Study||1
8482993|NCT00591006|20905673|P22|NOT COMPLETED|Overall Study||0
8482994|NCT00591006|20905674|P21|NOT COMPLETED|Overall Study||0
8482995|NCT00591006|20905675|P20|NOT COMPLETED|Overall Study||0
8482996|NCT00591006|20905676|P19|NOT COMPLETED|Overall Study||0
8482997|NCT00591006|20905677|P18|NOT COMPLETED|Overall Study||0
8482998|NCT00591006|20905678|P17|NOT COMPLETED|Overall Study||0
8482999|NCT00591006|20905679|P16|NOT COMPLETED|Overall Study||1
8483000|NCT00591006|20905680|P15|NOT COMPLETED|Overall Study||0
8483001|NCT00591006|20905681|P14|NOT COMPLETED|Overall Study||0
8483002|NCT00591006|20905682|P13|NOT COMPLETED|Overall Study||0
8483003|NCT00591006|20905683|P12|NOT COMPLETED|Overall Study||0
8483004|NCT00591006|20905684|P11|NOT COMPLETED|Overall Study||0
8483005|NCT00591006|20905685|P10|NOT COMPLETED|Overall Study||0
8483006|NCT00591006|20905686|P9|NOT COMPLETED|Overall Study||0
8483007|NCT00591006|20905687|P8|NOT COMPLETED|Overall Study||0
8483008|NCT00591006|20905688|P7|NOT COMPLETED|Overall Study||0
8483009|NCT00591006|20905689|P6|NOT COMPLETED|Overall Study||0
8483010|NCT00591006|20905690|P5|NOT COMPLETED|Overall Study||0
8483011|NCT00591006|20905691|P4|NOT COMPLETED|Overall Study||0
8483012|NCT00591006|20905692|P3|NOT COMPLETED|Overall Study||0
8483013|NCT00591006|20905693|P2|NOT COMPLETED|Overall Study||0
8483014|NCT00591006|20905694|P1|NOT COMPLETED|Overall Study||0
8483015|NCT00591006|20905671|P24|COMPLETED|Overall Study||0
8483016|NCT00591006|20905672|P23|COMPLETED|Overall Study||0
8483017|NCT00591006|20905673|P22|COMPLETED|Overall Study||1
8483018|NCT00591006|20905674|P21|COMPLETED|Overall Study||0
8483019|NCT00591006|20905675|P20|COMPLETED|Overall Study||1
8483020|NCT00591006|20905676|P19|COMPLETED|Overall Study||0
8483021|NCT00591006|20905677|P18|COMPLETED|Overall Study||1
8483022|NCT00591006|20905678|P17|COMPLETED|Overall Study||0
8483023|NCT00591006|20905679|P16|COMPLETED|Overall Study||0
8483024|NCT00591006|20905680|P15|COMPLETED|Overall Study||0
8483025|NCT00591006|20905681|P14|COMPLETED|Overall Study||2
8483026|NCT00591006|20905682|P13|COMPLETED|Overall Study||1
8483027|NCT00591006|20905683|P12|COMPLETED|Overall Study||1
8483028|NCT00591006|20905684|P11|COMPLETED|Overall Study||0
8483029|NCT00591006|20905685|P10|COMPLETED|Overall Study||1
8483030|NCT00591006|20905686|P9|COMPLETED|Overall Study||1
8483031|NCT00591006|20905687|P8|COMPLETED|Overall Study||0
8483032|NCT00591006|20905688|P7|COMPLETED|Overall Study||1
8483033|NCT00591006|20905689|P6|COMPLETED|Overall Study||0
8483034|NCT00591006|20905690|P5|COMPLETED|Overall Study||1
8483035|NCT00591006|20905691|P4|COMPLETED|Overall Study||1
8483036|NCT00591006|20905692|P3|COMPLETED|Overall Study||1
8483037|NCT00591006|20905693|P2|COMPLETED|Overall Study||0
8483038|NCT00591006|20905694|P1|COMPLETED|Overall Study||1
8483039|NCT00591006|20905671|P24|Treatment #4|Overall Study||0
8483040|NCT00591006|20905672|P23|Treatment #4|Overall Study||0
8483041|NCT00591006|20905673|P22|Treatment #4|Overall Study||1
8483042|NCT00591006|20905674|P21|Treatment #4|Overall Study||0
8483043|NCT00591006|20905675|P20|Treatment #4|Overall Study||1
8483044|NCT00591006|20905676|P19|Treatment #4|Overall Study||0
8483045|NCT00591006|20905677|P18|Treatment #4|Overall Study||1
8483046|NCT00591006|20905678|P17|Treatment #4|Overall Study||0
8483047|NCT00591006|20905679|P16|Treatment #4|Overall Study||0
8483048|NCT00591006|20905680|P15|Treatment #4|Overall Study||0
8483049|NCT00591006|20905681|P14|Treatment #4|Overall Study||2
8483050|NCT00591006|20905682|P13|Treatment #4|Overall Study||1
8483051|NCT00591006|20905683|P12|Treatment #4|Overall Study||1
8483052|NCT00591006|20905684|P11|Treatment #4|Overall Study||0
8483053|NCT00591006|20905685|P10|Treatment #4|Overall Study||1
8483054|NCT00591006|20905686|P9|Treatment #4|Overall Study||1
8483055|NCT00591006|20905687|P8|Treatment #4|Overall Study||0
8483056|NCT00591006|20905688|P7|Treatment #4|Overall Study||1
8483057|NCT00591006|20905689|P6|Treatment #4|Overall Study||0
8483058|NCT00591006|20905690|P5|Treatment #4|Overall Study||1
8483059|NCT00591006|20905691|P4|Treatment #4|Overall Study||1
8483060|NCT00591006|20905692|P3|Treatment #4|Overall Study||1
8483061|NCT00591006|20905693|P2|Treatment #4|Overall Study||0
8483062|NCT00591006|20905694|P1|Treatment #4|Overall Study||1
8483063|NCT00591006|20905671|P24|Treatment #3|Overall Study||1
8483064|NCT00591006|20905672|P23|Treatment #3|Overall Study||1
8483065|NCT00591006|20905673|P22|Treatment #3|Overall Study||1
8483066|NCT00591006|20905674|P21|Treatment #3|Overall Study||0
8483067|NCT00591006|20905675|P20|Treatment #3|Overall Study||1
8483068|NCT00591006|20905676|P19|Treatment #3|Overall Study||0
8483069|NCT00591006|20905677|P18|Treatment #3|Overall Study||1
8483070|NCT00591006|20905678|P17|Treatment #3|Overall Study||0
8483071|NCT00591006|20905679|P16|Treatment #3|Overall Study||0
8483072|NCT00591006|20905680|P15|Treatment #3|Overall Study||0
8483073|NCT00591006|20905681|P14|Treatment #3|Overall Study||2
8483074|NCT00591006|20905682|P13|Treatment #3|Overall Study||1
8483075|NCT00591006|20905683|P12|Treatment #3|Overall Study||1
8483076|NCT00591006|20905684|P11|Treatment #3|Overall Study||0
8483077|NCT00591006|20905685|P10|Treatment #3|Overall Study||1
8483078|NCT00591006|20905686|P9|Treatment #3|Overall Study||1
8483079|NCT00591006|20905687|P8|Treatment #3|Overall Study||0
8483080|NCT00591006|20905688|P7|Treatment #3|Overall Study||1
8483081|NCT00591006|20905689|P6|Treatment #3|Overall Study||0
8483082|NCT00591006|20905690|P5|Treatment #3|Overall Study||1
8483083|NCT00591006|20905691|P4|Treatment #3|Overall Study||1
8483084|NCT00591006|20905692|P3|Treatment #3|Overall Study||1
8483085|NCT00591006|20905693|P2|Treatment #3|Overall Study||0
8483086|NCT00591006|20905694|P1|Treatment #3|Overall Study||1
8483087|NCT00591006|20905671|P24|Treatment #2|Overall Study||1
8483088|NCT00591006|20905672|P23|Treatment #2|Overall Study||1
8483089|NCT00591006|20905673|P22|Treatment #2|Overall Study||1
8483090|NCT00591006|20905674|P21|Treatment #2|Overall Study||0
8483091|NCT00591006|20905675|P20|Treatment #2|Overall Study||1
8483092|NCT00591006|20905676|P19|Treatment #2|Overall Study||0
8483093|NCT00591006|20905677|P18|Treatment #2|Overall Study||1
8483094|NCT00591006|20905678|P17|Treatment #2|Overall Study||0
8483095|NCT00591006|20905679|P16|Treatment #2|Overall Study||0
8483096|NCT00591006|20905680|P15|Treatment #2|Overall Study||0
8483097|NCT00591006|20905681|P14|Treatment #2|Overall Study||2
8483098|NCT00591006|20905682|P13|Treatment #2|Overall Study||1
8483099|NCT00591006|20905683|P12|Treatment #2|Overall Study||1
8483100|NCT00591006|20905684|P11|Treatment #2|Overall Study||0
8483101|NCT00591006|20905685|P10|Treatment #2|Overall Study||1
8483102|NCT00591006|20905686|P9|Treatment #2|Overall Study||1
8483103|NCT00591006|20905687|P8|Treatment #2|Overall Study||0
8483104|NCT00591006|20905688|P7|Treatment #2|Overall Study||1
8483105|NCT00591006|20905689|P6|Treatment #2|Overall Study||0
8483106|NCT00591006|20905690|P5|Treatment #2|Overall Study||1
8483107|NCT00591006|20905691|P4|Treatment #2|Overall Study||1
8483108|NCT00591006|20905692|P3|Treatment #2|Overall Study||1
8483109|NCT00591006|20905693|P2|Treatment #2|Overall Study||0
8483110|NCT00591006|20905694|P1|Treatment #2|Overall Study||1
8483111|NCT00591006|20905671|P24|STARTED|Overall Study||1
8483112|NCT00591006|20905672|P23|STARTED|Overall Study||1
8483113|NCT00591006|20905673|P22|STARTED|Overall Study||1
8483114|NCT00591006|20905674|P21|STARTED|Overall Study||0
8483115|NCT00591006|20905675|P20|STARTED|Overall Study||1
8483116|NCT00591006|20905676|P19|STARTED|Overall Study||0
8483117|NCT00591006|20905677|P18|STARTED|Overall Study||1
8483118|NCT00591006|20905678|P17|STARTED|Overall Study||0
8483119|NCT00591006|20905679|P16|STARTED|Overall Study||1
8483120|NCT00591006|20905680|P15|STARTED|Overall Study||0
8483121|NCT00591006|20905681|P14|STARTED|Overall Study||2
8483122|NCT00591006|20905682|P13|STARTED|Overall Study||1
8483123|NCT00591006|20905683|P12|STARTED|Overall Study||1
8483124|NCT00591006|20905684|P11|STARTED|Overall Study||0
8483125|NCT00591006|20905685|P10|STARTED|Overall Study||1
8483126|NCT00591006|20905686|P9|STARTED|Overall Study||1
8483127|NCT00591006|20905687|P8|STARTED|Overall Study||0
8483128|NCT00591006|20905688|P7|STARTED|Overall Study||1
8483129|NCT00591006|20905689|P6|STARTED|Overall Study||0
8483130|NCT00591006|20905690|P5|STARTED|Overall Study||1
8483131|NCT00591006|20905691|P4|STARTED|Overall Study||1
8483132|NCT00591006|20905692|P3|STARTED|Overall Study||1
8483133|NCT00591006|20905693|P2|STARTED|Overall Study||0
8483134|NCT00591006|20905694|P1|STARTED|Overall Study||1
8483135|NCT00590980|20905712|P1|NOT COMPLETED|Overall Study||10
8483136|NCT00590980|20905712|P1|COMPLETED|Overall Study||72
8483137|NCT00590980|20905712|P1|STARTED|Overall Study||82
8483138|NCT00590967|20905718|P2|NOT COMPLETED|Overall Study||5
8483139|NCT00590967|20905719|P1|NOT COMPLETED|Overall Study||3
8483140|NCT00590967|20905718|P2|COMPLETED|Overall Study||20
8483141|NCT00590967|20905719|P1|COMPLETED|Overall Study||41
8483142|NCT00590967|20905718|P2|STARTED|Overall Study||25
8483143|NCT00590967|20905719|P1|STARTED|Overall Study||44
8483144|NCT00590954|20905731|P1|NOT COMPLETED|Overall Study||2
8483145|NCT00590954|20905731|P1|COMPLETED|Overall Study||30
8483146|NCT00590954|20905731|P1|STARTED|Overall Study||32
8483147|NCT00590902|20905737|P1|NOT COMPLETED|Overall Study||1
8483148|NCT00590902|20905737|P1|COMPLETED|Overall Study||80
8483149|NCT00590902|20905737|P1|STARTED|Overall Study||81
8483150|NCT00590889|20905743|P2|NOT COMPLETED|Overall Study||299
8483151|NCT00590889|20905744|P1|NOT COMPLETED|Overall Study||286
8483152|NCT00590889|20905743|P2|COMPLETED|Overall Study||104
8483153|NCT00590889|20905744|P1|COMPLETED|Overall Study||118
8483154|NCT00590889|20905743|P2|STARTED|Overall Study||403
8483155|NCT00590889|20905744|P1|STARTED|Overall Study||404
8483156|NCT00590863|20905753|P3|NOT COMPLETED|Overall Study||78
8483157|NCT00590863|20905754|P2|NOT COMPLETED|Overall Study||82
8483158|NCT00590863|20905755|P1|NOT COMPLETED|Overall Study||84
8483159|NCT00590863|20905753|P3|COMPLETED|Overall Study||146
8483160|NCT00590863|20905754|P2|COMPLETED|Overall Study||138
8483161|NCT00590863|20905755|P1|COMPLETED|Overall Study||137
8483162|NCT00590863|20905753|P3|STARTED|Overall Study||224
8483163|NCT00590863|20905754|P2|STARTED|Overall Study||220
8483164|NCT00590863|20905755|P1|STARTED|Overall Study||221
8483165|NCT00590824|20905770|P4|NOT COMPLETED|Overall Study||1
8483166|NCT00590824|20905771|P3|NOT COMPLETED|Overall Study||1
8483167|NCT00590824|20905772|P2|NOT COMPLETED|Overall Study||2
8483168|NCT00590824|20905773|P1|NOT COMPLETED|Overall Study||0
8483169|NCT00590824|20905770|P4|COMPLETED|Overall Study||0
8483170|NCT00590824|20905771|P3|COMPLETED|Overall Study||1
8483171|NCT00590824|20905772|P2|COMPLETED|Overall Study||7
8483172|NCT00590824|20905773|P1|COMPLETED|Overall Study||11
8483173|NCT00590824|20905770|P4|STARTED|Overall Study||1
8483174|NCT00590824|20905771|P3|STARTED|Overall Study||2
8483175|NCT00590824|20905772|P2|STARTED|Overall Study||9
8483176|NCT00590824|20905773|P1|STARTED|Overall Study||11
8483177|NCT00590772|20905793|P1|NOT COMPLETED|Overall Study||0
8483178|NCT00590772|20905793|P1|COMPLETED|Overall Study||31
8483179|NCT00590772|20905793|P1|STARTED|Overall Study||31
8483180|NCT00590759|20905799|P1|NOT COMPLETED|Overall Study||80
8483181|NCT00590759|20905799|P1|COMPLETED|Overall Study||70
8483182|NCT00590759|20905799|P1|STARTED|Overall Study||150
8483183|NCT00590720|20905806|P2|NOT COMPLETED|Overall Study||1
8483184|NCT00590720|20905807|P1|NOT COMPLETED|Overall Study||1
8483185|NCT00590720|20905806|P2|COMPLETED|Overall Study||6
8483186|NCT00590720|20905807|P1|COMPLETED|Overall Study||3
8483187|NCT00590720|20905806|P2|STARTED|Overall Study||7
8483188|NCT00590720|20905807|P1|STARTED|Overall Study||4
8483189|NCT00590707|20905851|P2|NOT COMPLETED|Overall Study||0
8483190|NCT00590707|20905852|P1|NOT COMPLETED|Overall Study||0
8483191|NCT00590707|20905851|P2|COMPLETED|Overall Study||100
8483192|NCT00590707|20905852|P1|COMPLETED|Overall Study||100
8483193|NCT00590707|20905851|P2|STARTED|Overall Study||100
8483194|NCT00590707|20905852|P1|STARTED|Overall Study||100
8483195|NCT00590590|20905869|P3|NOT COMPLETED|Overall Study||6
8483196|NCT00590590|20905870|P2|NOT COMPLETED|Overall Study||6
8483197|NCT00590590|20905871|P1|NOT COMPLETED|Overall Study||7
8483198|NCT00590590|20905869|P3|COMPLETED|Overall Study||21
8483199|NCT00590590|20905870|P2|COMPLETED|Overall Study||33
8483200|NCT00590590|20905871|P1|COMPLETED|Overall Study||32
8483201|NCT00590590|20905869|P3|STARTED|Overall Study||27
8483202|NCT00590590|20905870|P2|STARTED|Overall Study||39
8483203|NCT00590590|20905871|P1|STARTED|Overall Study||39
8483204|NCT00590577|20905898|P4|NOT COMPLETED|Overall Study||93
8483205|NCT00590577|20905899|P3|NOT COMPLETED|Overall Study||73
8483206|NCT00590577|20905900|P2|NOT COMPLETED|Overall Study||76
8483207|NCT00590577|20905901|P1|NOT COMPLETED|Overall Study||77
8483208|NCT00590577|20905898|P4|COMPLETED|Overall Study||71
8483209|NCT00590577|20905899|P3|COMPLETED|Overall Study||90
8483210|NCT00590577|20905900|P2|COMPLETED|Overall Study||89
8483211|NCT00590577|20905901|P1|COMPLETED|Overall Study||83
8483212|NCT00590577|20905898|P4|STARTED|Overall Study||164
8483213|NCT00590577|20905899|P3|STARTED|Overall Study||163
8483214|NCT00590577|20905900|P2|STARTED|Overall Study||165
8483215|NCT00590577|20905901|P1|STARTED|Overall Study||160
8483216|NCT00590564|20905919|P1|NOT COMPLETED|Overall Study||18
8483217|NCT00590564|20905919|P1|COMPLETED|Overall Study||24
8483218|NCT00590564|20905919|P1|STARTED|Overall Study||42
8483219|NCT00590538|20905923|P1|NOT COMPLETED|Overall Study||2
8483220|NCT00590538|20905923|P1|COMPLETED|Overall Study||7
8483221|NCT00590538|20905923|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
8483222|NCT00590460|20905931|P1|NOT COMPLETED|Overall Study||0
8483223|NCT00590460|20905931|P1|COMPLETED|Overall Study||5
8483224|NCT00590460|20905931|P1|STARTED|Overall Study||5
8483225|NCT00590395|20905944|P1|NOT COMPLETED|Overall Study||0
8483226|NCT00590395|20905944|P1|COMPLETED|Overall Study||19
8483227|NCT00590395|20905944|P1|STARTED|Overall Study||19
8483228|NCT00590369|20905950|P2|NOT COMPLETED|Overall Study||0
8483229|NCT00590369|20905951|P1|NOT COMPLETED|Overall Study||0
8483230|NCT00590369|20905950|P2|COMPLETED|Overall Study||5
8483231|NCT00590369|20905951|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
8483232|NCT00590369|20905950|P2|STARTED|Overall Study||5
8483233|NCT00590369|20905951|P1|STARTED|Overall Study||6
8483234|NCT00590317|20905969|P2|NOT COMPLETED|Overall Study||5
8483235|NCT00590317|20905970|P1|NOT COMPLETED|Overall Study||1
8483236|NCT00590317|20905969|P2|COMPLETED|Overall Study||27
8483237|NCT00590317|20905970|P1|COMPLETED|Overall Study||31
8483238|NCT00590317|20905969|P2|STARTED|Overall Study||32
8483239|NCT00590317|20905970|P1|STARTED|Overall Study||32
8483240|NCT00590226|20905982|P2|NOT COMPLETED|Overall Study||0
8483241|NCT00590226|20905983|P1|NOT COMPLETED|Overall Study||0
8483242|NCT00590226|20905982|P2|COMPLETED|Overall Study||63
8483243|NCT00590226|20905983|P1|COMPLETED|Overall Study||67
8483244|NCT00590226|20905982|P2|STARTED|Overall Study||63
8483245|NCT00590226|20905983|P1|STARTED|Overall Study||67
8483246|NCT00590161|20905993|P2|NOT COMPLETED|Overall Study||3
8483247|NCT00590161|20905994|P1|NOT COMPLETED|Overall Study||3
8483248|NCT00590161|20905993|P2|COMPLETED|Overall Study||26
8483249|NCT00590161|20905994|P1|COMPLETED|Overall Study||23
8483250|NCT00590161|20905993|P2|STARTED|Overall Study||29
8483251|NCT00590161|20905994|P1|STARTED|Overall Study||26
8483252|NCT00590135|20906000|P1|NOT COMPLETED|Overall Study||59
8483253|NCT00590135|20906000|P1|COMPLETED|Overall Study||0
8483254|NCT00590135|20906000|P1|STARTED|Overall Study||59
8483255|NCT00590044|20906010|P2|NOT COMPLETED|Overall Study||2
8483256|NCT00590044|20906011|P1|NOT COMPLETED|Overall Study||4
8483257|NCT00590044|20906010|P2|COMPLETED|Overall Study||34
8483258|NCT00590044|20906011|P1|COMPLETED|Overall Study||34
8483259|NCT00590044|20906010|P2|STARTED|Overall Study||36
8483260|NCT00590044|20906011|P1|STARTED|Overall Study||38
8483261|NCT00590031|20906023|P1|NOT COMPLETED|Overall Study||6
8483262|NCT00590031|20906023|P1|COMPLETED|Overall Study||55
8483263|NCT00590031|20906023|P1|STARTED|Overall Study||61
8483264|NCT00590018|20906030|P2|NOT COMPLETED|Overall Study||0
8483265|NCT00590018|20906031|P1|NOT COMPLETED|Overall Study||0
8483266|NCT00590018|20906030|P2|COMPLETED|Overall Study||9
8483267|NCT00590018|20906031|P1|COMPLETED|Overall Study||9
8483268|NCT00590018|20906030|P2|STARTED|Overall Study||9
8483269|NCT00590018|20906031|P1|STARTED|Overall Study||9
8483270|NCT00590005|20906039|P2|NOT COMPLETED|Overall Study||0
8483271|NCT00590005|20906040|P1|NOT COMPLETED|Overall Study||0
8483272|NCT00590005|20906039|P2|COMPLETED|Overall Study||119
8483273|NCT00590005|20906040|P1|COMPLETED|Overall Study||106
8483274|NCT00590005|20906039|P2|STARTED|Overall Study||119
8483275|NCT00590005|20906040|P1|STARTED|Overall Study||106
8483276|NCT00589979|20906050|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
8483277|NCT00589979|20906051|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
8483278|NCT00589979|20906052|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
8483279|NCT00589979|20906050|P3|COMPLETED|Double-Blind Treatment Period 3||38
8483280|NCT00589979|20906051|P2|COMPLETED|Double-Blind Treatment Period 3||46
8483281|NCT00589979|20906052|P1|COMPLETED|Double-Blind Treatment Period 3||0
8483282|NCT00589979|20906050|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
8483283|NCT00589979|20906051|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
8483284|NCT00589979|20906052|P1|STARTED|Double-Blind Treatment Period 3||0
8483285|NCT00589979|20906050|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
8483286|NCT00589979|20906051|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
8483287|NCT00589979|20906052|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
8483288|NCT00589979|20906050|P3|COMPLETED|Double-Blind Treatment Period 2||39
8483289|NCT00589979|20906051|P2|COMPLETED|Double-Blind Treatment Period 2||47
8483290|NCT00589979|20906052|P1|COMPLETED|Double-Blind Treatment Period 2||0
8483291|NCT00589979|20906050|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
8483292|NCT00589979|20906051|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
8483293|NCT00589979|20906052|P1|STARTED|Double-Blind Treatment Period 2||0
8483294|NCT00589979|20906050|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
8483295|NCT00589979|20906051|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
8483296|NCT00589979|20906052|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
8483297|NCT00589979|20906050|P3|COMPLETED|Double-Blind Treatment Period 1||41
8483298|NCT00589979|20906051|P2|COMPLETED|Double-Blind Treatment Period 1||48
8483299|NCT00589979|20906052|P1|COMPLETED|Double-Blind Treatment Period 1||0
8483300|NCT00589979|20906050|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
8483301|NCT00589979|20906051|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
8483302|NCT00589979|20906052|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
8483303|NCT00589979|20906050|P3|NOT COMPLETED|Run-In Period||0
8483304|NCT00589979|20906051|P2|NOT COMPLETED|Run-In Period||0
8483305|NCT00589979|20906052|P1|NOT COMPLETED|Run-In Period||76
8483306|NCT00589979|20906050|P3|COMPLETED|Run-In Period||0
8483307|NCT00589979|20906051|P2|COMPLETED|Run-In Period||0
8483308|NCT00589979|20906052|P1|COMPLETED|Run-In Period||93
8483309|NCT00589979|20906050|P3|STARTED|Run-In Period||0
8483310|NCT00589979|20906051|P2|STARTED|Run-In Period||0
8483311|NCT00589979|20906052|P1|STARTED|Run-In Period||169
8483312|NCT00589914|20906091|P2|NOT COMPLETED|Overall Study||137
8483313|NCT00589914|20906092|P1|NOT COMPLETED|Overall Study||150
8483314|NCT00589914|20906091|P2|COMPLETED|Overall Study||471
8483315|NCT00589914|20906092|P1|COMPLETED|Overall Study||456
8483316|NCT00589914|20906091|P2|STARTED|Overall Study||608
8483317|NCT00589914|20906092|P1|STARTED|Overall Study||606
8483318|NCT00589888|20906102|P5|NOT COMPLETED|64-gram Oral Fat Load||0
8483319|NCT00589888|20906103|P4|NOT COMPLETED|64-gram Oral Fat Load||0
8483320|NCT00589888|20906104|P3|NOT COMPLETED|64-gram Oral Fat Load||0
8483321|NCT00589888|20906105|P2|NOT COMPLETED|64-gram Oral Fat Load||0
8483322|NCT00589888|20906106|P1|NOT COMPLETED|64-gram Oral Fat Load||0
8483323|NCT00589888|20906102|P5|COMPLETED|64-gram Oral Fat Load||13
8483324|NCT00589888|20906103|P4|COMPLETED|64-gram Oral Fat Load||0
8483325|NCT00589888|20906104|P3|COMPLETED|64-gram Oral Fat Load||0
8483326|NCT00589888|20906105|P2|COMPLETED|64-gram Oral Fat Load||0
8483327|NCT00589888|20906106|P1|COMPLETED|64-gram Oral Fat Load||0
8483328|NCT00589888|20906102|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
8483329|NCT00589888|20906103|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
8483330|NCT00589888|20906104|P3|STARTED|64-gram Oral Fat Load||0
8483331|NCT00589888|20906105|P2|STARTED|64-gram Oral Fat Load||0
8483332|NCT00589888|20906106|P1|STARTED|64-gram Oral Fat Load||0
8483333|NCT00589888|20906102|P5|NOT COMPLETED|32-gram Oral Fat Load||0
8483334|NCT00589888|20906103|P4|NOT COMPLETED|32-gram Oral Fat Load||0
8483335|NCT00589888|20906104|P3|NOT COMPLETED|32-gram Oral Fat Load||0
8483336|NCT00589888|20906105|P2|NOT COMPLETED|32-gram Oral Fat Load||0
8483337|NCT00589888|20906106|P1|NOT COMPLETED|32-gram Oral Fat Load||0
8483338|NCT00589888|20906102|P5|COMPLETED|32-gram Oral Fat Load||0
8483339|NCT00589888|20906103|P4|COMPLETED|32-gram Oral Fat Load||13
8483340|NCT00589888|20906104|P3|COMPLETED|32-gram Oral Fat Load||0
8483341|NCT00589888|20906105|P2|COMPLETED|32-gram Oral Fat Load||0
8483342|NCT00589888|20906106|P1|COMPLETED|32-gram Oral Fat Load||0
8483343|NCT00589888|20906102|P5|STARTED|32-gram Oral Fat Load||0
8483344|NCT00589888|20906103|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
8483345|NCT00589888|20906104|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
8483346|NCT00589888|20906105|P2|STARTED|32-gram Oral Fat Load||0
8483347|NCT00589888|20906106|P1|STARTED|32-gram Oral Fat Load||0
8483348|NCT00589888|20906102|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483349|NCT00589888|20906103|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483350|NCT00589888|20906104|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483351|NCT00589888|20906105|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483352|NCT00589888|20906106|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483353|NCT00589888|20906102|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483354|NCT00589888|20906103|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483355|NCT00589888|20906104|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
8483356|NCT00589888|20906105|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483357|NCT00589888|20906106|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483358|NCT00589888|20906102|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
8483359|NCT00589888|20906103|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
8483360|NCT00589888|20906104|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
8483361|NCT00589888|20906105|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
8483362|NCT00589888|20906106|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
8483363|NCT00589888|20906102|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483364|NCT00589888|20906103|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483365|NCT00589888|20906104|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483366|NCT00589888|20906105|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483367|NCT00589888|20906106|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483368|NCT00589888|20906102|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483369|NCT00589888|20906103|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483370|NCT00589888|20906104|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483371|NCT00589888|20906105|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
8483372|NCT00589888|20906106|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483373|NCT00589888|20906102|P5|STARTED|Intralipid 20% @ 20cc/hr||0
8483374|NCT00589888|20906103|P4|STARTED|Intralipid 20% @ 20cc/hr||0
8483375|NCT00589888|20906104|P3|STARTED|Intralipid 20% @ 20cc/hr||0
8483376|NCT00589888|20906105|P2|STARTED|Intralipid 20% @ 20cc/hr||13
8483377|NCT00589888|20906106|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
8483378|NCT00589888|20906102|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483379|NCT00589888|20906103|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483380|NCT00589888|20906104|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483381|NCT00589888|20906105|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483382|NCT00589888|20906106|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483383|NCT00589888|20906102|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
8483384|NCT00589888|20906103|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
8483385|NCT00589888|20906104|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
8483386|NCT00589888|20906105|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
8483387|NCT00589888|20906106|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
8483388|NCT00589888|20906102|P5|STARTED|Normal Saline @ 40cc/Hour||0
8483389|NCT00589888|20906103|P4|STARTED|Normal Saline @ 40cc/Hour||0
8483390|NCT00589888|20906104|P3|STARTED|Normal Saline @ 40cc/Hour||0
8483391|NCT00589888|20906105|P2|STARTED|Normal Saline @ 40cc/Hour||0
8483392|NCT00589888|20906106|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
8483393|NCT00589849|20906138|P1|NOT COMPLETED|Overall Study||0
8483394|NCT00589849|20906138|P1|COMPLETED|Overall Study||32
8483395|NCT00589849|20906138|P1|STARTED|Overall Study||32
8483396|NCT00589836|20906142|P1|NOT COMPLETED|Overall Study||0
8483397|NCT00589836|20906142|P1|COMPLETED|Overall Study||20
8483398|NCT00589836|20906142|P1|STARTED|Overall Study||20
8483399|NCT00589797|20906148|P2|NOT COMPLETED|Overall Study||23
8483400|NCT00589797|20906149|P1|NOT COMPLETED|Overall Study||73
8483401|NCT00589797|20906148|P2|COMPLETED|Overall Study||89
8483402|NCT00589797|20906149|P1|COMPLETED|Overall Study||191
8483403|NCT00589797|20906148|P2|24 Months|Overall Study||89
8483404|NCT00589797|20906149|P1|24 Months|Overall Study||191
8483405|NCT00589797|20906148|P2|Baseline|Overall Study||106
8483406|NCT00589797|20906149|P1|Baseline|Overall Study||218
8483407|NCT00589797|20906148|P2|STARTED|Overall Study||112
8483408|NCT00589797|20906149|P1|STARTED|Overall Study||264
8483409|NCT00589784|20906173|P2|NOT COMPLETED|Overall Study||10
8483410|NCT00589784|20906174|P1|NOT COMPLETED|Overall Study||1
8483411|NCT00589784|20906173|P2|COMPLETED|Overall Study||4
8483412|NCT00589784|20906174|P1|COMPLETED|Overall Study||35
8483413|NCT00589784|20906173|P2|STARTED|Overall Study||14
8483414|NCT00589784|20906174|P1|STARTED|Overall Study||36
8483415|NCT00589693|20906181|P2|NOT COMPLETED|Overall Study||29
8483416|NCT00589693|20906182|P1|NOT COMPLETED|Overall Study||44
8483417|NCT00589693|20906181|P2|COMPLETED|Overall Study||83
8483418|NCT00589693|20906182|P1|COMPLETED|Overall Study||71
8483419|NCT00589693|20906181|P2|STARTED|Overall Study||112
8483420|NCT00589693|20906182|P1|STARTED|Overall Study||115
8483421|NCT00589667|20906196|P1|NOT COMPLETED|Overall Study||3
8483422|NCT00589667|20906196|P1|COMPLETED|Overall Study||23
8483423|NCT00589667|20906196|P1|STARTED|Overall Study||26
8483424|NCT00589628|20906203|P2|NOT COMPLETED|Overall Study||1
8483425|NCT00589628|20906204|P1|NOT COMPLETED|Overall Study||0
8483426|NCT00589628|20906203|P2|COMPLETED|Overall Study||5
8483427|NCT00589628|20906204|P1|COMPLETED|Overall Study||7
8483428|NCT00589628|20906203|P2|STARTED|Overall Study||6
8483429|NCT00589628|20906204|P1|STARTED|Overall Study||7
8483430|NCT00589602|20906210|P1|NOT COMPLETED|Overall Study||1
8483431|NCT00589602|20906210|P1|COMPLETED|Overall Study||12
8483432|NCT00589602|20906210|P1|STARTED|Overall Study||13
8483433|NCT00589563|20906218|P1|NOT COMPLETED|Overall Study||0
8483434|NCT00589563|20906218|P1|COMPLETED|Overall Study||32
8483435|NCT00589563|20906218|P1|STARTED|Overall Study||32
8483436|NCT00589550|20906235|P1|NOT COMPLETED|Overall Study||1
8483437|NCT00589550|20906235|P1|COMPLETED|Overall Study||0
8483438|NCT00589550|20906235|P1|Withdrew From Study|Overall Study||1
8483439|NCT00589550|20906235|P1|STARTED|Overall Study||1
8483440|NCT00589472|20906245|P1|NOT COMPLETED|Overall Study||1
8483441|NCT00589472|20906245|P1|COMPLETED|Overall Study||18
8483442|NCT00589472|20906245|P1|STARTED|Overall Study||19
8483443|NCT00589329|20906257|P2|NOT COMPLETED|Overall Study||0
8483444|NCT00589329|20906258|P1|NOT COMPLETED|Overall Study||0
8483445|NCT00589329|20906257|P2|COMPLETED|Overall Study||10
8483446|NCT00589329|20906258|P1|COMPLETED|Overall Study||10
8483447|NCT00589329|20906257|P2|STARTED|Overall Study||10
8483448|NCT00589329|20906258|P1|STARTED|Overall Study||10
8483449|NCT00589303|20906268|P2|NOT COMPLETED|Overall Study||1
8483450|NCT00589303|20906269|P1|NOT COMPLETED|Overall Study||2
8483451|NCT00589303|20906268|P2|COMPLETED|Overall Study||12
8483452|NCT00589303|20906269|P1|COMPLETED|Overall Study||12
8483453|NCT00589303|20906268|P2|STARTED|Overall Study||13
8483454|NCT00589303|20906269|P1|STARTED|Overall Study||14
8483455|NCT00589290|20906275|P1|NOT COMPLETED|Overall Study||1
8483456|NCT00589290|20906275|P1|COMPLETED|Overall Study||40
8483457|NCT00589290|20906275|P1|STARTED|Overall Study||41
8483458|NCT00589277|20906285|P2|NOT COMPLETED|Overall Study||286
8483459|NCT00589277|20906286|P1|NOT COMPLETED|Overall Study||460
8483460|NCT00589277|20906285|P2|COMPLETED|Overall Study||524
8483461|NCT00589277|20906286|P1|COMPLETED|Overall Study||762
8483462|NCT00589277|20906285|P2|Completed 3 Month Follow Up|Overall Study||524
8483463|NCT00589277|20906286|P1|Completed 3 Month Follow Up|Overall Study||762
8483464|NCT00589277|20906285|P2|Completed 2 Week Follow Up|Overall Study||424
8483465|NCT00589277|20906286|P1|Completed 2 Week Follow Up|Overall Study||603
8483466|NCT00589277|20906285|P2|STARTED|Overall Study||810
8483467|NCT00589277|20906286|P1|STARTED|Overall Study||1222
8483468|NCT00589121|20906298|P2|NOT COMPLETED|Overall Study||7
8483469|NCT00589121|20906299|P1|NOT COMPLETED|Overall Study||2
8483470|NCT00589121|20906298|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
8483471|NCT00589121|20906299|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
8483472|NCT00589121|20906298|P2|STARTED|Overall Study||86
8483473|NCT00589121|20906299|P1|STARTED|Overall Study||12
8483474|NCT00589108|20906321|P3|NOT COMPLETED|Overall Study||5
8483475|NCT00589108|20906322|P2|NOT COMPLETED|Overall Study||4
8483476|NCT00589108|20906323|P1|NOT COMPLETED|Overall Study||4
8483477|NCT00589108|20906321|P3|COMPLETED|Overall Study||75
8483478|NCT00589108|20906322|P2|COMPLETED|Overall Study||76
8483479|NCT00589108|20906323|P1|COMPLETED|Overall Study||76
8483480|NCT00589108|20906321|P3|STARTED|Overall Study||80
8483481|NCT00589108|20906322|P2|STARTED|Overall Study||80
8483482|NCT00589108|20906323|P1|STARTED|Overall Study||80
8483483|NCT00589056|20906343|P1|NOT COMPLETED|Overall Study||3
8483484|NCT00589056|20906343|P1|COMPLETED|Overall Study||52
8483485|NCT00589056|20906343|P1|STARTED|Overall Study||55
8483486|NCT00588965|20906349|P1|NOT COMPLETED|Overall Study||0
8483487|NCT00588965|20906349|P1|COMPLETED|Overall Study||35
8483488|NCT00588965|20906349|P1|STARTED|Overall Study||35
8483489|NCT00588952|20906359|P2|NOT COMPLETED|Overall Study||7
8483490|NCT00588952|20906360|P1|NOT COMPLETED|Overall Study||3
8483491|NCT00588952|20906359|P2|COMPLETED|Overall Study||63
8483492|NCT00588952|20906360|P1|COMPLETED|Overall Study||26
8483493|NCT00588952|20906359|P2|STARTED|Overall Study||70
8483494|NCT00588952|20906360|P1|STARTED|Overall Study||29
8483495|NCT00588900|20906380|P1|NOT COMPLETED|Overall Study||0
8483496|NCT00588900|20906380|P1|COMPLETED|Overall Study||5
8483497|NCT00588900|20906380|P1|STARTED|Overall Study||5
8483498|NCT00588861|20906388|P2|NOT COMPLETED|10 Years||114
8483499|NCT00588861|20906389|P1|NOT COMPLETED|10 Years||107
8483500|NCT00588861|20906388|P2|COMPLETED|10 Years||0
8483501|NCT00588861|20906389|P1|COMPLETED|10 Years||0
8483502|NCT00588861|20906388|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
8483503|NCT00588861|20906389|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
8483504|NCT00588861|20906388|P2|NOT COMPLETED|8 Years||114
8483505|NCT00588861|20906389|P1|NOT COMPLETED|8 Years||105
8483506|NCT00588861|20906388|P2|COMPLETED|8 Years||0
8483507|NCT00588861|20906389|P1|COMPLETED|8 Years||2
8483508|NCT00588861|20906388|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
8483509|NCT00588861|20906389|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
8483510|NCT00588861|20906388|P2|NOT COMPLETED|6 Years||109
8483511|NCT00588861|20906389|P1|NOT COMPLETED|6 Years||104
8483512|NCT00588861|20906388|P2|COMPLETED|6 Years||5
8483513|NCT00588861|20906389|P1|COMPLETED|6 Years||3
8483514|NCT00588861|20906388|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
8483515|NCT00588861|20906389|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
8483516|NCT00588861|20906388|P2|NOT COMPLETED|4 Years||103
8483517|NCT00588861|20906389|P1|NOT COMPLETED|4 Years||91
8483518|NCT00588861|20906388|P2|COMPLETED|4 Years||11
8483519|NCT00588861|20906389|P1|COMPLETED|4 Years||16
8483520|NCT00588861|20906388|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
8483521|NCT00588861|20906389|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
8483522|NCT00588861|20906388|P2|NOT COMPLETED|2 Years||87
8483523|NCT00588861|20906389|P1|NOT COMPLETED|2 Years||92
8483524|NCT00588861|20906388|P2|COMPLETED|2 Years||27
8483525|NCT00588861|20906389|P1|COMPLETED|2 Years||15
8483526|NCT00588861|20906388|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
8483527|NCT00588861|20906389|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
8483528|NCT00588861|20906388|P2|NOT COMPLETED|1 Year||82
8483529|NCT00588861|20906389|P1|NOT COMPLETED|1 Year||89
8483530|NCT00588861|20906388|P2|COMPLETED|1 Year||32
8483531|NCT00588861|20906389|P1|COMPLETED|1 Year||18
8483532|NCT00588861|20906388|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
8483533|NCT00588861|20906389|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
8483534|NCT00588861|20906388|P2|NOT COMPLETED|6 Months||73
8483535|NCT00588861|20906389|P1|NOT COMPLETED|6 Months||98
8483536|NCT00588861|20906388|P2|COMPLETED|6 Months||41
8483537|NCT00588861|20906389|P1|COMPLETED|6 Months||9
8483538|NCT00588861|20906388|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
8483539|NCT00588861|20906389|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
8483540|NCT00588861|20906388|P2|NOT COMPLETED|Pre-Operative||86
8483541|NCT00588861|20906389|P1|NOT COMPLETED|Pre-Operative||95
8483542|NCT00588861|20906388|P2|COMPLETED|Pre-Operative||114
8483543|NCT00588861|20906389|P1|COMPLETED|Pre-Operative||107
8483544|NCT00588861|20906388|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
8483545|NCT00588861|20906389|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
8483546|NCT00588848|20906399|P2|NOT COMPLETED|Overall Study||3
8483547|NCT00588848|20906400|P1|NOT COMPLETED|Overall Study||0
8483548|NCT00588848|20906399|P2|COMPLETED|Overall Study||5
8483549|NCT00588848|20906400|P1|COMPLETED|Overall Study||3
8483550|NCT00588848|20906399|P2|STARTED|Overall Study||8
8483551|NCT00588848|20906400|P1|STARTED|Overall Study||3
8483552|NCT00588822|20906410|P1|NOT COMPLETED|Overall Study||8
8483553|NCT00588822|20906410|P1|COMPLETED|Overall Study||13
8483554|NCT00588822|20906410|P1|STARTED|Overall Study||21
8483555|NCT00588809|20906419|P1|NOT COMPLETED|Overall Study||0
8483556|NCT00588809|20906419|P1|COMPLETED|Overall Study||47
8483557|NCT00588809|20906419|P1|STARTED|Overall Study||47
8483568|NCT00588731|20906443|P2|NOT COMPLETED|Overall Study||2
8483569|NCT00588731|20906444|P1|NOT COMPLETED|Overall Study||3
8483570|NCT00588731|20906443|P2|COMPLETED|Overall Study||18
8483571|NCT00588731|20906444|P1|COMPLETED|Overall Study||18
8483572|NCT00588731|20906443|P2|STARTED|Overall Study||20
8483573|NCT00588731|20906444|P1|STARTED|Overall Study||21
8483574|NCT00588692|20906454|P2|NOT COMPLETED|Overall Study||3
8483575|NCT00588692|20906455|P1|NOT COMPLETED|Overall Study||7
8483576|NCT00588692|20906454|P2|COMPLETED|Overall Study||27
8483577|NCT00588692|20906455|P1|COMPLETED|Overall Study||23
8483578|NCT00588692|20906454|P2|STARTED|Overall Study||30
8483579|NCT00588692|20906455|P1|STARTED|Overall Study||30
8483580|NCT00588666|20906491|P1|NOT COMPLETED|Overall Study||4
8483581|NCT00588666|20906491|P1|COMPLETED|Overall Study||47
8483582|NCT00588666|20906491|P1|STARTED|Overall Study||51
8483583|NCT00588640|20906496|P1|NOT COMPLETED|Overall Study||2
8483584|NCT00588640|20906496|P1|COMPLETED|Overall Study||8
8483585|NCT00588640|20906496|P1|STARTED|Overall Study||10
8483586|NCT00588536|20906500|P1|NOT COMPLETED|Overall Study||0
8483587|NCT00588536|20906500|P1|COMPLETED|Overall Study||5
8483588|NCT00588536|20906500|P1|STARTED|Overall Study||5
8483589|NCT00588471|20906506|P2|NOT COMPLETED|Overall Study||0
8483590|NCT00588471|20906507|P1|NOT COMPLETED|Overall Study||0
8483591|NCT00588471|20906506|P2|COMPLETED|Overall Study||29
8483592|NCT00588471|20906507|P1|COMPLETED|Overall Study||28
8483593|NCT00588471|20906506|P2|STARTED|Overall Study||29
8483594|NCT00588471|20906507|P1|STARTED|Overall Study||28
8483595|NCT00588445|20906515|P1|NOT COMPLETED|Overall Study||15
8483596|NCT00588445|20906515|P1|COMPLETED|Overall Study||50
8483597|NCT00588445|20906515|P1|STARTED|Overall Study||65
8483598|NCT00588406|20906523|P2|NOT COMPLETED|Overall Study||0
8483599|NCT00588406|20906524|P1|NOT COMPLETED|Overall Study||0
8483600|NCT00588406|20906523|P2|COMPLETED|Overall Study||49
8483601|NCT00588406|20906524|P1|COMPLETED|Overall Study||46
8483602|NCT00588406|20906523|P2|STARTED|Overall Study||49
8483603|NCT00588406|20906524|P1|STARTED|Overall Study||46
8483604|NCT00588380|20906532|P1|NOT COMPLETED|Overall Study||0
8483605|NCT00588380|20906532|P1|COMPLETED|Overall Study||88
8483606|NCT00588380|20906532|P1|STARTED|Overall Study||88
8483607|NCT00588354|20906539|P2|NOT COMPLETED|Baseline to 4 Weeks||1
8483608|NCT00588354|20906540|P1|NOT COMPLETED|Baseline to 4 Weeks||0
8483609|NCT00588354|20906539|P2|COMPLETED|Baseline to 4 Weeks||14
8483610|NCT00588354|20906540|P1|COMPLETED|Baseline to 4 Weeks||9
8483611|NCT00588354|20906539|P2|STARTED|Baseline to 4 Weeks||15
8483612|NCT00588354|20906540|P1|STARTED|Baseline to 4 Weeks||9
8483613|NCT00588354|20906539|P2|NOT COMPLETED|Baseline to 2 Weeks||0
8483614|NCT00588354|20906540|P1|NOT COMPLETED|Baseline to 2 Weeks||2
8483615|NCT00588354|20906539|P2|COMPLETED|Baseline to 2 Weeks||15
8483616|NCT00588354|20906540|P1|COMPLETED|Baseline to 2 Weeks||9
8483617|NCT00588354|20906539|P2|STARTED|Baseline to 2 Weeks||15
8483618|NCT00588354|20906540|P1|STARTED|Baseline to 2 Weeks||11
8483619|NCT00588341|20906560|P1|NOT COMPLETED|Overall Study||5
8483620|NCT00588341|20906560|P1|COMPLETED|Overall Study||19
8483621|NCT00588341|20906560|P1|STARTED|Overall Study||24
8483622|NCT00588237|20906564|P1|NOT COMPLETED|Overall Study||4
8483623|NCT00588237|20906564|P1|COMPLETED|Overall Study||38
8483624|NCT00588237|20906564|P1|STARTED|Overall Study||42
8483625|NCT00588159|20906570|P2|NOT COMPLETED|Overall Study||11
8483626|NCT00588159|20906571|P1|NOT COMPLETED|Overall Study||15
8483627|NCT00588159|20906570|P2|COMPLETED|Overall Study||63
8483628|NCT00588159|20906571|P1|COMPLETED|Overall Study||57
8483629|NCT00588159|20906570|P2|STARTED|Overall Study||74
8483630|NCT00588159|20906571|P1|STARTED|Overall Study||72
8483631|NCT00588146|20906587|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
8483632|NCT00588146|20906588|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
8483633|NCT00588146|20906587|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
8483634|NCT00588146|20906588|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
8483635|NCT00588146|20906587|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
8483636|NCT00588146|20906588|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
8483637|NCT00588146|20906587|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
8483638|NCT00588146|20906588|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
8483639|NCT00588146|20906587|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
8483640|NCT00588146|20906588|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
8483641|NCT00588146|20906587|P2|STARTED|First Intervention (Baseline to 6 mo)||5
8483642|NCT00588146|20906588|P1|STARTED|First Intervention (Baseline to 6 mo)||5
8483643|NCT00588094|20906594|P1|NOT COMPLETED|Overall Study||5
8483644|NCT00588094|20906594|P1|COMPLETED|Overall Study||15
8483645|NCT00588094|20906594|P1|STARTED|Overall Study||20
8483646|NCT00587990|20906601|P3|NOT COMPLETED|Overall Study||1
8483647|NCT00587990|20906602|P2|NOT COMPLETED|Overall Study||0
8483648|NCT00587990|20906603|P1|NOT COMPLETED|Overall Study||0
8483649|NCT00587990|20906601|P3|COMPLETED|Overall Study||2
8483650|NCT00587990|20906602|P2|COMPLETED|Overall Study||4
8483651|NCT00587990|20906603|P1|COMPLETED|Overall Study||2
8483652|NCT00587990|20906601|P3|STARTED|Overall Study||3
8483653|NCT00587990|20906602|P2|STARTED|Overall Study||4
8483654|NCT00587990|20906603|P1|STARTED|Overall Study||2
8483655|NCT00587964|20906646|P1|NOT COMPLETED|Overall Study||12
8483656|NCT00587964|20906646|P1|COMPLETED|Overall Study||39
8483657|NCT00587964|20906646|P1|STARTED|Overall Study||51
8483658|NCT00587860|20906652|P2|NOT COMPLETED|Overall Study||5
8483659|NCT00587860|20906653|P1|NOT COMPLETED|Overall Study||5
8483660|NCT00587860|20906652|P2|COMPLETED|Overall Study||30
8483661|NCT00587860|20906653|P1|COMPLETED|Overall Study||30
8483662|NCT00587860|20906652|P2|STARTED|Overall Study||35
8483663|NCT00587860|20906653|P1|STARTED|Overall Study||35
8483664|NCT00587847|20906673|P1|NOT COMPLETED|Overall Study||7
8483665|NCT00587847|20906673|P1|COMPLETED|Overall Study||5
8483666|NCT00587847|20906673|P1|STARTED|Overall Study||12
8483667|NCT00587834|20906678|P1|NOT COMPLETED|Overall Study||0
8483668|NCT00587834|20906678|P1|COMPLETED|Overall Study||96
8483669|NCT00587834|20906678|P1|STARTED|Overall Study||96
8483670|NCT00587795|20906696|P2|NOT COMPLETED|Overall Study||0
8483671|NCT00587795|20906697|P1|NOT COMPLETED|Overall Study||1
8483672|NCT00587795|20906696|P2|COMPLETED|Overall Study||0
8483673|NCT00587795|20906697|P1|COMPLETED|Overall Study||0
8483674|NCT00587795|20906696|P2|STARTED|Overall Study||0
8483675|NCT00587795|20906697|P1|STARTED|Overall Study||1
8483676|NCT00587769|20906703|P1|NOT COMPLETED|Overall Study||0
8483677|NCT00587769|20906703|P1|COMPLETED|Overall Study||38
8483678|NCT00587769|20906703|P1|STARTED|Overall Study||38
8483679|NCT00587678|20906711|P3|NOT COMPLETED|Overall Study||8
8483680|NCT00587678|20906712|P2|NOT COMPLETED|Overall Study||4
8483681|NCT00587678|20906713|P1|NOT COMPLETED|Overall Study||6
8483682|NCT00587678|20906711|P3|COMPLETED|Overall Study||33
8483683|NCT00587678|20906712|P2|COMPLETED|Overall Study||18
8483684|NCT00587678|20906713|P1|COMPLETED|Overall Study||16
8483685|NCT00587678|20906711|P3|STARTED|Overall Study||41
8483686|NCT00587678|20906712|P2|STARTED|Overall Study||22
8483687|NCT00587678|20906713|P1|STARTED|Overall Study||22
8483688|NCT00587639|20906751|P1|NOT COMPLETED|Overall Study||1
8483689|NCT00587639|20906751|P1|COMPLETED|Overall Study||7
8483690|NCT00587639|20906751|P1|STARTED|Overall Study||8
8483691|NCT00587587|20906758|P2|NOT COMPLETED|Overall Study||1
8483692|NCT00587587|20906759|P1|NOT COMPLETED|Overall Study||6
8483693|NCT00587587|20906758|P2|COMPLETED|Overall Study||12
8483694|NCT00587587|20906759|P1|COMPLETED|Overall Study||11
8483695|NCT00587587|20906758|P2|STARTED|Overall Study||13
8483696|NCT00587587|20906759|P1|STARTED|Overall Study||17
8483697|NCT00587483|20906782|P3|NOT COMPLETED|Overall Study||0
8483698|NCT00587483|20906783|P2|NOT COMPLETED|Overall Study||0
8483699|NCT00587483|20906784|P1|NOT COMPLETED|Overall Study||0
8483700|NCT00587483|20906782|P3|COMPLETED|Overall Study||112
8483701|NCT00587483|20906783|P2|COMPLETED|Overall Study||115
8483702|NCT00587483|20906784|P1|COMPLETED|Overall Study||115
8483703|NCT00587483|20906782|P3|STARTED|Overall Study||112
8483704|NCT00587483|20906783|P2|STARTED|Overall Study||115
8483705|NCT00587483|20906784|P1|STARTED|Overall Study||115
8483706|NCT00587457|20906813|P3|NOT COMPLETED|Overall Study||5
8483707|NCT00587457|20906814|P2|NOT COMPLETED|Overall Study||3
8483708|NCT00587457|20906815|P1|NOT COMPLETED|Overall Study||3
8483709|NCT00587457|20906813|P3|COMPLETED|Overall Study||0
8483710|NCT00587457|20906814|P2|COMPLETED|Overall Study||0
8483711|NCT00587457|20906815|P1|COMPLETED|Overall Study||0
8483712|NCT00587457|20906813|P3|STARTED|Overall Study||5
8483713|NCT00587457|20906814|P2|STARTED|Overall Study||3
8483714|NCT00587457|20906815|P1|STARTED|Overall Study||3
8483715|NCT00587431|20906852|P2|NOT COMPLETED|Overall Study||1
8483716|NCT00587431|20906853|P1|NOT COMPLETED|Overall Study||1
8483717|NCT00587431|20906852|P2|COMPLETED|Overall Study||38
8483718|NCT00587431|20906853|P1|COMPLETED|Overall Study||62
8483719|NCT00587431|20906852|P2|STARTED|Overall Study||39
8483720|NCT00587431|20906853|P1|STARTED|Overall Study||63
8483721|NCT00587288|20906864|P2|NOT COMPLETED|Overall Study||9
8483722|NCT00587288|20906865|P1|NOT COMPLETED|Overall Study||3
8483723|NCT00587288|20906864|P2|COMPLETED|Overall Study||44
8483724|NCT00587288|20906865|P1|COMPLETED|Overall Study||50
8483725|NCT00587288|20906864|P2|STARTED|Overall Study||53
8483726|NCT00587288|20906865|P1|STARTED|Overall Study||53
8483727|NCT00587223|20906883|P1|NOT COMPLETED|Overall Study||1
8483728|NCT00587223|20906883|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
8483729|NCT00587223|20906883|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
8483730|NCT00587171|20906900|P2|NOT COMPLETED|Overall Study||1
8483731|NCT00587171|20906901|P1|NOT COMPLETED|Overall Study||1
8483732|NCT00587171|20906900|P2|COMPLETED|Overall Study||9
8483733|NCT00587171|20906901|P1|COMPLETED|Overall Study||8
8483734|NCT00587171|20906900|P2|STARTED|Overall Study||10
8483735|NCT00587171|20906901|P1|STARTED|Overall Study||9
8483736|NCT00587158|20906931|P2|NOT COMPLETED|Overall Study||8
8483737|NCT00587158|20906932|P1|NOT COMPLETED|Overall Study||5
8483738|NCT00587158|20906931|P2|COMPLETED|Overall Study||43
8483739|NCT00587158|20906932|P1|COMPLETED|Overall Study||44
8483740|NCT00587158|20906931|P2|Continued in Study|Overall Study||46
8483741|NCT00587158|20906932|P1|Continued in Study|Overall Study||45
8483742|NCT00587158|20906931|P2|STARTED|Overall Study||51
8483743|NCT00587158|20906932|P1|STARTED|Overall Study||49
8483744|NCT00587132|20906966|P4|NOT COMPLETED|Overall Study||0
8483745|NCT00587132|20906967|P3|NOT COMPLETED|Overall Study||0
8483746|NCT00587132|20906968|P2|NOT COMPLETED|Overall Study||0
8483747|NCT00587132|20906969|P1|NOT COMPLETED|Overall Study||0
8483748|NCT00587132|20906966|P4|COMPLETED|Overall Study||0
8483749|NCT00587132|20906967|P3|COMPLETED|Overall Study||0
8483750|NCT00587132|20906968|P2|COMPLETED|Overall Study||0
8483751|NCT00587132|20906969|P1|COMPLETED|Overall Study||4
8483752|NCT00587132|20906966|P4|STARTED|Overall Study||0
8483753|NCT00587132|20906967|P3|STARTED|Overall Study||0
8483754|NCT00587132|20906968|P2|STARTED|Overall Study||0
8483755|NCT00587132|20906969|P1|STARTED|Overall Study||4
8483756|NCT00587067|20906979|P1|NOT COMPLETED|Overall Study||0
8483757|NCT00587067|20906979|P1|COMPLETED|Overall Study||34
8483758|NCT00587067|20906979|P1|STARTED|Overall Study||34
8483759|NCT00587054|20906985|P1|NOT COMPLETED|Overall Study||9
8483760|NCT00587054|20906985|P1|COMPLETED|Overall Study||120
8483761|NCT00587054|20906985|P1|STARTED|Overall Study||129
8483762|NCT00587041|20906992|P3|NOT COMPLETED|Overall Study||0
8483763|NCT00587041|20906993|P2|NOT COMPLETED|Overall Study||0
8483764|NCT00587041|20906994|P1|NOT COMPLETED|Overall Study||0
8483765|NCT00587041|20906992|P3|COMPLETED|Overall Study||14
8483766|NCT00587041|20906993|P2|COMPLETED|Overall Study||14
8483767|NCT00587041|20906994|P1|COMPLETED|Overall Study||12
8483768|NCT00587041|20906992|P3|STARTED|Overall Study||14
8483769|NCT00587041|20906993|P2|STARTED|Overall Study||14
8483770|NCT00587041|20906994|P1|STARTED|Overall Study||12
8483771|NCT00586924|20907011|P6|NOT COMPLETED|Overall Study||33
8483772|NCT00586924|20907012|P5|NOT COMPLETED|Overall Study||4
8483773|NCT00586924|20907013|P4|NOT COMPLETED|Overall Study||3
8483774|NCT00586924|20907014|P3|NOT COMPLETED|Overall Study||3
8483775|NCT00586924|20907015|P2|NOT COMPLETED|Overall Study||3
8483776|NCT00586924|20907016|P1|NOT COMPLETED|Overall Study||3
8483777|NCT00586924|20907011|P6|COMPLETED|Overall Study||0
8483778|NCT00586924|20907012|P5|COMPLETED|Overall Study||0
8483779|NCT00586924|20907013|P4|COMPLETED|Overall Study||0
8483780|NCT00586924|20907014|P3|COMPLETED|Overall Study||0
8483781|NCT00586924|20907015|P2|COMPLETED|Overall Study||0
8483782|NCT00586924|20907016|P1|COMPLETED|Overall Study||0
8483783|NCT00586924|20907011|P6|STARTED|Overall Study||33
8483784|NCT00586924|20907012|P5|STARTED|Overall Study||4
8483785|NCT00586924|20907013|P4|STARTED|Overall Study||3
8483786|NCT00586924|20907014|P3|STARTED|Overall Study||3
8483787|NCT00586924|20907015|P2|STARTED|Overall Study||3
8483788|NCT00586924|20907016|P1|STARTED|Overall Study||3
8483789|NCT00586898|20907216|P1|NOT COMPLETED|Overall Study||7
8483790|NCT00586898|20907216|P1|COMPLETED|Overall Study||29
8483791|NCT00586898|20907216|P1|STARTED|Overall Study||36
8483792|NCT00586846|20907220|P1|NOT COMPLETED|Overall Study||6
8483793|NCT00586846|20907220|P1|COMPLETED|Overall Study||34
8483794|NCT00586846|20907220|P1|STARTED|Overall Study||40
8483795|NCT00586820|20907226|P2|NOT COMPLETED|Overall Study||0
8483796|NCT00586820|20907227|P1|NOT COMPLETED|Overall Study||1
8483797|NCT00586820|20907226|P2|COMPLETED|Overall Study||11
8483798|NCT00586820|20907227|P1|COMPLETED|Overall Study||11
8483799|NCT00586820|20907226|P2|STARTED|Overall Study||11
8483800|NCT00586820|20907227|P1|STARTED|Overall Study||12
8483801|NCT00586729|20907237|P2|NOT COMPLETED|Overall Study||1
8483802|NCT00586729|20907238|P1|NOT COMPLETED|Overall Study||3
8483803|NCT00586729|20907237|P2|COMPLETED|Overall Study||8
8483804|NCT00586729|20907238|P1|COMPLETED|Overall Study||11
8483805|NCT00586729|20907237|P2|STARTED|Overall Study||9
8483806|NCT00586729|20907238|P1|STARTED|Overall Study||14
8483807|NCT00586716|20907250|P2|NOT COMPLETED|Overall Study||0
8483808|NCT00586716|20907251|P1|NOT COMPLETED|Overall Study||0
8483809|NCT00586716|20907250|P2|COMPLETED|Overall Study||8
8483810|NCT00586716|20907251|P1|COMPLETED|Overall Study||14
8483811|NCT00586716|20907250|P2|STARTED|Overall Study||8
8483812|NCT00586716|20907251|P1|STARTED|Overall Study||14
8483813|NCT00586703|20907258|P1|NOT COMPLETED|Overall Study||12
8483814|NCT00586703|20907258|P1|COMPLETED|Overall Study||4
8483815|NCT00586703|20907258|P1|STARTED|Overall Study||16
8483816|NCT00586690|20907265|P2|NOT COMPLETED|Overall Study||0
8483817|NCT00586690|20907266|P1|NOT COMPLETED|Overall Study||16
8483818|NCT00586690|20907265|P2|COMPLETED|Overall Study||22
8483819|NCT00586690|20907266|P1|COMPLETED|Overall Study||5
8483820|NCT00586690|20907265|P2|STARTED|Overall Study||22
8483821|NCT00586690|20907266|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
8483822|NCT00586664|20907276|P3|NOT COMPLETED|Overall Study||1
8483823|NCT00586664|20907277|P2|NOT COMPLETED|Overall Study||7
8483824|NCT00586664|20907278|P1|NOT COMPLETED|Overall Study||5
8483825|NCT00586664|20907276|P3|COMPLETED|Overall Study||43
8483826|NCT00586664|20907277|P2|COMPLETED|Overall Study||36
8483827|NCT00586664|20907278|P1|COMPLETED|Overall Study||38
8483828|NCT00586664|20907276|P3|STARTED|Overall Study||44
8483829|NCT00586664|20907277|P2|STARTED|Overall Study||43
8483830|NCT00586664|20907278|P1|STARTED|Overall Study||43
8483831|NCT00586625|20907324|P2|NOT COMPLETED|Overall Study||17
8483832|NCT00586625|20907325|P1|NOT COMPLETED|Overall Study||43
8483833|NCT00586625|20907324|P2|COMPLETED|Overall Study||269
8483834|NCT00586625|20907325|P1|COMPLETED|Overall Study||532
8483835|NCT00586625|20907324|P2|STARTED|Overall Study||286
8483836|NCT00586625|20907325|P1|STARTED|Overall Study||575
8483837|NCT00586612|20907333|P2|NOT COMPLETED|Booster Phase||1
8483838|NCT00586612|20907334|P1|NOT COMPLETED|Booster Phase||3
8483839|NCT00586612|20907333|P2|COMPLETED|Booster Phase||143
8483840|NCT00586612|20907334|P1|COMPLETED|Booster Phase||151
8483841|NCT00586612|20907333|P2|STARTED|Booster Phase||144
8483842|NCT00586612|20907334|P1|STARTED|Booster Phase||154
8483843|NCT00586612|20907333|P2|NOT COMPLETED|Primary Phase||3
8483844|NCT00586612|20907334|P1|NOT COMPLETED|Primary Phase||1
8483845|NCT00586612|20907333|P2|COMPLETED|Primary Phase||147
8483846|NCT00586612|20907334|P1|COMPLETED|Primary Phase||162
8483847|NCT00586612|20907333|P2|STARTED|Primary Phase||150
8483848|NCT00586612|20907334|P1|STARTED|Primary Phase||163
8483849|NCT00586573|20907400|P1|NOT COMPLETED|Overall Study||6
8483850|NCT00586573|20907400|P1|COMPLETED|Overall Study||28
8483851|NCT00586573|20907400|P1|STARTED|Overall Study||34
8483852|NCT00586521|20907404|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
8483853|NCT00586521|20907404|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
8483854|NCT00586521|20907404|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
8483855|NCT00586521|20907404|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
8483856|NCT00586521|20907404|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
8483857|NCT00586521|20907404|P1|STARTED|On Demand Treatment (Months 1-6)||20
8483858|NCT00586508|20907413|P2|NOT COMPLETED|Overall Study||13
8483859|NCT00586508|20907414|P1|NOT COMPLETED|Overall Study||68
8483860|NCT00586508|20907413|P2|COMPLETED|Overall Study||0
8483861|NCT00586508|20907414|P1|COMPLETED|Overall Study||0
8483862|NCT00586508|20907413|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8483863|NCT00586508|20907414|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
8483864|NCT00586508|20907413|P2|STARTED|Overall Study||13
8483865|NCT00586508|20907414|P1|STARTED|Overall Study||68
8483866|NCT00586495|20907430|P1|NOT COMPLETED|Follow-up||92
8483867|NCT00586495|20907430|P1|COMPLETED|Follow-up||0
8483868|NCT00586495|20907430|P1|STARTED|Follow-up||92
8483869|NCT00586495|20907430|P1|NOT COMPLETED|Treatment Period||95
8483870|NCT00586495|20907430|P1|COMPLETED|Treatment Period||0
8483871|NCT00586495|20907430|P1|STARTED|Treatment Period||95
8483872|NCT00586482|20907442|P2|NOT COMPLETED|Overall Study||0
8483873|NCT00586482|20907443|P1|NOT COMPLETED|Overall Study||0
8483874|NCT00586482|20907442|P2|COMPLETED|Overall Study||24
8483875|NCT00586482|20907443|P1|COMPLETED|Overall Study||22
8483876|NCT00586482|20907442|P2|STARTED|Overall Study||24
8483877|NCT00586482|20907443|P1|STARTED|Overall Study||22
8483878|NCT00586469|20907459|P2|NOT COMPLETED|Overall Study||1
8483879|NCT00586469|20907460|P1|NOT COMPLETED|Overall Study||0
8483880|NCT00586469|20907459|P2|COMPLETED|Overall Study||499
8483881|NCT00586469|20907460|P1|COMPLETED|Overall Study||500
8483882|NCT00586469|20907459|P2|STARTED|Overall Study||500
8483883|NCT00586469|20907460|P1|STARTED|Overall Study||500
8483884|NCT00586339|20907487|P3|NOT COMPLETED|Overall Study||6
8483885|NCT00586339|20907488|P2|NOT COMPLETED|Overall Study||7
8483886|NCT00586339|20907489|P1|NOT COMPLETED|Overall Study||7
8483887|NCT00586339|20907487|P3|COMPLETED|Overall Study||24
8483888|NCT00586339|20907488|P2|COMPLETED|Overall Study||52
8483889|NCT00586339|20907489|P1|COMPLETED|Overall Study||54
8483890|NCT00586339|20907487|P3|STARTED|Overall Study||30
8483891|NCT00586339|20907488|P2|STARTED|Overall Study||59
8483892|NCT00586339|20907489|P1|STARTED|Overall Study||61
8483893|NCT00586326|20907590|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
8483894|NCT00586326|20907590|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
8483895|NCT00586326|20907590|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
8483896|NCT00586326|20907590|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
8483897|NCT00586326|20907590|P1|COMPLETED|Device Placed toTreatment-ITT||100
8483898|NCT00586326|20907590|P1|STARTED|Device Placed toTreatment-ITT||118
8483899|NCT00586326|20907590|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
8483900|NCT00586326|20907590|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
8483901|NCT00586326|20907590|P1|STARTED|Enrollment to Device Placement-Enrolled||133
8483902|NCT00586313|20907601|P1|NOT COMPLETED|Overall Study||2
8483903|NCT00586313|20907601|P1|COMPLETED|Overall Study||19
8483904|NCT00586313|20907601|P1|STARTED|Overall Study||21
8483905|NCT00586261|20907608|P2|NOT COMPLETED|Overall Study||0
8483906|NCT00586261|20907609|P1|NOT COMPLETED|Overall Study||0
8483907|NCT00586261|20907608|P2|COMPLETED|Overall Study||19
8483908|NCT00586261|20907609|P1|COMPLETED|Overall Study||17
8483909|NCT00586261|20907608|P2|STARTED|Overall Study||19
8483910|NCT00586261|20907609|P1|STARTED|Overall Study||17
8483911|NCT00586196|20907617|P2|NOT COMPLETED|Overall Study||0
8483912|NCT00586196|20907618|P1|NOT COMPLETED|Overall Study||0
8483913|NCT00586196|20907617|P2|COMPLETED|Overall Study||9
8483914|NCT00586196|20907618|P1|COMPLETED|Overall Study||7
8483915|NCT00586196|20907617|P2|STARTED|Overall Study||9
8483916|NCT00586196|20907618|P1|STARTED|Overall Study||7
8483917|NCT00586170|20907628|P2|NOT COMPLETED|Overall Study||0
8483918|NCT00586170|20907629|P1|NOT COMPLETED|Overall Study||0
8483919|NCT00586170|20907628|P2|COMPLETED|Overall Study||3
8483920|NCT00586170|20907629|P1|COMPLETED|Overall Study||5
8483921|NCT00586170|20907628|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
8483922|NCT00586170|20907629|P1|STARTED|Overall Study||5
8483923|NCT00586157|20907637|P2|NOT COMPLETED|Second Intervention||1
8483924|NCT00586157|20907638|P1|NOT COMPLETED|Second Intervention||2
8483925|NCT00586157|20907637|P2|COMPLETED|Second Intervention||14
8483926|NCT00586157|20907638|P1|COMPLETED|Second Intervention||12
8483927|NCT00586157|20907637|P2|STARTED|Second Intervention||15
8483928|NCT00586157|20907638|P1|STARTED|Second Intervention||14
8483929|NCT00586157|20907637|P2|NOT COMPLETED|First Intervention||0
8483930|NCT00586157|20907638|P1|NOT COMPLETED|First Intervention||1
8483931|NCT00586157|20907637|P2|COMPLETED|First Intervention||15
8483932|NCT00586157|20907638|P1|COMPLETED|First Intervention||14
8483933|NCT00586157|20907637|P2|STARTED|First Intervention||15
8483934|NCT00586157|20907638|P1|STARTED|First Intervention||15
8483935|NCT00586105|20907648|P1|NOT COMPLETED|Overall Study||39
8483936|NCT00586105|20907648|P1|COMPLETED|Overall Study||0
8483937|NCT00586105|20907648|P1|STARTED|Overall Study||39
8483938|NCT00586066|20907663|P2|NOT COMPLETED|Overall Study||10
8483939|NCT00586066|20907664|P1|NOT COMPLETED|Overall Study||18
8483940|NCT00586066|20907663|P2|COMPLETED|Overall Study||14
8483941|NCT00586066|20907664|P1|COMPLETED|Overall Study||30
8483942|NCT00586066|20907663|P2|STARTED|Overall Study||24
8483943|NCT00586066|20907664|P1|STARTED|Overall Study||48
8483944|NCT00586001|20907676|P2|NOT COMPLETED|Overall Study||1
8483945|NCT00586001|20907677|P1|NOT COMPLETED|Overall Study||4
8483946|NCT00586001|20907676|P2|COMPLETED|Overall Study||10
8483947|NCT00586001|20907677|P1|COMPLETED|Overall Study||22
8483948|NCT00586001|20907676|P2|STARTED|Overall Study||11
8483949|NCT00586001|20907677|P1|STARTED|Overall Study||26
8483950|NCT00585975|20907721|P2|NOT COMPLETED|Overall Study||13
8483951|NCT00585975|20907722|P1|NOT COMPLETED|Overall Study||15
8483952|NCT00585975|20907721|P2|COMPLETED|Overall Study||278
8483953|NCT00585975|20907722|P1|COMPLETED|Overall Study||262
8483954|NCT00585975|20907721|P2|STARTED|Overall Study||291
8483955|NCT00585975|20907722|P1|STARTED|Overall Study||277
8483956|NCT00585923|20907732|P2|NOT COMPLETED|Overall Study||33
8483957|NCT00585923|20907733|P1|NOT COMPLETED|Overall Study||31
8483958|NCT00585923|20907732|P2|COMPLETED|Overall Study||26
8483959|NCT00585923|20907733|P1|COMPLETED|Overall Study||25
8483960|NCT00585923|20907732|P2|STARTED|Overall Study||59
8483961|NCT00585923|20907733|P1|STARTED|Overall Study||56
8483962|NCT00585910|20907747|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
8483963|NCT00585910|20907747|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
8483964|NCT00585910|20907747|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
8483965|NCT00585910|20907747|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
8483966|NCT00585910|20907747|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
8483967|NCT00585910|20907747|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
8483968|NCT00585780|20907757|P4|NOT COMPLETED|Overall Study||8
8483969|NCT00585780|20907758|P3|NOT COMPLETED|Overall Study||13
8483970|NCT00585780|20907759|P2|NOT COMPLETED|Overall Study||9
8483971|NCT00585780|20907760|P1|NOT COMPLETED|Overall Study||8
8483972|NCT00585780|20907757|P4|COMPLETED|Overall Study||14
8483973|NCT00585780|20907758|P3|COMPLETED|Overall Study||21
8483974|NCT00585780|20907759|P2|COMPLETED|Overall Study||14
8483975|NCT00585780|20907760|P1|COMPLETED|Overall Study||13
8483976|NCT00585780|20907757|P4|STARTED|Overall Study||22
8483977|NCT00585780|20907758|P3|STARTED|Overall Study||34
8483978|NCT00585780|20907759|P2|STARTED|Overall Study||23
8483979|NCT00585780|20907760|P1|STARTED|Overall Study||21
8483980|NCT00585715|20907776|P2|NOT COMPLETED|Overall Study||0
8483981|NCT00585715|20907777|P1|NOT COMPLETED|Overall Study||3
8483982|NCT00585715|20907776|P2|COMPLETED|Overall Study||11
8483983|NCT00585715|20907777|P1|COMPLETED|Overall Study||8
8483984|NCT00585715|20907776|P2|STARTED|Overall Study||11
8483985|NCT00585715|20907777|P1|STARTED|Overall Study||11
8483986|NCT00585689|20907785|P1|NOT COMPLETED|Overall Study||7
8483987|NCT00585689|20907785|P1|COMPLETED|Overall Study||22
8483988|NCT00585689|20907785|P1|STARTED|Overall Study||29
8483989|NCT00585650|20907791|P2|NOT COMPLETED|Overall Study||0
8483990|NCT00585650|20907792|P1|NOT COMPLETED|Overall Study||0
8483991|NCT00585650|20907791|P2|COMPLETED|Overall Study||12
8483992|NCT00585650|20907792|P1|COMPLETED|Overall Study||8
8483993|NCT00585650|20907791|P2|STARTED|Overall Study||12
8483994|NCT00585650|20907792|P1|STARTED|Overall Study||8
8483995|NCT00585637|20907802|P4|NOT COMPLETED|6-month Time Point||6
8483996|NCT00585637|20907803|P3|NOT COMPLETED|6-month Time Point||11
8483997|NCT00585637|20907804|P2|NOT COMPLETED|6-month Time Point||13
8483998|NCT00585637|20907805|P1|NOT COMPLETED|6-month Time Point||6
8483999|NCT00585637|20907802|P4|COMPLETED|6-month Time Point||77
8484000|NCT00585637|20907803|P3|COMPLETED|6-month Time Point||72
8484001|NCT00585637|20907804|P2|COMPLETED|6-month Time Point||68
8484002|NCT00585637|20907805|P1|COMPLETED|6-month Time Point||75
8484003|NCT00585637|20907802|P4|STARTED|6-month Time Point||83
8484004|NCT00585637|20907803|P3|STARTED|6-month Time Point||83
8484005|NCT00585637|20907804|P2|STARTED|6-month Time Point||81
8484006|NCT00585637|20907805|P1|STARTED|6-month Time Point||81
8484007|NCT00585637|20907802|P4|NOT COMPLETED|3-month Time Point||5
8484008|NCT00585637|20907803|P3|NOT COMPLETED|3-month Time Point||7
8484009|NCT00585637|20907804|P2|NOT COMPLETED|3-month Time Point||14
8484010|NCT00585637|20907805|P1|NOT COMPLETED|3-month Time Point||10
8484011|NCT00585637|20907802|P4|COMPLETED|3-month Time Point||78
8484012|NCT00585637|20907803|P3|COMPLETED|3-month Time Point||76
8484013|NCT00585637|20907804|P2|COMPLETED|3-month Time Point||67
8484014|NCT00585637|20907805|P1|COMPLETED|3-month Time Point||71
8484015|NCT00585637|20907802|P4|STARTED|3-month Time Point||83
8484016|NCT00585637|20907803|P3|STARTED|3-month Time Point||83
8484017|NCT00585637|20907804|P2|STARTED|3-month Time Point||81
8484018|NCT00585637|20907805|P1|STARTED|3-month Time Point||81
8484019|NCT00585637|20907802|P4|NOT COMPLETED|Baseline||0
8484020|NCT00585637|20907803|P3|NOT COMPLETED|Baseline||0
8484021|NCT00585637|20907804|P2|NOT COMPLETED|Baseline||0
8484022|NCT00585637|20907805|P1|NOT COMPLETED|Baseline||0
8484023|NCT00585637|20907802|P4|COMPLETED|Baseline||83
8484024|NCT00585637|20907803|P3|COMPLETED|Baseline||83
8484025|NCT00585637|20907804|P2|COMPLETED|Baseline||81
8484026|NCT00585637|20907805|P1|COMPLETED|Baseline||81
8484027|NCT00585637|20907802|P4|STARTED|Baseline||83
8484028|NCT00585637|20907803|P3|STARTED|Baseline||83
8484029|NCT00585637|20907804|P2|STARTED|Baseline||81
8484030|NCT00585637|20907805|P1|STARTED|Baseline||81
8484031|NCT00585611|20907833|P2|NOT COMPLETED|Overall Study||0
8484032|NCT00585611|20907834|P1|NOT COMPLETED|Overall Study||0
8484033|NCT00585611|20907833|P2|COMPLETED|Overall Study||0
8484034|NCT00585611|20907834|P1|COMPLETED|Overall Study||0
8484035|NCT00585611|20907833|P2|STARTED|Overall Study||0
8484036|NCT00585611|20907834|P1|STARTED|Overall Study||0
8484037|NCT00585585|20907844|P1|NOT COMPLETED|Overall Study||1
8484038|NCT00585585|20907844|P1|COMPLETED|Overall Study||0
8484039|NCT00585585|20907844|P1|Patients Receiving Drug|Overall Study||1
8484040|NCT00585585|20907844|P1|STARTED|Overall Study||1
8484041|NCT00585546|20907848|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
8484042|NCT00585546|20907848|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
8484043|NCT00585546|20907848|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
8484044|NCT00585546|20907848|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
8484045|NCT00585546|20907848|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
8484046|NCT00585546|20907848|P1|STARTED|LVAD Implantation Required for 4 Months||18
8484047|NCT00585533|20907862|P1|NOT COMPLETED|Overall Study||9
8484048|NCT00585533|20907862|P1|COMPLETED|Overall Study||31
8484049|NCT00585533|20907862|P1|STARTED|Overall Study||40
8484050|NCT00585494|20907867|P1|NOT COMPLETED|Overall Study||56
8484051|NCT00585494|20907867|P1|COMPLETED|Overall Study||244
8484052|NCT00585494|20907867|P1|STARTED|Overall Study||300
8484053|NCT00585468|20907871|P2|NOT COMPLETED|Second Intervention||0
8484054|NCT00585468|20907872|P1|NOT COMPLETED|Second Intervention||0
8484055|NCT00585468|20907871|P2|COMPLETED|Second Intervention||10
8484056|NCT00585468|20907872|P1|COMPLETED|Second Intervention||9
8484057|NCT00585468|20907871|P2|STARTED|Second Intervention||10
8484058|NCT00585468|20907872|P1|STARTED|Second Intervention||9
8484059|NCT00585468|20907871|P2|NOT COMPLETED|First Intervention||1
8484060|NCT00585468|20907872|P1|NOT COMPLETED|First Intervention||1
8484061|NCT00585468|20907871|P2|COMPLETED|First Intervention||10
8484062|NCT00585468|20907872|P1|COMPLETED|First Intervention||9
8484063|NCT00585468|20907871|P2|STARTED|First Intervention||11
8484064|NCT00585468|20907872|P1|STARTED|First Intervention||10
8484065|NCT00585377|20907892|P1|NOT COMPLETED|Overall Study||0
8484066|NCT00585377|20907892|P1|COMPLETED|Overall Study||50
8484067|NCT00585377|20907892|P1|STARTED|Overall Study||50
8484068|NCT00585351|20907904|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
8484069|NCT00585351|20907905|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
8484070|NCT00585351|20907906|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
8484071|NCT00585351|20907907|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
8484072|NCT00585351|20907908|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
8484073|NCT00585351|20907909|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
8484074|NCT00585351|20907910|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
8484075|NCT00585351|20907911|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
8484076|NCT00585351|20907904|P8|COMPLETED|Enrollment Period (Intervention)||2
8484077|NCT00585351|20907905|P7|COMPLETED|Enrollment Period (Intervention)||5
8484078|NCT00585351|20907906|P6|COMPLETED|Enrollment Period (Intervention)||5
8484079|NCT00585351|20907907|P5|COMPLETED|Enrollment Period (Intervention)||3
8484080|NCT00585351|20907908|P4|COMPLETED|Enrollment Period (Intervention)||15
8484081|NCT00585351|20907909|P3|COMPLETED|Enrollment Period (Intervention)||15
8484082|NCT00585351|20907910|P2|COMPLETED|Enrollment Period (Intervention)||0
8484083|NCT00585351|20907911|P1|COMPLETED|Enrollment Period (Intervention)||0
8484084|NCT00585351|20907904|P8|STARTED|Enrollment Period (Intervention)||3
8484085|NCT00585351|20907905|P7|STARTED|Enrollment Period (Intervention)||7
8484086|NCT00585351|20907906|P6|STARTED|Enrollment Period (Intervention)||7
8484087|NCT00585351|20907907|P5|STARTED|Enrollment Period (Intervention)||5
8484088|NCT00585351|20907908|P4|STARTED|Enrollment Period (Intervention)||15
8484089|NCT00585351|20907909|P3|STARTED|Enrollment Period (Intervention)||15
8484090|NCT00585351|20907910|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
8484091|NCT00585351|20907911|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
8484092|NCT00585351|20907904|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
8484093|NCT00585351|20907905|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
8484094|NCT00585351|20907906|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
8484095|NCT00585351|20907907|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
8484096|NCT00585351|20907908|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
8484097|NCT00585351|20907909|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
8484098|NCT00585351|20907910|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
8484099|NCT00585351|20907911|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
8484100|NCT00585351|20907904|P8|COMPLETED|Notification Period (Informed Consent)||0
8484101|NCT00585351|20907905|P7|COMPLETED|Notification Period (Informed Consent)||0
8484102|NCT00585351|20907906|P6|COMPLETED|Notification Period (Informed Consent)||0
8484103|NCT00585351|20907907|P5|COMPLETED|Notification Period (Informed Consent)||0
8484104|NCT00585351|20907908|P4|COMPLETED|Notification Period (Informed Consent)||0
8484105|NCT00585351|20907909|P3|COMPLETED|Notification Period (Informed Consent)||0
8484106|NCT00585351|20907910|P2|COMPLETED|Notification Period (Informed Consent)||25
8484107|NCT00585351|20907911|P1|COMPLETED|Notification Period (Informed Consent)||27
8484108|NCT00585351|20907904|P8|STARTED|Notification Period (Informed Consent)||0
8484109|NCT00585351|20907905|P7|STARTED|Notification Period (Informed Consent)||0
8484110|NCT00585351|20907906|P6|STARTED|Notification Period (Informed Consent)||0
8484111|NCT00585351|20907907|P5|STARTED|Notification Period (Informed Consent)||0
8484112|NCT00585351|20907908|P4|STARTED|Notification Period (Informed Consent)||0
8484113|NCT00585351|20907909|P3|STARTED|Notification Period (Informed Consent)||0
8484114|NCT00585351|20907910|P2|STARTED|Notification Period (Informed Consent)||50
8484115|NCT00585351|20907911|P1|STARTED|Notification Period (Informed Consent)||50
8484116|NCT00585325|20907927|P2|NOT COMPLETED|Overall Study||1
8484117|NCT00585325|20907928|P1|NOT COMPLETED|Overall Study||1
8484118|NCT00585325|20907927|P2|COMPLETED|Overall Study||12
8484119|NCT00585325|20907928|P1|COMPLETED|Overall Study||9
8484120|NCT00585325|20907927|P2|STARTED|Overall Study||13
8484121|NCT00585325|20907928|P1|STARTED|Overall Study||10
8484130|NCT00585286|20907949|P1|NOT COMPLETED|Overall Study||1
8484131|NCT00585286|20907949|P1|COMPLETED|Overall Study||14
8484132|NCT00585286|20907949|P1|STARTED|Overall Study||15
8484133|NCT00585247|20907958|P2|NOT COMPLETED|Overall Study||0
8484134|NCT00585247|20907959|P1|NOT COMPLETED|Overall Study||0
8484135|NCT00585247|20907958|P2|COMPLETED|Overall Study||13
8484136|NCT00585247|20907959|P1|COMPLETED|Overall Study||14
8484137|NCT00585247|20907958|P2|STARTED|Overall Study||13
8484138|NCT00585247|20907959|P1|STARTED|Overall Study||14
8484139|NCT00585221|20907965|P1|NOT COMPLETED|Overall Study||8
8484140|NCT00585221|20907965|P1|COMPLETED|Overall Study||0
8484141|NCT00585221|20907965|P1|STARTED|Overall Study||8
8484142|NCT00585182|20907970|P1|NOT COMPLETED|Overall Study||0
8484143|NCT00585182|20907970|P1|COMPLETED|Overall Study||28
8484144|NCT00585182|20907970|P1|STARTED|Overall Study||28
8484145|NCT00585169|20907975|P1|NOT COMPLETED|Overall Study||1
8484146|NCT00585169|20907975|P1|COMPLETED|Overall Study||28
8484147|NCT00585169|20907975|P1|STARTED|Overall Study||29
8484148|NCT00585104|20907981|P1|NOT COMPLETED|Overall Study||4
8484149|NCT00585104|20907981|P1|COMPLETED|Overall Study||6
8484150|NCT00585104|20907981|P1|STARTED|Overall Study||10
8484151|NCT00585078|20907985|P1|NOT COMPLETED|Overall Study||40
8484152|NCT00585078|20907985|P1|COMPLETED|Overall Study||0
8484153|NCT00585078|20907985|P1|Response Evaluable|Overall Study||24
8484154|NCT00585078|20907985|P1|Toxicity Evaluable|Overall Study||36
8484155|NCT00585078|20907985|P1|Treated|Overall Study||37
8484156|NCT00585078|20907985|P1|STARTED|Overall Study||40
8484157|NCT00585052|20907992|P1|NOT COMPLETED|Overall Study||1
8484158|NCT00585052|20907992|P1|COMPLETED|Overall Study||10
8484159|NCT00585052|20907992|P1|STARTED|Overall Study||11
8484160|NCT00585039|20907999|P2|NOT COMPLETED|Overall Study||0
8484161|NCT00585039|20908000|P1|NOT COMPLETED|Overall Study||2
8484162|NCT00585039|20907999|P2|COMPLETED|Overall Study||44
8484163|NCT00585039|20908000|P1|COMPLETED|Overall Study||55
8484164|NCT00585039|20907999|P2|STARTED|Overall Study||44
8484165|NCT00585039|20908000|P1|STARTED|Overall Study||57
8484166|NCT00585013|20908010|P2|NOT COMPLETED|Overall Study||0
8484167|NCT00585013|20908011|P1|NOT COMPLETED|Overall Study||0
8484168|NCT00585013|20908010|P2|COMPLETED|Overall Study||8
8484169|NCT00585013|20908011|P1|COMPLETED|Overall Study||8
8484170|NCT00585013|20908010|P2|STARTED|Overall Study||8
8484171|NCT00585013|20908011|P1|STARTED|Overall Study||8
8484172|NCT00584987|20908029|P4|NOT COMPLETED|Overall Study||1
8484173|NCT00584987|20908030|P3|NOT COMPLETED|Overall Study||1
8484174|NCT00584987|20908031|P2|NOT COMPLETED|Overall Study||1
8484175|NCT00584987|20908032|P1|NOT COMPLETED|Overall Study||1
8484176|NCT00584987|20908029|P4|COMPLETED|Overall Study||15
8484177|NCT00584987|20908030|P3|COMPLETED|Overall Study||16
8484178|NCT00584987|20908031|P2|COMPLETED|Overall Study||15
8484179|NCT00584987|20908032|P1|COMPLETED|Overall Study||14
8484180|NCT00584987|20908029|P4|STARTED|Overall Study||16
8484181|NCT00584987|20908030|P3|STARTED|Overall Study||17
8484182|NCT00584987|20908031|P2|STARTED|Overall Study||16
8484183|NCT00584987|20908032|P1|STARTED|Overall Study||15
8484184|NCT00584948|20908064|P2|NOT COMPLETED|Overall Study||11
8484185|NCT00584948|20908065|P1|NOT COMPLETED|Overall Study||13
8484186|NCT00584948|20908064|P2|COMPLETED|Overall Study||36
8484187|NCT00584948|20908065|P1|COMPLETED|Overall Study||34
8484188|NCT00584948|20908064|P2|STARTED|Overall Study||47
8484189|NCT00584948|20908065|P1|STARTED|Overall Study||47
8484190|NCT00584935|20908073|P1|NOT COMPLETED|Overall Study||0
8484191|NCT00584935|20908073|P1|COMPLETED|Overall Study||3
8484192|NCT00584935|20908073|P1|STARTED|Overall Study||3
8484193|NCT00584922|20908080|P1|NOT COMPLETED|Overall Study||0
8484194|NCT00584922|20908080|P1|COMPLETED|Overall Study||175
8484195|NCT00584922|20908080|P1|STARTED|Overall Study||175
8484196|NCT00584909|20908084|P1|NOT COMPLETED|Overall Study||4
8484197|NCT00584909|20908084|P1|COMPLETED|Overall Study||9
8484198|NCT00584909|20908084|P1|STARTED|Overall Study||13
8484199|NCT00584857|20908089|P1|NOT COMPLETED|Overall Study||0
8484200|NCT00584857|20908089|P1|COMPLETED|Overall Study||30
8484201|NCT00584857|20908089|P1|STARTED|Overall Study||30
8484202|NCT00584844|20908094|P1|NOT COMPLETED|Overall Study||79
8484203|NCT00584844|20908094|P1|COMPLETED|Overall Study||405
8484204|NCT00584844|20908094|P1|STARTED|Overall Study||484
8484205|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 4||0
8484206|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 4||0
8484207|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 4||0
8484208|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 4||0
8484209|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 4||0
8484210|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 4||0
8484211|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 4||0
8484212|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 4||0
8484213|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 4||0
8484214|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 4||0
8484215|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 4||0
8484216|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 4||0
8484217|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 4||0
8484218|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 4||0
8484219|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 4||0
8484220|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 4||0
8484221|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 4||0
8484222|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 4||0
8484223|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 4||0
8484224|NCT00584831|20908104|P19|COMPLETED|Intervention 4||1
8484225|NCT00584831|20908105|P18|COMPLETED|Intervention 4||1
8484226|NCT00584831|20908106|P17|COMPLETED|Intervention 4||4
8484227|NCT00584831|20908107|P16|COMPLETED|Intervention 4||1
8484228|NCT00584831|20908108|P15|COMPLETED|Intervention 4||2
8484229|NCT00584831|20908109|P14|COMPLETED|Intervention 4||1
8484230|NCT00584831|20908110|P13|COMPLETED|Intervention 4||2
8484231|NCT00584831|20908111|P12|COMPLETED|Intervention 4||1
8484232|NCT00584831|20908112|P11|COMPLETED|Intervention 4||2
8484233|NCT00584831|20908113|P10|COMPLETED|Intervention 4||2
8484234|NCT00584831|20908114|P9|COMPLETED|Intervention 4||3
8484235|NCT00584831|20908115|P8|COMPLETED|Intervention 4||2
8484236|NCT00584831|20908116|P7|COMPLETED|Intervention 4||6
8484237|NCT00584831|20908117|P6|COMPLETED|Intervention 4||1
8484238|NCT00584831|20908118|P5|COMPLETED|Intervention 4||2
8484239|NCT00584831|20908119|P4|COMPLETED|Intervention 4||1
8484240|NCT00584831|20908120|P3|COMPLETED|Intervention 4||2
8484241|NCT00584831|20908121|P2|COMPLETED|Intervention 4||3
8484242|NCT00584831|20908122|P1|COMPLETED|Intervention 4||1
8484243|NCT00584831|20908104|P19|STARTED|Intervention 4||1
8484244|NCT00584831|20908105|P18|STARTED|Intervention 4||1
8484245|NCT00584831|20908106|P17|STARTED|Intervention 4||4
8484246|NCT00584831|20908107|P16|STARTED|Intervention 4||1
8484247|NCT00584831|20908108|P15|STARTED|Intervention 4||2
8484248|NCT00584831|20908109|P14|STARTED|Intervention 4||1
8484249|NCT00584831|20908110|P13|STARTED|Intervention 4||2
8484250|NCT00584831|20908111|P12|STARTED|Intervention 4||1
8484251|NCT00584831|20908112|P11|STARTED|Intervention 4||2
8484252|NCT00584831|20908113|P10|STARTED|Intervention 4||2
8484253|NCT00584831|20908114|P9|STARTED|Intervention 4||3
8484254|NCT00584831|20908115|P8|STARTED|Intervention 4||2
8484255|NCT00584831|20908116|P7|STARTED|Intervention 4||6
8484256|NCT00584831|20908117|P6|STARTED|Intervention 4||1
8484257|NCT00584831|20908118|P5|STARTED|Intervention 4||2
8484258|NCT00584831|20908119|P4|STARTED|Intervention 4||1
8484259|NCT00584831|20908120|P3|STARTED|Intervention 4||2
8484260|NCT00584831|20908121|P2|STARTED|Intervention 4||3
8484261|NCT00584831|20908122|P1|STARTED|Intervention 4||1
8484262|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 3||0
8484263|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 3||0
8484264|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 3||0
8484265|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 3||0
8484266|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 3||0
8484267|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 3||0
8484268|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 3||0
8484269|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 3||0
8484270|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 3||0
8484271|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 3||0
8484272|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 3||0
8484273|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 3||0
8484274|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 3||0
8484275|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 3||0
8484276|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 3||0
8484277|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 3||0
8484278|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 3||0
8484279|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 3||0
8484280|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 3||0
8484281|NCT00584831|20908104|P19|COMPLETED|Intervention 3||1
8484282|NCT00584831|20908105|P18|COMPLETED|Intervention 3||1
8484283|NCT00584831|20908106|P17|COMPLETED|Intervention 3||4
8484284|NCT00584831|20908107|P16|COMPLETED|Intervention 3||1
8484285|NCT00584831|20908108|P15|COMPLETED|Intervention 3||3
8484286|NCT00584831|20908109|P14|COMPLETED|Intervention 3||1
8484287|NCT00584831|20908110|P13|COMPLETED|Intervention 3||2
8484288|NCT00584831|20908111|P12|COMPLETED|Intervention 3||1
8484289|NCT00584831|20908112|P11|COMPLETED|Intervention 3||2
8484290|NCT00584831|20908113|P10|COMPLETED|Intervention 3||2
8484291|NCT00584831|20908114|P9|COMPLETED|Intervention 3||4
8484292|NCT00584831|20908115|P8|COMPLETED|Intervention 3||2
8484293|NCT00584831|20908116|P7|COMPLETED|Intervention 3||6
8484294|NCT00584831|20908117|P6|COMPLETED|Intervention 3||1
8484295|NCT00584831|20908118|P5|COMPLETED|Intervention 3||2
8484296|NCT00584831|20908119|P4|COMPLETED|Intervention 3||1
8484297|NCT00584831|20908120|P3|COMPLETED|Intervention 3||2
8484298|NCT00584831|20908121|P2|COMPLETED|Intervention 3||3
8484299|NCT00584831|20908122|P1|COMPLETED|Intervention 3||1
8484300|NCT00584831|20908104|P19|STARTED|Intervention 3||1
8484301|NCT00584831|20908105|P18|STARTED|Intervention 3||1
8484302|NCT00584831|20908106|P17|STARTED|Intervention 3||4
8484303|NCT00584831|20908107|P16|STARTED|Intervention 3||1
8484304|NCT00584831|20908108|P15|STARTED|Intervention 3||3
8484305|NCT00584831|20908109|P14|STARTED|Intervention 3||1
8484306|NCT00584831|20908110|P13|STARTED|Intervention 3||2
8484307|NCT00584831|20908111|P12|STARTED|Intervention 3||1
8484308|NCT00584831|20908112|P11|STARTED|Intervention 3||2
8484309|NCT00584831|20908113|P10|STARTED|Intervention 3||2
8484310|NCT00584831|20908114|P9|STARTED|Intervention 3||4
8484311|NCT00584831|20908115|P8|STARTED|Intervention 3||2
8484312|NCT00584831|20908116|P7|STARTED|Intervention 3||6
8484313|NCT00584831|20908117|P6|STARTED|Intervention 3||1
8484314|NCT00584831|20908118|P5|STARTED|Intervention 3||2
8484315|NCT00584831|20908119|P4|STARTED|Intervention 3||1
8484316|NCT00584831|20908120|P3|STARTED|Intervention 3||2
8484317|NCT00584831|20908121|P2|STARTED|Intervention 3||3
8484318|NCT00584831|20908122|P1|STARTED|Intervention 3||1
8484319|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 2||0
8484320|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 2||0
8484321|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 2||0
8484322|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 2||0
8484323|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 2||0
8484324|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 2||0
8484325|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 2||0
8484326|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 2||0
8484327|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 2||0
8484328|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 2||0
8484329|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 2||0
8484330|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 2||0
8484331|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 2||0
8484332|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 2||0
8484333|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 2||0
8484334|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 2||0
8484335|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 2||0
8484336|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 2||0
8484337|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 2||0
8484338|NCT00584831|20908104|P19|COMPLETED|Intervention 2||1
8484339|NCT00584831|20908105|P18|COMPLETED|Intervention 2||1
8484340|NCT00584831|20908106|P17|COMPLETED|Intervention 2||4
8484341|NCT00584831|20908107|P16|COMPLETED|Intervention 2||1
8484342|NCT00584831|20908108|P15|COMPLETED|Intervention 2||3
8484343|NCT00584831|20908109|P14|COMPLETED|Intervention 2||1
8484344|NCT00584831|20908110|P13|COMPLETED|Intervention 2||2
8484345|NCT00584831|20908111|P12|COMPLETED|Intervention 2||1
8484346|NCT00584831|20908112|P11|COMPLETED|Intervention 2||2
8484347|NCT00584831|20908113|P10|COMPLETED|Intervention 2||2
8484348|NCT00584831|20908114|P9|COMPLETED|Intervention 2||4
8484349|NCT00584831|20908115|P8|COMPLETED|Intervention 2||2
8484350|NCT00584831|20908116|P7|COMPLETED|Intervention 2||6
8484351|NCT00584831|20908117|P6|COMPLETED|Intervention 2||1
8484352|NCT00584831|20908118|P5|COMPLETED|Intervention 2||2
8484353|NCT00584831|20908119|P4|COMPLETED|Intervention 2||1
8484354|NCT00584831|20908120|P3|COMPLETED|Intervention 2||2
8484355|NCT00584831|20908121|P2|COMPLETED|Intervention 2||3
8484356|NCT00584831|20908122|P1|COMPLETED|Intervention 2||1
8484357|NCT00584831|20908104|P19|STARTED|Intervention 2||1
8484358|NCT00584831|20908105|P18|STARTED|Intervention 2||1
8484359|NCT00584831|20908106|P17|STARTED|Intervention 2||4
8484360|NCT00584831|20908107|P16|STARTED|Intervention 2||1
8484361|NCT00584831|20908108|P15|STARTED|Intervention 2||3
8484362|NCT00584831|20908109|P14|STARTED|Intervention 2||1
8484363|NCT00584831|20908110|P13|STARTED|Intervention 2||2
8484364|NCT00584831|20908111|P12|STARTED|Intervention 2||1
8484365|NCT00584831|20908112|P11|STARTED|Intervention 2||2
8484366|NCT00584831|20908113|P10|STARTED|Intervention 2||2
8484367|NCT00584831|20908114|P9|STARTED|Intervention 2||4
8484368|NCT00584831|20908115|P8|STARTED|Intervention 2||2
8484369|NCT00584831|20908116|P7|STARTED|Intervention 2||6
8484370|NCT00584831|20908117|P6|STARTED|Intervention 2||1
8484371|NCT00584831|20908118|P5|STARTED|Intervention 2||2
8484372|NCT00584831|20908119|P4|STARTED|Intervention 2||1
8484373|NCT00584831|20908120|P3|STARTED|Intervention 2||2
8484374|NCT00584831|20908121|P2|STARTED|Intervention 2||3
8484375|NCT00584831|20908122|P1|STARTED|Intervention 2||1
8484376|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 1||0
8484377|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 1||0
8484378|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 1||0
8484379|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 1||0
8484380|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 1||0
8484381|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 1||0
8484382|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 1||0
8484383|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 1||0
8484384|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 1||0
8484385|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 1||0
8484386|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 1||0
8484387|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 1||0
8484388|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 1||0
8484389|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 1||0
8484390|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 1||0
8484391|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 1||0
8484392|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 1||0
8484393|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 1||0
8484394|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 1||0
8484395|NCT00584831|20908104|P19|COMPLETED|Intervention 1||1
8484396|NCT00584831|20908105|P18|COMPLETED|Intervention 1||1
8484397|NCT00584831|20908106|P17|COMPLETED|Intervention 1||4
8484398|NCT00584831|20908107|P16|COMPLETED|Intervention 1||1
8484399|NCT00584831|20908108|P15|COMPLETED|Intervention 1||3
8484400|NCT00584831|20908109|P14|COMPLETED|Intervention 1||1
8484401|NCT00584831|20908110|P13|COMPLETED|Intervention 1||2
8484402|NCT00584831|20908111|P12|COMPLETED|Intervention 1||1
8484403|NCT00584831|20908112|P11|COMPLETED|Intervention 1||2
8484404|NCT00584831|20908113|P10|COMPLETED|Intervention 1||2
8484405|NCT00584831|20908114|P9|COMPLETED|Intervention 1||4
8484406|NCT00584831|20908115|P8|COMPLETED|Intervention 1||2
8484407|NCT00584831|20908116|P7|COMPLETED|Intervention 1||6
8484408|NCT00584831|20908117|P6|COMPLETED|Intervention 1||1
8484409|NCT00584831|20908118|P5|COMPLETED|Intervention 1||2
8484410|NCT00584831|20908119|P4|COMPLETED|Intervention 1||1
8484411|NCT00584831|20908120|P3|COMPLETED|Intervention 1||2
8484412|NCT00584831|20908121|P2|COMPLETED|Intervention 1||3
8484413|NCT00584831|20908122|P1|COMPLETED|Intervention 1||1
8484414|NCT00584831|20908104|P19|STARTED|Intervention 1||1
8484415|NCT00584831|20908105|P18|STARTED|Intervention 1||1
8484416|NCT00584831|20908106|P17|STARTED|Intervention 1||4
8484417|NCT00584831|20908107|P16|STARTED|Intervention 1||1
8484418|NCT00584831|20908108|P15|STARTED|Intervention 1||3
8484419|NCT00584831|20908109|P14|STARTED|Intervention 1||1
8484420|NCT00584831|20908110|P13|STARTED|Intervention 1||2
8484421|NCT00584831|20908111|P12|STARTED|Intervention 1||1
8484422|NCT00584831|20908112|P11|STARTED|Intervention 1||2
8484423|NCT00584831|20908113|P10|STARTED|Intervention 1||2
8484424|NCT00584831|20908114|P9|STARTED|Intervention 1||4
8484425|NCT00584831|20908115|P8|STARTED|Intervention 1||2
8484426|NCT00584831|20908116|P7|STARTED|Intervention 1||6
8484427|NCT00584831|20908117|P6|STARTED|Intervention 1||1
8484428|NCT00584831|20908118|P5|STARTED|Intervention 1||2
8484429|NCT00584831|20908119|P4|STARTED|Intervention 1||1
8484430|NCT00584831|20908120|P3|STARTED|Intervention 1||2
8484431|NCT00584831|20908121|P2|STARTED|Intervention 1||3
8484432|NCT00584831|20908122|P1|STARTED|Intervention 1||1
8484433|NCT00584805|20908144|P1|NOT COMPLETED|Overall Study||99
8484434|NCT00584805|20908144|P1|COMPLETED|Overall Study||39
8484435|NCT00584805|20908144|P1|STARTED|Overall Study||138
8484436|NCT00584740|20908157|P2|NOT COMPLETED|Overall Study||6
8484437|NCT00584740|20908158|P1|NOT COMPLETED|Overall Study||12
8484438|NCT00584740|20908157|P2|COMPLETED|Overall Study||14
8484439|NCT00584740|20908158|P1|COMPLETED|Overall Study||27
8484440|NCT00584740|20908157|P2|STARTED|Overall Study||20
8484441|NCT00584740|20908158|P1|STARTED|Overall Study||39
8484442|NCT00584727|20908176|P6|NOT COMPLETED|Third Intervention||2
8484443|NCT00584727|20908177|P5|NOT COMPLETED|Third Intervention||4
8484444|NCT00584727|20908178|P4|NOT COMPLETED|Third Intervention||0
8484445|NCT00584727|20908179|P3|NOT COMPLETED|Third Intervention||1
8484446|NCT00584727|20908180|P2|NOT COMPLETED|Third Intervention||0
8484447|NCT00584727|20908181|P1|NOT COMPLETED|Third Intervention||0
8484448|NCT00584727|20908176|P6|COMPLETED|Third Intervention||14
8484449|NCT00584727|20908177|P5|COMPLETED|Third Intervention||12
8484450|NCT00584727|20908178|P4|COMPLETED|Third Intervention||14
8484451|NCT00584727|20908179|P3|COMPLETED|Third Intervention||14
8484452|NCT00584727|20908180|P2|COMPLETED|Third Intervention||17
8484453|NCT00584727|20908181|P1|COMPLETED|Third Intervention||17
8484454|NCT00584727|20908176|P6|STARTED|Third Intervention||16
8484455|NCT00584727|20908177|P5|STARTED|Third Intervention||16
8484456|NCT00584727|20908178|P4|STARTED|Third Intervention||14
8484457|NCT00584727|20908179|P3|STARTED|Third Intervention||15
8484458|NCT00584727|20908180|P2|STARTED|Third Intervention||17
8484459|NCT00584727|20908181|P1|STARTED|Third Intervention||17
8484460|NCT00584727|20908176|P6|NOT COMPLETED|Second Intervention||0
8484461|NCT00584727|20908177|P5|NOT COMPLETED|Second Intervention||0
8484462|NCT00584727|20908178|P4|NOT COMPLETED|Second Intervention||0
8484463|NCT00584727|20908179|P3|NOT COMPLETED|Second Intervention||0
8484464|NCT00584727|20908180|P2|NOT COMPLETED|Second Intervention||0
8484465|NCT00584727|20908181|P1|NOT COMPLETED|Second Intervention||0
8484466|NCT00584727|20908176|P6|COMPLETED|Second Intervention||16
8484467|NCT00584727|20908177|P5|COMPLETED|Second Intervention||16
8484468|NCT00584727|20908178|P4|COMPLETED|Second Intervention||14
8484469|NCT00584727|20908179|P3|COMPLETED|Second Intervention||15
8484470|NCT00584727|20908180|P2|COMPLETED|Second Intervention||17
8484471|NCT00584727|20908181|P1|COMPLETED|Second Intervention||17
8484472|NCT00584727|20908176|P6|STARTED|Second Intervention||16
8484473|NCT00584727|20908177|P5|STARTED|Second Intervention||16
8484474|NCT00584727|20908178|P4|STARTED|Second Intervention||14
8484475|NCT00584727|20908179|P3|STARTED|Second Intervention||15
8484476|NCT00584727|20908180|P2|STARTED|Second Intervention||17
8484477|NCT00584727|20908181|P1|STARTED|Second Intervention||17
8484478|NCT00584727|20908176|P6|NOT COMPLETED|First Intervention||0
8484479|NCT00584727|20908177|P5|NOT COMPLETED|First Intervention||0
8484480|NCT00584727|20908178|P4|NOT COMPLETED|First Intervention||0
8484481|NCT00584727|20908179|P3|NOT COMPLETED|First Intervention||1
8484482|NCT00584727|20908180|P2|NOT COMPLETED|First Intervention||0
8484483|NCT00584727|20908181|P1|NOT COMPLETED|First Intervention||0
8484484|NCT00584727|20908176|P6|COMPLETED|First Intervention||16
8484485|NCT00584727|20908177|P5|COMPLETED|First Intervention||16
8484486|NCT00584727|20908178|P4|COMPLETED|First Intervention||14
8484487|NCT00584727|20908179|P3|COMPLETED|First Intervention||15
8484488|NCT00584727|20908180|P2|COMPLETED|First Intervention||17
8484489|NCT00584727|20908181|P1|COMPLETED|First Intervention||17
8484490|NCT00584727|20908176|P6|STARTED|First Intervention||16
8484491|NCT00584727|20908177|P5|STARTED|First Intervention||16
8484492|NCT00584727|20908178|P4|STARTED|First Intervention||14
8484493|NCT00584727|20908179|P3|STARTED|First Intervention||16
8484494|NCT00584727|20908180|P2|STARTED|First Intervention||17
8484495|NCT00584727|20908181|P1|STARTED|First Intervention||17
8484496|NCT00584701|20908205|P1|NOT COMPLETED|Follow-up||12
8484497|NCT00584701|20908205|P1|COMPLETED|Follow-up||34
8484498|NCT00584701|20908205|P1|STARTED|Follow-up||46
8484499|NCT00584701|20908205|P1|NOT COMPLETED|Active Risperidone||3
8484500|NCT00584701|20908205|P1|COMPLETED|Active Risperidone||46
8484501|NCT00584701|20908205|P1|STARTED|Active Risperidone||49
8484502|NCT00584558|20908210|P1|NOT COMPLETED|Overall Study||0
8484503|NCT00584558|20908210|P1|COMPLETED|Overall Study||2420
8484504|NCT00584558|20908210|P1|STARTED|Overall Study||2420
8484505|NCT00584480|20908215|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
8484506|NCT00584480|20908215|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
8484507|NCT00584480|20908215|P1|STARTED|Second 8 Weeks (40 Treatments)||10
8484508|NCT00584480|20908215|P1|NOT COMPLETED|4-Week Break From Treatment||0
8484509|NCT00584480|20908215|P1|COMPLETED|4-Week Break From Treatment||10
8484510|NCT00584480|20908215|P1|STARTED|4-Week Break From Treatment||10
8484511|NCT00584480|20908215|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
8484512|NCT00584480|20908215|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
8484513|NCT00584480|20908215|P1|STARTED|First 8 Weeks (40 Treatments)||10
8484514|NCT00584454|20908219|P1|NOT COMPLETED|Overall Study||4
8484515|NCT00584454|20908219|P1|COMPLETED|Overall Study||6
8484516|NCT00584454|20908219|P1|STARTED|Overall Study||10
8484517|NCT00584415|20908223|P1|NOT COMPLETED|Overall Study||7
8484518|NCT00584415|20908223|P1|COMPLETED|Overall Study||112
8484519|NCT00584415|20908223|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
8484520|NCT00584402|20908228|P1|NOT COMPLETED|Overall Study||0
8484521|NCT00584402|20908228|P1|COMPLETED|Overall Study||8
8484522|NCT00584402|20908228|P1|STARTED|Overall Study||8
8484523|NCT00584285|20908233|P1|NOT COMPLETED|Overall Study||0
8484524|NCT00584285|20908233|P1|COMPLETED|Overall Study||18
8484525|NCT00584285|20908233|P1|STARTED|Overall Study||18
8484526|NCT00584220|20908237|P2|NOT COMPLETED|Second Period||0
8484527|NCT00584220|20908238|P1|NOT COMPLETED|Second Period||0
8484528|NCT00584220|20908237|P2|COMPLETED|Second Period||39
8484529|NCT00584220|20908238|P1|COMPLETED|Second Period||48
8484530|NCT00584220|20908237|P2|STARTED|Second Period||39
8484531|NCT00584220|20908238|P1|STARTED|Second Period||48
8484532|NCT00584220|20908237|P2|NOT COMPLETED|First Period||0
8484533|NCT00584220|20908238|P1|NOT COMPLETED|First Period||0
8484534|NCT00584220|20908237|P2|COMPLETED|First Period||39
8484535|NCT00584220|20908238|P1|COMPLETED|First Period||48
8484536|NCT00584220|20908237|P2|STARTED|First Period||39
8484537|NCT00584220|20908238|P1|STARTED|First Period||48
8484538|NCT00584194|20908246|P1|NOT COMPLETED|Overall Study||135
8484539|NCT00584194|20908246|P1|COMPLETED|Overall Study||143
8484540|NCT00584194|20908246|P1|STARTED|Overall Study||278
8484541|NCT00584077|20908254|P1|NOT COMPLETED|Overall Study||0
8484542|NCT00584077|20908254|P1|COMPLETED|Overall Study||15
8484543|NCT00584077|20908254|P1|STARTED|Overall Study||15
8484544|NCT00584012|20908259|P1|NOT COMPLETED|Overall Study||1
8484545|NCT00584012|20908259|P1|COMPLETED|Overall Study||8
8484546|NCT00584012|20908259|P1|STARTED|Overall Study||9
8484547|NCT00583947|20908265|P2|NOT COMPLETED|Open Label Period||0
8484548|NCT00583947|20908266|P1|NOT COMPLETED|Open Label Period||0
8484549|NCT00583947|20908265|P2|COMPLETED|Open Label Period||24
8484550|NCT00583947|20908266|P1|COMPLETED|Open Label Period||22
8484551|NCT00583947|20908265|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
8484552|NCT00583947|20908266|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
8484553|NCT00583947|20908265|P2|NOT COMPLETED|Washout||0
8484554|NCT00583947|20908266|P1|NOT COMPLETED|Washout||0
8484555|NCT00583947|20908265|P2|COMPLETED|Washout||24
8484556|NCT00583947|20908266|P1|COMPLETED|Washout||22
8484557|NCT00583947|20908265|P2|STARTED|Washout||24
8484558|NCT00583947|20908266|P1|STARTED|Washout||22
8484559|NCT00583947|20908265|P2|NOT COMPLETED|Cross-over Period||2
8484560|NCT00583947|20908266|P1|NOT COMPLETED|Cross-over Period||5
8484561|NCT00583947|20908265|P2|COMPLETED|Cross-over Period||24
8484562|NCT00583947|20908266|P1|COMPLETED|Cross-over Period||22
8484563|NCT00583947|20908265|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
8484564|NCT00583947|20908266|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
8484565|NCT00583908|20908316|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484566|NCT00583908|20908317|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484567|NCT00583908|20908318|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484568|NCT00583908|20908319|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484569|NCT00583908|20908320|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484570|NCT00583908|20908321|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484571|NCT00583908|20908322|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484572|NCT00583908|20908323|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484573|NCT00583908|20908324|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484574|NCT00583908|20908325|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484575|NCT00583908|20908326|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484576|NCT00583908|20908327|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484577|NCT00583908|20908316|P12|COMPLETED|Period 4 - Fourth Intervention||1
8484578|NCT00583908|20908317|P11|COMPLETED|Period 4 - Fourth Intervention||1
8484579|NCT00583908|20908318|P10|COMPLETED|Period 4 - Fourth Intervention||1
8484580|NCT00583908|20908319|P9|COMPLETED|Period 4 - Fourth Intervention||1
8484581|NCT00583908|20908320|P8|COMPLETED|Period 4 - Fourth Intervention||1
8484582|NCT00583908|20908321|P7|COMPLETED|Period 4 - Fourth Intervention||1
8484583|NCT00583908|20908322|P6|COMPLETED|Period 4 - Fourth Intervention||1
8484584|NCT00583908|20908323|P5|COMPLETED|Period 4 - Fourth Intervention||2
8484585|NCT00583908|20908324|P4|COMPLETED|Period 4 - Fourth Intervention||1
8484586|NCT00583908|20908325|P3|COMPLETED|Period 4 - Fourth Intervention||1
8484587|NCT00583908|20908326|P2|COMPLETED|Period 4 - Fourth Intervention||2
8484588|NCT00583908|20908327|P1|COMPLETED|Period 4 - Fourth Intervention||1
8484589|NCT00583908|20908316|P12|STARTED|Period 4 - Fourth Intervention||1
8484590|NCT00583908|20908317|P11|STARTED|Period 4 - Fourth Intervention||1
8484591|NCT00583908|20908318|P10|STARTED|Period 4 - Fourth Intervention||1
8484592|NCT00583908|20908319|P9|STARTED|Period 4 - Fourth Intervention||1
8484593|NCT00583908|20908320|P8|STARTED|Period 4 - Fourth Intervention||1
8484594|NCT00583908|20908321|P7|STARTED|Period 4 - Fourth Intervention||1
8484595|NCT00583908|20908322|P6|STARTED|Period 4 - Fourth Intervention||1
8484596|NCT00583908|20908323|P5|STARTED|Period 4 - Fourth Intervention||2
8484597|NCT00583908|20908324|P4|STARTED|Period 4 - Fourth Intervention||1
8484598|NCT00583908|20908325|P3|STARTED|Period 4 - Fourth Intervention||1
8484599|NCT00583908|20908326|P2|STARTED|Period 4 - Fourth Intervention||2
8484600|NCT00583908|20908327|P1|STARTED|Period 4 - Fourth Intervention||1
8484601|NCT00583908|20908316|P12|NOT COMPLETED|Period 3 - Third Intervention||0
8484602|NCT00583908|20908317|P11|NOT COMPLETED|Period 3 - Third Intervention||0
8484603|NCT00583908|20908318|P10|NOT COMPLETED|Period 3 - Third Intervention||0
8484604|NCT00583908|20908319|P9|NOT COMPLETED|Period 3 - Third Intervention||0
8484605|NCT00583908|20908320|P8|NOT COMPLETED|Period 3 - Third Intervention||0
8484606|NCT00583908|20908321|P7|NOT COMPLETED|Period 3 - Third Intervention||0
8484607|NCT00583908|20908322|P6|NOT COMPLETED|Period 3 - Third Intervention||0
8484608|NCT00583908|20908323|P5|NOT COMPLETED|Period 3 - Third Intervention||0
8484609|NCT00583908|20908324|P4|NOT COMPLETED|Period 3 - Third Intervention||0
8484610|NCT00583908|20908325|P3|NOT COMPLETED|Period 3 - Third Intervention||0
8484611|NCT00583908|20908326|P2|NOT COMPLETED|Period 3 - Third Intervention||0
8484612|NCT00583908|20908327|P1|NOT COMPLETED|Period 3 - Third Intervention||0
8484613|NCT00583908|20908316|P12|COMPLETED|Period 3 - Third Intervention||1
8484614|NCT00583908|20908317|P11|COMPLETED|Period 3 - Third Intervention||1
8484615|NCT00583908|20908318|P10|COMPLETED|Period 3 - Third Intervention||1
8484616|NCT00583908|20908319|P9|COMPLETED|Period 3 - Third Intervention||1
8484617|NCT00583908|20908320|P8|COMPLETED|Period 3 - Third Intervention||1
8484618|NCT00583908|20908321|P7|COMPLETED|Period 3 - Third Intervention||1
8484619|NCT00583908|20908322|P6|COMPLETED|Period 3 - Third Intervention||1
8484620|NCT00583908|20908323|P5|COMPLETED|Period 3 - Third Intervention||2
8484621|NCT00583908|20908324|P4|COMPLETED|Period 3 - Third Intervention||1
8484622|NCT00583908|20908325|P3|COMPLETED|Period 3 - Third Intervention||1
8484623|NCT00583908|20908326|P2|COMPLETED|Period 3 - Third Intervention||2
8484624|NCT00583908|20908327|P1|COMPLETED|Period 3 - Third Intervention||1
8484625|NCT00583908|20908316|P12|STARTED|Period 3 - Third Intervention||1
8484626|NCT00583908|20908317|P11|STARTED|Period 3 - Third Intervention||1
8484627|NCT00583908|20908318|P10|STARTED|Period 3 - Third Intervention||1
8484628|NCT00583908|20908319|P9|STARTED|Period 3 - Third Intervention||1
8484629|NCT00583908|20908320|P8|STARTED|Period 3 - Third Intervention||1
8484630|NCT00583908|20908321|P7|STARTED|Period 3 - Third Intervention||1
8484631|NCT00583908|20908322|P6|STARTED|Period 3 - Third Intervention||1
8484632|NCT00583908|20908323|P5|STARTED|Period 3 - Third Intervention||2
8484633|NCT00583908|20908324|P4|STARTED|Period 3 - Third Intervention||1
8484634|NCT00583908|20908325|P3|STARTED|Period 3 - Third Intervention||1
8484635|NCT00583908|20908326|P2|STARTED|Period 3 - Third Intervention||2
8484636|NCT00583908|20908327|P1|STARTED|Period 3 - Third Intervention||1
8484637|NCT00583908|20908316|P12|NOT COMPLETED|Period 2 - Second Intervention||0
8484638|NCT00583908|20908317|P11|NOT COMPLETED|Period 2 - Second Intervention||0
8484639|NCT00583908|20908318|P10|NOT COMPLETED|Period 2 - Second Intervention||0
8484640|NCT00583908|20908319|P9|NOT COMPLETED|Period 2 - Second Intervention||0
8484641|NCT00583908|20908320|P8|NOT COMPLETED|Period 2 - Second Intervention||0
8484642|NCT00583908|20908321|P7|NOT COMPLETED|Period 2 - Second Intervention||0
8484643|NCT00583908|20908322|P6|NOT COMPLETED|Period 2 - Second Intervention||0
8484644|NCT00583908|20908323|P5|NOT COMPLETED|Period 2 - Second Intervention||0
8484645|NCT00583908|20908324|P4|NOT COMPLETED|Period 2 - Second Intervention||0
8484646|NCT00583908|20908325|P3|NOT COMPLETED|Period 2 - Second Intervention||0
8484647|NCT00583908|20908326|P2|NOT COMPLETED|Period 2 - Second Intervention||0
8484648|NCT00583908|20908327|P1|NOT COMPLETED|Period 2 - Second Intervention||0
8484649|NCT00583908|20908316|P12|COMPLETED|Period 2 - Second Intervention||1
8484650|NCT00583908|20908317|P11|COMPLETED|Period 2 - Second Intervention||1
8484651|NCT00583908|20908318|P10|COMPLETED|Period 2 - Second Intervention||1
8484652|NCT00583908|20908319|P9|COMPLETED|Period 2 - Second Intervention||1
8484653|NCT00583908|20908320|P8|COMPLETED|Period 2 - Second Intervention||1
8484654|NCT00583908|20908321|P7|COMPLETED|Period 2 - Second Intervention||1
8484655|NCT00583908|20908322|P6|COMPLETED|Period 2 - Second Intervention||1
8484656|NCT00583908|20908323|P5|COMPLETED|Period 2 - Second Intervention||2
8484657|NCT00583908|20908324|P4|COMPLETED|Period 2 - Second Intervention||1
8484658|NCT00583908|20908325|P3|COMPLETED|Period 2 - Second Intervention||1
8484659|NCT00583908|20908326|P2|COMPLETED|Period 2 - Second Intervention||2
8484660|NCT00583908|20908327|P1|COMPLETED|Period 2 - Second Intervention||1
8484661|NCT00583908|20908316|P12|STARTED|Period 2 - Second Intervention||1
8484662|NCT00583908|20908317|P11|STARTED|Period 2 - Second Intervention||1
8484663|NCT00583908|20908318|P10|STARTED|Period 2 - Second Intervention||1
8484664|NCT00583908|20908319|P9|STARTED|Period 2 - Second Intervention||1
8484665|NCT00583908|20908320|P8|STARTED|Period 2 - Second Intervention||1
8484666|NCT00583908|20908321|P7|STARTED|Period 2 - Second Intervention||1
8484667|NCT00583908|20908322|P6|STARTED|Period 2 - Second Intervention||1
8484668|NCT00583908|20908323|P5|STARTED|Period 2 - Second Intervention||2
8484669|NCT00583908|20908324|P4|STARTED|Period 2 - Second Intervention||1
8484670|NCT00583908|20908325|P3|STARTED|Period 2 - Second Intervention||1
8484671|NCT00583908|20908326|P2|STARTED|Period 2 - Second Intervention||2
8484672|NCT00583908|20908327|P1|STARTED|Period 2 - Second Intervention||1
8484673|NCT00583908|20908316|P12|NOT COMPLETED|Period 1 - First Intervention||0
8484674|NCT00583908|20908317|P11|NOT COMPLETED|Period 1 - First Intervention||0
8484675|NCT00583908|20908318|P10|NOT COMPLETED|Period 1 - First Intervention||0
8484676|NCT00583908|20908319|P9|NOT COMPLETED|Period 1 - First Intervention||0
8484677|NCT00583908|20908320|P8|NOT COMPLETED|Period 1 - First Intervention||0
8484678|NCT00583908|20908321|P7|NOT COMPLETED|Period 1 - First Intervention||0
8484679|NCT00583908|20908322|P6|NOT COMPLETED|Period 1 - First Intervention||0
8484680|NCT00583908|20908323|P5|NOT COMPLETED|Period 1 - First Intervention||0
8484681|NCT00583908|20908324|P4|NOT COMPLETED|Period 1 - First Intervention||0
8484682|NCT00583908|20908325|P3|NOT COMPLETED|Period 1 - First Intervention||0
8484683|NCT00583908|20908326|P2|NOT COMPLETED|Period 1 - First Intervention||0
8484684|NCT00583908|20908327|P1|NOT COMPLETED|Period 1 - First Intervention||0
8484685|NCT00583908|20908316|P12|COMPLETED|Period 1 - First Intervention||1
8484686|NCT00583908|20908317|P11|COMPLETED|Period 1 - First Intervention||1
8484687|NCT00583908|20908318|P10|COMPLETED|Period 1 - First Intervention||1
8484688|NCT00583908|20908319|P9|COMPLETED|Period 1 - First Intervention||1
8484689|NCT00583908|20908320|P8|COMPLETED|Period 1 - First Intervention||1
8484690|NCT00583908|20908321|P7|COMPLETED|Period 1 - First Intervention||1
8484691|NCT00583908|20908322|P6|COMPLETED|Period 1 - First Intervention||1
8484692|NCT00583908|20908323|P5|COMPLETED|Period 1 - First Intervention||2
8484693|NCT00583908|20908324|P4|COMPLETED|Period 1 - First Intervention||1
8484694|NCT00583908|20908325|P3|COMPLETED|Period 1 - First Intervention||1
8484695|NCT00583908|20908326|P2|COMPLETED|Period 1 - First Intervention||2
8484696|NCT00583908|20908327|P1|COMPLETED|Period 1 - First Intervention||1
8484697|NCT00583908|20908316|P12|STARTED|Period 1 - First Intervention||1
8484698|NCT00583908|20908317|P11|STARTED|Period 1 - First Intervention||1
8484699|NCT00583908|20908318|P10|STARTED|Period 1 - First Intervention||1
8484700|NCT00583908|20908319|P9|STARTED|Period 1 - First Intervention||1
8484701|NCT00583908|20908320|P8|STARTED|Period 1 - First Intervention||1
8484702|NCT00583908|20908321|P7|STARTED|Period 1 - First Intervention||1
8484703|NCT00583908|20908322|P6|STARTED|Period 1 - First Intervention||1
8484704|NCT00583908|20908323|P5|STARTED|Period 1 - First Intervention||2
8484705|NCT00583908|20908324|P4|STARTED|Period 1 - First Intervention||1
8484706|NCT00583908|20908325|P3|STARTED|Period 1 - First Intervention||1
8484707|NCT00583908|20908326|P2|STARTED|Period 1 - First Intervention||2
8484708|NCT00583908|20908327|P1|STARTED|Period 1 - First Intervention||1
8484709|NCT00583804|20908381|P1|NOT COMPLETED|Overall Study||0
8484710|NCT00583804|20908381|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
8484711|NCT00583804|20908381|P1|STARTED|Overall Study||10
8484712|NCT00583791|20908387|P1|NOT COMPLETED|Overall Study||73
8484713|NCT00583791|20908387|P1|COMPLETED|Overall Study||18
8484714|NCT00583791|20908387|P1|STARTED|Overall Study||91
8484715|NCT00583713|20908394|P3|NOT COMPLETED|Overall Study||0
8484716|NCT00583713|20908395|P2|NOT COMPLETED|Overall Study||0
8484717|NCT00583713|20908396|P1|NOT COMPLETED|Overall Study||0
8484718|NCT00583713|20908394|P3|COMPLETED|Overall Study||6
8484719|NCT00583713|20908395|P2|COMPLETED|Overall Study||6
8484720|NCT00583713|20908396|P1|COMPLETED|Overall Study||6
8484721|NCT00583713|20908394|P3|STARTED|Overall Study||6
8484722|NCT00583713|20908395|P2|STARTED|Overall Study||6
8484723|NCT00583713|20908396|P1|STARTED|Overall Study||6
8484724|NCT00583700|20908421|P2|NOT COMPLETED|Overall Study||4
8484725|NCT00583700|20908422|P1|NOT COMPLETED|Overall Study||3
8484726|NCT00583700|20908421|P2|COMPLETED|Overall Study||23
8484727|NCT00583700|20908422|P1|COMPLETED|Overall Study||24
8484728|NCT00583700|20908421|P2|STARTED|Overall Study||27
8484729|NCT00583700|20908422|P1|STARTED|Overall Study||27
8484730|NCT00583661|20908430|P1|NOT COMPLETED|Overall Study||0
8484731|NCT00583661|20908430|P1|COMPLETED|Overall Study||48
8484732|NCT00583661|20908430|P1|STARTED|Overall Study||48
8484733|NCT00583622|20908437|P1|NOT COMPLETED|Overall Study||0
8484734|NCT00583622|20908437|P1|COMPLETED|Overall Study||12
8484735|NCT00583622|20908437|P1|STARTED|Overall Study||12
8484736|NCT00583596|20908442|P1|NOT COMPLETED|Overall Study||284
8484737|NCT00583596|20908442|P1|COMPLETED|Overall Study||152
8484738|NCT00583596|20908442|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
8484739|NCT00583557|20908447|P1|NOT COMPLETED|Overall Study||70
8484740|NCT00583557|20908447|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
8484741|NCT00583557|20908447|P1|Received at Least 1 Dose Belimumab|Overall Study||153
8484742|NCT00583557|20908447|P1|STARTED|Overall Study||155
8484743|NCT00583492|20908453|P2|NOT COMPLETED|Overall Study||0
8484744|NCT00583492|20908454|P1|NOT COMPLETED|Overall Study||0
8484745|NCT00583492|20908453|P2|COMPLETED|Overall Study||23
8484746|NCT00583492|20908454|P1|COMPLETED|Overall Study||21
8484747|NCT00583492|20908453|P2|STARTED|Overall Study||23
8484748|NCT00583492|20908454|P1|STARTED|Overall Study||21
8484749|NCT00583466|20908470|P1|NOT COMPLETED|Overall Study||0
8484750|NCT00583466|20908470|P1|COMPLETED|Overall Study||18
8484751|NCT00583466|20908470|P1|STARTED|Overall Study||18
8484752|NCT00583453|20908478|P2|NOT COMPLETED|Overall Study||2
8484753|NCT00583453|20908479|P1|NOT COMPLETED|Overall Study||0
8484754|NCT00583453|20908478|P2|COMPLETED|Overall Study||6
8484755|NCT00583453|20908479|P1|COMPLETED|Overall Study||9
8484756|NCT00583453|20908478|P2|STARTED|Overall Study||8
8484757|NCT00583453|20908479|P1|STARTED|Overall Study||9
8484758|NCT00583414|20908493|P1|NOT COMPLETED|Overall Study||0
8484759|NCT00583414|20908493|P1|COMPLETED|Overall Study||401
8484760|NCT00583414|20908493|P1|STARTED|Overall Study||401
8484761|NCT00583375|20908499|P2|NOT COMPLETED|Overall Study||0
8484762|NCT00583375|20908500|P1|NOT COMPLETED|Overall Study||0
8484763|NCT00583375|20908499|P2|COMPLETED|Overall Study||272
8484764|NCT00583375|20908500|P1|COMPLETED|Overall Study||142
8484765|NCT00583375|20908499|P2|STARTED|Overall Study||272
8484766|NCT00583375|20908500|P1|STARTED|Overall Study||142
8484767|NCT00583362|20908516|P1|NOT COMPLETED|Overall Study||202
8484768|NCT00583362|20908516|P1|COMPLETED|Overall Study||96
8484769|NCT00583362|20908516|P1|STARTED|Overall Study||298
8484770|NCT00583219|20908540|P1|NOT COMPLETED|Phase 2||1
8484771|NCT00583219|20908540|P1|COMPLETED|Phase 2||21
8484772|NCT00583219|20908540|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
8484773|NCT00583219|20908540|P1|NOT COMPLETED|Phase 1||0
8484774|NCT00583219|20908540|P1|COMPLETED|Phase 1||9
8484775|NCT00583219|20908540|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
8484776|NCT00583115|20908557|P1|NOT COMPLETED|Overall Study||1
8484777|NCT00583115|20908557|P1|COMPLETED|Overall Study||0
8484778|NCT00583115|20908557|P1|STARTED|Overall Study||1
8484779|NCT00583102|20908562|P1|NOT COMPLETED|Overall Study||3
8484780|NCT00583102|20908562|P1|COMPLETED|Overall Study||20
8484781|NCT00583102|20908562|P1|STARTED|Overall Study||23
8484782|NCT00583050|20908566|P1|NOT COMPLETED|Overall Study||0
8484783|NCT00583050|20908566|P1|COMPLETED|Overall Study||1366
8484784|NCT00583050|20908566|P1|STARTED|Overall Study||1366
8484785|NCT00582998|20908572|P2|NOT COMPLETED|Overall Study||0
8484786|NCT00582998|20908573|P1|NOT COMPLETED|Overall Study||0
8484787|NCT00582998|20908572|P2|COMPLETED|Overall Study||130
8484788|NCT00582998|20908573|P1|COMPLETED|Overall Study||119
8484789|NCT00582998|20908572|P2|STARTED|Overall Study||130
8484790|NCT00582998|20908573|P1|STARTED|Overall Study||119
8484791|NCT00582972|20908579|P1|NOT COMPLETED|Overall Study||2
8484792|NCT00582972|20908579|P1|COMPLETED|Overall Study||21
8484793|NCT00582972|20908579|P1|STARTED|Overall Study||23
8484794|NCT00582946|20908584|P1|NOT COMPLETED|Overall Study||0
8484795|NCT00582946|20908584|P1|COMPLETED|Overall Study||16
8484796|NCT00582946|20908584|P1|STARTED|Overall Study||16
8484797|NCT00582933|20908588|P1|NOT COMPLETED|Overall Study||3
8484798|NCT00582933|20908588|P1|COMPLETED|Overall Study||92
8484799|NCT00582933|20908588|P1|STARTED|Overall Study||95
8484800|NCT00582907|20908592|P4|NOT COMPLETED|4th Course||0
8484801|NCT00582907|20908593|P3|NOT COMPLETED|4th Course||0
8484802|NCT00582907|20908594|P2|NOT COMPLETED|4th Course||0
8484803|NCT00582907|20908595|P1|NOT COMPLETED|4th Course||0
8484804|NCT00582907|20908592|P4|COMPLETED|4th Course||3
8484805|NCT00582907|20908593|P3|COMPLETED|4th Course||3
8484806|NCT00582907|20908594|P2|COMPLETED|4th Course||3
8484807|NCT00582907|20908595|P1|COMPLETED|4th Course||2
8484808|NCT00582907|20908592|P4|STARTED|4th Course||3
8484809|NCT00582907|20908593|P3|STARTED|4th Course||3
8484810|NCT00582907|20908594|P2|STARTED|4th Course||3
8484811|NCT00582907|20908595|P1|STARTED|4th Course||2
8484812|NCT00582907|20908592|P4|NOT COMPLETED|3rd Course||0
8484813|NCT00582907|20908593|P3|NOT COMPLETED|3rd Course||0
8484814|NCT00582907|20908594|P2|NOT COMPLETED|3rd Course||0
8484815|NCT00582907|20908595|P1|NOT COMPLETED|3rd Course||0
8484816|NCT00582907|20908592|P4|COMPLETED|3rd Course||3
8484817|NCT00582907|20908593|P3|COMPLETED|3rd Course||3
8484818|NCT00582907|20908594|P2|COMPLETED|3rd Course||3
8484819|NCT00582907|20908595|P1|COMPLETED|3rd Course||2
8484820|NCT00582907|20908592|P4|STARTED|3rd Course||3
8484821|NCT00582907|20908593|P3|STARTED|3rd Course||3
8484822|NCT00582907|20908594|P2|STARTED|3rd Course||3
8484823|NCT00582907|20908595|P1|STARTED|3rd Course||2
8484824|NCT00582907|20908592|P4|NOT COMPLETED|2nd Course||0
8484825|NCT00582907|20908593|P3|NOT COMPLETED|2nd Course||0
8484826|NCT00582907|20908594|P2|NOT COMPLETED|2nd Course||0
8484827|NCT00582907|20908595|P1|NOT COMPLETED|2nd Course||1
8484828|NCT00582907|20908592|P4|COMPLETED|2nd Course||3
8484829|NCT00582907|20908593|P3|COMPLETED|2nd Course||3
8484830|NCT00582907|20908594|P2|COMPLETED|2nd Course||3
8484831|NCT00582907|20908595|P1|COMPLETED|2nd Course||2
8484832|NCT00582907|20908592|P4|STARTED|2nd Course||3
8484833|NCT00582907|20908593|P3|STARTED|2nd Course||3
8484834|NCT00582907|20908594|P2|STARTED|2nd Course||3
8484835|NCT00582907|20908595|P1|STARTED|2nd Course||3
8484836|NCT00582907|20908592|P4|NOT COMPLETED|1st Course||1
8484837|NCT00582907|20908593|P3|NOT COMPLETED|1st Course||0
8484838|NCT00582907|20908594|P2|NOT COMPLETED|1st Course||0
8484839|NCT00582907|20908595|P1|NOT COMPLETED|1st Course||1
8484840|NCT00582907|20908592|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
8484841|NCT00582907|20908593|P3|COMPLETED|1st Course||3
8484842|NCT00582907|20908594|P2|COMPLETED|1st Course||3
8484843|NCT00582907|20908595|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
8484844|NCT00582907|20908592|P4|STARTED|1st Course||4
8484845|NCT00582907|20908593|P3|STARTED|1st Course||3
8484846|NCT00582907|20908594|P2|STARTED|1st Course||3
8484847|NCT00582907|20908595|P1|STARTED|1st Course||4
8484848|NCT00582894|20908627|P1|NOT COMPLETED|Overall Study||0
8484849|NCT00582894|20908627|P1|COMPLETED|Overall Study||17
8484850|NCT00582894|20908627|P1|Day 100 Post Transplant|Overall Study||17
8484851|NCT00582894|20908627|P1|STARTED|Overall Study||17
8484852|NCT00582816|20908634|P1|NOT COMPLETED|Overall Study||3
8484853|NCT00582816|20908634|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
8484854|NCT00582816|20908634|P1|STARTED|Overall Study||9
8484855|NCT00582790|20908644|P1|NOT COMPLETED|Overall Study||1
8484856|NCT00582790|20908644|P1|COMPLETED|Overall Study||11
8484857|NCT00582790|20908644|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
8484858|NCT00582738|20908653|P2|NOT COMPLETED|Overall Study||18
8484859|NCT00582738|20908654|P1|NOT COMPLETED|Overall Study||9
8484860|NCT00582738|20908653|P2|COMPLETED|Overall Study||4
8484861|NCT00582738|20908654|P1|COMPLETED|Overall Study||12
8484862|NCT00582738|20908653|P2|STARTED|Overall Study||22
8484863|NCT00582738|20908654|P1|STARTED|Overall Study||21
8484864|NCT00582712|20908678|P1|NOT COMPLETED|Overall Study||4
8484865|NCT00582712|20908678|P1|COMPLETED|Overall Study||1
8484866|NCT00582712|20908678|P1|STARTED|Overall Study||5
8484867|NCT00582660|20908684|P2|NOT COMPLETED|Overall Study||0
8484868|NCT00582660|20908685|P1|NOT COMPLETED|Overall Study||0
8484869|NCT00582660|20908684|P2|COMPLETED|Overall Study||20
8484870|NCT00582660|20908685|P1|COMPLETED|Overall Study||20
8484871|NCT00582660|20908684|P2|STARTED|Overall Study||20
8484872|NCT00582660|20908685|P1|STARTED|Overall Study||20
8484873|NCT00582608|20908693|P1|NOT COMPLETED|Overall Study||12
8484874|NCT00582608|20908693|P1|COMPLETED|Overall Study||0
8484875|NCT00582608|20908693|P1|STARTED|Overall Study||12
8484876|NCT00582556|20908700|P3|NOT COMPLETED|Overall Study||2
8484877|NCT00582556|20908701|P2|NOT COMPLETED|Overall Study||1
8484878|NCT00582556|20908702|P1|NOT COMPLETED|Overall Study||0
8484879|NCT00582556|20908700|P3|COMPLETED|Overall Study||12
8484880|NCT00582556|20908701|P2|COMPLETED|Overall Study||14
8484881|NCT00582556|20908702|P1|COMPLETED|Overall Study||14
8484882|NCT00582556|20908700|P3|STARTED|Overall Study||14
8484883|NCT00582556|20908701|P2|STARTED|Overall Study||15
8484884|NCT00582556|20908702|P1|STARTED|Overall Study||14
8484885|NCT00582517|20908721|P2|NOT COMPLETED|Overall Study||0
8484886|NCT00582517|20908722|P1|NOT COMPLETED|Overall Study||0
8484887|NCT00582517|20908721|P2|COMPLETED|Overall Study||55
8484888|NCT00582517|20908722|P1|COMPLETED|Overall Study||45
8484889|NCT00582517|20908721|P2|STARTED|Overall Study||55
8484890|NCT00582517|20908722|P1|STARTED|Overall Study||45
8484891|NCT00582491|20908730|P2|NOT COMPLETED|Overall Study||0
8484892|NCT00582491|20908731|P1|NOT COMPLETED|Overall Study||1
8484893|NCT00582491|20908730|P2|COMPLETED|Overall Study||10
8484894|NCT00582491|20908731|P1|COMPLETED|Overall Study||10
8484895|NCT00582491|20908730|P2|STARTED|Overall Study||10
8484896|NCT00582491|20908731|P1|STARTED|Overall Study||11
8484897|NCT00582426|20908755|P2|NOT COMPLETED|Overall Study||13
8484898|NCT00582426|20908756|P1|NOT COMPLETED|Overall Study||20
8484899|NCT00582426|20908755|P2|COMPLETED|Overall Study||58
8484900|NCT00582426|20908756|P1|COMPLETED|Overall Study||48
8484901|NCT00582426|20908755|P2|STARTED|Overall Study||71
8484902|NCT00582426|20908756|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
8484903|NCT00582400|20908782|P1|NOT COMPLETED|Overall Study||3
8484904|NCT00582400|20908782|P1|COMPLETED|Overall Study||6
8484905|NCT00582400|20908782|P1|STARTED|Overall Study||9
8484906|NCT00582361|20908791|P2|NOT COMPLETED|Overall Study||0
8484907|NCT00582361|20908792|P1|NOT COMPLETED|Overall Study||0
8484908|NCT00582361|20908791|P2|COMPLETED|Overall Study||38
8484909|NCT00582361|20908792|P1|COMPLETED|Overall Study||25
8484910|NCT00582361|20908791|P2|STARTED|Overall Study||38
8484911|NCT00582361|20908792|P1|STARTED|Overall Study||25
8484912|NCT00582309|20908803|P3|NOT COMPLETED|Overall Study||2
8484913|NCT00582309|20908804|P2|NOT COMPLETED|Overall Study||0
8484914|NCT00582309|20908805|P1|NOT COMPLETED|Overall Study||0
8484915|NCT00582309|20908803|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
8484916|NCT00582309|20908804|P2|COMPLETED|Overall Study||49
8484917|NCT00582309|20908805|P1|COMPLETED|Overall Study||56
8484918|NCT00582309|20908803|P3|STARTED|Overall Study||46
8484919|NCT00582309|20908804|P2|STARTED|Overall Study||49
8484920|NCT00582309|20908805|P1|STARTED|Overall Study||56
8484921|NCT00582205|20908813|P1|NOT COMPLETED|Overall Study||10
8484922|NCT00582205|20908813|P1|COMPLETED|Overall Study||11
8484923|NCT00582205|20908813|P1|STARTED|Overall Study||21
8484924|NCT00582166|20908818|P1|NOT COMPLETED|Overall Study||2
8484925|NCT00582166|20908818|P1|COMPLETED|Overall Study||16
8484926|NCT00582166|20908818|P1|STARTED|Overall Study||18
8484927|NCT00582114|20908828|P2|NOT COMPLETED|Overall Study||54
8484928|NCT00582114|20908829|P1|NOT COMPLETED|Overall Study||42
8484929|NCT00582114|20908828|P2|COMPLETED|Overall Study||46
8484930|NCT00582114|20908829|P1|COMPLETED|Overall Study||58
8484931|NCT00582114|20908828|P2|STARTED|Overall Study||100
8484932|NCT00582114|20908829|P1|STARTED|Overall Study||100
8484933|NCT00582075|20908837|P1|NOT COMPLETED|Overall Study||0
8484934|NCT00582075|20908837|P1|COMPLETED|Overall Study||25
8484935|NCT00582075|20908837|P1|STARTED|Overall Study||25
8484936|NCT00582036|20908844|P2|NOT COMPLETED|Overall Study||1
8484937|NCT00582036|20908845|P1|NOT COMPLETED|Overall Study||0
8484938|NCT00582036|20908844|P2|COMPLETED|Overall Study|One patient withdrew consent|5
8484939|NCT00582036|20908845|P1|COMPLETED|Overall Study||5
8484940|NCT00582036|20908844|P2|STARTED|Overall Study||6
8484941|NCT00582036|20908845|P1|STARTED|Overall Study||5
8484942|NCT00582010|20908853|P2|NOT COMPLETED|Overall Study||1
8484943|NCT00582010|20908854|P1|NOT COMPLETED|Overall Study||0
8484944|NCT00582010|20908853|P2|COMPLETED|Overall Study||39
8484945|NCT00582010|20908854|P1|COMPLETED|Overall Study||40
8484946|NCT00582010|20908853|P2|STARTED|Overall Study||40
8484947|NCT00582010|20908854|P1|STARTED|Overall Study||40
8484948|NCT00581971|20908876|P1|NOT COMPLETED|Overall Study||0
8484949|NCT00581971|20908876|P1|COMPLETED|Overall Study||30
8484950|NCT00581971|20908876|P1|STARTED|Overall Study||30
8484951|NCT00581945|20908883|P2|NOT COMPLETED|Overall Study||10
8484952|NCT00581945|20908884|P1|NOT COMPLETED|Overall Study||9
8484953|NCT00581945|20908883|P2|COMPLETED|Overall Study||63
8484954|NCT00581945|20908884|P1|COMPLETED|Overall Study||65
8484955|NCT00581945|20908883|P2|STARTED|Overall Study||73
8484956|NCT00581945|20908884|P1|STARTED|Overall Study||74
8484957|NCT00581919|20908900|P1|NOT COMPLETED|Overall Study||24
8484958|NCT00581919|20908900|P1|COMPLETED|Overall Study||8
8484959|NCT00581919|20908900|P1|STARTED|Overall Study||32
8484960|NCT00581867|20908906|P2|NOT COMPLETED|Second Intervention||0
8484961|NCT00581867|20908907|P1|NOT COMPLETED|Second Intervention||0
8484962|NCT00581867|20908906|P2|COMPLETED|Second Intervention||14
8484963|NCT00581867|20908907|P1|COMPLETED|Second Intervention||15
8484964|NCT00581867|20908906|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
8484965|NCT00581867|20908907|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
8484966|NCT00581867|20908906|P2|NOT COMPLETED|First Intervention||0
8484967|NCT00581867|20908907|P1|NOT COMPLETED|First Intervention||0
8484968|NCT00581867|20908906|P2|COMPLETED|First Intervention||15
8484969|NCT00581867|20908907|P1|COMPLETED|First Intervention||16
8484970|NCT00581867|20908906|P2|STARTED|First Intervention||15
8484971|NCT00581867|20908907|P1|STARTED|First Intervention||16
8484972|NCT00581854|20908915|P1|NOT COMPLETED|Overall Study||0
8484973|NCT00581854|20908915|P1|COMPLETED|Overall Study||22
8484974|NCT00581854|20908915|P1|STARTED|Overall Study||22
8484975|NCT00581828|20908919|P1|NOT COMPLETED|Overall Study||1
8484976|NCT00581828|20908919|P1|COMPLETED|Overall Study||18
8484977|NCT00581828|20908919|P1|STARTED|Overall Study||19
8484978|NCT00581776|20908923|P1|NOT COMPLETED|Overall Study||3
8484979|NCT00581776|20908923|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
8484980|NCT00581776|20908923|P1|STARTED|Overall Study||30
8484981|NCT00581581|20908932|P2|NOT COMPLETED|Overall Study||0
8484982|NCT00581581|20908933|P1|NOT COMPLETED|Overall Study||0
8484983|NCT00581581|20908932|P2|COMPLETED|Overall Study||30
8484984|NCT00581581|20908933|P1|COMPLETED|Overall Study||32
8484985|NCT00581581|20908932|P2|STARTED|Overall Study||30
8484986|NCT00581581|20908933|P1|STARTED|Overall Study||32
8484987|NCT00581555|20908941|P2|NOT COMPLETED|Overall Study||20
8484988|NCT00581555|20908942|P1|NOT COMPLETED|Overall Study||43
8484989|NCT00581555|20908941|P2|COMPLETED|Overall Study||38
8484990|NCT00581555|20908942|P1|COMPLETED|Overall Study||19
8484991|NCT00581555|20908941|P2|STARTED|Overall Study||58
8484992|NCT00581555|20908942|P1|STARTED|Overall Study||62
8484993|NCT00581542|20908966|P2|NOT COMPLETED|Overall Study||23
8484994|NCT00581542|20908967|P1|NOT COMPLETED|Overall Study||11
8484995|NCT00581542|20908966|P2|COMPLETED|Overall Study||39
8484996|NCT00581542|20908967|P1|COMPLETED|Overall Study||51
8484997|NCT00581542|20908966|P2|STARTED|Overall Study||62
8484998|NCT00581542|20908967|P1|STARTED|Overall Study||62
8484999|NCT00581529|20908975|P1|NOT COMPLETED|Overall Study||0
8485000|NCT00581529|20908975|P1|COMPLETED|Overall Study||34
8485001|NCT00581529|20908975|P1|STARTED|Overall Study||34
8485002|NCT00581399|20908984|P2|NOT COMPLETED|Overall Study||0
8485003|NCT00581399|20908985|P1|NOT COMPLETED|Overall Study||0
8485004|NCT00581399|20908984|P2|COMPLETED|Overall Study||48
8485005|NCT00581399|20908985|P1|COMPLETED|Overall Study||46
8485006|NCT00581399|20908984|P2|STARTED|Overall Study||48
8485007|NCT00581399|20908985|P1|STARTED|Overall Study||46
8485008|NCT00581386|20908996|P3|NOT COMPLETED|Overall Study||0
8485009|NCT00581386|20908997|P2|NOT COMPLETED|Overall Study||0
8485010|NCT00581386|20908998|P1|NOT COMPLETED|Overall Study||0
8485011|NCT00581386|20908996|P3|COMPLETED|Overall Study|04/15/2009|72
8485012|NCT00581386|20908997|P2|COMPLETED|Overall Study|04/15/2009|73
8485013|NCT00581386|20908998|P1|COMPLETED|Overall Study|04/15/2009|73
8485014|NCT00581386|20908996|P3|STARTED|Overall Study|05/30/2007|72
8485015|NCT00581386|20908997|P2|STARTED|Overall Study|05/30/2007|73
8485016|NCT00581386|20908998|P1|STARTED|Overall Study|05/30/2007|73
8485017|NCT00581360|20909021|P1|NOT COMPLETED|Overall Study||1
8485018|NCT00581360|20909021|P1|COMPLETED|Overall Study||9
8485019|NCT00581360|20909021|P1|STARTED|Overall Study||10
8485020|NCT00581347|20909031|P2|NOT COMPLETED|Overall Study||0
8485021|NCT00581347|20909032|P1|NOT COMPLETED|Overall Study||0
8485022|NCT00581347|20909031|P2|COMPLETED|Overall Study||3707
8485023|NCT00581347|20909032|P1|COMPLETED|Overall Study||3839
8485024|NCT00581347|20909031|P2|STARTED|Overall Study||3707
8485025|NCT00581347|20909032|P1|STARTED|Overall Study||3839
8485026|NCT00581308|20909040|P1|NOT COMPLETED|60 Months||3
8485027|NCT00581308|20909040|P1|COMPLETED|60 Months||158
8485028|NCT00581308|20909040|P1|STARTED|60 Months||161
8485029|NCT00581308|20909040|P1|NOT COMPLETED|48 Months||9
8485030|NCT00581308|20909040|P1|COMPLETED|48 Months||161
8485031|NCT00581308|20909040|P1|STARTED|48 Months||170
8485032|NCT00581308|20909040|P1|NOT COMPLETED|36 Months||6
8485033|NCT00581308|20909040|P1|COMPLETED|36 Months||170
8485034|NCT00581308|20909040|P1|STARTED|36 Months||176
8485035|NCT00581308|20909040|P1|NOT COMPLETED|24 Months||6
8485036|NCT00581308|20909040|P1|COMPLETED|24 Months||176
8485037|NCT00581308|20909040|P1|STARTED|24 Months||182
8485038|NCT00581308|20909040|P1|NOT COMPLETED|Month 12||20
8485039|NCT00581308|20909040|P1|COMPLETED|Month 12||182
8485040|NCT00581308|20909040|P1|STARTED|Month 12||202
8485041|NCT00581308|20909040|P1|NOT COMPLETED|Month 6||3
8485042|NCT00581308|20909040|P1|COMPLETED|Month 6||202
8485043|NCT00581308|20909040|P1|STARTED|Month 6||205
8485044|NCT00581308|20909040|P1|NOT COMPLETED|Month 1||8
8485045|NCT00581308|20909040|P1|COMPLETED|Month 1||205
8485046|NCT00581308|20909040|P1|STARTED|Month 1||213
8485047|NCT00581308|20909040|P1|NOT COMPLETED|Pre Discharge||2
8485048|NCT00581308|20909040|P1|COMPLETED|Pre Discharge||213
8485049|NCT00581308|20909040|P1|STARTED|Pre Discharge||215
8485050|NCT00581256|20909049|P2|NOT COMPLETED|Overall Study||0
8485051|NCT00581256|20909050|P1|NOT COMPLETED|Overall Study||0
8485052|NCT00581256|20909049|P2|COMPLETED|Overall Study||26
8485053|NCT00581256|20909050|P1|COMPLETED|Overall Study||28
8485054|NCT00581256|20909049|P2|STARTED|Overall Study||26
8485055|NCT00581256|20909050|P1|STARTED|Overall Study||28
8485056|NCT00581230|20909062|P1|NOT COMPLETED|Overall Study||0
8485057|NCT00581230|20909062|P1|COMPLETED|Overall Study||51
8485058|NCT00581230|20909062|P1|Laryngoscopy With RAMP|Overall Study||51
8485059|NCT00581230|20909062|P1|Laryngoscopy Without RAMP|Overall Study||51
8485060|NCT00581230|20909062|P1|STARTED|Overall Study||51
8485061|NCT00581113|20909071|P2|NOT COMPLETED|Overall Study||1
8485062|NCT00581113|20909072|P1|NOT COMPLETED|Overall Study||0
8485063|NCT00581113|20909071|P2|COMPLETED|Overall Study||3
8485064|NCT00581113|20909072|P1|COMPLETED|Overall Study||4
8485065|NCT00581113|20909071|P2|STARTED|Overall Study||4
8485066|NCT00581113|20909072|P1|STARTED|Overall Study||4
8485067|NCT00581100|20909082|P2|NOT COMPLETED|Overall Study||5
8485068|NCT00581100|20909083|P1|NOT COMPLETED|Overall Study||7
8485069|NCT00581100|20909082|P2|COMPLETED|Overall Study||29
8485070|NCT00581100|20909083|P1|COMPLETED|Overall Study||31
8485071|NCT00581100|20909082|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
8485072|NCT00581100|20909083|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
8485073|NCT00581100|20909082|P2|STARTED|Overall Study||34
8485074|NCT00581100|20909083|P1|STARTED|Overall Study||38
8485075|NCT00581061|20909119|P1|NOT COMPLETED|Overall Study||0
8485076|NCT00581061|20909119|P1|COMPLETED|Overall Study||13
8485077|NCT00581061|20909119|P1|STARTED|Overall Study||13
8485078|NCT00581048|20909125|P1|NOT COMPLETED|Overall Study||0
8485079|NCT00581048|20909125|P1|COMPLETED|Overall Study||33
8485080|NCT00581048|20909125|P1|STARTED|Overall Study||33
8485081|NCT00580983|20909136|P1|NOT COMPLETED|Overall Study||7
8485082|NCT00580983|20909136|P1|COMPLETED|Overall Study||73
8485083|NCT00580983|20909136|P1|STARTED|Overall Study||80
8485084|NCT00580970|20909143|P1|NOT COMPLETED|Treatment (Lovastatin)||19
8485085|NCT00580970|20909143|P1|COMPLETED|Treatment (Lovastatin)||53
8485086|NCT00580970|20909143|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
8485087|NCT00580970|20909143|P1|STARTED|Treatment (Lovastatin)||72
8485088|NCT00580970|20909143|P1|NOT COMPLETED|Pre-treatment||1
8485089|NCT00580970|20909143|P1|COMPLETED|Pre-treatment||72
8485090|NCT00580970|20909143|P1|STARTED|Pre-treatment||73
8485091|NCT00580957|20909149|P2|NOT COMPLETED|Overall Study||7
8485092|NCT00580957|20909150|P1|NOT COMPLETED|Overall Study||7
8485093|NCT00580957|20909149|P2|COMPLETED|Overall Study||21
8485094|NCT00580957|20909150|P1|COMPLETED|Overall Study||21
8485095|NCT00580957|20909149|P2|STARTED|Overall Study||28
8485096|NCT00580957|20909150|P1|STARTED|Overall Study||28
8485097|NCT00580866|20909158|P2|NOT COMPLETED|Overall Study||2
8485098|NCT00580866|20909159|P1|NOT COMPLETED|Overall Study||2
8485099|NCT00580866|20909158|P2|COMPLETED|Overall Study||5
8485100|NCT00580866|20909159|P1|COMPLETED|Overall Study||8
8485101|NCT00580866|20909158|P2|STARTED|Overall Study||7
8485102|NCT00580866|20909159|P1|STARTED|Overall Study||10
8485103|NCT00580853|20909170|P3|NOT COMPLETED|Overall Study||0
8485104|NCT00580853|20909171|P2|NOT COMPLETED|Overall Study||0
8485105|NCT00580853|20909172|P1|NOT COMPLETED|Overall Study||0
8485106|NCT00580853|20909170|P3|COMPLETED|Overall Study||21
8485107|NCT00580853|20909171|P2|COMPLETED|Overall Study||21
8485108|NCT00580853|20909172|P1|COMPLETED|Overall Study||20
8485109|NCT00580853|20909170|P3|STARTED|Overall Study||21
8485110|NCT00580853|20909171|P2|STARTED|Overall Study||21
8485111|NCT00580853|20909172|P1|STARTED|Overall Study||20
8485112|NCT00580840|20909183|P4|NOT COMPLETED|Double-Blind||15
8485113|NCT00580840|20909184|P3|NOT COMPLETED|Double-Blind||9
8485114|NCT00580840|20909185|P2|NOT COMPLETED|Double-Blind||7
8485115|NCT00580840|20909186|P1|NOT COMPLETED|Double-Blind||0
8485116|NCT00580840|20909183|P4|COMPLETED|Double-Blind||54
8485117|NCT00580840|20909184|P3|COMPLETED|Double-Blind||61
8485118|NCT00580840|20909185|P2|COMPLETED|Double-Blind||63
8485119|NCT00580840|20909186|P1|COMPLETED|Double-Blind||0
8485120|NCT00580840|20909183|P4|STARTED|Double-Blind||69
8485121|NCT00580840|20909184|P3|STARTED|Double-Blind||70
8485122|NCT00580840|20909185|P2|STARTED|Double-Blind||70
8485123|NCT00580840|20909186|P1|STARTED|Double-Blind||0
8485124|NCT00580840|20909183|P4|NOT COMPLETED|Run-in||0
8485125|NCT00580840|20909184|P3|NOT COMPLETED|Run-in||0
8485126|NCT00580840|20909185|P2|NOT COMPLETED|Run-in||0
8485127|NCT00580840|20909186|P1|NOT COMPLETED|Run-in||124
8485128|NCT00580840|20909183|P4|COMPLETED|Run-in||0
8485129|NCT00580840|20909184|P3|COMPLETED|Run-in||0
8485130|NCT00580840|20909185|P2|COMPLETED|Run-in||0
8485131|NCT00580840|20909186|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
8485132|NCT00580840|20909183|P4|STARTED|Run-in||0
8485133|NCT00580840|20909184|P3|STARTED|Run-in||0
8485134|NCT00580840|20909185|P2|STARTED|Run-in||0
8485135|NCT00580840|20909186|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
8485136|NCT00580801|20909294|P3|NOT COMPLETED|Overall Study||3
8485137|NCT00580801|20909295|P2|NOT COMPLETED|Overall Study||1
8485138|NCT00580801|20909296|P1|NOT COMPLETED|Overall Study||6
8485139|NCT00580801|20909294|P3|COMPLETED|Overall Study||5
8485140|NCT00580801|20909295|P2|COMPLETED|Overall Study||7
8485141|NCT00580801|20909296|P1|COMPLETED|Overall Study||2
8485142|NCT00580801|20909294|P3|STARTED|Overall Study||8
8485143|NCT00580801|20909295|P2|STARTED|Overall Study||8
8485144|NCT00580801|20909296|P1|STARTED|Overall Study||8
8485145|NCT00580788|20909335|P4|NOT COMPLETED|Overall Study||1
8485146|NCT00580788|20909336|P3|NOT COMPLETED|Overall Study||0
8485147|NCT00580788|20909337|P2|NOT COMPLETED|Overall Study||0
8485148|NCT00580788|20909338|P1|NOT COMPLETED|Overall Study||0
8485149|NCT00580788|20909335|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
8485150|NCT00580788|20909336|P3|COMPLETED|Overall Study||3
8485151|NCT00580788|20909337|P2|COMPLETED|Overall Study||6
8485152|NCT00580788|20909338|P1|COMPLETED|Overall Study||3
8485153|NCT00580788|20909335|P4|STARTED|Overall Study||2
8485154|NCT00580788|20909336|P3|STARTED|Overall Study||3
8485155|NCT00580788|20909337|P2|STARTED|Overall Study||6
8485156|NCT00580788|20909338|P1|STARTED|Overall Study||3
8485157|NCT00580723|20909396|P1|NOT COMPLETED|Overall Study||8
8485158|NCT00580723|20909396|P1|COMPLETED|Overall Study||16
8485159|NCT00580723|20909396|P1|STARTED|Overall Study||24
8485160|NCT00580671|20909405|P3|NOT COMPLETED|Overall Study||17
8485161|NCT00580671|20909406|P2|NOT COMPLETED|Overall Study||16
8485162|NCT00580671|20909407|P1|NOT COMPLETED|Overall Study||16
8485163|NCT00580671|20909405|P3|COMPLETED|Overall Study||34
8485164|NCT00580671|20909406|P2|COMPLETED|Overall Study||35
8485165|NCT00580671|20909407|P1|COMPLETED|Overall Study||35
8485166|NCT00580671|20909405|P3|STARTED|Overall Study||51
8485167|NCT00580671|20909406|P2|STARTED|Overall Study||51
8485168|NCT00580671|20909407|P1|STARTED|Overall Study||51
8485169|NCT00580645|20909424|P3|NOT COMPLETED|Overall Study||0
8485170|NCT00580645|20909425|P2|NOT COMPLETED|Overall Study||0
8485171|NCT00580645|20909426|P1|NOT COMPLETED|Overall Study||0
8485172|NCT00580645|20909424|P3|COMPLETED|Overall Study||20
8485173|NCT00580645|20909425|P2|COMPLETED|Overall Study||20
8485174|NCT00580645|20909426|P1|COMPLETED|Overall Study||20
8485175|NCT00580645|20909424|P3|STARTED|Overall Study||20
8485176|NCT00580645|20909425|P2|STARTED|Overall Study||20
8485177|NCT00580645|20909426|P1|STARTED|Overall Study||20
8485178|NCT00580606|20909439|P2|NOT COMPLETED|Open Label (OL)||12
8485179|NCT00580606|20909440|P1|NOT COMPLETED|Open Label (OL)||9
8485180|NCT00580606|20909439|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
8485181|NCT00580606|20909440|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
8485182|NCT00580606|20909439|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
8485183|NCT00580606|20909440|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
8485184|NCT00580606|20909439|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
8485185|NCT00580606|20909440|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
8485186|NCT00580606|20909439|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
8485187|NCT00580606|20909440|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
8485188|NCT00580606|20909439|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
8485189|NCT00580606|20909440|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
8485190|NCT00580606|20909439|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
8485191|NCT00580606|20909440|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
8485192|NCT00580606|20909439|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
8485193|NCT00580606|20909440|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
8485194|NCT00580606|20909439|P2|NOT COMPLETED|Double Blind (DB)||0
8485195|NCT00580606|20909440|P1|NOT COMPLETED|Double Blind (DB)||0
8485196|NCT00580606|20909439|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
8485197|NCT00580606|20909440|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
8485198|NCT00580606|20909439|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
8485199|NCT00580606|20909440|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
8485200|NCT00580606|20909439|P2|STARTED|Double Blind (DB)||20
8485201|NCT00580606|20909440|P1|STARTED|Double Blind (DB)||20
8485202|NCT00580502|20909458|P1|NOT COMPLETED|Overall Study||0
8485203|NCT00580502|20909458|P1|COMPLETED|Overall Study||50
8485204|NCT00580502|20909458|P1|STARTED|Overall Study||50
8485205|NCT00580398|20909467|P2|NOT COMPLETED|Overall Study||0
8485206|NCT00580398|20909468|P1|NOT COMPLETED|Overall Study||0
8485207|NCT00580398|20909467|P2|COMPLETED|Overall Study||32
8485208|NCT00580398|20909468|P1|COMPLETED|Overall Study||17
8485209|NCT00580398|20909467|P2|STARTED|Overall Study||32
8485210|NCT00580398|20909468|P1|STARTED|Overall Study||17
8485211|NCT00580372|20909476|P1|NOT COMPLETED|Overall Study||0
8485212|NCT00580372|20909476|P1|COMPLETED|Overall Study||231
8485213|NCT00580372|20909476|P1|STARTED|Overall Study||231
8485214|NCT00580333|20909480|P1|NOT COMPLETED|Overall Study||0
8485215|NCT00580333|20909480|P1|COMPLETED|Overall Study||51
8485216|NCT00580333|20909480|P1|STARTED|Overall Study||51
8485217|NCT00580294|20909487|P1|NOT COMPLETED|Overall Study||0
8485218|NCT00580294|20909487|P1|COMPLETED|Overall Study||12
8485219|NCT00580294|20909487|P1|STARTED|Overall Study||12
8485220|NCT00580229|20909491|P1|NOT COMPLETED|Overall Study||0
8485221|NCT00580229|20909491|P1|COMPLETED|Overall Study||50
8485222|NCT00580229|20909491|P1|STARTED|Overall Study||50
8485223|NCT00580151|20909499|P2|NOT COMPLETED|Overall Study||0
8485224|NCT00580151|20909500|P1|NOT COMPLETED|Overall Study||0
8485225|NCT00580151|20909499|P2|COMPLETED|Overall Study||0
8485226|NCT00580151|20909500|P1|COMPLETED|Overall Study||9
8485227|NCT00580151|20909499|P2|STARTED|Overall Study||0
8485228|NCT00580151|20909500|P1|STARTED|Overall Study||9
8485229|NCT00580138|20909508|P1|NOT COMPLETED|Overall Study||0
8485230|NCT00580138|20909508|P1|COMPLETED|Overall Study||30
8485231|NCT00580138|20909508|P1|STARTED|Overall Study||30
8485232|NCT00580073|20909512|P1|NOT COMPLETED|Overall Study||0
8485233|NCT00580073|20909512|P1|COMPLETED|Overall Study||6
8485234|NCT00580073|20909512|P1|STARTED|Overall Study||6
8485235|NCT00580047|20909521|P3|NOT COMPLETED|Overall Study||2
8485236|NCT00580047|20909522|P2|NOT COMPLETED|Overall Study||2
8485237|NCT00580047|20909523|P1|NOT COMPLETED|Overall Study||3
8485238|NCT00580047|20909521|P3|COMPLETED|Overall Study||10
8485239|NCT00580047|20909522|P2|COMPLETED|Overall Study||21
8485240|NCT00580047|20909523|P1|COMPLETED|Overall Study||21
8485241|NCT00580047|20909521|P3|STARTED|Overall Study||12
8485242|NCT00580047|20909522|P2|STARTED|Overall Study||23
8485243|NCT00580047|20909523|P1|STARTED|Overall Study||24
8485244|NCT00580034|20909534|P2|NOT COMPLETED|Overall Study||0
8485245|NCT00580034|20909535|P1|NOT COMPLETED|Overall Study||10
8485246|NCT00580034|20909534|P2|COMPLETED|Overall Study||88
8485247|NCT00580034|20909535|P1|COMPLETED|Overall Study||78
8485248|NCT00580034|20909534|P2|STARTED|Overall Study||88
8485249|NCT00580034|20909535|P1|STARTED|Overall Study||88
8485250|NCT00579982|20909541|P1|NOT COMPLETED|Overall Study||8
8485251|NCT00579982|20909541|P1|COMPLETED|Overall Study||89
8485252|NCT00579982|20909541|P1|STARTED|Overall Study||97
8485262|NCT00579826|20909575|P2|NOT COMPLETED|Overall Study||3
8485263|NCT00579826|20909576|P1|NOT COMPLETED|Overall Study||5
8485264|NCT00579826|20909575|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
8485265|NCT00579826|20909576|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
8485266|NCT00579826|20909575|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
8485267|NCT00579826|20909576|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
8485268|NCT00579826|20909575|P2|STARTED|Overall Study||26
8485269|NCT00579826|20909576|P1|STARTED|Overall Study||29
8485270|NCT00579813|20909588|P2|NOT COMPLETED|Overall Study||0
8485271|NCT00579813|20909589|P1|NOT COMPLETED|Overall Study||0
8485272|NCT00579813|20909588|P2|COMPLETED|Overall Study||10
8485273|NCT00579813|20909589|P1|COMPLETED|Overall Study||60
8485274|NCT00579813|20909588|P2|STARTED|Overall Study||10
8485275|NCT00579813|20909589|P1|STARTED|Overall Study||60
8485276|NCT00579670|20909610|P5|NOT COMPLETED|Overall Study||0
8485277|NCT00579670|20909611|P4|NOT COMPLETED|Overall Study||22
8485278|NCT00579670|20909612|P3|NOT COMPLETED|Overall Study||4
8485279|NCT00579670|20909613|P2|NOT COMPLETED|Overall Study||1
8485280|NCT00579670|20909614|P1|NOT COMPLETED|Overall Study||2
8485281|NCT00579670|20909610|P5|COMPLETED|Overall Study||5
8485282|NCT00579670|20909611|P4|COMPLETED|Overall Study||263
8485283|NCT00579670|20909612|P3|COMPLETED|Overall Study||84
8485284|NCT00579670|20909613|P2|COMPLETED|Overall Study||56
8485285|NCT00579670|20909614|P1|COMPLETED|Overall Study||13
8485286|NCT00579670|20909610|P5|Population: Within SmPC (Completed)|Overall Study||0
8485287|NCT00579670|20909611|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
8485288|NCT00579670|20909612|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
8485289|NCT00579670|20909613|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
8485290|NCT00579670|20909614|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
8485291|NCT00579670|20909610|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
8485292|NCT00579670|20909611|P4|Population: Within SmPC (Started)|Overall Study||159
8485293|NCT00579670|20909612|P3|Population: Within SmPC (Started)|Overall Study||83
8485294|NCT00579670|20909613|P2|Population: Within SmPC (Started)|Overall Study||56
8485295|NCT00579670|20909614|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
8485296|NCT00579670|20909610|P5|STARTED|Overall Study||5
8485297|NCT00579670|20909611|P4|STARTED|Overall Study||285
8485298|NCT00579670|20909612|P3|STARTED|Overall Study||88
8485299|NCT00579670|20909613|P2|STARTED|Overall Study||57
8485300|NCT00579670|20909614|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
8485301|NCT00579527|20909826|P1|NOT COMPLETED|Overall Study||4
8485302|NCT00579527|20909826|P1|COMPLETED|Overall Study||10
8485303|NCT00579527|20909826|P1|STARTED|Overall Study||14
8485304|NCT00579501|20909838|P1|NOT COMPLETED|Overall Study||29
8485305|NCT00579501|20909838|P1|COMPLETED|Overall Study||0
8485306|NCT00579501|20909838|P1|STARTED|Overall Study||29
8485307|NCT00579436|20909845|P2|NOT COMPLETED|Overall Study||0
8485308|NCT00579436|20909846|P1|NOT COMPLETED|Overall Study||0
8485309|NCT00579436|20909845|P2|COMPLETED|Overall Study||14
8485310|NCT00579436|20909846|P1|COMPLETED|Overall Study||19
8485311|NCT00579436|20909845|P2|STARTED|Overall Study||14
8485312|NCT00579436|20909846|P1|STARTED|Overall Study||19
8485313|NCT00579345|20909866|P8|NOT COMPLETED|Overall Study||2
8485314|NCT00579345|20909867|P7|NOT COMPLETED|Overall Study||0
8485315|NCT00579345|20909868|P6|NOT COMPLETED|Overall Study||0
8485316|NCT00579345|20909869|P5|NOT COMPLETED|Overall Study||0
8485317|NCT00579345|20909870|P4|NOT COMPLETED|Overall Study||1
8485318|NCT00579345|20909871|P3|NOT COMPLETED|Overall Study||2
8485319|NCT00579345|20909872|P2|NOT COMPLETED|Overall Study||1
8485320|NCT00579345|20909873|P1|NOT COMPLETED|Overall Study||5
8485321|NCT00579345|20909866|P8|COMPLETED|Overall Study||42
8485322|NCT00579345|20909867|P7|COMPLETED|Overall Study||57
8485323|NCT00579345|20909868|P6|COMPLETED|Overall Study||78
8485324|NCT00579345|20909869|P5|COMPLETED|Overall Study||90
8485325|NCT00579345|20909870|P4|COMPLETED|Overall Study||143
8485326|NCT00579345|20909871|P3|COMPLETED|Overall Study||389
8485327|NCT00579345|20909872|P2|COMPLETED|Overall Study||168
8485328|NCT00579345|20909873|P1|COMPLETED|Overall Study||544
8485329|NCT00579345|20909866|P8|STARTED|Overall Study||44
8485330|NCT00579345|20909867|P7|STARTED|Overall Study||57
8485331|NCT00579345|20909868|P6|STARTED|Overall Study||78
8485332|NCT00579345|20909869|P5|STARTED|Overall Study||90
8485333|NCT00579345|20909870|P4|STARTED|Overall Study||144
8485334|NCT00579345|20909871|P3|STARTED|Overall Study||391
8485335|NCT00579345|20909872|P2|STARTED|Overall Study||169
8485336|NCT00579345|20909873|P1|STARTED|Overall Study||549
8485337|NCT00579280|20909908|P3|NOT COMPLETED|Overall Study||0
8485338|NCT00579280|20909909|P2|NOT COMPLETED|Overall Study||3
8485339|NCT00579280|20909910|P1|NOT COMPLETED|Overall Study||2
8485340|NCT00579280|20909908|P3|COMPLETED|Overall Study|LOCF evaluable sample|51
8485341|NCT00579280|20909909|P2|COMPLETED|Overall Study|LOCF evaluable sample|46
8485342|NCT00579280|20909910|P1|COMPLETED|Overall Study|LOCF evaluable sample|47
8485343|NCT00579280|20909908|P3|STARTED|Overall Study||51
8485344|NCT00579280|20909909|P2|STARTED|Overall Study||49
8485345|NCT00579280|20909910|P1|STARTED|Overall Study||49
8485346|NCT00579137|20909948|P1|NOT COMPLETED|Overall Study||0
8485347|NCT00579137|20909948|P1|COMPLETED|Overall Study||3
8485348|NCT00579137|20909948|P1|STARTED|Overall Study||3
8485349|NCT00579111|20909957|P2|NOT COMPLETED|Overall Study||1
8485350|NCT00579111|20909958|P1|NOT COMPLETED|Overall Study||2
8485351|NCT00579111|20909957|P2|COMPLETED|Overall Study||0
8485352|NCT00579111|20909958|P1|COMPLETED|Overall Study||1
8485353|NCT00579111|20909957|P2|STARTED|Overall Study||1
8485354|NCT00579111|20909958|P1|STARTED|Overall Study||3
8485355|NCT00579098|20909968|P2|NOT COMPLETED|Overall Study||8
8485356|NCT00579098|20909969|P1|NOT COMPLETED|Overall Study||9
8485357|NCT00579098|20909968|P2|COMPLETED|Overall Study||55
8485358|NCT00579098|20909969|P1|COMPLETED|Overall Study||53
8485359|NCT00579098|20909968|P2|STARTED|Overall Study||63
8485360|NCT00579098|20909969|P1|STARTED|Overall Study||62
8485361|NCT00579059|20909985|P2|NOT COMPLETED|Overall Study||10
8485362|NCT00579059|20909986|P1|NOT COMPLETED|Overall Study||21
8485363|NCT00579059|20909985|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
8485447|NCT00578786|20910166|P2|COMPLETED|Overall Study||124
8485364|NCT00579059|20909986|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
8485365|NCT00579059|20909985|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485366|NCT00579059|20909986|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485367|NCT00579059|20909985|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485368|NCT00579059|20909986|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485369|NCT00579059|20909985|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
8485370|NCT00579059|20909986|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
8485371|NCT00579059|20909985|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
8485372|NCT00579059|20909986|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
8485373|NCT00579059|20909985|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
8485374|NCT00579059|20909986|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
8485375|NCT00579059|20909985|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
8485376|NCT00579059|20909986|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
8485377|NCT00578968|20909997|P3|NOT COMPLETED|Intervention||0
8485378|NCT00578968|20909998|P2|NOT COMPLETED|Intervention||0
8485379|NCT00578968|20909999|P1|NOT COMPLETED|Intervention||0
8485380|NCT00578968|20909997|P3|COMPLETED|Intervention||0
8485381|NCT00578968|20909998|P2|COMPLETED|Intervention||12
8485382|NCT00578968|20909999|P1|COMPLETED|Intervention||12
8485383|NCT00578968|20909997|P3|STARTED|Intervention||0
8485384|NCT00578968|20909998|P2|STARTED|Intervention||12
8485385|NCT00578968|20909999|P1|STARTED|Intervention||12
8485386|NCT00578968|20909997|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
8485387|NCT00578968|20909998|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
8485388|NCT00578968|20909999|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
8485389|NCT00578968|20909997|P3|COMPLETED|Baseline (Prior to Intervention)||12
8485390|NCT00578968|20909998|P2|COMPLETED|Baseline (Prior to Intervention)||12
8485391|NCT00578968|20909999|P1|COMPLETED|Baseline (Prior to Intervention)||12
8485392|NCT00578968|20909997|P3|STARTED|Baseline (Prior to Intervention)||12
8485393|NCT00578968|20909998|P2|STARTED|Baseline (Prior to Intervention)||12
8485394|NCT00578968|20909999|P1|STARTED|Baseline (Prior to Intervention)||12
8485395|NCT00578942|20910060|P1|NOT COMPLETED|Overall Study||1
8485396|NCT00578942|20910060|P1|COMPLETED|Overall Study||47
8485397|NCT00578942|20910060|P1|STARTED|Overall Study||48
8485398|NCT00578929|20910070|P4|NOT COMPLETED|Randomized Period||14
8485399|NCT00578929|20910071|P3|NOT COMPLETED|Randomized Period||8
8485400|NCT00578929|20910072|P2|NOT COMPLETED|Randomized Period||14
8485401|NCT00578929|20910073|P1|NOT COMPLETED|Randomized Period||17
8485402|NCT00578929|20910070|P4|COMPLETED|Randomized Period||283
8485403|NCT00578929|20910071|P3|COMPLETED|Randomized Period||288
8485404|NCT00578929|20910072|P2|COMPLETED|Randomized Period||283
8485405|NCT00578929|20910073|P1|COMPLETED|Randomized Period||281
8485406|NCT00578929|20910070|P4|STARTED|Randomized Period||297
8485407|NCT00578929|20910071|P3|STARTED|Randomized Period||296
8485408|NCT00578929|20910072|P2|STARTED|Randomized Period||297
8485409|NCT00578929|20910073|P1|STARTED|Randomized Period||298
8485410|NCT00578929|20910070|P4|NOT COMPLETED|Vehicle Run-In Period||0
8485411|NCT00578929|20910071|P3|NOT COMPLETED|Vehicle Run-In Period||0
8485412|NCT00578929|20910072|P2|NOT COMPLETED|Vehicle Run-In Period||0
8485413|NCT00578929|20910073|P1|NOT COMPLETED|Vehicle Run-In Period||0
8485414|NCT00578929|20910070|P4|COMPLETED|Vehicle Run-In Period||0
8485415|NCT00578929|20910071|P3|COMPLETED|Vehicle Run-In Period||0
8485416|NCT00578929|20910072|P2|COMPLETED|Vehicle Run-In Period||2388
8485417|NCT00578929|20910073|P1|COMPLETED|Vehicle Run-In Period||0
8485418|NCT00578929|20910070|P4|STARTED|Vehicle Run-In Period||0
8485419|NCT00578929|20910071|P3|STARTED|Vehicle Run-In Period||0
8485420|NCT00578929|20910072|P2|STARTED|Vehicle Run-In Period||2388
8485421|NCT00578929|20910073|P1|STARTED|Vehicle Run-In Period||0
8485422|NCT00578903|20910088|P1|NOT COMPLETED|Overall Study||0
8485423|NCT00578903|20910088|P1|COMPLETED|Overall Study||22
8485424|NCT00578903|20910088|P1|STARTED|Overall Study||22
8485425|NCT00578877|20910099|P2|NOT COMPLETED|Overall Study||128
8485426|NCT00578877|20910100|P1|NOT COMPLETED|Overall Study||81
8485427|NCT00578877|20910099|P2|COMPLETED|Overall Study||172
8485428|NCT00578877|20910100|P1|COMPLETED|Overall Study||69
8485429|NCT00578877|20910099|P2|STARTED|Overall Study||300
8485430|NCT00578877|20910100|P1|STARTED|Overall Study||150
8485431|NCT00578864|20910108|P2|NOT COMPLETED|Overall Study||0
8485432|NCT00578864|20910109|P1|NOT COMPLETED|Overall Study||1
8485433|NCT00578864|20910108|P2|COMPLETED|Overall Study||6
8485434|NCT00578864|20910109|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
8485435|NCT00578864|20910108|P2|STARTED|Overall Study||6
8485436|NCT00578864|20910109|P1|STARTED|Overall Study||7
8485437|NCT00578812|20910125|P2|NOT COMPLETED|Overall Study||7
8485438|NCT00578812|20910126|P1|NOT COMPLETED|Overall Study||6
8485439|NCT00578812|20910125|P2|COMPLETED|Overall Study||185
8485440|NCT00578812|20910126|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
8485441|NCT00578812|20910125|P2|STARTED|Overall Study||192
8485442|NCT00578812|20910126|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
8485443|NCT00578786|20910165|P3|NOT COMPLETED|Overall Study||30
8485444|NCT00578786|20910166|P2|NOT COMPLETED|Overall Study||66
8485445|NCT00578786|20910167|P1|NOT COMPLETED|Overall Study||39
8485446|NCT00578786|20910165|P3|COMPLETED|Overall Study||67
8485448|NCT00578786|20910167|P1|COMPLETED|Overall Study||57
8485449|NCT00578786|20910165|P3|STARTED|Overall Study||97
8485450|NCT00578786|20910166|P2|STARTED|Overall Study||190
8485451|NCT00578786|20910167|P1|STARTED|Overall Study||96
8485452|NCT00578734|20910248|P2|NOT COMPLETED|Overall Study||0
8485453|NCT00578734|20910249|P1|NOT COMPLETED|Overall Study||0
8485454|NCT00578734|20910248|P2|COMPLETED|Overall Study||81
8485455|NCT00578734|20910249|P1|COMPLETED|Overall Study||84
8485456|NCT00578734|20910248|P2|STARTED|Overall Study||81
8485457|NCT00578734|20910249|P1|STARTED|Overall Study||84
8485458|NCT00578669|20910259|P2|NOT COMPLETED|Overall Study||0
8485459|NCT00578669|20910260|P1|NOT COMPLETED|Overall Study||0
8485460|NCT00578669|20910259|P2|COMPLETED|Overall Study||99
8485461|NCT00578669|20910260|P1|COMPLETED|Overall Study||107
8485462|NCT00578669|20910259|P2|STARTED|Overall Study||99
8485463|NCT00578669|20910260|P1|STARTED|Overall Study||107
8485464|NCT00578643|20910268|P1|NOT COMPLETED|Overall Study||2
8485465|NCT00578643|20910268|P1|COMPLETED|Overall Study||13
8485466|NCT00578643|20910268|P1|STARTED|Overall Study||15
8485467|NCT00578617|20910277|P2|NOT COMPLETED|Overall Study||0
8485468|NCT00578617|20910278|P1|NOT COMPLETED|Overall Study||0
8485469|NCT00578617|20910277|P2|COMPLETED|Overall Study||29
8485470|NCT00578617|20910278|P1|COMPLETED|Overall Study||31
8485471|NCT00578617|20910277|P2|STARTED|Overall Study||29
8485472|NCT00578617|20910278|P1|STARTED|Overall Study||31
8485473|NCT00578565|20910284|P1|NOT COMPLETED|Overall Study||3
8485474|NCT00578565|20910284|P1|COMPLETED|Overall Study||7
8485475|NCT00578565|20910284|P1|STARTED|Overall Study||10
8485476|NCT00578552|20910296|P3|NOT COMPLETED|Overall Study||15
8485477|NCT00578552|20910297|P2|NOT COMPLETED|Overall Study||14
8485478|NCT00578552|20910298|P1|NOT COMPLETED|Overall Study||15
8485479|NCT00578552|20910296|P3|COMPLETED|Overall Study||11
8485480|NCT00578552|20910297|P2|COMPLETED|Overall Study||13
8485481|NCT00578552|20910298|P1|COMPLETED|Overall Study||12
8485482|NCT00578552|20910296|P3|STARTED|Overall Study||26
8485483|NCT00578552|20910297|P2|STARTED|Overall Study||27
8485484|NCT00578552|20910298|P1|STARTED|Overall Study||27
8485485|NCT00578539|20910306|P1|NOT COMPLETED|Overall Study||0
8485486|NCT00578539|20910306|P1|COMPLETED|Overall Study||24
8485487|NCT00578539|20910306|P1|STARTED|Overall Study||24
8485488|NCT00578461|20910310|P1|NOT COMPLETED|Overall Study||0
8485489|NCT00578461|20910310|P1|COMPLETED|Overall Study||26
8485490|NCT00578461|20910310|P1|STARTED|Overall Study||26
8485491|NCT00578448|20910314|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
8485492|NCT00578448|20910314|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
8485493|NCT00578448|20910314|P1|STARTED|1 Year Long Term Extension (LTE)||9
8485494|NCT00578448|20910314|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
8485495|NCT00578448|20910314|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
8485496|NCT00578448|20910314|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
8485497|NCT00578383|20910332|P4|NOT COMPLETED|Overall Study||6
8485498|NCT00578383|20910333|P3|NOT COMPLETED|Overall Study||6
8485499|NCT00578383|20910334|P2|NOT COMPLETED|Overall Study||16
8485500|NCT00578383|20910335|P1|NOT COMPLETED|Overall Study||16
8485501|NCT00578383|20910332|P4|COMPLETED|Overall Study||9
8485502|NCT00578383|20910333|P3|COMPLETED|Overall Study||13
8485503|NCT00578383|20910334|P2|COMPLETED|Overall Study||20
8485504|NCT00578383|20910335|P1|COMPLETED|Overall Study||21
8485505|NCT00578383|20910332|P4|STARTED|Overall Study||15
8485506|NCT00578383|20910333|P3|STARTED|Overall Study||19
8485507|NCT00578383|20910334|P2|STARTED|Overall Study||36
8485508|NCT00578383|20910335|P1|STARTED|Overall Study||37
8485509|NCT00578344|20910365|P1|NOT COMPLETED|Overall Study||2
8485510|NCT00578344|20910365|P1|COMPLETED|Overall Study||6
8485511|NCT00578344|20910365|P1|STARTED|Overall Study||8
8485512|NCT00578331|20910373|P2|NOT COMPLETED|Overall Study||125
8485513|NCT00578331|20910374|P1|NOT COMPLETED|Overall Study||116
8485514|NCT00578331|20910373|P2|COMPLETED|Overall Study||320
8485515|NCT00578331|20910374|P1|COMPLETED|Overall Study||329
8485516|NCT00578331|20910373|P2|STARTED|Overall Study||445
8485517|NCT00578331|20910374|P1|STARTED|Overall Study||445
8485518|NCT00578318|20910384|P2|NOT COMPLETED|Overall Study||0
8485519|NCT00578318|20910385|P1|NOT COMPLETED|Overall Study||3
8485520|NCT00578318|20910384|P2|COMPLETED|Overall Study||8
8485521|NCT00578318|20910385|P1|COMPLETED|Overall Study||5
8485522|NCT00578318|20910384|P2|STARTED|Overall Study||8
8485523|NCT00578318|20910385|P1|STARTED|Overall Study||8
8485524|NCT00578305|20910394|P3|NOT COMPLETED|Safety Follow-up Phase||46
8485525|NCT00578305|20910395|P2|NOT COMPLETED|Safety Follow-up Phase||45
8485526|NCT00578305|20910396|P1|NOT COMPLETED|Safety Follow-up Phase||46
8485527|NCT00578305|20910394|P3|COMPLETED|Safety Follow-up Phase||8
8485528|NCT00578305|20910395|P2|COMPLETED|Safety Follow-up Phase||9
8485529|NCT00578305|20910396|P1|COMPLETED|Safety Follow-up Phase||11
8485530|NCT00578305|20910394|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
8485531|NCT00578305|20910395|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
8485532|NCT00578305|20910396|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
8485533|NCT00578305|20910394|P3|NOT COMPLETED|Extension Phase||3
8485534|NCT00578305|20910395|P2|NOT COMPLETED|Extension Phase||1
8485535|NCT00578305|20910396|P1|NOT COMPLETED|Extension Phase||4
8485536|NCT00578305|20910394|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
8485537|NCT00578305|20910395|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
8485538|NCT00578305|20910396|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
8485539|NCT00578305|20910394|P3|STARTED|Extension Phase||43
8485540|NCT00578305|20910395|P2|STARTED|Extension Phase||50
8485541|NCT00578305|20910396|P1|STARTED|Extension Phase||53
8485542|NCT00578305|20910394|P3|NOT COMPLETED|Double-blind Treatment Phase||14
8485543|NCT00578305|20910395|P2|NOT COMPLETED|Double-blind Treatment Phase||4
8485544|NCT00578305|20910396|P1|NOT COMPLETED|Double-blind Treatment Phase||3
8485545|NCT00578305|20910394|P3|COMPLETED|Double-blind Treatment Phase||49
8485546|NCT00578305|20910395|P2|COMPLETED|Double-blind Treatment Phase||56
8485547|NCT00578305|20910396|P1|COMPLETED|Double-blind Treatment Phase||59
8485548|NCT00578305|20910394|P3|Treated|Double-blind Treatment Phase||63
8485549|NCT00578305|20910395|P2|Treated|Double-blind Treatment Phase||60
8485550|NCT00578305|20910396|P1|Treated|Double-blind Treatment Phase||62
8485551|NCT00578305|20910394|P3|STARTED|Double-blind Treatment Phase||63
8485552|NCT00578305|20910395|P2|STARTED|Double-blind Treatment Phase||60
8485553|NCT00578305|20910396|P1|STARTED|Double-blind Treatment Phase||62
8485554|NCT00578292|20910455|P1|NOT COMPLETED|Overall Study||3
8485555|NCT00578292|20910455|P1|COMPLETED|Overall Study||7
8485556|NCT00578292|20910455|P1|STARTED|Overall Study||10
8485557|NCT00578279|20910469|P2|NOT COMPLETED|Overall Study||0
8485558|NCT00578279|20910470|P1|NOT COMPLETED|Overall Study||0
8485559|NCT00578279|20910469|P2|COMPLETED|Overall Study||10
8485560|NCT00578279|20910470|P1|COMPLETED|Overall Study||10
8485561|NCT00578279|20910469|P2|STARTED|Overall Study||10
8485562|NCT00578279|20910470|P1|STARTED|Overall Study||10
8485563|NCT00578227|20910479|P3|NOT COMPLETED|Overall Study||4
8485564|NCT00578227|20910480|P2|NOT COMPLETED|Overall Study||2
8485565|NCT00578227|20910481|P1|NOT COMPLETED|Overall Study||5
8485566|NCT00578227|20910479|P3|COMPLETED|Overall Study||267
8485567|NCT00578227|20910480|P2|COMPLETED|Overall Study||268
8485568|NCT00578227|20910481|P1|COMPLETED|Overall Study||267
8485569|NCT00578227|20910479|P3|STARTED|Overall Study||271
8485570|NCT00578227|20910480|P2|STARTED|Overall Study||270
8485571|NCT00578227|20910481|P1|STARTED|Overall Study||272
8485572|NCT00578214|20910554|P3|NOT COMPLETED|Overall Study||0
8485573|NCT00578214|20910555|P2|NOT COMPLETED|Overall Study||0
8485574|NCT00578214|20910556|P1|NOT COMPLETED|Overall Study||0
8485575|NCT00578214|20910554|P3|COMPLETED|Overall Study||31
8485576|NCT00578214|20910555|P2|COMPLETED|Overall Study||22
8485577|NCT00578214|20910556|P1|COMPLETED|Overall Study||22
8485578|NCT00578214|20910554|P3|STARTED|Overall Study||31
8485579|NCT00578214|20910555|P2|STARTED|Overall Study||22
8485580|NCT00578214|20910556|P1|STARTED|Overall Study||22
8485581|NCT00578175|20910606|P3|NOT COMPLETED|Overall Study||24
8485582|NCT00578175|20910607|P2|NOT COMPLETED|Overall Study||43
8485583|NCT00578175|20910608|P1|NOT COMPLETED|Overall Study||70
8485584|NCT00578175|20910606|P3|COMPLETED|Overall Study||365
8485585|NCT00578175|20910607|P2|COMPLETED|Overall Study||646
8485586|NCT00578175|20910608|P1|COMPLETED|Overall Study||635
8485587|NCT00578175|20910606|P3|STARTED|Overall Study||389
8485588|NCT00578175|20910607|P2|STARTED|Overall Study||689
8485589|NCT00578175|20910608|P1|STARTED|Overall Study||705
8485590|NCT00578136|20910687|P2|NOT COMPLETED|Overall Study||1
8485591|NCT00578136|20910688|P1|NOT COMPLETED|Overall Study||1
8485592|NCT00578136|20910687|P2|COMPLETED|Overall Study||26
8485593|NCT00578136|20910688|P1|COMPLETED|Overall Study||26
8485594|NCT00578136|20910687|P2|STARTED|Overall Study||27
8485595|NCT00578136|20910688|P1|STARTED|Overall Study||27
8485596|NCT00578071|20910696|P1|NOT COMPLETED|Overall Study||0
8485597|NCT00578071|20910696|P1|COMPLETED|Overall Study||29
8485598|NCT00578071|20910696|P1|STARTED|Overall Study||29
8485599|NCT00577993|20910706|P3|NOT COMPLETED|Overall Study||3
8485600|NCT00577993|20910707|P2|NOT COMPLETED|Overall Study||10
8485601|NCT00577993|20910708|P1|NOT COMPLETED|Overall Study||7
8485602|NCT00577993|20910706|P3|COMPLETED|Overall Study||32
8485603|NCT00577993|20910707|P2|COMPLETED|Overall Study||80
8485604|NCT00577993|20910708|P1|COMPLETED|Overall Study||78
8485605|NCT00577993|20910706|P3|STARTED|Overall Study||35
8485606|NCT00577993|20910707|P2|STARTED|Overall Study||90
8485607|NCT00577993|20910708|P1|STARTED|Overall Study||85
8485608|NCT00577889|20910719|P3|NOT COMPLETED|Overall Study||0
8485609|NCT00577889|20910720|P2|NOT COMPLETED|Overall Study||0
8485610|NCT00577889|20910721|P1|NOT COMPLETED|Overall Study||1
8485611|NCT00577889|20910719|P3|COMPLETED|Overall Study||6
8485612|NCT00577889|20910720|P2|COMPLETED|Overall Study||6
8485613|NCT00577889|20910721|P1|COMPLETED|Overall Study||8
8485614|NCT00577889|20910719|P3|STARTED|Overall Study||6
8485615|NCT00577889|20910720|P2|STARTED|Overall Study||6
8485616|NCT00577889|20910721|P1|STARTED|Overall Study||9
8485617|NCT00577863|20910740|P2|NOT COMPLETED|Overall Study||14
8485618|NCT00577863|20910741|P1|NOT COMPLETED|Overall Study||10
8485619|NCT00577863|20910740|P2|COMPLETED|Overall Study||94
8485620|NCT00577863|20910741|P1|COMPLETED|Overall Study||82
8485621|NCT00577863|20910740|P2|Received at Least One Injection|Overall Study||107
8485622|NCT00577863|20910741|P1|Received at Least One Injection|Overall Study||92
8485623|NCT00577863|20910740|P2|STARTED|Overall Study||108
8485624|NCT00577863|20910741|P1|STARTED|Overall Study||92
8485625|NCT00577824|20910783|P3|NOT COMPLETED|Overall Study||2
8485626|NCT00577824|20910784|P2|NOT COMPLETED|Overall Study||20
8485627|NCT00577824|20910785|P1|NOT COMPLETED|Overall Study||7
8485628|NCT00577824|20910783|P3|COMPLETED|Overall Study||34
8485629|NCT00577824|20910784|P2|COMPLETED|Overall Study||53
8485630|NCT00577824|20910785|P1|COMPLETED|Overall Study||65
8485631|NCT00577824|20910783|P3|Full Analysis Set|Overall Study||35
8485632|NCT00577824|20910784|P2|Full Analysis Set|Overall Study||72
8485633|NCT00577824|20910785|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
8485634|NCT00577824|20910783|P3|STARTED|Overall Study||36
8485635|NCT00577824|20910784|P2|STARTED|Overall Study||73
8485636|NCT00577824|20910785|P1|STARTED|Overall Study|Started=Randomized|72
8485637|NCT00577772|20910843|P2|NOT COMPLETED|Overall Study||1
8485638|NCT00577772|20910844|P1|NOT COMPLETED|Overall Study||0
8485639|NCT00577772|20910843|P2|COMPLETED|Overall Study||6
8485640|NCT00577772|20910844|P1|COMPLETED|Overall Study||10
8485641|NCT00577772|20910843|P2|STARTED|Overall Study||7
8485642|NCT00577772|20910844|P1|STARTED|Overall Study||10
8485643|NCT00577720|20910854|P4|NOT COMPLETED|Overall Study||7
8485644|NCT00577720|20910855|P3|NOT COMPLETED|Overall Study||1
8485645|NCT00577720|20910856|P2|NOT COMPLETED|Overall Study||1
8485646|NCT00577720|20910857|P1|NOT COMPLETED|Overall Study||4
8485647|NCT00577720|20910854|P4|COMPLETED|Overall Study||65
8485648|NCT00577720|20910855|P3|COMPLETED|Overall Study||35
8485649|NCT00577720|20910856|P2|COMPLETED|Overall Study||35
8485650|NCT00577720|20910857|P1|COMPLETED|Overall Study||33
8485651|NCT00577720|20910854|P4|ITT (Intent to Treat) Population|Overall Study||65
8485652|NCT00577720|20910855|P3|ITT (Intent to Treat) Population|Overall Study||35
8485653|NCT00577720|20910856|P2|ITT (Intent to Treat) Population|Overall Study||35
8485654|NCT00577720|20910857|P1|ITT (Intent to Treat) Population|Overall Study||34
8485655|NCT00577720|20910854|P4|STARTED|Overall Study||72
8485656|NCT00577720|20910855|P3|STARTED|Overall Study||36
8485657|NCT00577720|20910856|P2|STARTED|Overall Study||36
8485658|NCT00577720|20910857|P1|STARTED|Overall Study||37
8485659|NCT00577707|20910875|P1|NOT COMPLETED|Overall Study||3
8485660|NCT00577707|20910875|P1|COMPLETED|Overall Study||6
8485661|NCT00577707|20910875|P1|STARTED|Overall Study||9
8485662|NCT00577655|20910883|P2|NOT COMPLETED|Overall Study||4
8485663|NCT00577655|20910884|P1|NOT COMPLETED|Overall Study||1
8485664|NCT00577655|20910883|P2|COMPLETED|Overall Study||47
8485665|NCT00577655|20910884|P1|COMPLETED|Overall Study||51
8485666|NCT00577655|20910883|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
8485667|NCT00577655|20910884|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
8485668|NCT00577642|20910922|P1|NOT COMPLETED|Overall Study||1
8485669|NCT00577642|20910922|P1|COMPLETED|Overall Study||28
8485670|NCT00577642|20910922|P1|STARTED|Overall Study||29
8485671|NCT00577629|20910926|P1|NOT COMPLETED|Long Term Follow-Up||25
8485672|NCT00577629|20910926|P1|COMPLETED|Long Term Follow-Up||13
8485673|NCT00577629|20910926|P1|STARTED|Long Term Follow-Up||38
8485674|NCT00577629|20910926|P1|NOT COMPLETED|Treatment Period||1
8485675|NCT00577629|20910926|P1|COMPLETED|Treatment Period||38
8485676|NCT00577629|20910926|P1|STARTED|Treatment Period||39
8485677|NCT00577590|20910937|P3|NOT COMPLETED|Overall Study||0
8485678|NCT00577590|20910938|P2|NOT COMPLETED|Overall Study||0
8485679|NCT00577590|20910939|P1|NOT COMPLETED|Overall Study||0
8485680|NCT00577590|20910937|P3|COMPLETED|Overall Study||23
8485681|NCT00577590|20910938|P2|COMPLETED|Overall Study||27
8485682|NCT00577590|20910939|P1|COMPLETED|Overall Study||28
8485683|NCT00577590|20910937|P3|STARTED|Overall Study||23
8485684|NCT00577590|20910938|P2|STARTED|Overall Study||27
8485685|NCT00577590|20910939|P1|STARTED|Overall Study||28
8485686|NCT00577512|20910947|P1|NOT COMPLETED|Overall Study||4
8485687|NCT00577512|20910947|P1|COMPLETED|Overall Study||0
8485688|NCT00577512|20910947|P1|STARTED|Overall Study||4
8485689|NCT00577473|20910953|P2|NOT COMPLETED|Overall Study||24
8485690|NCT00577473|20910954|P1|NOT COMPLETED|Overall Study||21
8485691|NCT00577473|20910953|P2|COMPLETED|Overall Study||123
8485692|NCT00577473|20910954|P1|COMPLETED|Overall Study||133
8485693|NCT00577473|20910953|P2|ITT Population|Overall Study||136
8485694|NCT00577473|20910954|P1|ITT Population|Overall Study||150
8485695|NCT00577473|20910953|P2|STARTED|Overall Study||147
8485696|NCT00577473|20910954|P1|STARTED|Overall Study||154
8485697|NCT00577460|20910985|P3|NOT COMPLETED|Overall Study||27
8485698|NCT00577460|20910986|P2|NOT COMPLETED|Overall Study||19
8485699|NCT00577460|20910987|P1|NOT COMPLETED|Overall Study||16
8485700|NCT00577460|20910985|P3|COMPLETED|Overall Study||112
8485701|NCT00577460|20910986|P2|COMPLETED|Overall Study||104
8485702|NCT00577460|20910987|P1|COMPLETED|Overall Study||113
8485703|NCT00577460|20910985|P3|STARTED|Overall Study||139
8485704|NCT00577460|20910986|P2|STARTED|Overall Study||123
8485705|NCT00577460|20910987|P1|STARTED|Overall Study||129
8485706|NCT00577408|20911096|P2|NOT COMPLETED|Overall Study||23
8485707|NCT00577408|20911097|P1|NOT COMPLETED|Overall Study||12
8485708|NCT00577408|20911096|P2|COMPLETED|Overall Study||9
8485709|NCT00577408|20911097|P1|COMPLETED|Overall Study||16
8485710|NCT00577408|20911096|P2|STARTED|Overall Study||32
8485711|NCT00577408|20911097|P1|STARTED|Overall Study||28
8485712|NCT00577395|20911105|P2|NOT COMPLETED|Overall Study||6
8485713|NCT00577395|20911106|P1|NOT COMPLETED|Overall Study||7
8485714|NCT00577395|20911105|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
8485715|NCT00577395|20911106|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
8485716|NCT00577395|20911105|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
8485800|NCT00576927|20911351|P1|COMPLETED|Clinical Assessment||43
8485717|NCT00577395|20911106|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
8485718|NCT00577382|20911116|P2|NOT COMPLETED|Overall Study||31
8485719|NCT00577382|20911117|P1|NOT COMPLETED|Overall Study||21
8485720|NCT00577382|20911116|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8485721|NCT00577382|20911117|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8485722|NCT00577382|20911116|P2|STARTED|Overall Study||31
8485723|NCT00577382|20911117|P1|STARTED|Overall Study||21
8485724|NCT00577356|20911129|P1|NOT COMPLETED|Overall Study||0
8485725|NCT00577356|20911129|P1|COMPLETED|Overall Study||6
8485726|NCT00577356|20911129|P1|STARTED|Overall Study||6
8485727|NCT00577135|20911137|P4|NOT COMPLETED|Overall Study||0
8485728|NCT00577135|20911138|P3|NOT COMPLETED|Overall Study||0
8485729|NCT00577135|20911139|P2|NOT COMPLETED|Overall Study||0
8485730|NCT00577135|20911140|P1|NOT COMPLETED|Overall Study||0
8485731|NCT00577135|20911137|P4|COMPLETED|Overall Study||75
8485732|NCT00577135|20911138|P3|COMPLETED|Overall Study||77
8485733|NCT00577135|20911139|P2|COMPLETED|Overall Study||82
8485734|NCT00577135|20911140|P1|COMPLETED|Overall Study||74
8485735|NCT00577135|20911137|P4|STARTED|Overall Study||75
8485736|NCT00577135|20911138|P3|STARTED|Overall Study||77
8485737|NCT00577135|20911139|P2|STARTED|Overall Study||82
8485738|NCT00577135|20911140|P1|STARTED|Overall Study||74
8485739|NCT00577122|20911260|P2|NOT COMPLETED|Overall Study||16
8485740|NCT00577122|20911261|P1|NOT COMPLETED|Overall Study||14
8485741|NCT00577122|20911260|P2|COMPLETED|Overall Study||0
8485742|NCT00577122|20911261|P1|COMPLETED|Overall Study||0
8485743|NCT00577122|20911260|P2|STARTED|Overall Study||16
8485744|NCT00577122|20911261|P1|STARTED|Overall Study||14
8485745|NCT00577096|20911275|P2|NOT COMPLETED|Long Term Participation||0
8485746|NCT00577096|20911276|P1|NOT COMPLETED|Long Term Participation||0
8485747|NCT00577096|20911275|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
8485748|NCT00577096|20911276|P1|COMPLETED|Long Term Participation||34
8485749|NCT00577096|20911275|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
8485750|NCT00577096|20911276|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
8485751|NCT00577096|20911275|P2|NOT COMPLETED|Short Term Participation||8
8485752|NCT00577096|20911276|P1|NOT COMPLETED|Short Term Participation||7
8485753|NCT00577096|20911275|P2|COMPLETED|Short Term Participation||58
8485754|NCT00577096|20911276|P1|COMPLETED|Short Term Participation||62
8485755|NCT00577096|20911275|P2|STARTED|Short Term Participation||66
8485756|NCT00577096|20911276|P1|STARTED|Short Term Participation||69
8485757|NCT00577083|20911302|P2|NOT COMPLETED|Second Intervention (14days)||0
8485758|NCT00577083|20911303|P1|NOT COMPLETED|Second Intervention (14days)||0
8485759|NCT00577083|20911302|P2|COMPLETED|Second Intervention (14days)||52
8485760|NCT00577083|20911303|P1|COMPLETED|Second Intervention (14days)||48
8485761|NCT00577083|20911302|P2|STARTED|Second Intervention (14days)||52
8485762|NCT00577083|20911303|P1|STARTED|Second Intervention (14days)||48
8485763|NCT00577083|20911302|P2|NOT COMPLETED|Washout (14 Days)||0
8485764|NCT00577083|20911303|P1|NOT COMPLETED|Washout (14 Days)||0
8485765|NCT00577083|20911302|P2|COMPLETED|Washout (14 Days)||52
8485766|NCT00577083|20911303|P1|COMPLETED|Washout (14 Days)||48
8485767|NCT00577083|20911302|P2|STARTED|Washout (14 Days)||52
8485768|NCT00577083|20911303|P1|STARTED|Washout (14 Days)||48
8485769|NCT00577083|20911302|P2|NOT COMPLETED|First Intervention (14 Days)||0
8485770|NCT00577083|20911303|P1|NOT COMPLETED|First Intervention (14 Days)||0
8485771|NCT00577083|20911302|P2|COMPLETED|First Intervention (14 Days)||52
8485772|NCT00577083|20911303|P1|COMPLETED|First Intervention (14 Days)||48
8485773|NCT00577083|20911302|P2|STARTED|First Intervention (14 Days)||52
8485774|NCT00577083|20911303|P1|STARTED|First Intervention (14 Days)||48
8485775|NCT00577031|20911315|P1|NOT COMPLETED|Overall Study||205
8485776|NCT00577031|20911315|P1|COMPLETED|Overall Study||0
8485777|NCT00577031|20911315|P1|STARTED|Overall Study||205
8485778|NCT00577005|20911336|P2|NOT COMPLETED|Overall Study||3
8485779|NCT00577005|20911337|P1|NOT COMPLETED|Overall Study||5
8485780|NCT00577005|20911336|P2|COMPLETED|Overall Study||9
8485781|NCT00577005|20911337|P1|COMPLETED|Overall Study||11
8485782|NCT00577005|20911336|P2|STARTED|Overall Study||12
8485783|NCT00577005|20911337|P1|STARTED|Overall Study||16
8485784|NCT00576927|20911351|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
8485785|NCT00576927|20911351|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
8485786|NCT00576927|20911351|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
8485787|NCT00576927|20911351|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
8485788|NCT00576927|20911351|P1|COMPLETED|Sleep Hygiene With Study Drug||22
8485789|NCT00576927|20911351|P1|STARTED|Sleep Hygiene With Study Drug||22
8485790|NCT00576927|20911351|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
8485791|NCT00576927|20911351|P1|COMPLETED|Sleep Hygiene With the Placebo||22
8485792|NCT00576927|20911351|P1|STARTED|Sleep Hygiene With the Placebo||23
8485793|NCT00576927|20911351|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
8485794|NCT00576927|20911351|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
8485795|NCT00576927|20911351|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
8485796|NCT00576927|20911351|P1|NOT COMPLETED|Baseline||13
8485797|NCT00576927|20911351|P1|COMPLETED|Baseline||30
8485798|NCT00576927|20911351|P1|STARTED|Baseline||43
8485799|NCT00576927|20911351|P1|NOT COMPLETED|Clinical Assessment||36
8485801|NCT00576927|20911351|P1|STARTED|Clinical Assessment||79
8485802|NCT00576901|20911363|P1|NOT COMPLETED|Overall Study||3
8485803|NCT00576901|20911363|P1|COMPLETED|Overall Study||20
8485804|NCT00576901|20911363|P1|STARTED|Overall Study||23
8485805|NCT00576836|20911371|P2|NOT COMPLETED|Overall Study||2
8485806|NCT00576836|20911372|P1|NOT COMPLETED|Overall Study||0
8485807|NCT00576836|20911371|P2|COMPLETED|Overall Study||5
8485808|NCT00576836|20911372|P1|COMPLETED|Overall Study||0
8485809|NCT00576836|20911371|P2|STARTED|Overall Study||7
8485810|NCT00576836|20911372|P1|STARTED|Overall Study||0
8485811|NCT00576823|20911387|P3|NOT COMPLETED|40-week Safety Extension Phase||0
8485812|NCT00576823|20911388|P2|NOT COMPLETED|40-week Safety Extension Phase||0
8485813|NCT00576823|20911389|P1|NOT COMPLETED|40-week Safety Extension Phase||1
8485814|NCT00576823|20911387|P3|COMPLETED|40-week Safety Extension Phase||6
8485815|NCT00576823|20911388|P2|COMPLETED|40-week Safety Extension Phase||6
8485816|NCT00576823|20911389|P1|COMPLETED|40-week Safety Extension Phase||10
8485817|NCT00576823|20911387|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
8485818|NCT00576823|20911388|P2|STARTED|40-week Safety Extension Phase||6
8485819|NCT00576823|20911389|P1|STARTED|40-week Safety Extension Phase||11
8485820|NCT00576823|20911387|P3|NOT COMPLETED|12-week Efficacy Phase||0
8485821|NCT00576823|20911388|P2|NOT COMPLETED|12-week Efficacy Phase||0
8485822|NCT00576823|20911389|P1|NOT COMPLETED|12-week Efficacy Phase||1
8485823|NCT00576823|20911387|P3|COMPLETED|12-week Efficacy Phase||7
8485824|NCT00576823|20911388|P2|COMPLETED|12-week Efficacy Phase||6
8485825|NCT00576823|20911389|P1|COMPLETED|12-week Efficacy Phase||11
8485826|NCT00576823|20911387|P3|STARTED|12-week Efficacy Phase||7
8485827|NCT00576823|20911388|P2|STARTED|12-week Efficacy Phase||6
8485828|NCT00576823|20911389|P1|STARTED|12-week Efficacy Phase||12
8485829|NCT00576758|20911405|P2|NOT COMPLETED|Follow-up Period||17
8485830|NCT00576758|20911406|P1|NOT COMPLETED|Follow-up Period||27
8485831|NCT00576758|20911405|P2|COMPLETED|Follow-up Period||34
8485832|NCT00576758|20911406|P1|COMPLETED|Follow-up Period||28
8485833|NCT00576758|20911405|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
8485834|NCT00576758|20911406|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
8485835|NCT00576758|20911405|P2|NOT COMPLETED|Extension Treatment Period||43
8485836|NCT00576758|20911406|P1|NOT COMPLETED|Extension Treatment Period||42
8485837|NCT00576758|20911405|P2|COMPLETED|Extension Treatment Period||30
8485838|NCT00576758|20911406|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
8485839|NCT00576758|20911405|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
8485840|NCT00576758|20911406|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
8485841|NCT00576758|20911405|P2|NOT COMPLETED|Induction Treatment Period||5
8485842|NCT00576758|20911406|P1|NOT COMPLETED|Induction Treatment Period||8
8485843|NCT00576758|20911405|P2|COMPLETED|Induction Treatment Period||83
8485844|NCT00576758|20911406|P1|COMPLETED|Induction Treatment Period||79
8485845|NCT00576758|20911405|P2|Received Treatment|Induction Treatment Period||87
8485846|NCT00576758|20911406|P1|Received Treatment|Induction Treatment Period||86
8485847|NCT00576758|20911405|P2|STARTED|Induction Treatment Period||88
8485848|NCT00576758|20911406|P1|STARTED|Induction Treatment Period||87
8485849|NCT00576732|20911452|P6|NOT COMPLETED|OPEN LABEL||8
8485850|NCT00576732|20911453|P5|NOT COMPLETED|OPEN LABEL||4
8485851|NCT00576732|20911454|P4|NOT COMPLETED|OPEN LABEL||11
8485852|NCT00576732|20911455|P3|NOT COMPLETED|OPEN LABEL||0
8485853|NCT00576732|20911456|P2|NOT COMPLETED|OPEN LABEL||0
8485854|NCT00576732|20911457|P1|NOT COMPLETED|OPEN LABEL||0
8485855|NCT00576732|20911452|P6|COMPLETED|OPEN LABEL||17
8485856|NCT00576732|20911453|P5|COMPLETED|OPEN LABEL||20
8485857|NCT00576732|20911454|P4|COMPLETED|OPEN LABEL||19
8485858|NCT00576732|20911455|P3|COMPLETED|OPEN LABEL||0
8485859|NCT00576732|20911456|P2|COMPLETED|OPEN LABEL||0
8485860|NCT00576732|20911457|P1|COMPLETED|OPEN LABEL||0
8485861|NCT00576732|20911452|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
8485862|NCT00576732|20911453|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
8485863|NCT00576732|20911454|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
8485864|NCT00576732|20911455|P3|STARTED|OPEN LABEL||0
8485865|NCT00576732|20911456|P2|STARTED|OPEN LABEL||0
8485866|NCT00576732|20911457|P1|STARTED|OPEN LABEL||0
8485867|NCT00576732|20911452|P6|NOT COMPLETED|DOUBLE BLIND||0
8485868|NCT00576732|20911453|P5|NOT COMPLETED|DOUBLE BLIND||0
8485869|NCT00576732|20911454|P4|NOT COMPLETED|DOUBLE BLIND||0
8485870|NCT00576732|20911455|P3|NOT COMPLETED|DOUBLE BLIND||6
8485871|NCT00576732|20911456|P2|NOT COMPLETED|DOUBLE BLIND||5
8485872|NCT00576732|20911457|P1|NOT COMPLETED|DOUBLE BLIND||8
8485873|NCT00576732|20911452|P6|COMPLETED|DOUBLE BLIND||0
8485874|NCT00576732|20911453|P5|COMPLETED|DOUBLE BLIND||0
8485875|NCT00576732|20911454|P4|COMPLETED|DOUBLE BLIND||0
8485876|NCT00576732|20911455|P3|COMPLETED|DOUBLE BLIND||25
8485877|NCT00576732|20911456|P2|COMPLETED|DOUBLE BLIND||25
8485878|NCT00576732|20911457|P1|COMPLETED|DOUBLE BLIND||27
8485879|NCT00576732|20911452|P6|STARTED|DOUBLE BLIND||0
8485880|NCT00576732|20911453|P5|STARTED|DOUBLE BLIND||0
8485881|NCT00576732|20911454|P4|STARTED|DOUBLE BLIND||0
8485882|NCT00576732|20911455|P3|STARTED|DOUBLE BLIND||31
8485883|NCT00576732|20911456|P2|STARTED|DOUBLE BLIND||30
8485884|NCT00576732|20911457|P1|STARTED|DOUBLE BLIND||35
8485885|NCT00576693|20911489|P2|NOT COMPLETED|Overall Study||24
8485886|NCT00576693|20911490|P1|NOT COMPLETED|Overall Study||10
8485887|NCT00576693|20911489|P2|COMPLETED|Overall Study||203
8485888|NCT00576693|20911490|P1|COMPLETED|Overall Study||214
8485889|NCT00576693|20911489|P2|STARTED|Overall Study||227
8485890|NCT00576693|20911490|P1|STARTED|Overall Study||224
8485891|NCT00576680|20911496|P1|NOT COMPLETED|Overall Study||0
8485892|NCT00576680|20911496|P1|COMPLETED|Overall Study||43
8485893|NCT00576680|20911496|P1|STARTED|Overall Study||43
8485894|NCT00576628|20911502|P1|NOT COMPLETED|Overall Study||43
8485895|NCT00576628|20911502|P1|COMPLETED|Overall Study||82
8485896|NCT00576628|20911502|P1|STARTED|Overall Study||125
8485897|NCT00576576|20911522|P1|NOT COMPLETED|Overall Study||7
8485898|NCT00576576|20911522|P1|COMPLETED|Overall Study||20
8485899|NCT00576576|20911522|P1|STARTED|Overall Study||27
8485900|NCT00576524|20911530|P2|NOT COMPLETED|Overall Study||0
8485901|NCT00576524|20911531|P1|NOT COMPLETED|Overall Study||0
8485902|NCT00576524|20911530|P2|COMPLETED|Overall Study||0
8485903|NCT00576524|20911531|P1|COMPLETED|Overall Study||2
8485904|NCT00576524|20911530|P2|STARTED|Overall Study||0
8485905|NCT00576524|20911531|P1|STARTED|Overall Study||2
8485906|NCT00576472|20911556|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
8485907|NCT00576472|20911557|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
8485908|NCT00576472|20911558|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
8485909|NCT00576472|20911559|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
8485910|NCT00576472|20911560|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
8485911|NCT00576472|20911561|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
8485912|NCT00576472|20911562|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
8485913|NCT00576472|20911563|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
8485914|NCT00576472|20911564|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
8485915|NCT00576472|20911565|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
8485916|NCT00576472|20911566|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
8485917|NCT00576472|20911567|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
8485918|NCT00576472|20911568|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
8485919|NCT00576472|20911569|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
8485920|NCT00576472|20911570|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
8485921|NCT00576472|20911556|P15|COMPLETED|MPH Home Maintenance Phase||68
8485922|NCT00576472|20911557|P14|COMPLETED|MPH Home Maintenance Phase||0
8485923|NCT00576472|20911558|P13|COMPLETED|MPH Home Maintenance Phase||0
8485924|NCT00576472|20911559|P12|COMPLETED|MPH Home Maintenance Phase||0
8485925|NCT00576472|20911560|P11|COMPLETED|MPH Home Maintenance Phase||0
8485926|NCT00576472|20911561|P10|COMPLETED|MPH Home Maintenance Phase||0
8485927|NCT00576472|20911562|P9|COMPLETED|MPH Home Maintenance Phase||0
8485928|NCT00576472|20911563|P8|COMPLETED|MPH Home Maintenance Phase||0
8485929|NCT00576472|20911564|P7|COMPLETED|MPH Home Maintenance Phase||0
8485930|NCT00576472|20911565|P6|COMPLETED|MPH Home Maintenance Phase||0
8485931|NCT00576472|20911566|P5|COMPLETED|MPH Home Maintenance Phase||0
8485932|NCT00576472|20911567|P4|COMPLETED|MPH Home Maintenance Phase||0
8485933|NCT00576472|20911568|P3|COMPLETED|MPH Home Maintenance Phase||0
8485934|NCT00576472|20911569|P2|COMPLETED|MPH Home Maintenance Phase||0
8485935|NCT00576472|20911570|P1|COMPLETED|MPH Home Maintenance Phase||0
8485936|NCT00576472|20911556|P15|STARTED|MPH Home Maintenance Phase||91
8485937|NCT00576472|20911557|P14|STARTED|MPH Home Maintenance Phase||27
8485938|NCT00576472|20911558|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485939|NCT00576472|20911559|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485940|NCT00576472|20911560|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485941|NCT00576472|20911561|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485942|NCT00576472|20911562|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485943|NCT00576472|20911563|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485944|NCT00576472|20911564|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485945|NCT00576472|20911565|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485946|NCT00576472|20911566|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485947|NCT00576472|20911567|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485948|NCT00576472|20911568|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485949|NCT00576472|20911569|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485950|NCT00576472|20911570|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485951|NCT00576472|20911556|P15|NOT COMPLETED|MPH Cross Over Phase||0
8485952|NCT00576472|20911557|P14|NOT COMPLETED|MPH Cross Over Phase||0
8485953|NCT00576472|20911558|P13|NOT COMPLETED|MPH Cross Over Phase||0
8485954|NCT00576472|20911559|P12|NOT COMPLETED|MPH Cross Over Phase||1
8485955|NCT00576472|20911560|P11|NOT COMPLETED|MPH Cross Over Phase||1
8485956|NCT00576472|20911561|P10|NOT COMPLETED|MPH Cross Over Phase||0
8485957|NCT00576472|20911562|P9|NOT COMPLETED|MPH Cross Over Phase||2
8485958|NCT00576472|20911563|P8|NOT COMPLETED|MPH Cross Over Phase||0
8485959|NCT00576472|20911564|P7|NOT COMPLETED|MPH Cross Over Phase||12
8485960|NCT00576472|20911565|P6|NOT COMPLETED|MPH Cross Over Phase||0
8485961|NCT00576472|20911566|P5|NOT COMPLETED|MPH Cross Over Phase||0
8485962|NCT00576472|20911567|P4|NOT COMPLETED|MPH Cross Over Phase||0
8485963|NCT00576472|20911568|P3|NOT COMPLETED|MPH Cross Over Phase||0
8485964|NCT00576472|20911569|P2|NOT COMPLETED|MPH Cross Over Phase||0
8485965|NCT00576472|20911570|P1|NOT COMPLETED|MPH Cross Over Phase||0
8485966|NCT00576472|20911556|P15|COMPLETED|MPH Cross Over Phase||0
8485967|NCT00576472|20911557|P14|COMPLETED|MPH Cross Over Phase||0
8485968|NCT00576472|20911558|P13|COMPLETED|MPH Cross Over Phase||21
8485969|NCT00576472|20911559|P12|COMPLETED|MPH Cross Over Phase||17
8485970|NCT00576472|20911560|P11|COMPLETED|MPH Cross Over Phase||22
8485971|NCT00576472|20911561|P10|COMPLETED|MPH Cross Over Phase||22
8485972|NCT00576472|20911562|P9|COMPLETED|MPH Cross Over Phase||16
8485973|NCT00576472|20911563|P8|COMPLETED|MPH Cross Over Phase||20
8485974|NCT00576472|20911564|P7|COMPLETED|MPH Cross Over Phase||0
8485975|NCT00576472|20911565|P6|COMPLETED|MPH Cross Over Phase||0
8485976|NCT00576472|20911566|P5|COMPLETED|MPH Cross Over Phase||0
8485977|NCT00576472|20911567|P4|COMPLETED|MPH Cross Over Phase||0
8485978|NCT00576472|20911568|P3|COMPLETED|MPH Cross Over Phase||0
8485979|NCT00576472|20911569|P2|COMPLETED|MPH Cross Over Phase||0
8485980|NCT00576472|20911570|P1|COMPLETED|MPH Cross Over Phase||0
8485981|NCT00576472|20911556|P15|STARTED|MPH Cross Over Phase||0
8485982|NCT00576472|20911557|P14|STARTED|MPH Cross Over Phase||0
8485983|NCT00576472|20911558|P13|STARTED|MPH Cross Over Phase||21
8485984|NCT00576472|20911559|P12|STARTED|MPH Cross Over Phase||18
8485985|NCT00576472|20911560|P11|STARTED|MPH Cross Over Phase||23
8485986|NCT00576472|20911561|P10|STARTED|MPH Cross Over Phase||22
8485987|NCT00576472|20911562|P9|STARTED|MPH Cross Over Phase||18
8485988|NCT00576472|20911563|P8|STARTED|MPH Cross Over Phase||20
8485989|NCT00576472|20911564|P7|STARTED|MPH Cross Over Phase||12
8485990|NCT00576472|20911565|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485991|NCT00576472|20911566|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485992|NCT00576472|20911567|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485993|NCT00576472|20911568|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485994|NCT00576472|20911569|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485995|NCT00576472|20911570|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485996|NCT00576472|20911556|P15|NOT COMPLETED|MPH In-Lab Phase||0
8485997|NCT00576472|20911557|P14|NOT COMPLETED|MPH In-Lab Phase||0
8485998|NCT00576472|20911558|P13|NOT COMPLETED|MPH In-Lab Phase||0
8485999|NCT00576472|20911559|P12|NOT COMPLETED|MPH In-Lab Phase||0
8486000|NCT00576472|20911560|P11|NOT COMPLETED|MPH In-Lab Phase||0
8486001|NCT00576472|20911561|P10|NOT COMPLETED|MPH In-Lab Phase||0
8486002|NCT00576472|20911562|P9|NOT COMPLETED|MPH In-Lab Phase||0
8486003|NCT00576472|20911563|P8|NOT COMPLETED|MPH In-Lab Phase||0
8486004|NCT00576472|20911564|P7|NOT COMPLETED|MPH In-Lab Phase||0
8486005|NCT00576472|20911565|P6|NOT COMPLETED|MPH In-Lab Phase||0
8486006|NCT00576472|20911566|P5|NOT COMPLETED|MPH In-Lab Phase||0
8486007|NCT00576472|20911567|P4|NOT COMPLETED|MPH In-Lab Phase||335
8486008|NCT00576472|20911568|P3|NOT COMPLETED|MPH In-Lab Phase||0
8486009|NCT00576472|20911569|P2|NOT COMPLETED|MPH In-Lab Phase||0
8486010|NCT00576472|20911570|P1|NOT COMPLETED|MPH In-Lab Phase||0
8486011|NCT00576472|20911556|P15|COMPLETED|MPH In-Lab Phase||0
8486012|NCT00576472|20911557|P14|COMPLETED|MPH In-Lab Phase||0
8486013|NCT00576472|20911558|P13|COMPLETED|MPH In-Lab Phase||0
8486014|NCT00576472|20911559|P12|COMPLETED|MPH In-Lab Phase||0
8486015|NCT00576472|20911560|P11|COMPLETED|MPH In-Lab Phase||0
8486016|NCT00576472|20911561|P10|COMPLETED|MPH In-Lab Phase||0
8486017|NCT00576472|20911562|P9|COMPLETED|MPH In-Lab Phase||0
8486018|NCT00576472|20911563|P8|COMPLETED|MPH In-Lab Phase||0
8486019|NCT00576472|20911564|P7|COMPLETED|MPH In-Lab Phase||0
8486020|NCT00576472|20911565|P6|COMPLETED|MPH In-Lab Phase||67
8486021|NCT00576472|20911566|P5|COMPLETED|MPH In-Lab Phase||67
8486022|NCT00576472|20911567|P4|COMPLETED|MPH In-Lab Phase||0
8486023|NCT00576472|20911568|P3|COMPLETED|MPH In-Lab Phase||0
8486024|NCT00576472|20911569|P2|COMPLETED|MPH In-Lab Phase||0
8486025|NCT00576472|20911570|P1|COMPLETED|MPH In-Lab Phase||0
8486026|NCT00576472|20911556|P15|STARTED|MPH In-Lab Phase||0
8486027|NCT00576472|20911557|P14|STARTED|MPH In-Lab Phase||0
8486028|NCT00576472|20911558|P13|STARTED|MPH In-Lab Phase||0
8486029|NCT00576472|20911559|P12|STARTED|MPH In-Lab Phase||0
8486030|NCT00576472|20911560|P11|STARTED|MPH In-Lab Phase||0
8486031|NCT00576472|20911561|P10|STARTED|MPH In-Lab Phase||0
8486032|NCT00576472|20911562|P9|STARTED|MPH In-Lab Phase||0
8486033|NCT00576472|20911563|P8|STARTED|MPH In-Lab Phase||0
8486034|NCT00576472|20911564|P7|STARTED|MPH In-Lab Phase||0
8486035|NCT00576472|20911565|P6|STARTED|MPH In-Lab Phase||67
8486036|NCT00576472|20911566|P5|STARTED|MPH In-Lab Phase||67
8486037|NCT00576472|20911567|P4|STARTED|MPH In-Lab Phase||335
8486038|NCT00576472|20911568|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8486039|NCT00576472|20911569|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8486040|NCT00576472|20911570|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8486041|NCT00576472|20911556|P15|NOT COMPLETED|Initial Screening||0
8486042|NCT00576472|20911557|P14|NOT COMPLETED|Initial Screening||0
8486043|NCT00576472|20911558|P13|NOT COMPLETED|Initial Screening||0
8486044|NCT00576472|20911559|P12|NOT COMPLETED|Initial Screening||0
8486045|NCT00576472|20911560|P11|NOT COMPLETED|Initial Screening||0
8486046|NCT00576472|20911561|P10|NOT COMPLETED|Initial Screening||0
8486047|NCT00576472|20911562|P9|NOT COMPLETED|Initial Screening||0
8486048|NCT00576472|20911563|P8|NOT COMPLETED|Initial Screening||0
8486049|NCT00576472|20911564|P7|NOT COMPLETED|Initial Screening||0
8486050|NCT00576472|20911565|P6|NOT COMPLETED|Initial Screening||0
8486051|NCT00576472|20911566|P5|NOT COMPLETED|Initial Screening||0
8486052|NCT00576472|20911567|P4|NOT COMPLETED|Initial Screening||0
8486053|NCT00576472|20911568|P3|NOT COMPLETED|Initial Screening||0
8486054|NCT00576472|20911569|P2|NOT COMPLETED|Initial Screening||0
8486055|NCT00576472|20911570|P1|NOT COMPLETED|Initial Screening||0
8486056|NCT00576472|20911556|P15|COMPLETED|Initial Screening||0
8486057|NCT00576472|20911557|P14|COMPLETED|Initial Screening||0
8486058|NCT00576472|20911558|P13|COMPLETED|Initial Screening||0
8486059|NCT00576472|20911559|P12|COMPLETED|Initial Screening||0
8486060|NCT00576472|20911560|P11|COMPLETED|Initial Screening||0
8486061|NCT00576472|20911561|P10|COMPLETED|Initial Screening||0
8486062|NCT00576472|20911562|P9|COMPLETED|Initial Screening||0
8486063|NCT00576472|20911563|P8|COMPLETED|Initial Screening||0
8486064|NCT00576472|20911564|P7|COMPLETED|Initial Screening||0
8486065|NCT00576472|20911565|P6|COMPLETED|Initial Screening||0
8486066|NCT00576472|20911566|P5|COMPLETED|Initial Screening||0
8486067|NCT00576472|20911567|P4|COMPLETED|Initial Screening||0
8486068|NCT00576472|20911568|P3|COMPLETED|Initial Screening||199
8486069|NCT00576472|20911569|P2|COMPLETED|Initial Screening||40
8486070|NCT00576472|20911570|P1|COMPLETED|Initial Screening||230
8486071|NCT00576472|20911556|P15|STARTED|Initial Screening||0
8486072|NCT00576472|20911557|P14|STARTED|Initial Screening||0
8486073|NCT00576472|20911558|P13|STARTED|Initial Screening||0
8486074|NCT00576472|20911559|P12|STARTED|Initial Screening||0
8486075|NCT00576472|20911560|P11|STARTED|Initial Screening||0
8486076|NCT00576472|20911561|P10|STARTED|Initial Screening||0
8486077|NCT00576472|20911562|P9|STARTED|Initial Screening||0
8486078|NCT00576472|20911563|P8|STARTED|Initial Screening||0
8486079|NCT00576472|20911564|P7|STARTED|Initial Screening||0
8486080|NCT00576472|20911565|P6|STARTED|Initial Screening||0
8486081|NCT00576472|20911566|P5|STARTED|Initial Screening||0
8486082|NCT00576472|20911567|P4|STARTED|Initial Screening||0
8486083|NCT00576472|20911568|P3|STARTED|Initial Screening||199
8486084|NCT00576472|20911569|P2|STARTED|Initial Screening||40
8486085|NCT00576472|20911570|P1|STARTED|Initial Screening||230
8486086|NCT00576420|20911663|P3|NOT COMPLETED|Overall Study||1
8486087|NCT00576420|20911664|P2|NOT COMPLETED|Overall Study||0
8486088|NCT00576420|20911665|P1|NOT COMPLETED|Overall Study||0
8486089|NCT00576420|20911663|P3|COMPLETED|Overall Study||22
8486090|NCT00576420|20911664|P2|COMPLETED|Overall Study||24
8486091|NCT00576420|20911665|P1|COMPLETED|Overall Study||26
8486092|NCT00576420|20911663|P3|STARTED|Overall Study||23
8486093|NCT00576420|20911664|P2|STARTED|Overall Study||24
8486094|NCT00576420|20911665|P1|STARTED|Overall Study||26
8486095|NCT00576407|20911830|P1|NOT COMPLETED|Overall Study||8
8486096|NCT00576407|20911830|P1|COMPLETED|Overall Study||18
8486097|NCT00576407|20911830|P1|STARTED|Overall Study||26
8486098|NCT00576381|20911842|P1|NOT COMPLETED|Overall Study||7
8486099|NCT00576381|20911842|P1|COMPLETED|Overall Study||23
8486100|NCT00576381|20911842|P1|STARTED|Overall Study||30
8486101|NCT00576316|20911846|P1|NOT COMPLETED|Overall Study||20
8486102|NCT00576316|20911846|P1|COMPLETED|Overall Study|Number of patients who completed study|181
8486103|NCT00576316|20911846|P1|STARTED|Overall Study|Number of patients recruited|201
8486104|NCT00576303|20911851|P1|NOT COMPLETED|Long Term Safety Period||16
8486105|NCT00576303|20911851|P1|COMPLETED|Long Term Safety Period||162
8486106|NCT00576303|20911851|P1|STARTED|Long Term Safety Period||178
8486107|NCT00576303|20911851|P1|NOT COMPLETED|Efficacy Evaluation Period||5
8486108|NCT00576303|20911851|P1|COMPLETED|Efficacy Evaluation Period||178
8486109|NCT00576303|20911851|P1|STARTED|Efficacy Evaluation Period||183
8486110|NCT00576303|20911851|P1|NOT COMPLETED|Dose Titration Period||17
8486111|NCT00576303|20911851|P1|COMPLETED|Dose Titration Period||183
8486112|NCT00576303|20911851|P1|STARTED|Dose Titration Period||200
8486113|NCT00576251|20911862|P2|NOT COMPLETED|Overall Study||1
8486114|NCT00576251|20911863|P1|NOT COMPLETED|Overall Study||1
8486115|NCT00576251|20911862|P2|COMPLETED|Overall Study||111
8486116|NCT00576251|20911863|P1|COMPLETED|Overall Study||108
8486117|NCT00576251|20911862|P2|STARTED|Overall Study||112
8486118|NCT00576251|20911863|P1|STARTED|Overall Study||109
8486119|NCT00576199|20911869|P1|NOT COMPLETED|Overall Study||30
8486120|NCT00576199|20911869|P1|COMPLETED|Overall Study||0
8486121|NCT00576199|20911869|P1|STARTED|Overall Study||30
8486122|NCT00576147|20911878|P1|NOT COMPLETED|Overall Study||0
8486123|NCT00576147|20911878|P1|COMPLETED|Overall Study||431
8486124|NCT00576147|20911878|P1|STARTED|Overall Study||431
8486125|NCT00576056|20911882|P1|NOT COMPLETED|Overall Study||14
8486126|NCT00576056|20911882|P1|COMPLETED|Overall Study||5
8486127|NCT00576056|20911882|P1|STARTED|Overall Study||19
8486128|NCT00575965|20911887|P1|NOT COMPLETED|Overall Study||0
8486129|NCT00575965|20911887|P1|COMPLETED|Overall Study||18
8486130|NCT00575965|20911887|P1|STARTED|Overall Study||18
8486131|NCT00575887|20911892|P1|NOT COMPLETED|Overall Study||0
8486132|NCT00575887|20911892|P1|COMPLETED|Overall Study||25
8486133|NCT00575887|20911892|P1|STARTED|Overall Study||25
8486134|NCT00575666|20911898|P2|NOT COMPLETED|Overall Study||3
8486135|NCT00575666|20911899|P1|NOT COMPLETED|Overall Study||4
8486136|NCT00575666|20911898|P2|COMPLETED|Overall Study||21
8486137|NCT00575666|20911899|P1|COMPLETED|Overall Study||17
8486138|NCT00575666|20911898|P2|STARTED|Overall Study||24
8486139|NCT00575666|20911899|P1|STARTED|Overall Study||21
8486140|NCT00575588|20911939|P2|NOT COMPLETED|Overall Study||283
8486141|NCT00575588|20911940|P1|NOT COMPLETED|Overall Study||263
8486142|NCT00575588|20911939|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
8486143|NCT00575588|20911940|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
8486144|NCT00575588|20911939|P2|STARTED|Overall Study|Randomized and treated|430
8486145|NCT00575588|20911940|P1|STARTED|Overall Study|Randomized and treated|428
8486146|NCT00575510|20911963|P3|NOT COMPLETED|Overall Study||17
8486147|NCT00575510|20911964|P2|NOT COMPLETED|Overall Study||13
8486148|NCT00575510|20911965|P1|NOT COMPLETED|Overall Study||12
8486149|NCT00575510|20911963|P3|COMPLETED|Overall Study||96
8486150|NCT00575510|20911964|P2|COMPLETED|Overall Study||101
8486151|NCT00575510|20911965|P1|COMPLETED|Overall Study||102
8486152|NCT00575510|20911963|P3|STARTED|Overall Study||113
8486153|NCT00575510|20911964|P2|STARTED|Overall Study||114
8486154|NCT00575510|20911965|P1|STARTED|Overall Study||114
8486155|NCT00575380|20911978|P2|NOT COMPLETED|Overall Study||3
8486156|NCT00575380|20911979|P1|NOT COMPLETED|Overall Study||1
8486157|NCT00575380|20911978|P2|COMPLETED|Overall Study||55
8486158|NCT00575380|20911979|P1|COMPLETED|Overall Study||57
8486159|NCT00575380|20911978|P2|STARTED|Overall Study||58
8486160|NCT00575380|20911979|P1|STARTED|Overall Study||58
8486161|NCT00575367|20911989|P2|NOT COMPLETED|Overall Study||0
8486162|NCT00575367|20911990|P1|NOT COMPLETED|Overall Study||0
8486163|NCT00575367|20911989|P2|COMPLETED|Overall Study||18
8486164|NCT00575367|20911990|P1|COMPLETED|Overall Study||19
8486165|NCT00575367|20911989|P2|STARTED|Overall Study||18
8486166|NCT00575367|20911990|P1|STARTED|Overall Study||19
8486167|NCT00575328|20911998|P2|NOT COMPLETED|Overall Study||2
8486168|NCT00575328|20911999|P1|NOT COMPLETED|Overall Study||3
8486169|NCT00575328|20911998|P2|COMPLETED|Overall Study||2
8486170|NCT00575328|20911999|P1|COMPLETED|Overall Study||1
8486171|NCT00575328|20911998|P2|STARTED|Overall Study||4
8486172|NCT00575328|20911999|P1|STARTED|Overall Study||4
8486173|NCT00575185|20912009|P2|NOT COMPLETED|Overall Study||0
8486174|NCT00575185|20912010|P1|NOT COMPLETED|Overall Study||0
8486175|NCT00575185|20912009|P2|COMPLETED|Overall Study||11
8486176|NCT00575185|20912010|P1|COMPLETED|Overall Study||12
8486177|NCT00575185|20912009|P2|STARTED|Overall Study||11
8486178|NCT00575185|20912010|P1|STARTED|Overall Study||12
8486179|NCT00575159|20912018|P1|NOT COMPLETED|Overall Study||0
8486180|NCT00575159|20912018|P1|COMPLETED|Overall Study||10
8486181|NCT00575159|20912018|P1|STARTED|Overall Study||10
8486182|NCT00575146|20912126|P1|NOT COMPLETED|Overall Study||3
8486183|NCT00575146|20912126|P1|COMPLETED|Overall Study||17
8486184|NCT00575146|20912126|P1|STARTED|Overall Study||20
8486185|NCT00575094|20912132|P1|NOT COMPLETED|Overall Study||3
8486186|NCT00575094|20912132|P1|COMPLETED|Overall Study||6
8486187|NCT00575094|20912132|P1|STARTED|Overall Study||9
8486188|NCT00575042|20912136|P1|NOT COMPLETED|Overall Study||3
8486189|NCT00575042|20912136|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
8486190|NCT00575042|20912136|P1|STARTED|Overall Study||20
8486191|NCT00575029|20912141|P1|NOT COMPLETED|Overall Study||0
8486192|NCT00575029|20912141|P1|COMPLETED|Overall Study||7
8486193|NCT00575029|20912141|P1|STARTED|Overall Study||7
8486194|NCT00575016|20912150|P4|NOT COMPLETED|Treatment Cycle 2||0
8486195|NCT00575016|20912151|P3|NOT COMPLETED|Treatment Cycle 2||0
8486196|NCT00575016|20912152|P2|NOT COMPLETED|Treatment Cycle 2||0
8486197|NCT00575016|20912153|P1|NOT COMPLETED|Treatment Cycle 2||1
8486198|NCT00575016|20912150|P4|COMPLETED|Treatment Cycle 2||0
8486199|NCT00575016|20912151|P3|COMPLETED|Treatment Cycle 2||0
8486200|NCT00575016|20912152|P2|COMPLETED|Treatment Cycle 2||0
8486201|NCT00575016|20912153|P1|COMPLETED|Treatment Cycle 2||30
8486202|NCT00575016|20912150|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8486203|NCT00575016|20912151|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8486204|NCT00575016|20912152|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8486205|NCT00575016|20912153|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
8486206|NCT00575016|20912150|P4|NOT COMPLETED|Treatment Cycle 1||5
8486207|NCT00575016|20912151|P3|NOT COMPLETED|Treatment Cycle 1||4
8486208|NCT00575016|20912152|P2|NOT COMPLETED|Treatment Cycle 1||5
8486209|NCT00575016|20912153|P1|NOT COMPLETED|Treatment Cycle 1||9
8486210|NCT00575016|20912150|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
8486211|NCT00575016|20912151|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
8486212|NCT00575016|20912152|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
8486213|NCT00575016|20912153|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
8486214|NCT00575016|20912150|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
8486215|NCT00575016|20912151|P3|STARTED|Treatment Cycle 1||19
8486216|NCT00575016|20912152|P2|STARTED|Treatment Cycle 1||21
8486217|NCT00575016|20912153|P1|STARTED|Treatment Cycle 1||17
8486218|NCT00574990|20912174|P3|NOT COMPLETED|Overall Study||0
8486219|NCT00574990|20912175|P2|NOT COMPLETED|Overall Study||0
8486220|NCT00574990|20912176|P1|NOT COMPLETED|Overall Study||0
8486221|NCT00574990|20912174|P3|COMPLETED|Overall Study||8
8486222|NCT00574990|20912175|P2|COMPLETED|Overall Study||19
8486223|NCT00574990|20912176|P1|COMPLETED|Overall Study||12
8486224|NCT00574990|20912174|P3|STARTED|Overall Study||8
8486225|NCT00574990|20912175|P2|STARTED|Overall Study||19
8486226|NCT00574990|20912176|P1|STARTED|Overall Study||12
8486227|NCT00574951|20912187|P1|NOT COMPLETED|Overall Study||1
8486228|NCT00574951|20912187|P1|COMPLETED|Overall Study||22
8486229|NCT00574951|20912187|P1|STARTED|Overall Study||23
8486230|NCT00574912|20912195|P1|NOT COMPLETED|Overall Study||8
8486231|NCT00574912|20912195|P1|COMPLETED|Overall Study||12
8486232|NCT00574912|20912195|P1|Completed 2.0|Overall Study||12
8486233|NCT00574912|20912195|P1|Completed 1.5|Overall Study||12
8486234|NCT00574912|20912195|P1|Completed 1.0|Overall Study||12
8486235|NCT00574912|20912195|P1|Completed 0.5|Overall Study||12
8486236|NCT00574912|20912195|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
8486237|NCT00574912|20912195|P1|STARTED|Overall Study||20
8486238|NCT00574873|20912209|P2|NOT COMPLETED|Overall Study||251
8486239|NCT00574873|20912210|P1|NOT COMPLETED|Overall Study||238
8486240|NCT00574873|20912209|P2|COMPLETED|Overall Study||1
8486241|NCT00574873|20912210|P1|COMPLETED|Overall Study||12
8486242|NCT00574873|20912209|P2|Treated|Overall Study||251
8486243|NCT00574873|20912210|P1|Treated|Overall Study||248
8486244|NCT00574873|20912209|P2|STARTED|Overall Study||252
8486245|NCT00574873|20912210|P1|STARTED|Overall Study||250
8486246|NCT00574847|20912228|P2|NOT COMPLETED|Overall Study||7
8486247|NCT00574847|20912229|P1|NOT COMPLETED|Overall Study||8
8486248|NCT00574847|20912228|P2|COMPLETED|Overall Study||56
8486249|NCT00574847|20912229|P1|COMPLETED|Overall Study||56
8486250|NCT00574847|20912228|P2|STARTED|Overall Study||63
8486251|NCT00574847|20912229|P1|STARTED|Overall Study||64
8486252|NCT00574834|20912264|P3|NOT COMPLETED|Overall Study||0
8486253|NCT00574834|20912265|P2|NOT COMPLETED|Overall Study||0
8486254|NCT00574834|20912266|P1|NOT COMPLETED|Overall Study||0
8486255|NCT00574834|20912264|P3|COMPLETED|Overall Study||4
8486256|NCT00574834|20912265|P2|COMPLETED|Overall Study||4
8486257|NCT00574834|20912266|P1|COMPLETED|Overall Study||9
8486258|NCT00574834|20912264|P3|STARTED|Overall Study||4
8486259|NCT00574834|20912265|P2|STARTED|Overall Study||4
8486260|NCT00574834|20912266|P1|STARTED|Overall Study||9
8486261|NCT00574795|20912274|P1|NOT COMPLETED|Toddler Dose||1
8486262|NCT00574795|20912274|P1|COMPLETED|Toddler Dose||184
8486263|NCT00574795|20912274|P1|STARTED|Toddler Dose||185
8486264|NCT00574795|20912274|P1|NOT COMPLETED|After Infant Series||3
8486265|NCT00574795|20912274|P1|COMPLETED|After Infant Series||185
8486266|NCT00574795|20912274|P1|STARTED|After Infant Series||188
8486267|NCT00574795|20912274|P1|NOT COMPLETED|Infant Series||5
8486268|NCT00574795|20912274|P1|COMPLETED|Infant Series||188
8486269|NCT00574795|20912274|P1|Vaccinated Dose 3|Infant Series||190
8486270|NCT00574795|20912274|P1|Vaccinated Dose 2|Infant Series||190
8486271|NCT00574795|20912274|P1|Vaccinated Dose 1|Infant Series||193
8486272|NCT00574795|20912274|P1|STARTED|Infant Series||193
8486273|NCT00574704|20912295|P4|NOT COMPLETED|Overall Study||0
8486274|NCT00574704|20912296|P3|NOT COMPLETED|Overall Study||1
8486275|NCT00574704|20912297|P2|NOT COMPLETED|Overall Study||0
8486276|NCT00574704|20912298|P1|NOT COMPLETED|Overall Study||0
8486277|NCT00574704|20912295|P4|COMPLETED|Overall Study||10
8486278|NCT00574704|20912296|P3|COMPLETED|Overall Study||9
8486279|NCT00574704|20912297|P2|COMPLETED|Overall Study||10
8486280|NCT00574704|20912298|P1|COMPLETED|Overall Study||10
8486281|NCT00574704|20912295|P4|STARTED|Overall Study||10
8486282|NCT00574704|20912296|P3|STARTED|Overall Study||10
8486283|NCT00574704|20912297|P2|STARTED|Overall Study||10
8486284|NCT00574704|20912298|P1|STARTED|Overall Study||10
8486285|NCT00574587|20912312|P4|NOT COMPLETED|Overall Study||0
8486286|NCT00574587|20912313|P3|NOT COMPLETED|Overall Study||0
8486287|NCT00574587|20912314|P2|NOT COMPLETED|Overall Study||0
8486288|NCT00574587|20912315|P1|NOT COMPLETED|Overall Study||0
8486289|NCT00574587|20912312|P4|COMPLETED|Overall Study||13
8486290|NCT00574587|20912313|P3|COMPLETED|Overall Study||16
8486291|NCT00574587|20912314|P2|COMPLETED|Overall Study||23
8486292|NCT00574587|20912315|P1|COMPLETED|Overall Study||3
8486293|NCT00574587|20912312|P4|STARTED|Overall Study||13
8486294|NCT00574587|20912313|P3|STARTED|Overall Study||16
8486295|NCT00574587|20912314|P2|STARTED|Overall Study||23
8486296|NCT00574587|20912315|P1|STARTED|Overall Study||3
8486297|NCT00574548|20912328|P2|NOT COMPLETED|Overall Study||16
8486298|NCT00574548|20912329|P1|NOT COMPLETED|Overall Study||61
8486299|NCT00574548|20912328|P2|COMPLETED|Overall Study||222
8486300|NCT00574548|20912329|P1|COMPLETED|Overall Study||421
8486301|NCT00574548|20912328|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
8486302|NCT00574548|20912329|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
8486303|NCT00574548|20912328|P2|Received Vax 2|Overall Study||223
8486304|NCT00574548|20912329|P1|Received Vax 2|Overall Study||427
8486305|NCT00574548|20912328|P2|Withdrawn Before Vax 2|Overall Study||11
8486306|NCT00574548|20912329|P1|Withdrawn Before Vax 2|Overall Study||41
8486307|NCT00574548|20912328|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
8486308|NCT00574548|20912329|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
8486309|NCT00574548|20912328|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
8486310|NCT00574548|20912329|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
8486311|NCT00574548|20912328|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
8486312|NCT00574548|20912329|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
8486313|NCT00574548|20912328|P2|STARTED|Overall Study||238
8486314|NCT00574548|20912329|P1|STARTED|Overall Study||482
8486315|NCT00574405|20912375|P2|NOT COMPLETED|Overall Study||2
8486316|NCT00574405|20912376|P1|NOT COMPLETED|Overall Study||3
8486317|NCT00574405|20912375|P2|COMPLETED|Overall Study||10
8486318|NCT00574405|20912376|P1|COMPLETED|Overall Study||9
8486319|NCT00574405|20912375|P2|STARTED|Overall Study||12
8486320|NCT00574405|20912376|P1|STARTED|Overall Study||12
8486321|NCT00574340|20912382|P2|NOT COMPLETED|Study 2 (2 Days)||0
8486322|NCT00574340|20912383|P1|NOT COMPLETED|Study 2 (2 Days)||0
8486323|NCT00574340|20912382|P2|COMPLETED|Study 2 (2 Days)||6
8486324|NCT00574340|20912383|P1|COMPLETED|Study 2 (2 Days)||6
8486325|NCT00574340|20912382|P2|STARTED|Study 2 (2 Days)||6
8486326|NCT00574340|20912383|P1|STARTED|Study 2 (2 Days)||6
8486327|NCT00574340|20912382|P2|NOT COMPLETED|Study 1 (2 Days)||0
8486328|NCT00574340|20912383|P1|NOT COMPLETED|Study 1 (2 Days)||0
8486329|NCT00574340|20912382|P2|COMPLETED|Study 1 (2 Days)||10
8486330|NCT00574340|20912383|P1|COMPLETED|Study 1 (2 Days)||10
8486331|NCT00574340|20912382|P2|STARTED|Study 1 (2 Days)||10
8486332|NCT00574340|20912383|P1|STARTED|Study 1 (2 Days)||10
8486333|NCT00574288|20912396|P7|NOT COMPLETED|Overall Study||28
8486334|NCT00574288|20912397|P6|NOT COMPLETED|Overall Study||26
8486335|NCT00574288|20912398|P5|NOT COMPLETED|Overall Study||2
8486336|NCT00574288|20912399|P4|NOT COMPLETED|Overall Study||2
8486337|NCT00574288|20912400|P3|NOT COMPLETED|Overall Study||3
8486338|NCT00574288|20912401|P2|NOT COMPLETED|Overall Study||3
8486339|NCT00574288|20912402|P1|NOT COMPLETED|Overall Study||20
8486340|NCT00574288|20912396|P7|COMPLETED|Overall Study||14
8486341|NCT00574288|20912397|P6|COMPLETED|Overall Study||4
8486342|NCT00574288|20912398|P5|COMPLETED|Overall Study||1
8486343|NCT00574288|20912399|P4|COMPLETED|Overall Study||1
8486344|NCT00574288|20912400|P3|COMPLETED|Overall Study||0
8486345|NCT00574288|20912401|P2|COMPLETED|Overall Study||0
8486346|NCT00574288|20912402|P1|COMPLETED|Overall Study||0
8486347|NCT00574288|20912396|P7|STARTED|Overall Study||42
8486348|NCT00574288|20912397|P6|STARTED|Overall Study||30
8486349|NCT00574288|20912398|P5|STARTED|Overall Study||3
8486350|NCT00574288|20912399|P4|STARTED|Overall Study||3
8486351|NCT00574288|20912400|P3|STARTED|Overall Study||3
8486352|NCT00574288|20912401|P2|STARTED|Overall Study||3
8486353|NCT00574288|20912402|P1|STARTED|Overall Study||20
8486354|NCT00574275|20912440|P2|NOT COMPLETED|Overall Study||271
8486355|NCT00574275|20912441|P1|NOT COMPLETED|Overall Study||275
8486356|NCT00574275|20912440|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
8486357|NCT00574275|20912441|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
8486358|NCT00574275|20912440|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
8486359|NCT00574275|20912441|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
8486360|NCT00574275|20912440|P2|TREATED|Overall Study||268
8486361|NCT00574275|20912441|P1|TREATED|Overall Study||273
8486362|NCT00574275|20912440|P2|STARTED|Overall Study||271
8486363|NCT00574275|20912441|P1|STARTED|Overall Study||275
8486364|NCT00574249|20912459|P2|NOT COMPLETED|Overall Study||28
8486365|NCT00574249|20912460|P1|NOT COMPLETED|Overall Study||26
8486366|NCT00574249|20912459|P2|COMPLETED|Overall Study||338
8486367|NCT00574249|20912460|P1|COMPLETED|Overall Study||338
8486368|NCT00574249|20912459|P2|STARTED|Overall Study||366
8486369|NCT00574249|20912460|P1|STARTED|Overall Study||364
8486370|NCT00574236|20912500|P1|NOT COMPLETED|Overall Study||0
8486371|NCT00574236|20912500|P1|COMPLETED|Overall Study||4
8486372|NCT00574236|20912500|P1|STARTED|Overall Study||4
8486373|NCT00574197|20912505|P1|NOT COMPLETED|Overall Study||5
8486374|NCT00574197|20912505|P1|COMPLETED|Overall Study||6
8486375|NCT00574197|20912505|P1|STARTED|Overall Study||11
8486376|NCT00574171|20912510|P1|NOT COMPLETED|Overall Study||0
8486377|NCT00574171|20912510|P1|COMPLETED|Overall Study||29
8486378|NCT00574171|20912510|P1|STARTED|Overall Study||29
8486379|NCT00574145|20912516|P2|NOT COMPLETED|Overall Study||1
8486380|NCT00574145|20912517|P1|NOT COMPLETED|Overall Study||2
8486381|NCT00574145|20912516|P2|COMPLETED|Overall Study||21
8486382|NCT00574145|20912517|P1|COMPLETED|Overall Study||20
8486383|NCT00574145|20912516|P2|STARTED|Overall Study||22
8486384|NCT00574145|20912517|P1|STARTED|Overall Study||22
8486385|NCT00574119|20912527|P1|NOT COMPLETED|Overall Study||4
8486386|NCT00574119|20912527|P1|COMPLETED|Overall Study||12
8486387|NCT00574119|20912527|P1|STARTED|Overall Study||16
8486388|NCT00574080|20912541|P2|NOT COMPLETED|Overall Study||10
8486389|NCT00574080|20912542|P1|NOT COMPLETED|Overall Study||10
8486390|NCT00574080|20912541|P2|COMPLETED|Overall Study||0
8486391|NCT00574080|20912542|P1|COMPLETED|Overall Study||0
8486392|NCT00574080|20912541|P2|STARTED|Overall Study||10
8486393|NCT00574080|20912542|P1|STARTED|Overall Study||10
8486394|NCT00574067|20912552|P4|NOT COMPLETED|Overall Study||0
8486395|NCT00574067|20912553|P3|NOT COMPLETED|Overall Study||0
8486396|NCT00574067|20912554|P2|NOT COMPLETED|Overall Study||1
8486397|NCT00574067|20912555|P1|NOT COMPLETED|Overall Study||1
8486398|NCT00574067|20912552|P4|COMPLETED|Overall Study||53
8486399|NCT00574067|20912553|P3|COMPLETED|Overall Study||54
8486400|NCT00574067|20912554|P2|COMPLETED|Overall Study||52
8486401|NCT00574067|20912555|P1|COMPLETED|Overall Study||52
8486402|NCT00574067|20912552|P4|STARTED|Overall Study||53
8486403|NCT00574067|20912553|P3|STARTED|Overall Study||54
8486404|NCT00574067|20912554|P2|STARTED|Overall Study||53
8486405|NCT00574067|20912555|P1|STARTED|Overall Study||53
8486406|NCT00573989|20912589|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486407|NCT00573989|20912590|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486408|NCT00573989|20912591|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486409|NCT00573989|20912592|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486410|NCT00573989|20912589|P4|COMPLETED|Erlotinib 125mg- Phase II||12
8486411|NCT00573989|20912590|P3|COMPLETED|Erlotinib 125mg- Phase II||0
8486412|NCT00573989|20912591|P2|COMPLETED|Erlotinib 125mg- Phase II||0
8486413|NCT00573989|20912592|P1|COMPLETED|Erlotinib 125mg- Phase II||0
8486414|NCT00573989|20912589|P4|STARTED|Erlotinib 125mg- Phase II||12
8486415|NCT00573989|20912590|P3|STARTED|Erlotinib 125mg- Phase II||0
8486416|NCT00573989|20912591|P2|STARTED|Erlotinib 125mg- Phase II||0
8486417|NCT00573989|20912592|P1|STARTED|Erlotinib 125mg- Phase II||0
8486418|NCT00573989|20912589|P4|NOT COMPLETED|Erlotinib Phase I||0
8486419|NCT00573989|20912590|P3|NOT COMPLETED|Erlotinib Phase I||0
8486420|NCT00573989|20912591|P2|NOT COMPLETED|Erlotinib Phase I||0
8486421|NCT00573989|20912592|P1|NOT COMPLETED|Erlotinib Phase I||0
8486422|NCT00573989|20912589|P4|COMPLETED|Erlotinib Phase I||0
8486423|NCT00573989|20912590|P3|COMPLETED|Erlotinib Phase I||5
8486424|NCT00573989|20912591|P2|COMPLETED|Erlotinib Phase I||6
8486425|NCT00573989|20912592|P1|COMPLETED|Erlotinib Phase I||4
8486426|NCT00573989|20912589|P4|STARTED|Erlotinib Phase I||0
8486427|NCT00573989|20912590|P3|STARTED|Erlotinib Phase I||5
8486428|NCT00573989|20912591|P2|STARTED|Erlotinib Phase I||6
8486429|NCT00573989|20912592|P1|STARTED|Erlotinib Phase I||4
8486430|NCT00573937|20912611|P2|NOT COMPLETED|Overall Study||1
8486431|NCT00573937|20912612|P1|NOT COMPLETED|Overall Study||0
8486432|NCT00573937|20912611|P2|COMPLETED|Overall Study||0
8486433|NCT00573937|20912612|P1|COMPLETED|Overall Study||0
8486434|NCT00573937|20912611|P2|STARTED|Overall Study||1
8486435|NCT00573937|20912612|P1|STARTED|Overall Study||0
8486436|NCT00573872|20912620|P1|NOT COMPLETED|Overall Study||11
8486437|NCT00573872|20912620|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
8486438|NCT00573872|20912620|P1|STARTED|Overall Study|# of patients that signed consent|43
8486439|NCT00573859|20912626|P1|NOT COMPLETED|Smoking Versus Abstinence||12
8486440|NCT00573859|20912626|P1|COMPLETED|Smoking Versus Abstinence||15
8486441|NCT00573859|20912626|P1|STARTED|Smoking Versus Abstinence||27
8486442|NCT00573859|20912626|P1|NOT COMPLETED|Medication Versus Placebo||12
8486443|NCT00573859|20912626|P1|COMPLETED|Medication Versus Placebo||15
8486444|NCT00573859|20912626|P1|STARTED|Medication Versus Placebo||27
8486445|NCT00573833|20912632|P1|NOT COMPLETED|Overall Study||2
8486446|NCT00573833|20912632|P1|COMPLETED|Overall Study||21
8486447|NCT00573833|20912632|P1|STARTED|Overall Study||23
8486448|NCT00573794|20912639|P1|NOT COMPLETED|Overall Study||330
8486449|NCT00573794|20912639|P1|COMPLETED|Overall Study||255
8486450|NCT00573794|20912639|P1|STARTED|Overall Study||585
8486451|NCT00573768|20912670|P3|NOT COMPLETED|Overall Study||4
8486452|NCT00573768|20912671|P2|NOT COMPLETED|Overall Study||2
8486453|NCT00573768|20912672|P1|NOT COMPLETED|Overall Study||2
8486454|NCT00573768|20912670|P3|COMPLETED|Overall Study||87
8486455|NCT00573768|20912671|P2|COMPLETED|Overall Study||89
8486456|NCT00573768|20912672|P1|COMPLETED|Overall Study||87
8486457|NCT00573768|20912670|P3|STARTED|Overall Study||91
8486458|NCT00573768|20912671|P2|STARTED|Overall Study||91
8486459|NCT00573768|20912672|P1|STARTED|Overall Study||89
8486460|NCT00573755|20912682|P2|NOT COMPLETED|Overall Study||0
8486461|NCT00573755|20912683|P1|NOT COMPLETED|Overall Study||1
8486462|NCT00573755|20912682|P2|COMPLETED|Overall Study||2
8486463|NCT00573755|20912683|P1|COMPLETED|Overall Study||1
8486464|NCT00573755|20912682|P2|STARTED|Overall Study||2
8486465|NCT00573755|20912683|P1|STARTED|Overall Study||2
8486466|NCT00573534|20912699|P1|NOT COMPLETED|Overall Study||3
8486467|NCT00573534|20912699|P1|COMPLETED|Overall Study||5
8486468|NCT00573534|20912699|P1|STARTED|Overall Study||8
8486469|NCT00573508|20912706|P2|NOT COMPLETED|Overall Study||41
8486470|NCT00573508|20912707|P1|NOT COMPLETED|Overall Study||64
8486471|NCT00573508|20912706|P2|COMPLETED|Overall Study||345
8486472|NCT00573508|20912707|P1|COMPLETED|Overall Study||318
8486473|NCT00573508|20912706|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
8486474|NCT00573508|20912707|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
8486475|NCT00573508|20912706|P2|STARTED|Overall Study||386
8486476|NCT00573508|20912707|P1|STARTED|Overall Study||382
8486477|NCT00573469|20912740|P3|NOT COMPLETED|Overall Study||4
8486478|NCT00573469|20912741|P2|NOT COMPLETED|Overall Study||4
8486479|NCT00573469|20912742|P1|NOT COMPLETED|Overall Study||6
8486480|NCT00573469|20912740|P3|COMPLETED|Overall Study||22
8486481|NCT00573469|20912741|P2|COMPLETED|Overall Study||21
8486482|NCT00573469|20912742|P1|COMPLETED|Overall Study||20
8486483|NCT00573469|20912740|P3|STARTED|Overall Study||26
8486484|NCT00573469|20912741|P2|STARTED|Overall Study||25
8486485|NCT00573469|20912742|P1|STARTED|Overall Study||26
8486486|NCT00573443|20912765|P3|NOT COMPLETED|Open-Label Extension Phase||0
8486487|NCT00573443|20912766|P2|NOT COMPLETED|Open-Label Extension Phase||0
8486488|NCT00573443|20912767|P1|NOT COMPLETED|Open-Label Extension Phase||18
8486489|NCT00573443|20912765|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486490|NCT00573443|20912766|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486491|NCT00573443|20912767|P1|COMPLETED|Open-Label Extension Phase||235
8486492|NCT00573443|20912765|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486493|NCT00573443|20912766|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486494|NCT00573443|20912767|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
8486495|NCT00573443|20912765|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486496|NCT00573443|20912766|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486497|NCT00573443|20912767|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
8486585|NCT00573170|20912913|P2|STARTED|Third Treatment Period||54
8486498|NCT00573443|20912765|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486499|NCT00573443|20912766|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486500|NCT00573443|20912767|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
8486501|NCT00573443|20912765|P3|NOT COMPLETED|Double-Blind Phase||15
8486502|NCT00573443|20912766|P2|NOT COMPLETED|Double-Blind Phase||19
8486503|NCT00573443|20912767|P1|NOT COMPLETED|Double-Blind Phase||9
8486504|NCT00573443|20912765|P3|COMPLETED|Double-Blind Phase||94
8486505|NCT00573443|20912766|P2|COMPLETED|Double-Blind Phase||88
8486506|NCT00573443|20912767|P1|COMPLETED|Double-Blind Phase||101
8486507|NCT00573443|20912765|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
8486508|NCT00573443|20912766|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
8486509|NCT00573443|20912767|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
8486510|NCT00573443|20912765|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
8486511|NCT00573443|20912766|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
8486512|NCT00573443|20912767|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
8486513|NCT00573443|20912765|P3|STARTED|Double-Blind Phase||109
8486514|NCT00573443|20912766|P2|STARTED|Double-Blind Phase||107
8486515|NCT00573443|20912767|P1|STARTED|Double-Blind Phase||110
8486516|NCT00573430|20912797|P3|NOT COMPLETED|Overall Study||10
8486517|NCT00573430|20912798|P2|NOT COMPLETED|Overall Study||5
8486518|NCT00573430|20912799|P1|NOT COMPLETED|Overall Study||1
8486519|NCT00573430|20912797|P3|COMPLETED|Overall Study||33
8486520|NCT00573430|20912798|P2|COMPLETED|Overall Study||40
8486521|NCT00573430|20912799|P1|COMPLETED|Overall Study||39
8486522|NCT00573430|20912797|P3|STARTED|Overall Study|randomized|43
8486523|NCT00573430|20912798|P2|STARTED|Overall Study|randomized|45
8486524|NCT00573430|20912799|P1|STARTED|Overall Study|randomized|40
8486525|NCT00573391|20912821|P2|NOT COMPLETED|Overall Study||2
8486526|NCT00573391|20912822|P1|NOT COMPLETED|Overall Study||3
8486527|NCT00573391|20912821|P2|COMPLETED|Overall Study||0
8486528|NCT00573391|20912822|P1|COMPLETED|Overall Study||0
8486529|NCT00573391|20912821|P2|STARTED|Overall Study||2
8486530|NCT00573391|20912822|P1|STARTED|Overall Study||3
8486531|NCT00573313|20912832|P4|NOT COMPLETED|Overall Study||0
8486532|NCT00573313|20912833|P3|NOT COMPLETED|Overall Study||6
8486533|NCT00573313|20912834|P2|NOT COMPLETED|Overall Study||0
8486534|NCT00573313|20912835|P1|NOT COMPLETED|Overall Study||5
8486535|NCT00573313|20912832|P4|COMPLETED|Overall Study||26
8486536|NCT00573313|20912833|P3|COMPLETED|Overall Study||13
8486537|NCT00573313|20912834|P2|COMPLETED|Overall Study||28
8486538|NCT00573313|20912835|P1|COMPLETED|Overall Study||13
8486539|NCT00573313|20912832|P4|STARTED|Overall Study||26
8486540|NCT00573313|20912833|P3|STARTED|Overall Study|Nineteen recruited to start.|19
8486541|NCT00573313|20912834|P2|STARTED|Overall Study||28
8486542|NCT00573313|20912835|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
8486543|NCT00573287|20912845|P2|NOT COMPLETED|Overall Study||3
8486544|NCT00573287|20912846|P1|NOT COMPLETED|Overall Study||4
8486545|NCT00573287|20912845|P2|COMPLETED|Overall Study||4
8486546|NCT00573287|20912846|P1|COMPLETED|Overall Study||3
8486547|NCT00573287|20912845|P2|STARTED|Overall Study||7
8486548|NCT00573287|20912846|P1|STARTED|Overall Study||7
8486549|NCT00573261|20912856|P2|NOT COMPLETED|Overall Study||5
8486550|NCT00573261|20912857|P1|NOT COMPLETED|Overall Study||6
8486551|NCT00573261|20912856|P2|COMPLETED|Overall Study||15
8486552|NCT00573261|20912857|P1|COMPLETED|Overall Study||14
8486553|NCT00573261|20912856|P2|STARTED|Overall Study||20
8486554|NCT00573261|20912857|P1|STARTED|Overall Study||20
8486555|NCT00573248|20912885|P2|NOT COMPLETED|Overall Study||11
8486556|NCT00573248|20912886|P1|NOT COMPLETED|Overall Study||15
8486557|NCT00573248|20912885|P2|COMPLETED|Overall Study||27
8486558|NCT00573248|20912886|P1|COMPLETED|Overall Study||25
8486559|NCT00573248|20912885|P2|Nicotine Patches and Placebo Patches|Overall Study||27
8486560|NCT00573248|20912886|P1|Nicotine Patches and Placebo Patches|Overall Study||25
8486561|NCT00573248|20912885|P2|STARTED|Overall Study||38
8486562|NCT00573248|20912886|P1|STARTED|Overall Study||40
8486563|NCT00573183|20912900|P2|NOT COMPLETED|Overall Study||63
8486564|NCT00573183|20912901|P1|NOT COMPLETED|Overall Study||72
8486565|NCT00573183|20912900|P2|COMPLETED|Overall Study||174
8486566|NCT00573183|20912901|P1|COMPLETED|Overall Study||162
8486567|NCT00573183|20912900|P2|STARTED|Overall Study||237
8486568|NCT00573183|20912901|P1|STARTED|Overall Study||234
8486569|NCT00573170|20912909|P6|NOT COMPLETED|Third Treatment Period||2
8486570|NCT00573170|20912910|P5|NOT COMPLETED|Third Treatment Period||0
8486571|NCT00573170|20912911|P4|NOT COMPLETED|Third Treatment Period||0
8486572|NCT00573170|20912912|P3|NOT COMPLETED|Third Treatment Period||0
8486573|NCT00573170|20912913|P2|NOT COMPLETED|Third Treatment Period||0
8486574|NCT00573170|20912914|P1|NOT COMPLETED|Third Treatment Period||1
8486575|NCT00573170|20912909|P6|COMPLETED|Third Treatment Period||51
8486576|NCT00573170|20912910|P5|COMPLETED|Third Treatment Period||51
8486577|NCT00573170|20912911|P4|COMPLETED|Third Treatment Period||56
8486578|NCT00573170|20912912|P3|COMPLETED|Third Treatment Period||55
8486579|NCT00573170|20912913|P2|COMPLETED|Third Treatment Period||54
8486580|NCT00573170|20912914|P1|COMPLETED|Third Treatment Period||50
8486581|NCT00573170|20912909|P6|STARTED|Third Treatment Period||53
8486582|NCT00573170|20912910|P5|STARTED|Third Treatment Period||51
8486583|NCT00573170|20912911|P4|STARTED|Third Treatment Period||56
8486584|NCT00573170|20912912|P3|STARTED|Third Treatment Period||55
8486586|NCT00573170|20912914|P1|STARTED|Third Treatment Period||51
8486587|NCT00573170|20912909|P6|NOT COMPLETED|Second Washout Period||2
8486588|NCT00573170|20912910|P5|NOT COMPLETED|Second Washout Period||8
8486589|NCT00573170|20912911|P4|NOT COMPLETED|Second Washout Period||5
8486590|NCT00573170|20912912|P3|NOT COMPLETED|Second Washout Period||4
8486591|NCT00573170|20912913|P2|NOT COMPLETED|Second Washout Period||4
8486592|NCT00573170|20912914|P1|NOT COMPLETED|Second Washout Period||5
8486593|NCT00573170|20912909|P6|COMPLETED|Second Washout Period||53
8486594|NCT00573170|20912910|P5|COMPLETED|Second Washout Period||51
8486595|NCT00573170|20912911|P4|COMPLETED|Second Washout Period||56
8486596|NCT00573170|20912912|P3|COMPLETED|Second Washout Period||55
8486597|NCT00573170|20912913|P2|COMPLETED|Second Washout Period||54
8486598|NCT00573170|20912914|P1|COMPLETED|Second Washout Period||51
8486599|NCT00573170|20912909|P6|STARTED|Second Washout Period||55
8486600|NCT00573170|20912910|P5|STARTED|Second Washout Period||59
8486601|NCT00573170|20912911|P4|STARTED|Second Washout Period||61
8486602|NCT00573170|20912912|P3|STARTED|Second Washout Period||59
8486603|NCT00573170|20912913|P2|STARTED|Second Washout Period||58
8486604|NCT00573170|20912914|P1|STARTED|Second Washout Period||56
8486605|NCT00573170|20912909|P6|NOT COMPLETED|Second Treatment Period||0
8486606|NCT00573170|20912910|P5|NOT COMPLETED|Second Treatment Period||0
8486607|NCT00573170|20912911|P4|NOT COMPLETED|Second Treatment Period||0
8486608|NCT00573170|20912912|P3|NOT COMPLETED|Second Treatment Period||0
8486609|NCT00573170|20912913|P2|NOT COMPLETED|Second Treatment Period||0
8486610|NCT00573170|20912914|P1|NOT COMPLETED|Second Treatment Period||0
8486611|NCT00573170|20912909|P6|COMPLETED|Second Treatment Period||55
8486612|NCT00573170|20912910|P5|COMPLETED|Second Treatment Period||59
8486613|NCT00573170|20912911|P4|COMPLETED|Second Treatment Period||61
8486614|NCT00573170|20912912|P3|COMPLETED|Second Treatment Period||59
8486615|NCT00573170|20912913|P2|COMPLETED|Second Treatment Period||58
8486616|NCT00573170|20912914|P1|COMPLETED|Second Treatment Period||56
8486617|NCT00573170|20912909|P6|STARTED|Second Treatment Period||55
8486618|NCT00573170|20912910|P5|STARTED|Second Treatment Period||59
8486619|NCT00573170|20912911|P4|STARTED|Second Treatment Period||61
8486620|NCT00573170|20912912|P3|STARTED|Second Treatment Period||59
8486621|NCT00573170|20912913|P2|STARTED|Second Treatment Period||58
8486622|NCT00573170|20912914|P1|STARTED|Second Treatment Period||56
8486623|NCT00573170|20912909|P6|NOT COMPLETED|First Washout Period||7
8486624|NCT00573170|20912910|P5|NOT COMPLETED|First Washout Period||3
8486625|NCT00573170|20912911|P4|NOT COMPLETED|First Washout Period||5
8486626|NCT00573170|20912912|P3|NOT COMPLETED|First Washout Period||1
8486627|NCT00573170|20912913|P2|NOT COMPLETED|First Washout Period||2
8486628|NCT00573170|20912914|P1|NOT COMPLETED|First Washout Period||8
8486629|NCT00573170|20912909|P6|COMPLETED|First Washout Period||55
8486630|NCT00573170|20912910|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
8486631|NCT00573170|20912911|P4|COMPLETED|First Washout Period||61
8486632|NCT00573170|20912912|P3|COMPLETED|First Washout Period||59
8486633|NCT00573170|20912913|P2|COMPLETED|First Washout Period||58
8486634|NCT00573170|20912914|P1|COMPLETED|First Washout Period||56
8486635|NCT00573170|20912909|P6|STARTED|First Washout Period||62
8486636|NCT00573170|20912910|P5|STARTED|First Washout Period||62
8486637|NCT00573170|20912911|P4|STARTED|First Washout Period||66
8486638|NCT00573170|20912912|P3|STARTED|First Washout Period||60
8486639|NCT00573170|20912913|P2|STARTED|First Washout Period||60
8486640|NCT00573170|20912914|P1|STARTED|First Washout Period||64
8486641|NCT00573170|20912909|P6|NOT COMPLETED|First Treatment Period||0
8486642|NCT00573170|20912910|P5|NOT COMPLETED|First Treatment Period||1
8486643|NCT00573170|20912911|P4|NOT COMPLETED|First Treatment Period||0
8486644|NCT00573170|20912912|P3|NOT COMPLETED|First Treatment Period||0
8486645|NCT00573170|20912913|P2|NOT COMPLETED|First Treatment Period||0
8486646|NCT00573170|20912914|P1|NOT COMPLETED|First Treatment Period||0
8486647|NCT00573170|20912909|P6|COMPLETED|First Treatment Period||62
8486648|NCT00573170|20912910|P5|COMPLETED|First Treatment Period||62
8486649|NCT00573170|20912911|P4|COMPLETED|First Treatment Period||66
8486650|NCT00573170|20912912|P3|COMPLETED|First Treatment Period||60
8486651|NCT00573170|20912913|P2|COMPLETED|First Treatment Period||60
8486652|NCT00573170|20912914|P1|COMPLETED|First Treatment Period||64
8486653|NCT00573170|20912909|P6|STARTED|First Treatment Period||62
8486654|NCT00573170|20912910|P5|STARTED|First Treatment Period||63
8486655|NCT00573170|20912911|P4|STARTED|First Treatment Period||66
8486656|NCT00573170|20912912|P3|STARTED|First Treatment Period||60
8486657|NCT00573170|20912913|P2|STARTED|First Treatment Period||60
8486658|NCT00573170|20912914|P1|STARTED|First Treatment Period||64
8486659|NCT00573157|20912990|P2|NOT COMPLETED|Overall Study||2
8486660|NCT00573157|20912991|P1|NOT COMPLETED|Overall Study||4
8486661|NCT00573157|20912990|P2|COMPLETED|Overall Study||0
8486662|NCT00573157|20912991|P1|COMPLETED|Overall Study||0
8486663|NCT00573157|20912990|P2|STARTED|Overall Study||2
8486664|NCT00573157|20912991|P1|STARTED|Overall Study||4
8486665|NCT00573144|20913003|P2|NOT COMPLETED|Overall Study||3
8486666|NCT00573144|20913004|P1|NOT COMPLETED|Overall Study||2
8486667|NCT00573144|20913003|P2|COMPLETED|Overall Study||25
8486668|NCT00573144|20913004|P1|COMPLETED|Overall Study||28
8486669|NCT00573144|20913003|P2|STARTED|Overall Study||28
8486670|NCT00573144|20913004|P1|STARTED|Overall Study||30
8486671|NCT00573131|20913016|P2|NOT COMPLETED|Overall Study||8
8486672|NCT00573131|20913017|P1|NOT COMPLETED|Overall Study||10
8486673|NCT00573131|20913016|P2|COMPLETED|Overall Study||57
8486674|NCT00573131|20913017|P1|COMPLETED|Overall Study||62
8486675|NCT00573131|20913016|P2|STARTED|Overall Study||65
8486676|NCT00573131|20913017|P1|STARTED|Overall Study||72
8486677|NCT00573066|20913023|P1|NOT COMPLETED|Overall Study||20
8486678|NCT00573066|20913023|P1|COMPLETED|Overall Study||36
8486679|NCT00573066|20913023|P1|STARTED|Overall Study||56
8486680|NCT00572936|20913027|P6|NOT COMPLETED|Third Intervention||0
8486681|NCT00572936|20913028|P5|NOT COMPLETED|Third Intervention||0
8486682|NCT00572936|20913029|P4|NOT COMPLETED|Third Intervention||0
8486683|NCT00572936|20913030|P3|NOT COMPLETED|Third Intervention||0
8486684|NCT00572936|20913031|P2|NOT COMPLETED|Third Intervention||0
8486685|NCT00572936|20913032|P1|NOT COMPLETED|Third Intervention||0
8486686|NCT00572936|20913027|P6|COMPLETED|Third Intervention||5
8486687|NCT00572936|20913028|P5|COMPLETED|Third Intervention||3
8486688|NCT00572936|20913029|P4|COMPLETED|Third Intervention||5
8486689|NCT00572936|20913030|P3|COMPLETED|Third Intervention||4
8486690|NCT00572936|20913031|P2|COMPLETED|Third Intervention||3
8486691|NCT00572936|20913032|P1|COMPLETED|Third Intervention||4
8486692|NCT00572936|20913027|P6|STARTED|Third Intervention||5
8486693|NCT00572936|20913028|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
8486694|NCT00572936|20913029|P4|STARTED|Third Intervention||5
8486695|NCT00572936|20913030|P3|STARTED|Third Intervention||4
8486696|NCT00572936|20913031|P2|STARTED|Third Intervention||3
8486697|NCT00572936|20913032|P1|STARTED|Third Intervention||4
8486698|NCT00572936|20913027|P6|NOT COMPLETED|Second Intervention||0
8486699|NCT00572936|20913028|P5|NOT COMPLETED|Second Intervention||0
8486700|NCT00572936|20913029|P4|NOT COMPLETED|Second Intervention||0
8486701|NCT00572936|20913030|P3|NOT COMPLETED|Second Intervention||0
8486702|NCT00572936|20913031|P2|NOT COMPLETED|Second Intervention||0
8486703|NCT00572936|20913032|P1|NOT COMPLETED|Second Intervention||0
8486704|NCT00572936|20913027|P6|COMPLETED|Second Intervention||5
8486705|NCT00572936|20913028|P5|COMPLETED|Second Intervention||4
8486706|NCT00572936|20913029|P4|COMPLETED|Second Intervention||5
8486707|NCT00572936|20913030|P3|COMPLETED|Second Intervention||4
8486708|NCT00572936|20913031|P2|COMPLETED|Second Intervention||3
8486709|NCT00572936|20913032|P1|COMPLETED|Second Intervention||4
8486710|NCT00572936|20913027|P6|STARTED|Second Intervention||5
8486711|NCT00572936|20913028|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
8486712|NCT00572936|20913029|P4|STARTED|Second Intervention||5
8486713|NCT00572936|20913030|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
8486714|NCT00572936|20913031|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
8486715|NCT00572936|20913032|P1|STARTED|Second Intervention||4
8486716|NCT00572936|20913027|P6|NOT COMPLETED|First Intervention||0
8486717|NCT00572936|20913028|P5|NOT COMPLETED|First Intervention||0
8486718|NCT00572936|20913029|P4|NOT COMPLETED|First Intervention||0
8486719|NCT00572936|20913030|P3|NOT COMPLETED|First Intervention||0
8486720|NCT00572936|20913031|P2|NOT COMPLETED|First Intervention||0
8486721|NCT00572936|20913032|P1|NOT COMPLETED|First Intervention||0
8486722|NCT00572936|20913027|P6|COMPLETED|First Intervention||5
8486723|NCT00572936|20913028|P5|COMPLETED|First Intervention||5
8486724|NCT00572936|20913029|P4|COMPLETED|First Intervention||5
8486725|NCT00572936|20913030|P3|COMPLETED|First Intervention||5
8486726|NCT00572936|20913031|P2|COMPLETED|First Intervention||4
8486727|NCT00572936|20913032|P1|COMPLETED|First Intervention||4
8486728|NCT00572936|20913027|P6|STARTED|First Intervention||5
8486729|NCT00572936|20913028|P5|STARTED|First Intervention||5
8486730|NCT00572936|20913029|P4|STARTED|First Intervention||5
8486731|NCT00572936|20913030|P3|STARTED|First Intervention||5
8486732|NCT00572936|20913031|P2|STARTED|First Intervention||4
8486733|NCT00572936|20913032|P1|STARTED|First Intervention||4
8486734|NCT00572910|20913067|P11|NOT COMPLETED|Overall Study||3
8486735|NCT00572910|20913068|P10|NOT COMPLETED|Overall Study||6
8486736|NCT00572910|20913069|P9|NOT COMPLETED|Overall Study||3
8486737|NCT00572910|20913070|P8|NOT COMPLETED|Overall Study||4
8486738|NCT00572910|20913071|P7|NOT COMPLETED|Overall Study||4
8486739|NCT00572910|20913072|P6|NOT COMPLETED|Overall Study||3
8486740|NCT00572910|20913073|P5|NOT COMPLETED|Overall Study||2
8486741|NCT00572910|20913074|P4|NOT COMPLETED|Overall Study||4
8486742|NCT00572910|20913075|P3|NOT COMPLETED|Overall Study||2
8486743|NCT00572910|20913076|P2|NOT COMPLETED|Overall Study||3
8486744|NCT00572910|20913077|P1|NOT COMPLETED|Overall Study||4
8486745|NCT00572910|20913067|P11|COMPLETED|Overall Study||15
8486746|NCT00572910|20913068|P10|COMPLETED|Overall Study||13
8486747|NCT00572910|20913069|P9|COMPLETED|Overall Study||16
8486748|NCT00572910|20913070|P8|COMPLETED|Overall Study||15
8486749|NCT00572910|20913071|P7|COMPLETED|Overall Study||15
8486750|NCT00572910|20913072|P6|COMPLETED|Overall Study||16
8486751|NCT00572910|20913073|P5|COMPLETED|Overall Study||17
8486752|NCT00572910|20913074|P4|COMPLETED|Overall Study||14
8486753|NCT00572910|20913075|P3|COMPLETED|Overall Study||17
8486754|NCT00572910|20913076|P2|COMPLETED|Overall Study||15
8486755|NCT00572910|20913077|P1|COMPLETED|Overall Study||15
8486756|NCT00572910|20913067|P11|STARTED|Overall Study||18
8486757|NCT00572910|20913068|P10|STARTED|Overall Study||19
8486758|NCT00572910|20913069|P9|STARTED|Overall Study||19
8486759|NCT00572910|20913070|P8|STARTED|Overall Study||19
8486760|NCT00572910|20913071|P7|STARTED|Overall Study||19
8486761|NCT00572910|20913072|P6|STARTED|Overall Study||19
8486762|NCT00572910|20913073|P5|STARTED|Overall Study||19
8486763|NCT00572910|20913074|P4|STARTED|Overall Study||18
8486764|NCT00572910|20913075|P3|STARTED|Overall Study||19
8486765|NCT00572910|20913076|P2|STARTED|Overall Study||18
8486766|NCT00572910|20913077|P1|STARTED|Overall Study||19
8486767|NCT00572897|20913125|P2|NOT COMPLETED|Overall Study||0
8486768|NCT00572897|20913126|P1|NOT COMPLETED|Overall Study||0
8486769|NCT00572897|20913125|P2|COMPLETED|Overall Study||34
8486770|NCT00572897|20913126|P1|COMPLETED|Overall Study||32
8486771|NCT00572897|20913125|P2|STARTED|Overall Study||34
8486772|NCT00572897|20913126|P1|STARTED|Overall Study||32
8486773|NCT00572832|20913144|P2|NOT COMPLETED|Overall Study||12
8486774|NCT00572832|20913145|P1|NOT COMPLETED|Overall Study||0
8486775|NCT00572832|20913144|P2|COMPLETED|Overall Study||88
8486776|NCT00572832|20913145|P1|COMPLETED|Overall Study||100
8486777|NCT00572832|20913144|P2|STARTED|Overall Study||100
8486778|NCT00572832|20913145|P1|STARTED|Overall Study||100
8486779|NCT00572728|20913151|P1|NOT COMPLETED|Overall Study||39
8486780|NCT00572728|20913151|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
8486781|NCT00572728|20913151|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
8486782|NCT00572728|20913151|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
8486783|NCT00572728|20913151|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
8486784|NCT00572728|20913151|P1|Pathology Complete|Overall Study||51
8486785|NCT00572728|20913151|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
8486786|NCT00572728|20913151|P1|Second Chemotherapy Initiated|Overall Study||59
8486787|NCT00572728|20913151|P1|Completed FLT2 Scan|Overall Study||60
8486788|NCT00572728|20913151|P1|First Therapy Initiated|Overall Study||65
8486789|NCT00572728|20913151|P1|Completed FLT1 Scan|Overall Study||67
8486790|NCT00572728|20913151|P1|On Study|Overall Study||71
8486791|NCT00572728|20913151|P1|Did Not Withdraw|Overall Study||72
8486792|NCT00572728|20913151|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
8486793|NCT00572728|20913151|P1|Eligible|Overall Study||87
8486794|NCT00572728|20913151|P1|STARTED|Overall Study|Registered|90
8486795|NCT00572624|20913165|P2|NOT COMPLETED|Overall Study||4
8486796|NCT00572624|20913166|P1|NOT COMPLETED|Overall Study||17
8486797|NCT00572624|20913165|P2|COMPLETED|Overall Study||10
8486798|NCT00572624|20913166|P1|COMPLETED|Overall Study||20
8486799|NCT00572624|20913165|P2|STARTED|Overall Study||14
8486800|NCT00572624|20913166|P1|STARTED|Overall Study||37
8486801|NCT00572572|20913194|P2|NOT COMPLETED|Overall Study||6
8486802|NCT00572572|20913195|P1|NOT COMPLETED|Overall Study||3
8486803|NCT00572572|20913194|P2|COMPLETED|Overall Study||28
8486804|NCT00572572|20913195|P1|COMPLETED|Overall Study||32
8486805|NCT00572572|20913194|P2|STARTED|Overall Study||34
8486806|NCT00572572|20913195|P1|STARTED|Overall Study||35
8486807|NCT00572533|20913213|P2|NOT COMPLETED|Overall Study||3
8486808|NCT00572533|20913214|P1|NOT COMPLETED|Overall Study||7
8486809|NCT00572533|20913213|P2|COMPLETED|Overall Study||28
8486810|NCT00572533|20913214|P1|COMPLETED|Overall Study||24
8486811|NCT00572533|20913213|P2|STARTED|Overall Study||31
8486812|NCT00572533|20913214|P1|STARTED|Overall Study||31
8486813|NCT00572468|20913236|P2|NOT COMPLETED|Overall Study||4
8486814|NCT00572468|20913237|P1|NOT COMPLETED|Overall Study||2
8486815|NCT00572468|20913236|P2|COMPLETED|Overall Study||16
8486816|NCT00572468|20913237|P1|COMPLETED|Overall Study||20
8486817|NCT00572468|20913236|P2|STARTED|Overall Study||20
8486818|NCT00572468|20913237|P1|STARTED|Overall Study||22
8486819|NCT00572260|20913245|P1|NOT COMPLETED|Overall Study||0
8486820|NCT00572260|20913245|P1|COMPLETED|Overall Study||11
8486821|NCT00572260|20913245|P1|STARTED|Overall Study||11
8486822|NCT00572234|20913251|P2|NOT COMPLETED|Overall Study||5
8486823|NCT00572234|20913252|P1|NOT COMPLETED|Overall Study||1
8486824|NCT00572234|20913251|P2|COMPLETED|Overall Study||16
8486825|NCT00572234|20913252|P1|COMPLETED|Overall Study||18
8486826|NCT00572234|20913251|P2|STARTED|Overall Study||21
8486827|NCT00572234|20913252|P1|STARTED|Overall Study||19
8486828|NCT00572195|20913258|P1|NOT COMPLETED|Overall Study||68
8486829|NCT00572195|20913258|P1|COMPLETED|Overall Study||162
8486830|NCT00572195|20913258|P1|STARTED|Overall Study||230
8486831|NCT00572156|20913270|P4|NOT COMPLETED|Overall Study||25
8486832|NCT00572156|20913271|P3|NOT COMPLETED|Overall Study||27
8486833|NCT00572156|20913272|P2|NOT COMPLETED|Overall Study||26
8486834|NCT00572156|20913273|P1|NOT COMPLETED|Overall Study||26
8486835|NCT00572156|20913270|P4|COMPLETED|Overall Study||1
8486836|NCT00572156|20913271|P3|COMPLETED|Overall Study||0
8486837|NCT00572156|20913272|P2|COMPLETED|Overall Study||1
8486838|NCT00572156|20913273|P1|COMPLETED|Overall Study||0
8486839|NCT00572156|20913270|P4|STARTED|Overall Study||26
8486840|NCT00572156|20913271|P3|STARTED|Overall Study||27
8486841|NCT00572156|20913272|P2|STARTED|Overall Study||27
8486842|NCT00572156|20913273|P1|STARTED|Overall Study||26
8486843|NCT00572117|20913333|P2|NOT COMPLETED|Overall Study||2
8486844|NCT00572117|20913334|P1|NOT COMPLETED|Overall Study||2
8486845|NCT00572117|20913333|P2|COMPLETED|Overall Study||5
8486846|NCT00572117|20913334|P1|COMPLETED|Overall Study||3
8486847|NCT00572117|20913333|P2|STARTED|Overall Study||7
8486848|NCT00572117|20913334|P1|STARTED|Overall Study||5
8486849|NCT00572039|20913344|P2|NOT COMPLETED|Overall Study||10
8486850|NCT00572039|20913345|P1|NOT COMPLETED|Overall Study||16
8486851|NCT00572039|20913344|P2|COMPLETED|Overall Study||110
8486852|NCT00572039|20913345|P1|COMPLETED|Overall Study||105
8486853|NCT00572039|20913344|P2|STARTED|Overall Study||120
8486854|NCT00572039|20913345|P1|STARTED|Overall Study||121
8486855|NCT00571987|20913357|P1|NOT COMPLETED|Overall Study||7
8486856|NCT00571987|20913357|P1|COMPLETED|Overall Study||100
8486857|NCT00571987|20913357|P1|STARTED|Overall Study||107
8486858|NCT00571974|20913364|P2|NOT COMPLETED|Phase II||4
8486859|NCT00571974|20913365|P1|NOT COMPLETED|Phase II||0
8486860|NCT00571974|20913364|P2|COMPLETED|Phase II||17
8486861|NCT00571974|20913365|P1|COMPLETED|Phase II||0
8486862|NCT00571974|20913364|P2|STARTED|Phase II|3 participants are from phase I|21
8486863|NCT00571974|20913365|P1|STARTED|Phase II||0
8486864|NCT00571974|20913364|P2|NOT COMPLETED|Phase I||0
8486865|NCT00571974|20913365|P1|NOT COMPLETED|Phase I||0
8486866|NCT00571974|20913364|P2|COMPLETED|Phase I||0
8486867|NCT00571974|20913365|P1|COMPLETED|Phase I||9
8486868|NCT00571974|20913364|P2|STARTED|Phase I||0
8486869|NCT00571974|20913365|P1|STARTED|Phase I||9
8486870|NCT00571961|20913371|P1|NOT COMPLETED|Overall Study||0
8486871|NCT00571961|20913371|P1|COMPLETED|Overall Study||12
8486872|NCT00571961|20913371|P1|STARTED|Overall Study||12
8486873|NCT00571948|20913377|P2|NOT COMPLETED|Overall Study||14
8486874|NCT00571948|20913378|P1|NOT COMPLETED|Overall Study||11
8486875|NCT00571948|20913377|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
8486876|NCT00571948|20913378|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
8486877|NCT00571948|20913377|P2|STARTED|Overall Study||66
8486878|NCT00571948|20913378|P1|STARTED|Overall Study||66
8486879|NCT00571922|20913386|P2|NOT COMPLETED|Overall Study||36
8486880|NCT00571922|20913387|P1|NOT COMPLETED|Overall Study||36
8486881|NCT00571922|20913386|P2|COMPLETED|Overall Study||0
8486882|NCT00571922|20913387|P1|COMPLETED|Overall Study||0
8486883|NCT00571922|20913386|P2|STARTED|Overall Study||36
8486884|NCT00571922|20913387|P1|STARTED|Overall Study||36
8486885|NCT00571701|20913397|P2|NOT COMPLETED|Second Intervention 12 Months||1
8486886|NCT00571701|20913398|P1|NOT COMPLETED|Second Intervention 12 Months||3
8486887|NCT00571701|20913397|P2|COMPLETED|Second Intervention 12 Months||20
8486888|NCT00571701|20913398|P1|COMPLETED|Second Intervention 12 Months||13
8486889|NCT00571701|20913397|P2|STARTED|Second Intervention 12 Months||21
8486890|NCT00571701|20913398|P1|STARTED|Second Intervention 12 Months||16
8486891|NCT00571701|20913397|P2|NOT COMPLETED|First Intervention 12 Months||1
8486892|NCT00571701|20913398|P1|NOT COMPLETED|First Intervention 12 Months||3
8486893|NCT00571701|20913397|P2|COMPLETED|First Intervention 12 Months||21
8486894|NCT00571701|20913398|P1|COMPLETED|First Intervention 12 Months||16
8486895|NCT00571701|20913397|P2|STARTED|First Intervention 12 Months||22
8486896|NCT00571701|20913398|P1|STARTED|First Intervention 12 Months||19
8486897|NCT00571688|20913424|P2|NOT COMPLETED|Overall Study||6
8486898|NCT00571688|20913425|P1|NOT COMPLETED|Overall Study||5
8486899|NCT00571688|20913424|P2|COMPLETED|Overall Study||19
8486900|NCT00571688|20913425|P1|COMPLETED|Overall Study||20
8486901|NCT00571688|20913424|P2|STARTED|Overall Study||25
8486902|NCT00571688|20913425|P1|STARTED|Overall Study||25
8486903|NCT00571662|20913431|P1|NOT COMPLETED|Overall Study||8
8486904|NCT00571662|20913431|P1|COMPLETED|Overall Study||68
8486905|NCT00571662|20913431|P1|STARTED|Overall Study||76
8486906|NCT00571649|20913442|P2|NOT COMPLETED|Follow-up Period||528
8486907|NCT00571649|20913443|P1|NOT COMPLETED|Follow-up Period||545
8486908|NCT00571649|20913442|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
8486909|NCT00571649|20913443|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
8486910|NCT00571649|20913442|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
8486911|NCT00571649|20913443|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
8486912|NCT00571649|20913442|P2|NOT COMPLETED|Treatment Period||1004
8486913|NCT00571649|20913443|P1|NOT COMPLETED|Treatment Period||1092
8486914|NCT00571649|20913442|P2|COMPLETED|Treatment Period||3047
8486915|NCT00571649|20913443|P1|COMPLETED|Treatment Period||2958
8486916|NCT00571649|20913442|P2|Day 35|Treatment Period||3115
8486917|NCT00571649|20913443|P1|Day 35|Treatment Period||3033
8486918|NCT00571649|20913442|P2|Day 10|Treatment Period||3499
8486919|NCT00571649|20913443|P1|Day 10|Treatment Period||3454
8486920|NCT00571649|20913442|P2|Participants Received Treatment|Treatment Period||4001
8486921|NCT00571649|20913443|P1|Participants Received Treatment|Treatment Period||3997
8486922|NCT00571649|20913442|P2|STARTED|Treatment Period||4051
8486923|NCT00571649|20913443|P1|STARTED|Treatment Period||4050
8486924|NCT00571493|20913475|P7|NOT COMPLETED|Overall Study||0
8486925|NCT00571493|20913476|P6|NOT COMPLETED|Overall Study||0
8486926|NCT00571493|20913477|P5|NOT COMPLETED|Overall Study||0
8486927|NCT00571493|20913478|P4|NOT COMPLETED|Overall Study||0
8486928|NCT00571493|20913479|P3|NOT COMPLETED|Overall Study||0
8486929|NCT00571493|20913480|P2|NOT COMPLETED|Overall Study||0
8486930|NCT00571493|20913481|P1|NOT COMPLETED|Overall Study||0
8486931|NCT00571493|20913475|P7|COMPLETED|Overall Study||6
8486932|NCT00571493|20913476|P6|COMPLETED|Overall Study||12
8486933|NCT00571493|20913477|P5|COMPLETED|Overall Study||11
8486934|NCT00571493|20913478|P4|COMPLETED|Overall Study||3
8486935|NCT00571493|20913479|P3|COMPLETED|Overall Study||3
8486936|NCT00571493|20913480|P2|COMPLETED|Overall Study||4
8486937|NCT00571493|20913481|P1|COMPLETED|Overall Study||3
8486938|NCT00571493|20913475|P7|STARTED|Overall Study||6
8486939|NCT00571493|20913476|P6|STARTED|Overall Study||12
8486940|NCT00571493|20913477|P5|STARTED|Overall Study||11
8486941|NCT00571493|20913478|P4|STARTED|Overall Study||3
8486942|NCT00571493|20913479|P3|STARTED|Overall Study||3
8486943|NCT00571493|20913480|P2|STARTED|Overall Study||4
8486944|NCT00571493|20913481|P1|STARTED|Overall Study||3
8486945|NCT00571428|20913491|P2|NOT COMPLETED|Overall Study||0
8486946|NCT00571428|20913492|P1|NOT COMPLETED|Overall Study||0
8486947|NCT00571428|20913491|P2|COMPLETED|Overall Study||18
8486948|NCT00571428|20913492|P1|COMPLETED|Overall Study||15
8486949|NCT00571428|20913491|P2|STARTED|Overall Study||18
8486950|NCT00571428|20913492|P1|STARTED|Overall Study||15
8486951|NCT00571324|20913524|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
8486952|NCT00571324|20913525|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
8486953|NCT00571324|20913524|P2|COMPLETED|Intervention 2 (7 Hours)||4
8486954|NCT00571324|20913525|P1|COMPLETED|Intervention 2 (7 Hours)||5
8486955|NCT00571324|20913524|P2|STARTED|Intervention 2 (7 Hours)||4
8486956|NCT00571324|20913525|P1|STARTED|Intervention 2 (7 Hours)||5
8486957|NCT00571324|20913524|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
8486958|NCT00571324|20913525|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
8486959|NCT00571324|20913524|P2|COMPLETED|Intervention 1 (7 Hours)||4
8486960|NCT00571324|20913525|P1|COMPLETED|Intervention 1 (7 Hours)||5
8486961|NCT00571324|20913524|P2|STARTED|Intervention 1 (7 Hours)||4
8486962|NCT00571324|20913525|P1|STARTED|Intervention 1 (7 Hours)||5
8486963|NCT00571194|20913537|P1|NOT COMPLETED|Overall Study||0
8486964|NCT00571194|20913537|P1|COMPLETED|Overall Study||7
8486965|NCT00571194|20913537|P1|STARTED|Overall Study||7
8486966|NCT00571103|20913541|P1|NOT COMPLETED|Overall Study||2
8486967|NCT00571103|20913541|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
8486968|NCT00571103|20913541|P1|STARTED|Overall Study||28
8486969|NCT00571064|20913546|P1|NOT COMPLETED|Overall Study||21
8486970|NCT00571064|20913546|P1|COMPLETED|Overall Study||76
8486971|NCT00571064|20913546|P1|STARTED|Overall Study||97
8486972|NCT00571038|20913561|P2|NOT COMPLETED|Overall Study||14
8486973|NCT00571038|20913562|P1|NOT COMPLETED|Overall Study||11
8486974|NCT00571038|20913561|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
8486975|NCT00571038|20913562|P1|COMPLETED|Overall Study|"7 died 2 moved
~1 asked to be withdrawn
~1 unable to reach"|208
8486976|NCT00571038|20913561|P2|18 Month Survey Only|Overall Study||163
8486977|NCT00571038|20913562|P1|18 Month Survey Only|Overall Study||199
8486978|NCT00571038|20913561|P2|6 Month Follow up|Overall Study||176
8486979|NCT00571038|20913562|P1|6 Month Follow up|Overall Study||208
8486980|NCT00571038|20913561|P2|STARTED|Overall Study||185
8486981|NCT00571038|20913562|P1|STARTED|Overall Study||219
8486982|NCT00570960|20913610|P2|NOT COMPLETED|Overall Study||0
8486983|NCT00570960|20913611|P1|NOT COMPLETED|Overall Study||0
8486984|NCT00570960|20913610|P2|COMPLETED|Overall Study||4
8486985|NCT00570960|20913611|P1|COMPLETED|Overall Study||4
8486986|NCT00570960|20913610|P2|STARTED|Overall Study||4
8486987|NCT00570960|20913611|P1|STARTED|Overall Study||4
8486988|NCT00570921|20913617|P1|NOT COMPLETED|Overall Study||2
8486989|NCT00570921|20913617|P1|COMPLETED|Overall Study||31
8486990|NCT00570921|20913617|P1|STARTED|Overall Study||33
8486991|NCT00570908|20913623|P1|NOT COMPLETED|Overall Study||7
8486992|NCT00570908|20913623|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
8486993|NCT00570908|20913623|P1|STARTED|Overall Study||12
8486994|NCT00570778|20913627|P4|NOT COMPLETED|Overall Study||4
8486995|NCT00570778|20913628|P3|NOT COMPLETED|Overall Study||7
8486996|NCT00570778|20913629|P2|NOT COMPLETED|Overall Study||4
8486997|NCT00570778|20913630|P1|NOT COMPLETED|Overall Study||4
8486998|NCT00570778|20913627|P4|COMPLETED|Overall Study||34
8486999|NCT00570778|20913628|P3|COMPLETED|Overall Study||30
8487000|NCT00570778|20913629|P2|COMPLETED|Overall Study||34
8487001|NCT00570778|20913630|P1|COMPLETED|Overall Study||37
8487002|NCT00570778|20913627|P4|Modified Intent-to-treat Population|Overall Study||37
8487003|NCT00570778|20913628|P3|Modified Intent-to-treat Population|Overall Study||35
8487004|NCT00570778|20913629|P2|Modified Intent-to-treat Population|Overall Study||37
8487005|NCT00570778|20913630|P1|Modified Intent-to-treat Population|Overall Study||40
8487006|NCT00570778|20913627|P4|Safety Population: Received Study Drug|Overall Study||38
8487007|NCT00570778|20913628|P3|Safety Population: Received Study Drug|Overall Study||36
8487008|NCT00570778|20913629|P2|Safety Population: Received Study Drug|Overall Study||38
8487009|NCT00570778|20913630|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
8487010|NCT00570778|20913627|P4|STARTED|Overall Study||38
8487011|NCT00570778|20913628|P3|STARTED|Overall Study||37
8487012|NCT00570778|20913629|P2|STARTED|Overall Study||38
8487013|NCT00570778|20913630|P1|STARTED|Overall Study||41
8487023|NCT00570739|20913671|P4|NOT COMPLETED|Overall Study||12
8487024|NCT00570739|20913672|P3|NOT COMPLETED|Overall Study||16
8487025|NCT00570739|20913673|P2|NOT COMPLETED|Overall Study||21
8487026|NCT00570739|20913674|P1|NOT COMPLETED|Overall Study||21
8487027|NCT00570739|20913671|P4|COMPLETED|Overall Study||96
8487028|NCT00570739|20913672|P3|COMPLETED|Overall Study||92
8487029|NCT00570739|20913673|P2|COMPLETED|Overall Study||124
8487030|NCT00570739|20913674|P1|COMPLETED|Overall Study||120
8487031|NCT00570739|20913671|P4|STARTED|Overall Study||108
8487032|NCT00570739|20913672|P3|STARTED|Overall Study||108
8487033|NCT00570739|20913673|P2|STARTED|Overall Study||145
8487034|NCT00570739|20913674|P1|STARTED|Overall Study||141
8487035|NCT00570713|20913826|P2|NOT COMPLETED|Overall Study||77
8487036|NCT00570713|20913827|P1|NOT COMPLETED|Overall Study||78
8487037|NCT00570713|20913826|P2|COMPLETED|Overall Study||0
8487038|NCT00570713|20913827|P1|COMPLETED|Overall Study||0
8487039|NCT00570713|20913826|P2|STARTED|Overall Study||77
8487040|NCT00570713|20913827|P1|STARTED|Overall Study||78
8487041|NCT00570700|20913837|P1|NOT COMPLETED|Overall Study||11
8487042|NCT00570700|20913837|P1|COMPLETED|Overall Study||27
8487043|NCT00570700|20913837|P1|STARTED|Overall Study||38
8487044|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487045|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487046|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487047|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487048|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487049|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487050|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487051|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487052|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487053|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487054|NCT00570687|20913845|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487055|NCT00570687|20913846|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487056|NCT00570687|20913847|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487057|NCT00570687|20913848|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487058|NCT00570687|20913849|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487059|NCT00570687|20913850|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487060|NCT00570687|20913851|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
8487061|NCT00570687|20913852|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
8487062|NCT00570687|20913853|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
8487063|NCT00570687|20913854|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
8487064|NCT00570687|20913845|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487065|NCT00570687|20913846|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487066|NCT00570687|20913847|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487067|NCT00570687|20913848|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487068|NCT00570687|20913849|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487069|NCT00570687|20913850|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487070|NCT00570687|20913851|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
8487071|NCT00570687|20913852|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
8487072|NCT00570687|20913853|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
8487073|NCT00570687|20913854|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
8487074|NCT00570687|20913845|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487075|NCT00570687|20913846|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487076|NCT00570687|20913847|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487077|NCT00570687|20913848|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487078|NCT00570687|20913849|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487079|NCT00570687|20913850|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487080|NCT00570687|20913851|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487081|NCT00570687|20913852|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487082|NCT00570687|20913853|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487083|NCT00570687|20913854|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487084|NCT00570687|20913845|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487085|NCT00570687|20913846|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487086|NCT00570687|20913847|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487087|NCT00570687|20913848|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487088|NCT00570687|20913849|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487089|NCT00570687|20913850|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487090|NCT00570687|20913851|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
8487091|NCT00570687|20913852|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
8487092|NCT00570687|20913853|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
8487093|NCT00570687|20913854|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
8487094|NCT00570687|20913845|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487095|NCT00570687|20913846|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487096|NCT00570687|20913847|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487097|NCT00570687|20913848|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487098|NCT00570687|20913849|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487099|NCT00570687|20913850|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487100|NCT00570687|20913851|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
8487101|NCT00570687|20913852|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
8487102|NCT00570687|20913853|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
8487103|NCT00570687|20913854|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
8487104|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487105|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487106|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487107|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487108|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487109|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487110|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487111|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487112|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487113|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487114|NCT00570687|20913845|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487115|NCT00570687|20913846|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487116|NCT00570687|20913847|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487117|NCT00570687|20913848|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487118|NCT00570687|20913849|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487119|NCT00570687|20913850|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487120|NCT00570687|20913851|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
8487121|NCT00570687|20913852|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
8487122|NCT00570687|20913853|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
8487123|NCT00570687|20913854|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
8487124|NCT00570687|20913845|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487125|NCT00570687|20913846|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487126|NCT00570687|20913847|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487127|NCT00570687|20913848|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487128|NCT00570687|20913849|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487129|NCT00570687|20913850|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487130|NCT00570687|20913851|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
8487131|NCT00570687|20913852|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
8487132|NCT00570687|20913853|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
8487133|NCT00570687|20913854|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
8487134|NCT00570687|20913845|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487135|NCT00570687|20913846|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487136|NCT00570687|20913847|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487137|NCT00570687|20913848|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487138|NCT00570687|20913849|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487139|NCT00570687|20913850|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487140|NCT00570687|20913851|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487141|NCT00570687|20913852|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487142|NCT00570687|20913853|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487143|NCT00570687|20913854|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487144|NCT00570687|20913845|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487145|NCT00570687|20913846|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487146|NCT00570687|20913847|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487147|NCT00570687|20913848|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487148|NCT00570687|20913849|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487149|NCT00570687|20913850|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487150|NCT00570687|20913851|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
8487151|NCT00570687|20913852|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
8487152|NCT00570687|20913853|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
8487153|NCT00570687|20913854|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
8487154|NCT00570687|20913845|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487155|NCT00570687|20913846|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487156|NCT00570687|20913847|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487157|NCT00570687|20913848|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487158|NCT00570687|20913849|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487159|NCT00570687|20913850|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487160|NCT00570687|20913851|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
8487161|NCT00570687|20913852|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
8487162|NCT00570687|20913853|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
8487163|NCT00570687|20913854|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
8487164|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487165|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487166|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487167|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487168|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487169|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487170|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487171|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487172|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487173|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487174|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487175|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487176|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487177|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487178|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487179|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487180|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487181|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487182|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487183|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487184|NCT00570687|20913845|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487185|NCT00570687|20913846|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487186|NCT00570687|20913847|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487187|NCT00570687|20913848|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487188|NCT00570687|20913849|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487569|NCT00570674|20913881|P6|PEG Evaluable|Overall Study||10
8487189|NCT00570687|20913850|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487190|NCT00570687|20913851|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487191|NCT00570687|20913852|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487192|NCT00570687|20913853|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487193|NCT00570687|20913854|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487194|NCT00570687|20913845|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487195|NCT00570687|20913846|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487196|NCT00570687|20913847|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487197|NCT00570687|20913848|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487198|NCT00570687|20913849|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487199|NCT00570687|20913850|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487200|NCT00570687|20913851|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487201|NCT00570687|20913852|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487202|NCT00570687|20913853|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487203|NCT00570687|20913854|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487204|NCT00570687|20913845|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487205|NCT00570687|20913846|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487206|NCT00570687|20913847|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487207|NCT00570687|20913848|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487208|NCT00570687|20913849|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487209|NCT00570687|20913850|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487210|NCT00570687|20913851|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
8487211|NCT00570687|20913852|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
8487212|NCT00570687|20913853|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
8487213|NCT00570687|20913854|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
8487214|NCT00570687|20913845|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487215|NCT00570687|20913846|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487216|NCT00570687|20913847|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487217|NCT00570687|20913848|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487218|NCT00570687|20913849|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487219|NCT00570687|20913850|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487220|NCT00570687|20913851|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
8487221|NCT00570687|20913852|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
8487222|NCT00570687|20913853|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
8487223|NCT00570687|20913854|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
8487224|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487225|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487226|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487227|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487228|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487229|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487230|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487231|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487232|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487233|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487234|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487235|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487236|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487237|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487238|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487239|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487240|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487241|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487242|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487243|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487244|NCT00570687|20913845|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487245|NCT00570687|20913846|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487246|NCT00570687|20913847|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487247|NCT00570687|20913848|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487248|NCT00570687|20913849|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487249|NCT00570687|20913850|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487250|NCT00570687|20913851|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487251|NCT00570687|20913852|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487252|NCT00570687|20913853|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487253|NCT00570687|20913854|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487254|NCT00570687|20913845|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487255|NCT00570687|20913846|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487256|NCT00570687|20913847|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487257|NCT00570687|20913848|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
8487258|NCT00570687|20913849|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487259|NCT00570687|20913850|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487260|NCT00570687|20913851|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487261|NCT00570687|20913852|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487262|NCT00570687|20913853|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487263|NCT00570687|20913854|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487264|NCT00570687|20913845|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487265|NCT00570687|20913846|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487266|NCT00570687|20913847|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487267|NCT00570687|20913848|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487268|NCT00570687|20913849|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487269|NCT00570687|20913850|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487270|NCT00570687|20913851|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487271|NCT00570687|20913852|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487272|NCT00570687|20913853|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487273|NCT00570687|20913854|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487274|NCT00570687|20913845|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487275|NCT00570687|20913846|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487276|NCT00570687|20913847|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487277|NCT00570687|20913848|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
8487278|NCT00570687|20913849|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487279|NCT00570687|20913850|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487280|NCT00570687|20913851|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487281|NCT00570687|20913852|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487282|NCT00570687|20913853|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487283|NCT00570687|20913854|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487284|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487285|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487286|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487287|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487288|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487289|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487290|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487291|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487292|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487293|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487294|NCT00570687|20913845|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487295|NCT00570687|20913846|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487296|NCT00570687|20913847|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487297|NCT00570687|20913848|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
8487298|NCT00570687|20913849|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487299|NCT00570687|20913850|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487300|NCT00570687|20913851|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487301|NCT00570687|20913852|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487302|NCT00570687|20913853|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487303|NCT00570687|20913854|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487304|NCT00570687|20913845|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487305|NCT00570687|20913846|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487306|NCT00570687|20913847|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487307|NCT00570687|20913848|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
8487308|NCT00570687|20913849|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487309|NCT00570687|20913850|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487310|NCT00570687|20913851|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487311|NCT00570687|20913852|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487312|NCT00570687|20913853|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487313|NCT00570687|20913854|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487314|NCT00570687|20913845|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487315|NCT00570687|20913846|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
8487316|NCT00570687|20913847|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487317|NCT00570687|20913848|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487318|NCT00570687|20913849|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487319|NCT00570687|20913850|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487320|NCT00570687|20913851|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487321|NCT00570687|20913852|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487322|NCT00570687|20913853|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487323|NCT00570687|20913854|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487324|NCT00570687|20913845|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487325|NCT00570687|20913846|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487326|NCT00570687|20913847|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487327|NCT00570687|20913848|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
8487328|NCT00570687|20913849|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487329|NCT00570687|20913850|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487330|NCT00570687|20913851|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487331|NCT00570687|20913852|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487332|NCT00570687|20913853|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487333|NCT00570687|20913854|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487334|NCT00570687|20913845|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487335|NCT00570687|20913846|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
8487336|NCT00570687|20913847|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487337|NCT00570687|20913848|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
8487338|NCT00570687|20913849|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487339|NCT00570687|20913850|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487340|NCT00570687|20913851|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487341|NCT00570687|20913852|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487342|NCT00570687|20913853|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487343|NCT00570687|20913854|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487344|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487345|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487346|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487347|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487348|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487349|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487350|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487351|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487352|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487353|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487354|NCT00570687|20913845|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487355|NCT00570687|20913846|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
8487356|NCT00570687|20913847|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487357|NCT00570687|20913848|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
8487358|NCT00570687|20913849|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487359|NCT00570687|20913850|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487360|NCT00570687|20913851|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487361|NCT00570687|20913852|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487362|NCT00570687|20913853|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487363|NCT00570687|20913854|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487364|NCT00570687|20913845|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487365|NCT00570687|20913846|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
8487366|NCT00570687|20913847|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487367|NCT00570687|20913848|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
8487368|NCT00570687|20913849|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487369|NCT00570687|20913850|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487370|NCT00570687|20913851|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487371|NCT00570687|20913852|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487372|NCT00570687|20913853|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487373|NCT00570687|20913854|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487374|NCT00570687|20913845|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487375|NCT00570687|20913846|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
8487376|NCT00570687|20913847|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487377|NCT00570687|20913848|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
8487378|NCT00570687|20913849|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487379|NCT00570687|20913850|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487380|NCT00570687|20913851|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487381|NCT00570687|20913852|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487382|NCT00570687|20913853|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487383|NCT00570687|20913854|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487384|NCT00570687|20913845|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487385|NCT00570687|20913846|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
8487386|NCT00570687|20913847|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487387|NCT00570687|20913848|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
8487388|NCT00570687|20913849|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487389|NCT00570687|20913850|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487390|NCT00570687|20913851|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487391|NCT00570687|20913852|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487392|NCT00570687|20913853|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487393|NCT00570687|20913854|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487394|NCT00570687|20913845|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487395|NCT00570687|20913846|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487396|NCT00570687|20913847|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487397|NCT00570687|20913848|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487398|NCT00570687|20913849|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487399|NCT00570687|20913850|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487400|NCT00570687|20913851|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487401|NCT00570687|20913852|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487402|NCT00570687|20913853|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487403|NCT00570687|20913854|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487404|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487405|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487406|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487407|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487408|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487409|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487410|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487411|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487412|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487413|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487414|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487415|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487416|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487417|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487418|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487419|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487420|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487421|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487422|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487423|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487424|NCT00570687|20913845|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487425|NCT00570687|20913846|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487426|NCT00570687|20913847|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487427|NCT00570687|20913848|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487428|NCT00570687|20913849|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487429|NCT00570687|20913850|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487430|NCT00570687|20913851|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487431|NCT00570687|20913852|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487432|NCT00570687|20913853|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487433|NCT00570687|20913854|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487434|NCT00570687|20913845|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487435|NCT00570687|20913846|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487436|NCT00570687|20913847|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487437|NCT00570687|20913848|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487438|NCT00570687|20913849|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487439|NCT00570687|20913850|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487440|NCT00570687|20913851|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487441|NCT00570687|20913852|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487442|NCT00570687|20913853|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487443|NCT00570687|20913854|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487444|NCT00570687|20913845|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487445|NCT00570687|20913846|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487446|NCT00570687|20913847|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487447|NCT00570687|20913848|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487448|NCT00570687|20913849|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487449|NCT00570687|20913850|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487450|NCT00570687|20913851|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487451|NCT00570687|20913852|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487452|NCT00570687|20913853|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487453|NCT00570687|20913854|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487454|NCT00570687|20913845|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487455|NCT00570687|20913846|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487456|NCT00570687|20913847|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487457|NCT00570687|20913848|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487458|NCT00570687|20913849|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487459|NCT00570687|20913850|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487460|NCT00570687|20913851|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487461|NCT00570687|20913852|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487462|NCT00570687|20913853|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487463|NCT00570687|20913854|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487464|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487465|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487466|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487467|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487468|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487469|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487470|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487471|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487472|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487473|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487474|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487475|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487476|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487477|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487478|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487479|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487480|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487481|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487482|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487483|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487484|NCT00570687|20913845|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487485|NCT00570687|20913846|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487486|NCT00570687|20913847|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487487|NCT00570687|20913848|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487488|NCT00570687|20913849|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487489|NCT00570687|20913850|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487490|NCT00570687|20913851|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487491|NCT00570687|20913852|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487492|NCT00570687|20913853|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487493|NCT00570687|20913854|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487494|NCT00570687|20913845|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487495|NCT00570687|20913846|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487496|NCT00570687|20913847|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487497|NCT00570687|20913848|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487498|NCT00570687|20913849|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487499|NCT00570687|20913850|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487500|NCT00570687|20913851|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487501|NCT00570687|20913852|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487502|NCT00570687|20913853|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487503|NCT00570687|20913854|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487504|NCT00570687|20913845|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487505|NCT00570687|20913846|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487506|NCT00570687|20913847|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487507|NCT00570687|20913848|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487508|NCT00570687|20913849|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487509|NCT00570687|20913850|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487510|NCT00570687|20913851|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487511|NCT00570687|20913852|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487512|NCT00570687|20913853|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487513|NCT00570687|20913854|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487514|NCT00570687|20913845|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487515|NCT00570687|20913846|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487516|NCT00570687|20913847|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487517|NCT00570687|20913848|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487518|NCT00570687|20913849|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487519|NCT00570687|20913850|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487520|NCT00570687|20913851|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487521|NCT00570687|20913852|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487522|NCT00570687|20913853|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487523|NCT00570687|20913854|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487524|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487525|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487526|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487527|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487528|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487529|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487530|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487531|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487532|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487533|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487534|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487535|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487536|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487537|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487538|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487539|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487540|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487541|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487542|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487543|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487544|NCT00570687|20913845|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487545|NCT00570687|20913846|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487546|NCT00570687|20913847|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487547|NCT00570687|20913848|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487548|NCT00570687|20913849|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487549|NCT00570687|20913850|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487550|NCT00570687|20913851|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487551|NCT00570687|20913852|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487552|NCT00570687|20913853|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487553|NCT00570687|20913854|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487554|NCT00570674|20913880|P7|NOT COMPLETED|Overall Study||0
8487555|NCT00570674|20913881|P6|NOT COMPLETED|Overall Study||0
8487556|NCT00570674|20913882|P5|NOT COMPLETED|Overall Study||0
8487557|NCT00570674|20913883|P4|NOT COMPLETED|Overall Study||0
8487558|NCT00570674|20913884|P3|NOT COMPLETED|Overall Study||1
8487559|NCT00570674|20913885|P2|NOT COMPLETED|Overall Study||0
8487560|NCT00570674|20913886|P1|NOT COMPLETED|Overall Study||0
8487561|NCT00570674|20913880|P7|COMPLETED|Overall Study||0
8487562|NCT00570674|20913881|P6|COMPLETED|Overall Study||10
8487563|NCT00570674|20913882|P5|COMPLETED|Overall Study||3
8487564|NCT00570674|20913883|P4|COMPLETED|Overall Study||3
8487565|NCT00570674|20913884|P3|COMPLETED|Overall Study||3
8487566|NCT00570674|20913885|P2|COMPLETED|Overall Study||3
8487567|NCT00570674|20913886|P1|COMPLETED|Overall Study||6
8487568|NCT00570674|20913880|P7|PEG Evaluable|Overall Study||0
8487570|NCT00570674|20913882|P5|PEG Evaluable|Overall Study||2
8487571|NCT00570674|20913883|P4|PEG Evaluable|Overall Study||3
8487572|NCT00570674|20913884|P3|PEG Evaluable|Overall Study||3
8487573|NCT00570674|20913885|P2|PEG Evaluable|Overall Study||3
8487574|NCT00570674|20913886|P1|PEG Evaluable|Overall Study||6
8487575|NCT00570674|20913880|P7|Treated|Overall Study||0
8487576|NCT00570674|20913881|P6|Treated|Overall Study||10
8487577|NCT00570674|20913882|P5|Treated|Overall Study||3
8487578|NCT00570674|20913883|P4|Treated|Overall Study||3
8487579|NCT00570674|20913884|P3|Treated|Overall Study||3
8487580|NCT00570674|20913885|P2|Treated|Overall Study||3
8487581|NCT00570674|20913886|P1|Treated|Overall Study||6
8487582|NCT00570674|20913880|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
8487583|NCT00570674|20913881|P6|STARTED|Overall Study||10
8487584|NCT00570674|20913882|P5|STARTED|Overall Study||3
8487585|NCT00570674|20913883|P4|STARTED|Overall Study||3
8487586|NCT00570674|20913884|P3|STARTED|Overall Study||4
8487587|NCT00570674|20913885|P2|STARTED|Overall Study||3
8487588|NCT00570674|20913886|P1|STARTED|Overall Study||6
8487589|NCT00570531|20913903|P1|NOT COMPLETED|Overall Study||0
8487590|NCT00570531|20913903|P1|COMPLETED|Overall Study||6
8487591|NCT00570531|20913903|P1|STARTED|Overall Study||6
8487592|NCT00570505|20913909|P1|NOT COMPLETED|Overall Study||41
8487593|NCT00570505|20913909|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
8487594|NCT00570505|20913909|P1|STARTED|Overall Study||149
8487595|NCT00570492|20913922|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
8487596|NCT00570492|20913923|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
8487597|NCT00570492|20913924|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
8487598|NCT00570492|20913922|P3|COMPLETED|52-week Double-blind Treatment Period||186
8487599|NCT00570492|20913923|P2|COMPLETED|52-week Double-blind Treatment Period||187
8487600|NCT00570492|20913924|P1|COMPLETED|52-week Double-blind Treatment Period||0
8487601|NCT00570492|20913922|P3|STARTED|52-week Double-blind Treatment Period||237
8487602|NCT00570492|20913923|P2|STARTED|52-week Double-blind Treatment Period||237
8487603|NCT00570492|20913924|P1|STARTED|52-week Double-blind Treatment Period||0
8487604|NCT00570492|20913922|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
8487605|NCT00570492|20913923|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
8487606|NCT00570492|20913924|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
8487607|NCT00570492|20913922|P3|COMPLETED|16-week Single-blind Baseline Period||0
8487608|NCT00570492|20913923|P2|COMPLETED|16-week Single-blind Baseline Period||0
8487609|NCT00570492|20913924|P1|COMPLETED|16-week Single-blind Baseline Period||474
8487610|NCT00570492|20913922|P3|STARTED|16-week Single-blind Baseline Period||0
8487611|NCT00570492|20913923|P2|STARTED|16-week Single-blind Baseline Period||0
8487612|NCT00570492|20913924|P1|STARTED|16-week Single-blind Baseline Period||910
8487613|NCT00570401|20913962|P1|NOT COMPLETED|Overall Study||2
8487614|NCT00570401|20913962|P1|COMPLETED|Overall Study||19
8487615|NCT00570401|20913962|P1|STARTED|Overall Study||21
8487616|NCT00570362|20913968|P2|NOT COMPLETED|Overall Study||0
8487617|NCT00570362|20913969|P1|NOT COMPLETED|Overall Study||0
8487618|NCT00570362|20913968|P2|COMPLETED|Overall Study||30
8487619|NCT00570362|20913969|P1|COMPLETED|Overall Study||19
8487620|NCT00570362|20913968|P2|STARTED|Overall Study||30
8487621|NCT00570362|20913969|P1|STARTED|Overall Study||19
8487622|NCT00570349|20913978|P3|NOT COMPLETED|Overall Study||0
8487623|NCT00570349|20913979|P2|NOT COMPLETED|Overall Study||0
8487624|NCT00570349|20913980|P1|NOT COMPLETED|Overall Study||0
8487625|NCT00570349|20913978|P3|COMPLETED|Overall Study||6
8487626|NCT00570349|20913979|P2|COMPLETED|Overall Study||6
8487627|NCT00570349|20913980|P1|COMPLETED|Overall Study||6
8487628|NCT00570349|20913978|P3|STARTED|Overall Study||6
8487629|NCT00570349|20913979|P2|STARTED|Overall Study||6
8487630|NCT00570349|20913980|P1|STARTED|Overall Study||6
8487631|NCT00570323|20913996|P2|NOT COMPLETED|Complete Study After Start||1
8487632|NCT00570323|20913997|P1|NOT COMPLETED|Complete Study After Start||3
8487633|NCT00570323|20913996|P2|COMPLETED|Complete Study After Start||34
8487634|NCT00570323|20913997|P1|COMPLETED|Complete Study After Start||31
8487635|NCT00570323|20913996|P2|STARTED|Complete Study After Start||35
8487636|NCT00570323|20913997|P1|STARTED|Complete Study After Start||34
8487637|NCT00570323|20913996|P2|NOT COMPLETED|Started Treatment After Randomization||1
8487638|NCT00570323|20913997|P1|NOT COMPLETED|Started Treatment After Randomization||2
8487639|NCT00570323|20913996|P2|COMPLETED|Started Treatment After Randomization||35
8487640|NCT00570323|20913997|P1|COMPLETED|Started Treatment After Randomization||34
8487641|NCT00570323|20913996|P2|STARTED|Started Treatment After Randomization||36
8487642|NCT00570323|20913997|P1|STARTED|Started Treatment After Randomization||36
8487643|NCT00570310|20914009|P2|NOT COMPLETED|Overall Study||6
8487644|NCT00570310|20914010|P1|NOT COMPLETED|Overall Study||2
8487645|NCT00570310|20914009|P2|COMPLETED|Overall Study||45
8487646|NCT00570310|20914010|P1|COMPLETED|Overall Study||51
8487647|NCT00570310|20914009|P2|STARTED|Overall Study||51
8487648|NCT00570310|20914010|P1|STARTED|Overall Study||53
8487649|NCT00570258|20914020|P2|NOT COMPLETED|Overall Study||15
8487650|NCT00570258|20914021|P1|NOT COMPLETED|Overall Study||12
8487651|NCT00570258|20914020|P2|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
8487652|NCT00570258|20914021|P1|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
8487653|NCT00570258|20914020|P2|STARTED|Overall Study||15
8487654|NCT00570258|20914021|P1|STARTED|Overall Study||12
8487655|NCT00570232|20914029|P1|NOT COMPLETED|Overall Study||23
8487656|NCT00570232|20914029|P1|COMPLETED|Overall Study||8
8487657|NCT00570232|20914029|P1|STARTED|Overall Study||31
8487658|NCT00570141|20914035|P1|NOT COMPLETED|Overall Study||3
8487659|NCT00570141|20914035|P1|COMPLETED|Overall Study||10
8487660|NCT00570141|20914035|P1|STARTED|Overall Study||13
8487661|NCT00570089|20914040|P2|NOT COMPLETED|Perod 2||0
8487662|NCT00570089|20914041|P1|NOT COMPLETED|Perod 2||0
8487663|NCT00570089|20914040|P2|COMPLETED|Perod 2||10
8487664|NCT00570089|20914041|P1|COMPLETED|Perod 2||10
8487665|NCT00570089|20914040|P2|STARTED|Perod 2||10
8487666|NCT00570089|20914041|P1|STARTED|Perod 2||10
8487667|NCT00570089|20914040|P2|NOT COMPLETED|Period 1||0
8487668|NCT00570089|20914041|P1|NOT COMPLETED|Period 1||0
8487669|NCT00570089|20914040|P2|COMPLETED|Period 1||10
8487670|NCT00570089|20914041|P1|COMPLETED|Period 1||10
8487671|NCT00570089|20914040|P2|STARTED|Period 1||10
8487672|NCT00570089|20914041|P1|STARTED|Period 1||10
8487673|NCT00570063|20914051|P2|NOT COMPLETED|Overall Study||8
8487674|NCT00570063|20914052|P1|NOT COMPLETED|Overall Study||15
8487675|NCT00570063|20914051|P2|COMPLETED|Overall Study||3
8487676|NCT00570063|20914052|P1|COMPLETED|Overall Study||9
8487677|NCT00570063|20914051|P2|STARTED|Overall Study||11
8487678|NCT00570063|20914052|P1|STARTED|Overall Study||24
8487679|NCT00570037|20914118|P2|NOT COMPLETED|Overall Study||69
8487680|NCT00570037|20914119|P1|NOT COMPLETED|Overall Study||44
8487681|NCT00570037|20914118|P2|COMPLETED|Overall Study||237
8487682|NCT00570037|20914119|P1|COMPLETED|Overall Study||194
8487683|NCT00570037|20914118|P2|STARTED|Overall Study||306
8487684|NCT00570037|20914119|P1|STARTED|Overall Study||238
8487685|NCT00569946|20914129|P1|NOT COMPLETED|Overall Study||59
8487686|NCT00569946|20914129|P1|COMPLETED|Overall Study||5
8487687|NCT00569946|20914129|P1|STARTED|Overall Study||64
8487688|NCT00569868|20914145|P1|NOT COMPLETED|Overall Study||0
8487689|NCT00569868|20914145|P1|COMPLETED|Overall Study||11
8487690|NCT00569868|20914145|P1|STARTED|Overall Study||11
8487691|NCT00569855|20914149|P1|NOT COMPLETED|Overall Study||0
8487692|NCT00569855|20914149|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
8487693|NCT00569855|20914149|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
8487694|NCT00569803|20914161|P8|NOT COMPLETED|Overall Study||1
8487695|NCT00569803|20914162|P7|NOT COMPLETED|Overall Study||0
8487696|NCT00569803|20914163|P6|NOT COMPLETED|Overall Study||0
8487697|NCT00569803|20914164|P5|NOT COMPLETED|Overall Study||0
8487698|NCT00569803|20914165|P4|NOT COMPLETED|Overall Study||1
8487699|NCT00569803|20914166|P3|NOT COMPLETED|Overall Study||0
8487700|NCT00569803|20914167|P2|NOT COMPLETED|Overall Study||0
8487701|NCT00569803|20914168|P1|NOT COMPLETED|Overall Study||1
8487702|NCT00569803|20914161|P8|COMPLETED|Overall Study||5
8487703|NCT00569803|20914162|P7|COMPLETED|Overall Study||10
8487704|NCT00569803|20914163|P6|COMPLETED|Overall Study||5
8487705|NCT00569803|20914164|P5|COMPLETED|Overall Study||5
8487706|NCT00569803|20914165|P4|COMPLETED|Overall Study||5
8487707|NCT00569803|20914166|P3|COMPLETED|Overall Study||5
8487708|NCT00569803|20914167|P2|COMPLETED|Overall Study||5
8487709|NCT00569803|20914168|P1|COMPLETED|Overall Study||4
8487710|NCT00569803|20914161|P8|STARTED|Overall Study||6
8487711|NCT00569803|20914162|P7|STARTED|Overall Study||10
8487712|NCT00569803|20914163|P6|STARTED|Overall Study||5
8487713|NCT00569803|20914164|P5|STARTED|Overall Study||5
8487714|NCT00569803|20914165|P4|STARTED|Overall Study||6
8487715|NCT00569803|20914166|P3|STARTED|Overall Study||5
8487716|NCT00569803|20914167|P2|STARTED|Overall Study||5
8487717|NCT00569803|20914168|P1|STARTED|Overall Study||5
8487718|NCT00569777|20914295|P2|NOT COMPLETED|Overall Study||3
8487719|NCT00569777|20914296|P1|NOT COMPLETED|Overall Study||10
8487720|NCT00569777|20914295|P2|COMPLETED|Overall Study||101
8487721|NCT00569777|20914296|P1|COMPLETED|Overall Study||196
8487722|NCT00569777|20914295|P2|STARTED|Overall Study||104
8487723|NCT00569777|20914296|P1|STARTED|Overall Study||206
8487724|NCT00569673|20914338|P1|NOT COMPLETED|Overall Study||0
8487725|NCT00569673|20914338|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
8487726|NCT00569673|20914338|P1|STARTED|Overall Study|Total number participants enrolled on study|71
8487727|NCT00569660|20914343|P1|NOT COMPLETED|Overall Study||0
8487728|NCT00569660|20914343|P1|COMPLETED|Overall Study||34
8487729|NCT00569660|20914343|P1|STARTED|Overall Study||34
8487730|NCT00569582|20914347|P1|NOT COMPLETED|Overall Study||16
8487731|NCT00569582|20914347|P1|COMPLETED|Overall Study||34
8487732|NCT00569582|20914347|P1|STARTED|Overall Study||50
8487733|NCT00569530|20914354|P2|NOT COMPLETED|Overall Study||0
8487734|NCT00569530|20914355|P1|NOT COMPLETED|Overall Study||0
8487735|NCT00569530|20914354|P2|COMPLETED|Overall Study||42
8487736|NCT00569530|20914355|P1|COMPLETED|Overall Study||43
8487737|NCT00569530|20914354|P2|STARTED|Overall Study||42
8487738|NCT00569530|20914355|P1|STARTED|Overall Study||43
8487739|NCT00569374|20914363|P1|NOT COMPLETED|Overall Study||4
8487740|NCT00569374|20914363|P1|COMPLETED|Overall Study||4
8487741|NCT00569374|20914363|P1|STARTED|Overall Study||8
8487742|NCT00569309|20914373|P1|NOT COMPLETED|Overall Study||0
8487743|NCT00569309|20914373|P1|COMPLETED|Overall Study||30
8487744|NCT00569309|20914373|P1|STARTED|Overall Study||30
8487745|NCT00569270|20914382|P2|NOT COMPLETED|Period: Second Intervention||0
8487746|NCT00569270|20914383|P1|NOT COMPLETED|Period: Second Intervention||0
8487747|NCT00569270|20914382|P2|COMPLETED|Period: Second Intervention||14
8487748|NCT00569270|20914383|P1|COMPLETED|Period: Second Intervention||15
8487749|NCT00569270|20914382|P2|29 Days|Period: Second Intervention||14
8487750|NCT00569270|20914383|P1|29 Days|Period: Second Intervention||15
8487751|NCT00569270|20914382|P2|STARTED|Period: Second Intervention||14
8487752|NCT00569270|20914383|P1|STARTED|Period: Second Intervention||15
8487753|NCT00569270|20914382|P2|NOT COMPLETED|Period: First Intervention||1
8487754|NCT00569270|20914383|P1|NOT COMPLETED|Period: First Intervention||0
8487755|NCT00569270|20914382|P2|COMPLETED|Period: First Intervention||14
8487756|NCT00569270|20914383|P1|COMPLETED|Period: First Intervention||15
8487757|NCT00569270|20914382|P2|STARTED|Period: First Intervention||15
8487758|NCT00569270|20914383|P1|STARTED|Period: First Intervention|randomized cross over study|15
8487759|NCT00569231|20914418|P1|NOT COMPLETED|Overall Study||7
8487760|NCT00569231|20914418|P1|COMPLETED|Overall Study||11
8487761|NCT00569231|20914418|P1|STARTED|Overall Study||18
8487762|NCT00569192|20914428|P3|NOT COMPLETED|Overall Study||25
8487763|NCT00569192|20914429|P2|NOT COMPLETED|Overall Study||20
8487764|NCT00569192|20914430|P1|NOT COMPLETED|Overall Study||23
8487765|NCT00569192|20914428|P3|COMPLETED|Overall Study||99
8487766|NCT00569192|20914429|P2|COMPLETED|Overall Study||105
8487767|NCT00569192|20914430|P1|COMPLETED|Overall Study||88
8487768|NCT00569192|20914428|P3|STARTED|Overall Study||124
8487769|NCT00569192|20914429|P2|STARTED|Overall Study||125
8487770|NCT00569192|20914430|P1|STARTED|Overall Study||111
8487771|NCT00569166|20914456|P3|NOT COMPLETED|Overall Study||4
8487772|NCT00569166|20914457|P2|NOT COMPLETED|Overall Study||6
8487773|NCT00569166|20914458|P1|NOT COMPLETED|Overall Study||9
8487774|NCT00569166|20914456|P3|COMPLETED|Overall Study||27
8487775|NCT00569166|20914457|P2|COMPLETED|Overall Study||25
8487776|NCT00569166|20914458|P1|COMPLETED|Overall Study||21
8487777|NCT00569166|20914456|P3|STARTED|Overall Study||31
8487778|NCT00569166|20914457|P2|STARTED|Overall Study||31
8487779|NCT00569166|20914458|P1|STARTED|Overall Study||30
8487780|NCT00569127|20914492|P2|NOT COMPLETED|Overall Study||213
8487781|NCT00569127|20914493|P1|NOT COMPLETED|Overall Study||214
8487782|NCT00569127|20914492|P2|COMPLETED|Overall Study||0
8487783|NCT00569127|20914493|P1|COMPLETED|Overall Study||0
8487784|NCT00569127|20914492|P2|Eligible|Overall Study||202
8487785|NCT00569127|20914493|P1|Eligible|Overall Study||200
8487786|NCT00569127|20914492|P2|STARTED|Overall Study||213
8487787|NCT00569127|20914493|P1|STARTED|Overall Study||214
8487788|NCT00569010|20914513|P4|NOT COMPLETED|Overall Study||0
8487789|NCT00569010|20914514|P3|NOT COMPLETED|Overall Study||0
8487790|NCT00569010|20914515|P2|NOT COMPLETED|Overall Study||0
8487791|NCT00569010|20914516|P1|NOT COMPLETED|Overall Study||0
8487792|NCT00569010|20914513|P4|COMPLETED|Overall Study||11
8487793|NCT00569010|20914514|P3|COMPLETED|Overall Study||11
8487794|NCT00569010|20914515|P2|COMPLETED|Overall Study||6
8487795|NCT00569010|20914516|P1|COMPLETED|Overall Study||6
8487796|NCT00569010|20914513|P4|STARTED|Overall Study||11
8487797|NCT00569010|20914514|P3|STARTED|Overall Study||11
8487798|NCT00569010|20914515|P2|STARTED|Overall Study||6
8487799|NCT00569010|20914516|P1|STARTED|Overall Study||6
8487800|NCT00568958|20914528|P2|NOT COMPLETED|Follow-Up||7
8487801|NCT00568958|20914529|P1|NOT COMPLETED|Follow-Up||9
8487802|NCT00568958|20914528|P2|COMPLETED|Follow-Up||60
8487803|NCT00568958|20914529|P1|COMPLETED|Follow-Up||52
8487804|NCT00568958|20914528|P2|STARTED|Follow-Up||67
8487805|NCT00568958|20914529|P1|STARTED|Follow-Up||61
8487806|NCT00568958|20914528|P2|NOT COMPLETED|Allocation||3
8487807|NCT00568958|20914529|P1|NOT COMPLETED|Allocation||9
8487808|NCT00568958|20914528|P2|COMPLETED|Allocation||67
8487809|NCT00568958|20914529|P1|COMPLETED|Allocation||61
8487810|NCT00568958|20914528|P2|STARTED|Allocation||70
8487811|NCT00568958|20914529|P1|STARTED|Allocation||70
8487812|NCT00568854|20914549|P2|NOT COMPLETED|Overall Study||0
8487813|NCT00568854|20914550|P1|NOT COMPLETED|Overall Study||0
8487814|NCT00568854|20914549|P2|COMPLETED|Overall Study||4
8487815|NCT00568854|20914550|P1|COMPLETED|Overall Study||6
8487816|NCT00568854|20914549|P2|STARTED|Overall Study||4
8487817|NCT00568854|20914550|P1|STARTED|Overall Study||6
8487818|NCT00568802|20914558|P1|NOT COMPLETED|Overall Study||3
8487819|NCT00568802|20914558|P1|COMPLETED|Overall Study||24
8487820|NCT00568802|20914558|P1|STARTED|Overall Study||27
8487821|NCT00568776|20914576|P4|NOT COMPLETED|Overall Study||72
8487822|NCT00568776|20914577|P3|NOT COMPLETED|Overall Study||74
8487823|NCT00568776|20914578|P2|NOT COMPLETED|Overall Study||36
8487824|NCT00568776|20914579|P1|NOT COMPLETED|Overall Study||30
8487825|NCT00568776|20914576|P4|COMPLETED|Overall Study||19
8487826|NCT00568776|20914577|P3|COMPLETED|Overall Study||15
8487827|NCT00568776|20914578|P2|COMPLETED|Overall Study||52
8487828|NCT00568776|20914579|P1|COMPLETED|Overall Study||53
8487829|NCT00568776|20914576|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
8487830|NCT00568776|20914577|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
8487831|NCT00568776|20914578|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
8487832|NCT00568776|20914579|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
8487833|NCT00568698|20914613|P1|NOT COMPLETED|Overall Study||11
8487834|NCT00568698|20914613|P1|COMPLETED|Overall Study||18
8487835|NCT00568698|20914613|P1|STARTED|Overall Study||29
8487836|NCT00568685|20914628|P3|NOT COMPLETED|Overall Study||5
8487837|NCT00568685|20914629|P2|NOT COMPLETED|Overall Study||5
8487838|NCT00568685|20914630|P1|NOT COMPLETED|Overall Study||10
8487839|NCT00568685|20914628|P3|COMPLETED|Overall Study||46
8487840|NCT00568685|20914629|P2|COMPLETED|Overall Study||46
8487841|NCT00568685|20914630|P1|COMPLETED|Overall Study||41
8487842|NCT00568685|20914628|P3|STARTED|Overall Study||51
8487843|NCT00568685|20914629|P2|STARTED|Overall Study||51
8487844|NCT00568685|20914630|P1|STARTED|Overall Study||51
8487845|NCT00568633|20914664|P2|NOT COMPLETED|Overall Study||0
8487846|NCT00568633|20914665|P1|NOT COMPLETED|Overall Study||0
8487847|NCT00568633|20914664|P2|COMPLETED|Overall Study||33
8487848|NCT00568633|20914665|P1|COMPLETED|Overall Study||25
8487849|NCT00568633|20914664|P2|STARTED|Overall Study||33
8487850|NCT00568633|20914665|P1|STARTED|Overall Study||25
8487851|NCT00568555|20914687|P2|NOT COMPLETED|Overall Study||1
8487852|NCT00568555|20914688|P1|NOT COMPLETED|Overall Study||1
8487853|NCT00568555|20914687|P2|COMPLETED|Overall Study||14
8487854|NCT00568555|20914688|P1|COMPLETED|Overall Study||15
8487855|NCT00568555|20914687|P2|STARTED|Overall Study||15
8487856|NCT00568555|20914688|P1|STARTED|Overall Study||16
8487857|NCT00568451|20914706|P4|NOT COMPLETED|Overall Study||7
8487858|NCT00568451|20914707|P3|NOT COMPLETED|Overall Study||2
8487859|NCT00568451|20914708|P2|NOT COMPLETED|Overall Study||0
8487860|NCT00568451|20914709|P1|NOT COMPLETED|Overall Study||0
8487861|NCT00568451|20914706|P4|COMPLETED|Overall Study||2
8487862|NCT00568451|20914707|P3|COMPLETED|Overall Study||0
8487863|NCT00568451|20914708|P2|COMPLETED|Overall Study||0
8487864|NCT00568451|20914709|P1|COMPLETED|Overall Study||0
8487865|NCT00568451|20914706|P4|STARTED|Overall Study||9
8487866|NCT00568451|20914707|P3|STARTED|Overall Study||2
8487867|NCT00568451|20914708|P2|STARTED|Overall Study||0
8487868|NCT00568451|20914709|P1|STARTED|Overall Study||0
8487869|NCT00568399|20914725|P1|NOT COMPLETED|Overall Study||15
8487870|NCT00568399|20914725|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
8487871|NCT00568399|20914725|P1|STARTED|Overall Study||37
8487872|NCT00568386|20914731|P2|NOT COMPLETED|Overall Study||0
8487873|NCT00568386|20914732|P1|NOT COMPLETED|Overall Study||0
8487874|NCT00568386|20914731|P2|COMPLETED|Overall Study||20
8487875|NCT00568386|20914732|P1|COMPLETED|Overall Study||20
8487876|NCT00568386|20914731|P2|STARTED|Overall Study||20
8487877|NCT00568386|20914732|P1|STARTED|Overall Study||20
8487878|NCT00568334|20914740|P2|NOT COMPLETED|Overall Study||1
8487879|NCT00568334|20914741|P1|NOT COMPLETED|Overall Study||1
8487880|NCT00568334|20914740|P2|COMPLETED|Overall Study||121
8487881|NCT00568334|20914741|P1|COMPLETED|Overall Study||121
8487882|NCT00568334|20914740|P2|STARTED|Overall Study||122
8487883|NCT00568334|20914741|P1|STARTED|Overall Study||122
8487884|NCT00568178|20914767|P6|NOT COMPLETED|Open Label Extension||80
8487885|NCT00568178|20914768|P5|NOT COMPLETED|Open Label Extension||79
8487886|NCT00568178|20914769|P4|NOT COMPLETED|Open Label Extension||0
8487887|NCT00568178|20914770|P3|NOT COMPLETED|Open Label Extension||0
8487888|NCT00568178|20914771|P2|NOT COMPLETED|Open Label Extension||0
8487889|NCT00568178|20914772|P1|NOT COMPLETED|Open Label Extension||0
8487890|NCT00568178|20914767|P6|COMPLETED|Open Label Extension||54
8487891|NCT00568178|20914768|P5|COMPLETED|Open Label Extension||55
8487892|NCT00568178|20914769|P4|COMPLETED|Open Label Extension||0
8487893|NCT00568178|20914770|P3|COMPLETED|Open Label Extension||0
8487894|NCT00568178|20914771|P2|COMPLETED|Open Label Extension||0
8487895|NCT00568178|20914772|P1|COMPLETED|Open Label Extension||0
8487896|NCT00568178|20914767|P6|STARTED|Open Label Extension||134
8487897|NCT00568178|20914768|P5|STARTED|Open Label Extension||134
8487898|NCT00568178|20914769|P4|STARTED|Open Label Extension||0
8487899|NCT00568178|20914770|P3|STARTED|Open Label Extension||0
8487900|NCT00568178|20914771|P2|STARTED|Open Label Extension||0
8487901|NCT00568178|20914772|P1|STARTED|Open Label Extension||0
8487902|NCT00568178|20914767|P6|NOT COMPLETED|Double Blind Base Study||0
8487903|NCT00568178|20914768|P5|NOT COMPLETED|Double Blind Base Study||0
8487904|NCT00568178|20914769|P4|NOT COMPLETED|Double Blind Base Study||5
8487905|NCT00568178|20914770|P3|NOT COMPLETED|Double Blind Base Study||1
8487906|NCT00568178|20914771|P2|NOT COMPLETED|Double Blind Base Study||6
8487907|NCT00568178|20914772|P1|NOT COMPLETED|Double Blind Base Study||6
8487908|NCT00568178|20914767|P6|COMPLETED|Double Blind Base Study||0
8487909|NCT00568178|20914768|P5|COMPLETED|Double Blind Base Study||0
8487910|NCT00568178|20914769|P4|COMPLETED|Double Blind Base Study||25
8487911|NCT00568178|20914770|P3|COMPLETED|Double Blind Base Study||29
8487912|NCT00568178|20914771|P2|COMPLETED|Double Blind Base Study||118
8487913|NCT00568178|20914772|P1|COMPLETED|Double Blind Base Study||116
8487914|NCT00568178|20914767|P6|STARTED|Double Blind Base Study||0
8487915|NCT00568178|20914768|P5|STARTED|Double Blind Base Study||0
8487916|NCT00568178|20914769|P4|STARTED|Double Blind Base Study||30
8487917|NCT00568178|20914770|P3|STARTED|Double Blind Base Study||30
8487918|NCT00568178|20914771|P2|STARTED|Double Blind Base Study||124
8487919|NCT00568178|20914772|P1|STARTED|Double Blind Base Study||122
8487920|NCT00568126|20914790|P2|NOT COMPLETED|Overall Study||9
8487921|NCT00568126|20914791|P1|NOT COMPLETED|Overall Study||11
8487922|NCT00568126|20914790|P2|COMPLETED|Overall Study||12
8487923|NCT00568126|20914791|P1|COMPLETED|Overall Study||13
8487924|NCT00568126|20914790|P2|STARTED|Overall Study||21
8487925|NCT00568126|20914791|P1|STARTED|Overall Study||24
8487926|NCT00568087|20914801|P2|NOT COMPLETED|Overall Study||7
8487927|NCT00568087|20914802|P1|NOT COMPLETED|Overall Study||7
8487928|NCT00568087|20914801|P2|COMPLETED|Overall Study||17
8487929|NCT00568087|20914802|P1|COMPLETED|Overall Study||15
8487930|NCT00568087|20914801|P2|Received Intervention|Overall Study||23
8487931|NCT00568087|20914802|P1|Received Intervention|Overall Study||21
8487932|NCT00568087|20914801|P2|STARTED|Overall Study||24
8487933|NCT00568087|20914802|P1|STARTED|Overall Study||22
8487934|NCT00568061|20914816|P2|NOT COMPLETED|Overall Study||2
8487935|NCT00568061|20914817|P1|NOT COMPLETED|Overall Study||5
8487936|NCT00568061|20914816|P2|COMPLETED|Overall Study||14
8487937|NCT00568061|20914817|P1|COMPLETED|Overall Study||8
8487938|NCT00568061|20914816|P2|STARTED|Overall Study||16
8487939|NCT00568061|20914817|P1|STARTED|Overall Study||13
8487940|NCT00568022|20914845|P3|NOT COMPLETED|Overall Study||0
8487941|NCT00568022|20914846|P2|NOT COMPLETED|Overall Study||0
8487942|NCT00568022|20914847|P1|NOT COMPLETED|Overall Study||0
8487943|NCT00568022|20914845|P3|COMPLETED|Overall Study||3
8487944|NCT00568022|20914846|P2|COMPLETED|Overall Study||3
8487945|NCT00568022|20914847|P1|COMPLETED|Overall Study||3
8487946|NCT00568022|20914845|P3|STARTED|Overall Study||3
8487947|NCT00568022|20914846|P2|STARTED|Overall Study||3
8487948|NCT00568022|20914847|P1|STARTED|Overall Study||3
8487949|NCT00567996|20914880|P3|NOT COMPLETED|Overall Study||70
8487950|NCT00567996|20914881|P2|NOT COMPLETED|Overall Study||50
8487951|NCT00567996|20914882|P1|NOT COMPLETED|Overall Study||44
8487952|NCT00567996|20914880|P3|COMPLETED|Overall Study||265
8487953|NCT00567996|20914881|P2|COMPLETED|Overall Study||284
8487954|NCT00567996|20914882|P1|COMPLETED|Overall Study||289
8487955|NCT00567996|20914880|P3|Intent-to-treat: Received Study Drug|Overall Study||335
8487956|NCT00567996|20914881|P2|Intent-to-treat: Received Study Drug|Overall Study||333
8487957|NCT00567996|20914882|P1|Intent-to-treat: Received Study Drug|Overall Study||330
8487958|NCT00567996|20914880|P3|STARTED|Overall Study||335
8487959|NCT00567996|20914881|P2|STARTED|Overall Study||334
8487960|NCT00567996|20914882|P1|STARTED|Overall Study|Randomized participants|333
8487961|NCT00567892|20914898|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
8487962|NCT00567892|20914899|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8487963|NCT00567892|20914900|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8487964|NCT00567892|20914901|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8487965|NCT00567892|20914898|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
8487966|NCT00567892|20914899|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
8487967|NCT00567892|20914900|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
8487968|NCT00567892|20914901|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
8487969|NCT00567892|20914898|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
8487970|NCT00567892|20914899|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
8487971|NCT00567892|20914900|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
8487972|NCT00567892|20914901|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
8487973|NCT00567892|20914898|P4|NOT COMPLETED|Washout (2 Weeks)||0
8487974|NCT00567892|20914899|P3|NOT COMPLETED|Washout (2 Weeks)||0
8487975|NCT00567892|20914900|P2|NOT COMPLETED|Washout (2 Weeks)||0
8487976|NCT00567892|20914901|P1|NOT COMPLETED|Washout (2 Weeks)||0
8487977|NCT00567892|20914898|P4|COMPLETED|Washout (2 Weeks)||6
8487978|NCT00567892|20914899|P3|COMPLETED|Washout (2 Weeks)||9
8487979|NCT00567892|20914900|P2|COMPLETED|Washout (2 Weeks)||7
8487980|NCT00567892|20914901|P1|COMPLETED|Washout (2 Weeks)||7
8487981|NCT00567892|20914898|P4|STARTED|Washout (2 Weeks)||6
8487982|NCT00567892|20914899|P3|STARTED|Washout (2 Weeks)||9
8487983|NCT00567892|20914900|P2|STARTED|Washout (2 Weeks)||7
8487984|NCT00567892|20914901|P1|STARTED|Washout (2 Weeks)||7
8487985|NCT00567892|20914898|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
8487986|NCT00567892|20914899|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
8487987|NCT00567892|20914900|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
8487988|NCT00567892|20914901|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
8487989|NCT00567892|20914898|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
8487990|NCT00567892|20914899|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
8487991|NCT00567892|20914900|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
8487992|NCT00567892|20914901|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
8487993|NCT00567892|20914898|P4|STARTED|First Treatment (2 or 4 Weeks)||10
8487994|NCT00567892|20914899|P3|STARTED|First Treatment (2 or 4 Weeks)||10
8487995|NCT00567892|20914900|P2|STARTED|First Treatment (2 or 4 Weeks)||7
8487996|NCT00567892|20914901|P1|STARTED|First Treatment (2 or 4 Weeks)||7
8487997|NCT00567879|20914919|P6|NOT COMPLETED|Overall Study||3
8487998|NCT00567879|20914920|P5|NOT COMPLETED|Overall Study||12
8487999|NCT00567879|20914921|P4|NOT COMPLETED|Overall Study||6
8488000|NCT00567879|20914922|P3|NOT COMPLETED|Overall Study||21
8488001|NCT00567879|20914923|P2|NOT COMPLETED|Overall Study||7
8488002|NCT00567879|20914924|P1|NOT COMPLETED|Overall Study||7
8488003|NCT00567879|20914919|P6|COMPLETED|Overall Study||0
8488004|NCT00567879|20914920|P5|COMPLETED|Overall Study||0
8488005|NCT00567879|20914921|P4|COMPLETED|Overall Study||0
8488006|NCT00567879|20914922|P3|COMPLETED|Overall Study||0
8488007|NCT00567879|20914923|P2|COMPLETED|Overall Study||0
8488008|NCT00567879|20914924|P1|COMPLETED|Overall Study||0
8488009|NCT00567879|20914919|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
8488010|NCT00567879|20914920|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
8488011|NCT00567879|20914921|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
8488012|NCT00567879|20914922|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
8488013|NCT00567879|20914923|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
8488014|NCT00567879|20914924|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
8488015|NCT00567879|20914919|P6|STARTED|Overall Study||3
8488016|NCT00567879|20914920|P5|STARTED|Overall Study||12
8488017|NCT00567879|20914921|P4|STARTED|Overall Study||6
8488018|NCT00567879|20914922|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
8488019|NCT00567879|20914923|P2|STARTED|Overall Study||7
8488020|NCT00567879|20914924|P1|STARTED|Overall Study||7
8488021|NCT00567840|20914950|P5|NOT COMPLETED|Overall Study||0
8488022|NCT00567840|20914951|P4|NOT COMPLETED|Overall Study||1
8488023|NCT00567840|20914952|P3|NOT COMPLETED|Overall Study||1
8488024|NCT00567840|20914953|P2|NOT COMPLETED|Overall Study||0
8488025|NCT00567840|20914954|P1|NOT COMPLETED|Overall Study||2
8488026|NCT00567840|20914950|P5|COMPLETED|Overall Study||8
8488027|NCT00567840|20914951|P4|COMPLETED|Overall Study||14
8488028|NCT00567840|20914952|P3|COMPLETED|Overall Study||15
8488029|NCT00567840|20914953|P2|COMPLETED|Overall Study||15
8488030|NCT00567840|20914954|P1|COMPLETED|Overall Study||13
8488031|NCT00567840|20914950|P5|STARTED|Overall Study||8
8488032|NCT00567840|20914951|P4|STARTED|Overall Study||15
8488033|NCT00567840|20914952|P3|STARTED|Overall Study||16
8488034|NCT00567840|20914953|P2|STARTED|Overall Study||15
8488035|NCT00567840|20914954|P1|STARTED|Overall Study||15
8488036|NCT00567593|20914991|P1|NOT COMPLETED|Overall Study||2
8488037|NCT00567593|20914991|P1|COMPLETED|Overall Study||10
8488038|NCT00567593|20914991|P1|STARTED|Overall Study||12
8488039|NCT00567567|20914998|P3|NOT COMPLETED|Overall Study||278
8488040|NCT00567567|20914999|P2|NOT COMPLETED|Overall Study||134
8488041|NCT00567567|20915000|P1|NOT COMPLETED|Overall Study||152
8488042|NCT00567567|20914998|P3|COMPLETED|Overall Study||1
8488043|NCT00567567|20914999|P2|COMPLETED|Overall Study||42
8488044|NCT00567567|20915000|P1|COMPLETED|Overall Study||58
8488045|NCT00567567|20914998|P3|STARTED|Overall Study||279
8488046|NCT00567567|20914999|P2|STARTED|Overall Study||176
8488047|NCT00567567|20915000|P1|STARTED|Overall Study||210
8488048|NCT00567541|20915048|P2|NOT COMPLETED|Overall Study||1
8488049|NCT00567541|20915049|P1|NOT COMPLETED|Overall Study||0
8488050|NCT00567541|20915048|P2|COMPLETED|Overall Study||8
8488051|NCT00567541|20915049|P1|COMPLETED|Overall Study||7
8488052|NCT00567541|20915048|P2|STARTED|Overall Study||9
8488053|NCT00567541|20915049|P1|STARTED|Overall Study||7
8488054|NCT00567502|20915059|P4|NOT COMPLETED|Overall Study||87
8488055|NCT00567502|20915060|P3|NOT COMPLETED|Overall Study||908
8488056|NCT00567502|20915061|P2|NOT COMPLETED|Overall Study||33
8488057|NCT00567502|20915062|P1|NOT COMPLETED|Overall Study||241
8488058|NCT00567502|20915059|P4|COMPLETED|Overall Study||23
8488059|NCT00567502|20915060|P3|COMPLETED|Overall Study||1758
8488060|NCT00567502|20915061|P2|COMPLETED|Overall Study||108
8488061|NCT00567502|20915062|P1|COMPLETED|Overall Study||563
8488062|NCT00567502|20915059|P4|Initiated Treatment|Overall Study||38
8488063|NCT00567502|20915060|P3|Initiated Treatment|Overall Study||2666
8488064|NCT00567502|20915061|P2|Initiated Treatment|Overall Study||141
8488065|NCT00567502|20915062|P1|Initiated Treatment|Overall Study||804
8488066|NCT00567502|20915059|P4|STARTED|Overall Study||110
8488067|NCT00567502|20915060|P3|STARTED|Overall Study||2666
8488068|NCT00567502|20915061|P2|STARTED|Overall Study||141
8488069|NCT00567502|20915062|P1|STARTED|Overall Study||804
8488070|NCT00567489|20915099|P2|NOT COMPLETED|Overall Study||23
8488071|NCT00567489|20915100|P1|NOT COMPLETED|Overall Study||7
8488072|NCT00567489|20915099|P2|COMPLETED|Overall Study||101
8488073|NCT00567489|20915100|P1|COMPLETED|Overall Study||120
8488074|NCT00567489|20915099|P2|STARTED|Overall Study||124
8488075|NCT00567489|20915100|P1|STARTED|Overall Study||127
8488076|NCT00567476|20915150|P2|NOT COMPLETED|Overall Study||4
8488077|NCT00567476|20915151|P1|NOT COMPLETED|Overall Study||8
8488078|NCT00567476|20915150|P2|COMPLETED|Overall Study||34
8488079|NCT00567476|20915151|P1|COMPLETED|Overall Study||70
8488080|NCT00567476|20915150|P2|STARTED|Overall Study||38
8488081|NCT00567476|20915151|P1|STARTED|Overall Study||78
8488082|NCT00567398|20915177|P2|NOT COMPLETED|Overall Study||23
8488083|NCT00567398|20915178|P1|NOT COMPLETED|Overall Study||7
8488084|NCT00567398|20915177|P2|COMPLETED|Overall Study||101
8488085|NCT00567398|20915178|P1|COMPLETED|Overall Study||120
8488086|NCT00567398|20915177|P2|STARTED|Overall Study||124
8488087|NCT00567398|20915178|P1|STARTED|Overall Study||127
8488088|NCT00567359|20915226|P1|NOT COMPLETED|Overall Study||1
8488089|NCT00567359|20915226|P1|COMPLETED|Overall Study||99
8488090|NCT00567359|20915226|P1|STARTED|Overall Study||100
8488091|NCT00567320|20915235|P2|NOT COMPLETED|Overall Study||0
8488092|NCT00567320|20915236|P1|NOT COMPLETED|Overall Study||0
8488093|NCT00567320|20915235|P2|COMPLETED|Overall Study||18
8488094|NCT00567320|20915236|P1|COMPLETED|Overall Study||13
8488095|NCT00567320|20915235|P2|STARTED|Overall Study||18
8488096|NCT00567320|20915236|P1|STARTED|Overall Study||13
8488097|NCT00567307|20915244|P2|NOT COMPLETED|Overall Study||1
8488098|NCT00567307|20915245|P1|NOT COMPLETED|Overall Study||12
8488099|NCT00567307|20915244|P2|COMPLETED|Overall Study||104
8488100|NCT00567307|20915245|P1|COMPLETED|Overall Study||99
8488101|NCT00567307|20915244|P2|STARTED|Overall Study||105
8488102|NCT00567307|20915245|P1|STARTED|Overall Study||111
8488106|NCT00567255|20915302|P2|NOT COMPLETED|Overall Study||228
8488107|NCT00567255|20915303|P1|NOT COMPLETED|Overall Study||463
8488108|NCT00567255|20915302|P2|COMPLETED|Overall Study||267
8488109|NCT00567255|20915303|P1|COMPLETED|Overall Study||538
8488110|NCT00567255|20915302|P2|STARTED|Overall Study||495
8488111|NCT00567255|20915303|P1|STARTED|Overall Study||1001
8488112|NCT00567242|20915349|P2|NOT COMPLETED|Overall Study||0
8488113|NCT00567242|20915350|P1|NOT COMPLETED|Overall Study||0
8488114|NCT00567242|20915349|P2|COMPLETED|Overall Study||7
8488115|NCT00567242|20915350|P1|COMPLETED|Overall Study||7
8488116|NCT00567242|20915349|P2|STARTED|Overall Study||7
8488117|NCT00567242|20915350|P1|STARTED|Overall Study||7
8488118|NCT00567229|20915360|P1|NOT COMPLETED|Overall Study||0
8488119|NCT00567229|20915360|P1|COMPLETED|Overall Study||3
8488120|NCT00567229|20915360|P1|STARTED|Overall Study||3
8488121|NCT00567190|20915366|P2|NOT COMPLETED|Overall Study||333
8488122|NCT00567190|20915367|P1|NOT COMPLETED|Overall Study||283
8488123|NCT00567190|20915366|P2|COMPLETED|Overall Study||73
8488124|NCT00567190|20915367|P1|COMPLETED|Overall Study||119
8488125|NCT00567190|20915366|P2|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
8488126|NCT00567190|20915367|P1|Crossover From Placebo to Pertuzumab|Overall Study||0
8488127|NCT00567190|20915366|P2|Received at Least One Dose of Placebo|Overall Study||395
8488128|NCT00567190|20915367|P1|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
8488129|NCT00567190|20915366|P2|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
8488130|NCT00567190|20915367|P1|Received at Least One Dose of Pertuzumab|Overall Study||399
8488131|NCT00567190|20915366|P2|Did Not Receive Any Study Treatment|Overall Study||2
8488132|NCT00567190|20915367|P1|Did Not Receive Any Study Treatment|Overall Study||2
8488133|NCT00567190|20915366|P2|STARTED|Overall Study||406
8488134|NCT00567190|20915367|P1|STARTED|Overall Study||402
8488135|NCT00567164|20915418|P3|NOT COMPLETED|Overall Study||72
8488136|NCT00567164|20915419|P2|NOT COMPLETED|Overall Study||73
8488137|NCT00567164|20915420|P1|NOT COMPLETED|Overall Study||546
8488138|NCT00567164|20915418|P3|COMPLETED|Overall Study||160
8488139|NCT00567164|20915419|P2|COMPLETED|Overall Study||161
8488140|NCT00567164|20915420|P1|COMPLETED|Overall Study||875
8488141|NCT00567164|20915418|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
8488142|NCT00567164|20915419|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
8488143|NCT00567164|20915420|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
8488144|NCT00567164|20915418|P3|STARTED|Overall Study||232
8488145|NCT00567164|20915419|P2|STARTED|Overall Study||234
8488146|NCT00567164|20915420|P1|STARTED|Overall Study||1421
8488147|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8488148|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8488149|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8488150|NCT00567112|20915492|P3|COMPLETED|Treatment Period 4 (3 Days)||3
8488151|NCT00567112|20915493|P2|COMPLETED|Treatment Period 4 (3 Days)||7
8488152|NCT00567112|20915494|P1|COMPLETED|Treatment Period 4 (3 Days)||4
8488153|NCT00567112|20915492|P3|STARTED|Treatment Period 4 (3 Days)||3
8488154|NCT00567112|20915493|P2|STARTED|Treatment Period 4 (3 Days)||7
8488155|NCT00567112|20915494|P1|STARTED|Treatment Period 4 (3 Days)||4
8488156|NCT00567112|20915492|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
8488157|NCT00567112|20915493|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
8488158|NCT00567112|20915494|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
8488159|NCT00567112|20915492|P3|COMPLETED|Washout Period 3 (3 Days)||3
8488160|NCT00567112|20915493|P2|COMPLETED|Washout Period 3 (3 Days)||7
8488161|NCT00567112|20915494|P1|COMPLETED|Washout Period 3 (3 Days)||4
8488162|NCT00567112|20915492|P3|STARTED|Washout Period 3 (3 Days)||3
8488163|NCT00567112|20915493|P2|STARTED|Washout Period 3 (3 Days)||7
8488164|NCT00567112|20915494|P1|STARTED|Washout Period 3 (3 Days)||7
8488165|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8488166|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8488167|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8488168|NCT00567112|20915492|P3|COMPLETED|Treatment Period 3 (3 Days)||3
8488169|NCT00567112|20915493|P2|COMPLETED|Treatment Period 3 (3 Days)||7
8488170|NCT00567112|20915494|P1|COMPLETED|Treatment Period 3 (3 Days)||7
8488171|NCT00567112|20915492|P3|STARTED|Treatment Period 3 (3 Days)||3
8488172|NCT00567112|20915493|P2|STARTED|Treatment Period 3 (3 Days)||7
8488173|NCT00567112|20915494|P1|STARTED|Treatment Period 3 (3 Days)||7
8488174|NCT00567112|20915492|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
8488175|NCT00567112|20915493|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
8488176|NCT00567112|20915494|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
8488177|NCT00567112|20915492|P3|COMPLETED|Washout Period 2 (3 Days)||3
8488178|NCT00567112|20915493|P2|COMPLETED|Washout Period 2 (3 Days)||7
8488179|NCT00567112|20915494|P1|COMPLETED|Washout Period 2 (3 Days)||7
8488180|NCT00567112|20915492|P3|STARTED|Washout Period 2 (3 Days)||3
8488181|NCT00567112|20915493|P2|STARTED|Washout Period 2 (3 Days)||7
8488182|NCT00567112|20915494|P1|STARTED|Washout Period 2 (3 Days)||7
8488183|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8488184|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
8488185|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8488186|NCT00567112|20915492|P3|COMPLETED|Treatment Period 2 (3 Days)||3
8488187|NCT00567112|20915493|P2|COMPLETED|Treatment Period 2 (3 Days)||7
8488188|NCT00567112|20915494|P1|COMPLETED|Treatment Period 2 (3 Days)||7
8488189|NCT00567112|20915492|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
8488190|NCT00567112|20915493|P2|STARTED|Treatment Period 2 (3 Days)||8
8488191|NCT00567112|20915494|P1|STARTED|Treatment Period 2 (3 Days)||7
8488192|NCT00567112|20915492|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
8488193|NCT00567112|20915493|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
8488194|NCT00567112|20915494|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
8488195|NCT00567112|20915492|P3|COMPLETED|Washout Period 1 (3 Days)||0
8488196|NCT00567112|20915493|P2|COMPLETED|Washout Period 1 (3 Days)||8
8488197|NCT00567112|20915494|P1|COMPLETED|Washout Period 1 (3 Days)||7
8488198|NCT00567112|20915492|P3|STARTED|Washout Period 1 (3 Days)||0
8488199|NCT00567112|20915493|P2|STARTED|Washout Period 1 (3 Days)||8
8488200|NCT00567112|20915494|P1|STARTED|Washout Period 1 (3 Days)||7
8488201|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8488202|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8488203|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8488204|NCT00567112|20915492|P3|COMPLETED|Treatment Period 1 (3 Days)||0
8488205|NCT00567112|20915493|P2|COMPLETED|Treatment Period 1 (3 Days)||8
8488206|NCT00567112|20915494|P1|COMPLETED|Treatment Period 1 (3 Days)||7
8488207|NCT00567112|20915492|P3|STARTED|Treatment Period 1 (3 Days)||0
8488208|NCT00567112|20915493|P2|STARTED|Treatment Period 1 (3 Days)||8
8488209|NCT00567112|20915494|P1|STARTED|Treatment Period 1 (3 Days)||7
8488210|NCT00567008|20915518|P2|NOT COMPLETED|Overall Study||1
8488211|NCT00567008|20915519|P1|NOT COMPLETED|Overall Study||1
8488212|NCT00567008|20915518|P2|COMPLETED|Overall Study||18
8488213|NCT00567008|20915519|P1|COMPLETED|Overall Study||17
8488214|NCT00567008|20915518|P2|STARTED|Overall Study||19
8488215|NCT00567008|20915519|P1|STARTED|Overall Study||18
8488216|NCT00566995|20915525|P1|NOT COMPLETED|Overall Study||7
8488217|NCT00566995|20915525|P1|COMPLETED|Overall Study||30
8488218|NCT00566995|20915525|P1|STARTED|Overall Study||37
8488219|NCT00566982|20915540|P2|NOT COMPLETED|Overall Study||69
8488220|NCT00566982|20915541|P1|NOT COMPLETED|Overall Study||8
8488221|NCT00566982|20915540|P2|COMPLETED|Overall Study||294
8488222|NCT00566982|20915541|P1|COMPLETED|Overall Study||55
8488223|NCT00566982|20915540|P2|STARTED|Overall Study||363
8488224|NCT00566982|20915541|P1|STARTED|Overall Study||63
8488225|NCT00566969|20915566|P3|NOT COMPLETED|Overall Study||12
8488226|NCT00566969|20915567|P2|NOT COMPLETED|Overall Study||9
8488227|NCT00566969|20915568|P1|NOT COMPLETED|Overall Study||15
8488228|NCT00566969|20915566|P3|COMPLETED|Overall Study||23
8488229|NCT00566969|20915567|P2|COMPLETED|Overall Study||28
8488230|NCT00566969|20915568|P1|COMPLETED|Overall Study||19
8488231|NCT00566969|20915566|P3|STARTED|Overall Study||35
8488232|NCT00566969|20915567|P2|STARTED|Overall Study||37
8488233|NCT00566969|20915568|P1|STARTED|Overall Study||34
8488234|NCT00566943|20915578|P2|NOT COMPLETED|Overall Study||0
8488235|NCT00566943|20915579|P1|NOT COMPLETED|Overall Study||0
8488236|NCT00566943|20915578|P2|COMPLETED|Overall Study||49
8488237|NCT00566943|20915579|P1|COMPLETED|Overall Study||52
8488238|NCT00566943|20915578|P2|STARTED|Overall Study||49
8488239|NCT00566943|20915579|P1|STARTED|Overall Study||52
8488240|NCT00566930|20915594|P3|NOT COMPLETED|Overall Study||1
8488241|NCT00566930|20915595|P2|NOT COMPLETED|Overall Study||4
8488242|NCT00566930|20915596|P1|NOT COMPLETED|Overall Study||2
8488243|NCT00566930|20915594|P3|COMPLETED|Overall Study||32
8488244|NCT00566930|20915595|P2|COMPLETED|Overall Study||32
8488245|NCT00566930|20915596|P1|COMPLETED|Overall Study||27
8488246|NCT00566930|20915594|P3|STARTED|Overall Study||33
8488247|NCT00566930|20915595|P2|STARTED|Overall Study||36
8488248|NCT00566930|20915596|P1|STARTED|Overall Study||29
8488249|NCT00566852|20915606|P2|NOT COMPLETED|Overall Study||198
8488250|NCT00566852|20915607|P1|NOT COMPLETED|Overall Study||207
8488251|NCT00566852|20915606|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
8488252|NCT00566852|20915607|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
8488253|NCT00566852|20915606|P2|STARTED|Overall Study||276
8488254|NCT00566852|20915607|P1|STARTED|Overall Study||278
8488255|NCT00566813|20915625|P2|NOT COMPLETED|Overall Study||0
8488256|NCT00566813|20915626|P1|NOT COMPLETED|Overall Study||0
8488257|NCT00566813|20915625|P2|COMPLETED|Overall Study||6
8488258|NCT00566813|20915626|P1|COMPLETED|Overall Study||4
8488259|NCT00566813|20915625|P2|STARTED|Overall Study||6
8488260|NCT00566813|20915626|P1|STARTED|Overall Study||4
8488261|NCT00566735|20915638|P2|NOT COMPLETED|Overall Study||7
8488262|NCT00566735|20915639|P1|NOT COMPLETED|Overall Study||2
8488263|NCT00566735|20915638|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
8488264|NCT00566735|20915639|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
8488265|NCT00566735|20915638|P2|Withdrew Before Baseline Measures|Overall Study||7
8488266|NCT00566735|20915639|P1|Withdrew Before Baseline Measures|Overall Study||2
8488267|NCT00566735|20915638|P2|STARTED|Overall Study||19
8488268|NCT00566735|20915639|P1|STARTED|Overall Study||20
8488269|NCT00566722|20915652|P3|NOT COMPLETED|Overall Study||9
8488270|NCT00566722|20915653|P2|NOT COMPLETED|Overall Study||5
8488271|NCT00566722|20915654|P1|NOT COMPLETED|Overall Study||2
8488272|NCT00566722|20915652|P3|COMPLETED|Overall Study||73
8488273|NCT00566722|20915653|P2|COMPLETED|Overall Study||24
8488274|NCT00566722|20915654|P1|COMPLETED|Overall Study||39
8488275|NCT00566722|20915652|P3|STARTED|Overall Study||82
8488276|NCT00566722|20915653|P2|STARTED|Overall Study||29
8488277|NCT00566722|20915654|P1|STARTED|Overall Study||41
8488278|NCT00566709|20915700|P2|NOT COMPLETED|Overall Study||0
8488279|NCT00566709|20915701|P1|NOT COMPLETED|Overall Study||5
8488280|NCT00566709|20915700|P2|COMPLETED|Overall Study||51
8488281|NCT00566709|20915701|P1|COMPLETED|Overall Study||46
8488282|NCT00566709|20915700|P2|STARTED|Overall Study||51
8488283|NCT00566709|20915701|P1|STARTED|Overall Study||51
8488284|NCT00566696|20915717|P1|NOT COMPLETED|Overall Study||42
8488285|NCT00566696|20915717|P1|COMPLETED|Overall Study||31
8488286|NCT00566696|20915717|P1|STARTED|Overall Study||73
8488287|NCT00566631|20915727|P1|NOT COMPLETED|Part 2: Extension Phase||82
8488288|NCT00566631|20915727|P1|COMPLETED|Part 2: Extension Phase||57
8488289|NCT00566631|20915727|P1|STARTED|Part 2: Extension Phase||139
8488290|NCT00566631|20915727|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
8488291|NCT00566631|20915727|P1|COMPLETED|Between Treatment and Extension Phase||139
8488292|NCT00566631|20915727|P1|STARTED|Between Treatment and Extension Phase||234
8488293|NCT00566631|20915727|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
8488294|NCT00566631|20915727|P1|COMPLETED|Part 1: Core Treatment Phase||234
8488295|NCT00566631|20915727|P1|STARTED|Part 1: Core Treatment Phase||294
8488296|NCT00566579|20915744|P2|NOT COMPLETED|Overall Study||0
8488297|NCT00566579|20915745|P1|NOT COMPLETED|Overall Study||0
8488298|NCT00566579|20915744|P2|COMPLETED|Overall Study||31
8488299|NCT00566579|20915745|P1|COMPLETED|Overall Study||29
8488300|NCT00566579|20915744|P2|STARTED|Overall Study||31
8488301|NCT00566579|20915745|P1|STARTED|Overall Study||29
8488302|NCT00566527|20915754|P3|NOT COMPLETED|Overall Study||78
8488303|NCT00566527|20915755|P2|NOT COMPLETED|Overall Study||66
8488304|NCT00566527|20915756|P1|NOT COMPLETED|Overall Study||17
8488305|NCT00566527|20915754|P3|COMPLETED|Overall Study||461
8488306|NCT00566527|20915755|P2|COMPLETED|Overall Study||474
8488307|NCT00566527|20915756|P1|COMPLETED|Overall Study||524
8488308|NCT00566527|20915754|P3|Received ProQuad® Dose 2|Overall Study||462
8488309|NCT00566527|20915755|P2|Received ProQuad® Dose 2|Overall Study||478
8488310|NCT00566527|20915756|P1|Received ProQuad® Dose 2|Overall Study||525
8488311|NCT00566527|20915754|P3|Received ProQuad® Dose 1|Overall Study||470
8488312|NCT00566527|20915755|P2|Received ProQuad® Dose 1|Overall Study||484
8488313|NCT00566527|20915756|P1|Received ProQuad® Dose 1|Overall Study||529
8488314|NCT00566527|20915754|P3|STARTED|Overall Study|Number randomized.|539
8488315|NCT00566527|20915755|P2|STARTED|Overall Study|Number randomized.|540
8488316|NCT00566527|20915756|P1|STARTED|Overall Study|Number randomized.|541
8488317|NCT00566501|20915797|P2|NOT COMPLETED|Overall Study||126
8488318|NCT00566501|20915798|P1|NOT COMPLETED|Overall Study||156
8488319|NCT00566501|20915797|P2|COMPLETED|Overall Study||210
8488320|NCT00566501|20915798|P1|COMPLETED|Overall Study||423
8488321|NCT00566501|20915797|P2|Not Determined|Overall Study||0
8488322|NCT00566501|20915798|P1|Not Determined|Overall Study||1
8488323|NCT00566501|20915797|P2|Other ( Not Specified)|Overall Study||21
8488324|NCT00566501|20915798|P1|Other ( Not Specified)|Overall Study||24
8488325|NCT00566501|20915797|P2|Medication Non-compliance|Overall Study||0
8488326|NCT00566501|20915798|P1|Medication Non-compliance|Overall Study||5
8488327|NCT00566501|20915797|P2|Protocol Violation|Overall Study||2
8488328|NCT00566501|20915798|P1|Protocol Violation|Overall Study||2
8488329|NCT00566501|20915797|P2|Request of Investigator or Sponsor|Overall Study||7
8488330|NCT00566501|20915798|P1|Request of Investigator or Sponsor|Overall Study||6
8488331|NCT00566501|20915797|P2|Withdraw of Consent by Subject|Overall Study||30
8488332|NCT00566501|20915798|P1|Withdraw of Consent by Subject|Overall Study||33
8488333|NCT00566501|20915797|P2|Lack of Efficacy|Overall Study||3
8488334|NCT00566501|20915798|P1|Lack of Efficacy|Overall Study||8
8488335|NCT00566501|20915797|P2|Adverse Event|Overall Study||59
8488336|NCT00566501|20915798|P1|Adverse Event|Overall Study||68
8488337|NCT00566501|20915797|P2|Discontinued|Overall Study||122
8488338|NCT00566501|20915798|P1|Discontinued|Overall Study||146
8488339|NCT00566501|20915797|P2|Safety Population|Overall Study||332
8488340|NCT00566501|20915798|P1|Safety Population|Overall Study||570
8488341|NCT00566501|20915797|P2|STARTED|Overall Study||336
8488342|NCT00566501|20915798|P1|STARTED|Overall Study||579
8488343|NCT00566462|20915806|P2|NOT COMPLETED|Overall Study||0
8488344|NCT00566462|20915807|P1|NOT COMPLETED|Overall Study||0
8488345|NCT00566462|20915806|P2|COMPLETED|Overall Study||0
8488346|NCT00566462|20915807|P1|COMPLETED|Overall Study||1
8488347|NCT00566462|20915806|P2|STARTED|Overall Study||0
8488348|NCT00566462|20915807|P1|STARTED|Overall Study||1
8488349|NCT00566254|20915817|P2|NOT COMPLETED|Overall Study||14
8488350|NCT00566254|20915818|P1|NOT COMPLETED|Overall Study||10
8488351|NCT00566254|20915817|P2|COMPLETED|Overall Study||93
8488352|NCT00566254|20915818|P1|COMPLETED|Overall Study||90
8488353|NCT00566254|20915817|P2|STARTED|Overall Study||107
8488354|NCT00566254|20915818|P1|STARTED|Overall Study||100
8488355|NCT00566228|20915832|P2|NOT COMPLETED|Overall Study||5
8488356|NCT00566228|20915833|P1|NOT COMPLETED|Overall Study||6
8488357|NCT00566228|20915832|P2|COMPLETED|Overall Study||55
8488358|NCT00566228|20915833|P1|COMPLETED|Overall Study||56
8488359|NCT00566228|20915832|P2|STARTED|Overall Study||60
8488360|NCT00566228|20915833|P1|STARTED|Overall Study||62
8488361|NCT00566150|20915851|P2|NOT COMPLETED|Overall Study||5
8488362|NCT00566150|20915852|P1|NOT COMPLETED|Overall Study||9
8488363|NCT00566150|20915851|P2|COMPLETED|Overall Study||11
8488364|NCT00566150|20915852|P1|COMPLETED|Overall Study||10
8488365|NCT00566150|20915851|P2|STARTED|Overall Study||16
8488366|NCT00566150|20915852|P1|STARTED|Overall Study||19
8488367|NCT00566111|20915866|P2|NOT COMPLETED|Overall Study||2
8488368|NCT00566111|20915867|P1|NOT COMPLETED|Overall Study||0
8488369|NCT00566111|20915866|P2|COMPLETED|Overall Study||1
8488370|NCT00566111|20915867|P1|COMPLETED|Overall Study||2
8488371|NCT00566111|20915866|P2|STARTED|Overall Study||3
8488372|NCT00566111|20915867|P1|STARTED|Overall Study||2
8488373|NCT00566098|20915881|P1|NOT COMPLETED|Administration of ASCT+MILs||18
8488374|NCT00566098|20915881|P1|COMPLETED|Administration of ASCT+MILs||4
8488375|NCT00566098|20915881|P1|STARTED|Administration of ASCT+MILs||22
8488376|NCT00566098|20915881|P1|NOT COMPLETED|Generation of MILs Product||1
8488377|NCT00566098|20915881|P1|COMPLETED|Generation of MILs Product||22
8488378|NCT00566098|20915881|P1|STARTED|Generation of MILs Product||23
8488379|NCT00566098|20915881|P1|NOT COMPLETED|Collection of MILs||2
8488380|NCT00566098|20915881|P1|COMPLETED|Collection of MILs||23
8488381|NCT00566098|20915881|P1|STARTED|Collection of MILs||25
8488382|NCT00566020|20915891|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
8488383|NCT00566020|20915892|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
8488384|NCT00566020|20915891|P2|COMPLETED|46-week Long-term Administration Phase||68
8488385|NCT00566020|20915892|P1|COMPLETED|46-week Long-term Administration Phase||0
8488386|NCT00566020|20915891|P2|STARTED|46-week Long-term Administration Phase||85
8488387|NCT00566020|20915892|P1|STARTED|46-week Long-term Administration Phase||0
8488388|NCT00566020|20915891|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
8488389|NCT00566020|20915892|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
8488390|NCT00566020|20915891|P2|COMPLETED|6-week Dosage Adjustment Phase||0
8488391|NCT00566020|20915892|P1|COMPLETED|6-week Dosage Adjustment Phase||85
8488392|NCT00566020|20915891|P2|STARTED|6-week Dosage Adjustment Phase||0
8488393|NCT00566020|20915892|P1|STARTED|6-week Dosage Adjustment Phase||92
8488394|NCT00565916|20915919|P2|NOT COMPLETED|Overall Study||0
8488395|NCT00565916|20915920|P1|NOT COMPLETED|Overall Study||0
8488396|NCT00565916|20915919|P2|COMPLETED|Overall Study||11
8488397|NCT00565916|20915920|P1|COMPLETED|Overall Study||11
8488398|NCT00565916|20915919|P2|STARTED|Overall Study||11
8488399|NCT00565916|20915920|P1|STARTED|Overall Study||11
8488400|NCT00565864|20915929|P3|NOT COMPLETED|Overall Study||11
8488401|NCT00565864|20915930|P2|NOT COMPLETED|Overall Study||12
8488402|NCT00565864|20915931|P1|NOT COMPLETED|Overall Study||12
8488403|NCT00565864|20915929|P3|COMPLETED|Overall Study||45
8488404|NCT00565864|20915930|P2|COMPLETED|Overall Study||47
8488405|NCT00565864|20915931|P1|COMPLETED|Overall Study||46
8488406|NCT00565864|20915929|P3|STARTED|Overall Study||56
8488407|NCT00565864|20915930|P2|STARTED|Overall Study||59
8488408|NCT00565864|20915931|P1|STARTED|Overall Study||58
8488409|NCT00565812|20915981|P3|NOT COMPLETED|Overall Study||130
8488410|NCT00565812|20915982|P2|NOT COMPLETED|Overall Study||135
8488411|NCT00565812|20915983|P1|NOT COMPLETED|Overall Study||144
8488412|NCT00565812|20915981|P3|COMPLETED|Overall Study||356
8488413|NCT00565812|20915982|P2|COMPLETED|Overall Study||351
8488414|NCT00565812|20915983|P1|COMPLETED|Overall Study||341
8488415|NCT00565812|20915981|P3|STARTED|Overall Study||486
8488416|NCT00565812|20915982|P2|STARTED|Overall Study||486
8488417|NCT00565812|20915983|P1|STARTED|Overall Study||485
8488418|NCT00565773|20916120|P1|NOT COMPLETED|Overall Study||2
8488419|NCT00565773|20916120|P1|COMPLETED|Overall Study||38
8488420|NCT00565773|20916120|P1|STARTED|Overall Study||40
8488421|NCT00565747|20916132|P2|NOT COMPLETED|Overall Study||73
8488422|NCT00565747|20916133|P1|NOT COMPLETED|Overall Study||67
8488423|NCT00565747|20916132|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
8488424|NCT00565747|20916133|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
8488425|NCT00565747|20916132|P2|STARTED|Overall Study||678
8488426|NCT00565747|20916133|P1|STARTED|Overall Study||654
8488427|NCT00565721|20916143|P1|NOT COMPLETED|Overall Study||17
8488428|NCT00565721|20916143|P1|COMPLETED|Overall Study||16
8488429|NCT00565721|20916143|P1|STARTED|Overall Study||33
8488430|NCT00565669|20916164|P2|NOT COMPLETED|Overall Study||0
8488431|NCT00565669|20916165|P1|NOT COMPLETED|Overall Study||0
8488432|NCT00565669|20916164|P2|COMPLETED|Overall Study||9
8488433|NCT00565669|20916165|P1|COMPLETED|Overall Study||11
8488434|NCT00565669|20916164|P2|STARTED|Overall Study||9
8488435|NCT00565669|20916165|P1|STARTED|Overall Study||11
8488436|NCT00565643|20916173|P2|NOT COMPLETED|Overall Study||0
8488437|NCT00565643|20916174|P1|NOT COMPLETED|Overall Study||0
8488438|NCT00565643|20916173|P2|COMPLETED|Overall Study||373
8488439|NCT00565643|20916174|P1|COMPLETED|Overall Study||380
8488440|NCT00565643|20916173|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
8488441|NCT00565643|20916174|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
8488442|NCT00565643|20916173|P2|Safety Data|Overall Study||373
8488443|NCT00565643|20916174|P1|Safety Data|Overall Study||380
8488444|NCT00565643|20916173|P2|STARTED|Overall Study||373
8488445|NCT00565643|20916174|P1|STARTED|Overall Study||380
8488446|NCT00565617|20916192|P1|NOT COMPLETED|Overall Study||1
8488447|NCT00565617|20916192|P1|COMPLETED|Overall Study||5
8488448|NCT00565617|20916192|P1|STARTED|Overall Study||6
8488449|NCT00565604|20916196|P1|NOT COMPLETED|Overall Study||4
8488450|NCT00565604|20916196|P1|COMPLETED|Overall Study||39
8488451|NCT00565604|20916196|P1|6 Month|Overall Study||39
8488452|NCT00565604|20916196|P1|6 Week|Overall Study||39
8488453|NCT00565604|20916196|P1|2 Week|Overall Study||41
8488454|NCT00565604|20916196|P1|7 Day|Overall Study||41
8488455|NCT00565604|20916196|P1|STARTED|Overall Study||43
8488456|NCT00565461|20916207|P4|NOT COMPLETED|Overall Study||3
8488457|NCT00565461|20916208|P3|NOT COMPLETED|Overall Study||1
8488458|NCT00565461|20916209|P2|NOT COMPLETED|Overall Study||1
8488459|NCT00565461|20916210|P1|NOT COMPLETED|Overall Study||0
8488460|NCT00565461|20916207|P4|COMPLETED|Overall Study||37
8488461|NCT00565461|20916208|P3|COMPLETED|Overall Study||39
8488462|NCT00565461|20916209|P2|COMPLETED|Overall Study||39
8488463|NCT00565461|20916210|P1|COMPLETED|Overall Study||40
8488464|NCT00565461|20916207|P4|STARTED|Overall Study||40
8488465|NCT00565461|20916208|P3|STARTED|Overall Study||40
8488466|NCT00565461|20916209|P2|STARTED|Overall Study||40
8488467|NCT00565461|20916210|P1|STARTED|Overall Study||40
8488468|NCT00565448|20916242|P2|NOT COMPLETED|Overall Study||2
8488469|NCT00565448|20916243|P1|NOT COMPLETED|Overall Study||3
8488470|NCT00565448|20916242|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
8488471|NCT00565448|20916243|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
8488472|NCT00565448|20916242|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
8488473|NCT00565448|20916243|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
8488474|NCT00565409|20916254|P4|NOT COMPLETED|Period 2 Double-Blind||59
8488475|NCT00565409|20916255|P3|NOT COMPLETED|Period 2 Double-Blind||27
8488476|NCT00565409|20916256|P2|NOT COMPLETED|Period 2 Double-Blind||21
8488477|NCT00565409|20916257|P1|NOT COMPLETED|Period 2 Double-Blind||0
8488478|NCT00565409|20916254|P4|COMPLETED|Period 2 Double-Blind||141
8488479|NCT00565409|20916255|P3|COMPLETED|Period 2 Double-Blind||175
8488480|NCT00565409|20916256|P2|COMPLETED|Period 2 Double-Blind||181
8488481|NCT00565409|20916257|P1|COMPLETED|Period 2 Double-Blind||0
8488482|NCT00565409|20916254|P4|STARTED|Period 2 Double-Blind||200
8488483|NCT00565409|20916255|P3|STARTED|Period 2 Double-Blind||202
8488484|NCT00565409|20916256|P2|STARTED|Period 2 Double-Blind||202
8488485|NCT00565409|20916257|P1|STARTED|Period 2 Double-Blind||0
8488486|NCT00565409|20916254|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
8488487|NCT00565409|20916255|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
8488488|NCT00565409|20916256|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
8488489|NCT00565409|20916257|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
8488490|NCT00565409|20916254|P4|COMPLETED|After Period 1, Prior to Period 2||0
8488491|NCT00565409|20916255|P3|COMPLETED|After Period 1, Prior to Period 2||0
8488492|NCT00565409|20916256|P2|COMPLETED|After Period 1, Prior to Period 2||0
8488493|NCT00565409|20916257|P1|COMPLETED|After Period 1, Prior to Period 2||604
8488494|NCT00565409|20916254|P4|STARTED|After Period 1, Prior to Period 2||0
8488495|NCT00565409|20916255|P3|STARTED|After Period 1, Prior to Period 2||0
8488496|NCT00565409|20916256|P2|STARTED|After Period 1, Prior to Period 2||0
8488497|NCT00565409|20916257|P1|STARTED|After Period 1, Prior to Period 2||756
8488498|NCT00565409|20916254|P4|NOT COMPLETED|Period 1 Open Label||0
8488499|NCT00565409|20916255|P3|NOT COMPLETED|Period 1 Open Label||0
8488500|NCT00565409|20916256|P2|NOT COMPLETED|Period 1 Open Label||0
8488501|NCT00565409|20916257|P1|NOT COMPLETED|Period 1 Open Label||78
8488502|NCT00565409|20916254|P4|COMPLETED|Period 1 Open Label||0
8488503|NCT00565409|20916255|P3|COMPLETED|Period 1 Open Label||0
8488504|NCT00565409|20916256|P2|COMPLETED|Period 1 Open Label||0
8488505|NCT00565409|20916257|P1|COMPLETED|Period 1 Open Label||756
8488506|NCT00565409|20916254|P4|STARTED|Period 1 Open Label||0
8488507|NCT00565409|20916255|P3|STARTED|Period 1 Open Label||0
8488508|NCT00565409|20916256|P2|STARTED|Period 1 Open Label||0
8488509|NCT00565409|20916257|P1|STARTED|Period 1 Open Label||834
8488510|NCT00565370|20916359|P1|NOT COMPLETED|Overall Study||0
8488511|NCT00565370|20916359|P1|COMPLETED|Overall Study||21
8488512|NCT00565370|20916359|P1|STARTED|Overall Study||21
8488513|NCT00565266|20916367|P1|NOT COMPLETED|Overall Study||36
8488514|NCT00565266|20916367|P1|COMPLETED|Overall Study||174
8488515|NCT00565266|20916367|P1|STARTED|Overall Study||210
8488516|NCT00565136|20916393|P1|NOT COMPLETED|Overall Study||3
8488517|NCT00565136|20916393|P1|COMPLETED|Overall Study||26
8488518|NCT00565136|20916393|P1|STARTED|Overall Study||29
8488519|NCT00565110|20916413|P2|NOT COMPLETED|Overall Study||131
8488520|NCT00565110|20916414|P1|NOT COMPLETED|Overall Study||131
8488521|NCT00565110|20916413|P2|COMPLETED|Overall Study||111
8488522|NCT00565110|20916414|P1|COMPLETED|Overall Study||99
8488523|NCT00565110|20916413|P2|12-Month|Overall Study||144
8488524|NCT00565110|20916414|P1|12-Month|Overall Study||114
8488525|NCT00565110|20916413|P2|STARTED|Overall Study||242
8488526|NCT00565110|20916414|P1|STARTED|Overall Study||230
8488527|NCT00565084|20916422|P3|NOT COMPLETED|Third Treatment Period||0
8488528|NCT00565084|20916423|P2|NOT COMPLETED|Third Treatment Period||0
8488529|NCT00565084|20916424|P1|NOT COMPLETED|Third Treatment Period||0
8488530|NCT00565084|20916422|P3|COMPLETED|Third Treatment Period||11
8488531|NCT00565084|20916423|P2|COMPLETED|Third Treatment Period||11
8488532|NCT00565084|20916424|P1|COMPLETED|Third Treatment Period||11
8488533|NCT00565084|20916422|P3|STARTED|Third Treatment Period||11
8488534|NCT00565084|20916423|P2|STARTED|Third Treatment Period||11
8488535|NCT00565084|20916424|P1|STARTED|Third Treatment Period||11
8488536|NCT00565084|20916422|P3|NOT COMPLETED|Second Treatment Period||0
8488537|NCT00565084|20916423|P2|NOT COMPLETED|Second Treatment Period||0
8488538|NCT00565084|20916424|P1|NOT COMPLETED|Second Treatment Period||0
8488539|NCT00565084|20916422|P3|COMPLETED|Second Treatment Period||11
8488540|NCT00565084|20916423|P2|COMPLETED|Second Treatment Period||11
8488541|NCT00565084|20916424|P1|COMPLETED|Second Treatment Period||11
8488542|NCT00565084|20916422|P3|STARTED|Second Treatment Period||11
8488543|NCT00565084|20916423|P2|STARTED|Second Treatment Period||11
8488544|NCT00565084|20916424|P1|STARTED|Second Treatment Period||11
8488545|NCT00565084|20916422|P3|NOT COMPLETED|First Treatment Period||0
8488546|NCT00565084|20916423|P2|NOT COMPLETED|First Treatment Period||0
8488547|NCT00565084|20916424|P1|NOT COMPLETED|First Treatment Period||0
8488548|NCT00565084|20916422|P3|COMPLETED|First Treatment Period||11
8488549|NCT00565084|20916423|P2|COMPLETED|First Treatment Period||11
8488550|NCT00565084|20916424|P1|COMPLETED|First Treatment Period||11
8488551|NCT00565084|20916422|P3|STARTED|First Treatment Period||11
8488552|NCT00565084|20916423|P2|STARTED|First Treatment Period||11
8488553|NCT00565084|20916424|P1|STARTED|First Treatment Period||11
8488554|NCT00565058|20916434|P2|NOT COMPLETED|Overall Study||0
8488555|NCT00565058|20916435|P1|NOT COMPLETED|Overall Study||1
8488556|NCT00565058|20916434|P2|COMPLETED|Overall Study||15
8488557|NCT00565058|20916435|P1|COMPLETED|Overall Study||9
8488558|NCT00565058|20916434|P2|STARTED|Overall Study||15
8488559|NCT00565058|20916435|P1|STARTED|Overall Study||10
8488560|NCT00565045|20916445|P2|NOT COMPLETED|Overall Study||3
8488561|NCT00565045|20916446|P1|NOT COMPLETED|Overall Study||1
8488562|NCT00565045|20916445|P2|COMPLETED|Overall Study||8
8488563|NCT00565045|20916446|P1|COMPLETED|Overall Study||9
8488564|NCT00565045|20916445|P2|STARTED|Overall Study||11
8488565|NCT00565045|20916446|P1|STARTED|Overall Study||10
8488566|NCT00564954|20916462|P2|NOT COMPLETED|Period 2- 1 Week||0
8488567|NCT00564954|20916463|P1|NOT COMPLETED|Period 2- 1 Week||0
8488568|NCT00564954|20916462|P2|COMPLETED|Period 2- 1 Week||42
8488569|NCT00564954|20916463|P1|COMPLETED|Period 2- 1 Week||44
8488570|NCT00564954|20916462|P2|STARTED|Period 2- 1 Week||42
8488571|NCT00564954|20916463|P1|STARTED|Period 2- 1 Week||44
8488572|NCT00564954|20916462|P2|NOT COMPLETED|Period 1- 1 Week||0
8488573|NCT00564954|20916463|P1|NOT COMPLETED|Period 1- 1 Week||0
8488574|NCT00564954|20916462|P2|COMPLETED|Period 1- 1 Week||42
8488575|NCT00564954|20916463|P1|COMPLETED|Period 1- 1 Week||44
8488576|NCT00564954|20916462|P2|STARTED|Period 1- 1 Week||42
8488577|NCT00564954|20916463|P1|STARTED|Period 1- 1 Week||44
8488578|NCT00564902|20916482|P3|NOT COMPLETED|Overall Study||4
8488579|NCT00564902|20916483|P2|NOT COMPLETED|Overall Study||4
8488580|NCT00564902|20916484|P1|NOT COMPLETED|Overall Study||1
8488581|NCT00564902|20916482|P3|COMPLETED|Overall Study||21
8488582|NCT00564902|20916483|P2|COMPLETED|Overall Study||21
8488583|NCT00564902|20916484|P1|COMPLETED|Overall Study||9
8488584|NCT00564902|20916482|P3|12 Months|Overall Study||21
8488585|NCT00564902|20916483|P2|12 Months|Overall Study||21
8488586|NCT00564902|20916484|P1|12 Months|Overall Study||9
8488587|NCT00564902|20916482|P3|8 Months|Overall Study||21
8488588|NCT00564902|20916483|P2|8 Months|Overall Study||22
8488589|NCT00564902|20916484|P1|8 Months|Overall Study||9
8488590|NCT00564902|20916482|P3|4 Months|Overall Study||23
8488591|NCT00564902|20916483|P2|4 Months|Overall Study||24
8488592|NCT00564902|20916484|P1|4 Months|Overall Study||9
8488593|NCT00564902|20916482|P3|STARTED|Overall Study||25
8488594|NCT00564902|20916483|P2|STARTED|Overall Study||25
8488595|NCT00564902|20916484|P1|STARTED|Overall Study||10
8488596|NCT00564889|20916516|P1|NOT COMPLETED|Overall Study||29
8488597|NCT00564889|20916516|P1|COMPLETED|Overall Study||6
8488598|NCT00564889|20916516|P1|STARTED|Overall Study||35
8488599|NCT00564876|20916524|P1|NOT COMPLETED|Overall Study||0
8488600|NCT00564876|20916524|P1|COMPLETED|Overall Study||2
8488601|NCT00564876|20916524|P1|STARTED|Overall Study||2
8488602|NCT00564850|20916531|P1|NOT COMPLETED|Overall Study||2
8488603|NCT00564850|20916531|P1|COMPLETED|Overall Study||35
8488604|NCT00564850|20916531|P1|STARTED|Overall Study||37
8488605|NCT00564733|20916549|P1|NOT COMPLETED|Overall Study||9
8488606|NCT00564733|20916549|P1|COMPLETED|Overall Study||46
8488607|NCT00564733|20916549|P1|STARTED|Overall Study||55
8488608|NCT00564681|20916557|P4|NOT COMPLETED|Overall Study||2
8488609|NCT00564681|20916558|P3|NOT COMPLETED|Overall Study||3
8488610|NCT00564681|20916559|P2|NOT COMPLETED|Overall Study||3
8488611|NCT00564681|20916560|P1|NOT COMPLETED|Overall Study||11
8488612|NCT00564681|20916557|P4|COMPLETED|Overall Study||19
8488613|NCT00564681|20916558|P3|COMPLETED|Overall Study||40
8488614|NCT00564681|20916559|P2|COMPLETED|Overall Study||58
8488615|NCT00564681|20916560|P1|COMPLETED|Overall Study||106
8488616|NCT00564681|20916557|P4|STARTED|Overall Study||21
8488617|NCT00564681|20916558|P3|STARTED|Overall Study||43
8488618|NCT00564681|20916559|P2|STARTED|Overall Study||61
8488619|NCT00564681|20916560|P1|STARTED|Overall Study||117
8488620|NCT00564629|20916583|P2|NOT COMPLETED|Overall Study||9
8488621|NCT00564629|20916584|P1|NOT COMPLETED|Overall Study||15
8488622|NCT00564629|20916583|P2|COMPLETED|Overall Study||45
8488623|NCT00564629|20916584|P1|COMPLETED|Overall Study||36
8488624|NCT00564629|20916583|P2|STARTED|Overall Study||54
8488625|NCT00564629|20916584|P1|STARTED|Overall Study||51
8488626|NCT00564486|20916609|P4|NOT COMPLETED|Overall Study||7
8488627|NCT00564486|20916610|P3|NOT COMPLETED|Overall Study||3
8488628|NCT00564486|20916611|P2|NOT COMPLETED|Overall Study||1
8488629|NCT00564486|20916612|P1|NOT COMPLETED|Overall Study||7
8488630|NCT00564486|20916609|P4|COMPLETED|Overall Study||60
8488631|NCT00564486|20916610|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
8488632|NCT00564486|20916611|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
8488633|NCT00564486|20916612|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
8488634|NCT00564486|20916609|P4|STARTED|Overall Study||67
8488635|NCT00564486|20916610|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
8488636|NCT00564486|20916611|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
8488637|NCT00564486|20916612|P1|STARTED|Overall Study||43
8488638|NCT00564447|20916636|P8|NOT COMPLETED|Overall Study||0
8488639|NCT00564447|20916637|P7|NOT COMPLETED|Overall Study||0
8488640|NCT00564447|20916638|P6|NOT COMPLETED|Overall Study||0
8488641|NCT00564447|20916639|P5|NOT COMPLETED|Overall Study||0
8488642|NCT00564447|20916640|P4|NOT COMPLETED|Overall Study||0
8488643|NCT00564447|20916641|P3|NOT COMPLETED|Overall Study||0
8488644|NCT00564447|20916642|P2|NOT COMPLETED|Overall Study||0
8488645|NCT00564447|20916643|P1|NOT COMPLETED|Overall Study||0
8488646|NCT00564447|20916636|P8|COMPLETED|Overall Study||6
8488647|NCT00564447|20916637|P7|COMPLETED|Overall Study||6
8488648|NCT00564447|20916638|P6|COMPLETED|Overall Study||6
8488649|NCT00564447|20916639|P5|COMPLETED|Overall Study||6
8488650|NCT00564447|20916640|P4|COMPLETED|Overall Study||6
8488651|NCT00564447|20916641|P3|COMPLETED|Overall Study||6
8488652|NCT00564447|20916642|P2|COMPLETED|Overall Study||6
8488653|NCT00564447|20916643|P1|COMPLETED|Overall Study||6
8488654|NCT00564447|20916636|P8|STARTED|Overall Study||6
8488655|NCT00564447|20916637|P7|STARTED|Overall Study||6
8488656|NCT00564447|20916638|P6|STARTED|Overall Study||6
8488657|NCT00564447|20916639|P5|STARTED|Overall Study||6
8488658|NCT00564447|20916640|P4|STARTED|Overall Study||6
8488659|NCT00564447|20916641|P3|STARTED|Overall Study||6
8488660|NCT00564447|20916642|P2|STARTED|Overall Study||6
8488661|NCT00564447|20916643|P1|STARTED|Overall Study||6
8488662|NCT00564395|20916661|P2|NOT COMPLETED|Second Intervention (10 Days)||0
8488663|NCT00564395|20916662|P1|NOT COMPLETED|Second Intervention (10 Days)||0
8488664|NCT00564395|20916661|P2|COMPLETED|Second Intervention (10 Days)||7
8488665|NCT00564395|20916662|P1|COMPLETED|Second Intervention (10 Days)||7
8488666|NCT00564395|20916661|P2|STARTED|Second Intervention (10 Days)||7
8488667|NCT00564395|20916662|P1|STARTED|Second Intervention (10 Days)||7
8488668|NCT00564395|20916661|P2|NOT COMPLETED|First Intervention (10 Days)||2
8488669|NCT00564395|20916662|P1|NOT COMPLETED|First Intervention (10 Days)||2
8488670|NCT00564395|20916661|P2|COMPLETED|First Intervention (10 Days)||7
8488671|NCT00564395|20916662|P1|COMPLETED|First Intervention (10 Days)||7
8488672|NCT00564395|20916661|P2|Received Intervention|First Intervention (10 Days)||7
8488673|NCT00564395|20916662|P1|Received Intervention|First Intervention (10 Days)||7
8488674|NCT00564395|20916661|P2|STARTED|First Intervention (10 Days)||9
8488675|NCT00564395|20916662|P1|STARTED|First Intervention (10 Days)||9
8488676|NCT00564278|20916670|P2|NOT COMPLETED|Overall Study||42
8488677|NCT00564278|20916671|P1|NOT COMPLETED|Overall Study||47
8488678|NCT00564278|20916670|P2|COMPLETED|Overall Study||56
8488679|NCT00564278|20916671|P1|COMPLETED|Overall Study||50
8488680|NCT00564278|20916670|P2|STARTED|Overall Study||98
8488681|NCT00564278|20916671|P1|STARTED|Overall Study||97
8488682|NCT00564265|20916687|P1|NOT COMPLETED|Overall Study||0
8488683|NCT00564265|20916687|P1|COMPLETED|Overall Study||24
8488684|NCT00564265|20916687|P1|STARTED|Overall Study||24
8488685|NCT00564070|20916693|P2|NOT COMPLETED|Overall Study||7
8488686|NCT00564070|20916694|P1|NOT COMPLETED|Overall Study||12
8488687|NCT00564070|20916693|P2|COMPLETED|Overall Study||38
8488688|NCT00564070|20916694|P1|COMPLETED|Overall Study||30
8488689|NCT00564070|20916693|P2|STARTED|Overall Study||45
8488690|NCT00564070|20916694|P1|STARTED|Overall Study||42
8488691|NCT00564018|20916721|P3|NOT COMPLETED|Overall Study||1
8488692|NCT00564018|20916722|P2|NOT COMPLETED|Overall Study||3
8488693|NCT00564018|20916723|P1|NOT COMPLETED|Overall Study||2
8488694|NCT00564018|20916721|P3|COMPLETED|Overall Study||11
8488695|NCT00564018|20916722|P2|COMPLETED|Overall Study||7
8488696|NCT00564018|20916723|P1|COMPLETED|Overall Study||9
8488697|NCT00564018|20916721|P3|STARTED|Overall Study||12
8488698|NCT00564018|20916722|P2|STARTED|Overall Study||10
8488699|NCT00564018|20916723|P1|STARTED|Overall Study||11
8488700|NCT00563797|20916736|P2|NOT COMPLETED|Overall Study||2
8488701|NCT00563797|20916737|P1|NOT COMPLETED|Overall Study||7
8488702|NCT00563797|20916736|P2|COMPLETED|Overall Study||8
8488703|NCT00563797|20916737|P1|COMPLETED|Overall Study||4
8488704|NCT00563797|20916736|P2|Follow-Up|Overall Study||10
8488705|NCT00563797|20916737|P1|Follow-Up|Overall Study||11
8488706|NCT00563797|20916736|P2|Received Allocated Intervention|Overall Study||10
8488707|NCT00563797|20916737|P1|Received Allocated Intervention|Overall Study||11
8488708|NCT00563797|20916736|P2|STARTED|Overall Study||10
8488709|NCT00563797|20916737|P1|STARTED|Overall Study||11
8488710|NCT00563784|20916749|P1|NOT COMPLETED|Overall Study||22
8488711|NCT00563784|20916749|P1|COMPLETED|Overall Study||46
8488712|NCT00563784|20916749|P1|STARTED|Overall Study||68
8488713|NCT00563706|20916763|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488714|NCT00563706|20916764|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488715|NCT00563706|20916765|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488716|NCT00563706|20916766|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488717|NCT00563706|20916767|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488718|NCT00563706|20916768|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488719|NCT00563706|20916769|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488720|NCT00563706|20916770|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488721|NCT00563706|20916771|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488722|NCT00563706|20916763|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
8488723|NCT00563706|20916764|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
8488724|NCT00563706|20916765|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
8488725|NCT00563706|20916766|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
8488726|NCT00563706|20916767|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
8488727|NCT00563706|20916768|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
8488728|NCT00563706|20916769|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
8488729|NCT00563706|20916770|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
8488730|NCT00563706|20916771|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
8488731|NCT00563706|20916763|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
8488732|NCT00563706|20916764|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
8488733|NCT00563706|20916765|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
8488734|NCT00563706|20916766|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
8488735|NCT00563706|20916767|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
8488736|NCT00563706|20916768|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
8488737|NCT00563706|20916769|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
8488738|NCT00563706|20916770|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
8488739|NCT00563706|20916771|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
8488740|NCT00563706|20916763|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
8488741|NCT00563706|20916764|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
8488742|NCT00563706|20916765|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
8488743|NCT00563706|20916766|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488744|NCT00563706|20916767|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488745|NCT00563706|20916768|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
8488746|NCT00563706|20916769|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488747|NCT00563706|20916770|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488748|NCT00563706|20916771|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
8488749|NCT00563706|20916763|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
8488750|NCT00563706|20916764|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
8488751|NCT00563706|20916765|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
8488752|NCT00563706|20916766|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
8488753|NCT00563706|20916767|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
8488754|NCT00563706|20916768|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
8488755|NCT00563706|20916769|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
8488756|NCT00563706|20916770|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
8488757|NCT00563706|20916771|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
8488758|NCT00563706|20916763|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
8488759|NCT00563706|20916764|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
8488760|NCT00563706|20916765|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
8488761|NCT00563706|20916766|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
8488762|NCT00563706|20916767|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
8488763|NCT00563706|20916768|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
8488764|NCT00563706|20916769|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
8488765|NCT00563706|20916770|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
8488766|NCT00563706|20916771|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
8488767|NCT00563576|20916874|P2|NOT COMPLETED|Overall Study||14
8488768|NCT00563576|20916875|P1|NOT COMPLETED|Overall Study||14
8488769|NCT00563576|20916874|P2|COMPLETED|Overall Study||22
8488770|NCT00563576|20916875|P1|COMPLETED|Overall Study||21
8488771|NCT00563576|20916874|P2|STARTED|Overall Study||36
8488772|NCT00563576|20916875|P1|STARTED|Overall Study||35
8488773|NCT00563381|20916889|P2|NOT COMPLETED|Overall Study||648
8488774|NCT00563381|20916890|P1|NOT COMPLETED|Overall Study||585
8488775|NCT00563381|20916889|P2|COMPLETED|Overall Study|Completed treatment|3021
8488776|NCT00563381|20916890|P1|COMPLETED|Overall Study|Completed treatment|3122
8488777|NCT00563381|20916889|P2|STARTED|Overall Study|Started treatment|3669
8488778|NCT00563381|20916890|P1|STARTED|Overall Study|Started treatment|3707
8488779|NCT00563368|20916963|P7|NOT COMPLETED|Overall Study||33
8488780|NCT00563368|20916964|P6|NOT COMPLETED|Overall Study||30
8488781|NCT00563368|20916965|P5|NOT COMPLETED|Overall Study||28
8488782|NCT00563368|20916966|P4|NOT COMPLETED|Overall Study||29
8488783|NCT00563368|20916967|P3|NOT COMPLETED|Overall Study||30
8488784|NCT00563368|20916968|P2|NOT COMPLETED|Overall Study||30
8488785|NCT00563368|20916969|P1|NOT COMPLETED|Overall Study||35
8488786|NCT00563368|20916963|P7|COMPLETED|Overall Study||75
8488787|NCT00563368|20916964|P6|COMPLETED|Overall Study||77
8488788|NCT00563368|20916965|P5|COMPLETED|Overall Study||80
8488789|NCT00563368|20916966|P4|COMPLETED|Overall Study||78
8488790|NCT00563368|20916967|P3|COMPLETED|Overall Study||78
8488791|NCT00563368|20916968|P2|COMPLETED|Overall Study||79
8488792|NCT00563368|20916969|P1|COMPLETED|Overall Study||74
8488793|NCT00563368|20916963|P7|STARTED|Overall Study||108
8488794|NCT00563368|20916964|P6|STARTED|Overall Study||107
8488795|NCT00563368|20916965|P5|STARTED|Overall Study||108
8488796|NCT00563368|20916966|P4|STARTED|Overall Study||107
8488797|NCT00563368|20916967|P3|STARTED|Overall Study||108
8488798|NCT00563368|20916968|P2|STARTED|Overall Study||109
8488799|NCT00563368|20916969|P1|STARTED|Overall Study||109
8488800|NCT00563316|20916992|P1|NOT COMPLETED|Overall Study||12
8488801|NCT00563316|20916992|P1|COMPLETED|Overall Study||16
8488802|NCT00563316|20916992|P1|Received Investigational Product|Overall Study||27
8488803|NCT00563316|20916992|P1|STARTED|Overall Study||28
8488804|NCT00563290|20917005|P2|NOT COMPLETED|Overall Study||0
8488805|NCT00563290|20917006|P1|NOT COMPLETED|Overall Study||0
8488806|NCT00563290|20917005|P2|COMPLETED|Overall Study||4
8488807|NCT00563290|20917006|P1|COMPLETED|Overall Study||3
8488808|NCT00563290|20917005|P2|STARTED|Overall Study||4
8488809|NCT00563290|20917006|P1|STARTED|Overall Study||3
8488810|NCT00563186|20917017|P2|NOT COMPLETED|Overall Study||75
8488811|NCT00563186|20917018|P1|NOT COMPLETED|Overall Study||98
8488812|NCT00563186|20917017|P2|COMPLETED|Overall Study||604
8488813|NCT00563186|20917018|P1|COMPLETED|Overall Study||910
8488814|NCT00563186|20917017|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
8488815|NCT00563186|20917018|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
8488816|NCT00562965|20917029|P2|NOT COMPLETED|Overall Study||6
8488817|NCT00562965|20917030|P1|NOT COMPLETED|Overall Study||3
8488818|NCT00562965|20917029|P2|COMPLETED|Overall Study||8
8488819|NCT00562965|20917030|P1|COMPLETED|Overall Study||12
8488820|NCT00562965|20917029|P2|Treated|Overall Study||13
8488821|NCT00562965|20917030|P1|Treated|Overall Study||15
8488822|NCT00562965|20917029|P2|STARTED|Overall Study||14
8488823|NCT00562965|20917030|P1|STARTED|Overall Study||15
8488824|NCT00562861|20917051|P2|NOT COMPLETED|Overall Study||11
8488825|NCT00562861|20917052|P1|NOT COMPLETED|Overall Study||20
8488826|NCT00562861|20917051|P2|COMPLETED|Overall Study||48
8488827|NCT00562861|20917052|P1|COMPLETED|Overall Study||40
8488828|NCT00562861|20917051|P2|STARTED|Overall Study||59
8488829|NCT00562861|20917052|P1|STARTED|Overall Study||60
8488830|NCT00562718|20917058|P1|NOT COMPLETED|Overall Study||11
8488831|NCT00562718|20917058|P1|COMPLETED|Overall Study||39
8488832|NCT00562718|20917058|P1|STARTED|Overall Study||50
8488833|NCT00562627|20917067|P3|NOT COMPLETED|Overall Study||1
8488834|NCT00562627|20917068|P2|NOT COMPLETED|Overall Study||1
8488835|NCT00562627|20917069|P1|NOT COMPLETED|Overall Study||1
8488836|NCT00562627|20917067|P3|COMPLETED|Overall Study||33
8488837|NCT00562627|20917068|P2|COMPLETED|Overall Study||33
8488838|NCT00562627|20917069|P1|COMPLETED|Overall Study||33
8488839|NCT00562627|20917067|P3|STARTED|Overall Study||34
8488840|NCT00562627|20917068|P2|STARTED|Overall Study||34
8488841|NCT00562627|20917069|P1|STARTED|Overall Study||34
8488842|NCT00562588|20917085|P2|NOT COMPLETED|Overall Study||99
8488843|NCT00562588|20917086|P1|NOT COMPLETED|Overall Study||92
8488844|NCT00562588|20917085|P2|COMPLETED|Overall Study||184
8488845|NCT00562588|20917086|P1|COMPLETED|Overall Study||168
8488846|NCT00562588|20917085|P2|STARTED|Overall Study||283
8488847|NCT00562588|20917086|P1|STARTED|Overall Study||260
8488848|NCT00562484|20917116|P2|NOT COMPLETED|Overall Study||104
8488849|NCT00562484|20917117|P1|NOT COMPLETED|Overall Study||206
8488850|NCT00562484|20917116|P2|COMPLETED|Overall Study||4907
8488851|NCT00562484|20917117|P1|COMPLETED|Overall Study||9827
8488852|NCT00562484|20917116|P2|STARTED|Overall Study||5011
8488853|NCT00562484|20917117|P1|STARTED|Overall Study||10033
8488854|NCT00562354|20917149|P2|NOT COMPLETED|Overall Study||2
8488855|NCT00562354|20917150|P1|NOT COMPLETED|Overall Study||0
8488856|NCT00562354|20917149|P2|COMPLETED|Overall Study||135
8488857|NCT00562354|20917150|P1|COMPLETED|Overall Study||134
8488858|NCT00562354|20917149|P2|Evaluable Immunogenicity Population|Overall Study||134
8488859|NCT00562354|20917150|P1|Evaluable Immunogenicity Population|Overall Study||134
8488860|NCT00562354|20917149|P2|Received Study Treatment|Overall Study||136
8488861|NCT00562354|20917150|P1|Received Study Treatment|Overall Study||134
8488862|NCT00562354|20917149|P2|STARTED|Overall Study||137
8488863|NCT00562354|20917150|P1|STARTED|Overall Study||134
8488864|NCT00562328|20917191|P1|NOT COMPLETED|Overall Study||0
8488865|NCT00562328|20917191|P1|COMPLETED|Overall Study||33
8488866|NCT00562328|20917191|P1|STARTED|Overall Study||33
8488867|NCT00562315|20917199|P1|NOT COMPLETED|Overall Study||0
8488868|NCT00562315|20917199|P1|COMPLETED|Overall Study||93
8488869|NCT00562315|20917199|P1|STARTED|Overall Study||93
8488870|NCT00562302|20917216|P2|NOT COMPLETED|Overall Study||32
8488871|NCT00562302|20917217|P1|NOT COMPLETED|Overall Study||20
8488872|NCT00562302|20917216|P2|COMPLETED|Overall Study||137
8488873|NCT00562302|20917217|P1|COMPLETED|Overall Study||150
8488874|NCT00562302|20917216|P2|STARTED|Overall Study||169
8488875|NCT00562302|20917217|P1|STARTED|Overall Study||170
8488876|NCT00562159|20917239|P2|NOT COMPLETED|Overall Study||33
8488877|NCT00562159|20917240|P1|NOT COMPLETED|Overall Study||38
8488878|NCT00562159|20917239|P2|COMPLETED|Overall Study||192
8488879|NCT00562159|20917240|P1|COMPLETED|Overall Study||175
8488880|NCT00562159|20917239|P2|STARTED|Overall Study||225
8488881|NCT00562159|20917240|P1|STARTED|Overall Study||213
8488882|NCT00562120|20917252|P4|NOT COMPLETED|Fourth Intervention Period||0
8488883|NCT00562120|20917253|P3|NOT COMPLETED|Fourth Intervention Period||0
8488884|NCT00562120|20917254|P2|NOT COMPLETED|Fourth Intervention Period||0
8488885|NCT00562120|20917255|P1|NOT COMPLETED|Fourth Intervention Period||0
8488886|NCT00562120|20917252|P4|COMPLETED|Fourth Intervention Period||5
8488887|NCT00562120|20917253|P3|COMPLETED|Fourth Intervention Period||5
8488888|NCT00562120|20917254|P2|COMPLETED|Fourth Intervention Period||5
8488889|NCT00562120|20917255|P1|COMPLETED|Fourth Intervention Period||4
8488890|NCT00562120|20917252|P4|STARTED|Fourth Intervention Period||5
8488891|NCT00562120|20917253|P3|STARTED|Fourth Intervention Period||5
8488892|NCT00562120|20917254|P2|STARTED|Fourth Intervention Period||5
8488893|NCT00562120|20917255|P1|STARTED|Fourth Intervention Period||4
8488894|NCT00562120|20917252|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488895|NCT00562120|20917253|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488896|NCT00562120|20917254|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488897|NCT00562120|20917255|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488898|NCT00562120|20917252|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8488899|NCT00562120|20917253|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8488900|NCT00562120|20917254|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8488901|NCT00562120|20917255|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
8488902|NCT00562120|20917252|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
8488903|NCT00562120|20917253|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
8488904|NCT00562120|20917254|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
8488905|NCT00562120|20917255|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
8488906|NCT00562120|20917252|P4|NOT COMPLETED|Third Intervention Period||0
8488907|NCT00562120|20917253|P3|NOT COMPLETED|Third Intervention Period||0
8488908|NCT00562120|20917254|P2|NOT COMPLETED|Third Intervention Period||0
8488909|NCT00562120|20917255|P1|NOT COMPLETED|Third Intervention Period||0
8488910|NCT00562120|20917252|P4|COMPLETED|Third Intervention Period||5
8488911|NCT00562120|20917253|P3|COMPLETED|Third Intervention Period||5
8488912|NCT00562120|20917254|P2|COMPLETED|Third Intervention Period||5
8488913|NCT00562120|20917255|P1|COMPLETED|Third Intervention Period||4
8488914|NCT00562120|20917252|P4|STARTED|Third Intervention Period||5
8488915|NCT00562120|20917253|P3|STARTED|Third Intervention Period||5
8488916|NCT00562120|20917254|P2|STARTED|Third Intervention Period||5
8488917|NCT00562120|20917255|P1|STARTED|Third Intervention Period||4
8488918|NCT00562120|20917252|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488919|NCT00562120|20917253|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488920|NCT00562120|20917254|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488921|NCT00562120|20917255|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488922|NCT00562120|20917252|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8488923|NCT00562120|20917253|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8488924|NCT00562120|20917254|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8488925|NCT00562120|20917255|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
8488926|NCT00562120|20917252|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
8488927|NCT00562120|20917253|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
8488928|NCT00562120|20917254|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
8488929|NCT00562120|20917255|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
8488930|NCT00562120|20917252|P4|NOT COMPLETED|Second Intervention Period||0
8488931|NCT00562120|20917253|P3|NOT COMPLETED|Second Intervention Period||0
8488932|NCT00562120|20917254|P2|NOT COMPLETED|Second Intervention Period||0
8488933|NCT00562120|20917255|P1|NOT COMPLETED|Second Intervention Period||0
8488934|NCT00562120|20917252|P4|COMPLETED|Second Intervention Period||5
8488935|NCT00562120|20917253|P3|COMPLETED|Second Intervention Period||5
8488936|NCT00562120|20917254|P2|COMPLETED|Second Intervention Period||5
8488937|NCT00562120|20917255|P1|COMPLETED|Second Intervention Period||4
8488938|NCT00562120|20917252|P4|STARTED|Second Intervention Period||5
8488939|NCT00562120|20917253|P3|STARTED|Second Intervention Period||5
8488940|NCT00562120|20917254|P2|STARTED|Second Intervention Period||5
8488941|NCT00562120|20917255|P1|STARTED|Second Intervention Period||4
8488942|NCT00562120|20917252|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488943|NCT00562120|20917253|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488944|NCT00562120|20917254|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488945|NCT00562120|20917255|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488946|NCT00562120|20917252|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8488947|NCT00562120|20917253|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8488948|NCT00562120|20917254|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8488949|NCT00562120|20917255|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
8488950|NCT00562120|20917252|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
8488951|NCT00562120|20917253|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
8488952|NCT00562120|20917254|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
8488953|NCT00562120|20917255|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
8488954|NCT00562120|20917252|P4|NOT COMPLETED|First Intervention Period||0
8488955|NCT00562120|20917253|P3|NOT COMPLETED|First Intervention Period||0
8488956|NCT00562120|20917254|P2|NOT COMPLETED|First Intervention Period||0
8488957|NCT00562120|20917255|P1|NOT COMPLETED|First Intervention Period||2
8488958|NCT00562120|20917252|P4|COMPLETED|First Intervention Period||5
8488959|NCT00562120|20917253|P3|COMPLETED|First Intervention Period||5
8488960|NCT00562120|20917254|P2|COMPLETED|First Intervention Period||5
8488961|NCT00562120|20917255|P1|COMPLETED|First Intervention Period||4
8488962|NCT00562120|20917252|P4|Treated|First Intervention Period||5
8488963|NCT00562120|20917253|P3|Treated|First Intervention Period||5
8488964|NCT00562120|20917254|P2|Treated|First Intervention Period||5
8488965|NCT00562120|20917255|P1|Treated|First Intervention Period||5
8488966|NCT00562120|20917252|P4|STARTED|First Intervention Period||5
8488967|NCT00562120|20917253|P3|STARTED|First Intervention Period||5
8488968|NCT00562120|20917254|P2|STARTED|First Intervention Period||5
8488969|NCT00562120|20917255|P1|STARTED|First Intervention Period||6
8488970|NCT00562094|20917287|P1|NOT COMPLETED|Overall Study||62
8488971|NCT00562094|20917287|P1|COMPLETED|Overall Study||8554
8488972|NCT00562094|20917287|P1|STARTED|Overall Study||8616
8488973|NCT00561977|20917302|P3|NOT COMPLETED|Overall Study||2
8488974|NCT00561977|20917303|P2|NOT COMPLETED|Overall Study||3
8488975|NCT00561977|20917304|P1|NOT COMPLETED|Overall Study||0
8488976|NCT00561977|20917302|P3|COMPLETED|Overall Study||10
8488977|NCT00561977|20917303|P2|COMPLETED|Overall Study||9
8488978|NCT00561977|20917304|P1|COMPLETED|Overall Study||12
8488979|NCT00561977|20917302|P3|STARTED|Overall Study||12
8488980|NCT00561977|20917303|P2|STARTED|Overall Study||12
8488981|NCT00561977|20917304|P1|STARTED|Overall Study||12
8488982|NCT00561951|20917330|P3|NOT COMPLETED|Overall Study||32
8488983|NCT00561951|20917331|P2|NOT COMPLETED|Overall Study||34
8488984|NCT00561951|20917332|P1|NOT COMPLETED|Overall Study||33
8488985|NCT00561951|20917330|P3|COMPLETED|Overall Study||281
8488986|NCT00561951|20917331|P2|COMPLETED|Overall Study||286
8488987|NCT00561951|20917332|P1|COMPLETED|Overall Study||285
8488988|NCT00561951|20917330|P3|STARTED|Overall Study||313
8488989|NCT00561951|20917331|P2|STARTED|Overall Study||320
8488990|NCT00561951|20917332|P1|STARTED|Overall Study||318
8488991|NCT00561925|20917388|P5|NOT COMPLETED|Open-Label Extension Period||50
8488992|NCT00561925|20917389|P4|NOT COMPLETED|Open-Label Extension Period||43
8488993|NCT00561925|20917390|P3|NOT COMPLETED|Open-Label Extension Period||0
8488994|NCT00561925|20917391|P2|NOT COMPLETED|Open-Label Extension Period||0
8488995|NCT00561925|20917392|P1|NOT COMPLETED|Open-Label Extension Period||0
8488996|NCT00561925|20917388|P5|COMPLETED|Open-Label Extension Period||328
8488997|NCT00561925|20917389|P4|COMPLETED|Open-Label Extension Period||315
8488998|NCT00561925|20917390|P3|COMPLETED|Open-Label Extension Period||0
8488999|NCT00561925|20917391|P2|COMPLETED|Open-Label Extension Period||1
8489000|NCT00561925|20917392|P1|COMPLETED|Open-Label Extension Period||0
8489001|NCT00561925|20917388|P5|STARTED|Open-Label Extension Period||378
8489002|NCT00561925|20917389|P4|STARTED|Open-Label Extension Period||358
8489003|NCT00561925|20917390|P3|STARTED|Open-Label Extension Period||0
8489004|NCT00561925|20917391|P2|STARTED|Open-Label Extension Period||1
8489005|NCT00561925|20917392|P1|STARTED|Open-Label Extension Period||0
8489006|NCT00561925|20917388|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8489007|NCT00561925|20917389|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8489008|NCT00561925|20917390|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
8489009|NCT00561925|20917391|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
8489010|NCT00561925|20917392|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8489011|NCT00561925|20917388|P5|COMPLETED|144-week Double-blind, Double-dummy||0
8489012|NCT00561925|20917389|P4|COMPLETED|144-week Double-blind, Double-dummy||0
8489013|NCT00561925|20917390|P3|COMPLETED|144-week Double-blind, Double-dummy||378
8489014|NCT00561925|20917391|P2|COMPLETED|144-week Double-blind, Double-dummy||358
8489015|NCT00561925|20917392|P1|COMPLETED|144-week Double-blind, Double-dummy||0
8489016|NCT00561925|20917388|P5|STARTED|144-week Double-blind, Double-dummy||0
8489017|NCT00561925|20917389|P4|STARTED|144-week Double-blind, Double-dummy||0
8489018|NCT00561925|20917390|P3|STARTED|144-week Double-blind, Double-dummy||505
8489019|NCT00561925|20917391|P2|STARTED|144-week Double-blind, Double-dummy||508
8489020|NCT00561925|20917392|P1|STARTED|144-week Double-blind, Double-dummy||0
8489021|NCT00561925|20917388|P5|NOT COMPLETED|14 Day Lead-In Period||0
8489022|NCT00561925|20917389|P4|NOT COMPLETED|14 Day Lead-In Period||0
8489023|NCT00561925|20917390|P3|NOT COMPLETED|14 Day Lead-In Period||0
8489024|NCT00561925|20917391|P2|NOT COMPLETED|14 Day Lead-In Period||0
8489025|NCT00561925|20917392|P1|NOT COMPLETED|14 Day Lead-In Period||55
8489026|NCT00561925|20917388|P5|COMPLETED|14 Day Lead-In Period||0
8489027|NCT00561925|20917389|P4|COMPLETED|14 Day Lead-In Period||0
8489028|NCT00561925|20917390|P3|COMPLETED|14 Day Lead-In Period||0
8489029|NCT00561925|20917391|P2|COMPLETED|14 Day Lead-In Period||0
8489030|NCT00561925|20917392|P1|COMPLETED|14 Day Lead-In Period||1013
8489031|NCT00561925|20917388|P5|STARTED|14 Day Lead-In Period||0
8489032|NCT00561925|20917389|P4|STARTED|14 Day Lead-In Period||0
8489033|NCT00561925|20917390|P3|STARTED|14 Day Lead-In Period||0
8489034|NCT00561925|20917391|P2|STARTED|14 Day Lead-In Period||0
8489035|NCT00561925|20917392|P1|STARTED|14 Day Lead-In Period||1068
8489036|NCT00561912|20917441|P1|NOT COMPLETED|Overall Study||1
8489037|NCT00561912|20917441|P1|COMPLETED|Overall Study||1
8489038|NCT00561912|20917441|P1|STARTED|Overall Study||2
8489039|NCT00561834|20917445|P1|NOT COMPLETED|Overall Study||0
8489040|NCT00561834|20917445|P1|COMPLETED|Overall Study||2
8489041|NCT00561834|20917445|P1|STARTED|Overall Study||2
8489042|NCT00561821|20917453|P4|NOT COMPLETED|Overall Study||3
8489043|NCT00561821|20917454|P3|NOT COMPLETED|Overall Study||2
8489044|NCT00561821|20917455|P2|NOT COMPLETED|Overall Study||6
8489045|NCT00561821|20917456|P1|NOT COMPLETED|Overall Study||5
8489046|NCT00561821|20917453|P4|COMPLETED|Overall Study||133
8489047|NCT00561821|20917454|P3|COMPLETED|Overall Study||132
8489048|NCT00561821|20917455|P2|COMPLETED|Overall Study||130
8489049|NCT00561821|20917456|P1|COMPLETED|Overall Study||127
8489050|NCT00561821|20917453|P4|Treated|Overall Study||136
8489051|NCT00561821|20917454|P3|Treated|Overall Study||133
8489052|NCT00561821|20917455|P2|Treated|Overall Study||136
8489053|NCT00561821|20917456|P1|Treated|Overall Study||132
8489054|NCT00561821|20917453|P4|STARTED|Overall Study||136
8489055|NCT00561821|20917454|P3|STARTED|Overall Study||134
8489056|NCT00561821|20917455|P2|STARTED|Overall Study||136
8489057|NCT00561821|20917456|P1|STARTED|Overall Study||132
8489058|NCT00561795|20917532|P4|NOT COMPLETED|Overall Study||0
8489059|NCT00561795|20917533|P3|NOT COMPLETED|Overall Study||0
8489060|NCT00561795|20917534|P2|NOT COMPLETED|Overall Study||6
8489061|NCT00561795|20917535|P1|NOT COMPLETED|Overall Study||4
8489062|NCT00561795|20917532|P4|COMPLETED|Overall Study||0
8489063|NCT00561795|20917533|P3|COMPLETED|Overall Study||0
8489064|NCT00561795|20917534|P2|COMPLETED|Overall Study||0
8489065|NCT00561795|20917535|P1|COMPLETED|Overall Study||2
8489066|NCT00561795|20917532|P4|STARTED|Overall Study||0
8489067|NCT00561795|20917533|P3|STARTED|Overall Study||0
8489068|NCT00561795|20917534|P2|STARTED|Overall Study||6
8489069|NCT00561795|20917535|P1|STARTED|Overall Study||6
8489070|NCT00561730|20917555|P1|NOT COMPLETED|Overall Study||9
8489071|NCT00561730|20917555|P1|COMPLETED|Overall Study||1986
8489072|NCT00561730|20917555|P1|STARTED|Overall Study||1995
8489073|NCT00561678|20917571|P2|NOT COMPLETED|Overall Study||6
8489074|NCT00561678|20917572|P1|NOT COMPLETED|Overall Study||8
8489075|NCT00561678|20917571|P2|COMPLETED|Overall Study||201
8489076|NCT00561678|20917572|P1|COMPLETED|Overall Study||189
8489077|NCT00561678|20917571|P2|STARTED|Overall Study||207
8489078|NCT00561678|20917572|P1|STARTED|Overall Study||197
8489079|NCT00561652|20917590|P2|NOT COMPLETED|Overall Study||1
8489080|NCT00561652|20917591|P1|NOT COMPLETED|Overall Study||0
8489081|NCT00561652|20917590|P2|COMPLETED|Overall Study||19
8489082|NCT00561652|20917591|P1|COMPLETED|Overall Study||10
8489083|NCT00561652|20917590|P2|STARTED|Overall Study||20
8489084|NCT00561652|20917591|P1|STARTED|Overall Study||10
8489085|NCT00561600|20917611|P2|NOT COMPLETED|Overall Study||16
8489086|NCT00561600|20917612|P1|NOT COMPLETED|Overall Study||18
8489087|NCT00561600|20917611|P2|COMPLETED|Overall Study||119
8489088|NCT00561600|20917612|P1|COMPLETED|Overall Study||112
8489089|NCT00561600|20917611|P2|STARTED|Overall Study||135
8489090|NCT00561600|20917612|P1|STARTED|Overall Study||130
8489091|NCT00561574|20917674|P2|NOT COMPLETED|Overall Study||58
8489092|NCT00561574|20917675|P1|NOT COMPLETED|Overall Study||48
8489093|NCT00561574|20917674|P2|COMPLETED|Overall Study||73
8489094|NCT00561574|20917675|P1|COMPLETED|Overall Study||80
8489095|NCT00561574|20917674|P2|STARTED|Overall Study||131
8489096|NCT00561574|20917675|P1|STARTED|Overall Study||128
8489097|NCT00561470|20917701|P2|NOT COMPLETED|Overall Study||612
8489098|NCT00561470|20917702|P1|NOT COMPLETED|Overall Study||614
8489099|NCT00561470|20917701|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
8489100|NCT00561470|20917702|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
8489101|NCT00561470|20917701|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
8489102|NCT00561470|20917702|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
8489103|NCT00561470|20917701|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
8489104|NCT00561470|20917702|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
8489105|NCT00561470|20917701|P2|TREATED|Overall Study||607
8489106|NCT00561470|20917702|P1|TREATED|Overall Study||609
8489107|NCT00561470|20917701|P2|STARTED|Overall Study||612
8489108|NCT00561470|20917702|P1|STARTED|Overall Study||614
8489109|NCT00561457|20917716|P1|NOT COMPLETED|Overall Study||24
8489110|NCT00561457|20917716|P1|COMPLETED|Overall Study||110
8489111|NCT00561457|20917716|P1|STARTED|Overall Study||134
8489112|NCT00561431|20917722|P2|NOT COMPLETED|Overall Study||0
8489113|NCT00561431|20917723|P1|NOT COMPLETED|Overall Study||0
8489114|NCT00561431|20917722|P2|COMPLETED|Overall Study||100
8489115|NCT00561431|20917723|P1|COMPLETED|Overall Study||100
8489116|NCT00561431|20917722|P2|STARTED|Overall Study||100
8489117|NCT00561431|20917723|P1|STARTED|Overall Study||100
8489118|NCT00561418|20917731|P1|NOT COMPLETED|Overall Study||0
8489119|NCT00561418|20917731|P1|COMPLETED|Overall Study||23
8489120|NCT00561418|20917731|P1|STARTED|Overall Study||23
8489121|NCT00561392|20917738|P1|NOT COMPLETED|Overall Study||53
8489122|NCT00561392|20917738|P1|COMPLETED|Overall Study||155
8489123|NCT00561392|20917738|P1|STARTED|Overall Study||208
8489124|NCT00561353|20917760|P10|NOT COMPLETED|Overall Study||2
8489125|NCT00561353|20917761|P9|NOT COMPLETED|Overall Study||7
8489126|NCT00561353|20917762|P8|NOT COMPLETED|Overall Study||4
8489127|NCT00561353|20917763|P7|NOT COMPLETED|Overall Study||6
8489128|NCT00561353|20917764|P6|NOT COMPLETED|Overall Study||6
8489129|NCT00561353|20917765|P5|NOT COMPLETED|Overall Study||1
8489130|NCT00561353|20917766|P4|NOT COMPLETED|Overall Study||6
8489131|NCT00561353|20917767|P3|NOT COMPLETED|Overall Study||3
8489132|NCT00561353|20917768|P2|NOT COMPLETED|Overall Study||3
8489133|NCT00561353|20917769|P1|NOT COMPLETED|Overall Study||5
8489134|NCT00561353|20917760|P10|COMPLETED|Overall Study||3
8489135|NCT00561353|20917761|P9|COMPLETED|Overall Study||2
8489136|NCT00561353|20917762|P8|COMPLETED|Overall Study||6
8489137|NCT00561353|20917763|P7|COMPLETED|Overall Study||3
8489138|NCT00561353|20917764|P6|COMPLETED|Overall Study||3
8489139|NCT00561353|20917765|P5|COMPLETED|Overall Study||5
8489140|NCT00561353|20917766|P4|COMPLETED|Overall Study||12
8489141|NCT00561353|20917767|P3|COMPLETED|Overall Study||10
8489142|NCT00561353|20917768|P2|COMPLETED|Overall Study||16
8489143|NCT00561353|20917769|P1|COMPLETED|Overall Study||13
8489144|NCT00561353|20917760|P10|STARTED|Overall Study||5
8489145|NCT00561353|20917761|P9|STARTED|Overall Study||9
8489146|NCT00561353|20917762|P8|STARTED|Overall Study||10
8489147|NCT00561353|20917763|P7|STARTED|Overall Study||9
8489148|NCT00561353|20917764|P6|STARTED|Overall Study||9
8489149|NCT00561353|20917765|P5|STARTED|Overall Study||6
8489150|NCT00561353|20917766|P4|STARTED|Overall Study||18
8489151|NCT00561353|20917767|P3|STARTED|Overall Study||13
8489152|NCT00561353|20917768|P2|STARTED|Overall Study||19
8489153|NCT00561353|20917769|P1|STARTED|Overall Study||18
8489154|NCT00561340|20917924|P2|NOT COMPLETED|Overall Study||0
8489155|NCT00561340|20917925|P1|NOT COMPLETED|Overall Study||6
8489156|NCT00561340|20917924|P2|COMPLETED|Overall Study||16
8489157|NCT00561340|20917925|P1|COMPLETED|Overall Study||7
8489158|NCT00561340|20917924|P2|STARTED|Overall Study||16
8489159|NCT00561340|20917925|P1|STARTED|Overall Study||13
8489160|NCT00561145|20917935|P2|NOT COMPLETED|Overall Study||0
8489161|NCT00561145|20917936|P1|NOT COMPLETED|Overall Study||0
8489162|NCT00561145|20917935|P2|COMPLETED|Overall Study||17
8489163|NCT00561145|20917936|P1|COMPLETED|Overall Study||15
8489164|NCT00561145|20917935|P2|STARTED|Overall Study||17
8489165|NCT00561145|20917936|P1|STARTED|Overall Study||15
8489166|NCT00561080|20917945|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8489167|NCT00561080|20917946|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8489168|NCT00561080|20917947|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8489169|NCT00561080|20917945|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
8489170|NCT00561080|20917946|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
8489171|NCT00561080|20917947|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
8489172|NCT00561080|20917945|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489173|NCT00561080|20917946|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489174|NCT00561080|20917947|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489175|NCT00561080|20917945|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8489176|NCT00561080|20917946|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8489177|NCT00561080|20917947|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8489178|NCT00561080|20917945|P3|COMPLETED|24-month Post Last Dose Follow-up||0
8489179|NCT00561080|20917946|P2|COMPLETED|24-month Post Last Dose Follow-up||0
8489180|NCT00561080|20917947|P1|COMPLETED|24-month Post Last Dose Follow-up||0
8489181|NCT00561080|20917945|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489182|NCT00561080|20917946|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489183|NCT00561080|20917947|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489184|NCT00561080|20917945|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
8489185|NCT00561080|20917946|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
8489186|NCT00561080|20917947|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
8489187|NCT00561080|20917945|P3|COMPLETED|12-month Post Last Dose Follow-up||215
8489188|NCT00561080|20917946|P2|COMPLETED|12-month Post Last Dose Follow-up||220
8489189|NCT00561080|20917947|P1|COMPLETED|12-month Post Last Dose Follow-up||243
8489190|NCT00561080|20917945|P3|STARTED|12-month Post Last Dose Follow-up||225
8489191|NCT00561080|20917946|P2|STARTED|12-month Post Last Dose Follow-up||229
8489192|NCT00561080|20917947|P1|STARTED|12-month Post Last Dose Follow-up||250
8489193|NCT00561080|20917945|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
8489194|NCT00561080|20917946|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
8489195|NCT00561080|20917947|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
8489196|NCT00561080|20917945|P3|COMPLETED|Vaccination Period (up to Month 4)||225
8489197|NCT00561080|20917946|P2|COMPLETED|Vaccination Period (up to Month 4)||229
8489198|NCT00561080|20917947|P1|COMPLETED|Vaccination Period (up to Month 4)||250
8489199|NCT00561080|20917945|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
8489200|NCT00561080|20917946|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
8489201|NCT00561080|20917947|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
8489202|NCT00561080|20917945|P3|STARTED|Vaccination Period (up to Month 4)||251
8489203|NCT00561080|20917946|P2|STARTED|Vaccination Period (up to Month 4)||255
8489204|NCT00561080|20917947|P1|STARTED|Vaccination Period (up to Month 4)||253
8489205|NCT00561015|20918024|P6|NOT COMPLETED|Overall Study||3
8489206|NCT00561015|20918025|P5|NOT COMPLETED|Overall Study||1
8489207|NCT00561015|20918026|P4|NOT COMPLETED|Overall Study||1
8489208|NCT00561015|20918027|P3|NOT COMPLETED|Overall Study||0
8489209|NCT00561015|20918028|P2|NOT COMPLETED|Overall Study||0
8489210|NCT00561015|20918029|P1|NOT COMPLETED|Overall Study||4
8489211|NCT00561015|20918024|P6|COMPLETED|Overall Study||6
8489212|NCT00561015|20918025|P5|COMPLETED|Overall Study||8
8489213|NCT00561015|20918026|P4|COMPLETED|Overall Study||7
8489214|NCT00561015|20918027|P3|COMPLETED|Overall Study||9
8489215|NCT00561015|20918028|P2|COMPLETED|Overall Study||5
8489216|NCT00561015|20918029|P1|COMPLETED|Overall Study||5
8489217|NCT00561015|20918024|P6|STARTED|Overall Study||9
8489218|NCT00561015|20918025|P5|STARTED|Overall Study||9
8489219|NCT00561015|20918026|P4|STARTED|Overall Study||8
8489220|NCT00561015|20918027|P3|STARTED|Overall Study||9
8489221|NCT00561015|20918028|P2|STARTED|Overall Study||5
8489222|NCT00561015|20918029|P1|STARTED|Overall Study||9
8489223|NCT00561002|20918105|P2|NOT COMPLETED|Overall Study||0
8489224|NCT00561002|20918106|P1|NOT COMPLETED|Overall Study||0
8489225|NCT00561002|20918105|P2|COMPLETED|Overall Study||9
8489226|NCT00561002|20918106|P1|COMPLETED|Overall Study||23
8489227|NCT00561002|20918105|P2|STARTED|Overall Study||9
8489228|NCT00561002|20918106|P1|STARTED|Overall Study||23
8489229|NCT00560950|20918120|P2|NOT COMPLETED|Overall Study||0
8489230|NCT00560950|20918121|P1|NOT COMPLETED|Overall Study||1
8489231|NCT00560950|20918120|P2|COMPLETED|Overall Study||71
8489232|NCT00560950|20918121|P1|COMPLETED|Overall Study||71
8489233|NCT00560950|20918120|P2|STARTED|Overall Study||71
8489234|NCT00560950|20918121|P1|STARTED|Overall Study||72
8489235|NCT00560937|20918159|P2|NOT COMPLETED|Overall Study||2
8489236|NCT00560937|20918160|P1|NOT COMPLETED|Overall Study||1
8489237|NCT00560937|20918159|P2|COMPLETED|Overall Study||9
8489238|NCT00560937|20918160|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
8489239|NCT00560937|20918159|P2|STARTED|Overall Study||11
8489240|NCT00560937|20918160|P1|STARTED|Overall Study||10
8489241|NCT00560885|20918176|P1|NOT COMPLETED|Overall Study||8
8489242|NCT00560885|20918176|P1|COMPLETED|Overall Study||47
8489243|NCT00560885|20918176|P1|2 Year Follow-up|Overall Study||47
8489244|NCT00560885|20918176|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
8489245|NCT00560885|20918176|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
8489246|NCT00560885|20918176|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
8489247|NCT00560885|20918176|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
8489248|NCT00560885|20918176|P1|STARTED|Overall Study||55
8489249|NCT00560859|20918185|P2|NOT COMPLETED|Overall Study||24
8489250|NCT00560859|20918186|P1|NOT COMPLETED|Overall Study||32
8489251|NCT00560859|20918185|P2|COMPLETED|Overall Study||203
8489252|NCT00560859|20918186|P1|COMPLETED|Overall Study||194
8489253|NCT00560859|20918185|P2|STARTED|Overall Study||227
8489254|NCT00560859|20918186|P1|STARTED|Overall Study||226
8489255|NCT00560833|20918201|P5|NOT COMPLETED|Overall Study||42
8489256|NCT00560833|20918202|P4|NOT COMPLETED|Overall Study||31
8489257|NCT00560833|20918203|P3|NOT COMPLETED|Overall Study||39
8489258|NCT00560833|20918204|P2|NOT COMPLETED|Overall Study||26
8489259|NCT00560833|20918205|P1|NOT COMPLETED|Overall Study||44
8489260|NCT00560833|20918201|P5|COMPLETED|Overall Study||114
8489261|NCT00560833|20918202|P4|COMPLETED|Overall Study||124
8489262|NCT00560833|20918203|P3|COMPLETED|Overall Study||121
8489263|NCT00560833|20918204|P2|COMPLETED|Overall Study||129
8489264|NCT00560833|20918205|P1|COMPLETED|Overall Study||273
8489265|NCT00560833|20918201|P5|Treated|Overall Study|One participant was randomized but not treated|155
8489266|NCT00560833|20918202|P4|Treated|Overall Study||155
8489267|NCT00560833|20918203|P3|Treated|Overall Study||160
8489268|NCT00560833|20918204|P2|Treated|Overall Study|One participant was randomized but not treated|154
8489269|NCT00560833|20918205|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
8489270|NCT00560833|20918201|P5|STARTED|Overall Study||156
8489271|NCT00560833|20918202|P4|STARTED|Overall Study||155
8489272|NCT00560833|20918203|P3|STARTED|Overall Study||160
8489273|NCT00560833|20918204|P2|STARTED|Overall Study||155
8489274|NCT00560833|20918205|P1|STARTED|Overall Study||317
8489275|NCT00560794|20918237|P1|NOT COMPLETED|Overall Study||11
8489276|NCT00560794|20918237|P1|COMPLETED|Overall Study||10
8489277|NCT00560794|20918237|P1|Completed 1 Treatment Cycle|Overall Study||20
8489278|NCT00560794|20918237|P1|STARTED|Overall Study||21
8489279|NCT00560755|20918254|P1|NOT COMPLETED|Overall Study||60
8489280|NCT00560755|20918254|P1|COMPLETED|Overall Study||3328
8489281|NCT00560755|20918254|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
8489282|NCT00560755|20918254|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
8489289|NCT00560612|20918286|P2|NOT COMPLETED|Overall Study||0
8489290|NCT00560612|20918287|P1|NOT COMPLETED|Overall Study||0
8489291|NCT00560612|20918286|P2|COMPLETED|Overall Study||7
8489292|NCT00560612|20918287|P1|COMPLETED|Overall Study||5
8489293|NCT00560612|20918286|P2|STARTED|Overall Study||7
8489294|NCT00560612|20918287|P1|STARTED|Overall Study||5
8489295|NCT00560573|20918299|P6|NOT COMPLETED|Overall Study||13
8489296|NCT00560573|20918300|P5|NOT COMPLETED|Overall Study||7
8489297|NCT00560573|20918301|P4|NOT COMPLETED|Overall Study||10
8489298|NCT00560573|20918302|P3|NOT COMPLETED|Overall Study||6
8489299|NCT00560573|20918303|P2|NOT COMPLETED|Overall Study||3
8489300|NCT00560573|20918304|P1|NOT COMPLETED|Overall Study||6
8489301|NCT00560573|20918299|P6|COMPLETED|Overall Study||0
8489302|NCT00560573|20918300|P5|COMPLETED|Overall Study||1
8489303|NCT00560573|20918301|P4|COMPLETED|Overall Study||0
8489304|NCT00560573|20918302|P3|COMPLETED|Overall Study||0
8489305|NCT00560573|20918303|P2|COMPLETED|Overall Study||0
8489306|NCT00560573|20918304|P1|COMPLETED|Overall Study||0
8489307|NCT00560573|20918299|P6|Treated|Overall Study||13
8489308|NCT00560573|20918300|P5|Treated|Overall Study||7
8489309|NCT00560573|20918301|P4|Treated|Overall Study||10
8489310|NCT00560573|20918302|P3|Treated|Overall Study||6
8489311|NCT00560573|20918303|P2|Treated|Overall Study||3
8489312|NCT00560573|20918304|P1|Treated|Overall Study||6
8489313|NCT00560573|20918299|P6|STARTED|Overall Study||13
8489314|NCT00560573|20918300|P5|STARTED|Overall Study||8
8489315|NCT00560573|20918301|P4|STARTED|Overall Study||10
8489316|NCT00560573|20918302|P3|STARTED|Overall Study||6
8489317|NCT00560573|20918303|P2|STARTED|Overall Study||3
8489318|NCT00560573|20918304|P1|STARTED|Overall Study||6
8489319|NCT00560560|20918358|P2|NOT COMPLETED|Overall Study||83
8489320|NCT00560560|20918359|P1|NOT COMPLETED|Overall Study||85
8489321|NCT00560560|20918358|P2|COMPLETED|Overall Study||0
8489322|NCT00560560|20918359|P1|COMPLETED|Overall Study||0
8489323|NCT00560560|20918358|P2|STARTED|Overall Study||83
8489324|NCT00560560|20918359|P1|STARTED|Overall Study||85
8489325|NCT00560508|20918381|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
8489326|NCT00560508|20918382|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
8489327|NCT00560508|20918381|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
8489328|NCT00560508|20918382|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
8489329|NCT00560508|20918381|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
8489330|NCT00560508|20918382|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
8489331|NCT00560508|20918381|P2|NOT COMPLETED|12 Week Double-blind Period||3
8489332|NCT00560508|20918382|P1|NOT COMPLETED|12 Week Double-blind Period||5
8489333|NCT00560508|20918381|P2|COMPLETED|12 Week Double-blind Period||53
8489334|NCT00560508|20918382|P1|COMPLETED|12 Week Double-blind Period||51
8489335|NCT00560508|20918381|P2|STARTED|12 Week Double-blind Period||56
8489336|NCT00560508|20918382|P1|STARTED|12 Week Double-blind Period||56
8489337|NCT00560417|20918441|P2|NOT COMPLETED|Overall Study||17
8489338|NCT00560417|20918442|P1|NOT COMPLETED|Overall Study||17
8489339|NCT00560417|20918441|P2|COMPLETED|Overall Study||151
8489340|NCT00560417|20918442|P1|COMPLETED|Overall Study||154
8489341|NCT00560417|20918441|P2|Intention to Treat (ITT) Population|Overall Study||167
8489342|NCT00560417|20918442|P1|Intention to Treat (ITT) Population|Overall Study||170
8489343|NCT00560417|20918441|P2|STARTED|Overall Study||168
8489344|NCT00560417|20918442|P1|STARTED|Overall Study||171
8489345|NCT00560404|20918470|P2|NOT COMPLETED|Overall Study||21
8489346|NCT00560404|20918471|P1|NOT COMPLETED|Overall Study||36
8489347|NCT00560404|20918470|P2|COMPLETED|Overall Study||100
8489348|NCT00560404|20918471|P1|COMPLETED|Overall Study||76
8489349|NCT00560404|20918470|P2|STARTED|Overall Study||121
8489350|NCT00560404|20918471|P1|STARTED|Overall Study||112
8489351|NCT00560391|20918518|P5|NOT COMPLETED|Overall Study||2
8489352|NCT00560391|20918519|P4|NOT COMPLETED|Overall Study||1
8489353|NCT00560391|20918520|P3|NOT COMPLETED|Overall Study||0
8489354|NCT00560391|20918521|P2|NOT COMPLETED|Overall Study||0
8489355|NCT00560391|20918522|P1|NOT COMPLETED|Overall Study||0
8489356|NCT00560391|20918518|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
8489357|NCT00560391|20918519|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
8489358|NCT00560391|20918520|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
8489359|NCT00560391|20918521|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
8489360|NCT00560391|20918522|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
8489361|NCT00560391|20918518|P5|STARTED|Overall Study|Participants who received treatment|17
8489362|NCT00560391|20918519|P4|STARTED|Overall Study|Participants who received treatment|6
8489363|NCT00560391|20918520|P3|STARTED|Overall Study|Participants who received treatment|3
8489364|NCT00560391|20918521|P2|STARTED|Overall Study|Participants who received treatment|3
8489365|NCT00560391|20918522|P1|STARTED|Overall Study|Participants who received treatment|6
8489366|NCT00560352|20918578|P3|NOT COMPLETED|Overall Study||4
8489367|NCT00560352|20918579|P2|NOT COMPLETED|Overall Study||3
8489368|NCT00560352|20918580|P1|NOT COMPLETED|Overall Study||7
8489369|NCT00560352|20918578|P3|COMPLETED|Overall Study||0
8489370|NCT00560352|20918579|P2|COMPLETED|Overall Study||0
8489371|NCT00560352|20918580|P1|COMPLETED|Overall Study||0
8489372|NCT00560352|20918578|P3|STARTED|Overall Study||4
8489373|NCT00560352|20918579|P2|STARTED|Overall Study||3
8489374|NCT00560352|20918580|P1|STARTED|Overall Study||7
8489375|NCT00560313|20918597|P1|NOT COMPLETED|Overall Study||6
8489376|NCT00560313|20918597|P1|COMPLETED|Overall Study||48
8489377|NCT00560313|20918597|P1|STARTED|Overall Study||54
8489378|NCT00560235|20918624|P3|NOT COMPLETED|Phase 2||97
8489379|NCT00560235|20918625|P2|NOT COMPLETED|Phase 2||0
8489380|NCT00560235|20918626|P1|NOT COMPLETED|Phase 2||0
8489381|NCT00560235|20918624|P3|COMPLETED|Phase 2||10
8489382|NCT00560235|20918625|P2|COMPLETED|Phase 2||0
8489383|NCT00560235|20918626|P1|COMPLETED|Phase 2||0
8489384|NCT00560235|20918624|P3|STARTED|Phase 2||107
8489385|NCT00560235|20918625|P2|STARTED|Phase 2||0
8489386|NCT00560235|20918626|P1|STARTED|Phase 2||0
8489387|NCT00560235|20918624|P3|NOT COMPLETED|Phase 1B||0
8489388|NCT00560235|20918625|P2|NOT COMPLETED|Phase 1B||19
8489389|NCT00560235|20918626|P1|NOT COMPLETED|Phase 1B||0
8489390|NCT00560235|20918624|P3|COMPLETED|Phase 1B||0
8489391|NCT00560235|20918625|P2|COMPLETED|Phase 1B||2
8489392|NCT00560235|20918626|P1|COMPLETED|Phase 1B||0
8489393|NCT00560235|20918624|P3|STARTED|Phase 1B||0
8489394|NCT00560235|20918625|P2|STARTED|Phase 1B||21
8489395|NCT00560235|20918626|P1|STARTED|Phase 1B||0
8489396|NCT00560235|20918624|P3|NOT COMPLETED|Phase 1||0
8489397|NCT00560235|20918625|P2|NOT COMPLETED|Phase 1||0
8489398|NCT00560235|20918626|P1|NOT COMPLETED|Phase 1||8
8489399|NCT00560235|20918624|P3|COMPLETED|Phase 1||0
8489400|NCT00560235|20918625|P2|COMPLETED|Phase 1||0
8489401|NCT00560235|20918626|P1|COMPLETED|Phase 1||2
8489402|NCT00560235|20918624|P3|STARTED|Phase 1||0
8489403|NCT00560235|20918625|P2|STARTED|Phase 1||0
8489404|NCT00560235|20918626|P1|STARTED|Phase 1||10
8489405|NCT00560105|20918657|P2|NOT COMPLETED|Overall Study||2
8489406|NCT00560105|20918658|P1|NOT COMPLETED|Overall Study||1
8489407|NCT00560105|20918657|P2|COMPLETED|Overall Study||18
8489408|NCT00560105|20918658|P1|COMPLETED|Overall Study||19
8489409|NCT00560105|20918657|P2|STARTED|Overall Study||20
8489410|NCT00560105|20918658|P1|STARTED|Overall Study||20
8489411|NCT00560066|20918672|P2|NOT COMPLETED|Overall Study||22
8489412|NCT00560066|20918673|P1|NOT COMPLETED|Overall Study||6
8489413|NCT00560066|20918672|P2|COMPLETED|Overall Study||980
8489414|NCT00560066|20918673|P1|COMPLETED|Overall Study||390
8489415|NCT00560066|20918672|P2|STARTED|Overall Study||1002
8489416|NCT00560066|20918673|P1|STARTED|Overall Study||396
8489417|NCT00559988|20918705|P2|NOT COMPLETED|Overall Study||352
8489418|NCT00559988|20918706|P1|NOT COMPLETED|Overall Study||351
8489419|NCT00559988|20918705|P2|COMPLETED|Overall Study||1009
8489420|NCT00559988|20918706|P1|COMPLETED|Overall Study||1006
8489421|NCT00559988|20918705|P2|STARTED|Overall Study||1361
8489422|NCT00559988|20918706|P1|STARTED|Overall Study||1357
8489423|NCT00559962|20918736|P8|NOT COMPLETED|Overall Study||4
8489424|NCT00559962|20918737|P7|NOT COMPLETED|Overall Study||5
8489425|NCT00559962|20918738|P6|NOT COMPLETED|Overall Study||5
8489426|NCT00559962|20918739|P5|NOT COMPLETED|Overall Study||14
8489427|NCT00559962|20918740|P4|NOT COMPLETED|Overall Study||5
8489428|NCT00559962|20918741|P3|NOT COMPLETED|Overall Study||10
8489429|NCT00559962|20918742|P2|NOT COMPLETED|Overall Study||9
8489430|NCT00559962|20918743|P1|NOT COMPLETED|Overall Study||2
8489431|NCT00559962|20918736|P8|COMPLETED|Overall Study||25
8489432|NCT00559962|20918737|P7|COMPLETED|Overall Study||28
8489433|NCT00559962|20918738|P6|COMPLETED|Overall Study||23
8489434|NCT00559962|20918739|P5|COMPLETED|Overall Study||21
8489435|NCT00559962|20918740|P4|COMPLETED|Overall Study||29
8489436|NCT00559962|20918741|P3|COMPLETED|Overall Study||24
8489437|NCT00559962|20918742|P2|COMPLETED|Overall Study||25
8489438|NCT00559962|20918743|P1|COMPLETED|Overall Study||31
8489439|NCT00559962|20918736|P8|STARTED|Overall Study||29
8489440|NCT00559962|20918737|P7|STARTED|Overall Study||33
8489441|NCT00559962|20918738|P6|STARTED|Overall Study||28
8489442|NCT00559962|20918739|P5|STARTED|Overall Study||35
8489443|NCT00559962|20918740|P4|STARTED|Overall Study||34
8489444|NCT00559962|20918741|P3|STARTED|Overall Study||34
8489445|NCT00559962|20918742|P2|STARTED|Overall Study||34
8489446|NCT00559962|20918743|P1|STARTED|Overall Study||33
8489447|NCT00559949|20918763|P1|NOT COMPLETED|Overall Study||7
8489448|NCT00559949|20918763|P1|COMPLETED|Overall Study||32
8489449|NCT00559949|20918763|P1|STARTED|Overall Study||39
8489450|NCT00559936|20918770|P1|NOT COMPLETED|Overall Study||4
8489451|NCT00559936|20918770|P1|COMPLETED|Overall Study||20
8489452|NCT00559936|20918770|P1|STARTED|Overall Study||24
8489453|NCT00559897|20918775|P1|NOT COMPLETED|Overall Study||0
8489454|NCT00559897|20918775|P1|COMPLETED|Overall Study||6
8489455|NCT00559897|20918775|P1|STARTED|Overall Study||6
8489456|NCT00559845|20918779|P1|NOT COMPLETED|Overall Study||7
8489457|NCT00559845|20918779|P1|COMPLETED|Overall Study||49
8489458|NCT00559845|20918779|P1|STARTED|Overall Study||56
8489459|NCT00559754|20918788|P1|NOT COMPLETED|Overall Study||11
8489460|NCT00559754|20918788|P1|COMPLETED|Overall Study||61
8489461|NCT00559754|20918788|P1|STARTED|Overall Study||72
8489462|NCT00559637|20918812|P1|NOT COMPLETED|Overall Study||54
8489463|NCT00559637|20918812|P1|COMPLETED|Overall Study||130
8489464|NCT00559637|20918812|P1|STARTED|Overall Study||184
8489465|NCT00559585|20918825|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
8489466|NCT00559585|20918826|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
8489467|NCT00559585|20918825|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
8489468|NCT00559585|20918826|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
8489469|NCT00559585|20918825|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
8489470|NCT00559585|20918826|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
8489471|NCT00559585|20918825|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
8489472|NCT00559585|20918826|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
8489473|NCT00559585|20918825|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
8489474|NCT00559585|20918826|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
8489475|NCT00559585|20918825|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
8489476|NCT00559585|20918826|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
8489477|NCT00559585|20918825|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
8489478|NCT00559585|20918826|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
8489479|NCT00559585|20918825|P2|COMPLETED|Double Blind ST Period Main Study||676
8489480|NCT00559585|20918826|P1|COMPLETED|Double Blind ST Period Main Study||693
8489481|NCT00559585|20918825|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
8489482|NCT00559585|20918826|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
8489483|NCT00559507|20918886|P1|NOT COMPLETED|Overall Study||3
8489484|NCT00559507|20918886|P1|COMPLETED|Overall Study||9
8489485|NCT00559507|20918886|P1|STARTED|Overall Study||12
8489486|NCT00559468|20918894|P2|NOT COMPLETED|Overall Study||1
8489487|NCT00559468|20918895|P1|NOT COMPLETED|Overall Study||0
8489488|NCT00559468|20918894|P2|COMPLETED|Overall Study||25
8489489|NCT00559468|20918895|P1|COMPLETED|Overall Study||26
8489490|NCT00559468|20918894|P2|Treated|Overall Study||25
8489491|NCT00559468|20918895|P1|Treated|Overall Study||26
8489492|NCT00559468|20918894|P2|STARTED|Overall Study||26
8489493|NCT00559468|20918895|P1|STARTED|Overall Study||26
8489494|NCT00559377|20918905|P1|NOT COMPLETED|Overall Study||9
8489495|NCT00559377|20918905|P1|COMPLETED|Overall Study||7
8489496|NCT00559377|20918905|P1|STARTED|Overall Study||16
8489497|NCT00559364|20918915|P2|NOT COMPLETED|Overall Study||0
8489498|NCT00559364|20918916|P1|NOT COMPLETED|Overall Study||1
8489499|NCT00559364|20918915|P2|COMPLETED|Overall Study||20
8489500|NCT00559364|20918916|P1|COMPLETED|Overall Study||29
8489501|NCT00559364|20918915|P2|STARTED|Overall Study||20
8489502|NCT00559364|20918916|P1|STARTED|Overall Study||30
8489503|NCT00559273|20918928|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
8489504|NCT00559273|20918929|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
8489505|NCT00559273|20918928|P2|COMPLETED|Evaluation Period (8 Weeks)||137
8489506|NCT00559273|20918929|P1|COMPLETED|Evaluation Period (8 Weeks)||141
8489507|NCT00559273|20918928|P2|STARTED|Evaluation Period (8 Weeks)||142
8489508|NCT00559273|20918929|P1|STARTED|Evaluation Period (8 Weeks)||144
8489509|NCT00559273|20918928|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
8489510|NCT00559273|20918929|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
8489511|NCT00559273|20918928|P2|COMPLETED|Correction Period (20 Weeks)||142
8489512|NCT00559273|20918929|P1|COMPLETED|Correction Period (20 Weeks)||144
8489513|NCT00559273|20918928|P2|Treated|Correction Period (20 Weeks)||154
8489514|NCT00559273|20918929|P1|Treated|Correction Period (20 Weeks)||151
8489515|NCT00559273|20918928|P2|STARTED|Correction Period (20 Weeks)||154
8489516|NCT00559273|20918929|P1|STARTED|Correction Period (20 Weeks)||153
8489517|NCT00559104|20918951|P2|NOT COMPLETED|Overall Study||0
8489518|NCT00559104|20918952|P1|NOT COMPLETED|Overall Study||9
8489519|NCT00559104|20918951|P2|COMPLETED|Overall Study||5
8489520|NCT00559104|20918952|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
8489521|NCT00559104|20918951|P2|STARTED|Overall Study||5
8489522|NCT00559104|20918952|P1|STARTED|Overall Study||55
8489523|NCT00559013|20918962|P1|NOT COMPLETED|Overall Study||0
8489524|NCT00559013|20918962|P1|COMPLETED|Overall Study||38
8489525|NCT00559013|20918962|P1|STARTED|Overall Study||38
8489526|NCT00558896|20918973|P7|NOT COMPLETED|Overall Study||24
8489527|NCT00558896|20918974|P6|NOT COMPLETED|Overall Study||52
8489528|NCT00558896|20918975|P5|NOT COMPLETED|Overall Study||23
8489529|NCT00558896|20918976|P4|NOT COMPLETED|Overall Study||12
8489530|NCT00558896|20918977|P3|NOT COMPLETED|Overall Study||5
8489531|NCT00558896|20918978|P2|NOT COMPLETED|Overall Study||7
8489532|NCT00558896|20918979|P1|NOT COMPLETED|Overall Study||21
8489533|NCT00558896|20918973|P7|COMPLETED|Overall Study||9
8489534|NCT00558896|20918974|P6|COMPLETED|Overall Study||68
8489535|NCT00558896|20918975|P5|COMPLETED|Overall Study||37
8489536|NCT00558896|20918976|P4|COMPLETED|Overall Study||23
8489537|NCT00558896|20918977|P3|COMPLETED|Overall Study||30
8489538|NCT00558896|20918978|P2|COMPLETED|Overall Study||27
8489539|NCT00558896|20918979|P1|COMPLETED|Overall Study||39
8489540|NCT00558896|20918973|P7|STARTED|Overall Study||33
8489541|NCT00558896|20918974|P6|STARTED|Overall Study||120
8489542|NCT00558896|20918975|P5|STARTED|Overall Study||60
8489543|NCT00558896|20918976|P4|STARTED|Overall Study||35
8489544|NCT00558896|20918977|P3|STARTED|Overall Study||35
8489545|NCT00558896|20918978|P2|STARTED|Overall Study||34
8489546|NCT00558896|20918979|P1|STARTED|Overall Study||60
8489547|NCT00558870|20919011|P2|NOT COMPLETED|Overall Study||0
8489548|NCT00558870|20919012|P1|NOT COMPLETED|Overall Study||0
8489549|NCT00558870|20919011|P2|COMPLETED|Overall Study||2
8489550|NCT00558870|20919012|P1|COMPLETED|Overall Study||2
8489551|NCT00558870|20919011|P2|STARTED|Overall Study||2
8489552|NCT00558870|20919012|P1|STARTED|Overall Study||2
8489553|NCT00558844|20919025|P5|NOT COMPLETED|Overall Study||1
8489554|NCT00558844|20919026|P4|NOT COMPLETED|Overall Study||0
8489555|NCT00558844|20919027|P3|NOT COMPLETED|Overall Study||1
8489556|NCT00558844|20919028|P2|NOT COMPLETED|Overall Study||0
8489557|NCT00558844|20919029|P1|NOT COMPLETED|Overall Study||3
8489558|NCT00558844|20919025|P5|COMPLETED|Overall Study||6
8489559|NCT00558844|20919026|P4|COMPLETED|Overall Study||5
8489560|NCT00558844|20919027|P3|COMPLETED|Overall Study||6
8489561|NCT00558844|20919028|P2|COMPLETED|Overall Study||7
8489562|NCT00558844|20919029|P1|COMPLETED|Overall Study||12
8489563|NCT00558844|20919025|P5|STARTED|Overall Study||7
8489564|NCT00558844|20919026|P4|STARTED|Overall Study||5
8489565|NCT00558844|20919027|P3|STARTED|Overall Study||7
8489566|NCT00558844|20919028|P2|STARTED|Overall Study||7
8489567|NCT00558844|20919029|P1|STARTED|Overall Study||15
8489568|NCT00558831|20919081|P1|NOT COMPLETED|Overall Study||1
8489569|NCT00558831|20919081|P1|COMPLETED|Overall Study||10
8489570|NCT00558831|20919081|P1|STARTED|Overall Study||11
8489571|NCT00558792|20919090|P3|NOT COMPLETED|Overall Study||0
8489572|NCT00558792|20919091|P2|NOT COMPLETED|Overall Study||0
8489573|NCT00558792|20919092|P1|NOT COMPLETED|Overall Study||0
8489574|NCT00558792|20919090|P3|COMPLETED|Overall Study||60
8489575|NCT00558792|20919091|P2|COMPLETED|Overall Study||63
8489576|NCT00558792|20919092|P1|COMPLETED|Overall Study||68
8489577|NCT00558792|20919090|P3|STARTED|Overall Study||60
8489578|NCT00558792|20919091|P2|STARTED|Overall Study||63
8489579|NCT00558792|20919092|P1|STARTED|Overall Study||68
8489580|NCT00558753|20919138|P2|NOT COMPLETED|Overall Study||7
8489581|NCT00558753|20919139|P1|NOT COMPLETED|Overall Study||5
8489582|NCT00558753|20919138|P2|COMPLETED|Overall Study||113
8489583|NCT00558753|20919139|P1|COMPLETED|Overall Study||115
8489584|NCT00558753|20919138|P2|STARTED|Overall Study||120
8489585|NCT00558753|20919139|P1|STARTED|Overall Study||120
8489586|NCT00558701|20919151|P2|NOT COMPLETED|Overall Study||4
8489587|NCT00558701|20919152|P1|NOT COMPLETED|Overall Study||1
8489588|NCT00558701|20919151|P2|COMPLETED|Overall Study||11
8489589|NCT00558701|20919152|P1|COMPLETED|Overall Study||14
8489590|NCT00558701|20919151|P2|STARTED|Overall Study||15
8489591|NCT00558701|20919152|P1|STARTED|Overall Study||15
8489592|NCT00558636|20919160|P2|NOT COMPLETED|Follow-up||7
8489593|NCT00558636|20919161|P1|NOT COMPLETED|Follow-up||12
8489594|NCT00558636|20919160|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
8489595|NCT00558636|20919161|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
8489596|NCT00558636|20919160|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
8489597|NCT00558636|20919161|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
8489598|NCT00558636|20919160|P2|NOT COMPLETED|Treatment||44
8489599|NCT00558636|20919161|P1|NOT COMPLETED|Treatment||47
8489600|NCT00558636|20919160|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
8489601|NCT00558636|20919161|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
8489602|NCT00558636|20919160|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
8489603|NCT00558636|20919161|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
8489604|NCT00558636|20919160|P2|STARTED|Treatment||44
8489605|NCT00558636|20919161|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
8489606|NCT00558571|20919183|P4|NOT COMPLETED|Overall Study||0
8489607|NCT00558571|20919184|P3|NOT COMPLETED|Overall Study||0
8489608|NCT00558571|20919185|P2|NOT COMPLETED|Overall Study||0
8489609|NCT00558571|20919186|P1|NOT COMPLETED|Overall Study||0
8489610|NCT00558571|20919183|P4|COMPLETED|Overall Study||30
8489611|NCT00558571|20919184|P3|COMPLETED|Overall Study||16
8489612|NCT00558571|20919185|P2|COMPLETED|Overall Study||16
8489613|NCT00558571|20919186|P1|COMPLETED|Overall Study||16
8489614|NCT00558571|20919183|P4|STARTED|Overall Study||30
8489615|NCT00558571|20919184|P3|STARTED|Overall Study||16
8489616|NCT00558571|20919185|P2|STARTED|Overall Study||16
8489617|NCT00558571|20919186|P1|STARTED|Overall Study||16
8489618|NCT00558558|20919261|P1|NOT COMPLETED|Overall Study||6
8489619|NCT00558558|20919261|P1|COMPLETED|Overall Study||0
8489620|NCT00558558|20919261|P1|STARTED|Overall Study||6
8489621|NCT00558519|20919265|P1|NOT COMPLETED|Overall Study||23
8489622|NCT00558519|20919265|P1|COMPLETED|Overall Study||295
8489623|NCT00558519|20919265|P1|STARTED|Overall Study||318
8489624|NCT00558467|20919275|P2|NOT COMPLETED|Overall Study||4
8489625|NCT00558467|20919276|P1|NOT COMPLETED|Overall Study||1
8489626|NCT00558467|20919275|P2|COMPLETED|Overall Study||39
8489627|NCT00558467|20919276|P1|COMPLETED|Overall Study||19
8489628|NCT00558467|20919275|P2|STARTED|Overall Study||43
8489629|NCT00558467|20919276|P1|STARTED|Overall Study||20
8489630|NCT00558428|20919336|P4|NOT COMPLETED|Overall Study||11
8489631|NCT00558428|20919337|P3|NOT COMPLETED|Overall Study||4
8489632|NCT00558428|20919338|P2|NOT COMPLETED|Overall Study||24
8489633|NCT00558428|20919339|P1|NOT COMPLETED|Overall Study||12
8489634|NCT00558428|20919336|P4|COMPLETED|Overall Study||266
8489635|NCT00558428|20919337|P3|COMPLETED|Overall Study||273
8489636|NCT00558428|20919338|P2|COMPLETED|Overall Study||252
8489637|NCT00558428|20919339|P1|COMPLETED|Overall Study||255
8489638|NCT00558428|20919336|P4|STARTED|Overall Study||277
8489639|NCT00558428|20919337|P3|STARTED|Overall Study||277
8489640|NCT00558428|20919338|P2|STARTED|Overall Study||276
8489641|NCT00558428|20919339|P1|STARTED|Overall Study||267
8489642|NCT00558363|20919379|P2|NOT COMPLETED|Overall Study||36
8489643|NCT00558363|20919380|P1|NOT COMPLETED|Overall Study||71
8489644|NCT00558363|20919379|P2|COMPLETED|Overall Study||111
8489645|NCT00558363|20919380|P1|COMPLETED|Overall Study||76
8489646|NCT00558363|20919379|P2|STARTED|Overall Study||147
8489647|NCT00558363|20919380|P1|STARTED|Overall Study||147
8489648|NCT00558285|20919435|P5|NOT COMPLETED|Overall Study||4
8489649|NCT00558285|20919436|P4|NOT COMPLETED|Overall Study||4
8489650|NCT00558285|20919437|P3|NOT COMPLETED|Overall Study||5
8489651|NCT00558285|20919438|P2|NOT COMPLETED|Overall Study||3
8489652|NCT00558285|20919439|P1|NOT COMPLETED|Overall Study||6
8489653|NCT00558285|20919435|P5|COMPLETED|Overall Study||49
8489654|NCT00558285|20919436|P4|COMPLETED|Overall Study||48
8489655|NCT00558285|20919437|P3|COMPLETED|Overall Study||46
8489656|NCT00558285|20919438|P2|COMPLETED|Overall Study||48
8489657|NCT00558285|20919439|P1|COMPLETED|Overall Study||44
8489658|NCT00558285|20919435|P5|Safety: Received Study Drug|Overall Study||53
8489659|NCT00558285|20919436|P4|Safety: Received Study Drug|Overall Study||51
8489660|NCT00558285|20919437|P3|Safety: Received Study Drug|Overall Study||51
8489661|NCT00558285|20919438|P2|Safety: Received Study Drug|Overall Study||51
8489662|NCT00558285|20919439|P1|Safety: Received Study Drug|Overall Study||49
8489663|NCT00558285|20919435|P5|STARTED|Overall Study||53
8489664|NCT00558285|20919436|P4|STARTED|Overall Study||52
8489665|NCT00558285|20919437|P3|STARTED|Overall Study||51
8489666|NCT00558285|20919438|P2|STARTED|Overall Study||51
8489667|NCT00558285|20919439|P1|STARTED|Overall Study||50
8489668|NCT00558272|20919483|P2|NOT COMPLETED|Overall Study||2
8489669|NCT00558272|20919484|P1|NOT COMPLETED|Overall Study||13
8489670|NCT00558272|20919483|P2|COMPLETED|Overall Study|4-week treatment period|68
8489671|NCT00558272|20919484|P1|COMPLETED|Overall Study|4-week treatment period|56
8489672|NCT00558272|20919483|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
8489673|NCT00558272|20919484|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
8489674|NCT00558272|20919483|P2|STARTED|Overall Study|Randomised|70
8489675|NCT00558272|20919484|P1|STARTED|Overall Study|Randomised|69
8489676|NCT00558259|20919524|P2|NOT COMPLETED|Overall Study||99
8489677|NCT00558259|20919525|P1|NOT COMPLETED|Overall Study||71
8489678|NCT00558259|20919524|P2|COMPLETED|Overall Study|Completed treatment.|563
8489679|NCT00558259|20919525|P1|COMPLETED|Overall Study|Completed treatment.|610
8489680|NCT00558259|20919524|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
8489681|NCT00558259|20919525|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
8489682|NCT00558246|20919545|P1|NOT COMPLETED|Overall Study||0
8489683|NCT00558246|20919545|P1|COMPLETED|Overall Study||79
8489684|NCT00558246|20919545|P1|STARTED|Overall Study||79
8489685|NCT00558103|20919565|P6|NOT COMPLETED|Monotherapy Extension Phase||9
8489686|NCT00558103|20919566|P5|NOT COMPLETED|Monotherapy Extension Phase||0
8489687|NCT00558103|20919567|P4|NOT COMPLETED|Monotherapy Extension Phase||0
8489688|NCT00558103|20919568|P3|NOT COMPLETED|Monotherapy Extension Phase||0
8489689|NCT00558103|20919569|P2|NOT COMPLETED|Monotherapy Extension Phase||0
8489690|NCT00558103|20919570|P1|NOT COMPLETED|Monotherapy Extension Phase||0
8489691|NCT00558103|20919565|P6|COMPLETED|Monotherapy Extension Phase||0
8489692|NCT00558103|20919566|P5|COMPLETED|Monotherapy Extension Phase||0
8489693|NCT00558103|20919567|P4|COMPLETED|Monotherapy Extension Phase||0
8489694|NCT00558103|20919568|P3|COMPLETED|Monotherapy Extension Phase||0
8489695|NCT00558103|20919569|P2|COMPLETED|Monotherapy Extension Phase||0
8489696|NCT00558103|20919570|P1|COMPLETED|Monotherapy Extension Phase||0
8489784|NCT00557856|20919680|P9|COMPLETED|Part 1: Dose Escalation Phase||0
8489697|NCT00558103|20919565|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
8489698|NCT00558103|20919566|P5|STARTED|Monotherapy Extension Phase||0
8489699|NCT00558103|20919567|P4|STARTED|Monotherapy Extension Phase||0
8489700|NCT00558103|20919568|P3|STARTED|Monotherapy Extension Phase||0
8489701|NCT00558103|20919569|P2|STARTED|Monotherapy Extension Phase||0
8489702|NCT00558103|20919570|P1|STARTED|Monotherapy Extension Phase||0
8489703|NCT00558103|20919565|P6|NOT COMPLETED|Randomized Treatment Phase||0
8489704|NCT00558103|20919566|P5|NOT COMPLETED|Randomized Treatment Phase||5
8489705|NCT00558103|20919567|P4|NOT COMPLETED|Randomized Treatment Phase||2
8489706|NCT00558103|20919568|P3|NOT COMPLETED|Randomized Treatment Phase||3
8489707|NCT00558103|20919569|P2|NOT COMPLETED|Randomized Treatment Phase||4
8489708|NCT00558103|20919570|P1|NOT COMPLETED|Randomized Treatment Phase||5
8489709|NCT00558103|20919565|P6|COMPLETED|Randomized Treatment Phase||0
8489710|NCT00558103|20919566|P5|COMPLETED|Randomized Treatment Phase||33
8489711|NCT00558103|20919567|P4|COMPLETED|Randomized Treatment Phase||11
8489712|NCT00558103|20919568|P3|COMPLETED|Randomized Treatment Phase||33
8489713|NCT00558103|20919569|P2|COMPLETED|Randomized Treatment Phase||34
8489714|NCT00558103|20919570|P1|COMPLETED|Randomized Treatment Phase||33
8489715|NCT00558103|20919565|P6|STARTED|Randomized Treatment Phase||0
8489716|NCT00558103|20919566|P5|STARTED|Randomized Treatment Phase||38
8489717|NCT00558103|20919567|P4|STARTED|Randomized Treatment Phase||13
8489718|NCT00558103|20919568|P3|STARTED|Randomized Treatment Phase||36
8489719|NCT00558103|20919569|P2|STARTED|Randomized Treatment Phase||38
8489720|NCT00558103|20919570|P1|STARTED|Randomized Treatment Phase||38
8489721|NCT00558064|20919600|P2|NOT COMPLETED|Overall Study||5
8489722|NCT00558064|20919601|P1|NOT COMPLETED|Overall Study||5
8489723|NCT00558064|20919600|P2|COMPLETED|Overall Study||257
8489724|NCT00558064|20919601|P1|COMPLETED|Overall Study||264
8489725|NCT00558064|20919600|P2|STARTED|Overall Study||262
8489726|NCT00558064|20919601|P1|STARTED|Overall Study||269
8489727|NCT00558025|20919623|P2|NOT COMPLETED|Overall Study||3
8489728|NCT00558025|20919624|P1|NOT COMPLETED|Overall Study||4
8489729|NCT00558025|20919623|P2|COMPLETED|Overall Study||49
8489730|NCT00558025|20919624|P1|COMPLETED|Overall Study||100
8489731|NCT00558025|20919623|P2|STARTED|Overall Study||52
8489732|NCT00558025|20919624|P1|STARTED|Overall Study||104
8489733|NCT00558012|20919648|P2|NOT COMPLETED|Overall Study||18
8489734|NCT00558012|20919649|P1|NOT COMPLETED|Overall Study||25
8489735|NCT00558012|20919648|P2|COMPLETED|Overall Study||74
8489736|NCT00558012|20919649|P1|COMPLETED|Overall Study||64
8489737|NCT00558012|20919648|P2|STARTED|Overall Study||92
8489738|NCT00558012|20919649|P1|STARTED|Overall Study||89
8489739|NCT00557947|20919655|P1|NOT COMPLETED|Overall Study||0
8489740|NCT00557947|20919655|P1|COMPLETED|Overall Study||83
8489741|NCT00557947|20919655|P1|STARTED|Overall Study||83
8489742|NCT00557882|20919673|P2|NOT COMPLETED|Overall Study||0
8489743|NCT00557882|20919674|P1|NOT COMPLETED|Overall Study||5
8489744|NCT00557882|20919673|P2|COMPLETED|Overall Study||33
8489745|NCT00557882|20919674|P1|COMPLETED|Overall Study||27
8489746|NCT00557882|20919673|P2|STARTED|Overall Study||33
8489747|NCT00557882|20919674|P1|STARTED|Overall Study||32
8489748|NCT00557856|20919680|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
8489749|NCT00557856|20919681|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
8489750|NCT00557856|20919682|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
8489751|NCT00557856|20919683|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
8489752|NCT00557856|20919684|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
8489753|NCT00557856|20919685|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
8489754|NCT00557856|20919686|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
8489755|NCT00557856|20919687|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
8489756|NCT00557856|20919688|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
8489757|NCT00557856|20919680|P9|COMPLETED|Part 2: Exploratory Phase||0
8489758|NCT00557856|20919681|P8|COMPLETED|Part 2: Exploratory Phase||0
8489759|NCT00557856|20919682|P7|COMPLETED|Part 2: Exploratory Phase||0
8489760|NCT00557856|20919683|P6|COMPLETED|Part 2: Exploratory Phase||0
8489761|NCT00557856|20919684|P5|COMPLETED|Part 2: Exploratory Phase||0
8489762|NCT00557856|20919685|P4|COMPLETED|Part 2: Exploratory Phase||0
8489763|NCT00557856|20919686|P3|COMPLETED|Part 2: Exploratory Phase||0
8489764|NCT00557856|20919687|P2|COMPLETED|Part 2: Exploratory Phase||0
8489765|NCT00557856|20919688|P1|COMPLETED|Part 2: Exploratory Phase||0
8489766|NCT00557856|20919680|P9|STARTED|Part 2: Exploratory Phase||24
8489767|NCT00557856|20919681|P8|STARTED|Part 2: Exploratory Phase||0
8489768|NCT00557856|20919682|P7|STARTED|Part 2: Exploratory Phase||0
8489769|NCT00557856|20919683|P6|STARTED|Part 2: Exploratory Phase||0
8489770|NCT00557856|20919684|P5|STARTED|Part 2: Exploratory Phase||0
8489771|NCT00557856|20919685|P4|STARTED|Part 2: Exploratory Phase||0
8489772|NCT00557856|20919686|P3|STARTED|Part 2: Exploratory Phase||0
8489773|NCT00557856|20919687|P2|STARTED|Part 2: Exploratory Phase||0
8489774|NCT00557856|20919688|P1|STARTED|Part 2: Exploratory Phase||0
8489775|NCT00557856|20919680|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
8489776|NCT00557856|20919681|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
8489777|NCT00557856|20919682|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
8489778|NCT00557856|20919683|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
8489779|NCT00557856|20919684|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
8489780|NCT00557856|20919685|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
8489781|NCT00557856|20919686|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
8489782|NCT00557856|20919687|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
8489783|NCT00557856|20919688|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
8489785|NCT00557856|20919681|P8|COMPLETED|Part 1: Dose Escalation Phase||0
8489786|NCT00557856|20919682|P7|COMPLETED|Part 1: Dose Escalation Phase||0
8489787|NCT00557856|20919683|P6|COMPLETED|Part 1: Dose Escalation Phase||0
8489788|NCT00557856|20919684|P5|COMPLETED|Part 1: Dose Escalation Phase||0
8489789|NCT00557856|20919685|P4|COMPLETED|Part 1: Dose Escalation Phase||0
8489790|NCT00557856|20919686|P3|COMPLETED|Part 1: Dose Escalation Phase||0
8489791|NCT00557856|20919687|P2|COMPLETED|Part 1: Dose Escalation Phase||0
8489792|NCT00557856|20919688|P1|COMPLETED|Part 1: Dose Escalation Phase||0
8489793|NCT00557856|20919680|P9|Treated|Part 1: Dose Escalation Phase||0
8489794|NCT00557856|20919681|P8|Treated|Part 1: Dose Escalation Phase||6
8489795|NCT00557856|20919682|P7|Treated|Part 1: Dose Escalation Phase||7
8489796|NCT00557856|20919683|P6|Treated|Part 1: Dose Escalation Phase||8
8489797|NCT00557856|20919684|P5|Treated|Part 1: Dose Escalation Phase||4
8489798|NCT00557856|20919685|P4|Treated|Part 1: Dose Escalation Phase||3
8489799|NCT00557856|20919686|P3|Treated|Part 1: Dose Escalation Phase||6
8489800|NCT00557856|20919687|P2|Treated|Part 1: Dose Escalation Phase||5
8489801|NCT00557856|20919688|P1|Treated|Part 1: Dose Escalation Phase||5
8489802|NCT00557856|20919680|P9|STARTED|Part 1: Dose Escalation Phase||0
8489803|NCT00557856|20919681|P8|STARTED|Part 1: Dose Escalation Phase||6
8489804|NCT00557856|20919682|P7|STARTED|Part 1: Dose Escalation Phase||7
8489805|NCT00557856|20919683|P6|STARTED|Part 1: Dose Escalation Phase||8
8489806|NCT00557856|20919684|P5|STARTED|Part 1: Dose Escalation Phase||4
8489807|NCT00557856|20919685|P4|STARTED|Part 1: Dose Escalation Phase||3
8489808|NCT00557856|20919686|P3|STARTED|Part 1: Dose Escalation Phase||6
8489809|NCT00557856|20919687|P2|STARTED|Part 1: Dose Escalation Phase||5
8489810|NCT00557856|20919688|P1|STARTED|Part 1: Dose Escalation Phase||7
8489811|NCT00557830|20919887|P3|NOT COMPLETED|Treatment Phase||0
8489812|NCT00557830|20919888|P2|NOT COMPLETED|Treatment Phase||0
8489813|NCT00557830|20919889|P1|NOT COMPLETED|Treatment Phase||0
8489814|NCT00557830|20919887|P3|COMPLETED|Treatment Phase||2
8489815|NCT00557830|20919888|P2|COMPLETED|Treatment Phase||4
8489816|NCT00557830|20919889|P1|COMPLETED|Treatment Phase||0
8489817|NCT00557830|20919887|P3|STARTED|Treatment Phase||2
8489818|NCT00557830|20919888|P2|STARTED|Treatment Phase||4
8489819|NCT00557830|20919889|P1|STARTED|Treatment Phase||0
8489820|NCT00557830|20919887|P3|NOT COMPLETED|Screening Treatment Phase||0
8489821|NCT00557830|20919888|P2|NOT COMPLETED|Screening Treatment Phase||0
8489822|NCT00557830|20919889|P1|NOT COMPLETED|Screening Treatment Phase||6
8489823|NCT00557830|20919887|P3|COMPLETED|Screening Treatment Phase||0
8489824|NCT00557830|20919888|P2|COMPLETED|Screening Treatment Phase||0
8489825|NCT00557830|20919889|P1|COMPLETED|Screening Treatment Phase||6
8489826|NCT00557830|20919887|P3|STARTED|Screening Treatment Phase||0
8489827|NCT00557830|20919888|P2|STARTED|Screening Treatment Phase||0
8489828|NCT00557830|20919889|P1|STARTED|Screening Treatment Phase||12
8489829|NCT00557622|20919911|P2|NOT COMPLETED|12-Week Treatment Phase||1
8489830|NCT00557622|20919912|P1|NOT COMPLETED|12-Week Treatment Phase||0
8489831|NCT00557622|20919911|P2|COMPLETED|12-Week Treatment Phase||1
8489832|NCT00557622|20919912|P1|COMPLETED|12-Week Treatment Phase||1
8489833|NCT00557622|20919911|P2|STARTED|12-Week Treatment Phase||2
8489834|NCT00557622|20919912|P1|STARTED|12-Week Treatment Phase||1
8489835|NCT00557622|20919911|P2|NOT COMPLETED|4-Week Run-in Phase||0
8489836|NCT00557622|20919912|P1|NOT COMPLETED|4-Week Run-in Phase||2
8489837|NCT00557622|20919911|P2|COMPLETED|4-Week Run-in Phase||0
8489838|NCT00557622|20919912|P1|COMPLETED|4-Week Run-in Phase||3
8489839|NCT00557622|20919911|P2|STARTED|4-Week Run-in Phase||0
8489840|NCT00557622|20919912|P1|STARTED|4-Week Run-in Phase||5
8489841|NCT00557505|20919941|P9|NOT COMPLETED|Overall Study||17
8489842|NCT00557505|20919942|P8|NOT COMPLETED|Overall Study||5
8489843|NCT00557505|20919943|P7|NOT COMPLETED|Overall Study||3
8489844|NCT00557505|20919944|P6|NOT COMPLETED|Overall Study||3
8489845|NCT00557505|20919945|P5|NOT COMPLETED|Overall Study||2
8489846|NCT00557505|20919946|P4|NOT COMPLETED|Overall Study||3
8489847|NCT00557505|20919947|P3|NOT COMPLETED|Overall Study||4
8489848|NCT00557505|20919948|P2|NOT COMPLETED|Overall Study||3
8489849|NCT00557505|20919949|P1|NOT COMPLETED|Overall Study||3
8489850|NCT00557505|20919941|P9|COMPLETED|Overall Study||0
8489851|NCT00557505|20919942|P8|COMPLETED|Overall Study||0
8489852|NCT00557505|20919943|P7|COMPLETED|Overall Study||0
8489853|NCT00557505|20919944|P6|COMPLETED|Overall Study||0
8489854|NCT00557505|20919945|P5|COMPLETED|Overall Study||0
8489855|NCT00557505|20919946|P4|COMPLETED|Overall Study||0
8489856|NCT00557505|20919947|P3|COMPLETED|Overall Study||0
8489857|NCT00557505|20919948|P2|COMPLETED|Overall Study||0
8489858|NCT00557505|20919949|P1|COMPLETED|Overall Study||0
8489859|NCT00557505|20919941|P9|STARTED|Overall Study||17
8489860|NCT00557505|20919942|P8|STARTED|Overall Study||5
8489861|NCT00557505|20919943|P7|STARTED|Overall Study||3
8489862|NCT00557505|20919944|P6|STARTED|Overall Study||3
8489863|NCT00557505|20919945|P5|STARTED|Overall Study||2
8489864|NCT00557505|20919946|P4|STARTED|Overall Study||3
8489865|NCT00557505|20919947|P3|STARTED|Overall Study||4
8489866|NCT00557505|20919948|P2|STARTED|Overall Study||3
8489867|NCT00557505|20919949|P1|STARTED|Overall Study||3
8489868|NCT00557492|20920113|P1|NOT COMPLETED|Overall Study||1
8489869|NCT00557492|20920113|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
8489870|NCT00557492|20920113|P1|STARTED|Overall Study||59
8489871|NCT00557466|20920131|P6|NOT COMPLETED|Overall Study||6
8489872|NCT00557466|20920132|P5|NOT COMPLETED|Overall Study||3
8489873|NCT00557466|20920133|P4|NOT COMPLETED|Overall Study||4
8489874|NCT00557466|20920134|P3|NOT COMPLETED|Overall Study||6
8489875|NCT00557466|20920135|P2|NOT COMPLETED|Overall Study||5
8489876|NCT00557466|20920136|P1|NOT COMPLETED|Overall Study||4
8489877|NCT00557466|20920131|P6|COMPLETED|Overall Study||85
8489878|NCT00557466|20920132|P5|COMPLETED|Overall Study||87
8489879|NCT00557466|20920133|P4|COMPLETED|Overall Study||92
8489880|NCT00557466|20920134|P3|COMPLETED|Overall Study||95
8489881|NCT00557466|20920135|P2|COMPLETED|Overall Study||87
8489882|NCT00557466|20920136|P1|COMPLETED|Overall Study||94
8489883|NCT00557466|20920131|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
8489884|NCT00557466|20920132|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
8489885|NCT00557466|20920133|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
8489886|NCT00557466|20920134|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
8489887|NCT00557466|20920135|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
8489888|NCT00557466|20920136|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
8489889|NCT00557466|20920131|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
8489890|NCT00557466|20920132|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
8489891|NCT00557466|20920133|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
8489892|NCT00557466|20920134|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
8489893|NCT00557466|20920135|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
8489894|NCT00557466|20920136|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
8489895|NCT00557466|20920131|P6|STARTED|Overall Study||91
8489896|NCT00557466|20920132|P5|STARTED|Overall Study||90
8489897|NCT00557466|20920133|P4|STARTED|Overall Study||96
8489898|NCT00557466|20920134|P3|STARTED|Overall Study||101
8489899|NCT00557466|20920135|P2|STARTED|Overall Study||92
8489900|NCT00557466|20920136|P1|STARTED|Overall Study||98
8489901|NCT00557440|20920189|P3|NOT COMPLETED|Treatment Period 3||0
8489902|NCT00557440|20920190|P2|NOT COMPLETED|Treatment Period 3||0
8489903|NCT00557440|20920191|P1|NOT COMPLETED|Treatment Period 3||0
8489904|NCT00557440|20920189|P3|COMPLETED|Treatment Period 3||12
8489905|NCT00557440|20920190|P2|COMPLETED|Treatment Period 3||12
8489906|NCT00557440|20920191|P1|COMPLETED|Treatment Period 3||12
8489907|NCT00557440|20920189|P3|STARTED|Treatment Period 3||12
8489908|NCT00557440|20920190|P2|STARTED|Treatment Period 3||12
8489909|NCT00557440|20920191|P1|STARTED|Treatment Period 3||12
8489910|NCT00557440|20920189|P3|NOT COMPLETED|Treatment Period 2||0
8489911|NCT00557440|20920190|P2|NOT COMPLETED|Treatment Period 2||0
8489912|NCT00557440|20920191|P1|NOT COMPLETED|Treatment Period 2||0
8489913|NCT00557440|20920189|P3|COMPLETED|Treatment Period 2||12
8489914|NCT00557440|20920190|P2|COMPLETED|Treatment Period 2||12
8489915|NCT00557440|20920191|P1|COMPLETED|Treatment Period 2||12
8489916|NCT00557440|20920189|P3|STARTED|Treatment Period 2||12
8489917|NCT00557440|20920190|P2|STARTED|Treatment Period 2||12
8489918|NCT00557440|20920191|P1|STARTED|Treatment Period 2||12
8489919|NCT00557440|20920189|P3|NOT COMPLETED|Treatment Period 1||1
8489920|NCT00557440|20920190|P2|NOT COMPLETED|Treatment Period 1||0
8489921|NCT00557440|20920191|P1|NOT COMPLETED|Treatment Period 1||0
8489922|NCT00557440|20920189|P3|COMPLETED|Treatment Period 1||12
8489923|NCT00557440|20920190|P2|COMPLETED|Treatment Period 1||12
8489924|NCT00557440|20920191|P1|COMPLETED|Treatment Period 1||12
8489925|NCT00557440|20920189|P3|STARTED|Treatment Period 1||13
8489926|NCT00557440|20920190|P2|STARTED|Treatment Period 1||12
8489927|NCT00557440|20920191|P1|STARTED|Treatment Period 1||12
8489928|NCT00557362|20920215|P4|NOT COMPLETED|Overall Study||3
8489929|NCT00557362|20920216|P3|NOT COMPLETED|Overall Study||4
8489930|NCT00557362|20920217|P2|NOT COMPLETED|Overall Study||2
8489931|NCT00557362|20920218|P1|NOT COMPLETED|Overall Study||2
8489932|NCT00557362|20920215|P4|COMPLETED|Overall Study||27
8489933|NCT00557362|20920216|P3|COMPLETED|Overall Study||26
8489934|NCT00557362|20920217|P2|COMPLETED|Overall Study||28
8489935|NCT00557362|20920218|P1|COMPLETED|Overall Study||28
8489936|NCT00557362|20920215|P4|STARTED|Overall Study||30
8489937|NCT00557362|20920216|P3|STARTED|Overall Study||30
8489938|NCT00557362|20920217|P2|STARTED|Overall Study||30
8489939|NCT00557362|20920218|P1|STARTED|Overall Study||30
8489940|NCT00557349|20920236|P2|NOT COMPLETED|Overall Study||5
8489941|NCT00557349|20920237|P1|NOT COMPLETED|Overall Study||5
8489942|NCT00557349|20920236|P2|COMPLETED|Overall Study||13
8489943|NCT00557349|20920237|P1|COMPLETED|Overall Study||17
8489944|NCT00557349|20920236|P2|STARTED|Overall Study||18
8489945|NCT00557349|20920237|P1|STARTED|Overall Study|omeprazole/bicarb|22
8489946|NCT00557323|20920245|P1|NOT COMPLETED|Overall Study||7
8489947|NCT00557323|20920245|P1|COMPLETED|Overall Study||27
8489948|NCT00557323|20920245|P1|STARTED|Overall Study||34
8489949|NCT00557310|20920250|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
8489950|NCT00557310|20920250|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
8489951|NCT00557310|20920250|P1|STARTED|Extension Phase (18 - 24 Months)||30
8489952|NCT00557310|20920250|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
8490211|NCT00555971|20920903|P2|NOT COMPLETED|Overall Study||1
8489953|NCT00557310|20920250|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
8489954|NCT00557310|20920250|P1|STARTED|Main Study (0 - 18 Months)||35
8489955|NCT00557284|20920272|P2|NOT COMPLETED|Overall Study||0
8489956|NCT00557284|20920273|P1|NOT COMPLETED|Overall Study||0
8489957|NCT00557284|20920272|P2|COMPLETED|Overall Study||11
8489958|NCT00557284|20920273|P1|COMPLETED|Overall Study||9
8489959|NCT00557284|20920272|P2|STARTED|Overall Study||11
8489960|NCT00557284|20920273|P1|STARTED|Overall Study||9
8489961|NCT00557245|20920296|P3|NOT COMPLETED|Overall Study||12
8489962|NCT00557245|20920297|P2|NOT COMPLETED|Overall Study||12
8489963|NCT00557245|20920298|P1|NOT COMPLETED|Overall Study||12
8489964|NCT00557245|20920296|P3|COMPLETED|Overall Study||1574
8489965|NCT00557245|20920297|P2|COMPLETED|Overall Study||1571
8489966|NCT00557245|20920298|P1|COMPLETED|Overall Study||1577
8489967|NCT00557245|20920296|P3|STARTED|Overall Study||1586
8489968|NCT00557245|20920297|P2|STARTED|Overall Study||1583
8489969|NCT00557245|20920298|P1|STARTED|Overall Study||1589
8489970|NCT00557193|20920336|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
8489971|NCT00557193|20920337|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
8489972|NCT00557193|20920338|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
8489973|NCT00557193|20920339|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
8489974|NCT00557193|20920340|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
8489975|NCT00557193|20920341|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
8489976|NCT00557193|20920336|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
8489977|NCT00557193|20920337|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
8489978|NCT00557193|20920338|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
8489979|NCT00557193|20920339|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
8489980|NCT00557193|20920340|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
8489981|NCT00557193|20920341|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
8489982|NCT00557193|20920336|P6|STARTED|Post Induction Therapy by Tx Assignment||56
8489983|NCT00557193|20920337|P5|STARTED|Post Induction Therapy by Tx Assignment||11
8489984|NCT00557193|20920338|P4|STARTED|Post Induction Therapy by Tx Assignment||11
8489985|NCT00557193|20920339|P3|STARTED|Post Induction Therapy by Tx Assignment||54
8489986|NCT00557193|20920340|P2|STARTED|Post Induction Therapy by Tx Assignment||60
8489987|NCT00557193|20920341|P1|STARTED|Post Induction Therapy by Tx Assignment||0
8489988|NCT00557193|20920336|P6|NOT COMPLETED|Induction||0
8489989|NCT00557193|20920337|P5|NOT COMPLETED|Induction||0
8489990|NCT00557193|20920338|P4|NOT COMPLETED|Induction||0
8489991|NCT00557193|20920339|P3|NOT COMPLETED|Induction||0
8489992|NCT00557193|20920340|P2|NOT COMPLETED|Induction||0
8489993|NCT00557193|20920341|P1|NOT COMPLETED|Induction||26
8489994|NCT00557193|20920336|P6|COMPLETED|Induction||0
8489995|NCT00557193|20920337|P5|COMPLETED|Induction||0
8489996|NCT00557193|20920338|P4|COMPLETED|Induction||0
8489997|NCT00557193|20920339|P3|COMPLETED|Induction||0
8489998|NCT00557193|20920340|P2|COMPLETED|Induction||0
8489999|NCT00557193|20920341|P1|COMPLETED|Induction||192
8490000|NCT00557193|20920336|P6|STARTED|Induction||0
8490001|NCT00557193|20920337|P5|STARTED|Induction||0
8490002|NCT00557193|20920338|P4|STARTED|Induction||0
8490003|NCT00557193|20920339|P3|STARTED|Induction||0
8490004|NCT00557193|20920340|P2|STARTED|Induction||0
8490005|NCT00557193|20920341|P1|STARTED|Induction||218
8490006|NCT00557076|20920381|P2|NOT COMPLETED|Overall Study||1
8490007|NCT00557076|20920382|P1|NOT COMPLETED|Overall Study||0
8490008|NCT00557076|20920381|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
8490009|NCT00557076|20920382|P1|COMPLETED|Overall Study||8
8490010|NCT00557076|20920381|P2|STARTED|Overall Study||8
8490011|NCT00557076|20920382|P1|STARTED|Overall Study||8
8490012|NCT00556998|20920390|P1|NOT COMPLETED|Voriconazole Oral||2
8490013|NCT00556998|20920390|P1|COMPLETED|Voriconazole Oral||20
8490014|NCT00556998|20920390|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
8490015|NCT00556998|20920390|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
8490016|NCT00556998|20920390|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
8490017|NCT00556998|20920390|P1|Treated|Voriconazole Intravenous (IV)||26
8490018|NCT00556998|20920390|P1|STARTED|Voriconazole Intravenous (IV)||26
8490019|NCT00556972|20920410|P1|NOT COMPLETED|Overall Study||0
8490020|NCT00556972|20920410|P1|COMPLETED|Overall Study||4
8490021|NCT00556972|20920410|P1|STARTED|Overall Study||4
8490022|NCT00556946|20920417|P1|NOT COMPLETED|Overall Study||1
8490023|NCT00556946|20920417|P1|COMPLETED|Overall Study||16
8490024|NCT00556946|20920417|P1|STARTED|Overall Study||17
8490025|NCT00556933|20920425|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
8490026|NCT00556933|20920426|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
8490027|NCT00556933|20920427|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
8490028|NCT00556933|20920428|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
8490029|NCT00556933|20920425|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
8490030|NCT00556933|20920426|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
8490031|NCT00556933|20920427|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
8490032|NCT00556933|20920428|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
8490033|NCT00556933|20920425|P4|STARTED|CNI Withdrawal vs. Minimization||43
8490034|NCT00556933|20920426|P3|STARTED|CNI Withdrawal vs. Minimization||39
8490035|NCT00556933|20920427|P2|STARTED|CNI Withdrawal vs. Minimization||37
8490036|NCT00556933|20920428|P1|STARTED|CNI Withdrawal vs. Minimization||43
8490037|NCT00556933|20920425|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
8490038|NCT00556933|20920426|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
8490039|NCT00556933|20920427|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
8490040|NCT00556933|20920428|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
8490041|NCT00556933|20920425|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
8490042|NCT00556933|20920426|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
8490043|NCT00556933|20920427|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
8490044|NCT00556933|20920428|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
8490045|NCT00556933|20920425|P4|STARTED|Single vs. Divided-dose rATG Induction||45
8490046|NCT00556933|20920426|P3|STARTED|Single vs. Divided-dose rATG Induction||45
8490047|NCT00556933|20920427|P2|STARTED|Single vs. Divided-dose rATG Induction||45
8490048|NCT00556933|20920428|P1|STARTED|Single vs. Divided-dose rATG Induction||45
8490049|NCT00556894|20920485|P3|NOT COMPLETED|Overall Study||19
8490050|NCT00556894|20920486|P2|NOT COMPLETED|Overall Study||19
8490051|NCT00556894|20920487|P1|NOT COMPLETED|Overall Study||16
8490052|NCT00556894|20920485|P3|COMPLETED|Overall Study||65
8490053|NCT00556894|20920486|P2|COMPLETED|Overall Study||68
8490054|NCT00556894|20920487|P1|COMPLETED|Overall Study||66
8490055|NCT00556894|20920485|P3|STARTED|Overall Study||84
8490056|NCT00556894|20920486|P2|STARTED|Overall Study||87
8490057|NCT00556894|20920487|P1|STARTED|Overall Study||82
8490058|NCT00556842|20920497|P2|NOT COMPLETED|Overall Study||23
8490059|NCT00556842|20920498|P1|NOT COMPLETED|Overall Study||31
8490060|NCT00556842|20920497|P2|COMPLETED|Overall Study||723
8490061|NCT00556842|20920498|P1|COMPLETED|Overall Study||718
8490062|NCT00556842|20920497|P2|STARTED|Overall Study||746
8490063|NCT00556842|20920498|P1|STARTED|Overall Study||749
8490064|NCT00556712|20920516|P2|NOT COMPLETED|Overall Study||438
8490065|NCT00556712|20920517|P1|NOT COMPLETED|Overall Study||451
8490066|NCT00556712|20920516|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
8490067|NCT00556712|20920517|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
8490068|NCT00556712|20920516|P2|STARTED|Overall Study||438
8490069|NCT00556712|20920517|P1|STARTED|Overall Study||451
8490070|NCT00556673|20920595|P2|NOT COMPLETED|Overall Study||2
8490071|NCT00556673|20920596|P1|NOT COMPLETED|Overall Study||3
8490072|NCT00556673|20920595|P2|COMPLETED|Overall Study||13
8490073|NCT00556673|20920596|P1|COMPLETED|Overall Study||13
8490074|NCT00556673|20920595|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
8490075|NCT00556673|20920596|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
8490076|NCT00556673|20920595|P2|STARTED|Overall Study||15
8490077|NCT00556673|20920596|P1|STARTED|Overall Study||16
8490078|NCT00556543|20920632|P1|NOT COMPLETED|Overall Study||0
8490079|NCT00556543|20920632|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
8490080|NCT00556543|20920632|P1|STARTED|Overall Study||10
8490081|NCT00556504|20920650|P2|NOT COMPLETED|Overall Study||9
8490082|NCT00556504|20920651|P1|NOT COMPLETED|Overall Study||8
8490083|NCT00556504|20920650|P2|COMPLETED|Overall Study||33
8490084|NCT00556504|20920651|P1|COMPLETED|Overall Study||34
8490085|NCT00556504|20920650|P2|Safety Population|Overall Study||42
8490086|NCT00556504|20920651|P1|Safety Population|Overall Study||41
8490087|NCT00556504|20920650|P2|Intend-to Treat Population|Overall Study||42
8490088|NCT00556504|20920651|P1|Intend-to Treat Population|Overall Study||42
8490089|NCT00556504|20920650|P2|STARTED|Overall Study||42
8490090|NCT00556504|20920651|P1|STARTED|Overall Study||42
8490091|NCT00556491|20920671|P2|NOT COMPLETED|Overall Study||1
8490092|NCT00556491|20920672|P1|NOT COMPLETED|Overall Study||1
8490093|NCT00556491|20920671|P2|COMPLETED|Overall Study||19
8490094|NCT00556491|20920672|P1|COMPLETED|Overall Study||19
8490095|NCT00556491|20920671|P2|STARTED|Overall Study||20
8490096|NCT00556491|20920672|P1|STARTED|Overall Study|January 2008|20
8490097|NCT00556478|20920690|P2|NOT COMPLETED|Open-Label Phase||10
8490098|NCT00556478|20920691|P1|NOT COMPLETED|Open-Label Phase||14
8490099|NCT00556478|20920690|P2|COMPLETED|Open-Label Phase||67
8490100|NCT00556478|20920691|P1|COMPLETED|Open-Label Phase||132
8490101|NCT00556478|20920690|P2|Treated in Open-label|Open-Label Phase||71
8490102|NCT00556478|20920691|P1|Treated in Open-label|Open-Label Phase||142
8490103|NCT00556478|20920690|P2|STARTED|Open-Label Phase||77
8490104|NCT00556478|20920691|P1|STARTED|Open-Label Phase||146
8490105|NCT00556478|20920690|P2|NOT COMPLETED|Double-blind Phase||8
8490106|NCT00556478|20920691|P1|NOT COMPLETED|Double-blind Phase||21
8490107|NCT00556478|20920690|P2|COMPLETED|Double-blind Phase||77
8490108|NCT00556478|20920691|P1|COMPLETED|Double-blind Phase||150
8490109|NCT00556478|20920690|P2|ITT|Double-blind Phase||82
8490110|NCT00556478|20920691|P1|ITT|Double-blind Phase||167
8490111|NCT00556478|20920690|P2|STARTED|Double-blind Phase||85
8490112|NCT00556478|20920691|P1|STARTED|Double-blind Phase||171
8490113|NCT00556452|20920719|P3|NOT COMPLETED|Overall Study||0
8490114|NCT00556452|20920720|P2|NOT COMPLETED|Overall Study||0
8490115|NCT00556452|20920721|P1|NOT COMPLETED|Overall Study||0
8490116|NCT00556452|20920719|P3|COMPLETED|Overall Study||19
8490117|NCT00556452|20920720|P2|COMPLETED|Overall Study||21
8490118|NCT00556452|20920721|P1|COMPLETED|Overall Study||6
8490119|NCT00556452|20920719|P3|STARTED|Overall Study||19
8490120|NCT00556452|20920720|P2|STARTED|Overall Study||21
8490121|NCT00556452|20920721|P1|STARTED|Overall Study||6
8490122|NCT00556439|20920732|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
8490123|NCT00556439|20920733|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
8490124|NCT00556439|20920734|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
8490125|NCT00556439|20920735|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
8490126|NCT00556439|20920732|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
8490127|NCT00556439|20920733|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
8490128|NCT00556439|20920734|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
8490129|NCT00556439|20920735|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
8490130|NCT00556439|20920732|P4|STARTED|After Week 12 (Randomized Study Period)||15
8490131|NCT00556439|20920733|P3|STARTED|After Week 12 (Randomized Study Period)||11
8490132|NCT00556439|20920734|P2|STARTED|After Week 12 (Randomized Study Period)||21
8490133|NCT00556439|20920735|P1|STARTED|After Week 12 (Randomized Study Period)||20
8490134|NCT00556439|20920732|P4|NOT COMPLETED|Study Entry to Week 12||0
8490135|NCT00556439|20920733|P3|NOT COMPLETED|Study Entry to Week 12||8
8490136|NCT00556439|20920734|P2|NOT COMPLETED|Study Entry to Week 12||0
8490137|NCT00556439|20920735|P1|NOT COMPLETED|Study Entry to Week 12||8
8490138|NCT00556439|20920732|P4|COMPLETED|Study Entry to Week 12||0
8490139|NCT00556439|20920733|P3|COMPLETED|Study Entry to Week 12||26
8490140|NCT00556439|20920734|P2|COMPLETED|Study Entry to Week 12||0
8490141|NCT00556439|20920735|P1|COMPLETED|Study Entry to Week 12||41
8490142|NCT00556439|20920732|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
8490143|NCT00556439|20920733|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
8490144|NCT00556439|20920734|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
8490145|NCT00556439|20920735|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
8490146|NCT00556426|20920745|P1|NOT COMPLETED|Overall Study||9
8490147|NCT00556426|20920745|P1|COMPLETED|Overall Study||91
8490148|NCT00556426|20920745|P1|STARTED|Overall Study||100
8490149|NCT00556400|20920755|P2|NOT COMPLETED|Overall Study||0
8490150|NCT00556400|20920756|P1|NOT COMPLETED|Overall Study||0
8490151|NCT00556400|20920755|P2|COMPLETED|Overall Study||0
8490152|NCT00556400|20920756|P1|COMPLETED|Overall Study||1
8490153|NCT00556400|20920755|P2|STARTED|Overall Study||0
8490154|NCT00556400|20920756|P1|STARTED|Overall Study||1
8490155|NCT00556374|20920767|P2|NOT COMPLETED|Overall Study||220
8490156|NCT00556374|20920768|P1|NOT COMPLETED|Overall Study||247
8490157|NCT00556374|20920767|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
8490158|NCT00556374|20920768|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
8490159|NCT00556374|20920767|P2|Received Study Drug|Overall Study||1700
8490160|NCT00556374|20920768|P1|Received Study Drug|Overall Study||1699
8490161|NCT00556374|20920767|P2|STARTED|Overall Study||1711
8490162|NCT00556374|20920768|P1|STARTED|Overall Study||1709
8490163|NCT00556322|20920788|P2|NOT COMPLETED|Overall Study||203
8490164|NCT00556322|20920789|P1|NOT COMPLETED|Overall Study||221
8490165|NCT00556322|20920788|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
8490166|NCT00556322|20920789|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
8490167|NCT00556322|20920788|P2|STARTED|Overall Study||203
8490168|NCT00556322|20920789|P1|STARTED|Overall Study||221
8490169|NCT00556166|20920837|P1|NOT COMPLETED|Overall Study||1
8490170|NCT00556166|20920837|P1|COMPLETED|Overall Study||3
8490171|NCT00556166|20920837|P1|STARTED|Overall Study||4
8490172|NCT00556140|20920842|P1|NOT COMPLETED|Overall Study||3
8490173|NCT00556140|20920842|P1|COMPLETED|Overall Study||13
8490174|NCT00556140|20920842|P1|STARTED|Overall Study||16
8490175|NCT00556075|20920850|P3|NOT COMPLETED|Overall Study||8
8490176|NCT00556075|20920851|P2|NOT COMPLETED|Overall Study||9
8490177|NCT00556075|20920852|P1|NOT COMPLETED|Overall Study||13
8490178|NCT00556075|20920850|P3|COMPLETED|Overall Study||15
8490179|NCT00556075|20920851|P2|COMPLETED|Overall Study||13
8490180|NCT00556075|20920852|P1|COMPLETED|Overall Study||9
8490181|NCT00556075|20920850|P3|STARTED|Overall Study||23
8490182|NCT00556075|20920851|P2|STARTED|Overall Study||22
8490183|NCT00556075|20920852|P1|STARTED|Overall Study||22
8490184|NCT00556049|20920875|P1|NOT COMPLETED|Overall Study||0
8490185|NCT00556049|20920875|P1|COMPLETED|Overall Study||72
8490186|NCT00556049|20920875|P1|STARTED|Overall Study||72
8490187|NCT00555997|20920882|P4|NOT COMPLETED|Phase 2 SPCD||3
8490188|NCT00555997|20920883|P3|NOT COMPLETED|Phase 2 SPCD||7
8490189|NCT00555997|20920884|P2|NOT COMPLETED|Phase 2 SPCD||0
8490190|NCT00555997|20920885|P1|NOT COMPLETED|Phase 2 SPCD||0
8490191|NCT00555997|20920882|P4|COMPLETED|Phase 2 SPCD||22
8490192|NCT00555997|20920883|P3|COMPLETED|Phase 2 SPCD||31
8490193|NCT00555997|20920884|P2|COMPLETED|Phase 2 SPCD||0
8490194|NCT00555997|20920885|P1|COMPLETED|Phase 2 SPCD||0
8490195|NCT00555997|20920882|P4|STARTED|Phase 2 SPCD||25
8490196|NCT00555997|20920883|P3|STARTED|Phase 2 SPCD||38
8490197|NCT00555997|20920884|P2|STARTED|Phase 2 SPCD||0
8490198|NCT00555997|20920885|P1|STARTED|Phase 2 SPCD||0
8490199|NCT00555997|20920882|P4|NOT COMPLETED|Phase 1 SPCD||0
8490200|NCT00555997|20920883|P3|NOT COMPLETED|Phase 1 SPCD||0
8490201|NCT00555997|20920884|P2|NOT COMPLETED|Phase 1 SPCD||15
8490202|NCT00555997|20920885|P1|NOT COMPLETED|Phase 1 SPCD||12
8490203|NCT00555997|20920882|P4|COMPLETED|Phase 1 SPCD||0
8490204|NCT00555997|20920883|P3|COMPLETED|Phase 1 SPCD||0
8490205|NCT00555997|20920884|P2|COMPLETED|Phase 1 SPCD||76
8490206|NCT00555997|20920885|P1|COMPLETED|Phase 1 SPCD||17
8490207|NCT00555997|20920882|P4|STARTED|Phase 1 SPCD||0
8490208|NCT00555997|20920883|P3|STARTED|Phase 1 SPCD||0
8490209|NCT00555997|20920884|P2|STARTED|Phase 1 SPCD||91
8490210|NCT00555997|20920885|P1|STARTED|Phase 1 SPCD||29
8490212|NCT00555971|20920904|P1|NOT COMPLETED|Overall Study||1
8490213|NCT00555971|20920903|P2|COMPLETED|Overall Study||7
8490214|NCT00555971|20920904|P1|COMPLETED|Overall Study||4
8490215|NCT00555971|20920903|P2|STARTED|Overall Study||8
8490216|NCT00555971|20920904|P1|STARTED|Overall Study||5
8490217|NCT00555906|20920915|P5|NOT COMPLETED|Phase 2||32
8490218|NCT00555906|20920916|P4|NOT COMPLETED|Phase 2||0
8490219|NCT00555906|20920917|P3|NOT COMPLETED|Phase 2||0
8490220|NCT00555906|20920918|P2|NOT COMPLETED|Phase 2||0
8490221|NCT00555906|20920919|P1|NOT COMPLETED|Phase 2||0
8490222|NCT00555906|20920915|P5|COMPLETED|Phase 2||0
8490223|NCT00555906|20920916|P4|COMPLETED|Phase 2||0
8490224|NCT00555906|20920917|P3|COMPLETED|Phase 2||0
8490225|NCT00555906|20920918|P2|COMPLETED|Phase 2||0
8490226|NCT00555906|20920919|P1|COMPLETED|Phase 2||0
8490227|NCT00555906|20920915|P5|Treated|Phase 2||30
8490228|NCT00555906|20920916|P4|Treated|Phase 2||0
8490229|NCT00555906|20920917|P3|Treated|Phase 2||0
8490230|NCT00555906|20920918|P2|Treated|Phase 2||0
8490231|NCT00555906|20920919|P1|Treated|Phase 2||0
8490232|NCT00555906|20920915|P5|STARTED|Phase 2||32
8490233|NCT00555906|20920916|P4|STARTED|Phase 2||0
8490234|NCT00555906|20920917|P3|STARTED|Phase 2||0
8490235|NCT00555906|20920918|P2|STARTED|Phase 2||0
8490236|NCT00555906|20920919|P1|STARTED|Phase 2||0
8490237|NCT00555906|20920915|P5|NOT COMPLETED|Phase 1||0
8490238|NCT00555906|20920916|P4|NOT COMPLETED|Phase 1||5
8490239|NCT00555906|20920917|P3|NOT COMPLETED|Phase 1||7
8490240|NCT00555906|20920918|P2|NOT COMPLETED|Phase 1||6
8490241|NCT00555906|20920919|P1|NOT COMPLETED|Phase 1||3
8490242|NCT00555906|20920915|P5|COMPLETED|Phase 1||0
8490243|NCT00555906|20920916|P4|COMPLETED|Phase 1||0
8490244|NCT00555906|20920917|P3|COMPLETED|Phase 1||0
8490245|NCT00555906|20920918|P2|COMPLETED|Phase 1||0
8490246|NCT00555906|20920919|P1|COMPLETED|Phase 1||0
8490247|NCT00555906|20920915|P5|STARTED|Phase 1||0
8490248|NCT00555906|20920916|P4|STARTED|Phase 1||5
8490249|NCT00555906|20920917|P3|STARTED|Phase 1||7
8490250|NCT00555906|20920918|P2|STARTED|Phase 1||6
8490251|NCT00555906|20920919|P1|STARTED|Phase 1||3
8490252|NCT00555893|20920951|P2|NOT COMPLETED|Overall Study||0
8490253|NCT00555893|20920952|P1|NOT COMPLETED|Overall Study||0
8490254|NCT00555893|20920951|P2|COMPLETED|Overall Study||63
8490255|NCT00555893|20920952|P1|COMPLETED|Overall Study||130
8490256|NCT00555893|20920951|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
8490257|NCT00555893|20920952|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
8490258|NCT00555893|20920951|P2|STARTED|Overall Study||63
8490259|NCT00555893|20920952|P1|STARTED|Overall Study||130
8490260|NCT00555880|20920968|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8490261|NCT00555880|20920969|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8490262|NCT00555880|20920968|P2|COMPLETED|Treatment Period 2 (1 Day)||11
8490263|NCT00555880|20920969|P1|COMPLETED|Treatment Period 2 (1 Day)||13
8490264|NCT00555880|20920968|P2|STARTED|Treatment Period 2 (1 Day)||11
8490265|NCT00555880|20920969|P1|STARTED|Treatment Period 2 (1 Day)||13
8490266|NCT00555880|20920968|P2|NOT COMPLETED|Washout (1 Day)||0
8490267|NCT00555880|20920969|P1|NOT COMPLETED|Washout (1 Day)||0
8490268|NCT00555880|20920968|P2|COMPLETED|Washout (1 Day)||11
8490269|NCT00555880|20920969|P1|COMPLETED|Washout (1 Day)||13
8490270|NCT00555880|20920968|P2|STARTED|Washout (1 Day)||11
8490271|NCT00555880|20920969|P1|STARTED|Washout (1 Day)||13
8490272|NCT00555880|20920968|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8490273|NCT00555880|20920969|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8490274|NCT00555880|20920968|P2|COMPLETED|Treatment Period 1 (1 Day)||11
8490275|NCT00555880|20920969|P1|COMPLETED|Treatment Period 1 (1 Day)||13
8490276|NCT00555880|20920968|P2|STARTED|Treatment Period 1 (1 Day)||11
8490277|NCT00555880|20920969|P1|STARTED|Treatment Period 1 (1 Day)||13
8490278|NCT00555750|20921008|P2|NOT COMPLETED|Overall Study||0
8490279|NCT00555750|20921009|P1|NOT COMPLETED|Overall Study||0
8490280|NCT00555750|20921008|P2|COMPLETED|Overall Study||10
8490281|NCT00555750|20921009|P1|COMPLETED|Overall Study||10
8490282|NCT00555750|20921008|P2|STARTED|Overall Study||10
8490283|NCT00555750|20921009|P1|STARTED|Overall Study||10
8490284|NCT00555672|20921041|P2|NOT COMPLETED|Overall Study||10
8490285|NCT00555672|20921042|P1|NOT COMPLETED|Overall Study||24
8490286|NCT00555672|20921041|P2|COMPLETED|Overall Study||0
8490287|NCT00555672|20921042|P1|COMPLETED|Overall Study||0
8490288|NCT00555672|20921041|P2|STARTED|Overall Study||10
8490289|NCT00555672|20921042|P1|STARTED|Overall Study||24
8490290|NCT00555620|20921067|P6|NOT COMPLETED|Overall Study||22
8490291|NCT00555620|20921068|P5|NOT COMPLETED|Overall Study||3
8490292|NCT00555620|20921069|P4|NOT COMPLETED|Overall Study||23
8490293|NCT00555620|20921070|P3|NOT COMPLETED|Overall Study||15
8490294|NCT00555620|20921071|P2|NOT COMPLETED|Overall Study||7
8490295|NCT00555620|20921072|P1|NOT COMPLETED|Overall Study||6
8490296|NCT00555620|20921067|P6|COMPLETED|Overall Study||0
8490297|NCT00555620|20921068|P5|COMPLETED|Overall Study||0
8490298|NCT00555620|20921069|P4|COMPLETED|Overall Study||0
8490299|NCT00555620|20921070|P3|COMPLETED|Overall Study||0
8490300|NCT00555620|20921071|P2|COMPLETED|Overall Study||0
8490301|NCT00555620|20921072|P1|COMPLETED|Overall Study||0
8490302|NCT00555620|20921067|P6|STARTED|Overall Study||22
8490303|NCT00555620|20921068|P5|STARTED|Overall Study||3
8490304|NCT00555620|20921069|P4|STARTED|Overall Study||23
8490305|NCT00555620|20921070|P3|STARTED|Overall Study||15
8490306|NCT00555620|20921071|P2|STARTED|Overall Study||7
8490307|NCT00555620|20921072|P1|STARTED|Overall Study||6
8490308|NCT00555581|20921184|P1|NOT COMPLETED|Overall Study||6
8490309|NCT00555581|20921184|P1|COMPLETED|Overall Study||24
8490310|NCT00555581|20921184|P1|STARTED|Overall Study||30
8490311|NCT00555568|20921196|P3|NOT COMPLETED|Overall Study||16
8490312|NCT00555568|20921197|P2|NOT COMPLETED|Overall Study||16
8490313|NCT00555568|20921198|P1|NOT COMPLETED|Overall Study||26
8490314|NCT00555568|20921196|P3|COMPLETED|Overall Study||84
8490315|NCT00555568|20921197|P2|COMPLETED|Overall Study||82
8490316|NCT00555568|20921198|P1|COMPLETED|Overall Study||74
8490317|NCT00555568|20921196|P3|STARTED|Overall Study||100
8490318|NCT00555568|20921197|P2|STARTED|Overall Study||98
8490319|NCT00555568|20921198|P1|STARTED|Overall Study||100
8490320|NCT00555477|20921220|P2|NOT COMPLETED|Overall Study||13
8490321|NCT00555477|20921221|P1|NOT COMPLETED|Overall Study||2
8490322|NCT00555477|20921220|P2|COMPLETED|Overall Study||32
8490323|NCT00555477|20921221|P1|COMPLETED|Overall Study||12
8490324|NCT00555477|20921220|P2|STARTED|Overall Study||45
8490325|NCT00555477|20921221|P1|STARTED|Overall Study||14
8490326|NCT00555464|20921228|P2|NOT COMPLETED|Overall Study||3
8490327|NCT00555464|20921229|P1|NOT COMPLETED|Overall Study||0
8490328|NCT00555464|20921228|P2|COMPLETED|Overall Study||1
8490329|NCT00555464|20921229|P1|COMPLETED|Overall Study||4
8490330|NCT00555464|20921228|P2|STARTED|Overall Study||4
8490331|NCT00555464|20921229|P1|STARTED|Overall Study||4
8490332|NCT00555438|20921237|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
8490333|NCT00555438|20921237|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
8490334|NCT00555438|20921237|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
8490335|NCT00555438|20921237|P1|NOT COMPLETED|10 Days Post-operative||4
8490336|NCT00555438|20921237|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
8490337|NCT00555438|20921237|P1|STARTED|10 Days Post-operative||442
8490338|NCT00555425|20921247|P2|NOT COMPLETED|Overall Study||19
8490339|NCT00555425|20921248|P1|NOT COMPLETED|Overall Study||51
8490340|NCT00555425|20921247|P2|COMPLETED|Overall Study||37
8490341|NCT00555425|20921248|P1|COMPLETED|Overall Study||6
8490342|NCT00555425|20921247|P2|STARTED|Overall Study||56
8490343|NCT00555425|20921248|P1|STARTED|Overall Study||57
8490344|NCT00555360|20921268|P2|NOT COMPLETED|Overall Study||36
8490345|NCT00555360|20921269|P1|NOT COMPLETED|Overall Study||27
8490346|NCT00555360|20921268|P2|COMPLETED|Overall Study||153
8490347|NCT00555360|20921269|P1|COMPLETED|Overall Study||156
8490348|NCT00555360|20921268|P2|STARTED|Overall Study||189
8490349|NCT00555360|20921269|P1|STARTED|Overall Study||183
8490350|NCT00555321|20921284|P5|NOT COMPLETED|Long-term Extension Phase||26
8490351|NCT00555321|20921285|P4|NOT COMPLETED|Long-term Extension Phase||38
8490352|NCT00555321|20921286|P3|NOT COMPLETED|Long-term Extension Phase||24
8490353|NCT00555321|20921287|P2|NOT COMPLETED|Long-term Extension Phase||27
8490354|NCT00555321|20921288|P1|NOT COMPLETED|Long-term Extension Phase||30
8490355|NCT00555321|20921284|P5|COMPLETED|Long-term Extension Phase||0
8490356|NCT00555321|20921285|P4|COMPLETED|Long-term Extension Phase||0
8490357|NCT00555321|20921286|P3|COMPLETED|Long-term Extension Phase||0
8490358|NCT00555321|20921287|P2|COMPLETED|Long-term Extension Phase||0
8490359|NCT00555321|20921288|P1|COMPLETED|Long-term Extension Phase||0
8490360|NCT00555321|20921284|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
8490361|NCT00555321|20921285|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
8490362|NCT00555321|20921286|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
8490363|NCT00555321|20921287|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
8490364|NCT00555321|20921288|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
8490365|NCT00555321|20921284|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
8490366|NCT00555321|20921285|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
8490367|NCT00555321|20921286|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
8490368|NCT00555321|20921287|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
8490369|NCT00555321|20921288|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
8490370|NCT00555321|20921284|P5|COMPLETED|Treatment Phase up to 12-months||32
8490371|NCT00555321|20921285|P4|COMPLETED|Treatment Phase up to 12-months||46
8490372|NCT00555321|20921286|P3|COMPLETED|Treatment Phase up to 12-months||26
8490373|NCT00555321|20921287|P2|COMPLETED|Treatment Phase up to 12-months||29
8490374|NCT00555321|20921288|P1|COMPLETED|Treatment Phase up to 12-months||31
8490375|NCT00555321|20921284|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
8490376|NCT00555321|20921285|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
8490377|NCT00555321|20921286|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
8490378|NCT00555321|20921287|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
8490379|NCT00555321|20921288|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
8490380|NCT00555321|20921284|P5|STARTED|Treatment Phase up to 12-months||54
8490381|NCT00555321|20921285|P4|STARTED|Treatment Phase up to 12-months||53
8490382|NCT00555321|20921286|P3|STARTED|Treatment Phase up to 12-months||50
8490383|NCT00555321|20921287|P2|STARTED|Treatment Phase up to 12-months||51
8490384|NCT00555321|20921288|P1|STARTED|Treatment Phase up to 12-months||52
8490385|NCT00555217|20921592|P2|NOT COMPLETED|Overall Study||68
8490386|NCT00555217|20921593|P1|NOT COMPLETED|Overall Study||75
8490387|NCT00555217|20921592|P2|COMPLETED|Overall Study||656
8490388|NCT00555217|20921593|P1|COMPLETED|Overall Study||649
8490389|NCT00555217|20921592|P2|STARTED|Overall Study||724
8490390|NCT00555217|20921593|P1|STARTED|Overall Study||724
8490391|NCT00555152|20921605|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490392|NCT00555152|20921606|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490393|NCT00555152|20921607|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490394|NCT00555152|20921608|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490395|NCT00555152|20921605|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
8490396|NCT00555152|20921606|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490397|NCT00555152|20921607|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
8490398|NCT00555152|20921608|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490399|NCT00555152|20921605|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
8490400|NCT00555152|20921606|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490401|NCT00555152|20921607|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
8490402|NCT00555152|20921608|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
8490403|NCT00555152|20921605|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490404|NCT00555152|20921606|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490405|NCT00555152|20921607|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490406|NCT00555152|20921608|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490407|NCT00555152|20921605|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
8490408|NCT00555152|20921606|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490409|NCT00555152|20921607|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490410|NCT00555152|20921608|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
8490411|NCT00555152|20921605|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
8490412|NCT00555152|20921606|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
8490413|NCT00555152|20921607|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
8490414|NCT00555152|20921608|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
8490415|NCT00555061|20921630|P1|NOT COMPLETED|Overall Study||9
8490416|NCT00555061|20921630|P1|COMPLETED|Overall Study||78
8490417|NCT00555061|20921630|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
8490418|NCT00555048|20921637|P1|NOT COMPLETED|Overall Study||0
8490419|NCT00555048|20921637|P1|COMPLETED|Overall Study||1
8490420|NCT00555048|20921637|P1|STARTED|Overall Study||1
8490421|NCT00555009|20921649|P2|NOT COMPLETED|Overall Study||6
8490422|NCT00555009|20921650|P1|NOT COMPLETED|Overall Study||2
8490423|NCT00555009|20921649|P2|COMPLETED|Overall Study||0
8490424|NCT00555009|20921650|P1|COMPLETED|Overall Study||2
8490425|NCT00555009|20921649|P2|STARTED|Overall Study||6
8490426|NCT00555009|20921650|P1|STARTED|Overall Study||4
8490427|NCT00554996|20921672|P1|NOT COMPLETED|Overall Study||0
8490428|NCT00554996|20921672|P1|COMPLETED|Overall Study||10
8490429|NCT00554996|20921672|P1|STARTED|Overall Study||10
8490430|NCT00554970|20921680|P4|NOT COMPLETED|Period 2||0
8490431|NCT00554970|20921681|P3|NOT COMPLETED|Period 2||1
8490432|NCT00554970|20921682|P2|NOT COMPLETED|Period 2||0
8490433|NCT00554970|20921683|P1|NOT COMPLETED|Period 2||0
8490434|NCT00554970|20921680|P4|COMPLETED|Period 2||8
8490435|NCT00554970|20921681|P3|COMPLETED|Period 2||7
8490436|NCT00554970|20921682|P2|COMPLETED|Period 2||8
8490437|NCT00554970|20921683|P1|COMPLETED|Period 2||7
8490438|NCT00554970|20921680|P4|STARTED|Period 2||8
8490439|NCT00554970|20921681|P3|STARTED|Period 2||8
8490440|NCT00554970|20921682|P2|STARTED|Period 2||8
8490441|NCT00554970|20921683|P1|STARTED|Period 2||7
8490442|NCT00554970|20921680|P4|NOT COMPLETED|Period 1||0
8490443|NCT00554970|20921681|P3|NOT COMPLETED|Period 1||0
8490444|NCT00554970|20921682|P2|NOT COMPLETED|Period 1||0
8490445|NCT00554970|20921683|P1|NOT COMPLETED|Period 1||1
8490446|NCT00554970|20921680|P4|COMPLETED|Period 1||8
8490447|NCT00554970|20921681|P3|COMPLETED|Period 1||8
8490448|NCT00554970|20921682|P2|COMPLETED|Period 1||8
8490449|NCT00554970|20921683|P1|COMPLETED|Period 1||7
8490450|NCT00554970|20921680|P4|STARTED|Period 1||8
8490451|NCT00554970|20921681|P3|STARTED|Period 1||8
8490452|NCT00554970|20921682|P2|STARTED|Period 1||8
8490453|NCT00554970|20921683|P1|STARTED|Period 1||8
8490454|NCT00554853|20921715|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
8490455|NCT00554853|20921716|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
8490456|NCT00554853|20921715|P2|COMPLETED|Crossover Arm (3 Months)||55
8490457|NCT00554853|20921716|P1|COMPLETED|Crossover Arm (3 Months)||53
8490458|NCT00554853|20921715|P2|STARTED|Crossover Arm (3 Months)||57
8490459|NCT00554853|20921716|P1|STARTED|Crossover Arm (3 Months)||56
8490460|NCT00554853|20921715|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
8490461|NCT00554853|20921716|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8490462|NCT00554853|20921715|P2|COMPLETED|Washout Period (2 Weeks)||57
8490463|NCT00554853|20921716|P1|COMPLETED|Washout Period (2 Weeks)||56
8490464|NCT00554853|20921715|P2|STARTED|Washout Period (2 Weeks)||64
8490465|NCT00554853|20921716|P1|STARTED|Washout Period (2 Weeks)||56
8490466|NCT00554853|20921715|P2|NOT COMPLETED|First Arm of Study||7
8490467|NCT00554853|20921716|P1|NOT COMPLETED|First Arm of Study||16
8490468|NCT00554853|20921715|P2|COMPLETED|First Arm of Study||64
8490469|NCT00554853|20921716|P1|COMPLETED|First Arm of Study||56
8490470|NCT00554853|20921715|P2|STARTED|First Arm of Study||71
8490471|NCT00554853|20921716|P1|STARTED|First Arm of Study||72
8490472|NCT00554840|20921730|P2|NOT COMPLETED|Overall Study||1
8490473|NCT00554840|20921731|P1|NOT COMPLETED|Overall Study||0
8490474|NCT00554840|20921730|P2|COMPLETED|Overall Study||4
8490475|NCT00554840|20921731|P1|COMPLETED|Overall Study||4
8490476|NCT00554840|20921730|P2|STARTED|Overall Study||5
8490477|NCT00554840|20921731|P1|STARTED|Overall Study||4
8490478|NCT00554801|20921749|P2|NOT COMPLETED|Overall Study||0
8490479|NCT00554801|20921750|P1|NOT COMPLETED|Overall Study||19
8490480|NCT00554801|20921749|P2|COMPLETED|Overall Study||29
8490481|NCT00554801|20921750|P1|COMPLETED|Overall Study||36
8490482|NCT00554801|20921749|P2|STARTED|Overall Study||29
8490483|NCT00554801|20921750|P1|STARTED|Overall Study||55
8490484|NCT00554788|20921761|P3|NOT COMPLETED|Overall Study||14
8490485|NCT00554788|20921762|P2|NOT COMPLETED|Overall Study||6
8490486|NCT00554788|20921763|P1|NOT COMPLETED|Overall Study||7
8490487|NCT00554788|20921761|P3|COMPLETED|Overall Study||7
8490488|NCT00554788|20921762|P2|COMPLETED|Overall Study||12
8490489|NCT00554788|20921763|P1|COMPLETED|Overall Study||14
8490490|NCT00554788|20921761|P3|STARTED|Overall Study||21
8490491|NCT00554788|20921762|P2|STARTED|Overall Study||18
8490492|NCT00554788|20921763|P1|STARTED|Overall Study||21
8490493|NCT00554749|20921775|P1|NOT COMPLETED|Overall Study||0
8490494|NCT00554749|20921775|P1|COMPLETED|Overall Study||7
8490495|NCT00554749|20921775|P1|STARTED|Overall Study||7
8490496|NCT00554671|20921782|P2|NOT COMPLETED|Overall Study||16
8490497|NCT00554671|20921783|P1|NOT COMPLETED|Overall Study||20
8490498|NCT00554671|20921782|P2|COMPLETED|Overall Study||117
8490499|NCT00554671|20921783|P1|COMPLETED|Overall Study||97
8490500|NCT00554671|20921782|P2|STARTED|Overall Study||133
8490501|NCT00554671|20921783|P1|STARTED|Overall Study||117
8490502|NCT00554619|20921795|P1|NOT COMPLETED|Overall Study||3
8490503|NCT00554619|20921795|P1|COMPLETED|Overall Study||18
8490504|NCT00554619|20921795|P1|STARTED|Overall Study||21
8490505|NCT00554515|20921807|P1|NOT COMPLETED|Overall Study||118
8490506|NCT00554515|20921807|P1|COMPLETED|Overall Study||5
8490507|NCT00554515|20921807|P1|Treated|Overall Study||120
8490508|NCT00554515|20921807|P1|STARTED|Overall Study||123
8490509|NCT00554463|20921836|P1|NOT COMPLETED|Overall Study||0
8490510|NCT00554463|20921836|P1|COMPLETED|Overall Study||5
8490511|NCT00554463|20921836|P1|STARTED|Overall Study||5
8490512|NCT00554372|20921848|P2|NOT COMPLETED|Overall Study||0
8490513|NCT00554372|20921849|P1|NOT COMPLETED|Overall Study||0
8490514|NCT00554372|20921848|P2|COMPLETED|Overall Study||16
8490515|NCT00554372|20921849|P1|COMPLETED|Overall Study||14
8490516|NCT00554372|20921848|P2|STARTED|Overall Study||16
8490517|NCT00554372|20921849|P1|STARTED|Overall Study||14
8490518|NCT00554294|20921863|P2|NOT COMPLETED|Overall Study||80
8490519|NCT00554294|20921864|P1|NOT COMPLETED|Overall Study||160
8490520|NCT00554294|20921863|P2|COMPLETED|Overall Study||1641
8490521|NCT00554294|20921864|P1|COMPLETED|Overall Study||1309
8490522|NCT00554294|20921863|P2|STARTED|Overall Study||1721
8490523|NCT00554294|20921864|P1|STARTED|Overall Study||1469
8490524|NCT00554229|20921870|P2|NOT COMPLETED|Overall Study||225
8490525|NCT00554229|20921871|P1|NOT COMPLETED|Overall Study||226
8490526|NCT00554229|20921870|P2|COMPLETED|Overall Study||70
8490527|NCT00554229|20921871|P1|COMPLETED|Overall Study||73
8490528|NCT00554229|20921870|P2|Patients Who Received Treatment|Overall Study||295
8490529|NCT00554229|20921871|P1|Patients Who Received Treatment|Overall Study||298
8490530|NCT00554229|20921870|P2|STARTED|Overall Study||295
8490531|NCT00554229|20921871|P1|STARTED|Overall Study||299
8490532|NCT00554216|20921896|P3|NOT COMPLETED|Overall Study||172
8490533|NCT00554216|20921897|P2|NOT COMPLETED|Overall Study||94
8490534|NCT00554216|20921898|P1|NOT COMPLETED|Overall Study||242
8490535|NCT00554216|20921896|P3|COMPLETED|Overall Study||340
8490536|NCT00554216|20921897|P2|COMPLETED|Overall Study||147
8490537|NCT00554216|20921898|P1|COMPLETED|Overall Study||272
8490538|NCT00554216|20921896|P3|STARTED|Overall Study||512
8490539|NCT00554216|20921897|P2|STARTED|Overall Study||241
8490540|NCT00554216|20921898|P1|STARTED|Overall Study||514
8490541|NCT00554190|20921909|P1|NOT COMPLETED|Overall Study||10
8490542|NCT00554190|20921909|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
8490543|NCT00554190|20921909|P1|STARTED|Overall Study|29 subjects treated.|29
8490544|NCT00554099|20921918|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
8490545|NCT00554099|20921919|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
8490546|NCT00554099|20921920|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
8490547|NCT00554099|20921918|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
8490548|NCT00554099|20921919|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
8490549|NCT00554099|20921920|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
8490550|NCT00554099|20921918|P3|STARTED|Non-Treatment Phase (9 Months)||27
8490551|NCT00554099|20921919|P2|STARTED|Non-Treatment Phase (9 Months)||32
8490552|NCT00554099|20921920|P1|STARTED|Non-Treatment Phase (9 Months)||29
8490553|NCT00554099|20921918|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
8490554|NCT00554099|20921919|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
8490555|NCT00554099|20921920|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
8490556|NCT00554099|20921918|P3|COMPLETED|Treatment Period (12 Weeks)||27
8490557|NCT00554099|20921919|P2|COMPLETED|Treatment Period (12 Weeks)||32
8490558|NCT00554099|20921920|P1|COMPLETED|Treatment Period (12 Weeks)||29
8490559|NCT00554099|20921918|P3|STARTED|Treatment Period (12 Weeks)||36
8490560|NCT00554099|20921919|P2|STARTED|Treatment Period (12 Weeks)||40
8490561|NCT00554099|20921920|P1|STARTED|Treatment Period (12 Weeks)||41
8490562|NCT00553969|20921953|P4|NOT COMPLETED|Overall Study||1
8490563|NCT00553969|20921954|P3|NOT COMPLETED|Overall Study||1
8490564|NCT00553969|20921955|P2|NOT COMPLETED|Overall Study||0
8490565|NCT00553969|20921956|P1|NOT COMPLETED|Overall Study||8
8490566|NCT00553969|20921953|P4|COMPLETED|Overall Study||23
8490567|NCT00553969|20921954|P3|COMPLETED|Overall Study||21
8490568|NCT00553969|20921955|P2|COMPLETED|Overall Study||24
8490569|NCT00553969|20921956|P1|COMPLETED|Overall Study||23
8490570|NCT00553969|20921953|P4|STARTED|Overall Study||24
8490571|NCT00553969|20921954|P3|STARTED|Overall Study||22
8490572|NCT00553969|20921955|P2|STARTED|Overall Study||24
8490573|NCT00553969|20921956|P1|STARTED|Overall Study||31
8490574|NCT00553839|20921966|P1|NOT COMPLETED|Overall Study||0
8490575|NCT00553839|20921966|P1|COMPLETED|Overall Study||21
8490576|NCT00553839|20921966|P1|STARTED|Overall Study||21
8490577|NCT00553787|20921975|P3|NOT COMPLETED|Overall Study||262
8490578|NCT00553787|20921976|P2|NOT COMPLETED|Overall Study||124
8490579|NCT00553787|20921977|P1|NOT COMPLETED|Overall Study||378
8490580|NCT00553787|20921975|P3|COMPLETED|Overall Study||733
8490581|NCT00553787|20921976|P2|COMPLETED|Overall Study||374
8490582|NCT00553787|20921977|P1|COMPLETED|Overall Study||616
8490583|NCT00553787|20921975|P3|STARTED|Overall Study||995
8490584|NCT00553787|20921976|P2|STARTED|Overall Study||498
8490585|NCT00553787|20921977|P1|STARTED|Overall Study||994
8490586|NCT00553735|20921988|P1|NOT COMPLETED|Overall Study||7
8490587|NCT00553735|20921988|P1|COMPLETED|Overall Study||1
8490588|NCT00553735|20921988|P1|STARTED|Overall Study||8
8490589|NCT00553696|20922009|P4|NOT COMPLETED|Overall Study||1
8490590|NCT00553696|20922010|P3|NOT COMPLETED|Overall Study||6
8490591|NCT00553696|20922011|P2|NOT COMPLETED|Overall Study||16
8490592|NCT00553696|20922012|P1|NOT COMPLETED|Overall Study||4
8490593|NCT00553696|20922009|P4|COMPLETED|Overall Study||0
8490594|NCT00553696|20922010|P3|COMPLETED|Overall Study||0
8490595|NCT00553696|20922011|P2|COMPLETED|Overall Study||0
8490596|NCT00553696|20922012|P1|COMPLETED|Overall Study||0
8490597|NCT00553696|20922009|P4|STARTED|Overall Study||1
8490598|NCT00553696|20922010|P3|STARTED|Overall Study||6
8490599|NCT00553696|20922011|P2|STARTED|Overall Study||16
8490600|NCT00553696|20922012|P1|STARTED|Overall Study||4
8490601|NCT00553644|20922050|P1|NOT COMPLETED|Overall Study||28
8490602|NCT00553644|20922050|P1|COMPLETED|Overall Study||25
8490603|NCT00553644|20922050|P1|STARTED|Overall Study||53
8490604|NCT00553631|20922059|P2|NOT COMPLETED|Overall Study||1
8490605|NCT00553631|20922060|P1|NOT COMPLETED|Overall Study||1
8490606|NCT00553631|20922059|P2|COMPLETED|Overall Study||16
8490607|NCT00553631|20922060|P1|COMPLETED|Overall Study||16
8490608|NCT00553631|20922059|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
8490609|NCT00553631|20922060|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
8490610|NCT00553605|20922082|P2|NOT COMPLETED|Overall Study||3
8490611|NCT00553605|20922083|P1|NOT COMPLETED|Overall Study||4
8490612|NCT00553605|20922082|P2|COMPLETED|Overall Study||161
8490613|NCT00553605|20922083|P1|COMPLETED|Overall Study||172
8490614|NCT00553605|20922082|P2|Treated|Overall Study||164
8490615|NCT00553605|20922083|P1|Treated|Overall Study||174
8490616|NCT00553605|20922082|P2|STARTED|Overall Study||164
8490617|NCT00553605|20922083|P1|STARTED|Overall Study||176
8490618|NCT00553540|20922109|P2|NOT COMPLETED|Overall Study||5
8490619|NCT00553540|20922110|P1|NOT COMPLETED|Overall Study||2
8490620|NCT00553540|20922109|P2|COMPLETED|Overall Study||20
8490621|NCT00553540|20922110|P1|COMPLETED|Overall Study||23
8490622|NCT00553540|20922109|P2|STARTED|Overall Study||25
8490623|NCT00553540|20922110|P1|STARTED|Overall Study||25
8490624|NCT00553514|20922121|P5|NOT COMPLETED|Overall Study||7
8490625|NCT00553514|20922122|P4|NOT COMPLETED|Overall Study||7
8490626|NCT00553514|20922123|P3|NOT COMPLETED|Overall Study||6
8490627|NCT00553514|20922124|P2|NOT COMPLETED|Overall Study||8
8490628|NCT00553514|20922125|P1|NOT COMPLETED|Overall Study||8
8490629|NCT00553514|20922121|P5|COMPLETED|Overall Study||8
8490630|NCT00553514|20922122|P4|COMPLETED|Overall Study||6
8490631|NCT00553514|20922123|P3|COMPLETED|Overall Study||9
8490632|NCT00553514|20922124|P2|COMPLETED|Overall Study||6
8490633|NCT00553514|20922125|P1|COMPLETED|Overall Study||6
8490634|NCT00553514|20922121|P5|STARTED|Overall Study||15
8490635|NCT00553514|20922122|P4|STARTED|Overall Study||13
8490636|NCT00553514|20922123|P3|STARTED|Overall Study||15
8490637|NCT00553514|20922124|P2|STARTED|Overall Study||14
8490638|NCT00553514|20922125|P1|STARTED|Overall Study||14
8490639|NCT00553501|20922162|P1|NOT COMPLETED|Overall Study||4
8490640|NCT00553501|20922162|P1|COMPLETED|Overall Study||55
8490641|NCT00553501|20922162|P1|STARTED|Overall Study||59
8490642|NCT00553475|20922171|P3|NOT COMPLETED|Overall Study||13
8490643|NCT00553475|20922172|P2|NOT COMPLETED|Overall Study||20
8490644|NCT00553475|20922173|P1|NOT COMPLETED|Overall Study||16
8490645|NCT00553475|20922171|P3|COMPLETED|Overall Study||32
8490646|NCT00553475|20922172|P2|COMPLETED|Overall Study||114
8490647|NCT00553475|20922173|P1|COMPLETED|Overall Study||119
8490648|NCT00553475|20922171|P3|STARTED|Overall Study||45
8490649|NCT00553475|20922172|P2|STARTED|Overall Study||134
8490650|NCT00553475|20922173|P1|STARTED|Overall Study||135
8490651|NCT00553462|20922295|P1|NOT COMPLETED|Overall Study||14
8490652|NCT00553462|20922295|P1|COMPLETED|Overall Study||61
8490653|NCT00553462|20922295|P1|STARTED|Overall Study||75
8490654|NCT00553436|20922301|P1|NOT COMPLETED|Overall Study||1
8490655|NCT00553436|20922301|P1|COMPLETED|Overall Study|09 April 2009|6
8490656|NCT00553436|20922301|P1|STARTED|Overall Study|20 August 2007|7
8490657|NCT00553410|20922309|P2|NOT COMPLETED|Overall Study||18
8490658|NCT00553410|20922310|P1|NOT COMPLETED|Overall Study||15
8490659|NCT00553410|20922309|P2|COMPLETED|Overall Study||2425
8490660|NCT00553410|20922310|P1|COMPLETED|Overall Study||2426
8490661|NCT00553410|20922309|P2|STARTED|Overall Study||2443
8490662|NCT00553410|20922310|P1|STARTED|Overall Study||2441
8490672|NCT00553332|20922353|P1|NOT COMPLETED|Overall Study||1
8490673|NCT00553332|20922353|P1|COMPLETED|Overall Study|evaluable for response|28
8490674|NCT00553332|20922353|P1|STARTED|Overall Study||29
8490675|NCT00553319|20922365|P3|NOT COMPLETED|Overall Study||9
8490676|NCT00553319|20922366|P2|NOT COMPLETED|Overall Study||10
8490677|NCT00553319|20922367|P1|NOT COMPLETED|Overall Study||14
8490678|NCT00553319|20922365|P3|COMPLETED|Overall Study||34
8490679|NCT00553319|20922366|P2|COMPLETED|Overall Study||30
8490680|NCT00553319|20922367|P1|COMPLETED|Overall Study||29
8490681|NCT00553319|20922365|P3|STARTED|Overall Study||43
8490682|NCT00553319|20922366|P2|STARTED|Overall Study||40
8490683|NCT00553319|20922367|P1|STARTED|Overall Study||43
8490684|NCT00553280|20922378|P1|NOT COMPLETED|Overall Study||26
8490685|NCT00553280|20922378|P1|COMPLETED|Overall Study||97
8490686|NCT00553280|20922378|P1|STARTED|Overall Study||123
8490687|NCT00553267|20922390|P3|NOT COMPLETED|Overall Study||10
8490688|NCT00553267|20922391|P2|NOT COMPLETED|Overall Study||18
8490689|NCT00553267|20922392|P1|NOT COMPLETED|Overall Study||14
8490690|NCT00553267|20922390|P3|COMPLETED|Overall Study||307
8490691|NCT00553267|20922391|P2|COMPLETED|Overall Study||297
8490692|NCT00553267|20922392|P1|COMPLETED|Overall Study||301
8490693|NCT00553267|20922390|P3|STARTED|Overall Study||317
8490694|NCT00553267|20922391|P2|STARTED|Overall Study||315
8490695|NCT00553267|20922392|P1|STARTED|Overall Study||315
8490696|NCT00553254|20922429|P3|NOT COMPLETED|Overall Study||43
8490697|NCT00553254|20922430|P2|NOT COMPLETED|Overall Study||6
8490698|NCT00553254|20922431|P1|NOT COMPLETED|Overall Study||6
8490699|NCT00553254|20922429|P3|COMPLETED|Overall Study||0
8490700|NCT00553254|20922430|P2|COMPLETED|Overall Study||0
8490701|NCT00553254|20922431|P1|COMPLETED|Overall Study||0
8490702|NCT00553254|20922429|P3|STARTED|Overall Study||43
8490703|NCT00553254|20922430|P2|STARTED|Overall Study||6
8490704|NCT00553254|20922431|P1|STARTED|Overall Study||6
8490705|NCT00553202|20922473|P1|NOT COMPLETED|Overall Study||68
8490706|NCT00553202|20922473|P1|COMPLETED|Overall Study||90
8490707|NCT00553202|20922473|P1|STARTED|Overall Study||158
8490708|NCT00553163|20922483|P2|NOT COMPLETED|Overall Study||0
8490709|NCT00553163|20922484|P1|NOT COMPLETED|Overall Study||0
8490710|NCT00553163|20922483|P2|COMPLETED|Overall Study||10
8490711|NCT00553163|20922484|P1|COMPLETED|Overall Study||16
8490712|NCT00553163|20922483|P2|STARTED|Overall Study||10
8490713|NCT00553163|20922484|P1|STARTED|Overall Study||16
8490714|NCT00553150|20922500|P4|NOT COMPLETED|Overall Study||4
8490715|NCT00553150|20922501|P3|NOT COMPLETED|Overall Study||0
8490716|NCT00553150|20922502|P2|NOT COMPLETED|Overall Study||0
8490717|NCT00553150|20922503|P1|NOT COMPLETED|Overall Study||0
8490718|NCT00553150|20922500|P4|COMPLETED|Overall Study||100
8490719|NCT00553150|20922501|P3|COMPLETED|Overall Study||6
8490720|NCT00553150|20922502|P2|COMPLETED|Overall Study||6
8490721|NCT00553150|20922503|P1|COMPLETED|Overall Study||6
8490722|NCT00553150|20922500|P4|STARTED|Overall Study||104
8490723|NCT00553150|20922501|P3|STARTED|Overall Study||6
8490724|NCT00553150|20922502|P2|STARTED|Overall Study||6
8490725|NCT00553150|20922503|P1|STARTED|Overall Study||6
8490726|NCT00553098|20922515|P1|NOT COMPLETED|Overall Study||1
8490727|NCT00553098|20922515|P1|COMPLETED|Overall Study||28
8490728|NCT00553098|20922515|P1|STARTED|Overall Study||29
8490729|NCT00553059|20922531|P2|NOT COMPLETED|Overall Study||2
8490730|NCT00553059|20922532|P1|NOT COMPLETED|Overall Study||1
8490731|NCT00553059|20922531|P2|COMPLETED|Overall Study||29
8490732|NCT00553059|20922532|P1|COMPLETED|Overall Study||30
8490733|NCT00553059|20922531|P2|STARTED|Overall Study||31
8490734|NCT00553059|20922532|P1|STARTED|Overall Study||31
8490735|NCT00552929|20922560|P10|NOT COMPLETED|Overall Study||0
8490736|NCT00552929|20922561|P9|NOT COMPLETED|Overall Study||1
8490737|NCT00552929|20922562|P8|NOT COMPLETED|Overall Study||0
8490738|NCT00552929|20922563|P7|NOT COMPLETED|Overall Study||0
8490739|NCT00552929|20922564|P6|NOT COMPLETED|Overall Study||1
8490740|NCT00552929|20922565|P5|NOT COMPLETED|Overall Study||0
8490741|NCT00552929|20922566|P4|NOT COMPLETED|Overall Study||0
8490742|NCT00552929|20922567|P3|NOT COMPLETED|Overall Study||0
8490743|NCT00552929|20922568|P2|NOT COMPLETED|Overall Study||0
8490744|NCT00552929|20922569|P1|NOT COMPLETED|Overall Study||0
8490745|NCT00552929|20922560|P10|COMPLETED|Overall Study||11
8490746|NCT00552929|20922561|P9|COMPLETED|Overall Study||9
8490747|NCT00552929|20922562|P8|COMPLETED|Overall Study||11
8490748|NCT00552929|20922563|P7|COMPLETED|Overall Study||10
8490749|NCT00552929|20922564|P6|COMPLETED|Overall Study||9
8490750|NCT00552929|20922565|P5|COMPLETED|Overall Study||10
8490751|NCT00552929|20922566|P4|COMPLETED|Overall Study||11
8490752|NCT00552929|20922567|P3|COMPLETED|Overall Study||10
8490753|NCT00552929|20922568|P2|COMPLETED|Overall Study||10
8490754|NCT00552929|20922569|P1|COMPLETED|Overall Study||9
8490755|NCT00552929|20922560|P10|Participants as Treated|Overall Study||11
8490756|NCT00552929|20922561|P9|Participants as Treated|Overall Study||10
8490757|NCT00552929|20922562|P8|Participants as Treated|Overall Study||11
8490758|NCT00552929|20922563|P7|Participants as Treated|Overall Study||10
8490759|NCT00552929|20922564|P6|Participants as Treated|Overall Study||9
8490760|NCT00552929|20922565|P5|Participants as Treated|Overall Study||10
8490848|NCT00552617|20922691|P8|STARTED|Overall Study||10
8490761|NCT00552929|20922566|P4|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
8490762|NCT00552929|20922567|P3|Participants as Treated|Overall Study||10
8490763|NCT00552929|20922568|P2|Participants as Treated|Overall Study||10
8490764|NCT00552929|20922569|P1|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
8490765|NCT00552929|20922560|P10|STARTED|Overall Study||11
8490766|NCT00552929|20922561|P9|STARTED|Overall Study||10
8490767|NCT00552929|20922562|P8|STARTED|Overall Study||11
8490768|NCT00552929|20922563|P7|STARTED|Overall Study||10
8490769|NCT00552929|20922564|P6|STARTED|Overall Study||10
8490770|NCT00552929|20922565|P5|STARTED|Overall Study||10
8490771|NCT00552929|20922566|P4|STARTED|Overall Study||11
8490772|NCT00552929|20922567|P3|STARTED|Overall Study||10
8490773|NCT00552929|20922568|P2|STARTED|Overall Study||10
8490774|NCT00552929|20922569|P1|STARTED|Overall Study||9
8490775|NCT00552812|20922621|P1|NOT COMPLETED|Overall Study||20
8490776|NCT00552812|20922621|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
8490777|NCT00552812|20922621|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
8490778|NCT00552786|20922629|P2|NOT COMPLETED|Second Intervention||0
8490779|NCT00552786|20922630|P1|NOT COMPLETED|Second Intervention||0
8490780|NCT00552786|20922629|P2|COMPLETED|Second Intervention||28
8490781|NCT00552786|20922630|P1|COMPLETED|Second Intervention||25
8490782|NCT00552786|20922629|P2|STARTED|Second Intervention||28
8490783|NCT00552786|20922630|P1|STARTED|Second Intervention||25
8490784|NCT00552786|20922629|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8490785|NCT00552786|20922630|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8490786|NCT00552786|20922629|P2|COMPLETED|Washout Period of 2 Weeks||28
8490787|NCT00552786|20922630|P1|COMPLETED|Washout Period of 2 Weeks||25
8490788|NCT00552786|20922629|P2|STARTED|Washout Period of 2 Weeks||28
8490789|NCT00552786|20922630|P1|STARTED|Washout Period of 2 Weeks||25
8490790|NCT00552786|20922629|P2|NOT COMPLETED|First Intervention||0
8490791|NCT00552786|20922630|P1|NOT COMPLETED|First Intervention||0
8490792|NCT00552786|20922629|P2|COMPLETED|First Intervention||28
8490793|NCT00552786|20922630|P1|COMPLETED|First Intervention||25
8490794|NCT00552786|20922629|P2|Medication and Hearing Evaluation|First Intervention||28
8490795|NCT00552786|20922630|P1|Medication and Hearing Evaluation|First Intervention||25
8490796|NCT00552786|20922629|P2|STARTED|First Intervention||28
8490797|NCT00552786|20922630|P1|STARTED|First Intervention||25
8490798|NCT00552760|20922640|P2|NOT COMPLETED|Overall Study||33
8490799|NCT00552760|20922641|P1|NOT COMPLETED|Overall Study||26
8490800|NCT00552760|20922640|P2|COMPLETED|Overall Study||8
8490801|NCT00552760|20922641|P1|COMPLETED|Overall Study||16
8490802|NCT00552760|20922640|P2|STARTED|Overall Study||41
8490803|NCT00552760|20922641|P1|STARTED|Overall Study||42
8490804|NCT00552695|20922657|P2|NOT COMPLETED|Overall Study||0
8490805|NCT00552695|20922658|P1|NOT COMPLETED|Overall Study||0
8490806|NCT00552695|20922657|P2|COMPLETED|Overall Study|September 2007|23
8490807|NCT00552695|20922658|P1|COMPLETED|Overall Study|September 2007|22
8490808|NCT00552695|20922657|P2|STARTED|Overall Study|August 2007|23
8490809|NCT00552695|20922658|P1|STARTED|Overall Study|August 2007|22
8490810|NCT00552669|20922668|P2|NOT COMPLETED|Overall Study||7
8490811|NCT00552669|20922669|P1|NOT COMPLETED|Overall Study||3
8490812|NCT00552669|20922668|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
8490813|NCT00552669|20922669|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
8490814|NCT00552669|20922668|P2|STARTED|Overall Study|patients|100
8490815|NCT00552669|20922669|P1|STARTED|Overall Study|patients|100
8490816|NCT00552617|20922689|P10|NOT COMPLETED|Overall Study||1
8490817|NCT00552617|20922690|P9|NOT COMPLETED|Overall Study||2
8490818|NCT00552617|20922691|P8|NOT COMPLETED|Overall Study||0
8490819|NCT00552617|20922692|P7|NOT COMPLETED|Overall Study||0
8490820|NCT00552617|20922693|P6|NOT COMPLETED|Overall Study||2
8490821|NCT00552617|20922694|P5|NOT COMPLETED|Overall Study||0
8490822|NCT00552617|20922695|P4|NOT COMPLETED|Overall Study||1
8490823|NCT00552617|20922696|P3|NOT COMPLETED|Overall Study||1
8490824|NCT00552617|20922697|P2|NOT COMPLETED|Overall Study||0
8490825|NCT00552617|20922698|P1|NOT COMPLETED|Overall Study||0
8490826|NCT00552617|20922689|P10|COMPLETED|Overall Study||9
8490827|NCT00552617|20922690|P9|COMPLETED|Overall Study||8
8490828|NCT00552617|20922691|P8|COMPLETED|Overall Study||10
8490829|NCT00552617|20922692|P7|COMPLETED|Overall Study||10
8490830|NCT00552617|20922693|P6|COMPLETED|Overall Study||8
8490831|NCT00552617|20922694|P5|COMPLETED|Overall Study||10
8490832|NCT00552617|20922695|P4|COMPLETED|Overall Study||9
8490833|NCT00552617|20922696|P3|COMPLETED|Overall Study||9
8490834|NCT00552617|20922697|P2|COMPLETED|Overall Study||10
8490835|NCT00552617|20922698|P1|COMPLETED|Overall Study||10
8490836|NCT00552617|20922689|P10|Treated|Overall Study||9
8490837|NCT00552617|20922690|P9|Treated|Overall Study||10
8490838|NCT00552617|20922691|P8|Treated|Overall Study||10
8490839|NCT00552617|20922692|P7|Treated|Overall Study||10
8490840|NCT00552617|20922693|P6|Treated|Overall Study||10
8490841|NCT00552617|20922694|P5|Treated|Overall Study||10
8490842|NCT00552617|20922695|P4|Treated|Overall Study||10
8490843|NCT00552617|20922696|P3|Treated|Overall Study||9
8490844|NCT00552617|20922697|P2|Treated|Overall Study||10
8490845|NCT00552617|20922698|P1|Treated|Overall Study||10
8490846|NCT00552617|20922689|P10|STARTED|Overall Study||10
8490847|NCT00552617|20922690|P9|STARTED|Overall Study||10
8490849|NCT00552617|20922692|P7|STARTED|Overall Study||10
8490850|NCT00552617|20922693|P6|STARTED|Overall Study||10
8490851|NCT00552617|20922694|P5|STARTED|Overall Study||10
8490852|NCT00552617|20922695|P4|STARTED|Overall Study||10
8490853|NCT00552617|20922696|P3|STARTED|Overall Study||10
8490854|NCT00552617|20922697|P2|STARTED|Overall Study||10
8490855|NCT00552617|20922698|P1|STARTED|Overall Study||10
8490856|NCT00552578|20922742|P2|NOT COMPLETED|Overall Study||1
8490857|NCT00552578|20922743|P1|NOT COMPLETED|Overall Study||1
8490858|NCT00552578|20922742|P2|COMPLETED|Overall Study||5
8490859|NCT00552578|20922743|P1|COMPLETED|Overall Study||5
8490860|NCT00552578|20922742|P2|STARTED|Overall Study||6
8490861|NCT00552578|20922743|P1|STARTED|Overall Study||6
8490862|NCT00552513|20922755|P2|NOT COMPLETED|Overall Study||1
8490863|NCT00552513|20922756|P1|NOT COMPLETED|Overall Study||5
8490864|NCT00552513|20922755|P2|COMPLETED|Overall Study||1437
8490865|NCT00552513|20922756|P1|COMPLETED|Overall Study||1588
8490866|NCT00552513|20922755|P2|STARTED|Overall Study||1438
8490867|NCT00552513|20922756|P1|STARTED|Overall Study||1593
8490868|NCT00552448|20922768|P2|NOT COMPLETED|Overall Study||0
8490869|NCT00552448|20922769|P1|NOT COMPLETED|Overall Study||1
8490870|NCT00552448|20922768|P2|COMPLETED|Overall Study||16
8490871|NCT00552448|20922769|P1|COMPLETED|Overall Study||19
8490872|NCT00552448|20922768|P2|STARTED|Overall Study||16
8490873|NCT00552448|20922769|P1|STARTED|Overall Study||20
8490874|NCT00552422|20922781|P1|NOT COMPLETED|Overall Study||0
8490875|NCT00552422|20922781|P1|COMPLETED|Overall Study||6
8490876|NCT00552422|20922781|P1|STARTED|Overall Study||6
8490877|NCT00552409|20922787|P2|NOT COMPLETED|Overall Study||2
8490878|NCT00552409|20922788|P1|NOT COMPLETED|Overall Study||1
8490879|NCT00552409|20922787|P2|COMPLETED|Overall Study||9
8490880|NCT00552409|20922788|P1|COMPLETED|Overall Study||10
8490881|NCT00552409|20922787|P2|STARTED|Overall Study||11
8490882|NCT00552409|20922788|P1|STARTED|Overall Study||11
8490883|NCT00552396|20922801|P7|NOT COMPLETED|Overall Study||9
8490884|NCT00552396|20922802|P6|NOT COMPLETED|Overall Study||3
8490885|NCT00552396|20922803|P5|NOT COMPLETED|Overall Study||3
8490886|NCT00552396|20922804|P4|NOT COMPLETED|Overall Study||6
8490887|NCT00552396|20922805|P3|NOT COMPLETED|Overall Study||3
8490888|NCT00552396|20922806|P2|NOT COMPLETED|Overall Study||3
8490889|NCT00552396|20922807|P1|NOT COMPLETED|Overall Study||3
8490890|NCT00552396|20922801|P7|COMPLETED|Overall Study||1
8490891|NCT00552396|20922802|P6|COMPLETED|Overall Study||0
8490892|NCT00552396|20922803|P5|COMPLETED|Overall Study||0
8490893|NCT00552396|20922804|P4|COMPLETED|Overall Study||0
8490894|NCT00552396|20922805|P3|COMPLETED|Overall Study||0
8490895|NCT00552396|20922806|P2|COMPLETED|Overall Study||0
8490896|NCT00552396|20922807|P1|COMPLETED|Overall Study||1
8490897|NCT00552396|20922801|P7|STARTED|Overall Study||10
8490898|NCT00552396|20922802|P6|STARTED|Overall Study||3
8490899|NCT00552396|20922803|P5|STARTED|Overall Study||3
8490900|NCT00552396|20922804|P4|STARTED|Overall Study||6
8490901|NCT00552396|20922805|P3|STARTED|Overall Study||3
8490902|NCT00552396|20922806|P2|STARTED|Overall Study||3
8490903|NCT00552396|20922807|P1|STARTED|Overall Study||4
8490904|NCT00552344|20922844|P1|NOT COMPLETED|Overall Study||315
8490905|NCT00552344|20922844|P1|COMPLETED|Overall Study||87
8490906|NCT00552344|20922844|P1|STARTED|Overall Study||402
8490907|NCT00552305|20922853|P1|NOT COMPLETED|Overall Study||250
8490908|NCT00552305|20922853|P1|COMPLETED|Overall Study||120
8490909|NCT00552305|20922853|P1|STARTED|Overall Study||370
8490910|NCT00552279|20922863|P2|NOT COMPLETED|Overall Study||3
8490911|NCT00552279|20922864|P1|NOT COMPLETED|Overall Study||14
8490912|NCT00552279|20922863|P2|COMPLETED|Overall Study||398
8490913|NCT00552279|20922864|P1|COMPLETED|Overall Study||389
8490914|NCT00552279|20922863|P2|STARTED|Overall Study||401
8490915|NCT00552279|20922864|P1|STARTED|Overall Study||403
8490916|NCT00552240|20922890|P2|NOT COMPLETED|Overall Study||18
8490917|NCT00552240|20922891|P1|NOT COMPLETED|Overall Study||24
8490918|NCT00552240|20922890|P2|COMPLETED|Overall Study||59
8490919|NCT00552240|20922891|P1|COMPLETED|Overall Study||51
8490920|NCT00552240|20922890|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
8490921|NCT00552240|20922891|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
8490922|NCT00552188|20922993|P2|NOT COMPLETED|Overall Study||5
8490923|NCT00552188|20922994|P1|NOT COMPLETED|Overall Study||2
8490924|NCT00552188|20922993|P2|COMPLETED|Overall Study||21
8490925|NCT00552188|20922994|P1|COMPLETED|Overall Study||24
8490926|NCT00552188|20922993|P2|STARTED|Overall Study||26
8490927|NCT00552188|20922994|P1|STARTED|Overall Study||26
8490928|NCT00552175|20923005|P3|NOT COMPLETED|Overall Study||14
8490929|NCT00552175|20923006|P2|NOT COMPLETED|Overall Study||13
8490930|NCT00552175|20923007|P1|NOT COMPLETED|Overall Study||17
8490931|NCT00552175|20923005|P3|COMPLETED|Overall Study||72
8490932|NCT00552175|20923006|P2|COMPLETED|Overall Study||73
8490933|NCT00552175|20923007|P1|COMPLETED|Overall Study||150
8490934|NCT00552175|20923005|P3|Full Analysis Set Population|Overall Study||86
8490935|NCT00552175|20923006|P2|Full Analysis Set Population|Overall Study||85
8490936|NCT00552175|20923007|P1|Full Analysis Set Population|Overall Study||167
8490937|NCT00552175|20923005|P3|STARTED|Overall Study||86
8490938|NCT00552175|20923006|P2|STARTED|Overall Study||86
8490939|NCT00552175|20923007|P1|STARTED|Overall Study||167
8490940|NCT00552110|20923047|P5|NOT COMPLETED|Overall Study||9
8490941|NCT00552110|20923048|P4|NOT COMPLETED|Overall Study||8
8490942|NCT00552110|20923049|P3|NOT COMPLETED|Overall Study||2
8490943|NCT00552110|20923050|P2|NOT COMPLETED|Overall Study||5
8492001|NCT00546273|20926295|P5|STARTED|IV||2
8490944|NCT00552110|20923051|P1|NOT COMPLETED|Overall Study||4
8490945|NCT00552110|20923047|P5|COMPLETED|Overall Study||133
8490946|NCT00552110|20923048|P4|COMPLETED|Overall Study||133
8490947|NCT00552110|20923049|P3|COMPLETED|Overall Study||137
8490948|NCT00552110|20923050|P2|COMPLETED|Overall Study||134
8490949|NCT00552110|20923051|P1|COMPLETED|Overall Study||142
8490950|NCT00552110|20923047|P5|STARTED|Overall Study||142
8490951|NCT00552110|20923048|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
8490952|NCT00552110|20923049|P3|STARTED|Overall Study||139
8490953|NCT00552110|20923050|P2|STARTED|Overall Study||139
8490954|NCT00552110|20923051|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
8490955|NCT00552084|20923070|P2|NOT COMPLETED|Overall Study||9
8490956|NCT00552084|20923071|P1|NOT COMPLETED|Overall Study||8
8490957|NCT00552084|20923070|P2|COMPLETED|Overall Study||55
8490958|NCT00552084|20923071|P1|COMPLETED|Overall Study||118
8490959|NCT00552084|20923070|P2|STARTED|Overall Study||64
8490960|NCT00552084|20923071|P1|STARTED|Overall Study||126
8490961|NCT00552071|20923079|P2|NOT COMPLETED|Overall Study||2
8490962|NCT00552071|20923080|P1|NOT COMPLETED|Overall Study||4
8490963|NCT00552071|20923079|P2|COMPLETED|Overall Study||9
8490964|NCT00552071|20923080|P1|COMPLETED|Overall Study||6
8490965|NCT00552071|20923079|P2|STARTED|Overall Study||11
8490966|NCT00552071|20923080|P1|STARTED|Overall Study||10
8490967|NCT00552058|20923090|P2|NOT COMPLETED|Overall Study||24
8490968|NCT00552058|20923091|P1|NOT COMPLETED|Overall Study||16
8490969|NCT00552058|20923090|P2|COMPLETED|Overall Study||192
8490970|NCT00552058|20923091|P1|COMPLETED|Overall Study||207
8490971|NCT00552058|20923090|P2|STARTED|Overall Study||216
8490972|NCT00552058|20923091|P1|STARTED|Overall Study||223
8490973|NCT00552032|20923131|P2|NOT COMPLETED|Overall Study||19
8490974|NCT00552032|20923132|P1|NOT COMPLETED|Overall Study||17
8490975|NCT00552032|20923131|P2|COMPLETED|Overall Study||47
8490976|NCT00552032|20923132|P1|COMPLETED|Overall Study||49
8490977|NCT00552032|20923131|P2|STARTED|Overall Study||66
8490978|NCT00552032|20923132|P1|STARTED|Overall Study||66
8490979|NCT00551759|20923176|P1|NOT COMPLETED|Overall Study||13
8490980|NCT00551759|20923176|P1|COMPLETED|Overall Study||9
8490981|NCT00551759|20923176|P1|Received Adjuvant Therapy|Overall Study||12
8490982|NCT00551759|20923176|P1|Underwent Surgery|Overall Study||17
8490983|NCT00551759|20923176|P1|Eligible and Began Treatment|Overall Study||21
8490984|NCT00551759|20923176|P1|STARTED|Overall Study||22
8490985|NCT00551746|20923182|P2|NOT COMPLETED|Overall Study||8
8490986|NCT00551746|20923183|P1|NOT COMPLETED|Overall Study||11
8490987|NCT00551746|20923182|P2|COMPLETED|Overall Study||26
8490988|NCT00551746|20923183|P1|COMPLETED|Overall Study||25
8490989|NCT00551746|20923182|P2|STARTED|Overall Study||34
8490990|NCT00551746|20923183|P1|STARTED|Overall Study||36
8490991|NCT00551707|20923194|P5|NOT COMPLETED|Overall Study||1
8490992|NCT00551707|20923195|P4|NOT COMPLETED|Overall Study||4
8490993|NCT00551707|20923196|P3|NOT COMPLETED|Overall Study||3
8490994|NCT00551707|20923197|P2|NOT COMPLETED|Overall Study||6
8490995|NCT00551707|20923198|P1|NOT COMPLETED|Overall Study||0
8490996|NCT00551707|20923194|P5|COMPLETED|Overall Study||3
8490997|NCT00551707|20923195|P4|COMPLETED|Overall Study||4
8490998|NCT00551707|20923196|P3|COMPLETED|Overall Study||10
8490999|NCT00551707|20923197|P2|COMPLETED|Overall Study||16
8491000|NCT00551707|20923198|P1|COMPLETED|Overall Study||4
8491001|NCT00551707|20923194|P5|STARTED|Overall Study||4
8491002|NCT00551707|20923195|P4|STARTED|Overall Study||8
8491003|NCT00551707|20923196|P3|STARTED|Overall Study||13
8491004|NCT00551707|20923197|P2|STARTED|Overall Study||22
8491005|NCT00551707|20923198|P1|STARTED|Overall Study||4
8491012|NCT00551525|20923224|P1|NOT COMPLETED|Overall Study||5
8491013|NCT00551525|20923224|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
8491014|NCT00551525|20923224|P1|STARTED|Overall Study||67
8491015|NCT00551460|20923233|P1|NOT COMPLETED|Overall Study||18
8491016|NCT00551460|20923233|P1|COMPLETED|Overall Study||60
8491017|NCT00551460|20923233|P1|STARTED|Overall Study||78
8491018|NCT00551421|20923239|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
8491019|NCT00551421|20923239|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
8491020|NCT00551421|20923239|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
8491021|NCT00551421|20923239|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
8491022|NCT00551421|20923239|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
8491023|NCT00551421|20923239|P1|STARTED|Original Protocol, Dose Level 1||3
8491024|NCT00551369|20923246|P1|NOT COMPLETED|Overall Study||7
8491025|NCT00551369|20923246|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
8491026|NCT00551369|20923246|P1|STARTED|Overall Study||33
8491027|NCT00551291|20923255|P1|NOT COMPLETED|Overall Study||1
8491028|NCT00551291|20923255|P1|COMPLETED|Overall Study||9
8491029|NCT00551291|20923255|P1|STARTED|Overall Study||10
8491030|NCT00551213|20923263|P2|NOT COMPLETED|Overall Study||17
8491031|NCT00551213|20923264|P1|NOT COMPLETED|Overall Study||50
8491032|NCT00551213|20923263|P2|COMPLETED|Overall Study||0
8491033|NCT00551213|20923264|P1|COMPLETED|Overall Study||0
8491034|NCT00551213|20923263|P2|Treated|Overall Study||15
8491035|NCT00551213|20923264|P1|Treated|Overall Study||49
8491036|NCT00551213|20923263|P2|STARTED|Overall Study||17
8491037|NCT00551213|20923264|P1|STARTED|Overall Study||50
8491038|NCT00551200|20923280|P1|NOT COMPLETED|Overall Study||4
8491039|NCT00551200|20923280|P1|COMPLETED|Overall Study||10
8491040|NCT00551200|20923280|P1|STARTED|Overall Study||14
8491041|NCT00551174|20923295|P2|NOT COMPLETED|Overall Study||6
8491042|NCT00551174|20923296|P1|NOT COMPLETED|Overall Study||19
8491043|NCT00551174|20923295|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
8491044|NCT00551174|20923296|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
8491045|NCT00551174|20923295|P2|STARTED|Overall Study||400
8491046|NCT00551174|20923296|P1|STARTED|Overall Study||381
8491047|NCT00551161|20923308|P1|NOT COMPLETED|Overall Study||1
8491048|NCT00551161|20923308|P1|COMPLETED|Overall Study||11
8491049|NCT00551161|20923308|P1|STARTED|Overall Study||12
8491050|NCT00551135|20923316|P4|NOT COMPLETED|Overall Study||5
8491051|NCT00551135|20923317|P3|NOT COMPLETED|Overall Study||5
8491052|NCT00551135|20923318|P2|NOT COMPLETED|Overall Study||2
8491053|NCT00551135|20923319|P1|NOT COMPLETED|Overall Study||5
8491054|NCT00551135|20923316|P4|COMPLETED|Overall Study||103
8491055|NCT00551135|20923317|P3|COMPLETED|Overall Study||98
8491056|NCT00551135|20923318|P2|COMPLETED|Overall Study||104
8491057|NCT00551135|20923319|P1|COMPLETED|Overall Study||103
8491058|NCT00551135|20923316|P4|STARTED|Overall Study||108
8491059|NCT00551135|20923317|P3|STARTED|Overall Study||103
8491060|NCT00551135|20923318|P2|STARTED|Overall Study||106
8491061|NCT00551135|20923319|P1|STARTED|Overall Study||108
8491062|NCT00551070|20923433|P1|NOT COMPLETED|Overall Study||0
8491063|NCT00551070|20923433|P1|COMPLETED|Overall Study||52
8491064|NCT00551070|20923433|P1|STARTED|Overall Study||52
8491065|NCT00551031|20923448|P5|NOT COMPLETED|Overall Study||1
8491066|NCT00551031|20923449|P4|NOT COMPLETED|Overall Study||3
8491067|NCT00551031|20923450|P3|NOT COMPLETED|Overall Study||2
8491068|NCT00551031|20923451|P2|NOT COMPLETED|Overall Study||11
8491069|NCT00551031|20923452|P1|NOT COMPLETED|Overall Study||2
8491070|NCT00551031|20923448|P5|COMPLETED|Overall Study||185
8491071|NCT00551031|20923449|P4|COMPLETED|Overall Study||317
8491072|NCT00551031|20923450|P3|COMPLETED|Overall Study||317
8491073|NCT00551031|20923451|P2|COMPLETED|Overall Study||625
8491074|NCT00551031|20923452|P1|COMPLETED|Overall Study||635
8491075|NCT00551031|20923448|P5|STARTED|Overall Study||186
8491076|NCT00551031|20923449|P4|STARTED|Overall Study||320
8491077|NCT00551031|20923450|P3|STARTED|Overall Study||319
8491078|NCT00551031|20923451|P2|STARTED|Overall Study||636
8491079|NCT00551031|20923452|P1|STARTED|Overall Study||637
8491080|NCT00550953|20923481|P2|NOT COMPLETED|Overall Study||6
8491081|NCT00550953|20923482|P1|NOT COMPLETED|Overall Study||6
8491082|NCT00550953|20923481|P2|COMPLETED|Overall Study||152
8491083|NCT00550953|20923482|P1|COMPLETED|Overall Study||150
8491084|NCT00550953|20923481|P2|STARTED|Overall Study||158
8491085|NCT00550953|20923482|P1|STARTED|Overall Study||156
8491086|NCT00550862|20923506|P4|NOT COMPLETED|Overall Study||1
8491087|NCT00550862|20923507|P3|NOT COMPLETED|Overall Study||16
8491088|NCT00550862|20923508|P2|NOT COMPLETED|Overall Study||6
8491089|NCT00550862|20923509|P1|NOT COMPLETED|Overall Study||6
8491090|NCT00550862|20923506|P4|COMPLETED|Overall Study||37
8491091|NCT00550862|20923507|P3|COMPLETED|Overall Study||25
8491092|NCT00550862|20923508|P2|COMPLETED|Overall Study||42
8491093|NCT00550862|20923509|P1|COMPLETED|Overall Study||32
8491094|NCT00550862|20923506|P4|STARTED|Overall Study||38
8491095|NCT00550862|20923507|P3|STARTED|Overall Study||41
8491096|NCT00550862|20923508|P2|STARTED|Overall Study||48
8491097|NCT00550862|20923509|P1|STARTED|Overall Study||38
8491098|NCT00550836|20923529|P2|NOT COMPLETED|Overall Study||9
8491099|NCT00550836|20923530|P1|NOT COMPLETED|Overall Study||3
8491100|NCT00550836|20923529|P2|COMPLETED|Overall Study||46
8491101|NCT00550836|20923530|P1|COMPLETED|Overall Study||46
8491102|NCT00550836|20923529|P2|STARTED|Overall Study||55
8491103|NCT00550836|20923530|P1|STARTED|Overall Study||49
8491104|NCT00550771|20923546|P2|NOT COMPLETED|Overall Study||10
8491105|NCT00550771|20923547|P1|NOT COMPLETED|Overall Study||17
8491106|NCT00550771|20923546|P2|COMPLETED|Overall Study||50
8491107|NCT00550771|20923547|P1|COMPLETED|Overall Study||104
8491108|NCT00550771|20923546|P2|STARTED|Overall Study||60
8491109|NCT00550771|20923547|P1|STARTED|Overall Study||121
8491110|NCT00550745|20923561|P2|NOT COMPLETED|Overall Study||60
8491111|NCT00550745|20923562|P1|NOT COMPLETED|Overall Study||87
8491112|NCT00550745|20923561|P2|COMPLETED|Overall Study||5939
8491113|NCT00550745|20923562|P1|COMPLETED|Overall Study||5913
8491114|NCT00550745|20923561|P2|STARTED|Overall Study||5999
8491115|NCT00550745|20923562|P1|STARTED|Overall Study||6000
8491116|NCT00550732|20923570|P1|NOT COMPLETED|Overall Study||11
8491117|NCT00550732|20923570|P1|COMPLETED|Overall Study||29
8491118|NCT00550732|20923570|P1|STARTED|Overall Study||40
8491119|NCT00550680|20923581|P1|NOT COMPLETED|Overall Study||56
8491120|NCT00550680|20923581|P1|COMPLETED|Overall Study||152
8491121|NCT00550680|20923581|P1|STARTED|Overall Study||208
8491122|NCT00550654|20923590|P1|NOT COMPLETED|Overall Study||0
8491123|NCT00550654|20923590|P1|COMPLETED|Overall Study||1
8491124|NCT00550654|20923590|P1|STARTED|Overall Study||1
8491125|NCT00550615|20923602|P4|NOT COMPLETED|Overall Study||10
8491126|NCT00550615|20923603|P3|NOT COMPLETED|Overall Study||4
8491127|NCT00550615|20923604|P2|NOT COMPLETED|Overall Study||0
8491128|NCT00550615|20923605|P1|NOT COMPLETED|Overall Study||0
8491129|NCT00550615|20923602|P4|COMPLETED|Overall Study||12
8491130|NCT00550615|20923603|P3|COMPLETED|Overall Study||6
8491131|NCT00550615|20923604|P2|COMPLETED|Overall Study||3
8491132|NCT00550615|20923605|P1|COMPLETED|Overall Study||3
8491133|NCT00550615|20923602|P4|STARTED|Overall Study||22
8491134|NCT00550615|20923603|P3|STARTED|Overall Study||10
8491135|NCT00550615|20923604|P2|STARTED|Overall Study||3
8491136|NCT00550615|20923605|P1|STARTED|Overall Study||3
8491137|NCT00550589|20923611|P1|NOT COMPLETED|Overall Study||0
8491138|NCT00550589|20923611|P1|COMPLETED|Overall Study||33
8491139|NCT00550589|20923611|P1|STARTED|Overall Study||33
8491140|NCT00550550|20923624|P2|NOT COMPLETED|Overall Study||29
8491141|NCT00550550|20923625|P1|NOT COMPLETED|Overall Study||34
8491142|NCT00550550|20923624|P2|COMPLETED|Overall Study||140
8491143|NCT00550550|20923625|P1|COMPLETED|Overall Study||142
8491144|NCT00550550|20923624|P2|Number Treated|Overall Study||169
8491145|NCT00550550|20923625|P1|Number Treated|Overall Study||175
8491146|NCT00550550|20923624|P2|STARTED|Overall Study||169
8491147|NCT00550550|20923625|P1|STARTED|Overall Study||176
8491148|NCT00550537|20923637|P1|NOT COMPLETED|Overall Study||104
8491149|NCT00550537|20923637|P1|COMPLETED|Overall Study||12
8491150|NCT00550537|20923637|P1|STARTED|Overall Study||116
8491151|NCT00550459|20923654|P2|NOT COMPLETED|Overall Study||3
8491152|NCT00550459|20923655|P1|NOT COMPLETED|Overall Study||1
8491153|NCT00550459|20923654|P2|COMPLETED|Overall Study||26
8491154|NCT00550459|20923655|P1|COMPLETED|Overall Study||27
8491155|NCT00550459|20923654|P2|STARTED|Overall Study||29
8491156|NCT00550459|20923655|P1|STARTED|Overall Study||28
8491157|NCT00550446|20923724|P11|NOT COMPLETED|Post Week 12||1
8491158|NCT00550446|20923725|P10|NOT COMPLETED|Post Week 12||7
8491159|NCT00550446|20923726|P9|NOT COMPLETED|Post Week 12||2
8491160|NCT00550446|20923727|P8|NOT COMPLETED|Post Week 12||1
8491161|NCT00550446|20923728|P7|NOT COMPLETED|Post Week 12||2
8491162|NCT00550446|20923729|P6|NOT COMPLETED|Post Week 12||1
8491163|NCT00550446|20923730|P5|NOT COMPLETED|Post Week 12||2
8491164|NCT00550446|20923731|P4|NOT COMPLETED|Post Week 12||3
8491165|NCT00550446|20923732|P3|NOT COMPLETED|Post Week 12||3
8491166|NCT00550446|20923733|P2|NOT COMPLETED|Post Week 12||2
8491167|NCT00550446|20923734|P1|NOT COMPLETED|Post Week 12||3
8491168|NCT00550446|20923724|P11|COMPLETED|Post Week 12||24
8491169|NCT00550446|20923725|P10|COMPLETED|Post Week 12||37
8491170|NCT00550446|20923726|P9|COMPLETED|Post Week 12||15
8491171|NCT00550446|20923727|P8|COMPLETED|Post Week 12||16
8491172|NCT00550446|20923728|P7|COMPLETED|Post Week 12||19
8491173|NCT00550446|20923729|P6|COMPLETED|Post Week 12||0
8491174|NCT00550446|20923730|P5|COMPLETED|Post Week 12||52
8491175|NCT00550446|20923731|P4|COMPLETED|Post Week 12||55
8491176|NCT00550446|20923732|P3|COMPLETED|Post Week 12||43
8491177|NCT00550446|20923733|P2|COMPLETED|Post Week 12||28
8491178|NCT00550446|20923734|P1|COMPLETED|Post Week 12||24
8491179|NCT00550446|20923724|P11|STARTED|Post Week 12||25
8491180|NCT00550446|20923725|P10|STARTED|Post Week 12||44
8491181|NCT00550446|20923726|P9|STARTED|Post Week 12||17
8491182|NCT00550446|20923727|P8|STARTED|Post Week 12||17
8491183|NCT00550446|20923728|P7|STARTED|Post Week 12||21
8491184|NCT00550446|20923729|P6|STARTED|Post Week 12||1
8491185|NCT00550446|20923730|P5|STARTED|Post Week 12||54
8491186|NCT00550446|20923731|P4|STARTED|Post Week 12||58
8491187|NCT00550446|20923732|P3|STARTED|Post Week 12||46
8491188|NCT00550446|20923733|P2|STARTED|Post Week 12||30
8491189|NCT00550446|20923734|P1|STARTED|Post Week 12||27
8491190|NCT00550446|20923724|P11|NOT COMPLETED|Up To Week 12||0
8491191|NCT00550446|20923725|P10|NOT COMPLETED|Up To Week 12||0
8491192|NCT00550446|20923726|P9|NOT COMPLETED|Up To Week 12||0
8491193|NCT00550446|20923727|P8|NOT COMPLETED|Up To Week 12||0
8491194|NCT00550446|20923728|P7|NOT COMPLETED|Up To Week 12||13
8491195|NCT00550446|20923729|P6|NOT COMPLETED|Up To Week 12||8
8491196|NCT00550446|20923730|P5|NOT COMPLETED|Up To Week 12||3
8491197|NCT00550446|20923731|P4|NOT COMPLETED|Up To Week 12||3
8491198|NCT00550446|20923732|P3|NOT COMPLETED|Up To Week 12||4
8491199|NCT00550446|20923733|P2|NOT COMPLETED|Up To Week 12||5
8491200|NCT00550446|20923734|P1|NOT COMPLETED|Up To Week 12||10
8491201|NCT00550446|20923724|P11|COMPLETED|Up To Week 12||0
8491202|NCT00550446|20923725|P10|COMPLETED|Up To Week 12||0
8491203|NCT00550446|20923726|P9|COMPLETED|Up To Week 12||0
8491204|NCT00550446|20923727|P8|COMPLETED|Up To Week 12||0
8491205|NCT00550446|20923728|P7|COMPLETED|Up To Week 12||46
8491206|NCT00550446|20923729|P6|COMPLETED|Up To Week 12||45
8491207|NCT00550446|20923730|P5|COMPLETED|Up To Week 12||54
8491208|NCT00550446|20923731|P4|COMPLETED|Up To Week 12||58
8491209|NCT00550446|20923732|P3|COMPLETED|Up To Week 12||46
8491210|NCT00550446|20923733|P2|COMPLETED|Up To Week 12||47
8491211|NCT00550446|20923734|P1|COMPLETED|Up To Week 12||44
8491212|NCT00550446|20923724|P11|Treated|Up To Week 12||0
8491213|NCT00550446|20923725|P10|Treated|Up To Week 12||0
8491214|NCT00550446|20923726|P9|Treated|Up To Week 12||0
8491215|NCT00550446|20923727|P8|Treated|Up To Week 12||0
8491216|NCT00550446|20923728|P7|Treated|Up To Week 12||59
8491217|NCT00550446|20923729|P6|Treated|Up To Week 12||53
8491218|NCT00550446|20923730|P5|Treated|Up To Week 12||57
8491219|NCT00550446|20923731|P4|Treated|Up To Week 12||61
8491220|NCT00550446|20923732|P3|Treated|Up To Week 12||49
8491221|NCT00550446|20923733|P2|Treated|Up To Week 12||51
8491222|NCT00550446|20923734|P1|Treated|Up To Week 12||54
8491223|NCT00550446|20923724|P11|STARTED|Up To Week 12||0
8491224|NCT00550446|20923725|P10|STARTED|Up To Week 12||0
8492002|NCT00546273|20926296|P4|STARTED|IV||4
8491225|NCT00550446|20923726|P9|STARTED|Up To Week 12||0
8491226|NCT00550446|20923727|P8|STARTED|Up To Week 12||0
8491227|NCT00550446|20923728|P7|STARTED|Up To Week 12||59
8491228|NCT00550446|20923729|P6|STARTED|Up To Week 12||53
8491229|NCT00550446|20923730|P5|STARTED|Up To Week 12||57
8491230|NCT00550446|20923731|P4|STARTED|Up To Week 12||61
8491231|NCT00550446|20923732|P3|STARTED|Up To Week 12||50
8491232|NCT00550446|20923733|P2|STARTED|Up To Week 12||52
8491233|NCT00550446|20923734|P1|STARTED|Up To Week 12||54
8491234|NCT00550420|20924166|P1|NOT COMPLETED|Overall Study||305
8491235|NCT00550420|20924166|P1|COMPLETED|Overall Study||26
8491236|NCT00550420|20924166|P1|STARTED|Overall Study||331
8491237|NCT00550407|20924189|P3|NOT COMPLETED|26-Week Randomized Phase||24
8491238|NCT00550407|20924190|P2|NOT COMPLETED|26-Week Randomized Phase||43
8491239|NCT00550407|20924191|P1|NOT COMPLETED|26-Week Randomized Phase||0
8491240|NCT00550407|20924189|P3|COMPLETED|26-Week Randomized Phase||21
8491241|NCT00550407|20924190|P2|COMPLETED|26-Week Randomized Phase||15
8491242|NCT00550407|20924191|P1|COMPLETED|26-Week Randomized Phase||0
8491243|NCT00550407|20924189|P3|STARTED|26-Week Randomized Phase||45
8491244|NCT00550407|20924190|P2|STARTED|26-Week Randomized Phase||58
8491245|NCT00550407|20924191|P1|STARTED|26-Week Randomized Phase||0
8491246|NCT00550407|20924189|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491247|NCT00550407|20924190|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491248|NCT00550407|20924191|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
8491249|NCT00550407|20924189|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491250|NCT00550407|20924190|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491251|NCT00550407|20924191|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
8491252|NCT00550407|20924189|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
8491253|NCT00550407|20924190|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
8491254|NCT00550407|20924191|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
8491255|NCT00550394|20924226|P2|NOT COMPLETED|Overall Study||13
8491256|NCT00550394|20924227|P1|NOT COMPLETED|Overall Study||12
8491257|NCT00550394|20924226|P2|COMPLETED|Overall Study||5
8491258|NCT00550394|20924227|P1|COMPLETED|Overall Study||9
8491259|NCT00550394|20924226|P2|STARTED|Overall Study||18
8491260|NCT00550394|20924227|P1|STARTED|Overall Study||21
8491261|NCT00550368|20924241|P2|NOT COMPLETED|Overall Study||0
8491262|NCT00550368|20924242|P1|NOT COMPLETED|Overall Study||0
8491263|NCT00550368|20924241|P2|COMPLETED|Overall Study||19
8491264|NCT00550368|20924242|P1|COMPLETED|Overall Study||26
8491265|NCT00550368|20924241|P2|STARTED|Overall Study||19
8491266|NCT00550368|20924242|P1|STARTED|Overall Study||26
8491267|NCT00550290|20924252|P2|NOT COMPLETED|Overall Study||0
8491268|NCT00550290|20924253|P1|NOT COMPLETED|Overall Study||0
8491269|NCT00550290|20924252|P2|COMPLETED|Overall Study||8
8491270|NCT00550290|20924253|P1|COMPLETED|Overall Study||10
8491271|NCT00550290|20924252|P2|STARTED|Overall Study||8
8491272|NCT00550290|20924253|P1|STARTED|Overall Study||10
8491273|NCT00550277|20924259|P1|NOT COMPLETED|Overall Study||9
8491274|NCT00550277|20924259|P1|COMPLETED|Overall Study||11
8491275|NCT00550277|20924259|P1|STARTED|Overall Study||20
8491276|NCT00550238|20924263|P1|NOT COMPLETED|Overall Study||459
8491277|NCT00550238|20924263|P1|COMPLETED|Overall Study||0
8491278|NCT00550238|20924263|P1|STARTED|Overall Study||459
8491279|NCT00550173|20924270|P3|NOT COMPLETED|Overall Study||73
8491280|NCT00550173|20924271|P2|NOT COMPLETED|Overall Study||63
8491281|NCT00550173|20924272|P1|NOT COMPLETED|Overall Study||72
8491282|NCT00550173|20924270|P3|COMPLETED|Overall Study||11
8491283|NCT00550173|20924271|P2|COMPLETED|Overall Study||19
8491284|NCT00550173|20924272|P1|COMPLETED|Overall Study||9
8491285|NCT00550173|20924270|P3|Not Discontinued at 18 Months|Overall Study||11
8491286|NCT00550173|20924271|P2|Not Discontinued at 18 Months|Overall Study||19
8491287|NCT00550173|20924272|P1|Not Discontinued at 18 Months|Overall Study||9
8491288|NCT00550173|20924270|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
8491289|NCT00550173|20924271|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
8491290|NCT00550173|20924272|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
8491291|NCT00550173|20924270|P3|STARTED|Overall Study||84
8491292|NCT00550173|20924271|P2|STARTED|Overall Study||82
8491293|NCT00550173|20924272|P1|STARTED|Overall Study||81
8491294|NCT00550147|20924301|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
8491295|NCT00550147|20924301|P1|COMPLETED|Quetiapine Addition Treatment Period||18
8491296|NCT00550147|20924301|P1|STARTED|Quetiapine Addition Treatment Period||24
8491297|NCT00550147|20924301|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
8491298|NCT00550147|20924301|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
8491299|NCT00550147|20924301|P1|STARTED|OROS Methylphenidate Monotherapy||30
8491300|NCT00550043|20924324|P5|NOT COMPLETED|Overall Study||1
8491301|NCT00550043|20924325|P4|NOT COMPLETED|Overall Study||2
8491302|NCT00550043|20924326|P3|NOT COMPLETED|Overall Study||1
8491303|NCT00550043|20924327|P2|NOT COMPLETED|Overall Study||3
8491304|NCT00550043|20924328|P1|NOT COMPLETED|Overall Study||0
8491305|NCT00550043|20924324|P5|COMPLETED|Overall Study||9
8491306|NCT00550043|20924325|P4|COMPLETED|Overall Study||8
8491307|NCT00550043|20924326|P3|COMPLETED|Overall Study||8
8491308|NCT00550043|20924327|P2|COMPLETED|Overall Study||9
8491309|NCT00550043|20924328|P1|COMPLETED|Overall Study||9
8491310|NCT00550043|20924324|P5|STARTED|Overall Study||10
8491311|NCT00550043|20924325|P4|STARTED|Overall Study||10
8491312|NCT00550043|20924326|P3|STARTED|Overall Study||9
8492003|NCT00546273|20926297|P3|STARTED|IV||0
8491313|NCT00550043|20924327|P2|STARTED|Overall Study||12
8491314|NCT00550043|20924328|P1|STARTED|Overall Study||9
8491315|NCT00549939|20924383|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
8491316|NCT00549939|20924384|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
8491317|NCT00549939|20924385|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
8491318|NCT00549939|20924383|P3|COMPLETED|40-week Open Label Treatment Period||78
8491319|NCT00549939|20924384|P2|COMPLETED|40-week Open Label Treatment Period||75
8491320|NCT00549939|20924385|P1|COMPLETED|40-week Open Label Treatment Period||0
8491321|NCT00549939|20924383|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
8491322|NCT00549939|20924384|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
8491323|NCT00549939|20924385|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
8491324|NCT00549939|20924383|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
8491325|NCT00549939|20924384|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
8491326|NCT00549939|20924385|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
8491327|NCT00549939|20924383|P3|COMPLETED|12-week Double Blind Treatment Period||56
8491328|NCT00549939|20924384|P2|COMPLETED|12-week Double Blind Treatment Period||55
8491329|NCT00549939|20924385|P1|COMPLETED|12-week Double Blind Treatment Period||56
8491330|NCT00549939|20924383|P3|STARTED|12-week Double Blind Treatment Period||58
8491331|NCT00549939|20924384|P2|STARTED|12-week Double Blind Treatment Period||57
8491332|NCT00549939|20924385|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
8491333|NCT00549900|20924412|P1|NOT COMPLETED|Overall Study||1
8491334|NCT00549900|20924412|P1|COMPLETED|Overall Study||29
8491335|NCT00549900|20924412|P1|STARTED|Overall Study||30
8491336|NCT00549822|20924421|P1|NOT COMPLETED|Overall Study||0
8491337|NCT00549822|20924421|P1|COMPLETED|Overall Study||3
8491338|NCT00549822|20924421|P1|STARTED|Overall Study||3
8491339|NCT00549783|20924429|P2|NOT COMPLETED|Overall Study||13
8491340|NCT00549783|20924430|P1|NOT COMPLETED|Overall Study||8
8491341|NCT00549783|20924429|P2|COMPLETED|Overall Study||122
8491342|NCT00549783|20924430|P1|COMPLETED|Overall Study||131
8491343|NCT00549783|20924429|P2|STARTED|Overall Study||135
8491344|NCT00549783|20924430|P1|STARTED|Overall Study||139
8491345|NCT00549770|20924468|P8|NOT COMPLETED|Overall Study||25
8491346|NCT00549770|20924469|P7|NOT COMPLETED|Overall Study||14
8491347|NCT00549770|20924470|P6|NOT COMPLETED|Overall Study||13
8491348|NCT00549770|20924471|P5|NOT COMPLETED|Overall Study||17
8491349|NCT00549770|20924472|P4|NOT COMPLETED|Overall Study||16
8491350|NCT00549770|20924473|P3|NOT COMPLETED|Overall Study||10
8491351|NCT00549770|20924474|P2|NOT COMPLETED|Overall Study||11
8491352|NCT00549770|20924475|P1|NOT COMPLETED|Overall Study||7
8491353|NCT00549770|20924468|P8|COMPLETED|Overall Study||148
8491354|NCT00549770|20924469|P7|COMPLETED|Overall Study||151
8491355|NCT00549770|20924470|P6|COMPLETED|Overall Study||151
8491356|NCT00549770|20924471|P5|COMPLETED|Overall Study||149
8491357|NCT00549770|20924472|P4|COMPLETED|Overall Study||147
8491358|NCT00549770|20924473|P3|COMPLETED|Overall Study||162
8491359|NCT00549770|20924474|P2|COMPLETED|Overall Study||158
8491360|NCT00549770|20924475|P1|COMPLETED|Overall Study||149
8491361|NCT00549770|20924468|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
8491362|NCT00549770|20924469|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
8491363|NCT00549770|20924470|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
8491364|NCT00549770|20924471|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
8491365|NCT00549770|20924472|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
8491366|NCT00549770|20924473|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
8491367|NCT00549770|20924474|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
8491368|NCT00549770|20924475|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
8491369|NCT00549770|20924468|P8|Intent-to-treat Population|Overall Study||172
8491370|NCT00549770|20924469|P7|Intent-to-treat Population|Overall Study||164
8491371|NCT00549770|20924470|P6|Intent-to-treat Population|Overall Study||163
8491372|NCT00549770|20924471|P5|Intent-to-treat Population|Overall Study||163
8491373|NCT00549770|20924472|P4|Intent-to-treat Population|Overall Study||163
8491374|NCT00549770|20924473|P3|Intent-to-treat Population|Overall Study||170
8491375|NCT00549770|20924474|P2|Intent-to-treat Population|Overall Study||168
8491376|NCT00549770|20924475|P1|Intent-to-treat Population|Overall Study||154
8491377|NCT00549770|20924468|P8|STARTED|Overall Study||173
8491378|NCT00549770|20924469|P7|STARTED|Overall Study||165
8491379|NCT00549770|20924470|P6|STARTED|Overall Study||164
8491380|NCT00549770|20924471|P5|STARTED|Overall Study||166
8491381|NCT00549770|20924472|P4|STARTED|Overall Study||163
8491382|NCT00549770|20924473|P3|STARTED|Overall Study||172
8491383|NCT00549770|20924474|P2|STARTED|Overall Study||169
8491384|NCT00549770|20924475|P1|STARTED|Overall Study||156
8491385|NCT00549757|20924559|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
8491386|NCT00549757|20924560|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
8491387|NCT00549757|20924559|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
8491388|NCT00549757|20924560|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
8491389|NCT00549757|20924559|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
8491390|NCT00549757|20924560|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
8491391|NCT00549757|20924559|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
8491392|NCT00549757|20924560|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
8491393|NCT00549757|20924559|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
8491394|NCT00549757|20924560|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
8491395|NCT00549757|20924559|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
8491396|NCT00549757|20924560|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
8491397|NCT00549757|20924559|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
8491398|NCT00549757|20924560|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
8491399|NCT00549757|20924559|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
8491400|NCT00549757|20924560|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
8491401|NCT00549718|20924622|P4|NOT COMPLETED|Overall Study||55
8491402|NCT00549718|20924623|P3|NOT COMPLETED|Overall Study||39
8491403|NCT00549718|20924624|P2|NOT COMPLETED|Overall Study||37
8491404|NCT00549718|20924625|P1|NOT COMPLETED|Overall Study||41
8491405|NCT00549718|20924622|P4|COMPLETED|Overall Study||73
8491406|NCT00549718|20924623|P3|COMPLETED|Overall Study||85
8491407|NCT00549718|20924624|P2|COMPLETED|Overall Study||86
8491408|NCT00549718|20924625|P1|COMPLETED|Overall Study||84
8491409|NCT00549718|20924622|P4|STARTED|Overall Study||128
8491410|NCT00549718|20924623|P3|STARTED|Overall Study||124
8491411|NCT00549718|20924624|P2|STARTED|Overall Study||123
8491412|NCT00549718|20924625|P1|STARTED|Overall Study||125
8491413|NCT00549640|20924641|P2|NOT COMPLETED|Overall Study||16
8491414|NCT00549640|20924642|P1|NOT COMPLETED|Overall Study||18
8491415|NCT00549640|20924641|P2|COMPLETED|Overall Study||24
8491416|NCT00549640|20924642|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
8491417|NCT00549640|20924641|P2|STARTED|Overall Study||40
8491418|NCT00549640|20924642|P1|STARTED|Overall Study||40
8491419|NCT00549601|20924655|P3|NOT COMPLETED|Received Study Drug||4
8491420|NCT00549601|20924656|P2|NOT COMPLETED|Received Study Drug||11
8491421|NCT00549601|20924657|P1|NOT COMPLETED|Received Study Drug||7
8491422|NCT00549601|20924655|P3|COMPLETED|Received Study Drug||45
8491423|NCT00549601|20924656|P2|COMPLETED|Received Study Drug||36
8491424|NCT00549601|20924657|P1|COMPLETED|Received Study Drug||36
8491425|NCT00549601|20924655|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
8491426|NCT00549601|20924656|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
8491427|NCT00549601|20924657|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
8491428|NCT00549601|20924655|P3|NOT COMPLETED|Randomized||2
8491429|NCT00549601|20924656|P2|NOT COMPLETED|Randomized||1
8491430|NCT00549601|20924657|P1|NOT COMPLETED|Randomized||0
8491431|NCT00549601|20924655|P3|COMPLETED|Randomized||49
8491432|NCT00549601|20924656|P2|COMPLETED|Randomized||47
8491433|NCT00549601|20924657|P1|COMPLETED|Randomized||43
8491434|NCT00549601|20924655|P3|STARTED|Randomized||51
8491435|NCT00549601|20924656|P2|STARTED|Randomized||48
8491436|NCT00549601|20924657|P1|STARTED|Randomized||43
8491437|NCT00549562|20924679|P1|NOT COMPLETED|Overall Study||2
8491438|NCT00549562|20924679|P1|COMPLETED|Overall Study||23
8491439|NCT00549562|20924679|P1|STARTED|Overall Study||25
8491456|NCT00549445|20924762|P2|NOT COMPLETED|Overall Study||17
8491457|NCT00549445|20924763|P1|NOT COMPLETED|Overall Study||15
8491458|NCT00549445|20924762|P2|COMPLETED|Overall Study||13
8491459|NCT00549445|20924763|P1|COMPLETED|Overall Study||8
8491460|NCT00549445|20924762|P2|STARTED|Overall Study||30
8491461|NCT00549445|20924763|P1|STARTED|Overall Study||23
8491462|NCT00549393|20924771|P2|NOT COMPLETED|Period 3 (6 Months)||0
8491463|NCT00549393|20924772|P1|NOT COMPLETED|Period 3 (6 Months)||0
8491464|NCT00549393|20924771|P2|COMPLETED|Period 3 (6 Months)||1326
8491465|NCT00549393|20924772|P1|COMPLETED|Period 3 (6 Months)||1103
8491466|NCT00549393|20924771|P2|Per Protocol|Period 3 (6 Months)||1326
8491467|NCT00549393|20924772|P1|Per Protocol|Period 3 (6 Months)||667
8491468|NCT00549393|20924771|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
8491469|NCT00549393|20924772|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
8491470|NCT00549393|20924771|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
8491471|NCT00549393|20924772|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
8491472|NCT00549393|20924771|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
8491473|NCT00549393|20924772|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
8491474|NCT00549393|20924771|P2|STARTED|Period 2 Washout (2 Weeks)||0
8491475|NCT00549393|20924772|P1|STARTED|Period 2 Washout (2 Weeks)||0
8491476|NCT00549393|20924771|P2|NOT COMPLETED|Period 1 (6 Months)||0
8492004|NCT00546273|20926298|P2|STARTED|IV||0
8491477|NCT00549393|20924772|P1|NOT COMPLETED|Period 1 (6 Months)||0
8491478|NCT00549393|20924771|P2|COMPLETED|Period 1 (6 Months)||1199
8491479|NCT00549393|20924772|P1|COMPLETED|Period 1 (6 Months)||1319
8491480|NCT00549393|20924771|P2|Per Protocol|Period 1 (6 Months)||1199
8491481|NCT00549393|20924772|P1|Per Protocol|Period 1 (6 Months)||880
8491482|NCT00549393|20924771|P2|STARTED|Period 1 (6 Months)|ITT|1199
8491483|NCT00549393|20924772|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
8491484|NCT00549328|20924782|P1|NOT COMPLETED|Overall Study||14
8491485|NCT00549328|20924782|P1|COMPLETED|Overall Study||0
8491486|NCT00549328|20924782|P1|STARTED|Overall Study||14
8491487|NCT00549302|20924793|P3|NOT COMPLETED|Open-Label||69
8491488|NCT00549302|20924794|P2|NOT COMPLETED|Open-Label||0
8491489|NCT00549302|20924795|P1|NOT COMPLETED|Open-Label||0
8491490|NCT00549302|20924793|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
8491491|NCT00549302|20924794|P2|COMPLETED|Open-Label||0
8491492|NCT00549302|20924795|P1|COMPLETED|Open-Label||0
8491493|NCT00549302|20924793|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
8491494|NCT00549302|20924794|P2|STARTED|Open-Label||0
8491495|NCT00549302|20924795|P1|STARTED|Open-Label||0
8491496|NCT00549302|20924793|P3|NOT COMPLETED|Double-Blind||0
8491497|NCT00549302|20924794|P2|NOT COMPLETED|Double-Blind||53
8491498|NCT00549302|20924795|P1|NOT COMPLETED|Double-Blind||11
8491499|NCT00549302|20924793|P3|COMPLETED|Double-Blind||0
8491500|NCT00549302|20924794|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
8491501|NCT00549302|20924795|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
8491502|NCT00549302|20924793|P3|Received at Least One Dose of Study Drug|Double-Blind||0
8491503|NCT00549302|20924794|P2|Received at Least One Dose of Study Drug|Double-Blind||294
8491504|NCT00549302|20924795|P1|Received at Least One Dose of Study Drug|Double-Blind||63
8491505|NCT00549302|20924793|P3|STARTED|Double-Blind||0
8491506|NCT00549302|20924794|P2|STARTED|Double-Blind||294
8491507|NCT00549302|20924795|P1|STARTED|Double-Blind||63
8491508|NCT00549198|20924807|P2|NOT COMPLETED|Overall Study||63
8491509|NCT00549198|20924808|P1|NOT COMPLETED|Overall Study||80
8491510|NCT00549198|20924807|P2|COMPLETED|Overall Study||134
8491511|NCT00549198|20924808|P1|COMPLETED|Overall Study||115
8491512|NCT00549198|20924807|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
8491513|NCT00549198|20924808|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
8491514|NCT00549172|20924930|P2|NOT COMPLETED|Overall Study||0
8491515|NCT00549172|20924931|P1|NOT COMPLETED|Overall Study||0
8491516|NCT00549172|20924930|P2|COMPLETED|Overall Study||76
8491517|NCT00549172|20924931|P1|COMPLETED|Overall Study||70
8491518|NCT00549172|20924930|P2|STARTED|Overall Study||76
8491519|NCT00549172|20924931|P1|STARTED|Overall Study||70
8491520|NCT00549055|20924945|P1|NOT COMPLETED|Overall Study||35
8491521|NCT00549055|20924945|P1|COMPLETED|Overall Study||3
8491522|NCT00549055|20924945|P1|STARTED|Overall Study||38
8491523|NCT00549042|20924957|P2|NOT COMPLETED|Double-blind Phase||90
8491524|NCT00549042|20924958|P1|NOT COMPLETED|Double-blind Phase||68
8491525|NCT00549042|20924957|P2|COMPLETED|Double-blind Phase||44
8491526|NCT00549042|20924958|P1|COMPLETED|Double-blind Phase||66
8491527|NCT00549042|20924957|P2|STARTED|Double-blind Phase||134
8491528|NCT00549042|20924958|P1|STARTED|Double-blind Phase||134
8491529|NCT00549042|20924957|P2|NOT COMPLETED|Conversion and Titration Phase||0
8491530|NCT00549042|20924958|P1|NOT COMPLETED|Conversion and Titration Phase||191
8491531|NCT00549042|20924957|P2|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8491532|NCT00549042|20924958|P1|COMPLETED|Conversion and Titration Phase||268
8491533|NCT00549042|20924957|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8491534|NCT00549042|20924958|P1|STARTED|Conversion and Titration Phase||459
8491535|NCT00548886|20924975|P1|NOT COMPLETED|Overall Study||0
8491536|NCT00548886|20924975|P1|COMPLETED|Overall Study||7
8491537|NCT00548886|20924975|P1|STARTED|Overall Study||7
8491538|NCT00548860|20924982|P2|NOT COMPLETED|Overall Study||175
8491539|NCT00548860|20924983|P1|NOT COMPLETED|Overall Study||136
8491540|NCT00548860|20924982|P2|COMPLETED|Overall Study||847
8491541|NCT00548860|20924983|P1|COMPLETED|Overall Study||860
8491542|NCT00548860|20924982|P2|STARTED|Overall Study||1022
8491543|NCT00548860|20924983|P1|STARTED|Overall Study||996
8491544|NCT00548847|20924989|P1|NOT COMPLETED|Overall Study||7
8491545|NCT00548847|20924989|P1|COMPLETED|Overall Study||8
8491546|NCT00548847|20924989|P1|STARTED|Overall Study||15
8491547|NCT00548808|20924996|P2|NOT COMPLETED|Overall Study||26
8491548|NCT00548808|20924997|P1|NOT COMPLETED|Overall Study||42
8491549|NCT00548808|20924996|P2|COMPLETED|Overall Study||186
8491550|NCT00548808|20924997|P1|COMPLETED|Overall Study||172
8491551|NCT00548808|20924996|P2|Per-Protocol Set|Overall Study||184
8491552|NCT00548808|20924997|P1|Per-Protocol Set|Overall Study||177
8491553|NCT00548808|20924996|P2|Full Analysis Set|Overall Study||212
8491554|NCT00548808|20924997|P1|Full Analysis Set|Overall Study||211
8491555|NCT00548808|20924996|P2|STARTED|Overall Study||212
8491556|NCT00548808|20924997|P1|STARTED|Overall Study||214
8491557|NCT00548717|20925021|P2|NOT COMPLETED|Overall Study||2
8491558|NCT00548717|20925022|P1|NOT COMPLETED|Overall Study||9
8491559|NCT00548717|20925021|P2|COMPLETED|Overall Study||0
8491560|NCT00548717|20925022|P1|COMPLETED|Overall Study||4
8491561|NCT00548717|20925021|P2|STARTED|Overall Study||2
8491562|NCT00548717|20925022|P1|STARTED|Overall Study||13
8491563|NCT00548691|20925041|P2|NOT COMPLETED|Overall Study||9
8491564|NCT00548691|20925042|P1|NOT COMPLETED|Overall Study||7
8491565|NCT00548691|20925041|P2|COMPLETED|Overall Study||250
8491566|NCT00548691|20925042|P1|COMPLETED|Overall Study||251
8491567|NCT00548691|20925041|P2|STARTED|Overall Study||259
8491568|NCT00548691|20925042|P1|STARTED|Overall Study||258
8491569|NCT00548652|20925051|P3|NOT COMPLETED|Overall Study||11
8491570|NCT00548652|20925052|P2|NOT COMPLETED|Overall Study||9
8491571|NCT00548652|20925053|P1|NOT COMPLETED|Overall Study||2
8491572|NCT00548652|20925051|P3|COMPLETED|Overall Study||34
8491573|NCT00548652|20925052|P2|COMPLETED|Overall Study||29
8491574|NCT00548652|20925053|P1|COMPLETED|Overall Study||16
8491575|NCT00548652|20925051|P3|STARTED|Overall Study||45
8491576|NCT00548652|20925052|P2|STARTED|Overall Study||38
8491577|NCT00548652|20925053|P1|STARTED|Overall Study||18
8491578|NCT00548548|20925066|P2|NOT COMPLETED|Overall Study||366
8491579|NCT00548548|20925067|P1|NOT COMPLETED|Overall Study||362
8491580|NCT00548548|20925066|P2|COMPLETED|Overall Study||21
8491581|NCT00548548|20925067|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
8491582|NCT00548548|20925066|P2|Safety Population|Overall Study||381
8491583|NCT00548548|20925067|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
8491584|NCT00548548|20925066|P2|Treated|Overall Study||384
8491585|NCT00548548|20925067|P1|Treated|Overall Study||383
8491586|NCT00548548|20925066|P2|STARTED|Overall Study||387
8491587|NCT00548548|20925067|P1|STARTED|Overall Study||387
8491588|NCT00548470|20925087|P1|NOT COMPLETED|Overall Study||2
8491589|NCT00548470|20925087|P1|COMPLETED|Overall Study||12
8491590|NCT00548470|20925087|P1|STARTED|Overall Study||14
8491591|NCT00548431|20925095|P1|NOT COMPLETED|Overall Study||0
8491592|NCT00548431|20925095|P1|COMPLETED|Overall Study||38
8491593|NCT00548431|20925095|P1|STARTED|Overall Study||38
8491594|NCT00548418|20925099|P1|NOT COMPLETED|Overall Study||0
8491595|NCT00548418|20925099|P1|COMPLETED|Overall Study||27
8491596|NCT00548418|20925099|P1|STARTED|Overall Study||27
8491597|NCT00548405|20925110|P3|NOT COMPLETED|Overall Study||9
8491598|NCT00548405|20925111|P2|NOT COMPLETED|Overall Study||20
8491599|NCT00548405|20925112|P1|NOT COMPLETED|Overall Study||56
8491600|NCT00548405|20925110|P3|COMPLETED|Overall Study||164
8491601|NCT00548405|20925111|P2|COMPLETED|Overall Study||416
8491602|NCT00548405|20925112|P1|COMPLETED|Overall Study||175
8491603|NCT00548405|20925110|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
8491604|NCT00548405|20925111|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
8491605|NCT00548405|20925112|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
8491606|NCT00548405|20925110|P3|STARTED|Overall Study|Randomized.|173
8491607|NCT00548405|20925111|P2|STARTED|Overall Study|Randomized.|436
8491608|NCT00548405|20925112|P1|STARTED|Overall Study|Randomized.|231
8491609|NCT00548340|20925133|P3|NOT COMPLETED|Overall Study||9
8491610|NCT00548340|20925134|P2|NOT COMPLETED|Overall Study||11
8491611|NCT00548340|20925135|P1|NOT COMPLETED|Overall Study||8
8491612|NCT00548340|20925133|P3|COMPLETED|Overall Study||95
8491613|NCT00548340|20925134|P2|COMPLETED|Overall Study||98
8491614|NCT00548340|20925135|P1|COMPLETED|Overall Study||101
8491615|NCT00548340|20925133|P3|STARTED|Overall Study||104
8491616|NCT00548340|20925134|P2|STARTED|Overall Study||109
8491617|NCT00548340|20925135|P1|STARTED|Overall Study||109
8491618|NCT00548327|20925154|P2|NOT COMPLETED|Overall Study||1
8491619|NCT00548327|20925155|P1|NOT COMPLETED|Overall Study||0
8491620|NCT00548327|20925154|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
8491621|NCT00548327|20925155|P1|COMPLETED|Overall Study||6
8491622|NCT00548327|20925154|P2|STARTED|Overall Study||5
8491623|NCT00548327|20925155|P1|STARTED|Overall Study||6
8491624|NCT00548262|20925173|P1|NOT COMPLETED|Overall Study||32
8491625|NCT00548262|20925173|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
8491626|NCT00548262|20925173|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
8491627|NCT00548249|20925203|P5|NOT COMPLETED|Overall Study||21
8491628|NCT00548249|20925204|P4|NOT COMPLETED|Overall Study||13
8491629|NCT00548249|20925205|P3|NOT COMPLETED|Overall Study||20
8491630|NCT00548249|20925206|P2|NOT COMPLETED|Overall Study||13
8491631|NCT00548249|20925207|P1|NOT COMPLETED|Overall Study||16
8491632|NCT00548249|20925203|P5|COMPLETED|Overall Study||7
8491633|NCT00548249|20925204|P4|COMPLETED|Overall Study||9
8491634|NCT00548249|20925205|P3|COMPLETED|Overall Study||9
8491635|NCT00548249|20925206|P2|COMPLETED|Overall Study||13
8491636|NCT00548249|20925207|P1|COMPLETED|Overall Study||10
8491637|NCT00548249|20925203|P5|STARTED|Overall Study||28
8491638|NCT00548249|20925204|P4|STARTED|Overall Study||22
8491639|NCT00548249|20925205|P3|STARTED|Overall Study||29
8491640|NCT00548249|20925206|P2|STARTED|Overall Study||26
8491641|NCT00548249|20925207|P1|STARTED|Overall Study||26
8491642|NCT00548197|20925246|P2|NOT COMPLETED|Overall Study||0
8491643|NCT00548197|20925247|P1|NOT COMPLETED|Overall Study||0
8491644|NCT00548197|20925246|P2|COMPLETED|Overall Study||22
8491645|NCT00548197|20925247|P1|COMPLETED|Overall Study||18
8491646|NCT00548197|20925246|P2|STARTED|Overall Study||22
8491647|NCT00548197|20925247|P1|STARTED|Overall Study||18
8491648|NCT00548184|20925255|P1|NOT COMPLETED|Overall Study||5
8492005|NCT00546273|20926299|P1|STARTED|IV||0
8491649|NCT00548184|20925255|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
8491650|NCT00548184|20925255|P1|STARTED|Overall Study||65
8491651|NCT00548171|20925261|P2|NOT COMPLETED|Overall Study||0
8491652|NCT00548171|20925262|P1|NOT COMPLETED|Overall Study||0
8491653|NCT00548171|20925261|P2|COMPLETED|Overall Study||39
8491654|NCT00548171|20925262|P1|COMPLETED|Overall Study||164
8491655|NCT00548171|20925261|P2|STARTED|Overall Study||39
8491656|NCT00548171|20925262|P1|STARTED|Overall Study||164
8491657|NCT00548145|20925303|P2|NOT COMPLETED|Overall Study||4
8491658|NCT00548145|20925304|P1|NOT COMPLETED|Overall Study||1
8491659|NCT00548145|20925303|P2|COMPLETED|Overall Study||16
8491660|NCT00548145|20925304|P1|COMPLETED|Overall Study||17
8491661|NCT00548145|20925303|P2|STARTED|Overall Study||20
8491662|NCT00548145|20925304|P1|STARTED|Overall Study||18
8491663|NCT00548132|20925312|P2|NOT COMPLETED|Overall Study||0
8491664|NCT00548132|20925313|P1|NOT COMPLETED|Overall Study||0
8491665|NCT00548132|20925312|P2|COMPLETED|Overall Study||554
8491666|NCT00548132|20925313|P1|COMPLETED|Overall Study||534
8491667|NCT00548132|20925312|P2|Consented to Study|Overall Study||554
8491668|NCT00548132|20925313|P1|Consented to Study|Overall Study||534
8491669|NCT00548132|20925312|P2|STARTED|Overall Study||554
8491670|NCT00548132|20925313|P1|STARTED|Overall Study||534
8491671|NCT00548093|20925323|P2|NOT COMPLETED|Overall Study||16
8491672|NCT00548093|20925324|P1|NOT COMPLETED|Overall Study||50
8491673|NCT00548093|20925323|P2|COMPLETED|Overall Study||0
8491674|NCT00548093|20925324|P1|COMPLETED|Overall Study||0
8491675|NCT00548093|20925323|P2|STARTED|Overall Study||16
8491676|NCT00548093|20925324|P1|STARTED|Overall Study||50
8491677|NCT00548041|20925354|P1|NOT COMPLETED|Overall Study||0
8491678|NCT00548041|20925354|P1|COMPLETED|Overall Study||100
8491679|NCT00548041|20925354|P1|STARTED|Overall Study||100
8491680|NCT00547911|20925362|P6|NOT COMPLETED|Overall Study||0
8491681|NCT00547911|20925363|P5|NOT COMPLETED|Overall Study||0
8491682|NCT00547911|20925364|P4|NOT COMPLETED|Overall Study||1
8491683|NCT00547911|20925365|P3|NOT COMPLETED|Overall Study||0
8491684|NCT00547911|20925366|P2|NOT COMPLETED|Overall Study||0
8491685|NCT00547911|20925367|P1|NOT COMPLETED|Overall Study||0
8491686|NCT00547911|20925362|P6|COMPLETED|Overall Study||3
8491687|NCT00547911|20925363|P5|COMPLETED|Overall Study||3
8491688|NCT00547911|20925364|P4|COMPLETED|Overall Study||1
8491689|NCT00547911|20925365|P3|COMPLETED|Overall Study||2
8491690|NCT00547911|20925366|P2|COMPLETED|Overall Study||2
8491691|NCT00547911|20925367|P1|COMPLETED|Overall Study||2
8491692|NCT00547911|20925362|P6|STARTED|Overall Study||3
8491693|NCT00547911|20925363|P5|STARTED|Overall Study||3
8491694|NCT00547911|20925364|P4|STARTED|Overall Study||2
8491695|NCT00547911|20925365|P3|STARTED|Overall Study||2
8491696|NCT00547911|20925366|P2|STARTED|Overall Study||2
8491697|NCT00547911|20925367|P1|STARTED|Overall Study||2
8491698|NCT00547898|20925400|P4|NOT COMPLETED|Overall Study||6
8491699|NCT00547898|20925401|P3|NOT COMPLETED|Overall Study||0
8491700|NCT00547898|20925402|P2|NOT COMPLETED|Overall Study||10
8491701|NCT00547898|20925403|P1|NOT COMPLETED|Overall Study||9
8491702|NCT00547898|20925400|P4|COMPLETED|Overall Study||40
8491703|NCT00547898|20925401|P3|COMPLETED|Overall Study||54
8491704|NCT00547898|20925402|P2|COMPLETED|Overall Study||126
8491705|NCT00547898|20925403|P1|COMPLETED|Overall Study||129
8491706|NCT00547898|20925400|P4|STARTED|Overall Study||46
8491707|NCT00547898|20925401|P3|STARTED|Overall Study||54
8491708|NCT00547898|20925402|P2|STARTED|Overall Study||136
8491709|NCT00547898|20925403|P1|STARTED|Overall Study||138
8491710|NCT00547703|20925417|P2|NOT COMPLETED|Overall Study||0
8491711|NCT00547703|20925418|P1|NOT COMPLETED|Overall Study||1
8491712|NCT00547703|20925417|P2|COMPLETED|Overall Study||1
8491713|NCT00547703|20925418|P1|COMPLETED|Overall Study||3
8491714|NCT00547703|20925417|P2|STARTED|Overall Study||1
8491715|NCT00547703|20925418|P1|STARTED|Overall Study||4
8491716|NCT00547638|20925426|P2|NOT COMPLETED|Overall Study||14
8491717|NCT00547638|20925427|P1|NOT COMPLETED|Overall Study||24
8491718|NCT00547638|20925426|P2|COMPLETED|Overall Study||59
8491719|NCT00547638|20925427|P1|COMPLETED|Overall Study||119
8491720|NCT00547638|20925426|P2|STARTED|Overall Study||73
8491721|NCT00547638|20925427|P1|STARTED|Overall Study||143
8491722|NCT00547586|20925448|P5|NOT COMPLETED|Overall Study||3
8491723|NCT00547586|20925449|P4|NOT COMPLETED|Overall Study||6
8491724|NCT00547586|20925450|P3|NOT COMPLETED|Overall Study||1
8491725|NCT00547586|20925451|P2|NOT COMPLETED|Overall Study||1
8491726|NCT00547586|20925452|P1|NOT COMPLETED|Overall Study||5
8491727|NCT00547586|20925448|P5|COMPLETED|Overall Study||32
8491728|NCT00547586|20925449|P4|COMPLETED|Overall Study||27
8491729|NCT00547586|20925450|P3|COMPLETED|Overall Study||13
8491730|NCT00547586|20925451|P2|COMPLETED|Overall Study||6
8491731|NCT00547586|20925452|P1|COMPLETED|Overall Study||28
8491732|NCT00547586|20925448|P5|STARTED|Overall Study||35
8491733|NCT00547586|20925449|P4|STARTED|Overall Study||33
8491734|NCT00547586|20925450|P3|STARTED|Overall Study||14
8491735|NCT00547586|20925451|P2|STARTED|Overall Study||7
8491736|NCT00547586|20925452|P1|STARTED|Overall Study||33
8491737|NCT00547534|20925464|P1|NOT COMPLETED|Overall Study||11
8491738|NCT00547534|20925464|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
8491739|NCT00547534|20925464|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
8491740|NCT00547521|20925472|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
8491741|NCT00547521|20925473|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
8491742|NCT00547521|20925472|P2|COMPLETED|Long Term Extension (LTE) Study||59
8491743|NCT00547521|20925473|P1|COMPLETED|Long Term Extension (LTE) Study||0
8491744|NCT00547521|20925472|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
8491745|NCT00547521|20925473|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
8491746|NCT00547521|20925472|P2|NOT COMPLETED|Short Term Study (4 Months)||4
8491747|NCT00547521|20925473|P1|NOT COMPLETED|Short Term Study (4 Months)||1
8491748|NCT00547521|20925472|P2|COMPLETED|Short Term Study (4 Months)||45
8491749|NCT00547521|20925473|P1|COMPLETED|Short Term Study (4 Months)||50
8491750|NCT00547521|20925472|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
8491751|NCT00547521|20925473|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
8491752|NCT00547456|20925543|P1|NOT COMPLETED|Overall Study||0
8491753|NCT00547456|20925543|P1|COMPLETED|Overall Study||20
8491754|NCT00547456|20925543|P1|STARTED|Overall Study||20
8491755|NCT00547378|20925550|P3|NOT COMPLETED|All Implanted Cohort||70
8491756|NCT00547378|20925551|P2|NOT COMPLETED|All Implanted Cohort||18
8491757|NCT00547378|20925552|P1|NOT COMPLETED|All Implanted Cohort||15
8491758|NCT00547378|20925550|P3|COMPLETED|All Implanted Cohort||111
8491759|NCT00547378|20925551|P2|COMPLETED|All Implanted Cohort||22
8491760|NCT00547378|20925552|P1|COMPLETED|All Implanted Cohort||36
8491761|NCT00547378|20925550|P3|Month 60|All Implanted Cohort||114
8491762|NCT00547378|20925551|P2|Month 60|All Implanted Cohort||23
8491763|NCT00547378|20925552|P1|Month 60|All Implanted Cohort||36
8491764|NCT00547378|20925550|P3|Month 48|All Implanted Cohort||136
8491765|NCT00547378|20925551|P2|Month 48|All Implanted Cohort||27
8491766|NCT00547378|20925552|P1|Month 48|All Implanted Cohort||38
8491767|NCT00547378|20925550|P3|Month 36|All Implanted Cohort||146
8491768|NCT00547378|20925551|P2|Month 36|All Implanted Cohort||29
8491769|NCT00547378|20925552|P1|Month 36|All Implanted Cohort||42
8491770|NCT00547378|20925550|P3|Month 24|All Implanted Cohort||161
8491771|NCT00547378|20925551|P2|Month 24|All Implanted Cohort||30
8491772|NCT00547378|20925552|P1|Month 24|All Implanted Cohort||42
8491773|NCT00547378|20925550|P3|Month 12|All Implanted Cohort||175
8491774|NCT00547378|20925551|P2|Month 12|All Implanted Cohort||32
8491775|NCT00547378|20925552|P1|Month 12|All Implanted Cohort||48
8491776|NCT00547378|20925550|P3|Month 6|All Implanted Cohort||178
8491777|NCT00547378|20925551|P2|Month 6|All Implanted Cohort||36
8491778|NCT00547378|20925552|P1|Month 6|All Implanted Cohort||50
8491779|NCT00547378|20925550|P3|Month 3|All Implanted Cohort||178
8491780|NCT00547378|20925551|P2|Month 3|All Implanted Cohort||39
8491781|NCT00547378|20925552|P1|Month 3|All Implanted Cohort||51
8491782|NCT00547378|20925550|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
8491783|NCT00547378|20925551|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
8491784|NCT00547378|20925552|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
8491785|NCT00547378|20925550|P3|NOT COMPLETED|Randomized Cohort||0
8491786|NCT00547378|20925551|P2|NOT COMPLETED|Randomized Cohort||6
8491787|NCT00547378|20925552|P1|NOT COMPLETED|Randomized Cohort||11
8491788|NCT00547378|20925550|P3|COMPLETED|Randomized Cohort||0
8491789|NCT00547378|20925551|P2|COMPLETED|Randomized Cohort||71
8491790|NCT00547378|20925552|P1|COMPLETED|Randomized Cohort||59
8491791|NCT00547378|20925550|P3|Month 6|Randomized Cohort||0
8491792|NCT00547378|20925551|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
8491793|NCT00547378|20925552|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
8491794|NCT00547378|20925550|P3|Month 3|Randomized Cohort||0
8491795|NCT00547378|20925551|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
8491796|NCT00547378|20925552|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
8491797|NCT00547378|20925550|P3|STARTED|Randomized Cohort||0
8491798|NCT00547378|20925551|P2|STARTED|Randomized Cohort||77
8491799|NCT00547378|20925552|P1|STARTED|Randomized Cohort||70
8491800|NCT00547365|20925562|P1|NOT COMPLETED|Overall Study||8
8491801|NCT00547365|20925562|P1|COMPLETED|Overall Study||2
8491802|NCT00547365|20925562|P1|STARTED|Overall Study||10
8491803|NCT00547300|20925569|P2|NOT COMPLETED|Overall Study||26
8491804|NCT00547300|20925570|P1|NOT COMPLETED|Overall Study||25
8491805|NCT00547300|20925569|P2|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
8491806|NCT00547300|20925570|P1|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
8491807|NCT00547300|20925569|P2|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
8491808|NCT00547300|20925570|P1|STARTED|Overall Study||25
8491809|NCT00547248|20925584|P4|NOT COMPLETED|Overall Study||2
8491810|NCT00547248|20925585|P3|NOT COMPLETED|Overall Study||10
8491811|NCT00547248|20925586|P2|NOT COMPLETED|Overall Study||0
8491812|NCT00547248|20925587|P1|NOT COMPLETED|Overall Study||0
8491813|NCT00547248|20925584|P4|COMPLETED|Overall Study||96
8491814|NCT00547248|20925585|P3|COMPLETED|Overall Study||275
8491815|NCT00547248|20925586|P2|COMPLETED|Overall Study||93
8491816|NCT00547248|20925587|P1|COMPLETED|Overall Study||280
8491817|NCT00547248|20925584|P4|STARTED|Overall Study||98
8491818|NCT00547248|20925585|P3|STARTED|Overall Study||285
8491819|NCT00547248|20925586|P2|STARTED|Overall Study||93
8491820|NCT00547248|20925587|P1|STARTED|Overall Study||280
8491821|NCT00547157|20925705|P2|NOT COMPLETED|Overall Study||23
8491822|NCT00547157|20925706|P1|NOT COMPLETED|Overall Study||49
8491823|NCT00547157|20925705|P2|COMPLETED|Overall Study||39
8491824|NCT00547157|20925706|P1|COMPLETED|Overall Study||41
8491825|NCT00547157|20925705|P2|STARTED|Overall Study||62
8491826|NCT00547157|20925706|P1|STARTED|Overall Study||90
8491827|NCT00547118|20925724|P2|NOT COMPLETED|Overall Study||9
8491828|NCT00547118|20925725|P1|NOT COMPLETED|Overall Study||8
8491829|NCT00547118|20925724|P2|COMPLETED|Overall Study||0
8491830|NCT00547118|20925725|P1|COMPLETED|Overall Study||0
8491831|NCT00547118|20925724|P2|STARTED|Overall Study||9
8491832|NCT00547118|20925725|P1|STARTED|Overall Study||8
8491833|NCT00547105|20925757|P1|NOT COMPLETED|Overall Study||0
8491834|NCT00547105|20925757|P1|COMPLETED|Overall Study||24
8491835|NCT00547105|20925757|P1|STARTED|Overall Study||24
8491836|NCT00546910|20925769|P2|NOT COMPLETED|Overall Study||11
8491837|NCT00546910|20925770|P1|NOT COMPLETED|Overall Study||9
8491838|NCT00546910|20925769|P2|COMPLETED|Overall Study||51
8491839|NCT00546910|20925770|P1|COMPLETED|Overall Study||54
8491840|NCT00546910|20925769|P2|STARTED|Overall Study||62
8491841|NCT00546910|20925770|P1|STARTED|Overall Study||63
8491842|NCT00546897|20925790|P2|NOT COMPLETED|Overall Study||0
8491843|NCT00546897|20925791|P1|NOT COMPLETED|Overall Study||0
8491844|NCT00546897|20925790|P2|COMPLETED|Overall Study||33
8491845|NCT00546897|20925791|P1|COMPLETED|Overall Study||15
8491846|NCT00546897|20925790|P2|STARTED|Overall Study||33
8491847|NCT00546897|20925791|P1|STARTED|Overall Study||15
8491848|NCT00546884|20925829|P2|NOT COMPLETED|Overall Study||0
8491849|NCT00546884|20925830|P1|NOT COMPLETED|Overall Study||0
8491850|NCT00546884|20925829|P2|COMPLETED|Overall Study||117
8491851|NCT00546884|20925830|P1|COMPLETED|Overall Study||145
8491852|NCT00546884|20925829|P2|STARTED|Overall Study||117
8491853|NCT00546884|20925830|P1|STARTED|Overall Study||145
8491854|NCT00546871|20925836|P2|NOT COMPLETED|Study Extension Period||1
8491855|NCT00546871|20925837|P1|NOT COMPLETED|Study Extension Period||1
8491856|NCT00546871|20925836|P2|COMPLETED|Study Extension Period||25
8491857|NCT00546871|20925837|P1|COMPLETED|Study Extension Period||9
8491858|NCT00546871|20925836|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
8491859|NCT00546871|20925837|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
8491860|NCT00546871|20925836|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
8491861|NCT00546871|20925837|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
8491862|NCT00546871|20925836|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
8491863|NCT00546871|20925837|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
8491864|NCT00546871|20925836|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
8491865|NCT00546871|20925837|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
8491866|NCT00546871|20925836|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
8491867|NCT00546871|20925837|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
8491868|NCT00546871|20925836|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
8491869|NCT00546871|20925837|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
8491870|NCT00546871|20925836|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
8491871|NCT00546871|20925837|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
8491872|NCT00546871|20925836|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
8491873|NCT00546871|20925837|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
8491874|NCT00546871|20925836|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
8491875|NCT00546871|20925837|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
8491876|NCT00546871|20925836|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
8491877|NCT00546871|20925837|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
8491878|NCT00546871|20925836|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
8491879|NCT00546871|20925837|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
8491880|NCT00546871|20925836|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
8491881|NCT00546871|20925837|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
8491882|NCT00546871|20925836|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
8491883|NCT00546871|20925837|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
8491884|NCT00546819|20925942|P2|NOT COMPLETED|Overall Study||6
8491885|NCT00546819|20925943|P1|NOT COMPLETED|Overall Study||8
8491886|NCT00546819|20925942|P2|COMPLETED|Overall Study||96
8491887|NCT00546819|20925943|P1|COMPLETED|Overall Study||199
8491888|NCT00546819|20925942|P2|VACCINATED|Overall Study||100
8491889|NCT00546819|20925943|P1|VACCINATED|Overall Study||206
8491890|NCT00546819|20925942|P2|STARTED|Overall Study||102
8491891|NCT00546819|20925943|P1|STARTED|Overall Study||207
8491892|NCT00546754|20925955|P2|NOT COMPLETED|Overall Study||49
8491893|NCT00546754|20925956|P1|NOT COMPLETED|Overall Study||50
8491894|NCT00546754|20925955|P2|COMPLETED|Overall Study||334
8491895|NCT00546754|20925956|P1|COMPLETED|Overall Study||375
8491896|NCT00546754|20925955|P2|Week 12|Overall Study||334
8491897|NCT00546754|20925956|P1|Week 12|Overall Study||375
8491898|NCT00546754|20925955|P2|Week 6|Overall Study||347
8491899|NCT00546754|20925956|P1|Week 6|Overall Study||396
8491900|NCT00546754|20925955|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
8491901|NCT00546754|20925956|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
8491902|NCT00546754|20925955|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
8491903|NCT00546754|20925956|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
8491904|NCT00546728|20925988|P2|NOT COMPLETED|Overall Study||0
8491905|NCT00546728|20925989|P1|NOT COMPLETED|Overall Study||0
8491906|NCT00546728|20925988|P2|COMPLETED|Overall Study||25
8491907|NCT00546728|20925989|P1|COMPLETED|Overall Study||25
8491908|NCT00546728|20925988|P2|STARTED|Overall Study||25
8491909|NCT00546728|20925989|P1|STARTED|Overall Study||25
8491910|NCT00546715|20925999|P4|NOT COMPLETED|Overall Study||0
8491911|NCT00546715|20926000|P3|NOT COMPLETED|Overall Study||0
8491912|NCT00546715|20926001|P2|NOT COMPLETED|Overall Study||1
8491913|NCT00546715|20926002|P1|NOT COMPLETED|Overall Study||0
8491914|NCT00546715|20925999|P4|COMPLETED|Overall Study||2
8491915|NCT00546715|20926000|P3|COMPLETED|Overall Study||5
8491916|NCT00546715|20926001|P2|COMPLETED|Overall Study||4
8491917|NCT00546715|20926002|P1|COMPLETED|Overall Study||6
8491918|NCT00546715|20925999|P4|STARTED|Overall Study||2
8491919|NCT00546715|20926000|P3|STARTED|Overall Study||5
8491920|NCT00546715|20926001|P2|STARTED|Overall Study||5
8491921|NCT00546715|20926002|P1|STARTED|Overall Study||6
8491922|NCT00546637|20926057|P2|NOT COMPLETED|Overall Study||49
8491923|NCT00546637|20926058|P1|NOT COMPLETED|Overall Study||73
8491924|NCT00546637|20926057|P2|COMPLETED|Overall Study||424
8491925|NCT00546637|20926058|P1|COMPLETED|Overall Study||401
8491926|NCT00546637|20926057|P2|Received Treatment|Overall Study||472
8491927|NCT00546637|20926058|P1|Received Treatment|Overall Study||471
8491928|NCT00546637|20926057|P2|STARTED|Overall Study||473
8491929|NCT00546637|20926058|P1|STARTED|Overall Study||474
8491930|NCT00546572|20926132|P2|NOT COMPLETED|Vax 2 / Year 1||2
8491931|NCT00546572|20926133|P1|NOT COMPLETED|Vax 2 / Year 1||4
8491932|NCT00546572|20926132|P2|COMPLETED|Vax 2 / Year 1||402
8491933|NCT00546572|20926133|P1|COMPLETED|Vax 2 / Year 1||387
8491934|NCT00546572|20926132|P2|Received Vax 2|Vax 2 / Year 1||404
8491935|NCT00546572|20926133|P1|Received Vax 2|Vax 2 / Year 1||391
8491936|NCT00546572|20926132|P2|STARTED|Vax 2 / Year 1||404
8491937|NCT00546572|20926133|P1|STARTED|Vax 2 / Year 1||391
8491938|NCT00546572|20926132|P2|NOT COMPLETED|Vax 1 / Year 0||70
8491939|NCT00546572|20926133|P1|NOT COMPLETED|Vax 1 / Year 0||73
8491940|NCT00546572|20926132|P2|COMPLETED|Vax 1 / Year 0||404
8491941|NCT00546572|20926133|P1|COMPLETED|Vax 1 / Year 0||391
8491942|NCT00546572|20926132|P2|Received Vax 1|Vax 1 / Year 0||473
8491943|NCT00546572|20926133|P1|Received Vax 1|Vax 1 / Year 0||463
8491944|NCT00546572|20926132|P2|STARTED|Vax 1 / Year 0||474
8491945|NCT00546572|20926133|P1|STARTED|Vax 1 / Year 0||464
8491946|NCT00546481|20926177|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
8491947|NCT00546481|20926178|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
8491948|NCT00546481|20926179|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
8491949|NCT00546481|20926177|P3|COMPLETED|Maintenance Phase (CERA)||50
8491950|NCT00546481|20926178|P2|COMPLETED|Maintenance Phase (CERA)||0
8491951|NCT00546481|20926179|P1|COMPLETED|Maintenance Phase (CERA)||0
8491952|NCT00546481|20926177|P3|STARTED|Maintenance Phase (CERA)||54
8491953|NCT00546481|20926178|P2|STARTED|Maintenance Phase (CERA)||0
8491954|NCT00546481|20926179|P1|STARTED|Maintenance Phase (CERA)||0
8491955|NCT00546481|20926177|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
8491956|NCT00546481|20926178|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
8491957|NCT00546481|20926179|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
8491958|NCT00546481|20926177|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
8491959|NCT00546481|20926178|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
8491960|NCT00546481|20926179|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
8491961|NCT00546481|20926177|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
8491962|NCT00546481|20926178|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
8491963|NCT00546481|20926179|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
8491964|NCT00546429|20926202|P1|NOT COMPLETED|Overall Study||30
8491965|NCT00546429|20926202|P1|COMPLETED|Overall Study||32
8491966|NCT00546429|20926202|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
8491967|NCT00546390|20926208|P2|NOT COMPLETED|Overall Study||0
8491968|NCT00546390|20926209|P1|NOT COMPLETED|Overall Study||0
8491969|NCT00546390|20926208|P2|COMPLETED|Overall Study||28
8491970|NCT00546390|20926209|P1|COMPLETED|Overall Study||27
8491971|NCT00546390|20926208|P2|STARTED|Overall Study||28
8491972|NCT00546390|20926209|P1|STARTED|Overall Study||27
8491973|NCT00546377|20926217|P1|NOT COMPLETED|Overall Study||7
8491974|NCT00546377|20926217|P1|COMPLETED|Overall Study||43
8491975|NCT00546377|20926217|P1|STARTED|Overall Study||50
8491976|NCT00546364|20926225|P3|NOT COMPLETED|Overall Study||17
8491977|NCT00546364|20926226|P2|NOT COMPLETED|Overall Study||18
8491978|NCT00546364|20926227|P1|NOT COMPLETED|Overall Study||17
8491979|NCT00546364|20926225|P3|COMPLETED|Overall Study|Still on treatment|3
8491980|NCT00546364|20926226|P2|COMPLETED|Overall Study|Still on treatment|4
8491981|NCT00546364|20926227|P1|COMPLETED|Overall Study|Still on treatment|3
8491982|NCT00546364|20926225|P3|Never Treated|Overall Study||0
8491983|NCT00546364|20926226|P2|Never Treated|Overall Study||0
8491984|NCT00546364|20926227|P1|Never Treated|Overall Study||0
8491985|NCT00546364|20926225|P3|STARTED|Overall Study||20
8491986|NCT00546364|20926226|P2|STARTED|Overall Study||22
8491987|NCT00546364|20926227|P1|STARTED|Overall Study||20
8491988|NCT00546351|20926262|P1|NOT COMPLETED|Overall Study||236
8491989|NCT00546351|20926262|P1|COMPLETED|Overall Study||385
8491990|NCT00546351|20926262|P1|STARTED|Overall Study||621
8491991|NCT00546273|20926295|P5|NOT COMPLETED|IV||0
8491992|NCT00546273|20926296|P4|NOT COMPLETED|IV||0
8491993|NCT00546273|20926297|P3|NOT COMPLETED|IV||0
8491994|NCT00546273|20926298|P2|NOT COMPLETED|IV||0
8491995|NCT00546273|20926299|P1|NOT COMPLETED|IV||0
8491996|NCT00546273|20926295|P5|COMPLETED|IV||2
8491997|NCT00546273|20926296|P4|COMPLETED|IV||4
8491998|NCT00546273|20926297|P3|COMPLETED|IV||0
8491999|NCT00546273|20926298|P2|COMPLETED|IV||0
8492000|NCT00546273|20926299|P1|COMPLETED|IV||0
8492006|NCT00546273|20926295|P5|NOT COMPLETED|III||0
8492007|NCT00546273|20926296|P4|NOT COMPLETED|III||0
8492008|NCT00546273|20926297|P3|NOT COMPLETED|III||0
8492009|NCT00546273|20926298|P2|NOT COMPLETED|III||0
8492010|NCT00546273|20926299|P1|NOT COMPLETED|III||0
8492011|NCT00546273|20926295|P5|COMPLETED|III||2
8492012|NCT00546273|20926296|P4|COMPLETED|III||0
8492013|NCT00546273|20926297|P3|COMPLETED|III||4
8492014|NCT00546273|20926298|P2|COMPLETED|III||0
8492015|NCT00546273|20926299|P1|COMPLETED|III||0
8492016|NCT00546273|20926295|P5|STARTED|III||2
8492017|NCT00546273|20926296|P4|STARTED|III||0
8492018|NCT00546273|20926297|P3|STARTED|III||4
8492019|NCT00546273|20926298|P2|STARTED|III||0
8492020|NCT00546273|20926299|P1|STARTED|III||0
8492021|NCT00546273|20926295|P5|NOT COMPLETED|II||0
8492022|NCT00546273|20926296|P4|NOT COMPLETED|II||0
8492023|NCT00546273|20926297|P3|NOT COMPLETED|II||0
8492024|NCT00546273|20926298|P2|NOT COMPLETED|II||0
8492025|NCT00546273|20926299|P1|NOT COMPLETED|II||0
8492026|NCT00546273|20926295|P5|COMPLETED|II||2
8492027|NCT00546273|20926296|P4|COMPLETED|II||0
8492028|NCT00546273|20926297|P3|COMPLETED|II||0
8492029|NCT00546273|20926298|P2|COMPLETED|II||4
8492030|NCT00546273|20926299|P1|COMPLETED|II||0
8492031|NCT00546273|20926295|P5|STARTED|II||2
8492032|NCT00546273|20926296|P4|STARTED|II||0
8492033|NCT00546273|20926297|P3|STARTED|II||0
8492034|NCT00546273|20926298|P2|STARTED|II||4
8492035|NCT00546273|20926299|P1|STARTED|II||0
8492036|NCT00546273|20926295|P5|NOT COMPLETED|I||0
8492037|NCT00546273|20926296|P4|NOT COMPLETED|I||0
8492038|NCT00546273|20926297|P3|NOT COMPLETED|I||0
8492039|NCT00546273|20926298|P2|NOT COMPLETED|I||0
8492040|NCT00546273|20926299|P1|NOT COMPLETED|I||0
8492041|NCT00546273|20926295|P5|COMPLETED|I||2
8492042|NCT00546273|20926296|P4|COMPLETED|I||0
8492043|NCT00546273|20926297|P3|COMPLETED|I||0
8492044|NCT00546273|20926298|P2|COMPLETED|I||0
8492045|NCT00546273|20926299|P1|COMPLETED|I||4
8492046|NCT00546273|20926295|P5|STARTED|I||2
8492047|NCT00546273|20926296|P4|STARTED|I||0
8492048|NCT00546273|20926297|P3|STARTED|I||0
8492049|NCT00546273|20926298|P2|STARTED|I||0
8492050|NCT00546273|20926299|P1|STARTED|I||4
8492051|NCT00546260|20926308|P2|NOT COMPLETED|Overall Study||2
8492052|NCT00546260|20926309|P1|NOT COMPLETED|Overall Study||8
8492053|NCT00546260|20926308|P2|COMPLETED|Overall Study||32
8492054|NCT00546260|20926309|P1|COMPLETED|Overall Study||28
8492055|NCT00546260|20926308|P2|STARTED|Overall Study||34
8492056|NCT00546260|20926309|P1|STARTED|Overall Study||36
8492057|NCT00546156|20926321|P2|NOT COMPLETED|Overall Study||1
8492058|NCT00546156|20926322|P1|NOT COMPLETED|Overall Study||14
8492059|NCT00546156|20926321|P2|COMPLETED|Overall Study||19
8492060|NCT00546156|20926322|P1|COMPLETED|Overall Study||70
8492061|NCT00546156|20926321|P2|STARTED|Overall Study||20
8492062|NCT00546156|20926322|P1|STARTED|Overall Study||84
8492063|NCT00546117|20926331|P2|NOT COMPLETED|Overall Study||0
8492064|NCT00546117|20926332|P1|NOT COMPLETED|Overall Study||4
8492065|NCT00546117|20926331|P2|COMPLETED|Overall Study||7
8492066|NCT00546117|20926332|P1|COMPLETED|Overall Study||5
8492067|NCT00546117|20926331|P2|STARTED|Overall Study||7
8492068|NCT00546117|20926332|P1|STARTED|Overall Study||9
8492069|NCT00546104|20926346|P1|NOT COMPLETED|Overall Study||0
8492070|NCT00546104|20926346|P1|COMPLETED|Overall Study||31
8492071|NCT00546104|20926346|P1|STARTED|Overall Study||31
8492072|NCT00546078|20926357|P2|NOT COMPLETED|Overall Study||7
8492073|NCT00546078|20926358|P1|NOT COMPLETED|Overall Study||4
8492074|NCT00546078|20926357|P2|COMPLETED|Overall Study||43
8492075|NCT00546078|20926358|P1|COMPLETED|Overall Study||61
8492076|NCT00546078|20926357|P2|Month 18|Overall Study||45
8492077|NCT00546078|20926358|P1|Month 18|Overall Study||61
8492078|NCT00546078|20926357|P2|STARTED|Overall Study||50
8492079|NCT00546078|20926358|P1|STARTED|Overall Study||65
8492080|NCT00546052|20926396|P1|NOT COMPLETED|Overall Study||227
8492081|NCT00546052|20926396|P1|COMPLETED|Overall Study||1511
8492082|NCT00546052|20926396|P1|Week 52|Overall Study||1511
8492083|NCT00546052|20926396|P1|Week 32|Overall Study||1583
8492084|NCT00546052|20926396|P1|Week 12|Overall Study||1650
8492085|NCT00546052|20926396|P1|Week 8|Overall Study||1680
8492086|NCT00546052|20926396|P1|Week 4|Overall Study||1714
8492087|NCT00546052|20926396|P1|STARTED|Overall Study||1738
8492088|NCT00546000|20926414|P1|NOT COMPLETED|Overall Study||4
8492089|NCT00546000|20926414|P1|COMPLETED|Overall Study||52
8492090|NCT00546000|20926414|P1|STARTED|Overall Study||56
8492091|NCT00545974|20926421|P2|NOT COMPLETED|Overall Study||3
8492092|NCT00545974|20926422|P1|NOT COMPLETED|Overall Study||2
8492093|NCT00545974|20926421|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
8492094|NCT00545974|20926422|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
8492095|NCT00545974|20926421|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
8492096|NCT00545974|20926422|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
8492097|NCT00545948|20926439|P3|NOT COMPLETED|Overall Study||7
8492098|NCT00545948|20926440|P2|NOT COMPLETED|Overall Study||1
8492099|NCT00545948|20926441|P1|NOT COMPLETED|Overall Study||1
8492100|NCT00545948|20926439|P3|COMPLETED|Overall Study||0
8492101|NCT00545948|20926440|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
8492102|NCT00545948|20926441|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
8492103|NCT00545948|20926439|P3|Assigned Treatment|Overall Study||0
8492104|NCT00545948|20926440|P2|Assigned Treatment|Overall Study||15
8492105|NCT00545948|20926441|P1|Assigned Treatment|Overall Study||9
8492106|NCT00545948|20926439|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
8492107|NCT00545948|20926440|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
8492108|NCT00545948|20926441|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
8492109|NCT00545844|20926451|P1|NOT COMPLETED|Overall Study||12
8492110|NCT00545844|20926451|P1|COMPLETED|Overall Study||301
8492111|NCT00545844|20926451|P1|STARTED|Overall Study||313
8492112|NCT00545818|20926467|P2|NOT COMPLETED|Overall Study||7
8492113|NCT00545818|20926468|P1|NOT COMPLETED|Overall Study||3
8492114|NCT00545818|20926467|P2|COMPLETED|Overall Study||39
8492115|NCT00545818|20926468|P1|COMPLETED|Overall Study||46
8492116|NCT00545818|20926467|P2|STARTED|Overall Study||46
8492117|NCT00545818|20926468|P1|STARTED|Overall Study||49
8492118|NCT00545792|20926482|P1|NOT COMPLETED|Overall Study||1
8492119|NCT00545792|20926482|P1|COMPLETED|Overall Study||20
8492120|NCT00545792|20926482|P1|STARTED|Overall Study||21
8492121|NCT00545779|20926487|P1|NOT COMPLETED|Overall Study||44
8492122|NCT00545779|20926487|P1|COMPLETED|Overall Study||633
8492123|NCT00545779|20926487|P1|STARTED|Overall Study||677
8492124|NCT00545766|20926500|P1|NOT COMPLETED|Overall Study||5
8492125|NCT00545766|20926500|P1|COMPLETED|Overall Study||36
8492126|NCT00545766|20926500|P1|STARTED|Overall Study||41
8492127|NCT00545753|20926507|P3|NOT COMPLETED|Overall Study||26
8492128|NCT00545753|20926508|P2|NOT COMPLETED|Overall Study||5
8492129|NCT00545753|20926509|P1|NOT COMPLETED|Overall Study||16
8492130|NCT00545753|20926507|P3|COMPLETED|Overall Study||230
8492131|NCT00545753|20926508|P2|COMPLETED|Overall Study||54
8492132|NCT00545753|20926509|P1|COMPLETED|Overall Study||227
8492133|NCT00545753|20926507|P3|STARTED|Overall Study||256
8492134|NCT00545753|20926508|P2|STARTED|Overall Study||59
8492135|NCT00545753|20926509|P1|STARTED|Overall Study||243
8492136|NCT00545740|20926522|P4|NOT COMPLETED|Overall Study||71
8492137|NCT00545740|20926523|P3|NOT COMPLETED|Overall Study||96
8492138|NCT00545740|20926524|P2|NOT COMPLETED|Overall Study||83
8492139|NCT00545740|20926525|P1|NOT COMPLETED|Overall Study||75
8492140|NCT00545740|20926522|P4|COMPLETED|Overall Study||78
8492141|NCT00545740|20926523|P3|COMPLETED|Overall Study||55
8492142|NCT00545740|20926524|P2|COMPLETED|Overall Study||62
8492143|NCT00545740|20926525|P1|COMPLETED|Overall Study||70
8492144|NCT00545740|20926522|P4|STARTED|Overall Study||149
8492145|NCT00545740|20926523|P3|STARTED|Overall Study||151
8492146|NCT00545740|20926524|P2|STARTED|Overall Study||145
8492147|NCT00545740|20926525|P1|STARTED|Overall Study||145
8492148|NCT00545714|20926559|P1|NOT COMPLETED|Maintenance Phase (36 Months)||32
8492149|NCT00545714|20926559|P1|COMPLETED|Maintenance Phase (36 Months)||42
8492150|NCT00545714|20926559|P1|STARTED|Maintenance Phase (36 Months)||74
8492151|NCT00545714|20926559|P1|NOT COMPLETED|Induction Phase (6 Months)||12
8492152|NCT00545714|20926559|P1|COMPLETED|Induction Phase (6 Months)||74
8492153|NCT00545714|20926559|P1|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
8492154|NCT00545714|20926559|P1|Safety Population|Induction Phase (6 Months)||86
8492155|NCT00545714|20926559|P1|STARTED|Induction Phase (6 Months)||86
8492156|NCT00545688|20926580|P4|NOT COMPLETED|Follow-Up Period||27
8492157|NCT00545688|20926581|P3|NOT COMPLETED|Follow-Up Period||20
8492158|NCT00545688|20926582|P2|NOT COMPLETED|Follow-Up Period||19
8492159|NCT00545688|20926583|P1|NOT COMPLETED|Follow-Up Period||21
8492160|NCT00545688|20926580|P4|COMPLETED|Follow-Up Period||60
8492161|NCT00545688|20926581|P3|COMPLETED|Follow-Up Period||78
8492162|NCT00545688|20926582|P2|COMPLETED|Follow-Up Period||83
8492163|NCT00545688|20926583|P1|COMPLETED|Follow-Up Period||77
8492164|NCT00545688|20926580|P4|STARTED|Follow-Up Period||87
8492165|NCT00545688|20926581|P3|STARTED|Follow-Up Period||98
8492166|NCT00545688|20926582|P2|STARTED|Follow-Up Period||102
8492167|NCT00545688|20926583|P1|STARTED|Follow-Up Period||98
8492168|NCT00545688|20926580|P4|NOT COMPLETED|Adjuvant Treatment Period||14
8492169|NCT00545688|20926581|P3|NOT COMPLETED|Adjuvant Treatment Period||4
8492170|NCT00545688|20926582|P2|NOT COMPLETED|Adjuvant Treatment Period||8
8492171|NCT00545688|20926583|P1|NOT COMPLETED|Adjuvant Treatment Period||5
8492172|NCT00545688|20926580|P4|COMPLETED|Adjuvant Treatment Period||74
8492173|NCT00545688|20926581|P3|COMPLETED|Adjuvant Treatment Period||90
8492174|NCT00545688|20926582|P2|COMPLETED|Adjuvant Treatment Period||94
8492175|NCT00545688|20926583|P1|COMPLETED|Adjuvant Treatment Period||98
8492176|NCT00545688|20926580|P4|STARTED|Adjuvant Treatment Period||88
8492177|NCT00545688|20926581|P3|STARTED|Adjuvant Treatment Period||94
8492178|NCT00545688|20926582|P2|STARTED|Adjuvant Treatment Period||102
8492179|NCT00545688|20926583|P1|STARTED|Adjuvant Treatment Period||103
8492180|NCT00545688|20926580|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
8492181|NCT00545688|20926581|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
8492182|NCT00545688|20926582|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
8492183|NCT00545688|20926583|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
8492184|NCT00545688|20926580|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
8492185|NCT00545688|20926581|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
8492186|NCT00545688|20926582|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
8492187|NCT00545688|20926583|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
8492188|NCT00545688|20926580|P4|STARTED|Neo-Adjuvant Treatment Period||94
8492189|NCT00545688|20926581|P3|STARTED|Neo-Adjuvant Treatment Period||108
8492190|NCT00545688|20926582|P2|STARTED|Neo-Adjuvant Treatment Period||107
8492191|NCT00545688|20926583|P1|STARTED|Neo-Adjuvant Treatment Period||107
8492192|NCT00545662|20926655|P2|NOT COMPLETED|Overall Study||79
8492193|NCT00545662|20926656|P1|NOT COMPLETED|Overall Study||85
8492194|NCT00545662|20926655|P2|COMPLETED|Overall Study||528
8492195|NCT00545662|20926656|P1|COMPLETED|Overall Study||521
8492196|NCT00545662|20926655|P2|STARTED|Overall Study||607
8492197|NCT00545662|20926656|P1|STARTED|Overall Study||606
8492198|NCT00545623|20926666|P4|NOT COMPLETED|Overall Study||11
8492199|NCT00545623|20926667|P3|NOT COMPLETED|Overall Study||13
8492200|NCT00545623|20926668|P2|NOT COMPLETED|Overall Study||10
8492201|NCT00545623|20926669|P1|NOT COMPLETED|Overall Study||7
8492202|NCT00545623|20926666|P4|COMPLETED|Overall Study||23
8492203|NCT00545623|20926667|P3|COMPLETED|Overall Study||20
8492204|NCT00545623|20926668|P2|COMPLETED|Overall Study||21
8492205|NCT00545623|20926669|P1|COMPLETED|Overall Study||25
8492206|NCT00545623|20926666|P4|STARTED|Overall Study||34
8492207|NCT00545623|20926667|P3|STARTED|Overall Study||33
8492208|NCT00545623|20926668|P2|STARTED|Overall Study||31
8492209|NCT00545623|20926669|P1|STARTED|Overall Study||32
8492210|NCT00545584|20926682|P3|NOT COMPLETED|Overall Study||56
8492211|NCT00545584|20926683|P2|NOT COMPLETED|Overall Study||80
8492212|NCT00545584|20926684|P1|NOT COMPLETED|Overall Study||79
8492213|NCT00545584|20926682|P3|COMPLETED|Overall Study||250
8492214|NCT00545584|20926683|P2|COMPLETED|Overall Study||334
8492215|NCT00545584|20926684|P1|COMPLETED|Overall Study||333
8492216|NCT00545584|20926682|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
8492217|NCT00545584|20926683|P2|STARTED|Overall Study||414
8492218|NCT00545584|20926684|P1|STARTED|Overall Study||412
8492219|NCT00545571|20926695|P1|NOT COMPLETED|Overall Study||67
8492220|NCT00545571|20926695|P1|COMPLETED|Overall Study||53
8492221|NCT00545571|20926695|P1|STARTED|Overall Study||120
8492222|NCT00545532|20926710|P2|NOT COMPLETED|Overall Study||10
8492223|NCT00545532|20926711|P1|NOT COMPLETED|Overall Study||6
8492224|NCT00545532|20926710|P2|COMPLETED|Overall Study||100
8492225|NCT00545532|20926711|P1|COMPLETED|Overall Study||99
8492226|NCT00545532|20926710|P2|STARTED|Overall Study||110
8492227|NCT00545532|20926711|P1|STARTED|Overall Study||105
8492228|NCT00545506|20926793|P2|NOT COMPLETED|Overall Study||0
8492229|NCT00545506|20926794|P1|NOT COMPLETED|Overall Study||0
8492230|NCT00545506|20926793|P2|COMPLETED|Overall Study||3
8492231|NCT00545506|20926794|P1|COMPLETED|Overall Study||3
8492232|NCT00545506|20926793|P2|STARTED|Overall Study||3
8492233|NCT00545506|20926794|P1|STARTED|Overall Study||3
8492234|NCT00545441|20926802|P2|NOT COMPLETED|Overall Study||16
8492235|NCT00545441|20926803|P1|NOT COMPLETED|Overall Study||18
8492236|NCT00545441|20926802|P2|COMPLETED|Overall Study||26
8492237|NCT00545441|20926803|P1|COMPLETED|Overall Study||26
8492238|NCT00545441|20926802|P2|STARTED|Overall Study||42
8492239|NCT00545441|20926803|P1|STARTED|Overall Study||44
8492240|NCT00545402|20926811|P2|NOT COMPLETED|Overall Study||29
8492241|NCT00545402|20926812|P1|NOT COMPLETED|Overall Study||34
8492242|NCT00545402|20926811|P2|COMPLETED|Overall Study||61
8492243|NCT00545402|20926812|P1|COMPLETED|Overall Study||56
8492244|NCT00545402|20926811|P2|STARTED|Overall Study||90
8492245|NCT00545402|20926812|P1|STARTED|Overall Study||90
8492246|NCT00545363|20926830|P2|NOT COMPLETED|Overall Study||15
8492247|NCT00545363|20926831|P1|NOT COMPLETED|Overall Study||19
8492248|NCT00545363|20926830|P2|COMPLETED|Overall Study||343
8492249|NCT00545363|20926831|P1|COMPLETED|Overall Study||339
8492250|NCT00545363|20926830|P2|Treated|Overall Study||357
8492251|NCT00545363|20926831|P1|Treated|Overall Study||354
8492252|NCT00545363|20926830|P2|STARTED|Overall Study||358
8492253|NCT00545363|20926831|P1|STARTED|Overall Study||358
8492254|NCT00545298|20926846|P3|NOT COMPLETED|Overall Study||1
8492255|NCT00545298|20926847|P2|NOT COMPLETED|Overall Study||0
8492256|NCT00545298|20926848|P1|NOT COMPLETED|Overall Study||2
8492257|NCT00545298|20926846|P3|COMPLETED|Overall Study||0
8492258|NCT00545298|20926847|P2|COMPLETED|Overall Study||1
8492259|NCT00545298|20926848|P1|COMPLETED|Overall Study||0
8492260|NCT00545298|20926846|P3|STARTED|Overall Study||1
8492261|NCT00545298|20926847|P2|STARTED|Overall Study||1
8492262|NCT00545298|20926848|P1|STARTED|Overall Study||2
8492263|NCT00545272|20926865|P6|NOT COMPLETED|Overall Study||3
8492264|NCT00545272|20926866|P5|NOT COMPLETED|Overall Study||2
8492265|NCT00545272|20926867|P4|NOT COMPLETED|Overall Study||1
8492266|NCT00545272|20926868|P3|NOT COMPLETED|Overall Study||1
8492267|NCT00545272|20926869|P2|NOT COMPLETED|Overall Study||1
8492268|NCT00545272|20926870|P1|NOT COMPLETED|Overall Study||0
8492269|NCT00545272|20926865|P6|COMPLETED|Overall Study||59
8492270|NCT00545272|20926866|P5|COMPLETED|Overall Study||62
8492271|NCT00545272|20926867|P4|COMPLETED|Overall Study||71
8492272|NCT00545272|20926868|P3|COMPLETED|Overall Study||64
8492273|NCT00545272|20926869|P2|COMPLETED|Overall Study||67
8492274|NCT00545272|20926870|P1|COMPLETED|Overall Study||61
8492275|NCT00545272|20926865|P6|STARTED|Overall Study||62
8492276|NCT00545272|20926866|P5|STARTED|Overall Study||64
8492277|NCT00545272|20926867|P4|STARTED|Overall Study||72
8492278|NCT00545272|20926868|P3|STARTED|Overall Study||65
8492279|NCT00545272|20926869|P2|STARTED|Overall Study||68
8492280|NCT00545272|20926870|P1|STARTED|Overall Study||61
8492281|NCT00545233|20926922|P2|NOT COMPLETED|Overall Study||35
8492282|NCT00545233|20926923|P1|NOT COMPLETED|Overall Study||46
8492283|NCT00545233|20926922|P2|COMPLETED|Overall Study||41
8492284|NCT00545233|20926923|P1|COMPLETED|Overall Study||33
8492285|NCT00545233|20926922|P2|Intent-to-Treat (ITT)|Overall Study||73
8492286|NCT00545233|20926923|P1|Intent-to-Treat (ITT)|Overall Study||77
8492287|NCT00545233|20926922|P2|Safety Set|Overall Study||75
8492288|NCT00545233|20926923|P1|Safety Set|Overall Study||77
8492289|NCT00545233|20926922|P2|STARTED|Overall Study||76
8492290|NCT00545233|20926923|P1|STARTED|Overall Study||79
8492291|NCT00545181|20926972|P2|NOT COMPLETED|Overall Study||0
8492292|NCT00545181|20926973|P1|NOT COMPLETED|Overall Study||0
8492293|NCT00545181|20926972|P2|COMPLETED|Overall Study||25
8492294|NCT00545181|20926973|P1|COMPLETED|Overall Study||29
8492295|NCT00545181|20926972|P2|STARTED|Overall Study||25
8492296|NCT00545181|20926973|P1|STARTED|Overall Study||29
8492297|NCT00545168|20926982|P3|NOT COMPLETED|Overall Study||21
8492298|NCT00545168|20926983|P2|NOT COMPLETED|Overall Study||5
8492299|NCT00545168|20926984|P1|NOT COMPLETED|Overall Study||16
8492300|NCT00545168|20926982|P3|COMPLETED|Overall Study||193
8492301|NCT00545168|20926983|P2|COMPLETED|Overall Study||58
8492302|NCT00545168|20926984|P1|COMPLETED|Overall Study||187
8492303|NCT00545168|20926982|P3|STARTED|Overall Study||214
8492304|NCT00545168|20926983|P2|STARTED|Overall Study||63
8492305|NCT00545168|20926984|P1|STARTED|Overall Study||203
8492306|NCT00545155|20926993|P1|NOT COMPLETED|Overall Study||0
8492307|NCT00545155|20926993|P1|COMPLETED|Overall Study||187
8492308|NCT00545155|20926993|P1|STARTED|Overall Study||187
8492309|NCT00545103|20927010|P4|NOT COMPLETED|Overall Study||70
8492310|NCT00545103|20927011|P3|NOT COMPLETED|Overall Study||76
8492311|NCT00545103|20927012|P2|NOT COMPLETED|Overall Study||78
8492312|NCT00545103|20927013|P1|NOT COMPLETED|Overall Study||75
8492313|NCT00545103|20927010|P4|COMPLETED|Overall Study||76
8492314|NCT00545103|20927011|P3|COMPLETED|Overall Study||74
8492315|NCT00545103|20927012|P2|COMPLETED|Overall Study||70
8492316|NCT00545103|20927013|P1|COMPLETED|Overall Study||73
8492317|NCT00545103|20927010|P4|STARTED|Overall Study||146
8492318|NCT00545103|20927011|P3|STARTED|Overall Study||150
8492319|NCT00545103|20927012|P2|STARTED|Overall Study||148
8492320|NCT00545103|20927013|P1|STARTED|Overall Study||148
8492321|NCT00545077|20927049|P2|NOT COMPLETED|Overall Study||155
8492322|NCT00545077|20927050|P1|NOT COMPLETED|Overall Study||148
8492323|NCT00545077|20927049|P2|COMPLETED|Overall Study||36
8492324|NCT00545077|20927050|P1|COMPLETED|Overall Study||41
8492325|NCT00545077|20927049|P2|STARTED|Overall Study||191
8492326|NCT00545077|20927050|P1|STARTED|Overall Study||189
8492327|NCT00545064|20927066|P1|NOT COMPLETED|Overall Study||8
8492328|NCT00545064|20927066|P1|COMPLETED|Overall Study||170
8492329|NCT00545064|20927066|P1|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
8492330|NCT00545064|20927066|P1|Visit 2 (Week 4)|Overall Study||169
8492331|NCT00545064|20927066|P1|Visit 1 (Baseline)|Overall Study||178
8492332|NCT00545064|20927066|P1|STARTED|Overall Study||178
8492333|NCT00545051|20927077|P2|NOT COMPLETED|Overall Study||7
8492334|NCT00545051|20927078|P1|NOT COMPLETED|Overall Study||9
8492335|NCT00545051|20927077|P2|COMPLETED|Overall Study||65
8492336|NCT00545051|20927078|P1|COMPLETED|Overall Study||59
8492337|NCT00545051|20927077|P2|STARTED|Overall Study||72
8492338|NCT00545051|20927078|P1|STARTED|Overall Study||68
8492339|NCT00545025|20927094|P2|NOT COMPLETED|Overall Study||0
8492340|NCT00545025|20927095|P1|NOT COMPLETED|Overall Study||0
8492341|NCT00545025|20927094|P2|COMPLETED|Overall Study||83
8492342|NCT00545025|20927095|P1|COMPLETED|Overall Study||160
8492343|NCT00545025|20927094|P2|STARTED|Overall Study||83
8492344|NCT00545025|20927095|P1|STARTED|Overall Study||160
8492345|NCT00544908|20927115|P1|NOT COMPLETED|Overall Study||0
8492346|NCT00544908|20927115|P1|COMPLETED|Overall Study||7
8492347|NCT00544908|20927115|P1|STARTED|Overall Study||7
8492348|NCT00544882|20927122|P3|NOT COMPLETED|Cycle 3: Follow-up||0
8492349|NCT00544882|20927123|P2|NOT COMPLETED|Cycle 3: Follow-up||2
8492350|NCT00544882|20927124|P1|NOT COMPLETED|Cycle 3: Follow-up||0
8492351|NCT00544882|20927122|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
8492352|NCT00544882|20927123|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
8492353|NCT00544882|20927124|P1|COMPLETED|Cycle 3: Follow-up||0
8492354|NCT00544882|20927122|P3|STARTED|Cycle 3: Follow-up||28
8492355|NCT00544882|20927123|P2|STARTED|Cycle 3: Follow-up||28
8492356|NCT00544882|20927124|P1|STARTED|Cycle 3: Follow-up||0
8492357|NCT00544882|20927122|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
8492358|NCT00544882|20927123|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
8492359|NCT00544882|20927124|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
8492360|NCT00544882|20927122|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
8492361|NCT00544882|20927123|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
8492362|NCT00544882|20927124|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
8492363|NCT00544882|20927122|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
8492364|NCT00544882|20927123|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
8492365|NCT00544882|20927124|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
8492366|NCT00544882|20927122|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
8492367|NCT00544882|20927123|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
8492368|NCT00544882|20927124|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
8492369|NCT00544882|20927122|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
8492370|NCT00544882|20927123|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
8492371|NCT00544882|20927124|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
8492372|NCT00544882|20927122|P3|COMPLETED|Cycle 1: Run-in Cycle||0
8492373|NCT00544882|20927123|P2|COMPLETED|Cycle 1: Run-in Cycle||0
8492374|NCT00544882|20927124|P1|COMPLETED|Cycle 1: Run-in Cycle||58
8492375|NCT00544882|20927122|P3|STARTED|Cycle 1: Run-in Cycle||0
8492376|NCT00544882|20927123|P2|STARTED|Cycle 1: Run-in Cycle||0
8492377|NCT00544882|20927124|P1|STARTED|Cycle 1: Run-in Cycle||61
8492378|NCT00544869|20927149|P3|NOT COMPLETED|Overall Study||0
8492379|NCT00544869|20927150|P2|NOT COMPLETED|Overall Study||2
8492380|NCT00544869|20927151|P1|NOT COMPLETED|Overall Study||12
8492381|NCT00544869|20927149|P3|COMPLETED|Overall Study||2
8492382|NCT00544869|20927150|P2|COMPLETED|Overall Study||12
8492383|NCT00544869|20927151|P1|COMPLETED|Overall Study||24
8492384|NCT00544869|20927149|P3|STARTED|Overall Study||2
8492385|NCT00544869|20927150|P2|STARTED|Overall Study||14
8492386|NCT00544869|20927151|P1|STARTED|Overall Study||36
8492387|NCT00544817|20927159|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
8492388|NCT00544817|20927159|P1|COMPLETED|Follow-up Systemic Therapy||9
8492389|NCT00544817|20927159|P1|STARTED|Follow-up Systemic Therapy||28
8492390|NCT00544817|20927159|P1|NOT COMPLETED|No Treatment Interval||12
8492391|NCT00544817|20927159|P1|COMPLETED|No Treatment Interval||28
8492392|NCT00544817|20927159|P1|STARTED|No Treatment Interval||40
8492393|NCT00544817|20927159|P1|NOT COMPLETED|Combined Modality||7
8492394|NCT00544817|20927159|P1|COMPLETED|Combined Modality||40
8492395|NCT00544817|20927159|P1|STARTED|Combined Modality||47
8492396|NCT00544778|20927165|P1|NOT COMPLETED|Overall Study||0
8492397|NCT00544778|20927165|P1|COMPLETED|Overall Study||7
8492398|NCT00544778|20927165|P1|STARTED|Overall Study||7
8492399|NCT00544713|20927171|P2|NOT COMPLETED|Overall Study||5
8492400|NCT00544713|20927172|P1|NOT COMPLETED|Overall Study||3
8492401|NCT00544713|20927171|P2|COMPLETED|Overall Study||109
8492402|NCT00544713|20927172|P1|COMPLETED|Overall Study||111
8492403|NCT00544713|20927171|P2|STARTED|Overall Study||114
8492404|NCT00544713|20927172|P1|STARTED|Overall Study||114
8492405|NCT00544674|20927202|P1|NOT COMPLETED|Overall Study||1
8492406|NCT00544674|20927202|P1|COMPLETED|Overall Study||4
8492407|NCT00544674|20927202|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
8492408|NCT00544648|20927208|P2|NOT COMPLETED|Overall Study||1
8492409|NCT00544648|20927209|P1|NOT COMPLETED|Overall Study||3
8492410|NCT00544648|20927208|P2|COMPLETED|Overall Study||1
8492411|NCT00544648|20927209|P1|COMPLETED|Overall Study||8
8492412|NCT00544648|20927208|P2|STARTED|Overall Study||2
8492413|NCT00544648|20927209|P1|STARTED|Overall Study||11
8492414|NCT00544557|20927223|P1|NOT COMPLETED|Overall Study||434
8492415|NCT00544557|20927223|P1|COMPLETED|Overall Study||1251
8492416|NCT00544557|20927223|P1|STARTED|Overall Study||1685
8492417|NCT00544544|20927254|P1|NOT COMPLETED|Overall Study||3
8492418|NCT00544544|20927254|P1|COMPLETED|Overall Study||11
8492419|NCT00544544|20927254|P1|STARTED|Overall Study||14
8492420|NCT00544440|20927261|P1|NOT COMPLETED|Overall Study||57
8492421|NCT00544440|20927261|P1|COMPLETED|Overall Study||0
8492422|NCT00544440|20927261|P1|STARTED|Overall Study||57
8492423|NCT00544167|20927268|P1|NOT COMPLETED|Overall Study||29
8492424|NCT00544167|20927268|P1|COMPLETED|Overall Study||16
8492425|NCT00544167|20927268|P1|STARTED|Overall Study||45
8492426|NCT00544076|20927275|P3|NOT COMPLETED|Overall Study||11
8492427|NCT00544076|20927276|P2|NOT COMPLETED|Overall Study||16
8492428|NCT00544076|20927277|P1|NOT COMPLETED|Overall Study||17
8492429|NCT00544076|20927275|P3|COMPLETED|Overall Study||20
8492430|NCT00544076|20927276|P2|COMPLETED|Overall Study||19
8492431|NCT00544076|20927277|P1|COMPLETED|Overall Study||17
8492432|NCT00544076|20927275|P3|STARTED|Overall Study||31
8492433|NCT00544076|20927276|P2|STARTED|Overall Study||35
8492434|NCT00544076|20927277|P1|STARTED|Overall Study||34
8492435|NCT00543985|20927294|P1|NOT COMPLETED|Overall Study||4
8492436|NCT00543985|20927294|P1|COMPLETED|Overall Study||32
8492437|NCT00543985|20927294|P1|STARTED|Overall Study||36
8492438|NCT00543855|20927305|P4|NOT COMPLETED|Overall Study||4
8492439|NCT00543855|20927306|P3|NOT COMPLETED|Overall Study||6
8492440|NCT00543855|20927307|P2|NOT COMPLETED|Overall Study||2
8492441|NCT00543855|20927308|P1|NOT COMPLETED|Overall Study||4
8492442|NCT00543855|20927305|P4|COMPLETED|Overall Study||30
8492443|NCT00543855|20927306|P3|COMPLETED|Overall Study||31
8492444|NCT00543855|20927307|P2|COMPLETED|Overall Study||31
8492445|NCT00543855|20927308|P1|COMPLETED|Overall Study||31
8492446|NCT00543855|20927305|P4|STARTED|Overall Study||34
8492447|NCT00543855|20927306|P3|STARTED|Overall Study||37
8492448|NCT00543855|20927307|P2|STARTED|Overall Study||33
8492449|NCT00543855|20927308|P1|STARTED|Overall Study||35
8492450|NCT00543803|20927330|P1|NOT COMPLETED|Overall Study||142
8492451|NCT00543803|20927330|P1|COMPLETED|Overall Study||192
8492452|NCT00543803|20927330|P1|STARTED|Overall Study||334
8492453|NCT00543764|20927349|P2|NOT COMPLETED|Overall Study||0
8492454|NCT00543764|20927350|P1|NOT COMPLETED|Overall Study||0
8492455|NCT00543764|20927349|P2|COMPLETED|Overall Study||50
8492456|NCT00543764|20927350|P1|COMPLETED|Overall Study||100
8492457|NCT00543764|20927349|P2|STARTED|Overall Study||50
8492458|NCT00543764|20927350|P1|STARTED|Overall Study||100
8492459|NCT00543725|20927358|P2|NOT COMPLETED|Overall Study||74
8492460|NCT00543725|20927359|P1|NOT COMPLETED|Overall Study||68
8492461|NCT00543725|20927358|P2|COMPLETED|Overall Study||264
8492462|NCT00543725|20927359|P1|COMPLETED|Overall Study||272
8492463|NCT00543725|20927358|P2|STARTED|Overall Study||338
8492464|NCT00543725|20927359|P1|STARTED|Overall Study||340
8492465|NCT00543569|20927385|P4|NOT COMPLETED|Overall Study||9
8492466|NCT00543569|20927386|P3|NOT COMPLETED|Overall Study||20
8492467|NCT00543569|20927387|P2|NOT COMPLETED|Overall Study||8
8492468|NCT00543569|20927388|P1|NOT COMPLETED|Overall Study||12
8492469|NCT00543569|20927385|P4|COMPLETED|Overall Study||72
8492470|NCT00543569|20927386|P3|COMPLETED|Overall Study||60
8492471|NCT00543569|20927387|P2|COMPLETED|Overall Study||72
8492472|NCT00543569|20927388|P1|COMPLETED|Overall Study||70
8492473|NCT00543569|20927385|P4|Received Treatment|Overall Study||78
8492474|NCT00543569|20927386|P3|Received Treatment|Overall Study||75
8492475|NCT00543569|20927387|P2|Received Treatment|Overall Study||77
8492476|NCT00543569|20927388|P1|Received Treatment|Overall Study||79
8492477|NCT00543569|20927385|P4|STARTED|Overall Study||81
8492478|NCT00543569|20927386|P3|STARTED|Overall Study||80
8492479|NCT00543569|20927387|P2|STARTED|Overall Study||80
8492480|NCT00543569|20927388|P1|STARTED|Overall Study||82
8492481|NCT00543543|20927494|P4|NOT COMPLETED|Extension Study||226
8492482|NCT00543543|20927495|P3|NOT COMPLETED|Extension Study||0
8492483|NCT00543543|20927496|P2|NOT COMPLETED|Extension Study||0
8492484|NCT00543543|20927497|P1|NOT COMPLETED|Extension Study||0
8492485|NCT00543543|20927494|P4|COMPLETED|Extension Study||2824
8492486|NCT00543543|20927495|P3|COMPLETED|Extension Study||0
8492487|NCT00543543|20927496|P2|COMPLETED|Extension Study||150
8492488|NCT00543543|20927497|P1|COMPLETED|Extension Study||0
8492489|NCT00543543|20927494|P4|STARTED|Extension Study|Cohort 2|3050
8492490|NCT00543543|20927495|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
8492491|NCT00543543|20927496|P2|STARTED|Extension Study|Cohort 1|150
8492492|NCT00543543|20927497|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
8492493|NCT00543543|20927494|P4|NOT COMPLETED|Base Study||1222
8492494|NCT00543543|20927495|P3|NOT COMPLETED|Base Study||14
8492495|NCT00543543|20927496|P2|NOT COMPLETED|Base Study||1252
8492496|NCT00543543|20927497|P1|NOT COMPLETED|Base Study||20
8492497|NCT00543543|20927494|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
8492498|NCT00543543|20927495|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
8492499|NCT00543543|20927496|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
8492500|NCT00543543|20927497|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
8492501|NCT00543543|20927494|P4|Completed 3 Vaccinations|Base Study||6934
8492502|NCT00543543|20927495|P3|Completed 3 Vaccinations|Base Study||297
8492503|NCT00543543|20927496|P2|Completed 3 Vaccinations|Base Study||6928
8492504|NCT00543543|20927497|P1|Completed 3 Vaccinations|Base Study||300
8492505|NCT00543543|20927494|P4|STARTED|Base Study||7109
8492506|NCT00543543|20927495|P3|STARTED|Base Study||310
8492507|NCT00543543|20927496|P2|STARTED|Base Study||7106
8492508|NCT00543543|20927497|P1|STARTED|Base Study||315
8492509|NCT00543439|20927541|P3|NOT COMPLETED|Period 2||2
8492510|NCT00543439|20927542|P2|NOT COMPLETED|Period 2||1
8492511|NCT00543439|20927543|P1|NOT COMPLETED|Period 2||1
8492512|NCT00543439|20927541|P3|COMPLETED|Period 2||23
8492513|NCT00543439|20927542|P2|COMPLETED|Period 2||25
8492514|NCT00543439|20927543|P1|COMPLETED|Period 2||8
8492515|NCT00543439|20927541|P3|STARTED|Period 2||25
8492516|NCT00543439|20927542|P2|STARTED|Period 2||26
8492517|NCT00543439|20927543|P1|STARTED|Period 2||9
8492518|NCT00543439|20927541|P3|NOT COMPLETED|Period 1||2
8492519|NCT00543439|20927542|P2|NOT COMPLETED|Period 1||3
8492520|NCT00543439|20927543|P1|NOT COMPLETED|Period 1||1
8492521|NCT00543439|20927541|P3|COMPLETED|Period 1||25
8492522|NCT00543439|20927542|P2|COMPLETED|Period 1||26
8492523|NCT00543439|20927543|P1|COMPLETED|Period 1||9
8492524|NCT00543439|20927541|P3|Treated|Period 1||27
8492525|NCT00543439|20927542|P2|Treated|Period 1||29
8492526|NCT00543439|20927543|P1|Treated|Period 1||9
8492527|NCT00543439|20927541|P3|STARTED|Period 1||27
8492528|NCT00543439|20927542|P2|STARTED|Period 1||29
8492529|NCT00543439|20927543|P1|STARTED|Period 1||10
8492530|NCT00543400|20927590|P4|NOT COMPLETED|Overall Study||5
8492531|NCT00543400|20927591|P3|NOT COMPLETED|Overall Study||4
8492532|NCT00543400|20927592|P2|NOT COMPLETED|Overall Study||1
8492533|NCT00543400|20927593|P1|NOT COMPLETED|Overall Study||5
8492534|NCT00543400|20927590|P4|COMPLETED|Overall Study||151
8492535|NCT00543400|20927591|P3|COMPLETED|Overall Study||148
8492536|NCT00543400|20927592|P2|COMPLETED|Overall Study||43
8492537|NCT00543400|20927593|P1|COMPLETED|Overall Study||146
8492538|NCT00543400|20927590|P4|STARTED|Overall Study||156
8492539|NCT00543400|20927591|P3|STARTED|Overall Study||152
8492540|NCT00543400|20927592|P2|STARTED|Overall Study||44
8492541|NCT00543400|20927593|P1|STARTED|Overall Study||151
8492542|NCT00543387|20927612|P11|NOT COMPLETED|Crossover Participants||3
8492543|NCT00543387|20927613|P10|NOT COMPLETED|Crossover Participants||1
8492544|NCT00543387|20927614|P9|NOT COMPLETED|Crossover Participants||0
8492545|NCT00543387|20927615|P8|NOT COMPLETED|Crossover Participants||0
8492546|NCT00543387|20927616|P7|NOT COMPLETED|Crossover Participants||0
8492547|NCT00543387|20927617|P6|NOT COMPLETED|Crossover Participants||0
8492548|NCT00543387|20927618|P5|NOT COMPLETED|Crossover Participants||0
8492549|NCT00543387|20927619|P4|NOT COMPLETED|Crossover Participants||0
8492550|NCT00543387|20927620|P3|NOT COMPLETED|Crossover Participants||0
8492551|NCT00543387|20927621|P2|NOT COMPLETED|Crossover Participants||0
8492552|NCT00543387|20927622|P1|NOT COMPLETED|Crossover Participants||0
8492553|NCT00543387|20927612|P11|COMPLETED|Crossover Participants||0
8492554|NCT00543387|20927613|P10|COMPLETED|Crossover Participants||0
8492555|NCT00543387|20927614|P9|COMPLETED|Crossover Participants||0
8492556|NCT00543387|20927615|P8|COMPLETED|Crossover Participants||0
8492557|NCT00543387|20927616|P7|COMPLETED|Crossover Participants||0
8492558|NCT00543387|20927617|P6|COMPLETED|Crossover Participants||0
8492559|NCT00543387|20927618|P5|COMPLETED|Crossover Participants||0
8492560|NCT00543387|20927619|P4|COMPLETED|Crossover Participants||0
8492561|NCT00543387|20927620|P3|COMPLETED|Crossover Participants||0
8492562|NCT00543387|20927621|P2|COMPLETED|Crossover Participants||0
8492563|NCT00543387|20927622|P1|COMPLETED|Crossover Participants||0
8492564|NCT00543387|20927612|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
8492565|NCT00543387|20927613|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
8492566|NCT00543387|20927614|P9|STARTED|Crossover Participants||0
8492567|NCT00543387|20927615|P8|STARTED|Crossover Participants||0
8492568|NCT00543387|20927616|P7|STARTED|Crossover Participants||0
8492569|NCT00543387|20927617|P6|STARTED|Crossover Participants||0
8492570|NCT00543387|20927618|P5|STARTED|Crossover Participants||0
8492571|NCT00543387|20927619|P4|STARTED|Crossover Participants||0
8492572|NCT00543387|20927620|P3|STARTED|Crossover Participants||0
8492573|NCT00543387|20927621|P2|STARTED|Crossover Participants||0
8492574|NCT00543387|20927622|P1|STARTED|Crossover Participants||0
8492575|NCT00543387|20927612|P11|NOT COMPLETED|Panel 1 + Panel 2||0
8492576|NCT00543387|20927613|P10|NOT COMPLETED|Panel 1 + Panel 2||0
8492577|NCT00543387|20927614|P9|NOT COMPLETED|Panel 1 + Panel 2||5
8492578|NCT00543387|20927615|P8|NOT COMPLETED|Panel 1 + Panel 2||6
8492579|NCT00543387|20927616|P7|NOT COMPLETED|Panel 1 + Panel 2||6
8492580|NCT00543387|20927617|P6|NOT COMPLETED|Panel 1 + Panel 2||3
8492581|NCT00543387|20927618|P5|NOT COMPLETED|Panel 1 + Panel 2||3
8492582|NCT00543387|20927619|P4|NOT COMPLETED|Panel 1 + Panel 2||3
8492583|NCT00543387|20927620|P3|NOT COMPLETED|Panel 1 + Panel 2||3
8492584|NCT00543387|20927621|P2|NOT COMPLETED|Panel 1 + Panel 2||3
8492585|NCT00543387|20927622|P1|NOT COMPLETED|Panel 1 + Panel 2||3
8492586|NCT00543387|20927612|P11|COMPLETED|Panel 1 + Panel 2||0
8492587|NCT00543387|20927613|P10|COMPLETED|Panel 1 + Panel 2||0
8492588|NCT00543387|20927614|P9|COMPLETED|Panel 1 + Panel 2||0
8492589|NCT00543387|20927615|P8|COMPLETED|Panel 1 + Panel 2||0
8492590|NCT00543387|20927616|P7|COMPLETED|Panel 1 + Panel 2||0
8492591|NCT00543387|20927617|P6|COMPLETED|Panel 1 + Panel 2||0
8492592|NCT00543387|20927618|P5|COMPLETED|Panel 1 + Panel 2||0
8492593|NCT00543387|20927619|P4|COMPLETED|Panel 1 + Panel 2||0
8492594|NCT00543387|20927620|P3|COMPLETED|Panel 1 + Panel 2||0
8492595|NCT00543387|20927621|P2|COMPLETED|Panel 1 + Panel 2||0
8492596|NCT00543387|20927622|P1|COMPLETED|Panel 1 + Panel 2||0
8492597|NCT00543387|20927612|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492598|NCT00543387|20927613|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492599|NCT00543387|20927614|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492600|NCT00543387|20927615|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492601|NCT00543387|20927616|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492602|NCT00543387|20927617|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
8492603|NCT00543387|20927618|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
8492604|NCT00543387|20927619|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492605|NCT00543387|20927620|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492606|NCT00543387|20927621|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
8492607|NCT00543387|20927622|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492608|NCT00543387|20927612|P11|STARTED|Panel 1 + Panel 2||0
8492609|NCT00543387|20927613|P10|STARTED|Panel 1 + Panel 2||0
8492610|NCT00543387|20927614|P9|STARTED|Panel 1 + Panel 2||5
8492611|NCT00543387|20927615|P8|STARTED|Panel 1 + Panel 2||6
8492612|NCT00543387|20927616|P7|STARTED|Panel 1 + Panel 2||6
8492613|NCT00543387|20927617|P6|STARTED|Panel 1 + Panel 2||3
8492614|NCT00543387|20927618|P5|STARTED|Panel 1 + Panel 2||3
8492615|NCT00543387|20927619|P4|STARTED|Panel 1 + Panel 2||3
8492616|NCT00543387|20927620|P3|STARTED|Panel 1 + Panel 2||3
8492617|NCT00543387|20927621|P2|STARTED|Panel 1 + Panel 2||3
8492618|NCT00543387|20927622|P1|STARTED|Panel 1 + Panel 2||3
8492619|NCT00543309|20927660|P3|NOT COMPLETED|Overall Study||0
8492620|NCT00543309|20927661|P2|NOT COMPLETED|Overall Study||1
8492621|NCT00543309|20927662|P1|NOT COMPLETED|Overall Study||0
8492622|NCT00543309|20927660|P3|COMPLETED|Overall Study||35
8492623|NCT00543309|20927661|P2|COMPLETED|Overall Study||35
8492624|NCT00543309|20927662|P1|COMPLETED|Overall Study||35
8492625|NCT00543309|20927660|P3|STARTED|Overall Study||35
8492626|NCT00543309|20927661|P2|STARTED|Overall Study||36
8492627|NCT00543309|20927662|P1|STARTED|Overall Study||35
8492628|NCT00543296|20927712|P1|NOT COMPLETED|Overall Study||7
8492629|NCT00543296|20927712|P1|COMPLETED|Overall Study||14
8492630|NCT00543296|20927712|P1|STARTED|Overall Study||21
8492631|NCT00543140|20927719|P1|NOT COMPLETED|Overall Study||72
8492632|NCT00543140|20927719|P1|COMPLETED|Overall Study||231
8492633|NCT00543140|20927719|P1|STARTED|Overall Study||303
8492634|NCT00543127|20927729|P2|NOT COMPLETED|Overall Study||87
8492635|NCT00543127|20927730|P1|NOT COMPLETED|Overall Study||130
8492636|NCT00543127|20927729|P2|COMPLETED|Overall Study||350
8492637|NCT00543127|20927730|P1|COMPLETED|Overall Study||303
8492638|NCT00543127|20927729|P2|STARTED|Overall Study||437
8492639|NCT00543127|20927730|P1|STARTED|Overall Study||433
8492640|NCT00543101|20927744|P2|NOT COMPLETED|Overall Study||0
8492641|NCT00543101|20927745|P1|NOT COMPLETED|Overall Study||0
8492642|NCT00543101|20927744|P2|COMPLETED|Overall Study||12
8492643|NCT00543101|20927745|P1|COMPLETED|Overall Study||12
8492644|NCT00543101|20927744|P2|STARTED|Overall Study||12
8492645|NCT00543101|20927745|P1|STARTED|Overall Study||12
8492646|NCT00543062|20927757|P4|NOT COMPLETED|Overall Study||1
8492647|NCT00543062|20927758|P3|NOT COMPLETED|Overall Study||3
8492648|NCT00543062|20927759|P2|NOT COMPLETED|Overall Study||1
8492649|NCT00543062|20927760|P1|NOT COMPLETED|Overall Study||2
8492650|NCT00543062|20927757|P4|COMPLETED|Overall Study||11
8492651|NCT00543062|20927758|P3|COMPLETED|Overall Study||9
8492652|NCT00543062|20927759|P2|COMPLETED|Overall Study||11
8492653|NCT00543062|20927760|P1|COMPLETED|Overall Study||10
8492654|NCT00543062|20927757|P4|STARTED|Overall Study||12
8492655|NCT00543062|20927758|P3|STARTED|Overall Study||12
8492656|NCT00543062|20927759|P2|STARTED|Overall Study||12
8492657|NCT00543062|20927760|P1|STARTED|Overall Study||12
8492658|NCT00542997|20927782|P1|NOT COMPLETED|Efficacy Period||3
8492659|NCT00542997|20927782|P1|COMPLETED|Efficacy Period||43
8492660|NCT00542997|20927782|P1|STARTED|Efficacy Period||46
8492661|NCT00542997|20927782|P1|NOT COMPLETED|Wash in / Wash Out Period||5
8492662|NCT00542997|20927782|P1|COMPLETED|Wash in / Wash Out Period||46
8492663|NCT00542997|20927782|P1|STARTED|Wash in / Wash Out Period||51
8492664|NCT00542971|20927797|P1|NOT COMPLETED|Overall Study||0
8492665|NCT00542971|20927797|P1|COMPLETED|Overall Study||75
8492666|NCT00542971|20927797|P1|STARTED|Overall Study||75
8492667|NCT00542919|20927805|P3|NOT COMPLETED|Overall Study||6
8492668|NCT00542919|20927806|P2|NOT COMPLETED|Overall Study||7
8492669|NCT00542919|20927807|P1|NOT COMPLETED|Overall Study||7
8492670|NCT00542919|20927805|P3|COMPLETED|Overall Study||9
8492671|NCT00542919|20927806|P2|COMPLETED|Overall Study||12
8492672|NCT00542919|20927807|P1|COMPLETED|Overall Study||16
8492673|NCT00542919|20927805|P3|Death|Overall Study||2
8492674|NCT00542919|20927806|P2|Death|Overall Study||1
8492675|NCT00542919|20927807|P1|Death|Overall Study||1
8492676|NCT00542919|20927805|P3|Progressive Disease|Overall Study||7
8492677|NCT00542919|20927806|P2|Progressive Disease|Overall Study||11
8492678|NCT00542919|20927807|P1|Progressive Disease|Overall Study||15
8492679|NCT00542919|20927805|P3|Received At Least One Dose of Study Drug|Overall Study||15
8492680|NCT00542919|20927806|P2|Received At Least One Dose of Study Drug|Overall Study||19
8492681|NCT00542919|20927807|P1|Received At Least One Dose of Study Drug|Overall Study||23
8492682|NCT00542919|20927805|P3|STARTED|Overall Study||15
8492683|NCT00542919|20927806|P2|STARTED|Overall Study||19
8492684|NCT00542919|20927807|P1|STARTED|Overall Study||23
8492685|NCT00542880|20927852|P2|NOT COMPLETED|Period 3||2
8492686|NCT00542880|20927853|P1|NOT COMPLETED|Period 3||0
8492687|NCT00542880|20927852|P2|COMPLETED|Period 3||201
8492688|NCT00542880|20927853|P1|COMPLETED|Period 3||204
8492689|NCT00542880|20927852|P2|STARTED|Period 3||203
8492690|NCT00542880|20927853|P1|STARTED|Period 3||204
8492691|NCT00542880|20927852|P2|NOT COMPLETED|Period 2||10
8492692|NCT00542880|20927853|P1|NOT COMPLETED|Period 2||7
8492693|NCT00542880|20927852|P2|COMPLETED|Period 2||203
8492694|NCT00542880|20927853|P1|COMPLETED|Period 2||204
8492695|NCT00542880|20927852|P2|STARTED|Period 2||213
8492696|NCT00542880|20927853|P1|STARTED|Period 2||211
8492697|NCT00542880|20927852|P2|NOT COMPLETED|Period 1||12
8492698|NCT00542880|20927853|P1|NOT COMPLETED|Period 1||6
8492699|NCT00542880|20927852|P2|COMPLETED|Period 1||213
8492700|NCT00542880|20927853|P1|COMPLETED|Period 1||211
8492701|NCT00542880|20927852|P2|STARTED|Period 1||225
8492702|NCT00542880|20927853|P1|STARTED|Period 1|This was a cross-over study|217
8492703|NCT00542828|20927889|P1|NOT COMPLETED|Overall Study||13
8492704|NCT00542828|20927889|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
8492705|NCT00542828|20927889|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
8492706|NCT00542815|20927907|P3|NOT COMPLETED|Overall Study||32
8492707|NCT00542815|20927908|P2|NOT COMPLETED|Overall Study||32
8492708|NCT00542815|20927909|P1|NOT COMPLETED|Overall Study||106
8492709|NCT00542815|20927907|P3|COMPLETED|Overall Study||92
8492710|NCT00542815|20927908|P2|COMPLETED|Overall Study||44
8492711|NCT00542815|20927909|P1|COMPLETED|Overall Study||326
8492712|NCT00542815|20927907|P3|STARTED|Overall Study||124
8492713|NCT00542815|20927908|P2|STARTED|Overall Study||76
8492714|NCT00542815|20927909|P1|STARTED|Overall Study||432
8492715|NCT00542789|20927922|P2|NOT COMPLETED|Overall Study||78
8492716|NCT00542789|20927923|P1|NOT COMPLETED|Overall Study||41
8492717|NCT00542789|20927922|P2|COMPLETED|Overall Study||90
8492718|NCT00542789|20927923|P1|COMPLETED|Overall Study||134
8492719|NCT00542789|20927922|P2|STARTED|Overall Study|Randomised|168
8492720|NCT00542789|20927923|P1|STARTED|Overall Study|Randomised|175
8492721|NCT00542750|20927933|P1|NOT COMPLETED|Overall Study||0
8492722|NCT00542750|20927933|P1|COMPLETED|Overall Study||24
8492723|NCT00542750|20927933|P1|STARTED|Overall Study||24
8492724|NCT00542620|20927939|P2|NOT COMPLETED|Overall Study||0
8492725|NCT00542620|20927940|P1|NOT COMPLETED|Overall Study||0
8492726|NCT00542620|20927939|P2|COMPLETED|Overall Study||12
8492727|NCT00542620|20927940|P1|COMPLETED|Overall Study||13
8492728|NCT00542620|20927939|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
8492729|NCT00542620|20927940|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
8492730|NCT00542620|20927939|P2|STARTED|Overall Study||12
8492731|NCT00542620|20927940|P1|STARTED|Overall Study||13
8492732|NCT00542542|20928006|P2|NOT COMPLETED|Overall Study||0
8492733|NCT00542542|20928007|P1|NOT COMPLETED|Overall Study||0
8492734|NCT00542542|20928006|P2|COMPLETED|Overall Study||44
8492735|NCT00542542|20928007|P1|COMPLETED|Overall Study||44
8492736|NCT00542542|20928006|P2|STARTED|Overall Study||44
8492737|NCT00542542|20928007|P1|STARTED|Overall Study||44
8492738|NCT00542490|20928013|P1|NOT COMPLETED|Overall Study||2
8492739|NCT00542490|20928013|P1|COMPLETED|Overall Study||21
8492740|NCT00542490|20928013|P1|STARTED|Overall Study||23
8492741|NCT00542425|20928023|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8492742|NCT00542425|20928024|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8492743|NCT00542425|20928025|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
8492744|NCT00542425|20928026|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
8492745|NCT00542425|20928027|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8492746|NCT00542425|20928023|P5|COMPLETED|Extended 24 Weeks of Treatment||13
8492747|NCT00542425|20928024|P4|COMPLETED|Extended 24 Weeks of Treatment||6
8492748|NCT00542425|20928025|P3|COMPLETED|Extended 24 Weeks of Treatment||8
8492749|NCT00542425|20928026|P2|COMPLETED|Extended 24 Weeks of Treatment||11
8492750|NCT00542425|20928027|P1|COMPLETED|Extended 24 Weeks of Treatment||10
8492751|NCT00542425|20928023|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
8492752|NCT00542425|20928024|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
8492753|NCT00542425|20928025|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
8492754|NCT00542425|20928026|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
8492755|NCT00542425|20928027|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
8492756|NCT00542425|20928023|P5|NOT COMPLETED|Initial 24 Weeks||6
8492757|NCT00542425|20928024|P4|NOT COMPLETED|Initial 24 Weeks||11
8492758|NCT00542425|20928025|P3|NOT COMPLETED|Initial 24 Weeks||7
8492759|NCT00542425|20928026|P2|NOT COMPLETED|Initial 24 Weeks||10
8492760|NCT00542425|20928027|P1|NOT COMPLETED|Initial 24 Weeks||4
8492761|NCT00542425|20928023|P5|COMPLETED|Initial 24 Weeks||39
8492762|NCT00542425|20928024|P4|COMPLETED|Initial 24 Weeks||34
8492763|NCT00542425|20928025|P3|COMPLETED|Initial 24 Weeks||36
8492764|NCT00542425|20928026|P2|COMPLETED|Initial 24 Weeks||33
8492765|NCT00542425|20928027|P1|COMPLETED|Initial 24 Weeks||42
8492766|NCT00542425|20928023|P5|STARTED|Initial 24 Weeks||45
8492767|NCT00542425|20928024|P4|STARTED|Initial 24 Weeks||45
8492768|NCT00542425|20928025|P3|STARTED|Initial 24 Weeks||43
8492769|NCT00542425|20928026|P2|STARTED|Initial 24 Weeks||43
8492770|NCT00542425|20928027|P1|STARTED|Initial 24 Weeks||46
8492771|NCT00542386|20928065|P6|NOT COMPLETED|Overall Study||50
8492772|NCT00542386|20928066|P5|NOT COMPLETED|Overall Study||40
8492773|NCT00542386|20928067|P4|NOT COMPLETED|Overall Study||38
8492774|NCT00542386|20928068|P3|NOT COMPLETED|Overall Study||33
8492775|NCT00542386|20928069|P2|NOT COMPLETED|Overall Study||28
8492776|NCT00542386|20928070|P1|NOT COMPLETED|Overall Study||43
8492777|NCT00542386|20928065|P6|COMPLETED|Overall Study||82
8492778|NCT00542386|20928066|P5|COMPLETED|Overall Study||62
8492779|NCT00542386|20928067|P4|COMPLETED|Overall Study||65
8492780|NCT00542386|20928068|P3|COMPLETED|Overall Study||66
8492781|NCT00542386|20928069|P2|COMPLETED|Overall Study||74
8492782|NCT00542386|20928070|P1|COMPLETED|Overall Study||61
8492783|NCT00542386|20928065|P6|STARTED|Overall Study||132
8492784|NCT00542386|20928066|P5|STARTED|Overall Study||102
8492785|NCT00542386|20928067|P4|STARTED|Overall Study||103
8492786|NCT00542386|20928068|P3|STARTED|Overall Study||99
8492787|NCT00542386|20928069|P2|STARTED|Overall Study||102
8492788|NCT00542386|20928070|P1|STARTED|Overall Study||104
8492789|NCT00542321|20928092|P2|NOT COMPLETED|Overall Study||1
8492790|NCT00542321|20928093|P1|NOT COMPLETED|Overall Study||0
8492791|NCT00542321|20928092|P2|COMPLETED|Overall Study||7
8492792|NCT00542321|20928093|P1|COMPLETED|Overall Study||8
8492793|NCT00542321|20928092|P2|STARTED|Overall Study||8
8492794|NCT00542321|20928093|P1|STARTED|Overall Study||8
8492795|NCT00542308|20928107|P1|NOT COMPLETED|Overall Study||0
8492796|NCT00542308|20928107|P1|COMPLETED|Overall Study||90
8492797|NCT00542308|20928107|P1|STARTED|Overall Study||90
8492798|NCT00542269|20928115|P3|NOT COMPLETED|Overall Study||6
8492799|NCT00542269|20928116|P2|NOT COMPLETED|Overall Study||6
8492800|NCT00542269|20928117|P1|NOT COMPLETED|Overall Study||13
8492801|NCT00542269|20928115|P3|COMPLETED|Overall Study||51
8492802|NCT00542269|20928116|P2|COMPLETED|Overall Study||54
8492803|NCT00542269|20928117|P1|COMPLETED|Overall Study||48
8492804|NCT00542269|20928115|P3|STARTED|Overall Study||57
8492805|NCT00542269|20928116|P2|STARTED|Overall Study||60
8492806|NCT00542269|20928117|P1|STARTED|Overall Study||61
8492807|NCT00542191|20928146|P1|NOT COMPLETED|Overall Study||3
8492808|NCT00542191|20928146|P1|COMPLETED|Overall Study||18
8492809|NCT00542191|20928146|P1|STARTED|Overall Study||21
8492810|NCT00542178|20928156|P8|NOT COMPLETED|Overall Study||85
8492811|NCT00542178|20928157|P7|NOT COMPLETED|Overall Study||87
8492812|NCT00542178|20928158|P6|NOT COMPLETED|Overall Study||89
8492813|NCT00542178|20928159|P5|NOT COMPLETED|Overall Study||64
8492814|NCT00542178|20928160|P4|NOT COMPLETED|Overall Study||62
8492815|NCT00542178|20928161|P3|NOT COMPLETED|Overall Study||74
8492816|NCT00542178|20928162|P2|NOT COMPLETED|Overall Study||80
8492817|NCT00542178|20928163|P1|NOT COMPLETED|Overall Study||75
8492818|NCT00542178|20928156|P8|COMPLETED|Overall Study||381
8492819|NCT00542178|20928157|P7|COMPLETED|Overall Study||406
8492820|NCT00542178|20928158|P6|COMPLETED|Overall Study||406
8492821|NCT00542178|20928159|P5|COMPLETED|Overall Study||400
8492822|NCT00542178|20928160|P4|COMPLETED|Overall Study||308
8492823|NCT00542178|20928161|P3|COMPLETED|Overall Study||308
8492824|NCT00542178|20928162|P2|COMPLETED|Overall Study||332
8492825|NCT00542178|20928163|P1|COMPLETED|Overall Study||315
8492826|NCT00542178|20928156|P8|STARTED|Overall Study||466
8492827|NCT00542178|20928157|P7|STARTED|Overall Study||493
8492828|NCT00542178|20928158|P6|STARTED|Overall Study||495
8492829|NCT00542178|20928159|P5|STARTED|Overall Study||464
8492830|NCT00542178|20928160|P4|STARTED|Overall Study||370
8492831|NCT00542178|20928161|P3|STARTED|Overall Study||382
8492832|NCT00542178|20928162|P2|STARTED|Overall Study||412
8492833|NCT00542178|20928163|P1|STARTED|Overall Study||390
8492834|NCT00541970|20928199|P4|NOT COMPLETED|Month 60||72
8492835|NCT00541970|20928200|P3|NOT COMPLETED|Month 60||82
8492836|NCT00541970|20928201|P2|NOT COMPLETED|Month 60||77
8492837|NCT00541970|20928202|P1|NOT COMPLETED|Month 60||78
8492838|NCT00541970|20928199|P4|COMPLETED|Month 60||167
8492839|NCT00541970|20928200|P3|COMPLETED|Month 60||158
8492840|NCT00541970|20928201|P2|COMPLETED|Month 60||164
8492841|NCT00541970|20928202|P1|COMPLETED|Month 60||162
8492842|NCT00541970|20928199|P4|STARTED|Month 60||239
8492843|NCT00541970|20928200|P3|STARTED|Month 60||240
8492844|NCT00541970|20928201|P2|STARTED|Month 60||241
8492845|NCT00541970|20928202|P1|STARTED|Month 60||240
8492846|NCT00541970|20928199|P4|NOT COMPLETED|Month 48||75
8492847|NCT00541970|20928200|P3|NOT COMPLETED|Month 48||73
8492848|NCT00541970|20928201|P2|NOT COMPLETED|Month 48||73
8492849|NCT00541970|20928202|P1|NOT COMPLETED|Month 48||71
8492850|NCT00541970|20928199|P4|COMPLETED|Month 48||164
8492851|NCT00541970|20928200|P3|COMPLETED|Month 48||167
8492852|NCT00541970|20928201|P2|COMPLETED|Month 48||168
8492853|NCT00541970|20928202|P1|COMPLETED|Month 48||169
8492854|NCT00541970|20928199|P4|STARTED|Month 48||239
8492855|NCT00541970|20928200|P3|STARTED|Month 48||240
8492856|NCT00541970|20928201|P2|STARTED|Month 48||241
8492857|NCT00541970|20928202|P1|STARTED|Month 48||240
8492858|NCT00541970|20928199|P4|NOT COMPLETED|Month 36||60
8492859|NCT00541970|20928200|P3|NOT COMPLETED|Month 36||66
8492860|NCT00541970|20928201|P2|NOT COMPLETED|Month 36||66
8492861|NCT00541970|20928202|P1|NOT COMPLETED|Month 36||61
8492862|NCT00541970|20928199|P4|COMPLETED|Month 36||179
8492863|NCT00541970|20928200|P3|COMPLETED|Month 36||174
8492864|NCT00541970|20928201|P2|COMPLETED|Month 36||175
8492865|NCT00541970|20928202|P1|COMPLETED|Month 36||179
8492866|NCT00541970|20928199|P4|STARTED|Month 36||239
8492867|NCT00541970|20928200|P3|STARTED|Month 36||240
8492868|NCT00541970|20928201|P2|STARTED|Month 36||241
8492869|NCT00541970|20928202|P1|STARTED|Month 36||240
8492870|NCT00541970|20928199|P4|NOT COMPLETED|Month 24||22
8492871|NCT00541970|20928200|P3|NOT COMPLETED|Month 24||32
8492872|NCT00541970|20928201|P2|NOT COMPLETED|Month 24||32
8492873|NCT00541970|20928202|P1|NOT COMPLETED|Month 24||29
8492874|NCT00541970|20928199|P4|COMPLETED|Month 24||217
8492875|NCT00541970|20928200|P3|COMPLETED|Month 24||208
8492876|NCT00541970|20928201|P2|COMPLETED|Month 24||209
8492877|NCT00541970|20928202|P1|COMPLETED|Month 24||211
8492878|NCT00541970|20928199|P4|STARTED|Month 24||239
8492879|NCT00541970|20928200|P3|STARTED|Month 24||240
8492880|NCT00541970|20928201|P2|STARTED|Month 24||241
8492881|NCT00541970|20928202|P1|STARTED|Month 24||240
8492882|NCT00541970|20928199|P4|NOT COMPLETED|Month 18||17
8492883|NCT00541970|20928200|P3|NOT COMPLETED|Month 18||25
8492884|NCT00541970|20928201|P2|NOT COMPLETED|Month 18||24
8492885|NCT00541970|20928202|P1|NOT COMPLETED|Month 18||14
8492886|NCT00541970|20928199|P4|COMPLETED|Month 18||222
8492887|NCT00541970|20928200|P3|COMPLETED|Month 18||215
8492888|NCT00541970|20928201|P2|COMPLETED|Month 18||217
8492889|NCT00541970|20928202|P1|COMPLETED|Month 18||226
8492890|NCT00541970|20928199|P4|STARTED|Month 18||239
8492891|NCT00541970|20928200|P3|STARTED|Month 18||240
8492892|NCT00541970|20928201|P2|STARTED|Month 18||241
8492893|NCT00541970|20928202|P1|STARTED|Month 18||240
8492894|NCT00541970|20928199|P4|NOT COMPLETED|Month 12||16
8492895|NCT00541970|20928200|P3|NOT COMPLETED|Month 12||21
8492896|NCT00541970|20928201|P2|NOT COMPLETED|Month 12||22
8492897|NCT00541970|20928202|P1|NOT COMPLETED|Month 12||12
8492898|NCT00541970|20928199|P4|COMPLETED|Month 12||223
8492899|NCT00541970|20928200|P3|COMPLETED|Month 12||219
8492900|NCT00541970|20928201|P2|COMPLETED|Month 12||219
8492901|NCT00541970|20928202|P1|COMPLETED|Month 12||228
8492902|NCT00541970|20928199|P4|STARTED|Month 12||239
8492903|NCT00541970|20928200|P3|STARTED|Month 12||240
8492904|NCT00541970|20928201|P2|STARTED|Month 12||241
8492905|NCT00541970|20928202|P1|STARTED|Month 12||240
8492906|NCT00541970|20928199|P4|NOT COMPLETED|Month 7||5
8492907|NCT00541970|20928200|P3|NOT COMPLETED|Month 7||11
8492908|NCT00541970|20928201|P2|NOT COMPLETED|Month 7||13
8492909|NCT00541970|20928202|P1|NOT COMPLETED|Month 7||9
8492910|NCT00541970|20928199|P4|COMPLETED|Month 7||234
8492911|NCT00541970|20928200|P3|COMPLETED|Month 7||229
8492912|NCT00541970|20928201|P2|COMPLETED|Month 7||228
8492913|NCT00541970|20928202|P1|COMPLETED|Month 7||231
8492914|NCT00541970|20928199|P4|STARTED|Month 7||239
8492915|NCT00541970|20928200|P3|STARTED|Month 7||240
8492916|NCT00541970|20928201|P2|STARTED|Month 7||241
8492917|NCT00541970|20928202|P1|STARTED|Month 7||240
8492918|NCT00541931|20928353|P2|NOT COMPLETED|Overall Study||4
8492919|NCT00541931|20928354|P1|NOT COMPLETED|Overall Study||5
8492920|NCT00541931|20928353|P2|COMPLETED|Overall Study||11
8492921|NCT00541931|20928354|P1|COMPLETED|Overall Study||17
8492922|NCT00541931|20928353|P2|STARTED|Overall Study||15
8492923|NCT00541931|20928354|P1|STARTED|Overall Study||22
8492924|NCT00541866|20928367|P5|NOT COMPLETED|Overall Study||15
8492925|NCT00541866|20928368|P4|NOT COMPLETED|Overall Study||16
8492926|NCT00541866|20928369|P3|NOT COMPLETED|Overall Study||15
8492927|NCT00541866|20928370|P2|NOT COMPLETED|Overall Study||18
8492928|NCT00541866|20928371|P1|NOT COMPLETED|Overall Study||34
8492929|NCT00541866|20928367|P5|COMPLETED|Overall Study||3
8492930|NCT00541866|20928368|P4|COMPLETED|Overall Study||0
8492931|NCT00541866|20928369|P3|COMPLETED|Overall Study||2
8492932|NCT00541866|20928370|P2|COMPLETED|Overall Study||0
8492933|NCT00541866|20928371|P1|COMPLETED|Overall Study||7
8492934|NCT00541866|20928367|P5|STARTED|Overall Study||18
8492935|NCT00541866|20928368|P4|STARTED|Overall Study||16
8492936|NCT00541866|20928369|P3|STARTED|Overall Study||17
8492937|NCT00541866|20928370|P2|STARTED|Overall Study||18
8492938|NCT00541866|20928371|P1|STARTED|Overall Study|41 started, but only 39 treated|41
8492939|NCT00541775|20928412|P3|NOT COMPLETED|Overall Study||8
8492940|NCT00541775|20928413|P2|NOT COMPLETED|Overall Study||2
8492941|NCT00541775|20928414|P1|NOT COMPLETED|Overall Study||9
8492942|NCT00541775|20928412|P3|COMPLETED|Overall Study||84
8492943|NCT00541775|20928413|P2|COMPLETED|Overall Study||85
8492944|NCT00541775|20928414|P1|COMPLETED|Overall Study||85
8492945|NCT00541775|20928412|P3|STARTED|Overall Study||92
8492946|NCT00541775|20928413|P2|STARTED|Overall Study||87
8492947|NCT00541775|20928414|P1|STARTED|Overall Study||94
8492948|NCT00541671|20928430|P2|NOT COMPLETED|Overall Study||0
8492949|NCT00541671|20928431|P1|NOT COMPLETED|Overall Study||0
8492950|NCT00541671|20928430|P2|COMPLETED|Overall Study||12
8492951|NCT00541671|20928431|P1|COMPLETED|Overall Study||13
8492952|NCT00541671|20928430|P2|STARTED|Overall Study||12
8492953|NCT00541671|20928431|P1|STARTED|Overall Study||13
8492954|NCT00541658|20928440|P3|NOT COMPLETED|Overall Study||68
8492955|NCT00541658|20928441|P2|NOT COMPLETED|Overall Study||73
8492956|NCT00541658|20928442|P1|NOT COMPLETED|Overall Study||60
8492957|NCT00541658|20928440|P3|COMPLETED|Overall Study||240
8492958|NCT00541658|20928441|P2|COMPLETED|Overall Study||234
8492959|NCT00541658|20928442|P1|COMPLETED|Overall Study||248
8492960|NCT00541658|20928440|P3|ITT Population|Overall Study||308
8492961|NCT00541658|20928441|P2|ITT Population|Overall Study||307
8492962|NCT00541658|20928442|P1|ITT Population|Overall Study||307
8492963|NCT00541658|20928440|P3|STARTED|Overall Study||308
8492964|NCT00541658|20928441|P2|STARTED|Overall Study||307
8492965|NCT00541658|20928442|P1|STARTED|Overall Study||308
8492966|NCT00541593|20928599|P1|NOT COMPLETED|Overall Study||0
8492967|NCT00541593|20928599|P1|COMPLETED|Overall Study||5
8492968|NCT00541593|20928599|P1|STARTED|Overall Study||5
8492969|NCT00541450|20928605|P2|NOT COMPLETED|Phase B||31
8492970|NCT00541450|20928606|P1|NOT COMPLETED|Phase B||37
8492971|NCT00541450|20928605|P2|COMPLETED|Phase B||200
8492972|NCT00541450|20928606|P1|COMPLETED|Phase B||187
8492973|NCT00541450|20928605|P2|STARTED|Phase B||231
8492974|NCT00541450|20928606|P1|STARTED|Phase B||224
8492975|NCT00541450|20928605|P2|NOT COMPLETED|Phase A||17
8492976|NCT00541450|20928606|P1|NOT COMPLETED|Phase A||20
8492977|NCT00541450|20928605|P2|COMPLETED|Phase A||231
8492978|NCT00541450|20928606|P1|COMPLETED|Phase A||224
8492979|NCT00541450|20928605|P2|STARTED|Phase A||248
8492980|NCT00541450|20928606|P1|STARTED|Phase A||244
8492981|NCT00541346|20928624|P1|NOT COMPLETED|Follow-up||1
8492982|NCT00541346|20928624|P1|COMPLETED|Follow-up||15
8492983|NCT00541346|20928624|P1|STARTED|Follow-up||16
8492984|NCT00541346|20928624|P1|NOT COMPLETED|Baseline||0
8492985|NCT00541346|20928624|P1|COMPLETED|Baseline||16
8492986|NCT00541346|20928624|P1|STARTED|Baseline||16
8492987|NCT00541307|20928638|P1|NOT COMPLETED|Overall Study||24
8492988|NCT00541307|20928638|P1|COMPLETED|Overall Study||95
8492989|NCT00541307|20928638|P1|STARTED|Overall Study||119
8492990|NCT00541242|20928648|P2|NOT COMPLETED|Treatment Period 2||7
8492991|NCT00541242|20928649|P1|NOT COMPLETED|Treatment Period 2||9
8492992|NCT00541242|20928648|P2|COMPLETED|Treatment Period 2||266
8492993|NCT00541242|20928649|P1|COMPLETED|Treatment Period 2||261
8492994|NCT00541242|20928648|P2|STARTED|Treatment Period 2||273
8492995|NCT00541242|20928649|P1|STARTED|Treatment Period 2||270
8492996|NCT00541242|20928648|P2|NOT COMPLETED|Treatment Period 1||0
8492997|NCT00541242|20928649|P1|NOT COMPLETED|Treatment Period 1||0
8492998|NCT00541242|20928648|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
8492999|NCT00541242|20928649|P1|COMPLETED|Treatment Period 1||0
8493000|NCT00541242|20928648|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
8493001|NCT00541242|20928649|P1|STARTED|Treatment Period 1||0
8493002|NCT00541229|20928663|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
8493003|NCT00541229|20928664|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
8493004|NCT00541229|20928665|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
8493005|NCT00541229|20928666|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
8493006|NCT00541229|20928667|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
8493007|NCT00541229|20928668|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
8493008|NCT00541229|20928663|P6|COMPLETED|Treatment Period III (Week 11)||4
8493009|NCT00541229|20928664|P5|COMPLETED|Treatment Period III (Week 11)||6
8493010|NCT00541229|20928665|P4|COMPLETED|Treatment Period III (Week 11)||8
8493011|NCT00541229|20928666|P3|COMPLETED|Treatment Period III (Week 11)||9
8493012|NCT00541229|20928667|P2|COMPLETED|Treatment Period III (Week 11)||8
8493013|NCT00541229|20928668|P1|COMPLETED|Treatment Period III (Week 11)||7
8493014|NCT00541229|20928663|P6|STARTED|Treatment Period III (Week 11)||5
8493015|NCT00541229|20928664|P5|STARTED|Treatment Period III (Week 11)||7
8493016|NCT00541229|20928665|P4|STARTED|Treatment Period III (Week 11)||8
8493017|NCT00541229|20928666|P3|STARTED|Treatment Period III (Week 11)||10
8493018|NCT00541229|20928667|P2|STARTED|Treatment Period III (Week 11)||8
8493019|NCT00541229|20928668|P1|STARTED|Treatment Period III (Week 11)||7
8493020|NCT00541229|20928663|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
8493021|NCT00541229|20928664|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493022|NCT00541229|20928665|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493023|NCT00541229|20928666|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
8493024|NCT00541229|20928667|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493025|NCT00541229|20928668|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493026|NCT00541229|20928663|P6|COMPLETED|Washout Period II (Week 7-10)||5
8493027|NCT00541229|20928664|P5|COMPLETED|Washout Period II (Week 7-10)||7
8493028|NCT00541229|20928665|P4|COMPLETED|Washout Period II (Week 7-10)||8
8493029|NCT00541229|20928666|P3|COMPLETED|Washout Period II (Week 7-10)||10
8493030|NCT00541229|20928667|P2|COMPLETED|Washout Period II (Week 7-10)||8
8493031|NCT00541229|20928668|P1|COMPLETED|Washout Period II (Week 7-10)||7
8493032|NCT00541229|20928663|P6|STARTED|Washout Period II (Week 7-10)||8
8493033|NCT00541229|20928664|P5|STARTED|Washout Period II (Week 7-10)||11
8493034|NCT00541229|20928665|P4|STARTED|Washout Period II (Week 7-10)||12
8493035|NCT00541229|20928666|P3|STARTED|Washout Period II (Week 7-10)||12
8493036|NCT00541229|20928667|P2|STARTED|Washout Period II (Week 7-10)||12
8493037|NCT00541229|20928668|P1|STARTED|Washout Period II (Week 7-10)||11
8493038|NCT00541229|20928663|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
8493039|NCT00541229|20928664|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
8493040|NCT00541229|20928665|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
8493041|NCT00541229|20928666|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
8493042|NCT00541229|20928667|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
8493043|NCT00541229|20928668|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
8493044|NCT00541229|20928663|P6|COMPLETED|Treatment Period II (Week 6)||8
8493045|NCT00541229|20928664|P5|COMPLETED|Treatment Period II (Week 6)||11
8493046|NCT00541229|20928665|P4|COMPLETED|Treatment Period II (Week 6)||12
8493047|NCT00541229|20928666|P3|COMPLETED|Treatment Period II (Week 6)||12
8493048|NCT00541229|20928667|P2|COMPLETED|Treatment Period II (Week 6)||12
8493049|NCT00541229|20928668|P1|COMPLETED|Treatment Period II (Week 6)||11
8493050|NCT00541229|20928663|P6|STARTED|Treatment Period II (Week 6)||11
8493051|NCT00541229|20928664|P5|STARTED|Treatment Period II (Week 6)||13
8493052|NCT00541229|20928665|P4|STARTED|Treatment Period II (Week 6)||13
8493053|NCT00541229|20928666|P3|STARTED|Treatment Period II (Week 6)||13
8493054|NCT00541229|20928667|P2|STARTED|Treatment Period II (Week 6)||13
8493055|NCT00541229|20928668|P1|STARTED|Treatment Period II (Week 6)||13
8493056|NCT00541229|20928663|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
8493057|NCT00541229|20928664|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
8493058|NCT00541229|20928665|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
8493059|NCT00541229|20928666|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
8493060|NCT00541229|20928667|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
8493061|NCT00541229|20928668|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
8493062|NCT00541229|20928663|P6|COMPLETED|Washout Period I (Week 2-5)||11
8493063|NCT00541229|20928664|P5|COMPLETED|Washout Period I (Week 2-5)||13
8493064|NCT00541229|20928665|P4|COMPLETED|Washout Period I (Week 2-5)||13
8493065|NCT00541229|20928666|P3|COMPLETED|Washout Period I (Week 2-5)||13
8493066|NCT00541229|20928667|P2|COMPLETED|Washout Period I (Week 2-5)||13
8493067|NCT00541229|20928668|P1|COMPLETED|Washout Period I (Week 2-5)||13
8493068|NCT00541229|20928663|P6|STARTED|Washout Period I (Week 2-5)||16
8493069|NCT00541229|20928664|P5|STARTED|Washout Period I (Week 2-5)||14
8493070|NCT00541229|20928665|P4|STARTED|Washout Period I (Week 2-5)||17
8493071|NCT00541229|20928666|P3|STARTED|Washout Period I (Week 2-5)||17
8493072|NCT00541229|20928667|P2|STARTED|Washout Period I (Week 2-5)||15
8493073|NCT00541229|20928668|P1|STARTED|Washout Period I (Week 2-5)||17
8493074|NCT00541229|20928663|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
8493075|NCT00541229|20928664|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
8493076|NCT00541229|20928665|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
8493077|NCT00541229|20928666|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
8493078|NCT00541229|20928667|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
8493079|NCT00541229|20928668|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
8493080|NCT00541229|20928663|P6|COMPLETED|Treatment Period I (Week 1)||16
8493081|NCT00541229|20928664|P5|COMPLETED|Treatment Period I (Week 1)||14
8493082|NCT00541229|20928665|P4|COMPLETED|Treatment Period I (Week 1)||17
8493083|NCT00541229|20928666|P3|COMPLETED|Treatment Period I (Week 1)||17
8493084|NCT00541229|20928667|P2|COMPLETED|Treatment Period I (Week 1)||15
8493085|NCT00541229|20928668|P1|COMPLETED|Treatment Period I (Week 1)||17
8493086|NCT00541229|20928663|P6|STARTED|Treatment Period I (Week 1)||18
8493087|NCT00541229|20928664|P5|STARTED|Treatment Period I (Week 1)||14
8493088|NCT00541229|20928665|P4|STARTED|Treatment Period I (Week 1)||18
8493089|NCT00541229|20928666|P3|STARTED|Treatment Period I (Week 1)||20
8493090|NCT00541229|20928667|P2|STARTED|Treatment Period I (Week 1)||16
8493091|NCT00541229|20928668|P1|STARTED|Treatment Period I (Week 1)||17
8493092|NCT00541190|20928678|P2|NOT COMPLETED|Overall Study||0
8493093|NCT00541190|20928679|P1|NOT COMPLETED|Overall Study||0
8493094|NCT00541190|20928678|P2|COMPLETED|Overall Study||11
8493095|NCT00541190|20928679|P1|COMPLETED|Overall Study||10
8493096|NCT00541190|20928678|P2|STARTED|Overall Study||11
8493097|NCT00541190|20928679|P1|STARTED|Overall Study||10
8493098|NCT00541099|20928687|P1|NOT COMPLETED|Overall Study||3
8493099|NCT00541099|20928687|P1|COMPLETED|Overall Study||8
8493100|NCT00541099|20928687|P1|STARTED|Overall Study||11
8493101|NCT00541034|20928695|P1|NOT COMPLETED|Overall Study||3
8493102|NCT00541034|20928695|P1|COMPLETED|Overall Study||46
8493103|NCT00541034|20928695|P1|STARTED|Overall Study||49
8493104|NCT00540982|20928699|P1|NOT COMPLETED|Overall Study||0
8493105|NCT00540982|20928699|P1|COMPLETED|Overall Study||47
8493106|NCT00540982|20928699|P1|Severe Liver Dysfunction|Overall Study||12
8493107|NCT00540982|20928699|P1|Moderate Liver Dysfunction|Overall Study||18
8493108|NCT00540982|20928699|P1|Mild Liver Dysfunction|Overall Study||6
8493109|NCT00540982|20928699|P1|Normal Liver Function|Overall Study||11
8493110|NCT00540982|20928699|P1|STARTED|Overall Study||47
8493111|NCT00540969|20928723|P2|NOT COMPLETED|Overall Study||0
8493112|NCT00540969|20928724|P1|NOT COMPLETED|Overall Study||0
8493113|NCT00540969|20928723|P2|COMPLETED|Overall Study||1
8493114|NCT00540969|20928724|P1|COMPLETED|Overall Study||2
8493115|NCT00540969|20928723|P2|STARTED|Overall Study||1
8493116|NCT00540969|20928724|P1|STARTED|Overall Study||2
8493117|NCT00540722|20928734|P1|NOT COMPLETED|Overall Study||0
8493118|NCT00540722|20928734|P1|COMPLETED|Overall Study||56
8493119|NCT00540722|20928734|P1|STARTED|Overall Study||56
8493120|NCT00540644|20928744|P2|NOT COMPLETED|Overall Study||9
8493121|NCT00540644|20928745|P1|NOT COMPLETED|Overall Study||9
8493122|NCT00540644|20928744|P2|COMPLETED|Overall Study||13
8493123|NCT00540644|20928745|P1|COMPLETED|Overall Study||39
8493124|NCT00540644|20928744|P2|STARTED|Overall Study||22
8493125|NCT00540644|20928745|P1|STARTED|Overall Study||48
8493126|NCT00540592|20928765|P10|NOT COMPLETED|Overall Study||2
8493127|NCT00540592|20928766|P9|NOT COMPLETED|Overall Study||1
8493128|NCT00540592|20928767|P8|NOT COMPLETED|Overall Study||1
8493129|NCT00540592|20928768|P7|NOT COMPLETED|Overall Study||0
8493130|NCT00540592|20928769|P6|NOT COMPLETED|Overall Study||0
8493131|NCT00540592|20928770|P5|NOT COMPLETED|Overall Study||1
8493132|NCT00540592|20928771|P4|NOT COMPLETED|Overall Study||1
8493133|NCT00540592|20928772|P3|NOT COMPLETED|Overall Study||1
8493134|NCT00540592|20928773|P2|NOT COMPLETED|Overall Study||1
8493135|NCT00540592|20928774|P1|NOT COMPLETED|Overall Study||2
8493136|NCT00540592|20928765|P10|COMPLETED|Overall Study||201
8493137|NCT00540592|20928766|P9|COMPLETED|Overall Study||199
8493138|NCT00540592|20928767|P8|COMPLETED|Overall Study||198
8493139|NCT00540592|20928768|P7|COMPLETED|Overall Study||198
8493140|NCT00540592|20928769|P6|COMPLETED|Overall Study||198
8493141|NCT00540592|20928770|P5|COMPLETED|Overall Study||198
8493142|NCT00540592|20928771|P4|COMPLETED|Overall Study||201
8493143|NCT00540592|20928772|P3|COMPLETED|Overall Study||201
8493144|NCT00540592|20928773|P2|COMPLETED|Overall Study||201
8493145|NCT00540592|20928774|P1|COMPLETED|Overall Study||202
8493146|NCT00540592|20928765|P10|Completed at Day 180|Overall Study||189
8493147|NCT00540592|20928766|P9|Completed at Day 180|Overall Study||198
8493148|NCT00540592|20928767|P8|Completed at Day 180|Overall Study||193
8493149|NCT00540592|20928768|P7|Completed at Day 180|Overall Study||196
8493150|NCT00540592|20928769|P6|Completed at Day 180|Overall Study||198
8493151|NCT00540592|20928770|P5|Completed at Day 180|Overall Study||195
8493152|NCT00540592|20928771|P4|Completed at Day 180|Overall Study||197
8493153|NCT00540592|20928772|P3|Completed at Day 180|Overall Study||197
8493154|NCT00540592|20928773|P2|Completed at Day 180|Overall Study||201
8493155|NCT00540592|20928774|P1|Completed at Day 180|Overall Study||200
8493156|NCT00540592|20928765|P10|STARTED|Overall Study||203
8493157|NCT00540592|20928766|P9|STARTED|Overall Study||200
8493158|NCT00540592|20928767|P8|STARTED|Overall Study||199
8493159|NCT00540592|20928768|P7|STARTED|Overall Study||198
8493160|NCT00540592|20928769|P6|STARTED|Overall Study||198
8493161|NCT00540592|20928770|P5|STARTED|Overall Study||199
8493162|NCT00540592|20928771|P4|STARTED|Overall Study||202
8493163|NCT00540592|20928772|P3|STARTED|Overall Study||202
8493164|NCT00540592|20928773|P2|STARTED|Overall Study||202
8493165|NCT00540592|20928774|P1|STARTED|Overall Study||204
8493166|NCT00540579|20929006|P1|NOT COMPLETED|Overall Study||0
8493167|NCT00540579|20929006|P1|COMPLETED|Overall Study||23
8493168|NCT00540579|20929006|P1|STARTED|Overall Study||23
8493169|NCT00540514|20929013|P2|NOT COMPLETED|Overall Study||266
8493170|NCT00540514|20929014|P1|NOT COMPLETED|Overall Study||246
8493171|NCT00540514|20929013|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
8493172|NCT00540514|20929014|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
8493173|NCT00540514|20929013|P2|Biomarker Population|Overall Study||36
8493174|NCT00540514|20929014|P1|Biomarker Population|Overall Study||35
8493175|NCT00540514|20929013|P2|Treated|Overall Study||524
8493176|NCT00540514|20929014|P1|Treated|Overall Study||514
8493177|NCT00540514|20929013|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
8493178|NCT00540514|20929014|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
8493179|NCT00540449|20929046|P2|NOT COMPLETED|Overall Study||78
8493180|NCT00540449|20929047|P1|NOT COMPLETED|Overall Study||84
8493181|NCT00540449|20929046|P2|COMPLETED|Overall Study||266
8493182|NCT00540449|20929047|P1|COMPLETED|Overall Study||262
8493183|NCT00540449|20929046|P2|STARTED|Overall Study||344
8493184|NCT00540449|20929047|P1|STARTED|Overall Study||346
8493185|NCT00540436|20929069|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
8493186|NCT00540436|20929069|P1|COMPLETED|Second 12-Week Treatment Period||21
8493187|NCT00540436|20929069|P1|STARTED|Second 12-Week Treatment Period||22
8493188|NCT00540436|20929069|P1|NOT COMPLETED|First 12-Week Treatment Period||3
8493189|NCT00540436|20929069|P1|COMPLETED|First 12-Week Treatment Period||22
8493190|NCT00540436|20929069|P1|STARTED|First 12-Week Treatment Period||25
8493191|NCT00540423|20929084|P3|NOT COMPLETED|Open-Label Treatment Period||2
8493192|NCT00540423|20929085|P2|NOT COMPLETED|Open-Label Treatment Period||0
8493193|NCT00540423|20929086|P1|NOT COMPLETED|Open-Label Treatment Period||0
8493194|NCT00540423|20929084|P3|COMPLETED|Open-Label Treatment Period||20
8493195|NCT00540423|20929085|P2|COMPLETED|Open-Label Treatment Period||0
8493196|NCT00540423|20929086|P1|COMPLETED|Open-Label Treatment Period||0
8493197|NCT00540423|20929084|P3|STARTED|Open-Label Treatment Period||22
8493198|NCT00540423|20929085|P2|STARTED|Open-Label Treatment Period||0
8493199|NCT00540423|20929086|P1|STARTED|Open-Label Treatment Period||0
8493200|NCT00540423|20929084|P3|NOT COMPLETED|Double-Blind Treatment Period||0
8493201|NCT00540423|20929085|P2|NOT COMPLETED|Double-Blind Treatment Period||1
8493202|NCT00540423|20929086|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8493203|NCT00540423|20929084|P3|COMPLETED|Double-Blind Treatment Period||0
8493204|NCT00540423|20929085|P2|COMPLETED|Double-Blind Treatment Period||14
8493205|NCT00540423|20929086|P1|COMPLETED|Double-Blind Treatment Period||8
8493206|NCT00540423|20929084|P3|STARTED|Double-Blind Treatment Period||0
8493207|NCT00540423|20929085|P2|STARTED|Double-Blind Treatment Period||15
8493208|NCT00540423|20929086|P1|STARTED|Double-Blind Treatment Period||8
8493209|NCT00540293|20929136|P1|NOT COMPLETED|Overall Study||35
8493210|NCT00540293|20929136|P1|COMPLETED|Overall Study||390
8493211|NCT00540293|20929136|P1|STARTED|Overall Study||425
8493212|NCT00540228|20929184|P5|NOT COMPLETED|Overall Study||0
8493213|NCT00540228|20929185|P4|NOT COMPLETED|Overall Study||0
8493214|NCT00540228|20929186|P3|NOT COMPLETED|Overall Study||0
8493215|NCT00540228|20929187|P2|NOT COMPLETED|Overall Study||1
8493216|NCT00540228|20929188|P1|NOT COMPLETED|Overall Study||3
8493217|NCT00540228|20929184|P5|COMPLETED|Overall Study||202
8493218|NCT00540228|20929185|P4|COMPLETED|Overall Study||202
8493219|NCT00540228|20929186|P3|COMPLETED|Overall Study||204
8493220|NCT00540228|20929187|P2|COMPLETED|Overall Study||197
8493221|NCT00540228|20929188|P1|COMPLETED|Overall Study||197
8493222|NCT00540228|20929184|P5|STARTED|Overall Study||202
8493223|NCT00540228|20929185|P4|STARTED|Overall Study||202
8493224|NCT00540228|20929186|P3|STARTED|Overall Study||204
8493225|NCT00540228|20929187|P2|STARTED|Overall Study||198
8493226|NCT00540228|20929188|P1|STARTED|Overall Study||200
8493227|NCT00540124|20929258|P3|NOT COMPLETED|Overall Study||1
8493228|NCT00540124|20929259|P2|NOT COMPLETED|Overall Study||3
8493229|NCT00540124|20929260|P1|NOT COMPLETED|Overall Study||4
8493230|NCT00540124|20929258|P3|COMPLETED|Overall Study||48
8493231|NCT00540124|20929259|P2|COMPLETED|Overall Study||48
8493232|NCT00540124|20929260|P1|COMPLETED|Overall Study||47
8493233|NCT00540124|20929258|P3|STARTED|Overall Study||49
8493234|NCT00540124|20929259|P2|STARTED|Overall Study||51
8493235|NCT00540124|20929260|P1|STARTED|Overall Study||51
8493236|NCT00540046|20929306|P2|NOT COMPLETED|Overall Study||23
8493237|NCT00540046|20929307|P1|NOT COMPLETED|Overall Study||33
8493238|NCT00540046|20929306|P2|COMPLETED|Overall Study||88
8493239|NCT00540046|20929307|P1|COMPLETED|Overall Study||71
8493240|NCT00540046|20929306|P2|STARTED|Overall Study||111
8493241|NCT00540046|20929307|P1|STARTED|Overall Study||104
8493242|NCT00540007|20929317|P2|NOT COMPLETED|Overall Study||0
8493243|NCT00540007|20929318|P1|NOT COMPLETED|Overall Study||0
8493244|NCT00540007|20929317|P2|COMPLETED|Overall Study||42
8493245|NCT00540007|20929318|P1|COMPLETED|Overall Study||38
8493246|NCT00540007|20929317|P2|STARTED|Overall Study||42
8493247|NCT00540007|20929318|P1|STARTED|Overall Study||38
8493248|NCT00539994|20929343|P3|NOT COMPLETED|Overall Study||2
8493249|NCT00539994|20929344|P2|NOT COMPLETED|Overall Study||1
8493250|NCT00539994|20929345|P1|NOT COMPLETED|Overall Study||3
8493251|NCT00539994|20929343|P3|COMPLETED|Overall Study||13
8493252|NCT00539994|20929344|P2|COMPLETED|Overall Study||18
8493253|NCT00539994|20929345|P1|COMPLETED|Overall Study||20
8493254|NCT00539994|20929343|P3|STARTED|Overall Study||15
8493255|NCT00539994|20929344|P2|STARTED|Overall Study||19
8493256|NCT00539994|20929345|P1|STARTED|Overall Study||23
8493257|NCT00539942|20929384|P2|NOT COMPLETED|Overall Study||0
8493258|NCT00539942|20929385|P1|NOT COMPLETED|Overall Study||0
8493259|NCT00539942|20929384|P2|COMPLETED|Overall Study||3
8493260|NCT00539942|20929385|P1|COMPLETED|Overall Study||4
8493261|NCT00539942|20929384|P2|STARTED|Overall Study||3
8493262|NCT00539942|20929385|P1|STARTED|Overall Study||4
8493263|NCT00539864|20929395|P2|NOT COMPLETED|Overall Study||2
8493264|NCT00539864|20929396|P1|NOT COMPLETED|Overall Study||1
8493265|NCT00539864|20929395|P2|COMPLETED|Overall Study||300
8493266|NCT00539864|20929396|P1|COMPLETED|Overall Study||299
8493267|NCT00539864|20929395|P2|STARTED|Overall Study||302
8493268|NCT00539864|20929396|P1|STARTED|Overall Study||300
8493269|NCT00539838|20929411|P3|NOT COMPLETED|Overall Study||9
8493270|NCT00539838|20929412|P2|NOT COMPLETED|Overall Study||6
8493271|NCT00539838|20929413|P1|NOT COMPLETED|Overall Study||7
8493272|NCT00539838|20929411|P3|COMPLETED|Overall Study||1
8493273|NCT00539838|20929412|P2|COMPLETED|Overall Study||5
8493274|NCT00539838|20929413|P1|COMPLETED|Overall Study||5
8493275|NCT00539838|20929411|P3|STARTED|Overall Study||10
8493276|NCT00539838|20929412|P2|STARTED|Overall Study||11
8493277|NCT00539838|20929413|P1|STARTED|Overall Study||12
8493278|NCT00539734|20929463|P1|NOT COMPLETED|Overall Study||1
8493279|NCT00539734|20929463|P1|COMPLETED|Overall Study||25
8493280|NCT00539734|20929463|P1|STARTED|Overall Study||26
8493281|NCT00539695|20929468|P1|NOT COMPLETED|Overall Study||13
8493282|NCT00539695|20929468|P1|COMPLETED|Overall Study||12
8493283|NCT00539695|20929468|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
8493284|NCT00539695|20929468|P1|STARTED|Overall Study||25
8493285|NCT00539656|20929474|P1|NOT COMPLETED|Overall Study||0
8493286|NCT00539656|20929474|P1|COMPLETED|Overall Study||3
8493287|NCT00539656|20929474|P1|STARTED|Overall Study||3
8493288|NCT00539617|20929480|P1|NOT COMPLETED|Treatment Period||0
8493289|NCT00539617|20929480|P1|COMPLETED|Treatment Period||3
8493290|NCT00539617|20929480|P1|STARTED|Treatment Period||3
8493291|NCT00539617|20929480|P1|NOT COMPLETED|Run-In Period||1
8493292|NCT00539617|20929480|P1|COMPLETED|Run-In Period||3
8493293|NCT00539617|20929480|P1|STARTED|Run-In Period||4
8493294|NCT00539617|20929480|P1|NOT COMPLETED|Pre-screening Period||3
8493295|NCT00539617|20929480|P1|COMPLETED|Pre-screening Period||4
8493296|NCT00539617|20929480|P1|STARTED|Pre-screening Period||7
8493297|NCT00539591|20929489|P3|NOT COMPLETED|Overall Study||3
8493298|NCT00539591|20929490|P2|NOT COMPLETED|Overall Study||2
8493299|NCT00539591|20929491|P1|NOT COMPLETED|Overall Study||5
8493300|NCT00539591|20929489|P3|COMPLETED|Overall Study||1
8493301|NCT00539591|20929490|P2|COMPLETED|Overall Study||0
8493302|NCT00539591|20929491|P1|COMPLETED|Overall Study||18
8493303|NCT00539591|20929489|P3|STARTED|Overall Study||4
8493304|NCT00539591|20929490|P2|STARTED|Overall Study||2
8493305|NCT00539591|20929491|P1|STARTED|Overall Study||23
8493306|NCT00539539|20929601|P2|NOT COMPLETED|Overall Study||0
8493307|NCT00539539|20929602|P1|NOT COMPLETED|Overall Study||0
8493308|NCT00539539|20929601|P2|COMPLETED|Overall Study||771
8493309|NCT00539539|20929602|P1|COMPLETED|Overall Study||815
8493310|NCT00539539|20929601|P2|STARTED|Overall Study||771
8493311|NCT00539539|20929602|P1|STARTED|Overall Study||815
8493312|NCT00539526|20929625|P3|NOT COMPLETED|Overall Study||2
8493313|NCT00539526|20929626|P2|NOT COMPLETED|Overall Study||2
8493314|NCT00539526|20929627|P1|NOT COMPLETED|Overall Study||3
8493315|NCT00539526|20929625|P3|COMPLETED|Overall Study||36
8493316|NCT00539526|20929626|P2|COMPLETED|Overall Study||31
8493317|NCT00539526|20929627|P1|COMPLETED|Overall Study||32
8493318|NCT00539526|20929625|P3|STARTED|Overall Study||38
8493319|NCT00539526|20929626|P2|STARTED|Overall Study||33
8493320|NCT00539526|20929627|P1|STARTED|Overall Study||35
8493321|NCT00539513|20929643|P2|NOT COMPLETED|Overall Study||2
8493322|NCT00539513|20929644|P1|NOT COMPLETED|Overall Study||2
8493323|NCT00539513|20929643|P2|COMPLETED|Overall Study||3
8493324|NCT00539513|20929644|P1|COMPLETED|Overall Study||3
8493325|NCT00539513|20929643|P2|Received Allocated Intervention|Overall Study||4
8493326|NCT00539513|20929644|P1|Received Allocated Intervention|Overall Study||3
8493327|NCT00539513|20929643|P2|STARTED|Overall Study||5
8493328|NCT00539513|20929644|P1|STARTED|Overall Study||5
8493329|NCT00539500|20929656|P1|NOT COMPLETED|Overall Study||3
8493330|NCT00539500|20929656|P1|COMPLETED|Overall Study||0
8493331|NCT00539500|20929656|P1|STARTED|Overall Study||3
8493332|NCT00539305|20929664|P2|NOT COMPLETED|Overall Study||2
8493333|NCT00539305|20929665|P1|NOT COMPLETED|Overall Study||1
8493334|NCT00539305|20929664|P2|COMPLETED|Overall Study||10
8493335|NCT00539305|20929665|P1|COMPLETED|Overall Study||9
8493336|NCT00539305|20929664|P2|STARTED|Overall Study||12
8493337|NCT00539305|20929665|P1|STARTED|Overall Study||10
8493338|NCT00539279|20929679|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
8493339|NCT00539279|20929680|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
8493340|NCT00539279|20929679|P2|COMPLETED|6-Month Follow-Up Assessment||22
8493341|NCT00539279|20929680|P1|COMPLETED|6-Month Follow-Up Assessment||17
8493342|NCT00539279|20929679|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
8493343|NCT00539279|20929680|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
8493344|NCT00539279|20929679|P2|NOT COMPLETED|Post-Treatment Assessment||9
8493345|NCT00539279|20929680|P1|NOT COMPLETED|Post-Treatment Assessment||12
8493346|NCT00539279|20929679|P2|COMPLETED|Post-Treatment Assessment||29
8493347|NCT00539279|20929680|P1|COMPLETED|Post-Treatment Assessment||18
8493348|NCT00539279|20929679|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
8493349|NCT00539279|20929680|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
8493350|NCT00539279|20929679|P2|NOT COMPLETED|Treatment||8
8493351|NCT00539279|20929680|P1|NOT COMPLETED|Treatment||11
8493352|NCT00539279|20929679|P2|COMPLETED|Treatment||38
8493353|NCT00539279|20929680|P1|COMPLETED|Treatment||30
8493354|NCT00539279|20929679|P2|STARTED|Treatment||46
8493355|NCT00539279|20929680|P1|STARTED|Treatment||41
8493356|NCT00539253|20929698|P1|NOT COMPLETED|Overall Study||26
8493357|NCT00539253|20929698|P1|COMPLETED|Overall Study||19
8493358|NCT00539253|20929698|P1|STARTED|Overall Study||45
8493359|NCT00539240|20929706|P3|NOT COMPLETED|Overall Study||15
8493360|NCT00539240|20929707|P2|NOT COMPLETED|Overall Study||7
8493361|NCT00539240|20929708|P1|NOT COMPLETED|Overall Study||6
8493362|NCT00539240|20929706|P3|COMPLETED|Overall Study||39
8493363|NCT00539240|20929707|P2|COMPLETED|Overall Study||48
8493364|NCT00539240|20929708|P1|COMPLETED|Overall Study||53
8493365|NCT00539240|20929706|P3|STARTED|Overall Study||54
8493366|NCT00539240|20929707|P2|STARTED|Overall Study||55
8493367|NCT00539240|20929708|P1|STARTED|Overall Study||59
8493368|NCT00539188|20929727|P2|NOT COMPLETED|Overall Study||1
8493369|NCT00539188|20929728|P1|NOT COMPLETED|Overall Study||3
8493370|NCT00539188|20929727|P2|COMPLETED|Overall Study||1
8493371|NCT00539188|20929728|P1|COMPLETED|Overall Study||1
8493372|NCT00539188|20929727|P2|Received Allocated Intervention|Overall Study||2
8493373|NCT00539188|20929728|P1|Received Allocated Intervention|Overall Study||3
8493374|NCT00539188|20929727|P2|STARTED|Overall Study||2
8493375|NCT00539188|20929728|P1|STARTED|Overall Study||4
8493376|NCT00539110|20929742|P2|NOT COMPLETED|Overall Study||0
8493377|NCT00539110|20929743|P1|NOT COMPLETED|Overall Study||0
8493378|NCT00539110|20929742|P2|COMPLETED|Overall Study||5
8493379|NCT00539110|20929743|P1|COMPLETED|Overall Study||5
8493380|NCT00539110|20929742|P2|STARTED|Overall Study||5
8493381|NCT00539110|20929743|P1|STARTED|Overall Study||5
8493382|NCT00539032|20929751|P2|NOT COMPLETED|Overall Study||1
8493383|NCT00539032|20929752|P1|NOT COMPLETED|Overall Study||2
8493384|NCT00539032|20929751|P2|COMPLETED|Overall Study||84
8493385|NCT00539032|20929752|P1|COMPLETED|Overall Study||151
8493386|NCT00539032|20929751|P2|STARTED|Overall Study||85
8493387|NCT00539032|20929752|P1|STARTED|Overall Study||153
8493388|NCT00539006|20929766|P4|NOT COMPLETED|Post-Study||0
8493389|NCT00539006|20929767|P3|NOT COMPLETED|Post-Study||0
8493390|NCT00539006|20929768|P2|NOT COMPLETED|Post-Study||0
8493391|NCT00539006|20929769|P1|NOT COMPLETED|Post-Study||0
8493392|NCT00539006|20929766|P4|COMPLETED|Post-Study||81
8493393|NCT00539006|20929767|P3|COMPLETED|Post-Study||77
8493394|NCT00539006|20929768|P2|COMPLETED|Post-Study||83
8493395|NCT00539006|20929769|P1|COMPLETED|Post-Study||75
8493396|NCT00539006|20929766|P4|STARTED|Post-Study||81
8493397|NCT00539006|20929767|P3|STARTED|Post-Study||77
8493398|NCT00539006|20929768|P2|STARTED|Post-Study||83
8493399|NCT00539006|20929769|P1|STARTED|Post-Study||75
8493400|NCT00539006|20929766|P4|NOT COMPLETED|Treatment Period 2||0
8493401|NCT00539006|20929767|P3|NOT COMPLETED|Treatment Period 2||0
8493402|NCT00539006|20929768|P2|NOT COMPLETED|Treatment Period 2||1
8493403|NCT00539006|20929769|P1|NOT COMPLETED|Treatment Period 2||1
8493404|NCT00539006|20929766|P4|COMPLETED|Treatment Period 2||81
8493405|NCT00539006|20929767|P3|COMPLETED|Treatment Period 2||77
8493406|NCT00539006|20929768|P2|COMPLETED|Treatment Period 2||83
8493407|NCT00539006|20929769|P1|COMPLETED|Treatment Period 2||75
8493408|NCT00539006|20929766|P4|STARTED|Treatment Period 2||81
8493409|NCT00539006|20929767|P3|STARTED|Treatment Period 2||77
8493410|NCT00539006|20929768|P2|STARTED|Treatment Period 2||84
8493411|NCT00539006|20929769|P1|STARTED|Treatment Period 2||76
8493412|NCT00539006|20929766|P4|NOT COMPLETED|Washout||9
8493413|NCT00539006|20929767|P3|NOT COMPLETED|Washout||16
8493414|NCT00539006|20929768|P2|NOT COMPLETED|Washout||10
8493415|NCT00539006|20929769|P1|NOT COMPLETED|Washout||20
8493416|NCT00539006|20929766|P4|COMPLETED|Washout||81
8493417|NCT00539006|20929767|P3|COMPLETED|Washout||77
8493418|NCT00539006|20929768|P2|COMPLETED|Washout||84
8493419|NCT00539006|20929769|P1|COMPLETED|Washout||76
8493420|NCT00539006|20929766|P4|STARTED|Washout||90
8493421|NCT00539006|20929767|P3|STARTED|Washout||93
8493422|NCT00539006|20929768|P2|STARTED|Washout||94
8493423|NCT00539006|20929769|P1|STARTED|Washout||96
8493424|NCT00539006|20929766|P4|NOT COMPLETED|Treatment Period 1||1
8493425|NCT00539006|20929767|P3|NOT COMPLETED|Treatment Period 1||2
8493426|NCT00539006|20929768|P2|NOT COMPLETED|Treatment Period 1||0
8493427|NCT00539006|20929769|P1|NOT COMPLETED|Treatment Period 1||0
8493428|NCT00539006|20929766|P4|COMPLETED|Treatment Period 1||90
8493429|NCT00539006|20929767|P3|COMPLETED|Treatment Period 1||93
8493430|NCT00539006|20929768|P2|COMPLETED|Treatment Period 1||94
8493431|NCT00539006|20929769|P1|COMPLETED|Treatment Period 1||96
8493432|NCT00539006|20929766|P4|STARTED|Treatment Period 1||91
8493433|NCT00539006|20929767|P3|STARTED|Treatment Period 1||95
8493434|NCT00539006|20929768|P2|STARTED|Treatment Period 1||94
8493435|NCT00539006|20929769|P1|STARTED|Treatment Period 1||96
8493436|NCT00539006|20929766|P4|NOT COMPLETED|Pre-treatment||0
8493437|NCT00539006|20929767|P3|NOT COMPLETED|Pre-treatment||0
8493438|NCT00539006|20929768|P2|NOT COMPLETED|Pre-treatment||1
8493439|NCT00539006|20929769|P1|NOT COMPLETED|Pre-treatment||0
8493440|NCT00539006|20929766|P4|COMPLETED|Pre-treatment||91
8493441|NCT00539006|20929767|P3|COMPLETED|Pre-treatment||95
8493442|NCT00539006|20929768|P2|COMPLETED|Pre-treatment||94
8493443|NCT00539006|20929769|P1|COMPLETED|Pre-treatment||96
8493444|NCT00539006|20929766|P4|STARTED|Pre-treatment||91
8493445|NCT00539006|20929767|P3|STARTED|Pre-treatment||95
8493446|NCT00539006|20929768|P2|STARTED|Pre-treatment||95
8493447|NCT00539006|20929769|P1|STARTED|Pre-treatment||96
8493448|NCT00538980|20929799|P1|NOT COMPLETED|Overall Study||10
8493449|NCT00538980|20929799|P1|COMPLETED|Overall Study||0
8493450|NCT00538980|20929799|P1|STARTED|Overall Study||10
8493451|NCT00538915|20929807|P1|NOT COMPLETED|Overall Study||11
8493452|NCT00538915|20929807|P1|COMPLETED|Overall Study||52
8493453|NCT00538915|20929807|P1|STARTED|Overall Study||63
8493454|NCT00538902|20929814|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
8493455|NCT00538902|20929815|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
8493456|NCT00538902|20929816|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
8493457|NCT00538902|20929814|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
8493458|NCT00538902|20929815|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
8493459|NCT00538902|20929816|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
8493460|NCT00538902|20929814|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
8493461|NCT00538902|20929815|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
8493462|NCT00538902|20929816|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
8493463|NCT00538902|20929814|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
8493464|NCT00538902|20929815|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
8493465|NCT00538902|20929816|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
8493466|NCT00538902|20929814|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
8493467|NCT00538902|20929815|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
8493468|NCT00538902|20929816|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
8493469|NCT00538902|20929814|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
8493470|NCT00538902|20929815|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
8493471|NCT00538902|20929816|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
8493472|NCT00538863|20929851|P1|NOT COMPLETED|Open-label Maintenance||106
8493473|NCT00538863|20929851|P1|COMPLETED|Open-label Maintenance||163
8493474|NCT00538863|20929851|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
8493475|NCT00538863|20929851|P1|NOT COMPLETED|Open-label Titration||45
8493476|NCT00538863|20929851|P1|COMPLETED|Open-label Titration||184
8493477|NCT00538863|20929851|P1|STARTED|Open-label Titration||229
8493478|NCT00538850|20929857|P3|NOT COMPLETED|Placebo - Double-blind||3
8493479|NCT00538850|20929858|P2|NOT COMPLETED|Placebo - Double-blind||0
8493480|NCT00538850|20929859|P1|NOT COMPLETED|Placebo - Double-blind||0
8493481|NCT00538850|20929857|P3|COMPLETED|Placebo - Double-blind||95
8493482|NCT00538850|20929858|P2|COMPLETED|Placebo - Double-blind||0
8493483|NCT00538850|20929859|P1|COMPLETED|Placebo - Double-blind||0
8493484|NCT00538850|20929857|P3|STARTED|Placebo - Double-blind||98
8493485|NCT00538850|20929858|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493486|NCT00538850|20929859|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493487|NCT00538850|20929857|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493488|NCT00538850|20929858|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
8493489|NCT00538850|20929859|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493490|NCT00538850|20929857|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493491|NCT00538850|20929858|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
8493492|NCT00538850|20929859|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493493|NCT00538850|20929857|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493494|NCT00538850|20929858|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
8493495|NCT00538850|20929859|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493496|NCT00538850|20929857|P3|NOT COMPLETED|Titration Period||0
8493497|NCT00538850|20929858|P2|NOT COMPLETED|Titration Period||0
8493498|NCT00538850|20929859|P1|NOT COMPLETED|Titration Period||32
8493499|NCT00538850|20929857|P3|COMPLETED|Titration Period||0
8493500|NCT00538850|20929858|P2|COMPLETED|Titration Period||0
8493501|NCT00538850|20929859|P1|COMPLETED|Titration Period||98
8493502|NCT00538850|20929857|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
8493503|NCT00538850|20929858|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
8493504|NCT00538850|20929859|P1|STARTED|Titration Period||130
8493505|NCT00538824|20929871|P1|NOT COMPLETED|Overall Study||0
8493506|NCT00538824|20929871|P1|COMPLETED|Overall Study||5
8493507|NCT00538824|20929871|P1|Progression of Disease|Overall Study||2
8493508|NCT00538824|20929871|P1|STARTED|Overall Study||5
8493509|NCT00538785|20929877|P2|NOT COMPLETED|Overall Study||17
8493510|NCT00538785|20929878|P1|NOT COMPLETED|Overall Study||19
8493511|NCT00538785|20929877|P2|COMPLETED|Overall Study||595
8493512|NCT00538785|20929878|P1|COMPLETED|Overall Study||604
8493513|NCT00538785|20929877|P2|STARTED|Overall Study||612
8493514|NCT00538785|20929878|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
8493515|NCT00538759|20929901|P2|NOT COMPLETED|Overall Study||0
8493516|NCT00538759|20929902|P1|NOT COMPLETED|Overall Study||0
8493517|NCT00538759|20929901|P2|COMPLETED|Overall Study||8
8493518|NCT00538759|20929902|P1|COMPLETED|Overall Study||13
8493519|NCT00538759|20929901|P2|STARTED|Overall Study||8
8493520|NCT00538759|20929902|P1|STARTED|Overall Study||13
8493521|NCT00538733|20929920|P1|NOT COMPLETED|Overall Study||12
8493522|NCT00538733|20929920|P1|COMPLETED|Overall Study||14
8493523|NCT00538733|20929920|P1|Removed to Pursue Alternative Theray|Overall Study||2
8493524|NCT00538733|20929920|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
8493525|NCT00538733|20929920|P1|Removed Due to Progression of Disease|Overall Study||1
8493526|NCT00538733|20929920|P1|STARTED|Overall Study||26
8493527|NCT00538681|20929932|P4|NOT COMPLETED|Overall Study||11
8493528|NCT00538681|20929933|P3|NOT COMPLETED|Overall Study||11
8493529|NCT00538681|20929934|P2|NOT COMPLETED|Overall Study||4
8493530|NCT00538681|20929935|P1|NOT COMPLETED|Overall Study||9
8493531|NCT00538681|20929932|P4|COMPLETED|Overall Study||0
8493532|NCT00538681|20929933|P3|COMPLETED|Overall Study||0
8493533|NCT00538681|20929934|P2|COMPLETED|Overall Study||0
8493534|NCT00538681|20929935|P1|COMPLETED|Overall Study||0
8493535|NCT00538681|20929932|P4|Received ≥1 Dose of Any Study Drug|Overall Study||11
8493536|NCT00538681|20929933|P3|Received ≥1 Dose of Any Study Drug|Overall Study||11
8493537|NCT00538681|20929934|P2|Received ≥1 Dose of Any Study Drug|Overall Study||4
8493538|NCT00538681|20929935|P1|Received ≥1 Dose of Any Study Drug|Overall Study||9
8493539|NCT00538681|20929932|P4|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
8493540|NCT00538681|20929933|P3|STARTED|Overall Study||11
8493541|NCT00538681|20929934|P2|STARTED|Overall Study||4
8493542|NCT00538681|20929935|P1|STARTED|Overall Study||9
8493543|NCT00538642|20929960|P2|NOT COMPLETED|Overall Study||5
8493544|NCT00538642|20929961|P1|NOT COMPLETED|Overall Study||1
8493545|NCT00538642|20929960|P2|COMPLETED|Overall Study||9
8493546|NCT00538642|20929961|P1|COMPLETED|Overall Study||9
8493547|NCT00538642|20929960|P2|STARTED|Overall Study||14
8493548|NCT00538642|20929961|P1|STARTED|Overall Study||10
8493549|NCT00538629|20930001|P1|NOT COMPLETED|Overall Study||22
8493550|NCT00538629|20930001|P1|COMPLETED|Overall Study||449
8493551|NCT00538629|20930001|P1|STARTED|Overall Study||471
8493552|NCT00538616|20930048|P2|NOT COMPLETED|Overall Study||0
8493553|NCT00538616|20930049|P1|NOT COMPLETED|Overall Study||0
8493554|NCT00538616|20930048|P2|COMPLETED|Overall Study||3
8493555|NCT00538616|20930049|P1|COMPLETED|Overall Study||5
8493556|NCT00538616|20930048|P2|STARTED|Overall Study||3
8493557|NCT00538616|20930049|P1|STARTED|Overall Study||5
8493558|NCT00538590|20930057|P2|NOT COMPLETED|Overall Study||0
8493559|NCT00538590|20930058|P1|NOT COMPLETED|Overall Study||1
8493560|NCT00538590|20930057|P2|COMPLETED|Overall Study||10
8493561|NCT00538590|20930058|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
8493562|NCT00538590|20930057|P2|STARTED|Overall Study||10
8493563|NCT00538590|20930058|P1|STARTED|Overall Study||10
8493564|NCT00538512|20930075|P3|NOT COMPLETED|Overall Study||13
8493565|NCT00538512|20930076|P2|NOT COMPLETED|Overall Study||30
8493566|NCT00538512|20930077|P1|NOT COMPLETED|Overall Study||27
8493567|NCT00538512|20930075|P3|COMPLETED|Overall Study||312
8493568|NCT00538512|20930076|P2|COMPLETED|Overall Study||783
8493569|NCT00538512|20930077|P1|COMPLETED|Overall Study||787
8493570|NCT00538512|20930075|P3|STARTED|Overall Study||325
8493571|NCT00538512|20930076|P2|STARTED|Overall Study||813
8493572|NCT00538512|20930077|P1|STARTED|Overall Study||814
8493573|NCT00538473|20930096|P2|NOT COMPLETED|Overall Study||0
8493574|NCT00538473|20930097|P1|NOT COMPLETED|Overall Study||1
8493575|NCT00538473|20930096|P2|COMPLETED|Overall Study||35
8493576|NCT00538473|20930097|P1|COMPLETED|Overall Study||32
8493577|NCT00538473|20930096|P2|STARTED|Overall Study||35
8493578|NCT00538473|20930097|P1|STARTED|Overall Study||33
8493579|NCT00538434|20930133|P4|NOT COMPLETED|Overall Study||6
8493580|NCT00538434|20930134|P3|NOT COMPLETED|Overall Study||7
8493581|NCT00538434|20930135|P2|NOT COMPLETED|Overall Study||11
8493582|NCT00538434|20930136|P1|NOT COMPLETED|Overall Study||9
8493583|NCT00538434|20930133|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
8493584|NCT00538434|20930134|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
8493585|NCT00538434|20930135|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
8493586|NCT00538434|20930136|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
8493587|NCT00538434|20930133|P4|Intent-to-treat (ITT) Population|Overall Study||57
8493588|NCT00538434|20930134|P3|Intent-to-treat (ITT) Population|Overall Study||57
8493589|NCT00538434|20930135|P2|Intent-to-treat (ITT) Population|Overall Study||57
8493590|NCT00538434|20930136|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
8493591|NCT00538434|20930133|P4|STARTED|Overall Study||57
8493592|NCT00538434|20930134|P3|STARTED|Overall Study||57
8493593|NCT00538434|20930135|P2|STARTED|Overall Study||57
8493594|NCT00538434|20930136|P1|STARTED|Overall Study||56
8493595|NCT00538304|20930160|P2|NOT COMPLETED|Overall Study||5
8493596|NCT00538304|20930161|P1|NOT COMPLETED|Overall Study||7
8493597|NCT00538304|20930160|P2|COMPLETED|Overall Study||66
8493598|NCT00538304|20930161|P1|COMPLETED|Overall Study||144
8493599|NCT00538304|20930160|P2|STARTED|Overall Study||71
8493600|NCT00538304|20930161|P1|STARTED|Overall Study||151
8493601|NCT00538291|20930177|P1|NOT COMPLETED|Overall Study||3
8493602|NCT00538291|20930177|P1|COMPLETED|Overall Study||10
8493603|NCT00538291|20930177|P1|STARTED|Overall Study||13
8493604|NCT00538213|20930184|P3|NOT COMPLETED|Overall Study||0
8493605|NCT00538213|20930185|P2|NOT COMPLETED|Overall Study||0
8493606|NCT00538213|20930186|P1|NOT COMPLETED|Overall Study||0
8493607|NCT00538213|20930184|P3|COMPLETED|Overall Study||38
8493608|NCT00538213|20930185|P2|COMPLETED|Overall Study||40
8493609|NCT00538213|20930186|P1|COMPLETED|Overall Study||55
8493610|NCT00538213|20930184|P3|STARTED|Overall Study||38
8493611|NCT00538213|20930185|P2|STARTED|Overall Study||40
8493612|NCT00538213|20930186|P1|STARTED|Overall Study||55
8493613|NCT00537979|20930235|P2|NOT COMPLETED|Overall Study||20
8493614|NCT00537979|20930236|P1|NOT COMPLETED|Overall Study||6
8493615|NCT00537979|20930235|P2|COMPLETED|Overall Study||89
8493616|NCT00537979|20930236|P1|COMPLETED|Overall Study||32
8493617|NCT00537979|20930235|P2|STARTED|Overall Study||109
8493618|NCT00537979|20930236|P1|STARTED|Overall Study||38
8493619|NCT00537940|20930252|P2|NOT COMPLETED|Overall Study||179
8493620|NCT00537940|20930253|P1|NOT COMPLETED|Overall Study||183
8493621|NCT00537940|20930252|P2|COMPLETED|Overall Study||62
8493622|NCT00537940|20930253|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
8493623|NCT00537940|20930252|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
8493624|NCT00537940|20930253|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
8493625|NCT00537940|20930252|P2|Completed Maintenance Phase|Overall Study||172
8493626|NCT00537940|20930253|P1|Completed Maintenance Phase|Overall Study||187
8493627|NCT00537940|20930252|P2|Completed Titration Phase|Overall Study||210
8493628|NCT00537940|20930253|P1|Completed Titration Phase|Overall Study||213
8493629|NCT00537940|20930252|P2|STARTED|Overall Study||241
8493630|NCT00537940|20930253|P1|STARTED|Overall Study||241
8493631|NCT00537823|20930277|P2|NOT COMPLETED|Overall Study||0
8493632|NCT00537823|20930278|P1|NOT COMPLETED|Overall Study||2
8493633|NCT00537823|20930277|P2|COMPLETED|Overall Study||2
8493634|NCT00537823|20930278|P1|COMPLETED|Overall Study||5
8493635|NCT00537823|20930277|P2|STARTED|Overall Study||2
8493636|NCT00537823|20930278|P1|STARTED|Overall Study||7
8493637|NCT00537810|20930304|P4|NOT COMPLETED|Overall Study||4
8493638|NCT00537810|20930305|P3|NOT COMPLETED|Overall Study||4
8493639|NCT00537810|20930306|P2|NOT COMPLETED|Overall Study||13
8493640|NCT00537810|20930307|P1|NOT COMPLETED|Overall Study||6
8493641|NCT00537810|20930304|P4|COMPLETED|Overall Study||22
8493642|NCT00537810|20930305|P3|COMPLETED|Overall Study||21
8493643|NCT00537810|20930306|P2|COMPLETED|Overall Study||14
8493644|NCT00537810|20930307|P1|COMPLETED|Overall Study||20
8493645|NCT00537810|20930304|P4|STARTED|Overall Study||26
8493646|NCT00537810|20930305|P3|STARTED|Overall Study||25
8493647|NCT00537810|20930306|P2|STARTED|Overall Study||27
8493648|NCT00537810|20930307|P1|STARTED|Overall Study||26
8493649|NCT00537771|20930323|P2|NOT COMPLETED|Overall Study||61
8493650|NCT00537771|20930324|P1|NOT COMPLETED|Overall Study||29
8493651|NCT00537771|20930323|P2|COMPLETED|Overall Study||114
8493652|NCT00537771|20930324|P1|COMPLETED|Overall Study||149
8493653|NCT00537771|20930323|P2|STARTED|Overall Study||175
8493654|NCT00537771|20930324|P1|STARTED|Overall Study||178
8493655|NCT00537745|20930334|P1|NOT COMPLETED|Overall Study||5
8493656|NCT00537745|20930334|P1|COMPLETED|Overall Study||9
8493657|NCT00537745|20930334|P1|Began Intervention|Overall Study||11
8493658|NCT00537745|20930334|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
8493659|NCT00537680|20930342|P3|NOT COMPLETED|Overall Study||0
8493660|NCT00537680|20930343|P2|NOT COMPLETED|Overall Study||2
8493661|NCT00537680|20930344|P1|NOT COMPLETED|Overall Study||0
8493662|NCT00537680|20930342|P3|COMPLETED|Overall Study||24
8493663|NCT00537680|20930343|P2|COMPLETED|Overall Study||22
8493664|NCT00537680|20930344|P1|COMPLETED|Overall Study||22
8493665|NCT00537680|20930342|P3|STARTED|Overall Study||24
8493666|NCT00537680|20930343|P2|STARTED|Overall Study||24
8493667|NCT00537680|20930344|P1|STARTED|Overall Study||22
8493668|NCT00537576|20930358|P6|NOT COMPLETED|Overall Study||0
8493669|NCT00537576|20930359|P5|NOT COMPLETED|Overall Study||0
8493670|NCT00537576|20930360|P4|NOT COMPLETED|Overall Study||0
8493671|NCT00537576|20930361|P3|NOT COMPLETED|Overall Study||0
8493672|NCT00537576|20930362|P2|NOT COMPLETED|Overall Study||0
8493673|NCT00537576|20930363|P1|NOT COMPLETED|Overall Study||0
8493674|NCT00537576|20930358|P6|COMPLETED|Overall Study||1
8493675|NCT00537576|20930359|P5|COMPLETED|Overall Study||1
8493676|NCT00537576|20930360|P4|COMPLETED|Overall Study||1
8493677|NCT00537576|20930361|P3|COMPLETED|Overall Study||3
8493678|NCT00537576|20930362|P2|COMPLETED|Overall Study||3
8493679|NCT00537576|20930363|P1|COMPLETED|Overall Study||3
8493680|NCT00537576|20930358|P6|STARTED|Overall Study||1
8493681|NCT00537576|20930359|P5|STARTED|Overall Study||1
8493682|NCT00537576|20930360|P4|STARTED|Overall Study||1
8493683|NCT00537576|20930361|P3|STARTED|Overall Study||3
8493684|NCT00537576|20930362|P2|STARTED|Overall Study||3
8493685|NCT00537576|20930363|P1|STARTED|Overall Study||3
8493686|NCT00537511|20930389|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
8493687|NCT00537511|20930389|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
8493688|NCT00537511|20930389|P1|STARTED|Maintenance Phase (Monotherapy)||8
8493689|NCT00537511|20930389|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
8493690|NCT00537511|20930389|P1|COMPLETED|Recovery Period (Monotherapy)||3
8493691|NCT00537511|20930389|P1|STARTED|Recovery Period (Monotherapy)||11
8493692|NCT00537511|20930389|P1|NOT COMPLETED|Extension Period (Combination)||6
8493693|NCT00537511|20930389|P1|COMPLETED|Extension Period (Combination)||11
8493694|NCT00537511|20930389|P1|STARTED|Extension Period (Combination)||17
8493695|NCT00537511|20930389|P1|NOT COMPLETED|Treatment Period (Combination)||5
8493696|NCT00537511|20930389|P1|COMPLETED|Treatment Period (Combination)||17
8493697|NCT00537511|20930389|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
8493698|NCT00537511|20930389|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
8493699|NCT00537511|20930389|P1|STARTED|Treatment Period (Combination)||22
8493700|NCT00537485|20930416|P2|NOT COMPLETED|Overall Study||10
8493701|NCT00537485|20930417|P1|NOT COMPLETED|Overall Study||15
8493702|NCT00537485|20930416|P2|COMPLETED|Overall Study||80
8493703|NCT00537485|20930417|P1|COMPLETED|Overall Study||75
8493704|NCT00537485|20930416|P2|STARTED|Overall Study||90
8493705|NCT00537485|20930417|P1|STARTED|Overall Study||90
8493706|NCT00537446|20930441|P1|NOT COMPLETED|Overall Study||0
8493707|NCT00537446|20930441|P1|COMPLETED|Overall Study||8
8493708|NCT00537446|20930441|P1|STARTED|Overall Study||8
8493709|NCT00537407|20930456|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
8493710|NCT00537407|20930457|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
8493711|NCT00537407|20930458|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
8493712|NCT00537407|20930459|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
8493713|NCT00537407|20930460|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
8493714|NCT00537407|20930456|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
8493715|NCT00537407|20930457|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
8493716|NCT00537407|20930458|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
8493717|NCT00537407|20930459|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
8493718|NCT00537407|20930460|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
8493719|NCT00537407|20930456|P5|STARTED|Part 2 Weeks 5-48 or 72||10
8493720|NCT00537407|20930457|P4|STARTED|Part 2 Weeks 5-48 or 72||10
8493721|NCT00537407|20930458|P3|STARTED|Part 2 Weeks 5-48 or 72||11
8493722|NCT00537407|20930459|P2|STARTED|Part 2 Weeks 5-48 or 72||9
8493723|NCT00537407|20930460|P1|STARTED|Part 2 Weeks 5-48 or 72||10
8493724|NCT00537407|20930456|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
8493725|NCT00537407|20930457|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
8493726|NCT00537407|20930458|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
8493727|NCT00537407|20930459|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
8493728|NCT00537407|20930460|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
8493729|NCT00537407|20930456|P5|COMPLETED|Part 1 Weeks 1-4||10
8493730|NCT00537407|20930457|P4|COMPLETED|Part 1 Weeks 1-4||10
8493731|NCT00537407|20930458|P3|COMPLETED|Part 1 Weeks 1-4||11
8493732|NCT00537407|20930459|P2|COMPLETED|Part 1 Weeks 1-4||9
8493733|NCT00537407|20930460|P1|COMPLETED|Part 1 Weeks 1-4||10
8493734|NCT00537407|20930456|P5|STARTED|Part 1 Weeks 1-4||10
8493735|NCT00537407|20930457|P4|STARTED|Part 1 Weeks 1-4||10
8493736|NCT00537407|20930458|P3|STARTED|Part 1 Weeks 1-4||11
8493737|NCT00537407|20930459|P2|STARTED|Part 1 Weeks 1-4||9
8493738|NCT00537407|20930460|P1|STARTED|Part 1 Weeks 1-4||10
8493739|NCT00537394|20930500|P3|NOT COMPLETED|2nd Year of Follow-up||6
8493740|NCT00537394|20930501|P2|NOT COMPLETED|2nd Year of Follow-up||9
8493741|NCT00537394|20930502|P1|NOT COMPLETED|2nd Year of Follow-up||11
8493742|NCT00537394|20930500|P3|COMPLETED|2nd Year of Follow-up||44
8493743|NCT00537394|20930501|P2|COMPLETED|2nd Year of Follow-up||159
8493744|NCT00537394|20930502|P1|COMPLETED|2nd Year of Follow-up||158
8493745|NCT00537394|20930500|P3|STARTED|2nd Year of Follow-up||50
8493746|NCT00537394|20930501|P2|STARTED|2nd Year of Follow-up||168
8493747|NCT00537394|20930502|P1|STARTED|2nd Year of Follow-up||169
8493748|NCT00537394|20930500|P3|NOT COMPLETED|First Year of Follow-up||3
8493749|NCT00537394|20930501|P2|NOT COMPLETED|First Year of Follow-up||11
8493750|NCT00537394|20930502|P1|NOT COMPLETED|First Year of Follow-up||12
8493751|NCT00537394|20930500|P3|COMPLETED|First Year of Follow-up||50
8493752|NCT00537394|20930501|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
8493753|NCT00537394|20930502|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
8493754|NCT00537394|20930500|P3|STARTED|First Year of Follow-up||53
8493755|NCT00537394|20930501|P2|STARTED|First Year of Follow-up||179
8493756|NCT00537394|20930502|P1|STARTED|First Year of Follow-up||181
8493757|NCT00537381|20930538|P2|NOT COMPLETED|Overall Study||62
8493758|NCT00537381|20930539|P1|NOT COMPLETED|Overall Study||56
8493759|NCT00537381|20930538|P2|COMPLETED|Overall Study||4
8493760|NCT00537381|20930539|P1|COMPLETED|Overall Study||9
8493761|NCT00537381|20930538|P2|STARTED|Overall Study||66
8493762|NCT00537381|20930539|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
8493763|NCT00537329|20930559|P1|NOT COMPLETED|Overall Study||26
8493764|NCT00537329|20930559|P1|COMPLETED|Overall Study||17
8493765|NCT00537329|20930559|P1|STARTED|Overall Study||43
8493766|NCT00537316|20930579|P7|NOT COMPLETED|Part 2||2
8493767|NCT00537316|20930580|P6|NOT COMPLETED|Part 2||4
8493768|NCT00537316|20930581|P5|NOT COMPLETED|Part 2||1
8493769|NCT00537316|20930582|P4|NOT COMPLETED|Part 2||3
8493770|NCT00537316|20930583|P3|NOT COMPLETED|Part 2||32
8493771|NCT00537316|20930584|P2|NOT COMPLETED|Part 2||9
8493772|NCT00537316|20930585|P1|NOT COMPLETED|Part 2||26
8493773|NCT00537316|20930579|P7|COMPLETED|Part 2||0
8493774|NCT00537316|20930580|P6|COMPLETED|Part 2||0
8493775|NCT00537316|20930581|P5|COMPLETED|Part 2||1
8493776|NCT00537316|20930582|P4|COMPLETED|Part 2||2
8493777|NCT00537316|20930583|P3|COMPLETED|Part 2||16
8493778|NCT00537316|20930584|P2|COMPLETED|Part 2||1
8493779|NCT00537316|20930585|P1|COMPLETED|Part 2||11
8493780|NCT00537316|20930579|P7|STARTED|Part 2||2
8493781|NCT00537316|20930580|P6|STARTED|Part 2||4
8493782|NCT00537316|20930581|P5|STARTED|Part 2||2
8493783|NCT00537316|20930582|P4|STARTED|Part 2||5
8493784|NCT00537316|20930583|P3|STARTED|Part 2||48
8493785|NCT00537316|20930584|P2|STARTED|Part 2||10
8493786|NCT00537316|20930585|P1|STARTED|Part 2||37
8493787|NCT00537316|20930579|P7|NOT COMPLETED|Part 1||0
8493788|NCT00537316|20930580|P6|NOT COMPLETED|Part 1||0
8493789|NCT00537316|20930581|P5|NOT COMPLETED|Part 1||0
8493790|NCT00537316|20930582|P4|NOT COMPLETED|Part 1||0
8493791|NCT00537316|20930583|P3|NOT COMPLETED|Part 1||17
8493792|NCT00537316|20930584|P2|NOT COMPLETED|Part 1||27
8493793|NCT00537316|20930585|P1|NOT COMPLETED|Part 1||14
8493794|NCT00537316|20930579|P7|COMPLETED|Part 1||0
8493795|NCT00537316|20930580|P6|COMPLETED|Part 1||0
8493796|NCT00537316|20930581|P5|COMPLETED|Part 1||0
8493797|NCT00537316|20930582|P4|COMPLETED|Part 1||0
8493798|NCT00537316|20930583|P3|COMPLETED|Part 1||63
8493799|NCT00537316|20930584|P2|COMPLETED|Part 1||53
8493800|NCT00537316|20930585|P1|COMPLETED|Part 1||65
8493801|NCT00537316|20930579|P7|STARTED|Part 1||0
8493802|NCT00537316|20930580|P6|STARTED|Part 1||0
8493803|NCT00537316|20930581|P5|STARTED|Part 1||0
8493804|NCT00537316|20930582|P4|STARTED|Part 1||0
8493805|NCT00537316|20930583|P3|STARTED|Part 1||80
8493806|NCT00537316|20930584|P2|STARTED|Part 1||80
8493807|NCT00537316|20930585|P1|STARTED|Part 1||79
8493808|NCT00537303|20930612|P2|NOT COMPLETED|Overall Study||25
8493809|NCT00537303|20930613|P1|NOT COMPLETED|Overall Study||26
8493810|NCT00537303|20930612|P2|COMPLETED|Overall Study||125
8493811|NCT00537303|20930613|P1|COMPLETED|Overall Study||120
8493812|NCT00537303|20930612|P2|STARTED|Overall Study||150
8493813|NCT00537303|20930613|P1|STARTED|Overall Study||146
8493814|NCT00537290|20930629|P1|NOT COMPLETED|Overall Study||0
8493815|NCT00537290|20930629|P1|COMPLETED|Overall Study||19
8493816|NCT00537290|20930629|P1|STARTED|Overall Study||19
8493817|NCT00537277|20930634|P1|NOT COMPLETED|Overall Study||49
8493818|NCT00537277|20930634|P1|COMPLETED|Overall Study||112
8493819|NCT00537277|20930634|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
8493820|NCT00537277|20930634|P1|STARTED|Overall Study||161
8493821|NCT00537199|20930643|P1|NOT COMPLETED|Overall Study||1
8493822|NCT00537199|20930643|P1|COMPLETED|Overall Study||0
8493823|NCT00537199|20930643|P1|STARTED|Overall Study||1
8493830|NCT00537082|20930665|P3|NOT COMPLETED|Overall Study||6
8493831|NCT00537082|20930666|P2|NOT COMPLETED|Overall Study||9
8493832|NCT00537082|20930667|P1|NOT COMPLETED|Overall Study||9
8493833|NCT00537082|20930665|P3|COMPLETED|Overall Study||51
8493834|NCT00537082|20930666|P2|COMPLETED|Overall Study||48
8493835|NCT00537082|20930667|P1|COMPLETED|Overall Study||48
8493836|NCT00537082|20930665|P3|STARTED|Overall Study||57
8493837|NCT00537082|20930666|P2|STARTED|Overall Study||57
8493838|NCT00537082|20930667|P1|STARTED|Overall Study||57
8493839|NCT00537056|20930684|P1|NOT COMPLETED|12-month Follow-up||0
8493840|NCT00537056|20930684|P1|COMPLETED|12-month Follow-up||17
8493841|NCT00537056|20930684|P1|STARTED|12-month Follow-up||17
8493842|NCT00537056|20930684|P1|NOT COMPLETED|Interim PET/CT||5
8493843|NCT00537056|20930684|P1|COMPLETED|Interim PET/CT||12
8493844|NCT00537056|20930684|P1|STARTED|Interim PET/CT||17
8493845|NCT00537056|20930684|P1|NOT COMPLETED|Baseline PET/CT||0
8493846|NCT00537056|20930684|P1|COMPLETED|Baseline PET/CT||17
8493847|NCT00537056|20930684|P1|STARTED|Baseline PET/CT||17
8493848|NCT00537030|20930696|P1|NOT COMPLETED|Overall Study||16
8493849|NCT00537030|20930696|P1|COMPLETED|Overall Study||43
8493850|NCT00537030|20930696|P1|STARTED|Overall Study||59
8493857|NCT00536991|20930714|P1|NOT COMPLETED|Overall Study||13
8493858|NCT00536991|20930714|P1|COMPLETED|Overall Study||38
8493859|NCT00536991|20930714|P1|STARTED|Overall Study||51
8493860|NCT00536978|20930721|P1|NOT COMPLETED|Overall Study||22
8493861|NCT00536978|20930721|P1|COMPLETED|Overall Study||0
8493862|NCT00536978|20930721|P1|STARTED|Overall Study||22
8493863|NCT00536939|20930725|P2|NOT COMPLETED|Overall Study||0
8493864|NCT00536939|20930726|P1|NOT COMPLETED|Overall Study||2
8493865|NCT00536939|20930725|P2|COMPLETED|Overall Study||0
8493866|NCT00536939|20930726|P1|COMPLETED|Overall Study||0
8493867|NCT00536939|20930725|P2|Randomized|Overall Study||0
8493868|NCT00536939|20930726|P1|Randomized|Overall Study||0
8493869|NCT00536939|20930725|P2|Entered Safety lead-in|Overall Study||0
8493870|NCT00536939|20930726|P1|Entered Safety lead-in|Overall Study||2
8493871|NCT00536939|20930725|P2|STARTED|Overall Study||0
8493872|NCT00536939|20930726|P1|STARTED|Overall Study||2
8493873|NCT00536913|20930734|P2|NOT COMPLETED|Overall Study||0
8493874|NCT00536913|20930735|P1|NOT COMPLETED|Overall Study||0
8493875|NCT00536913|20930734|P2|COMPLETED|Overall Study||52
8493876|NCT00536913|20930735|P1|COMPLETED|Overall Study||55
8493877|NCT00536913|20930734|P2|STARTED|Overall Study||52
8493878|NCT00536913|20930735|P1|STARTED|Overall Study||55
8493879|NCT00536874|20930757|P1|NOT COMPLETED|Overall Study||4
8493880|NCT00536874|20930757|P1|COMPLETED|Overall Study||35
8493881|NCT00536874|20930757|P1|STARTED|Overall Study||39
8493882|NCT00536809|20930767|P1|NOT COMPLETED|Phase II||2
8493883|NCT00536809|20930767|P1|COMPLETED|Phase II||0
8493884|NCT00536809|20930767|P1|STARTED|Phase II||2
8493885|NCT00536809|20930767|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
8493886|NCT00536809|20930767|P1|COMPLETED|Phase I (Dose-finding Phase)||10
8493887|NCT00536809|20930767|P1|STARTED|Phase I (Dose-finding Phase)||10
8493888|NCT00536744|20930790|P2|NOT COMPLETED|Overall Study||28
8493889|NCT00536744|20930791|P1|NOT COMPLETED|Overall Study||29
8493890|NCT00536744|20930790|P2|COMPLETED|Overall Study||71
8493891|NCT00536744|20930791|P1|COMPLETED|Overall Study||78
8493892|NCT00536744|20930790|P2|STARTED|Overall Study||99
8493893|NCT00536744|20930791|P1|STARTED|Overall Study||107
8493894|NCT00536731|20930800|P3|NOT COMPLETED|Overall Study||5
8493895|NCT00536731|20930801|P2|NOT COMPLETED|Overall Study||5
8493896|NCT00536731|20930802|P1|NOT COMPLETED|Overall Study||4
8493897|NCT00536731|20930800|P3|COMPLETED|Overall Study||238
8493898|NCT00536731|20930801|P2|COMPLETED|Overall Study||241
8493899|NCT00536731|20930802|P1|COMPLETED|Overall Study||249
8493900|NCT00536731|20930800|P3|STARTED|Overall Study||243
8493901|NCT00536731|20930801|P2|STARTED|Overall Study||246
8493902|NCT00536731|20930802|P1|STARTED|Overall Study||253
8493903|NCT00536575|20930846|P1|NOT COMPLETED|Overall Study||2
8493904|NCT00536575|20930846|P1|COMPLETED|Overall Study||11
8493905|NCT00536575|20930846|P1|STARTED|Overall Study||13
8493906|NCT00536510|20930852|P2|NOT COMPLETED|Overall Study||29
8493907|NCT00536510|20930853|P1|NOT COMPLETED|Overall Study||82
8493908|NCT00536510|20930852|P2|COMPLETED|Overall Study||295
8493909|NCT00536510|20930853|P1|COMPLETED|Overall Study||240
8493910|NCT00536510|20930852|P2|STARTED|Overall Study||324
8493911|NCT00536510|20930853|P1|STARTED|Overall Study||322
8493912|NCT00536484|20930863|P2|NOT COMPLETED|Overall Study||56
8493913|NCT00536484|20930864|P1|NOT COMPLETED|Overall Study||60
8493914|NCT00536484|20930863|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
8493915|NCT00536484|20930864|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
8493916|NCT00536484|20930863|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
8493917|NCT00536484|20930864|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
8493918|NCT00536471|20930898|P4|NOT COMPLETED|Overall Study||74
8493919|NCT00536471|20930899|P3|NOT COMPLETED|Overall Study||139
8493920|NCT00536471|20930900|P2|NOT COMPLETED|Overall Study||84
8493921|NCT00536471|20930901|P1|NOT COMPLETED|Overall Study||156
8493922|NCT00536471|20930898|P4|COMPLETED|Overall Study||57
8493923|NCT00536471|20930899|P3|COMPLETED|Overall Study||122
8493924|NCT00536471|20930900|P2|COMPLETED|Overall Study||43
8493925|NCT00536471|20930901|P1|COMPLETED|Overall Study||101
8493926|NCT00536471|20930898|P4|STARTED|Overall Study||131
8493927|NCT00536471|20930899|P3|STARTED|Overall Study||261
8493928|NCT00536471|20930900|P2|STARTED|Overall Study||127
8493929|NCT00536471|20930901|P1|STARTED|Overall Study||257
8493930|NCT00536380|20931146|P3|NOT COMPLETED|Overall Study||10
8493931|NCT00536380|20931147|P2|NOT COMPLETED|Overall Study||9
8493932|NCT00536380|20931148|P1|NOT COMPLETED|Overall Study||12
8493933|NCT00536380|20931146|P3|COMPLETED|Overall Study||94
8493934|NCT00536380|20931147|P2|COMPLETED|Overall Study||95
8493935|NCT00536380|20931148|P1|COMPLETED|Overall Study||94
8493936|NCT00536380|20931146|P3|STARTED|Overall Study||104
8493937|NCT00536380|20931147|P2|STARTED|Overall Study||104
8493938|NCT00536380|20931148|P1|STARTED|Overall Study||106
8493939|NCT00536341|20931158|P2|NOT COMPLETED|Overall Study||11
8493940|NCT00536341|20931159|P1|NOT COMPLETED|Overall Study||5
8493941|NCT00536341|20931158|P2|COMPLETED|Overall Study||43
8493942|NCT00536341|20931159|P1|COMPLETED|Overall Study||5
8493943|NCT00536341|20931158|P2|STARTED|Overall Study||54
8493944|NCT00536341|20931159|P1|STARTED|Overall Study||10
8493945|NCT00536263|20931172|P3|NOT COMPLETED|Overall Study||21
8493946|NCT00536263|20931173|P2|NOT COMPLETED|Overall Study||14
8493947|NCT00536263|20931174|P1|NOT COMPLETED|Overall Study||11
8493948|NCT00536263|20931172|P3|COMPLETED|Overall Study||204
8493949|NCT00536263|20931173|P2|COMPLETED|Overall Study||207
8493950|NCT00536263|20931174|P1|COMPLETED|Overall Study||214
8493951|NCT00536263|20931172|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
8493952|NCT00536263|20931173|P2|STARTED|Overall Study||221
8493953|NCT00536263|20931174|P1|STARTED|Overall Study||225
8493954|NCT00536198|20931214|P2|NOT COMPLETED|Overall Study||39
8493955|NCT00536198|20931215|P1|NOT COMPLETED|Overall Study||37
8493956|NCT00536198|20931214|P2|COMPLETED|Overall Study||88
8493957|NCT00536198|20931215|P1|COMPLETED|Overall Study||88
8493958|NCT00536198|20931214|P2|Cycle 6|Overall Study||88
8493959|NCT00536198|20931215|P1|Cycle 6|Overall Study||88
8493960|NCT00536198|20931214|P2|Cycle 5|Overall Study||85
8493961|NCT00536198|20931215|P1|Cycle 5|Overall Study||88
8493962|NCT00536198|20931214|P2|Cycle 4|Overall Study||98
8493963|NCT00536198|20931215|P1|Cycle 4|Overall Study||95
8493964|NCT00536198|20931214|P2|Cycle 3|Overall Study||101
8493965|NCT00536198|20931215|P1|Cycle 3|Overall Study||100
8493966|NCT00536198|20931214|P2|Cycle 2|Overall Study||112
8493967|NCT00536198|20931215|P1|Cycle 2|Overall Study||104
8493968|NCT00536198|20931214|P2|Cycle 1|Overall Study||123
8493969|NCT00536198|20931215|P1|Cycle 1|Overall Study||110
8493970|NCT00536198|20931214|P2|STARTED|Overall Study||127
8493971|NCT00536198|20931215|P1|STARTED|Overall Study||125
8493972|NCT00536172|20931245|P2|NOT COMPLETED|Overall Study||9
8493973|NCT00536172|20931246|P1|NOT COMPLETED|Overall Study||14
8493974|NCT00536172|20931245|P2|COMPLETED|Overall Study||65
8493975|NCT00536172|20931246|P1|COMPLETED|Overall Study||60
8493976|NCT00536172|20931245|P2|STARTED|Overall Study||74
8493977|NCT00536172|20931246|P1|STARTED|Overall Study||74
8493978|NCT00536120|20931254|P2|NOT COMPLETED|Overall Study||3
8493979|NCT00536120|20931255|P1|NOT COMPLETED|Overall Study||6
8493980|NCT00536120|20931254|P2|COMPLETED|Overall Study||27
8493981|NCT00536120|20931255|P1|COMPLETED|Overall Study||24
8493982|NCT00536120|20931254|P2|STARTED|Overall Study||30
8493983|NCT00536120|20931255|P1|STARTED|Overall Study||30
8493984|NCT00536107|20931269|P2|NOT COMPLETED|Overall Study||6
8493985|NCT00536107|20931270|P1|NOT COMPLETED|Overall Study||8
8493986|NCT00536107|20931269|P2|COMPLETED|Overall Study||0
8493987|NCT00536107|20931270|P1|COMPLETED|Overall Study||0
8493988|NCT00536107|20931269|P2|STARTED|Overall Study||6
8493989|NCT00536107|20931270|P1|STARTED|Overall Study||8
8493990|NCT00535938|20931280|P2|NOT COMPLETED|Overall Study||462
8493991|NCT00535938|20931281|P1|NOT COMPLETED|Overall Study||391
8493992|NCT00535938|20931280|P2|COMPLETED|Overall Study||404
8493993|NCT00535938|20931281|P1|COMPLETED|Overall Study||115
8493994|NCT00535938|20931280|P2|STARTED|Overall Study||866
8493995|NCT00535938|20931281|P1|STARTED|Overall Study||506
8493996|NCT00535925|20931319|P2|NOT COMPLETED|Overall Study||8
8493997|NCT00535925|20931320|P1|NOT COMPLETED|Overall Study||19
8493998|NCT00535925|20931319|P2|COMPLETED|Overall Study||199
8493999|NCT00535925|20931320|P1|COMPLETED|Overall Study||169
8494000|NCT00535925|20931319|P2|STARTED|Overall Study||207
8494001|NCT00535925|20931320|P1|STARTED|Overall Study||188
8494002|NCT00535873|20931328|P1|NOT COMPLETED|Overall Study||0
8494003|NCT00535873|20931328|P1|COMPLETED|Overall Study||60
8494004|NCT00535873|20931328|P1|STARTED|Overall Study||60
8494005|NCT00535847|20931335|P3|NOT COMPLETED|Overall Study||2
8494006|NCT00535847|20931336|P2|NOT COMPLETED|Overall Study||14
8494007|NCT00535847|20931337|P1|NOT COMPLETED|Overall Study||22
8494008|NCT00535847|20931335|P3|COMPLETED|Overall Study||0
8494009|NCT00535847|20931336|P2|COMPLETED|Overall Study||20
8494010|NCT00535847|20931337|P1|COMPLETED|Overall Study||59
8494011|NCT00535847|20931335|P3|STARTED|Overall Study||2
8494012|NCT00535847|20931336|P2|STARTED|Overall Study||34
8494013|NCT00535847|20931337|P1|STARTED|Overall Study||81
8494014|NCT00535821|20931363|P2|NOT COMPLETED|Overall Study||0
8494015|NCT00535821|20931364|P1|NOT COMPLETED|Overall Study||0
8494016|NCT00535821|20931363|P2|COMPLETED|Overall Study||3
8494017|NCT00535821|20931364|P1|COMPLETED|Overall Study||2
8494018|NCT00535821|20931363|P2|STARTED|Overall Study||3
8494019|NCT00535821|20931364|P1|STARTED|Overall Study||2
8494020|NCT00535782|20931372|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
8494021|NCT00535782|20931373|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
8494022|NCT00535782|20931374|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
8494023|NCT00535782|20931372|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
8494024|NCT00535782|20931373|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
8494025|NCT00535782|20931374|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
8494026|NCT00535782|20931372|P3|STARTED|Part 2: 80-Week Open-label Period||124
8494027|NCT00535782|20931373|P2|STARTED|Part 2: 80-Week Open-label Period||0
8494028|NCT00535782|20931374|P1|STARTED|Part 2: 80-Week Open-label Period||0
8494029|NCT00535782|20931372|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
8494030|NCT00535782|20931373|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
8494031|NCT00535782|20931374|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
8494032|NCT00535782|20931372|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
8494033|NCT00535782|20931373|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
8494034|NCT00535782|20931374|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
8494035|NCT00535782|20931372|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
8494036|NCT00535782|20931373|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
8494037|NCT00535782|20931374|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
8494038|NCT00535782|20931372|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
8494039|NCT00535782|20931373|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
8494040|NCT00535782|20931374|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
8494041|NCT00535782|20931372|P3|STARTED|Part 1: 24-Week Double-blind Period||0
8494042|NCT00535782|20931373|P2|STARTED|Part 1: 24-Week Double-blind Period||63
8494043|NCT00535782|20931374|P1|STARTED|Part 1: 24-Week Double-blind Period||69
8494044|NCT00535769|20931391|P2|NOT COMPLETED|Overall Study||0
8494045|NCT00535769|20931392|P1|NOT COMPLETED|Overall Study||0
8494046|NCT00535769|20931391|P2|COMPLETED|Overall Study||35
8494047|NCT00535769|20931392|P1|COMPLETED|Overall Study||35
8494048|NCT00535769|20931391|P2|STARTED|Overall Study||35
8494049|NCT00535769|20931392|P1|STARTED|Overall Study||35
8494050|NCT00535743|20931425|P24|NOT COMPLETED|Overall Study||0
8494051|NCT00535743|20931426|P23|NOT COMPLETED|Overall Study||0
8494052|NCT00535743|20931427|P22|NOT COMPLETED|Overall Study||1
8494053|NCT00535743|20931428|P21|NOT COMPLETED|Overall Study||0
8494054|NCT00535743|20931429|P20|NOT COMPLETED|Overall Study||0
8494055|NCT00535743|20931430|P19|NOT COMPLETED|Overall Study||0
8494056|NCT00535743|20931431|P18|NOT COMPLETED|Overall Study||0
8494057|NCT00535743|20931432|P17|NOT COMPLETED|Overall Study||0
8494058|NCT00535743|20931433|P16|NOT COMPLETED|Overall Study||0
8494059|NCT00535743|20931434|P15|NOT COMPLETED|Overall Study||0
8494060|NCT00535743|20931435|P14|NOT COMPLETED|Overall Study||0
8494061|NCT00535743|20931436|P13|NOT COMPLETED|Overall Study||0
8494062|NCT00535743|20931437|P12|NOT COMPLETED|Overall Study||0
8494063|NCT00535743|20931438|P11|NOT COMPLETED|Overall Study||0
8494064|NCT00535743|20931439|P10|NOT COMPLETED|Overall Study||1
8494065|NCT00535743|20931440|P9|NOT COMPLETED|Overall Study||1
8494066|NCT00535743|20931441|P8|NOT COMPLETED|Overall Study||0
8494067|NCT00535743|20931442|P7|NOT COMPLETED|Overall Study||0
8494068|NCT00535743|20931443|P6|NOT COMPLETED|Overall Study||0
8494069|NCT00535743|20931444|P5|NOT COMPLETED|Overall Study||0
8494070|NCT00535743|20931445|P4|NOT COMPLETED|Overall Study||0
8494071|NCT00535743|20931446|P3|NOT COMPLETED|Overall Study||0
8494072|NCT00535743|20931447|P2|NOT COMPLETED|Overall Study||0
8494073|NCT00535743|20931448|P1|NOT COMPLETED|Overall Study||0
8494074|NCT00535743|20931425|P24|COMPLETED|Overall Study||5
8494075|NCT00535743|20931426|P23|COMPLETED|Overall Study||6
8494076|NCT00535743|20931427|P22|COMPLETED|Overall Study||4
8494077|NCT00535743|20931428|P21|COMPLETED|Overall Study||5
8494078|NCT00535743|20931429|P20|COMPLETED|Overall Study||5
8494079|NCT00535743|20931430|P19|COMPLETED|Overall Study||3
8494080|NCT00535743|20931431|P18|COMPLETED|Overall Study||11
8494081|NCT00535743|20931432|P17|COMPLETED|Overall Study||10
8494082|NCT00535743|20931433|P16|COMPLETED|Overall Study||13
8494083|NCT00535743|20931434|P15|COMPLETED|Overall Study||9
8494084|NCT00535743|20931435|P14|COMPLETED|Overall Study||10
8494085|NCT00535743|20931436|P13|COMPLETED|Overall Study||5
8494086|NCT00535743|20931437|P12|COMPLETED|Overall Study||5
8494087|NCT00535743|20931438|P11|COMPLETED|Overall Study||5
8494088|NCT00535743|20931439|P10|COMPLETED|Overall Study||4
8494089|NCT00535743|20931440|P9|COMPLETED|Overall Study||4
8494090|NCT00535743|20931441|P8|COMPLETED|Overall Study||5
8494091|NCT00535743|20931442|P7|COMPLETED|Overall Study||3
8494092|NCT00535743|20931443|P6|COMPLETED|Overall Study||10
8494093|NCT00535743|20931444|P5|COMPLETED|Overall Study||11
8494094|NCT00535743|20931445|P4|COMPLETED|Overall Study||11
8494095|NCT00535743|20931446|P3|COMPLETED|Overall Study||11
8494096|NCT00535743|20931447|P2|COMPLETED|Overall Study||11
8494097|NCT00535743|20931448|P1|COMPLETED|Overall Study||5
8494098|NCT00535743|20931425|P24|Treated|Overall Study||5
8494099|NCT00535743|20931426|P23|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
8494100|NCT00535743|20931427|P22|Treated|Overall Study||5
8494101|NCT00535743|20931428|P21|Treated|Overall Study||5
8494102|NCT00535743|20931429|P20|Treated|Overall Study||5
8494103|NCT00535743|20931430|P19|Treated|Overall Study||3
8494104|NCT00535743|20931431|P18|Treated|Overall Study||11
8494105|NCT00535743|20931432|P17|Treated|Overall Study||10
8494106|NCT00535743|20931433|P16|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
8494107|NCT00535743|20931434|P15|Treated|Overall Study||9
8494108|NCT00535743|20931435|P14|Treated|Overall Study||10
8494109|NCT00535743|20931436|P13|Treated|Overall Study||5
8494110|NCT00535743|20931437|P12|Treated|Overall Study||5
8494111|NCT00535743|20931438|P11|Treated|Overall Study||5
8494112|NCT00535743|20931439|P10|Treated|Overall Study||5
8494113|NCT00535743|20931440|P9|Treated|Overall Study||4
8494114|NCT00535743|20931441|P8|Treated|Overall Study||5
8494115|NCT00535743|20931442|P7|Treated|Overall Study||3
8494116|NCT00535743|20931443|P6|Treated|Overall Study||10
8494117|NCT00535743|20931444|P5|Treated|Overall Study||11
8494118|NCT00535743|20931445|P4|Treated|Overall Study||11
8494119|NCT00535743|20931446|P3|Treated|Overall Study||11
8494120|NCT00535743|20931447|P2|Treated|Overall Study||11
8494121|NCT00535743|20931448|P1|Treated|Overall Study||5
8494122|NCT00535743|20931425|P24|STARTED|Overall Study||5
8494123|NCT00535743|20931426|P23|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
8494124|NCT00535743|20931427|P22|STARTED|Overall Study||5
8494125|NCT00535743|20931428|P21|STARTED|Overall Study||5
8494126|NCT00535743|20931429|P20|STARTED|Overall Study||5
8494127|NCT00535743|20931430|P19|STARTED|Overall Study||3
8494128|NCT00535743|20931431|P18|STARTED|Overall Study||11
8494129|NCT00535743|20931432|P17|STARTED|Overall Study||10
8494130|NCT00535743|20931433|P16|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
8494131|NCT00535743|20931434|P15|STARTED|Overall Study||9
8494132|NCT00535743|20931435|P14|STARTED|Overall Study||10
8494133|NCT00535743|20931436|P13|STARTED|Overall Study||5
8494134|NCT00535743|20931437|P12|STARTED|Overall Study||5
8494135|NCT00535743|20931438|P11|STARTED|Overall Study||5
8494136|NCT00535743|20931439|P10|STARTED|Overall Study||5
8494137|NCT00535743|20931440|P9|STARTED|Overall Study||5
8494138|NCT00535743|20931441|P8|STARTED|Overall Study||5
8494139|NCT00535743|20931442|P7|STARTED|Overall Study||3
8494140|NCT00535743|20931443|P6|STARTED|Overall Study||10
8494141|NCT00535743|20931444|P5|STARTED|Overall Study||11
8494142|NCT00535743|20931445|P4|STARTED|Overall Study||11
8494143|NCT00535743|20931446|P3|STARTED|Overall Study||11
8494144|NCT00535743|20931447|P2|STARTED|Overall Study||11
8494145|NCT00535743|20931448|P1|STARTED|Overall Study||5
8494146|NCT00535730|20931572|P2|NOT COMPLETED|Overall Study||7
8494147|NCT00535730|20931573|P1|NOT COMPLETED|Overall Study||2
8494148|NCT00535730|20931572|P2|COMPLETED|Overall Study||230
8494149|NCT00535730|20931573|P1|COMPLETED|Overall Study||234
8494150|NCT00535730|20931572|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
8494151|NCT00535730|20931573|P1|STARTED|Overall Study||236
8494152|NCT00535652|20931590|P1|NOT COMPLETED|Overall Study||3
8494153|NCT00535652|20931590|P1|COMPLETED|Overall Study||20
8494154|NCT00535652|20931590|P1|STARTED|Overall Study||23
8494155|NCT00535626|20931594|P1|NOT COMPLETED|Overall Study||105
8494156|NCT00535626|20931594|P1|COMPLETED|Overall Study||85
8494157|NCT00535626|20931594|P1|STARTED|Overall Study||190
8494158|NCT00535613|20931606|P2|NOT COMPLETED|Overall Study||0
8494159|NCT00535613|20931607|P1|NOT COMPLETED|Overall Study||0
8494160|NCT00535613|20931606|P2|COMPLETED|Overall Study||50
8494161|NCT00535613|20931607|P1|COMPLETED|Overall Study||49
8494162|NCT00535613|20931606|P2|STARTED|Overall Study||50
8494163|NCT00535613|20931607|P1|STARTED|Overall Study||49
8494164|NCT00535587|20931621|P4|NOT COMPLETED|Overall Study||13
8494165|NCT00535587|20931622|P3|NOT COMPLETED|Overall Study||8
8494166|NCT00535587|20931623|P2|NOT COMPLETED|Overall Study||11
8494167|NCT00535587|20931624|P1|NOT COMPLETED|Overall Study||10
8494168|NCT00535587|20931621|P4|COMPLETED|Overall Study||41
8494169|NCT00535587|20931622|P3|COMPLETED|Overall Study||39
8494170|NCT00535587|20931623|P2|COMPLETED|Overall Study||42
8494171|NCT00535587|20931624|P1|COMPLETED|Overall Study||43
8494172|NCT00535587|20931621|P4|STARTED|Overall Study||54
8494173|NCT00535587|20931622|P3|STARTED|Overall Study||47
8494174|NCT00535587|20931623|P2|STARTED|Overall Study||53
8494175|NCT00535587|20931624|P1|STARTED|Overall Study||53
8494176|NCT00535496|20931634|P4|NOT COMPLETED|Overall Study||0
8494177|NCT00535496|20931635|P3|NOT COMPLETED|Overall Study||0
8494178|NCT00535496|20931636|P2|NOT COMPLETED|Overall Study||2
8494179|NCT00535496|20931637|P1|NOT COMPLETED|Overall Study||0
8494180|NCT00535496|20931634|P4|COMPLETED|Overall Study||31
8494181|NCT00535496|20931635|P3|COMPLETED|Overall Study||30
8494182|NCT00535496|20931636|P2|COMPLETED|Overall Study||13
8494183|NCT00535496|20931637|P1|COMPLETED|Overall Study||15
8494184|NCT00535496|20931634|P4|All-Subjects-Treated (AST) Group|Overall Study||31
8494185|NCT00535496|20931635|P3|All-Subjects-Treated (AST) Group|Overall Study||30
8494186|NCT00535496|20931636|P2|All-Subjects-Treated (AST) Group|Overall Study||14
8494187|NCT00535496|20931637|P1|All-Subjects-Treated (AST) Group|Overall Study||15
8494188|NCT00535496|20931634|P4|STARTED|Overall Study||31
8494189|NCT00535496|20931635|P3|STARTED|Overall Study||30
8494190|NCT00535496|20931636|P2|STARTED|Overall Study||15
8494191|NCT00535496|20931637|P1|STARTED|Overall Study||15
8494192|NCT00535405|20931657|P5|NOT COMPLETED|Overall Study||16
8494193|NCT00535405|20931658|P4|NOT COMPLETED|Overall Study||22
8494194|NCT00535405|20931659|P3|NOT COMPLETED|Overall Study||18
8494195|NCT00535405|20931660|P2|NOT COMPLETED|Overall Study||26
8494196|NCT00535405|20931661|P1|NOT COMPLETED|Overall Study||17
8494197|NCT00535405|20931657|P5|COMPLETED|Overall Study||241
8494198|NCT00535405|20931658|P4|COMPLETED|Overall Study||235
8494199|NCT00535405|20931659|P3|COMPLETED|Overall Study||241
8494200|NCT00535405|20931660|P2|COMPLETED|Overall Study||233
8494201|NCT00535405|20931661|P1|COMPLETED|Overall Study||240
8494202|NCT00535405|20931657|P5|STARTED|Overall Study||257
8494203|NCT00535405|20931658|P4|STARTED|Overall Study||257
8494204|NCT00535405|20931659|P3|STARTED|Overall Study||259
8494205|NCT00535405|20931660|P2|STARTED|Overall Study||259
8494206|NCT00535405|20931661|P1|STARTED|Overall Study||257
8494207|NCT00535392|20931698|P1|NOT COMPLETED|Overall Study||0
8494208|NCT00535392|20931698|P1|COMPLETED|Overall Study||33
8494209|NCT00535392|20931698|P1|STARTED|Overall Study||33
8494210|NCT00535301|20931706|P2|NOT COMPLETED|Overall Study||5
8494211|NCT00535301|20931707|P1|NOT COMPLETED|Overall Study||5
8494212|NCT00535301|20931706|P2|COMPLETED|Overall Study||33
8494213|NCT00535301|20931707|P1|COMPLETED|Overall Study||33
8494214|NCT00535301|20931706|P2|STARTED|Overall Study||38
8494215|NCT00535301|20931707|P1|STARTED|Overall Study||38
8494216|NCT00535288|20931722|P5|NOT COMPLETED|Overall Study||42
8494217|NCT00535288|20931723|P4|NOT COMPLETED|Overall Study||29
8494218|NCT00535288|20931724|P3|NOT COMPLETED|Overall Study||33
8494219|NCT00535288|20931725|P2|NOT COMPLETED|Overall Study||32
8494220|NCT00535288|20931726|P1|NOT COMPLETED|Overall Study||54
8494221|NCT00535288|20931722|P5|COMPLETED|Overall Study||116
8494222|NCT00535288|20931723|P4|COMPLETED|Overall Study||122
8494223|NCT00535288|20931724|P3|COMPLETED|Overall Study||127
8494224|NCT00535288|20931725|P2|COMPLETED|Overall Study||130
8494225|NCT00535288|20931726|P1|COMPLETED|Overall Study||260
8494226|NCT00535288|20931722|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
8494227|NCT00535288|20931723|P4|STARTED|Overall Study||151
8494228|NCT00535288|20931724|P3|STARTED|Overall Study||160
8494229|NCT00535288|20931725|P2|STARTED|Overall Study||162
8494230|NCT00535288|20931726|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
8494231|NCT00535262|20931803|P1|NOT COMPLETED|Overall Study||3
8494232|NCT00535262|20931803|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
8494233|NCT00535262|20931803|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
8494234|NCT00535236|20931817|P10|NOT COMPLETED|Overall Study||4
8494235|NCT00535236|20931818|P9|NOT COMPLETED|Overall Study||13
8494236|NCT00535236|20931819|P8|NOT COMPLETED|Overall Study||1
8494237|NCT00535236|20931820|P7|NOT COMPLETED|Overall Study||11
8494238|NCT00535236|20931821|P6|NOT COMPLETED|Overall Study||1
8494239|NCT00535236|20931822|P5|NOT COMPLETED|Overall Study||12
8494240|NCT00535236|20931823|P4|NOT COMPLETED|Overall Study||4
8494241|NCT00535236|20931824|P3|NOT COMPLETED|Overall Study||12
8494242|NCT00535236|20931825|P2|NOT COMPLETED|Overall Study||2
8494243|NCT00535236|20931826|P1|NOT COMPLETED|Overall Study||7
8494244|NCT00535236|20931817|P10|COMPLETED|Overall Study||16
8494245|NCT00535236|20931818|P9|COMPLETED|Overall Study||47
8494246|NCT00535236|20931819|P8|COMPLETED|Overall Study||18
8494247|NCT00535236|20931820|P7|COMPLETED|Overall Study||51
8494248|NCT00535236|20931821|P6|COMPLETED|Overall Study||19
8494249|NCT00535236|20931822|P5|COMPLETED|Overall Study||47
8494250|NCT00535236|20931823|P4|COMPLETED|Overall Study||6
8494251|NCT00535236|20931824|P3|COMPLETED|Overall Study||29
8494252|NCT00535236|20931825|P2|COMPLETED|Overall Study||8
8494253|NCT00535236|20931826|P1|COMPLETED|Overall Study||33
8494254|NCT00535236|20931817|P10|Vaccination 4|Overall Study||17
8494255|NCT00535236|20931818|P9|Vaccination 4|Overall Study||50
8494256|NCT00535236|20931819|P8|Vaccination 4|Overall Study||18
8494257|NCT00535236|20931820|P7|Vaccination 4|Overall Study||51
8494258|NCT00535236|20931821|P6|Vaccination 4|Overall Study||19
8494259|NCT00535236|20931822|P5|Vaccination 4|Overall Study||47
8494260|NCT00535236|20931823|P4|Vaccination 4|Overall Study||6
8494261|NCT00535236|20931824|P3|Vaccination 4|Overall Study||32
8494262|NCT00535236|20931825|P2|Vaccination 4|Overall Study||10
8494263|NCT00535236|20931826|P1|Vaccination 4|Overall Study||34
8494264|NCT00535236|20931817|P10|Vaccination 3|Overall Study||18
8494265|NCT00535236|20931818|P9|Vaccination 3|Overall Study||53
8494266|NCT00535236|20931819|P8|Vaccination 3|Overall Study||18
8494267|NCT00535236|20931820|P7|Vaccination 3|Overall Study||51
8494268|NCT00535236|20931821|P6|Vaccination 3|Overall Study||19
8494269|NCT00535236|20931822|P5|Vaccination 3|Overall Study||48
8494270|NCT00535236|20931823|P4|Vaccination 3|Overall Study||8
8494271|NCT00535236|20931824|P3|Vaccination 3|Overall Study||35
8494272|NCT00535236|20931825|P2|Vaccination 3|Overall Study||10
8494273|NCT00535236|20931826|P1|Vaccination 3|Overall Study||34
8494274|NCT00535236|20931817|P10|Vaccination 2|Overall Study||19
8494275|NCT00535236|20931818|P9|Vaccination 2|Overall Study||57
8494276|NCT00535236|20931819|P8|Vaccination 2|Overall Study||19
8494277|NCT00535236|20931820|P7|Vaccination 2|Overall Study||58
8494278|NCT00535236|20931821|P6|Vaccination 2|Overall Study||19
8494279|NCT00535236|20931822|P5|Vaccination 2|Overall Study||52
8494280|NCT00535236|20931823|P4|Vaccination 2|Overall Study||8
8494281|NCT00535236|20931824|P3|Vaccination 2|Overall Study||37
8494282|NCT00535236|20931825|P2|Vaccination 2|Overall Study||10
8494283|NCT00535236|20931826|P1|Vaccination 2|Overall Study||35
8494284|NCT00535236|20931817|P10|Vaccination 1|Overall Study||20
8494285|NCT00535236|20931818|P9|Vaccination 1|Overall Study||60
8494286|NCT00535236|20931819|P8|Vaccination 1|Overall Study||19
8494287|NCT00535236|20931820|P7|Vaccination 1|Overall Study||61
8494288|NCT00535236|20931821|P6|Vaccination 1|Overall Study||19
8494289|NCT00535236|20931822|P5|Vaccination 1|Overall Study||58
8494290|NCT00535236|20931823|P4|Vaccination 1|Overall Study||10
8494291|NCT00535236|20931824|P3|Vaccination 1|Overall Study||40
8494292|NCT00535236|20931825|P2|Vaccination 1|Overall Study||10
8494293|NCT00535236|20931826|P1|Vaccination 1|Overall Study||40
8494294|NCT00535236|20931817|P10|STARTED|Overall Study||20
8494295|NCT00535236|20931818|P9|STARTED|Overall Study||60
8494296|NCT00535236|20931819|P8|STARTED|Overall Study||19
8494297|NCT00535236|20931820|P7|STARTED|Overall Study||62
8494298|NCT00535236|20931821|P6|STARTED|Overall Study||20
8494299|NCT00535236|20931822|P5|STARTED|Overall Study||59
8494300|NCT00535236|20931823|P4|STARTED|Overall Study||10
8494301|NCT00535236|20931824|P3|STARTED|Overall Study||41
8494302|NCT00535236|20931825|P2|STARTED|Overall Study||10
8494303|NCT00535236|20931826|P1|STARTED|Overall Study||40
8494304|NCT00535223|20931886|P2|NOT COMPLETED|Overall Study||1
8494305|NCT00535223|20931887|P1|NOT COMPLETED|Overall Study||4
8494306|NCT00535223|20931886|P2|COMPLETED|Overall Study||39
8494307|NCT00535223|20931887|P1|COMPLETED|Overall Study||37
8494308|NCT00535223|20931886|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
8494309|NCT00535223|20931887|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
8494310|NCT00535145|20931895|P1|NOT COMPLETED|Phase II||15
8494311|NCT00535145|20931895|P1|COMPLETED|Phase II||69
8494312|NCT00535145|20931895|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
8494313|NCT00535145|20931895|P1|NOT COMPLETED|Phase I||29
8494314|NCT00535145|20931895|P1|COMPLETED|Phase I||85
8494315|NCT00535145|20931895|P1|STARTED|Phase I||114
8494316|NCT00535132|20931907|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
8494317|NCT00535132|20931908|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
8494318|NCT00535132|20931907|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
8494319|NCT00535132|20931908|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
8494320|NCT00535132|20931907|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
8494321|NCT00535132|20931908|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
8494322|NCT00535132|20931907|P2|NOT COMPLETED|Safety Analysis Set||2
8494323|NCT00535132|20931908|P1|NOT COMPLETED|Safety Analysis Set||2
8494324|NCT00535132|20931907|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
8494325|NCT00535132|20931908|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
8494326|NCT00535132|20931907|P2|STARTED|Safety Analysis Set||101
8494327|NCT00535132|20931908|P1|STARTED|Safety Analysis Set||100
8494328|NCT00535132|20931907|P2|NOT COMPLETED|Randomized Population||0
8494329|NCT00535132|20931908|P1|NOT COMPLETED|Randomized Population||0
8494330|NCT00535132|20931907|P2|COMPLETED|Randomized Population||101
8494331|NCT00535132|20931908|P1|COMPLETED|Randomized Population||100
8494332|NCT00535132|20931907|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
8494333|NCT00535132|20931908|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
8494334|NCT00535002|20931966|P8|NOT COMPLETED|Overall Study||0
8494335|NCT00535002|20931967|P7|NOT COMPLETED|Overall Study||0
8494336|NCT00535002|20931968|P6|NOT COMPLETED|Overall Study||0
8494337|NCT00535002|20931969|P5|NOT COMPLETED|Overall Study||0
8494338|NCT00535002|20931970|P4|NOT COMPLETED|Overall Study||0
8494339|NCT00535002|20931971|P3|NOT COMPLETED|Overall Study||0
8494340|NCT00535002|20931972|P2|NOT COMPLETED|Overall Study||0
8494341|NCT00535002|20931973|P1|NOT COMPLETED|Overall Study||0
8494342|NCT00535002|20931966|P8|COMPLETED|Overall Study||16
8494343|NCT00535002|20931967|P7|COMPLETED|Overall Study||12
8494344|NCT00535002|20931968|P6|COMPLETED|Overall Study||17
8494345|NCT00535002|20931969|P5|COMPLETED|Overall Study||9
8494346|NCT00535002|20931970|P4|COMPLETED|Overall Study||14
8494347|NCT00535002|20931971|P3|COMPLETED|Overall Study||13
8494348|NCT00535002|20931972|P2|COMPLETED|Overall Study||12
8494349|NCT00535002|20931973|P1|COMPLETED|Overall Study||19
8494350|NCT00535002|20931966|P8|STARTED|Overall Study||16
8494351|NCT00535002|20931967|P7|STARTED|Overall Study||12
8494352|NCT00535002|20931968|P6|STARTED|Overall Study||17
8494353|NCT00535002|20931969|P5|STARTED|Overall Study||9
8494354|NCT00535002|20931970|P4|STARTED|Overall Study||14
8494355|NCT00535002|20931971|P3|STARTED|Overall Study||13
8494356|NCT00535002|20931972|P2|STARTED|Overall Study||12
8494357|NCT00535002|20931973|P1|STARTED|Overall Study||19
8494358|NCT00534976|20931989|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
8494359|NCT00534976|20931990|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
8494360|NCT00534976|20931989|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
8494361|NCT00534976|20931990|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
8494362|NCT00534976|20931989|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
8494363|NCT00534976|20931990|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
8494364|NCT00534976|20931989|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
8494365|NCT00534976|20931990|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
8494366|NCT00534976|20931989|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
8494367|NCT00534976|20931990|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
8494368|NCT00534976|20931989|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
8494369|NCT00534976|20931990|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
8494370|NCT00534976|20931989|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
8494371|NCT00534976|20931990|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
8494372|NCT00534976|20931989|P2|COMPLETED|Period 1: Placebo Run-in||33
8494373|NCT00534976|20931990|P1|COMPLETED|Period 1: Placebo Run-in||33
8494374|NCT00534976|20931989|P2|STARTED|Period 1: Placebo Run-in||33
8494375|NCT00534976|20931990|P1|STARTED|Period 1: Placebo Run-in||33
8494376|NCT00534937|20932012|P2|NOT COMPLETED|Overall Study||12
8494377|NCT00534937|20932013|P1|NOT COMPLETED|Overall Study||8
8494378|NCT00534937|20932012|P2|COMPLETED|Overall Study||35
8494379|NCT00534937|20932013|P1|COMPLETED|Overall Study||34
8494380|NCT00534937|20932012|P2|STARTED|Overall Study||47
8494381|NCT00534937|20932013|P1|STARTED|Overall Study||42
8494382|NCT00534833|20932027|P2|NOT COMPLETED|Overall Study||0
8494383|NCT00534833|20932028|P1|NOT COMPLETED|Overall Study||0
8494384|NCT00534833|20932027|P2|COMPLETED|Overall Study||180
8494385|NCT00534833|20932028|P1|COMPLETED|Overall Study||182
8494386|NCT00534833|20932027|P2|STARTED|Overall Study||180
8494387|NCT00534833|20932028|P1|STARTED|Overall Study||182
8494388|NCT00534794|20932040|P2|NOT COMPLETED|Overall Study||0
8494389|NCT00534794|20932041|P1|NOT COMPLETED|Overall Study||0
8494390|NCT00534794|20932040|P2|COMPLETED|Overall Study||39
8494391|NCT00534794|20932041|P1|COMPLETED|Overall Study||40
8494392|NCT00534794|20932040|P2|STARTED|Overall Study||39
8494393|NCT00534794|20932041|P1|STARTED|Overall Study||40
8494394|NCT00534703|20932051|P2|NOT COMPLETED|Overall Study||0
8494395|NCT00534703|20932052|P1|NOT COMPLETED|Overall Study||0
8494396|NCT00534703|20932051|P2|COMPLETED|Overall Study||1
8494397|NCT00534703|20932052|P1|COMPLETED|Overall Study||4
8494398|NCT00534703|20932051|P2|STARTED|Overall Study||1
8494399|NCT00534703|20932052|P1|STARTED|Overall Study||4
8494400|NCT00534638|20932070|P2|NOT COMPLETED|Overall Study||11791
8494401|NCT00534638|20932071|P1|NOT COMPLETED|Overall Study||6491
8494402|NCT00534638|20932070|P2|COMPLETED|Overall Study||5547
8494403|NCT00534638|20932071|P1|COMPLETED|Overall Study||8346
8494404|NCT00534638|20932070|P2|STARTED|Overall Study||17338
8494405|NCT00534638|20932071|P1|STARTED|Overall Study||14837
8494406|NCT00534599|20932109|P2|NOT COMPLETED|Overall Study||32
8494407|NCT00534599|20932110|P1|NOT COMPLETED|Overall Study||57
8494408|NCT00534599|20932109|P2|COMPLETED|Overall Study||168
8494409|NCT00534599|20932110|P1|COMPLETED|Overall Study||152
8494410|NCT00534599|20932109|P2|STARTED|Overall Study|Randomized|200
8494411|NCT00534599|20932110|P1|STARTED|Overall Study|Randomized|209
8494412|NCT00534495|20932146|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
8494413|NCT00534495|20932147|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494414|NCT00534495|20932148|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494415|NCT00534495|20932146|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
8494416|NCT00534495|20932147|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494417|NCT00534495|20932148|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494418|NCT00534495|20932146|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
8494419|NCT00534495|20932147|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
8494420|NCT00534495|20932148|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
8494421|NCT00534495|20932146|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
8494422|NCT00534495|20932147|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
8494423|NCT00534495|20932148|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
8494424|NCT00534495|20932146|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
8494425|NCT00534495|20932147|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
8494426|NCT00534495|20932148|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
8494427|NCT00534495|20932146|P3|STARTED|All Active Treatment Phase Week 4-24||0
8494428|NCT00534495|20932147|P2|STARTED|All Active Treatment Phase Week 4-24||34
8494429|NCT00534495|20932148|P1|STARTED|All Active Treatment Phase Week 4-24||36
8494430|NCT00534495|20932146|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
8494431|NCT00534495|20932147|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
8494432|NCT00534495|20932148|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
8494433|NCT00534495|20932146|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
8494434|NCT00534495|20932147|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
8494435|NCT00534495|20932148|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
8494436|NCT00534495|20932146|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
8494437|NCT00534495|20932147|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
8494438|NCT00534495|20932148|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
8494439|NCT00534417|20932171|P1|NOT COMPLETED|Overall Study||0
8494440|NCT00534417|20932171|P1|COMPLETED|Overall Study||41
8494441|NCT00534417|20932171|P1|STARTED|Overall Study||41
8494442|NCT00534404|20932186|P3|NOT COMPLETED|Overall Study||242
8494443|NCT00534404|20932187|P2|NOT COMPLETED|Overall Study||143
8494444|NCT00534404|20932188|P1|NOT COMPLETED|Overall Study||180
8494445|NCT00534404|20932186|P3|COMPLETED|Overall Study||586
8494446|NCT00534404|20932187|P2|COMPLETED|Overall Study||687
8494447|NCT00534404|20932188|P1|COMPLETED|Overall Study||647
8494448|NCT00534404|20932186|P3|3-month Follow up Completed|Overall Study||593
8494449|NCT00534404|20932187|P2|3-month Follow up Completed|Overall Study||731
8494450|NCT00534404|20932188|P1|3-month Follow up Completed|Overall Study||682
8494451|NCT00534404|20932186|P3|1-month Follow up Completed|Overall Study||626
8494452|NCT00534404|20932187|P2|1-month Follow up Completed|Overall Study||781
8494453|NCT00534404|20932188|P1|1-month Follow up Completed|Overall Study||742
8494454|NCT00534404|20932186|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
8494455|NCT00534404|20932187|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
8494456|NCT00534404|20932188|P1|Completed at Least 1 Counseling Call|Overall Study||813
8494457|NCT00534404|20932186|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
8494458|NCT00534404|20932187|P2|Completed Second NRT Order|Overall Study||789
8494459|NCT00534404|20932188|P1|Completed Second NRT Order|Overall Study||640
8494460|NCT00534404|20932186|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
8494461|NCT00534404|20932187|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
8494462|NCT00534404|20932188|P1|Completed First NRT Order|Overall Study||765
8494463|NCT00534404|20932186|P3|Completed at Least 1 Online Session|Overall Study||658
8494464|NCT00534404|20932187|P2|Completed at Least 1 Online Session|Overall Study||813
8494465|NCT00534404|20932188|P1|Completed at Least 1 Online Session|Overall Study||781
8494466|NCT00534404|20932186|P3|STARTED|Overall Study||828
8494467|NCT00534404|20932187|P2|STARTED|Overall Study||830
8494468|NCT00534404|20932188|P1|STARTED|Overall Study||827
8494469|NCT00534365|20932204|P2|NOT COMPLETED|Overall Study||7
8494470|NCT00534365|20932205|P1|NOT COMPLETED|Overall Study||0
8494471|NCT00534365|20932204|P2|COMPLETED|Overall Study||129
8494472|NCT00534365|20932205|P1|COMPLETED|Overall Study||127
8494473|NCT00534365|20932204|P2|Included in Intent to Treat Analysis|Overall Study||136
8494474|NCT00534365|20932205|P1|Included in Intent to Treat Analysis|Overall Study||127
8494475|NCT00534365|20932204|P2|Follow up at 12 Months or More|Overall Study||128
8494476|NCT00534365|20932205|P1|Follow up at 12 Months or More|Overall Study||119
8494477|NCT00534365|20932204|P2|Any Follow up|Overall Study||135
8494478|NCT00534365|20932205|P1|Any Follow up|Overall Study||126
8494479|NCT00534365|20932204|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
8494480|NCT00534365|20932205|P1|Received Procedure|Overall Study||127
8494481|NCT00534365|20932204|P2|STARTED|Overall Study||136
8494482|NCT00534365|20932205|P1|STARTED|Overall Study||127
8494483|NCT00534352|20932219|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
8494484|NCT00534352|20932219|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
8494485|NCT00534352|20932219|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
8494486|NCT00534352|20932219|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
8494487|NCT00534352|20932219|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
8494488|NCT00534352|20932219|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
8494489|NCT00534352|20932219|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
8494490|NCT00534352|20932219|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
8494491|NCT00534352|20932219|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
8494492|NCT00534352|20932219|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
8494493|NCT00534352|20932219|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
8494494|NCT00534352|20932219|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
8494495|NCT00534313|20932263|P4|NOT COMPLETED|Long-term Period||33
8494496|NCT00534313|20932264|P3|NOT COMPLETED|Long-term Period||43
8494497|NCT00534313|20932265|P2|NOT COMPLETED|Long-term Period||34
8494498|NCT00534313|20932266|P1|NOT COMPLETED|Long-term Period||37
8494499|NCT00534313|20932263|P4|COMPLETED|Long-term Period||0
8494500|NCT00534313|20932264|P3|COMPLETED|Long-term Period||0
8494501|NCT00534313|20932265|P2|COMPLETED|Long-term Period||0
8494502|NCT00534313|20932266|P1|COMPLETED|Long-term Period||0
8494503|NCT00534313|20932263|P4|STARTED|Long-term Period||33
8494504|NCT00534313|20932264|P3|STARTED|Long-term Period||43
8494505|NCT00534313|20932265|P2|STARTED|Long-term Period||34
8494506|NCT00534313|20932266|P1|STARTED|Long-term Period||37
8494507|NCT00534313|20932263|P4|NOT COMPLETED|Short-term Period||9
8494508|NCT00534313|20932264|P3|NOT COMPLETED|Short-term Period||2
8494509|NCT00534313|20932265|P2|NOT COMPLETED|Short-term Period||6
8494510|NCT00534313|20932266|P1|NOT COMPLETED|Short-term Period||6
8494511|NCT00534313|20932263|P4|COMPLETED|Short-term Period|Completed the short-term study|33
8494512|NCT00534313|20932264|P3|COMPLETED|Short-term Period|Completed the short-term study|43
8494513|NCT00534313|20932265|P2|COMPLETED|Short-term Period|Completed the short-term study|34
8494514|NCT00534313|20932266|P1|COMPLETED|Short-term Period|Completed the short-term study|37
8494515|NCT00534313|20932263|P4|STARTED|Short-term Period||42
8494516|NCT00534313|20932264|P3|STARTED|Short-term Period||45
8494517|NCT00534313|20932265|P2|STARTED|Short-term Period||40
8494518|NCT00534313|20932266|P1|STARTED|Short-term Period||43
8494519|NCT00534248|20932361|P2|NOT COMPLETED|Overall Study||673
8494520|NCT00534248|20932362|P1|NOT COMPLETED|Overall Study||661
8494521|NCT00534248|20932361|P2|COMPLETED|Overall Study||10555
8494522|NCT00534248|20932362|P1|COMPLETED|Overall Study||10550
8494523|NCT00534248|20932361|P2|VACCINATED|Overall Study||11210
8494524|NCT00534248|20932362|P1|VACCINATED|Overall Study||11186
8494525|NCT00534248|20932361|P2|STARTED|Overall Study||11228
8494526|NCT00534248|20932362|P1|STARTED|Overall Study||11211
8494527|NCT00534235|20932374|P2|NOT COMPLETED|Overall Study||23
8494528|NCT00534235|20932375|P1|NOT COMPLETED|Overall Study||16
8494529|NCT00534235|20932374|P2|COMPLETED|Overall Study||192
8494530|NCT00534235|20932375|P1|COMPLETED|Overall Study||91
8494531|NCT00534235|20932374|P2|STARTED|Overall Study||215
8494532|NCT00534235|20932375|P1|STARTED|Overall Study||107
8494533|NCT00534209|20932499|P1|NOT COMPLETED|Overall Study||0
8494534|NCT00534209|20932499|P1|COMPLETED|Overall Study||1
8494535|NCT00534209|20932499|P1|STARTED|Overall Study||1
8494536|NCT00534118|20932519|P2|NOT COMPLETED|Overall Study||0
8494537|NCT00534118|20932520|P1|NOT COMPLETED|Overall Study||0
8494538|NCT00534118|20932519|P2|COMPLETED|Overall Study||22
8494539|NCT00534118|20932520|P1|COMPLETED|Overall Study||17
8494540|NCT00534118|20932519|P2|STARTED|Overall Study||22
8494541|NCT00534118|20932520|P1|STARTED|Overall Study||17
8494542|NCT00534105|20932532|P2|NOT COMPLETED|Overall Study||39
8494543|NCT00534105|20932533|P1|NOT COMPLETED|Overall Study||23
8494544|NCT00534105|20932532|P2|COMPLETED|Overall Study||20
8494545|NCT00534105|20932533|P1|COMPLETED|Overall Study||24
8494546|NCT00534105|20932532|P2|STARTED|Overall Study||59
8494547|NCT00534105|20932533|P1|STARTED|Overall Study||47
8494548|NCT00534092|20932547|P2|NOT COMPLETED|Overall Study||0
8494549|NCT00534092|20932548|P1|NOT COMPLETED|Overall Study||2
8494550|NCT00534092|20932547|P2|COMPLETED|Overall Study||14
8494551|NCT00534092|20932548|P1|COMPLETED|Overall Study||53
8494552|NCT00534092|20932547|P2|STARTED|Overall Study||14
8494553|NCT00534092|20932548|P1|STARTED|Overall Study||55
8494554|NCT00534001|20932573|P2|NOT COMPLETED|Overall Study||4
8494555|NCT00534001|20932574|P1|NOT COMPLETED|Overall Study||5
8494556|NCT00534001|20932573|P2|COMPLETED|Overall Study||43
8494557|NCT00534001|20932574|P1|COMPLETED|Overall Study||43
8494558|NCT00534001|20932573|P2|STARTED|Overall Study||47
8494559|NCT00534001|20932574|P1|STARTED|Overall Study||48
8494560|NCT00533949|20932586|P4|NOT COMPLETED|Overall Study||10
8494561|NCT00533949|20932587|P3|NOT COMPLETED|Overall Study||10
8494562|NCT00533949|20932588|P2|NOT COMPLETED|Overall Study||14
8494563|NCT00533949|20932589|P1|NOT COMPLETED|Overall Study||15
8494564|NCT00533949|20932586|P4|COMPLETED|Overall Study||100
8494565|NCT00533949|20932587|P3|COMPLETED|Overall Study||137
8494566|NCT00533949|20932588|P2|COMPLETED|Overall Study||107
8494567|NCT00533949|20932589|P1|COMPLETED|Overall Study||151
8494568|NCT00533949|20932586|P4|STARTED|Overall Study||110
8494569|NCT00533949|20932587|P3|STARTED|Overall Study||147
8494570|NCT00533949|20932588|P2|STARTED|Overall Study||121
8494571|NCT00533949|20932589|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
8494572|NCT00533910|20932629|P2|NOT COMPLETED|Overall Study||0
8494573|NCT00533910|20932630|P1|NOT COMPLETED|Overall Study||0
8494574|NCT00533910|20932629|P2|COMPLETED|Overall Study||21
8494575|NCT00533910|20932630|P1|COMPLETED|Overall Study||21
8494576|NCT00533910|20932629|P2|STARTED|Overall Study||21
8494577|NCT00533910|20932630|P1|STARTED|Overall Study||21
8494578|NCT00533897|20932643|P8|NOT COMPLETED|Long Term Extension (LTE)||25
8494579|NCT00533897|20932644|P7|NOT COMPLETED|Long Term Extension (LTE)||13
8494580|NCT00533897|20932645|P6|NOT COMPLETED|Long Term Extension (LTE)||0
8494581|NCT00533897|20932646|P5|NOT COMPLETED|Long Term Extension (LTE)||0
8494582|NCT00533897|20932647|P4|NOT COMPLETED|Long Term Extension (LTE)||0
8494583|NCT00533897|20932648|P3|NOT COMPLETED|Long Term Extension (LTE)||0
8494584|NCT00533897|20932649|P2|NOT COMPLETED|Long Term Extension (LTE)||0
8494585|NCT00533897|20932650|P1|NOT COMPLETED|Long Term Extension (LTE)||0
8494586|NCT00533897|20932643|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
8494587|NCT00533897|20932644|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
8494588|NCT00533897|20932645|P6|COMPLETED|Long Term Extension (LTE)||0
8494589|NCT00533897|20932646|P5|COMPLETED|Long Term Extension (LTE)||0
8494590|NCT00533897|20932647|P4|COMPLETED|Long Term Extension (LTE)||0
8494591|NCT00533897|20932648|P3|COMPLETED|Long Term Extension (LTE)||0
8494592|NCT00533897|20932649|P2|COMPLETED|Long Term Extension (LTE)||0
8494593|NCT00533897|20932650|P1|COMPLETED|Long Term Extension (LTE)||0
8494594|NCT00533897|20932643|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
8494595|NCT00533897|20932644|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
8494596|NCT00533897|20932645|P6|STARTED|Long Term Extension (LTE)||0
8494597|NCT00533897|20932646|P5|STARTED|Long Term Extension (LTE)||0
8494598|NCT00533897|20932647|P4|STARTED|Long Term Extension (LTE)||0
8494599|NCT00533897|20932648|P3|STARTED|Long Term Extension (LTE)||0
8494600|NCT00533897|20932649|P2|STARTED|Long Term Extension (LTE)||0
8494601|NCT00533897|20932650|P1|STARTED|Long Term Extension (LTE)||0
8494602|NCT00533897|20932643|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494603|NCT00533897|20932644|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494604|NCT00533897|20932645|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
8494605|NCT00533897|20932646|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494606|NCT00533897|20932647|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494607|NCT00533897|20932648|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494608|NCT00533897|20932649|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494609|NCT00533897|20932650|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494610|NCT00533897|20932643|P8|COMPLETED|Re-introduction (RI) Period 3||0
8494611|NCT00533897|20932644|P7|COMPLETED|Re-introduction (RI) Period 3||0
8494612|NCT00533897|20932645|P6|COMPLETED|Re-introduction (RI) Period 3||42
8494613|NCT00533897|20932646|P5|COMPLETED|Re-introduction (RI) Period 3||35
8494614|NCT00533897|20932647|P4|COMPLETED|Re-introduction (RI) Period 3||40
8494615|NCT00533897|20932648|P3|COMPLETED|Re-introduction (RI) Period 3||0
8494616|NCT00533897|20932649|P2|COMPLETED|Re-introduction (RI) Period 3||0
8494617|NCT00533897|20932650|P1|COMPLETED|Re-introduction (RI) Period 3||0
8494618|NCT00533897|20932643|P8|STARTED|Re-introduction (RI) Period 3||0
8494619|NCT00533897|20932644|P7|STARTED|Re-introduction (RI) Period 3||0
8494620|NCT00533897|20932645|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
8494621|NCT00533897|20932646|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
8494622|NCT00533897|20932647|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
8494623|NCT00533897|20932648|P3|STARTED|Re-introduction (RI) Period 3||0
8494624|NCT00533897|20932649|P2|STARTED|Re-introduction (RI) Period 3||0
8494625|NCT00533897|20932650|P1|STARTED|Re-introduction (RI) Period 3||0
8494626|NCT00533897|20932643|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494627|NCT00533897|20932644|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494628|NCT00533897|20932645|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494629|NCT00533897|20932646|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494630|NCT00533897|20932647|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494631|NCT00533897|20932648|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
8494632|NCT00533897|20932649|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
8494633|NCT00533897|20932650|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494634|NCT00533897|20932643|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494635|NCT00533897|20932644|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494636|NCT00533897|20932645|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494637|NCT00533897|20932646|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494638|NCT00533897|20932647|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494639|NCT00533897|20932648|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
8494640|NCT00533897|20932649|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
8494641|NCT00533897|20932650|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494642|NCT00533897|20932643|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494643|NCT00533897|20932644|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494644|NCT00533897|20932645|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494645|NCT00533897|20932646|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494646|NCT00533897|20932647|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494647|NCT00533897|20932648|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
8494648|NCT00533897|20932649|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
8494649|NCT00533897|20932650|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494650|NCT00533897|20932643|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
8494651|NCT00533897|20932644|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
8494652|NCT00533897|20932645|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
8494653|NCT00533897|20932646|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
8494654|NCT00533897|20932647|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
8494655|NCT00533897|20932648|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
8494656|NCT00533897|20932649|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
8494657|NCT00533897|20932650|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
8494658|NCT00533897|20932643|P8|COMPLETED|Lead-in (LI) Period 1||0
8494659|NCT00533897|20932644|P7|COMPLETED|Lead-in (LI) Period 1||0
8494660|NCT00533897|20932645|P6|COMPLETED|Lead-in (LI) Period 1||0
8494661|NCT00533897|20932646|P5|COMPLETED|Lead-in (LI) Period 1||0
8494662|NCT00533897|20932647|P4|COMPLETED|Lead-in (LI) Period 1||0
8494663|NCT00533897|20932648|P3|COMPLETED|Lead-in (LI) Period 1||0
8494664|NCT00533897|20932649|P2|COMPLETED|Lead-in (LI) Period 1||0
8494665|NCT00533897|20932650|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
8494666|NCT00533897|20932643|P8|STARTED|Lead-in (LI) Period 1||0
8494667|NCT00533897|20932644|P7|STARTED|Lead-in (LI) Period 1||0
8494668|NCT00533897|20932645|P6|STARTED|Lead-in (LI) Period 1||0
8494669|NCT00533897|20932646|P5|STARTED|Lead-in (LI) Period 1||0
8494670|NCT00533897|20932647|P4|STARTED|Lead-in (LI) Period 1||0
8494671|NCT00533897|20932648|P3|STARTED|Lead-in (LI) Period 1||0
8494672|NCT00533897|20932649|P2|STARTED|Lead-in (LI) Period 1||0
8494673|NCT00533897|20932650|P1|STARTED|Lead-in (LI) Period 1||167
8494674|NCT00533845|20932790|P2|NOT COMPLETED|Overall Study||0
8494675|NCT00533845|20932791|P1|NOT COMPLETED|Overall Study||1
8494676|NCT00533845|20932790|P2|COMPLETED|Overall Study||15
8494677|NCT00533845|20932791|P1|COMPLETED|Overall Study||14
8494678|NCT00533845|20932790|P2|STARTED|Overall Study||15
8494679|NCT00533845|20932791|P1|STARTED|Overall Study||15
8494680|NCT00533702|20932799|P2|NOT COMPLETED|Overall Study||2
8494681|NCT00533702|20932800|P1|NOT COMPLETED|Overall Study||5
8494682|NCT00533702|20932799|P2|COMPLETED|Overall Study||50
8494683|NCT00533702|20932800|P1|COMPLETED|Overall Study||49
8494684|NCT00533702|20932799|P2|Received Any Quantity of Study Drug|Overall Study||50
8494685|NCT00533702|20932800|P1|Received Any Quantity of Study Drug|Overall Study||52
8494686|NCT00533702|20932799|P2|STARTED|Overall Study||52
8494687|NCT00533702|20932800|P1|STARTED|Overall Study||54
8494688|NCT00533546|20932824|P1|NOT COMPLETED|Overall Study||0
8494689|NCT00533546|20932824|P1|COMPLETED|Overall Study||12
8494690|NCT00533546|20932824|P1|STARTED|Overall Study||12
8494691|NCT00533507|20932831|P1|NOT COMPLETED|Overall Study||1
8494692|NCT00533507|20932831|P1|COMPLETED|Overall Study||229
8494693|NCT00533507|20932831|P1|STARTED|Overall Study||230
8494694|NCT00533442|20932852|P2|NOT COMPLETED|Follow-up||10
8494695|NCT00533442|20932853|P1|NOT COMPLETED|Follow-up||9
8494696|NCT00533442|20932852|P2|COMPLETED|Follow-up||74
8494697|NCT00533442|20932853|P1|COMPLETED|Follow-up||77
8494698|NCT00533442|20932852|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
8494699|NCT00533442|20932853|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
8494700|NCT00533442|20932852|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
8494701|NCT00533442|20932853|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
8494702|NCT00533442|20932852|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
8494703|NCT00533442|20932853|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
8494704|NCT00533442|20932852|P2|STARTED|Allocation and Intent to Treat Analysis||84
8494705|NCT00533442|20932853|P1|STARTED|Allocation and Intent to Treat Analysis||86
8494706|NCT00533351|20932865|P2|NOT COMPLETED|Period 3||0
8494707|NCT00533351|20932866|P1|NOT COMPLETED|Period 3||0
8494708|NCT00533351|20932865|P2|COMPLETED|Period 3||0
8494709|NCT00533351|20932866|P1|COMPLETED|Period 3||3
8494710|NCT00533351|20932865|P2|STARTED|Period 3|No patients continued to Period 3|0
8494711|NCT00533351|20932866|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
8494712|NCT00533351|20932865|P2|NOT COMPLETED|Period 2||0
8494713|NCT00533351|20932866|P1|NOT COMPLETED|Period 2||0
8494714|NCT00533351|20932865|P2|COMPLETED|Period 2||1
8494715|NCT00533351|20932866|P1|COMPLETED|Period 2||5
8494716|NCT00533351|20932865|P2|STARTED|Period 2||1
8494717|NCT00533351|20932866|P1|STARTED|Period 2||5
8494718|NCT00533351|20932865|P2|NOT COMPLETED|Period 1||1
8494719|NCT00533351|20932866|P1|NOT COMPLETED|Period 1||2
8494720|NCT00533351|20932865|P2|COMPLETED|Period 1||1
8494721|NCT00533351|20932866|P1|COMPLETED|Period 1||5
8494722|NCT00533351|20932865|P2|STARTED|Period 1||2
8494723|NCT00533351|20932866|P1|STARTED|Period 1||7
8494724|NCT00533273|20932876|P2|NOT COMPLETED|Open-label||0
8494725|NCT00533273|20932877|P1|NOT COMPLETED|Open-label||6
8494726|NCT00533273|20932876|P2|COMPLETED|Open-label||0
8494727|NCT00533273|20932877|P1|COMPLETED|Open-label||58
8494728|NCT00533273|20932876|P2|STARTED|Open-label|no placebo - this phase was open label|0
8494729|NCT00533273|20932877|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
8494730|NCT00533273|20932876|P2|NOT COMPLETED|Double-blind||2
8494731|NCT00533273|20932877|P1|NOT COMPLETED|Double-blind||0
8494732|NCT00533273|20932876|P2|COMPLETED|Double-blind||19
8494733|NCT00533273|20932877|P1|COMPLETED|Double-blind||45
8494734|NCT00533273|20932876|P2|STARTED|Double-blind||21
8494735|NCT00533273|20932877|P1|STARTED|Double-blind||45
8494736|NCT00533117|20932912|P4|NOT COMPLETED|Overall Study||5
8494737|NCT00533117|20932913|P3|NOT COMPLETED|Overall Study||6
8494738|NCT00533117|20932914|P2|NOT COMPLETED|Overall Study||5
8494739|NCT00533117|20932915|P1|NOT COMPLETED|Overall Study||4
8494740|NCT00533117|20932912|P4|COMPLETED|Overall Study||13
8494741|NCT00533117|20932913|P3|COMPLETED|Overall Study||14
8494742|NCT00533117|20932914|P2|COMPLETED|Overall Study||14
8494743|NCT00533117|20932915|P1|COMPLETED|Overall Study||14
8494744|NCT00533117|20932912|P4|STARTED|Overall Study||18
8494745|NCT00533117|20932913|P3|STARTED|Overall Study||20
8494746|NCT00533117|20932914|P2|STARTED|Overall Study||19
8494747|NCT00533117|20932915|P1|STARTED|Overall Study||18
8494748|NCT00532948|20932928|P3|NOT COMPLETED|Overall Study||4
8494749|NCT00532948|20932929|P2|NOT COMPLETED|Overall Study||5
8494750|NCT00532948|20932930|P1|NOT COMPLETED|Overall Study||4
8494751|NCT00532948|20932928|P3|COMPLETED|Overall Study||2
8494752|NCT00532948|20932929|P2|COMPLETED|Overall Study||9
8494753|NCT00532948|20932930|P1|COMPLETED|Overall Study||0
8494754|NCT00532948|20932928|P3|STARTED|Overall Study||6
8494755|NCT00532948|20932929|P2|STARTED|Overall Study||14
8494756|NCT00532948|20932930|P1|STARTED|Overall Study||4
8494757|NCT00532935|20932962|P2|NOT COMPLETED|Overall Study||52
8494758|NCT00532935|20932963|P1|NOT COMPLETED|Overall Study||51
8494759|NCT00532935|20932962|P2|COMPLETED|Overall Study||204
8494760|NCT00532935|20932963|P1|COMPLETED|Overall Study||210
8494761|NCT00532935|20932962|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
8494762|NCT00532935|20932963|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
8494763|NCT00532883|20932981|P4|NOT COMPLETED|Overall Study||5
8494764|NCT00532883|20932982|P3|NOT COMPLETED|Overall Study||4
8494765|NCT00532883|20932983|P2|NOT COMPLETED|Overall Study||7
8494766|NCT00532883|20932984|P1|NOT COMPLETED|Overall Study||6
8494767|NCT00532883|20932981|P4|COMPLETED|Overall Study|Study terminated early.|6
8494768|NCT00532883|20932982|P3|COMPLETED|Overall Study|Study terminated early.|6
8494769|NCT00532883|20932983|P2|COMPLETED|Overall Study|Study terminated early.|5
8494770|NCT00532883|20932984|P1|COMPLETED|Overall Study|Study terminated early.|5
8494771|NCT00532883|20932981|P4|STARTED|Overall Study||11
8494772|NCT00532883|20932982|P3|STARTED|Overall Study||10
8494773|NCT00532883|20932983|P2|STARTED|Overall Study||12
8494774|NCT00532883|20932984|P1|STARTED|Overall Study||11
8494775|NCT00532779|20932997|P3|NOT COMPLETED|Overall Study||291
8494776|NCT00532779|20932998|P2|NOT COMPLETED|Overall Study||287
8494777|NCT00532779|20932999|P1|NOT COMPLETED|Overall Study||294
8494778|NCT00532779|20932997|P3|COMPLETED|Overall Study||290
8494779|NCT00532779|20932998|P2|COMPLETED|Overall Study||296
8494780|NCT00532779|20932999|P1|COMPLETED|Overall Study||284
8494781|NCT00532779|20932997|P3|STARTED|Overall Study||581
8494782|NCT00532779|20932998|P2|STARTED|Overall Study||583
8494783|NCT00532779|20932999|P1|STARTED|Overall Study||578
8494784|NCT00532493|20933060|P2|NOT COMPLETED|Overall Study||29
8494785|NCT00532493|20933061|P1|NOT COMPLETED|Overall Study||30
8494786|NCT00532493|20933060|P2|COMPLETED|Overall Study||123
8494787|NCT00532493|20933061|P1|COMPLETED|Overall Study||122
8494788|NCT00532493|20933060|P2|STARTED|Overall Study||152
8494789|NCT00532493|20933061|P1|STARTED|Overall Study||152
8494790|NCT00532480|20933091|P1|NOT COMPLETED|Overall Study||3
8494791|NCT00532480|20933091|P1|COMPLETED|Overall Study||7
8494792|NCT00532480|20933091|P1|STARTED|Overall Study||10
8494793|NCT00532441|20933095|P2|NOT COMPLETED|Overall Study||0
8494794|NCT00532441|20933096|P1|NOT COMPLETED|Overall Study||1
8494795|NCT00532441|20933095|P2|COMPLETED|Overall Study||11
8494796|NCT00532441|20933096|P1|COMPLETED|Overall Study||13
8494797|NCT00532441|20933095|P2|STARTED|Overall Study||11
8494798|NCT00532441|20933096|P1|STARTED|Overall Study||14
8494799|NCT00532298|20933111|P6|NOT COMPLETED|Overall Study||2
8494800|NCT00532298|20933112|P5|NOT COMPLETED|Overall Study||1
8494801|NCT00532298|20933113|P4|NOT COMPLETED|Overall Study||0
8494802|NCT00532298|20933114|P3|NOT COMPLETED|Overall Study||1
8494803|NCT00532298|20933115|P2|NOT COMPLETED|Overall Study||1
8494804|NCT00532298|20933116|P1|NOT COMPLETED|Overall Study||2
8494805|NCT00532298|20933111|P6|COMPLETED|Overall Study||261
8494806|NCT00532298|20933112|P5|COMPLETED|Overall Study||267
8494807|NCT00532298|20933113|P4|COMPLETED|Overall Study||264
8494808|NCT00532298|20933114|P3|COMPLETED|Overall Study||263
8494809|NCT00532298|20933115|P2|COMPLETED|Overall Study||265
8494810|NCT00532298|20933116|P1|COMPLETED|Overall Study||267
8494811|NCT00532298|20933111|P6|STARTED|Overall Study||263
8494812|NCT00532298|20933112|P5|STARTED|Overall Study||268
8494813|NCT00532298|20933113|P4|STARTED|Overall Study||264
8494814|NCT00532298|20933114|P3|STARTED|Overall Study||264
8494815|NCT00532298|20933115|P2|STARTED|Overall Study||266
8494816|NCT00532298|20933116|P1|STARTED|Overall Study||269
8494817|NCT00532259|20933196|P1|NOT COMPLETED|Overall Study||32
8494818|NCT00532259|20933196|P1|COMPLETED|Overall Study||40
8494819|NCT00532259|20933196|P1|STARTED|Overall Study||72
8494820|NCT00532155|20933203|P2|NOT COMPLETED|Overall Study||456
8494821|NCT00532155|20933204|P1|NOT COMPLETED|Overall Study||457
8494822|NCT00532155|20933203|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
8494823|NCT00532155|20933204|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
8494824|NCT00532155|20933203|P2|SAFETY POPULATION|Overall Study||450
8494825|NCT00532155|20933204|P1|SAFETY POPULATION|Overall Study||455
8494826|NCT00532155|20933203|P2|STARTED|Overall Study||456
8494827|NCT00532155|20933204|P1|STARTED|Overall Study||457
8494828|NCT00532129|20933218|P1|NOT COMPLETED|Follow-up Period||65
8494829|NCT00532129|20933218|P1|COMPLETED|Follow-up Period||33
8494830|NCT00532129|20933218|P1|STARTED|Follow-up Period||98
8494831|NCT00532129|20933218|P1|NOT COMPLETED|Treatment Period||49
8494832|NCT00532129|20933218|P1|COMPLETED|Treatment Period||51
8494833|NCT00532129|20933218|P1|STARTED|Treatment Period||100
8494834|NCT00531960|20933238|P2|NOT COMPLETED|Overall Study||63
8494835|NCT00531960|20933239|P1|NOT COMPLETED|Overall Study||61
8494836|NCT00531960|20933238|P2|COMPLETED|Overall Study||0
8494837|NCT00531960|20933239|P1|COMPLETED|Overall Study||0
8494838|NCT00531960|20933238|P2|STARTED|Overall Study||63
8494839|NCT00531960|20933239|P1|STARTED|Overall Study||61
8494840|NCT00531947|20933257|P2|NOT COMPLETED|Overall Study||51
8494841|NCT00531947|20933258|P1|NOT COMPLETED|Overall Study||42
8494842|NCT00531947|20933257|P2|COMPLETED|Overall Study||101
8494843|NCT00531947|20933258|P1|COMPLETED|Overall Study||114
8494844|NCT00531947|20933257|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
8494845|NCT00531947|20933258|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
8494846|NCT00531934|20933302|P2|NOT COMPLETED|Overall Study||63
8494847|NCT00531934|20933303|P1|NOT COMPLETED|Overall Study||66
8494848|NCT00531934|20933302|P2|COMPLETED|Overall Study||11
8494849|NCT00531934|20933303|P1|COMPLETED|Overall Study||7
8494850|NCT00531934|20933302|P2|STARTED|Overall Study||74
8494851|NCT00531934|20933303|P1|STARTED|Overall Study||73
8494852|NCT00531882|20933374|P3|NOT COMPLETED|Overall Study||0
8494853|NCT00531882|20933375|P2|NOT COMPLETED|Overall Study||0
8494854|NCT00531882|20933376|P1|NOT COMPLETED|Overall Study||0
8494855|NCT00531882|20933374|P3|COMPLETED|Overall Study||5
8494856|NCT00531882|20933375|P2|COMPLETED|Overall Study||10
8494857|NCT00531882|20933376|P1|COMPLETED|Overall Study||10
8494858|NCT00531882|20933374|P3|STARTED|Overall Study||5
8494859|NCT00531882|20933375|P2|STARTED|Overall Study||10
8494860|NCT00531882|20933376|P1|STARTED|Overall Study||10
8494861|NCT00531843|20933386|P2|NOT COMPLETED|Overall Study||0
8494862|NCT00531843|20933387|P1|NOT COMPLETED|Overall Study||0
8494863|NCT00531843|20933386|P2|COMPLETED|Overall Study||6
8494864|NCT00531843|20933387|P1|COMPLETED|Overall Study||81
8494865|NCT00531843|20933386|P2|STARTED|Overall Study||6
8494866|NCT00531843|20933387|P1|STARTED|Overall Study||81
8494867|NCT00531817|20933399|P2|NOT COMPLETED|Entered Extended Treatment Period||57
8494868|NCT00531817|20933400|P1|NOT COMPLETED|Entered Extended Treatment Period||137
8494869|NCT00531817|20933399|P2|COMPLETED|Entered Extended Treatment Period||113
8494870|NCT00531817|20933400|P1|COMPLETED|Entered Extended Treatment Period||206
8494871|NCT00531817|20933399|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
8494872|NCT00531817|20933400|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
8494873|NCT00531817|20933399|P2|NOT COMPLETED|Randomized||34
8494874|NCT00531817|20933400|P1|NOT COMPLETED|Randomized||59
8494875|NCT00531817|20933399|P2|COMPLETED|Randomized||173
8494876|NCT00531817|20933400|P1|COMPLETED|Randomized||353
8494877|NCT00531817|20933399|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
8494960|NCT00531284|20933607|P16|NOT COMPLETED|Overall Study||12
8494878|NCT00531817|20933400|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
8494879|NCT00531817|20933399|P2|STARTED|Randomized||207
8494880|NCT00531817|20933400|P1|STARTED|Randomized||412
8494881|NCT00531752|20933431|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
8494882|NCT00531752|20933432|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
8494883|NCT00531752|20933433|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
8494884|NCT00531752|20933434|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
8494885|NCT00531752|20933431|P4|COMPLETED|Second Double-blind Intervention Period||11
8494886|NCT00531752|20933432|P3|COMPLETED|Second Double-blind Intervention Period||9
8494887|NCT00531752|20933433|P2|COMPLETED|Second Double-blind Intervention Period||11
8494888|NCT00531752|20933434|P1|COMPLETED|Second Double-blind Intervention Period||9
8494889|NCT00531752|20933431|P4|STARTED|Second Double-blind Intervention Period||13
8494890|NCT00531752|20933432|P3|STARTED|Second Double-blind Intervention Period||9
8494891|NCT00531752|20933433|P2|STARTED|Second Double-blind Intervention Period||13
8494892|NCT00531752|20933434|P1|STARTED|Second Double-blind Intervention Period||11
8494893|NCT00531752|20933431|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494894|NCT00531752|20933432|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494895|NCT00531752|20933433|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494896|NCT00531752|20933434|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494897|NCT00531752|20933431|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
8494898|NCT00531752|20933432|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
8494899|NCT00531752|20933433|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
8494900|NCT00531752|20933434|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
8494901|NCT00531752|20933431|P4|STARTED|Wash-out Period (at Least 7 Days)||13
8494902|NCT00531752|20933432|P3|STARTED|Wash-out Period (at Least 7 Days)||9
8494903|NCT00531752|20933433|P2|STARTED|Wash-out Period (at Least 7 Days)||13
8494904|NCT00531752|20933434|P1|STARTED|Wash-out Period (at Least 7 Days)||11
8494905|NCT00531752|20933431|P4|NOT COMPLETED|First Double-blind Intervention Period||3
8494906|NCT00531752|20933432|P3|NOT COMPLETED|First Double-blind Intervention Period||7
8494907|NCT00531752|20933433|P2|NOT COMPLETED|First Double-blind Intervention Period||4
8494908|NCT00531752|20933434|P1|NOT COMPLETED|First Double-blind Intervention Period||6
8494909|NCT00531752|20933431|P4|COMPLETED|First Double-blind Intervention Period||13
8494910|NCT00531752|20933432|P3|COMPLETED|First Double-blind Intervention Period||9
8494911|NCT00531752|20933433|P2|COMPLETED|First Double-blind Intervention Period||13
8494912|NCT00531752|20933434|P1|COMPLETED|First Double-blind Intervention Period||11
8494913|NCT00531752|20933431|P4|Treated|First Double-blind Intervention Period||16
8494914|NCT00531752|20933432|P3|Treated|First Double-blind Intervention Period||16
8494915|NCT00531752|20933433|P2|Treated|First Double-blind Intervention Period||17
8494916|NCT00531752|20933434|P1|Treated|First Double-blind Intervention Period||16
8494917|NCT00531752|20933431|P4|STARTED|First Double-blind Intervention Period||16
8494918|NCT00531752|20933432|P3|STARTED|First Double-blind Intervention Period||16
8494919|NCT00531752|20933433|P2|STARTED|First Double-blind Intervention Period||17
8494920|NCT00531752|20933434|P1|STARTED|First Double-blind Intervention Period||17
8494921|NCT00531661|20933513|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
8494922|NCT00531661|20933514|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
8494923|NCT00531661|20933513|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
8494924|NCT00531661|20933514|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
8494925|NCT00531661|20933513|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
8494926|NCT00531661|20933514|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
8494927|NCT00531661|20933513|P2|NOT COMPLETED|6 Months||26
8494928|NCT00531661|20933514|P1|NOT COMPLETED|6 Months||26
8494929|NCT00531661|20933513|P2|COMPLETED|6 Months||254
8494930|NCT00531661|20933514|P1|COMPLETED|6 Months||244
8494931|NCT00531661|20933513|P2|STARTED|6 Months||280
8494932|NCT00531661|20933514|P1|STARTED|6 Months||270
8494933|NCT00531518|20933536|P2|NOT COMPLETED|Overall Study||71
8494934|NCT00531518|20933537|P1|NOT COMPLETED|Overall Study||32
8494935|NCT00531518|20933536|P2|COMPLETED|Overall Study||134
8494936|NCT00531518|20933537|P1|COMPLETED|Overall Study||55
8494937|NCT00531518|20933536|P2|STARTED|Overall Study||205
8494938|NCT00531518|20933537|P1|STARTED|Overall Study||87
8494939|NCT00531479|20933545|P2|NOT COMPLETED|Overall Study||83
8494940|NCT00531479|20933546|P1|NOT COMPLETED|Overall Study||76
8494941|NCT00531479|20933545|P2|COMPLETED|Overall Study||146
8494942|NCT00531479|20933546|P1|COMPLETED|Overall Study||154
8494943|NCT00531479|20933545|P2|Treated|Overall Study||226
8494944|NCT00531479|20933546|P1|Treated|Overall Study||228
8494945|NCT00531479|20933545|P2|STARTED|Overall Study||229
8494946|NCT00531479|20933546|P1|STARTED|Overall Study||230
8494947|NCT00531453|20933566|P2|NOT COMPLETED|Overall Study||0
8494948|NCT00531453|20933567|P1|NOT COMPLETED|Overall Study||0
8494949|NCT00531453|20933566|P2|COMPLETED|Overall Study|10 April 2009|49
8494950|NCT00531453|20933567|P1|COMPLETED|Overall Study|10 April 2009|49
8494951|NCT00531453|20933566|P2|STARTED|Overall Study|02 October 2007|49
8494952|NCT00531453|20933567|P1|STARTED|Overall Study|02 October 2007|49
8494953|NCT00531427|20933577|P2|NOT COMPLETED|Overall Study||94
8494954|NCT00531427|20933578|P1|NOT COMPLETED|Overall Study||73
8494955|NCT00531427|20933577|P2|COMPLETED|Overall Study||191
8494956|NCT00531427|20933578|P1|COMPLETED|Overall Study||209
8494957|NCT00531427|20933577|P2|STARTED|Overall Study||285
8494958|NCT00531427|20933578|P1|STARTED|Overall Study||282
8494959|NCT00531284|20933606|P17|NOT COMPLETED|Overall Study||8
8494961|NCT00531284|20933608|P15|NOT COMPLETED|Overall Study||4
8494962|NCT00531284|20933609|P14|NOT COMPLETED|Overall Study||3
8494963|NCT00531284|20933610|P13|NOT COMPLETED|Overall Study||2
8494964|NCT00531284|20933611|P12|NOT COMPLETED|Overall Study||24
8494965|NCT00531284|20933612|P11|NOT COMPLETED|Overall Study||3
8494966|NCT00531284|20933613|P10|NOT COMPLETED|Overall Study||4
8494967|NCT00531284|20933614|P9|NOT COMPLETED|Overall Study||11
8494968|NCT00531284|20933615|P8|NOT COMPLETED|Overall Study||10
8494969|NCT00531284|20933616|P7|NOT COMPLETED|Overall Study||6
8494970|NCT00531284|20933617|P6|NOT COMPLETED|Overall Study||7
8494971|NCT00531284|20933618|P5|NOT COMPLETED|Overall Study||6
8494972|NCT00531284|20933619|P4|NOT COMPLETED|Overall Study||63
8494973|NCT00531284|20933620|P3|NOT COMPLETED|Overall Study||6
8494974|NCT00531284|20933621|P2|NOT COMPLETED|Overall Study||4
8494975|NCT00531284|20933622|P1|NOT COMPLETED|Overall Study||3
8494976|NCT00531284|20933606|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494977|NCT00531284|20933607|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
8494978|NCT00531284|20933608|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
8494979|NCT00531284|20933609|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494980|NCT00531284|20933610|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494981|NCT00531284|20933611|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494982|NCT00531284|20933612|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494983|NCT00531284|20933613|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494984|NCT00531284|20933614|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494985|NCT00531284|20933615|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494986|NCT00531284|20933616|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494987|NCT00531284|20933617|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494988|NCT00531284|20933618|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494989|NCT00531284|20933619|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
8494990|NCT00531284|20933620|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
8494991|NCT00531284|20933621|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
8494992|NCT00531284|20933622|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
8494993|NCT00531284|20933606|P17|STARTED|Overall Study||8
8494994|NCT00531284|20933607|P16|STARTED|Overall Study||14
8494995|NCT00531284|20933608|P15|STARTED|Overall Study||7
8494996|NCT00531284|20933609|P14|STARTED|Overall Study||3
8494997|NCT00531284|20933610|P13|STARTED|Overall Study||2
8494998|NCT00531284|20933611|P12|STARTED|Overall Study||24
8494999|NCT00531284|20933612|P11|STARTED|Overall Study||3
8495000|NCT00531284|20933613|P10|STARTED|Overall Study||4
8495001|NCT00531284|20933614|P9|STARTED|Overall Study||11
8495002|NCT00531284|20933615|P8|STARTED|Overall Study||10
8495003|NCT00531284|20933616|P7|STARTED|Overall Study||6
8495004|NCT00531284|20933617|P6|STARTED|Overall Study||7
8495005|NCT00531284|20933618|P5|STARTED|Overall Study||6
8495006|NCT00531284|20933619|P4|STARTED|Overall Study||65
8495007|NCT00531284|20933620|P3|STARTED|Overall Study||7
8495008|NCT00531284|20933621|P2|STARTED|Overall Study||4
8495009|NCT00531284|20933622|P1|STARTED|Overall Study||3
8495010|NCT00531206|20933772|P1|NOT COMPLETED|Overall Study||20
8495011|NCT00531206|20933772|P1|COMPLETED|Overall Study||45
8495012|NCT00531206|20933772|P1|STARTED|Overall Study||65
8495013|NCT00531050|20933802|P6|NOT COMPLETED|Part 2: Period 3||1
8495014|NCT00531050|20933803|P5|NOT COMPLETED|Part 2: Period 3||0
8495015|NCT00531050|20933804|P4|NOT COMPLETED|Part 2: Period 3||0
8495016|NCT00531050|20933805|P3|NOT COMPLETED|Part 2: Period 3||0
8495017|NCT00531050|20933806|P2|NOT COMPLETED|Part 2: Period 3||0
8495018|NCT00531050|20933807|P1|NOT COMPLETED|Part 2: Period 3||1
8495019|NCT00531050|20933802|P6|COMPLETED|Part 2: Period 3||3
8495020|NCT00531050|20933803|P5|COMPLETED|Part 2: Period 3||4
8495021|NCT00531050|20933804|P4|COMPLETED|Part 2: Period 3||4
8495022|NCT00531050|20933805|P3|COMPLETED|Part 2: Period 3||4
8495023|NCT00531050|20933806|P2|COMPLETED|Part 2: Period 3||4
8495024|NCT00531050|20933807|P1|COMPLETED|Part 2: Period 3||2
8495025|NCT00531050|20933802|P6|STARTED|Part 2: Period 3||4
8495026|NCT00531050|20933803|P5|STARTED|Part 2: Period 3||4
8495027|NCT00531050|20933804|P4|STARTED|Part 2: Period 3||4
8495028|NCT00531050|20933805|P3|STARTED|Part 2: Period 3||4
8495029|NCT00531050|20933806|P2|STARTED|Part 2: Period 3||4
8495030|NCT00531050|20933807|P1|STARTED|Part 2: Period 3||3
8495031|NCT00531050|20933802|P6|NOT COMPLETED|Part 2: Period 2||0
8495032|NCT00531050|20933803|P5|NOT COMPLETED|Part 2: Period 2||0
8495033|NCT00531050|20933804|P4|NOT COMPLETED|Part 2: Period 2||0
8495034|NCT00531050|20933805|P3|NOT COMPLETED|Part 2: Period 2||0
8495035|NCT00531050|20933806|P2|NOT COMPLETED|Part 2: Period 2||0
8495036|NCT00531050|20933807|P1|NOT COMPLETED|Part 2: Period 2||0
8495037|NCT00531050|20933802|P6|COMPLETED|Part 2: Period 2||4
8495038|NCT00531050|20933803|P5|COMPLETED|Part 2: Period 2||4
8495039|NCT00531050|20933804|P4|COMPLETED|Part 2: Period 2||4
8495040|NCT00531050|20933805|P3|COMPLETED|Part 2: Period 2||4
8495041|NCT00531050|20933806|P2|COMPLETED|Part 2: Period 2||4
8495042|NCT00531050|20933807|P1|COMPLETED|Part 2: Period 2||3
8495043|NCT00531050|20933802|P6|STARTED|Part 2: Period 2||4
8495044|NCT00531050|20933803|P5|STARTED|Part 2: Period 2||4
8495045|NCT00531050|20933804|P4|STARTED|Part 2: Period 2||4
8495046|NCT00531050|20933805|P3|STARTED|Part 2: Period 2||4
8495047|NCT00531050|20933806|P2|STARTED|Part 2: Period 2||4
8495048|NCT00531050|20933807|P1|STARTED|Part 2: Period 2||3
8495049|NCT00531050|20933802|P6|NOT COMPLETED|Part 2: Period 1||1
8495050|NCT00531050|20933803|P5|NOT COMPLETED|Part 2: Period 1||0
8495051|NCT00531050|20933804|P4|NOT COMPLETED|Part 2: Period 1||0
8495052|NCT00531050|20933805|P3|NOT COMPLETED|Part 2: Period 1||0
8495053|NCT00531050|20933806|P2|NOT COMPLETED|Part 2: Period 1||0
8495054|NCT00531050|20933807|P1|NOT COMPLETED|Part 2: Period 1||0
8495055|NCT00531050|20933802|P6|COMPLETED|Part 2: Period 1||4
8495056|NCT00531050|20933803|P5|COMPLETED|Part 2: Period 1||4
8495057|NCT00531050|20933804|P4|COMPLETED|Part 2: Period 1||4
8495058|NCT00531050|20933805|P3|COMPLETED|Part 2: Period 1||4
8495059|NCT00531050|20933806|P2|COMPLETED|Part 2: Period 1||4
8495060|NCT00531050|20933807|P1|COMPLETED|Part 2: Period 1||3
8495061|NCT00531050|20933802|P6|STARTED|Part 2: Period 1||5
8495062|NCT00531050|20933803|P5|STARTED|Part 2: Period 1||4
8495063|NCT00531050|20933804|P4|STARTED|Part 2: Period 1||4
8495064|NCT00531050|20933805|P3|STARTED|Part 2: Period 1||4
8495065|NCT00531050|20933806|P2|STARTED|Part 2: Period 1||4
8495066|NCT00531050|20933807|P1|STARTED|Part 2: Period 1||3
8495067|NCT00531050|20933802|P6|NOT COMPLETED|Part 1: Period 3||0
8495068|NCT00531050|20933803|P5|NOT COMPLETED|Part 1: Period 3||0
8495069|NCT00531050|20933804|P4|NOT COMPLETED|Part 1: Period 3||0
8495070|NCT00531050|20933805|P3|NOT COMPLETED|Part 1: Period 3||0
8495071|NCT00531050|20933806|P2|NOT COMPLETED|Part 1: Period 3||0
8495072|NCT00531050|20933807|P1|NOT COMPLETED|Part 1: Period 3||1
8495073|NCT00531050|20933802|P6|COMPLETED|Part 1: Period 3||5
8495074|NCT00531050|20933803|P5|COMPLETED|Part 1: Period 3||4
8495075|NCT00531050|20933804|P4|COMPLETED|Part 1: Period 3||4
8495076|NCT00531050|20933805|P3|COMPLETED|Part 1: Period 3||4
8495077|NCT00531050|20933806|P2|COMPLETED|Part 1: Period 3||4
8495078|NCT00531050|20933807|P1|COMPLETED|Part 1: Period 3||3
8495079|NCT00531050|20933802|P6|STARTED|Part 1: Period 3||5
8495080|NCT00531050|20933803|P5|STARTED|Part 1: Period 3||4
8495081|NCT00531050|20933804|P4|STARTED|Part 1: Period 3||4
8495082|NCT00531050|20933805|P3|STARTED|Part 1: Period 3||4
8495083|NCT00531050|20933806|P2|STARTED|Part 1: Period 3||4
8495084|NCT00531050|20933807|P1|STARTED|Part 1: Period 3||4
8495085|NCT00531050|20933802|P6|NOT COMPLETED|Part 1: Period 2||0
8495086|NCT00531050|20933803|P5|NOT COMPLETED|Part 1: Period 2||0
8495087|NCT00531050|20933804|P4|NOT COMPLETED|Part 1: Period 2||0
8495088|NCT00531050|20933805|P3|NOT COMPLETED|Part 1: Period 2||0
8495089|NCT00531050|20933806|P2|NOT COMPLETED|Part 1: Period 2||0
8495090|NCT00531050|20933807|P1|NOT COMPLETED|Part 1: Period 2||0
8495091|NCT00531050|20933802|P6|COMPLETED|Part 1: Period 2||5
8495092|NCT00531050|20933803|P5|COMPLETED|Part 1: Period 2||4
8495093|NCT00531050|20933804|P4|COMPLETED|Part 1: Period 2||4
8495094|NCT00531050|20933805|P3|COMPLETED|Part 1: Period 2||4
8495095|NCT00531050|20933806|P2|COMPLETED|Part 1: Period 2||4
8495096|NCT00531050|20933807|P1|COMPLETED|Part 1: Period 2||4
8495097|NCT00531050|20933802|P6|STARTED|Part 1: Period 2||5
8495098|NCT00531050|20933803|P5|STARTED|Part 1: Period 2||4
8495099|NCT00531050|20933804|P4|STARTED|Part 1: Period 2||4
8495100|NCT00531050|20933805|P3|STARTED|Part 1: Period 2||4
8495101|NCT00531050|20933806|P2|STARTED|Part 1: Period 2||4
8495102|NCT00531050|20933807|P1|STARTED|Part 1: Period 2||4
8495103|NCT00531050|20933802|P6|NOT COMPLETED|Part 1: Period 1||0
8495104|NCT00531050|20933803|P5|NOT COMPLETED|Part 1: Period 1||0
8495105|NCT00531050|20933804|P4|NOT COMPLETED|Part 1: Period 1||1
8495106|NCT00531050|20933805|P3|NOT COMPLETED|Part 1: Period 1||0
8495107|NCT00531050|20933806|P2|NOT COMPLETED|Part 1: Period 1||1
8495108|NCT00531050|20933807|P1|NOT COMPLETED|Part 1: Period 1||0
8495109|NCT00531050|20933802|P6|COMPLETED|Part 1: Period 1||5
8495110|NCT00531050|20933803|P5|COMPLETED|Part 1: Period 1||4
8495111|NCT00531050|20933804|P4|COMPLETED|Part 1: Period 1||4
8495112|NCT00531050|20933805|P3|COMPLETED|Part 1: Period 1||4
8495113|NCT00531050|20933806|P2|COMPLETED|Part 1: Period 1||4
8495114|NCT00531050|20933807|P1|COMPLETED|Part 1: Period 1||4
8495115|NCT00531050|20933802|P6|STARTED|Part 1: Period 1||5
8495116|NCT00531050|20933803|P5|STARTED|Part 1: Period 1||4
8495117|NCT00531050|20933804|P4|STARTED|Part 1: Period 1||5
8495118|NCT00531050|20933805|P3|STARTED|Part 1: Period 1||4
8495119|NCT00531050|20933806|P2|STARTED|Part 1: Period 1||5
8495120|NCT00531050|20933807|P1|STARTED|Part 1: Period 1||4
8495121|NCT00531011|20933836|P2|NOT COMPLETED|Overall Study||7
8495122|NCT00531011|20933837|P1|NOT COMPLETED|Overall Study||4
8495123|NCT00531011|20933836|P2|COMPLETED|Overall Study||90
8495124|NCT00531011|20933837|P1|COMPLETED|Overall Study||99
8495125|NCT00531011|20933836|P2|STARTED|Overall Study||97
8495126|NCT00531011|20933837|P1|STARTED|Overall Study||103
8495127|NCT00530920|20933882|P3|NOT COMPLETED|Overall Study||4
8495128|NCT00530920|20933883|P2|NOT COMPLETED|Overall Study||2
8495129|NCT00530920|20933884|P1|NOT COMPLETED|Overall Study||0
8495130|NCT00530920|20933882|P3|COMPLETED|Overall Study||24
8495131|NCT00530920|20933883|P2|COMPLETED|Overall Study||25
8495132|NCT00530920|20933884|P1|COMPLETED|Overall Study||30
8495133|NCT00530920|20933882|P3|STARTED|Overall Study||28
8495134|NCT00530920|20933883|P2|STARTED|Overall Study||27
8495135|NCT00530920|20933884|P1|STARTED|Overall Study||30
8495136|NCT00530894|20933944|P4|NOT COMPLETED|Overall Study||94
8495137|NCT00530894|20933945|P3|NOT COMPLETED|Overall Study||55
8495138|NCT00530894|20933946|P2|NOT COMPLETED|Overall Study||115
8495139|NCT00530894|20933947|P1|NOT COMPLETED|Overall Study||88
8495140|NCT00530894|20933944|P4|COMPLETED|Overall Study||85
8495141|NCT00530894|20933945|P3|COMPLETED|Overall Study||124
8495142|NCT00530894|20933946|P2|COMPLETED|Overall Study||236
8495143|NCT00530894|20933947|P1|COMPLETED|Overall Study||260
8495144|NCT00530894|20933944|P4|STARTED|Overall Study||179
8495145|NCT00530894|20933945|P3|STARTED|Overall Study||179
8495146|NCT00530894|20933946|P2|STARTED|Overall Study||351
8495147|NCT00530894|20933947|P1|STARTED|Overall Study||348
8495148|NCT00530855|20933975|P1|NOT COMPLETED|Overall Study||112
8495149|NCT00530855|20933975|P1|COMPLETED|Overall Study||210
8495150|NCT00530855|20933975|P1|STARTED|Overall Study||322
8495151|NCT00530842|20933984|P2|NOT COMPLETED|Period 2||9
8495152|NCT00530842|20933985|P1|NOT COMPLETED|Period 2||8
8495153|NCT00530842|20933984|P2|COMPLETED|Period 2||151
8495154|NCT00530842|20933985|P1|COMPLETED|Period 2||149
8495155|NCT00530842|20933984|P2|STARTED|Period 2||160
8495156|NCT00530842|20933985|P1|STARTED|Period 2||157
8495157|NCT00530842|20933984|P2|NOT COMPLETED|Period 1||11
8495158|NCT00530842|20933985|P1|NOT COMPLETED|Period 1||14
8495159|NCT00530842|20933984|P2|COMPLETED|Period 1||161
8495160|NCT00530842|20933985|P1|COMPLETED|Period 1||158
8495161|NCT00530842|20933984|P2|STARTED|Period 1||172
8495162|NCT00530842|20933985|P1|STARTED|Period 1||172
8495163|NCT00530842|20933984|P2|NOT COMPLETED|Overall Study||21
8495164|NCT00530842|20933985|P1|NOT COMPLETED|Overall Study||23
8495165|NCT00530842|20933984|P2|COMPLETED|Overall Study||151
8495166|NCT00530842|20933985|P1|COMPLETED|Overall Study||149
8495167|NCT00530842|20933984|P2|STARTED|Overall Study||172
8495168|NCT00530842|20933985|P1|STARTED|Overall Study||172
8495169|NCT00530816|20934112|P3|NOT COMPLETED|Overall Study||41
8495170|NCT00530816|20934113|P2|NOT COMPLETED|Overall Study||42
8495171|NCT00530816|20934114|P1|NOT COMPLETED|Overall Study||26
8495172|NCT00530816|20934112|P3|COMPLETED|Overall Study||29
8495173|NCT00530816|20934113|P2|COMPLETED|Overall Study||17
8495174|NCT00530816|20934114|P1|COMPLETED|Overall Study||9
8495175|NCT00530816|20934112|P3|STARTED|Overall Study||70
8495176|NCT00530816|20934113|P2|STARTED|Overall Study||59
8495177|NCT00530816|20934114|P1|STARTED|Overall Study||35
8495178|NCT00530803|20934142|P2|NOT COMPLETED|Overall Study||0
8495179|NCT00530803|20934143|P1|NOT COMPLETED|Overall Study||0
8495180|NCT00530803|20934142|P2|COMPLETED|Overall Study||50
8495181|NCT00530803|20934143|P1|COMPLETED|Overall Study||50
8495182|NCT00530803|20934142|P2|STARTED|Overall Study||50
8495183|NCT00530803|20934143|P1|STARTED|Overall Study||50
8495184|NCT00530790|20934157|P1|NOT COMPLETED|Overall Study||5
8495185|NCT00530790|20934157|P1|COMPLETED|Overall Study||30
8495186|NCT00530790|20934157|P1|STARTED|Overall Study||35
8495187|NCT00530777|20934179|P2|NOT COMPLETED|Overall Study||5
8495188|NCT00530777|20934180|P1|NOT COMPLETED|Overall Study||7
8495189|NCT00530777|20934179|P2|COMPLETED|Overall Study||69
8495190|NCT00530777|20934180|P1|COMPLETED|Overall Study||67
8495191|NCT00530777|20934179|P2|STARTED|Overall Study||74
8495192|NCT00530777|20934180|P1|STARTED|Overall Study||74
8495193|NCT00530764|20934192|P4|NOT COMPLETED|Overall Study||25
8495194|NCT00530764|20934193|P3|NOT COMPLETED|Overall Study||20
8495195|NCT00530764|20934194|P2|NOT COMPLETED|Overall Study||21
8495196|NCT00530764|20934195|P1|NOT COMPLETED|Overall Study||31
8495197|NCT00530764|20934192|P4|COMPLETED|Overall Study||66
8495198|NCT00530764|20934193|P3|COMPLETED|Overall Study||71
8495199|NCT00530764|20934194|P2|COMPLETED|Overall Study||67
8495200|NCT00530764|20934195|P1|COMPLETED|Overall Study||59
8495201|NCT00530764|20934192|P4|STARTED|Overall Study||91
8495202|NCT00530764|20934193|P3|STARTED|Overall Study||91
8495203|NCT00530764|20934194|P2|STARTED|Overall Study||88
8495204|NCT00530764|20934195|P1|STARTED|Overall Study||90
8495205|NCT00530712|20934237|P1|NOT COMPLETED|12 Month Follow-up Visit||24
8495206|NCT00530712|20934237|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
8495207|NCT00530712|20934237|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
8495208|NCT00530712|20934237|P1|NOT COMPLETED|6 Month Follow-up Visit||12
8495209|NCT00530712|20934237|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
8495210|NCT00530712|20934237|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
8495211|NCT00530712|20934237|P1|NOT COMPLETED|30 Day Follow-up Visit||7
8495212|NCT00530712|20934237|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
8495213|NCT00530712|20934237|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
8495214|NCT00530712|20934237|P1|NOT COMPLETED|Enrollment||0
8495215|NCT00530712|20934237|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
8495216|NCT00530712|20934237|P1|STARTED|Enrollment|Total Enrolled Subjects|287
8495217|NCT00530634|20934254|P1|NOT COMPLETED|Overall Study||0
8495218|NCT00530634|20934254|P1|COMPLETED|Overall Study||3
8495219|NCT00530634|20934254|P1|STARTED|Overall Study||3
8495220|NCT00530621|20934260|P2|NOT COMPLETED|Overall Study||80
8495221|NCT00530621|20934261|P1|NOT COMPLETED|Overall Study||80
8495222|NCT00530621|20934260|P2|COMPLETED|Overall Study||0
8495223|NCT00530621|20934261|P1|COMPLETED|Overall Study||0
8495224|NCT00530621|20934260|P2|Received at Least 1 Dose of Study Drug|Overall Study||80
8495225|NCT00530621|20934261|P1|Received at Least 1 Dose of Study Drug|Overall Study||79
8495226|NCT00530621|20934260|P2|STARTED|Overall Study||80
8495227|NCT00530621|20934261|P1|STARTED|Overall Study||80
8495228|NCT00530504|20934282|P1|NOT COMPLETED|Overall Study||152
8495229|NCT00530504|20934282|P1|COMPLETED|Overall Study||1348
8495230|NCT00530504|20934282|P1|STARTED|Overall Study||1500
8495231|NCT00530439|20934288|P2|NOT COMPLETED|Overall Study||26
8495232|NCT00530439|20934289|P1|NOT COMPLETED|Overall Study||30
8495233|NCT00530439|20934288|P2|COMPLETED|Overall Study||154
8495234|NCT00530439|20934289|P1|COMPLETED|Overall Study||150
8495235|NCT00530439|20934288|P2|STARTED|Overall Study||180
8495236|NCT00530439|20934289|P1|STARTED|Overall Study||180
8495237|NCT00530348|20934297|P2|NOT COMPLETED|Overall Study||19
8495238|NCT00530348|20934298|P1|NOT COMPLETED|Overall Study||22
8495239|NCT00530348|20934297|P2|COMPLETED|Overall Study||367
8495240|NCT00530348|20934298|P1|COMPLETED|Overall Study||173
8495241|NCT00530348|20934297|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
8495242|NCT00530348|20934298|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
8495243|NCT00530348|20934297|P2|STARTED|Overall Study|Randomized.|386
8495244|NCT00530348|20934298|P1|STARTED|Overall Study|Randomized.|195
8495245|NCT00530335|20934314|P1|NOT COMPLETED|Overall Study||6
8495246|NCT00530335|20934314|P1|COMPLETED|Overall Study||39
8495247|NCT00530335|20934314|P1|STARTED|Overall Study||45
8495248|NCT00530270|20934331|P2|NOT COMPLETED|Overall Study||0
8495249|NCT00530270|20934332|P1|NOT COMPLETED|Overall Study||1
8495250|NCT00530270|20934331|P2|COMPLETED|Overall Study||6
8495251|NCT00530270|20934332|P1|COMPLETED|Overall Study||5
8495252|NCT00530270|20934331|P2|STARTED|Overall Study||6
8495253|NCT00530270|20934332|P1|STARTED|Overall Study||6
8495254|NCT00530257|20934346|P1|NOT COMPLETED|Overall Study||1
8495255|NCT00530257|20934346|P1|COMPLETED|Overall Study||30
8495256|NCT00530257|20934346|P1|STARTED|Overall Study||31
8495257|NCT00530218|20934374|P1|NOT COMPLETED|Overall Study||25
8495258|NCT00530218|20934374|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
8495259|NCT00530218|20934374|P1|STARTED|Overall Study||61
8495260|NCT00530088|20934381|P1|NOT COMPLETED|Overall Study||10
8495261|NCT00530088|20934381|P1|COMPLETED|Overall Study||20
8495262|NCT00530088|20934381|P1|STARTED|Overall Study||30
8495263|NCT00530075|20934386|P1|NOT COMPLETED|Overall Study||7
8495264|NCT00530075|20934386|P1|COMPLETED|Overall Study||38
8495265|NCT00530075|20934386|P1|STARTED|Overall Study||45
8495266|NCT00530023|20934399|P2|NOT COMPLETED|Overall Study||1
8495267|NCT00530023|20934400|P1|NOT COMPLETED|Overall Study||0
8495268|NCT00530023|20934399|P2|COMPLETED|Overall Study||14
8495269|NCT00530023|20934400|P1|COMPLETED|Overall Study||14
8495270|NCT00530023|20934399|P2|STARTED|Overall Study||15
8495271|NCT00530023|20934400|P1|STARTED|Overall Study||14
8495272|NCT00529958|20934417|P3|NOT COMPLETED|5-Year Follow-up||1
8495273|NCT00529958|20934418|P2|NOT COMPLETED|5-Year Follow-up||3
8495274|NCT00529958|20934419|P1|NOT COMPLETED|5-Year Follow-up||3
8495275|NCT00529958|20934417|P3|COMPLETED|5-Year Follow-up||107
8495276|NCT00529958|20934418|P2|COMPLETED|5-Year Follow-up||105
8495277|NCT00529958|20934419|P1|COMPLETED|5-Year Follow-up||103
8495278|NCT00529958|20934417|P3|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
8495279|NCT00529958|20934418|P2|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
8495280|NCT00529958|20934419|P1|STARTED|5-Year Follow-up||106
8495281|NCT00529958|20934417|P3|NOT COMPLETED|2-Year Follow-up||2
8495282|NCT00529958|20934418|P2|NOT COMPLETED|2-Year Follow-up||2
8495283|NCT00529958|20934419|P1|NOT COMPLETED|2-Year Follow-up||4
8495284|NCT00529958|20934417|P3|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
8495285|NCT00529958|20934418|P2|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
8495286|NCT00529958|20934419|P1|COMPLETED|2-Year Follow-up||106
8495287|NCT00529958|20934417|P3|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
8495288|NCT00529958|20934418|P2|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
8495289|NCT00529958|20934419|P1|STARTED|2-Year Follow-up||110
8495290|NCT00529802|20934460|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
8495291|NCT00529802|20934460|P1|COMPLETED|Evaluable for Secondary Endpoint||48
8495292|NCT00529802|20934460|P1|STARTED|Evaluable for Secondary Endpoint||50
8495293|NCT00529802|20934460|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
8495294|NCT00529802|20934460|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
8495295|NCT00529802|20934460|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
8495296|NCT00529789|20934466|P1|NOT COMPLETED|Study Period IV||6
8495297|NCT00529789|20934466|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
8495298|NCT00529789|20934466|P1|STARTED|Study Period IV||48
8495299|NCT00529789|20934466|P1|NOT COMPLETED|Study Period II/III||24
8495300|NCT00529789|20934466|P1|COMPLETED|Study Period II/III||48
8495301|NCT00529789|20934466|P1|STARTED|Study Period II/III||72
8495302|NCT00529763|20934491|P3|NOT COMPLETED|Overall Study||7
8495303|NCT00529763|20934492|P2|NOT COMPLETED|Overall Study||33
8495304|NCT00529763|20934493|P1|NOT COMPLETED|Overall Study||10
8495305|NCT00529763|20934491|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
8495306|NCT00529763|20934492|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
8495397|NCT00529399|20934852|P1|NOT COMPLETED|Overall Study||2
8495307|NCT00529763|20934493|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
8495308|NCT00529763|20934491|P3|STARTED|Overall Study||59
8495309|NCT00529763|20934492|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
8495310|NCT00529763|20934493|P1|STARTED|Overall Study||25
8495311|NCT00529659|20934531|P2|NOT COMPLETED|Overall Study||23
8495312|NCT00529659|20934532|P1|NOT COMPLETED|Overall Study||11
8495313|NCT00529659|20934531|P2|COMPLETED|Overall Study||66
8495314|NCT00529659|20934532|P1|COMPLETED|Overall Study||70
8495315|NCT00529659|20934531|P2|STARTED|Overall Study||89
8495316|NCT00529659|20934532|P1|STARTED|Overall Study||81
8495317|NCT00529633|20934550|P2|NOT COMPLETED|Overall Study||1
8495318|NCT00529633|20934551|P1|NOT COMPLETED|Overall Study||1
8495319|NCT00529633|20934550|P2|COMPLETED|Overall Study||1
8495320|NCT00529633|20934551|P1|COMPLETED|Overall Study||1
8495321|NCT00529633|20934550|P2|STARTED|Overall Study||2
8495322|NCT00529633|20934551|P1|STARTED|Overall Study||2
8495323|NCT00529568|20934563|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
8495324|NCT00529568|20934564|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
8495325|NCT00529568|20934565|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
8495326|NCT00529568|20934563|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
8495327|NCT00529568|20934564|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
8495328|NCT00529568|20934565|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
8495329|NCT00529568|20934563|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
8495330|NCT00529568|20934564|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
8495331|NCT00529568|20934565|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
8495332|NCT00529568|20934563|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495333|NCT00529568|20934564|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495334|NCT00529568|20934565|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
8495335|NCT00529568|20934563|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495336|NCT00529568|20934564|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495337|NCT00529568|20934565|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
8495338|NCT00529568|20934563|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
8495339|NCT00529568|20934564|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
8495340|NCT00529568|20934565|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
8495341|NCT00529555|20934616|P3|NOT COMPLETED|Overall Study||26
8495342|NCT00529555|20934617|P2|NOT COMPLETED|Overall Study||30
8495343|NCT00529555|20934618|P1|NOT COMPLETED|Overall Study||29
8495344|NCT00529555|20934616|P3|COMPLETED|Overall Study||174
8495345|NCT00529555|20934617|P2|COMPLETED|Overall Study||172
8495346|NCT00529555|20934618|P1|COMPLETED|Overall Study||171
8495347|NCT00529555|20934616|P3|STARTED|Overall Study||200
8495348|NCT00529555|20934617|P2|STARTED|Overall Study||202
8495349|NCT00529555|20934618|P1|STARTED|Overall Study||200
8495350|NCT00529542|20934628|P2|NOT COMPLETED|Overall Study||1
8495351|NCT00529542|20934629|P1|NOT COMPLETED|Overall Study||1
8495352|NCT00529542|20934628|P2|COMPLETED|Overall Study||10
8495353|NCT00529542|20934629|P1|COMPLETED|Overall Study||8
8495354|NCT00529542|20934628|P2|STARTED|Overall Study||11
8495355|NCT00529542|20934629|P1|STARTED|Overall Study||9
8495356|NCT00529529|20934672|P3|NOT COMPLETED|Overall Study||31
8495357|NCT00529529|20934673|P2|NOT COMPLETED|Overall Study||43
8495358|NCT00529529|20934674|P1|NOT COMPLETED|Overall Study||43
8495359|NCT00529529|20934672|P3|COMPLETED|Overall Study||238
8495360|NCT00529529|20934673|P2|COMPLETED|Overall Study||225
8495361|NCT00529529|20934674|P1|COMPLETED|Overall Study||225
8495362|NCT00529529|20934672|P3|STARTED|Overall Study||269
8495363|NCT00529529|20934673|P2|STARTED|Overall Study||268
8495364|NCT00529529|20934674|P1|STARTED|Overall Study||268
8495365|NCT00529516|20934733|P3|NOT COMPLETED|Overall Study||1
8495366|NCT00529516|20934734|P2|NOT COMPLETED|Overall Study||2
8495367|NCT00529516|20934735|P1|NOT COMPLETED|Overall Study||3
8495368|NCT00529516|20934733|P3|COMPLETED|Overall Study||288
8495369|NCT00529516|20934734|P2|COMPLETED|Overall Study||486
8495370|NCT00529516|20934735|P1|COMPLETED|Overall Study||472
8495371|NCT00529516|20934733|P3|STARTED|Overall Study||289
8495372|NCT00529516|20934734|P2|STARTED|Overall Study||488
8495373|NCT00529516|20934735|P1|STARTED|Overall Study||475
8495374|NCT00529464|20934806|P3|NOT COMPLETED|Overall Study||0
8495375|NCT00529464|20934807|P2|NOT COMPLETED|Overall Study||0
8495376|NCT00529464|20934808|P1|NOT COMPLETED|Overall Study||0
8495377|NCT00529464|20934806|P3|COMPLETED|Overall Study||0
8495378|NCT00529464|20934807|P2|COMPLETED|Overall Study||0
8495379|NCT00529464|20934808|P1|COMPLETED|Overall Study||0
8495380|NCT00529464|20934806|P3|STARTED|Overall Study||0
8495381|NCT00529464|20934807|P2|STARTED|Overall Study||0
8495382|NCT00529464|20934808|P1|STARTED|Overall Study||0
8495383|NCT00529451|20934820|P4|NOT COMPLETED|Overall Study||31
8495384|NCT00529451|20934821|P3|NOT COMPLETED|Overall Study||40
8495385|NCT00529451|20934822|P2|NOT COMPLETED|Overall Study||48
8495386|NCT00529451|20934823|P1|NOT COMPLETED|Overall Study||37
8495387|NCT00529451|20934820|P4|COMPLETED|Overall Study||299
8495388|NCT00529451|20934821|P3|COMPLETED|Overall Study||292
8495389|NCT00529451|20934822|P2|COMPLETED|Overall Study||275
8495390|NCT00529451|20934823|P1|COMPLETED|Overall Study||294
8495391|NCT00529451|20934820|P4|STARTED|Overall Study||330
8495392|NCT00529451|20934821|P3|STARTED|Overall Study||332
8495393|NCT00529451|20934822|P2|STARTED|Overall Study||323
8495394|NCT00529451|20934823|P1|STARTED|Overall Study||331
8495395|NCT00529399|20934850|P3|NOT COMPLETED|Overall Study||2
8495396|NCT00529399|20934851|P2|NOT COMPLETED|Overall Study||1
8495398|NCT00529399|20934850|P3|COMPLETED|Overall Study||46
8495399|NCT00529399|20934851|P2|COMPLETED|Overall Study||48
8495400|NCT00529399|20934852|P1|COMPLETED|Overall Study||46
8495401|NCT00529399|20934850|P3|STARTED|Overall Study||48
8495402|NCT00529399|20934851|P2|STARTED|Overall Study||49
8495403|NCT00529399|20934852|P1|STARTED|Overall Study||48
8495404|NCT00529386|20934860|P1|NOT COMPLETED|Overall Study||1
8495405|NCT00529386|20934860|P1|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
8495406|NCT00529386|20934860|P1|STARTED|Overall Study|Study has been discontinued|7
8495407|NCT00529373|20934866|P2|NOT COMPLETED|Second Extension Study||197
8495408|NCT00529373|20934867|P1|NOT COMPLETED|Second Extension Study||300
8495409|NCT00529373|20934866|P2|COMPLETED|Second Extension Study||2112
8495410|NCT00529373|20934867|P1|COMPLETED|Second Extension Study||2844
8495411|NCT00529373|20934866|P2|STARTED|Second Extension Study||2309
8495412|NCT00529373|20934867|P1|STARTED|Second Extension Study||3144
8495413|NCT00529373|20934866|P2|NOT COMPLETED|First Extension Study||1651
8495414|NCT00529373|20934867|P1|NOT COMPLETED|First Extension Study||1153
8495415|NCT00529373|20934866|P2|COMPLETED|First Extension Study||2309
8495416|NCT00529373|20934867|P1|COMPLETED|First Extension Study||3144
8495417|NCT00529373|20934866|P2|STARTED|First Extension Study||3960
8495418|NCT00529373|20934867|P1|STARTED|First Extension Study||4297
8495419|NCT00529373|20934866|P2|NOT COMPLETED|Base Study||4068
8495420|NCT00529373|20934867|P1|NOT COMPLETED|Base Study||3746
8495421|NCT00529373|20934866|P2|COMPLETED|Base Study||3960
8495422|NCT00529373|20934867|P1|COMPLETED|Base Study||4297
8495423|NCT00529373|20934866|P2|STARTED|Base Study||8028
8495424|NCT00529373|20934867|P1|STARTED|Base Study||8043
8495425|NCT00529308|20935061|P2|NOT COMPLETED|Overall Study||1
8495426|NCT00529308|20935062|P1|NOT COMPLETED|Overall Study||1
8495427|NCT00529308|20935061|P2|COMPLETED|Overall Study||10
8495428|NCT00529308|20935062|P1|COMPLETED|Overall Study||8
8495429|NCT00529308|20935061|P2|STARTED|Overall Study||11
8495430|NCT00529308|20935062|P1|STARTED|Overall Study||9
8495431|NCT00529282|20935078|P2|NOT COMPLETED|Overall Study||0
8495432|NCT00529282|20935079|P1|NOT COMPLETED|Overall Study||0
8495433|NCT00529282|20935078|P2|COMPLETED|Overall Study||2
8495434|NCT00529282|20935079|P1|COMPLETED|Overall Study||0
8495435|NCT00529282|20935078|P2|STARTED|Overall Study||2
8495436|NCT00529282|20935079|P1|STARTED|Overall Study||0
8495437|NCT00529243|20935091|P1|NOT COMPLETED|Overall Study||3
8495438|NCT00529243|20935091|P1|COMPLETED|Overall Study||49
8495439|NCT00529243|20935091|P1|STARTED|Overall Study||52
8495440|NCT00529217|20935096|P1|NOT COMPLETED|Overall Study||4
8495441|NCT00529217|20935096|P1|COMPLETED|Overall Study||8
8495442|NCT00529217|20935096|P1|STARTED|Overall Study||12
8495443|NCT00529204|20935101|P1|NOT COMPLETED|Overall Study||0
8495444|NCT00529204|20935101|P1|COMPLETED|Overall Study||1
8495445|NCT00529204|20935101|P1|STARTED|Overall Study||1
8495446|NCT00529191|20935109|P2|NOT COMPLETED|Overall Study||0
8495447|NCT00529191|20935110|P1|NOT COMPLETED|Overall Study||3
8495448|NCT00529191|20935109|P2|COMPLETED|Overall Study||13
8495449|NCT00529191|20935110|P1|COMPLETED|Overall Study||24
8495450|NCT00529191|20935109|P2|STARTED|Overall Study||13
8495451|NCT00529191|20935110|P1|STARTED|Overall Study||27
8495452|NCT00529152|20935132|P1|NOT COMPLETED|Overall Study||5
8495453|NCT00529152|20935132|P1|COMPLETED|Overall Study||95
8495454|NCT00529152|20935132|P1|STARTED|Overall Study||100
8495455|NCT00529126|20935140|P4|NOT COMPLETED|Overall Study||0
8495456|NCT00529126|20935141|P3|NOT COMPLETED|Overall Study||0
8495457|NCT00529126|20935142|P2|NOT COMPLETED|Overall Study||0
8495458|NCT00529126|20935143|P1|NOT COMPLETED|Overall Study||0
8495459|NCT00529126|20935140|P4|COMPLETED|Overall Study||26
8495460|NCT00529126|20935141|P3|COMPLETED|Overall Study||24
8495461|NCT00529126|20935142|P2|COMPLETED|Overall Study||25
8495462|NCT00529126|20935143|P1|COMPLETED|Overall Study||25
8495463|NCT00529126|20935140|P4|STARTED|Overall Study||26
8495464|NCT00529126|20935141|P3|STARTED|Overall Study||24
8495465|NCT00529126|20935142|P2|STARTED|Overall Study||25
8495466|NCT00529126|20935143|P1|STARTED|Overall Study||25
8495467|NCT00529100|20935156|P2|NOT COMPLETED|Overall Study||9
8495468|NCT00529100|20935157|P1|NOT COMPLETED|Overall Study||0
8495469|NCT00529100|20935156|P2|COMPLETED|Overall Study||24
8495470|NCT00529100|20935157|P1|COMPLETED|Overall Study||16
8495471|NCT00529100|20935156|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
8495472|NCT00529100|20935157|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
8495473|NCT00529100|20935156|P2|STARTED|Overall Study||33
8495474|NCT00529100|20935157|P1|STARTED|Overall Study||16
8495475|NCT00529087|20935174|P3|NOT COMPLETED|Overall Study||16
8495476|NCT00529087|20935175|P2|NOT COMPLETED|Overall Study||28
8495477|NCT00529087|20935176|P1|NOT COMPLETED|Overall Study||28
8495478|NCT00529087|20935174|P3|COMPLETED|Overall Study||146
8495479|NCT00529087|20935175|P2|COMPLETED|Overall Study||120
8495480|NCT00529087|20935176|P1|COMPLETED|Overall Study||122
8495481|NCT00529087|20935174|P3|STARTED|Overall Study||162
8495482|NCT00529087|20935175|P2|STARTED|Overall Study||148
8495483|NCT00529087|20935176|P1|STARTED|Overall Study||150
8495484|NCT00529035|20935240|P1|NOT COMPLETED|Overall Study||1
8495485|NCT00529035|20935240|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
8495486|NCT00529035|20935240|P1|STARTED|Overall Study|29 enrolled|29
8495487|NCT00528970|20935254|P3|NOT COMPLETED|Overall Study||20
8495488|NCT00528970|20935255|P2|NOT COMPLETED|Overall Study||15
8495489|NCT00528970|20935256|P1|NOT COMPLETED|Overall Study||14
8495490|NCT00528970|20935254|P3|COMPLETED|Overall Study||105
8495491|NCT00528970|20935255|P2|COMPLETED|Overall Study||110
8495492|NCT00528970|20935256|P1|COMPLETED|Overall Study||110
8495493|NCT00528970|20935254|P3|Received at Least 1 Dose of Study Drug|Overall Study||124
8495494|NCT00528970|20935255|P2|Received at Least 1 Dose of Study Drug|Overall Study||125
8495495|NCT00528970|20935256|P1|Received at Least 1 Dose of Study Drug|Overall Study||124
8495496|NCT00528970|20935254|P3|STARTED|Overall Study||125
8495497|NCT00528970|20935255|P2|STARTED|Overall Study||125
8495498|NCT00528970|20935256|P1|STARTED|Overall Study||124
8495499|NCT00528957|20935275|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
8495500|NCT00528957|20935276|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
8495501|NCT00528957|20935275|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
8495502|NCT00528957|20935276|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
8495503|NCT00528957|20935275|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
8495504|NCT00528957|20935276|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
8495505|NCT00528957|20935275|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
8495506|NCT00528957|20935276|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
8495507|NCT00528957|20935275|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
8495508|NCT00528957|20935276|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
8495509|NCT00528957|20935275|P2|STARTED|Third Extension (Week 240 to Week 336)||37
8495510|NCT00528957|20935276|P1|STARTED|Third Extension (Week 240 to Week 336)||27
8495511|NCT00528957|20935275|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
8495512|NCT00528957|20935276|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
8495513|NCT00528957|20935275|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
8495514|NCT00528957|20935276|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
8495515|NCT00528957|20935275|P2|STARTED|Second Extension (Week 144 to Week 240)||40
8495516|NCT00528957|20935276|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
8495517|NCT00528957|20935275|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
8495518|NCT00528957|20935276|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
8495519|NCT00528957|20935275|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
8495520|NCT00528957|20935276|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
8495521|NCT00528957|20935275|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
8495522|NCT00528957|20935276|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
8495523|NCT00528957|20935275|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
8495524|NCT00528957|20935276|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
8495525|NCT00528957|20935275|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
8495526|NCT00528957|20935276|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
8495527|NCT00528957|20935275|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
8495528|NCT00528957|20935276|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
8495529|NCT00528931|20935417|P1|NOT COMPLETED|Overall Study||1
8495530|NCT00528931|20935417|P1|COMPLETED|Overall Study||15
8495531|NCT00528931|20935417|P1|STARTED|Overall Study||16
8495532|NCT00528879|20935429|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
8495533|NCT00528879|20935430|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
8495534|NCT00528879|20935431|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
8495535|NCT00528879|20935432|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
8495536|NCT00528879|20935429|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
8495537|NCT00528879|20935430|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
8495538|NCT00528879|20935431|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
8495539|NCT00528879|20935432|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
8495540|NCT00528879|20935429|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
8495541|NCT00528879|20935430|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
8495542|NCT00528879|20935431|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
8495543|NCT00528879|20935432|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
8495544|NCT00528879|20935429|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
8495545|NCT00528879|20935430|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
8495546|NCT00528879|20935431|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
8495547|NCT00528879|20935432|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
8495548|NCT00528879|20935429|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
8495549|NCT00528879|20935430|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
8495550|NCT00528879|20935431|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
8495551|NCT00528879|20935432|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
8495552|NCT00528879|20935429|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
8495553|NCT00528879|20935430|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
8495554|NCT00528879|20935431|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
8495555|NCT00528879|20935432|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
8495556|NCT00528879|20935429|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
8495557|NCT00528879|20935430|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
8495558|NCT00528879|20935431|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
8495559|NCT00528879|20935432|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
8495560|NCT00528866|20935498|P1|NOT COMPLETED|Overall Study||6
8495653|NCT00528372|20935855|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
8495561|NCT00528866|20935498|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
8495562|NCT00528866|20935498|P1|STARTED|Overall Study||80
8495563|NCT00528840|20935511|P1|NOT COMPLETED|Overall Study||33
8495564|NCT00528840|20935511|P1|COMPLETED|Overall Study||168
8495565|NCT00528840|20935511|P1|STARTED|Overall Study||201
8495566|NCT00528801|20935525|P2|NOT COMPLETED|Overall Study||11
8495567|NCT00528801|20935526|P1|NOT COMPLETED|Overall Study||27
8495568|NCT00528801|20935525|P2|COMPLETED|Overall Study||41
8495569|NCT00528801|20935526|P1|COMPLETED|Overall Study||133
8495570|NCT00528801|20935525|P2|STARTED|Overall Study||52
8495571|NCT00528801|20935526|P1|STARTED|Overall Study||160
8495572|NCT00528788|20935536|P1|NOT COMPLETED|Overall Study||4
8495573|NCT00528788|20935536|P1|COMPLETED|Overall Study||20
8495574|NCT00528788|20935536|P1|STARTED|Overall Study||24
8495575|NCT00528775|20935540|P1|NOT COMPLETED|Overall Study||1
8495576|NCT00528775|20935540|P1|COMPLETED|Overall Study||5
8495577|NCT00528775|20935540|P1|STARTED|Overall Study||6
8495578|NCT00528645|20935548|P1|NOT COMPLETED|Overall Study||3
8495579|NCT00528645|20935548|P1|COMPLETED|Overall Study||20
8495580|NCT00528645|20935548|P1|STARTED|Overall Study||23
8495581|NCT00528606|20935557|P2|NOT COMPLETED|Overall Study||4
8495582|NCT00528606|20935558|P1|NOT COMPLETED|Overall Study||13
8495583|NCT00528606|20935557|P2|COMPLETED|Overall Study||100
8495584|NCT00528606|20935558|P1|COMPLETED|Overall Study||191
8495585|NCT00528606|20935557|P2|STARTED|Overall Study||104
8495586|NCT00528606|20935558|P1|STARTED|Overall Study||204
8495587|NCT00528580|20935582|P2|NOT COMPLETED|Overall Study||0
8495588|NCT00528580|20935583|P1|NOT COMPLETED|Overall Study||0
8495589|NCT00528580|20935582|P2|COMPLETED|Overall Study||34
8495590|NCT00528580|20935583|P1|COMPLETED|Overall Study||34
8495591|NCT00528580|20935582|P2|STARTED|Overall Study||34
8495592|NCT00528580|20935583|P1|STARTED|Overall Study||34
8495593|NCT00528567|20935591|P2|NOT COMPLETED|Overall Study||308
8495594|NCT00528567|20935592|P1|NOT COMPLETED|Overall Study||431
8495595|NCT00528567|20935591|P2|COMPLETED|Overall Study||982
8495596|NCT00528567|20935592|P1|COMPLETED|Overall Study||870
8495597|NCT00528567|20935591|P2|Safety Population|Overall Study||1271
8495598|NCT00528567|20935592|P1|Safety Population|Overall Study||1288
8495599|NCT00528567|20935591|P2|Intention to Treat|Overall Study||1290
8495600|NCT00528567|20935592|P1|Intention to Treat|Overall Study||1301
8495601|NCT00528567|20935591|P2|STARTED|Overall Study||1290
8495602|NCT00528567|20935592|P1|STARTED|Overall Study||1301
8495603|NCT00528541|20935632|P2|NOT COMPLETED|Overall Study||1
8495604|NCT00528541|20935633|P1|NOT COMPLETED|Overall Study||2
8495605|NCT00528541|20935632|P2|COMPLETED|Overall Study||69
8495606|NCT00528541|20935633|P1|COMPLETED|Overall Study||73
8495607|NCT00528541|20935632|P2|STARTED|Overall Study||70
8495608|NCT00528541|20935633|P1|STARTED|Overall Study||75
8495609|NCT00528528|20935659|P4|NOT COMPLETED|Overall Study||3
8495610|NCT00528528|20935660|P3|NOT COMPLETED|Overall Study||3
8495611|NCT00528528|20935661|P2|NOT COMPLETED|Overall Study||3
8495612|NCT00528528|20935662|P1|NOT COMPLETED|Overall Study||3
8495613|NCT00528528|20935659|P4|COMPLETED|Overall Study||36
8495614|NCT00528528|20935660|P3|COMPLETED|Overall Study||37
8495615|NCT00528528|20935661|P2|COMPLETED|Overall Study||39
8495616|NCT00528528|20935662|P1|COMPLETED|Overall Study||37
8495617|NCT00528528|20935659|P4|Ongoing at Time of Cut-off|Overall Study||0
8495618|NCT00528528|20935660|P3|Ongoing at Time of Cut-off|Overall Study||1
8495619|NCT00528528|20935661|P2|Ongoing at Time of Cut-off|Overall Study||0
8495620|NCT00528528|20935662|P1|Ongoing at Time of Cut-off|Overall Study||0
8495621|NCT00528528|20935659|P4|STARTED|Overall Study||39
8495622|NCT00528528|20935660|P3|STARTED|Overall Study||40
8495623|NCT00528528|20935661|P2|STARTED|Overall Study||42
8495624|NCT00528528|20935662|P1|STARTED|Overall Study||40
8495625|NCT00528450|20935696|P1|NOT COMPLETED|Overall Study||0
8495626|NCT00528450|20935696|P1|COMPLETED|Overall Study||1
8495627|NCT00528450|20935696|P1|STARTED|Overall Study||1
8495628|NCT00528424|20935700|P1|NOT COMPLETED|Overall Study||29
8495629|NCT00528424|20935700|P1|COMPLETED|Overall Study||257
8495630|NCT00528424|20935700|P1|STARTED|Overall Study||286
8495631|NCT00528411|20935715|P3|NOT COMPLETED|Overall Study||1
8495632|NCT00528411|20935716|P2|NOT COMPLETED|Overall Study||3
8495633|NCT00528411|20935717|P1|NOT COMPLETED|Overall Study||5
8495634|NCT00528411|20935715|P3|COMPLETED|Overall Study||11
8495635|NCT00528411|20935716|P2|COMPLETED|Overall Study||51
8495636|NCT00528411|20935717|P1|COMPLETED|Overall Study||52
8495637|NCT00528411|20935715|P3|STARTED|Overall Study||12
8495638|NCT00528411|20935716|P2|STARTED|Overall Study||54
8495639|NCT00528411|20935717|P1|STARTED|Overall Study||57
8495640|NCT00528398|20935840|P1|NOT COMPLETED|Overall Study||0
8495641|NCT00528398|20935840|P1|COMPLETED|Overall Study||111
8495642|NCT00528398|20935840|P1|STARTED|Overall Study||111
8495643|NCT00528372|20935854|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
8495644|NCT00528372|20935855|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
8495645|NCT00528372|20935856|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
8495646|NCT00528372|20935857|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
8495647|NCT00528372|20935858|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
8495648|NCT00528372|20935859|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
8495649|NCT00528372|20935860|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
8495650|NCT00528372|20935861|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
8495651|NCT00528372|20935862|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
8495652|NCT00528372|20935854|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
8495654|NCT00528372|20935856|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
8495655|NCT00528372|20935857|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8495656|NCT00528372|20935858|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
8495657|NCT00528372|20935859|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8495658|NCT00528372|20935860|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
8495659|NCT00528372|20935861|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
8495660|NCT00528372|20935862|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8495661|NCT00528372|20935854|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
8495662|NCT00528372|20935855|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
8495663|NCT00528372|20935856|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
8495664|NCT00528372|20935857|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
8495665|NCT00528372|20935858|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
8495666|NCT00528372|20935859|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
8495667|NCT00528372|20935860|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
8495668|NCT00528372|20935861|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
8495669|NCT00528372|20935862|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
8495670|NCT00528372|20935854|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
8495671|NCT00528372|20935855|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
8495672|NCT00528372|20935856|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
8495673|NCT00528372|20935857|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
8495674|NCT00528372|20935858|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
8495675|NCT00528372|20935859|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
8495676|NCT00528372|20935860|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
8495677|NCT00528372|20935861|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
8495678|NCT00528372|20935862|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
8495679|NCT00528372|20935854|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
8495680|NCT00528372|20935855|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
8495681|NCT00528372|20935856|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
8495682|NCT00528372|20935857|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
8495683|NCT00528372|20935858|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
8495684|NCT00528372|20935859|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
8495685|NCT00528372|20935860|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
8495686|NCT00528372|20935861|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
8495687|NCT00528372|20935862|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
8495688|NCT00528372|20935854|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
8495689|NCT00528372|20935855|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
8495690|NCT00528372|20935856|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
8495691|NCT00528372|20935857|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
8495692|NCT00528372|20935858|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
8495693|NCT00528372|20935859|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
8495694|NCT00528372|20935860|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
8495695|NCT00528372|20935861|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
8495696|NCT00528372|20935862|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
8495697|NCT00528268|20935976|P2|NOT COMPLETED|Overall Study||1
8495698|NCT00528268|20935977|P1|NOT COMPLETED|Overall Study||1
8495699|NCT00528268|20935976|P2|COMPLETED|Overall Study||7
8495700|NCT00528268|20935977|P1|COMPLETED|Overall Study||5
8495701|NCT00528268|20935976|P2|STARTED|Overall Study||8
8495702|NCT00528268|20935977|P1|STARTED|Overall Study||6
8495703|NCT00528190|20935985|P2|NOT COMPLETED|Overall Study||1
8495704|NCT00528190|20935986|P1|NOT COMPLETED|Overall Study||0
8495705|NCT00528190|20935985|P2|COMPLETED|Overall Study||16
8495706|NCT00528190|20935986|P1|COMPLETED|Overall Study||18
8495707|NCT00528190|20935985|P2|STARTED|Overall Study||17
8495708|NCT00528190|20935986|P1|STARTED|Overall Study||18
8495709|NCT00528112|20935994|P2|NOT COMPLETED|Extension Phase||157
8495710|NCT00528112|20935995|P1|NOT COMPLETED|Extension Phase||0
8495711|NCT00528112|20935994|P2|COMPLETED|Extension Phase||550
8495712|NCT00528112|20935995|P1|COMPLETED|Extension Phase||0
8495713|NCT00528112|20935994|P2|STARTED|Extension Phase||707
8495714|NCT00528112|20935995|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
8495715|NCT00528112|20935994|P2|NOT COMPLETED|Treatment up to 3 Years||583
8495716|NCT00528112|20935995|P1|NOT COMPLETED|Treatment up to 3 Years||613
8495717|NCT00528112|20935994|P2|COMPLETED|Treatment up to 3 Years||870
8495718|NCT00528112|20935995|P1|COMPLETED|Treatment up to 3 Years||819
8495719|NCT00528112|20935994|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
8495720|NCT00528112|20935995|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
8495721|NCT00528112|20935994|P2|STARTED|Treatment up to 3 Years||1453
8495722|NCT00528112|20935995|P1|STARTED|Treatment up to 3 Years||1432
8495723|NCT00528021|20936053|P4|NOT COMPLETED|Overall Study||9
8495724|NCT00528021|20936054|P3|NOT COMPLETED|Overall Study||7
8495725|NCT00528021|20936055|P2|NOT COMPLETED|Overall Study||13
8495726|NCT00528021|20936056|P1|NOT COMPLETED|Overall Study||17
8495727|NCT00528021|20936053|P4|COMPLETED|Overall Study||47
8495728|NCT00528021|20936054|P3|COMPLETED|Overall Study||49
8495729|NCT00528021|20936055|P2|COMPLETED|Overall Study||46
8495730|NCT00528021|20936056|P1|COMPLETED|Overall Study||42
8495731|NCT00528021|20936053|P4|STARTED|Overall Study||56
8495732|NCT00528021|20936054|P3|STARTED|Overall Study||56
8495733|NCT00528021|20936055|P2|STARTED|Overall Study||59
8495734|NCT00528021|20936056|P1|STARTED|Overall Study||59
8495735|NCT00527982|20936068|P2|NOT COMPLETED|Overall Study||0
8495736|NCT00527982|20936069|P1|NOT COMPLETED|Overall Study||1
8495737|NCT00527982|20936068|P2|COMPLETED|Overall Study||0
8495738|NCT00527982|20936069|P1|COMPLETED|Overall Study||0
8495739|NCT00527982|20936068|P2|STARTED|Overall Study||0
8495740|NCT00527982|20936069|P1|STARTED|Overall Study||1
8495741|NCT00527943|20936077|P2|NOT COMPLETED|Overall Study||146
8495742|NCT00527943|20936078|P1|NOT COMPLETED|Overall Study||160
8495743|NCT00527943|20936077|P2|COMPLETED|Overall Study||6327
8495744|NCT00527943|20936078|P1|COMPLETED|Overall Study||6311
8495745|NCT00527943|20936077|P2|Received Treatment|Overall Study||6446
8495746|NCT00527943|20936078|P1|Received Treatment|Overall Study||6441
8495747|NCT00527943|20936077|P2|STARTED|Overall Study||6473
8495748|NCT00527943|20936078|P1|STARTED|Overall Study||6471
8495749|NCT00527904|20936110|P1|NOT COMPLETED|Overall Study||96
8495750|NCT00527904|20936110|P1|COMPLETED|Overall Study||143
8495751|NCT00527904|20936110|P1|STARTED|Overall Study||239
8495752|NCT00527878|20936114|P2|NOT COMPLETED|Intervention 2||0
8495753|NCT00527878|20936115|P1|NOT COMPLETED|Intervention 2||0
8495754|NCT00527878|20936114|P2|COMPLETED|Intervention 2||4
8495755|NCT00527878|20936115|P1|COMPLETED|Intervention 2||5
8495756|NCT00527878|20936114|P2|STARTED|Intervention 2||4
8495757|NCT00527878|20936115|P1|STARTED|Intervention 2||5
8495758|NCT00527878|20936114|P2|NOT COMPLETED|Intervention 1||3
8495759|NCT00527878|20936115|P1|NOT COMPLETED|Intervention 1||2
8495760|NCT00527878|20936114|P2|COMPLETED|Intervention 1||4
8495761|NCT00527878|20936115|P1|COMPLETED|Intervention 1||5
8495762|NCT00527878|20936114|P2|STARTED|Intervention 1||7
8495763|NCT00527878|20936115|P1|STARTED|Intervention 1||7
8495764|NCT00527826|20936129|P2|NOT COMPLETED|Overall Study||26
8495765|NCT00527826|20936130|P1|NOT COMPLETED|Overall Study||21
8495766|NCT00527826|20936129|P2|COMPLETED|Overall Study||80
8495767|NCT00527826|20936130|P1|COMPLETED|Overall Study||87
8495768|NCT00527826|20936129|P2|STARTED|Overall Study||106
8495769|NCT00527826|20936130|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
8495770|NCT00527787|20936179|P2|NOT COMPLETED|Overall Study||63
8495771|NCT00527787|20936180|P1|NOT COMPLETED|Overall Study||38
8495772|NCT00527787|20936179|P2|COMPLETED|Overall Study||153
8495773|NCT00527787|20936180|P1|COMPLETED|Overall Study||180
8495774|NCT00527787|20936179|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
8495775|NCT00527787|20936180|P1|STARTED|Overall Study||218
8495776|NCT00527748|20936202|P1|NOT COMPLETED|Overall Study||3
8495777|NCT00527748|20936202|P1|COMPLETED|Overall Study||23
8495778|NCT00527748|20936202|P1|STARTED|Overall Study||26
8495779|NCT00527735|20936209|P3|NOT COMPLETED|Overall Study||107
8495780|NCT00527735|20936210|P2|NOT COMPLETED|Overall Study||107
8495781|NCT00527735|20936211|P1|NOT COMPLETED|Overall Study||108
8495782|NCT00527735|20936209|P3|COMPLETED|Overall Study|Still on treatment|2
8495783|NCT00527735|20936210|P2|COMPLETED|Overall Study|Still on treatment|2
8495784|NCT00527735|20936211|P1|COMPLETED|Overall Study|Still on treatment|5
8495785|NCT00527735|20936209|P3|STARTED|Overall Study|Treated|109
8495786|NCT00527735|20936210|P2|STARTED|Overall Study|Treated|109
8495787|NCT00527735|20936211|P1|STARTED|Overall Study|Treated|113
8495788|NCT00527722|20936285|P2|NOT COMPLETED|Overall Study||0
8495789|NCT00527722|20936286|P1|NOT COMPLETED|Overall Study||0
8495790|NCT00527722|20936285|P2|COMPLETED|Overall Study||25
8495791|NCT00527722|20936286|P1|COMPLETED|Overall Study||22
8495792|NCT00527722|20936285|P2|STARTED|Overall Study||25
8495793|NCT00527722|20936286|P1|STARTED|Overall Study||22
8495794|NCT00527644|20936292|P1|NOT COMPLETED|Overall Study||0
8495795|NCT00527644|20936292|P1|COMPLETED|Overall Study||14
8495796|NCT00527644|20936292|P1|STARTED|Overall Study||14
8495797|NCT00527618|20936297|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
8495798|NCT00527618|20936298|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
8495799|NCT00527618|20936297|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
8495800|NCT00527618|20936298|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
8495801|NCT00527618|20936297|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
8495802|NCT00527618|20936298|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
8495803|NCT00527618|20936297|P2|NOT COMPLETED|Week 13-14 (Washout)||0
8495804|NCT00527618|20936298|P1|NOT COMPLETED|Week 13-14 (Washout)||1
8495805|NCT00527618|20936297|P2|COMPLETED|Week 13-14 (Washout)||16
8495806|NCT00527618|20936298|P1|COMPLETED|Week 13-14 (Washout)||12
8495807|NCT00527618|20936297|P2|STARTED|Week 13-14 (Washout)||16
8495808|NCT00527618|20936298|P1|STARTED|Week 13-14 (Washout)||13
8495809|NCT00527618|20936297|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
8495810|NCT00527618|20936298|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
8495811|NCT00527618|20936297|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
8495812|NCT00527618|20936298|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
8495813|NCT00527618|20936297|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
8495814|NCT00527618|20936298|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
8495815|NCT00527605|20936313|P2|NOT COMPLETED|Overall Study||11
8495816|NCT00527605|20936314|P1|NOT COMPLETED|Overall Study||13
8495817|NCT00527605|20936313|P2|COMPLETED|Overall Study||116
8495818|NCT00527605|20936314|P1|COMPLETED|Overall Study||113
8495819|NCT00527605|20936313|P2|STARTED|Overall Study||127
8495820|NCT00527605|20936314|P1|STARTED|Overall Study||126
8495821|NCT00527592|20936350|P1|NOT COMPLETED|Overall Study||0
8495822|NCT00527592|20936350|P1|COMPLETED|Overall Study||54
8495823|NCT00527592|20936350|P1|STARTED|Overall Study||54
8495824|NCT00527566|20936356|P1|NOT COMPLETED|Overall Study||0
8495825|NCT00527566|20936356|P1|COMPLETED|Overall Study||10
8495826|NCT00527566|20936356|P1|STARTED|Overall Study||10
8495827|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
8495828|NCT00527514|20936365|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
8495829|NCT00527514|20936365|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
8495830|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
8495831|NCT00527514|20936365|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
8495832|NCT00527514|20936365|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
8495833|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
8495834|NCT00527514|20936365|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
8495835|NCT00527514|20936365|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
8495836|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
8495837|NCT00527514|20936365|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
8495838|NCT00527514|20936365|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
8495839|NCT00527488|20936381|P4|NOT COMPLETED|Overall Study||0
8495840|NCT00527488|20936382|P3|NOT COMPLETED|Overall Study||1
8495841|NCT00527488|20936383|P2|NOT COMPLETED|Overall Study||1
8495842|NCT00527488|20936384|P1|NOT COMPLETED|Overall Study||0
8495843|NCT00527488|20936381|P4|COMPLETED|Overall Study||13
8495844|NCT00527488|20936382|P3|COMPLETED|Overall Study||12
8495845|NCT00527488|20936383|P2|COMPLETED|Overall Study||12
8495846|NCT00527488|20936384|P1|COMPLETED|Overall Study||13
8495847|NCT00527488|20936381|P4|STARTED|Overall Study||13
8495848|NCT00527488|20936382|P3|STARTED|Overall Study||13
8495849|NCT00527488|20936383|P2|STARTED|Overall Study||13
8495850|NCT00527488|20936384|P1|STARTED|Overall Study||13
8495851|NCT00527475|20936460|P2|NOT COMPLETED|Overall Study||1
8495852|NCT00527475|20936461|P1|NOT COMPLETED|Overall Study||3
8495853|NCT00527475|20936460|P2|COMPLETED|Overall Study||29
8495854|NCT00527475|20936461|P1|COMPLETED|Overall Study||27
8495855|NCT00527475|20936460|P2|STARTED|Overall Study||30
8495856|NCT00527475|20936461|P1|STARTED|Overall Study||30
8495857|NCT00527423|20936467|P1|NOT COMPLETED|Overall Study||37
8495858|NCT00527423|20936467|P1|COMPLETED|Overall Study||120
8495859|NCT00527423|20936467|P1|STARTED|Overall Study||157
8495860|NCT00527397|20936473|P1|NOT COMPLETED|Overall Study||24
8495861|NCT00527397|20936473|P1|COMPLETED|Overall Study||0
8495862|NCT00527397|20936473|P1|STARTED|Overall Study||24
8495863|NCT00527332|20936499|P2|NOT COMPLETED|Overall Study||9
8495864|NCT00527332|20936500|P1|NOT COMPLETED|Overall Study||9
8495865|NCT00527332|20936499|P2|COMPLETED|Overall Study||80
8495866|NCT00527332|20936500|P1|COMPLETED|Overall Study||82
8495867|NCT00527332|20936499|P2|STARTED|Overall Study||89
8495868|NCT00527332|20936500|P1|STARTED|Overall Study||91
8495869|NCT00527319|20936509|P3|NOT COMPLETED|Overall Study||6
8495870|NCT00527319|20936510|P2|NOT COMPLETED|Overall Study||4
8495871|NCT00527319|20936511|P1|NOT COMPLETED|Overall Study||6
8495872|NCT00527319|20936509|P3|COMPLETED|Overall Study||7
8495873|NCT00527319|20936510|P2|COMPLETED|Overall Study||8
8495874|NCT00527319|20936511|P1|COMPLETED|Overall Study||6
8495875|NCT00527319|20936509|P3|STARTED|Overall Study||13
8495876|NCT00527319|20936510|P2|STARTED|Overall Study||12
8495877|NCT00527319|20936511|P1|STARTED|Overall Study||12
8495878|NCT00527124|20936524|P2|NOT COMPLETED|Overall Study||0
8495879|NCT00527124|20936525|P1|NOT COMPLETED|Overall Study||0
8495880|NCT00527124|20936524|P2|COMPLETED|Overall Study||28
8495881|NCT00527124|20936525|P1|COMPLETED|Overall Study||29
8495882|NCT00527124|20936524|P2|STARTED|Overall Study||28
8495883|NCT00527124|20936525|P1|STARTED|Overall Study||29
8495884|NCT00527111|20936541|P2|NOT COMPLETED|Overall Study||22
8495885|NCT00527111|20936542|P1|NOT COMPLETED|Overall Study||20
8495886|NCT00527111|20936541|P2|COMPLETED|Overall Study||47
8495887|NCT00527111|20936542|P1|COMPLETED|Overall Study||50
8495888|NCT00527111|20936541|P2|STARTED|Overall Study||69
8495889|NCT00527111|20936542|P1|STARTED|Overall Study||70
8495890|NCT00527098|20936558|P2|NOT COMPLETED|Overall Study||0
8495891|NCT00527098|20936559|P1|NOT COMPLETED|Overall Study||0
8495892|NCT00527098|20936558|P2|COMPLETED|Overall Study||83
8495893|NCT00527098|20936559|P1|COMPLETED|Overall Study||36
8495894|NCT00527098|20936558|P2|STARTED|Overall Study||83
8495895|NCT00527098|20936559|P1|STARTED|Overall Study||36
8495896|NCT00527072|20936564|P1|NOT COMPLETED|Overall Study||36
8495897|NCT00527072|20936564|P1|COMPLETED|Overall Study||179
8495898|NCT00527072|20936564|P1|STARTED|Overall Study||215
8495899|NCT00526994|20936573|P3|NOT COMPLETED|Overall Study||107
8495900|NCT00526994|20936574|P2|NOT COMPLETED|Overall Study||121
8495901|NCT00526994|20936575|P1|NOT COMPLETED|Overall Study||108
8495902|NCT00526994|20936573|P3|COMPLETED|Overall Study||791
8495903|NCT00526994|20936574|P2|COMPLETED|Overall Study||772
8495904|NCT00526994|20936575|P1|COMPLETED|Overall Study||801
8495905|NCT00526994|20936573|P3|STARTED|Overall Study||898
8495906|NCT00526994|20936574|P2|STARTED|Overall Study||893
8495907|NCT00526994|20936575|P1|STARTED|Overall Study||909
8495908|NCT00526890|20936592|P1|NOT COMPLETED|Overall Study||2
8495909|NCT00526890|20936592|P1|COMPLETED|Overall Study||14
8495910|NCT00526890|20936592|P1|STARTED|Overall Study||16
8495911|NCT00526799|20936604|P2|NOT COMPLETED|Overall Study||1
8495912|NCT00526799|20936605|P1|NOT COMPLETED|Overall Study||1
8495913|NCT00526799|20936604|P2|COMPLETED|Overall Study||13
8495914|NCT00526799|20936605|P1|COMPLETED|Overall Study||15
8495915|NCT00526799|20936604|P2|STARTED|Overall Study||14
8495916|NCT00526799|20936605|P1|STARTED|Overall Study||16
8495917|NCT00526669|20936613|P2|NOT COMPLETED|Combined Treatment Phase||8
8495918|NCT00526669|20936614|P1|NOT COMPLETED|Combined Treatment Phase||0
8495919|NCT00526669|20936613|P2|COMPLETED|Combined Treatment Phase||59
8495920|NCT00526669|20936614|P1|COMPLETED|Combined Treatment Phase||0
8495921|NCT00526669|20936613|P2|STARTED|Combined Treatment Phase||67
8495922|NCT00526669|20936614|P1|STARTED|Combined Treatment Phase||0
8495923|NCT00526669|20936613|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8495924|NCT00526669|20936614|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8495925|NCT00526669|20936613|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8495926|NCT00526669|20936614|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
8495927|NCT00526669|20936613|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
8495928|NCT00526669|20936614|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
8495929|NCT00526656|20936643|P1|NOT COMPLETED|Overall Study||2
8495930|NCT00526656|20936643|P1|COMPLETED|Overall Study||7
8495931|NCT00526656|20936643|P1|STARTED|Overall Study||9
8495932|NCT00526630|20936649|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
8495933|NCT00526630|20936650|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
8495934|NCT00526630|20936649|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
8495935|NCT00526630|20936650|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
8495936|NCT00526630|20936649|P2|STARTED|Second Intervention Period - 12 Weeks||8
8495937|NCT00526630|20936650|P1|STARTED|Second Intervention Period - 12 Weeks||12
8495938|NCT00526630|20936649|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
8495939|NCT00526630|20936650|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
8495940|NCT00526630|20936649|P2|COMPLETED|First Intervention Period - 12 Weeks||8
8495941|NCT00526630|20936650|P1|COMPLETED|First Intervention Period - 12 Weeks||12
8495942|NCT00526630|20936649|P2|STARTED|First Intervention Period - 12 Weeks||11
8495943|NCT00526630|20936650|P1|STARTED|First Intervention Period - 12 Weeks||12
8495944|NCT00526591|20936680|P2|NOT COMPLETED|Overall Study||0
8495945|NCT00526591|20936681|P1|NOT COMPLETED|Overall Study||0
8495946|NCT00526591|20936680|P2|COMPLETED|Overall Study||9
8495947|NCT00526591|20936681|P1|COMPLETED|Overall Study||8
8495948|NCT00526591|20936680|P2|STARTED|Overall Study||9
8495949|NCT00526591|20936681|P1|STARTED|Overall Study||8
8495950|NCT00526474|20936693|P2|NOT COMPLETED|Overall Study||272
8495951|NCT00526474|20936694|P1|NOT COMPLETED|Overall Study||292
8495952|NCT00526474|20936693|P2|COMPLETED|Overall Study||12953
8495953|NCT00526474|20936694|P1|COMPLETED|Overall Study||12932
8495954|NCT00526474|20936693|P2|Received Study Drug|Overall Study||13186
8495955|NCT00526474|20936694|P1|Received Study Drug|Overall Study||13166
8495956|NCT00526474|20936693|P2|STARTED|Overall Study||13225
8495957|NCT00526474|20936694|P1|STARTED|Overall Study||13224
8495958|NCT00526331|20936762|P1|NOT COMPLETED|Overall Study||55
8495959|NCT00526331|20936762|P1|COMPLETED|Overall Study||0
8495960|NCT00526331|20936762|P1|STARTED|Overall Study||55
8495961|NCT00526292|20936766|P1|NOT COMPLETED|Overall Study||0
8495962|NCT00526292|20936766|P1|COMPLETED|Overall Study||6
8495963|NCT00526292|20936766|P1|STARTED|Overall Study||6
8495964|NCT00526227|20936770|P1|NOT COMPLETED|Overall Study||2
8495965|NCT00526227|20936770|P1|COMPLETED|Overall Study||79
8495966|NCT00526227|20936770|P1|STARTED|Overall Study||81
8495967|NCT00526188|20936777|P1|NOT COMPLETED|Overall Study||0
8495968|NCT00526188|20936777|P1|COMPLETED|Overall Study||234
8495969|NCT00526188|20936777|P1|STARTED|Overall Study||234
8495970|NCT00526162|20936783|P1|NOT COMPLETED|Overall Study||3
8495971|NCT00526162|20936783|P1|COMPLETED|Overall Study||80
8495972|NCT00526162|20936783|P1|STARTED|Overall Study||83
8495973|NCT00526123|20936793|P2|NOT COMPLETED|Overall Study||246
8495974|NCT00526123|20936794|P1|NOT COMPLETED|Overall Study||264
8495975|NCT00526123|20936793|P2|COMPLETED|Overall Study||50
8495976|NCT00526123|20936794|P1|COMPLETED|Overall Study||39
8495977|NCT00526123|20936793|P2|STARTED|Overall Study|Intent-to-Treat population|296
8495978|NCT00526123|20936794|P1|STARTED|Overall Study|Intent-to-Treat population|303
8495979|NCT00526110|20936816|P2|NOT COMPLETED|Overall Study||41
8495980|NCT00526110|20936817|P1|NOT COMPLETED|Overall Study||2
8495981|NCT00526110|20936816|P2|COMPLETED|Overall Study||4
8495982|NCT00526110|20936817|P1|COMPLETED|Overall Study||51
8495983|NCT00526110|20936816|P2|STARTED|Overall Study||45
8495984|NCT00526110|20936817|P1|STARTED|Overall Study||53
8495985|NCT00526097|20936826|P2|NOT COMPLETED|Overall Study||56
8495986|NCT00526097|20936827|P1|NOT COMPLETED|Overall Study||15
8495987|NCT00526097|20936826|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
8495988|NCT00526097|20936827|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
8495989|NCT00526097|20936826|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
8495990|NCT00526097|20936827|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
8495991|NCT00526071|20937003|P1|NOT COMPLETED|Overall Study||6
8495992|NCT00526071|20937003|P1|COMPLETED|Overall Study||17
8495993|NCT00526071|20937003|P1|Non-amenable Population; Women|Overall Study||4
8495994|NCT00526071|20937003|P1|Non-amenable Population; Men|Overall Study||3
8495995|NCT00526071|20937003|P1|Amenable Population; Women|Overall Study||5
8495996|NCT00526071|20937003|P1|Amenable Population; Men|Overall Study||11
8495997|NCT00526071|20937003|P1|Pharmacodynamic (PD) Population|Overall Study||23
8495998|NCT00526071|20937003|P1|Safety Population|Overall Study||23
8495999|NCT00526071|20937003|P1|STARTED|Overall Study||23
8496000|NCT00526058|20937014|P2|NOT COMPLETED|Period: Second Intervention||0
8496001|NCT00526058|20937015|P1|NOT COMPLETED|Period: Second Intervention||0
8496002|NCT00526058|20937014|P2|COMPLETED|Period: Second Intervention||9
8496003|NCT00526058|20937015|P1|COMPLETED|Period: Second Intervention||9
8496004|NCT00526058|20937014|P2|STARTED|Period: Second Intervention||9
8496005|NCT00526058|20937015|P1|STARTED|Period: Second Intervention||9
8496006|NCT00526058|20937014|P2|NOT COMPLETED|Period: First Intervention||0
8496007|NCT00526058|20937015|P1|NOT COMPLETED|Period: First Intervention||0
8496008|NCT00526058|20937014|P2|COMPLETED|Period: First Intervention||9
8496009|NCT00526058|20937015|P1|COMPLETED|Period: First Intervention||9
8496010|NCT00526058|20937014|P2|STARTED|Period: First Intervention||9
8496011|NCT00526058|20937015|P1|STARTED|Period: First Intervention||9
8496012|NCT00525915|20937029|P2|NOT COMPLETED|Overall Study||9
8496013|NCT00525915|20937030|P1|NOT COMPLETED|Overall Study||8
8496014|NCT00525915|20937029|P2|COMPLETED|Overall Study||54
8496015|NCT00525915|20937030|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
8496016|NCT00525915|20937029|P2|STARTED|Overall Study||63
8496017|NCT00525915|20937030|P1|STARTED|Overall Study||63
8496018|NCT00525902|20937036|P1|NOT COMPLETED|Overall Study||1
8496019|NCT00525902|20937036|P1|COMPLETED|Overall Study||30
8496020|NCT00525902|20937036|P1|50 Weeks|Overall Study||12
8496021|NCT00525902|20937036|P1|10 Weeks|Overall Study||30
8496022|NCT00525902|20937036|P1|STARTED|Overall Study||31
8496023|NCT00525876|20937043|P2|NOT COMPLETED|Overall Study||0
8496024|NCT00525876|20937044|P1|NOT COMPLETED|Overall Study||0
8496025|NCT00525876|20937043|P2|COMPLETED|Overall Study||20
8496026|NCT00525876|20937044|P1|COMPLETED|Overall Study||16
8496027|NCT00525876|20937043|P2|STARTED|Overall Study||20
8496028|NCT00525876|20937044|P1|STARTED|Overall Study||16
8496029|NCT00525837|20937050|P1|NOT COMPLETED|Overall Study||4
8496030|NCT00525837|20937050|P1|COMPLETED|Overall Study||14
8496031|NCT00525837|20937050|P1|STARTED|Overall Study||18
8496032|NCT00525824|20937060|P4|NOT COMPLETED|Overall Study||15
8496033|NCT00525824|20937061|P3|NOT COMPLETED|Overall Study||19
8496034|NCT00525824|20937062|P2|NOT COMPLETED|Overall Study||28
8496035|NCT00525824|20937063|P1|NOT COMPLETED|Overall Study||19
8496036|NCT00525824|20937060|P4|COMPLETED|Overall Study||188
8496037|NCT00525824|20937061|P3|COMPLETED|Overall Study||183
8496038|NCT00525824|20937062|P2|COMPLETED|Overall Study||186
8496039|NCT00525824|20937063|P1|COMPLETED|Overall Study||195
8496040|NCT00525824|20937060|P4|STARTED|Overall Study|Randomized population|203
8496041|NCT00525824|20937061|P3|STARTED|Overall Study|Randomized population|202
8496042|NCT00525824|20937062|P2|STARTED|Overall Study|Randomized population|214
8496043|NCT00525824|20937063|P1|STARTED|Overall Study|Randomized population|214
8496044|NCT00525798|20937127|P2|NOT COMPLETED|Overall Study||599
8496045|NCT00525798|20937128|P1|NOT COMPLETED|Overall Study||756
8496046|NCT00525798|20937127|P2|COMPLETED|Overall Study||1732
8496047|NCT00525798|20937128|P1|COMPLETED|Overall Study||1578
8496048|NCT00525798|20937127|P2|STARTED|Overall Study||2331
8496049|NCT00525798|20937128|P1|STARTED|Overall Study||2334
8496050|NCT00525785|20937136|P1|NOT COMPLETED|Overall Study||3
8496051|NCT00525785|20937136|P1|COMPLETED|Overall Study||55
8496052|NCT00525785|20937136|P1|STARTED|Overall Study||58
8496053|NCT00525733|20937142|P2|NOT COMPLETED|Overall Study||3
8496054|NCT00525733|20937143|P1|NOT COMPLETED|Overall Study||3
8496055|NCT00525733|20937142|P2|COMPLETED|Overall Study||23
8496056|NCT00525733|20937143|P1|COMPLETED|Overall Study||11
8496057|NCT00525733|20937142|P2|STARTED|Overall Study||26
8496058|NCT00525733|20937143|P1|STARTED|Overall Study||14
8496059|NCT00525629|20937149|P2|NOT COMPLETED|Second Intervention||15
8496060|NCT00525629|20937150|P1|NOT COMPLETED|Second Intervention||15
8496061|NCT00525629|20937149|P2|COMPLETED|Second Intervention||0
8496062|NCT00525629|20937150|P1|COMPLETED|Second Intervention||0
8496063|NCT00525629|20937149|P2|STARTED|Second Intervention||15
8496064|NCT00525629|20937150|P1|STARTED|Second Intervention||15
8496065|NCT00525629|20937149|P2|NOT COMPLETED|Washout||0
8496066|NCT00525629|20937150|P1|NOT COMPLETED|Washout||0
8496067|NCT00525629|20937149|P2|COMPLETED|Washout||15
8496068|NCT00525629|20937150|P1|COMPLETED|Washout||15
8496069|NCT00525629|20937149|P2|STARTED|Washout||15
8496070|NCT00525629|20937150|P1|STARTED|Washout||15
8496071|NCT00525629|20937149|P2|NOT COMPLETED|First Intervention||5
8496072|NCT00525629|20937150|P1|NOT COMPLETED|First Intervention||5
8496073|NCT00525629|20937149|P2|COMPLETED|First Intervention||15
8496074|NCT00525629|20937150|P1|COMPLETED|First Intervention||15
8496075|NCT00525629|20937149|P2|STARTED|First Intervention||20
8496076|NCT00525629|20937150|P1|STARTED|First Intervention||20
8496077|NCT00525603|20937156|P1|NOT COMPLETED|Overall Study||0
8496078|NCT00525603|20937156|P1|COMPLETED|Overall Study||60
8496079|NCT00525603|20937156|P1|STARTED|Overall Study||60
8496080|NCT00525590|20937160|P1|NOT COMPLETED|Overall Study||45
8496081|NCT00525590|20937160|P1|COMPLETED|Overall Study||14
8496082|NCT00525590|20937160|P1|STARTED|Overall Study||59
8496083|NCT00525525|20937178|P2|NOT COMPLETED|Overall Study||0
8496084|NCT00525525|20937179|P1|NOT COMPLETED|Overall Study||0
8496085|NCT00525525|20937178|P2|COMPLETED|Overall Study||15
8496086|NCT00525525|20937179|P1|COMPLETED|Overall Study||59
8496087|NCT00525525|20937178|P2|STARTED|Overall Study||15
8496088|NCT00525525|20937179|P1|STARTED|Overall Study||59
8496089|NCT00525512|20937188|P4|NOT COMPLETED|Open-Label Phase||5
8496090|NCT00525512|20937189|P3|NOT COMPLETED|Open-Label Phase||6
8496091|NCT00525512|20937190|P2|NOT COMPLETED|Open-Label Phase||0
8496092|NCT00525512|20937191|P1|NOT COMPLETED|Open-Label Phase||0
8496093|NCT00525512|20937188|P4|COMPLETED|Open-Label Phase||189
8496094|NCT00525512|20937189|P3|COMPLETED|Open-Label Phase||158
8496095|NCT00525512|20937190|P2|COMPLETED|Open-Label Phase||0
8496096|NCT00525512|20937191|P1|COMPLETED|Open-Label Phase||0
8496097|NCT00525512|20937188|P4|STARTED|Open-Label Phase||194
8496098|NCT00525512|20937189|P3|STARTED|Open-Label Phase||164
8496099|NCT00525512|20937190|P2|STARTED|Open-Label Phase||0
8496100|NCT00525512|20937191|P1|STARTED|Open-Label Phase||0
8496101|NCT00525512|20937188|P4|NOT COMPLETED|Double-Blind Phase||0
8496102|NCT00525512|20937189|P3|NOT COMPLETED|Double-Blind Phase||0
8496103|NCT00525512|20937190|P2|NOT COMPLETED|Double-Blind Phase||66
8496104|NCT00525512|20937191|P1|NOT COMPLETED|Double-Blind Phase||96
8496105|NCT00525512|20937188|P4|COMPLETED|Double-Blind Phase||0
8496106|NCT00525512|20937189|P3|COMPLETED|Double-Blind Phase||0
8496107|NCT00525512|20937190|P2|COMPLETED|Double-Blind Phase||194
8496108|NCT00525512|20937191|P1|COMPLETED|Double-Blind Phase||163
8496109|NCT00525512|20937188|P4|STARTED|Double-Blind Phase||0
8496110|NCT00525512|20937189|P3|STARTED|Double-Blind Phase||0
8496111|NCT00525512|20937190|P2|STARTED|Double-Blind Phase||260
8496112|NCT00525512|20937191|P1|STARTED|Double-Blind Phase||259
8496113|NCT00525499|20937333|P4|NOT COMPLETED|Overall Study||7
8496114|NCT00525499|20937334|P3|NOT COMPLETED|Overall Study||7
8496115|NCT00525499|20937335|P2|NOT COMPLETED|Overall Study||7
8496116|NCT00525499|20937336|P1|NOT COMPLETED|Overall Study||7
8496117|NCT00525499|20937333|P4|COMPLETED|Overall Study||39
8496118|NCT00525499|20937334|P3|COMPLETED|Overall Study||40
8496119|NCT00525499|20937335|P2|COMPLETED|Overall Study||39
8496120|NCT00525499|20937336|P1|COMPLETED|Overall Study||40
8496121|NCT00525499|20937333|P4|STARTED|Overall Study||46
8496122|NCT00525499|20937334|P3|STARTED|Overall Study||47
8496123|NCT00525499|20937335|P2|STARTED|Overall Study||46
8496124|NCT00525499|20937336|P1|STARTED|Overall Study||47
8496125|NCT00525421|20937352|P2|NOT COMPLETED|Overall Study||0
8496126|NCT00525421|20937353|P1|NOT COMPLETED|Overall Study||0
8496127|NCT00525421|20937352|P2|COMPLETED|Overall Study||10
8496128|NCT00525421|20937353|P1|COMPLETED|Overall Study||10
8496129|NCT00525421|20937352|P2|STARTED|Overall Study||10
8496130|NCT00525421|20937353|P1|STARTED|Overall Study|Enrollment started october 2007|10
8496131|NCT00525265|20937363|P2|NOT COMPLETED|Overall Study||0
8496132|NCT00525265|20937364|P1|NOT COMPLETED|Overall Study||1
8496133|NCT00525265|20937363|P2|COMPLETED|Overall Study||10
8496134|NCT00525265|20937364|P1|COMPLETED|Overall Study||9
8496135|NCT00525265|20937363|P2|STARTED|Overall Study||10
8496136|NCT00525265|20937364|P1|STARTED|Overall Study||10
8496137|NCT00525174|20937372|P2|NOT COMPLETED|Overall Study||8
8496138|NCT00525174|20937373|P1|NOT COMPLETED|Overall Study||9
8496139|NCT00525174|20937372|P2|COMPLETED|Overall Study||81
8496140|NCT00525174|20937373|P1|COMPLETED|Overall Study||88
8496141|NCT00525174|20937372|P2|STARTED|Overall Study||89
8496142|NCT00525174|20937373|P1|STARTED|Overall Study||97
8496143|NCT00525161|20937421|P1|NOT COMPLETED|Overall Study||1
8496144|NCT00525161|20937421|P1|COMPLETED|Overall Study||10
8496145|NCT00525161|20937421|P1|STARTED|Overall Study||11
8496146|NCT00525148|20937431|P4|NOT COMPLETED|Overall Study||61
8496147|NCT00525148|20937432|P3|NOT COMPLETED|Overall Study||7
8496148|NCT00525148|20937433|P2|NOT COMPLETED|Overall Study||38
8496149|NCT00525148|20937434|P1|NOT COMPLETED|Overall Study||23
8496150|NCT00525148|20937431|P4|COMPLETED|Overall Study||0
8496151|NCT00525148|20937432|P3|COMPLETED|Overall Study||0
8496152|NCT00525148|20937433|P2|COMPLETED|Overall Study||0
8496153|NCT00525148|20937434|P1|COMPLETED|Overall Study||0
8496154|NCT00525148|20937431|P4|STARTED|Overall Study|entered and treated|61
8496155|NCT00525148|20937432|P3|STARTED|Overall Study|entered and treated|7
8496156|NCT00525148|20937433|P2|STARTED|Overall Study|entered and treated|38
8496157|NCT00525148|20937434|P1|STARTED|Overall Study|entered and treated|23
8496158|NCT00525135|20937452|P1|NOT COMPLETED|Overall Study||0
8496159|NCT00525135|20937452|P1|COMPLETED|Overall Study||5
8496160|NCT00525135|20937452|P1|STARTED|Overall Study||5
8496161|NCT00525057|20937462|P2|NOT COMPLETED|Overall Study||0
8496162|NCT00525057|20937463|P1|NOT COMPLETED|Overall Study||0
8496163|NCT00525057|20937462|P2|COMPLETED|Overall Study||25
8496164|NCT00525057|20937463|P1|COMPLETED|Overall Study||25
8496165|NCT00525057|20937462|P2|STARTED|Overall Study||25
8496166|NCT00525057|20937463|P1|STARTED|Overall Study||25
8496167|NCT00525044|20937475|P2|NOT COMPLETED|Overall Study||1
8496168|NCT00525044|20937476|P1|NOT COMPLETED|Overall Study||0
8496169|NCT00525044|20937475|P2|COMPLETED|Overall Study||124
8496170|NCT00525044|20937476|P1|COMPLETED|Overall Study||124
8496171|NCT00525044|20937475|P2|STARTED|Overall Study||125
8496172|NCT00525044|20937476|P1|STARTED|Overall Study||124
8496173|NCT00525031|20937492|P2|NOT COMPLETED|Overall Study||1
8496174|NCT00525031|20937493|P1|NOT COMPLETED|Overall Study||1
8496175|NCT00525031|20937492|P2|COMPLETED|Overall Study||24
8496176|NCT00525031|20937493|P1|COMPLETED|Overall Study||26
8496177|NCT00525031|20937492|P2|STARTED|Overall Study||25
8496178|NCT00525031|20937493|P1|STARTED|Overall Study||27
8496179|NCT00524940|20937500|P1|NOT COMPLETED|Overall Study||0
8496180|NCT00524940|20937500|P1|COMPLETED|Overall Study||124
8496181|NCT00524940|20937500|P1|STARTED|Overall Study||124
8496182|NCT00524771|20937507|P2|NOT COMPLETED|Overall Study||585
8496183|NCT00524771|20937508|P1|NOT COMPLETED|Overall Study||220
8496184|NCT00524771|20937507|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
8496185|NCT00524771|20937508|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
8496186|NCT00524771|20937507|P2|STARTED|Overall Study||17016
8496187|NCT00524771|20937508|P1|STARTED|Overall Study||17084
8496188|NCT00524745|20937522|P4|NOT COMPLETED|Overall Study||22
8496189|NCT00524745|20937523|P3|NOT COMPLETED|Overall Study||29
8496190|NCT00524745|20937524|P2|NOT COMPLETED|Overall Study||13
8496191|NCT00524745|20937525|P1|NOT COMPLETED|Overall Study||34
8496192|NCT00524745|20937522|P4|COMPLETED|Overall Study||205
8496193|NCT00524745|20937523|P3|COMPLETED|Overall Study||212
8496194|NCT00524745|20937524|P2|COMPLETED|Overall Study||193
8496195|NCT00524745|20937525|P1|COMPLETED|Overall Study||195
8496196|NCT00524745|20937522|P4|STARTED|Overall Study||227
8496197|NCT00524745|20937523|P3|STARTED|Overall Study||241
8496198|NCT00524745|20937524|P2|STARTED|Overall Study||206
8496199|NCT00524745|20937525|P1|STARTED|Overall Study||229
8496200|NCT00524680|20937551|P4|NOT COMPLETED|Overall Study||6
8496201|NCT00524680|20937552|P3|NOT COMPLETED|Overall Study||3
8496202|NCT00524680|20937553|P2|NOT COMPLETED|Overall Study||1
8496203|NCT00524680|20937554|P1|NOT COMPLETED|Overall Study||3
8496204|NCT00524680|20937551|P4|COMPLETED|Overall Study||34
8496205|NCT00524680|20937552|P3|COMPLETED|Overall Study||33
8496206|NCT00524680|20937553|P2|COMPLETED|Overall Study||34
8496207|NCT00524680|20937554|P1|COMPLETED|Overall Study||34
8496208|NCT00524680|20937551|P4|STARTED|Overall Study||40
8496209|NCT00524680|20937552|P3|STARTED|Overall Study||36
8496210|NCT00524680|20937553|P2|STARTED|Overall Study||35
8496211|NCT00524680|20937554|P1|STARTED|Overall Study||37
8496212|NCT00524589|20937576|P1|NOT COMPLETED|Overall Study||18
8496213|NCT00524589|20937576|P1|COMPLETED|Overall Study||0
8496214|NCT00524589|20937576|P1|STARTED|Overall Study||18
8496215|NCT00524576|20937583|P2|NOT COMPLETED|Overall Study||0
8496216|NCT00524576|20937584|P1|NOT COMPLETED|Overall Study||0
8496217|NCT00524576|20937583|P2|COMPLETED|Overall Study||47
8496218|NCT00524576|20937584|P1|COMPLETED|Overall Study||97
8496219|NCT00524576|20937583|P2|STARTED|Overall Study||47
8496220|NCT00524576|20937584|P1|STARTED|Overall Study||97
8496221|NCT00524537|20937602|P1|NOT COMPLETED|Overall Study||2574
8496222|NCT00524537|20937602|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
8496223|NCT00524537|20937602|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
8496224|NCT00524537|20937602|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
8496225|NCT00524537|20937602|P1|Discontinued|Overall Study|Discontinued from study|2811
8496226|NCT00524537|20937602|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
8496227|NCT00524511|20937618|P2|NOT COMPLETED|Overall Study||7
8496228|NCT00524511|20937619|P1|NOT COMPLETED|Overall Study||4
8496229|NCT00524511|20937618|P2|COMPLETED|Overall Study||61
8496230|NCT00524511|20937619|P1|COMPLETED|Overall Study||64
8496231|NCT00524511|20937618|P2|STARTED|Overall Study||68
8496232|NCT00524511|20937619|P1|STARTED|Overall Study||68
8496233|NCT00524485|20937627|P1|NOT COMPLETED|Overall Study||5
8496234|NCT00524485|20937627|P1|COMPLETED|Overall Study||7
8496235|NCT00524485|20937627|P1|STARTED|Overall Study||12
8496236|NCT00524472|20937639|P2|NOT COMPLETED|Overall Study||0
8496237|NCT00524472|20937640|P1|NOT COMPLETED|Overall Study||0
8496238|NCT00524472|20937639|P2|COMPLETED|Overall Study||730
8496239|NCT00524472|20937640|P1|COMPLETED|Overall Study||709
8496240|NCT00524472|20937639|P2|STARTED|Overall Study||730
8496241|NCT00524472|20937640|P1|STARTED|Overall Study||709
8496242|NCT00524459|20937656|P1|NOT COMPLETED|Overall Study||2
8496243|NCT00524459|20937656|P1|COMPLETED|Overall Study||4
8496244|NCT00524459|20937656|P1|STARTED|Overall Study||6
8496245|NCT00524420|20937666|P2|NOT COMPLETED|Overall Study||0
8496246|NCT00524420|20937667|P1|NOT COMPLETED|Overall Study||1
8496247|NCT00524420|20937666|P2|COMPLETED|Overall Study||11
8496248|NCT00524420|20937667|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
8496249|NCT00524420|20937666|P2|STARTED|Overall Study||11
8496250|NCT00524420|20937667|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
8496251|NCT00524394|20937679|P1|NOT COMPLETED|Overall Study||1
8496252|NCT00524394|20937679|P1|COMPLETED|Overall Study||1
8496253|NCT00524394|20937679|P1|STARTED|Overall Study||2
8496254|NCT00524368|20937685|P2|NOT COMPLETED|Overall Study||48
8496255|NCT00524368|20937686|P1|NOT COMPLETED|Overall Study||41
8496256|NCT00524368|20937685|P2|COMPLETED|Overall Study||248
8496257|NCT00524368|20937686|P1|COMPLETED|Overall Study||253
8496258|NCT00524368|20937685|P2|STARTED|Overall Study||296
8496259|NCT00524368|20937686|P1|STARTED|Overall Study||294
8496260|NCT00524342|20937714|P1|NOT COMPLETED|Overall Study||0
8496261|NCT00524342|20937714|P1|COMPLETED|Overall Study||7
8496262|NCT00524342|20937714|P1|STARTED|Overall Study||7
8496263|NCT00524316|20937720|P1|NOT COMPLETED|Overall Study||16
8496264|NCT00524316|20937720|P1|COMPLETED|Overall Study||0
8496265|NCT00524316|20937720|P1|STARTED|Overall Study||16
8496266|NCT00524303|20937732|P3|NOT COMPLETED|Overall Study||18
8496267|NCT00524303|20937733|P2|NOT COMPLETED|Overall Study||10
8496268|NCT00524303|20937734|P1|NOT COMPLETED|Overall Study||12
8496269|NCT00524303|20937732|P3|COMPLETED|Overall Study||15
8496270|NCT00524303|20937733|P2|COMPLETED|Overall Study||24
8496271|NCT00524303|20937734|P1|COMPLETED|Overall Study||21
8496272|NCT00524303|20937732|P3|STARTED|Overall Study||33
8496273|NCT00524303|20937733|P2|STARTED|Overall Study||34
8496274|NCT00524303|20937734|P1|STARTED|Overall Study||33
8496275|NCT00524264|20937764|P2|NOT COMPLETED|Overall Study||27
8496276|NCT00524264|20937765|P1|NOT COMPLETED|Overall Study||20
8496277|NCT00524264|20937764|P2|COMPLETED|Overall Study||57
8496278|NCT00524264|20937765|P1|COMPLETED|Overall Study||144
8496279|NCT00524264|20937764|P2|STARTED|Overall Study||84
8496280|NCT00524264|20937765|P1|STARTED|Overall Study||164
8496281|NCT00524225|20937777|P1|NOT COMPLETED|Overall Study||0
8496282|NCT00524225|20937777|P1|COMPLETED|Overall Study||3
8496283|NCT00524225|20937777|P1|STARTED|Overall Study||3
8496284|NCT00524173|20937786|P2|NOT COMPLETED|Overall Study||2
8496285|NCT00524173|20937787|P1|NOT COMPLETED|Overall Study||5
8496286|NCT00524173|20937786|P2|COMPLETED|Overall Study||13
8496287|NCT00524173|20937787|P1|COMPLETED|Overall Study||12
8496288|NCT00524173|20937786|P2|STARTED|Overall Study||15
8496289|NCT00524173|20937787|P1|STARTED|Overall Study||17
8496290|NCT00524134|20937799|P1|NOT COMPLETED|Overall Study||2
8496291|NCT00524134|20937799|P1|COMPLETED|Overall Study||4
8496292|NCT00524134|20937799|P1|STARTED|Overall Study||6
8496293|NCT00524121|20937806|P1|NOT COMPLETED|Overall Study||19
8496294|NCT00524121|20937806|P1|COMPLETED|Overall Study||3
8496295|NCT00524121|20937806|P1|STARTED|Overall Study||22
8496296|NCT00524043|20937826|P3|NOT COMPLETED|Overall Study||31
8496297|NCT00524043|20937827|P2|NOT COMPLETED|Overall Study||28
8496298|NCT00524043|20937828|P1|NOT COMPLETED|Overall Study||30
8496299|NCT00524043|20937826|P3|COMPLETED|Overall Study||35
8496300|NCT00524043|20937827|P2|COMPLETED|Overall Study||42
8496301|NCT00524043|20937828|P1|COMPLETED|Overall Study||34
8496302|NCT00524043|20937826|P3|STARTED|Overall Study||66
8496303|NCT00524043|20937827|P2|STARTED|Overall Study||70
8496304|NCT00524043|20937828|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
8496305|NCT00524030|20937850|P2|NOT COMPLETED|Overall Study||59
8496306|NCT00524030|20937851|P1|NOT COMPLETED|Overall Study||17
8496307|NCT00524030|20937850|P2|COMPLETED|Overall Study||70
8496308|NCT00524030|20937851|P1|COMPLETED|Overall Study||15
8496309|NCT00524030|20937850|P2|Completed Taper/Titration Phase|Overall Study||70
8496310|NCT00524030|20937851|P1|Completed Taper/Titration Phase|Overall Study||15
8496311|NCT00524030|20937850|P2|Completed Double-Blind Treatment Phase|Overall Study||70
8496312|NCT00524030|20937851|P1|Completed Double-Blind Treatment Phase|Overall Study||15
8496313|NCT00524030|20937850|P2|STARTED|Overall Study||129
8496314|NCT00524030|20937851|P1|STARTED|Overall Study||32
8496315|NCT00524017|20937871|P2|NOT COMPLETED|Overall Study||1
8496316|NCT00524017|20937872|P1|NOT COMPLETED|Overall Study||0
8496317|NCT00524017|20937871|P2|COMPLETED|Overall Study||5
8496318|NCT00524017|20937872|P1|COMPLETED|Overall Study||13
8496319|NCT00524017|20937871|P2|STARTED|Overall Study||6
8496320|NCT00524017|20937872|P1|STARTED|Overall Study||13
8496321|NCT00523991|20937890|P2|NOT COMPLETED|Overall Study||27
8496322|NCT00523991|20937891|P1|NOT COMPLETED|Overall Study||21
8496323|NCT00523991|20937890|P2|COMPLETED|Overall Study||211
8496324|NCT00523991|20937891|P1|COMPLETED|Overall Study||198
8496325|NCT00523991|20937890|P2|STARTED|Overall Study||238
8496326|NCT00523991|20937891|P1|STARTED|Overall Study||219
8496327|NCT00523978|20938171|P2|NOT COMPLETED|Overall Study||8
8496328|NCT00523978|20938172|P1|NOT COMPLETED|Overall Study||9
8496329|NCT00523978|20938171|P2|COMPLETED|Overall Study||79
8496330|NCT00523978|20938172|P1|COMPLETED|Overall Study||162
8496331|NCT00523978|20938171|P2|STARTED|Overall Study||87
8496332|NCT00523978|20938172|P1|STARTED|Overall Study||171
8496333|NCT00523939|20938186|P2|NOT COMPLETED|Overall Study||0
8496334|NCT00523939|20938187|P1|NOT COMPLETED|Overall Study||0
8496335|NCT00523939|20938186|P2|COMPLETED|Overall Study||2
8496336|NCT00523939|20938187|P1|COMPLETED|Overall Study||2
8496337|NCT00523939|20938186|P2|STARTED|Overall Study||2
8496338|NCT00523939|20938187|P1|STARTED|Overall Study||2
8496339|NCT00523848|20938194|P1|NOT COMPLETED|Overall Study||24
8496340|NCT00523848|20938194|P1|COMPLETED|Overall Study||22
8496341|NCT00523848|20938194|P1|Treated With Study Therapy|Overall Study||44
8496342|NCT00523848|20938194|P1|STARTED|Overall Study||46
8496343|NCT00523809|20938200|P1|NOT COMPLETED|Overall Study||0
8496344|NCT00523809|20938200|P1|COMPLETED|Overall Study||5
8496345|NCT00523809|20938200|P1|STARTED|Overall Study||5
8496346|NCT00523744|20938204|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
8496347|NCT00523744|20938204|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
8496348|NCT00523744|20938204|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
8496349|NCT00523744|20938204|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
8496350|NCT00523744|20938204|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
8496351|NCT00523744|20938204|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
8496352|NCT00523744|20938204|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
8496353|NCT00523744|20938204|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
8496354|NCT00523744|20938204|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
8496355|NCT00523718|20938223|P2|NOT COMPLETED|Overall Study||0
8496356|NCT00523718|20938224|P1|NOT COMPLETED|Overall Study||3
8496357|NCT00523718|20938223|P2|COMPLETED|Overall Study||18
8496358|NCT00523718|20938224|P1|COMPLETED|Overall Study||17
8496359|NCT00523718|20938223|P2|STARTED|Overall Study||18
8496360|NCT00523718|20938224|P1|STARTED|Overall Study||20
8496361|NCT00523705|20938238|P2|NOT COMPLETED|Overall Study||1
8496362|NCT00523705|20938239|P1|NOT COMPLETED|Overall Study||0
8496363|NCT00523705|20938238|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
8496364|NCT00523705|20938239|P1|COMPLETED|Overall Study||7
8496365|NCT00523705|20938238|P2|STARTED|Overall Study||4
8496366|NCT00523705|20938239|P1|STARTED|Overall Study||7
8496367|NCT00523640|20938251|P1|NOT COMPLETED|Overall Study||1
8496368|NCT00523640|20938251|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
8496369|NCT00523640|20938251|P1|STARTED|Overall Study||30
8496370|NCT00523614|20938259|P2|NOT COMPLETED|Overall Study||0
8496371|NCT00523614|20938260|P1|NOT COMPLETED|Overall Study||0
8496372|NCT00523614|20938259|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
8496373|NCT00523614|20938260|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
8496374|NCT00523614|20938259|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
8496375|NCT00523614|20938260|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
8496376|NCT00523549|20938268|P2|NOT COMPLETED|Overall Study||16
8496377|NCT00523549|20938269|P1|NOT COMPLETED|Overall Study||19
8496378|NCT00523549|20938268|P2|COMPLETED|Overall Study||99
8496379|NCT00523549|20938269|P1|COMPLETED|Overall Study||95
8496380|NCT00523549|20938268|P2|STARTED|Overall Study||115
8496381|NCT00523549|20938269|P1|STARTED|Overall Study||114
8496382|NCT00523419|20938287|P1|NOT COMPLETED|Overall Study||32
8496383|NCT00523419|20938287|P1|COMPLETED|Overall Study||0
8496384|NCT00523419|20938287|P1|STARTED|Overall Study||32
8496385|NCT00523367|20938297|P1|NOT COMPLETED|Overall Study||23
8496386|NCT00523367|20938297|P1|COMPLETED|Overall Study||2
8496387|NCT00523367|20938297|P1|STARTED|Overall Study||25
8496388|NCT00523341|20938303|P2|NOT COMPLETED|Overall Study||1000
8496389|NCT00523341|20938304|P1|NOT COMPLETED|Overall Study||924
8496390|NCT00523341|20938303|P2|COMPLETED|Overall Study||1343
8496391|NCT00523341|20938304|P1|COMPLETED|Overall Study||1283
8496392|NCT00523341|20938303|P2|Received Treatment|Overall Study||2343
8496393|NCT00523341|20938304|P1|Received Treatment|Overall Study||2206
8496394|NCT00523341|20938303|P2|STARTED|Overall Study||2343
8496395|NCT00523341|20938304|P1|STARTED|Overall Study||2207
8496396|NCT00523302|20938406|P2|NOT COMPLETED|Overall Study||0
8496397|NCT00523302|20938407|P1|NOT COMPLETED|Overall Study||0
8496398|NCT00523302|20938406|P2|COMPLETED|Overall Study||10
8496399|NCT00523302|20938407|P1|COMPLETED|Overall Study||10
8496400|NCT00523302|20938406|P2|STARTED|Overall Study||10
8496401|NCT00523302|20938407|P1|STARTED|Overall Study||10
8496402|NCT00523237|20938417|P1|NOT COMPLETED|Overall Study||0
8496403|NCT00523237|20938417|P1|COMPLETED|Overall Study||14
8496404|NCT00523237|20938417|P1|STARTED|Overall Study||14
8496405|NCT00522951|20938421|P2|NOT COMPLETED|Period 2||1
8496406|NCT00522951|20938422|P1|NOT COMPLETED|Period 2||2
8496407|NCT00522951|20938421|P2|COMPLETED|Period 2||75
8496408|NCT00522951|20938422|P1|COMPLETED|Period 2||84
8496409|NCT00522951|20938421|P2|Subjects Received Treatment|Period 2||75
8496410|NCT00522951|20938422|P1|Subjects Received Treatment|Period 2||84
8496411|NCT00522951|20938421|P2|STARTED|Period 2||76
8496412|NCT00522951|20938422|P1|STARTED|Period 2||86
8496413|NCT00522951|20938421|P2|NOT COMPLETED|Washout Period||2
8496414|NCT00522951|20938422|P1|NOT COMPLETED|Washout Period||0
8496415|NCT00522951|20938421|P2|COMPLETED|Washout Period||76
8496416|NCT00522951|20938422|P1|COMPLETED|Washout Period||86
8496417|NCT00522951|20938421|P2|STARTED|Washout Period||78
8496418|NCT00522951|20938422|P1|STARTED|Washout Period||86
8496419|NCT00522951|20938421|P2|NOT COMPLETED|Period 1||1
8496420|NCT00522951|20938422|P1|NOT COMPLETED|Period 1||0
8496421|NCT00522951|20938421|P2|COMPLETED|Period 1||78
8496422|NCT00522951|20938422|P1|COMPLETED|Period 1||86
8496423|NCT00522951|20938421|P2|Received Treatment|Period 1||78
8496424|NCT00522951|20938422|P1|Received Treatment|Period 1||86
8496425|NCT00522951|20938421|P2|STARTED|Period 1||79
8496426|NCT00522951|20938422|P1|STARTED|Period 1||86
8496427|NCT00522925|20938465|P3|NOT COMPLETED|Overall Study||2
8496428|NCT00522925|20938466|P2|NOT COMPLETED|Overall Study||1
8496429|NCT00522925|20938467|P1|NOT COMPLETED|Overall Study||8
8496430|NCT00522925|20938465|P3|COMPLETED|Overall Study||36
8496431|NCT00522925|20938466|P2|COMPLETED|Overall Study||38
8496432|NCT00522925|20938467|P1|COMPLETED|Overall Study||28
8496433|NCT00522925|20938465|P3|STARTED|Overall Study||38
8496434|NCT00522925|20938466|P2|STARTED|Overall Study||39
8496435|NCT00522925|20938467|P1|STARTED|Overall Study||36
8496436|NCT00522873|20938477|P2|NOT COMPLETED|Overall Study||44
8496437|NCT00522873|20938478|P1|NOT COMPLETED|Overall Study||96
8496438|NCT00522873|20938477|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
8496439|NCT00522873|20938478|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
8496440|NCT00522873|20938477|P2|Received Treatment|Overall Study||172
8496441|NCT00522873|20938478|P1|Received Treatment|Overall Study||489
8496442|NCT00522873|20938477|P2|STARTED|Overall Study||172
8496443|NCT00522873|20938478|P1|STARTED|Overall Study||490
8496444|NCT00522795|20938487|P1|NOT COMPLETED|Overall Study||0
8496445|NCT00522795|20938487|P1|COMPLETED|Overall Study||40
8496446|NCT00522795|20938487|P1|STARTED|Overall Study||40
8496447|NCT00522626|20938491|P1|NOT COMPLETED|Overall Study||7
8496448|NCT00522626|20938491|P1|COMPLETED|Overall Study||12
8496449|NCT00522626|20938491|P1|STARTED|Overall Study||19
8496450|NCT00522548|20938497|P2|NOT COMPLETED|Overall Study||4
8496451|NCT00522548|20938498|P1|NOT COMPLETED|Overall Study||2
8496452|NCT00522548|20938497|P2|COMPLETED|Overall Study||15
8496453|NCT00522548|20938498|P1|COMPLETED|Overall Study||16
8496454|NCT00522548|20938497|P2|Completed 2/2 PK Visits|Overall Study||5
8496455|NCT00522548|20938498|P1|Completed 2/2 PK Visits|Overall Study||7
8496456|NCT00522548|20938497|P2|Completed 1/2 PK Visits|Overall Study||1
8496457|NCT00522548|20938498|P1|Completed 1/2 PK Visits|Overall Study||1
8496458|NCT00522548|20938497|P2|Completed 0/2 PK Visits|Overall Study||4
8496459|NCT00522548|20938498|P1|Completed 0/2 PK Visits|Overall Study||3
8496460|NCT00522548|20938497|P2|Consented to Pharmacokinetic Study|Overall Study||10
8496461|NCT00522548|20938498|P1|Consented to Pharmacokinetic Study|Overall Study||11
8496462|NCT00522548|20938497|P2|STARTED|Overall Study||19
8496463|NCT00522548|20938498|P1|STARTED|Overall Study||18
8496464|NCT00522457|20938526|P1|NOT COMPLETED|Overall Study||18
8496465|NCT00522457|20938526|P1|COMPLETED|Overall Study||1
8496466|NCT00522457|20938526|P1|STARTED|Overall Study||19
8496467|NCT00522431|20938532|P1|NOT COMPLETED|Overall Study||11
8496468|NCT00522431|20938532|P1|COMPLETED|Overall Study||138
8496469|NCT00522431|20938532|P1|STARTED|Overall Study||149
8496470|NCT00522418|20938539|P2|NOT COMPLETED|Overall Study||58
8496471|NCT00522418|20938540|P1|NOT COMPLETED|Overall Study||57
8496472|NCT00522418|20938539|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
8496473|NCT00522418|20938540|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
8496474|NCT00522418|20938539|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
8496475|NCT00522418|20938540|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
8496476|NCT00522418|20938539|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
8496477|NCT00522418|20938540|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
8496478|NCT00522418|20938539|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
8496479|NCT00522418|20938540|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
8496480|NCT00522418|20938539|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
8496481|NCT00522418|20938540|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
8496482|NCT00522418|20938539|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
8496483|NCT00522418|20938540|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
8496484|NCT00522418|20938539|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
8496485|NCT00522418|20938540|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
8496486|NCT00522418|20938539|P2|STARTED|Overall Study||63
8496487|NCT00522418|20938540|P1|STARTED|Overall Study||59
8496488|NCT00522392|20938588|P2|NOT COMPLETED|Overall Study||13
8496489|NCT00522392|20938589|P1|NOT COMPLETED|Overall Study||8
8496490|NCT00522392|20938588|P2|COMPLETED|Overall Study||12
8496491|NCT00522392|20938589|P1|COMPLETED|Overall Study||15
8496492|NCT00522392|20938588|P2|Pts w/ QOL Assessments Complete|Overall Study||8
8496493|NCT00522392|20938589|P1|Pts w/ QOL Assessments Complete|Overall Study||12
8496494|NCT00522392|20938588|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
8496495|NCT00522392|20938589|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
8496496|NCT00522392|20938588|P2|STARTED|Overall Study||25
8496497|NCT00522392|20938589|P1|STARTED|Overall Study||23
8496498|NCT00522379|20938606|P5|NOT COMPLETED|Overall Study||27
8496499|NCT00522379|20938607|P4|NOT COMPLETED|Overall Study||14
8496500|NCT00522379|20938608|P3|NOT COMPLETED|Overall Study||22
8496501|NCT00522379|20938609|P2|NOT COMPLETED|Overall Study||23
8496502|NCT00522379|20938610|P1|NOT COMPLETED|Overall Study||22
8496503|NCT00522379|20938606|P5|COMPLETED|Overall Study||81
8496504|NCT00522379|20938607|P4|COMPLETED|Overall Study||80
8496505|NCT00522379|20938608|P3|COMPLETED|Overall Study||82
8496506|NCT00522379|20938609|P2|COMPLETED|Overall Study||84
8496507|NCT00522379|20938610|P1|COMPLETED|Overall Study||79
8496508|NCT00522379|20938606|P5|STARTED|Overall Study||108
8496509|NCT00522379|20938607|P4|STARTED|Overall Study||94
8496510|NCT00522379|20938608|P3|STARTED|Overall Study||104
8496511|NCT00522379|20938609|P2|STARTED|Overall Study||107
8496512|NCT00522379|20938610|P1|STARTED|Overall Study||101
8496513|NCT00522301|20938712|P1|NOT COMPLETED|Overall Study||6
8496514|NCT00522301|20938712|P1|COMPLETED|Overall Study||0
8496515|NCT00522301|20938712|P1|STARTED|Overall Study||6
8496516|NCT00522275|20938716|P1|NOT COMPLETED|Overall Study||170
8496517|NCT00522275|20938716|P1|COMPLETED|Overall Study||138
8496518|NCT00522275|20938716|P1|STARTED|Overall Study||308
8496519|NCT00522171|20938726|P2|NOT COMPLETED|Overall Study||0
8496520|NCT00522171|20938727|P1|NOT COMPLETED|Overall Study||0
8496521|NCT00522171|20938726|P2|COMPLETED|Overall Study||15
8496522|NCT00522171|20938727|P1|COMPLETED|Overall Study||15
8496523|NCT00522171|20938726|P2|STARTED|Overall Study||15
8496524|NCT00522171|20938727|P1|STARTED|Overall Study||15
8496525|NCT00522041|20938737|P2|NOT COMPLETED|Overall Study||12
8496526|NCT00522041|20938738|P1|NOT COMPLETED|Overall Study||17
8496527|NCT00522041|20938737|P2|COMPLETED|Overall Study||113
8496528|NCT00522041|20938738|P1|COMPLETED|Overall Study||106
8496529|NCT00522041|20938737|P2|Received Treatment|Overall Study||124
8496530|NCT00522041|20938738|P1|Received Treatment|Overall Study||123
8496531|NCT00522041|20938737|P2|STARTED|Overall Study||125
8496532|NCT00522041|20938738|P1|STARTED|Overall Study||123
8496533|NCT00521989|20938753|P5|NOT COMPLETED|Overall Study||23
8496534|NCT00521989|20938754|P4|NOT COMPLETED|Overall Study||12
8496535|NCT00521989|20938755|P3|NOT COMPLETED|Overall Study||16
8496536|NCT00521989|20938756|P2|NOT COMPLETED|Overall Study||17
8496537|NCT00521989|20938757|P1|NOT COMPLETED|Overall Study||20
8496538|NCT00521989|20938753|P5|COMPLETED|Overall Study||35
8496539|NCT00521989|20938754|P4|COMPLETED|Overall Study||42
8496540|NCT00521989|20938755|P3|COMPLETED|Overall Study||41
8496541|NCT00521989|20938756|P2|COMPLETED|Overall Study||37
8496542|NCT00521989|20938757|P1|COMPLETED|Overall Study||36
8496543|NCT00521989|20938753|P5|STARTED|Overall Study||58
8496544|NCT00521989|20938754|P4|STARTED|Overall Study||54
8496545|NCT00521989|20938755|P3|STARTED|Overall Study||57
8496546|NCT00521989|20938756|P2|STARTED|Overall Study||54
8496547|NCT00521989|20938757|P1|STARTED|Overall Study||56
8496548|NCT00521976|20938769|P1|NOT COMPLETED|Overall Study||0
8496549|NCT00521976|20938769|P1|COMPLETED|Overall Study||871
8496550|NCT00521976|20938769|P1|STARTED|Overall Study||871
8496551|NCT00521924|20938776|P2|NOT COMPLETED|Overall Study||4
8496552|NCT00521924|20938777|P1|NOT COMPLETED|Overall Study||4
8496553|NCT00521924|20938776|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
8496554|NCT00521924|20938777|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
8496555|NCT00521924|20938776|P2|STARTED|Overall Study|Subjects randomized|4
8496556|NCT00521924|20938777|P1|STARTED|Overall Study|Subjects randomized|4
8496557|NCT00521885|20938785|P2|NOT COMPLETED|Overall Study||0
8496558|NCT00521885|20938786|P1|NOT COMPLETED|Overall Study||0
8496559|NCT00521885|20938785|P2|COMPLETED|Overall Study||0
8496560|NCT00521885|20938786|P1|COMPLETED|Overall Study||0
8496561|NCT00521885|20938785|P2|STARTED|Overall Study||0
8496562|NCT00521885|20938786|P1|STARTED|Overall Study||0
8496563|NCT00521599|20938797|P3|NOT COMPLETED|Overall Study||36
8496564|NCT00521599|20938798|P2|NOT COMPLETED|Overall Study||29
8496565|NCT00521599|20938799|P1|NOT COMPLETED|Overall Study||25
8496566|NCT00521599|20938797|P3|COMPLETED|Overall Study||100
8496567|NCT00521599|20938798|P2|COMPLETED|Overall Study||239
8496568|NCT00521599|20938799|P1|COMPLETED|Overall Study||243
8496569|NCT00521599|20938797|P3|STARTED|Overall Study||136
8496570|NCT00521599|20938798|P2|STARTED|Overall Study||268
8496571|NCT00521599|20938799|P1|STARTED|Overall Study||268
8496572|NCT00521586|20938810|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
8496573|NCT00521586|20938811|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
8496574|NCT00521586|20938810|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
8496575|NCT00521586|20938811|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
8496576|NCT00521586|20938810|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
8496577|NCT00521586|20938811|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
8496578|NCT00521586|20938810|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
8496579|NCT00521586|20938811|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
8496580|NCT00521586|20938810|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
8496581|NCT00521586|20938811|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
8496582|NCT00521586|20938810|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
8496583|NCT00521586|20938811|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
8496584|NCT00521586|20938810|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
8496585|NCT00521586|20938811|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
8496586|NCT00521586|20938810|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
8496587|NCT00521586|20938811|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
8496588|NCT00521586|20938810|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
8496589|NCT00521586|20938811|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
8496590|NCT00521586|20938810|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
8496591|NCT00521586|20938811|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
8496592|NCT00521586|20938810|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
8496593|NCT00521586|20938811|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
8496594|NCT00521586|20938810|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
8496595|NCT00521586|20938811|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
8496596|NCT00521586|20938810|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
8496597|NCT00521586|20938811|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
8496598|NCT00521586|20938810|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
8496599|NCT00521586|20938811|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
8496600|NCT00521586|20938810|P2|STARTED|Initial Vaccination (Year 0)||562
8496601|NCT00521586|20938811|P1|STARTED|Initial Vaccination (Year 0)||554
8496602|NCT00521456|20938871|P2|NOT COMPLETED|Overall Study||28
8496603|NCT00521456|20938872|P1|NOT COMPLETED|Overall Study||13
8496604|NCT00521456|20938871|P2|COMPLETED|Overall Study||59
8496605|NCT00521456|20938872|P1|COMPLETED|Overall Study||163
8496606|NCT00521456|20938871|P2|STARTED|Overall Study||87
8496607|NCT00521456|20938872|P1|STARTED|Overall Study||176
8496608|NCT00521404|20938884|P1|NOT COMPLETED|Overall Study||62
8496609|NCT00521404|20938884|P1|COMPLETED|Overall Study||0
8496610|NCT00521404|20938884|P1|STARTED|Overall Study||62
8496611|NCT00521365|20938893|P1|NOT COMPLETED|Overall Study||20
8496612|NCT00521365|20938893|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
8496613|NCT00521365|20938893|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
8496614|NCT00521365|20938893|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
8496615|NCT00521365|20938893|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
8496616|NCT00521365|20938893|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
8496617|NCT00521352|20938912|P2|NOT COMPLETED|Overall Study||3
8496618|NCT00521352|20938913|P1|NOT COMPLETED|Overall Study||1
8496619|NCT00521352|20938912|P2|COMPLETED|Overall Study||10
8496620|NCT00521352|20938913|P1|COMPLETED|Overall Study||11
8496621|NCT00521352|20938912|P2|STARTED|Overall Study||13
8496622|NCT00521352|20938913|P1|STARTED|Overall Study||12
8496623|NCT00521339|20938923|P3|NOT COMPLETED|Observational Follow Up Phase||0
8496624|NCT00521339|20938924|P2|NOT COMPLETED|Observational Follow Up Phase||0
8496625|NCT00521339|20938925|P1|NOT COMPLETED|Observational Follow Up Phase||0
8496626|NCT00521339|20938923|P3|COMPLETED|Observational Follow Up Phase||4
8496627|NCT00521339|20938924|P2|COMPLETED|Observational Follow Up Phase||4
8496628|NCT00521339|20938925|P1|COMPLETED|Observational Follow Up Phase||14
8496629|NCT00521339|20938923|P3|STARTED|Observational Follow Up Phase||4
8496630|NCT00521339|20938924|P2|STARTED|Observational Follow Up Phase||4
8496631|NCT00521339|20938925|P1|STARTED|Observational Follow Up Phase||14
8496632|NCT00521339|20938923|P3|NOT COMPLETED|Treatment Extension Phase||3
8496633|NCT00521339|20938924|P2|NOT COMPLETED|Treatment Extension Phase||0
8496634|NCT00521339|20938925|P1|NOT COMPLETED|Treatment Extension Phase||0
8496635|NCT00521339|20938923|P3|COMPLETED|Treatment Extension Phase||4
8496636|NCT00521339|20938924|P2|COMPLETED|Treatment Extension Phase||4
8496637|NCT00521339|20938925|P1|COMPLETED|Treatment Extension Phase||0
8496638|NCT00521339|20938923|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
8496639|NCT00521339|20938924|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
8496640|NCT00521339|20938925|P1|STARTED|Treatment Extension Phase||0
8496641|NCT00521339|20938923|P3|NOT COMPLETED|Treatment Phase||0
8496642|NCT00521339|20938924|P2|NOT COMPLETED|Treatment Phase||0
8496643|NCT00521339|20938925|P1|NOT COMPLETED|Treatment Phase||12
8496644|NCT00521339|20938923|P3|COMPLETED|Treatment Phase||0
8496645|NCT00521339|20938924|P2|COMPLETED|Treatment Phase||0
8496646|NCT00521339|20938925|P1|COMPLETED|Treatment Phase||19
8496647|NCT00521339|20938923|P3|Received Apremilast|Treatment Phase||0
8496648|NCT00521339|20938924|P2|Received Apremilast|Treatment Phase||0
8496649|NCT00521339|20938925|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
8496650|NCT00521339|20938923|P3|STARTED|Treatment Phase||0
8496651|NCT00521339|20938924|P2|STARTED|Treatment Phase||0
8496652|NCT00521339|20938925|P1|STARTED|Treatment Phase||31
8496653|NCT00521144|20938993|P5|NOT COMPLETED|Overall Study||7
8496654|NCT00521144|20938994|P4|NOT COMPLETED|Overall Study||1
8496655|NCT00521144|20938995|P3|NOT COMPLETED|Overall Study||2
8496656|NCT00521144|20938996|P2|NOT COMPLETED|Overall Study||3
8496657|NCT00521144|20938997|P1|NOT COMPLETED|Overall Study||4
8496658|NCT00521144|20938993|P5|COMPLETED|Overall Study||0
8496659|NCT00521144|20938994|P4|COMPLETED|Overall Study||0
8496660|NCT00521144|20938995|P3|COMPLETED|Overall Study||1
8496661|NCT00521144|20938996|P2|COMPLETED|Overall Study||2
8496662|NCT00521144|20938997|P1|COMPLETED|Overall Study||2
8496663|NCT00521144|20938993|P5|STARTED|Overall Study||7
8496664|NCT00521144|20938994|P4|STARTED|Overall Study||1
8496665|NCT00521144|20938995|P3|STARTED|Overall Study||3
8496666|NCT00521144|20938996|P2|STARTED|Overall Study||5
8496667|NCT00521144|20938997|P1|STARTED|Overall Study||6
8496668|NCT00521079|20939011|P2|NOT COMPLETED|Overall Study||5
8496669|NCT00521079|20939012|P1|NOT COMPLETED|Overall Study||14
8496670|NCT00521079|20939011|P2|COMPLETED|Overall Study||97
8496671|NCT00521079|20939012|P1|COMPLETED|Overall Study||178
8496672|NCT00521079|20939011|P2|Surgical Roll-In|Overall Study||5
8496673|NCT00521079|20939012|P1|Surgical Roll-In|Overall Study||9
8496674|NCT00521079|20939011|P2|STARTED|Overall Study||102
8496675|NCT00521079|20939012|P1|STARTED|Overall Study||192
8496676|NCT00521053|20939022|P1|NOT COMPLETED|Observation Phase||68
8496677|NCT00521053|20939022|P1|COMPLETED|Observation Phase||12
8496678|NCT00521053|20939022|P1|STARTED|Observation Phase||80
8496679|NCT00521053|20939022|P1|NOT COMPLETED|Treatment Phase||0
8496680|NCT00521053|20939022|P1|COMPLETED|Treatment Phase||80
8496681|NCT00521053|20939022|P1|Received 4 Cycles of PV-10|Treatment Phase||3
8496682|NCT00521053|20939022|P1|Received 3 Cycles of PV-10|Treatment Phase||16
8496683|NCT00521053|20939022|P1|Received 2 Cycles of PV-10|Treatment Phase||26
8496684|NCT00521053|20939022|P1|Received 1 Cycle of PV-10|Treatment Phase||35
8496685|NCT00521053|20939022|P1|STARTED|Treatment Phase||80
8496686|NCT00521014|20939032|P1|NOT COMPLETED|Overall Study||1
8496687|NCT00521014|20939032|P1|COMPLETED|Overall Study||13
8496688|NCT00521014|20939032|P1|STARTED|Overall Study||14
8496689|NCT00521001|20939036|P1|NOT COMPLETED|Overall Study||1
8496690|NCT00521001|20939036|P1|COMPLETED|Overall Study||48
8496691|NCT00521001|20939036|P1|STARTED|Overall Study||49
8496692|NCT00520975|20939045|P2|NOT COMPLETED|Overall Study||48
8496693|NCT00520975|20939046|P1|NOT COMPLETED|Overall Study||48
8496694|NCT00520975|20939045|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
8496695|NCT00520975|20939046|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
8496696|NCT00520975|20939045|P2|Treated and Reported Adverse Events Data|Overall Study||45
8496697|NCT00520975|20939046|P1|Treated and Reported Adverse Events Data|Overall Study||47
8496698|NCT00520975|20939045|P2|STARTED|Overall Study||48
8496699|NCT00520975|20939046|P1|STARTED|Overall Study||48
8496700|NCT00520936|20939078|P8|NOT COMPLETED|Overall Study||1
8496701|NCT00520936|20939079|P7|NOT COMPLETED|Overall Study||4
8496702|NCT00520936|20939080|P6|NOT COMPLETED|Overall Study||0
8496703|NCT00520936|20939081|P5|NOT COMPLETED|Overall Study||1
8496704|NCT00520936|20939082|P4|NOT COMPLETED|Overall Study||0
8496705|NCT00520936|20939083|P3|NOT COMPLETED|Overall Study||2
8496706|NCT00520936|20939084|P2|NOT COMPLETED|Overall Study||4
8496707|NCT00520936|20939085|P1|NOT COMPLETED|Overall Study||0
8496708|NCT00520936|20939078|P8|COMPLETED|Overall Study||9
8496709|NCT00520936|20939079|P7|COMPLETED|Overall Study||7
8496710|NCT00520936|20939080|P6|COMPLETED|Overall Study||10
8496711|NCT00520936|20939081|P5|COMPLETED|Overall Study||5
8496712|NCT00520936|20939082|P4|COMPLETED|Overall Study||5
8496713|NCT00520936|20939083|P3|COMPLETED|Overall Study||7
8496714|NCT00520936|20939084|P2|COMPLETED|Overall Study||7
8496715|NCT00520936|20939085|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
8496716|NCT00520936|20939078|P8|STARTED|Overall Study||10
8496717|NCT00520936|20939079|P7|STARTED|Overall Study||11
8496718|NCT00520936|20939080|P6|STARTED|Overall Study||10
8496719|NCT00520936|20939081|P5|STARTED|Overall Study||6
8496720|NCT00520936|20939082|P4|STARTED|Overall Study||5
8496721|NCT00520936|20939083|P3|STARTED|Overall Study||9
8496722|NCT00520936|20939084|P2|STARTED|Overall Study||11
8496723|NCT00520936|20939085|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
8496724|NCT00520910|20939114|P2|NOT COMPLETED|Overall Study||0
8496725|NCT00520910|20939115|P1|NOT COMPLETED|Overall Study||0
8496726|NCT00520910|20939114|P2|COMPLETED|Overall Study||5
8496727|NCT00520910|20939115|P1|COMPLETED|Overall Study||5
8496728|NCT00520910|20939114|P2|STARTED|Overall Study||5
8496729|NCT00520910|20939115|P1|STARTED|Overall Study||5
8496730|NCT00520884|20939125|P4|NOT COMPLETED|Overall Study||0
8496731|NCT00520884|20939126|P3|NOT COMPLETED|Overall Study||0
8496732|NCT00520884|20939127|P2|NOT COMPLETED|Overall Study||0
8496733|NCT00520884|20939128|P1|NOT COMPLETED|Overall Study||0
8496734|NCT00520884|20939125|P4|COMPLETED|Overall Study||3
8496735|NCT00520884|20939126|P3|COMPLETED|Overall Study||2
8496736|NCT00520884|20939127|P2|COMPLETED|Overall Study||2
8496737|NCT00520884|20939128|P1|COMPLETED|Overall Study||3
8496738|NCT00520884|20939125|P4|STARTED|Overall Study||3
8496739|NCT00520884|20939126|P3|STARTED|Overall Study||2
8496740|NCT00520884|20939127|P2|STARTED|Overall Study||2
8496741|NCT00520884|20939128|P1|STARTED|Overall Study||3
8496742|NCT00520845|20939140|P1|NOT COMPLETED|Overall Study||22
8496743|NCT00520845|20939140|P1|COMPLETED|Overall Study||1
8496744|NCT00520845|20939140|P1|STARTED|Overall Study||23
8496745|NCT00520767|20939148|P1|NOT COMPLETED|Overall Study||2
8496746|NCT00520767|20939148|P1|COMPLETED|Overall Study||33
8496747|NCT00520767|20939148|P1|STARTED|Overall Study||35
8496748|NCT00520741|20939154|P2|NOT COMPLETED|Overall Study||125
8496749|NCT00520741|20939155|P1|NOT COMPLETED|Overall Study||37
8496750|NCT00520741|20939154|P2|COMPLETED|Overall Study||194
8496751|NCT00520741|20939155|P1|COMPLETED|Overall Study||69
8496752|NCT00520741|20939154|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
8496753|NCT00520741|20939155|P1|STARTED|Overall Study||106
8496754|NCT00520676|20939173|P2|NOT COMPLETED|Overall Study||103
8496755|NCT00520676|20939174|P1|NOT COMPLETED|Overall Study||101
8496756|NCT00520676|20939173|P2|COMPLETED|Overall Study||29
8496757|NCT00520676|20939174|P1|COMPLETED|Overall Study||27
8496758|NCT00520676|20939173|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
8496759|NCT00520676|20939174|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
8496760|NCT00520676|20939173|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
8496761|NCT00520676|20939174|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
8496762|NCT00520676|20939173|P2|STARTED|Overall Study||132
8496763|NCT00520676|20939174|P1|STARTED|Overall Study||128
8496764|NCT00520572|20939200|P6|NOT COMPLETED|Overall Study||2
8496765|NCT00520572|20939201|P5|NOT COMPLETED|Overall Study||12
8496766|NCT00520572|20939202|P4|NOT COMPLETED|Overall Study||14
8496767|NCT00520572|20939203|P3|NOT COMPLETED|Overall Study||15
8496768|NCT00520572|20939204|P2|NOT COMPLETED|Overall Study||14
8496769|NCT00520572|20939205|P1|NOT COMPLETED|Overall Study||12
8496770|NCT00520572|20939200|P6|COMPLETED|Overall Study|Participants completed the study.|62
8496771|NCT00520572|20939201|P5|COMPLETED|Overall Study|Participants completed the study.|53
8496772|NCT00520572|20939202|P4|COMPLETED|Overall Study|Participants completed the study.|50
8496773|NCT00520572|20939203|P3|COMPLETED|Overall Study|Participants completed the study.|49
8496774|NCT00520572|20939204|P2|COMPLETED|Overall Study|Participants completed the study.|50
8496775|NCT00520572|20939205|P1|COMPLETED|Overall Study|Participants completed the study.|52
8496776|NCT00520572|20939200|P6|STARTED|Overall Study|Participants randomised.|64
8496777|NCT00520572|20939201|P5|STARTED|Overall Study|Participants randomised.|65
8496778|NCT00520572|20939202|P4|STARTED|Overall Study|Participants randomised.|64
8496779|NCT00520572|20939203|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
8496780|NCT00520572|20939204|P2|STARTED|Overall Study|Participants randomised.|64
8496781|NCT00520572|20939205|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
8496782|NCT00520546|20939243|P1|NOT COMPLETED|Overall Study||6
8496783|NCT00520546|20939243|P1|COMPLETED|Overall Study||38
8496784|NCT00520546|20939243|P1|STARTED|Overall Study||44
8496785|NCT00520494|20939258|P1|NOT COMPLETED|Overall Study||1
8496786|NCT00520494|20939258|P1|COMPLETED|Overall Study||17
8496787|NCT00520494|20939258|P1|STARTED|Overall Study||18
8496788|NCT00520481|20939283|P2|NOT COMPLETED|Overall Study||1
8496789|NCT00520481|20939284|P1|NOT COMPLETED|Overall Study||7
8496790|NCT00520481|20939283|P2|COMPLETED|Overall Study||9
8496791|NCT00520481|20939284|P1|COMPLETED|Overall Study||24
8496792|NCT00520481|20939283|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8496793|NCT00520481|20939284|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8496794|NCT00520481|20939283|P2|STARTED|Overall Study||10
8496795|NCT00520481|20939284|P1|STARTED|Overall Study||31
8496796|NCT00520468|20939304|P1|NOT COMPLETED|Overall Study||0
8496797|NCT00520468|20939304|P1|COMPLETED|Overall Study||14
8496798|NCT00520468|20939304|P1|STARTED|Overall Study||14
8496799|NCT00520403|20939308|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
8496800|NCT00520403|20939308|P1|COMPLETED|Bevacizumab Monotherapy||0
8496801|NCT00520403|20939308|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
8496802|NCT00520403|20939308|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
8496803|NCT00520403|20939308|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
8496804|NCT00520403|20939308|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
8496805|NCT00520351|20939317|P2|NOT COMPLETED|Second Intervention||0
8496806|NCT00520351|20939318|P1|NOT COMPLETED|Second Intervention||0
8496807|NCT00520351|20939317|P2|COMPLETED|Second Intervention||14
8496808|NCT00520351|20939318|P1|COMPLETED|Second Intervention||14
8496809|NCT00520351|20939317|P2|STARTED|Second Intervention||14
8496810|NCT00520351|20939318|P1|STARTED|Second Intervention||14
8496811|NCT00520351|20939317|P2|NOT COMPLETED|First Intervention||1
8496812|NCT00520351|20939318|P1|NOT COMPLETED|First Intervention||1
8496813|NCT00520351|20939317|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
8496814|NCT00520351|20939318|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
8496815|NCT00520351|20939317|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
8496816|NCT00520351|20939318|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
8496817|NCT00520299|20939333|P3|NOT COMPLETED|Overall Study||6
8496818|NCT00520299|20939334|P2|NOT COMPLETED|Overall Study||3
8496819|NCT00520299|20939335|P1|NOT COMPLETED|Overall Study||0
8496820|NCT00520299|20939333|P3|COMPLETED|Overall Study||13
8496821|NCT00520299|20939334|P2|COMPLETED|Overall Study||3
8496822|NCT00520299|20939335|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
8496823|NCT00520299|20939333|P3|STARTED|Overall Study||19
8496824|NCT00520299|20939334|P2|STARTED|Overall Study||6
8496825|NCT00520299|20939335|P1|STARTED|Overall Study||6
8496826|NCT00520286|20939366|P2|NOT COMPLETED|Overall Study||32
8496827|NCT00520286|20939367|P1|NOT COMPLETED|Overall Study||66
8496828|NCT00520286|20939366|P2|COMPLETED|Overall Study||36
8496829|NCT00520286|20939367|P1|COMPLETED|Overall Study||76
8496830|NCT00520286|20939366|P2|STARTED|Overall Study||68
8496831|NCT00520286|20939367|P1|STARTED|Overall Study||142
8496832|NCT00520234|20939377|P2|NOT COMPLETED|Overall Study||2
8496833|NCT00520234|20939378|P1|NOT COMPLETED|Overall Study||1
8496834|NCT00520234|20939377|P2|COMPLETED|Overall Study||102
8496835|NCT00520234|20939378|P1|COMPLETED|Overall Study||117
8496836|NCT00520234|20939377|P2|STARTED|Overall Study||104
8496837|NCT00520234|20939378|P1|STARTED|Overall Study||118
8496838|NCT00520130|20939390|P2|NOT COMPLETED|Overall Study||1
8496839|NCT00520130|20939391|P1|NOT COMPLETED|Overall Study||5
8496840|NCT00520130|20939390|P2|COMPLETED|Overall Study||44
8496841|NCT00520130|20939391|P1|COMPLETED|Overall Study||39
8496842|NCT00520130|20939390|P2|STARTED|Overall Study||45
8496843|NCT00520130|20939391|P1|STARTED|Overall Study||44
8496844|NCT00520039|20939433|P2|NOT COMPLETED|Overall Study||5
8496845|NCT00520039|20939434|P1|NOT COMPLETED|Overall Study||7
8496846|NCT00520039|20939433|P2|COMPLETED|Overall Study||19
8496847|NCT00520039|20939434|P1|COMPLETED|Overall Study||21
8496848|NCT00520039|20939433|P2|STARTED|Overall Study||24
8496849|NCT00520039|20939434|P1|STARTED|Overall Study||28
8496850|NCT00520013|20939447|P3|NOT COMPLETED|Overall Study||11
8496851|NCT00520013|20939448|P2|NOT COMPLETED|Overall Study||15
8496852|NCT00520013|20939449|P1|NOT COMPLETED|Overall Study||12
8496853|NCT00520013|20939447|P3|COMPLETED|Overall Study||0
8496854|NCT00520013|20939448|P2|COMPLETED|Overall Study||10
8496855|NCT00520013|20939449|P1|COMPLETED|Overall Study||11
8496856|NCT00520013|20939447|P3|Treated|Overall Study||11
8496857|NCT00520013|20939448|P2|Treated|Overall Study||25
8496858|NCT00520013|20939449|P1|Treated|Overall Study||23
8496859|NCT00520013|20939447|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
8496860|NCT00520013|20939448|P2|STARTED|Overall Study||25
8496861|NCT00520013|20939449|P1|STARTED|Overall Study||23
8496862|NCT00519896|20939459|P1|NOT COMPLETED|Overall Study||2
8496863|NCT00519896|20939459|P1|COMPLETED|Overall Study||33
8496864|NCT00519896|20939459|P1|STARTED|Overall Study||35
8496865|NCT00519831|20939465|P1|NOT COMPLETED|Overall Study||3
8496866|NCT00519831|20939465|P1|COMPLETED|Overall Study||13
8496867|NCT00519831|20939465|P1|STARTED|Overall Study||16
8496868|NCT00519818|20939472|P1|NOT COMPLETED|Overall Study||0
8496869|NCT00519818|20939472|P1|COMPLETED|Overall Study||14
8496870|NCT00519818|20939472|P1|STARTED|Overall Study||14
8496871|NCT00519779|20939482|P2|NOT COMPLETED|Overall Study||1
8496872|NCT00519779|20939483|P1|NOT COMPLETED|Overall Study||0
8496873|NCT00519779|20939482|P2|COMPLETED|Overall Study||33
8496874|NCT00519779|20939483|P1|COMPLETED|Overall Study||34
8496875|NCT00519779|20939482|P2|STARTED|Overall Study||34
8496876|NCT00519779|20939483|P1|STARTED|Overall Study||34
8496877|NCT00519649|20939499|P1|NOT COMPLETED|Overall Study||1
8496878|NCT00519649|20939499|P1|COMPLETED|Overall Study||299
8496879|NCT00519649|20939499|P1|STARTED|Overall Study||300
8496880|NCT00519636|20939512|P4|NOT COMPLETED|Post Study Period||1
8496881|NCT00519636|20939513|P3|NOT COMPLETED|Post Study Period||0
8496882|NCT00519636|20939514|P2|NOT COMPLETED|Post Study Period||0
8496883|NCT00519636|20939515|P1|NOT COMPLETED|Post Study Period||0
8496884|NCT00519636|20939512|P4|COMPLETED|Post Study Period||85
8496885|NCT00519636|20939513|P3|COMPLETED|Post Study Period||74
8496886|NCT00519636|20939514|P2|COMPLETED|Post Study Period||71
8496887|NCT00519636|20939515|P1|COMPLETED|Post Study Period||69
8496888|NCT00519636|20939512|P4|STARTED|Post Study Period||86
8496889|NCT00519636|20939513|P3|STARTED|Post Study Period||74
8496890|NCT00519636|20939514|P2|STARTED|Post Study Period||71
8496891|NCT00519636|20939515|P1|STARTED|Post Study Period||69
8496892|NCT00519636|20939512|P4|NOT COMPLETED|Treatment Period 2||2
8496893|NCT00519636|20939513|P3|NOT COMPLETED|Treatment Period 2||1
8496894|NCT00519636|20939514|P2|NOT COMPLETED|Treatment Period 2||1
8496895|NCT00519636|20939515|P1|NOT COMPLETED|Treatment Period 2||0
8496896|NCT00519636|20939512|P4|COMPLETED|Treatment Period 2||86
8496897|NCT00519636|20939513|P3|COMPLETED|Treatment Period 2||74
8496898|NCT00519636|20939514|P2|COMPLETED|Treatment Period 2||71
8496899|NCT00519636|20939515|P1|COMPLETED|Treatment Period 2||69
8496900|NCT00519636|20939512|P4|STARTED|Treatment Period 2||88
8496901|NCT00519636|20939513|P3|STARTED|Treatment Period 2||75
8496902|NCT00519636|20939514|P2|STARTED|Treatment Period 2||72
8496903|NCT00519636|20939515|P1|STARTED|Treatment Period 2||69
8496904|NCT00519636|20939512|P4|NOT COMPLETED|Washout Period||5
8496905|NCT00519636|20939513|P3|NOT COMPLETED|Washout Period||14
8496906|NCT00519636|20939514|P2|NOT COMPLETED|Washout Period||14
8496907|NCT00519636|20939515|P1|NOT COMPLETED|Washout Period||20
8496908|NCT00519636|20939512|P4|COMPLETED|Washout Period||88
8496909|NCT00519636|20939513|P3|COMPLETED|Washout Period||75
8496910|NCT00519636|20939514|P2|COMPLETED|Washout Period||72
8496911|NCT00519636|20939515|P1|COMPLETED|Washout Period||69
8496912|NCT00519636|20939512|P4|STARTED|Washout Period||93
8496913|NCT00519636|20939513|P3|STARTED|Washout Period||89
8496914|NCT00519636|20939514|P2|STARTED|Washout Period||86
8496915|NCT00519636|20939515|P1|STARTED|Washout Period||89
8496916|NCT00519636|20939512|P4|NOT COMPLETED|Treatment Period 1||0
8496917|NCT00519636|20939513|P3|NOT COMPLETED|Treatment Period 1||1
8496918|NCT00519636|20939514|P2|NOT COMPLETED|Treatment Period 1||0
8496919|NCT00519636|20939515|P1|NOT COMPLETED|Treatment Period 1||2
8496920|NCT00519636|20939512|P4|COMPLETED|Treatment Period 1||93
8496921|NCT00519636|20939513|P3|COMPLETED|Treatment Period 1||89
8496922|NCT00519636|20939514|P2|COMPLETED|Treatment Period 1||86
8496923|NCT00519636|20939515|P1|COMPLETED|Treatment Period 1||89
8496924|NCT00519636|20939512|P4|STARTED|Treatment Period 1||93
8496925|NCT00519636|20939513|P3|STARTED|Treatment Period 1||90
8496926|NCT00519636|20939514|P2|STARTED|Treatment Period 1||86
8496927|NCT00519636|20939515|P1|STARTED|Treatment Period 1||91
8496928|NCT00519623|20939545|P1|NOT COMPLETED|Overall Study||1
8496929|NCT00519623|20939545|P1|COMPLETED|Overall Study||8
8496930|NCT00519623|20939545|P1|STARTED|Overall Study||9
8496931|NCT00519584|20939554|P4|NOT COMPLETED|Overall Study||0
8496932|NCT00519584|20939555|P3|NOT COMPLETED|Overall Study||0
8496933|NCT00519584|20939556|P2|NOT COMPLETED|Overall Study||0
8496934|NCT00519584|20939557|P1|NOT COMPLETED|Overall Study||0
8496935|NCT00519584|20939554|P4|COMPLETED|Overall Study||56
8496936|NCT00519584|20939555|P3|COMPLETED|Overall Study||54
8496937|NCT00519584|20939556|P2|COMPLETED|Overall Study||54
8496938|NCT00519584|20939557|P1|COMPLETED|Overall Study||54
8496939|NCT00519584|20939554|P4|STARTED|Overall Study||56
8496940|NCT00519584|20939555|P3|STARTED|Overall Study||54
8496941|NCT00519584|20939556|P2|STARTED|Overall Study||54
8496942|NCT00519584|20939557|P1|STARTED|Overall Study||54
8496943|NCT00519532|20939579|P1|NOT COMPLETED|Overall Study||18
8496944|NCT00519532|20939579|P1|COMPLETED|Overall Study||66
8496945|NCT00519532|20939579|P1|STARTED|Overall Study||84
8496946|NCT00519428|20939589|P3|NOT COMPLETED|Overall Study||25
8496947|NCT00519428|20939590|P2|NOT COMPLETED|Overall Study||15
8496948|NCT00519428|20939591|P1|NOT COMPLETED|Overall Study||21
8496949|NCT00519428|20939589|P3|COMPLETED|Overall Study||58
8496950|NCT00519428|20939590|P2|COMPLETED|Overall Study||69
8496951|NCT00519428|20939591|P1|COMPLETED|Overall Study||57
8496952|NCT00519428|20939589|P3|STARTED|Overall Study||83
8496953|NCT00519428|20939590|P2|STARTED|Overall Study||84
8496954|NCT00519428|20939591|P1|STARTED|Overall Study||78
8496955|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 4||0
8496956|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 4||0
8496957|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 4||0
8496958|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 4||0
8496959|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 4||0
8496960|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 4||0
8496961|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 4||0
8496962|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 4||0
8496963|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 4||0
8496964|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 4||0
8496965|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 4||0
8496966|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 4||0
8496967|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 4||0
8496968|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 4||1
8496969|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 4||0
8496970|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 4||0
8496971|NCT00519376|20939611|P16|COMPLETED|Treatment Period 4||1
8496972|NCT00519376|20939612|P15|COMPLETED|Treatment Period 4||1
8496973|NCT00519376|20939613|P14|COMPLETED|Treatment Period 4||1
8496974|NCT00519376|20939614|P13|COMPLETED|Treatment Period 4||0
8496975|NCT00519376|20939615|P12|COMPLETED|Treatment Period 4||1
8496976|NCT00519376|20939616|P11|COMPLETED|Treatment Period 4||1
8496977|NCT00519376|20939617|P10|COMPLETED|Treatment Period 4||1
8496978|NCT00519376|20939618|P9|COMPLETED|Treatment Period 4||1
8496979|NCT00519376|20939619|P8|COMPLETED|Treatment Period 4||1
8496980|NCT00519376|20939620|P7|COMPLETED|Treatment Period 4||1
8496981|NCT00519376|20939621|P6|COMPLETED|Treatment Period 4||1
8496982|NCT00519376|20939622|P5|COMPLETED|Treatment Period 4||1
8496983|NCT00519376|20939623|P4|COMPLETED|Treatment Period 4||2
8496984|NCT00519376|20939624|P3|COMPLETED|Treatment Period 4||1
8496985|NCT00519376|20939625|P2|COMPLETED|Treatment Period 4||2
8496986|NCT00519376|20939626|P1|COMPLETED|Treatment Period 4||2
8496987|NCT00519376|20939611|P16|STARTED|Treatment Period 4||1
8496988|NCT00519376|20939612|P15|STARTED|Treatment Period 4||1
8496989|NCT00519376|20939613|P14|STARTED|Treatment Period 4||1
8496990|NCT00519376|20939614|P13|STARTED|Treatment Period 4||0
8496991|NCT00519376|20939615|P12|STARTED|Treatment Period 4||1
8496992|NCT00519376|20939616|P11|STARTED|Treatment Period 4||1
8496993|NCT00519376|20939617|P10|STARTED|Treatment Period 4||1
8496994|NCT00519376|20939618|P9|STARTED|Treatment Period 4||1
8496995|NCT00519376|20939619|P8|STARTED|Treatment Period 4||1
8496996|NCT00519376|20939620|P7|STARTED|Treatment Period 4||1
8496997|NCT00519376|20939621|P6|STARTED|Treatment Period 4||1
8496998|NCT00519376|20939622|P5|STARTED|Treatment Period 4||1
8496999|NCT00519376|20939623|P4|STARTED|Treatment Period 4||2
8497000|NCT00519376|20939624|P3|STARTED|Treatment Period 4||2
8497001|NCT00519376|20939625|P2|STARTED|Treatment Period 4||2
8497002|NCT00519376|20939626|P1|STARTED|Treatment Period 4||2
8497003|NCT00519376|20939611|P16|NOT COMPLETED|Washout Period 3||0
8497004|NCT00519376|20939612|P15|NOT COMPLETED|Washout Period 3||0
8497005|NCT00519376|20939613|P14|NOT COMPLETED|Washout Period 3||0
8497006|NCT00519376|20939614|P13|NOT COMPLETED|Washout Period 3||0
8497007|NCT00519376|20939615|P12|NOT COMPLETED|Washout Period 3||0
8497008|NCT00519376|20939616|P11|NOT COMPLETED|Washout Period 3||0
8497009|NCT00519376|20939617|P10|NOT COMPLETED|Washout Period 3||0
8497010|NCT00519376|20939618|P9|NOT COMPLETED|Washout Period 3||0
8497011|NCT00519376|20939619|P8|NOT COMPLETED|Washout Period 3||0
8497012|NCT00519376|20939620|P7|NOT COMPLETED|Washout Period 3||0
8497013|NCT00519376|20939621|P6|NOT COMPLETED|Washout Period 3||0
8497014|NCT00519376|20939622|P5|NOT COMPLETED|Washout Period 3||0
8497015|NCT00519376|20939623|P4|NOT COMPLETED|Washout Period 3||0
8497016|NCT00519376|20939624|P3|NOT COMPLETED|Washout Period 3||0
8497017|NCT00519376|20939625|P2|NOT COMPLETED|Washout Period 3||0
8497018|NCT00519376|20939626|P1|NOT COMPLETED|Washout Period 3||0
8497019|NCT00519376|20939611|P16|COMPLETED|Washout Period 3||1
8497020|NCT00519376|20939612|P15|COMPLETED|Washout Period 3||1
8497021|NCT00519376|20939613|P14|COMPLETED|Washout Period 3||1
8497022|NCT00519376|20939614|P13|COMPLETED|Washout Period 3||0
8497023|NCT00519376|20939615|P12|COMPLETED|Washout Period 3||1
8497024|NCT00519376|20939616|P11|COMPLETED|Washout Period 3||1
8497025|NCT00519376|20939617|P10|COMPLETED|Washout Period 3||1
8497026|NCT00519376|20939618|P9|COMPLETED|Washout Period 3||1
8497027|NCT00519376|20939619|P8|COMPLETED|Washout Period 3||1
8497028|NCT00519376|20939620|P7|COMPLETED|Washout Period 3||1
8497029|NCT00519376|20939621|P6|COMPLETED|Washout Period 3||1
8497030|NCT00519376|20939622|P5|COMPLETED|Washout Period 3||1
8497031|NCT00519376|20939623|P4|COMPLETED|Washout Period 3||2
8497032|NCT00519376|20939624|P3|COMPLETED|Washout Period 3||2
8497033|NCT00519376|20939625|P2|COMPLETED|Washout Period 3||2
8497034|NCT00519376|20939626|P1|COMPLETED|Washout Period 3||2
8497035|NCT00519376|20939611|P16|STARTED|Washout Period 3||1
8497036|NCT00519376|20939612|P15|STARTED|Washout Period 3||1
8497037|NCT00519376|20939613|P14|STARTED|Washout Period 3||1
8497038|NCT00519376|20939614|P13|STARTED|Washout Period 3||0
8497039|NCT00519376|20939615|P12|STARTED|Washout Period 3||1
8497040|NCT00519376|20939616|P11|STARTED|Washout Period 3||1
8497041|NCT00519376|20939617|P10|STARTED|Washout Period 3||1
8497042|NCT00519376|20939618|P9|STARTED|Washout Period 3||1
8497043|NCT00519376|20939619|P8|STARTED|Washout Period 3||1
8497044|NCT00519376|20939620|P7|STARTED|Washout Period 3||1
8497045|NCT00519376|20939621|P6|STARTED|Washout Period 3||1
8497046|NCT00519376|20939622|P5|STARTED|Washout Period 3||1
8497047|NCT00519376|20939623|P4|STARTED|Washout Period 3||2
8497048|NCT00519376|20939624|P3|STARTED|Washout Period 3||2
8497049|NCT00519376|20939625|P2|STARTED|Washout Period 3||2
8497050|NCT00519376|20939626|P1|STARTED|Washout Period 3||2
8497051|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 3||0
8497052|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 3||0
8497053|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 3||0
8497054|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 3||0
8497055|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 3||0
8497056|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 3||0
8497057|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 3||0
8497058|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 3||0
8497059|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 3||0
8497060|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 3||0
8497061|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 3||0
8497062|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 3||0
8497063|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 3||0
8497064|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 3||0
8497065|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 3||0
8497066|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 3||0
8497067|NCT00519376|20939611|P16|COMPLETED|Treatment Period 3||1
8497068|NCT00519376|20939612|P15|COMPLETED|Treatment Period 3||1
8497069|NCT00519376|20939613|P14|COMPLETED|Treatment Period 3||1
8497070|NCT00519376|20939614|P13|COMPLETED|Treatment Period 3||0
8497071|NCT00519376|20939615|P12|COMPLETED|Treatment Period 3||1
8497072|NCT00519376|20939616|P11|COMPLETED|Treatment Period 3||1
8497073|NCT00519376|20939617|P10|COMPLETED|Treatment Period 3||1
8497074|NCT00519376|20939618|P9|COMPLETED|Treatment Period 3||1
8497075|NCT00519376|20939619|P8|COMPLETED|Treatment Period 3||1
8497076|NCT00519376|20939620|P7|COMPLETED|Treatment Period 3||1
8497077|NCT00519376|20939621|P6|COMPLETED|Treatment Period 3||1
8497078|NCT00519376|20939622|P5|COMPLETED|Treatment Period 3||1
8497079|NCT00519376|20939623|P4|COMPLETED|Treatment Period 3||2
8497080|NCT00519376|20939624|P3|COMPLETED|Treatment Period 3||2
8497081|NCT00519376|20939625|P2|COMPLETED|Treatment Period 3||2
8497082|NCT00519376|20939626|P1|COMPLETED|Treatment Period 3||2
8497083|NCT00519376|20939611|P16|STARTED|Treatment Period 3||1
8497084|NCT00519376|20939612|P15|STARTED|Treatment Period 3||1
8497085|NCT00519376|20939613|P14|STARTED|Treatment Period 3||1
8497086|NCT00519376|20939614|P13|STARTED|Treatment Period 3||0
8497087|NCT00519376|20939615|P12|STARTED|Treatment Period 3||1
8497088|NCT00519376|20939616|P11|STARTED|Treatment Period 3||1
8497089|NCT00519376|20939617|P10|STARTED|Treatment Period 3||1
8497090|NCT00519376|20939618|P9|STARTED|Treatment Period 3||1
8497091|NCT00519376|20939619|P8|STARTED|Treatment Period 3||1
8497092|NCT00519376|20939620|P7|STARTED|Treatment Period 3||1
8497093|NCT00519376|20939621|P6|STARTED|Treatment Period 3||1
8497094|NCT00519376|20939622|P5|STARTED|Treatment Period 3||1
8497095|NCT00519376|20939623|P4|STARTED|Treatment Period 3||2
8497096|NCT00519376|20939624|P3|STARTED|Treatment Period 3||2
8497097|NCT00519376|20939625|P2|STARTED|Treatment Period 3||2
8497098|NCT00519376|20939626|P1|STARTED|Treatment Period 3||2
8497099|NCT00519376|20939611|P16|NOT COMPLETED|Washout Period 2||0
8497100|NCT00519376|20939612|P15|NOT COMPLETED|Washout Period 2||0
8497101|NCT00519376|20939613|P14|NOT COMPLETED|Washout Period 2||0
8497102|NCT00519376|20939614|P13|NOT COMPLETED|Washout Period 2||0
8497103|NCT00519376|20939615|P12|NOT COMPLETED|Washout Period 2||0
8497104|NCT00519376|20939616|P11|NOT COMPLETED|Washout Period 2||0
8497105|NCT00519376|20939617|P10|NOT COMPLETED|Washout Period 2||0
8497106|NCT00519376|20939618|P9|NOT COMPLETED|Washout Period 2||0
8497107|NCT00519376|20939619|P8|NOT COMPLETED|Washout Period 2||0
8497108|NCT00519376|20939620|P7|NOT COMPLETED|Washout Period 2||0
8497109|NCT00519376|20939621|P6|NOT COMPLETED|Washout Period 2||0
8497110|NCT00519376|20939622|P5|NOT COMPLETED|Washout Period 2||0
8497111|NCT00519376|20939623|P4|NOT COMPLETED|Washout Period 2||0
8497112|NCT00519376|20939624|P3|NOT COMPLETED|Washout Period 2||0
8497113|NCT00519376|20939625|P2|NOT COMPLETED|Washout Period 2||0
8497114|NCT00519376|20939626|P1|NOT COMPLETED|Washout Period 2||0
8497115|NCT00519376|20939611|P16|COMPLETED|Washout Period 2||1
8497116|NCT00519376|20939612|P15|COMPLETED|Washout Period 2||1
8497117|NCT00519376|20939613|P14|COMPLETED|Washout Period 2||1
8497118|NCT00519376|20939614|P13|COMPLETED|Washout Period 2||0
8497119|NCT00519376|20939615|P12|COMPLETED|Washout Period 2||1
8497120|NCT00519376|20939616|P11|COMPLETED|Washout Period 2||1
8497121|NCT00519376|20939617|P10|COMPLETED|Washout Period 2||1
8497122|NCT00519376|20939618|P9|COMPLETED|Washout Period 2||1
8497123|NCT00519376|20939619|P8|COMPLETED|Washout Period 2||1
8497124|NCT00519376|20939620|P7|COMPLETED|Washout Period 2||1
8497125|NCT00519376|20939621|P6|COMPLETED|Washout Period 2||1
8497126|NCT00519376|20939622|P5|COMPLETED|Washout Period 2||1
8497127|NCT00519376|20939623|P4|COMPLETED|Washout Period 2||2
8497128|NCT00519376|20939624|P3|COMPLETED|Washout Period 2||2
8497129|NCT00519376|20939625|P2|COMPLETED|Washout Period 2||2
8497130|NCT00519376|20939626|P1|COMPLETED|Washout Period 2||2
8497131|NCT00519376|20939611|P16|STARTED|Washout Period 2||1
8497132|NCT00519376|20939612|P15|STARTED|Washout Period 2||1
8497133|NCT00519376|20939613|P14|STARTED|Washout Period 2||1
8497134|NCT00519376|20939614|P13|STARTED|Washout Period 2||0
8497135|NCT00519376|20939615|P12|STARTED|Washout Period 2||1
8497136|NCT00519376|20939616|P11|STARTED|Washout Period 2||1
8497137|NCT00519376|20939617|P10|STARTED|Washout Period 2||1
8497138|NCT00519376|20939618|P9|STARTED|Washout Period 2||1
8497139|NCT00519376|20939619|P8|STARTED|Washout Period 2||1
8497140|NCT00519376|20939620|P7|STARTED|Washout Period 2||1
8497141|NCT00519376|20939621|P6|STARTED|Washout Period 2||1
8497142|NCT00519376|20939622|P5|STARTED|Washout Period 2||1
8497143|NCT00519376|20939623|P4|STARTED|Washout Period 2||2
8497144|NCT00519376|20939624|P3|STARTED|Washout Period 2||2
8497145|NCT00519376|20939625|P2|STARTED|Washout Period 2||2
8497146|NCT00519376|20939626|P1|STARTED|Washout Period 2||2
8497147|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 2||0
8497148|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 2||0
8497149|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 2||0
8497150|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 2||1
8497151|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 2||0
8497152|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 2||0
8497153|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 2||0
8497154|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 2||0
8497155|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 2||0
8497156|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 2||0
8497157|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 2||0
8497158|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 2||0
8497159|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 2||0
8497160|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 2||0
8497161|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 2||0
8497162|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 2||0
8497163|NCT00519376|20939611|P16|COMPLETED|Treatment Period 2||1
8497164|NCT00519376|20939612|P15|COMPLETED|Treatment Period 2||1
8497165|NCT00519376|20939613|P14|COMPLETED|Treatment Period 2||1
8497166|NCT00519376|20939614|P13|COMPLETED|Treatment Period 2||0
8497167|NCT00519376|20939615|P12|COMPLETED|Treatment Period 2||1
8497168|NCT00519376|20939616|P11|COMPLETED|Treatment Period 2||1
8497169|NCT00519376|20939617|P10|COMPLETED|Treatment Period 2||1
8497170|NCT00519376|20939618|P9|COMPLETED|Treatment Period 2||1
8497171|NCT00519376|20939619|P8|COMPLETED|Treatment Period 2||1
8497172|NCT00519376|20939620|P7|COMPLETED|Treatment Period 2||1
8497173|NCT00519376|20939621|P6|COMPLETED|Treatment Period 2||1
8497174|NCT00519376|20939622|P5|COMPLETED|Treatment Period 2||1
8497175|NCT00519376|20939623|P4|COMPLETED|Treatment Period 2||2
8497176|NCT00519376|20939624|P3|COMPLETED|Treatment Period 2||2
8497177|NCT00519376|20939625|P2|COMPLETED|Treatment Period 2||2
8497178|NCT00519376|20939626|P1|COMPLETED|Treatment Period 2||2
8497179|NCT00519376|20939611|P16|STARTED|Treatment Period 2||1
8497180|NCT00519376|20939612|P15|STARTED|Treatment Period 2||1
8497181|NCT00519376|20939613|P14|STARTED|Treatment Period 2||1
8497182|NCT00519376|20939614|P13|STARTED|Treatment Period 2||1
8497183|NCT00519376|20939615|P12|STARTED|Treatment Period 2||1
8497184|NCT00519376|20939616|P11|STARTED|Treatment Period 2||1
8497185|NCT00519376|20939617|P10|STARTED|Treatment Period 2||1
8497186|NCT00519376|20939618|P9|STARTED|Treatment Period 2||1
8497187|NCT00519376|20939619|P8|STARTED|Treatment Period 2||1
8497188|NCT00519376|20939620|P7|STARTED|Treatment Period 2||1
8497189|NCT00519376|20939621|P6|STARTED|Treatment Period 2||1
8497190|NCT00519376|20939622|P5|STARTED|Treatment Period 2||1
8497191|NCT00519376|20939623|P4|STARTED|Treatment Period 2||2
8497192|NCT00519376|20939624|P3|STARTED|Treatment Period 2||2
8497193|NCT00519376|20939625|P2|STARTED|Treatment Period 2||2
8497194|NCT00519376|20939626|P1|STARTED|Treatment Period 2||2
8497195|NCT00519376|20939611|P16|NOT COMPLETED|Washout Period 1||0
8497196|NCT00519376|20939612|P15|NOT COMPLETED|Washout Period 1||0
8497197|NCT00519376|20939613|P14|NOT COMPLETED|Washout Period 1||0
8497198|NCT00519376|20939614|P13|NOT COMPLETED|Washout Period 1||0
8497199|NCT00519376|20939615|P12|NOT COMPLETED|Washout Period 1||0
8497200|NCT00519376|20939616|P11|NOT COMPLETED|Washout Period 1||0
8497201|NCT00519376|20939617|P10|NOT COMPLETED|Washout Period 1||0
8497202|NCT00519376|20939618|P9|NOT COMPLETED|Washout Period 1||0
8497203|NCT00519376|20939619|P8|NOT COMPLETED|Washout Period 1||0
8497204|NCT00519376|20939620|P7|NOT COMPLETED|Washout Period 1||0
8497205|NCT00519376|20939621|P6|NOT COMPLETED|Washout Period 1||0
8497206|NCT00519376|20939622|P5|NOT COMPLETED|Washout Period 1||0
8497207|NCT00519376|20939623|P4|NOT COMPLETED|Washout Period 1||0
8497208|NCT00519376|20939624|P3|NOT COMPLETED|Washout Period 1||0
8497209|NCT00519376|20939625|P2|NOT COMPLETED|Washout Period 1||0
8497210|NCT00519376|20939626|P1|NOT COMPLETED|Washout Period 1||0
8497211|NCT00519376|20939611|P16|COMPLETED|Washout Period 1||1
8497212|NCT00519376|20939612|P15|COMPLETED|Washout Period 1||1
8497213|NCT00519376|20939613|P14|COMPLETED|Washout Period 1||1
8497214|NCT00519376|20939614|P13|COMPLETED|Washout Period 1||1
8497215|NCT00519376|20939615|P12|COMPLETED|Washout Period 1||1
8497216|NCT00519376|20939616|P11|COMPLETED|Washout Period 1||1
8497217|NCT00519376|20939617|P10|COMPLETED|Washout Period 1||1
8497218|NCT00519376|20939618|P9|COMPLETED|Washout Period 1||1
8497219|NCT00519376|20939619|P8|COMPLETED|Washout Period 1||1
8497220|NCT00519376|20939620|P7|COMPLETED|Washout Period 1||1
8497221|NCT00519376|20939621|P6|COMPLETED|Washout Period 1||1
8497222|NCT00519376|20939622|P5|COMPLETED|Washout Period 1||1
8497223|NCT00519376|20939623|P4|COMPLETED|Washout Period 1||2
8497224|NCT00519376|20939624|P3|COMPLETED|Washout Period 1||2
8497225|NCT00519376|20939625|P2|COMPLETED|Washout Period 1||2
8497226|NCT00519376|20939626|P1|COMPLETED|Washout Period 1||2
8497227|NCT00519376|20939611|P16|STARTED|Washout Period 1||1
8497228|NCT00519376|20939612|P15|STARTED|Washout Period 1||1
8497229|NCT00519376|20939613|P14|STARTED|Washout Period 1||1
8497230|NCT00519376|20939614|P13|STARTED|Washout Period 1||1
8497231|NCT00519376|20939615|P12|STARTED|Washout Period 1||1
8497232|NCT00519376|20939616|P11|STARTED|Washout Period 1||1
8497233|NCT00519376|20939617|P10|STARTED|Washout Period 1||1
8497234|NCT00519376|20939618|P9|STARTED|Washout Period 1||1
8497235|NCT00519376|20939619|P8|STARTED|Washout Period 1||1
8497236|NCT00519376|20939620|P7|STARTED|Washout Period 1||1
8497237|NCT00519376|20939621|P6|STARTED|Washout Period 1||1
8497238|NCT00519376|20939622|P5|STARTED|Washout Period 1||1
8497239|NCT00519376|20939623|P4|STARTED|Washout Period 1||2
8497240|NCT00519376|20939624|P3|STARTED|Washout Period 1||2
8497241|NCT00519376|20939625|P2|STARTED|Washout Period 1||2
8497242|NCT00519376|20939626|P1|STARTED|Washout Period 1||2
8497243|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 1||0
8497244|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 1||0
8497245|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 1||0
8497246|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 1||0
8497247|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 1||0
8497248|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 1||0
8497249|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 1||0
8497250|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 1||0
8497251|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 1||0
8497252|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 1||0
8497253|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 1||0
8497254|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 1||0
8497255|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 1||0
8497256|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 1||0
8497257|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 1||0
8497258|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 1||0
8497259|NCT00519376|20939611|P16|COMPLETED|Treatment Period 1||1
8497260|NCT00519376|20939612|P15|COMPLETED|Treatment Period 1||1
8497261|NCT00519376|20939613|P14|COMPLETED|Treatment Period 1||1
8497262|NCT00519376|20939614|P13|COMPLETED|Treatment Period 1||1
8497263|NCT00519376|20939615|P12|COMPLETED|Treatment Period 1||1
8497264|NCT00519376|20939616|P11|COMPLETED|Treatment Period 1||1
8497265|NCT00519376|20939617|P10|COMPLETED|Treatment Period 1||1
8497266|NCT00519376|20939618|P9|COMPLETED|Treatment Period 1||1
8497267|NCT00519376|20939619|P8|COMPLETED|Treatment Period 1||1
8497268|NCT00519376|20939620|P7|COMPLETED|Treatment Period 1||1
8497269|NCT00519376|20939621|P6|COMPLETED|Treatment Period 1||1
8497270|NCT00519376|20939622|P5|COMPLETED|Treatment Period 1||1
8497271|NCT00519376|20939623|P4|COMPLETED|Treatment Period 1||2
8497272|NCT00519376|20939624|P3|COMPLETED|Treatment Period 1||2
8497273|NCT00519376|20939625|P2|COMPLETED|Treatment Period 1||2
8497274|NCT00519376|20939626|P1|COMPLETED|Treatment Period 1||2
8497275|NCT00519376|20939611|P16|STARTED|Treatment Period 1||1
8497276|NCT00519376|20939612|P15|STARTED|Treatment Period 1||1
8497277|NCT00519376|20939613|P14|STARTED|Treatment Period 1||1
8497278|NCT00519376|20939614|P13|STARTED|Treatment Period 1||1
8497279|NCT00519376|20939615|P12|STARTED|Treatment Period 1||1
8497280|NCT00519376|20939616|P11|STARTED|Treatment Period 1||1
8497281|NCT00519376|20939617|P10|STARTED|Treatment Period 1||1
8497282|NCT00519376|20939618|P9|STARTED|Treatment Period 1||1
8497283|NCT00519376|20939619|P8|STARTED|Treatment Period 1||1
8497284|NCT00519376|20939620|P7|STARTED|Treatment Period 1||1
8497285|NCT00519376|20939621|P6|STARTED|Treatment Period 1||1
8497286|NCT00519376|20939622|P5|STARTED|Treatment Period 1||1
8497287|NCT00519376|20939623|P4|STARTED|Treatment Period 1||2
8497288|NCT00519376|20939624|P3|STARTED|Treatment Period 1||2
8497289|NCT00519376|20939625|P2|STARTED|Treatment Period 1||2
8497290|NCT00519376|20939626|P1|STARTED|Treatment Period 1||2
8497291|NCT00519285|20939750|P2|NOT COMPLETED|Overall Study||612
8497292|NCT00519285|20939751|P1|NOT COMPLETED|Overall Study||612
8497293|NCT00519285|20939750|P2|COMPLETED|Overall Study||0
8497294|NCT00519285|20939751|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
8497295|NCT00519285|20939750|P2|Still Treated at Cut-off Date|Overall Study||2
8497296|NCT00519285|20939751|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
8497297|NCT00519285|20939750|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
8497298|NCT00519285|20939751|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
8497299|NCT00519285|20939750|P2|STARTED|Overall Study|Randomized|612
8497300|NCT00519285|20939751|P1|STARTED|Overall Study|Randomized|612
8497301|NCT00519194|20939777|P1|NOT COMPLETED|Overall Study||21
8497302|NCT00519194|20939777|P1|COMPLETED|Overall Study||91
8497303|NCT00519194|20939777|P1|STARTED|Overall Study||112
8497304|NCT00519090|20939783|P2|NOT COMPLETED|Overall Study||0
8497305|NCT00519090|20939784|P1|NOT COMPLETED|Overall Study||0
8497306|NCT00519090|20939783|P2|COMPLETED|Overall Study||4
8497307|NCT00519090|20939784|P1|COMPLETED|Overall Study||2
8497308|NCT00519090|20939783|P2|STARTED|Overall Study||4
8497309|NCT00519090|20939784|P1|STARTED|Overall Study||2
8497310|NCT00519077|20939792|P1|NOT COMPLETED|Overall Study||8
8497311|NCT00519077|20939792|P1|COMPLETED|Overall Study||36
8497312|NCT00519077|20939792|P1|STARTED|Overall Study||44
8497313|NCT00518986|20939799|P2|NOT COMPLETED|Overall Study||26
8497314|NCT00518986|20939800|P1|NOT COMPLETED|Overall Study||26
8497315|NCT00518986|20939799|P2|COMPLETED|Overall Study||98
8497316|NCT00518986|20939800|P1|COMPLETED|Overall Study||99
8497317|NCT00518986|20939799|P2|STARTED|Overall Study||124
8497318|NCT00518986|20939800|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
8497319|NCT00518973|20939926|P2|NOT COMPLETED|Overall Study||2
8497320|NCT00518973|20939927|P1|NOT COMPLETED|Overall Study||3
8497321|NCT00518973|20939926|P2|COMPLETED|Overall Study||4
8497322|NCT00518973|20939927|P1|COMPLETED|Overall Study||6
8497323|NCT00518973|20939926|P2|STARTED|Overall Study||6
8497324|NCT00518973|20939927|P1|STARTED|Overall Study||9
8497325|NCT00518882|20939943|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
8497326|NCT00518882|20939944|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
8497327|NCT00518882|20939943|P2|COMPLETED|Open-Label Extension, Week 26-78||138
8497328|NCT00518882|20939944|P1|COMPLETED|Open-Label Extension, Week 26-78||161
8497329|NCT00518882|20939943|P2|STARTED|Open-Label Extension, Week 26-78||187
8497330|NCT00518882|20939944|P1|STARTED|Open-Label Extension, Week 26-78||202
8497331|NCT00518882|20939943|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
8497332|NCT00518882|20939944|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
8497333|NCT00518882|20939943|P2|COMPLETED|Double-Blind, Week 0-26||187
8497334|NCT00518882|20939944|P1|COMPLETED|Double-Blind, Week 0-26||202
8497335|NCT00518882|20939943|P2|Randomised|Double-Blind, Week 0-26||231
8497336|NCT00518882|20939944|P1|Randomised|Double-Blind, Week 0-26||233
8497337|NCT00518882|20939943|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
8497338|NCT00518882|20939944|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
8497339|NCT00518713|20940062|P4|NOT COMPLETED|Overall Study||18
8497340|NCT00518713|20940063|P3|NOT COMPLETED|Overall Study||18
8497341|NCT00518713|20940064|P2|NOT COMPLETED|Overall Study||17
8497342|NCT00518713|20940065|P1|NOT COMPLETED|Overall Study||8
8497343|NCT00518713|20940062|P4|COMPLETED|Overall Study||41
8497344|NCT00518713|20940063|P3|COMPLETED|Overall Study||41
8497345|NCT00518713|20940064|P2|COMPLETED|Overall Study||45
8497346|NCT00518713|20940065|P1|COMPLETED|Overall Study||50
8497347|NCT00518713|20940062|P4|Modified Intent-to-Treat Population|Overall Study||57
8497348|NCT00518713|20940063|P3|Modified Intent-to-Treat Population|Overall Study||49
8497349|NCT00518713|20940064|P2|Modified Intent-to-Treat Population|Overall Study||58
8497350|NCT00518713|20940065|P1|Modified Intent-to-Treat Population|Overall Study||53
8497351|NCT00518713|20940062|P4|STARTED|Overall Study||59
8497352|NCT00518713|20940063|P3|STARTED|Overall Study||59
8497353|NCT00518713|20940064|P2|STARTED|Overall Study||62
8497354|NCT00518713|20940065|P1|STARTED|Overall Study||58
8497355|NCT00518687|20940125|P2|NOT COMPLETED|Overall Study||1420
8497356|NCT00518687|20940126|P1|NOT COMPLETED|Overall Study||1437
8497357|NCT00518687|20940125|P2|COMPLETED|Overall Study||2585
8497358|NCT00518687|20940126|P1|COMPLETED|Overall Study||2568
8497359|NCT00518687|20940125|P2|Vaccinated|Overall Study||3982
8497360|NCT00518687|20940126|P1|Vaccinated|Overall Study||3981
8497361|NCT00518687|20940125|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
8497362|NCT00518687|20940126|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
8497363|NCT00518622|20940146|P8|NOT COMPLETED|Overall Study||0
8497364|NCT00518622|20940147|P7|NOT COMPLETED|Overall Study||0
8497365|NCT00518622|20940148|P6|NOT COMPLETED|Overall Study||0
8497366|NCT00518622|20940149|P5|NOT COMPLETED|Overall Study||0
8497367|NCT00518622|20940150|P4|NOT COMPLETED|Overall Study||0
8497368|NCT00518622|20940151|P3|NOT COMPLETED|Overall Study||1
8497369|NCT00518622|20940152|P2|NOT COMPLETED|Overall Study||1
8497370|NCT00518622|20940153|P1|NOT COMPLETED|Overall Study||0
8497371|NCT00518622|20940146|P8|COMPLETED|Overall Study||5
8497372|NCT00518622|20940147|P7|COMPLETED|Overall Study||4
8497373|NCT00518622|20940148|P6|COMPLETED|Overall Study||5
8497374|NCT00518622|20940149|P5|COMPLETED|Overall Study||6
8497375|NCT00518622|20940150|P4|COMPLETED|Overall Study||5
8497376|NCT00518622|20940151|P3|COMPLETED|Overall Study||5
8497377|NCT00518622|20940152|P2|COMPLETED|Overall Study||5
8497378|NCT00518622|20940153|P1|COMPLETED|Overall Study||3
8497379|NCT00518622|20940146|P8|Discontinued Therapy|Overall Study||0
8497380|NCT00518622|20940147|P7|Discontinued Therapy|Overall Study||0
8497381|NCT00518622|20940148|P6|Discontinued Therapy|Overall Study||0
8497382|NCT00518622|20940149|P5|Discontinued Therapy|Overall Study||0
8497383|NCT00518622|20940150|P4|Discontinued Therapy|Overall Study||0
8497384|NCT00518622|20940151|P3|Discontinued Therapy|Overall Study||0
8497385|NCT00518622|20940152|P2|Discontinued Therapy|Overall Study||1
8497386|NCT00518622|20940153|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
8497387|NCT00518622|20940146|P8|Completed Therapy|Overall Study||5
8497388|NCT00518622|20940147|P7|Completed Therapy|Overall Study||4
8497389|NCT00518622|20940148|P6|Completed Therapy|Overall Study||5
8497390|NCT00518622|20940149|P5|Completed Therapy|Overall Study||6
8497391|NCT00518622|20940150|P4|Completed Therapy|Overall Study||5
8497392|NCT00518622|20940151|P3|Completed Therapy|Overall Study||6
8497393|NCT00518622|20940152|P2|Completed Therapy|Overall Study||5
8497394|NCT00518622|20940153|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
8497395|NCT00518622|20940146|P8|STARTED|Overall Study||5
8497396|NCT00518622|20940147|P7|STARTED|Overall Study||4
8497397|NCT00518622|20940148|P6|STARTED|Overall Study||5
8497398|NCT00518622|20940149|P5|STARTED|Overall Study||6
8497399|NCT00518622|20940150|P4|STARTED|Overall Study||5
8497400|NCT00518622|20940151|P3|STARTED|Overall Study||6
8497401|NCT00518622|20940152|P2|STARTED|Overall Study||6
8497402|NCT00518622|20940153|P1|STARTED|Overall Study||3
8497403|NCT00518531|20940181|P2|NOT COMPLETED|Treatment Period 2||20
8497404|NCT00518531|20940182|P1|NOT COMPLETED|Treatment Period 2||3
8497405|NCT00518531|20940181|P2|COMPLETED|Treatment Period 2||95
8497406|NCT00518531|20940182|P1|COMPLETED|Treatment Period 2||103
8497407|NCT00518531|20940181|P2|Received Treatment|Treatment Period 2||110
8497408|NCT00518531|20940182|P1|Received Treatment|Treatment Period 2||106
8497409|NCT00518531|20940181|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
8497410|NCT00518531|20940182|P1|STARTED|Treatment Period 2||106
8497411|NCT00518531|20940181|P2|NOT COMPLETED|Treatment Period 1||12
8497412|NCT00518531|20940182|P1|NOT COMPLETED|Treatment Period 1||18
8497413|NCT00518531|20940181|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
8497414|NCT00518531|20940182|P1|COMPLETED|Treatment Period 1||106
8497415|NCT00518531|20940181|P2|Received Treatment|Treatment Period 1||124
8497416|NCT00518531|20940182|P1|Received Treatment|Treatment Period 1||119
8497417|NCT00518531|20940181|P2|STARTED|Treatment Period 1||126
8497418|NCT00518531|20940182|P1|STARTED|Treatment Period 1||124
8497419|NCT00518349|20940218|P2|NOT COMPLETED|Overall Study||0
8497420|NCT00518349|20940219|P1|NOT COMPLETED|Overall Study||0
8497421|NCT00518349|20940218|P2|COMPLETED|Overall Study||60
8497422|NCT00518349|20940219|P1|COMPLETED|Overall Study||60
8497423|NCT00518349|20940218|P2|STARTED|Overall Study||60
8497424|NCT00518349|20940219|P1|STARTED|Overall Study||60
8497425|NCT00518336|20940227|P2|NOT COMPLETED|Year 9||1
8497426|NCT00518336|20940228|P1|NOT COMPLETED|Year 9||5
8497427|NCT00518336|20940227|P2|COMPLETED|Year 9||212
8497428|NCT00518336|20940228|P1|COMPLETED|Year 9||219
8497429|NCT00518336|20940227|P2|STARTED|Year 9||213
8497430|NCT00518336|20940228|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
8497431|NCT00518336|20940227|P2|NOT COMPLETED|Year 8||2
8497432|NCT00518336|20940228|P1|NOT COMPLETED|Year 8||1
8497433|NCT00518336|20940227|P2|COMPLETED|Year 8||211
8497434|NCT00518336|20940228|P1|COMPLETED|Year 8||222
8497435|NCT00518336|20940227|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
8497436|NCT00518336|20940228|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
8497437|NCT00518336|20940227|P2|NOT COMPLETED|Year 7||3
8497438|NCT00518336|20940228|P1|NOT COMPLETED|Year 7||2
8497439|NCT00518336|20940227|P2|COMPLETED|Year 7||208
8497440|NCT00518336|20940228|P1|COMPLETED|Year 7||220
8497441|NCT00518336|20940227|P2|STARTED|Year 7||211
8497442|NCT00518336|20940228|P1|STARTED|Year 7||222
8497443|NCT00518323|20940394|P4|NOT COMPLETED|Overall Study||25
8497444|NCT00518323|20940395|P3|NOT COMPLETED|Overall Study||11
8497445|NCT00518323|20940396|P2|NOT COMPLETED|Overall Study||8
8497446|NCT00518323|20940397|P1|NOT COMPLETED|Overall Study||19
8497447|NCT00518323|20940394|P4|COMPLETED|Overall Study||26
8497448|NCT00518323|20940395|P3|COMPLETED|Overall Study||37
8497449|NCT00518323|20940396|P2|COMPLETED|Overall Study||40
8497450|NCT00518323|20940397|P1|COMPLETED|Overall Study||35
8497451|NCT00518323|20940394|P4|STARTED|Overall Study||51
8497452|NCT00518323|20940395|P3|STARTED|Overall Study||48
8497453|NCT00518323|20940396|P2|STARTED|Overall Study||48
8497454|NCT00518323|20940397|P1|STARTED|Overall Study||54
8497455|NCT00518284|20940427|P4|NOT COMPLETED|Overall Study||2
8497456|NCT00518284|20940428|P3|NOT COMPLETED|Overall Study||1
8497457|NCT00518284|20940429|P2|NOT COMPLETED|Overall Study||3
8497458|NCT00518284|20940430|P1|NOT COMPLETED|Overall Study||0
8497459|NCT00518284|20940427|P4|COMPLETED|Overall Study||0
8497460|NCT00518284|20940428|P3|COMPLETED|Overall Study||0
8497461|NCT00518284|20940429|P2|COMPLETED|Overall Study||0
8497462|NCT00518284|20940430|P1|COMPLETED|Overall Study||0
8497463|NCT00518284|20940427|P4|STARTED|Overall Study||2
8497464|NCT00518284|20940428|P3|STARTED|Overall Study||1
8497465|NCT00518284|20940429|P2|STARTED|Overall Study||3
8497466|NCT00518284|20940430|P1|STARTED|Overall Study||0
8497467|NCT00518206|20940486|P2|NOT COMPLETED|Overall Study||6
8497468|NCT00518206|20940487|P1|NOT COMPLETED|Overall Study||11
8497469|NCT00518206|20940486|P2|COMPLETED|Overall Study||13
8497470|NCT00518206|20940487|P1|COMPLETED|Overall Study||16
8497471|NCT00518206|20940486|P2|STARTED|Overall Study||19
8497472|NCT00518206|20940487|P1|STARTED|Overall Study||27
8497473|NCT00518180|20940504|P3|NOT COMPLETED|Overall Study||82
8497474|NCT00518180|20940505|P2|NOT COMPLETED|Overall Study||69
8497475|NCT00518180|20940506|P1|NOT COMPLETED|Overall Study||65
8497476|NCT00518180|20940504|P3|COMPLETED|Overall Study||457
8497477|NCT00518180|20940505|P2|COMPLETED|Overall Study||472
8497478|NCT00518180|20940506|P1|COMPLETED|Overall Study||475
8497479|NCT00518180|20940504|P3|STARTED|Overall Study||539
8497480|NCT00518180|20940505|P2|STARTED|Overall Study||541
8497481|NCT00518180|20940506|P1|STARTED|Overall Study||540
8497482|NCT00518154|20940548|P1|NOT COMPLETED|Overall Study||0
8497483|NCT00518154|20940548|P1|COMPLETED|Overall Study||7
8497484|NCT00518154|20940548|P1|STARTED|Overall Study||7
8497485|NCT00518115|20940562|P10|NOT COMPLETED|Overall Study||15
8497486|NCT00518115|20940563|P9|NOT COMPLETED|Overall Study||5
8497487|NCT00518115|20940564|P8|NOT COMPLETED|Overall Study||15
8497488|NCT00518115|20940565|P7|NOT COMPLETED|Overall Study||8
8497489|NCT00518115|20940566|P6|NOT COMPLETED|Overall Study||15
8497490|NCT00518115|20940567|P5|NOT COMPLETED|Overall Study||10
8497491|NCT00518115|20940568|P4|NOT COMPLETED|Overall Study||11
8497492|NCT00518115|20940569|P3|NOT COMPLETED|Overall Study||17
8497493|NCT00518115|20940570|P2|NOT COMPLETED|Overall Study||6
8497494|NCT00518115|20940571|P1|NOT COMPLETED|Overall Study||12
8497495|NCT00518115|20940562|P10|COMPLETED|Overall Study||20
8497496|NCT00518115|20940563|P9|COMPLETED|Overall Study||30
8497497|NCT00518115|20940564|P8|COMPLETED|Overall Study||20
8497498|NCT00518115|20940565|P7|COMPLETED|Overall Study||25
8497499|NCT00518115|20940566|P6|COMPLETED|Overall Study||19
8497500|NCT00518115|20940567|P5|COMPLETED|Overall Study||21
8497501|NCT00518115|20940568|P4|COMPLETED|Overall Study||24
8497502|NCT00518115|20940569|P3|COMPLETED|Overall Study||19
8497503|NCT00518115|20940570|P2|COMPLETED|Overall Study||29
8497504|NCT00518115|20940571|P1|COMPLETED|Overall Study||40
8497505|NCT00518115|20940562|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
8497506|NCT00518115|20940563|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497507|NCT00518115|20940564|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497508|NCT00518115|20940565|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
8497509|NCT00518115|20940566|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
8497510|NCT00518115|20940567|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
8497511|NCT00518115|20940568|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497512|NCT00518115|20940569|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497513|NCT00518115|20940570|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497514|NCT00518115|20940571|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
8497515|NCT00518115|20940562|P10|STARTED|Overall Study||35
8497516|NCT00518115|20940563|P9|STARTED|Overall Study||35
8497517|NCT00518115|20940564|P8|STARTED|Overall Study||35
8497518|NCT00518115|20940565|P7|STARTED|Overall Study||33
8497519|NCT00518115|20940566|P6|STARTED|Overall Study||34
8497520|NCT00518115|20940567|P5|STARTED|Overall Study||31
8497521|NCT00518115|20940568|P4|STARTED|Overall Study||35
8497522|NCT00518115|20940569|P3|STARTED|Overall Study||36
8497523|NCT00518115|20940570|P2|STARTED|Overall Study||35
8497524|NCT00518115|20940571|P1|STARTED|Overall Study||52
8497525|NCT00518089|20940729|P2|NOT COMPLETED|Overall Study||31
8497526|NCT00518089|20940730|P1|NOT COMPLETED|Overall Study||28
8497527|NCT00518089|20940729|P2|COMPLETED|Overall Study||398
8497528|NCT00518089|20940730|P1|COMPLETED|Overall Study||402
8497529|NCT00518089|20940729|P2|STARTED|Overall Study||429
8497530|NCT00518089|20940730|P1|STARTED|Overall Study||430
8497531|NCT00518011|20940746|P2|NOT COMPLETED|Overall Study||8
8497532|NCT00518011|20940747|P1|NOT COMPLETED|Overall Study||9
8497533|NCT00518011|20940746|P2|COMPLETED|Overall Study||0
8497534|NCT00518011|20940747|P1|COMPLETED|Overall Study||0
8497535|NCT00518011|20940746|P2|STARTED|Overall Study||8
8497536|NCT00518011|20940747|P1|STARTED|Overall Study||9
8497537|NCT00517933|20940769|P2|NOT COMPLETED|Period 2||13
8497538|NCT00517933|20940770|P1|NOT COMPLETED|Period 2||6
8497539|NCT00517933|20940769|P2|COMPLETED|Period 2||70
8497540|NCT00517933|20940770|P1|COMPLETED|Period 2||73
8497541|NCT00517933|20940769|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
8497542|NCT00517933|20940770|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
8497543|NCT00517933|20940769|P2|NOT COMPLETED|Period 1||6
8497544|NCT00517933|20940770|P1|NOT COMPLETED|Period 1||8
8497545|NCT00517933|20940769|P2|COMPLETED|Period 1||85
8497546|NCT00517933|20940770|P1|COMPLETED|Period 1||81
8497547|NCT00517933|20940769|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
8497548|NCT00517933|20940770|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
8497549|NCT00517881|20940834|P1|NOT COMPLETED|Overall Study||5
8497550|NCT00517881|20940834|P1|COMPLETED|Overall Study||24
8497551|NCT00517881|20940834|P1|STARTED|Overall Study||29
8497552|NCT00517829|20940846|P2|NOT COMPLETED|Overall Study||75
8497553|NCT00517829|20940847|P1|NOT COMPLETED|Overall Study||75
8497554|NCT00517829|20940846|P2|COMPLETED|Overall Study||0
8497555|NCT00517829|20940847|P1|COMPLETED|Overall Study||0
8497556|NCT00517829|20940846|P2|STARTED|Overall Study||75
8497557|NCT00517829|20940847|P1|STARTED|Overall Study||75
8497558|NCT00517751|20940861|P1|NOT COMPLETED|Overall Study||129
8497559|NCT00517751|20940861|P1|COMPLETED|Overall Study||33
8497560|NCT00517751|20940861|P1|STARTED|Overall Study||162
8497561|NCT00517699|20940884|P1|NOT COMPLETED|Overall Study||5
8497562|NCT00517699|20940884|P1|COMPLETED|Overall Study||0
8497563|NCT00517699|20940884|P1|STARTED|Overall Study||5
8497564|NCT00517634|20940892|P6|NOT COMPLETED|Third Treatment Period||0
8497565|NCT00517634|20940893|P5|NOT COMPLETED|Third Treatment Period||0
8497566|NCT00517634|20940894|P4|NOT COMPLETED|Third Treatment Period||0
8497567|NCT00517634|20940895|P3|NOT COMPLETED|Third Treatment Period||0
8497568|NCT00517634|20940896|P2|NOT COMPLETED|Third Treatment Period||0
8497569|NCT00517634|20940897|P1|NOT COMPLETED|Third Treatment Period||0
8497570|NCT00517634|20940892|P6|COMPLETED|Third Treatment Period||4
8497571|NCT00517634|20940893|P5|COMPLETED|Third Treatment Period||3
8497572|NCT00517634|20940894|P4|COMPLETED|Third Treatment Period||3
8497573|NCT00517634|20940895|P3|COMPLETED|Third Treatment Period||4
8497574|NCT00517634|20940896|P2|COMPLETED|Third Treatment Period||4
8497575|NCT00517634|20940897|P1|COMPLETED|Third Treatment Period||4
8497576|NCT00517634|20940892|P6|STARTED|Third Treatment Period||4
8497577|NCT00517634|20940893|P5|STARTED|Third Treatment Period||3
8497578|NCT00517634|20940894|P4|STARTED|Third Treatment Period||3
8497579|NCT00517634|20940895|P3|STARTED|Third Treatment Period||4
8497580|NCT00517634|20940896|P2|STARTED|Third Treatment Period||4
8497581|NCT00517634|20940897|P1|STARTED|Third Treatment Period||4
8497582|NCT00517634|20940892|P6|NOT COMPLETED|Second Treatment Period||0
8497583|NCT00517634|20940893|P5|NOT COMPLETED|Second Treatment Period||1
8497584|NCT00517634|20940894|P4|NOT COMPLETED|Second Treatment Period||0
8497585|NCT00517634|20940895|P3|NOT COMPLETED|Second Treatment Period||0
8497586|NCT00517634|20940896|P2|NOT COMPLETED|Second Treatment Period||0
8497587|NCT00517634|20940897|P1|NOT COMPLETED|Second Treatment Period||0
8497588|NCT00517634|20940892|P6|COMPLETED|Second Treatment Period||4
8497589|NCT00517634|20940893|P5|COMPLETED|Second Treatment Period||3
8497590|NCT00517634|20940894|P4|COMPLETED|Second Treatment Period||3
8497591|NCT00517634|20940895|P3|COMPLETED|Second Treatment Period||4
8497592|NCT00517634|20940896|P2|COMPLETED|Second Treatment Period||4
8497593|NCT00517634|20940897|P1|COMPLETED|Second Treatment Period||4
8497594|NCT00517634|20940892|P6|STARTED|Second Treatment Period||4
8497595|NCT00517634|20940893|P5|STARTED|Second Treatment Period||4
8497596|NCT00517634|20940894|P4|STARTED|Second Treatment Period||3
8497597|NCT00517634|20940895|P3|STARTED|Second Treatment Period||4
8497598|NCT00517634|20940896|P2|STARTED|Second Treatment Period||4
8497599|NCT00517634|20940897|P1|STARTED|Second Treatment Period||4
8497600|NCT00517634|20940892|P6|NOT COMPLETED|First Treatment Period||0
8497601|NCT00517634|20940893|P5|NOT COMPLETED|First Treatment Period||0
8497602|NCT00517634|20940894|P4|NOT COMPLETED|First Treatment Period||0
8497603|NCT00517634|20940895|P3|NOT COMPLETED|First Treatment Period||0
8497604|NCT00517634|20940896|P2|NOT COMPLETED|First Treatment Period||0
8497605|NCT00517634|20940897|P1|NOT COMPLETED|First Treatment Period||0
8497606|NCT00517634|20940892|P6|COMPLETED|First Treatment Period||4
8497607|NCT00517634|20940893|P5|COMPLETED|First Treatment Period||4
8497608|NCT00517634|20940894|P4|COMPLETED|First Treatment Period||3
8497609|NCT00517634|20940895|P3|COMPLETED|First Treatment Period||4
8497610|NCT00517634|20940896|P2|COMPLETED|First Treatment Period||4
8497611|NCT00517634|20940897|P1|COMPLETED|First Treatment Period||4
8497612|NCT00517634|20940892|P6|STARTED|First Treatment Period||4
8497613|NCT00517634|20940893|P5|STARTED|First Treatment Period||4
8497614|NCT00517634|20940894|P4|STARTED|First Treatment Period||3
8497615|NCT00517634|20940895|P3|STARTED|First Treatment Period||4
8497616|NCT00517634|20940896|P2|STARTED|First Treatment Period||4
8497617|NCT00517634|20940897|P1|STARTED|First Treatment Period||4
8497618|NCT00517595|20940908|P1|NOT COMPLETED|Overall Study||0
8497619|NCT00517595|20940908|P1|COMPLETED|Overall Study||48
8497620|NCT00517595|20940908|P1|STARTED|Overall Study||48
8497621|NCT00517556|20940919|P2|NOT COMPLETED|Overall Study||5
8497622|NCT00517556|20940920|P1|NOT COMPLETED|Overall Study||4
8497623|NCT00517556|20940919|P2|COMPLETED|Overall Study||14
8497624|NCT00517556|20940920|P1|COMPLETED|Overall Study||15
8497625|NCT00517556|20940919|P2|STARTED|Overall Study||19
8497626|NCT00517556|20940920|P1|STARTED|Overall Study||19
8497627|NCT00517530|20940933|P7|NOT COMPLETED|Overall Study||19
8497628|NCT00517530|20940934|P6|NOT COMPLETED|Overall Study||19
8497629|NCT00517530|20940935|P5|NOT COMPLETED|Overall Study||20
8497630|NCT00517530|20940936|P4|NOT COMPLETED|Overall Study||21
8497631|NCT00517530|20940937|P3|NOT COMPLETED|Overall Study||18
8497632|NCT00517530|20940938|P2|NOT COMPLETED|Overall Study||13
8497633|NCT00517530|20940939|P1|NOT COMPLETED|Overall Study||19
8497634|NCT00517530|20940933|P7|COMPLETED|Overall Study||1
8497635|NCT00517530|20940934|P6|COMPLETED|Overall Study||0
8497636|NCT00517530|20940935|P5|COMPLETED|Overall Study||1
8497637|NCT00517530|20940936|P4|COMPLETED|Overall Study||1
8497638|NCT00517530|20940937|P3|COMPLETED|Overall Study||0
8497639|NCT00517530|20940938|P2|COMPLETED|Overall Study||0
8497640|NCT00517530|20940939|P1|COMPLETED|Overall Study||2
8497641|NCT00517530|20940933|P7|Retreated Population|Overall Study||0
8497642|NCT00517530|20940934|P6|Retreated Population|Overall Study||2
8497643|NCT00517530|20940935|P5|Retreated Population|Overall Study||2
8497644|NCT00517530|20940936|P4|Retreated Population|Overall Study||4
8497645|NCT00517530|20940937|P3|Retreated Population|Overall Study||1
8497646|NCT00517530|20940938|P2|Retreated Population|Overall Study||2
8497647|NCT00517530|20940939|P1|Retreated Population|Overall Study||2
8497648|NCT00517530|20940933|P7|Completed Follow-up|Overall Study||1
8497649|NCT00517530|20940934|P6|Completed Follow-up|Overall Study||0
8497650|NCT00517530|20940935|P5|Completed Follow-up|Overall Study||0
8497651|NCT00517530|20940936|P4|Completed Follow-up|Overall Study||1
8497652|NCT00517530|20940937|P3|Completed Follow-up|Overall Study||0
8497653|NCT00517530|20940938|P2|Completed Follow-up|Overall Study||0
8497654|NCT00517530|20940939|P1|Completed Follow-up|Overall Study||2
8497655|NCT00517530|20940933|P7|Started Follow-up|Overall Study||19
8497656|NCT00517530|20940934|P6|Started Follow-up|Overall Study||16
8497657|NCT00517530|20940935|P5|Started Follow-up|Overall Study||17
8497658|NCT00517530|20940936|P4|Started Follow-up|Overall Study||21
8497659|NCT00517530|20940937|P3|Started Follow-up|Overall Study||17
8497660|NCT00517530|20940938|P2|Started Follow-up|Overall Study||13
8497661|NCT00517530|20940939|P1|Started Follow-up|Overall Study||20
8497662|NCT00517530|20940933|P7|Completed Treatment|Overall Study||13
8497663|NCT00517530|20940934|P6|Completed Treatment|Overall Study||9
8497664|NCT00517530|20940935|P5|Completed Treatment|Overall Study||9
8497665|NCT00517530|20940936|P4|Completed Treatment|Overall Study||18
8497666|NCT00517530|20940937|P3|Completed Treatment|Overall Study||13
8497667|NCT00517530|20940938|P2|Completed Treatment|Overall Study||13
8497668|NCT00517530|20940939|P1|Completed Treatment|Overall Study||11
8497669|NCT00517530|20940933|P7|STARTED|Overall Study||20
8497670|NCT00517530|20940934|P6|STARTED|Overall Study||19
8497671|NCT00517530|20940935|P5|STARTED|Overall Study||21
8497672|NCT00517530|20940936|P4|STARTED|Overall Study||22
8497673|NCT00517530|20940937|P3|STARTED|Overall Study||18
8497674|NCT00517530|20940938|P2|STARTED|Overall Study||13
8497675|NCT00517530|20940939|P1|STARTED|Overall Study||21
8497676|NCT00517413|20940999|P1|NOT COMPLETED|Overall Study||61
8497677|NCT00517413|20940999|P1|COMPLETED|Overall Study||102
8497678|NCT00517413|20940999|P1|STARTED|Overall Study||163
8497679|NCT00517361|20941020|P1|NOT COMPLETED|Overall Study||11
8497680|NCT00517361|20941020|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
8497681|NCT00517361|20941020|P1|STARTED|Overall Study||11
8497682|NCT00517296|20941029|P2|NOT COMPLETED|Overall Study||0
8497683|NCT00517296|20941030|P1|NOT COMPLETED|Overall Study||1
8497684|NCT00517296|20941029|P2|COMPLETED|Overall Study||11
8497685|NCT00517296|20941030|P1|COMPLETED|Overall Study||9
8497686|NCT00517296|20941029|P2|STARTED|Overall Study||11
8497687|NCT00517296|20941030|P1|STARTED|Overall Study||10
8497688|NCT00517192|20941042|P2|NOT COMPLETED|Overall Study||20
8497689|NCT00517192|20941043|P1|NOT COMPLETED|Overall Study||19
8497690|NCT00517192|20941042|P2|COMPLETED|Overall Study||0
8497691|NCT00517192|20941043|P1|COMPLETED|Overall Study||0
8497692|NCT00517192|20941042|P2|STARTED|Overall Study||20
8497693|NCT00517192|20941043|P1|STARTED|Overall Study||19
8497694|NCT00517075|20941095|P4|NOT COMPLETED|Overall Study||0
8497695|NCT00517075|20941096|P3|NOT COMPLETED|Overall Study||0
8497696|NCT00517075|20941097|P2|NOT COMPLETED|Overall Study||0
8497697|NCT00517075|20941098|P1|NOT COMPLETED|Overall Study||0
8497698|NCT00517075|20941095|P4|COMPLETED|Overall Study||0
8497699|NCT00517075|20941096|P3|COMPLETED|Overall Study||0
8497700|NCT00517075|20941097|P2|COMPLETED|Overall Study||0
8497701|NCT00517075|20941098|P1|COMPLETED|Overall Study||0
8497702|NCT00517075|20941095|P4|STARTED|Overall Study||0
8497703|NCT00517075|20941096|P3|STARTED|Overall Study||0
8497704|NCT00517075|20941097|P2|STARTED|Overall Study||0
8497705|NCT00517075|20941098|P1|STARTED|Overall Study||0
8497706|NCT00517010|20941136|P1|NOT COMPLETED|Overall Study||1
8497707|NCT00517010|20941136|P1|COMPLETED|Overall Study||5
8497708|NCT00517010|20941136|P1|STARTED|Overall Study||6
8497709|NCT00516919|20941141|P2|NOT COMPLETED|Overall Study||7
8497710|NCT00516919|20941142|P1|NOT COMPLETED|Overall Study||10
8497711|NCT00516919|20941141|P2|COMPLETED|Overall Study||32
8497712|NCT00516919|20941142|P1|COMPLETED|Overall Study||30
8497713|NCT00516919|20941141|P2|STARTED|Overall Study||39
8497714|NCT00516919|20941142|P1|STARTED|Overall Study||40
8497715|NCT00516906|20941150|P2|NOT COMPLETED|Overall Study||2
8497716|NCT00516906|20941151|P1|NOT COMPLETED|Overall Study||6
8497717|NCT00516906|20941150|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
8497718|NCT00516906|20941151|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
8497719|NCT00516906|20941150|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
8497720|NCT00516906|20941151|P1|STARTED|Overall Study||36
8497721|NCT00516893|20941161|P1|NOT COMPLETED|Overall Study||21
8497722|NCT00516893|20941161|P1|COMPLETED|Overall Study||92
8497723|NCT00516893|20941161|P1|Received Study Treatment|Overall Study||112
8497724|NCT00516893|20941161|P1|STARTED|Overall Study||113
8497725|NCT00516737|20941170|P2|NOT COMPLETED|Overall Study||8
8497726|NCT00516737|20941171|P1|NOT COMPLETED|Overall Study||11
8497727|NCT00516737|20941170|P2|COMPLETED|Overall Study||96
8497728|NCT00516737|20941171|P1|COMPLETED|Overall Study||92
8497729|NCT00516737|20941170|P2|STARTED|Overall Study||104
8497730|NCT00516737|20941171|P1|STARTED|Overall Study||103
8497731|NCT00516503|20941191|P2|NOT COMPLETED|Overall Study||0
8497732|NCT00516503|20941192|P1|NOT COMPLETED|Overall Study||0
8497733|NCT00516503|20941191|P2|COMPLETED|Overall Study||102
8497734|NCT00516503|20941192|P1|COMPLETED|Overall Study||101
8497735|NCT00516503|20941191|P2|STARTED|Overall Study||102
8497736|NCT00516503|20941192|P1|STARTED|Overall Study||101
8497737|NCT00516386|20941210|P1|NOT COMPLETED|Overall Study||6
8497738|NCT00516386|20941210|P1|COMPLETED|Overall Study||10
8497739|NCT00516386|20941210|P1|STARTED|Overall Study||16
8497740|NCT00516321|20941217|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
8497741|NCT00516321|20941218|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
8497742|NCT00516321|20941219|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
8497743|NCT00516321|20941217|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
8497744|NCT00516321|20941218|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
8497745|NCT00516321|20941219|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
8497746|NCT00516321|20941217|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
8497747|NCT00516321|20941218|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
8497748|NCT00516321|20941219|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
8497749|NCT00516321|20941217|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497750|NCT00516321|20941218|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497751|NCT00516321|20941219|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
8497752|NCT00516321|20941217|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497753|NCT00516321|20941218|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497754|NCT00516321|20941219|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
8497755|NCT00516321|20941217|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
8497756|NCT00516321|20941218|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
8497757|NCT00516321|20941219|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
8497758|NCT00516295|20941270|P3|NOT COMPLETED|Overall Study||0
8497759|NCT00516295|20941271|P2|NOT COMPLETED|Overall Study||0
8497760|NCT00516295|20941272|P1|NOT COMPLETED|Overall Study||3
8497761|NCT00516295|20941270|P3|COMPLETED|Overall Study||0
8497762|NCT00516295|20941271|P2|COMPLETED|Overall Study||0
8497763|NCT00516295|20941272|P1|COMPLETED|Overall Study||4
8497764|NCT00516295|20941270|P3|STARTED|Overall Study||0
8497765|NCT00516295|20941271|P2|STARTED|Overall Study||0
8497766|NCT00516295|20941272|P1|STARTED|Overall Study||7
8497767|NCT00516269|20941285|P2|NOT COMPLETED|Overall Study||3
8497768|NCT00516269|20941286|P1|NOT COMPLETED|Overall Study||2
8497769|NCT00516269|20941285|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
8497770|NCT00516269|20941286|P1|COMPLETED|Overall Study|2 patients had an early termination|17
8497771|NCT00516269|20941285|P2|STARTED|Overall Study||19
8497772|NCT00516269|20941286|P1|STARTED|Overall Study||19
8497773|NCT00516217|20941292|P1|NOT COMPLETED|Overall Study||0
8497774|NCT00516217|20941292|P1|COMPLETED|Overall Study||29
8497775|NCT00516217|20941292|P1|STARTED|Overall Study||29
8497776|NCT00516165|20941298|P1|NOT COMPLETED|Overall Study||0
8497777|NCT00516165|20941298|P1|COMPLETED|Overall Study||28
8497778|NCT00516165|20941298|P1|STARTED|Overall Study||28
8497779|NCT00516139|20941307|P1|NOT COMPLETED|Overall Study||38
8497780|NCT00516139|20941307|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
8497781|NCT00516139|20941307|P1|STARTED|Overall Study||122
8497782|NCT00516074|20941338|P2|NOT COMPLETED|Overall Study||3
8497783|NCT00516074|20941339|P1|NOT COMPLETED|Overall Study||6
8497784|NCT00516074|20941338|P2|COMPLETED|Overall Study||23
8497785|NCT00516074|20941339|P1|COMPLETED|Overall Study||22
8497786|NCT00516074|20941338|P2|STARTED|Overall Study||26
8497787|NCT00516074|20941339|P1|STARTED|Overall Study||28
8497788|NCT00516048|20941357|P3|NOT COMPLETED|Overall Study||1
8497789|NCT00516048|20941358|P2|NOT COMPLETED|Overall Study||2
8497790|NCT00516048|20941359|P1|NOT COMPLETED|Overall Study||0
8497791|NCT00516048|20941357|P3|COMPLETED|Overall Study||0
8497792|NCT00516048|20941358|P2|COMPLETED|Overall Study||40
8497793|NCT00516048|20941359|P1|COMPLETED|Overall Study||15
8497794|NCT00516048|20941357|P3|STARTED|Overall Study||1
8497795|NCT00516048|20941358|P2|STARTED|Overall Study||42
8497796|NCT00516048|20941359|P1|STARTED|Overall Study||15
8497797|NCT00515879|20941375|P2|NOT COMPLETED|Overall Study||20
8497798|NCT00515879|20941376|P1|NOT COMPLETED|Overall Study||25
8497799|NCT00515879|20941375|P2|COMPLETED|Overall Study||62
8497800|NCT00515879|20941376|P1|COMPLETED|Overall Study||62
8497801|NCT00515879|20941375|P2|STARTED|Overall Study||82
8497802|NCT00515879|20941376|P1|STARTED|Overall Study||87
8497803|NCT00515827|20941394|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8497804|NCT00515827|20941395|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
8497805|NCT00515827|20941394|P2|COMPLETED|Second Intervention (12 Weeks)||25
8497806|NCT00515827|20941395|P1|COMPLETED|Second Intervention (12 Weeks)||25
8497807|NCT00515827|20941394|P2|STARTED|Second Intervention (12 Weeks)||25
8497808|NCT00515827|20941395|P1|STARTED|Second Intervention (12 Weeks)||26
8497809|NCT00515827|20941394|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8497810|NCT00515827|20941395|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
8497811|NCT00515827|20941394|P2|COMPLETED|First Intervention (12 Weeks)||25
8497812|NCT00515827|20941395|P1|COMPLETED|First Intervention (12 Weeks)||26
8497813|NCT00515827|20941394|P2|STARTED|First Intervention (12 Weeks)||26
8497814|NCT00515827|20941395|P1|STARTED|First Intervention (12 Weeks)||27
8497815|NCT00515723|20941421|P4|NOT COMPLETED|Overall Study||6
8497816|NCT00515723|20941422|P3|NOT COMPLETED|Overall Study||1
8497817|NCT00515723|20941423|P2|NOT COMPLETED|Overall Study||1
8497818|NCT00515723|20941424|P1|NOT COMPLETED|Overall Study||5
8497819|NCT00515723|20941421|P4|COMPLETED|Overall Study||21
8497820|NCT00515723|20941422|P3|COMPLETED|Overall Study||21
8497821|NCT00515723|20941423|P2|COMPLETED|Overall Study||21
8497822|NCT00515723|20941424|P1|COMPLETED|Overall Study||20
8497823|NCT00515723|20941421|P4|STARTED|Overall Study||27
8497824|NCT00515723|20941422|P3|STARTED|Overall Study||22
8497825|NCT00515723|20941423|P2|STARTED|Overall Study||22
8497826|NCT00515723|20941424|P1|STARTED|Overall Study||25
8497827|NCT00515697|20941440|P1|NOT COMPLETED|Overall Study||0
8497828|NCT00515697|20941440|P1|COMPLETED|Overall Study||39
8497829|NCT00515697|20941440|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
8497830|NCT00515697|20941440|P1|STARTED|Overall Study||39
8497831|NCT00515671|20941453|P2|NOT COMPLETED|Overall Study||17
8497832|NCT00515671|20941454|P1|NOT COMPLETED|Overall Study||17
8497833|NCT00515671|20941453|P2|COMPLETED|Overall Study||41
8497834|NCT00515671|20941454|P1|COMPLETED|Overall Study||43
8497835|NCT00515671|20941453|P2|STARTED|Overall Study||58
8497836|NCT00515671|20941454|P1|STARTED|Overall Study||60
8497837|NCT00515619|20941462|P1|NOT COMPLETED|Overall Study||216
8497838|NCT00515619|20941462|P1|COMPLETED|Overall Study||160
8497839|NCT00515619|20941462|P1|Safety Set|Overall Study||376
8497840|NCT00515619|20941462|P1|STARTED|Overall Study||376
8497841|NCT00515541|20941474|P4|NOT COMPLETED|Overall Study||5
8497842|NCT00515541|20941475|P3|NOT COMPLETED|Overall Study||0
8497843|NCT00515541|20941476|P2|NOT COMPLETED|Overall Study||5
8497844|NCT00515541|20941477|P1|NOT COMPLETED|Overall Study||0
8497845|NCT00515541|20941474|P4|COMPLETED|Overall Study||6
8497846|NCT00515541|20941475|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
8497847|NCT00515541|20941476|P2|COMPLETED|Overall Study||7
8497848|NCT00515541|20941477|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
8497849|NCT00515541|20941474|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
8497850|NCT00515541|20941475|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
8497851|NCT00515541|20941476|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
8497852|NCT00515541|20941477|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
8497853|NCT00515541|20941474|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
8497854|NCT00515541|20941475|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
8497944|NCT00515502|20941517|P3|STARTED|Washout Period 3||4
8497855|NCT00515541|20941476|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
8497856|NCT00515541|20941477|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
8497857|NCT00515541|20941474|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
8497858|NCT00515541|20941475|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
8497859|NCT00515541|20941476|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
8497860|NCT00515541|20941477|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
8497861|NCT00515541|20941474|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
8497862|NCT00515541|20941475|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
8497863|NCT00515541|20941476|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
8497864|NCT00515541|20941477|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
8497865|NCT00515541|20941474|P4|STARTED|Overall Study||11
8497866|NCT00515541|20941475|P3|STARTED|Overall Study||10
8497867|NCT00515541|20941476|P2|STARTED|Overall Study||12
8497868|NCT00515541|20941477|P1|STARTED|Overall Study||10
8497869|NCT00515528|20941501|P2|NOT COMPLETED|Overall Study||0
8497870|NCT00515528|20941502|P1|NOT COMPLETED|Overall Study||0
8497871|NCT00515528|20941501|P2|COMPLETED|Overall Study||7
8497872|NCT00515528|20941502|P1|COMPLETED|Overall Study||10
8497873|NCT00515528|20941501|P2|STARTED|Overall Study||7
8497874|NCT00515528|20941502|P1|STARTED|Overall Study||10
8497875|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 4||0
8497876|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 4||0
8497877|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 4||0
8497878|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 4||0
8497879|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 4||0
8497880|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 4||0
8497881|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 4||0
8497882|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 4||0
8497883|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 4||0
8497884|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 4||0
8497885|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 4||0
8497886|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 4||0
8497887|NCT00515502|20941508|P12|COMPLETED|Treatment Period 4||0
8497888|NCT00515502|20941509|P11|COMPLETED|Treatment Period 4||1
8497889|NCT00515502|20941510|P10|COMPLETED|Treatment Period 4||2
8497890|NCT00515502|20941511|P9|COMPLETED|Treatment Period 4||0
8497891|NCT00515502|20941512|P8|COMPLETED|Treatment Period 4||1
8497892|NCT00515502|20941513|P7|COMPLETED|Treatment Period 4||1
8497893|NCT00515502|20941514|P6|COMPLETED|Treatment Period 4||1
8497894|NCT00515502|20941515|P5|COMPLETED|Treatment Period 4||3
8497895|NCT00515502|20941516|P4|COMPLETED|Treatment Period 4||3
8497896|NCT00515502|20941517|P3|COMPLETED|Treatment Period 4||4
8497897|NCT00515502|20941518|P2|COMPLETED|Treatment Period 4||3
8497898|NCT00515502|20941519|P1|COMPLETED|Treatment Period 4||1
8497899|NCT00515502|20941508|P12|STARTED|Treatment Period 4||0
8497900|NCT00515502|20941509|P11|STARTED|Treatment Period 4||1
8497901|NCT00515502|20941510|P10|STARTED|Treatment Period 4||2
8497902|NCT00515502|20941511|P9|STARTED|Treatment Period 4||0
8497903|NCT00515502|20941512|P8|STARTED|Treatment Period 4||1
8497904|NCT00515502|20941513|P7|STARTED|Treatment Period 4||1
8497905|NCT00515502|20941514|P6|STARTED|Treatment Period 4||1
8497906|NCT00515502|20941515|P5|STARTED|Treatment Period 4||3
8497907|NCT00515502|20941516|P4|STARTED|Treatment Period 4||3
8497908|NCT00515502|20941517|P3|STARTED|Treatment Period 4||4
8497909|NCT00515502|20941518|P2|STARTED|Treatment Period 4||3
8497910|NCT00515502|20941519|P1|STARTED|Treatment Period 4||1
8497911|NCT00515502|20941508|P12|NOT COMPLETED|Washout Period 3||0
8497912|NCT00515502|20941509|P11|NOT COMPLETED|Washout Period 3||0
8497913|NCT00515502|20941510|P10|NOT COMPLETED|Washout Period 3||0
8497914|NCT00515502|20941511|P9|NOT COMPLETED|Washout Period 3||0
8497915|NCT00515502|20941512|P8|NOT COMPLETED|Washout Period 3||0
8497916|NCT00515502|20941513|P7|NOT COMPLETED|Washout Period 3||0
8497917|NCT00515502|20941514|P6|NOT COMPLETED|Washout Period 3||0
8497918|NCT00515502|20941515|P5|NOT COMPLETED|Washout Period 3||0
8497919|NCT00515502|20941516|P4|NOT COMPLETED|Washout Period 3||0
8497920|NCT00515502|20941517|P3|NOT COMPLETED|Washout Period 3||0
8497921|NCT00515502|20941518|P2|NOT COMPLETED|Washout Period 3||0
8497922|NCT00515502|20941519|P1|NOT COMPLETED|Washout Period 3||0
8497923|NCT00515502|20941508|P12|COMPLETED|Washout Period 3||0
8497924|NCT00515502|20941509|P11|COMPLETED|Washout Period 3||1
8497925|NCT00515502|20941510|P10|COMPLETED|Washout Period 3||2
8497926|NCT00515502|20941511|P9|COMPLETED|Washout Period 3||0
8497927|NCT00515502|20941512|P8|COMPLETED|Washout Period 3||1
8497928|NCT00515502|20941513|P7|COMPLETED|Washout Period 3||1
8497929|NCT00515502|20941514|P6|COMPLETED|Washout Period 3||1
8497930|NCT00515502|20941515|P5|COMPLETED|Washout Period 3||3
8497931|NCT00515502|20941516|P4|COMPLETED|Washout Period 3||3
8497932|NCT00515502|20941517|P3|COMPLETED|Washout Period 3||4
8497933|NCT00515502|20941518|P2|COMPLETED|Washout Period 3||3
8497934|NCT00515502|20941519|P1|COMPLETED|Washout Period 3||1
8497935|NCT00515502|20941508|P12|STARTED|Washout Period 3||0
8497936|NCT00515502|20941509|P11|STARTED|Washout Period 3||1
8497937|NCT00515502|20941510|P10|STARTED|Washout Period 3||2
8497938|NCT00515502|20941511|P9|STARTED|Washout Period 3||0
8497939|NCT00515502|20941512|P8|STARTED|Washout Period 3||1
8497940|NCT00515502|20941513|P7|STARTED|Washout Period 3||1
8497941|NCT00515502|20941514|P6|STARTED|Washout Period 3||1
8497942|NCT00515502|20941515|P5|STARTED|Washout Period 3||3
8497943|NCT00515502|20941516|P4|STARTED|Washout Period 3||3
8497945|NCT00515502|20941518|P2|STARTED|Washout Period 3||3
8497946|NCT00515502|20941519|P1|STARTED|Washout Period 3||1
8497947|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 3||0
8497948|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 3||0
8497949|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 3||0
8497950|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 3||0
8497951|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 3||0
8497952|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 3||0
8497953|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 3||0
8497954|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 3||0
8497955|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 3||0
8497956|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 3||0
8497957|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 3||0
8497958|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 3||0
8497959|NCT00515502|20941508|P12|COMPLETED|Treatment Period 3||0
8497960|NCT00515502|20941509|P11|COMPLETED|Treatment Period 3||1
8497961|NCT00515502|20941510|P10|COMPLETED|Treatment Period 3||2
8497962|NCT00515502|20941511|P9|COMPLETED|Treatment Period 3||0
8497963|NCT00515502|20941512|P8|COMPLETED|Treatment Period 3||1
8497964|NCT00515502|20941513|P7|COMPLETED|Treatment Period 3||1
8497965|NCT00515502|20941514|P6|COMPLETED|Treatment Period 3||1
8497966|NCT00515502|20941515|P5|COMPLETED|Treatment Period 3||3
8497967|NCT00515502|20941516|P4|COMPLETED|Treatment Period 3||3
8497968|NCT00515502|20941517|P3|COMPLETED|Treatment Period 3||4
8497969|NCT00515502|20941518|P2|COMPLETED|Treatment Period 3||3
8497970|NCT00515502|20941519|P1|COMPLETED|Treatment Period 3||1
8497971|NCT00515502|20941508|P12|STARTED|Treatment Period 3||0
8497972|NCT00515502|20941509|P11|STARTED|Treatment Period 3||1
8497973|NCT00515502|20941510|P10|STARTED|Treatment Period 3||2
8497974|NCT00515502|20941511|P9|STARTED|Treatment Period 3||0
8497975|NCT00515502|20941512|P8|STARTED|Treatment Period 3||1
8497976|NCT00515502|20941513|P7|STARTED|Treatment Period 3||1
8497977|NCT00515502|20941514|P6|STARTED|Treatment Period 3||1
8497978|NCT00515502|20941515|P5|STARTED|Treatment Period 3||3
8497979|NCT00515502|20941516|P4|STARTED|Treatment Period 3||3
8497980|NCT00515502|20941517|P3|STARTED|Treatment Period 3||4
8497981|NCT00515502|20941518|P2|STARTED|Treatment Period 3||3
8497982|NCT00515502|20941519|P1|STARTED|Treatment Period 3||1
8497983|NCT00515502|20941508|P12|NOT COMPLETED|Washout Period 2||0
8497984|NCT00515502|20941509|P11|NOT COMPLETED|Washout Period 2||0
8497985|NCT00515502|20941510|P10|NOT COMPLETED|Washout Period 2||0
8497986|NCT00515502|20941511|P9|NOT COMPLETED|Washout Period 2||0
8497987|NCT00515502|20941512|P8|NOT COMPLETED|Washout Period 2||0
8497988|NCT00515502|20941513|P7|NOT COMPLETED|Washout Period 2||0
8497989|NCT00515502|20941514|P6|NOT COMPLETED|Washout Period 2||0
8497990|NCT00515502|20941515|P5|NOT COMPLETED|Washout Period 2||0
8497991|NCT00515502|20941516|P4|NOT COMPLETED|Washout Period 2||0
8497992|NCT00515502|20941517|P3|NOT COMPLETED|Washout Period 2||0
8497993|NCT00515502|20941518|P2|NOT COMPLETED|Washout Period 2||0
8497994|NCT00515502|20941519|P1|NOT COMPLETED|Washout Period 2||0
8497995|NCT00515502|20941508|P12|COMPLETED|Washout Period 2||0
8497996|NCT00515502|20941509|P11|COMPLETED|Washout Period 2||1
8497997|NCT00515502|20941510|P10|COMPLETED|Washout Period 2||2
8497998|NCT00515502|20941511|P9|COMPLETED|Washout Period 2||0
8497999|NCT00515502|20941512|P8|COMPLETED|Washout Period 2||1
8498000|NCT00515502|20941513|P7|COMPLETED|Washout Period 2||1
8498001|NCT00515502|20941514|P6|COMPLETED|Washout Period 2||1
8498002|NCT00515502|20941515|P5|COMPLETED|Washout Period 2||3
8498003|NCT00515502|20941516|P4|COMPLETED|Washout Period 2||3
8498004|NCT00515502|20941517|P3|COMPLETED|Washout Period 2||4
8498005|NCT00515502|20941518|P2|COMPLETED|Washout Period 2||3
8498006|NCT00515502|20941519|P1|COMPLETED|Washout Period 2||1
8498007|NCT00515502|20941508|P12|STARTED|Washout Period 2||0
8498008|NCT00515502|20941509|P11|STARTED|Washout Period 2||1
8498009|NCT00515502|20941510|P10|STARTED|Washout Period 2||2
8498010|NCT00515502|20941511|P9|STARTED|Washout Period 2||0
8498011|NCT00515502|20941512|P8|STARTED|Washout Period 2||1
8498012|NCT00515502|20941513|P7|STARTED|Washout Period 2||1
8498013|NCT00515502|20941514|P6|STARTED|Washout Period 2||1
8498014|NCT00515502|20941515|P5|STARTED|Washout Period 2||3
8498015|NCT00515502|20941516|P4|STARTED|Washout Period 2||3
8498016|NCT00515502|20941517|P3|STARTED|Washout Period 2||4
8498017|NCT00515502|20941518|P2|STARTED|Washout Period 2||3
8498018|NCT00515502|20941519|P1|STARTED|Washout Period 2||1
8498019|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 2||0
8498020|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 2||0
8498021|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 2||0
8498022|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 2||0
8498023|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 2||0
8498024|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 2||0
8498025|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 2||0
8498026|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 2||0
8498027|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 2||0
8498028|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 2||0
8498029|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 2||1
8498030|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 2||0
8498031|NCT00515502|20941508|P12|COMPLETED|Treatment Period 2||0
8498032|NCT00515502|20941509|P11|COMPLETED|Treatment Period 2||1
8498033|NCT00515502|20941510|P10|COMPLETED|Treatment Period 2||2
8498034|NCT00515502|20941511|P9|COMPLETED|Treatment Period 2||0
8498035|NCT00515502|20941512|P8|COMPLETED|Treatment Period 2||1
8498036|NCT00515502|20941513|P7|COMPLETED|Treatment Period 2||1
8498037|NCT00515502|20941514|P6|COMPLETED|Treatment Period 2||1
8498038|NCT00515502|20941515|P5|COMPLETED|Treatment Period 2||3
8498039|NCT00515502|20941516|P4|COMPLETED|Treatment Period 2||3
8498040|NCT00515502|20941517|P3|COMPLETED|Treatment Period 2||4
8498041|NCT00515502|20941518|P2|COMPLETED|Treatment Period 2||3
8498042|NCT00515502|20941519|P1|COMPLETED|Treatment Period 2||1
8498043|NCT00515502|20941508|P12|STARTED|Treatment Period 2||0
8498044|NCT00515502|20941509|P11|STARTED|Treatment Period 2||1
8498045|NCT00515502|20941510|P10|STARTED|Treatment Period 2||2
8498046|NCT00515502|20941511|P9|STARTED|Treatment Period 2||0
8498047|NCT00515502|20941512|P8|STARTED|Treatment Period 2||1
8498048|NCT00515502|20941513|P7|STARTED|Treatment Period 2||1
8498049|NCT00515502|20941514|P6|STARTED|Treatment Period 2||1
8498050|NCT00515502|20941515|P5|STARTED|Treatment Period 2||3
8498051|NCT00515502|20941516|P4|STARTED|Treatment Period 2||3
8498052|NCT00515502|20941517|P3|STARTED|Treatment Period 2||4
8498053|NCT00515502|20941518|P2|STARTED|Treatment Period 2||4
8498054|NCT00515502|20941519|P1|STARTED|Treatment Period 2||1
8498055|NCT00515502|20941508|P12|NOT COMPLETED|Washout Period 1||0
8498056|NCT00515502|20941509|P11|NOT COMPLETED|Washout Period 1||0
8498057|NCT00515502|20941510|P10|NOT COMPLETED|Washout Period 1||0
8498058|NCT00515502|20941511|P9|NOT COMPLETED|Washout Period 1||0
8498059|NCT00515502|20941512|P8|NOT COMPLETED|Washout Period 1||0
8498060|NCT00515502|20941513|P7|NOT COMPLETED|Washout Period 1||0
8498061|NCT00515502|20941514|P6|NOT COMPLETED|Washout Period 1||0
8498062|NCT00515502|20941515|P5|NOT COMPLETED|Washout Period 1||0
8498063|NCT00515502|20941516|P4|NOT COMPLETED|Washout Period 1||0
8498064|NCT00515502|20941517|P3|NOT COMPLETED|Washout Period 1||0
8498065|NCT00515502|20941518|P2|NOT COMPLETED|Washout Period 1||0
8498066|NCT00515502|20941519|P1|NOT COMPLETED|Washout Period 1||0
8498067|NCT00515502|20941508|P12|COMPLETED|Washout Period 1||0
8498068|NCT00515502|20941509|P11|COMPLETED|Washout Period 1||1
8498069|NCT00515502|20941510|P10|COMPLETED|Washout Period 1||2
8498070|NCT00515502|20941511|P9|COMPLETED|Washout Period 1||0
8498071|NCT00515502|20941512|P8|COMPLETED|Washout Period 1||1
8498072|NCT00515502|20941513|P7|COMPLETED|Washout Period 1||1
8498073|NCT00515502|20941514|P6|COMPLETED|Washout Period 1||1
8498074|NCT00515502|20941515|P5|COMPLETED|Washout Period 1||3
8498075|NCT00515502|20941516|P4|COMPLETED|Washout Period 1||3
8498076|NCT00515502|20941517|P3|COMPLETED|Washout Period 1||4
8498077|NCT00515502|20941518|P2|COMPLETED|Washout Period 1||4
8498078|NCT00515502|20941519|P1|COMPLETED|Washout Period 1||1
8498079|NCT00515502|20941508|P12|STARTED|Washout Period 1||0
8498080|NCT00515502|20941509|P11|STARTED|Washout Period 1||1
8498081|NCT00515502|20941510|P10|STARTED|Washout Period 1||2
8498082|NCT00515502|20941511|P9|STARTED|Washout Period 1||0
8498083|NCT00515502|20941512|P8|STARTED|Washout Period 1||1
8498084|NCT00515502|20941513|P7|STARTED|Washout Period 1||1
8498085|NCT00515502|20941514|P6|STARTED|Washout Period 1||1
8498086|NCT00515502|20941515|P5|STARTED|Washout Period 1||3
8498087|NCT00515502|20941516|P4|STARTED|Washout Period 1||3
8498088|NCT00515502|20941517|P3|STARTED|Washout Period 1||4
8498089|NCT00515502|20941518|P2|STARTED|Washout Period 1||4
8498090|NCT00515502|20941519|P1|STARTED|Washout Period 1||1
8498091|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 1||1
8498092|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 1||0
8498093|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 1||0
8498094|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 1||1
8498095|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 1||0
8498096|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 1||1
8498097|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 1||0
8498098|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 1||0
8498099|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 1||0
8498100|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 1||0
8498101|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 1||0
8498102|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 1||0
8498103|NCT00515502|20941508|P12|COMPLETED|Treatment Period 1||0
8498104|NCT00515502|20941509|P11|COMPLETED|Treatment Period 1||1
8498105|NCT00515502|20941510|P10|COMPLETED|Treatment Period 1||2
8498106|NCT00515502|20941511|P9|COMPLETED|Treatment Period 1||0
8498107|NCT00515502|20941512|P8|COMPLETED|Treatment Period 1||1
8498108|NCT00515502|20941513|P7|COMPLETED|Treatment Period 1||1
8498109|NCT00515502|20941514|P6|COMPLETED|Treatment Period 1||1
8498110|NCT00515502|20941515|P5|COMPLETED|Treatment Period 1||3
8498111|NCT00515502|20941516|P4|COMPLETED|Treatment Period 1||3
8498112|NCT00515502|20941517|P3|COMPLETED|Treatment Period 1||4
8498113|NCT00515502|20941518|P2|COMPLETED|Treatment Period 1||4
8498114|NCT00515502|20941519|P1|COMPLETED|Treatment Period 1||1
8498115|NCT00515502|20941508|P12|STARTED|Treatment Period 1||1
8498116|NCT00515502|20941509|P11|STARTED|Treatment Period 1||1
8498117|NCT00515502|20941510|P10|STARTED|Treatment Period 1||2
8498118|NCT00515502|20941511|P9|STARTED|Treatment Period 1||1
8498119|NCT00515502|20941512|P8|STARTED|Treatment Period 1||1
8498120|NCT00515502|20941513|P7|STARTED|Treatment Period 1||2
8498121|NCT00515502|20941514|P6|STARTED|Treatment Period 1||1
8498122|NCT00515502|20941515|P5|STARTED|Treatment Period 1||3
8498123|NCT00515502|20941516|P4|STARTED|Treatment Period 1||3
8498124|NCT00515502|20941517|P3|STARTED|Treatment Period 1||4
8498125|NCT00515502|20941518|P2|STARTED|Treatment Period 1||4
8498126|NCT00515502|20941519|P1|STARTED|Treatment Period 1||1
8498127|NCT00515463|20941679|P2|NOT COMPLETED|Overall Study||14
8498128|NCT00515463|20941680|P1|NOT COMPLETED|Overall Study||14
8498129|NCT00515463|20941679|P2|COMPLETED|Overall Study||142
8498130|NCT00515463|20941680|P1|COMPLETED|Overall Study||141
8498131|NCT00515463|20941679|P2|Received Study Medication|Overall Study||156
8498132|NCT00515463|20941680|P1|Received Study Medication|Overall Study||154
8498133|NCT00515463|20941679|P2|STARTED|Overall Study||156
8498134|NCT00515463|20941680|P1|STARTED|Overall Study||155
8498135|NCT00515437|20941834|P4|NOT COMPLETED|Overall Study||1
8498136|NCT00515437|20941835|P3|NOT COMPLETED|Overall Study||0
8498137|NCT00515437|20941836|P2|NOT COMPLETED|Overall Study||0
8498138|NCT00515437|20941837|P1|NOT COMPLETED|Overall Study||0
8498139|NCT00515437|20941834|P4|COMPLETED|Overall Study||14
8498140|NCT00515437|20941835|P3|COMPLETED|Overall Study||13
8498141|NCT00515437|20941836|P2|COMPLETED|Overall Study||12
8498142|NCT00515437|20941837|P1|COMPLETED|Overall Study||14
8498143|NCT00515437|20941834|P4|STARTED|Overall Study||15
8498144|NCT00515437|20941835|P3|STARTED|Overall Study||13
8498145|NCT00515437|20941836|P2|STARTED|Overall Study||12
8498146|NCT00515437|20941837|P1|STARTED|Overall Study||14
8498147|NCT00515411|20941862|P3|NOT COMPLETED|Overall Study||0
8498148|NCT00515411|20941863|P2|NOT COMPLETED|Overall Study||0
8498149|NCT00515411|20941864|P1|NOT COMPLETED|Overall Study||0
8498150|NCT00515411|20941862|P3|COMPLETED|Overall Study||26
8498151|NCT00515411|20941863|P2|COMPLETED|Overall Study||31
8498152|NCT00515411|20941864|P1|COMPLETED|Overall Study||54
8498153|NCT00515411|20941862|P3|STARTED|Overall Study||26
8498154|NCT00515411|20941863|P2|STARTED|Overall Study||31
8498155|NCT00515411|20941864|P1|STARTED|Overall Study||54
8498156|NCT00515294|20941879|P4|NOT COMPLETED|Overall Study||4
8498157|NCT00515294|20941880|P3|NOT COMPLETED|Overall Study||11
8498158|NCT00515294|20941881|P2|NOT COMPLETED|Overall Study||3
8498159|NCT00515294|20941882|P1|NOT COMPLETED|Overall Study||9
8498160|NCT00515294|20941879|P4|COMPLETED|Overall Study||35
8498161|NCT00515294|20941880|P3|COMPLETED|Overall Study||27
8498162|NCT00515294|20941881|P2|COMPLETED|Overall Study||36
8498163|NCT00515294|20941882|P1|COMPLETED|Overall Study||29
8498164|NCT00515294|20941879|P4|STARTED|Overall Study||39
8498165|NCT00515294|20941880|P3|STARTED|Overall Study||38
8498166|NCT00515294|20941881|P2|STARTED|Overall Study||39
8498167|NCT00515294|20941882|P1|STARTED|Overall Study||38
8498168|NCT00515216|20941896|P1|NOT COMPLETED|Overall Study||1
8498169|NCT00515216|20941896|P1|COMPLETED|Overall Study||25
8498170|NCT00515216|20941896|P1|STARTED|Overall Study||26
8498171|NCT00515203|20941920|P2|NOT COMPLETED|Overall Study||0
8498172|NCT00515203|20941921|P1|NOT COMPLETED|Overall Study||0
8498173|NCT00515203|20941920|P2|COMPLETED|Overall Study||5
8498174|NCT00515203|20941921|P1|COMPLETED|Overall Study||17
8498175|NCT00515203|20941920|P2|STARTED|Overall Study||5
8498176|NCT00515203|20941921|P1|STARTED|Overall Study||17
8498177|NCT00515177|20941939|P2|NOT COMPLETED|Overall Study||1
8498178|NCT00515177|20941940|P1|NOT COMPLETED|Overall Study||2
8498179|NCT00515177|20941939|P2|COMPLETED|Overall Study||9
8498180|NCT00515177|20941940|P1|COMPLETED|Overall Study||18
8498181|NCT00515177|20941939|P2|STARTED|Overall Study||10
8498182|NCT00515177|20941940|P1|STARTED|Overall Study||20
8498183|NCT00515112|20941958|P2|NOT COMPLETED|Overall Study||3
8498184|NCT00515112|20941959|P1|NOT COMPLETED|Overall Study||3
8498185|NCT00515112|20941958|P2|COMPLETED|Overall Study||0
8498186|NCT00515112|20941959|P1|COMPLETED|Overall Study||0
8498187|NCT00515112|20941958|P2|STARTED|Overall Study||3
8498188|NCT00515112|20941959|P1|STARTED|Overall Study||3
8498189|NCT00515099|20941969|P2|NOT COMPLETED|Overall Study||4
8498190|NCT00515099|20941970|P1|NOT COMPLETED|Overall Study||3
8498191|NCT00515099|20941969|P2|COMPLETED|Overall Study||16
8498192|NCT00515099|20941970|P1|COMPLETED|Overall Study||35
8498193|NCT00515099|20941969|P2|STARTED|Overall Study||20
8498194|NCT00515099|20941970|P1|STARTED|Overall Study||38
8498195|NCT00515086|20941992|P4|NOT COMPLETED|Overall Study||6
8498196|NCT00515086|20941993|P3|NOT COMPLETED|Overall Study||5
8498197|NCT00515086|20941994|P2|NOT COMPLETED|Overall Study||6
8498198|NCT00515086|20941995|P1|NOT COMPLETED|Overall Study||24
8498199|NCT00515086|20941992|P4|COMPLETED|Overall Study||0
8498200|NCT00515086|20941993|P3|COMPLETED|Overall Study||0
8498201|NCT00515086|20941994|P2|COMPLETED|Overall Study||0
8498202|NCT00515086|20941995|P1|COMPLETED|Overall Study||0
8498203|NCT00515086|20941992|P4|STARTED|Overall Study||6
8498204|NCT00515086|20941993|P3|STARTED|Overall Study||5
8498205|NCT00515086|20941994|P2|STARTED|Overall Study||6
8498206|NCT00515086|20941995|P1|STARTED|Overall Study||24
8498207|NCT00515073|20942022|P1|NOT COMPLETED|Overall Study||2
8498208|NCT00515073|20942022|P1|COMPLETED|Overall Study||28
8498209|NCT00515073|20942022|P1|STARTED|Overall Study||30
8498210|NCT00515034|20942030|P4|NOT COMPLETED|Overall Study||5
8498211|NCT00515034|20942031|P3|NOT COMPLETED|Overall Study||8
8498212|NCT00515034|20942032|P2|NOT COMPLETED|Overall Study||2
8498213|NCT00515034|20942033|P1|NOT COMPLETED|Overall Study||8
8498214|NCT00515034|20942030|P4|COMPLETED|Overall Study||15
8498215|NCT00515034|20942031|P3|COMPLETED|Overall Study||54
8498216|NCT00515034|20942032|P2|COMPLETED|Overall Study||13
8498217|NCT00515034|20942033|P1|COMPLETED|Overall Study||41
8498218|NCT00515034|20942030|P4|TREATED|Overall Study||19
8498219|NCT00515034|20942031|P3|TREATED|Overall Study||61
8498220|NCT00515034|20942032|P2|TREATED|Overall Study||15
8498221|NCT00515034|20942033|P1|TREATED|Overall Study||48
8498222|NCT00515034|20942030|P4|STARTED|Overall Study||20
8498223|NCT00515034|20942031|P3|STARTED|Overall Study||62
8498224|NCT00515034|20942032|P2|STARTED|Overall Study||15
8498225|NCT00515034|20942033|P1|STARTED|Overall Study||49
8498226|NCT00515021|20942053|P2|NOT COMPLETED|Overall Study||0
8498227|NCT00515021|20942054|P1|NOT COMPLETED|Overall Study||0
8498228|NCT00515021|20942053|P2|COMPLETED|Overall Study||11
8498229|NCT00515021|20942054|P1|COMPLETED|Overall Study||9
8498230|NCT00515021|20942053|P2|STARTED|Overall Study||11
8498231|NCT00515021|20942054|P1|STARTED|Overall Study||9
8498232|NCT00515008|20942064|P2|NOT COMPLETED|Overall Study||4
8498233|NCT00515008|20942065|P1|NOT COMPLETED|Overall Study||3
8498234|NCT00515008|20942064|P2|COMPLETED|Overall Study||29
8498235|NCT00515008|20942065|P1|COMPLETED|Overall Study||30
8498236|NCT00515008|20942064|P2|Completed 12 Week Evaluation|Overall Study||29
8498237|NCT00515008|20942065|P1|Completed 12 Week Evaluation|Overall Study||32
8498238|NCT00515008|20942064|P2|STARTED|Overall Study||33
8498239|NCT00515008|20942065|P1|STARTED|Overall Study||33
8498240|NCT00514943|20942089|P2|NOT COMPLETED|Stage 2||36
8498241|NCT00514943|20942090|P1|NOT COMPLETED|Stage 2||32
8498242|NCT00514943|20942089|P2|COMPLETED|Stage 2||0
8498243|NCT00514943|20942090|P1|COMPLETED|Stage 2||0
8498244|NCT00514943|20942089|P2|STARTED|Stage 2||36
8498245|NCT00514943|20942090|P1|STARTED|Stage 2||32
8498246|NCT00514943|20942089|P2|NOT COMPLETED|Stage 1||26
8498247|NCT00514943|20942090|P1|NOT COMPLETED|Stage 1||30
8498248|NCT00514943|20942089|P2|COMPLETED|Stage 1||36
8498249|NCT00514943|20942090|P1|COMPLETED|Stage 1||32
8498250|NCT00514943|20942089|P2|STARTED|Stage 1|2 randomized patients were not treated|62
8498251|NCT00514943|20942090|P1|STARTED|Stage 1|1 randomized patient was not treated|62
8498252|NCT00514917|20942148|P2|NOT COMPLETED|Overall Study||115
8498253|NCT00514917|20942149|P1|NOT COMPLETED|Overall Study||126
8498254|NCT00514917|20942148|P2|COMPLETED|Overall Study||91
8498255|NCT00514917|20942149|P1|COMPLETED|Overall Study||81
8498256|NCT00514917|20942148|P2|Testosterone-Specific Evaluable|Overall Study||124
8498257|NCT00514917|20942149|P1|Testosterone-Specific Evaluable|Overall Study||122
8498258|NCT00514917|20942148|P2|Completed Study Treatment|Overall Study||182
8498259|NCT00514917|20942149|P1|Completed Study Treatment|Overall Study||170
8498260|NCT00514917|20942148|P2|Treated|Overall Study||204
8498261|NCT00514917|20942149|P1|Treated|Overall Study||196
8498262|NCT00514917|20942148|P2|STARTED|Overall Study||206
8498263|NCT00514917|20942149|P1|STARTED|Overall Study||207
8498264|NCT00514904|20942177|P2|NOT COMPLETED|Overall Study||5
8498265|NCT00514904|20942178|P1|NOT COMPLETED|Overall Study||24
8498266|NCT00514904|20942177|P2|COMPLETED|Overall Study||371
8498267|NCT00514904|20942178|P1|COMPLETED|Overall Study||1101
8498268|NCT00514904|20942177|P2|STARTED|Overall Study||376
8498269|NCT00514904|20942178|P1|STARTED|Overall Study||1125
8498270|NCT00514852|20942214|P2|NOT COMPLETED|Overall Study||5
8498271|NCT00514852|20942215|P1|NOT COMPLETED|Overall Study||5
8498272|NCT00514852|20942214|P2|COMPLETED|Overall Study||154
8498273|NCT00514852|20942215|P1|COMPLETED|Overall Study||152
8498274|NCT00514852|20942214|P2|STARTED|Overall Study||159
8498275|NCT00514852|20942215|P1|STARTED|Overall Study||157
8498276|NCT00514813|20942243|P4|NOT COMPLETED|Overall Study||4
8498277|NCT00514813|20942244|P3|NOT COMPLETED|Overall Study||47
8498278|NCT00514813|20942245|P2|NOT COMPLETED|Overall Study||86
8498279|NCT00514813|20942246|P1|NOT COMPLETED|Overall Study||15
8498280|NCT00514813|20942243|P4|COMPLETED|Overall Study||0
8498281|NCT00514813|20942244|P3|COMPLETED|Overall Study||0
8498282|NCT00514813|20942245|P2|COMPLETED|Overall Study||0
8498283|NCT00514813|20942246|P1|COMPLETED|Overall Study||0
8498284|NCT00514813|20942243|P4|STARTED|Overall Study||4
8498285|NCT00514813|20942244|P3|STARTED|Overall Study||47
8498286|NCT00514813|20942245|P2|STARTED|Overall Study||86
8498287|NCT00514813|20942246|P1|STARTED|Overall Study||15
8498288|NCT00514735|20942266|P2|NOT COMPLETED|Overall Study||6
8498289|NCT00514735|20942267|P1|NOT COMPLETED|Overall Study||14
8498290|NCT00514735|20942266|P2|COMPLETED|Overall Study||66
8498291|NCT00514735|20942267|P1|COMPLETED|Overall Study||124
8498292|NCT00514735|20942266|P2|STARTED|Overall Study||72
8498293|NCT00514735|20942267|P1|STARTED|Overall Study||138
8498294|NCT00514709|20942287|P2|NOT COMPLETED|Overall Study||0
8498295|NCT00514709|20942288|P1|NOT COMPLETED|Overall Study||0
8498296|NCT00514709|20942287|P2|COMPLETED|Overall Study||613
8498297|NCT00514709|20942288|P1|COMPLETED|Overall Study||1230
8498298|NCT00514709|20942287|P2|STARTED|Overall Study||613
8498299|NCT00514709|20942288|P1|STARTED|Overall Study||1230
8498300|NCT00514683|20942303|P5|NOT COMPLETED|Overall Study||33
8498301|NCT00514683|20942304|P4|NOT COMPLETED|Overall Study||14
8498302|NCT00514683|20942305|P3|NOT COMPLETED|Overall Study||18
8498303|NCT00514683|20942306|P2|NOT COMPLETED|Overall Study||25
8498304|NCT00514683|20942307|P1|NOT COMPLETED|Overall Study||26
8498305|NCT00514683|20942303|P5|COMPLETED|Overall Study||53
8498306|NCT00514683|20942304|P4|COMPLETED|Overall Study||72
8498307|NCT00514683|20942305|P3|COMPLETED|Overall Study||68
8498308|NCT00514683|20942306|P2|COMPLETED|Overall Study||62
8498309|NCT00514683|20942307|P1|COMPLETED|Overall Study||61
8498310|NCT00514683|20942303|P5|STARTED|Overall Study|Randomised|86
8498311|NCT00514683|20942304|P4|STARTED|Overall Study|Randomised|86
8498312|NCT00514683|20942305|P3|STARTED|Overall Study|Randomised|86
8498313|NCT00514683|20942306|P2|STARTED|Overall Study|Randomised|87
8498314|NCT00514683|20942307|P1|STARTED|Overall Study|Randomised|87
8498315|NCT00514592|20942498|P1|NOT COMPLETED|Overall Study||0
8498316|NCT00514592|20942498|P1|COMPLETED|Overall Study||230
8498317|NCT00514592|20942498|P1|STARTED|Overall Study||230
8498318|NCT00514540|20942503|P1|NOT COMPLETED|Second-Line||31
8498319|NCT00514540|20942503|P1|COMPLETED|Second-Line||74
8498320|NCT00514540|20942503|P1|STARTED|Second-Line||105
8498321|NCT00514540|20942503|P1|NOT COMPLETED|First-Line Chemo||8
8498322|NCT00514540|20942503|P1|COMPLETED|First-Line Chemo||105
8498323|NCT00514540|20942503|P1|STARTED|First-Line Chemo||113
8498324|NCT00514514|20942514|P3|NOT COMPLETED|Extension - 4 Years||21
8498325|NCT00514514|20942515|P2|NOT COMPLETED|Extension - 4 Years||22
8498326|NCT00514514|20942516|P1|NOT COMPLETED|Extension - 4 Years||37
8498327|NCT00514514|20942514|P3|COMPLETED|Extension - 4 Years||113
8498328|NCT00514514|20942515|P2|COMPLETED|Extension - 4 Years||117
8498329|NCT00514514|20942516|P1|COMPLETED|Extension - 4 Years||108
8498330|NCT00514514|20942514|P3|Non-randomized (Followed)|Extension - 4 Years||0
8498331|NCT00514514|20942515|P2|Non-randomized (Followed)|Extension - 4 Years||0
8498332|NCT00514514|20942516|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
8498333|NCT00514514|20942514|P3|STARTED|Extension - 4 Years||134
8498334|NCT00514514|20942515|P2|STARTED|Extension - 4 Years||139
8498335|NCT00514514|20942516|P1|STARTED|Extension - 4 Years||145
8498336|NCT00514514|20942514|P3|NOT COMPLETED|Randomized - 9 Month||38
8498337|NCT00514514|20942515|P2|NOT COMPLETED|Randomized - 9 Month||61
8498338|NCT00514514|20942516|P1|NOT COMPLETED|Randomized - 9 Month||39
8498339|NCT00514514|20942514|P3|COMPLETED|Randomized - 9 Month||124
8498340|NCT00514514|20942515|P2|COMPLETED|Randomized - 9 Month||110
8498341|NCT00514514|20942516|P1|COMPLETED|Randomized - 9 Month||127
8498342|NCT00514514|20942514|P3|Randomized - Received Treatment|Randomized - 9 Month||161
8498343|NCT00514514|20942515|P2|Randomized - Received Treatment|Randomized - 9 Month||171
8498344|NCT00514514|20942516|P1|Randomized - Received Treatment|Randomized - 9 Month||165
8498345|NCT00514514|20942514|P3|STARTED|Randomized - 9 Month||162
8498346|NCT00514514|20942515|P2|STARTED|Randomized - 9 Month||171
8498347|NCT00514514|20942516|P1|STARTED|Randomized - 9 Month||166
8498348|NCT00514514|20942514|P3|NOT COMPLETED|Pre-phase||0
8498349|NCT00514514|20942515|P2|NOT COMPLETED|Pre-phase||0
8498350|NCT00514514|20942516|P1|NOT COMPLETED|Pre-phase||303
8498351|NCT00514514|20942514|P3|COMPLETED|Pre-phase||0
8498352|NCT00514514|20942515|P2|COMPLETED|Pre-phase||0
8498353|NCT00514514|20942516|P1|COMPLETED|Pre-phase||499
8498354|NCT00514514|20942514|P3|STARTED|Pre-phase||0
8498355|NCT00514514|20942515|P2|STARTED|Pre-phase||0
8498356|NCT00514514|20942516|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
8498357|NCT00514501|20942560|P1|NOT COMPLETED|Overall Study||3
8498358|NCT00514501|20942560|P1|COMPLETED|Overall Study||507
8498359|NCT00514501|20942560|P1|STARTED|Overall Study||510
8498360|NCT00514449|20942568|P2|NOT COMPLETED|Overall Study||4
8498361|NCT00514449|20942569|P1|NOT COMPLETED|Overall Study||3
8498362|NCT00514449|20942568|P2|COMPLETED|Overall Study||8
8498363|NCT00514449|20942569|P1|COMPLETED|Overall Study||9
8498364|NCT00514449|20942568|P2|STARTED|Overall Study||12
8498365|NCT00514449|20942569|P1|STARTED|Overall Study||12
8498366|NCT00514215|20942579|P1|NOT COMPLETED|Overall Study||0
8498367|NCT00514215|20942579|P1|COMPLETED|Overall Study||8
8498368|NCT00514215|20942579|P1|STARTED|Overall Study||8
8498369|NCT00514137|20942586|P1|NOT COMPLETED|Overall Study||0
8498370|NCT00514137|20942586|P1|COMPLETED|Overall Study||13
8498371|NCT00514137|20942586|P1|STARTED|Overall Study||13
8498372|NCT00514046|20942602|P9|NOT COMPLETED|Overall Study||1
8498373|NCT00514046|20942603|P8|NOT COMPLETED|Overall Study||1
8498374|NCT00514046|20942604|P7|NOT COMPLETED|Overall Study||0
8498375|NCT00514046|20942605|P6|NOT COMPLETED|Overall Study||1
8498376|NCT00514046|20942606|P5|NOT COMPLETED|Overall Study||1
8498377|NCT00514046|20942607|P4|NOT COMPLETED|Overall Study||0
8498378|NCT00514046|20942608|P3|NOT COMPLETED|Overall Study||5
8498379|NCT00514046|20942609|P2|NOT COMPLETED|Overall Study||1
8498380|NCT00514046|20942610|P1|NOT COMPLETED|Overall Study||3
8498381|NCT00514046|20942602|P9|COMPLETED|Overall Study||0
8498382|NCT00514046|20942603|P8|COMPLETED|Overall Study||0
8498383|NCT00514046|20942604|P7|COMPLETED|Overall Study||1
8498384|NCT00514046|20942605|P6|COMPLETED|Overall Study||0
8498385|NCT00514046|20942606|P5|COMPLETED|Overall Study||0
8498386|NCT00514046|20942607|P4|COMPLETED|Overall Study||1
8498387|NCT00514046|20942608|P3|COMPLETED|Overall Study||0
8498388|NCT00514046|20942609|P2|COMPLETED|Overall Study||0
8498389|NCT00514046|20942610|P1|COMPLETED|Overall Study||2
8498390|NCT00514046|20942602|P9|STARTED|Overall Study||1
8498391|NCT00514046|20942603|P8|STARTED|Overall Study||1
8498392|NCT00514046|20942604|P7|STARTED|Overall Study||1
8498393|NCT00514046|20942605|P6|STARTED|Overall Study||1
8498394|NCT00514046|20942606|P5|STARTED|Overall Study||1
8498395|NCT00514046|20942607|P4|STARTED|Overall Study||1
8498396|NCT00514046|20942608|P3|STARTED|Overall Study||5
8498397|NCT00514046|20942609|P2|STARTED|Overall Study||1
8498398|NCT00514046|20942610|P1|STARTED|Overall Study||5
8498399|NCT00514020|20942652|P1|NOT COMPLETED|Overall Study||28
8498400|NCT00514020|20942652|P1|COMPLETED|Overall Study||5
8498401|NCT00514020|20942652|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
8498402|NCT00513799|20942660|P4|NOT COMPLETED|Four-Month Follow-Up||3
8498403|NCT00513799|20942661|P3|NOT COMPLETED|Four-Month Follow-Up||7
8498404|NCT00513799|20942662|P2|NOT COMPLETED|Four-Month Follow-Up||5
8498405|NCT00513799|20942663|P1|NOT COMPLETED|Four-Month Follow-Up||0
8498406|NCT00513799|20942660|P4|COMPLETED|Four-Month Follow-Up||51
8498407|NCT00513799|20942661|P3|COMPLETED|Four-Month Follow-Up||57
8498408|NCT00513799|20942662|P2|COMPLETED|Four-Month Follow-Up||57
8498409|NCT00513799|20942663|P1|COMPLETED|Four-Month Follow-Up||64
8498410|NCT00513799|20942660|P4|STARTED|Four-Month Follow-Up||54
8498411|NCT00513799|20942661|P3|STARTED|Four-Month Follow-Up||64
8498412|NCT00513799|20942662|P2|STARTED|Four-Month Follow-Up||62
8498413|NCT00513799|20942663|P1|STARTED|Four-Month Follow-Up||64
8498414|NCT00513799|20942660|P4|NOT COMPLETED|One-Month Follow-Up||21
8498415|NCT00513799|20942661|P3|NOT COMPLETED|One-Month Follow-Up||11
8498416|NCT00513799|20942662|P2|NOT COMPLETED|One-Month Follow-Up||13
8498417|NCT00513799|20942663|P1|NOT COMPLETED|One-Month Follow-Up||11
8498418|NCT00513799|20942660|P4|COMPLETED|One-Month Follow-Up||54
8498419|NCT00513799|20942661|P3|COMPLETED|One-Month Follow-Up||64
8498420|NCT00513799|20942662|P2|COMPLETED|One-Month Follow-Up||62
8498421|NCT00513799|20942663|P1|COMPLETED|One-Month Follow-Up||64
8498422|NCT00513799|20942660|P4|STARTED|One-Month Follow-Up||75
8498423|NCT00513799|20942661|P3|STARTED|One-Month Follow-Up||75
8498424|NCT00513799|20942662|P2|STARTED|One-Month Follow-Up||75
8498425|NCT00513799|20942663|P1|STARTED|One-Month Follow-Up||75
8498426|NCT00513747|20942684|P3|NOT COMPLETED|Overall Study||0
8498427|NCT00513747|20942685|P2|NOT COMPLETED|Overall Study||0
8498428|NCT00513747|20942686|P1|NOT COMPLETED|Overall Study||0
8498429|NCT00513747|20942684|P3|COMPLETED|Overall Study||55
8498430|NCT00513747|20942685|P2|COMPLETED|Overall Study||11
8498431|NCT00513747|20942686|P1|COMPLETED|Overall Study||17
8498432|NCT00513747|20942684|P3|Received at Least One Dose of Treatment|Overall Study||40
8498433|NCT00513747|20942685|P2|Received at Least One Dose of Treatment|Overall Study||11
8498434|NCT00513747|20942686|P1|Received at Least One Dose of Treatment|Overall Study||9
8498435|NCT00513747|20942684|P3|STARTED|Overall Study||55
8498436|NCT00513747|20942685|P2|STARTED|Overall Study||11
8498437|NCT00513747|20942686|P1|STARTED|Overall Study||17
8498438|NCT00513708|20942706|P3|NOT COMPLETED|Overall Study||4
8498439|NCT00513708|20942707|P2|NOT COMPLETED|Overall Study||4
8498440|NCT00513708|20942708|P1|NOT COMPLETED|Overall Study||4
8498441|NCT00513708|20942706|P3|COMPLETED|Overall Study||46
8498442|NCT00513708|20942707|P2|COMPLETED|Overall Study||46
8498443|NCT00513708|20942708|P1|COMPLETED|Overall Study||46
8498444|NCT00513708|20942706|P3|STARTED|Overall Study||50
8498445|NCT00513708|20942707|P2|STARTED|Overall Study||50
8498446|NCT00513708|20942708|P1|STARTED|Overall Study||50
8498447|NCT00513695|20942722|P1|NOT COMPLETED|Overall Study||5
8498448|NCT00513695|20942722|P1|COMPLETED|Overall Study||63
8498449|NCT00513695|20942722|P1|STARTED|Overall Study||68
8498450|NCT00513682|20942731|P1|NOT COMPLETED|Treatment Phase||0
8498451|NCT00513682|20942731|P1|COMPLETED|Treatment Phase||7
8498452|NCT00513682|20942731|P1|STARTED|Treatment Phase||7
8498453|NCT00513682|20942731|P1|NOT COMPLETED|Washout Phase||2
8498454|NCT00513682|20942731|P1|COMPLETED|Washout Phase||7
8498455|NCT00513682|20942731|P1|STARTED|Washout Phase||9
8498456|NCT00513682|20942731|P1|NOT COMPLETED|Screening Phase||0
8498457|NCT00513682|20942731|P1|COMPLETED|Screening Phase||9
8498458|NCT00513682|20942731|P1|STARTED|Screening Phase||9
8498459|NCT00513617|20942743|P3|NOT COMPLETED|Overall Study||8
8498460|NCT00513617|20942744|P2|NOT COMPLETED|Overall Study||10
8498461|NCT00513617|20942745|P1|NOT COMPLETED|Overall Study||11
8498462|NCT00513617|20942743|P3|COMPLETED|Overall Study||30
8498463|NCT00513617|20942744|P2|COMPLETED|Overall Study||25
8498464|NCT00513617|20942745|P1|COMPLETED|Overall Study||25
8498465|NCT00513617|20942743|P3|STARTED|Overall Study||38
8498466|NCT00513617|20942744|P2|STARTED|Overall Study||35
8498467|NCT00513617|20942745|P1|STARTED|Overall Study||36
8498468|NCT00513604|20942761|P5|NOT COMPLETED|Overall Study||0
8498469|NCT00513604|20942762|P4|NOT COMPLETED|Overall Study||0
8498470|NCT00513604|20942763|P3|NOT COMPLETED|Overall Study||3
8498471|NCT00513604|20942764|P2|NOT COMPLETED|Overall Study||3
8498472|NCT00513604|20942765|P1|NOT COMPLETED|Overall Study||2
8498473|NCT00513604|20942761|P5|COMPLETED|Overall Study||35
8498474|NCT00513604|20942762|P4|COMPLETED|Overall Study||34
8498475|NCT00513604|20942763|P3|COMPLETED|Overall Study||21
8498476|NCT00513604|20942764|P2|COMPLETED|Overall Study||36
8498477|NCT00513604|20942765|P1|COMPLETED|Overall Study||24
8498478|NCT00513604|20942761|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
8498479|NCT00513604|20942762|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
8498480|NCT00513604|20942763|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
8498481|NCT00513604|20942764|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
8498482|NCT00513604|20942765|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
8498483|NCT00513526|20942782|P1|NOT COMPLETED|Overall Study||17
8498484|NCT00513526|20942782|P1|COMPLETED|Overall Study||92
8498485|NCT00513526|20942782|P1|STARTED|Overall Study||109
8498486|NCT00513500|20942799|P2|NOT COMPLETED|Overall Study||54
8498487|NCT00513500|20942800|P1|NOT COMPLETED|Overall Study||41
8498488|NCT00513500|20942799|P2|COMPLETED|Overall Study||2054
8498489|NCT00513500|20942800|P1|COMPLETED|Overall Study||976
8498490|NCT00513500|20942799|P2|STARTED|Overall Study||2108
8498491|NCT00513500|20942800|P1|STARTED|Overall Study||1017
8498492|NCT00513474|20942812|P2|NOT COMPLETED|Overall Study||9
8498493|NCT00513474|20942813|P1|NOT COMPLETED|Overall Study||7
8498494|NCT00513474|20942812|P2|COMPLETED|Overall Study||12
8498495|NCT00513474|20942813|P1|COMPLETED|Overall Study||18
8498496|NCT00513474|20942812|P2|Received Rasburicase Per Protocol|Overall Study||0
8498497|NCT00513474|20942813|P1|Received Rasburicase Per Protocol|Overall Study||24
8498498|NCT00513474|20942812|P2|STARTED|Overall Study||21
8498499|NCT00513474|20942813|P1|STARTED|Overall Study||25
8498500|NCT00513461|20942827|P2|NOT COMPLETED|Overall Study||10
8498501|NCT00513461|20942828|P1|NOT COMPLETED|Overall Study||13
8498502|NCT00513461|20942827|P2|COMPLETED|Overall Study||43
8498503|NCT00513461|20942828|P1|COMPLETED|Overall Study||44
8498504|NCT00513461|20942827|P2|STARTED|Overall Study||53
8498505|NCT00513461|20942828|P1|STARTED|Overall Study||57
8498506|NCT00513435|20942862|P1|NOT COMPLETED|Overall Study||0
8498507|NCT00513435|20942862|P1|COMPLETED|Overall Study||9
8498508|NCT00513435|20942862|P1|STARTED|Overall Study||9
8498509|NCT00513409|20942869|P2|NOT COMPLETED|Overall Study||6
8498510|NCT00513409|20942870|P1|NOT COMPLETED|Overall Study||2
8498511|NCT00513409|20942869|P2|COMPLETED|Overall Study||73
8498512|NCT00513409|20942870|P1|COMPLETED|Overall Study||82
8498513|NCT00513409|20942869|P2|STARTED|Overall Study||79
8498514|NCT00513409|20942870|P1|STARTED|Overall Study||84
8498515|NCT00513370|20942896|P1|NOT COMPLETED|Overall Study||24
8498516|NCT00513370|20942896|P1|COMPLETED|Overall Study||179
8498517|NCT00513370|20942896|P1|STARTED|Overall Study||203
8498518|NCT00513357|20942926|P2|NOT COMPLETED|Overall Study||10
8498519|NCT00513357|20942927|P1|NOT COMPLETED|Overall Study||15
8498520|NCT00513357|20942926|P2|COMPLETED|Overall Study||25
8498521|NCT00513357|20942927|P1|COMPLETED|Overall Study||23
8498522|NCT00513357|20942926|P2|STARTED|Overall Study||35
8498523|NCT00513357|20942927|P1|STARTED|Overall Study||38
8498524|NCT00513344|20942933|P1|NOT COMPLETED|3rd Intervention 1 Day||0
8498525|NCT00513344|20942933|P1|COMPLETED|3rd Intervention 1 Day||5
8498526|NCT00513344|20942933|P1|STARTED|3rd Intervention 1 Day||5
8498527|NCT00513344|20942933|P1|NOT COMPLETED|Washout Period 3 Days||0
8498528|NCT00513344|20942933|P1|COMPLETED|Washout Period 3 Days||5
8498529|NCT00513344|20942933|P1|STARTED|Washout Period 3 Days||5
8498530|NCT00513344|20942933|P1|NOT COMPLETED|2nd Intervention 1 Day||0
8498531|NCT00513344|20942933|P1|COMPLETED|2nd Intervention 1 Day||5
8498532|NCT00513344|20942933|P1|STARTED|2nd Intervention 1 Day||5
8498533|NCT00513344|20942933|P1|NOT COMPLETED|Washout Period 3 Days||0
8498534|NCT00513344|20942933|P1|COMPLETED|Washout Period 3 Days||5
8498535|NCT00513344|20942933|P1|STARTED|Washout Period 3 Days||5
8498536|NCT00513344|20942933|P1|NOT COMPLETED|1st Intervention 1 Day||0
8498537|NCT00513344|20942933|P1|COMPLETED|1st Intervention 1 Day||5
8498538|NCT00513344|20942933|P1|STARTED|1st Intervention 1 Day||5
8498539|NCT00513344|20942933|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
8498540|NCT00513344|20942933|P1|COMPLETED|Diet Restriction (3 Days)||5
8498541|NCT00513344|20942933|P1|STARTED|Diet Restriction (3 Days)||5
8498542|NCT00513305|20942946|P2|NOT COMPLETED|Overall Study||27
8498543|NCT00513305|20942947|P1|NOT COMPLETED|Overall Study||28
8498544|NCT00513305|20942946|P2|COMPLETED|Overall Study||7
8498545|NCT00513305|20942947|P1|COMPLETED|Overall Study||5
8498546|NCT00513305|20942946|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
8498547|NCT00513305|20942947|P1|STARTED|Overall Study||33
8498548|NCT00513292|20942965|P2|NOT COMPLETED|Overall Study||0
8498549|NCT00513292|20942966|P1|NOT COMPLETED|Overall Study||0
8498550|NCT00513292|20942965|P2|COMPLETED|Overall Study||142
8498551|NCT00513292|20942966|P1|COMPLETED|Overall Study||138
8498552|NCT00513292|20942965|P2|STARTED|Overall Study||142
8498553|NCT00513292|20942966|P1|STARTED|Overall Study||138
8498554|NCT00513240|20942990|P2|NOT COMPLETED|Overall Study||7
8498555|NCT00513240|20942991|P1|NOT COMPLETED|Overall Study||13
8498556|NCT00513240|20942990|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
8498557|NCT00513240|20942991|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
8498558|NCT00513240|20942990|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
8498559|NCT00513240|20942991|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
8498560|NCT00513240|20942990|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
8498561|NCT00513240|20942991|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
8498562|NCT00513071|20943004|P1|NOT COMPLETED|Overall Study||5
8498563|NCT00513071|20943004|P1|COMPLETED|Overall Study||23
8498564|NCT00513071|20943004|P1|STARTED|Overall Study||28
8498565|NCT00513019|20943016|P2|NOT COMPLETED|Overall Study||5
8498566|NCT00513019|20943017|P1|NOT COMPLETED|Overall Study||5
8498567|NCT00513019|20943016|P2|COMPLETED|Overall Study||13
8498568|NCT00513019|20943017|P1|COMPLETED|Overall Study||12
8498569|NCT00513019|20943016|P2|STARTED|Overall Study||18
8498570|NCT00513019|20943017|P1|STARTED|Overall Study||17
8498571|NCT00512902|20943023|P1|NOT COMPLETED|Overall Study||8
8498572|NCT00512902|20943023|P1|COMPLETED|Overall Study||12
8498573|NCT00512902|20943023|P1|STARTED|Overall Study||20
8498574|NCT00512876|20943031|P1|NOT COMPLETED|Overall Study||4
8498575|NCT00512876|20943031|P1|COMPLETED|Overall Study||20
8498576|NCT00512876|20943031|P1|STARTED|Overall Study||24
8498577|NCT00512798|20943038|P2|NOT COMPLETED|Overall Study||27
8498578|NCT00512798|20943039|P1|NOT COMPLETED|Overall Study||19
8498579|NCT00512798|20943038|P2|COMPLETED|Overall Study||1
8498580|NCT00512798|20943039|P1|COMPLETED|Overall Study||0
8498581|NCT00512798|20943038|P2|STARTED|Overall Study||28
8498582|NCT00512798|20943039|P1|STARTED|Overall Study||19
8498583|NCT00512707|20943050|P2|NOT COMPLETED|Overall Study||12
8498584|NCT00512707|20943051|P1|NOT COMPLETED|Overall Study||10
8498585|NCT00512707|20943050|P2|COMPLETED|Overall Study||58
8498586|NCT00512707|20943051|P1|COMPLETED|Overall Study||60
8498587|NCT00512707|20943050|P2|STARTED|Overall Study||70
8498588|NCT00512707|20943051|P1|STARTED|Overall Study||70
8498589|NCT00512278|20943083|P2|NOT COMPLETED|Overall Study||17
8498590|NCT00512278|20943084|P1|NOT COMPLETED|Overall Study||28
8498591|NCT00512278|20943083|P2|COMPLETED|Overall Study||56
8498592|NCT00512278|20943084|P1|COMPLETED|Overall Study||45
8498593|NCT00512278|20943083|P2|STARTED|Overall Study||73
8498594|NCT00512278|20943084|P1|STARTED|Overall Study||73
8498595|NCT00512252|20943101|P3|NOT COMPLETED|Overall Study||3
8498596|NCT00512252|20943102|P2|NOT COMPLETED|Overall Study||0
8498597|NCT00512252|20943103|P1|NOT COMPLETED|Overall Study||0
8498598|NCT00512252|20943101|P3|COMPLETED|Overall Study||43
8498599|NCT00512252|20943102|P2|COMPLETED|Overall Study||3
8498600|NCT00512252|20943103|P1|COMPLETED|Overall Study||3
8498601|NCT00512252|20943101|P3|STARTED|Overall Study||46
8498602|NCT00512252|20943102|P2|STARTED|Overall Study||3
8498603|NCT00512252|20943103|P1|STARTED|Overall Study||3
8498604|NCT00512148|20943131|P1|NOT COMPLETED|Long Term Follow Up Period||6
8498605|NCT00512148|20943131|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
8498606|NCT00512148|20943131|P1|STARTED|Long Term Follow Up Period||6
8498607|NCT00512148|20943131|P1|NOT COMPLETED|Primay Study Period||1
8498608|NCT00512148|20943131|P1|COMPLETED|Primay Study Period||6
8498609|NCT00512148|20943131|P1|STARTED|Primay Study Period||7
8498610|NCT00512096|20943137|P1|NOT COMPLETED|Overall Study||7
8498611|NCT00512096|20943137|P1|COMPLETED|Overall Study||23
8498612|NCT00512096|20943137|P1|STARTED|Overall Study||30
8498613|NCT00511992|20943141|P1|NOT COMPLETED|Overall Study||7
8498614|NCT00511992|20943141|P1|COMPLETED|Overall Study||13
8498615|NCT00511992|20943141|P1|STARTED|Overall Study||20
8498616|NCT00511914|20943148|P2|NOT COMPLETED|Overall Study||0
8498617|NCT00511914|20943149|P1|NOT COMPLETED|Overall Study||0
8498618|NCT00511914|20943148|P2|COMPLETED|Overall Study||67
8498619|NCT00511914|20943149|P1|COMPLETED|Overall Study||68
8498620|NCT00511914|20943148|P2|STARTED|Overall Study||67
8498621|NCT00511914|20943149|P1|STARTED|Overall Study||68
8498622|NCT00511901|20943165|P2|NOT COMPLETED|Overall Study||3
8498623|NCT00511901|20943166|P1|NOT COMPLETED|Overall Study||1
8498624|NCT00511901|20943165|P2|COMPLETED|Overall Study||8
8498625|NCT00511901|20943166|P1|COMPLETED|Overall Study||10
8498626|NCT00511901|20943165|P2|STARTED|Overall Study||11
8498627|NCT00511901|20943166|P1|STARTED|Overall Study||11
8498628|NCT00511875|20943188|P2|NOT COMPLETED|Overall Study||0
8498629|NCT00511875|20943189|P1|NOT COMPLETED|Overall Study||5
8498630|NCT00511875|20943188|P2|COMPLETED|Overall Study||15
8498631|NCT00511875|20943189|P1|COMPLETED|Overall Study||10
8498632|NCT00511875|20943188|P2|STARTED|Overall Study||15
8498633|NCT00511875|20943189|P1|STARTED|Overall Study||15
8498634|NCT00511862|20943214|P3|NOT COMPLETED|Overall Study||0
8498635|NCT00511862|20943215|P2|NOT COMPLETED|Overall Study||0
8498636|NCT00511862|20943216|P1|NOT COMPLETED|Overall Study||0
8498637|NCT00511862|20943214|P3|COMPLETED|Overall Study||47
8498638|NCT00511862|20943215|P2|COMPLETED|Overall Study||43
8498639|NCT00511862|20943216|P1|COMPLETED|Overall Study||61
8498640|NCT00511862|20943214|P3|STARTED|Overall Study||47
8498641|NCT00511862|20943215|P2|STARTED|Overall Study||43
8498642|NCT00511862|20943216|P1|STARTED|Overall Study||61
8498643|NCT00511836|20943229|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
8498644|NCT00511836|20943230|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
8498645|NCT00511836|20943229|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
8498646|NCT00511836|20943230|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
8498647|NCT00511836|20943229|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
8498648|NCT00511836|20943230|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
8498649|NCT00511836|20943229|P2|NOT COMPLETED|Double-blind Period||0
8498650|NCT00511836|20943230|P1|NOT COMPLETED|Double-blind Period||1
8498651|NCT00511836|20943229|P2|COMPLETED|Double-blind Period||15
8498652|NCT00511836|20943230|P1|COMPLETED|Double-blind Period||15
8498653|NCT00511836|20943229|P2|STARTED|Double-blind Period||15
8498654|NCT00511836|20943230|P1|STARTED|Double-blind Period||16
8498655|NCT00511810|20943247|P2|NOT COMPLETED|Overall Study||5
8498656|NCT00511810|20943248|P1|NOT COMPLETED|Overall Study||1
8498657|NCT00511810|20943247|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
8498658|NCT00511810|20943248|P1|COMPLETED|Overall Study||7
8498659|NCT00511810|20943247|P2|STARTED|Overall Study||12
8498660|NCT00511810|20943248|P1|STARTED|Overall Study||8
8498661|NCT00511797|20943258|P4|NOT COMPLETED|Overall Study||15
8498662|NCT00511797|20943259|P3|NOT COMPLETED|Overall Study||11
8498663|NCT00511797|20943260|P2|NOT COMPLETED|Overall Study||8
8498664|NCT00511797|20943261|P1|NOT COMPLETED|Overall Study||7
8498665|NCT00511797|20943258|P4|COMPLETED|Overall Study||47
8498666|NCT00511797|20943259|P3|COMPLETED|Overall Study||51
8498667|NCT00511797|20943260|P2|COMPLETED|Overall Study||55
8498668|NCT00511797|20943261|P1|COMPLETED|Overall Study||55
8498669|NCT00511797|20943258|P4|Subjects Received Treatment|Overall Study|FAS|58
8498670|NCT00511797|20943259|P3|Subjects Received Treatment|Overall Study|FAS|61
8498671|NCT00511797|20943260|P2|Subjects Received Treatment|Overall Study|FAS|62
8498672|NCT00511797|20943261|P1|Subjects Received Treatment|Overall Study|FAS|61
8498673|NCT00511797|20943258|P4|Subjects Dispensed Drugs|Overall Study||59
8498674|NCT00511797|20943259|P3|Subjects Dispensed Drugs|Overall Study||61
8498675|NCT00511797|20943260|P2|Subjects Dispensed Drugs|Overall Study||63
8498676|NCT00511797|20943261|P1|Subjects Dispensed Drugs|Overall Study||61
8498677|NCT00511797|20943258|P4|STARTED|Overall Study||62
8498678|NCT00511797|20943259|P3|STARTED|Overall Study||62
8498679|NCT00511797|20943260|P2|STARTED|Overall Study||63
8498680|NCT00511797|20943261|P1|STARTED|Overall Study||62
8498681|NCT00511706|20943365|P2|NOT COMPLETED|Overall Study||5
8498682|NCT00511706|20943366|P1|NOT COMPLETED|Overall Study||8
8498683|NCT00511706|20943365|P2|COMPLETED|Overall Study||115
8498684|NCT00511706|20943366|P1|COMPLETED|Overall Study||115
8498685|NCT00511706|20943365|P2|STARTED|Overall Study||120
8498686|NCT00511706|20943366|P1|STARTED|Overall Study||123
8498687|NCT00511667|20943380|P2|NOT COMPLETED|Overall Study||3
8498688|NCT00511667|20943381|P1|NOT COMPLETED|Overall Study||12
8498689|NCT00511667|20943380|P2|COMPLETED|Overall Study||15
8498690|NCT00511667|20943381|P1|COMPLETED|Overall Study||40
8498691|NCT00511667|20943380|P2|STARTED|Overall Study||18
8498692|NCT00511667|20943381|P1|STARTED|Overall Study||52
8498693|NCT00511472|20943416|P2|NOT COMPLETED|Overall Study||6
8498694|NCT00511472|20943417|P1|NOT COMPLETED|Overall Study||3
8498695|NCT00511472|20943416|P2|COMPLETED|Overall Study||17
8498696|NCT00511472|20943417|P1|COMPLETED|Overall Study||44
8498697|NCT00511472|20943416|P2|STARTED|Overall Study||23
8498698|NCT00511472|20943417|P1|STARTED|Overall Study||47
8498699|NCT00511433|20943436|P2|NOT COMPLETED|Overall Study||1
8498700|NCT00511433|20943437|P1|NOT COMPLETED|Overall Study||6
8498701|NCT00511433|20943436|P2|COMPLETED|Overall Study||15
8498702|NCT00511433|20943437|P1|COMPLETED|Overall Study||26
8498703|NCT00511433|20943436|P2|STARTED|Overall Study||16
8498704|NCT00511433|20943437|P1|STARTED|Overall Study||32
8498705|NCT00511355|20943477|P2|NOT COMPLETED|Overall Study||9
8498706|NCT00511355|20943478|P1|NOT COMPLETED|Overall Study||7
8498707|NCT00511355|20943477|P2|COMPLETED|Overall Study||52
8498708|NCT00511355|20943478|P1|COMPLETED|Overall Study||53
8498709|NCT00511355|20943477|P2|STARTED|Overall Study||61
8498710|NCT00511355|20943478|P1|STARTED|Overall Study||60
8498711|NCT00511342|20943578|P2|NOT COMPLETED|Overall Study||22
8498712|NCT00511342|20943579|P1|NOT COMPLETED|Overall Study||13
8498713|NCT00511342|20943578|P2|COMPLETED|Overall Study||32
8498714|NCT00511342|20943579|P1|COMPLETED|Overall Study||43
8498715|NCT00511342|20943578|P2|STARTED|Overall Study||54
8498716|NCT00511342|20943579|P1|STARTED|Overall Study||56
8498717|NCT00511329|20943603|P1|NOT COMPLETED|Overall Study||0
8498718|NCT00511329|20943603|P1|COMPLETED|Overall Study||0
8498719|NCT00511329|20943603|P1|STARTED|Overall Study||0
8498720|NCT00511238|20943610|P2|NOT COMPLETED|Overall Study||226
8498721|NCT00511238|20943611|P1|NOT COMPLETED|Overall Study||42
8498722|NCT00511238|20943610|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
8498723|NCT00511238|20943611|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
8498724|NCT00511238|20943610|P2|STARTED|Overall Study||266
8498725|NCT00511238|20943611|P1|STARTED|Overall Study||46
8498726|NCT00511199|20943630|P2|NOT COMPLETED|Overall Study||125
8498727|NCT00511199|20943631|P1|NOT COMPLETED|Overall Study||449
8498728|NCT00511199|20943630|P2|COMPLETED|Overall Study||410
8498729|NCT00511199|20943631|P1|COMPLETED|Overall Study||1142
8498730|NCT00511199|20943630|P2|STARTED|Overall Study||535
8498731|NCT00511199|20943631|P1|STARTED|Overall Study||1591
8498732|NCT00511173|20943655|P1|NOT COMPLETED|Overall Study||0
8498733|NCT00511173|20943655|P1|COMPLETED|Overall Study||102
8498734|NCT00511173|20943655|P1|STARTED|Overall Study||102
8498735|NCT00511147|20943660|P1|NOT COMPLETED|Overall Study||7
8498736|NCT00511147|20943660|P1|COMPLETED|Overall Study||57
8498737|NCT00511147|20943660|P1|STARTED|Overall Study||64
8498738|NCT00511134|20943669|P2|NOT COMPLETED|Overall Study||2
8498739|NCT00511134|20943670|P1|NOT COMPLETED|Overall Study||0
8498740|NCT00511134|20943669|P2|COMPLETED|Overall Study||1
8498741|NCT00511134|20943670|P1|COMPLETED|Overall Study||1
8498742|NCT00511134|20943669|P2|STARTED|Overall Study||3
8498743|NCT00511134|20943670|P1|STARTED|Overall Study||1
8498744|NCT00511108|20943682|P4|NOT COMPLETED|Overall Study||5
8498745|NCT00511108|20943683|P3|NOT COMPLETED|Overall Study||5
8498746|NCT00511108|20943684|P2|NOT COMPLETED|Overall Study||2
8498747|NCT00511108|20943685|P1|NOT COMPLETED|Overall Study||6
8498748|NCT00511108|20943682|P4|COMPLETED|Overall Study||48
8498749|NCT00511108|20943683|P3|COMPLETED|Overall Study||47
8498750|NCT00511108|20943684|P2|COMPLETED|Overall Study||52
8498751|NCT00511108|20943685|P1|COMPLETED|Overall Study||46
8498752|NCT00511108|20943682|P4|STARTED|Overall Study||53
8498753|NCT00511108|20943683|P3|STARTED|Overall Study||52
8498754|NCT00511108|20943684|P2|STARTED|Overall Study||54
8498755|NCT00511108|20943685|P1|STARTED|Overall Study||52
8498756|NCT00511095|20943703|P1|NOT COMPLETED|Overall Study||11
8498757|NCT00511095|20943703|P1|COMPLETED|Overall Study||196
8498758|NCT00511095|20943703|P1|STARTED|Overall Study||207
8498759|NCT00511004|20943716|P3|NOT COMPLETED|Overall Study||4
8498760|NCT00511004|20943717|P2|NOT COMPLETED|Overall Study||0
8498761|NCT00511004|20943718|P1|NOT COMPLETED|Overall Study||0
8498762|NCT00511004|20943716|P3|COMPLETED|Overall Study||10
8498763|NCT00511004|20943717|P2|COMPLETED|Overall Study||13
8498764|NCT00511004|20943718|P1|COMPLETED|Overall Study||13
8498765|NCT00511004|20943716|P3|STARTED|Overall Study||14
8498766|NCT00511004|20943717|P2|STARTED|Overall Study||13
8498767|NCT00511004|20943718|P1|STARTED|Overall Study||13
8498768|NCT00510952|20943737|P2|NOT COMPLETED|Overall Study||16
8498769|NCT00510952|20943738|P1|NOT COMPLETED|Overall Study||26
8498770|NCT00510952|20943737|P2|COMPLETED|Overall Study||220
8498771|NCT00510952|20943738|P1|COMPLETED|Overall Study||209
8498772|NCT00510952|20943737|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
8498773|NCT00510952|20943738|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
8498774|NCT00510952|20943737|P2|STARTED|Overall Study||236
8498775|NCT00510952|20943738|P1|STARTED|Overall Study||235
8498776|NCT00510887|20943764|P1|NOT COMPLETED|Overall Study||1
8498777|NCT00510887|20943764|P1|COMPLETED|Overall Study||11
8498778|NCT00510887|20943764|P1|STARTED|Overall Study||12
8498779|NCT00510874|20943780|P7|NOT COMPLETED|Overall Study||1
8498780|NCT00510874|20943781|P6|NOT COMPLETED|Overall Study||0
8498781|NCT00510874|20943782|P5|NOT COMPLETED|Overall Study||7
8498782|NCT00510874|20943783|P4|NOT COMPLETED|Overall Study||3
8498783|NCT00510874|20943784|P3|NOT COMPLETED|Overall Study||1
8498784|NCT00510874|20943785|P2|NOT COMPLETED|Overall Study||4
8498785|NCT00510874|20943786|P1|NOT COMPLETED|Overall Study||3
8498786|NCT00510874|20943780|P7|COMPLETED|Overall Study|Upto Day 182|49
8498787|NCT00510874|20943781|P6|COMPLETED|Overall Study|Upto Day 182|50
8498788|NCT00510874|20943782|P5|COMPLETED|Overall Study|Upto Day 182|141
8498789|NCT00510874|20943783|P4|COMPLETED|Overall Study|Upto Day 182|148
8498790|NCT00510874|20943784|P3|COMPLETED|Overall Study|Upto Day 182|150
8498791|NCT00510874|20943785|P2|COMPLETED|Overall Study|Upto Day 182|148
8498792|NCT00510874|20943786|P1|COMPLETED|Overall Study|Upto Day 182|75
8498793|NCT00510874|20943780|P7|STARTED|Overall Study||50
8498794|NCT00510874|20943781|P6|STARTED|Overall Study||50
8498795|NCT00510874|20943782|P5|STARTED|Overall Study||148
8498796|NCT00510874|20943783|P4|STARTED|Overall Study||151
8498797|NCT00510874|20943784|P3|STARTED|Overall Study||151
8498798|NCT00510874|20943785|P2|STARTED|Overall Study||152
8498799|NCT00510874|20943786|P1|STARTED|Overall Study||78
8498800|NCT00510835|20943889|P3|NOT COMPLETED|Overall Study||2
8498801|NCT00510835|20943890|P2|NOT COMPLETED|Overall Study||2
8498802|NCT00510835|20943891|P1|NOT COMPLETED|Overall Study||6
8498803|NCT00510835|20943889|P3|COMPLETED|Overall Study||456
8498804|NCT00510835|20943890|P2|COMPLETED|Overall Study||446
8498805|NCT00510835|20943891|P1|COMPLETED|Overall Study||439
8498806|NCT00510835|20943889|P3|STARTED|Overall Study||458
8498807|NCT00510835|20943890|P2|STARTED|Overall Study||448
8498808|NCT00510835|20943891|P1|STARTED|Overall Study||445
8498809|NCT00510809|20943902|P3|NOT COMPLETED|Overall Study||0
8498810|NCT00510809|20943903|P2|NOT COMPLETED|Overall Study||0
8498811|NCT00510809|20943904|P1|NOT COMPLETED|Overall Study||0
8498812|NCT00510809|20943902|P3|COMPLETED|Overall Study||18
8498813|NCT00510809|20943903|P2|COMPLETED|Overall Study||18
8498814|NCT00510809|20943904|P1|COMPLETED|Overall Study||18
8498815|NCT00510809|20943902|P3|STARTED|Overall Study||18
8498816|NCT00510809|20943903|P2|STARTED|Overall Study||18
8498817|NCT00510809|20943904|P1|STARTED|Overall Study||18
8498818|NCT00510783|20943917|P2|NOT COMPLETED|Overall Study||29
8498819|NCT00510783|20943918|P1|NOT COMPLETED|Overall Study||31
8498820|NCT00510783|20943917|P2|COMPLETED|Overall Study||47
8498821|NCT00510783|20943918|P1|COMPLETED|Overall Study||51
8498822|NCT00510783|20943917|P2|STARTED|Overall Study||76
8498823|NCT00510783|20943918|P1|STARTED|Overall Study||82
8498824|NCT00510744|20943924|P1|NOT COMPLETED|Overall Study||0
8498825|NCT00510744|20943924|P1|COMPLETED|Overall Study||5
8498826|NCT00510744|20943924|P1|STARTED|Overall Study||5
8498827|NCT00510718|20943935|P2|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
8498828|NCT00510718|20943936|P1|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
8498829|NCT00510718|20943935|P2|COMPLETED|Multiple Dose Period: 12 Weeks||43
8498830|NCT00510718|20943936|P1|COMPLETED|Multiple Dose Period: 12 Weeks||50
8498831|NCT00510718|20943935|P2|600 mg/Day|Multiple Dose Period: 12 Weeks||3
8498832|NCT00510718|20943936|P1|600 mg/Day|Multiple Dose Period: 12 Weeks||0
8498833|NCT00510718|20943935|P2|480 mg/Day|Multiple Dose Period: 12 Weeks||22
8498834|NCT00510718|20943936|P1|480 mg/Day|Multiple Dose Period: 12 Weeks||0
8498835|NCT00510718|20943935|P2|360 mg/Day|Multiple Dose Period: 12 Weeks||13
8498836|NCT00510718|20943936|P1|360 mg/Day|Multiple Dose Period: 12 Weeks||15
8498837|NCT00510718|20943935|P2|240 mg/Day|Multiple Dose Period: 12 Weeks||12
8498838|NCT00510718|20943936|P1|240 mg/Day|Multiple Dose Period: 12 Weeks||17
8498839|NCT00510718|20943935|P2|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
8498840|NCT00510718|20943936|P1|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
8498841|NCT00510718|20943935|P2|60 mg/Day|Multiple Dose Period: 12 Weeks||12
8498842|NCT00510718|20943936|P1|60 mg/Day|Multiple Dose Period: 12 Weeks||15
8498843|NCT00510718|20943935|P2|30 mg/Day|Multiple Dose Period: 12 Weeks||0
8498844|NCT00510718|20943936|P1|30 mg/Day|Multiple Dose Period: 12 Weeks||3
8498845|NCT00510718|20943935|P2|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
8498846|NCT00510718|20943936|P1|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
8498847|NCT00510718|20943935|P2|NOT COMPLETED|Single Dose Period: 1 Week||0
8498848|NCT00510718|20943936|P1|NOT COMPLETED|Single Dose Period: 1 Week||0
8498849|NCT00510718|20943935|P2|COMPLETED|Single Dose Period: 1 Week||12
8498850|NCT00510718|20943936|P1|COMPLETED|Single Dose Period: 1 Week||15
8498851|NCT00510718|20943935|P2|600 mg/Day|Single Dose Period: 1 Week||3
8498852|NCT00510718|20943936|P1|600 mg/Day|Single Dose Period: 1 Week||0
8498853|NCT00510718|20943935|P2|480 mg/Day|Single Dose Period: 1 Week||6
8498854|NCT00510718|20943936|P1|480 mg/Day|Single Dose Period: 1 Week||0
8498855|NCT00510718|20943935|P2|360 mg/Day|Single Dose Period: 1 Week||2
8498856|NCT00510718|20943936|P1|360 mg/Day|Single Dose Period: 1 Week||4
8498857|NCT00510718|20943935|P2|240 mg/Day|Single Dose Period: 1 Week||0
8498858|NCT00510718|20943936|P1|240 mg/Day|Single Dose Period: 1 Week||3
8498859|NCT00510718|20943935|P2|150/160 mg/Day|Single Dose Period: 1 Week||1
8498860|NCT00510718|20943936|P1|150/160 mg/Day|Single Dose Period: 1 Week||2
8498861|NCT00510718|20943935|P2|60 mg/Day|Single Dose Period: 1 Week||0
8498862|NCT00510718|20943936|P1|60 mg/Day|Single Dose Period: 1 Week||3
8498863|NCT00510718|20943935|P2|30 mg/Day|Single Dose Period: 1 Week||0
8498864|NCT00510718|20943936|P1|30 mg/Day|Single Dose Period: 1 Week||3
8498865|NCT00510718|20943935|P2|STARTED|Single Dose Period: 1 Week||12
8498866|NCT00510718|20943936|P1|STARTED|Single Dose Period: 1 Week||15
8498867|NCT00510692|20944062|P2|NOT COMPLETED|Overall Study||3
8498868|NCT00510692|20944063|P1|NOT COMPLETED|Overall Study||2
8498869|NCT00510692|20944062|P2|COMPLETED|Overall Study||26
8498870|NCT00510692|20944063|P1|COMPLETED|Overall Study||27
8498871|NCT00510692|20944062|P2|STARTED|Overall Study||29
8498872|NCT00510692|20944063|P1|STARTED|Overall Study||29
8498873|NCT00510653|20944077|P1|NOT COMPLETED|Overall Study||11
8498874|NCT00510653|20944077|P1|COMPLETED|Overall Study||13
8498875|NCT00510653|20944077|P1|STARTED|Overall Study||24
8498876|NCT00510510|20944084|P3|NOT COMPLETED|Overall Study||17
8498877|NCT00510510|20944085|P2|NOT COMPLETED|Overall Study||9
8498878|NCT00510510|20944086|P1|NOT COMPLETED|Overall Study||5
8498879|NCT00510510|20944084|P3|COMPLETED|Overall Study||74
8498880|NCT00510510|20944085|P2|COMPLETED|Overall Study||89
8498881|NCT00510510|20944086|P1|COMPLETED|Overall Study||87
8498882|NCT00510510|20944084|P3|STARTED|Overall Study||91
8498883|NCT00510510|20944085|P2|STARTED|Overall Study||98
8498884|NCT00510510|20944086|P1|STARTED|Overall Study||92
8498885|NCT00510497|20944097|P1|NOT COMPLETED|Overall Study||3
8498886|NCT00510497|20944097|P1|COMPLETED|Overall Study||8
8498887|NCT00510497|20944097|P1|STARTED|Overall Study||11
8498888|NCT00510484|20944104|P2|NOT COMPLETED|Period 2||0
8498889|NCT00510484|20944105|P1|NOT COMPLETED|Period 2||0
8498890|NCT00510484|20944104|P2|COMPLETED|Period 2||15
8498891|NCT00510484|20944105|P1|COMPLETED|Period 2||16
8498892|NCT00510484|20944104|P2|STARTED|Period 2||15
8498893|NCT00510484|20944105|P1|STARTED|Period 2||16
8498894|NCT00510484|20944104|P2|NOT COMPLETED|Wash-out Period||1
8498895|NCT00510484|20944105|P1|NOT COMPLETED|Wash-out Period||0
8498896|NCT00510484|20944104|P2|COMPLETED|Wash-out Period||15
8498897|NCT00510484|20944105|P1|COMPLETED|Wash-out Period||16
8498898|NCT00510484|20944104|P2|STARTED|Wash-out Period||16
8498899|NCT00510484|20944105|P1|STARTED|Wash-out Period||16
8498900|NCT00510484|20944104|P2|NOT COMPLETED|Period 1||0
8498901|NCT00510484|20944105|P1|NOT COMPLETED|Period 1||0
8498902|NCT00510484|20944104|P2|COMPLETED|Period 1||16
8498903|NCT00510484|20944105|P1|COMPLETED|Period 1||16
8498904|NCT00510484|20944104|P2|STARTED|Period 1||16
8498905|NCT00510484|20944105|P1|STARTED|Period 1||16
8498906|NCT00510458|20944125|P1|NOT COMPLETED|Overall Study||47
8498907|NCT00510458|20944125|P1|COMPLETED|Overall Study||27
8498908|NCT00510458|20944125|P1|STARTED|Overall Study||74
8498909|NCT00510289|20944138|P1|NOT COMPLETED|Overall Study||12
8498910|NCT00510289|20944138|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
8498911|NCT00510289|20944138|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
8498912|NCT00510289|20944138|P1|STARTED|Overall Study|All patients who consented|19
8498913|NCT00510276|20944148|P2|NOT COMPLETED|Extension Open-Label Phase||48
8498914|NCT00510276|20944149|P1|NOT COMPLETED|Extension Open-Label Phase||33
8498915|NCT00510276|20944148|P2|COMPLETED|Extension Open-Label Phase||81
8498916|NCT00510276|20944149|P1|COMPLETED|Extension Open-Label Phase||78
8498917|NCT00510276|20944148|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
8498918|NCT00510276|20944149|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
8498919|NCT00510276|20944148|P2|NOT COMPLETED|Acute Double-Blind Phase||95
8498920|NCT00510276|20944149|P1|NOT COMPLETED|Acute Double-Blind Phase||105
8498921|NCT00510276|20944148|P2|COMPLETED|Acute Double-Blind Phase||130
8498922|NCT00510276|20944149|P1|COMPLETED|Acute Double-Blind Phase||115
8498923|NCT00510276|20944148|P2|STARTED|Acute Double-Blind Phase||225
8498924|NCT00510276|20944149|P1|STARTED|Acute Double-Blind Phase||220
8498925|NCT00510224|20944234|P1|NOT COMPLETED|Overall Study||3
8498926|NCT00510224|20944234|P1|COMPLETED|Overall Study||10
8498927|NCT00510224|20944234|P1|STARTED|Overall Study||13
8498928|NCT00510198|20944243|P2|NOT COMPLETED|Overall Study||4
8498929|NCT00510198|20944244|P1|NOT COMPLETED|Overall Study||5
8498930|NCT00510198|20944243|P2|COMPLETED|Overall Study||54
8498931|NCT00510198|20944244|P1|COMPLETED|Overall Study||54
8498932|NCT00510198|20944243|P2|STARTED|Overall Study||58
8498933|NCT00510198|20944244|P1|STARTED|Overall Study||59
8498934|NCT00510146|20944258|P2|NOT COMPLETED|Open-Label Treatment||26
8498935|NCT00510146|20944259|P1|NOT COMPLETED|Open-Label Treatment||71
8498936|NCT00510146|20944258|P2|COMPLETED|Open-Label Treatment||96
8498937|NCT00510146|20944259|P1|COMPLETED|Open-Label Treatment||196
8498938|NCT00510146|20944258|P2|STARTED|Open-Label Treatment||122
8498939|NCT00510146|20944259|P1|STARTED|Open-Label Treatment||267
8498940|NCT00510146|20944258|P2|NOT COMPLETED|Double-Blind Treatment||49
8498941|NCT00510146|20944259|P1|NOT COMPLETED|Double-Blind Treatment||76
8498942|NCT00510146|20944258|P2|COMPLETED|Double-Blind Treatment||122
8498943|NCT00510146|20944259|P1|COMPLETED|Double-Blind Treatment||267
8498944|NCT00510146|20944258|P2|STARTED|Double-Blind Treatment||171
8498945|NCT00510146|20944259|P1|STARTED|Double-Blind Treatment||343
8498946|NCT00510068|20944348|P2|NOT COMPLETED|Open-label Period||0
8498947|NCT00510068|20944349|P1|NOT COMPLETED|Open-label Period||225
8498948|NCT00510068|20944348|P2|COMPLETED|Open-label Period||0
8498949|NCT00510068|20944349|P1|COMPLETED|Open-label Period||0
8498950|NCT00510068|20944348|P2|STARTED|Open-label Period||0
8498951|NCT00510068|20944349|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
8498952|NCT00510068|20944348|P2|NOT COMPLETED|Double-blind Period||203
8498953|NCT00510068|20944349|P1|NOT COMPLETED|Double-blind Period||207
8498954|NCT00510068|20944348|P2|COMPLETED|Double-blind Period||0
8498955|NCT00510068|20944349|P1|COMPLETED|Double-blind Period||0
8498956|NCT00510068|20944348|P2|Safety Population|Double-blind Period||203
8498957|NCT00510068|20944349|P1|Safety Population|Double-blind Period||204
8498958|NCT00510068|20944348|P2|STARTED|Double-blind Period||203
8498959|NCT00510068|20944349|P1|STARTED|Double-blind Period||207
8498960|NCT00509925|20944390|P2|NOT COMPLETED|Overall Study||1
8498961|NCT00509925|20944391|P1|NOT COMPLETED|Overall Study||0
8498962|NCT00509925|20944390|P2|COMPLETED|Overall Study||10
8498963|NCT00509925|20944391|P1|COMPLETED|Overall Study||12
8498964|NCT00509925|20944390|P2|STARTED|Overall Study||11
8498965|NCT00509925|20944391|P1|STARTED|Overall Study||12
8498966|NCT00509899|20944439|P8|NOT COMPLETED|Overall Study||1
8498967|NCT00509899|20944440|P7|NOT COMPLETED|Overall Study||1
8498968|NCT00509899|20944441|P6|NOT COMPLETED|Overall Study||10
8498969|NCT00509899|20944442|P5|NOT COMPLETED|Overall Study||5
8498970|NCT00509899|20944443|P4|NOT COMPLETED|Overall Study||4
8498971|NCT00509899|20944444|P3|NOT COMPLETED|Overall Study||20
8498972|NCT00509899|20944445|P2|NOT COMPLETED|Overall Study||9
8498973|NCT00509899|20944446|P1|NOT COMPLETED|Overall Study||16
8498974|NCT00509899|20944439|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
8498975|NCT00509899|20944440|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
8498976|NCT00509899|20944441|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
8498977|NCT00509899|20944442|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
8498978|NCT00509899|20944443|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
8498979|NCT00509899|20944444|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
8498980|NCT00509899|20944445|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
8498981|NCT00509899|20944446|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
8498982|NCT00509899|20944439|P8|STARTED|Overall Study||3
8498983|NCT00509899|20944440|P7|STARTED|Overall Study||6
8498984|NCT00509899|20944441|P6|STARTED|Overall Study||22
8498985|NCT00509899|20944442|P5|STARTED|Overall Study||6
8498986|NCT00509899|20944443|P4|STARTED|Overall Study||5
8498987|NCT00509899|20944444|P3|STARTED|Overall Study||47
8498988|NCT00509899|20944445|P2|STARTED|Overall Study||35
8498989|NCT00509899|20944446|P1|STARTED|Overall Study||30
8498990|NCT00509873|20944486|P2|NOT COMPLETED|Overall Study||15
8498991|NCT00509873|20944487|P1|NOT COMPLETED|Overall Study||11
8498992|NCT00509873|20944486|P2|COMPLETED|Overall Study||276
8498993|NCT00509873|20944487|P1|COMPLETED|Overall Study||276
8498994|NCT00509873|20944486|P2|STARTED|Overall Study||291
8498995|NCT00509873|20944487|P1|STARTED|Overall Study||287
8498996|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 4 (Follow Up)||0
8498997|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 4 (Follow Up)||0
8498998|NCT00509821|20944503|P2|COMPLETED|Study Period 4 (Follow Up)||50
8498999|NCT00509821|20944504|P1|COMPLETED|Study Period 4 (Follow Up)||2
8499000|NCT00509821|20944503|P2|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
8499001|NCT00509821|20944504|P1|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
8499002|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 3 (Maintenance)||49
8499003|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 3 (Maintenance)||0
8499004|NCT00509821|20944503|P2|COMPLETED|Study Period 3 (Maintenance)||0
8499005|NCT00509821|20944504|P1|COMPLETED|Study Period 3 (Maintenance)||3
8499006|NCT00509821|20944503|P2|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
8499007|NCT00509821|20944504|P1|STARTED|Study Period 3 (Maintenance)||3
8499008|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 2 (Radiation)||53
8499009|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 2 (Radiation)||0
8499010|NCT00509821|20944503|P2|COMPLETED|Study Period 2 (Radiation)||0
8499011|NCT00509821|20944504|P1|COMPLETED|Study Period 2 (Radiation)||3
8499012|NCT00509821|20944503|P2|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
8499013|NCT00509821|20944504|P1|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
8499014|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 1 (Induction)||4
8499015|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 1 (Induction)||0
8499016|NCT00509821|20944503|P2|COMPLETED|Study Period 1 (Induction)||53
8499017|NCT00509821|20944504|P1|COMPLETED|Study Period 1 (Induction)||3
8499018|NCT00509821|20944503|P2|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
8499019|NCT00509821|20944504|P1|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
8499020|NCT00509821|20944503|P2|STARTED|Study Period 1 (Induction)||57
8499021|NCT00509821|20944504|P1|STARTED|Study Period 1 (Induction)||3
8499022|NCT00509795|20944522|P4|NOT COMPLETED|Overall Study||27
8499023|NCT00509795|20944523|P3|NOT COMPLETED|Overall Study||27
8499024|NCT00509795|20944524|P2|NOT COMPLETED|Overall Study||11
8499025|NCT00509795|20944525|P1|NOT COMPLETED|Overall Study||22
8499026|NCT00509795|20944522|P4|COMPLETED|Overall Study||276
8499027|NCT00509795|20944523|P3|COMPLETED|Overall Study||277
8499028|NCT00509795|20944524|P2|COMPLETED|Overall Study||293
8499029|NCT00509795|20944525|P1|COMPLETED|Overall Study||284
8499030|NCT00509795|20944522|P4|Per Protocol Set (PPS) Population|Overall Study||265
8499031|NCT00509795|20944523|P3|Per Protocol Set (PPS) Population|Overall Study||270
8499032|NCT00509795|20944524|P2|Per Protocol Set (PPS) Population|Overall Study||285
8499033|NCT00509795|20944525|P1|Per Protocol Set (PPS) Population|Overall Study||269
8499034|NCT00509795|20944522|P4|Full Analysis Set (FAS) Population|Overall Study||301
8499035|NCT00509795|20944523|P3|Full Analysis Set (FAS) Population|Overall Study||301
8499036|NCT00509795|20944524|P2|Full Analysis Set (FAS) Population|Overall Study||304
8499037|NCT00509795|20944525|P1|Full Analysis Set (FAS) Population|Overall Study||304
8499038|NCT00509795|20944522|P4|Patients Received Treatment (SAF)|Overall Study||303
8499039|NCT00509795|20944523|P3|Patients Received Treatment (SAF)|Overall Study||304
8499040|NCT00509795|20944524|P2|Patients Received Treatment (SAF)|Overall Study||304
8499041|NCT00509795|20944525|P1|Patients Received Treatment (SAF)|Overall Study||304
8499042|NCT00509795|20944522|P4|STARTED|Overall Study||303
8499043|NCT00509795|20944523|P3|STARTED|Overall Study||304
8499044|NCT00509795|20944524|P2|STARTED|Overall Study||304
8499045|NCT00509795|20944525|P1|STARTED|Overall Study||306
8499046|NCT00509769|20944556|P1|NOT COMPLETED|Overall Study||91
8499047|NCT00509769|20944556|P1|COMPLETED|Overall Study||21
8499048|NCT00509769|20944556|P1|STARTED|Overall Study||112
8499049|NCT00509665|20944565|P1|NOT COMPLETED|Overall Study||0
8499050|NCT00509665|20944565|P1|COMPLETED|Overall Study||18
8499051|NCT00509665|20944565|P1|STARTED|Overall Study||18
8499052|NCT00509600|20944575|P1|NOT COMPLETED|Overall Study||1
8499053|NCT00509600|20944575|P1|COMPLETED|Overall Study||0
8499054|NCT00509600|20944575|P1|STARTED|Overall Study||1
8499055|NCT00509587|20944579|P1|NOT COMPLETED|Overall Study||0
8499056|NCT00509587|20944579|P1|COMPLETED|Overall Study||21
8499057|NCT00509587|20944579|P1|STARTED|Overall Study||21
8499058|NCT00509496|20944590|P2|NOT COMPLETED|Overall Study||0
8499059|NCT00509496|20944591|P1|NOT COMPLETED|Overall Study||0
8499060|NCT00509496|20944590|P2|COMPLETED|Overall Study||2
8499061|NCT00509496|20944591|P1|COMPLETED|Overall Study||19
8499062|NCT00509496|20944590|P2|STARTED|Overall Study||2
8499063|NCT00509496|20944591|P1|STARTED|Overall Study||19
8499064|NCT00509392|20944601|P3|NOT COMPLETED|Overall Study||0
8499065|NCT00509392|20944602|P2|NOT COMPLETED|Overall Study||0
8499066|NCT00509392|20944603|P1|NOT COMPLETED|Overall Study||0
8499067|NCT00509392|20944601|P3|COMPLETED|Overall Study||4
8499068|NCT00509392|20944602|P2|COMPLETED|Overall Study||33
8499069|NCT00509392|20944603|P1|COMPLETED|Overall Study||32
8499070|NCT00509392|20944601|P3|STARTED|Overall Study||4
8499071|NCT00509392|20944602|P2|STARTED|Overall Study||33
8499072|NCT00509392|20944603|P1|STARTED|Overall Study||32
8499073|NCT00509366|20944654|P5|NOT COMPLETED|Overall Study||0
8499074|NCT00509366|20944655|P4|NOT COMPLETED|Overall Study||0
8499075|NCT00509366|20944656|P3|NOT COMPLETED|Overall Study||1
8499076|NCT00509366|20944657|P2|NOT COMPLETED|Overall Study||1
8499077|NCT00509366|20944658|P1|NOT COMPLETED|Overall Study||1
8499078|NCT00509366|20944654|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
8499079|NCT00509366|20944655|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
8499080|NCT00509366|20944656|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
8499081|NCT00509366|20944657|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
8499082|NCT00509366|20944658|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
8499083|NCT00509366|20944654|P5|Assigned Treatment|Overall Study||0
8499084|NCT00509366|20944655|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
8499085|NCT00509366|20944656|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
8499086|NCT00509366|20944657|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
8499087|NCT00509366|20944658|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
8499088|NCT00509366|20944654|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
8499089|NCT00509366|20944655|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
8499090|NCT00509366|20944656|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
8499091|NCT00509366|20944657|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
8499092|NCT00509366|20944658|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
8499093|NCT00509288|20944671|P2|NOT COMPLETED|Overall Study||0
8499094|NCT00509288|20944672|P1|NOT COMPLETED|Overall Study||0
8499095|NCT00509288|20944671|P2|COMPLETED|Overall Study||3
8499096|NCT00509288|20944672|P1|COMPLETED|Overall Study||21
8499097|NCT00509288|20944671|P2|STARTED|Overall Study||3
8499098|NCT00509288|20944672|P1|STARTED|Overall Study||21
8499099|NCT00509262|20944682|P2|NOT COMPLETED|Overall Study||42
8499100|NCT00509262|20944683|P1|NOT COMPLETED|Overall Study||47
8499101|NCT00509262|20944682|P2|COMPLETED|Overall Study||170
8499102|NCT00509262|20944683|P1|COMPLETED|Overall Study||164
8499103|NCT00509262|20944682|P2|STARTED|Overall Study||212
8499104|NCT00509262|20944683|P1|STARTED|Overall Study||211
8499105|NCT00509249|20944695|P1|NOT COMPLETED|Overall Study||0
8499106|NCT00509249|20944695|P1|COMPLETED|Overall Study||18
8499107|NCT00509249|20944695|P1|STARTED|Overall Study||18
8499108|NCT00509236|20944701|P2|NOT COMPLETED|Overall Study||20
8499109|NCT00509236|20944702|P1|NOT COMPLETED|Overall Study||17
8499110|NCT00509236|20944701|P2|COMPLETED|Overall Study||45
8499111|NCT00509236|20944702|P1|COMPLETED|Overall Study||47
8499112|NCT00509236|20944701|P2|STARTED|Overall Study||65
8499113|NCT00509236|20944702|P1|STARTED|Overall Study||64
8499114|NCT00509223|20944717|P2|NOT COMPLETED|Overall Study||72
8499115|NCT00509223|20944718|P1|NOT COMPLETED|Overall Study||88
8499116|NCT00509223|20944717|P2|COMPLETED|Overall Study||137
8499117|NCT00509223|20944718|P1|COMPLETED|Overall Study||119
8499118|NCT00509223|20944717|P2|STARTED|Overall Study||209
8499119|NCT00509223|20944718|P1|STARTED|Overall Study||207
8499120|NCT00509197|20944726|P2|NOT COMPLETED|Overall Study||0
8499121|NCT00509197|20944727|P1|NOT COMPLETED|Overall Study||0
8499122|NCT00509197|20944726|P2|COMPLETED|Overall Study||6
8499123|NCT00509197|20944727|P1|COMPLETED|Overall Study||6
8499124|NCT00509197|20944726|P2|STARTED|Overall Study||6
8499125|NCT00509197|20944727|P1|STARTED|Overall Study||6
8499126|NCT00509171|20944741|P2|NOT COMPLETED|Overall Study||0
8499127|NCT00509171|20944742|P1|NOT COMPLETED|Overall Study||0
8499128|NCT00509171|20944741|P2|COMPLETED|Overall Study||11
8499129|NCT00509171|20944742|P1|COMPLETED|Overall Study||11
8499130|NCT00509171|20944741|P2|STARTED|Overall Study||11
8499131|NCT00509171|20944742|P1|STARTED|Overall Study||11
8499132|NCT00509106|20944750|P2|NOT COMPLETED|Overall Study||29
8499133|NCT00509106|20944751|P1|NOT COMPLETED|Overall Study||31
8499134|NCT00509106|20944750|P2|COMPLETED|Overall Study||278
8499135|NCT00509106|20944751|P1|COMPLETED|Overall Study||284
8499136|NCT00509106|20944750|P2|STARTED|Overall Study||307
8499137|NCT00509106|20944751|P1|STARTED|Overall Study||315
8499138|NCT00509093|20944757|P1|NOT COMPLETED|Overall Study||24
8499139|NCT00509093|20944757|P1|COMPLETED|Overall Study||8
8499140|NCT00509093|20944757|P1|STARTED|Overall Study||32
8499141|NCT00509067|20944767|P2|NOT COMPLETED|Overall Study||5
8499142|NCT00509067|20944768|P1|NOT COMPLETED|Overall Study||4
8499143|NCT00509067|20944767|P2|COMPLETED|Overall Study||19
8499144|NCT00509067|20944768|P1|COMPLETED|Overall Study||15
8499145|NCT00509067|20944767|P2|STARTED|Overall Study||24
8499146|NCT00509067|20944768|P1|STARTED|Overall Study||19
8499147|NCT00509041|20944778|P1|NOT COMPLETED|Overall Study||0
8499148|NCT00509041|20944778|P1|COMPLETED|Overall Study||43
8499149|NCT00509041|20944778|P1|STARTED|Overall Study||43
8499150|NCT00509028|20944787|P2|NOT COMPLETED|Overall Study||7
8499151|NCT00509028|20944788|P1|NOT COMPLETED|Overall Study||12
8499152|NCT00509028|20944787|P2|COMPLETED|Overall Study||113
8499153|NCT00509028|20944788|P1|COMPLETED|Overall Study||109
8499154|NCT00509028|20944787|P2|STARTED|Overall Study||120
8499155|NCT00509028|20944788|P1|STARTED|Overall Study||121
8499156|NCT00509002|20944820|P1|NOT COMPLETED|Overall Study||0
8499157|NCT00509002|20944820|P1|COMPLETED|Overall Study||37
8499158|NCT00509002|20944820|P1|STARTED|Overall Study||37
8499159|NCT00508924|20944828|P4|NOT COMPLETED|Overall Study||1
8499160|NCT00508924|20944829|P3|NOT COMPLETED|Overall Study||1
8499161|NCT00508924|20944830|P2|NOT COMPLETED|Overall Study||0
8499162|NCT00508924|20944831|P1|NOT COMPLETED|Overall Study||0
8499163|NCT00508924|20944828|P4|COMPLETED|Overall Study||33
8499164|NCT00508924|20944829|P3|COMPLETED|Overall Study||31
8499165|NCT00508924|20944830|P2|COMPLETED|Overall Study||38
8499166|NCT00508924|20944831|P1|COMPLETED|Overall Study||36
8499167|NCT00508924|20944828|P4|STARTED|Overall Study||34
8499168|NCT00508924|20944829|P3|STARTED|Overall Study||32
8499169|NCT00508924|20944830|P2|STARTED|Overall Study||38
8499170|NCT00508924|20944831|P1|STARTED|Overall Study||36
8499171|NCT00508872|20944845|P1|NOT COMPLETED|Overall Study||2
8499172|NCT00508872|20944845|P1|COMPLETED|Overall Study||0
8499173|NCT00508872|20944845|P1|STARTED|Overall Study||2
8499174|NCT00508820|20944851|P2|NOT COMPLETED|Overall Study||64
8499175|NCT00508820|20944852|P1|NOT COMPLETED|Overall Study||55
8499176|NCT00508820|20944851|P2|COMPLETED|Overall Study||175
8499177|NCT00508820|20944852|P1|COMPLETED|Overall Study||113
8499178|NCT00508820|20944851|P2|STARTED|Overall Study||239
8499179|NCT00508820|20944852|P1|STARTED|Overall Study||168
8499180|NCT00508755|20944862|P1|NOT COMPLETED|Overall Study||1
8499181|NCT00508755|20944862|P1|COMPLETED|Overall Study||5
8499182|NCT00508755|20944862|P1|STARTED|Overall Study||6
8499183|NCT00508742|20944870|P2|NOT COMPLETED|Period 3: Toddler Dose||15
8499184|NCT00508742|20944871|P1|NOT COMPLETED|Period 3: Toddler Dose||25
8499185|NCT00508742|20944870|P2|COMPLETED|Period 3: Toddler Dose||863
8499186|NCT00508742|20944871|P1|COMPLETED|Period 3: Toddler Dose||858
8499187|NCT00508742|20944870|P2|STARTED|Period 3: Toddler Dose||878
8499188|NCT00508742|20944871|P1|STARTED|Period 3: Toddler Dose||883
8499189|NCT00508742|20944870|P2|NOT COMPLETED|Period 2: After Infant Series||11
8499190|NCT00508742|20944871|P1|NOT COMPLETED|Period 2: After Infant Series||7
8499191|NCT00508742|20944870|P2|COMPLETED|Period 2: After Infant Series||878
8499192|NCT00508742|20944871|P1|COMPLETED|Period 2: After Infant Series||883
8499193|NCT00508742|20944870|P2|STARTED|Period 2: After Infant Series||889
8499194|NCT00508742|20944871|P1|STARTED|Period 2: After Infant Series||890
8499195|NCT00508742|20944870|P2|NOT COMPLETED|Period 1: Infant Series||45
8499196|NCT00508742|20944871|P1|NOT COMPLETED|Period 1: Infant Series||42
8499197|NCT00508742|20944870|P2|COMPLETED|Period 1: Infant Series||889
8499198|NCT00508742|20944871|P1|COMPLETED|Period 1: Infant Series||890
8499199|NCT00508742|20944870|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
8499288|NCT00508261|20945086|P3|STARTED|Overall Study||224
8499200|NCT00508742|20944871|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
8499201|NCT00508742|20944870|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
8499202|NCT00508742|20944871|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
8499203|NCT00508742|20944870|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
8499204|NCT00508742|20944871|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
8499205|NCT00508742|20944870|P2|STARTED|Period 1: Infant Series||934
8499206|NCT00508742|20944871|P1|STARTED|Period 1: Infant Series||932
8499207|NCT00508716|20944887|P2|NOT COMPLETED|Overall Study||0
8499208|NCT00508716|20944888|P1|NOT COMPLETED|Overall Study||0
8499209|NCT00508716|20944887|P2|COMPLETED|Overall Study||63
8499210|NCT00508716|20944888|P1|COMPLETED|Overall Study||61
8499211|NCT00508716|20944887|P2|STARTED|Overall Study||63
8499212|NCT00508716|20944888|P1|STARTED|Overall Study||61
8499213|NCT00508651|20944896|P2|NOT COMPLETED|Overall Study||2
8499214|NCT00508651|20944897|P1|NOT COMPLETED|Overall Study||4
8499215|NCT00508651|20944896|P2|COMPLETED|Overall Study||8
8499216|NCT00508651|20944897|P1|COMPLETED|Overall Study||16
8499217|NCT00508651|20944896|P2|STARTED|Overall Study||10
8499218|NCT00508651|20944897|P1|STARTED|Overall Study||20
8499219|NCT00508521|20944971|P1|NOT COMPLETED|Overall Study||0
8499220|NCT00508521|20944971|P1|COMPLETED|Overall Study||4
8499221|NCT00508521|20944971|P1|STARTED|Overall Study||4
8499222|NCT00508482|20944978|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
8499223|NCT00508482|20944979|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
8499224|NCT00508482|20944980|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
8499225|NCT00508482|20944978|P3|COMPLETED|at the 12th Week of Follow-up||98
8499226|NCT00508482|20944979|P2|COMPLETED|at the 12th Week of Follow-up||96
8499227|NCT00508482|20944980|P1|COMPLETED|at the 12th Week of Follow-up||196
8499228|NCT00508482|20944978|P3|STARTED|at the 12th Week of Follow-up||98
8499229|NCT00508482|20944979|P2|STARTED|at the 12th Week of Follow-up||96
8499230|NCT00508482|20944980|P1|STARTED|at the 12th Week of Follow-up||196
8499231|NCT00508482|20944978|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
8499232|NCT00508482|20944979|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
8499233|NCT00508482|20944980|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
8499234|NCT00508482|20944978|P3|COMPLETED|at the 4th Week of Follow-up||98
8499235|NCT00508482|20944979|P2|COMPLETED|at the 4th Week of Follow-up||96
8499236|NCT00508482|20944980|P1|COMPLETED|at the 4th Week of Follow-up||196
8499237|NCT00508482|20944978|P3|STARTED|at the 4th Week of Follow-up||99
8499238|NCT00508482|20944979|P2|STARTED|at the 4th Week of Follow-up||102
8499239|NCT00508482|20944980|P1|STARTED|at the 4th Week of Follow-up||216
8499240|NCT00508482|20944978|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
8499241|NCT00508482|20944979|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
8499242|NCT00508482|20944980|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
8499243|NCT00508482|20944978|P3|COMPLETED|Over 4 Weeks of Treatment||99
8499244|NCT00508482|20944979|P2|COMPLETED|Over 4 Weeks of Treatment||102
8499245|NCT00508482|20944980|P1|COMPLETED|Over 4 Weeks of Treatment||216
8499246|NCT00508482|20944978|P3|STARTED|Over 4 Weeks of Treatment||119
8499247|NCT00508482|20944979|P2|STARTED|Over 4 Weeks of Treatment||119
8499248|NCT00508482|20944980|P1|STARTED|Over 4 Weeks of Treatment||237
8499249|NCT00508469|20945017|P2|NOT COMPLETED|Overall Study||10
8499250|NCT00508469|20945018|P1|NOT COMPLETED|Overall Study||17
8499251|NCT00508469|20945017|P2|COMPLETED|Overall Study||40
8499252|NCT00508469|20945018|P1|COMPLETED|Overall Study||35
8499253|NCT00508469|20945017|P2|STARTED|Overall Study||50
8499254|NCT00508469|20945018|P1|STARTED|Overall Study||52
8499255|NCT00508404|20945024|P1|NOT COMPLETED|Overall Study||42
8499256|NCT00508404|20945024|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
8499257|NCT00508404|20945024|P1|STARTED|Overall Study||154
8499258|NCT00508391|20945051|P2|NOT COMPLETED|Second Treatment||0
8499259|NCT00508391|20945052|P1|NOT COMPLETED|Second Treatment||2
8499260|NCT00508391|20945051|P2|COMPLETED|Second Treatment||59
8499261|NCT00508391|20945052|P1|COMPLETED|Second Treatment||52
8499262|NCT00508391|20945051|P2|STARTED|Second Treatment||59
8499263|NCT00508391|20945052|P1|STARTED|Second Treatment||54
8499264|NCT00508391|20945051|P2|NOT COMPLETED|First Treatment||3
8499265|NCT00508391|20945052|P1|NOT COMPLETED|First Treatment||6
8499266|NCT00508391|20945051|P2|COMPLETED|First Treatment||59
8499267|NCT00508391|20945052|P1|COMPLETED|First Treatment||54
8499268|NCT00508391|20945051|P2|STARTED|First Treatment||62
8499269|NCT00508391|20945052|P1|STARTED|First Treatment||60
8499270|NCT00508300|20945065|P2|NOT COMPLETED|Overall Study||4
8499271|NCT00508300|20945066|P1|NOT COMPLETED|Overall Study||2
8499272|NCT00508300|20945065|P2|COMPLETED|Overall Study||57
8499273|NCT00508300|20945066|P1|COMPLETED|Overall Study||65
8499274|NCT00508300|20945065|P2|STARTED|Overall Study||61
8499275|NCT00508300|20945066|P1|STARTED|Overall Study||67
8499276|NCT00508274|20945072|P1|NOT COMPLETED|Overall Study||2
8499277|NCT00508274|20945072|P1|COMPLETED|Overall Study||50
8499278|NCT00508274|20945072|P1|STARTED|Overall Study||52
8499279|NCT00508261|20945085|P4|NOT COMPLETED|Overall Study||1
8499280|NCT00508261|20945086|P3|NOT COMPLETED|Overall Study||6
8499281|NCT00508261|20945087|P2|NOT COMPLETED|Overall Study||8
8499282|NCT00508261|20945088|P1|NOT COMPLETED|Overall Study||3
8499283|NCT00508261|20945085|P4|COMPLETED|Overall Study||126
8499284|NCT00508261|20945086|P3|COMPLETED|Overall Study||218
8499285|NCT00508261|20945087|P2|COMPLETED|Overall Study||212
8499286|NCT00508261|20945088|P1|COMPLETED|Overall Study||219
8499287|NCT00508261|20945085|P4|STARTED|Overall Study||127
8499289|NCT00508261|20945087|P2|STARTED|Overall Study||220
8499290|NCT00508261|20945088|P1|STARTED|Overall Study||222
8499291|NCT00508196|20945198|P2|NOT COMPLETED|Overall Study||0
8499292|NCT00508196|20945199|P1|NOT COMPLETED|Overall Study||0
8499293|NCT00508196|20945198|P2|COMPLETED|Overall Study||11
8499294|NCT00508196|20945199|P1|COMPLETED|Overall Study||11
8499295|NCT00508196|20945198|P2|STARTED|Overall Study||11
8499296|NCT00508196|20945199|P1|STARTED|Overall Study||11
8499297|NCT00508183|20945211|P2|NOT COMPLETED|Overall Study||8
8499298|NCT00508183|20945212|P1|NOT COMPLETED|Overall Study||9
8499299|NCT00508183|20945211|P2|COMPLETED|Overall Study||34
8499300|NCT00508183|20945212|P1|COMPLETED|Overall Study||39
8499301|NCT00508183|20945211|P2|STARTED|Overall Study||42
8499302|NCT00508183|20945212|P1|STARTED|Overall Study||48
8499303|NCT00508157|20945228|P2|NOT COMPLETED|Overall Study||3
8499304|NCT00508157|20945229|P1|NOT COMPLETED|Overall Study||2
8499305|NCT00508157|20945228|P2|COMPLETED|Overall Study||23
8499306|NCT00508157|20945229|P1|COMPLETED|Overall Study||24
8499307|NCT00508157|20945228|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
8499308|NCT00508157|20945229|P1|Safety Sample|Overall Study||26
8499309|NCT00508157|20945228|P2|Randomized Sample|Overall Study||26
8499310|NCT00508157|20945229|P1|Randomized Sample|Overall Study||26
8499311|NCT00508157|20945228|P2|STARTED|Overall Study||26
8499312|NCT00508157|20945229|P1|STARTED|Overall Study||26
8499313|NCT00508144|20945251|P1|NOT COMPLETED|Overall Study||11
8499314|NCT00508144|20945251|P1|COMPLETED|Overall Study||53
8499315|NCT00508144|20945251|P1|STARTED|Overall Study||64
8499316|NCT00508118|20945257|P2|NOT COMPLETED|Overall Study||0
8499317|NCT00508118|20945258|P1|NOT COMPLETED|Overall Study||0
8499318|NCT00508118|20945257|P2|COMPLETED|Overall Study||4
8499319|NCT00508118|20945258|P1|COMPLETED|Overall Study||3
8499320|NCT00508118|20945257|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
8499321|NCT00508118|20945258|P1|STARTED|Overall Study||3
8499322|NCT00508105|20945279|P2|NOT COMPLETED|Overall Study||6
8499323|NCT00508105|20945280|P1|NOT COMPLETED|Overall Study||4
8499324|NCT00508105|20945279|P2|COMPLETED|Overall Study||37
8499325|NCT00508105|20945280|P1|COMPLETED|Overall Study||40
8499326|NCT00508105|20945279|P2|STARTED|Overall Study||43
8499327|NCT00508105|20945280|P1|STARTED|Overall Study||44
8499328|NCT00508027|20945290|P1|NOT COMPLETED|Dose Level 3||0
8499329|NCT00508027|20945290|P1|COMPLETED|Dose Level 3||2
8499330|NCT00508027|20945290|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
8499331|NCT00508027|20945290|P1|NOT COMPLETED|Dose Level 2||4
8499332|NCT00508027|20945290|P1|COMPLETED|Dose Level 2||16
8499333|NCT00508027|20945290|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
8499334|NCT00508027|20945290|P1|NOT COMPLETED|Dose Level 1||8
8499335|NCT00508027|20945290|P1|COMPLETED|Dose Level 1||12
8499336|NCT00508027|20945290|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
8499337|NCT00508001|20945331|P3|NOT COMPLETED|Overall Study||7
8499338|NCT00508001|20945332|P2|NOT COMPLETED|Overall Study||12
8499339|NCT00508001|20945333|P1|NOT COMPLETED|Overall Study||19
8499340|NCT00508001|20945331|P3|COMPLETED|Overall Study||16
8499341|NCT00508001|20945332|P2|COMPLETED|Overall Study||13
8499342|NCT00508001|20945333|P1|COMPLETED|Overall Study||0
8499343|NCT00508001|20945331|P3|Secondary Treatment Phase|Overall Study||16
8499344|NCT00508001|20945332|P2|Secondary Treatment Phase|Overall Study||13
8499345|NCT00508001|20945333|P1|Secondary Treatment Phase|Overall Study||0
8499346|NCT00508001|20945331|P3|STARTED|Overall Study||23
8499347|NCT00508001|20945332|P2|STARTED|Overall Study||25
8499348|NCT00508001|20945333|P1|STARTED|Overall Study||19
8499349|NCT00507819|20945350|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8499350|NCT00507819|20945351|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8499351|NCT00507819|20945350|P2|COMPLETED|Second Intervention (6 Weeks)||14
8499352|NCT00507819|20945351|P1|COMPLETED|Second Intervention (6 Weeks)||13
8499353|NCT00507819|20945350|P2|STARTED|Second Intervention (6 Weeks)||14
8499354|NCT00507819|20945351|P1|STARTED|Second Intervention (6 Weeks)||13
8499355|NCT00507819|20945350|P2|NOT COMPLETED|Washout (6 Weeks)||0
8499356|NCT00507819|20945351|P1|NOT COMPLETED|Washout (6 Weeks)||1
8499357|NCT00507819|20945350|P2|COMPLETED|Washout (6 Weeks)||14
8499358|NCT00507819|20945351|P1|COMPLETED|Washout (6 Weeks)||13
8499359|NCT00507819|20945350|P2|STARTED|Washout (6 Weeks)||14
8499360|NCT00507819|20945351|P1|STARTED|Washout (6 Weeks)||14
8499361|NCT00507819|20945350|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8499362|NCT00507819|20945351|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8499363|NCT00507819|20945350|P2|COMPLETED|First Intervention (6 Weeks)||14
8499364|NCT00507819|20945351|P1|COMPLETED|First Intervention (6 Weeks)||14
8499365|NCT00507819|20945350|P2|STARTED|First Intervention (6 Weeks)||14
8499366|NCT00507819|20945351|P1|STARTED|First Intervention (6 Weeks)||14
8499367|NCT00507767|20945363|P1|NOT COMPLETED|Overall Study||0
8499368|NCT00507767|20945363|P1|COMPLETED|Overall Study||15
8499369|NCT00507767|20945363|P1|STARTED|Overall Study||15
8499370|NCT00507689|20945370|P2|NOT COMPLETED|Randomized Period||2
8499371|NCT00507689|20945371|P1|NOT COMPLETED|Randomized Period||1
8499372|NCT00507689|20945370|P2|COMPLETED|Randomized Period||16
8499373|NCT00507689|20945371|P1|COMPLETED|Randomized Period||18
8499374|NCT00507689|20945370|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
8499553|NCT00506454|20945840|P2|COMPLETED|Overall Study||10
8499375|NCT00507689|20945371|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
8499376|NCT00507689|20945370|P2|NOT COMPLETED|Pre-Randomization Period||0
8499377|NCT00507689|20945371|P1|NOT COMPLETED|Pre-Randomization Period||3
8499378|NCT00507689|20945370|P2|COMPLETED|Pre-Randomization Period||0
8499379|NCT00507689|20945371|P1|COMPLETED|Pre-Randomization Period||37
8499380|NCT00507689|20945370|P2|STARTED|Pre-Randomization Period||0
8499381|NCT00507689|20945371|P1|STARTED|Pre-Randomization Period||40
8499382|NCT00507559|20945388|P1|NOT COMPLETED|Overall Study||71
8499383|NCT00507559|20945388|P1|COMPLETED|Overall Study||84
8499384|NCT00507559|20945388|P1|STARTED|Overall Study||155
8499385|NCT00507546|20945403|P2|NOT COMPLETED|Overall Study||1
8499386|NCT00507546|20945404|P1|NOT COMPLETED|Overall Study||2
8499387|NCT00507546|20945403|P2|COMPLETED|Overall Study||3
8499388|NCT00507546|20945404|P1|COMPLETED|Overall Study||2
8499389|NCT00507546|20945403|P2|STARTED|Overall Study||4
8499390|NCT00507546|20945404|P1|STARTED|Overall Study||4
8499391|NCT00507507|20945414|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
8499392|NCT00507507|20945415|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
8499393|NCT00507507|20945414|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
8499394|NCT00507507|20945415|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
8499395|NCT00507507|20945414|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
8499396|NCT00507507|20945415|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
8499397|NCT00507507|20945414|P2|NOT COMPLETED|Treatment Period||53
8499398|NCT00507507|20945415|P1|NOT COMPLETED|Treatment Period||52
8499399|NCT00507507|20945414|P2|COMPLETED|Treatment Period||9
8499400|NCT00507507|20945415|P1|COMPLETED|Treatment Period||12
8499401|NCT00507507|20945414|P2|Completed 192 Weeks of Treatment|Treatment Period||52
8499402|NCT00507507|20945415|P1|Completed 192 Weeks of Treatment|Treatment Period||52
8499403|NCT00507507|20945414|P2|STARTED|Treatment Period||62
8499404|NCT00507507|20945415|P1|STARTED|Treatment Period||64
8499405|NCT00507455|20945450|P3|NOT COMPLETED|Overall Study||12
8499406|NCT00507455|20945451|P2|NOT COMPLETED|Overall Study||6
8499407|NCT00507455|20945452|P1|NOT COMPLETED|Overall Study||12
8499408|NCT00507455|20945450|P3|COMPLETED|Overall Study||62
8499409|NCT00507455|20945451|P2|COMPLETED|Overall Study||68
8499410|NCT00507455|20945452|P1|COMPLETED|Overall Study||62
8499411|NCT00507455|20945450|P3|STARTED|Overall Study||74
8499412|NCT00507455|20945451|P2|STARTED|Overall Study||74
8499413|NCT00507455|20945452|P1|STARTED|Overall Study||74
8499414|NCT00507442|20945515|P4|NOT COMPLETED|Overall Study||5
8499415|NCT00507442|20945516|P3|NOT COMPLETED|Overall Study||15
8499416|NCT00507442|20945517|P2|NOT COMPLETED|Overall Study||27
8499417|NCT00507442|20945518|P1|NOT COMPLETED|Overall Study||16
8499418|NCT00507442|20945515|P4|COMPLETED|Overall Study||12
8499419|NCT00507442|20945516|P3|COMPLETED|Overall Study||18
8499420|NCT00507442|20945517|P2|COMPLETED|Overall Study||39
8499421|NCT00507442|20945518|P1|COMPLETED|Overall Study||26
8499422|NCT00507442|20945515|P4|STARTED|Overall Study||17
8499423|NCT00507442|20945516|P3|STARTED|Overall Study||33
8499424|NCT00507442|20945517|P2|STARTED|Overall Study||66
8499425|NCT00507442|20945518|P1|STARTED|Overall Study||42
8499426|NCT00507429|20945570|P2|NOT COMPLETED|Maintenance Phase||0
8499427|NCT00507429|20945571|P1|NOT COMPLETED|Maintenance Phase||14
8499428|NCT00507429|20945570|P2|COMPLETED|Maintenance Phase||0
8499429|NCT00507429|20945571|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
8499430|NCT00507429|20945570|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
8499431|NCT00507429|20945571|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
8499432|NCT00507429|20945570|P2|NOT COMPLETED|Treatment Phase||18
8499433|NCT00507429|20945571|P1|NOT COMPLETED|Treatment Phase||37
8499434|NCT00507429|20945570|P2|COMPLETED|Treatment Phase||7
8499435|NCT00507429|20945571|P1|COMPLETED|Treatment Phase||18
8499436|NCT00507429|20945570|P2|STARTED|Treatment Phase|Randomized|25
8499437|NCT00507429|20945571|P1|STARTED|Treatment Phase|Randomized|55
8499438|NCT00507416|20945582|P3|NOT COMPLETED|Overall Study||114
8499439|NCT00507416|20945583|P2|NOT COMPLETED|Overall Study||125
8499440|NCT00507416|20945584|P1|NOT COMPLETED|Overall Study||118
8499441|NCT00507416|20945582|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
8499442|NCT00507416|20945583|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
8499443|NCT00507416|20945584|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
8499444|NCT00507416|20945582|P3|Completed 8 Treatment Cycles|Overall Study||69
8499445|NCT00507416|20945583|P2|Completed 8 Treatment Cycles|Overall Study||60
8499446|NCT00507416|20945584|P1|Completed 8 Treatment Cycles|Overall Study||82
8499447|NCT00507416|20945582|P3|Treated (Safety Population)|Overall Study||163
8499448|NCT00507416|20945583|P2|Treated (Safety Population)|Overall Study||158
8499449|NCT00507416|20945584|P1|Treated (Safety Population)|Overall Study||165
8499450|NCT00507416|20945582|P3|STARTED|Overall Study||167
8499451|NCT00507416|20945583|P2|STARTED|Overall Study||167
8499452|NCT00507416|20945584|P1|STARTED|Overall Study||168
8499453|NCT00507208|20945615|P2|NOT COMPLETED|Overall Study||0
8499454|NCT00507208|20945616|P1|NOT COMPLETED|Overall Study||0
8499455|NCT00507208|20945615|P2|COMPLETED|Overall Study||26
8499456|NCT00507208|20945616|P1|COMPLETED|Overall Study||27
8499457|NCT00507208|20945615|P2|Received Dynasplint in Crossover|Overall Study||3
8499458|NCT00507208|20945616|P1|Received Dynasplint in Crossover|Overall Study||0
8499459|NCT00507208|20945615|P2|STARTED|Overall Study||26
8499460|NCT00507208|20945616|P1|STARTED|Overall Study||27
8499461|NCT00507130|20945626|P4|NOT COMPLETED|Overall Study||1
8499462|NCT00507130|20945627|P3|NOT COMPLETED|Overall Study||1
8499463|NCT00507130|20945628|P2|NOT COMPLETED|Overall Study||0
8499464|NCT00507130|20945629|P1|NOT COMPLETED|Overall Study||1
8499465|NCT00507130|20945626|P4|COMPLETED|Overall Study||8
8499466|NCT00507130|20945627|P3|COMPLETED|Overall Study||8
8499467|NCT00507130|20945628|P2|COMPLETED|Overall Study||9
8499468|NCT00507130|20945629|P1|COMPLETED|Overall Study||8
8499469|NCT00507130|20945626|P4|STARTED|Overall Study||9
8499470|NCT00507130|20945627|P3|STARTED|Overall Study||9
8499471|NCT00507130|20945628|P2|STARTED|Overall Study||9
8499472|NCT00507130|20945629|P1|STARTED|Overall Study||9
8499473|NCT00506948|20945671|P1|NOT COMPLETED|Overall Study||10
8499474|NCT00506948|20945671|P1|COMPLETED|Overall Study||0
8499475|NCT00506948|20945671|P1|STARTED|Overall Study||10
8499476|NCT00506922|20945680|P5|NOT COMPLETED|Overall Study||1
8499477|NCT00506922|20945681|P4|NOT COMPLETED|Overall Study||2
8499478|NCT00506922|20945682|P3|NOT COMPLETED|Overall Study||0
8499479|NCT00506922|20945683|P2|NOT COMPLETED|Overall Study||0
8499480|NCT00506922|20945684|P1|NOT COMPLETED|Overall Study||0
8499481|NCT00506922|20945680|P5|COMPLETED|Overall Study||10
8499482|NCT00506922|20945681|P4|COMPLETED|Overall Study||61
8499483|NCT00506922|20945682|P3|COMPLETED|Overall Study||29
8499484|NCT00506922|20945683|P2|COMPLETED|Overall Study||10
8499485|NCT00506922|20945684|P1|COMPLETED|Overall Study||37
8499486|NCT00506922|20945680|P5|STARTED|Overall Study||11
8499487|NCT00506922|20945681|P4|STARTED|Overall Study||63
8499488|NCT00506922|20945682|P3|STARTED|Overall Study||29
8499489|NCT00506922|20945683|P2|STARTED|Overall Study||10
8499490|NCT00506922|20945684|P1|STARTED|Overall Study||37
8499491|NCT00506909|20945692|P1|NOT COMPLETED|Overall Study||0
8499492|NCT00506909|20945692|P1|COMPLETED|Overall Study||0
8499493|NCT00506909|20945692|P1|STARTED|Overall Study||0
8499494|NCT00506883|20945711|P3|NOT COMPLETED|Overall Study||4
8499495|NCT00506883|20945712|P2|NOT COMPLETED|Overall Study||3
8499496|NCT00506883|20945713|P1|NOT COMPLETED|Overall Study||7
8499497|NCT00506883|20945711|P3|COMPLETED|Overall Study||55
8499498|NCT00506883|20945712|P2|COMPLETED|Overall Study||71
8499499|NCT00506883|20945713|P1|COMPLETED|Overall Study||45
8499500|NCT00506883|20945711|P3|STARTED|Overall Study||59
8499501|NCT00506883|20945712|P2|STARTED|Overall Study||74
8499502|NCT00506883|20945713|P1|STARTED|Overall Study||52
8499503|NCT00506857|20945721|P1|NOT COMPLETED|Overall Study||0
8499504|NCT00506857|20945721|P1|COMPLETED|Overall Study||80
8499505|NCT00506857|20945721|P1|STARTED|Overall Study||80
8499506|NCT00506831|20945726|P1|NOT COMPLETED|Overall Study||2
8499507|NCT00506831|20945726|P1|COMPLETED|Overall Study||7
8499508|NCT00506831|20945726|P1|STARTED|Overall Study||9
8499509|NCT00506779|20945739|P4|NOT COMPLETED|Overall Study||1
8499510|NCT00506779|20945740|P3|NOT COMPLETED|Overall Study||2
8499511|NCT00506779|20945741|P2|NOT COMPLETED|Overall Study||1
8499512|NCT00506779|20945742|P1|NOT COMPLETED|Overall Study||1
8499513|NCT00506779|20945739|P4|COMPLETED|Overall Study||4
8499514|NCT00506779|20945740|P3|COMPLETED|Overall Study||0
8499515|NCT00506779|20945741|P2|COMPLETED|Overall Study||5
8499516|NCT00506779|20945742|P1|COMPLETED|Overall Study||3
8499517|NCT00506779|20945739|P4|STARTED|Overall Study||5
8499518|NCT00506779|20945740|P3|STARTED|Overall Study||2
8499519|NCT00506779|20945741|P2|STARTED|Overall Study||6
8499520|NCT00506779|20945742|P1|STARTED|Overall Study||4
8499521|NCT00506753|20945757|P2|NOT COMPLETED|Overall Study||15
8499522|NCT00506753|20945758|P1|NOT COMPLETED|Overall Study||21
8499523|NCT00506753|20945757|P2|COMPLETED|Overall Study||84
8499524|NCT00506753|20945758|P1|COMPLETED|Overall Study||79
8499525|NCT00506753|20945757|P2|STARTED|Overall Study||99
8499526|NCT00506753|20945758|P1|STARTED|Overall Study||100
8499527|NCT00506714|20945770|P2|NOT COMPLETED|Overall Study||0
8499528|NCT00506714|20945771|P1|NOT COMPLETED|Overall Study||0
8499529|NCT00506714|20945770|P2|COMPLETED|Overall Study||13
8499530|NCT00506714|20945771|P1|COMPLETED|Overall Study||13
8499531|NCT00506714|20945770|P2|STARTED|Overall Study||13
8499532|NCT00506714|20945771|P1|STARTED|Overall Study||13
8499533|NCT00506675|20945781|P2|NOT COMPLETED|Overall Study||0
8499534|NCT00506675|20945782|P1|NOT COMPLETED|Overall Study||0
8499535|NCT00506675|20945781|P2|COMPLETED|Overall Study||28
8499536|NCT00506675|20945782|P1|COMPLETED|Overall Study||27
8499537|NCT00506675|20945781|P2|STARTED|Overall Study||28
8499538|NCT00506675|20945782|P1|STARTED|Overall Study||27
8499539|NCT00506662|20945796|P2|NOT COMPLETED|Overall Study||28
8499540|NCT00506662|20945797|P1|NOT COMPLETED|Overall Study||17
8499541|NCT00506662|20945796|P2|COMPLETED|Overall Study||20
8499542|NCT00506662|20945797|P1|COMPLETED|Overall Study||21
8499543|NCT00506662|20945796|P2|STARTED|Overall Study||48
8499544|NCT00506662|20945797|P1|STARTED|Overall Study||38
8499545|NCT00506597|20945827|P1|NOT COMPLETED|Overall Study||0
8499546|NCT00506597|20945827|P1|COMPLETED|Overall Study||33
8499547|NCT00506597|20945827|P1|STARTED|Overall Study||33
8499548|NCT00506493|20945831|P1|NOT COMPLETED|Overall Study||11
8499549|NCT00506493|20945831|P1|COMPLETED|Overall Study||64
8499550|NCT00506493|20945831|P1|STARTED|Overall Study||75
8499551|NCT00506454|20945840|P2|NOT COMPLETED|Overall Study||1
8499552|NCT00506454|20945841|P1|NOT COMPLETED|Overall Study||1
8499554|NCT00506454|20945841|P1|COMPLETED|Overall Study||10
8499555|NCT00506454|20945840|P2|STARTED|Overall Study||11
8499556|NCT00506454|20945841|P1|STARTED|Overall Study||11
8499557|NCT00506441|20945847|P2|NOT COMPLETED|Period 2; Double-blind Period||5
8499558|NCT00506441|20945848|P1|NOT COMPLETED|Period 2; Double-blind Period||3
8499559|NCT00506441|20945847|P2|COMPLETED|Period 2; Double-blind Period||79
8499560|NCT00506441|20945848|P1|COMPLETED|Period 2; Double-blind Period||82
8499561|NCT00506441|20945847|P2|STARTED|Period 2; Double-blind Period||84
8499562|NCT00506441|20945848|P1|STARTED|Period 2; Double-blind Period||85
8499563|NCT00506441|20945847|P2|NOT COMPLETED|Period 1; Open-label Period||0
8499564|NCT00506441|20945848|P1|NOT COMPLETED|Period 1; Open-label Period||76
8499565|NCT00506441|20945847|P2|COMPLETED|Period 1; Open-label Period||0
8499566|NCT00506441|20945848|P1|COMPLETED|Period 1; Open-label Period||169
8499567|NCT00506441|20945847|P2|STARTED|Period 1; Open-label Period||0
8499568|NCT00506441|20945848|P1|STARTED|Period 1; Open-label Period||245
8499569|NCT00506415|20945856|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
8499570|NCT00506415|20945857|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499571|NCT00506415|20945858|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499572|NCT00506415|20945859|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499573|NCT00506415|20945856|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
8499574|NCT00506415|20945857|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499575|NCT00506415|20945858|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499576|NCT00506415|20945859|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499577|NCT00506415|20945856|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
8499578|NCT00506415|20945857|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8499579|NCT00506415|20945858|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8499580|NCT00506415|20945859|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8499581|NCT00506415|20945856|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499582|NCT00506415|20945857|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
8499583|NCT00506415|20945858|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
8499584|NCT00506415|20945859|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499585|NCT00506415|20945856|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499586|NCT00506415|20945857|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
8499587|NCT00506415|20945858|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
8499588|NCT00506415|20945859|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499589|NCT00506415|20945856|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
8499590|NCT00506415|20945857|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
8499591|NCT00506415|20945858|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
8499592|NCT00506415|20945859|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
8499593|NCT00506415|20945856|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499594|NCT00506415|20945857|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499595|NCT00506415|20945858|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499596|NCT00506415|20945859|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
8499597|NCT00506415|20945856|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499598|NCT00506415|20945857|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499599|NCT00506415|20945858|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499600|NCT00506415|20945859|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
8499601|NCT00506415|20945856|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8499602|NCT00506415|20945857|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8499603|NCT00506415|20945858|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8499604|NCT00506415|20945859|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
8499605|NCT00506415|20945856|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8499606|NCT00506415|20945857|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8499607|NCT00506415|20945858|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8499608|NCT00506415|20945859|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
8499609|NCT00506389|20945884|P3|NOT COMPLETED|Follow-up Period||0
8499610|NCT00506389|20945885|P2|NOT COMPLETED|Follow-up Period||0
8499611|NCT00506389|20945886|P1|NOT COMPLETED|Follow-up Period||0
8499612|NCT00506389|20945884|P3|COMPLETED|Follow-up Period||136
8499613|NCT00506389|20945885|P2|COMPLETED|Follow-up Period||138
8499614|NCT00506389|20945886|P1|COMPLETED|Follow-up Period||139
8499615|NCT00506389|20945884|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
8499616|NCT00506389|20945885|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
8499617|NCT00506389|20945886|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
8499618|NCT00506389|20945884|P3|NOT COMPLETED|In-treatment Period||12
8499619|NCT00506389|20945885|P2|NOT COMPLETED|In-treatment Period||15
8499620|NCT00506389|20945886|P1|NOT COMPLETED|In-treatment Period||26
8499621|NCT00506389|20945884|P3|COMPLETED|In-treatment Period||125
8499622|NCT00506389|20945885|P2|COMPLETED|In-treatment Period||124
8499623|NCT00506389|20945886|P1|COMPLETED|In-treatment Period||117
8499624|NCT00506389|20945884|P3|All Participants Treated|In-treatment Period||136
8499625|NCT00506389|20945885|P2|All Participants Treated|In-treatment Period||138
8499626|NCT00506389|20945886|P1|All Participants Treated|In-treatment Period||139
8499627|NCT00506389|20945884|P3|STARTED|In-treatment Period||137
8499628|NCT00506389|20945885|P2|STARTED|In-treatment Period||139
8499629|NCT00506389|20945886|P1|STARTED|In-treatment Period||143
8499630|NCT00506350|20945912|P9|NOT COMPLETED|Overall Study||5
8499631|NCT00506350|20945913|P8|NOT COMPLETED|Overall Study||5
8499632|NCT00506350|20945914|P7|NOT COMPLETED|Overall Study||2
8499633|NCT00506350|20945915|P6|NOT COMPLETED|Overall Study||2
8499634|NCT00506350|20945916|P5|NOT COMPLETED|Overall Study||10
8499635|NCT00506350|20945917|P4|NOT COMPLETED|Overall Study||2
8499636|NCT00506350|20945918|P3|NOT COMPLETED|Overall Study||6
8499637|NCT00506350|20945919|P2|NOT COMPLETED|Overall Study||3
8499638|NCT00506350|20945920|P1|NOT COMPLETED|Overall Study||3
8499639|NCT00506350|20945912|P9|COMPLETED|Overall Study||30
8499640|NCT00506350|20945913|P8|COMPLETED|Overall Study||36
8499641|NCT00506350|20945914|P7|COMPLETED|Overall Study||33
8499642|NCT00506350|20945915|P6|COMPLETED|Overall Study||38
8499643|NCT00506350|20945916|P5|COMPLETED|Overall Study||40
8499644|NCT00506350|20945917|P4|COMPLETED|Overall Study||34
8499645|NCT00506350|20945918|P3|COMPLETED|Overall Study||31
8499646|NCT00506350|20945919|P2|COMPLETED|Overall Study||37
8499647|NCT00506350|20945920|P1|COMPLETED|Overall Study||33
8499648|NCT00506350|20945912|P9|STARTED|Overall Study||35
8499649|NCT00506350|20945913|P8|STARTED|Overall Study||41
8499650|NCT00506350|20945914|P7|STARTED|Overall Study||35
8499651|NCT00506350|20945915|P6|STARTED|Overall Study||40
8499652|NCT00506350|20945916|P5|STARTED|Overall Study||50
8499653|NCT00506350|20945917|P4|STARTED|Overall Study||36
8499654|NCT00506350|20945918|P3|STARTED|Overall Study||37
8499655|NCT00506350|20945919|P2|STARTED|Overall Study||40
8499656|NCT00506350|20945920|P1|STARTED|Overall Study||36
8499657|NCT00506285|20946067|P2|NOT COMPLETED|6-month Open Label Phase||12
8499658|NCT00506285|20946068|P1|NOT COMPLETED|6-month Open Label Phase||10
8499659|NCT00506285|20946067|P2|COMPLETED|6-month Open Label Phase||19
8499660|NCT00506285|20946068|P1|COMPLETED|6-month Open Label Phase||10
8499661|NCT00506285|20946067|P2|STARTED|6-month Open Label Phase||31
8499662|NCT00506285|20946068|P1|STARTED|6-month Open Label Phase||20
8499663|NCT00506285|20946067|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
8499664|NCT00506285|20946068|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
8499665|NCT00506285|20946067|P2|COMPLETED|Double Blind Cross-Over Phase||31
8499666|NCT00506285|20946068|P1|COMPLETED|Double Blind Cross-Over Phase||20
8499667|NCT00506285|20946067|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
8499668|NCT00506285|20946068|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
8499669|NCT00506285|20946067|P2|STARTED|Double Blind Cross-Over Phase||36
8499670|NCT00506285|20946068|P1|STARTED|Double Blind Cross-Over Phase||29
8499671|NCT00506285|20946067|P2|NOT COMPLETED|3 Week Screening Phase||10
8499672|NCT00506285|20946068|P1|NOT COMPLETED|3 Week Screening Phase||17
8499673|NCT00506285|20946067|P2|COMPLETED|3 Week Screening Phase||36
8499674|NCT00506285|20946068|P1|COMPLETED|3 Week Screening Phase||29
8499675|NCT00506285|20946067|P2|STARTED|3 Week Screening Phase||46
8499676|NCT00506285|20946068|P1|STARTED|3 Week Screening Phase||46
8499677|NCT00506155|20946076|P1|NOT COMPLETED|Overall Study||0
8499678|NCT00506155|20946076|P1|COMPLETED|Overall Study||60
8499679|NCT00506155|20946076|P1|STARTED|Overall Study||60
8499680|NCT00506142|20946083|P2|NOT COMPLETED|Overall Study||19
8499681|NCT00506142|20946084|P1|NOT COMPLETED|Overall Study||35
8499682|NCT00506142|20946083|P2|COMPLETED|Overall Study||0
8499683|NCT00506142|20946084|P1|COMPLETED|Overall Study||0
8499684|NCT00506142|20946083|P2|STARTED|Overall Study||19
8499685|NCT00506142|20946084|P1|STARTED|Overall Study||35
8499686|NCT00506129|20946090|P1|NOT COMPLETED|Overall Study||22
8499687|NCT00506129|20946090|P1|COMPLETED|Overall Study||11
8499688|NCT00506129|20946090|P1|STARTED|Overall Study||33
8499689|NCT00506077|20946097|P2|NOT COMPLETED|Treatment Period 2||1
8499690|NCT00506077|20946098|P1|NOT COMPLETED|Treatment Period 2||1
8499691|NCT00506077|20946097|P2|COMPLETED|Treatment Period 2||23
8499692|NCT00506077|20946098|P1|COMPLETED|Treatment Period 2||23
8499693|NCT00506077|20946097|P2|STARTED|Treatment Period 2||24
8499694|NCT00506077|20946098|P1|STARTED|Treatment Period 2||24
8499695|NCT00506077|20946097|P2|NOT COMPLETED|Washout||0
8499696|NCT00506077|20946098|P1|NOT COMPLETED|Washout||0
8499697|NCT00506077|20946097|P2|COMPLETED|Washout||24
8499698|NCT00506077|20946098|P1|COMPLETED|Washout||24
8499699|NCT00506077|20946097|P2|STARTED|Washout||24
8499700|NCT00506077|20946098|P1|STARTED|Washout||24
8499701|NCT00506077|20946097|P2|NOT COMPLETED|Treatment Period 1||3
8499702|NCT00506077|20946098|P1|NOT COMPLETED|Treatment Period 1||4
8499703|NCT00506077|20946097|P2|COMPLETED|Treatment Period 1||24
8499704|NCT00506077|20946098|P1|COMPLETED|Treatment Period 1||24
8499705|NCT00506077|20946097|P2|STARTED|Treatment Period 1||27
8499706|NCT00506077|20946098|P1|STARTED|Treatment Period 1||28
8499707|NCT00506064|20946120|P2|NOT COMPLETED|Overall Study||0
8499708|NCT00506064|20946121|P1|NOT COMPLETED|Overall Study||0
8499709|NCT00506064|20946120|P2|COMPLETED|Overall Study||0
8499710|NCT00506064|20946121|P1|COMPLETED|Overall Study||1
8499711|NCT00506064|20946120|P2|STARTED|Overall Study||0
8499712|NCT00506064|20946121|P1|STARTED|Overall Study||1
8499713|NCT00506025|20946130|P3|NOT COMPLETED|Overall Study||0
8499714|NCT00506025|20946131|P2|NOT COMPLETED|Overall Study||0
8499715|NCT00506025|20946132|P1|NOT COMPLETED|Overall Study||0
8499716|NCT00506025|20946130|P3|COMPLETED|Overall Study||8
8499717|NCT00506025|20946131|P2|COMPLETED|Overall Study||9
8499718|NCT00506025|20946132|P1|COMPLETED|Overall Study||10
8499719|NCT00506025|20946130|P3|STARTED|Overall Study||8
8499720|NCT00506025|20946131|P2|STARTED|Overall Study||9
8499721|NCT00506025|20946132|P1|STARTED|Overall Study||10
8499722|NCT00505934|20946140|P1|NOT COMPLETED|Overall Study||3
8499723|NCT00505934|20946140|P1|COMPLETED|Overall Study||16
8499724|NCT00505934|20946140|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
8499725|NCT00505921|20946146|P1|NOT COMPLETED|Overall Study||9
8499726|NCT00505921|20946146|P1|COMPLETED|Overall Study||18
8499727|NCT00505921|20946146|P1|STARTED|Overall Study||27
8499728|NCT00505895|20946152|P2|NOT COMPLETED|Overall Study||0
8499729|NCT00505895|20946153|P1|NOT COMPLETED|Overall Study||0
8499730|NCT00505895|20946152|P2|COMPLETED|Overall Study||23
8499731|NCT00505895|20946153|P1|COMPLETED|Overall Study||27
8499732|NCT00505895|20946152|P2|STARTED|Overall Study||23
8499733|NCT00505895|20946153|P1|STARTED|Overall Study||27
8499734|NCT00505778|20946163|P2|NOT COMPLETED|Overall Study||135
8499735|NCT00505778|20946164|P1|NOT COMPLETED|Overall Study||134
8499736|NCT00505778|20946163|P2|COMPLETED|Overall Study||378
8499737|NCT00505778|20946164|P1|COMPLETED|Overall Study||380
8499738|NCT00505778|20946163|P2|Intent to Treat (ITT) Population|Overall Study||511
8499739|NCT00505778|20946164|P1|Intent to Treat (ITT) Population|Overall Study||512
8499740|NCT00505778|20946163|P2|STARTED|Overall Study||513
8499741|NCT00505778|20946164|P1|STARTED|Overall Study||514
8499742|NCT00505765|20946183|P3|NOT COMPLETED|Overall Study||3
8499743|NCT00505765|20946184|P2|NOT COMPLETED|Overall Study||3
8499744|NCT00505765|20946185|P1|NOT COMPLETED|Overall Study||2
8499745|NCT00505765|20946183|P3|COMPLETED|Overall Study||19
8499746|NCT00505765|20946184|P2|COMPLETED|Overall Study||17
8499747|NCT00505765|20946185|P1|COMPLETED|Overall Study||19
8499748|NCT00505765|20946183|P3|Mid-Point Assessment|Overall Study||21
8499749|NCT00505765|20946184|P2|Mid-Point Assessment|Overall Study||19
8499750|NCT00505765|20946185|P1|Mid-Point Assessment|Overall Study||20
8499751|NCT00505765|20946183|P3|STARTED|Overall Study||22
8499752|NCT00505765|20946184|P2|STARTED|Overall Study||20
8499753|NCT00505765|20946185|P1|STARTED|Overall Study||21
8499754|NCT00505752|20946212|P4|NOT COMPLETED|Overall Study||6
8499755|NCT00505752|20946213|P3|NOT COMPLETED|Overall Study||8
8499756|NCT00505752|20946214|P2|NOT COMPLETED|Overall Study||9
8499757|NCT00505752|20946215|P1|NOT COMPLETED|Overall Study||6
8499758|NCT00505752|20946212|P4|COMPLETED|Overall Study||126
8499759|NCT00505752|20946213|P3|COMPLETED|Overall Study||120
8499760|NCT00505752|20946214|P2|COMPLETED|Overall Study||119
8499761|NCT00505752|20946215|P1|COMPLETED|Overall Study||126
8499762|NCT00505752|20946212|P4|STARTED|Overall Study||132
8499763|NCT00505752|20946213|P3|STARTED|Overall Study||128
8499764|NCT00505752|20946214|P2|STARTED|Overall Study||128
8499765|NCT00505752|20946215|P1|STARTED|Overall Study||132
8499766|NCT00505687|20946229|P1|NOT COMPLETED|Overall Study||95
8499767|NCT00505687|20946229|P1|COMPLETED|Overall Study||91
8499768|NCT00505687|20946229|P1|STARTED|Overall Study||186
8499769|NCT00505661|20946235|P1|NOT COMPLETED|Overall Study||4
8499770|NCT00505661|20946235|P1|COMPLETED|Overall Study||12
8499771|NCT00505661|20946235|P1|STARTED|Overall Study||16
8499772|NCT00505635|20946239|P1|NOT COMPLETED|Overall Study||0
8499773|NCT00505635|20946239|P1|COMPLETED|Overall Study||5
8499774|NCT00505635|20946239|P1|STARTED|Overall Study||5
8499775|NCT00505622|20946246|P3|NOT COMPLETED|Overall Study||96
8499776|NCT00505622|20946247|P2|NOT COMPLETED|Overall Study||108
8499777|NCT00505622|20946248|P1|NOT COMPLETED|Overall Study||121
8499778|NCT00505622|20946246|P3|COMPLETED|Overall Study||0
8499779|NCT00505622|20946247|P2|COMPLETED|Overall Study||0
8499780|NCT00505622|20946248|P1|COMPLETED|Overall Study||0
8499781|NCT00505622|20946246|P3|STARTED|Overall Study||96
8499782|NCT00505622|20946247|P2|STARTED|Overall Study||108
8499783|NCT00505622|20946248|P1|STARTED|Overall Study||121
8499784|NCT00505518|20946265|P1|NOT COMPLETED|Overall Study||0
8499785|NCT00505518|20946265|P1|COMPLETED|Overall Study||9
8499786|NCT00505518|20946265|P1|STARTED|Overall Study||9
8499787|NCT00505414|20946273|P5|NOT COMPLETED|Maintenance Phase||0
8499788|NCT00505414|20946274|P4|NOT COMPLETED|Maintenance Phase||0
8499789|NCT00505414|20946275|P3|NOT COMPLETED|Maintenance Phase||8
8499790|NCT00505414|20946276|P2|NOT COMPLETED|Maintenance Phase||5
8499791|NCT00505414|20946277|P1|NOT COMPLETED|Maintenance Phase||6
8499792|NCT00505414|20946273|P5|COMPLETED|Maintenance Phase||0
8499793|NCT00505414|20946274|P4|COMPLETED|Maintenance Phase||0
8499794|NCT00505414|20946275|P3|COMPLETED|Maintenance Phase||6
8499795|NCT00505414|20946276|P2|COMPLETED|Maintenance Phase||10
8499796|NCT00505414|20946277|P1|COMPLETED|Maintenance Phase||12
8499797|NCT00505414|20946273|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
8499798|NCT00505414|20946274|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
8499799|NCT00505414|20946275|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8499800|NCT00505414|20946276|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8499801|NCT00505414|20946277|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8499802|NCT00505414|20946273|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
8499803|NCT00505414|20946274|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
8499804|NCT00505414|20946275|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
8499805|NCT00505414|20946276|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
8499806|NCT00505414|20946277|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
8499807|NCT00505414|20946273|P5|NOT COMPLETED|Titration Phase||12
8499808|NCT00505414|20946274|P4|NOT COMPLETED|Titration Phase||30
8499809|NCT00505414|20946275|P3|NOT COMPLETED|Titration Phase||0
8499810|NCT00505414|20946276|P2|NOT COMPLETED|Titration Phase||0
8499811|NCT00505414|20946277|P1|NOT COMPLETED|Titration Phase||0
8499812|NCT00505414|20946273|P5|COMPLETED|Titration Phase||19
8499813|NCT00505414|20946274|P4|COMPLETED|Titration Phase||32
8499814|NCT00505414|20946275|P3|COMPLETED|Titration Phase||0
8499815|NCT00505414|20946276|P2|COMPLETED|Titration Phase||0
8499816|NCT00505414|20946277|P1|COMPLETED|Titration Phase||0
8499817|NCT00505414|20946273|P5|STARTED|Titration Phase||31
8499818|NCT00505414|20946274|P4|STARTED|Titration Phase||62
8499819|NCT00505414|20946275|P3|STARTED|Titration Phase||0
8499820|NCT00505414|20946276|P2|STARTED|Titration Phase||0
8499821|NCT00505414|20946277|P1|STARTED|Titration Phase||0
8499822|NCT00505375|20946294|P2|NOT COMPLETED|Overall Study||5
8499823|NCT00505375|20946295|P1|NOT COMPLETED|Overall Study||4
8499824|NCT00505375|20946294|P2|COMPLETED|Overall Study||30
8499825|NCT00505375|20946295|P1|COMPLETED|Overall Study||73
8499826|NCT00505375|20946294|P2|STARTED|Overall Study||35
8499827|NCT00505375|20946295|P1|STARTED|Overall Study||77
8499828|NCT00505362|20946303|P2|NOT COMPLETED|Overall Study||0
8499829|NCT00505362|20946304|P1|NOT COMPLETED|Overall Study||0
8499830|NCT00505362|20946303|P2|COMPLETED|Overall Study||28
8499831|NCT00505362|20946304|P1|COMPLETED|Overall Study||35
8499832|NCT00505362|20946303|P2|STARTED|Overall Study||28
8499833|NCT00505362|20946304|P1|STARTED|Overall Study||35
8499834|NCT00505284|20946317|P5|NOT COMPLETED|Overall Study||33
8499835|NCT00505284|20946318|P4|NOT COMPLETED|Overall Study||19
8499836|NCT00505284|20946319|P3|NOT COMPLETED|Overall Study||12
8499837|NCT00505284|20946320|P2|NOT COMPLETED|Overall Study||16
8499838|NCT00505284|20946321|P1|NOT COMPLETED|Overall Study||10
8499839|NCT00505284|20946317|P5|COMPLETED|Overall Study||37
8499840|NCT00505284|20946318|P4|COMPLETED|Overall Study||49
8499841|NCT00505284|20946319|P3|COMPLETED|Overall Study||57
8499842|NCT00505284|20946320|P2|COMPLETED|Overall Study||56
8499843|NCT00505284|20946321|P1|COMPLETED|Overall Study||63
8499844|NCT00505284|20946317|P5|STARTED|Overall Study||70
8499845|NCT00505284|20946318|P4|STARTED|Overall Study||68
8499846|NCT00505284|20946319|P3|STARTED|Overall Study||69
8499847|NCT00505284|20946320|P2|STARTED|Overall Study||72
8499848|NCT00505284|20946321|P1|STARTED|Overall Study||73
8499849|NCT00505076|20946391|P3|NOT COMPLETED|Overall Study||5
8499850|NCT00505076|20946392|P2|NOT COMPLETED|Overall Study||2
8499851|NCT00505076|20946393|P1|NOT COMPLETED|Overall Study||3
8499852|NCT00505076|20946391|P3|COMPLETED|Overall Study||17
8499853|NCT00505076|20946392|P2|COMPLETED|Overall Study||17
8499854|NCT00505076|20946393|P1|COMPLETED|Overall Study||19
8499855|NCT00505076|20946391|P3|STARTED|Overall Study||22
8499856|NCT00505076|20946392|P2|STARTED|Overall Study||19
8499857|NCT00505076|20946393|P1|STARTED|Overall Study||22
8499858|NCT00504985|20946407|P1|NOT COMPLETED|Overall Study||0
8499859|NCT00504985|20946407|P1|COMPLETED|Overall Study||14
8499860|NCT00504985|20946407|P1|STARTED|Overall Study||14
8499861|NCT00504894|20946413|P2|NOT COMPLETED|Overall Study||0
8499862|NCT00504894|20946414|P1|NOT COMPLETED|Overall Study||0
8499863|NCT00504894|20946413|P2|COMPLETED|Overall Study||18
8499864|NCT00504894|20946414|P1|COMPLETED|Overall Study||17
8499865|NCT00504894|20946413|P2|STARTED|Overall Study||18
8499866|NCT00504894|20946414|P1|STARTED|Overall Study||17
8499867|NCT00504881|20946422|P2|NOT COMPLETED|Overall Study||36
8499868|NCT00504881|20946423|P1|NOT COMPLETED|Overall Study||10
8499869|NCT00504881|20946422|P2|COMPLETED|Overall Study||323
8499870|NCT00504881|20946423|P1|COMPLETED|Overall Study||111
8499871|NCT00504881|20946422|P2|STARTED|Overall Study||359
8499872|NCT00504881|20946423|P1|STARTED|Overall Study||121
8499873|NCT00504829|20946476|P3|NOT COMPLETED|Overall Study||10
8499874|NCT00504829|20946477|P2|NOT COMPLETED|Overall Study||4
8499875|NCT00504829|20946478|P1|NOT COMPLETED|Overall Study||6
8499876|NCT00504829|20946476|P3|COMPLETED|Overall Study||63
8499877|NCT00504829|20946477|P2|COMPLETED|Overall Study||70
8499878|NCT00504829|20946478|P1|COMPLETED|Overall Study||67
8499879|NCT00504829|20946476|P3|STARTED|Overall Study||73
8499880|NCT00504829|20946477|P2|STARTED|Overall Study||74
8499881|NCT00504829|20946478|P1|STARTED|Overall Study||73
8499882|NCT00504777|20946487|P1|NOT COMPLETED|Overall Study||1
8499883|NCT00504777|20946487|P1|COMPLETED|Overall Study||35
8499884|NCT00504777|20946487|P1|STARTED|Overall Study||36
8499885|NCT00504751|20946494|P1|NOT COMPLETED|Overall Study||0
8499886|NCT00504751|20946494|P1|COMPLETED|Overall Study||15
8499887|NCT00504751|20946494|P1|STARTED|Overall Study||15
8499888|NCT00504725|20946500|P2|NOT COMPLETED|Overall Study||0
8499889|NCT00504725|20946501|P1|NOT COMPLETED|Overall Study||1
8499890|NCT00504725|20946500|P2|COMPLETED|Overall Study||20
8499891|NCT00504725|20946501|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
8499892|NCT00504725|20946500|P2|STARTED|Overall Study||20
8499893|NCT00504725|20946501|P1|STARTED|Overall Study||21
8499894|NCT00504660|20946513|P2|NOT COMPLETED|Overall Study||0
8499895|NCT00504660|20946514|P1|NOT COMPLETED|Overall Study||0
8499896|NCT00504660|20946513|P2|COMPLETED|Overall Study||43
8499897|NCT00504660|20946514|P1|COMPLETED|Overall Study||31
8499898|NCT00504660|20946513|P2|STARTED|Overall Study||43
8499899|NCT00504660|20946514|P1|STARTED|Overall Study||31
8499900|NCT00504595|20946524|P4|NOT COMPLETED|Overall Study||0
8499901|NCT00504595|20946525|P3|NOT COMPLETED|Overall Study||2
8499902|NCT00504595|20946526|P2|NOT COMPLETED|Overall Study||0
8499903|NCT00504595|20946527|P1|NOT COMPLETED|Overall Study||1
8499904|NCT00504595|20946524|P4|COMPLETED|Overall Study||10
8499905|NCT00504595|20946525|P3|COMPLETED|Overall Study||8
8499906|NCT00504595|20946526|P2|COMPLETED|Overall Study||10
8499907|NCT00504595|20946527|P1|COMPLETED|Overall Study||49
8499908|NCT00504595|20946524|P4|STARTED|Overall Study||10
8499909|NCT00504595|20946525|P3|STARTED|Overall Study||10
8499910|NCT00504595|20946526|P2|STARTED|Overall Study||10
8499911|NCT00504595|20946527|P1|STARTED|Overall Study||50
8499912|NCT00504556|20946544|P5|NOT COMPLETED|Overall Study||25
8499913|NCT00504556|20946545|P4|NOT COMPLETED|Overall Study||128
8499914|NCT00504556|20946546|P3|NOT COMPLETED|Overall Study||31
8499915|NCT00504556|20946547|P2|NOT COMPLETED|Overall Study||38
8499916|NCT00504556|20946548|P1|NOT COMPLETED|Overall Study||35
8499917|NCT00504556|20946544|P5|COMPLETED|Overall Study||226
8499918|NCT00504556|20946545|P4|COMPLETED|Overall Study||52
8499919|NCT00504556|20946546|P3|COMPLETED|Overall Study||204
8499920|NCT00504556|20946547|P2|COMPLETED|Overall Study||207
8499921|NCT00504556|20946548|P1|COMPLETED|Overall Study||200
8499922|NCT00504556|20946544|P5|Pharmacodynamic Analysis Set|Overall Study||244
8499923|NCT00504556|20946545|P4|Pharmacodynamic Analysis Set|Overall Study||170
8499924|NCT00504556|20946546|P3|Pharmacodynamic Analysis Set|Overall Study||228
8499925|NCT00504556|20946547|P2|Pharmacodynamic Analysis Set|Overall Study||236
8499926|NCT00504556|20946548|P1|Pharmacodynamic Analysis Set|Overall Study||230
8499927|NCT00504556|20946544|P5|Per Protocol Analysis Set|Overall Study||250
8499928|NCT00504556|20946545|P4|Per Protocol Analysis Set|Overall Study||180
8499929|NCT00504556|20946546|P3|Per Protocol Analysis Set|Overall Study||234
8499930|NCT00504556|20946547|P2|Per Protocol Analysis Set|Overall Study||243
8499931|NCT00504556|20946548|P1|Per Protocol Analysis Set|Overall Study||235
8499932|NCT00504556|20946544|P5|Safety Analysis Set|Overall Study||250
8499933|NCT00504556|20946545|P4|Safety Analysis Set|Overall Study||180
8499934|NCT00504556|20946546|P3|Safety Analysis Set|Overall Study||234
8499935|NCT00504556|20946547|P2|Safety Analysis Set|Overall Study||244
8499936|NCT00504556|20946548|P1|Safety Analysis Set|Overall Study||235
8499937|NCT00504556|20946544|P5|STARTED|Overall Study||251
8499938|NCT00504556|20946545|P4|STARTED|Overall Study||180
8499939|NCT00504556|20946546|P3|STARTED|Overall Study||235
8499940|NCT00504556|20946547|P2|STARTED|Overall Study||245
8499941|NCT00504556|20946548|P1|STARTED|Overall Study||235
8499942|NCT00504504|20946608|P1|NOT COMPLETED|Overall Study||0
8499943|NCT00504504|20946608|P1|COMPLETED|Overall Study||82
8499944|NCT00504504|20946608|P1|STARTED|Overall Study||82
8499945|NCT00504426|20946616|P4|NOT COMPLETED|Overall Study||0
8499946|NCT00504426|20946617|P3|NOT COMPLETED|Overall Study||4
8499947|NCT00504426|20946618|P2|NOT COMPLETED|Overall Study||1
8499948|NCT00504426|20946619|P1|NOT COMPLETED|Overall Study||3
8499949|NCT00504426|20946616|P4|COMPLETED|Overall Study||24
8499950|NCT00504426|20946617|P3|COMPLETED|Overall Study||18
8499951|NCT00504426|20946618|P2|COMPLETED|Overall Study||22
8499952|NCT00504426|20946619|P1|COMPLETED|Overall Study||29
8499953|NCT00504426|20946616|P4|STARTED|Overall Study||24
8499954|NCT00504426|20946617|P3|STARTED|Overall Study||22
8499955|NCT00504426|20946618|P2|STARTED|Overall Study||23
8499956|NCT00504426|20946619|P1|STARTED|Overall Study||32
8499957|NCT00504348|20946633|P1|NOT COMPLETED|Overall Study||8
8499958|NCT00504348|20946633|P1|COMPLETED|Overall Study||17
8499959|NCT00504348|20946633|P1|STARTED|Overall Study||25
8499960|NCT00504309|20946644|P6|NOT COMPLETED|Overall Study||0
8499961|NCT00504309|20946645|P5|NOT COMPLETED|Overall Study||1
8499962|NCT00504309|20946646|P4|NOT COMPLETED|Overall Study||0
8499963|NCT00504309|20946647|P3|NOT COMPLETED|Overall Study||1
8499964|NCT00504309|20946648|P2|NOT COMPLETED|Overall Study||0
8499965|NCT00504309|20946649|P1|NOT COMPLETED|Overall Study||0
8499966|NCT00504309|20946644|P6|COMPLETED|Overall Study||3
8499967|NCT00504309|20946645|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
8499968|NCT00504309|20946646|P4|COMPLETED|Overall Study||3
8499969|NCT00504309|20946647|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
8499970|NCT00504309|20946648|P2|COMPLETED|Overall Study||5
8499971|NCT00504309|20946649|P1|COMPLETED|Overall Study||7
8499972|NCT00504309|20946644|P6|STARTED|Overall Study||3
8499973|NCT00504309|20946645|P5|STARTED|Overall Study||8
8499974|NCT00504309|20946646|P4|STARTED|Overall Study||3
8499975|NCT00504309|20946647|P3|STARTED|Overall Study||2
8499976|NCT00504309|20946648|P2|STARTED|Overall Study||5
8499977|NCT00504309|20946649|P1|STARTED|Overall Study||7
8499978|NCT00504257|20946687|P1|NOT COMPLETED|Overall Study||4
8499979|NCT00504257|20946687|P1|COMPLETED|Overall Study||41
8499980|NCT00504257|20946687|P1|STARTED|Overall Study||45
8499981|NCT00504231|20946699|P4|NOT COMPLETED|Overall Study||0
8499982|NCT00504231|20946700|P3|NOT COMPLETED|Overall Study||1
8499983|NCT00504231|20946701|P2|NOT COMPLETED|Overall Study||0
8499984|NCT00504231|20946702|P1|NOT COMPLETED|Overall Study||0
8499985|NCT00504231|20946699|P4|COMPLETED|Overall Study||65
8499986|NCT00504231|20946700|P3|COMPLETED|Overall Study||63
8499987|NCT00504231|20946701|P2|COMPLETED|Overall Study||64
8499988|NCT00504231|20946702|P1|COMPLETED|Overall Study||65
8499989|NCT00504231|20946699|P4|STARTED|Overall Study||65
8499990|NCT00504231|20946700|P3|STARTED|Overall Study||64
8499991|NCT00504231|20946701|P2|STARTED|Overall Study||64
8499992|NCT00504231|20946702|P1|STARTED|Overall Study||65
8499993|NCT00504166|20946722|P2|NOT COMPLETED|Overall Study||14
8499994|NCT00504166|20946723|P1|NOT COMPLETED|Overall Study||6
8499995|NCT00504166|20946722|P2|COMPLETED|Overall Study||13
8499996|NCT00504166|20946723|P1|COMPLETED|Overall Study||20
8499997|NCT00504166|20946722|P2|STARTED|Overall Study||27
8499998|NCT00504166|20946723|P1|STARTED|Overall Study||26
8499999|NCT00504153|20946729|P1|NOT COMPLETED|Overall Study||6
8500000|NCT00504153|20946729|P1|COMPLETED|Overall Study||13
8500001|NCT00504153|20946729|P1|STARTED|Overall Study||19
8500002|NCT00504075|20946737|P1|NOT COMPLETED|Overall Study||8
8500003|NCT00504075|20946737|P1|COMPLETED|Overall Study||27
8500004|NCT00504075|20946737|P1|STARTED|Overall Study||35
8500005|NCT00504023|20946743|P1|NOT COMPLETED|Overall Study||0
8500006|NCT00504023|20946743|P1|COMPLETED|Overall Study||8
8500007|NCT00504023|20946743|P1|STARTED|Overall Study||8
8500008|NCT00503997|20946747|P1|NOT COMPLETED|Overall Study||8
8500009|NCT00503997|20946747|P1|COMPLETED|Overall Study||34
8500010|NCT00503997|20946747|P1|STARTED|Overall Study||42
8500011|NCT00503984|20946753|P6|NOT COMPLETED|Overall Study||0
8500012|NCT00503984|20946754|P5|NOT COMPLETED|Overall Study||1
8500013|NCT00503984|20946755|P4|NOT COMPLETED|Overall Study||0
8500014|NCT00503984|20946756|P3|NOT COMPLETED|Overall Study||0
8500015|NCT00503984|20946757|P2|NOT COMPLETED|Overall Study||2
8500016|NCT00503984|20946758|P1|NOT COMPLETED|Overall Study||0
8500017|NCT00503984|20946753|P6|COMPLETED|Overall Study||1
8500018|NCT00503984|20946754|P5|COMPLETED|Overall Study||5
8500019|NCT00503984|20946755|P4|COMPLETED|Overall Study||6
8500020|NCT00503984|20946756|P3|COMPLETED|Overall Study||3
8500021|NCT00503984|20946757|P2|COMPLETED|Overall Study||1
8500022|NCT00503984|20946758|P1|COMPLETED|Overall Study||3
8500023|NCT00503984|20946753|P6|STARTED|Overall Study||1
8500024|NCT00503984|20946754|P5|STARTED|Overall Study||6
8500025|NCT00503984|20946755|P4|STARTED|Overall Study||6
8500026|NCT00503984|20946756|P3|STARTED|Overall Study||3
8500027|NCT00503984|20946757|P2|STARTED|Overall Study||3
8500028|NCT00503984|20946758|P1|STARTED|Overall Study||3
8500029|NCT00503906|20946784|P1|NOT COMPLETED|Overall Study||1
8500030|NCT00503906|20946784|P1|COMPLETED|Overall Study||29
8500031|NCT00503906|20946784|P1|STARTED|Overall Study||30
8500032|NCT00503880|20946793|P5|NOT COMPLETED|Overall Study||0
8500033|NCT00503880|20946794|P4|NOT COMPLETED|Overall Study||0
8500034|NCT00503880|20946795|P3|NOT COMPLETED|Overall Study||0
8500035|NCT00503880|20946796|P2|NOT COMPLETED|Overall Study||0
8500036|NCT00503880|20946797|P1|NOT COMPLETED|Overall Study||2
8500037|NCT00503880|20946793|P5|COMPLETED|Overall Study||0
8500038|NCT00503880|20946794|P4|COMPLETED|Overall Study||0
8500039|NCT00503880|20946795|P3|COMPLETED|Overall Study||0
8500040|NCT00503880|20946796|P2|COMPLETED|Overall Study||0
8500041|NCT00503880|20946797|P1|COMPLETED|Overall Study||0
8500042|NCT00503880|20946793|P5|STARTED|Overall Study||0
8500043|NCT00503880|20946794|P4|STARTED|Overall Study||0
8500044|NCT00503880|20946795|P3|STARTED|Overall Study||0
8500045|NCT00503880|20946796|P2|STARTED|Overall Study||0
8500046|NCT00503880|20946797|P1|STARTED|Overall Study||2
8500047|NCT00503867|20946806|P1|NOT COMPLETED|Overall Study||2
8500048|NCT00503867|20946806|P1|COMPLETED|Overall Study||8
8500049|NCT00503867|20946806|P1|STARTED|Overall Study||10
8500050|NCT00503841|20946814|P1|NOT COMPLETED|Overall Study||44
8500051|NCT00503841|20946814|P1|COMPLETED|Overall Study||0
8500052|NCT00503841|20946814|P1|STARTED|Overall Study||44
8500053|NCT00503776|20946825|P4|NOT COMPLETED|Overall Study||2
8500054|NCT00503776|20946826|P3|NOT COMPLETED|Overall Study||2
8500055|NCT00503776|20946827|P2|NOT COMPLETED|Overall Study||0
8500056|NCT00503776|20946828|P1|NOT COMPLETED|Overall Study||1
8500057|NCT00503776|20946825|P4|COMPLETED|Overall Study||8
8500058|NCT00503776|20946826|P3|COMPLETED|Overall Study||10
8500059|NCT00503776|20946827|P2|COMPLETED|Overall Study||12
8500060|NCT00503776|20946828|P1|COMPLETED|Overall Study||7
8500061|NCT00503776|20946825|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
8500062|NCT00503776|20946826|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
8500063|NCT00503776|20946827|P2|STARTED|Overall Study||12
8500064|NCT00503776|20946828|P1|STARTED|Overall Study||8
8500065|NCT00503750|20946854|P1|NOT COMPLETED|Overall Study||0
8500066|NCT00503750|20946854|P1|COMPLETED|Overall Study||27
8500067|NCT00503750|20946854|P1|STARTED|Overall Study||27
8500068|NCT00503698|20946861|P2|NOT COMPLETED|Overall Study||355
8500069|NCT00503698|20946862|P1|NOT COMPLETED|Overall Study||357
8500070|NCT00503698|20946861|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
8500071|NCT00503698|20946862|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
8500072|NCT00503698|20946861|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
8500073|NCT00503698|20946862|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
8500074|NCT00503698|20946861|P2|STARTED|Overall Study|Randomised|355
8500075|NCT00503698|20946862|P1|STARTED|Overall Study|Randomised|357
8500076|NCT00503685|20946879|P3|NOT COMPLETED|Overall Study||2
8500077|NCT00503685|20946880|P2|NOT COMPLETED|Overall Study||3
8500078|NCT00503685|20946881|P1|NOT COMPLETED|Overall Study||0
8500079|NCT00503685|20946879|P3|COMPLETED|Overall Study||18
8500080|NCT00503685|20946880|P2|COMPLETED|Overall Study||19
8500081|NCT00503685|20946881|P1|COMPLETED|Overall Study||23
8500082|NCT00503685|20946879|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
8500083|NCT00503685|20946880|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
8500084|NCT00503685|20946881|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
8500085|NCT00503685|20946879|P3|STARTED|Overall Study||20
8500086|NCT00503685|20946880|P2|STARTED|Overall Study||22
8500087|NCT00503685|20946881|P1|STARTED|Overall Study||23
8500088|NCT00503581|20946926|P3|NOT COMPLETED|Overall Study||2
8500089|NCT00503581|20946927|P2|NOT COMPLETED|Overall Study||4
8500090|NCT00503581|20946928|P1|NOT COMPLETED|Overall Study||3
8500091|NCT00503581|20946926|P3|COMPLETED|Overall Study||0
8500092|NCT00503581|20946927|P2|COMPLETED|Overall Study||0
8500093|NCT00503581|20946928|P1|COMPLETED|Overall Study||0
8500094|NCT00503581|20946926|P3|STARTED|Overall Study||2
8500095|NCT00503581|20946927|P2|STARTED|Overall Study||4
8500096|NCT00503581|20946928|P1|STARTED|Overall Study||3
8500097|NCT00503425|20946939|P1|NOT COMPLETED|Overall Study||54
8500098|NCT00503425|20946939|P1|COMPLETED|Overall Study||161
8500099|NCT00503425|20946939|P1|STARTED|Overall Study||215
8500100|NCT00503399|20946949|P2|NOT COMPLETED|Overall Study||8
8500101|NCT00503399|20946950|P1|NOT COMPLETED|Overall Study||7
8500102|NCT00503399|20946949|P2|COMPLETED|Overall Study||39
8500103|NCT00503399|20946950|P1|COMPLETED|Overall Study||38
8500104|NCT00503399|20946949|P2|STARTED|Overall Study||47
8500105|NCT00503399|20946950|P1|STARTED|Overall Study||45
8500106|NCT00503308|20946974|P2|NOT COMPLETED|Overall Study||1
8500107|NCT00503308|20946975|P1|NOT COMPLETED|Overall Study||2
8500108|NCT00503308|20946974|P2|COMPLETED|Overall Study||134
8500109|NCT00503308|20946975|P1|COMPLETED|Overall Study||144
8500110|NCT00503308|20946974|P2|STARTED|Overall Study||135
8500111|NCT00503308|20946975|P1|STARTED|Overall Study||146
8500112|NCT00503139|20946981|P1|NOT COMPLETED|Overall Study||8
8500113|NCT00503139|20946981|P1|COMPLETED|Overall Study||676
8500114|NCT00503139|20946981|P1|STARTED|Overall Study||684
8500115|NCT00503113|20946995|P3|NOT COMPLETED|Overall Study||28
8500116|NCT00503113|20946996|P2|NOT COMPLETED|Overall Study||28
8500117|NCT00503113|20946997|P1|NOT COMPLETED|Overall Study||33
8500118|NCT00503113|20946995|P3|COMPLETED|Overall Study||241
8500119|NCT00503113|20946996|P2|COMPLETED|Overall Study||236
8500120|NCT00503113|20946997|P1|COMPLETED|Overall Study||235
8500121|NCT00503113|20946995|P3|Safety Population|Overall Study||267
8500122|NCT00503113|20946996|P2|Safety Population|Overall Study||263
8500123|NCT00503113|20946997|P1|Safety Population|Overall Study||263
8500124|NCT00503113|20946995|P3|Per Protocol Population (PP)|Overall Study||241
8500125|NCT00503113|20946996|P2|Per Protocol Population (PP)|Overall Study||243
8500126|NCT00503113|20946997|P1|Per Protocol Population (PP)|Overall Study||246
8500127|NCT00503113|20946995|P3|Intent to Treat Population (ITT)|Overall Study||268
8500128|NCT00503113|20946996|P2|Intent to Treat Population (ITT)|Overall Study||261
8500129|NCT00503113|20946997|P1|Intent to Treat Population (ITT)|Overall Study||262
8500130|NCT00503113|20946995|P3|STARTED|Overall Study||269
8500131|NCT00503113|20946996|P2|STARTED|Overall Study||264
8500132|NCT00503113|20946997|P1|STARTED|Overall Study||268
8500133|NCT00503009|20947029|P3|NOT COMPLETED|Overall Study||3
8500134|NCT00503009|20947030|P2|NOT COMPLETED|Overall Study||2
8500135|NCT00503009|20947031|P1|NOT COMPLETED|Overall Study||1
8500136|NCT00503009|20947029|P3|COMPLETED|Overall Study||3
8500137|NCT00503009|20947030|P2|COMPLETED|Overall Study||3
8500138|NCT00503009|20947031|P1|COMPLETED|Overall Study||4
8500139|NCT00503009|20947029|P3|STARTED|Overall Study||6
8500140|NCT00503009|20947030|P2|STARTED|Overall Study||5
8500141|NCT00503009|20947031|P1|STARTED|Overall Study||5
8500142|NCT00502996|20947048|P1|NOT COMPLETED|Overall Study||44
8500143|NCT00502996|20947048|P1|COMPLETED|Overall Study||188
8500144|NCT00502996|20947048|P1|STARTED|Overall Study||232
8500145|NCT00502944|20947074|P2|NOT COMPLETED|Overall Study||1766
8500146|NCT00502944|20947075|P1|NOT COMPLETED|Overall Study||1064
8500147|NCT00502944|20947074|P2|COMPLETED|Overall Study||643
8500148|NCT00502944|20947075|P1|COMPLETED|Overall Study||1382
8500149|NCT00502944|20947074|P2|STARTED|Overall Study||2409
8500150|NCT00502944|20947075|P1|STARTED|Overall Study||2446
8500151|NCT00502905|20947087|P1|NOT COMPLETED|Overall Study||0
8500152|NCT00502905|20947087|P1|COMPLETED|Overall Study||196
8500153|NCT00502905|20947087|P1|STARTED|Overall Study||196
8500154|NCT00502853|20947091|P1|NOT COMPLETED|Overall Study||0
8500155|NCT00502853|20947091|P1|COMPLETED|Overall Study||10
8500156|NCT00502853|20947091|P1|STARTED|Overall Study||10
8500157|NCT00502840|20947116|P1|NOT COMPLETED|Overall Study||100
8500158|NCT00502840|20947116|P1|COMPLETED|Overall Study||93
8500159|NCT00502840|20947116|P1|STARTED|Overall Study||193
8500160|NCT00502801|20947144|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
8500161|NCT00502801|20947144|P1|COMPLETED|End of Therapy to Test of Cure||121
8500162|NCT00502801|20947144|P1|STARTED|End of Therapy to Test of Cure||129
8500163|NCT00502801|20947144|P1|NOT COMPLETED|Treatment Period||54
8500164|NCT00502801|20947144|P1|COMPLETED|Treatment Period||129
8500165|NCT00502801|20947144|P1|STARTED|Treatment Period||183
8500166|NCT00502775|20947152|P3|NOT COMPLETED|Overall Study||13
8500167|NCT00502775|20947153|P2|NOT COMPLETED|Overall Study||15
8500168|NCT00502775|20947154|P1|NOT COMPLETED|Overall Study||10
8500169|NCT00502775|20947152|P3|COMPLETED|Overall Study||214
8500170|NCT00502775|20947153|P2|COMPLETED|Overall Study||209
8500171|NCT00502775|20947154|P1|COMPLETED|Overall Study||219
8500172|NCT00502775|20947152|P3|STARTED|Overall Study||227
8500173|NCT00502775|20947153|P2|STARTED|Overall Study||224
8500174|NCT00502775|20947154|P1|STARTED|Overall Study||229
8500175|NCT00502697|20947197|P2|NOT COMPLETED|Overall Study||12
8500176|NCT00502697|20947198|P1|NOT COMPLETED|Overall Study||13
8500177|NCT00502697|20947197|P2|COMPLETED|Overall Study||102
8500178|NCT00502697|20947198|P1|COMPLETED|Overall Study||109
8500179|NCT00502697|20947197|P2|STARTED|Overall Study||114
8500180|NCT00502697|20947198|P1|STARTED|Overall Study||122
8500181|NCT00502671|20947206|P1|NOT COMPLETED|Overall Study||77
8500182|NCT00502671|20947206|P1|COMPLETED|Overall Study||151
8500183|NCT00502671|20947206|P1|STARTED|Overall Study||228
8500184|NCT00502593|20947223|P12|NOT COMPLETED|Overall Study||0
8500185|NCT00502593|20947224|P11|NOT COMPLETED|Overall Study||2
8500186|NCT00502593|20947225|P10|NOT COMPLETED|Overall Study||0
8500187|NCT00502593|20947226|P9|NOT COMPLETED|Overall Study||6
8500188|NCT00502593|20947227|P8|NOT COMPLETED|Overall Study||0
8500189|NCT00502593|20947228|P7|NOT COMPLETED|Overall Study||5
8500190|NCT00502593|20947229|P6|NOT COMPLETED|Overall Study||0
8500191|NCT00502593|20947230|P5|NOT COMPLETED|Overall Study||4
8500192|NCT00502593|20947231|P4|NOT COMPLETED|Overall Study||4
8500193|NCT00502593|20947232|P3|NOT COMPLETED|Overall Study||10
8500194|NCT00502593|20947233|P2|NOT COMPLETED|Overall Study||2
8500195|NCT00502593|20947234|P1|NOT COMPLETED|Overall Study||3
8500196|NCT00502593|20947223|P12|COMPLETED|Overall Study||18
8500197|NCT00502593|20947224|P11|COMPLETED|Overall Study||47
8500198|NCT00502593|20947225|P10|COMPLETED|Overall Study||17
8500199|NCT00502593|20947226|P9|COMPLETED|Overall Study||43
8500200|NCT00502593|20947227|P8|COMPLETED|Overall Study||17
8500201|NCT00502593|20947228|P7|COMPLETED|Overall Study||44
8500202|NCT00502593|20947229|P6|COMPLETED|Overall Study||17
8500203|NCT00502593|20947230|P5|COMPLETED|Overall Study||47
8500204|NCT00502593|20947231|P4|COMPLETED|Overall Study||14
8500205|NCT00502593|20947232|P3|COMPLETED|Overall Study||41
8500206|NCT00502593|20947233|P2|COMPLETED|Overall Study||16
8500207|NCT00502593|20947234|P1|COMPLETED|Overall Study||48
8500208|NCT00502593|20947223|P12|STARTED|Overall Study||18
8500209|NCT00502593|20947224|P11|STARTED|Overall Study||49
8500210|NCT00502593|20947225|P10|STARTED|Overall Study||17
8500211|NCT00502593|20947226|P9|STARTED|Overall Study||49
8500212|NCT00502593|20947227|P8|STARTED|Overall Study||17
8500213|NCT00502593|20947228|P7|STARTED|Overall Study||49
8500214|NCT00502593|20947229|P6|STARTED|Overall Study||17
8500215|NCT00502593|20947230|P5|STARTED|Overall Study||51
8500216|NCT00502593|20947231|P4|STARTED|Overall Study||18
8500217|NCT00502593|20947232|P3|STARTED|Overall Study||51
8500218|NCT00502593|20947233|P2|STARTED|Overall Study||18
8500219|NCT00502593|20947234|P1|STARTED|Overall Study||51
8500220|NCT00502320|20947750|P2|NOT COMPLETED|Overall Study||7
8500221|NCT00502320|20947751|P1|NOT COMPLETED|Overall Study||6
8500222|NCT00502320|20947750|P2|COMPLETED|Overall Study||18
8500223|NCT00502320|20947751|P1|COMPLETED|Overall Study||19
8500224|NCT00502320|20947750|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
8500225|NCT00502320|20947751|P1|Screening Visit|Overall Study||25
8500226|NCT00502320|20947750|P2|STARTED|Overall Study||25
8500227|NCT00502320|20947751|P1|STARTED|Overall Study||25
8500228|NCT00502307|20947761|P3|NOT COMPLETED|Maintenance Period||0
8500229|NCT00502307|20947762|P2|NOT COMPLETED|Maintenance Period||0
8500230|NCT00502307|20947763|P1|NOT COMPLETED|Maintenance Period||148
8500231|NCT00502307|20947761|P3|COMPLETED|Maintenance Period||0
8500232|NCT00502307|20947762|P2|COMPLETED|Maintenance Period||0
8500233|NCT00502307|20947763|P1|COMPLETED|Maintenance Period||0
8500234|NCT00502307|20947761|P3|STARTED|Maintenance Period||0
8500235|NCT00502307|20947762|P2|STARTED|Maintenance Period||0
8500236|NCT00502307|20947763|P1|STARTED|Maintenance Period||148
8500237|NCT00502307|20947761|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
8500238|NCT00502307|20947762|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
8500239|NCT00502307|20947763|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8500240|NCT00502307|20947761|P3|COMPLETED|Double-Blind Period (12 Weeks)||48
8500241|NCT00502307|20947762|P2|COMPLETED|Double-Blind Period (12 Weeks)||35
8500242|NCT00502307|20947763|P1|COMPLETED|Double-Blind Period (12 Weeks)||0
8500243|NCT00502307|20947761|P3|STARTED|Double-Blind Period (12 Weeks)||57
8500244|NCT00502307|20947762|P2|STARTED|Double-Blind Period (12 Weeks)||61
8500245|NCT00502307|20947763|P1|STARTED|Double-Blind Period (12 Weeks)||0
8500246|NCT00502307|20947761|P3|NOT COMPLETED|Open Label Period (16 Weeks)||0
8500247|NCT00502307|20947762|P2|NOT COMPLETED|Open Label Period (16 Weeks)||0
8500248|NCT00502307|20947763|P1|NOT COMPLETED|Open Label Period (16 Weeks)||76
8500249|NCT00502307|20947761|P3|COMPLETED|Open Label Period (16 Weeks)||0
8500250|NCT00502307|20947762|P2|COMPLETED|Open Label Period (16 Weeks)||0
8500251|NCT00502307|20947763|P1|COMPLETED|Open Label Period (16 Weeks)||196
8500252|NCT00502307|20947761|P3|STARTED|Open Label Period (16 Weeks)||0
8500253|NCT00502307|20947762|P2|STARTED|Open Label Period (16 Weeks)||0
8500254|NCT00502307|20947763|P1|STARTED|Open Label Period (16 Weeks)||272
8500255|NCT00502242|20947790|P2|NOT COMPLETED|Overall Study||56
8500256|NCT00502242|20947791|P1|NOT COMPLETED|Overall Study||51
8500257|NCT00502242|20947790|P2|COMPLETED|Overall Study||84
8500258|NCT00502242|20947791|P1|COMPLETED|Overall Study||104
8500259|NCT00502242|20947790|P2|STARTED|Overall Study||140
8500260|NCT00502242|20947791|P1|STARTED|Overall Study||155
8500261|NCT00502216|20947844|P2|NOT COMPLETED|Overall Study||0
8500262|NCT00502216|20947845|P1|NOT COMPLETED|Overall Study||0
8500263|NCT00502216|20947844|P2|COMPLETED|Overall Study||19
8500264|NCT00502216|20947845|P1|COMPLETED|Overall Study||21
8500265|NCT00502216|20947844|P2|STARTED|Overall Study||19
8500266|NCT00502216|20947845|P1|STARTED|Overall Study||21
8500267|NCT00502203|20947855|P1|NOT COMPLETED|Overall Study||1
8500268|NCT00502203|20947855|P1|COMPLETED|Overall Study||22
8500269|NCT00502203|20947855|P1|STARTED|Overall Study||23
8500270|NCT00501995|20947859|P1|NOT COMPLETED|Overall Study||1
8500271|NCT00501995|20947859|P1|COMPLETED|Overall Study||5
8500272|NCT00501995|20947859|P1|STARTED|Overall Study||6
8500273|NCT00501969|20947864|P1|NOT COMPLETED|Overall Study||206
8500274|NCT00501969|20947864|P1|COMPLETED|Overall Study||189
8500275|NCT00501969|20947864|P1|STARTED|Overall Study||395
8500276|NCT00501943|20947872|P2|NOT COMPLETED|Overall Study||3
8500277|NCT00501943|20947873|P1|NOT COMPLETED|Overall Study||2
8500278|NCT00501943|20947872|P2|COMPLETED|Overall Study||18
8500279|NCT00501943|20947873|P1|COMPLETED|Overall Study||20
8500280|NCT00501943|20947872|P2|STARTED|Overall Study||21
8500281|NCT00501943|20947873|P1|STARTED|Overall Study||22
8500282|NCT00501891|20947889|P1|NOT COMPLETED|Overall Study||0
8500283|NCT00501891|20947889|P1|COMPLETED|Overall Study||32
8500284|NCT00501891|20947889|P1|STARTED|Overall Study||32
8500285|NCT00501852|20947896|P1|NOT COMPLETED|Overall Study||5
8500286|NCT00501852|20947896|P1|COMPLETED|Overall Study||78
8500287|NCT00501852|20947896|P1|Tiotropium|Overall Study||55
8500288|NCT00501852|20947896|P1|Placebo|Overall Study||55
8500289|NCT00501852|20947896|P1|NVA237 100µg|Overall Study||54
8500290|NCT00501852|20947896|P1|NVA237 50µg|Overall Study||53
8500291|NCT00501852|20947896|P1|NVA237 25µg|Overall Study||51
8500292|NCT00501852|20947896|P1|NVA237 12.5µg|Overall Study||55
8500293|NCT00501852|20947896|P1|STARTED|Overall Study||83
8500294|NCT00501644|20947916|P1|NOT COMPLETED|Overall Study||5
8500295|NCT00501644|20947916|P1|COMPLETED|Overall Study||54
8500296|NCT00501644|20947916|P1|STARTED|Overall Study||59
8500297|NCT00501631|20947922|P2|NOT COMPLETED|Part B (Open-label Period)||51
8500298|NCT00501631|20947923|P1|NOT COMPLETED|Part B (Open-label Period)||53
8500299|NCT00501631|20947922|P2|COMPLETED|Part B (Open-label Period)||48
8500300|NCT00501631|20947923|P1|COMPLETED|Part B (Open-label Period)||37
8500301|NCT00501631|20947922|P2|STARTED|Part B (Open-label Period)||99
8500302|NCT00501631|20947923|P1|STARTED|Part B (Open-label Period)||90
8500303|NCT00501631|20947922|P2|NOT COMPLETED|Part A (Double-blind Period)||49
8500304|NCT00501631|20947923|P1|NOT COMPLETED|Part A (Double-blind Period)||62
8500305|NCT00501631|20947922|P2|COMPLETED|Part A (Double-blind Period)||99
8500306|NCT00501631|20947923|P1|COMPLETED|Part A (Double-blind Period)||90
8500307|NCT00501631|20947922|P2|STARTED|Part A (Double-blind Period)||148
8500308|NCT00501631|20947923|P1|STARTED|Part A (Double-blind Period)||152
8500309|NCT00501592|20947932|P3|NOT COMPLETED|Overall Study||3
8500310|NCT00501592|20947933|P2|NOT COMPLETED|Overall Study||5
8500311|NCT00501592|20947934|P1|NOT COMPLETED|Overall Study||0
8500312|NCT00501592|20947932|P3|COMPLETED|Overall Study||20
8500313|NCT00501592|20947933|P2|COMPLETED|Overall Study||16
8500314|NCT00501592|20947934|P1|COMPLETED|Overall Study||20
8500315|NCT00501592|20947932|P3|STARTED|Overall Study||23
8500316|NCT00501592|20947933|P2|STARTED|Overall Study||21
8500317|NCT00501592|20947934|P1|STARTED|Overall Study||20
8500318|NCT00501540|20947945|P1|NOT COMPLETED|Overall Study||5
8500319|NCT00501540|20947945|P1|COMPLETED|Overall Study||10
8500320|NCT00501540|20947945|P1|STARTED|Overall Study||15
8500321|NCT00501345|20947951|P1|NOT COMPLETED|Overall Study||0
8500322|NCT00501345|20947951|P1|COMPLETED|Overall Study||5
8500323|NCT00501345|20947951|P1|STARTED|Overall Study||5
8500324|NCT00501293|20947957|P2|NOT COMPLETED|Maintenance Period||28
8500325|NCT00501293|20947958|P1|NOT COMPLETED|Maintenance Period||46
8500326|NCT00501293|20947957|P2|COMPLETED|Maintenance Period||25
8500327|NCT00501293|20947958|P1|COMPLETED|Maintenance Period||63
8500328|NCT00501293|20947957|P2|STARTED|Maintenance Period||53
8500329|NCT00501293|20947958|P1|STARTED|Maintenance Period||109
8500330|NCT00501293|20947957|P2|NOT COMPLETED|Optimization Period||0
8500331|NCT00501293|20947958|P1|NOT COMPLETED|Optimization Period||1
8500332|NCT00501293|20947957|P2|COMPLETED|Optimization Period||53
8500333|NCT00501293|20947958|P1|COMPLETED|Optimization Period||109
8500334|NCT00501293|20947957|P2|STARTED|Optimization Period||53
8500335|NCT00501293|20947958|P1|STARTED|Optimization Period||110
8500336|NCT00501228|20947985|P1|NOT COMPLETED|Overall Study||1
8500337|NCT00501228|20947985|P1|COMPLETED|Overall Study||1
8500338|NCT00501228|20947985|P1|STARTED|Overall Study||2
8500339|NCT00501085|20947989|P1|NOT COMPLETED|Overall Study||432
8500340|NCT00501085|20947989|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
8500341|NCT00501085|20947989|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
8500342|NCT00501059|20947999|P2|NOT COMPLETED|Overall Study||1892
8500343|NCT00501059|20948000|P1|NOT COMPLETED|Overall Study||1868
8500344|NCT00501059|20947999|P2|COMPLETED|Overall Study||4384
8500345|NCT00501059|20948000|P1|COMPLETED|Overall Study||4402
8500346|NCT00501059|20947999|P2|STARTED|Overall Study||6276
8500347|NCT00501059|20948000|P1|STARTED|Overall Study||6270
8500348|NCT00501046|20948024|P2|NOT COMPLETED|Overall Study||294
8500349|NCT00501046|20948025|P1|NOT COMPLETED|Overall Study||270
8500350|NCT00501046|20948024|P2|COMPLETED|Overall Study||213
8500351|NCT00501046|20948025|P1|COMPLETED|Overall Study||238
8500352|NCT00501046|20948024|P2|STARTED|Overall Study||507
8500353|NCT00501046|20948025|P1|STARTED|Overall Study||508
8500354|NCT00501007|20948031|P2|NOT COMPLETED|Overall Study||25
8500355|NCT00501007|20948032|P1|NOT COMPLETED|Overall Study||29
8500356|NCT00501007|20948031|P2|COMPLETED|Overall Study||78
8500357|NCT00501007|20948032|P1|COMPLETED|Overall Study||71
8500358|NCT00501007|20948031|P2|STARTED|Overall Study||103
8500359|NCT00501007|20948032|P1|STARTED|Overall Study||100
8500360|NCT00500903|20948041|P3|NOT COMPLETED|Overall Study||20
8500361|NCT00500903|20948042|P2|NOT COMPLETED|Overall Study||2
8500362|NCT00500903|20948043|P1|NOT COMPLETED|Overall Study||65
8500363|NCT00500903|20948041|P3|COMPLETED|Overall Study||0
8500364|NCT00500903|20948042|P2|COMPLETED|Overall Study||0
8500365|NCT00500903|20948043|P1|COMPLETED|Overall Study||0
8500366|NCT00500903|20948041|P3|STARTED|Overall Study||20
8500367|NCT00500903|20948042|P2|STARTED|Overall Study||2
8500368|NCT00500903|20948043|P1|STARTED|Overall Study||65
8500369|NCT00500890|20948224|P2|NOT COMPLETED|Overall Study||0
8500370|NCT00500890|20948225|P1|NOT COMPLETED|Overall Study||0
8500371|NCT00500890|20948224|P2|COMPLETED|Overall Study||1
8500372|NCT00500890|20948225|P1|COMPLETED|Overall Study||1
8500373|NCT00500890|20948224|P2|STARTED|Overall Study||1
8500374|NCT00500890|20948225|P1|STARTED|Overall Study||1
8500375|NCT00500760|20948239|P2|NOT COMPLETED|Overall Study||24
8500376|NCT00500760|20948240|P1|NOT COMPLETED|Overall Study||43
8500377|NCT00500760|20948239|P2|COMPLETED|Overall Study||40
8500378|NCT00500760|20948240|P1|COMPLETED|Overall Study||46
8500379|NCT00500760|20948239|P2|Received Treatment|Overall Study||63
8500380|NCT00500760|20948240|P1|Received Treatment|Overall Study||87
8500381|NCT00500760|20948239|P2|STARTED|Overall Study||64
8500382|NCT00500760|20948240|P1|STARTED|Overall Study||89
8500383|NCT00500682|20948260|P2|NOT COMPLETED|Overall Study||287
8500384|NCT00500682|20948261|P1|NOT COMPLETED|Overall Study||306
8500385|NCT00500682|20948260|P2|COMPLETED|Overall Study||223
8500386|NCT00500682|20948261|P1|COMPLETED|Overall Study||204
8500387|NCT00500682|20948260|P2|STARTED|Overall Study||510
8500388|NCT00500682|20948261|P1|STARTED|Overall Study||510
8500389|NCT00500656|20948271|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
8500390|NCT00500656|20948272|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
8500391|NCT00500656|20948273|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
8500392|NCT00500656|20948274|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
8500393|NCT00500656|20948271|P4|COMPLETED|Open Label Extension (OLE) Phase||6
8500394|NCT00500656|20948272|P3|COMPLETED|Open Label Extension (OLE) Phase||1
8500395|NCT00500656|20948273|P2|COMPLETED|Open Label Extension (OLE) Phase||9
8500396|NCT00500656|20948274|P1|COMPLETED|Open Label Extension (OLE) Phase||16
8500397|NCT00500656|20948271|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
8500398|NCT00500656|20948272|P3|STARTED|Open Label Extension (OLE) Phase||2
8500399|NCT00500656|20948273|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
8500400|NCT00500656|20948274|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
8500401|NCT00500656|20948271|P4|NOT COMPLETED|Controlled Phase||8
8500402|NCT00500656|20948272|P3|NOT COMPLETED|Controlled Phase||1
8500403|NCT00500656|20948273|P2|NOT COMPLETED|Controlled Phase||10
8500404|NCT00500656|20948274|P1|NOT COMPLETED|Controlled Phase||10
8500405|NCT00500656|20948271|P4|COMPLETED|Controlled Phase||0
8500406|NCT00500656|20948272|P3|COMPLETED|Controlled Phase||2
8500407|NCT00500656|20948273|P2|COMPLETED|Controlled Phase||28
8500408|NCT00500656|20948274|P1|COMPLETED|Controlled Phase||26
8500409|NCT00500656|20948271|P4|STARTED|Controlled Phase||8
8500410|NCT00500656|20948272|P3|STARTED|Controlled Phase||3
8500411|NCT00500656|20948273|P2|STARTED|Controlled Phase||38
8500412|NCT00500656|20948274|P1|STARTED|Controlled Phase||36
8500413|NCT00500578|20948288|P2|NOT COMPLETED|Overall Study||0
8500414|NCT00500578|20948289|P1|NOT COMPLETED|Overall Study||0
8500415|NCT00500578|20948288|P2|COMPLETED|Overall Study|All completed|32
8500416|NCT00500578|20948289|P1|COMPLETED|Overall Study|All completed|18
8500417|NCT00500578|20948288|P2|STARTED|Overall Study||32
8500418|NCT00500578|20948289|P1|STARTED|Overall Study||18
8500419|NCT00500539|20948295|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
8500420|NCT00500539|20948295|P1|COMPLETED|Follow-up Period (16 Weeks)||136
8500421|NCT00500539|20948295|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
8500422|NCT00500539|20948295|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
8500423|NCT00500539|20948295|P1|COMPLETED|Treatment Period (24 Weeks)||140
8500424|NCT00500539|20948295|P1|STARTED|Treatment Period (24 Weeks)||155
8500425|NCT00500448|20948304|P2|NOT COMPLETED|Overall Study||0
8500426|NCT00500448|20948305|P1|NOT COMPLETED|Overall Study||0
8500427|NCT00500448|20948304|P2|COMPLETED|Overall Study||16
8500428|NCT00500448|20948305|P1|COMPLETED|Overall Study||14
8500429|NCT00500448|20948304|P2|STARTED|Overall Study||16
8500430|NCT00500448|20948305|P1|STARTED|Overall Study||14
8500431|NCT00500370|20948321|P2|NOT COMPLETED|Overall Study||34
8500432|NCT00500370|20948322|P1|NOT COMPLETED|Overall Study||33
8500433|NCT00500370|20948321|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
8500434|NCT00500370|20948322|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
8500435|NCT00500370|20948321|P2|Treatment Complete (Week 24)|Overall Study||54
8500436|NCT00500370|20948322|P1|Treatment Complete (Week 24)|Overall Study||48
8500437|NCT00500370|20948321|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
8500438|NCT00500370|20948322|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
8500439|NCT00500370|20948321|P2|STARTED|Overall Study||83
8500440|NCT00500370|20948322|P1|STARTED|Overall Study||80
8500441|NCT00500357|20948358|P1|NOT COMPLETED|Overall Study||1
8500442|NCT00500357|20948358|P1|COMPLETED|Overall Study||104
8500443|NCT00500357|20948358|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
8500444|NCT00500357|20948358|P1|Received 13vPnC (Vax 3)|Overall Study||105
8500445|NCT00500357|20948358|P1|STARTED|Overall Study||105
8500446|NCT00500331|20948384|P7|NOT COMPLETED|Overall Study||2
8500447|NCT00500331|20948385|P6|NOT COMPLETED|Overall Study||5
8500448|NCT00500331|20948386|P5|NOT COMPLETED|Overall Study||4
8500449|NCT00500331|20948387|P4|NOT COMPLETED|Overall Study||10
8500450|NCT00500331|20948388|P3|NOT COMPLETED|Overall Study||5
8500451|NCT00500331|20948389|P2|NOT COMPLETED|Overall Study||5
8500452|NCT00500331|20948390|P1|NOT COMPLETED|Overall Study||15
8500453|NCT00500331|20948384|P7|COMPLETED|Overall Study||46
8500454|NCT00500331|20948385|P6|COMPLETED|Overall Study||42
8500455|NCT00500331|20948386|P5|COMPLETED|Overall Study||44
8500456|NCT00500331|20948387|P4|COMPLETED|Overall Study||38
8500457|NCT00500331|20948388|P3|COMPLETED|Overall Study||43
8500458|NCT00500331|20948389|P2|COMPLETED|Overall Study||42
8500459|NCT00500331|20948390|P1|COMPLETED|Overall Study||33
8500460|NCT00500331|20948384|P7|STARTED|Overall Study||48
8500461|NCT00500331|20948385|P6|STARTED|Overall Study||47
8500462|NCT00500331|20948386|P5|STARTED|Overall Study||48
8500463|NCT00500331|20948387|P4|STARTED|Overall Study||48
8500464|NCT00500331|20948388|P3|STARTED|Overall Study||48
8500465|NCT00500331|20948389|P2|STARTED|Overall Study||47
8500466|NCT00500331|20948390|P1|STARTED|Overall Study||48
8500467|NCT00500318|20948527|P2|NOT COMPLETED|Overall Study||17
8500468|NCT00500318|20948528|P1|NOT COMPLETED|Overall Study||5
8500469|NCT00500318|20948527|P2|COMPLETED|Overall Study||78
8500470|NCT00500318|20948528|P1|COMPLETED|Overall Study||81
8500471|NCT00500318|20948527|P2|STARTED|Overall Study||95
8500472|NCT00500318|20948528|P1|STARTED|Overall Study||86
8500473|NCT00500292|20948545|P3|NOT COMPLETED|Overall Study||27
8500474|NCT00500292|20948546|P2|NOT COMPLETED|Overall Study||31
8500475|NCT00500292|20948547|P1|NOT COMPLETED|Overall Study||25
8500476|NCT00500292|20948545|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
8500477|NCT00500292|20948546|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
8500478|NCT00500292|20948547|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
8500479|NCT00500292|20948545|P3|STARTED|Overall Study|randomised patients|37
8500480|NCT00500292|20948546|P2|STARTED|Overall Study|randomised patients|35
8500481|NCT00500292|20948547|P1|STARTED|Overall Study|randomised patients|32
8500482|NCT00500240|20948557|P2|NOT COMPLETED|Overall Study||0
8500483|NCT00500240|20948558|P1|NOT COMPLETED|Overall Study||0
8500484|NCT00500240|20948557|P2|COMPLETED|Overall Study||26
8500485|NCT00500240|20948558|P1|COMPLETED|Overall Study||25
8500486|NCT00500240|20948557|P2|STARTED|Overall Study||26
8500487|NCT00500240|20948558|P1|STARTED|Overall Study||25
8500488|NCT00500149|20948568|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
8500489|NCT00500149|20948569|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
8500490|NCT00500149|20948568|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
8500491|NCT00500149|20948569|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
8500492|NCT00500149|20948568|P2|STARTED|Second Intervention (Cross-over Phase)||57
8500493|NCT00500149|20948569|P1|STARTED|Second Intervention (Cross-over Phase)||56
8500494|NCT00500149|20948568|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
8500495|NCT00500149|20948569|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
8500496|NCT00500149|20948568|P2|COMPLETED|First Intervention (Cross-over Phase)||57
8500497|NCT00500149|20948569|P1|COMPLETED|First Intervention (Cross-over Phase)||56
8500498|NCT00500149|20948568|P2|STARTED|First Intervention (Cross-over Phase)||59
8500499|NCT00500149|20948569|P1|STARTED|First Intervention (Cross-over Phase)||58
8500500|NCT00500149|20948568|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
8500501|NCT00500149|20948569|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
8500502|NCT00500149|20948568|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
8500503|NCT00500149|20948569|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
8500504|NCT00500149|20948568|P2|STARTED|Enrolled (Dose-optimization Phase)||0
8500505|NCT00500149|20948569|P1|STARTED|Enrolled (Dose-optimization Phase)||129
8500506|NCT00500110|20948577|P1|NOT COMPLETED|Overall Study||3
8500507|NCT00500110|20948577|P1|COMPLETED|Overall Study||36
8500508|NCT00500110|20948577|P1|STARTED|Overall Study||39
8500509|NCT00500071|20948581|P1|NOT COMPLETED|30-day Safety Follow-up||17
8500510|NCT00500071|20948581|P1|COMPLETED|30-day Safety Follow-up||278
8500511|NCT00500071|20948581|P1|STARTED|30-day Safety Follow-up||295
8500512|NCT00500071|20948581|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
8500513|NCT00500071|20948581|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
8500514|NCT00500071|20948581|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
8500515|NCT00500071|20948581|P1|NOT COMPLETED|Screening and Washout Phase||1
8500516|NCT00500071|20948581|P1|COMPLETED|Screening and Washout Phase||317
8500517|NCT00500071|20948581|P1|STARTED|Screening and Washout Phase||318
8500518|NCT00500045|20948590|P1|NOT COMPLETED|Overall Study||0
8500519|NCT00500045|20948590|P1|COMPLETED|Overall Study||0
8500520|NCT00500045|20948590|P1|STARTED|Overall Study||0
8500521|NCT00499915|20948597|P2|NOT COMPLETED|Overall Study||6
8500522|NCT00499915|20948598|P1|NOT COMPLETED|Overall Study||15
8500523|NCT00499915|20948597|P2|COMPLETED|Overall Study||76
8500524|NCT00499915|20948598|P1|COMPLETED|Overall Study||68
8500525|NCT00499915|20948597|P2|STARTED|Overall Study||82
8500526|NCT00499915|20948598|P1|STARTED|Overall Study||83
8500527|NCT00499889|20948604|P1|NOT COMPLETED|Overall Study||1
8500528|NCT00499889|20948604|P1|COMPLETED|Overall Study||41
8500529|NCT00499889|20948604|P1|STARTED|Overall Study||42
8500530|NCT00499863|20948612|P2|NOT COMPLETED|Overall Study||43
8500531|NCT00499863|20948613|P1|NOT COMPLETED|Overall Study||50
8500532|NCT00499863|20948612|P2|COMPLETED|Overall Study||29
8500533|NCT00499863|20948613|P1|COMPLETED|Overall Study||95
8500534|NCT00499863|20948612|P2|STARTED|Overall Study||72
8500535|NCT00499863|20948613|P1|STARTED|Overall Study||145
8500536|NCT00500266|20948641|P1|NOT COMPLETED|Overall Study||13
8500537|NCT00500266|20948641|P1|COMPLETED|Overall Study||1040
8500538|NCT00500266|20948641|P1|Treated|Overall Study||1049
8500539|NCT00500266|20948641|P1|STARTED|Overall Study||1053
8500540|NCT00499746|20948648|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
8500541|NCT00499746|20948648|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
8500542|NCT00499746|20948648|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
8500543|NCT00499746|20948648|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
8500544|NCT00499746|20948648|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
8500545|NCT00499746|20948648|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
8500546|NCT00499746|20948648|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
8500547|NCT00499746|20948648|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
8500548|NCT00499746|20948648|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
8500549|NCT00499694|20948717|P1|NOT COMPLETED|Overall Study||1
8500550|NCT00499694|20948717|P1|COMPLETED|Overall Study||30
8500551|NCT00499694|20948717|P1|STARTED|Overall Study||31
8500552|NCT00499681|20948726|P2|NOT COMPLETED|Overall Study||2
8500553|NCT00499681|20948727|P1|NOT COMPLETED|Overall Study||0
8500554|NCT00499681|20948726|P2|COMPLETED|Overall Study||0
8500555|NCT00499681|20948727|P1|COMPLETED|Overall Study||4
8500556|NCT00499681|20948726|P2|STARTED|Overall Study||2
8500557|NCT00499681|20948727|P1|STARTED|Overall Study||4
8500558|NCT00499655|20948735|P2|NOT COMPLETED|Overall Study||0
8500559|NCT00499655|20948736|P1|NOT COMPLETED|Overall Study||0
8500560|NCT00499655|20948735|P2|COMPLETED|Overall Study||54
8500561|NCT00499655|20948736|P1|COMPLETED|Overall Study||53
8500562|NCT00499655|20948735|P2|STARTED|Overall Study||54
8500563|NCT00499655|20948736|P1|STARTED|Overall Study||53
8500564|NCT00499616|20948754|P4|NOT COMPLETED|Overall Study||57
8500565|NCT00499616|20948755|P3|NOT COMPLETED|Overall Study||36
8500566|NCT00499616|20948756|P2|NOT COMPLETED|Overall Study||28
8500567|NCT00499616|20948757|P1|NOT COMPLETED|Overall Study||15
8500568|NCT00499616|20948754|P4|COMPLETED|Overall Study||0
8500569|NCT00499616|20948755|P3|COMPLETED|Overall Study||53
8500570|NCT00499616|20948756|P2|COMPLETED|Overall Study||114
8500571|NCT00499616|20948757|P1|COMPLETED|Overall Study||161
8500572|NCT00499616|20948754|P4|STARTED|Overall Study||57
8500573|NCT00499616|20948755|P3|STARTED|Overall Study||89
8500574|NCT00499616|20948756|P2|STARTED|Overall Study||142
8500575|NCT00499616|20948757|P1|STARTED|Overall Study||176
8500576|NCT00499603|20948802|P2|NOT COMPLETED|Overall Study||1
8500577|NCT00499603|20948803|P1|NOT COMPLETED|Overall Study||0
8500578|NCT00499603|20948802|P2|COMPLETED|Overall Study||22
8500579|NCT00499603|20948803|P1|COMPLETED|Overall Study||27
8500580|NCT00499603|20948802|P2|STARTED|Overall Study||23
8500581|NCT00499603|20948803|P1|STARTED|Overall Study||27
8500582|NCT00499590|20948816|P3|NOT COMPLETED|Overall Study||113
8500583|NCT00499590|20948817|P2|NOT COMPLETED|Overall Study||112
8500584|NCT00499590|20948818|P1|NOT COMPLETED|Overall Study||113
8500585|NCT00499590|20948816|P3|COMPLETED|Overall Study||0
8500586|NCT00499590|20948817|P2|COMPLETED|Overall Study||0
8500587|NCT00499590|20948818|P1|COMPLETED|Overall Study||0
8500588|NCT00499590|20948816|P3|STARTED|Overall Study||113
8500589|NCT00499590|20948817|P2|STARTED|Overall Study||112
8500590|NCT00499590|20948818|P1|STARTED|Overall Study||113
8500591|NCT00499486|20948829|P1|NOT COMPLETED|Overall Study||16
8500592|NCT00499486|20948829|P1|COMPLETED|Overall Study||31
8500593|NCT00499486|20948829|P1|STARTED|Overall Study||47
8500594|NCT00499473|20948837|P2|NOT COMPLETED|Overall Study||0
8500595|NCT00499473|20948838|P1|NOT COMPLETED|Overall Study||6
8500596|NCT00499473|20948837|P2|COMPLETED|Overall Study||4
8500597|NCT00499473|20948838|P1|COMPLETED|Overall Study|Patients evaluable|21
8500598|NCT00499473|20948837|P2|STARTED|Overall Study||4
8500599|NCT00499473|20948838|P1|STARTED|Overall Study||27
8500600|NCT00499460|20948856|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
8500601|NCT00499460|20948857|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
8500602|NCT00499460|20948856|P2|COMPLETED|Intervention 2 (30 Days)||6
8500603|NCT00499460|20948857|P1|COMPLETED|Intervention 2 (30 Days)||6
8500604|NCT00499460|20948856|P2|STARTED|Intervention 2 (30 Days)||7
8500605|NCT00499460|20948857|P1|STARTED|Intervention 2 (30 Days)||6
8500606|NCT00499460|20948856|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
8500607|NCT00499460|20948857|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
8500608|NCT00499460|20948856|P2|COMPLETED|Intervention 1 (30 Days)||7
8500609|NCT00499460|20948857|P1|COMPLETED|Intervention 1 (30 Days)||6
8500610|NCT00499460|20948856|P2|STARTED|Intervention 1 (30 Days)||7
8500611|NCT00499460|20948857|P1|STARTED|Intervention 1 (30 Days)||8
8500612|NCT00499447|20948873|P1|NOT COMPLETED|Overall Study||0
8500613|NCT00499447|20948873|P1|COMPLETED|Overall Study||13
8500614|NCT00499447|20948873|P1|STARTED|Overall Study||13
8500615|NCT00499408|20948877|P1|NOT COMPLETED|Overall Study||0
8500616|NCT00499408|20948877|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
8500617|NCT00499408|20948877|P1|STARTED|Overall Study||26
8500618|NCT00499369|20948890|P5|NOT COMPLETED|Overall Study||12
8500619|NCT00499369|20948891|P4|NOT COMPLETED|Overall Study||9
8500620|NCT00499369|20948892|P3|NOT COMPLETED|Overall Study||17
8500621|NCT00499369|20948893|P2|NOT COMPLETED|Overall Study||18
8500622|NCT00499369|20948894|P1|NOT COMPLETED|Overall Study||16
8500623|NCT00499369|20948890|P5|COMPLETED|Overall Study||0
8500624|NCT00499369|20948891|P4|COMPLETED|Overall Study||0
8500625|NCT00499369|20948892|P3|COMPLETED|Overall Study||0
8500626|NCT00499369|20948893|P2|COMPLETED|Overall Study||0
8500627|NCT00499369|20948894|P1|COMPLETED|Overall Study||0
8500628|NCT00499369|20948890|P5|Eligible|Overall Study||12
8500629|NCT00499369|20948891|P4|Eligible|Overall Study||8
8500630|NCT00499369|20948892|P3|Eligible|Overall Study||16
8500631|NCT00499369|20948893|P2|Eligible|Overall Study||16
8500632|NCT00499369|20948894|P1|Eligible|Overall Study||14
8500633|NCT00499369|20948890|P5|STARTED|Overall Study||12
8500634|NCT00499369|20948891|P4|STARTED|Overall Study||9
8500635|NCT00499369|20948892|P3|STARTED|Overall Study||17
8500636|NCT00499369|20948893|P2|STARTED|Overall Study||18
8500637|NCT00499369|20948894|P1|STARTED|Overall Study||16
8500638|NCT00499343|20948923|P2|NOT COMPLETED|Overall Study||0
8500639|NCT00499343|20948924|P1|NOT COMPLETED|Overall Study||0
8500640|NCT00499343|20948923|P2|COMPLETED|Overall Study||43
8500641|NCT00499343|20948924|P1|COMPLETED|Overall Study||41
8500642|NCT00499343|20948923|P2|STARTED|Overall Study||43
8500643|NCT00499343|20948924|P1|STARTED|Overall Study||41
8500644|NCT00499252|20948930|P1|NOT COMPLETED|Overall Study||12
8500645|NCT00499252|20948930|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
8500646|NCT00499252|20948930|P1|STARTED|Overall Study||51
8500647|NCT00499122|20948940|P1|NOT COMPLETED|Overall Study||2
8500648|NCT00499122|20948940|P1|COMPLETED|Overall Study||39
8500649|NCT00499122|20948940|P1|STARTED|Overall Study||41
8500650|NCT00499109|20948948|P2|NOT COMPLETED|Overall Study||7
8500651|NCT00499109|20948949|P1|NOT COMPLETED|Overall Study||18
8500652|NCT00499109|20948948|P2|COMPLETED|Overall Study||85
8500653|NCT00499109|20948949|P1|COMPLETED|Overall Study||165
8500654|NCT00499109|20948948|P2|STARTED|Overall Study||92
8500655|NCT00499109|20948949|P1|STARTED|Overall Study||183
8500656|NCT00499096|20948964|P2|NOT COMPLETED|Overall Study||20
8500657|NCT00499096|20948965|P1|NOT COMPLETED|Overall Study||23
8500658|NCT00499096|20948964|P2|COMPLETED|Overall Study||40
8500659|NCT00499096|20948965|P1|COMPLETED|Overall Study||35
8500660|NCT00499096|20948964|P2|STARTED|Overall Study||60
8500661|NCT00499096|20948965|P1|STARTED|Overall Study||58
8500662|NCT00499083|20948983|P1|NOT COMPLETED|Overall Study||3
8500663|NCT00499083|20948983|P1|COMPLETED|Overall Study||14
8500664|NCT00499083|20948983|P1|Participants at Moffitt Cancer Center|Overall Study||14
8500665|NCT00499083|20948983|P1|Participants at UNMC|Overall Study||3
8500666|NCT00499083|20948983|P1|STARTED|Overall Study||17
8500667|NCT00499031|20948990|P1|NOT COMPLETED|Overall Study||3
8500668|NCT00499031|20948990|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
8500669|NCT00499031|20948990|P1|STARTED|Overall Study|Total number participants enrolled on study|38
8500670|NCT00498940|20948997|P2|NOT COMPLETED|Overall Study||0
8500671|NCT00498940|20948998|P1|NOT COMPLETED|Overall Study||0
8500672|NCT00498940|20948997|P2|COMPLETED|Overall Study||31
8500673|NCT00498940|20948998|P1|COMPLETED|Overall Study||30
8500674|NCT00498940|20948997|P2|STARTED|Overall Study||31
8500675|NCT00498940|20948998|P1|STARTED|Overall Study||30
8500676|NCT00498927|20949006|P1|NOT COMPLETED|Overall Study||0
8500677|NCT00498927|20949006|P1|COMPLETED|Overall Study||47
8500678|NCT00498927|20949006|P1|STARTED|Overall Study||47
8500679|NCT00498797|20949013|P2|NOT COMPLETED|Overall Study||29
8500680|NCT00498797|20949014|P1|NOT COMPLETED|Overall Study||38
8500681|NCT00498797|20949013|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
8500682|NCT00498797|20949014|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
8500683|NCT00498797|20949013|P2|STARTED|Overall Study|randomised patients|43
8500684|NCT00498797|20949014|P1|STARTED|Overall Study|randomised patients|43
8500685|NCT00498706|20949024|P2|NOT COMPLETED|Overall Study||0
8500686|NCT00498706|20949025|P1|NOT COMPLETED|Overall Study||0
8500687|NCT00498706|20949024|P2|COMPLETED|Overall Study||162
8500688|NCT00498706|20949025|P1|COMPLETED|Overall Study||163
8500689|NCT00498706|20949024|P2|Post Treatment Week 18|Overall Study||162
8500690|NCT00498706|20949025|P1|Post Treatment Week 18|Overall Study||163
8500691|NCT00498706|20949024|P2|STARTED|Overall Study||162
8500692|NCT00498706|20949025|P1|STARTED|Overall Study||163
8500693|NCT00498628|20949039|P2|NOT COMPLETED|Overall Study||21
8500694|NCT00498628|20949040|P1|NOT COMPLETED|Overall Study||15
8500695|NCT00498628|20949039|P2|COMPLETED|Overall Study||92
8500696|NCT00498628|20949040|P1|COMPLETED|Overall Study||90
8500697|NCT00498628|20949039|P2|STARTED|Overall Study||113
8500698|NCT00498628|20949040|P1|STARTED|Overall Study||105
8500699|NCT00498615|20949072|P6|NOT COMPLETED|Placebo||0
8500700|NCT00498615|20949073|P5|NOT COMPLETED|Placebo||0
8500701|NCT00498615|20949074|P4|NOT COMPLETED|Placebo||0
8500702|NCT00498615|20949075|P3|NOT COMPLETED|Placebo||0
8500703|NCT00498615|20949076|P2|NOT COMPLETED|Placebo||0
8500704|NCT00498615|20949077|P1|NOT COMPLETED|Placebo||0
8500705|NCT00498615|20949072|P6|COMPLETED|Placebo||3
8500706|NCT00498615|20949073|P5|COMPLETED|Placebo||3
8500707|NCT00498615|20949074|P4|COMPLETED|Placebo||2
8500708|NCT00498615|20949075|P3|COMPLETED|Placebo||3
8500709|NCT00498615|20949076|P2|COMPLETED|Placebo||4
8500710|NCT00498615|20949077|P1|COMPLETED|Placebo||2
8500711|NCT00498615|20949072|P6|STARTED|Placebo||3
8500712|NCT00498615|20949073|P5|STARTED|Placebo||3
8500713|NCT00498615|20949074|P4|STARTED|Placebo||2
8500714|NCT00498615|20949075|P3|STARTED|Placebo||3
8500715|NCT00498615|20949076|P2|STARTED|Placebo||4
8500716|NCT00498615|20949077|P1|STARTED|Placebo||2
8500717|NCT00498615|20949072|P6|NOT COMPLETED|Fasudil 40mg||0
8500718|NCT00498615|20949073|P5|NOT COMPLETED|Fasudil 40mg||0
8500719|NCT00498615|20949074|P4|NOT COMPLETED|Fasudil 40mg||0
8500720|NCT00498615|20949075|P3|NOT COMPLETED|Fasudil 40mg||0
8500721|NCT00498615|20949076|P2|NOT COMPLETED|Fasudil 40mg||0
8500722|NCT00498615|20949077|P1|NOT COMPLETED|Fasudil 40mg||0
8500723|NCT00498615|20949072|P6|COMPLETED|Fasudil 40mg||3
8500724|NCT00498615|20949073|P5|COMPLETED|Fasudil 40mg||3
8500725|NCT00498615|20949074|P4|COMPLETED|Fasudil 40mg||2
8500726|NCT00498615|20949075|P3|COMPLETED|Fasudil 40mg||3
8500727|NCT00498615|20949076|P2|COMPLETED|Fasudil 40mg||4
8500728|NCT00498615|20949077|P1|COMPLETED|Fasudil 40mg||2
8500729|NCT00498615|20949072|P6|STARTED|Fasudil 40mg||3
8500730|NCT00498615|20949073|P5|STARTED|Fasudil 40mg||3
8500731|NCT00498615|20949074|P4|STARTED|Fasudil 40mg||2
8500732|NCT00498615|20949075|P3|STARTED|Fasudil 40mg||3
8500733|NCT00498615|20949076|P2|STARTED|Fasudil 40mg||4
8500734|NCT00498615|20949077|P1|STARTED|Fasudil 40mg||2
8500735|NCT00498615|20949072|P6|NOT COMPLETED|Fasudil 80mg||0
8500736|NCT00498615|20949073|P5|NOT COMPLETED|Fasudil 80mg||0
8500737|NCT00498615|20949074|P4|NOT COMPLETED|Fasudil 80mg||0
8500738|NCT00498615|20949075|P3|NOT COMPLETED|Fasudil 80mg||0
8500739|NCT00498615|20949076|P2|NOT COMPLETED|Fasudil 80mg||0
8500740|NCT00498615|20949077|P1|NOT COMPLETED|Fasudil 80mg||0
8500741|NCT00498615|20949072|P6|COMPLETED|Fasudil 80mg||3
8500742|NCT00498615|20949073|P5|COMPLETED|Fasudil 80mg||3
8500743|NCT00498615|20949074|P4|COMPLETED|Fasudil 80mg||2
8500744|NCT00498615|20949075|P3|COMPLETED|Fasudil 80mg||3
8500745|NCT00498615|20949076|P2|COMPLETED|Fasudil 80mg||4
8500746|NCT00498615|20949077|P1|COMPLETED|Fasudil 80mg||2
8500747|NCT00498615|20949072|P6|STARTED|Fasudil 80mg||3
8500748|NCT00498615|20949073|P5|STARTED|Fasudil 80mg||3
8500749|NCT00498615|20949074|P4|STARTED|Fasudil 80mg||2
8500750|NCT00498615|20949075|P3|STARTED|Fasudil 80mg||3
8500751|NCT00498615|20949076|P2|STARTED|Fasudil 80mg||4
8500752|NCT00498615|20949077|P1|STARTED|Fasudil 80mg||2
8500753|NCT00498602|20949098|P7|NOT COMPLETED|Overall Study||2
8500754|NCT00498602|20949099|P6|NOT COMPLETED|Overall Study||13
8500755|NCT00498602|20949100|P5|NOT COMPLETED|Overall Study||4
8500756|NCT00498602|20949101|P4|NOT COMPLETED|Overall Study||5
8500757|NCT00498602|20949102|P3|NOT COMPLETED|Overall Study||8
8500758|NCT00498602|20949103|P2|NOT COMPLETED|Overall Study||10
8500759|NCT00498602|20949104|P1|NOT COMPLETED|Overall Study||10
8500760|NCT00498602|20949098|P7|COMPLETED|Overall Study||15
8500761|NCT00498602|20949099|P6|COMPLETED|Overall Study||31
8500762|NCT00498602|20949100|P5|COMPLETED|Overall Study||8
8500763|NCT00498602|20949101|P4|COMPLETED|Overall Study||30
8500764|NCT00498602|20949102|P3|COMPLETED|Overall Study||32
8500765|NCT00498602|20949103|P2|COMPLETED|Overall Study||51
8500766|NCT00498602|20949104|P1|COMPLETED|Overall Study||26
8500767|NCT00498602|20949098|P7|Treated|Overall Study||17
8500768|NCT00498602|20949099|P6|Treated|Overall Study||44
8500769|NCT00498602|20949100|P5|Treated|Overall Study||12
8500770|NCT00498602|20949101|P4|Treated|Overall Study||35
8500771|NCT00498602|20949102|P3|Treated|Overall Study||40
8500772|NCT00498602|20949103|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
8500773|NCT00498602|20949104|P1|Treated|Overall Study||36
8500774|NCT00498602|20949098|P7|STARTED|Overall Study||17
8500775|NCT00498602|20949099|P6|STARTED|Overall Study||44
8500776|NCT00498602|20949100|P5|STARTED|Overall Study||12
8500777|NCT00498602|20949101|P4|STARTED|Overall Study||35
8500778|NCT00498602|20949102|P3|STARTED|Overall Study||40
8500779|NCT00498602|20949103|P2|STARTED|Overall Study||61
8500780|NCT00498602|20949104|P1|STARTED|Overall Study||36
8500781|NCT00498550|20949143|P2|NOT COMPLETED|Overall Study||1
8500782|NCT00498550|20949144|P1|NOT COMPLETED|Overall Study||0
8500783|NCT00498550|20949143|P2|COMPLETED|Overall Study||15
8500784|NCT00498550|20949144|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
8500785|NCT00498550|20949143|P2|STARTED|Overall Study||16
8500786|NCT00498550|20949144|P1|STARTED|Overall Study||15
8500787|NCT00498485|20949152|P2|NOT COMPLETED|Overall Study||5
8500788|NCT00498485|20949153|P1|NOT COMPLETED|Overall Study||1
8500789|NCT00498485|20949152|P2|COMPLETED|Overall Study||5
8500790|NCT00498485|20949153|P1|COMPLETED|Overall Study||6
8500791|NCT00498485|20949152|P2|STARTED|Overall Study||10
8500792|NCT00498485|20949153|P1|STARTED|Overall Study||7
8500793|NCT00498433|20949164|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500794|NCT00498433|20949165|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500795|NCT00498433|20949166|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500796|NCT00498433|20949164|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
8500797|NCT00498433|20949165|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
8500798|NCT00498433|20949166|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500799|NCT00498433|20949164|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
8500800|NCT00498433|20949165|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
8500801|NCT00498433|20949166|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
8500802|NCT00498433|20949164|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500803|NCT00498433|20949165|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500804|NCT00498433|20949166|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
8500805|NCT00498433|20949164|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500806|NCT00498433|20949165|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500807|NCT00498433|20949166|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
8500808|NCT00498433|20949164|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
8500809|NCT00498433|20949165|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
8500810|NCT00498433|20949166|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
8500811|NCT00498433|20949164|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500812|NCT00498433|20949165|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500813|NCT00498433|20949166|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500814|NCT00498433|20949164|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
8500815|NCT00498433|20949165|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500816|NCT00498433|20949166|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500817|NCT00498433|20949164|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
8500818|NCT00498433|20949165|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500819|NCT00498433|20949166|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500820|NCT00498433|20949164|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500821|NCT00498433|20949165|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500822|NCT00498433|20949166|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500823|NCT00498433|20949164|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500824|NCT00498433|20949165|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
8500825|NCT00498433|20949166|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500826|NCT00498433|20949164|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500827|NCT00498433|20949165|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
8500828|NCT00498433|20949166|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500829|NCT00498433|20949164|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500830|NCT00498433|20949165|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500831|NCT00498433|20949166|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500832|NCT00498433|20949164|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500833|NCT00498433|20949165|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500834|NCT00498433|20949166|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
8500835|NCT00498433|20949164|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500836|NCT00498433|20949165|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500837|NCT00498433|20949166|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
8500838|NCT00498368|20949211|P2|NOT COMPLETED|Overall Study||2
8500839|NCT00498368|20949212|P1|NOT COMPLETED|Overall Study||3
8500840|NCT00498368|20949211|P2|COMPLETED|Overall Study||15
8500841|NCT00498368|20949212|P1|COMPLETED|Overall Study||14
8500842|NCT00498368|20949211|P2|STARTED|Overall Study||17
8500843|NCT00498368|20949212|P1|STARTED|Overall Study||17
8500844|NCT00498355|20949224|P1|NOT COMPLETED|Overall Study||1
8500845|NCT00498355|20949224|P1|COMPLETED|Overall Study||6
8500846|NCT00498355|20949224|P1|STARTED|Overall Study||7
8500847|NCT00498186|20949232|P1|NOT COMPLETED|Overall Study||173
8500848|NCT00498186|20949232|P1|COMPLETED|Overall Study||122
8500849|NCT00498186|20949232|P1|STARTED|Overall Study||295
8500850|NCT00498173|20949239|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500851|NCT00498173|20949240|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500852|NCT00498173|20949241|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500853|NCT00498173|20949239|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
8500854|NCT00498173|20949240|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500855|NCT00498173|20949241|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500856|NCT00498173|20949239|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
8500857|NCT00498173|20949240|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500858|NCT00498173|20949241|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500859|NCT00498173|20949239|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
8500860|NCT00498173|20949240|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
8500861|NCT00498173|20949241|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
8500862|NCT00498173|20949239|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
8500863|NCT00498173|20949240|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
8500864|NCT00498173|20949241|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
8500865|NCT00498173|20949239|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
8500866|NCT00498173|20949240|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
8500867|NCT00498173|20949241|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
8500874|NCT00497796|20949290|P2|NOT COMPLETED|Overall Study||59
8500875|NCT00497796|20949291|P1|NOT COMPLETED|Overall Study||85
8500876|NCT00497796|20949290|P2|COMPLETED|Overall Study||101
8500877|NCT00497796|20949291|P1|COMPLETED|Overall Study||62
8500878|NCT00497796|20949290|P2|STARTED|Overall Study||160
8500879|NCT00497796|20949291|P1|STARTED|Overall Study||147
8500880|NCT00497770|20949323|P4|NOT COMPLETED|Overall Study||0
8500881|NCT00497770|20949324|P3|NOT COMPLETED|Overall Study||0
8500882|NCT00497770|20949325|P2|NOT COMPLETED|Overall Study||0
8500883|NCT00497770|20949326|P1|NOT COMPLETED|Overall Study||0
8500884|NCT00497770|20949323|P4|COMPLETED|Overall Study||28
8500885|NCT00497770|20949324|P3|COMPLETED|Overall Study||37
8500886|NCT00497770|20949325|P2|COMPLETED|Overall Study||65
8500887|NCT00497770|20949326|P1|COMPLETED|Overall Study||304
8500888|NCT00497770|20949323|P4|STARTED|Overall Study||28
8500889|NCT00497770|20949324|P3|STARTED|Overall Study||37
8500890|NCT00497770|20949325|P2|STARTED|Overall Study||65
8500891|NCT00497770|20949326|P1|STARTED|Overall Study||304
8500892|NCT00497198|20949378|P2|NOT COMPLETED|Overall Study||5
8500893|NCT00497198|20949379|P1|NOT COMPLETED|Overall Study||5
8500894|NCT00497198|20949378|P2|COMPLETED|Overall Study||86
8500895|NCT00497198|20949379|P1|COMPLETED|Overall Study||87
8500896|NCT00497198|20949378|P2|STARTED|Overall Study||91
8500897|NCT00497198|20949379|P1|STARTED|Overall Study||92
8500898|NCT00497146|20949395|P2|NOT COMPLETED|Long-term Follow-up Period||6
8500899|NCT00497146|20949396|P1|NOT COMPLETED|Long-term Follow-up Period||15
8500900|NCT00497146|20949395|P2|COMPLETED|Long-term Follow-up Period||66
8500901|NCT00497146|20949396|P1|COMPLETED|Long-term Follow-up Period||50
8500902|NCT00497146|20949395|P2|STARTED|Long-term Follow-up Period||72
8500903|NCT00497146|20949396|P1|STARTED|Long-term Follow-up Period||65
8500904|NCT00497146|20949395|P2|NOT COMPLETED|Treatment Period||21
8500905|NCT00497146|20949396|P1|NOT COMPLETED|Treatment Period||27
8500906|NCT00497146|20949395|P2|COMPLETED|Treatment Period||91
8500907|NCT00497146|20949396|P1|COMPLETED|Treatment Period||88
8500908|NCT00497146|20949395|P2|STARTED|Treatment Period||112
8500909|NCT00497146|20949396|P1|STARTED|Treatment Period||115
8500910|NCT00497081|20949438|P2|NOT COMPLETED|Overall Study||2
8500911|NCT00497081|20949439|P1|NOT COMPLETED|Overall Study||2
8500912|NCT00497081|20949438|P2|COMPLETED|Overall Study||28
8500913|NCT00497081|20949439|P1|COMPLETED|Overall Study||28
8500914|NCT00497081|20949438|P2|STARTED|Overall Study||30
8500915|NCT00497081|20949439|P1|STARTED|Overall Study||30
8500916|NCT00497055|20949451|P2|NOT COMPLETED|Overall Study||5
8500917|NCT00497055|20949452|P1|NOT COMPLETED|Overall Study||10
8500918|NCT00497055|20949451|P2|COMPLETED|Overall Study||40
8500919|NCT00497055|20949452|P1|COMPLETED|Overall Study||35
8500920|NCT00497055|20949451|P2|STARTED|Overall Study||45
8500921|NCT00497055|20949452|P1|STARTED|Overall Study||45
8500922|NCT00496964|20949464|P2|NOT COMPLETED|Overall Study||1
8500923|NCT00496964|20949465|P1|NOT COMPLETED|Overall Study||0
8500924|NCT00496964|20949464|P2|COMPLETED|Overall Study||3
8500925|NCT00496964|20949465|P1|COMPLETED|Overall Study||1
8500926|NCT00496964|20949464|P2|STARTED|Overall Study||4
8500927|NCT00496964|20949465|P1|STARTED|Overall Study||1
8500928|NCT00496873|20949483|P1|NOT COMPLETED|Overall Study||7
8500929|NCT00496873|20949483|P1|COMPLETED|Overall Study||78
8500930|NCT00496873|20949483|P1|STARTED|Overall Study||85
8500931|NCT00496860|20949492|P3|NOT COMPLETED|Overall Study||0
8500932|NCT00496860|20949493|P2|NOT COMPLETED|Overall Study||1
8500933|NCT00496860|20949494|P1|NOT COMPLETED|Overall Study||1
8500934|NCT00496860|20949492|P3|COMPLETED|Overall Study||6
8500935|NCT00496860|20949493|P2|COMPLETED|Overall Study||15
8500936|NCT00496860|20949494|P1|COMPLETED|Overall Study||3
8500937|NCT00496860|20949492|P3|STARTED|Overall Study||6
8500938|NCT00496860|20949493|P2|STARTED|Overall Study||16
8500939|NCT00496860|20949494|P1|STARTED|Overall Study||4
8500940|NCT00496834|20949516|P2|NOT COMPLETED|Overall Study||13
8500941|NCT00496834|20949517|P1|NOT COMPLETED|Overall Study||18
8500942|NCT00496834|20949516|P2|COMPLETED|Overall Study||87
8500943|NCT00496834|20949517|P1|COMPLETED|Overall Study||83
8500944|NCT00496834|20949516|P2|STARTED|Overall Study||100
8500945|NCT00496834|20949517|P1|STARTED|Overall Study||101
8500946|NCT00496808|20949529|P1|NOT COMPLETED|Overall Study||0
8500947|NCT00496808|20949529|P1|COMPLETED|Overall Study||69
8500948|NCT00496808|20949529|P1|STARTED|Overall Study||69
8500949|NCT00496782|20949536|P2|NOT COMPLETED|Overall Study||2
8500950|NCT00496782|20949537|P1|NOT COMPLETED|Overall Study||1
8500951|NCT00496782|20949536|P2|COMPLETED|Overall Study||5
8500952|NCT00496782|20949537|P1|COMPLETED|Overall Study||8
8500953|NCT00496782|20949536|P2|STARTED|Overall Study||7
8500954|NCT00496782|20949537|P1|STARTED|Overall Study||9
8500955|NCT00496769|20949571|P3|NOT COMPLETED|Open Label||1011
8500956|NCT00496769|20949572|P2|NOT COMPLETED|Open Label||0
8500957|NCT00496769|20949573|P1|NOT COMPLETED|Open Label||0
8500958|NCT00496769|20949571|P3|COMPLETED|Open Label||2264
8500959|NCT00496769|20949572|P2|COMPLETED|Open Label||0
8500960|NCT00496769|20949573|P1|COMPLETED|Open Label||0
8500961|NCT00496769|20949571|P3|STARTED|Open Label||3275
8500962|NCT00496769|20949572|P2|STARTED|Open Label||0
8500963|NCT00496769|20949573|P1|STARTED|Open Label||0
8500964|NCT00496769|20949571|P3|NOT COMPLETED|Double Blind||0
8500965|NCT00496769|20949572|P2|NOT COMPLETED|Double Blind||649
8500966|NCT00496769|20949573|P1|NOT COMPLETED|Double Blind||558
8500967|NCT00496769|20949571|P3|COMPLETED|Double Blind||0
8500968|NCT00496769|20949572|P2|COMPLETED|Double Blind||2142
8500969|NCT00496769|20949573|P1|COMPLETED|Double Blind||2249
8500970|NCT00496769|20949571|P3|Received Treatment|Double Blind||0
8500971|NCT00496769|20949572|P2|Received Treatment|Double Blind||2708
8500972|NCT00496769|20949573|P1|Received Treatment|Double Blind||2798
8500973|NCT00496769|20949571|P3|STARTED|Double Blind||0
8500974|NCT00496769|20949572|P2|STARTED|Double Blind|Randomized|2791
8500975|NCT00496769|20949573|P1|STARTED|Double Blind|Randomized|2807
8500976|NCT00496756|20949596|P1|NOT COMPLETED|Overall Study||3
8500977|NCT00496756|20949596|P1|COMPLETED|Overall Study||11
8500978|NCT00496756|20949596|P1|STARTED|Overall Study||14
8500979|NCT00496730|20949603|P2|NOT COMPLETED|Overall Study||5
8500980|NCT00496730|20949604|P1|NOT COMPLETED|Overall Study||6
8500981|NCT00496730|20949603|P2|COMPLETED|Overall Study||121
8500982|NCT00496730|20949604|P1|COMPLETED|Overall Study||124
8500983|NCT00496730|20949603|P2|STARTED|Overall Study||126
8500984|NCT00496730|20949604|P1|STARTED|Overall Study||130
8500985|NCT00496626|20949616|P2|NOT COMPLETED|Overall Study||6
8500986|NCT00496626|20949617|P1|NOT COMPLETED|Overall Study||6
8500987|NCT00496626|20949616|P2|COMPLETED|Overall Study||292
8500988|NCT00496626|20949617|P1|COMPLETED|Overall Study||296
8500989|NCT00496626|20949616|P2|STARTED|Overall Study||298
8500990|NCT00496626|20949617|P1|STARTED|Overall Study||302
8500991|NCT00496587|20949629|P1|NOT COMPLETED|Overall Study||31
8500992|NCT00496587|20949629|P1|COMPLETED|Overall Study||3
8500993|NCT00496587|20949629|P1|STARTED|Overall Study||34
8500994|NCT00496483|20949635|P1|NOT COMPLETED|Overall Study||12
8500995|NCT00496483|20949635|P1|COMPLETED|Overall Study||48
8500996|NCT00496483|20949635|P1|Dosed|Overall Study||51
8500997|NCT00496483|20949635|P1|STARTED|Overall Study||60
8500998|NCT00496470|20949652|P2|NOT COMPLETED|Overall Study||29
8500999|NCT00496470|20949653|P1|NOT COMPLETED|Overall Study||26
8501000|NCT00496470|20949652|P2|COMPLETED|Overall Study||302
8501001|NCT00496470|20949653|P1|COMPLETED|Overall Study||303
8501002|NCT00496470|20949652|P2|Received Study Medication|Overall Study||330
8501003|NCT00496470|20949653|P1|Received Study Medication|Overall Study||329
8501004|NCT00496470|20949652|P2|STARTED|Overall Study||331
8501005|NCT00496470|20949653|P1|STARTED|Overall Study||329
8501006|NCT00496379|20949731|P1|NOT COMPLETED|Overall Study||0
8501007|NCT00496379|20949731|P1|COMPLETED|Overall Study||15
8501008|NCT00496379|20949731|P1|STARTED|Overall Study||15
8501009|NCT00496366|20949739|P1|NOT COMPLETED|Overall Study||1
8501010|NCT00496366|20949739|P1|COMPLETED|Overall Study||10
8501011|NCT00496366|20949739|P1|STARTED|Overall Study||11
8501012|NCT00496340|20949744|P1|NOT COMPLETED|Overall Study||0
8501013|NCT00496340|20949744|P1|COMPLETED|Overall Study||42
8501014|NCT00496340|20949744|P1|STARTED|Overall Study||42
8501015|NCT00496262|20949757|P1|NOT COMPLETED|Overall Study||0
8501016|NCT00496262|20949757|P1|COMPLETED|Overall Study||15
8501017|NCT00496262|20949757|P1|STARTED|Overall Study||15
8501018|NCT00496197|20949770|P1|NOT COMPLETED|Overall Study||122
8501019|NCT00496197|20949770|P1|COMPLETED|Overall Study||160
8501020|NCT00496197|20949770|P1|STARTED|Overall Study||282
8501021|NCT00496080|20949797|P1|NOT COMPLETED|Overall Study||27
8501022|NCT00496080|20949797|P1|COMPLETED|Overall Study||60
8501023|NCT00496080|20949797|P1|STARTED|Overall Study||87
8501024|NCT00496054|20949807|P1|NOT COMPLETED|Overall Study||8
8501025|NCT00496054|20949807|P1|COMPLETED|Overall Study||102
8501026|NCT00496054|20949807|P1|STARTED|Overall Study||110
8501027|NCT00496015|20949839|P5|NOT COMPLETED|Overall Study||0
8501028|NCT00496015|20949840|P4|NOT COMPLETED|Overall Study||1
8501029|NCT00496015|20949841|P3|NOT COMPLETED|Overall Study||0
8501030|NCT00496015|20949842|P2|NOT COMPLETED|Overall Study||0
8501031|NCT00496015|20949843|P1|NOT COMPLETED|Overall Study||1
8501032|NCT00496015|20949839|P5|COMPLETED|Overall Study||336
8501033|NCT00496015|20949840|P4|COMPLETED|Overall Study||36
8501034|NCT00496015|20949841|P3|COMPLETED|Overall Study||172
8501035|NCT00496015|20949842|P2|COMPLETED|Overall Study||27
8501036|NCT00496015|20949843|P1|COMPLETED|Overall Study||177
8501037|NCT00496015|20949839|P5|STARTED|Overall Study||336
8501038|NCT00496015|20949840|P4|STARTED|Overall Study||37
8501039|NCT00496015|20949841|P3|STARTED|Overall Study||172
8501040|NCT00496015|20949842|P2|STARTED|Overall Study||27
8501041|NCT00496015|20949843|P1|STARTED|Overall Study||178
8501042|NCT00495820|20949967|P2|NOT COMPLETED|Overall Study||1
8501043|NCT00495820|20949968|P1|NOT COMPLETED|Overall Study||1
8501044|NCT00495820|20949967|P2|COMPLETED|Overall Study||29
8501045|NCT00495820|20949968|P1|COMPLETED|Overall Study||29
8501046|NCT00495820|20949967|P2|STARTED|Overall Study||30
8501047|NCT00495820|20949968|P1|STARTED|Overall Study||30
8501048|NCT00495794|20949980|P2|NOT COMPLETED|Overall Study||0
8501049|NCT00495794|20949981|P1|NOT COMPLETED|Overall Study||522
8501050|NCT00495794|20949980|P2|COMPLETED|Overall Study||2303
8501051|NCT00495794|20949981|P1|COMPLETED|Overall Study||1797
8501052|NCT00495794|20949980|P2|STARTED|Overall Study||2303
8501053|NCT00495794|20949981|P1|STARTED|Overall Study||2319
8501054|NCT00495755|20949991|P1|NOT COMPLETED|Overall Study||3
8501055|NCT00495755|20949991|P1|COMPLETED|Overall Study||10
8501056|NCT00495755|20949991|P1|STARTED|Overall Study||13
8501057|NCT00495716|20949998|P2|NOT COMPLETED|Overall Study||13
8501058|NCT00495716|20949999|P1|NOT COMPLETED|Overall Study||15
8501059|NCT00495716|20949998|P2|COMPLETED|Overall Study||24
8501060|NCT00495716|20949999|P1|COMPLETED|Overall Study||20
8501061|NCT00495716|20949998|P2|STARTED|Overall Study||37
8501062|NCT00495716|20949999|P1|STARTED|Overall Study||35
8501063|NCT00495677|20950012|P7|NOT COMPLETED|Stage 2 (25 Days)||0
8501064|NCT00495677|20950013|P6|NOT COMPLETED|Stage 2 (25 Days)||0
8501065|NCT00495677|20950014|P5|NOT COMPLETED|Stage 2 (25 Days)||0
8501066|NCT00495677|20950015|P4|NOT COMPLETED|Stage 2 (25 Days)||0
8501067|NCT00495677|20950016|P3|NOT COMPLETED|Stage 2 (25 Days)||0
8501068|NCT00495677|20950017|P2|NOT COMPLETED|Stage 2 (25 Days)||0
8501069|NCT00495677|20950018|P1|NOT COMPLETED|Stage 2 (25 Days)||0
8501070|NCT00495677|20950012|P7|COMPLETED|Stage 2 (25 Days)||7
8501071|NCT00495677|20950013|P6|COMPLETED|Stage 2 (25 Days)||8
8501072|NCT00495677|20950014|P5|COMPLETED|Stage 2 (25 Days)||8
8501073|NCT00495677|20950015|P4|COMPLETED|Stage 2 (25 Days)||0
8501074|NCT00495677|20950016|P3|COMPLETED|Stage 2 (25 Days)||0
8501075|NCT00495677|20950017|P2|COMPLETED|Stage 2 (25 Days)||0
8501076|NCT00495677|20950018|P1|COMPLETED|Stage 2 (25 Days)||0
8501077|NCT00495677|20950012|P7|STARTED|Stage 2 (25 Days)||7
8501078|NCT00495677|20950013|P6|STARTED|Stage 2 (25 Days)||8
8501079|NCT00495677|20950014|P5|STARTED|Stage 2 (25 Days)||8
8501080|NCT00495677|20950015|P4|STARTED|Stage 2 (25 Days)||0
8501081|NCT00495677|20950016|P3|STARTED|Stage 2 (25 Days)||0
8501082|NCT00495677|20950017|P2|STARTED|Stage 2 (25 Days)||0
8501083|NCT00495677|20950018|P1|STARTED|Stage 2 (25 Days)||0
8501084|NCT00495677|20950012|P7|NOT COMPLETED|Stage 1 (25 Days)||0
8501085|NCT00495677|20950013|P6|NOT COMPLETED|Stage 1 (25 Days)||0
8501086|NCT00495677|20950014|P5|NOT COMPLETED|Stage 1 (25 Days)||0
8501087|NCT00495677|20950015|P4|NOT COMPLETED|Stage 1 (25 Days)||0
8501088|NCT00495677|20950016|P3|NOT COMPLETED|Stage 1 (25 Days)||1
8501089|NCT00495677|20950017|P2|NOT COMPLETED|Stage 1 (25 Days)||0
8501090|NCT00495677|20950018|P1|NOT COMPLETED|Stage 1 (25 Days)||0
8501091|NCT00495677|20950012|P7|COMPLETED|Stage 1 (25 Days)||0
8501092|NCT00495677|20950013|P6|COMPLETED|Stage 1 (25 Days)||0
8501093|NCT00495677|20950014|P5|COMPLETED|Stage 1 (25 Days)||0
8501094|NCT00495677|20950015|P4|COMPLETED|Stage 1 (25 Days)||6
8501095|NCT00495677|20950016|P3|COMPLETED|Stage 1 (25 Days)||5
8501096|NCT00495677|20950017|P2|COMPLETED|Stage 1 (25 Days)||6
8501097|NCT00495677|20950018|P1|COMPLETED|Stage 1 (25 Days)||2
8501098|NCT00495677|20950012|P7|STARTED|Stage 1 (25 Days)||0
8501099|NCT00495677|20950013|P6|STARTED|Stage 1 (25 Days)||0
8501100|NCT00495677|20950014|P5|STARTED|Stage 1 (25 Days)||0
8501101|NCT00495677|20950015|P4|STARTED|Stage 1 (25 Days)||6
8501102|NCT00495677|20950016|P3|STARTED|Stage 1 (25 Days)||6
8501103|NCT00495677|20950017|P2|STARTED|Stage 1 (25 Days)||6
8501104|NCT00495677|20950018|P1|STARTED|Stage 1 (25 Days)||2
8501105|NCT00495625|20950073|P1|NOT COMPLETED|Overall Study||10
8501106|NCT00495625|20950073|P1|COMPLETED|Overall Study||23
8501107|NCT00495625|20950073|P1|STARTED|Overall Study||33
8501108|NCT00495612|20950084|P2|NOT COMPLETED|Overall Study||0
8501109|NCT00495612|20950085|P1|NOT COMPLETED|Overall Study||4
8501110|NCT00495612|20950084|P2|COMPLETED|Overall Study||33
8501111|NCT00495612|20950085|P1|COMPLETED|Overall Study||32
8501112|NCT00495612|20950084|P2|STARTED|Overall Study||33
8501113|NCT00495612|20950085|P1|STARTED|Overall Study||36
8501114|NCT00495586|20950103|P2|NOT COMPLETED|Overall Study||4
8501115|NCT00495586|20950104|P1|NOT COMPLETED|Overall Study||4
8501116|NCT00495586|20950103|P2|COMPLETED|Overall Study||158
8501117|NCT00495586|20950104|P1|COMPLETED|Overall Study||152
8501118|NCT00495586|20950103|P2|STARTED|Overall Study||162
8501119|NCT00495586|20950104|P1|STARTED|Overall Study||156
8501120|NCT00495521|20950114|P2|NOT COMPLETED|Overall Study||1
8501121|NCT00495521|20950115|P1|NOT COMPLETED|Overall Study||0
8501122|NCT00495521|20950114|P2|COMPLETED|Overall Study||0
8501123|NCT00495521|20950115|P1|COMPLETED|Overall Study||1
8501124|NCT00495521|20950114|P2|STARTED|Overall Study||1
8501125|NCT00495521|20950115|P1|STARTED|Overall Study||1
8501126|NCT00495495|20950145|P1|NOT COMPLETED|Overall Study||99
8501127|NCT00495495|20950145|P1|COMPLETED|Overall Study||295
8501128|NCT00495495|20950145|P1|STARTED|Overall Study||394
8501129|NCT00495469|20950165|P7|NOT COMPLETED|Overall Study||5
8501130|NCT00495469|20950166|P6|NOT COMPLETED|Overall Study||5
8501131|NCT00495469|20950167|P5|NOT COMPLETED|Overall Study||5
8501132|NCT00495469|20950168|P4|NOT COMPLETED|Overall Study||4
8501133|NCT00495469|20950169|P3|NOT COMPLETED|Overall Study||7
8501134|NCT00495469|20950170|P2|NOT COMPLETED|Overall Study||7
8501135|NCT00495469|20950171|P1|NOT COMPLETED|Overall Study||6
8501136|NCT00495469|20950165|P7|COMPLETED|Overall Study||30
8501137|NCT00495469|20950166|P6|COMPLETED|Overall Study||31
8501138|NCT00495469|20950167|P5|COMPLETED|Overall Study||31
8501139|NCT00495469|20950168|P4|COMPLETED|Overall Study||32
8501140|NCT00495469|20950169|P3|COMPLETED|Overall Study||27
8501141|NCT00495469|20950170|P2|COMPLETED|Overall Study||30
8501142|NCT00495469|20950171|P1|COMPLETED|Overall Study||30
8501143|NCT00495469|20950165|P7|STARTED|Overall Study||35
8501144|NCT00495469|20950166|P6|STARTED|Overall Study||36
8501145|NCT00495469|20950167|P5|STARTED|Overall Study||36
8501146|NCT00495469|20950168|P4|STARTED|Overall Study||36
8501147|NCT00495469|20950169|P3|STARTED|Overall Study||34
8501148|NCT00495469|20950170|P2|STARTED|Overall Study||37
8501149|NCT00495469|20950171|P1|STARTED|Overall Study||36
8501150|NCT00495391|20950315|P2|NOT COMPLETED|Overall Study||21
8501151|NCT00495391|20950316|P1|NOT COMPLETED|Overall Study||36
8501152|NCT00495391|20950315|P2|COMPLETED|Overall Study||1
8501153|NCT00495391|20950316|P1|COMPLETED|Overall Study||6
8501154|NCT00495391|20950315|P2|From Baseline to End of Follow up|Overall Study||1
8501155|NCT00495391|20950316|P1|From Baseline to End of Follow up|Overall Study||6
8501156|NCT00495391|20950315|P2|From Baseline to End of Treatment|Overall Study||1
8501157|NCT00495391|20950316|P1|From Baseline to End of Treatment|Overall Study||6
8501158|NCT00495391|20950315|P2|From Baseline to Week 16|Overall Study||11
8501159|NCT00495391|20950316|P1|From Baseline to Week 16|Overall Study||24
8501160|NCT00495391|20950315|P2|From Baseline to Week 8|Overall Study||20
8501161|NCT00495391|20950316|P1|From Baseline to Week 8|Overall Study||31
8501162|NCT00495391|20950315|P2|STARTED|Overall Study||22
8501163|NCT00495391|20950316|P1|STARTED|Overall Study||42
8501164|NCT00495222|20950336|P1|NOT COMPLETED|Overall Study||0
8501165|NCT00495222|20950336|P1|COMPLETED|Overall Study||9
8501166|NCT00495222|20950336|P1|STARTED|Overall Study||9
8501167|NCT00495170|20950339|P1|NOT COMPLETED|Overall Study||20
8501168|NCT00495170|20950339|P1|COMPLETED|Overall Study||64
8501169|NCT00495170|20950339|P1|STARTED|Overall Study||84
8501170|NCT00495157|20950346|P3|NOT COMPLETED|Overall Study||13
8501171|NCT00495157|20950347|P2|NOT COMPLETED|Overall Study||23
8501172|NCT00495157|20950348|P1|NOT COMPLETED|Overall Study||16
8501173|NCT00495157|20950346|P3|COMPLETED|Overall Study||101
8501174|NCT00495157|20950347|P2|COMPLETED|Overall Study||92
8501175|NCT00495157|20950348|P1|COMPLETED|Overall Study||97
8501176|NCT00495157|20950346|P3|STARTED|Overall Study||114
8501177|NCT00495157|20950347|P2|STARTED|Overall Study||115
8501178|NCT00495157|20950348|P1|STARTED|Overall Study||113
8501179|NCT00495131|20950358|P2|NOT COMPLETED|Overall Study||6
8501180|NCT00495131|20950359|P1|NOT COMPLETED|Overall Study||7
8501181|NCT00495131|20950358|P2|COMPLETED|Overall Study||148
8501182|NCT00495131|20950359|P1|COMPLETED|Overall Study||147
8501183|NCT00495131|20950358|P2|STARTED|Overall Study||154
8501184|NCT00495131|20950359|P1|STARTED|Overall Study||154
8501185|NCT00495079|20950369|P1|NOT COMPLETED|Overall Study||0
8501186|NCT00495079|20950369|P1|COMPLETED|Overall Study||65
8501187|NCT00495079|20950369|P1|STARTED|Overall Study||65
8501188|NCT00495040|20950376|P1|NOT COMPLETED|Overall Study||3
8501189|NCT00495040|20950376|P1|COMPLETED|Overall Study||35
8501190|NCT00495040|20950376|P1|STARTED|Overall Study||38
8501191|NCT00494975|20950382|P2|NOT COMPLETED|Overall Study||1
8501192|NCT00494975|20950383|P1|NOT COMPLETED|Overall Study||2
8501193|NCT00494975|20950382|P2|COMPLETED|Overall Study||10
8501194|NCT00494975|20950383|P1|COMPLETED|Overall Study||8
8501195|NCT00494975|20950382|P2|STARTED|Overall Study||11
8501196|NCT00494975|20950383|P1|STARTED|Overall Study||10
8501197|NCT00494871|20950391|P2|NOT COMPLETED|Follow-up (FU) Period||23
8501198|NCT00494871|20950392|P1|NOT COMPLETED|Follow-up (FU) Period||29
8501199|NCT00494871|20950391|P2|COMPLETED|Follow-up (FU) Period||616
8501200|NCT00494871|20950392|P1|COMPLETED|Follow-up (FU) Period||610
8501201|NCT00494871|20950391|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
8501202|NCT00494871|20950392|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
8501203|NCT00494871|20950391|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
8501204|NCT00494871|20950392|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
8501205|NCT00494871|20950391|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
8501206|NCT00494871|20950392|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
8501207|NCT00494871|20950391|P2|COMPLETED|Double-blind (DB) Treatment Period||468
8501208|NCT00494871|20950392|P1|COMPLETED|Double-blind (DB) Treatment Period||480
8501209|NCT00494871|20950391|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
8501210|NCT00494871|20950392|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
8501211|NCT00494871|20950391|P2|STARTED|Double-blind (DB) Treatment Period||640
8501212|NCT00494871|20950392|P1|STARTED|Double-blind (DB) Treatment Period||640
8501213|NCT00494806|20950424|P2|NOT COMPLETED|Overall Study||0
8501214|NCT00494806|20950425|P1|NOT COMPLETED|Overall Study||0
8501215|NCT00494806|20950424|P2|COMPLETED|Overall Study||32
8501216|NCT00494806|20950425|P1|COMPLETED|Overall Study||34
8501217|NCT00494806|20950424|P2|STARTED|Overall Study||32
8501218|NCT00494806|20950425|P1|STARTED|Overall Study||34
8501219|NCT00494780|20950433|P2|NOT COMPLETED|Overall Study||13
8501220|NCT00494780|20950434|P1|NOT COMPLETED|Overall Study||11
8501221|NCT00494780|20950433|P2|COMPLETED|Overall Study||17
8501222|NCT00494780|20950434|P1|COMPLETED|Overall Study||18
8501223|NCT00494780|20950433|P2|STARTED|Overall Study||30
8501224|NCT00494780|20950434|P1|STARTED|Overall Study||29
8501225|NCT00494676|20950472|P2|NOT COMPLETED|Second Intervention||1
8501226|NCT00494676|20950473|P1|NOT COMPLETED|Second Intervention||1
8501227|NCT00494676|20950472|P2|COMPLETED|Second Intervention||28
8501228|NCT00494676|20950473|P1|COMPLETED|Second Intervention||33
8501229|NCT00494676|20950472|P2|STARTED|Second Intervention||29
8501230|NCT00494676|20950473|P1|STARTED|Second Intervention||34
8501231|NCT00494676|20950472|P2|NOT COMPLETED|First Intervention||3
8501232|NCT00494676|20950473|P1|NOT COMPLETED|First Intervention||1
8501233|NCT00494676|20950472|P2|COMPLETED|First Intervention||29
8501234|NCT00494676|20950473|P1|COMPLETED|First Intervention||34
8501235|NCT00494676|20950472|P2|STARTED|First Intervention||32
8501236|NCT00494676|20950473|P1|STARTED|First Intervention||35
8501237|NCT00494676|20950472|P2|NOT COMPLETED|Allocation||4
8501238|NCT00494676|20950473|P1|NOT COMPLETED|Allocation||2
8501239|NCT00494676|20950472|P2|COMPLETED|Allocation||32
8501240|NCT00494676|20950473|P1|COMPLETED|Allocation||35
8501241|NCT00494676|20950472|P2|STARTED|Allocation||36
8501242|NCT00494676|20950473|P1|STARTED|Allocation||37
8501243|NCT00494585|20950480|P1|NOT COMPLETED|Overall Study||0
8501244|NCT00494585|20950480|P1|COMPLETED|Overall Study||22
8501245|NCT00494585|20950480|P1|STARTED|Overall Study||22
8501246|NCT00494507|20950488|P4|NOT COMPLETED|Open-Label Phase||5
8501247|NCT00494507|20950489|P3|NOT COMPLETED|Open-Label Phase||5
8501248|NCT00494507|20950490|P2|NOT COMPLETED|Open-Label Phase||1
8501249|NCT00494507|20950491|P1|NOT COMPLETED|Open-Label Phase||0
8501250|NCT00494507|20950488|P4|COMPLETED|Open-Label Phase||14
8501251|NCT00494507|20950489|P3|COMPLETED|Open-Label Phase||17
8501252|NCT00494507|20950490|P2|COMPLETED|Open-Label Phase||7
8501253|NCT00494507|20950491|P1|COMPLETED|Open-Label Phase||9
8501254|NCT00494507|20950488|P4|STARTED|Open-Label Phase||19
8501255|NCT00494507|20950489|P3|STARTED|Open-Label Phase||22
8501256|NCT00494507|20950490|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
8501257|NCT00494507|20950491|P1|STARTED|Open-Label Phase||9
8501258|NCT00494507|20950488|P4|NOT COMPLETED|Double-Blind Phase||1
8501259|NCT00494507|20950489|P3|NOT COMPLETED|Double-Blind Phase||2
8501260|NCT00494507|20950490|P2|NOT COMPLETED|Double-Blind Phase||0
8501261|NCT00494507|20950491|P1|NOT COMPLETED|Double-Blind Phase||3
8501262|NCT00494507|20950488|P4|COMPLETED|Double-Blind Phase||19
8501263|NCT00494507|20950489|P3|COMPLETED|Double-Blind Phase||22
8501264|NCT00494507|20950490|P2|COMPLETED|Double-Blind Phase||9
8501265|NCT00494507|20950491|P1|COMPLETED|Double-Blind Phase||9
8501266|NCT00494507|20950488|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
8501267|NCT00494507|20950489|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
8501268|NCT00494507|20950490|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
8501269|NCT00494507|20950491|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
8501270|NCT00494507|20950488|P4|STARTED|Double-Blind Phase||20
8501271|NCT00494507|20950489|P3|STARTED|Double-Blind Phase||24
8501272|NCT00494507|20950490|P2|STARTED|Double-Blind Phase||9
8501273|NCT00494507|20950491|P1|STARTED|Double-Blind Phase||12
8501274|NCT00494494|20950541|P2|NOT COMPLETED|Overall Study||0
8501275|NCT00494494|20950542|P1|NOT COMPLETED|Overall Study||0
8501276|NCT00494494|20950541|P2|COMPLETED|Overall Study||39
8501277|NCT00494494|20950542|P1|COMPLETED|Overall Study||40
8501278|NCT00494494|20950541|P2|STARTED|Overall Study||39
8501279|NCT00494494|20950542|P1|STARTED|Overall Study||40
8501280|NCT00494481|20950558|P2|NOT COMPLETED|Overall Study||24
8501281|NCT00494481|20950559|P1|NOT COMPLETED|Overall Study||29
8501282|NCT00494481|20950558|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
8501283|NCT00494481|20950559|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
8501284|NCT00494481|20950558|P2|STARTED|Overall Study|randomised patients|29
8501285|NCT00494481|20950559|P1|STARTED|Overall Study|randomised patients|35
8501286|NCT00494442|20950567|P2|NOT COMPLETED|Overall Study||16
8501287|NCT00494442|20950568|P1|NOT COMPLETED|Overall Study||17
8501288|NCT00494442|20950567|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
8501289|NCT00494442|20950568|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
8501290|NCT00494442|20950567|P2|STARTED|Overall Study|Patients received treatment|33
8501291|NCT00494442|20950568|P1|STARTED|Overall Study|Patients received treatment|24
8501292|NCT00494299|20950584|P2|NOT COMPLETED|Overall Study||229
8501293|NCT00494299|20950585|P1|NOT COMPLETED|Overall Study||229
8501294|NCT00494299|20950584|P2|COMPLETED|Overall Study||0
8501295|NCT00494299|20950585|P1|COMPLETED|Overall Study||0
8501296|NCT00494299|20950584|P2|Received Treatment|Overall Study||227
8501297|NCT00494299|20950585|P1|Received Treatment|Overall Study||229
8501298|NCT00494299|20950584|P2|STARTED|Overall Study||229
8501299|NCT00494299|20950585|P1|STARTED|Overall Study||229
8501306|NCT00494221|20950617|P3|NOT COMPLETED|Overall Study||14
8501307|NCT00494221|20950618|P2|NOT COMPLETED|Overall Study||11
8501308|NCT00494221|20950619|P1|NOT COMPLETED|Overall Study||16
8501309|NCT00494221|20950617|P3|COMPLETED|Overall Study||44
8501310|NCT00494221|20950618|P2|COMPLETED|Overall Study||45
8501311|NCT00494221|20950619|P1|COMPLETED|Overall Study||42
8501312|NCT00494221|20950617|P3|STARTED|Overall Study||58
8501313|NCT00494221|20950618|P2|STARTED|Overall Study||56
8501314|NCT00494221|20950619|P1|STARTED|Overall Study||58
8501315|NCT00494143|20950639|P6|NOT COMPLETED|Overall Study||0
8501316|NCT00494143|20950640|P5|NOT COMPLETED|Overall Study||0
8501317|NCT00494143|20950641|P4|NOT COMPLETED|Overall Study||0
8501318|NCT00494143|20950642|P3|NOT COMPLETED|Overall Study||0
8501319|NCT00494143|20950643|P2|NOT COMPLETED|Overall Study||0
8501320|NCT00494143|20950644|P1|NOT COMPLETED|Overall Study||0
8501321|NCT00494143|20950639|P6|COMPLETED|Overall Study||0
8501322|NCT00494143|20950640|P5|COMPLETED|Overall Study||1
8501323|NCT00494143|20950641|P4|COMPLETED|Overall Study||0
8501324|NCT00494143|20950642|P3|COMPLETED|Overall Study||3
8501325|NCT00494143|20950643|P2|COMPLETED|Overall Study||2
8501326|NCT00494143|20950644|P1|COMPLETED|Overall Study||1
8501327|NCT00494143|20950639|P6|STARTED|Overall Study||0
8501328|NCT00494143|20950640|P5|STARTED|Overall Study||1
8501329|NCT00494143|20950641|P4|STARTED|Overall Study||0
8501330|NCT00494143|20950642|P3|STARTED|Overall Study||3
8501331|NCT00494143|20950643|P2|STARTED|Overall Study||2
8501332|NCT00494143|20950644|P1|STARTED|Overall Study||1
8501333|NCT00494091|20950660|P2|NOT COMPLETED|Overall Study||76
8501334|NCT00494091|20950661|P1|NOT COMPLETED|Overall Study||6
8501335|NCT00494091|20950660|P2|COMPLETED|Overall Study||0
8501336|NCT00494091|20950661|P1|COMPLETED|Overall Study||0
8501337|NCT00494091|20950660|P2|STARTED|Overall Study||76
8501338|NCT00494091|20950661|P1|STARTED|Overall Study||6
8501339|NCT00494026|20950683|P1|NOT COMPLETED|Overall Study||4
8501340|NCT00494026|20950683|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
8501341|NCT00494026|20950683|P1|STARTED|Overall Study||4
8501342|NCT00494013|20950693|P2|NOT COMPLETED|Overall Study||36
8501343|NCT00494013|20950694|P1|NOT COMPLETED|Overall Study||30
8501344|NCT00494013|20950693|P2|COMPLETED|Overall Study||183
8501345|NCT00494013|20950694|P1|COMPLETED|Overall Study||193
8501346|NCT00494013|20950693|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
8501347|NCT00494013|20950694|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
8501348|NCT00494013|20950693|P2|STARTED|Overall Study||219
8501349|NCT00494013|20950694|P1|STARTED|Overall Study||223
8501350|NCT00493974|20950724|P2|NOT COMPLETED|Overall Study||14
8501351|NCT00493974|20950725|P1|NOT COMPLETED|Overall Study||13
8501352|NCT00493974|20950724|P2|COMPLETED|Overall Study||45
8501353|NCT00493974|20950725|P1|COMPLETED|Overall Study||47
8501354|NCT00493974|20950724|P2|STARTED|Overall Study||59
8501355|NCT00493974|20950725|P1|STARTED|Overall Study||60
8501356|NCT00493805|20950743|P2|NOT COMPLETED|Overall Study||0
8501357|NCT00493805|20950744|P1|NOT COMPLETED|Overall Study||0
8501358|NCT00493805|20950743|P2|COMPLETED|Overall Study||42
8501359|NCT00493805|20950744|P1|COMPLETED|Overall Study||17
8501360|NCT00493805|20950743|P2|STARTED|Overall Study||42
8501361|NCT00493805|20950744|P1|STARTED|Overall Study||17
8501362|NCT00493779|20950752|P1|NOT COMPLETED|Overall Study||1
8501363|NCT00493779|20950752|P1|COMPLETED|Overall Study|Completed follow-up phase|97
8501364|NCT00493779|20950752|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
8501365|NCT00493649|20950759|P1|NOT COMPLETED|Overall Study||82
8501366|NCT00493649|20950759|P1|COMPLETED|Overall Study||411
8501367|NCT00493649|20950759|P1|STARTED|Overall Study||493
8501368|NCT00493636|20950772|P2|NOT COMPLETED|Overall Study||2
8501369|NCT00493636|20950773|P1|NOT COMPLETED|Overall Study||2
8501370|NCT00493636|20950772|P2|COMPLETED|Overall Study||77
8501371|NCT00493636|20950773|P1|COMPLETED|Overall Study||79
8501372|NCT00493636|20950772|P2|STARTED|Overall Study||79
8501373|NCT00493636|20950773|P1|STARTED|Overall Study||81
8501374|NCT00493467|20950787|P1|NOT COMPLETED|Overall Study||1
8501375|NCT00493467|20950787|P1|COMPLETED|Overall Study||30
8501376|NCT00493467|20950787|P1|STARTED|Overall Study||31
8501377|NCT00493454|20950792|P1|NOT COMPLETED|Overall Study||1
8501378|NCT00493454|20950792|P1|COMPLETED|Overall Study||5
8501379|NCT00493454|20950792|P1|STARTED|Overall Study||6
8501380|NCT00493311|20950798|P2|NOT COMPLETED|Overall Study||2
8501381|NCT00493311|20950799|P1|NOT COMPLETED|Overall Study||2
8501382|NCT00493311|20950798|P2|COMPLETED|Overall Study||29
8501383|NCT00493311|20950799|P1|COMPLETED|Overall Study||27
8501384|NCT00493311|20950798|P2|STARTED|Overall Study||31
8501385|NCT00493311|20950799|P1|STARTED|Overall Study||29
8501386|NCT00493285|20950819|P6|NOT COMPLETED|Overall Study||0
8501387|NCT00493285|20950820|P5|NOT COMPLETED|Overall Study||1
8501388|NCT00493285|20950821|P4|NOT COMPLETED|Overall Study||0
8501389|NCT00493285|20950822|P3|NOT COMPLETED|Overall Study||0
8501390|NCT00493285|20950823|P2|NOT COMPLETED|Overall Study||0
8501391|NCT00493285|20950824|P1|NOT COMPLETED|Overall Study||0
8501392|NCT00493285|20950819|P6|COMPLETED|Overall Study||5
8501393|NCT00493285|20950820|P5|COMPLETED|Overall Study||9
8501394|NCT00493285|20950821|P4|COMPLETED|Overall Study||6
8501395|NCT00493285|20950822|P3|COMPLETED|Overall Study||9
8501396|NCT00493285|20950823|P2|COMPLETED|Overall Study||6
8501397|NCT00493285|20950824|P1|COMPLETED|Overall Study||13
8501398|NCT00493285|20950819|P6|STARTED|Overall Study||5
8501399|NCT00493285|20950820|P5|STARTED|Overall Study||10
8501400|NCT00493285|20950821|P4|STARTED|Overall Study||6
8501401|NCT00493285|20950822|P3|STARTED|Overall Study||9
8501402|NCT00493285|20950823|P2|STARTED|Overall Study||6
8501403|NCT00493285|20950824|P1|STARTED|Overall Study||13
8501404|NCT00493246|20951056|P8|NOT COMPLETED|Overall Study||0
8501405|NCT00493246|20951057|P7|NOT COMPLETED|Overall Study||1
8501406|NCT00493246|20951058|P6|NOT COMPLETED|Overall Study||1
8501407|NCT00493246|20951059|P5|NOT COMPLETED|Overall Study||1
8501408|NCT00493246|20951060|P4|NOT COMPLETED|Overall Study||0
8501409|NCT00493246|20951061|P3|NOT COMPLETED|Overall Study||0
8501410|NCT00493246|20951062|P2|NOT COMPLETED|Overall Study||0
8501411|NCT00493246|20951063|P1|NOT COMPLETED|Overall Study||0
8501412|NCT00493246|20951056|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
8501413|NCT00493246|20951057|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
8501414|NCT00493246|20951058|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
8501415|NCT00493246|20951059|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
8501416|NCT00493246|20951060|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
8501417|NCT00493246|20951061|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
8501418|NCT00493246|20951062|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
8501419|NCT00493246|20951063|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
8501420|NCT00493246|20951056|P8|STARTED|Overall Study|All subjects who were randomized.|10
8501421|NCT00493246|20951057|P7|STARTED|Overall Study|All subjects who were randomized.|12
8501422|NCT00493246|20951058|P6|STARTED|Overall Study|All subjects who were randomized.|16
8501423|NCT00493246|20951059|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
8501424|NCT00493246|20951060|P4|STARTED|Overall Study||13
8501425|NCT00493246|20951061|P3|STARTED|Overall Study||12
8501426|NCT00493246|20951062|P2|STARTED|Overall Study||1
8501427|NCT00493246|20951063|P1|STARTED|Overall Study||2
8501428|NCT00493220|20951127|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501429|NCT00493220|20951128|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501430|NCT00493220|20951129|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501431|NCT00493220|20951130|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501432|NCT00493220|20951131|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501433|NCT00493220|20951132|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501434|NCT00493220|20951127|P6|COMPLETED|Final 7-Day Safety Follow-up||5
8501435|NCT00493220|20951128|P5|COMPLETED|Final 7-Day Safety Follow-up||5
8501436|NCT00493220|20951129|P4|COMPLETED|Final 7-Day Safety Follow-up||5
8501437|NCT00493220|20951130|P3|COMPLETED|Final 7-Day Safety Follow-up||5
8501438|NCT00493220|20951131|P2|COMPLETED|Final 7-Day Safety Follow-up||5
8501439|NCT00493220|20951132|P1|COMPLETED|Final 7-Day Safety Follow-up||4
8501440|NCT00493220|20951127|P6|STARTED|Final 7-Day Safety Follow-up||5
8501441|NCT00493220|20951128|P5|STARTED|Final 7-Day Safety Follow-up||5
8501442|NCT00493220|20951129|P4|STARTED|Final 7-Day Safety Follow-up||5
8501443|NCT00493220|20951130|P3|STARTED|Final 7-Day Safety Follow-up||5
8501444|NCT00493220|20951131|P2|STARTED|Final 7-Day Safety Follow-up||5
8501445|NCT00493220|20951132|P1|STARTED|Final 7-Day Safety Follow-up||4
8501446|NCT00493220|20951127|P6|NOT COMPLETED|Third Intervention||0
8501447|NCT00493220|20951128|P5|NOT COMPLETED|Third Intervention||0
8501448|NCT00493220|20951129|P4|NOT COMPLETED|Third Intervention||0
8501449|NCT00493220|20951130|P3|NOT COMPLETED|Third Intervention||0
8501450|NCT00493220|20951131|P2|NOT COMPLETED|Third Intervention||0
8501451|NCT00493220|20951132|P1|NOT COMPLETED|Third Intervention||1
8501452|NCT00493220|20951127|P6|COMPLETED|Third Intervention||5
8501453|NCT00493220|20951128|P5|COMPLETED|Third Intervention||5
8501454|NCT00493220|20951129|P4|COMPLETED|Third Intervention||5
8501455|NCT00493220|20951130|P3|COMPLETED|Third Intervention||5
8501456|NCT00493220|20951131|P2|COMPLETED|Third Intervention||5
8501457|NCT00493220|20951132|P1|COMPLETED|Third Intervention||4
8501458|NCT00493220|20951127|P6|STARTED|Third Intervention||5
8501459|NCT00493220|20951128|P5|STARTED|Third Intervention||5
8501460|NCT00493220|20951129|P4|STARTED|Third Intervention||5
8501461|NCT00493220|20951130|P3|STARTED|Third Intervention||5
8501462|NCT00493220|20951131|P2|STARTED|Third Intervention||5
8501463|NCT00493220|20951132|P1|STARTED|Third Intervention||5
8501464|NCT00493220|20951127|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501465|NCT00493220|20951128|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501466|NCT00493220|20951129|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501467|NCT00493220|20951130|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501468|NCT00493220|20951131|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501469|NCT00493220|20951132|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501470|NCT00493220|20951127|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501471|NCT00493220|20951128|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501472|NCT00493220|20951129|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501473|NCT00493220|20951130|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501474|NCT00493220|20951131|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501475|NCT00493220|20951132|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501476|NCT00493220|20951127|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501477|NCT00493220|20951128|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501478|NCT00493220|20951129|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501479|NCT00493220|20951130|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501480|NCT00493220|20951131|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501481|NCT00493220|20951132|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501482|NCT00493220|20951127|P6|NOT COMPLETED|Second Intervention||0
8501483|NCT00493220|20951128|P5|NOT COMPLETED|Second Intervention||0
8501484|NCT00493220|20951129|P4|NOT COMPLETED|Second Intervention||0
8501485|NCT00493220|20951130|P3|NOT COMPLETED|Second Intervention||0
8501486|NCT00493220|20951131|P2|NOT COMPLETED|Second Intervention||0
8501487|NCT00493220|20951132|P1|NOT COMPLETED|Second Intervention||0
8501488|NCT00493220|20951127|P6|COMPLETED|Second Intervention||5
8501489|NCT00493220|20951128|P5|COMPLETED|Second Intervention||5
8501490|NCT00493220|20951129|P4|COMPLETED|Second Intervention||5
8501491|NCT00493220|20951130|P3|COMPLETED|Second Intervention||5
8501492|NCT00493220|20951131|P2|COMPLETED|Second Intervention||5
8501493|NCT00493220|20951132|P1|COMPLETED|Second Intervention||5
8501494|NCT00493220|20951127|P6|STARTED|Second Intervention||5
8501495|NCT00493220|20951128|P5|STARTED|Second Intervention||5
8501496|NCT00493220|20951129|P4|STARTED|Second Intervention||5
8501497|NCT00493220|20951130|P3|STARTED|Second Intervention||5
8501498|NCT00493220|20951131|P2|STARTED|Second Intervention||5
8501499|NCT00493220|20951132|P1|STARTED|Second Intervention||5
8501500|NCT00493220|20951127|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501501|NCT00493220|20951128|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501502|NCT00493220|20951129|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501503|NCT00493220|20951130|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501504|NCT00493220|20951131|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501505|NCT00493220|20951132|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501506|NCT00493220|20951127|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501507|NCT00493220|20951128|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501508|NCT00493220|20951129|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501509|NCT00493220|20951130|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501510|NCT00493220|20951131|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501511|NCT00493220|20951132|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501512|NCT00493220|20951127|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
8501513|NCT00493220|20951128|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
8501514|NCT00493220|20951129|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
8501515|NCT00493220|20951130|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
8501516|NCT00493220|20951131|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
8501517|NCT00493220|20951132|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
8501518|NCT00493220|20951127|P6|NOT COMPLETED|First Intervention||0
8501519|NCT00493220|20951128|P5|NOT COMPLETED|First Intervention||0
8501520|NCT00493220|20951129|P4|NOT COMPLETED|First Intervention||0
8501521|NCT00493220|20951130|P3|NOT COMPLETED|First Intervention||0
8501522|NCT00493220|20951131|P2|NOT COMPLETED|First Intervention||0
8501523|NCT00493220|20951132|P1|NOT COMPLETED|First Intervention||0
8501524|NCT00493220|20951127|P6|COMPLETED|First Intervention||5
8501525|NCT00493220|20951128|P5|COMPLETED|First Intervention||5
8501526|NCT00493220|20951129|P4|COMPLETED|First Intervention||5
8501527|NCT00493220|20951130|P3|COMPLETED|First Intervention||5
8501528|NCT00493220|20951131|P2|COMPLETED|First Intervention||5
8501529|NCT00493220|20951132|P1|COMPLETED|First Intervention||5
8501530|NCT00493220|20951127|P6|STARTED|First Intervention||5
8501531|NCT00493220|20951128|P5|STARTED|First Intervention||5
8501532|NCT00493220|20951129|P4|STARTED|First Intervention||5
8501533|NCT00493220|20951130|P3|STARTED|First Intervention||5
8501534|NCT00493220|20951131|P2|STARTED|First Intervention||5
8501535|NCT00493220|20951132|P1|STARTED|First Intervention||5
8501536|NCT00493181|20951149|P1|NOT COMPLETED|Overall Study||0
8501537|NCT00493181|20951149|P1|COMPLETED|Overall Study||8
8501538|NCT00493181|20951149|P1|STARTED|Overall Study||8
8501539|NCT00493064|20951153|P1|NOT COMPLETED|Overall Study||11
8501540|NCT00493064|20951153|P1|COMPLETED|Overall Study||52
8501541|NCT00493064|20951153|P1|STARTED|Overall Study||63
8501542|NCT00493038|20951160|P2|NOT COMPLETED|Follow-up||0
8501543|NCT00493038|20951161|P1|NOT COMPLETED|Follow-up||1
8501544|NCT00493038|20951160|P2|COMPLETED|Follow-up||126
8501545|NCT00493038|20951161|P1|COMPLETED|Follow-up||122
8501546|NCT00493038|20951160|P2|STARTED|Follow-up||126
8501547|NCT00493038|20951161|P1|STARTED|Follow-up||123
8501548|NCT00493038|20951160|P2|NOT COMPLETED|Treatment||20
8501549|NCT00493038|20951161|P1|NOT COMPLETED|Treatment||24
8501550|NCT00493038|20951160|P2|COMPLETED|Treatment||126
8501551|NCT00493038|20951161|P1|COMPLETED|Treatment||123
8501552|NCT00493038|20951160|P2|Test-of-Cure Visit|Treatment||126
8501553|NCT00493038|20951161|P1|Test-of-Cure Visit|Treatment||123
8501554|NCT00493038|20951160|P2|Treated With Study Medication|Treatment||142
8501555|NCT00493038|20951161|P1|Treated With Study Medication|Treatment||145
8501556|NCT00493038|20951160|P2|Randomization|Treatment||146
8501557|NCT00493038|20951161|P1|Randomization|Treatment||147
8501558|NCT00493038|20951160|P2|STARTED|Treatment||146
8501559|NCT00493038|20951161|P1|STARTED|Treatment||147
8501560|NCT00493025|20951175|P1|NOT COMPLETED|Overall Study||19
8501561|NCT00493025|20951175|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
8501562|NCT00493025|20951175|P1|STARTED|Overall Study||19
8501563|NCT00493012|20951186|P2|NOT COMPLETED|Overall Study||17
8501564|NCT00493012|20951187|P1|NOT COMPLETED|Overall Study||18
8501565|NCT00493012|20951186|P2|COMPLETED|Overall Study||83
8501566|NCT00493012|20951187|P1|COMPLETED|Overall Study||82
8501567|NCT00493012|20951186|P2|STARTED|Overall Study||100
8501568|NCT00493012|20951187|P1|STARTED|Overall Study||100
8501569|NCT00492973|20951215|P2|NOT COMPLETED|Overall Study||1
8501570|NCT00492973|20951216|P1|NOT COMPLETED|Overall Study||0
8501571|NCT00492973|20951215|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
8501572|NCT00492973|20951216|P1|COMPLETED|Overall Study||37
8501573|NCT00492973|20951215|P2|STARTED|Overall Study||39
8501574|NCT00492973|20951216|P1|STARTED|Overall Study||37
8501575|NCT00492921|20951230|P3|NOT COMPLETED|Overall Study||1
8501576|NCT00492921|20951231|P2|NOT COMPLETED|Overall Study||0
8501577|NCT00492921|20951232|P1|NOT COMPLETED|Overall Study||1
8501578|NCT00492921|20951230|P3|COMPLETED|Overall Study||2
8501579|NCT00492921|20951231|P2|COMPLETED|Overall Study||4
8501580|NCT00492921|20951232|P1|COMPLETED|Overall Study||4
8501581|NCT00492921|20951230|P3|STARTED|Overall Study||3
8501582|NCT00492921|20951231|P2|STARTED|Overall Study||4
8501583|NCT00492921|20951232|P1|STARTED|Overall Study||5
8501584|NCT00492856|20951243|P4|NOT COMPLETED|Post-consolidation||1
8501585|NCT00492856|20951244|P3|NOT COMPLETED|Post-consolidation||27
8501586|NCT00492856|20951245|P2|NOT COMPLETED|Post-consolidation||12
8501587|NCT00492856|20951246|P1|NOT COMPLETED|Post-consolidation||0
8501588|NCT00492856|20951243|P4|COMPLETED|Post-consolidation||0
8501589|NCT00492856|20951244|P3|COMPLETED|Post-consolidation||0
8501590|NCT00492856|20951245|P2|COMPLETED|Post-consolidation||29
8501591|NCT00492856|20951246|P1|COMPLETED|Post-consolidation||0
8501592|NCT00492856|20951243|P4|STARTED|Post-consolidation||1
8501593|NCT00492856|20951244|P3|STARTED|Post-consolidation||27
8501594|NCT00492856|20951245|P2|STARTED|Post-consolidation||41
8501595|NCT00492856|20951246|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
8501596|NCT00492856|20951243|P4|NOT COMPLETED|Consolidation||0
8501597|NCT00492856|20951244|P3|NOT COMPLETED|Consolidation||0
8501598|NCT00492856|20951245|P2|NOT COMPLETED|Consolidation||0
8501599|NCT00492856|20951246|P1|NOT COMPLETED|Consolidation||9
8501600|NCT00492856|20951243|P4|COMPLETED|Consolidation||0
8501601|NCT00492856|20951244|P3|COMPLETED|Consolidation||0
8501602|NCT00492856|20951245|P2|COMPLETED|Consolidation||0
8501603|NCT00492856|20951246|P1|COMPLETED|Consolidation||83
8501604|NCT00492856|20951243|P4|STARTED|Consolidation||0
8501605|NCT00492856|20951244|P3|STARTED|Consolidation||0
8501606|NCT00492856|20951245|P2|STARTED|Consolidation||0
8501607|NCT00492856|20951246|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
8501608|NCT00492856|20951243|P4|NOT COMPLETED|Induction||0
8501609|NCT00492856|20951244|P3|NOT COMPLETED|Induction||0
8501610|NCT00492856|20951245|P2|NOT COMPLETED|Induction||0
8501611|NCT00492856|20951246|P1|NOT COMPLETED|Induction||6
8501612|NCT00492856|20951243|P4|COMPLETED|Induction||0
8501613|NCT00492856|20951244|P3|COMPLETED|Induction||0
8501614|NCT00492856|20951245|P2|COMPLETED|Induction||0
8501615|NCT00492856|20951246|P1|COMPLETED|Induction||99
8501616|NCT00492856|20951243|P4|STARTED|Induction||0
8501617|NCT00492856|20951244|P3|STARTED|Induction||0
8501618|NCT00492856|20951245|P2|STARTED|Induction||0
8501619|NCT00492856|20951246|P1|STARTED|Induction||105
8501620|NCT00492752|20951260|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
8501621|NCT00492752|20951261|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
8501622|NCT00492752|20951262|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
8501623|NCT00492752|20951263|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
8501624|NCT00492752|20951260|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
8501625|NCT00492752|20951261|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
8501626|NCT00492752|20951262|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
8501627|NCT00492752|20951263|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
8501628|NCT00492752|20951260|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
8501629|NCT00492752|20951261|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
8501630|NCT00492752|20951262|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
8501631|NCT00492752|20951263|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
8501632|NCT00492752|20951260|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
8501633|NCT00492752|20951261|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
8501634|NCT00492752|20951262|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
8501635|NCT00492752|20951263|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
8501636|NCT00492752|20951260|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
8501637|NCT00492752|20951261|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
8501638|NCT00492752|20951262|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
8501639|NCT00492752|20951263|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
8501640|NCT00492752|20951260|P4|NOT COMPLETED|Double Blind Treatment||0
8501641|NCT00492752|20951261|P3|NOT COMPLETED|Double Blind Treatment||3
8501642|NCT00492752|20951262|P2|NOT COMPLETED|Double Blind Treatment||0
8501643|NCT00492752|20951263|P1|NOT COMPLETED|Double Blind Treatment||14
8501644|NCT00492752|20951260|P4|COMPLETED|Double Blind Treatment||6
8501645|NCT00492752|20951261|P3|COMPLETED|Double Blind Treatment||67
8501646|NCT00492752|20951262|P2|COMPLETED|Double Blind Treatment||16
8501647|NCT00492752|20951263|P1|COMPLETED|Double Blind Treatment||120
8501648|NCT00492752|20951260|P4|Received Treatment|Double Blind Treatment|Safety Population|6
8501649|NCT00492752|20951261|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
8501650|NCT00492752|20951262|P2|Received Treatment|Double Blind Treatment|Safety Population|16
8501651|NCT00492752|20951263|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
8501652|NCT00492752|20951260|P4|STARTED|Double Blind Treatment||6
8501653|NCT00492752|20951261|P3|STARTED|Double Blind Treatment||70
8501654|NCT00492752|20951262|P2|STARTED|Double Blind Treatment||16
8501655|NCT00492752|20951263|P1|STARTED|Double Blind Treatment||134
8501656|NCT00492726|20951298|P2|NOT COMPLETED|Overall Study||36
8501657|NCT00492726|20951299|P1|NOT COMPLETED|Overall Study||50
8501658|NCT00492726|20951298|P2|COMPLETED|Overall Study||358
8501659|NCT00492726|20951299|P1|COMPLETED|Overall Study||360
8501660|NCT00492726|20951298|P2|End of Study|Overall Study||358
8501661|NCT00492726|20951299|P1|End of Study|Overall Study||360
8501662|NCT00492726|20951298|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
8501663|NCT00492726|20951299|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
8501664|NCT00492726|20951298|P2|STARTED|Overall Study||394
8501665|NCT00492726|20951299|P1|STARTED|Overall Study||410
8501666|NCT00492648|20951325|P2|NOT COMPLETED|Month 42 (109674 Study)||0
8501667|NCT00492648|20951326|P1|NOT COMPLETED|Month 42 (109674 Study)||0
8501668|NCT00492648|20951325|P2|COMPLETED|Month 42 (109674 Study)||20
8501669|NCT00492648|20951326|P1|COMPLETED|Month 42 (109674 Study)||3
8501670|NCT00492648|20951325|P2|STARTED|Month 42 (109674 Study)||20
8501671|NCT00492648|20951326|P1|STARTED|Month 42 (109674 Study)||3
8501672|NCT00492648|20951325|P2|NOT COMPLETED|Month 30 (109671 Study)||1
8501673|NCT00492648|20951326|P1|NOT COMPLETED|Month 30 (109671 Study)||0
8501674|NCT00492648|20951325|P2|COMPLETED|Month 30 (109671 Study)||29
8501675|NCT00492648|20951326|P1|COMPLETED|Month 30 (109671 Study)||4
8501676|NCT00492648|20951325|P2|STARTED|Month 30 (109671 Study)||30
8501677|NCT00492648|20951326|P1|STARTED|Month 30 (109671 Study)||4
8501678|NCT00492622|20951352|P1|NOT COMPLETED|Overall Study||0
8501679|NCT00492622|20951352|P1|COMPLETED|Overall Study||12
8501680|NCT00492622|20951352|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
8501681|NCT00492583|20951364|P2|NOT COMPLETED|Overall Study||0
8501682|NCT00492583|20951365|P1|NOT COMPLETED|Overall Study||0
8501683|NCT00492583|20951364|P2|COMPLETED|Overall Study||87
8501684|NCT00492583|20951365|P1|COMPLETED|Overall Study||95
8501685|NCT00492583|20951364|P2|STARTED|Overall Study||87
8501686|NCT00492583|20951365|P1|STARTED|Overall Study||95
8501687|NCT00492557|20951373|P2|NOT COMPLETED|Overall Study||23
8501688|NCT00492557|20951374|P1|NOT COMPLETED|Overall Study||24
8501689|NCT00492557|20951373|P2|COMPLETED|Overall Study||557
8501690|NCT00492557|20951374|P1|COMPLETED|Overall Study||556
8501691|NCT00492557|20951373|P2|Vaccinated Dose 2|Overall Study||558
8501692|NCT00492557|20951374|P1|Vaccinated Dose 2|Overall Study||560
8501693|NCT00492557|20951373|P2|Vaccinated Dose 1|Overall Study||575
8501694|NCT00492557|20951374|P1|Vaccinated Dose 1|Overall Study||577
8501695|NCT00492557|20951373|P2|STARTED|Overall Study||580
8501696|NCT00492557|20951374|P1|STARTED|Overall Study||580
8501697|NCT00492544|20951390|P1|NOT COMPLETED|Overall Study||0
8501698|NCT00492544|20951390|P1|COMPLETED|Overall Study||100
8501699|NCT00492544|20951390|P1|STARTED|Overall Study||100
8501700|NCT00492531|20951404|P2|NOT COMPLETED|Overall Study||23
8501701|NCT00492531|20951405|P1|NOT COMPLETED|Overall Study||22
8501702|NCT00492531|20951404|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
8501703|NCT00492531|20951405|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
8501704|NCT00492531|20951404|P2|STARTED|Overall Study||37
8501705|NCT00492531|20951405|P1|STARTED|Overall Study||37
8501706|NCT00492401|20951417|P1|NOT COMPLETED|Overall Study||0
8501707|NCT00492401|20951417|P1|COMPLETED|Overall Study||55
8501708|NCT00492401|20951417|P1|STARTED|Overall Study||55
8501709|NCT00492349|20951428|P2|NOT COMPLETED|Overall Study||7
8501710|NCT00492349|20951429|P1|NOT COMPLETED|Overall Study||3
8501711|NCT00492349|20951428|P2|COMPLETED|Overall Study||27
8501712|NCT00492349|20951429|P1|COMPLETED|Overall Study||32
8501713|NCT00492349|20951428|P2|Week 8|Overall Study||27
8501714|NCT00492349|20951429|P1|Week 8|Overall Study||32
8501715|NCT00492349|20951428|P2|Week 2|Overall Study||33
8501716|NCT00492349|20951429|P1|Week 2|Overall Study||32
8501717|NCT00492349|20951428|P2|STARTED|Overall Study||34
8501718|NCT00492349|20951429|P1|STARTED|Overall Study||35
8501719|NCT00492336|20951451|P2|NOT COMPLETED|Overall Study||6
8501720|NCT00492336|20951452|P1|NOT COMPLETED|Overall Study||2
8501721|NCT00492336|20951451|P2|COMPLETED|Overall Study||23
8501722|NCT00492336|20951452|P1|COMPLETED|Overall Study||26
8501723|NCT00492336|20951451|P2|STARTED|Overall Study||29
8501724|NCT00492336|20951452|P1|STARTED|Overall Study||28
8501725|NCT00492297|20951478|P1|NOT COMPLETED|Survival Only Follow-up||59
8501726|NCT00492297|20951478|P1|COMPLETED|Survival Only Follow-up||0
8501727|NCT00492297|20951478|P1|STARTED|Survival Only Follow-up||59
8501728|NCT00492297|20951478|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
8501729|NCT00492297|20951478|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
8501730|NCT00492297|20951478|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
8501731|NCT00492297|20951478|P1|NOT COMPLETED|Treatment||5
8501732|NCT00492297|20951478|P1|COMPLETED|Treatment||78
8501733|NCT00492297|20951478|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
8501734|NCT00492297|20951478|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
8501735|NCT00492297|20951478|P1|STARTED|Treatment||83
8501736|NCT00492284|20951496|P4|NOT COMPLETED|Overall Study||10
8501737|NCT00492284|20951497|P3|NOT COMPLETED|Overall Study||6
8501738|NCT00492284|20951498|P2|NOT COMPLETED|Overall Study||4
8501739|NCT00492284|20951499|P1|NOT COMPLETED|Overall Study||1
8501740|NCT00492284|20951496|P4|COMPLETED|Overall Study||31
8501741|NCT00492284|20951497|P3|COMPLETED|Overall Study||37
8501742|NCT00492284|20951498|P2|COMPLETED|Overall Study||35
8501743|NCT00492284|20951499|P1|COMPLETED|Overall Study||38
8501744|NCT00492284|20951496|P4|STARTED|Overall Study||41
8501745|NCT00492284|20951497|P3|STARTED|Overall Study||43
8501746|NCT00492284|20951498|P2|STARTED|Overall Study||39
8501747|NCT00492284|20951499|P1|STARTED|Overall Study||39
8501748|NCT00492232|20951543|P2|NOT COMPLETED|Open-Label Treatment||0
8501749|NCT00492232|20951544|P1|NOT COMPLETED|Open-Label Treatment||1
8501750|NCT00492232|20951543|P2|COMPLETED|Open-Label Treatment||0
8501751|NCT00492232|20951544|P1|COMPLETED|Open-Label Treatment||88
8501752|NCT00492232|20951543|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
8501753|NCT00492232|20951544|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
8501754|NCT00492232|20951543|P2|NOT COMPLETED|Double-Blind Treatment||25
8501755|NCT00492232|20951544|P1|NOT COMPLETED|Double-Blind Treatment||18
8501756|NCT00492232|20951543|P2|COMPLETED|Double-Blind Treatment||45
8501757|NCT00492232|20951544|P1|COMPLETED|Double-Blind Treatment||47
8501758|NCT00492232|20951543|P2|STARTED|Double-Blind Treatment||70
8501759|NCT00492232|20951544|P1|STARTED|Double-Blind Treatment||65
8501760|NCT00492232|20951543|P2|NOT COMPLETED|Placebo Run-in||70
8501761|NCT00492232|20951544|P1|NOT COMPLETED|Placebo Run-in||0
8501762|NCT00492232|20951543|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
8501763|NCT00492232|20951544|P1|COMPLETED|Placebo Run-in||0
8501764|NCT00492232|20951543|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
8501765|NCT00492232|20951544|P1|STARTED|Placebo Run-in||0
8501766|NCT00492206|20951576|P1|NOT COMPLETED|Overall Study||0
8501767|NCT00492206|20951576|P1|COMPLETED|Overall Study||40
8501768|NCT00492206|20951576|P1|STARTED|Overall Study||40
8501769|NCT00492115|20951585|P2|NOT COMPLETED|Overall Study||4
8501770|NCT00492115|20951586|P1|NOT COMPLETED|Overall Study||3
8501771|NCT00492115|20951585|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
8501772|NCT00492115|20951586|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
8501773|NCT00492115|20951585|P2|STARTED|Overall Study||19
8501774|NCT00492115|20951586|P1|STARTED|Overall Study||19
8501775|NCT00492089|20951596|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8501776|NCT00492089|20951597|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8501777|NCT00492089|20951596|P2|COMPLETED|Second Intervention (6 Weeks)||6
8501778|NCT00492089|20951597|P1|COMPLETED|Second Intervention (6 Weeks)||5
8501779|NCT00492089|20951596|P2|STARTED|Second Intervention (6 Weeks)||6
8501780|NCT00492089|20951597|P1|STARTED|Second Intervention (6 Weeks)||5
8501781|NCT00492089|20951596|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8501782|NCT00492089|20951597|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8501783|NCT00492089|20951596|P2|COMPLETED|First Intervention (6 Weeks)||6
8501784|NCT00492089|20951597|P1|COMPLETED|First Intervention (6 Weeks)||5
8501785|NCT00492089|20951596|P2|STARTED|First Intervention (6 Weeks)||6
8501786|NCT00492089|20951597|P1|STARTED|First Intervention (6 Weeks)||5
8501787|NCT00492063|20951607|P4|NOT COMPLETED|Overall Study||10
8501788|NCT00492063|20951608|P3|NOT COMPLETED|Overall Study||11
8501789|NCT00492063|20951609|P2|NOT COMPLETED|Overall Study||14
8501790|NCT00492063|20951610|P1|NOT COMPLETED|Overall Study||10
8501791|NCT00492063|20951607|P4|COMPLETED|Overall Study||666
8501792|NCT00492063|20951608|P3|COMPLETED|Overall Study||667
8501793|NCT00492063|20951609|P2|COMPLETED|Overall Study||634
8501794|NCT00492063|20951610|P1|COMPLETED|Overall Study||642
8501795|NCT00492063|20951607|P4|STARTED|Overall Study||676
8501796|NCT00492063|20951608|P3|STARTED|Overall Study||678
8501797|NCT00492063|20951609|P2|STARTED|Overall Study||648
8501798|NCT00492063|20951610|P1|STARTED|Overall Study||652
8501799|NCT00492024|20951634|P2|NOT COMPLETED|Follow up||2
8501800|NCT00492024|20951635|P1|NOT COMPLETED|Follow up||1
8501801|NCT00492024|20951634|P2|COMPLETED|Follow up||99
8501802|NCT00492024|20951635|P1|COMPLETED|Follow up||221
8501803|NCT00492024|20951634|P2|STARTED|Follow up||101
8501804|NCT00492024|20951635|P1|STARTED|Follow up||222
8501805|NCT00492024|20951634|P2|NOT COMPLETED|Treatment||22
8501806|NCT00492024|20951635|P1|NOT COMPLETED|Treatment||29
8501807|NCT00492024|20951634|P2|COMPLETED|Treatment||101
8501808|NCT00492024|20951635|P1|COMPLETED|Treatment||222
8501809|NCT00492024|20951634|P2|STARTED|Treatment||123
8501810|NCT00492024|20951635|P1|STARTED|Treatment||251
8501811|NCT00491894|20951651|P1|NOT COMPLETED|Overall Study||34
8501812|NCT00491894|20951651|P1|COMPLETED|Overall Study||103
8501813|NCT00491894|20951651|P1|STARTED|Overall Study||137
8501814|NCT00491829|20951662|P3|NOT COMPLETED|Overall Study||75
8501815|NCT00491829|20951663|P2|NOT COMPLETED|Overall Study||114
8501816|NCT00491829|20951664|P1|NOT COMPLETED|Overall Study||95
8501817|NCT00491829|20951662|P3|COMPLETED|Overall Study||243
8501818|NCT00491829|20951663|P2|COMPLETED|Overall Study||202
8501819|NCT00491829|20951664|P1|COMPLETED|Overall Study||216
8501820|NCT00491829|20951662|P3|STARTED|Overall Study||318
8501821|NCT00491829|20951663|P2|STARTED|Overall Study||316
8501822|NCT00491829|20951664|P1|STARTED|Overall Study||311
8501823|NCT00491764|20951678|P6|NOT COMPLETED|Overall Study||9
8501824|NCT00491764|20951679|P5|NOT COMPLETED|Overall Study||3
8501825|NCT00491764|20951680|P4|NOT COMPLETED|Overall Study||8
8501826|NCT00491764|20951681|P3|NOT COMPLETED|Overall Study||8
8501827|NCT00491764|20951682|P2|NOT COMPLETED|Overall Study||7
8501828|NCT00491764|20951683|P1|NOT COMPLETED|Overall Study||5
8501829|NCT00491764|20951678|P6|COMPLETED|Overall Study||27
8501830|NCT00491764|20951679|P5|COMPLETED|Overall Study||33
8501831|NCT00491764|20951680|P4|COMPLETED|Overall Study||28
8501832|NCT00491764|20951681|P3|COMPLETED|Overall Study||28
8501833|NCT00491764|20951682|P2|COMPLETED|Overall Study||30
8501834|NCT00491764|20951683|P1|COMPLETED|Overall Study||32
8501835|NCT00491764|20951678|P6|STARTED|Overall Study||36
8501836|NCT00491764|20951679|P5|STARTED|Overall Study||36
8501837|NCT00491764|20951680|P4|STARTED|Overall Study||36
8501838|NCT00491764|20951681|P3|STARTED|Overall Study||36
8501839|NCT00491764|20951682|P2|STARTED|Overall Study||37
8501840|NCT00491764|20951683|P1|STARTED|Overall Study||37
8501841|NCT00491751|20951712|P3|NOT COMPLETED|Overall Study||0
8501842|NCT00491751|20951713|P2|NOT COMPLETED|Overall Study||0
8501843|NCT00491751|20951714|P1|NOT COMPLETED|Overall Study||0
8501844|NCT00491751|20951712|P3|COMPLETED|Overall Study||42
8501845|NCT00491751|20951713|P2|COMPLETED|Overall Study||44
8501846|NCT00491751|20951714|P1|COMPLETED|Overall Study||22
8501847|NCT00491751|20951712|P3|STARTED|Overall Study||42
8501848|NCT00491751|20951713|P2|STARTED|Overall Study||44
8501849|NCT00491751|20951714|P1|STARTED|Overall Study||22
8501850|NCT00491738|20951726|P2|NOT COMPLETED|Overall Study||0
8501851|NCT00491738|20951727|P1|NOT COMPLETED|Overall Study||0
8501852|NCT00491738|20951726|P2|COMPLETED|Overall Study||9
8501853|NCT00491738|20951727|P1|COMPLETED|Overall Study||7
8501854|NCT00491738|20951726|P2|STARTED|Overall Study||9
8501855|NCT00491738|20951727|P1|STARTED|Overall Study||7
8501856|NCT00491608|20951731|P1|NOT COMPLETED|Overall Study||3
8501857|NCT00491608|20951731|P1|COMPLETED|Overall Study||206
8501858|NCT00491608|20951731|P1|STARTED|Overall Study|Participants who received treatment|209
8501859|NCT00491556|20951742|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
8501860|NCT00491556|20951743|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
8501861|NCT00491556|20951742|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
8501862|NCT00491556|20951743|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
8501863|NCT00491556|20951742|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
8501864|NCT00491556|20951743|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
8501865|NCT00491556|20951742|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
8501866|NCT00491556|20951743|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
8501867|NCT00491556|20951742|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
8501868|NCT00491556|20951743|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
8501869|NCT00491556|20951742|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
8501870|NCT00491556|20951743|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
8501871|NCT00491556|20951742|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
8501872|NCT00491556|20951743|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
8501873|NCT00491530|20951802|P3|NOT COMPLETED|Overall Study||5
8501874|NCT00491530|20951803|P2|NOT COMPLETED|Overall Study||6
8501875|NCT00491530|20951804|P1|NOT COMPLETED|Overall Study||12
8501876|NCT00491530|20951802|P3|COMPLETED|Overall Study||81
8501877|NCT00491530|20951803|P2|COMPLETED|Overall Study||44
8501878|NCT00491530|20951804|P1|COMPLETED|Overall Study||162
8501879|NCT00491530|20951802|P3|STARTED|Overall Study||86
8501880|NCT00491530|20951803|P2|STARTED|Overall Study||50
8501881|NCT00491530|20951804|P1|STARTED|Overall Study||174
8501882|NCT00491504|20951834|P4|NOT COMPLETED|Overall Study||4
8501883|NCT00491504|20951835|P3|NOT COMPLETED|Overall Study||4
8501884|NCT00491504|20951836|P2|NOT COMPLETED|Overall Study||1
8501885|NCT00491504|20951837|P1|NOT COMPLETED|Overall Study||0
8501886|NCT00491504|20951834|P4|COMPLETED|Overall Study||73
8501887|NCT00491504|20951835|P3|COMPLETED|Overall Study||74
8501888|NCT00491504|20951836|P2|COMPLETED|Overall Study||77
8501889|NCT00491504|20951837|P1|COMPLETED|Overall Study||77
8501890|NCT00491504|20951834|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
8501891|NCT00491504|20951835|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
8501892|NCT00491504|20951836|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
8501893|NCT00491504|20951837|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
8501894|NCT00491491|20951847|P2|NOT COMPLETED|Overall Study||0
8501895|NCT00491491|20951848|P1|NOT COMPLETED|Overall Study||0
8501896|NCT00491491|20951847|P2|COMPLETED|Overall Study||21
8501897|NCT00491491|20951848|P1|COMPLETED|Overall Study||22
8501898|NCT00491491|20951847|P2|STARTED|Overall Study||21
8501899|NCT00491491|20951848|P1|STARTED|Overall Study||22
8501900|NCT00491400|20951866|P2|NOT COMPLETED|Overall Study||4
8501901|NCT00491400|20951867|P1|NOT COMPLETED|Overall Study||5
8501902|NCT00491400|20951866|P2|COMPLETED|Overall Study||9
8501903|NCT00491400|20951867|P1|COMPLETED|Overall Study||10
8501904|NCT00491400|20951866|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
8501905|NCT00491400|20951867|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
8501906|NCT00491400|20951866|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
8501907|NCT00491400|20951867|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
8501908|NCT00491400|20951866|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
8501909|NCT00491400|20951867|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
8501910|NCT00491400|20951866|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
8501911|NCT00491400|20951867|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
8501912|NCT00491400|20951866|P2|STARTED|Overall Study||13
8501913|NCT00491400|20951867|P1|STARTED|Overall Study||15
8501914|NCT00491387|20951875|P1|NOT COMPLETED|Overall Study||20
8501915|NCT00491387|20951875|P1|COMPLETED|Overall Study||4
8501916|NCT00491387|20951875|P1|Study Enrollment|Overall Study||24
8501917|NCT00491387|20951875|P1|STARTED|Overall Study||24
8501918|NCT00491374|20951881|P2|NOT COMPLETED|Overall Study||0
8501919|NCT00491374|20951882|P1|NOT COMPLETED|Overall Study||0
8501920|NCT00491374|20951881|P2|COMPLETED|Overall Study||0
8501921|NCT00491374|20951882|P1|COMPLETED|Overall Study||0
8501922|NCT00491374|20951881|P2|STARTED|Overall Study||0
8501923|NCT00491374|20951882|P1|STARTED|Overall Study||0
8501924|NCT00491322|20951890|P2|NOT COMPLETED|Overall Study||1
8501925|NCT00491322|20951891|P1|NOT COMPLETED|Overall Study||1
8501926|NCT00491322|20951890|P2|COMPLETED|Overall Study||50
8501927|NCT00491322|20951891|P1|COMPLETED|Overall Study||40
8501928|NCT00491322|20951890|P2|STARTED|Overall Study||51
8501929|NCT00491322|20951891|P1|STARTED|Overall Study||41
8501930|NCT00491244|20951899|P2|NOT COMPLETED|Overall Study||20
8501931|NCT00491244|20951900|P1|NOT COMPLETED|Overall Study||27
8501932|NCT00491244|20951899|P2|COMPLETED|Overall Study||168
8501933|NCT00491244|20951900|P1|COMPLETED|Overall Study||162
8501934|NCT00491244|20951899|P2|STARTED|Overall Study||188
8501935|NCT00491244|20951900|P1|STARTED|Overall Study||189
8501936|NCT00491179|20951910|P2|NOT COMPLETED|Overall Study||2
8501937|NCT00491179|20951911|P1|NOT COMPLETED|Overall Study||7
8501938|NCT00491179|20951910|P2|COMPLETED|Overall Study||8
8501939|NCT00491179|20951911|P1|COMPLETED|Overall Study||18
8501940|NCT00491179|20951910|P2|STARTED|Overall Study||10
8501941|NCT00491179|20951911|P1|STARTED|Overall Study||25
8501942|NCT00491075|20951919|P1|NOT COMPLETED|Overall Study||2
8501943|NCT00491075|20951919|P1|COMPLETED|Overall Study||14
8501944|NCT00491075|20951919|P1|STARTED|Overall Study||16
8501945|NCT00490971|20951925|P5|NOT COMPLETED|Maintenance||39
8501946|NCT00490971|20951926|P4|NOT COMPLETED|Maintenance||53
8501947|NCT00490971|20951927|P3|NOT COMPLETED|Maintenance||51
8501948|NCT00490971|20951928|P2|NOT COMPLETED|Maintenance||0
8501949|NCT00490971|20951929|P1|NOT COMPLETED|Maintenance||0
8501950|NCT00490971|20951925|P5|COMPLETED|Maintenance||44
8501951|NCT00490971|20951926|P4|COMPLETED|Maintenance||96
8501952|NCT00490971|20951927|P3|COMPLETED|Maintenance||96
8501953|NCT00490971|20951928|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501954|NCT00490971|20951929|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501955|NCT00490971|20951925|P5|STARTED|Maintenance||83
8501956|NCT00490971|20951926|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
8501957|NCT00490971|20951927|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
8501958|NCT00490971|20951928|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501959|NCT00490971|20951929|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501960|NCT00490971|20951925|P5|NOT COMPLETED|Acute/Continuation||0
8501961|NCT00490971|20951926|P4|NOT COMPLETED|Acute/Continuation||0
8501962|NCT00490971|20951927|P3|NOT COMPLETED|Acute/Continuation||0
8501963|NCT00490971|20951928|P2|NOT COMPLETED|Acute/Continuation||62
8501964|NCT00490971|20951929|P1|NOT COMPLETED|Acute/Continuation||306
8501965|NCT00490971|20951925|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501966|NCT00490971|20951926|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501967|NCT00490971|20951927|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501968|NCT00490971|20951928|P2|COMPLETED|Acute/Continuation||86
8501969|NCT00490971|20951929|P1|COMPLETED|Acute/Continuation||308
8501970|NCT00490971|20951925|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501971|NCT00490971|20951926|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501972|NCT00490971|20951927|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501973|NCT00490971|20951928|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
8501974|NCT00490971|20951929|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
8501975|NCT00490945|20951976|P5|NOT COMPLETED|Overall Study||0
8501976|NCT00490945|20951977|P4|NOT COMPLETED|Overall Study||0
8501977|NCT00490945|20951978|P3|NOT COMPLETED|Overall Study||0
8501978|NCT00490945|20951979|P2|NOT COMPLETED|Overall Study||1
8501979|NCT00490945|20951980|P1|NOT COMPLETED|Overall Study||0
8501980|NCT00490945|20951976|P5|COMPLETED|Overall Study||7
8501981|NCT00490945|20951977|P4|COMPLETED|Overall Study||7
8501982|NCT00490945|20951978|P3|COMPLETED|Overall Study||8
8501983|NCT00490945|20951979|P2|COMPLETED|Overall Study||8
8501984|NCT00490945|20951980|P1|COMPLETED|Overall Study||8
8501985|NCT00490945|20951976|P5|STARTED|Overall Study||7
8501986|NCT00490945|20951977|P4|STARTED|Overall Study||7
8501987|NCT00490945|20951978|P3|STARTED|Overall Study||8
8501988|NCT00490945|20951979|P2|STARTED|Overall Study||9
8501989|NCT00490945|20951980|P1|STARTED|Overall Study||8
8501990|NCT00490919|20952016|P3|NOT COMPLETED|Double-blind Phase||84
8501991|NCT00490919|20952017|P2|NOT COMPLETED|Double-blind Phase||86
8501992|NCT00490919|20952018|P1|NOT COMPLETED|Double-blind Phase||0
8501993|NCT00490919|20952016|P3|COMPLETED|Double-blind Phase||199
8501994|NCT00490919|20952017|P2|COMPLETED|Double-blind Phase||170
8501995|NCT00490919|20952018|P1|COMPLETED|Double-blind Phase||0
8501996|NCT00490919|20952016|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
8501997|NCT00490919|20952017|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
8501998|NCT00490919|20952018|P1|STARTED|Double-blind Phase||0
8501999|NCT00490919|20952016|P3|NOT COMPLETED|Open-label Run-in Period||0
8502000|NCT00490919|20952017|P2|NOT COMPLETED|Open-label Run-in Period||0
8502001|NCT00490919|20952018|P1|NOT COMPLETED|Open-label Run-in Period||483
8502002|NCT00490919|20952016|P3|COMPLETED|Open-label Run-in Period||0
8502003|NCT00490919|20952017|P2|COMPLETED|Open-label Run-in Period||0
8502004|NCT00490919|20952018|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
8502005|NCT00490919|20952016|P3|STARTED|Open-label Run-in Period||0
8502006|NCT00490919|20952017|P2|STARTED|Open-label Run-in Period||0
8502007|NCT00490919|20952018|P1|STARTED|Open-label Run-in Period||1024
8502008|NCT00490841|20952029|P1|NOT COMPLETED|Overall Study||13
8502009|NCT00490841|20952029|P1|COMPLETED|Overall Study||189
8502010|NCT00490841|20952029|P1|STARTED|Overall Study||202
8502011|NCT00490815|20952051|P2|NOT COMPLETED|Overall Study||9
8502012|NCT00490815|20952052|P1|NOT COMPLETED|Overall Study||8
8502013|NCT00490815|20952051|P2|COMPLETED|Overall Study||8
8502014|NCT00490815|20952052|P1|COMPLETED|Overall Study||12
8502015|NCT00490815|20952051|P2|STARTED|Overall Study||17
8502016|NCT00490815|20952052|P1|STARTED|Overall Study||20
8502017|NCT00490802|20952062|P2|NOT COMPLETED|Overall Study||2
8502018|NCT00490802|20952063|P1|NOT COMPLETED|Overall Study||1
8502019|NCT00490802|20952062|P2|COMPLETED|Overall Study||7
8502020|NCT00490802|20952063|P1|COMPLETED|Overall Study||9
8502021|NCT00490802|20952062|P2|STARTED|Overall Study||9
8502022|NCT00490802|20952063|P1|STARTED|Overall Study||10
8502023|NCT00490724|20952080|P3|NOT COMPLETED|Period II||3
8502024|NCT00490724|20952081|P2|NOT COMPLETED|Period II||1
8502025|NCT00490724|20952082|P1|NOT COMPLETED|Period II||3
8502026|NCT00490724|20952080|P3|COMPLETED|Period II||16
8502027|NCT00490724|20952081|P2|COMPLETED|Period II||19
8502028|NCT00490724|20952082|P1|COMPLETED|Period II||18
8502029|NCT00490724|20952080|P3|STARTED|Period II||19
8502030|NCT00490724|20952081|P2|STARTED|Period II||20
8502031|NCT00490724|20952082|P1|STARTED|Period II||21
8502032|NCT00490724|20952080|P3|NOT COMPLETED|Period I||1
8502033|NCT00490724|20952081|P2|NOT COMPLETED|Period I||0
8502034|NCT00490724|20952082|P1|NOT COMPLETED|Period I||0
8502035|NCT00490724|20952080|P3|COMPLETED|Period I||19
8502036|NCT00490724|20952081|P2|COMPLETED|Period I||20
8502037|NCT00490724|20952082|P1|COMPLETED|Period I||21
8502038|NCT00490724|20952080|P3|STARTED|Period I||20
8502039|NCT00490724|20952081|P2|STARTED|Period I||20
8502040|NCT00490724|20952082|P1|STARTED|Period I||21
8502041|NCT00490698|20952147|P1|NOT COMPLETED|Overall Study||10
8502042|NCT00490698|20952147|P1|COMPLETED|Overall Study||1
8502043|NCT00490698|20952147|P1|STARTED|Overall Study||11
8502044|NCT00490646|20952153|P2|NOT COMPLETED|Overall Study||2
8502045|NCT00490646|20952154|P1|NOT COMPLETED|Overall Study||2
8502046|NCT00490646|20952153|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
8502047|NCT00490646|20952154|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
8502048|NCT00490646|20952153|P2|Treated|Overall Study||24
8502049|NCT00490646|20952154|P1|Treated|Overall Study||24
8502050|NCT00490646|20952153|P2|STARTED|Overall Study||25
8502051|NCT00490646|20952154|P1|STARTED|Overall Study||25
8502052|NCT00490568|20952174|P1|NOT COMPLETED|Overall Study||1364
8502053|NCT00490568|20952174|P1|COMPLETED|Overall Study||97
8502054|NCT00490568|20952174|P1|STARTED|Overall Study||1461
8502055|NCT00490555|20952198|P4|NOT COMPLETED|Overall Study||0
8502056|NCT00490555|20952199|P3|NOT COMPLETED|Overall Study||2
8502057|NCT00490555|20952200|P2|NOT COMPLETED|Overall Study||0
8502058|NCT00490555|20952201|P1|NOT COMPLETED|Overall Study||0
8502059|NCT00490555|20952198|P4|COMPLETED|Overall Study||7
8502060|NCT00490555|20952199|P3|COMPLETED|Overall Study||7
8502061|NCT00490555|20952200|P2|COMPLETED|Overall Study||8
8502062|NCT00490555|20952201|P1|COMPLETED|Overall Study||8
8502063|NCT00490555|20952198|P4|STARTED|Overall Study||7
8502064|NCT00490555|20952199|P3|STARTED|Overall Study||9
8502065|NCT00490555|20952200|P2|STARTED|Overall Study||8
8502066|NCT00490555|20952201|P1|STARTED|Overall Study||8
8502067|NCT00490542|20952229|P2|NOT COMPLETED|Overall Study||4
8502068|NCT00490542|20952230|P1|NOT COMPLETED|Overall Study||7
8502069|NCT00490542|20952229|P2|COMPLETED|Overall Study||31
8502070|NCT00490542|20952230|P1|COMPLETED|Overall Study||31
8502071|NCT00490542|20952229|P2|STARTED|Overall Study||35
8502072|NCT00490542|20952230|P1|STARTED|Overall Study||38
8502073|NCT00490529|20952236|P1|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
8502074|NCT00490529|20952236|P1|COMPLETED|Treatment With CpG-MCL Vaccine||47
8502075|NCT00490529|20952236|P1|STARTED|Treatment With CpG-MCL Vaccine||48
8502076|NCT00490529|20952236|P1|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
8502077|NCT00490529|20952236|P1|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
8502078|NCT00490529|20952236|P1|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
8502079|NCT00490490|20952244|P1|NOT COMPLETED|Completed Assessment for TTP||3
8502080|NCT00490490|20952244|P1|COMPLETED|Completed Assessment for TTP||5
8502081|NCT00490490|20952244|P1|STARTED|Completed Assessment for TTP||8
8502082|NCT00490490|20952244|P1|NOT COMPLETED|Completed Assessment for CR||0
8502083|NCT00490490|20952244|P1|COMPLETED|Completed Assessment for CR||8
8502084|NCT00490490|20952244|P1|STARTED|Completed Assessment for CR||8
8502085|NCT00490477|20952252|P2|NOT COMPLETED|Overall Study||0
8502086|NCT00490477|20952253|P1|NOT COMPLETED|Overall Study||0
8502087|NCT00490477|20952252|P2|COMPLETED|Overall Study||8
8502088|NCT00490477|20952253|P1|COMPLETED|Overall Study||8
8502089|NCT00490477|20952252|P2|STARTED|Overall Study||8
8502090|NCT00490477|20952253|P1|STARTED|Overall Study||8
8502091|NCT00490451|20952261|P2|NOT COMPLETED|Overall Study||38
8502092|NCT00490451|20952262|P1|NOT COMPLETED|Overall Study||63
8502093|NCT00490451|20952261|P2|COMPLETED|Overall Study||0
8502094|NCT00490451|20952262|P1|COMPLETED|Overall Study||0
8502095|NCT00490451|20952261|P2|STARTED|Overall Study||38
8502096|NCT00490451|20952262|P1|STARTED|Overall Study||63
8502097|NCT00490282|20952282|P1|NOT COMPLETED|Overall Study||3
8502098|NCT00490282|20952282|P1|COMPLETED|Overall Study||22
8502099|NCT00490282|20952282|P1|STARTED|Overall Study||25
8502100|NCT00490269|20952290|P2|NOT COMPLETED|Placebo Then Dronabinol||0
8502101|NCT00490269|20952291|P1|NOT COMPLETED|Placebo Then Dronabinol||0
8502102|NCT00490269|20952290|P2|COMPLETED|Placebo Then Dronabinol||6
8502103|NCT00490269|20952291|P1|COMPLETED|Placebo Then Dronabinol||6
8502104|NCT00490269|20952290|P2|STARTED|Placebo Then Dronabinol||6
8502105|NCT00490269|20952291|P1|STARTED|Placebo Then Dronabinol||6
8502106|NCT00490269|20952290|P2|NOT COMPLETED|Dronabinol Then Placebo||0
8502107|NCT00490269|20952291|P1|NOT COMPLETED|Dronabinol Then Placebo||0
8502108|NCT00490269|20952290|P2|COMPLETED|Dronabinol Then Placebo||6
8502109|NCT00490269|20952291|P1|COMPLETED|Dronabinol Then Placebo||6
8502110|NCT00490269|20952290|P2|STARTED|Dronabinol Then Placebo||6
8502111|NCT00490269|20952291|P1|STARTED|Dronabinol Then Placebo||6
8502112|NCT00490256|20952299|P2|NOT COMPLETED|Overall Study||0
8502113|NCT00490256|20952300|P1|NOT COMPLETED|Overall Study||0
8502114|NCT00490256|20952299|P2|COMPLETED|Overall Study||7
8502115|NCT00490256|20952300|P1|COMPLETED|Overall Study||7
8502116|NCT00490256|20952299|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
8502117|NCT00490256|20952300|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
8502118|NCT00490256|20952299|P2|STARTED|Overall Study||7
8502119|NCT00490256|20952300|P1|STARTED|Overall Study||7
8502120|NCT00490139|20952310|P4|NOT COMPLETED|Overall Study||307
8502121|NCT00490139|20952311|P3|NOT COMPLETED|Overall Study||434
8502122|NCT00490139|20952312|P2|NOT COMPLETED|Overall Study||275
8502123|NCT00490139|20952313|P1|NOT COMPLETED|Overall Study||308
8502124|NCT00490139|20952310|P4|COMPLETED|Overall Study||1790
8502125|NCT00490139|20952311|P3|COMPLETED|Overall Study||1666
8502126|NCT00490139|20952312|P2|COMPLETED|Overall Study||1816
8502127|NCT00490139|20952313|P1|COMPLETED|Overall Study||1785
8502128|NCT00490139|20952310|P4|STARTED|Overall Study||2097
8502129|NCT00490139|20952311|P3|STARTED|Overall Study||2100
8502130|NCT00490139|20952312|P2|STARTED|Overall Study||2091
8502131|NCT00490139|20952313|P1|STARTED|Overall Study||2093
8502132|NCT00490100|20952343|P1|NOT COMPLETED|Overall Study||3
8502133|NCT00490100|20952343|P1|COMPLETED|Overall Study||3
8502134|NCT00490100|20952343|P1|STARTED|Overall Study||6
8502135|NCT00490061|20952348|P1|NOT COMPLETED|Overall Study||1
8502136|NCT00490061|20952348|P1|COMPLETED|Overall Study||16
8502137|NCT00490061|20952348|P1|STARTED|Overall Study||17
8502138|NCT00490035|20952357|P4|NOT COMPLETED|Overall Study||6
8502139|NCT00490035|20952358|P3|NOT COMPLETED|Overall Study||12
8502140|NCT00490035|20952359|P2|NOT COMPLETED|Overall Study||6
8502141|NCT00490035|20952360|P1|NOT COMPLETED|Overall Study||8
8502142|NCT00490035|20952357|P4|COMPLETED|Overall Study||94
8502143|NCT00490035|20952358|P3|COMPLETED|Overall Study||88
8502144|NCT00490035|20952359|P2|COMPLETED|Overall Study||93
8502145|NCT00490035|20952360|P1|COMPLETED|Overall Study||92
8502146|NCT00490035|20952357|P4|STARTED|Overall Study||100
8502147|NCT00490035|20952358|P3|STARTED|Overall Study||100
8502148|NCT00490035|20952359|P2|STARTED|Overall Study||99
8502149|NCT00490035|20952360|P1|STARTED|Overall Study||100
8502150|NCT00490022|20952460|P2|NOT COMPLETED|Overall Study||3
8502151|NCT00490022|20952461|P1|NOT COMPLETED|Overall Study||1
8502152|NCT00490022|20952460|P2|COMPLETED|Overall Study||12
8502153|NCT00490022|20952461|P1|COMPLETED|Overall Study||15
8502154|NCT00490022|20952460|P2|STARTED|Overall Study||15
8502155|NCT00490022|20952461|P1|STARTED|Overall Study||16
8502156|NCT00490009|20952469|P1|NOT COMPLETED|Overall Study||0
8502157|NCT00490009|20952469|P1|COMPLETED|Overall Study||9
8502158|NCT00490009|20952469|P1|STARTED|Overall Study||9
8502159|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 9||5
8502160|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 9||2
8502161|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 9||3
8502162|NCT00489970|20952478|P3|COMPLETED|Persistence Year 9||357
8502163|NCT00489970|20952479|P2|COMPLETED|Persistence Year 9||136
8502164|NCT00489970|20952480|P1|COMPLETED|Persistence Year 9||306
8502165|NCT00489970|20952478|P3|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
8502166|NCT00489970|20952479|P2|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
8502167|NCT00489970|20952480|P1|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
8502168|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 5||0
8502169|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 5||0
8502170|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 5||0
8502171|NCT00489970|20952478|P3|COMPLETED|Persistence Year 5||0
8502172|NCT00489970|20952479|P2|COMPLETED|Persistence Year 5||401
8502173|NCT00489970|20952480|P1|COMPLETED|Persistence Year 5||856
8502174|NCT00489970|20952478|P3|STARTED|Persistence Year 5||0
8502175|NCT00489970|20952479|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
8502176|NCT00489970|20952480|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
8502177|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 3||0
8502178|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 3||0
8502179|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 3||0
8502180|NCT00489970|20952478|P3|COMPLETED|Persistence Year 3||0
8502181|NCT00489970|20952479|P2|COMPLETED|Persistence Year 3||486
8502182|NCT00489970|20952480|P1|COMPLETED|Persistence Year 3||1019
8502183|NCT00489970|20952478|P3|STARTED|Persistence Year 3||0
8502184|NCT00489970|20952479|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
8502185|NCT00489970|20952480|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
8502186|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 1||0
8502187|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 1||0
8502188|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 1||0
8502189|NCT00489970|20952478|P3|COMPLETED|Persistence Year 1||0
8502190|NCT00489970|20952479|P2|COMPLETED|Persistence Year 1||523
8502191|NCT00489970|20952480|P1|COMPLETED|Persistence Year 1||1069
8502192|NCT00489970|20952478|P3|STARTED|Persistence Year 1||0
8502193|NCT00489970|20952479|P2|STARTED|Persistence Year 1||523
8502194|NCT00489970|20952480|P1|STARTED|Persistence Year 1||1069
8502195|NCT00489918|20952584|P5|NOT COMPLETED|Overall Study||1
8502196|NCT00489918|20952585|P4|NOT COMPLETED|Overall Study||1
8502197|NCT00489918|20952586|P3|NOT COMPLETED|Overall Study||4
8502198|NCT00489918|20952587|P2|NOT COMPLETED|Overall Study||2
8502199|NCT00489918|20952588|P1|NOT COMPLETED|Overall Study||2
8502200|NCT00489918|20952584|P5|COMPLETED|Overall Study||32
8502201|NCT00489918|20952585|P4|COMPLETED|Overall Study||32
8502202|NCT00489918|20952586|P3|COMPLETED|Overall Study||28
8502203|NCT00489918|20952587|P2|COMPLETED|Overall Study||32
8502204|NCT00489918|20952588|P1|COMPLETED|Overall Study||31
8502205|NCT00489918|20952584|P5|STARTED|Overall Study||33
8502206|NCT00489918|20952585|P4|STARTED|Overall Study||33
8502207|NCT00489918|20952586|P3|STARTED|Overall Study||32
8502208|NCT00489918|20952587|P2|STARTED|Overall Study||34
8502209|NCT00489918|20952588|P1|STARTED|Overall Study||33
8502210|NCT00489866|20952622|P2|NOT COMPLETED|Overall Study||0
8502211|NCT00489866|20952623|P1|NOT COMPLETED|Overall Study||2
8502212|NCT00489866|20952622|P2|COMPLETED|Overall Study||7
8502213|NCT00489866|20952623|P1|COMPLETED|Overall Study||5
8502214|NCT00489866|20952622|P2|STARTED|Overall Study||7
8502215|NCT00489866|20952623|P1|STARTED|Overall Study||7
8502216|NCT00489853|20952637|P3|NOT COMPLETED|Follow-up Period||0
8502217|NCT00489853|20952638|P2|NOT COMPLETED|Follow-up Period||0
8502218|NCT00489853|20952639|P1|NOT COMPLETED|Follow-up Period||0
8502219|NCT00489853|20952637|P3|COMPLETED|Follow-up Period||33
8502220|NCT00489853|20952638|P2|COMPLETED|Follow-up Period||29
8502221|NCT00489853|20952639|P1|COMPLETED|Follow-up Period||29
8502222|NCT00489853|20952637|P3|STARTED|Follow-up Period||33
8502223|NCT00489853|20952638|P2|STARTED|Follow-up Period||29
8502224|NCT00489853|20952639|P1|STARTED|Follow-up Period||29
8502225|NCT00489853|20952637|P3|NOT COMPLETED|Treatment Period 3||0
8502226|NCT00489853|20952638|P2|NOT COMPLETED|Treatment Period 3||1
8502227|NCT00489853|20952639|P1|NOT COMPLETED|Treatment Period 3||0
8502228|NCT00489853|20952637|P3|COMPLETED|Treatment Period 3||33
8502229|NCT00489853|20952638|P2|COMPLETED|Treatment Period 3||29
8502230|NCT00489853|20952639|P1|COMPLETED|Treatment Period 3||29
8502231|NCT00489853|20952637|P3|STARTED|Treatment Period 3||33
8502232|NCT00489853|20952638|P2|STARTED|Treatment Period 3||30
8502233|NCT00489853|20952639|P1|STARTED|Treatment Period 3||29
8502234|NCT00489853|20952637|P3|NOT COMPLETED|Wash-out Period 2||2
8502235|NCT00489853|20952638|P2|NOT COMPLETED|Wash-out Period 2||3
8502236|NCT00489853|20952639|P1|NOT COMPLETED|Wash-out Period 2||4
8502237|NCT00489853|20952637|P3|COMPLETED|Wash-out Period 2||31
8502238|NCT00489853|20952638|P2|COMPLETED|Wash-out Period 2||32
8502239|NCT00489853|20952639|P1|COMPLETED|Wash-out Period 2||29
8502240|NCT00489853|20952637|P3|STARTED|Wash-out Period 2||33
8502241|NCT00489853|20952638|P2|STARTED|Wash-out Period 2||35
8502242|NCT00489853|20952639|P1|STARTED|Wash-out Period 2||33
8502243|NCT00489853|20952637|P3|NOT COMPLETED|Treatment Period 2||0
8502244|NCT00489853|20952638|P2|NOT COMPLETED|Treatment Period 2||0
8502245|NCT00489853|20952639|P1|NOT COMPLETED|Treatment Period 2||0
8502246|NCT00489853|20952637|P3|COMPLETED|Treatment Period 2||33
8502247|NCT00489853|20952638|P2|COMPLETED|Treatment Period 2||35
8502248|NCT00489853|20952639|P1|COMPLETED|Treatment Period 2||33
8502249|NCT00489853|20952637|P3|STARTED|Treatment Period 2||33
8502250|NCT00489853|20952638|P2|STARTED|Treatment Period 2||35
8502251|NCT00489853|20952639|P1|STARTED|Treatment Period 2||33
8502252|NCT00489853|20952637|P3|NOT COMPLETED|Wash-out Period 1||6
8502253|NCT00489853|20952638|P2|NOT COMPLETED|Wash-out Period 1||3
8502254|NCT00489853|20952639|P1|NOT COMPLETED|Wash-out Period 1||1
8502255|NCT00489853|20952637|P3|COMPLETED|Wash-out Period 1||32
8502256|NCT00489853|20952638|P2|COMPLETED|Wash-out Period 1||34
8502257|NCT00489853|20952639|P1|COMPLETED|Wash-out Period 1||35
8502258|NCT00489853|20952637|P3|STARTED|Wash-out Period 1||38
8502259|NCT00489853|20952638|P2|STARTED|Wash-out Period 1||37
8502260|NCT00489853|20952639|P1|STARTED|Wash-out Period 1||36
8502261|NCT00489853|20952637|P3|NOT COMPLETED|Treatment Period 1||0
8502262|NCT00489853|20952638|P2|NOT COMPLETED|Treatment Period 1||0
8502263|NCT00489853|20952639|P1|NOT COMPLETED|Treatment Period 1||0
8502264|NCT00489853|20952637|P3|COMPLETED|Treatment Period 1||38
8502265|NCT00489853|20952638|P2|COMPLETED|Treatment Period 1||37
8502266|NCT00489853|20952639|P1|COMPLETED|Treatment Period 1||36
8502267|NCT00489853|20952637|P3|STARTED|Treatment Period 1||38
8502268|NCT00489853|20952638|P2|STARTED|Treatment Period 1||37
8502269|NCT00489853|20952639|P1|STARTED|Treatment Period 1||36
8502270|NCT00489827|20952736|P2|NOT COMPLETED|Overall Study||2
8502271|NCT00489827|20952737|P1|NOT COMPLETED|Overall Study||2
8502272|NCT00489827|20952736|P2|COMPLETED|Overall Study||433
8502273|NCT00489827|20952737|P1|COMPLETED|Overall Study||428
8502274|NCT00489827|20952736|P2|STARTED|Overall Study||435
8502275|NCT00489827|20952737|P1|STARTED|Overall Study||430
8502276|NCT00489736|20952761|P2|NOT COMPLETED|Overall Study||69
8502277|NCT00489736|20952762|P1|NOT COMPLETED|Overall Study||96
8502278|NCT00489736|20952761|P2|COMPLETED|Overall Study|completed study drug period|186
8502279|NCT00489736|20952762|P1|COMPLETED|Overall Study|completed study drug period|153
8502280|NCT00489736|20952761|P2|STARTED|Overall Study|Randomized and treated patients|255
8502281|NCT00489736|20952762|P1|STARTED|Overall Study|Randomized and treated patients|249
8502282|NCT00489554|20952772|P1|NOT COMPLETED|Overall Study||4
8502283|NCT00489554|20952772|P1|COMPLETED|Overall Study||226
8502284|NCT00489554|20952772|P1|STARTED|Overall Study||230
8502285|NCT00489541|20952792|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
8502286|NCT00489541|20952793|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
8502287|NCT00489541|20952792|P2|COMPLETED|9-Month Angiographic Follow-up||108
8502288|NCT00489541|20952793|P1|COMPLETED|9-Month Angiographic Follow-up||197
8502289|NCT00489541|20952792|P2|STARTED|9-Month Angiographic Follow-up||125
8502290|NCT00489541|20952793|P1|STARTED|9-Month Angiographic Follow-up||224
8502291|NCT00489541|20952792|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
8502292|NCT00489541|20952793|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
8502293|NCT00489541|20952792|P2|COMPLETED|12-Month Clinical Follow-up||120
8502294|NCT00489541|20952793|P1|COMPLETED|12-Month Clinical Follow-up||215
8502295|NCT00489541|20952792|P2|STARTED|12-Month Clinical Follow-up||125
8502296|NCT00489541|20952793|P1|STARTED|12-Month Clinical Follow-up||224
8502297|NCT00489489|20952804|P3|NOT COMPLETED|Overall Study||3
8502298|NCT00489489|20952805|P2|NOT COMPLETED|Overall Study||5
8502299|NCT00489489|20952806|P1|NOT COMPLETED|Overall Study||3
8502300|NCT00489489|20952804|P3|COMPLETED|Overall Study|completed treatment period|37
8502301|NCT00489489|20952805|P2|COMPLETED|Overall Study|completed treatment period|32
8502302|NCT00489489|20952806|P1|COMPLETED|Overall Study|completed treatment period|38
8502303|NCT00489489|20952804|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
8502304|NCT00489489|20952805|P2|Treated|Overall Study||36
8502305|NCT00489489|20952806|P1|Treated|Overall Study||41
8502306|NCT00489489|20952804|P3|STARTED|Overall Study|randomized|40
8502307|NCT00489489|20952805|P2|STARTED|Overall Study|randomized|37
8502308|NCT00489489|20952806|P1|STARTED|Overall Study|randomized|41
8502309|NCT00489476|20952838|P4|NOT COMPLETED|Overall Study||0
8502310|NCT00489476|20952839|P3|NOT COMPLETED|Overall Study||0
8502311|NCT00489476|20952840|P2|NOT COMPLETED|Overall Study||1
8502312|NCT00489476|20952841|P1|NOT COMPLETED|Overall Study||0
8502313|NCT00489476|20952838|P4|COMPLETED|Overall Study||43
8502314|NCT00489476|20952839|P3|COMPLETED|Overall Study||43
8502315|NCT00489476|20952840|P2|COMPLETED|Overall Study||42
8502316|NCT00489476|20952841|P1|COMPLETED|Overall Study||39
8502317|NCT00489476|20952838|P4|STARTED|Overall Study||43
8502318|NCT00489476|20952839|P3|STARTED|Overall Study||43
8502319|NCT00489476|20952840|P2|STARTED|Overall Study||43
8502320|NCT00489476|20952841|P1|STARTED|Overall Study||39
8502321|NCT00489424|20952862|P3|NOT COMPLETED|Overall Study||5
8502322|NCT00489424|20952863|P2|NOT COMPLETED|Overall Study||5
8502323|NCT00489424|20952864|P1|NOT COMPLETED|Overall Study||4
8502324|NCT00489424|20952862|P3|COMPLETED|Overall Study||257
8502325|NCT00489424|20952863|P2|COMPLETED|Overall Study||259
8502326|NCT00489424|20952864|P1|COMPLETED|Overall Study||263
8502327|NCT00489424|20952862|P3|STARTED|Overall Study||262
8502328|NCT00489424|20952863|P2|STARTED|Overall Study||264
8502329|NCT00489424|20952864|P1|STARTED|Overall Study||267
8502330|NCT00489411|20952895|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
8502331|NCT00489411|20952896|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
8502332|NCT00489411|20952895|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
8502333|NCT00489411|20952896|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
8502334|NCT00489411|20952895|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
8502335|NCT00489411|20952896|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
8502336|NCT00489411|20952895|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
8502337|NCT00489411|20952896|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
8502338|NCT00489411|20952895|P2|COMPLETED|Washout Period (Weeks 6-7)||93
8502339|NCT00489411|20952896|P1|COMPLETED|Washout Period (Weeks 6-7)||85
8502340|NCT00489411|20952895|P2|STARTED|Washout Period (Weeks 6-7)||94
8502341|NCT00489411|20952896|P1|STARTED|Washout Period (Weeks 6-7)||87
8502342|NCT00489411|20952895|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
8502343|NCT00489411|20952896|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
8502344|NCT00489411|20952895|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
8502345|NCT00489411|20952896|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
8502346|NCT00489411|20952895|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
8502347|NCT00489411|20952896|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
8502348|NCT00489359|20952910|P2|NOT COMPLETED|Overall Study||29
8502349|NCT00489359|20952911|P1|NOT COMPLETED|Overall Study||7
8502350|NCT00489359|20952910|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
8502351|NCT00489359|20952911|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
8502352|NCT00489359|20952910|P2|STARTED|Overall Study||66
8502353|NCT00489359|20952911|P1|STARTED|Overall Study||20
8502354|NCT00489281|20952936|P2|NOT COMPLETED|Overall Study||0
8502355|NCT00489281|20952937|P1|NOT COMPLETED|Overall Study||0
8502356|NCT00489281|20952936|P2|COMPLETED|Overall Study||13
8502357|NCT00489281|20952937|P1|COMPLETED|Overall Study||29
8502358|NCT00489281|20952936|P2|STARTED|Overall Study||13
8502359|NCT00489281|20952937|P1|STARTED|Overall Study||29
8502360|NCT00489268|20952954|P5|NOT COMPLETED|Overall Study||20
8502361|NCT00489268|20952955|P4|NOT COMPLETED|Overall Study||0
8502362|NCT00489268|20952956|P3|NOT COMPLETED|Overall Study||1
8502363|NCT00489268|20952957|P2|NOT COMPLETED|Overall Study||0
8502364|NCT00489268|20952958|P1|NOT COMPLETED|Overall Study||0
8502365|NCT00489268|20952954|P5|COMPLETED|Overall Study||50
8502366|NCT00489268|20952955|P4|COMPLETED|Overall Study||11
8502367|NCT00489268|20952956|P3|COMPLETED|Overall Study||9
8502368|NCT00489268|20952957|P2|COMPLETED|Overall Study||10
8502369|NCT00489268|20952958|P1|COMPLETED|Overall Study||1
8502370|NCT00489268|20952954|P5|STARTED|Overall Study||70
8502371|NCT00489268|20952955|P4|STARTED|Overall Study||11
8502372|NCT00489268|20952956|P3|STARTED|Overall Study||10
8502373|NCT00489268|20952957|P2|STARTED|Overall Study||10
8502374|NCT00489268|20952958|P1|STARTED|Overall Study||1
8502375|NCT00489255|20952987|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
8502376|NCT00489255|20952988|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
8502377|NCT00489255|20952987|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
8502378|NCT00489255|20952988|P1|COMPLETED|Period 3: Days 57 to 84||24
8502379|NCT00489255|20952987|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
8502380|NCT00489255|20952988|P1|STARTED|Period 3: Days 57 to 84||28
8502381|NCT00489255|20952987|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
8502382|NCT00489255|20952988|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
8502383|NCT00489255|20952987|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
8502384|NCT00489255|20952988|P1|COMPLETED|Period 2: Days 29 to 56||61
8502385|NCT00489255|20952987|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
8502386|NCT00489255|20952988|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
8502387|NCT00489255|20952987|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
8502476|NCT00488826|20953080|P1|STARTED|Overall Study||300
8502388|NCT00489255|20952988|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
8502389|NCT00489255|20952987|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
8502390|NCT00489255|20952988|P1|STARTED|Period 2: Days 29 to 56||64
8502391|NCT00489255|20952987|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
8502392|NCT00489255|20952988|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
8502393|NCT00489255|20952987|P2|COMPLETED|Period 1: Days 1 to 28||34
8502394|NCT00489255|20952988|P1|COMPLETED|Period 1: Days 1 to 28||107
8502395|NCT00489255|20952987|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
8502396|NCT00489255|20952988|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
8502397|NCT00489255|20952987|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
8502398|NCT00489255|20952988|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
8502399|NCT00489255|20952987|P2|STARTED|Period 1: Days 1 to 28||46
8502400|NCT00489255|20952988|P1|STARTED|Period 1: Days 1 to 28||136
8502401|NCT00489255|20952987|P2|NOT COMPLETED|Screening and Initial Randomization||3
8502402|NCT00489255|20952988|P1|NOT COMPLETED|Screening and Initial Randomization||9
8502403|NCT00489255|20952987|P2|COMPLETED|Screening and Initial Randomization||46
8502404|NCT00489255|20952988|P1|COMPLETED|Screening and Initial Randomization||136
8502405|NCT00489255|20952987|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
8502406|NCT00489255|20952988|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
8502407|NCT00489216|20953036|P1|NOT COMPLETED|Overall Study||1
8502408|NCT00489216|20953036|P1|COMPLETED|Overall Study||1
8502409|NCT00489216|20953036|P1|STARTED|Overall Study||2
8502410|NCT00489086|20953045|P1|NOT COMPLETED|Overall Study||23
8502411|NCT00489086|20953045|P1|COMPLETED|Overall Study||13
8502412|NCT00489086|20953045|P1|Completed 18 Months|Overall Study||23
8502413|NCT00489086|20953045|P1|STARTED|Overall Study||36
8502414|NCT00488982|20953053|P3|NOT COMPLETED|Response to Course 3||3
8502415|NCT00488982|20953054|P2|NOT COMPLETED|Response to Course 3||1
8502416|NCT00488982|20953055|P1|NOT COMPLETED|Response to Course 3||0
8502417|NCT00488982|20953053|P3|COMPLETED|Response to Course 3||0
8502418|NCT00488982|20953054|P2|COMPLETED|Response to Course 3||1
8502419|NCT00488982|20953055|P1|COMPLETED|Response to Course 3||0
8502420|NCT00488982|20953053|P3|STARTED|Response to Course 3||3
8502421|NCT00488982|20953054|P2|STARTED|Response to Course 3||2
8502422|NCT00488982|20953055|P1|STARTED|Response to Course 3||0
8502423|NCT00488982|20953053|P3|NOT COMPLETED|Course 3||5
8502424|NCT00488982|20953054|P2|NOT COMPLETED|Course 3||2
8502425|NCT00488982|20953055|P1|NOT COMPLETED|Course 3||0
8502426|NCT00488982|20953053|P3|COMPLETED|Course 3||3
8502427|NCT00488982|20953054|P2|COMPLETED|Course 3||2
8502428|NCT00488982|20953055|P1|COMPLETED|Course 3||0
8502429|NCT00488982|20953053|P3|STARTED|Course 3||8
8502430|NCT00488982|20953054|P2|STARTED|Course 3||4
8502431|NCT00488982|20953055|P1|STARTED|Course 3||0
8502432|NCT00488982|20953053|P3|NOT COMPLETED|Course 2||5
8502433|NCT00488982|20953054|P2|NOT COMPLETED|Course 2||9
8502434|NCT00488982|20953055|P1|NOT COMPLETED|Course 2||0
8502435|NCT00488982|20953053|P3|COMPLETED|Course 2||8
8502436|NCT00488982|20953054|P2|COMPLETED|Course 2||4
8502437|NCT00488982|20953055|P1|COMPLETED|Course 2||0
8502438|NCT00488982|20953053|P3|STARTED|Course 2||13
8502439|NCT00488982|20953054|P2|STARTED|Course 2||13
8502440|NCT00488982|20953055|P1|STARTED|Course 2||0
8502441|NCT00488982|20953053|P3|NOT COMPLETED|Course 1||14
8502442|NCT00488982|20953054|P2|NOT COMPLETED|Course 1||12
8502443|NCT00488982|20953055|P1|NOT COMPLETED|Course 1||0
8502444|NCT00488982|20953053|P3|COMPLETED|Course 1||13
8502445|NCT00488982|20953054|P2|COMPLETED|Course 1||13
8502446|NCT00488982|20953055|P1|COMPLETED|Course 1||0
8502447|NCT00488982|20953053|P3|STARTED|Course 1||27
8502448|NCT00488982|20953054|P2|STARTED|Course 1||25
8502449|NCT00488982|20953055|P1|STARTED|Course 1||0
8502450|NCT00488982|20953053|P3|NOT COMPLETED|Induction Chemotherapy||0
8502451|NCT00488982|20953054|P2|NOT COMPLETED|Induction Chemotherapy||0
8502452|NCT00488982|20953055|P1|NOT COMPLETED|Induction Chemotherapy||73
8502453|NCT00488982|20953053|P3|COMPLETED|Induction Chemotherapy||0
8502454|NCT00488982|20953054|P2|COMPLETED|Induction Chemotherapy||0
8502455|NCT00488982|20953055|P1|COMPLETED|Induction Chemotherapy||52
8502456|NCT00488982|20953053|P3|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
8502457|NCT00488982|20953054|P2|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
8502458|NCT00488982|20953055|P1|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
8502459|NCT00488982|20953053|P3|6 Cycles Completed|Induction Chemotherapy||0
8502460|NCT00488982|20953054|P2|6 Cycles Completed|Induction Chemotherapy||0
8502461|NCT00488982|20953055|P1|6 Cycles Completed|Induction Chemotherapy||94
8502462|NCT00488982|20953053|P3|STARTED|Induction Chemotherapy||0
8502463|NCT00488982|20953054|P2|STARTED|Induction Chemotherapy||0
8502464|NCT00488982|20953055|P1|STARTED|Induction Chemotherapy||125
8502465|NCT00488865|20953069|P1|NOT COMPLETED|Overall Study||0
8502466|NCT00488865|20953069|P1|COMPLETED|Overall Study||100
8502467|NCT00488865|20953069|P1|STARTED|Overall Study||100
8502468|NCT00488826|20953078|P3|NOT COMPLETED|Overall Study||26
8502469|NCT00488826|20953079|P2|NOT COMPLETED|Overall Study||52
8502470|NCT00488826|20953080|P1|NOT COMPLETED|Overall Study||56
8502471|NCT00488826|20953078|P3|COMPLETED|Overall Study||178
8502472|NCT00488826|20953079|P2|COMPLETED|Overall Study||244
8502473|NCT00488826|20953080|P1|COMPLETED|Overall Study||244
8502474|NCT00488826|20953078|P3|STARTED|Overall Study||204
8502475|NCT00488826|20953079|P2|STARTED|Overall Study||296
8502477|NCT00488774|20953095|P4|NOT COMPLETED|Overall Study||3
8502478|NCT00488774|20953096|P3|NOT COMPLETED|Overall Study||5
8502479|NCT00488774|20953097|P2|NOT COMPLETED|Overall Study||5
8502480|NCT00488774|20953098|P1|NOT COMPLETED|Overall Study||8
8502481|NCT00488774|20953095|P4|COMPLETED|Overall Study||74
8502482|NCT00488774|20953096|P3|COMPLETED|Overall Study||70
8502483|NCT00488774|20953097|P2|COMPLETED|Overall Study||57
8502484|NCT00488774|20953098|P1|COMPLETED|Overall Study||69
8502485|NCT00488774|20953095|P4|STARTED|Overall Study||77
8502486|NCT00488774|20953096|P3|STARTED|Overall Study||75
8502487|NCT00488774|20953097|P2|STARTED|Overall Study||62
8502488|NCT00488774|20953098|P1|STARTED|Overall Study||77
8502489|NCT00488683|20953115|P3|NOT COMPLETED|Overall Study||2
8502490|NCT00488683|20953116|P2|NOT COMPLETED|Overall Study||6
8502491|NCT00488683|20953117|P1|NOT COMPLETED|Overall Study||12
8502492|NCT00488683|20953115|P3|COMPLETED|Overall Study||52
8502493|NCT00488683|20953116|P2|COMPLETED|Overall Study||48
8502494|NCT00488683|20953117|P1|COMPLETED|Overall Study||96
8502495|NCT00488683|20953115|P3|STARTED|Overall Study||54
8502496|NCT00488683|20953116|P2|STARTED|Overall Study||54
8502497|NCT00488683|20953117|P1|STARTED|Overall Study||108
8502498|NCT00488644|20953176|P1|NOT COMPLETED|Overall Study||2
8502499|NCT00488644|20953176|P1|COMPLETED|Overall Study||10
8502500|NCT00488644|20953176|P1|STARTED|Overall Study||12
8502501|NCT00488631|20953186|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
8502502|NCT00488631|20953187|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
8502503|NCT00488631|20953188|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
8502504|NCT00488631|20953189|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
8502505|NCT00488631|20953190|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502506|NCT00488631|20953191|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502507|NCT00488631|20953192|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502508|NCT00488631|20953193|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502509|NCT00488631|20953194|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502510|NCT00488631|20953195|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502511|NCT00488631|20953186|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
8502512|NCT00488631|20953187|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
8502513|NCT00488631|20953188|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
8502514|NCT00488631|20953189|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
8502515|NCT00488631|20953190|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502516|NCT00488631|20953191|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502517|NCT00488631|20953192|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502518|NCT00488631|20953193|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502519|NCT00488631|20953194|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502520|NCT00488631|20953195|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502521|NCT00488631|20953186|P10|STARTED|Open Label Study Extension (Week 54-228)||7
8502522|NCT00488631|20953187|P9|STARTED|Open Label Study Extension (Week 54-228)||470
8502523|NCT00488631|20953188|P8|STARTED|Open Label Study Extension (Week 54-228)||93
8502524|NCT00488631|20953189|P7|STARTED|Open Label Study Extension (Week 54-228)||96
8502525|NCT00488631|20953190|P6|STARTED|Open Label Study Extension (Week 54-228)||0
8502526|NCT00488631|20953191|P5|STARTED|Open Label Study Extension (Week 54-228)||0
8502527|NCT00488631|20953192|P4|STARTED|Open Label Study Extension (Week 54-228)||0
8502528|NCT00488631|20953193|P3|STARTED|Open Label Study Extension (Week 54-228)||0
8502529|NCT00488631|20953194|P2|STARTED|Open Label Study Extension (Week 54-228)||0
8502530|NCT00488631|20953195|P1|STARTED|Open Label Study Extension (Week 54-228)||0
8502531|NCT00488631|20953186|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502532|NCT00488631|20953187|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502533|NCT00488631|20953188|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502534|NCT00488631|20953189|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502535|NCT00488631|20953190|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
8502536|NCT00488631|20953191|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
8502537|NCT00488631|20953192|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
8502538|NCT00488631|20953193|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
8502539|NCT00488631|20953194|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
8502540|NCT00488631|20953195|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
8502541|NCT00488631|20953186|P10|COMPLETED|Double Blind Period (Week 0-54)||0
8502542|NCT00488631|20953187|P9|COMPLETED|Double Blind Period (Week 0-54)||0
8502543|NCT00488631|20953188|P8|COMPLETED|Double Blind Period (Week 0-54)||0
8502544|NCT00488631|20953189|P7|COMPLETED|Double Blind Period (Week 0-54)||0
8502545|NCT00488631|20953190|P6|COMPLETED|Double Blind Period (Week 0-54)||189
8502546|NCT00488631|20953191|P5|COMPLETED|Double Blind Period (Week 0-54)||127
8502547|NCT00488631|20953192|P4|COMPLETED|Double Blind Period (Week 0-54)||88
8502548|NCT00488631|20953193|P3|COMPLETED|Double Blind Period (Week 0-54)||109
8502549|NCT00488631|20953194|P2|COMPLETED|Double Blind Period (Week 0-54)||111
8502550|NCT00488631|20953195|P1|COMPLETED|Double Blind Period (Week 0-54)||113
8502551|NCT00488631|20953186|P10|STARTED|Double Blind Period (Week 0-54)||0
8502552|NCT00488631|20953187|P9|STARTED|Double Blind Period (Week 0-54)||0
8502553|NCT00488631|20953188|P8|STARTED|Double Blind Period (Week 0-54)||0
8502554|NCT00488631|20953189|P7|STARTED|Double Blind Period (Week 0-54)||0
8502555|NCT00488631|20953190|P6|STARTED|Double Blind Period (Week 0-54)||405
8502556|NCT00488631|20953191|P5|STARTED|Double Blind Period (Week 0-54)||230
8502557|NCT00488631|20953192|P4|STARTED|Double Blind Period (Week 0-54)||129
8502558|NCT00488631|20953193|P3|STARTED|Double Blind Period (Week 0-54)||154
8502559|NCT00488631|20953194|P2|STARTED|Double Blind Period (Week 0-54)||154
8502560|NCT00488631|20953195|P1|STARTED|Double Blind Period (Week 0-54)||156
8502561|NCT00488618|20953232|P2|NOT COMPLETED|Overall Study||43
8502562|NCT00488618|20953233|P1|NOT COMPLETED|Overall Study||47
8502563|NCT00488618|20953232|P2|COMPLETED|Overall Study||75
8502564|NCT00488618|20953233|P1|COMPLETED|Overall Study||73
8502565|NCT00488618|20953232|P2|Safety Population: Received Study Drug|Overall Study||118
8502566|NCT00488618|20953233|P1|Safety Population: Received Study Drug|Overall Study||118
8502567|NCT00488618|20953232|P2|STARTED|Overall Study||118
8502568|NCT00488618|20953233|P1|STARTED|Overall Study||120
8502569|NCT00488592|20953241|P1|NOT COMPLETED|Overall Study||3
8502570|NCT00488592|20953241|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
8502571|NCT00488592|20953241|P1|STARTED|Overall Study|10 subjects were accrued|10
8502572|NCT00488514|20953245|P1|NOT COMPLETED|Overall Study||293
8502573|NCT00488514|20953245|P1|COMPLETED|Overall Study||363
8502574|NCT00488514|20953245|P1|STARTED|Overall Study||656
8502575|NCT00488488|20953318|P1|NOT COMPLETED|Overall Study||268
8502576|NCT00488488|20953318|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
8502577|NCT00488488|20953318|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
8502578|NCT00488488|20953318|P1|STARTED|Overall Study||1028
8502579|NCT00488475|20953333|P1|NOT COMPLETED|Overall Study||1754
8502580|NCT00488475|20953333|P1|COMPLETED|Overall Study||3191
8502581|NCT00488475|20953333|P1|STARTED|Overall Study||4945
8502582|NCT00488345|20953362|P3|NOT COMPLETED|Overall Study||3
8502583|NCT00488345|20953363|P2|NOT COMPLETED|Overall Study||4
8502584|NCT00488345|20953364|P1|NOT COMPLETED|Overall Study||0
8502585|NCT00488345|20953362|P3|COMPLETED|Overall Study||17
8502586|NCT00488345|20953363|P2|COMPLETED|Overall Study||17
8502587|NCT00488345|20953364|P1|COMPLETED|Overall Study||17
8502588|NCT00488345|20953362|P3|STARTED|Overall Study||20
8502589|NCT00488345|20953363|P2|STARTED|Overall Study||21
8502590|NCT00488345|20953364|P1|STARTED|Overall Study||17
8502591|NCT00488319|20953390|P3|NOT COMPLETED|Overall Study||122
8502592|NCT00488319|20953391|P2|NOT COMPLETED|Overall Study||43
8502593|NCT00488319|20953392|P1|NOT COMPLETED|Overall Study||15
8502594|NCT00488319|20953390|P3|COMPLETED|Overall Study||121
8502595|NCT00488319|20953391|P2|COMPLETED|Overall Study||75
8502596|NCT00488319|20953392|P1|COMPLETED|Overall Study||24
8502597|NCT00488319|20953390|P3|STARTED|Overall Study||243
8502598|NCT00488319|20953391|P2|STARTED|Overall Study||118
8502599|NCT00488319|20953392|P1|STARTED|Overall Study||39
8502600|NCT00488293|20953479|P2|NOT COMPLETED|Overall Study||30
8502601|NCT00488293|20953480|P1|NOT COMPLETED|Overall Study||36
8502602|NCT00488293|20953479|P2|COMPLETED|Overall Study||166
8502603|NCT00488293|20953480|P1|COMPLETED|Overall Study||160
8502604|NCT00488293|20953479|P2|STARTED|Overall Study||196
8502605|NCT00488293|20953480|P1|STARTED|Overall Study||196
8502606|NCT00488059|20953504|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
8502607|NCT00488059|20953505|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502608|NCT00488059|20953506|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502609|NCT00488059|20953504|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
8502610|NCT00488059|20953505|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502611|NCT00488059|20953506|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502612|NCT00488059|20953504|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
8502613|NCT00488059|20953505|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502614|NCT00488059|20953506|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502615|NCT00488059|20953504|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502616|NCT00488059|20953505|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
8502617|NCT00488059|20953506|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502618|NCT00488059|20953504|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502619|NCT00488059|20953505|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
8502620|NCT00488059|20953506|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502621|NCT00488059|20953504|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502622|NCT00488059|20953505|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
8502623|NCT00488059|20953506|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502624|NCT00488059|20953504|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
8502625|NCT00488059|20953505|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
8502626|NCT00488059|20953506|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
8502627|NCT00488059|20953504|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
8502628|NCT00488059|20953505|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
8502629|NCT00488059|20953506|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
8502630|NCT00488059|20953504|P3|STARTED|Phase I: ENF 90mg SC BID||0
8502631|NCT00488059|20953505|P2|STARTED|Phase I: ENF 90mg SC BID||0
8502632|NCT00488059|20953506|P1|STARTED|Phase I: ENF 90mg SC BID||29
8502633|NCT00488033|20953525|P2|NOT COMPLETED|Overall Study||0
8502634|NCT00488033|20953526|P1|NOT COMPLETED|Overall Study||1
8502635|NCT00488033|20953525|P2|COMPLETED|Overall Study||452
8502636|NCT00488033|20953526|P1|COMPLETED|Overall Study||447
8502637|NCT00488033|20953525|P2|STARTED|Overall Study||452
8502638|NCT00488033|20953526|P1|STARTED|Overall Study||448
8502639|NCT00487981|20953542|P1|NOT COMPLETED|Overall Study||1
8502640|NCT00487981|20953542|P1|COMPLETED|Overall Study||0
8502641|NCT00487981|20953542|P1|STARTED|Overall Study||1
8502642|NCT00487942|20953550|P4|NOT COMPLETED|Overall Study||2
8502643|NCT00487942|20953551|P3|NOT COMPLETED|Overall Study||3
8502644|NCT00487942|20953552|P2|NOT COMPLETED|Overall Study||3
8502645|NCT00487942|20953553|P1|NOT COMPLETED|Overall Study||3
8502646|NCT00487942|20953550|P4|COMPLETED|Overall Study||13
8502647|NCT00487942|20953551|P3|COMPLETED|Overall Study||12
8502648|NCT00487942|20953552|P2|COMPLETED|Overall Study||12
8502649|NCT00487942|20953553|P1|COMPLETED|Overall Study||12
8502650|NCT00487942|20953550|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
8502651|NCT00487942|20953551|P3|STARTED|Overall Study||15
8502652|NCT00487942|20953552|P2|STARTED|Overall Study||15
8502653|NCT00487942|20953553|P1|STARTED|Overall Study||15
8502654|NCT00487825|20953937|P2|NOT COMPLETED|Overall Study||5
8502655|NCT00487825|20953938|P1|NOT COMPLETED|Overall Study||6
8502656|NCT00487825|20953937|P2|COMPLETED|Overall Study||21
8502657|NCT00487825|20953938|P1|COMPLETED|Overall Study||46
8502658|NCT00487825|20953937|P2|STARTED|Overall Study||26
8502659|NCT00487825|20953938|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
8502660|NCT00487747|20953950|P1|NOT COMPLETED|Overall Study||11
8502661|NCT00487747|20953950|P1|COMPLETED|Overall Study||7
8502662|NCT00487747|20953950|P1|STARTED|Overall Study||18
8502663|NCT00487721|20953961|P2|NOT COMPLETED|Overall Study||0
8502664|NCT00487721|20953962|P1|NOT COMPLETED|Overall Study||0
8502665|NCT00487721|20953961|P2|COMPLETED|Overall Study||6
8502666|NCT00487721|20953962|P1|COMPLETED|Overall Study||6
8502667|NCT00487721|20953961|P2|STARTED|Overall Study||6
8502668|NCT00487721|20953962|P1|STARTED|Overall Study||6
8502669|NCT00487695|20953967|P2|NOT COMPLETED|Second Procedure||3
8502670|NCT00487695|20953968|P1|NOT COMPLETED|Second Procedure||1
8502671|NCT00487695|20953967|P2|COMPLETED|Second Procedure||20
8502672|NCT00487695|20953968|P1|COMPLETED|Second Procedure||19
8502673|NCT00487695|20953967|P2|STARTED|Second Procedure||23
8502674|NCT00487695|20953968|P1|STARTED|Second Procedure||20
8502675|NCT00487695|20953967|P2|NOT COMPLETED|First Procedure||0
8502676|NCT00487695|20953968|P1|NOT COMPLETED|First Procedure||3
8502677|NCT00487695|20953967|P2|COMPLETED|First Procedure||23
8502678|NCT00487695|20953968|P1|COMPLETED|First Procedure||20
8502679|NCT00487695|20953967|P2|STARTED|First Procedure||23
8502680|NCT00487695|20953968|P1|STARTED|First Procedure||23
8502681|NCT00487669|20953984|P1|NOT COMPLETED|Overall Study||0
8502682|NCT00487669|20953984|P1|COMPLETED|Overall Study||12
8502683|NCT00487669|20953984|P1|STARTED|Overall Study||12
8502684|NCT00487578|20953996|P2|NOT COMPLETED|Overall Study||4
8502685|NCT00487578|20953997|P1|NOT COMPLETED|Overall Study||1
8502686|NCT00487578|20953996|P2|COMPLETED|Overall Study||5
8502687|NCT00487578|20953997|P1|COMPLETED|Overall Study||2
8502688|NCT00487578|20953996|P2|STARTED|Overall Study||9
8502689|NCT00487578|20953997|P1|STARTED|Overall Study||3
8502690|NCT00487565|20954013|P1|NOT COMPLETED|Overall Study||28
8502691|NCT00487565|20954013|P1|COMPLETED|Overall Study||182
8502692|NCT00487565|20954013|P1|STARTED|Overall Study||210
8502693|NCT00487552|20954017|P1|NOT COMPLETED|Overall Study||6
8502694|NCT00487552|20954017|P1|COMPLETED|Overall Study||12
8502695|NCT00487552|20954017|P1|STARTED|Overall Study||18
8502696|NCT00487539|20954026|P4|NOT COMPLETED|Overall Study||4
8502697|NCT00487539|20954027|P3|NOT COMPLETED|Overall Study||3
8502698|NCT00487539|20954028|P2|NOT COMPLETED|Overall Study||3
8502699|NCT00487539|20954029|P1|NOT COMPLETED|Overall Study||7
8502700|NCT00487539|20954026|P4|COMPLETED|Overall Study||327
8502701|NCT00487539|20954027|P3|COMPLETED|Overall Study||328
8502702|NCT00487539|20954028|P2|COMPLETED|Overall Study||69
8502703|NCT00487539|20954029|P1|COMPLETED|Overall Study||324
8502704|NCT00487539|20954026|P4|STARTED|Overall Study||331
8502705|NCT00487539|20954027|P3|STARTED|Overall Study||331
8502706|NCT00487539|20954028|P2|STARTED|Overall Study||72
8502707|NCT00487539|20954029|P1|STARTED|Overall Study||331
8502708|NCT00487461|20954050|P3|NOT COMPLETED|Overall Study||4
8502709|NCT00487461|20954051|P2|NOT COMPLETED|Overall Study||2
8502710|NCT00487461|20954052|P1|NOT COMPLETED|Overall Study||0
8502711|NCT00487461|20954050|P3|COMPLETED|Overall Study||7
8502712|NCT00487461|20954051|P2|COMPLETED|Overall Study||10
8502713|NCT00487461|20954052|P1|COMPLETED|Overall Study||2
8502714|NCT00487461|20954050|P3|STARTED|Overall Study||11
8502715|NCT00487461|20954051|P2|STARTED|Overall Study||12
8502716|NCT00487461|20954052|P1|STARTED|Overall Study||2
8502717|NCT00487435|20954063|P1|NOT COMPLETED|Overall Study||485
8502718|NCT00487435|20954063|P1|COMPLETED|Overall Study||669
8502719|NCT00487435|20954063|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
8502720|NCT00487396|20954068|P1|NOT COMPLETED|Overall Study||3
8502721|NCT00487396|20954068|P1|COMPLETED|Overall Study||95
8502722|NCT00487396|20954068|P1|STARTED|Overall Study||98
8502723|NCT00487279|20954079|P2|NOT COMPLETED|Overall Study||2
8502724|NCT00487279|20954080|P1|NOT COMPLETED|Overall Study||1
8502725|NCT00487279|20954079|P2|COMPLETED|Overall Study||35
8502726|NCT00487279|20954080|P1|COMPLETED|Overall Study||43
8502727|NCT00487279|20954079|P2|STARTED|Overall Study||37
8502728|NCT00487279|20954080|P1|STARTED|Overall Study||44
8502729|NCT00487240|20954090|P2|NOT COMPLETED|Overall Study||26
8502730|NCT00487240|20954091|P1|NOT COMPLETED|Overall Study||31
8502731|NCT00487240|20954090|P2|COMPLETED|Overall Study||166
8502732|NCT00487240|20954091|P1|COMPLETED|Overall Study||164
8502733|NCT00487240|20954090|P2|Full Analysis Set (ITT Population)|Overall Study||189
8502734|NCT00487240|20954091|P1|Full Analysis Set (ITT Population)|Overall Study||192
8502735|NCT00487240|20954090|P2|STARTED|Overall Study||192
8502736|NCT00487240|20954091|P1|STARTED|Overall Study||195
8502737|NCT00487188|20954119|P3|NOT COMPLETED|Maintenance Phase||1
8502738|NCT00487188|20954120|P2|NOT COMPLETED|Maintenance Phase||0
8502739|NCT00487188|20954121|P1|NOT COMPLETED|Maintenance Phase||3
8502740|NCT00487188|20954119|P3|COMPLETED|Maintenance Phase||8
8502741|NCT00487188|20954120|P2|COMPLETED|Maintenance Phase||8
8502742|NCT00487188|20954121|P1|COMPLETED|Maintenance Phase||7
8502743|NCT00487188|20954119|P3|STARTED|Maintenance Phase||9
8502744|NCT00487188|20954120|P2|STARTED|Maintenance Phase||8
8502745|NCT00487188|20954121|P1|STARTED|Maintenance Phase||10
8502746|NCT00487188|20954119|P3|NOT COMPLETED|Induction Phase||0
8502747|NCT00487188|20954120|P2|NOT COMPLETED|Induction Phase||7
8502748|NCT00487188|20954121|P1|NOT COMPLETED|Induction Phase||9
8502749|NCT00487188|20954119|P3|COMPLETED|Induction Phase||0
8502750|NCT00487188|20954120|P2|COMPLETED|Induction Phase||9
8502751|NCT00487188|20954121|P1|COMPLETED|Induction Phase||22
8502752|NCT00487188|20954119|P3|Safety Population|Induction Phase||0
8502753|NCT00487188|20954120|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
8502754|NCT00487188|20954121|P1|Safety Population|Induction Phase||29
8502755|NCT00487188|20954119|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
8502756|NCT00487188|20954120|P2|STARTED|Induction Phase||16
8502757|NCT00487188|20954121|P1|STARTED|Induction Phase||31
8502758|NCT00487162|20954160|P2|NOT COMPLETED|Overall Study||5
8502759|NCT00487162|20954161|P1|NOT COMPLETED|Overall Study||2
8502760|NCT00487162|20954160|P2|COMPLETED|Overall Study||21
8502761|NCT00487162|20954161|P1|COMPLETED|Overall Study||28
8502762|NCT00487162|20954160|P2|STARTED|Overall Study||26
8502763|NCT00487162|20954161|P1|STARTED|Overall Study||30
8502764|NCT00487084|20954172|P3|NOT COMPLETED|Overall Study||5
8502765|NCT00487084|20954173|P2|NOT COMPLETED|Overall Study||3
8502766|NCT00487084|20954174|P1|NOT COMPLETED|Overall Study||4
8502767|NCT00487084|20954172|P3|COMPLETED|Overall Study||28
8502768|NCT00487084|20954173|P2|COMPLETED|Overall Study||30
8502769|NCT00487084|20954174|P1|COMPLETED|Overall Study||29
8502770|NCT00487084|20954172|P3|STARTED|Overall Study||33
8502771|NCT00487084|20954173|P2|STARTED|Overall Study||33
8502772|NCT00487084|20954174|P1|STARTED|Overall Study||33
8502773|NCT00486954|20954195|P5|NOT COMPLETED|Randomized Part||14
8502774|NCT00486954|20954196|P4|NOT COMPLETED|Randomized Part||20
8502775|NCT00486954|20954197|P3|NOT COMPLETED|Randomized Part||0
8502776|NCT00486954|20954198|P2|NOT COMPLETED|Randomized Part||0
8502777|NCT00486954|20954199|P1|NOT COMPLETED|Randomized Part||0
8502778|NCT00486954|20954195|P5|COMPLETED|Randomized Part||115
8502779|NCT00486954|20954196|P4|COMPLETED|Randomized Part||112
8502780|NCT00486954|20954197|P3|COMPLETED|Randomized Part||0
8502781|NCT00486954|20954198|P2|COMPLETED|Randomized Part||0
8502782|NCT00486954|20954199|P1|COMPLETED|Randomized Part||0
8502783|NCT00486954|20954195|P5|STARTED|Randomized Part||129
8502784|NCT00486954|20954196|P4|STARTED|Randomized Part||132
8502785|NCT00486954|20954197|P3|STARTED|Randomized Part||0
8502786|NCT00486954|20954198|P2|STARTED|Randomized Part||0
8502787|NCT00486954|20954199|P1|STARTED|Randomized Part||0
8502788|NCT00486954|20954195|P5|NOT COMPLETED|Pilot Part||0
8502789|NCT00486954|20954196|P4|NOT COMPLETED|Pilot Part||0
8502790|NCT00486954|20954197|P3|NOT COMPLETED|Pilot Part||6
8502791|NCT00486954|20954198|P2|NOT COMPLETED|Pilot Part||0
8502792|NCT00486954|20954199|P1|NOT COMPLETED|Pilot Part||6
8502793|NCT00486954|20954195|P5|COMPLETED|Pilot Part||0
8502794|NCT00486954|20954196|P4|COMPLETED|Pilot Part||0
8502795|NCT00486954|20954197|P3|COMPLETED|Pilot Part||0
8502796|NCT00486954|20954198|P2|COMPLETED|Pilot Part||0
8502797|NCT00486954|20954199|P1|COMPLETED|Pilot Part||0
8502798|NCT00486954|20954195|P5|STARTED|Pilot Part||0
8502799|NCT00486954|20954196|P4|STARTED|Pilot Part||0
8502800|NCT00486954|20954197|P3|STARTED|Pilot Part||6
8502801|NCT00486954|20954198|P2|STARTED|Pilot Part||0
8502802|NCT00486954|20954199|P1|STARTED|Pilot Part||6
8502803|NCT00486902|20954297|P2|NOT COMPLETED|Overall Study||5
8502804|NCT00486902|20954298|P1|NOT COMPLETED|Overall Study||9
8502805|NCT00486902|20954297|P2|COMPLETED|Overall Study||89
8502806|NCT00486902|20954298|P1|COMPLETED|Overall Study||85
8502807|NCT00486902|20954297|P2|STARTED|Overall Study||94
8502808|NCT00486902|20954298|P1|STARTED|Overall Study||94
8502809|NCT00486863|20954320|P2|NOT COMPLETED|Overall Study||3
8502810|NCT00486863|20954321|P1|NOT COMPLETED|Overall Study||1
8502811|NCT00486863|20954320|P2|COMPLETED|Overall Study||183
8502812|NCT00486863|20954321|P1|COMPLETED|Overall Study||183
8502813|NCT00486863|20954320|P2|STARTED|Overall Study||186
8502814|NCT00486863|20954321|P1|STARTED|Overall Study||184
8502815|NCT00486837|20954365|P2|NOT COMPLETED|Overall Study||7
8502816|NCT00486837|20954366|P1|NOT COMPLETED|Overall Study||9
8502817|NCT00486837|20954365|P2|COMPLETED|Overall Study||28
8502818|NCT00486837|20954366|P1|COMPLETED|Overall Study||28
8502819|NCT00486837|20954365|P2|STARTED|Overall Study||35
8502820|NCT00486837|20954366|P1|STARTED|Overall Study||37
8502821|NCT00486824|20954384|P2|NOT COMPLETED|Overall Study||2
8502822|NCT00486824|20954385|P1|NOT COMPLETED|Overall Study||2
8502823|NCT00486824|20954384|P2|COMPLETED|Overall Study||3
8502824|NCT00486824|20954385|P1|COMPLETED|Overall Study||3
8502825|NCT00486824|20954384|P2|STARTED|Overall Study||5
8502826|NCT00486824|20954385|P1|STARTED|Overall Study||5
8502827|NCT00486811|20954406|P3|NOT COMPLETED|Overall Study||214
8502828|NCT00486811|20954407|P2|NOT COMPLETED|Overall Study||141
8502829|NCT00486811|20954408|P1|NOT COMPLETED|Overall Study||122
8502830|NCT00486811|20954406|P3|COMPLETED|Overall Study||119
8502831|NCT00486811|20954407|P2|COMPLETED|Overall Study||179
8502832|NCT00486811|20954408|P1|COMPLETED|Overall Study||215
8502833|NCT00486811|20954406|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
8502834|NCT00486811|20954407|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
8502835|NCT00486811|20954408|P1|STARTED|Overall Study||337
8502836|NCT00486759|20954451|P2|NOT COMPLETED|Safety Follow-up||118
8502837|NCT00486759|20954452|P1|NOT COMPLETED|Safety Follow-up||139
8502838|NCT00486759|20954451|P2|COMPLETED|Safety Follow-up||142
8502839|NCT00486759|20954452|P1|COMPLETED|Safety Follow-up||64
8502840|NCT00486759|20954451|P2|STARTED|Safety Follow-up||260
8502841|NCT00486759|20954452|P1|STARTED|Safety Follow-up||203
8502842|NCT00486759|20954451|P2|NOT COMPLETED|Treatment||137
8502843|NCT00486759|20954452|P1|NOT COMPLETED|Treatment||187
8502844|NCT00486759|20954451|P2|COMPLETED|Treatment||260
8502845|NCT00486759|20954452|P1|COMPLETED|Treatment||203
8502846|NCT00486759|20954451|P2|STARTED|Treatment||397
8502847|NCT00486759|20954452|P1|STARTED|Treatment||390
8502848|NCT00486720|20954464|P2|NOT COMPLETED|Overall Study||12
8502849|NCT00486720|20954465|P1|NOT COMPLETED|Overall Study||10
8502850|NCT00486720|20954464|P2|COMPLETED|Overall Study||0
8502851|NCT00486720|20954465|P1|COMPLETED|Overall Study||0
8502852|NCT00486720|20954464|P2|STARTED|Overall Study||12
8502853|NCT00486720|20954465|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
8502854|NCT00486642|20954475|P2|NOT COMPLETED|Overall Study||0
8502855|NCT00486642|20954476|P1|NOT COMPLETED|Overall Study||0
8502856|NCT00486642|20954475|P2|COMPLETED|Overall Study||13
8502857|NCT00486642|20954476|P1|COMPLETED|Overall Study||10
8502858|NCT00486642|20954475|P2|STARTED|Overall Study||13
8502859|NCT00486642|20954476|P1|STARTED|Overall Study||10
8502860|NCT00486603|20954500|P5|NOT COMPLETED|Overall Study||0
8502861|NCT00486603|20954501|P4|NOT COMPLETED|Overall Study||0
8502862|NCT00486603|20954502|P3|NOT COMPLETED|Overall Study||0
8502863|NCT00486603|20954503|P2|NOT COMPLETED|Overall Study||1
8502864|NCT00486603|20954504|P1|NOT COMPLETED|Overall Study||1
8502865|NCT00486603|20954500|P5|COMPLETED|Overall Study||76
8502866|NCT00486603|20954501|P4|COMPLETED|Overall Study||3
8502867|NCT00486603|20954502|P3|COMPLETED|Overall Study||3
8502868|NCT00486603|20954503|P2|COMPLETED|Overall Study||6
8502869|NCT00486603|20954504|P1|COMPLETED|Overall Study||2
8502870|NCT00486603|20954500|P5|STARTED|Overall Study||76
8502871|NCT00486603|20954501|P4|STARTED|Overall Study||3
8502872|NCT00486603|20954502|P3|STARTED|Overall Study||3
8502873|NCT00486603|20954503|P2|STARTED|Overall Study||7
8502874|NCT00486603|20954504|P1|STARTED|Overall Study||3
8502875|NCT00486525|20954528|P2|NOT COMPLETED|Overall Study||13
8502876|NCT00486525|20954529|P1|NOT COMPLETED|Overall Study||6
8502877|NCT00486525|20954528|P2|COMPLETED|Overall Study||87
8502878|NCT00486525|20954529|P1|COMPLETED|Overall Study||94
8502879|NCT00486525|20954528|P2|STARTED|Overall Study||100
8502880|NCT00486525|20954529|P1|STARTED|Overall Study||100
8502881|NCT00486447|20954545|P1|NOT COMPLETED|Overall Study||0
8502882|NCT00486447|20954545|P1|COMPLETED|Overall Study||249
8502883|NCT00486447|20954545|P1|STARTED|Overall Study||249
8502884|NCT00486434|20954552|P2|NOT COMPLETED|Overall Study||134
8502885|NCT00486434|20954553|P1|NOT COMPLETED|Overall Study||194
8502886|NCT00486434|20954552|P2|COMPLETED|Overall Study||454
8502887|NCT00486434|20954553|P1|COMPLETED|Overall Study||394
8502888|NCT00486434|20954552|P2|STARTED|Overall Study||588
8502889|NCT00486434|20954553|P1|STARTED|Overall Study||588
8502890|NCT00486330|20954572|P1|NOT COMPLETED|Overall Study||2
8502891|NCT00486330|20954572|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
8502892|NCT00486330|20954572|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
8502893|NCT00486291|20954578|P2|NOT COMPLETED|Overall Study||29
8502894|NCT00486291|20954579|P1|NOT COMPLETED|Overall Study||16
8502895|NCT00486291|20954578|P2|COMPLETED|Overall Study||76
8502896|NCT00486291|20954579|P1|COMPLETED|Overall Study||89
8502897|NCT00486291|20954578|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
8502898|NCT00486291|20954579|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
8502899|NCT00486278|20954587|P1|NOT COMPLETED|Overall Study||9
8502900|NCT00486278|20954587|P1|COMPLETED|Overall Study||42
8502901|NCT00486278|20954587|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
8502902|NCT00486265|20954721|P1|NOT COMPLETED|Overall Study||9
8502903|NCT00486265|20954721|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
8502904|NCT00486265|20954721|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
8502908|NCT00486226|20954740|P1|NOT COMPLETED|Overall Study||13
8502909|NCT00486226|20954740|P1|COMPLETED|Overall Study||92
8502910|NCT00486226|20954740|P1|STARTED|Overall Study||105
8502911|NCT00486044|20954750|P2|NOT COMPLETED|Overall Study||3
8502912|NCT00486044|20954751|P1|NOT COMPLETED|Overall Study||2
8502913|NCT00486044|20954750|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
8502914|NCT00486044|20954751|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
8502915|NCT00486044|20954750|P2|STARTED|Overall Study|23 in MRI sub-study|49
8502916|NCT00486044|20954751|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
8502917|NCT00486031|20954763|P1|NOT COMPLETED|Overall Study||3
8502918|NCT00486031|20954763|P1|COMPLETED|Overall Study||440
8502919|NCT00486031|20954763|P1|STARTED|Overall Study||443
8502920|NCT00486018|20954771|P3|NOT COMPLETED|Overall Study||6
8502921|NCT00486018|20954772|P2|NOT COMPLETED|Overall Study||6
8502922|NCT00486018|20954773|P1|NOT COMPLETED|Overall Study||9
8502923|NCT00486018|20954771|P3|COMPLETED|Overall Study||125
8502924|NCT00486018|20954772|P2|COMPLETED|Overall Study||128
8502925|NCT00486018|20954773|P1|COMPLETED|Overall Study||123
8502926|NCT00486018|20954771|P3|Received Drug (Safety Population)|Overall Study||130
8502927|NCT00486018|20954772|P2|Received Drug (Safety Population)|Overall Study||134
8502928|NCT00486018|20954773|P1|Received Drug (Safety Population)|Overall Study||131
8502929|NCT00486018|20954771|P3|STARTED|Overall Study||131
8502930|NCT00486018|20954772|P2|STARTED|Overall Study||134
8502931|NCT00486018|20954773|P1|STARTED|Overall Study||132
8502932|NCT00485953|20954801|P2|NOT COMPLETED|Overall Study||7
8502933|NCT00485953|20954802|P1|NOT COMPLETED|Overall Study||7
8502934|NCT00485953|20954801|P2|COMPLETED|Overall Study||47
8502935|NCT00485953|20954802|P1|COMPLETED|Overall Study||48
8502936|NCT00485953|20954801|P2|STARTED|Overall Study||54
8502937|NCT00485953|20954802|P1|STARTED|Overall Study||55
8502938|NCT00485836|20954815|P3|NOT COMPLETED|Overall Study||11
8502939|NCT00485836|20954816|P2|NOT COMPLETED|Overall Study||3
8502940|NCT00485836|20954817|P1|NOT COMPLETED|Overall Study||15
8502941|NCT00485836|20954815|P3|COMPLETED|Overall Study||119
8502942|NCT00485836|20954816|P2|COMPLETED|Overall Study||129
8502943|NCT00485836|20954817|P1|COMPLETED|Overall Study||115
8502944|NCT00485836|20954815|P3|Received Study Drug (Safety Population)|Overall Study||129
8502945|NCT00485836|20954816|P2|Received Study Drug (Safety Population)|Overall Study||132
8502946|NCT00485836|20954817|P1|Received Study Drug (Safety Population)|Overall Study||129
8502947|NCT00485836|20954815|P3|STARTED|Overall Study||130
8502948|NCT00485836|20954816|P2|STARTED|Overall Study||132
8502949|NCT00485836|20954817|P1|STARTED|Overall Study||130
8502950|NCT00485758|20954845|P2|NOT COMPLETED|Overall Study||65
8502951|NCT00485758|20954846|P1|NOT COMPLETED|Overall Study||156
8502952|NCT00485758|20954845|P2|COMPLETED|Overall Study||277
8502953|NCT00485758|20954846|P1|COMPLETED|Overall Study||298
8502954|NCT00485758|20954845|P2|STARTED|Overall Study||342
8502955|NCT00485758|20954846|P1|STARTED|Overall Study||454
8502956|NCT00485732|20954858|P2|NOT COMPLETED|Overall Study||9
8502957|NCT00485732|20954859|P1|NOT COMPLETED|Overall Study||8
8502958|NCT00485732|20954858|P2|COMPLETED|Overall Study||67
8502959|NCT00485732|20954859|P1|COMPLETED|Overall Study||141
8502960|NCT00485732|20954858|P2|STARTED|Overall Study||76
8502961|NCT00485732|20954859|P1|STARTED|Overall Study||149
8502962|NCT00485693|20954881|P2|NOT COMPLETED|Overall Study||0
8502963|NCT00485693|20954882|P1|NOT COMPLETED|Overall Study||0
8502964|NCT00485693|20954881|P2|COMPLETED|Overall Study||104
8502965|NCT00485693|20954882|P1|COMPLETED|Overall Study||34
8502966|NCT00485693|20954881|P2|STARTED|Overall Study||104
8502967|NCT00485693|20954882|P1|STARTED|Overall Study||34
8502968|NCT00485589|20954894|P3|NOT COMPLETED|Overall Study||18
8502969|NCT00485589|20954895|P2|NOT COMPLETED|Overall Study||20
8502970|NCT00485589|20954896|P1|NOT COMPLETED|Overall Study||27
8502971|NCT00485589|20954894|P3|COMPLETED|Overall Study||185
8502972|NCT00485589|20954895|P2|COMPLETED|Overall Study||180
8502973|NCT00485589|20954896|P1|COMPLETED|Overall Study||183
8502974|NCT00485589|20954894|P3|STARTED|Overall Study||203
8502975|NCT00485589|20954895|P2|STARTED|Overall Study||200
8502976|NCT00485589|20954896|P1|STARTED|Overall Study||210
8502977|NCT00485485|20954922|P1|NOT COMPLETED|Overall Study||0
8502978|NCT00485485|20954922|P1|COMPLETED|Overall Study||7
8502979|NCT00485485|20954922|P1|STARTED|Overall Study||7
8502980|NCT00485472|20954928|P2|NOT COMPLETED|Overall Study||12
8502981|NCT00485472|20954929|P1|NOT COMPLETED|Overall Study||16
8502982|NCT00485472|20954928|P2|COMPLETED|Overall Study||64
8502983|NCT00485472|20954929|P1|COMPLETED|Overall Study||57
8502984|NCT00485472|20954928|P2|Entered Maintenance Phase|Overall Study||67
8502985|NCT00485472|20954929|P1|Entered Maintenance Phase|Overall Study||65
8502986|NCT00485472|20954928|P2|STARTED|Overall Study||76
8502987|NCT00485472|20954929|P1|STARTED|Overall Study||73
8502988|NCT00485433|20954955|P4|NOT COMPLETED|Overall Study||0
8502989|NCT00485433|20954956|P3|NOT COMPLETED|Overall Study||0
8502990|NCT00485433|20954957|P2|NOT COMPLETED|Overall Study||0
8502991|NCT00485433|20954958|P1|NOT COMPLETED|Overall Study||0
8502992|NCT00485433|20954955|P4|COMPLETED|Overall Study||25
8502993|NCT00485433|20954956|P3|COMPLETED|Overall Study||24
8502994|NCT00485433|20954957|P2|COMPLETED|Overall Study||25
8502995|NCT00485433|20954958|P1|COMPLETED|Overall Study||24
8502996|NCT00485433|20954955|P4|STARTED|Overall Study||25
8502997|NCT00485433|20954956|P3|STARTED|Overall Study||24
8502998|NCT00485433|20954957|P2|STARTED|Overall Study||25
8502999|NCT00485433|20954958|P1|STARTED|Overall Study||24
8503000|NCT00485303|20954966|P1|NOT COMPLETED|Overall Study||56
8503001|NCT00485303|20954966|P1|COMPLETED|Overall Study||2
8503002|NCT00485303|20954966|P1|STARTED|Overall Study||58
8503003|NCT00485264|20954984|P6|NOT COMPLETED|Overall Study||7
8503004|NCT00485264|20954985|P5|NOT COMPLETED|Overall Study||6
8503005|NCT00485264|20954986|P4|NOT COMPLETED|Overall Study||4
8503006|NCT00485264|20954987|P3|NOT COMPLETED|Overall Study||6
8503007|NCT00485264|20954988|P2|NOT COMPLETED|Overall Study||7
8503008|NCT00485264|20954989|P1|NOT COMPLETED|Overall Study||36
8503009|NCT00485264|20954984|P6|COMPLETED|Overall Study||5
8503010|NCT00485264|20954985|P5|COMPLETED|Overall Study||9
8503011|NCT00485264|20954986|P4|COMPLETED|Overall Study||17
8503012|NCT00485264|20954987|P3|COMPLETED|Overall Study||12
8503013|NCT00485264|20954988|P2|COMPLETED|Overall Study||9
8503014|NCT00485264|20954989|P1|COMPLETED|Overall Study||35
8503015|NCT00485264|20954984|P6|Completed Week 24|Overall Study||11
8503016|NCT00485264|20954985|P5|Completed Week 24|Overall Study||14
8503017|NCT00485264|20954986|P4|Completed Week 24|Overall Study||21
8503018|NCT00485264|20954987|P3|Completed Week 24|Overall Study||18
8503019|NCT00485264|20954988|P2|Completed Week 24|Overall Study||16
8503020|NCT00485264|20954989|P1|Completed Week 24|Overall Study||67
8503021|NCT00485264|20954984|P6|STARTED|Overall Study||12
8503022|NCT00485264|20954985|P5|STARTED|Overall Study||15
8503023|NCT00485264|20954986|P4|STARTED|Overall Study||21
8503024|NCT00485264|20954987|P3|STARTED|Overall Study||18
8503025|NCT00485264|20954988|P2|STARTED|Overall Study||16
8503026|NCT00485264|20954989|P1|STARTED|Overall Study||71
8503027|NCT00485173|20955077|P2|NOT COMPLETED|Overall Study||64
8503028|NCT00485173|20955078|P1|NOT COMPLETED|Overall Study||36
8503029|NCT00485173|20955077|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
8503030|NCT00485173|20955078|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
8503031|NCT00485173|20955077|P2|STARTED|Overall Study||486
8503032|NCT00485173|20955078|P1|STARTED|Overall Study||224
8503033|NCT00485134|20955126|P8|NOT COMPLETED|Overall Study||1
8503034|NCT00485134|20955127|P7|NOT COMPLETED|Overall Study||3
8503035|NCT00485134|20955128|P6|NOT COMPLETED|Overall Study||4
8503036|NCT00485134|20955129|P5|NOT COMPLETED|Overall Study||3
8503037|NCT00485134|20955130|P4|NOT COMPLETED|Overall Study||1
8503038|NCT00485134|20955131|P3|NOT COMPLETED|Overall Study||3
8503039|NCT00485134|20955132|P2|NOT COMPLETED|Overall Study||2
8503040|NCT00485134|20955133|P1|NOT COMPLETED|Overall Study||1
8503041|NCT00485134|20955126|P8|COMPLETED|Overall Study||20
8503042|NCT00485134|20955127|P7|COMPLETED|Overall Study||28
8503043|NCT00485134|20955128|P6|COMPLETED|Overall Study||3
8503044|NCT00485134|20955129|P5|COMPLETED|Overall Study||7
8503045|NCT00485134|20955130|P4|COMPLETED|Overall Study||7
8503046|NCT00485134|20955131|P3|COMPLETED|Overall Study||9
8503047|NCT00485134|20955132|P2|COMPLETED|Overall Study||10
8503048|NCT00485134|20955133|P1|COMPLETED|Overall Study||11
8503049|NCT00485134|20955126|P8|STARTED|Overall Study||21
8503050|NCT00485134|20955127|P7|STARTED|Overall Study||31
8503051|NCT00485134|20955128|P6|STARTED|Overall Study||7
8503052|NCT00485134|20955129|P5|STARTED|Overall Study||10
8503053|NCT00485134|20955130|P4|STARTED|Overall Study||8
8503054|NCT00485134|20955131|P3|STARTED|Overall Study||12
8503055|NCT00485134|20955132|P2|STARTED|Overall Study||12
8503056|NCT00485134|20955133|P1|STARTED|Overall Study||12
8503057|NCT00485069|20955155|P2|NOT COMPLETED|Overall Study||12
8503058|NCT00485069|20955156|P1|NOT COMPLETED|Overall Study||18
8503059|NCT00485069|20955155|P2|COMPLETED|Overall Study||46
8503060|NCT00485069|20955156|P1|COMPLETED|Overall Study||47
8503061|NCT00485069|20955155|P2|STARTED|Overall Study||58
8503062|NCT00485069|20955156|P1|STARTED|Overall Study||65
8503063|NCT00484939|20955201|P2|NOT COMPLETED|Overall Study||140
8503064|NCT00484939|20955202|P1|NOT COMPLETED|Overall Study||140
8503065|NCT00484939|20955201|P2|COMPLETED|Overall Study||0
8503066|NCT00484939|20955202|P1|COMPLETED|Overall Study||0
8503067|NCT00484939|20955201|P2|STARTED|Overall Study||140
8503068|NCT00484939|20955202|P1|STARTED|Overall Study||140
8503069|NCT00484874|20955222|P1|NOT COMPLETED|Overall Study||0
8503070|NCT00484874|20955222|P1|COMPLETED|Overall Study||12
8503071|NCT00484874|20955222|P1|STARTED|Overall Study||12
8503072|NCT00484679|20955229|P1|NOT COMPLETED|Overall Study||3
8503073|NCT00484679|20955229|P1|COMPLETED|Overall Study||15
8503074|NCT00484679|20955229|P1|STARTED|Overall Study||18
8503075|NCT00484419|20955236|P3|NOT COMPLETED|Overall Study||11
8503076|NCT00484419|20955237|P2|NOT COMPLETED|Overall Study||5
8503077|NCT00484419|20955238|P1|NOT COMPLETED|Overall Study||12
8503078|NCT00484419|20955236|P3|COMPLETED|Overall Study||45
8503079|NCT00484419|20955237|P2|COMPLETED|Overall Study||51
8503080|NCT00484419|20955238|P1|COMPLETED|Overall Study||45
8503081|NCT00484419|20955236|P3|STARTED|Overall Study||56
8503082|NCT00484419|20955237|P2|STARTED|Overall Study||56
8503083|NCT00484419|20955238|P1|STARTED|Overall Study||57
8503084|NCT00484393|20955296|P2|NOT COMPLETED|Overall Study||0
8503085|NCT00484393|20955297|P1|NOT COMPLETED|Overall Study||0
8503086|NCT00484393|20955296|P2|COMPLETED|Overall Study||3
8503087|NCT00484393|20955297|P1|COMPLETED|Overall Study||4
8503088|NCT00484393|20955296|P2|STARTED|Overall Study||3
8503089|NCT00484393|20955297|P1|STARTED|Overall Study||4
8503090|NCT00484354|20955305|P2|NOT COMPLETED|Overall Study||2
8503091|NCT00484354|20955306|P1|NOT COMPLETED|Overall Study||1
8503092|NCT00484354|20955305|P2|COMPLETED|Overall Study||57
8503093|NCT00484354|20955306|P1|COMPLETED|Overall Study||63
8503094|NCT00484354|20955305|P2|STARTED|Overall Study||59
8503095|NCT00484354|20955306|P1|STARTED|Overall Study||64
8503096|NCT00484315|20955322|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
8503097|NCT00484315|20955323|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
8503098|NCT00484315|20955322|P2|COMPLETED|9-Month Angiographic Follow-up||61
8503099|NCT00484315|20955323|P1|COMPLETED|9-Month Angiographic Follow-up||228
8503100|NCT00484315|20955322|P2|STARTED|9-Month Angiographic Follow-up||74
8503101|NCT00484315|20955323|P1|STARTED|9-Month Angiographic Follow-up||256
8503102|NCT00484315|20955322|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
8503103|NCT00484315|20955323|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
8503104|NCT00484315|20955322|P2|COMPLETED|12-Month Clinical Follow-up||311
8503105|NCT00484315|20955323|P1|COMPLETED|12-Month Clinical Follow-up||914
8503106|NCT00484315|20955322|P2|STARTED|12-Month Clinical Follow-up||320
8503107|NCT00484315|20955323|P1|STARTED|12-Month Clinical Follow-up||942
8503108|NCT00484289|20955334|P3|NOT COMPLETED|Post Marketing Phase||0
8503109|NCT00484289|20955335|P2|NOT COMPLETED|Post Marketing Phase||1
8503110|NCT00484289|20955336|P1|NOT COMPLETED|Post Marketing Phase||0
8503111|NCT00484289|20955334|P3|COMPLETED|Post Marketing Phase||10
8503112|NCT00484289|20955335|P2|COMPLETED|Post Marketing Phase||141
8503113|NCT00484289|20955336|P1|COMPLETED|Post Marketing Phase||10
8503114|NCT00484289|20955334|P3|STARTED|Post Marketing Phase||10
8503115|NCT00484289|20955335|P2|STARTED|Post Marketing Phase||142
8503116|NCT00484289|20955336|P1|STARTED|Post Marketing Phase||10
8503117|NCT00484289|20955334|P3|NOT COMPLETED|Long Term Phase||16
8503118|NCT00484289|20955335|P2|NOT COMPLETED|Long Term Phase||36
8503119|NCT00484289|20955336|P1|NOT COMPLETED|Long Term Phase||3
8503120|NCT00484289|20955334|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
8503121|NCT00484289|20955335|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
8503122|NCT00484289|20955336|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
8503123|NCT00484289|20955334|P3|STARTED|Long Term Phase||26
8503124|NCT00484289|20955335|P2|STARTED|Long Term Phase||178
8503125|NCT00484289|20955336|P1|STARTED|Long Term Phase||13
8503126|NCT00484185|20955408|P1|NOT COMPLETED|Overall Study||71
8503127|NCT00484185|20955408|P1|COMPLETED|Overall Study||112
8503128|NCT00484185|20955408|P1|Treated|Overall Study||178
8503129|NCT00484185|20955408|P1|STARTED|Overall Study||183
8503130|NCT00484159|20955430|P3|NOT COMPLETED|Overall Study||0
8503131|NCT00484159|20955431|P2|NOT COMPLETED|Overall Study||1
8503132|NCT00484159|20955432|P1|NOT COMPLETED|Overall Study||1
8503133|NCT00484159|20955430|P3|COMPLETED|Overall Study||51
8503134|NCT00484159|20955431|P2|COMPLETED|Overall Study||49
8503135|NCT00484159|20955432|P1|COMPLETED|Overall Study||49
8503136|NCT00484159|20955430|P3|STARTED|Overall Study||51
8503137|NCT00484159|20955431|P2|STARTED|Overall Study||50
8503138|NCT00484159|20955432|P1|STARTED|Overall Study||50
8503139|NCT00484094|20955443|P1|NOT COMPLETED|Overall Study||42
8503140|NCT00484094|20955443|P1|COMPLETED|Overall Study||167
8503141|NCT00484094|20955443|P1|STARTED|Overall Study||209
8503142|NCT00483938|20955459|P7|NOT COMPLETED|Overall Study||40
8503143|NCT00483938|20955460|P6|NOT COMPLETED|Overall Study||8
8503144|NCT00483938|20955461|P5|NOT COMPLETED|Overall Study||2
8503145|NCT00483938|20955462|P4|NOT COMPLETED|Overall Study||6
8503146|NCT00483938|20955463|P3|NOT COMPLETED|Overall Study||0
8503147|NCT00483938|20955464|P2|NOT COMPLETED|Overall Study||19
8503148|NCT00483938|20955465|P1|NOT COMPLETED|Overall Study||5
8503149|NCT00483938|20955459|P7|COMPLETED|Overall Study||0
8503150|NCT00483938|20955460|P6|COMPLETED|Overall Study||18
8503151|NCT00483938|20955461|P5|COMPLETED|Overall Study||23
8503152|NCT00483938|20955462|P4|COMPLETED|Overall Study||25
8503153|NCT00483938|20955463|P3|COMPLETED|Overall Study||30
8503154|NCT00483938|20955464|P2|COMPLETED|Overall Study||24
8503155|NCT00483938|20955465|P1|COMPLETED|Overall Study||36
8503156|NCT00483938|20955459|P7|STARTED|Overall Study||40
8503157|NCT00483938|20955460|P6|STARTED|Overall Study||26
8503158|NCT00483938|20955461|P5|STARTED|Overall Study||25
8503159|NCT00483938|20955462|P4|STARTED|Overall Study||31
8503160|NCT00483938|20955463|P3|STARTED|Overall Study||30
8503161|NCT00483938|20955464|P2|STARTED|Overall Study||43
8503162|NCT00483938|20955465|P1|STARTED|Overall Study||41
8503163|NCT00483756|20955489|P3|NOT COMPLETED|Overall Study||52
8503164|NCT00483756|20955490|P2|NOT COMPLETED|Overall Study||50
8503165|NCT00483756|20955491|P1|NOT COMPLETED|Overall Study||33
8503166|NCT00483756|20955489|P3|COMPLETED|Overall Study||59
8503167|NCT00483756|20955490|P2|COMPLETED|Overall Study||60
8503168|NCT00483756|20955491|P1|COMPLETED|Overall Study||77
8503169|NCT00483756|20955489|P3|Treated|Overall Study||107
8503170|NCT00483756|20955490|P2|Treated|Overall Study||106
8503171|NCT00483756|20955491|P1|Treated|Overall Study||109
8503172|NCT00483756|20955489|P3|STARTED|Overall Study||111
8503173|NCT00483756|20955490|P2|STARTED|Overall Study||110
8503174|NCT00483756|20955491|P1|STARTED|Overall Study||110
8503175|NCT00483717|20955555|P2|NOT COMPLETED|Overall Study||21
8503176|NCT00483717|20955556|P1|NOT COMPLETED|Overall Study||24
8503177|NCT00483717|20955555|P2|COMPLETED|Overall Study||65
8503178|NCT00483717|20955556|P1|COMPLETED|Overall Study||63
8503179|NCT00483717|20955555|P2|STARTED|Overall Study||86
8503180|NCT00483717|20955556|P1|STARTED|Overall Study||87
8503181|NCT00483704|20955579|P3|NOT COMPLETED|Treatment||156
8503182|NCT00483704|20955580|P2|NOT COMPLETED|Treatment||129
8503183|NCT00483704|20955581|P1|NOT COMPLETED|Treatment||129
8503184|NCT00483704|20955579|P3|COMPLETED|Treatment||399
8503185|NCT00483704|20955580|P2|COMPLETED|Treatment||420
8503186|NCT00483704|20955581|P1|COMPLETED|Treatment||444
8503187|NCT00483704|20955579|P3|STARTED|Treatment||555
8503188|NCT00483704|20955580|P2|STARTED|Treatment||549
8503189|NCT00483704|20955581|P1|STARTED|Treatment||573
8503190|NCT00483704|20955579|P3|NOT COMPLETED|Randomization||91
8503191|NCT00483704|20955580|P2|NOT COMPLETED|Randomization||96
8503192|NCT00483704|20955581|P1|NOT COMPLETED|Randomization||71
8503193|NCT00483704|20955579|P3|COMPLETED|Randomization||555
8503194|NCT00483704|20955580|P2|COMPLETED|Randomization||549
8503195|NCT00483704|20955581|P1|COMPLETED|Randomization||573
8503196|NCT00483704|20955579|P3|STARTED|Randomization||646
8503197|NCT00483704|20955580|P2|STARTED|Randomization||645
8503198|NCT00483704|20955581|P1|STARTED|Randomization||644
8503199|NCT00483652|20955627|P2|NOT COMPLETED|Post-study Follow-up||0
8503200|NCT00483652|20955628|P1|NOT COMPLETED|Post-study Follow-up||0
8503201|NCT00483652|20955627|P2|COMPLETED|Post-study Follow-up||114
8503202|NCT00483652|20955628|P1|COMPLETED|Post-study Follow-up||113
8503203|NCT00483652|20955627|P2|STARTED|Post-study Follow-up||114
8503204|NCT00483652|20955628|P1|STARTED|Post-study Follow-up||113
8503205|NCT00483652|20955627|P2|NOT COMPLETED|Double-blind Treatment Period||5
8503206|NCT00483652|20955628|P1|NOT COMPLETED|Double-blind Treatment Period||7
8503207|NCT00483652|20955627|P2|COMPLETED|Double-blind Treatment Period||114
8503208|NCT00483652|20955628|P1|COMPLETED|Double-blind Treatment Period||113
8503209|NCT00483652|20955627|P2|STARTED|Double-blind Treatment Period||119
8503210|NCT00483652|20955628|P1|STARTED|Double-blind Treatment Period||120
8503211|NCT00483574|20955638|P2|NOT COMPLETED|Overall Study||13
8503212|NCT00483574|20955639|P1|NOT COMPLETED|Overall Study||102
8503213|NCT00483574|20955638|P2|COMPLETED|Overall Study||308
8503214|NCT00483574|20955639|P1|COMPLETED|Overall Study||951
8503215|NCT00483574|20955638|P2|STARTED|Overall Study||321
8503216|NCT00483574|20955639|P1|STARTED|Overall Study||1053
8503217|NCT00483561|20955647|P1|NOT COMPLETED|Overall Study||11
8503218|NCT00483561|20955647|P1|COMPLETED|Overall Study||15
8503219|NCT00483561|20955647|P1|STARTED|Overall Study||26
8503220|NCT00483548|20955654|P2|NOT COMPLETED|Overall Study||46
8503221|NCT00483548|20955655|P1|NOT COMPLETED|Overall Study||60
8503222|NCT00483548|20955654|P2|COMPLETED|Overall Study||104
8503223|NCT00483548|20955655|P1|COMPLETED|Overall Study||88
8503224|NCT00483548|20955654|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
8503225|NCT00483548|20955655|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
8503226|NCT00483548|20955654|P2|STARTED|Overall Study||150
8503227|NCT00483548|20955655|P1|STARTED|Overall Study||148
8503228|NCT00483509|20955693|P1|NOT COMPLETED|Overall Study||0
8503229|NCT00483509|20955693|P1|COMPLETED|Overall Study||28
8503230|NCT00483509|20955693|P1|STARTED|Overall Study||28
8503231|NCT00483496|20955701|P1|NOT COMPLETED|Overall Study||1
8503232|NCT00483496|20955701|P1|COMPLETED|Overall Study||15
8503233|NCT00483496|20955701|P1|STARTED|Overall Study||16
8503234|NCT00483405|20955713|P1|NOT COMPLETED|Overall Study||28
8503235|NCT00483405|20955713|P1|COMPLETED|Overall Study||0
8503236|NCT00483405|20955713|P1|STARTED|Overall Study||28
8503237|NCT00483379|20955722|P2|NOT COMPLETED|Extension Period||0
8503238|NCT00483379|20955723|P1|NOT COMPLETED|Extension Period||0
8503239|NCT00483379|20955722|P2|COMPLETED|Extension Period||2
8503240|NCT00483379|20955723|P1|COMPLETED|Extension Period||1
8503241|NCT00483379|20955722|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
8503242|NCT00483379|20955723|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
8503243|NCT00483379|20955722|P2|NOT COMPLETED|Treatment Period||0
8503244|NCT00483379|20955723|P1|NOT COMPLETED|Treatment Period||2
8503245|NCT00483379|20955722|P2|COMPLETED|Treatment Period||7
8503246|NCT00483379|20955723|P1|COMPLETED|Treatment Period||4
8503247|NCT00483379|20955722|P2|STARTED|Treatment Period||7
8503248|NCT00483379|20955723|P1|STARTED|Treatment Period||6
8503249|NCT00483327|20955759|P1|NOT COMPLETED|Overall Study||10
8503250|NCT00483327|20955759|P1|COMPLETED|Overall Study||20
8503251|NCT00483327|20955759|P1|STARTED|Overall Study||30
8503252|NCT00483262|20955770|P2|NOT COMPLETED|Overall Study||0
8503253|NCT00483262|20955771|P1|NOT COMPLETED|Overall Study||0
8503254|NCT00483262|20955770|P2|COMPLETED|Overall Study||43
8503255|NCT00483262|20955771|P1|COMPLETED|Overall Study||20
8503256|NCT00483262|20955770|P2|STARTED|Overall Study||43
8503257|NCT00483262|20955771|P1|STARTED|Overall Study||20
8503258|NCT00483223|20955781|P1|NOT COMPLETED|Overall Study||0
8503259|NCT00483223|20955781|P1|COMPLETED|Overall Study||86
8503260|NCT00483223|20955781|P1|STARTED|Overall Study||86
8503261|NCT00483184|20955791|P3|NOT COMPLETED|Overall Study||3
8503262|NCT00483184|20955792|P2|NOT COMPLETED|Overall Study||4
8503263|NCT00483184|20955793|P1|NOT COMPLETED|Overall Study||5
8503264|NCT00483184|20955791|P3|COMPLETED|Overall Study||23
8503265|NCT00483184|20955792|P2|COMPLETED|Overall Study||27
8503266|NCT00483184|20955793|P1|COMPLETED|Overall Study||22
8503267|NCT00483184|20955791|P3|STARTED|Overall Study||26
8503268|NCT00483184|20955792|P2|STARTED|Overall Study||31
8503269|NCT00483184|20955793|P1|STARTED|Overall Study||27
8503270|NCT00483119|20955803|P2|NOT COMPLETED|Overall Study||1
8503271|NCT00483119|20955804|P1|NOT COMPLETED|Overall Study||1
8503272|NCT00483119|20955803|P2|COMPLETED|Overall Study||3
8503273|NCT00483119|20955804|P1|COMPLETED|Overall Study||4
8503274|NCT00483119|20955803|P2|STARTED|Overall Study||4
8503275|NCT00483119|20955804|P1|STARTED|Overall Study||5
8503276|NCT00483041|20955818|P2|NOT COMPLETED|Overall Study||1
8503277|NCT00483041|20955819|P1|NOT COMPLETED|Overall Study||0
8503278|NCT00483041|20955818|P2|COMPLETED|Overall Study||5
8503279|NCT00483041|20955819|P1|COMPLETED|Overall Study||5
8503280|NCT00483041|20955818|P2|STARTED|Overall Study||6
8503281|NCT00483041|20955819|P1|STARTED|Overall Study||5
8503282|NCT00483002|20955849|P1|NOT COMPLETED|Overall Study||2554
8503283|NCT00483002|20955849|P1|COMPLETED|Overall Study||1165
8503284|NCT00483002|20955849|P1|STARTED|Overall Study||3719
8503285|NCT00482911|20955857|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503286|NCT00482911|20955858|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503287|NCT00482911|20955857|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
8503288|NCT00482911|20955858|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503289|NCT00482911|20955857|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
8503290|NCT00482911|20955858|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503291|NCT00482911|20955857|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
8503292|NCT00482911|20955858|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
8503293|NCT00482911|20955857|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
8503294|NCT00482911|20955858|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
8503295|NCT00482911|20955857|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
8503296|NCT00482911|20955858|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
8503297|NCT00482911|20955857|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
8503298|NCT00482911|20955858|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
8503299|NCT00482911|20955857|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
8503300|NCT00482911|20955858|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
8503301|NCT00482911|20955857|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
8503302|NCT00482911|20955858|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
8503303|NCT00482729|20955874|P2|NOT COMPLETED|Overall Study||218
8503304|NCT00482729|20955875|P1|NOT COMPLETED|Overall Study||217
8503305|NCT00482729|20955874|P2|COMPLETED|Overall Study||406
8503306|NCT00482729|20955875|P1|COMPLETED|Overall Study||409
8503307|NCT00482729|20955874|P2|Completed Phase B|Overall Study||406
8503308|NCT00482729|20955875|P1|Completed Phase B|Overall Study||409
8503309|NCT00482729|20955874|P2|Completed Phase A|Overall Study||482
8503310|NCT00482729|20955875|P1|Completed Phase A|Overall Study||484
8503311|NCT00482729|20955874|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
8503312|NCT00482729|20955875|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
8503313|NCT00482703|20955891|P2|NOT COMPLETED|Overall Study||0
8503314|NCT00482703|20955892|P1|NOT COMPLETED|Overall Study||1
8503315|NCT00482703|20955891|P2|COMPLETED|Overall Study||12
8503316|NCT00482703|20955892|P1|COMPLETED|Overall Study||10
8503317|NCT00482703|20955891|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
8503318|NCT00482703|20955892|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
8503319|NCT00482677|20955939|P2|NOT COMPLETED|Overall Study||0
8503320|NCT00482677|20955940|P1|NOT COMPLETED|Overall Study||0
8503321|NCT00482677|20955939|P2|COMPLETED|Overall Study||281
8503322|NCT00482677|20955940|P1|COMPLETED|Overall Study||281
8503323|NCT00482677|20955939|P2|STARTED|Overall Study||281
8503324|NCT00482677|20955940|P1|STARTED|Overall Study||281
8503325|NCT00482625|20955950|P1|NOT COMPLETED|Overall Study||0
8503326|NCT00482625|20955950|P1|COMPLETED|Overall Study||6
8503327|NCT00482625|20955950|P1|STARTED|Overall Study||6
8503328|NCT00482612|20955963|P4|NOT COMPLETED|Follow-up Period||8
8503329|NCT00482612|20955964|P3|NOT COMPLETED|Follow-up Period||22
8503330|NCT00482612|20955965|P2|NOT COMPLETED|Follow-up Period||18
8503331|NCT00482612|20955966|P1|NOT COMPLETED|Follow-up Period||14
8503332|NCT00482612|20955963|P4|COMPLETED|Follow-up Period||127
8503333|NCT00482612|20955964|P3|COMPLETED|Follow-up Period||106
8503334|NCT00482612|20955965|P2|COMPLETED|Follow-up Period||107
8503335|NCT00482612|20955966|P1|COMPLETED|Follow-up Period||123
8503336|NCT00482612|20955963|P4|STARTED|Follow-up Period||135
8503337|NCT00482612|20955964|P3|STARTED|Follow-up Period||128
8503338|NCT00482612|20955965|P2|STARTED|Follow-up Period||125
8503339|NCT00482612|20955966|P1|STARTED|Follow-up Period||137
8503340|NCT00482612|20955963|P4|NOT COMPLETED|In-treatment Period||0
8503341|NCT00482612|20955964|P3|NOT COMPLETED|In-treatment Period||1
8503342|NCT00482612|20955965|P2|NOT COMPLETED|In-treatment Period||0
8503343|NCT00482612|20955966|P1|NOT COMPLETED|In-treatment Period||0
8503344|NCT00482612|20955963|P4|COMPLETED|In-treatment Period||135
8503345|NCT00482612|20955964|P3|COMPLETED|In-treatment Period||128
8503346|NCT00482612|20955965|P2|COMPLETED|In-treatment Period||125
8503347|NCT00482612|20955966|P1|COMPLETED|In-treatment Period||137
8503348|NCT00482612|20955963|P4|Treated|In-treatment Period||135
8503349|NCT00482612|20955964|P3|Treated|In-treatment Period||128
8503350|NCT00482612|20955965|P2|Treated|In-treatment Period||125
8503351|NCT00482612|20955966|P1|Treated|In-treatment Period||137
8503352|NCT00482612|20955963|P4|STARTED|In-treatment Period||135
8503353|NCT00482612|20955964|P3|STARTED|In-treatment Period||129
8503354|NCT00482612|20955965|P2|STARTED|In-treatment Period||125
8503355|NCT00482612|20955966|P1|STARTED|In-treatment Period||137
8503356|NCT00482547|20955994|P2|NOT COMPLETED|Overall Study||161
8503357|NCT00482547|20955995|P1|NOT COMPLETED|Overall Study||173
8503358|NCT00482547|20955994|P2|COMPLETED|Overall Study||428
8503359|NCT00482547|20955995|P1|COMPLETED|Overall Study||426
8503360|NCT00482547|20955994|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
8503361|NCT00482547|20955995|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
8503362|NCT00482547|20955994|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
8503363|NCT00482547|20955995|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
8503364|NCT00482547|20955994|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
8503365|NCT00482547|20955995|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
8503366|NCT00482391|20956015|P1|NOT COMPLETED|Overall Study||3
8503367|NCT00482391|20956015|P1|COMPLETED|Overall Study||92
8503368|NCT00482391|20956015|P1|STARTED|Overall Study||95
8503369|NCT00482274|20956020|P1|NOT COMPLETED|Overall Study||1
8503370|NCT00482274|20956020|P1|COMPLETED|Overall Study||2
8503371|NCT00482274|20956020|P1|STARTED|Overall Study||3
8503372|NCT00482170|20956030|P2|NOT COMPLETED|Overall Study||20
8503373|NCT00482170|20956031|P1|NOT COMPLETED|Overall Study||15
8503374|NCT00482170|20956030|P2|COMPLETED|Overall Study||194
8503375|NCT00482170|20956031|P1|COMPLETED|Overall Study||192
8503376|NCT00482170|20956030|P2|Treated|Overall Study||211
8503377|NCT00482170|20956031|P1|Treated|Overall Study||207
8503378|NCT00482170|20956030|P2|STARTED|Overall Study||214
8503379|NCT00482170|20956031|P1|STARTED|Overall Study||207
8503380|NCT00482053|20956149|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
8503381|NCT00482053|20956149|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
8503382|NCT00482053|20956149|P1|STARTED|Allogeneic Peripheral Stem Cells||2
8503383|NCT00482053|20956149|P1|NOT COMPLETED|Inter-treatment Period||1
8503384|NCT00482053|20956149|P1|COMPLETED|Inter-treatment Period||2
8503385|NCT00482053|20956149|P1|STARTED|Inter-treatment Period||3
8503386|NCT00482053|20956149|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
8503387|NCT00482053|20956149|P1|COMPLETED|Autologous Peripheral Stem Cells||3
8503388|NCT00482053|20956149|P1|STARTED|Autologous Peripheral Stem Cells||3
8503389|NCT00482014|20956163|P4|NOT COMPLETED|Overall Study||23
8503390|NCT00482014|20956164|P3|NOT COMPLETED|Overall Study||11
8503391|NCT00482014|20956165|P2|NOT COMPLETED|Overall Study||6
8503392|NCT00482014|20956166|P1|NOT COMPLETED|Overall Study||7
8503393|NCT00482014|20956163|P4|COMPLETED|Overall Study||29
8503394|NCT00482014|20956164|P3|COMPLETED|Overall Study||35
8503395|NCT00482014|20956165|P2|COMPLETED|Overall Study||7
8503396|NCT00482014|20956166|P1|COMPLETED|Overall Study||2
8503397|NCT00482014|20956163|P4|STARTED|Overall Study||52
8503398|NCT00482014|20956164|P3|STARTED|Overall Study||46
8503399|NCT00482014|20956165|P2|STARTED|Overall Study||13
8503400|NCT00482014|20956166|P1|STARTED|Overall Study||9
8503401|NCT00482001|20956190|P2|NOT COMPLETED|Overall Study||1
8503402|NCT00482001|20956191|P1|NOT COMPLETED|Overall Study||1
8503403|NCT00482001|20956190|P2|COMPLETED|Overall Study||10
8503404|NCT00482001|20956191|P1|COMPLETED|Overall Study||10
8503405|NCT00482001|20956190|P2|STARTED|Overall Study||11
8503406|NCT00482001|20956191|P1|STARTED|Overall Study||11
8503407|NCT00481988|20956211|P2|NOT COMPLETED|Overall Study||1
8503408|NCT00481988|20956212|P1|NOT COMPLETED|Overall Study||1
8503409|NCT00481988|20956211|P2|COMPLETED|Overall Study||8
8503410|NCT00481988|20956212|P1|COMPLETED|Overall Study||11
8503411|NCT00481988|20956211|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
8503412|NCT00481988|20956212|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
8503413|NCT00481988|20956211|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
8503414|NCT00481988|20956212|P1|STARTED|Overall Study||12
8503415|NCT00481871|20956225|P5|NOT COMPLETED|Overall Study||0
8503416|NCT00481871|20956226|P4|NOT COMPLETED|Overall Study||0
8503417|NCT00481871|20956227|P3|NOT COMPLETED|Overall Study||1
8503418|NCT00481871|20956228|P2|NOT COMPLETED|Overall Study||0
8503419|NCT00481871|20956229|P1|NOT COMPLETED|Overall Study||0
8503420|NCT00481871|20956225|P5|COMPLETED|Overall Study||34
8503421|NCT00481871|20956226|P4|COMPLETED|Overall Study||38
8503422|NCT00481871|20956227|P3|COMPLETED|Overall Study||17
8503423|NCT00481871|20956228|P2|COMPLETED|Overall Study||10
8503424|NCT00481871|20956229|P1|COMPLETED|Overall Study||7
8503425|NCT00481871|20956225|P5|STARTED|Overall Study||34
8503426|NCT00481871|20956226|P4|STARTED|Overall Study||38
8503427|NCT00481871|20956227|P3|STARTED|Overall Study||18
8503428|NCT00481871|20956228|P2|STARTED|Overall Study||10
8503429|NCT00481871|20956229|P1|STARTED|Overall Study||7
8503430|NCT00481845|20956245|P2|NOT COMPLETED|Overall Study||0
8503431|NCT00481845|20956246|P1|NOT COMPLETED|Overall Study||0
8503432|NCT00481845|20956245|P2|COMPLETED|Overall Study||0
8503433|NCT00481845|20956246|P1|COMPLETED|Overall Study||1
8503434|NCT00481845|20956245|P2|STARTED|Overall Study||0
8503435|NCT00481845|20956246|P1|STARTED|Overall Study||1
8503436|NCT00481832|20956254|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
8503437|NCT00481832|20956254|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
8503438|NCT00481832|20956254|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
8503439|NCT00481832|20956254|P1|NOT COMPLETED|Inter-transplant Period||27
8503440|NCT00481832|20956254|P1|COMPLETED|Inter-transplant Period||13
8503441|NCT00481832|20956254|P1|STARTED|Inter-transplant Period||40
8503442|NCT00481832|20956254|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
8503443|NCT00481832|20956254|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
8503444|NCT00481832|20956254|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
8503445|NCT00481832|20956254|P1|NOT COMPLETED|Enrollment||10
8503446|NCT00481832|20956254|P1|COMPLETED|Enrollment||40
8503447|NCT00481832|20956254|P1|STARTED|Enrollment||50
8503448|NCT00481767|20956269|P2|NOT COMPLETED|Overall Study||21
8503449|NCT00481767|20956270|P1|NOT COMPLETED|Overall Study||32
8503450|NCT00481767|20956269|P2|COMPLETED|Overall Study||205
8503451|NCT00481767|20956270|P1|COMPLETED|Overall Study||418
8503452|NCT00481767|20956269|P2|STARTED|Overall Study||226
8503453|NCT00481767|20956270|P1|STARTED|Overall Study||450
8503454|NCT00481676|20956304|P2|NOT COMPLETED|Overall Study||5
8503455|NCT00481676|20956305|P1|NOT COMPLETED|Overall Study||2
8503456|NCT00481676|20956304|P2|COMPLETED|Overall Study||17
8503457|NCT00481676|20956305|P1|COMPLETED|Overall Study||25
8503458|NCT00481676|20956304|P2|STARTED|Overall Study||22
8503459|NCT00481676|20956305|P1|STARTED|Overall Study||27
8503460|NCT00481507|20956329|P2|NOT COMPLETED|Overall Study||0
8503461|NCT00481507|20956330|P1|NOT COMPLETED|Overall Study||0
8503462|NCT00481507|20956329|P2|COMPLETED|Overall Study||61
8503463|NCT00481507|20956330|P1|COMPLETED|Overall Study||64
8503464|NCT00481507|20956329|P2|STARTED|Overall Study||61
8503465|NCT00481507|20956330|P1|STARTED|Overall Study||64
8503466|NCT00481351|20956340|P2|NOT COMPLETED|Overall Study||0
8503467|NCT00481351|20956341|P1|NOT COMPLETED|Overall Study||0
8503468|NCT00481351|20956340|P2|COMPLETED|Overall Study||12
8503469|NCT00481351|20956341|P1|COMPLETED|Overall Study||13
8503470|NCT00481351|20956340|P2|STARTED|Overall Study||12
8503471|NCT00481351|20956341|P1|STARTED|Overall Study||13
8503472|NCT00481247|20956357|P2|NOT COMPLETED|Overall Study||260
8503473|NCT00481247|20956358|P1|NOT COMPLETED|Overall Study||259
8503474|NCT00481247|20956357|P2|COMPLETED|Overall Study||0
8503475|NCT00481247|20956358|P1|COMPLETED|Overall Study||0
8503476|NCT00481247|20956357|P2|Received Treatment|Overall Study||258
8503477|NCT00481247|20956358|P1|Received Treatment|Overall Study||258
8503478|NCT00481247|20956357|P2|STARTED|Overall Study|Randomized|260
8503479|NCT00481247|20956358|P1|STARTED|Overall Study|Randomized|259
8503480|NCT00481195|20956382|P2|NOT COMPLETED|Overall Study||39
8503481|NCT00481195|20956383|P1|NOT COMPLETED|Overall Study||39
8503482|NCT00481195|20956382|P2|COMPLETED|Overall Study||90
8503483|NCT00481195|20956383|P1|COMPLETED|Overall Study||89
8503484|NCT00481195|20956382|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
8503485|NCT00481195|20956383|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
8503486|NCT00481078|20956469|P2|NOT COMPLETED|Overall Study||20
8503487|NCT00481078|20956470|P1|NOT COMPLETED|Overall Study||42
8503488|NCT00481078|20956469|P2|COMPLETED|Overall Study||12
8503489|NCT00481078|20956470|P1|COMPLETED|Overall Study||20
8503490|NCT00481078|20956469|P2|STARTED|Overall Study||32
8503491|NCT00481078|20956470|P1|STARTED|Overall Study||62
8503492|NCT00481065|20956488|P8|NOT COMPLETED|Overall Study||19
8503493|NCT00481065|20956489|P7|NOT COMPLETED|Overall Study||16
8503494|NCT00481065|20956490|P6|NOT COMPLETED|Overall Study||24
8503495|NCT00481065|20956491|P5|NOT COMPLETED|Overall Study||23
8503496|NCT00481065|20956492|P4|NOT COMPLETED|Overall Study||15
8503497|NCT00481065|20956493|P3|NOT COMPLETED|Overall Study||19
8503498|NCT00481065|20956494|P2|NOT COMPLETED|Overall Study||17
8503499|NCT00481065|20956495|P1|NOT COMPLETED|Overall Study||22
8503500|NCT00481065|20956488|P8|COMPLETED|Overall Study||30
8503501|NCT00481065|20956489|P7|COMPLETED|Overall Study||34
8503502|NCT00481065|20956490|P6|COMPLETED|Overall Study||27
8503503|NCT00481065|20956491|P5|COMPLETED|Overall Study||28
8503504|NCT00481065|20956492|P4|COMPLETED|Overall Study||37
8503505|NCT00481065|20956493|P3|COMPLETED|Overall Study||32
8503506|NCT00481065|20956494|P2|COMPLETED|Overall Study||33
8503507|NCT00481065|20956495|P1|COMPLETED|Overall Study||29
8503508|NCT00481065|20956488|P8|STARTED|Overall Study||49
8503509|NCT00481065|20956489|P7|STARTED|Overall Study||50
8503510|NCT00481065|20956490|P6|STARTED|Overall Study||51
8503511|NCT00481065|20956491|P5|STARTED|Overall Study||51
8503512|NCT00481065|20956492|P4|STARTED|Overall Study||52
8503513|NCT00481065|20956493|P3|STARTED|Overall Study||51
8503514|NCT00481065|20956494|P2|STARTED|Overall Study||50
8503515|NCT00481065|20956495|P1|STARTED|Overall Study||51
8503516|NCT00480987|20956581|P1|NOT COMPLETED|Overall Study||0
8503517|NCT00480987|20956581|P1|COMPLETED|Overall Study||27
8503518|NCT00480987|20956581|P1|STARTED|Overall Study||27
8503519|NCT00480857|20956585|P1|NOT COMPLETED|Overall Study||2
8503520|NCT00480857|20956585|P1|COMPLETED|Overall Study||17
8503521|NCT00480857|20956585|P1|STARTED|Overall Study||19
8503522|NCT00480779|20956595|P2|NOT COMPLETED|Overall Study||3
8503523|NCT00480779|20956596|P1|NOT COMPLETED|Overall Study||2
8503524|NCT00480779|20956595|P2|COMPLETED|Overall Study||19
8503525|NCT00480779|20956596|P1|COMPLETED|Overall Study||24
8503526|NCT00480779|20956595|P2|STARTED|Overall Study||22
8503527|NCT00480779|20956596|P1|STARTED|Overall Study||26
8503528|NCT00480740|20956623|P3|NOT COMPLETED|Overall Study||0
8503529|NCT00480740|20956624|P2|NOT COMPLETED|Overall Study||0
8503530|NCT00480740|20956625|P1|NOT COMPLETED|Overall Study||0
8503531|NCT00480740|20956623|P3|COMPLETED|Overall Study||6
8503532|NCT00480740|20956624|P2|COMPLETED|Overall Study||9
8503533|NCT00480740|20956625|P1|COMPLETED|Overall Study||26
8503534|NCT00480740|20956623|P3|STARTED|Overall Study||6
8503535|NCT00480740|20956624|P2|STARTED|Overall Study||9
8503536|NCT00480740|20956625|P1|STARTED|Overall Study||26
8503537|NCT00480636|20956633|P1|NOT COMPLETED|Overall Study||19
8503538|NCT00480636|20956633|P1|COMPLETED|Overall Study||83
8503539|NCT00480636|20956633|P1|STARTED|Overall Study||102
8503540|NCT00480532|20956645|P4|NOT COMPLETED|Overall Study||1
8503541|NCT00480532|20956646|P3|NOT COMPLETED|Overall Study||4
8503542|NCT00480532|20956647|P2|NOT COMPLETED|Overall Study||4
8503543|NCT00480532|20956648|P1|NOT COMPLETED|Overall Study||2
8503544|NCT00480532|20956645|P4|COMPLETED|Overall Study||31
8503545|NCT00480532|20956646|P3|COMPLETED|Overall Study||29
8503546|NCT00480532|20956647|P2|COMPLETED|Overall Study||29
8503547|NCT00480532|20956648|P1|COMPLETED|Overall Study||31
8503548|NCT00480532|20956645|P4|STARTED|Overall Study||32
8503549|NCT00480532|20956646|P3|STARTED|Overall Study||33
8503550|NCT00480532|20956647|P2|STARTED|Overall Study||33
8503551|NCT00480532|20956648|P1|STARTED|Overall Study||33
8503552|NCT00480493|20956668|P2|NOT COMPLETED|Overall Study||7
8503553|NCT00480493|20956669|P1|NOT COMPLETED|Overall Study||2
8503554|NCT00480493|20956668|P2|COMPLETED|Overall Study||21
8503555|NCT00480493|20956669|P1|COMPLETED|Overall Study||30
8503556|NCT00480493|20956668|P2|Randomized|Overall Study||28
8503557|NCT00480493|20956669|P1|Randomized|Overall Study||32
8503558|NCT00480493|20956668|P2|STARTED|Overall Study||28
8503559|NCT00480493|20956669|P1|STARTED|Overall Study||32
8503560|NCT00480441|20956681|P3|NOT COMPLETED|Randomization||2
8503561|NCT00480441|20956682|P2|NOT COMPLETED|Randomization||7
8503562|NCT00480441|20956683|P1|NOT COMPLETED|Randomization||0
8503563|NCT00480441|20956681|P3|COMPLETED|Randomization||9
8503564|NCT00480441|20956682|P2|COMPLETED|Randomization||6
8503565|NCT00480441|20956683|P1|COMPLETED|Randomization||0
8503566|NCT00480441|20956681|P3|STARTED|Randomization||11
8503567|NCT00480441|20956682|P2|STARTED|Randomization||13
8503568|NCT00480441|20956683|P1|STARTED|Randomization||0
8503569|NCT00480441|20956681|P3|NOT COMPLETED|Baseline Functional MRI||0
8503570|NCT00480441|20956682|P2|NOT COMPLETED|Baseline Functional MRI||0
8503571|NCT00480441|20956683|P1|NOT COMPLETED|Baseline Functional MRI||12
8503572|NCT00480441|20956681|P3|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503573|NCT00480441|20956682|P2|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503574|NCT00480441|20956683|P1|COMPLETED|Baseline Functional MRI||12
8503575|NCT00480441|20956681|P3|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503576|NCT00480441|20956682|P2|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503577|NCT00480441|20956683|P1|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
8503578|NCT00480441|20956681|P3|NOT COMPLETED|Screening||0
8503579|NCT00480441|20956682|P2|NOT COMPLETED|Screening||0
8503580|NCT00480441|20956683|P1|NOT COMPLETED|Screening||37
8503581|NCT00480441|20956681|P3|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503582|NCT00480441|20956682|P2|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503583|NCT00480441|20956683|P1|COMPLETED|Screening||24
8503584|NCT00480441|20956681|P3|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503585|NCT00480441|20956682|P2|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503586|NCT00480441|20956683|P1|STARTED|Screening||61
8503587|NCT00480324|20956692|P2|NOT COMPLETED|Overall Study||16
8503588|NCT00480324|20956693|P1|NOT COMPLETED|Overall Study||32
8503589|NCT00480324|20956692|P2|COMPLETED|Overall Study||241
8503590|NCT00480324|20956693|P1|COMPLETED|Overall Study||476
8503591|NCT00480324|20956692|P2|STARTED|Overall Study||257
8503592|NCT00480324|20956693|P1|STARTED|Overall Study||508
8503593|NCT00480077|20956721|P2|NOT COMPLETED|Overall Study||26
8503594|NCT00480077|20956722|P1|NOT COMPLETED|Overall Study||31
8503595|NCT00480077|20956721|P2|COMPLETED|Overall Study||141
8503596|NCT00480077|20956722|P1|COMPLETED|Overall Study||137
8503597|NCT00480077|20956721|P2|STARTED|Overall Study||167
8503598|NCT00480077|20956722|P1|STARTED|Overall Study||168
8503599|NCT00480025|20956730|P2|NOT COMPLETED|Overall Study||369
8503600|NCT00480025|20956731|P1|NOT COMPLETED|Overall Study||752
8503601|NCT00480025|20956730|P2|COMPLETED|Overall Study||388
8503602|NCT00480025|20956731|P1|COMPLETED|Overall Study||763
8503603|NCT00480025|20956730|P2|STARTED|Overall Study||757
8503604|NCT00480025|20956731|P1|STARTED|Overall Study||1515
8503605|NCT00479882|20956803|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
8503606|NCT00479882|20956804|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
8503607|NCT00479882|20956805|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
8503608|NCT00479882|20956806|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
8503609|NCT00479882|20956803|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
8503610|NCT00479882|20956804|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
8503611|NCT00479882|20956805|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
8503612|NCT00479882|20956806|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
8503613|NCT00479882|20956803|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
8503614|NCT00479882|20956804|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
8503615|NCT00479882|20956805|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
8503616|NCT00479882|20956806|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
8503617|NCT00479882|20956803|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
8503618|NCT00479882|20956804|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
8503619|NCT00479882|20956805|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
8503620|NCT00479882|20956806|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
8503621|NCT00479882|20956803|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
8503622|NCT00479882|20956804|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
8503623|NCT00479882|20956805|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
8503624|NCT00479882|20956806|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
8503625|NCT00479882|20956803|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
8503626|NCT00479882|20956804|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
8503627|NCT00479882|20956805|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
8503628|NCT00479882|20956806|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
8503629|NCT00479856|20956936|P1|NOT COMPLETED|Overall Study||3
8503630|NCT00479856|20956936|P1|COMPLETED|Overall Study||6
8503631|NCT00479856|20956936|P1|STARTED|Overall Study||9
8503632|NCT00479765|20956945|P1|NOT COMPLETED|Overall Study||4
8503633|NCT00479765|20956945|P1|COMPLETED|Overall Study||0
8503634|NCT00479765|20956945|P1|STARTED|Overall Study||4
8503635|NCT00479713|20956951|P2|NOT COMPLETED|Overall Study||9
8503636|NCT00479713|20956952|P1|NOT COMPLETED|Overall Study||13
8503637|NCT00479713|20956951|P2|COMPLETED|Overall Study||295
8503638|NCT00479713|20956952|P1|COMPLETED|Overall Study||301
8503639|NCT00479713|20956951|P2|STARTED|Overall Study||304
8503640|NCT00479713|20956952|P1|STARTED|Overall Study||314
8503641|NCT00479674|20956976|P1|NOT COMPLETED|Overall Study||41
8503642|NCT00479674|20956976|P1|COMPLETED|Overall Study||0
8503643|NCT00479674|20956976|P1|STARTED|Overall Study||41
8503644|NCT00479557|20956991|P7|NOT COMPLETED|Overall Study||2
8503645|NCT00479557|20956992|P6|NOT COMPLETED|Overall Study||13
8503646|NCT00479557|20956993|P5|NOT COMPLETED|Overall Study||4
8503647|NCT00479557|20956994|P4|NOT COMPLETED|Overall Study||5
8503648|NCT00479557|20956995|P3|NOT COMPLETED|Overall Study||8
8503649|NCT00479557|20956996|P2|NOT COMPLETED|Overall Study||10
8503650|NCT00479557|20956997|P1|NOT COMPLETED|Overall Study||10
8503651|NCT00479557|20956991|P7|COMPLETED|Overall Study||15
8503652|NCT00479557|20956992|P6|COMPLETED|Overall Study||31
8503653|NCT00479557|20956993|P5|COMPLETED|Overall Study||8
8503654|NCT00479557|20956994|P4|COMPLETED|Overall Study||30
8503655|NCT00479557|20956995|P3|COMPLETED|Overall Study||32
8503656|NCT00479557|20956996|P2|COMPLETED|Overall Study||51
8503657|NCT00479557|20956997|P1|COMPLETED|Overall Study||26
8503658|NCT00479557|20956991|P7|Treated|Overall Study||17
8503659|NCT00479557|20956992|P6|Treated|Overall Study||44
8503660|NCT00479557|20956993|P5|Treated|Overall Study||12
8503661|NCT00479557|20956994|P4|Treated|Overall Study||35
8503662|NCT00479557|20956995|P3|Treated|Overall Study||40
8503663|NCT00479557|20956996|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
8503664|NCT00479557|20956997|P1|Treated|Overall Study||36
8503665|NCT00479557|20956991|P7|STARTED|Overall Study||17
8503666|NCT00479557|20956992|P6|STARTED|Overall Study||44
8503667|NCT00479557|20956993|P5|STARTED|Overall Study||12
8503668|NCT00479557|20956994|P4|STARTED|Overall Study||35
8503669|NCT00479557|20956995|P3|STARTED|Overall Study||40
8503670|NCT00479557|20956996|P2|STARTED|Overall Study||61
8503671|NCT00479557|20956997|P1|STARTED|Overall Study||36
8503672|NCT00479466|20957040|P6|NOT COMPLETED|Overall Study||4
8503673|NCT00479466|20957041|P5|NOT COMPLETED|Overall Study||8
8503674|NCT00479466|20957042|P4|NOT COMPLETED|Overall Study||3
8503675|NCT00479466|20957043|P3|NOT COMPLETED|Overall Study||3
8503676|NCT00479466|20957044|P2|NOT COMPLETED|Overall Study||8
8503677|NCT00479466|20957045|P1|NOT COMPLETED|Overall Study||13
8503678|NCT00479466|20957040|P6|COMPLETED|Overall Study||53
8503679|NCT00479466|20957041|P5|COMPLETED|Overall Study||48
8503680|NCT00479466|20957042|P4|COMPLETED|Overall Study||55
8503681|NCT00479466|20957043|P3|COMPLETED|Overall Study||54
8503682|NCT00479466|20957044|P2|COMPLETED|Overall Study||49
8503683|NCT00479466|20957045|P1|COMPLETED|Overall Study||44
8503684|NCT00479466|20957040|P6|STARTED|Overall Study||57
8503685|NCT00479466|20957041|P5|STARTED|Overall Study||56
8503686|NCT00479466|20957042|P4|STARTED|Overall Study||58
8503687|NCT00479466|20957043|P3|STARTED|Overall Study||57
8503688|NCT00479466|20957044|P2|STARTED|Overall Study||57
8503689|NCT00479466|20957045|P1|STARTED|Overall Study||57
8503690|NCT00479401|20957074|P3|NOT COMPLETED|Overall Study||12
8503691|NCT00479401|20957075|P2|NOT COMPLETED|Overall Study||37
8503692|NCT00479401|20957076|P1|NOT COMPLETED|Overall Study||49
8503693|NCT00479401|20957074|P3|COMPLETED|Overall Study||91
8503694|NCT00479401|20957075|P2|COMPLETED|Overall Study||176
8503695|NCT00479401|20957076|P1|COMPLETED|Overall Study||174
8503696|NCT00479401|20957074|P3|STARTED|Overall Study||103
8503697|NCT00479401|20957075|P2|STARTED|Overall Study||213
8503698|NCT00479401|20957076|P1|STARTED|Overall Study||223
8503699|NCT00479388|20957131|P2|NOT COMPLETED|Overall Study||73
8503700|NCT00479388|20957132|P1|NOT COMPLETED|Overall Study||132
8503701|NCT00479388|20957131|P2|COMPLETED|Overall Study||537
8503702|NCT00479388|20957132|P1|COMPLETED|Overall Study||474
8503703|NCT00479388|20957131|P2|STARTED|Overall Study||610
8503704|NCT00479388|20957132|P1|STARTED|Overall Study||606
8503705|NCT00479336|20957146|P4|NOT COMPLETED|Overall Study||5
8503706|NCT00479336|20957147|P3|NOT COMPLETED|Overall Study||1
8503707|NCT00479336|20957148|P2|NOT COMPLETED|Overall Study||6
8503708|NCT00479336|20957149|P1|NOT COMPLETED|Overall Study||4
8503709|NCT00479336|20957146|P4|COMPLETED|Overall Study||21
8503710|NCT00479336|20957147|P3|COMPLETED|Overall Study||24
8503711|NCT00479336|20957148|P2|COMPLETED|Overall Study||20
8503712|NCT00479336|20957149|P1|COMPLETED|Overall Study||23
8503713|NCT00479336|20957146|P4|STARTED|Overall Study||26
8503714|NCT00479336|20957147|P3|STARTED|Overall Study||25
8503715|NCT00479336|20957148|P2|STARTED|Overall Study||26
8503716|NCT00479336|20957149|P1|STARTED|Overall Study||27
8503717|NCT00479258|20957165|P2|NOT COMPLETED|Overall Study||0
8503718|NCT00479258|20957166|P1|NOT COMPLETED|Overall Study||0
8503719|NCT00479258|20957165|P2|COMPLETED|Overall Study||0
8503720|NCT00479258|20957166|P1|COMPLETED|Overall Study||0
8503721|NCT00479258|20957165|P2|STARTED|Overall Study||0
8503722|NCT00479258|20957166|P1|STARTED|Overall Study||0
8503723|NCT00479232|20957172|P6|NOT COMPLETED|Overall Study||30
8503724|NCT00479232|20957173|P5|NOT COMPLETED|Overall Study||4
8503725|NCT00479232|20957174|P4|NOT COMPLETED|Overall Study||3
8503726|NCT00479232|20957175|P3|NOT COMPLETED|Overall Study||28
8503727|NCT00479232|20957176|P2|NOT COMPLETED|Overall Study||3
8503728|NCT00479232|20957177|P1|NOT COMPLETED|Overall Study||3
8503729|NCT00479232|20957172|P6|COMPLETED|Overall Study||0
8503730|NCT00479232|20957173|P5|COMPLETED|Overall Study||0
8503731|NCT00479232|20957174|P4|COMPLETED|Overall Study||0
8503732|NCT00479232|20957175|P3|COMPLETED|Overall Study||0
8503733|NCT00479232|20957176|P2|COMPLETED|Overall Study||0
8503734|NCT00479232|20957177|P1|COMPLETED|Overall Study||0
8503735|NCT00479232|20957172|P6|STARTED|Overall Study||30
8503736|NCT00479232|20957173|P5|STARTED|Overall Study||4
8503737|NCT00479232|20957174|P4|STARTED|Overall Study||3
8503738|NCT00479232|20957175|P3|STARTED|Overall Study||28
8503739|NCT00479232|20957176|P2|STARTED|Overall Study||3
8503740|NCT00479232|20957177|P1|STARTED|Overall Study||3
8503741|NCT00479154|20957197|P2|NOT COMPLETED|Overall Study||0
8503742|NCT00479154|20957198|P1|NOT COMPLETED|Overall Study||0
8503743|NCT00479154|20957197|P2|COMPLETED|Overall Study||3
8503744|NCT00479154|20957198|P1|COMPLETED|Overall Study||3
8503745|NCT00479154|20957197|P2|STARTED|Overall Study||3
8503746|NCT00479154|20957198|P1|STARTED|Overall Study||3
8503747|NCT00479115|20957204|P1|NOT COMPLETED|Overall Study||0
8503748|NCT00479115|20957204|P1|COMPLETED|Overall Study||1
8503749|NCT00479115|20957204|P1|STARTED|Overall Study||1
8503750|NCT00479089|20957215|P2|NOT COMPLETED|Overall Study||0
8503751|NCT00479089|20957216|P1|NOT COMPLETED|Overall Study||0
8503752|NCT00479089|20957215|P2|COMPLETED|Overall Study||25
8503753|NCT00479089|20957216|P1|COMPLETED|Overall Study||25
8503754|NCT00479089|20957215|P2|STARTED|Overall Study||25
8503755|NCT00479089|20957216|P1|STARTED|Overall Study||25
8503756|NCT00479037|20957228|P2|NOT COMPLETED|Overall Study||6
8503757|NCT00479037|20957229|P1|NOT COMPLETED|Overall Study||3
8503758|NCT00479037|20957228|P2|COMPLETED|Overall Study||34
8503759|NCT00479037|20957229|P1|COMPLETED|Overall Study||38
8503760|NCT00479037|20957228|P2|STARTED|Overall Study||40
8503761|NCT00479037|20957229|P1|STARTED|Overall Study||41
8503762|NCT00478933|20957239|P1|NOT COMPLETED|Overall Study||78
8503763|NCT00478933|20957239|P1|COMPLETED|Overall Study||1145
8503764|NCT00478933|20957239|P1|STARTED|Overall Study||1223
8503765|NCT00478881|20957265|P2|NOT COMPLETED|Overall Study||22
8503766|NCT00478881|20957266|P1|NOT COMPLETED|Overall Study||39
8503767|NCT00478881|20957265|P2|COMPLETED|Overall Study||176
8503768|NCT00478881|20957266|P1|COMPLETED|Overall Study||160
8503769|NCT00478881|20957265|P2|Received Medication|Overall Study||198
8503770|NCT00478881|20957266|P1|Received Medication|Overall Study||198
8503771|NCT00478881|20957265|P2|STARTED|Overall Study||198
8503772|NCT00478881|20957266|P1|STARTED|Overall Study||199
8503773|NCT00478777|20957290|P1|NOT COMPLETED|Overall Study||77
8503774|NCT00478777|20957290|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
8503775|NCT00478777|20957290|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
8503776|NCT00478777|20957290|P1|STARTED|Overall Study||150
8503777|NCT00478673|20957297|P1|NOT COMPLETED|12-Months Post-Procedure||64
8503778|NCT00478673|20957297|P1|COMPLETED|12-Months Post-Procedure||231
8503779|NCT00478673|20957297|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
8503780|NCT00478673|20957297|P1|NOT COMPLETED|30-Days Post-Procedure||10
8503781|NCT00478673|20957297|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
8503782|NCT00478673|20957297|P1|STARTED|30-Days Post-Procedure||298
8503783|NCT00478647|20957302|P1|NOT COMPLETED|Overall Study||2
8503784|NCT00478647|20957302|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
8503785|NCT00478647|20957302|P1|STARTED|Overall Study||40
8503786|NCT00478608|20957310|P1|NOT COMPLETED|Overall Study||20
8503787|NCT00478608|20957310|P1|COMPLETED|Overall Study||59
8503788|NCT00478608|20957310|P1|STARTED|Overall Study||79
8503789|NCT00478569|20957318|P1|NOT COMPLETED|Overall Study||409
8503790|NCT00478569|20957318|P1|COMPLETED|Overall Study||761
8503791|NCT00478569|20957318|P1|STARTED|Overall Study||1170
8503792|NCT00478556|20957334|P2|NOT COMPLETED|Overall Study||0
8503793|NCT00478556|20957335|P1|NOT COMPLETED|Overall Study||0
8503794|NCT00478556|20957334|P2|COMPLETED|Overall Study||149
8503795|NCT00478556|20957335|P1|COMPLETED|Overall Study||151
8503796|NCT00478556|20957334|P2|STARTED|Overall Study||149
8503797|NCT00478556|20957335|P1|STARTED|Overall Study||151
8503798|NCT00478426|20957343|P1|NOT COMPLETED|Overall Study||1
8503799|NCT00478426|20957343|P1|COMPLETED|Overall Study||33
8503800|NCT00478426|20957343|P1|STARTED|Overall Study||34
8503801|NCT00478361|20957351|P1|NOT COMPLETED|Overall Study||0
8503802|NCT00478361|20957351|P1|COMPLETED|Overall Study||39
8503803|NCT00478361|20957351|P1|STARTED|Overall Study||39
8503804|NCT00478335|20957359|P2|NOT COMPLETED|Period 2 (4 Days)||0
8503805|NCT00478335|20957360|P1|NOT COMPLETED|Period 2 (4 Days)||0
8503806|NCT00478335|20957359|P2|COMPLETED|Period 2 (4 Days)||2
8503807|NCT00478335|20957360|P1|COMPLETED|Period 2 (4 Days)||2
8503808|NCT00478335|20957359|P2|STARTED|Period 2 (4 Days)||2
8503809|NCT00478335|20957360|P1|STARTED|Period 2 (4 Days)||2
8503810|NCT00478335|20957359|P2|NOT COMPLETED|Period 1 (4 Days)||0
8503811|NCT00478335|20957360|P1|NOT COMPLETED|Period 1 (4 Days)||0
8503812|NCT00478335|20957359|P2|COMPLETED|Period 1 (4 Days)||2
8503813|NCT00478335|20957360|P1|COMPLETED|Period 1 (4 Days)||2
8503814|NCT00478335|20957359|P2|STARTED|Period 1 (4 Days)||2
8503815|NCT00478335|20957360|P1|STARTED|Period 1 (4 Days)||2
8503816|NCT00478257|20957368|P2|NOT COMPLETED|Overall Study||3
8503817|NCT00478257|20957369|P1|NOT COMPLETED|Overall Study||8
8503818|NCT00478257|20957368|P2|COMPLETED|Overall Study||13
8503819|NCT00478257|20957369|P1|COMPLETED|Overall Study||15
8503820|NCT00478257|20957368|P2|STARTED|Overall Study||16
8503821|NCT00478257|20957369|P1|STARTED|Overall Study||23
8503822|NCT00478244|20957375|P1|NOT COMPLETED|Overall Study||1
8503823|NCT00478244|20957375|P1|COMPLETED|Overall Study||6
8503824|NCT00478244|20957375|P1|STARTED|Overall Study||7
8503825|NCT00478231|20957388|P1|NOT COMPLETED|Overall Study||84
8503826|NCT00478231|20957388|P1|COMPLETED|Overall Study||125
8503827|NCT00478231|20957388|P1|Treated|Overall Study||206
8503828|NCT00478231|20957388|P1|STARTED|Overall Study||209
8503829|NCT00478218|20957409|P2|NOT COMPLETED|Overall Study||0
8503830|NCT00478218|20957410|P1|NOT COMPLETED|Overall Study||0
8503831|NCT00478218|20957409|P2|COMPLETED|Overall Study||19
8503832|NCT00478218|20957410|P1|COMPLETED|Overall Study||34
8503833|NCT00478218|20957409|P2|STARTED|Overall Study||19
8503834|NCT00478218|20957410|P1|STARTED|Overall Study||34
8503835|NCT00478205|20957424|P2|NOT COMPLETED|Overall Study||87
8503836|NCT00478205|20957425|P1|NOT COMPLETED|Overall Study||296
8503837|NCT00478205|20957424|P2|COMPLETED|Overall Study||399
8503838|NCT00478205|20957425|P1|COMPLETED|Overall Study||685
8503839|NCT00478205|20957424|P2|STARTED|Overall Study||486
8503840|NCT00478205|20957425|P1|STARTED|Overall Study||981
8503841|NCT00478192|20957440|P3|NOT COMPLETED|Overall Study||2
8503842|NCT00478192|20957441|P2|NOT COMPLETED|Overall Study||5
8503843|NCT00478192|20957442|P1|NOT COMPLETED|Overall Study||4
8503844|NCT00478192|20957440|P3|COMPLETED|Overall Study||8
8503845|NCT00478192|20957441|P2|COMPLETED|Overall Study||15
8503846|NCT00478192|20957442|P1|COMPLETED|Overall Study||16
8503847|NCT00478192|20957440|P3|End of Treatment|Overall Study||8
8503848|NCT00478192|20957441|P2|End of Treatment|Overall Study||16
8503849|NCT00478192|20957442|P1|End of Treatment|Overall Study||18
8503850|NCT00478192|20957440|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
8503851|NCT00478192|20957441|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
8503852|NCT00478192|20957442|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
8503853|NCT00478192|20957440|P3|STARTED|Overall Study||10
8503854|NCT00478192|20957441|P2|STARTED|Overall Study||20
8503855|NCT00478192|20957442|P1|STARTED|Overall Study||20
8503856|NCT00478140|20957469|P1|NOT COMPLETED|Overall Study||1
8503857|NCT00478140|20957469|P1|COMPLETED|Overall Study||3
8503858|NCT00478140|20957469|P1|STARTED|Overall Study||4
8503859|NCT00478062|20957476|P1|NOT COMPLETED|Overall Study||0
8503860|NCT00478062|20957476|P1|COMPLETED|Overall Study||1
8503861|NCT00478062|20957476|P1|STARTED|Overall Study||1
8503862|NCT00478036|20957486|P3|NOT COMPLETED|Overall Study||0
8503863|NCT00478036|20957487|P2|NOT COMPLETED|Overall Study||0
8503864|NCT00478036|20957488|P1|NOT COMPLETED|Overall Study||0
8503865|NCT00478036|20957486|P3|COMPLETED|Overall Study||14
8503866|NCT00478036|20957487|P2|COMPLETED|Overall Study||7
8503867|NCT00478036|20957488|P1|COMPLETED|Overall Study||10
8503868|NCT00478036|20957486|P3|STARTED|Overall Study||14
8503869|NCT00478036|20957487|P2|STARTED|Overall Study||7
8503870|NCT00478036|20957488|P1|STARTED|Overall Study||10
8503871|NCT00478023|20957501|P5|NOT COMPLETED|Overall Study||55
8503872|NCT00478023|20957502|P4|NOT COMPLETED|Overall Study||30
8503873|NCT00478023|20957503|P3|NOT COMPLETED|Overall Study||20
8503874|NCT00478023|20957504|P2|NOT COMPLETED|Overall Study||24
8503875|NCT00478023|20957505|P1|NOT COMPLETED|Overall Study||35
8503876|NCT00478023|20957501|P5|COMPLETED|Overall Study||114
8503877|NCT00478023|20957502|P4|COMPLETED|Overall Study||146
8503878|NCT00478023|20957503|P3|COMPLETED|Overall Study||151
8503879|NCT00478023|20957504|P2|COMPLETED|Overall Study||144
8503880|NCT00478023|20957505|P1|COMPLETED|Overall Study||135
8503881|NCT00478023|20957501|P5|STARTED|Overall Study||169
8503882|NCT00478023|20957502|P4|STARTED|Overall Study||176
8503883|NCT00478023|20957503|P3|STARTED|Overall Study||171
8503884|NCT00478023|20957504|P2|STARTED|Overall Study||168
8503885|NCT00478023|20957505|P1|STARTED|Overall Study||170
8503886|NCT00477971|20957524|P2|NOT COMPLETED|Overall Study||6
8503887|NCT00477971|20957525|P1|NOT COMPLETED|Overall Study||17
8503888|NCT00477971|20957524|P2|COMPLETED|Overall Study||49
8503889|NCT00477971|20957525|P1|COMPLETED|Overall Study||17
8503890|NCT00477971|20957524|P2|STARTED|Overall Study||55
8503891|NCT00477971|20957525|P1|STARTED|Overall Study||34
8503892|NCT00477750|20957537|P1|NOT COMPLETED|Overall Study||11
8503893|NCT00477750|20957537|P1|COMPLETED|Overall Study||15
8503894|NCT00477750|20957537|P1|STARTED|Overall Study||26
8503895|NCT00477685|20957545|P1|NOT COMPLETED|Overall Study||0
8503896|NCT00477685|20957545|P1|COMPLETED|Overall Study||10
8503897|NCT00477685|20957545|P1|STARTED|Overall Study||10
8503898|NCT00477672|20957553|P3|NOT COMPLETED|Overall Study||16
8503899|NCT00477672|20957554|P2|NOT COMPLETED|Overall Study||16
8503900|NCT00477672|20957555|P1|NOT COMPLETED|Overall Study||7
8503901|NCT00477672|20957553|P3|COMPLETED|Overall Study||83
8503902|NCT00477672|20957554|P2|COMPLETED|Overall Study||85
8503903|NCT00477672|20957555|P1|COMPLETED|Overall Study||91
8503904|NCT00477672|20957553|P3|STARTED|Overall Study||99
8503905|NCT00477672|20957554|P2|STARTED|Overall Study||101
8503906|NCT00477672|20957555|P1|STARTED|Overall Study||98
8503907|NCT00477633|20957566|P1|NOT COMPLETED|Overall Study||709
8503908|NCT00477633|20957566|P1|COMPLETED|Overall Study||991
8503909|NCT00477633|20957566|P1|STARTED|Overall Study||1700
8503910|NCT00477607|20957574|P2|NOT COMPLETED|Overall Study||7
8503911|NCT00477607|20957575|P1|NOT COMPLETED|Overall Study||7
8503912|NCT00477607|20957574|P2|COMPLETED|Overall Study||13
8503913|NCT00477607|20957575|P1|COMPLETED|Overall Study||12
8503914|NCT00477607|20957574|P2|STARTED|Overall Study||20
8503915|NCT00477607|20957575|P1|STARTED|Overall Study||19
8503916|NCT00477594|20957587|P2|NOT COMPLETED|Follow-up Period||1
8503917|NCT00477594|20957588|P1|NOT COMPLETED|Follow-up Period||3
8503918|NCT00477594|20957587|P2|COMPLETED|Follow-up Period||4
8503919|NCT00477594|20957588|P1|COMPLETED|Follow-up Period||13
8503920|NCT00477594|20957587|P2|STARTED|Follow-up Period||5
8503921|NCT00477594|20957588|P1|STARTED|Follow-up Period||16
8503922|NCT00477594|20957587|P2|NOT COMPLETED|Year 3||0
8503923|NCT00477594|20957588|P1|NOT COMPLETED|Year 3||2
8503924|NCT00477594|20957587|P2|COMPLETED|Year 3||0
8503925|NCT00477594|20957588|P1|COMPLETED|Year 3||2
8503926|NCT00477594|20957587|P2|STARTED|Year 3||0
8503927|NCT00477594|20957588|P1|STARTED|Year 3||4
8503928|NCT00477594|20957587|P2|NOT COMPLETED|Year 1 and Year 2||4
8503929|NCT00477594|20957588|P1|NOT COMPLETED|Year 1 and Year 2||9
8503930|NCT00477594|20957587|P2|COMPLETED|Year 1 and Year 2||1
8503931|NCT00477594|20957588|P1|COMPLETED|Year 1 and Year 2||7
8503932|NCT00477594|20957587|P2|STARTED|Year 1 and Year 2||5
8503933|NCT00477594|20957588|P1|STARTED|Year 1 and Year 2||16
8503934|NCT00477490|20957649|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
8503935|NCT00477490|20957650|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
8503936|NCT00477490|20957651|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
8503937|NCT00477490|20957652|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
8503938|NCT00477490|20957653|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
8503939|NCT00477490|20957654|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
8503940|NCT00477490|20957655|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
8503941|NCT00477490|20957656|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
8503942|NCT00477490|20957657|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
8503943|NCT00477490|20957649|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
8503944|NCT00477490|20957650|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
8503945|NCT00477490|20957651|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
8503946|NCT00477490|20957652|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
8503947|NCT00477490|20957653|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
8503948|NCT00477490|20957654|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
8503949|NCT00477490|20957655|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
8503950|NCT00477490|20957656|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
8503951|NCT00477490|20957657|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
8503952|NCT00477490|20957649|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
8503953|NCT00477490|20957650|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
8503954|NCT00477490|20957651|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
8503955|NCT00477490|20957652|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
8503956|NCT00477490|20957653|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
8503957|NCT00477490|20957654|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
8503958|NCT00477490|20957655|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
8503959|NCT00477490|20957656|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
8503960|NCT00477490|20957657|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
8503961|NCT00477490|20957649|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503962|NCT00477490|20957650|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503963|NCT00477490|20957651|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503964|NCT00477490|20957652|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503965|NCT00477490|20957653|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
8503966|NCT00477490|20957654|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
8503967|NCT00477490|20957655|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
8503968|NCT00477490|20957656|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
8503969|NCT00477490|20957657|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
8503970|NCT00477490|20957649|P9|COMPLETED|Part I: 4 Week Efficacy||0
8503971|NCT00477490|20957650|P8|COMPLETED|Part I: 4 Week Efficacy||0
8503972|NCT00477490|20957651|P7|COMPLETED|Part I: 4 Week Efficacy||0
8503973|NCT00477490|20957652|P6|COMPLETED|Part I: 4 Week Efficacy||0
8503974|NCT00477490|20957653|P5|COMPLETED|Part I: 4 Week Efficacy||135
8503975|NCT00477490|20957654|P4|COMPLETED|Part I: 4 Week Efficacy||138
8503976|NCT00477490|20957655|P3|COMPLETED|Part I: 4 Week Efficacy||148
8503977|NCT00477490|20957656|P2|COMPLETED|Part I: 4 Week Efficacy||144
8503978|NCT00477490|20957657|P1|COMPLETED|Part I: 4 Week Efficacy||145
8503979|NCT00477490|20957649|P9|ITT Population|Part I: 4 Week Efficacy||0
8503980|NCT00477490|20957650|P8|ITT Population|Part I: 4 Week Efficacy||0
8503981|NCT00477490|20957651|P7|ITT Population|Part I: 4 Week Efficacy||0
8503982|NCT00477490|20957652|P6|ITT Population|Part I: 4 Week Efficacy||0
8503983|NCT00477490|20957653|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
8503984|NCT00477490|20957654|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
8503985|NCT00477490|20957655|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
8503986|NCT00477490|20957656|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
8503987|NCT00477490|20957657|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
8503988|NCT00477490|20957649|P9|STARTED|Part I: 4 Week Efficacy||0
8503989|NCT00477490|20957650|P8|STARTED|Part I: 4 Week Efficacy||0
8503990|NCT00477490|20957651|P7|STARTED|Part I: 4 Week Efficacy||0
8503991|NCT00477490|20957652|P6|STARTED|Part I: 4 Week Efficacy||0
8503992|NCT00477490|20957653|P5|STARTED|Part I: 4 Week Efficacy||160
8503993|NCT00477490|20957654|P4|STARTED|Part I: 4 Week Efficacy||158
8503994|NCT00477490|20957655|P3|STARTED|Part I: 4 Week Efficacy||158
8503995|NCT00477490|20957656|P2|STARTED|Part I: 4 Week Efficacy||163
8503996|NCT00477490|20957657|P1|STARTED|Part I: 4 Week Efficacy||160
8503997|NCT00477464|20957741|P1|NOT COMPLETED|Overall Study||51
8503998|NCT00477464|20957741|P1|COMPLETED|Overall Study||0
8503999|NCT00477464|20957741|P1|STARTED|Overall Study||51
8504000|NCT00477451|20957768|P4|NOT COMPLETED|Overall Study||0
8504001|NCT00477451|20957769|P3|NOT COMPLETED|Overall Study||0
8504002|NCT00477451|20957770|P2|NOT COMPLETED|Overall Study||0
8504003|NCT00477451|20957771|P1|NOT COMPLETED|Overall Study||0
8504004|NCT00477451|20957768|P4|COMPLETED|Overall Study||2
8504005|NCT00477451|20957769|P3|COMPLETED|Overall Study||7
8504006|NCT00477451|20957770|P2|COMPLETED|Overall Study||20
8504007|NCT00477451|20957771|P1|COMPLETED|Overall Study||20
8504008|NCT00477451|20957768|P4|STARTED|Overall Study||2
8504009|NCT00477451|20957769|P3|STARTED|Overall Study||7
8504010|NCT00477451|20957770|P2|STARTED|Overall Study||20
8504011|NCT00477451|20957771|P1|STARTED|Overall Study||20
8504012|NCT00477386|20957785|P2|NOT COMPLETED|Overall Study||17
8504013|NCT00477386|20957786|P1|NOT COMPLETED|Overall Study||11
8504014|NCT00477386|20957785|P2|COMPLETED|Overall Study||0
8504015|NCT00477386|20957786|P1|COMPLETED|Overall Study||0
8504016|NCT00477386|20957785|P2|STARTED|Overall Study||17
8504017|NCT00477386|20957786|P1|STARTED|Overall Study||11
8504018|NCT00477334|20957796|P2|NOT COMPLETED|Overall Study||76
8504019|NCT00477334|20957797|P1|NOT COMPLETED|Overall Study||170
8504020|NCT00477334|20957796|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
8504021|NCT00477334|20957797|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
8504022|NCT00477334|20957796|P2|Modified Intent to Treat Population|Overall Study||78
8504023|NCT00477334|20957797|P1|Modified Intent to Treat Population|Overall Study||152
8504024|NCT00477334|20957796|P2|Participants Completing First Recurrence|Overall Study||92
8504025|NCT00477334|20957797|P1|Participants Completing First Recurrence|Overall Study||187
8504026|NCT00477334|20957796|P2|Intent to Treat Population|Overall Study||98
8504027|NCT00477334|20957797|P1|Intent to Treat Population|Overall Study||201
8504028|NCT00477334|20957796|P2|Randomized and Took Study Drug|Overall Study||98
8504029|NCT00477334|20957797|P1|Randomized and Took Study Drug|Overall Study||206
8504030|NCT00477334|20957796|P2|STARTED|Overall Study||151
8504031|NCT00477334|20957797|P1|STARTED|Overall Study||312
8504032|NCT00477295|20957823|P2|NOT COMPLETED|Overall Study||109
8504033|NCT00477295|20957824|P1|NOT COMPLETED|Overall Study||121
8504034|NCT00477295|20957823|P2|COMPLETED|Overall Study||192
8504035|NCT00477295|20957824|P1|COMPLETED|Overall Study||161
8504036|NCT00477295|20957823|P2|STARTED|Overall Study||301
8504037|NCT00477295|20957824|P1|STARTED|Overall Study||282
8504038|NCT00477269|20957852|P3|NOT COMPLETED|Open Label Extension||13
8504039|NCT00477269|20957853|P2|NOT COMPLETED|Open Label Extension||0
8504040|NCT00477269|20957854|P1|NOT COMPLETED|Open Label Extension||0
8504041|NCT00477269|20957852|P3|COMPLETED|Open Label Extension||9
8504042|NCT00477269|20957853|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
8504043|NCT00477269|20957854|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
8504044|NCT00477269|20957852|P3|STARTED|Open Label Extension||22
8504045|NCT00477269|20957853|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
8504046|NCT00477269|20957854|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
8504047|NCT00477269|20957852|P3|NOT COMPLETED|Core Study||0
8504048|NCT00477269|20957853|P2|NOT COMPLETED|Core Study||8
8504049|NCT00477269|20957854|P1|NOT COMPLETED|Core Study||9
8504050|NCT00477269|20957852|P3|COMPLETED|Core Study||0
8504051|NCT00477269|20957853|P2|COMPLETED|Core Study||23
8504052|NCT00477269|20957854|P1|COMPLETED|Core Study||19
8504053|NCT00477269|20957852|P3|STARTED|Core Study||0
8504054|NCT00477269|20957853|P2|STARTED|Core Study||31
8504055|NCT00477269|20957854|P1|STARTED|Core Study||28
8504056|NCT00477230|20957908|P2|NOT COMPLETED|Overall Study||31
8504057|NCT00477230|20957909|P1|NOT COMPLETED|Overall Study||20
8504058|NCT00477230|20957908|P2|COMPLETED|Overall Study||1
8504059|NCT00477230|20957909|P1|COMPLETED|Overall Study||12
8504060|NCT00477230|20957908|P2|STARTED|Overall Study||32
8504061|NCT00477230|20957909|P1|STARTED|Overall Study||32
8504062|NCT00477204|20957917|P2|NOT COMPLETED|Overall Study||0
8504063|NCT00477204|20957918|P1|NOT COMPLETED|Overall Study||0
8504064|NCT00477204|20957917|P2|COMPLETED|Overall Study||5
8504065|NCT00477204|20957918|P1|COMPLETED|Overall Study||4
8504066|NCT00477204|20957917|P2|STARTED|Overall Study||5
8504067|NCT00477204|20957918|P1|STARTED|Overall Study||4
8504068|NCT00477191|20957924|P1|NOT COMPLETED|Overall Study||5
8504069|NCT00477191|20957924|P1|COMPLETED|Overall Study||13
8504070|NCT00477191|20957924|P1|STARTED|Overall Study||18
8504071|NCT00477165|20957933|P2|NOT COMPLETED|Overall Study||2
8504072|NCT00477165|20957934|P1|NOT COMPLETED|Overall Study||7
8504073|NCT00477165|20957933|P2|COMPLETED|Overall Study||25
8504074|NCT00477165|20957934|P1|COMPLETED|Overall Study||20
8504075|NCT00477165|20957933|P2|STARTED|Overall Study||27
8504076|NCT00477165|20957934|P1|STARTED|Overall Study||27
8504077|NCT00477152|20957946|P1|NOT COMPLETED|Overall Study||3
8504078|NCT00477152|20957946|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
8504079|NCT00477152|20957946|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
8504080|NCT00477087|20957953|P1|NOT COMPLETED|Overall Study||0
8504081|NCT00477087|20957953|P1|COMPLETED|Overall Study||10
8504082|NCT00477087|20957953|P1|STARTED|Overall Study||10
8504083|NCT00476996|20957962|P4|NOT COMPLETED|OLE Phase (From Week 48)||664
8504084|NCT00476996|20957963|P3|NOT COMPLETED|OLE Phase (From Week 48)||0
8504085|NCT00476996|20957964|P2|NOT COMPLETED|OLE Phase (From Week 48)||0
8504086|NCT00476996|20957965|P1|NOT COMPLETED|OLE Phase (From Week 48)||0
8504087|NCT00476996|20957962|P4|COMPLETED|OLE Phase (From Week 48)||0
8504088|NCT00476996|20957963|P3|COMPLETED|OLE Phase (From Week 48)||0
8504089|NCT00476996|20957964|P2|COMPLETED|OLE Phase (From Week 48)||0
8504090|NCT00476996|20957965|P1|COMPLETED|OLE Phase (From Week 48)||0
8504091|NCT00476996|20957962|P4|STARTED|OLE Phase (From Week 48)||664
8504092|NCT00476996|20957963|P3|STARTED|OLE Phase (From Week 48)||0
8504093|NCT00476996|20957964|P2|STARTED|OLE Phase (From Week 48)||0
8504094|NCT00476996|20957965|P1|STARTED|OLE Phase (From Week 48)||0
8504095|NCT00476996|20957962|P4|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
8504096|NCT00476996|20957963|P3|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
8504097|NCT00476996|20957964|P2|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
8504098|NCT00476996|20957965|P1|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
8504099|NCT00476996|20957962|P4|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
8504100|NCT00476996|20957963|P3|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
8504101|NCT00476996|20957964|P2|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
8504102|NCT00476996|20957965|P1|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
8504103|NCT00476996|20957962|P4|STARTED|Blinded Treatment Phase (up to Week 48)||0
8504104|NCT00476996|20957963|P3|STARTED|Blinded Treatment Phase (up to Week 48)||282
8504105|NCT00476996|20957964|P2|STARTED|Blinded Treatment Phase (up to Week 48)||277
8504106|NCT00476996|20957965|P1|STARTED|Blinded Treatment Phase (up to Week 48)||277
8504107|NCT00476957|20957997|P2|NOT COMPLETED|Overall Study||193
8504108|NCT00476957|20957998|P1|NOT COMPLETED|Overall Study||176
8504109|NCT00476957|20957997|P2|COMPLETED|Overall Study||4159
8504110|NCT00476957|20957998|P1|COMPLETED|Overall Study||4181
8504111|NCT00476957|20957997|P2|STARTED|Overall Study||4352
8504112|NCT00476957|20957998|P1|STARTED|Overall Study||4357
8504113|NCT00476827|20958012|P6|NOT COMPLETED|Overall Study||0
8504114|NCT00476827|20958013|P5|NOT COMPLETED|Overall Study||0
8504115|NCT00476827|20958014|P4|NOT COMPLETED|Overall Study||0
8504116|NCT00476827|20958015|P3|NOT COMPLETED|Overall Study||0
8504117|NCT00476827|20958016|P2|NOT COMPLETED|Overall Study||0
8504118|NCT00476827|20958017|P1|NOT COMPLETED|Overall Study||0
8504119|NCT00476827|20958012|P6|COMPLETED|Overall Study||2
8504120|NCT00476827|20958013|P5|COMPLETED|Overall Study||2
8504121|NCT00476827|20958014|P4|COMPLETED|Overall Study||0
8504122|NCT00476827|20958015|P3|COMPLETED|Overall Study||1
8504123|NCT00476827|20958016|P2|COMPLETED|Overall Study||0
8504124|NCT00476827|20958017|P1|COMPLETED|Overall Study||3
8504125|NCT00476827|20958012|P6|STARTED|Overall Study||2
8504126|NCT00476827|20958013|P5|STARTED|Overall Study||2
8504127|NCT00476827|20958014|P4|STARTED|Overall Study||0
8504128|NCT00476827|20958015|P3|STARTED|Overall Study||1
8504129|NCT00476827|20958016|P2|STARTED|Overall Study||0
8504130|NCT00476827|20958017|P1|STARTED|Overall Study||3
8504131|NCT00476788|20958047|P1|NOT COMPLETED|Overall Study||3
8504132|NCT00476788|20958047|P1|COMPLETED|Overall Study||11
8504133|NCT00476788|20958047|P1|STARTED|Overall Study||14
8504134|NCT00476645|20958052|P1|NOT COMPLETED|Overall Study||0
8504135|NCT00476645|20958052|P1|COMPLETED|Overall Study||10
8504136|NCT00476645|20958052|P1|STARTED|Overall Study||10
8504137|NCT00476593|20958062|P4|NOT COMPLETED|Overall Study||22
8504138|NCT00476593|20958063|P3|NOT COMPLETED|Overall Study||8
8504139|NCT00476593|20958064|P2|NOT COMPLETED|Overall Study||2
8504140|NCT00476593|20958065|P1|NOT COMPLETED|Overall Study||10
8504141|NCT00476593|20958062|P4|COMPLETED|Overall Study||107
8504142|NCT00476593|20958063|P3|COMPLETED|Overall Study||30
8504143|NCT00476593|20958064|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
8504144|NCT00476593|20958065|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
8504145|NCT00476593|20958062|P4|STARTED|Overall Study||129
8504146|NCT00476593|20958063|P3|STARTED|Overall Study||38
8504147|NCT00476593|20958064|P2|STARTED|Overall Study||19
8504148|NCT00476593|20958065|P1|STARTED|Overall Study||32
8504149|NCT00476476|20958077|P2|NOT COMPLETED|Overall Study||24
8504150|NCT00476476|20958078|P1|NOT COMPLETED|Overall Study||2
8504151|NCT00476476|20958077|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
8504152|NCT00476476|20958078|P1|COMPLETED|Overall Study||15
8504153|NCT00476476|20958077|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
8504154|NCT00476476|20958078|P1|Response Evaluable|Overall Study||17
8504155|NCT00476476|20958077|P2|STARTED|Overall Study||24
8504156|NCT00476476|20958078|P1|STARTED|Overall Study||17
8504157|NCT00476242|20958085|P2|NOT COMPLETED|Overall Study||16
8504158|NCT00476242|20958086|P1|NOT COMPLETED|Overall Study||8
8504159|NCT00476242|20958085|P2|COMPLETED|Overall Study||12
8504160|NCT00476242|20958086|P1|COMPLETED|Overall Study||19
8504161|NCT00476242|20958085|P2|STARTED|Overall Study||28
8504162|NCT00476242|20958086|P1|STARTED|Overall Study||27
8504163|NCT00476229|20958096|P1|NOT COMPLETED|Overall Study||1
8504164|NCT00476229|20958096|P1|COMPLETED|Overall Study||19
8504165|NCT00476229|20958096|P1|STARTED|Overall Study||20
8504166|NCT00476151|20958102|P2|NOT COMPLETED|Overall Study||7
8504167|NCT00476151|20958103|P1|NOT COMPLETED|Overall Study||3
8504168|NCT00476151|20958102|P2|COMPLETED|Overall Study||107
8504169|NCT00476151|20958103|P1|COMPLETED|Overall Study||109
8504170|NCT00476151|20958102|P2|STARTED|Overall Study||114
8504171|NCT00476151|20958103|P1|STARTED|Overall Study||112
8504172|NCT00476086|20958109|P1|NOT COMPLETED|Overall Study||5
8504173|NCT00476086|20958109|P1|COMPLETED|Overall Study||15
8504174|NCT00476086|20958109|P1|Received Radiation|Overall Study||15
8504175|NCT00476086|20958109|P1|Received Chemotherapy|Overall Study||19
8504176|NCT00476086|20958109|P1|STARTED|Overall Study||20
8504177|NCT00476047|20958115|P1|NOT COMPLETED|Overall Study||1
8504178|NCT00476047|20958115|P1|COMPLETED|Overall Study||15
8504179|NCT00476047|20958115|P1|Completed Treatment|Overall Study||16
8504180|NCT00476047|20958115|P1|STARTED|Overall Study||16
8504181|NCT00476021|20958124|P2|NOT COMPLETED|Overall Study||0
8504182|NCT00476021|20958125|P1|NOT COMPLETED|Overall Study||0
8504183|NCT00476021|20958124|P2|COMPLETED|Overall Study||51
8504184|NCT00476021|20958125|P1|COMPLETED|Overall Study||51
8504185|NCT00476021|20958124|P2|STARTED|Overall Study||51
8504186|NCT00476021|20958125|P1|STARTED|Overall Study||51
8504187|NCT00476008|20958141|P2|NOT COMPLETED|Overall Study||8
8504188|NCT00476008|20958142|P1|NOT COMPLETED|Overall Study||9
8504189|NCT00476008|20958141|P2|COMPLETED|Overall Study||13
8504190|NCT00476008|20958142|P1|COMPLETED|Overall Study||13
8504191|NCT00476008|20958141|P2|6 Month Testing|Overall Study||14
8504192|NCT00476008|20958142|P1|6 Month Testing|Overall Study||15
8504193|NCT00476008|20958141|P2|STARTED|Overall Study||21
8504194|NCT00476008|20958142|P1|STARTED|Overall Study||22
8504195|NCT00475982|20958168|P2|NOT COMPLETED|Overall Study||3
8504196|NCT00475982|20958169|P1|NOT COMPLETED|Overall Study||7
8504197|NCT00475982|20958168|P2|COMPLETED|Overall Study||18
8504198|NCT00475982|20958169|P1|COMPLETED|Overall Study||16
8504199|NCT00475982|20958168|P2|STARTED|Overall Study||21
8504200|NCT00475982|20958169|P1|STARTED|Overall Study||23
8504201|NCT00475904|20958190|P3|NOT COMPLETED|Overall Study||4
8504202|NCT00475904|20958191|P2|NOT COMPLETED|Overall Study||13
8504203|NCT00475904|20958192|P1|NOT COMPLETED|Overall Study||15
8504204|NCT00475904|20958190|P3|COMPLETED|Overall Study||72
8504205|NCT00475904|20958191|P2|COMPLETED|Overall Study||131
8504206|NCT00475904|20958192|P1|COMPLETED|Overall Study||125
8504207|NCT00475904|20958190|P3|STARTED|Overall Study||76
8504208|NCT00475904|20958191|P2|STARTED|Overall Study||144
8504209|NCT00475904|20958192|P1|STARTED|Overall Study||140
8504210|NCT00475878|20958205|P2|NOT COMPLETED|Overall Study||0
8504211|NCT00475878|20958206|P1|NOT COMPLETED|Overall Study||0
8504212|NCT00475878|20958205|P2|COMPLETED|Overall Study||72
8504213|NCT00475878|20958206|P1|COMPLETED|Overall Study||75
8504214|NCT00475878|20958205|P2|STARTED|Overall Study||72
8504215|NCT00475878|20958206|P1|STARTED|Overall Study||75
8504216|NCT00475865|20958217|P3|NOT COMPLETED|Overall Study||6
8504217|NCT00475865|20958218|P2|NOT COMPLETED|Overall Study||5
8504218|NCT00475865|20958219|P1|NOT COMPLETED|Overall Study||2
8504219|NCT00475865|20958217|P3|COMPLETED|Overall Study|completed treatment period|34
8504220|NCT00475865|20958218|P2|COMPLETED|Overall Study|completed treatment period|37
8504221|NCT00475865|20958219|P1|COMPLETED|Overall Study||39
8504222|NCT00475865|20958217|P3|Treated|Overall Study||40
8504223|NCT00475865|20958218|P2|Treated|Overall Study||42
8504224|NCT00475865|20958219|P1|Treated|Overall Study|completed treatment period|41
8504225|NCT00475865|20958217|P3|STARTED|Overall Study|randomized|40
8504226|NCT00475865|20958218|P2|STARTED|Overall Study|randomized|42
8504227|NCT00475865|20958219|P1|STARTED|Overall Study|randomized|41
8504228|NCT00475852|20958249|P2|NOT COMPLETED|Overall Study||548
8504229|NCT00475852|20958250|P1|NOT COMPLETED|Overall Study||517
8504230|NCT00475852|20958249|P2|COMPLETED|Overall Study||3029
8504231|NCT00475852|20958250|P1|COMPLETED|Overall Study||3047
8504232|NCT00475852|20958249|P2|STARTED|Overall Study||3577
8504233|NCT00475852|20958250|P1|STARTED|Overall Study||3564
8504234|NCT00475787|20958280|P2|NOT COMPLETED|Overall Study||7
8504235|NCT00475787|20958281|P1|NOT COMPLETED|Overall Study||8
8504236|NCT00475787|20958280|P2|COMPLETED|Overall Study||60
8504237|NCT00475787|20958281|P1|COMPLETED|Overall Study||61
8504238|NCT00475787|20958280|P2|STARTED|Overall Study||67
8504239|NCT00475787|20958281|P1|STARTED|Overall Study||69
8504240|NCT00475735|20958301|P6|NOT COMPLETED|Treatment Period 2||1
8504241|NCT00475735|20958302|P5|NOT COMPLETED|Treatment Period 2||1
8504242|NCT00475735|20958303|P4|NOT COMPLETED|Treatment Period 2||2
8504243|NCT00475735|20958304|P3|NOT COMPLETED|Treatment Period 2||0
8504244|NCT00475735|20958305|P2|NOT COMPLETED|Treatment Period 2||1
8504245|NCT00475735|20958306|P1|NOT COMPLETED|Treatment Period 2||0
8504246|NCT00475735|20958301|P6|COMPLETED|Treatment Period 2||13
8504247|NCT00475735|20958302|P5|COMPLETED|Treatment Period 2||15
8504248|NCT00475735|20958303|P4|COMPLETED|Treatment Period 2||4
8504249|NCT00475735|20958304|P3|COMPLETED|Treatment Period 2||7
8504250|NCT00475735|20958305|P2|COMPLETED|Treatment Period 2||9
8504251|NCT00475735|20958306|P1|COMPLETED|Treatment Period 2||10
8504252|NCT00475735|20958301|P6|STARTED|Treatment Period 2||14
8504253|NCT00475735|20958302|P5|STARTED|Treatment Period 2||16
8504254|NCT00475735|20958303|P4|STARTED|Treatment Period 2||6
8504255|NCT00475735|20958304|P3|STARTED|Treatment Period 2||7
8504256|NCT00475735|20958305|P2|STARTED|Treatment Period 2||10
8504257|NCT00475735|20958306|P1|STARTED|Treatment Period 2||10
8504258|NCT00475735|20958301|P6|NOT COMPLETED|Treatment Washout||0
8504259|NCT00475735|20958302|P5|NOT COMPLETED|Treatment Washout||0
8504260|NCT00475735|20958303|P4|NOT COMPLETED|Treatment Washout||0
8504261|NCT00475735|20958304|P3|NOT COMPLETED|Treatment Washout||0
8504262|NCT00475735|20958305|P2|NOT COMPLETED|Treatment Washout||2
8504263|NCT00475735|20958306|P1|NOT COMPLETED|Treatment Washout||0
8504264|NCT00475735|20958301|P6|COMPLETED|Treatment Washout||14
8504265|NCT00475735|20958302|P5|COMPLETED|Treatment Washout||16
8504266|NCT00475735|20958303|P4|COMPLETED|Treatment Washout||6
8504267|NCT00475735|20958304|P3|COMPLETED|Treatment Washout||7
8504268|NCT00475735|20958305|P2|COMPLETED|Treatment Washout||10
8504269|NCT00475735|20958306|P1|COMPLETED|Treatment Washout||10
8504270|NCT00475735|20958301|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
8504271|NCT00475735|20958302|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
8504272|NCT00475735|20958303|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
8504273|NCT00475735|20958304|P3|STARTED|Treatment Washout||7
8504274|NCT00475735|20958305|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
8504275|NCT00475735|20958306|P1|STARTED|Treatment Washout||10
8504276|NCT00475735|20958301|P6|NOT COMPLETED|Treatment Period 1||3
8504277|NCT00475735|20958302|P5|NOT COMPLETED|Treatment Period 1||2
8504278|NCT00475735|20958303|P4|NOT COMPLETED|Treatment Period 1||2
8504279|NCT00475735|20958304|P3|NOT COMPLETED|Treatment Period 1||0
8504280|NCT00475735|20958305|P2|NOT COMPLETED|Treatment Period 1||2
8504281|NCT00475735|20958306|P1|NOT COMPLETED|Treatment Period 1||4
8504282|NCT00475735|20958301|P6|COMPLETED|Treatment Period 1||12
8504283|NCT00475735|20958302|P5|COMPLETED|Treatment Period 1||14
8504284|NCT00475735|20958303|P4|COMPLETED|Treatment Period 1||5
8504285|NCT00475735|20958304|P3|COMPLETED|Treatment Period 1||7
8504286|NCT00475735|20958305|P2|COMPLETED|Treatment Period 1||11
8504287|NCT00475735|20958306|P1|COMPLETED|Treatment Period 1||10
8504288|NCT00475735|20958301|P6|STARTED|Treatment Period 1||15
8504289|NCT00475735|20958302|P5|STARTED|Treatment Period 1||16
8504290|NCT00475735|20958303|P4|STARTED|Treatment Period 1||7
8504291|NCT00475735|20958304|P3|STARTED|Treatment Period 1||7
8504292|NCT00475735|20958305|P2|STARTED|Treatment Period 1||13
8504293|NCT00475735|20958306|P1|STARTED|Treatment Period 1||14
8504294|NCT00475722|20958319|P2|NOT COMPLETED|Overall Study||12
8504295|NCT00475722|20958320|P1|NOT COMPLETED|Overall Study||15
8504296|NCT00475722|20958319|P2|COMPLETED|Overall Study||47
8504297|NCT00475722|20958320|P1|COMPLETED|Overall Study||46
8504298|NCT00475722|20958319|P2|STARTED|Overall Study||59
8504299|NCT00475722|20958320|P1|STARTED|Overall Study||61
8504300|NCT00475709|20958326|P1|NOT COMPLETED|Overall Study||76
8504301|NCT00475709|20958326|P1|COMPLETED|Overall Study||946
8504302|NCT00475709|20958326|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
8504303|NCT00475709|20958326|P1|STARTED|Overall Study||1022
8504304|NCT00475670|20958334|P2|NOT COMPLETED|Overall Study||41
8504305|NCT00475670|20958335|P1|NOT COMPLETED|Overall Study||3
8504306|NCT00475670|20958334|P2|COMPLETED|Overall Study||0
8504307|NCT00475670|20958335|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
8504308|NCT00475670|20958334|P2|STARTED|Overall Study||41
8504309|NCT00475670|20958335|P1|STARTED|Overall Study||3
8504310|NCT00475657|20958359|P1|NOT COMPLETED|Overall Study||4
8504311|NCT00475657|20958359|P1|COMPLETED|Overall Study||1
8504312|NCT00475657|20958359|P1|STARTED|Overall Study||5
8504313|NCT00475644|20958367|P1|NOT COMPLETED|Overall Study||13
8504314|NCT00475644|20958367|P1|COMPLETED|Overall Study||53
8504315|NCT00475644|20958367|P1|Received at Least One Dose of Study Drug|Overall Study||66
8504316|NCT00475644|20958367|P1|STARTED|Overall Study||66
8504317|NCT00475501|20958379|P4|NOT COMPLETED|Overall Study||4
8504318|NCT00475501|20958380|P3|NOT COMPLETED|Overall Study||4
8504319|NCT00475501|20958381|P2|NOT COMPLETED|Overall Study||5
8504320|NCT00475501|20958382|P1|NOT COMPLETED|Overall Study||7
8504321|NCT00475501|20958379|P4|COMPLETED|Overall Study||12
8504322|NCT00475501|20958380|P3|COMPLETED|Overall Study||13
8504323|NCT00475501|20958381|P2|COMPLETED|Overall Study||8
8504324|NCT00475501|20958382|P1|COMPLETED|Overall Study||7
8504325|NCT00475501|20958379|P4|STARTED|Overall Study||16
8504326|NCT00475501|20958380|P3|STARTED|Overall Study||17
8504327|NCT00475501|20958381|P2|STARTED|Overall Study||13
8504328|NCT00475501|20958382|P1|STARTED|Overall Study||14
8504329|NCT00475423|20958432|P1|NOT COMPLETED|Overall Study||32
8504330|NCT00475423|20958432|P1|COMPLETED|Overall Study||90
8504331|NCT00475423|20958432|P1|STARTED|Overall Study||122
8504332|NCT00475332|20958453|P1|NOT COMPLETED|Overall Study||0
8504333|NCT00475332|20958453|P1|COMPLETED|Overall Study||2
8504334|NCT00475332|20958453|P1|STARTED|Overall Study||2
8504335|NCT00475319|20958461|P3|NOT COMPLETED|Overall Study||4
8504336|NCT00475319|20958462|P2|NOT COMPLETED|Overall Study||1
8504337|NCT00475319|20958463|P1|NOT COMPLETED|Overall Study||2
8504338|NCT00475319|20958461|P3|COMPLETED|Overall Study||99
8504339|NCT00475319|20958462|P2|COMPLETED|Overall Study||101
8504340|NCT00475319|20958463|P1|COMPLETED|Overall Study||101
8504341|NCT00475319|20958461|P3|STARTED|Overall Study||103
8504342|NCT00475319|20958462|P2|STARTED|Overall Study||102
8504343|NCT00475319|20958463|P1|STARTED|Overall Study||103
8504344|NCT00475306|20958478|P4|NOT COMPLETED|Overall Study||1
8504345|NCT00475306|20958479|P3|NOT COMPLETED|Overall Study||0
8504346|NCT00475306|20958480|P2|NOT COMPLETED|Overall Study||1
8504347|NCT00475306|20958481|P1|NOT COMPLETED|Overall Study||1
8504348|NCT00475306|20958478|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
8504349|NCT00475306|20958479|P3|COMPLETED|Overall Study||72
8504350|NCT00475306|20958480|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
8504351|NCT00475306|20958481|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
8504352|NCT00475306|20958478|P4|STARTED|Overall Study||72
8504353|NCT00475306|20958479|P3|STARTED|Overall Study||72
8504354|NCT00475306|20958480|P2|STARTED|Overall Study||72
8504355|NCT00475306|20958481|P1|STARTED|Overall Study||73
8504356|NCT00475241|20958497|P2|NOT COMPLETED|Overall Study||3
8504357|NCT00475241|20958498|P1|NOT COMPLETED|Overall Study||7
8504358|NCT00475241|20958497|P2|COMPLETED|Overall Study||15
8504359|NCT00475241|20958498|P1|COMPLETED|Overall Study||11
8504360|NCT00475241|20958497|P2|STARTED|Overall Study||18
8504361|NCT00475241|20958498|P1|STARTED|Overall Study||18
8504362|NCT00475228|20958512|P2|NOT COMPLETED|Overall Study||17
8504363|NCT00475228|20958513|P1|NOT COMPLETED|Overall Study||17
8504364|NCT00475228|20958512|P2|COMPLETED|Overall Study||27
8504365|NCT00475228|20958513|P1|COMPLETED|Overall Study||27
8504366|NCT00475228|20958512|P2|STARTED|Overall Study||44
8504367|NCT00475228|20958513|P1|STARTED|Overall Study||44
8504368|NCT00475215|20958525|P2|NOT COMPLETED|Overall Study||4
8504369|NCT00475215|20958526|P1|NOT COMPLETED|Overall Study||5
8504370|NCT00475215|20958525|P2|COMPLETED|Overall Study||38
8504371|NCT00475215|20958526|P1|COMPLETED|Overall Study||39
8504372|NCT00475215|20958525|P2|Treated|Overall Study||38
8504373|NCT00475215|20958526|P1|Treated|Overall Study||39
8504374|NCT00475215|20958525|P2|STARTED|Overall Study||42
8504375|NCT00475215|20958526|P1|STARTED|Overall Study||44
8504376|NCT00475176|20958552|P1|NOT COMPLETED|Overall Study||4
8504377|NCT00475176|20958552|P1|COMPLETED|Overall Study||20
8504378|NCT00475176|20958552|P1|STARTED|Overall Study||24
8504379|NCT00475150|20958559|P2|NOT COMPLETED|Overall Study||0
8504380|NCT00475150|20958560|P1|NOT COMPLETED|Overall Study||0
8504381|NCT00475150|20958559|P2|COMPLETED|Overall Study||16
8504382|NCT00475150|20958560|P1|COMPLETED|Overall Study||23
8504383|NCT00475150|20958559|P2|STARTED|Overall Study||16
8504384|NCT00475150|20958560|P1|STARTED|Overall Study||23
8504385|NCT00475085|20958577|P4|NOT COMPLETED|Overall Study||20
8504386|NCT00475085|20958578|P3|NOT COMPLETED|Overall Study||19
8504387|NCT00475085|20958579|P2|NOT COMPLETED|Overall Study||20
8504388|NCT00475085|20958580|P1|NOT COMPLETED|Overall Study||18
8504389|NCT00475085|20958577|P4|COMPLETED|Overall Study||234
8504390|NCT00475085|20958578|P3|COMPLETED|Overall Study||241
8504391|NCT00475085|20958579|P2|COMPLETED|Overall Study||234
8504392|NCT00475085|20958580|P1|COMPLETED|Overall Study||235
8504393|NCT00475085|20958577|P4|STARTED|Overall Study||254
8504394|NCT00475085|20958578|P3|STARTED|Overall Study||260
8504395|NCT00475085|20958579|P2|STARTED|Overall Study||254
8504396|NCT00475085|20958580|P1|STARTED|Overall Study||253
8504397|NCT00475033|20958592|P2|NOT COMPLETED|Toddler Dose||0
8504398|NCT00475033|20958593|P1|NOT COMPLETED|Toddler Dose||4
8504399|NCT00475033|20958592|P2|COMPLETED|Toddler Dose||282
8504400|NCT00475033|20958593|P1|COMPLETED|Toddler Dose||283
8504401|NCT00475033|20958592|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
8504402|NCT00475033|20958593|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
8504403|NCT00475033|20958592|P2|NOT COMPLETED|After the Infant Series||8
8504404|NCT00475033|20958593|P1|NOT COMPLETED|After the Infant Series||6
8504405|NCT00475033|20958592|P2|COMPLETED|After the Infant Series||282
8504406|NCT00475033|20958593|P1|COMPLETED|After the Infant Series||287
8504407|NCT00475033|20958592|P2|Withdrawn After Infant Series|After the Infant Series||8
8504408|NCT00475033|20958593|P1|Withdrawn After Infant Series|After the Infant Series||6
8504409|NCT00475033|20958592|P2|STARTED|After the Infant Series||290
8504410|NCT00475033|20958593|P1|STARTED|After the Infant Series||293
8504411|NCT00475033|20958592|P2|NOT COMPLETED|Infant Series||13
8504412|NCT00475033|20958593|P1|NOT COMPLETED|Infant Series||7
8504413|NCT00475033|20958592|P2|COMPLETED|Infant Series||290
8504414|NCT00475033|20958593|P1|COMPLETED|Infant Series||293
8504415|NCT00475033|20958592|P2|Vaccinated Dose 3|Infant Series||294
8504416|NCT00475033|20958593|P1|Vaccinated Dose 3|Infant Series||293
8504417|NCT00475033|20958592|P2|Vaccinated Dose 2|Infant Series||296
8504418|NCT00475033|20958593|P1|Vaccinated Dose 2|Infant Series||297
8504419|NCT00475033|20958592|P2|Vaccinated Dose 1|Infant Series||303
8504420|NCT00475033|20958593|P1|Vaccinated Dose 1|Infant Series||300
8504421|NCT00475033|20958592|P2|STARTED|Infant Series||303
8504422|NCT00475033|20958593|P1|STARTED|Infant Series||300
8504423|NCT00475020|20958641|P1|NOT COMPLETED|Overall Study||5
8504424|NCT00475020|20958641|P1|COMPLETED|Overall Study||58
8504425|NCT00475020|20958641|P1|STARTED|Overall Study||63
8504426|NCT00474994|20958646|P1|NOT COMPLETED|Overall Study||5
8504427|NCT00474994|20958646|P1|COMPLETED|Overall Study||48
8504428|NCT00474994|20958646|P1|STARTED|Overall Study||53
8504429|NCT00474968|20958652|P2|NOT COMPLETED|Overall Study||16
8504430|NCT00474968|20958653|P1|NOT COMPLETED|Overall Study||18
8504431|NCT00474968|20958652|P2|COMPLETED|Overall Study||355
8504432|NCT00474968|20958653|P1|COMPLETED|Overall Study||348
8504433|NCT00474968|20958652|P2|STARTED|Overall Study||371
8504434|NCT00474968|20958653|P1|STARTED|Overall Study||366
8504435|NCT00474955|20958663|P1|NOT COMPLETED|Overall Study||8
8504436|NCT00474955|20958663|P1|COMPLETED|Overall Study||19
8504437|NCT00474955|20958663|P1|STARTED|Overall Study||27
8504438|NCT00474929|20958679|P5|NOT COMPLETED|Overall Study||0
8504439|NCT00474929|20958680|P4|NOT COMPLETED|Overall Study||2
8504440|NCT00474929|20958681|P3|NOT COMPLETED|Overall Study||2
8504441|NCT00474929|20958682|P2|NOT COMPLETED|Overall Study||1
8504442|NCT00474929|20958683|P1|NOT COMPLETED|Overall Study||0
8504443|NCT00474929|20958679|P5|COMPLETED|Overall Study||77
8504444|NCT00474929|20958680|P4|COMPLETED|Overall Study||5
8504445|NCT00474929|20958681|P3|COMPLETED|Overall Study||5
8504446|NCT00474929|20958682|P2|COMPLETED|Overall Study||5
8504447|NCT00474929|20958683|P1|COMPLETED|Overall Study||6
8504448|NCT00474929|20958679|P5|STARTED|Overall Study||77
8504449|NCT00474929|20958680|P4|STARTED|Overall Study||7
8504450|NCT00474929|20958681|P3|STARTED|Overall Study||7
8504451|NCT00474929|20958682|P2|STARTED|Overall Study||6
8504452|NCT00474929|20958683|P1|STARTED|Overall Study||6
8504453|NCT00474903|20958700|P3|NOT COMPLETED|Overall Study||2
8504454|NCT00474903|20958701|P2|NOT COMPLETED|Overall Study||5
8504455|NCT00474903|20958702|P1|NOT COMPLETED|Overall Study||1
8504456|NCT00474903|20958700|P3|COMPLETED|Overall Study||43
8504457|NCT00474903|20958701|P2|COMPLETED|Overall Study||42
8504458|NCT00474903|20958702|P1|COMPLETED|Overall Study||29
8504459|NCT00474903|20958700|P3|STARTED|Overall Study||45
8504460|NCT00474903|20958701|P2|STARTED|Overall Study||47
8504461|NCT00474903|20958702|P1|STARTED|Overall Study||30
8504462|NCT00474851|20958715|P2|NOT COMPLETED|Overall Study||11
8504463|NCT00474851|20958716|P1|NOT COMPLETED|Overall Study||8
8504464|NCT00474851|20958715|P2|COMPLETED|Overall Study||16
8504465|NCT00474851|20958716|P1|COMPLETED|Overall Study||18
8504466|NCT00474851|20958715|P2|Completed Baseline|Overall Study||26
8504467|NCT00474851|20958716|P1|Completed Baseline|Overall Study||25
8504468|NCT00474851|20958715|P2|STARTED|Overall Study||27
8504469|NCT00474851|20958716|P1|STARTED|Overall Study||26
8504470|NCT00474812|20958724|P1|NOT COMPLETED|Overall Study||7
8504471|NCT00474812|20958724|P1|COMPLETED|Overall Study||44
8504472|NCT00474812|20958724|P1|STARTED|Overall Study||51
8504473|NCT00474786|20958734|P2|NOT COMPLETED|Overall Study||253
8504474|NCT00474786|20958735|P1|NOT COMPLETED|Overall Study||259
8504475|NCT00474786|20958734|P2|COMPLETED|Overall Study||0
8504476|NCT00474786|20958735|P1|COMPLETED|Overall Study||0
8504477|NCT00474786|20958734|P2|STARTED|Overall Study||253
8504478|NCT00474786|20958735|P1|STARTED|Overall Study||259
8504479|NCT00474760|20958760|P7|NOT COMPLETED|Overall Study||10
8504480|NCT00474760|20958761|P6|NOT COMPLETED|Overall Study||29
8504481|NCT00474760|20958762|P5|NOT COMPLETED|Overall Study||12
8504482|NCT00474760|20958763|P4|NOT COMPLETED|Overall Study||3
8504483|NCT00474760|20958764|P3|NOT COMPLETED|Overall Study||3
8504484|NCT00474760|20958765|P2|NOT COMPLETED|Overall Study||3
8504485|NCT00474760|20958766|P1|NOT COMPLETED|Overall Study||3
8504486|NCT00474760|20958760|P7|COMPLETED|Overall Study||1
8504487|NCT00474760|20958761|P6|COMPLETED|Overall Study||0
8504488|NCT00474760|20958762|P5|COMPLETED|Overall Study||1
8504489|NCT00474760|20958763|P4|COMPLETED|Overall Study||0
8504490|NCT00474760|20958764|P3|COMPLETED|Overall Study||0
8504491|NCT00474760|20958765|P2|COMPLETED|Overall Study||0
8504492|NCT00474760|20958766|P1|COMPLETED|Overall Study||0
8504493|NCT00474760|20958760|P7|STARTED|Overall Study||11
8504494|NCT00474760|20958761|P6|STARTED|Overall Study||29
8504495|NCT00474760|20958762|P5|STARTED|Overall Study||13
8504496|NCT00474760|20958763|P4|STARTED|Overall Study||3
8504497|NCT00474760|20958764|P3|STARTED|Overall Study||3
8504498|NCT00474760|20958765|P2|STARTED|Overall Study||3
8504499|NCT00474760|20958766|P1|STARTED|Overall Study||3
8504500|NCT00474708|20958873|P2|NOT COMPLETED|Overall Study||25
8504501|NCT00474708|20958874|P1|NOT COMPLETED|Overall Study||57
8504502|NCT00474708|20958873|P2|COMPLETED|Overall Study||342
8504503|NCT00474708|20958874|P1|COMPLETED|Overall Study||734
8504504|NCT00474708|20958873|P2|STARTED|Overall Study||367
8504505|NCT00474708|20958874|P1|STARTED|Overall Study||791
8504506|NCT00474630|20958884|P2|NOT COMPLETED|Overall Study||70
8504507|NCT00474630|20958885|P1|NOT COMPLETED|Overall Study||160
8504508|NCT00474630|20958884|P2|COMPLETED|Overall Study||100
8504509|NCT00474630|20958885|P1|COMPLETED|Overall Study||175
8504510|NCT00474630|20958884|P2|STARTED|Overall Study||170
8504511|NCT00474630|20958885|P1|STARTED|Overall Study||335
8504512|NCT00474617|20958942|P3|NOT COMPLETED|Overall Study||2
8504513|NCT00474617|20958943|P2|NOT COMPLETED|Overall Study||3
8504514|NCT00474617|20958944|P1|NOT COMPLETED|Overall Study||8
8504515|NCT00474617|20958942|P3|COMPLETED|Overall Study||40
8504516|NCT00474617|20958943|P2|COMPLETED|Overall Study||61
8504517|NCT00474617|20958944|P1|COMPLETED|Overall Study||48
8504518|NCT00474617|20958942|P3|Treated|Overall Study||40
8504519|NCT00474617|20958943|P2|Treated|Overall Study||62
8504520|NCT00474617|20958944|P1|Treated|Overall Study||48
8504521|NCT00474617|20958942|P3|STARTED|Overall Study||42
8504522|NCT00474617|20958943|P2|STARTED|Overall Study||64
8504523|NCT00474617|20958944|P1|STARTED|Overall Study||56
8504524|NCT00474539|20958978|P2|NOT COMPLETED|Toddler Dose||0
8504525|NCT00474539|20958979|P1|NOT COMPLETED|Toddler Dose||1
8504526|NCT00474539|20958978|P2|COMPLETED|Toddler Dose||220
8504527|NCT00474539|20958979|P1|COMPLETED|Toddler Dose||208
8504528|NCT00474539|20958978|P2|STARTED|Toddler Dose||220
8504529|NCT00474539|20958979|P1|STARTED|Toddler Dose||209
8504530|NCT00474539|20958978|P2|NOT COMPLETED|After Infant Series||0
8504531|NCT00474539|20958979|P1|NOT COMPLETED|After Infant Series||4
8504532|NCT00474539|20958978|P2|COMPLETED|After Infant Series||220
8504533|NCT00474539|20958979|P1|COMPLETED|After Infant Series||209
8504534|NCT00474539|20958978|P2|STARTED|After Infant Series||220
8504535|NCT00474539|20958979|P1|STARTED|After Infant Series||213
8504536|NCT00474539|20958978|P2|NOT COMPLETED|Infant Series||6
8504537|NCT00474539|20958979|P1|NOT COMPLETED|Infant Series||10
8504538|NCT00474539|20958978|P2|COMPLETED|Infant Series||220
8504539|NCT00474539|20958979|P1|COMPLETED|Infant Series||213
8504540|NCT00474539|20958978|P2|Vaccinated Dose 3|Infant Series||221
8504541|NCT00474539|20958979|P1|Vaccinated Dose 3|Infant Series||214
8504542|NCT00474539|20958978|P2|Vaccinated Dose 2|Infant Series||222
8504543|NCT00474539|20958979|P1|Vaccinated Dose 2|Infant Series||217
8504544|NCT00474539|20958978|P2|Vaccinated Dose 1|Infant Series||226
8504545|NCT00474539|20958979|P1|Vaccinated Dose 1|Infant Series||218
8504546|NCT00474539|20958978|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
8504547|NCT00474539|20958979|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
8504548|NCT00474526|20959044|P17|NOT COMPLETED|Overall Study||9
8504549|NCT00474526|20959045|P16|NOT COMPLETED|Overall Study||18
8504550|NCT00474526|20959046|P15|NOT COMPLETED|Overall Study||77
8504551|NCT00474526|20959047|P14|NOT COMPLETED|Overall Study||156
8504552|NCT00474526|20959048|P13|NOT COMPLETED|Overall Study||15
8504553|NCT00474526|20959049|P12|NOT COMPLETED|Overall Study||11
8504554|NCT00474526|20959050|P11|NOT COMPLETED|Overall Study||10
8504555|NCT00474526|20959051|P10|NOT COMPLETED|Overall Study||27
8504556|NCT00474526|20959052|P9|NOT COMPLETED|Overall Study||6
8504557|NCT00474526|20959053|P8|NOT COMPLETED|Overall Study||6
8504558|NCT00474526|20959054|P7|NOT COMPLETED|Overall Study||25
8504559|NCT00474526|20959055|P6|NOT COMPLETED|Overall Study||16
8504560|NCT00474526|20959056|P5|NOT COMPLETED|Overall Study||68
8504561|NCT00474526|20959057|P4|NOT COMPLETED|Overall Study||119
8504562|NCT00474526|20959058|P3|NOT COMPLETED|Overall Study||49
8504563|NCT00474526|20959059|P2|NOT COMPLETED|Overall Study||46
8504564|NCT00474526|20959060|P1|NOT COMPLETED|Overall Study||33
8504565|NCT00474526|20959044|P17|COMPLETED|Overall Study||174
8504566|NCT00474526|20959045|P16|COMPLETED|Overall Study||152
8504567|NCT00474526|20959046|P15|COMPLETED|Overall Study||281
8504568|NCT00474526|20959047|P14|COMPLETED|Overall Study||1270
8504569|NCT00474526|20959048|P13|COMPLETED|Overall Study||135
8504570|NCT00474526|20959049|P12|COMPLETED|Overall Study||139
8504571|NCT00474526|20959050|P11|COMPLETED|Overall Study||141
8504572|NCT00474526|20959051|P10|COMPLETED|Overall Study||121
8504573|NCT00474526|20959052|P9|COMPLETED|Overall Study||144
8504574|NCT00474526|20959053|P8|COMPLETED|Overall Study||145
8504575|NCT00474526|20959054|P7|COMPLETED|Overall Study||178
8504576|NCT00474526|20959055|P6|COMPLETED|Overall Study||54
8504577|NCT00474526|20959056|P5|COMPLETED|Overall Study||8
8504578|NCT00474526|20959057|P4|COMPLETED|Overall Study||561
8504579|NCT00474526|20959058|P3|COMPLETED|Overall Study||110
8504580|NCT00474526|20959059|P2|COMPLETED|Overall Study||120
8504581|NCT00474526|20959060|P1|COMPLETED|Overall Study||121
8504582|NCT00474526|20959044|P17|STARTED|Overall Study||183
8504583|NCT00474526|20959045|P16|STARTED|Overall Study||170
8504584|NCT00474526|20959046|P15|STARTED|Overall Study||358
8504585|NCT00474526|20959047|P14|STARTED|Overall Study||1426
8504586|NCT00474526|20959048|P13|STARTED|Overall Study||150
8504587|NCT00474526|20959049|P12|STARTED|Overall Study||150
8504588|NCT00474526|20959050|P11|STARTED|Overall Study||151
8504589|NCT00474526|20959051|P10|STARTED|Overall Study||148
8504590|NCT00474526|20959052|P9|STARTED|Overall Study||150
8504591|NCT00474526|20959053|P8|STARTED|Overall Study||151
8504592|NCT00474526|20959054|P7|STARTED|Overall Study||203
8504593|NCT00474526|20959055|P6|STARTED|Overall Study||70
8504594|NCT00474526|20959056|P5|STARTED|Overall Study||76
8504595|NCT00474526|20959057|P4|STARTED|Overall Study||680
8504596|NCT00474526|20959058|P3|STARTED|Overall Study||159
8504597|NCT00474526|20959059|P2|STARTED|Overall Study||166
8504598|NCT00474526|20959060|P1|STARTED|Overall Study||154
8504599|NCT00474487|20959225|P4|NOT COMPLETED|Overall Study||0
8504600|NCT00474487|20959226|P3|NOT COMPLETED|Overall Study||14
8504601|NCT00474487|20959227|P2|NOT COMPLETED|Overall Study||2
8504602|NCT00474487|20959228|P1|NOT COMPLETED|Overall Study||30
8504603|NCT00474487|20959225|P4|COMPLETED|Overall Study||109
8504604|NCT00474487|20959226|P3|COMPLETED|Overall Study||885
8504605|NCT00474487|20959227|P2|COMPLETED|Overall Study||215
8504606|NCT00474487|20959228|P1|COMPLETED|Overall Study||1576
8504607|NCT00474487|20959225|P4|STARTED|Overall Study||109
8504608|NCT00474487|20959226|P3|STARTED|Overall Study||899
8504609|NCT00474487|20959227|P2|STARTED|Overall Study||217
8504610|NCT00474487|20959228|P1|STARTED|Overall Study||1606
8504611|NCT00474383|20959248|P2|NOT COMPLETED|Extension||5
8504612|NCT00474383|20959249|P1|NOT COMPLETED|Extension||0
8504613|NCT00474383|20959248|P2|COMPLETED|Extension||0
8504614|NCT00474383|20959249|P1|COMPLETED|Extension||0
8504615|NCT00474383|20959248|P2|STARTED|Extension||5
8504616|NCT00474383|20959249|P1|STARTED|Extension||0
8504617|NCT00474383|20959248|P2|NOT COMPLETED|Between Main Study and Extension||0
8504618|NCT00474383|20959249|P1|NOT COMPLETED|Between Main Study and Extension||6
8504619|NCT00474383|20959248|P2|COMPLETED|Between Main Study and Extension||0
8504620|NCT00474383|20959249|P1|COMPLETED|Between Main Study and Extension||5
8504621|NCT00474383|20959248|P2|STARTED|Between Main Study and Extension||0
8504622|NCT00474383|20959249|P1|STARTED|Between Main Study and Extension||11
8504623|NCT00474383|20959248|P2|NOT COMPLETED|Main Study||0
8504624|NCT00474383|20959249|P1|NOT COMPLETED|Main Study||36
8504625|NCT00474383|20959248|P2|COMPLETED|Main Study||0
8504626|NCT00474383|20959249|P1|COMPLETED|Main Study||11
8504627|NCT00474383|20959248|P2|STARTED|Main Study||0
8504628|NCT00474383|20959249|P1|STARTED|Main Study||47
8504629|NCT00474266|20959264|P4|NOT COMPLETED|Overall Study||7
8504630|NCT00474266|20959265|P3|NOT COMPLETED|Overall Study||4
8504631|NCT00474266|20959266|P2|NOT COMPLETED|Overall Study||20
8504632|NCT00474266|20959267|P1|NOT COMPLETED|Overall Study||7
8504633|NCT00474266|20959264|P4|COMPLETED|Overall Study||118
8504634|NCT00474266|20959265|P3|COMPLETED|Overall Study||122
8504635|NCT00474266|20959266|P2|COMPLETED|Overall Study||354
8504636|NCT00474266|20959267|P1|COMPLETED|Overall Study||368
8504637|NCT00474266|20959264|P4|STARTED|Overall Study||125
8504638|NCT00474266|20959265|P3|STARTED|Overall Study||126
8504639|NCT00474266|20959266|P2|STARTED|Overall Study||374
8504640|NCT00474266|20959267|P1|STARTED|Overall Study||375
8504641|NCT00474253|20959371|P2|NOT COMPLETED|Overall Study||4
8504642|NCT00474253|20959372|P1|NOT COMPLETED|Overall Study||3
8504643|NCT00474253|20959371|P2|COMPLETED|Overall Study|Based on actual treatment received.|53
8504644|NCT00474253|20959372|P1|COMPLETED|Overall Study|Based on actual treatment received.|55
8504645|NCT00474253|20959371|P2|Treated|Overall Study|Based on actual treatment received.|54
8504646|NCT00474253|20959372|P1|Treated|Overall Study|Based on actual treatment received.|56
8504647|NCT00474253|20959371|P2|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
8504648|NCT00474253|20959372|P1|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
8504649|NCT00474240|20959396|P6|NOT COMPLETED|Overall Study||18
8504650|NCT00474240|20959397|P5|NOT COMPLETED|Overall Study||8
8504651|NCT00474240|20959398|P4|NOT COMPLETED|Overall Study||16
8504652|NCT00474240|20959399|P3|NOT COMPLETED|Overall Study||9
8504653|NCT00474240|20959400|P2|NOT COMPLETED|Overall Study||1
8504654|NCT00474240|20959401|P1|NOT COMPLETED|Overall Study||1
8504655|NCT00474240|20959396|P6|COMPLETED|Overall Study||8
8504656|NCT00474240|20959397|P5|COMPLETED|Overall Study||18
8504657|NCT00474240|20959398|P4|COMPLETED|Overall Study||10
8504658|NCT00474240|20959399|P3|COMPLETED|Overall Study||17
8504659|NCT00474240|20959400|P2|COMPLETED|Overall Study||25
8504660|NCT00474240|20959401|P1|COMPLETED|Overall Study||26
8504661|NCT00474240|20959396|P6|STARTED|Overall Study||26
8504662|NCT00474240|20959397|P5|STARTED|Overall Study||26
8504663|NCT00474240|20959398|P4|STARTED|Overall Study||26
8504664|NCT00474240|20959399|P3|STARTED|Overall Study||26
8504665|NCT00474240|20959400|P2|STARTED|Overall Study||26
8504666|NCT00474240|20959401|P1|STARTED|Overall Study||27
8504667|NCT00474201|20959421|P1|NOT COMPLETED|Overall Study||0
8504668|NCT00474201|20959421|P1|COMPLETED|Overall Study||15
8504669|NCT00474201|20959421|P1|STARTED|Overall Study||15
8504670|NCT00474188|20959426|P1|NOT COMPLETED|Overall Study||6
8504671|NCT00474188|20959426|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
8504672|NCT00474188|20959426|P1|STARTED|Overall Study||26
8504673|NCT00474175|20959436|P3|NOT COMPLETED|Overall Study||4
8504674|NCT00474175|20959437|P2|NOT COMPLETED|Overall Study||7
8504675|NCT00474175|20959438|P1|NOT COMPLETED|Overall Study||1
8504676|NCT00474175|20959436|P3|COMPLETED|Overall Study||225
8504677|NCT00474175|20959437|P2|COMPLETED|Overall Study||226
8504678|NCT00474175|20959438|P1|COMPLETED|Overall Study||114
8504679|NCT00474175|20959436|P3|Treated|Overall Study||228
8504680|NCT00474175|20959437|P2|Treated|Overall Study||233
8504681|NCT00474175|20959438|P1|Treated|Overall Study||115
8504682|NCT00474175|20959436|P3|STARTED|Overall Study||229
8504683|NCT00474175|20959437|P2|STARTED|Overall Study||233
8504684|NCT00474175|20959438|P1|STARTED|Overall Study||115
8504685|NCT00474123|20959475|P2|NOT COMPLETED|Overall Study||0
8504686|NCT00474123|20959476|P1|NOT COMPLETED|Overall Study||0
8504687|NCT00474123|20959475|P2|COMPLETED|Overall Study||40
8504688|NCT00474123|20959476|P1|COMPLETED|Overall Study||38
8504689|NCT00474123|20959475|P2|STARTED|Overall Study||40
8504690|NCT00474123|20959476|P1|STARTED|Overall Study||38
8504691|NCT00474058|20959502|P2|NOT COMPLETED|Overall Study||17
8504692|NCT00474058|20959503|P1|NOT COMPLETED|Overall Study||24
8504693|NCT00474058|20959502|P2|COMPLETED|Overall Study||80
8504694|NCT00474058|20959503|P1|COMPLETED|Overall Study||166
8504695|NCT00474058|20959502|P2|STARTED|Overall Study||97
8504696|NCT00474058|20959503|P1|STARTED|Overall Study||190
8504697|NCT00474045|20959517|P2|NOT COMPLETED|Overall Study||101
8504698|NCT00474045|20959518|P1|NOT COMPLETED|Overall Study||106
8504699|NCT00474045|20959517|P2|COMPLETED|Overall Study||136
8504700|NCT00474045|20959518|P1|COMPLETED|Overall Study||127
8504701|NCT00474045|20959517|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
8504702|NCT00474045|20959518|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
8504703|NCT00474045|20959517|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
8504704|NCT00474045|20959518|P1|Exposed-Pregnant Subjects|Overall Study||152
8504705|NCT00474045|20959517|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
8504706|NCT00474045|20959518|P1|Exposed-All Subjects|Overall Study||233
8504707|NCT00474045|20959517|P2|STARTED|Overall Study||237
8504708|NCT00474045|20959518|P1|STARTED|Overall Study||233
8504709|NCT00473889|20959618|P2|NOT COMPLETED|Overall Study||64
8504710|NCT00473889|20959619|P1|NOT COMPLETED|Overall Study||83
8504711|NCT00473889|20959618|P2|COMPLETED|Overall Study||63
8504712|NCT00473889|20959619|P1|COMPLETED|Overall Study||43
8504713|NCT00473889|20959618|P2|STARTED|Overall Study||127
8504714|NCT00473889|20959619|P1|STARTED|Overall Study||126
8504715|NCT00473876|20959631|P2|NOT COMPLETED|Overall Study||1
8504716|NCT00473876|20959632|P1|NOT COMPLETED|Overall Study||3
8504717|NCT00473876|20959631|P2|COMPLETED|Overall Study||22
8504718|NCT00473876|20959632|P1|COMPLETED|Overall Study||36
8504719|NCT00473876|20959631|P2|STARTED|Overall Study||23
8504720|NCT00473876|20959632|P1|STARTED|Overall Study||39
8504721|NCT00473837|20959642|P2|NOT COMPLETED|Overall Study||3
8504722|NCT00473837|20959643|P1|NOT COMPLETED|Overall Study||1
8504723|NCT00473837|20959642|P2|COMPLETED|Overall Study||43
8504724|NCT00473837|20959643|P1|COMPLETED|Overall Study||49
8504725|NCT00473837|20959642|P2|STARTED|Overall Study||46
8504726|NCT00473837|20959643|P1|STARTED|Overall Study||50
8504727|NCT00473824|20959651|P2|NOT COMPLETED|Overall Study||0
8504728|NCT00473824|20959652|P1|NOT COMPLETED|Overall Study||5
8504729|NCT00473824|20959651|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
8504730|NCT00473824|20959652|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
8504731|NCT00473824|20959651|P2|STARTED|Overall Study||2
8504732|NCT00473824|20959652|P1|STARTED|Overall Study||5
8504733|NCT00473746|20959663|P5|NOT COMPLETED|Period 2 (Phase 2)||27
8504734|NCT00473746|20959664|P4|NOT COMPLETED|Period 2 (Phase 2)||0
8504735|NCT00473746|20959665|P3|NOT COMPLETED|Period 2 (Phase 2)||0
8504736|NCT00473746|20959666|P2|NOT COMPLETED|Period 2 (Phase 2)||0
8504737|NCT00473746|20959667|P1|NOT COMPLETED|Period 2 (Phase 2)||0
8504738|NCT00473746|20959663|P5|COMPLETED|Period 2 (Phase 2)||6
8504739|NCT00473746|20959664|P4|COMPLETED|Period 2 (Phase 2)||0
8504740|NCT00473746|20959665|P3|COMPLETED|Period 2 (Phase 2)||0
8504741|NCT00473746|20959666|P2|COMPLETED|Period 2 (Phase 2)||0
8504742|NCT00473746|20959667|P1|COMPLETED|Period 2 (Phase 2)||0
8504743|NCT00473746|20959663|P5|STARTED|Period 2 (Phase 2)||33
8504744|NCT00473746|20959664|P4|STARTED|Period 2 (Phase 2)||0
8504745|NCT00473746|20959665|P3|STARTED|Period 2 (Phase 2)||0
8504746|NCT00473746|20959666|P2|STARTED|Period 2 (Phase 2)||0
8504747|NCT00473746|20959667|P1|STARTED|Period 2 (Phase 2)||0
8504748|NCT00473746|20959663|P5|NOT COMPLETED|Period 1 (Phase 1)||0
8504749|NCT00473746|20959664|P4|NOT COMPLETED|Period 1 (Phase 1)||10
8504750|NCT00473746|20959665|P3|NOT COMPLETED|Period 1 (Phase 1)||6
8504751|NCT00473746|20959666|P2|NOT COMPLETED|Period 1 (Phase 1)||9
8504752|NCT00473746|20959667|P1|NOT COMPLETED|Period 1 (Phase 1)||6
8504753|NCT00473746|20959663|P5|COMPLETED|Period 1 (Phase 1)||0
8504754|NCT00473746|20959664|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
8504755|NCT00473746|20959665|P3|COMPLETED|Period 1 (Phase 1)||0
8504756|NCT00473746|20959666|P2|COMPLETED|Period 1 (Phase 1)||0
8504757|NCT00473746|20959667|P1|COMPLETED|Period 1 (Phase 1)||0
8504758|NCT00473746|20959663|P5|STARTED|Period 1 (Phase 1)||0
8504759|NCT00473746|20959664|P4|STARTED|Period 1 (Phase 1)||12
8504760|NCT00473746|20959665|P3|STARTED|Period 1 (Phase 1)||6
8504761|NCT00473746|20959666|P2|STARTED|Period 1 (Phase 1)||9
8504762|NCT00473746|20959667|P1|STARTED|Period 1 (Phase 1)||6
8504763|NCT00473694|20959716|P4|NOT COMPLETED|Overall Study||7
8504764|NCT00473694|20959717|P3|NOT COMPLETED|Overall Study||5
8504765|NCT00473694|20959718|P2|NOT COMPLETED|Overall Study||4
8504766|NCT00473694|20959719|P1|NOT COMPLETED|Overall Study||11
8504767|NCT00473694|20959716|P4|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
8504768|NCT00473694|20959717|P3|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
8504769|NCT00473694|20959718|P2|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
8504770|NCT00473694|20959719|P1|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
8504771|NCT00473694|20959716|P4|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
8504772|NCT00473694|20959717|P3|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
8504773|NCT00473694|20959718|P2|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
8504774|NCT00473694|20959719|P1|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
8504775|NCT00473694|20959716|P4|STARTED|Overall Study||42
8504776|NCT00473694|20959717|P3|STARTED|Overall Study||51
8504777|NCT00473694|20959718|P2|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
8504778|NCT00473694|20959719|P1|STARTED|Overall Study||48
8504779|NCT00473668|20959760|P3|NOT COMPLETED|Overall Study||10
8504780|NCT00473668|20959761|P2|NOT COMPLETED|Overall Study||11
8504781|NCT00473668|20959762|P1|NOT COMPLETED|Overall Study||5
8504782|NCT00473668|20959760|P3|COMPLETED|Overall Study||89
8504783|NCT00473668|20959761|P2|COMPLETED|Overall Study||89
8504784|NCT00473668|20959762|P1|COMPLETED|Overall Study||95
8504785|NCT00473668|20959760|P3|STARTED|Overall Study||99
8504786|NCT00473668|20959761|P2|STARTED|Overall Study||100
8504787|NCT00473668|20959762|P1|STARTED|Overall Study||100
8504788|NCT00473655|20959815|P3|NOT COMPLETED|Overall Study||8
8504789|NCT00473655|20959816|P2|NOT COMPLETED|Overall Study||5
8504790|NCT00473655|20959817|P1|NOT COMPLETED|Overall Study||9
8504791|NCT00473655|20959815|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
8504792|NCT00473655|20959816|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
8504793|NCT00473655|20959817|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
8504794|NCT00473655|20959815|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
8504795|NCT00473655|20959816|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
8504796|NCT00473655|20959817|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
8504797|NCT00473642|20959852|P3|NOT COMPLETED|Overall Study||2
8504798|NCT00473642|20959853|P2|NOT COMPLETED|Overall Study||1
8504799|NCT00473642|20959854|P1|NOT COMPLETED|Overall Study||2
8504800|NCT00473642|20959852|P3|COMPLETED|Overall Study||8
8504801|NCT00473642|20959853|P2|COMPLETED|Overall Study||10
8504802|NCT00473642|20959854|P1|COMPLETED|Overall Study||8
8504803|NCT00473642|20959852|P3|STARTED|Overall Study||10
8504804|NCT00473642|20959853|P2|STARTED|Overall Study||11
8504805|NCT00473642|20959854|P1|STARTED|Overall Study||10
8504806|NCT00473590|20959878|P2|NOT COMPLETED|Overall Study||38
8504807|NCT00473590|20959879|P1|NOT COMPLETED|Overall Study||45
8504808|NCT00473590|20959878|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
8504809|NCT00473590|20959879|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
8504810|NCT00473590|20959878|P2|Safety Population|Overall Study||50
8504811|NCT00473590|20959879|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
8504812|NCT00473590|20959878|P2|Treated|Overall Study||48
8504813|NCT00473590|20959879|P1|Treated|Overall Study||52
8504814|NCT00473590|20959878|P2|STARTED|Overall Study||49
8504815|NCT00473590|20959879|P1|STARTED|Overall Study||53
8504816|NCT00473564|20959895|P1|NOT COMPLETED|Overall Study||23
8504817|NCT00473564|20959895|P1|COMPLETED|Overall Study||147
8504818|NCT00473564|20959895|P1|STARTED|Overall Study||170
8504819|NCT00473512|20959905|P5|NOT COMPLETED|Period 2 (Phase 2)||2
8504820|NCT00473512|20959906|P4|NOT COMPLETED|Period 2 (Phase 2)||23
8504821|NCT00473512|20959907|P3|NOT COMPLETED|Period 2 (Phase 2)||2
8504822|NCT00473512|20959908|P2|NOT COMPLETED|Period 2 (Phase 2)||2
8504823|NCT00473512|20959909|P1|NOT COMPLETED|Period 2 (Phase 2)||1
8504824|NCT00473512|20959905|P5|COMPLETED|Period 2 (Phase 2)||0
8504825|NCT00473512|20959906|P4|COMPLETED|Period 2 (Phase 2)||0
8504826|NCT00473512|20959907|P3|COMPLETED|Period 2 (Phase 2)||0
8504827|NCT00473512|20959908|P2|COMPLETED|Period 2 (Phase 2)||0
8504828|NCT00473512|20959909|P1|COMPLETED|Period 2 (Phase 2)||0
8504829|NCT00473512|20959905|P5|STARTED|Period 2 (Phase 2)||2
8504830|NCT00473512|20959906|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
8504831|NCT00473512|20959907|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
8504832|NCT00473512|20959908|P2|STARTED|Period 2 (Phase 2)||2
8504833|NCT00473512|20959909|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
8504834|NCT00473512|20959905|P5|NOT COMPLETED|Period 1 (Phase 1)||1
8504835|NCT00473512|20959906|P4|NOT COMPLETED|Period 1 (Phase 1)||17
8504836|NCT00473512|20959907|P3|NOT COMPLETED|Period 1 (Phase 1)||0
8504837|NCT00473512|20959908|P2|NOT COMPLETED|Period 1 (Phase 1)||1
8504838|NCT00473512|20959909|P1|NOT COMPLETED|Period 1 (Phase 1)||1
8504839|NCT00473512|20959905|P5|COMPLETED|Period 1 (Phase 1)||2
8504840|NCT00473512|20959906|P4|COMPLETED|Period 1 (Phase 1)||25
8504841|NCT00473512|20959907|P3|COMPLETED|Period 1 (Phase 1)||3
8504842|NCT00473512|20959908|P2|COMPLETED|Period 1 (Phase 1)||2
8504843|NCT00473512|20959909|P1|COMPLETED|Period 1 (Phase 1)||2
8504844|NCT00473512|20959905|P5|STARTED|Period 1 (Phase 1)||3
8504845|NCT00473512|20959906|P4|STARTED|Period 1 (Phase 1)||42
8504846|NCT00473512|20959907|P3|STARTED|Period 1 (Phase 1)||3
8504847|NCT00473512|20959908|P2|STARTED|Period 1 (Phase 1)||3
8504848|NCT00473512|20959909|P1|STARTED|Period 1 (Phase 1)||3
8504849|NCT00473434|20959967|P1|NOT COMPLETED|Overall Study||32
8504850|NCT00473434|20959967|P1|COMPLETED|Overall Study||32
8504851|NCT00473434|20959967|P1|STARTED|Overall Study||64
8504852|NCT00473382|20960032|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
8504853|NCT00473382|20960033|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
8504854|NCT00473382|20960034|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
8504855|NCT00473382|20960032|P3|COMPLETED|Open-label Extension Through Month 60||2
8504856|NCT00473382|20960033|P2|COMPLETED|Open-label Extension Through Month 60||1
8504857|NCT00473382|20960034|P1|COMPLETED|Open-label Extension Through Month 60||2
8504858|NCT00473382|20960032|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
8504859|NCT00473382|20960033|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
8504860|NCT00473382|20960034|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
8504861|NCT00473382|20960032|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
8504862|NCT00473382|20960033|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
8504863|NCT00473382|20960034|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
8504864|NCT00473382|20960032|P3|COMPLETED|Open-label Extension Through Month 48||37
8504865|NCT00473382|20960033|P2|COMPLETED|Open-label Extension Through Month 48||42
8504866|NCT00473382|20960034|P1|COMPLETED|Open-label Extension Through Month 48||38
8504867|NCT00473382|20960032|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
8504868|NCT00473382|20960033|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
8504869|NCT00473382|20960034|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
8504870|NCT00473382|20960032|P3|NOT COMPLETED|Core Study||29
8504871|NCT00473382|20960033|P2|NOT COMPLETED|Core Study||27
8504872|NCT00473382|20960034|P1|NOT COMPLETED|Core Study||28
8504873|NCT00473382|20960032|P3|COMPLETED|Core Study||98
8504874|NCT00473382|20960033|P2|COMPLETED|Core Study||98
8504875|NCT00473382|20960034|P1|COMPLETED|Core Study||102
8504876|NCT00473382|20960032|P3|STARTED|Core Study||127
8504877|NCT00473382|20960033|P2|STARTED|Core Study||125
8504878|NCT00473382|20960034|P1|STARTED|Core Study||130
8504879|NCT00473330|20960092|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
8504880|NCT00473330|20960093|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
8504881|NCT00473330|20960094|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
8504882|NCT00473330|20960092|P3|COMPLETED|Open-label Extension Through Month 60||0
8504967|NCT00472420|20960291|P1|COMPLETED|Induction Treatment Period||32
8504883|NCT00473330|20960093|P2|COMPLETED|Open-label Extension Through Month 60||1
8504884|NCT00473330|20960094|P1|COMPLETED|Open-label Extension Through Month 60||1
8504885|NCT00473330|20960092|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
8504886|NCT00473330|20960093|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
8504887|NCT00473330|20960094|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
8504888|NCT00473330|20960092|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
8504889|NCT00473330|20960093|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
8504890|NCT00473330|20960094|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
8504891|NCT00473330|20960092|P3|COMPLETED|Open-label Extension Through Month 48||50
8504892|NCT00473330|20960093|P2|COMPLETED|Open-label Extension Through Month 48||59
8504893|NCT00473330|20960094|P1|COMPLETED|Open-label Extension Through Month 48||63
8504894|NCT00473330|20960092|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
8504895|NCT00473330|20960093|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
8504896|NCT00473330|20960094|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
8504897|NCT00473330|20960092|P3|NOT COMPLETED|Core Study||41
8504898|NCT00473330|20960093|P2|NOT COMPLETED|Core Study||25
8504899|NCT00473330|20960094|P1|NOT COMPLETED|Core Study||27
8504900|NCT00473330|20960092|P3|COMPLETED|Core Study||86
8504901|NCT00473330|20960093|P2|COMPLETED|Core Study||100
8504902|NCT00473330|20960094|P1|COMPLETED|Core Study||98
8504903|NCT00473330|20960092|P3|STARTED|Core Study||127
8504904|NCT00473330|20960093|P2|STARTED|Core Study||125
8504905|NCT00473330|20960094|P1|STARTED|Core Study||125
8504906|NCT00473265|20960149|P1|NOT COMPLETED|Overall Study||20
8504907|NCT00473265|20960149|P1|COMPLETED|Overall Study||48
8504908|NCT00473265|20960149|P1|STARTED|Overall Study||68
8504909|NCT00473083|20960161|P3|NOT COMPLETED|Overall Study||0
8504910|NCT00473083|20960162|P2|NOT COMPLETED|Overall Study||0
8504911|NCT00473083|20960163|P1|NOT COMPLETED|Overall Study||1
8504912|NCT00473083|20960161|P3|COMPLETED|Overall Study||50
8504913|NCT00473083|20960162|P2|COMPLETED|Overall Study||50
8504914|NCT00473083|20960163|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
8504915|NCT00473083|20960161|P3|STARTED|Overall Study||50
8504916|NCT00473083|20960162|P2|STARTED|Overall Study||50
8504917|NCT00473083|20960163|P1|STARTED|Overall Study||50
8504918|NCT00472849|20960191|P2|NOT COMPLETED|Overall Study||0
8504919|NCT00472849|20960192|P1|NOT COMPLETED|Overall Study||0
8504920|NCT00472849|20960191|P2|COMPLETED|Overall Study||78
8504921|NCT00472849|20960192|P1|COMPLETED|Overall Study||12
8504922|NCT00472849|20960191|P2|STARTED|Overall Study||78
8504923|NCT00472849|20960192|P1|STARTED|Overall Study||12
8504924|NCT00472797|20960200|P2|NOT COMPLETED|Overall Study||1
8504925|NCT00472797|20960201|P1|NOT COMPLETED|Overall Study||4
8504926|NCT00472797|20960200|P2|COMPLETED|Overall Study||112
8504927|NCT00472797|20960201|P1|COMPLETED|Overall Study||115
8504928|NCT00472797|20960200|P2|STARTED|Overall Study||113
8504929|NCT00472797|20960201|P1|STARTED|Overall Study||119
8504930|NCT00472732|20960227|P2|NOT COMPLETED|Overall Study||0
8504931|NCT00472732|20960228|P1|NOT COMPLETED|Overall Study||0
8504932|NCT00472732|20960227|P2|COMPLETED|Overall Study||22
8504933|NCT00472732|20960228|P1|COMPLETED|Overall Study||24
8504934|NCT00472732|20960227|P2|STARTED|Overall Study||22
8504935|NCT00472732|20960228|P1|STARTED|Overall Study||24
8504936|NCT00472641|20960238|P1|NOT COMPLETED|Overall Study||7
8504937|NCT00472641|20960238|P1|COMPLETED|Overall Study||18
8504938|NCT00472641|20960238|P1|STARTED|Overall Study||25
8504939|NCT00472576|20960245|P2|NOT COMPLETED|Second Intervention||0
8504940|NCT00472576|20960246|P1|NOT COMPLETED|Second Intervention||0
8504941|NCT00472576|20960245|P2|COMPLETED|Second Intervention||3
8504942|NCT00472576|20960246|P1|COMPLETED|Second Intervention||2
8504943|NCT00472576|20960245|P2|STARTED|Second Intervention||3
8504944|NCT00472576|20960246|P1|STARTED|Second Intervention||2
8504945|NCT00472576|20960245|P2|NOT COMPLETED|First Intervention||0
8504946|NCT00472576|20960246|P1|NOT COMPLETED|First Intervention||0
8504947|NCT00472576|20960245|P2|COMPLETED|First Intervention||3
8504948|NCT00472576|20960246|P1|COMPLETED|First Intervention||2
8504949|NCT00472576|20960245|P2|STARTED|First Intervention||3
8504950|NCT00472576|20960246|P1|STARTED|First Intervention||2
8504951|NCT00472446|20960258|P4|NOT COMPLETED|Overall Study||6
8504952|NCT00472446|20960259|P3|NOT COMPLETED|Overall Study||7
8504953|NCT00472446|20960260|P2|NOT COMPLETED|Overall Study||6
8504954|NCT00472446|20960261|P1|NOT COMPLETED|Overall Study||5
8504955|NCT00472446|20960258|P4|COMPLETED|Overall Study||39
8504956|NCT00472446|20960259|P3|COMPLETED|Overall Study||38
8504957|NCT00472446|20960260|P2|COMPLETED|Overall Study||41
8504958|NCT00472446|20960261|P1|COMPLETED|Overall Study||41
8504959|NCT00472446|20960258|P4|STARTED|Overall Study||45
8504960|NCT00472446|20960259|P3|STARTED|Overall Study||45
8504961|NCT00472446|20960260|P2|STARTED|Overall Study||47
8504962|NCT00472446|20960261|P1|STARTED|Overall Study||46
8504963|NCT00472420|20960291|P1|NOT COMPLETED|Follow-up Period||17
8504964|NCT00472420|20960291|P1|COMPLETED|Follow-up Period||15
8504965|NCT00472420|20960291|P1|STARTED|Follow-up Period||32
8504966|NCT00472420|20960291|P1|NOT COMPLETED|Induction Treatment Period||16
8504968|NCT00472420|20960291|P1|STARTED|Induction Treatment Period||48
8504969|NCT00472303|20960299|P3|NOT COMPLETED|Maintenance Phase||17
8504970|NCT00472303|20960300|P2|NOT COMPLETED|Maintenance Phase||16
8504971|NCT00472303|20960301|P1|NOT COMPLETED|Maintenance Phase||17
8504972|NCT00472303|20960299|P3|COMPLETED|Maintenance Phase||95
8504973|NCT00472303|20960300|P2|COMPLETED|Maintenance Phase||93
8504974|NCT00472303|20960301|P1|COMPLETED|Maintenance Phase||89
8504975|NCT00472303|20960299|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
8504976|NCT00472303|20960300|P2|STARTED|Maintenance Phase||109
8504977|NCT00472303|20960301|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
8504978|NCT00472303|20960299|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
8504979|NCT00472303|20960300|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
8504980|NCT00472303|20960301|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
8504981|NCT00472303|20960299|P3|COMPLETED|Discontinuations After Titration Phase||0
8504982|NCT00472303|20960300|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
8504983|NCT00472303|20960301|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
8504984|NCT00472303|20960299|P3|STARTED|Discontinuations After Titration Phase||0
8504985|NCT00472303|20960300|P2|STARTED|Discontinuations After Titration Phase||129
8504986|NCT00472303|20960301|P1|STARTED|Discontinuations After Titration Phase||279
8504987|NCT00472303|20960299|P3|NOT COMPLETED|Titration Phase||0
8504988|NCT00472303|20960300|P2|NOT COMPLETED|Titration Phase||29
8504989|NCT00472303|20960301|P1|NOT COMPLETED|Titration Phase||59
8504990|NCT00472303|20960299|P3|COMPLETED|Titration Phase||0
8504991|NCT00472303|20960300|P2|COMPLETED|Titration Phase||129
8504992|NCT00472303|20960301|P1|COMPLETED|Titration Phase||279
8504993|NCT00472303|20960299|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
8504994|NCT00472303|20960300|P2|STARTED|Titration Phase||158
8504995|NCT00472303|20960301|P1|STARTED|Titration Phase||338
8504996|NCT00472290|20960364|P1|NOT COMPLETED|Overall Study||72
8504997|NCT00472290|20960364|P1|COMPLETED|Overall Study||0
8504998|NCT00472290|20960364|P1|STARTED|Overall Study||72
8504999|NCT00472199|20960376|P2|NOT COMPLETED|Overall Study||60
8505000|NCT00472199|20960377|P1|NOT COMPLETED|Overall Study||35
8505001|NCT00472199|20960376|P2|COMPLETED|Overall Study||103
8505002|NCT00472199|20960377|P1|COMPLETED|Overall Study||131
8505003|NCT00472199|20960376|P2|STARTED|Overall Study||163
8505004|NCT00472199|20960377|P1|STARTED|Overall Study||166
8505005|NCT00472082|20960443|P1|NOT COMPLETED|Overall Study||5
8505006|NCT00472082|20960443|P1|COMPLETED|Overall Study||0
8505007|NCT00472082|20960443|P1|STARTED|Overall Study||5
8505008|NCT00472056|20960452|P4|NOT COMPLETED|Overall Study||0
8505009|NCT00472056|20960453|P3|NOT COMPLETED|Overall Study||0
8505010|NCT00472056|20960454|P2|NOT COMPLETED|Overall Study||0
8505011|NCT00472056|20960455|P1|NOT COMPLETED|Overall Study||0
8505012|NCT00472056|20960452|P4|COMPLETED|Overall Study||17
8505013|NCT00472056|20960453|P3|COMPLETED|Overall Study||32
8505014|NCT00472056|20960454|P2|COMPLETED|Overall Study||19
8505015|NCT00472056|20960455|P1|COMPLETED|Overall Study||25
8505016|NCT00472056|20960452|P4|STARTED|Overall Study||17
8505017|NCT00472056|20960453|P3|STARTED|Overall Study||32
8505018|NCT00472056|20960454|P2|STARTED|Overall Study||19
8505019|NCT00472056|20960455|P1|STARTED|Overall Study||25
8505020|NCT00472030|20960465|P2|NOT COMPLETED|Overall Study||0
8505021|NCT00472030|20960466|P1|NOT COMPLETED|Overall Study||1
8505022|NCT00472030|20960465|P2|COMPLETED|Overall Study||0
8505023|NCT00472030|20960466|P1|COMPLETED|Overall Study||1
8505024|NCT00472030|20960465|P2|STARTED|Overall Study||0
8505025|NCT00472030|20960466|P1|STARTED|Overall Study||2
8505026|NCT00471887|20960482|P1|NOT COMPLETED|Overall Study||9
8505027|NCT00471887|20960482|P1|COMPLETED|Overall Study||23
8505028|NCT00471887|20960482|P1|STARTED|Overall Study||32
8505029|NCT00471822|20960491|P1|NOT COMPLETED|Overall Study||2
8505030|NCT00471822|20960491|P1|COMPLETED|Overall Study||9705
8505031|NCT00471822|20960491|P1|Treated|Overall Study||9705
8505032|NCT00471822|20960491|P1|STARTED|Overall Study||9707
8505033|NCT00471718|20960499|P1|NOT COMPLETED|Overall Study||27
8505034|NCT00471718|20960499|P1|COMPLETED|Overall Study||0
8505035|NCT00471718|20960499|P1|STARTED|Overall Study||27
8505036|NCT00471705|20960511|P3|NOT COMPLETED|Overall Study||15
8505037|NCT00471705|20960512|P2|NOT COMPLETED|Overall Study||22
8505038|NCT00471705|20960513|P1|NOT COMPLETED|Overall Study||24
8505039|NCT00471705|20960511|P3|COMPLETED|Overall Study||134
8505040|NCT00471705|20960512|P2|COMPLETED|Overall Study||121
8505041|NCT00471705|20960513|P1|COMPLETED|Overall Study||121
8505042|NCT00471705|20960511|P3|STARTED|Overall Study||149
8505043|NCT00471705|20960512|P2|STARTED|Overall Study||143
8505044|NCT00471705|20960513|P1|STARTED|Overall Study||145
8505045|NCT00471536|20960527|P1|NOT COMPLETED|Overall Study||1
8505046|NCT00471536|20960527|P1|COMPLETED|Overall Study||18
8505047|NCT00471536|20960527|P1|STARTED|Overall Study||19
8505048|NCT00471497|20960539|P3|NOT COMPLETED|Extension Phase||1
8505049|NCT00471497|20960540|P2|NOT COMPLETED|Extension Phase||14
8505050|NCT00471497|20960541|P1|NOT COMPLETED|Extension Phase||27
8505051|NCT00471497|20960539|P3|COMPLETED|Extension Phase||2
8505052|NCT00471497|20960540|P2|COMPLETED|Extension Phase||12
8505053|NCT00471497|20960541|P1|COMPLETED|Extension Phase||21
8505054|NCT00471497|20960539|P3|STARTED|Extension Phase||3
8505055|NCT00471497|20960540|P2|STARTED|Extension Phase||26
8505056|NCT00471497|20960541|P1|STARTED|Extension Phase||48
8505057|NCT00471497|20960539|P3|NOT COMPLETED|Core Treatment Phase||182
8505058|NCT00471497|20960540|P2|NOT COMPLETED|Core Treatment Phase||175
8505059|NCT00471497|20960541|P1|NOT COMPLETED|Core Treatment Phase||184
8505060|NCT00471497|20960539|P3|COMPLETED|Core Treatment Phase||99
8505061|NCT00471497|20960540|P2|COMPLETED|Core Treatment Phase||107
8505062|NCT00471497|20960541|P1|COMPLETED|Core Treatment Phase||99
8505063|NCT00471497|20960539|P3|Discontinued Core/Entered Ext.|Core Treatment Phase||3
8505064|NCT00471497|20960540|P2|Discontinued Core/Entered Ext.|Core Treatment Phase||26
8505065|NCT00471497|20960541|P1|Discontinued Core/Entered Ext.|Core Treatment Phase||48
8505066|NCT00471497|20960539|P3|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
8505067|NCT00471497|20960540|P2|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
8505068|NCT00471497|20960541|P1|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
8505069|NCT00471497|20960539|P3|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
8505070|NCT00471497|20960540|P2|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
8505071|NCT00471497|20960541|P1|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
8505072|NCT00471497|20960539|P3|STARTED|Core Treatment Phase||281
8505073|NCT00471497|20960540|P2|STARTED|Core Treatment Phase||282
8505074|NCT00471497|20960541|P1|STARTED|Core Treatment Phase||283
8505075|NCT00471445|20960637|P2|NOT COMPLETED|Overall Study||2
8505076|NCT00471445|20960638|P1|NOT COMPLETED|Overall Study||2
8505077|NCT00471445|20960637|P2|COMPLETED|Overall Study||231
8505078|NCT00471445|20960638|P1|COMPLETED|Overall Study||227
8505079|NCT00471445|20960637|P2|STARTED|Overall Study||233
8505080|NCT00471445|20960638|P1|STARTED|Overall Study||229
8505081|NCT00471380|20960644|P2|NOT COMPLETED|Third Intervention||2
8505082|NCT00471380|20960645|P1|NOT COMPLETED|Third Intervention||1
8505083|NCT00471380|20960644|P2|COMPLETED|Third Intervention||14
8505084|NCT00471380|20960645|P1|COMPLETED|Third Intervention||17
8505085|NCT00471380|20960644|P2|STARTED|Third Intervention||16
8505086|NCT00471380|20960645|P1|STARTED|Third Intervention||18
8505087|NCT00471380|20960644|P2|NOT COMPLETED|Second Intervention||4
8505088|NCT00471380|20960645|P1|NOT COMPLETED|Second Intervention||0
8505089|NCT00471380|20960644|P2|COMPLETED|Second Intervention||16
8505090|NCT00471380|20960645|P1|COMPLETED|Second Intervention||18
8505091|NCT00471380|20960644|P2|STARTED|Second Intervention||20
8505092|NCT00471380|20960645|P1|STARTED|Second Intervention||18
8505093|NCT00471380|20960644|P2|NOT COMPLETED|First Intervention||4
8505094|NCT00471380|20960645|P1|NOT COMPLETED|First Intervention||4
8505095|NCT00471380|20960644|P2|COMPLETED|First Intervention||20
8505096|NCT00471380|20960645|P1|COMPLETED|First Intervention||18
8505097|NCT00471380|20960644|P2|STARTED|First Intervention||24
8505098|NCT00471380|20960645|P1|STARTED|First Intervention||22
8505099|NCT00471354|20960651|P1|NOT COMPLETED|Overall Study||52
8505100|NCT00471354|20960651|P1|COMPLETED|Overall Study||176
8505101|NCT00471354|20960651|P1|STARTED|Overall Study||228
8505102|NCT00471328|20960663|P2|NOT COMPLETED|Extension Phase||67
8505103|NCT00471328|20960664|P1|NOT COMPLETED|Extension Phase||41
8505104|NCT00471328|20960663|P2|COMPLETED|Extension Phase||0
8505105|NCT00471328|20960664|P1|COMPLETED|Extension Phase||0
8505106|NCT00471328|20960663|P2|Started:CrossOver During Extension|Extension Phase||10
8505107|NCT00471328|20960664|P1|Started:CrossOver During Extension|Extension Phase||0
8505108|NCT00471328|20960663|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
8505109|NCT00471328|20960664|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
8505110|NCT00471328|20960663|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
8505111|NCT00471328|20960664|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
8505112|NCT00471328|20960663|P2|STARTED|Extension Phase||67
8505113|NCT00471328|20960664|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
8505114|NCT00471328|20960663|P2|NOT COMPLETED|Core Phase||67
8505115|NCT00471328|20960664|P1|NOT COMPLETED|Core Phase||107
8505116|NCT00471328|20960663|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
8505117|NCT00471328|20960664|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
8505118|NCT00471328|20960663|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
8505119|NCT00471328|20960664|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
8505120|NCT00471328|20960663|P2|STARTED|Core Phase||83
8505121|NCT00471328|20960664|P1|STARTED|Core Phase||165
8505122|NCT00471315|20960683|P1|NOT COMPLETED|Overall Study||8
8505123|NCT00471315|20960683|P1|COMPLETED|Overall Study||10
8505124|NCT00471315|20960683|P1|STARTED|Overall Study||18
8505125|NCT00471276|20960688|P1|NOT COMPLETED|Overall Study||83
8505126|NCT00471276|20960688|P1|COMPLETED|Overall Study||0
8505127|NCT00471276|20960688|P1|STARTED|Overall Study||83
8505128|NCT00471237|20960718|P7|NOT COMPLETED|Overall Study||3
8505129|NCT00471237|20960719|P6|NOT COMPLETED|Overall Study||39
8505130|NCT00471237|20960720|P5|NOT COMPLETED|Overall Study||41
8505131|NCT00471237|20960721|P4|NOT COMPLETED|Overall Study||45
8505132|NCT00471237|20960722|P3|NOT COMPLETED|Overall Study||34
8505133|NCT00471237|20960723|P2|NOT COMPLETED|Overall Study||42
8505134|NCT00471237|20960724|P1|NOT COMPLETED|Overall Study||41
8505135|NCT00471237|20960718|P7|COMPLETED|Overall Study||38
8505136|NCT00471237|20960719|P6|COMPLETED|Overall Study||50
8505137|NCT00471237|20960720|P5|COMPLETED|Overall Study||46
8505138|NCT00471237|20960721|P4|COMPLETED|Overall Study||43
8505139|NCT00471237|20960722|P3|COMPLETED|Overall Study||48
8505140|NCT00471237|20960723|P2|COMPLETED|Overall Study||45
8505141|NCT00471237|20960724|P1|COMPLETED|Overall Study||49
8505142|NCT00471237|20960718|P7|STARTED|Overall Study||41
8505143|NCT00471237|20960719|P6|STARTED|Overall Study||89
8505144|NCT00471237|20960720|P5|STARTED|Overall Study||87
8505145|NCT00471237|20960721|P4|STARTED|Overall Study||88
8505146|NCT00471237|20960722|P3|STARTED|Overall Study||82
8505147|NCT00471237|20960723|P2|STARTED|Overall Study||87
8505148|NCT00471237|20960724|P1|STARTED|Overall Study||90
8505149|NCT00471146|20960874|P2|NOT COMPLETED|Overall Study||174
8505150|NCT00471146|20960875|P1|NOT COMPLETED|Overall Study||172
8505151|NCT00471146|20960874|P2|COMPLETED|Overall Study||142
8505152|NCT00471146|20960875|P1|COMPLETED|Overall Study||142
8505153|NCT00471146|20960874|P2|Treated|Overall Study||308
8505154|NCT00471146|20960875|P1|Treated|Overall Study||305
8505155|NCT00471146|20960874|P2|STARTED|Overall Study||316
8505156|NCT00471146|20960875|P1|STARTED|Overall Study||314
8505157|NCT00471107|20960900|P3|NOT COMPLETED|Overall Study||3
8505158|NCT00471107|20960901|P2|NOT COMPLETED|Overall Study||1
8505159|NCT00471107|20960902|P1|NOT COMPLETED|Overall Study||3
8505160|NCT00471107|20960900|P3|COMPLETED|Overall Study||12
8505161|NCT00471107|20960901|P2|COMPLETED|Overall Study||14
8505162|NCT00471107|20960902|P1|COMPLETED|Overall Study||12
8505163|NCT00471107|20960900|P3|STARTED|Overall Study||15
8505164|NCT00471107|20960901|P2|STARTED|Overall Study||15
8505165|NCT00471107|20960902|P1|STARTED|Overall Study||15
8505166|NCT00471081|20960912|P2|NOT COMPLETED|Extended Safety Follow-Up||13
8505167|NCT00471081|20960913|P1|NOT COMPLETED|Extended Safety Follow-Up||2
8505168|NCT00471081|20960912|P2|COMPLETED|Extended Safety Follow-Up||176
8505169|NCT00471081|20960913|P1|COMPLETED|Extended Safety Follow-Up||158
8505170|NCT00471081|20960912|P2|STARTED|Extended Safety Follow-Up||189
8505171|NCT00471081|20960913|P1|STARTED|Extended Safety Follow-Up||160
8505172|NCT00471081|20960912|P2|NOT COMPLETED|Active Phase||13
8505173|NCT00471081|20960913|P1|NOT COMPLETED|Active Phase||2
8505174|NCT00471081|20960912|P2|COMPLETED|Active Phase||176
8505175|NCT00471081|20960913|P1|COMPLETED|Active Phase||158
8505176|NCT00471081|20960912|P2|STARTED|Active Phase||189
8505177|NCT00471081|20960913|P1|STARTED|Active Phase||160
8505178|NCT00471068|20960952|P2|NOT COMPLETED|Overall Study||1
8505179|NCT00471068|20960953|P1|NOT COMPLETED|Overall Study||1
8505180|NCT00471068|20960952|P2|COMPLETED|Overall Study||24
8505181|NCT00471068|20960953|P1|COMPLETED|Overall Study||20
8505182|NCT00471068|20960952|P2|STARTED|Overall Study||25
8505183|NCT00471068|20960953|P1|STARTED|Overall Study||21
8505184|NCT00470847|20960959|P1|NOT COMPLETED|Overall Study||1
8505185|NCT00470847|20960959|P1|COMPLETED|Overall Study||34
8505186|NCT00470847|20960959|P1|STARTED|Overall Study||35
8505187|NCT00470834|20960972|P2|NOT COMPLETED|Extension Period (24 Months)||23
8505188|NCT00470834|20960973|P1|NOT COMPLETED|Extension Period (24 Months)||15
8505189|NCT00470834|20960972|P2|COMPLETED|Extension Period (24 Months)||7
8505190|NCT00470834|20960973|P1|COMPLETED|Extension Period (24 Months)||11
8505191|NCT00470834|20960972|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
8505192|NCT00470834|20960973|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
8505193|NCT00470834|20960972|P2|NOT COMPLETED|Treatment Period (18 Months)||31
8505194|NCT00470834|20960973|P1|NOT COMPLETED|Treatment Period (18 Months)||38
8505195|NCT00470834|20960972|P2|COMPLETED|Treatment Period (18 Months)||31
8505196|NCT00470834|20960973|P1|COMPLETED|Treatment Period (18 Months)||27
8505197|NCT00470834|20960972|P2|STARTED|Treatment Period (18 Months)||62
8505198|NCT00470834|20960973|P1|STARTED|Treatment Period (18 Months)||65
8505199|NCT00470626|20960987|P1|NOT COMPLETED|Overall Study||17
8505200|NCT00470626|20960987|P1|COMPLETED|Overall Study||112
8505201|NCT00470626|20960987|P1|STARTED|Overall Study||129
8505202|NCT00470600|20960995|P2|NOT COMPLETED|Overall Study||0
8505203|NCT00470600|20960996|P1|NOT COMPLETED|Overall Study||0
8505204|NCT00470600|20960995|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
8505205|NCT00470600|20960996|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
8505206|NCT00470600|20960995|P2|STARTED|Overall Study||99
8505207|NCT00470600|20960996|P1|STARTED|Overall Study||86
8505208|NCT00470574|20961006|P1|NOT COMPLETED|Overall Study||0
8505209|NCT00470574|20961006|P1|COMPLETED|Overall Study||7
8505210|NCT00470574|20961006|P1|STARTED|Overall Study||7
8505211|NCT00470548|20961014|P4|NOT COMPLETED|Overall Study||0
8505212|NCT00470548|20961015|P3|NOT COMPLETED|Overall Study||0
8505213|NCT00470548|20961016|P2|NOT COMPLETED|Overall Study||0
8505214|NCT00470548|20961017|P1|NOT COMPLETED|Overall Study||0
8505215|NCT00470548|20961014|P4|COMPLETED|Overall Study||37
8505216|NCT00470548|20961015|P3|COMPLETED|Overall Study||6
8505217|NCT00470548|20961016|P2|COMPLETED|Overall Study||3
8505218|NCT00470548|20961017|P1|COMPLETED|Overall Study||3
8505219|NCT00470548|20961014|P4|STARTED|Overall Study||37
8505220|NCT00470548|20961015|P3|STARTED|Overall Study||6
8505221|NCT00470548|20961016|P2|STARTED|Overall Study||3
8505222|NCT00470548|20961017|P1|STARTED|Overall Study||3
8505223|NCT00470535|20961035|P1|NOT COMPLETED|Overall Study||18
8505224|NCT00470535|20961035|P1|COMPLETED|Overall Study||0
8505225|NCT00470535|20961035|P1|STARTED|Overall Study||18
8505226|NCT00470470|20961044|P1|NOT COMPLETED|Overall Study||5
8505227|NCT00470470|20961044|P1|COMPLETED|Overall Study||25
8505228|NCT00470470|20961044|P1|STARTED|Overall Study||30
8505229|NCT00470418|20961051|P2|NOT COMPLETED|Overall Study||0
8505230|NCT00470418|20961052|P1|NOT COMPLETED|Overall Study||1
8505231|NCT00470418|20961051|P2|COMPLETED|Overall Study||3
8505232|NCT00470418|20961052|P1|COMPLETED|Overall Study||6
8505233|NCT00470418|20961051|P2|STARTED|Overall Study||3
8505234|NCT00470418|20961052|P1|STARTED|Overall Study||7
8505235|NCT00470392|20961062|P2|NOT COMPLETED|Overall Study||0
8505236|NCT00470392|20961063|P1|NOT COMPLETED|Overall Study||0
8505237|NCT00470392|20961062|P2|COMPLETED|Overall Study||2
8505238|NCT00470392|20961063|P1|COMPLETED|Overall Study||7
8505239|NCT00470392|20961062|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
8505240|NCT00470392|20961063|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
8505241|NCT00470366|20961073|P1|NOT COMPLETED|Overall Study||4
8505242|NCT00470366|20961073|P1|COMPLETED|Overall Study||56
8505243|NCT00470366|20961073|P1|STARTED|Overall Study||60
8505247|NCT00470275|20961084|P1|NOT COMPLETED|Overall Study||10
8505248|NCT00470275|20961084|P1|COMPLETED|Overall Study||0
8505249|NCT00470275|20961084|P1|STARTED|Overall Study||10
8505250|NCT00470262|20961090|P2|NOT COMPLETED|Overall Study||0
8505251|NCT00470262|20961091|P1|NOT COMPLETED|Overall Study||2
8505252|NCT00470262|20961090|P2|COMPLETED|Overall Study||12
8505253|NCT00470262|20961091|P1|COMPLETED|Overall Study||13
8505254|NCT00470262|20961090|P2|STARTED|Overall Study||12
8505255|NCT00470262|20961091|P1|STARTED|Overall Study||15
8505256|NCT00470184|20961099|P1|NOT COMPLETED|Overall Study||22
8505257|NCT00470184|20961099|P1|COMPLETED|Overall Study||19
8505258|NCT00470184|20961099|P1|Treated With Study Therapy|Overall Study||36
8505259|NCT00470184|20961099|P1|STARTED|Overall Study||41
8505260|NCT00470158|20961111|P5|NOT COMPLETED|Overall Study||6
8505261|NCT00470158|20961112|P4|NOT COMPLETED|Overall Study||5
8505262|NCT00470158|20961113|P3|NOT COMPLETED|Overall Study||8
8505263|NCT00470158|20961114|P2|NOT COMPLETED|Overall Study||8
8505264|NCT00470158|20961115|P1|NOT COMPLETED|Overall Study||8
8505265|NCT00470158|20961111|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
8505266|NCT00470158|20961112|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8505267|NCT00470158|20961113|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8505268|NCT00470158|20961114|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
8505269|NCT00470158|20961115|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8505270|NCT00470158|20961111|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8505271|NCT00470158|20961112|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
8505272|NCT00470158|20961113|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8505273|NCT00470158|20961114|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
8505274|NCT00470158|20961115|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8505275|NCT00470106|20961131|P4|NOT COMPLETED|Overall Study||2
8505276|NCT00470106|20961132|P3|NOT COMPLETED|Overall Study||7
8505277|NCT00470106|20961133|P2|NOT COMPLETED|Overall Study||5
8505278|NCT00470106|20961134|P1|NOT COMPLETED|Overall Study||3
8505279|NCT00470106|20961131|P4|COMPLETED|Overall Study||19
8505280|NCT00470106|20961132|P3|COMPLETED|Overall Study||14
8505281|NCT00470106|20961133|P2|COMPLETED|Overall Study||19
8505282|NCT00470106|20961134|P1|COMPLETED|Overall Study||16
8505283|NCT00470106|20961131|P4|STARTED|Overall Study||21
8505284|NCT00470106|20961132|P3|STARTED|Overall Study||21
8505285|NCT00470106|20961133|P2|STARTED|Overall Study||24
8505286|NCT00470106|20961134|P1|STARTED|Overall Study||19
8505287|NCT00470093|20961148|P1|NOT COMPLETED|Overall Study||2
8505288|NCT00470093|20961148|P1|COMPLETED|Overall Study||0
8505289|NCT00470093|20961148|P1|STARTED|Overall Study||2
8505290|NCT00470067|20961155|P1|NOT COMPLETED|Overall Study||7
8505291|NCT00470067|20961155|P1|COMPLETED|Overall Study||2
8505292|NCT00470067|20961155|P1|STARTED|Overall Study||9
8505293|NCT00470054|20961159|P1|NOT COMPLETED|Overall Study||1
8505294|NCT00470054|20961159|P1|COMPLETED|Overall Study||43
8505295|NCT00470054|20961159|P1|STARTED|Overall Study||44
8505296|NCT00469911|20961169|P2|NOT COMPLETED|Overall Study||0
8505297|NCT00469911|20961170|P1|NOT COMPLETED|Overall Study||0
8505298|NCT00469911|20961169|P2|COMPLETED|Overall Study||10
8505299|NCT00469911|20961170|P1|COMPLETED|Overall Study||8
8505300|NCT00469911|20961169|P2|STARTED|Overall Study||10
8505301|NCT00469911|20961170|P1|STARTED|Overall Study||8
8505302|NCT00469898|20961175|P1|NOT COMPLETED|Overall Study||25
8505303|NCT00469898|20961175|P1|COMPLETED|Overall Study||25
8505304|NCT00469898|20961175|P1|STARTED|Overall Study||50
8505305|NCT00469859|20961184|P2|NOT COMPLETED|Overall Study||2
8505306|NCT00469859|20961185|P1|NOT COMPLETED|Overall Study||0
8505307|NCT00469859|20961184|P2|COMPLETED|Overall Study||6
8505308|NCT00469859|20961185|P1|COMPLETED|Overall Study||6
8505309|NCT00469859|20961184|P2|STARTED|Overall Study||8
8505310|NCT00469859|20961185|P1|STARTED|Overall Study||6
8505311|NCT00469833|20961193|P1|NOT COMPLETED|Overall Study||2
8505312|NCT00469833|20961193|P1|COMPLETED|Overall Study||15
8505313|NCT00469833|20961193|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
8505314|NCT00469612|20961205|P2|NOT COMPLETED|Overall Study||0
8505315|NCT00469612|20961206|P1|NOT COMPLETED|Overall Study||2
8505316|NCT00469612|20961205|P2|COMPLETED|Overall Study||0
8505317|NCT00469612|20961206|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
8505318|NCT00469612|20961205|P2|STARTED|Overall Study||0
8505319|NCT00469612|20961206|P1|STARTED|Overall Study||2
8505320|NCT00469508|20961218|P2|NOT COMPLETED|Overall Study||24
8505321|NCT00469508|20961219|P1|NOT COMPLETED|Overall Study||20
8505322|NCT00469508|20961218|P2|COMPLETED|Overall Study||13
8505323|NCT00469508|20961219|P1|COMPLETED|Overall Study||14
8505324|NCT00469508|20961218|P2|STARTED|Overall Study||37
8505325|NCT00469508|20961219|P1|STARTED|Overall Study||34
8505326|NCT00469456|20961233|P2|NOT COMPLETED|Overall Study||4
8505327|NCT00469456|20961234|P1|NOT COMPLETED|Overall Study||9
8505328|NCT00469456|20961233|P2|COMPLETED|Overall Study||131
8505329|NCT00469456|20961234|P1|COMPLETED|Overall Study||120
8505330|NCT00469456|20961233|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
8505331|NCT00469456|20961234|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
8505332|NCT00469391|20961244|P2|NOT COMPLETED|Overall Study||5
8505333|NCT00469391|20961245|P1|NOT COMPLETED|Overall Study||14
8505334|NCT00469391|20961244|P2|COMPLETED|Overall Study||24
8505335|NCT00469391|20961245|P1|COMPLETED|Overall Study||13
8505336|NCT00469391|20961244|P2|Patient Preference|Overall Study||1
8505337|NCT00469391|20961245|P1|Patient Preference|Overall Study||0
8505338|NCT00469391|20961244|P2|Lost to Follow up|Overall Study||1
8505339|NCT00469391|20961245|P1|Lost to Follow up|Overall Study||0
8505340|NCT00469391|20961244|P2|Adverse Event|Overall Study||0
8505341|NCT00469391|20961245|P1|Adverse Event|Overall Study||8
8505342|NCT00469391|20961244|P2|Unsuccessful Implant Procedure|Overall Study||0
8505343|NCT00469391|20961245|P1|Unsuccessful Implant Procedure|Overall Study||4
8505344|NCT00469391|20961244|P2|Discontinued Prior to Procedure|Overall Study||3
8505345|NCT00469391|20961245|P1|Discontinued Prior to Procedure|Overall Study||2
8505346|NCT00469391|20961244|P2|STARTED|Overall Study||29
8505347|NCT00469391|20961245|P1|STARTED|Overall Study||27
8505348|NCT00469274|20961253|P2|NOT COMPLETED|Overall Study||0
8505349|NCT00469274|20961254|P1|NOT COMPLETED|Overall Study||0
8505350|NCT00469274|20961253|P2|COMPLETED|Overall Study||42
8505351|NCT00469274|20961254|P1|COMPLETED|Overall Study||44
8505352|NCT00469274|20961253|P2|STARTED|Overall Study||42
8505353|NCT00469274|20961254|P1|STARTED|Overall Study||44
8505354|NCT00469209|20961263|P3|NOT COMPLETED|Overall Study||1
8505355|NCT00469209|20961264|P2|NOT COMPLETED|Overall Study||0
8505356|NCT00469209|20961265|P1|NOT COMPLETED|Overall Study||1
8505357|NCT00469209|20961263|P3|COMPLETED|Overall Study||19
8505358|NCT00469209|20961264|P2|COMPLETED|Overall Study||20
8505359|NCT00469209|20961265|P1|COMPLETED|Overall Study||19
8505360|NCT00469209|20961263|P3|STARTED|Overall Study||20
8505361|NCT00469209|20961264|P2|STARTED|Overall Study||20
8505362|NCT00469209|20961265|P1|STARTED|Overall Study||20
8505363|NCT00469144|20961275|P2|NOT COMPLETED|Overall Study||6
8505364|NCT00469144|20961276|P1|NOT COMPLETED|Overall Study||6
8505365|NCT00469144|20961275|P2|COMPLETED|Overall Study||105
8505366|NCT00469144|20961276|P1|COMPLETED|Overall Study||108
8505367|NCT00469144|20961275|P2|STARTED|Overall Study||111
8505368|NCT00469144|20961276|P1|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
8505369|NCT00469092|20961288|P2|NOT COMPLETED|Overall Study||21
8505370|NCT00469092|20961289|P1|NOT COMPLETED|Overall Study||26
8505371|NCT00469092|20961288|P2|COMPLETED|Overall Study||220
8505372|NCT00469092|20961289|P1|COMPLETED|Overall Study||213
8505373|NCT00469092|20961288|P2|Exposed to Study Drug|Overall Study||238
8505374|NCT00469092|20961289|P1|Exposed to Study Drug|Overall Study||231
8505375|NCT00469092|20961288|P2|STARTED|Overall Study||241
8505376|NCT00469092|20961289|P1|STARTED|Overall Study||239
8505377|NCT00469079|20961308|P3|NOT COMPLETED|Overall Study||19
8505378|NCT00469079|20961309|P2|NOT COMPLETED|Overall Study||22
8505379|NCT00469079|20961310|P1|NOT COMPLETED|Overall Study||9
8505380|NCT00469079|20961308|P3|COMPLETED|Overall Study||32
8505381|NCT00469079|20961309|P2|COMPLETED|Overall Study||30
8505382|NCT00469079|20961310|P1|COMPLETED|Overall Study||18
8505383|NCT00469079|20961308|P3|STARTED|Overall Study||51
8505384|NCT00469079|20961309|P2|STARTED|Overall Study||52
8505385|NCT00469079|20961310|P1|STARTED|Overall Study||27
8505386|NCT00469014|20961331|P4|NOT COMPLETED|Adaptive Randomization||1
8505387|NCT00469014|20961332|P3|NOT COMPLETED|Adaptive Randomization||1
8505388|NCT00469014|20961333|P2|NOT COMPLETED|Adaptive Randomization||1
8505389|NCT00469014|20961334|P1|NOT COMPLETED|Adaptive Randomization||1
8505390|NCT00469014|20961331|P4|COMPLETED|Adaptive Randomization||10
8505391|NCT00469014|20961332|P3|COMPLETED|Adaptive Randomization||23
8505392|NCT00469014|20961333|P2|COMPLETED|Adaptive Randomization||2
8505393|NCT00469014|20961334|P1|COMPLETED|Adaptive Randomization||12
8505394|NCT00469014|20961331|P4|STARTED|Adaptive Randomization||11
8505395|NCT00469014|20961332|P3|STARTED|Adaptive Randomization||24
8505396|NCT00469014|20961333|P2|STARTED|Adaptive Randomization||3
8505397|NCT00469014|20961334|P1|STARTED|Adaptive Randomization||13
8505398|NCT00469014|20961331|P4|NOT COMPLETED|Initial Phase Randomization||1
8505399|NCT00469014|20961332|P3|NOT COMPLETED|Initial Phase Randomization||1
8505400|NCT00469014|20961333|P2|NOT COMPLETED|Initial Phase Randomization||1
8505401|NCT00469014|20961334|P1|NOT COMPLETED|Initial Phase Randomization||1
8505402|NCT00469014|20961331|P4|COMPLETED|Initial Phase Randomization||5
8505403|NCT00469014|20961332|P3|COMPLETED|Initial Phase Randomization||4
8505404|NCT00469014|20961333|P2|COMPLETED|Initial Phase Randomization||3
8505405|NCT00469014|20961334|P1|COMPLETED|Initial Phase Randomization||4
8505406|NCT00469014|20961331|P4|STARTED|Initial Phase Randomization||6
8505407|NCT00469014|20961332|P3|STARTED|Initial Phase Randomization||5
8505408|NCT00469014|20961333|P2|STARTED|Initial Phase Randomization||4
8505409|NCT00469014|20961334|P1|STARTED|Initial Phase Randomization||5
8505410|NCT00468910|20961346|P2|NOT COMPLETED|Overall Study||3
8505411|NCT00468910|20961347|P1|NOT COMPLETED|Overall Study||4
8505412|NCT00468910|20961346|P2|COMPLETED|Overall Study||36
8505413|NCT00468910|20961347|P1|COMPLETED|Overall Study||36
8505414|NCT00468910|20961346|P2|Follow-up|Overall Study||36
8505415|NCT00468910|20961347|P1|Follow-up|Overall Study||36
8505416|NCT00468910|20961346|P2|Post-Treatment Biopsy|Overall Study||36
8505417|NCT00468910|20961347|P1|Post-Treatment Biopsy|Overall Study||36
8505418|NCT00468910|20961346|P2|Treatment|Overall Study||36
8505419|NCT00468910|20961347|P1|Treatment|Overall Study||36
8505420|NCT00468910|20961346|P2|Randomization|Overall Study||39
8505421|NCT00468910|20961347|P1|Randomization|Overall Study||40
8505422|NCT00468910|20961346|P2|STARTED|Overall Study||39
8505423|NCT00468910|20961347|P1|STARTED|Overall Study||40
8505424|NCT00468858|20961366|P3|NOT COMPLETED|Overall Study||14
8505425|NCT00468858|20961367|P2|NOT COMPLETED|Overall Study||10
8505426|NCT00468858|20961368|P1|NOT COMPLETED|Overall Study||9
8505427|NCT00468858|20961366|P3|COMPLETED|Overall Study||199
8505428|NCT00468858|20961367|P2|COMPLETED|Overall Study||202
8505429|NCT00468858|20961368|P1|COMPLETED|Overall Study||202
8505430|NCT00468858|20961366|P3|STARTED|Overall Study||213
8505431|NCT00468858|20961367|P2|STARTED|Overall Study||212
8505432|NCT00468858|20961368|P1|STARTED|Overall Study||211
8505445|NCT00468819|20961628|P3|NOT COMPLETED|Overall Study||2
8505446|NCT00468819|20961629|P2|NOT COMPLETED|Overall Study||0
8505447|NCT00468819|20961630|P1|NOT COMPLETED|Overall Study||6
8505448|NCT00468819|20961628|P3|COMPLETED|Overall Study||46
8505449|NCT00468819|20961629|P2|COMPLETED|Overall Study||44
8505450|NCT00468819|20961630|P1|COMPLETED|Overall Study||42
8505451|NCT00468819|20961628|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
8505452|NCT00468819|20961629|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
8505453|NCT00468819|20961630|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
8505454|NCT00468819|20961628|P3|STARTED|Overall Study|Enrolled participants|48
8505455|NCT00468819|20961629|P2|STARTED|Overall Study|Enrolled participants|44
8505456|NCT00468819|20961630|P1|STARTED|Overall Study|Enrolled participants|48
8505457|NCT00468728|20961710|P2|NOT COMPLETED|Follow-up||31
8505458|NCT00468728|20961711|P1|NOT COMPLETED|Follow-up||34
8505459|NCT00468728|20961710|P2|COMPLETED|Follow-up||222
8505460|NCT00468728|20961711|P1|COMPLETED|Follow-up||222
8505461|NCT00468728|20961710|P2|STARTED|Follow-up||253
8505462|NCT00468728|20961711|P1|STARTED|Follow-up||256
8505463|NCT00468728|20961710|P2|NOT COMPLETED|Treatment||11
8505464|NCT00468728|20961711|P1|NOT COMPLETED|Treatment||4
8505465|NCT00468728|20961710|P2|COMPLETED|Treatment||253
8505466|NCT00468728|20961711|P1|COMPLETED|Treatment||256
8505467|NCT00468728|20961710|P2|STARTED|Treatment||264
8505468|NCT00468728|20961711|P1|STARTED|Treatment||260
8505469|NCT00468728|20961710|P2|NOT COMPLETED|Enrollment||7
8505470|NCT00468728|20961711|P1|NOT COMPLETED|Enrollment||4
8505471|NCT00468728|20961710|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
8505472|NCT00468728|20961711|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
8505473|NCT00468728|20961710|P2|STARTED|Enrollment||271
8505474|NCT00468728|20961711|P1|STARTED|Enrollment||264
8505475|NCT00468676|20961723|P2|NOT COMPLETED|Overall Study||12
8505476|NCT00468676|20961724|P1|NOT COMPLETED|Overall Study||16
8505477|NCT00468676|20961723|P2|COMPLETED|Overall Study||94
8505478|NCT00468676|20961724|P1|COMPLETED|Overall Study||92
8505479|NCT00468676|20961723|P2|STARTED|Overall Study||106
8505480|NCT00468676|20961724|P1|STARTED|Overall Study||108
8505484|NCT00468585|20961789|P4|NOT COMPLETED|Overall Study||1
8505485|NCT00468585|20961790|P3|NOT COMPLETED|Overall Study||5
8505486|NCT00468585|20961791|P2|NOT COMPLETED|Overall Study||0
8505487|NCT00468585|20961792|P1|NOT COMPLETED|Overall Study||1
8505488|NCT00468585|20961789|P4|COMPLETED|Overall Study||5
8505489|NCT00468585|20961790|P3|COMPLETED|Overall Study||45
8505490|NCT00468585|20961791|P2|COMPLETED|Overall Study||3
8505491|NCT00468585|20961792|P1|COMPLETED|Overall Study||3
8505492|NCT00468585|20961789|P4|STARTED|Overall Study||6
8505493|NCT00468585|20961790|P3|STARTED|Overall Study||50
8505494|NCT00468585|20961791|P2|STARTED|Overall Study||3
8505495|NCT00468585|20961792|P1|STARTED|Overall Study||4
8505496|NCT00468559|20961804|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
8505497|NCT00468559|20961805|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
8505498|NCT00468559|20961806|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
8505499|NCT00468559|20961804|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
8505500|NCT00468559|20961805|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
8505501|NCT00468559|20961806|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
8505502|NCT00468559|20961804|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
8505503|NCT00468559|20961805|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
8505504|NCT00468559|20961806|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
8505505|NCT00468559|20961804|P3|NOT COMPLETED|Open-label Treatment Phase||0
8505506|NCT00468559|20961805|P2|NOT COMPLETED|Open-label Treatment Phase||0
8505507|NCT00468559|20961806|P1|NOT COMPLETED|Open-label Treatment Phase||18
8505508|NCT00468559|20961804|P3|COMPLETED|Open-label Treatment Phase||0
8505509|NCT00468559|20961805|P2|COMPLETED|Open-label Treatment Phase||0
8505510|NCT00468559|20961806|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
8505511|NCT00468559|20961804|P3|STARTED|Open-label Treatment Phase||0
8505512|NCT00468559|20961805|P2|STARTED|Open-label Treatment Phase||0
8505513|NCT00468559|20961806|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
8505514|NCT00468546|20961834|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
8505515|NCT00468546|20961835|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
8505516|NCT00468546|20961834|P2|COMPLETED|Week 24 to Week 104 Analysis||83
8505517|NCT00468546|20961835|P1|COMPLETED|Week 24 to Week 104 Analysis||103
8505518|NCT00468546|20961834|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
8505519|NCT00468546|20961835|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
8505520|NCT00468546|20961834|P2|NOT COMPLETED|Week 24 Analysis||55
8505521|NCT00468546|20961835|P1|NOT COMPLETED|Week 24 Analysis||97
8505522|NCT00468546|20961834|P2|COMPLETED|Week 24 Analysis||253
8505523|NCT00468546|20961835|P1|COMPLETED|Week 24 Analysis||111
8505524|NCT00468546|20961834|P2|STARTED|Week 24 Analysis||308
8505525|NCT00468546|20961835|P1|STARTED|Week 24 Analysis||208
8505526|NCT00468481|20961865|P2|NOT COMPLETED|Overall Study||24
8505527|NCT00468481|20961866|P1|NOT COMPLETED|Overall Study||88
8505528|NCT00468481|20961865|P2|COMPLETED|Overall Study||70
8505529|NCT00468481|20961866|P1|COMPLETED|Overall Study||203
8505530|NCT00468481|20961865|P2|Subjects Treated|Overall Study||94
8505531|NCT00468481|20961866|P1|Subjects Treated|Overall Study||285
8505532|NCT00468481|20961865|P2|STARTED|Overall Study||94
8505533|NCT00468481|20961866|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
8505534|NCT00468312|20961966|P2|NOT COMPLETED|Overall Study||5
8505535|NCT00468312|20961967|P1|NOT COMPLETED|Overall Study||4
8505536|NCT00468312|20961966|P2|COMPLETED|Overall Study||204
8505537|NCT00468312|20961967|P1|COMPLETED|Overall Study||216
8505538|NCT00468312|20961966|P2|STARTED|Overall Study||209
8505539|NCT00468312|20961967|P1|STARTED|Overall Study||220
8505540|NCT00468299|20961983|P2|NOT COMPLETED|Overall Study||1
8505541|NCT00468299|20961984|P1|NOT COMPLETED|Overall Study||0
8505542|NCT00468299|20961983|P2|COMPLETED|Overall Study||7
8505543|NCT00468299|20961984|P1|COMPLETED|Overall Study||9
8505544|NCT00468299|20961983|P2|STARTED|Overall Study||8
8505545|NCT00468299|20961984|P1|STARTED|Overall Study||9
8505546|NCT00468286|20961994|P2|NOT COMPLETED|Overall Study||12
8505547|NCT00468286|20961995|P1|NOT COMPLETED|Overall Study||7
8505548|NCT00468286|20961994|P2|COMPLETED|Overall Study||54
8505549|NCT00468286|20961995|P1|COMPLETED|Overall Study||60
8505550|NCT00468286|20961994|P2|STARTED|Overall Study||66
8505551|NCT00468286|20961995|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
8505552|NCT00468208|20962017|P1|NOT COMPLETED|Overall Study||0
8505553|NCT00468208|20962017|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
8505554|NCT00468208|20962017|P1|STARTED|Overall Study||20
8505555|NCT00468169|20962027|P2|NOT COMPLETED|Overall Study||0
8505556|NCT00468169|20962028|P1|NOT COMPLETED|Overall Study||1
8505557|NCT00468169|20962027|P2|COMPLETED|Overall Study||53
8505558|NCT00468169|20962028|P1|COMPLETED|Overall Study||56
8505559|NCT00468169|20962027|P2|STARTED|Overall Study||53
8505560|NCT00468169|20962028|P1|STARTED|Overall Study||57
8505561|NCT00468143|20962044|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
8505562|NCT00468143|20962045|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
8505563|NCT00468143|20962044|P2|COMPLETED|Second Intervention (3 Weeks)||24
8505564|NCT00468143|20962045|P1|COMPLETED|Second Intervention (3 Weeks)||25
8505565|NCT00468143|20962044|P2|STARTED|Second Intervention (3 Weeks)||27
8505566|NCT00468143|20962045|P1|STARTED|Second Intervention (3 Weeks)||28
8505567|NCT00468143|20962044|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
8505568|NCT00468143|20962045|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
8505569|NCT00468143|20962044|P2|COMPLETED|First Intervention (3 Weeks)||27
8505570|NCT00468143|20962045|P1|COMPLETED|First Intervention (3 Weeks)||28
8505571|NCT00468143|20962044|P2|STARTED|First Intervention (3 Weeks)||31
8505572|NCT00468143|20962045|P1|STARTED|First Intervention (3 Weeks)||31
8505573|NCT00468104|20962059|P2|NOT COMPLETED|Second Intervention||4
8505574|NCT00468104|20962060|P1|NOT COMPLETED|Second Intervention||5
8505575|NCT00468104|20962059|P2|COMPLETED|Second Intervention||37
8505576|NCT00468104|20962060|P1|COMPLETED|Second Intervention||3
8505577|NCT00468104|20962059|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
8505578|NCT00468104|20962060|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
8505579|NCT00468104|20962059|P2|NOT COMPLETED|First Intervention||1
8505580|NCT00468104|20962060|P1|NOT COMPLETED|First Intervention||9
8505581|NCT00468104|20962059|P2|COMPLETED|First Intervention||45
8505582|NCT00468104|20962060|P1|COMPLETED|First Intervention||45
8505583|NCT00468104|20962059|P2|STARTED|First Intervention||46
8505584|NCT00468104|20962060|P1|STARTED|First Intervention||54
8505585|NCT00468052|20962077|P2|NOT COMPLETED|Overall Study||8
8505586|NCT00468052|20962078|P1|NOT COMPLETED|Overall Study||7
8505587|NCT00468052|20962077|P2|COMPLETED|Overall Study||61
8505588|NCT00468052|20962078|P1|COMPLETED|Overall Study||61
8505589|NCT00468052|20962077|P2|Target Enrollment|Overall Study||70
8505590|NCT00468052|20962078|P1|Target Enrollment|Overall Study||70
8505591|NCT00468052|20962077|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
8505592|NCT00468052|20962078|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
8505593|NCT00467961|20962096|P1|NOT COMPLETED|Overall Study||7
8505594|NCT00467961|20962096|P1|COMPLETED|Overall Study||24
8505595|NCT00467961|20962096|P1|STARTED|Overall Study||31
8505596|NCT00467896|20962100|P1|NOT COMPLETED|Overall Study||51
8505597|NCT00467896|20962100|P1|COMPLETED|Overall Study||11
8505598|NCT00467896|20962100|P1|STARTED|Overall Study||62
8505599|NCT00467870|20962126|P6|NOT COMPLETED|Overall Study||2
8505600|NCT00467870|20962127|P5|NOT COMPLETED|Overall Study||37
8505601|NCT00467870|20962128|P4|NOT COMPLETED|Overall Study||33
8505602|NCT00467870|20962129|P3|NOT COMPLETED|Overall Study||4
8505603|NCT00467870|20962130|P2|NOT COMPLETED|Overall Study||43
8505604|NCT00467870|20962131|P1|NOT COMPLETED|Overall Study||45
8505605|NCT00467870|20962126|P6|COMPLETED|Overall Study||21
8505606|NCT00467870|20962127|P5|COMPLETED|Overall Study||93
8505607|NCT00467870|20962128|P4|COMPLETED|Overall Study||79
8505608|NCT00467870|20962129|P3|COMPLETED|Overall Study||18
8505609|NCT00467870|20962130|P2|COMPLETED|Overall Study||74
8505610|NCT00467870|20962131|P1|COMPLETED|Overall Study||75
8505611|NCT00467870|20962126|P6|STARTED|Overall Study||23
8505612|NCT00467870|20962127|P5|STARTED|Overall Study||130
8505613|NCT00467870|20962128|P4|STARTED|Overall Study||112
8505614|NCT00467870|20962129|P3|STARTED|Overall Study||22
8505615|NCT00467870|20962130|P2|STARTED|Overall Study||117
8505616|NCT00467870|20962131|P1|STARTED|Overall Study||120
8505617|NCT00467857|20962174|P2|NOT COMPLETED|Overall Study||8
8505618|NCT00467857|20962175|P1|NOT COMPLETED|Overall Study||3
8505619|NCT00467857|20962174|P2|COMPLETED|Overall Study||139
8505620|NCT00467857|20962175|P1|COMPLETED|Overall Study||143
8505621|NCT00467857|20962174|P2|STARTED|Overall Study||147
8505622|NCT00467857|20962175|P1|STARTED|Overall Study||146
8505623|NCT00467844|20962210|P3|NOT COMPLETED|Overall Study||14
8505624|NCT00467844|20962211|P2|NOT COMPLETED|Overall Study||20
8505625|NCT00467844|20962212|P1|NOT COMPLETED|Overall Study||19
8505626|NCT00467844|20962210|P3|COMPLETED|Overall Study||38
8505627|NCT00467844|20962211|P2|COMPLETED|Overall Study||34
8505628|NCT00467844|20962212|P1|COMPLETED|Overall Study||34
8505629|NCT00467844|20962210|P3|STARTED|Overall Study||52
8505630|NCT00467844|20962211|P2|STARTED|Overall Study||54
8505631|NCT00467844|20962212|P1|STARTED|Overall Study||53
8505632|NCT00467831|20962223|P1|NOT COMPLETED|Overall Study||3
8505633|NCT00467831|20962223|P1|COMPLETED|Overall Study||0
8505634|NCT00467831|20962223|P1|STARTED|Overall Study||3
8505635|NCT00467818|20962229|P2|NOT COMPLETED|Overall Study||2
8505636|NCT00467818|20962230|P1|NOT COMPLETED|Overall Study||3
8505637|NCT00467818|20962229|P2|COMPLETED|Overall Study||6
8505638|NCT00467818|20962230|P1|COMPLETED|Overall Study||6
8505639|NCT00467818|20962229|P2|STARTED|Overall Study||8
8505640|NCT00467818|20962230|P1|STARTED|Overall Study||9
8505641|NCT00467779|20962259|P15|NOT COMPLETED|Stage 3||17
8505642|NCT00467779|20962260|P14|NOT COMPLETED|Stage 3||0
8505643|NCT00467779|20962261|P13|NOT COMPLETED|Stage 3||0
8505644|NCT00467779|20962262|P12|NOT COMPLETED|Stage 3||0
8505645|NCT00467779|20962263|P11|NOT COMPLETED|Stage 3||0
8505646|NCT00467779|20962264|P10|NOT COMPLETED|Stage 3||0
8505647|NCT00467779|20962265|P9|NOT COMPLETED|Stage 3||0
8505648|NCT00467779|20962266|P8|NOT COMPLETED|Stage 3||0
8505649|NCT00467779|20962267|P7|NOT COMPLETED|Stage 3||0
8505650|NCT00467779|20962268|P6|NOT COMPLETED|Stage 3||0
8505651|NCT00467779|20962269|P5|NOT COMPLETED|Stage 3||0
8505652|NCT00467779|20962270|P4|NOT COMPLETED|Stage 3||0
8505653|NCT00467779|20962271|P3|NOT COMPLETED|Stage 3||0
8505654|NCT00467779|20962272|P2|NOT COMPLETED|Stage 3||0
8505655|NCT00467779|20962273|P1|NOT COMPLETED|Stage 3||0
8505656|NCT00467779|20962259|P15|COMPLETED|Stage 3||3
8505657|NCT00467779|20962260|P14|COMPLETED|Stage 3||0
8505658|NCT00467779|20962261|P13|COMPLETED|Stage 3||0
8505659|NCT00467779|20962262|P12|COMPLETED|Stage 3||0
8505660|NCT00467779|20962263|P11|COMPLETED|Stage 3||0
8505661|NCT00467779|20962264|P10|COMPLETED|Stage 3||0
8505662|NCT00467779|20962265|P9|COMPLETED|Stage 3||0
8505663|NCT00467779|20962266|P8|COMPLETED|Stage 3||0
8505664|NCT00467779|20962267|P7|COMPLETED|Stage 3||0
8505665|NCT00467779|20962268|P6|COMPLETED|Stage 3||0
8505666|NCT00467779|20962269|P5|COMPLETED|Stage 3||0
8505667|NCT00467779|20962270|P4|COMPLETED|Stage 3||0
8505668|NCT00467779|20962271|P3|COMPLETED|Stage 3||0
8505669|NCT00467779|20962272|P2|COMPLETED|Stage 3||0
8505670|NCT00467779|20962273|P1|COMPLETED|Stage 3||0
8505671|NCT00467779|20962259|P15|STARTED|Stage 3||20
8505672|NCT00467779|20962260|P14|STARTED|Stage 3||0
8505673|NCT00467779|20962261|P13|STARTED|Stage 3||0
8505674|NCT00467779|20962262|P12|STARTED|Stage 3||0
8505675|NCT00467779|20962263|P11|STARTED|Stage 3||0
8505676|NCT00467779|20962264|P10|STARTED|Stage 3||0
8505677|NCT00467779|20962265|P9|STARTED|Stage 3||0
8505678|NCT00467779|20962266|P8|STARTED|Stage 3||0
8505679|NCT00467779|20962267|P7|STARTED|Stage 3||0
8505680|NCT00467779|20962268|P6|STARTED|Stage 3||0
8505681|NCT00467779|20962269|P5|STARTED|Stage 3||0
8505682|NCT00467779|20962270|P4|STARTED|Stage 3||0
8505683|NCT00467779|20962271|P3|STARTED|Stage 3||0
8505684|NCT00467779|20962272|P2|STARTED|Stage 3||0
8505685|NCT00467779|20962273|P1|STARTED|Stage 3||0
8505686|NCT00467779|20962259|P15|NOT COMPLETED|Stage 2A||0
8505687|NCT00467779|20962260|P14|NOT COMPLETED|Stage 2A||21
8505688|NCT00467779|20962261|P13|NOT COMPLETED|Stage 2A||0
8505689|NCT00467779|20962262|P12|NOT COMPLETED|Stage 2A||0
8505690|NCT00467779|20962263|P11|NOT COMPLETED|Stage 2A||0
8505691|NCT00467779|20962264|P10|NOT COMPLETED|Stage 2A||0
8505692|NCT00467779|20962265|P9|NOT COMPLETED|Stage 2A||0
8505693|NCT00467779|20962266|P8|NOT COMPLETED|Stage 2A||0
8505694|NCT00467779|20962267|P7|NOT COMPLETED|Stage 2A||0
8505695|NCT00467779|20962268|P6|NOT COMPLETED|Stage 2A||0
8505696|NCT00467779|20962269|P5|NOT COMPLETED|Stage 2A||0
8505697|NCT00467779|20962270|P4|NOT COMPLETED|Stage 2A||0
8505698|NCT00467779|20962271|P3|NOT COMPLETED|Stage 2A||0
8505699|NCT00467779|20962272|P2|NOT COMPLETED|Stage 2A||0
8505700|NCT00467779|20962273|P1|NOT COMPLETED|Stage 2A||0
8505701|NCT00467779|20962259|P15|COMPLETED|Stage 2A||0
8505702|NCT00467779|20962260|P14|COMPLETED|Stage 2A||1
8505703|NCT00467779|20962261|P13|COMPLETED|Stage 2A||0
8505704|NCT00467779|20962262|P12|COMPLETED|Stage 2A||0
8505705|NCT00467779|20962263|P11|COMPLETED|Stage 2A||0
8505706|NCT00467779|20962264|P10|COMPLETED|Stage 2A||0
8505707|NCT00467779|20962265|P9|COMPLETED|Stage 2A||0
8505708|NCT00467779|20962266|P8|COMPLETED|Stage 2A||0
8505709|NCT00467779|20962267|P7|COMPLETED|Stage 2A||0
8505710|NCT00467779|20962268|P6|COMPLETED|Stage 2A||0
8505711|NCT00467779|20962269|P5|COMPLETED|Stage 2A||0
8505712|NCT00467779|20962270|P4|COMPLETED|Stage 2A||0
8505713|NCT00467779|20962271|P3|COMPLETED|Stage 2A||0
8505714|NCT00467779|20962272|P2|COMPLETED|Stage 2A||0
8505715|NCT00467779|20962273|P1|COMPLETED|Stage 2A||0
8505716|NCT00467779|20962259|P15|STARTED|Stage 2A||0
8505717|NCT00467779|20962260|P14|STARTED|Stage 2A||22
8505718|NCT00467779|20962261|P13|STARTED|Stage 2A||0
8505719|NCT00467779|20962262|P12|STARTED|Stage 2A||0
8505720|NCT00467779|20962263|P11|STARTED|Stage 2A||0
8505721|NCT00467779|20962264|P10|STARTED|Stage 2A||0
8505722|NCT00467779|20962265|P9|STARTED|Stage 2A||0
8505723|NCT00467779|20962266|P8|STARTED|Stage 2A||0
8505724|NCT00467779|20962267|P7|STARTED|Stage 2A||0
8505725|NCT00467779|20962268|P6|STARTED|Stage 2A||0
8505726|NCT00467779|20962269|P5|STARTED|Stage 2A||0
8505727|NCT00467779|20962270|P4|STARTED|Stage 2A||0
8505728|NCT00467779|20962271|P3|STARTED|Stage 2A||0
8505729|NCT00467779|20962272|P2|STARTED|Stage 2A||0
8505730|NCT00467779|20962273|P1|STARTED|Stage 2A||0
8505731|NCT00467779|20962259|P15|NOT COMPLETED|Stage 2||0
8505732|NCT00467779|20962260|P14|NOT COMPLETED|Stage 2||0
8505733|NCT00467779|20962261|P13|NOT COMPLETED|Stage 2||0
8505734|NCT00467779|20962262|P12|NOT COMPLETED|Stage 2||0
8505735|NCT00467779|20962263|P11|NOT COMPLETED|Stage 2||0
8505736|NCT00467779|20962264|P10|NOT COMPLETED|Stage 2||0
8505737|NCT00467779|20962265|P9|NOT COMPLETED|Stage 2||21
8505738|NCT00467779|20962266|P8|NOT COMPLETED|Stage 2||0
8505739|NCT00467779|20962267|P7|NOT COMPLETED|Stage 2||0
8505740|NCT00467779|20962268|P6|NOT COMPLETED|Stage 2||0
8505741|NCT00467779|20962269|P5|NOT COMPLETED|Stage 2||0
8505742|NCT00467779|20962270|P4|NOT COMPLETED|Stage 2||0
8505743|NCT00467779|20962271|P3|NOT COMPLETED|Stage 2||0
8505744|NCT00467779|20962272|P2|NOT COMPLETED|Stage 2||0
8505745|NCT00467779|20962273|P1|NOT COMPLETED|Stage 2||0
8505746|NCT00467779|20962259|P15|COMPLETED|Stage 2||0
8505747|NCT00467779|20962260|P14|COMPLETED|Stage 2||0
8505748|NCT00467779|20962261|P13|COMPLETED|Stage 2||0
8505749|NCT00467779|20962262|P12|COMPLETED|Stage 2||0
8505750|NCT00467779|20962263|P11|COMPLETED|Stage 2||0
8505751|NCT00467779|20962264|P10|COMPLETED|Stage 2||0
8505752|NCT00467779|20962265|P9|COMPLETED|Stage 2||0
8505753|NCT00467779|20962266|P8|COMPLETED|Stage 2||0
8505754|NCT00467779|20962267|P7|COMPLETED|Stage 2||0
8505755|NCT00467779|20962268|P6|COMPLETED|Stage 2||0
8505756|NCT00467779|20962269|P5|COMPLETED|Stage 2||0
8505757|NCT00467779|20962270|P4|COMPLETED|Stage 2||0
8505758|NCT00467779|20962271|P3|COMPLETED|Stage 2||0
8505759|NCT00467779|20962272|P2|COMPLETED|Stage 2||0
8505760|NCT00467779|20962273|P1|COMPLETED|Stage 2||0
8505761|NCT00467779|20962259|P15|STARTED|Stage 2||0
8505762|NCT00467779|20962260|P14|STARTED|Stage 2||0
8505763|NCT00467779|20962261|P13|STARTED|Stage 2||0
8505764|NCT00467779|20962262|P12|STARTED|Stage 2||0
8505765|NCT00467779|20962263|P11|STARTED|Stage 2||0
8505766|NCT00467779|20962264|P10|STARTED|Stage 2||0
8505767|NCT00467779|20962265|P9|STARTED|Stage 2||21
8505768|NCT00467779|20962266|P8|STARTED|Stage 2||0
8505769|NCT00467779|20962267|P7|STARTED|Stage 2||0
8505770|NCT00467779|20962268|P6|STARTED|Stage 2||0
8505771|NCT00467779|20962269|P5|STARTED|Stage 2||0
8505772|NCT00467779|20962270|P4|STARTED|Stage 2||0
8505773|NCT00467779|20962271|P3|STARTED|Stage 2||0
8505774|NCT00467779|20962272|P2|STARTED|Stage 2||0
8505775|NCT00467779|20962273|P1|STARTED|Stage 2||0
8505776|NCT00467779|20962259|P15|NOT COMPLETED|Stage 1A||0
8505777|NCT00467779|20962260|P14|NOT COMPLETED|Stage 1A||0
8505778|NCT00467779|20962261|P13|NOT COMPLETED|Stage 1A||6
8505779|NCT00467779|20962262|P12|NOT COMPLETED|Stage 1A||8
8505780|NCT00467779|20962263|P11|NOT COMPLETED|Stage 1A||3
8505781|NCT00467779|20962264|P10|NOT COMPLETED|Stage 1A||3
8505782|NCT00467779|20962265|P9|NOT COMPLETED|Stage 1A||0
8505783|NCT00467779|20962266|P8|NOT COMPLETED|Stage 1A||0
8505784|NCT00467779|20962267|P7|NOT COMPLETED|Stage 1A||0
8505785|NCT00467779|20962268|P6|NOT COMPLETED|Stage 1A||0
8505786|NCT00467779|20962269|P5|NOT COMPLETED|Stage 1A||0
8505787|NCT00467779|20962270|P4|NOT COMPLETED|Stage 1A||0
8505788|NCT00467779|20962271|P3|NOT COMPLETED|Stage 1A||0
8505789|NCT00467779|20962272|P2|NOT COMPLETED|Stage 1A||0
8505790|NCT00467779|20962273|P1|NOT COMPLETED|Stage 1A||0
8505791|NCT00467779|20962259|P15|COMPLETED|Stage 1A||0
8505792|NCT00467779|20962260|P14|COMPLETED|Stage 1A||0
8505793|NCT00467779|20962261|P13|COMPLETED|Stage 1A||0
8505794|NCT00467779|20962262|P12|COMPLETED|Stage 1A||0
8505795|NCT00467779|20962263|P11|COMPLETED|Stage 1A||0
8505796|NCT00467779|20962264|P10|COMPLETED|Stage 1A||0
8505797|NCT00467779|20962265|P9|COMPLETED|Stage 1A||0
8505798|NCT00467779|20962266|P8|COMPLETED|Stage 1A||0
8505799|NCT00467779|20962267|P7|COMPLETED|Stage 1A||0
8505800|NCT00467779|20962268|P6|COMPLETED|Stage 1A||0
8505801|NCT00467779|20962269|P5|COMPLETED|Stage 1A||0
8505802|NCT00467779|20962270|P4|COMPLETED|Stage 1A||0
8505803|NCT00467779|20962271|P3|COMPLETED|Stage 1A||0
8505804|NCT00467779|20962272|P2|COMPLETED|Stage 1A||0
8505805|NCT00467779|20962273|P1|COMPLETED|Stage 1A||0
8505806|NCT00467779|20962259|P15|STARTED|Stage 1A||0
8505807|NCT00467779|20962260|P14|STARTED|Stage 1A||0
8505808|NCT00467779|20962261|P13|STARTED|Stage 1A||6
8505809|NCT00467779|20962262|P12|STARTED|Stage 1A||8
8505810|NCT00467779|20962263|P11|STARTED|Stage 1A||3
8505811|NCT00467779|20962264|P10|STARTED|Stage 1A||3
8505812|NCT00467779|20962265|P9|STARTED|Stage 1A||0
8505813|NCT00467779|20962266|P8|STARTED|Stage 1A||0
8505814|NCT00467779|20962267|P7|STARTED|Stage 1A||0
8505815|NCT00467779|20962268|P6|STARTED|Stage 1A||0
8505816|NCT00467779|20962269|P5|STARTED|Stage 1A||0
8505817|NCT00467779|20962270|P4|STARTED|Stage 1A||0
8505818|NCT00467779|20962271|P3|STARTED|Stage 1A||0
8505819|NCT00467779|20962272|P2|STARTED|Stage 1A||0
8505820|NCT00467779|20962273|P1|STARTED|Stage 1A||0
8505821|NCT00467779|20962259|P15|NOT COMPLETED|Stage 1||0
8505822|NCT00467779|20962260|P14|NOT COMPLETED|Stage 1||0
8505823|NCT00467779|20962261|P13|NOT COMPLETED|Stage 1||0
8505824|NCT00467779|20962262|P12|NOT COMPLETED|Stage 1||0
8505825|NCT00467779|20962263|P11|NOT COMPLETED|Stage 1||0
8505826|NCT00467779|20962264|P10|NOT COMPLETED|Stage 1||0
8505827|NCT00467779|20962265|P9|NOT COMPLETED|Stage 1||0
8505828|NCT00467779|20962266|P8|NOT COMPLETED|Stage 1||7
8505829|NCT00467779|20962267|P7|NOT COMPLETED|Stage 1||7
8505830|NCT00467779|20962268|P6|NOT COMPLETED|Stage 1||5
8505831|NCT00467779|20962269|P5|NOT COMPLETED|Stage 1||3
8505832|NCT00467779|20962270|P4|NOT COMPLETED|Stage 1||3
8505833|NCT00467779|20962271|P3|NOT COMPLETED|Stage 1||3
8505834|NCT00467779|20962272|P2|NOT COMPLETED|Stage 1||3
8505835|NCT00467779|20962273|P1|NOT COMPLETED|Stage 1||4
8505836|NCT00467779|20962259|P15|COMPLETED|Stage 1||0
8505837|NCT00467779|20962260|P14|COMPLETED|Stage 1||0
8505838|NCT00467779|20962261|P13|COMPLETED|Stage 1||0
8505839|NCT00467779|20962262|P12|COMPLETED|Stage 1||0
8505840|NCT00467779|20962263|P11|COMPLETED|Stage 1||0
8505841|NCT00467779|20962264|P10|COMPLETED|Stage 1||0
8505842|NCT00467779|20962265|P9|COMPLETED|Stage 1||0
8505843|NCT00467779|20962266|P8|COMPLETED|Stage 1||0
8505844|NCT00467779|20962267|P7|COMPLETED|Stage 1||0
8505845|NCT00467779|20962268|P6|COMPLETED|Stage 1||1
8505846|NCT00467779|20962269|P5|COMPLETED|Stage 1||0
8505847|NCT00467779|20962270|P4|COMPLETED|Stage 1||0
8505848|NCT00467779|20962271|P3|COMPLETED|Stage 1||0
8505849|NCT00467779|20962272|P2|COMPLETED|Stage 1||0
8505850|NCT00467779|20962273|P1|COMPLETED|Stage 1||0
8505851|NCT00467779|20962259|P15|STARTED|Stage 1||0
8505852|NCT00467779|20962260|P14|STARTED|Stage 1||0
8505853|NCT00467779|20962261|P13|STARTED|Stage 1||0
8505854|NCT00467779|20962262|P12|STARTED|Stage 1||0
8505855|NCT00467779|20962263|P11|STARTED|Stage 1||0
8505856|NCT00467779|20962264|P10|STARTED|Stage 1||0
8505857|NCT00467779|20962265|P9|STARTED|Stage 1||0
8505858|NCT00467779|20962266|P8|STARTED|Stage 1||7
8505859|NCT00467779|20962267|P7|STARTED|Stage 1||7
8505860|NCT00467779|20962268|P6|STARTED|Stage 1||6
8505861|NCT00467779|20962269|P5|STARTED|Stage 1||3
8505862|NCT00467779|20962270|P4|STARTED|Stage 1||3
8505863|NCT00467779|20962271|P3|STARTED|Stage 1||3
8505864|NCT00467779|20962272|P2|STARTED|Stage 1||3
8505865|NCT00467779|20962273|P1|STARTED|Stage 1||4
8505866|NCT00467753|20962447|P2|NOT COMPLETED|Overall Study||2
8505867|NCT00467753|20962448|P1|NOT COMPLETED|Overall Study||3
8505868|NCT00467753|20962447|P2|COMPLETED|Overall Study||0
8505869|NCT00467753|20962448|P1|COMPLETED|Overall Study||0
8505870|NCT00467753|20962447|P2|STARTED|Overall Study||2
8505871|NCT00467753|20962448|P1|STARTED|Overall Study||3
8505872|NCT00467740|20962465|P5|NOT COMPLETED|Overall Study||0
8505873|NCT00467740|20962466|P4|NOT COMPLETED|Overall Study||1
8505874|NCT00467740|20962467|P3|NOT COMPLETED|Overall Study||2
8505875|NCT00467740|20962468|P2|NOT COMPLETED|Overall Study||3
8505876|NCT00467740|20962469|P1|NOT COMPLETED|Overall Study||1
8505877|NCT00467740|20962465|P5|COMPLETED|Overall Study||61
8505878|NCT00467740|20962466|P4|COMPLETED|Overall Study||59
8505879|NCT00467740|20962467|P3|COMPLETED|Overall Study||58
8505880|NCT00467740|20962468|P2|COMPLETED|Overall Study||58
8505881|NCT00467740|20962469|P1|COMPLETED|Overall Study||53
8505882|NCT00467740|20962465|P5|STARTED|Overall Study||61
8505883|NCT00467740|20962466|P4|STARTED|Overall Study||60
8505884|NCT00467740|20962467|P3|STARTED|Overall Study||60
8505885|NCT00467740|20962468|P2|STARTED|Overall Study||61
8505886|NCT00467740|20962469|P1|STARTED|Overall Study||54
8505887|NCT00467649|20962658|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
8505888|NCT00467649|20962659|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505889|NCT00467649|20962660|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
8505890|NCT00467649|20962661|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505891|NCT00467649|20962662|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505892|NCT00467649|20962663|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505893|NCT00467649|20962658|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
8505894|NCT00467649|20962659|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
8505895|NCT00467649|20962660|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
8505896|NCT00467649|20962661|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
8505897|NCT00467649|20962662|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505898|NCT00467649|20962663|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505899|NCT00467649|20962658|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
8505900|NCT00467649|20962659|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
8505901|NCT00467649|20962660|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
8505902|NCT00467649|20962661|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
8505903|NCT00467649|20962662|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
8505904|NCT00467649|20962663|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
8505905|NCT00467649|20962658|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505906|NCT00467649|20962659|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505907|NCT00467649|20962660|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505908|NCT00467649|20962661|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505909|NCT00467649|20962662|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
8505910|NCT00467649|20962663|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
8505911|NCT00467649|20962658|P6|COMPLETED|Phase 1 (Randomized Population)||0
8505912|NCT00467649|20962659|P5|COMPLETED|Phase 1 (Randomized Population)||0
8505913|NCT00467649|20962660|P4|COMPLETED|Phase 1 (Randomized Population)||0
8505914|NCT00467649|20962661|P3|COMPLETED|Phase 1 (Randomized Population)||0
8505915|NCT00467649|20962662|P2|COMPLETED|Phase 1 (Randomized Population)||50
8505916|NCT00467649|20962663|P1|COMPLETED|Phase 1 (Randomized Population)||48
8505917|NCT00467649|20962658|P6|Intent to Treat|Phase 1 (Randomized Population)||0
8505918|NCT00467649|20962659|P5|Intent to Treat|Phase 1 (Randomized Population)||0
8505919|NCT00467649|20962660|P4|Intent to Treat|Phase 1 (Randomized Population)||0
8505920|NCT00467649|20962661|P3|Intent to Treat|Phase 1 (Randomized Population)||0
8505921|NCT00467649|20962662|P2|Intent to Treat|Phase 1 (Randomized Population)||56
8505922|NCT00467649|20962663|P1|Intent to Treat|Phase 1 (Randomized Population)||56
8505923|NCT00467649|20962658|P6|STARTED|Phase 1 (Randomized Population)||0
8505924|NCT00467649|20962659|P5|STARTED|Phase 1 (Randomized Population)||0
8505925|NCT00467649|20962660|P4|STARTED|Phase 1 (Randomized Population)||0
8505926|NCT00467649|20962661|P3|STARTED|Phase 1 (Randomized Population)||0
8505927|NCT00467649|20962662|P2|STARTED|Phase 1 (Randomized Population)||56
8505928|NCT00467649|20962663|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
8505929|NCT00467610|20962703|P1|NOT COMPLETED|Overall Study||1
8505930|NCT00467610|20962703|P1|COMPLETED|Overall Study||5
8505931|NCT00467610|20962703|P1|STARTED|Overall Study||6
8505932|NCT00467597|20962714|P2|NOT COMPLETED|Overall Study||0
8505933|NCT00467597|20962715|P1|NOT COMPLETED|Overall Study||2
8505934|NCT00467597|20962714|P2|COMPLETED|Overall Study||6
8505935|NCT00467597|20962715|P1|COMPLETED|Overall Study||24
8505936|NCT00467597|20962714|P2|STARTED|Overall Study||6
8505937|NCT00467597|20962715|P1|STARTED|Overall Study||26
8505938|NCT00467584|20962728|P3|NOT COMPLETED|Overall Study||1
8505939|NCT00467584|20962729|P2|NOT COMPLETED|Overall Study||5
8505940|NCT00467584|20962730|P1|NOT COMPLETED|Overall Study||4
8505941|NCT00467584|20962728|P3|COMPLETED|Overall Study||20
8505942|NCT00467584|20962729|P2|COMPLETED|Overall Study||15
8505943|NCT00467584|20962730|P1|COMPLETED|Overall Study||17
8505944|NCT00467584|20962728|P3|STARTED|Overall Study||21
8505945|NCT00467584|20962729|P2|STARTED|Overall Study||20
8505946|NCT00467584|20962730|P1|STARTED|Overall Study||21
8505947|NCT00467558|20962740|P2|NOT COMPLETED|Overall Study||0
8505948|NCT00467558|20962741|P1|NOT COMPLETED|Overall Study||2
8505949|NCT00467558|20962740|P2|COMPLETED|Overall Study||3
8505950|NCT00467558|20962741|P1|COMPLETED|Overall Study||2
8505951|NCT00467558|20962740|P2|STARTED|Overall Study||3
8505952|NCT00467558|20962741|P1|STARTED|Overall Study||4
8505953|NCT00467519|20962751|P2|NOT COMPLETED|Overall Study||23
8505954|NCT00467519|20962752|P1|NOT COMPLETED|Overall Study||14
8505955|NCT00467519|20962751|P2|COMPLETED|Overall Study||488
8505956|NCT00467519|20962752|P1|COMPLETED|Overall Study||517
8505957|NCT00467519|20962751|P2|STARTED|Overall Study||511
8505958|NCT00467519|20962752|P1|STARTED|Overall Study||531
8505959|NCT00467389|20962768|P2|NOT COMPLETED|Overall Study||0
8505960|NCT00467389|20962769|P1|NOT COMPLETED|Overall Study||0
8505961|NCT00467389|20962768|P2|COMPLETED|Overall Study||6
8505962|NCT00467389|20962769|P1|COMPLETED|Overall Study||6
8505963|NCT00467389|20962768|P2|STARTED|Overall Study||6
8505964|NCT00467389|20962769|P1|STARTED|Overall Study||6
8505965|NCT00467363|20962781|P2|NOT COMPLETED|Overall Study||70
8505966|NCT00467363|20962782|P1|NOT COMPLETED|Overall Study||80
8505967|NCT00467363|20962781|P2|COMPLETED|Overall Study||543
8505968|NCT00467363|20962782|P1|COMPLETED|Overall Study||535
8505969|NCT00467363|20962781|P2|STARTED|Overall Study||613
8505970|NCT00467363|20962782|P1|STARTED|Overall Study||615
8505971|NCT00467350|20962818|P2|NOT COMPLETED|Overall Study||0
8505972|NCT00467350|20962819|P1|NOT COMPLETED|Overall Study||1
8505973|NCT00467350|20962818|P2|COMPLETED|Overall Study||39
8505974|NCT00467350|20962819|P1|COMPLETED|Overall Study||40
8505975|NCT00467350|20962818|P2|STARTED|Overall Study||39
8505976|NCT00467350|20962819|P1|STARTED|Overall Study||41
8505977|NCT00467298|20962827|P2|NOT COMPLETED|Overall Study||6
8505978|NCT00467298|20962828|P1|NOT COMPLETED|Overall Study||4
8505979|NCT00467298|20962827|P2|COMPLETED|Overall Study||38
8505980|NCT00467298|20962828|P1|COMPLETED|Overall Study||42
8505981|NCT00467298|20962827|P2|STARTED|Overall Study||44
8505982|NCT00467298|20962828|P1|STARTED|Overall Study||46
8505983|NCT00467285|20962838|P2|NOT COMPLETED|Overall Study||4
8505984|NCT00467285|20962839|P1|NOT COMPLETED|Overall Study||4
8505985|NCT00467285|20962838|P2|COMPLETED|Overall Study||60
8505986|NCT00467285|20962839|P1|COMPLETED|Overall Study||28
8505987|NCT00467285|20962838|P2|STARTED|Overall Study||64
8505988|NCT00467285|20962839|P1|STARTED|Overall Study||32
8505989|NCT00467259|20962859|P2|NOT COMPLETED|Overall Study||242
8505990|NCT00467259|20962860|P1|NOT COMPLETED|Overall Study||75
8505991|NCT00467259|20962859|P2|COMPLETED|Overall Study||778
8505992|NCT00467259|20962860|P1|COMPLETED|Overall Study||176
8505993|NCT00467259|20962859|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
8505994|NCT00467259|20962860|P1|ITT Population|Overall Study||251
8505995|NCT00467259|20962859|P2|STARTED|Overall Study||1020
8505996|NCT00467259|20962860|P1|STARTED|Overall Study||251
8505997|NCT00467077|20962870|P1|NOT COMPLETED|Overall Study||0
8505998|NCT00467077|20962870|P1|COMPLETED|Overall Study||21
8505999|NCT00467077|20962870|P1|STARTED|Overall Study||21
8506000|NCT00467051|20962877|P1|NOT COMPLETED|Overall Study||2
8506001|NCT00467051|20962877|P1|COMPLETED|Overall Study||18
8506002|NCT00467051|20962877|P1|STARTED|Overall Study||20
8506003|NCT00467038|20962884|P2|NOT COMPLETED|Overall Study||0
8506004|NCT00467038|20962885|P1|NOT COMPLETED|Overall Study||0
8506005|NCT00467038|20962884|P2|COMPLETED|Overall Study||11
8506006|NCT00467038|20962885|P1|COMPLETED|Overall Study||11
8506007|NCT00467038|20962884|P2|STARTED|Overall Study||11
8506008|NCT00467038|20962885|P1|STARTED|Overall Study||11
8506009|NCT00466960|20962893|P1|NOT COMPLETED|Overall Study||0
8506010|NCT00466960|20962893|P1|COMPLETED|Overall Study||21
8506011|NCT00466960|20962893|P1|STARTED|Overall Study||21
8506012|NCT00466947|20962904|P2|NOT COMPLETED|Study End Analysis Period||2534
8506013|NCT00466947|20962905|P1|NOT COMPLETED|Study End Analysis Period||2496
8506014|NCT00466947|20962904|P2|COMPLETED|Study End Analysis Period||9265
8506015|NCT00466947|20962905|P1|COMPLETED|Study End Analysis Period||9302
8506016|NCT00466947|20962904|P2|STARTED|Study End Analysis Period||11799
8506017|NCT00466947|20962905|P1|STARTED|Study End Analysis Period||11798
8506018|NCT00466947|20962904|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
8506019|NCT00466947|20962905|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
8506020|NCT00466947|20962904|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
8506021|NCT00466947|20962905|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
8506022|NCT00466947|20962904|P2|Ongoing|Primary Outcome Analysis Period||11863
8506023|NCT00466947|20962905|P1|Ongoing|Primary Outcome Analysis Period||11875
8506024|NCT00466947|20962904|P2|STARTED|Primary Outcome Analysis Period||11863
8506025|NCT00466947|20962905|P1|STARTED|Primary Outcome Analysis Period||11875
8506026|NCT00466921|20963027|P1|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
8506027|NCT00466921|20963027|P1|COMPLETED|Follow up for a Minimum of 1 Year||27
8506028|NCT00466921|20963027|P1|STARTED|Follow up for a Minimum of 1 Year||33
8506029|NCT00466921|20963027|P1|NOT COMPLETED|Continued Treatment||0
8506030|NCT00466921|20963027|P1|COMPLETED|Continued Treatment||21
8506031|NCT00466921|20963027|P1|STARTED|Continued Treatment||21
8506032|NCT00466921|20963027|P1|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
8506033|NCT00466921|20963027|P1|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
8506034|NCT00466921|20963027|P1|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
8506035|NCT00466921|20963027|P1|STARTED|Completed 4 Cycles/Reached 1st Response||26
8506036|NCT00466921|20963027|P1|NOT COMPLETED|First 3 Cycles of Treatment||7
8506037|NCT00466921|20963027|P1|COMPLETED|First 3 Cycles of Treatment||26
8506038|NCT00466921|20963027|P1|Completed 3 Cycles|First 3 Cycles of Treatment||26
8506039|NCT00466921|20963027|P1|Started Cycle 2|First 3 Cycles of Treatment||31
8506040|NCT00466921|20963027|P1|Completed 1 Cycle|First 3 Cycles of Treatment||32
8506041|NCT00466921|20963027|P1|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
8506042|NCT00466817|20963036|P2|NOT COMPLETED|Overall Study||4
8506043|NCT00466817|20963037|P1|NOT COMPLETED|Overall Study||5
8506044|NCT00466817|20963036|P2|COMPLETED|Overall Study||43
8506045|NCT00466817|20963037|P1|COMPLETED|Overall Study||44
8506046|NCT00466817|20963036|P2|STARTED|Overall Study||47
8506047|NCT00466817|20963037|P1|STARTED|Overall Study||49
8506048|NCT00466752|20963092|P2|NOT COMPLETED|Overall Study||0
8506049|NCT00466752|20963093|P1|NOT COMPLETED|Overall Study||0
8506050|NCT00466752|20963092|P2|COMPLETED|Overall Study||0
8506051|NCT00466752|20963093|P1|COMPLETED|Overall Study||5
8506052|NCT00466752|20963092|P2|STARTED|Overall Study||0
8506053|NCT00466752|20963093|P1|STARTED|Overall Study||5
8506054|NCT00466726|20963103|P1|NOT COMPLETED|Overall Study||14
8506055|NCT00466726|20963103|P1|COMPLETED|Overall Study||43
8506056|NCT00466726|20963103|P1|STARTED|Overall Study||57
8506057|NCT00466687|20963109|P1|NOT COMPLETED|Overall Study||34
8506058|NCT00466687|20963109|P1|COMPLETED|Overall Study||0
8506059|NCT00466687|20963109|P1|STARTED|Overall Study||34
8506060|NCT00466661|20963118|P2|NOT COMPLETED|Overall Study||6
8506061|NCT00466661|20963119|P1|NOT COMPLETED|Overall Study||4
8506062|NCT00466661|20963118|P2|COMPLETED|Overall Study||11
8506063|NCT00466661|20963119|P1|COMPLETED|Overall Study||12
8506064|NCT00466661|20963118|P2|At Least 1 Postrandomization Visit|Overall Study||16
8506065|NCT00466661|20963119|P1|At Least 1 Postrandomization Visit|Overall Study||14
8506066|NCT00466661|20963118|P2|STARTED|Overall Study||17
8506067|NCT00466661|20963119|P1|STARTED|Overall Study||16
8506068|NCT00466505|20963141|P1|NOT COMPLETED|Overall Study||17
8506069|NCT00466505|20963141|P1|COMPLETED|Overall Study||0
8506070|NCT00466505|20963141|P1|STARTED|Overall Study||17
8506071|NCT00466440|20963156|P3|NOT COMPLETED|Overall Study||12
8506072|NCT00466440|20963157|P2|NOT COMPLETED|Overall Study||12
8506073|NCT00466440|20963158|P1|NOT COMPLETED|Overall Study||14
8506074|NCT00466440|20963156|P3|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
8506075|NCT00466440|20963157|P2|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
8506076|NCT00466440|20963158|P1|COMPLETED|Overall Study||0
8506077|NCT00466440|20963156|P3|Received at Least One Dose of Study Drug|Overall Study||41
8506078|NCT00466440|20963157|P2|Received at Least One Dose of Study Drug|Overall Study||47
8506079|NCT00466440|20963158|P1|Received at Least One Dose of Study Drug|Overall Study||14
8506080|NCT00466440|20963156|P3|STARTED|Overall Study||46
8506081|NCT00466440|20963157|P2|STARTED|Overall Study||48
8506082|NCT00466440|20963158|P1|STARTED|Overall Study||14
8506083|NCT00466323|20963197|P2|NOT COMPLETED|Overall Study||23
8506084|NCT00466323|20963198|P1|NOT COMPLETED|Overall Study||28
8506085|NCT00466323|20963197|P2|COMPLETED|Overall Study||92
8506086|NCT00466323|20963198|P1|COMPLETED|Overall Study||89
8506087|NCT00466323|20963197|P2|STARTED|Overall Study||115
8506088|NCT00466323|20963198|P1|STARTED|Overall Study||117
8506089|NCT00466310|20963213|P3|NOT COMPLETED|Overall Study||0
8506090|NCT00466310|20963214|P2|NOT COMPLETED|Overall Study||0
8506091|NCT00466310|20963215|P1|NOT COMPLETED|Overall Study||0
8506092|NCT00466310|20963213|P3|COMPLETED|Overall Study||31
8506093|NCT00466310|20963214|P2|COMPLETED|Overall Study||20
8506094|NCT00466310|20963215|P1|COMPLETED|Overall Study||20
8506095|NCT00466310|20963213|P3|STARTED|Overall Study||31
8506096|NCT00466310|20963214|P2|STARTED|Overall Study||20
8506097|NCT00466310|20963215|P1|STARTED|Overall Study||20
8506098|NCT00466206|20963223|P1|NOT COMPLETED|Overall Study||0
8506099|NCT00466206|20963223|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
8506100|NCT00466206|20963223|P1|STARTED|Overall Study||10
8506101|NCT00466193|20963233|P2|NOT COMPLETED|Overall Study||8
8506102|NCT00466193|20963234|P1|NOT COMPLETED|Overall Study||12
8506103|NCT00466193|20963233|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
8506104|NCT00466193|20963234|P1|COMPLETED|Overall Study||138
8506105|NCT00466193|20963233|P2|STARTED|Overall Study||145
8506106|NCT00466193|20963234|P1|STARTED|Overall Study||150
8506107|NCT00466167|20963261|P3|NOT COMPLETED|Overall Study||21
8506108|NCT00466167|20963262|P2|NOT COMPLETED|Overall Study||12
8506109|NCT00466167|20963263|P1|NOT COMPLETED|Overall Study||20
8506110|NCT00466167|20963261|P3|COMPLETED|Overall Study||157
8506111|NCT00466167|20963262|P2|COMPLETED|Overall Study||163
8506112|NCT00466167|20963263|P1|COMPLETED|Overall Study||145
8506113|NCT00466167|20963261|P3|STARTED|Overall Study||178
8506114|NCT00466167|20963262|P2|STARTED|Overall Study||175
8506115|NCT00466167|20963263|P1|STARTED|Overall Study||165
8506116|NCT00465998|20963319|P1|NOT COMPLETED|Overall Study||0
8506117|NCT00465998|20963319|P1|COMPLETED|Overall Study||275
8506118|NCT00465998|20963319|P1|STARTED|Overall Study||275
8506119|NCT00465985|20963324|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
8506120|NCT00465985|20963325|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
8506121|NCT00465985|20963324|P2|COMPLETED|Part III - Open-label Treatment Period||0
8506122|NCT00465985|20963325|P1|COMPLETED|Part III - Open-label Treatment Period||29
8506123|NCT00465985|20963324|P2|STARTED|Part III - Open-label Treatment Period||0
8506124|NCT00465985|20963325|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
8506125|NCT00465985|20963324|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
8506126|NCT00465985|20963325|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
8506127|NCT00465985|20963324|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
8506128|NCT00465985|20963325|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
8506129|NCT00465985|20963324|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
8506130|NCT00465985|20963325|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
8506131|NCT00465985|20963324|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
8506132|NCT00465985|20963325|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
8506133|NCT00465985|20963324|P2|COMPLETED|Part I - Open-label Treatment Period||0
8506134|NCT00465985|20963325|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
8506135|NCT00465985|20963324|P2|STARTED|Part I - Open-label Treatment Period||0
8506136|NCT00465985|20963325|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
8506137|NCT00465972|20963348|P2|NOT COMPLETED|Overall Study||1
8506138|NCT00465972|20963349|P1|NOT COMPLETED|Overall Study||2
8506139|NCT00465972|20963348|P2|COMPLETED|Overall Study||23
8506140|NCT00465972|20963349|P1|COMPLETED|Overall Study||18
8506141|NCT00465972|20963348|P2|STARTED|Overall Study||24
8506142|NCT00465972|20963349|P1|STARTED|Overall Study||20
8506143|NCT00465894|20963359|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
8506144|NCT00465894|20963360|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
8506145|NCT00465894|20963359|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
8506146|NCT00465894|20963360|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
8506147|NCT00465894|20963359|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
8506148|NCT00465894|20963360|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
8506149|NCT00465894|20963359|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
8506150|NCT00465894|20963360|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
8506151|NCT00465894|20963359|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
8506152|NCT00465894|20963360|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
8506153|NCT00465894|20963359|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
8506154|NCT00465894|20963360|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
8506155|NCT00465894|20963359|P2|NOT COMPLETED|Treatment For 12 Weeks||3
8506156|NCT00465894|20963360|P1|NOT COMPLETED|Treatment For 12 Weeks||5
8506157|NCT00465894|20963359|P2|COMPLETED|Treatment For 12 Weeks||25
8506158|NCT00465894|20963360|P1|COMPLETED|Treatment For 12 Weeks||25
8506159|NCT00465894|20963359|P2|STARTED|Treatment For 12 Weeks||28
8506160|NCT00465894|20963360|P1|STARTED|Treatment For 12 Weeks||30
8506161|NCT00465816|20963393|P3|NOT COMPLETED|Overall Study||2
8506162|NCT00465816|20963394|P2|NOT COMPLETED|Overall Study||0
8506163|NCT00465816|20963395|P1|NOT COMPLETED|Overall Study||0
8506164|NCT00465816|20963393|P3|COMPLETED|Overall Study||120
8506165|NCT00465816|20963394|P2|COMPLETED|Overall Study||122
8506166|NCT00465816|20963395|P1|COMPLETED|Overall Study||367
8506167|NCT00465816|20963393|P3|STARTED|Overall Study||122
8506168|NCT00465816|20963394|P2|STARTED|Overall Study||122
8506169|NCT00465816|20963395|P1|STARTED|Overall Study||367
8506170|NCT00465738|20963458|P2|NOT COMPLETED|Overall Study||6
8506171|NCT00465738|20963459|P1|NOT COMPLETED|Overall Study||6
8506172|NCT00465738|20963458|P2|COMPLETED|Overall Study||89
8506173|NCT00465738|20963459|P1|COMPLETED|Overall Study||91
8506174|NCT00465738|20963458|P2|STARTED|Overall Study||95
8506175|NCT00465738|20963459|P1|STARTED|Overall Study||97
8506176|NCT00465647|20963553|P4|NOT COMPLETED|Overall Study||13
8506177|NCT00465647|20963554|P3|NOT COMPLETED|Overall Study||11
8506178|NCT00465647|20963555|P2|NOT COMPLETED|Overall Study||8
8506179|NCT00465647|20963556|P1|NOT COMPLETED|Overall Study||13
8506180|NCT00465647|20963553|P4|COMPLETED|Overall Study||12
8506181|NCT00465647|20963554|P3|COMPLETED|Overall Study||18
8506182|NCT00465647|20963555|P2|COMPLETED|Overall Study||15
8506183|NCT00465647|20963556|P1|COMPLETED|Overall Study||26
8506184|NCT00465647|20963553|P4|STARTED|Overall Study||25
8506185|NCT00465647|20963554|P3|STARTED|Overall Study||29
8506186|NCT00465647|20963555|P2|STARTED|Overall Study||23
8506187|NCT00465647|20963556|P1|STARTED|Overall Study||39
8506188|NCT00465595|20963581|P2|NOT COMPLETED|Overall Study||5
8506189|NCT00465595|20963582|P1|NOT COMPLETED|Overall Study||5
8506190|NCT00465595|20963581|P2|COMPLETED|Overall Study||24
8506191|NCT00465595|20963582|P1|COMPLETED|Overall Study||22
8506192|NCT00465595|20963581|P2|STARTED|Overall Study||29
8506193|NCT00465595|20963582|P1|STARTED|Overall Study||27
8506194|NCT00465569|20963604|P2|NOT COMPLETED|Overall Study||0
8506195|NCT00465569|20963605|P1|NOT COMPLETED|Overall Study||1
8506196|NCT00465569|20963604|P2|COMPLETED|Overall Study||7
8506197|NCT00465569|20963605|P1|COMPLETED|Overall Study||12
8506198|NCT00465569|20963604|P2|STARTED|Overall Study||7
8506199|NCT00465569|20963605|P1|STARTED|Overall Study||13
8506200|NCT00465530|20963617|P2|NOT COMPLETED|Overall Study||4
8506201|NCT00465530|20963618|P1|NOT COMPLETED|Overall Study||2
8506202|NCT00465530|20963617|P2|COMPLETED|Overall Study||15
8506203|NCT00465530|20963618|P1|COMPLETED|Overall Study||19
8506204|NCT00465530|20963617|P2|STARTED|Overall Study||19
8506205|NCT00465530|20963618|P1|STARTED|Overall Study||21
8506206|NCT00465361|20963628|P1|NOT COMPLETED|Post-Intervention Assessment||0
8506207|NCT00465361|20963628|P1|COMPLETED|Post-Intervention Assessment||3
8506208|NCT00465361|20963628|P1|STARTED|Post-Intervention Assessment||3
8506209|NCT00465361|20963628|P1|NOT COMPLETED|Baseline Assessment||4
8506210|NCT00465361|20963628|P1|COMPLETED|Baseline Assessment||3
8506211|NCT00465361|20963628|P1|STARTED|Baseline Assessment||7
8506212|NCT00465270|20963634|P2|NOT COMPLETED|Overall Study||160
8506213|NCT00465270|20963635|P1|NOT COMPLETED|Overall Study||104
8506214|NCT00465270|20963634|P2|COMPLETED|Overall Study||321
8506215|NCT00465270|20963635|P1|COMPLETED|Overall Study||395
8506216|NCT00465270|20963634|P2|STARTED|Overall Study||481
8506217|NCT00465270|20963635|P1|STARTED|Overall Study||499
8506218|NCT00465179|20963644|P1|NOT COMPLETED|Overall Study||53
8506219|NCT00465179|20963644|P1|COMPLETED|Overall Study||4
8506220|NCT00465179|20963644|P1|STARTED|Overall Study||57
8506221|NCT00465101|20963650|P1|NOT COMPLETED|Overall Study||59
8506222|NCT00465101|20963650|P1|COMPLETED|Overall Study||91
8506223|NCT00465101|20963650|P1|STARTED|Overall Study||150
8506224|NCT00465088|20963685|P2|NOT COMPLETED|Overall Study||9
8506225|NCT00465088|20963686|P1|NOT COMPLETED|Overall Study||32
8506226|NCT00465088|20963685|P2|COMPLETED|Overall Study||70
8506227|NCT00465088|20963686|P1|COMPLETED|Overall Study||82
8506228|NCT00465088|20963685|P2|STARTED|Overall Study||79
8506229|NCT00465088|20963686|P1|STARTED|Overall Study|For both arms, started means treated.|114
8506230|NCT00464945|20963720|P2|NOT COMPLETED|Toddler Dose||1
8506231|NCT00464945|20963721|P1|NOT COMPLETED|Toddler Dose||0
8506232|NCT00464945|20963720|P2|COMPLETED|Toddler Dose||130
8506233|NCT00464945|20963721|P1|COMPLETED|Toddler Dose||131
8506234|NCT00464945|20963720|P2|STARTED|Toddler Dose||131
8506235|NCT00464945|20963721|P1|STARTED|Toddler Dose||131
8506236|NCT00464945|20963720|P2|NOT COMPLETED|After Infant Series||2
8506237|NCT00464945|20963721|P1|NOT COMPLETED|After Infant Series||0
8506238|NCT00464945|20963720|P2|COMPLETED|After Infant Series||131
8506239|NCT00464945|20963721|P1|COMPLETED|After Infant Series||131
8506240|NCT00464945|20963720|P2|STARTED|After Infant Series||133
8506241|NCT00464945|20963721|P1|STARTED|After Infant Series||131
8506242|NCT00464945|20963720|P2|NOT COMPLETED|Infant Series||1
8506243|NCT00464945|20963721|P1|NOT COMPLETED|Infant Series||4
8506244|NCT00464945|20963720|P2|COMPLETED|Infant Series||133
8506245|NCT00464945|20963721|P1|COMPLETED|Infant Series||131
8506246|NCT00464945|20963720|P2|Vaccinated Dose 3|Infant Series||133
8506247|NCT00464945|20963721|P1|Vaccinated Dose 3|Infant Series||132
8506248|NCT00464945|20963720|P2|Vaccinated Dose 2|Infant Series||133
8506249|NCT00464945|20963721|P1|Vaccinated Dose 2|Infant Series||132
8506250|NCT00464945|20963720|P2|Vaccinated Dose 1|Infant Series||134
8506251|NCT00464945|20963721|P1|Vaccinated Dose 1|Infant Series||134
8506252|NCT00464945|20963720|P2|STARTED|Infant Series||134
8506253|NCT00464945|20963721|P1|STARTED|Infant Series||135
8506254|NCT00464815|20963751|P2|NOT COMPLETED|Overall Study||3
8506255|NCT00464815|20963752|P1|NOT COMPLETED|Overall Study||6
8506256|NCT00464815|20963751|P2|COMPLETED|Overall Study||254
8506257|NCT00464815|20963752|P1|COMPLETED|Overall Study||762
8506258|NCT00464815|20963751|P2|STARTED|Overall Study||257
8506259|NCT00464815|20963752|P1|STARTED|Overall Study||768
8506260|NCT00464737|20963785|P3|NOT COMPLETED|Overall Study||55
8506261|NCT00464737|20963786|P2|NOT COMPLETED|Overall Study||32
8506262|NCT00464737|20963787|P1|NOT COMPLETED|Overall Study||32
8506263|NCT00464737|20963785|P3|COMPLETED|Overall Study||19
8506264|NCT00464737|20963786|P2|COMPLETED|Overall Study||42
8506265|NCT00464737|20963787|P1|COMPLETED|Overall Study||50
8506266|NCT00464737|20963785|P3|STARTED|Overall Study||74
8506267|NCT00464737|20963786|P2|STARTED|Overall Study||74
8506268|NCT00464737|20963787|P1|STARTED|Overall Study||82
8506269|NCT00464711|20963834|P1|NOT COMPLETED|Overall Study||15
8506270|NCT00464711|20963834|P1|COMPLETED|Overall Study||25
8506271|NCT00464711|20963834|P1|STARTED|Overall Study||40
8506272|NCT00464698|20963838|P1|NOT COMPLETED|Period 3: 120mg||2
8506273|NCT00464698|20963838|P1|COMPLETED|Period 3: 120mg||12
8506274|NCT00464698|20963838|P1|STARTED|Period 3: 120mg||14
8506275|NCT00464698|20963838|P1|NOT COMPLETED|Period 2: 60 mg||0
8506276|NCT00464698|20963838|P1|COMPLETED|Period 2: 60 mg||17
8506277|NCT00464698|20963838|P1|STARTED|Period 2: 60 mg||17
8506278|NCT00464698|20963838|P1|NOT COMPLETED|Period 1: 30 mg||3
8506279|NCT00464698|20963838|P1|COMPLETED|Period 1: 30 mg||17
8506280|NCT00464698|20963838|P1|STARTED|Period 1: 30 mg||20
8506281|NCT00464685|20963850|P2|NOT COMPLETED|Overall Study||33
8506282|NCT00464685|20963851|P1|NOT COMPLETED|Overall Study||23
8506283|NCT00464685|20963850|P2|COMPLETED|Overall Study||94
8506284|NCT00464685|20963851|P1|COMPLETED|Overall Study||103
8506285|NCT00464685|20963850|P2|STARTED|Overall Study||127
8506286|NCT00464685|20963851|P1|STARTED|Overall Study||126
8506287|NCT00464672|20963867|P6|NOT COMPLETED|Overall Study||4
8506288|NCT00464672|20963868|P5|NOT COMPLETED|Overall Study||10
8506289|NCT00464672|20963869|P4|NOT COMPLETED|Overall Study||1
8506290|NCT00464672|20963870|P3|NOT COMPLETED|Overall Study||0
8506291|NCT00464672|20963871|P2|NOT COMPLETED|Overall Study||10
8506292|NCT00464672|20963872|P1|NOT COMPLETED|Overall Study||25
8506293|NCT00464672|20963867|P6|COMPLETED|Overall Study||195
8506294|NCT00464672|20963868|P5|COMPLETED|Overall Study||392
8506295|NCT00464672|20963869|P4|COMPLETED|Overall Study||199
8506296|NCT00464672|20963870|P3|COMPLETED|Overall Study||400
8506297|NCT00464672|20963871|P2|COMPLETED|Overall Study||222
8506298|NCT00464672|20963872|P1|COMPLETED|Overall Study||435
8506299|NCT00464672|20963867|P6|STARTED|Overall Study||199
8506300|NCT00464672|20963868|P5|STARTED|Overall Study||402
8506301|NCT00464672|20963869|P4|STARTED|Overall Study||200
8506302|NCT00464672|20963870|P3|STARTED|Overall Study||400
8506303|NCT00464672|20963871|P2|STARTED|Overall Study||232
8506304|NCT00464672|20963872|P1|STARTED|Overall Study||460
8506305|NCT00464646|20963944|P2|NOT COMPLETED|Overall Study||0
8506306|NCT00464646|20963945|P1|NOT COMPLETED|Overall Study||0
8506307|NCT00464646|20963944|P2|COMPLETED|Overall Study||29
8506308|NCT00464646|20963945|P1|COMPLETED|Overall Study||76
8506309|NCT00464646|20963944|P2|STARTED|Overall Study||29
8506310|NCT00464646|20963945|P1|STARTED|Overall Study||76
8506311|NCT00464620|20963951|P3|NOT COMPLETED|Overall Study||7
8506312|NCT00464620|20963952|P2|NOT COMPLETED|Overall Study||2
8506313|NCT00464620|20963953|P1|NOT COMPLETED|Overall Study||2
8506314|NCT00464620|20963951|P3|COMPLETED|Overall Study||109
8506315|NCT00464620|20963952|P2|COMPLETED|Overall Study||198
8506316|NCT00464620|20963953|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
8506317|NCT00464620|20963951|P3|STARTED|Overall Study||116
8506318|NCT00464620|20963952|P2|STARTED|Overall Study||200
8506319|NCT00464620|20963953|P1|STARTED|Overall Study||50
8506320|NCT00464568|20963980|P1|NOT COMPLETED|Overall Study||2
8506321|NCT00464568|20963980|P1|COMPLETED|Overall Study||30
8506322|NCT00464568|20963980|P1|STARTED|Overall Study||32
8506323|NCT00464542|20964053|P1|NOT COMPLETED|Post-treatment||0
8506324|NCT00464542|20964053|P1|COMPLETED|Post-treatment||10
8506325|NCT00464542|20964053|P1|STARTED|Post-treatment||10
8506326|NCT00464542|20964053|P1|NOT COMPLETED|Pre-treatment||2
8506327|NCT00464542|20964053|P1|COMPLETED|Pre-treatment||10
8506328|NCT00464542|20964053|P1|STARTED|Pre-treatment||12
8506329|NCT00464490|20964060|P2|NOT COMPLETED|Overall Study||11
8506330|NCT00464490|20964061|P1|NOT COMPLETED|Overall Study||11
8506331|NCT00464490|20964060|P2|COMPLETED|Overall Study||10
8506332|NCT00464490|20964061|P1|COMPLETED|Overall Study||10
8506333|NCT00464490|20964060|P2|STARTED|Overall Study||21
8506334|NCT00464490|20964061|P1|STARTED|Overall Study||21
8506335|NCT00464464|20964069|P2|NOT COMPLETED|Overall Study||3
8506336|NCT00464464|20964070|P1|NOT COMPLETED|Overall Study||5
8506337|NCT00464464|20964069|P2|COMPLETED|Overall Study||36
8506338|NCT00464464|20964070|P1|COMPLETED|Overall Study||36
8506339|NCT00464464|20964069|P2|STARTED|Overall Study||39
8506340|NCT00464464|20964070|P1|STARTED|Overall Study||41
8506341|NCT00464438|20964084|P2|NOT COMPLETED|Overall Study||6
8506342|NCT00464438|20964085|P1|NOT COMPLETED|Overall Study||2
8506343|NCT00464438|20964084|P2|COMPLETED|Overall Study||80
8506344|NCT00464438|20964085|P1|COMPLETED|Overall Study||83
8506345|NCT00464438|20964084|P2|STARTED|Overall Study||86
8506346|NCT00464438|20964085|P1|STARTED|Overall Study||85
8506347|NCT00464334|20964108|P11|NOT COMPLETED|Overall Study||4
8506348|NCT00464334|20964109|P10|NOT COMPLETED|Overall Study||1
8506349|NCT00464334|20964110|P9|NOT COMPLETED|Overall Study||6
8506350|NCT00464334|20964111|P8|NOT COMPLETED|Overall Study||1
8506351|NCT00464334|20964112|P7|NOT COMPLETED|Overall Study||3
8506352|NCT00464334|20964113|P6|NOT COMPLETED|Overall Study||4
8506353|NCT00464334|20964114|P5|NOT COMPLETED|Overall Study||4
8506354|NCT00464334|20964115|P4|NOT COMPLETED|Overall Study||4
8506355|NCT00464334|20964116|P3|NOT COMPLETED|Overall Study||5
8506356|NCT00464334|20964117|P2|NOT COMPLETED|Overall Study||8
8506357|NCT00464334|20964118|P1|NOT COMPLETED|Overall Study||1
8506358|NCT00464334|20964108|P11|COMPLETED|Overall Study||4
8506359|NCT00464334|20964109|P10|COMPLETED|Overall Study||4
8506360|NCT00464334|20964110|P9|COMPLETED|Overall Study||2
8506361|NCT00464334|20964111|P8|COMPLETED|Overall Study||7
8506362|NCT00464334|20964112|P7|COMPLETED|Overall Study||6
8506363|NCT00464334|20964113|P6|COMPLETED|Overall Study||3
8506364|NCT00464334|20964114|P5|COMPLETED|Overall Study||3
8506365|NCT00464334|20964115|P4|COMPLETED|Overall Study||4
8506366|NCT00464334|20964116|P3|COMPLETED|Overall Study||3
8506367|NCT00464334|20964117|P2|COMPLETED|Overall Study||5
8506368|NCT00464334|20964118|P1|COMPLETED|Overall Study||4
8506369|NCT00464334|20964108|P11|STARTED|Overall Study||8
8506370|NCT00464334|20964109|P10|STARTED|Overall Study||5
8506371|NCT00464334|20964110|P9|STARTED|Overall Study||8
8506372|NCT00464334|20964111|P8|STARTED|Overall Study||8
8506373|NCT00464334|20964112|P7|STARTED|Overall Study||9
8506374|NCT00464334|20964113|P6|STARTED|Overall Study||7
8506375|NCT00464334|20964114|P5|STARTED|Overall Study||7
8506376|NCT00464334|20964115|P4|STARTED|Overall Study||8
8506377|NCT00464334|20964116|P3|STARTED|Overall Study||8
8506378|NCT00464334|20964117|P2|STARTED|Overall Study||13
8506379|NCT00464334|20964118|P1|STARTED|Overall Study||5
8506380|NCT00464308|20964178|P3|NOT COMPLETED|Overall Study||59
8506381|NCT00464308|20964179|P2|NOT COMPLETED|Overall Study||63
8506382|NCT00464308|20964180|P1|NOT COMPLETED|Overall Study||69
8506383|NCT00464308|20964178|P3|COMPLETED|Overall Study||400
8506384|NCT00464308|20964179|P2|COMPLETED|Overall Study||406
8506385|NCT00464308|20964180|P1|COMPLETED|Overall Study||395
8506386|NCT00464308|20964178|P3|STARTED|Overall Study||459
8506387|NCT00464308|20964179|P2|STARTED|Overall Study||469
8506388|NCT00464308|20964180|P1|STARTED|Overall Study||464
8506389|NCT00464269|20964210|P4|NOT COMPLETED|Overall Study||9
8506390|NCT00464269|20964211|P3|NOT COMPLETED|Overall Study||7
8506391|NCT00464269|20964212|P2|NOT COMPLETED|Overall Study||17
8506392|NCT00464269|20964213|P1|NOT COMPLETED|Overall Study||6
8506393|NCT00464269|20964210|P4|COMPLETED|Overall Study||93
8506394|NCT00464269|20964211|P3|COMPLETED|Overall Study||93
8506395|NCT00464269|20964212|P2|COMPLETED|Overall Study||82
8506396|NCT00464269|20964213|P1|COMPLETED|Overall Study||93
8506397|NCT00464269|20964210|P4|STARTED|Overall Study||102
8506398|NCT00464269|20964211|P3|STARTED|Overall Study||100
8506399|NCT00464269|20964212|P2|STARTED|Overall Study||99
8506400|NCT00464269|20964213|P1|STARTED|Overall Study||99
8506401|NCT00464204|20964313|P2|NOT COMPLETED|Overall Study||32
8506402|NCT00464204|20964314|P1|NOT COMPLETED|Overall Study||49
8506403|NCT00464204|20964313|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
8506404|NCT00464204|20964314|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
8506405|NCT00464204|20964313|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
8506406|NCT00464204|20964314|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
8506407|NCT00464204|20964313|P2|Day 90 Follow-up Performed|Overall Study||74
8506408|NCT00464204|20964314|P1|Day 90 Follow-up Performed|Overall Study||69
8506409|NCT00464204|20964313|P2|Day 30 Follow-up Performed|Overall Study||83
8506410|NCT00464204|20964314|P1|Day 30 Follow-up Performed|Overall Study||89
8506411|NCT00464204|20964313|P2|Completed Treatment|Overall Study||83
8506412|NCT00464204|20964314|P1|Completed Treatment|Overall Study||81
8506413|NCT00464204|20964313|P2|STARTED|Overall Study||96
8506414|NCT00464204|20964314|P1|STARTED|Overall Study||100
8506415|NCT00464087|20964351|P3|NOT COMPLETED|Overall Study||29
8506416|NCT00464087|20964352|P2|NOT COMPLETED|Overall Study||0
8506417|NCT00464087|20964353|P1|NOT COMPLETED|Overall Study||0
8506418|NCT00464087|20964351|P3|COMPLETED|Overall Study||0
8506419|NCT00464087|20964352|P2|COMPLETED|Overall Study||51
8506420|NCT00464087|20964353|P1|COMPLETED|Overall Study||49
8506421|NCT00464087|20964351|P3|STARTED|Overall Study||29
8506422|NCT00464087|20964352|P2|STARTED|Overall Study||51
8506423|NCT00464087|20964353|P1|STARTED|Overall Study||49
8506424|NCT00463866|20964371|P2|NOT COMPLETED|Overall Study||340
8506425|NCT00463866|20964372|P1|NOT COMPLETED|Overall Study||309
8506426|NCT00463866|20964371|P2|COMPLETED|Overall Study||3705
8506427|NCT00463866|20964372|P1|COMPLETED|Overall Study||3699
8506428|NCT00463866|20964371|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
8506429|NCT00463866|20964372|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
8506430|NCT00463840|20964392|P1|NOT COMPLETED|Overall Study||12
8506431|NCT00463840|20964392|P1|COMPLETED|Overall Study||12
8506432|NCT00463840|20964392|P1|STARTED|Overall Study||24
8506433|NCT00463801|20964397|P1|NOT COMPLETED|Overall Study||13
8506434|NCT00463801|20964397|P1|COMPLETED|Overall Study||39
8506435|NCT00463801|20964397|P1|STARTED|Overall Study||52
8506436|NCT00463788|20964403|P2|NOT COMPLETED|Overall Study||54
8506437|NCT00463788|20964404|P1|NOT COMPLETED|Overall Study||109
8506438|NCT00463788|20964403|P2|COMPLETED|Overall Study||4
8506439|NCT00463788|20964404|P1|COMPLETED|Overall Study||6
8506440|NCT00463788|20964403|P2|Treated|Overall Study||57
8506441|NCT00463788|20964404|P1|Treated|Overall Study||114
8506442|NCT00463788|20964403|P2|STARTED|Overall Study||58
8506443|NCT00463788|20964404|P1|STARTED|Overall Study||115
8506444|NCT00463684|20964419|P1|NOT COMPLETED|Overall Study||4
8506445|NCT00463684|20964419|P1|COMPLETED|Overall Study||274
8506446|NCT00463684|20964419|P1|STARTED|Overall Study||278
8506447|NCT00463606|20964437|P3|NOT COMPLETED|Overall Study||20
8506448|NCT00463606|20964438|P2|NOT COMPLETED|Overall Study||34
8506449|NCT00463606|20964439|P1|NOT COMPLETED|Overall Study||41
8506450|NCT00463606|20964437|P3|COMPLETED|Overall Study||231
8506451|NCT00463606|20964438|P2|COMPLETED|Overall Study||220
8506452|NCT00463606|20964439|P1|COMPLETED|Overall Study||212
8506453|NCT00463606|20964437|P3|STARTED|Overall Study||251
8506454|NCT00463606|20964438|P2|STARTED|Overall Study||254
8506455|NCT00463606|20964439|P1|STARTED|Overall Study||253
8506456|NCT00463580|20964464|P2|NOT COMPLETED|Overall Study||2
8506457|NCT00463580|20964465|P1|NOT COMPLETED|Overall Study||3
8506458|NCT00463580|20964464|P2|COMPLETED|Overall Study||28
8506459|NCT00463580|20964465|P1|COMPLETED|Overall Study||27
8506460|NCT00463580|20964464|P2|STARTED|Overall Study||30
8506461|NCT00463580|20964465|P1|STARTED|Overall Study||30
8506462|NCT00463567|20964498|P7|NOT COMPLETED|Overall Study||11
8506463|NCT00463567|20964499|P6|NOT COMPLETED|Overall Study||21
8506464|NCT00463567|20964500|P5|NOT COMPLETED|Overall Study||23
8506465|NCT00463567|20964501|P4|NOT COMPLETED|Overall Study||131
8506466|NCT00463567|20964502|P3|NOT COMPLETED|Overall Study||89
8506467|NCT00463567|20964503|P2|NOT COMPLETED|Overall Study||77
8506468|NCT00463567|20964504|P1|NOT COMPLETED|Overall Study||95
8506469|NCT00463567|20964498|P7|COMPLETED|Overall Study||112
8506470|NCT00463567|20964499|P6|COMPLETED|Overall Study||102
8506471|NCT00463567|20964500|P5|COMPLETED|Overall Study||107
8506472|NCT00463567|20964501|P4|COMPLETED|Overall Study||294
8506473|NCT00463567|20964502|P3|COMPLETED|Overall Study||331
8506474|NCT00463567|20964503|P2|COMPLETED|Overall Study||341
8506475|NCT00463567|20964504|P1|COMPLETED|Overall Study||325
8506476|NCT00463567|20964498|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
8506477|NCT00463567|20964499|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
8506478|NCT00463567|20964500|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
8506479|NCT00463567|20964501|P4|Safety Population: Received Study Drug|Overall Study||418
8506480|NCT00463567|20964502|P3|Safety Population: Received Study Drug|Overall Study||415
8506481|NCT00463567|20964503|P2|Safety Population: Received Study Drug|Overall Study||416
8506482|NCT00463567|20964504|P1|Safety Population: Received Study Drug|Overall Study||416
8506483|NCT00463567|20964498|P7|STARTED|Overall Study||123
8506484|NCT00463567|20964499|P6|STARTED|Overall Study||123
8506485|NCT00463567|20964500|P5|STARTED|Overall Study||130
8506486|NCT00463567|20964501|P4|STARTED|Overall Study||425
8506487|NCT00463567|20964502|P3|STARTED|Overall Study||420
8506488|NCT00463567|20964503|P2|STARTED|Overall Study||418
8506489|NCT00463567|20964504|P1|STARTED|Overall Study|Randomized Participants|420
8506490|NCT00463476|20964537|P2|NOT COMPLETED|Overall Study||3
8506491|NCT00463476|20964538|P1|NOT COMPLETED|Overall Study||2
8506492|NCT00463476|20964537|P2|COMPLETED|Overall Study||151
8506493|NCT00463476|20964538|P1|COMPLETED|Overall Study||149
8506494|NCT00463476|20964537|P2|STARTED|Overall Study||154
8506495|NCT00463476|20964538|P1|STARTED|Overall Study||151
8506496|NCT00463437|20964558|P4|NOT COMPLETED|Overall Study||7
8506497|NCT00463437|20964559|P3|NOT COMPLETED|Overall Study||6
8506498|NCT00463437|20964560|P2|NOT COMPLETED|Overall Study||11
8506499|NCT00463437|20964561|P1|NOT COMPLETED|Overall Study||4
8506500|NCT00463437|20964558|P4|COMPLETED|Overall Study||350
8506501|NCT00463437|20964559|P3|COMPLETED|Overall Study||352
8506502|NCT00463437|20964560|P2|COMPLETED|Overall Study||352
8506503|NCT00463437|20964561|P1|COMPLETED|Overall Study||355
8506504|NCT00463437|20964558|P4|STARTED|Overall Study||357
8506505|NCT00463437|20964559|P3|STARTED|Overall Study||358
8506506|NCT00463437|20964560|P2|STARTED|Overall Study||363
8506507|NCT00463437|20964561|P1|STARTED|Overall Study||359
8506508|NCT00463385|20964627|P4|NOT COMPLETED|Overall Study||22
8506509|NCT00463385|20964628|P3|NOT COMPLETED|Overall Study||22
8506510|NCT00463385|20964629|P2|NOT COMPLETED|Overall Study||22
8506511|NCT00463385|20964630|P1|NOT COMPLETED|Overall Study||22
8506512|NCT00463385|20964627|P4|COMPLETED|Overall Study||0
8506513|NCT00463385|20964628|P3|COMPLETED|Overall Study||0
8506514|NCT00463385|20964629|P2|COMPLETED|Overall Study||0
8506515|NCT00463385|20964630|P1|COMPLETED|Overall Study||0
8506516|NCT00463385|20964627|P4|Treated|Overall Study||22
8506517|NCT00463385|20964628|P3|Treated|Overall Study||19
8506518|NCT00463385|20964629|P2|Treated|Overall Study||22
8506519|NCT00463385|20964630|P1|Treated|Overall Study||22
8506520|NCT00463385|20964627|P4|STARTED|Overall Study||22
8506521|NCT00463385|20964628|P3|STARTED|Overall Study||22
8506522|NCT00463385|20964629|P2|STARTED|Overall Study||22
8506523|NCT00463385|20964630|P1|STARTED|Overall Study||22
8506524|NCT00463346|20964682|P2|NOT COMPLETED|Overall Study||3
8506525|NCT00463346|20964683|P1|NOT COMPLETED|Overall Study||3
8506526|NCT00463346|20964682|P2|COMPLETED|Overall Study||8
8506527|NCT00463346|20964683|P1|COMPLETED|Overall Study||9
8506528|NCT00463346|20964682|P2|STARTED|Overall Study||11
8506529|NCT00463346|20964683|P1|STARTED|Overall Study||12
8506530|NCT00463229|20964693|P2|NOT COMPLETED|Overall Study||10
8506531|NCT00463229|20964694|P1|NOT COMPLETED|Overall Study||9
8506532|NCT00463229|20964693|P2|COMPLETED|Overall Study||39
8506533|NCT00463229|20964694|P1|COMPLETED|Overall Study||43
8506534|NCT00463229|20964693|P2|STARTED|Overall Study||49
8506535|NCT00463229|20964694|P1|STARTED|Overall Study||52
8506536|NCT00463060|20964714|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
8506537|NCT00463060|20964714|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
8506538|NCT00463060|20964714|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
8506539|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
8506540|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
8506541|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
8506542|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
8506543|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
8506544|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
8506545|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
8506546|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
8506547|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
8506548|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
8506549|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
8506550|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
8506551|NCT00463047|20964728|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
8506552|NCT00463047|20964729|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
8506553|NCT00463047|20964728|P2|COMPLETED|Double-Blind Treatment Period 2||88
8506554|NCT00463047|20964729|P1|COMPLETED|Double-Blind Treatment Period 2||92
8506555|NCT00463047|20964728|P2|STARTED|Double-Blind Treatment Period 2||90
8506556|NCT00463047|20964729|P1|STARTED|Double-Blind Treatment Period 2||93
8506557|NCT00463047|20964728|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
8506558|NCT00463047|20964729|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
8506559|NCT00463047|20964728|P2|COMPLETED|Double-Blind Treatment Period 1||90
8506560|NCT00463047|20964729|P1|COMPLETED|Double-Blind Treatment Period 1||93
8506561|NCT00463047|20964728|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
8506562|NCT00463047|20964729|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
8506563|NCT00463047|20964728|P2|NOT COMPLETED|Titration Period 2||23
8506564|NCT00463047|20964729|P1|NOT COMPLETED|Titration Period 2||30
8506565|NCT00463047|20964728|P2|COMPLETED|Titration Period 2||98
8506566|NCT00463047|20964729|P1|COMPLETED|Titration Period 2||93
8506567|NCT00463047|20964728|P2|STARTED|Titration Period 2||121
8506568|NCT00463047|20964729|P1|STARTED|Titration Period 2||123
8506569|NCT00463047|20964728|P2|NOT COMPLETED|Titration Period 1||39
8506570|NCT00463047|20964729|P1|NOT COMPLETED|Titration Period 1||37
8506571|NCT00463047|20964728|P2|COMPLETED|Titration Period 1||121
8506572|NCT00463047|20964729|P1|COMPLETED|Titration Period 1||123
8506573|NCT00463047|20964728|P2|STARTED|Titration Period 1||160
8506574|NCT00463047|20964729|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
8506575|NCT00462982|20964814|P1|NOT COMPLETED|Overall Study||3
8506576|NCT00462982|20964814|P1|COMPLETED|Overall Study||5
8506577|NCT00462982|20964814|P1|STARTED|Overall Study||8
8506578|NCT00462943|20964821|P3|NOT COMPLETED|Overall Study||23
8506579|NCT00462943|20964822|P2|NOT COMPLETED|Overall Study||30
8506580|NCT00462943|20964823|P1|NOT COMPLETED|Overall Study||45
8506581|NCT00462943|20964821|P3|COMPLETED|Overall Study||0
8506582|NCT00462943|20964822|P2|COMPLETED|Overall Study||1
8506583|NCT00462943|20964823|P1|COMPLETED|Overall Study||1
8506584|NCT00462943|20964821|P3|STARTED|Overall Study||23
8506585|NCT00462943|20964822|P2|STARTED|Overall Study||31
8506586|NCT00462943|20964823|P1|STARTED|Overall Study||46
8506587|NCT00462917|20964894|P4|NOT COMPLETED|Overall Study||11
8506588|NCT00462917|20964895|P3|NOT COMPLETED|Overall Study||12
8506589|NCT00462917|20964896|P2|NOT COMPLETED|Overall Study||10
8506590|NCT00462917|20964897|P1|NOT COMPLETED|Overall Study||10
8506591|NCT00462917|20964894|P4|COMPLETED|Overall Study||66
8506592|NCT00462917|20964895|P3|COMPLETED|Overall Study||54
8506593|NCT00462917|20964896|P2|COMPLETED|Overall Study||65
8506594|NCT00462917|20964897|P1|COMPLETED|Overall Study||62
8506595|NCT00462917|20964894|P4|Completed 6 Month Follow-up|Overall Study||66
8506596|NCT00462917|20964895|P3|Completed 6 Month Follow-up|Overall Study||55
8506597|NCT00462917|20964896|P2|Completed 6 Month Follow-up|Overall Study||68
8506598|NCT00462917|20964897|P1|Completed 6 Month Follow-up|Overall Study||63
8506599|NCT00462917|20964894|P4|Completed 6 Week Follow-up|Overall Study||68
8506600|NCT00462917|20964895|P3|Completed 6 Week Follow-up|Overall Study||55
8506601|NCT00462917|20964896|P2|Completed 6 Week Follow-up|Overall Study||70
8506602|NCT00462917|20964897|P1|Completed 6 Week Follow-up|Overall Study||63
8506603|NCT00462917|20964894|P4|Received Risk Information|Overall Study||68
8506604|NCT00462917|20964895|P3|Received Risk Information|Overall Study||55
8506605|NCT00462917|20964896|P2|Received Risk Information|Overall Study||70
8506606|NCT00462917|20964897|P1|Received Risk Information|Overall Study||64
8506607|NCT00462917|20964894|P4|Met With Genetic Counselor|Overall Study||71
8506608|NCT00462917|20964895|P3|Met With Genetic Counselor|Overall Study||56
8506609|NCT00462917|20964896|P2|Met With Genetic Counselor|Overall Study||71
8506610|NCT00462917|20964897|P1|Met With Genetic Counselor|Overall Study||66
8506611|NCT00462917|20964894|P4|STARTED|Overall Study||77
8506612|NCT00462917|20964895|P3|STARTED|Overall Study||66
8506613|NCT00462917|20964896|P2|STARTED|Overall Study||75
8506614|NCT00462917|20964897|P1|STARTED|Overall Study||72
8506615|NCT00462904|20964915|P1|NOT COMPLETED|Overall Study||1
8506616|NCT00462904|20964915|P1|COMPLETED|Overall Study||3
8506617|NCT00462904|20964915|P1|STARTED|Overall Study||4
8506618|NCT00462865|20964920|P1|NOT COMPLETED|Overall Study||1
8506619|NCT00462865|20964920|P1|COMPLETED|Overall Study||17
8506620|NCT00462865|20964920|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
8506621|NCT00462839|20964927|P2|NOT COMPLETED|Viewed Second||0
8506622|NCT00462839|20964928|P1|NOT COMPLETED|Viewed Second||0
8506623|NCT00462839|20964927|P2|COMPLETED|Viewed Second||53
8506624|NCT00462839|20964928|P1|COMPLETED|Viewed Second||53
8506625|NCT00462839|20964927|P2|STARTED|Viewed Second||53
8506626|NCT00462839|20964928|P1|STARTED|Viewed Second||53
8506627|NCT00462839|20964927|P2|NOT COMPLETED|Viewed First||0
8506628|NCT00462839|20964928|P1|NOT COMPLETED|Viewed First||0
8506629|NCT00462839|20964927|P2|COMPLETED|Viewed First||53
8506630|NCT00462839|20964928|P1|COMPLETED|Viewed First||53
8506631|NCT00462839|20964927|P2|STARTED|Viewed First||53
8506632|NCT00462839|20964928|P1|STARTED|Viewed First||53
8506633|NCT00462826|20964940|P1|NOT COMPLETED|Overall Study||5
8506634|NCT00462826|20964940|P1|COMPLETED|Overall Study||44
8506635|NCT00462826|20964940|P1|STARTED|Overall Study||49
8506636|NCT00462761|20964953|P1|NOT COMPLETED|Overall Study||76
8506637|NCT00462761|20964953|P1|COMPLETED|Overall Study||0
8506638|NCT00462761|20964953|P1|STARTED|Overall Study||76
8506639|NCT00462748|20965028|P3|NOT COMPLETED|Overall Study||11
8506640|NCT00462748|20965029|P2|NOT COMPLETED|Overall Study||11
8506641|NCT00462748|20965030|P1|NOT COMPLETED|Overall Study||12
8506642|NCT00462748|20965028|P3|COMPLETED|Overall Study||251
8506643|NCT00462748|20965029|P2|COMPLETED|Overall Study||252
8506644|NCT00462748|20965030|P1|COMPLETED|Overall Study||249
8506645|NCT00462748|20965028|P3|STARTED|Overall Study||262
8506646|NCT00462748|20965029|P2|STARTED|Overall Study||263
8506647|NCT00462748|20965030|P1|STARTED|Overall Study||261
8506648|NCT00462735|20965038|P1|NOT COMPLETED|Overall Study||0
8506649|NCT00462735|20965038|P1|COMPLETED|Overall Study||33
8506650|NCT00462735|20965038|P1|STARTED|Overall Study||33
8506651|NCT00462722|20965049|P3|NOT COMPLETED|Overall Study||12
8506652|NCT00462722|20965050|P2|NOT COMPLETED|Overall Study||4
8506653|NCT00462722|20965051|P1|NOT COMPLETED|Overall Study||13
8506654|NCT00462722|20965049|P3|COMPLETED|Overall Study||42
8506655|NCT00462722|20965050|P2|COMPLETED|Overall Study||51
8506656|NCT00462722|20965051|P1|COMPLETED|Overall Study||37
8506657|NCT00462722|20965049|P3|STARTED|Overall Study||54
8506658|NCT00462722|20965050|P2|STARTED|Overall Study||55
8506659|NCT00462722|20965051|P1|STARTED|Overall Study||50
8506660|NCT00462709|20965083|P1|NOT COMPLETED|Overall Study||67
8506661|NCT00462709|20965083|P1|COMPLETED|Overall Study||79
8506662|NCT00462709|20965083|P1|STARTED|Overall Study||146
8506663|NCT00462670|20965092|P2|NOT COMPLETED|Overall Study||7
8506664|NCT00462670|20965093|P1|NOT COMPLETED|Overall Study||5
8506665|NCT00462670|20965092|P2|COMPLETED|Overall Study||46
8506666|NCT00462670|20965093|P1|COMPLETED|Overall Study||52
8506667|NCT00462670|20965092|P2|STARTED|Overall Study||53
8506668|NCT00462670|20965093|P1|STARTED|Overall Study||57
8506669|NCT00462644|20965103|P2|NOT COMPLETED|Overall Study||0
8506670|NCT00462644|20965104|P1|NOT COMPLETED|Overall Study||0
8506671|NCT00462644|20965103|P2|COMPLETED|Overall Study||12
8506672|NCT00462644|20965104|P1|COMPLETED|Overall Study||18
8506673|NCT00462644|20965103|P2|STARTED|Overall Study||12
8506674|NCT00462644|20965104|P1|STARTED|Overall Study||18
8506675|NCT00462605|20965122|P1|NOT COMPLETED|Overall Study||14
8506676|NCT00462605|20965122|P1|COMPLETED|Overall Study||10
8506677|NCT00462605|20965122|P1|STARTED|Overall Study||24
8506678|NCT00462501|20965130|P1|NOT COMPLETED|Overall Study||5
8506679|NCT00462501|20965130|P1|COMPLETED|Overall Study||30
8506680|NCT00462501|20965130|P1|STARTED|Overall Study||35
8506681|NCT00462488|20965136|P2|NOT COMPLETED|Overall Study||17
8506682|NCT00462488|20965137|P1|NOT COMPLETED|Overall Study||20
8506683|NCT00462488|20965136|P2|COMPLETED|Overall Study||6
8506684|NCT00462488|20965137|P1|COMPLETED|Overall Study||3
8506685|NCT00462488|20965136|P2|Completed Maintenance 2|Overall Study||6
8506686|NCT00462488|20965137|P1|Completed Maintenance 2|Overall Study||7
8506687|NCT00462488|20965136|P2|Completed Induction 2/Maintenance 1|Overall Study||9
8506688|NCT00462488|20965137|P1|Completed Induction 2/Maintenance 1|Overall Study||18
8506689|NCT00462488|20965136|P2|Completed Induction Phase|Overall Study||23
8506690|NCT00462488|20965137|P1|Completed Induction Phase|Overall Study||22
8506691|NCT00462488|20965136|P2|STARTED|Overall Study||23
8506692|NCT00462488|20965137|P1|STARTED|Overall Study||23
8506693|NCT00462462|20965145|P2|NOT COMPLETED|Overall Study||1
8506694|NCT00462462|20965146|P1|NOT COMPLETED|Overall Study||0
8506695|NCT00462462|20965145|P2|COMPLETED|Overall Study||13
8506696|NCT00462462|20965146|P1|COMPLETED|Overall Study||17
8506697|NCT00462462|20965145|P2|STARTED|Overall Study||14
8506698|NCT00462462|20965146|P1|STARTED|Overall Study||17
8506699|NCT00462449|20965156|P2|NOT COMPLETED|Overall Study||0
8506700|NCT00462449|20965157|P1|NOT COMPLETED|Overall Study||0
8506701|NCT00462449|20965156|P2|COMPLETED|Overall Study||10
8506702|NCT00462449|20965157|P1|COMPLETED|Overall Study||13
8506703|NCT00462449|20965156|P2|STARTED|Overall Study||10
8506704|NCT00462449|20965157|P1|STARTED|Overall Study||13
8506705|NCT00462423|20965167|P1|NOT COMPLETED|Overall Study||0
8506706|NCT00462423|20965167|P1|COMPLETED|Overall Study||50
8506707|NCT00462423|20965167|P1|STARTED|Overall Study||50
8506708|NCT00462384|20965174|P1|NOT COMPLETED|Overall Study||9
8506709|NCT00462384|20965174|P1|COMPLETED|Overall Study||30
8506710|NCT00462384|20965174|P1|STARTED|Overall Study||39
8506711|NCT00462345|20965182|P1|NOT COMPLETED|Overall Study||3
8506712|NCT00462345|20965182|P1|COMPLETED|Overall Study||37
8506713|NCT00462345|20965182|P1|Completed First Course|Overall Study||38
8506714|NCT00462345|20965182|P1|STARTED|Overall Study||40
8506715|NCT00462332|20965206|P2|NOT COMPLETED|Overall Study||0
8506716|NCT00462332|20965207|P1|NOT COMPLETED|Overall Study||0
8506717|NCT00462332|20965206|P2|COMPLETED|Overall Study||41
8506718|NCT00462332|20965207|P1|COMPLETED|Overall Study||45
8506719|NCT00462332|20965206|P2|STARTED|Overall Study||41
8506720|NCT00462332|20965207|P1|STARTED|Overall Study||45
8506721|NCT00462306|20965217|P2|NOT COMPLETED|Overall Study||13
8506722|NCT00462306|20965218|P1|NOT COMPLETED|Overall Study||0
8506723|NCT00462306|20965217|P2|COMPLETED|Overall Study||490
8506724|NCT00462306|20965218|P1|COMPLETED|Overall Study||4074
8506725|NCT00462306|20965217|P2|STARTED|Overall Study||503
8506726|NCT00462306|20965218|P1|STARTED|Overall Study||4074
8506727|NCT00462280|20965230|P4|NOT COMPLETED|Overall Study||3
8506728|NCT00462280|20965231|P3|NOT COMPLETED|Overall Study||0
8506729|NCT00462280|20965232|P2|NOT COMPLETED|Overall Study||7
8506730|NCT00462280|20965233|P1|NOT COMPLETED|Overall Study||10
8506731|NCT00462280|20965230|P4|COMPLETED|Overall Study||4
8506732|NCT00462280|20965231|P3|COMPLETED|Overall Study||7
8506733|NCT00462280|20965232|P2|COMPLETED|Overall Study||25
8506734|NCT00462280|20965233|P1|COMPLETED|Overall Study||24
8506735|NCT00462280|20965230|P4|STARTED|Overall Study||7
8506736|NCT00462280|20965231|P3|STARTED|Overall Study||7
8506737|NCT00462280|20965232|P2|STARTED|Overall Study||32
8506738|NCT00462280|20965233|P1|STARTED|Overall Study||34
8506739|NCT00462228|20965293|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
8506740|NCT00462228|20965293|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
8506741|NCT00462228|20965293|P1|STARTED|No Treatment (Washout) 4 Weeks||11
8506742|NCT00462228|20965293|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
8506743|NCT00462228|20965293|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
8506744|NCT00462228|20965293|P1|STARTED|Placebo or Memantine 12 Weeks||11
8506745|NCT00462228|20965293|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
8506746|NCT00462228|20965293|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
8506747|NCT00462228|20965293|P1|STARTED|No Treatment (Washout) 4 Weeks||11
8506748|NCT00462228|20965293|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
8506749|NCT00462228|20965293|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
8506750|NCT00462228|20965293|P1|STARTED|Memantine or Placebo 12 Weeks||11
8506751|NCT00462124|20965314|P1|NOT COMPLETED|Overall Study||1
8506752|NCT00462124|20965314|P1|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
8506753|NCT00462124|20965314|P1|STARTED|Overall Study||7
8506754|NCT00462072|20965322|P3|NOT COMPLETED|Week 10||0
8506755|NCT00462072|20965323|P2|NOT COMPLETED|Week 10||0
8506756|NCT00462072|20965324|P1|NOT COMPLETED|Week 10||0
8506757|NCT00462072|20965322|P3|COMPLETED|Week 10||9
8506758|NCT00462072|20965323|P2|COMPLETED|Week 10||12
8506759|NCT00462072|20965324|P1|COMPLETED|Week 10||10
8506760|NCT00462072|20965322|P3|STARTED|Week 10||9
8506761|NCT00462072|20965323|P2|STARTED|Week 10||12
8506762|NCT00462072|20965324|P1|STARTED|Week 10||10
8506763|NCT00462072|20965322|P3|NOT COMPLETED|Baseline (Week 0)||0
8506764|NCT00462072|20965323|P2|NOT COMPLETED|Baseline (Week 0)||0
8506765|NCT00462072|20965324|P1|NOT COMPLETED|Baseline (Week 0)||0
8506766|NCT00462072|20965322|P3|COMPLETED|Baseline (Week 0)||9
8506767|NCT00462072|20965323|P2|COMPLETED|Baseline (Week 0)||12
8506768|NCT00462072|20965324|P1|COMPLETED|Baseline (Week 0)||10
8506769|NCT00462072|20965322|P3|STARTED|Baseline (Week 0)||9
8506770|NCT00462072|20965323|P2|STARTED|Baseline (Week 0)||12
8506771|NCT00462072|20965324|P1|STARTED|Baseline (Week 0)||10
8506778|NCT00461981|20965349|P2|NOT COMPLETED|Overall Study||9
8506779|NCT00461981|20965350|P1|NOT COMPLETED|Overall Study||11
8506780|NCT00461981|20965349|P2|COMPLETED|Overall Study||42
8506781|NCT00461981|20965350|P1|COMPLETED|Overall Study||39
8506782|NCT00461981|20965349|P2|STARTED|Overall Study||51
8506783|NCT00461981|20965350|P1|STARTED|Overall Study||50
8506784|NCT00461851|20965460|P1|NOT COMPLETED|Overall Study||0
8506785|NCT00461851|20965460|P1|COMPLETED|Overall Study||17
8506786|NCT00461851|20965460|P1|STARTED|Overall Study||17
8506787|NCT00461812|20965466|P1|NOT COMPLETED|Overall Study||10
8506788|NCT00461812|20965466|P1|COMPLETED|Overall Study||0
8506789|NCT00461812|20965466|P1|STARTED|Overall Study||10
8506790|NCT00461786|20965471|P1|NOT COMPLETED|Overall Study||3
8506791|NCT00461786|20965471|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
8506792|NCT00461786|20965471|P1|STARTED|Overall Study||51
8506793|NCT00461734|20965481|P2|NOT COMPLETED|Overall Study||60
8506794|NCT00461734|20965482|P1|NOT COMPLETED|Overall Study||58
8506795|NCT00461734|20965481|P2|COMPLETED|Overall Study||60
8506796|NCT00461734|20965482|P1|COMPLETED|Overall Study||62
8506797|NCT00461734|20965481|P2|STARTED|Overall Study||120
8506798|NCT00461734|20965482|P1|STARTED|Overall Study||120
8506799|NCT00461708|20965516|P2|NOT COMPLETED|Overall Study||38
8506800|NCT00461708|20965517|P1|NOT COMPLETED|Overall Study||115
8506801|NCT00461708|20965516|P2|COMPLETED|Overall Study||0
8506802|NCT00461708|20965517|P1|COMPLETED|Overall Study||0
8506803|NCT00461708|20965516|P2|STARTED|Overall Study||38
8506804|NCT00461708|20965517|P1|STARTED|Overall Study||115
8506805|NCT00461682|20965543|P1|NOT COMPLETED|Overall Study||1
8506806|NCT00461682|20965543|P1|COMPLETED|Overall Study||0
8506807|NCT00461682|20965543|P1|STARTED|Overall Study||1
8506808|NCT00461630|20965571|P2|NOT COMPLETED|Overall Study||827
8506809|NCT00461630|20965572|P1|NOT COMPLETED|Overall Study||906
8506810|NCT00461630|20965571|P2|COMPLETED|Overall Study||12008
8506811|NCT00461630|20965572|P1|COMPLETED|Overall Study||11932
8506812|NCT00461630|20965571|P2|STARTED|Overall Study||12835
8506813|NCT00461630|20965572|P1|STARTED|Overall Study||12838
8506814|NCT00461591|20965588|P2|NOT COMPLETED|Overall Study||85
8506815|NCT00461591|20965589|P1|NOT COMPLETED|Overall Study||89
8506816|NCT00461591|20965588|P2|COMPLETED|Overall Study||311
8506817|NCT00461591|20965589|P1|COMPLETED|Overall Study||317
8506818|NCT00461591|20965588|P2|STARTED|Overall Study||396
8506819|NCT00461591|20965589|P1|STARTED|Overall Study||406
8506820|NCT00461552|20965611|P2|NOT COMPLETED|Overall Study||2
8506821|NCT00461552|20965612|P1|NOT COMPLETED|Overall Study||0
8506822|NCT00461552|20965611|P2|COMPLETED|Overall Study||5
8506823|NCT00461552|20965612|P1|COMPLETED|Overall Study||7
8506824|NCT00461552|20965611|P2|STARTED|Overall Study||7
8506825|NCT00461552|20965612|P1|STARTED|Overall Study||7
8506826|NCT00461513|20965622|P2|NOT COMPLETED|Overall Study||25
8506827|NCT00461513|20965623|P1|NOT COMPLETED|Overall Study||22
8506828|NCT00461513|20965622|P2|COMPLETED|Overall Study||172
8506829|NCT00461513|20965623|P1|COMPLETED|Overall Study||165
8506830|NCT00461513|20965622|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
8506831|NCT00461513|20965623|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
8506832|NCT00461500|20965635|P2|NOT COMPLETED|Overall Study||6
8506833|NCT00461500|20965636|P1|NOT COMPLETED|Overall Study||7
8506834|NCT00461500|20965635|P2|COMPLETED|Overall Study||38
8506835|NCT00461500|20965636|P1|COMPLETED|Overall Study||30
8506836|NCT00461500|20965635|P2|STARTED|Overall Study||44
8506837|NCT00461500|20965636|P1|STARTED|Overall Study||37
8506838|NCT00461331|20965666|P2|NOT COMPLETED|Intervention 2||0
8506839|NCT00461331|20965667|P1|NOT COMPLETED|Intervention 2||0
8506840|NCT00461331|20965666|P2|COMPLETED|Intervention 2||10
8506841|NCT00461331|20965667|P1|COMPLETED|Intervention 2||10
8506842|NCT00461331|20965666|P2|STARTED|Intervention 2||10
8506843|NCT00461331|20965667|P1|STARTED|Intervention 2||10
8506844|NCT00461331|20965666|P2|NOT COMPLETED|Washout||0
8506845|NCT00461331|20965667|P1|NOT COMPLETED|Washout||0
8506846|NCT00461331|20965666|P2|COMPLETED|Washout||10
8506847|NCT00461331|20965667|P1|COMPLETED|Washout||10
8506848|NCT00461331|20965666|P2|STARTED|Washout||10
8506849|NCT00461331|20965667|P1|STARTED|Washout||10
8506850|NCT00461331|20965666|P2|NOT COMPLETED|Intervention 1||0
8506851|NCT00461331|20965667|P1|NOT COMPLETED|Intervention 1||0
8506852|NCT00461331|20965666|P2|COMPLETED|Intervention 1||10
8506853|NCT00461331|20965667|P1|COMPLETED|Intervention 1||10
8506854|NCT00461331|20965666|P2|STARTED|Intervention 1||10
8506855|NCT00461331|20965667|P1|STARTED|Intervention 1||10
8506856|NCT00461305|20965679|P2|NOT COMPLETED|Continued Treatment||0
8506857|NCT00461305|20965680|P1|NOT COMPLETED|Continued Treatment||95
8506858|NCT00461305|20965679|P2|COMPLETED|Continued Treatment||0
8506859|NCT00461305|20965680|P1|COMPLETED|Continued Treatment||254
8506860|NCT00461305|20965679|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
8506861|NCT00461305|20965680|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
8506862|NCT00461305|20965679|P2|NOT COMPLETED|Treatment||9
8506863|NCT00461305|20965680|P1|NOT COMPLETED|Treatment||101
8506864|NCT00461305|20965679|P2|COMPLETED|Treatment||56
8506865|NCT00461305|20965680|P1|COMPLETED|Treatment||254
8506866|NCT00461305|20965679|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
8506867|NCT00461305|20965680|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
8506868|NCT00461305|20965679|P2|Subjects Dispensed Drugs|Treatment||65
8506869|NCT00461305|20965680|P1|Subjects Dispensed Drugs|Treatment||350
8506870|NCT00461305|20965679|P2|STARTED|Treatment|Enrolled|65
8506871|NCT00461305|20965680|P1|STARTED|Treatment|Enrolled|355
8506872|NCT00461292|20965743|P3|NOT COMPLETED|Treatment Cycle 2||0
8506873|NCT00461292|20965744|P2|NOT COMPLETED|Treatment Cycle 2||2
8506874|NCT00461292|20965745|P1|NOT COMPLETED|Treatment Cycle 2||5
8506875|NCT00461292|20965743|P3|COMPLETED|Treatment Cycle 2||0
8506876|NCT00461292|20965744|P2|COMPLETED|Treatment Cycle 2||72
8506877|NCT00461292|20965745|P1|COMPLETED|Treatment Cycle 2||58
8506878|NCT00461292|20965743|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
8506879|NCT00461292|20965744|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
8506880|NCT00461292|20965745|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
8506881|NCT00461292|20965743|P3|NOT COMPLETED|Treatment Cycle 1||11
8506882|NCT00461292|20965744|P2|NOT COMPLETED|Treatment Cycle 1||12
8506883|NCT00461292|20965745|P1|NOT COMPLETED|Treatment Cycle 1||15
8506884|NCT00461292|20965743|P3|COMPLETED|Treatment Cycle 1||81
8506885|NCT00461292|20965744|P2|COMPLETED|Treatment Cycle 1||80
8506886|NCT00461292|20965745|P1|COMPLETED|Treatment Cycle 1||76
8506887|NCT00461292|20965743|P3|STARTED|Treatment Cycle 1||92
8506888|NCT00461292|20965744|P2|STARTED|Treatment Cycle 1||92
8506889|NCT00461292|20965745|P1|STARTED|Treatment Cycle 1||91
8506890|NCT00461253|20965764|P2|NOT COMPLETED|Overall Study||19798
8506891|NCT00461253|20965765|P1|NOT COMPLETED|Overall Study||4980
8506892|NCT00461253|20965764|P2|COMPLETED|Overall Study|Analyzed controls|20452
8506893|NCT00461253|20965765|P1|COMPLETED|Overall Study|Analyzed cases|5113
8506894|NCT00461253|20965764|P2|STARTED|Overall Study|Identified controls|40250
8506895|NCT00461253|20965765|P1|STARTED|Overall Study|Identified cases|10093
8506896|NCT00461175|20965773|P2|NOT COMPLETED|Overall Study||365
8506897|NCT00461175|20965774|P1|NOT COMPLETED|Overall Study||522
8506898|NCT00461175|20965773|P2|COMPLETED|Overall Study||18370
8506899|NCT00461175|20965774|P1|COMPLETED|Overall Study||43078
8506900|NCT00461175|20965773|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
8506901|NCT00461175|20965774|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
8506902|NCT00461123|20965784|P2|NOT COMPLETED|Overall Study||6
8506903|NCT00461123|20965785|P1|NOT COMPLETED|Overall Study||6
8506904|NCT00461123|20965784|P2|COMPLETED|Overall Study||19
8506905|NCT00461123|20965785|P1|COMPLETED|Overall Study||19
8506906|NCT00461123|20965784|P2|STARTED|Overall Study||25
8506907|NCT00461123|20965785|P1|STARTED|Overall Study||25
8506908|NCT00461097|20965801|P2|NOT COMPLETED|Overall Study||0
8506909|NCT00461097|20965802|P1|NOT COMPLETED|Overall Study||0
8506910|NCT00461097|20965801|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
8506911|NCT00461097|20965802|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
8506912|NCT00461097|20965801|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
8506913|NCT00461097|20965802|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
8506914|NCT00461097|20965801|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
8506915|NCT00461097|20965802|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
8506916|NCT00461097|20965801|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
8506917|NCT00461097|20965802|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
8506918|NCT00461097|20965801|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
8506919|NCT00461097|20965802|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
8506920|NCT00461097|20965801|P2|STARTED|Overall Study||15
8506921|NCT00461097|20965802|P1|STARTED|Overall Study||40
8506922|NCT00461045|20965818|P1|NOT COMPLETED|Overall Study||0
8506923|NCT00461045|20965818|P1|COMPLETED|Overall Study||15
8506924|NCT00461045|20965818|P1|STARTED|Overall Study||15
8506925|NCT00461032|20965830|P2|NOT COMPLETED|Overall Study||44
8506926|NCT00461032|20965831|P1|NOT COMPLETED|Overall Study||37
8506927|NCT00461032|20965830|P2|COMPLETED|Overall Study||536
8506928|NCT00461032|20965831|P1|COMPLETED|Overall Study||545
8506929|NCT00461032|20965830|P2|STARTED|Overall Study||580
8506930|NCT00461032|20965831|P1|STARTED|Overall Study||582
8506931|NCT00460993|20965845|P2|NOT COMPLETED|Phase 2 (6 Days)||0
8506932|NCT00460993|20965846|P1|NOT COMPLETED|Phase 2 (6 Days)||0
8506933|NCT00460993|20965845|P2|COMPLETED|Phase 2 (6 Days)||17
8506934|NCT00460993|20965846|P1|COMPLETED|Phase 2 (6 Days)||14
8506935|NCT00460993|20965845|P2|STARTED|Phase 2 (6 Days)||17
8506936|NCT00460993|20965846|P1|STARTED|Phase 2 (6 Days)||14
8506937|NCT00460993|20965845|P2|NOT COMPLETED|Phase 1 (6 Days)||0
8506938|NCT00460993|20965846|P1|NOT COMPLETED|Phase 1 (6 Days)||0
8506939|NCT00460993|20965845|P2|COMPLETED|Phase 1 (6 Days)||17
8506940|NCT00460993|20965846|P1|COMPLETED|Phase 1 (6 Days)||14
8506941|NCT00460993|20965845|P2|STARTED|Phase 1 (6 Days)||17
8506942|NCT00460993|20965846|P1|STARTED|Phase 1 (6 Days)||14
8506943|NCT00460811|20965857|P5|NOT COMPLETED|Overall Study||20
8506944|NCT00460811|20965858|P4|NOT COMPLETED|Overall Study||18
8506945|NCT00460811|20965859|P3|NOT COMPLETED|Overall Study||14
8506946|NCT00460811|20965860|P2|NOT COMPLETED|Overall Study||15
8506947|NCT00460811|20965861|P1|NOT COMPLETED|Overall Study||16
8506948|NCT00460811|20965857|P5|COMPLETED|Overall Study||65
8506949|NCT00460811|20965858|P4|COMPLETED|Overall Study||71
8506950|NCT00460811|20965859|P3|COMPLETED|Overall Study||71
8506951|NCT00460811|20965860|P2|COMPLETED|Overall Study||67
8506952|NCT00460811|20965861|P1|COMPLETED|Overall Study||63
8506953|NCT00460811|20965857|P5|STARTED|Overall Study||85
8506954|NCT00460811|20965858|P4|STARTED|Overall Study||89
8506955|NCT00460811|20965859|P3|STARTED|Overall Study||85
8506956|NCT00460811|20965860|P2|STARTED|Overall Study||82
8506957|NCT00460811|20965861|P1|STARTED|Overall Study||79
8506958|NCT00460798|20965903|P1|NOT COMPLETED|Overall Study||340
8506959|NCT00460798|20965903|P1|COMPLETED|Overall Study||108
8506960|NCT00460798|20965903|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
8506961|NCT00460798|20965903|P1|STARTED|Overall Study||448
8506962|NCT00460746|20965911|P1|NOT COMPLETED|Overall Study||2
8506963|NCT00460746|20965911|P1|COMPLETED|Overall Study||8
8506964|NCT00460746|20965911|P1|STARTED|Overall Study||10
8506965|NCT00460655|20965926|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
8506966|NCT00460655|20965927|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
8506967|NCT00460655|20965928|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8506968|NCT00460655|20965929|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8506969|NCT00460655|20965926|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
8506970|NCT00460655|20965927|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
8506971|NCT00460655|20965928|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
8506972|NCT00460655|20965929|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
8506973|NCT00460655|20965926|P4|STARTED|Open-Label Phase (36 Weeks)||61
8506974|NCT00460655|20965927|P3|STARTED|Open-Label Phase (36 Weeks)||52
8506975|NCT00460655|20965928|P2|STARTED|Open-Label Phase (36 Weeks)||0
8506976|NCT00460655|20965929|P1|STARTED|Open-Label Phase (36 Weeks)||0
8506977|NCT00460655|20965926|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8506978|NCT00460655|20965927|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8506979|NCT00460655|20965928|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
8506980|NCT00460655|20965929|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
8506981|NCT00460655|20965926|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
8506982|NCT00460655|20965927|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
8506983|NCT00460655|20965928|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
8506984|NCT00460655|20965929|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
8506985|NCT00460655|20965926|P4|STARTED|Double-Blind Phase (12 Weeks)||0
8506986|NCT00460655|20965927|P3|STARTED|Double-Blind Phase (12 Weeks)||0
8506987|NCT00460655|20965928|P2|STARTED|Double-Blind Phase (12 Weeks)||62
8506988|NCT00460655|20965929|P1|STARTED|Double-Blind Phase (12 Weeks)||58
8506989|NCT00460603|20965973|P12|NOT COMPLETED|Phase 2||41
8506990|NCT00460603|20965974|P11|NOT COMPLETED|Phase 2||43
8506991|NCT00460603|20965975|P10|NOT COMPLETED|Phase 2||42
8506992|NCT00460603|20965976|P9|NOT COMPLETED|Phase 2||0
8506993|NCT00460603|20965977|P8|NOT COMPLETED|Phase 2||0
8506994|NCT00460603|20965978|P7|NOT COMPLETED|Phase 2||0
8506995|NCT00460603|20965979|P6|NOT COMPLETED|Phase 2||0
8506996|NCT00460603|20965980|P5|NOT COMPLETED|Phase 2||0
8506997|NCT00460603|20965981|P4|NOT COMPLETED|Phase 2||0
8506998|NCT00460603|20965982|P3|NOT COMPLETED|Phase 2||0
8506999|NCT00460603|20965983|P2|NOT COMPLETED|Phase 2||0
8507000|NCT00460603|20965984|P1|NOT COMPLETED|Phase 2||0
8507001|NCT00460603|20965973|P12|COMPLETED|Phase 2||0
8507002|NCT00460603|20965974|P11|COMPLETED|Phase 2||0
8507003|NCT00460603|20965975|P10|COMPLETED|Phase 2||0
8507004|NCT00460603|20965976|P9|COMPLETED|Phase 2||0
8507005|NCT00460603|20965977|P8|COMPLETED|Phase 2||0
8507006|NCT00460603|20965978|P7|COMPLETED|Phase 2||0
8507007|NCT00460603|20965979|P6|COMPLETED|Phase 2||0
8507008|NCT00460603|20965980|P5|COMPLETED|Phase 2||0
8507009|NCT00460603|20965981|P4|COMPLETED|Phase 2||0
8507010|NCT00460603|20965982|P3|COMPLETED|Phase 2||0
8507011|NCT00460603|20965983|P2|COMPLETED|Phase 2||0
8507012|NCT00460603|20965984|P1|COMPLETED|Phase 2||0
8507013|NCT00460603|20965973|P12|Treated|Phase 2||41
8507014|NCT00460603|20965974|P11|Treated|Phase 2||43
8507015|NCT00460603|20965975|P10|Treated|Phase 2||39
8507016|NCT00460603|20965976|P9|Treated|Phase 2||0
8507017|NCT00460603|20965977|P8|Treated|Phase 2||0
8507018|NCT00460603|20965978|P7|Treated|Phase 2||0
8507019|NCT00460603|20965979|P6|Treated|Phase 2||0
8507020|NCT00460603|20965980|P5|Treated|Phase 2||0
8507021|NCT00460603|20965981|P4|Treated|Phase 2||0
8507022|NCT00460603|20965982|P3|Treated|Phase 2||0
8507023|NCT00460603|20965983|P2|Treated|Phase 2||0
8507024|NCT00460603|20965984|P1|Treated|Phase 2||0
8507025|NCT00460603|20965973|P12|STARTED|Phase 2||41
8507026|NCT00460603|20965974|P11|STARTED|Phase 2||43
8507027|NCT00460603|20965975|P10|STARTED|Phase 2||42
8507028|NCT00460603|20965976|P9|STARTED|Phase 2||0
8507029|NCT00460603|20965977|P8|STARTED|Phase 2||0
8507030|NCT00460603|20965978|P7|STARTED|Phase 2||0
8507031|NCT00460603|20965979|P6|STARTED|Phase 2||0
8507032|NCT00460603|20965980|P5|STARTED|Phase 2||0
8507033|NCT00460603|20965981|P4|STARTED|Phase 2||0
8507034|NCT00460603|20965982|P3|STARTED|Phase 2||0
8507035|NCT00460603|20965983|P2|STARTED|Phase 2||0
8507036|NCT00460603|20965984|P1|STARTED|Phase 2||0
8507037|NCT00460603|20965973|P12|NOT COMPLETED|Phase 1||0
8507038|NCT00460603|20965974|P11|NOT COMPLETED|Phase 1||0
8507039|NCT00460603|20965975|P10|NOT COMPLETED|Phase 1||0
8507040|NCT00460603|20965976|P9|NOT COMPLETED|Phase 1||18
8507041|NCT00460603|20965977|P8|NOT COMPLETED|Phase 1||3
8507042|NCT00460603|20965978|P7|NOT COMPLETED|Phase 1||6
8507043|NCT00460603|20965979|P6|NOT COMPLETED|Phase 1||4
8507044|NCT00460603|20965980|P5|NOT COMPLETED|Phase 1||6
8507045|NCT00460603|20965981|P4|NOT COMPLETED|Phase 1||8
8507046|NCT00460603|20965982|P3|NOT COMPLETED|Phase 1||4
8507047|NCT00460603|20965983|P2|NOT COMPLETED|Phase 1||6
8507048|NCT00460603|20965984|P1|NOT COMPLETED|Phase 1||6
8507049|NCT00460603|20965973|P12|COMPLETED|Phase 1||0
8507050|NCT00460603|20965974|P11|COMPLETED|Phase 1||0
8507051|NCT00460603|20965975|P10|COMPLETED|Phase 1||0
8507052|NCT00460603|20965976|P9|COMPLETED|Phase 1||0
8507053|NCT00460603|20965977|P8|COMPLETED|Phase 1||0
8507054|NCT00460603|20965978|P7|COMPLETED|Phase 1||0
8507055|NCT00460603|20965979|P6|COMPLETED|Phase 1||0
8507056|NCT00460603|20965980|P5|COMPLETED|Phase 1||0
8507057|NCT00460603|20965981|P4|COMPLETED|Phase 1||0
8507058|NCT00460603|20965982|P3|COMPLETED|Phase 1||0
8507059|NCT00460603|20965983|P2|COMPLETED|Phase 1||0
8507060|NCT00460603|20965984|P1|COMPLETED|Phase 1||0
8507061|NCT00460603|20965973|P12|STARTED|Phase 1||0
8507062|NCT00460603|20965974|P11|STARTED|Phase 1||0
8507063|NCT00460603|20965975|P10|STARTED|Phase 1||0
8507064|NCT00460603|20965976|P9|STARTED|Phase 1||18
8507065|NCT00460603|20965977|P8|STARTED|Phase 1||3
8507066|NCT00460603|20965978|P7|STARTED|Phase 1||6
8507067|NCT00460603|20965979|P6|STARTED|Phase 1||4
8507068|NCT00460603|20965980|P5|STARTED|Phase 1||6
8507069|NCT00460603|20965981|P4|STARTED|Phase 1||8
8507070|NCT00460603|20965982|P3|STARTED|Phase 1||4
8507071|NCT00460603|20965983|P2|STARTED|Phase 1||6
8507072|NCT00460603|20965984|P1|STARTED|Phase 1||6
8507073|NCT00460577|20966078|P2|NOT COMPLETED|Overall Study||6
8507074|NCT00460577|20966079|P1|NOT COMPLETED|Overall Study||2
8507075|NCT00460577|20966078|P2|COMPLETED|Overall Study||24
8507076|NCT00460577|20966079|P1|COMPLETED|Overall Study||28
8507077|NCT00460577|20966078|P2|STARTED|Overall Study||30
8507078|NCT00460577|20966079|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
8507079|NCT00460564|20966097|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507080|NCT00460564|20966098|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
8507081|NCT00460564|20966099|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
8507082|NCT00460564|20966100|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
8507083|NCT00460564|20966101|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507084|NCT00460564|20966102|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507085|NCT00460564|20966103|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507086|NCT00460564|20966104|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507087|NCT00460564|20966097|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
8507088|NCT00460564|20966098|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
8507089|NCT00460564|20966099|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
8507090|NCT00460564|20966100|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
8507091|NCT00460564|20966101|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
8507092|NCT00460564|20966102|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
8507093|NCT00460564|20966103|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
8507094|NCT00460564|20966104|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
8507095|NCT00460564|20966097|P8|STARTED|Open-Label Phase (36 Weeks)||11
8507096|NCT00460564|20966098|P7|STARTED|Open-Label Phase (36 Weeks)||21
8507097|NCT00460564|20966099|P6|STARTED|Open-Label Phase (36 Weeks)||25
8507098|NCT00460564|20966100|P5|STARTED|Open-Label Phase (36 Weeks)||47
8507099|NCT00460564|20966101|P4|STARTED|Open-Label Phase (36 Weeks)||0
8507100|NCT00460564|20966102|P3|STARTED|Open-Label Phase (36 Weeks)||0
8507101|NCT00460564|20966103|P2|STARTED|Open-Label Phase (36 Weeks)||0
8507102|NCT00460564|20966104|P1|STARTED|Open-Label Phase (36 Weeks)||0
8507103|NCT00460564|20966097|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507104|NCT00460564|20966098|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507105|NCT00460564|20966099|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507106|NCT00460564|20966100|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507107|NCT00460564|20966101|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507108|NCT00460564|20966102|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507109|NCT00460564|20966103|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
8507110|NCT00460564|20966104|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
8507111|NCT00460564|20966097|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507112|NCT00460564|20966098|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507113|NCT00460564|20966099|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507114|NCT00460564|20966100|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507115|NCT00460564|20966101|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
8507116|NCT00460564|20966102|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
8507117|NCT00460564|20966103|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
8507118|NCT00460564|20966104|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
8507119|NCT00460564|20966097|P8|STARTED|Double-Blind Phase (12 Weeks)||0
8507120|NCT00460564|20966098|P7|STARTED|Double-Blind Phase (12 Weeks)||0
8507121|NCT00460564|20966099|P6|STARTED|Double-Blind Phase (12 Weeks)||0
8507122|NCT00460564|20966100|P5|STARTED|Double-Blind Phase (12 Weeks)||0
8507123|NCT00460564|20966101|P4|STARTED|Double-Blind Phase (12 Weeks)||11
8507124|NCT00460564|20966102|P3|STARTED|Double-Blind Phase (12 Weeks)||21
8507125|NCT00460564|20966103|P2|STARTED|Double-Blind Phase (12 Weeks)||26
8507126|NCT00460564|20966104|P1|STARTED|Double-Blind Phase (12 Weeks)||51
8507127|NCT00460551|20966198|P1|NOT COMPLETED|Overall Study||0
8507128|NCT00460551|20966198|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
8507129|NCT00460551|20966198|P1|STARTED|Overall Study||13
8507130|NCT00460525|20966205|P2|NOT COMPLETED|Overall Study||5
8507131|NCT00460525|20966206|P1|NOT COMPLETED|Overall Study||11
8507132|NCT00460525|20966205|P2|COMPLETED|Overall Study||194
8507133|NCT00460525|20966206|P1|COMPLETED|Overall Study||190
8507134|NCT00460525|20966205|P2|STARTED|Overall Study||199
8507135|NCT00460525|20966206|P1|STARTED|Overall Study||201
8507136|NCT00460434|20966248|P2|NOT COMPLETED|Overall Study||7
8507137|NCT00460434|20966249|P1|NOT COMPLETED|Overall Study||3
8507138|NCT00460434|20966248|P2|COMPLETED|Overall Study||165
8507139|NCT00460434|20966249|P1|COMPLETED|Overall Study||162
8507140|NCT00460434|20966248|P2|12 Months|Overall Study||165
8507141|NCT00460434|20966249|P1|12 Months|Overall Study||162
8507142|NCT00460434|20966248|P2|3 Months|Overall Study||171
8507143|NCT00460434|20966249|P1|3 Months|Overall Study||163
8507144|NCT00460434|20966248|P2|STARTED|Overall Study||172
8507145|NCT00460434|20966249|P1|STARTED|Overall Study||165
8507146|NCT00460421|20966278|P3|NOT COMPLETED|Overall Study||0
8507147|NCT00460421|20966279|P2|NOT COMPLETED|Overall Study||0
8507148|NCT00460421|20966280|P1|NOT COMPLETED|Overall Study||0
8507149|NCT00460421|20966278|P3|COMPLETED|Overall Study||9
8507150|NCT00460421|20966279|P2|COMPLETED|Overall Study||9
8507151|NCT00460421|20966280|P1|COMPLETED|Overall Study||9
8507152|NCT00460421|20966278|P3|STARTED|Overall Study||9
8507153|NCT00460421|20966279|P2|STARTED|Overall Study||9
8507154|NCT00460421|20966280|P1|STARTED|Overall Study||9
8507155|NCT00460408|20966328|P4|NOT COMPLETED|Overall Study||0
8507156|NCT00460408|20966329|P3|NOT COMPLETED|Overall Study||6
8507157|NCT00460408|20966330|P2|NOT COMPLETED|Overall Study||3
8507158|NCT00460408|20966331|P1|NOT COMPLETED|Overall Study||67
8507159|NCT00460408|20966328|P4|COMPLETED|Overall Study||7
8507160|NCT00460408|20966329|P3|COMPLETED|Overall Study||69
8507161|NCT00460408|20966330|P2|COMPLETED|Overall Study||13
8507162|NCT00460408|20966331|P1|COMPLETED|Overall Study||336
8507163|NCT00460408|20966328|P4|STARTED|Overall Study||7
8507164|NCT00460408|20966329|P3|STARTED|Overall Study||75
8507165|NCT00460408|20966330|P2|STARTED|Overall Study||16
8507166|NCT00460408|20966331|P1|STARTED|Overall Study||403
8507167|NCT00460265|20966368|P2|NOT COMPLETED|Overall Study||89
8507168|NCT00460265|20966369|P1|NOT COMPLETED|Overall Study||85
8507169|NCT00460265|20966368|P2|COMPLETED|Overall Study|Completed study=death|241
8507170|NCT00460265|20966369|P1|COMPLETED|Overall Study|Completed study=death|243
8507171|NCT00460265|20966368|P2|Received Study Medication|Overall Study||325
8507172|NCT00460265|20966369|P1|Received Study Medication|Overall Study||325
8507173|NCT00460265|20966368|P2|Randomized While Alive|Overall Study||330
8507174|NCT00460265|20966369|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
8507175|NCT00460265|20966368|P2|STARTED|Overall Study||330
8507176|NCT00460265|20966369|P1|STARTED|Overall Study||328
8507177|NCT00460239|20966385|P9|NOT COMPLETED|Overall Study||0
8507178|NCT00460239|20966386|P8|NOT COMPLETED|Overall Study||0
8507179|NCT00460239|20966387|P7|NOT COMPLETED|Overall Study||0
8507180|NCT00460239|20966388|P6|NOT COMPLETED|Overall Study||3
8507181|NCT00460239|20966389|P5|NOT COMPLETED|Overall Study||0
8507182|NCT00460239|20966390|P4|NOT COMPLETED|Overall Study||0
8507183|NCT00460239|20966391|P3|NOT COMPLETED|Overall Study||0
8507184|NCT00460239|20966392|P2|NOT COMPLETED|Overall Study||1
8507185|NCT00460239|20966393|P1|NOT COMPLETED|Overall Study||0
8507186|NCT00460239|20966385|P9|COMPLETED|Overall Study||1
8507187|NCT00460239|20966386|P8|COMPLETED|Overall Study||1
8507188|NCT00460239|20966387|P7|COMPLETED|Overall Study||1
8507189|NCT00460239|20966388|P6|COMPLETED|Overall Study||1
8507190|NCT00460239|20966389|P5|COMPLETED|Overall Study||1
8507191|NCT00460239|20966390|P4|COMPLETED|Overall Study||0
8507192|NCT00460239|20966391|P3|COMPLETED|Overall Study||1
8507193|NCT00460239|20966392|P2|COMPLETED|Overall Study||2
8507194|NCT00460239|20966393|P1|COMPLETED|Overall Study||0
8507195|NCT00460239|20966385|P9|STARTED|Overall Study||1
8507196|NCT00460239|20966386|P8|STARTED|Overall Study||1
8507197|NCT00460239|20966387|P7|STARTED|Overall Study||1
8507198|NCT00460239|20966388|P6|STARTED|Overall Study||4
8507199|NCT00460239|20966389|P5|STARTED|Overall Study||1
8507200|NCT00460239|20966390|P4|STARTED|Overall Study||0
8507201|NCT00460239|20966391|P3|STARTED|Overall Study||1
8507202|NCT00460239|20966392|P2|STARTED|Overall Study||3
8507203|NCT00460239|20966393|P1|STARTED|Overall Study||0
8507204|NCT00460109|20966462|P1|NOT COMPLETED|Overall Study||1
8507205|NCT00460109|20966462|P1|COMPLETED|Overall Study||23
8507206|NCT00460109|20966462|P1|STARTED|Overall Study||24
8507207|NCT00460031|20966470|P1|NOT COMPLETED|Overall Study||11
8507208|NCT00460031|20966470|P1|COMPLETED|Overall Study||23
8507209|NCT00460031|20966470|P1|STARTED|Overall Study||34
8507210|NCT00459979|20966478|P1|NOT COMPLETED|Overall Study||2
8507211|NCT00459979|20966478|P1|COMPLETED|Overall Study||28
8507212|NCT00459979|20966478|P1|STARTED|Overall Study||30
8507213|NCT00459953|20966490|P2|NOT COMPLETED|Overall Study||1
8507214|NCT00459953|20966491|P1|NOT COMPLETED|Overall Study||1
8507215|NCT00459953|20966490|P2|COMPLETED|Overall Study||70
8507216|NCT00459953|20966491|P1|COMPLETED|Overall Study||71
8507217|NCT00459953|20966490|P2|STARTED|Overall Study||71
8507218|NCT00459953|20966491|P1|STARTED|Overall Study||72
8507219|NCT00459875|20966497|P1|NOT COMPLETED|Overall Study||3
8507220|NCT00459875|20966497|P1|COMPLETED|Overall Study||21
8507221|NCT00459875|20966497|P1|STARTED|Overall Study||24
8507222|NCT00459862|20966501|P1|NOT COMPLETED|Overall Study||0
8507223|NCT00459862|20966501|P1|COMPLETED|Overall Study||34
8507224|NCT00459862|20966501|P1|STARTED|Overall Study||34
8507225|NCT00459810|20966510|P1|NOT COMPLETED|Overall Study||0
8507226|NCT00459810|20966510|P1|COMPLETED|Overall Study||21
8507227|NCT00459810|20966510|P1|STARTED|Overall Study||21
8507228|NCT00459732|20966520|P2|NOT COMPLETED|Overall Study||3
8507229|NCT00459732|20966521|P1|NOT COMPLETED|Overall Study||4
8507230|NCT00459732|20966520|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
8507231|NCT00459732|20966521|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
8507232|NCT00459732|20966520|P2|STARTED|Overall Study||17
8507233|NCT00459732|20966521|P1|STARTED|Overall Study||23
8507234|NCT00459706|20966533|P2|NOT COMPLETED|Overall Study||21
8507235|NCT00459706|20966534|P1|NOT COMPLETED|Overall Study||26
8507236|NCT00459706|20966533|P2|COMPLETED|Overall Study||294
8507237|NCT00459706|20966534|P1|COMPLETED|Overall Study||299
8507238|NCT00459706|20966533|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
8507239|NCT00459706|20966534|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
8507240|NCT00459706|20966533|P2|STARTED|Overall Study||315
8507241|NCT00459706|20966534|P1|STARTED|Overall Study||325
8507242|NCT00459667|20966677|P3|NOT COMPLETED|Overall Study||20
8507243|NCT00459667|20966678|P2|NOT COMPLETED|Overall Study||47
8507244|NCT00459667|20966679|P1|NOT COMPLETED|Overall Study||38
8507245|NCT00459667|20966677|P3|COMPLETED|Overall Study||161
8507246|NCT00459667|20966678|P2|COMPLETED|Overall Study||600
8507247|NCT00459667|20966679|P1|COMPLETED|Overall Study||554
8507248|NCT00459667|20966677|P3|Started Treatment|Overall Study||180
8507249|NCT00459667|20966678|P2|Started Treatment|Overall Study||644
8507250|NCT00459667|20966679|P1|Started Treatment|Overall Study||586
8507251|NCT00459667|20966677|P3|Study Medication Dispensed|Overall Study||180
8507252|NCT00459667|20966678|P2|Study Medication Dispensed|Overall Study||645
8507253|NCT00459667|20966679|P1|Study Medication Dispensed|Overall Study||586
8507254|NCT00459667|20966677|P3|STARTED|Overall Study||181
8507255|NCT00459667|20966678|P2|STARTED|Overall Study||647
8507256|NCT00459667|20966679|P1|STARTED|Overall Study||592
8507257|NCT00459537|20966701|P2|NOT COMPLETED|Overall Study||76
8507258|NCT00459537|20966702|P1|NOT COMPLETED|Overall Study||66
8507259|NCT00459537|20966701|P2|COMPLETED|Overall Study||446
8507260|NCT00459537|20966702|P1|COMPLETED|Overall Study||441
8507261|NCT00459537|20966701|P2|Safety Population|Overall Study||512
8507262|NCT00459537|20966702|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
8507263|NCT00459537|20966701|P2|STARTED|Overall Study||522
8507264|NCT00459537|20966702|P1|STARTED|Overall Study||507
8507265|NCT00459381|20966716|P1|NOT COMPLETED|Overall Study||0
8507266|NCT00459381|20966716|P1|COMPLETED|Overall Study||35
8507267|NCT00459381|20966716|P1|STARTED|Overall Study||35
8507268|NCT00459368|20966728|P2|NOT COMPLETED|Overall Study||329
8507269|NCT00459368|20966729|P1|NOT COMPLETED|Overall Study||295
8507270|NCT00459368|20966728|P2|COMPLETED|Overall Study||1034
8507271|NCT00459368|20966729|P1|COMPLETED|Overall Study||1040
8507272|NCT00459368|20966728|P2|STARTED|Overall Study||1363
8507273|NCT00459368|20966729|P1|STARTED|Overall Study||1335
8507274|NCT00459355|20966737|P2|NOT COMPLETED|Overall Study||18
8507275|NCT00459355|20966738|P1|NOT COMPLETED|Overall Study||20
8507276|NCT00459355|20966737|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
8507277|NCT00459355|20966738|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
8507278|NCT00459355|20966737|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
8507279|NCT00459355|20966738|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
8507280|NCT00459342|20966750|P1|NOT COMPLETED|Overall Study||1
8507281|NCT00459342|20966750|P1|COMPLETED|Overall Study||34
8507282|NCT00459342|20966750|P1|STARTED|Overall Study||35
8507283|NCT00459316|20966763|P3|NOT COMPLETED|Step 3||1
8507284|NCT00459316|20966764|P2|NOT COMPLETED|Step 3||0
8507285|NCT00459316|20966765|P1|NOT COMPLETED|Step 3||3
8507286|NCT00459316|20966763|P3|COMPLETED|Step 3||39
8507287|NCT00459316|20966764|P2|COMPLETED|Step 3||0
8507288|NCT00459316|20966765|P1|COMPLETED|Step 3||149
8507289|NCT00459316|20966763|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
8507290|NCT00459316|20966764|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
8507291|NCT00459316|20966765|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
8507292|NCT00459316|20966763|P3|NOT COMPLETED|Steps 1 & 2||2
8507293|NCT00459316|20966764|P2|NOT COMPLETED|Steps 1 & 2||7
8507294|NCT00459316|20966765|P1|NOT COMPLETED|Steps 1 & 2||21
8507295|NCT00459316|20966763|P3|COMPLETED|Steps 1 & 2||57
8507296|NCT00459316|20966764|P2|COMPLETED|Steps 1 & 2||32
8507297|NCT00459316|20966765|P1|COMPLETED|Steps 1 & 2||259
8507298|NCT00459316|20966763|P3|STARTED|Steps 1 & 2||59
8507299|NCT00459316|20966764|P2|STARTED|Steps 1 & 2||39
8507300|NCT00459316|20966765|P1|STARTED|Steps 1 & 2||280
8507301|NCT00459303|20966819|P1|NOT COMPLETED|Overall Study||0
8507302|NCT00459303|20966819|P1|COMPLETED|Overall Study||20
8507303|NCT00459303|20966819|P1|STARTED|Overall Study||20
8507304|NCT00459290|20966830|P1|NOT COMPLETED|Overall Study||5
8507305|NCT00459290|20966830|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
8507306|NCT00459290|20966830|P1|STARTED|Overall Study||24
8507307|NCT00459186|20966845|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
8507308|NCT00459186|20966845|P1|COMPLETED|Combination RAD001 + Docetaxel||15
8507309|NCT00459186|20966845|P1|STARTED|Combination RAD001 + Docetaxel||15
8507310|NCT00459186|20966845|P1|NOT COMPLETED|PET Imaging and Assessment||3
8507311|NCT00459186|20966845|P1|COMPLETED|PET Imaging and Assessment||15
8507312|NCT00459186|20966845|P1|STARTED|PET Imaging and Assessment||18
8507313|NCT00459186|20966845|P1|NOT COMPLETED|Single Agent RAD001||1
8507314|NCT00459186|20966845|P1|COMPLETED|Single Agent RAD001||18
8507315|NCT00459186|20966845|P1|STARTED|Single Agent RAD001||19
8507316|NCT00459134|20966852|P2|NOT COMPLETED|Overall Study||25
8507317|NCT00459134|20966853|P1|NOT COMPLETED|Overall Study||23
8507318|NCT00459134|20966852|P2|COMPLETED|Overall Study||67
8507319|NCT00459134|20966853|P1|COMPLETED|Overall Study||71
8507320|NCT00459134|20966852|P2|STARTED|Overall Study||92
8507321|NCT00459134|20966853|P1|STARTED|Overall Study||94
8507322|NCT00459121|20966861|P1|NOT COMPLETED|Overall Study||0
8507323|NCT00459121|20966861|P1|COMPLETED|Overall Study||2
8507324|NCT00459121|20966861|P1|STARTED|Overall Study||2
8507325|NCT00459108|20966869|P1|NOT COMPLETED|Overall Study||11
8507326|NCT00459108|20966869|P1|COMPLETED|Overall Study||14
8507327|NCT00459108|20966869|P1|STARTED|Overall Study||25
8507328|NCT00459056|20966879|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
8507329|NCT00459056|20966880|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
8507330|NCT00459056|20966879|P2|COMPLETED|Second Intervention (Final Three Months)||14
8507331|NCT00459056|20966880|P1|COMPLETED|Second Intervention (Final Three Months)||9
8507332|NCT00459056|20966879|P2|STARTED|Second Intervention (Final Three Months)||14
8507333|NCT00459056|20966880|P1|STARTED|Second Intervention (Final Three Months)||9
8507334|NCT00459056|20966879|P2|NOT COMPLETED|Washout (1 Month)||0
8507335|NCT00459056|20966880|P1|NOT COMPLETED|Washout (1 Month)||0
8507336|NCT00459056|20966879|P2|COMPLETED|Washout (1 Month)||14
8507337|NCT00459056|20966880|P1|COMPLETED|Washout (1 Month)||9
8507338|NCT00459056|20966879|P2|STARTED|Washout (1 Month)||14
8507339|NCT00459056|20966880|P1|STARTED|Washout (1 Month)||9
8507340|NCT00459056|20966879|P2|NOT COMPLETED|First Intervention (First Three Months)||1
8507341|NCT00459056|20966880|P1|NOT COMPLETED|First Intervention (First Three Months)||1
8507342|NCT00459056|20966879|P2|COMPLETED|First Intervention (First Three Months)||14
8507343|NCT00459056|20966880|P1|COMPLETED|First Intervention (First Three Months)||9
8507344|NCT00459056|20966879|P2|STARTED|First Intervention (First Three Months)||15
8507345|NCT00459056|20966880|P1|STARTED|First Intervention (First Three Months)||10
8507346|NCT00459043|20966888|P2|NOT COMPLETED|Overall Study||0
8507347|NCT00459043|20966889|P1|NOT COMPLETED|Overall Study||1
8507348|NCT00459043|20966888|P2|COMPLETED|Overall Study||15
8507349|NCT00459043|20966889|P1|COMPLETED|Overall Study||14
8507350|NCT00459043|20966888|P2|STARTED|Overall Study||15
8507351|NCT00459043|20966889|P1|STARTED|Overall Study||15
8507352|NCT00458952|20966901|P2|NOT COMPLETED|Overall Study||5
8507353|NCT00458952|20966902|P1|NOT COMPLETED|Overall Study||2
8507354|NCT00458952|20966901|P2|COMPLETED|Overall Study||9
8507355|NCT00458952|20966902|P1|COMPLETED|Overall Study||5
8507356|NCT00458952|20966901|P2|STARTED|Overall Study||14
8507357|NCT00458952|20966902|P1|STARTED|Overall Study||7
8507358|NCT00458848|20966906|P1|NOT COMPLETED|Overall Study||0
8507359|NCT00458848|20966906|P1|COMPLETED|Overall Study||51
8507360|NCT00458848|20966906|P1|STARTED|Overall Study||51
8507361|NCT00458822|20966912|P1|NOT COMPLETED|Overall Study||0
8507362|NCT00458822|20966912|P1|COMPLETED|Overall Study||40
8507363|NCT00458822|20966912|P1|STARTED|Overall Study||40
8507364|NCT00458705|20966916|P1|NOT COMPLETED|Overall Study||5
8507365|NCT00458705|20966916|P1|COMPLETED|Overall Study||40
8507366|NCT00458705|20966916|P1|STARTED|Overall Study||45
8507367|NCT00458536|20966920|P1|NOT COMPLETED|Overall Study||19
8507368|NCT00458536|20966920|P1|COMPLETED|Overall Study||19
8507369|NCT00458536|20966920|P1|STARTED|Overall Study||38
8507370|NCT00458484|20966931|P7|NOT COMPLETED|Overall Study||0
8507371|NCT00458484|20966932|P6|NOT COMPLETED|Overall Study||1
8507372|NCT00458484|20966933|P5|NOT COMPLETED|Overall Study||0
8507373|NCT00458484|20966934|P4|NOT COMPLETED|Overall Study||0
8507374|NCT00458484|20966935|P3|NOT COMPLETED|Overall Study||0
8507375|NCT00458484|20966936|P2|NOT COMPLETED|Overall Study||0
8507376|NCT00458484|20966937|P1|NOT COMPLETED|Overall Study||0
8507377|NCT00458484|20966931|P7|COMPLETED|Overall Study||3
8507378|NCT00458484|20966932|P6|COMPLETED|Overall Study||4
8507379|NCT00458484|20966933|P5|COMPLETED|Overall Study||4
8507380|NCT00458484|20966934|P4|COMPLETED|Overall Study||6
8507381|NCT00458484|20966935|P3|COMPLETED|Overall Study||3
8507382|NCT00458484|20966936|P2|COMPLETED|Overall Study||6
8507383|NCT00458484|20966937|P1|COMPLETED|Overall Study||4
8507384|NCT00458484|20966931|P7|STARTED|Overall Study||3
8507385|NCT00458484|20966932|P6|STARTED|Overall Study||5
8507386|NCT00458484|20966933|P5|STARTED|Overall Study||4
8507387|NCT00458484|20966934|P4|STARTED|Overall Study||6
8507388|NCT00458484|20966935|P3|STARTED|Overall Study||3
8507389|NCT00458484|20966936|P2|STARTED|Overall Study||6
8507390|NCT00458484|20966937|P1|STARTED|Overall Study||4
8507391|NCT00458406|20966978|P2|NOT COMPLETED|Month 3||0
8507392|NCT00458406|20966979|P1|NOT COMPLETED|Month 3||0
8507393|NCT00458406|20966978|P2|COMPLETED|Month 3||13
8507394|NCT00458406|20966979|P1|COMPLETED|Month 3||43
8507395|NCT00458406|20966978|P2|STARTED|Month 3||13
8507396|NCT00458406|20966979|P1|STARTED|Month 3||43
8507397|NCT00458406|20966978|P2|NOT COMPLETED|Month 1||0
8507398|NCT00458406|20966979|P1|NOT COMPLETED|Month 1||0
8507399|NCT00458406|20966978|P2|COMPLETED|Month 1||13
8507400|NCT00458406|20966979|P1|COMPLETED|Month 1||43
8507401|NCT00458406|20966978|P2|STARTED|Month 1||13
8507402|NCT00458406|20966979|P1|STARTED|Month 1||43
8507403|NCT00458393|20967003|P2|NOT COMPLETED|Overall Study||295
8507404|NCT00458393|20967004|P1|NOT COMPLETED|Overall Study||309
8507405|NCT00458393|20967003|P2|COMPLETED|Overall Study||953
8507406|NCT00458393|20967004|P1|COMPLETED|Overall Study||942
8507407|NCT00458393|20967003|P2|STARTED|Overall Study||1248
8507408|NCT00458393|20967004|P1|STARTED|Overall Study||1251
8507409|NCT00458341|20967052|P2|NOT COMPLETED|Cycle 2||0
8507410|NCT00458341|20967053|P1|NOT COMPLETED|Cycle 2||0
8507411|NCT00458341|20967052|P2|COMPLETED|Cycle 2||15
8507412|NCT00458341|20967053|P1|COMPLETED|Cycle 2||15
8507413|NCT00458341|20967052|P2|Received at Least 1 Dose of Study Drug|Cycle 2||15
8507414|NCT00458341|20967053|P1|Received at Least 1 Dose of Study Drug|Cycle 2||15
8507415|NCT00458341|20967052|P2|STARTED|Cycle 2||15
8507416|NCT00458341|20967053|P1|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
8507417|NCT00458341|20967052|P2|NOT COMPLETED|Cycle 1||0
8507418|NCT00458341|20967053|P1|NOT COMPLETED|Cycle 1||1
8507419|NCT00458341|20967052|P2|COMPLETED|Cycle 1||15
8507420|NCT00458341|20967053|P1|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
8507421|NCT00458341|20967052|P2|Received at Least 1 Dose of Study Drug|Cycle 1||15
8507422|NCT00458341|20967053|P1|Received at Least 1 Dose of Study Drug|Cycle 1||15
8507423|NCT00458341|20967052|P2|STARTED|Cycle 1||15
8507424|NCT00458341|20967053|P1|STARTED|Cycle 1||15
8507425|NCT00458302|20967093|P2|NOT COMPLETED|Overall Study||24
8507426|NCT00458302|20967094|P1|NOT COMPLETED|Overall Study||20
8507427|NCT00458302|20967093|P2|COMPLETED|Overall Study||103
8507428|NCT00458302|20967094|P1|COMPLETED|Overall Study||109
8507429|NCT00458302|20967093|P2|STARTED|Overall Study||127
8507430|NCT00458302|20967094|P1|STARTED|Overall Study||129
8507431|NCT00458237|20967128|P3|NOT COMPLETED|Overall Study||0
8507432|NCT00458237|20967129|P2|NOT COMPLETED|Overall Study||0
8507433|NCT00458237|20967130|P1|NOT COMPLETED|Overall Study||0
8507434|NCT00458237|20967128|P3|COMPLETED|Overall Study||5
8507435|NCT00458237|20967129|P2|COMPLETED|Overall Study||3
8507436|NCT00458237|20967130|P1|COMPLETED|Overall Study||3
8507437|NCT00458237|20967128|P3|STARTED|Overall Study||5
8507438|NCT00458237|20967129|P2|STARTED|Overall Study||3
8507439|NCT00458237|20967130|P1|STARTED|Overall Study||3
8507440|NCT00458211|20967139|P1|NOT COMPLETED|Overall Study||16
8507441|NCT00458211|20967139|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
8507442|NCT00458211|20967139|P1|STARTED|Overall Study||40
8507443|NCT00457977|20967160|P2|NOT COMPLETED|Overall Study||25
8507444|NCT00457977|20967161|P1|NOT COMPLETED|Overall Study||28
8507445|NCT00457977|20967160|P2|COMPLETED|Overall Study||66
8507446|NCT00457977|20967161|P1|COMPLETED|Overall Study||62
8507447|NCT00457977|20967160|P2|2-Year|Overall Study||66
8507448|NCT00457977|20967161|P1|2-Year|Overall Study||62
8507449|NCT00457977|20967160|P2|1-Year|Overall Study||76
8507450|NCT00457977|20967161|P1|1-Year|Overall Study||69
8507451|NCT00457977|20967160|P2|1-Month|Overall Study||87
8507452|NCT00457977|20967161|P1|1-Month|Overall Study||88
8507453|NCT00457977|20967160|P2|STARTED|Overall Study||91
8507454|NCT00457977|20967161|P1|STARTED|Overall Study||90
8507455|NCT00457951|20967172|P3|NOT COMPLETED|Overall Study||12
8507456|NCT00457951|20967173|P2|NOT COMPLETED|Overall Study||16
8507457|NCT00457951|20967174|P1|NOT COMPLETED|Overall Study||0
8507458|NCT00457951|20967172|P3|COMPLETED|Overall Study||60
8507459|NCT00457951|20967173|P2|COMPLETED|Overall Study||50
8507460|NCT00457951|20967174|P1|COMPLETED|Overall Study||13
8507461|NCT00457951|20967172|P3|STARTED|Overall Study||72
8507462|NCT00457951|20967173|P2|STARTED|Overall Study||66
8507463|NCT00457951|20967174|P1|STARTED|Overall Study||13
8507464|NCT00457821|20967189|P8|NOT COMPLETED|Part 2||1
8507465|NCT00457821|20967190|P7|NOT COMPLETED|Part 2||0
8507466|NCT00457821|20967191|P6|NOT COMPLETED|Part 2||0
8507467|NCT00457821|20967192|P5|NOT COMPLETED|Part 2||0
8507468|NCT00457821|20967193|P4|NOT COMPLETED|Part 2||0
8507469|NCT00457821|20967194|P3|NOT COMPLETED|Part 2||0
8507470|NCT00457821|20967195|P2|NOT COMPLETED|Part 2||0
8507471|NCT00457821|20967196|P1|NOT COMPLETED|Part 2||0
8507472|NCT00457821|20967189|P8|COMPLETED|Part 2||4
8507473|NCT00457821|20967190|P7|COMPLETED|Part 2||7
8507474|NCT00457821|20967191|P6|COMPLETED|Part 2||8
8507475|NCT00457821|20967192|P5|COMPLETED|Part 2||0
8507476|NCT00457821|20967193|P4|COMPLETED|Part 2||0
8507477|NCT00457821|20967194|P3|COMPLETED|Part 2||0
8507478|NCT00457821|20967195|P2|COMPLETED|Part 2||0
8507479|NCT00457821|20967196|P1|COMPLETED|Part 2||0
8507480|NCT00457821|20967189|P8|Completed Study Drug Treatment|Part 2||4
8507481|NCT00457821|20967190|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
8507482|NCT00457821|20967191|P6|Completed Study Drug Treatment|Part 2||8
8507483|NCT00457821|20967192|P5|Completed Study Drug Treatment|Part 2||0
8507484|NCT00457821|20967193|P4|Completed Study Drug Treatment|Part 2||0
8507485|NCT00457821|20967194|P3|Completed Study Drug Treatment|Part 2||0
8507486|NCT00457821|20967195|P2|Completed Study Drug Treatment|Part 2||0
8507487|NCT00457821|20967196|P1|Completed Study Drug Treatment|Part 2||0
8507488|NCT00457821|20967189|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
8507489|NCT00457821|20967190|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
8507490|NCT00457821|20967191|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
8507491|NCT00457821|20967192|P5|STARTED|Part 2|Arm in Part 1 only|0
8507492|NCT00457821|20967193|P4|STARTED|Part 2|Arm in Part 1 only|0
8507493|NCT00457821|20967194|P3|STARTED|Part 2|Arm in Part 1 only|0
8507494|NCT00457821|20967195|P2|STARTED|Part 2|Arm in Part 1 only|0
8507495|NCT00457821|20967196|P1|STARTED|Part 2|Arm in Part 1 only|0
8507496|NCT00457821|20967189|P8|NOT COMPLETED|Part 1||0
8507497|NCT00457821|20967190|P7|NOT COMPLETED|Part 1||0
8507498|NCT00457821|20967191|P6|NOT COMPLETED|Part 1||0
8507499|NCT00457821|20967192|P5|NOT COMPLETED|Part 1||0
8507500|NCT00457821|20967193|P4|NOT COMPLETED|Part 1||0
8507501|NCT00457821|20967194|P3|NOT COMPLETED|Part 1||1
8507502|NCT00457821|20967195|P2|NOT COMPLETED|Part 1||0
8507503|NCT00457821|20967196|P1|NOT COMPLETED|Part 1||0
8507504|NCT00457821|20967189|P8|COMPLETED|Part 1||0
8507505|NCT00457821|20967190|P7|COMPLETED|Part 1||0
8507506|NCT00457821|20967191|P6|COMPLETED|Part 1||0
8507507|NCT00457821|20967192|P5|COMPLETED|Part 1||4
8507508|NCT00457821|20967193|P4|COMPLETED|Part 1||4
8507509|NCT00457821|20967194|P3|COMPLETED|Part 1||4
8507510|NCT00457821|20967195|P2|COMPLETED|Part 1||4
8507511|NCT00457821|20967196|P1|COMPLETED|Part 1||4
8507512|NCT00457821|20967189|P8|STARTED|Part 1|Arm in Part 2 only|0
8507513|NCT00457821|20967190|P7|STARTED|Part 1|Arm in Part 2 only|0
8507514|NCT00457821|20967191|P6|STARTED|Part 1|Arm in Part 2 only|0
8507515|NCT00457821|20967192|P5|STARTED|Part 1|Number of subjects randomized|4
8507516|NCT00457821|20967193|P4|STARTED|Part 1|Number of subjects randomized|4
8507517|NCT00457821|20967194|P3|STARTED|Part 1|Number of subjects randomized|5
8507518|NCT00457821|20967195|P2|STARTED|Part 1|Number of subjects randomized|4
8507519|NCT00457821|20967196|P1|STARTED|Part 1|Number of subjects randomized|4
8507520|NCT00457795|20967225|P1|NOT COMPLETED|Overall Study||0
8507521|NCT00457795|20967225|P1|COMPLETED|Overall Study||15
8507522|NCT00457795|20967225|P1|STARTED|Overall Study||15
8507523|NCT00457743|20967235|P3|NOT COMPLETED|Overall Study||3
8507524|NCT00457743|20967236|P2|NOT COMPLETED|Overall Study||27
8507525|NCT00457743|20967237|P1|NOT COMPLETED|Overall Study||3
8507526|NCT00457743|20967235|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
8507527|NCT00457743|20967236|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
8507528|NCT00457743|20967237|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
8507529|NCT00457743|20967235|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
8507530|NCT00457743|20967236|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
8507531|NCT00457743|20967237|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
8507532|NCT00457743|20967235|P3|Completed Phase 1|Overall Study||3
8507533|NCT00457743|20967236|P2|Completed Phase 1|Overall Study||6
8507534|NCT00457743|20967237|P1|Completed Phase 1|Overall Study||3
8507535|NCT00457743|20967235|P3|Enrolled in Phase 1|Overall Study||3
8507536|NCT00457743|20967236|P2|Enrolled in Phase 1|Overall Study||6
8507537|NCT00457743|20967237|P1|Enrolled in Phase 1|Overall Study||3
8507538|NCT00457743|20967235|P3|STARTED|Overall Study|Overall study|3
8507539|NCT00457743|20967236|P2|STARTED|Overall Study|Overall study|30
8507540|NCT00457743|20967237|P1|STARTED|Overall Study|Overall study|3
8507541|NCT00457730|20967281|P2|NOT COMPLETED|Overall Study||1
8507542|NCT00457730|20967282|P1|NOT COMPLETED|Overall Study||4
8507543|NCT00457730|20967281|P2|COMPLETED|Overall Study||19
8507544|NCT00457730|20967282|P1|COMPLETED|Overall Study||14
8507545|NCT00457730|20967281|P2|STARTED|Overall Study||20
8507546|NCT00457730|20967282|P1|STARTED|Overall Study||18
8507547|NCT00457691|20967294|P2|NOT COMPLETED|Overall Study||382
8507548|NCT00457691|20967295|P1|NOT COMPLETED|Overall Study||386
8507549|NCT00457691|20967294|P2|COMPLETED|Overall Study||0
8507550|NCT00457691|20967295|P1|COMPLETED|Overall Study||0
8507551|NCT00457691|20967294|P2|STARTED|Overall Study||382
8507552|NCT00457691|20967295|P1|STARTED|Overall Study||386
8507553|NCT00457665|20967317|P2|NOT COMPLETED|24 Months||8
8507554|NCT00457665|20967318|P1|NOT COMPLETED|24 Months||5
8507555|NCT00457665|20967317|P2|COMPLETED|24 Months||11
8507556|NCT00457665|20967318|P1|COMPLETED|24 Months||15
8507557|NCT00457665|20967317|P2|STARTED|24 Months||19
8507558|NCT00457665|20967318|P1|STARTED|24 Months||20
8507559|NCT00457665|20967317|P2|NOT COMPLETED|12 Months||9
8507560|NCT00457665|20967318|P1|NOT COMPLETED|12 Months||8
8507561|NCT00457665|20967317|P2|COMPLETED|12 Months||19
8507562|NCT00457665|20967318|P1|COMPLETED|12 Months||20
8507563|NCT00457665|20967317|P2|STARTED|12 Months||28
8507564|NCT00457665|20967318|P1|STARTED|12 Months||28
8507565|NCT00457639|20967324|P2|NOT COMPLETED|Intervention 2 (6 Months)||1
8507566|NCT00457639|20967325|P1|NOT COMPLETED|Intervention 2 (6 Months)||0
8507567|NCT00457639|20967324|P2|COMPLETED|Intervention 2 (6 Months)||6
8507568|NCT00457639|20967325|P1|COMPLETED|Intervention 2 (6 Months)||6
8507569|NCT00457639|20967324|P2|STARTED|Intervention 2 (6 Months)||7
8507570|NCT00457639|20967325|P1|STARTED|Intervention 2 (6 Months)||6
8507571|NCT00457639|20967324|P2|NOT COMPLETED|Intervention 1 (6 Months)||2
8507572|NCT00457639|20967325|P1|NOT COMPLETED|Intervention 1 (6 Months)||3
8507573|NCT00457639|20967324|P2|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
8507574|NCT00457639|20967325|P1|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
8507575|NCT00457639|20967324|P2|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
8507576|NCT00457639|20967325|P1|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
8507577|NCT00457418|20967333|P1|NOT COMPLETED|Post PK Maintenance||28
8507578|NCT00457418|20967333|P1|COMPLETED|Post PK Maintenance||3
8507579|NCT00457418|20967333|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
8507580|NCT00457418|20967333|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
8507581|NCT00457418|20967333|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
8507582|NCT00457418|20967333|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
8507583|NCT00457392|20967345|P2|NOT COMPLETED|Overall Study||480
8507584|NCT00457392|20967346|P1|NOT COMPLETED|Overall Study||480
8507585|NCT00457392|20967345|P2|COMPLETED|Overall Study||0
8507586|NCT00457392|20967346|P1|COMPLETED|Overall Study||0
8507587|NCT00457392|20967345|P2|Treated|Overall Study||477
8507588|NCT00457392|20967346|P1|Treated|Overall Study||473
8507589|NCT00457392|20967345|P2|STARTED|Overall Study||480
8507590|NCT00457392|20967346|P1|STARTED|Overall Study||480
8507591|NCT00457366|20967364|P2|NOT COMPLETED|Overall Study||0
8507592|NCT00457366|20967365|P1|NOT COMPLETED|Overall Study||0
8507593|NCT00457366|20967364|P2|COMPLETED|Overall Study||32
8507594|NCT00457366|20967365|P1|COMPLETED|Overall Study||40
8507595|NCT00457366|20967364|P2|STARTED|Overall Study||32
8507596|NCT00457366|20967365|P1|STARTED|Overall Study||40
8507597|NCT00457301|20967373|P2|NOT COMPLETED|Overall Study||24
8507598|NCT00457301|20967374|P1|NOT COMPLETED|Overall Study||23
8507599|NCT00457301|20967373|P2|COMPLETED|Overall Study||84
8507600|NCT00457301|20967374|P1|COMPLETED|Overall Study||82
8507601|NCT00457301|20967373|P2|STARTED|Overall Study||108
8507602|NCT00457301|20967374|P1|STARTED|Overall Study||105
8507603|NCT00457249|20967388|P2|NOT COMPLETED|Overall Study||2
8507604|NCT00457249|20967389|P1|NOT COMPLETED|Overall Study||12
8507605|NCT00457249|20967388|P2|COMPLETED|Overall Study||389
8507606|NCT00457249|20967389|P1|COMPLETED|Overall Study||1158
8507607|NCT00457249|20967388|P2|STARTED|Overall Study||391
8507608|NCT00457249|20967389|P1|STARTED|Overall Study||1170
8507609|NCT00457197|20967403|P2|NOT COMPLETED|Overall Study||1
8507610|NCT00457197|20967404|P1|NOT COMPLETED|Overall Study||1
8507611|NCT00457197|20967403|P2|COMPLETED|Overall Study||44
8507612|NCT00457197|20967404|P1|COMPLETED|Overall Study||44
8507613|NCT00457197|20967403|P2|STARTED|Overall Study||45
8507614|NCT00457197|20967404|P1|STARTED|Overall Study||45
8507615|NCT00457015|20967428|P2|NOT COMPLETED|Overall Study||1
8507616|NCT00457015|20967429|P1|NOT COMPLETED|Overall Study||0
8507617|NCT00457015|20967428|P2|COMPLETED|Overall Study||47
8507618|NCT00457015|20967429|P1|COMPLETED|Overall Study||48
8507619|NCT00457015|20967428|P2|STARTED|Overall Study||48
8507620|NCT00457015|20967429|P1|STARTED|Overall Study||48
8507621|NCT00457002|20967445|P2|NOT COMPLETED|Overall Study||757
8507622|NCT00457002|20967446|P1|NOT COMPLETED|Overall Study||813
8507623|NCT00457002|20967445|P2|COMPLETED|Overall Study||2516
8507624|NCT00457002|20967446|P1|COMPLETED|Overall Study||2442
8507625|NCT00457002|20967445|P2|STARTED|Overall Study||3273
8507626|NCT00457002|20967446|P1|STARTED|Overall Study||3255
8507627|NCT00456989|20967514|P1|NOT COMPLETED|Overall Study||0
8507628|NCT00456989|20967514|P1|COMPLETED|Overall Study||39
8507629|NCT00456989|20967514|P1|STARTED|Overall Study||39
8507630|NCT00456885|20967519|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
8507631|NCT00456885|20967520|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
8507632|NCT00456885|20967519|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
8507633|NCT00456885|20967520|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
8507634|NCT00456885|20967519|P2|STARTED|Second Treatment Period, 16 Weeks||17
8507635|NCT00456885|20967520|P1|STARTED|Second Treatment Period, 16 Weeks||24
8507636|NCT00456885|20967519|P2|NOT COMPLETED|Washout, 3 Weeks||0
8507637|NCT00456885|20967520|P1|NOT COMPLETED|Washout, 3 Weeks||0
8507638|NCT00456885|20967519|P2|COMPLETED|Washout, 3 Weeks||17
8507639|NCT00456885|20967520|P1|COMPLETED|Washout, 3 Weeks||24
8507640|NCT00456885|20967519|P2|STARTED|Washout, 3 Weeks||17
8507641|NCT00456885|20967520|P1|STARTED|Washout, 3 Weeks||24
8507642|NCT00456885|20967519|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
8507643|NCT00456885|20967520|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
8507644|NCT00456885|20967519|P2|COMPLETED|First Treatment Period, 16 Weeks||17
8507645|NCT00456885|20967520|P1|COMPLETED|First Treatment Period, 16 Weeks||24
8507646|NCT00456885|20967519|P2|STARTED|First Treatment Period, 16 Weeks||17
8507647|NCT00456885|20967520|P1|STARTED|First Treatment Period, 16 Weeks||24
8507648|NCT00456846|20967551|P2|NOT COMPLETED|Overall Study||28
8507649|NCT00456846|20967552|P1|NOT COMPLETED|Overall Study||16
8507650|NCT00456846|20967551|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
8507651|NCT00456846|20967552|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
8507652|NCT00456846|20967551|P2|STARTED|Overall Study||76
8507653|NCT00456846|20967552|P1|STARTED|Overall Study||47
8507654|NCT00456807|20967574|P2|NOT COMPLETED|Overall Study||0
8507655|NCT00456807|20967575|P1|NOT COMPLETED|Overall Study||1
8507656|NCT00456807|20967574|P2|COMPLETED|Overall Study||47
8507657|NCT00456807|20967575|P1|COMPLETED|Overall Study||52
8507658|NCT00456807|20967574|P2|STARTED|Overall Study||47
8507659|NCT00456807|20967575|P1|STARTED|Overall Study||53
8507660|NCT00456755|20967593|P2|NOT COMPLETED|Overall Study||1
8507661|NCT00456755|20967594|P1|NOT COMPLETED|Overall Study||2
8507662|NCT00456755|20967593|P2|COMPLETED|Overall Study||62
8507663|NCT00456755|20967594|P1|COMPLETED|Overall Study||61
8507664|NCT00456755|20967593|P2|STARTED|Overall Study||63
8507665|NCT00456755|20967594|P1|STARTED|Overall Study||63
8507666|NCT00456625|20967602|P1|NOT COMPLETED|Overall Study||0
8507667|NCT00456625|20967602|P1|COMPLETED|Overall Study||76
8507668|NCT00456625|20967602|P1|STARTED|Overall Study||76
8507669|NCT00456612|20967608|P1|NOT COMPLETED|Overall Study||3
8507670|NCT00456612|20967608|P1|COMPLETED|Overall Study||1
8507671|NCT00456612|20967608|P1|STARTED|Overall Study||4
8507672|NCT00456599|20967613|P1|NOT COMPLETED|Overall Study||3
8507673|NCT00456599|20967613|P1|COMPLETED|Overall Study||68
8507674|NCT00456599|20967613|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
8507675|NCT00456599|20967613|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
8507676|NCT00456599|20967613|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
8507677|NCT00456599|20967613|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
8507678|NCT00456599|20967613|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
8507679|NCT00456599|20967613|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
8507680|NCT00456599|20967613|P1|STARTED|Overall Study||71
8507681|NCT00456547|20967621|P2|NOT COMPLETED|Overall Study||0
8507682|NCT00456547|20967622|P1|NOT COMPLETED|Overall Study||0
8507683|NCT00456547|20967621|P2|COMPLETED|Overall Study||12
8507684|NCT00456547|20967622|P1|COMPLETED|Overall Study||12
8507685|NCT00456547|20967621|P2|STARTED|Overall Study||12
8507686|NCT00456547|20967622|P1|STARTED|Overall Study||12
8507687|NCT00456521|20967636|P2|NOT COMPLETED|Overall Study||84
8507688|NCT00456521|20967637|P1|NOT COMPLETED|Overall Study||249
8507689|NCT00456521|20967636|P2|COMPLETED|Overall Study||118
8507690|NCT00456521|20967637|P1|COMPLETED|Overall Study||342
8507691|NCT00456521|20967636|P2|STARTED|Overall Study||202
8507692|NCT00456521|20967637|P1|STARTED|Overall Study||591
8507693|NCT00456508|20967677|P1|NOT COMPLETED|Overall Study||0
8507694|NCT00456508|20967677|P1|COMPLETED|Overall Study||147
8507695|NCT00456508|20967677|P1|STARTED|Overall Study||147
8507696|NCT00456495|20967683|P1|NOT COMPLETED|Overall Study||2
8507697|NCT00456495|20967683|P1|COMPLETED|Overall Study||3
8507698|NCT00456495|20967683|P1|STARTED|Overall Study||5
8507699|NCT00456365|20967690|P2|NOT COMPLETED|Overall Study||12
8507700|NCT00456365|20967691|P1|NOT COMPLETED|Overall Study||7
8507701|NCT00456365|20967690|P2|COMPLETED|Overall Study||42
8507702|NCT00456365|20967691|P1|COMPLETED|Overall Study||49
8507703|NCT00456365|20967690|P2|STARTED|Overall Study||54
8507704|NCT00456365|20967691|P1|STARTED|Overall Study||56
8507705|NCT00456300|20967703|P2|NOT COMPLETED|Overall Study||0
8507706|NCT00456300|20967704|P1|NOT COMPLETED|Overall Study||1
8507707|NCT00456300|20967703|P2|COMPLETED|Overall Study||4
8507708|NCT00456300|20967704|P1|COMPLETED|Overall Study||4
8507709|NCT00456300|20967703|P2|STARTED|Overall Study||4
8507710|NCT00456300|20967704|P1|STARTED|Overall Study||5
8507711|NCT00456261|20967714|P2|NOT COMPLETED|Maintenance Therapy||0
8507712|NCT00456261|20967715|P1|NOT COMPLETED|Maintenance Therapy||0
8507713|NCT00456261|20967714|P2|COMPLETED|Maintenance Therapy||29
8507714|NCT00456261|20967715|P1|COMPLETED|Maintenance Therapy||3
8507715|NCT00456261|20967714|P2|STARTED|Maintenance Therapy||29
8507716|NCT00456261|20967715|P1|STARTED|Maintenance Therapy||3
8507717|NCT00456261|20967714|P2|NOT COMPLETED|Combination Therapy||26
8507718|NCT00456261|20967715|P1|NOT COMPLETED|Combination Therapy||52
8507719|NCT00456261|20967714|P2|COMPLETED|Combination Therapy||29
8507720|NCT00456261|20967715|P1|COMPLETED|Combination Therapy||3
8507721|NCT00456261|20967714|P2|STARTED|Combination Therapy||55
8507722|NCT00456261|20967715|P1|STARTED|Combination Therapy||55
8507723|NCT00456092|20967728|P5|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8507724|NCT00456092|20967729|P4|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8507725|NCT00456092|20967730|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||18
8507726|NCT00456092|20967731|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||14
8507727|NCT00456092|20967732|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||7
8507728|NCT00456092|20967728|P5|COMPLETED|Treatment Phase (12 Weeks)||0
8507729|NCT00456092|20967729|P4|COMPLETED|Treatment Phase (12 Weeks)||0
8507730|NCT00456092|20967730|P3|COMPLETED|Treatment Phase (12 Weeks)||50
8507731|NCT00456092|20967731|P2|COMPLETED|Treatment Phase (12 Weeks)||55
8507732|NCT00456092|20967732|P1|COMPLETED|Treatment Phase (12 Weeks)||60
8507733|NCT00456092|20967728|P5|STARTED|Treatment Phase (12 Weeks)||0
8507734|NCT00456092|20967729|P4|STARTED|Treatment Phase (12 Weeks)||0
8507735|NCT00456092|20967730|P3|STARTED|Treatment Phase (12 Weeks)||68
8507736|NCT00456092|20967731|P2|STARTED|Treatment Phase (12 Weeks)||69
8507737|NCT00456092|20967732|P1|STARTED|Treatment Phase (12 Weeks)||67
8507738|NCT00456092|20967728|P5|NOT COMPLETED|Extension Phase||7
8507739|NCT00456092|20967729|P4|NOT COMPLETED|Extension Phase||1
8507740|NCT00456092|20967730|P3|NOT COMPLETED|Extension Phase||0
8507741|NCT00456092|20967731|P2|NOT COMPLETED|Extension Phase||4
8507742|NCT00456092|20967732|P1|NOT COMPLETED|Extension Phase||11
8507743|NCT00456092|20967728|P5|COMPLETED|Extension Phase||13
8507744|NCT00456092|20967729|P4|COMPLETED|Extension Phase||19
8507745|NCT00456092|20967730|P3|COMPLETED|Extension Phase||0
8507746|NCT00456092|20967731|P2|COMPLETED|Extension Phase||36
8507747|NCT00456092|20967732|P1|COMPLETED|Extension Phase||35
8507748|NCT00456092|20967728|P5|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
8507749|NCT00456092|20967729|P4|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
8507750|NCT00456092|20967730|P3|STARTED|Extension Phase||0
8507751|NCT00456092|20967731|P2|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
8507752|NCT00456092|20967732|P1|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
8507753|NCT00456014|20967882|P1|NOT COMPLETED|Tricyclic Phase||3
8507754|NCT00456014|20967882|P1|COMPLETED|Tricyclic Phase||1
8507755|NCT00456014|20967882|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
8507756|NCT00456014|20967882|P1|NOT COMPLETED|SSRI Phase||9
8507757|NCT00456014|20967882|P1|COMPLETED|SSRI Phase||28
8507758|NCT00456014|20967882|P1|STARTED|SSRI Phase||37
8507759|NCT00455975|20967890|P2|NOT COMPLETED|Overall Study||21
8507760|NCT00455975|20967891|P1|NOT COMPLETED|Overall Study||18
8507761|NCT00455975|20967890|P2|COMPLETED|Overall Study||40
8507762|NCT00455975|20967891|P1|COMPLETED|Overall Study||40
8507763|NCT00455975|20967890|P2|STARTED|Overall Study||61
8507764|NCT00455975|20967891|P1|STARTED|Overall Study||58
8507765|NCT00455962|20967905|P2|NOT COMPLETED|Overall Study||0
8507766|NCT00455962|20967906|P1|NOT COMPLETED|Overall Study||0
8507767|NCT00455962|20967905|P2|COMPLETED|Overall Study||13
8507768|NCT00455962|20967906|P1|COMPLETED|Overall Study||10
8507769|NCT00455962|20967905|P2|STARTED|Overall Study||13
8507770|NCT00455962|20967906|P1|STARTED|Overall Study||10
8507771|NCT00455923|20967914|P2|NOT COMPLETED|Overall Study||3
8507772|NCT00455923|20967915|P1|NOT COMPLETED|Overall Study||3
8507773|NCT00455923|20967914|P2|COMPLETED|Overall Study||47
8507774|NCT00455923|20967915|P1|COMPLETED|Overall Study||47
8507775|NCT00455923|20967914|P2|STARTED|Overall Study||50
8507776|NCT00455923|20967915|P1|STARTED|Overall Study||50
8507777|NCT00455858|20967931|P1|NOT COMPLETED|Overall Study||6
8507778|NCT00455858|20967931|P1|COMPLETED|Overall Study||81
8507779|NCT00455858|20967931|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
8507780|NCT00455741|20967941|P2|NOT COMPLETED|Overall Study||1
8507781|NCT00455741|20967942|P1|NOT COMPLETED|Overall Study||0
8507782|NCT00455741|20967941|P2|COMPLETED|Overall Study||11
8507783|NCT00455741|20967942|P1|COMPLETED|Overall Study||13
8507784|NCT00455741|20967941|P2|STARTED|Overall Study||12
8507785|NCT00455741|20967942|P1|STARTED|Overall Study||13
8507786|NCT00455702|20967960|P2|NOT COMPLETED|Overall Study||3
8507787|NCT00455702|20967961|P1|NOT COMPLETED|Overall Study||3
8507788|NCT00455702|20967960|P2|COMPLETED|Overall Study||16
8507789|NCT00455702|20967961|P1|COMPLETED|Overall Study||16
8507790|NCT00455702|20967960|P2|STARTED|Overall Study||19
8507791|NCT00455702|20967961|P1|STARTED|Overall Study||19
8507792|NCT00455689|20967971|P2|NOT COMPLETED|Overall Study||0
8507793|NCT00455689|20967972|P1|NOT COMPLETED|Overall Study||0
8507794|NCT00455689|20967971|P2|COMPLETED|Overall Study||6
8507795|NCT00455689|20967972|P1|COMPLETED|Overall Study||14
8507796|NCT00455689|20967971|P2|STARTED|Overall Study||6
8507797|NCT00455689|20967972|P1|STARTED|Overall Study||14
8507798|NCT00455663|20967982|P3|NOT COMPLETED|Overall Study||3
8507799|NCT00455663|20967983|P2|NOT COMPLETED|Overall Study||4
8507800|NCT00455663|20967984|P1|NOT COMPLETED|Overall Study||3
8507801|NCT00455663|20967982|P3|COMPLETED|Overall Study||29
8507802|NCT00455663|20967983|P2|COMPLETED|Overall Study||32
8507803|NCT00455663|20967984|P1|COMPLETED|Overall Study||34
8507804|NCT00455663|20967982|P3|STARTED|Overall Study||32
8507805|NCT00455663|20967983|P2|STARTED|Overall Study||36
8507806|NCT00455663|20967984|P1|STARTED|Overall Study||37
8507807|NCT00455650|20968003|P6|NOT COMPLETED|Week 3||0
8507808|NCT00455650|20968004|P5|NOT COMPLETED|Week 3||0
8507809|NCT00455650|20968005|P4|NOT COMPLETED|Week 3||0
8507810|NCT00455650|20968006|P3|NOT COMPLETED|Week 3||0
8507811|NCT00455650|20968007|P2|NOT COMPLETED|Week 3||0
8507812|NCT00455650|20968008|P1|NOT COMPLETED|Week 3||0
8507813|NCT00455650|20968003|P6|COMPLETED|Week 3||13
8507814|NCT00455650|20968004|P5|COMPLETED|Week 3||14
8507815|NCT00455650|20968005|P4|COMPLETED|Week 3||14
8507816|NCT00455650|20968006|P3|COMPLETED|Week 3||10
8507817|NCT00455650|20968007|P2|COMPLETED|Week 3||10
8507818|NCT00455650|20968008|P1|COMPLETED|Week 3||10
8507819|NCT00455650|20968003|P6|STARTED|Week 3||13
8507820|NCT00455650|20968004|P5|STARTED|Week 3||14
8507821|NCT00455650|20968005|P4|STARTED|Week 3||14
8507822|NCT00455650|20968006|P3|STARTED|Week 3||10
8507823|NCT00455650|20968007|P2|STARTED|Week 3||10
8507824|NCT00455650|20968008|P1|STARTED|Week 3||10
8507825|NCT00455650|20968003|P6|NOT COMPLETED|Week 2||0
8507826|NCT00455650|20968004|P5|NOT COMPLETED|Week 2||0
8507827|NCT00455650|20968005|P4|NOT COMPLETED|Week 2||0
8507828|NCT00455650|20968006|P3|NOT COMPLETED|Week 2||0
8507829|NCT00455650|20968007|P2|NOT COMPLETED|Week 2||0
8507830|NCT00455650|20968008|P1|NOT COMPLETED|Week 2||0
8507831|NCT00455650|20968003|P6|COMPLETED|Week 2||13
8507832|NCT00455650|20968004|P5|COMPLETED|Week 2||14
8507833|NCT00455650|20968005|P4|COMPLETED|Week 2||14
8507834|NCT00455650|20968006|P3|COMPLETED|Week 2||10
8507835|NCT00455650|20968007|P2|COMPLETED|Week 2||10
8507836|NCT00455650|20968008|P1|COMPLETED|Week 2||10
8507837|NCT00455650|20968003|P6|STARTED|Week 2||13
8507838|NCT00455650|20968004|P5|STARTED|Week 2||14
8507839|NCT00455650|20968005|P4|STARTED|Week 2||14
8507840|NCT00455650|20968006|P3|STARTED|Week 2||10
8507841|NCT00455650|20968007|P2|STARTED|Week 2||10
8507842|NCT00455650|20968008|P1|STARTED|Week 2||10
8507843|NCT00455650|20968003|P6|NOT COMPLETED|Week 1||0
8507844|NCT00455650|20968004|P5|NOT COMPLETED|Week 1||0
8507845|NCT00455650|20968005|P4|NOT COMPLETED|Week 1||0
8507846|NCT00455650|20968006|P3|NOT COMPLETED|Week 1||0
8507847|NCT00455650|20968007|P2|NOT COMPLETED|Week 1||0
8507848|NCT00455650|20968008|P1|NOT COMPLETED|Week 1||0
8507849|NCT00455650|20968003|P6|COMPLETED|Week 1||13
8507850|NCT00455650|20968004|P5|COMPLETED|Week 1||14
8507851|NCT00455650|20968005|P4|COMPLETED|Week 1||14
8507852|NCT00455650|20968006|P3|COMPLETED|Week 1||10
8507853|NCT00455650|20968007|P2|COMPLETED|Week 1||10
8507854|NCT00455650|20968008|P1|COMPLETED|Week 1||10
8507855|NCT00455650|20968003|P6|STARTED|Week 1||13
8507856|NCT00455650|20968004|P5|STARTED|Week 1||14
8507857|NCT00455650|20968005|P4|STARTED|Week 1||14
8507858|NCT00455650|20968006|P3|STARTED|Week 1||10
8507859|NCT00455650|20968007|P2|STARTED|Week 1||10
8507860|NCT00455650|20968008|P1|STARTED|Week 1||10
8507861|NCT00455533|20968038|P3|NOT COMPLETED|Period Two: Randomized Period||6
8507862|NCT00455533|20968039|P2|NOT COMPLETED|Period Two: Randomized Period||6
8507863|NCT00455533|20968040|P1|NOT COMPLETED|Period Two: Randomized Period||0
8507864|NCT00455533|20968038|P3|COMPLETED|Period Two: Randomized Period||138
8507865|NCT00455533|20968039|P2|COMPLETED|Period Two: Randomized Period||139
8507866|NCT00455533|20968040|P1|COMPLETED|Period Two: Randomized Period||0
8507867|NCT00455533|20968038|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
8507868|NCT00455533|20968039|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
8507869|NCT00455533|20968040|P1|STARTED|Period Two: Randomized Period||0
8507870|NCT00455533|20968038|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
8507871|NCT00455533|20968039|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
8507872|NCT00455533|20968040|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
8507873|NCT00455533|20968038|P3|COMPLETED|Period One: Initial Chemotherapy||0
8507874|NCT00455533|20968039|P2|COMPLETED|Period One: Initial Chemotherapy||0
8507875|NCT00455533|20968040|P1|COMPLETED|Period One: Initial Chemotherapy||295
8507876|NCT00455533|20968038|P3|STARTED|Period One: Initial Chemotherapy||0
8507877|NCT00455533|20968039|P2|STARTED|Period One: Initial Chemotherapy||0
8507878|NCT00455533|20968040|P1|STARTED|Period One: Initial Chemotherapy||313
8507879|NCT00455520|20968089|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
8507880|NCT00455520|20968090|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
8507881|NCT00455520|20968089|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
8507882|NCT00455520|20968090|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
8507883|NCT00455520|20968089|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
8507884|NCT00455520|20968090|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
8507885|NCT00455520|20968089|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
8507886|NCT00455520|20968090|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
8507887|NCT00455520|20968089|P2|COMPLETED|Open Label Tapentadol Extended Release||0
8507888|NCT00455520|20968090|P1|COMPLETED|Open Label Tapentadol Extended Release||395
8507889|NCT00455520|20968089|P2|STARTED|Open Label Tapentadol Extended Release||0
8507890|NCT00455520|20968090|P1|STARTED|Open Label Tapentadol Extended Release||591
8507891|NCT00455455|20968106|P2|NOT COMPLETED|Second Intervention||0
8507892|NCT00455455|20968107|P1|NOT COMPLETED|Second Intervention||0
8507893|NCT00455455|20968106|P2|COMPLETED|Second Intervention||24
8507894|NCT00455455|20968107|P1|COMPLETED|Second Intervention||24
8507895|NCT00455455|20968106|P2|STARTED|Second Intervention||24
8507896|NCT00455455|20968107|P1|STARTED|Second Intervention||24
8507897|NCT00455455|20968106|P2|NOT COMPLETED|Washout||0
8507898|NCT00455455|20968107|P1|NOT COMPLETED|Washout||1
8507899|NCT00455455|20968106|P2|COMPLETED|Washout||24
8507900|NCT00455455|20968107|P1|COMPLETED|Washout||24
8507901|NCT00455455|20968106|P2|STARTED|Washout||24
8507902|NCT00455455|20968107|P1|STARTED|Washout||25
8507903|NCT00455455|20968106|P2|NOT COMPLETED|First Intervention||0
8507904|NCT00455455|20968107|P1|NOT COMPLETED|First Intervention||0
8507905|NCT00455455|20968106|P2|COMPLETED|First Intervention||24
8507906|NCT00455455|20968107|P1|COMPLETED|First Intervention||25
8507907|NCT00455455|20968106|P2|STARTED|First Intervention||24
8507908|NCT00455455|20968107|P1|STARTED|First Intervention||25
8507909|NCT00455455|20968106|P2|NOT COMPLETED|Washout||1
8507910|NCT00455455|20968107|P1|NOT COMPLETED|Washout||0
8507911|NCT00455455|20968106|P2|COMPLETED|Washout||24
8507912|NCT00455455|20968107|P1|COMPLETED|Washout||25
8507913|NCT00455455|20968106|P2|STARTED|Washout||25
8507914|NCT00455455|20968107|P1|STARTED|Washout||25
8507915|NCT00455429|20968127|P4|NOT COMPLETED|Overall Study||14
8507916|NCT00455429|20968128|P3|NOT COMPLETED|Overall Study||1
8507917|NCT00455429|20968129|P2|NOT COMPLETED|Overall Study||5
8507918|NCT00455429|20968130|P1|NOT COMPLETED|Overall Study||2
8507919|NCT00455429|20968127|P4|COMPLETED|Overall Study||20
8507920|NCT00455429|20968128|P3|COMPLETED|Overall Study||16
8507921|NCT00455429|20968129|P2|COMPLETED|Overall Study||10
8507922|NCT00455429|20968130|P1|COMPLETED|Overall Study||16
8507923|NCT00455429|20968127|P4|Treated|Overall Study||32
8507924|NCT00455429|20968128|P3|Treated|Overall Study||17
8507925|NCT00455429|20968129|P2|Treated|Overall Study||15
8507926|NCT00455429|20968130|P1|Treated|Overall Study||18
8507927|NCT00455429|20968127|P4|STARTED|Overall Study||34
8507928|NCT00455429|20968128|P3|STARTED|Overall Study||17
8507929|NCT00455429|20968129|P2|STARTED|Overall Study||15
8507930|NCT00455429|20968130|P1|STARTED|Overall Study||18
8507931|NCT00455312|20968189|P2|NOT COMPLETED|Overall Study||1
8507932|NCT00455312|20968190|P1|NOT COMPLETED|Overall Study||0
8507933|NCT00455312|20968189|P2|COMPLETED|Overall Study||20
8507934|NCT00455312|20968190|P1|COMPLETED|Overall Study||15
8507935|NCT00455312|20968189|P2|STARTED|Overall Study||21
8507936|NCT00455312|20968190|P1|STARTED|Overall Study||15
8507937|NCT00455195|20968216|P2|NOT COMPLETED|Extension Study AGLU03206||0
8507938|NCT00455195|20968217|P1|NOT COMPLETED|Extension Study AGLU03206||0
8507939|NCT00455195|20968216|P2|COMPLETED|Extension Study AGLU03206||26
8507940|NCT00455195|20968217|P1|COMPLETED|Extension Study AGLU03206||55
8507941|NCT00455195|20968216|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
8507942|NCT00455195|20968217|P1|STARTED|Extension Study AGLU03206||55
8507943|NCT00455195|20968216|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
8507944|NCT00455195|20968217|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
8507945|NCT00455195|20968216|P2|COMPLETED|Double-blind Study AGLU02704||26
8507946|NCT00455195|20968217|P1|COMPLETED|Double-blind Study AGLU02704||55
8507947|NCT00455195|20968216|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
8507948|NCT00455195|20968217|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
8507949|NCT00455143|20968231|P1|NOT COMPLETED|Overall Study||6
8507950|NCT00455143|20968231|P1|COMPLETED|Overall Study||21
8507951|NCT00455143|20968231|P1|STARTED|Overall Study||27
8507952|NCT00455013|20968255|P3|NOT COMPLETED|Long Term Extension (LTE)||7
8507953|NCT00455013|20968256|P2|NOT COMPLETED|Long Term Extension (LTE)||3
8507954|NCT00455013|20968257|P1|NOT COMPLETED|Long Term Extension (LTE)||2
8507955|NCT00455013|20968255|P3|COMPLETED|Long Term Extension (LTE)||20
8507956|NCT00455013|20968256|P2|COMPLETED|Long Term Extension (LTE)||16
8507957|NCT00455013|20968257|P1|COMPLETED|Long Term Extension (LTE)||25
8507958|NCT00455013|20968255|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
8507959|NCT00455013|20968256|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
8507960|NCT00455013|20968257|P1|STARTED|Long Term Extension (LTE)||27
8507961|NCT00455013|20968255|P3|NOT COMPLETED|Short Term Period||2
8507962|NCT00455013|20968256|P2|NOT COMPLETED|Short Term Period||5
8507963|NCT00455013|20968257|P1|NOT COMPLETED|Short Term Period||6
8507964|NCT00455013|20968255|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
8507965|NCT00455013|20968256|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
8507966|NCT00455013|20968257|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
8507967|NCT00455013|20968255|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
8507968|NCT00455013|20968256|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
8507969|NCT00455013|20968257|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
8507970|NCT00454987|20968325|P3|NOT COMPLETED|Year 4 (NCT00454987)||0
8507971|NCT00454987|20968326|P2|NOT COMPLETED|Year 4 (NCT00454987)||0
8507972|NCT00454987|20968327|P1|NOT COMPLETED|Year 4 (NCT00454987)||0
8507973|NCT00454987|20968325|P3|COMPLETED|Year 4 (NCT00454987)||0
8507974|NCT00454987|20968326|P2|COMPLETED|Year 4 (NCT00454987)||62
8507975|NCT00454987|20968327|P1|COMPLETED|Year 4 (NCT00454987)||206
8507976|NCT00454987|20968325|P3|STARTED|Year 4 (NCT00454987)||0
8507977|NCT00454987|20968326|P2|STARTED|Year 4 (NCT00454987)||62
8507978|NCT00454987|20968327|P1|STARTED|Year 4 (NCT00454987)||206
8507979|NCT00454987|20968325|P3|NOT COMPLETED|Year 2 (NCT00454987)||0
8507980|NCT00454987|20968326|P2|NOT COMPLETED|Year 2 (NCT00454987)||0
8507981|NCT00454987|20968327|P1|NOT COMPLETED|Year 2 (NCT00454987)||0
8507982|NCT00454987|20968325|P3|COMPLETED|Year 2 (NCT00454987)||74
8507983|NCT00454987|20968326|P2|COMPLETED|Year 2 (NCT00454987)||77
8507984|NCT00454987|20968327|P1|COMPLETED|Year 2 (NCT00454987)||235
8507985|NCT00454987|20968325|P3|STARTED|Year 2 (NCT00454987)||74
8507986|NCT00454987|20968326|P2|STARTED|Year 2 (NCT00454987)||77
8507987|NCT00454987|20968327|P1|STARTED|Year 2 (NCT00454987)||235
8507988|NCT00454987|20968325|P3|NOT COMPLETED|Year 1 (NCT00454987)||0
8507989|NCT00454987|20968326|P2|NOT COMPLETED|Year 1 (NCT00454987)||0
8507990|NCT00454987|20968327|P1|NOT COMPLETED|Year 1 (NCT00454987)||0
8507991|NCT00454987|20968325|P3|COMPLETED|Year 1 (NCT00454987)||0
8507992|NCT00454987|20968326|P2|COMPLETED|Year 1 (NCT00454987)||67
8507993|NCT00454987|20968327|P1|COMPLETED|Year 1 (NCT00454987)||221
8507994|NCT00454987|20968325|P3|STARTED|Year 1 (NCT00454987)||0
8507995|NCT00454987|20968326|P2|STARTED|Year 1 (NCT00454987)||67
8507996|NCT00454987|20968327|P1|STARTED|Year 1 (NCT00454987)||221
8507997|NCT00454987|20968325|P3|NOT COMPLETED|Booster Period (NCT00258700)||0
8507998|NCT00454987|20968326|P2|NOT COMPLETED|Booster Period (NCT00258700)||1
8507999|NCT00454987|20968327|P1|NOT COMPLETED|Booster Period (NCT00258700)||2
8508000|NCT00454987|20968325|P3|COMPLETED|Booster Period (NCT00258700)||0
8508001|NCT00454987|20968326|P2|COMPLETED|Booster Period (NCT00258700)||116
8508002|NCT00454987|20968327|P1|COMPLETED|Booster Period (NCT00258700)||357
8508003|NCT00454987|20968325|P3|STARTED|Booster Period (NCT00258700)||0
8508004|NCT00454987|20968326|P2|STARTED|Booster Period (NCT00258700)||117
8508005|NCT00454987|20968327|P1|STARTED|Booster Period (NCT00258700)||359
8508006|NCT00454909|20968401|P3|NOT COMPLETED|Overall Study||2
8508007|NCT00454909|20968402|P2|NOT COMPLETED|Overall Study||3
8508008|NCT00454909|20968403|P1|NOT COMPLETED|Overall Study||7
8508009|NCT00454909|20968401|P3|COMPLETED|Overall Study||86
8508010|NCT00454909|20968402|P2|COMPLETED|Overall Study||194
8508011|NCT00454909|20968403|P1|COMPLETED|Overall Study||580
8508012|NCT00454909|20968401|P3|STARTED|Overall Study||88
8508013|NCT00454909|20968402|P2|STARTED|Overall Study||197
8508014|NCT00454909|20968403|P1|STARTED|Overall Study||587
8508015|NCT00454857|20968441|P1|NOT COMPLETED|Overall Study||54
8508016|NCT00454857|20968441|P1|COMPLETED|Overall Study||272
8508017|NCT00454857|20968441|P1|Completed ≥1 Observational Study Visit|Overall Study||319
8508018|NCT00454857|20968441|P1|Completed Retrospective Chart Review|Overall Study||324
8508019|NCT00454857|20968441|P1|STARTED|Overall Study||326
8508020|NCT00454818|20968466|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
8508021|NCT00454818|20968467|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
8508022|NCT00454818|20968468|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
8508023|NCT00454818|20968469|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
8508024|NCT00454818|20968470|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
8508025|NCT00454818|20968466|P5|COMPLETED|Phase 2: Randomized Double-blind||10
8508026|NCT00454818|20968467|P4|COMPLETED|Phase 2: Randomized Double-blind||8
8508027|NCT00454818|20968468|P3|COMPLETED|Phase 2: Randomized Double-blind||5
8508028|NCT00454818|20968469|P2|COMPLETED|Phase 2: Randomized Double-blind||6
8508029|NCT00454818|20968470|P1|COMPLETED|Phase 2: Randomized Double-blind||0
8508030|NCT00454818|20968466|P5|STARTED|Phase 2: Randomized Double-blind||14
8508031|NCT00454818|20968467|P4|STARTED|Phase 2: Randomized Double-blind||9
8508032|NCT00454818|20968468|P3|STARTED|Phase 2: Randomized Double-blind||8
8508033|NCT00454818|20968469|P2|STARTED|Phase 2: Randomized Double-blind||8
8508034|NCT00454818|20968470|P1|STARTED|Phase 2: Randomized Double-blind||0
8508035|NCT00454818|20968466|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
8508036|NCT00454818|20968467|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508037|NCT00454818|20968468|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508038|NCT00454818|20968469|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508039|NCT00454818|20968470|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508040|NCT00454818|20968466|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
8508041|NCT00454818|20968467|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
8508042|NCT00454818|20968468|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
8508043|NCT00454818|20968469|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
8508044|NCT00454818|20968470|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
8508045|NCT00454818|20968466|P5|STARTED|Phase I: Open-label Dose-escalation||0
8508046|NCT00454818|20968467|P4|STARTED|Phase I: Open-label Dose-escalation||3
8508047|NCT00454818|20968468|P3|STARTED|Phase I: Open-label Dose-escalation||3
8508048|NCT00454818|20968469|P2|STARTED|Phase I: Open-label Dose-escalation||3
8508049|NCT00454818|20968470|P1|STARTED|Phase I: Open-label Dose-escalation||3
8508050|NCT00454805|20968549|P2|NOT COMPLETED|Overall Study||23
8508051|NCT00454805|20968550|P1|NOT COMPLETED|Overall Study||26
8508052|NCT00454805|20968549|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
8508053|NCT00454805|20968550|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
8508054|NCT00454805|20968549|P2|STARTED|Overall Study|Randomised|31
8508055|NCT00454805|20968550|P1|STARTED|Overall Study|Randomised|31
8508056|NCT00454779|20968566|P2|NOT COMPLETED|Second-line Treatment Phase||3
8508057|NCT00454779|20968567|P1|NOT COMPLETED|Second-line Treatment Phase||0
8508058|NCT00454779|20968566|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
8508059|NCT00454779|20968567|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
8508060|NCT00454779|20968566|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
8508061|NCT00454779|20968567|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
8508062|NCT00454779|20968566|P2|NOT COMPLETED|First-line Treatment Phase||8
8508063|NCT00454779|20968567|P1|NOT COMPLETED|First-line Treatment Phase||5
8508064|NCT00454779|20968566|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
8508065|NCT00454779|20968567|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
8508066|NCT00454779|20968566|P2|Received Study Medication|First-line Treatment Phase||55
8508067|NCT00454779|20968567|P1|Received Study Medication|First-line Treatment Phase||56
8508068|NCT00454779|20968566|P2|STARTED|First-line Treatment Phase||57
8508069|NCT00454779|20968567|P1|STARTED|First-line Treatment Phase||56
8508070|NCT00454649|20968605|P10|NOT COMPLETED|Overall Study||5
8508071|NCT00454649|20968606|P9|NOT COMPLETED|Overall Study||20
8508072|NCT00454649|20968607|P8|NOT COMPLETED|Overall Study||19
8508073|NCT00454649|20968608|P7|NOT COMPLETED|Overall Study||9
8508074|NCT00454649|20968609|P6|NOT COMPLETED|Overall Study||7
8508075|NCT00454649|20968610|P5|NOT COMPLETED|Overall Study||1
8508076|NCT00454649|20968611|P4|NOT COMPLETED|Overall Study||6
8508077|NCT00454649|20968612|P3|NOT COMPLETED|Overall Study||19
8508078|NCT00454649|20968613|P2|NOT COMPLETED|Overall Study||4
8508079|NCT00454649|20968614|P1|NOT COMPLETED|Overall Study||3
8508080|NCT00454649|20968605|P10|COMPLETED|Overall Study||1
8508081|NCT00454649|20968606|P9|COMPLETED|Overall Study||1
8508082|NCT00454649|20968607|P8|COMPLETED|Overall Study||0
8508083|NCT00454649|20968608|P7|COMPLETED|Overall Study||0
8508084|NCT00454649|20968609|P6|COMPLETED|Overall Study||0
8508085|NCT00454649|20968610|P5|COMPLETED|Overall Study||0
8508086|NCT00454649|20968611|P4|COMPLETED|Overall Study||1
8508087|NCT00454649|20968612|P3|COMPLETED|Overall Study||1
8508088|NCT00454649|20968613|P2|COMPLETED|Overall Study||1
8508089|NCT00454649|20968614|P1|COMPLETED|Overall Study||0
8508090|NCT00454649|20968605|P10|STARTED|Overall Study||6
8508091|NCT00454649|20968606|P9|STARTED|Overall Study||21
8508092|NCT00454649|20968607|P8|STARTED|Overall Study||19
8508093|NCT00454649|20968608|P7|STARTED|Overall Study||9
8508094|NCT00454649|20968609|P6|STARTED|Overall Study||7
8508095|NCT00454649|20968610|P5|STARTED|Overall Study||1
8508096|NCT00454649|20968611|P4|STARTED|Overall Study||7
8508097|NCT00454649|20968612|P3|STARTED|Overall Study||20
8508098|NCT00454649|20968613|P2|STARTED|Overall Study||5
8508099|NCT00454649|20968614|P1|STARTED|Overall Study||3
8508100|NCT00454636|20968743|P4|NOT COMPLETED|Overall Study||32
8508101|NCT00454636|20968744|P3|NOT COMPLETED|Overall Study||20
8508102|NCT00454636|20968745|P2|NOT COMPLETED|Overall Study||23
8508103|NCT00454636|20968746|P1|NOT COMPLETED|Overall Study||31
8508104|NCT00454636|20968743|P4|COMPLETED|Overall Study||26
8508105|NCT00454636|20968744|P3|COMPLETED|Overall Study||7
8508106|NCT00454636|20968745|P2|COMPLETED|Overall Study||9
8508107|NCT00454636|20968746|P1|COMPLETED|Overall Study||10
8508108|NCT00454636|20968743|P4|STARTED|Overall Study||58
8508109|NCT00454636|20968744|P3|STARTED|Overall Study||27
8508110|NCT00454636|20968745|P2|STARTED|Overall Study||32
8508111|NCT00454636|20968746|P1|STARTED|Overall Study||41
8508112|NCT00454584|20968779|P6|NOT COMPLETED|After Controlled Period||32
8508113|NCT00454584|20968780|P5|NOT COMPLETED|After Controlled Period||12
8508114|NCT00454584|20968781|P4|NOT COMPLETED|After Controlled Period||26
8508115|NCT00454584|20968782|P3|NOT COMPLETED|After Controlled Period||0
8508116|NCT00454584|20968783|P2|NOT COMPLETED|After Controlled Period||0
8508117|NCT00454584|20968784|P1|NOT COMPLETED|After Controlled Period||0
8508118|NCT00454584|20968779|P6|COMPLETED|After Controlled Period||310
8508119|NCT00454584|20968780|P5|COMPLETED|After Controlled Period||189
8508120|NCT00454584|20968781|P4|COMPLETED|After Controlled Period||310
8508121|NCT00454584|20968782|P3|COMPLETED|After Controlled Period||0
8508122|NCT00454584|20968783|P2|COMPLETED|After Controlled Period||0
8508123|NCT00454584|20968784|P1|COMPLETED|After Controlled Period||0
8508124|NCT00454584|20968779|P6|STARTED|After Controlled Period||342
8508125|NCT00454584|20968780|P5|STARTED|After Controlled Period||201
8508126|NCT00454584|20968781|P4|STARTED|After Controlled Period||336
8508127|NCT00454584|20968782|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8508128|NCT00454584|20968783|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8508129|NCT00454584|20968784|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8508130|NCT00454584|20968779|P6|NOT COMPLETED|Controlled Period||0
8508131|NCT00454584|20968780|P5|NOT COMPLETED|Controlled Period||0
8508132|NCT00454584|20968781|P4|NOT COMPLETED|Controlled Period||0
8508133|NCT00454584|20968782|P3|NOT COMPLETED|Controlled Period||5
8508134|NCT00454584|20968783|P2|NOT COMPLETED|Controlled Period||8
8508135|NCT00454584|20968784|P1|NOT COMPLETED|Controlled Period||11
8508136|NCT00454584|20968779|P6|COMPLETED|Controlled Period||0
8508137|NCT00454584|20968780|P5|COMPLETED|Controlled Period||0
8508138|NCT00454584|20968781|P4|COMPLETED|Controlled Period||0
8508139|NCT00454584|20968782|P3|COMPLETED|Controlled Period||342
8508140|NCT00454584|20968783|P2|COMPLETED|Controlled Period||201
8508141|NCT00454584|20968784|P1|COMPLETED|Controlled Period||336
8508142|NCT00454584|20968779|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8508143|NCT00454584|20968780|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8508144|NCT00454584|20968781|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8508145|NCT00454584|20968782|P3|STARTED|Controlled Period||347
8508146|NCT00454584|20968783|P2|STARTED|Controlled Period||209
8508147|NCT00454584|20968784|P1|STARTED|Controlled Period||347
8508148|NCT00454571|20968806|P2|NOT COMPLETED|Overall Study||6
8508149|NCT00454571|20968807|P1|NOT COMPLETED|Overall Study||13
8508150|NCT00454571|20968806|P2|COMPLETED|Overall Study||13
8508151|NCT00454571|20968807|P1|COMPLETED|Overall Study||5
8508152|NCT00454571|20968806|P2|STARTED|Overall Study||19
8508153|NCT00454571|20968807|P1|STARTED|Overall Study||18
8508154|NCT00454532|20968819|P4|NOT COMPLETED|Overall Study||0
8508155|NCT00454532|20968820|P3|NOT COMPLETED|Overall Study||0
8508156|NCT00454532|20968821|P2|NOT COMPLETED|Overall Study||0
8508157|NCT00454532|20968822|P1|NOT COMPLETED|Overall Study||0
8508158|NCT00454532|20968819|P4|COMPLETED|Overall Study||7
8508159|NCT00454532|20968820|P3|COMPLETED|Overall Study||3
8508160|NCT00454532|20968821|P2|COMPLETED|Overall Study||6
8508161|NCT00454532|20968822|P1|COMPLETED|Overall Study||11
8508162|NCT00454532|20968819|P4|STARTED|Overall Study||7
8508163|NCT00454532|20968820|P3|STARTED|Overall Study||3
8508164|NCT00454532|20968821|P2|STARTED|Overall Study||6
8508165|NCT00454532|20968822|P1|STARTED|Overall Study||11
8508166|NCT00454363|20968842|P2|NOT COMPLETED|Overall Study||2
8508167|NCT00454363|20968843|P1|NOT COMPLETED|Overall Study||5
8508168|NCT00454363|20968842|P2|COMPLETED|Overall Study||29
8508169|NCT00454363|20968843|P1|COMPLETED|Overall Study||15
8508170|NCT00454363|20968842|P2|STARTED|Overall Study||31
8508171|NCT00454363|20968843|P1|STARTED|Overall Study||20
8508172|NCT00454324|20968856|P2|NOT COMPLETED|Overall Study||0
8508173|NCT00454324|20968857|P1|NOT COMPLETED|Overall Study||0
8508174|NCT00454324|20968856|P2|COMPLETED|Overall Study||13
8508175|NCT00454324|20968857|P1|COMPLETED|Overall Study||14
8508176|NCT00454324|20968856|P2|STARTED|Overall Study||13
8508177|NCT00454324|20968857|P1|STARTED|Overall Study||14
8508178|NCT00454246|20968872|P3|NOT COMPLETED|Overall Study||9
8508179|NCT00454246|20968873|P2|NOT COMPLETED|Overall Study||29
8508180|NCT00454246|20968874|P1|NOT COMPLETED|Overall Study||73
8508181|NCT00454246|20968872|P3|COMPLETED|Overall Study||0
8508182|NCT00454246|20968873|P2|COMPLETED|Overall Study||0
8508183|NCT00454246|20968874|P1|COMPLETED|Overall Study||0
8508184|NCT00454246|20968872|P3|STARTED|Overall Study||9
8508185|NCT00454246|20968873|P2|STARTED|Overall Study||29
8508186|NCT00454246|20968874|P1|STARTED|Overall Study||73
8508193|NCT00454194|20968936|P2|NOT COMPLETED|Overall Study||14
8508194|NCT00454194|20968937|P1|NOT COMPLETED|Overall Study||22
8508195|NCT00454194|20968936|P2|COMPLETED|Overall Study||37
8508196|NCT00454194|20968937|P1|COMPLETED|Overall Study||25
8508197|NCT00454194|20968936|P2|STARTED|Overall Study||51
8508198|NCT00454194|20968937|P1|STARTED|Overall Study||47
8508199|NCT00454181|20968955|P2|NOT COMPLETED|Overall Study||3
8508200|NCT00454181|20968956|P1|NOT COMPLETED|Overall Study||15
8508201|NCT00454181|20968955|P2|COMPLETED|Overall Study||11
8508202|NCT00454181|20968956|P1|COMPLETED|Overall Study||30
8508203|NCT00454181|20968955|P2|STARTED|Overall Study||14
8508204|NCT00454181|20968956|P1|STARTED|Overall Study||45
8508205|NCT00454142|20968972|P1|NOT COMPLETED|Overall Study||1
8508206|NCT00454142|20968972|P1|COMPLETED|Overall Study||32
8508207|NCT00454142|20968972|P1|STARTED|Overall Study||33
8508208|NCT00454116|20968990|P3|NOT COMPLETED|Overall Study||28
8508209|NCT00454116|20968991|P2|NOT COMPLETED|Overall Study||29
8508210|NCT00454116|20968992|P1|NOT COMPLETED|Overall Study||27
8508211|NCT00454116|20968990|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
8508212|NCT00454116|20968991|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
8508213|NCT00454116|20968992|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
8508214|NCT00454116|20968990|P3|STARTED|Overall Study|randomised patients|35
8508215|NCT00454116|20968991|P2|STARTED|Overall Study|randomised patients|36
8508216|NCT00454116|20968992|P1|STARTED|Overall Study|randomised patients|35
8508217|NCT00454051|20969002|P2|NOT COMPLETED|Overall Study||3
8508218|NCT00454051|20969003|P1|NOT COMPLETED|Overall Study||3
8508219|NCT00454051|20969002|P2|COMPLETED|Overall Study||8
8508220|NCT00454051|20969003|P1|COMPLETED|Overall Study||17
8508221|NCT00454051|20969002|P2|STARTED|Overall Study||11
8508222|NCT00454051|20969003|P1|STARTED|Overall Study||20
8508223|NCT00453999|20969036|P3|NOT COMPLETED|Overall Study||3
8508224|NCT00453999|20969037|P2|NOT COMPLETED|Overall Study||5
8508225|NCT00453999|20969038|P1|NOT COMPLETED|Overall Study||5
8508226|NCT00453999|20969036|P3|COMPLETED|Overall Study||43
8508227|NCT00453999|20969037|P2|COMPLETED|Overall Study||41
8508228|NCT00453999|20969038|P1|COMPLETED|Overall Study||40
8508229|NCT00453999|20969036|P3|STARTED|Overall Study||46
8508230|NCT00453999|20969037|P2|STARTED|Overall Study||46
8508231|NCT00453999|20969038|P1|STARTED|Overall Study||45
8508232|NCT00453986|20969066|P5|NOT COMPLETED|Overall Study||0
8508233|NCT00453986|20969067|P4|NOT COMPLETED|Overall Study||2
8508234|NCT00453986|20969068|P3|NOT COMPLETED|Overall Study||6
8508235|NCT00453986|20969069|P2|NOT COMPLETED|Overall Study||5
8508236|NCT00453986|20969070|P1|NOT COMPLETED|Overall Study||6
8508237|NCT00453986|20969066|P5|COMPLETED|Overall Study||105
8508238|NCT00453986|20969067|P4|COMPLETED|Overall Study||310
8508239|NCT00453986|20969068|P3|COMPLETED|Overall Study||307
8508240|NCT00453986|20969069|P2|COMPLETED|Overall Study||306
8508241|NCT00453986|20969070|P1|COMPLETED|Overall Study||305
8508242|NCT00453986|20969066|P5|STARTED|Overall Study||105
8508243|NCT00453986|20969067|P4|STARTED|Overall Study||312
8508244|NCT00453986|20969068|P3|STARTED|Overall Study||313
8508245|NCT00453986|20969069|P2|STARTED|Overall Study||311
8508246|NCT00453986|20969070|P1|STARTED|Overall Study||311
8508247|NCT00453973|20969163|P2|NOT COMPLETED|Overall Study||48
8508248|NCT00453973|20969164|P1|NOT COMPLETED|Overall Study||51
8508249|NCT00453973|20969163|P2|COMPLETED|Overall Study||15
8508250|NCT00453973|20969164|P1|COMPLETED|Overall Study||0
8508251|NCT00453973|20969163|P2|STARTED|Overall Study||63
8508252|NCT00453973|20969164|P1|STARTED|Overall Study||51
8508253|NCT00453921|20969174|P4|NOT COMPLETED|Overall Study||1
8508254|NCT00453921|20969175|P3|NOT COMPLETED|Overall Study||2
8508255|NCT00453921|20969176|P2|NOT COMPLETED|Overall Study||1
8508256|NCT00453921|20969177|P1|NOT COMPLETED|Overall Study||1
8508257|NCT00453921|20969174|P4|COMPLETED|Overall Study||18
8508258|NCT00453921|20969175|P3|COMPLETED|Overall Study||18
8508259|NCT00453921|20969176|P2|COMPLETED|Overall Study||17
8508260|NCT00453921|20969177|P1|COMPLETED|Overall Study||18
8508261|NCT00453921|20969174|P4|STARTED|Overall Study||19
8508262|NCT00453921|20969175|P3|STARTED|Overall Study||20
8508263|NCT00453921|20969176|P2|STARTED|Overall Study||18
8508264|NCT00453921|20969177|P1|STARTED|Overall Study||19
8508265|NCT00453895|20969211|P1|NOT COMPLETED|Overall Study||0
8508266|NCT00453895|20969211|P1|COMPLETED|Overall Study||39
8508267|NCT00453895|20969211|P1|STARTED|Overall Study||39
8508268|NCT00453479|20969222|P3|NOT COMPLETED|Overall Study||0
8508269|NCT00453479|20969223|P2|NOT COMPLETED|Overall Study||0
8508270|NCT00453479|20969224|P1|NOT COMPLETED|Overall Study||0
8508271|NCT00453479|20969222|P3|COMPLETED|Overall Study||8
8508272|NCT00453479|20969223|P2|COMPLETED|Overall Study||9
8508273|NCT00453479|20969224|P1|COMPLETED|Overall Study||6
8508274|NCT00453479|20969222|P3|STARTED|Overall Study||8
8508275|NCT00453479|20969223|P2|STARTED|Overall Study||9
8508276|NCT00453479|20969224|P1|STARTED|Overall Study||6
8508277|NCT00453388|20969299|P4|NOT COMPLETED|Overall Study||0
8508278|NCT00453388|20969300|P3|NOT COMPLETED|Overall Study||0
8508279|NCT00453388|20969301|P2|NOT COMPLETED|Overall Study||0
8508280|NCT00453388|20969302|P1|NOT COMPLETED|Overall Study||0
8508281|NCT00453388|20969299|P4|COMPLETED|Overall Study||0
8508282|NCT00453388|20969300|P3|COMPLETED|Overall Study||1
8508283|NCT00453388|20969301|P2|COMPLETED|Overall Study||5
8508284|NCT00453388|20969302|P1|COMPLETED|Overall Study||0
8508285|NCT00453388|20969299|P4|STARTED|Overall Study||0
8508286|NCT00453388|20969300|P3|STARTED|Overall Study||1
8508287|NCT00453388|20969301|P2|STARTED|Overall Study||5
8508288|NCT00453388|20969302|P1|STARTED|Overall Study||0
8508289|NCT00453362|20969324|P1|NOT COMPLETED|Overall Study||87
8508290|NCT00453362|20969324|P1|COMPLETED|Overall Study||1
8508291|NCT00453362|20969324|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
8508292|NCT00453362|20969324|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
8508293|NCT00453362|20969324|P1|Treated With Erlotinib|Overall Study||74
8508294|NCT00453362|20969324|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
8508295|NCT00453349|20969350|P2|NOT COMPLETED|Completed Study||34
8508296|NCT00453349|20969351|P1|NOT COMPLETED|Completed Study||27
8508297|NCT00453349|20969350|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
8508298|NCT00453349|20969351|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
8508299|NCT00453349|20969350|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
8508300|NCT00453349|20969351|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
8508301|NCT00453349|20969350|P2|STARTED|Completed Study||232
8508302|NCT00453349|20969351|P1|STARTED|Completed Study||228
8508303|NCT00453349|20969350|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
8508304|NCT00453349|20969351|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
8508305|NCT00453349|20969350|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
8508306|NCT00453349|20969351|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
8508307|NCT00453349|20969350|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
8508308|NCT00453349|20969351|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
8508309|NCT00453349|20969350|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
8508310|NCT00453349|20969351|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
8508311|NCT00453349|20969350|P2|NOT COMPLETED|Randomized||23
8508312|NCT00453349|20969351|P1|NOT COMPLETED|Randomized||25
8508313|NCT00453349|20969350|P2|COMPLETED|Randomized||209
8508314|NCT00453349|20969351|P1|COMPLETED|Randomized||203
8508315|NCT00453349|20969350|P2|STARTED|Randomized||232
8508316|NCT00453349|20969351|P1|STARTED|Randomized||228
8508317|NCT00453336|20969377|P1|NOT COMPLETED|Overall Study||0
8508318|NCT00453336|20969377|P1|COMPLETED|Overall Study||45
8508319|NCT00453336|20969377|P1|STARTED|Overall Study||45
8508320|NCT00453310|20969382|P1|NOT COMPLETED|Overall Study||10
8508321|NCT00453310|20969382|P1|COMPLETED|Overall Study||0
8508322|NCT00453310|20969382|P1|STARTED|Overall Study||10
8508323|NCT00453206|20969386|P1|NOT COMPLETED|Overall Study||1
8508324|NCT00453206|20969386|P1|COMPLETED|Overall Study||65
8508325|NCT00453206|20969386|P1|STARTED|Overall Study||66
8508326|NCT00453193|20969390|P1|NOT COMPLETED|Overall Study||0
8508327|NCT00453193|20969390|P1|COMPLETED|Overall Study||24
8508328|NCT00453193|20969390|P1|STARTED|Overall Study||24
8508329|NCT00453180|20969396|P2|NOT COMPLETED|Overall Study||3
8508330|NCT00453180|20969397|P1|NOT COMPLETED|Overall Study||3
8508331|NCT00453180|20969396|P2|COMPLETED|Overall Study||12
8508332|NCT00453180|20969397|P1|COMPLETED|Overall Study||13
8508333|NCT00453180|20969396|P2|STARTED|Overall Study||15
8508334|NCT00453180|20969397|P1|STARTED|Overall Study||16
8508335|NCT00453154|20969416|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508336|NCT00453154|20969417|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508337|NCT00453154|20969418|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508338|NCT00453154|20969419|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508339|NCT00453154|20969416|P4|COMPLETED|Open Label Sunitinib Crossover||0
8508340|NCT00453154|20969417|P3|COMPLETED|Open Label Sunitinib Crossover||18
8508341|NCT00453154|20969418|P2|COMPLETED|Open Label Sunitinib Crossover||0
8508342|NCT00453154|20969419|P1|COMPLETED|Open Label Sunitinib Crossover||0
8508343|NCT00453154|20969416|P4|STARTED|Open Label Sunitinib Crossover||0
8508344|NCT00453154|20969417|P3|STARTED|Open Label Sunitinib Crossover||18
8508345|NCT00453154|20969418|P2|STARTED|Open Label Sunitinib Crossover||0
8508346|NCT00453154|20969419|P1|STARTED|Open Label Sunitinib Crossover||0
8508347|NCT00453154|20969416|P4|NOT COMPLETED|Double BIind Maintenance||49
8508348|NCT00453154|20969417|P3|NOT COMPLETED|Double BIind Maintenance||46
8508349|NCT00453154|20969418|P2|NOT COMPLETED|Double BIind Maintenance||0
8508350|NCT00453154|20969419|P1|NOT COMPLETED|Double BIind Maintenance||0
8508351|NCT00453154|20969416|P4|COMPLETED|Double BIind Maintenance||0
8508352|NCT00453154|20969417|P3|COMPLETED|Double BIind Maintenance||0
8508353|NCT00453154|20969418|P2|COMPLETED|Double BIind Maintenance||0
8508354|NCT00453154|20969419|P1|COMPLETED|Double BIind Maintenance||0
8508355|NCT00453154|20969416|P4|STARTED|Double BIind Maintenance||49
8508356|NCT00453154|20969417|P3|STARTED|Double BIind Maintenance||46
8508357|NCT00453154|20969418|P2|STARTED|Double BIind Maintenance||0
8508358|NCT00453154|20969419|P1|STARTED|Double BIind Maintenance||0
8508359|NCT00453154|20969416|P4|NOT COMPLETED|Combination Chemotherapy||0
8508360|NCT00453154|20969417|P3|NOT COMPLETED|Combination Chemotherapy||0
8508361|NCT00453154|20969418|P2|NOT COMPLETED|Combination Chemotherapy||49
8508362|NCT00453154|20969419|P1|NOT COMPLETED|Combination Chemotherapy||0
8508363|NCT00453154|20969416|P4|COMPLETED|Combination Chemotherapy||0
8508364|NCT00453154|20969417|P3|COMPLETED|Combination Chemotherapy||0
8508365|NCT00453154|20969418|P2|COMPLETED|Combination Chemotherapy||95
8508366|NCT00453154|20969419|P1|COMPLETED|Combination Chemotherapy||12
8508367|NCT00453154|20969416|P4|STARTED|Combination Chemotherapy||0
8508368|NCT00453154|20969417|P3|STARTED|Combination Chemotherapy||0
8508369|NCT00453154|20969418|P2|STARTED|Combination Chemotherapy||144
8508370|NCT00453154|20969419|P1|STARTED|Combination Chemotherapy||12
8508371|NCT00453102|20969432|P1|NOT COMPLETED|Overall Study||2
8508372|NCT00453102|20969432|P1|COMPLETED|Overall Study||16
8508373|NCT00453102|20969432|P1|STARTED|Overall Study||18
8508374|NCT00453063|20969443|P2|NOT COMPLETED|Overall Study||3
8508375|NCT00453063|20969444|P1|NOT COMPLETED|Overall Study||3
8508376|NCT00453063|20969443|P2|COMPLETED|Overall Study||212
8508377|NCT00453063|20969444|P1|COMPLETED|Overall Study||208
8508378|NCT00453063|20969443|P2|STARTED|Overall Study||215
8508379|NCT00453063|20969444|P1|STARTED|Overall Study||211
8508380|NCT00452868|20969458|P1|NOT COMPLETED|Overall Study||2
8508381|NCT00452868|20969458|P1|COMPLETED|Overall Study||11
8508382|NCT00452868|20969458|P1|STARTED|Overall Study||13
8508383|NCT00452790|20969464|P2|NOT COMPLETED|Toddler Dose||2
8508384|NCT00452790|20969465|P1|NOT COMPLETED|Toddler Dose||0
8508385|NCT00452790|20969464|P2|COMPLETED|Toddler Dose||198
8508386|NCT00452790|20969465|P1|COMPLETED|Toddler Dose||198
8508387|NCT00452790|20969464|P2|STARTED|Toddler Dose||200
8508388|NCT00452790|20969465|P1|STARTED|Toddler Dose||198
8508389|NCT00452790|20969464|P2|NOT COMPLETED|After Infant Series||14
8508390|NCT00452790|20969465|P1|NOT COMPLETED|After Infant Series||21
8508391|NCT00452790|20969464|P2|COMPLETED|After Infant Series||200
8508392|NCT00452790|20969465|P1|COMPLETED|After Infant Series||198
8508393|NCT00452790|20969464|P2|STARTED|After Infant Series||214
8508394|NCT00452790|20969465|P1|STARTED|After Infant Series||219
8508395|NCT00452790|20969464|P2|NOT COMPLETED|Infant Series||141
8508396|NCT00452790|20969465|P1|NOT COMPLETED|Infant Series||135
8508397|NCT00452790|20969464|P2|COMPLETED|Infant Series||214
8508398|NCT00452790|20969465|P1|COMPLETED|Infant Series||219
8508399|NCT00452790|20969464|P2|Vaccinated Dose 3|Infant Series||218
8508400|NCT00452790|20969465|P1|Vaccinated Dose 3|Infant Series||221
8508401|NCT00452790|20969464|P2|Vaccinated Dose 2|Infant Series||300
8508402|NCT00452790|20969465|P1|Vaccinated Dose 2|Infant Series||300
8508403|NCT00452790|20969464|P2|Vaccinated Dose 1|Infant Series||353
8508404|NCT00452790|20969465|P1|Vaccinated Dose 1|Infant Series||353
8508405|NCT00452790|20969464|P2|STARTED|Infant Series||355
8508406|NCT00452790|20969465|P1|STARTED|Infant Series||354
8508407|NCT00452699|20969501|P2|NOT COMPLETED|Overall Study||73
8508408|NCT00452699|20969502|P1|NOT COMPLETED|Overall Study||81
8508409|NCT00452699|20969501|P2|COMPLETED|Overall Study||242
8508410|NCT00452699|20969502|P1|COMPLETED|Overall Study||225
8508411|NCT00452699|20969501|P2|STARTED|Overall Study||315
8508412|NCT00452699|20969502|P1|STARTED|Overall Study||306
8508413|NCT00452673|20969518|P5|NOT COMPLETED|Dose Expansion Period||21
8508414|NCT00452673|20969519|P4|NOT COMPLETED|Dose Expansion Period||0
8508415|NCT00452673|20969520|P3|NOT COMPLETED|Dose Expansion Period||0
8508416|NCT00452673|20969521|P2|NOT COMPLETED|Dose Expansion Period||0
8508417|NCT00452673|20969522|P1|NOT COMPLETED|Dose Expansion Period||0
8508418|NCT00452673|20969518|P5|COMPLETED|Dose Expansion Period||0
8508419|NCT00452673|20969519|P4|COMPLETED|Dose Expansion Period||0
8508420|NCT00452673|20969520|P3|COMPLETED|Dose Expansion Period||0
8508421|NCT00452673|20969521|P2|COMPLETED|Dose Expansion Period||0
8508422|NCT00452673|20969522|P1|COMPLETED|Dose Expansion Period||0
8508423|NCT00452673|20969518|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
8508424|NCT00452673|20969519|P4|STARTED|Dose Expansion Period||0
8508425|NCT00452673|20969520|P3|STARTED|Dose Expansion Period||0
8508426|NCT00452673|20969521|P2|STARTED|Dose Expansion Period||0
8508427|NCT00452673|20969522|P1|STARTED|Dose Expansion Period||0
8508428|NCT00452673|20969518|P5|NOT COMPLETED|Dose Escalation Period||0
8508429|NCT00452673|20969519|P4|NOT COMPLETED|Dose Escalation Period||9
8508430|NCT00452673|20969520|P3|NOT COMPLETED|Dose Escalation Period||6
8508431|NCT00452673|20969521|P2|NOT COMPLETED|Dose Escalation Period||9
8508432|NCT00452673|20969522|P1|NOT COMPLETED|Dose Escalation Period||7
8508433|NCT00452673|20969518|P5|COMPLETED|Dose Escalation Period||0
8508434|NCT00452673|20969519|P4|COMPLETED|Dose Escalation Period||0
8508435|NCT00452673|20969520|P3|COMPLETED|Dose Escalation Period||0
8508436|NCT00452673|20969521|P2|COMPLETED|Dose Escalation Period||0
8508437|NCT00452673|20969522|P1|COMPLETED|Dose Escalation Period||0
8508438|NCT00452673|20969518|P5|STARTED|Dose Escalation Period||0
8508439|NCT00452673|20969519|P4|STARTED|Dose Escalation Period||9
8508440|NCT00452673|20969520|P3|STARTED|Dose Escalation Period||6
8508441|NCT00452673|20969521|P2|STARTED|Dose Escalation Period||9
8508442|NCT00452673|20969522|P1|STARTED|Dose Escalation Period||7
8508443|NCT00452543|20969554|P2|NOT COMPLETED|Overall Study||6
8508444|NCT00452543|20969555|P1|NOT COMPLETED|Overall Study||5
8508445|NCT00452543|20969554|P2|COMPLETED|Overall Study||5
8508446|NCT00452543|20969555|P1|COMPLETED|Overall Study||7
8508447|NCT00452543|20969554|P2|STARTED|Overall Study||11
8508448|NCT00452543|20969555|P1|STARTED|Overall Study||12
8508449|NCT00452530|20969569|P2|NOT COMPLETED|Overall Study||136
8508450|NCT00452530|20969570|P1|NOT COMPLETED|Overall Study||136
8508451|NCT00452530|20969569|P2|COMPLETED|Overall Study||1393
8508452|NCT00452530|20969570|P1|COMPLETED|Overall Study||1392
8508453|NCT00452530|20969569|P2|Primary Participants|Overall Study||997
8508454|NCT00452530|20969570|P1|Primary Participants|Overall Study||976
8508455|NCT00452530|20969569|P2|Evaluable Participants|Overall Study||921
8508456|NCT00452530|20969570|P1|Evaluable Participants|Overall Study||907
8508457|NCT00452530|20969569|P2|Received Treatment|Overall Study||1508
8508458|NCT00452530|20969570|P1|Received Treatment|Overall Study||1501
8508459|NCT00452530|20969569|P2|STARTED|Overall Study|Randomized|1529
8508460|NCT00452530|20969570|P1|STARTED|Overall Study|Randomized|1528
8508461|NCT00452452|20969591|P3|NOT COMPLETED|Overall Study||1
8508462|NCT00452452|20969592|P2|NOT COMPLETED|Overall Study||0
8508463|NCT00452452|20969593|P1|NOT COMPLETED|Overall Study||2
8508464|NCT00452452|20969591|P3|COMPLETED|Overall Study||152
8508465|NCT00452452|20969592|P2|COMPLETED|Overall Study||112
8508466|NCT00452452|20969593|P1|COMPLETED|Overall Study||88
8508467|NCT00452452|20969591|P3|Vaccinated Dose 3|Overall Study||0
8508468|NCT00452452|20969592|P2|Vaccinated Dose 3|Overall Study||0
8508469|NCT00452452|20969593|P1|Vaccinated Dose 3|Overall Study||89
8508470|NCT00452452|20969591|P3|Vaccinated Dose 2|Overall Study||0
8508471|NCT00452452|20969592|P2|Vaccinated Dose 2|Overall Study||112
8508472|NCT00452452|20969593|P1|Vaccinated Dose 2|Overall Study||90
8508473|NCT00452452|20969591|P3|Vaccinated Dose 1|Overall Study||152
8508474|NCT00452452|20969592|P2|Vaccinated Dose 1|Overall Study||112
8508475|NCT00452452|20969593|P1|Vaccinated Dose 1|Overall Study||90
8508476|NCT00452452|20969591|P3|STARTED|Overall Study||153
8508477|NCT00452452|20969592|P2|STARTED|Overall Study||112
8508478|NCT00452452|20969593|P1|STARTED|Overall Study||90
8508479|NCT00452439|20969618|P2|NOT COMPLETED|Overall Study||7
8508480|NCT00452439|20969619|P1|NOT COMPLETED|Overall Study||14
8508481|NCT00452439|20969618|P2|COMPLETED|Overall Study||29
8508482|NCT00452439|20969619|P1|COMPLETED|Overall Study||22
8508483|NCT00452439|20969618|P2|STARTED|Overall Study||36
8508484|NCT00452439|20969619|P1|STARTED|Overall Study||36
8508485|NCT00452426|20969629|P2|NOT COMPLETED|Overall Study||11
8508486|NCT00452426|20969630|P1|NOT COMPLETED|Overall Study||7
8508487|NCT00452426|20969629|P2|COMPLETED|Overall Study||493
8508488|NCT00452426|20969630|P1|COMPLETED|Overall Study||489
8508489|NCT00452426|20969629|P2|STARTED|Overall Study||504
8508490|NCT00452426|20969630|P1|STARTED|Overall Study||496
8508491|NCT00452400|20969649|P5|NOT COMPLETED|Overall Study||3
8508492|NCT00452400|20969650|P4|NOT COMPLETED|Overall Study||1
8508493|NCT00452400|20969651|P3|NOT COMPLETED|Overall Study||7
8508494|NCT00452400|20969652|P2|NOT COMPLETED|Overall Study||1
8508495|NCT00452400|20969653|P1|NOT COMPLETED|Overall Study||5
8508496|NCT00452400|20969649|P5|COMPLETED|Overall Study||76
8508497|NCT00452400|20969650|P4|COMPLETED|Overall Study||85
8508498|NCT00452400|20969651|P3|COMPLETED|Overall Study||73
8508499|NCT00452400|20969652|P2|COMPLETED|Overall Study||80
8508500|NCT00452400|20969653|P1|COMPLETED|Overall Study||74
8508501|NCT00452400|20969649|P5|STARTED|Overall Study||79
8508502|NCT00452400|20969650|P4|STARTED|Overall Study||86
8508503|NCT00452400|20969651|P3|STARTED|Overall Study||80
8508504|NCT00452400|20969652|P2|STARTED|Overall Study||81
8508505|NCT00452400|20969653|P1|STARTED|Overall Study||79
8508506|NCT00452387|20969825|P1|NOT COMPLETED|Overall Study||0
8508507|NCT00452387|20969825|P1|COMPLETED|Overall Study||22
8508508|NCT00452387|20969825|P1|STARTED|Overall Study||22
8508509|NCT00452374|20969833|P1|NOT COMPLETED|Overall Study||0
8508510|NCT00452374|20969833|P1|COMPLETED|Overall Study||48
8508511|NCT00452374|20969833|P1|STARTED|Overall Study||48
8508512|NCT00452361|20969840|P2|NOT COMPLETED|Overall Study||10
8508513|NCT00452361|20969841|P1|NOT COMPLETED|Overall Study||21
8508514|NCT00452361|20969840|P2|COMPLETED|Overall Study||0
8508515|NCT00452361|20969841|P1|COMPLETED|Overall Study||0
8508516|NCT00452361|20969840|P2|STARTED|Overall Study||10
8508517|NCT00452361|20969841|P1|STARTED|Overall Study||21
8508518|NCT00452348|20969885|P2|NOT COMPLETED|Overall Study||84
8508519|NCT00452348|20969886|P1|NOT COMPLETED|Overall Study||79
8508520|NCT00452348|20969885|P2|COMPLETED|Overall Study||234
8508521|NCT00452348|20969886|P1|COMPLETED|Overall Study||231
8508522|NCT00452348|20969885|P2|STARTED|Overall Study||318
8508523|NCT00452348|20969886|P1|STARTED|Overall Study||310
8508524|NCT00452335|20969901|P3|NOT COMPLETED|Overall Study||9
8508525|NCT00452335|20969902|P2|NOT COMPLETED|Overall Study||4
8508526|NCT00452335|20969903|P1|NOT COMPLETED|Overall Study||2
8508527|NCT00452335|20969901|P3|COMPLETED|Overall Study||23
8508528|NCT00452335|20969902|P2|COMPLETED|Overall Study||61
8508529|NCT00452335|20969903|P1|COMPLETED|Overall Study||25
8508530|NCT00452335|20969901|P3|STARTED|Overall Study||32
8508531|NCT00452335|20969902|P2|STARTED|Overall Study||65
8508532|NCT00452335|20969903|P1|STARTED|Overall Study||27
8508533|NCT00452114|20969940|P2|NOT COMPLETED|Overall Study||3
8508534|NCT00452114|20969941|P1|NOT COMPLETED|Overall Study||3
8508535|NCT00452114|20969940|P2|COMPLETED|Overall Study||10
8508536|NCT00452114|20969941|P1|COMPLETED|Overall Study||12
8508537|NCT00452114|20969940|P2|STARTED|Overall Study||13
8508538|NCT00452114|20969941|P1|STARTED|Overall Study||15
8508539|NCT00451958|20969957|P5|NOT COMPLETED|CS21A (NCT00451958)||0
8508540|NCT00451958|20969958|P4|NOT COMPLETED|CS21A (NCT00451958)||39
8508541|NCT00451958|20969959|P3|NOT COMPLETED|CS21A (NCT00451958)||42
8508542|NCT00451958|20969960|P2|NOT COMPLETED|CS21A (NCT00451958)||77
8508543|NCT00451958|20969961|P1|NOT COMPLETED|CS21A (NCT00451958)||65
8508544|NCT00451958|20969957|P5|COMPLETED|CS21A (NCT00451958)||0
8508545|NCT00451958|20969958|P4|COMPLETED|CS21A (NCT00451958)||27
8508546|NCT00451958|20969959|P3|COMPLETED|CS21A (NCT00451958)||27
8508547|NCT00451958|20969960|P2|COMPLETED|CS21A (NCT00451958)||49
8508548|NCT00451958|20969961|P1|COMPLETED|CS21A (NCT00451958)||60
8508549|NCT00451958|20969957|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
8508550|NCT00451958|20969958|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
8508551|NCT00451958|20969959|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
8508552|NCT00451958|20969960|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
8508553|NCT00451958|20969961|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
8508554|NCT00451958|20969957|P5|NOT COMPLETED|CS21 (NCT00295750)||32
8508555|NCT00451958|20969958|P4|NOT COMPLETED|CS21 (NCT00295750)||0
8508556|NCT00451958|20969959|P3|NOT COMPLETED|CS21 (NCT00295750)||0
8508557|NCT00451958|20969960|P2|NOT COMPLETED|CS21 (NCT00295750)||43
8508558|NCT00451958|20969961|P1|NOT COMPLETED|CS21 (NCT00295750)||41
8508559|NCT00451958|20969957|P5|COMPLETED|CS21 (NCT00295750)||172
8508560|NCT00451958|20969958|P4|COMPLETED|CS21 (NCT00295750)||0
8508561|NCT00451958|20969959|P3|COMPLETED|CS21 (NCT00295750)||0
8508562|NCT00451958|20969960|P2|COMPLETED|CS21 (NCT00295750)||163
8508563|NCT00451958|20969961|P1|COMPLETED|CS21 (NCT00295750)||169
8508564|NCT00451958|20969957|P5|STARTED|CS21 (NCT00295750)||204
8508565|NCT00451958|20969958|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
8508566|NCT00451958|20969959|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
8508567|NCT00451958|20969960|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
8508568|NCT00451958|20969961|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
8508569|NCT00451906|20969991|P1|NOT COMPLETED|Overall Study||2239
8508570|NCT00451906|20969991|P1|COMPLETED|Overall Study||13
8508571|NCT00451906|20969991|P1|STARTED|Overall Study||2252
8508572|NCT00451698|20970001|P2|NOT COMPLETED|Overall Study||0
8508573|NCT00451698|20970002|P1|NOT COMPLETED|Overall Study||0
8508574|NCT00451698|20970001|P2|COMPLETED|Overall Study||6
8508575|NCT00451698|20970002|P1|COMPLETED|Overall Study||3
8508576|NCT00451698|20970001|P2|STARTED|Overall Study||6
8508577|NCT00451698|20970002|P1|STARTED|Overall Study||3
8508578|NCT00451555|20970019|P2|NOT COMPLETED|Overall Study||4
8508579|NCT00451555|20970020|P1|NOT COMPLETED|Overall Study||13
8508580|NCT00451555|20970019|P2|COMPLETED|Overall Study||56
8508581|NCT00451555|20970020|P1|COMPLETED|Overall Study||83
8508582|NCT00451555|20970019|P2|Death|Overall Study||0
8508583|NCT00451555|20970020|P1|Death|Overall Study||2
8508584|NCT00451555|20970019|P2|Progressive Disease|Overall Study||54
8508585|NCT00451555|20970020|P1|Progressive Disease|Overall Study||75
8508586|NCT00451555|20970019|P2|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
8508587|NCT00451555|20970020|P1|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
8508588|NCT00451555|20970019|P2|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
8508589|NCT00451555|20970020|P1|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
8508590|NCT00451555|20970019|P2|Received at Least One Dose of Study Drug|Overall Study||58
8508591|NCT00451555|20970020|P1|Received at Least One Dose of Study Drug|Overall Study||94
8508592|NCT00451555|20970019|P2|STARTED|Overall Study||60
8508593|NCT00451555|20970020|P1|STARTED|Overall Study||96
8508594|NCT00451451|20970054|P4|NOT COMPLETED|Overall Study||58
8508595|NCT00451451|20970055|P3|NOT COMPLETED|Overall Study||72
8508596|NCT00451451|20970056|P2|NOT COMPLETED|Overall Study||75
8508597|NCT00451451|20970057|P1|NOT COMPLETED|Overall Study||85
8508598|NCT00451451|20970054|P4|COMPLETED|Overall Study||292
8508599|NCT00451451|20970055|P3|COMPLETED|Overall Study||273
8508600|NCT00451451|20970056|P2|COMPLETED|Overall Study||284
8508601|NCT00451451|20970057|P1|COMPLETED|Overall Study||278
8508602|NCT00451451|20970054|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
8508603|NCT00451451|20970055|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
8508604|NCT00451451|20970056|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
8508605|NCT00451451|20970057|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
8508606|NCT00451321|20970092|P8|NOT COMPLETED|Overall Study||6
8508607|NCT00451321|20970093|P7|NOT COMPLETED|Overall Study||6
8508608|NCT00451321|20970094|P6|NOT COMPLETED|Overall Study||9
8508609|NCT00451321|20970095|P5|NOT COMPLETED|Overall Study||7
8508610|NCT00451321|20970096|P4|NOT COMPLETED|Overall Study||12
8508611|NCT00451321|20970097|P3|NOT COMPLETED|Overall Study||18
8508612|NCT00451321|20970098|P2|NOT COMPLETED|Overall Study||5
8508613|NCT00451321|20970099|P1|NOT COMPLETED|Overall Study||7
8508614|NCT00451321|20970092|P8|COMPLETED|Overall Study||0
8508615|NCT00451321|20970093|P7|COMPLETED|Overall Study||0
8508616|NCT00451321|20970094|P6|COMPLETED|Overall Study||0
8508617|NCT00451321|20970095|P5|COMPLETED|Overall Study||0
8508618|NCT00451321|20970096|P4|COMPLETED|Overall Study||7
8508619|NCT00451321|20970097|P3|COMPLETED|Overall Study||0
8508620|NCT00451321|20970098|P2|COMPLETED|Overall Study||10
8508621|NCT00451321|20970099|P1|COMPLETED|Overall Study||1
8508622|NCT00451321|20970092|P8|STARTED|Overall Study||6
8508623|NCT00451321|20970093|P7|STARTED|Overall Study||6
8508624|NCT00451321|20970094|P6|STARTED|Overall Study||9
8508625|NCT00451321|20970095|P5|STARTED|Overall Study||7
8508626|NCT00451321|20970096|P4|STARTED|Overall Study||19
8508627|NCT00451321|20970097|P3|STARTED|Overall Study||18
8508628|NCT00451321|20970098|P2|STARTED|Overall Study||15
8508629|NCT00451321|20970099|P1|STARTED|Overall Study||8
8508630|NCT00451282|20970271|P2|NOT COMPLETED|Overall Study||5
8508631|NCT00451282|20970272|P1|NOT COMPLETED|Overall Study||6
8508632|NCT00451282|20970271|P2|COMPLETED|Overall Study||34
8508633|NCT00451282|20970272|P1|COMPLETED|Overall Study||40
8508634|NCT00451282|20970271|P2|STARTED|Overall Study||39
8508635|NCT00451282|20970272|P1|STARTED|Overall Study||46
8508636|NCT00451217|20970288|P4|NOT COMPLETED|Overall Study||5
8508637|NCT00451217|20970289|P3|NOT COMPLETED|Overall Study||4
8508638|NCT00451217|20970290|P2|NOT COMPLETED|Overall Study||2
8508639|NCT00451217|20970291|P1|NOT COMPLETED|Overall Study||2
8508640|NCT00451217|20970288|P4|COMPLETED|Overall Study||44
8508641|NCT00451217|20970289|P3|COMPLETED|Overall Study||47
8508642|NCT00451217|20970290|P2|COMPLETED|Overall Study||47
8508643|NCT00451217|20970291|P1|COMPLETED|Overall Study||47
8508644|NCT00451217|20970288|P4|Treated|Overall Study||45
8508645|NCT00451217|20970289|P3|Treated|Overall Study||48
8508646|NCT00451217|20970290|P2|Treated|Overall Study||48
8508647|NCT00451217|20970291|P1|Treated|Overall Study||48
8508648|NCT00451217|20970288|P4|STARTED|Overall Study||49
8508649|NCT00451217|20970289|P3|STARTED|Overall Study||51
8508650|NCT00451217|20970290|P2|STARTED|Overall Study||49
8508651|NCT00451217|20970291|P1|STARTED|Overall Study||49
8508652|NCT00451204|20970319|P2|NOT COMPLETED|Overall Study||20
8508653|NCT00451204|20970320|P1|NOT COMPLETED|Overall Study||22
8508654|NCT00451204|20970319|P2|COMPLETED|Overall Study||56
8508655|NCT00451204|20970320|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
8508656|NCT00451204|20970319|P2|STARTED|Overall Study||76
8508657|NCT00451204|20970320|P1|STARTED|Overall Study||82
8508658|NCT00451191|20970338|P2|NOT COMPLETED|Overall Study||11
8508659|NCT00451191|20970339|P1|NOT COMPLETED|Overall Study||15
8508660|NCT00451191|20970338|P2|COMPLETED|Overall Study||55
8508661|NCT00451191|20970339|P1|COMPLETED|Overall Study||53
8508662|NCT00451191|20970338|P2|STARTED|Overall Study||66
8508663|NCT00451191|20970339|P1|STARTED|Overall Study||68
8508664|NCT00451178|20970347|P2|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
8508665|NCT00451178|20970348|P1|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
8508666|NCT00451178|20970347|P2|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
8508667|NCT00451178|20970348|P1|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
8508668|NCT00451178|20970347|P2|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
8508669|NCT00451178|20970348|P1|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
8508670|NCT00451178|20970347|P2|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
8508671|NCT00451178|20970348|P1|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
8508672|NCT00451178|20970347|P2|COMPLETED|Maintenance Therapy (up to 3 Years)||0
8508673|NCT00451178|20970348|P1|COMPLETED|Maintenance Therapy (up to 3 Years)||6
8508674|NCT00451178|20970347|P2|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
8508675|NCT00451178|20970348|P1|STARTED|Maintenance Therapy (up to 3 Years)||36
8508676|NCT00451178|20970347|P2|NOT COMPLETED|Prior to Maintenance Therapy||0
8508677|NCT00451178|20970348|P1|NOT COMPLETED|Prior to Maintenance Therapy||4
8508678|NCT00451178|20970347|P2|COMPLETED|Prior to Maintenance Therapy||0
8508679|NCT00451178|20970348|P1|COMPLETED|Prior to Maintenance Therapy||36
8508680|NCT00451178|20970347|P2|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
8508681|NCT00451178|20970348|P1|STARTED|Prior to Maintenance Therapy||40
8508682|NCT00451178|20970347|P2|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
8508683|NCT00451178|20970348|P1|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
8508684|NCT00451178|20970347|P2|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
8508685|NCT00451178|20970348|P1|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
8508686|NCT00451178|20970347|P2|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
8508687|NCT00451178|20970348|P1|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
8508688|NCT00451178|20970347|P2|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
8508689|NCT00451178|20970348|P1|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
8508690|NCT00451048|20970374|P1|NOT COMPLETED|Overall Study||0
8508691|NCT00451048|20970374|P1|COMPLETED|Overall Study||10
8508692|NCT00451048|20970374|P1|STARTED|Overall Study||10
8508693|NCT00450983|20970383|P1|NOT COMPLETED|Overall Study||0
8508694|NCT00450983|20970383|P1|COMPLETED|Overall Study||1
8508695|NCT00450983|20970383|P1|STARTED|Overall Study||1
8508696|NCT00450866|20970395|P2|NOT COMPLETED|Overall Study||3
8508697|NCT00450866|20970396|P1|NOT COMPLETED|Overall Study||7
8508698|NCT00450866|20970395|P2|COMPLETED|Overall Study||7
8508699|NCT00450866|20970396|P1|COMPLETED|Overall Study||38
8508700|NCT00450866|20970395|P2|STARTED|Overall Study||10
8508701|NCT00450866|20970396|P1|STARTED|Overall Study||45
8508702|NCT00450814|20970416|P11|NOT COMPLETED|Overall Study||0
8508703|NCT00450814|20970417|P10|NOT COMPLETED|Overall Study||1
8508704|NCT00450814|20970418|P9|NOT COMPLETED|Overall Study||0
8508705|NCT00450814|20970419|P8|NOT COMPLETED|Overall Study||0
8508706|NCT00450814|20970420|P7|NOT COMPLETED|Overall Study||0
8508707|NCT00450814|20970421|P6|NOT COMPLETED|Overall Study||1
8508708|NCT00450814|20970422|P5|NOT COMPLETED|Overall Study||1
8508709|NCT00450814|20970423|P4|NOT COMPLETED|Overall Study||1
8508710|NCT00450814|20970424|P3|NOT COMPLETED|Overall Study||0
8508711|NCT00450814|20970425|P2|NOT COMPLETED|Overall Study||0
8508712|NCT00450814|20970426|P1|NOT COMPLETED|Overall Study||0
8508713|NCT00450814|20970416|P11|COMPLETED|Overall Study||4
8508714|NCT00450814|20970417|P10|COMPLETED|Overall Study||11
8508715|NCT00450814|20970418|P9|COMPLETED|Overall Study||2
8508716|NCT00450814|20970419|P8|COMPLETED|Overall Study||3
8508717|NCT00450814|20970420|P7|COMPLETED|Overall Study||3
8508718|NCT00450814|20970421|P6|COMPLETED|Overall Study||6
8508719|NCT00450814|20970422|P5|COMPLETED|Overall Study||3
8508720|NCT00450814|20970423|P4|COMPLETED|Overall Study||3
8508721|NCT00450814|20970424|P3|COMPLETED|Overall Study||3
8508722|NCT00450814|20970425|P2|COMPLETED|Overall Study||3
8508723|NCT00450814|20970426|P1|COMPLETED|Overall Study||3
8508724|NCT00450814|20970416|P11|STARTED|Overall Study||4
8508725|NCT00450814|20970417|P10|STARTED|Overall Study||12
8508726|NCT00450814|20970418|P9|STARTED|Overall Study||2
8508727|NCT00450814|20970419|P8|STARTED|Overall Study||3
8508728|NCT00450814|20970420|P7|STARTED|Overall Study||3
8508729|NCT00450814|20970421|P6|STARTED|Overall Study||7
8508730|NCT00450814|20970422|P5|STARTED|Overall Study||4
8508731|NCT00450814|20970423|P4|STARTED|Overall Study||4
8508732|NCT00450814|20970424|P3|STARTED|Overall Study||3
8508733|NCT00450814|20970425|P2|STARTED|Overall Study||3
8508734|NCT00450814|20970426|P1|STARTED|Overall Study||3
8508735|NCT00450801|20970460|P1|NOT COMPLETED|Overall Study||1
8508736|NCT00450801|20970460|P1|COMPLETED|Overall Study||21
8508737|NCT00450801|20970460|P1|STARTED|Overall Study||22
8508738|NCT00450749|20970474|P3|NOT COMPLETED|Overall Study||2
8508739|NCT00450749|20970475|P2|NOT COMPLETED|Overall Study||1
8508740|NCT00450749|20970476|P1|NOT COMPLETED|Overall Study||0
8508741|NCT00450749|20970474|P3|COMPLETED|Overall Study||2
8508742|NCT00450749|20970475|P2|COMPLETED|Overall Study||2
8508743|NCT00450749|20970476|P1|COMPLETED|Overall Study||3
8508744|NCT00450749|20970474|P3|STARTED|Overall Study||4
8508745|NCT00450749|20970475|P2|STARTED|Overall Study||3
8508746|NCT00450749|20970476|P1|STARTED|Overall Study||3
8508747|NCT00450723|20970514|P1|NOT COMPLETED|Overall Study||5
8508748|NCT00450723|20970514|P1|COMPLETED|Overall Study||34
8508749|NCT00450723|20970514|P1|STARTED|Overall Study||39
8508750|NCT00450658|20970522|P2|NOT COMPLETED|Overall Study||90
8508751|NCT00450658|20970523|P1|NOT COMPLETED|Overall Study||143
8508752|NCT00450658|20970522|P2|COMPLETED|Overall Study||122
8508753|NCT00450658|20970523|P1|COMPLETED|Overall Study||272
8508754|NCT00450658|20970522|P2|STARTED|Overall Study||212
8508755|NCT00450658|20970523|P1|STARTED|Overall Study||415
8508756|NCT00450619|20970537|P2|NOT COMPLETED|Overall Study||1
8508757|NCT00450619|20970538|P1|NOT COMPLETED|Overall Study||4
8508758|NCT00450619|20970537|P2|COMPLETED|Overall Study||21
8508759|NCT00450619|20970538|P1|COMPLETED|Overall Study||18
8508760|NCT00450619|20970537|P2|STARTED|Overall Study||22
8508761|NCT00450619|20970538|P1|STARTED|Overall Study||22
8508762|NCT00450580|20970564|P2|NOT COMPLETED|Overall Study||16
8508763|NCT00450580|20970565|P1|NOT COMPLETED|Overall Study||16
8508764|NCT00450580|20970564|P2|COMPLETED|Overall Study||90
8508765|NCT00450580|20970565|P1|COMPLETED|Overall Study||90
8508766|NCT00450580|20970564|P2|STARTED|Overall Study||106
8508767|NCT00450580|20970565|P1|STARTED|Overall Study||106
8508768|NCT00450463|20970585|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
8508769|NCT00450463|20970586|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
8508770|NCT00450463|20970585|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
8508771|NCT00450463|20970586|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
8508772|NCT00450463|20970585|P2|STARTED|Progressed to Receive Vaccine Alone||0
8508773|NCT00450463|20970586|P1|STARTED|Progressed to Receive Vaccine Alone||11
8508774|NCT00450463|20970585|P2|NOT COMPLETED|Initial Drug Administration||0
8508775|NCT00450463|20970586|P1|NOT COMPLETED|Initial Drug Administration||0
8508776|NCT00450463|20970585|P2|COMPLETED|Initial Drug Administration||31
8508777|NCT00450463|20970586|P1|COMPLETED|Initial Drug Administration||33
8508778|NCT00450463|20970585|P2|STARTED|Initial Drug Administration||31
8508779|NCT00450463|20970586|P1|STARTED|Initial Drug Administration||33
8508780|NCT00450450|20970602|P2|NOT COMPLETED|Overall Study||3
8508781|NCT00450450|20970603|P1|NOT COMPLETED|Overall Study||5
8508782|NCT00450450|20970602|P2|COMPLETED|Overall Study||11
8508783|NCT00450450|20970603|P1|COMPLETED|Overall Study||8
8508784|NCT00450450|20970602|P2|STARTED|Overall Study||14
8508785|NCT00450450|20970603|P1|STARTED|Overall Study||13
8508786|NCT00450437|20970627|P4|NOT COMPLETED|Overall Study||11
8508787|NCT00450437|20970628|P3|NOT COMPLETED|Overall Study||24
8508788|NCT00450437|20970629|P2|NOT COMPLETED|Overall Study||16
8508789|NCT00450437|20970630|P1|NOT COMPLETED|Overall Study||46
8508790|NCT00450437|20970627|P4|COMPLETED|Overall Study||325
8508791|NCT00450437|20970628|P3|COMPLETED|Overall Study||999
8508792|NCT00450437|20970629|P2|COMPLETED|Overall Study||524
8508793|NCT00450437|20970630|P1|COMPLETED|Overall Study||1594
8508794|NCT00450437|20970627|P4|STARTED|Overall Study||336
8508795|NCT00450437|20970628|P3|STARTED|Overall Study||1023
8508796|NCT00450437|20970629|P2|STARTED|Overall Study||540
8508797|NCT00450437|20970630|P1|STARTED|Overall Study||1640
8508798|NCT00450424|20970654|P2|NOT COMPLETED|Overall Study||11
8508799|NCT00450424|20970655|P1|NOT COMPLETED|Overall Study||20
8508800|NCT00450424|20970654|P2|COMPLETED|Overall Study||106
8508801|NCT00450424|20970655|P1|COMPLETED|Overall Study||102
8508802|NCT00450424|20970654|P2|STARTED|Overall Study||117
8508803|NCT00450424|20970655|P1|STARTED|Overall Study||122
8508804|NCT00450411|20970661|P1|NOT COMPLETED|Overall Study||8
8508805|NCT00450411|20970661|P1|COMPLETED|Overall Study||92
8508806|NCT00450411|20970661|P1|STARTED|Overall Study||100
8508807|NCT00450385|20970666|P1|NOT COMPLETED|Overall Study||13
8508808|NCT00450385|20970666|P1|COMPLETED|Overall Study||44
8508809|NCT00450385|20970666|P1|STARTED|Overall Study||57
8508810|NCT00450372|20970675|P1|NOT COMPLETED|Overall Study||1
8508811|NCT00450372|20970675|P1|COMPLETED|Overall Study||37
8508812|NCT00450372|20970675|P1|STARTED|Overall Study||38
8508813|NCT00450333|20970688|P4|NOT COMPLETED|Overall Study||28
8508814|NCT00450333|20970689|P3|NOT COMPLETED|Overall Study||25
8508815|NCT00450333|20970690|P2|NOT COMPLETED|Overall Study||63
8508816|NCT00450333|20970691|P1|NOT COMPLETED|Overall Study||54
8508817|NCT00450333|20970688|P4|COMPLETED|Overall Study||74
8508818|NCT00450333|20970689|P3|COMPLETED|Overall Study||75
8508819|NCT00450333|20970690|P2|COMPLETED|Overall Study||44
8508820|NCT00450333|20970691|P1|COMPLETED|Overall Study||44
8508821|NCT00450333|20970688|P4|STARTED|Overall Study||102
8508822|NCT00450333|20970689|P3|STARTED|Overall Study||100
8508823|NCT00450333|20970690|P2|STARTED|Overall Study||107
8508824|NCT00450333|20970691|P1|STARTED|Overall Study||98
8508825|NCT00450294|20970709|P1|NOT COMPLETED|Overall Study||0
8508826|NCT00450294|20970709|P1|COMPLETED|Overall Study||10
8508827|NCT00450294|20970709|P1|STARTED|Overall Study||10
8508828|NCT00450255|20970714|P1|NOT COMPLETED|Overall Study||1
8508829|NCT00450255|20970714|P1|COMPLETED|Overall Study||40
8508830|NCT00450255|20970714|P1|STARTED|Overall Study||41
8508831|NCT00450242|20970724|P2|NOT COMPLETED|Overall Study||1
8508832|NCT00450242|20970725|P1|NOT COMPLETED|Overall Study||3
8508833|NCT00450242|20970724|P2|COMPLETED|Overall Study||6
8508834|NCT00450242|20970725|P1|COMPLETED|Overall Study||4
8508835|NCT00450242|20970724|P2|STARTED|Overall Study||7
8508836|NCT00450242|20970725|P1|STARTED|Overall Study||7
8508837|NCT00450216|20970739|P2|NOT COMPLETED|Overall Study||129
8508838|NCT00450216|20970740|P1|NOT COMPLETED|Overall Study||174
8508839|NCT00450216|20970739|P2|COMPLETED|Overall Study||170
8508840|NCT00450216|20970740|P1|COMPLETED|Overall Study||433
8508841|NCT00450216|20970739|P2|STARTED|Overall Study||299
8508842|NCT00450216|20970740|P1|STARTED|Overall Study||607
8508843|NCT00450190|20970752|P1|NOT COMPLETED|Overall Study||2
8508844|NCT00450190|20970752|P1|COMPLETED|Overall Study||18
8508845|NCT00450190|20970752|P1|STARTED|Overall Study||20
8508846|NCT00450177|20970762|P2|NOT COMPLETED|Overall Study||11
8508847|NCT00450177|20970763|P1|NOT COMPLETED|Overall Study||9
8508848|NCT00450177|20970762|P2|COMPLETED|Overall Study||92
8508849|NCT00450177|20970763|P1|COMPLETED|Overall Study||88
8508850|NCT00450177|20970762|P2|STARTED|Overall Study||103
8508851|NCT00450177|20970763|P1|STARTED|Overall Study||97
8508852|NCT00450112|20970789|P2|NOT COMPLETED|Overall Study||6
8508853|NCT00450112|20970790|P1|NOT COMPLETED|Overall Study||13
8508854|NCT00450112|20970789|P2|COMPLETED|Overall Study||71
8508855|NCT00450112|20970790|P1|COMPLETED|Overall Study||112
8508856|NCT00450112|20970789|P2|Analyzed Participants|Overall Study||74
8508857|NCT00450112|20970790|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
8508858|NCT00450112|20970789|P2|Received Injection|Overall Study||74
8508859|NCT00450112|20970790|P1|Received Injection|Overall Study||125
8508860|NCT00450112|20970789|P2|STARTED|Overall Study||77
8508861|NCT00450112|20970790|P1|STARTED|Overall Study||125
8508862|NCT00450073|20970815|P3|NOT COMPLETED|Overall Study||1
8508863|NCT00450073|20970816|P2|NOT COMPLETED|Overall Study||0
8508864|NCT00450073|20970817|P1|NOT COMPLETED|Overall Study||1
8508865|NCT00450073|20970815|P3|COMPLETED|Overall Study||9
8508866|NCT00450073|20970816|P2|COMPLETED|Overall Study||10
8508867|NCT00450073|20970817|P1|COMPLETED|Overall Study||9
8508868|NCT00450073|20970815|P3|STARTED|Overall Study||10
8508869|NCT00450073|20970816|P2|STARTED|Overall Study||10
8508870|NCT00450073|20970817|P1|STARTED|Overall Study||10
8508871|NCT00449956|20970828|P3|NOT COMPLETED|Overall Study||9
8508872|NCT00449956|20970829|P2|NOT COMPLETED|Overall Study||4
8508873|NCT00449956|20970830|P1|NOT COMPLETED|Overall Study||10
8508874|NCT00449956|20970828|P3|COMPLETED|Overall Study||184
8508875|NCT00449956|20970829|P2|COMPLETED|Overall Study||88
8508876|NCT00449956|20970830|P1|COMPLETED|Overall Study||179
8508877|NCT00449956|20970828|P3|STARTED|Overall Study||193
8508878|NCT00449956|20970829|P2|STARTED|Overall Study||92
8508879|NCT00449956|20970830|P1|STARTED|Overall Study||189
8508880|NCT00449930|20970846|P2|NOT COMPLETED|Overall Study||75
8508881|NCT00449930|20970847|P1|NOT COMPLETED|Overall Study||61
8508882|NCT00449930|20970846|P2|COMPLETED|Overall Study||447
8508883|NCT00449930|20970847|P1|COMPLETED|Overall Study||467
8508884|NCT00449930|20970846|P2|STARTED|Overall Study||522
8508885|NCT00449930|20970847|P1|STARTED|Overall Study||528
8508886|NCT00449865|20970863|P2|NOT COMPLETED|Overall Study||534
8508887|NCT00449865|20970864|P1|NOT COMPLETED|Overall Study||522
8508888|NCT00449865|20970863|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
8508889|NCT00449865|20970864|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
8508890|NCT00449865|20970863|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
8508891|NCT00449865|20970864|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
8508892|NCT00449865|20970863|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
8508893|NCT00449865|20970864|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
8508894|NCT00449865|20970863|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
8508895|NCT00449865|20970864|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
8508896|NCT00449865|20970863|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
8508897|NCT00449865|20970864|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
8508898|NCT00449865|20970863|P2|STARTED|Overall Study||874
8508899|NCT00449865|20970864|P1|STARTED|Overall Study||867
8508900|NCT00449787|20970872|P2|NOT COMPLETED|Overall Study||100
8508901|NCT00449787|20970873|P1|NOT COMPLETED|Overall Study||105
8508902|NCT00449787|20970872|P2|COMPLETED|Overall Study||98
8508903|NCT00449787|20970873|P1|COMPLETED|Overall Study||98
8508904|NCT00449787|20970872|P2|STARTED|Overall Study||198
8508905|NCT00449787|20970873|P1|STARTED|Overall Study||203
8508906|NCT00449748|20970883|P1|NOT COMPLETED|Overall Study||0
8508907|NCT00449748|20970883|P1|COMPLETED|Overall Study||10
8508908|NCT00449748|20970883|P1|STARTED|Overall Study||10
8508909|NCT00449696|20970889|P2|NOT COMPLETED|Overall Study||9
8508910|NCT00449696|20970890|P1|NOT COMPLETED|Overall Study||20
8508911|NCT00449696|20970889|P2|COMPLETED|Overall Study||119
8508912|NCT00449696|20970890|P1|COMPLETED|Overall Study||231
8508913|NCT00449696|20970889|P2|Analyzed Participants|Overall Study||128
8508914|NCT00449696|20970890|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
8508915|NCT00449696|20970889|P2|Received Injection|Overall Study||128
8508916|NCT00449696|20970890|P1|Received Injection|Overall Study||249
8508917|NCT00449696|20970889|P2|STARTED|Overall Study||128
8508918|NCT00449696|20970890|P1|STARTED|Overall Study||251
8508919|NCT00449670|20970914|P2|NOT COMPLETED|Booster Phase (Study no.109873)||3
8508920|NCT00449670|20970915|P1|NOT COMPLETED|Booster Phase (Study no.109873)||0
8508921|NCT00449670|20970914|P2|COMPLETED|Booster Phase (Study no.109873)||233
8508922|NCT00449670|20970915|P1|COMPLETED|Booster Phase (Study no.109873)||265
8508923|NCT00449670|20970914|P2|STARTED|Booster Phase (Study no.109873)||236
8508924|NCT00449670|20970915|P1|STARTED|Booster Phase (Study no.109873)||265
8508925|NCT00449670|20970914|P2|NOT COMPLETED|Primary Phase (Study no.109630)||2
8508926|NCT00449670|20970915|P1|NOT COMPLETED|Primary Phase (Study no.109630)||14
8508927|NCT00449670|20970914|P2|COMPLETED|Primary Phase (Study no.109630)||243
8508928|NCT00449670|20970915|P1|COMPLETED|Primary Phase (Study no.109630)||947
8508929|NCT00449670|20970914|P2|STARTED|Primary Phase (Study no.109630)||245
8508930|NCT00449670|20970915|P1|STARTED|Primary Phase (Study no.109630)||961
8508931|NCT00449644|20971028|P4|NOT COMPLETED|Overall Study||32
8508932|NCT00449644|20971029|P3|NOT COMPLETED|Overall Study||29
8508933|NCT00449644|20971030|P2|NOT COMPLETED|Overall Study||13
8508934|NCT00449644|20971031|P1|NOT COMPLETED|Overall Study||10
8508935|NCT00449644|20971028|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
8508936|NCT00449644|20971029|P3|COMPLETED|Overall Study||50
8508937|NCT00449644|20971030|P2|COMPLETED|Overall Study||11
8508938|NCT00449644|20971031|P1|COMPLETED|Overall Study||13
8508939|NCT00449644|20971028|P4|Rollover|Overall Study||1
8508940|NCT00449644|20971029|P3|Rollover|Overall Study||0
8508941|NCT00449644|20971030|P2|Rollover|Overall Study||0
8508942|NCT00449644|20971031|P1|Rollover|Overall Study||0
8508943|NCT00449644|20971028|P4|STARTED|Overall Study||81
8508944|NCT00449644|20971029|P3|STARTED|Overall Study||79
8508945|NCT00449644|20971030|P2|STARTED|Overall Study||24
8508946|NCT00449644|20971031|P1|STARTED|Overall Study||23
8508947|NCT00449540|20971051|P3|NOT COMPLETED|Treatment Phase||17
8508948|NCT00449540|20971052|P2|NOT COMPLETED|Treatment Phase||20
8508949|NCT00449540|20971053|P1|NOT COMPLETED|Treatment Phase||0
8508950|NCT00449540|20971051|P3|COMPLETED|Treatment Phase||82
8508951|NCT00449540|20971052|P2|COMPLETED|Treatment Phase||82
8508952|NCT00449540|20971053|P1|COMPLETED|Treatment Phase||0
8508953|NCT00449540|20971051|P3|STARTED|Treatment Phase||99
8508954|NCT00449540|20971052|P2|STARTED|Treatment Phase||102
8508955|NCT00449540|20971053|P1|STARTED|Treatment Phase||0
8508956|NCT00449540|20971051|P3|NOT COMPLETED|Pretreatment Phase||0
8508957|NCT00449540|20971052|P2|NOT COMPLETED|Pretreatment Phase||0
8508958|NCT00449540|20971053|P1|NOT COMPLETED|Pretreatment Phase||66
8508959|NCT00449540|20971051|P3|COMPLETED|Pretreatment Phase||0
8508960|NCT00449540|20971052|P2|COMPLETED|Pretreatment Phase||0
8508961|NCT00449540|20971053|P1|COMPLETED|Pretreatment Phase||201
8508962|NCT00449540|20971051|P3|STARTED|Pretreatment Phase||0
8508963|NCT00449540|20971052|P2|STARTED|Pretreatment Phase||0
8508964|NCT00449540|20971053|P1|STARTED|Pretreatment Phase||267
8508965|NCT00449176|20971070|P3|NOT COMPLETED|Overall Study||167
8508966|NCT00449176|20971071|P2|NOT COMPLETED|Overall Study||195
8508967|NCT00449176|20971072|P1|NOT COMPLETED|Overall Study||152
8508968|NCT00449176|20971070|P3|COMPLETED|Overall Study||152
8508969|NCT00449176|20971071|P2|COMPLETED|Overall Study||133
8508970|NCT00449176|20971072|P1|COMPLETED|Overall Study||166
8508971|NCT00449176|20971070|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
8508972|NCT00449176|20971071|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
8508973|NCT00449176|20971072|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
8508974|NCT00449163|20971098|P1|NOT COMPLETED|Overall Study||3
8508975|NCT00449163|20971098|P1|COMPLETED|Overall Study||22
8508976|NCT00449163|20971098|P1|STARTED|Overall Study||25
8508977|NCT00449150|20971108|P3|NOT COMPLETED|Overall Study||47
8508978|NCT00449150|20971109|P2|NOT COMPLETED|Overall Study||53
8508979|NCT00449150|20971110|P1|NOT COMPLETED|Overall Study||46
8508980|NCT00449150|20971108|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
8508981|NCT00449150|20971109|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
8508982|NCT00449150|20971110|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
8508983|NCT00449150|20971108|P3|STARTED|Overall Study||218
8508984|NCT00449150|20971109|P2|STARTED|Overall Study||230
8508985|NCT00449150|20971110|P1|STARTED|Overall Study||219
8508986|NCT00449072|20971123|P2|NOT COMPLETED|Overall Study||42
8508987|NCT00449072|20971124|P1|NOT COMPLETED|Overall Study||41
8508988|NCT00449072|20971123|P2|COMPLETED|Overall Study||109
8508989|NCT00449072|20971124|P1|COMPLETED|Overall Study||107
8508990|NCT00449072|20971123|P2|STARTED|Overall Study||151
8508991|NCT00449072|20971124|P1|STARTED|Overall Study||148
8508992|NCT00449046|20971148|P1|NOT COMPLETED|Overall Study||0
8508993|NCT00449046|20971148|P1|COMPLETED|Overall Study||40
8508994|NCT00449046|20971148|P1|STARTED|Overall Study||40
8508995|NCT00449033|20971161|P2|NOT COMPLETED|Follow-up Period||434
8508996|NCT00449033|20971162|P1|NOT COMPLETED|Follow-up Period||425
8508997|NCT00449033|20971161|P2|COMPLETED|Follow-up Period||0
8508998|NCT00449033|20971162|P1|COMPLETED|Follow-up Period||0
8508999|NCT00449033|20971161|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
8509000|NCT00449033|20971162|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
8509001|NCT00449033|20971161|P2|NOT COMPLETED|Treatment Period||452
8509002|NCT00449033|20971162|P1|NOT COMPLETED|Treatment Period||452
8509003|NCT00449033|20971161|P2|COMPLETED|Treatment Period||0
8509004|NCT00449033|20971162|P1|COMPLETED|Treatment Period||0
8509005|NCT00449033|20971161|P2|Received Treatment|Treatment Period||449
8509006|NCT00449033|20971162|P1|Received Treatment|Treatment Period||452
8509007|NCT00449033|20971161|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
8509008|NCT00449033|20971162|P1|STARTED|Treatment Period||452
8509009|NCT00448916|20971200|P4|NOT COMPLETED|Overall Study||6
8509010|NCT00448916|20971201|P3|NOT COMPLETED|Overall Study||6
8509011|NCT00448916|20971202|P2|NOT COMPLETED|Overall Study||6
8509012|NCT00448916|20971203|P1|NOT COMPLETED|Overall Study||7
8509013|NCT00448916|20971200|P4|COMPLETED|Overall Study||5
8509014|NCT00448916|20971201|P3|COMPLETED|Overall Study||6
8509015|NCT00448916|20971202|P2|COMPLETED|Overall Study||9
8509016|NCT00448916|20971203|P1|COMPLETED|Overall Study||9
8509017|NCT00448916|20971200|P4|STARTED|Overall Study||11
8509018|NCT00448916|20971201|P3|STARTED|Overall Study||12
8509019|NCT00448916|20971202|P2|STARTED|Overall Study||15
8509020|NCT00448916|20971203|P1|STARTED|Overall Study||16
8509021|NCT00448864|20971277|P3|NOT COMPLETED|Overall Study||1
8509022|NCT00448864|20971278|P2|NOT COMPLETED|Overall Study||5
8509023|NCT00448864|20971279|P1|NOT COMPLETED|Overall Study||5
8509024|NCT00448864|20971277|P3|COMPLETED|Overall Study||18
8509025|NCT00448864|20971278|P2|COMPLETED|Overall Study||24
8509026|NCT00448864|20971279|P1|COMPLETED|Overall Study||22
8509027|NCT00448864|20971277|P3|Completed Post-operative Period|Overall Study||18
8509028|NCT00448864|20971278|P2|Completed Post-operative Period|Overall Study||25
8509029|NCT00448864|20971279|P1|Completed Post-operative Period|Overall Study||26
8509030|NCT00448864|20971277|P3|Started Post-operative Period|Overall Study||18
8509031|NCT00448864|20971278|P2|Started Post-operative Period|Overall Study||25
8509032|NCT00448864|20971279|P1|Started Post-operative Period|Overall Study||26
8509033|NCT00448864|20971277|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
8509034|NCT00448864|20971278|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
8509035|NCT00448864|20971279|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
8509036|NCT00448864|20971277|P3|STARTED|Overall Study||19
8509037|NCT00448864|20971278|P2|STARTED|Overall Study||29
8509038|NCT00448864|20971279|P1|STARTED|Overall Study||27
8509039|NCT00448760|20971295|P1|NOT COMPLETED|Overall Study||3
8509040|NCT00448760|20971295|P1|COMPLETED|Overall Study||26
8509041|NCT00448760|20971295|P1|STARTED|Overall Study||29
8509042|NCT00448747|20971304|P2|NOT COMPLETED|Overall Study||0
8509043|NCT00448747|20971305|P1|NOT COMPLETED|Overall Study||1
8509044|NCT00448747|20971304|P2|COMPLETED|Overall Study||48
8509045|NCT00448747|20971305|P1|COMPLETED|Overall Study||52
8509046|NCT00448747|20971304|P2|Per Protocol Population (PPS)|Overall Study||48
8509047|NCT00448747|20971305|P1|Per Protocol Population (PPS)|Overall Study||50
8509048|NCT00448747|20971304|P2|Received L-ARG-GHRH and AEZS-130|Overall Study||10
8509049|NCT00448747|20971305|P1|Received L-ARG-GHRH and AEZS-130|Overall Study||42
8509050|NCT00448747|20971304|P2|Received L-ARG-GHRH|Overall Study||10
8509051|NCT00448747|20971305|P1|Received L-ARG-GHRH|Overall Study||43
8509052|NCT00448747|20971304|P2|Received AEZS-130|Overall Study||48
8509053|NCT00448747|20971305|P1|Received AEZS-130|Overall Study||52
8509054|NCT00448747|20971304|P2|Received Second Drug Administration|Overall Study||10
8509055|NCT00448747|20971305|P1|Received Second Drug Administration|Overall Study||42
8509056|NCT00448747|20971304|P2|Received First Drug Administration|Overall Study||48
8509057|NCT00448747|20971305|P1|Received First Drug Administration|Overall Study||53
8509058|NCT00448747|20971304|P2|STARTED|Overall Study||48
8509059|NCT00448747|20971305|P1|STARTED|Overall Study||53
8509060|NCT00448708|20971323|P2|NOT COMPLETED|Overall Study||31
8509061|NCT00448708|20971324|P1|NOT COMPLETED|Overall Study||35
8509062|NCT00448708|20971323|P2|COMPLETED|Overall Study||79
8509063|NCT00448708|20971324|P1|COMPLETED|Overall Study||77
8509064|NCT00448708|20971323|P2|STARTED|Overall Study||110
8509065|NCT00448708|20971324|P1|STARTED|Overall Study||112
8509066|NCT00448682|20971332|P1|NOT COMPLETED|Overall Study||0
8509067|NCT00448682|20971332|P1|COMPLETED|Overall Study||25
8509068|NCT00448682|20971332|P1|STARTED|Overall Study||25
8509069|NCT00448669|20971340|P2|NOT COMPLETED|Overall Study||198
8509070|NCT00448669|20971341|P1|NOT COMPLETED|Overall Study||218
8509071|NCT00448669|20971340|P2|COMPLETED|Overall Study||410
8509072|NCT00448669|20971341|P1|COMPLETED|Overall Study||393
8509073|NCT00448669|20971340|P2|STARTED|Overall Study||608
8509074|NCT00448669|20971341|P1|STARTED|Overall Study||611
8509075|NCT00448630|20971357|P1|NOT COMPLETED|Overall Study||27
8509076|NCT00448630|20971357|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
8509077|NCT00448630|20971357|P1|STARTED|Overall Study||328
8509078|NCT00448591|20971402|P1|NOT COMPLETED|Overall Study||2296
8509079|NCT00448591|20971402|P1|COMPLETED|Overall Study||0
8509080|NCT00448591|20971402|P1|STARTED|Overall Study||2296
8509081|NCT00448539|20971413|P2|NOT COMPLETED|Overall Study||152
8509082|NCT00448539|20971414|P1|NOT COMPLETED|Overall Study||134
8509083|NCT00448539|20971413|P2|COMPLETED|Overall Study||0
8509084|NCT00448539|20971414|P1|COMPLETED|Overall Study||0
8509085|NCT00448539|20971413|P2|STARTED|Overall Study||152
8509086|NCT00448539|20971414|P1|STARTED|Overall Study||134
8509087|NCT00448448|20971422|P2|NOT COMPLETED|Overall Study||41
8509088|NCT00448448|20971423|P1|NOT COMPLETED|Overall Study||100
8509089|NCT00448448|20971422|P2|COMPLETED|Overall Study||96
8509090|NCT00448448|20971423|P1|COMPLETED|Overall Study||146
8509091|NCT00448448|20971422|P2|STARTED|Overall Study||137
8509092|NCT00448448|20971423|P1|STARTED|Overall Study||246
8509093|NCT00448435|20971429|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
8509094|NCT00448435|20971430|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
8509095|NCT00448435|20971429|P2|COMPLETED|Extension Period - 20 Weeks||0
8509096|NCT00448435|20971430|P1|COMPLETED|Extension Period - 20 Weeks||50
8509097|NCT00448435|20971429|P2|STARTED|Extension Period - 20 Weeks||0
8509098|NCT00448435|20971430|P1|STARTED|Extension Period - 20 Weeks||50
8509099|NCT00448435|20971429|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
8509100|NCT00448435|20971430|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
8509101|NCT00448435|20971429|P2|COMPLETED|Treatment Period II - 4 Weeks||25
8509102|NCT00448435|20971430|P1|COMPLETED|Treatment Period II - 4 Weeks||25
8509103|NCT00448435|20971429|P2|STARTED|Treatment Period II - 4 Weeks||25
8509104|NCT00448435|20971430|P1|STARTED|Treatment Period II - 4 Weeks||25
8509105|NCT00448435|20971429|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
8509106|NCT00448435|20971430|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
8509107|NCT00448435|20971429|P2|COMPLETED|Washout Period - 2 Weeks||25
8509108|NCT00448435|20971430|P1|COMPLETED|Washout Period - 2 Weeks||25
8509109|NCT00448435|20971429|P2|STARTED|Washout Period - 2 Weeks||25
8509110|NCT00448435|20971430|P1|STARTED|Washout Period - 2 Weeks||26
8509111|NCT00448435|20971429|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
8509112|NCT00448435|20971430|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
8509113|NCT00448435|20971429|P2|COMPLETED|Treatment Period I - 4 Weeks||25
8509114|NCT00448435|20971430|P1|COMPLETED|Treatment Period I - 4 Weeks||26
8509115|NCT00448435|20971429|P2|STARTED|Treatment Period I - 4 Weeks||25
8509116|NCT00448435|20971430|P1|STARTED|Treatment Period I - 4 Weeks||26
8509117|NCT00448357|20971456|P1|NOT COMPLETED|Overall Study||0
8509118|NCT00448357|20971456|P1|COMPLETED|Overall Study||54
8509119|NCT00448357|20971456|P1|STARTED|Overall Study||54
8509120|NCT00448344|20971481|P2|NOT COMPLETED|Overall Study||36
8509121|NCT00448344|20971482|P1|NOT COMPLETED|Overall Study||30
8509122|NCT00448344|20971481|P2|COMPLETED|Overall Study||200
8509123|NCT00448344|20971482|P1|COMPLETED|Overall Study||205
8509124|NCT00448344|20971481|P2|STARTED|Overall Study||236
8509125|NCT00448344|20971482|P1|STARTED|Overall Study||235
8509126|NCT00448279|20971492|P2|NOT COMPLETED|Overall Study||29
8509127|NCT00448279|20971493|P1|NOT COMPLETED|Overall Study||29
8509128|NCT00448279|20971492|P2|COMPLETED|Overall Study||0
8509129|NCT00448279|20971493|P1|COMPLETED|Overall Study||0
8509130|NCT00448279|20971492|P2|STARTED|Overall Study||29
8509131|NCT00448279|20971493|P1|STARTED|Overall Study||29
8509132|NCT00448227|20971509|P1|NOT COMPLETED|Overall Study||0
8509133|NCT00448227|20971509|P1|COMPLETED|Overall Study||18
8509134|NCT00448227|20971509|P1|STARTED|Overall Study||18
8509135|NCT00448201|20971536|P1|NOT COMPLETED|Overall Study||0
8509136|NCT00448201|20971536|P1|COMPLETED|Overall Study||71
8509137|NCT00448201|20971536|P1|STARTED|Overall Study||71
8509138|NCT00448175|20971547|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
8509139|NCT00448175|20971548|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
8509140|NCT00448175|20971547|P2|COMPLETED|Continued PTNS Through 12 Months||0
8509141|NCT00448175|20971548|P1|COMPLETED|Continued PTNS Through 12 Months||25
8509142|NCT00448175|20971547|P2|STARTED|Continued PTNS Through 12 Months||0
8509143|NCT00448175|20971548|P1|STARTED|Continued PTNS Through 12 Months||35
8509144|NCT00448175|20971547|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
8509145|NCT00448175|20971548|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
8509146|NCT00448175|20971547|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
8509147|NCT00448175|20971548|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
8509148|NCT00448175|20971547|P2|STARTED|12 Weeks PTNS vs. Drug||50
8509149|NCT00448175|20971548|P1|STARTED|12 Weeks PTNS vs. Drug||50
8509150|NCT00448136|20971556|P2|NOT COMPLETED|Overall Study||8
8509151|NCT00448136|20971557|P1|NOT COMPLETED|Overall Study||4
8509152|NCT00448136|20971556|P2|COMPLETED|Overall Study||41
8509153|NCT00448136|20971557|P1|COMPLETED|Overall Study||30
8509154|NCT00448136|20971556|P2|STARTED|Overall Study||49
8509155|NCT00448136|20971557|P1|STARTED|Overall Study||34
8509156|NCT00448123|20971595|P2|NOT COMPLETED|Overall Study||12
8509157|NCT00448123|20971596|P1|NOT COMPLETED|Overall Study||15
8509158|NCT00448123|20971595|P2|COMPLETED|Overall Study||53
8509159|NCT00448123|20971596|P1|COMPLETED|Overall Study||47
8509160|NCT00448123|20971595|P2|STARTED|Overall Study||65
8509161|NCT00448123|20971596|P1|STARTED|Overall Study||62
8509162|NCT00448019|20971606|P1|NOT COMPLETED|Overall Study||7
8509163|NCT00448019|20971606|P1|COMPLETED|Overall Study||57
8509164|NCT00448019|20971606|P1|STARTED|Overall Study||64
8509165|NCT00447902|20971614|P2|NOT COMPLETED|Overall Study||6
8509166|NCT00447902|20971615|P1|NOT COMPLETED|Overall Study||4
8509167|NCT00447902|20971614|P2|COMPLETED|Overall Study||0
8509168|NCT00447902|20971615|P1|COMPLETED|Overall Study||1
8509169|NCT00447902|20971614|P2|STARTED|Overall Study||6
8509170|NCT00447902|20971615|P1|STARTED|Overall Study||5
8509171|NCT00447876|20971657|P2|NOT COMPLETED|Overall Study||4
8509172|NCT00447876|20971658|P1|NOT COMPLETED|Overall Study||3
8509173|NCT00447876|20971657|P2|COMPLETED|Overall Study||16
8509174|NCT00447876|20971658|P1|COMPLETED|Overall Study||17
8509175|NCT00447876|20971657|P2|STARTED|Overall Study||20
8509176|NCT00447876|20971658|P1|STARTED|Overall Study||20
8509177|NCT00447772|20971688|P1|NOT COMPLETED|Overall Study||27
8509178|NCT00447772|20971688|P1|COMPLETED|Overall Study||489
8509179|NCT00447772|20971688|P1|STARTED|Overall Study||516
8509180|NCT00447603|20971708|P3|NOT COMPLETED|Filter Period||15
8509181|NCT00447603|20971709|P2|NOT COMPLETED|Filter Period||4
8509182|NCT00447603|20971710|P1|NOT COMPLETED|Filter Period||0
8509183|NCT00447603|20971708|P3|COMPLETED|Filter Period||0
8509184|NCT00447603|20971709|P2|COMPLETED|Filter Period||0
8509185|NCT00447603|20971710|P1|COMPLETED|Filter Period||0
8509186|NCT00447603|20971708|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
8509187|NCT00447603|20971709|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
8509188|NCT00447603|20971710|P1|STARTED|Filter Period||0
8509189|NCT00447603|20971708|P3|NOT COMPLETED|Screening||0
8509190|NCT00447603|20971709|P2|NOT COMPLETED|Screening||0
8509191|NCT00447603|20971710|P1|NOT COMPLETED|Screening||21
8509192|NCT00447603|20971708|P3|COMPLETED|Screening||0
8509193|NCT00447603|20971709|P2|COMPLETED|Screening||0
8509194|NCT00447603|20971710|P1|COMPLETED|Screening||19
8509195|NCT00447603|20971708|P3|STARTED|Screening||0
8509196|NCT00447603|20971709|P2|STARTED|Screening||0
8509197|NCT00447603|20971710|P1|STARTED|Screening||40
8509198|NCT00447590|20971730|P1|NOT COMPLETED|Overall Study||60
8509199|NCT00447590|20971730|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
8509200|NCT00447590|20971730|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
8509201|NCT00447499|20971739|P1|NOT COMPLETED|Overall Study||7
8509202|NCT00447499|20971739|P1|COMPLETED|Overall Study||52
8509203|NCT00447499|20971739|P1|STARTED|Overall Study||59
8509204|NCT00447421|20971749|P1|NOT COMPLETED|Overall Study||6
8509205|NCT00447421|20971749|P1|COMPLETED|Overall Study||3
8509206|NCT00447421|20971749|P1|STARTED|Overall Study||9
8509207|NCT00447382|20971761|P2|NOT COMPLETED|Overall Study||6
8509208|NCT00447382|20971762|P1|NOT COMPLETED|Overall Study||6
8509209|NCT00447382|20971761|P2|COMPLETED|Overall Study||160
8509210|NCT00447382|20971762|P1|COMPLETED|Overall Study||158
8509211|NCT00447382|20971761|P2|STARTED|Overall Study||166
8509212|NCT00447382|20971762|P1|STARTED|Overall Study||164
8509213|NCT00447330|20971814|P1|NOT COMPLETED|Overall Study||2
8509214|NCT00447330|20971814|P1|COMPLETED|Overall Study||58
8509215|NCT00447330|20971814|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
8509216|NCT00447278|20971823|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
8509217|NCT00447278|20971824|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
8509218|NCT00447278|20971823|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
8509219|NCT00447278|20971824|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
8509220|NCT00447278|20971823|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
8509221|NCT00447278|20971824|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
8509222|NCT00447278|20971823|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
8509223|NCT00447278|20971824|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
8509224|NCT00447278|20971823|P2|COMPLETED|Period II (6 Month Open-Label)||171
8509225|NCT00447278|20971824|P1|COMPLETED|Period II (6 Month Open-Label)||157
8509226|NCT00447278|20971823|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
8509227|NCT00447278|20971824|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
8509228|NCT00447278|20971823|P2|STARTED|Period II (6 Month Open-Label)||200
8509229|NCT00447278|20971824|P1|STARTED|Period II (6 Month Open-Label)||199
8509230|NCT00447265|20971845|P2|NOT COMPLETED|Overall Study||0
8509231|NCT00447265|20971846|P1|NOT COMPLETED|Overall Study||1
8509232|NCT00447265|20971845|P2|COMPLETED|Overall Study||0
8509233|NCT00447265|20971846|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
8509234|NCT00447265|20971845|P2|STARTED|Overall Study||0
8509235|NCT00447265|20971846|P1|STARTED|Overall Study||1
8509236|NCT00447226|20971859|P2|NOT COMPLETED|Double-blind Phase||3
8509237|NCT00447226|20971860|P1|NOT COMPLETED|Double-blind Phase||4
8509238|NCT00447226|20971859|P2|COMPLETED|Double-blind Phase||0
8509239|NCT00447226|20971860|P1|COMPLETED|Double-blind Phase||0
8509240|NCT00447226|20971859|P2|STARTED|Double-blind Phase||3
8509241|NCT00447226|20971860|P1|STARTED|Double-blind Phase||4
8509242|NCT00447226|20971859|P2|NOT COMPLETED|12-Week Open-label Phase||25
8509243|NCT00447226|20971860|P1|NOT COMPLETED|12-Week Open-label Phase||0
8509244|NCT00447226|20971859|P2|COMPLETED|12-Week Open-label Phase||7
8509245|NCT00447226|20971860|P1|COMPLETED|12-Week Open-label Phase||0
8509246|NCT00447226|20971859|P2|STARTED|12-Week Open-label Phase||32
8509247|NCT00447226|20971860|P1|STARTED|12-Week Open-label Phase||0
8509248|NCT00447122|20971878|P1|NOT COMPLETED|Overall Study||2
8509249|NCT00447122|20971878|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
8509250|NCT00447122|20971878|P1|STARTED|Overall Study||31
8509251|NCT00447083|20971884|P4|NOT COMPLETED|Phase II||1
8509252|NCT00447083|20971885|P3|NOT COMPLETED|Phase II||1
8509253|NCT00447083|20971886|P2|NOT COMPLETED|Phase II||0
8509254|NCT00447083|20971887|P1|NOT COMPLETED|Phase II||0
8509255|NCT00447083|20971884|P4|COMPLETED|Phase II||7
8509256|NCT00447083|20971885|P3|COMPLETED|Phase II||7
8509257|NCT00447083|20971886|P2|COMPLETED|Phase II||0
8509258|NCT00447083|20971887|P1|COMPLETED|Phase II||0
8509259|NCT00447083|20971884|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
8509260|NCT00447083|20971885|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
8509261|NCT00447083|20971886|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
8509262|NCT00447083|20971887|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
8509263|NCT00447083|20971884|P4|NOT COMPLETED|Phase I||0
8509264|NCT00447083|20971885|P3|NOT COMPLETED|Phase I||0
8509265|NCT00447083|20971886|P2|NOT COMPLETED|Phase I||0
8509266|NCT00447083|20971887|P1|NOT COMPLETED|Phase I||0
8509267|NCT00447083|20971884|P4|COMPLETED|Phase I||0
8509268|NCT00447083|20971885|P3|COMPLETED|Phase I||0
8509269|NCT00447083|20971886|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
8509270|NCT00447083|20971887|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
8509271|NCT00447083|20971884|P4|STARTED|Phase I||0
8509272|NCT00447083|20971885|P3|STARTED|Phase I||0
8509273|NCT00447083|20971886|P2|STARTED|Phase I||9
8509274|NCT00447083|20971887|P1|STARTED|Phase I||10
8509275|NCT00447057|20971903|P4|NOT COMPLETED|Overall Study||26
8509276|NCT00447057|20971904|P3|NOT COMPLETED|Overall Study||19
8509277|NCT00447057|20971905|P2|NOT COMPLETED|Overall Study||73
8509278|NCT00447057|20971906|P1|NOT COMPLETED|Overall Study||83
8509279|NCT00447057|20971903|P4|COMPLETED|Overall Study||0
8509280|NCT00447057|20971904|P3|COMPLETED|Overall Study||0
8509281|NCT00447057|20971905|P2|COMPLETED|Overall Study||3
8509282|NCT00447057|20971906|P1|COMPLETED|Overall Study||0
8509283|NCT00447057|20971903|P4|STARTED|Overall Study||26
8509284|NCT00447057|20971904|P3|STARTED|Overall Study||19
8509285|NCT00447057|20971905|P2|STARTED|Overall Study||76
8509286|NCT00447057|20971906|P1|STARTED|Overall Study||83
8509287|NCT00447005|20971924|P1|NOT COMPLETED|Overall Study||12
8509288|NCT00447005|20971924|P1|COMPLETED|Overall Study||0
8509289|NCT00447005|20971924|P1|STARTED|Overall Study||12
8509290|NCT00446992|20971938|P1|NOT COMPLETED|Overall Study||16
8509291|NCT00446992|20971938|P1|COMPLETED|Overall Study|Intervention Completion|14
8509292|NCT00446992|20971938|P1|STARTED|Overall Study|Beginning of Intervention|30
8509293|NCT00446966|20971952|P2|NOT COMPLETED|Overall Study||7
8509294|NCT00446966|20971953|P1|NOT COMPLETED|Overall Study||10
8509295|NCT00446966|20971952|P2|COMPLETED|Overall Study||123
8509296|NCT00446966|20971953|P1|COMPLETED|Overall Study||120
8509297|NCT00446966|20971952|P2|STARTED|Overall Study||130
8509298|NCT00446966|20971953|P1|STARTED|Overall Study||130
8509299|NCT00446849|20971959|P1|NOT COMPLETED|Maintenance Phase||70
8509300|NCT00446849|20971959|P1|COMPLETED|Maintenance Phase||138
8509301|NCT00446849|20971959|P1|STARTED|Maintenance Phase||208
8509302|NCT00446849|20971959|P1|NOT COMPLETED|Acute Phase||82
8509303|NCT00446849|20971959|P1|COMPLETED|Acute Phase||56
8509304|NCT00446849|20971959|P1|STARTED|Acute Phase||138
8509311|NCT00446654|20972018|P2|NOT COMPLETED|Overall Study||0
8509312|NCT00446654|20972019|P1|NOT COMPLETED|Overall Study||2
8509313|NCT00446654|20972018|P2|COMPLETED|Overall Study||22
8509314|NCT00446654|20972019|P1|COMPLETED|Overall Study||19
8509315|NCT00446654|20972018|P2|STARTED|Overall Study||22
8509316|NCT00446654|20972019|P1|STARTED|Overall Study||21
8509317|NCT00446641|20972027|P2|NOT COMPLETED|Overall Study||10
8509318|NCT00446641|20972028|P1|NOT COMPLETED|Overall Study||17
8509319|NCT00446641|20972027|P2|COMPLETED|Overall Study||109
8509320|NCT00446641|20972028|P1|COMPLETED|Overall Study||108
8509321|NCT00446641|20972027|P2|STARTED|Overall Study||119
8509322|NCT00446641|20972028|P1|STARTED|Overall Study||125
8509323|NCT00446563|20972048|P2|NOT COMPLETED|Overall Study||9
8509324|NCT00446563|20972049|P1|NOT COMPLETED|Overall Study||7
8509325|NCT00446563|20972048|P2|COMPLETED|Overall Study||38
8509326|NCT00446563|20972049|P1|COMPLETED|Overall Study||36
8509327|NCT00446563|20972048|P2|STARTED|Overall Study||47
8509328|NCT00446563|20972049|P1|STARTED|Overall Study||43
8509329|NCT00446550|20972085|P2|NOT COMPLETED|Overall Study||0
8509330|NCT00446550|20972086|P1|NOT COMPLETED|Overall Study||1
8509331|NCT00446550|20972085|P2|COMPLETED|Overall Study||8
8509332|NCT00446550|20972086|P1|COMPLETED|Overall Study||10
8509333|NCT00446550|20972085|P2|PD Population|Overall Study||8
8509334|NCT00446550|20972086|P1|PD Population|Overall Study||11
8509335|NCT00446550|20972085|P2|Safety Population|Overall Study||8
8509336|NCT00446550|20972086|P1|Safety Population|Overall Study||11
8509337|NCT00446550|20972085|P2|STARTED|Overall Study||8
8509338|NCT00446550|20972086|P1|STARTED|Overall Study||11
8509339|NCT00446511|20972098|P4|NOT COMPLETED|Overall Study||6
8509340|NCT00446511|20972099|P3|NOT COMPLETED|Overall Study||7
8509341|NCT00446511|20972100|P2|NOT COMPLETED|Overall Study||2
8509342|NCT00446511|20972101|P1|NOT COMPLETED|Overall Study||10
8509343|NCT00446511|20972098|P4|COMPLETED|Overall Study||103
8509344|NCT00446511|20972099|P3|COMPLETED|Overall Study||96
8509345|NCT00446511|20972100|P2|COMPLETED|Overall Study||15
8509346|NCT00446511|20972101|P1|COMPLETED|Overall Study||11
8509347|NCT00446511|20972098|P4|STARTED|Overall Study||109
8509348|NCT00446511|20972099|P3|STARTED|Overall Study||103
8509349|NCT00446511|20972100|P2|STARTED|Overall Study||17
8509350|NCT00446511|20972101|P1|STARTED|Overall Study||21
8509351|NCT00446459|20972125|P1|NOT COMPLETED|12 Months||18
8509352|NCT00446459|20972125|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
8509353|NCT00446459|20972125|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
8509354|NCT00446459|20972125|P1|NOT COMPLETED|8 Months||12
8509355|NCT00446459|20972125|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
8509356|NCT00446459|20972125|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
8509357|NCT00446446|20972133|P1|NOT COMPLETED|Overall Study||24
8509358|NCT00446446|20972133|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
8509359|NCT00446446|20972133|P1|STARTED|Overall Study||52
8509360|NCT00446290|20972144|P1|NOT COMPLETED|Overall Study||0
8509361|NCT00446290|20972144|P1|COMPLETED|Overall Study||22
8509362|NCT00446290|20972144|P1|STARTED|Overall Study||22
8509363|NCT00446264|20972148|P1|NOT COMPLETED|Overall Study||0
8509364|NCT00446264|20972148|P1|COMPLETED|Overall Study||14
8509365|NCT00446264|20972148|P1|STARTED|Overall Study||14
8509366|NCT00446251|20972157|P1|NOT COMPLETED|Overall Study||5
8509367|NCT00446251|20972157|P1|COMPLETED|Overall Study||9
8509368|NCT00446251|20972157|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
8509369|NCT00446199|20972167|P4|NOT COMPLETED|Overall Study||30
8509370|NCT00446199|20972168|P3|NOT COMPLETED|Overall Study||27
8509371|NCT00446199|20972169|P2|NOT COMPLETED|Overall Study||20
8509372|NCT00446199|20972170|P1|NOT COMPLETED|Overall Study||23
8509373|NCT00446199|20972167|P4|COMPLETED|Overall Study||153
8509374|NCT00446199|20972168|P3|COMPLETED|Overall Study||158
8509375|NCT00446199|20972169|P2|COMPLETED|Overall Study||164
8509376|NCT00446199|20972170|P1|COMPLETED|Overall Study||160
8509377|NCT00446199|20972167|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
8509378|NCT00446199|20972168|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
8509379|NCT00446199|20972169|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
8509380|NCT00446199|20972170|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
8509381|NCT00446199|20972167|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
8509382|NCT00446199|20972168|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
8509383|NCT00446199|20972169|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
8509384|NCT00446199|20972170|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
8509385|NCT00446199|20972167|P4|STARTED|Overall Study||183
8509386|NCT00446199|20972168|P3|STARTED|Overall Study||185
8509387|NCT00446199|20972169|P2|STARTED|Overall Study||184
8509388|NCT00446199|20972170|P1|STARTED|Overall Study||183
8509389|NCT00446147|20972250|P2|NOT COMPLETED|Overall Study||14
8509390|NCT00446147|20972251|P1|NOT COMPLETED|Overall Study||15
8509391|NCT00446147|20972250|P2|COMPLETED|Overall Study||180
8509392|NCT00446147|20972251|P1|COMPLETED|Overall Study||180
8509393|NCT00446147|20972250|P2|STARTED|Overall Study||194
8509394|NCT00446147|20972251|P1|STARTED|Overall Study||195
8509395|NCT00446134|20972263|P4|NOT COMPLETED|Overall Study||45
8509396|NCT00446134|20972264|P3|NOT COMPLETED|Overall Study||43
8509397|NCT00446134|20972265|P2|NOT COMPLETED|Overall Study||45
8509398|NCT00446134|20972266|P1|NOT COMPLETED|Overall Study||34
8509399|NCT00446134|20972263|P4|COMPLETED|Overall Study||25
8509400|NCT00446134|20972264|P3|COMPLETED|Overall Study||26
8509401|NCT00446134|20972265|P2|COMPLETED|Overall Study||25
8509402|NCT00446134|20972266|P1|COMPLETED|Overall Study||35
8509403|NCT00446134|20972263|P4|STARTED|Overall Study||70
8509404|NCT00446134|20972264|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
8509405|NCT00446134|20972265|P2|STARTED|Overall Study||70
8509406|NCT00446134|20972266|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
8509407|NCT00446095|20972293|P5|NOT COMPLETED|Phase I (28 Days)||3
8509408|NCT00446095|20972294|P4|NOT COMPLETED|Phase I (28 Days)||1
8509409|NCT00446095|20972295|P3|NOT COMPLETED|Phase I (28 Days)||0
8509410|NCT00446095|20972296|P2|NOT COMPLETED|Phase I (28 Days)||0
8509411|NCT00446095|20972297|P1|NOT COMPLETED|Phase I (28 Days)||0
8509412|NCT00446095|20972293|P5|COMPLETED|Phase I (28 Days)||4
8509413|NCT00446095|20972294|P4|COMPLETED|Phase I (28 Days)||5
8509414|NCT00446095|20972295|P3|COMPLETED|Phase I (28 Days)||0
8509415|NCT00446095|20972296|P2|COMPLETED|Phase I (28 Days)||0
8509416|NCT00446095|20972297|P1|COMPLETED|Phase I (28 Days)||0
8509417|NCT00446095|20972293|P5|STARTED|Phase I (28 Days)||7
8509418|NCT00446095|20972294|P4|STARTED|Phase I (28 Days)||6
8509419|NCT00446095|20972295|P3|STARTED|Phase I (28 Days)||0
8509420|NCT00446095|20972296|P2|STARTED|Phase I (28 Days)||0
8509421|NCT00446095|20972297|P1|STARTED|Phase I (28 Days)||0
8509422|NCT00446095|20972293|P5|NOT COMPLETED|Phase II (8 Weeks)||0
8509423|NCT00446095|20972294|P4|NOT COMPLETED|Phase II (8 Weeks)||0
8509424|NCT00446095|20972295|P3|NOT COMPLETED|Phase II (8 Weeks)||3
8509425|NCT00446095|20972296|P2|NOT COMPLETED|Phase II (8 Weeks)||3
8509426|NCT00446095|20972297|P1|NOT COMPLETED|Phase II (8 Weeks)||12
8509427|NCT00446095|20972293|P5|COMPLETED|Phase II (8 Weeks)||0
8509428|NCT00446095|20972294|P4|COMPLETED|Phase II (8 Weeks)||0
8509429|NCT00446095|20972295|P3|COMPLETED|Phase II (8 Weeks)||21
8509430|NCT00446095|20972296|P2|COMPLETED|Phase II (8 Weeks)||18
8509431|NCT00446095|20972297|P1|COMPLETED|Phase II (8 Weeks)||11
8509432|NCT00446095|20972293|P5|STARTED|Phase II (8 Weeks)||0
8509433|NCT00446095|20972294|P4|STARTED|Phase II (8 Weeks)||0
8509434|NCT00446095|20972295|P3|STARTED|Phase II (8 Weeks)||24
8509435|NCT00446095|20972296|P2|STARTED|Phase II (8 Weeks)||21
8509436|NCT00446095|20972297|P1|STARTED|Phase II (8 Weeks)||23
8509437|NCT00446030|20972320|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
8509438|NCT00446030|20972321|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
8509439|NCT00446030|20972320|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
8509440|NCT00446030|20972321|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
8509441|NCT00446030|20972320|P2|STARTED|FOLLOW-UP (up to 2-years)||34
8509442|NCT00446030|20972321|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
8509443|NCT00446030|20972320|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
8509444|NCT00446030|20972321|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
8509445|NCT00446030|20972320|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
8509446|NCT00446030|20972321|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
8509447|NCT00446030|20972320|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
8509448|NCT00446030|20972321|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
8509449|NCT00446030|20972320|P2|STARTED|TREATMENT (up to 52 Weeks)||34
8509450|NCT00446030|20972321|P1|STARTED|TREATMENT (up to 52 Weeks)||93
8509451|NCT00445939|20972332|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
8509452|NCT00445939|20972333|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
8509453|NCT00445939|20972334|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
8509454|NCT00445939|20972335|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
8509455|NCT00445939|20972332|P4|COMPLETED|Period B - Week 4 - Week 8||20
8509456|NCT00445939|20972333|P3|COMPLETED|Period B - Week 4 - Week 8||0
8509457|NCT00445939|20972334|P2|COMPLETED|Period B - Week 4 - Week 8||0
8509458|NCT00445939|20972335|P1|COMPLETED|Period B - Week 4 - Week 8||14
8509459|NCT00445939|20972332|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
8509460|NCT00445939|20972333|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
8509461|NCT00445939|20972334|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
8509462|NCT00445939|20972335|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
8509463|NCT00445939|20972332|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
8509464|NCT00445939|20972333|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
8509465|NCT00445939|20972334|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
8509466|NCT00445939|20972335|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
8509467|NCT00445939|20972332|P4|COMPLETED|Period A - Week 0 - Week 4||0
8509468|NCT00445939|20972333|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
8509469|NCT00445939|20972334|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
8509470|NCT00445939|20972335|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
8509471|NCT00445939|20972332|P4|STARTED|Period A - Week 0 - Week 4||0
8509472|NCT00445939|20972333|P3|STARTED|Period A - Week 0 - Week 4||23
8509473|NCT00445939|20972334|P2|STARTED|Period A - Week 0 - Week 4||34
8509474|NCT00445939|20972335|P1|STARTED|Period A - Week 0 - Week 4||33
8509475|NCT00445887|20972360|P2|NOT COMPLETED|Overall Study||0
8509476|NCT00445887|20972361|P1|NOT COMPLETED|Overall Study||0
8509477|NCT00445887|20972360|P2|COMPLETED|Overall Study||31
8509478|NCT00445887|20972361|P1|COMPLETED|Overall Study||33
8509479|NCT00445887|20972360|P2|STARTED|Overall Study||31
8509480|NCT00445887|20972361|P1|STARTED|Overall Study||33
8509481|NCT00445848|20972383|P1|NOT COMPLETED|Overall Study||85
8509482|NCT00445848|20972383|P1|COMPLETED|Overall Study||0
8509483|NCT00445848|20972383|P1|STARTED|Overall Study||85
8509484|NCT00445770|20972393|P3|NOT COMPLETED|Overall Study||31
8509485|NCT00445770|20972394|P2|NOT COMPLETED|Overall Study||35
8509486|NCT00445770|20972395|P1|NOT COMPLETED|Overall Study||53
8509487|NCT00445770|20972393|P3|COMPLETED|Overall Study||151
8509488|NCT00445770|20972394|P2|COMPLETED|Overall Study||157
8509489|NCT00445770|20972395|P1|COMPLETED|Overall Study||123
8509490|NCT00445770|20972393|P3|STARTED|Overall Study||182
8509491|NCT00445770|20972394|P2|STARTED|Overall Study||192
8509492|NCT00445770|20972395|P1|STARTED|Overall Study||176
8509493|NCT00445744|20972462|P1|NOT COMPLETED|Overall Study||1
8509494|NCT00445744|20972462|P1|COMPLETED|Overall Study||51
8509495|NCT00445744|20972462|P1|STARTED|Overall Study||52
8509496|NCT00445705|20972471|P4|NOT COMPLETED|Overall Study||14
8509497|NCT00445705|20972472|P3|NOT COMPLETED|Overall Study||11
8509498|NCT00445705|20972473|P2|NOT COMPLETED|Overall Study||11
8509499|NCT00445705|20972474|P1|NOT COMPLETED|Overall Study||9
8509500|NCT00445705|20972471|P4|COMPLETED|Overall Study||39
8509501|NCT00445705|20972472|P3|COMPLETED|Overall Study||41
8509502|NCT00445705|20972473|P2|COMPLETED|Overall Study||42
8509503|NCT00445705|20972474|P1|COMPLETED|Overall Study||44
8509504|NCT00445705|20972471|P4|STARTED|Overall Study||53
8509505|NCT00445705|20972472|P3|STARTED|Overall Study||52
8509506|NCT00445705|20972473|P2|STARTED|Overall Study||53
8509507|NCT00445705|20972474|P1|STARTED|Overall Study||53
8509508|NCT00445692|20972496|P1|NOT COMPLETED|Overall Study||16
8509509|NCT00445692|20972496|P1|COMPLETED|Overall Study||15
8509510|NCT00445692|20972496|P1|STARTED|Overall Study||31
8509511|NCT00445679|20972506|P4|NOT COMPLETED|Overall Study||47
8509512|NCT00445679|20972507|P3|NOT COMPLETED|Overall Study||66
8509513|NCT00445679|20972508|P2|NOT COMPLETED|Overall Study||46
8509514|NCT00445679|20972509|P1|NOT COMPLETED|Overall Study||48
8509515|NCT00445679|20972506|P4|COMPLETED|Overall Study||149
8509516|NCT00445679|20972507|P3|COMPLETED|Overall Study||139
8509517|NCT00445679|20972508|P2|COMPLETED|Overall Study||157
8509518|NCT00445679|20972509|P1|COMPLETED|Overall Study||155
8509519|NCT00445679|20972506|P4|STARTED|Overall Study||196
8509520|NCT00445679|20972507|P3|STARTED|Overall Study||205
8509521|NCT00445679|20972508|P2|STARTED|Overall Study||203
8509522|NCT00445679|20972509|P1|STARTED|Overall Study||203
8509523|NCT00445601|20972545|P2|NOT COMPLETED|Overall Study||28
8509524|NCT00445601|20972546|P1|NOT COMPLETED|Overall Study||33
8509525|NCT00445601|20972545|P2|COMPLETED|Overall Study||177
8509526|NCT00445601|20972546|P1|COMPLETED|Overall Study||168
8509527|NCT00445601|20972545|P2|Received TURBT|Overall Study||193
8509528|NCT00445601|20972546|P1|Received TURBT|Overall Study||190
8509529|NCT00445601|20972545|P2|STARTED|Overall Study||205
8509530|NCT00445601|20972546|P1|STARTED|Overall Study||201
8509531|NCT00445588|20972558|P1|NOT COMPLETED|Overall Study||0
8509532|NCT00445588|20972558|P1|COMPLETED|Overall Study||56
8509533|NCT00445588|20972558|P1|STARTED|Overall Study||56
8509534|NCT00445549|20972563|P1|NOT COMPLETED|Overall Study||12
8509535|NCT00445549|20972563|P1|COMPLETED|Overall Study||0
8509536|NCT00445549|20972563|P1|STARTED|Overall Study||12
8509537|NCT00445484|20972570|P2|NOT COMPLETED|Overall Study||1
8509538|NCT00445484|20972571|P1|NOT COMPLETED|Overall Study||4
8509539|NCT00445484|20972570|P2|COMPLETED|Overall Study||10
8509540|NCT00445484|20972571|P1|COMPLETED|Overall Study||7
8509541|NCT00445484|20972570|P2|STARTED|Overall Study||11
8509542|NCT00445484|20972571|P1|STARTED|Overall Study||11
8509543|NCT00445458|20972587|P4|NOT COMPLETED|Overall Study||28
8509544|NCT00445458|20972588|P3|NOT COMPLETED|Overall Study||68
8509545|NCT00445458|20972589|P2|NOT COMPLETED|Overall Study||5
8509546|NCT00445458|20972590|P1|NOT COMPLETED|Overall Study||3
8509547|NCT00445458|20972587|P4|COMPLETED|Overall Study||3
8509548|NCT00445458|20972588|P3|COMPLETED|Overall Study||3
8509549|NCT00445458|20972589|P2|COMPLETED|Overall Study||0
8509550|NCT00445458|20972590|P1|COMPLETED|Overall Study||0
8509551|NCT00445458|20972587|P4|STARTED|Overall Study||31
8509552|NCT00445458|20972588|P3|STARTED|Overall Study||71
8509553|NCT00445458|20972589|P2|STARTED|Overall Study||5
8509554|NCT00445458|20972590|P1|STARTED|Overall Study||3
8509555|NCT00445432|20972608|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
8509556|NCT00445432|20972609|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8509557|NCT00445432|20972610|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8509558|NCT00445432|20972611|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8509559|NCT00445432|20972608|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
8509560|NCT00445432|20972609|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
8509561|NCT00445432|20972610|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
8509562|NCT00445432|20972611|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
8509563|NCT00445432|20972608|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
8509564|NCT00445432|20972609|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8509565|NCT00445432|20972610|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8509566|NCT00445432|20972611|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8509567|NCT00445432|20972608|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
8509568|NCT00445432|20972609|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
8509569|NCT00445432|20972610|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
8509570|NCT00445432|20972611|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
8509571|NCT00445432|20972608|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
8509572|NCT00445432|20972609|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
8509573|NCT00445432|20972610|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
8509574|NCT00445432|20972611|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
8509575|NCT00445432|20972608|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
8509576|NCT00445432|20972609|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
8509577|NCT00445432|20972610|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
8509578|NCT00445432|20972611|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
8509579|NCT00445341|20972644|P1|NOT COMPLETED|Overall Study||2
8509580|NCT00445341|20972644|P1|COMPLETED|Overall Study||26
8509581|NCT00445341|20972644|P1|STARTED|Overall Study||28
8509582|NCT00445328|20972651|P2|NOT COMPLETED|Overall Study||6
8509583|NCT00445328|20972652|P1|NOT COMPLETED|Overall Study||3
8509584|NCT00445328|20972651|P2|COMPLETED|Overall Study||36
8509585|NCT00445328|20972652|P1|COMPLETED|Overall Study||39
8509586|NCT00445328|20972651|P2|Received Treatment|Overall Study||42
8509587|NCT00445328|20972652|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
8509588|NCT00445328|20972651|P2|STARTED|Overall Study||42
8509589|NCT00445328|20972652|P1|STARTED|Overall Study||42
8509590|NCT00445315|20972675|P5|NOT COMPLETED|Overall Study||0
8509591|NCT00445315|20972676|P4|NOT COMPLETED|Overall Study||0
8509592|NCT00445315|20972677|P3|NOT COMPLETED|Overall Study||0
8509593|NCT00445315|20972678|P2|NOT COMPLETED|Overall Study||0
8509594|NCT00445315|20972679|P1|NOT COMPLETED|Overall Study||0
8509595|NCT00445315|20972675|P5|COMPLETED|Overall Study||8
8509596|NCT00445315|20972676|P4|COMPLETED|Overall Study||6
8509597|NCT00445315|20972677|P3|COMPLETED|Overall Study||6
8509598|NCT00445315|20972678|P2|COMPLETED|Overall Study||6
8509599|NCT00445315|20972679|P1|COMPLETED|Overall Study||6
8509600|NCT00445315|20972675|P5|STARTED|Overall Study||8
8509601|NCT00445315|20972676|P4|STARTED|Overall Study||6
8509602|NCT00445315|20972677|P3|STARTED|Overall Study||6
8509603|NCT00445315|20972678|P2|STARTED|Overall Study||6
8509604|NCT00445315|20972679|P1|STARTED|Overall Study||6
8509605|NCT00445302|20972773|P4|NOT COMPLETED|Overall Study||0
8509606|NCT00445302|20972774|P3|NOT COMPLETED|Overall Study||0
8509607|NCT00445302|20972775|P2|NOT COMPLETED|Overall Study||0
8509608|NCT00445302|20972776|P1|NOT COMPLETED|Overall Study||0
8509609|NCT00445302|20972773|P4|COMPLETED|Overall Study||6
8509610|NCT00445302|20972774|P3|COMPLETED|Overall Study||6
8509611|NCT00445302|20972775|P2|COMPLETED|Overall Study||5
8509612|NCT00445302|20972776|P1|COMPLETED|Overall Study||6
8509613|NCT00445302|20972773|P4|STARTED|Overall Study||6
8509614|NCT00445302|20972774|P3|STARTED|Overall Study||6
8509615|NCT00445302|20972775|P2|STARTED|Overall Study||5
8509616|NCT00445302|20972776|P1|STARTED|Overall Study||6
8509617|NCT00445263|20972804|P2|NOT COMPLETED|Overall Study||1
8509618|NCT00445263|20972805|P1|NOT COMPLETED|Overall Study||0
8509619|NCT00445263|20972804|P2|COMPLETED|Overall Study||86
8509620|NCT00445263|20972805|P1|COMPLETED|Overall Study||83
8509621|NCT00445263|20972804|P2|STARTED|Overall Study||87
8509622|NCT00445263|20972805|P1|STARTED|Overall Study||83
8509623|NCT00445224|20972813|P2|NOT COMPLETED|Combined Exercises||0
8509624|NCT00445224|20972814|P1|NOT COMPLETED|Combined Exercises||0
8509625|NCT00445224|20972813|P2|COMPLETED|Combined Exercises||13
8509626|NCT00445224|20972814|P1|COMPLETED|Combined Exercises||13
8509627|NCT00445224|20972813|P2|STARTED|Combined Exercises||13
8509628|NCT00445224|20972814|P1|STARTED|Combined Exercises||13
8509629|NCT00445224|20972813|P2|NOT COMPLETED|Specific Exercises||3
8509630|NCT00445224|20972814|P1|NOT COMPLETED|Specific Exercises||4
8509631|NCT00445224|20972813|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
8509632|NCT00445224|20972814|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
8509633|NCT00445224|20972813|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
8509634|NCT00445224|20972814|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
8509635|NCT00445224|20972813|P2|Baseline|Specific Exercises||16
8509636|NCT00445224|20972814|P1|Baseline|Specific Exercises||17
8509637|NCT00445224|20972813|P2|STARTED|Specific Exercises||16
8509638|NCT00445224|20972814|P1|STARTED|Specific Exercises||17
8509639|NCT00445211|20972826|P2|NOT COMPLETED|Overall Study||0
8509640|NCT00445211|20972827|P1|NOT COMPLETED|Overall Study||0
8509641|NCT00445211|20972826|P2|COMPLETED|Overall Study||23
8509642|NCT00445211|20972827|P1|COMPLETED|Overall Study||23
8509643|NCT00445211|20972826|P2|STARTED|Overall Study||23
8509644|NCT00445211|20972827|P1|STARTED|Overall Study||23
8509645|NCT00445146|20972841|P1|NOT COMPLETED|Overall Study||119
8509646|NCT00445146|20972841|P1|COMPLETED|Overall Study||73
8509647|NCT00445146|20972841|P1|STARTED|Overall Study||192
8509648|NCT00445003|20972863|P3|NOT COMPLETED|Overall Study||4
8509649|NCT00445003|20972864|P2|NOT COMPLETED|Overall Study||10
8509650|NCT00445003|20972865|P1|NOT COMPLETED|Overall Study||5
8509651|NCT00445003|20972863|P3|COMPLETED|Overall Study||105
8509652|NCT00445003|20972864|P2|COMPLETED|Overall Study||103
8509653|NCT00445003|20972865|P1|COMPLETED|Overall Study||118
8509654|NCT00445003|20972863|P3|STARTED|Overall Study||109
8509655|NCT00445003|20972864|P2|STARTED|Overall Study||113
8509656|NCT00445003|20972865|P1|STARTED|Overall Study||123
8509657|NCT00444964|20972894|P1|NOT COMPLETED|Overall Study||0
8509658|NCT00444964|20972894|P1|COMPLETED|Overall Study||11
8509659|NCT00444964|20972894|P1|STARTED|Overall Study||11
8509660|NCT00444951|20972903|P3|NOT COMPLETED|Overall Study||3
8509661|NCT00444951|20972904|P2|NOT COMPLETED|Overall Study||6
8509662|NCT00444951|20972905|P1|NOT COMPLETED|Overall Study||5
8509663|NCT00444951|20972903|P3|COMPLETED|Overall Study||160
8509664|NCT00444951|20972904|P2|COMPLETED|Overall Study||136
8509665|NCT00444951|20972905|P1|COMPLETED|Overall Study||140
8509666|NCT00444951|20972903|P3|STARTED|Overall Study||163
8509667|NCT00444951|20972904|P2|STARTED|Overall Study||142
8509668|NCT00444951|20972905|P1|STARTED|Overall Study||145
8509669|NCT00444925|20972922|P3|NOT COMPLETED|Double-blind Treatment Period||81
8509670|NCT00444925|20972923|P2|NOT COMPLETED|Double-blind Treatment Period||56
8509671|NCT00444925|20972924|P1|NOT COMPLETED|Double-blind Treatment Period||30
8509672|NCT00444925|20972922|P3|COMPLETED|Double-blind Treatment Period||598
8509673|NCT00444925|20972923|P2|COMPLETED|Double-blind Treatment Period||628
8509674|NCT00444925|20972924|P1|COMPLETED|Double-blind Treatment Period||304
8509675|NCT00444925|20972922|P3|STARTED|Double-blind Treatment Period||679
8509676|NCT00444925|20972923|P2|STARTED|Double-blind Treatment Period||684
8509677|NCT00444925|20972924|P1|STARTED|Double-blind Treatment Period||334
8509678|NCT00444925|20972922|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
8509679|NCT00444925|20972923|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
8509680|NCT00444925|20972924|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
8509681|NCT00444925|20972922|P3|COMPLETED|Randomized to Double-blind Treatment||679
8509682|NCT00444925|20972923|P2|COMPLETED|Randomized to Double-blind Treatment||684
8509683|NCT00444925|20972924|P1|COMPLETED|Randomized to Double-blind Treatment||334
8509684|NCT00444925|20972922|P3|STARTED|Randomized to Double-blind Treatment||685
8509685|NCT00444925|20972923|P2|STARTED|Randomized to Double-blind Treatment||690
8509686|NCT00444925|20972924|P1|STARTED|Randomized to Double-blind Treatment||337
8509687|NCT00444925|20972922|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
8509688|NCT00444925|20972923|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
8509689|NCT00444925|20972924|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
8509690|NCT00444925|20972922|P3|COMPLETED|Single-blind Placebo Run-In Period||0
8509691|NCT00444925|20972923|P2|COMPLETED|Single-blind Placebo Run-In Period||0
8509692|NCT00444925|20972924|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
8509693|NCT00444925|20972922|P3|STARTED|Single-blind Placebo Run-In Period||0
8509694|NCT00444925|20972923|P2|STARTED|Single-blind Placebo Run-In Period||0
8509695|NCT00444925|20972924|P1|STARTED|Single-blind Placebo Run-In Period||2446
8509696|NCT00444912|20972988|P2|NOT COMPLETED|Overall Study||2
8509697|NCT00444912|20972989|P1|NOT COMPLETED|Overall Study||3
8509698|NCT00444912|20972988|P2|COMPLETED|Overall Study||13
8509699|NCT00444912|20972989|P1|COMPLETED|Overall Study||12
8509700|NCT00444912|20972988|P2|Received Transplant|Overall Study||14
8509701|NCT00444912|20972989|P1|Received Transplant|Overall Study||14
8509702|NCT00444912|20972988|P2|Received Plerixafor|Overall Study||15
8509703|NCT00444912|20972989|P1|Received Plerixafor|Overall Study||15
8509704|NCT00444912|20972988|P2|STARTED|Overall Study||15
8509705|NCT00444912|20972989|P1|STARTED|Overall Study||15
8509706|NCT00444821|20973019|P2|NOT COMPLETED|Overall Study||366
8509707|NCT00444821|20973020|P1|NOT COMPLETED|Overall Study||362
8509708|NCT00444821|20973019|P2|COMPLETED|Overall Study||0
8509709|NCT00444821|20973020|P1|COMPLETED|Overall Study||0
8509710|NCT00444821|20973019|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
8509711|NCT00444821|20973020|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
8509712|NCT00444821|20973019|P2|STARTED|Overall Study||366
8509713|NCT00444821|20973020|P1|STARTED|Overall Study||362
8509714|NCT00444795|20973030|P1|NOT COMPLETED|Overall Study||3
8509715|NCT00444795|20973030|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
8509716|NCT00444795|20973030|P1|STARTED|Overall Study||620
8509717|NCT00444678|20973035|P1|NOT COMPLETED|Overall Study||31
8509718|NCT00444678|20973035|P1|COMPLETED|Overall Study||5
8509719|NCT00444678|20973035|P1|STARTED|Overall Study||36
8509720|NCT00444626|20973042|P1|NOT COMPLETED|Repeat Treatment Period||0
8509721|NCT00444626|20973042|P1|COMPLETED|Repeat Treatment Period||105
8509722|NCT00444626|20973042|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
8509723|NCT00444626|20973042|P1|NOT COMPLETED|Initial Treatment Period||12
8509724|NCT00444626|20973042|P1|COMPLETED|Initial Treatment Period||128
8509725|NCT00444626|20973042|P1|STARTED|Initial Treatment Period||140
8509726|NCT00444600|20973072|P4|NOT COMPLETED|Overall Study||10
8509727|NCT00444600|20973073|P3|NOT COMPLETED|Overall Study||10
8509728|NCT00444600|20973074|P2|NOT COMPLETED|Overall Study||16
8509729|NCT00444600|20973075|P1|NOT COMPLETED|Overall Study||19
8509730|NCT00444600|20973072|P4|COMPLETED|Overall Study|Number of eyes|176
8509731|NCT00444600|20973073|P3|COMPLETED|Overall Study|Number of eyes|178
8509732|NCT00444600|20973074|P2|COMPLETED|Overall Study|Number of eyes|171
8509733|NCT00444600|20973075|P1|COMPLETED|Overall Study|Number of eyes|274
8509734|NCT00444600|20973072|P4|STARTED|Overall Study|Number of eyes|186
8509735|NCT00444600|20973073|P3|STARTED|Overall Study|Number of eyes|188
8509736|NCT00444600|20973074|P2|STARTED|Overall Study|Number of eyes|187
8509737|NCT00444600|20973075|P1|STARTED|Overall Study|Number of eyes|293
8509738|NCT00444587|20973167|P2|NOT COMPLETED|Overall Study||15
8509739|NCT00444587|20973168|P1|NOT COMPLETED|Overall Study||83
8509740|NCT00444587|20973167|P2|COMPLETED|Overall Study||1
8509741|NCT00444587|20973168|P1|COMPLETED|Overall Study||10
8509742|NCT00444587|20973167|P2|STARTED|Overall Study||16
8509743|NCT00444587|20973168|P1|STARTED|Overall Study||93
8509744|NCT00444535|20973189|P1|NOT COMPLETED|Overall Study||24
8509745|NCT00444535|20973189|P1|COMPLETED|Overall Study||28
8509746|NCT00444535|20973189|P1|STARTED|Overall Study||52
8509747|NCT00444457|20973200|P4|NOT COMPLETED|Toddler Dose||8
8509748|NCT00444457|20973201|P3|NOT COMPLETED|Toddler Dose||4
8509749|NCT00444457|20973202|P2|NOT COMPLETED|Toddler Dose||6
8509750|NCT00444457|20973203|P1|NOT COMPLETED|Toddler Dose||7
8509751|NCT00444457|20973200|P4|COMPLETED|Toddler Dose||200
8509752|NCT00444457|20973201|P3|COMPLETED|Toddler Dose||404
8509753|NCT00444457|20973202|P2|COMPLETED|Toddler Dose||391
8509754|NCT00444457|20973203|P1|COMPLETED|Toddler Dose||408
8509755|NCT00444457|20973200|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
8509756|NCT00444457|20973201|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
8509757|NCT00444457|20973202|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
8509758|NCT00444457|20973203|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
8509759|NCT00444457|20973200|P4|NOT COMPLETED|After Infant Series||10
8509760|NCT00444457|20973201|P3|NOT COMPLETED|After Infant Series||19
8509761|NCT00444457|20973202|P2|NOT COMPLETED|After Infant Series||30
8509762|NCT00444457|20973203|P1|NOT COMPLETED|After Infant Series||20
8509763|NCT00444457|20973200|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
8509764|NCT00444457|20973201|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
8509765|NCT00444457|20973202|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
8509766|NCT00444457|20973203|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
8509767|NCT00444457|20973200|P4|STARTED|After Infant Series||218
8509768|NCT00444457|20973201|P3|STARTED|After Infant Series||427
8509769|NCT00444457|20973202|P2|STARTED|After Infant Series||427
8509770|NCT00444457|20973203|P1|STARTED|After Infant Series||435
8509771|NCT00444457|20973200|P4|NOT COMPLETED|Infant Series||28
8509772|NCT00444457|20973201|P3|NOT COMPLETED|Infant Series||61
8509773|NCT00444457|20973202|P2|NOT COMPLETED|Infant Series||61
8509774|NCT00444457|20973203|P1|NOT COMPLETED|Infant Series||54
8509775|NCT00444457|20973200|P4|COMPLETED|Infant Series||218
8509776|NCT00444457|20973201|P3|COMPLETED|Infant Series||428
8509777|NCT00444457|20973202|P2|COMPLETED|Infant Series||427
8509778|NCT00444457|20973203|P1|COMPLETED|Infant Series||435
8509779|NCT00444457|20973200|P4|Vaccinated Dose 3|Infant Series||225
8509780|NCT00444457|20973201|P3|Vaccinated Dose 3|Infant Series||438
8509781|NCT00444457|20973202|P2|Vaccinated Dose 3|Infant Series||435
8509782|NCT00444457|20973203|P1|Vaccinated Dose 3|Infant Series||442
8509783|NCT00444457|20973200|P4|Vaccinated Dose 2|Infant Series||228
8509784|NCT00444457|20973201|P3|Vaccinated Dose 2|Infant Series||455
8509785|NCT00444457|20973202|P2|Vaccinated Dose 2|Infant Series||447
8509786|NCT00444457|20973203|P1|Vaccinated Dose 2|Infant Series||455
8509787|NCT00444457|20973200|P4|Vaccinated Dose 1|Infant Series||244
8509788|NCT00444457|20973201|P3|Vaccinated Dose 1|Infant Series||485
8509789|NCT00444457|20973202|P2|Vaccinated Dose 1|Infant Series||484
8509790|NCT00444457|20973203|P1|Vaccinated Dose 1|Infant Series||486
8509791|NCT00444457|20973200|P4|STARTED|Infant Series||246
8509792|NCT00444457|20973201|P3|STARTED|Infant Series||489
8509793|NCT00444457|20973202|P2|STARTED|Infant Series||488
8509794|NCT00444457|20973203|P1|STARTED|Infant Series||489
8509795|NCT00444275|20973268|P5|NOT COMPLETED|Maintenance Treatment Phase||179
8509796|NCT00444275|20973269|P4|NOT COMPLETED|Maintenance Treatment Phase||133
8509797|NCT00444275|20973270|P3|NOT COMPLETED|Maintenance Treatment Phase||161
8509798|NCT00444275|20973271|P2|NOT COMPLETED|Maintenance Treatment Phase||0
8509799|NCT00444275|20973272|P1|NOT COMPLETED|Maintenance Treatment Phase||0
8509800|NCT00444275|20973268|P5|COMPLETED|Maintenance Treatment Phase||701
8509801|NCT00444275|20973269|P4|COMPLETED|Maintenance Treatment Phase||764
8509802|NCT00444275|20973270|P3|COMPLETED|Maintenance Treatment Phase||747
8509803|NCT00444275|20973271|P2|COMPLETED|Maintenance Treatment Phase||0
8509804|NCT00444275|20973272|P1|COMPLETED|Maintenance Treatment Phase||0
8509805|NCT00444275|20973268|P5|STARTED|Maintenance Treatment Phase||880
8509806|NCT00444275|20973269|P4|STARTED|Maintenance Treatment Phase||897
8509807|NCT00444275|20973270|P3|STARTED|Maintenance Treatment Phase||908
8509808|NCT00444275|20973271|P2|STARTED|Maintenance Treatment Phase||0
8509809|NCT00444275|20973272|P1|STARTED|Maintenance Treatment Phase||0
8509810|NCT00444275|20973268|P5|NOT COMPLETED|Initial Treatment Phase||0
8509811|NCT00444275|20973269|P4|NOT COMPLETED|Initial Treatment Phase||0
8509812|NCT00444275|20973270|P3|NOT COMPLETED|Initial Treatment Phase||0
8509813|NCT00444275|20973271|P2|NOT COMPLETED|Initial Treatment Phase||96
8509814|NCT00444275|20973272|P1|NOT COMPLETED|Initial Treatment Phase||248
8509815|NCT00444275|20973268|P5|COMPLETED|Initial Treatment Phase||0
8509816|NCT00444275|20973269|P4|COMPLETED|Initial Treatment Phase||0
8509817|NCT00444275|20973270|P3|COMPLETED|Initial Treatment Phase||0
8509818|NCT00444275|20973271|P2|COMPLETED|Initial Treatment Phase||777
8509819|NCT00444275|20973272|P1|COMPLETED|Initial Treatment Phase||1908
8509820|NCT00444275|20973268|P5|STARTED|Initial Treatment Phase||0
8509821|NCT00444275|20973269|P4|STARTED|Initial Treatment Phase||0
8509822|NCT00444275|20973270|P3|STARTED|Initial Treatment Phase||0
8509823|NCT00444275|20973271|P2|STARTED|Initial Treatment Phase||873
8509824|NCT00444275|20973272|P1|STARTED|Initial Treatment Phase||2156
8509825|NCT00444145|20973322|P1|NOT COMPLETED|Overall Study||19
8509826|NCT00444145|20973322|P1|COMPLETED|Overall Study||19
8509827|NCT00444145|20973322|P1|STARTED|Overall Study||38
8509828|NCT00444106|20973329|P3|NOT COMPLETED|Overall Study||1
8509829|NCT00444106|20973330|P2|NOT COMPLETED|Overall Study||1
8509830|NCT00444106|20973331|P1|NOT COMPLETED|Overall Study||2
8509831|NCT00444106|20973329|P3|COMPLETED|Overall Study||52
8509832|NCT00444106|20973330|P2|COMPLETED|Overall Study||52
8509833|NCT00444106|20973331|P1|COMPLETED|Overall Study||157
8509834|NCT00444106|20973329|P3|Completed Treatment Period|Overall Study||53
8509835|NCT00444106|20973330|P2|Completed Treatment Period|Overall Study||53
8509836|NCT00444106|20973331|P1|Completed Treatment Period|Overall Study||159
8509837|NCT00444106|20973329|P3|STARTED|Overall Study||53
8509838|NCT00444106|20973330|P2|STARTED|Overall Study||53
8509839|NCT00444106|20973331|P1|STARTED|Overall Study||159
8509840|NCT00444080|20973348|P2|NOT COMPLETED|Overall Study||0
8509841|NCT00444080|20973349|P1|NOT COMPLETED|Overall Study||0
8509842|NCT00444080|20973348|P2|COMPLETED|Overall Study||59
8509843|NCT00444080|20973349|P1|COMPLETED|Overall Study||61
8509844|NCT00444080|20973348|P2|STARTED|Overall Study||59
8509845|NCT00444080|20973349|P1|STARTED|Overall Study||61
8509846|NCT00444067|20973363|P2|NOT COMPLETED|Overall Study||1
8509847|NCT00444067|20973364|P1|NOT COMPLETED|Overall Study||0
8509848|NCT00444067|20973363|P2|COMPLETED|Overall Study||23
8509849|NCT00444067|20973364|P1|COMPLETED|Overall Study||74
8509850|NCT00444067|20973363|P2|STARTED|Overall Study||24
8509851|NCT00444067|20973364|P1|STARTED|Overall Study||74
8509852|NCT00444028|20973380|P6|NOT COMPLETED|Overall Study||0
8509853|NCT00444028|20973381|P5|NOT COMPLETED|Overall Study||0
8509854|NCT00444028|20973382|P4|NOT COMPLETED|Overall Study||0
8509855|NCT00444028|20973383|P3|NOT COMPLETED|Overall Study||0
8509856|NCT00444028|20973384|P2|NOT COMPLETED|Overall Study||0
8509857|NCT00444028|20973385|P1|NOT COMPLETED|Overall Study||0
8509858|NCT00444028|20973380|P6|COMPLETED|Overall Study||8
8509859|NCT00444028|20973381|P5|COMPLETED|Overall Study||7
8509860|NCT00444028|20973382|P4|COMPLETED|Overall Study||6
8509861|NCT00444028|20973383|P3|COMPLETED|Overall Study||8
8509862|NCT00444028|20973384|P2|COMPLETED|Overall Study||7
8509863|NCT00444028|20973385|P1|COMPLETED|Overall Study||14
8509864|NCT00444028|20973380|P6|STARTED|Overall Study||8
8509865|NCT00444028|20973381|P5|STARTED|Overall Study||7
8509866|NCT00444028|20973382|P4|STARTED|Overall Study||6
8509867|NCT00444028|20973383|P3|STARTED|Overall Study||8
8509868|NCT00444028|20973384|P2|STARTED|Overall Study||7
8509869|NCT00444028|20973385|P1|STARTED|Overall Study||14
8509870|NCT00443898|20973427|P4|NOT COMPLETED|Overall Study||18
8509871|NCT00443898|20973428|P3|NOT COMPLETED|Overall Study||29
8509872|NCT00443898|20973429|P2|NOT COMPLETED|Overall Study||25
8509873|NCT00443898|20973430|P1|NOT COMPLETED|Overall Study||24
8509874|NCT00443898|20973427|P4|COMPLETED|Overall Study||110
8509875|NCT00443898|20973428|P3|COMPLETED|Overall Study||107
8509876|NCT00443898|20973429|P2|COMPLETED|Overall Study||103
8509877|NCT00443898|20973430|P1|COMPLETED|Overall Study||102
8509878|NCT00443898|20973427|P4|STARTED|Overall Study||128
8509879|NCT00443898|20973428|P3|STARTED|Overall Study||136
8509880|NCT00443898|20973429|P2|STARTED|Overall Study||128
8509881|NCT00443898|20973430|P1|STARTED|Overall Study||126
8509882|NCT00443872|20973452|P1|NOT COMPLETED|Overall Study||17
8509883|NCT00443872|20973452|P1|COMPLETED|Overall Study||60
8509884|NCT00443872|20973452|P1|STARTED|Overall Study||77
8509885|NCT00443846|20973467|P2|NOT COMPLETED|Overall Study||6
8509886|NCT00443846|20973468|P1|NOT COMPLETED|Overall Study||11
8509887|NCT00443846|20973467|P2|COMPLETED|Overall Study||117
8509888|NCT00443846|20973468|P1|COMPLETED|Overall Study||113
8509889|NCT00443846|20973467|P2|Vaccinated|Overall Study||123
8509890|NCT00443846|20973468|P1|Vaccinated|Overall Study||116
8509891|NCT00443846|20973467|P2|STARTED|Overall Study||123
8509892|NCT00443846|20973468|P1|STARTED|Overall Study||124
8509893|NCT00443820|20973478|P4|NOT COMPLETED|Overall Study||17
8509894|NCT00443820|20973479|P3|NOT COMPLETED|Overall Study||18
8509895|NCT00443820|20973480|P2|NOT COMPLETED|Overall Study||19
8509896|NCT00443820|20973481|P1|NOT COMPLETED|Overall Study||21
8509897|NCT00443820|20973478|P4|COMPLETED|Overall Study||111
8509898|NCT00443820|20973479|P3|COMPLETED|Overall Study||117
8509899|NCT00443820|20973480|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
8509900|NCT00443820|20973481|P1|COMPLETED|Overall Study||112
8509901|NCT00443820|20973478|P4|Safety Population|Overall Study||126
8509902|NCT00443820|20973479|P3|Safety Population|Overall Study||134
8509903|NCT00443820|20973480|P2|Safety Population|Overall Study||129
8509904|NCT00443820|20973481|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
8509905|NCT00443820|20973478|P4|STARTED|Overall Study||128
8509906|NCT00443820|20973479|P3|STARTED|Overall Study||135
8509907|NCT00443820|20973480|P2|STARTED|Overall Study||130
8509908|NCT00443820|20973481|P1|STARTED|Overall Study||133
8509909|NCT00443781|20973503|P1|NOT COMPLETED|Overall Study||25
8509910|NCT00443781|20973503|P1|COMPLETED|Overall Study||37
8509911|NCT00443781|20973503|P1|STARTED|Overall Study||62
8509912|NCT00443755|20973509|P2|NOT COMPLETED|Overall Study||1
8509913|NCT00443755|20973510|P1|NOT COMPLETED|Overall Study||2
8509914|NCT00443755|20973509|P2|COMPLETED|Overall Study||13
8509915|NCT00443755|20973510|P1|COMPLETED|Overall Study||12
8509916|NCT00443755|20973509|P2|STARTED|Overall Study||14
8509917|NCT00443755|20973510|P1|STARTED|Overall Study||14
8509918|NCT00443729|20973544|P2|NOT COMPLETED|Overall Study||7
8509919|NCT00443729|20973545|P1|NOT COMPLETED|Overall Study||10
8509920|NCT00443729|20973544|P2|COMPLETED|Overall Study||172
8509921|NCT00443729|20973545|P1|COMPLETED|Overall Study||166
8509922|NCT00443729|20973544|P2|Treated|Overall Study||178
8509923|NCT00443729|20973545|P1|Treated|Overall Study||176
8509924|NCT00443729|20973544|P2|STARTED|Overall Study||179
8509925|NCT00443729|20973545|P1|STARTED|Overall Study||176
8509926|NCT00443703|20973593|P2|NOT COMPLETED|Overall Study||18
8509927|NCT00443703|20973594|P1|NOT COMPLETED|Overall Study||28
8509928|NCT00443703|20973593|P2|COMPLETED|Overall Study||157
8509929|NCT00443703|20973594|P1|COMPLETED|Overall Study||149
8509930|NCT00443703|20973593|P2|Treated|Overall Study||174
8509931|NCT00443703|20973594|P1|Treated|Overall Study||174
8509932|NCT00443703|20973593|P2|STARTED|Overall Study||175
8509933|NCT00443703|20973594|P1|STARTED|Overall Study||177
8509934|NCT00443651|20973646|P2|NOT COMPLETED|Overall Study||58
8509935|NCT00443651|20973647|P1|NOT COMPLETED|Overall Study||95
8509936|NCT00443651|20973646|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
8509937|NCT00443651|20973647|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
8509938|NCT00443651|20973646|P2|Week 48|Overall Study||134
8509939|NCT00443651|20973647|P1|Week 48|Overall Study||338
8509940|NCT00443651|20973646|P2|Week 24|Overall Study||160
8509941|NCT00443651|20973647|P1|Week 24|Overall Study||376
8509942|NCT00443651|20973646|P2|STARTED|Overall Study||176
8509943|NCT00443651|20973647|P1|STARTED|Overall Study||401
8509950|NCT00443560|20973702|P2|NOT COMPLETED|Overall Study||30
8509951|NCT00443560|20973703|P1|NOT COMPLETED|Overall Study||60
8509952|NCT00443560|20973702|P2|COMPLETED|Overall Study||1051
8509953|NCT00443560|20973703|P1|COMPLETED|Overall Study||1021
8509954|NCT00443560|20973702|P2|STARTED|Overall Study||1081
8509955|NCT00443560|20973703|P1|STARTED|Overall Study||1081
8509956|NCT00443547|20973717|P4|NOT COMPLETED|Overall Study||2
8509957|NCT00443547|20973718|P3|NOT COMPLETED|Overall Study||21
8509958|NCT00443547|20973719|P2|NOT COMPLETED|Overall Study||42
8509959|NCT00443547|20973720|P1|NOT COMPLETED|Overall Study||45
8509960|NCT00443547|20973717|P4|COMPLETED|Overall Study||4
8509961|NCT00443547|20973718|P3|COMPLETED|Overall Study||27
8509962|NCT00443547|20973719|P2|COMPLETED|Overall Study||46
8509963|NCT00443547|20973720|P1|COMPLETED|Overall Study||44
8509964|NCT00443547|20973717|P4|Evaluated at 12 Months|Overall Study||5
8509965|NCT00443547|20973718|P3|Evaluated at 12 Months|Overall Study||37
8509966|NCT00443547|20973719|P2|Evaluated at 12 Months|Overall Study||55
8509967|NCT00443547|20973720|P1|Evaluated at 12 Months|Overall Study||58
8509968|NCT00443547|20973717|P4|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
8509969|NCT00443547|20973718|P3|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
8509970|NCT00443547|20973719|P2|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
8509971|NCT00443547|20973720|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
8509972|NCT00443534|20973738|P1|NOT COMPLETED|Overall Study||123
8509973|NCT00443534|20973738|P1|COMPLETED|Overall Study||0
8509974|NCT00443534|20973738|P1|Treated|Overall Study||122
8509975|NCT00443534|20973738|P1|STARTED|Overall Study||123
8509976|NCT00443456|20973745|P1|NOT COMPLETED|Overall Study||18
8509977|NCT00443456|20973745|P1|COMPLETED|Overall Study||116
8509978|NCT00443456|20973745|P1|STARTED|Overall Study||134
8509979|NCT00443430|20973780|P2|NOT COMPLETED|Overall Study||4
8509980|NCT00443430|20973781|P1|NOT COMPLETED|Overall Study||4
8509981|NCT00443430|20973780|P2|COMPLETED|Overall Study||38
8509982|NCT00443430|20973781|P1|COMPLETED|Overall Study||39
8509983|NCT00443430|20973780|P2|STARTED|Overall Study||42
8509984|NCT00443430|20973781|P1|STARTED|Overall Study||43
8509985|NCT00443352|20973791|P1|NOT COMPLETED|Overall Study||5
8509986|NCT00443352|20973791|P1|COMPLETED|Overall Study||22
8509987|NCT00443352|20973791|P1|STARTED|Overall Study||27
8509988|NCT00443261|20973795|P1|NOT COMPLETED|Overall Study||1
8509989|NCT00443261|20973795|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
8509990|NCT00443261|20973795|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
8509991|NCT00443261|20973795|P1|STARTED|Overall Study||1
8509992|NCT00443209|20973801|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
8509993|NCT00443209|20973802|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
8509994|NCT00443209|20973801|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
8509995|NCT00443209|20973802|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
8509996|NCT00443209|20973801|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
8509997|NCT00443209|20973802|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
8509998|NCT00443209|20973801|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
8509999|NCT00443209|20973802|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
8510000|NCT00443209|20973801|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
8510001|NCT00443209|20973802|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
8510002|NCT00443209|20973801|P2|Treated|Months 1 to 12 Treatment Period||313
8510003|NCT00443209|20973802|P1|Treated|Months 1 to 12 Treatment Period||641
8510004|NCT00443209|20973801|P2|STARTED|Months 1 to 12 Treatment Period||356
8510005|NCT00443209|20973802|P1|STARTED|Months 1 to 12 Treatment Period||712
8510006|NCT00443118|20973819|P3|NOT COMPLETED|Overall Study||0
8510007|NCT00443118|20973820|P2|NOT COMPLETED|Overall Study||1
8510008|NCT00443118|20973821|P1|NOT COMPLETED|Overall Study||4
8510009|NCT00443118|20973819|P3|COMPLETED|Overall Study||226
8510010|NCT00443118|20973820|P2|COMPLETED|Overall Study||290
8510011|NCT00443118|20973821|P1|COMPLETED|Overall Study||511
8510012|NCT00443118|20973819|P3|STARTED|Overall Study||226
8510013|NCT00443118|20973820|P2|STARTED|Overall Study||291
8510014|NCT00443118|20973821|P1|STARTED|Overall Study||515
8510015|NCT00443053|20973870|P2|NOT COMPLETED|Overall Study||33
8510016|NCT00443053|20973871|P1|NOT COMPLETED|Overall Study||21
8510017|NCT00443053|20973870|P2|COMPLETED|Overall Study||1467
8510018|NCT00443053|20973871|P1|COMPLETED|Overall Study||1481
8510019|NCT00443053|20973870|P2|STARTED|Overall Study||1500
8510020|NCT00443053|20973871|P1|STARTED|Overall Study||1502
8510021|NCT00443040|20973892|P3|NOT COMPLETED|Overall Study||1
8510022|NCT00443040|20973893|P2|NOT COMPLETED|Overall Study||0
8510023|NCT00443040|20973894|P1|NOT COMPLETED|Overall Study||4
8510024|NCT00443040|20973892|P3|COMPLETED|Overall Study||9
8510025|NCT00443040|20973893|P2|COMPLETED|Overall Study||11
8510026|NCT00443040|20973894|P1|COMPLETED|Overall Study||10
8510027|NCT00443040|20973892|P3|STARTED|Overall Study||10
8510028|NCT00443040|20973893|P2|STARTED|Overall Study||11
8510029|NCT00443040|20973894|P1|STARTED|Overall Study||14
8510030|NCT00442962|20973902|P1|NOT COMPLETED|Overall Study||8
8510031|NCT00442962|20973902|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
8510032|NCT00442962|20973902|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
8510033|NCT00442962|20973902|P1|STARTED|Overall Study||54
8510034|NCT00442936|20973920|P4|NOT COMPLETED|Overall Study||1
8510035|NCT00442936|20973921|P3|NOT COMPLETED|Overall Study||1
8510036|NCT00442936|20973922|P2|NOT COMPLETED|Overall Study||0
8510037|NCT00442936|20973923|P1|NOT COMPLETED|Overall Study||1
8510038|NCT00442936|20973920|P4|COMPLETED|Overall Study||347
8510039|NCT00442936|20973921|P3|COMPLETED|Overall Study||344
8510040|NCT00442936|20973922|P2|COMPLETED|Overall Study||354
8510041|NCT00442936|20973923|P1|COMPLETED|Overall Study||332
8510042|NCT00442936|20973920|P4|STARTED|Overall Study||348
8510043|NCT00442936|20973921|P3|STARTED|Overall Study||345
8510044|NCT00442936|20973922|P2|STARTED|Overall Study||354
8510045|NCT00442936|20973923|P1|STARTED|Overall Study||333
8510046|NCT00442897|20973971|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
8510047|NCT00442897|20973972|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
8510048|NCT00442897|20973971|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
8510049|NCT00442897|20973972|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
8510050|NCT00442897|20973971|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
8510051|NCT00442897|20973972|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
8510052|NCT00442897|20973971|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
8510053|NCT00442897|20973972|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
8510054|NCT00442897|20973971|P2|COMPLETED|Base Study (12 Week Follow-up)||99
8510055|NCT00442897|20973972|P1|COMPLETED|Base Study (12 Week Follow-up)||101
8510056|NCT00442897|20973971|P2|STARTED|Base Study (12 Week Follow-up)||111
8510057|NCT00442897|20973972|P1|STARTED|Base Study (12 Week Follow-up)||118
8510058|NCT00442767|20973980|P1|NOT COMPLETED|Overall Study||0
8510059|NCT00442767|20973980|P1|COMPLETED|Overall Study||8
8510060|NCT00442767|20973980|P1|STARTED|Overall Study||8
8510061|NCT00442702|20973990|P2|NOT COMPLETED|Evaluation Period||4
8510062|NCT00442702|20973991|P1|NOT COMPLETED|Evaluation Period||5
8510063|NCT00442702|20973990|P2|COMPLETED|Evaluation Period||107
8510064|NCT00442702|20973991|P1|COMPLETED|Evaluation Period||97
8510065|NCT00442702|20973990|P2|STARTED|Evaluation Period||111
8510066|NCT00442702|20973991|P1|STARTED|Evaluation Period||102
8510067|NCT00442702|20973990|P2|NOT COMPLETED|Titration Period||3
8510068|NCT00442702|20973991|P1|NOT COMPLETED|Titration Period||12
8510069|NCT00442702|20973990|P2|COMPLETED|Titration Period||111
8510070|NCT00442702|20973991|P1|COMPLETED|Titration Period||102
8510071|NCT00442702|20973990|P2|Safety Population|Titration Period||113
8510072|NCT00442702|20973991|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
8510073|NCT00442702|20973990|P2|STARTED|Titration Period||114
8510074|NCT00442702|20973991|P1|STARTED|Titration Period||114
8510075|NCT00442689|20974006|P3|NOT COMPLETED|Overall Study||9
8510076|NCT00442689|20974007|P2|NOT COMPLETED|Overall Study||11
8510077|NCT00442689|20974008|P1|NOT COMPLETED|Overall Study||10
8510078|NCT00442689|20974006|P3|COMPLETED|Overall Study||13
8510079|NCT00442689|20974007|P2|COMPLETED|Overall Study||13
8510080|NCT00442689|20974008|P1|COMPLETED|Overall Study||11
8510081|NCT00442689|20974006|P3|STARTED|Overall Study||22
8510082|NCT00442689|20974007|P2|STARTED|Overall Study||24
8510083|NCT00442689|20974008|P1|STARTED|Overall Study||21
8510084|NCT00442611|20974036|P2|NOT COMPLETED|Overall Study||0
8510085|NCT00442611|20974037|P1|NOT COMPLETED|Overall Study||1
8510086|NCT00442611|20974036|P2|COMPLETED|Overall Study||3
8510087|NCT00442611|20974037|P1|COMPLETED|Overall Study||6
8510088|NCT00442611|20974036|P2|STARTED|Overall Study||3
8510089|NCT00442611|20974037|P1|STARTED|Overall Study||7
8510090|NCT00442598|20974056|P3|NOT COMPLETED|Overall Study||0
8510091|NCT00442598|20974057|P2|NOT COMPLETED|Overall Study||8
8510092|NCT00442598|20974058|P1|NOT COMPLETED|Overall Study||6
8510093|NCT00442598|20974056|P3|COMPLETED|Overall Study||0
8510094|NCT00442598|20974057|P2|COMPLETED|Overall Study||2
8510095|NCT00442598|20974058|P1|COMPLETED|Overall Study||1
8510096|NCT00442598|20974056|P3|Two Cycles|Overall Study||0
8510097|NCT00442598|20974057|P2|Two Cycles|Overall Study||6
8510098|NCT00442598|20974058|P1|Two Cycles|Overall Study||5
8510099|NCT00442598|20974056|P3|STARTED|Overall Study||0
8510100|NCT00442598|20974057|P2|STARTED|Overall Study||10
8510101|NCT00442598|20974058|P1|STARTED|Overall Study||7
8510102|NCT00442572|20974076|P2|NOT COMPLETED|Overall Study||3
8510103|NCT00442572|20974077|P1|NOT COMPLETED|Overall Study||8
8510104|NCT00442572|20974076|P2|COMPLETED|Overall Study||1
8510105|NCT00442572|20974077|P1|COMPLETED|Overall Study||9
8510106|NCT00442572|20974076|P2|STARTED|Overall Study||4
8510107|NCT00442572|20974077|P1|STARTED|Overall Study||17
8510108|NCT00442559|20974117|P2|NOT COMPLETED|Overall Study||35
8510109|NCT00442559|20974118|P1|NOT COMPLETED|Overall Study||34
8510110|NCT00442559|20974117|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
8510111|NCT00442559|20974118|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
8510112|NCT00442559|20974117|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
8510113|NCT00442559|20974118|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
8510114|NCT00442559|20974117|P2|STARTED|Overall Study||91
8510115|NCT00442559|20974118|P1|STARTED|Overall Study||100
8510116|NCT00442546|20974133|P3|NOT COMPLETED|Overall Study||33
8510117|NCT00442546|20974134|P2|NOT COMPLETED|Overall Study||37
8510118|NCT00442546|20974135|P1|NOT COMPLETED|Overall Study||26
8510119|NCT00442546|20974133|P3|COMPLETED|Overall Study||71
8510120|NCT00442546|20974134|P2|COMPLETED|Overall Study||63
8510121|NCT00442546|20974135|P1|COMPLETED|Overall Study||77
8510122|NCT00442546|20974133|P3|Received Treatment|Overall Study||98
8510123|NCT00442546|20974134|P2|Received Treatment|Overall Study||96
8510124|NCT00442546|20974135|P1|Received Treatment|Overall Study||98
8510125|NCT00442546|20974133|P3|STARTED|Overall Study||104
8510126|NCT00442546|20974134|P2|STARTED|Overall Study||100
8510127|NCT00442546|20974135|P1|STARTED|Overall Study||103
8510128|NCT00442507|20974257|P1|NOT COMPLETED|Overall Study||0
8510129|NCT00442507|20974257|P1|COMPLETED|Overall Study||6
8510130|NCT00442507|20974257|P1|STARTED|Overall Study||6
8510131|NCT00442468|20974264|P1|NOT COMPLETED|Overall Study||183
8510132|NCT00442468|20974264|P1|COMPLETED|Overall Study||1100
8510133|NCT00442468|20974264|P1|STARTED|Overall Study||1283
8510134|NCT00442416|20974294|P2|NOT COMPLETED|Overall Study||39
8510135|NCT00442416|20974295|P1|NOT COMPLETED|Overall Study||37
8510136|NCT00442416|20974294|P2|COMPLETED|Overall Study||2
8510137|NCT00442416|20974295|P1|COMPLETED|Overall Study||2
8510138|NCT00442416|20974294|P2|STARTED|Overall Study||41
8510139|NCT00442416|20974295|P1|STARTED|Overall Study||39
8510140|NCT00442364|20974328|P1|NOT COMPLETED|Overall Study||0
8510141|NCT00442364|20974328|P1|COMPLETED|Overall Study||60
8510142|NCT00442364|20974328|P1|STARTED|Overall Study||60
8510143|NCT00442351|20974334|P2|NOT COMPLETED|Overall Study||6
8510144|NCT00442351|20974335|P1|NOT COMPLETED|Overall Study||7
8510145|NCT00442351|20974334|P2|COMPLETED|Overall Study||3
8510146|NCT00442351|20974335|P1|COMPLETED|Overall Study||10
8510147|NCT00442351|20974334|P2|STARTED|Overall Study||9
8510148|NCT00442351|20974335|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
8510149|NCT00442338|20974344|P3|NOT COMPLETED|Overall Study||0
8510150|NCT00442338|20974345|P2|NOT COMPLETED|Overall Study||0
8510151|NCT00442338|20974346|P1|NOT COMPLETED|Overall Study||0
8510152|NCT00442338|20974344|P3|COMPLETED|Overall Study||31
8510153|NCT00442338|20974345|P2|COMPLETED|Overall Study||30
8510154|NCT00442338|20974346|P1|COMPLETED|Overall Study||30
8510155|NCT00442338|20974344|P3|STARTED|Overall Study||31
8510156|NCT00442338|20974345|P2|STARTED|Overall Study||30
8510157|NCT00442338|20974346|P1|STARTED|Overall Study||30
8510158|NCT00442286|20974357|P2|NOT COMPLETED|Overall Study||2
8510159|NCT00442286|20974358|P1|NOT COMPLETED|Overall Study||7
8510160|NCT00442286|20974357|P2|COMPLETED|Overall Study||82
8510161|NCT00442286|20974358|P1|COMPLETED|Overall Study||174
8510162|NCT00442286|20974357|P2|12 Months|Overall Study||82
8510163|NCT00442286|20974358|P1|12 Months|Overall Study||174
8510164|NCT00442286|20974357|P2|6 Months|Overall Study||83
8510165|NCT00442286|20974358|P1|6 Months|Overall Study||177
8510166|NCT00442286|20974357|P2|STARTED|Overall Study||84
8510167|NCT00442286|20974358|P1|STARTED|Overall Study||181
8510168|NCT00442260|20974369|P1|NOT COMPLETED|Overall Study||0
8510169|NCT00442260|20974369|P1|COMPLETED|Overall Study||2
8510170|NCT00442260|20974369|P1|STARTED|Overall Study||2
8510171|NCT00442169|20974379|P6|NOT COMPLETED|Part 2||0
8510172|NCT00442169|20974380|P5|NOT COMPLETED|Part 2||0
8510173|NCT00442169|20974381|P4|NOT COMPLETED|Part 2||0
8510174|NCT00442169|20974382|P3|NOT COMPLETED|Part 2||0
8510175|NCT00442169|20974383|P2|NOT COMPLETED|Part 2||0
8510176|NCT00442169|20974384|P1|NOT COMPLETED|Part 2||0
8510177|NCT00442169|20974379|P6|COMPLETED|Part 2||57
8510178|NCT00442169|20974380|P5|COMPLETED|Part 2||25
8510179|NCT00442169|20974381|P4|COMPLETED|Part 2||0
8510180|NCT00442169|20974382|P3|COMPLETED|Part 2||0
8510181|NCT00442169|20974383|P2|COMPLETED|Part 2||0
8510182|NCT00442169|20974384|P1|COMPLETED|Part 2||0
8510183|NCT00442169|20974379|P6|STARTED|Part 2||57
8510184|NCT00442169|20974380|P5|STARTED|Part 2||25
8510185|NCT00442169|20974381|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510186|NCT00442169|20974382|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510187|NCT00442169|20974383|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510188|NCT00442169|20974384|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510189|NCT00442169|20974379|P6|NOT COMPLETED|Part 1||0
8510190|NCT00442169|20974380|P5|NOT COMPLETED|Part 1||0
8510191|NCT00442169|20974381|P4|NOT COMPLETED|Part 1||0
8510192|NCT00442169|20974382|P3|NOT COMPLETED|Part 1||0
8510193|NCT00442169|20974383|P2|NOT COMPLETED|Part 1||0
8510194|NCT00442169|20974384|P1|NOT COMPLETED|Part 1||0
8510195|NCT00442169|20974379|P6|COMPLETED|Part 1||0
8510196|NCT00442169|20974380|P5|COMPLETED|Part 1||0
8510197|NCT00442169|20974381|P4|COMPLETED|Part 1||31
8510198|NCT00442169|20974382|P3|COMPLETED|Part 1||40
8510199|NCT00442169|20974383|P2|COMPLETED|Part 1||24
8510200|NCT00442169|20974384|P1|COMPLETED|Part 1||17
8510201|NCT00442169|20974379|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
8510202|NCT00442169|20974380|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
8510203|NCT00442169|20974381|P4|STARTED|Part 1||31
8510204|NCT00442169|20974382|P3|STARTED|Part 1||40
8510205|NCT00442169|20974383|P2|STARTED|Part 1||24
8510206|NCT00442169|20974384|P1|STARTED|Part 1||17
8510207|NCT00442117|20974424|P2|NOT COMPLETED|Overall Study||38
8510208|NCT00442117|20974425|P1|NOT COMPLETED|Overall Study||38
8510209|NCT00442117|20974424|P2|COMPLETED|Overall Study||49
8510210|NCT00442117|20974425|P1|COMPLETED|Overall Study||47
8510211|NCT00442117|20974424|P2|STARTED|Overall Study||87
8510212|NCT00442117|20974425|P1|STARTED|Overall Study||85
8510213|NCT00442013|20974439|P2|NOT COMPLETED|Overall Study||17
8510214|NCT00442013|20974440|P1|NOT COMPLETED|Overall Study||26
8510215|NCT00442013|20974439|P2|COMPLETED|Overall Study||132
8510216|NCT00442013|20974440|P1|COMPLETED|Overall Study||131
8510217|NCT00442013|20974439|P2|STARTED|Overall Study||149
8510218|NCT00442013|20974440|P1|STARTED|Overall Study||157
8510219|NCT00441974|20974456|P1|NOT COMPLETED|Overall Study||128
8510220|NCT00441974|20974456|P1|COMPLETED|Overall Study||1342
8510221|NCT00441974|20974456|P1|STARTED|Overall Study||1470
8510222|NCT00441883|20974475|P5|NOT COMPLETED|Overall Study||2
8510223|NCT00441883|20974476|P4|NOT COMPLETED|Overall Study||0
8510224|NCT00441883|20974477|P3|NOT COMPLETED|Overall Study||0
8510225|NCT00441883|20974478|P2|NOT COMPLETED|Overall Study||0
8510226|NCT00441883|20974479|P1|NOT COMPLETED|Overall Study||1
8510227|NCT00441883|20974475|P5|COMPLETED|Overall Study||43
8510228|NCT00441883|20974476|P4|COMPLETED|Overall Study||28
8510229|NCT00441883|20974477|P3|COMPLETED|Overall Study||28
8510230|NCT00441883|20974478|P2|COMPLETED|Overall Study||32
8510231|NCT00441883|20974479|P1|COMPLETED|Overall Study||42
8510232|NCT00441883|20974475|P5|Safety Population|Overall Study||45
8510233|NCT00441883|20974476|P4|Safety Population|Overall Study||28
8510234|NCT00441883|20974477|P3|Safety Population|Overall Study||28
8510235|NCT00441883|20974478|P2|Safety Population|Overall Study||32
8510236|NCT00441883|20974479|P1|Safety Population|Overall Study||43
8510237|NCT00441883|20974475|P5|Per Protocol Population|Overall Study||38
8510238|NCT00441883|20974476|P4|Per Protocol Population|Overall Study||24
8510239|NCT00441883|20974477|P3|Per Protocol Population|Overall Study||25
8510240|NCT00441883|20974478|P2|Per Protocol Population|Overall Study||29
8510241|NCT00441883|20974479|P1|Per Protocol Population|Overall Study||38
8510242|NCT00441883|20974475|P5|ITT Population|Overall Study||43
8510243|NCT00441883|20974476|P4|ITT Population|Overall Study||30
8510244|NCT00441883|20974477|P3|ITT Population|Overall Study||30
8510245|NCT00441883|20974478|P2|ITT Population|Overall Study||30
8510246|NCT00441883|20974479|P1|ITT Population|Overall Study||43
8510247|NCT00441883|20974475|P5|STARTED|Overall Study||45
8510248|NCT00441883|20974476|P4|STARTED|Overall Study||28
8510249|NCT00441883|20974477|P3|STARTED|Overall Study||28
8510250|NCT00441883|20974478|P2|STARTED|Overall Study||32
8510251|NCT00441883|20974479|P1|STARTED|Overall Study||43
8510252|NCT00441792|20974503|P2|NOT COMPLETED|Overall Study||2
8510253|NCT00441792|20974504|P1|NOT COMPLETED|Overall Study||0
8510254|NCT00441792|20974503|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
8510255|NCT00441792|20974504|P1|COMPLETED|Overall Study||59
8510256|NCT00441792|20974503|P2|STARTED|Overall Study||63
8510257|NCT00441792|20974504|P1|STARTED|Overall Study||59
8510258|NCT00441766|20974516|P4|NOT COMPLETED|Overall Study||6
8510259|NCT00441766|20974517|P3|NOT COMPLETED|Overall Study||9
8510260|NCT00441766|20974518|P2|NOT COMPLETED|Overall Study||7
8510261|NCT00441766|20974519|P1|NOT COMPLETED|Overall Study||14
8510262|NCT00441766|20974516|P4|COMPLETED|Overall Study||48
8510263|NCT00441766|20974517|P3|COMPLETED|Overall Study||44
8510264|NCT00441766|20974518|P2|COMPLETED|Overall Study||46
8510265|NCT00441766|20974519|P1|COMPLETED|Overall Study||39
8510266|NCT00441766|20974516|P4|STARTED|Overall Study||54
8510267|NCT00441766|20974517|P3|STARTED|Overall Study||53
8510268|NCT00441766|20974518|P2|STARTED|Overall Study||53
8510269|NCT00441766|20974519|P1|STARTED|Overall Study||53
8510270|NCT00441727|20974544|P3|NOT COMPLETED|Overall Study||168
8510271|NCT00441727|20974545|P2|NOT COMPLETED|Overall Study||118
8510272|NCT00441727|20974546|P1|NOT COMPLETED|Overall Study||106
8510273|NCT00441727|20974544|P3|COMPLETED|Overall Study|ITT/randomised|637
8510274|NCT00441727|20974545|P2|COMPLETED|Overall Study|ITT/randomised|686
8510275|NCT00441727|20974546|P1|COMPLETED|Overall Study|ITT/randomised|711
8510276|NCT00441727|20974544|P3|STARTED|Overall Study|ITT/randomised|805
8510277|NCT00441727|20974545|P2|STARTED|Overall Study|ITT/randomised|804
8510278|NCT00441727|20974546|P1|STARTED|Overall Study|ITT/randomised|817
8510279|NCT00441701|20974579|P10|NOT COMPLETED|Overall Study||0
8510280|NCT00441701|20974580|P9|NOT COMPLETED|Overall Study||0
8510281|NCT00441701|20974581|P8|NOT COMPLETED|Overall Study||0
8510282|NCT00441701|20974582|P7|NOT COMPLETED|Overall Study||0
8510283|NCT00441701|20974583|P6|NOT COMPLETED|Overall Study||3
8510284|NCT00441701|20974584|P5|NOT COMPLETED|Overall Study||2
8510285|NCT00441701|20974585|P4|NOT COMPLETED|Overall Study||3
8510286|NCT00441701|20974586|P3|NOT COMPLETED|Overall Study||4
8510287|NCT00441701|20974587|P2|NOT COMPLETED|Overall Study||4
8510288|NCT00441701|20974588|P1|NOT COMPLETED|Overall Study||5
8510289|NCT00441701|20974579|P10|COMPLETED|Overall Study||0
8510290|NCT00441701|20974580|P9|COMPLETED|Overall Study||0
8510291|NCT00441701|20974581|P8|COMPLETED|Overall Study||0
8510292|NCT00441701|20974582|P7|COMPLETED|Overall Study||0
8510293|NCT00441701|20974583|P6|COMPLETED|Overall Study||8
8510294|NCT00441701|20974584|P5|COMPLETED|Overall Study||20
8510295|NCT00441701|20974585|P4|COMPLETED|Overall Study||8
8510296|NCT00441701|20974586|P3|COMPLETED|Overall Study||18
8510297|NCT00441701|20974587|P2|COMPLETED|Overall Study||7
8510298|NCT00441701|20974588|P1|COMPLETED|Overall Study||17
8510299|NCT00441701|20974579|P10|STARTED|Overall Study||0
8510300|NCT00441701|20974580|P9|STARTED|Overall Study||0
8510301|NCT00441701|20974581|P8|STARTED|Overall Study||0
8510302|NCT00441701|20974582|P7|STARTED|Overall Study||0
8510303|NCT00441701|20974583|P6|STARTED|Overall Study||11
8510304|NCT00441701|20974584|P5|STARTED|Overall Study||22
8510305|NCT00441701|20974585|P4|STARTED|Overall Study||11
8510306|NCT00441701|20974586|P3|STARTED|Overall Study||22
8510307|NCT00441701|20974587|P2|STARTED|Overall Study||11
8510308|NCT00441701|20974588|P1|STARTED|Overall Study||22
8510309|NCT00441584|20974670|P1|NOT COMPLETED|Overall Study||105
8510310|NCT00441584|20974670|P1|COMPLETED|Overall Study||12
8510311|NCT00441584|20974670|P1|STARTED|Overall Study||117
8510312|NCT00441558|20974674|P1|NOT COMPLETED|Overall Study||1056
8510313|NCT00441558|20974674|P1|COMPLETED|Overall Study||667
8510314|NCT00441558|20974674|P1|STARTED|Overall Study||1723
8510315|NCT00441545|20974678|P2|NOT COMPLETED|Second Intervention||7
8510316|NCT00441545|20974679|P1|NOT COMPLETED|Second Intervention||12
8510317|NCT00441545|20974678|P2|COMPLETED|Second Intervention||68
8510318|NCT00441545|20974679|P1|COMPLETED|Second Intervention||65
8510319|NCT00441545|20974678|P2|STARTED|Second Intervention||75
8510320|NCT00441545|20974679|P1|STARTED|Second Intervention||77
8510321|NCT00441545|20974678|P2|NOT COMPLETED|Washout||0
8510322|NCT00441545|20974679|P1|NOT COMPLETED|Washout||0
8510323|NCT00441545|20974678|P2|COMPLETED|Washout||75
8510324|NCT00441545|20974679|P1|COMPLETED|Washout||77
8510325|NCT00441545|20974678|P2|STARTED|Washout||75
8510326|NCT00441545|20974679|P1|STARTED|Washout||77
8510327|NCT00441545|20974678|P2|NOT COMPLETED|First Intervention||12
8510328|NCT00441545|20974679|P1|NOT COMPLETED|First Intervention||18
8510329|NCT00441545|20974678|P2|COMPLETED|First Intervention||75
8510330|NCT00441545|20974679|P1|COMPLETED|First Intervention||77
8510331|NCT00441545|20974678|P2|STARTED|First Intervention||87
8510332|NCT00441545|20974679|P1|STARTED|First Intervention||95
8510333|NCT00441480|20974693|P2|NOT COMPLETED|Overall Study||4
8510334|NCT00441480|20974694|P1|NOT COMPLETED|Overall Study||3
8510335|NCT00441480|20974693|P2|COMPLETED|Overall Study||41
8510336|NCT00441480|20974694|P1|COMPLETED|Overall Study||43
8510337|NCT00441480|20974693|P2|STARTED|Overall Study||45
8510338|NCT00441480|20974694|P1|STARTED|Overall Study||46
8510339|NCT00441467|20974726|P1|NOT COMPLETED|Overall Study||18
8510340|NCT00441467|20974726|P1|COMPLETED|Overall Study||4
8510341|NCT00441467|20974726|P1|4 Cycles|Overall Study||7
8510342|NCT00441467|20974726|P1|2 Cycles|Overall Study||17
8510343|NCT00441467|20974726|P1|STARTED|Overall Study||22
8510344|NCT00441441|20974734|P2|NOT COMPLETED|Overall Study||14
8510345|NCT00441441|20974735|P1|NOT COMPLETED|Overall Study||11
8510346|NCT00441441|20974734|P2|COMPLETED|Overall Study||163
8510347|NCT00441441|20974735|P1|COMPLETED|Overall Study||162
8510348|NCT00441441|20974734|P2|STARTED|Overall Study||177
8510349|NCT00441441|20974735|P1|STARTED|Overall Study||173
8510350|NCT00441363|20974795|P2|NOT COMPLETED|Overall Study||15
8510351|NCT00441363|20974796|P1|NOT COMPLETED|Overall Study||17
8510352|NCT00441363|20974795|P2|COMPLETED|Overall Study||19
8510353|NCT00441363|20974796|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
8510354|NCT00441363|20974795|P2|STARTED|Overall Study||34
8510355|NCT00441363|20974796|P1|STARTED|Overall Study||32
8510356|NCT00441337|20974808|P4|NOT COMPLETED|Overall Study||21
8510357|NCT00441337|20974809|P3|NOT COMPLETED|Overall Study||6
8510358|NCT00441337|20974810|P2|NOT COMPLETED|Overall Study||6
8510359|NCT00441337|20974811|P1|NOT COMPLETED|Overall Study||6
8510360|NCT00441337|20974808|P4|COMPLETED|Overall Study||0
8510361|NCT00441337|20974809|P3|COMPLETED|Overall Study||0
8510362|NCT00441337|20974810|P2|COMPLETED|Overall Study||0
8510363|NCT00441337|20974811|P1|COMPLETED|Overall Study||0
8510364|NCT00441337|20974808|P4|STARTED|Overall Study||21
8510365|NCT00441337|20974809|P3|STARTED|Overall Study||6
8510366|NCT00441337|20974810|P2|STARTED|Overall Study||6
8510367|NCT00441337|20974811|P1|STARTED|Overall Study||6
8510368|NCT00441285|20974894|P5|NOT COMPLETED|Overall Study||0
8510369|NCT00441285|20974895|P4|NOT COMPLETED|Overall Study||0
8510370|NCT00441285|20974896|P3|NOT COMPLETED|Overall Study||0
8510371|NCT00441285|20974897|P2|NOT COMPLETED|Overall Study||0
8510372|NCT00441285|20974898|P1|NOT COMPLETED|Overall Study||0
8510373|NCT00441285|20974894|P5|COMPLETED|Overall Study||43
8510374|NCT00441285|20974895|P4|COMPLETED|Overall Study||40
8510375|NCT00441285|20974896|P3|COMPLETED|Overall Study||41
8510376|NCT00441285|20974897|P2|COMPLETED|Overall Study||16
8510377|NCT00441285|20974898|P1|COMPLETED|Overall Study||16
8510378|NCT00441285|20974894|P5|STARTED|Overall Study||43
8510379|NCT00441285|20974895|P4|STARTED|Overall Study||40
8510380|NCT00441285|20974896|P3|STARTED|Overall Study||41
8510381|NCT00441285|20974897|P2|STARTED|Overall Study||16
8510382|NCT00441285|20974898|P1|STARTED|Overall Study||16
8510383|NCT00441272|20974924|P2|NOT COMPLETED|Overall Study||25
8510384|NCT00441272|20974925|P1|NOT COMPLETED|Overall Study||25
8510385|NCT00441272|20974924|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
8510386|NCT00441272|20974925|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
8510387|NCT00441272|20974924|P2|STARTED|Overall Study||25
8510388|NCT00441272|20974925|P1|STARTED|Overall Study||25
8510389|NCT00441259|20974933|P2|NOT COMPLETED|Overall Study||0
8510390|NCT00441259|20974934|P1|NOT COMPLETED|Overall Study||0
8510391|NCT00441259|20974933|P2|COMPLETED|Overall Study||48
8510392|NCT00441259|20974934|P1|COMPLETED|Overall Study||48
8510393|NCT00441259|20974933|P2|STARTED|Overall Study||48
8510394|NCT00441259|20974934|P1|STARTED|Overall Study||48
8510395|NCT00441168|20974952|P2|NOT COMPLETED|Follow-up Period||9
8510396|NCT00441168|20974953|P1|NOT COMPLETED|Follow-up Period||12
8510397|NCT00441168|20974952|P2|COMPLETED|Follow-up Period||4
8510398|NCT00441168|20974953|P1|COMPLETED|Follow-up Period||5
8510485|NCT00440947|20975171|P1|COMPLETED|Optional 60-Week Extension Phase||0
8510399|NCT00441168|20974952|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
8510400|NCT00441168|20974953|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
8510401|NCT00441168|20974952|P2|NOT COMPLETED|Treatment Period||6
8510402|NCT00441168|20974953|P1|NOT COMPLETED|Treatment Period||11
8510403|NCT00441168|20974952|P2|COMPLETED|Treatment Period||7
8510404|NCT00441168|20974953|P1|COMPLETED|Treatment Period||6
8510405|NCT00441168|20974952|P2|TREATED|Treatment Period||13
8510406|NCT00441168|20974953|P1|TREATED|Treatment Period||16
8510407|NCT00441168|20974952|P2|STARTED|Treatment Period||13
8510408|NCT00441168|20974953|P1|STARTED|Treatment Period||17
8510409|NCT00441142|20974967|P4|NOT COMPLETED|Overall Study||68
8510410|NCT00441142|20974968|P3|NOT COMPLETED|Overall Study||22
8510411|NCT00441142|20974969|P2|NOT COMPLETED|Overall Study||7
8510412|NCT00441142|20974970|P1|NOT COMPLETED|Overall Study||6
8510413|NCT00441142|20974967|P4|COMPLETED|Overall Study||1
8510414|NCT00441142|20974968|P3|COMPLETED|Overall Study||7
8510415|NCT00441142|20974969|P2|COMPLETED|Overall Study||0
8510416|NCT00441142|20974970|P1|COMPLETED|Overall Study||0
8510417|NCT00441142|20974967|P4|STARTED|Overall Study||69
8510418|NCT00441142|20974968|P3|STARTED|Overall Study||29
8510419|NCT00441142|20974969|P2|STARTED|Overall Study||7
8510420|NCT00441142|20974970|P1|STARTED|Overall Study||6
8510421|NCT00441129|20974992|P2|NOT COMPLETED|Overall Study||14
8510422|NCT00441129|20974993|P1|NOT COMPLETED|Overall Study||6
8510423|NCT00441129|20974992|P2|COMPLETED|Overall Study||41
8510424|NCT00441129|20974993|P1|COMPLETED|Overall Study||54
8510425|NCT00441129|20974992|P2|STARTED|Overall Study||55
8510426|NCT00441129|20974993|P1|STARTED|Overall Study||60
8510427|NCT00441116|20975005|P2|NOT COMPLETED|Overall Study||2
8510428|NCT00441116|20975006|P1|NOT COMPLETED|Overall Study||3
8510429|NCT00441116|20975005|P2|COMPLETED|Overall Study||75
8510430|NCT00441116|20975006|P1|COMPLETED|Overall Study||73
8510431|NCT00441116|20975005|P2|STARTED|Overall Study||77
8510432|NCT00441116|20975006|P1|STARTED|Overall Study||76
8510433|NCT00441103|20975074|P2|NOT COMPLETED|Overall Study||4
8510434|NCT00441103|20975075|P1|NOT COMPLETED|Overall Study||11
8510435|NCT00441103|20975074|P2|COMPLETED|Overall Study||56
8510436|NCT00441103|20975075|P1|COMPLETED|Overall Study||109
8510437|NCT00441103|20975074|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
8510438|NCT00441103|20975075|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
8510439|NCT00441090|20975091|P5|NOT COMPLETED|Overall Study||0
8510440|NCT00441090|20975092|P4|NOT COMPLETED|Overall Study||2
8510441|NCT00441090|20975093|P3|NOT COMPLETED|Overall Study||2
8510442|NCT00441090|20975094|P2|NOT COMPLETED|Overall Study||1
8510443|NCT00441090|20975095|P1|NOT COMPLETED|Overall Study||2
8510444|NCT00441090|20975091|P5|COMPLETED|Overall Study||5
8510445|NCT00441090|20975092|P4|COMPLETED|Overall Study||13
8510446|NCT00441090|20975093|P3|COMPLETED|Overall Study||12
8510447|NCT00441090|20975094|P2|COMPLETED|Overall Study||14
8510448|NCT00441090|20975095|P1|COMPLETED|Overall Study||13
8510449|NCT00441090|20975091|P5|STARTED|Overall Study||5
8510450|NCT00441090|20975092|P4|STARTED|Overall Study||15
8510451|NCT00441090|20975093|P3|STARTED|Overall Study||14
8510452|NCT00441090|20975094|P2|STARTED|Overall Study||15
8510453|NCT00441090|20975095|P1|STARTED|Overall Study||15
8510454|NCT00441064|20975139|P2|NOT COMPLETED|Overall Study||7
8510455|NCT00441064|20975140|P1|NOT COMPLETED|Overall Study||10
8510456|NCT00441064|20975139|P2|COMPLETED|Overall Study||56
8510457|NCT00441064|20975140|P1|COMPLETED|Overall Study||59
8510458|NCT00441064|20975139|P2|Intent-to-treat (ITT) Population|Overall Study||57
8510459|NCT00441064|20975140|P1|Intent-to-treat (ITT) Population|Overall Study||61
8510460|NCT00441064|20975139|P2|Safety Population (SP)|Overall Study||63
8510461|NCT00441064|20975140|P1|Safety Population (SP)|Overall Study||69
8510462|NCT00441064|20975139|P2|STARTED|Overall Study||63
8510463|NCT00441064|20975140|P1|STARTED|Overall Study||69
8510464|NCT00441012|20975152|P2|NOT COMPLETED|Overall Study||13
8510465|NCT00441012|20975153|P1|NOT COMPLETED|Overall Study||18
8510466|NCT00441012|20975152|P2|COMPLETED|Overall Study||263
8510467|NCT00441012|20975153|P1|COMPLETED|Overall Study||252
8510468|NCT00441012|20975152|P2|Vaccination Visit 3|Overall Study||269
8510469|NCT00441012|20975153|P1|Vaccination Visit 3|Overall Study||265
8510470|NCT00441012|20975152|P2|Vaccination Visit 2|Overall Study||272
8510471|NCT00441012|20975153|P1|Vaccination Visit 2|Overall Study||267
8510472|NCT00441012|20975152|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
8510473|NCT00441012|20975153|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
8510474|NCT00441012|20975152|P2|STARTED|Overall Study||276
8510475|NCT00441012|20975153|P1|STARTED|Overall Study||270
8510476|NCT00440947|20975167|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
8510477|NCT00440947|20975168|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
8510478|NCT00440947|20975169|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
8510479|NCT00440947|20975170|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
8510480|NCT00440947|20975171|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
8510481|NCT00440947|20975167|P5|COMPLETED|Optional 60-Week Extension Phase||154
8510482|NCT00440947|20975168|P4|COMPLETED|Optional 60-Week Extension Phase||160
8510483|NCT00440947|20975169|P3|COMPLETED|Optional 60-Week Extension Phase||0
8510484|NCT00440947|20975170|P2|COMPLETED|Optional 60-Week Extension Phase||0
8510486|NCT00440947|20975167|P5|STARTED|Optional 60-Week Extension Phase||180
8510487|NCT00440947|20975168|P4|STARTED|Optional 60-Week Extension Phase||189
8510488|NCT00440947|20975169|P3|STARTED|Optional 60-Week Extension Phase||0
8510489|NCT00440947|20975170|P2|STARTED|Optional 60-Week Extension Phase||0
8510490|NCT00440947|20975171|P1|STARTED|Optional 60-Week Extension Phase||0
8510491|NCT00440947|20975167|P5|NOT COMPLETED|48-Week Randomization Phase||0
8510492|NCT00440947|20975168|P4|NOT COMPLETED|48-Week Randomization Phase||0
8510493|NCT00440947|20975169|P3|NOT COMPLETED|48-Week Randomization Phase||24
8510494|NCT00440947|20975170|P2|NOT COMPLETED|48-Week Randomization Phase||16
8510495|NCT00440947|20975171|P1|NOT COMPLETED|48-Week Randomization Phase||0
8510496|NCT00440947|20975167|P5|COMPLETED|48-Week Randomization Phase||0
8510497|NCT00440947|20975168|P4|COMPLETED|48-Week Randomization Phase||0
8510498|NCT00440947|20975169|P3|COMPLETED|48-Week Randomization Phase||185
8510499|NCT00440947|20975170|P2|COMPLETED|48-Week Randomization Phase||194
8510500|NCT00440947|20975171|P1|COMPLETED|48-Week Randomization Phase||0
8510501|NCT00440947|20975167|P5|STARTED|48-Week Randomization Phase||0
8510502|NCT00440947|20975168|P4|STARTED|48-Week Randomization Phase||0
8510503|NCT00440947|20975169|P3|STARTED|48-Week Randomization Phase||209
8510504|NCT00440947|20975170|P2|STARTED|48-Week Randomization Phase||210
8510505|NCT00440947|20975171|P1|STARTED|48-Week Randomization Phase||0
8510506|NCT00440947|20975167|P5|NOT COMPLETED|36-Week Induction Phase||0
8510507|NCT00440947|20975168|P4|NOT COMPLETED|36-Week Induction Phase||0
8510508|NCT00440947|20975169|P3|NOT COMPLETED|36-Week Induction Phase||0
8510509|NCT00440947|20975170|P2|NOT COMPLETED|36-Week Induction Phase||0
8510510|NCT00440947|20975171|P1|NOT COMPLETED|36-Week Induction Phase||73
8510511|NCT00440947|20975167|P5|COMPLETED|36-Week Induction Phase||0
8510512|NCT00440947|20975168|P4|COMPLETED|36-Week Induction Phase||0
8510513|NCT00440947|20975169|P3|COMPLETED|36-Week Induction Phase||0
8510514|NCT00440947|20975170|P2|COMPLETED|36-Week Induction Phase||0
8510515|NCT00440947|20975171|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
8510516|NCT00440947|20975167|P5|STARTED|36-Week Induction Phase||0
8510517|NCT00440947|20975168|P4|STARTED|36-Week Induction Phase||0
8510518|NCT00440947|20975169|P3|STARTED|36-Week Induction Phase||0
8510519|NCT00440947|20975170|P2|STARTED|36-Week Induction Phase||0
8510520|NCT00440947|20975171|P1|STARTED|36-Week Induction Phase||515
8510521|NCT00440830|20975226|P4|NOT COMPLETED|Overall Study||0
8510522|NCT00440830|20975227|P3|NOT COMPLETED|Overall Study||0
8510523|NCT00440830|20975228|P2|NOT COMPLETED|Overall Study||0
8510524|NCT00440830|20975229|P1|NOT COMPLETED|Overall Study||0
8510525|NCT00440830|20975226|P4|COMPLETED|Overall Study||10
8510526|NCT00440830|20975227|P3|COMPLETED|Overall Study||30
8510527|NCT00440830|20975228|P2|COMPLETED|Overall Study||8
8510528|NCT00440830|20975229|P1|COMPLETED|Overall Study||20
8510529|NCT00440830|20975226|P4|STARTED|Overall Study||10
8510530|NCT00440830|20975227|P3|STARTED|Overall Study||30
8510531|NCT00440830|20975228|P2|STARTED|Overall Study||8
8510532|NCT00440830|20975229|P1|STARTED|Overall Study||20
8510533|NCT00440726|20975246|P3|NOT COMPLETED|Phase 2||2
8510534|NCT00440726|20975247|P2|NOT COMPLETED|Phase 2||0
8510535|NCT00440726|20975248|P1|NOT COMPLETED|Phase 2||0
8510536|NCT00440726|20975246|P3|COMPLETED|Phase 2||20
8510537|NCT00440726|20975247|P2|COMPLETED|Phase 2||0
8510538|NCT00440726|20975248|P1|COMPLETED|Phase 2||0
8510539|NCT00440726|20975246|P3|STARTED|Phase 2||22
8510540|NCT00440726|20975247|P2|STARTED|Phase 2||0
8510541|NCT00440726|20975248|P1|STARTED|Phase 2||0
8510542|NCT00440726|20975246|P3|NOT COMPLETED|Phase 1||0
8510543|NCT00440726|20975247|P2|NOT COMPLETED|Phase 1||1
8510544|NCT00440726|20975248|P1|NOT COMPLETED|Phase 1||1
8510545|NCT00440726|20975246|P3|COMPLETED|Phase 1||0
8510546|NCT00440726|20975247|P2|COMPLETED|Phase 1||5
8510547|NCT00440726|20975248|P1|COMPLETED|Phase 1||3
8510548|NCT00440726|20975246|P3|STARTED|Phase 1||0
8510549|NCT00440726|20975247|P2|STARTED|Phase 1||6
8510550|NCT00440726|20975248|P1|STARTED|Phase 1||4
8510551|NCT00440700|20975262|P3|NOT COMPLETED|Overall Study||4
8510552|NCT00440700|20975263|P2|NOT COMPLETED|Overall Study||8
8510553|NCT00440700|20975264|P1|NOT COMPLETED|Overall Study||8
8510554|NCT00440700|20975262|P3|COMPLETED|Overall Study||120
8510555|NCT00440700|20975263|P2|COMPLETED|Overall Study||110
8510556|NCT00440700|20975264|P1|COMPLETED|Overall Study||114
8510557|NCT00440700|20975262|P3|STARTED|Overall Study||124
8510558|NCT00440700|20975263|P2|STARTED|Overall Study||118
8510559|NCT00440700|20975264|P1|STARTED|Overall Study||122
8510560|NCT00440596|20975286|P2|NOT COMPLETED|Overall Study||11
8510561|NCT00440596|20975287|P1|NOT COMPLETED|Overall Study||7
8510562|NCT00440596|20975286|P2|COMPLETED|Overall Study||17
8510563|NCT00440596|20975287|P1|COMPLETED|Overall Study||21
8510564|NCT00440596|20975286|P2|STARTED|Overall Study||28
8510565|NCT00440596|20975287|P1|STARTED|Overall Study||28
8510566|NCT00440557|20975298|P3|NOT COMPLETED|Overall Study||35
8510567|NCT00440557|20975299|P2|NOT COMPLETED|Overall Study||29
8510568|NCT00440557|20975300|P1|NOT COMPLETED|Overall Study||25
8510569|NCT00440557|20975298|P3|COMPLETED|Overall Study||90
8510570|NCT00440557|20975299|P2|COMPLETED|Overall Study||96
8510571|NCT00440557|20975300|P1|COMPLETED|Overall Study||98
8510572|NCT00440557|20975298|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
8510573|NCT00440557|20975299|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
8510662|NCT00440505|20975376|P3|STARTED|First Intervention||1
8510574|NCT00440557|20975300|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
8510575|NCT00440531|20975332|P3|NOT COMPLETED|Overall Study||7
8510576|NCT00440531|20975333|P2|NOT COMPLETED|Overall Study||5
8510577|NCT00440531|20975334|P1|NOT COMPLETED|Overall Study||10
8510578|NCT00440531|20975332|P3|COMPLETED|Overall Study||165
8510579|NCT00440531|20975333|P2|COMPLETED|Overall Study||178
8510580|NCT00440531|20975334|P1|COMPLETED|Overall Study||175
8510581|NCT00440531|20975332|P3|Vaccination 3|Overall Study||166
8510582|NCT00440531|20975333|P2|Vaccination 3|Overall Study||178
8510583|NCT00440531|20975334|P1|Vaccination 3|Overall Study||176
8510584|NCT00440531|20975332|P3|Vaccination 2|Overall Study||171
8510585|NCT00440531|20975333|P2|Vaccination 2|Overall Study||182
8510586|NCT00440531|20975334|P1|Vaccination 2|Overall Study||181
8510587|NCT00440531|20975332|P3|Vaccination 1|Overall Study||172
8510588|NCT00440531|20975333|P2|Vaccination 1|Overall Study||183
8510589|NCT00440531|20975334|P1|Vaccination 1|Overall Study||183
8510590|NCT00440531|20975332|P3|STARTED|Overall Study||172
8510591|NCT00440531|20975333|P2|STARTED|Overall Study||183
8510592|NCT00440531|20975334|P1|STARTED|Overall Study||185
8510593|NCT00440518|20975351|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
8510594|NCT00440518|20975352|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
8510595|NCT00440518|20975353|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
8510596|NCT00440518|20975351|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
8510597|NCT00440518|20975352|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
8510598|NCT00440518|20975353|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
8510599|NCT00440518|20975351|P3|STARTED|Maintenance and Safety Follow-up Periods||70
8510600|NCT00440518|20975352|P2|STARTED|Maintenance and Safety Follow-up Periods||63
8510601|NCT00440518|20975353|P1|STARTED|Maintenance and Safety Follow-up Periods||59
8510602|NCT00440518|20975351|P3|NOT COMPLETED|Randomized /Titration Period||4
8510603|NCT00440518|20975352|P2|NOT COMPLETED|Randomized /Titration Period||9
8510604|NCT00440518|20975353|P1|NOT COMPLETED|Randomized /Titration Period||13
8510605|NCT00440518|20975351|P3|COMPLETED|Randomized /Titration Period||70
8510606|NCT00440518|20975352|P2|COMPLETED|Randomized /Titration Period||63
8510607|NCT00440518|20975353|P1|COMPLETED|Randomized /Titration Period||59
8510608|NCT00440518|20975351|P3|STARTED|Randomized /Titration Period||74
8510609|NCT00440518|20975352|P2|STARTED|Randomized /Titration Period||72
8510610|NCT00440518|20975353|P1|STARTED|Randomized /Titration Period||72
8510611|NCT00440505|20975373|P6|NOT COMPLETED|Third Intervention||0
8510612|NCT00440505|20975374|P5|NOT COMPLETED|Third Intervention||0
8510613|NCT00440505|20975375|P4|NOT COMPLETED|Third Intervention||1
8510614|NCT00440505|20975376|P3|NOT COMPLETED|Third Intervention||0
8510615|NCT00440505|20975377|P2|NOT COMPLETED|Third Intervention||0
8510616|NCT00440505|20975378|P1|NOT COMPLETED|Third Intervention||0
8510617|NCT00440505|20975373|P6|COMPLETED|Third Intervention||5
8510618|NCT00440505|20975374|P5|COMPLETED|Third Intervention||5
8510619|NCT00440505|20975375|P4|COMPLETED|Third Intervention||1
8510620|NCT00440505|20975376|P3|COMPLETED|Third Intervention||1
8510621|NCT00440505|20975377|P2|COMPLETED|Third Intervention||2
8510622|NCT00440505|20975378|P1|COMPLETED|Third Intervention||5
8510623|NCT00440505|20975373|P6|STARTED|Third Intervention||5
8510624|NCT00440505|20975374|P5|STARTED|Third Intervention||5
8510625|NCT00440505|20975375|P4|STARTED|Third Intervention||2
8510626|NCT00440505|20975376|P3|STARTED|Third Intervention||1
8510627|NCT00440505|20975377|P2|STARTED|Third Intervention||2
8510628|NCT00440505|20975378|P1|STARTED|Third Intervention||5
8510629|NCT00440505|20975373|P6|NOT COMPLETED|Second Intervention||0
8510630|NCT00440505|20975374|P5|NOT COMPLETED|Second Intervention||0
8510631|NCT00440505|20975375|P4|NOT COMPLETED|Second Intervention||0
8510632|NCT00440505|20975376|P3|NOT COMPLETED|Second Intervention||0
8510633|NCT00440505|20975377|P2|NOT COMPLETED|Second Intervention||0
8510634|NCT00440505|20975378|P1|NOT COMPLETED|Second Intervention||0
8510635|NCT00440505|20975373|P6|COMPLETED|Second Intervention||5
8510636|NCT00440505|20975374|P5|COMPLETED|Second Intervention||5
8510637|NCT00440505|20975375|P4|COMPLETED|Second Intervention||2
8510638|NCT00440505|20975376|P3|COMPLETED|Second Intervention||1
8510639|NCT00440505|20975377|P2|COMPLETED|Second Intervention||2
8510640|NCT00440505|20975378|P1|COMPLETED|Second Intervention||5
8510641|NCT00440505|20975373|P6|STARTED|Second Intervention||5
8510642|NCT00440505|20975374|P5|STARTED|Second Intervention||5
8510643|NCT00440505|20975375|P4|STARTED|Second Intervention||2
8510644|NCT00440505|20975376|P3|STARTED|Second Intervention||1
8510645|NCT00440505|20975377|P2|STARTED|Second Intervention||2
8510646|NCT00440505|20975378|P1|STARTED|Second Intervention||5
8510647|NCT00440505|20975373|P6|NOT COMPLETED|First Intervention||0
8510648|NCT00440505|20975374|P5|NOT COMPLETED|First Intervention||0
8510649|NCT00440505|20975375|P4|NOT COMPLETED|First Intervention||0
8510650|NCT00440505|20975376|P3|NOT COMPLETED|First Intervention||0
8510651|NCT00440505|20975377|P2|NOT COMPLETED|First Intervention||0
8510652|NCT00440505|20975378|P1|NOT COMPLETED|First Intervention||0
8510653|NCT00440505|20975373|P6|COMPLETED|First Intervention||5
8510654|NCT00440505|20975374|P5|COMPLETED|First Intervention||5
8510655|NCT00440505|20975375|P4|COMPLETED|First Intervention||2
8510656|NCT00440505|20975376|P3|COMPLETED|First Intervention||1
8510657|NCT00440505|20975377|P2|COMPLETED|First Intervention||2
8510658|NCT00440505|20975378|P1|COMPLETED|First Intervention||5
8510659|NCT00440505|20975373|P6|STARTED|First Intervention||5
8510660|NCT00440505|20975374|P5|STARTED|First Intervention||5
8510661|NCT00440505|20975375|P4|STARTED|First Intervention||2
8510663|NCT00440505|20975377|P2|STARTED|First Intervention||2
8510664|NCT00440505|20975378|P1|STARTED|First Intervention||5
8510665|NCT00440466|20975398|P3|NOT COMPLETED|Overall Study||41
8510666|NCT00440466|20975399|P2|NOT COMPLETED|Overall Study||15
8510667|NCT00440466|20975400|P1|NOT COMPLETED|Overall Study||13
8510668|NCT00440466|20975398|P3|COMPLETED|Overall Study||174
8510669|NCT00440466|20975399|P2|COMPLETED|Overall Study||92
8510670|NCT00440466|20975400|P1|COMPLETED|Overall Study||95
8510671|NCT00440466|20975398|P3|STARTED|Overall Study||215
8510672|NCT00440466|20975399|P2|STARTED|Overall Study||107
8510673|NCT00440466|20975400|P1|STARTED|Overall Study||108
8510674|NCT00440401|20975434|P2|NOT COMPLETED|Overall Study||6
8510675|NCT00440401|20975435|P1|NOT COMPLETED|Overall Study||4
8510676|NCT00440401|20975434|P2|COMPLETED|Overall Study||54
8510677|NCT00440401|20975435|P1|COMPLETED|Overall Study||55
8510678|NCT00440401|20975434|P2|STARTED|Overall Study||60
8510679|NCT00440401|20975435|P1|STARTED|Overall Study||59
8510680|NCT00440310|20975445|P2|NOT COMPLETED|Overall Study||30
8510681|NCT00440310|20975446|P1|NOT COMPLETED|Overall Study||28
8510682|NCT00440310|20975445|P2|COMPLETED|Overall Study||209
8510683|NCT00440310|20975446|P1|COMPLETED|Overall Study||216
8510684|NCT00440310|20975445|P2|Treated|Overall Study||232
8510685|NCT00440310|20975446|P1|Treated|Overall Study||222
8510686|NCT00440310|20975445|P2|STARTED|Overall Study||239
8510687|NCT00440310|20975446|P1|STARTED|Overall Study||244
8510688|NCT00440297|20975454|P2|NOT COMPLETED|Overall Study||18
8510689|NCT00440297|20975455|P1|NOT COMPLETED|Overall Study||23
8510690|NCT00440297|20975454|P2|COMPLETED|Overall Study||120
8510691|NCT00440297|20975455|P1|COMPLETED|Overall Study||116
8510692|NCT00440297|20975454|P2|Vaccination Visit 4|Overall Study||122
8510693|NCT00440297|20975455|P1|Vaccination Visit 4|Overall Study||116
8510694|NCT00440297|20975454|P2|Vaccination Visit 3|Overall Study||125
8510695|NCT00440297|20975455|P1|Vaccination Visit 3|Overall Study||124
8510696|NCT00440297|20975454|P2|Vaccination Visit 2|Overall Study||134
8510697|NCT00440297|20975455|P1|Vaccination Visit 2|Overall Study||136
8510698|NCT00440297|20975454|P2|Vaccination Visit 1|Overall Study||138
8510699|NCT00440297|20975455|P1|Vaccination Visit 1|Overall Study||138
8510700|NCT00440297|20975454|P2|STARTED|Overall Study||138
8510701|NCT00440297|20975455|P1|STARTED|Overall Study||139
8510702|NCT00440271|20975471|P2|NOT COMPLETED|Overall Study||15
8510703|NCT00440271|20975472|P1|NOT COMPLETED|Overall Study||12
8510704|NCT00440271|20975471|P2|COMPLETED|Overall Study||3
8510705|NCT00440271|20975472|P1|COMPLETED|Overall Study||3
8510706|NCT00440271|20975471|P2|STARTED|Overall Study||18
8510707|NCT00440271|20975472|P1|STARTED|Overall Study||15
8510708|NCT00440232|20975506|P2|NOT COMPLETED|Overall Study||4
8510709|NCT00440232|20975507|P1|NOT COMPLETED|Overall Study||3
8510710|NCT00440232|20975506|P2|COMPLETED|Overall Study||34
8510711|NCT00440232|20975507|P1|COMPLETED|Overall Study||33
8510712|NCT00440232|20975506|P2|STARTED|Overall Study||38
8510713|NCT00440232|20975507|P1|STARTED|Overall Study||36
8510714|NCT00440193|20975517|P2|NOT COMPLETED|Observational Period||38
8510715|NCT00440193|20975518|P1|NOT COMPLETED|Observational Period||45
8510716|NCT00440193|20975517|P2|COMPLETED|Observational Period||1369
8510717|NCT00440193|20975518|P1|COMPLETED|Observational Period||1380
8510718|NCT00440193|20975517|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
8510719|NCT00440193|20975518|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
8510720|NCT00440193|20975517|P2|NOT COMPLETED|Treatment Period||351
8510721|NCT00440193|20975518|P1|NOT COMPLETED|Treatment Period||305
8510722|NCT00440193|20975517|P2|COMPLETED|Treatment Period||1367
8510723|NCT00440193|20975518|P1|COMPLETED|Treatment Period||1426
8510724|NCT00440193|20975517|P2|Participants Received Treatment|Treatment Period||1711
8510725|NCT00440193|20975518|P1|Participants Received Treatment|Treatment Period||1718
8510726|NCT00440193|20975517|P2|STARTED|Treatment Period||1718
8510727|NCT00440193|20975518|P1|STARTED|Treatment Period||1731
8510728|NCT00440180|20975554|P2|NOT COMPLETED|Overall Study||0
8510729|NCT00440180|20975555|P1|NOT COMPLETED|Overall Study||0
8510730|NCT00440180|20975554|P2|COMPLETED|Overall Study||10
8510731|NCT00440180|20975555|P1|COMPLETED|Overall Study||10
8510732|NCT00440180|20975554|P2|STARTED|Overall Study||10
8510733|NCT00440180|20975555|P1|STARTED|Overall Study||10
8510734|NCT00440115|20975564|P3|NOT COMPLETED|Overall Study||6
8510735|NCT00440115|20975565|P2|NOT COMPLETED|Overall Study||11
8510736|NCT00440115|20975566|P1|NOT COMPLETED|Overall Study||7
8510737|NCT00440115|20975564|P3|COMPLETED|Overall Study||244
8510738|NCT00440115|20975565|P2|COMPLETED|Overall Study||238
8510739|NCT00440115|20975566|P1|COMPLETED|Overall Study||244
8510740|NCT00440115|20975564|P3|STARTED|Overall Study||250
8510741|NCT00440115|20975565|P2|STARTED|Overall Study||249
8510742|NCT00440115|20975566|P1|STARTED|Overall Study||251
8510743|NCT00440050|20975582|P2|NOT COMPLETED|Overall Study||67
8510744|NCT00440050|20975583|P1|NOT COMPLETED|Overall Study||40
8510745|NCT00440050|20975582|P2|COMPLETED|Overall Study||171
8510746|NCT00440050|20975583|P1|COMPLETED|Overall Study||124
8510747|NCT00440050|20975582|P2|STARTED|Overall Study||238
8510748|NCT00440050|20975583|P1|STARTED|Overall Study||164
8510749|NCT00440037|20975595|P1|NOT COMPLETED|Overall Study||9
8510750|NCT00440037|20975595|P1|COMPLETED|Overall Study||35
8510751|NCT00440037|20975595|P1|STARTED|Overall Study||44
8510752|NCT00440011|20975605|P2|NOT COMPLETED|Overall Study||3
8510753|NCT00440011|20975606|P1|NOT COMPLETED|Overall Study||4
8510754|NCT00440011|20975605|P2|COMPLETED|Overall Study||132
8510755|NCT00440011|20975606|P1|COMPLETED|Overall Study||127
8510756|NCT00440011|20975605|P2|STARTED|Overall Study||135
8510757|NCT00440011|20975606|P1|STARTED|Overall Study||131
8510758|NCT00439946|20975614|P1|NOT COMPLETED|Overall Study||0
8510759|NCT00439946|20975614|P1|COMPLETED|Overall Study||8
8510760|NCT00439946|20975614|P1|STARTED|Overall Study||8
8510761|NCT00439777|20975633|P2|NOT COMPLETED|Observational Period||41
8510762|NCT00439777|20975634|P1|NOT COMPLETED|Observational Period||41
8510763|NCT00439777|20975633|P2|COMPLETED|Observational Period||2156
8510764|NCT00439777|20975634|P1|COMPLETED|Observational Period||2165
8510765|NCT00439777|20975633|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
8510766|NCT00439777|20975634|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
8510767|NCT00439777|20975633|P2|NOT COMPLETED|Treatment Period||459
8510768|NCT00439777|20975634|P1|NOT COMPLETED|Treatment Period||419
8510769|NCT00439777|20975633|P2|COMPLETED|Treatment Period||1954
8510770|NCT00439777|20975634|P1|COMPLETED|Treatment Period||2001
8510771|NCT00439777|20975633|P2|Participants Received Treatment|Treatment Period||2405
8510772|NCT00439777|20975634|P1|Participants Received Treatment|Treatment Period||2412
8510773|NCT00439777|20975633|P2|STARTED|Treatment Period||2413
8510774|NCT00439777|20975634|P1|STARTED|Treatment Period||2420
8510775|NCT00439738|20975672|P2|NOT COMPLETED|Overall Study||28
8510776|NCT00439738|20975673|P1|NOT COMPLETED|Overall Study||36
8510777|NCT00439738|20975672|P2|COMPLETED|Overall Study||178
8510778|NCT00439738|20975673|P1|COMPLETED|Overall Study||170
8510779|NCT00439738|20975672|P2|STARTED|Overall Study||206
8510780|NCT00439738|20975673|P1|STARTED|Overall Study||206
8510781|NCT00439725|20975691|P2|NOT COMPLETED|Observational Period||7
8510782|NCT00439725|20975692|P1|NOT COMPLETED|Observational Period||8
8510783|NCT00439725|20975691|P2|COMPLETED|Observational Period||553
8510784|NCT00439725|20975692|P1|COMPLETED|Observational Period||569
8510785|NCT00439725|20975691|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
8510786|NCT00439725|20975692|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
8510787|NCT00439725|20975691|P2|NOT COMPLETED|Treatment Period||246
8510788|NCT00439725|20975692|P1|NOT COMPLETED|Treatment Period||236
8510789|NCT00439725|20975691|P2|COMPLETED|Treatment Period||349
8510790|NCT00439725|20975692|P1|COMPLETED|Treatment Period||366
8510791|NCT00439725|20975691|P2|Participants Received Treatment|Treatment Period|Safety population|590
8510792|NCT00439725|20975692|P1|Participants Received Treatment|Treatment Period|Safety population|598
8510793|NCT00439725|20975691|P2|STARTED|Treatment Period||595
8510794|NCT00439725|20975692|P1|STARTED|Treatment Period||602
8510795|NCT00439673|20975736|P1|NOT COMPLETED|Overall Study||36
8510796|NCT00439673|20975736|P1|COMPLETED|Overall Study||26
8510797|NCT00439673|20975736|P1|STARTED|Overall Study||62
8510798|NCT00439647|20975743|P2|NOT COMPLETED|Overall Study||71
8510799|NCT00439647|20975744|P1|NOT COMPLETED|Overall Study||58
8510800|NCT00439647|20975743|P2|COMPLETED|Overall Study||540
8510801|NCT00439647|20975744|P1|COMPLETED|Overall Study||530
8510802|NCT00439647|20975743|P2|Modified Intent to Treat (mITT)|Overall Study||574
8510803|NCT00439647|20975744|P1|Modified Intent to Treat (mITT)|Overall Study||553
8510804|NCT00439647|20975743|P2|STARTED|Overall Study||611
8510805|NCT00439647|20975744|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
8510806|NCT00439608|20975776|P1|NOT COMPLETED|Overall Study||0
8510807|NCT00439608|20975776|P1|COMPLETED|Overall Study||60
8510808|NCT00439608|20975776|P1|STARTED|Overall Study||60
8510809|NCT00439569|20975781|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
8510810|NCT00439569|20975781|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
8510811|NCT00439569|20975781|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
8510812|NCT00439569|20975781|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
8510813|NCT00439569|20975781|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
8510814|NCT00439569|20975781|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
8510815|NCT00439556|20975795|P3|NOT COMPLETED|Overall Study||0
8510816|NCT00439556|20975796|P2|NOT COMPLETED|Overall Study||1
8510817|NCT00439556|20975797|P1|NOT COMPLETED|Overall Study||0
8510818|NCT00439556|20975795|P3|COMPLETED|Overall Study||0
8510819|NCT00439556|20975796|P2|COMPLETED|Overall Study||3
8510820|NCT00439556|20975797|P1|COMPLETED|Overall Study||36
8510821|NCT00439556|20975795|P3|STARTED|Overall Study||0
8510822|NCT00439556|20975796|P2|STARTED|Overall Study||4
8510823|NCT00439556|20975797|P1|STARTED|Overall Study||36
8510824|NCT00439517|20975810|P2|NOT COMPLETED|Overall Study||0
8510825|NCT00439517|20975811|P1|NOT COMPLETED|Overall Study||2
8510826|NCT00439517|20975810|P2|COMPLETED|Overall Study||150
8510827|NCT00439517|20975811|P1|COMPLETED|Overall Study||150
8510828|NCT00439517|20975810|P2|STARTED|Overall Study||150
8510829|NCT00439517|20975811|P1|STARTED|Overall Study||152
8510830|NCT00439465|20975833|P1|NOT COMPLETED|Overall Study||4
8510831|NCT00439465|20975833|P1|COMPLETED|Overall Study||19
8510832|NCT00439465|20975833|P1|STARTED|Overall Study||23
8510833|NCT00439413|20975845|P2|NOT COMPLETED|Overall Study||37
8510834|NCT00439413|20975846|P1|NOT COMPLETED|Overall Study||31
8510835|NCT00439413|20975845|P2|COMPLETED|Overall Study||88
8510836|NCT00439413|20975846|P1|COMPLETED|Overall Study||90
8510837|NCT00439413|20975845|P2|STARTED|Overall Study||125
8510838|NCT00439413|20975846|P1|STARTED|Overall Study||121
8510839|NCT00439374|20975856|P2|NOT COMPLETED|Overall Study||0
8510840|NCT00439374|20975857|P1|NOT COMPLETED|Overall Study||0
8510841|NCT00439374|20975856|P2|COMPLETED|Overall Study||330
8510842|NCT00439374|20975857|P1|COMPLETED|Overall Study||327
8510843|NCT00439374|20975856|P2|STARTED|Overall Study||330
8510844|NCT00439374|20975857|P1|STARTED|Overall Study||327
8510845|NCT00439335|20975917|P2|NOT COMPLETED|Overall Study||0
8510846|NCT00439335|20975918|P1|NOT COMPLETED|Overall Study||2
8510847|NCT00439335|20975917|P2|COMPLETED|Overall Study||114
8510848|NCT00439335|20975918|P1|COMPLETED|Overall Study||111
8510849|NCT00439335|20975917|P2|STARTED|Overall Study||114
8510850|NCT00439335|20975918|P1|STARTED|Overall Study||113
8510851|NCT00439309|20975950|P2|NOT COMPLETED|Follow-Up||2
8510852|NCT00439309|20975951|P1|NOT COMPLETED|Follow-Up||3
8510853|NCT00439309|20975950|P2|COMPLETED|Follow-Up||13
8510854|NCT00439309|20975951|P1|COMPLETED|Follow-Up||51
8510855|NCT00439309|20975950|P2|STARTED|Follow-Up||15
8510856|NCT00439309|20975951|P1|STARTED|Follow-Up||54
8510857|NCT00439309|20975950|P2|NOT COMPLETED|Treatment||0
8510858|NCT00439309|20975951|P1|NOT COMPLETED|Treatment||0
8510859|NCT00439309|20975950|P2|COMPLETED|Treatment||15
8510860|NCT00439309|20975951|P1|COMPLETED|Treatment||54
8510861|NCT00439309|20975950|P2|STARTED|Treatment||15
8510862|NCT00439309|20975951|P1|STARTED|Treatment||54
8510863|NCT00439296|20975967|P2|NOT COMPLETED|Overall Study||0
8510864|NCT00439296|20975968|P1|NOT COMPLETED|Overall Study||0
8510865|NCT00439296|20975967|P2|COMPLETED|Overall Study||4
8510866|NCT00439296|20975968|P1|COMPLETED|Overall Study||5
8510867|NCT00439296|20975967|P2|Treatment Course 2|Overall Study||1
8510868|NCT00439296|20975968|P1|Treatment Course 2|Overall Study||1
8510869|NCT00439296|20975967|P2|Treatment Course 1|Overall Study||3
8510870|NCT00439296|20975968|P1|Treatment Course 1|Overall Study||5
8510871|NCT00439296|20975967|P2|STARTED|Overall Study||4
8510872|NCT00439296|20975968|P1|STARTED|Overall Study||5
8510873|NCT00439270|20975983|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510874|NCT00439270|20975984|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
8510875|NCT00439270|20975985|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510876|NCT00439270|20975986|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510877|NCT00439270|20975987|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510878|NCT00439270|20975983|P5|COMPLETED|Phase 2 (51.6 Months)||0
8510879|NCT00439270|20975984|P4|COMPLETED|Phase 2 (51.6 Months)||0
8510880|NCT00439270|20975985|P3|COMPLETED|Phase 2 (51.6 Months)||0
8510881|NCT00439270|20975986|P2|COMPLETED|Phase 2 (51.6 Months)||0
8510882|NCT00439270|20975987|P1|COMPLETED|Phase 2 (51.6 Months)||0
8510883|NCT00439270|20975983|P5|STARTED|Phase 2 (51.6 Months)||0
8510884|NCT00439270|20975984|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
8510885|NCT00439270|20975985|P3|STARTED|Phase 2 (51.6 Months)||0
8510886|NCT00439270|20975986|P2|STARTED|Phase 2 (51.6 Months)||0
8510887|NCT00439270|20975987|P1|STARTED|Phase 2 (51.6 Months)||0
8510888|NCT00439270|20975983|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510889|NCT00439270|20975984|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
8510890|NCT00439270|20975985|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510891|NCT00439270|20975986|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510892|NCT00439270|20975987|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510893|NCT00439270|20975983|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510894|NCT00439270|20975984|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
8510895|NCT00439270|20975985|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510896|NCT00439270|20975986|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510897|NCT00439270|20975987|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510898|NCT00439270|20975983|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510899|NCT00439270|20975984|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
8510900|NCT00439270|20975985|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510901|NCT00439270|20975986|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510902|NCT00439270|20975987|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510903|NCT00439244|20976029|P3|NOT COMPLETED|Overall Study||7
8510904|NCT00439244|20976030|P2|NOT COMPLETED|Overall Study||6
8510905|NCT00439244|20976031|P1|NOT COMPLETED|Overall Study||11
8510906|NCT00439244|20976029|P3|COMPLETED|Overall Study||131
8510907|NCT00439244|20976030|P2|COMPLETED|Overall Study||131
8510908|NCT00439244|20976031|P1|COMPLETED|Overall Study||126
8510909|NCT00439244|20976029|P3|Safety Population|Overall Study||137
8510910|NCT00439244|20976030|P2|Safety Population|Overall Study||137
8510911|NCT00439244|20976031|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
8510912|NCT00439244|20976029|P3|STARTED|Overall Study||138
8510913|NCT00439244|20976030|P2|STARTED|Overall Study||137
8510914|NCT00439244|20976031|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
8510915|NCT00439231|20976051|P1|NOT COMPLETED|Overall Study||28
8510916|NCT00439231|20976051|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
8510917|NCT00439231|20976051|P1|STARTED|Overall Study||33
8510918|NCT00439218|20976055|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
8510919|NCT00439218|20976055|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
8510920|NCT00439218|20976055|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
8510921|NCT00439218|20976055|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
8510922|NCT00439218|20976055|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
8510923|NCT00439218|20976055|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
8510924|NCT00439179|20976070|P4|NOT COMPLETED|Overall Study||0
8510925|NCT00439179|20976071|P3|NOT COMPLETED|Overall Study||0
8510926|NCT00439179|20976072|P2|NOT COMPLETED|Overall Study||2
8510927|NCT00439179|20976073|P1|NOT COMPLETED|Overall Study||0
8510928|NCT00439179|20976070|P4|COMPLETED|Overall Study||5
8510929|NCT00439179|20976071|P3|COMPLETED|Overall Study||6
8510930|NCT00439179|20976072|P2|COMPLETED|Overall Study||11
8510931|NCT00439179|20976073|P1|COMPLETED|Overall Study||3
8510932|NCT00439179|20976070|P4|STARTED|Overall Study|2 with biliry|5
8510933|NCT00439179|20976071|P3|STARTED|Overall Study|2 with biliary|6
8510934|NCT00439179|20976072|P2|STARTED|Overall Study|2 with biliary|13
8510935|NCT00439179|20976073|P1|STARTED|Overall Study|1 with biliary|3
8510936|NCT00439140|20976090|P3|NOT COMPLETED|Treatment Cycle 2||0
8510937|NCT00439140|20976091|P2|NOT COMPLETED|Treatment Cycle 2||1
8510938|NCT00439140|20976092|P1|NOT COMPLETED|Treatment Cycle 2||2
8510939|NCT00439140|20976090|P3|COMPLETED|Treatment Cycle 2||0
8510940|NCT00439140|20976091|P2|COMPLETED|Treatment Cycle 2||6
8510941|NCT00439140|20976092|P1|COMPLETED|Treatment Cycle 2||11
8510942|NCT00439140|20976090|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
8510943|NCT00439140|20976091|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
8510944|NCT00439140|20976092|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
8510945|NCT00439140|20976090|P3|NOT COMPLETED|Treatment Cycle 1||1
8510946|NCT00439140|20976091|P2|NOT COMPLETED|Treatment Cycle 1||4
8510947|NCT00439140|20976092|P1|NOT COMPLETED|Treatment Cycle 1||1
8510948|NCT00439140|20976090|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
8510949|NCT00439140|20976091|P2|COMPLETED|Treatment Cycle 1||10
8510950|NCT00439140|20976092|P1|COMPLETED|Treatment Cycle 1||14
8510951|NCT00439140|20976090|P3|STARTED|Treatment Cycle 1||12
8510952|NCT00439140|20976091|P2|STARTED|Treatment Cycle 1||14
8510953|NCT00439140|20976092|P1|STARTED|Treatment Cycle 1||15
8510954|NCT00438971|20976121|P1|NOT COMPLETED|Overall Study||2
8510955|NCT00438971|20976121|P1|COMPLETED|Overall Study||15
8510956|NCT00438971|20976121|P1|STARTED|Overall Study||17
8510957|NCT00438932|20976136|P4|NOT COMPLETED|Overall Study||0
8510958|NCT00438932|20976137|P3|NOT COMPLETED|Overall Study||0
8510959|NCT00438932|20976138|P2|NOT COMPLETED|Overall Study||0
8510960|NCT00438932|20976139|P1|NOT COMPLETED|Overall Study||0
8510961|NCT00438932|20976136|P4|COMPLETED|Overall Study||4
8510962|NCT00438932|20976137|P3|COMPLETED|Overall Study||4
8510963|NCT00438932|20976138|P2|COMPLETED|Overall Study||4
8510964|NCT00438932|20976139|P1|COMPLETED|Overall Study||4
8510965|NCT00438932|20976136|P4|STARTED|Overall Study||4
8510966|NCT00438932|20976137|P3|STARTED|Overall Study||4
8510967|NCT00438932|20976138|P2|STARTED|Overall Study||4
8510968|NCT00438932|20976139|P1|STARTED|Overall Study||4
8510969|NCT00438880|20976155|P2|NOT COMPLETED|Overall Study||0
8510970|NCT00438880|20976156|P1|NOT COMPLETED|Overall Study||0
8510971|NCT00438880|20976155|P2|COMPLETED|Overall Study||8
8510972|NCT00438880|20976156|P1|COMPLETED|Overall Study||30
8510973|NCT00438880|20976155|P2|STARTED|Overall Study||8
8510974|NCT00438880|20976156|P1|STARTED|Overall Study||30
8510975|NCT00438854|20976168|P1|NOT COMPLETED|Overall Study||0
8510976|NCT00438854|20976168|P1|COMPLETED|Overall Study||15
8510977|NCT00438854|20976168|P1|STARTED|Overall Study||15
8510978|NCT00438815|20976175|P1|NOT COMPLETED|Overall Study||70
8510979|NCT00438815|20976175|P1|COMPLETED|Overall Study||43
8510980|NCT00438815|20976175|P1|STARTED|Overall Study||113
8510981|NCT00438802|20976188|P3|NOT COMPLETED|Overall Study||0
8510982|NCT00438802|20976189|P2|NOT COMPLETED|Overall Study||0
8510983|NCT00438802|20976190|P1|NOT COMPLETED|Overall Study||0
8510984|NCT00438802|20976188|P3|COMPLETED|Overall Study||9
8510985|NCT00438802|20976189|P2|COMPLETED|Overall Study||8
8510986|NCT00438802|20976190|P1|COMPLETED|Overall Study||6
8510987|NCT00438802|20976188|P3|STARTED|Overall Study||9
8510988|NCT00438802|20976189|P2|STARTED|Overall Study||8
8510989|NCT00438802|20976190|P1|STARTED|Overall Study||6
8510990|NCT00438750|20976204|P2|NOT COMPLETED|Overall Study||9
8510991|NCT00438750|20976205|P1|NOT COMPLETED|Overall Study||9
8510992|NCT00438750|20976204|P2|COMPLETED|Overall Study||37
8510993|NCT00438750|20976205|P1|COMPLETED|Overall Study||39
8510994|NCT00438750|20976204|P2|STARTED|Overall Study||46
8510995|NCT00438750|20976205|P1|STARTED|Overall Study||48
8510996|NCT00438672|20976225|P2|NOT COMPLETED|Overall Study||9
8510997|NCT00438672|20976226|P1|NOT COMPLETED|Overall Study||7
8510998|NCT00438672|20976225|P2|COMPLETED|Overall Study||24
8510999|NCT00438672|20976226|P1|COMPLETED|Overall Study||24
8511000|NCT00438672|20976225|P2|STARTED|Overall Study||33
8511001|NCT00438672|20976226|P1|STARTED|Overall Study||31
8511002|NCT00438659|20976236|P2|NOT COMPLETED|Overall Study||4
8511003|NCT00438659|20976237|P1|NOT COMPLETED|Overall Study||6
8511004|NCT00438659|20976236|P2|COMPLETED|Overall Study||82
8511005|NCT00438659|20976237|P1|COMPLETED|Overall Study||84
8511006|NCT00438659|20976236|P2|STARTED|Overall Study||86
8511007|NCT00438659|20976237|P1|STARTED|Overall Study||90
8511008|NCT00438633|20976261|P2|NOT COMPLETED|Overall Study||17
8511009|NCT00438633|20976262|P1|NOT COMPLETED|Overall Study||16
8511010|NCT00438633|20976261|P2|COMPLETED|Overall Study||14
8511011|NCT00438633|20976262|P1|COMPLETED|Overall Study||16
8511012|NCT00438633|20976261|P2|3-month Follow-up|Overall Study||24
8511013|NCT00438633|20976262|P1|3-month Follow-up|Overall Study||26
8511014|NCT00438633|20976261|P2|STARTED|Overall Study||31
8511015|NCT00438633|20976262|P1|STARTED|Overall Study||32
8511016|NCT00438490|20976278|P2|NOT COMPLETED|Overall Study||0
8511017|NCT00438490|20976279|P1|NOT COMPLETED|Overall Study||0
8511018|NCT00438490|20976278|P2|COMPLETED|Overall Study||9
8511019|NCT00438490|20976279|P1|COMPLETED|Overall Study||12
8511020|NCT00438490|20976278|P2|STARTED|Overall Study||9
8511021|NCT00438490|20976279|P1|STARTED|Overall Study||12
8511022|NCT00438464|20976293|P2|NOT COMPLETED|Overall Study||7
8511023|NCT00438464|20976294|P1|NOT COMPLETED|Overall Study||14
8511024|NCT00438464|20976293|P2|COMPLETED|Overall Study||94
8511025|NCT00438464|20976294|P1|COMPLETED|Overall Study||89
8511026|NCT00438464|20976293|P2|Received Assigned Intervention|Overall Study||94
8511027|NCT00438464|20976294|P1|Received Assigned Intervention|Overall Study||89
8511028|NCT00438464|20976293|P2|STARTED|Overall Study||101
8511029|NCT00438464|20976294|P1|STARTED|Overall Study||103
8511030|NCT00438451|20976349|P3|NOT COMPLETED|Overall Study||53
8511031|NCT00438451|20976350|P2|NOT COMPLETED|Overall Study||66
8511032|NCT00438451|20976351|P1|NOT COMPLETED|Overall Study||47
8511033|NCT00438451|20976349|P3|COMPLETED|Overall Study||65
8511034|NCT00438451|20976350|P2|COMPLETED|Overall Study||55
8511035|NCT00438451|20976351|P1|COMPLETED|Overall Study||75
8511036|NCT00438451|20976349|P3|Maintenance Phase (Week 7-58)|Overall Study||93
8511037|NCT00438451|20976350|P2|Maintenance Phase (Week 7-58)|Overall Study||89
8511038|NCT00438451|20976351|P1|Maintenance Phase (Week 7-58)|Overall Study||93
8511039|NCT00438451|20976349|P3|ITT Population|Overall Study||117
8511040|NCT00438451|20976350|P2|ITT Population|Overall Study||120
8511041|NCT00438451|20976351|P1|ITT Population|Overall Study||122
8511042|NCT00438451|20976349|P3|Safety Population|Overall Study||117
8511043|NCT00438451|20976350|P2|Safety Population|Overall Study||121
8511044|NCT00438451|20976351|P1|Safety Population|Overall Study||122
8511045|NCT00438451|20976349|P3|STARTED|Overall Study||118
8511046|NCT00438451|20976350|P2|STARTED|Overall Study||121
8511047|NCT00438451|20976351|P1|STARTED|Overall Study||122
8511072|NCT00438360|20976411|P2|NOT COMPLETED|Overall Study||43
8511073|NCT00438360|20976412|P1|NOT COMPLETED|Overall Study||72
8511074|NCT00438360|20976411|P2|COMPLETED|Overall Study||38
8511075|NCT00438360|20976412|P1|COMPLETED|Overall Study||90
8511076|NCT00438360|20976411|P2|Intention to Treat (ITT) Population|Overall Study||79
8511077|NCT00438360|20976412|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
8511078|NCT00438360|20976411|P2|STARTED|Overall Study||81
8511079|NCT00438360|20976412|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
8511080|NCT00438256|20976426|P4|NOT COMPLETED|Overall Study||9
8511081|NCT00438256|20976427|P3|NOT COMPLETED|Overall Study||1
8511082|NCT00438256|20976428|P2|NOT COMPLETED|Overall Study||1
8511083|NCT00438256|20976429|P1|NOT COMPLETED|Overall Study||2
8511084|NCT00438256|20976426|P4|COMPLETED|Overall Study||32
8511085|NCT00438256|20976427|P3|COMPLETED|Overall Study||2
8511086|NCT00438256|20976428|P2|COMPLETED|Overall Study||2
8511087|NCT00438256|20976429|P1|COMPLETED|Overall Study||1
8511088|NCT00438256|20976426|P4|Surgical Resection|Overall Study||34
8511089|NCT00438256|20976427|P3|Surgical Resection|Overall Study||2
8511090|NCT00438256|20976428|P2|Surgical Resection|Overall Study||2
8511091|NCT00438256|20976429|P1|Surgical Resection|Overall Study||1
8511092|NCT00438256|20976426|P4|STARTED|Overall Study||41
8511093|NCT00438256|20976427|P3|STARTED|Overall Study||3
8511094|NCT00438256|20976428|P2|STARTED|Overall Study||3
8511095|NCT00438256|20976429|P1|STARTED|Overall Study||3
8511096|NCT00438204|20976445|P1|NOT COMPLETED|Overall Study||0
8511097|NCT00438204|20976445|P1|COMPLETED|Overall Study||39
8511098|NCT00438204|20976445|P1|STARTED|Overall Study||39
8511099|NCT00438191|20976455|P2|NOT COMPLETED|Overall Study||14
8511100|NCT00438191|20976456|P1|NOT COMPLETED|Overall Study||11
8511101|NCT00438191|20976455|P2|COMPLETED|Overall Study||26
8511102|NCT00438191|20976456|P1|COMPLETED|Overall Study||32
8511103|NCT00438191|20976455|P2|STARTED|Overall Study||40
8511104|NCT00438191|20976456|P1|STARTED|Overall Study||43
8511105|NCT00438100|20976470|P2|NOT COMPLETED|Overall Study||4
8511106|NCT00438100|20976471|P1|NOT COMPLETED|Overall Study||2
8511107|NCT00438100|20976470|P2|COMPLETED|Overall Study||65
8511108|NCT00438100|20976471|P1|COMPLETED|Overall Study||71
8511109|NCT00438100|20976470|P2|STARTED|Overall Study||69
8511110|NCT00438100|20976471|P1|STARTED|Overall Study||73
8511111|NCT00437983|20976479|P2|NOT COMPLETED|Overall Study||13
8511112|NCT00437983|20976480|P1|NOT COMPLETED|Overall Study||13
8511113|NCT00437983|20976479|P2|COMPLETED|Overall Study||65
8511114|NCT00437983|20976480|P1|COMPLETED|Overall Study||66
8511115|NCT00437983|20976479|P2|STARTED|Overall Study||78
8511116|NCT00437983|20976480|P1|STARTED|Overall Study||79
8511117|NCT00437658|20976493|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
8511118|NCT00437658|20976494|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
8511119|NCT00437658|20976495|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
8511120|NCT00437658|20976493|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
8511121|NCT00437658|20976494|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
8511122|NCT00437658|20976495|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
8511123|NCT00437658|20976493|P3|STARTED|Post-treatment Period (24 Weeks)||51
8511124|NCT00437658|20976494|P2|STARTED|Post-treatment Period (24 Weeks)||62
8511125|NCT00437658|20976495|P1|STARTED|Post-treatment Period (24 Weeks)||56
8511126|NCT00437658|20976493|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
8511127|NCT00437658|20976494|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
8511128|NCT00437658|20976495|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
8511129|NCT00437658|20976493|P3|COMPLETED|Treatment Period (24 Weeks)||51
8511130|NCT00437658|20976494|P2|COMPLETED|Treatment Period (24 Weeks)||62
8511131|NCT00437658|20976495|P1|COMPLETED|Treatment Period (24 Weeks)||56
8511132|NCT00437658|20976493|P3|Received Study Drug|Treatment Period (24 Weeks)||84
8511133|NCT00437658|20976494|P2|Received Study Drug|Treatment Period (24 Weeks)||84
8511134|NCT00437658|20976495|P1|Received Study Drug|Treatment Period (24 Weeks)||84
8511135|NCT00437658|20976493|P3|STARTED|Treatment Period (24 Weeks)||84
8511136|NCT00437658|20976494|P2|STARTED|Treatment Period (24 Weeks)||84
8511137|NCT00437658|20976495|P1|STARTED|Treatment Period (24 Weeks)||84
8511138|NCT00437645|20976589|P2|NOT COMPLETED|Overall Study||115
8511139|NCT00437645|20976590|P1|NOT COMPLETED|Overall Study||35
8511140|NCT00437645|20976589|P2|COMPLETED|Overall Study||476
8511141|NCT00437645|20976590|P1|COMPLETED|Overall Study||557
8511142|NCT00437645|20976589|P2|STARTED|Overall Study||591
8511143|NCT00437645|20976590|P1|STARTED|Overall Study||592
8511144|NCT00437489|20976606|P2|NOT COMPLETED|Overall Study||22
8511145|NCT00437489|20976607|P1|NOT COMPLETED|Overall Study||23
8511146|NCT00437489|20976606|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
8511147|NCT00437489|20976607|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
8511148|NCT00437489|20976606|P2|STARTED|Overall Study||24
8511149|NCT00437489|20976607|P1|STARTED|Overall Study||25
8511150|NCT00437398|20976619|P1|NOT COMPLETED|Overall Study||0
8511151|NCT00437398|20976619|P1|COMPLETED|Overall Study||2
8511152|NCT00437398|20976619|P1|STARTED|Overall Study||2
8511153|NCT00437294|20976626|P2|NOT COMPLETED|Overall Study||43
8511154|NCT00437294|20976627|P1|NOT COMPLETED|Overall Study||43
8511155|NCT00437294|20976626|P2|COMPLETED|Overall Study||0
8511156|NCT00437294|20976627|P1|COMPLETED|Overall Study||0
8511157|NCT00437294|20976626|P2|Received at Least 1 Dose of Study Drug|Overall Study||43
8511158|NCT00437294|20976627|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
8511159|NCT00437294|20976626|P2|STARTED|Overall Study||43
8511160|NCT00437294|20976627|P1|STARTED|Overall Study||43
8511221|NCT00437268|20976983|P2|NOT COMPLETED|Overall Study||13
8511222|NCT00437268|20976984|P1|NOT COMPLETED|Overall Study||13
8511223|NCT00437268|20976983|P2|COMPLETED|Overall Study||0
8511224|NCT00437268|20976984|P1|COMPLETED|Overall Study||0
8511225|NCT00437268|20976983|P2|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
8511226|NCT00437268|20976984|P1|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
8511227|NCT00437268|20976983|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8511228|NCT00437268|20976984|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
8511229|NCT00437268|20976983|P2|STARTED|Overall Study||13
8511230|NCT00437268|20976984|P1|STARTED|Overall Study||13
8511231|NCT00437203|20977010|P10|NOT COMPLETED|Overall Study||4
8511232|NCT00437203|20977011|P9|NOT COMPLETED|Overall Study||3
8511233|NCT00437203|20977012|P8|NOT COMPLETED|Overall Study||3
8511234|NCT00437203|20977013|P7|NOT COMPLETED|Overall Study||7
8511235|NCT00437203|20977014|P6|NOT COMPLETED|Overall Study||3
8511236|NCT00437203|20977015|P5|NOT COMPLETED|Overall Study||3
8511237|NCT00437203|20977016|P4|NOT COMPLETED|Overall Study||3
8511238|NCT00437203|20977017|P3|NOT COMPLETED|Overall Study||3
8511239|NCT00437203|20977018|P2|NOT COMPLETED|Overall Study||8
8511240|NCT00437203|20977019|P1|NOT COMPLETED|Overall Study||6
8511241|NCT00437203|20977010|P10|COMPLETED|Overall Study||0
8511242|NCT00437203|20977011|P9|COMPLETED|Overall Study||0
8511243|NCT00437203|20977012|P8|COMPLETED|Overall Study||0
8511244|NCT00437203|20977013|P7|COMPLETED|Overall Study||0
8511245|NCT00437203|20977014|P6|COMPLETED|Overall Study||0
8511246|NCT00437203|20977015|P5|COMPLETED|Overall Study||0
8511247|NCT00437203|20977016|P4|COMPLETED|Overall Study||0
8511248|NCT00437203|20977017|P3|COMPLETED|Overall Study||0
8511249|NCT00437203|20977018|P2|COMPLETED|Overall Study||0
8511250|NCT00437203|20977019|P1|COMPLETED|Overall Study||0
8511251|NCT00437203|20977010|P10|STARTED|Overall Study||4
8511252|NCT00437203|20977011|P9|STARTED|Overall Study||3
8511253|NCT00437203|20977012|P8|STARTED|Overall Study||3
8511254|NCT00437203|20977013|P7|STARTED|Overall Study||7
8511255|NCT00437203|20977014|P6|STARTED|Overall Study||3
8511256|NCT00437203|20977015|P5|STARTED|Overall Study||3
8511257|NCT00437203|20977016|P4|STARTED|Overall Study||3
8511258|NCT00437203|20977017|P3|STARTED|Overall Study||3
8511259|NCT00437203|20977018|P2|STARTED|Overall Study||8
8511260|NCT00437203|20977019|P1|STARTED|Overall Study||6
8511261|NCT00437125|20977123|P1|NOT COMPLETED|Overall Study||32
8511262|NCT00437125|20977123|P1|COMPLETED|Overall Study||119
8511263|NCT00437125|20977123|P1|STARTED|Overall Study||151
8511264|NCT00437073|20977144|P2|NOT COMPLETED|Overall Study||1
8511265|NCT00437073|20977145|P1|NOT COMPLETED|Overall Study||1
8511266|NCT00437073|20977144|P2|COMPLETED|Overall Study||8
8511267|NCT00437073|20977145|P1|COMPLETED|Overall Study||12
8511268|NCT00437073|20977144|P2|STARTED|Overall Study||9
8511269|NCT00437073|20977145|P1|STARTED|Overall Study||13
8511273|NCT00436982|20977179|P2|NOT COMPLETED|Overall Study||4
8511274|NCT00436982|20977180|P1|NOT COMPLETED|Overall Study||4
8511275|NCT00436982|20977179|P2|COMPLETED|Overall Study||26
8511276|NCT00436982|20977180|P1|COMPLETED|Overall Study||26
8511277|NCT00436982|20977179|P2|STARTED|Overall Study||30
8511278|NCT00436982|20977180|P1|STARTED|Overall Study||30
8511279|NCT00436969|20977202|P2|NOT COMPLETED|Overall Study||52
8511280|NCT00436969|20977203|P1|NOT COMPLETED|Overall Study||22
8511281|NCT00436969|20977202|P2|COMPLETED|Overall Study||134
8511282|NCT00436969|20977203|P1|COMPLETED|Overall Study||66
8511283|NCT00436969|20977202|P2|Randomized But Not Treated|Overall Study||3
8511284|NCT00436969|20977203|P1|Randomized But Not Treated|Overall Study||1
8511285|NCT00436969|20977202|P2|STARTED|Overall Study||186
8511286|NCT00436969|20977203|P1|STARTED|Overall Study||88
8511287|NCT00436956|20977251|P2|NOT COMPLETED|Overall Study||0
8511288|NCT00436956|20977252|P1|NOT COMPLETED|Overall Study||1
8511289|NCT00436956|20977251|P2|COMPLETED|Overall Study||23
8511290|NCT00436956|20977252|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
8511291|NCT00436956|20977251|P2|STARTED|Overall Study||23
8511292|NCT00436956|20977252|P1|STARTED|Overall Study||36
8511293|NCT00436917|20977266|P1|NOT COMPLETED|Overall Study||21
8511294|NCT00436917|20977266|P1|COMPLETED|Overall Study||32
8511295|NCT00436917|20977266|P1|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
8511296|NCT00436904|20977281|P1|NOT COMPLETED|Overall Study||0
8511297|NCT00436904|20977281|P1|COMPLETED|Overall Study||30
8511298|NCT00436904|20977281|P1|STARTED|Overall Study||30
8511299|NCT00436852|20977292|P2|NOT COMPLETED|Overall Study||45
8511300|NCT00436852|20977293|P1|NOT COMPLETED|Overall Study||35
8511301|NCT00436852|20977292|P2|COMPLETED|Overall Study||2
8511302|NCT00436852|20977293|P1|COMPLETED|Overall Study||10
8511303|NCT00436852|20977292|P2|STARTED|Overall Study||47
8511304|NCT00436852|20977293|P1|STARTED|Overall Study||45
8511305|NCT00436826|20977312|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
8511306|NCT00436826|20977313|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
8511307|NCT00436826|20977314|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511308|NCT00436826|20977315|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511309|NCT00436826|20977316|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511310|NCT00436826|20977317|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511311|NCT00436826|20977312|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511312|NCT00436826|20977313|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
8511313|NCT00436826|20977314|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511314|NCT00436826|20977315|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511315|NCT00436826|20977316|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511316|NCT00436826|20977317|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511317|NCT00436826|20977312|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
8511318|NCT00436826|20977313|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
8511319|NCT00436826|20977314|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
8511320|NCT00436826|20977315|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
8511321|NCT00436826|20977316|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
8511322|NCT00436826|20977317|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
8511323|NCT00436826|20977312|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511324|NCT00436826|20977313|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511325|NCT00436826|20977314|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
8511326|NCT00436826|20977315|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
8511327|NCT00436826|20977316|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511328|NCT00436826|20977317|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511329|NCT00436826|20977312|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511330|NCT00436826|20977313|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511331|NCT00436826|20977314|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||2
8511332|NCT00436826|20977315|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||1
8511333|NCT00436826|20977316|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511334|NCT00436826|20977317|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511335|NCT00436826|20977312|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
8511336|NCT00436826|20977313|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
8511337|NCT00436826|20977314|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
8511338|NCT00436826|20977315|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
8511339|NCT00436826|20977316|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
8511340|NCT00436826|20977317|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
8511341|NCT00436826|20977312|P6|NOT COMPLETED|Double Blind Period (DBP)||0
8511342|NCT00436826|20977313|P5|NOT COMPLETED|Double Blind Period (DBP)||0
8511343|NCT00436826|20977314|P4|NOT COMPLETED|Double Blind Period (DBP)||0
8511344|NCT00436826|20977315|P3|NOT COMPLETED|Double Blind Period (DBP)||0
8511345|NCT00436826|20977316|P2|NOT COMPLETED|Double Blind Period (DBP)||11
8511346|NCT00436826|20977317|P1|NOT COMPLETED|Double Blind Period (DBP)||13
8511347|NCT00436826|20977312|P6|COMPLETED|Double Blind Period (DBP)||0
8511348|NCT00436826|20977313|P5|COMPLETED|Double Blind Period (DBP)||0
8511349|NCT00436826|20977314|P4|COMPLETED|Double Blind Period (DBP)||0
8511350|NCT00436826|20977315|P3|COMPLETED|Double Blind Period (DBP)||0
8511351|NCT00436826|20977316|P2|COMPLETED|Double Blind Period (DBP)||37
8511352|NCT00436826|20977317|P1|COMPLETED|Double Blind Period (DBP)||111
8511353|NCT00436826|20977312|P6|STARTED|Double Blind Period (DBP)||0
8511354|NCT00436826|20977313|P5|STARTED|Double Blind Period (DBP)||0
8511355|NCT00436826|20977314|P4|STARTED|Double Blind Period (DBP)||0
8511356|NCT00436826|20977315|P3|STARTED|Double Blind Period (DBP)||0
8511357|NCT00436826|20977316|P2|STARTED|Double Blind Period (DBP)||48
8511358|NCT00436826|20977317|P1|STARTED|Double Blind Period (DBP)||124
8511359|NCT00436748|20977415|P2|NOT COMPLETED|Overall Study||12
8511360|NCT00436748|20977416|P1|NOT COMPLETED|Overall Study||11
8511361|NCT00436748|20977415|P2|COMPLETED|Overall Study||45
8511362|NCT00436748|20977416|P1|COMPLETED|Overall Study||48
8511363|NCT00436748|20977415|P2|Received Treatment|Overall Study||56
8511364|NCT00436748|20977416|P1|Received Treatment|Overall Study||58
8511365|NCT00436748|20977415|P2|STARTED|Overall Study||57
8511366|NCT00436748|20977416|P1|STARTED|Overall Study||59
8511367|NCT00436644|20977450|P1|NOT COMPLETED|Overall Study||3
8511368|NCT00436644|20977450|P1|COMPLETED|Overall Study||15
8511369|NCT00436644|20977450|P1|STARTED|Overall Study||18
8511370|NCT00436618|20977460|P3|NOT COMPLETED|Overall Study||61
8511371|NCT00436618|20977461|P2|NOT COMPLETED|Overall Study||27
8511372|NCT00436618|20977462|P1|NOT COMPLETED|Overall Study||30
8511373|NCT00436618|20977460|P3|COMPLETED|Overall Study||46
8511374|NCT00436618|20977461|P2|COMPLETED|Overall Study||28
8511375|NCT00436618|20977462|P1|COMPLETED|Overall Study||84
8511376|NCT00436618|20977460|P3|STARTED|Overall Study||107
8511377|NCT00436618|20977461|P2|STARTED|Overall Study||55
8511378|NCT00436618|20977462|P1|STARTED|Overall Study||114
8511379|NCT00436605|20977479|P1|NOT COMPLETED|Overall Study||3
8511380|NCT00436605|20977479|P1|COMPLETED|Overall Study||36
8511381|NCT00436605|20977479|P1|STARTED|Overall Study||39
8511382|NCT00436566|20977484|P1|NOT COMPLETED|Overall Study||3
8511383|NCT00436566|20977484|P1|COMPLETED|Overall Study||109
8511384|NCT00436566|20977484|P1|STARTED|Overall Study||112
8511385|NCT00436553|20977491|P3|NOT COMPLETED|Overall Study||10
8511386|NCT00436553|20977492|P2|NOT COMPLETED|Overall Study||12
8511387|NCT00436553|20977493|P1|NOT COMPLETED|Overall Study||13
8511388|NCT00436553|20977491|P3|COMPLETED|Overall Study||102
8511389|NCT00436553|20977492|P2|COMPLETED|Overall Study||93
8511390|NCT00436553|20977493|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
8511391|NCT00436553|20977491|P3|STARTED|Overall Study||112
8511392|NCT00436553|20977492|P2|STARTED|Overall Study||105
8511393|NCT00436553|20977493|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
8511394|NCT00436501|20977514|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
8511395|NCT00436501|20977515|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
8511396|NCT00436501|20977514|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
8511397|NCT00436501|20977515|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
8511398|NCT00436501|20977514|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
8511399|NCT00436501|20977515|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
8511400|NCT00436501|20977514|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8511401|NCT00436501|20977515|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8511402|NCT00436501|20977514|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8511403|NCT00436501|20977515|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
8511404|NCT00436501|20977514|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
8511405|NCT00436501|20977515|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
8511406|NCT00436501|20977514|P2|NOT COMPLETED|Complete Study Participation||0
8511407|NCT00436501|20977515|P1|NOT COMPLETED|Complete Study Participation||0
8511408|NCT00436501|20977514|P2|COMPLETED|Complete Study Participation||49
8511409|NCT00436501|20977515|P1|COMPLETED|Complete Study Participation||9
8511410|NCT00436501|20977514|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
8511411|NCT00436501|20977515|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
8511412|NCT00436475|20977534|P4|NOT COMPLETED|Overall Study||2
8511413|NCT00436475|20977535|P3|NOT COMPLETED|Overall Study||1
8511414|NCT00436475|20977536|P2|NOT COMPLETED|Overall Study||1
8511415|NCT00436475|20977537|P1|NOT COMPLETED|Overall Study||0
8511416|NCT00436475|20977534|P4|COMPLETED|Overall Study||22
8511417|NCT00436475|20977535|P3|COMPLETED|Overall Study||21
8511418|NCT00436475|20977536|P2|COMPLETED|Overall Study||22
8511419|NCT00436475|20977537|P1|COMPLETED|Overall Study||23
8511420|NCT00436475|20977534|P4|STARTED|Overall Study||24
8511421|NCT00436475|20977535|P3|STARTED|Overall Study||22
8511422|NCT00436475|20977536|P2|STARTED|Overall Study||23
8511423|NCT00436475|20977537|P1|STARTED|Overall Study||23
8511424|NCT00436436|20977551|P1|NOT COMPLETED|Overall Study||12
8511425|NCT00436436|20977551|P1|COMPLETED|Overall Study||0
8511426|NCT00436436|20977551|P1|STARTED|Overall Study||12
8511427|NCT00436345|20977562|P2|NOT COMPLETED|Overall Study||0
8511428|NCT00436345|20977563|P1|NOT COMPLETED|Overall Study||3
8511429|NCT00436345|20977562|P2|COMPLETED|Overall Study||18
8511430|NCT00436345|20977563|P1|COMPLETED|Overall Study||18
8511431|NCT00436345|20977562|P2|STARTED|Overall Study||18
8511432|NCT00436345|20977563|P1|STARTED|Overall Study||21
8511433|NCT00436332|20977616|P1|NOT COMPLETED|Overall Study||83
8511434|NCT00436332|20977616|P1|COMPLETED|Overall Study||1
8511435|NCT00436332|20977616|P1|Eligible and Began Protocol Therapy|Overall Study||79
8511436|NCT00436332|20977616|P1|Eligible|Overall Study||82
8511437|NCT00436332|20977616|P1|STARTED|Overall Study||84
8511438|NCT00436280|20977623|P1|NOT COMPLETED|Period 3: Maintenance||18
8511439|NCT00436280|20977623|P1|COMPLETED|Period 3: Maintenance||5
8511440|NCT00436280|20977623|P1|STARTED|Period 3: Maintenance||23
8511441|NCT00436280|20977623|P1|NOT COMPLETED|Period 2: Consolidation||17
8511442|NCT00436280|20977623|P1|COMPLETED|Period 2: Consolidation||23
8511443|NCT00436280|20977623|P1|STARTED|Period 2: Consolidation||40
8511444|NCT00436280|20977623|P1|NOT COMPLETED|Period 1: Induction||28
8511445|NCT00436280|20977623|P1|COMPLETED|Period 1: Induction||40
8511446|NCT00436280|20977623|P1|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
8511447|NCT00436280|20977623|P1|STARTED|Period 1: Induction||68
8511448|NCT00436215|20977637|P1|NOT COMPLETED|Overall Study||4
8511449|NCT00436215|20977637|P1|COMPLETED|Overall Study||51
8511450|NCT00436215|20977637|P1|STARTED|Overall Study||55
8511451|NCT00436163|20977643|P1|NOT COMPLETED|Overall Study||3
8511452|NCT00436163|20977643|P1|COMPLETED|Overall Study||36
8511453|NCT00436163|20977643|P1|STARTED|Overall Study||39
8511454|NCT00436046|20977657|P3|NOT COMPLETED|Overall Study||0
8511455|NCT00436046|20977658|P2|NOT COMPLETED|Overall Study||0
8511456|NCT00436046|20977659|P1|NOT COMPLETED|Overall Study||0
8511457|NCT00436046|20977657|P3|COMPLETED|Overall Study||31
8511458|NCT00436046|20977658|P2|COMPLETED|Overall Study||32
8511459|NCT00436046|20977659|P1|COMPLETED|Overall Study||32
8511460|NCT00436046|20977657|P3|STARTED|Overall Study||31
8511461|NCT00436046|20977658|P2|STARTED|Overall Study||32
8511462|NCT00436046|20977659|P1|STARTED|Overall Study||32
8511463|NCT00436007|20977691|P3|NOT COMPLETED|Overall Study||23
8511464|NCT00436007|20977692|P2|NOT COMPLETED|Overall Study||14
8511465|NCT00436007|20977693|P1|NOT COMPLETED|Overall Study||19
8511466|NCT00436007|20977691|P3|COMPLETED|Overall Study||148
8511467|NCT00436007|20977692|P2|COMPLETED|Overall Study||156
8511468|NCT00436007|20977693|P1|COMPLETED|Overall Study||151
8511469|NCT00436007|20977691|P3|STARTED|Overall Study||171
8511470|NCT00436007|20977692|P2|STARTED|Overall Study||170
8511471|NCT00436007|20977693|P1|STARTED|Overall Study||170
8511472|NCT00435994|20977741|P3|NOT COMPLETED|Overall Study||0
8511473|NCT00435994|20977742|P2|NOT COMPLETED|Overall Study||0
8511474|NCT00435994|20977743|P1|NOT COMPLETED|Overall Study||7
8511475|NCT00435994|20977741|P3|COMPLETED|Overall Study||12
8511476|NCT00435994|20977742|P2|COMPLETED|Overall Study||25
8511477|NCT00435994|20977743|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
8511478|NCT00435994|20977741|P3|STARTED|Overall Study||12
8511479|NCT00435994|20977742|P2|STARTED|Overall Study||25
8511480|NCT00435994|20977743|P1|STARTED|Overall Study||22
8511481|NCT00435942|20977754|P2|NOT COMPLETED|Overall Study||27
8511482|NCT00435942|20977755|P1|NOT COMPLETED|Overall Study||23
8511483|NCT00435942|20977754|P2|COMPLETED|Overall Study||33
8511484|NCT00435942|20977755|P1|COMPLETED|Overall Study||97
8511485|NCT00435942|20977754|P2|STARTED|Overall Study||60
8511486|NCT00435942|20977755|P1|STARTED|Overall Study||120
8511487|NCT00435929|20977764|P2|NOT COMPLETED|Overall Study||0
8511488|NCT00435929|20977765|P1|NOT COMPLETED|Overall Study||0
8511489|NCT00435929|20977764|P2|COMPLETED|Overall Study||9
8511490|NCT00435929|20977765|P1|COMPLETED|Overall Study||7
8511491|NCT00435929|20977764|P2|STARTED|Overall Study||9
8511492|NCT00435929|20977765|P1|STARTED|Overall Study||7
8511493|NCT00435825|20977795|P4|NOT COMPLETED|Overall Study||16
8511494|NCT00435825|20977796|P3|NOT COMPLETED|Overall Study||11
8511495|NCT00435825|20977797|P2|NOT COMPLETED|Overall Study||12
8511496|NCT00435825|20977798|P1|NOT COMPLETED|Overall Study||18
8511497|NCT00435825|20977795|P4|COMPLETED|Overall Study||120
8511498|NCT00435825|20977796|P3|COMPLETED|Overall Study||127
8511499|NCT00435825|20977797|P2|COMPLETED|Overall Study||124
8511500|NCT00435825|20977798|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
8511501|NCT00435825|20977795|P4|Completed 48 Weeks Treatment|Overall Study||117
8511502|NCT00435825|20977796|P3|Completed 48 Weeks Treatment|Overall Study||124
8511503|NCT00435825|20977797|P2|Completed 48 Weeks Treatment|Overall Study||0
8511504|NCT00435825|20977798|P1|Completed 48 Weeks Treatment|Overall Study||0
8511505|NCT00435825|20977795|P4|Completed 24 Weeks Treatment|Overall Study||131
8511506|NCT00435825|20977796|P3|Completed 24 Weeks Treatment|Overall Study||134
8511507|NCT00435825|20977797|P2|Completed 24 Weeks Treatment|Overall Study||126
8511508|NCT00435825|20977798|P1|Completed 24 Weeks Treatment|Overall Study||128
8511509|NCT00435825|20977795|P4|Entered Follow-up|Overall Study||133
8511510|NCT00435825|20977796|P3|Entered Follow-up|Overall Study||135
8511511|NCT00435825|20977797|P2|Entered Follow-up|Overall Study||132
8511512|NCT00435825|20977798|P1|Entered Follow-up|Overall Study||140
8511513|NCT00435825|20977795|P4|Received Study Drug|Overall Study||136
8511514|NCT00435825|20977796|P3|Received Study Drug|Overall Study||136
8511515|NCT00435825|20977797|P2|Received Study Drug|Overall Study||136
8511516|NCT00435825|20977798|P1|Received Study Drug|Overall Study||140
8511517|NCT00435825|20977795|P4|STARTED|Overall Study||136
8511518|NCT00435825|20977796|P3|STARTED|Overall Study||138
8511519|NCT00435825|20977797|P2|STARTED|Overall Study||136
8511520|NCT00435825|20977798|P1|STARTED|Overall Study||141
8511521|NCT00435812|20977854|P2|NOT COMPLETED|Overall Study||18
8511522|NCT00435812|20977855|P1|NOT COMPLETED|Overall Study||63
8511523|NCT00435812|20977854|P2|COMPLETED|Overall Study||590
8511524|NCT00435812|20977855|P1|COMPLETED|Overall Study||1757
8511525|NCT00435812|20977854|P2|STARTED|Overall Study||608
8511526|NCT00435812|20977855|P1|STARTED|Overall Study||1820
8511527|NCT00435591|20977867|P4|NOT COMPLETED|Overall Study||11
8511528|NCT00435591|20977868|P3|NOT COMPLETED|Overall Study||5
8511529|NCT00435591|20977869|P2|NOT COMPLETED|Overall Study||4
8511530|NCT00435591|20977870|P1|NOT COMPLETED|Overall Study||7
8511531|NCT00435591|20977867|P4|COMPLETED|Overall Study||19
8511532|NCT00435591|20977868|P3|COMPLETED|Overall Study||25
8511533|NCT00435591|20977869|P2|COMPLETED|Overall Study||27
8511534|NCT00435591|20977870|P1|COMPLETED|Overall Study||23
8511535|NCT00435591|20977867|P4|End of Treatment|Overall Study||23
8511536|NCT00435591|20977868|P3|End of Treatment|Overall Study||27
8511537|NCT00435591|20977869|P2|End of Treatment|Overall Study||27
8511538|NCT00435591|20977870|P1|End of Treatment|Overall Study||25
8511539|NCT00435591|20977867|P4|Full Analysis Set|Overall Study||29
8511540|NCT00435591|20977868|P3|Full Analysis Set|Overall Study||30
8511541|NCT00435591|20977869|P2|Full Analysis Set|Overall Study||29
8511542|NCT00435591|20977870|P1|Full Analysis Set|Overall Study||28
8511543|NCT00435591|20977867|P4|Safety Analysis Set|Overall Study||29
8511544|NCT00435591|20977868|P3|Safety Analysis Set|Overall Study||30
8511545|NCT00435591|20977869|P2|Safety Analysis Set|Overall Study||30
8511546|NCT00435591|20977870|P1|Safety Analysis Set|Overall Study||28
8511547|NCT00435591|20977867|P4|STARTED|Overall Study||30
8511548|NCT00435591|20977868|P3|STARTED|Overall Study||30
8511549|NCT00435591|20977869|P2|STARTED|Overall Study||31
8511550|NCT00435591|20977870|P1|STARTED|Overall Study||30
8511551|NCT00435539|20977900|P5|NOT COMPLETED|Overall Study||0
8511552|NCT00435539|20977901|P4|NOT COMPLETED|Overall Study||0
8511553|NCT00435539|20977902|P3|NOT COMPLETED|Overall Study||0
8511554|NCT00435539|20977903|P2|NOT COMPLETED|Overall Study||0
8511555|NCT00435539|20977904|P1|NOT COMPLETED|Overall Study||0
8511556|NCT00435539|20977900|P5|COMPLETED|Overall Study||12
8511557|NCT00435539|20977901|P4|COMPLETED|Overall Study||12
8511558|NCT00435539|20977902|P3|COMPLETED|Overall Study||11
8511559|NCT00435539|20977903|P2|COMPLETED|Overall Study||13
8511560|NCT00435539|20977904|P1|COMPLETED|Overall Study||12
8511561|NCT00435539|20977900|P5|STARTED|Overall Study||12
8511562|NCT00435539|20977901|P4|STARTED|Overall Study||12
8511563|NCT00435539|20977902|P3|STARTED|Overall Study||11
8511564|NCT00435539|20977903|P2|STARTED|Overall Study||13
8511565|NCT00435539|20977904|P1|STARTED|Overall Study||12
8511566|NCT00435487|20977921|P2|NOT COMPLETED|Overall Study||15
8511567|NCT00435487|20977922|P1|NOT COMPLETED|Overall Study||12
8511568|NCT00435487|20977921|P2|COMPLETED|Overall Study||71
8511569|NCT00435487|20977922|P1|COMPLETED|Overall Study||76
8511570|NCT00435487|20977921|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
8511571|NCT00435487|20977922|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
8511572|NCT00435487|20977921|P2|STARTED|Overall Study||86
8511573|NCT00435487|20977922|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
8511574|NCT00435461|20977941|P3|NOT COMPLETED|Overall Study||24
8511575|NCT00435461|20977942|P2|NOT COMPLETED|Overall Study||14
8511576|NCT00435461|20977943|P1|NOT COMPLETED|Overall Study||23
8511577|NCT00435461|20977941|P3|COMPLETED|Overall Study||287
8511578|NCT00435461|20977942|P2|COMPLETED|Overall Study||298
8511579|NCT00435461|20977943|P1|COMPLETED|Overall Study||290
8511580|NCT00435461|20977941|P3|STARTED|Overall Study||311
8511581|NCT00435461|20977942|P2|STARTED|Overall Study||312
8511582|NCT00435461|20977943|P1|STARTED|Overall Study||313
8511583|NCT00435409|20977980|P3|NOT COMPLETED|Overall Study||78
8511584|NCT00435409|20977981|P2|NOT COMPLETED|Overall Study||143
8511585|NCT00435409|20977982|P1|NOT COMPLETED|Overall Study||221
8511586|NCT00435409|20977980|P3|COMPLETED|Overall Study||0
8511587|NCT00435409|20977981|P2|COMPLETED|Overall Study||0
8511588|NCT00435409|20977982|P1|COMPLETED|Overall Study||0
8511589|NCT00435409|20977980|P3|Treated|Overall Study||78
8511590|NCT00435409|20977981|P2|Treated|Overall Study||139
8511591|NCT00435409|20977982|P1|Treated|Overall Study||217
8511592|NCT00435409|20977980|P3|STARTED|Overall Study||78
8511593|NCT00435409|20977981|P2|STARTED|Overall Study||143
8511594|NCT00435409|20977982|P1|STARTED|Overall Study||221
8511595|NCT00435370|20978004|P2|NOT COMPLETED|Overall Study||20
8511596|NCT00435370|20978005|P1|NOT COMPLETED|Overall Study||22
8511597|NCT00435370|20978004|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
8511598|NCT00435370|20978005|P1|COMPLETED|Overall Study||68
8511599|NCT00435370|20978004|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
8511600|NCT00435370|20978005|P1|STARTED|Overall Study||90
8511601|NCT00435188|20978013|P2|NOT COMPLETED|Overall Study||23
8511602|NCT00435188|20978014|P1|NOT COMPLETED|Overall Study||22
8511603|NCT00435188|20978013|P2|COMPLETED|Overall Study||176
8511604|NCT00435188|20978014|P1|COMPLETED|Overall Study||177
8511605|NCT00435188|20978013|P2|STARTED|Overall Study||199
8511606|NCT00435188|20978014|P1|STARTED|Overall Study||199
8511607|NCT00435162|20978057|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
8511608|NCT00435162|20978058|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
8511609|NCT00435162|20978059|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
8511610|NCT00435162|20978060|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
8511611|NCT00435162|20978061|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
8511612|NCT00435162|20978062|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
8511613|NCT00435162|20978057|P6|COMPLETED|Period 2 (2 Weeks)||15
8511614|NCT00435162|20978058|P5|COMPLETED|Period 2 (2 Weeks)||15
8511615|NCT00435162|20978059|P4|COMPLETED|Period 2 (2 Weeks)||8
8511616|NCT00435162|20978060|P3|COMPLETED|Period 2 (2 Weeks)||6
8511617|NCT00435162|20978061|P2|COMPLETED|Period 2 (2 Weeks)||14
8511618|NCT00435162|20978062|P1|COMPLETED|Period 2 (2 Weeks)||15
8511619|NCT00435162|20978057|P6|STARTED|Period 2 (2 Weeks)||15
8511620|NCT00435162|20978058|P5|STARTED|Period 2 (2 Weeks)||15
8511621|NCT00435162|20978059|P4|STARTED|Period 2 (2 Weeks)||8
8511622|NCT00435162|20978060|P3|STARTED|Period 2 (2 Weeks)||6
8511623|NCT00435162|20978061|P2|STARTED|Period 2 (2 Weeks)||15
8511624|NCT00435162|20978062|P1|STARTED|Period 2 (2 Weeks)||15
8511625|NCT00435162|20978057|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
8511626|NCT00435162|20978058|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
8511627|NCT00435162|20978059|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
8511628|NCT00435162|20978060|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
8511629|NCT00435162|20978061|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
8511630|NCT00435162|20978062|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
8511631|NCT00435162|20978057|P6|COMPLETED|Period 1 (6 Weeks)||15
8511632|NCT00435162|20978058|P5|COMPLETED|Period 1 (6 Weeks)||15
8511633|NCT00435162|20978059|P4|COMPLETED|Period 1 (6 Weeks)||8
8511634|NCT00435162|20978060|P3|COMPLETED|Period 1 (6 Weeks)||6
8511635|NCT00435162|20978061|P2|COMPLETED|Period 1 (6 Weeks)||15
8511636|NCT00435162|20978062|P1|COMPLETED|Period 1 (6 Weeks)||15
8511637|NCT00435162|20978057|P6|STARTED|Period 1 (6 Weeks)||15
8511638|NCT00435162|20978058|P5|STARTED|Period 1 (6 Weeks)||15
8511639|NCT00435162|20978059|P4|STARTED|Period 1 (6 Weeks)||8
8511640|NCT00435162|20978060|P3|STARTED|Period 1 (6 Weeks)||6
8511641|NCT00435162|20978061|P2|STARTED|Period 1 (6 Weeks)||15
8511642|NCT00435162|20978062|P1|STARTED|Period 1 (6 Weeks)||15
8511643|NCT00435045|20978082|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
8511644|NCT00435045|20978083|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
8511645|NCT00435045|20978082|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
8511646|NCT00435045|20978083|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
8511647|NCT00435045|20978082|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
8511648|NCT00435045|20978083|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
8511649|NCT00435045|20978082|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
8511650|NCT00435045|20978083|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
8511651|NCT00435045|20978082|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
8511652|NCT00435045|20978083|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
8511653|NCT00435045|20978082|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
8511654|NCT00435045|20978083|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
8511655|NCT00435045|20978082|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
8511656|NCT00435045|20978083|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
8511657|NCT00435045|20978082|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
8511658|NCT00435045|20978083|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
8511659|NCT00435045|20978082|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
8511660|NCT00435045|20978083|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
8511661|NCT00435019|20978139|P2|NOT COMPLETED|Overall Study||10
8511662|NCT00435019|20978140|P1|NOT COMPLETED|Overall Study||13
8511663|NCT00435019|20978139|P2|COMPLETED|Overall Study||161
8511664|NCT00435019|20978140|P1|COMPLETED|Overall Study||164
8511665|NCT00435019|20978139|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
8511666|NCT00435019|20978140|P1|Exposed to Study Drug|Overall Study||177
8511667|NCT00435019|20978139|P2|STARTED|Overall Study|Randomised|171
8511668|NCT00435019|20978140|P1|STARTED|Overall Study|Randomised|177
8511669|NCT00434993|20978152|P2|NOT COMPLETED|Overall Study||0
8511670|NCT00434993|20978153|P1|NOT COMPLETED|Overall Study||0
8511671|NCT00434993|20978152|P2|COMPLETED|Overall Study||130
8511672|NCT00434993|20978153|P1|COMPLETED|Overall Study||152
8511673|NCT00434993|20978152|P2|STARTED|Overall Study||130
8511674|NCT00434993|20978153|P1|STARTED|Overall Study||152
8511675|NCT00434967|20978181|P4|NOT COMPLETED|Overall Study||14
8511676|NCT00434967|20978182|P3|NOT COMPLETED|Overall Study||9
8511677|NCT00434967|20978183|P2|NOT COMPLETED|Overall Study||8
8511678|NCT00434967|20978184|P1|NOT COMPLETED|Overall Study||7
8511679|NCT00434967|20978181|P4|COMPLETED|Overall Study||478
8511680|NCT00434967|20978182|P3|COMPLETED|Overall Study||461
8511681|NCT00434967|20978183|P2|COMPLETED|Overall Study||457
8511682|NCT00434967|20978184|P1|COMPLETED|Overall Study||90
8511683|NCT00434967|20978181|P4|STARTED|Overall Study||492
8511684|NCT00434967|20978182|P3|STARTED|Overall Study||470
8511685|NCT00434967|20978183|P2|STARTED|Overall Study||465
8511686|NCT00434967|20978184|P1|STARTED|Overall Study||97
8511687|NCT00434954|20978204|P2|NOT COMPLETED|Overall Study||71
8511688|NCT00434954|20978205|P1|NOT COMPLETED|Overall Study||82
8511689|NCT00434954|20978204|P2|COMPLETED|Overall Study||175
8511690|NCT00434954|20978205|P1|COMPLETED|Overall Study||166
8511691|NCT00434954|20978204|P2|Completed - Previous Treatment MET + SU|Overall Study||38
8511692|NCT00434954|20978205|P1|Completed - Previous Treatment MET + SU|Overall Study||31
8511693|NCT00434954|20978204|P2|Completed - Previous Treatment MET Only|Overall Study||137
8511694|NCT00434954|20978205|P1|Completed - Previous Treatment MET Only|Overall Study||135
8511695|NCT00434954|20978204|P2|FAS - Previous Treatment MET + SU|Overall Study||60
8511696|NCT00434954|20978205|P1|FAS - Previous Treatment MET + SU|Overall Study||66
8511697|NCT00434954|20978204|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
8511698|NCT00434954|20978205|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
8511699|NCT00434954|20978204|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
8511700|NCT00434954|20978205|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
8511701|NCT00434954|20978204|P2|Started - Previous Treatment MET + SU|Overall Study||65
8511702|NCT00434954|20978205|P1|Started - Previous Treatment MET + SU|Overall Study||66
8511703|NCT00434954|20978204|P2|Started - Previous Treatment MET Only|Overall Study||181
8511704|NCT00434954|20978205|P1|Started - Previous Treatment MET Only|Overall Study||182
8511705|NCT00434954|20978204|P2|STARTED|Overall Study||246
8511706|NCT00434954|20978205|P1|STARTED|Overall Study||248
8511707|NCT00434876|20978235|P2|NOT COMPLETED|Overall Study||1
8511708|NCT00434876|20978236|P1|NOT COMPLETED|Overall Study||1
8511709|NCT00434876|20978235|P2|COMPLETED|Overall Study||10
8511710|NCT00434876|20978236|P1|COMPLETED|Overall Study||10
8511711|NCT00434876|20978235|P2|STARTED|Overall Study||11
8511712|NCT00434876|20978236|P1|STARTED|Overall Study||11
8511713|NCT00434759|20978250|P2|NOT COMPLETED|Overall Study||5
8511714|NCT00434759|20978251|P1|NOT COMPLETED|Overall Study||24
8511715|NCT00434759|20978250|P2|COMPLETED|Overall Study||38
8511716|NCT00434759|20978251|P1|COMPLETED|Overall Study||22
8511717|NCT00434759|20978250|P2|STARTED|Overall Study||43
8511718|NCT00434759|20978251|P1|STARTED|Overall Study||46
8511719|NCT00434642|20978267|P2|NOT COMPLETED|Open-label Treatment Phase||11
8511720|NCT00434642|20978268|P1|NOT COMPLETED|Open-label Treatment Phase||0
8511721|NCT00434642|20978267|P2|COMPLETED|Open-label Treatment Phase||1
8511722|NCT00434642|20978268|P1|COMPLETED|Open-label Treatment Phase||0
8511820|NCT00434434|20978588|P1|COMPLETED|Overall Study||21
8511723|NCT00434642|20978267|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
8511724|NCT00434642|20978268|P1|STARTED|Open-label Treatment Phase||0
8511725|NCT00434642|20978267|P2|NOT COMPLETED|Blinded Treatment Phase||229
8511726|NCT00434642|20978268|P1|NOT COMPLETED|Blinded Treatment Phase||242
8511727|NCT00434642|20978267|P2|COMPLETED|Blinded Treatment Phase||13
8511728|NCT00434642|20978268|P1|COMPLETED|Blinded Treatment Phase||0
8511729|NCT00434642|20978267|P2|STARTED|Blinded Treatment Phase||242
8511730|NCT00434642|20978268|P1|STARTED|Blinded Treatment Phase||242
8511731|NCT00434590|20978286|P2|NOT COMPLETED|Overall Study||5
8511732|NCT00434590|20978287|P1|NOT COMPLETED|Overall Study||5
8511733|NCT00434590|20978286|P2|COMPLETED|Overall Study||0
8511734|NCT00434590|20978287|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
8511735|NCT00434590|20978286|P2|STARTED|Overall Study||5
8511736|NCT00434590|20978287|P1|STARTED|Overall Study||5
8511737|NCT00434577|20978298|P5|NOT COMPLETED|Month 36||0
8511738|NCT00434577|20978299|P4|NOT COMPLETED|Month 36||0
8511739|NCT00434577|20978300|P3|NOT COMPLETED|Month 36||0
8511740|NCT00434577|20978301|P2|NOT COMPLETED|Month 36||0
8511741|NCT00434577|20978302|P1|NOT COMPLETED|Month 36||0
8511742|NCT00434577|20978298|P5|COMPLETED|Month 36||47
8511743|NCT00434577|20978299|P4|COMPLETED|Month 36||155
8511744|NCT00434577|20978300|P3|COMPLETED|Month 36||150
8511745|NCT00434577|20978301|P2|COMPLETED|Month 36||147
8511746|NCT00434577|20978302|P1|COMPLETED|Month 36||147
8511747|NCT00434577|20978298|P5|STARTED|Month 36||47
8511748|NCT00434577|20978299|P4|STARTED|Month 36||155
8511749|NCT00434577|20978300|P3|STARTED|Month 36||150
8511750|NCT00434577|20978301|P2|STARTED|Month 36||147
8511751|NCT00434577|20978302|P1|STARTED|Month 36||147
8511752|NCT00434577|20978298|P5|NOT COMPLETED|Month 24||0
8511753|NCT00434577|20978299|P4|NOT COMPLETED|Month 24||0
8511754|NCT00434577|20978300|P3|NOT COMPLETED|Month 24||0
8511755|NCT00434577|20978301|P2|NOT COMPLETED|Month 24||0
8511756|NCT00434577|20978302|P1|NOT COMPLETED|Month 24||0
8511757|NCT00434577|20978298|P5|COMPLETED|Month 24||49
8511758|NCT00434577|20978299|P4|COMPLETED|Month 24||157
8511759|NCT00434577|20978300|P3|COMPLETED|Month 24||154
8511760|NCT00434577|20978301|P2|COMPLETED|Month 24||155
8511761|NCT00434577|20978302|P1|COMPLETED|Month 24||150
8511762|NCT00434577|20978298|P5|STARTED|Month 24||49
8511763|NCT00434577|20978299|P4|STARTED|Month 24||157
8511764|NCT00434577|20978300|P3|STARTED|Month 24||154
8511765|NCT00434577|20978301|P2|STARTED|Month 24||155
8511766|NCT00434577|20978302|P1|STARTED|Month 24||150
8511767|NCT00434577|20978298|P5|NOT COMPLETED|Month 12||0
8511768|NCT00434577|20978299|P4|NOT COMPLETED|Month 12||0
8511769|NCT00434577|20978300|P3|NOT COMPLETED|Month 12||0
8511770|NCT00434577|20978301|P2|NOT COMPLETED|Month 12||0
8511771|NCT00434577|20978302|P1|NOT COMPLETED|Month 12||0
8511772|NCT00434577|20978298|P5|COMPLETED|Month 12||50
8511773|NCT00434577|20978299|P4|COMPLETED|Month 12||161
8511774|NCT00434577|20978300|P3|COMPLETED|Month 12||159
8511775|NCT00434577|20978301|P2|COMPLETED|Month 12||159
8511776|NCT00434577|20978302|P1|COMPLETED|Month 12||156
8511777|NCT00434577|20978298|P5|STARTED|Month 12||50
8511778|NCT00434577|20978299|P4|STARTED|Month 12||161
8511779|NCT00434577|20978300|P3|STARTED|Month 12||159
8511780|NCT00434577|20978301|P2|STARTED|Month 12||159
8511781|NCT00434577|20978302|P1|STARTED|Month 12||156
8511782|NCT00434577|20978298|P5|NOT COMPLETED|Months 0-3||3
8511783|NCT00434577|20978299|P4|NOT COMPLETED|Months 0-3||1
8511784|NCT00434577|20978300|P3|NOT COMPLETED|Months 0-3||4
8511785|NCT00434577|20978301|P2|NOT COMPLETED|Months 0-3||2
8511786|NCT00434577|20978302|P1|NOT COMPLETED|Months 0-3||3
8511787|NCT00434577|20978298|P5|COMPLETED|Months 0-3||51
8511788|NCT00434577|20978299|P4|COMPLETED|Months 0-3||164
8511789|NCT00434577|20978300|P3|COMPLETED|Months 0-3||161
8511790|NCT00434577|20978301|P2|COMPLETED|Months 0-3||164
8511791|NCT00434577|20978302|P1|COMPLETED|Months 0-3||161
8511792|NCT00434577|20978298|P5|STARTED|Months 0-3||54
8511793|NCT00434577|20978299|P4|STARTED|Months 0-3||165
8511794|NCT00434577|20978300|P3|STARTED|Months 0-3||165
8511795|NCT00434577|20978301|P2|STARTED|Months 0-3||166
8511796|NCT00434577|20978302|P1|STARTED|Months 0-3||164
8511797|NCT00434512|20978480|P6|NOT COMPLETED|Overall Study||1
8511798|NCT00434512|20978481|P5|NOT COMPLETED|Overall Study||1
8511799|NCT00434512|20978482|P4|NOT COMPLETED|Overall Study||1
8511800|NCT00434512|20978483|P3|NOT COMPLETED|Overall Study||0
8511801|NCT00434512|20978484|P2|NOT COMPLETED|Overall Study||1
8511802|NCT00434512|20978485|P1|NOT COMPLETED|Overall Study||0
8511803|NCT00434512|20978480|P6|COMPLETED|Overall Study||49
8511804|NCT00434512|20978481|P5|COMPLETED|Overall Study||49
8511805|NCT00434512|20978482|P4|COMPLETED|Overall Study||49
8511806|NCT00434512|20978483|P3|COMPLETED|Overall Study||10
8511807|NCT00434512|20978484|P2|COMPLETED|Overall Study||9
8511808|NCT00434512|20978485|P1|COMPLETED|Overall Study||10
8511809|NCT00434512|20978480|P6|STARTED|Overall Study||50
8511810|NCT00434512|20978481|P5|STARTED|Overall Study||50
8511811|NCT00434512|20978482|P4|STARTED|Overall Study||50
8511812|NCT00434512|20978483|P3|STARTED|Overall Study||10
8511813|NCT00434512|20978484|P2|STARTED|Overall Study||10
8511814|NCT00434512|20978485|P1|STARTED|Overall Study||10
8511815|NCT00434434|20978586|P3|NOT COMPLETED|Overall Study||1
8511816|NCT00434434|20978587|P2|NOT COMPLETED|Overall Study||0
8511817|NCT00434434|20978588|P1|NOT COMPLETED|Overall Study||2
8511818|NCT00434434|20978586|P3|COMPLETED|Overall Study||13
8511819|NCT00434434|20978587|P2|COMPLETED|Overall Study||24
8511821|NCT00434434|20978586|P3|STARTED|Overall Study||14
8511822|NCT00434434|20978587|P2|STARTED|Overall Study||24
8511823|NCT00434434|20978588|P1|STARTED|Overall Study||23
8511824|NCT00434421|20978599|P1|NOT COMPLETED|Overall Study||2
8511825|NCT00434421|20978599|P1|COMPLETED|Overall Study||26
8511826|NCT00434421|20978599|P1|STARTED|Overall Study||28
8511827|NCT00434356|20978605|P2|NOT COMPLETED|Overall Study||23
8511828|NCT00434356|20978606|P1|NOT COMPLETED|Overall Study||23
8511829|NCT00434356|20978605|P2|COMPLETED|Overall Study||0
8511830|NCT00434356|20978606|P1|COMPLETED|Overall Study||0
8511831|NCT00434356|20978605|P2|STARTED|Overall Study||23
8511832|NCT00434356|20978606|P1|STARTED|Overall Study||23
8511833|NCT00434330|20978627|P6|NOT COMPLETED|Overall Study||1
8511834|NCT00434330|20978628|P5|NOT COMPLETED|Overall Study||1
8511835|NCT00434330|20978629|P4|NOT COMPLETED|Overall Study||2
8511836|NCT00434330|20978630|P3|NOT COMPLETED|Overall Study||3
8511837|NCT00434330|20978631|P2|NOT COMPLETED|Overall Study||0
8511838|NCT00434330|20978632|P1|NOT COMPLETED|Overall Study||1
8511839|NCT00434330|20978627|P6|COMPLETED|Overall Study||14
8511840|NCT00434330|20978628|P5|COMPLETED|Overall Study||14
8511841|NCT00434330|20978629|P4|COMPLETED|Overall Study||13
8511842|NCT00434330|20978630|P3|COMPLETED|Overall Study||13
8511843|NCT00434330|20978631|P2|COMPLETED|Overall Study||15
8511844|NCT00434330|20978632|P1|COMPLETED|Overall Study||14
8511845|NCT00434330|20978627|P6|STARTED|Overall Study||15
8511846|NCT00434330|20978628|P5|STARTED|Overall Study||15
8511847|NCT00434330|20978629|P4|STARTED|Overall Study||15
8511848|NCT00434330|20978630|P3|STARTED|Overall Study||16
8511849|NCT00434330|20978631|P2|STARTED|Overall Study||15
8511850|NCT00434330|20978632|P1|STARTED|Overall Study||15
8511851|NCT00434304|20978664|P1|NOT COMPLETED|Overall Study||20
8511852|NCT00434304|20978664|P1|COMPLETED|Overall Study||42
8511853|NCT00434304|20978664|P1|STARTED|Overall Study||62
8511854|NCT00434278|20978702|P2|NOT COMPLETED|Overall Study||0
8511855|NCT00434278|20978703|P1|NOT COMPLETED|Overall Study||2
8511856|NCT00434278|20978702|P2|COMPLETED|Overall Study||13
8511857|NCT00434278|20978703|P1|COMPLETED|Overall Study||12
8511858|NCT00434278|20978702|P2|STARTED|Overall Study||13
8511859|NCT00434278|20978703|P1|STARTED|Overall Study||14
8511860|NCT00434252|20978713|P2|NOT COMPLETED|Overall Study||131
8511861|NCT00434252|20978714|P1|NOT COMPLETED|Overall Study||64
8511862|NCT00434252|20978713|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
8511863|NCT00434252|20978714|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
8511864|NCT00434252|20978713|P2|Treated|Overall Study||143
8511865|NCT00434252|20978714|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
8511866|NCT00434252|20978713|P2|STARTED|Overall Study||143
8511867|NCT00434252|20978714|P1|STARTED|Overall Study||71
8511868|NCT00434226|20978736|P2|NOT COMPLETED|Overall Study||26
8511869|NCT00434226|20978737|P1|NOT COMPLETED|Overall Study||30
8511870|NCT00434226|20978736|P2|COMPLETED|Overall Study||0
8511871|NCT00434226|20978737|P1|COMPLETED|Overall Study||0
8511872|NCT00434226|20978736|P2|STARTED|Overall Study||26
8511873|NCT00434226|20978737|P1|STARTED|Overall Study||30
8511874|NCT00434213|20978748|P1|NOT COMPLETED|Overall Study||49
8511875|NCT00434213|20978748|P1|COMPLETED|Overall Study||260
8511876|NCT00434213|20978748|P1|STARTED|Overall Study||309
8511877|NCT00434161|20978756|P3|NOT COMPLETED|Overall Study||11
8511878|NCT00434161|20978757|P2|NOT COMPLETED|Overall Study||3
8511879|NCT00434161|20978758|P1|NOT COMPLETED|Overall Study||10
8511880|NCT00434161|20978756|P3|COMPLETED|Overall Study||104
8511881|NCT00434161|20978757|P2|COMPLETED|Overall Study||54
8511882|NCT00434161|20978758|P1|COMPLETED|Overall Study||99
8511883|NCT00434161|20978756|P3|STARTED|Overall Study||115
8511884|NCT00434161|20978757|P2|STARTED|Overall Study||57
8511885|NCT00434161|20978758|P1|STARTED|Overall Study||109
8511886|NCT00434148|20978802|P2|NOT COMPLETED|Overall Study||73
8511887|NCT00434148|20978803|P1|NOT COMPLETED|Overall Study||69
8511888|NCT00434148|20978802|P2|COMPLETED|Overall Study||7
8511889|NCT00434148|20978803|P1|COMPLETED|Overall Study||13
8511890|NCT00434148|20978802|P2|Completed Month 12; Entered Extension|Overall Study||32
8511891|NCT00434148|20978803|P1|Completed Month 12; Entered Extension|Overall Study||26
8511892|NCT00434148|20978802|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
8511893|NCT00434148|20978803|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
8511894|NCT00434148|20978802|P2|Completed Month 12|Overall Study||39
8511895|NCT00434148|20978803|P1|Completed Month 12|Overall Study||39
8511896|NCT00434148|20978802|P2|STARTED|Overall Study||80
8511897|NCT00434148|20978803|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
8511898|NCT00434122|20978839|P2|NOT COMPLETED|Overall Study||7
8511899|NCT00434122|20978840|P1|NOT COMPLETED|Overall Study||6
8511900|NCT00434122|20978839|P2|COMPLETED|Overall Study||36
8511901|NCT00434122|20978840|P1|COMPLETED|Overall Study||36
8511902|NCT00434122|20978839|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
8511903|NCT00434122|20978840|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
8511904|NCT00434122|20978839|P2|STARTED|Overall Study|Randomised|43
8511905|NCT00434122|20978840|P1|STARTED|Overall Study|Randomised|42
8511906|NCT00434109|20978849|P1|NOT COMPLETED|Overall Study||18
8511907|NCT00434109|20978849|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
8511908|NCT00434109|20978849|P1|STARTED|Overall Study||39
8511909|NCT00434057|20978858|P1|NOT COMPLETED|Overall Study||1
8511910|NCT00434057|20978858|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
8511911|NCT00434057|20978858|P1|STARTED|Overall Study||1383
8511912|NCT00434018|20978864|P2|NOT COMPLETED|Overall Study||12
8511913|NCT00434018|20978865|P1|NOT COMPLETED|Overall Study||17
8511914|NCT00434018|20978864|P2|COMPLETED|Overall Study||57
8511915|NCT00434018|20978865|P1|COMPLETED|Overall Study||52
8511916|NCT00434018|20978864|P2|STARTED|Overall Study||69
8511917|NCT00434018|20978865|P1|STARTED|Overall Study||69
8511918|NCT00433992|20978883|P2|NOT COMPLETED|Overall Study||8
8511919|NCT00433992|20978884|P1|NOT COMPLETED|Overall Study||9
8511920|NCT00433992|20978883|P2|COMPLETED|Overall Study||20
8511921|NCT00433992|20978884|P1|COMPLETED|Overall Study||19
8511922|NCT00433992|20978883|P2|STARTED|Overall Study||28
8511923|NCT00433992|20978884|P1|STARTED|Overall Study||28
8511924|NCT00433966|20978896|P4|NOT COMPLETED|Stent Intervention/Randomization||62
8511925|NCT00433966|20978897|P3|NOT COMPLETED|Stent Intervention/Randomization||154
8511926|NCT00433966|20978898|P2|NOT COMPLETED|Stent Intervention/Randomization||0
8511927|NCT00433966|20978899|P1|NOT COMPLETED|Stent Intervention/Randomization||0
8511928|NCT00433966|20978896|P4|COMPLETED|Stent Intervention/Randomization||687
8511929|NCT00433966|20978897|P3|COMPLETED|Stent Intervention/Randomization||2103
8511930|NCT00433966|20978898|P2|COMPLETED|Stent Intervention/Randomization||0
8511931|NCT00433966|20978899|P1|COMPLETED|Stent Intervention/Randomization||0
8511932|NCT00433966|20978896|P4|3-Year Follow-up|Stent Intervention/Randomization||687
8511933|NCT00433966|20978897|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
8511934|NCT00433966|20978898|P2|3-Year Follow-up|Stent Intervention/Randomization||0
8511935|NCT00433966|20978899|P1|3-Year Follow-up|Stent Intervention/Randomization||0
8511936|NCT00433966|20978896|P4|1-Year Follow-up|Stent Intervention/Randomization||715
8511937|NCT00433966|20978897|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
8511938|NCT00433966|20978898|P2|1-Year Follow-up|Stent Intervention/Randomization||0
8511939|NCT00433966|20978899|P1|1-Year Follow-up|Stent Intervention/Randomization||0
8511940|NCT00433966|20978896|P4|STARTED|Stent Intervention/Randomization||749
8511941|NCT00433966|20978897|P3|STARTED|Stent Intervention/Randomization||2257
8511942|NCT00433966|20978898|P2|STARTED|Stent Intervention/Randomization||0
8511943|NCT00433966|20978899|P1|STARTED|Stent Intervention/Randomization||0
8511944|NCT00433966|20978896|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
8511945|NCT00433966|20978897|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
8511946|NCT00433966|20978898|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
8511947|NCT00433966|20978899|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
8511948|NCT00433966|20978896|P4|COMPLETED|Pharmacology Intervention/Randomization||0
8511949|NCT00433966|20978897|P3|COMPLETED|Pharmacology Intervention/Randomization||0
8511950|NCT00433966|20978898|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
8511951|NCT00433966|20978899|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
8511952|NCT00433966|20978896|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
8511953|NCT00433966|20978897|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
8511954|NCT00433966|20978898|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
8511955|NCT00433966|20978899|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
8511956|NCT00433966|20978896|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
8511957|NCT00433966|20978897|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
8511958|NCT00433966|20978898|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
8511959|NCT00433966|20978899|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
8511960|NCT00433966|20978896|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
8511961|NCT00433966|20978897|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
8511962|NCT00433966|20978898|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
8511963|NCT00433966|20978899|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
8511964|NCT00433966|20978896|P4|STARTED|Pharmacology Intervention/Randomization||0
8511965|NCT00433966|20978897|P3|STARTED|Pharmacology Intervention/Randomization||0
8511966|NCT00433966|20978898|P2|STARTED|Pharmacology Intervention/Randomization||1802
8511967|NCT00433966|20978899|P1|STARTED|Pharmacology Intervention/Randomization||1800
8511968|NCT00433914|20978921|P2|NOT COMPLETED|Overall Study||3
8511969|NCT00433914|20978922|P1|NOT COMPLETED|Overall Study||0
8511970|NCT00433914|20978921|P2|COMPLETED|Overall Study||27
8511971|NCT00433914|20978922|P1|COMPLETED|Overall Study||30
8511972|NCT00433914|20978921|P2|STARTED|Overall Study||30
8511973|NCT00433914|20978922|P1|STARTED|Overall Study||30
8511974|NCT00433836|20978942|P2|NOT COMPLETED|Overall Study||6
8511975|NCT00433836|20978943|P1|NOT COMPLETED|Overall Study||13
8511976|NCT00433836|20978942|P2|COMPLETED|Overall Study||143
8511977|NCT00433836|20978943|P1|COMPLETED|Overall Study||138
8511978|NCT00433836|20978942|P2|STARTED|Overall Study||149
8511979|NCT00433836|20978943|P1|STARTED|Overall Study||151
8511980|NCT00433771|20978955|P1|NOT COMPLETED|Overall Study||19
8511981|NCT00433771|20978955|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
8511982|NCT00433771|20978955|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
8511983|NCT00433745|20978971|P1|NOT COMPLETED|Overall Study||0
8511984|NCT00433745|20978971|P1|COMPLETED|Overall Study||4
8511985|NCT00433745|20978971|P1|STARTED|Overall Study||4
8511986|NCT00433654|20978978|P2|NOT COMPLETED|Overall Study||5
8511987|NCT00433654|20978979|P1|NOT COMPLETED|Overall Study||15
8511988|NCT00433654|20978978|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
8512071|NCT00433290|20979092|P1|STARTED|Overall Study||128
8511989|NCT00433654|20978979|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
8511990|NCT00433654|20978978|P2|STARTED|Overall Study||206
8511991|NCT00433654|20978979|P1|STARTED|Overall Study||258
8511992|NCT00433550|20979013|P3|NOT COMPLETED|Overall Study||0
8511993|NCT00433550|20979014|P2|NOT COMPLETED|Overall Study||0
8511994|NCT00433550|20979015|P1|NOT COMPLETED|Overall Study||0
8511995|NCT00433550|20979013|P3|COMPLETED|Overall Study||6
8511996|NCT00433550|20979014|P2|COMPLETED|Overall Study||10
8511997|NCT00433550|20979015|P1|COMPLETED|Overall Study||17
8511998|NCT00433550|20979013|P3|STARTED|Overall Study||6
8511999|NCT00433550|20979014|P2|STARTED|Overall Study||10
8512000|NCT00433550|20979015|P1|STARTED|Overall Study||17
8512001|NCT00433537|20979025|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8512002|NCT00433537|20979026|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8512003|NCT00433537|20979027|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
8512004|NCT00433537|20979025|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8512005|NCT00433537|20979026|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
8512006|NCT00433537|20979027|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
8512007|NCT00433537|20979025|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
8512008|NCT00433537|20979026|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
8512009|NCT00433537|20979027|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
8512010|NCT00433537|20979025|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
8512011|NCT00433537|20979026|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
8512012|NCT00433537|20979027|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
8512013|NCT00433537|20979025|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
8512014|NCT00433537|20979026|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
8512015|NCT00433537|20979027|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
8512016|NCT00433537|20979025|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
8512017|NCT00433537|20979026|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
8512018|NCT00433537|20979027|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
8512019|NCT00433537|20979025|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
8512020|NCT00433537|20979026|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
8512021|NCT00433537|20979027|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
8512022|NCT00433537|20979025|P3|STARTED|Step 1 - VcR-CVAD Induction||10
8512023|NCT00433537|20979026|P2|STARTED|Step 1 - VcR-CVAD Induction||22
8512024|NCT00433537|20979027|P1|STARTED|Step 1 - VcR-CVAD Induction||45
8512025|NCT00433511|20979039|P3|NOT COMPLETED|Step 2 (Arm D)||491
8512026|NCT00433511|20979040|P2|NOT COMPLETED|Step 2 (Arm D)||0
8512027|NCT00433511|20979041|P1|NOT COMPLETED|Step 2 (Arm D)||0
8512028|NCT00433511|20979039|P3|COMPLETED|Step 2 (Arm D)||825
8512029|NCT00433511|20979040|P2|COMPLETED|Step 2 (Arm D)||0
8512030|NCT00433511|20979041|P1|COMPLETED|Step 2 (Arm D)||0
8512031|NCT00433511|20979039|P3|Patients Who Received Treatment|Step 2 (Arm D)||1168
8512032|NCT00433511|20979040|P2|Patients Who Received Treatment|Step 2 (Arm D)||0
8512033|NCT00433511|20979041|P1|Patients Who Received Treatment|Step 2 (Arm D)||0
8512034|NCT00433511|20979039|P3|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
8512035|NCT00433511|20979040|P2|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
8512036|NCT00433511|20979041|P1|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
8512037|NCT00433511|20979039|P3|NOT COMPLETED|Step 1||390
8512038|NCT00433511|20979040|P2|NOT COMPLETED|Step 1||385
8512039|NCT00433511|20979041|P1|NOT COMPLETED|Step 1||136
8512040|NCT00433511|20979039|P3|COMPLETED|Step 1||1618
8512041|NCT00433511|20979040|P2|COMPLETED|Step 1||1601
8512042|NCT00433511|20979041|P1|COMPLETED|Step 1||864
8512043|NCT00433511|20979039|P3|Patients in Genetic Ancestry Analysis|Step 1||1158
8512044|NCT00433511|20979040|P2|Patients in Genetic Ancestry Analysis|Step 1||1126
8512045|NCT00433511|20979041|P1|Patients in Genetic Ancestry Analysis|Step 1||575
8512046|NCT00433511|20979039|P3|Patients Who Received Treatment|Step 1||1942
8512047|NCT00433511|20979040|P2|Patients Who Received Treatment|Step 1||1922
8512048|NCT00433511|20979041|P1|Patients Who Received Treatment|Step 1||972
8512049|NCT00433511|20979039|P3|STARTED|Step 1||2008
8512050|NCT00433511|20979040|P2|STARTED|Step 1||1986
8512051|NCT00433511|20979041|P1|STARTED|Step 1||1000
8512052|NCT00433446|20979055|P1|NOT COMPLETED|Overall Study||61
8512053|NCT00433446|20979055|P1|COMPLETED|Overall Study||1
8512054|NCT00433446|20979055|P1|Eligible and Began Protocol Therapy|Overall Study||53
8512055|NCT00433446|20979055|P1|Eligible|Overall Study||53
8512056|NCT00433446|20979055|P1|STARTED|Overall Study||62
8512057|NCT00433381|20979065|P2|NOT COMPLETED|Overall Study||3
8512058|NCT00433381|20979066|P1|NOT COMPLETED|Overall Study||3
8512059|NCT00433381|20979065|P2|COMPLETED|Overall Study||57
8512060|NCT00433381|20979066|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
8512061|NCT00433381|20979065|P2|STARTED|Overall Study||60
8512062|NCT00433381|20979066|P1|STARTED|Overall Study||63
8512063|NCT00433329|20979085|P1|NOT COMPLETED|Overall Study||21
8512064|NCT00433329|20979085|P1|COMPLETED|Overall Study||79
8512065|NCT00433329|20979085|P1|STARTED|Overall Study||100
8512066|NCT00433290|20979091|P2|NOT COMPLETED|Overall Study||17
8512067|NCT00433290|20979092|P1|NOT COMPLETED|Overall Study||35
8512068|NCT00433290|20979091|P2|COMPLETED|Overall Study||111
8512069|NCT00433290|20979092|P1|COMPLETED|Overall Study||93
8512070|NCT00433290|20979091|P2|STARTED|Overall Study||128
8512072|NCT00433199|20979161|P2|NOT COMPLETED|Open-Label Period||34
8512073|NCT00433199|20979162|P1|NOT COMPLETED|Open-Label Period||0
8512074|NCT00433199|20979161|P2|COMPLETED|Open-Label Period||185
8512075|NCT00433199|20979162|P1|COMPLETED|Open-Label Period||0
8512076|NCT00433199|20979161|P2|STARTED|Open-Label Period||219
8512077|NCT00433199|20979162|P1|STARTED|Open-Label Period||0
8512078|NCT00433199|20979161|P2|NOT COMPLETED|Double-Blind Period||66
8512079|NCT00433199|20979162|P1|NOT COMPLETED|Double-Blind Period||12
8512080|NCT00433199|20979161|P2|COMPLETED|Double-Blind Period||168
8512081|NCT00433199|20979162|P1|COMPLETED|Double-Blind Period||28
8512082|NCT00433199|20979161|P2|STARTED|Double-Blind Period||234
8512083|NCT00433199|20979162|P1|STARTED|Double-Blind Period||40
8512084|NCT00433160|20979182|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
8512085|NCT00433160|20979183|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
8512086|NCT00433160|20979182|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
8512087|NCT00433160|20979183|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
8512088|NCT00433160|20979182|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
8512089|NCT00433160|20979183|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
8512090|NCT00433160|20979182|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
8512091|NCT00433160|20979183|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
8512092|NCT00433160|20979182|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
8512093|NCT00433160|20979183|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
8512094|NCT00433160|20979182|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
8512095|NCT00433160|20979183|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
8512096|NCT00433160|20979182|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
8512097|NCT00433160|20979183|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
8512098|NCT00433160|20979182|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
8512099|NCT00433160|20979183|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
8512100|NCT00433160|20979182|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
8512101|NCT00433160|20979183|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
8512102|NCT00433160|20979182|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
8512103|NCT00433160|20979183|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
8512104|NCT00433160|20979182|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
8512105|NCT00433160|20979183|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
8512106|NCT00433160|20979182|P2|STARTED|52-Week Double-Blind (DB) Period||70
8512107|NCT00433160|20979183|P1|STARTED|52-Week Double-Blind (DB) Period||137
8512108|NCT00433147|20979235|P4|NOT COMPLETED|Overall Study||0
8512109|NCT00433147|20979236|P3|NOT COMPLETED|Overall Study||0
8512110|NCT00433147|20979237|P2|NOT COMPLETED|Overall Study||1
8512111|NCT00433147|20979238|P1|NOT COMPLETED|Overall Study||0
8512112|NCT00433147|20979235|P4|COMPLETED|Overall Study||7
8512113|NCT00433147|20979236|P3|COMPLETED|Overall Study||9
8512114|NCT00433147|20979237|P2|COMPLETED|Overall Study||6
8512115|NCT00433147|20979238|P1|COMPLETED|Overall Study||7
8512116|NCT00433147|20979235|P4|Received at Least One Dose of Study Drug|Overall Study||7
8512117|NCT00433147|20979236|P3|Received at Least One Dose of Study Drug|Overall Study||9
8512118|NCT00433147|20979237|P2|Received at Least One Dose of Study Drug|Overall Study||7
8512119|NCT00433147|20979238|P1|Received at Least One Dose of Study Drug|Overall Study||7
8512120|NCT00433147|20979235|P4|PD Population|Overall Study||7
8512121|NCT00433147|20979236|P3|PD Population|Overall Study||9
8512122|NCT00433147|20979237|P2|PD Population|Overall Study||6
8512123|NCT00433147|20979238|P1|PD Population|Overall Study||7
8512124|NCT00433147|20979235|P4|Safety Population|Overall Study||7
8512125|NCT00433147|20979236|P3|Safety Population|Overall Study||9
8512126|NCT00433147|20979237|P2|Safety Population|Overall Study||7
8512127|NCT00433147|20979238|P1|Safety Population|Overall Study||7
8512128|NCT00433147|20979235|P4|STARTED|Overall Study||7
8512129|NCT00433147|20979236|P3|STARTED|Overall Study||9
8512130|NCT00433147|20979237|P2|STARTED|Overall Study||7
8512131|NCT00433147|20979238|P1|STARTED|Overall Study||7
8512132|NCT00433017|20979254|P2|NOT COMPLETED|Overall Study||101
8512133|NCT00433017|20979255|P1|NOT COMPLETED|Overall Study||96
8512134|NCT00433017|20979254|P2|COMPLETED|Overall Study||32
8512135|NCT00433017|20979255|P1|COMPLETED|Overall Study||26
8512136|NCT00433017|20979254|P2|Completed 12 Month Phase|Overall Study||126
8512137|NCT00433017|20979255|P1|Completed 12 Month Phase|Overall Study||114
8512138|NCT00433017|20979254|P2|STARTED|Overall Study||133
8512139|NCT00433017|20979255|P1|STARTED|Overall Study||122
8512140|NCT00433004|20979271|P2|NOT COMPLETED|Overall Study||7
8512141|NCT00433004|20979272|P1|NOT COMPLETED|Overall Study||5
8512142|NCT00433004|20979271|P2|COMPLETED|Overall Study||16
8512143|NCT00433004|20979272|P1|COMPLETED|Overall Study||22
8512144|NCT00433004|20979271|P2|STARTED|Overall Study||23
8512145|NCT00433004|20979272|P1|STARTED|Overall Study||27
8512146|NCT00432991|20979284|P2|NOT COMPLETED|Overall Study||12
8512147|NCT00432991|20979285|P1|NOT COMPLETED|Overall Study||7
8512148|NCT00432991|20979284|P2|COMPLETED|Overall Study||19
8512149|NCT00432991|20979285|P1|COMPLETED|Overall Study||15
8512150|NCT00432991|20979284|P2|STARTED|Overall Study||31
8512151|NCT00432991|20979285|P1|STARTED|Overall Study||22
8512152|NCT00432965|20979297|P2|NOT COMPLETED|Overall Study||86
8512153|NCT00432965|20979298|P1|NOT COMPLETED|Overall Study||94
8512154|NCT00432965|20979297|P2|COMPLETED|Overall Study||80
8512155|NCT00432965|20979298|P1|COMPLETED|Overall Study||75
8512156|NCT00432965|20979297|P2|STARTED|Overall Study||166
8512157|NCT00432965|20979298|P1|STARTED|Overall Study||169
8512158|NCT00432835|20979306|P2|NOT COMPLETED|Overall Study||7
8512159|NCT00432835|20979307|P1|NOT COMPLETED|Overall Study||6
8512160|NCT00432835|20979306|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
8512161|NCT00432835|20979307|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
8512162|NCT00432835|20979306|P2|Completed 2nd Intervention|Overall Study||23
8512163|NCT00432835|20979307|P1|Completed 2nd Intervention|Overall Study||22
8512164|NCT00432835|20979306|P2|Completed 1st Intervention|Overall Study||23
8512165|NCT00432835|20979307|P1|Completed 1st Intervention|Overall Study||22
8512166|NCT00432835|20979306|P2|STARTED|Overall Study||30
8512167|NCT00432835|20979307|P1|STARTED|Overall Study||28
8512168|NCT00432809|20979320|P3|NOT COMPLETED|2 Year Sub-study||1
8512169|NCT00432809|20979321|P2|NOT COMPLETED|2 Year Sub-study||2
8512170|NCT00432809|20979322|P1|NOT COMPLETED|2 Year Sub-study||3
8512171|NCT00432809|20979320|P3|COMPLETED|2 Year Sub-study||19
8512172|NCT00432809|20979321|P2|COMPLETED|2 Year Sub-study||18
8512173|NCT00432809|20979322|P1|COMPLETED|2 Year Sub-study||17
8512174|NCT00432809|20979320|P3|STARTED|2 Year Sub-study||20
8512175|NCT00432809|20979321|P2|STARTED|2 Year Sub-study||20
8512176|NCT00432809|20979322|P1|STARTED|2 Year Sub-study||20
8512177|NCT00432809|20979320|P3|NOT COMPLETED|1 Year Follow-up||1
8512178|NCT00432809|20979321|P2|NOT COMPLETED|1 Year Follow-up||0
8512179|NCT00432809|20979322|P1|NOT COMPLETED|1 Year Follow-up||9
8512180|NCT00432809|20979320|P3|COMPLETED|1 Year Follow-up||49
8512181|NCT00432809|20979321|P2|COMPLETED|1 Year Follow-up||50
8512182|NCT00432809|20979322|P1|COMPLETED|1 Year Follow-up||41
8512183|NCT00432809|20979320|P3|STARTED|1 Year Follow-up||50
8512184|NCT00432809|20979321|P2|STARTED|1 Year Follow-up||50
8512185|NCT00432809|20979322|P1|STARTED|1 Year Follow-up||50
8512186|NCT00432744|20979395|P2|NOT COMPLETED|Months 7 - 12||1
8512187|NCT00432744|20979396|P1|NOT COMPLETED|Months 7 - 12||1
8512188|NCT00432744|20979395|P2|COMPLETED|Months 7 - 12||7
8512189|NCT00432744|20979396|P1|COMPLETED|Months 7 - 12||6
8512190|NCT00432744|20979395|P2|STARTED|Months 7 - 12||8
8512191|NCT00432744|20979396|P1|STARTED|Months 7 - 12||7
8512192|NCT00432744|20979395|P2|NOT COMPLETED|Months 0-6||4
8512193|NCT00432744|20979396|P1|NOT COMPLETED|Months 0-6||5
8512194|NCT00432744|20979395|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
8512195|NCT00432744|20979396|P1|COMPLETED|Months 0-6||7
8512196|NCT00432744|20979395|P2|STARTED|Months 0-6||12
8512197|NCT00432744|20979396|P1|STARTED|Months 0-6||12
8512198|NCT00432679|20979408|P2|NOT COMPLETED|Overall Study||3
8512199|NCT00432679|20979409|P1|NOT COMPLETED|Overall Study||5
8512200|NCT00432679|20979408|P2|COMPLETED|Overall Study||72
8512201|NCT00432679|20979409|P1|COMPLETED|Overall Study||69
8512202|NCT00432679|20979408|P2|STARTED|Overall Study||75
8512203|NCT00432679|20979409|P1|STARTED|Overall Study||74
8512204|NCT00432666|20979433|P2|NOT COMPLETED|Open-Label Extension Period||0
8512205|NCT00432666|20979434|P1|NOT COMPLETED|Open-Label Extension Period||25
8512206|NCT00432666|20979433|P2|COMPLETED|Open-Label Extension Period||0
8512207|NCT00432666|20979434|P1|COMPLETED|Open-Label Extension Period||120
8512208|NCT00432666|20979433|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
8512209|NCT00432666|20979434|P1|STARTED|Open-Label Extension Period||145
8512210|NCT00432666|20979433|P2|NOT COMPLETED|Main Period||1
8512211|NCT00432666|20979434|P1|NOT COMPLETED|Main Period||2
8512212|NCT00432666|20979433|P2|COMPLETED|Main Period||74
8512213|NCT00432666|20979434|P1|COMPLETED|Main Period||71
8512214|NCT00432666|20979433|P2|STARTED|Main Period||75
8512215|NCT00432666|20979434|P1|STARTED|Main Period||73
8512216|NCT00432601|20979598|P2|NOT COMPLETED|Time 2 to Time 3||22
8512217|NCT00432601|20979599|P1|NOT COMPLETED|Time 2 to Time 3||19
8512218|NCT00432601|20979598|P2|COMPLETED|Time 2 to Time 3||122
8512219|NCT00432601|20979599|P1|COMPLETED|Time 2 to Time 3||122
8512220|NCT00432601|20979598|P2|STARTED|Time 2 to Time 3||144
8512221|NCT00432601|20979599|P1|STARTED|Time 2 to Time 3||141
8512222|NCT00432601|20979598|P2|NOT COMPLETED|Time 1 to Time 2||368
8512223|NCT00432601|20979599|P1|NOT COMPLETED|Time 1 to Time 2||369
8512224|NCT00432601|20979598|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
8512225|NCT00432601|20979599|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
8512226|NCT00432601|20979598|P2|STARTED|Time 1 to Time 2||512
8512227|NCT00432601|20979599|P1|STARTED|Time 1 to Time 2||510
8512228|NCT00432562|20979607|P2|NOT COMPLETED|Overall Study||0
8512229|NCT00432562|20979608|P1|NOT COMPLETED|Overall Study||3
8512230|NCT00432562|20979607|P2|COMPLETED|Overall Study||15
8512231|NCT00432562|20979608|P1|COMPLETED|Overall Study||13
8512232|NCT00432562|20979607|P2|STARTED|Overall Study||15
8512233|NCT00432562|20979608|P1|STARTED|Overall Study||16
8512234|NCT00432458|20979634|P2|NOT COMPLETED|Overall Study||1
8512235|NCT00432458|20979635|P1|NOT COMPLETED|Overall Study||5
8512236|NCT00432458|20979634|P2|COMPLETED|Overall Study||32
8512237|NCT00432458|20979635|P1|COMPLETED|Overall Study||30
8512238|NCT00432458|20979634|P2|STARTED|Overall Study||33
8512239|NCT00432458|20979635|P1|STARTED|Overall Study||35
8512240|NCT00432445|20979653|P1|NOT COMPLETED|Overall Study||0
8512241|NCT00432445|20979653|P1|COMPLETED|Overall Study||2
8512242|NCT00432445|20979653|P1|STARTED|Overall Study||2
8512243|NCT00432380|20979660|P3|NOT COMPLETED|Overall Study||1
8512244|NCT00432380|20979661|P2|NOT COMPLETED|Overall Study||4
8512245|NCT00432380|20979662|P1|NOT COMPLETED|Overall Study||4
8512246|NCT00432380|20979660|P3|COMPLETED|Overall Study||74
8512247|NCT00432380|20979661|P2|COMPLETED|Overall Study||146
8512248|NCT00432380|20979662|P1|COMPLETED|Overall Study||146
8512249|NCT00432380|20979660|P3|STARTED|Overall Study||75
8512250|NCT00432380|20979661|P2|STARTED|Overall Study||150
8512251|NCT00432380|20979662|P1|STARTED|Overall Study||150
8512252|NCT00432341|20979688|P2|NOT COMPLETED|Overall Study||0
8512253|NCT00432341|20979689|P1|NOT COMPLETED|Overall Study||0
8512254|NCT00432341|20979688|P2|COMPLETED|Overall Study||30
8512255|NCT00432341|20979689|P1|COMPLETED|Overall Study||24
8512256|NCT00432341|20979688|P2|STARTED|Overall Study||30
8512257|NCT00432341|20979689|P1|STARTED|Overall Study||24
8512258|NCT00432276|20979715|P2|NOT COMPLETED|Overall Study||156
8512259|NCT00432276|20979716|P1|NOT COMPLETED|Overall Study||121
8512260|NCT00432276|20979715|P2|COMPLETED|Overall Study||243
8512261|NCT00432276|20979716|P1|COMPLETED|Overall Study||283
8512262|NCT00432276|20979715|P2|Per Protocol Set|Overall Study||306
8512263|NCT00432276|20979716|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
8512264|NCT00432276|20979715|P2|STARTED|Overall Study||399
8512265|NCT00432276|20979716|P1|STARTED|Overall Study||404
8512266|NCT00432237|20979806|P4|NOT COMPLETED|Overall Study||124
8512267|NCT00432237|20979807|P3|NOT COMPLETED|Overall Study||109
8512268|NCT00432237|20979808|P2|NOT COMPLETED|Overall Study||101
8512269|NCT00432237|20979809|P1|NOT COMPLETED|Overall Study||67
8512270|NCT00432237|20979806|P4|COMPLETED|Overall Study||366
8512271|NCT00432237|20979807|P3|COMPLETED|Overall Study||375
8512272|NCT00432237|20979808|P2|COMPLETED|Overall Study||384
8512273|NCT00432237|20979809|P1|COMPLETED|Overall Study||177
8512274|NCT00432237|20979806|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
8512275|NCT00432237|20979807|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
8512276|NCT00432237|20979808|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
8512277|NCT00432237|20979809|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
8512278|NCT00432237|20979806|P4|Completed--With Data|Overall Study||365
8512279|NCT00432237|20979807|P3|Completed--With Data|Overall Study||370
8512280|NCT00432237|20979808|P2|Completed--With Data|Overall Study||381
8512281|NCT00432237|20979809|P1|Completed--With Data|Overall Study||176
8512282|NCT00432237|20979806|P4|STARTED|Overall Study||490
8512283|NCT00432237|20979807|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
8512284|NCT00432237|20979808|P2|STARTED|Overall Study||485
8512285|NCT00432237|20979809|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
8512286|NCT00432172|20979851|P4|NOT COMPLETED|Overall Study||7
8512287|NCT00432172|20979852|P3|NOT COMPLETED|Overall Study||11
8512288|NCT00432172|20979853|P2|NOT COMPLETED|Overall Study||7
8512289|NCT00432172|20979854|P1|NOT COMPLETED|Overall Study||6
8512290|NCT00432172|20979851|P4|COMPLETED|Overall Study||41
8512291|NCT00432172|20979852|P3|COMPLETED|Overall Study||35
8512292|NCT00432172|20979853|P2|COMPLETED|Overall Study||41
8512293|NCT00432172|20979854|P1|COMPLETED|Overall Study||41
8512294|NCT00432172|20979851|P4|STARTED|Overall Study||48
8512295|NCT00432172|20979852|P3|STARTED|Overall Study||46
8512296|NCT00432172|20979853|P2|STARTED|Overall Study||48
8512297|NCT00432172|20979854|P1|STARTED|Overall Study||47
8512298|NCT00432159|20979879|P5|NOT COMPLETED|Overall Study||10
8512299|NCT00432159|20979880|P4|NOT COMPLETED|Overall Study||5
8512300|NCT00432159|20979881|P3|NOT COMPLETED|Overall Study||4
8512301|NCT00432159|20979882|P2|NOT COMPLETED|Overall Study||30
8512302|NCT00432159|20979883|P1|NOT COMPLETED|Overall Study||22
8512303|NCT00432159|20979879|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
8512304|NCT00432159|20979880|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
8512305|NCT00432159|20979881|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
8512306|NCT00432159|20979882|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
8512307|NCT00432159|20979883|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
8512308|NCT00432159|20979879|P5|STARTED|Overall Study||89
8512309|NCT00432159|20979880|P4|STARTED|Overall Study||20
8512310|NCT00432159|20979881|P3|STARTED|Overall Study||39
8512311|NCT00432159|20979882|P2|STARTED|Overall Study||167
8512312|NCT00432159|20979883|P1|STARTED|Overall Study||185
8512313|NCT00432042|20979990|P3|NOT COMPLETED|Overall Study||2
8512314|NCT00432042|20979991|P2|NOT COMPLETED|Overall Study||1
8512315|NCT00432042|20979992|P1|NOT COMPLETED|Overall Study||7
8512316|NCT00432042|20979990|P3|COMPLETED|Overall Study||239
8512317|NCT00432042|20979991|P2|COMPLETED|Overall Study||234
8512318|NCT00432042|20979992|P1|COMPLETED|Overall Study||472
8512319|NCT00432042|20979990|P3|Vaccinated|Overall Study||240
8512320|NCT00432042|20979991|P2|Vaccinated|Overall Study||235
8512321|NCT00432042|20979992|P1|Vaccinated|Overall Study||477
8512322|NCT00432042|20979990|P3|STARTED|Overall Study|Number randomized.|241
8512323|NCT00432042|20979991|P2|STARTED|Overall Study|Number randomized.|235
8512324|NCT00432042|20979992|P1|STARTED|Overall Study|Number randomized.|479
8512325|NCT00431964|20980005|P2|NOT COMPLETED|Overall Study||8
8512326|NCT00431964|20980006|P1|NOT COMPLETED|Overall Study||6
8512327|NCT00431964|20980005|P2|COMPLETED|Overall Study||124
8512328|NCT00431964|20980006|P1|COMPLETED|Overall Study||125
8512329|NCT00431964|20980005|P2|Withdrew From Study|Overall Study||5
8512330|NCT00431964|20980006|P1|Withdrew From Study|Overall Study||6
8512331|NCT00431964|20980005|P2|Did Not Receive Drug|Overall Study||3
8512332|NCT00431964|20980006|P1|Did Not Receive Drug|Overall Study||0
8512333|NCT00431964|20980005|P2|Randomized/Received Drug|Overall Study||129
8512334|NCT00431964|20980006|P1|Randomized/Received Drug|Overall Study||131
8512335|NCT00431964|20980005|P2|STARTED|Overall Study||132
8512336|NCT00431964|20980006|P1|STARTED|Overall Study||131
8512337|NCT00431951|20980016|P4|NOT COMPLETED|Overall Study||2
8512338|NCT00431951|20980017|P3|NOT COMPLETED|Overall Study||2
8512339|NCT00431951|20980018|P2|NOT COMPLETED|Overall Study||2
8512340|NCT00431951|20980019|P1|NOT COMPLETED|Overall Study||1
8512341|NCT00431951|20980016|P4|COMPLETED|Overall Study||4
8512342|NCT00431951|20980017|P3|COMPLETED|Overall Study||6
8512343|NCT00431951|20980018|P2|COMPLETED|Overall Study||6
8512344|NCT00431951|20980019|P1|COMPLETED|Overall Study||7
8512345|NCT00431951|20980016|P4|STARTED|Overall Study||6
8512346|NCT00431951|20980017|P3|STARTED|Overall Study||8
8512347|NCT00431951|20980018|P2|STARTED|Overall Study||8
8512348|NCT00431951|20980019|P1|STARTED|Overall Study||8
8512349|NCT00431847|20980081|P5|NOT COMPLETED|Overall Study||1
8512350|NCT00431847|20980082|P4|NOT COMPLETED|Overall Study||14
8512351|NCT00431847|20980083|P3|NOT COMPLETED|Overall Study||4
8512352|NCT00431847|20980084|P2|NOT COMPLETED|Overall Study||3
8512353|NCT00431847|20980085|P1|NOT COMPLETED|Overall Study||6
8512354|NCT00431847|20980081|P5|COMPLETED|Overall Study||0
8512355|NCT00431847|20980082|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
8512356|NCT00431847|20980083|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
8512357|NCT00431847|20980084|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
8512358|NCT00431847|20980085|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
8512359|NCT00431847|20980081|P5|STARTED|Overall Study||1
8512360|NCT00431847|20980082|P4|STARTED|Overall Study||184
8512361|NCT00431847|20980083|P3|STARTED|Overall Study||24
8512362|NCT00431847|20980084|P2|STARTED|Overall Study||45
8512363|NCT00431847|20980085|P1|STARTED|Overall Study||132
8512364|NCT00431834|20980159|P1|NOT COMPLETED|Overall Study||13
8512365|NCT00431834|20980159|P1|COMPLETED|Overall Study||62
8512366|NCT00431834|20980159|P1|STARTED|Overall Study||75
8512367|NCT00431626|20980168|P2|NOT COMPLETED|Overall Study||0
8512368|NCT00431626|20980169|P1|NOT COMPLETED|Overall Study||0
8512369|NCT00431626|20980168|P2|COMPLETED|Overall Study||0
8512370|NCT00431626|20980169|P1|COMPLETED|Overall Study||4
8512371|NCT00431626|20980168|P2|STARTED|Overall Study||0
8512372|NCT00431626|20980169|P1|STARTED|Overall Study||4
8512373|NCT00431496|20980175|P1|NOT COMPLETED|Overall Study||11
8512374|NCT00431496|20980175|P1|COMPLETED|Overall Study||60
8512375|NCT00431496|20980175|P1|STARTED|Overall Study||71
8512376|NCT00431444|20980186|P2|NOT COMPLETED|Overall Study||7
8512377|NCT00431444|20980187|P1|NOT COMPLETED|Overall Study||5
8512378|NCT00431444|20980186|P2|COMPLETED|Overall Study||46
8512379|NCT00431444|20980187|P1|COMPLETED|Overall Study||51
8512380|NCT00431444|20980186|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
8512381|NCT00431444|20980187|P1|STARTED|Overall Study||56
8512382|NCT00431184|20980213|P2|NOT COMPLETED|Second Intervention (Day 2)||0
8512383|NCT00431184|20980214|P1|NOT COMPLETED|Second Intervention (Day 2)||0
8512384|NCT00431184|20980213|P2|COMPLETED|Second Intervention (Day 2)||9
8512385|NCT00431184|20980214|P1|COMPLETED|Second Intervention (Day 2)||10
8512386|NCT00431184|20980213|P2|STARTED|Second Intervention (Day 2)||9
8512387|NCT00431184|20980214|P1|STARTED|Second Intervention (Day 2)||10
8512388|NCT00431184|20980213|P2|NOT COMPLETED|1st Intervention (Day 1)||0
8512389|NCT00431184|20980214|P1|NOT COMPLETED|1st Intervention (Day 1)||0
8512390|NCT00431184|20980213|P2|COMPLETED|1st Intervention (Day 1)||9
8512391|NCT00431184|20980214|P1|COMPLETED|1st Intervention (Day 1)||10
8512392|NCT00431184|20980213|P2|STARTED|1st Intervention (Day 1)||9
8512393|NCT00431184|20980214|P1|STARTED|1st Intervention (Day 1)||10
8512394|NCT00431132|20980222|P1|NOT COMPLETED|Overall Study||44
8512395|NCT00431132|20980222|P1|COMPLETED|Overall Study||292
8512396|NCT00431132|20980222|P1|STARTED|Overall Study||336
8512397|NCT00431067|20980227|P1|NOT COMPLETED|Overall Study||41
8512398|NCT00431067|20980227|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
8512399|NCT00431067|20980227|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
8512400|NCT00431041|20980237|P2|NOT COMPLETED|Overall Study||24
8512401|NCT00431041|20980238|P1|NOT COMPLETED|Overall Study||16
8512402|NCT00431041|20980237|P2|COMPLETED|Overall Study||40
8512403|NCT00431041|20980238|P1|COMPLETED|Overall Study||52
8512404|NCT00431041|20980237|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
8512405|NCT00431041|20980238|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
8512406|NCT00430989|20980252|P2|NOT COMPLETED|Overall Study||60
8512407|NCT00430989|20980253|P1|NOT COMPLETED|Overall Study||60
8512408|NCT00430989|20980252|P2|COMPLETED|Overall Study||3509
8512409|NCT00430989|20980253|P1|COMPLETED|Overall Study||3483
8512410|NCT00430989|20980252|P2|STARTED|Overall Study||3569
8512411|NCT00430989|20980253|P1|STARTED|Overall Study||3543
8512412|NCT00430950|20980273|P2|NOT COMPLETED|Overall Study||13
8512413|NCT00430950|20980274|P1|NOT COMPLETED|Overall Study||13
8512414|NCT00430950|20980273|P2|COMPLETED|Overall Study||495
8512415|NCT00430950|20980274|P1|COMPLETED|Overall Study||489
8512416|NCT00430950|20980273|P2|STARTED|Overall Study||508
8512417|NCT00430950|20980274|P1|STARTED|Overall Study||502
8512418|NCT00430937|20980288|P2|NOT COMPLETED|Overall Study||28
8512419|NCT00430937|20980289|P1|NOT COMPLETED|Overall Study||27
8512420|NCT00430937|20980288|P2|COMPLETED|Overall Study||64
8512421|NCT00430937|20980289|P1|COMPLETED|Overall Study||70
8512422|NCT00430937|20980288|P2|STARTED|Overall Study||92
8512423|NCT00430937|20980289|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
8512424|NCT00430781|20980300|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
8512425|NCT00430781|20980301|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
8512426|NCT00430781|20980302|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
8512427|NCT00430781|20980300|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
8512428|NCT00430781|20980301|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
8512429|NCT00430781|20980302|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
8512430|NCT00430781|20980300|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
8512431|NCT00430781|20980301|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
8512432|NCT00430781|20980302|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
8512433|NCT00430781|20980300|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
8512434|NCT00430781|20980301|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
8512435|NCT00430781|20980302|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
8512436|NCT00430781|20980300|P3|COMPLETED|Final Analysis; 31 July 2008||26
8512437|NCT00430781|20980301|P2|COMPLETED|Final Analysis; 31 July 2008||39
8512438|NCT00430781|20980302|P1|COMPLETED|Final Analysis; 31 July 2008||0
8512439|NCT00430781|20980300|P3|Ongoing|Final Analysis; 31 July 2008||32
8512440|NCT00430781|20980301|P2|Ongoing|Final Analysis; 31 July 2008||29
8512441|NCT00430781|20980302|P1|Ongoing|Final Analysis; 31 July 2008||0
8512442|NCT00430781|20980300|P3|STARTED|Final Analysis; 31 July 2008||74
8512443|NCT00430781|20980301|P2|STARTED|Final Analysis; 31 July 2008||78
8512444|NCT00430781|20980302|P1|STARTED|Final Analysis; 31 July 2008||0
8512445|NCT00430781|20980300|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
8512446|NCT00430781|20980301|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
8512447|NCT00430781|20980302|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
8512448|NCT00430781|20980300|P3|COMPLETED|Interim Analysis; 11 February 2008||0
8512449|NCT00430781|20980301|P2|COMPLETED|Interim Analysis; 11 February 2008||0
8512450|NCT00430781|20980302|P1|COMPLETED|Interim Analysis; 11 February 2008||0
8512451|NCT00430781|20980300|P3|Ongoing|Interim Analysis; 11 February 2008||25
8512452|NCT00430781|20980301|P2|Ongoing|Interim Analysis; 11 February 2008||20
8512453|NCT00430781|20980302|P1|Ongoing|Interim Analysis; 11 February 2008||23
8512454|NCT00430781|20980300|P3|STARTED|Interim Analysis; 11 February 2008||60
8512455|NCT00430781|20980301|P2|STARTED|Interim Analysis; 11 February 2008||58
8512456|NCT00430781|20980302|P1|STARTED|Interim Analysis; 11 February 2008||59
8512457|NCT00430768|20980328|P3|NOT COMPLETED|Overall Study||0
8512458|NCT00430768|20980329|P2|NOT COMPLETED|Overall Study||0
8512459|NCT00430768|20980330|P1|NOT COMPLETED|Overall Study||0
8512460|NCT00430768|20980328|P3|COMPLETED|Overall Study||3
8512461|NCT00430768|20980329|P2|COMPLETED|Overall Study||3
8512462|NCT00430768|20980330|P1|COMPLETED|Overall Study||3
8512463|NCT00430768|20980328|P3|STARTED|Overall Study||3
8512464|NCT00430768|20980329|P2|STARTED|Overall Study||3
8512465|NCT00430768|20980330|P1|STARTED|Overall Study||3
8512466|NCT00430755|20980344|P1|NOT COMPLETED|Overall Study||53
8512467|NCT00430755|20980344|P1|COMPLETED|Overall Study||45
8512468|NCT00430755|20980344|P1|STARTED|Overall Study||98
8512469|NCT00430716|20980351|P3|NOT COMPLETED|Open Label Phase||7
8512470|NCT00430716|20980352|P2|NOT COMPLETED|Open Label Phase||7
8512471|NCT00430716|20980353|P1|NOT COMPLETED|Open Label Phase||9
8512472|NCT00430716|20980351|P3|COMPLETED|Open Label Phase||32
8512473|NCT00430716|20980352|P2|COMPLETED|Open Label Phase||31
8512474|NCT00430716|20980353|P1|COMPLETED|Open Label Phase||27
8512475|NCT00430716|20980351|P3|STARTED|Open Label Phase||39
8512476|NCT00430716|20980352|P2|STARTED|Open Label Phase||38
8512477|NCT00430716|20980353|P1|STARTED|Open Label Phase||36
8512478|NCT00430716|20980351|P3|NOT COMPLETED|Double Blind Phase||6
8512479|NCT00430716|20980352|P2|NOT COMPLETED|Double Blind Phase||5
8512480|NCT00430716|20980353|P1|NOT COMPLETED|Double Blind Phase||6
8512481|NCT00430716|20980351|P3|COMPLETED|Double Blind Phase||39
8512482|NCT00430716|20980352|P2|COMPLETED|Double Blind Phase||38
8512483|NCT00430716|20980353|P1|COMPLETED|Double Blind Phase||36
8512484|NCT00430716|20980351|P3|Treated|Double Blind Phase||45
8512485|NCT00430716|20980352|P2|Treated|Double Blind Phase||43
8512486|NCT00430716|20980353|P1|Treated|Double Blind Phase||41
8512487|NCT00430716|20980351|P3|STARTED|Double Blind Phase||45
8512488|NCT00430716|20980352|P2|STARTED|Double Blind Phase||43
8512489|NCT00430716|20980353|P1|STARTED|Double Blind Phase||42
8512490|NCT00430677|20980385|P3|NOT COMPLETED|Long-term Extension Period||63
8512491|NCT00430677|20980386|P2|NOT COMPLETED|Long-term Extension Period||58
8512492|NCT00430677|20980387|P1|NOT COMPLETED|Long-term Extension Period||60
8512493|NCT00430677|20980385|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
8512494|NCT00430677|20980386|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
8512495|NCT00430677|20980387|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
8512496|NCT00430677|20980385|P3|STARTED|Long-term Extension Period||74
8512497|NCT00430677|20980386|P2|STARTED|Long-term Extension Period||67
8512498|NCT00430677|20980387|P1|STARTED|Long-term Extension Period||70
8512499|NCT00430677|20980385|P3|NOT COMPLETED|Short-term Period||22
8512500|NCT00430677|20980386|P2|NOT COMPLETED|Short-term Period||25
8512501|NCT00430677|20980387|P1|NOT COMPLETED|Short-term Period||23
8512502|NCT00430677|20980385|P3|COMPLETED|Short-term Period|Completed the short-term period|78
8512503|NCT00430677|20980386|P2|COMPLETED|Short-term Period|Completed the short-term period|74
8512504|NCT00430677|20980387|P1|COMPLETED|Short-term Period|Completed the short-term period|76
8512505|NCT00430677|20980385|P3|STARTED|Short-term Period||100
8512506|NCT00430677|20980386|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
8512507|NCT00430677|20980387|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
8512508|NCT00430638|20980510|P2|NOT COMPLETED|Overall Study||48
8512509|NCT00430638|20980511|P1|NOT COMPLETED|Overall Study||78
8512510|NCT00430638|20980510|P2|COMPLETED|Overall Study||92
8512511|NCT00430638|20980511|P1|COMPLETED|Overall Study||60
8512512|NCT00430638|20980510|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
8512513|NCT00430638|20980511|P1|STARTED|Overall Study||138
8512514|NCT00430625|20980529|P2|NOT COMPLETED|Overall Study||0
8512515|NCT00430625|20980530|P1|NOT COMPLETED|Overall Study||0
8512516|NCT00430625|20980529|P2|COMPLETED|Overall Study||12
8512517|NCT00430625|20980530|P1|COMPLETED|Overall Study||13
8512518|NCT00430625|20980529|P2|STARTED|Overall Study||12
8512519|NCT00430625|20980530|P1|STARTED|Overall Study||13
8512520|NCT00430573|20980546|P1|NOT COMPLETED|Overall Study||5
8512521|NCT00430573|20980546|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
8512522|NCT00430573|20980546|P1|STARTED|Overall Study||10
8512523|NCT00430521|20980559|P8|NOT COMPLETED|Overall Study||12
8512524|NCT00430521|20980560|P7|NOT COMPLETED|Overall Study||10
8512525|NCT00430521|20980561|P6|NOT COMPLETED|Overall Study||5
8512526|NCT00430521|20980562|P5|NOT COMPLETED|Overall Study||5
8512527|NCT00430521|20980563|P4|NOT COMPLETED|Overall Study||8
8512528|NCT00430521|20980564|P3|NOT COMPLETED|Overall Study||3
8512529|NCT00430521|20980565|P2|NOT COMPLETED|Overall Study||9
8512530|NCT00430521|20980566|P1|NOT COMPLETED|Overall Study||11
8512531|NCT00430521|20980559|P8|COMPLETED|Overall Study||51
8512532|NCT00430521|20980560|P7|COMPLETED|Overall Study||55
8512533|NCT00430521|20980561|P6|COMPLETED|Overall Study||59
8512534|NCT00430521|20980562|P5|COMPLETED|Overall Study||59
8512535|NCT00430521|20980563|P4|COMPLETED|Overall Study||55
8512536|NCT00430521|20980564|P3|COMPLETED|Overall Study||61
8512537|NCT00430521|20980565|P2|COMPLETED|Overall Study||57
8512538|NCT00430521|20980566|P1|COMPLETED|Overall Study||52
8512539|NCT00430521|20980559|P8|STARTED|Overall Study||63
8512540|NCT00430521|20980560|P7|STARTED|Overall Study||65
8512541|NCT00430521|20980561|P6|STARTED|Overall Study||64
8512542|NCT00430521|20980562|P5|STARTED|Overall Study||64
8512543|NCT00430521|20980563|P4|STARTED|Overall Study||63
8512544|NCT00430521|20980564|P3|STARTED|Overall Study||64
8512545|NCT00430521|20980565|P2|STARTED|Overall Study||66
8512546|NCT00430521|20980566|P1|STARTED|Overall Study||63
8512547|NCT00430508|20980808|P4|NOT COMPLETED|Overall Study||5
8512548|NCT00430508|20980809|P3|NOT COMPLETED|Overall Study||13
8512549|NCT00430508|20980810|P2|NOT COMPLETED|Overall Study||6
8512550|NCT00430508|20980811|P1|NOT COMPLETED|Overall Study||3
8512551|NCT00430508|20980808|P4|COMPLETED|Overall Study||269
8512552|NCT00430508|20980809|P3|COMPLETED|Overall Study||266
8512553|NCT00430508|20980810|P2|COMPLETED|Overall Study||272
8512554|NCT00430508|20980811|P1|COMPLETED|Overall Study||137
8512555|NCT00430508|20980808|P4|STARTED|Overall Study||274
8512556|NCT00430508|20980809|P3|STARTED|Overall Study||279
8512557|NCT00430508|20980810|P2|STARTED|Overall Study||278
8512558|NCT00430508|20980811|P1|STARTED|Overall Study||140
8512559|NCT00430495|20980849|P4|NOT COMPLETED|Overall Study||4
8512560|NCT00430495|20980850|P3|NOT COMPLETED|Overall Study||13
8512561|NCT00430495|20980851|P2|NOT COMPLETED|Overall Study||7
8512562|NCT00430495|20980852|P1|NOT COMPLETED|Overall Study||14
8512563|NCT00430495|20980849|P4|COMPLETED|Overall Study||60
8512564|NCT00430495|20980850|P3|COMPLETED|Overall Study||49
8512565|NCT00430495|20980851|P2|COMPLETED|Overall Study||59
8512566|NCT00430495|20980852|P1|COMPLETED|Overall Study||50
8512567|NCT00430495|20980849|P4|Treated|Overall Study||64
8512568|NCT00430495|20980850|P3|Treated|Overall Study||62
8512569|NCT00430495|20980851|P2|Treated|Overall Study||66
8512570|NCT00430495|20980852|P1|Treated|Overall Study||62
8512571|NCT00430495|20980849|P4|STARTED|Overall Study||64
8512572|NCT00430495|20980850|P3|STARTED|Overall Study||62
8512573|NCT00430495|20980851|P2|STARTED|Overall Study||66
8512574|NCT00430495|20980852|P1|STARTED|Overall Study||64
8512575|NCT00430482|20980892|P2|NOT COMPLETED|Completed 2 Follow-Up Visits||6
8512576|NCT00430482|20980893|P1|NOT COMPLETED|Completed 2 Follow-Up Visits||5
8512577|NCT00430482|20980892|P2|COMPLETED|Completed 2 Follow-Up Visits||20
8512578|NCT00430482|20980893|P1|COMPLETED|Completed 2 Follow-Up Visits||29
8512579|NCT00430482|20980892|P2|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
8512580|NCT00430482|20980893|P1|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
8512581|NCT00430482|20980892|P2|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
8512582|NCT00430482|20980893|P1|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
8512583|NCT00430482|20980892|P2|STARTED|Completed 2 Follow-Up Visits||26
8512584|NCT00430482|20980893|P1|STARTED|Completed 2 Follow-Up Visits||34
8512585|NCT00430482|20980892|P2|NOT COMPLETED|Completed Treatment||11
8512586|NCT00430482|20980893|P1|NOT COMPLETED|Completed Treatment||7
8512587|NCT00430482|20980892|P2|COMPLETED|Completed Treatment||26
8512588|NCT00430482|20980893|P1|COMPLETED|Completed Treatment||34
8512589|NCT00430482|20980892|P2|Completed ASI at Midpoint|Completed Treatment||29
8512590|NCT00430482|20980893|P1|Completed ASI at Midpoint|Completed Treatment||35
8512591|NCT00430482|20980892|P2|STARTED|Completed Treatment||37
8512592|NCT00430482|20980893|P1|STARTED|Completed Treatment||41
8512593|NCT00430352|20980901|P1|NOT COMPLETED|Overall Study||138
8512594|NCT00430352|20980901|P1|COMPLETED|Overall Study||407
8512595|NCT00430352|20980901|P1|STARTED|Overall Study||545
8512596|NCT00430300|20980919|P4|NOT COMPLETED|Overall Study||2
8512597|NCT00430300|20980920|P3|NOT COMPLETED|Overall Study||6
8512598|NCT00430300|20980921|P2|NOT COMPLETED|Overall Study||2
8512599|NCT00430300|20980922|P1|NOT COMPLETED|Overall Study||2
8512600|NCT00430300|20980919|P4|COMPLETED|Overall Study||15
8512601|NCT00430300|20980920|P3|COMPLETED|Overall Study||29
8512602|NCT00430300|20980921|P2|COMPLETED|Overall Study||16
8512603|NCT00430300|20980922|P1|COMPLETED|Overall Study||15
8512604|NCT00430300|20980919|P4|STARTED|Overall Study||17
8512605|NCT00430300|20980920|P3|STARTED|Overall Study||35
8512606|NCT00430300|20980921|P2|STARTED|Overall Study||18
8512607|NCT00430300|20980922|P1|STARTED|Overall Study||17
8512608|NCT00430248|20981027|P3|NOT COMPLETED|Overall Study||135
8512609|NCT00430248|20981028|P2|NOT COMPLETED|Overall Study||158
8512610|NCT00430248|20981029|P1|NOT COMPLETED|Overall Study||125
8512611|NCT00430248|20981027|P3|COMPLETED|Overall Study||621
8512612|NCT00430248|20981028|P2|COMPLETED|Overall Study||598
8512613|NCT00430248|20981029|P1|COMPLETED|Overall Study||632
8512614|NCT00430248|20981027|P3|STARTED|Overall Study||756
8512615|NCT00430248|20981028|P2|STARTED|Overall Study||756
8512616|NCT00430248|20981029|P1|STARTED|Overall Study||757
8512617|NCT00430183|20981087|P2|NOT COMPLETED|Overall Study||0
8512618|NCT00430183|20981088|P1|NOT COMPLETED|Overall Study||0
8512619|NCT00430183|20981087|P2|COMPLETED|Overall Study||397
8512620|NCT00430183|20981088|P1|COMPLETED|Overall Study||391
8512621|NCT00430183|20981087|P2|STARTED|Overall Study||397
8512622|NCT00430183|20981088|P1|STARTED|Overall Study||391
8512623|NCT00430092|20981097|P3|NOT COMPLETED|Overall Study||57
8512624|NCT00430092|20981098|P2|NOT COMPLETED|Overall Study||4
8512625|NCT00430092|20981099|P1|NOT COMPLETED|Overall Study||6
8512626|NCT00430092|20981097|P3|COMPLETED|Overall Study||56
8512627|NCT00430092|20981098|P2|COMPLETED|Overall Study||48
8512628|NCT00430092|20981099|P1|COMPLETED|Overall Study||48
8512629|NCT00430092|20981097|P3|STARTED|Overall Study||113
8512630|NCT00430092|20981098|P2|STARTED|Overall Study||52
8512631|NCT00430092|20981099|P1|STARTED|Overall Study||54
8512632|NCT00430027|20981104|P1|NOT COMPLETED|Overall Study||8
8512633|NCT00430027|20981104|P1|COMPLETED|Overall Study||0
8512634|NCT00430027|20981104|P1|STARTED|Overall Study||8
8512635|NCT00429949|20981108|P1|NOT COMPLETED|Overall Study||0
8512636|NCT00429949|20981108|P1|COMPLETED|Overall Study||21
8512637|NCT00429949|20981108|P1|STARTED|Overall Study||21
8512638|NCT00429923|20981121|P3|NOT COMPLETED|Overall Study||39
8512639|NCT00429923|20981122|P2|NOT COMPLETED|Overall Study||4
8512640|NCT00429923|20981123|P1|NOT COMPLETED|Overall Study||5
8512641|NCT00429923|20981121|P3|COMPLETED|Overall Study||68
8512642|NCT00429923|20981122|P2|COMPLETED|Overall Study||51
8512643|NCT00429923|20981123|P1|COMPLETED|Overall Study||52
8512644|NCT00429923|20981121|P3|STARTED|Overall Study||107
8512645|NCT00429923|20981122|P2|STARTED|Overall Study||55
8512646|NCT00429923|20981123|P1|STARTED|Overall Study||57
8512647|NCT00429858|20981128|P1|NOT COMPLETED|Overall Study||2
8512648|NCT00429858|20981128|P1|COMPLETED|Overall Study||19
8512649|NCT00429858|20981128|P1|STARTED|Overall Study||21
8512650|NCT00429793|20981139|P1|NOT COMPLETED|Overall Study||6
8512651|NCT00429793|20981139|P1|COMPLETED|Overall Study||54
8512652|NCT00429793|20981139|P1|STARTED|Overall Study||60
8512653|NCT00429702|20981155|P2|NOT COMPLETED|Overall Study||0
8512654|NCT00429702|20981156|P1|NOT COMPLETED|Overall Study||0
8512655|NCT00429702|20981155|P2|COMPLETED|Overall Study||4
8512656|NCT00429702|20981156|P1|COMPLETED|Overall Study||3
8512657|NCT00429702|20981155|P2|STARTED|Overall Study||4
8512658|NCT00429702|20981156|P1|STARTED|Overall Study||3
8512659|NCT00429663|20981166|P2|NOT COMPLETED|Overall Study||39
8512660|NCT00429663|20981167|P1|NOT COMPLETED|Overall Study||36
8512661|NCT00429663|20981166|P2|COMPLETED|Overall Study||41
8512662|NCT00429663|20981167|P1|COMPLETED|Overall Study||40
8512663|NCT00429663|20981166|P2|STARTED|Overall Study||80
8512664|NCT00429663|20981167|P1|STARTED|Overall Study||76
8512665|NCT00429572|20981181|P1|NOT COMPLETED|Overall Study||1
8512666|NCT00429572|20981181|P1|COMPLETED|Overall Study||18
8512667|NCT00429572|20981181|P1|STARTED|Overall Study||19
8512668|NCT00429507|20981189|P1|NOT COMPLETED|Overall Study||0
8512669|NCT00429507|20981189|P1|COMPLETED|Overall Study||12
8512670|NCT00429507|20981189|P1|STARTED|Overall Study||12
8512671|NCT00429494|20981193|P1|NOT COMPLETED|Overall Study||15
8512672|NCT00429494|20981193|P1|COMPLETED|Overall Study||44
8512673|NCT00429494|20981193|P1|STARTED|Overall Study||59
8512674|NCT00429416|20981197|P1|NOT COMPLETED|Overall Study||1
8512675|NCT00429416|20981197|P1|COMPLETED|Overall Study||13
8512676|NCT00429416|20981197|P1|STARTED|Overall Study||14
8512677|NCT00429403|20981207|P2|NOT COMPLETED|Overall Study||0
8512678|NCT00429403|20981208|P1|NOT COMPLETED|Overall Study||0
8512679|NCT00429403|20981207|P2|COMPLETED|Overall Study||0
8512680|NCT00429403|20981208|P1|COMPLETED|Overall Study||1
8512681|NCT00429403|20981207|P2|STARTED|Overall Study||0
8512682|NCT00429403|20981208|P1|STARTED|Overall Study||1
8512683|NCT00429364|20981216|P2|NOT COMPLETED|Overall Study||33
8512684|NCT00429364|20981217|P1|NOT COMPLETED|Overall Study||32
8512685|NCT00429364|20981216|P2|COMPLETED|Overall Study||272
8512686|NCT00429364|20981217|P1|COMPLETED|Overall Study||271
8512687|NCT00429364|20981216|P2|STARTED|Overall Study||305
8512688|NCT00429364|20981217|P1|STARTED|Overall Study||303
8512689|NCT00429299|20981276|P3|NOT COMPLETED|Overall Study||4
8512690|NCT00429299|20981277|P2|NOT COMPLETED|Overall Study||7
8512691|NCT00429299|20981278|P1|NOT COMPLETED|Overall Study||4
8512692|NCT00429299|20981276|P3|COMPLETED|Overall Study||42
8512693|NCT00429299|20981277|P2|COMPLETED|Overall Study||32
8512694|NCT00429299|20981278|P1|COMPLETED|Overall Study||32
8512695|NCT00429299|20981276|P3|STARTED|Overall Study||46
8512696|NCT00429299|20981277|P2|STARTED|Overall Study||39
8512697|NCT00429299|20981278|P1|STARTED|Overall Study||36
8512698|NCT00429273|20981310|P3|NOT COMPLETED|Overall Study||9
8512699|NCT00429273|20981311|P2|NOT COMPLETED|Overall Study||8
8512700|NCT00429273|20981312|P1|NOT COMPLETED|Overall Study||8
8512701|NCT00429273|20981310|P3|COMPLETED|Overall Study||61
8512702|NCT00429273|20981311|P2|COMPLETED|Overall Study||61
8512703|NCT00429273|20981312|P1|COMPLETED|Overall Study||60
8512704|NCT00429273|20981310|P3|STARTED|Overall Study||70
8512705|NCT00429273|20981311|P2|STARTED|Overall Study||69
8512706|NCT00429273|20981312|P1|STARTED|Overall Study||68
8512707|NCT00429182|20981320|P1|NOT COMPLETED|Overall Study||7
8512708|NCT00429182|20981320|P1|COMPLETED|Overall Study||25
8512709|NCT00429182|20981320|P1|STARTED|Overall Study||32
8512710|NCT00429169|20981327|P2|NOT COMPLETED|Overall Study||2
8512711|NCT00429169|20981328|P1|NOT COMPLETED|Overall Study||2
8512712|NCT00429169|20981327|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
8512713|NCT00429169|20981328|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
8512714|NCT00429169|20981327|P2|STARTED|Overall Study||40
8512715|NCT00429169|20981328|P1|STARTED|Overall Study||38
8512716|NCT00429143|20981340|P1|NOT COMPLETED|Overall Study||0
8512717|NCT00429143|20981340|P1|COMPLETED|Overall Study||27
8512718|NCT00429143|20981340|P1|STARTED|Overall Study||27
8512719|NCT00429104|20981348|P1|NOT COMPLETED|Overall Study||1
8512720|NCT00429104|20981348|P1|COMPLETED|Overall Study||17
8512721|NCT00429104|20981348|P1|STARTED|Overall Study||18
8512722|NCT00429026|20981353|P1|NOT COMPLETED|Overall Study||40
8512723|NCT00429026|20981353|P1|COMPLETED|Overall Study||0
8512724|NCT00429026|20981353|P1|STARTED|Overall Study||40
8512725|NCT00428974|20981361|P4|NOT COMPLETED|Overall Study||3
8512726|NCT00428974|20981362|P3|NOT COMPLETED|Overall Study||1
8512727|NCT00428974|20981363|P2|NOT COMPLETED|Overall Study||0
8512728|NCT00428974|20981364|P1|NOT COMPLETED|Overall Study||8
8512729|NCT00428974|20981361|P4|COMPLETED|Overall Study||16
8512730|NCT00428974|20981362|P3|COMPLETED|Overall Study||14
8512731|NCT00428974|20981363|P2|COMPLETED|Overall Study||17
8512732|NCT00428974|20981364|P1|COMPLETED|Overall Study||17
8512733|NCT00428974|20981361|P4|STARTED|Overall Study||19
8512734|NCT00428974|20981362|P3|STARTED|Overall Study||15
8512735|NCT00428974|20981363|P2|STARTED|Overall Study||17
8512736|NCT00428974|20981364|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
8512737|NCT00428948|20981380|P2|NOT COMPLETED|Overall Study||67
8512738|NCT00428948|20981381|P1|NOT COMPLETED|Overall Study||221
8512739|NCT00428948|20981380|P2|COMPLETED|Overall Study||417
8512740|NCT00428948|20981381|P1|COMPLETED|Overall Study||740
8512741|NCT00428948|20981380|P2|Received Treatment|Overall Study||483
8512742|NCT00428948|20981381|P1|Received Treatment|Overall Study||961
8512743|NCT00428948|20981380|P2|STARTED|Overall Study||484
8512744|NCT00428948|20981381|P1|STARTED|Overall Study||961
8512745|NCT00428922|20981399|P1|NOT COMPLETED|Overall Study||0
8512746|NCT00428922|20981399|P1|COMPLETED|Overall Study||26
8512747|NCT00428922|20981399|P1|STARTED|Overall Study||26
8512748|NCT00428844|20981409|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
8512749|NCT00428844|20981410|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
8512750|NCT00428844|20981411|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
8512751|NCT00428844|20981409|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
8512752|NCT00428844|20981410|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
8512753|NCT00428844|20981411|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
8512754|NCT00428844|20981409|P3|STARTED|Completed Test of Cure (TOC) Visit||19
8512755|NCT00428844|20981410|P2|STARTED|Completed Test of Cure (TOC) Visit||18
8512756|NCT00428844|20981411|P1|STARTED|Completed Test of Cure (TOC) Visit||23
8512757|NCT00428844|20981409|P3|NOT COMPLETED|Completed Study Drug Treatment||7
8512758|NCT00428844|20981410|P2|NOT COMPLETED|Completed Study Drug Treatment||6
8512759|NCT00428844|20981411|P1|NOT COMPLETED|Completed Study Drug Treatment||2
8512760|NCT00428844|20981409|P3|COMPLETED|Completed Study Drug Treatment||19
8512761|NCT00428844|20981410|P2|COMPLETED|Completed Study Drug Treatment||18
8512762|NCT00428844|20981411|P1|COMPLETED|Completed Study Drug Treatment||23
8512763|NCT00428844|20981409|P3|Received First Dose|Completed Study Drug Treatment||25
8512764|NCT00428844|20981410|P2|Received First Dose|Completed Study Drug Treatment||24
8512765|NCT00428844|20981411|P1|Received First Dose|Completed Study Drug Treatment||25
8512766|NCT00428844|20981409|P3|STARTED|Completed Study Drug Treatment||26
8512767|NCT00428844|20981410|P2|STARTED|Completed Study Drug Treatment||24
8512768|NCT00428844|20981411|P1|STARTED|Completed Study Drug Treatment||25
8512769|NCT00428792|20981434|P2|NOT COMPLETED|Overall Study||4
8512770|NCT00428792|20981435|P1|NOT COMPLETED|Overall Study||1
8512771|NCT00428792|20981434|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
8512861|NCT00428116|20981662|P1|COMPLETED|Overall Study||18
8512772|NCT00428792|20981435|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
8512773|NCT00428792|20981434|P2|STARTED|Overall Study||70
8512774|NCT00428792|20981435|P1|STARTED|Overall Study||80
8512775|NCT00428714|20981461|P2|NOT COMPLETED|Overall Study||42
8512776|NCT00428714|20981462|P1|NOT COMPLETED|Overall Study||31
8512777|NCT00428714|20981461|P2|COMPLETED|Overall Study||0
8512778|NCT00428714|20981462|P1|COMPLETED|Overall Study||0
8512779|NCT00428714|20981461|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
8512780|NCT00428714|20981462|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8512781|NCT00428714|20981461|P2|STARTED|Overall Study||42
8512782|NCT00428714|20981462|P1|STARTED|Overall Study||31
8512783|NCT00428610|20981481|P3|NOT COMPLETED|Overall Study||32
8512784|NCT00428610|20981482|P2|NOT COMPLETED|Overall Study||18
8512785|NCT00428610|20981483|P1|NOT COMPLETED|Overall Study||53
8512786|NCT00428610|20981481|P3|COMPLETED|Overall Study||0
8512787|NCT00428610|20981482|P2|COMPLETED|Overall Study||0
8512788|NCT00428610|20981483|P1|COMPLETED|Overall Study||0
8512789|NCT00428610|20981481|P3|Received at Least One Dose of Study Drug|Overall Study||32
8512790|NCT00428610|20981482|P2|Received at Least One Dose of Study Drug|Overall Study||18
8512791|NCT00428610|20981483|P1|Received at Least One Dose of Study Drug|Overall Study||53
8512792|NCT00428610|20981481|P3|STARTED|Overall Study||32
8512793|NCT00428610|20981482|P2|STARTED|Overall Study||18
8512794|NCT00428610|20981483|P1|STARTED|Overall Study||53
8512795|NCT00428597|20981517|P2|NOT COMPLETED|Overall Study||85
8512796|NCT00428597|20981518|P1|NOT COMPLETED|Overall Study||86
8512797|NCT00428597|20981517|P2|COMPLETED|Overall Study||0
8512798|NCT00428597|20981518|P1|COMPLETED|Overall Study||0
8512799|NCT00428597|20981517|P2|Received Treatment|Overall Study||82
8512800|NCT00428597|20981518|P1|Received Treatment|Overall Study||83
8512801|NCT00428597|20981517|P2|STARTED|Overall Study||85
8512802|NCT00428597|20981518|P1|STARTED|Overall Study||86
8512803|NCT00428584|20981560|P2|NOT COMPLETED|Extension Phase||29
8512804|NCT00428584|20981561|P1|NOT COMPLETED|Extension Phase||21
8512805|NCT00428584|20981560|P2|COMPLETED|Extension Phase||34
8512806|NCT00428584|20981561|P1|COMPLETED|Extension Phase||35
8512807|NCT00428584|20981560|P2|STARTED|Extension Phase||63
8512808|NCT00428584|20981561|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
8512809|NCT00428584|20981560|P2|NOT COMPLETED|Comparative Phase||1
8512810|NCT00428584|20981561|P1|NOT COMPLETED|Comparative Phase||9
8512811|NCT00428584|20981560|P2|COMPLETED|Comparative Phase||63
8512812|NCT00428584|20981561|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
8512813|NCT00428584|20981560|P2|STARTED|Comparative Phase||64
8512814|NCT00428584|20981561|P1|STARTED|Comparative Phase||65
8512815|NCT00428441|20981585|P1|NOT COMPLETED|Overall Study||1
8512816|NCT00428441|20981585|P1|COMPLETED|Overall Study||74
8512817|NCT00428441|20981585|P1|STARTED|Overall Study||75
8512818|NCT00428389|20981591|P2|NOT COMPLETED|Extension Phase||26
8512819|NCT00428389|20981592|P1|NOT COMPLETED|Extension Phase||32
8512820|NCT00428389|20981591|P2|COMPLETED|Extension Phase||91
8512821|NCT00428389|20981592|P1|COMPLETED|Extension Phase||85
8512822|NCT00428389|20981591|P2|STARTED|Extension Phase||117
8512823|NCT00428389|20981592|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
8512824|NCT00428389|20981591|P2|NOT COMPLETED|Core Phase||11
8512825|NCT00428389|20981592|P1|NOT COMPLETED|Core Phase||11
8512826|NCT00428389|20981591|P2|COMPLETED|Core Phase||120
8512827|NCT00428389|20981592|P1|COMPLETED|Core Phase||120
8512828|NCT00428389|20981591|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
8512829|NCT00428389|20981592|P1|Intent-to-treat Population|Core Phase||131
8512830|NCT00428389|20981591|P2|STARTED|Core Phase||131
8512831|NCT00428389|20981592|P1|STARTED|Core Phase||131
8512832|NCT00428298|20981612|P2|NOT COMPLETED|Overall Study||11
8512833|NCT00428298|20981613|P1|NOT COMPLETED|Overall Study||14
8512834|NCT00428298|20981612|P2|COMPLETED|Overall Study||19
8512835|NCT00428298|20981613|P1|COMPLETED|Overall Study||16
8512836|NCT00428298|20981612|P2|Second RBANS at Study Exit|Overall Study||3
8512837|NCT00428298|20981613|P1|Second RBANS at Study Exit|Overall Study||3
8512838|NCT00428298|20981612|P2|STARTED|Overall Study||30
8512839|NCT00428298|20981613|P1|STARTED|Overall Study||30
8512840|NCT00428246|20981626|P3|NOT COMPLETED|Overall Study||1
8512841|NCT00428246|20981627|P2|NOT COMPLETED|Overall Study||0
8512842|NCT00428246|20981628|P1|NOT COMPLETED|Overall Study||1
8512843|NCT00428246|20981626|P3|COMPLETED|Overall Study||7
8512844|NCT00428246|20981627|P2|COMPLETED|Overall Study||8
8512845|NCT00428246|20981628|P1|COMPLETED|Overall Study||7
8512846|NCT00428246|20981626|P3|STARTED|Overall Study||8
8512847|NCT00428246|20981627|P2|STARTED|Overall Study||8
8512848|NCT00428246|20981628|P1|STARTED|Overall Study||8
8512849|NCT00428220|20981636|P1|NOT COMPLETED|Overall Study||223
8512850|NCT00428220|20981636|P1|COMPLETED|Overall Study||0
8512851|NCT00428220|20981636|P1|STARTED|Overall Study||223
8512852|NCT00428207|20981652|P2|NOT COMPLETED|Overall Study||0
8512853|NCT00428207|20981653|P1|NOT COMPLETED|Overall Study||0
8512854|NCT00428207|20981652|P2|COMPLETED|Overall Study||2
8512855|NCT00428207|20981653|P1|COMPLETED|Overall Study||2
8512856|NCT00428207|20981652|P2|STARTED|Overall Study||2
8512857|NCT00428207|20981653|P1|STARTED|Overall Study||2
8512858|NCT00428116|20981661|P2|NOT COMPLETED|Overall Study||0
8512859|NCT00428116|20981662|P1|NOT COMPLETED|Overall Study||3
8512860|NCT00428116|20981661|P2|COMPLETED|Overall Study||21
8512862|NCT00428116|20981661|P2|STARTED|Overall Study||21
8512863|NCT00428116|20981662|P1|STARTED|Overall Study||21
8512864|NCT00428090|20981674|P4|NOT COMPLETED|Overall Study||28
8512865|NCT00428090|20981675|P3|NOT COMPLETED|Overall Study||38
8512866|NCT00428090|20981676|P2|NOT COMPLETED|Overall Study||31
8512867|NCT00428090|20981677|P1|NOT COMPLETED|Overall Study||34
8512868|NCT00428090|20981674|P4|COMPLETED|Overall Study||55
8512869|NCT00428090|20981675|P3|COMPLETED|Overall Study||127
8512870|NCT00428090|20981676|P2|COMPLETED|Overall Study||135
8512871|NCT00428090|20981677|P1|COMPLETED|Overall Study||131
8512872|NCT00428090|20981674|P4|STARTED|Overall Study||83
8512873|NCT00428090|20981675|P3|STARTED|Overall Study||165
8512874|NCT00428090|20981676|P2|STARTED|Overall Study||166
8512875|NCT00428090|20981677|P1|STARTED|Overall Study||165
8512876|NCT00428077|20981791|P1|NOT COMPLETED|Overall Study||0
8512877|NCT00428077|20981791|P1|COMPLETED|Overall Study||4
8512878|NCT00428077|20981791|P1|STARTED|Overall Study||4
8512879|NCT00427999|20981795|P1|NOT COMPLETED|Overall Study||32
8512880|NCT00427999|20981795|P1|COMPLETED|Overall Study||33
8512881|NCT00427999|20981795|P1|Extension Follow-up|Overall Study||19
8512882|NCT00427999|20981795|P1|Intent to Treat (ITT)|Overall Study||61
8512883|NCT00427999|20981795|P1|STARTED|Overall Study||65
8512884|NCT00427973|20981804|P1|NOT COMPLETED|Overall Study||0
8512885|NCT00427973|20981804|P1|COMPLETED|Overall Study||17
8512886|NCT00427973|20981804|P1|STARTED|Overall Study||17
8512887|NCT00427960|20981813|P2|NOT COMPLETED|Overall Study||4
8512888|NCT00427960|20981814|P1|NOT COMPLETED|Overall Study||2
8512889|NCT00427960|20981813|P2|COMPLETED|Overall Study||21
8512890|NCT00427960|20981814|P1|COMPLETED|Overall Study||28
8512891|NCT00427960|20981813|P2|STARTED|Overall Study||25
8512892|NCT00427960|20981814|P1|STARTED|Overall Study||30
8512893|NCT00427934|20981852|P4|NOT COMPLETED|Overall Study||15
8512894|NCT00427934|20981853|P3|NOT COMPLETED|Overall Study||23
8512895|NCT00427934|20981854|P2|NOT COMPLETED|Overall Study||0
8512896|NCT00427934|20981855|P1|NOT COMPLETED|Overall Study||1
8512897|NCT00427934|20981852|P4|COMPLETED|Overall Study||19
8512898|NCT00427934|20981853|P3|COMPLETED|Overall Study||55
8512899|NCT00427934|20981854|P2|COMPLETED|Overall Study||8
8512900|NCT00427934|20981855|P1|COMPLETED|Overall Study||7
8512901|NCT00427934|20981852|P4|Treated|Overall Study||33
8512902|NCT00427934|20981853|P3|Treated|Overall Study||77
8512903|NCT00427934|20981854|P2|Treated|Overall Study||8
8512904|NCT00427934|20981855|P1|Treated|Overall Study||8
8512905|NCT00427934|20981852|P4|STARTED|Overall Study||34
8512906|NCT00427934|20981853|P3|STARTED|Overall Study||78
8512907|NCT00427934|20981854|P2|STARTED|Overall Study||8
8512908|NCT00427934|20981855|P1|STARTED|Overall Study||8
8512909|NCT00427921|20981923|P1|NOT COMPLETED|Overall Study||50
8512910|NCT00427921|20981923|P1|COMPLETED|Overall Study||254
8512911|NCT00427921|20981923|P1|STARTED|Overall Study||304
8512912|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 5||0
8512913|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 5||0
8512914|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 5||0
8512915|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 5||0
8512916|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 5||13
8512917|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 5||12
8512918|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 5||99
8512919|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 5||52
8512920|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 5||13
8512921|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 5||12
8512922|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 5||99
8512923|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 5||52
8512924|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 4||0
8512925|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 4||0
8512926|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 4||0
8512927|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 4||0
8512928|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 4||32
8512929|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 4||34
8512930|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 4||192
8512931|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 4||165
8512932|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 4||32
8512933|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 4||34
8512934|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 4||192
8512935|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 4||165
8512936|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 3||0
8512937|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 3||0
8512938|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 3||0
8512939|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 3||0
8512940|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 3||38
8512941|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 3||38
8512942|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 3||201
8512943|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 3||185
8512944|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 3||38
8512945|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 3||38
8512946|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 3||201
8512947|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 3||185
8512948|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 2||0
8512949|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 2||0
8512950|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 2||0
8512951|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 2||0
8512952|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 2||61
8512953|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 2||53
8512954|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 2||215
8512955|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 2||208
8512956|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 2||61
8512957|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 2||53
8512958|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 2||215
8512959|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 2||208
8512960|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 1||0
8512961|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 1||0
8512962|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 1||0
8512963|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 1||0
8512964|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 1||78
8512965|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 1||71
8512966|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 1||221
8512967|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 1||222
8512968|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 1||78
8512969|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 1||71
8512970|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 1||221
8512971|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 1||222
8512972|NCT00427908|20981946|P4|NOT COMPLETED|Primary Phase||0
8512973|NCT00427908|20981947|P3|NOT COMPLETED|Primary Phase||3
8512974|NCT00427908|20981948|P2|NOT COMPLETED|Primary Phase||3
8512975|NCT00427908|20981949|P1|NOT COMPLETED|Primary Phase||5
8512976|NCT00427908|20981946|P4|COMPLETED|Primary Phase||78
8512977|NCT00427908|20981947|P3|COMPLETED|Primary Phase||72
8512978|NCT00427908|20981948|P2|COMPLETED|Primary Phase||228
8512979|NCT00427908|20981949|P1|COMPLETED|Primary Phase||224
8512980|NCT00427908|20981946|P4|STARTED|Primary Phase||78
8512981|NCT00427908|20981947|P3|STARTED|Primary Phase||75
8512982|NCT00427908|20981948|P2|STARTED|Primary Phase||231
8512983|NCT00427908|20981949|P1|STARTED|Primary Phase||229
8512984|NCT00427895|20982149|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
8512985|NCT00427895|20982150|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512986|NCT00427895|20982151|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512987|NCT00427895|20982152|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
8512988|NCT00427895|20982153|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512989|NCT00427895|20982154|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512990|NCT00427895|20982155|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512991|NCT00427895|20982156|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512992|NCT00427895|20982149|P8|COMPLETED|Vax 2/Year 3 to 4||212
8512993|NCT00427895|20982150|P7|COMPLETED|Vax 2/Year 3 to 4||189
8512994|NCT00427895|20982151|P6|COMPLETED|Vax 2/Year 3 to 4||108
8512995|NCT00427895|20982152|P5|COMPLETED|Vax 2/Year 3 to 4||107
8512996|NCT00427895|20982153|P4|COMPLETED|Vax 2/Year 3 to 4||0
8512997|NCT00427895|20982154|P3|COMPLETED|Vax 2/Year 3 to 4||0
8512998|NCT00427895|20982155|P2|COMPLETED|Vax 2/Year 3 to 4||0
8512999|NCT00427895|20982156|P1|COMPLETED|Vax 2/Year 3 to 4||0
8513000|NCT00427895|20982149|P8|STARTED|Vax 2/Year 3 to 4||214
8513001|NCT00427895|20982150|P7|STARTED|Vax 2/Year 3 to 4||189
8513002|NCT00427895|20982151|P6|STARTED|Vax 2/Year 3 to 4||108
8513003|NCT00427895|20982152|P5|STARTED|Vax 2/Year 3 to 4||108
8513004|NCT00427895|20982153|P4|STARTED|Vax 2/Year 3 to 4||0
8513005|NCT00427895|20982154|P3|STARTED|Vax 2/Year 3 to 4||0
8513006|NCT00427895|20982155|P2|STARTED|Vax 2/Year 3 to 4||0
8513007|NCT00427895|20982156|P1|STARTED|Vax 2/Year 3 to 4||0
8513008|NCT00427895|20982149|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513009|NCT00427895|20982150|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513010|NCT00427895|20982151|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513011|NCT00427895|20982152|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513012|NCT00427895|20982153|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
8513013|NCT00427895|20982154|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
8513014|NCT00427895|20982155|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
8513015|NCT00427895|20982156|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
8513016|NCT00427895|20982149|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513017|NCT00427895|20982150|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513018|NCT00427895|20982151|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513019|NCT00427895|20982152|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513020|NCT00427895|20982153|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513021|NCT00427895|20982154|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
8513022|NCT00427895|20982155|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
8513023|NCT00427895|20982156|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
8513024|NCT00427895|20982149|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513025|NCT00427895|20982150|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513026|NCT00427895|20982151|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513027|NCT00427895|20982152|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513028|NCT00427895|20982153|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
8513029|NCT00427895|20982154|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
8513030|NCT00427895|20982155|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
8513031|NCT00427895|20982156|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
8513032|NCT00427895|20982149|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513033|NCT00427895|20982150|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513034|NCT00427895|20982151|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513035|NCT00427895|20982152|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513036|NCT00427895|20982153|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
8513037|NCT00427895|20982154|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
8513038|NCT00427895|20982155|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
8513039|NCT00427895|20982156|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
8513040|NCT00427895|20982149|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
8513041|NCT00427895|20982150|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
8513042|NCT00427895|20982151|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
8513043|NCT00427895|20982152|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
8513044|NCT00427895|20982153|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
8513045|NCT00427895|20982154|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
8513046|NCT00427895|20982155|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
8513047|NCT00427895|20982156|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
8513048|NCT00427895|20982149|P8|STARTED|Vax 1/Year 1 Follow-up||0
8513049|NCT00427895|20982150|P7|STARTED|Vax 1/Year 1 Follow-up||0
8513050|NCT00427895|20982151|P6|STARTED|Vax 1/Year 1 Follow-up||0
8513051|NCT00427895|20982152|P5|STARTED|Vax 1/Year 1 Follow-up||0
8513052|NCT00427895|20982153|P4|STARTED|Vax 1/Year 1 Follow-up||502
8513053|NCT00427895|20982154|P3|STARTED|Vax 1/Year 1 Follow-up||392
8513054|NCT00427895|20982155|P2|STARTED|Vax 1/Year 1 Follow-up||411
8513055|NCT00427895|20982156|P1|STARTED|Vax 1/Year 1 Follow-up||411
8513056|NCT00427895|20982149|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513057|NCT00427895|20982150|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513058|NCT00427895|20982151|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513059|NCT00427895|20982152|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513060|NCT00427895|20982153|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
8513061|NCT00427895|20982154|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513062|NCT00427895|20982155|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513063|NCT00427895|20982156|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513064|NCT00427895|20982149|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513065|NCT00427895|20982150|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513066|NCT00427895|20982151|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513067|NCT00427895|20982152|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513068|NCT00427895|20982153|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
8513069|NCT00427895|20982154|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
8513070|NCT00427895|20982155|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
8513071|NCT00427895|20982156|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
8513072|NCT00427895|20982149|P8|STARTED|Between 6-Month Follow-up - Year 1||0
8513073|NCT00427895|20982150|P7|STARTED|Between 6-Month Follow-up - Year 1||0
8513074|NCT00427895|20982151|P6|STARTED|Between 6-Month Follow-up - Year 1||0
8513075|NCT00427895|20982152|P5|STARTED|Between 6-Month Follow-up - Year 1||0
8513076|NCT00427895|20982153|P4|STARTED|Between 6-Month Follow-up - Year 1||854
8513077|NCT00427895|20982154|P3|STARTED|Between 6-Month Follow-up - Year 1||392
8513078|NCT00427895|20982155|P2|STARTED|Between 6-Month Follow-up - Year 1||411
8513079|NCT00427895|20982156|P1|STARTED|Between 6-Month Follow-up - Year 1||411
8513080|NCT00427895|20982149|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513081|NCT00427895|20982150|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513082|NCT00427895|20982151|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513083|NCT00427895|20982152|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513084|NCT00427895|20982153|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
8513085|NCT00427895|20982154|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
8513086|NCT00427895|20982155|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
8513087|NCT00427895|20982156|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
8513088|NCT00427895|20982149|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513089|NCT00427895|20982150|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513090|NCT00427895|20982151|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513091|NCT00427895|20982152|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513092|NCT00427895|20982153|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
8513093|NCT00427895|20982154|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
8513094|NCT00427895|20982155|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
8513095|NCT00427895|20982156|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
8513096|NCT00427895|20982149|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513097|NCT00427895|20982150|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513098|NCT00427895|20982151|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513099|NCT00427895|20982152|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513100|NCT00427895|20982153|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
8513101|NCT00427895|20982154|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
8513102|NCT00427895|20982155|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
8513103|NCT00427895|20982156|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
8513104|NCT00427895|20982149|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513105|NCT00427895|20982150|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513106|NCT00427895|20982151|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513107|NCT00427895|20982152|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513108|NCT00427895|20982153|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
8513109|NCT00427895|20982154|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
8513110|NCT00427895|20982155|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
8513111|NCT00427895|20982156|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
8513112|NCT00427804|20982213|P2|NOT COMPLETED|Overall Study||0
8513113|NCT00427804|20982214|P1|NOT COMPLETED|Overall Study||0
8513114|NCT00427804|20982213|P2|COMPLETED|Overall Study||5
8513115|NCT00427804|20982214|P1|COMPLETED|Overall Study||4
8513116|NCT00427804|20982213|P2|STARTED|Overall Study||5
8513117|NCT00427804|20982214|P1|STARTED|Overall Study||4
8513118|NCT00427791|20982222|P2|NOT COMPLETED|Overall Study||0
8513119|NCT00427791|20982223|P1|NOT COMPLETED|Overall Study||0
8513120|NCT00427791|20982222|P2|COMPLETED|Overall Study||13
8513121|NCT00427791|20982223|P1|COMPLETED|Overall Study||10
8513122|NCT00427791|20982222|P2|STARTED|Overall Study||13
8513123|NCT00427791|20982223|P1|STARTED|Overall Study||10
8513124|NCT00427778|20982231|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8513125|NCT00427778|20982232|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8513126|NCT00427778|20982231|P2|COMPLETED|Second Intervention (4 Weeks)||14
8513127|NCT00427778|20982232|P1|COMPLETED|Second Intervention (4 Weeks)||10
8513128|NCT00427778|20982231|P2|STARTED|Second Intervention (4 Weeks)||14
8513129|NCT00427778|20982232|P1|STARTED|Second Intervention (4 Weeks)||10
8513130|NCT00427778|20982231|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
8513131|NCT00427778|20982232|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
8513132|NCT00427778|20982231|P2|COMPLETED|Wash Out (2 Weeks)||14
8513133|NCT00427778|20982232|P1|COMPLETED|Wash Out (2 Weeks)||10
8513134|NCT00427778|20982231|P2|STARTED|Wash Out (2 Weeks)||14
8513135|NCT00427778|20982232|P1|STARTED|Wash Out (2 Weeks)||10
8513136|NCT00427778|20982231|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8513137|NCT00427778|20982232|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
8513138|NCT00427778|20982231|P2|COMPLETED|First Intervention (4 Weeks)||14
8513139|NCT00427778|20982232|P1|COMPLETED|First Intervention (4 Weeks)||10
8513140|NCT00427778|20982231|P2|STARTED|First Intervention (4 Weeks)||15
8513141|NCT00427778|20982232|P1|STARTED|First Intervention (4 Weeks)||14
8513142|NCT00427765|20982251|P1|NOT COMPLETED|Overall Study||0
8513143|NCT00427765|20982251|P1|COMPLETED|Overall Study||164
8513144|NCT00427765|20982251|P1|STARTED|Overall Study||164
8513145|NCT00427700|20982257|P2|NOT COMPLETED|Overall Study||11
8513146|NCT00427700|20982258|P1|NOT COMPLETED|Overall Study||3
8513147|NCT00427700|20982257|P2|COMPLETED|Overall Study||31
8513148|NCT00427700|20982258|P1|COMPLETED|Overall Study||37
8513149|NCT00427700|20982257|P2|STARTED|Overall Study||42
8513150|NCT00427700|20982258|P1|STARTED|Overall Study||40
8513151|NCT00427661|20982266|P1|NOT COMPLETED|Overall Study||0
8513152|NCT00427661|20982266|P1|COMPLETED|Overall Study||8
8513153|NCT00427661|20982266|P1|STARTED|Overall Study||8
8513154|NCT00427648|20982274|P2|NOT COMPLETED|Overall Study||3
8513155|NCT00427648|20982275|P1|NOT COMPLETED|Overall Study||1
8513156|NCT00427648|20982274|P2|COMPLETED|Overall Study||7
8513157|NCT00427648|20982275|P1|COMPLETED|Overall Study||11
8513158|NCT00427648|20982274|P2|STARTED|Overall Study||10
8513159|NCT00427648|20982275|P1|STARTED|Overall Study||12
8513160|NCT00427635|20982295|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
8513161|NCT00427635|20982296|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
8513162|NCT00427635|20982295|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
8513163|NCT00427635|20982296|P1|COMPLETED|Study Completion to Safety Follow-up||25
8513164|NCT00427635|20982295|P2|STARTED|Study Completion to Safety Follow-up||26
8513165|NCT00427635|20982296|P1|STARTED|Study Completion to Safety Follow-up||25
8513166|NCT00427635|20982295|P2|NOT COMPLETED|Treatment Phase||0
8513167|NCT00427635|20982296|P1|NOT COMPLETED|Treatment Phase||1
8513168|NCT00427635|20982295|P2|COMPLETED|Treatment Phase|ITT population|26
8513169|NCT00427635|20982296|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
8513170|NCT00427635|20982295|P2|STARTED|Treatment Phase|Randomised|26
8513171|NCT00427635|20982296|P1|STARTED|Treatment Phase|Randomised|26
8513172|NCT00427557|20982324|P1|NOT COMPLETED|Overall Study||0
8513173|NCT00427557|20982324|P1|COMPLETED|Overall Study||30
8513174|NCT00427557|20982324|P1|STARTED|Overall Study||30
8513175|NCT00427349|20982328|P1|NOT COMPLETED|Overall Study||46
8513176|NCT00427349|20982328|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
8513177|NCT00427349|20982328|P1|Eligible and Treated|Overall Study||44
8513178|NCT00427349|20982328|P1|Treated|Overall Study||45
8513179|NCT00427349|20982328|P1|Eligible|Overall Study||45
8513180|NCT00427349|20982328|P1|STARTED|Overall Study||46
8513181|NCT00427336|20982334|P1|NOT COMPLETED|Overall Study||0
8513182|NCT00427336|20982334|P1|COMPLETED|Overall Study||9
8513183|NCT00427336|20982334|P1|STARTED|Overall Study||9
8513184|NCT00427297|20982340|P2|NOT COMPLETED|Overall Study||0
8513185|NCT00427297|20982341|P1|NOT COMPLETED|Overall Study||0
8513186|NCT00427297|20982340|P2|COMPLETED|Overall Study||17
8513187|NCT00427297|20982341|P1|COMPLETED|Overall Study||17
8513188|NCT00427297|20982340|P2|STARTED|Overall Study||17
8513189|NCT00427297|20982341|P1|STARTED|Overall Study||17
8513196|NCT00427037|20982376|P2|NOT COMPLETED|Overall Study||7
8513197|NCT00427037|20982377|P1|NOT COMPLETED|Overall Study||7
8513198|NCT00427037|20982376|P2|COMPLETED|Overall Study||10
8513199|NCT00427037|20982377|P1|COMPLETED|Overall Study||10
8513200|NCT00427037|20982376|P2|STARTED|Overall Study||17
8513201|NCT00427037|20982377|P1|STARTED|Overall Study||17
8513202|NCT00427011|20982385|P1|NOT COMPLETED|Overall Study||25
8513203|NCT00427011|20982385|P1|COMPLETED|Overall Study||0
8513204|NCT00427011|20982385|P1|STARTED|Overall Study||25
8513205|NCT00426855|20982396|P1|NOT COMPLETED|Overall Study||0
8513206|NCT00426855|20982396|P1|COMPLETED|Overall Study||12
8513207|NCT00426855|20982396|P1|STARTED|Overall Study||12
8513208|NCT00426842|20982400|P1|NOT COMPLETED|Overall Study||1
8513209|NCT00426842|20982400|P1|COMPLETED|Overall Study||10
8513210|NCT00426842|20982400|P1|STARTED|Overall Study||11
8513211|NCT00426764|20982406|P1|NOT COMPLETED|Overall Study||131
8513212|NCT00426764|20982406|P1|COMPLETED|Overall Study||0
8513213|NCT00426764|20982406|P1|Discontinued at End of or After Cycle 6|Overall Study||33
8513214|NCT00426764|20982406|P1|Discontinued Prior to or During Cycle 6|Overall Study||98
8513215|NCT00426764|20982406|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
8513216|NCT00426751|20982423|P2|NOT COMPLETED|Overall Study||20
8513217|NCT00426751|20982424|P1|NOT COMPLETED|Overall Study||22
8513218|NCT00426751|20982423|P2|COMPLETED|Overall Study||183
8513219|NCT00426751|20982424|P1|COMPLETED|Overall Study||204
8513220|NCT00426751|20982423|P2|STARTED|Overall Study||203
8513221|NCT00426751|20982424|P1|STARTED|Overall Study||226
8513222|NCT00426660|20982468|P1|NOT COMPLETED|Overall Study||131
8513223|NCT00426660|20982468|P1|COMPLETED|Overall Study||916
8513224|NCT00426660|20982468|P1|Safety Analysis Set|Overall Study||1032
8513225|NCT00426660|20982468|P1|Treated|Overall Study||1032
8513226|NCT00426660|20982468|P1|STARTED|Overall Study||1047
8513227|NCT00426556|20982499|P4|NOT COMPLETED|Phase II - Extension Phase||23
8513228|NCT00426556|20982500|P3|NOT COMPLETED|Phase II - Extension Phase||0
8513229|NCT00426556|20982501|P2|NOT COMPLETED|Phase II - Extension Phase||0
8513230|NCT00426556|20982502|P1|NOT COMPLETED|Phase II - Extension Phase||0
8513231|NCT00426556|20982499|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
8513232|NCT00426556|20982500|P3|COMPLETED|Phase II - Extension Phase||0
8513233|NCT00426556|20982501|P2|COMPLETED|Phase II - Extension Phase||0
8513234|NCT00426556|20982502|P1|COMPLETED|Phase II - Extension Phase||0
8513235|NCT00426556|20982499|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
8513236|NCT00426556|20982500|P3|STARTED|Phase II - Extension Phase||0
8513237|NCT00426556|20982501|P2|STARTED|Phase II - Extension Phase||0
8513238|NCT00426556|20982502|P1|STARTED|Phase II - Extension Phase||0
8513239|NCT00426556|20982499|P4|NOT COMPLETED|Phase II - Core Phase||27
8513240|NCT00426556|20982500|P3|NOT COMPLETED|Phase II - Core Phase||0
8513241|NCT00426556|20982501|P2|NOT COMPLETED|Phase II - Core Phase||0
8513242|NCT00426556|20982502|P1|NOT COMPLETED|Phase II - Core Phase||0
8513243|NCT00426556|20982499|P4|COMPLETED|Phase II - Core Phase||28
8513244|NCT00426556|20982500|P3|COMPLETED|Phase II - Core Phase||0
8513245|NCT00426556|20982501|P2|COMPLETED|Phase II - Core Phase||0
8513246|NCT00426556|20982502|P1|COMPLETED|Phase II - Core Phase||0
8513247|NCT00426556|20982499|P4|STARTED|Phase II - Core Phase||55
8513248|NCT00426556|20982500|P3|STARTED|Phase II - Core Phase||0
8513249|NCT00426556|20982501|P2|STARTED|Phase II - Core Phase||0
8513250|NCT00426556|20982502|P1|STARTED|Phase II - Core Phase||0
8513251|NCT00426556|20982499|P4|NOT COMPLETED|Phase I - Extension Phase||0
8513252|NCT00426556|20982500|P3|NOT COMPLETED|Phase I - Extension Phase||7
8513253|NCT00426556|20982501|P2|NOT COMPLETED|Phase I - Extension Phase||6
8513254|NCT00426556|20982502|P1|NOT COMPLETED|Phase I - Extension Phase||5
8513255|NCT00426556|20982499|P4|COMPLETED|Phase I - Extension Phase||0
8513256|NCT00426556|20982500|P3|COMPLETED|Phase I - Extension Phase||0
8513257|NCT00426556|20982501|P2|COMPLETED|Phase I - Extension Phase||1
8513258|NCT00426556|20982502|P1|COMPLETED|Phase I - Extension Phase||0
8513259|NCT00426556|20982499|P4|STARTED|Phase I - Extension Phase||0
8513260|NCT00426556|20982500|P3|STARTED|Phase I - Extension Phase||7
8513261|NCT00426556|20982501|P2|STARTED|Phase I - Extension Phase||7
8513262|NCT00426556|20982502|P1|STARTED|Phase I - Extension Phase||5
8513263|NCT00426556|20982499|P4|NOT COMPLETED|Phase I - Core Phase||0
8513264|NCT00426556|20982500|P3|NOT COMPLETED|Phase I - Core Phase||3
8513265|NCT00426556|20982501|P2|NOT COMPLETED|Phase I - Core Phase||10
8513266|NCT00426556|20982502|P1|NOT COMPLETED|Phase I - Core Phase||1
8513267|NCT00426556|20982499|P4|COMPLETED|Phase I - Core Phase||0
8513268|NCT00426556|20982500|P3|COMPLETED|Phase I - Core Phase||7
8513269|NCT00426556|20982501|P2|COMPLETED|Phase I - Core Phase||7
8513270|NCT00426556|20982502|P1|COMPLETED|Phase I - Core Phase||5
8513271|NCT00426556|20982499|P4|STARTED|Phase I - Core Phase||0
8513272|NCT00426556|20982500|P3|STARTED|Phase I - Core Phase||10
8513273|NCT00426556|20982501|P2|STARTED|Phase I - Core Phase||17
8513274|NCT00426556|20982502|P1|STARTED|Phase I - Core Phase||6
8513275|NCT00426361|20982527|P3|NOT COMPLETED|Overall Study||5
8513276|NCT00426361|20982528|P2|NOT COMPLETED|Overall Study||5
8513277|NCT00426361|20982529|P1|NOT COMPLETED|Overall Study||4
8513278|NCT00426361|20982527|P3|COMPLETED|Overall Study||243
8513279|NCT00426361|20982528|P2|COMPLETED|Overall Study||250
8513280|NCT00426361|20982529|P1|COMPLETED|Overall Study||244
8513281|NCT00426361|20982527|P3|STARTED|Overall Study||248
8513282|NCT00426361|20982528|P2|STARTED|Overall Study||255
8513283|NCT00426361|20982529|P1|STARTED|Overall Study||248
8513284|NCT00426283|20982581|P2|NOT COMPLETED|Overall Study||1
8513285|NCT00426283|20982582|P1|NOT COMPLETED|Overall Study||5
8513286|NCT00426283|20982581|P2|COMPLETED|Overall Study||13
8513287|NCT00426283|20982582|P1|COMPLETED|Overall Study||23
8513288|NCT00426283|20982581|P2|STARTED|Overall Study||14
8513289|NCT00426283|20982582|P1|STARTED|Overall Study||28
8513290|NCT00426270|20982596|P1|NOT COMPLETED|Overall Study||6
8513291|NCT00426270|20982596|P1|COMPLETED|Overall Study||110
8513292|NCT00426270|20982596|P1|STARTED|Overall Study||116
8513293|NCT00426231|20982606|P2|NOT COMPLETED|Overall Study||12
8513294|NCT00426231|20982607|P1|NOT COMPLETED|Overall Study||9
8513295|NCT00426231|20982606|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
8513296|NCT00426231|20982607|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
8513297|NCT00426231|20982606|P2|STARTED|Overall Study||37
8513298|NCT00426231|20982607|P1|STARTED|Overall Study||36
8513299|NCT00426153|20982617|P2|NOT COMPLETED|Overall Study||0
8513300|NCT00426153|20982618|P1|NOT COMPLETED|Overall Study||0
8513301|NCT00426153|20982617|P2|COMPLETED|Overall Study||14
8513302|NCT00426153|20982618|P1|COMPLETED|Overall Study||28
8513303|NCT00426153|20982617|P2|STARTED|Overall Study||14
8513304|NCT00426153|20982618|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
8513305|NCT00426127|20982630|P1|NOT COMPLETED|Overall Study||2
8513306|NCT00426127|20982630|P1|COMPLETED|Overall Study||0
8513307|NCT00426127|20982630|P1|STARTED|Overall Study||2
8513308|NCT00425945|20982638|P2|NOT COMPLETED|Overall Study||5
8513309|NCT00425945|20982639|P1|NOT COMPLETED|Overall Study||4
8513310|NCT00425945|20982638|P2|COMPLETED|Overall Study||61
8513311|NCT00425945|20982639|P1|COMPLETED|Overall Study||60
8513312|NCT00425945|20982638|P2|STARTED|Overall Study||66
8513313|NCT00425945|20982639|P1|STARTED|Overall Study||64
8513314|NCT00425854|20982677|P2|NOT COMPLETED|Overall Study||21
8513315|NCT00425854|20982678|P1|NOT COMPLETED|Overall Study||29
8513316|NCT00425854|20982677|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
8513317|NCT00425854|20982678|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
8513318|NCT00425854|20982677|P2|STARTED|Overall Study|Treated|21
8513319|NCT00425854|20982678|P1|STARTED|Overall Study|Treated|29
8513320|NCT00425802|20982699|P1|NOT COMPLETED|Overall Study||0
8513321|NCT00425802|20982699|P1|COMPLETED|Overall Study||61
8513322|NCT00425802|20982699|P1|STARTED|Overall Study||61
8513323|NCT00425750|20982711|P1|NOT COMPLETED|Overall Study||25
8513324|NCT00425750|20982711|P1|COMPLETED|Overall Study||0
8513325|NCT00425750|20982711|P1|STARTED|Overall Study||25
8513326|NCT00425698|20982719|P2|NOT COMPLETED|Overall Study||2
8513327|NCT00425698|20982720|P1|NOT COMPLETED|Overall Study||3
8513328|NCT00425698|20982719|P2|COMPLETED|Overall Study||42
8513329|NCT00425698|20982720|P1|COMPLETED|Overall Study||41
8513330|NCT00425698|20982719|P2|STARTED|Overall Study||44
8513331|NCT00425698|20982720|P1|STARTED|Overall Study||44
8513332|NCT00425672|20982726|P1|NOT COMPLETED|Overall Study||1
8513333|NCT00425672|20982726|P1|COMPLETED|Overall Study||14
8513334|NCT00425672|20982726|P1|STARTED|Overall Study||15
8513335|NCT00425607|20982735|P1|NOT COMPLETED|Overall Study||2
8513336|NCT00425607|20982735|P1|COMPLETED|Overall Study||27
8513337|NCT00425607|20982735|P1|Received Treatment|Overall Study||28
8513338|NCT00425607|20982735|P1|STARTED|Overall Study||29
8513339|NCT00425503|20982739|P1|NOT COMPLETED|Overall Study||3
8513340|NCT00425503|20982739|P1|COMPLETED|Overall Study||37
8513341|NCT00425503|20982739|P1|STARTED|Overall Study||40
8513342|NCT00425477|20982743|P1|NOT COMPLETED|Overall Study||13
8513343|NCT00425477|20982743|P1|COMPLETED|Overall Study||13
8513344|NCT00425477|20982743|P1|STARTED|Overall Study||26
8513345|NCT00425438|20982751|P2|NOT COMPLETED|Overall Study||27
8513346|NCT00425438|20982752|P1|NOT COMPLETED|Overall Study||25
8513347|NCT00425438|20982751|P2|COMPLETED|Overall Study||0
8513348|NCT00425438|20982752|P1|COMPLETED|Overall Study||0
8513349|NCT00425438|20982751|P2|STARTED|Overall Study||27
8513350|NCT00425438|20982752|P1|STARTED|Overall Study||25
8513351|NCT00425386|20982768|P1|NOT COMPLETED|Overall Study||3
8513352|NCT00425386|20982768|P1|COMPLETED|Overall Study||43
8513353|NCT00425386|20982768|P1|STARTED|Overall Study||46
8513354|NCT00425373|20982786|P9|NOT COMPLETED|Overall Study||18
8513355|NCT00425373|20982787|P8|NOT COMPLETED|Overall Study||10
8513356|NCT00425373|20982788|P7|NOT COMPLETED|Overall Study||7
8513357|NCT00425373|20982789|P6|NOT COMPLETED|Overall Study||9
8513358|NCT00425373|20982790|P5|NOT COMPLETED|Overall Study||10
8513359|NCT00425373|20982791|P4|NOT COMPLETED|Overall Study||2
8513360|NCT00425373|20982792|P3|NOT COMPLETED|Overall Study||3
8513361|NCT00425373|20982793|P2|NOT COMPLETED|Overall Study||3
8513362|NCT00425373|20982794|P1|NOT COMPLETED|Overall Study||5
8513363|NCT00425373|20982786|P9|COMPLETED|Overall Study||148
8513364|NCT00425373|20982787|P8|COMPLETED|Overall Study||151
8513365|NCT00425373|20982788|P7|COMPLETED|Overall Study||154
8513366|NCT00425373|20982789|P6|COMPLETED|Overall Study||154
8513367|NCT00425373|20982790|P5|COMPLETED|Overall Study||159
8513368|NCT00425373|20982791|P4|COMPLETED|Overall Study||160
8513369|NCT00425373|20982792|P3|COMPLETED|Overall Study||157
8513370|NCT00425373|20982793|P2|COMPLETED|Overall Study||164
8513371|NCT00425373|20982794|P1|COMPLETED|Overall Study||154
8513372|NCT00425373|20982786|P9|STARTED|Overall Study||166
8513373|NCT00425373|20982787|P8|STARTED|Overall Study||161
8513374|NCT00425373|20982788|P7|STARTED|Overall Study||161
8513375|NCT00425373|20982789|P6|STARTED|Overall Study||163
8513376|NCT00425373|20982790|P5|STARTED|Overall Study||169
8513377|NCT00425373|20982791|P4|STARTED|Overall Study||162
8513378|NCT00425373|20982792|P3|STARTED|Overall Study||160
8513379|NCT00425373|20982793|P2|STARTED|Overall Study||167
8513380|NCT00425373|20982794|P1|STARTED|Overall Study||159
8513381|NCT00425308|20982852|P2|NOT COMPLETED|Overall Study||1
8513382|NCT00425308|20982853|P1|NOT COMPLETED|Overall Study||4
8513383|NCT00425308|20982852|P2|COMPLETED|Overall Study||14
8513384|NCT00425308|20982853|P1|COMPLETED|Overall Study||11
8513385|NCT00425308|20982852|P2|STARTED|Overall Study||15
8513386|NCT00425308|20982853|P1|STARTED|Overall Study||15
8513387|NCT00425269|20982883|P2|NOT COMPLETED|Overall Study||20
8513388|NCT00425269|20982884|P1|NOT COMPLETED|Overall Study||19
8513389|NCT00425269|20982883|P2|COMPLETED|Overall Study||77
8513390|NCT00425269|20982884|P1|COMPLETED|Overall Study||82
8513391|NCT00425269|20982883|P2|STARTED|Overall Study||97
8513392|NCT00425269|20982884|P1|STARTED|Overall Study||101
8513393|NCT00425113|20982962|P2|NOT COMPLETED|Overall Study||2
8513394|NCT00425113|20982963|P1|NOT COMPLETED|Overall Study||2
8513395|NCT00425113|20982962|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
8513396|NCT00425113|20982963|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
8513397|NCT00425113|20982962|P2|Exposed to Study Drug|Overall Study||17
8513398|NCT00425113|20982963|P1|Exposed to Study Drug|Overall Study||16
8513399|NCT00425113|20982962|P2|STARTED|Overall Study||18
8513400|NCT00425113|20982963|P1|STARTED|Overall Study||17
8513401|NCT00425100|20982971|P1|NOT COMPLETED|Overall Study||53
8513402|NCT00425100|20982971|P1|COMPLETED|Overall Study||463
8513403|NCT00425100|20982971|P1|STARTED|Overall Study||516
8513404|NCT00425061|20983015|P7|NOT COMPLETED|Overall Study||19
8513405|NCT00425061|20983016|P6|NOT COMPLETED|Overall Study||4
8513406|NCT00425061|20983017|P5|NOT COMPLETED|Overall Study||26
8513407|NCT00425061|20983018|P4|NOT COMPLETED|Overall Study||2
8513408|NCT00425061|20983019|P3|NOT COMPLETED|Overall Study||0
8513409|NCT00425061|20983020|P2|NOT COMPLETED|Overall Study||2
8513410|NCT00425061|20983021|P1|NOT COMPLETED|Overall Study||2
8513411|NCT00425061|20983015|P7|COMPLETED|Overall Study||26
8513412|NCT00425061|20983016|P6|COMPLETED|Overall Study||0
8513413|NCT00425061|20983017|P5|COMPLETED|Overall Study||19
8513414|NCT00425061|20983018|P4|COMPLETED|Overall Study||14
8513415|NCT00425061|20983019|P3|COMPLETED|Overall Study||16
8513416|NCT00425061|20983020|P2|COMPLETED|Overall Study||15
8513417|NCT00425061|20983021|P1|COMPLETED|Overall Study||14
8513418|NCT00425061|20983015|P7|STARTED|Overall Study||45
8513419|NCT00425061|20983016|P6|STARTED|Overall Study||4
8513420|NCT00425061|20983017|P5|STARTED|Overall Study||45
8513421|NCT00425061|20983018|P4|STARTED|Overall Study||16
8513422|NCT00425061|20983019|P3|STARTED|Overall Study||16
8513423|NCT00425061|20983020|P2|STARTED|Overall Study||17
8513424|NCT00425061|20983021|P1|STARTED|Overall Study||16
8513425|NCT00424840|20983137|P3|NOT COMPLETED|Overall Study||0
8513426|NCT00424840|20983138|P2|NOT COMPLETED|Overall Study||0
8513427|NCT00424840|20983139|P1|NOT COMPLETED|Overall Study||0
8513428|NCT00424840|20983137|P3|COMPLETED|Overall Study||5
8513429|NCT00424840|20983138|P2|COMPLETED|Overall Study||4
8513430|NCT00424840|20983139|P1|COMPLETED|Overall Study||3
8513431|NCT00424840|20983137|P3|STARTED|Overall Study||5
8513432|NCT00424840|20983138|P2|STARTED|Overall Study||4
8513433|NCT00424840|20983139|P1|STARTED|Overall Study||3
8513434|NCT00424827|20983145|P1|NOT COMPLETED|Overall Study||1
8513435|NCT00424827|20983145|P1|COMPLETED|Overall Study||10
8513436|NCT00424827|20983145|P1|STARTED|Overall Study||11
8513437|NCT00424775|20983153|P2|NOT COMPLETED|Overall Study||0
8513438|NCT00424775|20983154|P1|NOT COMPLETED|Overall Study||3
8513439|NCT00424775|20983153|P2|COMPLETED|Overall Study||0
8513440|NCT00424775|20983154|P1|COMPLETED|Overall Study||0
8513441|NCT00424775|20983153|P2|STARTED|Overall Study||0
8513442|NCT00424775|20983154|P1|STARTED|Overall Study||3
8513443|NCT00424762|20983164|P2|NOT COMPLETED|Overall Study||22
8513444|NCT00424762|20983165|P1|NOT COMPLETED|Overall Study||20
8513445|NCT00424762|20983164|P2|COMPLETED|Overall Study||54
8513446|NCT00424762|20983165|P1|COMPLETED|Overall Study||54
8513447|NCT00424762|20983164|P2|STARTED|Overall Study||76
8513448|NCT00424762|20983165|P1|STARTED|Overall Study||74
8513449|NCT00424749|20983175|P1|NOT COMPLETED|Overall Study||1
8513450|NCT00424749|20983175|P1|COMPLETED|Overall Study||3
8513451|NCT00424749|20983175|P1|STARTED|Overall Study||4
8513452|NCT00424645|20983182|P2|NOT COMPLETED|Overall Study||0
8513453|NCT00424645|20983183|P1|NOT COMPLETED|Overall Study||1
8513454|NCT00424645|20983182|P2|COMPLETED|Overall Study||0
8513455|NCT00424645|20983183|P1|COMPLETED|Overall Study||2
8513456|NCT00424645|20983182|P2|STARTED|Overall Study||0
8513457|NCT00424645|20983183|P1|STARTED|Overall Study||3
8513458|NCT00424632|20983191|P10|NOT COMPLETED|Overall Study||6
8513459|NCT00424632|20983192|P9|NOT COMPLETED|Overall Study||16
8513460|NCT00424632|20983193|P8|NOT COMPLETED|Overall Study||3
8513461|NCT00424632|20983194|P7|NOT COMPLETED|Overall Study||7
8513462|NCT00424632|20983195|P6|NOT COMPLETED|Overall Study||15
8513463|NCT00424632|20983196|P5|NOT COMPLETED|Overall Study||3
8513464|NCT00424632|20983197|P4|NOT COMPLETED|Overall Study||4
8513465|NCT00424632|20983198|P3|NOT COMPLETED|Overall Study||1
8513466|NCT00424632|20983199|P2|NOT COMPLETED|Overall Study||1
8513467|NCT00424632|20983200|P1|NOT COMPLETED|Overall Study||1
8513468|NCT00424632|20983191|P10|COMPLETED|Overall Study||0
8513469|NCT00424632|20983192|P9|COMPLETED|Overall Study||0
8513470|NCT00424632|20983193|P8|COMPLETED|Overall Study||0
8513471|NCT00424632|20983194|P7|COMPLETED|Overall Study||0
8513472|NCT00424632|20983195|P6|COMPLETED|Overall Study||0
8513473|NCT00424632|20983196|P5|COMPLETED|Overall Study||0
8513474|NCT00424632|20983197|P4|COMPLETED|Overall Study||0
8513475|NCT00424632|20983198|P3|COMPLETED|Overall Study||0
8513476|NCT00424632|20983199|P2|COMPLETED|Overall Study||0
8513477|NCT00424632|20983200|P1|COMPLETED|Overall Study||0
8513478|NCT00424632|20983191|P10|STARTED|Overall Study||6
8513479|NCT00424632|20983192|P9|STARTED|Overall Study||16
8513480|NCT00424632|20983193|P8|STARTED|Overall Study||3
8513481|NCT00424632|20983194|P7|STARTED|Overall Study||7
8513482|NCT00424632|20983195|P6|STARTED|Overall Study||15
8513483|NCT00424632|20983196|P5|STARTED|Overall Study||3
8513484|NCT00424632|20983197|P4|STARTED|Overall Study||4
8513485|NCT00424632|20983198|P3|STARTED|Overall Study||1
8513486|NCT00424632|20983199|P2|STARTED|Overall Study||1
8513487|NCT00424632|20983200|P1|STARTED|Overall Study||1
8513488|NCT00424619|20983334|P3|NOT COMPLETED|3 Month||0
8513489|NCT00424619|20983335|P2|NOT COMPLETED|3 Month||0
8513490|NCT00424619|20983336|P1|NOT COMPLETED|3 Month||0
8513491|NCT00424619|20983334|P3|COMPLETED|3 Month||17
8513492|NCT00424619|20983335|P2|COMPLETED|3 Month||18
8513493|NCT00424619|20983336|P1|COMPLETED|3 Month||12
8513494|NCT00424619|20983334|P3|STARTED|3 Month||17
8513495|NCT00424619|20983335|P2|STARTED|3 Month||18
8513496|NCT00424619|20983336|P1|STARTED|3 Month||12
8513497|NCT00424619|20983334|P3|NOT COMPLETED|4 Week||0
8513498|NCT00424619|20983335|P2|NOT COMPLETED|4 Week||0
8513499|NCT00424619|20983336|P1|NOT COMPLETED|4 Week||0
8513500|NCT00424619|20983334|P3|COMPLETED|4 Week||17
8513501|NCT00424619|20983335|P2|COMPLETED|4 Week||17
8513502|NCT00424619|20983336|P1|COMPLETED|4 Week||18
8513503|NCT00424619|20983334|P3|STARTED|4 Week||17
8513504|NCT00424619|20983335|P2|STARTED|4 Week||17
8513505|NCT00424619|20983336|P1|STARTED|4 Week||18
8513506|NCT00424619|20983334|P3|NOT COMPLETED|Baseline||1
8513507|NCT00424619|20983335|P2|NOT COMPLETED|Baseline||0
8513508|NCT00424619|20983336|P1|NOT COMPLETED|Baseline||0
8513509|NCT00424619|20983334|P3|COMPLETED|Baseline||20
8513510|NCT00424619|20983335|P2|COMPLETED|Baseline||22
8513511|NCT00424619|20983336|P1|COMPLETED|Baseline||22
8513512|NCT00424619|20983334|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
8513513|NCT00424619|20983335|P2|STARTED|Baseline||22
8513514|NCT00424619|20983336|P1|STARTED|Baseline||22
8513515|NCT00424593|20983370|P2|NOT COMPLETED|Dose-Blind Extension Period||0
8513516|NCT00424593|20983371|P1|NOT COMPLETED|Dose-Blind Extension Period||64
8513517|NCT00424593|20983370|P2|COMPLETED|Dose-Blind Extension Period||0
8513518|NCT00424593|20983371|P1|COMPLETED|Dose-Blind Extension Period||117
8513519|NCT00424593|20983370|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
8513520|NCT00424593|20983371|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
8513521|NCT00424593|20983370|P2|NOT COMPLETED|Acute Double-Blind Period||23
8513522|NCT00424593|20983371|P1|NOT COMPLETED|Acute Double-Blind Period||31
8513523|NCT00424593|20983370|P2|COMPLETED|Acute Double-Blind Period||98
8513524|NCT00424593|20983371|P1|COMPLETED|Acute Double-Blind Period||84
8513525|NCT00424593|20983370|P2|STARTED|Acute Double-Blind Period||121
8513526|NCT00424593|20983371|P1|STARTED|Acute Double-Blind Period||115
8513527|NCT00424554|20983417|P2|NOT COMPLETED|Overall Study||0
8513528|NCT00424554|20983418|P1|NOT COMPLETED|Overall Study||0
8513529|NCT00424554|20983417|P2|COMPLETED|Overall Study||6
8513530|NCT00424554|20983418|P1|COMPLETED|Overall Study||34
8513531|NCT00424554|20983417|P2|STARTED|Overall Study||6
8513532|NCT00424554|20983418|P1|STARTED|Overall Study||34
8513533|NCT00424528|20983435|P3|NOT COMPLETED|Overall Study||4
8513534|NCT00424528|20983436|P2|NOT COMPLETED|Overall Study||4
8513535|NCT00424528|20983437|P1|NOT COMPLETED|Overall Study||5
8513536|NCT00424528|20983435|P3|COMPLETED|Overall Study||74
8513537|NCT00424528|20983436|P2|COMPLETED|Overall Study||76
8513538|NCT00424528|20983437|P1|COMPLETED|Overall Study||71
8513539|NCT00424528|20983435|P3|STARTED|Overall Study||78
8513540|NCT00424528|20983436|P2|STARTED|Overall Study||80
8513541|NCT00424528|20983437|P1|STARTED|Overall Study||76
8513542|NCT00424515|20983492|P2|NOT COMPLETED|Overall Study||13
8513543|NCT00424515|20983493|P1|NOT COMPLETED|Overall Study||11
8513544|NCT00424515|20983492|P2|COMPLETED|Overall Study||0
8513545|NCT00424515|20983493|P1|COMPLETED|Overall Study||0
8513546|NCT00424515|20983492|P2|STARTED|Overall Study||13
8513547|NCT00424515|20983493|P1|STARTED|Overall Study||11
8513548|NCT00424502|20983503|P1|NOT COMPLETED|Overall Study||0
8513549|NCT00424502|20983503|P1|COMPLETED|Overall Study||20
8513550|NCT00424502|20983503|P1|STARTED|Overall Study||20
8513551|NCT00424489|20983512|P1|NOT COMPLETED|Overall Study||3
8513552|NCT00424489|20983512|P1|COMPLETED|Overall Study||6
8513553|NCT00424489|20983512|P1|STARTED|Overall Study||9
8513554|NCT00424476|20983519|P3|NOT COMPLETED|Overall Study||49
8513555|NCT00424476|20983520|P2|NOT COMPLETED|Overall Study||48
8513556|NCT00424476|20983521|P1|NOT COMPLETED|Overall Study||61
8513557|NCT00424476|20983519|P3|COMPLETED|Overall Study||241
8513558|NCT00424476|20983520|P2|COMPLETED|Overall Study||240
8513559|NCT00424476|20983521|P1|COMPLETED|Overall Study||226
8513560|NCT00424476|20983519|P3|STARTED|Overall Study||290
8513561|NCT00424476|20983520|P2|STARTED|Overall Study||288
8513562|NCT00424476|20983521|P1|STARTED|Overall Study||287
8513563|NCT00424463|20983547|P3|NOT COMPLETED|Overall Study||16
8513564|NCT00424463|20983548|P2|NOT COMPLETED|Overall Study||14
8513565|NCT00424463|20983549|P1|NOT COMPLETED|Overall Study||7
8513566|NCT00424463|20983547|P3|COMPLETED|Overall Study||72
8513567|NCT00424463|20983548|P2|COMPLETED|Overall Study||34
8513568|NCT00424463|20983549|P1|COMPLETED|Overall Study||38
8513569|NCT00424463|20983547|P3|STARTED|Overall Study||88
8513570|NCT00424463|20983548|P2|STARTED|Overall Study||48
8513571|NCT00424463|20983549|P1|STARTED|Overall Study||45
8513572|NCT00424398|20983578|P3|NOT COMPLETED|Overall Study||0
8513573|NCT00424398|20983579|P2|NOT COMPLETED|Overall Study||1
8513574|NCT00424398|20983580|P1|NOT COMPLETED|Overall Study||3
8513575|NCT00424398|20983578|P3|COMPLETED|Overall Study||36
8513576|NCT00424398|20983579|P2|COMPLETED|Overall Study||35
8513577|NCT00424398|20983580|P1|COMPLETED|Overall Study||32
8513578|NCT00424398|20983578|P3|STARTED|Overall Study||36
8513579|NCT00424398|20983579|P2|STARTED|Overall Study||36
8513580|NCT00424398|20983580|P1|STARTED|Overall Study||35
8513581|NCT00424385|20983624|P1|NOT COMPLETED|Cohort 1||1
8513582|NCT00424385|20983624|P1|COMPLETED|Cohort 1||4
8513583|NCT00424385|20983624|P1|STARTED|Cohort 1||5
8513584|NCT00424385|20983624|P1|NOT COMPLETED|Cohort 0||6
8513585|NCT00424385|20983624|P1|COMPLETED|Cohort 0||6
8513586|NCT00424385|20983624|P1|STARTED|Cohort 0||12
8513587|NCT00424372|20983631|P1|NOT COMPLETED|Overall Study||31
8513588|NCT00424372|20983631|P1|COMPLETED|Overall Study||95
8513589|NCT00424372|20983631|P1|STARTED|Overall Study||126
8513590|NCT00424346|20983643|P4|NOT COMPLETED|Extension Phase||55
8513591|NCT00424346|20983644|P3|NOT COMPLETED|Extension Phase||55
8513592|NCT00424346|20983645|P2|NOT COMPLETED|Extension Phase||102
8513593|NCT00424346|20983646|P1|NOT COMPLETED|Extension Phase||0
8513594|NCT00424346|20983643|P4|COMPLETED|Extension Phase||3
8513595|NCT00424346|20983644|P3|COMPLETED|Extension Phase||4
8513596|NCT00424346|20983645|P2|COMPLETED|Extension Phase||8
8513597|NCT00424346|20983646|P1|COMPLETED|Extension Phase||0
8513598|NCT00424346|20983643|P4|STARTED|Extension Phase||58
8513599|NCT00424346|20983644|P3|STARTED|Extension Phase||59
8513600|NCT00424346|20983645|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
8513601|NCT00424346|20983646|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
8513602|NCT00424346|20983643|P4|NOT COMPLETED|Core Study||7
8513603|NCT00424346|20983644|P3|NOT COMPLETED|Core Study||4
8513604|NCT00424346|20983645|P2|NOT COMPLETED|Core Study||8
8513605|NCT00424346|20983646|P1|NOT COMPLETED|Core Study||9
8513606|NCT00424346|20983643|P4|COMPLETED|Core Study||63
8513607|NCT00424346|20983644|P3|COMPLETED|Core Study||65
8513608|NCT00424346|20983645|P2|COMPLETED|Core Study||56
8513609|NCT00424346|20983646|P1|COMPLETED|Core Study||62
8513610|NCT00424346|20983643|P4|STARTED|Core Study||70
8513611|NCT00424346|20983644|P3|STARTED|Core Study||69
8513612|NCT00424346|20983645|P2|STARTED|Core Study||64
8513613|NCT00424346|20983646|P1|STARTED|Core Study||71
8513614|NCT00424294|20983761|P2|NOT COMPLETED|Overall Study||15
8513615|NCT00424294|20983762|P1|NOT COMPLETED|Overall Study||8
8513616|NCT00424294|20983761|P2|COMPLETED|Overall Study||19
8513617|NCT00424294|20983762|P1|COMPLETED|Overall Study||28
8513618|NCT00424294|20983761|P2|Treated|Overall Study||34
8513619|NCT00424294|20983762|P1|Treated|Overall Study||35
8513620|NCT00424294|20983761|P2|STARTED|Overall Study||34
8513621|NCT00424294|20983762|P1|STARTED|Overall Study||36
8513622|NCT00424268|20983812|P2|NOT COMPLETED|Overall Study||39
8513623|NCT00424268|20983813|P1|NOT COMPLETED|Overall Study||62
8513624|NCT00424268|20983812|P2|COMPLETED|Overall Study||333
8513625|NCT00424268|20983813|P1|COMPLETED|Overall Study||309
8513626|NCT00424268|20983812|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
8513627|NCT00424268|20983813|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
8513628|NCT00424255|20983829|P2|NOT COMPLETED|Overall Study||346
8513629|NCT00424255|20983830|P1|NOT COMPLETED|Overall Study||342
8513630|NCT00424255|20983829|P2|COMPLETED|Overall Study||0
8513631|NCT00424255|20983830|P1|COMPLETED|Overall Study||0
8513632|NCT00424255|20983829|P2|STARTED|Overall Study||346
8513633|NCT00424255|20983830|P1|STARTED|Overall Study||342
8513634|NCT00424190|20983878|P2|NOT COMPLETED|Overall Study||30
8513635|NCT00424190|20983879|P1|NOT COMPLETED|Overall Study||22
8513636|NCT00424190|20983878|P2|COMPLETED|Overall Study||317
8513637|NCT00424190|20983879|P1|COMPLETED|Overall Study||329
8513638|NCT00424190|20983878|P2|STARTED|Overall Study||347
8513639|NCT00424190|20983879|P1|STARTED|Overall Study||351
8513640|NCT00424177|20983885|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
8513641|NCT00424177|20983885|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
8513642|NCT00424177|20983885|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
8513643|NCT00424177|20983885|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
8513644|NCT00424177|20983885|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
8513645|NCT00424177|20983885|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
8513646|NCT00424177|20983885|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
8513647|NCT00424177|20983885|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
8513648|NCT00424177|20983885|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
8513649|NCT00424047|20983914|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
8513650|NCT00424047|20983915|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
8513651|NCT00424047|20983914|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
8513652|NCT00424047|20983915|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
8513653|NCT00424047|20983914|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
8513654|NCT00424047|20983915|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
8513655|NCT00424047|20983914|P2|NOT COMPLETED|On Study at Time of Unblinding||167
8513656|NCT00424047|20983915|P1|NOT COMPLETED|On Study at Time of Unblinding||155
8513657|NCT00424047|20983914|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
8513658|NCT00424047|20983915|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
8513659|NCT00424047|20983914|P2|STARTED|On Study at Time of Unblinding||175
8513660|NCT00424047|20983915|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
8513661|NCT00424047|20983914|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
8513662|NCT00424047|20983915|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
8513663|NCT00424047|20983914|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
8513664|NCT00424047|20983915|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
8513665|NCT00424047|20983914|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
8513666|NCT00424047|20983915|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
8513667|NCT00424047|20983914|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
8513668|NCT00424047|20983915|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
8513669|NCT00424047|20983914|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
8513670|NCT00424047|20983915|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
8513671|NCT00424021|20983947|P4|NOT COMPLETED|AMB-220-E Study Period||10
8513672|NCT00424021|20983948|P3|NOT COMPLETED|AMB-220-E Study Period||5
8513673|NCT00424021|20983949|P2|NOT COMPLETED|AMB-220-E Study Period||2
8513674|NCT00424021|20983950|P1|NOT COMPLETED|AMB-220-E Study Period||1
8513675|NCT00424021|20983947|P4|COMPLETED|AMB-220-E Study Period||16
8513676|NCT00424021|20983948|P3|COMPLETED|AMB-220-E Study Period||14
8513677|NCT00424021|20983949|P2|COMPLETED|AMB-220-E Study Period||5
8513678|NCT00424021|20983950|P1|COMPLETED|AMB-220-E Study Period||1
8513679|NCT00424021|20983947|P4|STARTED|AMB-220-E Study Period||26
8513680|NCT00424021|20983948|P3|STARTED|AMB-220-E Study Period||19
8513681|NCT00424021|20983949|P2|STARTED|AMB-220-E Study Period||7
8513682|NCT00424021|20983950|P1|STARTED|AMB-220-E Study Period||2
8513683|NCT00424021|20983947|P4|NOT COMPLETED|NCT00046319 Study Period||1
8513684|NCT00424021|20983948|P3|NOT COMPLETED|NCT00046319 Study Period||1
8513685|NCT00424021|20983949|P2|NOT COMPLETED|NCT00046319 Study Period||3
8513686|NCT00424021|20983950|P1|NOT COMPLETED|NCT00046319 Study Period||1
8513687|NCT00424021|20983947|P4|COMPLETED|NCT00046319 Study Period||12
8513688|NCT00424021|20983948|P3|COMPLETED|NCT00046319 Study Period||15
8513689|NCT00424021|20983949|P2|COMPLETED|NCT00046319 Study Period||16
8513690|NCT00424021|20983950|P1|COMPLETED|NCT00046319 Study Period||15
8513691|NCT00424021|20983947|P4|STARTED|NCT00046319 Study Period||13
8513692|NCT00424021|20983948|P3|STARTED|NCT00046319 Study Period||16
8513693|NCT00424021|20983949|P2|STARTED|NCT00046319 Study Period||19
8513694|NCT00424021|20983950|P1|STARTED|NCT00046319 Study Period||16
8513695|NCT00424008|20983993|P2|NOT COMPLETED|Overall Study||335
8513696|NCT00424008|20983994|P1|NOT COMPLETED|Overall Study||349
8513697|NCT00424008|20983993|P2|COMPLETED|Overall Study||16
8513698|NCT00424008|20983994|P1|COMPLETED|Overall Study||22
8513699|NCT00424008|20983993|P2|STARTED|Overall Study||351
8513700|NCT00424008|20983994|P1|STARTED|Overall Study||371
8513701|NCT00423943|20984009|P2|NOT COMPLETED|Overall Study||1
8513702|NCT00423943|20984010|P1|NOT COMPLETED|Overall Study||3
8513703|NCT00423943|20984009|P2|COMPLETED|Overall Study||13
8513704|NCT00423943|20984010|P1|COMPLETED|Overall Study||16
8513705|NCT00423943|20984009|P2|STARTED|Overall Study||14
8513706|NCT00423943|20984010|P1|STARTED|Overall Study||19
8513707|NCT00423930|20984024|P1|NOT COMPLETED|Overall Study||2
8513708|NCT00423930|20984024|P1|COMPLETED|Overall Study||42
8513709|NCT00423930|20984024|P1|STARTED|Overall Study||44
8513710|NCT00423917|20984029|P1|NOT COMPLETED|Overall Study||3
8513711|NCT00423917|20984029|P1|COMPLETED|Overall Study||33
8513712|NCT00423917|20984029|P1|STARTED|Overall Study||36
8513713|NCT00423891|20984042|P3|NOT COMPLETED|Post-Dosing Follow Up||2
8513714|NCT00423891|20984043|P2|NOT COMPLETED|Post-Dosing Follow Up||3
8513715|NCT00423891|20984044|P1|NOT COMPLETED|Post-Dosing Follow Up||2
8513716|NCT00423891|20984042|P3|COMPLETED|Post-Dosing Follow Up||3
8513717|NCT00423891|20984043|P2|COMPLETED|Post-Dosing Follow Up||15
8513718|NCT00423891|20984044|P1|COMPLETED|Post-Dosing Follow Up||20
8513719|NCT00423891|20984042|P3|STARTED|Post-Dosing Follow Up||5
8513720|NCT00423891|20984043|P2|STARTED|Post-Dosing Follow Up||18
8513721|NCT00423891|20984044|P1|STARTED|Post-Dosing Follow Up||22
8513722|NCT00423891|20984042|P3|NOT COMPLETED|Treatment||0
8513723|NCT00423891|20984043|P2|NOT COMPLETED|Treatment||0
8513724|NCT00423891|20984044|P1|NOT COMPLETED|Treatment||2
8513725|NCT00423891|20984042|P3|COMPLETED|Treatment||5
8513726|NCT00423891|20984043|P2|COMPLETED|Treatment||19
8513727|NCT00423891|20984044|P1|COMPLETED|Treatment||22
8513728|NCT00423891|20984042|P3|STARTED|Treatment||5
8513729|NCT00423891|20984043|P2|STARTED|Treatment||19
8513730|NCT00423891|20984044|P1|STARTED|Treatment||24
8513731|NCT00423891|20984042|P3|NOT COMPLETED|Enrolled||3
8513732|NCT00423891|20984043|P2|NOT COMPLETED|Enrolled||2
8513733|NCT00423891|20984044|P1|NOT COMPLETED|Enrolled||11
8513734|NCT00423891|20984042|P3|COMPLETED|Enrolled||5
8513735|NCT00423891|20984043|P2|COMPLETED|Enrolled||19
8513736|NCT00423891|20984044|P1|COMPLETED|Enrolled||24
8513737|NCT00423891|20984042|P3|STARTED|Enrolled||8
8513738|NCT00423891|20984043|P2|STARTED|Enrolled||21
8513739|NCT00423891|20984044|P1|STARTED|Enrolled||35
8513740|NCT00423878|20984113|P2|NOT COMPLETED|Overall Study||8
8513741|NCT00423878|20984114|P1|NOT COMPLETED|Overall Study||20
8513742|NCT00423878|20984113|P2|COMPLETED|Overall Study||98
8513743|NCT00423878|20984114|P1|COMPLETED|Overall Study||89
8513744|NCT00423878|20984113|P2|STARTED|Overall Study||106
8513745|NCT00423878|20984114|P1|STARTED|Overall Study||109
8513746|NCT00423852|20984122|P1|NOT COMPLETED|Overall Study||3
8513747|NCT00423852|20984122|P1|COMPLETED|Overall Study||23
8513748|NCT00423852|20984122|P1|STARTED|Overall Study||26
8513749|NCT00423813|20984130|P3|NOT COMPLETED|Overall Study||74
8513750|NCT00423813|20984131|P2|NOT COMPLETED|Overall Study||66
8513751|NCT00423813|20984132|P1|NOT COMPLETED|Overall Study||57
8513752|NCT00423813|20984130|P3|COMPLETED|Overall Study||116
8513753|NCT00423813|20984131|P2|COMPLETED|Overall Study||129
8513754|NCT00423813|20984132|P1|COMPLETED|Overall Study||131
8513755|NCT00423813|20984130|P3|Treated|Overall Study||189
8513756|NCT00423813|20984131|P2|Treated|Overall Study||194
8513757|NCT00423813|20984132|P1|Treated|Overall Study||188
8513758|NCT00423813|20984130|P3|STARTED|Overall Study||190
8513759|NCT00423813|20984131|P2|STARTED|Overall Study||195
8513760|NCT00423813|20984132|P1|STARTED|Overall Study||188
8513761|NCT00423800|20984142|P2|NOT COMPLETED|Overall Study||1
8513762|NCT00423800|20984143|P1|NOT COMPLETED|Overall Study||0
8513763|NCT00423800|20984142|P2|COMPLETED|Overall Study||1
8513764|NCT00423800|20984143|P1|COMPLETED|Overall Study||3
8513765|NCT00423800|20984142|P2|STARTED|Overall Study||2
8513766|NCT00423800|20984143|P1|STARTED|Overall Study||3
8513767|NCT00423735|20984155|P3|NOT COMPLETED|Overall Study||0
8513768|NCT00423735|20984156|P2|NOT COMPLETED|Overall Study||6
8513769|NCT00423735|20984157|P1|NOT COMPLETED|Overall Study||8
8513770|NCT00423735|20984155|P3|COMPLETED|Overall Study||0
8513771|NCT00423735|20984156|P2|COMPLETED|Overall Study||29
8513772|NCT00423735|20984157|P1|COMPLETED|Overall Study||21
8513773|NCT00423735|20984155|P3|STARTED|Overall Study||0
8513774|NCT00423735|20984156|P2|STARTED|Overall Study||35
8513775|NCT00423735|20984157|P1|STARTED|Overall Study||29
8513776|NCT00423722|20984180|P2|NOT COMPLETED|Overall Study||13
8513777|NCT00423722|20984181|P1|NOT COMPLETED|Overall Study||14
8513778|NCT00423722|20984180|P2|COMPLETED|Overall Study||53
8513779|NCT00423722|20984181|P1|COMPLETED|Overall Study||49
8513780|NCT00423722|20984180|P2|STARTED|Overall Study||66
8513781|NCT00423722|20984181|P1|STARTED|Overall Study||63
8513782|NCT00423683|20984203|P2|NOT COMPLETED|Overall Study||0
8513783|NCT00423683|20984204|P1|NOT COMPLETED|Overall Study||1
8513784|NCT00423683|20984203|P2|COMPLETED|Overall Study||33
8513785|NCT00423683|20984204|P1|COMPLETED|Overall Study||30
8513786|NCT00423683|20984203|P2|STARTED|Overall Study||33
8513787|NCT00423683|20984204|P1|STARTED|Overall Study||31
8513788|NCT00423670|20984223|P8|NOT COMPLETED|Follow-up Period||3
8513789|NCT00423670|20984224|P7|NOT COMPLETED|Follow-up Period||9
8513790|NCT00423670|20984225|P6|NOT COMPLETED|Follow-up Period||0
8513791|NCT00423670|20984226|P5|NOT COMPLETED|Follow-up Period||2
8513792|NCT00423670|20984227|P4|NOT COMPLETED|Follow-up Period||5
8513793|NCT00423670|20984228|P3|NOT COMPLETED|Follow-up Period||11
8513794|NCT00423670|20984229|P2|NOT COMPLETED|Follow-up Period||16
8513795|NCT00423670|20984230|P1|NOT COMPLETED|Follow-up Period||3
8513796|NCT00423670|20984223|P8|COMPLETED|Follow-up Period||32
8513797|NCT00423670|20984224|P7|COMPLETED|Follow-up Period||41
8513798|NCT00423670|20984225|P6|COMPLETED|Follow-up Period||14
8513799|NCT00423670|20984226|P5|COMPLETED|Follow-up Period||89
8513800|NCT00423670|20984227|P4|COMPLETED|Follow-up Period||91
8513801|NCT00423670|20984228|P3|COMPLETED|Follow-up Period||85
8513802|NCT00423670|20984229|P2|COMPLETED|Follow-up Period||84
8513803|NCT00423670|20984230|P1|COMPLETED|Follow-up Period||94
8513804|NCT00423670|20984223|P8|STARTED|Follow-up Period||35
8513805|NCT00423670|20984224|P7|STARTED|Follow-up Period||50
8513806|NCT00423670|20984225|P6|STARTED|Follow-up Period||14
8513807|NCT00423670|20984226|P5|STARTED|Follow-up Period||91
8513808|NCT00423670|20984227|P4|STARTED|Follow-up Period||96
8513809|NCT00423670|20984228|P3|STARTED|Follow-up Period||96
8513810|NCT00423670|20984229|P2|STARTED|Follow-up Period||100
8513811|NCT00423670|20984230|P1|STARTED|Follow-up Period||97
8513812|NCT00423670|20984223|P8|NOT COMPLETED|Treatment Period||21
8513813|NCT00423670|20984224|P7|NOT COMPLETED|Treatment Period||31
8513814|NCT00423670|20984225|P6|NOT COMPLETED|Treatment Period||8
8513815|NCT00423670|20984226|P5|NOT COMPLETED|Treatment Period||27
8513816|NCT00423670|20984227|P4|NOT COMPLETED|Treatment Period||40
8513817|NCT00423670|20984228|P3|NOT COMPLETED|Treatment Period||27
8513818|NCT00423670|20984229|P2|NOT COMPLETED|Treatment Period||30
8513819|NCT00423670|20984230|P1|NOT COMPLETED|Treatment Period||52
8513820|NCT00423670|20984223|P8|COMPLETED|Treatment Period||15
8513821|NCT00423670|20984224|P7|COMPLETED|Treatment Period||28
8513822|NCT00423670|20984225|P6|COMPLETED|Treatment Period||8
8513823|NCT00423670|20984226|P5|COMPLETED|Treatment Period||76
8513824|NCT00423670|20984227|P4|COMPLETED|Treatment Period||63
8513825|NCT00423670|20984228|P3|COMPLETED|Treatment Period||76
8513826|NCT00423670|20984229|P2|COMPLETED|Treatment Period||77
8513827|NCT00423670|20984230|P1|COMPLETED|Treatment Period||52
8513828|NCT00423670|20984223|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
8513829|NCT00423670|20984224|P7|STARTED|Treatment Period||59
8513830|NCT00423670|20984225|P6|STARTED|Treatment Period||16
8513831|NCT00423670|20984226|P5|STARTED|Treatment Period||103
8513832|NCT00423670|20984227|P4|STARTED|Treatment Period||103
8513833|NCT00423670|20984228|P3|STARTED|Treatment Period||103
8513834|NCT00423670|20984229|P2|STARTED|Treatment Period||107
8513835|NCT00423670|20984230|P1|STARTED|Treatment Period||104
8513836|NCT00423657|20984288|P2|NOT COMPLETED|Overall Study||25
8513837|NCT00423657|20984289|P1|NOT COMPLETED|Overall Study||26
8513838|NCT00423657|20984288|P2|COMPLETED|Overall Study||313
8513839|NCT00423657|20984289|P1|COMPLETED|Overall Study||316
8513840|NCT00423657|20984288|P2|STARTED|Overall Study||338
8513841|NCT00423657|20984289|P1|STARTED|Overall Study||342
8513842|NCT00423605|20984295|P1|NOT COMPLETED|Overall Study||241
8513843|NCT00423605|20984295|P1|COMPLETED|Overall Study||319
8513844|NCT00423605|20984295|P1|STARTED|Overall Study||560
8513845|NCT00423592|20984299|P1|NOT COMPLETED|Overall Study||7
8513846|NCT00423592|20984299|P1|COMPLETED|Overall Study|Completed study|29
8513847|NCT00423592|20984299|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
8513848|NCT00423592|20984299|P1|STARTED|Overall Study|Enrolled|36
8513849|NCT00423579|20984320|P2|NOT COMPLETED|Overall Study||4
8513850|NCT00423579|20984321|P1|NOT COMPLETED|Overall Study||4
8513851|NCT00423579|20984320|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
8513852|NCT00423579|20984321|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
8513853|NCT00423579|20984320|P2|STARTED|Overall Study||60
8513854|NCT00423579|20984321|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
8513855|NCT00423488|20984329|P2|NOT COMPLETED|Overall Study||1
8513856|NCT00423488|20984330|P1|NOT COMPLETED|Overall Study||5
8513857|NCT00423488|20984329|P2|COMPLETED|Overall Study||50
8513858|NCT00423488|20984330|P1|COMPLETED|Overall Study||37
8513859|NCT00423488|20984329|P2|STARTED|Overall Study||51
8513860|NCT00423488|20984330|P1|STARTED|Overall Study||42
8513861|NCT00423449|20984336|P5|NOT COMPLETED|Overall Study||7
8513862|NCT00423449|20984337|P4|NOT COMPLETED|Overall Study||22
8513863|NCT00423449|20984338|P3|NOT COMPLETED|Overall Study||15
8513864|NCT00423449|20984339|P2|NOT COMPLETED|Overall Study||4
8513865|NCT00423449|20984340|P1|NOT COMPLETED|Overall Study||3
8513866|NCT00423449|20984336|P5|COMPLETED|Overall Study||0
8513867|NCT00423449|20984337|P4|COMPLETED|Overall Study||5
8513868|NCT00423449|20984338|P3|COMPLETED|Overall Study||2
8513869|NCT00423449|20984339|P2|COMPLETED|Overall Study||2
8513870|NCT00423449|20984340|P1|COMPLETED|Overall Study||1
8513871|NCT00423449|20984336|P5|STARTED|Overall Study||7
8513872|NCT00423449|20984337|P4|STARTED|Overall Study||27
8513873|NCT00423449|20984338|P3|STARTED|Overall Study||17
8513874|NCT00423449|20984339|P2|STARTED|Overall Study||6
8513875|NCT00423449|20984340|P1|STARTED|Overall Study||4
8513876|NCT00423436|20984365|P2|NOT COMPLETED|Overall Study||0
8513877|NCT00423436|20984366|P1|NOT COMPLETED|Overall Study||0
8513878|NCT00423436|20984365|P2|COMPLETED|Overall Study||33
8513879|NCT00423436|20984366|P1|COMPLETED|Overall Study||35
8513880|NCT00423436|20984365|P2|STARTED|Overall Study||33
8513881|NCT00423436|20984366|P1|STARTED|Overall Study||35
8513882|NCT00423358|20984374|P2|NOT COMPLETED|Overall Study||0
8513883|NCT00423358|20984375|P1|NOT COMPLETED|Overall Study||0
8513884|NCT00423358|20984374|P2|COMPLETED|Overall Study||11
8513885|NCT00423358|20984375|P1|COMPLETED|Overall Study||11
8513886|NCT00423358|20984374|P2|STARTED|Overall Study||11
8513887|NCT00423358|20984375|P1|STARTED|Overall Study||11
8513888|NCT00423332|20984387|P2|NOT COMPLETED|Overall Study||7
8513889|NCT00423332|20984388|P1|NOT COMPLETED|Overall Study||9
8513890|NCT00423332|20984387|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
8513891|NCT00423332|20984388|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
8513892|NCT00423332|20984387|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
8513893|NCT00423332|20984388|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
8513894|NCT00423332|20984387|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
8513895|NCT00423332|20984388|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
8513896|NCT00423332|20984387|P2|STARTED|Overall Study|Number randomised|18
8513897|NCT00423332|20984388|P1|STARTED|Overall Study|Randomised|53
8513898|NCT00423319|20984407|P2|NOT COMPLETED|Overall Study||252
8513899|NCT00423319|20984408|P1|NOT COMPLETED|Overall Study||224
8513900|NCT00423319|20984407|P2|COMPLETED|Overall Study||2447
8513901|NCT00423319|20984408|P1|COMPLETED|Overall Study||2484
8513902|NCT00423319|20984407|P2|Participants Who Received Treatment|Overall Study||2659
8513903|NCT00423319|20984408|P1|Participants Who Received Treatment|Overall Study||2673
8513904|NCT00423319|20984407|P2|STARTED|Overall Study|Randomized|2699
8513905|NCT00423319|20984408|P1|STARTED|Overall Study|Randomized|2708
8513906|NCT00423293|20984440|P1|NOT COMPLETED|Overall Study||11
8513907|NCT00423293|20984440|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
8513908|NCT00423293|20984440|P1|STARTED|Overall Study||63
8513909|NCT00423267|20984457|P2|NOT COMPLETED|Period B||0
8513910|NCT00423267|20984458|P1|NOT COMPLETED|Period B||0
8513911|NCT00423267|20984457|P2|COMPLETED|Period B||0
8513912|NCT00423267|20984458|P1|COMPLETED|Period B||12
8513913|NCT00423267|20984457|P2|STARTED|Period B||0
8513914|NCT00423267|20984458|P1|STARTED|Period B||12
8513915|NCT00423267|20984457|P2|NOT COMPLETED|Period A||1
8513916|NCT00423267|20984458|P1|NOT COMPLETED|Period A||2
8513917|NCT00423267|20984457|P2|COMPLETED|Period A||6
8513918|NCT00423267|20984458|P1|COMPLETED|Period A||7
8513919|NCT00423267|20984457|P2|STARTED|Period A||7
8513920|NCT00423267|20984458|P1|STARTED|Period A||9
8513921|NCT00423189|20984478|P3|NOT COMPLETED|Overall Study||0
8513922|NCT00423189|20984479|P2|NOT COMPLETED|Overall Study||1
8513923|NCT00423189|20984480|P1|NOT COMPLETED|Overall Study||0
8513924|NCT00423189|20984478|P3|COMPLETED|Overall Study||2
8513925|NCT00423189|20984479|P2|COMPLETED|Overall Study||2
8513926|NCT00423189|20984480|P1|COMPLETED|Overall Study||2
8513927|NCT00423189|20984478|P3|STARTED|Overall Study||2
8513928|NCT00423189|20984479|P2|STARTED|Overall Study||3
8513929|NCT00423189|20984480|P1|STARTED|Overall Study||2
8513930|NCT00423176|20984502|P2|NOT COMPLETED|Overall Study||29
8513931|NCT00423176|20984503|P1|NOT COMPLETED|Overall Study||16
8513932|NCT00423176|20984502|P2|COMPLETED|Overall Study||94
8513933|NCT00423176|20984503|P1|COMPLETED|Overall Study||98
8513934|NCT00423176|20984502|P2|STARTED|Overall Study||123
8513935|NCT00423176|20984503|P1|STARTED|Overall Study||114
8513936|NCT00423150|20984511|P1|NOT COMPLETED|Overall Study||86
8513937|NCT00423150|20984511|P1|COMPLETED|Overall Study||0
8513938|NCT00423150|20984511|P1|STARTED|Overall Study||86
8513939|NCT00423098|20984517|P2|NOT COMPLETED|Overall Study||4
8513940|NCT00423098|20984518|P1|NOT COMPLETED|Overall Study||3
8513941|NCT00423098|20984517|P2|COMPLETED|Overall Study||35
8513942|NCT00423098|20984518|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
8513943|NCT00423098|20984517|P2|STARTED|Overall Study||39
8513944|NCT00423098|20984518|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
8513945|NCT00423085|20984545|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
8513946|NCT00423085|20984546|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8513947|NCT00423085|20984547|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8513948|NCT00423085|20984548|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8513949|NCT00423085|20984545|P4|COMPLETED|52-Week Open-Label Extension Phase||474
8513950|NCT00423085|20984546|P3|COMPLETED|52-Week Open-Label Extension Phase||0
8513951|NCT00423085|20984547|P2|COMPLETED|52-Week Open-Label Extension Phase||0
8513952|NCT00423085|20984548|P1|COMPLETED|52-Week Open-Label Extension Phase||0
8513953|NCT00423085|20984545|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
8513954|NCT00423085|20984546|P3|STARTED|52-Week Open-Label Extension Phase||0
8513955|NCT00423085|20984547|P2|STARTED|52-Week Open-Label Extension Phase||0
8513956|NCT00423085|20984548|P1|STARTED|52-Week Open-Label Extension Phase||0
8513957|NCT00423085|20984545|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
8513958|NCT00423085|20984546|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
8513959|NCT00423085|20984547|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
8513960|NCT00423085|20984548|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
8513961|NCT00423085|20984545|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
8513962|NCT00423085|20984546|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
8513963|NCT00423085|20984547|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
8513964|NCT00423085|20984548|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
8513965|NCT00423085|20984545|P4|STARTED|24-Week Double-Blind Treatment Phase||0
8513966|NCT00423085|20984546|P3|STARTED|24-Week Double-Blind Treatment Phase||287
8513967|NCT00423085|20984547|P2|STARTED|24-Week Double-Blind Treatment Phase||284
8513968|NCT00423085|20984548|P1|STARTED|24-Week Double-Blind Treatment Phase||288
8513969|NCT00423046|20984577|P2|NOT COMPLETED|Overall Study||345
8513970|NCT00423046|20984578|P1|NOT COMPLETED|Overall Study||340
8513971|NCT00423046|20984577|P2|COMPLETED|Overall Study|Completed until Month 60|208
8513972|NCT00423046|20984578|P1|COMPLETED|Overall Study|Completed until Month 60|213
8513973|NCT00423046|20984577|P2|STARTED|Overall Study||553
8513974|NCT00423046|20984578|P1|STARTED|Overall Study||553
8513975|NCT00422942|20984644|P1|NOT COMPLETED|Overall Study||3
8513976|NCT00422942|20984644|P1|COMPLETED|Overall Study||0
8513977|NCT00422942|20984644|P1|STARTED|Overall Study||3
8513978|NCT00422903|20984663|P2|NOT COMPLETED|Overall Study||5
8513979|NCT00422903|20984664|P1|NOT COMPLETED|Overall Study||4
8513980|NCT00422903|20984663|P2|COMPLETED|Overall Study||38
8513981|NCT00422903|20984664|P1|COMPLETED|Overall Study||45
8513982|NCT00422903|20984663|P2|STARTED|Overall Study||43
8513983|NCT00422903|20984664|P1|STARTED|Overall Study||49
8513984|NCT00422812|20984692|P4|NOT COMPLETED|Overall Study||2
8513985|NCT00422812|20984693|P3|NOT COMPLETED|Overall Study||2
8513986|NCT00422812|20984694|P2|NOT COMPLETED|Overall Study||1
8513987|NCT00422812|20984695|P1|NOT COMPLETED|Overall Study||0
8513988|NCT00422812|20984692|P4|COMPLETED|Overall Study||103
8513989|NCT00422812|20984693|P3|COMPLETED|Overall Study||91
8513990|NCT00422812|20984694|P2|COMPLETED|Overall Study||103
8513991|NCT00422812|20984695|P1|COMPLETED|Overall Study||98
8513992|NCT00422812|20984692|P4|STARTED|Overall Study||105
8513993|NCT00422812|20984693|P3|STARTED|Overall Study||93
8513994|NCT00422812|20984694|P2|STARTED|Overall Study||104
8513995|NCT00422812|20984695|P1|STARTED|Overall Study||98
8513996|NCT00422799|20984713|P1|NOT COMPLETED|Overall Study||13
8513997|NCT00422799|20984713|P1|COMPLETED|Overall Study||50
8513998|NCT00422799|20984713|P1|STARTED|Overall Study||63
8513999|NCT00422734|20984722|P2|NOT COMPLETED|Overall Study||21
8514000|NCT00422734|20984723|P1|NOT COMPLETED|Overall Study||14
8514001|NCT00422734|20984722|P2|COMPLETED|Overall Study||243
8514002|NCT00422734|20984723|P1|COMPLETED|Overall Study||64
8514003|NCT00422734|20984722|P2|STARTED|Overall Study||264
8514004|NCT00422734|20984723|P1|STARTED|Overall Study||78
8514005|NCT00422695|20984757|P2|NOT COMPLETED|Overall Study||0
8514006|NCT00422695|20984758|P1|NOT COMPLETED|Overall Study||0
8514007|NCT00422695|20984757|P2|COMPLETED|Overall Study||38
8514008|NCT00422695|20984758|P1|COMPLETED|Overall Study||105
8514009|NCT00422695|20984757|P2|STARTED|Overall Study||38
8514010|NCT00422695|20984758|P1|STARTED|Overall Study||105
8514011|NCT00422669|20984769|P3|NOT COMPLETED|Overall Study||7
8514012|NCT00422669|20984770|P2|NOT COMPLETED|Overall Study||100
8514013|NCT00422669|20984771|P1|NOT COMPLETED|Overall Study||98
8514014|NCT00422669|20984769|P3|COMPLETED|Overall Study||0
8514015|NCT00422669|20984770|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
8514199|NCT00422097|20985129|P3|COMPLETED|Dose Level 3||3
8514016|NCT00422669|20984771|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
8514017|NCT00422669|20984769|P3|STARTED|Overall Study||7
8514018|NCT00422669|20984770|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
8514019|NCT00422669|20984771|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
8514020|NCT00422656|20984792|P1|NOT COMPLETED|Overall Study||0
8514021|NCT00422656|20984792|P1|COMPLETED|Overall Study||37
8514022|NCT00422656|20984792|P1|STARTED|Overall Study||37
8514023|NCT00422591|20984799|P1|NOT COMPLETED|Overall Study||6
8514024|NCT00422591|20984799|P1|COMPLETED|Overall Study||169
8514025|NCT00422591|20984799|P1|STARTED|Overall Study||175
8514026|NCT00422513|20984807|P2|NOT COMPLETED|Overall Study||106
8514027|NCT00422513|20984808|P1|NOT COMPLETED|Overall Study||107
8514028|NCT00422513|20984807|P2|COMPLETED|Overall Study||24
8514029|NCT00422513|20984808|P1|COMPLETED|Overall Study||23
8514030|NCT00422513|20984807|P2|STARTED|Overall Study||130
8514031|NCT00422513|20984808|P1|STARTED|Overall Study||130
8514032|NCT00422448|20984820|P1|NOT COMPLETED|Overall Study||0
8514033|NCT00422448|20984820|P1|COMPLETED|Overall Study||43
8514034|NCT00422448|20984820|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
8514035|NCT00422422|20984825|P1|NOT COMPLETED|Overall Study||10
8514036|NCT00422422|20984825|P1|COMPLETED|Overall Study||90
8514037|NCT00422422|20984825|P1|STARTED|Overall Study||100
8514038|NCT00422383|20984842|P5|NOT COMPLETED|Overall Study||3
8514039|NCT00422383|20984843|P4|NOT COMPLETED|Overall Study||2
8514040|NCT00422383|20984844|P3|NOT COMPLETED|Overall Study||4
8514041|NCT00422383|20984845|P2|NOT COMPLETED|Overall Study||14
8514042|NCT00422383|20984846|P1|NOT COMPLETED|Overall Study||15
8514043|NCT00422383|20984842|P5|COMPLETED|Overall Study||22
8514044|NCT00422383|20984843|P4|COMPLETED|Overall Study||4
8514045|NCT00422383|20984844|P3|COMPLETED|Overall Study||89
8514046|NCT00422383|20984845|P2|COMPLETED|Overall Study||106
8514047|NCT00422383|20984846|P1|COMPLETED|Overall Study||119
8514048|NCT00422383|20984842|P5|STARTED|Overall Study||25
8514049|NCT00422383|20984843|P4|STARTED|Overall Study||6
8514050|NCT00422383|20984844|P3|STARTED|Overall Study||93
8514051|NCT00422383|20984845|P2|STARTED|Overall Study||120
8514052|NCT00422383|20984846|P1|STARTED|Overall Study||134
8514053|NCT00422292|20984989|P4|NOT COMPLETED|Overall Study||24
8514054|NCT00422292|20984990|P3|NOT COMPLETED|Overall Study||22
8514055|NCT00422292|20984991|P2|NOT COMPLETED|Overall Study||66
8514056|NCT00422292|20984992|P1|NOT COMPLETED|Overall Study||18
8514057|NCT00422292|20984989|P4|COMPLETED|Overall Study||452
8514058|NCT00422292|20984990|P3|COMPLETED|Overall Study||224
8514059|NCT00422292|20984991|P2|COMPLETED|Overall Study||598
8514060|NCT00422292|20984992|P1|COMPLETED|Overall Study||239
8514061|NCT00422292|20984989|P4|STARTED|Overall Study||476
8514062|NCT00422292|20984990|P3|STARTED|Overall Study||246
8514063|NCT00422292|20984991|P2|STARTED|Overall Study||664
8514064|NCT00422292|20984992|P1|STARTED|Overall Study||257
8514065|NCT00422279|20985020|P2|NOT COMPLETED|Overall Study||0
8514066|NCT00422279|20985021|P1|NOT COMPLETED|Overall Study||0
8514067|NCT00422279|20985020|P2|COMPLETED|Overall Study||2
8514068|NCT00422279|20985021|P1|COMPLETED|Overall Study||2
8514069|NCT00422279|20985020|P2|24 Month After Loading Period|Overall Study||2
8514070|NCT00422279|20985021|P1|24 Month After Loading Period|Overall Study||2
8514071|NCT00422279|20985020|P2|STARTED|Overall Study||2
8514072|NCT00422279|20985021|P1|STARTED|Overall Study||2
8514073|NCT00422227|20985031|P2|NOT COMPLETED|Overall Study||15
8514074|NCT00422227|20985032|P1|NOT COMPLETED|Overall Study||4
8514075|NCT00422227|20985031|P2|COMPLETED|Overall Study||88
8514076|NCT00422227|20985032|P1|COMPLETED|Overall Study||193
8514077|NCT00422227|20985031|P2|STARTED|Overall Study||103
8514078|NCT00422227|20985032|P1|STARTED|Overall Study||197
8514079|NCT00422201|20985056|P1|NOT COMPLETED|Overall Study||11
8514080|NCT00422201|20985056|P1|COMPLETED|Overall Study||7
8514081|NCT00422201|20985056|P1|STARTED|Overall Study||18
8514082|NCT00422162|20985063|P2|NOT COMPLETED|Overall Study||30
8514083|NCT00422162|20985064|P1|NOT COMPLETED|Overall Study||24
8514084|NCT00422162|20985063|P2|COMPLETED|Overall Study||142
8514085|NCT00422162|20985064|P1|COMPLETED|Overall Study||143
8514086|NCT00422162|20985063|P2|Received Treatment|Overall Study||171
8514087|NCT00422162|20985064|P1|Received Treatment|Overall Study||167
8514088|NCT00422162|20985063|P2|STARTED|Overall Study||172
8514089|NCT00422162|20985064|P1|STARTED|Overall Study||167
8514090|NCT00422097|20985124|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514091|NCT00422097|20985125|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514092|NCT00422097|20985126|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514093|NCT00422097|20985127|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514094|NCT00422097|20985128|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514095|NCT00422097|20985129|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514096|NCT00422097|20985130|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514097|NCT00422097|20985131|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514098|NCT00422097|20985124|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
8514099|NCT00422097|20985125|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
8514100|NCT00422097|20985126|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
8514101|NCT00422097|20985127|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
8514102|NCT00422097|20985128|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
8514103|NCT00422097|20985129|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
8514104|NCT00422097|20985130|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
8514105|NCT00422097|20985131|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
8514106|NCT00422097|20985124|P8|STARTED|Ixabepilone With Famotidine or Food||7
8514107|NCT00422097|20985125|P7|STARTED|Ixabepilone With Famotidine or Food||8
8514108|NCT00422097|20985126|P6|STARTED|Ixabepilone With Famotidine or Food||0
8514109|NCT00422097|20985127|P5|STARTED|Ixabepilone With Famotidine or Food||0
8514110|NCT00422097|20985128|P4|STARTED|Ixabepilone With Famotidine or Food||0
8514111|NCT00422097|20985129|P3|STARTED|Ixabepilone With Famotidine or Food||0
8514112|NCT00422097|20985130|P2|STARTED|Ixabepilone With Famotidine or Food||0
8514113|NCT00422097|20985131|P1|STARTED|Ixabepilone With Famotidine or Food||0
8514114|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 6||0
8514115|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 6||0
8514116|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 6||0
8514117|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 6||0
8514118|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 6||0
8514119|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 6||0
8514120|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 6||0
8514121|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 6||0
8514122|NCT00422097|20985124|P8|COMPLETED|Dose Level 6||0
8514123|NCT00422097|20985125|P7|COMPLETED|Dose Level 6||0
8514124|NCT00422097|20985126|P6|COMPLETED|Dose Level 6||6
8514125|NCT00422097|20985127|P5|COMPLETED|Dose Level 6||0
8514126|NCT00422097|20985128|P4|COMPLETED|Dose Level 6||0
8514127|NCT00422097|20985129|P3|COMPLETED|Dose Level 6||0
8514128|NCT00422097|20985130|P2|COMPLETED|Dose Level 6||0
8514129|NCT00422097|20985131|P1|COMPLETED|Dose Level 6||0
8514130|NCT00422097|20985124|P8|STARTED|Dose Level 6||0
8514131|NCT00422097|20985125|P7|STARTED|Dose Level 6||0
8514132|NCT00422097|20985126|P6|STARTED|Dose Level 6||6
8514133|NCT00422097|20985127|P5|STARTED|Dose Level 6||0
8514134|NCT00422097|20985128|P4|STARTED|Dose Level 6||0
8514135|NCT00422097|20985129|P3|STARTED|Dose Level 6||0
8514136|NCT00422097|20985130|P2|STARTED|Dose Level 6||0
8514137|NCT00422097|20985131|P1|STARTED|Dose Level 6||0
8514138|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 5||0
8514139|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 5||0
8514140|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 5||0
8514141|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 5||0
8514142|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 5||0
8514143|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 5||0
8514144|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 5||0
8514145|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 5||0
8514146|NCT00422097|20985124|P8|COMPLETED|Dose Level 5||0
8514147|NCT00422097|20985125|P7|COMPLETED|Dose Level 5||0
8514148|NCT00422097|20985126|P6|COMPLETED|Dose Level 5||0
8514149|NCT00422097|20985127|P5|COMPLETED|Dose Level 5||23
8514150|NCT00422097|20985128|P4|COMPLETED|Dose Level 5||0
8514151|NCT00422097|20985129|P3|COMPLETED|Dose Level 5||0
8514152|NCT00422097|20985130|P2|COMPLETED|Dose Level 5||0
8514153|NCT00422097|20985131|P1|COMPLETED|Dose Level 5||0
8514154|NCT00422097|20985124|P8|STARTED|Dose Level 5||0
8514155|NCT00422097|20985125|P7|STARTED|Dose Level 5||0
8514156|NCT00422097|20985126|P6|STARTED|Dose Level 5||0
8514157|NCT00422097|20985127|P5|STARTED|Dose Level 5||23
8514158|NCT00422097|20985128|P4|STARTED|Dose Level 5||0
8514159|NCT00422097|20985129|P3|STARTED|Dose Level 5||0
8514160|NCT00422097|20985130|P2|STARTED|Dose Level 5||0
8514161|NCT00422097|20985131|P1|STARTED|Dose Level 5||0
8514162|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 4||0
8514163|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 4||0
8514164|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 4||0
8514165|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 4||0
8514166|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 4||0
8514167|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 4||0
8514168|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 4||0
8514169|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 4||0
8514170|NCT00422097|20985124|P8|COMPLETED|Dose Level 4||0
8514171|NCT00422097|20985125|P7|COMPLETED|Dose Level 4||0
8514172|NCT00422097|20985126|P6|COMPLETED|Dose Level 4||0
8514173|NCT00422097|20985127|P5|COMPLETED|Dose Level 4||0
8514174|NCT00422097|20985128|P4|COMPLETED|Dose Level 4||3
8514175|NCT00422097|20985129|P3|COMPLETED|Dose Level 4||0
8514176|NCT00422097|20985130|P2|COMPLETED|Dose Level 4||0
8514177|NCT00422097|20985131|P1|COMPLETED|Dose Level 4||0
8514178|NCT00422097|20985124|P8|STARTED|Dose Level 4||0
8514179|NCT00422097|20985125|P7|STARTED|Dose Level 4||0
8514180|NCT00422097|20985126|P6|STARTED|Dose Level 4||0
8514181|NCT00422097|20985127|P5|STARTED|Dose Level 4||0
8514182|NCT00422097|20985128|P4|STARTED|Dose Level 4||3
8514183|NCT00422097|20985129|P3|STARTED|Dose Level 4||0
8514184|NCT00422097|20985130|P2|STARTED|Dose Level 4||0
8514185|NCT00422097|20985131|P1|STARTED|Dose Level 4||0
8514186|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 3||0
8514187|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 3||0
8514188|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 3||0
8514189|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 3||0
8514190|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 3||0
8514191|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 3||0
8514192|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 3||0
8514193|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 3||0
8514194|NCT00422097|20985124|P8|COMPLETED|Dose Level 3||0
8514195|NCT00422097|20985125|P7|COMPLETED|Dose Level 3||0
8514196|NCT00422097|20985126|P6|COMPLETED|Dose Level 3||0
8514197|NCT00422097|20985127|P5|COMPLETED|Dose Level 3||0
8514198|NCT00422097|20985128|P4|COMPLETED|Dose Level 3||0
8514200|NCT00422097|20985130|P2|COMPLETED|Dose Level 3||0
8514201|NCT00422097|20985131|P1|COMPLETED|Dose Level 3||0
8514202|NCT00422097|20985124|P8|STARTED|Dose Level 3||0
8514203|NCT00422097|20985125|P7|STARTED|Dose Level 3||0
8514204|NCT00422097|20985126|P6|STARTED|Dose Level 3||0
8514205|NCT00422097|20985127|P5|STARTED|Dose Level 3||0
8514206|NCT00422097|20985128|P4|STARTED|Dose Level 3||0
8514207|NCT00422097|20985129|P3|STARTED|Dose Level 3||3
8514208|NCT00422097|20985130|P2|STARTED|Dose Level 3||0
8514209|NCT00422097|20985131|P1|STARTED|Dose Level 3||0
8514210|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 2||0
8514211|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 2||0
8514212|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 2||0
8514213|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 2||0
8514214|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 2||0
8514215|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 2||0
8514216|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 2||1
8514217|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 2||0
8514218|NCT00422097|20985124|P8|COMPLETED|Dose Level 2||0
8514219|NCT00422097|20985125|P7|COMPLETED|Dose Level 2||0
8514220|NCT00422097|20985126|P6|COMPLETED|Dose Level 2||0
8514221|NCT00422097|20985127|P5|COMPLETED|Dose Level 2||0
8514222|NCT00422097|20985128|P4|COMPLETED|Dose Level 2||0
8514223|NCT00422097|20985129|P3|COMPLETED|Dose Level 2||0
8514224|NCT00422097|20985130|P2|COMPLETED|Dose Level 2||5
8514225|NCT00422097|20985131|P1|COMPLETED|Dose Level 2||0
8514226|NCT00422097|20985124|P8|STARTED|Dose Level 2||0
8514227|NCT00422097|20985125|P7|STARTED|Dose Level 2||0
8514228|NCT00422097|20985126|P6|STARTED|Dose Level 2||0
8514229|NCT00422097|20985127|P5|STARTED|Dose Level 2||0
8514230|NCT00422097|20985128|P4|STARTED|Dose Level 2||0
8514231|NCT00422097|20985129|P3|STARTED|Dose Level 2||0
8514232|NCT00422097|20985130|P2|STARTED|Dose Level 2||6
8514233|NCT00422097|20985131|P1|STARTED|Dose Level 2||0
8514234|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 1||0
8514235|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 1||0
8514236|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 1||0
8514237|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 1||0
8514238|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 1||0
8514239|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 1||0
8514240|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 1||0
8514241|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 1||0
8514242|NCT00422097|20985124|P8|COMPLETED|Dose Level 1||0
8514243|NCT00422097|20985125|P7|COMPLETED|Dose Level 1||0
8514244|NCT00422097|20985126|P6|COMPLETED|Dose Level 1||0
8514245|NCT00422097|20985127|P5|COMPLETED|Dose Level 1||0
8514246|NCT00422097|20985128|P4|COMPLETED|Dose Level 1||0
8514247|NCT00422097|20985129|P3|COMPLETED|Dose Level 1||0
8514248|NCT00422097|20985130|P2|COMPLETED|Dose Level 1||0
8514249|NCT00422097|20985131|P1|COMPLETED|Dose Level 1||3
8514250|NCT00422097|20985124|P8|STARTED|Dose Level 1||0
8514251|NCT00422097|20985125|P7|STARTED|Dose Level 1||0
8514252|NCT00422097|20985126|P6|STARTED|Dose Level 1||0
8514253|NCT00422097|20985127|P5|STARTED|Dose Level 1||0
8514254|NCT00422097|20985128|P4|STARTED|Dose Level 1||0
8514255|NCT00422097|20985129|P3|STARTED|Dose Level 1||0
8514256|NCT00422097|20985130|P2|STARTED|Dose Level 1||0
8514257|NCT00422097|20985131|P1|STARTED|Dose Level 1||3
8514258|NCT00422058|20985196|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
8514259|NCT00422058|20985197|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
8514260|NCT00422058|20985198|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
8514261|NCT00422058|20985199|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
8514262|NCT00422058|20985200|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
8514263|NCT00422058|20985201|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
8514264|NCT00422058|20985196|P6|COMPLETED|Open-Label Extension, Week 20-104||45
8514265|NCT00422058|20985197|P5|COMPLETED|Open-Label Extension, Week 20-104||47
8514266|NCT00422058|20985198|P4|COMPLETED|Open-Label Extension, Week 20-104||45
8514267|NCT00422058|20985199|P3|COMPLETED|Open-Label Extension, Week 20-104||38
8514268|NCT00422058|20985200|P2|COMPLETED|Open-Label Extension, Week 20-104||46
8514269|NCT00422058|20985201|P1|COMPLETED|Open-Label Extension, Week 20-104||47
8514270|NCT00422058|20985196|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
8514271|NCT00422058|20985197|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
8514272|NCT00422058|20985198|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
8514273|NCT00422058|20985199|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
8514274|NCT00422058|20985200|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
8514275|NCT00422058|20985201|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
8514276|NCT00422058|20985196|P6|STARTED|Open-Label Extension, Week 20-104||79
8514277|NCT00422058|20985197|P5|STARTED|Open-Label Extension, Week 20-104||82
8514278|NCT00422058|20985198|P4|STARTED|Open-Label Extension, Week 20-104||73
8514279|NCT00422058|20985199|P3|STARTED|Open-Label Extension, Week 20-104||74
8514280|NCT00422058|20985200|P2|STARTED|Open-Label Extension, Week 20-104||85
8514281|NCT00422058|20985201|P1|STARTED|Open-Label Extension, Week 20-104||79
8514282|NCT00422058|20985196|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
8514283|NCT00422058|20985197|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
8514284|NCT00422058|20985198|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
8514285|NCT00422058|20985199|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
8514286|NCT00422058|20985200|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
8514287|NCT00422058|20985201|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
8514288|NCT00422058|20985196|P6|COMPLETED|Double-Blind, Week 0-20||79
8514289|NCT00422058|20985197|P5|COMPLETED|Double-Blind, Week 0-20||82
8514290|NCT00422058|20985198|P4|COMPLETED|Double-Blind, Week 0-20||73
8514291|NCT00422058|20985199|P3|COMPLETED|Double-Blind, Week 0-20||74
8514292|NCT00422058|20985200|P2|COMPLETED|Double-Blind, Week 0-20||85
8514293|NCT00422058|20985201|P1|COMPLETED|Double-Blind, Week 0-20||79
8514294|NCT00422058|20985196|P6|STARTED|Double-Blind, Week 0-20||95
8514295|NCT00422058|20985197|P5|STARTED|Double-Blind, Week 0-20||93
8514296|NCT00422058|20985198|P4|STARTED|Double-Blind, Week 0-20||93
8514297|NCT00422058|20985199|P3|STARTED|Double-Blind, Week 0-20||90
8514298|NCT00422058|20985200|P2|STARTED|Double-Blind, Week 0-20||95
8514299|NCT00422058|20985201|P1|STARTED|Double-Blind, Week 0-20||98
8514300|NCT00422032|20985331|P2|NOT COMPLETED|Overall Study||0
8514301|NCT00422032|20985332|P1|NOT COMPLETED|Overall Study||0
8514302|NCT00422032|20985331|P2|COMPLETED|Overall Study||21
8514303|NCT00422032|20985332|P1|COMPLETED|Overall Study||37
8514304|NCT00422032|20985331|P2|STARTED|Overall Study||21
8514305|NCT00422032|20985332|P1|STARTED|Overall Study||37
8514318|NCT00421954|20985375|P1|NOT COMPLETED|Overall Study||0
8514319|NCT00421954|20985375|P1|COMPLETED|Overall Study||0
8514320|NCT00421954|20985375|P1|STARTED|Overall Study||0
8514321|NCT00421928|20985382|P3|NOT COMPLETED|Overall Study||134
8514322|NCT00421928|20985383|P2|NOT COMPLETED|Overall Study||224
8514323|NCT00421928|20985384|P1|NOT COMPLETED|Overall Study||163
8514324|NCT00421928|20985382|P3|COMPLETED|Overall Study||203
8514325|NCT00421928|20985383|P2|COMPLETED|Overall Study||118
8514326|NCT00421928|20985384|P1|COMPLETED|Overall Study||181
8514327|NCT00421928|20985382|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
8514328|NCT00421928|20985383|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
8514329|NCT00421928|20985384|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
8514330|NCT00421889|20985419|P9|NOT COMPLETED|Overall Study||11
8514331|NCT00421889|20985420|P8|NOT COMPLETED|Overall Study||2
8514332|NCT00421889|20985421|P7|NOT COMPLETED|Overall Study||4
8514333|NCT00421889|20985422|P6|NOT COMPLETED|Overall Study||35
8514334|NCT00421889|20985423|P5|NOT COMPLETED|Overall Study||6
8514335|NCT00421889|20985424|P4|NOT COMPLETED|Overall Study||4
8514336|NCT00421889|20985425|P3|NOT COMPLETED|Overall Study||3
8514337|NCT00421889|20985426|P2|NOT COMPLETED|Overall Study||5
8514338|NCT00421889|20985427|P1|NOT COMPLETED|Overall Study||5
8514339|NCT00421889|20985419|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
8514340|NCT00421889|20985420|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
8514341|NCT00421889|20985421|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
8514342|NCT00421889|20985422|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
8514343|NCT00421889|20985423|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
8514344|NCT00421889|20985424|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
8514345|NCT00421889|20985425|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
8514346|NCT00421889|20985426|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
8514347|NCT00421889|20985427|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
8514348|NCT00421889|20985419|P9|STARTED|Overall Study||15
8514349|NCT00421889|20985420|P8|STARTED|Overall Study||3
8514350|NCT00421889|20985421|P7|STARTED|Overall Study||4
8514351|NCT00421889|20985422|P6|STARTED|Overall Study||35
8514352|NCT00421889|20985423|P5|STARTED|Overall Study||6
8514353|NCT00421889|20985424|P4|STARTED|Overall Study||4
8514354|NCT00421889|20985425|P3|STARTED|Overall Study||3
8514355|NCT00421889|20985426|P2|STARTED|Overall Study||5
8514356|NCT00421889|20985427|P1|STARTED|Overall Study||5
8514357|NCT00421733|20985472|P3|NOT COMPLETED|Overall Study||20
8514358|NCT00421733|20985473|P2|NOT COMPLETED|Overall Study||26
8514359|NCT00421733|20985474|P1|NOT COMPLETED|Overall Study||15
8514360|NCT00421733|20985472|P3|COMPLETED|Overall Study||73
8514361|NCT00421733|20985473|P2|COMPLETED|Overall Study||69
8514362|NCT00421733|20985474|P1|COMPLETED|Overall Study||78
8514363|NCT00421733|20985472|P3|STARTED|Overall Study||93
8514364|NCT00421733|20985473|P2|STARTED|Overall Study||95
8514365|NCT00421733|20985474|P1|STARTED|Overall Study||93
8514366|NCT00421707|20985494|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
8514367|NCT00421707|20985495|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
8514368|NCT00421707|20985494|P2|COMPLETED|Period 3:Treatment Period 2||49
8514369|NCT00421707|20985495|P1|COMPLETED|Period 3:Treatment Period 2||53
8514370|NCT00421707|20985494|P2|STARTED|Period 3:Treatment Period 2||52
8514371|NCT00421707|20985495|P1|STARTED|Period 3:Treatment Period 2||55
8514372|NCT00421707|20985494|P2|NOT COMPLETED|Period 2: Washout||4
8514373|NCT00421707|20985495|P1|NOT COMPLETED|Period 2: Washout||1
8514374|NCT00421707|20985494|P2|COMPLETED|Period 2: Washout||52
8514375|NCT00421707|20985495|P1|COMPLETED|Period 2: Washout||55
8514376|NCT00421707|20985494|P2|STARTED|Period 2: Washout||56
8514377|NCT00421707|20985495|P1|STARTED|Period 2: Washout||56
8514378|NCT00421707|20985494|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
8514379|NCT00421707|20985495|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
8514380|NCT00421707|20985494|P2|COMPLETED|Period 1: Treatment Period 1||56
8514381|NCT00421707|20985495|P1|COMPLETED|Period 1: Treatment Period 1||56
8514382|NCT00421707|20985494|P2|STARTED|Period 1: Treatment Period 1||65
8514383|NCT00421707|20985495|P1|STARTED|Period 1: Treatment Period 1||67
8514384|NCT00421603|20985537|P2|NOT COMPLETED|Overall Study||12
8514385|NCT00421603|20985538|P1|NOT COMPLETED|Overall Study||11
8514386|NCT00421603|20985537|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
8514387|NCT00421603|20985538|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
8514388|NCT00421603|20985537|P2|STARTED|Overall Study||42
8514389|NCT00421603|20985538|P1|STARTED|Overall Study||39
8514390|NCT00421408|20985546|P2|NOT COMPLETED|Overall Study||45
8514391|NCT00421408|20985547|P1|NOT COMPLETED|Overall Study||42
8514392|NCT00421408|20985546|P2|COMPLETED|Overall Study||61
8514393|NCT00421408|20985547|P1|COMPLETED|Overall Study||60
8514394|NCT00421408|20985546|P2|STARTED|Overall Study||106
8514395|NCT00421408|20985547|P1|STARTED|Overall Study||102
8514396|NCT00421343|20985565|P1|NOT COMPLETED|Overall Study||6
8514397|NCT00421343|20985565|P1|COMPLETED|Overall Study||23
8514398|NCT00421343|20985565|P1|STARTED|Overall Study||29
8514399|NCT00421174|20985571|P2|NOT COMPLETED|Overall Study||1
8514400|NCT00421174|20985572|P1|NOT COMPLETED|Overall Study||2
8514401|NCT00421174|20985571|P2|COMPLETED|Overall Study||18
8514402|NCT00421174|20985572|P1|COMPLETED|Overall Study||16
8514403|NCT00421174|20985571|P2|STARTED|Overall Study||19
8514404|NCT00421174|20985572|P1|STARTED|Overall Study||18
8514405|NCT00421148|20985620|P20|NOT COMPLETED|Overall Study||0
8514406|NCT00421148|20985621|P19|NOT COMPLETED|Overall Study||1
8514407|NCT00421148|20985622|P18|NOT COMPLETED|Overall Study||2
8514408|NCT00421148|20985623|P17|NOT COMPLETED|Overall Study||0
8514409|NCT00421148|20985624|P16|NOT COMPLETED|Overall Study||0
8514410|NCT00421148|20985625|P15|NOT COMPLETED|Overall Study||0
8514411|NCT00421148|20985626|P14|NOT COMPLETED|Overall Study||0
8514412|NCT00421148|20985627|P13|NOT COMPLETED|Overall Study||0
8514413|NCT00421148|20985628|P12|NOT COMPLETED|Overall Study||0
8514414|NCT00421148|20985629|P11|NOT COMPLETED|Overall Study||0
8514415|NCT00421148|20985630|P10|NOT COMPLETED|Overall Study||0
8514416|NCT00421148|20985631|P9|NOT COMPLETED|Overall Study||0
8514417|NCT00421148|20985632|P8|NOT COMPLETED|Overall Study||0
8514418|NCT00421148|20985633|P7|NOT COMPLETED|Overall Study||0
8514419|NCT00421148|20985634|P6|NOT COMPLETED|Overall Study||1
8514420|NCT00421148|20985635|P5|NOT COMPLETED|Overall Study||0
8514421|NCT00421148|20985636|P4|NOT COMPLETED|Overall Study||0
8514422|NCT00421148|20985637|P3|NOT COMPLETED|Overall Study||0
8514423|NCT00421148|20985638|P2|NOT COMPLETED|Overall Study||0
8514424|NCT00421148|20985639|P1|NOT COMPLETED|Overall Study||0
8514425|NCT00421148|20985620|P20|COMPLETED|Overall Study||6
8514426|NCT00421148|20985621|P19|COMPLETED|Overall Study||5
8514427|NCT00421148|20985622|P18|COMPLETED|Overall Study||4
8514428|NCT00421148|20985623|P17|COMPLETED|Overall Study||6
8514429|NCT00421148|20985624|P16|COMPLETED|Overall Study||6
8514430|NCT00421148|20985625|P15|COMPLETED|Overall Study||6
8514431|NCT00421148|20985626|P14|COMPLETED|Overall Study||6
8514432|NCT00421148|20985627|P13|COMPLETED|Overall Study||6
8514433|NCT00421148|20985628|P12|COMPLETED|Overall Study||6
8514434|NCT00421148|20985629|P11|COMPLETED|Overall Study||6
8514435|NCT00421148|20985630|P10|COMPLETED|Overall Study||5
8514436|NCT00421148|20985631|P9|COMPLETED|Overall Study||5
8514437|NCT00421148|20985632|P8|COMPLETED|Overall Study||5
8514438|NCT00421148|20985633|P7|COMPLETED|Overall Study||6
8514439|NCT00421148|20985634|P6|COMPLETED|Overall Study||4
8514440|NCT00421148|20985635|P5|COMPLETED|Overall Study||1
8514441|NCT00421148|20985636|P4|COMPLETED|Overall Study||1
8514442|NCT00421148|20985637|P3|COMPLETED|Overall Study||2
8514443|NCT00421148|20985638|P2|COMPLETED|Overall Study||2
8514444|NCT00421148|20985639|P1|COMPLETED|Overall Study||2
8514445|NCT00421148|20985620|P20|Treated|Overall Study||6
8514446|NCT00421148|20985621|P19|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
8514447|NCT00421148|20985622|P18|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
8514448|NCT00421148|20985623|P17|Treated|Overall Study||6
8514449|NCT00421148|20985624|P16|Treated|Overall Study||6
8514450|NCT00421148|20985625|P15|Treated|Overall Study||6
8514451|NCT00421148|20985626|P14|Treated|Overall Study||6
8514452|NCT00421148|20985627|P13|Treated|Overall Study||6
8514453|NCT00421148|20985628|P12|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
8514454|NCT00421148|20985629|P11|Treated|Overall Study||6
8514455|NCT00421148|20985630|P10|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
8514456|NCT00421148|20985631|P9|Treated|Overall Study||5
8514457|NCT00421148|20985632|P8|Treated|Overall Study||5
8514458|NCT00421148|20985633|P7|Treated|Overall Study||6
8514459|NCT00421148|20985634|P6|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
8514460|NCT00421148|20985635|P5|Treated|Overall Study||1
8514461|NCT00421148|20985636|P4|Treated|Overall Study||1
8514462|NCT00421148|20985637|P3|Treated|Overall Study||2
8514463|NCT00421148|20985638|P2|Treated|Overall Study||2
8514464|NCT00421148|20985639|P1|Treated|Overall Study||2
8514465|NCT00421148|20985620|P20|STARTED|Overall Study||6
8514466|NCT00421148|20985621|P19|STARTED|Overall Study||6
8514467|NCT00421148|20985622|P18|STARTED|Overall Study||6
8514468|NCT00421148|20985623|P17|STARTED|Overall Study||6
8514469|NCT00421148|20985624|P16|STARTED|Overall Study||6
8514470|NCT00421148|20985625|P15|STARTED|Overall Study||6
8514471|NCT00421148|20985626|P14|STARTED|Overall Study||6
8514472|NCT00421148|20985627|P13|STARTED|Overall Study||6
8514473|NCT00421148|20985628|P12|STARTED|Overall Study||6
8514474|NCT00421148|20985629|P11|STARTED|Overall Study||6
8514475|NCT00421148|20985630|P10|STARTED|Overall Study||5
8514476|NCT00421148|20985631|P9|STARTED|Overall Study||5
8514477|NCT00421148|20985632|P8|STARTED|Overall Study||5
8514478|NCT00421148|20985633|P7|STARTED|Overall Study||6
8514479|NCT00421148|20985634|P6|STARTED|Overall Study||5
8514480|NCT00421148|20985635|P5|STARTED|Overall Study||1
8514481|NCT00421148|20985636|P4|STARTED|Overall Study||1
8514482|NCT00421148|20985637|P3|STARTED|Overall Study||2
8514483|NCT00421148|20985638|P2|STARTED|Overall Study||2
8514484|NCT00421148|20985639|P1|STARTED|Overall Study||2
8514485|NCT00420992|20985723|P2|NOT COMPLETED|Maintenance Phase||75
8514486|NCT00420992|20985724|P1|NOT COMPLETED|Maintenance Phase||61
8514487|NCT00420992|20985723|P2|COMPLETED|Maintenance Phase||98
8514488|NCT00420992|20985724|P1|COMPLETED|Maintenance Phase||110
8514489|NCT00420992|20985723|P2|STARTED|Maintenance Phase||173
8514490|NCT00420992|20985724|P1|STARTED|Maintenance Phase||171
8514491|NCT00420992|20985723|P2|NOT COMPLETED|Titration Phase||0
8514492|NCT00420992|20985724|P1|NOT COMPLETED|Titration Phase||203
8514493|NCT00420992|20985723|P2|COMPLETED|Titration Phase||0
8514494|NCT00420992|20985724|P1|COMPLETED|Titration Phase||344
8514495|NCT00420992|20985723|P2|STARTED|Titration Phase||0
8514496|NCT00420992|20985724|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
8514497|NCT00420927|20985738|P7|NOT COMPLETED|Period 2||53
8514498|NCT00420927|20985739|P6|NOT COMPLETED|Period 2||15
8514499|NCT00420927|20985740|P5|NOT COMPLETED|Period 2||43
8514500|NCT00420927|20985741|P4|NOT COMPLETED|Period 2||10
8514501|NCT00420927|20985742|P3|NOT COMPLETED|Period 2||13
8514502|NCT00420927|20985743|P2|NOT COMPLETED|Period 2||0
8514503|NCT00420927|20985744|P1|NOT COMPLETED|Period 2||0
8514504|NCT00420927|20985738|P7|COMPLETED|Period 2||295
8514505|NCT00420927|20985739|P6|COMPLETED|Period 2||97
8514506|NCT00420927|20985740|P5|COMPLETED|Period 2||216
8514507|NCT00420927|20985741|P4|COMPLETED|Period 2||95
8514508|NCT00420927|20985742|P3|COMPLETED|Period 2||89
8514509|NCT00420927|20985743|P2|COMPLETED|Period 2||0
8514510|NCT00420927|20985744|P1|COMPLETED|Period 2||0
8514511|NCT00420927|20985738|P7|STARTED|Period 2||348
8514512|NCT00420927|20985739|P6|STARTED|Period 2||112
8514513|NCT00420927|20985740|P5|STARTED|Period 2||259
8514514|NCT00420927|20985741|P4|STARTED|Period 2||105
8514515|NCT00420927|20985742|P3|STARTED|Period 2||102
8514516|NCT00420927|20985743|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
8514517|NCT00420927|20985744|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
8514518|NCT00420927|20985738|P7|NOT COMPLETED|Period 1||0
8514519|NCT00420927|20985739|P6|NOT COMPLETED|Period 1||0
8514520|NCT00420927|20985740|P5|NOT COMPLETED|Period 1||0
8514521|NCT00420927|20985741|P4|NOT COMPLETED|Period 1||0
8514522|NCT00420927|20985742|P3|NOT COMPLETED|Period 1||0
8514523|NCT00420927|20985743|P2|NOT COMPLETED|Period 1||57
8514524|NCT00420927|20985744|P1|NOT COMPLETED|Period 1||49
8514525|NCT00420927|20985738|P7|COMPLETED|Period 1||0
8514526|NCT00420927|20985739|P6|COMPLETED|Period 1||0
8514527|NCT00420927|20985740|P5|COMPLETED|Period 1||0
8514528|NCT00420927|20985741|P4|COMPLETED|Period 1||0
8514529|NCT00420927|20985742|P3|COMPLETED|Period 1||0
8514530|NCT00420927|20985743|P2|COMPLETED|Period 1||460
8514531|NCT00420927|20985744|P1|COMPLETED|Period 1||466
8514532|NCT00420927|20985738|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514533|NCT00420927|20985739|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514534|NCT00420927|20985740|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514535|NCT00420927|20985741|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514536|NCT00420927|20985742|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514537|NCT00420927|20985743|P2|STARTED|Period 1||517
8514538|NCT00420927|20985744|P1|STARTED|Period 1||515
8514539|NCT00420849|20985848|P1|NOT COMPLETED|Overall Study||331
8514540|NCT00420849|20985848|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
8514541|NCT00420849|20985848|P1|STARTED|Overall Study||587
8514542|NCT00420784|20985917|P4|NOT COMPLETED|Overall Study||78
8514543|NCT00420784|20985918|P3|NOT COMPLETED|Overall Study||53
8514544|NCT00420784|20985919|P2|NOT COMPLETED|Overall Study||58
8514545|NCT00420784|20985920|P1|NOT COMPLETED|Overall Study||29
8514546|NCT00420784|20985917|P4|COMPLETED|Overall Study||36
8514547|NCT00420784|20985918|P3|COMPLETED|Overall Study||58
8514548|NCT00420784|20985919|P2|COMPLETED|Overall Study||55
8514549|NCT00420784|20985920|P1|COMPLETED|Overall Study||86
8514550|NCT00420784|20985917|P4|STARTED|Overall Study||114
8514551|NCT00420784|20985918|P3|STARTED|Overall Study||111
8514552|NCT00420784|20985919|P2|STARTED|Overall Study||113
8514553|NCT00420784|20985920|P1|STARTED|Overall Study||115
8514554|NCT00420771|20985949|P2|NOT COMPLETED|Overall Study||4
8514555|NCT00420771|20985950|P1|NOT COMPLETED|Overall Study||3
8514556|NCT00420771|20985949|P2|COMPLETED|Overall Study||7
8514557|NCT00420771|20985950|P1|COMPLETED|Overall Study||5
8514558|NCT00420771|20985949|P2|STARTED|Overall Study||11
8514559|NCT00420771|20985950|P1|STARTED|Overall Study||8
8514560|NCT00420745|20985958|P2|NOT COMPLETED|Overall Study||6
8514561|NCT00420745|20985959|P1|NOT COMPLETED|Overall Study||15
8514562|NCT00420745|20985958|P2|COMPLETED|Overall Study||333
8514563|NCT00420745|20985959|P1|COMPLETED|Overall Study||655
8514564|NCT00420745|20985958|P2|STARTED|Overall Study||339
8514565|NCT00420745|20985959|P1|STARTED|Overall Study||670
8514566|NCT00420641|20985978|P3|NOT COMPLETED|Overall Study||44
8514567|NCT00420641|20985979|P2|NOT COMPLETED|Overall Study||72
8514568|NCT00420641|20985980|P1|NOT COMPLETED|Overall Study||45
8514569|NCT00420641|20985978|P3|COMPLETED|Overall Study||128
8514570|NCT00420641|20985979|P2|COMPLETED|Overall Study||100
8514571|NCT00420641|20985980|P1|COMPLETED|Overall Study||115
8514572|NCT00420641|20985978|P3|STARTED|Overall Study||172
8514573|NCT00420641|20985979|P2|STARTED|Overall Study||172
8514574|NCT00420641|20985980|P1|STARTED|Overall Study||160
8514575|NCT00420628|20986056|P2|NOT COMPLETED|Overall Study||4
8514576|NCT00420628|20986057|P1|NOT COMPLETED|Overall Study||9
8514577|NCT00420628|20986056|P2|COMPLETED|Overall Study||32
8514578|NCT00420628|20986057|P1|COMPLETED|Overall Study||63
8514579|NCT00420628|20986056|P2|STARTED|Overall Study||36
8514580|NCT00420628|20986057|P1|STARTED|Overall Study||72
8514581|NCT00420511|20986073|P2|NOT COMPLETED|Overall Study||1
8514582|NCT00420511|20986074|P1|NOT COMPLETED|Overall Study||2
8514583|NCT00420511|20986073|P2|COMPLETED|Overall Study||10
8514584|NCT00420511|20986074|P1|COMPLETED|Overall Study||8
8514585|NCT00420511|20986073|P2|STARTED|Overall Study||11
8514586|NCT00420511|20986074|P1|STARTED|Overall Study||10
8514587|NCT00420459|20986084|P1|NOT COMPLETED|Overall Study||0
8514588|NCT00420459|20986084|P1|COMPLETED|Overall Study||12
8514589|NCT00420459|20986084|P1|STARTED|Overall Study||12
8514590|NCT00420420|20986095|P2|NOT COMPLETED|Overall Study||4
8514591|NCT00420420|20986096|P1|NOT COMPLETED|Overall Study||8
8514592|NCT00420420|20986095|P2|COMPLETED|Overall Study||67
8514593|NCT00420420|20986096|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
8514594|NCT00420420|20986095|P2|STARTED|Overall Study|Number of patients randomized.|71
8514595|NCT00420420|20986096|P1|STARTED|Overall Study|Number of patients randomized.|73
8514596|NCT00420407|20986114|P2|NOT COMPLETED|Overall Study||6
8514597|NCT00420407|20986115|P1|NOT COMPLETED|Overall Study||4
8514598|NCT00420407|20986114|P2|COMPLETED|Overall Study||34
8514599|NCT00420407|20986115|P1|COMPLETED|Overall Study||37
8514600|NCT00420407|20986114|P2|STARTED|Overall Study||40
8514601|NCT00420407|20986115|P1|STARTED|Overall Study||41
8514602|NCT00420381|20986122|P1|NOT COMPLETED|Overall Study||1
8514603|NCT00420381|20986122|P1|COMPLETED|Overall Study||27
8514604|NCT00420381|20986122|P1|Received at Least One Dose of Study Drug|Overall Study||27
8514605|NCT00420381|20986122|P1|STARTED|Overall Study||28
8514606|NCT00420342|20986134|P3|NOT COMPLETED|Overall Study||1
8514607|NCT00420342|20986135|P2|NOT COMPLETED|Overall Study||2
8514608|NCT00420342|20986136|P1|NOT COMPLETED|Overall Study||1
8514609|NCT00420342|20986134|P3|COMPLETED|Overall Study||28
8514610|NCT00420342|20986135|P2|COMPLETED|Overall Study||31
8514611|NCT00420342|20986136|P1|COMPLETED|Overall Study||29
8514612|NCT00420342|20986134|P3|Received Treatment|Overall Study||29
8514613|NCT00420342|20986135|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
8514614|NCT00420342|20986136|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
8514615|NCT00420342|20986134|P3|STARTED|Overall Study||29
8514616|NCT00420342|20986135|P2|STARTED|Overall Study||33
8514617|NCT00420342|20986136|P1|STARTED|Overall Study||30
8514618|NCT00420316|20986179|P2|NOT COMPLETED|Overall Study||9
8514619|NCT00420316|20986180|P1|NOT COMPLETED|Overall Study||12
8514620|NCT00420316|20986179|P2|COMPLETED|Overall Study||522
8514621|NCT00420316|20986180|P1|COMPLETED|Overall Study||1070
8514622|NCT00420316|20986179|P2|STARTED|Overall Study||531
8514623|NCT00420316|20986180|P1|STARTED|Overall Study||1082
8514624|NCT00420303|20986204|P2|NOT COMPLETED|Overall Study||4
8514625|NCT00420303|20986205|P1|NOT COMPLETED|Overall Study||1
8514626|NCT00420303|20986204|P2|COMPLETED|Overall Study||8
8514627|NCT00420303|20986205|P1|COMPLETED|Overall Study||11
8514628|NCT00420303|20986204|P2|STARTED|Overall Study||12
8514629|NCT00420303|20986205|P1|STARTED|Overall Study||12
8514630|NCT00420290|20986217|P2|NOT COMPLETED|Overall Study||4
8514631|NCT00420290|20986218|P1|NOT COMPLETED|Overall Study||4
8514632|NCT00420290|20986217|P2|COMPLETED|Overall Study||7
8514633|NCT00420290|20986218|P1|COMPLETED|Overall Study||7
8514634|NCT00420290|20986217|P2|STARTED|Overall Study||11
8514635|NCT00420290|20986218|P1|STARTED|Overall Study||11
8514636|NCT00420238|20986234|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
8514637|NCT00420238|20986235|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
8514638|NCT00420238|20986234|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
8514639|NCT00420238|20986235|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
8514640|NCT00420238|20986234|P2|STARTED|12 Week Open-Label Treatment Period 2||39
8514641|NCT00420238|20986235|P1|STARTED|12 Week Open-Label Treatment Period 2||38
8514642|NCT00420238|20986234|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
8514643|NCT00420238|20986235|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
8514644|NCT00420238|20986234|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
8514645|NCT00420238|20986235|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
8514646|NCT00420238|20986234|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
8514647|NCT00420238|20986235|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
8514648|NCT00420212|20986374|P3|NOT COMPLETED|Overall Study||96
8514649|NCT00420212|20986375|P2|NOT COMPLETED|Overall Study||95
8514650|NCT00420212|20986376|P1|NOT COMPLETED|Overall Study||91
8514651|NCT00420212|20986374|P3|COMPLETED|Overall Study||320
8514652|NCT00420212|20986375|P2|COMPLETED|Overall Study||315
8514653|NCT00420212|20986376|P1|COMPLETED|Overall Study||317
8514654|NCT00420212|20986374|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
8514655|NCT00420212|20986375|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
8514656|NCT00420212|20986376|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
8514657|NCT00420199|20986402|P2|NOT COMPLETED|Overall Study||0
8514658|NCT00420199|20986403|P1|NOT COMPLETED|Overall Study||1
8514659|NCT00420199|20986402|P2|COMPLETED|Overall Study||23
8514660|NCT00420199|20986403|P1|COMPLETED|Overall Study||26
8514661|NCT00420199|20986402|P2|STARTED|Overall Study||23
8514662|NCT00420199|20986403|P1|STARTED|Overall Study||27
8514663|NCT00420147|20986458|P2|NOT COMPLETED|Overall Study||0
8514664|NCT00420147|20986459|P1|NOT COMPLETED|Overall Study||0
8514665|NCT00420147|20986458|P2|COMPLETED|Overall Study||19
8514666|NCT00420147|20986459|P1|COMPLETED|Overall Study||19
8514667|NCT00420147|20986458|P2|STARTED|Overall Study||19
8514668|NCT00420147|20986459|P1|STARTED|Overall Study||19
8514669|NCT00420095|20986469|P2|NOT COMPLETED|Overall Study||1
8514670|NCT00420095|20986470|P1|NOT COMPLETED|Overall Study||3
8514671|NCT00420095|20986469|P2|COMPLETED|Overall Study||59
8514672|NCT00420095|20986470|P1|COMPLETED|Overall Study||54
8514673|NCT00420095|20986469|P2|STARTED|Overall Study||60
8514674|NCT00420095|20986470|P1|STARTED|Overall Study||57
8514675|NCT00420056|20986488|P1|NOT COMPLETED|Overall Study||17
8514676|NCT00420056|20986488|P1|COMPLETED|Overall Study||0
8514677|NCT00420056|20986488|P1|STARTED|Overall Study||17
8514678|NCT00420017|20986512|P2|NOT COMPLETED|Overall Study||0
8514679|NCT00420017|20986513|P1|NOT COMPLETED|Overall Study||2
8514680|NCT00420017|20986512|P2|COMPLETED|Overall Study||40
8514681|NCT00420017|20986513|P1|COMPLETED|Overall Study|40 completed analysis|38
8514682|NCT00420017|20986512|P2|STARTED|Overall Study||40
8514683|NCT00420017|20986513|P1|STARTED|Overall Study||40
8514684|NCT00420004|20986528|P3|NOT COMPLETED|Overall Study||32
8514685|NCT00420004|20986529|P2|NOT COMPLETED|Overall Study||71
8514686|NCT00420004|20986530|P1|NOT COMPLETED|Overall Study||129
8514687|NCT00420004|20986528|P3|COMPLETED|Overall Study||30
8514688|NCT00420004|20986529|P2|COMPLETED|Overall Study||67
8514689|NCT00420004|20986530|P1|COMPLETED|Overall Study||140
8514690|NCT00420004|20986528|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
8514691|NCT00420004|20986529|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
8514692|NCT00420004|20986530|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
8514693|NCT00420004|20986528|P3|STARTED|Overall Study||62
8514694|NCT00420004|20986529|P2|STARTED|Overall Study||138
8514695|NCT00420004|20986530|P1|STARTED|Overall Study||269
8514696|NCT00419952|20986595|P2|NOT COMPLETED|Overall Study||125
8514697|NCT00419952|20986596|P1|NOT COMPLETED|Overall Study||149
8514698|NCT00419952|20986595|P2|COMPLETED|Overall Study||240
8514699|NCT00419952|20986596|P1|COMPLETED|Overall Study||228
8514700|NCT00419952|20986595|P2|STARTED|Overall Study||365
8514701|NCT00419952|20986596|P1|STARTED|Overall Study||377
8514702|NCT00419926|20986630|P2|NOT COMPLETED|Overall Study||10
8514703|NCT00419926|20986631|P1|NOT COMPLETED|Overall Study||14
8514704|NCT00419926|20986630|P2|COMPLETED|Overall Study||148
8514705|NCT00419926|20986631|P1|COMPLETED|Overall Study||141
8514706|NCT00419926|20986630|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
8514707|NCT00419926|20986631|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
8514708|NCT00419770|20986647|P2|NOT COMPLETED|Overall Study||1
8514709|NCT00419770|20986648|P1|NOT COMPLETED|Overall Study||5
8514710|NCT00419770|20986647|P2|COMPLETED|Overall Study||8
8514711|NCT00419770|20986648|P1|COMPLETED|Overall Study||6
8514712|NCT00419770|20986647|P2|STARTED|Overall Study||9
8514713|NCT00419770|20986648|P1|STARTED|Overall Study||11
8514714|NCT00419757|20986656|P2|NOT COMPLETED|Overall Study||21
8514715|NCT00419757|20986657|P1|NOT COMPLETED|Overall Study||18
8514716|NCT00419757|20986656|P2|COMPLETED|Overall Study|Randomized patients|102
8514717|NCT00419757|20986657|P1|COMPLETED|Overall Study|Randomized patients|109
8514718|NCT00419757|20986656|P2|STARTED|Overall Study|Randomized patients|123
8514719|NCT00419757|20986657|P1|STARTED|Overall Study|Randomized patients|127
8514720|NCT00419744|20986696|P3|NOT COMPLETED|Overall Study||133
8514721|NCT00419744|20986697|P2|NOT COMPLETED|Overall Study||118
8514722|NCT00419744|20986698|P1|NOT COMPLETED|Overall Study||117
8514723|NCT00419744|20986696|P3|COMPLETED|Overall Study||271
8514724|NCT00419744|20986697|P2|COMPLETED|Overall Study||290
8514725|NCT00419744|20986698|P1|COMPLETED|Overall Study||290
8514726|NCT00419744|20986696|P3|STARTED|Overall Study||404
8514727|NCT00419744|20986697|P2|STARTED|Overall Study||408
8514728|NCT00419744|20986698|P1|STARTED|Overall Study||407
8514732|NCT00419562|20986741|P2|NOT COMPLETED|Overall Study||31
8514733|NCT00419562|20986742|P1|NOT COMPLETED|Overall Study||33
8514734|NCT00419562|20986741|P2|COMPLETED|Overall Study||246
8514735|NCT00419562|20986742|P1|COMPLETED|Overall Study||250
8514736|NCT00419562|20986741|P2|STARTED|Overall Study||277
8514737|NCT00419562|20986742|P1|STARTED|Overall Study||283
8514738|NCT00419445|20986755|P3|NOT COMPLETED|Overall Study||1
8514739|NCT00419445|20986756|P2|NOT COMPLETED|Overall Study||2
8514740|NCT00419445|20986757|P1|NOT COMPLETED|Overall Study||1
8514741|NCT00419445|20986755|P3|COMPLETED|Overall Study||7
8514742|NCT00419445|20986756|P2|COMPLETED|Overall Study||14
8514743|NCT00419445|20986757|P1|COMPLETED|Overall Study||7
8514744|NCT00419445|20986755|P3|STARTED|Overall Study||8
8514745|NCT00419445|20986756|P2|STARTED|Overall Study||16
8514746|NCT00419445|20986757|P1|STARTED|Overall Study||8
8514747|NCT00419393|20986765|P1|NOT COMPLETED|Overall Study||24
8514748|NCT00419393|20986765|P1|COMPLETED|Overall Study||166
8514749|NCT00419393|20986765|P1|STARTED|Overall Study|One subject did not receive medication|190
8514750|NCT00419380|20986775|P2|NOT COMPLETED|Overall Study||10
8514751|NCT00419380|20986776|P1|NOT COMPLETED|Overall Study||1
8514752|NCT00419380|20986775|P2|COMPLETED|Overall Study||12
8514753|NCT00419380|20986776|P1|COMPLETED|Overall Study||18
8514754|NCT00419380|20986775|P2|STARTED|Overall Study||22
8514755|NCT00419380|20986776|P1|STARTED|Overall Study||19
8514756|NCT00419341|20986784|P1|NOT COMPLETED|Efficacy Period||10
8514757|NCT00419341|20986784|P1|COMPLETED|Efficacy Period||28
8514758|NCT00419341|20986784|P1|STARTED|Efficacy Period||38
8514759|NCT00419341|20986784|P1|NOT COMPLETED|Wash in/Wash Out Period||11
8514760|NCT00419341|20986784|P1|COMPLETED|Wash in/Wash Out Period||38
8514761|NCT00419341|20986784|P1|STARTED|Wash in/Wash Out Period||49
8514762|NCT00419315|20986807|P2|NOT COMPLETED|Overall Study||0
8514763|NCT00419315|20986808|P1|NOT COMPLETED|Overall Study||0
8514764|NCT00419315|20986807|P2|COMPLETED|Overall Study||78
8514765|NCT00419315|20986808|P1|COMPLETED|Overall Study||85
8514766|NCT00419315|20986807|P2|STARTED|Overall Study||78
8514767|NCT00419315|20986808|P1|STARTED|Overall Study||85
8514768|NCT00419263|20986819|P3|NOT COMPLETED|Overall Study||3
8514769|NCT00419263|20986820|P2|NOT COMPLETED|Overall Study||2
8514770|NCT00419263|20986821|P1|NOT COMPLETED|Overall Study||3
8514771|NCT00419263|20986819|P3|COMPLETED|Overall Study||112
8514772|NCT00419263|20986820|P2|COMPLETED|Overall Study||112
8514773|NCT00419263|20986821|P1|COMPLETED|Overall Study||112
8514774|NCT00419263|20986819|P3|STARTED|Overall Study||115
8514775|NCT00419263|20986820|P2|STARTED|Overall Study||114
8514776|NCT00419263|20986821|P1|STARTED|Overall Study||115
8514777|NCT00419159|20986850|P2|NOT COMPLETED|Overall Study||100
8514778|NCT00419159|20986851|P1|NOT COMPLETED|Overall Study||99
8514779|NCT00419159|20986850|P2|COMPLETED|Overall Study||0
8514780|NCT00419159|20986851|P1|COMPLETED|Overall Study||0
8514781|NCT00419159|20986850|P2|STARTED|Overall Study||100
8514782|NCT00419159|20986851|P1|STARTED|Overall Study|Full Analysis Set|99
8514783|NCT00419120|20986881|P1|NOT COMPLETED|Long Term Follow up Period||10
8514784|NCT00419120|20986881|P1|COMPLETED|Long Term Follow up Period||0
8514785|NCT00419120|20986881|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
8514786|NCT00419120|20986881|P1|NOT COMPLETED|Primary Study Period||0
8514787|NCT00419120|20986881|P1|COMPLETED|Primary Study Period||10
8514788|NCT00419120|20986881|P1|STARTED|Primary Study Period||10
8514789|NCT00419094|20986888|P2|NOT COMPLETED|Overall Study||30
8514790|NCT00419094|20986889|P1|NOT COMPLETED|Overall Study||7
8514791|NCT00419094|20986888|P2|COMPLETED|Overall Study||141
8514792|NCT00419094|20986889|P1|COMPLETED|Overall Study||50
8514793|NCT00419094|20986888|P2|STARTED|Overall Study||171
8514794|NCT00419094|20986889|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
8514795|NCT00419003|20986903|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
8514796|NCT00419003|20986904|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
8514797|NCT00419003|20986903|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
8514798|NCT00419003|20986904|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
8514799|NCT00419003|20986903|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
8514800|NCT00419003|20986904|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
8514801|NCT00419003|20986903|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
8514802|NCT00419003|20986904|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
8514803|NCT00419003|20986903|P2|COMPLETED|Phase I, Ketamine Infusion||7
8514804|NCT00419003|20986904|P1|COMPLETED|Phase I, Ketamine Infusion||7
8514805|NCT00419003|20986903|P2|STARTED|Phase I, Ketamine Infusion||13
8514806|NCT00419003|20986904|P1|STARTED|Phase I, Ketamine Infusion||13
8514807|NCT00418977|20986915|P2|NOT COMPLETED|Overall Study||3
8514808|NCT00418977|20986916|P1|NOT COMPLETED|Overall Study||3
8514809|NCT00418977|20986915|P2|COMPLETED|Overall Study||13
8514810|NCT00418977|20986916|P1|COMPLETED|Overall Study||40
8514811|NCT00418977|20986915|P2|STARTED|Overall Study||16
8514812|NCT00418977|20986916|P1|STARTED|Overall Study||43
8514813|NCT00418964|20986933|P3|NOT COMPLETED|Overall Study||6
8514814|NCT00418964|20986934|P2|NOT COMPLETED|Overall Study||3
8514815|NCT00418964|20986935|P1|NOT COMPLETED|Overall Study||1
8514816|NCT00418964|20986933|P3|COMPLETED|Overall Study||14
8514817|NCT00418964|20986934|P2|COMPLETED|Overall Study||17
8514818|NCT00418964|20986935|P1|COMPLETED|Overall Study||21
8514819|NCT00418964|20986933|P3|STARTED|Overall Study||20
8514820|NCT00418964|20986934|P2|STARTED|Overall Study||20
8514821|NCT00418964|20986935|P1|STARTED|Overall Study||22
8514822|NCT00418951|20986946|P3|NOT COMPLETED|Overall Study||0
8514823|NCT00418951|20986947|P2|NOT COMPLETED|Overall Study||0
8514824|NCT00418951|20986948|P1|NOT COMPLETED|Overall Study||0
8514825|NCT00418951|20986946|P3|COMPLETED|Overall Study||40
8514826|NCT00418951|20986947|P2|COMPLETED|Overall Study||33
8514827|NCT00418951|20986948|P1|COMPLETED|Overall Study||39
8514828|NCT00418951|20986946|P3|STARTED|Overall Study||40
8514829|NCT00418951|20986947|P2|STARTED|Overall Study||33
8514830|NCT00418951|20986948|P1|STARTED|Overall Study||39
8514831|NCT00418938|20986958|P2|NOT COMPLETED|Overall Study||23
8514832|NCT00418938|20986959|P1|NOT COMPLETED|Overall Study||24
8514833|NCT00418938|20986958|P2|COMPLETED|Overall Study||108
8514834|NCT00418938|20986959|P1|COMPLETED|Overall Study||109
8514835|NCT00418938|20986958|P2|STARTED|Overall Study||131
8514836|NCT00418938|20986959|P1|STARTED|Overall Study||133
8514837|NCT00418886|20986979|P2|NOT COMPLETED|Overall Study||255
8514838|NCT00418886|20986980|P1|NOT COMPLETED|Overall Study||226
8514839|NCT00418886|20986979|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
8514840|NCT00418886|20986980|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
8514841|NCT00418886|20986979|P2|STARTED|Overall Study|randomised patients|278
8514842|NCT00418886|20986980|P1|STARTED|Overall Study|randomised patients|256
8514843|NCT00418834|20987006|P2|NOT COMPLETED|Overall Study||20
8514844|NCT00418834|20987007|P1|NOT COMPLETED|Overall Study||23
8514845|NCT00418834|20987006|P2|COMPLETED|Overall Study||507
8514846|NCT00418834|20987007|P1|COMPLETED|Overall Study||503
8514847|NCT00418834|20987006|P2|STARTED|Overall Study||527
8514848|NCT00418834|20987007|P1|STARTED|Overall Study||526
8514849|NCT00418717|20987067|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
8514850|NCT00418717|20987067|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
8514851|NCT00418717|20987067|P1|STARTED|Treatment Period B - Weeks 5-12||41
8514852|NCT00418717|20987067|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
8514853|NCT00418717|20987067|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
8514854|NCT00418717|20987067|P1|STARTED|Treatment Period A - Weeks 1-4||42
8514855|NCT00418691|20987075|P3|NOT COMPLETED|Overall Study||5
8514856|NCT00418691|20987076|P2|NOT COMPLETED|Overall Study||2
8514857|NCT00418691|20987077|P1|NOT COMPLETED|Overall Study||2
8514858|NCT00418691|20987075|P3|COMPLETED|Overall Study||5
8514859|NCT00418691|20987076|P2|COMPLETED|Overall Study||10
8514860|NCT00418691|20987077|P1|COMPLETED|Overall Study||9
8514861|NCT00418691|20987075|P3|STARTED|Overall Study||10
8514862|NCT00418691|20987076|P2|STARTED|Overall Study||12
8514863|NCT00418691|20987077|P1|STARTED|Overall Study||11
8514864|NCT00418665|20987088|P3|NOT COMPLETED|Treatment Extension||2
8514865|NCT00418665|20987089|P2|NOT COMPLETED|Treatment Extension||4
8514866|NCT00418665|20987090|P1|NOT COMPLETED|Treatment Extension||6
8514867|NCT00418665|20987088|P3|COMPLETED|Treatment Extension||7
8514868|NCT00418665|20987089|P2|COMPLETED|Treatment Extension||4
8514869|NCT00418665|20987090|P1|COMPLETED|Treatment Extension||1
8514870|NCT00418665|20987088|P3|STARTED|Treatment Extension||9
8514871|NCT00418665|20987089|P2|STARTED|Treatment Extension||8
8514872|NCT00418665|20987090|P1|STARTED|Treatment Extension||7
8514873|NCT00418665|20987088|P3|NOT COMPLETED|Treatment Period||4
8514874|NCT00418665|20987089|P2|NOT COMPLETED|Treatment Period||6
8514875|NCT00418665|20987090|P1|NOT COMPLETED|Treatment Period||5
8514876|NCT00418665|20987088|P3|COMPLETED|Treatment Period||9
8514877|NCT00418665|20987089|P2|COMPLETED|Treatment Period||8
8514878|NCT00418665|20987090|P1|COMPLETED|Treatment Period||7
8514879|NCT00418665|20987088|P3|Received Study Medication|Treatment Period||13
8514880|NCT00418665|20987089|P2|Received Study Medication|Treatment Period||13
8514881|NCT00418665|20987090|P1|Received Study Medication|Treatment Period||11
8514882|NCT00418665|20987088|P3|STARTED|Treatment Period||13
8514883|NCT00418665|20987089|P2|STARTED|Treatment Period||14
8514884|NCT00418665|20987090|P1|STARTED|Treatment Period||12
8514885|NCT00418574|20987109|P2|NOT COMPLETED|Overall Study||23
8514886|NCT00418574|20987110|P1|NOT COMPLETED|Overall Study||48
8514887|NCT00418574|20987109|P2|COMPLETED|Overall Study||272
8514888|NCT00418574|20987110|P1|COMPLETED|Overall Study||545
8514889|NCT00418574|20987109|P2|TREATED|Overall Study||294
8514890|NCT00418574|20987110|P1|TREATED|Overall Study||592
8514891|NCT00418574|20987109|P2|STARTED|Overall Study||295
8514892|NCT00418574|20987110|P1|STARTED|Overall Study||593
8514893|NCT00418561|20987124|P3|NOT COMPLETED|Overall Study||0
8514894|NCT00418561|20987125|P2|NOT COMPLETED|Overall Study||1
8514895|NCT00418561|20987126|P1|NOT COMPLETED|Overall Study||0
8514896|NCT00418561|20987124|P3|COMPLETED|Overall Study||4
8514897|NCT00418561|20987125|P2|COMPLETED|Overall Study||4
8514898|NCT00418561|20987126|P1|COMPLETED|Overall Study||4
8514899|NCT00418561|20987124|P3|STARTED|Overall Study||4
8514900|NCT00418561|20987125|P2|STARTED|Overall Study||5
8514901|NCT00418561|20987126|P1|STARTED|Overall Study||4
8514902|NCT00418522|20987196|P2|NOT COMPLETED|Overall Study||42
8514903|NCT00418522|20987197|P1|NOT COMPLETED|Overall Study||83
8514904|NCT00418522|20987196|P2|COMPLETED|Overall Study||152
8514905|NCT00418522|20987197|P1|COMPLETED|Overall Study||136
8514906|NCT00418522|20987196|P2|Received Treatment|Overall Study||190
8514907|NCT00418522|20987197|P1|Received Treatment|Overall Study||212
8514908|NCT00418522|20987196|P2|STARTED|Overall Study||194
8514909|NCT00418522|20987197|P1|STARTED|Overall Study||219
8514910|NCT00418457|20987243|P2|NOT COMPLETED|Overall Study||0
8514911|NCT00418457|20987244|P1|NOT COMPLETED|Overall Study||0
8514912|NCT00418457|20987243|P2|COMPLETED|Overall Study||1043
8514913|NCT00418457|20987244|P1|COMPLETED|Overall Study||1065
8514914|NCT00418457|20987243|P2|STARTED|Overall Study||1043
8514915|NCT00418457|20987244|P1|STARTED|Overall Study||1065
8514916|NCT00418379|20987261|P3|NOT COMPLETED|Year 5||3
8514917|NCT00418379|20987262|P2|NOT COMPLETED|Year 5||5
8514918|NCT00418379|20987263|P1|NOT COMPLETED|Year 5||2
8514919|NCT00418379|20987261|P3|COMPLETED|Year 5||131
8514920|NCT00418379|20987262|P2|COMPLETED|Year 5||115
8514921|NCT00418379|20987263|P1|COMPLETED|Year 5||126
8514922|NCT00418379|20987261|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
8514923|NCT00418379|20987262|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
8514924|NCT00418379|20987263|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
8514925|NCT00418379|20987261|P3|NOT COMPLETED|Year 4||2
8514926|NCT00418379|20987262|P2|NOT COMPLETED|Year 4||5
8514927|NCT00418379|20987263|P1|NOT COMPLETED|Year 4||3
8514928|NCT00418379|20987261|P3|COMPLETED|Year 4||154
8514929|NCT00418379|20987262|P2|COMPLETED|Year 4||136
8514930|NCT00418379|20987263|P1|COMPLETED|Year 4||142
8514931|NCT00418379|20987261|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
8514932|NCT00418379|20987262|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
8514933|NCT00418379|20987263|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
8514934|NCT00418379|20987261|P3|NOT COMPLETED|Year 3||3
8514935|NCT00418379|20987262|P2|NOT COMPLETED|Year 3||2
8514936|NCT00418379|20987263|P1|NOT COMPLETED|Year 3||3
8514937|NCT00418379|20987261|P3|COMPLETED|Year 3||163
8514938|NCT00418379|20987262|P2|COMPLETED|Year 3||146
8514939|NCT00418379|20987263|P1|COMPLETED|Year 3||148
8514940|NCT00418379|20987261|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
8514941|NCT00418379|20987262|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
8514942|NCT00418379|20987263|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
8514943|NCT00418379|20987261|P3|NOT COMPLETED|Year 2||10
8514944|NCT00418379|20987262|P2|NOT COMPLETED|Year 2||4
8514945|NCT00418379|20987263|P1|NOT COMPLETED|Year 2||8
8514946|NCT00418379|20987261|P3|COMPLETED|Year 2||172
8514947|NCT00418379|20987262|P2|COMPLETED|Year 2||155
8514948|NCT00418379|20987263|P1|COMPLETED|Year 2||159
8514949|NCT00418379|20987261|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
8514950|NCT00418379|20987262|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
8514951|NCT00418379|20987263|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
8514952|NCT00418379|20987261|P3|NOT COMPLETED|Year 1||15
8514953|NCT00418379|20987262|P2|NOT COMPLETED|Year 1||28
8514954|NCT00418379|20987263|P1|NOT COMPLETED|Year 1||18
8514955|NCT00418379|20987261|P3|COMPLETED|Year 1||204
8514956|NCT00418379|20987262|P2|COMPLETED|Year 1||179
8514957|NCT00418379|20987263|P1|COMPLETED|Year 1||189
8514958|NCT00418379|20987261|P3|STARTED|Year 1||219
8514959|NCT00418379|20987262|P2|STARTED|Year 1||207
8514960|NCT00418379|20987263|P1|STARTED|Year 1||207
8514961|NCT00418314|20987273|P2|NOT COMPLETED|Overall Study||2
8514962|NCT00418314|20987274|P1|NOT COMPLETED|Overall Study||1
8514963|NCT00418314|20987273|P2|COMPLETED|Overall Study||828
8514964|NCT00418314|20987274|P1|COMPLETED|Overall Study||816
8514965|NCT00418314|20987273|P2|STARTED|Overall Study||830
8514966|NCT00418314|20987274|P1|STARTED|Overall Study||817
8514967|NCT00418262|20987284|P1|NOT COMPLETED|Visits 8 Thru 10||5
8514968|NCT00418262|20987284|P1|COMPLETED|Visits 8 Thru 10||11
8514969|NCT00418262|20987284|P1|STARTED|Visits 8 Thru 10||16
8514970|NCT00418262|20987284|P1|NOT COMPLETED|Visits 5 Thru 8||9
8514971|NCT00418262|20987284|P1|COMPLETED|Visits 5 Thru 8||16
8514972|NCT00418262|20987284|P1|STARTED|Visits 5 Thru 8||25
8514973|NCT00418262|20987284|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
8514974|NCT00418262|20987284|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
8514975|NCT00418262|20987284|P1|STARTED|Visits 1 (Baseline) Thru 5||27
8514976|NCT00418184|20987304|P2|NOT COMPLETED|Open-label Phase||5
8514977|NCT00418184|20987305|P1|NOT COMPLETED|Open-label Phase||5
8514978|NCT00418184|20987304|P2|COMPLETED|Open-label Phase|5 dropped out|43
8514979|NCT00418184|20987305|P1|COMPLETED|Open-label Phase|5 dropped out|97
8514980|NCT00418184|20987304|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
8514981|NCT00418184|20987305|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
8514982|NCT00418184|20987304|P2|NOT COMPLETED|Double-blind Phase||11
8514983|NCT00418184|20987305|P1|NOT COMPLETED|Double-blind Phase||27
8514984|NCT00418184|20987304|P2|COMPLETED|Double-blind Phase||52
8514985|NCT00418184|20987305|P1|COMPLETED|Double-blind Phase||110
8514986|NCT00418184|20987304|P2|STARTED|Double-blind Phase||63
8514987|NCT00418184|20987305|P1|STARTED|Double-blind Phase||137
8514988|NCT00418145|20987313|P1|NOT COMPLETED|Overall Study||6
8514989|NCT00418145|20987313|P1|COMPLETED|Overall Study||10
8514990|NCT00418145|20987313|P1|STARTED|Overall Study||16
8514991|NCT00418093|20987325|P1|NOT COMPLETED|Overall Study||0
8514992|NCT00418093|20987325|P1|COMPLETED|Overall Study||19
8514993|NCT00418093|20987325|P1|Completed Study|Overall Study||19
8514994|NCT00418093|20987325|P1|STARTED|Overall Study||19
8514995|NCT00418028|20987334|P2|NOT COMPLETED|Overall Study||1
8514996|NCT00418028|20987335|P1|NOT COMPLETED|Overall Study||2
8514997|NCT00418028|20987334|P2|COMPLETED|Overall Study||97
8514998|NCT00418028|20987335|P1|COMPLETED|Overall Study||95
8514999|NCT00418028|20987334|P2|STARTED|Overall Study||98
8515000|NCT00418028|20987335|P1|STARTED|Overall Study||97
8515001|NCT00418015|20987357|P4|NOT COMPLETED|Overall Study||0
8515002|NCT00418015|20987358|P3|NOT COMPLETED|Overall Study||0
8515003|NCT00418015|20987359|P2|NOT COMPLETED|Overall Study||0
8515004|NCT00418015|20987360|P1|NOT COMPLETED|Overall Study||0
8515005|NCT00418015|20987357|P4|COMPLETED|Overall Study||25
8515006|NCT00418015|20987358|P3|COMPLETED|Overall Study||78
8515007|NCT00418015|20987359|P2|COMPLETED|Overall Study||46
8515008|NCT00418015|20987360|P1|COMPLETED|Overall Study||144
8515009|NCT00418015|20987357|P4|STARTED|Overall Study||25
8515010|NCT00418015|20987358|P3|STARTED|Overall Study||78
8515011|NCT00418015|20987359|P2|STARTED|Overall Study||46
8515012|NCT00418015|20987360|P1|STARTED|Overall Study||144
8515013|NCT00417989|20987388|P2|NOT COMPLETED|Overall Study||22
8515014|NCT00417989|20987389|P1|NOT COMPLETED|Overall Study||20
8515015|NCT00417989|20987388|P2|COMPLETED|Overall Study||219
8515016|NCT00417989|20987389|P1|COMPLETED|Overall Study||224
8515017|NCT00417989|20987388|P2|STARTED|Overall Study||241
8515018|NCT00417989|20987389|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
8515019|NCT00417976|20987411|P1|NOT COMPLETED|Overall Study||3
8515020|NCT00417976|20987411|P1|COMPLETED|Overall Study||39
8515021|NCT00417976|20987411|P1|STARTED|Overall Study||42
8515022|NCT00417963|20987416|P1|NOT COMPLETED|Overall Study||41
8515023|NCT00417963|20987416|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
8515024|NCT00417963|20987416|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
8515025|NCT00417885|20987433|P1|NOT COMPLETED|Overall Study||6
8515026|NCT00417885|20987433|P1|COMPLETED|Overall Study||0
8515027|NCT00417885|20987433|P1|STARTED|Overall Study||6
8515028|NCT00417859|20987444|P2|NOT COMPLETED|Overall Study||1
8515029|NCT00417859|20987445|P1|NOT COMPLETED|Overall Study||0
8515030|NCT00417859|20987444|P2|COMPLETED|Overall Study||29
8515031|NCT00417859|20987445|P1|COMPLETED|Overall Study||26
8515032|NCT00417859|20987444|P2|STARTED|Overall Study||30
8515033|NCT00417859|20987445|P1|STARTED|Overall Study||26
8515034|NCT00417612|20987459|P2|NOT COMPLETED|Overall Study||3
8515035|NCT00417612|20987460|P1|NOT COMPLETED|Overall Study||3
8515036|NCT00417612|20987459|P2|COMPLETED|Overall Study||8
8515037|NCT00417612|20987460|P1|COMPLETED|Overall Study||19
8515038|NCT00417612|20987459|P2|STARTED|Overall Study||11
8515039|NCT00417612|20987460|P1|STARTED|Overall Study||22
8515040|NCT00417482|20987486|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
8515041|NCT00417482|20987487|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
8515042|NCT00417482|20987488|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
8515043|NCT00417482|20987486|P3|COMPLETED|Phase B 2nd 16 Weeks||10
8515044|NCT00417482|20987487|P2|COMPLETED|Phase B 2nd 16 Weeks||14
8515045|NCT00417482|20987488|P1|COMPLETED|Phase B 2nd 16 Weeks||10
8515046|NCT00417482|20987486|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
8515047|NCT00417482|20987487|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
8515048|NCT00417482|20987488|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
8515049|NCT00417482|20987486|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
8515050|NCT00417482|20987487|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
8515051|NCT00417482|20987488|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
8515052|NCT00417482|20987486|P3|COMPLETED|Phase B 1st 16 Weeks||13
8515053|NCT00417482|20987487|P2|COMPLETED|Phase B 1st 16 Weeks||27
8515054|NCT00417482|20987488|P1|COMPLETED|Phase B 1st 16 Weeks||13
8515055|NCT00417482|20987486|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
8515056|NCT00417482|20987487|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
8515057|NCT00417482|20987488|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
8515058|NCT00417417|20987514|P2|NOT COMPLETED|Overall Study||0
8515059|NCT00417417|20987515|P1|NOT COMPLETED|Overall Study||0
8515060|NCT00417417|20987514|P2|COMPLETED|Overall Study||6
8515061|NCT00417417|20987515|P1|COMPLETED|Overall Study||4
8515062|NCT00417417|20987514|P2|STARTED|Overall Study||6
8515063|NCT00417417|20987515|P1|STARTED|Overall Study||4
8515064|NCT00417274|20987523|P1|NOT COMPLETED|Overall Study||0
8515065|NCT00417274|20987523|P1|COMPLETED|Overall Study||31
8515066|NCT00417274|20987523|P1|STARTED|Overall Study||31
8515067|NCT00417248|20987527|P1|NOT COMPLETED|Overall Study||8
8515068|NCT00417248|20987527|P1|COMPLETED|Overall Study||0
8515069|NCT00417248|20987527|P1|STARTED|Overall Study||8
8515070|NCT00417170|20987534|P2|NOT COMPLETED|Overall Study||3
8515071|NCT00417170|20987535|P1|NOT COMPLETED|Overall Study||2
8515072|NCT00417170|20987534|P2|COMPLETED|Overall Study||22
8515073|NCT00417170|20987535|P1|COMPLETED|Overall Study||21
8515074|NCT00417170|20987534|P2|Pharmacodynamics Population|Overall Study||23
8515075|NCT00417170|20987535|P1|Pharmacodynamics Population|Overall Study||21
8515076|NCT00417170|20987534|P2|STARTED|Overall Study||25
8515077|NCT00417170|20987535|P1|STARTED|Overall Study|"Started indicates Safety population."|23
8515078|NCT00417079|20987551|P2|NOT COMPLETED|Overall Study||273
8515079|NCT00417079|20987552|P1|NOT COMPLETED|Overall Study||331
8515080|NCT00417079|20987551|P2|COMPLETED|Overall Study|Randomized patients|105
8515081|NCT00417079|20987552|P1|COMPLETED|Overall Study|Randomized patients|46
8515082|NCT00417079|20987551|P2|STARTED|Overall Study|Randomized patients|378
8515083|NCT00417079|20987552|P1|STARTED|Overall Study|Randomized patients|377
8515084|NCT00417027|20987575|P3|NOT COMPLETED|Overall Study||5
8515085|NCT00417027|20987576|P2|NOT COMPLETED|Overall Study||5
8515086|NCT00417027|20987577|P1|NOT COMPLETED|Overall Study||0
8515087|NCT00417027|20987575|P3|COMPLETED|Overall Study||54
8515088|NCT00417027|20987576|P2|COMPLETED|Overall Study||60
8515089|NCT00417027|20987577|P1|COMPLETED|Overall Study||66
8515090|NCT00417027|20987575|P3|STARTED|Overall Study||59
8515091|NCT00417027|20987576|P2|STARTED|Overall Study||65
8515092|NCT00417027|20987577|P1|STARTED|Overall Study||66
8515093|NCT00416949|20987603|P1|NOT COMPLETED|Overall Study||5
8515094|NCT00416949|20987603|P1|COMPLETED|Overall Study||4
8515095|NCT00416949|20987603|P1|STARTED|Overall Study||9
8515096|NCT00416884|20987607|P1|NOT COMPLETED|Overall Study||1
8515097|NCT00416884|20987607|P1|COMPLETED|Overall Study||0
8515098|NCT00416884|20987607|P1|STARTED|Overall Study||1
8515099|NCT00416793|20987611|P1|NOT COMPLETED|Overall Study||0
8515100|NCT00416793|20987611|P1|COMPLETED|Overall Study||9
8515101|NCT00416793|20987611|P1|STARTED|Overall Study||9
8515102|NCT00416715|20987616|P1|NOT COMPLETED|Overall Study||15
8515103|NCT00416715|20987616|P1|COMPLETED|Overall Study||85
8515104|NCT00416715|20987616|P1|STARTED|Overall Study||100
8515105|NCT00416624|20987627|P4|NOT COMPLETED|Overall Study||17
8515106|NCT00416624|20987628|P3|NOT COMPLETED|Overall Study||18
8515107|NCT00416624|20987629|P2|NOT COMPLETED|Overall Study||27
8515108|NCT00416624|20987630|P1|NOT COMPLETED|Overall Study||22
8515109|NCT00416624|20987627|P4|COMPLETED|Overall Study||40
8515110|NCT00416624|20987628|P3|COMPLETED|Overall Study||40
8515111|NCT00416624|20987629|P2|COMPLETED|Overall Study||33
8515112|NCT00416624|20987630|P1|COMPLETED|Overall Study||39
8515113|NCT00416624|20987627|P4|STARTED|Overall Study||57
8515114|NCT00416624|20987628|P3|STARTED|Overall Study||58
8515115|NCT00416624|20987629|P2|STARTED|Overall Study||60
8515116|NCT00416624|20987630|P1|STARTED|Overall Study||61
8515117|NCT00416598|20987684|P1|NOT COMPLETED|Decitabine Maintenance||72
8515118|NCT00416598|20987684|P1|COMPLETED|Decitabine Maintenance||62
8515119|NCT00416598|20987684|P1|STARTED|Decitabine Maintenance||134
8515120|NCT00416598|20987684|P1|NOT COMPLETED|Induction & Intensification||412
8515121|NCT00416598|20987684|P1|COMPLETED|Induction & Intensification||134
8515122|NCT00416598|20987684|P1|STARTED|Induction & Intensification||546
8515123|NCT00416572|20987692|P3|NOT COMPLETED|Overall Study||8
8515124|NCT00416572|20987693|P2|NOT COMPLETED|Overall Study||7
8515125|NCT00416572|20987694|P1|NOT COMPLETED|Overall Study||13
8515126|NCT00416572|20987692|P3|COMPLETED|Overall Study||76
8515127|NCT00416572|20987693|P2|COMPLETED|Overall Study||78
8515128|NCT00416572|20987694|P1|COMPLETED|Overall Study||70
8515129|NCT00416572|20987692|P3|STARTED|Overall Study||84
8515130|NCT00416572|20987693|P2|STARTED|Overall Study||85
8515131|NCT00416572|20987694|P1|STARTED|Overall Study||83
8515132|NCT00416520|20987710|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
8515133|NCT00416520|20987711|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
8515134|NCT00416520|20987712|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
8515135|NCT00416520|20987713|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
8515136|NCT00416520|20987710|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
8515137|NCT00416520|20987711|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
8515138|NCT00416520|20987712|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
8515139|NCT00416520|20987713|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
8515140|NCT00416520|20987710|P4|STARTED|Placebo-controlled Withdrawal Period||54
8515141|NCT00416520|20987711|P3|STARTED|Placebo-controlled Withdrawal Period||50
8515142|NCT00416520|20987712|P2|STARTED|Placebo-controlled Withdrawal Period||0
8515143|NCT00416520|20987713|P1|STARTED|Placebo-controlled Withdrawal Period||0
8515144|NCT00416520|20987710|P4|NOT COMPLETED|Open-label Period||0
8515145|NCT00416520|20987711|P3|NOT COMPLETED|Open-label Period||0
8515146|NCT00416520|20987712|P2|NOT COMPLETED|Open-label Period||32
8515147|NCT00416520|20987713|P1|NOT COMPLETED|Open-label Period||60
8515148|NCT00416520|20987710|P4|COMPLETED|Open-label Period||0
8515149|NCT00416520|20987711|P3|COMPLETED|Open-label Period||0
8515150|NCT00416520|20987712|P2|COMPLETED|Open-label Period||139
8515151|NCT00416520|20987713|P1|COMPLETED|Open-label Period||105
8515152|NCT00416520|20987710|P4|STARTED|Open-label Period||0
8515153|NCT00416520|20987711|P3|STARTED|Open-label Period||0
8515154|NCT00416520|20987712|P2|STARTED|Open-label Period||171
8515155|NCT00416520|20987713|P1|STARTED|Open-label Period||165
8515156|NCT00416494|20987725|P2|NOT COMPLETED|Overall Study||0
8515157|NCT00416494|20987726|P1|NOT COMPLETED|Overall Study||0
8515158|NCT00416494|20987725|P2|COMPLETED|Overall Study||31
8515159|NCT00416494|20987726|P1|COMPLETED|Overall Study||19
8515160|NCT00416494|20987725|P2|STARTED|Overall Study||31
8515161|NCT00416494|20987726|P1|STARTED|Overall Study||19
8515162|NCT00416455|20987742|P2|NOT COMPLETED|Overall Study||8
8515163|NCT00416455|20987743|P1|NOT COMPLETED|Overall Study||16
8515164|NCT00416455|20987742|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
8515165|NCT00416455|20987743|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
8515166|NCT00416455|20987742|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
8515167|NCT00416455|20987743|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
8515168|NCT00416312|20987778|P1|NOT COMPLETED|Overall Study||2
8515169|NCT00416312|20987778|P1|COMPLETED|Overall Study||7
8515170|NCT00416312|20987778|P1|Patient-specific Dosimetry|Overall Study||9
8515171|NCT00416312|20987778|P1|Conventional Dosimetry|Overall Study||9
8515172|NCT00416312|20987778|P1|STARTED|Overall Study||9
8515173|NCT00416195|20987784|P2|NOT COMPLETED|Overall Study||4
8515174|NCT00416195|20987785|P1|NOT COMPLETED|Overall Study||2
8515175|NCT00416195|20987784|P2|COMPLETED|Overall Study||34
8515176|NCT00416195|20987785|P1|COMPLETED|Overall Study||8
8515177|NCT00416195|20987784|P2|STARTED|Overall Study||38
8515178|NCT00416195|20987785|P1|STARTED|Overall Study||10
8515179|NCT00416182|20987795|P2|NOT COMPLETED|Overall Study||2
8515180|NCT00416182|20987796|P1|NOT COMPLETED|Overall Study||3
8515181|NCT00416182|20987795|P2|COMPLETED|Overall Study||6
8515182|NCT00416182|20987796|P1|COMPLETED|Overall Study||5
8515183|NCT00416182|20987795|P2|STARTED|Overall Study||8
8515184|NCT00416182|20987796|P1|STARTED|Overall Study||8
8515185|NCT00416078|20987810|P2|NOT COMPLETED|Overall Study||8
8515186|NCT00416078|20987811|P1|NOT COMPLETED|Overall Study||11
8515187|NCT00416078|20987810|P2|COMPLETED|Overall Study||16
8515188|NCT00416078|20987811|P1|COMPLETED|Overall Study||18
8515189|NCT00416078|20987810|P2|STARTED|Overall Study||24
8515190|NCT00416078|20987811|P1|STARTED|Overall Study||29
8515191|NCT00415909|20987827|P1|NOT COMPLETED|Overall Study||3
8515192|NCT00415909|20987827|P1|COMPLETED|Overall Study||0
8515193|NCT00415909|20987827|P1|STARTED|Overall Study||3
8515194|NCT00415870|20987833|P2|NOT COMPLETED|Overall Study||7
8515195|NCT00415870|20987834|P1|NOT COMPLETED|Overall Study||6
8515196|NCT00415870|20987833|P2|COMPLETED|Overall Study||26
8515197|NCT00415870|20987834|P1|COMPLETED|Overall Study||26
8515198|NCT00415870|20987833|P2|STARTED|Overall Study||33
8515199|NCT00415870|20987834|P1|STARTED|Overall Study||32
8515200|NCT00415857|20987846|P2|NOT COMPLETED|Overall Study||0
8515201|NCT00415857|20987847|P1|NOT COMPLETED|Overall Study||0
8515202|NCT00415857|20987846|P2|COMPLETED|Overall Study||3
8515203|NCT00415857|20987847|P1|COMPLETED|Overall Study||2
8515204|NCT00415857|20987846|P2|STARTED|Overall Study||3
8515205|NCT00415857|20987847|P1|STARTED|Overall Study||2
8515206|NCT00415636|20987861|P6|NOT COMPLETED|Overall Study||2
8515207|NCT00415636|20987862|P5|NOT COMPLETED|Overall Study||2
8515208|NCT00415636|20987863|P4|NOT COMPLETED|Overall Study||6
8515209|NCT00415636|20987864|P3|NOT COMPLETED|Overall Study||1
8515210|NCT00415636|20987865|P2|NOT COMPLETED|Overall Study||0
8515211|NCT00415636|20987866|P1|NOT COMPLETED|Overall Study||1
8515212|NCT00415636|20987861|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
8515213|NCT00415636|20987862|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
8515214|NCT00415636|20987863|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
8515215|NCT00415636|20987864|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
8515216|NCT00415636|20987865|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
8515217|NCT00415636|20987866|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
8515218|NCT00415636|20987861|P6|STARTED|Overall Study||3
8515219|NCT00415636|20987862|P5|STARTED|Overall Study||6
8515220|NCT00415636|20987863|P4|STARTED|Overall Study||13
8515221|NCT00415636|20987864|P3|STARTED|Overall Study||3
8515222|NCT00415636|20987865|P2|STARTED|Overall Study||3
8515223|NCT00415636|20987866|P1|STARTED|Overall Study||3
8515230|NCT00415610|20987928|P3|NOT COMPLETED|Overall Study||5
8515231|NCT00415610|20987929|P2|NOT COMPLETED|Overall Study||2
8515232|NCT00415610|20987930|P1|NOT COMPLETED|Overall Study||3
8515233|NCT00415610|20987928|P3|COMPLETED|Overall Study||17
8515234|NCT00415610|20987929|P2|COMPLETED|Overall Study||18
8515235|NCT00415610|20987930|P1|COMPLETED|Overall Study||15
8515236|NCT00415610|20987928|P3|STARTED|Overall Study||22
8515237|NCT00415610|20987929|P2|STARTED|Overall Study||20
8515238|NCT00415610|20987930|P1|STARTED|Overall Study||18
8515239|NCT00415597|20987950|P1|NOT COMPLETED|Treatment||305
8515240|NCT00415597|20987950|P1|COMPLETED|Treatment||160
8515241|NCT00415597|20987950|P1|STARTED|Treatment||465
8515242|NCT00415597|20987950|P1|NOT COMPLETED|Enrollment||2
8515243|NCT00415597|20987950|P1|COMPLETED|Enrollment||465
8515244|NCT00415597|20987950|P1|STARTED|Enrollment||467
8515245|NCT00415532|20987958|P2|NOT COMPLETED|Safety Follow Up Period||12
8515246|NCT00415532|20987959|P1|NOT COMPLETED|Safety Follow Up Period||9
8515247|NCT00415532|20987958|P2|COMPLETED|Safety Follow Up Period||18
8515248|NCT00415532|20987959|P1|COMPLETED|Safety Follow Up Period||34
8515249|NCT00415532|20987958|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
8515250|NCT00415532|20987959|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
8515251|NCT00415532|20987958|P2|NOT COMPLETED|Treatment Period||15
8515252|NCT00415532|20987959|P1|NOT COMPLETED|Treatment Period||17
8515253|NCT00415532|20987958|P2|COMPLETED|Treatment Period||142
8515254|NCT00415532|20987959|P1|COMPLETED|Treatment Period||60
8515255|NCT00415532|20987958|P2|Switched to Romiplostim Group|Treatment Period||0
8515256|NCT00415532|20987959|P1|Switched to Romiplostim Group|Treatment Period||2
8515257|NCT00415532|20987958|P2|Received Treatment|Treatment Period||154
8515258|NCT00415532|20987959|P1|Received Treatment|Treatment Period||75
8515259|NCT00415532|20987958|P2|STARTED|Treatment Period||157
8515260|NCT00415532|20987959|P1|STARTED|Treatment Period||77
8515261|NCT00415519|20987981|P2|NOT COMPLETED|Overall Study||0
8515262|NCT00415519|20987982|P1|NOT COMPLETED|Overall Study||4
8515263|NCT00415519|20987981|P2|COMPLETED|Overall Study||12
8515264|NCT00415519|20987982|P1|COMPLETED|Overall Study||9
8515265|NCT00415519|20987981|P2|STARTED|Overall Study||12
8515266|NCT00415519|20987982|P1|STARTED|Overall Study||13
8515267|NCT00415506|20988002|P2|NOT COMPLETED|Overall Study||1
8515268|NCT00415506|20988003|P1|NOT COMPLETED|Overall Study||3
8515269|NCT00415506|20988002|P2|COMPLETED|Overall Study||9
8515270|NCT00415506|20988003|P1|COMPLETED|Overall Study||9
8515271|NCT00415506|20988002|P2|STARTED|Overall Study||10
8515272|NCT00415506|20988003|P1|STARTED|Overall Study||12
8515273|NCT00415493|20988013|P2|NOT COMPLETED|Overall Study||0
8515274|NCT00415493|20988014|P1|NOT COMPLETED|Overall Study||0
8515275|NCT00415493|20988013|P2|COMPLETED|Overall Study||12
8515276|NCT00415493|20988014|P1|COMPLETED|Overall Study||12
8515277|NCT00415493|20988013|P2|STARTED|Overall Study||12
8515278|NCT00415493|20988014|P1|STARTED|Overall Study||12
8515279|NCT00415363|20988022|P2|NOT COMPLETED|Overall Study||54
8515280|NCT00415363|20988023|P1|NOT COMPLETED|Overall Study||55
8515281|NCT00415363|20988022|P2|COMPLETED|Overall Study||0
8515282|NCT00415363|20988023|P1|COMPLETED|Overall Study||0
8515283|NCT00415363|20988022|P2|Safety Population|Overall Study||53
8515284|NCT00415363|20988023|P1|Safety Population|Overall Study||54
8515285|NCT00415363|20988022|P2|STARTED|Overall Study||54
8515286|NCT00415363|20988023|P1|STARTED|Overall Study||55
8515287|NCT00415194|20988053|P2|NOT COMPLETED|Overall Study||342
8515288|NCT00415194|20988054|P1|NOT COMPLETED|Overall Study||328
8515289|NCT00415194|20988053|P2|COMPLETED|Overall Study||55
8515290|NCT00415194|20988054|P1|COMPLETED|Overall Study||70
8515291|NCT00415194|20988053|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
8515292|NCT00415194|20988054|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
8515293|NCT00415194|20988053|P2|STARTED|Overall Study||397
8515294|NCT00415194|20988054|P1|STARTED|Overall Study||398
8515295|NCT00415168|20988070|P1|NOT COMPLETED|Overall Study||52
8515296|NCT00415168|20988070|P1|COMPLETED|Overall Study||1
8515297|NCT00415168|20988070|P1|Completed Treatment|Overall Study||15
8515298|NCT00415168|20988070|P1|STARTED|Overall Study||53
8515299|NCT00415051|20988080|P1|NOT COMPLETED|Overall Study||1
8515300|NCT00415051|20988080|P1|COMPLETED|Overall Study||19
8515301|NCT00415051|20988080|P1|STARTED|Overall Study||20
8515302|NCT00414973|20988091|P4|NOT COMPLETED|Overall Study||0
8515303|NCT00414973|20988092|P3|NOT COMPLETED|Overall Study||3
8515304|NCT00414973|20988093|P2|NOT COMPLETED|Overall Study||10
8515305|NCT00414973|20988094|P1|NOT COMPLETED|Overall Study||28
8515306|NCT00414973|20988091|P4|COMPLETED|Overall Study||11
8515307|NCT00414973|20988092|P3|COMPLETED|Overall Study||21
8515308|NCT00414973|20988093|P2|COMPLETED|Overall Study||99
8515309|NCT00414973|20988094|P1|COMPLETED|Overall Study||190
8515310|NCT00414973|20988091|P4|STARTED|Overall Study||11
8515311|NCT00414973|20988092|P3|STARTED|Overall Study||24
8515312|NCT00414973|20988093|P2|STARTED|Overall Study||109
8515313|NCT00414973|20988094|P1|STARTED|Overall Study||218
8515314|NCT00414960|20988114|P2|NOT COMPLETED|Overall Study||1
8515315|NCT00414960|20988115|P1|NOT COMPLETED|Overall Study||7
8515316|NCT00414960|20988114|P2|COMPLETED|Overall Study||14
8515317|NCT00414960|20988115|P1|COMPLETED|Overall Study||18
8515318|NCT00414960|20988114|P2|Received at Least One Dose of Study Drug|Overall Study||15
8515319|NCT00414960|20988115|P1|Received at Least One Dose of Study Drug|Overall Study||24
8515320|NCT00414960|20988114|P2|STARTED|Overall Study||15
8515321|NCT00414960|20988115|P1|STARTED|Overall Study||25
8515322|NCT00414908|20988125|P2|NOT COMPLETED|Overall Study||1
8515323|NCT00414908|20988126|P1|NOT COMPLETED|Overall Study||1
8515324|NCT00414908|20988125|P2|COMPLETED|Overall Study||28
8515325|NCT00414908|20988126|P1|COMPLETED|Overall Study||24
8515326|NCT00414908|20988125|P2|STARTED|Overall Study||29
8515327|NCT00414908|20988126|P1|STARTED|Overall Study||25
8515328|NCT00414817|20988150|P2|NOT COMPLETED|Overall Study||3016
8515329|NCT00414817|20988151|P1|NOT COMPLETED|Overall Study||3130
8515330|NCT00414817|20988150|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
8515331|NCT00414817|20988151|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
8515332|NCT00414817|20988150|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
8515333|NCT00414817|20988151|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
8515334|NCT00414817|20988150|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
8515335|NCT00414817|20988151|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
8515336|NCT00414817|20988150|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
8515337|NCT00414817|20988151|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
8515338|NCT00414817|20988150|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
8515339|NCT00414817|20988151|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
8515340|NCT00414817|20988150|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
8515341|NCT00414817|20988151|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
8515342|NCT00414817|20988150|P2|STARTED|Overall Study||7031
8515343|NCT00414817|20988151|P1|STARTED|Overall Study||7033
8515344|NCT00414726|20988163|P2|NOT COMPLETED|Overall Study||1
8515345|NCT00414726|20988164|P1|NOT COMPLETED|Overall Study||0
8515346|NCT00414726|20988163|P2|COMPLETED|Overall Study||41
8515347|NCT00414726|20988164|P1|COMPLETED|Overall Study||43
8515348|NCT00414726|20988163|P2|STARTED|Overall Study||42
8515349|NCT00414726|20988164|P1|STARTED|Overall Study||43
8515350|NCT00414700|20988174|P2|NOT COMPLETED|Overall Study||3
8515351|NCT00414700|20988175|P1|NOT COMPLETED|Overall Study||6
8515352|NCT00414700|20988174|P2|COMPLETED|Overall Study||58
8515353|NCT00414700|20988175|P1|COMPLETED|Overall Study||51
8515354|NCT00414700|20988174|P2|STARTED|Overall Study||61
8515355|NCT00414700|20988175|P1|STARTED|Overall Study||57
8515356|NCT00414661|20988199|P4|NOT COMPLETED|Overall Study||3
8515357|NCT00414661|20988200|P3|NOT COMPLETED|Overall Study||2
8515358|NCT00414661|20988201|P2|NOT COMPLETED|Overall Study||14
8515359|NCT00414661|20988202|P1|NOT COMPLETED|Overall Study||14
8515360|NCT00414661|20988199|P4|COMPLETED|Overall Study||0
8515361|NCT00414661|20988200|P3|COMPLETED|Overall Study||20
8515362|NCT00414661|20988201|P2|COMPLETED|Overall Study||75
8515363|NCT00414661|20988202|P1|COMPLETED|Overall Study||34
8515364|NCT00414661|20988199|P4|STARTED|Overall Study||3
8515365|NCT00414661|20988200|P3|STARTED|Overall Study||22
8515366|NCT00414661|20988201|P2|STARTED|Overall Study||89
8515367|NCT00414661|20988202|P1|STARTED|Overall Study||48
8515368|NCT00414635|20988226|P2|NOT COMPLETED|Overall Study||2
8515369|NCT00414635|20988227|P1|NOT COMPLETED|Overall Study||5
8515370|NCT00414635|20988226|P2|COMPLETED|Overall Study||28
8515371|NCT00414635|20988227|P1|COMPLETED|Overall Study||25
8515372|NCT00414635|20988226|P2|STARTED|Overall Study||30
8515373|NCT00414635|20988227|P1|STARTED|Overall Study||30
8515374|NCT00414609|20988247|P3|NOT COMPLETED|Extension Study||57
8515375|NCT00414609|20988248|P2|NOT COMPLETED|Extension Study||0
8515376|NCT00414609|20988249|P1|NOT COMPLETED|Extension Study||0
8515377|NCT00414609|20988247|P3|COMPLETED|Extension Study||365
8515378|NCT00414609|20988248|P2|COMPLETED|Extension Study||0
8515379|NCT00414609|20988249|P1|COMPLETED|Extension Study||0
8515380|NCT00414609|20988247|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
8515381|NCT00414609|20988248|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
8515382|NCT00414609|20988249|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
8515383|NCT00414609|20988247|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
8515384|NCT00414609|20988248|P2|STARTED|Extension Study||0
8515385|NCT00414609|20988249|P1|STARTED|Extension Study||0
8515386|NCT00414609|20988247|P3|NOT COMPLETED|Core Study||0
8515387|NCT00414609|20988248|P2|NOT COMPLETED|Core Study||45
8515388|NCT00414609|20988249|P1|NOT COMPLETED|Core Study||34
8515389|NCT00414609|20988247|P3|COMPLETED|Core Study||0
8515390|NCT00414609|20988248|P2|COMPLETED|Core Study||378
8515391|NCT00414609|20988249|P1|COMPLETED|Core Study||363
8515392|NCT00414609|20988247|P3|Echocardiogram Evaluable Set|Core Study||0
8515393|NCT00414609|20988248|P2|Echocardiogram Evaluable Set|Core Study||343
8515394|NCT00414609|20988249|P1|Echocardiogram Evaluable Set|Core Study||330
8515395|NCT00414609|20988247|P3|Received Study Drug|Core Study||0
8515396|NCT00414609|20988248|P2|Received Study Drug|Core Study||422
8515397|NCT00414609|20988249|P1|Received Study Drug|Core Study||397
8515398|NCT00414609|20988247|P3|STARTED|Core Study||0
8515399|NCT00414609|20988248|P2|STARTED|Core Study||423
8515400|NCT00414609|20988249|P1|STARTED|Core Study||397
8515401|NCT00414596|20988272|P1|NOT COMPLETED|Overall Study||2
8515402|NCT00414596|20988272|P1|COMPLETED|Overall Study|April 2007|18
8515403|NCT00414596|20988272|P1|STARTED|Overall Study|December 2006|20
8515404|NCT00414544|20988281|P1|NOT COMPLETED|Overall Study||14
8515405|NCT00414544|20988281|P1|COMPLETED|Overall Study||131
8515406|NCT00414544|20988281|P1|STARTED|Overall Study||145
8515407|NCT00414518|20988289|P2|NOT COMPLETED|Overall Study||0
8515408|NCT00414518|20988290|P1|NOT COMPLETED|Overall Study||0
8515409|NCT00414518|20988289|P2|COMPLETED|Overall Study||9
8515410|NCT00414518|20988290|P1|COMPLETED|Overall Study||7
8515411|NCT00414518|20988289|P2|STARTED|Overall Study||9
8515412|NCT00414518|20988290|P1|STARTED|Overall Study||7
8515413|NCT00414466|20988304|P4|NOT COMPLETED|Overall Study||1
8515414|NCT00414466|20988305|P3|NOT COMPLETED|Overall Study||1
8515415|NCT00414466|20988306|P2|NOT COMPLETED|Overall Study||0
8515416|NCT00414466|20988307|P1|NOT COMPLETED|Overall Study||2
8515417|NCT00414466|20988304|P4|COMPLETED|Overall Study||42
8515418|NCT00414466|20988305|P3|COMPLETED|Overall Study||40
8515419|NCT00414466|20988306|P2|COMPLETED|Overall Study||42
8515420|NCT00414466|20988307|P1|COMPLETED|Overall Study||42
8515421|NCT00414466|20988304|P4|STARTED|Overall Study||43
8515422|NCT00414466|20988305|P3|STARTED|Overall Study||41
8515423|NCT00414466|20988306|P2|STARTED|Overall Study||42
8515424|NCT00414466|20988307|P1|STARTED|Overall Study||44
8515425|NCT00414453|20988325|P1|NOT COMPLETED|Overall Study||16
8515426|NCT00414453|20988325|P1|COMPLETED|Overall Study||3
8515427|NCT00414453|20988325|P1|STARTED|Overall Study||19
8515428|NCT00414440|20988373|P2|NOT COMPLETED|Extension Period||140
8515429|NCT00414440|20988374|P1|NOT COMPLETED|Extension Period||150
8515430|NCT00414440|20988373|P2|COMPLETED|Extension Period|Extension|77
8515431|NCT00414440|20988374|P1|COMPLETED|Extension Period|Extension|64
8515432|NCT00414440|20988373|P2|STARTED|Extension Period|Extension|217
8515433|NCT00414440|20988374|P1|STARTED|Extension Period|Extension|214
8515434|NCT00414440|20988373|P2|NOT COMPLETED|Core Period||32
8515435|NCT00414440|20988374|P1|NOT COMPLETED|Core Period||70
8515436|NCT00414440|20988373|P2|COMPLETED|Core Period|Core period|185
8515437|NCT00414440|20988374|P1|COMPLETED|Core Period|Core period|144
8515438|NCT00414440|20988373|P2|STARTED|Core Period|Core period|217
8515439|NCT00414440|20988374|P1|STARTED|Core Period|Core period|214
8515440|NCT00414388|20988388|P1|NOT COMPLETED|Overall Study||1
8515441|NCT00414388|20988388|P1|COMPLETED|Overall Study||21
8515442|NCT00414388|20988388|P1|STARTED|Overall Study||22
8515443|NCT00414310|20988396|P2|NOT COMPLETED|Overall Study||0
8515444|NCT00414310|20988397|P1|NOT COMPLETED|Overall Study||1
8515445|NCT00414310|20988396|P2|COMPLETED|Overall Study||79
8515446|NCT00414310|20988397|P1|COMPLETED|Overall Study||70
8515447|NCT00414310|20988396|P2|STARTED|Overall Study||79
8515448|NCT00414310|20988397|P1|STARTED|Overall Study||71
8515449|NCT00414271|20988407|P1|NOT COMPLETED|Overall Study||0
8515450|NCT00414271|20988407|P1|COMPLETED|Overall Study||18
8515451|NCT00414271|20988407|P1|STARTED|Overall Study||18
8515452|NCT00414206|20988418|P3|NOT COMPLETED|Overall Study||55
8515453|NCT00414206|20988419|P2|NOT COMPLETED|Overall Study||56
8515454|NCT00414206|20988420|P1|NOT COMPLETED|Overall Study||58
8515455|NCT00414206|20988418|P3|COMPLETED|Overall Study||59
8515456|NCT00414206|20988419|P2|COMPLETED|Overall Study||58
8515457|NCT00414206|20988420|P1|COMPLETED|Overall Study||57
8515458|NCT00414206|20988418|P3|STARTED|Overall Study||114
8515459|NCT00414206|20988419|P2|STARTED|Overall Study||114
8515460|NCT00414206|20988420|P1|STARTED|Overall Study||115
8515461|NCT00414167|20988430|P2|NOT COMPLETED|Overall Study||3
8515462|NCT00414167|20988431|P1|NOT COMPLETED|Overall Study||4
8515463|NCT00414167|20988430|P2|COMPLETED|Overall Study||27
8515464|NCT00414167|20988431|P1|COMPLETED|Overall Study||27
8515465|NCT00414167|20988430|P2|STARTED|Overall Study||30
8515466|NCT00414167|20988431|P1|STARTED|Overall Study||31
8515467|NCT00414076|20988441|P2|NOT COMPLETED|Overall Study||5
8515468|NCT00414076|20988442|P1|NOT COMPLETED|Overall Study||3
8515469|NCT00414076|20988441|P2|COMPLETED|Overall Study||0
8515470|NCT00414076|20988442|P1|COMPLETED|Overall Study||1
8515471|NCT00414076|20988441|P2|STARTED|Overall Study||5
8515472|NCT00414076|20988442|P1|STARTED|Overall Study||4
8515473|NCT00414050|20988452|P4|NOT COMPLETED|Overall Study||8
8515474|NCT00414050|20988453|P3|NOT COMPLETED|Overall Study||6
8515475|NCT00414050|20988454|P2|NOT COMPLETED|Overall Study||8
8515476|NCT00414050|20988455|P1|NOT COMPLETED|Overall Study||9
8515477|NCT00414050|20988452|P4|COMPLETED|Overall Study||423
8515478|NCT00414050|20988453|P3|COMPLETED|Overall Study||423
8515479|NCT00414050|20988454|P2|COMPLETED|Overall Study||419
8515480|NCT00414050|20988455|P1|COMPLETED|Overall Study||422
8515481|NCT00414050|20988452|P4|Received Vaccination 3|Overall Study||424
8515482|NCT00414050|20988453|P3|Received Vaccination 3|Overall Study||425
8515483|NCT00414050|20988454|P2|Received Vaccination 3|Overall Study||419
8515484|NCT00414050|20988455|P1|Received Vaccination 3|Overall Study||424
8515485|NCT00414050|20988452|P4|Received Vaccination 2|Overall Study||425
8515486|NCT00414050|20988453|P3|Received Vaccination 2|Overall Study||425
8515487|NCT00414050|20988454|P2|Received Vaccination 2|Overall Study||421
8515488|NCT00414050|20988455|P1|Received Vaccination 2|Overall Study||425
8515489|NCT00414050|20988452|P4|Received Vaccination 1|Overall Study||431
8515490|NCT00414050|20988453|P3|Received Vaccination 1|Overall Study||429
8515491|NCT00414050|20988454|P2|Received Vaccination 1|Overall Study||426
8515492|NCT00414050|20988455|P1|Received Vaccination 1|Overall Study||431
8515493|NCT00414050|20988452|P4|STARTED|Overall Study||431
8515494|NCT00414050|20988453|P3|STARTED|Overall Study||429
8515495|NCT00414050|20988454|P2|STARTED|Overall Study||427
8515496|NCT00414050|20988455|P1|STARTED|Overall Study||431
8515497|NCT00414011|20988469|P1|NOT COMPLETED|Overall Study||5
8515498|NCT00414011|20988469|P1|COMPLETED|Overall Study||35
8515499|NCT00414011|20988469|P1|STARTED|Overall Study||40
8515500|NCT00413972|20988478|P4|NOT COMPLETED|Overall Study||3
8515501|NCT00413972|20988479|P3|NOT COMPLETED|Overall Study||10
8515502|NCT00413972|20988480|P2|NOT COMPLETED|Overall Study||8
8515503|NCT00413972|20988481|P1|NOT COMPLETED|Overall Study||7
8515504|NCT00413972|20988478|P4|COMPLETED|Overall Study||95
8515505|NCT00413972|20988479|P3|COMPLETED|Overall Study||88
8515506|NCT00413972|20988480|P2|COMPLETED|Overall Study||90
8515507|NCT00413972|20988481|P1|COMPLETED|Overall Study||91
8515508|NCT00413972|20988478|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8515509|NCT00413972|20988479|P3|STARTED|Overall Study||98
8515510|NCT00413972|20988480|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8515511|NCT00413972|20988481|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8515512|NCT00413959|20988491|P1|NOT COMPLETED|Overall Study||1
8515513|NCT00413959|20988491|P1|COMPLETED|Overall Study||11
8515514|NCT00413959|20988491|P1|STARTED|Overall Study||12
8515515|NCT00413920|20988498|P2|NOT COMPLETED|Overall Study||28
8515516|NCT00413920|20988499|P1|NOT COMPLETED|Overall Study||28
8515517|NCT00413920|20988498|P2|COMPLETED|Overall Study||82
8515518|NCT00413920|20988499|P1|COMPLETED|Overall Study||84
8515519|NCT00413920|20988498|P2|STARTED|Overall Study||110
8515520|NCT00413920|20988499|P1|STARTED|Overall Study||112
8515521|NCT00413894|20988514|P1|NOT COMPLETED|Overall Study||80
8515522|NCT00413894|20988514|P1|COMPLETED|Overall Study||344
8515523|NCT00413894|20988514|P1|STARTED|Overall Study||424
8515524|NCT00413777|20988531|P2|NOT COMPLETED|Extension Period||0
8515525|NCT00413777|20988532|P1|NOT COMPLETED|Extension Period||0
8515526|NCT00413777|20988531|P2|COMPLETED|Extension Period||18
8515527|NCT00413777|20988532|P1|COMPLETED|Extension Period||17
8515528|NCT00413777|20988531|P2|STARTED|Extension Period||18
8515529|NCT00413777|20988532|P1|STARTED|Extension Period||17
8515530|NCT00413777|20988531|P2|NOT COMPLETED|Fixed-dose Period||3
8515531|NCT00413777|20988532|P1|NOT COMPLETED|Fixed-dose Period||4
8515532|NCT00413777|20988531|P2|COMPLETED|Fixed-dose Period||21
8515533|NCT00413777|20988532|P1|COMPLETED|Fixed-dose Period||18
8515534|NCT00413777|20988531|P2|STARTED|Fixed-dose Period||24
8515535|NCT00413777|20988532|P1|STARTED|Fixed-dose Period||22
8515536|NCT00413699|20988580|P3|NOT COMPLETED|Extension Period||5
8515537|NCT00413699|20988581|P2|NOT COMPLETED|Extension Period||0
8515538|NCT00413699|20988582|P1|NOT COMPLETED|Extension Period||0
8515539|NCT00413699|20988580|P3|COMPLETED|Extension Period||43
8515540|NCT00413699|20988581|P2|COMPLETED|Extension Period||0
8515541|NCT00413699|20988582|P1|COMPLETED|Extension Period||0
8515542|NCT00413699|20988580|P3|STARTED|Extension Period||48
8515543|NCT00413699|20988581|P2|STARTED|Extension Period||0
8515544|NCT00413699|20988582|P1|STARTED|Extension Period||0
8515545|NCT00413699|20988580|P3|NOT COMPLETED|Initial Period||0
8515546|NCT00413699|20988581|P2|NOT COMPLETED|Initial Period||1705
8515547|NCT00413699|20988582|P1|NOT COMPLETED|Initial Period||639
8515548|NCT00413699|20988580|P3|COMPLETED|Initial Period||0
8515549|NCT00413699|20988581|P2|COMPLETED|Initial Period||1653
8515550|NCT00413699|20988582|P1|COMPLETED|Initial Period||484
8515551|NCT00413699|20988580|P3|STARTED|Initial Period||0
8515552|NCT00413699|20988581|P2|STARTED|Initial Period||3358
8515553|NCT00413699|20988582|P1|STARTED|Initial Period||1123
8515554|NCT00413660|20988664|P11|NOT COMPLETED|Post Week 12||1
8515555|NCT00413660|20988665|P10|NOT COMPLETED|Post Week 12||1
8515556|NCT00413660|20988666|P9|NOT COMPLETED|Post Week 12||0
8515557|NCT00413660|20988667|P8|NOT COMPLETED|Post Week 12||0
8515558|NCT00413660|20988668|P7|NOT COMPLETED|Post Week 12||3
8515559|NCT00413660|20988669|P6|NOT COMPLETED|Post Week 12||3
8515560|NCT00413660|20988670|P5|NOT COMPLETED|Post Week 12||6
8515561|NCT00413660|20988671|P4|NOT COMPLETED|Post Week 12||1
8515562|NCT00413660|20988672|P3|NOT COMPLETED|Post Week 12||8
8515563|NCT00413660|20988673|P2|NOT COMPLETED|Post Week 12||4
8515564|NCT00413660|20988674|P1|NOT COMPLETED|Post Week 12||3
8515565|NCT00413660|20988664|P11|COMPLETED|Post Week 12||17
8515566|NCT00413660|20988665|P10|COMPLETED|Post Week 12||12
8515567|NCT00413660|20988666|P9|COMPLETED|Post Week 12||13
8515568|NCT00413660|20988667|P8|COMPLETED|Post Week 12||21
8515569|NCT00413660|20988668|P7|COMPLETED|Post Week 12||37
8515570|NCT00413660|20988669|P6|COMPLETED|Post Week 12||54
8515571|NCT00413660|20988670|P5|COMPLETED|Post Week 12||60
8515572|NCT00413660|20988671|P4|COMPLETED|Post Week 12||66
8515573|NCT00413660|20988672|P3|COMPLETED|Post Week 12||56
8515574|NCT00413660|20988673|P2|COMPLETED|Post Week 12||44
8515575|NCT00413660|20988674|P1|COMPLETED|Post Week 12||40
8515576|NCT00413660|20988664|P11|STARTED|Post Week 12||18
8515577|NCT00413660|20988665|P10|STARTED|Post Week 12||13
8515578|NCT00413660|20988666|P9|STARTED|Post Week 12||13
8515579|NCT00413660|20988667|P8|STARTED|Post Week 12||21
8515580|NCT00413660|20988668|P7|STARTED|Post Week 12||40
8515581|NCT00413660|20988669|P6|STARTED|Post Week 12||57
8515582|NCT00413660|20988670|P5|STARTED|Post Week 12||66
8515583|NCT00413660|20988671|P4|STARTED|Post Week 12||67
8515584|NCT00413660|20988672|P3|STARTED|Post Week 12||64
8515585|NCT00413660|20988673|P2|STARTED|Post Week 12||48
8515586|NCT00413660|20988674|P1|STARTED|Post Week 12||43
8515587|NCT00413660|20988664|P11|NOT COMPLETED|Up To Week 12||0
8515588|NCT00413660|20988665|P10|NOT COMPLETED|Up To Week 12||0
8515589|NCT00413660|20988666|P9|NOT COMPLETED|Up To Week 12||0
8515590|NCT00413660|20988667|P8|NOT COMPLETED|Up To Week 12||0
8515591|NCT00413660|20988668|P7|NOT COMPLETED|Up To Week 12||11
8515592|NCT00413660|20988669|P6|NOT COMPLETED|Up To Week 12||10
8515593|NCT00413660|20988670|P5|NOT COMPLETED|Up To Week 12||9
8515594|NCT00413660|20988671|P4|NOT COMPLETED|Up To Week 12||8
8515595|NCT00413660|20988672|P3|NOT COMPLETED|Up To Week 12||7
8515596|NCT00413660|20988673|P2|NOT COMPLETED|Up To Week 12||7
8515597|NCT00413660|20988674|P1|NOT COMPLETED|Up To Week 12||7
8515598|NCT00413660|20988664|P11|COMPLETED|Up To Week 12||0
8515599|NCT00413660|20988665|P10|COMPLETED|Up To Week 12||0
8515600|NCT00413660|20988666|P9|COMPLETED|Up To Week 12||0
8515601|NCT00413660|20988667|P8|COMPLETED|Up To Week 12||0
8515602|NCT00413660|20988668|P7|COMPLETED|Up To Week 12||58
8515603|NCT00413660|20988669|P6|COMPLETED|Up To Week 12||70
8515604|NCT00413660|20988670|P5|COMPLETED|Up To Week 12||66
8515605|NCT00413660|20988671|P4|COMPLETED|Up To Week 12||67
8515606|NCT00413660|20988672|P3|COMPLETED|Up To Week 12||64
8515607|NCT00413660|20988673|P2|COMPLETED|Up To Week 12||61
8515608|NCT00413660|20988674|P1|COMPLETED|Up To Week 12||64
8515609|NCT00413660|20988664|P11|Treated|Up To Week 12||0
8515610|NCT00413660|20988665|P10|Treated|Up To Week 12||0
8515611|NCT00413660|20988666|P9|Treated|Up To Week 12||0
8515612|NCT00413660|20988667|P8|Treated|Up To Week 12||0
8515613|NCT00413660|20988668|P7|Treated|Up To Week 12||69
8515614|NCT00413660|20988669|P6|Treated|Up To Week 12||80
8515615|NCT00413660|20988670|P5|Treated|Up To Week 12||75
8515616|NCT00413660|20988671|P4|Treated|Up To Week 12||74
8515617|NCT00413660|20988672|P3|Treated|Up To Week 12||71
8515618|NCT00413660|20988673|P2|Treated|Up To Week 12||68
8515619|NCT00413660|20988674|P1|Treated|Up To Week 12||70
8515620|NCT00413660|20988664|P11|STARTED|Up To Week 12||0
8515621|NCT00413660|20988665|P10|STARTED|Up To Week 12||0
8515622|NCT00413660|20988666|P9|STARTED|Up To Week 12||0
8515623|NCT00413660|20988667|P8|STARTED|Up To Week 12||0
8515624|NCT00413660|20988668|P7|STARTED|Up To Week 12||69
8515625|NCT00413660|20988669|P6|STARTED|Up To Week 12||80
8515626|NCT00413660|20988670|P5|STARTED|Up To Week 12||75
8515627|NCT00413660|20988671|P4|STARTED|Up To Week 12||75
8515628|NCT00413660|20988672|P3|STARTED|Up To Week 12||71
8515629|NCT00413660|20988673|P2|STARTED|Up To Week 12||68
8515630|NCT00413660|20988674|P1|STARTED|Up To Week 12||71
8515631|NCT00413634|20989022|P2|NOT COMPLETED|Overall Study||0
8515632|NCT00413634|20989023|P1|NOT COMPLETED|Overall Study||0
8515633|NCT00413634|20989022|P2|COMPLETED|Overall Study||12
8515634|NCT00413634|20989023|P1|COMPLETED|Overall Study||12
8515635|NCT00413634|20989022|P2|STARTED|Overall Study||12
8515636|NCT00413634|20989023|P1|STARTED|Overall Study||12
8515637|NCT00413582|20989061|P2|NOT COMPLETED|Overall Study||0
8515638|NCT00413582|20989062|P1|NOT COMPLETED|Overall Study||0
8515639|NCT00413582|20989061|P2|COMPLETED|Overall Study|all enrolled completed|55
8515640|NCT00413582|20989062|P1|COMPLETED|Overall Study|all enrolled completed|55
8515641|NCT00413582|20989061|P2|Completion of Study|Overall Study|all enrolled completed|55
8515642|NCT00413582|20989062|P1|Completion of Study|Overall Study|all enrolled completed|55
8515643|NCT00413582|20989061|P2|STARTED|Overall Study|all enrolled completed|55
8515644|NCT00413582|20989062|P1|STARTED|Overall Study|all enrolled completed|55
8515645|NCT00413478|20989070|P1|NOT COMPLETED|Overall Study||0
8515646|NCT00413478|20989070|P1|COMPLETED|Overall Study||9
8515647|NCT00413478|20989070|P1|STARTED|Overall Study||9
8515648|NCT00413413|20989077|P3|NOT COMPLETED|Double-Blind||18
8515649|NCT00413413|20989078|P2|NOT COMPLETED|Double-Blind||14
8515650|NCT00413413|20989079|P1|NOT COMPLETED|Double-Blind||15
8515651|NCT00413413|20989077|P3|COMPLETED|Double-Blind||285
8515652|NCT00413413|20989078|P2|COMPLETED|Double-Blind||293
8515653|NCT00413413|20989079|P1|COMPLETED|Double-Blind||293
8515654|NCT00413413|20989077|P3|STARTED|Double-Blind||303
8515655|NCT00413413|20989078|P2|STARTED|Double-Blind||307
8515656|NCT00413413|20989079|P1|STARTED|Double-Blind||308
8515657|NCT00413413|20989077|P3|NOT COMPLETED|Single-Blind||0
8515658|NCT00413413|20989078|P2|NOT COMPLETED|Single-Blind||216
8515659|NCT00413413|20989079|P1|NOT COMPLETED|Single-Blind||0
8515660|NCT00413413|20989077|P3|COMPLETED|Single-Blind||0
8515661|NCT00413413|20989078|P2|COMPLETED|Single-Blind||918
8515662|NCT00413413|20989079|P1|COMPLETED|Single-Blind||0
8515663|NCT00413413|20989077|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
8515664|NCT00413413|20989078|P2|STARTED|Single-Blind||1134
8515665|NCT00413413|20989079|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
8515666|NCT00413400|20989101|P2|NOT COMPLETED|Overall Study||4
8515667|NCT00413400|20989102|P1|NOT COMPLETED|Overall Study||2
8515668|NCT00413400|20989101|P2|COMPLETED|Overall Study||12
8515669|NCT00413400|20989102|P1|COMPLETED|Overall Study||22
8515670|NCT00413400|20989101|P2|3 Month Visit|Overall Study||12
8515671|NCT00413400|20989102|P1|3 Month Visit|Overall Study||22
8515672|NCT00413400|20989101|P2|STARTED|Overall Study||16
8515673|NCT00413400|20989102|P1|STARTED|Overall Study||24
8515674|NCT00413374|20989132|P2|NOT COMPLETED|Overall Study||0
8515675|NCT00413374|20989133|P1|NOT COMPLETED|Overall Study||6
8515676|NCT00413374|20989132|P2|COMPLETED|Overall Study||80
8515677|NCT00413374|20989133|P1|COMPLETED|Overall Study||34
8515678|NCT00413374|20989132|P2|STARTED|Overall Study||80
8515679|NCT00413374|20989133|P1|STARTED|Overall Study||40
8515680|NCT00413335|20989145|P2|NOT COMPLETED|Overall Study||0
8515681|NCT00413335|20989146|P1|NOT COMPLETED|Overall Study||0
8515682|NCT00413335|20989145|P2|COMPLETED|Overall Study||9
8515683|NCT00413335|20989146|P1|COMPLETED|Overall Study||12
8515684|NCT00413335|20989145|P2|STARTED|Overall Study||9
8515685|NCT00413335|20989146|P1|STARTED|Overall Study||12
8515686|NCT00413283|20989164|P4|NOT COMPLETED|Overall Study||4
8515687|NCT00413283|20989165|P3|NOT COMPLETED|Overall Study||2
8515688|NCT00413283|20989166|P2|NOT COMPLETED|Overall Study||3
8515689|NCT00413283|20989167|P1|NOT COMPLETED|Overall Study||1
8515690|NCT00413283|20989164|P4|COMPLETED|Overall Study||13
8515691|NCT00413283|20989165|P3|COMPLETED|Overall Study||16
8515692|NCT00413283|20989166|P2|COMPLETED|Overall Study||13
8515693|NCT00413283|20989167|P1|COMPLETED|Overall Study||11
8515694|NCT00413283|20989164|P4|Received Study Drug|Overall Study||16
8515695|NCT00413283|20989165|P3|Received Study Drug|Overall Study||18
8515696|NCT00413283|20989166|P2|Received Study Drug|Overall Study||16
8515697|NCT00413283|20989167|P1|Received Study Drug|Overall Study||12
8515698|NCT00413283|20989164|P4|STARTED|Overall Study||17
8515699|NCT00413283|20989165|P3|STARTED|Overall Study||18
8515700|NCT00413283|20989166|P2|STARTED|Overall Study||16
8515701|NCT00413283|20989167|P1|STARTED|Overall Study||12
8515702|NCT00413244|20989199|P2|NOT COMPLETED|Overall Study||1
8515703|NCT00413244|20989200|P1|NOT COMPLETED|Overall Study||10
8515704|NCT00413244|20989199|P2|COMPLETED|Overall Study||19
8515705|NCT00413244|20989200|P1|COMPLETED|Overall Study||21
8515706|NCT00413244|20989199|P2|STARTED|Overall Study||20
8515707|NCT00413244|20989200|P1|STARTED|Overall Study||31
8515708|NCT00413231|20989228|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
8515709|NCT00413231|20989228|P1|COMPLETED|365-day to 60-month Post Treatment||93
8515710|NCT00413231|20989228|P1|STARTED|365-day to 60-month Post Treatment||139
8515711|NCT00413231|20989228|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
8515712|NCT00413231|20989228|P1|COMPLETED|30-day to 365-day Post Treatment||139
8515713|NCT00413231|20989228|P1|STARTED|30-day to 365-day Post Treatment||152
8515714|NCT00413231|20989228|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
8515715|NCT00413231|20989228|P1|COMPLETED|0 to 30-day Post Treatment||152
8515716|NCT00413231|20989228|P1|STARTED|0 to 30-day Post Treatment||160
8515717|NCT00413218|20989260|P2|NOT COMPLETED|Overall Study||96
8515718|NCT00413218|20989261|P1|NOT COMPLETED|Overall Study||103
8515719|NCT00413218|20989260|P2|COMPLETED|Overall Study||131
8515720|NCT00413218|20989261|P1|COMPLETED|Overall Study||120
8515721|NCT00413218|20989260|P2|Intent to Treat Population (ITT)|Overall Study||219
8515722|NCT00413218|20989261|P1|Intent to Treat Population (ITT)|Overall Study||221
8515723|NCT00413218|20989260|P2|STARTED|Overall Study||227
8515724|NCT00413218|20989261|P1|STARTED|Overall Study||223
8515725|NCT00413192|20989287|P4|NOT COMPLETED|Overall Study||32
8515726|NCT00413192|20989288|P3|NOT COMPLETED|Overall Study||19
8515727|NCT00413192|20989289|P2|NOT COMPLETED|Overall Study||40
8515728|NCT00413192|20989290|P1|NOT COMPLETED|Overall Study||37
8515729|NCT00413192|20989287|P4|COMPLETED|Overall Study||0
8515730|NCT00413192|20989288|P3|COMPLETED|Overall Study||0
8515731|NCT00413192|20989289|P2|COMPLETED|Overall Study||0
8515732|NCT00413192|20989290|P1|COMPLETED|Overall Study||0
8515733|NCT00413192|20989287|P4|STARTED|Overall Study||32
8515734|NCT00413192|20989288|P3|STARTED|Overall Study||19
8515735|NCT00413192|20989289|P2|STARTED|Overall Study||40
8515736|NCT00413192|20989290|P1|STARTED|Overall Study||37
8515737|NCT00413166|20989331|P3|NOT COMPLETED|Overall Study||0
8515738|NCT00413166|20989332|P2|NOT COMPLETED|Overall Study||0
8515739|NCT00413166|20989333|P1|NOT COMPLETED|Overall Study||0
8515740|NCT00413166|20989331|P3|COMPLETED|Overall Study||16
8515741|NCT00413166|20989332|P2|COMPLETED|Overall Study||5
8515742|NCT00413166|20989333|P1|COMPLETED|Overall Study||57
8515743|NCT00413166|20989331|P3|STARTED|Overall Study||16
8515744|NCT00413166|20989332|P2|STARTED|Overall Study||5
8515745|NCT00413166|20989333|P1|STARTED|Overall Study||57
8515746|NCT00413153|20989343|P2|NOT COMPLETED|Overall Study||1
8515747|NCT00413153|20989344|P1|NOT COMPLETED|Overall Study||2
8515748|NCT00413153|20989343|P2|COMPLETED|Overall Study||7
8515749|NCT00413153|20989344|P1|COMPLETED|Overall Study||5
8515750|NCT00413153|20989343|P2|STARTED|Overall Study||8
8515751|NCT00413153|20989344|P1|STARTED|Overall Study||7
8515752|NCT00413062|20989368|P2|NOT COMPLETED|Overall Study||210
8515753|NCT00413062|20989369|P1|NOT COMPLETED|Overall Study||678
8515754|NCT00413062|20989368|P2|COMPLETED|Overall Study||344
8515755|NCT00413062|20989369|P1|COMPLETED|Overall Study||988
8515756|NCT00413062|20989368|P2|STARTED|Overall Study||554
8515757|NCT00413062|20989369|P1|STARTED|Overall Study||1666
8515758|NCT00413049|20989395|P2|NOT COMPLETED|Overall Study||18
8515759|NCT00413049|20989396|P1|NOT COMPLETED|Overall Study||24
8515760|NCT00413049|20989395|P2|COMPLETED|Overall Study||331
8515761|NCT00413049|20989396|P1|COMPLETED|Overall Study||325
8515762|NCT00413049|20989395|P2|STARTED|Overall Study||349
8515763|NCT00413049|20989396|P1|STARTED|Overall Study||349
8515764|NCT00413036|20989412|P1|NOT COMPLETED|Overall Study||217
8515765|NCT00413036|20989412|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
8515766|NCT00413036|20989412|P1|STARTED|Overall Study||217
8515773|NCT00412984|20989445|P2|NOT COMPLETED|Overall Study||2493
8515774|NCT00412984|20989446|P1|NOT COMPLETED|Overall Study||2310
8515775|NCT00412984|20989445|P2|COMPLETED|Overall Study||6588
8515776|NCT00412984|20989446|P1|COMPLETED|Overall Study||6810
8515777|NCT00412984|20989445|P2|STARTED|Overall Study|Randomized participants|9081
8515778|NCT00412984|20989446|P1|STARTED|Overall Study|Randomized participants|9120
8515779|NCT00412971|20989490|P2|NOT COMPLETED|Overall Study||10
8515780|NCT00412971|20989491|P1|NOT COMPLETED|Overall Study||30
8515781|NCT00412971|20989490|P2|COMPLETED|Overall Study||108
8515782|NCT00412971|20989491|P1|COMPLETED|Overall Study||85
8515783|NCT00412971|20989490|P2|STARTED|Overall Study||118
8515784|NCT00412971|20989491|P1|STARTED|Overall Study||115
8515785|NCT00412958|20989504|P4|NOT COMPLETED|Overall Study||1
8515786|NCT00412958|20989505|P3|NOT COMPLETED|Overall Study||0
8515787|NCT00412958|20989506|P2|NOT COMPLETED|Overall Study||4
8515788|NCT00412958|20989507|P1|NOT COMPLETED|Overall Study||3
8515789|NCT00412958|20989504|P4|COMPLETED|Overall Study||30
8515790|NCT00412958|20989505|P3|COMPLETED|Overall Study||32
8515791|NCT00412958|20989506|P2|COMPLETED|Overall Study||29
8515792|NCT00412958|20989507|P1|COMPLETED|Overall Study||26
8515793|NCT00412958|20989504|P4|STARTED|Overall Study||31
8515794|NCT00412958|20989505|P3|STARTED|Overall Study||32
8515795|NCT00412958|20989506|P2|STARTED|Overall Study||33
8515796|NCT00412958|20989507|P1|STARTED|Overall Study||29
8515797|NCT00412932|20989517|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
8515798|NCT00412932|20989517|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
8515799|NCT00412932|20989517|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
8515800|NCT00412932|20989517|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
8515801|NCT00412932|20989517|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
8515802|NCT00412932|20989517|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
8515803|NCT00412932|20989517|P1|NOT COMPLETED|Olmesartan 40 mg||8
8515804|NCT00412932|20989517|P1|COMPLETED|Olmesartan 40 mg||161
8515805|NCT00412932|20989517|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
8515806|NCT00412932|20989517|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
8515807|NCT00412932|20989517|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
8515808|NCT00412932|20989517|P1|STARTED|Olmesartan (Olm) 20 mg||178
8515809|NCT00412893|20989528|P2|NOT COMPLETED|Overall Study||144
8515810|NCT00412893|20989529|P1|NOT COMPLETED|Overall Study||145
8515811|NCT00412893|20989528|P2|COMPLETED|Overall Study|Defined as completed treatment|120
8515812|NCT00412893|20989529|P1|COMPLETED|Overall Study|Defined as completed treatment|118
8515813|NCT00412893|20989528|P2|Received Treatment|Overall Study||258
8515814|NCT00412893|20989529|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
8515815|NCT00412893|20989528|P2|STARTED|Overall Study||264
8515816|NCT00412893|20989529|P1|STARTED|Overall Study||263
8515817|NCT00412867|20989555|P1|NOT COMPLETED|Overall Study||0
8515818|NCT00412867|20989555|P1|COMPLETED|Overall Study||58
8515819|NCT00412867|20989555|P1|STARTED|Overall Study||58
8515820|NCT00412854|20989567|P2|NOT COMPLETED|Overall Study||16
8515821|NCT00412854|20989568|P1|NOT COMPLETED|Overall Study||14
8515822|NCT00412854|20989567|P2|COMPLETED|Overall Study||314
8515823|NCT00412854|20989568|P1|COMPLETED|Overall Study||316
8515824|NCT00412854|20989567|P2|STARTED|Overall Study||330
8515825|NCT00412854|20989568|P1|STARTED|Overall Study||330
8515826|NCT00412841|20989596|P2|NOT COMPLETED|Overall Study||5
8515827|NCT00412841|20989597|P1|NOT COMPLETED|Overall Study||10
8515828|NCT00412841|20989596|P2|COMPLETED|Overall Study||16
8515829|NCT00412841|20989597|P1|COMPLETED|Overall Study||12
8515830|NCT00412841|20989596|P2|STARTED|Overall Study||21
8515831|NCT00412841|20989597|P1|STARTED|Overall Study||22
8515832|NCT00412750|20989612|P3|NOT COMPLETED|Overall Study||23
8515833|NCT00412750|20989613|P2|NOT COMPLETED|Overall Study||21
8515834|NCT00412750|20989614|P1|NOT COMPLETED|Overall Study||31
8515835|NCT00412750|20989612|P3|COMPLETED|Overall Study||31
8515836|NCT00412750|20989613|P2|COMPLETED|Overall Study||34
8515837|NCT00412750|20989614|P1|COMPLETED|Overall Study||19
8515838|NCT00412750|20989612|P3|STARTED|Overall Study||54
8515839|NCT00412750|20989613|P2|STARTED|Overall Study||55
8515840|NCT00412750|20989614|P1|STARTED|Overall Study||50
8515841|NCT00412737|20989639|P2|NOT COMPLETED|Overall Study||6
8515842|NCT00412737|20989640|P1|NOT COMPLETED|Overall Study||16
8515843|NCT00412737|20989639|P2|COMPLETED|Overall Study||232
8515844|NCT00412737|20989640|P1|COMPLETED|Overall Study||221
8515845|NCT00412737|20989639|P2|STARTED|Overall Study||238
8515846|NCT00412737|20989640|P1|STARTED|Overall Study||237
8515847|NCT00412607|20989658|P1|NOT COMPLETED|Overall Study||104
8515848|NCT00412607|20989658|P1|COMPLETED|Overall Study||145
8515849|NCT00412607|20989658|P1|Started Study Catheter|Overall Study||233
8515850|NCT00412607|20989658|P1|STARTED|Overall Study||249
8515851|NCT00412542|20989671|P2|NOT COMPLETED|Overall Study||3
8515852|NCT00412542|20989672|P1|NOT COMPLETED|Overall Study||0
8515853|NCT00412542|20989671|P2|COMPLETED|Overall Study||42
8515854|NCT00412542|20989672|P1|COMPLETED|Overall Study||33
8515855|NCT00412542|20989671|P2|STARTED|Overall Study||45
8515856|NCT00412542|20989672|P1|STARTED|Overall Study||33
8515857|NCT00412529|20989678|P2|NOT COMPLETED|Overall Study||0
8515858|NCT00412529|20989679|P1|NOT COMPLETED|Overall Study||0
8515859|NCT00412529|20989678|P2|COMPLETED|Overall Study||21
8515860|NCT00412529|20989679|P1|COMPLETED|Overall Study||23
8515861|NCT00412529|20989678|P2|STARTED|Overall Study||21
8515862|NCT00412529|20989679|P1|STARTED|Overall Study||23
8515863|NCT00412516|20989702|P3|NOT COMPLETED|Overall Study||0
8515864|NCT00412516|20989703|P2|NOT COMPLETED|Overall Study||0
8515865|NCT00412516|20989704|P1|NOT COMPLETED|Overall Study||0
8515866|NCT00412516|20989702|P3|COMPLETED|Overall Study||214
8515867|NCT00412516|20989703|P2|COMPLETED|Overall Study||212
8515868|NCT00412516|20989704|P1|COMPLETED|Overall Study||93
8515869|NCT00412516|20989702|P3|STARTED|Overall Study||214
8515870|NCT00412516|20989703|P2|STARTED|Overall Study||212
8515871|NCT00412516|20989704|P1|STARTED|Overall Study||93
8515872|NCT00412464|20989721|P1|NOT COMPLETED|Overall Study||0
8515873|NCT00412464|20989721|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
8515874|NCT00412464|20989721|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
8515875|NCT00412451|20989733|P4|NOT COMPLETED|Overall Study||2
8515876|NCT00412451|20989734|P3|NOT COMPLETED|Overall Study||1
8515877|NCT00412451|20989735|P2|NOT COMPLETED|Overall Study||0
8515878|NCT00412451|20989736|P1|NOT COMPLETED|Overall Study||0
8515879|NCT00412451|20989733|P4|COMPLETED|Overall Study||11
8515880|NCT00412451|20989734|P3|COMPLETED|Overall Study||14
8515881|NCT00412451|20989735|P2|COMPLETED|Overall Study||15
8515882|NCT00412451|20989736|P1|COMPLETED|Overall Study||8
8515883|NCT00412451|20989733|P4|STARTED|Overall Study||13
8515884|NCT00412451|20989734|P3|STARTED|Overall Study||15
8515885|NCT00412451|20989735|P2|STARTED|Overall Study||15
8515886|NCT00412451|20989736|P1|STARTED|Overall Study||8
8515887|NCT00412425|20989748|P2|NOT COMPLETED|Overall Study||0
8515888|NCT00412425|20989749|P1|NOT COMPLETED|Overall Study||0
8515889|NCT00412425|20989748|P2|COMPLETED|Overall Study||15
8515890|NCT00412425|20989749|P1|COMPLETED|Overall Study||15
8515891|NCT00412425|20989748|P2|STARTED|Overall Study||15
8515892|NCT00412425|20989749|P1|STARTED|Overall Study||15
8515893|NCT00412373|20989757|P2|NOT COMPLETED|Overall Study||77
8515894|NCT00412373|20989758|P1|NOT COMPLETED|Overall Study||41
8515895|NCT00412373|20989757|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
8515896|NCT00412373|20989758|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
8515897|NCT00412373|20989757|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
8515898|NCT00412373|20989758|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
8515899|NCT00412360|20989800|P2|NOT COMPLETED|Overall Study||3
8515900|NCT00412360|20989801|P1|NOT COMPLETED|Overall Study||1
8515901|NCT00412360|20989800|P2|COMPLETED|Overall Study||108
8515902|NCT00412360|20989801|P1|COMPLETED|Overall Study||112
8515903|NCT00412360|20989800|P2|STARTED|Overall Study||111
8515904|NCT00412360|20989801|P1|STARTED|Overall Study||113
8515905|NCT00412243|20989825|P1|NOT COMPLETED|Overall Study||0
8515906|NCT00412243|20989825|P1|COMPLETED|Overall Study||50
8515907|NCT00412243|20989825|P1|STARTED|Overall Study||50
8515908|NCT00412217|20989831|P2|NOT COMPLETED|Overall Study||48
8515909|NCT00412217|20989832|P1|NOT COMPLETED|Overall Study||46
8515910|NCT00412217|20989831|P2|COMPLETED|Overall Study||0
8515911|NCT00412217|20989832|P1|COMPLETED|Overall Study||0
8515912|NCT00412217|20989831|P2|STARTED|Overall Study||48
8515913|NCT00412217|20989832|P1|STARTED|Overall Study||46
8515922|NCT00412087|20989901|P2|NOT COMPLETED|Overall Study||65
8515923|NCT00412087|20989902|P1|NOT COMPLETED|Overall Study||62
8515924|NCT00412087|20989901|P2|COMPLETED|Overall Study||66
8515925|NCT00412087|20989902|P1|COMPLETED|Overall Study||72
8515926|NCT00412087|20989901|P2|STARTED|Overall Study||131
8515927|NCT00412087|20989902|P1|STARTED|Overall Study||134
8515928|NCT00412074|20989913|P3|NOT COMPLETED|Overall Study||67
8515929|NCT00412074|20989914|P2|NOT COMPLETED|Overall Study||22
8515930|NCT00412074|20989915|P1|NOT COMPLETED|Overall Study||77
8515931|NCT00412074|20989913|P3|COMPLETED|Overall Study||128
8515932|NCT00412074|20989914|P2|COMPLETED|Overall Study||44
8515933|NCT00412074|20989915|P1|COMPLETED|Overall Study||122
8515934|NCT00412074|20989913|P3|STARTED|Overall Study||195
8515935|NCT00412074|20989914|P2|STARTED|Overall Study||66
8515936|NCT00412074|20989915|P1|STARTED|Overall Study||199
8515937|NCT00412061|20989931|P2|NOT COMPLETED|Open Label Phase||170
8515938|NCT00412061|20989932|P1|NOT COMPLETED|Open Label Phase||0
8515939|NCT00412061|20989931|P2|COMPLETED|Open Label Phase||0
8515940|NCT00412061|20989932|P1|COMPLETED|Open Label Phase||0
8515941|NCT00412061|20989931|P2|STARTED|Open Label Phase||170
8515942|NCT00412061|20989932|P1|STARTED|Open Label Phase||0
8515943|NCT00412061|20989931|P2|NOT COMPLETED|Double Blind Phase||213
8515944|NCT00412061|20989932|P1|NOT COMPLETED|Double Blind Phase||216
8515945|NCT00412061|20989931|P2|COMPLETED|Double Blind Phase||0
8515946|NCT00412061|20989932|P1|COMPLETED|Double Blind Phase||0
8515947|NCT00412061|20989931|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
8515948|NCT00412061|20989932|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
8515949|NCT00412061|20989931|P2|STARTED|Double Blind Phase||213
8515950|NCT00412061|20989932|P1|STARTED|Double Blind Phase||216
8515951|NCT00411788|20989950|P1|NOT COMPLETED|Overall Study||2
8515952|NCT00411788|20989950|P1|COMPLETED|Overall Study||9
8515953|NCT00411788|20989950|P1|STARTED|Overall Study||11
8515954|NCT00411762|20989959|P1|NOT COMPLETED|Overall Study||5
8515955|NCT00411762|20989959|P1|COMPLETED|Overall Study||20
8515956|NCT00411762|20989959|P1|STARTED|Overall Study||25
8515957|NCT00411749|20989966|P2|NOT COMPLETED|Overall Study||0
8515958|NCT00411749|20989967|P1|NOT COMPLETED|Overall Study||0
8515959|NCT00411749|20989966|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
8515960|NCT00411749|20989967|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
8515961|NCT00411749|20989966|P2|Vaccinated|Overall Study||25
8515962|NCT00411749|20989967|P1|Vaccinated|Overall Study||82
8515963|NCT00411749|20989966|P2|STARTED|Overall Study||25
8515964|NCT00411749|20989967|P1|STARTED|Overall Study||82
8515965|NCT00411671|20989983|P1|NOT COMPLETED|Overall Study||20
8515966|NCT00411671|20989983|P1|COMPLETED|Overall Study||85
8515967|NCT00411671|20989983|P1|STARTED|Overall Study||105
8515968|NCT00411645|20989991|P2|NOT COMPLETED|Overall Study||164
8515969|NCT00411645|20989992|P1|NOT COMPLETED|Overall Study||81
8515970|NCT00411645|20989991|P2|COMPLETED|Overall Study||290
8515971|NCT00411645|20989992|P1|COMPLETED|Overall Study||146
8515972|NCT00411645|20989991|P2|STARTED|Overall Study||454
8515973|NCT00411645|20989992|P1|STARTED|Overall Study||227
8515974|NCT00411632|20990016|P1|NOT COMPLETED|Overall Study||1
8515975|NCT00411632|20990016|P1|COMPLETED|Overall Study||36
8515976|NCT00411632|20990016|P1|STARTED|Overall Study||37
8515977|NCT00411619|20990020|P1|NOT COMPLETED|Overall Study||6
8515978|NCT00411619|20990020|P1|COMPLETED|Overall Study||22
8515979|NCT00411619|20990020|P1|STARTED|Overall Study||28
8515980|NCT00411554|20990027|P2|NOT COMPLETED|Overall Study||9
8515981|NCT00411554|20990028|P1|NOT COMPLETED|Overall Study||8
8515982|NCT00411554|20990027|P2|COMPLETED|Overall Study||147
8515983|NCT00411554|20990028|P1|COMPLETED|Overall Study||155
8515984|NCT00411554|20990027|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
8515985|NCT00411554|20990028|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
8515986|NCT00411463|20990040|P2|NOT COMPLETED|Overall Study||3
8515987|NCT00411463|20990041|P1|NOT COMPLETED|Overall Study||3
8515988|NCT00411463|20990040|P2|COMPLETED|Overall Study||8
8515989|NCT00411463|20990041|P1|COMPLETED|Overall Study||11
8515990|NCT00411463|20990040|P2|STARTED|Overall Study||11
8515991|NCT00411463|20990041|P1|STARTED|Overall Study||14
8515992|NCT00411450|20990054|P1|NOT COMPLETED|Overall Study||3
8515993|NCT00411450|20990054|P1|COMPLETED|Overall Study|Ended second-line treatment|113
8515994|NCT00411450|20990054|P1|Received Treatment|Overall Study||115
8515995|NCT00411450|20990054|P1|STARTED|Overall Study||116
8515996|NCT00411411|20990082|P2|NOT COMPLETED|Overall Study||0
8515997|NCT00411411|20990083|P1|NOT COMPLETED|Overall Study||0
8515998|NCT00411411|20990082|P2|COMPLETED|Overall Study||25
8515999|NCT00411411|20990083|P1|COMPLETED|Overall Study||24
8516000|NCT00411411|20990082|P2|STARTED|Overall Study||25
8516001|NCT00411411|20990083|P1|STARTED|Overall Study||24
8516002|NCT00411398|20990091|P1|NOT COMPLETED|Overall Study||5
8516003|NCT00411398|20990091|P1|COMPLETED|Overall Study||10
8516004|NCT00411398|20990091|P1|STARTED|Overall Study||15
8516005|NCT00411216|20990097|P2|NOT COMPLETED|Overall Study||2
8516006|NCT00411216|20990098|P1|NOT COMPLETED|Overall Study||0
8516007|NCT00411216|20990097|P2|COMPLETED|Overall Study||8
8516008|NCT00411216|20990098|P1|COMPLETED|Overall Study||13
8516009|NCT00411216|20990097|P2|STARTED|Overall Study||10
8516010|NCT00411216|20990098|P1|STARTED|Overall Study||13
8516011|NCT00411151|20990104|P1|NOT COMPLETED|Overall Study||47
8516012|NCT00411151|20990104|P1|COMPLETED|Overall Study||5
8516013|NCT00411151|20990104|P1|STARTED|Overall Study||52
8516014|NCT00411086|20990114|P1|NOT COMPLETED|Overall Study||0
8516015|NCT00411086|20990114|P1|COMPLETED|Overall Study||52
8516016|NCT00411086|20990114|P1|STARTED|Overall Study||52
8516017|NCT00410904|20990122|P2|NOT COMPLETED|Overall Study||0
8516018|NCT00410904|20990123|P1|NOT COMPLETED|Overall Study||0
8516019|NCT00410904|20990122|P2|COMPLETED|Overall Study||20
8516020|NCT00410904|20990123|P1|COMPLETED|Overall Study||40
8516021|NCT00410904|20990122|P2|STARTED|Overall Study||20
8516022|NCT00410904|20990123|P1|STARTED|Overall Study||40
8516023|NCT00410891|20990131|P1|NOT COMPLETED|Overall Study||0
8516024|NCT00410891|20990131|P1|COMPLETED|Overall Study||129
8516025|NCT00410891|20990131|P1|STARTED|Overall Study||129
8516026|NCT00410826|20990137|P2|NOT COMPLETED|Overall Study||4
8516027|NCT00410826|20990138|P1|NOT COMPLETED|Overall Study||9
8516028|NCT00410826|20990137|P2|COMPLETED|Overall Study||95
8516029|NCT00410826|20990138|P1|COMPLETED|Overall Study||96
8516030|NCT00410826|20990137|P2|STARTED|Overall Study||99
8516031|NCT00410826|20990138|P1|STARTED|Overall Study||105
8516032|NCT00410813|20990148|P2|NOT COMPLETED|Overall Study||42
8516033|NCT00410813|20990149|P1|NOT COMPLETED|Overall Study||43
8516034|NCT00410813|20990148|P2|COMPLETED|Overall Study||0
8516035|NCT00410813|20990149|P1|COMPLETED|Overall Study|Patients treated until progression.|0
8516036|NCT00410813|20990148|P2|Eligible|Overall Study||38
8516037|NCT00410813|20990149|P1|Eligible|Overall Study||41
8516038|NCT00410813|20990148|P2|STARTED|Overall Study||42
8516039|NCT00410813|20990149|P1|STARTED|Overall Study||43
8516040|NCT00410761|20990186|P2|NOT COMPLETED|Overall Study||72
8516041|NCT00410761|20990187|P1|NOT COMPLETED|Overall Study||120
8516042|NCT00410761|20990186|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
8516043|NCT00410761|20990187|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
8516044|NCT00410761|20990186|P2|STARTED|Overall Study|randomised patients|100
8516045|NCT00410761|20990187|P1|STARTED|Overall Study|randomised patients|231
8516046|NCT00410605|20990207|P1|NOT COMPLETED|Overall Study||25
8516047|NCT00410605|20990207|P1|COMPLETED|Overall Study||14
8516048|NCT00410605|20990207|P1|STARTED|Overall Study||39
8516049|NCT00410514|20990219|P3|NOT COMPLETED|Overall Study||7
8516050|NCT00410514|20990220|P2|NOT COMPLETED|Overall Study||3
8516051|NCT00410514|20990221|P1|NOT COMPLETED|Overall Study||2
8516052|NCT00410514|20990219|P3|COMPLETED|Overall Study||58
8516053|NCT00410514|20990220|P2|COMPLETED|Overall Study||67
8516054|NCT00410514|20990221|P1|COMPLETED|Overall Study||63
8516055|NCT00410514|20990219|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
8516056|NCT00410514|20990220|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
8516057|NCT00410514|20990221|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
8516058|NCT00410514|20990219|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
8516059|NCT00410514|20990220|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
8516060|NCT00410514|20990221|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
8516061|NCT00410514|20990219|P3|STARTED|Overall Study||65
8516062|NCT00410514|20990220|P2|STARTED|Overall Study||70
8516063|NCT00410514|20990221|P1|STARTED|Overall Study||65
8516064|NCT00410488|20990282|P2|NOT COMPLETED|Overall Study||0
8516065|NCT00410488|20990283|P1|NOT COMPLETED|Overall Study||0
8516066|NCT00410488|20990282|P2|COMPLETED|Overall Study||34
8516067|NCT00410488|20990283|P1|COMPLETED|Overall Study||16
8516068|NCT00410488|20990282|P2|STARTED|Overall Study||34
8516069|NCT00410488|20990283|P1|STARTED|Overall Study||16
8516070|NCT00410423|20990288|P4|NOT COMPLETED|Phase 2||0
8516071|NCT00410423|20990289|P3|NOT COMPLETED|Phase 2||0
8516072|NCT00410423|20990290|P2|NOT COMPLETED|Phase 2||0
8516073|NCT00410423|20990291|P1|NOT COMPLETED|Phase 2||0
8516074|NCT00410423|20990288|P4|COMPLETED|Phase 2||44
8516075|NCT00410423|20990289|P3|COMPLETED|Phase 2||0
8516076|NCT00410423|20990290|P2|COMPLETED|Phase 2||0
8516077|NCT00410423|20990291|P1|COMPLETED|Phase 2||0
8516078|NCT00410423|20990288|P4|STARTED|Phase 2||44
8516079|NCT00410423|20990289|P3|STARTED|Phase 2||0
8516080|NCT00410423|20990290|P2|STARTED|Phase 2||0
8516081|NCT00410423|20990291|P1|STARTED|Phase 2||0
8516082|NCT00410423|20990288|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516083|NCT00410423|20990289|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516084|NCT00410423|20990290|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516085|NCT00410423|20990291|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516086|NCT00410423|20990288|P4|COMPLETED|Phase 1 - Dose Level 3||0
8516087|NCT00410423|20990289|P3|COMPLETED|Phase 1 - Dose Level 3||3
8516088|NCT00410423|20990290|P2|COMPLETED|Phase 1 - Dose Level 3||0
8516089|NCT00410423|20990291|P1|COMPLETED|Phase 1 - Dose Level 3||0
8516090|NCT00410423|20990288|P4|STARTED|Phase 1 - Dose Level 3||0
8516091|NCT00410423|20990289|P3|STARTED|Phase 1 - Dose Level 3||3
8516092|NCT00410423|20990290|P2|STARTED|Phase 1 - Dose Level 3||0
8516093|NCT00410423|20990291|P1|STARTED|Phase 1 - Dose Level 3||0
8516094|NCT00410423|20990288|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516095|NCT00410423|20990289|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516096|NCT00410423|20990290|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516097|NCT00410423|20990291|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516098|NCT00410423|20990288|P4|COMPLETED|Phase 1 - Dose Level 2||0
8516099|NCT00410423|20990289|P3|COMPLETED|Phase 1 - Dose Level 2||0
8516100|NCT00410423|20990290|P2|COMPLETED|Phase 1 - Dose Level 2||5
8516101|NCT00410423|20990291|P1|COMPLETED|Phase 1 - Dose Level 2||0
8516102|NCT00410423|20990288|P4|STARTED|Phase 1 - Dose Level 2||0
8516103|NCT00410423|20990289|P3|STARTED|Phase 1 - Dose Level 2||0
8516104|NCT00410423|20990290|P2|STARTED|Phase 1 - Dose Level 2||5
8516105|NCT00410423|20990291|P1|STARTED|Phase 1 - Dose Level 2||0
8516106|NCT00410423|20990288|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516107|NCT00410423|20990289|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516108|NCT00410423|20990290|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516109|NCT00410423|20990291|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516110|NCT00410423|20990288|P4|COMPLETED|Phase 1 - Dose Level 1||0
8516111|NCT00410423|20990289|P3|COMPLETED|Phase 1 - Dose Level 1||0
8516112|NCT00410423|20990290|P2|COMPLETED|Phase 1 - Dose Level 1||0
8516113|NCT00410423|20990291|P1|COMPLETED|Phase 1 - Dose Level 1||3
8516114|NCT00410423|20990288|P4|STARTED|Phase 1 - Dose Level 1||0
8516115|NCT00410423|20990289|P3|STARTED|Phase 1 - Dose Level 1||0
8516116|NCT00410423|20990290|P2|STARTED|Phase 1 - Dose Level 1||0
8516117|NCT00410423|20990291|P1|STARTED|Phase 1 - Dose Level 1||3
8516118|NCT00410410|20990304|P9|NOT COMPLETED|Open-Label Period (OL)||349
8516119|NCT00410410|20990305|P8|NOT COMPLETED|Open-Label Period (OL)||0
8516120|NCT00410410|20990306|P7|NOT COMPLETED|Open-Label Period (OL)||0
8516121|NCT00410410|20990307|P6|NOT COMPLETED|Open-Label Period (OL)||0
8516122|NCT00410410|20990308|P5|NOT COMPLETED|Open-Label Period (OL)||0
8516123|NCT00410410|20990309|P4|NOT COMPLETED|Open-Label Period (OL)||0
8516124|NCT00410410|20990310|P3|NOT COMPLETED|Open-Label Period (OL)||0
8516125|NCT00410410|20990311|P2|NOT COMPLETED|Open-Label Period (OL)||0
8516126|NCT00410410|20990312|P1|NOT COMPLETED|Open-Label Period (OL)||0
8516127|NCT00410410|20990304|P9|COMPLETED|Open-Label Period (OL)||0
8516128|NCT00410410|20990305|P8|COMPLETED|Open-Label Period (OL)||0
8516129|NCT00410410|20990306|P7|COMPLETED|Open-Label Period (OL)||0
8516130|NCT00410410|20990307|P6|COMPLETED|Open-Label Period (OL)||0
8516131|NCT00410410|20990308|P5|COMPLETED|Open-Label Period (OL)||0
8516132|NCT00410410|20990309|P4|COMPLETED|Open-Label Period (OL)||0
8516133|NCT00410410|20990310|P3|COMPLETED|Open-Label Period (OL)||0
8516134|NCT00410410|20990311|P2|COMPLETED|Open-Label Period (OL)||0
8516135|NCT00410410|20990312|P1|COMPLETED|Open-Label Period (OL)||0
8516136|NCT00410410|20990304|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
8516137|NCT00410410|20990305|P8|STARTED|Open-Label Period (OL)||0
8516138|NCT00410410|20990306|P7|STARTED|Open-Label Period (OL)||0
8516139|NCT00410410|20990307|P6|STARTED|Open-Label Period (OL)||0
8516140|NCT00410410|20990308|P5|STARTED|Open-Label Period (OL)||0
8516141|NCT00410410|20990309|P4|STARTED|Open-Label Period (OL)||0
8516142|NCT00410410|20990310|P3|STARTED|Open-Label Period (OL)||0
8516143|NCT00410410|20990311|P2|STARTED|Open-Label Period (OL)||0
8516144|NCT00410410|20990312|P1|STARTED|Open-Label Period (OL)||0
8516145|NCT00410410|20990304|P9|NOT COMPLETED|Maintenance Period (MP)||0
8516146|NCT00410410|20990305|P8|NOT COMPLETED|Maintenance Period (MP)||55
8516147|NCT00410410|20990306|P7|NOT COMPLETED|Maintenance Period (MP)||50
8516148|NCT00410410|20990307|P6|NOT COMPLETED|Maintenance Period (MP)||0
8516149|NCT00410410|20990308|P5|NOT COMPLETED|Maintenance Period (MP)||0
8516150|NCT00410410|20990309|P4|NOT COMPLETED|Maintenance Period (MP)||0
8516151|NCT00410410|20990310|P3|NOT COMPLETED|Maintenance Period (MP)||0
8516152|NCT00410410|20990311|P2|NOT COMPLETED|Maintenance Period (MP)||0
8516153|NCT00410410|20990312|P1|NOT COMPLETED|Maintenance Period (MP)||0
8516154|NCT00410410|20990304|P9|COMPLETED|Maintenance Period (MP)||0
8516155|NCT00410410|20990305|P8|COMPLETED|Maintenance Period (MP)||11
8516156|NCT00410410|20990306|P7|COMPLETED|Maintenance Period (MP)||15
8516157|NCT00410410|20990307|P6|COMPLETED|Maintenance Period (MP)||0
8516158|NCT00410410|20990308|P5|COMPLETED|Maintenance Period (MP)||0
8516159|NCT00410410|20990309|P4|COMPLETED|Maintenance Period (MP)||0
8516160|NCT00410410|20990310|P3|COMPLETED|Maintenance Period (MP)||0
8516161|NCT00410410|20990311|P2|COMPLETED|Maintenance Period (MP)||0
8516162|NCT00410410|20990312|P1|COMPLETED|Maintenance Period (MP)||0
8516163|NCT00410410|20990304|P9|STARTED|Maintenance Period (MP)||0
8516164|NCT00410410|20990305|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
8516165|NCT00410410|20990306|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
8516166|NCT00410410|20990307|P6|STARTED|Maintenance Period (MP)||0
8516167|NCT00410410|20990308|P5|STARTED|Maintenance Period (MP)||0
8516168|NCT00410410|20990309|P4|STARTED|Maintenance Period (MP)||0
8516169|NCT00410410|20990310|P3|STARTED|Maintenance Period (MP)||0
8516170|NCT00410410|20990311|P2|STARTED|Maintenance Period (MP)||0
8516171|NCT00410410|20990312|P1|STARTED|Maintenance Period (MP)||0
8516172|NCT00410410|20990304|P9|NOT COMPLETED|Induction Period (IP)||0
8516173|NCT00410410|20990305|P8|NOT COMPLETED|Induction Period (IP)||0
8516174|NCT00410410|20990306|P7|NOT COMPLETED|Induction Period (IP)||0
8516175|NCT00410410|20990307|P6|NOT COMPLETED|Induction Period (IP)||29
8516176|NCT00410410|20990308|P5|NOT COMPLETED|Induction Period (IP)||32
8516177|NCT00410410|20990309|P4|NOT COMPLETED|Induction Period (IP)||20
8516178|NCT00410410|20990310|P3|NOT COMPLETED|Induction Period (IP)||17
8516179|NCT00410410|20990311|P2|NOT COMPLETED|Induction Period (IP)||35
8516180|NCT00410410|20990312|P1|NOT COMPLETED|Induction Period (IP)||35
8516181|NCT00410410|20990304|P9|COMPLETED|Induction Period (IP)||0
8516182|NCT00410410|20990305|P8|COMPLETED|Induction Period (IP)||0
8516183|NCT00410410|20990306|P7|COMPLETED|Induction Period (IP)||0
8516184|NCT00410410|20990307|P6|COMPLETED|Induction Period (IP)||21
8516185|NCT00410410|20990308|P5|COMPLETED|Induction Period (IP)||19
8516186|NCT00410410|20990309|P4|COMPLETED|Induction Period (IP)||120
8516187|NCT00410410|20990310|P3|COMPLETED|Induction Period (IP)||53
8516188|NCT00410410|20990311|P2|COMPLETED|Induction Period (IP)||104
8516189|NCT00410410|20990312|P1|COMPLETED|Induction Period (IP)||106
8516190|NCT00410410|20990304|P9|STARTED|Induction Period (IP)||0
8516191|NCT00410410|20990305|P8|STARTED|Induction Period (IP)||0
8516192|NCT00410410|20990306|P7|STARTED|Induction Period (IP)||0
8516193|NCT00410410|20990307|P6|STARTED|Induction Period (IP)||50
8516194|NCT00410410|20990308|P5|STARTED|Induction Period (IP)||51
8516195|NCT00410410|20990309|P4|STARTED|Induction Period (IP)||140
8516196|NCT00410410|20990310|P3|STARTED|Induction Period (IP)||70
8516197|NCT00410410|20990311|P2|STARTED|Induction Period (IP)||139
8516198|NCT00410410|20990312|P1|STARTED|Induction Period (IP)||141
8516199|NCT00410384|20990473|P3|NOT COMPLETED|Overall Study||82
8516200|NCT00410384|20990474|P2|NOT COMPLETED|Overall Study||72
8516201|NCT00410384|20990475|P1|NOT COMPLETED|Overall Study||89
8516202|NCT00410384|20990473|P3|COMPLETED|Overall Study||191
8516203|NCT00410384|20990474|P2|COMPLETED|Overall Study||199
8516204|NCT00410384|20990475|P1|COMPLETED|Overall Study||186
8516205|NCT00410384|20990473|P3|STARTED|Overall Study||273
8516206|NCT00410384|20990474|P2|STARTED|Overall Study||271
8516207|NCT00410384|20990475|P1|STARTED|Overall Study||275
8516208|NCT00410280|20990503|P2|NOT COMPLETED|Overall Study||0
8516209|NCT00410280|20990504|P1|NOT COMPLETED|Overall Study||0
8516210|NCT00410280|20990503|P2|COMPLETED|Overall Study||13
8516211|NCT00410280|20990504|P1|COMPLETED|Overall Study||14
8516212|NCT00410280|20990503|P2|STARTED|Overall Study||13
8516213|NCT00410280|20990504|P1|STARTED|Overall Study||14
8516214|NCT00410202|20990548|P3|NOT COMPLETED|Off-treatment Follow up||12
8516215|NCT00410202|20990549|P2|NOT COMPLETED|Off-treatment Follow up||8
8516216|NCT00410202|20990550|P1|NOT COMPLETED|Off-treatment Follow up||14
8516217|NCT00410202|20990548|P3|COMPLETED|Off-treatment Follow up||2
8516218|NCT00410202|20990549|P2|COMPLETED|Off-treatment Follow up||0
8516219|NCT00410202|20990550|P1|COMPLETED|Off-treatment Follow up||1
8516220|NCT00410202|20990548|P3|STARTED|Off-treatment Follow up||14
8516221|NCT00410202|20990549|P2|STARTED|Off-treatment Follow up||8
8516222|NCT00410202|20990550|P1|STARTED|Off-treatment Follow up||15
8516223|NCT00410202|20990548|P3|NOT COMPLETED|On-Treatment||71
8516224|NCT00410202|20990549|P2|NOT COMPLETED|On-Treatment||79
8516225|NCT00410202|20990550|P1|NOT COMPLETED|On-Treatment||75
8516226|NCT00410202|20990548|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
8516227|NCT00410202|20990549|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
8516228|NCT00410202|20990550|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
8516229|NCT00410202|20990548|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
8516230|NCT00410202|20990549|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
8516231|NCT00410202|20990550|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
8516232|NCT00410202|20990548|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
8516233|NCT00410202|20990549|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
8516234|NCT00410202|20990550|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
8516235|NCT00410202|20990548|P3|STARTED|On-Treatment||137
8516236|NCT00410202|20990549|P2|STARTED|On-Treatment||140
8516237|NCT00410202|20990550|P1|STARTED|On-Treatment||138
8516238|NCT00410189|20990630|P1|NOT COMPLETED|Overall Study||0
8516239|NCT00410189|20990630|P1|COMPLETED|Overall Study||54
8516240|NCT00410189|20990630|P1|STARTED|Overall Study||54
8516241|NCT00410163|20990637|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8516242|NCT00410163|20990638|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8516243|NCT00410163|20990637|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
8516244|NCT00410163|20990638|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8516245|NCT00410163|20990637|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
8516324|NCT00409773|20990871|P4|STARTED|Overall Study||228
8516325|NCT00409773|20990872|P3|STARTED|Overall Study||229
8516246|NCT00410163|20990638|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
8516247|NCT00410163|20990637|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
8516248|NCT00410163|20990638|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
8516249|NCT00410163|20990637|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
8516250|NCT00410163|20990638|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
8516251|NCT00410163|20990637|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
8516252|NCT00410163|20990638|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
8516253|NCT00410150|20990682|P2|NOT COMPLETED|Overall Study||3
8516254|NCT00410150|20990683|P1|NOT COMPLETED|Overall Study||2
8516255|NCT00410150|20990682|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
8516256|NCT00410150|20990683|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
8516257|NCT00410150|20990682|P2|STARTED|Overall Study||20
8516258|NCT00410150|20990683|P1|STARTED|Overall Study||22
8516259|NCT00410124|20990691|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
8516260|NCT00410124|20990692|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
8516261|NCT00410124|20990691|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
8516262|NCT00410124|20990692|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
8516263|NCT00410124|20990691|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
8516264|NCT00410124|20990692|P1|STARTED|Extension Phase - Open Label (45 Months)||67
8516265|NCT00410124|20990691|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
8516266|NCT00410124|20990692|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
8516267|NCT00410124|20990691|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
8516268|NCT00410124|20990692|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
8516269|NCT00410124|20990691|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
8516270|NCT00410124|20990692|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
8516271|NCT00410124|20990691|P2|Ongoing|Core Phase Double Blind (15 Months)||4
8516272|NCT00410124|20990692|P1|Ongoing|Core Phase Double Blind (15 Months)||13
8516273|NCT00410124|20990691|P2|STARTED|Core Phase Double Blind (15 Months)||139
8516274|NCT00410124|20990692|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
8516275|NCT00410072|20990723|P2|NOT COMPLETED|After Week 48 to Week 96||11
8516276|NCT00410072|20990724|P1|NOT COMPLETED|After Week 48 to Week 96||6
8516277|NCT00410072|20990723|P2|COMPLETED|After Week 48 to Week 96||174
8516278|NCT00410072|20990724|P1|COMPLETED|After Week 48 to Week 96||170
8516279|NCT00410072|20990723|P2|STARTED|After Week 48 to Week 96||185
8516280|NCT00410072|20990724|P1|STARTED|After Week 48 to Week 96||176
8516281|NCT00410072|20990723|P2|NOT COMPLETED|Day 1 to Week 48||12
8516282|NCT00410072|20990724|P1|NOT COMPLETED|Day 1 to Week 48||6
8516283|NCT00410072|20990723|P2|COMPLETED|Day 1 to Week 48||185
8516284|NCT00410072|20990724|P1|COMPLETED|Day 1 to Week 48||176
8516285|NCT00410072|20990723|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
8516286|NCT00410072|20990724|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
8516287|NCT00410059|20990760|P1|NOT COMPLETED|Overall Study||0
8516288|NCT00410059|20990760|P1|COMPLETED|Overall Study||59
8516289|NCT00410059|20990760|P1|STARTED|Overall Study||59
8516290|NCT00410046|20990764|P1|NOT COMPLETED|Overall Study||5
8516291|NCT00410046|20990764|P1|COMPLETED|Overall Study||79
8516292|NCT00410046|20990764|P1|STARTED|Overall Study||84
8516293|NCT00409838|20990795|P2|NOT COMPLETED|Long-term Extension Period||0
8516294|NCT00409838|20990796|P1|NOT COMPLETED|Long-term Extension Period||18
8516295|NCT00409838|20990795|P2|COMPLETED|Long-term Extension Period||0
8516296|NCT00409838|20990796|P1|COMPLETED|Long-term Extension Period||87
8516297|NCT00409838|20990795|P2|STARTED|Long-term Extension Period||0
8516298|NCT00409838|20990796|P1|STARTED|Long-term Extension Period||105
8516299|NCT00409838|20990795|P2|NOT COMPLETED|Short-term Period||5
8516300|NCT00409838|20990796|P1|NOT COMPLETED|Short-term Period||3
8516301|NCT00409838|20990795|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
8516302|NCT00409838|20990796|P1|COMPLETED|Short-term Period||53
8516303|NCT00409838|20990795|P2|Treated (Baseline) Population|Short-term Period||57
8516304|NCT00409838|20990796|P1|Treated (Baseline) Population|Short-term Period||55
8516305|NCT00409838|20990795|P2|STARTED|Short-term Period|Randomized|57
8516306|NCT00409838|20990796|P1|STARTED|Short-term Period|Randomized|56
8516307|NCT00409825|20990857|P1|NOT COMPLETED|Overall Study||0
8516308|NCT00409825|20990857|P1|COMPLETED|Overall Study||61
8516309|NCT00409825|20990857|P1|STARTED|Overall Study||61
8516310|NCT00409786|20990861|P1|NOT COMPLETED|Overall Study||3
8516311|NCT00409786|20990861|P1|COMPLETED|Overall Study||47
8516312|NCT00409786|20990861|P1|STARTED|Overall Study||50
8516313|NCT00409773|20990870|P5|NOT COMPLETED|Overall Study||10
8516314|NCT00409773|20990871|P4|NOT COMPLETED|Overall Study||12
8516315|NCT00409773|20990872|P3|NOT COMPLETED|Overall Study||9
8516316|NCT00409773|20990873|P2|NOT COMPLETED|Overall Study||7
8516317|NCT00409773|20990874|P1|NOT COMPLETED|Overall Study||9
8516318|NCT00409773|20990870|P5|COMPLETED|Overall Study||218
8516319|NCT00409773|20990871|P4|COMPLETED|Overall Study||216
8516320|NCT00409773|20990872|P3|COMPLETED|Overall Study||220
8516321|NCT00409773|20990873|P2|COMPLETED|Overall Study||222
8516322|NCT00409773|20990874|P1|COMPLETED|Overall Study||220
8516323|NCT00409773|20990870|P5|STARTED|Overall Study||228
8516326|NCT00409773|20990873|P2|STARTED|Overall Study||229
8516327|NCT00409773|20990874|P1|STARTED|Overall Study||229
8516328|NCT00409747|20990956|P1|NOT COMPLETED|Overall Study||1
8516329|NCT00409747|20990956|P1|COMPLETED|Overall Study||10
8516330|NCT00409747|20990956|P1|STARTED|Overall Study||11
8516331|NCT00409708|20990963|P2|NOT COMPLETED|Washout||10
8516332|NCT00409708|20990964|P1|NOT COMPLETED|Washout||21
8516333|NCT00409708|20990963|P2|COMPLETED|Washout||29
8516334|NCT00409708|20990964|P1|COMPLETED|Washout||17
8516335|NCT00409708|20990963|P2|STARTED|Washout||39
8516336|NCT00409708|20990964|P1|STARTED|Washout||38
8516337|NCT00409708|20990963|P2|NOT COMPLETED|Treatment||17
8516338|NCT00409708|20990964|P1|NOT COMPLETED|Treatment||15
8516339|NCT00409708|20990963|P2|COMPLETED|Treatment||39
8516340|NCT00409708|20990964|P1|COMPLETED|Treatment||38
8516341|NCT00409708|20990963|P2|STARTED|Treatment||56
8516342|NCT00409708|20990964|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
8516343|NCT00409682|20990985|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
8516344|NCT00409682|20990986|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
8516345|NCT00409682|20990987|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
8516346|NCT00409682|20990985|P3|COMPLETED|EOW Double-blind Maintenance Period||66
8516347|NCT00409682|20990986|P2|COMPLETED|EOW Double-blind Maintenance Period||58
8516348|NCT00409682|20990987|P1|COMPLETED|EOW Double-blind Maintenance Period||0
8516349|NCT00409682|20990985|P3|STARTED|EOW Double-blind Maintenance Period||93
8516350|NCT00409682|20990986|P2|STARTED|EOW Double-blind Maintenance Period||95
8516351|NCT00409682|20990987|P1|STARTED|EOW Double-blind Maintenance Period||0
8516352|NCT00409682|20990985|P3|NOT COMPLETED|Open-label Induction Period||0
8516353|NCT00409682|20990986|P2|NOT COMPLETED|Open-label Induction Period||0
8516354|NCT00409682|20990987|P1|NOT COMPLETED|Open-label Induction Period||4
8516355|NCT00409682|20990985|P3|COMPLETED|Open-label Induction Period||0
8516356|NCT00409682|20990986|P2|COMPLETED|Open-label Induction Period||0
8516357|NCT00409682|20990987|P1|COMPLETED|Open-label Induction Period||188
8516358|NCT00409682|20990985|P3|STARTED|Open-label Induction Period||0
8516359|NCT00409682|20990986|P2|STARTED|Open-label Induction Period||0
8516360|NCT00409682|20990987|P1|STARTED|Open-label Induction Period||192
8516361|NCT00409617|20991004|P1|NOT COMPLETED|Overall Study||160
8516362|NCT00409617|20991004|P1|COMPLETED|Overall Study||785
8516363|NCT00409617|20991004|P1|STARTED|Overall Study||945
8516364|NCT00409578|20991020|P4|NOT COMPLETED|Overall Study||67
8516365|NCT00409578|20991021|P3|NOT COMPLETED|Overall Study||54
8516366|NCT00409578|20991022|P2|NOT COMPLETED|Overall Study||70
8516367|NCT00409578|20991023|P1|NOT COMPLETED|Overall Study||52
8516368|NCT00409578|20991020|P4|COMPLETED|Overall Study||214
8516369|NCT00409578|20991021|P3|COMPLETED|Overall Study||215
8516370|NCT00409578|20991022|P2|COMPLETED|Overall Study||201
8516371|NCT00409578|20991023|P1|COMPLETED|Overall Study||228
8516372|NCT00409578|20991020|P4|STARTED|Overall Study||281
8516373|NCT00409578|20991021|P3|STARTED|Overall Study||269
8516374|NCT00409578|20991022|P2|STARTED|Overall Study||271
8516375|NCT00409578|20991023|P1|STARTED|Overall Study||280
8516376|NCT00409565|20991045|P1|NOT COMPLETED|Overall Study||1
8516377|NCT00409565|20991045|P1|COMPLETED|Overall Study||45
8516378|NCT00409565|20991045|P1|Overall Response Rate|Overall Study||7
8516379|NCT00409565|20991045|P1|STARTED|Overall Study||46
8516380|NCT00409539|20991058|P5|NOT COMPLETED|Overall Study||25
8516381|NCT00409539|20991059|P4|NOT COMPLETED|Overall Study||12
8516382|NCT00409539|20991060|P3|NOT COMPLETED|Overall Study||14
8516383|NCT00409539|20991061|P2|NOT COMPLETED|Overall Study||11
8516384|NCT00409539|20991062|P1|NOT COMPLETED|Overall Study||11
8516385|NCT00409539|20991058|P5|COMPLETED|Overall Study||85
8516386|NCT00409539|20991059|P4|COMPLETED|Overall Study||97
8516387|NCT00409539|20991060|P3|COMPLETED|Overall Study||95
8516388|NCT00409539|20991061|P2|COMPLETED|Overall Study||100
8516389|NCT00409539|20991062|P1|COMPLETED|Overall Study||100
8516390|NCT00409539|20991058|P5|STARTED|Overall Study||110
8516391|NCT00409539|20991059|P4|STARTED|Overall Study||109
8516392|NCT00409539|20991060|P3|STARTED|Overall Study||109
8516393|NCT00409539|20991061|P2|STARTED|Overall Study||111
8516394|NCT00409539|20991062|P1|STARTED|Overall Study||111
8516395|NCT00409409|20991081|P2|NOT COMPLETED|Overall Study||4
8516396|NCT00409409|20991082|P1|NOT COMPLETED|Overall Study||8
8516397|NCT00409409|20991081|P2|COMPLETED|Overall Study||135
8516398|NCT00409409|20991082|P1|COMPLETED|Overall Study||131
8516399|NCT00409409|20991081|P2|STARTED|Overall Study||139
8516400|NCT00409409|20991082|P1|STARTED|Overall Study||139
8516401|NCT00409344|20991090|P2|NOT COMPLETED|Overall Study||0
8516402|NCT00409344|20991091|P1|NOT COMPLETED|Overall Study||0
8516403|NCT00409344|20991090|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
8516404|NCT00409344|20991091|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
8516405|NCT00409344|20991090|P2|STARTED|Overall Study|No participants enrolled|0
8516406|NCT00409344|20991091|P1|STARTED|Overall Study|No participants enrolled|0
8516407|NCT00409331|20991109|P1|NOT COMPLETED|Overall Study||1
8516408|NCT00409331|20991109|P1|COMPLETED|Overall Study||0
8516409|NCT00409331|20991109|P1|STARTED|Overall Study||1
8516410|NCT00409292|20991113|P1|NOT COMPLETED|Overall Study||0
8516411|NCT00409292|20991113|P1|COMPLETED|Overall Study||33
8516412|NCT00409292|20991113|P1|STARTED|Overall Study||33
8516413|NCT00409240|20991122|P2|NOT COMPLETED|Overall Study||1
8516414|NCT00409240|20991123|P1|NOT COMPLETED|Overall Study||3
8516415|NCT00409240|20991122|P2|COMPLETED|Overall Study||49
8516416|NCT00409240|20991123|P1|COMPLETED|Overall Study||50
8516417|NCT00409240|20991122|P2|STARTED|Overall Study||50
8516418|NCT00409240|20991123|P1|STARTED|Overall Study||53
8516419|NCT00409188|20991131|P2|NOT COMPLETED|Overall Study||175
8516420|NCT00409188|20991132|P1|NOT COMPLETED|Overall Study||383
8516421|NCT00409188|20991131|P2|COMPLETED|Overall Study||332
8516422|NCT00409188|20991132|P1|COMPLETED|Overall Study||623
8516423|NCT00409188|20991131|P2|STARTED|Overall Study||507
8516424|NCT00409188|20991132|P1|STARTED|Overall Study||1006
8516425|NCT00409175|20991148|P2|NOT COMPLETED|Overall Study||19
8516426|NCT00409175|20991149|P1|NOT COMPLETED|Overall Study||18
8516427|NCT00409175|20991148|P2|COMPLETED|Overall Study||44
8516428|NCT00409175|20991149|P1|COMPLETED|Overall Study||47
8516429|NCT00409175|20991148|P2|STARTED|Overall Study||63
8516430|NCT00409175|20991149|P1|STARTED|Overall Study||65
8516431|NCT00409006|20991175|P2|NOT COMPLETED|Overall Study||12
8516432|NCT00409006|20991176|P1|NOT COMPLETED|Overall Study||20
8516433|NCT00409006|20991175|P2|COMPLETED|Overall Study||19
8516434|NCT00409006|20991176|P1|COMPLETED|Overall Study||19
8516435|NCT00409006|20991175|P2|STARTED|Overall Study||31
8516436|NCT00409006|20991176|P1|STARTED|Overall Study||39
8516437|NCT00408993|20991192|P2|NOT COMPLETED|Overall Study||17
8516438|NCT00408993|20991193|P1|NOT COMPLETED|Overall Study||19
8516439|NCT00408993|20991192|P2|COMPLETED|Overall Study||92
8516440|NCT00408993|20991193|P1|COMPLETED|Overall Study||87
8516441|NCT00408993|20991192|P2|STARTED|Overall Study||109
8516442|NCT00408993|20991193|P1|STARTED|Overall Study||106
8516443|NCT00408928|20991225|P1|NOT COMPLETED|Overall Study||3
8516444|NCT00408928|20991225|P1|COMPLETED|Overall Study||8
8516445|NCT00408928|20991225|P1|STARTED|Overall Study||11
8516446|NCT00408902|20991230|P1|NOT COMPLETED|Overall Study||10
8516447|NCT00408902|20991230|P1|COMPLETED|Overall Study||0
8516448|NCT00408902|20991230|P1|STARTED|Overall Study||10
8516449|NCT00408876|20991240|P4|NOT COMPLETED|Overall Study||35
8516450|NCT00408876|20991241|P3|NOT COMPLETED|Overall Study||50
8516451|NCT00408876|20991242|P2|NOT COMPLETED|Overall Study||36
8516452|NCT00408876|20991243|P1|NOT COMPLETED|Overall Study||16
8516453|NCT00408876|20991240|P4|COMPLETED|Overall Study||82
8516454|NCT00408876|20991241|P3|COMPLETED|Overall Study||62
8516455|NCT00408876|20991242|P2|COMPLETED|Overall Study||80
8516456|NCT00408876|20991243|P1|COMPLETED|Overall Study||43
8516457|NCT00408876|20991240|P4|STARTED|Overall Study||117
8516458|NCT00408876|20991241|P3|STARTED|Overall Study||112
8516459|NCT00408876|20991242|P2|STARTED|Overall Study||116
8516460|NCT00408876|20991243|P1|STARTED|Overall Study||59
8516461|NCT00408694|20991493|P1|NOT COMPLETED|Overall Study||2
8516462|NCT00408694|20991493|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8516463|NCT00408694|20991493|P1|STARTED|Overall Study||46
8516464|NCT00408681|20991505|P1|NOT COMPLETED|Overall Study||9
8516465|NCT00408681|20991505|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
8516466|NCT00408681|20991505|P1|STARTED|Overall Study||20
8516467|NCT00408629|20991524|P2|NOT COMPLETED|Overall Study||125
8516468|NCT00408629|20991525|P1|NOT COMPLETED|Overall Study||97
8516469|NCT00408629|20991524|P2|COMPLETED|Overall Study||135
8516470|NCT00408629|20991525|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
8516471|NCT00408629|20991524|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
8516472|NCT00408629|20991525|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
8516473|NCT00408603|20991567|P3|NOT COMPLETED|Overall Study||40
8516474|NCT00408603|20991568|P2|NOT COMPLETED|Overall Study||2
8516475|NCT00408603|20991569|P1|NOT COMPLETED|Overall Study||4
8516476|NCT00408603|20991567|P3|COMPLETED|Overall Study||35
8516477|NCT00408603|20991568|P2|COMPLETED|Overall Study||37
8516478|NCT00408603|20991569|P1|COMPLETED|Overall Study||65
8516479|NCT00408603|20991567|P3|STARTED|Overall Study||75
8516480|NCT00408603|20991568|P2|STARTED|Overall Study||39
8516481|NCT00408603|20991569|P1|STARTED|Overall Study||69
8516482|NCT00408590|20991585|P9|NOT COMPLETED|Overall Study||0
8516483|NCT00408590|20991586|P8|NOT COMPLETED|Overall Study||0
8516484|NCT00408590|20991587|P7|NOT COMPLETED|Overall Study||0
8516485|NCT00408590|20991588|P6|NOT COMPLETED|Overall Study||0
8516486|NCT00408590|20991589|P5|NOT COMPLETED|Overall Study||0
8516487|NCT00408590|20991590|P4|NOT COMPLETED|Overall Study||0
8516488|NCT00408590|20991591|P3|NOT COMPLETED|Overall Study||0
8516489|NCT00408590|20991592|P2|NOT COMPLETED|Overall Study||0
8516490|NCT00408590|20991593|P1|NOT COMPLETED|Overall Study||0
8516491|NCT00408590|20991585|P9|COMPLETED|Overall Study||13
8516492|NCT00408590|20991586|P8|COMPLETED|Overall Study||3
8516493|NCT00408590|20991587|P7|COMPLETED|Overall Study||3
8516494|NCT00408590|20991588|P6|COMPLETED|Overall Study||3
8516495|NCT00408590|20991589|P5|COMPLETED|Overall Study||3
8516496|NCT00408590|20991590|P4|COMPLETED|Overall Study||3
8516497|NCT00408590|20991591|P3|COMPLETED|Overall Study||3
8516498|NCT00408590|20991592|P2|COMPLETED|Overall Study||3
8516499|NCT00408590|20991593|P1|COMPLETED|Overall Study||3
8516500|NCT00408590|20991585|P9|STARTED|Overall Study||13
8516501|NCT00408590|20991586|P8|STARTED|Overall Study||3
8516502|NCT00408590|20991587|P7|STARTED|Overall Study||3
8516503|NCT00408590|20991588|P6|STARTED|Overall Study||3
8516504|NCT00408590|20991589|P5|STARTED|Overall Study||3
8516505|NCT00408590|20991590|P4|STARTED|Overall Study||3
8516506|NCT00408590|20991591|P3|STARTED|Overall Study||3
8516507|NCT00408590|20991592|P2|STARTED|Overall Study||3
8516508|NCT00408590|20991593|P1|STARTED|Overall Study||3
8516509|NCT00408564|20991612|P1|NOT COMPLETED|Overall Study||0
8516510|NCT00408564|20991612|P1|COMPLETED|Overall Study||39
8516511|NCT00408564|20991612|P1|STARTED|Overall Study||39
8516512|NCT00408499|20991621|P5|NOT COMPLETED|Phase II- MTD Expansion||20
8516513|NCT00408499|20991622|P4|NOT COMPLETED|Phase II- MTD Expansion||0
8516514|NCT00408499|20991623|P3|NOT COMPLETED|Phase II- MTD Expansion||0
8516515|NCT00408499|20991624|P2|NOT COMPLETED|Phase II- MTD Expansion||0
8516516|NCT00408499|20991625|P1|NOT COMPLETED|Phase II- MTD Expansion||0
8516517|NCT00408499|20991621|P5|COMPLETED|Phase II- MTD Expansion||24
8516518|NCT00408499|20991622|P4|COMPLETED|Phase II- MTD Expansion||0
8516519|NCT00408499|20991623|P3|COMPLETED|Phase II- MTD Expansion||0
8516520|NCT00408499|20991624|P2|COMPLETED|Phase II- MTD Expansion||0
8516521|NCT00408499|20991625|P1|COMPLETED|Phase II- MTD Expansion||0
8516522|NCT00408499|20991621|P5|STARTED|Phase II- MTD Expansion||44
8516523|NCT00408499|20991622|P4|STARTED|Phase II- MTD Expansion||0
8516524|NCT00408499|20991623|P3|STARTED|Phase II- MTD Expansion||0
8516525|NCT00408499|20991624|P2|STARTED|Phase II- MTD Expansion||0
8516526|NCT00408499|20991625|P1|STARTED|Phase II- MTD Expansion||0
8516527|NCT00408499|20991621|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
8516528|NCT00408499|20991622|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
8516529|NCT00408499|20991623|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
8516530|NCT00408499|20991624|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
8516531|NCT00408499|20991625|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
8516532|NCT00408499|20991621|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
8516533|NCT00408499|20991622|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
8516534|NCT00408499|20991623|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
8516535|NCT00408499|20991624|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
8516536|NCT00408499|20991625|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
8516537|NCT00408499|20991621|P5|STARTED|Phase 1: Dose Levels 1-4||0
8516538|NCT00408499|20991622|P4|STARTED|Phase 1: Dose Levels 1-4||6
8516539|NCT00408499|20991623|P3|STARTED|Phase 1: Dose Levels 1-4||3
8516540|NCT00408499|20991624|P2|STARTED|Phase 1: Dose Levels 1-4||7
8516541|NCT00408499|20991625|P1|STARTED|Phase 1: Dose Levels 1-4||4
8516542|NCT00408460|20991634|P1|NOT COMPLETED|Overall Study||0
8516543|NCT00408460|20991634|P1|COMPLETED|Overall Study||34
8516544|NCT00408460|20991634|P1|STARTED|Overall Study||34
8516545|NCT00408434|20991647|P7|NOT COMPLETED|Overall Study||4
8516546|NCT00408434|20991648|P6|NOT COMPLETED|Overall Study||3
8516547|NCT00408434|20991649|P5|NOT COMPLETED|Overall Study||6
8516548|NCT00408434|20991650|P4|NOT COMPLETED|Overall Study||3
8516549|NCT00408434|20991651|P3|NOT COMPLETED|Overall Study||6
8516550|NCT00408434|20991652|P2|NOT COMPLETED|Overall Study||3
8516551|NCT00408434|20991653|P1|NOT COMPLETED|Overall Study||6
8516552|NCT00408434|20991647|P7|COMPLETED|Overall Study||0
8516553|NCT00408434|20991648|P6|COMPLETED|Overall Study||0
8516554|NCT00408434|20991649|P5|COMPLETED|Overall Study||0
8516555|NCT00408434|20991650|P4|COMPLETED|Overall Study||0
8516556|NCT00408434|20991651|P3|COMPLETED|Overall Study||0
8516557|NCT00408434|20991652|P2|COMPLETED|Overall Study||0
8516558|NCT00408434|20991653|P1|COMPLETED|Overall Study||0
8516559|NCT00408434|20991647|P7|STARTED|Overall Study||4
8516560|NCT00408434|20991648|P6|STARTED|Overall Study||3
8516561|NCT00408434|20991649|P5|STARTED|Overall Study||6
8516562|NCT00408434|20991650|P4|STARTED|Overall Study||3
8516563|NCT00408434|20991651|P3|STARTED|Overall Study||6
8516564|NCT00408434|20991652|P2|STARTED|Overall Study||3
8516565|NCT00408434|20991653|P1|STARTED|Overall Study||6
8516566|NCT00408421|20991700|P3|NOT COMPLETED|Treatment Re-Randomization||5
8516567|NCT00408421|20991701|P2|NOT COMPLETED|Treatment Re-Randomization||7
8516568|NCT00408421|20991702|P1|NOT COMPLETED|Treatment Re-Randomization||7
8516569|NCT00408421|20991700|P3|COMPLETED|Treatment Re-Randomization||38
8516570|NCT00408421|20991701|P2|COMPLETED|Treatment Re-Randomization||39
8516571|NCT00408421|20991702|P1|COMPLETED|Treatment Re-Randomization||96
8516572|NCT00408421|20991700|P3|STARTED|Treatment Re-Randomization||43
8516573|NCT00408421|20991701|P2|STARTED|Treatment Re-Randomization||46
8516574|NCT00408421|20991702|P1|STARTED|Treatment Re-Randomization||103
8516575|NCT00408421|20991700|P3|NOT COMPLETED|Treatment Initial Randomization||0
8516576|NCT00408421|20991701|P2|NOT COMPLETED|Treatment Initial Randomization||22
8516577|NCT00408421|20991702|P1|NOT COMPLETED|Treatment Initial Randomization||17
8516578|NCT00408421|20991700|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
8516579|NCT00408421|20991701|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
8516580|NCT00408421|20991702|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
8516581|NCT00408421|20991700|P3|STARTED|Treatment Initial Randomization||0
8516582|NCT00408421|20991701|P2|STARTED|Treatment Initial Randomization||111
8516583|NCT00408421|20991702|P1|STARTED|Treatment Initial Randomization||120
8516584|NCT00408408|20991782|P6|NOT COMPLETED|Overall Study||3
8516585|NCT00408408|20991783|P5|NOT COMPLETED|Overall Study||5
8516586|NCT00408408|20991784|P4|NOT COMPLETED|Overall Study||7
8516587|NCT00408408|20991785|P3|NOT COMPLETED|Overall Study||0
8516588|NCT00408408|20991786|P2|NOT COMPLETED|Overall Study||3
8516589|NCT00408408|20991787|P1|NOT COMPLETED|Overall Study||2
8516590|NCT00408408|20991782|P6|COMPLETED|Overall Study||201
8516591|NCT00408408|20991783|P5|COMPLETED|Overall Study||192
8516592|NCT00408408|20991784|P4|COMPLETED|Overall Study||194
8516593|NCT00408408|20991785|P3|COMPLETED|Overall Study||204
8516594|NCT00408408|20991786|P2|COMPLETED|Overall Study||196
8516595|NCT00408408|20991787|P1|COMPLETED|Overall Study||199
8516596|NCT00408408|20991782|P6|STARTED|Overall Study||204
8516597|NCT00408408|20991783|P5|STARTED|Overall Study||197
8516598|NCT00408408|20991784|P4|STARTED|Overall Study||201
8516599|NCT00408408|20991785|P3|STARTED|Overall Study||204
8516600|NCT00408408|20991786|P2|STARTED|Overall Study||199
8516601|NCT00408408|20991787|P1|STARTED|Overall Study||201
8516602|NCT00408317|20991849|P2|NOT COMPLETED|Second Intervention Period||2
8516603|NCT00408317|20991850|P1|NOT COMPLETED|Second Intervention Period||2
8516604|NCT00408317|20991849|P2|COMPLETED|Second Intervention Period||14
8516605|NCT00408317|20991850|P1|COMPLETED|Second Intervention Period||12
8516606|NCT00408317|20991849|P2|STARTED|Second Intervention Period||16
8516607|NCT00408317|20991850|P1|STARTED|Second Intervention Period||14
8516608|NCT00408317|20991849|P2|NOT COMPLETED|First Intervention Period||1
8516609|NCT00408317|20991850|P1|NOT COMPLETED|First Intervention Period||0
8516610|NCT00408317|20991849|P2|COMPLETED|First Intervention Period||16
8516611|NCT00408317|20991850|P1|COMPLETED|First Intervention Period||14
8516612|NCT00408317|20991849|P2|STARTED|First Intervention Period||17
8516613|NCT00408317|20991850|P1|STARTED|First Intervention Period||14
8516614|NCT00408200|20991864|P2|NOT COMPLETED|Overall Study||0
8516615|NCT00408200|20991865|P1|NOT COMPLETED|Overall Study||0
8516616|NCT00408200|20991864|P2|COMPLETED|Overall Study||53
8516617|NCT00408200|20991865|P1|COMPLETED|Overall Study||57
8516618|NCT00408200|20991864|P2|STARTED|Overall Study||53
8516619|NCT00408200|20991865|P1|STARTED|Overall Study||57
8516620|NCT00408070|20991873|P1|NOT COMPLETED|Overall Study||0
8516621|NCT00408070|20991873|P1|COMPLETED|Overall Study||5
8516622|NCT00408070|20991873|P1|STARTED|Overall Study||5
8516735|NCT00407966|20991920|P1|NOT COMPLETED|Overall Study||0
8516736|NCT00407966|20991920|P1|COMPLETED|Overall Study||45
8516737|NCT00407966|20991920|P1|CR|Overall Study||30
8516738|NCT00407966|20991920|P1|STARTED|Overall Study||45
8516739|NCT00407888|20991924|P1|NOT COMPLETED|Overall Study||0
8516740|NCT00407888|20991924|P1|COMPLETED|Overall Study||60
8516741|NCT00407888|20991924|P1|STARTED|Overall Study||60
8516742|NCT00407797|20991932|P1|NOT COMPLETED|Overall Study||18
8516743|NCT00407797|20991932|P1|COMPLETED|Overall Study||118
8516744|NCT00407797|20991932|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
8516745|NCT00407797|20991932|P1|STARTED|Overall Study||136
8516746|NCT00407758|20991947|P1|NOT COMPLETED|Overall Study||1
8516747|NCT00407758|20991947|P1|COMPLETED|Overall Study||27
8516748|NCT00407758|20991947|P1|STARTED|Overall Study||28
8516749|NCT00407745|20991960|P2|NOT COMPLETED|Overall Study||17
8516750|NCT00407745|20991961|P1|NOT COMPLETED|Overall Study||19
8516751|NCT00407745|20991960|P2|COMPLETED|Overall Study||91
8516752|NCT00407745|20991961|P1|COMPLETED|Overall Study||93
8516753|NCT00407745|20991960|P2|Treated|Overall Study||107
8516754|NCT00407745|20991961|P1|Treated|Overall Study||112
8516755|NCT00407745|20991960|P2|STARTED|Overall Study||108
8516756|NCT00407745|20991961|P1|STARTED|Overall Study||112
8516757|NCT00407654|20992033|P1|NOT COMPLETED|Overall Study||0
8516758|NCT00407654|20992033|P1|COMPLETED|Overall Study||75
8516759|NCT00407654|20992033|P1|STARTED|Overall Study||75
8516760|NCT00407563|20992047|P1|NOT COMPLETED|Overall Study||1
8516761|NCT00407563|20992047|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
8516762|NCT00407563|20992047|P1|STARTED|Overall Study||48
8516763|NCT00407550|20992057|P2|NOT COMPLETED|Overall Study||4
8516764|NCT00407550|20992058|P1|NOT COMPLETED|Overall Study||3
8516765|NCT00407550|20992057|P2|COMPLETED|Overall Study||5
8516766|NCT00407550|20992058|P1|COMPLETED|Overall Study||7
8516767|NCT00407550|20992057|P2|STARTED|Overall Study||9
8516768|NCT00407550|20992058|P1|STARTED|Overall Study||10
8516772|NCT00407485|20992084|P1|NOT COMPLETED|Overall Study||0
8516773|NCT00407485|20992084|P1|COMPLETED|Overall Study||22
8516774|NCT00407485|20992084|P1|STARTED|Overall Study||22
8516775|NCT00407420|20992091|P2|NOT COMPLETED|Overall Study||6
8516776|NCT00407420|20992092|P1|NOT COMPLETED|Overall Study||9
8516777|NCT00407420|20992091|P2|COMPLETED|Overall Study||46
8516778|NCT00407420|20992092|P1|COMPLETED|Overall Study||45
8516779|NCT00407420|20992091|P2|STARTED|Overall Study||52
8516780|NCT00407420|20992092|P1|STARTED|Overall Study||54
8516781|NCT00407381|20992107|P3|NOT COMPLETED|Overall Study||2
8516782|NCT00407381|20992108|P2|NOT COMPLETED|Overall Study||4
8516783|NCT00407381|20992109|P1|NOT COMPLETED|Overall Study||3
8516784|NCT00407381|20992107|P3|COMPLETED|Overall Study||40
8516785|NCT00407381|20992108|P2|COMPLETED|Overall Study||38
8516786|NCT00407381|20992109|P1|COMPLETED|Overall Study||39
8516787|NCT00407381|20992107|P3|STARTED|Overall Study||42
8516788|NCT00407381|20992108|P2|STARTED|Overall Study||42
8516789|NCT00407381|20992109|P1|STARTED|Overall Study||42
8516790|NCT00407355|20992119|P2|NOT COMPLETED|Overall Study||11
8516791|NCT00407355|20992120|P1|NOT COMPLETED|Overall Study||10
8516792|NCT00407355|20992119|P2|COMPLETED|Overall Study||9
8516793|NCT00407355|20992120|P1|COMPLETED|Overall Study||10
8516794|NCT00407355|20992119|P2|STARTED|Overall Study||20
8516795|NCT00407355|20992120|P1|STARTED|Overall Study||20
8516796|NCT00407030|20992131|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
8516797|NCT00407030|20992132|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
8516798|NCT00407030|20992133|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
8516799|NCT00407030|20992131|P3|COMPLETED|Extension Period - up to 68 Weeks||0
8516800|NCT00407030|20992132|P2|COMPLETED|Extension Period - up to 68 Weeks||74
8516801|NCT00407030|20992133|P1|COMPLETED|Extension Period - up to 68 Weeks||84
8516802|NCT00407030|20992131|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
8516803|NCT00407030|20992132|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
8516804|NCT00407030|20992133|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
8516805|NCT00407030|20992131|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
8516806|NCT00407030|20992132|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
8516807|NCT00407030|20992133|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
8516808|NCT00407030|20992131|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
8516809|NCT00407030|20992132|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
8516810|NCT00407030|20992133|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
8516811|NCT00407030|20992131|P3|STARTED|Main Period - 8 to 20 Weeks||74
8516812|NCT00407030|20992132|P2|STARTED|Main Period - 8 to 20 Weeks||78
8516813|NCT00407030|20992133|P1|STARTED|Main Period - 8 to 20 Weeks||81
8516814|NCT00406848|20992161|P2|NOT COMPLETED|Overall Study||54
8516815|NCT00406848|20992162|P1|NOT COMPLETED|Overall Study||93
8516816|NCT00406848|20992161|P2|COMPLETED|Overall Study||67
8516817|NCT00406848|20992162|P1|COMPLETED|Overall Study||156
8516818|NCT00406848|20992161|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
8516819|NCT00406848|20992162|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
8516820|NCT00406783|20992226|P2|NOT COMPLETED|Overall Study||15
8516821|NCT00406783|20992227|P1|NOT COMPLETED|Overall Study||14
8516822|NCT00406783|20992226|P2|COMPLETED|Overall Study||256
8516823|NCT00406783|20992227|P1|COMPLETED|Overall Study||262
8516824|NCT00406783|20992226|P2|STARTED|Overall Study||271
8516825|NCT00406783|20992227|P1|STARTED|Overall Study||276
8516826|NCT00406718|20992242|P3|NOT COMPLETED|Overall Study||8
8516827|NCT00406718|20992243|P2|NOT COMPLETED|Overall Study||14
8516828|NCT00406718|20992244|P1|NOT COMPLETED|Overall Study||4
8516829|NCT00406718|20992242|P3|COMPLETED|Overall Study||39
8516830|NCT00406718|20992243|P2|COMPLETED|Overall Study||34
8516831|NCT00406718|20992244|P1|COMPLETED|Overall Study||43
8516832|NCT00406718|20992242|P3|STARTED|Overall Study||47
8516833|NCT00406718|20992243|P2|STARTED|Overall Study||48
8516834|NCT00406718|20992244|P1|STARTED|Overall Study||47
8516835|NCT00406692|20992258|P1|NOT COMPLETED|Overall Study||7
8516836|NCT00406692|20992258|P1|COMPLETED|Overall Study||9
8516837|NCT00406692|20992258|P1|STARTED|Overall Study||16
8516838|NCT00406653|20992268|P7|NOT COMPLETED|Open-Label Period||324
8516839|NCT00406653|20992269|P6|NOT COMPLETED|Open-Label Period||0
8516840|NCT00406653|20992270|P5|NOT COMPLETED|Open-Label Period||0
8516841|NCT00406653|20992271|P4|NOT COMPLETED|Open-Label Period||0
8516842|NCT00406653|20992272|P3|NOT COMPLETED|Open-Label Period||0
8516843|NCT00406653|20992273|P2|NOT COMPLETED|Open-Label Period||0
8516844|NCT00406653|20992274|P1|NOT COMPLETED|Open-Label Period||0
8516845|NCT00406653|20992268|P7|COMPLETED|Open-Label Period||0
8516846|NCT00406653|20992269|P6|COMPLETED|Open-Label Period||0
8516847|NCT00406653|20992270|P5|COMPLETED|Open-Label Period||0
8516848|NCT00406653|20992271|P4|COMPLETED|Open-Label Period||0
8516849|NCT00406653|20992272|P3|COMPLETED|Open-Label Period||0
8516850|NCT00406653|20992273|P2|COMPLETED|Open-Label Period||0
8516851|NCT00406653|20992274|P1|COMPLETED|Open-Label Period||0
8516852|NCT00406653|20992268|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
8516853|NCT00406653|20992269|P6|STARTED|Open-Label Period||0
8516854|NCT00406653|20992270|P5|STARTED|Open-Label Period||0
8516855|NCT00406653|20992271|P4|STARTED|Open-Label Period||0
8516856|NCT00406653|20992272|P3|STARTED|Open-Label Period||0
8516857|NCT00406653|20992273|P2|STARTED|Open-Label Period||0
8516858|NCT00406653|20992274|P1|STARTED|Open-Label Period||0
8516859|NCT00406653|20992268|P7|NOT COMPLETED|Maintenance Period||0
8516860|NCT00406653|20992269|P6|NOT COMPLETED|Maintenance Period||36
8516861|NCT00406653|20992270|P5|NOT COMPLETED|Maintenance Period||30
8516862|NCT00406653|20992271|P4|NOT COMPLETED|Maintenance Period||0
8516863|NCT00406653|20992272|P3|NOT COMPLETED|Maintenance Period||0
8516864|NCT00406653|20992273|P2|NOT COMPLETED|Maintenance Period||0
8516865|NCT00406653|20992274|P1|NOT COMPLETED|Maintenance Period||0
8516866|NCT00406653|20992268|P7|COMPLETED|Maintenance Period||0
8516867|NCT00406653|20992269|P6|COMPLETED|Maintenance Period||10
8516868|NCT00406653|20992270|P5|COMPLETED|Maintenance Period||14
8516869|NCT00406653|20992271|P4|COMPLETED|Maintenance Period||0
8516870|NCT00406653|20992272|P3|COMPLETED|Maintenance Period||0
8516871|NCT00406653|20992273|P2|COMPLETED|Maintenance Period||0
8516872|NCT00406653|20992274|P1|COMPLETED|Maintenance Period||0
8516873|NCT00406653|20992268|P7|STARTED|Maintenance Period||0
8516874|NCT00406653|20992269|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
8516875|NCT00406653|20992270|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
8516876|NCT00406653|20992271|P4|STARTED|Maintenance Period||0
8516877|NCT00406653|20992272|P3|STARTED|Maintenance Period||0
8516878|NCT00406653|20992273|P2|STARTED|Maintenance Period||0
8516879|NCT00406653|20992274|P1|STARTED|Maintenance Period||0
8516880|NCT00406653|20992268|P7|NOT COMPLETED|Induction Period||0
8516881|NCT00406653|20992269|P6|NOT COMPLETED|Induction Period||0
8516882|NCT00406653|20992270|P5|NOT COMPLETED|Induction Period||0
8516883|NCT00406653|20992271|P4|NOT COMPLETED|Induction Period||26
8516884|NCT00406653|20992272|P3|NOT COMPLETED|Induction Period||18
8516885|NCT00406653|20992273|P2|NOT COMPLETED|Induction Period||34
8516886|NCT00406653|20992274|P1|NOT COMPLETED|Induction Period||15
8516887|NCT00406653|20992268|P7|COMPLETED|Induction Period||0
8516888|NCT00406653|20992269|P6|COMPLETED|Induction Period||0
8516889|NCT00406653|20992270|P5|COMPLETED|Induction Period||0
8516890|NCT00406653|20992271|P4|COMPLETED|Induction Period||102
8516891|NCT00406653|20992272|P3|COMPLETED|Induction Period||112
8516892|NCT00406653|20992273|P2|COMPLETED|Induction Period||94
8516893|NCT00406653|20992274|P1|COMPLETED|Induction Period||50
8516894|NCT00406653|20992268|P7|STARTED|Induction Period||0
8516895|NCT00406653|20992269|P6|STARTED|Induction Period||0
8516896|NCT00406653|20992270|P5|STARTED|Induction Period||0
8516897|NCT00406653|20992271|P4|STARTED|Induction Period||128
8516898|NCT00406653|20992272|P3|STARTED|Induction Period||130
8516899|NCT00406653|20992273|P2|STARTED|Induction Period||128
8516900|NCT00406653|20992274|P1|STARTED|Induction Period||65
8516901|NCT00406640|20992355|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
8516902|NCT00406640|20992356|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
8516903|NCT00406640|20992355|P2|COMPLETED|OL Extension Phase for Non-Responders||36
8516904|NCT00406640|20992356|P1|COMPLETED|OL Extension Phase for Non-Responders||47
8516905|NCT00406640|20992355|P2|STARTED|OL Extension Phase for Non-Responders||60
8516906|NCT00406640|20992356|P1|STARTED|OL Extension Phase for Non-Responders||69
8516907|NCT00406640|20992355|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
8516908|NCT00406640|20992356|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
8516909|NCT00406640|20992355|P2|COMPLETED|DB Continuation Phase for Responders||151
8516910|NCT00406640|20992356|P1|COMPLETED|DB Continuation Phase for Responders||139
8516911|NCT00406640|20992355|P2|STARTED|DB Continuation Phase for Responders||188
8516912|NCT00406640|20992356|P1|STARTED|DB Continuation Phase for Responders||172
8516913|NCT00406640|20992355|P2|NOT COMPLETED|Acute Phase||43
8516914|NCT00406640|20992356|P1|NOT COMPLETED|Acute Phase||51
8516915|NCT00406640|20992355|P2|COMPLETED|Acute Phase||256
8516916|NCT00406640|20992356|P1|COMPLETED|Acute Phase||245
8516917|NCT00406640|20992355|P2|STARTED|Acute Phase||299
8516918|NCT00406640|20992356|P1|STARTED|Acute Phase||296
8516919|NCT00406419|20992389|P3|NOT COMPLETED|Overall Study||347
8516920|NCT00406419|20992390|P2|NOT COMPLETED|Overall Study||344
8516921|NCT00406419|20992391|P1|NOT COMPLETED|Overall Study||324
8516922|NCT00406419|20992389|P3|COMPLETED|Overall Study||0
8516923|NCT00406419|20992390|P2|COMPLETED|Overall Study||0
8516924|NCT00406419|20992391|P1|COMPLETED|Overall Study||0
8516925|NCT00406419|20992389|P3|STARTED|Overall Study||347
8516926|NCT00406419|20992390|P2|STARTED|Overall Study||344
8516927|NCT00406419|20992391|P1|STARTED|Overall Study||324
8516928|NCT00406393|20992476|P2|NOT COMPLETED|Overall Study||1
8516929|NCT00406393|20992477|P1|NOT COMPLETED|Overall Study||2
8516930|NCT00406393|20992476|P2|COMPLETED|Overall Study||152
8516931|NCT00406393|20992477|P1|COMPLETED|Overall Study||149
8516932|NCT00406393|20992476|P2|STARTED|Overall Study||153
8516933|NCT00406393|20992477|P1|STARTED|Overall Study||151
8516934|NCT00406367|20992507|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
8516935|NCT00406367|20992508|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
8516936|NCT00406367|20992507|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
8516937|NCT00406367|20992508|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
8516938|NCT00406367|20992507|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
8516939|NCT00406367|20992508|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
8516940|NCT00406367|20992507|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
8516941|NCT00406367|20992508|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
8516942|NCT00406367|20992507|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
8516943|NCT00406367|20992508|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
8516944|NCT00406367|20992507|P2|STARTED|Main Period - 6 to 20 Weeks||34
8516945|NCT00406367|20992508|P1|STARTED|Main Period - 6 to 20 Weeks||75
8516946|NCT00406354|20992523|P3|NOT COMPLETED|All Randomized and Treated Patients||22
8516947|NCT00406354|20992524|P2|NOT COMPLETED|All Randomized and Treated Patients||13
8516948|NCT00406354|20992525|P1|NOT COMPLETED|All Randomized and Treated Patients||16
8516949|NCT00406354|20992523|P3|COMPLETED|All Randomized and Treated Patients||37
8516950|NCT00406354|20992524|P2|COMPLETED|All Randomized and Treated Patients||48
8516951|NCT00406354|20992525|P1|COMPLETED|All Randomized and Treated Patients||44
8516952|NCT00406354|20992523|P3|STARTED|All Randomized and Treated Patients||59
8516953|NCT00406354|20992524|P2|STARTED|All Randomized and Treated Patients||61
8516954|NCT00406354|20992525|P1|STARTED|All Randomized and Treated Patients||60
8516955|NCT00406354|20992523|P3|NOT COMPLETED|All Randomized Patients||1
8516956|NCT00406354|20992524|P2|NOT COMPLETED|All Randomized Patients||0
8516957|NCT00406354|20992525|P1|NOT COMPLETED|All Randomized Patients||0
8516958|NCT00406354|20992523|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
8516959|NCT00406354|20992524|P2|COMPLETED|All Randomized Patients||61
8516960|NCT00406354|20992525|P1|COMPLETED|All Randomized Patients||60
8516961|NCT00406354|20992523|P3|STARTED|All Randomized Patients||60
8516962|NCT00406354|20992524|P2|STARTED|All Randomized Patients||61
8516963|NCT00406354|20992525|P1|STARTED|All Randomized Patients||60
8516964|NCT00406315|20992596|P1|NOT COMPLETED|Overall Study||141
8516965|NCT00406315|20992596|P1|COMPLETED|Overall Study||100
8516966|NCT00406315|20992596|P1|STARTED|Overall Study|Started = Treated|241
8516967|NCT00406276|20992614|P1|NOT COMPLETED|Overall Study||4
8516968|NCT00406276|20992614|P1|COMPLETED|Overall Study||24
8516969|NCT00406276|20992614|P1|STARTED|Overall Study||28
8516970|NCT00406133|20992623|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
8516971|NCT00406133|20992624|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
8516972|NCT00406133|20992625|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
8516973|NCT00406133|20992626|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
8516974|NCT00406133|20992623|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
8516975|NCT00406133|20992624|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
8516976|NCT00406133|20992625|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
8516977|NCT00406133|20992626|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
8516978|NCT00406133|20992623|P4|STARTED|Phase 2 (Second 26 Week Period)||60
8516979|NCT00406133|20992624|P3|STARTED|Phase 2 (Second 26 Week Period)||67
8516980|NCT00406133|20992625|P2|STARTED|Phase 2 (Second 26 Week Period)||155
8516981|NCT00406133|20992626|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
8516982|NCT00406133|20992623|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
8516983|NCT00406133|20992624|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
8516984|NCT00406133|20992625|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
8516985|NCT00406133|20992626|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
8516986|NCT00406133|20992623|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
8516987|NCT00406133|20992624|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
8516988|NCT00406133|20992625|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
8516989|NCT00406133|20992626|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
8516990|NCT00406133|20992623|P4|STARTED|Phase 1 (First 26 Week Period)||62
8516991|NCT00406133|20992624|P3|STARTED|Phase 1 (First 26 Week Period)||67
8516992|NCT00406133|20992625|P2|STARTED|Phase 1 (First 26 Week Period)||157
8516993|NCT00406133|20992626|P1|STARTED|Phase 1 (First 26 Week Period)||165
8516994|NCT00406107|20992690|P2|NOT COMPLETED|Overall Study||1
8516995|NCT00406107|20992691|P1|NOT COMPLETED|Overall Study||1
8516996|NCT00406107|20992690|P2|COMPLETED|Overall Study||4
8516997|NCT00406107|20992691|P1|COMPLETED|Overall Study||14
8516998|NCT00406107|20992690|P2|STARTED|Overall Study||5
8516999|NCT00406107|20992691|P1|STARTED|Overall Study||15
8517000|NCT00406029|20992706|P5|NOT COMPLETED|Overall Study||8
8517001|NCT00406029|20992707|P4|NOT COMPLETED|Overall Study||17
8517002|NCT00406029|20992708|P3|NOT COMPLETED|Overall Study||10
8517003|NCT00406029|20992709|P2|NOT COMPLETED|Overall Study||8
8517004|NCT00406029|20992710|P1|NOT COMPLETED|Overall Study||16
8517005|NCT00406029|20992706|P5|COMPLETED|Overall Study||41
8517006|NCT00406029|20992707|P4|COMPLETED|Overall Study||40
8517007|NCT00406029|20992708|P3|COMPLETED|Overall Study||39
8517008|NCT00406029|20992709|P2|COMPLETED|Overall Study||41
8517009|NCT00406029|20992710|P1|COMPLETED|Overall Study||33
8517010|NCT00406029|20992706|P5|Treated|Overall Study||47
8517011|NCT00406029|20992707|P4|Treated|Overall Study||54
8517012|NCT00406029|20992708|P3|Treated|Overall Study||47
8517013|NCT00406029|20992709|P2|Treated|Overall Study||49
8517014|NCT00406029|20992710|P1|Treated|Overall Study||49
8517015|NCT00406029|20992706|P5|STARTED|Overall Study||49
8517016|NCT00406029|20992707|P4|STARTED|Overall Study||57
8517017|NCT00406029|20992708|P3|STARTED|Overall Study||49
8517018|NCT00406029|20992709|P2|STARTED|Overall Study||49
8517019|NCT00406029|20992710|P1|STARTED|Overall Study||49
8517020|NCT00405964|20992814|P2|NOT COMPLETED|Overall Study||95
8517021|NCT00405964|20992815|P1|NOT COMPLETED|Overall Study||59
8517022|NCT00405964|20992814|P2|COMPLETED|Overall Study||261
8517023|NCT00405964|20992815|P1|COMPLETED|Overall Study||301
8517024|NCT00405964|20992814|P2|STARTED|Overall Study||356
8517025|NCT00405964|20992815|P1|STARTED|Overall Study||360
8517026|NCT00405938|20992827|P2|NOT COMPLETED|Overall Study||0
8517027|NCT00405938|20992828|P1|NOT COMPLETED|Overall Study||0
8517028|NCT00405938|20992827|P2|COMPLETED|Overall Study||41
8517029|NCT00405938|20992828|P1|COMPLETED|Overall Study||38
8517030|NCT00405938|20992827|P2|STARTED|Overall Study||41
8517031|NCT00405938|20992828|P1|STARTED|Overall Study||38
8517032|NCT00405912|20992837|P3|NOT COMPLETED|Overall Study||16
8517033|NCT00405912|20992838|P2|NOT COMPLETED|Overall Study||19
8517034|NCT00405912|20992839|P1|NOT COMPLETED|Overall Study||16
8517035|NCT00405912|20992837|P3|COMPLETED|Overall Study||23
8517036|NCT00405912|20992838|P2|COMPLETED|Overall Study||21
8517037|NCT00405912|20992839|P1|COMPLETED|Overall Study||23
8517038|NCT00405912|20992837|P3|STARTED|Overall Study||39
8517039|NCT00405912|20992838|P2|STARTED|Overall Study||40
8517040|NCT00405912|20992839|P1|STARTED|Overall Study||39
8517041|NCT00405821|20992852|P2|NOT COMPLETED|Overall Study||22
8517042|NCT00405821|20992853|P1|NOT COMPLETED|Overall Study||22
8517043|NCT00405821|20992852|P2|COMPLETED|Overall Study||198
8517044|NCT00405821|20992853|P1|COMPLETED|Overall Study||198
8517045|NCT00405821|20992852|P2|STARTED|Overall Study||220
8517046|NCT00405821|20992853|P1|STARTED|Overall Study||220
8517047|NCT00405756|20992866|P3|NOT COMPLETED|Follow-up||88
8517048|NCT00405756|20992867|P2|NOT COMPLETED|Follow-up||90
8517049|NCT00405756|20992868|P1|NOT COMPLETED|Follow-up||75
8517050|NCT00405756|20992866|P3|COMPLETED|Follow-up||0
8517051|NCT00405756|20992867|P2|COMPLETED|Follow-up||0
8517052|NCT00405756|20992868|P1|COMPLETED|Follow-up||0
8517053|NCT00405756|20992866|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
8517054|NCT00405756|20992867|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
8517055|NCT00405756|20992868|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
8517056|NCT00405756|20992866|P3|NOT COMPLETED|Open-label Extension||72
8517057|NCT00405756|20992867|P2|NOT COMPLETED|Open-label Extension||47
8517058|NCT00405756|20992868|P1|NOT COMPLETED|Open-label Extension||19
8517059|NCT00405756|20992866|P3|COMPLETED|Open-label Extension||0
8517060|NCT00405756|20992867|P2|COMPLETED|Open-label Extension||0
8517061|NCT00405756|20992868|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
8517062|NCT00405756|20992866|P3|STARTED|Open-label Extension||72
8517063|NCT00405756|20992867|P2|STARTED|Open-label Extension||47
8517064|NCT00405756|20992868|P1|STARTED|Open-label Extension||19
8517065|NCT00405756|20992866|P3|NOT COMPLETED|Double-blind Treatment||154
8517066|NCT00405756|20992867|P2|NOT COMPLETED|Double-blind Treatment||153
8517067|NCT00405756|20992868|P1|NOT COMPLETED|Double-blind Treatment||152
8517068|NCT00405756|20992866|P3|COMPLETED|Double-blind Treatment||0
8517069|NCT00405756|20992867|P2|COMPLETED|Double-blind Treatment||0
8517070|NCT00405756|20992868|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
8517071|NCT00405756|20992866|P3|Safety Population|Double-blind Treatment||153
8517072|NCT00405756|20992867|P2|Safety Population|Double-blind Treatment||152
8517073|NCT00405756|20992868|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
8517074|NCT00405756|20992866|P3|STARTED|Double-blind Treatment||154
8517075|NCT00405756|20992867|P2|STARTED|Double-blind Treatment||153
8517076|NCT00405756|20992868|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
8517077|NCT00405704|20992958|P2|NOT COMPLETED|Overall Study||46
8517078|NCT00405704|20992959|P1|NOT COMPLETED|Overall Study||41
8517079|NCT00405704|20992958|P2|COMPLETED|Overall Study||259
8517080|NCT00405704|20992959|P1|COMPLETED|Overall Study||261
8517081|NCT00405704|20992958|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
8517082|NCT00405704|20992959|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
8517083|NCT00405704|20992958|P2|Recurrent UTI With E. Coli|Overall Study||57
8517084|NCT00405704|20992959|P1|Recurrent UTI With E. Coli|Overall Study||30
8517085|NCT00405704|20992958|P2|Outcome Stool Assessed|Overall Study||210
8517086|NCT00405704|20992959|P1|Outcome Stool Assessed|Overall Study||203
8517087|NCT00405704|20992958|P2|Completed Assessments for New Scarring|Overall Study||227
8517088|NCT00405704|20992959|P1|Completed Assessments for New Scarring|Overall Study||220
8517089|NCT00405704|20992958|P2|Completed Outcome Renal Scan|Overall Study||235
8517090|NCT00405704|20992959|P1|Completed Outcome Renal Scan|Overall Study||227
8517091|NCT00405704|20992958|P2|STARTED|Overall Study||305
8517092|NCT00405704|20992959|P1|STARTED|Overall Study||302
8517093|NCT00405652|20992979|P1|NOT COMPLETED|Overall Study||4
8517094|NCT00405652|20992979|P1|COMPLETED|Overall Study||30
8517095|NCT00405652|20992979|P1|STARTED|Overall Study||34
8517096|NCT00405639|20992986|P2|NOT COMPLETED|Overall Study||0
8517097|NCT00405639|20992987|P1|NOT COMPLETED|Overall Study||3
8517098|NCT00405639|20992986|P2|COMPLETED|Overall Study||12
8517099|NCT00405639|20992987|P1|COMPLETED|Overall Study||22
8517100|NCT00405639|20992986|P2|STARTED|Overall Study||12
8517101|NCT00405639|20992987|P1|STARTED|Overall Study||25
8517102|NCT00405587|20993003|P4|NOT COMPLETED|Overall Study||20
8517103|NCT00405587|20993004|P3|NOT COMPLETED|Overall Study||22
8517104|NCT00405587|20993005|P2|NOT COMPLETED|Overall Study||28
8517105|NCT00405587|20993006|P1|NOT COMPLETED|Overall Study||26
8517106|NCT00405587|20993003|P4|COMPLETED|Overall Study||1
8517107|NCT00405587|20993004|P3|COMPLETED|Overall Study||10
8517108|NCT00405587|20993005|P2|COMPLETED|Overall Study||2
8517109|NCT00405587|20993006|P1|COMPLETED|Overall Study||0
8517110|NCT00405587|20993003|P4|STARTED|Overall Study||21
8517111|NCT00405587|20993004|P3|STARTED|Overall Study||32
8517112|NCT00405587|20993005|P2|STARTED|Overall Study||30
8517113|NCT00405587|20993006|P1|STARTED|Overall Study||26
8517114|NCT00405548|20993124|P2|NOT COMPLETED|Overall Study||1
8517115|NCT00405548|20993125|P1|NOT COMPLETED|Overall Study||4
8517116|NCT00405548|20993124|P2|COMPLETED|Overall Study||12
8517117|NCT00405548|20993125|P1|COMPLETED|Overall Study||24
8517118|NCT00405548|20993124|P2|STARTED|Overall Study||13
8517119|NCT00405548|20993125|P1|STARTED|Overall Study||28
8517120|NCT00405522|20993139|P2|NOT COMPLETED|Overall Study||0
8517121|NCT00405522|20993140|P1|NOT COMPLETED|Overall Study||0
8517122|NCT00405522|20993139|P2|COMPLETED|Overall Study||17
8517123|NCT00405522|20993140|P1|COMPLETED|Overall Study||17
8517124|NCT00405522|20993139|P2|STARTED|Overall Study||17
8517125|NCT00405522|20993140|P1|STARTED|Overall Study||17
8517126|NCT00405509|20993152|P2|NOT COMPLETED|Overall Study||0
8517127|NCT00405509|20993153|P1|NOT COMPLETED|Overall Study||0
8517128|NCT00405509|20993152|P2|COMPLETED|Overall Study||22
8517129|NCT00405509|20993153|P1|COMPLETED|Overall Study||11
8517130|NCT00405509|20993152|P2|STARTED|Overall Study||22
8517131|NCT00405509|20993153|P1|STARTED|Overall Study||11
8517132|NCT00405392|20993169|P2|NOT COMPLETED|Overall Study||27
8517133|NCT00405392|20993170|P1|NOT COMPLETED|Overall Study||30
8517134|NCT00405392|20993169|P2|COMPLETED|Overall Study||155
8517135|NCT00405392|20993170|P1|COMPLETED|Overall Study||153
8517136|NCT00405392|20993169|P2|STARTED|Overall Study||182
8517137|NCT00405392|20993170|P1|STARTED|Overall Study||183
8517138|NCT00405353|20993180|P1|NOT COMPLETED|Overall Study||0
8517139|NCT00405353|20993180|P1|COMPLETED|Overall Study||10
8517140|NCT00405353|20993180|P1|STARTED|Overall Study||10
8517141|NCT00405288|20993186|P2|NOT COMPLETED|Overall Study||0
8517142|NCT00405288|20993187|P1|NOT COMPLETED|Overall Study||0
8517143|NCT00405288|20993186|P2|COMPLETED|Overall Study||204
8517144|NCT00405288|20993187|P1|COMPLETED|Overall Study||204
8517145|NCT00405288|20993186|P2|STARTED|Overall Study||204
8517146|NCT00405288|20993187|P1|STARTED|Overall Study||204
8517147|NCT00405275|20993217|P2|NOT COMPLETED|Overall Study||19
8517148|NCT00405275|20993218|P1|NOT COMPLETED|Overall Study||23
8517149|NCT00405275|20993217|P2|COMPLETED|Overall Study||156
8517150|NCT00405275|20993218|P1|COMPLETED|Overall Study||155
8517151|NCT00405275|20993217|P2|24 Week (Switch)|Overall Study||44
8517152|NCT00405275|20993218|P1|24 Week (Switch)|Overall Study||44
8517153|NCT00405275|20993217|P2|24 Week (no Switch)|Overall Study||121
8517154|NCT00405275|20993218|P1|24 Week (no Switch)|Overall Study||119
8517155|NCT00405275|20993217|P2|24 Weeks (Total)|Overall Study||165
8517156|NCT00405275|20993218|P1|24 Weeks (Total)|Overall Study||163
8517157|NCT00405275|20993217|P2|STARTED|Overall Study||175
8517158|NCT00405275|20993218|P1|STARTED|Overall Study||178
8517159|NCT00405067|20993227|P3|NOT COMPLETED|Overall Study||5
8517160|NCT00405067|20993228|P2|NOT COMPLETED|Overall Study||9
8517161|NCT00405067|20993229|P1|NOT COMPLETED|Overall Study||4
8517162|NCT00405067|20993227|P3|COMPLETED|Overall Study||24
8517163|NCT00405067|20993228|P2|COMPLETED|Overall Study||19
8517164|NCT00405067|20993229|P1|COMPLETED|Overall Study||24
8517165|NCT00405067|20993227|P3|STARTED|Overall Study||29
8517166|NCT00405067|20993228|P2|STARTED|Overall Study||28
8517167|NCT00405067|20993229|P1|STARTED|Overall Study||28
8517168|NCT00404924|20993266|P2|NOT COMPLETED|Overall Study||306
8517169|NCT00404924|20993267|P1|NOT COMPLETED|Overall Study||603
8517170|NCT00404924|20993266|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
8517171|NCT00404924|20993267|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
8517172|NCT00404924|20993266|P2|STARTED|Overall Study|randomised patients|307
8517173|NCT00404924|20993267|P1|STARTED|Overall Study|randomised patients|617
8517174|NCT00404820|20993285|P2|NOT COMPLETED|Overall Study||24
8517175|NCT00404820|20993286|P1|NOT COMPLETED|Overall Study||19
8517176|NCT00404820|20993285|P2|COMPLETED|Overall Study||172
8517177|NCT00404820|20993286|P1|COMPLETED|Overall Study||389
8517178|NCT00404820|20993285|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
8517179|NCT00404820|20993286|P1|Started Treatment|Overall Study||408
8517180|NCT00404820|20993285|P2|STARTED|Overall Study||196
8517181|NCT00404820|20993286|P1|STARTED|Overall Study||408
8517182|NCT00404768|20993308|P4|NOT COMPLETED|Part C||14
8517183|NCT00404768|20993309|P3|NOT COMPLETED|Part C||8
8517184|NCT00404768|20993310|P2|NOT COMPLETED|Part C||0
8517185|NCT00404768|20993311|P1|NOT COMPLETED|Part C||0
8517186|NCT00404768|20993308|P4|COMPLETED|Part C||20
8517187|NCT00404768|20993309|P3|COMPLETED|Part C||22
8517188|NCT00404768|20993310|P2|COMPLETED|Part C||0
8517189|NCT00404768|20993311|P1|COMPLETED|Part C||0
8517190|NCT00404768|20993308|P4|STARTED|Part C||34
8517191|NCT00404768|20993309|P3|STARTED|Part C||30
8517192|NCT00404768|20993310|P2|STARTED|Part C||0
8517193|NCT00404768|20993311|P1|STARTED|Part C||0
8517194|NCT00404768|20993308|P4|NOT COMPLETED|Part A and B||0
8517195|NCT00404768|20993309|P3|NOT COMPLETED|Part A and B||0
8517196|NCT00404768|20993310|P2|NOT COMPLETED|Part A and B||1
8517197|NCT00404768|20993311|P1|NOT COMPLETED|Part A and B||1
8517198|NCT00404768|20993308|P4|COMPLETED|Part A and B||0
8517199|NCT00404768|20993309|P3|COMPLETED|Part A and B||0
8517200|NCT00404768|20993310|P2|COMPLETED|Part A and B||8
8517201|NCT00404768|20993311|P1|COMPLETED|Part A and B||19
8517202|NCT00404768|20993308|P4|STARTED|Part A and B||0
8517203|NCT00404768|20993309|P3|STARTED|Part A and B||0
8517204|NCT00404768|20993310|P2|STARTED|Part A and B||9
8517205|NCT00404768|20993311|P1|STARTED|Part A and B||20
8517206|NCT00404755|20993372|P1|NOT COMPLETED|Phase III (Imipramine)||0
8517207|NCT00404755|20993372|P1|COMPLETED|Phase III (Imipramine)||3
8517208|NCT00404755|20993372|P1|STARTED|Phase III (Imipramine)||3
8517209|NCT00404755|20993372|P1|NOT COMPLETED|Phase II (Escitalopram)||2
8517210|NCT00404755|20993372|P1|COMPLETED|Phase II (Escitalopram)||9
8517211|NCT00404755|20993372|P1|STARTED|Phase II (Escitalopram)||11
8517212|NCT00404755|20993372|P1|NOT COMPLETED|Phase I (Bupropion)||4
8517213|NCT00404755|20993372|P1|COMPLETED|Phase I (Bupropion)||13
8517214|NCT00404755|20993372|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
8517215|NCT00404651|20993387|P4|NOT COMPLETED|Overall Study||21
8517216|NCT00404651|20993388|P3|NOT COMPLETED|Overall Study||45
8517217|NCT00404651|20993389|P2|NOT COMPLETED|Overall Study||28
8517218|NCT00404651|20993390|P1|NOT COMPLETED|Overall Study||39
8517219|NCT00404651|20993387|P4|COMPLETED|Overall Study||146
8517220|NCT00404651|20993388|P3|COMPLETED|Overall Study||294
8517221|NCT00404651|20993389|P2|COMPLETED|Overall Study||315
8517222|NCT00404651|20993390|P1|COMPLETED|Overall Study||301
8517223|NCT00404651|20993387|P4|STARTED|Overall Study||167
8517224|NCT00404651|20993388|P3|STARTED|Overall Study||339
8517225|NCT00404651|20993389|P2|STARTED|Overall Study||343
8517226|NCT00404651|20993390|P1|STARTED|Overall Study||340
8517227|NCT00404547|20993418|P2|NOT COMPLETED|Overall Study||25
8517228|NCT00404547|20993419|P1|NOT COMPLETED|Overall Study||90
8517229|NCT00404547|20993418|P2|COMPLETED|Overall Study||334
8517230|NCT00404547|20993419|P1|COMPLETED|Overall Study||672
8517231|NCT00404547|20993418|P2|STARTED|Overall Study||359
8517232|NCT00404547|20993419|P1|STARTED|Overall Study||762
8517233|NCT00404495|20993429|P2|NOT COMPLETED|Overall Study||11
8517234|NCT00404495|20993430|P1|NOT COMPLETED|Overall Study||44
8517235|NCT00404495|20993429|P2|COMPLETED|Overall Study||6
8517236|NCT00404495|20993430|P1|COMPLETED|Overall Study||22
8517237|NCT00404495|20993429|P2|STARTED|Overall Study||17
8517238|NCT00404495|20993430|P1|STARTED|Overall Study||66
8517239|NCT00404352|20993449|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
8517240|NCT00404352|20993450|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
8517241|NCT00404352|20993451|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
8517242|NCT00404352|20993452|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517243|NCT00404352|20993453|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517244|NCT00404352|20993454|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517245|NCT00404352|20993455|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517246|NCT00404352|20993456|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517247|NCT00404352|20993457|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517248|NCT00404352|20993449|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
8517249|NCT00404352|20993450|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
8517250|NCT00404352|20993451|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
8517251|NCT00404352|20993452|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
8517252|NCT00404352|20993453|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
8517253|NCT00404352|20993454|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
8517254|NCT00404352|20993455|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
8517255|NCT00404352|20993456|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
8517256|NCT00404352|20993457|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
8517257|NCT00404352|20993449|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
8517258|NCT00404352|20993450|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
8517259|NCT00404352|20993451|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
8517260|NCT00404352|20993452|P6|STARTED|Open Label Extension (up to 36 Months)||0
8517261|NCT00404352|20993453|P5|STARTED|Open Label Extension (up to 36 Months)||0
8517262|NCT00404352|20993454|P4|STARTED|Open Label Extension (up to 36 Months)||0
8517263|NCT00404352|20993455|P3|STARTED|Open Label Extension (up to 36 Months)||0
8517264|NCT00404352|20993456|P2|STARTED|Open Label Extension (up to 36 Months)||0
8517265|NCT00404352|20993457|P1|STARTED|Open Label Extension (up to 36 Months)||0
8517266|NCT00404352|20993449|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
8517267|NCT00404352|20993450|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
8517268|NCT00404352|20993451|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
8517269|NCT00404352|20993452|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
8517270|NCT00404352|20993453|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
8517271|NCT00404352|20993454|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
8517272|NCT00404352|20993455|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
8517273|NCT00404352|20993456|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
8517274|NCT00404352|20993457|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
8517275|NCT00404352|20993449|P9|COMPLETED|Open Label (up to 24 Month)||0
8517276|NCT00404352|20993450|P8|COMPLETED|Open Label (up to 24 Month)||0
8517277|NCT00404352|20993451|P7|COMPLETED|Open Label (up to 24 Month)||0
8517278|NCT00404352|20993452|P6|COMPLETED|Open Label (up to 24 Month)||52
8517279|NCT00404352|20993453|P5|COMPLETED|Open Label (up to 24 Month)||28
8517280|NCT00404352|20993454|P4|COMPLETED|Open Label (up to 24 Month)||28
8517281|NCT00404352|20993455|P3|COMPLETED|Open Label (up to 24 Month)||0
8517282|NCT00404352|20993456|P2|COMPLETED|Open Label (up to 24 Month)||0
8517283|NCT00404352|20993457|P1|COMPLETED|Open Label (up to 24 Month)||0
8517284|NCT00404352|20993449|P9|STARTED|Open Label (up to 24 Month)||0
8517285|NCT00404352|20993450|P8|STARTED|Open Label (up to 24 Month)||0
8517286|NCT00404352|20993451|P7|STARTED|Open Label (up to 24 Month)||0
8517287|NCT00404352|20993452|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
8517288|NCT00404352|20993453|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
8517289|NCT00404352|20993454|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
8517290|NCT00404352|20993455|P3|STARTED|Open Label (up to 24 Month)||0
8517291|NCT00404352|20993456|P2|STARTED|Open Label (up to 24 Month)||0
8517292|NCT00404352|20993457|P1|STARTED|Open Label (up to 24 Month)||0
8517293|NCT00404352|20993449|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517294|NCT00404352|20993450|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517295|NCT00404352|20993451|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517296|NCT00404352|20993452|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517297|NCT00404352|20993453|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517298|NCT00404352|20993454|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517299|NCT00404352|20993455|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
8517300|NCT00404352|20993456|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
8517301|NCT00404352|20993457|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
8517302|NCT00404352|20993449|P9|COMPLETED|Double Blind (up to 24 Month)||0
8517303|NCT00404352|20993450|P8|COMPLETED|Double Blind (up to 24 Month)||0
8517304|NCT00404352|20993451|P7|COMPLETED|Double Blind (up to 24 Month)||0
8517305|NCT00404352|20993452|P6|COMPLETED|Double Blind (up to 24 Month)||0
8517306|NCT00404352|20993453|P5|COMPLETED|Double Blind (up to 24 Month)||0
8517307|NCT00404352|20993454|P4|COMPLETED|Double Blind (up to 24 Month)||0
8517308|NCT00404352|20993455|P3|COMPLETED|Double Blind (up to 24 Month)||92
8517309|NCT00404352|20993456|P2|COMPLETED|Double Blind (up to 24 Month)||128
8517310|NCT00404352|20993457|P1|COMPLETED|Double Blind (up to 24 Month)||119
8517311|NCT00404352|20993449|P9|Treated|Double Blind (up to 24 Month)||0
8517312|NCT00404352|20993450|P8|Treated|Double Blind (up to 24 Month)||0
8517313|NCT00404352|20993451|P7|Treated|Double Blind (up to 24 Month)||0
8517314|NCT00404352|20993452|P6|Treated|Double Blind (up to 24 Month)||0
8517315|NCT00404352|20993453|P5|Treated|Double Blind (up to 24 Month)||0
8517316|NCT00404352|20993454|P4|Treated|Double Blind (up to 24 Month)||0
8517317|NCT00404352|20993455|P3|Treated|Double Blind (up to 24 Month)||171
8517318|NCT00404352|20993456|P2|Treated|Double Blind (up to 24 Month)||173
8517319|NCT00404352|20993457|P1|Treated|Double Blind (up to 24 Month)||171
8517320|NCT00404352|20993449|P9|STARTED|Double Blind (up to 24 Month)||0
8517321|NCT00404352|20993450|P8|STARTED|Double Blind (up to 24 Month)||0
8517322|NCT00404352|20993451|P7|STARTED|Double Blind (up to 24 Month)||0
8517323|NCT00404352|20993452|P6|STARTED|Double Blind (up to 24 Month)||0
8517324|NCT00404352|20993453|P5|STARTED|Double Blind (up to 24 Month)||0
8517325|NCT00404352|20993454|P4|STARTED|Double Blind (up to 24 Month)||0
8517326|NCT00404352|20993455|P3|STARTED|Double Blind (up to 24 Month)||171
8517327|NCT00404352|20993456|P2|STARTED|Double Blind (up to 24 Month)||175
8517328|NCT00404352|20993457|P1|STARTED|Double Blind (up to 24 Month)||171
8517329|NCT00404248|20993492|P9|NOT COMPLETED|Overall Study||0
8517330|NCT00404248|20993493|P8|NOT COMPLETED|Overall Study||0
8517331|NCT00404248|20993494|P7|NOT COMPLETED|Overall Study||0
8517332|NCT00404248|20993495|P6|NOT COMPLETED|Overall Study||0
8517333|NCT00404248|20993496|P5|NOT COMPLETED|Overall Study||0
8517334|NCT00404248|20993497|P4|NOT COMPLETED|Overall Study||0
8517335|NCT00404248|20993498|P3|NOT COMPLETED|Overall Study||0
8517336|NCT00404248|20993499|P2|NOT COMPLETED|Overall Study||1
8517337|NCT00404248|20993500|P1|NOT COMPLETED|Overall Study||0
8517338|NCT00404248|20993492|P9|COMPLETED|Overall Study||3
8517339|NCT00404248|20993493|P8|COMPLETED|Overall Study||6
8517340|NCT00404248|20993494|P7|COMPLETED|Overall Study||6
8517341|NCT00404248|20993495|P6|COMPLETED|Overall Study||3
8517342|NCT00404248|20993496|P5|COMPLETED|Overall Study||3
8517343|NCT00404248|20993497|P4|COMPLETED|Overall Study||2
8517344|NCT00404248|20993498|P3|COMPLETED|Overall Study||5
8517345|NCT00404248|20993499|P2|COMPLETED|Overall Study||3
8517346|NCT00404248|20993500|P1|COMPLETED|Overall Study||3
8517347|NCT00404248|20993492|P9|STARTED|Overall Study||3
8517348|NCT00404248|20993493|P8|STARTED|Overall Study||6
8517349|NCT00404248|20993494|P7|STARTED|Overall Study||6
8517350|NCT00404248|20993495|P6|STARTED|Overall Study||3
8517351|NCT00404248|20993496|P5|STARTED|Overall Study||3
8517352|NCT00404248|20993497|P4|STARTED|Overall Study||2
8517353|NCT00404248|20993498|P3|STARTED|Overall Study||5
8517354|NCT00404248|20993499|P2|STARTED|Overall Study||4
8517355|NCT00404248|20993500|P1|STARTED|Overall Study||3
8517356|NCT00404235|20993533|P2|NOT COMPLETED|Overall Study||2
8517357|NCT00404235|20993534|P1|NOT COMPLETED|Overall Study||1
8517358|NCT00404235|20993533|P2|COMPLETED|Overall Study||39
8517359|NCT00404235|20993534|P1|COMPLETED|Overall Study||34
8517360|NCT00404235|20993533|P2|STARTED|Overall Study||41
8517361|NCT00404235|20993534|P1|STARTED|Overall Study||35
8517362|NCT00404092|20993552|P4|NOT COMPLETED|Overall Study||0
8517363|NCT00404092|20993553|P3|NOT COMPLETED|Overall Study||1
8517364|NCT00404092|20993554|P2|NOT COMPLETED|Overall Study||0
8517365|NCT00404092|20993555|P1|NOT COMPLETED|Overall Study||1
8517366|NCT00404092|20993552|P4|COMPLETED|Overall Study||20
8517367|NCT00404092|20993553|P3|COMPLETED|Overall Study||8
8517368|NCT00404092|20993554|P2|COMPLETED|Overall Study||8
8517369|NCT00404092|20993555|P1|COMPLETED|Overall Study||8
8517370|NCT00404092|20993552|P4|STARTED|Overall Study||20
8517371|NCT00404092|20993553|P3|STARTED|Overall Study||9
8517372|NCT00404092|20993554|P2|STARTED|Overall Study||8
8517373|NCT00404092|20993555|P1|STARTED|Overall Study||9
8517374|NCT00404079|20993571|P2|NOT COMPLETED|Overall Study||20
8517375|NCT00404079|20993572|P1|NOT COMPLETED|Overall Study||22
8517376|NCT00404079|20993571|P2|COMPLETED|Overall Study||105
8517377|NCT00404079|20993572|P1|COMPLETED|Overall Study||103
8517378|NCT00404079|20993571|P2|STARTED|Overall Study||125
8517379|NCT00404079|20993572|P1|STARTED|Overall Study||125
8517380|NCT00404066|20993578|P1|NOT COMPLETED|Overall Study||3
8517381|NCT00404066|20993578|P1|COMPLETED|Overall Study||18
8517382|NCT00404066|20993578|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
8517383|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 4||0
8517384|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 4||0
8517385|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 4||0
8517386|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 4||0
8517387|NCT00403845|20993583|P4|COMPLETED|Treatment Period 4||11
8517388|NCT00403845|20993584|P3|COMPLETED|Treatment Period 4||11
8517389|NCT00403845|20993585|P2|COMPLETED|Treatment Period 4||13
8517390|NCT00403845|20993586|P1|COMPLETED|Treatment Period 4||10
8517391|NCT00403845|20993583|P4|STARTED|Treatment Period 4||11
8517392|NCT00403845|20993584|P3|STARTED|Treatment Period 4||11
8517393|NCT00403845|20993585|P2|STARTED|Treatment Period 4||13
8517394|NCT00403845|20993586|P1|STARTED|Treatment Period 4||10
8517395|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 3||2
8517396|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 3||0
8517397|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 3||0
8517398|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 3||0
8517399|NCT00403845|20993583|P4|COMPLETED|Treatment Period 3||11
8517400|NCT00403845|20993584|P3|COMPLETED|Treatment Period 3||11
8517401|NCT00403845|20993585|P2|COMPLETED|Treatment Period 3||13
8517402|NCT00403845|20993586|P1|COMPLETED|Treatment Period 3||10
8517403|NCT00403845|20993583|P4|STARTED|Treatment Period 3||13
8517404|NCT00403845|20993584|P3|STARTED|Treatment Period 3||11
8517405|NCT00403845|20993585|P2|STARTED|Treatment Period 3||13
8517406|NCT00403845|20993586|P1|STARTED|Treatment Period 3||10
8517407|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 2||0
8517408|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 2||0
8517409|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 2||0
8517410|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 2||1
8517411|NCT00403845|20993583|P4|COMPLETED|Treatment Period 2||13
8517412|NCT00403845|20993584|P3|COMPLETED|Treatment Period 2||11
8517413|NCT00403845|20993585|P2|COMPLETED|Treatment Period 2||13
8517414|NCT00403845|20993586|P1|COMPLETED|Treatment Period 2||10
8517415|NCT00403845|20993583|P4|STARTED|Treatment Period 2||13
8517416|NCT00403845|20993584|P3|STARTED|Treatment Period 2||11
8517417|NCT00403845|20993585|P2|STARTED|Treatment Period 2||13
8517418|NCT00403845|20993586|P1|STARTED|Treatment Period 2||11
8517419|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 1||1
8517420|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 1||0
8517421|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 1||0
8517422|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 1||1
8517423|NCT00403845|20993583|P4|COMPLETED|Treatment Period 1||13
8517424|NCT00403845|20993584|P3|COMPLETED|Treatment Period 1||11
8517425|NCT00403845|20993585|P2|COMPLETED|Treatment Period 1||13
8517426|NCT00403845|20993586|P1|COMPLETED|Treatment Period 1||11
8517427|NCT00403845|20993583|P4|STARTED|Treatment Period 1||14
8517428|NCT00403845|20993584|P3|STARTED|Treatment Period 1||11
8517429|NCT00403845|20993585|P2|STARTED|Treatment Period 1||13
8517430|NCT00403845|20993586|P1|STARTED|Treatment Period 1||12
8517431|NCT00403767|20993610|P2|NOT COMPLETED|Overall Study||2468
8517432|NCT00403767|20993611|P1|NOT COMPLETED|Overall Study||2520
8517433|NCT00403767|20993610|P2|COMPLETED|Overall Study||4657
8517434|NCT00403767|20993611|P1|COMPLETED|Overall Study||4591
8517435|NCT00403767|20993610|P2|STARTED|Overall Study||7125
8517436|NCT00403767|20993611|P1|STARTED|Overall Study||7111
8517437|NCT00403754|20993635|P4|NOT COMPLETED|Open Label: Salmeterol||0
8517438|NCT00403754|20993636|P3|NOT COMPLETED|Open Label: Salmeterol||0
8517439|NCT00403754|20993637|P2|NOT COMPLETED|Open Label: Salmeterol||0
8517440|NCT00403754|20993638|P1|NOT COMPLETED|Open Label: Salmeterol||0
8517441|NCT00403754|20993635|P4|COMPLETED|Open Label: Salmeterol||11
8517442|NCT00403754|20993636|P3|COMPLETED|Open Label: Salmeterol||8
8517443|NCT00403754|20993637|P2|COMPLETED|Open Label: Salmeterol||9
8517444|NCT00403754|20993638|P1|COMPLETED|Open Label: Salmeterol||11
8517445|NCT00403754|20993635|P4|STARTED|Open Label: Salmeterol||11
8517446|NCT00403754|20993636|P3|STARTED|Open Label: Salmeterol||8
8517447|NCT00403754|20993637|P2|STARTED|Open Label: Salmeterol||9
8517448|NCT00403754|20993638|P1|STARTED|Open Label: Salmeterol||11
8517449|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 4||0
8517450|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 4||0
8517451|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 4||0
8517452|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 4||0
8517453|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 4||11
8517454|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 4||8
8517455|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 4||9
8517456|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 4||11
8517457|NCT00403754|20993635|P4|STARTED|Core Treatment Period 4||11
8517458|NCT00403754|20993636|P3|STARTED|Core Treatment Period 4||8
8517459|NCT00403754|20993637|P2|STARTED|Core Treatment Period 4||9
8517460|NCT00403754|20993638|P1|STARTED|Core Treatment Period 4||11
8517461|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 3||0
8517462|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 3||0
8517463|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 3||0
8517464|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 3||0
8517465|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 3||11
8517466|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 3||8
8517467|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 3||9
8517468|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 3||11
8517469|NCT00403754|20993635|P4|STARTED|Core Treatment Period 3||11
8517470|NCT00403754|20993636|P3|STARTED|Core Treatment Period 3||8
8517471|NCT00403754|20993637|P2|STARTED|Core Treatment Period 3||9
8517472|NCT00403754|20993638|P1|STARTED|Core Treatment Period 3||11
8517473|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 2||0
8517474|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 2||1
8517475|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 2||0
8517476|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 2||0
8517477|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 2||11
8517478|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 2||8
8517479|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 2||9
8517480|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 2||11
8517481|NCT00403754|20993635|P4|STARTED|Core Treatment Period 2||11
8517482|NCT00403754|20993636|P3|STARTED|Core Treatment Period 2||9
8517483|NCT00403754|20993637|P2|STARTED|Core Treatment Period 2||9
8517484|NCT00403754|20993638|P1|STARTED|Core Treatment Period 2||11
8517485|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 1||0
8517486|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 1||0
8517487|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 1||1
8517488|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 1||0
8517489|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 1||11
8517490|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 1||9
8517491|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 1||9
8517492|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 1||11
8517493|NCT00403754|20993635|P4|STARTED|Core Treatment Period 1||11
8517494|NCT00403754|20993636|P3|STARTED|Core Treatment Period 1||9
8517495|NCT00403754|20993637|P2|STARTED|Core Treatment Period 1||10
8517496|NCT00403754|20993638|P1|STARTED|Core Treatment Period 1||11
8517497|NCT00403585|20993665|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
8517498|NCT00403585|20993665|P1|COMPLETED|Open-Label Phase; Extension Study||74
8517499|NCT00403585|20993665|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
8517500|NCT00403585|20993665|P1|NOT COMPLETED|Initial Treatment Phase||2
8517501|NCT00403585|20993665|P1|COMPLETED|Initial Treatment Phase||102
8517502|NCT00403585|20993665|P1|STARTED|Initial Treatment Phase||104
8517503|NCT00403546|20993676|P3|NOT COMPLETED|Randomized Trial||16
8517504|NCT00403546|20993677|P2|NOT COMPLETED|Randomized Trial||17
8517505|NCT00403546|20993678|P1|NOT COMPLETED|Randomized Trial||0
8517506|NCT00403546|20993676|P3|COMPLETED|Randomized Trial||21
8517507|NCT00403546|20993677|P2|COMPLETED|Randomized Trial||21
8517508|NCT00403546|20993678|P1|COMPLETED|Randomized Trial||0
8517509|NCT00403546|20993676|P3|STARTED|Randomized Trial||37
8517510|NCT00403546|20993677|P2|STARTED|Randomized Trial||38
8517511|NCT00403546|20993678|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
8517512|NCT00403546|20993676|P3|NOT COMPLETED|Screening Phase||0
8517513|NCT00403546|20993677|P2|NOT COMPLETED|Screening Phase||0
8517514|NCT00403546|20993678|P1|NOT COMPLETED|Screening Phase||28
8517515|NCT00403546|20993676|P3|COMPLETED|Screening Phase||0
8517516|NCT00403546|20993677|P2|COMPLETED|Screening Phase||0
8517517|NCT00403546|20993678|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
8517518|NCT00403546|20993676|P3|STARTED|Screening Phase||0
8517519|NCT00403546|20993677|P2|STARTED|Screening Phase||0
8517520|NCT00403546|20993678|P1|STARTED|Screening Phase||103
8517521|NCT00403546|20993676|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
8517522|NCT00403546|20993677|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
8517523|NCT00403546|20993678|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
8517524|NCT00403546|20993676|P3|COMPLETED|Signed Informed Consent/Open-Label||0
8517525|NCT00403546|20993677|P2|COMPLETED|Signed Informed Consent/Open-Label||0
8517526|NCT00403546|20993678|P1|COMPLETED|Signed Informed Consent/Open-Label||103
8517527|NCT00403546|20993676|P3|STARTED|Signed Informed Consent/Open-Label||0
8517528|NCT00403546|20993677|P2|STARTED|Signed Informed Consent/Open-Label||0
8517529|NCT00403546|20993678|P1|STARTED|Signed Informed Consent/Open-Label||131
8517530|NCT00403494|20993720|P2|NOT COMPLETED|Overall Study||14
8517531|NCT00403494|20993721|P1|NOT COMPLETED|Overall Study||15
8517532|NCT00403494|20993720|P2|COMPLETED|Overall Study||80
8517533|NCT00403494|20993721|P1|COMPLETED|Overall Study||81
8517534|NCT00403494|20993720|P2|Safety Population|Overall Study||91
8517535|NCT00403494|20993721|P1|Safety Population|Overall Study||97
8517536|NCT00403494|20993720|P2|Per-protocol|Overall Study||69
8517537|NCT00403494|20993721|P1|Per-protocol|Overall Study||69
8517538|NCT00403494|20993720|P2|Intent to Treat|Overall Study||83
8517539|NCT00403494|20993721|P1|Intent to Treat|Overall Study||87
8517540|NCT00403494|20993720|P2|STARTED|Overall Study||94
8517541|NCT00403494|20993721|P1|STARTED|Overall Study||96
8517542|NCT00403481|20993733|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
8517543|NCT00403481|20993733|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
8517544|NCT00403481|20993733|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
8517545|NCT00403481|20993733|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
8517546|NCT00403481|20993733|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
8517547|NCT00403481|20993733|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
8517548|NCT00403481|20993733|P1|NOT COMPLETED|Olm 40 mg||5
8517549|NCT00403481|20993733|P1|COMPLETED|Olm 40 mg||177
8517550|NCT00403481|20993733|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
8517551|NCT00403481|20993733|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
8517552|NCT00403481|20993733|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
8517553|NCT00403481|20993733|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
8517554|NCT00403455|20993748|P1|NOT COMPLETED|Overall Study||1
8517555|NCT00403455|20993748|P1|COMPLETED|Overall Study||37
8517556|NCT00403455|20993748|P1|STARTED|Overall Study||38
8517557|NCT00403403|20993754|P2|NOT COMPLETED|Overall Study||0
8517558|NCT00403403|20993755|P1|NOT COMPLETED|Overall Study||0
8517559|NCT00403403|20993754|P2|COMPLETED|Overall Study||52
8517560|NCT00403403|20993755|P1|COMPLETED|Overall Study||50
8517561|NCT00403403|20993754|P2|Safety-Evaluable Patients|Overall Study||51
8517562|NCT00403403|20993755|P1|Safety-Evaluable Patients|Overall Study||47
8517563|NCT00403403|20993754|P2|STARTED|Overall Study||52
8517564|NCT00403403|20993755|P1|STARTED|Overall Study||50
8517565|NCT00403390|20993771|P2|NOT COMPLETED|Overall Study||0
8517566|NCT00403390|20993772|P1|NOT COMPLETED|Overall Study||3
8517567|NCT00403390|20993771|P2|COMPLETED|Overall Study||18
8517568|NCT00403390|20993772|P1|COMPLETED|Overall Study||13
8517569|NCT00403390|20993771|P2|STARTED|Overall Study||18
8517570|NCT00403390|20993772|P1|STARTED|Overall Study||16
8517571|NCT00403273|20993780|P2|NOT COMPLETED|Overall Study||4
8517572|NCT00403273|20993781|P1|NOT COMPLETED|Overall Study||3
8517573|NCT00403273|20993780|P2|COMPLETED|Overall Study||25
8517574|NCT00403273|20993781|P1|COMPLETED|Overall Study||22
8517575|NCT00403273|20993780|P2|STARTED|Overall Study||29
8517576|NCT00403273|20993781|P1|STARTED|Overall Study||25
8517577|NCT00403234|20993823|P4|NOT COMPLETED|Overall Study||0
8517578|NCT00403234|20993824|P3|NOT COMPLETED|Overall Study||1
8517579|NCT00403234|20993825|P2|NOT COMPLETED|Overall Study||1
8517580|NCT00403234|20993826|P1|NOT COMPLETED|Overall Study||1
8517581|NCT00403234|20993823|P4|COMPLETED|Overall Study||2
8517582|NCT00403234|20993824|P3|COMPLETED|Overall Study||2
8517583|NCT00403234|20993825|P2|COMPLETED|Overall Study||2
8517584|NCT00403234|20993826|P1|COMPLETED|Overall Study||1
8517585|NCT00403234|20993823|P4|STARTED|Overall Study||2
8517586|NCT00403234|20993824|P3|STARTED|Overall Study||3
8517587|NCT00403234|20993825|P2|STARTED|Overall Study||3
8517588|NCT00403234|20993826|P1|STARTED|Overall Study||2
8517589|NCT00403130|20993836|P1|NOT COMPLETED|Survival Follow-up up to 6 Years||10
8517590|NCT00403130|20993836|P1|COMPLETED|Survival Follow-up up to 6 Years||16
8517591|NCT00403130|20993836|P1|STARTED|Survival Follow-up up to 6 Years||26
8517592|NCT00403130|20993836|P1|NOT COMPLETED|2 Years From Start of Treatment||5
8517593|NCT00403130|20993836|P1|COMPLETED|2 Years From Start of Treatment||26
8517594|NCT00403130|20993836|P1|STARTED|2 Years From Start of Treatment||31
8517595|NCT00403117|20993843|P1|NOT COMPLETED|Overall Study||20
8517596|NCT00403117|20993843|P1|COMPLETED|Overall Study||29
8517597|NCT00403117|20993843|P1|STARTED|Overall Study||49
8517598|NCT00402987|20993889|P4|NOT COMPLETED|Overall Study||0
8517599|NCT00402987|20993890|P3|NOT COMPLETED|Overall Study||1
8517600|NCT00402987|20993891|P2|NOT COMPLETED|Overall Study||0
8517601|NCT00402987|20993892|P1|NOT COMPLETED|Overall Study||0
8517602|NCT00402987|20993889|P4|COMPLETED|Overall Study||89
8517603|NCT00402987|20993890|P3|COMPLETED|Overall Study||44
8517604|NCT00402987|20993891|P2|COMPLETED|Overall Study||45
8517605|NCT00402987|20993892|P1|COMPLETED|Overall Study||90
8517606|NCT00402987|20993889|P4|STARTED|Overall Study||89
8517607|NCT00402987|20993890|P3|STARTED|Overall Study||45
8517608|NCT00402987|20993891|P2|STARTED|Overall Study||45
8517609|NCT00402987|20993892|P1|STARTED|Overall Study||90
8517610|NCT00402896|20994054|P1|NOT COMPLETED|Overall Study||0
8517611|NCT00402896|20994054|P1|COMPLETED|Overall Study||20
8517612|NCT00402896|20994054|P1|STARTED|Overall Study||20
8517613|NCT00402883|20994058|P1|NOT COMPLETED|Maintenance Therapy||0
8517614|NCT00402883|20994058|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
8517615|NCT00402883|20994058|P1|STARTED|Maintenance Therapy||5
8517616|NCT00402883|20994058|P1|NOT COMPLETED|Consolidation Therapy||0
8517617|NCT00402883|20994058|P1|COMPLETED|Consolidation Therapy||5
8517618|NCT00402883|20994058|P1|STARTED|Consolidation Therapy||5
8517619|NCT00402883|20994058|P1|NOT COMPLETED|Induction Therapy||0
8517620|NCT00402883|20994058|P1|COMPLETED|Induction Therapy||5
8517621|NCT00402883|20994058|P1|STARTED|Induction Therapy||5
8517622|NCT00402831|20994064|P2|NOT COMPLETED|Overall Study||3
8517623|NCT00402831|20994065|P1|NOT COMPLETED|Overall Study||1
8517624|NCT00402831|20994064|P2|COMPLETED|Overall Study||200
8517625|NCT00402831|20994065|P1|COMPLETED|Overall Study||201
8517626|NCT00402831|20994064|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
8517627|NCT00402831|20994065|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
8517628|NCT00402831|20994064|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
8517629|NCT00402831|20994065|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
8517630|NCT00402831|20994064|P2|STARTED|Overall Study||203
8517631|NCT00402831|20994065|P1|STARTED|Overall Study||202
8517632|NCT00402779|20994099|P2|NOT COMPLETED|Overall Study||76
8517633|NCT00402779|20994100|P1|NOT COMPLETED|Overall Study||77
8517634|NCT00402779|20994099|P2|COMPLETED|Overall Study||75
8517635|NCT00402779|20994100|P1|COMPLETED|Overall Study||75
8517636|NCT00402779|20994099|P2|STARTED|Overall Study||151
8517637|NCT00402779|20994100|P1|STARTED|Overall Study||152
8517638|NCT00402740|20994106|P1|NOT COMPLETED|Overall Study||80
8517639|NCT00402740|20994106|P1|COMPLETED|Overall Study||242
8517640|NCT00402740|20994106|P1|STARTED|Overall Study||322
8517641|NCT00402727|20994118|P2|NOT COMPLETED|Overall Study||34
8517642|NCT00402727|20994119|P1|NOT COMPLETED|Overall Study||42
8517643|NCT00402727|20994118|P2|COMPLETED|Overall Study||347
8517644|NCT00402727|20994119|P1|COMPLETED|Overall Study||390
8517645|NCT00402727|20994118|P2|Achieving Test Of Cure (TOC)|Overall Study||347
8517646|NCT00402727|20994119|P1|Achieving Test Of Cure (TOC)|Overall Study||390
8517647|NCT00402727|20994118|P2|Achieving End Of Treatment (EOT)|Overall Study||355
8517648|NCT00402727|20994119|P1|Achieving End Of Treatment (EOT)|Overall Study||408
8517649|NCT00402727|20994118|P2|STARTED|Overall Study||381
8517650|NCT00402727|20994119|P1|STARTED|Overall Study||432
8517651|NCT00402714|20994149|P2|NOT COMPLETED|Overall Study||0
8517652|NCT00402714|20994150|P1|NOT COMPLETED|Overall Study||0
8517653|NCT00402714|20994149|P2|COMPLETED|Overall Study||11
8517654|NCT00402714|20994150|P1|COMPLETED|Overall Study||3
8517655|NCT00402714|20994149|P2|STARTED|Overall Study||11
8517656|NCT00402714|20994150|P1|STARTED|Overall Study||3
8517657|NCT00402688|20994161|P3|NOT COMPLETED|Overall Study||15
8517658|NCT00402688|20994162|P2|NOT COMPLETED|Overall Study||16
8517659|NCT00402688|20994163|P1|NOT COMPLETED|Overall Study||21
8517660|NCT00402688|20994161|P3|COMPLETED|Overall Study||65
8517661|NCT00402688|20994162|P2|COMPLETED|Overall Study||65
8517662|NCT00402688|20994163|P1|COMPLETED|Overall Study||60
8517663|NCT00402688|20994161|P3|STARTED|Overall Study||80
8517664|NCT00402688|20994162|P2|STARTED|Overall Study||81
8517665|NCT00402688|20994163|P1|STARTED|Overall Study||81
8517666|NCT00402649|20994186|P1|NOT COMPLETED|Overall Study||2
8517667|NCT00402649|20994186|P1|COMPLETED|Overall Study||33
8517668|NCT00402649|20994186|P1|STARTED|Overall Study||35
8517669|NCT00402597|20994201|P5|NOT COMPLETED|Overall Study||124
8517670|NCT00402597|20994202|P4|NOT COMPLETED|Overall Study||74
8517671|NCT00402597|20994203|P3|NOT COMPLETED|Overall Study||212
8517672|NCT00402597|20994204|P2|NOT COMPLETED|Overall Study||46
8517673|NCT00402597|20994205|P1|NOT COMPLETED|Overall Study||191
8517674|NCT00402597|20994201|P5|COMPLETED|Overall Study||479
8517675|NCT00402597|20994202|P4|COMPLETED|Overall Study||279
8517676|NCT00402597|20994203|P3|COMPLETED|Overall Study||834
8517677|NCT00402597|20994204|P2|COMPLETED|Overall Study||261
8517678|NCT00402597|20994205|P1|COMPLETED|Overall Study||962
8517679|NCT00402597|20994201|P5|STARTED|Overall Study||603
8517680|NCT00402597|20994202|P4|STARTED|Overall Study||353
8517681|NCT00402597|20994203|P3|STARTED|Overall Study||1046
8517682|NCT00402597|20994204|P2|STARTED|Overall Study||307
8517683|NCT00402597|20994205|P1|STARTED|Overall Study||1153
8517684|NCT00402363|20994246|P4|NOT COMPLETED|Overall Study||10
8517685|NCT00402363|20994247|P3|NOT COMPLETED|Overall Study||6
8517686|NCT00402363|20994248|P2|NOT COMPLETED|Overall Study||30
8517687|NCT00402363|20994249|P1|NOT COMPLETED|Overall Study||33
8517688|NCT00402363|20994246|P4|COMPLETED|Overall Study||45
8517689|NCT00402363|20994247|P3|COMPLETED|Overall Study||60
8517690|NCT00402363|20994248|P2|COMPLETED|Overall Study||246
8517691|NCT00402363|20994249|P1|COMPLETED|Overall Study||233
8517692|NCT00402363|20994246|P4|STARTED|Overall Study||55
8517693|NCT00402363|20994247|P3|STARTED|Overall Study||66
8517694|NCT00402363|20994248|P2|STARTED|Overall Study||276
8517695|NCT00402363|20994249|P1|STARTED|Overall Study||266
8517696|NCT00402337|20994312|P5|NOT COMPLETED|Overall Study||8
8517697|NCT00402337|20994313|P4|NOT COMPLETED|Overall Study||12
8517698|NCT00402337|20994314|P3|NOT COMPLETED|Overall Study||4
8517699|NCT00402337|20994315|P2|NOT COMPLETED|Overall Study||6
8517700|NCT00402337|20994316|P1|NOT COMPLETED|Overall Study||5
8517701|NCT00402337|20994312|P5|COMPLETED|Overall Study||61
8517702|NCT00402337|20994313|P4|COMPLETED|Overall Study||51
8517703|NCT00402337|20994314|P3|COMPLETED|Overall Study||58
8517704|NCT00402337|20994315|P2|COMPLETED|Overall Study||51
8517705|NCT00402337|20994316|P1|COMPLETED|Overall Study||54
8517706|NCT00402337|20994312|P5|STARTED|Overall Study||69
8517707|NCT00402337|20994313|P4|STARTED|Overall Study||63
8517708|NCT00402337|20994314|P3|STARTED|Overall Study||62
8517709|NCT00402337|20994315|P2|STARTED|Overall Study||57
8517710|NCT00402337|20994316|P1|STARTED|Overall Study||59
8517711|NCT00402324|20994355|P2|NOT COMPLETED|Overall Study||41
8517712|NCT00402324|20994356|P1|NOT COMPLETED|Overall Study||43
8517713|NCT00402324|20994355|P2|COMPLETED|Overall Study||60
8517714|NCT00402324|20994356|P1|COMPLETED|Overall Study||58
8517715|NCT00402324|20994355|P2|STARTED|Overall Study||101
8517716|NCT00402324|20994356|P1|STARTED|Overall Study||101
8517717|NCT00402285|20994389|P3|NOT COMPLETED|Overall Study||2
8517718|NCT00402285|20994390|P2|NOT COMPLETED|Overall Study||6
8517719|NCT00402285|20994391|P1|NOT COMPLETED|Overall Study||7
8517720|NCT00402285|20994389|P3|COMPLETED|Overall Study||26
8517721|NCT00402285|20994390|P2|COMPLETED|Overall Study||21
8517722|NCT00402285|20994391|P1|COMPLETED|Overall Study||22
8517723|NCT00402285|20994389|P3|STARTED|Overall Study||28
8517724|NCT00402285|20994390|P2|STARTED|Overall Study||27
8517725|NCT00402285|20994391|P1|STARTED|Overall Study||29
8517726|NCT00402246|20994399|P2|NOT COMPLETED|Overall Study||234
8517727|NCT00402246|20994400|P1|NOT COMPLETED|Overall Study||220
8517728|NCT00402246|20994399|P2|COMPLETED|Overall Study||749
8517729|NCT00402246|20994400|P1|COMPLETED|Overall Study||794
8517730|NCT00402246|20994399|P2|STARTED|Overall Study||983
8517731|NCT00402246|20994400|P1|STARTED|Overall Study||1014
8517732|NCT00402233|20994434|P4|NOT COMPLETED|Overall Study||11
8517733|NCT00402233|20994435|P3|NOT COMPLETED|Overall Study||11
8517734|NCT00402233|20994436|P2|NOT COMPLETED|Overall Study||10
8517735|NCT00402233|20994437|P1|NOT COMPLETED|Overall Study||5
8517736|NCT00402233|20994434|P4|COMPLETED|Overall Study||62
8517737|NCT00402233|20994435|P3|COMPLETED|Overall Study||70
8517738|NCT00402233|20994436|P2|COMPLETED|Overall Study||70
8517739|NCT00402233|20994437|P1|COMPLETED|Overall Study||72
8517740|NCT00402233|20994434|P4|STARTED|Overall Study||73
8517741|NCT00402233|20994435|P3|STARTED|Overall Study||81
8517742|NCT00402233|20994436|P2|STARTED|Overall Study||80
8517743|NCT00402233|20994437|P1|STARTED|Overall Study||77
8517744|NCT00402194|20994461|P2|NOT COMPLETED|Overall Study||0
8517745|NCT00402194|20994462|P1|NOT COMPLETED|Overall Study||0
8517746|NCT00402194|20994461|P2|COMPLETED|Overall Study||8
8517747|NCT00402194|20994462|P1|COMPLETED|Overall Study||9
8517748|NCT00402194|20994461|P2|STARTED|Overall Study||8
8517749|NCT00402194|20994462|P1|STARTED|Overall Study||9
8517750|NCT00402168|20994472|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
8517751|NCT00402168|20994473|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
8517752|NCT00402168|20994472|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
8517753|NCT00402168|20994473|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
8517754|NCT00402168|20994472|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
8517755|NCT00402168|20994473|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
8517756|NCT00402168|20994472|P2|NOT COMPLETED|Long Term (LT)||17
8517757|NCT00402168|20994473|P1|NOT COMPLETED|Long Term (LT)||11
8517758|NCT00402168|20994472|P2|COMPLETED|Long Term (LT)||64
8517759|NCT00402168|20994473|P1|COMPLETED|Long Term (LT)||70
8517760|NCT00402168|20994472|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
8517761|NCT00402168|20994473|P1|STARTED|Long Term (LT)||81
8517762|NCT00402168|20994472|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
8517763|NCT00402168|20994473|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
8517764|NCT00402168|20994472|P2|COMPLETED|Treatment (up to 12 Months)||86
8517765|NCT00402168|20994473|P1|COMPLETED|Treatment (up to 12 Months)||81
8517766|NCT00402168|20994472|P2|STARTED|Treatment (up to 12 Months)||88
8517767|NCT00402168|20994473|P1|STARTED|Treatment (up to 12 Months)||83
8517768|NCT00402168|20994472|P2|NOT COMPLETED|Randomized||1
8517769|NCT00402168|20994473|P1|NOT COMPLETED|Randomized||1
8517770|NCT00402168|20994472|P2|COMPLETED|Randomized||88
8517771|NCT00402168|20994473|P1|COMPLETED|Randomized||83
8517772|NCT00402168|20994472|P2|STARTED|Randomized||89
8517773|NCT00402168|20994473|P1|STARTED|Randomized||84
8517774|NCT00402116|20994531|P3|NOT COMPLETED|Overall Study||55
8517775|NCT00402116|20994532|P2|NOT COMPLETED|Overall Study||6
8517776|NCT00402116|20994533|P1|NOT COMPLETED|Overall Study||3
8517777|NCT00402116|20994531|P3|COMPLETED|Overall Study||5
8517778|NCT00402116|20994532|P2|COMPLETED|Overall Study||0
8517779|NCT00402116|20994533|P1|COMPLETED|Overall Study||3
8517780|NCT00402116|20994531|P3|STARTED|Overall Study||60
8517781|NCT00402116|20994532|P2|STARTED|Overall Study||6
8517782|NCT00402116|20994533|P1|STARTED|Overall Study||6
8517783|NCT00402103|20994563|P2|NOT COMPLETED|Overall Study||13
8517784|NCT00402103|20994564|P1|NOT COMPLETED|Overall Study||91
8517785|NCT00402103|20994563|P2|COMPLETED|Overall Study||73
8517786|NCT00402103|20994564|P1|COMPLETED|Overall Study||379
8517787|NCT00402103|20994563|P2|STARTED|Overall Study||86
8517788|NCT00402103|20994564|P1|STARTED|Overall Study||470
8517789|NCT00402051|20994580|P2|NOT COMPLETED|Overall Study||35
8517790|NCT00402051|20994581|P1|NOT COMPLETED|Overall Study||38
8517791|NCT00402051|20994580|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
8517792|NCT00402051|20994581|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
8517793|NCT00402051|20994580|P2|Received Treatment|Overall Study||65
8517794|NCT00402051|20994581|P1|Received Treatment|Overall Study||65
8517795|NCT00402051|20994580|P2|STARTED|Overall Study||67
8517796|NCT00402051|20994581|P1|STARTED|Overall Study||66
8517797|NCT00402025|20994598|P3|NOT COMPLETED|Overall Study||10
8517798|NCT00402025|20994599|P2|NOT COMPLETED|Overall Study||3
8517799|NCT00402025|20994600|P1|NOT COMPLETED|Overall Study||2
8517800|NCT00402025|20994598|P3|COMPLETED|Overall Study||0
8517801|NCT00402025|20994599|P2|COMPLETED|Overall Study||1
8517802|NCT00402025|20994600|P1|COMPLETED|Overall Study||1
8517803|NCT00402025|20994598|P3|STARTED|Overall Study||10
8517804|NCT00402025|20994599|P2|STARTED|Overall Study||4
8517805|NCT00402025|20994600|P1|STARTED|Overall Study||3
8517806|NCT00401973|20994626|P3|NOT COMPLETED|Overall Study||23
8517807|NCT00401973|20994627|P2|NOT COMPLETED|Overall Study||26
8517808|NCT00401973|20994628|P1|NOT COMPLETED|Overall Study||11
8517809|NCT00401973|20994626|P3|COMPLETED|Overall Study||50
8517810|NCT00401973|20994627|P2|COMPLETED|Overall Study||50
8517811|NCT00401973|20994628|P1|COMPLETED|Overall Study||39
8517812|NCT00401973|20994626|P3|STARTED|Overall Study||73
8517813|NCT00401973|20994627|P2|STARTED|Overall Study||76
8517814|NCT00401973|20994628|P1|STARTED|Overall Study||50
8517815|NCT00401960|20994667|P2|NOT COMPLETED|Overall Study||0
8517816|NCT00401960|20994668|P1|NOT COMPLETED|Overall Study||5
8517817|NCT00401960|20994667|P2|COMPLETED|Overall Study||1
8517818|NCT00401960|20994668|P1|COMPLETED|Overall Study||0
8517819|NCT00401960|20994667|P2|STARTED|Overall Study||1
8517820|NCT00401960|20994668|P1|STARTED|Overall Study||5
8517821|NCT00401882|20994678|P2|NOT COMPLETED|Overall Study||0
8517822|NCT00401882|20994679|P1|NOT COMPLETED|Overall Study||0
8517823|NCT00401882|20994678|P2|COMPLETED|Overall Study||5
8517824|NCT00401882|20994679|P1|COMPLETED|Overall Study||2
8517825|NCT00401882|20994678|P2|STARTED|Overall Study||5
8517826|NCT00401882|20994679|P1|STARTED|Overall Study||2
8517827|NCT00401843|20994698|P3|NOT COMPLETED|Overall Study||142
8517828|NCT00401843|20994699|P2|NOT COMPLETED|Overall Study||144
8517829|NCT00401843|20994700|P1|NOT COMPLETED|Overall Study||21
8517830|NCT00401843|20994698|P3|COMPLETED|Overall Study||0
8517831|NCT00401843|20994699|P2|COMPLETED|Overall Study||0
8517832|NCT00401843|20994700|P1|COMPLETED|Overall Study||0
8517833|NCT00401843|20994698|P3|Treated|Overall Study||139
8517834|NCT00401843|20994699|P2|Treated|Overall Study||142
8517835|NCT00401843|20994700|P1|Treated|Overall Study||21
8517836|NCT00401843|20994698|P3|STARTED|Overall Study||142
8517837|NCT00401843|20994699|P2|STARTED|Overall Study||144
8517838|NCT00401843|20994700|P1|STARTED|Overall Study||21
8517839|NCT00401830|20994718|P2|NOT COMPLETED|Overall Study||32
8517840|NCT00401830|20994719|P1|NOT COMPLETED|Overall Study||31
8517841|NCT00401830|20994718|P2|COMPLETED|Overall Study||46
8517842|NCT00401830|20994719|P1|COMPLETED|Overall Study||50
8517843|NCT00401830|20994718|P2|STARTED|Overall Study||78
8517844|NCT00401830|20994719|P1|STARTED|Overall Study||81
8517845|NCT00401817|20994751|P1|NOT COMPLETED|Overall Study||0
8517846|NCT00401817|20994751|P1|COMPLETED|Overall Study||11
8517847|NCT00401817|20994751|P1|STARTED|Overall Study||11
8517848|NCT00401778|20994761|P3|NOT COMPLETED|Overall Study||1
8517849|NCT00401778|20994762|P2|NOT COMPLETED|Overall Study||1
8517850|NCT00401778|20994763|P1|NOT COMPLETED|Overall Study||1
8517851|NCT00401778|20994761|P3|COMPLETED|Overall Study||10
8517852|NCT00401778|20994762|P2|COMPLETED|Overall Study||11
8517853|NCT00401778|20994763|P1|COMPLETED|Overall Study||9
8517854|NCT00401778|20994761|P3|STARTED|Overall Study||11
8517855|NCT00401778|20994762|P2|STARTED|Overall Study||12
8517856|NCT00401778|20994763|P1|STARTED|Overall Study||10
8517857|NCT00401752|20994777|P2|NOT COMPLETED|Overall Study||18
8517858|NCT00401752|20994778|P1|NOT COMPLETED|Overall Study||10
8517859|NCT00401752|20994777|P2|COMPLETED|Overall Study||94
8517860|NCT00401752|20994778|P1|COMPLETED|Overall Study||97
8517861|NCT00401752|20994777|P2|Patients Included in Per-Protocol Popula|Overall Study||99
8517862|NCT00401752|20994778|P1|Patients Included in Per-Protocol Popula|Overall Study||100
8517863|NCT00401752|20994777|P2|Patients Included in Safety Population|Overall Study||110
8517864|NCT00401752|20994778|P1|Patients Included in Safety Population|Overall Study||107
8517865|NCT00401752|20994777|P2|Patients Included in ITT Population|Overall Study||111
8517866|NCT00401752|20994778|P1|Patients Included in ITT Population|Overall Study||106
8517867|NCT00401752|20994777|P2|Number of Patients Received Treatment|Overall Study||111
8517868|NCT00401752|20994778|P1|Number of Patients Received Treatment|Overall Study||107
8517869|NCT00401752|20994777|P2|STARTED|Overall Study||112
8517870|NCT00401752|20994778|P1|STARTED|Overall Study||107
8517871|NCT00401726|20994796|P2|NOT COMPLETED|Overall Study||112
8517872|NCT00401726|20994797|P1|NOT COMPLETED|Overall Study||97
8517873|NCT00401726|20994796|P2|COMPLETED|Overall Study||156
8517874|NCT00401726|20994797|P1|COMPLETED|Overall Study||172
8517875|NCT00401726|20994796|P2|STARTED|Overall Study||268
8517876|NCT00401726|20994797|P1|STARTED|Overall Study||269
8517877|NCT00401622|20994819|P2|NOT COMPLETED|Overall Study||43
8517878|NCT00401622|20994820|P1|NOT COMPLETED|Overall Study||34
8517879|NCT00401622|20994819|P2|COMPLETED|Overall Study||117
8517880|NCT00401622|20994820|P1|COMPLETED|Overall Study||126
8517881|NCT00401622|20994819|P2|STARTED|Overall Study||160
8517882|NCT00401622|20994820|P1|STARTED|Overall Study||160
8517883|NCT00401544|20994832|P4|NOT COMPLETED|Overall Study||16
8517884|NCT00401544|20994833|P3|NOT COMPLETED|Overall Study||12
8517885|NCT00401544|20994834|P2|NOT COMPLETED|Overall Study||18
8517886|NCT00401544|20994835|P1|NOT COMPLETED|Overall Study||18
8517887|NCT00401544|20994832|P4|COMPLETED|Overall Study||44
8517888|NCT00401544|20994833|P3|COMPLETED|Overall Study||48
8517889|NCT00401544|20994834|P2|COMPLETED|Overall Study||44
8517890|NCT00401544|20994835|P1|COMPLETED|Overall Study||38
8517891|NCT00401544|20994832|P4|STARTED|Overall Study|Randomized and treated|60
8517892|NCT00401544|20994833|P3|STARTED|Overall Study|Randomized and treated|60
8517893|NCT00401544|20994834|P2|STARTED|Overall Study|Randomized and treated|62
8517894|NCT00401544|20994835|P1|STARTED|Overall Study|Randomized and treated|56
8517895|NCT00401531|20994875|P2|NOT COMPLETED|Overall Study||10
8517896|NCT00401531|20994876|P1|NOT COMPLETED|Overall Study||9
8517897|NCT00401531|20994875|P2|COMPLETED|Overall Study||196
8517898|NCT00401531|20994876|P1|COMPLETED|Overall Study||197
8517899|NCT00401531|20994875|P2|STARTED|Overall Study||206
8517900|NCT00401531|20994876|P1|STARTED|Overall Study||206
8517901|NCT00401518|20994895|P3|NOT COMPLETED|Overall Study||23
8517902|NCT00401518|20994896|P2|NOT COMPLETED|Overall Study||37
8517903|NCT00401518|20994897|P1|NOT COMPLETED|Overall Study||6
8517904|NCT00401518|20994895|P3|COMPLETED|Overall Study||94
8517905|NCT00401518|20994896|P2|COMPLETED|Overall Study||190
8517906|NCT00401518|20994897|P1|COMPLETED|Overall Study||40
8517907|NCT00401518|20994895|P3|STARTED|Overall Study||117
8517908|NCT00401518|20994896|P2|STARTED|Overall Study||227
8517909|NCT00401518|20994897|P1|STARTED|Overall Study||46
8517910|NCT00401414|20994926|P3|NOT COMPLETED|Overall Study||0
8517911|NCT00401414|20994927|P2|NOT COMPLETED|Overall Study||0
8517912|NCT00401414|20994928|P1|NOT COMPLETED|Overall Study||0
8517913|NCT00401414|20994926|P3|COMPLETED|Overall Study||79
8517914|NCT00401414|20994927|P2|COMPLETED|Overall Study||147
8517915|NCT00401414|20994928|P1|COMPLETED|Overall Study||118
8517916|NCT00401414|20994926|P3|STARTED|Overall Study||79
8517917|NCT00401414|20994927|P2|STARTED|Overall Study||147
8517918|NCT00401414|20994928|P1|STARTED|Overall Study||118
8517919|NCT00401401|20994952|P4|NOT COMPLETED|Overall Study||3
8517920|NCT00401401|20994953|P3|NOT COMPLETED|Overall Study||1
8517921|NCT00401401|20994954|P2|NOT COMPLETED|Overall Study||0
8517922|NCT00401401|20994955|P1|NOT COMPLETED|Overall Study||0
8517923|NCT00401401|20994952|P4|COMPLETED|Overall Study||9
8517924|NCT00401401|20994953|P3|COMPLETED|Overall Study||5
8517925|NCT00401401|20994954|P2|COMPLETED|Overall Study||6
8517926|NCT00401401|20994955|P1|COMPLETED|Overall Study||6
8517927|NCT00401401|20994952|P4|STARTED|Overall Study||12
8517928|NCT00401401|20994953|P3|STARTED|Overall Study||6
8517929|NCT00401401|20994954|P2|STARTED|Overall Study||6
8517930|NCT00401401|20994955|P1|STARTED|Overall Study||6
8517931|NCT00401375|20994980|P3|NOT COMPLETED|Overall Study||25
8517932|NCT00401375|20994981|P2|NOT COMPLETED|Overall Study||25
8517933|NCT00401375|20994982|P1|NOT COMPLETED|Overall Study||22
8517934|NCT00401375|20994980|P3|COMPLETED|Overall Study||149
8517935|NCT00401375|20994981|P2|COMPLETED|Overall Study||151
8517936|NCT00401375|20994982|P1|COMPLETED|Overall Study||152
8517937|NCT00401375|20994980|P3|Received at Least 1 Dose of Study Drug|Overall Study||171
8517938|NCT00401375|20994981|P2|Received at Least 1 Dose of Study Drug|Overall Study||173
8517939|NCT00401375|20994982|P1|Received at Least 1 Dose of Study Drug|Overall Study||171
8517940|NCT00401375|20994980|P3|STARTED|Overall Study||174
8517941|NCT00401375|20994981|P2|STARTED|Overall Study||176
8517942|NCT00401375|20994982|P1|STARTED|Overall Study||174
8517943|NCT00401258|20994999|P1|NOT COMPLETED|Overall Study||7
8517944|NCT00401258|20994999|P1|COMPLETED|Overall Study||8
8517945|NCT00401258|20994999|P1|STARTED|Overall Study||15
8517946|NCT00401245|20995014|P8|NOT COMPLETED|Double Blind Tapering Phase||7
8517947|NCT00401245|20995015|P7|NOT COMPLETED|Double Blind Tapering Phase||7
8517948|NCT00401245|20995016|P6|NOT COMPLETED|Double Blind Tapering Phase||4
8517949|NCT00401245|20995017|P5|NOT COMPLETED|Double Blind Tapering Phase||4
8517950|NCT00401245|20995018|P4|NOT COMPLETED|Double Blind Tapering Phase||0
8517951|NCT00401245|20995019|P3|NOT COMPLETED|Double Blind Tapering Phase||0
8517952|NCT00401245|20995020|P2|NOT COMPLETED|Double Blind Tapering Phase||0
8517953|NCT00401245|20995021|P1|NOT COMPLETED|Double Blind Tapering Phase||0
8517954|NCT00401245|20995014|P8|COMPLETED|Double Blind Tapering Phase||95
8517955|NCT00401245|20995015|P7|COMPLETED|Double Blind Tapering Phase||80
8517956|NCT00401245|20995016|P6|COMPLETED|Double Blind Tapering Phase||90
8517957|NCT00401245|20995017|P5|COMPLETED|Double Blind Tapering Phase||97
8517958|NCT00401245|20995018|P4|COMPLETED|Double Blind Tapering Phase||0
8517959|NCT00401245|20995019|P3|COMPLETED|Double Blind Tapering Phase||0
8517960|NCT00401245|20995020|P2|COMPLETED|Double Blind Tapering Phase||0
8517961|NCT00401245|20995021|P1|COMPLETED|Double Blind Tapering Phase||0
8517962|NCT00401245|20995014|P8|STARTED|Double Blind Tapering Phase||102
8517963|NCT00401245|20995015|P7|STARTED|Double Blind Tapering Phase||87
8517964|NCT00401245|20995016|P6|STARTED|Double Blind Tapering Phase||94
8517965|NCT00401245|20995017|P5|STARTED|Double Blind Tapering Phase||101
8517966|NCT00401245|20995018|P4|STARTED|Double Blind Tapering Phase||0
8517967|NCT00401245|20995019|P3|STARTED|Double Blind Tapering Phase||0
8517968|NCT00401245|20995020|P2|STARTED|Double Blind Tapering Phase||0
8517969|NCT00401245|20995021|P1|STARTED|Double Blind Tapering Phase||0
8517970|NCT00401245|20995014|P8|NOT COMPLETED|Open Label Phase||0
8517971|NCT00401245|20995015|P7|NOT COMPLETED|Open Label Phase||0
8517972|NCT00401245|20995016|P6|NOT COMPLETED|Open Label Phase||0
8517973|NCT00401245|20995017|P5|NOT COMPLETED|Open Label Phase||0
8517974|NCT00401245|20995018|P4|NOT COMPLETED|Open Label Phase||21
8517975|NCT00401245|20995019|P3|NOT COMPLETED|Open Label Phase||23
8517976|NCT00401245|20995020|P2|NOT COMPLETED|Open Label Phase||35
8517977|NCT00401245|20995021|P1|NOT COMPLETED|Open Label Phase||21
8517978|NCT00401245|20995014|P8|COMPLETED|Open Label Phase||0
8517979|NCT00401245|20995015|P7|COMPLETED|Open Label Phase||0
8517980|NCT00401245|20995016|P6|COMPLETED|Open Label Phase||0
8517981|NCT00401245|20995017|P5|COMPLETED|Open Label Phase||0
8517982|NCT00401245|20995018|P4|COMPLETED|Open Label Phase||84
8517983|NCT00401245|20995019|P3|COMPLETED|Open Label Phase||95
8517984|NCT00401245|20995020|P2|COMPLETED|Open Label Phase||81
8517985|NCT00401245|20995021|P1|COMPLETED|Open Label Phase||101
8517986|NCT00401245|20995014|P8|STARTED|Open Label Phase||0
8517987|NCT00401245|20995015|P7|STARTED|Open Label Phase||0
8517988|NCT00401245|20995016|P6|STARTED|Open Label Phase||0
8517989|NCT00401245|20995017|P5|STARTED|Open Label Phase||0
8517990|NCT00401245|20995018|P4|STARTED|Open Label Phase||105
8517991|NCT00401245|20995019|P3|STARTED|Open Label Phase||118
8517992|NCT00401245|20995020|P2|STARTED|Open Label Phase||116
8517993|NCT00401245|20995021|P1|STARTED|Open Label Phase||122
8517994|NCT00401245|20995014|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
8517995|NCT00401245|20995015|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
8517996|NCT00401245|20995016|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
8517997|NCT00401245|20995017|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
8517998|NCT00401245|20995018|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
8517999|NCT00401245|20995019|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
8518000|NCT00401245|20995020|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
8518001|NCT00401245|20995021|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
8518002|NCT00401245|20995014|P8|COMPLETED|Between Titration and Open Label Phase||0
8518003|NCT00401245|20995015|P7|COMPLETED|Between Titration and Open Label Phase||0
8518004|NCT00401245|20995016|P6|COMPLETED|Between Titration and Open Label Phase||0
8518005|NCT00401245|20995017|P5|COMPLETED|Between Titration and Open Label Phase||0
8518006|NCT00401245|20995018|P4|COMPLETED|Between Titration and Open Label Phase||105
8518007|NCT00401245|20995019|P3|COMPLETED|Between Titration and Open Label Phase||118
8518008|NCT00401245|20995020|P2|COMPLETED|Between Titration and Open Label Phase||116
8518009|NCT00401245|20995021|P1|COMPLETED|Between Titration and Open Label Phase||122
8518010|NCT00401245|20995014|P8|STARTED|Between Titration and Open Label Phase||0
8518011|NCT00401245|20995015|P7|STARTED|Between Titration and Open Label Phase||0
8518012|NCT00401245|20995016|P6|STARTED|Between Titration and Open Label Phase||0
8518013|NCT00401245|20995017|P5|STARTED|Between Titration and Open Label Phase||0
8518014|NCT00401245|20995018|P4|STARTED|Between Titration and Open Label Phase||107
8518015|NCT00401245|20995019|P3|STARTED|Between Titration and Open Label Phase||118
8518016|NCT00401245|20995020|P2|STARTED|Between Titration and Open Label Phase||118
8518017|NCT00401245|20995021|P1|STARTED|Between Titration and Open Label Phase||122
8518018|NCT00401245|20995014|P8|NOT COMPLETED|Double Blind Titration Phase||0
8518019|NCT00401245|20995015|P7|NOT COMPLETED|Double Blind Titration Phase||0
8518020|NCT00401245|20995016|P6|NOT COMPLETED|Double Blind Titration Phase||0
8518021|NCT00401245|20995017|P5|NOT COMPLETED|Double Blind Titration Phase||0
8518022|NCT00401245|20995018|P4|NOT COMPLETED|Double Blind Titration Phase||15
8518023|NCT00401245|20995019|P3|NOT COMPLETED|Double Blind Titration Phase||6
8518024|NCT00401245|20995020|P2|NOT COMPLETED|Double Blind Titration Phase||3
8518025|NCT00401245|20995021|P1|NOT COMPLETED|Double Blind Titration Phase||4
8518026|NCT00401245|20995014|P8|COMPLETED|Double Blind Titration Phase||0
8518027|NCT00401245|20995015|P7|COMPLETED|Double Blind Titration Phase||0
8518028|NCT00401245|20995016|P6|COMPLETED|Double Blind Titration Phase||0
8518029|NCT00401245|20995017|P5|COMPLETED|Double Blind Titration Phase||0
8518030|NCT00401245|20995018|P4|COMPLETED|Double Blind Titration Phase||107
8518031|NCT00401245|20995019|P3|COMPLETED|Double Blind Titration Phase||118
8518032|NCT00401245|20995020|P2|COMPLETED|Double Blind Titration Phase||118
8518033|NCT00401245|20995021|P1|COMPLETED|Double Blind Titration Phase||122
8518034|NCT00401245|20995014|P8|STARTED|Double Blind Titration Phase||0
8518035|NCT00401245|20995015|P7|STARTED|Double Blind Titration Phase||0
8518036|NCT00401245|20995016|P6|STARTED|Double Blind Titration Phase||0
8518037|NCT00401245|20995017|P5|STARTED|Double Blind Titration Phase||0
8518038|NCT00401245|20995018|P4|STARTED|Double Blind Titration Phase||122
8518039|NCT00401245|20995019|P3|STARTED|Double Blind Titration Phase||124
8518040|NCT00401245|20995020|P2|STARTED|Double Blind Titration Phase||121
8518041|NCT00401245|20995021|P1|STARTED|Double Blind Titration Phase||126
8518042|NCT00401193|20995089|P3|NOT COMPLETED|Overall Study||6
8518043|NCT00401193|20995090|P2|NOT COMPLETED|Overall Study||11
8518044|NCT00401193|20995091|P1|NOT COMPLETED|Overall Study||15
8518045|NCT00401193|20995089|P3|COMPLETED|Overall Study||63
8518046|NCT00401193|20995090|P2|COMPLETED|Overall Study||106
8518047|NCT00401193|20995091|P1|COMPLETED|Overall Study||103
8518048|NCT00401193|20995089|P3|Modified Intent to Treat Population|Overall Study||67
8518049|NCT00401193|20995090|P2|Modified Intent to Treat Population|Overall Study||115
8518050|NCT00401193|20995091|P1|Modified Intent to Treat Population|Overall Study||112
8518051|NCT00401193|20995089|P3|Intent to Treat Population|Overall Study||67
8518052|NCT00401193|20995090|P2|Intent to Treat Population|Overall Study||115
8518053|NCT00401193|20995091|P1|Intent to Treat Population|Overall Study||115
8518054|NCT00401193|20995089|P3|STARTED|Overall Study||69
8518055|NCT00401193|20995090|P2|STARTED|Overall Study||117
8518056|NCT00401193|20995091|P1|STARTED|Overall Study||118
8518057|NCT00401102|20995105|P1|NOT COMPLETED|Overall Study||7
8518058|NCT00401102|20995105|P1|COMPLETED|Overall Study||5
8518059|NCT00401102|20995105|P1|STARTED|Overall Study||12
8518060|NCT00400985|20995109|P1|NOT COMPLETED|Overall Study||52
8518061|NCT00400985|20995109|P1|COMPLETED|Overall Study||449
8518062|NCT00400985|20995109|P1|STARTED|Overall Study||501
8518063|NCT00400946|20995118|P5|NOT COMPLETED|Overall Study||38
8518064|NCT00400946|20995119|P4|NOT COMPLETED|Overall Study||47
8518065|NCT00400946|20995120|P3|NOT COMPLETED|Overall Study||2
8518066|NCT00400946|20995121|P2|NOT COMPLETED|Overall Study||11
8518067|NCT00400946|20995122|P1|NOT COMPLETED|Overall Study||14
8518068|NCT00400946|20995118|P5|COMPLETED|Overall Study||206
8518069|NCT00400946|20995119|P4|COMPLETED|Overall Study||4
8518070|NCT00400946|20995120|P3|COMPLETED|Overall Study||40
8518071|NCT00400946|20995121|P2|COMPLETED|Overall Study||221
8518072|NCT00400946|20995122|P1|COMPLETED|Overall Study||217
8518073|NCT00400946|20995118|P5|Eligible and Treated|Overall Study||243
8518074|NCT00400946|20995119|P4|Eligible and Treated|Overall Study||46
8518075|NCT00400946|20995120|P3|Eligible and Treated|Overall Study||42
8518076|NCT00400946|20995121|P2|Eligible and Treated|Overall Study||232
8518077|NCT00400946|20995122|P1|Eligible and Treated|Overall Study||231
8518078|NCT00400946|20995118|P5|Evaluable for Day 32 MRD|Overall Study||168
8518079|NCT00400946|20995119|P4|Evaluable for Day 32 MRD|Overall Study||12
8518080|NCT00400946|20995120|P3|Evaluable for Day 32 MRD|Overall Study||33
8518081|NCT00400946|20995121|P2|Evaluable for Day 32 MRD|Overall Study||167
8518082|NCT00400946|20995122|P1|Evaluable for Day 32 MRD|Overall Study||166
8518083|NCT00400946|20995118|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
8518084|NCT00400946|20995119|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
8518085|NCT00400946|20995120|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
8518086|NCT00400946|20995121|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
8518087|NCT00400946|20995122|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
8518088|NCT00400946|20995118|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
8518089|NCT00400946|20995119|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
8518090|NCT00400946|20995120|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
8518091|NCT00400946|20995121|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
8518092|NCT00400946|20995122|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
8518093|NCT00400946|20995118|P5|STARTED|Overall Study||244
8518094|NCT00400946|20995119|P4|STARTED|Overall Study||51
8518095|NCT00400946|20995120|P3|STARTED|Overall Study||42
8518096|NCT00400946|20995121|P2|STARTED|Overall Study||232
8518097|NCT00400946|20995122|P1|STARTED|Overall Study||231
8518098|NCT00400881|20995150|P2|NOT COMPLETED|Overall Study||0
8518099|NCT00400881|20995151|P1|NOT COMPLETED|Overall Study||0
8518100|NCT00400881|20995150|P2|COMPLETED|Overall Study||60
8518101|NCT00400881|20995151|P1|COMPLETED|Overall Study||62
8518102|NCT00400881|20995150|P2|STARTED|Overall Study||60
8518103|NCT00400881|20995151|P1|STARTED|Overall Study||62
8518104|NCT00400829|20995159|P1|NOT COMPLETED|Overall Study||0
8518105|NCT00400829|20995159|P1|COMPLETED|Overall Study||66
8518106|NCT00400829|20995159|P1|STARTED|Overall Study||66
8518107|NCT00400803|20995165|P1|NOT COMPLETED|Overall Study||0
8518108|NCT00400803|20995165|P1|COMPLETED|Overall Study||35
8518109|NCT00400803|20995165|P1|STARTED|Overall Study||35
8518110|NCT00400764|20995181|P5|NOT COMPLETED|Phase II||11
8518111|NCT00400764|20995182|P4|NOT COMPLETED|Phase II||26
8518112|NCT00400764|20995183|P3|NOT COMPLETED|Phase II||23
8518113|NCT00400764|20995184|P2|NOT COMPLETED|Phase II||0
8518114|NCT00400764|20995185|P1|NOT COMPLETED|Phase II||0
8518115|NCT00400764|20995181|P5|COMPLETED|Phase II||0
8518116|NCT00400764|20995182|P4|COMPLETED|Phase II||0
8518117|NCT00400764|20995183|P3|COMPLETED|Phase II||0
8518118|NCT00400764|20995184|P2|COMPLETED|Phase II||0
8518119|NCT00400764|20995185|P1|COMPLETED|Phase II||0
8518120|NCT00400764|20995181|P5|Treated|Phase II||11
8518121|NCT00400764|20995182|P4|Treated|Phase II||26
8518122|NCT00400764|20995183|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
8518123|NCT00400764|20995184|P2|Treated|Phase II||0
8518124|NCT00400764|20995185|P1|Treated|Phase II||0
8518125|NCT00400764|20995181|P5|STARTED|Phase II||11
8518126|NCT00400764|20995182|P4|STARTED|Phase II||26
8518127|NCT00400764|20995183|P3|STARTED|Phase II||23
8518128|NCT00400764|20995184|P2|STARTED|Phase II||0
8518129|NCT00400764|20995185|P1|STARTED|Phase II||0
8518130|NCT00400764|20995181|P5|NOT COMPLETED|Phase Ib||0
8518131|NCT00400764|20995182|P4|NOT COMPLETED|Phase Ib||0
8518132|NCT00400764|20995183|P3|NOT COMPLETED|Phase Ib||0
8518133|NCT00400764|20995184|P2|NOT COMPLETED|Phase Ib||4
8518134|NCT00400764|20995185|P1|NOT COMPLETED|Phase Ib||6
8518135|NCT00400764|20995181|P5|COMPLETED|Phase Ib||0
8518136|NCT00400764|20995182|P4|COMPLETED|Phase Ib||0
8518137|NCT00400764|20995183|P3|COMPLETED|Phase Ib||0
8518138|NCT00400764|20995184|P2|COMPLETED|Phase Ib||2
8518139|NCT00400764|20995185|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
8518140|NCT00400764|20995181|P5|Treated|Phase Ib||0
8518141|NCT00400764|20995182|P4|Treated|Phase Ib||0
8518142|NCT00400764|20995183|P3|Treated|Phase Ib||0
8518143|NCT00400764|20995184|P2|Treated|Phase Ib||6
8518144|NCT00400764|20995185|P1|Treated|Phase Ib||6
8518145|NCT00400764|20995181|P5|STARTED|Phase Ib||0
8518146|NCT00400764|20995182|P4|STARTED|Phase Ib||0
8518147|NCT00400764|20995183|P3|STARTED|Phase Ib||0
8518148|NCT00400764|20995184|P2|STARTED|Phase Ib||6
8518149|NCT00400764|20995185|P1|STARTED|Phase Ib||6
8518150|NCT00400712|20995238|P2|NOT COMPLETED|Overall Study||16
8518151|NCT00400712|20995239|P1|NOT COMPLETED|Overall Study||17
8518152|NCT00400712|20995238|P2|COMPLETED|Overall Study||35
8518153|NCT00400712|20995239|P1|COMPLETED|Overall Study||35
8518154|NCT00400712|20995238|P2|STARTED|Overall Study||51
8518155|NCT00400712|20995239|P1|STARTED|Overall Study||52
8518156|NCT00400686|20995257|P1|NOT COMPLETED|Overall Study||0
8518157|NCT00400686|20995257|P1|COMPLETED|Overall Study||31
8518158|NCT00400686|20995257|P1|STARTED|Overall Study||31
8518159|NCT00400634|20995265|P2|NOT COMPLETED|Overall Study||1
8518160|NCT00400634|20995266|P1|NOT COMPLETED|Overall Study||4
8518161|NCT00400634|20995265|P2|COMPLETED|Overall Study||19
8518162|NCT00400634|20995266|P1|COMPLETED|Overall Study||34
8518163|NCT00400634|20995265|P2|STARTED|Overall Study||20
8518164|NCT00400634|20995266|P1|STARTED|Overall Study||38
8518165|NCT00400569|20995274|P1|NOT COMPLETED|Overall Study||1
8518166|NCT00400569|20995274|P1|COMPLETED|Overall Study||47
8518167|NCT00400569|20995274|P1|STARTED|Overall Study||48
8518168|NCT00400517|20995285|P1|NOT COMPLETED|Overall Study||2
8518169|NCT00400517|20995285|P1|COMPLETED|Overall Study||26
8518170|NCT00400517|20995285|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
8518171|NCT00400439|20995294|P2|NOT COMPLETED|Overall Study||2
8518172|NCT00400439|20995295|P1|NOT COMPLETED|Overall Study||5
8518173|NCT00400439|20995294|P2|COMPLETED|Overall Study||23
8518174|NCT00400439|20995295|P1|COMPLETED|Overall Study||47
8518175|NCT00400439|20995294|P2|STARTED|Overall Study||25
8518176|NCT00400439|20995295|P1|STARTED|Overall Study||52
8518177|NCT00400400|20995305|P2|NOT COMPLETED|Overall Study||15
8518178|NCT00400400|20995306|P1|NOT COMPLETED|Overall Study||14
8518179|NCT00400400|20995305|P2|COMPLETED|Overall Study||185
8518180|NCT00400400|20995306|P1|COMPLETED|Overall Study||186
8518181|NCT00400400|20995305|P2|Intent-to-Treat Population|Overall Study||197
8518182|NCT00400400|20995306|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
8518183|NCT00400400|20995305|P2|STARTED|Overall Study||200
8518184|NCT00400400|20995306|P1|STARTED|Overall Study||200
8518185|NCT00400205|20995324|P1|NOT COMPLETED|Overall Study||5
8518186|NCT00400205|20995324|P1|COMPLETED|Overall Study||9
8518187|NCT00400205|20995324|P1|STARTED|Overall Study||14
8518188|NCT00400179|20995331|P2|NOT COMPLETED|Overall Study||18
8518189|NCT00400179|20995332|P1|NOT COMPLETED|Overall Study||6
8518190|NCT00400179|20995331|P2|COMPLETED|Overall Study||508
8518191|NCT00400179|20995332|P1|COMPLETED|Overall Study|Received Treatment|521
8518192|NCT00400179|20995331|P2|STARTED|Overall Study||526
8518193|NCT00400179|20995332|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
8518194|NCT00400153|20995349|P3|NOT COMPLETED|Overall Study||61
8518195|NCT00400153|20995350|P2|NOT COMPLETED|Overall Study||55
8518196|NCT00400153|20995351|P1|NOT COMPLETED|Overall Study||48
8518197|NCT00400153|20995349|P3|COMPLETED|Overall Study||422
8518198|NCT00400153|20995350|P2|COMPLETED|Overall Study||436
8518199|NCT00400153|20995351|P1|COMPLETED|Overall Study||438
8518200|NCT00400153|20995349|P3|STARTED|Overall Study||483
8518201|NCT00400153|20995350|P2|STARTED|Overall Study||491
8518202|NCT00400153|20995351|P1|STARTED|Overall Study||486
8518203|NCT00399893|20995598|P2|NOT COMPLETED|Overall Study||0
8518204|NCT00399893|20995599|P1|NOT COMPLETED|Overall Study||1
8518205|NCT00399893|20995598|P2|COMPLETED|Overall Study||3
8518206|NCT00399893|20995599|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
8518207|NCT00399893|20995598|P2|STARTED|Overall Study||3
8518208|NCT00399893|20995599|P1|STARTED|Overall Study||2
8518209|NCT00399880|20995627|P2|NOT COMPLETED|Overall Study||0
8518210|NCT00399880|20995628|P1|NOT COMPLETED|Overall Study||0
8518211|NCT00399880|20995627|P2|COMPLETED|Overall Study||65
8518212|NCT00399880|20995628|P1|COMPLETED|Overall Study||65
8518213|NCT00399880|20995627|P2|STARTED|Overall Study||65
8518214|NCT00399880|20995628|P1|STARTED|Overall Study||65
8518215|NCT00399841|20995636|P3|NOT COMPLETED|Overall Study||0
8518216|NCT00399841|20995637|P2|NOT COMPLETED|Overall Study||0
8518217|NCT00399841|20995638|P1|NOT COMPLETED|Overall Study||12
8518218|NCT00399841|20995636|P3|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518219|NCT00399841|20995637|P2|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518220|NCT00399841|20995638|P1|COMPLETED|Overall Study||1
8518221|NCT00399841|20995636|P3|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518222|NCT00399841|20995637|P2|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518223|NCT00399841|20995638|P1|12-week|Overall Study||2
8518224|NCT00399841|20995636|P3|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518225|NCT00399841|20995637|P2|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518226|NCT00399841|20995638|P1|Permanent Implant|Overall Study||6
8518227|NCT00399841|20995636|P3|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518228|NCT00399841|20995637|P2|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518229|NCT00399841|20995638|P1|STARTED|Overall Study||13
8518230|NCT00399802|20995645|P2|NOT COMPLETED|Overall Study||3
8518231|NCT00399802|20995646|P1|NOT COMPLETED|Overall Study||0
8518232|NCT00399802|20995645|P2|COMPLETED|Overall Study||26
8518233|NCT00399802|20995646|P1|COMPLETED|Overall Study||14
8518234|NCT00399802|20995645|P2|STARTED|Overall Study||29
8518235|NCT00399802|20995646|P1|STARTED|Overall Study||14
8518236|NCT00399763|20995660|P2|NOT COMPLETED|Overall Study||3
8518237|NCT00399763|20995661|P1|NOT COMPLETED|Overall Study||2
8518238|NCT00399763|20995660|P2|COMPLETED|Overall Study||32
8518239|NCT00399763|20995661|P1|COMPLETED|Overall Study||33
8518240|NCT00399763|20995660|P2|STARTED|Overall Study||35
8518241|NCT00399763|20995661|P1|STARTED|Overall Study||35
8518242|NCT00399568|20995673|P2|NOT COMPLETED|Overall Study||9
8518243|NCT00399568|20995674|P1|NOT COMPLETED|Overall Study||12
8518244|NCT00399568|20995673|P2|COMPLETED|Overall Study||156
8518245|NCT00399568|20995674|P1|COMPLETED|Overall Study||154
8518246|NCT00399568|20995673|P2|STARTED|Overall Study||165
8518247|NCT00399568|20995674|P1|STARTED|Overall Study||166
8518248|NCT00399542|20995688|P2|NOT COMPLETED|Overall Study||43
8518249|NCT00399542|20995689|P1|NOT COMPLETED|Overall Study||84
8518250|NCT00399542|20995688|P2|COMPLETED|Overall Study||151
8518251|NCT00399542|20995689|P1|COMPLETED|Overall Study||303
8518252|NCT00399542|20995688|P2|STARTED|Overall Study||194
8518253|NCT00399542|20995689|P1|STARTED|Overall Study||387
8518254|NCT00399529|20995751|P1|NOT COMPLETED|Overall Study||2
8518255|NCT00399529|20995751|P1|COMPLETED|Overall Study||20
8518256|NCT00399529|20995751|P1|STARTED|Overall Study||22
8518257|NCT00399516|20995757|P1|NOT COMPLETED|Overall Study||2
8518258|NCT00399516|20995757|P1|COMPLETED|Overall Study||19
8518259|NCT00399516|20995757|P1|STARTED|Overall Study||21
8518260|NCT00399360|20995765|P4|NOT COMPLETED|Overall Study||6
8518261|NCT00399360|20995766|P3|NOT COMPLETED|Overall Study||3
8518262|NCT00399360|20995767|P2|NOT COMPLETED|Overall Study||3
8518263|NCT00399360|20995768|P1|NOT COMPLETED|Overall Study||2
8518264|NCT00399360|20995765|P4|COMPLETED|Overall Study||9
8518265|NCT00399360|20995766|P3|COMPLETED|Overall Study||10
8518266|NCT00399360|20995767|P2|COMPLETED|Overall Study||8
8518267|NCT00399360|20995768|P1|COMPLETED|Overall Study||9
8518268|NCT00399360|20995765|P4|STARTED|Overall Study||15
8518269|NCT00399360|20995766|P3|STARTED|Overall Study||13
8518270|NCT00399360|20995767|P2|STARTED|Overall Study||11
8518271|NCT00399360|20995768|P1|STARTED|Overall Study||11
8518272|NCT00399308|20995817|P3|NOT COMPLETED|Overall Study||1
8518273|NCT00399308|20995818|P2|NOT COMPLETED|Overall Study||0
8518274|NCT00399308|20995819|P1|NOT COMPLETED|Overall Study||0
8518275|NCT00399308|20995817|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
8518276|NCT00399308|20995818|P2|COMPLETED|Overall Study||15
8518277|NCT00399308|20995819|P1|COMPLETED|Overall Study||13
8518278|NCT00399308|20995817|P3|STARTED|Overall Study||12
8518279|NCT00399308|20995818|P2|STARTED|Overall Study||15
8518280|NCT00399308|20995819|P1|STARTED|Overall Study||13
8518281|NCT00399035|20995839|P3|NOT COMPLETED|Overall Study||252
8518282|NCT00399035|20995840|P2|NOT COMPLETED|Overall Study||158
8518283|NCT00399035|20995841|P1|NOT COMPLETED|Overall Study||313
8518284|NCT00399035|20995839|P3|COMPLETED|Overall Study||106
8518285|NCT00399035|20995840|P2|COMPLETED|Overall Study||58
8518286|NCT00399035|20995841|P1|COMPLETED|Overall Study||189
8518287|NCT00399035|20995839|P3|STARTED|Overall Study||358
8518288|NCT00399035|20995840|P2|STARTED|Overall Study||216
8518289|NCT00399035|20995841|P1|STARTED|Overall Study||502
8518290|NCT00398983|20995862|P2|NOT COMPLETED|Overall Study||0
8518291|NCT00398983|20995863|P1|NOT COMPLETED|Overall Study||0
8518292|NCT00398983|20995862|P2|COMPLETED|Overall Study||25
8518293|NCT00398983|20995863|P1|COMPLETED|Overall Study||20
8518294|NCT00398983|20995862|P2|STARTED|Overall Study||25
8518295|NCT00398983|20995863|P1|STARTED|Overall Study||20
8518296|NCT00398918|20995869|P1|NOT COMPLETED|Overall Study||0
8518297|NCT00398918|20995869|P1|COMPLETED|Overall Study||10
8518298|NCT00398918|20995869|P1|STARTED|Overall Study||10
8518299|NCT00398866|20995877|P3|NOT COMPLETED|Overall Study||8
8518300|NCT00398866|20995878|P2|NOT COMPLETED|Overall Study||8
8518301|NCT00398866|20995879|P1|NOT COMPLETED|Overall Study||14
8518302|NCT00398866|20995877|P3|COMPLETED|Overall Study||58
8518303|NCT00398866|20995878|P2|COMPLETED|Overall Study||60
8518304|NCT00398866|20995879|P1|COMPLETED|Overall Study||52
8518305|NCT00398866|20995877|P3|STARTED|Overall Study||66
8518306|NCT00398866|20995878|P2|STARTED|Overall Study||68
8518307|NCT00398866|20995879|P1|STARTED|Overall Study||66
8518308|NCT00398632|20995890|P1|NOT COMPLETED|Overall Study||2
8518309|NCT00398632|20995890|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
8518310|NCT00398632|20995890|P1|STARTED|Overall Study||6
8518311|NCT00398567|20995898|P3|NOT COMPLETED|Overall Study||34
8518312|NCT00398567|20995899|P2|NOT COMPLETED|Overall Study||4
8518313|NCT00398567|20995900|P1|NOT COMPLETED|Overall Study||4
8518314|NCT00398567|20995898|P3|COMPLETED|Overall Study||3
8518315|NCT00398567|20995899|P2|COMPLETED|Overall Study||0
8518316|NCT00398567|20995900|P1|COMPLETED|Overall Study||0
8518317|NCT00398567|20995898|P3|STARTED|Overall Study||37
8518318|NCT00398567|20995899|P2|STARTED|Overall Study||4
8518319|NCT00398567|20995900|P1|STARTED|Overall Study||4
8518320|NCT00398476|20995912|P2|NOT COMPLETED|Treatment Period 2||0
8518321|NCT00398476|20995913|P1|NOT COMPLETED|Treatment Period 2||0
8518322|NCT00398476|20995912|P2|COMPLETED|Treatment Period 2||64
8518323|NCT00398476|20995913|P1|COMPLETED|Treatment Period 2||63
8518324|NCT00398476|20995912|P2|STARTED|Treatment Period 2||64
8518325|NCT00398476|20995913|P1|STARTED|Treatment Period 2||63
8518326|NCT00398476|20995912|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
8518327|NCT00398476|20995913|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
8518328|NCT00398476|20995912|P2|COMPLETED|Washout Period (20 Minutes)||64
8518329|NCT00398476|20995913|P1|COMPLETED|Washout Period (20 Minutes)||63
8518330|NCT00398476|20995912|P2|STARTED|Washout Period (20 Minutes)||64
8518331|NCT00398476|20995913|P1|STARTED|Washout Period (20 Minutes)||63
8518332|NCT00398476|20995912|P2|NOT COMPLETED|Treatment Period 1||0
8518333|NCT00398476|20995913|P1|NOT COMPLETED|Treatment Period 1||0
8518334|NCT00398476|20995912|P2|COMPLETED|Treatment Period 1||64
8518335|NCT00398476|20995913|P1|COMPLETED|Treatment Period 1||63
8518336|NCT00398476|20995912|P2|STARTED|Treatment Period 1||64
8518337|NCT00398476|20995913|P1|STARTED|Treatment Period 1||63
8518338|NCT00398411|20995954|P2|NOT COMPLETED|Overall Study||1
8518339|NCT00398411|20995955|P1|NOT COMPLETED|Overall Study||0
8518340|NCT00398411|20995954|P2|COMPLETED|Overall Study||31
8518341|NCT00398411|20995955|P1|COMPLETED|Overall Study||34
8518342|NCT00398411|20995954|P2|STARTED|Overall Study||32
8518343|NCT00398411|20995955|P1|STARTED|Overall Study||34
8518344|NCT00398398|20995971|P1|NOT COMPLETED|Overall Study||0
8518345|NCT00398398|20995971|P1|COMPLETED|Overall Study||44
8518346|NCT00398398|20995971|P1|STARTED|Overall Study||44
8518347|NCT00398320|20995978|P1|NOT COMPLETED|Overall Study||6
8518348|NCT00398320|20995978|P1|COMPLETED|Overall Study||34
8518349|NCT00398320|20995978|P1|STARTED|Overall Study||40
8518350|NCT00398216|20995991|P5|NOT COMPLETED|Overall Study||15
8518351|NCT00398216|20995992|P4|NOT COMPLETED|Overall Study||22
8518352|NCT00398216|20995993|P3|NOT COMPLETED|Overall Study||21
8518353|NCT00398216|20995994|P2|NOT COMPLETED|Overall Study||19
8518354|NCT00398216|20995995|P1|NOT COMPLETED|Overall Study||11
8518355|NCT00398216|20995991|P5|COMPLETED|Overall Study||157
8518356|NCT00398216|20995992|P4|COMPLETED|Overall Study||155
8518357|NCT00398216|20995993|P3|COMPLETED|Overall Study||164
8518358|NCT00398216|20995994|P2|COMPLETED|Overall Study||151
8518359|NCT00398216|20995995|P1|COMPLETED|Overall Study||181
8518360|NCT00398216|20995991|P5|STARTED|Overall Study||172
8518361|NCT00398216|20995992|P4|STARTED|Overall Study||177
8518362|NCT00398216|20995993|P3|STARTED|Overall Study||185
8518363|NCT00398216|20995994|P2|STARTED|Overall Study||170
8518364|NCT00398216|20995995|P1|STARTED|Overall Study||192
8518365|NCT00398138|20996022|P1|NOT COMPLETED|Overall Study||2
8518366|NCT00398138|20996022|P1|COMPLETED|Overall Study||10
8518367|NCT00398138|20996022|P1|STARTED|Overall Study||12
8518368|NCT00398112|20996027|P1|NOT COMPLETED|Overall Study||18
8518369|NCT00398112|20996027|P1|COMPLETED|Overall Study||0
8518370|NCT00398112|20996027|P1|STARTED|Overall Study||18
8518371|NCT00398086|20996038|P3|NOT COMPLETED|Overall Study||2
8518372|NCT00398086|20996039|P2|NOT COMPLETED|Overall Study||23
8518373|NCT00398086|20996040|P1|NOT COMPLETED|Overall Study||9
8518374|NCT00398086|20996038|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
8518375|NCT00398086|20996039|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
8518376|NCT00398086|20996040|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
8518377|NCT00398086|20996038|P3|Phase 1, Dose Escalation Population|Overall Study||3
8518378|NCT00398086|20996039|P2|Phase 1, Dose Escalation Population|Overall Study||7
8518379|NCT00398086|20996040|P1|Phase 1, Dose Escalation Population|Overall Study||20
8518380|NCT00398086|20996038|P3|STARTED|Overall Study||3
8518381|NCT00398086|20996039|P2|STARTED|Overall Study||44
8518382|NCT00398086|20996040|P1|STARTED|Overall Study||20
8518383|NCT00398073|20996074|P2|NOT COMPLETED|Overall Study||0
8518384|NCT00398073|20996075|P1|NOT COMPLETED|Overall Study||1
8518385|NCT00398073|20996074|P2|COMPLETED|Overall Study||17
8518386|NCT00398073|20996075|P1|COMPLETED|Overall Study||17
8518387|NCT00398073|20996074|P2|STARTED|Overall Study||17
8518388|NCT00398073|20996075|P1|STARTED|Overall Study||18
8518389|NCT00398047|20996085|P1|NOT COMPLETED|Overall Study||3
8518390|NCT00398047|20996085|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
8518391|NCT00398047|20996085|P1|STARTED|Overall Study||3
8518392|NCT00397982|20996095|P1|NOT COMPLETED|Overall Study||4
8518393|NCT00397982|20996095|P1|COMPLETED|Overall Study||13
8518394|NCT00397982|20996095|P1|STARTED|Overall Study||17
8518395|NCT00397943|20996109|P5|NOT COMPLETED|Overall Study||0
8518396|NCT00397943|20996110|P4|NOT COMPLETED|Overall Study||0
8518397|NCT00397943|20996111|P3|NOT COMPLETED|Overall Study||0
8518398|NCT00397943|20996112|P2|NOT COMPLETED|Overall Study||9
8518399|NCT00397943|20996113|P1|NOT COMPLETED|Overall Study||12
8518400|NCT00397943|20996109|P5|COMPLETED|Overall Study||10
8518401|NCT00397943|20996110|P4|COMPLETED|Overall Study||10
8518402|NCT00397943|20996111|P3|COMPLETED|Overall Study||10
8518403|NCT00397943|20996112|P2|COMPLETED|Overall Study||31
8518404|NCT00397943|20996113|P1|COMPLETED|Overall Study||28
8518405|NCT00397943|20996109|P5|STARTED|Overall Study||10
8518406|NCT00397943|20996110|P4|STARTED|Overall Study||10
8518407|NCT00397943|20996111|P3|STARTED|Overall Study||10
8518408|NCT00397943|20996112|P2|STARTED|Overall Study||40
8518409|NCT00397943|20996113|P1|STARTED|Overall Study||40
8518410|NCT00397930|20996269|P2|NOT COMPLETED|Overall Study||51
8518411|NCT00397930|20996270|P1|NOT COMPLETED|Overall Study||38
8518412|NCT00397930|20996269|P2|COMPLETED|Overall Study||153
8518413|NCT00397930|20996270|P1|COMPLETED|Overall Study||168
8518414|NCT00397930|20996269|P2|STARTED|Overall Study||204
8518415|NCT00397930|20996270|P1|STARTED|Overall Study||206
8518416|NCT00397904|20996276|P1|NOT COMPLETED|Overall Study||0
8518417|NCT00397904|20996276|P1|COMPLETED|Overall Study||16
8518418|NCT00397904|20996276|P1|STARTED|Overall Study||16
8518419|NCT00397891|20996285|P5|NOT COMPLETED|Overall Study||1
8518420|NCT00397891|20996286|P4|NOT COMPLETED|Overall Study||0
8518421|NCT00397891|20996287|P3|NOT COMPLETED|Overall Study||0
8518422|NCT00397891|20996288|P2|NOT COMPLETED|Overall Study||0
8518423|NCT00397891|20996289|P1|NOT COMPLETED|Overall Study||1
8518424|NCT00397891|20996285|P5|COMPLETED|Overall Study||7
8518425|NCT00397891|20996286|P4|COMPLETED|Overall Study||6
8518426|NCT00397891|20996287|P3|COMPLETED|Overall Study||6
8518427|NCT00397891|20996288|P2|COMPLETED|Overall Study||6
8518428|NCT00397891|20996289|P1|COMPLETED|Overall Study||5
8518429|NCT00397891|20996285|P5|STARTED|Overall Study||8
8518430|NCT00397891|20996286|P4|STARTED|Overall Study||6
8518431|NCT00397891|20996287|P3|STARTED|Overall Study||6
8518432|NCT00397891|20996288|P2|STARTED|Overall Study||6
8518433|NCT00397891|20996289|P1|STARTED|Overall Study||6
8518434|NCT00397878|20996387|P1|NOT COMPLETED|Overall Study||0
8518435|NCT00397878|20996387|P1|COMPLETED|Overall Study||10
8518436|NCT00397878|20996387|P1|STARTED|Overall Study||10
8518437|NCT00397839|20996396|P2|NOT COMPLETED|Overall Study||18
8518438|NCT00397839|20996397|P1|NOT COMPLETED|Overall Study||7
8518439|NCT00397839|20996396|P2|COMPLETED|Overall Study||69
8518440|NCT00397839|20996397|P1|COMPLETED|Overall Study||41
8518441|NCT00397839|20996396|P2|STARTED|Overall Study||87
8518442|NCT00397839|20996397|P1|STARTED|Overall Study||48
8518443|NCT00397813|20996417|P6|NOT COMPLETED|Overall Study||0
8518444|NCT00397813|20996418|P5|NOT COMPLETED|Overall Study||0
8518445|NCT00397813|20996419|P4|NOT COMPLETED|Overall Study||0
8518446|NCT00397813|20996420|P3|NOT COMPLETED|Overall Study||0
8518447|NCT00397813|20996421|P2|NOT COMPLETED|Overall Study||0
8518448|NCT00397813|20996422|P1|NOT COMPLETED|Overall Study||0
8518449|NCT00397813|20996417|P6|COMPLETED|Overall Study||24
8518450|NCT00397813|20996418|P5|COMPLETED|Overall Study||5
8518451|NCT00397813|20996419|P4|COMPLETED|Overall Study||12
8518452|NCT00397813|20996420|P3|COMPLETED|Overall Study||0
8518453|NCT00397813|20996421|P2|COMPLETED|Overall Study||0
8518454|NCT00397813|20996422|P1|COMPLETED|Overall Study||36
8518455|NCT00397813|20996417|P6|STARTED|Overall Study||24
8518456|NCT00397813|20996418|P5|STARTED|Overall Study||5
8518457|NCT00397813|20996419|P4|STARTED|Overall Study||12
8518458|NCT00397813|20996420|P3|STARTED|Overall Study||0
8518459|NCT00397813|20996421|P2|STARTED|Overall Study||0
8518460|NCT00397813|20996422|P1|STARTED|Overall Study||36
8518461|NCT00397631|20996462|P2|NOT COMPLETED|Overall Study||44
8518462|NCT00397631|20996463|P1|NOT COMPLETED|Overall Study||30
8518463|NCT00397631|20996462|P2|COMPLETED|Overall Study||215
8518464|NCT00397631|20996463|P1|COMPLETED|Overall Study||231
8518465|NCT00397631|20996462|P2|STARTED|Overall Study||259
8518466|NCT00397631|20996463|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
8518467|NCT00397579|20996473|P1|NOT COMPLETED|Overall Study||0
8518468|NCT00397579|20996473|P1|COMPLETED|Overall Study||11
8518469|NCT00397579|20996473|P1|STARTED|Overall Study||11
8518470|NCT00397540|20996479|P2|NOT COMPLETED|Overall Study||0
8518471|NCT00397540|20996480|P1|NOT COMPLETED|Overall Study||1
8518472|NCT00397540|20996479|P2|COMPLETED|Overall Study||85
8518473|NCT00397540|20996480|P1|COMPLETED|Overall Study||59
8518474|NCT00397540|20996479|P2|STARTED|Overall Study||85
8518475|NCT00397540|20996480|P1|STARTED|Overall Study||60
8518476|NCT00397514|20996488|P1|NOT COMPLETED|Overall Study||9
8518477|NCT00397514|20996488|P1|COMPLETED|Overall Study||25
8518478|NCT00397514|20996488|P1|STARTED|Overall Study||34
8518479|NCT00397488|20996498|P1|NOT COMPLETED|Overall Study||7
8518480|NCT00397488|20996498|P1|COMPLETED|Overall Study||71
8518481|NCT00397488|20996498|P1|STARTED|Overall Study||78
8518482|NCT00397462|20996505|P3|NOT COMPLETED|Overall Study||0
8518483|NCT00397462|20996506|P2|NOT COMPLETED|Overall Study||0
8518484|NCT00397462|20996507|P1|NOT COMPLETED|Overall Study||0
8518485|NCT00397462|20996505|P3|COMPLETED|Overall Study||15
8518486|NCT00397462|20996506|P2|COMPLETED|Overall Study||13
8518487|NCT00397462|20996507|P1|COMPLETED|Overall Study||16
8518488|NCT00397462|20996505|P3|STARTED|Overall Study||15
8518489|NCT00397462|20996506|P2|STARTED|Overall Study||13
8518490|NCT00397462|20996507|P1|STARTED|Overall Study||16
8518491|NCT00397254|20996518|P2|NOT COMPLETED|Overall Study||2
8518492|NCT00397254|20996519|P1|NOT COMPLETED|Overall Study||2
8518493|NCT00397254|20996518|P2|COMPLETED|Overall Study||74
8518494|NCT00397254|20996519|P1|COMPLETED|Overall Study||77
8518495|NCT00397254|20996518|P2|STARTED|Overall Study||76
8518496|NCT00397254|20996519|P1|STARTED|Overall Study||79
8518497|NCT00397215|20996541|P4|NOT COMPLETED|Month 24 (Day 720)||0
8518498|NCT00397215|20996542|P3|NOT COMPLETED|Month 24 (Day 720)||0
8518499|NCT00397215|20996543|P2|NOT COMPLETED|Month 24 (Day 720)||0
8518500|NCT00397215|20996544|P1|NOT COMPLETED|Month 24 (Day 720)||0
8518501|NCT00397215|20996541|P4|COMPLETED|Month 24 (Day 720)||36
8518502|NCT00397215|20996542|P3|COMPLETED|Month 24 (Day 720)||117
8518503|NCT00397215|20996543|P2|COMPLETED|Month 24 (Day 720)||45
8518504|NCT00397215|20996544|P1|COMPLETED|Month 24 (Day 720)||122
8518505|NCT00397215|20996541|P4|STARTED|Month 24 (Day 720)||36
8518506|NCT00397215|20996542|P3|STARTED|Month 24 (Day 720)||117
8518507|NCT00397215|20996543|P2|STARTED|Month 24 (Day 720)||45
8518508|NCT00397215|20996544|P1|STARTED|Month 24 (Day 720)||122
8518509|NCT00397215|20996541|P4|NOT COMPLETED|Month 12 (Day 360)||0
8518510|NCT00397215|20996542|P3|NOT COMPLETED|Month 12 (Day 360)||0
8518511|NCT00397215|20996543|P2|NOT COMPLETED|Month 12 (Day 360)||0
8518512|NCT00397215|20996544|P1|NOT COMPLETED|Month 12 (Day 360)||0
8518513|NCT00397215|20996541|P4|COMPLETED|Month 12 (Day 360)||42
8518514|NCT00397215|20996542|P3|COMPLETED|Month 12 (Day 360)||125
8518515|NCT00397215|20996543|P2|COMPLETED|Month 12 (Day 360)||48
8518516|NCT00397215|20996544|P1|COMPLETED|Month 12 (Day 360)||130
8518517|NCT00397215|20996541|P4|STARTED|Month 12 (Day 360)||42
8518518|NCT00397215|20996542|P3|STARTED|Month 12 (Day 360)||125
8518519|NCT00397215|20996543|P2|STARTED|Month 12 (Day 360)||48
8518520|NCT00397215|20996544|P1|STARTED|Month 12 (Day 360)||130
8518521|NCT00397215|20996541|P4|NOT COMPLETED|Month 6 (Day 180)||0
8518522|NCT00397215|20996542|P3|NOT COMPLETED|Month 6 (Day 180)||5
8518523|NCT00397215|20996543|P2|NOT COMPLETED|Month 6 (Day 180)||3
8518524|NCT00397215|20996544|P1|NOT COMPLETED|Month 6 (Day 180)||2
8518525|NCT00397215|20996541|P4|COMPLETED|Month 6 (Day 180)||51
8518526|NCT00397215|20996542|P3|COMPLETED|Month 6 (Day 180)||153
8518527|NCT00397215|20996543|P2|COMPLETED|Month 6 (Day 180)||55
8518528|NCT00397215|20996544|P1|COMPLETED|Month 6 (Day 180)||162
8518529|NCT00397215|20996541|P4|STARTED|Month 6 (Day 180)||51
8518530|NCT00397215|20996542|P3|STARTED|Month 6 (Day 180)||158
8518531|NCT00397215|20996543|P2|STARTED|Month 6 (Day 180)||58
8518532|NCT00397215|20996544|P1|STARTED|Month 6 (Day 180)||164
8518533|NCT00397215|20996541|P4|NOT COMPLETED|Month 0 (Day 0)||4
8518534|NCT00397215|20996542|P3|NOT COMPLETED|Month 0 (Day 0)||6
8518535|NCT00397215|20996543|P2|NOT COMPLETED|Month 0 (Day 0)||5
8518536|NCT00397215|20996544|P1|NOT COMPLETED|Month 0 (Day 0)||7
8518537|NCT00397215|20996541|P4|COMPLETED|Month 0 (Day 0)||48
8518538|NCT00397215|20996542|P3|COMPLETED|Month 0 (Day 0)||153
8518539|NCT00397215|20996543|P2|COMPLETED|Month 0 (Day 0)||56
8518540|NCT00397215|20996544|P1|COMPLETED|Month 0 (Day 0)||158
8518541|NCT00397215|20996541|P4|STARTED|Month 0 (Day 0)||52
8518542|NCT00397215|20996542|P3|STARTED|Month 0 (Day 0)||159
8518543|NCT00397215|20996543|P2|STARTED|Month 0 (Day 0)||61
8518544|NCT00397215|20996544|P1|STARTED|Month 0 (Day 0)||165
8518545|NCT00397189|20996680|P2|NOT COMPLETED|Extension Period||43
8518546|NCT00397189|20996681|P1|NOT COMPLETED|Extension Period||113
8518547|NCT00397189|20996680|P2|COMPLETED|Extension Period||134
8518548|NCT00397189|20996681|P1|COMPLETED|Extension Period||421
8518549|NCT00397189|20996680|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
8518550|NCT00397189|20996681|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
8518551|NCT00397189|20996680|P2|NOT COMPLETED|3 Weeks Period||22
8518552|NCT00397189|20996681|P1|NOT COMPLETED|3 Weeks Period||21
8518553|NCT00397189|20996680|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
8518554|NCT00397189|20996681|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
8518555|NCT00397189|20996680|P2|STARTED|3 Weeks Period||395
8518556|NCT00397189|20996681|P1|STARTED|3 Weeks Period||394
8518557|NCT00397150|20996691|P2|NOT COMPLETED|Overall Study||145
8518558|NCT00397150|20996692|P1|NOT COMPLETED|Overall Study||135
8518559|NCT00397150|20996691|P2|COMPLETED|Overall Study||1111
8518560|NCT00397150|20996692|P1|COMPLETED|Overall Study||1188
8518561|NCT00397150|20996691|P2|STARTED|Overall Study||1256
8518562|NCT00397150|20996692|P1|STARTED|Overall Study||1323
8518563|NCT00397046|20996708|P4|NOT COMPLETED|Overall Study||5
8518564|NCT00397046|20996709|P3|NOT COMPLETED|Overall Study||10
8518565|NCT00397046|20996710|P2|NOT COMPLETED|Overall Study||3
8518566|NCT00397046|20996711|P1|NOT COMPLETED|Overall Study||3
8518567|NCT00397046|20996708|P4|COMPLETED|Overall Study||0
8518568|NCT00397046|20996709|P3|COMPLETED|Overall Study||0
8518569|NCT00397046|20996710|P2|COMPLETED|Overall Study||0
8518570|NCT00397046|20996711|P1|COMPLETED|Overall Study||0
8518571|NCT00397046|20996708|P4|STARTED|Overall Study||5
8518572|NCT00397046|20996709|P3|STARTED|Overall Study||10
8518573|NCT00397046|20996710|P2|STARTED|Overall Study||3
8518574|NCT00397046|20996711|P1|STARTED|Overall Study||3
8518575|NCT00397033|20996733|P3|NOT COMPLETED|Overall Study||23
8518576|NCT00397033|20996734|P2|NOT COMPLETED|Overall Study||37
8518577|NCT00397033|20996735|P1|NOT COMPLETED|Overall Study||44
8518578|NCT00397033|20996733|P3|COMPLETED|Overall Study||77
8518579|NCT00397033|20996734|P2|COMPLETED|Overall Study||72
8518580|NCT00397033|20996735|P1|COMPLETED|Overall Study||63
8518581|NCT00397033|20996733|P3|ITT Population|Overall Study||98
8518582|NCT00397033|20996734|P2|ITT Population|Overall Study||105
8518583|NCT00397033|20996735|P1|ITT Population|Overall Study||107
8518584|NCT00397033|20996733|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
8518585|NCT00397033|20996734|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
8518586|NCT00397033|20996735|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
8518587|NCT00397033|20996733|P3|STARTED|Overall Study||100
8518588|NCT00397033|20996734|P2|STARTED|Overall Study||109
8518589|NCT00397033|20996735|P1|STARTED|Overall Study||107
8518590|NCT00397020|20996796|P2|NOT COMPLETED|Overall Study||1
8518591|NCT00397020|20996797|P1|NOT COMPLETED|Overall Study||1
8518592|NCT00397020|20996796|P2|COMPLETED|Overall Study||15
8518593|NCT00397020|20996797|P1|COMPLETED|Overall Study||13
8518594|NCT00397020|20996796|P2|STARTED|Overall Study||16
8518595|NCT00397020|20996797|P1|STARTED|Overall Study||14
8518596|NCT00396981|20996805|P2|NOT COMPLETED|Overall Study||9
8518597|NCT00396981|20996806|P1|NOT COMPLETED|Overall Study||15
8518598|NCT00396981|20996805|P2|COMPLETED|Overall Study||306
8518599|NCT00396981|20996806|P1|COMPLETED|Overall Study||296
8518600|NCT00396981|20996805|P2|STARTED|Overall Study||315
8518601|NCT00396981|20996806|P1|STARTED|Overall Study||311
8518602|NCT00396877|20996826|P2|NOT COMPLETED|Overall Study||8
8518603|NCT00396877|20996827|P1|NOT COMPLETED|Overall Study||6
8518604|NCT00396877|20996826|P2|COMPLETED|Overall Study|Completed follow-up|459
8518605|NCT00396877|20996827|P1|COMPLETED|Overall Study|Completed follow-up|433
8518606|NCT00396877|20996826|P2|Completed Treatment|Overall Study||352
8518607|NCT00396877|20996827|P1|Completed Treatment|Overall Study||356
8518608|NCT00396877|20996826|P2|Treated|Overall Study||464
8518609|NCT00396877|20996827|P1|Treated|Overall Study||436
8518610|NCT00396877|20996826|P2|STARTED|Overall Study|Randomized|467
8518611|NCT00396877|20996827|P1|STARTED|Overall Study|Randomized|439
8518612|NCT00396812|20996837|P1|NOT COMPLETED|Overall Study||1
8518613|NCT00396812|20996837|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
8518614|NCT00396812|20996837|P1|STARTED|Overall Study||4
8518615|NCT00396656|20996849|P2|NOT COMPLETED|Second Treatment Period||1
8518616|NCT00396656|20996850|P1|NOT COMPLETED|Second Treatment Period||0
8518617|NCT00396656|20996849|P2|COMPLETED|Second Treatment Period||12
8518618|NCT00396656|20996850|P1|COMPLETED|Second Treatment Period||15
8518619|NCT00396656|20996849|P2|STARTED|Second Treatment Period||13
8518620|NCT00396656|20996850|P1|STARTED|Second Treatment Period||15
8518621|NCT00396656|20996849|P2|NOT COMPLETED|First Treatment Period||2
8518622|NCT00396656|20996850|P1|NOT COMPLETED|First Treatment Period||0
8518623|NCT00396656|20996849|P2|COMPLETED|First Treatment Period||13
8518624|NCT00396656|20996850|P1|COMPLETED|First Treatment Period||15
8518625|NCT00396656|20996849|P2|STARTED|First Treatment Period||15
8518626|NCT00396656|20996850|P1|STARTED|First Treatment Period||15
8518627|NCT00396630|20996868|P2|NOT COMPLETED|Overall Study||5
8518628|NCT00396630|20996869|P1|NOT COMPLETED|Overall Study||5
8518629|NCT00396630|20996868|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
8518630|NCT00396630|20996869|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
8518631|NCT00396630|20996868|P2|STARTED|Overall Study||100
8518632|NCT00396630|20996869|P1|STARTED|Overall Study||100
8518633|NCT00396591|20996889|P1|NOT COMPLETED|Overall Study||16
8518634|NCT00396591|20996889|P1|COMPLETED|Overall Study||0
8518635|NCT00396591|20996889|P1|STARTED|Overall Study||16
8518636|NCT00396565|20996902|P3|NOT COMPLETED|Overall Study||17
8518637|NCT00396565|20996903|P2|NOT COMPLETED|Overall Study||91
8518638|NCT00396565|20996904|P1|NOT COMPLETED|Overall Study||48
8518639|NCT00396565|20996902|P3|COMPLETED|Overall Study||30
8518640|NCT00396565|20996903|P2|COMPLETED|Overall Study||47
8518641|NCT00396565|20996904|P1|COMPLETED|Overall Study||88
8518642|NCT00396565|20996902|P3|STARTED|Overall Study||47
8518643|NCT00396565|20996903|P2|STARTED|Overall Study||138
8518644|NCT00396565|20996904|P1|STARTED|Overall Study||136
8518645|NCT00396409|20996929|P2|NOT COMPLETED|Period 2 - 2008||2
8518646|NCT00396409|20996930|P1|NOT COMPLETED|Period 2 - 2008||7
8518647|NCT00396409|20996929|P2|COMPLETED|Period 2 - 2008||53
8518648|NCT00396409|20996930|P1|COMPLETED|Period 2 - 2008||52
8518649|NCT00396409|20996929|P2|STARTED|Period 2 - 2008||55
8518650|NCT00396409|20996930|P1|STARTED|Period 2 - 2008||59
8518651|NCT00396409|20996929|P2|NOT COMPLETED|Between Period 1 and Period 2||2
8518652|NCT00396409|20996930|P1|NOT COMPLETED|Between Period 1 and Period 2||3
8518653|NCT00396409|20996929|P2|COMPLETED|Between Period 1 and Period 2||55
8518654|NCT00396409|20996930|P1|COMPLETED|Between Period 1 and Period 2||59
8518655|NCT00396409|20996929|P2|STARTED|Between Period 1 and Period 2||57
8518656|NCT00396409|20996930|P1|STARTED|Between Period 1 and Period 2||62
8518657|NCT00396409|20996929|P2|NOT COMPLETED|Period 1 - 2007||6
8518658|NCT00396409|20996930|P1|NOT COMPLETED|Period 1 - 2007||3
8518659|NCT00396409|20996929|P2|COMPLETED|Period 1 - 2007||57
8518660|NCT00396409|20996930|P1|COMPLETED|Period 1 - 2007||62
8518661|NCT00396409|20996929|P2|STARTED|Period 1 - 2007||63
8518662|NCT00396409|20996930|P1|STARTED|Period 1 - 2007||65
8518663|NCT00396383|20996960|P1|NOT COMPLETED|Overall Study||3
8518664|NCT00396383|20996960|P1|COMPLETED|Overall Study||6
8518665|NCT00396383|20996960|P1|STARTED|Overall Study||9
8518666|NCT00396331|20996973|P1|NOT COMPLETED|Overall Study||32
8518667|NCT00396331|20996973|P1|COMPLETED|Overall Study||68
8518668|NCT00396331|20996973|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
8518669|NCT00396331|20996973|P1|Number of Participants Treated|Overall Study||100
8518670|NCT00396331|20996973|P1|STARTED|Overall Study||100
8518671|NCT00396318|20997026|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
8518672|NCT00396318|20997026|P1|COMPLETED|7-Day Post-Treatment Contact||240
8518673|NCT00396318|20997026|P1|STARTED|7-Day Post-Treatment Contact||241
8518674|NCT00396318|20997026|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
8518675|NCT00396318|20997026|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
8518676|NCT00396318|20997026|P1|STARTED|48- to 96-Hour Follow-Up Period||246
8518677|NCT00396318|20997026|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
8518678|NCT00396318|20997026|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
8518679|NCT00396318|20997026|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
8518680|NCT00396292|20997039|P2|NOT COMPLETED|Overall Study||16
8518681|NCT00396292|20997040|P1|NOT COMPLETED|Overall Study||9
8518682|NCT00396292|20997039|P2|COMPLETED|Overall Study||162
8518683|NCT00396292|20997040|P1|COMPLETED|Overall Study||165
8518684|NCT00396292|20997039|P2|STARTED|Overall Study||178
8518685|NCT00396292|20997040|P1|STARTED|Overall Study||174
8518686|NCT00396279|20997046|P1|NOT COMPLETED|Overall Study||30
8518687|NCT00396279|20997046|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
8518688|NCT00396279|20997046|P1|STARTED|Overall Study||37
8518689|NCT00396266|20997057|P2|NOT COMPLETED|Overall Study||0
8518690|NCT00396266|20997058|P1|NOT COMPLETED|Overall Study||0
8518691|NCT00396266|20997057|P2|COMPLETED|Overall Study||14
8518692|NCT00396266|20997058|P1|COMPLETED|Overall Study||8
8518693|NCT00396266|20997057|P2|STARTED|Overall Study||14
8518694|NCT00396266|20997058|P1|STARTED|Overall Study||8
8518695|NCT00396253|20997079|P1|NOT COMPLETED|Overall Study||13
8518696|NCT00396253|20997079|P1|COMPLETED|Overall Study||210
8518697|NCT00396253|20997079|P1|STARTED|Overall Study||223
8518698|NCT00396201|20997091|P1|NOT COMPLETED|Follow-up Period||0
8518699|NCT00396201|20997091|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
8518700|NCT00396201|20997091|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
8518701|NCT00396201|20997091|P1|NOT COMPLETED|Treatment Period||0
8518702|NCT00396201|20997091|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
8518703|NCT00396201|20997091|P1|STARTED|Treatment Period||22
8518704|NCT00396162|20997110|P2|NOT COMPLETED|Overall Study||3
8518705|NCT00396162|20997111|P1|NOT COMPLETED|Overall Study||2
8518706|NCT00396162|20997110|P2|COMPLETED|Overall Study||35
8518707|NCT00396162|20997111|P1|COMPLETED|Overall Study||37
8518708|NCT00396162|20997110|P2|STARTED|Overall Study||38
8518709|NCT00396162|20997111|P1|STARTED|Overall Study||39
8518710|NCT00396136|20997123|P1|NOT COMPLETED|Overall Study||125
8518711|NCT00396136|20997123|P1|COMPLETED|Overall Study||96
8518712|NCT00396136|20997123|P1|STARTED|Overall Study||221
8518713|NCT00396097|20997130|P2|NOT COMPLETED|Overall Study||46
8518714|NCT00396097|20997131|P1|NOT COMPLETED|Overall Study||26
8518715|NCT00396097|20997130|P2|COMPLETED|Overall Study||156
8518716|NCT00396097|20997131|P1|COMPLETED|Overall Study||88
8518717|NCT00396097|20997130|P2|STARTED|Overall Study||202
8518718|NCT00396097|20997131|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
8518719|NCT00396084|20997159|P6|NOT COMPLETED|Overall Study||2
8518720|NCT00396084|20997160|P5|NOT COMPLETED|Overall Study||1
8518721|NCT00396084|20997161|P4|NOT COMPLETED|Overall Study||1
8518722|NCT00396084|20997162|P3|NOT COMPLETED|Overall Study||0
8518723|NCT00396084|20997163|P2|NOT COMPLETED|Overall Study||0
8518724|NCT00396084|20997164|P1|NOT COMPLETED|Overall Study||0
8518725|NCT00396084|20997159|P6|COMPLETED|Overall Study||18
8518726|NCT00396084|20997160|P5|COMPLETED|Overall Study||9
8518727|NCT00396084|20997161|P4|COMPLETED|Overall Study||9
8518728|NCT00396084|20997162|P3|COMPLETED|Overall Study||10
8518729|NCT00396084|20997163|P2|COMPLETED|Overall Study||10
8518730|NCT00396084|20997164|P1|COMPLETED|Overall Study||10
8518731|NCT00396084|20997159|P6|STARTED|Overall Study||20
8518732|NCT00396084|20997160|P5|STARTED|Overall Study||10
8518733|NCT00396084|20997161|P4|STARTED|Overall Study||10
8518734|NCT00396084|20997162|P3|STARTED|Overall Study||10
8518735|NCT00396084|20997163|P2|STARTED|Overall Study||10
8518736|NCT00396084|20997164|P1|STARTED|Overall Study||10
8518737|NCT00396032|20997239|P2|NOT COMPLETED|Overall Study||5
8518738|NCT00396032|20997240|P1|NOT COMPLETED|Overall Study||4
8518739|NCT00396032|20997239|P2|COMPLETED|Overall Study||71
8518740|NCT00396032|20997240|P1|COMPLETED|Overall Study||70
8518741|NCT00396032|20997239|P2|STARTED|Overall Study||76
8518742|NCT00396032|20997240|P1|STARTED|Overall Study||74
8518743|NCT00396019|20997257|P3|NOT COMPLETED|Overall Study||1
8518744|NCT00396019|20997258|P2|NOT COMPLETED|Overall Study||3
8518745|NCT00396019|20997259|P1|NOT COMPLETED|Overall Study||0
8518746|NCT00396019|20997257|P3|COMPLETED|Overall Study||29
8518747|NCT00396019|20997258|P2|COMPLETED|Overall Study||26
8518748|NCT00396019|20997259|P1|COMPLETED|Overall Study||27
8518749|NCT00396019|20997257|P3|STARTED|Overall Study||30
8518750|NCT00396019|20997258|P2|STARTED|Overall Study||29
8518751|NCT00396019|20997259|P1|STARTED|Overall Study||27
8518752|NCT00396006|20997269|P1|NOT COMPLETED|Overall Study||0
8518753|NCT00396006|20997269|P1|COMPLETED|Overall Study||13
8518754|NCT00396006|20997269|P1|STARTED|Overall Study||13
8518755|NCT00395993|20997286|P2|NOT COMPLETED|Overall Study||19
8518756|NCT00395993|20997287|P1|NOT COMPLETED|Overall Study||35
8518757|NCT00395993|20997286|P2|COMPLETED|Overall Study||212
8518758|NCT00395993|20997287|P1|COMPLETED|Overall Study||211
8518759|NCT00395993|20997286|P2|STARTED|Overall Study||231
8518760|NCT00395993|20997287|P1|STARTED|Overall Study||246
8518761|NCT00395967|20997293|P1|NOT COMPLETED|Follow-up Period||2
8518762|NCT00395967|20997293|P1|COMPLETED|Follow-up Period||3
8518763|NCT00395967|20997293|P1|STARTED|Follow-up Period|Participants who had transplants.|5
8518764|NCT00395967|20997293|P1|NOT COMPLETED|Treatment Period||1
8518765|NCT00395967|20997293|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
8518766|NCT00395967|20997293|P1|STARTED|Treatment Period||5
8518767|NCT00395876|20997304|P2|NOT COMPLETED|Overall Study||0
8518768|NCT00395876|20997305|P1|NOT COMPLETED|Overall Study||3
8518769|NCT00395876|20997304|P2|COMPLETED|Overall Study||50
8518770|NCT00395876|20997305|P1|COMPLETED|Overall Study||47
8518771|NCT00395876|20997304|P2|STARTED|Overall Study||50
8518772|NCT00395876|20997305|P1|STARTED|Overall Study||50
8518773|NCT00395863|20997333|P2|NOT COMPLETED|Overall Study||3
8518774|NCT00395863|20997334|P1|NOT COMPLETED|Overall Study||2
8518775|NCT00395863|20997333|P2|COMPLETED|Overall Study||20
8518776|NCT00395863|20997334|P1|COMPLETED|Overall Study||21
8518777|NCT00395863|20997333|P2|STARTED|Overall Study||23
8518778|NCT00395863|20997334|P1|STARTED|Overall Study||23
8518779|NCT00395850|20997369|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
8518780|NCT00395850|20997370|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
8518781|NCT00395850|20997371|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
8518782|NCT00395850|20997372|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
8518783|NCT00395850|20997369|P4|COMPLETED|Disulfiram/Placebo Treatment||8
8518784|NCT00395850|20997370|P3|COMPLETED|Disulfiram/Placebo Treatment||5
8518785|NCT00395850|20997371|P2|COMPLETED|Disulfiram/Placebo Treatment||9
8518786|NCT00395850|20997372|P1|COMPLETED|Disulfiram/Placebo Treatment||11
8518787|NCT00395850|20997369|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
8518788|NCT00395850|20997370|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
8518789|NCT00395850|20997371|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
8518790|NCT00395850|20997372|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
8518791|NCT00395850|20997369|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
8518792|NCT00395850|20997370|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
8518793|NCT00395850|20997371|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
8518794|NCT00395850|20997372|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
8518795|NCT00395850|20997369|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
8518796|NCT00395850|20997370|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
8518797|NCT00395850|20997371|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
8518798|NCT00395850|20997372|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
8518799|NCT00395850|20997369|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
8518800|NCT00395850|20997370|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
8518801|NCT00395850|20997371|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
8518802|NCT00395850|20997372|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
8518803|NCT00395850|20997369|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8518804|NCT00395850|20997370|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8518805|NCT00395850|20997371|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8518806|NCT00395850|20997372|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
8518807|NCT00395850|20997369|P4|COMPLETED|Pre-randomization Baseline/Induction||0
8518808|NCT00395850|20997370|P3|COMPLETED|Pre-randomization Baseline/Induction||0
8518809|NCT00395850|20997371|P2|COMPLETED|Pre-randomization Baseline/Induction||0
8518810|NCT00395850|20997372|P1|COMPLETED|Pre-randomization Baseline/Induction||107
8518811|NCT00395850|20997369|P4|STARTED|Pre-randomization Baseline/Induction||0
8518812|NCT00395850|20997370|P3|STARTED|Pre-randomization Baseline/Induction||0
8518813|NCT00395850|20997371|P2|STARTED|Pre-randomization Baseline/Induction||0
8518814|NCT00395850|20997372|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
8518815|NCT00395746|20997389|P3|NOT COMPLETED|Overall Study||22
8518816|NCT00395746|20997390|P2|NOT COMPLETED|Overall Study||4
8518817|NCT00395746|20997391|P1|NOT COMPLETED|Overall Study||10
8518818|NCT00395746|20997389|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
8518819|NCT00395746|20997390|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
8518820|NCT00395746|20997391|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
8518821|NCT00395746|20997389|P3|STARTED|Overall Study|Exposed to study drug|88
8518822|NCT00395746|20997390|P2|STARTED|Overall Study|Exposed to study drug|88
8518823|NCT00395746|20997391|P1|STARTED|Overall Study|Exposed to study drug|88
8518824|NCT00395733|20997437|P2|NOT COMPLETED|Period 2||5
8518825|NCT00395733|20997438|P1|NOT COMPLETED|Period 2||2
8518826|NCT00395733|20997437|P2|COMPLETED|Period 2||37
8518827|NCT00395733|20997438|P1|COMPLETED|Period 2||39
8518828|NCT00395733|20997437|P2|STARTED|Period 2||42
8518829|NCT00395733|20997438|P1|STARTED|Period 2||41
8518830|NCT00395733|20997437|P2|NOT COMPLETED|Period 1||0
8518831|NCT00395733|20997438|P1|NOT COMPLETED|Period 1||0
8518832|NCT00395733|20997437|P2|COMPLETED|Period 1||42
8518833|NCT00395733|20997438|P1|COMPLETED|Period 1||41
8518834|NCT00395733|20997437|P2|STARTED|Period 1||42
8518835|NCT00395733|20997438|P1|STARTED|Period 1||41
8518836|NCT00395694|20997462|P2|NOT COMPLETED|Continuation Phase||13
8518837|NCT00395694|20997463|P1|NOT COMPLETED|Continuation Phase||15
8518838|NCT00395694|20997462|P2|COMPLETED|Continuation Phase||35
8518839|NCT00395694|20997463|P1|COMPLETED|Continuation Phase||34
8518840|NCT00395694|20997462|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
8518841|NCT00395694|20997463|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
8518842|NCT00395694|20997462|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
8518843|NCT00395694|20997463|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
8518844|NCT00395694|20997462|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
8518845|NCT00395694|20997463|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
8518846|NCT00395694|20997462|P2|STARTED|Escalation Phase + Maintenance Phase||51
8518847|NCT00395694|20997463|P1|STARTED|Escalation Phase + Maintenance Phase||51
8518848|NCT00395642|20997494|P1|NOT COMPLETED|Overall Study||13
8518849|NCT00395642|20997494|P1|COMPLETED|Overall Study||53
8518850|NCT00395642|20997494|P1|STARTED|Overall Study||66
8518851|NCT00395629|20997501|P3|NOT COMPLETED|Extension Study||3
8518852|NCT00395629|20997502|P2|NOT COMPLETED|Extension Study||0
8518853|NCT00395629|20997503|P1|NOT COMPLETED|Extension Study||0
8518854|NCT00395629|20997501|P3|COMPLETED|Extension Study||8
8518855|NCT00395629|20997502|P2|COMPLETED|Extension Study||6
8518856|NCT00395629|20997503|P1|COMPLETED|Extension Study||9
8518857|NCT00395629|20997501|P3|STARTED|Extension Study||11
8518858|NCT00395629|20997502|P2|STARTED|Extension Study||6
8518859|NCT00395629|20997503|P1|STARTED|Extension Study||9
8518860|NCT00395629|20997501|P3|NOT COMPLETED|Core Study||7
8518861|NCT00395629|20997502|P2|NOT COMPLETED|Core Study||4
8518862|NCT00395629|20997503|P1|NOT COMPLETED|Core Study||1
8518863|NCT00395629|20997501|P3|COMPLETED|Core Study||16
8518864|NCT00395629|20997502|P2|COMPLETED|Core Study||11
8518865|NCT00395629|20997503|P1|COMPLETED|Core Study||10
8518866|NCT00395629|20997501|P3|STARTED|Core Study||23
8518867|NCT00395629|20997502|P2|STARTED|Core Study||15
8518868|NCT00395629|20997503|P1|STARTED|Core Study||11
8518869|NCT00395538|20997520|P3|NOT COMPLETED|Overall Study||23
8518870|NCT00395538|20997521|P2|NOT COMPLETED|Overall Study||13
8518871|NCT00395538|20997522|P1|NOT COMPLETED|Overall Study||3
8518872|NCT00395538|20997520|P3|COMPLETED|Overall Study||0
8518873|NCT00395538|20997521|P2|COMPLETED|Overall Study||2
8518874|NCT00395538|20997522|P1|COMPLETED|Overall Study||5
8518875|NCT00395538|20997520|P3|Completed Bone Biopsy Year 4|Overall Study||1
8518876|NCT00395538|20997521|P2|Completed Bone Biopsy Year 4|Overall Study||1
8518877|NCT00395538|20997522|P1|Completed Bone Biopsy Year 4|Overall Study||0
8518878|NCT00395538|20997520|P3|Completed Bone Biopsy Year 2|Overall Study||3
8518879|NCT00395538|20997521|P2|Completed Bone Biopsy Year 2|Overall Study||2
8518880|NCT00395538|20997522|P1|Completed Bone Biopsy Year 2|Overall Study||0
8518881|NCT00395538|20997520|P3|Completed Bone Biopsy Year 1|Overall Study||4
8518882|NCT00395538|20997521|P2|Completed Bone Biopsy Year 1|Overall Study||1
8518883|NCT00395538|20997522|P1|Completed Bone Biopsy Year 1|Overall Study||0
8518884|NCT00395538|20997520|P3|Randomized to Bone Biospy Year 4|Overall Study||8
8518885|NCT00395538|20997521|P2|Randomized to Bone Biospy Year 4|Overall Study||2
8518886|NCT00395538|20997522|P1|Randomized to Bone Biospy Year 4|Overall Study||0
8518887|NCT00395538|20997520|P3|Randomized to Bone Biopsy Year 2|Overall Study||6
8518888|NCT00395538|20997521|P2|Randomized to Bone Biopsy Year 2|Overall Study||2
8518889|NCT00395538|20997522|P1|Randomized to Bone Biopsy Year 2|Overall Study||0
8518890|NCT00395538|20997520|P3|Randomized to Bone Biopsy Year 1|Overall Study||5
8518891|NCT00395538|20997521|P2|Randomized to Bone Biopsy Year 1|Overall Study||1
8518892|NCT00395538|20997522|P1|Randomized to Bone Biopsy Year 1|Overall Study||0
8518893|NCT00395538|20997520|P3|Received HPTH on New Protocol|Overall Study||19
8518894|NCT00395538|20997521|P2|Received HPTH on New Protocol|Overall Study||5
8518895|NCT00395538|20997522|P1|Received HPTH on New Protocol|Overall Study||7
8518896|NCT00395538|20997520|P3|Signed Consent to the New Protocol|Overall Study||23
8518897|NCT00395538|20997521|P2|Signed Consent to the New Protocol|Overall Study||5
8518898|NCT00395538|20997522|P1|Signed Consent to the New Protocol|Overall Study||7
8518899|NCT00395538|20997520|P3|STARTED|Overall Study||23
8518900|NCT00395538|20997521|P2|STARTED|Overall Study||15
8518901|NCT00395538|20997522|P1|STARTED|Overall Study||8
8518902|NCT00395512|20997595|P4|NOT COMPLETED|Overall Study||38
8518903|NCT00395512|20997596|P3|NOT COMPLETED|Overall Study||28
8518904|NCT00395512|20997597|P2|NOT COMPLETED|Overall Study||37
8518905|NCT00395512|20997598|P1|NOT COMPLETED|Overall Study||38
8518906|NCT00395512|20997595|P4|COMPLETED|Overall Study||126
8518907|NCT00395512|20997596|P3|COMPLETED|Overall Study||136
8518908|NCT00395512|20997597|P2|COMPLETED|Overall Study||126
8518909|NCT00395512|20997598|P1|COMPLETED|Overall Study||126
8518910|NCT00395512|20997595|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
8518911|NCT00395512|20997596|P3|Safety Set|Overall Study||164
8518912|NCT00395512|20997597|P2|Safety Set|Overall Study||163
8518913|NCT00395512|20997598|P1|Safety Set|Overall Study||164
8518914|NCT00395512|20997595|P4|STARTED|Overall Study||164
8518915|NCT00395512|20997596|P3|STARTED|Overall Study||164
8518916|NCT00395512|20997597|P2|STARTED|Overall Study||163
8518917|NCT00395512|20997598|P1|STARTED|Overall Study||164
8518918|NCT00395486|20997770|P2|NOT COMPLETED|Overall Study||5
8518919|NCT00395486|20997771|P1|NOT COMPLETED|Overall Study||6
8518920|NCT00395486|20997770|P2|COMPLETED|Overall Study|Completed subjects|121
8518921|NCT00395486|20997771|P1|COMPLETED|Overall Study|Completed subjects|126
8518922|NCT00395486|20997770|P2|STARTED|Overall Study|Randomized subjects|126
8518923|NCT00395486|20997771|P1|STARTED|Overall Study|Randomized subjects|132
8518924|NCT00395460|20997801|P2|NOT COMPLETED|Overall Study||0
8518925|NCT00395460|20997802|P1|NOT COMPLETED|Overall Study||1
8518926|NCT00395460|20997801|P2|COMPLETED|Overall Study||75
8518927|NCT00395460|20997802|P1|COMPLETED|Overall Study||71
8518928|NCT00395460|20997801|P2|Received Treatment|Overall Study||75
8518929|NCT00395460|20997802|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
8518930|NCT00395460|20997801|P2|STARTED|Overall Study||75
8518931|NCT00395460|20997802|P1|STARTED|Overall Study||72
8518932|NCT00395447|20997826|P2|NOT COMPLETED|Overall Study||111
8518933|NCT00395447|20997827|P1|NOT COMPLETED|Overall Study||121
8518934|NCT00395447|20997826|P2|COMPLETED|Overall Study||602
8518935|NCT00395447|20997827|P1|COMPLETED|Overall Study||910
8518936|NCT00395447|20997826|P2|STARTED|Overall Study||713
8518937|NCT00395447|20997827|P1|STARTED|Overall Study||1031
8518938|NCT00395343|20997835|P2|NOT COMPLETED|Overall Study||36
8518939|NCT00395343|20997836|P1|NOT COMPLETED|Overall Study||41
8518940|NCT00395343|20997835|P2|COMPLETED|Overall Study||283
8518941|NCT00395343|20997836|P1|COMPLETED|Overall Study||281
8518942|NCT00395343|20997835|P2|STARTED|Overall Study||319
8518943|NCT00395343|20997836|P1|STARTED|Overall Study||322
8518944|NCT00395304|20997854|P6|NOT COMPLETED|Treatment Period 3||1
8518945|NCT00395304|20997855|P5|NOT COMPLETED|Treatment Period 3||0
8518946|NCT00395304|20997856|P4|NOT COMPLETED|Treatment Period 3||2
8518947|NCT00395304|20997857|P3|NOT COMPLETED|Treatment Period 3||0
8518948|NCT00395304|20997858|P2|NOT COMPLETED|Treatment Period 3||2
8518949|NCT00395304|20997859|P1|NOT COMPLETED|Treatment Period 3||1
8518950|NCT00395304|20997854|P6|COMPLETED|Treatment Period 3||27
8518951|NCT00395304|20997855|P5|COMPLETED|Treatment Period 3||27
8518952|NCT00395304|20997856|P4|COMPLETED|Treatment Period 3||25
8518953|NCT00395304|20997857|P3|COMPLETED|Treatment Period 3||29
8518954|NCT00395304|20997858|P2|COMPLETED|Treatment Period 3||20
8518955|NCT00395304|20997859|P1|COMPLETED|Treatment Period 3||29
8518956|NCT00395304|20997854|P6|STARTED|Treatment Period 3||28
8518957|NCT00395304|20997855|P5|STARTED|Treatment Period 3||27
8518958|NCT00395304|20997856|P4|STARTED|Treatment Period 3||27
8518959|NCT00395304|20997857|P3|STARTED|Treatment Period 3||29
8518960|NCT00395304|20997858|P2|STARTED|Treatment Period 3||22
8518961|NCT00395304|20997859|P1|STARTED|Treatment Period 3||30
8518962|NCT00395304|20997854|P6|NOT COMPLETED|Treatment Period 2||2
8518963|NCT00395304|20997855|P5|NOT COMPLETED|Treatment Period 2||0
8518964|NCT00395304|20997856|P4|NOT COMPLETED|Treatment Period 2||1
8518965|NCT00395304|20997857|P3|NOT COMPLETED|Treatment Period 2||1
8518966|NCT00395304|20997858|P2|NOT COMPLETED|Treatment Period 2||4
8518967|NCT00395304|20997859|P1|NOT COMPLETED|Treatment Period 2||0
8518968|NCT00395304|20997854|P6|COMPLETED|Treatment Period 2||28
8518969|NCT00395304|20997855|P5|COMPLETED|Treatment Period 2||27
8518970|NCT00395304|20997856|P4|COMPLETED|Treatment Period 2||27
8518971|NCT00395304|20997857|P3|COMPLETED|Treatment Period 2||29
8518972|NCT00395304|20997858|P2|COMPLETED|Treatment Period 2||22
8518973|NCT00395304|20997859|P1|COMPLETED|Treatment Period 2||30
8518974|NCT00395304|20997854|P6|STARTED|Treatment Period 2||30
8518975|NCT00395304|20997855|P5|STARTED|Treatment Period 2||27
8518976|NCT00395304|20997856|P4|STARTED|Treatment Period 2||28
8518977|NCT00395304|20997857|P3|STARTED|Treatment Period 2||30
8518978|NCT00395304|20997858|P2|STARTED|Treatment Period 2||26
8518979|NCT00395304|20997859|P1|STARTED|Treatment Period 2||30
8518980|NCT00395304|20997854|P6|NOT COMPLETED|Treatment Period 1||2
8518981|NCT00395304|20997855|P5|NOT COMPLETED|Treatment Period 1||1
8518982|NCT00395304|20997856|P4|NOT COMPLETED|Treatment Period 1||3
8518983|NCT00395304|20997857|P3|NOT COMPLETED|Treatment Period 1||0
8518984|NCT00395304|20997858|P2|NOT COMPLETED|Treatment Period 1||4
8518985|NCT00395304|20997859|P1|NOT COMPLETED|Treatment Period 1||1
8518986|NCT00395304|20997854|P6|COMPLETED|Treatment Period 1||30
8518987|NCT00395304|20997855|P5|COMPLETED|Treatment Period 1||27
8518988|NCT00395304|20997856|P4|COMPLETED|Treatment Period 1||28
8518989|NCT00395304|20997857|P3|COMPLETED|Treatment Period 1||30
8518990|NCT00395304|20997858|P2|COMPLETED|Treatment Period 1||26
8518991|NCT00395304|20997859|P1|COMPLETED|Treatment Period 1||30
8518992|NCT00395304|20997854|P6|STARTED|Treatment Period 1||32
8518993|NCT00395304|20997855|P5|STARTED|Treatment Period 1||28
8518994|NCT00395304|20997856|P4|STARTED|Treatment Period 1||31
8518995|NCT00395304|20997857|P3|STARTED|Treatment Period 1||30
8518996|NCT00395304|20997858|P2|STARTED|Treatment Period 1||30
8518997|NCT00395304|20997859|P1|STARTED|Treatment Period 1||31
8518998|NCT00395291|20997902|P2|NOT COMPLETED|Second Intervention||0
8518999|NCT00395291|20997903|P1|NOT COMPLETED|Second Intervention||0
8519000|NCT00395291|20997902|P2|COMPLETED|Second Intervention||9
8519001|NCT00395291|20997903|P1|COMPLETED|Second Intervention||13
8519002|NCT00395291|20997902|P2|STARTED|Second Intervention||9
8519003|NCT00395291|20997903|P1|STARTED|Second Intervention||13
8519004|NCT00395291|20997902|P2|NOT COMPLETED|Washout Period for 30 Days||0
8519005|NCT00395291|20997903|P1|NOT COMPLETED|Washout Period for 30 Days||2
8519006|NCT00395291|20997902|P2|COMPLETED|Washout Period for 30 Days||9
8519007|NCT00395291|20997903|P1|COMPLETED|Washout Period for 30 Days||13
8519008|NCT00395291|20997902|P2|STARTED|Washout Period for 30 Days||9
8519009|NCT00395291|20997903|P1|STARTED|Washout Period for 30 Days||15
8519010|NCT00395291|20997902|P2|NOT COMPLETED|First Intervention||0
8519011|NCT00395291|20997903|P1|NOT COMPLETED|First Intervention||2
8519012|NCT00395291|20997902|P2|COMPLETED|First Intervention||9
8519013|NCT00395291|20997903|P1|COMPLETED|First Intervention||15
8519014|NCT00395291|20997902|P2|STARTED|First Intervention||9
8519015|NCT00395291|20997903|P1|STARTED|First Intervention||17
8519016|NCT00395226|20997935|P2|NOT COMPLETED|Overall Study||5
8519017|NCT00395226|20997936|P1|NOT COMPLETED|Overall Study||4
8519018|NCT00395226|20997935|P2|COMPLETED|Overall Study||22
8519019|NCT00395226|20997936|P1|COMPLETED|Overall Study||22
8519020|NCT00395226|20997935|P2|STARTED|Overall Study||27
8519021|NCT00395226|20997936|P1|STARTED|Overall Study||26
8519022|NCT00395161|20997944|P2|NOT COMPLETED|Overall Study||0
8519023|NCT00395161|20997945|P1|NOT COMPLETED|Overall Study||0
8519024|NCT00395161|20997944|P2|COMPLETED|Overall Study||144
8519025|NCT00395161|20997945|P1|COMPLETED|Overall Study||149
8519026|NCT00395161|20997944|P2|STARTED|Overall Study||144
8519027|NCT00395161|20997945|P1|STARTED|Overall Study||149
8519028|NCT00395135|20997961|P5|NOT COMPLETED|Year 2||190
8519029|NCT00395135|20997962|P4|NOT COMPLETED|Year 2||88
8519030|NCT00395135|20997963|P3|NOT COMPLETED|Year 2||147
8519031|NCT00395135|20997964|P2|NOT COMPLETED|Year 2||0
8519032|NCT00395135|20997965|P1|NOT COMPLETED|Year 2||0
8519033|NCT00395135|20997961|P5|COMPLETED|Year 2||507
8519034|NCT00395135|20997962|P4|COMPLETED|Year 2||195
8519035|NCT00395135|20997963|P3|COMPLETED|Year 2||426
8519036|NCT00395135|20997964|P2|COMPLETED|Year 2||0
8519037|NCT00395135|20997965|P1|COMPLETED|Year 2||0
8519038|NCT00395135|20997961|P5|STARTED|Year 2||697
8519039|NCT00395135|20997962|P4|STARTED|Year 2||283
8519040|NCT00395135|20997963|P3|STARTED|Year 2||573
8519041|NCT00395135|20997964|P2|STARTED|Year 2||0
8519042|NCT00395135|20997965|P1|STARTED|Year 2||0
8519043|NCT00395135|20997961|P5|NOT COMPLETED|Year 1||0
8519044|NCT00395135|20997962|P4|NOT COMPLETED|Year 1||0
8519045|NCT00395135|20997963|P3|NOT COMPLETED|Year 1||0
8519046|NCT00395135|20997964|P2|NOT COMPLETED|Year 1||871
8519047|NCT00395135|20997965|P1|NOT COMPLETED|Year 1||712
8519048|NCT00395135|20997961|P5|COMPLETED|Year 1||0
8519049|NCT00395135|20997962|P4|COMPLETED|Year 1||0
8519050|NCT00395135|20997963|P3|COMPLETED|Year 1||0
8519051|NCT00395135|20997964|P2|COMPLETED|Year 1||716
8519052|NCT00395135|20997965|P1|COMPLETED|Year 1||883
8519053|NCT00395135|20997961|P5|STARTED|Year 1||0
8519054|NCT00395135|20997962|P4|STARTED|Year 1||0
8519055|NCT00395135|20997963|P3|STARTED|Year 1||0
8519056|NCT00395135|20997964|P2|STARTED|Year 1||1587
8519057|NCT00395135|20997965|P1|STARTED|Year 1||1595
8519058|NCT00395083|20997983|P2|NOT COMPLETED|Overall Study||8
8519059|NCT00395083|20997984|P1|NOT COMPLETED|Overall Study||10
8519060|NCT00395083|20997983|P2|COMPLETED|Overall Study||201
8519061|NCT00395083|20997984|P1|COMPLETED|Overall Study||207
8519062|NCT00395083|20997983|P2|STARTED|Overall Study||209
8519063|NCT00395083|20997984|P1|STARTED|Overall Study||217
8519064|NCT00395057|20998000|P4|NOT COMPLETED|Overall Study||33
8519065|NCT00395057|20998001|P3|NOT COMPLETED|Overall Study||33
8519066|NCT00395057|20998002|P2|NOT COMPLETED|Overall Study||34
8519067|NCT00395057|20998003|P1|NOT COMPLETED|Overall Study||32
8519068|NCT00395057|20998000|P4|COMPLETED|Overall Study||1
8519069|NCT00395057|20998001|P3|COMPLETED|Overall Study||2
8519070|NCT00395057|20998002|P2|COMPLETED|Overall Study||1
8519071|NCT00395057|20998003|P1|COMPLETED|Overall Study||2
8519072|NCT00395057|20998000|P4|STARTED|Overall Study||34
8519073|NCT00395057|20998001|P3|STARTED|Overall Study||35
8519074|NCT00395057|20998002|P2|STARTED|Overall Study||35
8519075|NCT00395057|20998003|P1|STARTED|Overall Study||34
8519076|NCT00395044|20998031|P2|NOT COMPLETED|Overall Study||14
8519077|NCT00395044|20998032|P1|NOT COMPLETED|Overall Study||18
8519078|NCT00395044|20998031|P2|COMPLETED|Overall Study||11
8519079|NCT00395044|20998032|P1|COMPLETED|Overall Study||7
8519080|NCT00395044|20998031|P2|STARTED|Overall Study||25
8519081|NCT00395044|20998032|P1|STARTED|Overall Study||25
8519082|NCT00395018|20998050|P1|NOT COMPLETED|Off-Treatment Follow-up||4
8519083|NCT00395018|20998050|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
8519084|NCT00395018|20998050|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
8519085|NCT00395018|20998050|P1|NOT COMPLETED|On-Treatment||10
8519086|NCT00395018|20998050|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
8519087|NCT00395018|20998050|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
8519088|NCT00395018|20998050|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
8519089|NCT00395018|20998050|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
8519090|NCT00394953|20998071|P2|NOT COMPLETED|Second Treatment Period||74
8519091|NCT00394953|20998072|P1|NOT COMPLETED|Second Treatment Period||29
8519092|NCT00394953|20998071|P2|COMPLETED|Second Treatment Period||148
8519093|NCT00394953|20998072|P1|COMPLETED|Second Treatment Period||187
8519094|NCT00394953|20998071|P2|STARTED|Second Treatment Period||222
8519095|NCT00394953|20998072|P1|STARTED|Second Treatment Period||216
8519096|NCT00394953|20998071|P2|NOT COMPLETED|First Treatment Period||22
8519097|NCT00394953|20998072|P1|NOT COMPLETED|First Treatment Period||29
8519098|NCT00394953|20998071|P2|COMPLETED|First Treatment Period||222
8519099|NCT00394953|20998072|P1|COMPLETED|First Treatment Period||216
8519100|NCT00394953|20998071|P2|STARTED|First Treatment Period||244
8519101|NCT00394953|20998072|P1|STARTED|First Treatment Period||245
8519102|NCT00394914|20998090|P3|NOT COMPLETED|Treatment Period||6
8519103|NCT00394914|20998091|P2|NOT COMPLETED|Treatment Period||10
8519104|NCT00394914|20998092|P1|NOT COMPLETED|Treatment Period||0
8519105|NCT00394914|20998090|P3|COMPLETED|Treatment Period||151
8519106|NCT00394914|20998091|P2|COMPLETED|Treatment Period||144
8519107|NCT00394914|20998092|P1|COMPLETED|Treatment Period||0
8519108|NCT00394914|20998090|P3|STARTED|Treatment Period||157
8519109|NCT00394914|20998091|P2|STARTED|Treatment Period||154
8519110|NCT00394914|20998092|P1|STARTED|Treatment Period||0
8519111|NCT00394914|20998090|P3|NOT COMPLETED|Pre-exposure Period||0
8519112|NCT00394914|20998091|P2|NOT COMPLETED|Pre-exposure Period||0
8519113|NCT00394914|20998092|P1|NOT COMPLETED|Pre-exposure Period||0
8519114|NCT00394914|20998090|P3|COMPLETED|Pre-exposure Period||0
8519115|NCT00394914|20998091|P2|COMPLETED|Pre-exposure Period||0
8519116|NCT00394914|20998092|P1|COMPLETED|Pre-exposure Period||311
8519117|NCT00394914|20998090|P3|STARTED|Pre-exposure Period||0
8519118|NCT00394914|20998091|P2|STARTED|Pre-exposure Period||0
8519119|NCT00394914|20998092|P1|STARTED|Pre-exposure Period||311
8519120|NCT00394914|20998090|P3|NOT COMPLETED|Screening Period||0
8519121|NCT00394914|20998091|P2|NOT COMPLETED|Screening Period||0
8519122|NCT00394914|20998092|P1|NOT COMPLETED|Screening Period||0
8519123|NCT00394914|20998090|P3|COMPLETED|Screening Period||0
8519124|NCT00394914|20998091|P2|COMPLETED|Screening Period||0
8519125|NCT00394914|20998092|P1|COMPLETED|Screening Period||311
8519126|NCT00394914|20998090|P3|STARTED|Screening Period||0
8519127|NCT00394914|20998091|P2|STARTED|Screening Period||0
8519128|NCT00394914|20998092|P1|STARTED|Screening Period||311
8519153|NCT00394888|20998351|P3|NOT COMPLETED|Overall Study||0
8519154|NCT00394888|20998352|P2|NOT COMPLETED|Overall Study||0
8519155|NCT00394888|20998353|P1|NOT COMPLETED|Overall Study||0
8519156|NCT00394888|20998351|P3|COMPLETED|Overall Study||201
8519157|NCT00394888|20998352|P2|COMPLETED|Overall Study||48
8519158|NCT00394888|20998353|P1|COMPLETED|Overall Study||108
8519159|NCT00394888|20998351|P3|STARTED|Overall Study||201
8519160|NCT00394888|20998352|P2|STARTED|Overall Study||48
8519161|NCT00394888|20998353|P1|STARTED|Overall Study||108
8519162|NCT00394836|20998366|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
8519163|NCT00394836|20998367|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
8519164|NCT00394836|20998366|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
8519165|NCT00394836|20998367|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
8519166|NCT00394836|20998366|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
8519167|NCT00394836|20998367|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
8519168|NCT00394836|20998366|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
8519169|NCT00394836|20998367|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
8519170|NCT00394836|20998366|P2|COMPLETED|Teatment or Follow-up Phase||8
8519171|NCT00394836|20998367|P1|COMPLETED|Teatment or Follow-up Phase||2
8519172|NCT00394836|20998366|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
8519173|NCT00394836|20998367|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
8519174|NCT00394836|20998366|P2|STARTED|Teatment or Follow-up Phase||86
8519175|NCT00394836|20998367|P1|STARTED|Teatment or Follow-up Phase||30
8519176|NCT00394771|20998413|P4|NOT COMPLETED|Overall Study||39
8519177|NCT00394771|20998414|P3|NOT COMPLETED|Overall Study||47
8519178|NCT00394771|20998415|P2|NOT COMPLETED|Overall Study||34
8519179|NCT00394771|20998416|P1|NOT COMPLETED|Overall Study||41
8519180|NCT00394771|20998413|P4|COMPLETED|Overall Study||109
8519181|NCT00394771|20998414|P3|COMPLETED|Overall Study||96
8519182|NCT00394771|20998415|P2|COMPLETED|Overall Study||102
8519183|NCT00394771|20998416|P1|COMPLETED|Overall Study||99
8519184|NCT00394771|20998413|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
8519185|NCT00394771|20998414|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
8519186|NCT00394771|20998415|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
8519187|NCT00394771|20998416|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
8519188|NCT00394771|20998413|P4|STARTED|Overall Study|Safety population of treated participants|148
8519189|NCT00394771|20998414|P3|STARTED|Overall Study|Safety population of treated participants|143
8519190|NCT00394771|20998415|P2|STARTED|Overall Study|Safety population of treated participants|136
8519191|NCT00394771|20998416|P1|STARTED|Overall Study|Safety population of treated participants|140
8519192|NCT00394706|20998486|P8|NOT COMPLETED|Overall Study||0
8519193|NCT00394706|20998487|P7|NOT COMPLETED|Overall Study||3
8519194|NCT00394706|20998488|P6|NOT COMPLETED|Overall Study||7
8519195|NCT00394706|20998489|P5|NOT COMPLETED|Overall Study||2
8519196|NCT00394706|20998490|P4|NOT COMPLETED|Overall Study||1
8519197|NCT00394706|20998491|P3|NOT COMPLETED|Overall Study||9
8519198|NCT00394706|20998492|P2|NOT COMPLETED|Overall Study||2
8519199|NCT00394706|20998493|P1|NOT COMPLETED|Overall Study||4
8519200|NCT00394706|20998486|P8|COMPLETED|Overall Study||851
8519201|NCT00394706|20998487|P7|COMPLETED|Overall Study||926
8519202|NCT00394706|20998488|P6|COMPLETED|Overall Study||1377
8519203|NCT00394706|20998489|P5|COMPLETED|Overall Study||1634
8519204|NCT00394706|20998490|P4|COMPLETED|Overall Study||1632
8519205|NCT00394706|20998491|P3|COMPLETED|Overall Study||1615
8519206|NCT00394706|20998492|P2|COMPLETED|Overall Study||1860
8519207|NCT00394706|20998493|P1|COMPLETED|Overall Study||1815
8519208|NCT00394706|20998486|P8|STARTED|Overall Study||851
8519209|NCT00394706|20998487|P7|STARTED|Overall Study||929
8519210|NCT00394706|20998488|P6|STARTED|Overall Study||1384
8519211|NCT00394706|20998489|P5|STARTED|Overall Study||1636
8519212|NCT00394706|20998490|P4|STARTED|Overall Study||1633
8519213|NCT00394706|20998491|P3|STARTED|Overall Study||1624
8519214|NCT00394706|20998492|P2|STARTED|Overall Study||1862
8519215|NCT00394706|20998493|P1|STARTED|Overall Study||1819
8519216|NCT00394654|20998525|P2|NOT COMPLETED|Overall Study||0
8519217|NCT00394654|20998526|P1|NOT COMPLETED|Overall Study||2
8519218|NCT00394654|20998525|P2|COMPLETED|Overall Study||15
8519219|NCT00394654|20998526|P1|COMPLETED|Overall Study||13
8519220|NCT00394654|20998525|P2|STARTED|Overall Study||15
8519221|NCT00394654|20998526|P1|STARTED|Overall Study||15
8519222|NCT00394589|20998591|P3|NOT COMPLETED|Overall Study||7
8519223|NCT00394589|20998592|P2|NOT COMPLETED|Overall Study||3
8519224|NCT00394589|20998593|P1|NOT COMPLETED|Overall Study||8
8519225|NCT00394589|20998591|P3|COMPLETED|Overall Study||11
8519226|NCT00394589|20998592|P2|COMPLETED|Overall Study||8
8519227|NCT00394589|20998593|P1|COMPLETED|Overall Study||6
8519228|NCT00394589|20998591|P3|STARTED|Overall Study||18
8519229|NCT00394589|20998592|P2|STARTED|Overall Study||11
8519230|NCT00394589|20998593|P1|STARTED|Overall Study||14
8519231|NCT00394524|20998603|P2|NOT COMPLETED|Overall Study||4
8519232|NCT00394524|20998604|P1|NOT COMPLETED|Overall Study||3
8519233|NCT00394524|20998603|P2|COMPLETED|Overall Study||76
8519234|NCT00394524|20998604|P1|COMPLETED|Overall Study||77
8519235|NCT00394524|20998603|P2|STARTED|Overall Study||80
8519236|NCT00394524|20998604|P1|STARTED|Overall Study||80
8519237|NCT00394472|20998618|P2|NOT COMPLETED|Overall Study||11
8519238|NCT00394472|20998619|P1|NOT COMPLETED|Overall Study||9
8519239|NCT00394472|20998618|P2|COMPLETED|Overall Study||111
8519240|NCT00394472|20998619|P1|COMPLETED|Overall Study||113
8519241|NCT00394472|20998618|P2|STARTED|Overall Study||122
8519242|NCT00394472|20998619|P1|STARTED|Overall Study||122
8519243|NCT00394433|20998627|P1|NOT COMPLETED|Overall Study||3
8519244|NCT00394433|20998627|P1|COMPLETED|Overall Study||35
8519245|NCT00394433|20998627|P1|Evaluable and Treated|Overall Study||35
8519246|NCT00394433|20998627|P1|STARTED|Overall Study||38
8519247|NCT00394355|20998638|P4|NOT COMPLETED|Overall Study||31
8519248|NCT00394355|20998639|P3|NOT COMPLETED|Overall Study||38
8519249|NCT00394355|20998640|P2|NOT COMPLETED|Overall Study||34
8519250|NCT00394355|20998641|P1|NOT COMPLETED|Overall Study||35
8519251|NCT00394355|20998638|P4|COMPLETED|Overall Study||111
8519252|NCT00394355|20998639|P3|COMPLETED|Overall Study||109
8519253|NCT00394355|20998640|P2|COMPLETED|Overall Study||103
8519254|NCT00394355|20998641|P1|COMPLETED|Overall Study||105
8519255|NCT00394355|20998638|P4|STARTED|Overall Study||142
8519256|NCT00394355|20998639|P3|STARTED|Overall Study||147
8519257|NCT00394355|20998640|P2|STARTED|Overall Study||137
8519258|NCT00394355|20998641|P1|STARTED|Overall Study||140
8519259|NCT00394329|20998667|P4|NOT COMPLETED|Overall Study||24
8519260|NCT00394329|20998668|P3|NOT COMPLETED|Overall Study||13
8519261|NCT00394329|20998669|P2|NOT COMPLETED|Overall Study||9
8519262|NCT00394329|20998670|P1|NOT COMPLETED|Overall Study||8
8519263|NCT00394329|20998667|P4|COMPLETED|Overall Study||50
8519264|NCT00394329|20998668|P3|COMPLETED|Overall Study||58
8519265|NCT00394329|20998669|P2|COMPLETED|Overall Study||63
8519266|NCT00394329|20998670|P1|COMPLETED|Overall Study||63
8519267|NCT00394329|20998667|P4|STARTED|Overall Study||74
8519268|NCT00394329|20998668|P3|STARTED|Overall Study||71
8519269|NCT00394329|20998669|P2|STARTED|Overall Study||72
8519270|NCT00394329|20998670|P1|STARTED|Overall Study||71
8519271|NCT00394277|20998720|P4|NOT COMPLETED|Overall Study||125
8519272|NCT00394277|20998721|P3|NOT COMPLETED|Overall Study||120
8519273|NCT00394277|20998722|P2|NOT COMPLETED|Overall Study||60
8519274|NCT00394277|20998723|P1|NOT COMPLETED|Overall Study||58
8519275|NCT00394277|20998720|P4|COMPLETED|Overall Study||266
8519276|NCT00394277|20998721|P3|COMPLETED|Overall Study||273
8519277|NCT00394277|20998722|P2|COMPLETED|Overall Study||136
8519278|NCT00394277|20998723|P1|COMPLETED|Overall Study||137
8519279|NCT00394277|20998720|P4|STARTED|Overall Study||391
8519280|NCT00394277|20998721|P3|STARTED|Overall Study||393
8519281|NCT00394277|20998722|P2|STARTED|Overall Study||196
8519282|NCT00394277|20998723|P1|STARTED|Overall Study||195
8519283|NCT00394251|20998747|P2|NOT COMPLETED|Overall Study||38
8519284|NCT00394251|20998748|P1|NOT COMPLETED|Overall Study||37
8519285|NCT00394251|20998747|P2|COMPLETED|Overall Study||61
8519286|NCT00394251|20998748|P1|COMPLETED|Overall Study||61
8519287|NCT00394251|20998747|P2|At Least One Dose of Taxane|Overall Study||93
8519288|NCT00394251|20998748|P1|At Least One Dose of Taxane|Overall Study||93
8519289|NCT00394251|20998747|P2|STARTED|Overall Study||99
8519290|NCT00394251|20998748|P1|STARTED|Overall Study||98
8519291|NCT00394212|20998776|P2|NOT COMPLETED|Overall Study||1
8519292|NCT00394212|20998777|P1|NOT COMPLETED|Overall Study||7
8519293|NCT00394212|20998776|P2|COMPLETED|Overall Study||26
8519294|NCT00394212|20998777|P1|COMPLETED|Overall Study||43
8519295|NCT00394212|20998776|P2|6 Month Follow-up|Overall Study||26
8519296|NCT00394212|20998777|P1|6 Month Follow-up|Overall Study||43
8519297|NCT00394212|20998776|P2|3 Month Follow-up|Overall Study||26
8519298|NCT00394212|20998777|P1|3 Month Follow-up|Overall Study||45
8519299|NCT00394212|20998776|P2|6 Week Follow-up|Overall Study||26
8519300|NCT00394212|20998777|P1|6 Week Follow-up|Overall Study||45
8519301|NCT00394212|20998776|P2|STARTED|Overall Study||27
8519302|NCT00394212|20998777|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
8519303|NCT00394095|20998791|P2|NOT COMPLETED|Overall Study||0
8519304|NCT00394095|20998792|P1|NOT COMPLETED|Overall Study||1
8519305|NCT00394095|20998791|P2|COMPLETED|Overall Study||14
8519306|NCT00394095|20998792|P1|COMPLETED|Overall Study||16
8519307|NCT00394095|20998791|P2|Screened|Overall Study||14
8519308|NCT00394095|20998792|P1|Screened|Overall Study||17
8519309|NCT00394095|20998791|P2|STARTED|Overall Study||14
8519310|NCT00394095|20998792|P1|STARTED|Overall Study||17
8519311|NCT00394082|20998800|P1|NOT COMPLETED|Overall Study||26
8519312|NCT00394082|20998800|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
8519313|NCT00394082|20998800|P1|At Least One Response Assessment|Overall Study||43
8519314|NCT00394082|20998800|P1|STARTED|Overall Study||50
8519315|NCT00393978|20998811|P2|NOT COMPLETED|Overall Study||20
8519316|NCT00393978|20998812|P1|NOT COMPLETED|Overall Study||16
8519317|NCT00393978|20998811|P2|COMPLETED|Overall Study||18
8519318|NCT00393978|20998812|P1|COMPLETED|Overall Study||21
8519319|NCT00393978|20998811|P2|STARTED|Overall Study||38
8519320|NCT00393978|20998812|P1|STARTED|Overall Study||37
8519321|NCT00393939|20998822|P2|NOT COMPLETED|Overall Study||297
8519322|NCT00393939|20998823|P1|NOT COMPLETED|Overall Study||296
8519323|NCT00393939|20998822|P2|COMPLETED|Overall Study||0
8519324|NCT00393939|20998823|P1|COMPLETED|Overall Study||0
8519325|NCT00393939|20998822|P2|Treated|Overall Study||293
8519326|NCT00393939|20998823|P1|Treated|Overall Study||295
8519327|NCT00393939|20998822|P2|STARTED|Overall Study||297
8519328|NCT00393939|20998823|P1|STARTED|Overall Study||296
8519329|NCT00393913|20998841|P1|NOT COMPLETED|CPAP Withdrawal||0
8519330|NCT00393913|20998841|P1|COMPLETED|CPAP Withdrawal||42
8519331|NCT00393913|20998841|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
8519332|NCT00393913|20998841|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
8519333|NCT00393913|20998841|P1|NOT COMPLETED|CPAP||7
8519334|NCT00393913|20998841|P1|COMPLETED|CPAP||93
8519335|NCT00393913|20998841|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
8519336|NCT00393913|20998841|P1|NOT COMPLETED|Initial Assessment||37
8519337|NCT00393913|20998841|P1|COMPLETED|Initial Assessment||107
8519338|NCT00393913|20998841|P1|STARTED|Initial Assessment||144
8519339|NCT00393887|20998849|P2|NOT COMPLETED|Overall Study||9
8519340|NCT00393887|20998850|P1|NOT COMPLETED|Overall Study||16
8519341|NCT00393887|20998849|P2|COMPLETED|Overall Study||41
8519342|NCT00393887|20998850|P1|COMPLETED|Overall Study||34
8519343|NCT00393887|20998849|P2|1 Year|Overall Study||50
8519344|NCT00393887|20998850|P1|1 Year|Overall Study||45
8519345|NCT00393887|20998849|P2|STARTED|Overall Study||50
8519346|NCT00393887|20998850|P1|STARTED|Overall Study||50
8519347|NCT00393874|20998859|P3|NOT COMPLETED|Overall Study||2
8519348|NCT00393874|20998860|P2|NOT COMPLETED|Overall Study||4
8519349|NCT00393874|20998861|P1|NOT COMPLETED|Overall Study||3
8519350|NCT00393874|20998859|P3|COMPLETED|Overall Study||13
8519351|NCT00393874|20998860|P2|COMPLETED|Overall Study||13
8519352|NCT00393874|20998861|P1|COMPLETED|Overall Study||15
8519353|NCT00393874|20998859|P3|STARTED|Overall Study||15
8519354|NCT00393874|20998860|P2|STARTED|Overall Study||17
8519355|NCT00393874|20998861|P1|STARTED|Overall Study||18
8519356|NCT00393861|20998878|P1|NOT COMPLETED|Overall Study||26
8519357|NCT00393861|20998878|P1|COMPLETED|Overall Study||3
8519358|NCT00393861|20998878|P1|STARTED|Overall Study||29
8519359|NCT00393848|20998889|P4|NOT COMPLETED|Overall Study||1
8519360|NCT00393848|20998890|P3|NOT COMPLETED|Overall Study||2
8519361|NCT00393848|20998891|P2|NOT COMPLETED|Overall Study||0
8519362|NCT00393848|20998892|P1|NOT COMPLETED|Overall Study||0
8519363|NCT00393848|20998889|P4|COMPLETED|Overall Study||8
8519364|NCT00393848|20998890|P3|COMPLETED|Overall Study||4
8519365|NCT00393848|20998891|P2|COMPLETED|Overall Study||9
8519366|NCT00393848|20998892|P1|COMPLETED|Overall Study||16
8519367|NCT00393848|20998889|P4|STARTED|Overall Study||9
8519368|NCT00393848|20998890|P3|STARTED|Overall Study||6
8519369|NCT00393848|20998891|P2|STARTED|Overall Study||9
8519370|NCT00393848|20998892|P1|STARTED|Overall Study||16
8519371|NCT00393796|20998906|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
8519372|NCT00393796|20998907|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
8519373|NCT00393796|20998906|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
8519374|NCT00393796|20998907|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
8519375|NCT00393796|20998906|P2|STARTED|Open Label Period - Placebo to SUTENT||16
8519376|NCT00393796|20998907|P1|STARTED|Open Label Period - Placebo to SUTENT||0
8519377|NCT00393796|20998906|P2|NOT COMPLETED|Double Blind Period||0
8519378|NCT00393796|20998907|P1|NOT COMPLETED|Double Blind Period||0
8519379|NCT00393796|20998906|P2|COMPLETED|Double Blind Period||28
8519380|NCT00393796|20998907|P1|COMPLETED|Double Blind Period||26
8519381|NCT00393796|20998906|P2|STARTED|Double Blind Period||28
8519382|NCT00393796|20998907|P1|STARTED|Double Blind Period||26
8519383|NCT00393718|20998915|P2|NOT COMPLETED|Overall Study||22
8519384|NCT00393718|20998916|P1|NOT COMPLETED|Overall Study||43
8519385|NCT00393718|20998915|P2|COMPLETED|Overall Study||110
8519386|NCT00393718|20998916|P1|COMPLETED|Overall Study||225
8519387|NCT00393718|20998915|P2|STARTED|Overall Study||132
8519388|NCT00393718|20998916|P1|STARTED|Overall Study||268
8519389|NCT00393705|20998948|P2|NOT COMPLETED|Overall Study||23
8519390|NCT00393705|20998949|P1|NOT COMPLETED|Overall Study||23
8519391|NCT00393705|20998948|P2|COMPLETED|Overall Study||128
8519392|NCT00393705|20998949|P1|COMPLETED|Overall Study||128
8519393|NCT00393705|20998948|P2|Received at Least One Dose of Study Drug|Overall Study||139
8519394|NCT00393705|20998949|P1|Received at Least One Dose of Study Drug|Overall Study||139
8519395|NCT00393705|20998948|P2|STARTED|Overall Study||151
8519396|NCT00393705|20998949|P1|STARTED|Overall Study||151
8519397|NCT00393523|20998978|P5|NOT COMPLETED|Overall Study||1
8519398|NCT00393523|20998979|P4|NOT COMPLETED|Overall Study||6
8519399|NCT00393523|20998980|P3|NOT COMPLETED|Overall Study||4
8519400|NCT00393523|20998981|P2|NOT COMPLETED|Overall Study||9
8519401|NCT00393523|20998982|P1|NOT COMPLETED|Overall Study||12
8519402|NCT00393523|20998978|P5|COMPLETED|Overall Study||19
8519403|NCT00393523|20998979|P4|COMPLETED|Overall Study||348
8519404|NCT00393523|20998980|P3|COMPLETED|Overall Study||349
8519405|NCT00393523|20998981|P2|COMPLETED|Overall Study||366
8519406|NCT00393523|20998982|P1|COMPLETED|Overall Study||364
8519407|NCT00393523|20998978|P5|Vaccination Visit 1|Overall Study||20
8519408|NCT00393523|20998979|P4|Vaccination Visit 1|Overall Study||352
8519409|NCT00393523|20998980|P3|Vaccination Visit 1|Overall Study||349
8519410|NCT00393523|20998981|P2|Vaccination Visit 1|Overall Study||375
8519411|NCT00393523|20998982|P1|Vaccination Visit 1|Overall Study||374
8519412|NCT00393523|20998978|P5|STARTED|Overall Study||20
8519413|NCT00393523|20998979|P4|STARTED|Overall Study||354
8519414|NCT00393523|20998980|P3|STARTED|Overall Study||353
8519415|NCT00393523|20998981|P2|STARTED|Overall Study||375
8519416|NCT00393523|20998982|P1|STARTED|Overall Study||376
8519417|NCT00393510|20998999|P2|NOT COMPLETED|Overall Study||9
8519418|NCT00393510|20999000|P1|NOT COMPLETED|Overall Study||3
8519419|NCT00393510|20998999|P2|COMPLETED|Overall Study||31
8519420|NCT00393510|20999000|P1|COMPLETED|Overall Study||37
8519421|NCT00393510|20998999|P2|STARTED|Overall Study||40
8519422|NCT00393510|20999000|P1|STARTED|Overall Study||40
8519423|NCT00393484|20999012|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
8519424|NCT00393484|20999013|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
8519425|NCT00393484|20999012|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
8519426|NCT00393484|20999013|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
8519427|NCT00393484|20999012|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
8519428|NCT00393484|20999013|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
8519429|NCT00393484|20999012|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
8519430|NCT00393484|20999013|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
8519431|NCT00393484|20999012|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
8519432|NCT00393484|20999013|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
8519433|NCT00393484|20999012|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
8519434|NCT00393484|20999013|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
8519435|NCT00393484|20999012|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
8519436|NCT00393484|20999013|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
8519437|NCT00393484|20999012|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
8519438|NCT00393484|20999013|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
8519439|NCT00393484|20999012|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
8519440|NCT00393484|20999013|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
8519441|NCT00393458|20999049|P4|NOT COMPLETED|Overall Study||137
8519442|NCT00393458|20999050|P3|NOT COMPLETED|Overall Study||112
8519443|NCT00393458|20999051|P2|NOT COMPLETED|Overall Study||102
8519444|NCT00393458|20999052|P1|NOT COMPLETED|Overall Study||99
8519445|NCT00393458|20999049|P4|COMPLETED|Overall Study||295
8519446|NCT00393458|20999050|P3|COMPLETED|Overall Study||323
8519447|NCT00393458|20999051|P2|COMPLETED|Overall Study||326
8519448|NCT00393458|20999052|P1|COMPLETED|Overall Study||338
8519449|NCT00393458|20999049|P4|Exposed to Study Medication or Placebo|Overall Study||432
8519450|NCT00393458|20999050|P3|Exposed to Study Medication or Placebo|Overall Study||434
8519451|NCT00393458|20999051|P2|Exposed to Study Medication or Placebo|Overall Study||425
8519452|NCT00393458|20999052|P1|Exposed to Study Medication or Placebo|Overall Study||437
8519453|NCT00393458|20999049|P4|STARTED|Overall Study||432
8519454|NCT00393458|20999050|P3|STARTED|Overall Study||435
8519455|NCT00393458|20999051|P2|STARTED|Overall Study||428
8519456|NCT00393458|20999052|P1|STARTED|Overall Study||437
8519457|NCT00393380|20999066|P1|NOT COMPLETED|Overall Study||0
8519458|NCT00393380|20999066|P1|COMPLETED|Overall Study||13
8519459|NCT00393380|20999066|P1|STARTED|Overall Study||13
8519460|NCT00393367|20999079|P2|NOT COMPLETED|Overall Study||7
8519461|NCT00393367|20999080|P1|NOT COMPLETED|Overall Study||2
8519462|NCT00393367|20999079|P2|COMPLETED|Overall Study||81
8519463|NCT00393367|20999080|P1|COMPLETED|Overall Study||89
8519464|NCT00393367|20999079|P2|STARTED|Overall Study||88
8519465|NCT00393367|20999080|P1|STARTED|Overall Study||91
8519466|NCT00393094|20999108|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
8519467|NCT00393094|20999108|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
8519468|NCT00393094|20999108|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
8519469|NCT00393094|20999108|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
8519470|NCT00393094|20999108|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
8519471|NCT00393094|20999108|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
8519472|NCT00393068|20999115|P1|NOT COMPLETED|Overall Study||18
8519473|NCT00393068|20999115|P1|COMPLETED|Overall Study||44
8519474|NCT00393068|20999115|P1|STARTED|Overall Study||62
8519475|NCT00393042|20999119|P2|NOT COMPLETED|Second Intervetion||8
8519476|NCT00393042|20999120|P1|NOT COMPLETED|Second Intervetion||2
8519477|NCT00393042|20999119|P2|COMPLETED|Second Intervetion||19
8519478|NCT00393042|20999120|P1|COMPLETED|Second Intervetion||24
8519479|NCT00393042|20999119|P2|Completed 25/30 mg Dosage|Second Intervetion||20
8519480|NCT00393042|20999120|P1|Completed 25/30 mg Dosage|Second Intervetion||24
8519481|NCT00393042|20999119|P2|Completed the 20mg Dosage|Second Intervetion||21
8519482|NCT00393042|20999120|P1|Completed the 20mg Dosage|Second Intervetion||24
8519483|NCT00393042|20999119|P2|Completed 10 mg Dosage|Second Intervetion||24
8519484|NCT00393042|20999120|P1|Completed 10 mg Dosage|Second Intervetion||26
8519485|NCT00393042|20999119|P2|Completed Placebo Dosage|Second Intervetion||21
8519486|NCT00393042|20999120|P1|Completed Placebo Dosage|Second Intervetion||25
8519487|NCT00393042|20999119|P2|STARTED|Second Intervetion||27
8519488|NCT00393042|20999120|P1|STARTED|Second Intervetion||26
8519489|NCT00393042|20999119|P2|NOT COMPLETED|First Intervention||6
8519490|NCT00393042|20999120|P1|NOT COMPLETED|First Intervention||5
8519491|NCT00393042|20999119|P2|COMPLETED|First Intervention||27
8519492|NCT00393042|20999120|P1|COMPLETED|First Intervention||26
8519493|NCT00393042|20999119|P2|Completed 25/30mg Dosage|First Intervention||27
8519494|NCT00393042|20999120|P1|Completed 25/30mg Dosage|First Intervention||27
8519495|NCT00393042|20999119|P2|Completed 20 mg Dosage|First Intervention||28
8519496|NCT00393042|20999120|P1|Completed 20 mg Dosage|First Intervention||26
8519497|NCT00393042|20999119|P2|Completed 10mg Dosage|First Intervention||29
8519498|NCT00393042|20999120|P1|Completed 10mg Dosage|First Intervention||29
8519499|NCT00393042|20999119|P2|Completed the Placebo Dosage|First Intervention||29
8519500|NCT00393042|20999120|P1|Completed the Placebo Dosage|First Intervention||27
8519501|NCT00393042|20999119|P2|STARTED|First Intervention||33
8519502|NCT00393042|20999120|P1|STARTED|First Intervention||31
8519503|NCT00393029|20999192|P2|NOT COMPLETED|Overall Study||1
8519504|NCT00393029|20999193|P1|NOT COMPLETED|Overall Study||0
8519505|NCT00393029|20999192|P2|COMPLETED|Overall Study||9
8519506|NCT00393029|20999193|P1|COMPLETED|Overall Study||2
8519507|NCT00393029|20999192|P2|STARTED|Overall Study||10
8519508|NCT00393029|20999193|P1|STARTED|Overall Study||2
8519509|NCT00392990|20999204|P2|NOT COMPLETED|Follow up for 2 Years||0
8519510|NCT00392990|20999205|P1|NOT COMPLETED|Follow up for 2 Years||4
8519511|NCT00392990|20999204|P2|COMPLETED|Follow up for 2 Years||5
8519512|NCT00392990|20999205|P1|COMPLETED|Follow up for 2 Years||16
8519513|NCT00392990|20999204|P2|STARTED|Follow up for 2 Years||5
8519514|NCT00392990|20999205|P1|STARTED|Follow up for 2 Years||20
8519515|NCT00392990|20999204|P2|NOT COMPLETED|Treatment on Study||1
8519516|NCT00392990|20999205|P1|NOT COMPLETED|Treatment on Study||3
8519517|NCT00392990|20999204|P2|COMPLETED|Treatment on Study||4
8519518|NCT00392990|20999205|P1|COMPLETED|Treatment on Study||17
8519519|NCT00392990|20999204|P2|STARTED|Treatment on Study||5
8519520|NCT00392990|20999205|P1|STARTED|Treatment on Study||20
8519521|NCT00392951|20999217|P1|NOT COMPLETED|Overall Study||0
8519522|NCT00392951|20999217|P1|COMPLETED|Overall Study||30
8519523|NCT00392951|20999217|P1|STARTED|Overall Study||30
8519524|NCT00392925|20999229|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
8519525|NCT00392925|20999230|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
8519526|NCT00392925|20999231|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
8519527|NCT00392925|20999232|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
8519528|NCT00392925|20999229|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
8519529|NCT00392925|20999230|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
8519530|NCT00392925|20999231|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
8519531|NCT00392925|20999232|P1|COMPLETED|Randomization to Treatment Group Period||0
8519532|NCT00392925|20999229|P4|STARTED|Randomization to Treatment Group Period||56
8519533|NCT00392925|20999230|P3|STARTED|Randomization to Treatment Group Period||56
8519534|NCT00392925|20999231|P2|STARTED|Randomization to Treatment Group Period||27
8519535|NCT00392925|20999232|P1|STARTED|Randomization to Treatment Group Period||0
8519536|NCT00392925|20999229|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519537|NCT00392925|20999230|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519538|NCT00392925|20999231|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519539|NCT00392925|20999232|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
8519540|NCT00392925|20999229|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519541|NCT00392925|20999230|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519542|NCT00392925|20999231|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519543|NCT00392925|20999232|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
8519544|NCT00392925|20999229|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
8519545|NCT00392925|20999230|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
8519546|NCT00392925|20999231|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
8519547|NCT00392925|20999232|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
8519548|NCT00392860|20999320|P3|NOT COMPLETED|Overall Study||0
8519549|NCT00392860|20999321|P2|NOT COMPLETED|Overall Study||0
8519550|NCT00392860|20999322|P1|NOT COMPLETED|Overall Study||0
8519551|NCT00392860|20999320|P3|COMPLETED|Overall Study||1
8519552|NCT00392860|20999321|P2|COMPLETED|Overall Study||0
8519553|NCT00392860|20999322|P1|COMPLETED|Overall Study||3
8519554|NCT00392860|20999320|P3|STARTED|Overall Study||1
8519555|NCT00392860|20999321|P2|STARTED|Overall Study||0
8519556|NCT00392860|20999322|P1|STARTED|Overall Study||3
8519557|NCT00392834|20999330|P2|NOT COMPLETED|Overall Study||0
8519558|NCT00392834|20999331|P1|NOT COMPLETED|Overall Study||0
8519559|NCT00392834|20999330|P2|COMPLETED|Overall Study||32
8519560|NCT00392834|20999331|P1|COMPLETED|Overall Study||2
8519561|NCT00392834|20999330|P2|STARTED|Overall Study||32
8519562|NCT00392834|20999331|P1|STARTED|Overall Study||2
8519563|NCT00392821|20999337|P1|NOT COMPLETED|Overall Study||19
8519564|NCT00392821|20999337|P1|COMPLETED|Overall Study||59
8519565|NCT00392821|20999337|P1|STARTED|Overall Study||78
8519566|NCT00392808|20999346|P4|NOT COMPLETED|Overall Study||4
8519567|NCT00392808|20999347|P3|NOT COMPLETED|Overall Study||2
8519568|NCT00392808|20999348|P2|NOT COMPLETED|Overall Study||3
8519569|NCT00392808|20999349|P1|NOT COMPLETED|Overall Study||6
8519570|NCT00392808|20999346|P4|COMPLETED|Overall Study||100
8519571|NCT00392808|20999347|P3|COMPLETED|Overall Study||107
8519572|NCT00392808|20999348|P2|COMPLETED|Overall Study||86
8519573|NCT00392808|20999349|P1|COMPLETED|Overall Study||81
8519574|NCT00392808|20999346|P4|STARTED|Overall Study||104
8519575|NCT00392808|20999347|P3|STARTED|Overall Study||109
8519576|NCT00392808|20999348|P2|STARTED|Overall Study||89
8519577|NCT00392808|20999349|P1|STARTED|Overall Study||87
8519578|NCT00392782|20999363|P1|NOT COMPLETED|Overall Study||0
8519579|NCT00392782|20999363|P1|COMPLETED|Overall Study||24
8519580|NCT00392782|20999363|P1|STARTED|Overall Study||24
8519581|NCT00392769|20999373|P1|NOT COMPLETED|Overall Study||10
8519582|NCT00392769|20999373|P1|COMPLETED|Overall Study||23
8519583|NCT00392769|20999373|P1|STARTED|Overall Study||33
8519584|NCT00392704|20999377|P1|NOT COMPLETED|Combined Modality Therapy||5
8519585|NCT00392704|20999377|P1|COMPLETED|Combined Modality Therapy||49
8519586|NCT00392704|20999377|P1|STARTED|Combined Modality Therapy||54
8519587|NCT00392704|20999377|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
8519588|NCT00392704|20999377|P1|COMPLETED|Neoadjuvant Chemotherapy||54
8519589|NCT00392704|20999377|P1|STARTED|Neoadjuvant Chemotherapy||60
8519590|NCT00392678|20999386|P4|NOT COMPLETED|Overall Study||1
8519591|NCT00392678|20999387|P3|NOT COMPLETED|Overall Study||2
8519592|NCT00392678|20999388|P2|NOT COMPLETED|Overall Study||1
8519593|NCT00392678|20999389|P1|NOT COMPLETED|Overall Study||0
8519594|NCT00392678|20999386|P4|COMPLETED|Overall Study||26
8519595|NCT00392678|20999387|P3|COMPLETED|Overall Study||25
8519596|NCT00392678|20999388|P2|COMPLETED|Overall Study||26
8519597|NCT00392678|20999389|P1|COMPLETED|Overall Study||27
8519598|NCT00392678|20999386|P4|STARTED|Overall Study||27
8519599|NCT00392678|20999387|P3|STARTED|Overall Study||27
8519600|NCT00392678|20999388|P2|STARTED|Overall Study||27
8519601|NCT00392678|20999389|P1|STARTED|Overall Study||27
8519602|NCT00392665|20999425|P2|NOT COMPLETED|Overall Study||15
8519603|NCT00392665|20999426|P1|NOT COMPLETED|Overall Study||17
8519604|NCT00392665|20999425|P2|COMPLETED|Overall Study||3
8519605|NCT00392665|20999426|P1|COMPLETED|Overall Study||1
8519606|NCT00392665|20999425|P2|STARTED|Overall Study||18
8519607|NCT00392665|20999426|P1|STARTED|Overall Study||18
8519608|NCT00392496|20999438|P1|NOT COMPLETED|Overall Study||0
8519609|NCT00392496|20999438|P1|COMPLETED|Overall Study||19
8519610|NCT00392496|20999438|P1|STARTED|Overall Study||19
8519611|NCT00392444|20999442|P1|NOT COMPLETED|Overall Study||0
8519612|NCT00392444|20999442|P1|COMPLETED|Overall Study||39
8519613|NCT00392444|20999442|P1|STARTED|Overall Study||39
8519614|NCT00392392|20999446|P1|NOT COMPLETED|Overall Study||20
8519615|NCT00392392|20999446|P1|COMPLETED|Overall Study||9
8519616|NCT00392392|20999446|P1|STARTED|Overall Study||29
8519617|NCT00392379|20999452|P2|NOT COMPLETED|Overall Study||38
8519618|NCT00392379|20999453|P1|NOT COMPLETED|Overall Study||22
8519619|NCT00392379|20999452|P2|COMPLETED|Overall Study|Medication period|96
8519620|NCT00392379|20999453|P1|COMPLETED|Overall Study|Medication period|114
8519621|NCT00392379|20999452|P2|STARTED|Overall Study|Medication period|134
8519622|NCT00392379|20999453|P1|STARTED|Overall Study|Medication period|136
8519623|NCT00392327|20999471|P8|NOT COMPLETED|Overall Study||11
8519624|NCT00392327|20999472|P7|NOT COMPLETED|Overall Study||9
8519625|NCT00392327|20999473|P6|NOT COMPLETED|Overall Study||5
8519626|NCT00392327|20999474|P5|NOT COMPLETED|Overall Study||3
8519627|NCT00392327|20999475|P4|NOT COMPLETED|Overall Study||16
8519628|NCT00392327|20999476|P3|NOT COMPLETED|Overall Study||20
8519629|NCT00392327|20999477|P2|NOT COMPLETED|Overall Study||19
8519630|NCT00392327|20999478|P1|NOT COMPLETED|Overall Study||15
8519631|NCT00392327|20999471|P8|COMPLETED|Overall Study||11
8519632|NCT00392327|20999472|P7|COMPLETED|Overall Study||12
8519633|NCT00392327|20999473|P6|COMPLETED|Overall Study||14
8519634|NCT00392327|20999474|P5|COMPLETED|Overall Study||20
8519635|NCT00392327|20999475|P4|COMPLETED|Overall Study||42
8519636|NCT00392327|20999476|P3|COMPLETED|Overall Study||36
8519637|NCT00392327|20999477|P2|COMPLETED|Overall Study||74
8519638|NCT00392327|20999478|P1|COMPLETED|Overall Study||72
8519639|NCT00392327|20999471|P8|STARTED|Overall Study||22
8519640|NCT00392327|20999472|P7|STARTED|Overall Study||21
8519641|NCT00392327|20999473|P6|STARTED|Overall Study||19
8519642|NCT00392327|20999474|P5|STARTED|Overall Study||23
8519643|NCT00392327|20999475|P4|STARTED|Overall Study||58
8519644|NCT00392327|20999476|P3|STARTED|Overall Study||56
8519645|NCT00392327|20999477|P2|STARTED|Overall Study||93
8519646|NCT00392327|20999478|P1|STARTED|Overall Study||87
8519647|NCT00392288|20999547|P3|NOT COMPLETED|Overall Study||17
8519648|NCT00392288|20999548|P2|NOT COMPLETED|Overall Study||22
8519649|NCT00392288|20999549|P1|NOT COMPLETED|Overall Study||32
8519650|NCT00392288|20999547|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
8519651|NCT00392288|20999548|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
8519652|NCT00392288|20999549|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
8519653|NCT00392288|20999547|P3|Treatment Period|Overall Study||175
8519654|NCT00392288|20999548|P2|Treatment Period|Overall Study||174
8519655|NCT00392288|20999549|P1|Treatment Period|Overall Study||172
8519656|NCT00392288|20999547|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
8519657|NCT00392288|20999548|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
8519658|NCT00392288|20999549|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
8519659|NCT00392236|20999565|P2|NOT COMPLETED|Overall Study||6
8519660|NCT00392236|20999566|P1|NOT COMPLETED|Overall Study||12
8519661|NCT00392236|20999565|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
8519662|NCT00392236|20999566|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
8519663|NCT00392236|20999565|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
8519664|NCT00392236|20999566|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
8519665|NCT00392223|20999574|P2|NOT COMPLETED|Overall Study||13
8519666|NCT00392223|20999575|P1|NOT COMPLETED|Overall Study||9
8519667|NCT00392223|20999574|P2|COMPLETED|Overall Study||47
8519668|NCT00392223|20999575|P1|COMPLETED|Overall Study||49
8519669|NCT00392223|20999574|P2|STARTED|Overall Study||60
8519670|NCT00392223|20999575|P1|STARTED|Overall Study||58
8519671|NCT00392210|20999593|P2|NOT COMPLETED|Second Voiding Trial||0
8519672|NCT00392210|20999594|P1|NOT COMPLETED|Second Voiding Trial||0
8519673|NCT00392210|20999593|P2|COMPLETED|Second Voiding Trial||31
8519674|NCT00392210|20999594|P1|COMPLETED|Second Voiding Trial||34
8519675|NCT00392210|20999593|P2|STARTED|Second Voiding Trial||31
8519676|NCT00392210|20999594|P1|STARTED|Second Voiding Trial||34
8519677|NCT00392210|20999593|P2|NOT COMPLETED|First Voiding Trial||2
8519678|NCT00392210|20999594|P1|NOT COMPLETED|First Voiding Trial||2
8519679|NCT00392210|20999593|P2|COMPLETED|First Voiding Trial||31
8519680|NCT00392210|20999594|P1|COMPLETED|First Voiding Trial||34
8519681|NCT00392210|20999593|P2|STARTED|First Voiding Trial||33
8519682|NCT00392210|20999594|P1|STARTED|First Voiding Trial||36
8519683|NCT00392197|20999602|P2|NOT COMPLETED|Overall Study||30
8519684|NCT00392197|20999603|P1|NOT COMPLETED|Overall Study||21
8519685|NCT00392197|20999602|P2|COMPLETED|Overall Study||33
8519686|NCT00392197|20999603|P1|COMPLETED|Overall Study||27
8519687|NCT00392197|20999602|P2|STARTED|Overall Study||63
8519688|NCT00392197|20999603|P1|STARTED|Overall Study||48
8519689|NCT00392171|20999611|P1|NOT COMPLETED|Overall Study||105
8519690|NCT00392171|20999611|P1|COMPLETED|Overall Study||15
8519691|NCT00392171|20999611|P1|STARTED|Overall Study||120
8519692|NCT00392054|20999617|P2|NOT COMPLETED|Overall Study||0
8519693|NCT00392054|20999618|P1|NOT COMPLETED|Overall Study||0
8519694|NCT00392054|20999617|P2|COMPLETED|Overall Study||61
8519695|NCT00392054|20999618|P1|COMPLETED|Overall Study||66
8519696|NCT00392054|20999617|P2|Received Allocated Intervention|Overall Study||60
8519697|NCT00392054|20999618|P1|Received Allocated Intervention|Overall Study||65
8519698|NCT00392054|20999617|P2|STARTED|Overall Study|All participants randomized are included in final analysis|61
8519699|NCT00392054|20999618|P1|STARTED|Overall Study|All participants randomized are included in final analysis|66
8519700|NCT00392041|20999640|P2|NOT COMPLETED|Weeks 5 - 12||5
8519701|NCT00392041|20999641|P1|NOT COMPLETED|Weeks 5 - 12||4
8519702|NCT00392041|20999640|P2|COMPLETED|Weeks 5 - 12||9
8519703|NCT00392041|20999641|P1|COMPLETED|Weeks 5 - 12||7
8519704|NCT00392041|20999640|P2|STARTED|Weeks 5 - 12||14
8519705|NCT00392041|20999641|P1|STARTED|Weeks 5 - 12||11
8519706|NCT00392041|20999640|P2|NOT COMPLETED|First 4 Weeks||3
8519707|NCT00392041|20999641|P1|NOT COMPLETED|First 4 Weeks||8
8519708|NCT00392041|20999640|P2|COMPLETED|First 4 Weeks||14
8519709|NCT00392041|20999641|P1|COMPLETED|First 4 Weeks||11
8519710|NCT00392041|20999640|P2|STARTED|First 4 Weeks||17
8519711|NCT00392041|20999641|P1|STARTED|First 4 Weeks||19
8519712|NCT00391989|20999655|P1|NOT COMPLETED|Overall Study||2
8519713|NCT00391989|20999655|P1|COMPLETED|Overall Study||53
8519714|NCT00391989|20999655|P1|STARTED|Overall Study||55
8519715|NCT00391976|20999662|P3|NOT COMPLETED|Overall Study||35
8519716|NCT00391976|20999663|P2|NOT COMPLETED|Overall Study||25
8519717|NCT00391976|20999664|P1|NOT COMPLETED|Overall Study||27
8519718|NCT00391976|20999662|P3|COMPLETED|Overall Study||0
8519719|NCT00391976|20999663|P2|COMPLETED|Overall Study||18
8519720|NCT00391976|20999664|P1|COMPLETED|Overall Study||18
8519721|NCT00391976|20999662|P3|Safety Population|Overall Study||35
8519722|NCT00391976|20999663|P2|Safety Population|Overall Study||43
8519723|NCT00391976|20999664|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
8519724|NCT00391976|20999662|P3|Randomized|Overall Study||0
8519725|NCT00391976|20999663|P2|Randomized|Overall Study||43
8519726|NCT00391976|20999664|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
8519727|NCT00391976|20999662|P3|STARTED|Overall Study||35
8519728|NCT00391976|20999663|P2|STARTED|Overall Study||43
8519729|NCT00391976|20999664|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
8519730|NCT00391898|20999688|P2|NOT COMPLETED|Overall Study||10
8519731|NCT00391898|20999689|P1|NOT COMPLETED|Overall Study||11
8519732|NCT00391898|20999688|P2|COMPLETED|Overall Study||39
8519733|NCT00391898|20999689|P1|COMPLETED|Overall Study||35
8519734|NCT00391898|20999688|P2|STARTED|Overall Study||49
8519735|NCT00391898|20999689|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
8519736|NCT00391872|20999709|P2|NOT COMPLETED|Overall Study||255
8519737|NCT00391872|20999710|P1|NOT COMPLETED|Overall Study||307
8519738|NCT00391872|20999709|P2|COMPLETED|Overall Study||9036
8519739|NCT00391872|20999710|P1|COMPLETED|Overall Study||9026
8519740|NCT00391872|20999709|P2|STARTED|Overall Study||9291
8519741|NCT00391872|20999710|P1|STARTED|Overall Study||9333
8519742|NCT00391846|20999748|P2|NOT COMPLETED|Overall Study||7
8519743|NCT00391846|20999749|P1|NOT COMPLETED|Overall Study||8
8519744|NCT00391846|20999748|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
8519745|NCT00391846|20999749|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
8519746|NCT00391846|20999748|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
8519747|NCT00391846|20999749|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
8519748|NCT00391807|20999769|P1|NOT COMPLETED|Overall Study||715
8519749|NCT00391807|20999769|P1|COMPLETED|Overall Study||968
8519750|NCT00391807|20999769|P1|STARTED|Overall Study||1683
8519751|NCT00391768|20999796|P7|NOT COMPLETED|Overall Study||4
8519752|NCT00391768|20999797|P6|NOT COMPLETED|Overall Study||3
8519753|NCT00391768|20999798|P5|NOT COMPLETED|Overall Study||2
8519754|NCT00391768|20999799|P4|NOT COMPLETED|Overall Study||1
8519755|NCT00391768|20999800|P3|NOT COMPLETED|Overall Study||1
8519756|NCT00391768|20999801|P2|NOT COMPLETED|Overall Study||0
8519757|NCT00391768|20999802|P1|NOT COMPLETED|Overall Study||0
8519758|NCT00391768|20999796|P7|COMPLETED|Overall Study||19
8519759|NCT00391768|20999797|P6|COMPLETED|Overall Study||7
8519760|NCT00391768|20999798|P5|COMPLETED|Overall Study||22
8519761|NCT00391768|20999799|P4|COMPLETED|Overall Study||7
8519762|NCT00391768|20999800|P3|COMPLETED|Overall Study||6
8519763|NCT00391768|20999801|P2|COMPLETED|Overall Study||3
8519764|NCT00391768|20999802|P1|COMPLETED|Overall Study||12
8519765|NCT00391768|20999796|P7|STARTED|Overall Study||23
8519766|NCT00391768|20999797|P6|STARTED|Overall Study||10
8519767|NCT00391768|20999798|P5|STARTED|Overall Study||24
8519768|NCT00391768|20999799|P4|STARTED|Overall Study||8
8519769|NCT00391768|20999800|P3|STARTED|Overall Study||7
8519770|NCT00391768|20999801|P2|STARTED|Overall Study||3
8519771|NCT00391768|20999802|P1|STARTED|Overall Study||12
8519772|NCT00391716|20999870|P3|NOT COMPLETED|Overall Study||19
8519773|NCT00391716|20999871|P2|NOT COMPLETED|Overall Study||19
8519774|NCT00391716|20999872|P1|NOT COMPLETED|Overall Study||27
8519775|NCT00391716|20999870|P3|COMPLETED|Overall Study||30
8519776|NCT00391716|20999871|P2|COMPLETED|Overall Study||28
8519777|NCT00391716|20999872|P1|COMPLETED|Overall Study||27
8519778|NCT00391716|20999870|P3|STARTED|Overall Study||49
8519779|NCT00391716|20999871|P2|STARTED|Overall Study||47
8519780|NCT00391716|20999872|P1|STARTED|Overall Study||54
8519781|NCT00391625|20999889|P1|NOT COMPLETED|Month 84||0
8519782|NCT00391625|20999889|P1|COMPLETED|Month 84||8
8519783|NCT00391625|20999889|P1|STARTED|Month 84||8
8519784|NCT00391625|20999889|P1|NOT COMPLETED|Month 50||1
8519785|NCT00391625|20999889|P1|COMPLETED|Month 50||8
8519786|NCT00391625|20999889|P1|STARTED|Month 50||9
8519787|NCT00391625|20999889|P1|NOT COMPLETED|Month 14||1
8519788|NCT00391625|20999889|P1|COMPLETED|Month 14||9
8519789|NCT00391625|20999889|P1|STARTED|Month 14||10
8519790|NCT00391625|20999889|P1|NOT COMPLETED|Baseline||0
8519791|NCT00391625|20999889|P1|COMPLETED|Baseline||10
8519792|NCT00391625|20999889|P1|STARTED|Baseline||10
8519793|NCT00391599|20999931|P2|NOT COMPLETED|Overall Study||0
8519794|NCT00391599|20999932|P1|NOT COMPLETED|Overall Study||0
8519795|NCT00391599|20999931|P2|COMPLETED|Overall Study||65
8519796|NCT00391599|20999932|P1|COMPLETED|Overall Study||65
8519797|NCT00391599|20999931|P2|STARTED|Overall Study||65
8519798|NCT00391599|20999932|P1|STARTED|Overall Study||65
8519799|NCT00391586|20999942|P1|NOT COMPLETED|Overall Study||24
8519800|NCT00391586|20999942|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
8519801|NCT00391586|20999942|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
8519802|NCT00391586|20999942|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
8519803|NCT00391586|20999942|P1|STARTED|Overall Study||45
8519804|NCT00391469|20999951|P2|NOT COMPLETED|Overall Study||0
8519805|NCT00391469|20999952|P1|NOT COMPLETED|Overall Study||0
8519806|NCT00391469|20999951|P2|COMPLETED|Overall Study||671
8519807|NCT00391469|20999952|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
8519808|NCT00391469|20999951|P2|STARTED|Overall Study||671
8519809|NCT00391469|20999952|P1|STARTED|Overall Study||688
8519810|NCT00391443|20999966|P2|NOT COMPLETED|Overall Study||0
8519811|NCT00391443|20999967|P1|NOT COMPLETED|Overall Study||0
8519812|NCT00391443|20999966|P2|COMPLETED|Overall Study||407
8519813|NCT00391443|20999967|P1|COMPLETED|Overall Study||209
8519814|NCT00391443|20999966|P2|STARTED|Overall Study||407
8519815|NCT00391443|20999967|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
8519816|NCT00391391|20999979|P4|NOT COMPLETED|Overall Study||19
8519817|NCT00391391|20999980|P3|NOT COMPLETED|Overall Study||23
8519818|NCT00391391|20999981|P2|NOT COMPLETED|Overall Study||10
8519819|NCT00391391|20999982|P1|NOT COMPLETED|Overall Study||9
8519820|NCT00391391|20999979|P4|COMPLETED|Overall Study||145
8519821|NCT00391391|20999980|P3|COMPLETED|Overall Study||138
8519822|NCT00391391|20999981|P2|COMPLETED|Overall Study||87
8519823|NCT00391391|20999982|P1|COMPLETED|Overall Study||89
8519824|NCT00391391|20999979|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
8519825|NCT00391391|20999980|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
8519826|NCT00391391|20999981|P2|STARTED|Overall Study||97
8519827|NCT00391391|20999982|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
8519828|NCT00391365|21000014|P2|NOT COMPLETED|Overall Study||19
8519829|NCT00391365|21000015|P1|NOT COMPLETED|Overall Study||25
8519830|NCT00391365|21000014|P2|COMPLETED|Overall Study||151
8519831|NCT00391365|21000015|P1|COMPLETED|Overall Study||78
8519832|NCT00391365|21000014|P2|STARTED|Overall Study||170
8519833|NCT00391365|21000015|P1|STARTED|Overall Study||103
8519834|NCT00391274|21000027|P2|NOT COMPLETED|Overall Study||57
8519835|NCT00391274|21000028|P1|NOT COMPLETED|Overall Study||61
8519836|NCT00391274|21000027|P2|COMPLETED|Overall Study||47
8519837|NCT00391274|21000028|P1|COMPLETED|Overall Study||46
8519838|NCT00391274|21000027|P2|Received at Least One Dose of Study Drug|Overall Study||102
8519839|NCT00391274|21000028|P1|Received at Least One Dose of Study Drug|Overall Study||106
8519840|NCT00391274|21000027|P2|STARTED|Overall Study||104
8519841|NCT00391274|21000028|P1|STARTED|Overall Study||107
8519842|NCT00391222|21000047|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
8519843|NCT00391222|21000048|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
8519844|NCT00391222|21000049|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
8519845|NCT00391222|21000050|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
8519846|NCT00391222|21000047|P4|COMPLETED|Period III (Double-Blind Treatment)||0
8519847|NCT00391222|21000048|P3|COMPLETED|Period III (Double-Blind Treatment)||108
8519848|NCT00391222|21000049|P2|COMPLETED|Period III (Double-Blind Treatment)||113
8519849|NCT00391222|21000050|P1|COMPLETED|Period III (Double-Blind Treatment)||104
8519850|NCT00391222|21000047|P4|STARTED|Period III (Double-Blind Treatment)||0
8519851|NCT00391222|21000048|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
8519852|NCT00391222|21000049|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
8519853|NCT00391222|21000050|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
8519854|NCT00391222|21000047|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
8519855|NCT00391222|21000048|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8519856|NCT00391222|21000049|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8519857|NCT00391222|21000050|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8519858|NCT00391222|21000047|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
8519859|NCT00391222|21000048|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
8519860|NCT00391222|21000049|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
8519861|NCT00391222|21000050|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
8519862|NCT00391222|21000047|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
8519863|NCT00391222|21000048|P3|STARTED|Period II (Open-label Risperidone LAI)||0
8519864|NCT00391222|21000049|P2|STARTED|Period II (Open-label Risperidone LAI)||0
8519865|NCT00391222|21000050|P1|STARTED|Period II (Open-label Risperidone LAI)||0
8519866|NCT00391118|21000077|P3|NOT COMPLETED|Overall Study||58
8519867|NCT00391118|21000078|P2|NOT COMPLETED|Overall Study||55
8519868|NCT00391118|21000079|P1|NOT COMPLETED|Overall Study||11
8519869|NCT00391118|21000077|P3|COMPLETED|Overall Study||15
8519870|NCT00391118|21000078|P2|COMPLETED|Overall Study||14
8519871|NCT00391118|21000079|P1|COMPLETED|Overall Study||0
8519872|NCT00391118|21000077|P3|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
8519873|NCT00391118|21000078|P2|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
8519874|NCT00391118|21000079|P1|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
8519875|NCT00391118|21000077|P3|STARTED|Overall Study||73
8519876|NCT00391118|21000078|P2|STARTED|Overall Study||69
8519877|NCT00391118|21000079|P1|STARTED|Overall Study||11
8519878|NCT00391092|21000105|P2|NOT COMPLETED|Overall Study||216
8519879|NCT00391092|21000106|P1|NOT COMPLETED|Overall Study||208
8519880|NCT00391092|21000105|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
8519881|NCT00391092|21000106|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
8519882|NCT00391092|21000105|P2|Received Treatment|Overall Study||215
8519883|NCT00391092|21000106|P1|Received Treatment|Overall Study||206
8519884|NCT00391092|21000105|P2|STARTED|Overall Study||216
8519885|NCT00391092|21000106|P1|STARTED|Overall Study||208
8519886|NCT00391079|21000126|P2|NOT COMPLETED|Overall Study||16
8519887|NCT00391079|21000127|P1|NOT COMPLETED|Overall Study||26
8519888|NCT00391079|21000126|P2|COMPLETED|Overall Study||156
8519889|NCT00391079|21000127|P1|COMPLETED|Overall Study||141
8519890|NCT00391079|21000126|P2|STARTED|Overall Study||172
8519891|NCT00391079|21000127|P1|STARTED|Overall Study||167
8519892|NCT00391053|21000149|P4|NOT COMPLETED|Overall Study||10
8519893|NCT00391053|21000150|P3|NOT COMPLETED|Overall Study||2
8519894|NCT00391053|21000151|P2|NOT COMPLETED|Overall Study||1
8519895|NCT00391053|21000152|P1|NOT COMPLETED|Overall Study||9
8519896|NCT00391053|21000149|P4|COMPLETED|Overall Study||1252
8519897|NCT00391053|21000150|P3|COMPLETED|Overall Study||868
8519898|NCT00391053|21000151|P2|COMPLETED|Overall Study||847
8519899|NCT00391053|21000152|P1|COMPLETED|Overall Study||848
8519900|NCT00391053|21000149|P4|STARTED|Overall Study||1262
8519901|NCT00391053|21000150|P3|STARTED|Overall Study||870
8519902|NCT00391053|21000151|P2|STARTED|Overall Study||848
8519903|NCT00391053|21000152|P1|STARTED|Overall Study||857
8519904|NCT00391027|21000176|P2|NOT COMPLETED|Overall Study||12
8519905|NCT00391027|21000177|P1|NOT COMPLETED|Overall Study||25
8519906|NCT00391027|21000176|P2|COMPLETED|Overall Study||110
8519907|NCT00391027|21000177|P1|COMPLETED|Overall Study||110
8519908|NCT00391027|21000176|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
8519909|NCT00391027|21000177|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
8519910|NCT00390949|21000217|P2|NOT COMPLETED|Overall Study||2128
8519911|NCT00390949|21000218|P1|NOT COMPLETED|Overall Study||2098
8519912|NCT00390949|21000217|P2|COMPLETED|Overall Study||2664
8519913|NCT00390949|21000218|P1|COMPLETED|Overall Study||2564
8519914|NCT00390949|21000217|P2|STARTED|Overall Study||4792
8519915|NCT00390949|21000218|P1|STARTED|Overall Study||4662
8519916|NCT00390910|21000227|P3|NOT COMPLETED|Overall Study||10
8519917|NCT00390910|21000228|P2|NOT COMPLETED|Overall Study||4
8519918|NCT00390910|21000229|P1|NOT COMPLETED|Overall Study||2
8519919|NCT00390910|21000227|P3|COMPLETED|Overall Study||139
8519920|NCT00390910|21000228|P2|COMPLETED|Overall Study||83
8519921|NCT00390910|21000229|P1|COMPLETED|Overall Study||48
8519922|NCT00390910|21000227|P3|STARTED|Overall Study||149
8519923|NCT00390910|21000228|P2|STARTED|Overall Study||87
8519924|NCT00390910|21000229|P1|STARTED|Overall Study||50
8519925|NCT00390884|21000317|P2|NOT COMPLETED|Overall Study||2
8519926|NCT00390884|21000318|P1|NOT COMPLETED|Overall Study||2
8519927|NCT00390884|21000317|P2|COMPLETED|Overall Study||55
8519928|NCT00390884|21000318|P1|COMPLETED|Overall Study||114
8519929|NCT00390884|21000317|P2|STARTED|Overall Study||57
8519930|NCT00390884|21000318|P1|STARTED|Overall Study||116
8519931|NCT00390858|21000330|P2|NOT COMPLETED|Overall Study||7
8519932|NCT00390858|21000331|P1|NOT COMPLETED|Overall Study||9
8520021|NCT00390364|21000621|P1|STARTED|Overall Study||1
8519933|NCT00390858|21000330|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
8519934|NCT00390858|21000331|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
8519935|NCT00390858|21000330|P2|Completed Core & Entered Extension Study|Overall Study||20
8519936|NCT00390858|21000331|P1|Completed Core & Entered Extension Study|Overall Study||19
8519937|NCT00390858|21000330|P2|STARTED|Overall Study|20 Participants started the Core Study|20
8519938|NCT00390858|21000331|P1|STARTED|Overall Study|20 participants started the Core Study|20
8519939|NCT00390806|21000345|P2|NOT COMPLETED|Overall Study||32
8519940|NCT00390806|21000346|P1|NOT COMPLETED|Overall Study||30
8519941|NCT00390806|21000345|P2|COMPLETED|Overall Study||204
8519942|NCT00390806|21000346|P1|COMPLETED|Overall Study||206
8519943|NCT00390806|21000345|P2|Ongoing|Overall Study||2
8519944|NCT00390806|21000346|P1|Ongoing|Overall Study||4
8519945|NCT00390806|21000345|P2|STARTED|Overall Study||236
8519946|NCT00390806|21000346|P1|STARTED|Overall Study||236
8519947|NCT00390780|21000414|P2|NOT COMPLETED|Overall Study||27
8519948|NCT00390780|21000415|P1|NOT COMPLETED|Overall Study||23
8519949|NCT00390780|21000414|P2|COMPLETED|Overall Study||260
8519950|NCT00390780|21000415|P1|COMPLETED|Overall Study||268
8519951|NCT00390780|21000414|P2|Treatment|Overall Study||287
8519952|NCT00390780|21000415|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
8519953|NCT00390780|21000414|P2|STARTED|Overall Study||287
8519954|NCT00390780|21000415|P1|STARTED|Overall Study||291
8519955|NCT00390689|21000448|P3|NOT COMPLETED|Overall Study||3
8519956|NCT00390689|21000449|P2|NOT COMPLETED|Overall Study||5
8519957|NCT00390689|21000450|P1|NOT COMPLETED|Overall Study||5
8519958|NCT00390689|21000448|P3|COMPLETED|Overall Study||50
8519959|NCT00390689|21000449|P2|COMPLETED|Overall Study||48
8519960|NCT00390689|21000450|P1|COMPLETED|Overall Study||43
8519961|NCT00390689|21000448|P3|STARTED|Overall Study||53
8519962|NCT00390689|21000449|P2|STARTED|Overall Study||53
8519963|NCT00390689|21000450|P1|STARTED|Overall Study||48
8519964|NCT00390611|21000510|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
8519965|NCT00390611|21000511|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
8519966|NCT00390611|21000510|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
8519967|NCT00390611|21000511|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
8519968|NCT00390611|21000510|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
8519969|NCT00390611|21000511|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
8519970|NCT00390611|21000510|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
8519971|NCT00390611|21000511|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
8519972|NCT00390611|21000510|P2|COMPLETED|6 Cycles of Study Treatment||37
8519973|NCT00390611|21000511|P1|COMPLETED|6 Cycles of Study Treatment||34
8519974|NCT00390611|21000510|P2|STARTED|6 Cycles of Study Treatment||42
8519975|NCT00390611|21000511|P1|STARTED|6 Cycles of Study Treatment||43
8519976|NCT00390572|21000525|P2|NOT COMPLETED|Overall Study||5
8519977|NCT00390572|21000526|P1|NOT COMPLETED|Overall Study||8
8519978|NCT00390572|21000525|P2|COMPLETED|Overall Study||64
8519979|NCT00390572|21000526|P1|COMPLETED|Overall Study||60
8519980|NCT00390572|21000525|P2|STARTED|Overall Study||69
8519981|NCT00390572|21000526|P1|STARTED|Overall Study||68
8519982|NCT00390559|21000540|P1|NOT COMPLETED|Overall Study||44
8519983|NCT00390559|21000540|P1|COMPLETED|Overall Study||80
8519984|NCT00390559|21000540|P1|ActiveP/PlaceboC|Overall Study||90
8519985|NCT00390559|21000540|P1|PlaceboP/PlaceboC|Overall Study||93
8519986|NCT00390559|21000540|P1|ActiveP/ActiveC|Overall Study||87
8519987|NCT00390559|21000540|P1|Received PlaceboP/Active C|Overall Study||93
8519988|NCT00390559|21000540|P1|STARTED|Overall Study||124
8519989|NCT00390546|21000552|P2|NOT COMPLETED|Overall Study||5
8519990|NCT00390546|21000553|P1|NOT COMPLETED|Overall Study||6
8519991|NCT00390546|21000552|P2|COMPLETED|Overall Study||34
8519992|NCT00390546|21000553|P1|COMPLETED|Overall Study||27
8519993|NCT00390546|21000552|P2|STARTED|Overall Study||39
8519994|NCT00390546|21000553|P1|STARTED|Overall Study||33
8519995|NCT00390468|21000563|P1|NOT COMPLETED|Overall Study||3
8519996|NCT00390468|21000563|P1|COMPLETED|Overall Study||15
8519997|NCT00390468|21000563|P1|STARTED|Overall Study||18
8519998|NCT00390455|21000569|P2|NOT COMPLETED|Overall Study||23
8519999|NCT00390455|21000570|P1|NOT COMPLETED|Overall Study||32
8520000|NCT00390455|21000569|P2|COMPLETED|Overall Study||124
8520001|NCT00390455|21000570|P1|COMPLETED|Overall Study||116
8520002|NCT00390455|21000569|P2|STARTED|Overall Study||147
8520003|NCT00390455|21000570|P1|STARTED|Overall Study||148
8520004|NCT00390429|21000591|P4|NOT COMPLETED|Overall Study||0
8520005|NCT00390429|21000592|P3|NOT COMPLETED|Overall Study||0
8520006|NCT00390429|21000593|P2|NOT COMPLETED|Overall Study||0
8520007|NCT00390429|21000594|P1|NOT COMPLETED|Overall Study||0
8520008|NCT00390429|21000591|P4|COMPLETED|Overall Study||39
8520009|NCT00390429|21000592|P3|COMPLETED|Overall Study||25
8520010|NCT00390429|21000593|P2|COMPLETED|Overall Study||12
8520011|NCT00390429|21000594|P1|COMPLETED|Overall Study||5
8520012|NCT00390429|21000591|P4|STARTED|Overall Study||39
8520013|NCT00390429|21000592|P3|STARTED|Overall Study||25
8520014|NCT00390429|21000593|P2|STARTED|Overall Study||12
8520015|NCT00390429|21000594|P1|STARTED|Overall Study||5
8520016|NCT00390416|21000615|P1|NOT COMPLETED|Overall Study||4
8520017|NCT00390416|21000615|P1|COMPLETED|Overall Study||44
8520018|NCT00390416|21000615|P1|STARTED|Overall Study||48
8520019|NCT00390364|21000621|P1|NOT COMPLETED|Overall Study||0
8520020|NCT00390364|21000621|P1|COMPLETED|Overall Study||1
8520022|NCT00390325|21000627|P2|NOT COMPLETED|Overall Study||0
8520023|NCT00390325|21000628|P1|NOT COMPLETED|Overall Study||0
8520024|NCT00390325|21000627|P2|COMPLETED|Overall Study||16
8520025|NCT00390325|21000628|P1|COMPLETED|Overall Study||5
8520026|NCT00390325|21000627|P2|STARTED|Overall Study||16
8520027|NCT00390325|21000628|P1|STARTED|Overall Study||5
8520028|NCT00390299|21000653|P5|NOT COMPLETED|Overall Study||0
8520029|NCT00390299|21000654|P4|NOT COMPLETED|Overall Study||0
8520030|NCT00390299|21000655|P3|NOT COMPLETED|Overall Study||0
8520031|NCT00390299|21000656|P2|NOT COMPLETED|Overall Study||0
8520032|NCT00390299|21000657|P1|NOT COMPLETED|Overall Study||1
8520033|NCT00390299|21000653|P5|COMPLETED|Overall Study||10
8520034|NCT00390299|21000654|P4|COMPLETED|Overall Study||3
8520035|NCT00390299|21000655|P3|COMPLETED|Overall Study||3
8520036|NCT00390299|21000656|P2|COMPLETED|Overall Study||3
8520037|NCT00390299|21000657|P1|COMPLETED|Overall Study||3
8520038|NCT00390299|21000653|P5|STARTED|Overall Study||10
8520039|NCT00390299|21000654|P4|STARTED|Overall Study||3
8520040|NCT00390299|21000655|P3|STARTED|Overall Study||3
8520041|NCT00390299|21000656|P2|STARTED|Overall Study||3
8520042|NCT00390299|21000657|P1|STARTED|Overall Study||4
8520043|NCT00390234|21000677|P1|NOT COMPLETED|Overall Study||0
8520044|NCT00390234|21000677|P1|COMPLETED|Overall Study||63
8520045|NCT00390234|21000677|P1|STARTED|Overall Study||63
8520046|NCT00390221|21000688|P3|NOT COMPLETED|Overall Study||15
8520047|NCT00390221|21000689|P2|NOT COMPLETED|Overall Study||20
8520048|NCT00390221|21000690|P1|NOT COMPLETED|Overall Study||18
8520049|NCT00390221|21000688|P3|COMPLETED|Overall Study||194
8520050|NCT00390221|21000689|P2|COMPLETED|Overall Study||188
8520051|NCT00390221|21000690|P1|COMPLETED|Overall Study||186
8520052|NCT00390221|21000688|P3|STARTED|Overall Study||209
8520053|NCT00390221|21000689|P2|STARTED|Overall Study||208
8520054|NCT00390221|21000690|P1|STARTED|Overall Study||204
8520055|NCT00390182|21000711|P1|NOT COMPLETED|Overall Study||5
8520056|NCT00390182|21000711|P1|COMPLETED|Overall Study||33
8520057|NCT00390182|21000711|P1|STARTED|Overall Study||38
8520058|NCT00390013|21000720|P4|NOT COMPLETED|Phase 2 Second Treatment||0
8520059|NCT00390013|21000721|P3|NOT COMPLETED|Phase 2 Second Treatment||0
8520060|NCT00390013|21000722|P2|NOT COMPLETED|Phase 2 Second Treatment||0
8520061|NCT00390013|21000723|P1|NOT COMPLETED|Phase 2 Second Treatment||0
8520062|NCT00390013|21000720|P4|COMPLETED|Phase 2 Second Treatment||0
8520063|NCT00390013|21000721|P3|COMPLETED|Phase 2 Second Treatment||0
8520064|NCT00390013|21000722|P2|COMPLETED|Phase 2 Second Treatment||1
8520065|NCT00390013|21000723|P1|COMPLETED|Phase 2 Second Treatment||2
8520066|NCT00390013|21000720|P4|STARTED|Phase 2 Second Treatment||0
8520067|NCT00390013|21000721|P3|STARTED|Phase 2 Second Treatment||0
8520068|NCT00390013|21000722|P2|STARTED|Phase 2 Second Treatment||1
8520069|NCT00390013|21000723|P1|STARTED|Phase 2 Second Treatment||2
8520070|NCT00390013|21000720|P4|NOT COMPLETED|Phase 2 First Treatment||0
8520071|NCT00390013|21000721|P3|NOT COMPLETED|Phase 2 First Treatment||0
8520072|NCT00390013|21000722|P2|NOT COMPLETED|Phase 2 First Treatment||1
8520073|NCT00390013|21000723|P1|NOT COMPLETED|Phase 2 First Treatment||1
8520074|NCT00390013|21000720|P4|COMPLETED|Phase 2 First Treatment||0
8520075|NCT00390013|21000721|P3|COMPLETED|Phase 2 First Treatment||0
8520076|NCT00390013|21000722|P2|COMPLETED|Phase 2 First Treatment||1
8520077|NCT00390013|21000723|P1|COMPLETED|Phase 2 First Treatment||2
8520078|NCT00390013|21000720|P4|STARTED|Phase 2 First Treatment||0
8520079|NCT00390013|21000721|P3|STARTED|Phase 2 First Treatment||0
8520080|NCT00390013|21000722|P2|STARTED|Phase 2 First Treatment||2
8520081|NCT00390013|21000723|P1|STARTED|Phase 2 First Treatment||3
8520082|NCT00390013|21000720|P4|NOT COMPLETED|Phase 1||1
8520083|NCT00390013|21000721|P3|NOT COMPLETED|Phase 1||0
8520084|NCT00390013|21000722|P2|NOT COMPLETED|Phase 1||0
8520085|NCT00390013|21000723|P1|NOT COMPLETED|Phase 1||0
8520086|NCT00390013|21000720|P4|COMPLETED|Phase 1||1
8520087|NCT00390013|21000721|P3|COMPLETED|Phase 1||2
8520088|NCT00390013|21000722|P2|COMPLETED|Phase 1||0
8520089|NCT00390013|21000723|P1|COMPLETED|Phase 1||0
8520090|NCT00390013|21000720|P4|STARTED|Phase 1||2
8520091|NCT00390013|21000721|P3|STARTED|Phase 1||2
8520092|NCT00390013|21000722|P2|STARTED|Phase 1||0
8520093|NCT00390013|21000723|P1|STARTED|Phase 1||0
8520094|NCT00389974|21000729|P1|NOT COMPLETED|Overall Study||0
8520095|NCT00389974|21000729|P1|COMPLETED|Overall Study||19
8520096|NCT00389974|21000729|P1|STARTED|Overall Study||19
8520097|NCT00389857|21000735|P2|NOT COMPLETED|Overall Study||0
8520098|NCT00389857|21000736|P1|NOT COMPLETED|Overall Study||0
8520099|NCT00389857|21000735|P2|COMPLETED|Overall Study||17
8520100|NCT00389857|21000736|P1|COMPLETED|Overall Study||14
8520101|NCT00389857|21000735|P2|STARTED|Overall Study||17
8520102|NCT00389857|21000736|P1|STARTED|Overall Study||14
8520103|NCT00389831|21000748|P2|NOT COMPLETED|Overall Study||7
8520104|NCT00389831|21000749|P1|NOT COMPLETED|Overall Study||0
8520105|NCT00389831|21000748|P2|COMPLETED|Overall Study||27
8520106|NCT00389831|21000749|P1|COMPLETED|Overall Study||10
8520107|NCT00389831|21000748|P2|STARTED|Overall Study||34
8520108|NCT00389831|21000749|P1|STARTED|Overall Study||10
8520109|NCT00389818|21000775|P1|NOT COMPLETED|Overall Study||3
8520110|NCT00389818|21000775|P1|COMPLETED|Overall Study||40
8520111|NCT00389818|21000775|P1|STARTED|Overall Study||43
8520112|NCT00389805|21000781|P2|NOT COMPLETED|Phase II||0
8520113|NCT00389805|21000782|P1|NOT COMPLETED|Phase II||0
8520114|NCT00389805|21000781|P2|COMPLETED|Phase II||0
8520115|NCT00389805|21000782|P1|COMPLETED|Phase II||0
8520116|NCT00389805|21000781|P2|STARTED|Phase II|The Phase II study was not conducted.|0
8520117|NCT00389805|21000782|P1|STARTED|Phase II|The Phase II study was not conducted.|0
8520118|NCT00389805|21000781|P2|NOT COMPLETED|Phase I||0
8520119|NCT00389805|21000782|P1|NOT COMPLETED|Phase I||0
8520120|NCT00389805|21000781|P2|COMPLETED|Phase I||12
8520121|NCT00389805|21000782|P1|COMPLETED|Phase I||15
8520122|NCT00389805|21000781|P2|STARTED|Phase I||12
8520123|NCT00389805|21000782|P1|STARTED|Phase I||15
8520124|NCT00389597|21000812|P4|NOT COMPLETED|Overall Study||6
8520125|NCT00389597|21000813|P3|NOT COMPLETED|Overall Study||4
8520126|NCT00389597|21000814|P2|NOT COMPLETED|Overall Study||6
8520127|NCT00389597|21000815|P1|NOT COMPLETED|Overall Study||8
8520128|NCT00389597|21000812|P4|COMPLETED|Overall Study||99
8520129|NCT00389597|21000813|P3|COMPLETED|Overall Study||221
8520130|NCT00389597|21000814|P2|COMPLETED|Overall Study||75
8520131|NCT00389597|21000815|P1|COMPLETED|Overall Study||156
8520132|NCT00389597|21000812|P4|24 mo|Overall Study||99
8520133|NCT00389597|21000813|P3|24 mo|Overall Study||221
8520134|NCT00389597|21000814|P2|24 mo|Overall Study||75
8520135|NCT00389597|21000815|P1|24 mo|Overall Study||156
8520136|NCT00389597|21000812|P4|STARTED|Overall Study||105
8520137|NCT00389597|21000813|P3|STARTED|Overall Study||225
8520138|NCT00389597|21000814|P2|STARTED|Overall Study||81
8520139|NCT00389597|21000815|P1|STARTED|Overall Study||164
8520140|NCT00389532|21000827|P2|NOT COMPLETED|Overall Study||0
8520141|NCT00389532|21000828|P1|NOT COMPLETED|Overall Study||0
8520142|NCT00389532|21000827|P2|COMPLETED|Overall Study||56
8520143|NCT00389532|21000828|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
8520144|NCT00389532|21000827|P2|STARTED|Overall Study||56
8520145|NCT00389532|21000828|P1|STARTED|Overall Study||60
8520146|NCT00389519|21000840|P4|NOT COMPLETED|Treated||4
8520147|NCT00389519|21000841|P3|NOT COMPLETED|Treated||0
8520148|NCT00389519|21000842|P2|NOT COMPLETED|Treated||1
8520149|NCT00389519|21000843|P1|NOT COMPLETED|Treated||2
8520150|NCT00389519|21000840|P4|COMPLETED|Treated||76
8520151|NCT00389519|21000841|P3|COMPLETED|Treated||40
8520152|NCT00389519|21000842|P2|COMPLETED|Treated||40
8520153|NCT00389519|21000843|P1|COMPLETED|Treated||79
8520154|NCT00389519|21000840|P4|STARTED|Treated||80
8520155|NCT00389519|21000841|P3|STARTED|Treated||40
8520156|NCT00389519|21000842|P2|STARTED|Treated||41
8520157|NCT00389519|21000843|P1|STARTED|Treated||81
8520158|NCT00389519|21000840|P4|NOT COMPLETED|Randomized||0
8520159|NCT00389519|21000841|P3|NOT COMPLETED|Randomized||0
8520160|NCT00389519|21000842|P2|NOT COMPLETED|Randomized||0
8520161|NCT00389519|21000843|P1|NOT COMPLETED|Randomized||2
8520162|NCT00389519|21000840|P4|COMPLETED|Randomized||80
8520163|NCT00389519|21000841|P3|COMPLETED|Randomized||40
8520164|NCT00389519|21000842|P2|COMPLETED|Randomized||41
8520165|NCT00389519|21000843|P1|COMPLETED|Randomized||81
8520166|NCT00389519|21000840|P4|STARTED|Randomized||80
8520167|NCT00389519|21000841|P3|STARTED|Randomized||40
8520168|NCT00389519|21000842|P2|STARTED|Randomized||41
8520169|NCT00389519|21000843|P1|STARTED|Randomized||83
8520170|NCT00389519|21000840|P4|NOT COMPLETED|Placebo Run-In||0
8520171|NCT00389519|21000841|P3|NOT COMPLETED|Placebo Run-In||0
8520172|NCT00389519|21000842|P2|NOT COMPLETED|Placebo Run-In||0
8520173|NCT00389519|21000843|P1|NOT COMPLETED|Placebo Run-In||178
8520174|NCT00389519|21000840|P4|COMPLETED|Placebo Run-In||0
8520175|NCT00389519|21000841|P3|COMPLETED|Placebo Run-In||0
8520176|NCT00389519|21000842|P2|COMPLETED|Placebo Run-In||0
8520177|NCT00389519|21000843|P1|COMPLETED|Placebo Run-In||244
8520178|NCT00389519|21000840|P4|STARTED|Placebo Run-In||0
8520179|NCT00389519|21000841|P3|STARTED|Placebo Run-In||0
8520180|NCT00389519|21000842|P2|STARTED|Placebo Run-In||0
8520181|NCT00389519|21000843|P1|STARTED|Placebo Run-In||422
8520182|NCT00389493|21000872|P3|NOT COMPLETED|Overall Study||3
8520183|NCT00389493|21000873|P2|NOT COMPLETED|Overall Study||8
8520184|NCT00389493|21000874|P1|NOT COMPLETED|Overall Study||3
8520185|NCT00389493|21000872|P3|COMPLETED|Overall Study||17
8520186|NCT00389493|21000873|P2|COMPLETED|Overall Study||32
8520187|NCT00389493|21000874|P1|COMPLETED|Overall Study||37
8520188|NCT00389493|21000872|P3|STARTED|Overall Study||20
8520189|NCT00389493|21000873|P2|STARTED|Overall Study||40
8520190|NCT00389493|21000874|P1|STARTED|Overall Study||40
8520191|NCT00389467|21000898|P4|NOT COMPLETED|Overall Study||0
8520192|NCT00389467|21000899|P3|NOT COMPLETED|Overall Study||0
8520193|NCT00389467|21000900|P2|NOT COMPLETED|Overall Study||0
8520194|NCT00389467|21000901|P1|NOT COMPLETED|Overall Study||0
8520195|NCT00389467|21000898|P4|COMPLETED|Overall Study||20
8520196|NCT00389467|21000899|P3|COMPLETED|Overall Study||30
8520197|NCT00389467|21000900|P2|COMPLETED|Overall Study||34
8520198|NCT00389467|21000901|P1|COMPLETED|Overall Study||34
8520199|NCT00389467|21000898|P4|STARTED|Overall Study||20
8520200|NCT00389467|21000899|P3|STARTED|Overall Study||30
8520201|NCT00389467|21000900|P2|STARTED|Overall Study||34
8520202|NCT00389467|21000901|P1|STARTED|Overall Study||34
8520203|NCT00389441|21000920|P1|NOT COMPLETED|Overall Study||52
8520204|NCT00389441|21000920|P1|COMPLETED|Overall Study||0
8520205|NCT00389441|21000920|P1|STARTED|Overall Study||52
8520206|NCT00389324|21000929|P1|NOT COMPLETED|Subcutaneous Phase||7
8520207|NCT00389324|21000929|P1|COMPLETED|Subcutaneous Phase||25
8520208|NCT00389324|21000929|P1|STARTED|Subcutaneous Phase||32
8520209|NCT00389324|21000929|P1|NOT COMPLETED|Intravenous Phase||0
8520210|NCT00389324|21000929|P1|COMPLETED|Intravenous Phase||32
8520296|NCT00388414|21001228|P2|STARTED|Second Intervention (8 Weeks)||7
8520211|NCT00389324|21000929|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
8520212|NCT00389324|21000929|P1|NOT COMPLETED|Run-In Phase||3
8520213|NCT00389324|21000929|P1|COMPLETED|Run-In Phase||18
8520214|NCT00389324|21000929|P1|STARTED|Run-In Phase||21
8520215|NCT00389207|21000939|P3|NOT COMPLETED|Overall Study||41
8520216|NCT00389207|21000940|P2|NOT COMPLETED|Overall Study||72
8520217|NCT00389207|21000941|P1|NOT COMPLETED|Overall Study||63
8520218|NCT00389207|21000939|P3|COMPLETED|Overall Study||152
8520219|NCT00389207|21000940|P2|COMPLETED|Overall Study||116
8520220|NCT00389207|21000941|P1|COMPLETED|Overall Study||125
8520221|NCT00389207|21000939|P3|STARTED|Overall Study||193
8520222|NCT00389207|21000940|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
8520223|NCT00389207|21000941|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
8520224|NCT00389168|21001045|P2|NOT COMPLETED|Overall Study||5
8520225|NCT00389168|21001046|P1|NOT COMPLETED|Overall Study||9
8520226|NCT00389168|21001045|P2|COMPLETED|Overall Study||53
8520227|NCT00389168|21001046|P1|COMPLETED|Overall Study||47
8520228|NCT00389168|21001045|P2|STARTED|Overall Study||58
8520229|NCT00389168|21001046|P1|STARTED|Overall Study||56
8520230|NCT00389064|21001064|P2|NOT COMPLETED|Overall Study||59
8520231|NCT00389064|21001065|P1|NOT COMPLETED|Overall Study||45
8520232|NCT00389064|21001064|P2|COMPLETED|Overall Study||168
8520233|NCT00389064|21001065|P1|COMPLETED|Overall Study||178
8520234|NCT00389064|21001064|P2|STARTED|Overall Study||227
8520235|NCT00389064|21001065|P1|STARTED|Overall Study||223
8520236|NCT00388973|21001093|P2|NOT COMPLETED|Overall Study||58
8520237|NCT00388973|21001094|P1|NOT COMPLETED|Overall Study||56
8520238|NCT00388973|21001093|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
8520239|NCT00388973|21001094|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
8520240|NCT00388973|21001093|P2|Completed Study|Overall Study||114
8520241|NCT00388973|21001094|P1|Completed Study|Overall Study||110
8520242|NCT00388973|21001093|P2|STARTED|Overall Study|Randomized|172
8520243|NCT00388973|21001094|P1|STARTED|Overall Study|Randomized|166
8520244|NCT00388947|21001114|P1|NOT COMPLETED|Overall Study||47
8520245|NCT00388947|21001114|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
8520246|NCT00388947|21001114|P1|STARTED|Overall Study||1590
8520247|NCT00388804|21001121|P2|NOT COMPLETED|Overall Study||0
8520248|NCT00388804|21001122|P1|NOT COMPLETED|Overall Study||0
8520249|NCT00388804|21001121|P2|COMPLETED|Overall Study||21
8520250|NCT00388804|21001122|P1|COMPLETED|Overall Study||17
8520251|NCT00388804|21001121|P2|STARTED|Overall Study||21
8520252|NCT00388804|21001122|P1|STARTED|Overall Study||17
8520253|NCT00388726|21001130|P2|NOT COMPLETED|Overall Study||244
8520254|NCT00388726|21001131|P1|NOT COMPLETED|Overall Study||484
8520255|NCT00388726|21001130|P2|COMPLETED|Overall Study||10
8520256|NCT00388726|21001131|P1|COMPLETED|Overall Study||24
8520257|NCT00388726|21001130|P2|STARTED|Overall Study||254
8520258|NCT00388726|21001131|P1|STARTED|Overall Study||508
8520259|NCT00388674|21001147|P2|NOT COMPLETED|End of Study||2169
8520260|NCT00388674|21001148|P1|NOT COMPLETED|End of Study||1734
8520261|NCT00388674|21001147|P2|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
8520262|NCT00388674|21001148|P1|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
8520263|NCT00388674|21001147|P2|STARTED|End of Study||6162
8520264|NCT00388674|21001148|P1|STARTED|End of Study||6216
8520265|NCT00388674|21001147|P2|NOT COMPLETED|Initial Treatment||2586
8520266|NCT00388674|21001148|P1|NOT COMPLETED|Initial Treatment||1828
8520267|NCT00388674|21001147|P2|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
8520268|NCT00388674|21001148|P1|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
8520269|NCT00388674|21001147|P2|STARTED|Initial Treatment||6162
8520270|NCT00388674|21001148|P1|STARTED|Initial Treatment||6216
8520271|NCT00388583|21001166|P2|NOT COMPLETED|Overall Study||4
8520272|NCT00388583|21001167|P1|NOT COMPLETED|Overall Study||6
8520273|NCT00388583|21001166|P2|COMPLETED|Overall Study||406
8520274|NCT00388583|21001167|P1|COMPLETED|Overall Study||401
8520275|NCT00388583|21001166|P2|STARTED|Overall Study||410
8520276|NCT00388583|21001167|P1|STARTED|Overall Study||407
8520277|NCT00388505|21001181|P2|NOT COMPLETED|Overall Study||38
8520278|NCT00388505|21001182|P1|NOT COMPLETED|Overall Study||83
8520279|NCT00388505|21001181|P2|COMPLETED|Overall Study||171
8520280|NCT00388505|21001182|P1|COMPLETED|Overall Study||225
8520281|NCT00388505|21001181|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
8520282|NCT00388505|21001182|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
8520283|NCT00388453|21001207|P3|NOT COMPLETED|Overall Study||0
8520284|NCT00388453|21001208|P2|NOT COMPLETED|Overall Study||0
8520285|NCT00388453|21001209|P1|NOT COMPLETED|Overall Study||0
8520286|NCT00388453|21001207|P3|COMPLETED|Overall Study||10
8520287|NCT00388453|21001208|P2|COMPLETED|Overall Study||17
8520288|NCT00388453|21001209|P1|COMPLETED|Overall Study||20
8520289|NCT00388453|21001207|P3|STARTED|Overall Study||10
8520290|NCT00388453|21001208|P2|STARTED|Overall Study||17
8520291|NCT00388453|21001209|P1|STARTED|Overall Study||20
8520292|NCT00388414|21001228|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8520293|NCT00388414|21001229|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8520294|NCT00388414|21001228|P2|COMPLETED|Second Intervention (8 Weeks)||7
8520295|NCT00388414|21001229|P1|COMPLETED|Second Intervention (8 Weeks)||7
8520297|NCT00388414|21001229|P1|STARTED|Second Intervention (8 Weeks)||7
8520298|NCT00388414|21001228|P2|NOT COMPLETED|Washout (1 Week)||0
8520299|NCT00388414|21001229|P1|NOT COMPLETED|Washout (1 Week)||0
8520300|NCT00388414|21001228|P2|COMPLETED|Washout (1 Week)||7
8520301|NCT00388414|21001229|P1|COMPLETED|Washout (1 Week)||7
8520302|NCT00388414|21001228|P2|STARTED|Washout (1 Week)||7
8520303|NCT00388414|21001229|P1|STARTED|Washout (1 Week)||7
8520304|NCT00388414|21001228|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8520305|NCT00388414|21001229|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8520306|NCT00388414|21001228|P2|COMPLETED|First Intervention (8 Weeks)||7
8520307|NCT00388414|21001229|P1|COMPLETED|First Intervention (8 Weeks)||7
8520308|NCT00388414|21001228|P2|STARTED|First Intervention (8 Weeks)||7
8520309|NCT00388414|21001229|P1|STARTED|First Intervention (8 Weeks)||7
8520310|NCT00388362|21001237|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
8520311|NCT00388362|21001237|P1|COMPLETED|Remained on Study Median of 514 Days||21
8520312|NCT00388362|21001237|P1|STARTED|Remained on Study Median of 514 Days||23
8520313|NCT00388362|21001237|P1|NOT COMPLETED|Enrolled||13
8520314|NCT00388362|21001237|P1|COMPLETED|Enrolled||23
8520315|NCT00388362|21001237|P1|STARTED|Enrolled||36
8520316|NCT00388349|21001242|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
8520317|NCT00388349|21001243|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
8520318|NCT00388349|21001242|P2|COMPLETED|Phase 2 Dose Expansion||0
8520319|NCT00388349|21001243|P1|COMPLETED|Phase 2 Dose Expansion||139
8520320|NCT00388349|21001242|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
8520321|NCT00388349|21001243|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
8520322|NCT00388349|21001242|P2|NOT COMPLETED|Phase I Dose Escalation||3
8520323|NCT00388349|21001243|P1|NOT COMPLETED|Phase I Dose Escalation||0
8520324|NCT00388349|21001242|P2|COMPLETED|Phase I Dose Escalation||1
8520325|NCT00388349|21001243|P1|COMPLETED|Phase I Dose Escalation||3
8520326|NCT00388349|21001242|P2|STARTED|Phase I Dose Escalation||4
8520327|NCT00388349|21001243|P1|STARTED|Phase I Dose Escalation||3
8520328|NCT00388297|21001256|P4|NOT COMPLETED|Overall Study||8
8520329|NCT00388297|21001257|P3|NOT COMPLETED|Overall Study||11
8520330|NCT00388297|21001258|P2|NOT COMPLETED|Overall Study||12
8520331|NCT00388297|21001259|P1|NOT COMPLETED|Overall Study||16
8520332|NCT00388297|21001256|P4|COMPLETED|Overall Study||253
8520333|NCT00388297|21001257|P3|COMPLETED|Overall Study||254
8520334|NCT00388297|21001258|P2|COMPLETED|Overall Study||326
8520335|NCT00388297|21001259|P1|COMPLETED|Overall Study||323
8520336|NCT00388297|21001256|P4|STARTED|Overall Study||261
8520337|NCT00388297|21001257|P3|STARTED|Overall Study||265
8520338|NCT00388297|21001258|P2|STARTED|Overall Study||338
8520339|NCT00388297|21001259|P1|STARTED|Overall Study||339
8520340|NCT00388154|21001369|P1|NOT COMPLETED|Overall Study||1
8520341|NCT00388154|21001369|P1|COMPLETED|Overall Study||20
8520342|NCT00388154|21001369|P1|STARTED|Overall Study||21
8520343|NCT00388037|21001374|P1|NOT COMPLETED|Overall Study||1
8520344|NCT00388037|21001374|P1|COMPLETED|Overall Study||30
8520345|NCT00388037|21001374|P1|STARTED|Overall Study||31
8520346|NCT00387959|21001378|P1|NOT COMPLETED|Overall Study||1
8520347|NCT00387959|21001378|P1|COMPLETED|Overall Study||16
8520348|NCT00387959|21001378|P1|STARTED|Overall Study||17
8520349|NCT00387894|21001382|P1|NOT COMPLETED|Overall Study||1
8520350|NCT00387894|21001382|P1|COMPLETED|Overall Study||5
8520351|NCT00387894|21001382|P1|STARTED|Overall Study||6
8520352|NCT00387881|21001389|P2|NOT COMPLETED|Overall Study||102
8520353|NCT00387881|21001390|P1|NOT COMPLETED|Overall Study||89
8520354|NCT00387881|21001389|P2|COMPLETED|Overall Study||243
8520355|NCT00387881|21001390|P1|COMPLETED|Overall Study||245
8520356|NCT00387881|21001389|P2|STARTED|Overall Study||345
8520357|NCT00387881|21001390|P1|STARTED|Overall Study||334
8520358|NCT00387829|21001414|P2|NOT COMPLETED|Intent-to-treat Population||30
8520359|NCT00387829|21001415|P1|NOT COMPLETED|Intent-to-treat Population||38
8520360|NCT00387829|21001414|P2|COMPLETED|Intent-to-treat Population||136
8520361|NCT00387829|21001415|P1|COMPLETED|Intent-to-treat Population||139
8520362|NCT00387829|21001414|P2|STARTED|Intent-to-treat Population||166
8520363|NCT00387829|21001415|P1|STARTED|Intent-to-treat Population||177
8520364|NCT00387829|21001414|P2|NOT COMPLETED|Safety Population||33
8520365|NCT00387829|21001415|P1|NOT COMPLETED|Safety Population||39
8520366|NCT00387829|21001414|P2|COMPLETED|Safety Population||136
8520367|NCT00387829|21001415|P1|COMPLETED|Safety Population||139
8520368|NCT00387829|21001414|P2|STARTED|Safety Population||169
8520369|NCT00387829|21001415|P1|STARTED|Safety Population||178
8520370|NCT00387790|21001423|P1|NOT COMPLETED|Overall Study||14
8520371|NCT00387790|21001423|P1|COMPLETED|Overall Study||50
8520372|NCT00387790|21001423|P1|STARTED|Overall Study||64
8520373|NCT00387764|21001429|P1|NOT COMPLETED|Overall Study||31
8520374|NCT00387764|21001429|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
8520375|NCT00387764|21001429|P1|STARTED|Overall Study||80
8520376|NCT00387751|21001447|P1|NOT COMPLETED|Overall Study||0
8520377|NCT00387751|21001447|P1|COMPLETED|Overall Study||14
8520378|NCT00387751|21001447|P1|STARTED|Overall Study||14
8520379|NCT00387725|21001457|P4|NOT COMPLETED|Overall Study||2
8520380|NCT00387725|21001458|P3|NOT COMPLETED|Overall Study||2
8520381|NCT00387725|21001459|P2|NOT COMPLETED|Overall Study||1
8520382|NCT00387725|21001460|P1|NOT COMPLETED|Overall Study||1
8520383|NCT00387725|21001457|P4|COMPLETED|Overall Study||43
8520384|NCT00387725|21001458|P3|COMPLETED|Overall Study||43
8520385|NCT00387725|21001459|P2|COMPLETED|Overall Study||15
8520386|NCT00387725|21001460|P1|COMPLETED|Overall Study||20
8520387|NCT00387725|21001457|P4|STARTED|Overall Study||45
8520388|NCT00387725|21001458|P3|STARTED|Overall Study||45
8520389|NCT00387725|21001459|P2|STARTED|Overall Study||16
8520390|NCT00387725|21001460|P1|STARTED|Overall Study||21
8520391|NCT00387712|21001480|P2|NOT COMPLETED|Overall Study||36
8520392|NCT00387712|21001481|P1|NOT COMPLETED|Overall Study||29
8520393|NCT00387712|21001480|P2|COMPLETED|Overall Study||16
8520394|NCT00387712|21001481|P1|COMPLETED|Overall Study||18
8520395|NCT00387712|21001480|P2|STARTED|Overall Study||52
8520396|NCT00387712|21001481|P1|STARTED|Overall Study||47
8520397|NCT00387673|21001491|P3|NOT COMPLETED|Overall Study||0
8520398|NCT00387673|21001492|P2|NOT COMPLETED|Overall Study||0
8520399|NCT00387673|21001493|P1|NOT COMPLETED|Overall Study||0
8520400|NCT00387673|21001491|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520401|NCT00387673|21001492|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520402|NCT00387673|21001493|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520403|NCT00387673|21001491|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520404|NCT00387673|21001492|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520405|NCT00387673|21001493|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520406|NCT00387660|21001501|P2|NOT COMPLETED|Overall Study||0
8520407|NCT00387660|21001502|P1|NOT COMPLETED|Overall Study||0
8520408|NCT00387660|21001501|P2|COMPLETED|Overall Study||40
8520409|NCT00387660|21001502|P1|COMPLETED|Overall Study||40
8520410|NCT00387660|21001501|P2|STARTED|Overall Study||40
8520411|NCT00387660|21001502|P1|STARTED|Overall Study||40
8520412|NCT00387647|21001512|P1|NOT COMPLETED|Overall Study||18
8520413|NCT00387647|21001512|P1|COMPLETED|Overall Study||6
8520414|NCT00387647|21001512|P1|STARTED|Overall Study||24
8520415|NCT00387621|21001521|P2|NOT COMPLETED|Second Intervention||0
8520416|NCT00387621|21001522|P1|NOT COMPLETED|Second Intervention||0
8520417|NCT00387621|21001521|P2|COMPLETED|Second Intervention||29
8520418|NCT00387621|21001522|P1|COMPLETED|Second Intervention||29
8520419|NCT00387621|21001521|P2|STARTED|Second Intervention||29
8520420|NCT00387621|21001522|P1|STARTED|Second Intervention||29
8520421|NCT00387621|21001521|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8520422|NCT00387621|21001522|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8520423|NCT00387621|21001521|P2|COMPLETED|Washout Period of 2 Weeks||29
8520424|NCT00387621|21001522|P1|COMPLETED|Washout Period of 2 Weeks||29
8520425|NCT00387621|21001521|P2|STARTED|Washout Period of 2 Weeks||29
8520426|NCT00387621|21001522|P1|STARTED|Washout Period of 2 Weeks||29
8520427|NCT00387621|21001521|P2|NOT COMPLETED|First Intervention||0
8520428|NCT00387621|21001522|P1|NOT COMPLETED|First Intervention||0
8520429|NCT00387621|21001521|P2|COMPLETED|First Intervention||29
8520430|NCT00387621|21001522|P1|COMPLETED|First Intervention||29
8520431|NCT00387621|21001521|P2|STARTED|First Intervention||29
8520432|NCT00387621|21001522|P1|STARTED|First Intervention||29
8520433|NCT00387465|21001555|P3|NOT COMPLETED|Overall Study||0
8520434|NCT00387465|21001556|P2|NOT COMPLETED|Overall Study||1
8520435|NCT00387465|21001557|P1|NOT COMPLETED|Overall Study||0
8520436|NCT00387465|21001555|P3|COMPLETED|Overall Study||35
8520437|NCT00387465|21001556|P2|COMPLETED|Overall Study||6
8520438|NCT00387465|21001557|P1|COMPLETED|Overall Study||3
8520439|NCT00387465|21001555|P3|STARTED|Overall Study||35
8520440|NCT00387465|21001556|P2|STARTED|Overall Study||7
8520441|NCT00387465|21001557|P1|STARTED|Overall Study||3
8520442|NCT00387426|21001574|P1|NOT COMPLETED|Overall Study||14
8520443|NCT00387426|21001574|P1|COMPLETED|Overall Study||0
8520444|NCT00387426|21001574|P1|STARTED|Overall Study||14
8520445|NCT00387348|21001581|P3|NOT COMPLETED|Overall Study||4
8520446|NCT00387348|21001582|P2|NOT COMPLETED|Overall Study||3
8520447|NCT00387348|21001583|P1|NOT COMPLETED|Overall Study||3
8520448|NCT00387348|21001581|P3|COMPLETED|Overall Study||7
8520449|NCT00387348|21001582|P2|COMPLETED|Overall Study||2
8520450|NCT00387348|21001583|P1|COMPLETED|Overall Study||5
8520451|NCT00387348|21001581|P3|STARTED|Overall Study||11
8520452|NCT00387348|21001582|P2|STARTED|Overall Study||5
8520453|NCT00387348|21001583|P1|STARTED|Overall Study||8
8520454|NCT00387335|21001599|P2|NOT COMPLETED|Overall Study||0
8520455|NCT00387335|21001600|P1|NOT COMPLETED|Overall Study||0
8520456|NCT00387335|21001599|P2|COMPLETED|Overall Study||7
8520457|NCT00387335|21001600|P1|COMPLETED|Overall Study||15
8520458|NCT00387335|21001599|P2|STARTED|Overall Study||7
8520459|NCT00387335|21001600|P1|STARTED|Overall Study||15
8520460|NCT00387244|21001612|P1|NOT COMPLETED|Overall Study||7
8520461|NCT00387244|21001612|P1|COMPLETED|Overall Study||0
8520462|NCT00387244|21001612|P1|End of Trial|Overall Study||0
8520463|NCT00387244|21001612|P1|STARTED|Overall Study||7
8520464|NCT00387153|21001616|P1|NOT COMPLETED|Overall Study||8
8520465|NCT00387153|21001616|P1|COMPLETED|Overall Study||0
8520466|NCT00387153|21001616|P1|STARTED|Overall Study||8
8520467|NCT00387127|21001622|P2|NOT COMPLETED|Overall Study||34
8520468|NCT00387127|21001623|P1|NOT COMPLETED|Overall Study||33
8520469|NCT00387127|21001622|P2|COMPLETED|Overall Study||0
8520470|NCT00387127|21001623|P1|COMPLETED|Overall Study||0
8520471|NCT00387127|21001622|P2|STARTED|Overall Study||34
8520472|NCT00387127|21001623|P1|STARTED|Overall Study||33
8520473|NCT00387088|21001665|P2|NOT COMPLETED|Overall Study||373
8520474|NCT00387088|21001666|P1|NOT COMPLETED|Overall Study||318
8520475|NCT00387088|21001665|P2|COMPLETED|Overall Study||1629
8520476|NCT00387088|21001666|P1|COMPLETED|Overall Study||1671
8520477|NCT00387088|21001665|P2|STARTED|Overall Study||2002
8520478|NCT00387088|21001666|P1|STARTED|Overall Study||1989
8520479|NCT00387036|21001710|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
8520480|NCT00387036|21001711|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
8520481|NCT00387036|21001710|P2|COMPLETED|2-Week Crossover Second Intervention||6
8520482|NCT00387036|21001711|P1|COMPLETED|2-Week Crossover Second Intervention||6
8520483|NCT00387036|21001710|P2|STARTED|2-Week Crossover Second Intervention||6
8520484|NCT00387036|21001711|P1|STARTED|2-Week Crossover Second Intervention||6
8520485|NCT00387036|21001710|P2|NOT COMPLETED|2-Week Placebo Washout||0
8520486|NCT00387036|21001711|P1|NOT COMPLETED|2-Week Placebo Washout||0
8520487|NCT00387036|21001710|P2|COMPLETED|2-Week Placebo Washout||6
8520488|NCT00387036|21001711|P1|COMPLETED|2-Week Placebo Washout||6
8520489|NCT00387036|21001710|P2|STARTED|2-Week Placebo Washout||6
8520490|NCT00387036|21001711|P1|STARTED|2-Week Placebo Washout||6
8520491|NCT00387036|21001710|P2|NOT COMPLETED|2-Week First Intervention||0
8520492|NCT00387036|21001711|P1|NOT COMPLETED|2-Week First Intervention||0
8520493|NCT00387036|21001710|P2|COMPLETED|2-Week First Intervention||6
8520494|NCT00387036|21001711|P1|COMPLETED|2-Week First Intervention||6
8520495|NCT00387036|21001710|P2|STARTED|2-Week First Intervention||6
8520496|NCT00387036|21001711|P1|STARTED|2-Week First Intervention||6
8520497|NCT00387023|21001719|P1|NOT COMPLETED|Overall Study||0
8520498|NCT00387023|21001719|P1|COMPLETED|Overall Study||12
8520499|NCT00387023|21001719|P1|STARTED|Overall Study||12
8520500|NCT00387010|21001723|P1|NOT COMPLETED|Treatment Period||11
8520501|NCT00387010|21001723|P1|COMPLETED|Treatment Period||169
8520502|NCT00387010|21001723|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
8520503|NCT00387010|21001723|P1|STARTED|Treatment Period||180
8520504|NCT00387010|21001723|P1|NOT COMPLETED|Dose Titration Period||38
8520505|NCT00387010|21001723|P1|COMPLETED|Dose Titration Period||180
8520506|NCT00387010|21001723|P1|STARTED|Dose Titration Period||218
8520507|NCT00386880|21001744|P2|NOT COMPLETED|Overall Study||0
8520508|NCT00386880|21001745|P1|NOT COMPLETED|Overall Study||0
8520509|NCT00386880|21001744|P2|COMPLETED|Overall Study||8
8520510|NCT00386880|21001745|P1|COMPLETED|Overall Study||30
8520511|NCT00386880|21001744|P2|STARTED|Overall Study||8
8520512|NCT00386880|21001745|P1|STARTED|Overall Study||30
8520513|NCT00386776|21001750|P1|NOT COMPLETED|Overall Study||8
8520514|NCT00386776|21001750|P1|COMPLETED|Overall Study||32
8520515|NCT00386776|21001750|P1|STARTED|Overall Study||40
8520516|NCT00386724|21001760|P1|NOT COMPLETED|Overall Study||5
8520517|NCT00386724|21001760|P1|COMPLETED|Overall Study||3
8520518|NCT00386724|21001760|P1|3 Months Post-activation|Overall Study||4
8520519|NCT00386724|21001760|P1|STARTED|Overall Study||8
8520520|NCT00386607|21001764|P2|NOT COMPLETED|Extension||17
8520521|NCT00386607|21001765|P1|NOT COMPLETED|Extension||0
8520522|NCT00386607|21001764|P2|COMPLETED|Extension||145
8520523|NCT00386607|21001765|P1|COMPLETED|Extension||0
8520524|NCT00386607|21001764|P2|STARTED|Extension||162
8520525|NCT00386607|21001765|P1|STARTED|Extension||0
8520526|NCT00386607|21001764|P2|NOT COMPLETED|Core||0
8520527|NCT00386607|21001765|P1|NOT COMPLETED|Core||115
8520528|NCT00386607|21001764|P2|COMPLETED|Core||0
8520529|NCT00386607|21001765|P1|COMPLETED|Core||486
8520530|NCT00386607|21001764|P2|STARTED|Core||0
8520531|NCT00386607|21001765|P1|STARTED|Core||601
8520532|NCT00386477|21001783|P2|NOT COMPLETED|Overall Study||0
8520533|NCT00386477|21001784|P1|NOT COMPLETED|Overall Study||0
8520534|NCT00386477|21001783|P2|COMPLETED|Overall Study||145
8520535|NCT00386477|21001784|P1|COMPLETED|Overall Study||155
8520536|NCT00386477|21001783|P2|STARTED|Overall Study||145
8520537|NCT00386477|21001784|P1|STARTED|Overall Study||155
8520538|NCT00386425|21001793|P3|NOT COMPLETED|Overall Study||0
8520539|NCT00386425|21001794|P2|NOT COMPLETED|Overall Study||1
8520540|NCT00386425|21001795|P1|NOT COMPLETED|Overall Study||3
8520541|NCT00386425|21001793|P3|COMPLETED|Overall Study||53
8520542|NCT00386425|21001794|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
8520543|NCT00386425|21001795|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
8520544|NCT00386425|21001793|P3|Received Study Drug|Overall Study||53
8520545|NCT00386425|21001794|P2|Received Study Drug|Overall Study||206
8520546|NCT00386425|21001795|P1|Received Study Drug|Overall Study||227
8520547|NCT00386425|21001793|P3|STARTED|Overall Study||53
8520548|NCT00386425|21001794|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
8520549|NCT00386425|21001795|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
8520550|NCT00386360|21001821|P2|NOT COMPLETED|Overall Study||17
8520551|NCT00386360|21001822|P1|NOT COMPLETED|Overall Study||9
8520552|NCT00386360|21001821|P2|COMPLETED|Overall Study||95
8520553|NCT00386360|21001822|P1|COMPLETED|Overall Study||40
8520554|NCT00386360|21001821|P2|Primary Efficacy|Overall Study||77
8520555|NCT00386360|21001822|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
8520556|NCT00386360|21001821|P2|Intent to Treat Population (ITT)|Overall Study||110
8520557|NCT00386360|21001822|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
8520558|NCT00386360|21001821|P2|STARTED|Overall Study||112
8520559|NCT00386360|21001822|P1|STARTED|Overall Study||49
8520560|NCT00386334|21001856|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
8520561|NCT00386334|21001857|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
8520562|NCT00386334|21001856|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
8520563|NCT00386334|21001857|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
8520564|NCT00386334|21001856|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
8520565|NCT00386334|21001857|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
8520566|NCT00386334|21001856|P2|NOT COMPLETED|Double Blind Period||47
8520567|NCT00386334|21001857|P1|NOT COMPLETED|Double Blind Period||46
8520568|NCT00386334|21001856|P2|COMPLETED|Double Blind Period||147
8520569|NCT00386334|21001857|P1|COMPLETED|Double Blind Period||148
8520570|NCT00386334|21001856|P2|STARTED|Double Blind Period||194
8520571|NCT00386334|21001857|P1|STARTED|Double Blind Period||194
8520572|NCT00386308|21002001|P2|NOT COMPLETED|Overall Study||19
8520573|NCT00386308|21002002|P1|NOT COMPLETED|Overall Study||29
8520574|NCT00386308|21002001|P2|COMPLETED|Overall Study||54
8520575|NCT00386308|21002002|P1|COMPLETED|Overall Study||94
8520576|NCT00386308|21002001|P2|Modified Intent to Treat Population|Overall Study||72
8520577|NCT00386308|21002002|P1|Modified Intent to Treat Population|Overall Study||115
8520578|NCT00386308|21002001|P2|Intent to Treat Population|Overall Study||72
8520579|NCT00386308|21002002|P1|Intent to Treat Population|Overall Study||117
8520580|NCT00386308|21002001|P2|STARTED|Overall Study||73
8520581|NCT00386308|21002002|P1|STARTED|Overall Study||123
8520582|NCT00386256|21002018|P4|NOT COMPLETED|Overall Study||0
8520583|NCT00386256|21002019|P3|NOT COMPLETED|Overall Study||0
8520584|NCT00386256|21002020|P2|NOT COMPLETED|Overall Study||0
8520585|NCT00386256|21002021|P1|NOT COMPLETED|Overall Study||0
8520586|NCT00386256|21002018|P4|COMPLETED|Overall Study||3
8520587|NCT00386256|21002019|P3|COMPLETED|Overall Study||4
8520588|NCT00386256|21002020|P2|COMPLETED|Overall Study||15
8520589|NCT00386256|21002021|P1|COMPLETED|Overall Study||16
8520590|NCT00386256|21002018|P4|STARTED|Overall Study||3
8520591|NCT00386256|21002019|P3|STARTED|Overall Study||4
8520592|NCT00386256|21002020|P2|STARTED|Overall Study||15
8520593|NCT00386256|21002021|P1|STARTED|Overall Study||16
8520594|NCT00386243|21002037|P2|NOT COMPLETED|Overall Study||13
8520595|NCT00386243|21002038|P1|NOT COMPLETED|Overall Study||7
8520596|NCT00386243|21002037|P2|COMPLETED|Overall Study||108
8520597|NCT00386243|21002038|P1|COMPLETED|Overall Study||114
8520598|NCT00386243|21002037|P2|STARTED|Overall Study||121
8520599|NCT00386243|21002038|P1|STARTED|Overall Study||121
8520600|NCT00386152|21002059|P3|NOT COMPLETED|Overall Study||33
8520601|NCT00386152|21002060|P2|NOT COMPLETED|Overall Study||40
8520602|NCT00386152|21002061|P1|NOT COMPLETED|Overall Study||44
8520603|NCT00386152|21002059|P3|COMPLETED|Overall Study||42
8520604|NCT00386152|21002060|P2|COMPLETED|Overall Study||37
8520605|NCT00386152|21002061|P1|COMPLETED|Overall Study||31
8520606|NCT00386152|21002059|P3|STARTED|Overall Study|number of subjects treated|75
8520607|NCT00386152|21002060|P2|STARTED|Overall Study|number of subjects treated|77
8520608|NCT00386152|21002061|P1|STARTED|Overall Study|number of subjects treated|75
8520609|NCT00386100|21002080|P2|NOT COMPLETED|Overall Study||131
8520610|NCT00386100|21002081|P1|NOT COMPLETED|Overall Study||154
8520611|NCT00386100|21002080|P2|COMPLETED|Overall Study||217
8520612|NCT00386100|21002081|P1|COMPLETED|Overall Study||186
8520613|NCT00386100|21002080|P2|STARTED|Overall Study||348
8520614|NCT00386100|21002081|P1|STARTED|Overall Study||340
8520615|NCT00386022|21002145|P2|NOT COMPLETED|Plus Estrogen||1
8520616|NCT00386022|21002146|P1|NOT COMPLETED|Plus Estrogen||2
8520617|NCT00386022|21002145|P2|COMPLETED|Plus Estrogen||8
8520618|NCT00386022|21002146|P1|COMPLETED|Plus Estrogen||8
8520619|NCT00386022|21002145|P2|All Doses GnRH|Plus Estrogen||8
8520620|NCT00386022|21002146|P1|All Doses GnRH|Plus Estrogen||8
8520621|NCT00386022|21002145|P2|Estrogen Patch|Plus Estrogen||9
8520622|NCT00386022|21002146|P1|Estrogen Patch|Plus Estrogen||8
8520623|NCT00386022|21002145|P2|STARTED|Plus Estrogen||9
8520624|NCT00386022|21002146|P1|STARTED|Plus Estrogen||10
8520625|NCT00386022|21002145|P2|NOT COMPLETED|Baseline||0
8520626|NCT00386022|21002146|P1|NOT COMPLETED|Baseline||0
8520627|NCT00386022|21002145|P2|COMPLETED|Baseline||9
8520628|NCT00386022|21002146|P1|COMPLETED|Baseline||10
8520629|NCT00386022|21002145|P2|All Doses of GnRH|Baseline||9
8520630|NCT00386022|21002146|P1|All Doses of GnRH|Baseline||10
8520631|NCT00386022|21002145|P2|STARTED|Baseline||9
8520632|NCT00386022|21002146|P1|STARTED|Baseline||10
8520633|NCT00386009|21002156|P2|NOT COMPLETED|Overall Study||10
8520634|NCT00386009|21002157|P1|NOT COMPLETED|Overall Study||9
8520635|NCT00386009|21002156|P2|COMPLETED|Overall Study||89
8520636|NCT00386009|21002157|P1|COMPLETED|Overall Study||92
8520637|NCT00386009|21002156|P2|STARTED|Overall Study||99
8520638|NCT00386009|21002157|P1|STARTED|Overall Study||101
8520639|NCT00385996|21002195|P1|NOT COMPLETED|Overall Study||0
8520640|NCT00385996|21002195|P1|COMPLETED|Overall Study||22
8520641|NCT00385996|21002195|P1|STARTED|Overall Study||22
8520642|NCT00385944|21002204|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
8520643|NCT00385944|21002205|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
8520644|NCT00385944|21002206|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
8520645|NCT00385944|21002204|P3|COMPLETED|2nd Maintenance Dose Period||0
8520646|NCT00385944|21002205|P2|COMPLETED|2nd Maintenance Dose Period||19
8520647|NCT00385944|21002206|P1|COMPLETED|2nd Maintenance Dose Period||22
8520648|NCT00385944|21002204|P3|STARTED|2nd Maintenance Dose Period||0
8520649|NCT00385944|21002205|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
8520650|NCT00385944|21002206|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
8520651|NCT00385944|21002204|P3|NOT COMPLETED|1st Maintenance Dose Period||0
8520652|NCT00385944|21002205|P2|NOT COMPLETED|1st Maintenance Dose Period||1
8520653|NCT00385944|21002206|P1|NOT COMPLETED|1st Maintenance Dose Period||4
8520654|NCT00385944|21002204|P3|COMPLETED|1st Maintenance Dose Period||0
8520655|NCT00385944|21002205|P2|COMPLETED|1st Maintenance Dose Period||24
8520656|NCT00385944|21002206|P1|COMPLETED|1st Maintenance Dose Period||25
8520657|NCT00385944|21002204|P3|STARTED|1st Maintenance Dose Period||0
8520658|NCT00385944|21002205|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
8520659|NCT00385944|21002206|P1|STARTED|1st Maintenance Dose Period||29
8520660|NCT00385944|21002204|P3|NOT COMPLETED|Loading Dose||0
8520661|NCT00385944|21002205|P2|NOT COMPLETED|Loading Dose||0
8520662|NCT00385944|21002206|P1|NOT COMPLETED|Loading Dose||0
8520663|NCT00385944|21002204|P3|COMPLETED|Loading Dose||56
8520664|NCT00385944|21002205|P2|COMPLETED|Loading Dose||0
8520665|NCT00385944|21002206|P1|COMPLETED|Loading Dose||0
8520666|NCT00385944|21002204|P3|STARTED|Loading Dose||56
8520667|NCT00385944|21002205|P2|STARTED|Loading Dose||0
8520668|NCT00385944|21002206|P1|STARTED|Loading Dose||0
8520669|NCT00385918|21002249|P3|NOT COMPLETED|Intervention Phase After Randomization||0
8520670|NCT00385918|21002250|P2|NOT COMPLETED|Intervention Phase After Randomization||0
8520671|NCT00385918|21002251|P1|NOT COMPLETED|Intervention Phase After Randomization||3
8520672|NCT00385918|21002249|P3|COMPLETED|Intervention Phase After Randomization||0
8520673|NCT00385918|21002250|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
8520674|NCT00385918|21002251|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
8520675|NCT00385918|21002249|P3|STARTED|Intervention Phase After Randomization||0
8520676|NCT00385918|21002250|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
8520677|NCT00385918|21002251|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
8520678|NCT00385918|21002249|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
8520679|NCT00385918|21002250|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
8520680|NCT00385918|21002251|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
8520681|NCT00385918|21002249|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
8520682|NCT00385918|21002250|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
8520683|NCT00385918|21002251|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
8520684|NCT00385918|21002249|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
8520685|NCT00385918|21002250|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
8520686|NCT00385918|21002251|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
8520687|NCT00385918|21002249|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
8520688|NCT00385918|21002250|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
8520689|NCT00385918|21002251|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
8520690|NCT00385918|21002249|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
8520691|NCT00385918|21002250|P2|STARTED|Feasibility & Baseline Measurement Phase||0
8520692|NCT00385918|21002251|P1|STARTED|Feasibility & Baseline Measurement Phase||0
8520693|NCT00385840|21002275|P2|NOT COMPLETED|Overall Study||14
8520694|NCT00385840|21002276|P1|NOT COMPLETED|Overall Study||4
8520695|NCT00385840|21002275|P2|COMPLETED|Overall Study||531
8520696|NCT00385840|21002276|P1|COMPLETED|Overall Study||129
8520697|NCT00385840|21002275|P2|STARTED|Overall Study||545
8520698|NCT00385840|21002276|P1|STARTED|Overall Study||133
8520699|NCT00385827|21002299|P3|NOT COMPLETED|Part 2||48
8520700|NCT00385827|21002300|P2|NOT COMPLETED|Part 2||33
8520701|NCT00385827|21002301|P1|NOT COMPLETED|Part 2||0
8520702|NCT00385827|21002299|P3|COMPLETED|Part 2||0
8520703|NCT00385827|21002300|P2|COMPLETED|Part 2||16
8520704|NCT00385827|21002301|P1|COMPLETED|Part 2||0
8520705|NCT00385827|21002299|P3|Treated|Part 2||46
8520706|NCT00385827|21002300|P2|Treated|Part 2||47
8520707|NCT00385827|21002301|P1|Treated|Part 2||0
8520708|NCT00385827|21002299|P3|STARTED|Part 2||48
8520709|NCT00385827|21002300|P2|STARTED|Part 2||49
8520710|NCT00385827|21002301|P1|STARTED|Part 2||0
8520711|NCT00385827|21002299|P3|NOT COMPLETED|Part 1||0
8520712|NCT00385827|21002300|P2|NOT COMPLETED|Part 1||0
8520713|NCT00385827|21002301|P1|NOT COMPLETED|Part 1||9
8520714|NCT00385827|21002299|P3|COMPLETED|Part 1||0
8520715|NCT00385827|21002300|P2|COMPLETED|Part 1||0
8520716|NCT00385827|21002301|P1|COMPLETED|Part 1||0
8520717|NCT00385827|21002299|P3|Treated|Part 1||0
8520718|NCT00385827|21002300|P2|Treated|Part 1||0
8520719|NCT00385827|21002301|P1|Treated|Part 1||9
8520720|NCT00385827|21002299|P3|STARTED|Part 1||0
8520721|NCT00385827|21002300|P2|STARTED|Part 1||0
8520722|NCT00385827|21002301|P1|STARTED|Part 1||9
8520723|NCT00385801|21002323|P2|NOT COMPLETED|Overall Study||8
8520724|NCT00385801|21002324|P1|NOT COMPLETED|Overall Study||9
8520725|NCT00385801|21002323|P2|COMPLETED|Overall Study||8
8520726|NCT00385801|21002324|P1|COMPLETED|Overall Study||6
8520727|NCT00385801|21002323|P2|STARTED|Overall Study||16
8520728|NCT00385801|21002324|P1|STARTED|Overall Study||15
8520729|NCT00385788|21002338|P2|NOT COMPLETED|Overall Study||0
8520730|NCT00385788|21002339|P1|NOT COMPLETED|Overall Study||0
8520731|NCT00385788|21002338|P2|COMPLETED|Overall Study||40
8520732|NCT00385788|21002339|P1|COMPLETED|Overall Study||12
8520733|NCT00385788|21002338|P2|STARTED|Overall Study||40
8520734|NCT00385788|21002339|P1|STARTED|Overall Study||12
8520735|NCT00385762|21002345|P1|NOT COMPLETED|Overall Study||2
8520736|NCT00385762|21002345|P1|COMPLETED|Overall Study||33
8520737|NCT00385762|21002345|P1|STARTED|Overall Study||35
8520738|NCT00385736|21002355|P3|NOT COMPLETED|Safety Analysis Set||80
8520739|NCT00385736|21002356|P2|NOT COMPLETED|Safety Analysis Set||44
8520740|NCT00385736|21002357|P1|NOT COMPLETED|Safety Analysis Set||70
8520741|NCT00385736|21002355|P3|COMPLETED|Safety Analysis Set||143
8520742|NCT00385736|21002356|P2|COMPLETED|Safety Analysis Set||86
8520743|NCT00385736|21002357|P1|COMPLETED|Safety Analysis Set||153
8520744|NCT00385736|21002355|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
8520745|NCT00385736|21002356|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
8520746|NCT00385736|21002357|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
8520747|NCT00385736|21002355|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
8520748|NCT00385736|21002356|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
8520749|NCT00385736|21002357|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
8520750|NCT00385736|21002355|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
8520751|NCT00385736|21002356|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
8520752|NCT00385736|21002357|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
8520753|NCT00385736|21002355|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
8520754|NCT00385736|21002356|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
8520755|NCT00385736|21002357|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
8520756|NCT00385736|21002355|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
8520757|NCT00385736|21002356|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
8520758|NCT00385736|21002357|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
8520759|NCT00385736|21002355|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
8520760|NCT00385736|21002356|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
8520761|NCT00385736|21002357|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
8520762|NCT00385736|21002355|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8520763|NCT00385736|21002356|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8520764|NCT00385736|21002357|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8520765|NCT00385723|21002402|P3|NOT COMPLETED|Overall Study||2
8520766|NCT00385723|21002403|P2|NOT COMPLETED|Overall Study||1
8520767|NCT00385723|21002404|P1|NOT COMPLETED|Overall Study||2
8520768|NCT00385723|21002402|P3|COMPLETED|Overall Study||44
8520769|NCT00385723|21002403|P2|COMPLETED|Overall Study||45
8520770|NCT00385723|21002404|P1|COMPLETED|Overall Study||44
8520771|NCT00385723|21002402|P3|STARTED|Overall Study||46
8520772|NCT00385723|21002403|P2|STARTED|Overall Study||46
8520773|NCT00385723|21002404|P1|STARTED|Overall Study||46
8520774|NCT00385684|21002418|P2|NOT COMPLETED|PHASE B||0
8520775|NCT00385684|21002419|P1|NOT COMPLETED|PHASE B||0
8520776|NCT00385684|21002418|P2|COMPLETED|PHASE B||3
8520777|NCT00385684|21002419|P1|COMPLETED|PHASE B||5
8520778|NCT00385684|21002418|P2|STARTED|PHASE B||3
8520779|NCT00385684|21002419|P1|STARTED|PHASE B||5
8520780|NCT00385684|21002418|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
8520781|NCT00385684|21002419|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
8520782|NCT00385684|21002418|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
8520783|NCT00385684|21002419|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
8520784|NCT00385684|21002418|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
8520785|NCT00385684|21002419|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
8520786|NCT00385684|21002418|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
8520787|NCT00385684|21002419|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
8520788|NCT00385684|21002418|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
8520789|NCT00385684|21002419|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
8520790|NCT00385684|21002418|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
8520791|NCT00385684|21002419|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
8520792|NCT00385671|21002428|P3|NOT COMPLETED|Overall Study||36
8520793|NCT00385671|21002429|P2|NOT COMPLETED|Overall Study||51
8520794|NCT00385671|21002430|P1|NOT COMPLETED|Overall Study||38
8520795|NCT00385671|21002428|P3|COMPLETED|Overall Study||99
8520796|NCT00385671|21002429|P2|COMPLETED|Overall Study||87
8520797|NCT00385671|21002430|P1|COMPLETED|Overall Study||96
8520798|NCT00385671|21002428|P3|STARTED|Overall Study||135
8520799|NCT00385671|21002429|P2|STARTED|Overall Study||138
8520800|NCT00385671|21002430|P1|STARTED|Overall Study||134
8520801|NCT00385593|21002586|P2|NOT COMPLETED|Overall Study||37
8520802|NCT00385593|21002587|P1|NOT COMPLETED|Overall Study||58
8520803|NCT00385593|21002586|P2|COMPLETED|Overall Study||289
8520804|NCT00385593|21002587|P1|COMPLETED|Overall Study||270
8520805|NCT00385593|21002586|P2|STARTED|Overall Study||326
8520806|NCT00385593|21002587|P1|STARTED|Overall Study||328
8520807|NCT00385580|21002605|P2|NOT COMPLETED|Overall Study||0
8520808|NCT00385580|21002606|P1|NOT COMPLETED|Overall Study||0
8520809|NCT00385580|21002605|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
8520810|NCT00385580|21002606|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
8520811|NCT00385580|21002605|P2|STARTED|Overall Study|Number of participants treated.|47
8520812|NCT00385580|21002606|P1|STARTED|Overall Study|Number of participants treated.|48
8520813|NCT00385541|21002697|P2|NOT COMPLETED|Overall Study||1
8520814|NCT00385541|21002698|P1|NOT COMPLETED|Overall Study||0
8520815|NCT00385541|21002697|P2|COMPLETED|Overall Study||24
8520816|NCT00385541|21002698|P1|COMPLETED|Overall Study||25
8520817|NCT00385541|21002697|P2|STARTED|Overall Study||25
8520818|NCT00385541|21002698|P1|STARTED|Overall Study||25
8520819|NCT00385515|21002714|P2|NOT COMPLETED|Overall Study||3
8520820|NCT00385515|21002715|P1|NOT COMPLETED|Overall Study||4
8520821|NCT00385515|21002714|P2|COMPLETED|Overall Study||21
8520822|NCT00385515|21002715|P1|COMPLETED|Overall Study||53
8520823|NCT00385515|21002714|P2|STARTED|Overall Study||24
8520824|NCT00385515|21002715|P1|STARTED|Overall Study||57
8520825|NCT00385268|21002723|P2|NOT COMPLETED|Overall Study||8
8520826|NCT00385268|21002724|P1|NOT COMPLETED|Overall Study||16
8520827|NCT00385268|21002723|P2|COMPLETED|Overall Study||18
8520828|NCT00385268|21002724|P1|COMPLETED|Overall Study||18
8520829|NCT00385268|21002723|P2|STARTED|Overall Study||26
8520830|NCT00385268|21002724|P1|STARTED|Overall Study||34
8520831|NCT00385255|21002732|P2|NOT COMPLETED|Overall Study||73
8520832|NCT00385255|21002733|P1|NOT COMPLETED|Overall Study||21
8520833|NCT00385255|21002732|P2|COMPLETED|Overall Study||785
8520834|NCT00385255|21002733|P1|COMPLETED|Overall Study||839
8520835|NCT00385255|21002732|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
8520836|NCT00385255|21002733|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
8520837|NCT00385255|21002732|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
8520838|NCT00385255|21002733|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
8520839|NCT00385255|21002732|P2|STARTED|Overall Study||858
8520840|NCT00385255|21002733|P1|STARTED|Overall Study||860
8520841|NCT00385216|21002797|P2|NOT COMPLETED|Second Intervention||0
8520842|NCT00385216|21002798|P1|NOT COMPLETED|Second Intervention||0
8520843|NCT00385216|21002797|P2|COMPLETED|Second Intervention||9
8520844|NCT00385216|21002798|P1|COMPLETED|Second Intervention||11
8520845|NCT00385216|21002797|P2|STARTED|Second Intervention||9
8520846|NCT00385216|21002798|P1|STARTED|Second Intervention||11
8520847|NCT00385216|21002797|P2|NOT COMPLETED|First Intervention||0
8520848|NCT00385216|21002798|P1|NOT COMPLETED|First Intervention||0
8520849|NCT00385216|21002797|P2|COMPLETED|First Intervention||9
8520850|NCT00385216|21002798|P1|COMPLETED|First Intervention||11
8520851|NCT00385216|21002797|P2|STARTED|First Intervention||9
8520852|NCT00385216|21002798|P1|STARTED|First Intervention||11
8520853|NCT00385203|21002812|P2|NOT COMPLETED|Overall Study||7
8520854|NCT00385203|21002813|P1|NOT COMPLETED|Overall Study||26
8520855|NCT00385203|21002812|P2|COMPLETED|Overall Study||3
8520856|NCT00385203|21002813|P1|COMPLETED|Overall Study||0
8520857|NCT00385203|21002812|P2|STARTED|Overall Study||10
8520858|NCT00385203|21002813|P1|STARTED|Overall Study||26
8520859|NCT00385138|21002833|P2|NOT COMPLETED|Overall Study||28
8520860|NCT00385138|21002834|P1|NOT COMPLETED|Overall Study||30
8520861|NCT00385138|21002833|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
8520862|NCT00385138|21002834|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
8520863|NCT00385138|21002833|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
8520864|NCT00385138|21002834|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
8520865|NCT00385138|21002833|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
8520866|NCT00385138|21002834|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
8520867|NCT00385138|21002833|P2|Intent-to-treat (ITT)|Overall Study||2669
8520868|NCT00385138|21002834|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
8520869|NCT00385138|21002833|P2|STARTED|Overall Study||2669
8520870|NCT00385138|21002834|P1|STARTED|Overall Study||2695
8520871|NCT00385008|21002880|P2|NOT COMPLETED|Overall Study||0
8520872|NCT00385008|21002881|P1|NOT COMPLETED|Overall Study||0
8520873|NCT00385008|21002880|P2|COMPLETED|Overall Study||10
8520874|NCT00385008|21002881|P1|COMPLETED|Overall Study||10
8520875|NCT00385008|21002880|P2|In Presence of Migraine|Overall Study||5
8520876|NCT00385008|21002881|P1|In Presence of Migraine|Overall Study||5
8520877|NCT00385008|21002880|P2|In Absence of Migraine|Overall Study||10
8520878|NCT00385008|21002881|P1|In Absence of Migraine|Overall Study||10
8520879|NCT00385008|21002880|P2|STARTED|Overall Study||10
8520880|NCT00385008|21002881|P1|STARTED|Overall Study||10
8520881|NCT00384956|21002901|P1|NOT COMPLETED|Overall Study||3
8520882|NCT00384956|21002901|P1|COMPLETED|Overall Study||22
8520883|NCT00384956|21002901|P1|STARTED|Overall Study||25
8520884|NCT00384930|21002918|P5|NOT COMPLETED|Overall Study||47
8520885|NCT00384930|21002919|P4|NOT COMPLETED|Overall Study||41
8520886|NCT00384930|21002920|P3|NOT COMPLETED|Overall Study||30
8520887|NCT00384930|21002921|P2|NOT COMPLETED|Overall Study||27
8520888|NCT00384930|21002922|P1|NOT COMPLETED|Overall Study||27
8520889|NCT00384930|21002918|P5|COMPLETED|Overall Study||162
8520890|NCT00384930|21002919|P4|COMPLETED|Overall Study||175
8520891|NCT00384930|21002920|P3|COMPLETED|Overall Study||182
8520892|NCT00384930|21002921|P2|COMPLETED|Overall Study||182
8520893|NCT00384930|21002922|P1|COMPLETED|Overall Study||185
8520894|NCT00384930|21002918|P5|Received Double-Blind Study Drug|Overall Study||209
8520895|NCT00384930|21002919|P4|Received Double-Blind Study Drug|Overall Study||216
8520896|NCT00384930|21002920|P3|Received Double-Blind Study Drug|Overall Study||212
8520897|NCT00384930|21002921|P2|Received Double-Blind Study Drug|Overall Study||208
8520898|NCT00384930|21002922|P1|Received Double-Blind Study Drug|Overall Study||211
8520899|NCT00384930|21002918|P5|STARTED|Overall Study||209
8520900|NCT00384930|21002919|P4|STARTED|Overall Study||216
8520901|NCT00384930|21002920|P3|STARTED|Overall Study||212
8520902|NCT00384930|21002921|P2|STARTED|Overall Study||209
8520903|NCT00384930|21002922|P1|STARTED|Overall Study||212
8520904|NCT00384865|21002980|P4|NOT COMPLETED|Overall Study||0
8520905|NCT00384865|21002981|P3|NOT COMPLETED|Overall Study||0
8520906|NCT00384865|21002982|P2|NOT COMPLETED|Overall Study||0
8520907|NCT00384865|21002983|P1|NOT COMPLETED|Overall Study||0
8520908|NCT00384865|21002980|P4|COMPLETED|Overall Study||16
8520909|NCT00384865|21002981|P3|COMPLETED|Overall Study||16
8520910|NCT00384865|21002982|P2|COMPLETED|Overall Study||16
8520911|NCT00384865|21002983|P1|COMPLETED|Overall Study||16
8520912|NCT00384865|21002980|P4|Completed Six Month Assessment|Overall Study||11
8520913|NCT00384865|21002981|P3|Completed Six Month Assessment|Overall Study||15
8520914|NCT00384865|21002982|P2|Completed Six Month Assessment|Overall Study||12
8520915|NCT00384865|21002983|P1|Completed Six Month Assessment|Overall Study||11
8520916|NCT00384865|21002980|P4|STARTED|Overall Study||16
8520917|NCT00384865|21002981|P3|STARTED|Overall Study||16
8520918|NCT00384865|21002982|P2|STARTED|Overall Study||16
8520919|NCT00384865|21002983|P1|STARTED|Overall Study||16
8520920|NCT00384839|21003001|P1|NOT COMPLETED|Overall Study||8
8520921|NCT00384839|21003001|P1|COMPLETED|Overall Study||28
8520922|NCT00384839|21003001|P1|STARTED|Overall Study||36
8520923|NCT00384813|21003012|P2|NOT COMPLETED|Overall Study||0
8520924|NCT00384813|21003013|P1|NOT COMPLETED|Overall Study||2
8520925|NCT00384813|21003012|P2|COMPLETED|Overall Study||20
8520926|NCT00384813|21003013|P1|COMPLETED|Overall Study||21
8520927|NCT00384813|21003012|P2|STARTED|Overall Study||20
8520928|NCT00384813|21003013|P1|STARTED|Overall Study||23
8520929|NCT00384774|21003026|P7|NOT COMPLETED|Overall Study||0
8520930|NCT00384774|21003027|P6|NOT COMPLETED|Overall Study||0
8520931|NCT00384774|21003028|P5|NOT COMPLETED|Overall Study||0
8520932|NCT00384774|21003029|P4|NOT COMPLETED|Overall Study||0
8520933|NCT00384774|21003030|P3|NOT COMPLETED|Overall Study||0
8520934|NCT00384774|21003031|P2|NOT COMPLETED|Overall Study||0
8520935|NCT00384774|21003032|P1|NOT COMPLETED|Overall Study||0
8520936|NCT00384774|21003026|P7|COMPLETED|Overall Study||4
8520937|NCT00384774|21003027|P6|COMPLETED|Overall Study||16
8520938|NCT00384774|21003028|P5|COMPLETED|Overall Study||28
8520939|NCT00384774|21003029|P4|COMPLETED|Overall Study||24
8520940|NCT00384774|21003030|P3|COMPLETED|Overall Study||12
8520941|NCT00384774|21003031|P2|COMPLETED|Overall Study||4
8520942|NCT00384774|21003032|P1|COMPLETED|Overall Study||42
8520943|NCT00384774|21003026|P7|Received at Least 1 Dose of Study Drug|Overall Study||4
8520944|NCT00384774|21003027|P6|Received at Least 1 Dose of Study Drug|Overall Study||16
8520945|NCT00384774|21003028|P5|Received at Least 1 Dose of Study Drug|Overall Study||28
8520946|NCT00384774|21003029|P4|Received at Least 1 Dose of Study Drug|Overall Study||24
8520947|NCT00384774|21003030|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
8520948|NCT00384774|21003031|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8520949|NCT00384774|21003032|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
8520950|NCT00384774|21003026|P7|STARTED|Overall Study||4
8520951|NCT00384774|21003027|P6|STARTED|Overall Study||16
8520952|NCT00384774|21003028|P5|STARTED|Overall Study||28
8520953|NCT00384774|21003029|P4|STARTED|Overall Study||24
8520954|NCT00384774|21003030|P3|STARTED|Overall Study||12
8520955|NCT00384774|21003031|P2|STARTED|Overall Study||4
8520956|NCT00384774|21003032|P1|STARTED|Overall Study||42
8520957|NCT00384748|21003106|P2|NOT COMPLETED|Overall Study||0
8520958|NCT00384748|21003107|P1|NOT COMPLETED|Overall Study||0
8520959|NCT00384748|21003106|P2|COMPLETED|Overall Study||23
8520960|NCT00384748|21003107|P1|COMPLETED|Overall Study||25
8520961|NCT00384748|21003106|P2|STARTED|Overall Study||23
8520962|NCT00384748|21003107|P1|STARTED|Overall Study||25
8520963|NCT00384670|21003113|P1|NOT COMPLETED|Overall Study||0
8520964|NCT00384670|21003113|P1|COMPLETED|Overall Study||7
8520965|NCT00384670|21003113|P1|STARTED|Overall Study||7
8520966|NCT00384449|21003123|P1|NOT COMPLETED|Overall Study||0
8520967|NCT00384449|21003123|P1|COMPLETED|Overall Study||1
8520968|NCT00384449|21003123|P1|STARTED|Overall Study||1
8520969|NCT00384397|21003134|P3|NOT COMPLETED|Overall Study||33
8520970|NCT00384397|21003135|P2|NOT COMPLETED|Overall Study||46
8520971|NCT00384397|21003136|P1|NOT COMPLETED|Overall Study||32
8520972|NCT00384397|21003134|P3|COMPLETED|Overall Study||385
8520973|NCT00384397|21003135|P2|COMPLETED|Overall Study||247
8520974|NCT00384397|21003136|P1|COMPLETED|Overall Study||375
8520975|NCT00384397|21003134|P3|STARTED|Overall Study||418
8520976|NCT00384397|21003135|P2|STARTED|Overall Study||293
8520977|NCT00384397|21003136|P1|STARTED|Overall Study||407
8520978|NCT00384332|21003155|P2|NOT COMPLETED|Overall Study||0
8520979|NCT00384332|21003156|P1|NOT COMPLETED|Overall Study||4
8520980|NCT00384332|21003155|P2|COMPLETED|Overall Study||10
8520981|NCT00384332|21003156|P1|COMPLETED|Overall Study||9
8520982|NCT00384332|21003155|P2|STARTED|Overall Study||10
8520983|NCT00384332|21003156|P1|STARTED|Overall Study||13
8520984|NCT00384293|21003166|P3|NOT COMPLETED|Post-randomization Period||219
8520985|NCT00384293|21003167|P2|NOT COMPLETED|Post-randomization Period||214
8520986|NCT00384293|21003168|P1|NOT COMPLETED|Post-randomization Period||0
8520987|NCT00384293|21003166|P3|COMPLETED|Post-randomization Period||0
8520988|NCT00384293|21003167|P2|COMPLETED|Post-randomization Period||0
8520989|NCT00384293|21003168|P1|COMPLETED|Post-randomization Period||0
8520990|NCT00384293|21003166|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
8520991|NCT00384293|21003167|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
8520992|NCT00384293|21003168|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
8520993|NCT00384293|21003166|P3|STARTED|Post-randomization Period||219
8520994|NCT00384293|21003167|P2|STARTED|Post-randomization Period||214
8520995|NCT00384293|21003168|P1|STARTED|Post-randomization Period||0
8520996|NCT00384293|21003166|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8520997|NCT00384293|21003167|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8520998|NCT00384293|21003168|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
8520999|NCT00384293|21003166|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8521000|NCT00384293|21003167|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8521001|NCT00384293|21003168|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
8521002|NCT00384293|21003166|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
8521003|NCT00384293|21003167|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
8521004|NCT00384293|21003168|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
8521005|NCT00384293|21003166|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
8521006|NCT00384293|21003167|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
8521007|NCT00384293|21003168|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
8521008|NCT00384293|21003166|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
8521009|NCT00384293|21003167|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
8521010|NCT00384293|21003168|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
8521011|NCT00384241|21003181|P2|NOT COMPLETED|Overall Study||0
8521012|NCT00384241|21003182|P1|NOT COMPLETED|Overall Study||0
8521013|NCT00384241|21003181|P2|COMPLETED|Overall Study||599
8521014|NCT00384241|21003182|P1|COMPLETED|Overall Study||500
8521015|NCT00384241|21003181|P2|STARTED|Overall Study||599
8521016|NCT00384241|21003182|P1|STARTED|Overall Study||500
8521017|NCT00384189|21003192|P4|NOT COMPLETED|Overall Study||40
8521018|NCT00384189|21003193|P3|NOT COMPLETED|Overall Study||58
8521019|NCT00384189|21003194|P2|NOT COMPLETED|Overall Study||57
8521020|NCT00384189|21003195|P1|NOT COMPLETED|Overall Study||50
8521021|NCT00384189|21003192|P4|COMPLETED|Overall Study||110
8521022|NCT00384189|21003193|P3|COMPLETED|Overall Study||255
8521023|NCT00384189|21003194|P2|COMPLETED|Overall Study||255
8521024|NCT00384189|21003195|P1|COMPLETED|Overall Study||255
8521025|NCT00384189|21003192|P4|Actual Treatment Received|Overall Study||146
8521026|NCT00384189|21003193|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
8521027|NCT00384189|21003194|P2|Actual Treatment Received|Overall Study||312
8521028|NCT00384189|21003195|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
8521029|NCT00384189|21003192|P4|Randomized, Not Treated|Overall Study||4
8521030|NCT00384189|21003193|P3|Randomized, Not Treated|Overall Study||2
8521031|NCT00384189|21003194|P2|Randomized, Not Treated|Overall Study||0
8521032|NCT00384189|21003195|P1|Randomized, Not Treated|Overall Study||1
8521033|NCT00384189|21003192|P4|STARTED|Overall Study||150
8521034|NCT00384189|21003193|P3|STARTED|Overall Study||313
8521035|NCT00384189|21003194|P2|STARTED|Overall Study||312
8521036|NCT00384189|21003195|P1|STARTED|Overall Study||305
8521037|NCT00384176|21003256|P3|NOT COMPLETED|Overall Study||132
8521038|NCT00384176|21003257|P2|NOT COMPLETED|Overall Study||319
8521039|NCT00384176|21003258|P1|NOT COMPLETED|Overall Study||312
8521040|NCT00384176|21003256|P3|COMPLETED|Overall Study||60
8521041|NCT00384176|21003257|P2|COMPLETED|Overall Study||394
8521042|NCT00384176|21003258|P1|COMPLETED|Overall Study||397
8521043|NCT00384176|21003256|P3|STARTED|Overall Study||192
8521044|NCT00384176|21003257|P2|STARTED|Overall Study||713
8521045|NCT00384176|21003258|P1|STARTED|Overall Study||709
8521046|NCT00384085|21003284|P3|NOT COMPLETED|Overall Study||56
8521047|NCT00384085|21003285|P2|NOT COMPLETED|Overall Study||46
8521048|NCT00384085|21003286|P1|NOT COMPLETED|Overall Study||39
8521049|NCT00384085|21003284|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
8521050|NCT00384085|21003285|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
8521051|NCT00384085|21003286|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
8521052|NCT00384085|21003284|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
8521053|NCT00384085|21003285|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
8521054|NCT00384085|21003286|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
8521055|NCT00384085|21003284|P3|Treated (Safety Population)|Overall Study||194
8521056|NCT00384085|21003285|P2|Treated (Safety Population)|Overall Study||194
8521057|NCT00384085|21003286|P1|Treated (Safety Population)|Overall Study||194
8521058|NCT00384085|21003284|P3|Intent-To-Treat (ITT)|Overall Study||197
8521059|NCT00384085|21003285|P2|Intent-To-Treat (ITT)|Overall Study||196
8521060|NCT00384085|21003286|P1|Intent-To-Treat (ITT)|Overall Study||195
8521061|NCT00384085|21003284|P3|STARTED|Overall Study|Randomized|197
8521062|NCT00384085|21003285|P2|STARTED|Overall Study|Randomized|196
8521063|NCT00384085|21003286|P1|STARTED|Overall Study|Randomized|195
8521064|NCT00384059|21003312|P2|NOT COMPLETED|Toddler Dose||2
8521065|NCT00384059|21003313|P1|NOT COMPLETED|Toddler Dose||1
8521066|NCT00384059|21003312|P2|COMPLETED|Toddler Dose||120
8521067|NCT00384059|21003313|P1|COMPLETED|Toddler Dose||130
8521068|NCT00384059|21003312|P2|STARTED|Toddler Dose||122
8521069|NCT00384059|21003313|P1|STARTED|Toddler Dose||131
8521070|NCT00384059|21003312|P2|NOT COMPLETED|After Infant Series||10
8521071|NCT00384059|21003313|P1|NOT COMPLETED|After Infant Series||4
8521072|NCT00384059|21003312|P2|COMPLETED|After Infant Series||122
8521073|NCT00384059|21003313|P1|COMPLETED|After Infant Series||131
8521074|NCT00384059|21003312|P2|STARTED|After Infant Series||132
8521075|NCT00384059|21003313|P1|STARTED|After Infant Series||135
8521076|NCT00384059|21003312|P2|NOT COMPLETED|Infant Series||13
8521077|NCT00384059|21003313|P1|NOT COMPLETED|Infant Series||6
8521078|NCT00384059|21003312|P2|COMPLETED|Infant Series||132
8521079|NCT00384059|21003313|P1|COMPLETED|Infant Series||135
8521080|NCT00384059|21003312|P2|Vaccinated Dose 2|Infant Series||135
8521081|NCT00384059|21003313|P1|Vaccinated Dose 2|Infant Series||136
8521082|NCT00384059|21003312|P2|Vaccinated Dose 1|Infant Series||139
8521083|NCT00384059|21003313|P1|Vaccinated Dose 1|Infant Series||139
8521084|NCT00384059|21003312|P2|STARTED|Infant Series||145
8521085|NCT00384059|21003313|P1|STARTED|Infant Series||141
8521086|NCT00384033|21003363|P4|NOT COMPLETED|Overall Study||40
8521087|NCT00384033|21003364|P3|NOT COMPLETED|Overall Study||43
8521088|NCT00384033|21003365|P2|NOT COMPLETED|Overall Study||35
8521089|NCT00384033|21003366|P1|NOT COMPLETED|Overall Study||41
8521090|NCT00384033|21003363|P4|COMPLETED|Overall Study||119
8521091|NCT00384033|21003364|P3|COMPLETED|Overall Study||117
8521092|NCT00384033|21003365|P2|COMPLETED|Overall Study||120
8521093|NCT00384033|21003366|P1|COMPLETED|Overall Study||123
8521094|NCT00384033|21003363|P4|Treated|Overall Study||157
8521095|NCT00384033|21003364|P3|Treated|Overall Study||150
8521096|NCT00384033|21003365|P2|Treated|Overall Study||148
8521097|NCT00384033|21003366|P1|Treated|Overall Study||161
8521098|NCT00384033|21003363|P4|STARTED|Overall Study||159
8521099|NCT00384033|21003364|P3|STARTED|Overall Study||160
8521100|NCT00384033|21003365|P2|STARTED|Overall Study||155
8521101|NCT00384033|21003366|P1|STARTED|Overall Study||164
8521102|NCT00383942|21003410|P2|NOT COMPLETED|Overall Study||0
8521103|NCT00383942|21003411|P1|NOT COMPLETED|Overall Study||0
8521104|NCT00383942|21003410|P2|COMPLETED|Overall Study||40
8521105|NCT00383942|21003411|P1|COMPLETED|Overall Study||40
8521106|NCT00383942|21003410|P2|STARTED|Overall Study||40
8521107|NCT00383942|21003411|P1|STARTED|Overall Study||40
8521108|NCT00383786|21003419|P2|NOT COMPLETED|Overall Study||12
8521109|NCT00383786|21003420|P1|NOT COMPLETED|Overall Study||4
8521110|NCT00383786|21003419|P2|COMPLETED|Overall Study||13
8521111|NCT00383786|21003420|P1|COMPLETED|Overall Study||18
8521112|NCT00383786|21003419|P2|STARTED|Overall Study||25
8521113|NCT00383786|21003420|P1|STARTED|Overall Study||22
8521114|NCT00383760|21003426|P1|NOT COMPLETED|Overall Study||0
8521115|NCT00383760|21003426|P1|COMPLETED|Overall Study||15
8521116|NCT00383760|21003426|P1|STARTED|Overall Study||15
8521117|NCT00383747|21003442|P4|NOT COMPLETED|Visit 2||0
8521118|NCT00383747|21003443|P3|NOT COMPLETED|Visit 2||0
8521119|NCT00383747|21003444|P2|NOT COMPLETED|Visit 2||0
8521120|NCT00383747|21003445|P1|NOT COMPLETED|Visit 2||0
8521121|NCT00383747|21003442|P4|COMPLETED|Visit 2||16
8521122|NCT00383747|21003443|P3|COMPLETED|Visit 2||16
8521123|NCT00383747|21003444|P2|COMPLETED|Visit 2||14
8521124|NCT00383747|21003445|P1|COMPLETED|Visit 2||14
8521125|NCT00383747|21003442|P4|STARTED|Visit 2||16
8521126|NCT00383747|21003443|P3|STARTED|Visit 2||16
8521127|NCT00383747|21003444|P2|STARTED|Visit 2||14
8521128|NCT00383747|21003445|P1|STARTED|Visit 2||14
8521129|NCT00383747|21003442|P4|NOT COMPLETED|Visit 1||0
8521130|NCT00383747|21003443|P3|NOT COMPLETED|Visit 1||0
8521131|NCT00383747|21003444|P2|NOT COMPLETED|Visit 1||0
8521132|NCT00383747|21003445|P1|NOT COMPLETED|Visit 1||0
8521133|NCT00383747|21003442|P4|COMPLETED|Visit 1||16
8521134|NCT00383747|21003443|P3|COMPLETED|Visit 1||16
8521135|NCT00383747|21003444|P2|COMPLETED|Visit 1||14
8521136|NCT00383747|21003445|P1|COMPLETED|Visit 1||14
8521137|NCT00383747|21003442|P4|STARTED|Visit 1||16
8521138|NCT00383747|21003443|P3|STARTED|Visit 1||16
8521139|NCT00383747|21003444|P2|STARTED|Visit 1||14
8521140|NCT00383747|21003445|P1|STARTED|Visit 1||14
8521141|NCT00383721|21003470|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
8521142|NCT00383721|21003471|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
8521143|NCT00383721|21003472|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
8521144|NCT00383721|21003473|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
8521145|NCT00383721|21003474|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
8521146|NCT00383721|21003470|P5|COMPLETED|26-Week Treatment Safety Extension||8
8521147|NCT00383721|21003471|P4|COMPLETED|26-Week Treatment Safety Extension||131
8521148|NCT00383721|21003472|P3|COMPLETED|26-Week Treatment Safety Extension||126
8521149|NCT00383721|21003473|P2|COMPLETED|26-Week Treatment Safety Extension||136
8521150|NCT00383721|21003474|P1|COMPLETED|26-Week Treatment Safety Extension||126
8521151|NCT00383721|21003470|P5|STARTED|26-Week Treatment Safety Extension||8
8521152|NCT00383721|21003471|P4|STARTED|26-Week Treatment Safety Extension||148
8521153|NCT00383721|21003472|P3|STARTED|26-Week Treatment Safety Extension||149
8521154|NCT00383721|21003473|P2|STARTED|26-Week Treatment Safety Extension||153
8521155|NCT00383721|21003474|P1|STARTED|26-Week Treatment Safety Extension||145
8521156|NCT00383721|21003470|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
8521157|NCT00383721|21003471|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
8521158|NCT00383721|21003472|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
8521159|NCT00383721|21003473|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
8521160|NCT00383721|21003474|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
8521161|NCT00383721|21003470|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
8521162|NCT00383721|21003471|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
8521163|NCT00383721|21003472|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
8521164|NCT00383721|21003473|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
8521165|NCT00383721|21003474|P1|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
8521166|NCT00383721|21003470|P5|STARTED|26-Week Double-Blind Treatment Period||236
8521167|NCT00383721|21003471|P4|STARTED|26-Week Double-Blind Treatment Period||243
8521168|NCT00383721|21003472|P3|STARTED|26-Week Double-Blind Treatment Period||253
8521169|NCT00383721|21003473|P2|STARTED|26-Week Double-Blind Treatment Period||239
8521170|NCT00383721|21003474|P1|STARTED|26-Week Double-Blind Treatment Period||225
8521171|NCT00383708|21003511|P1|NOT COMPLETED|Co-administration Period||5
8521172|NCT00383708|21003511|P1|COMPLETED|Co-administration Period||52
8521173|NCT00383708|21003511|P1|STARTED|Co-administration Period||57
8521174|NCT00383708|21003511|P1|NOT COMPLETED|Run-in Period||7
8521175|NCT00383708|21003511|P1|COMPLETED|Run-in Period||85
8521176|NCT00383708|21003511|P1|STARTED|Run-in Period||92
8521177|NCT00383708|21003511|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
8521178|NCT00383708|21003511|P1|COMPLETED|Enrolment Through Start Treatment||92
8521179|NCT00383708|21003511|P1|STARTED|Enrolment Through Start Treatment||125
8521180|NCT00383643|21003548|P3|NOT COMPLETED|Overall Study||1
8521181|NCT00383643|21003549|P2|NOT COMPLETED|Overall Study||1
8521182|NCT00383643|21003550|P1|NOT COMPLETED|Overall Study||1
8521183|NCT00383643|21003548|P3|COMPLETED|Overall Study||13
8521184|NCT00383643|21003549|P2|COMPLETED|Overall Study||15
8521185|NCT00383643|21003550|P1|COMPLETED|Overall Study||17
8521186|NCT00383643|21003548|P3|STARTED|Overall Study||14
8521187|NCT00383643|21003549|P2|STARTED|Overall Study||16
8521188|NCT00383643|21003550|P1|STARTED|Overall Study||18
8521189|NCT00383630|21003570|P1|NOT COMPLETED|Overall Study||0
8521190|NCT00383630|21003570|P1|COMPLETED|Overall Study||1
8521191|NCT00383630|21003570|P1|STARTED|Overall Study||1
8521192|NCT00383565|21003576|P1|NOT COMPLETED|Overall Study||0
8521193|NCT00383565|21003576|P1|COMPLETED|Overall Study||9
8521194|NCT00383565|21003576|P1|STARTED|Overall Study||9
8521195|NCT00383552|21003586|P4|NOT COMPLETED|Overall Study||72
8521196|NCT00383552|21003587|P3|NOT COMPLETED|Overall Study||61
8521197|NCT00383552|21003588|P2|NOT COMPLETED|Overall Study||41
8521198|NCT00383552|21003589|P1|NOT COMPLETED|Overall Study||36
8521199|NCT00383552|21003586|P4|COMPLETED|Overall Study||116
8521200|NCT00383552|21003587|P3|COMPLETED|Overall Study||127
8521201|NCT00383552|21003588|P2|COMPLETED|Overall Study||147
8521202|NCT00383552|21003589|P1|COMPLETED|Overall Study||146
8521203|NCT00383552|21003586|P4|STARTED|Overall Study||188
8521204|NCT00383552|21003587|P3|STARTED|Overall Study||188
8521205|NCT00383552|21003588|P2|STARTED|Overall Study||188
8521206|NCT00383552|21003589|P1|STARTED|Overall Study||182
8521207|NCT00383500|21003631|P3|NOT COMPLETED|Overall Study||2
8521208|NCT00383500|21003632|P2|NOT COMPLETED|Overall Study||3
8521209|NCT00383500|21003633|P1|NOT COMPLETED|Overall Study||8
8521210|NCT00383500|21003631|P3|COMPLETED|Overall Study||22
8521211|NCT00383500|21003632|P2|COMPLETED|Overall Study||21
8521212|NCT00383500|21003633|P1|COMPLETED|Overall Study||19
8521213|NCT00383500|21003631|P3|STARTED|Overall Study||24
8521214|NCT00383500|21003632|P2|STARTED|Overall Study||24
8521215|NCT00383500|21003633|P1|STARTED|Overall Study||27
8521216|NCT00383448|21003644|P1|NOT COMPLETED|Overall Study||0
8521217|NCT00383448|21003644|P1|COMPLETED|Overall Study||38
8521218|NCT00383448|21003644|P1|STARTED|Overall Study||38
8521219|NCT00383435|21003657|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
8521220|NCT00383435|21003658|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
8521221|NCT00383435|21003659|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
8521222|NCT00383435|21003660|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
8521223|NCT00383435|21003661|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
8521224|NCT00383435|21003657|P5|COMPLETED|26-Week Treatment Safety Extension||10
8521225|NCT00383435|21003658|P4|COMPLETED|26-Week Treatment Safety Extension||116
8521226|NCT00383435|21003659|P3|COMPLETED|26-Week Treatment Safety Extension||108
8521227|NCT00383435|21003660|P2|COMPLETED|26-Week Treatment Safety Extension||121
8521228|NCT00383435|21003661|P1|COMPLETED|26-Week Treatment Safety Extension||117
8521229|NCT00383435|21003657|P5|STARTED|26-Week Treatment Safety Extension||13
8521230|NCT00383435|21003658|P4|STARTED|26-Week Treatment Safety Extension||131
8521231|NCT00383435|21003659|P3|STARTED|26-Week Treatment Safety Extension||124
8521232|NCT00383435|21003660|P2|STARTED|26-Week Treatment Safety Extension||130
8521233|NCT00383435|21003661|P1|STARTED|26-Week Treatment Safety Extension||131
8521234|NCT00383435|21003657|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
8521235|NCT00383435|21003658|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
8521236|NCT00383435|21003659|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
8521237|NCT00383435|21003660|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
8521238|NCT00383435|21003661|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
8521239|NCT00383435|21003657|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
8521240|NCT00383435|21003658|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
8521241|NCT00383435|21003659|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
8521242|NCT00383435|21003660|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
8521333|NCT00382993|21003956|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
8521243|NCT00383435|21003661|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
8521244|NCT00383435|21003657|P5|STARTED|26-Week Double-Blind Treatment Period||212
8521245|NCT00383435|21003658|P4|STARTED|26-Week Double-Blind Treatment Period||209
8521246|NCT00383435|21003659|P3|STARTED|26-Week Double-Blind Treatment Period||210
8521247|NCT00383435|21003660|P2|STARTED|26-Week Double-Blind Treatment Period||207
8521248|NCT00383435|21003661|P1|STARTED|26-Week Double-Blind Treatment Period||217
8521249|NCT00383331|21003700|P2|NOT COMPLETED|Overall Study||1
8521250|NCT00383331|21003701|P1|NOT COMPLETED|Overall Study||0
8521251|NCT00383331|21003700|P2|COMPLETED|Overall Study||8
8521252|NCT00383331|21003701|P1|COMPLETED|Overall Study||10
8521253|NCT00383331|21003700|P2|STARTED|Overall Study||9
8521254|NCT00383331|21003701|P1|STARTED|Overall Study||10
8521255|NCT00383292|21003720|P3|NOT COMPLETED|Overall Study||8
8521256|NCT00383292|21003721|P2|NOT COMPLETED|Overall Study||6
8521257|NCT00383292|21003722|P1|NOT COMPLETED|Overall Study||15
8521258|NCT00383292|21003720|P3|COMPLETED|Overall Study||22
8521259|NCT00383292|21003721|P2|COMPLETED|Overall Study||26
8521260|NCT00383292|21003722|P1|COMPLETED|Overall Study||53
8521261|NCT00383292|21003720|P3|Received at Least One Dose of Study Drug|Overall Study||30
8521262|NCT00383292|21003721|P2|Received at Least One Dose of Study Drug|Overall Study||32
8521263|NCT00383292|21003722|P1|Received at Least One Dose of Study Drug|Overall Study||68
8521264|NCT00383292|21003720|P3|STARTED|Overall Study||30
8521265|NCT00383292|21003721|P2|STARTED|Overall Study||32
8521266|NCT00383292|21003722|P1|STARTED|Overall Study||68
8521267|NCT00383266|21003750|P1|NOT COMPLETED|Overall Study||0
8521268|NCT00383266|21003750|P1|COMPLETED|Overall Study||9
8521269|NCT00383266|21003750|P1|STARTED|Overall Study||9
8521270|NCT00383240|21003763|P4|NOT COMPLETED|Overall Study||77
8521271|NCT00383240|21003764|P3|NOT COMPLETED|Overall Study||85
8521272|NCT00383240|21003765|P2|NOT COMPLETED|Overall Study||33
8521273|NCT00383240|21003766|P1|NOT COMPLETED|Overall Study||35
8521274|NCT00383240|21003763|P4|COMPLETED|Overall Study||119
8521275|NCT00383240|21003764|P3|COMPLETED|Overall Study||117
8521276|NCT00383240|21003765|P2|COMPLETED|Overall Study||159
8521277|NCT00383240|21003766|P1|COMPLETED|Overall Study||156
8521278|NCT00383240|21003763|P4|STARTED|Overall Study||196
8521279|NCT00383240|21003764|P3|STARTED|Overall Study||202
8521280|NCT00383240|21003765|P2|STARTED|Overall Study||192
8521281|NCT00383240|21003766|P1|STARTED|Overall Study||191
8521282|NCT00383162|21003797|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
8521283|NCT00383162|21003798|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
8521284|NCT00383162|21003797|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
8521285|NCT00383162|21003798|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
8521286|NCT00383162|21003797|P2|STARTED|Migraine Attack 2 (Period 2)||73
8521287|NCT00383162|21003798|P1|STARTED|Migraine Attack 2 (Period 2)||67
8521288|NCT00383162|21003797|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
8521289|NCT00383162|21003798|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
8521290|NCT00383162|21003797|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
8521291|NCT00383162|21003798|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
8521292|NCT00383162|21003797|P2|STARTED|Migraine Attack 1 (Period 1)||86
8521293|NCT00383162|21003798|P1|STARTED|Migraine Attack 1 (Period 1)||87
8521294|NCT00383149|21003840|P1|NOT COMPLETED|Overall Study||54
8521295|NCT00383149|21003840|P1|COMPLETED|Overall Study||0
8521296|NCT00383149|21003840|P1|STARTED|Overall Study||54
8521297|NCT00383123|21003859|P2|NOT COMPLETED|Overall Study||86
8521298|NCT00383123|21003860|P1|NOT COMPLETED|Overall Study||111
8521299|NCT00383123|21003859|P2|COMPLETED|Overall Study||1124
8521300|NCT00383123|21003860|P1|COMPLETED|Overall Study||2004
8521301|NCT00383123|21003859|P2|STARTED|Overall Study||1210
8521302|NCT00383123|21003860|P1|STARTED|Overall Study||2115
8521303|NCT00383110|21003882|P2|NOT COMPLETED|Overall Study||0
8521304|NCT00383110|21003883|P1|NOT COMPLETED|Overall Study||0
8521305|NCT00383110|21003882|P2|COMPLETED|Overall Study||150
8521306|NCT00383110|21003883|P1|COMPLETED|Overall Study||150
8521307|NCT00383110|21003882|P2|STARTED|Overall Study||150
8521308|NCT00383110|21003883|P1|STARTED|Overall Study||150
8521309|NCT00383084|21003901|P2|NOT COMPLETED|Overall Study||10
8521310|NCT00383084|21003902|P1|NOT COMPLETED|Overall Study||12
8521311|NCT00383084|21003901|P2|COMPLETED|Overall Study||28
8521312|NCT00383084|21003902|P1|COMPLETED|Overall Study||34
8521313|NCT00383084|21003901|P2|STARTED|Overall Study||38
8521314|NCT00383084|21003902|P1|STARTED|Overall Study||46
8521315|NCT00383071|21003918|P4|NOT COMPLETED|Overall Study||3
8521316|NCT00383071|21003919|P3|NOT COMPLETED|Overall Study||7
8521317|NCT00383071|21003920|P2|NOT COMPLETED|Overall Study||4
8521318|NCT00383071|21003921|P1|NOT COMPLETED|Overall Study||0
8521319|NCT00383071|21003918|P4|COMPLETED|Overall Study||22
8521320|NCT00383071|21003919|P3|COMPLETED|Overall Study||44
8521321|NCT00383071|21003920|P2|COMPLETED|Overall Study||21
8521322|NCT00383071|21003921|P1|COMPLETED|Overall Study||25
8521323|NCT00383071|21003918|P4|STARTED|Overall Study||25
8521324|NCT00383071|21003919|P3|STARTED|Overall Study||51
8521325|NCT00383071|21003920|P2|STARTED|Overall Study||25
8521326|NCT00383071|21003921|P1|STARTED|Overall Study||25
8521327|NCT00383019|21003933|P2|NOT COMPLETED|Overall Study||2
8521328|NCT00383019|21003934|P1|NOT COMPLETED|Overall Study||5
8521329|NCT00383019|21003933|P2|COMPLETED|Overall Study||143
8521330|NCT00383019|21003934|P1|COMPLETED|Overall Study||139
8521331|NCT00383019|21003933|P2|STARTED|Overall Study||145
8521332|NCT00383019|21003934|P1|STARTED|Overall Study||144
8521334|NCT00382993|21003957|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
8521335|NCT00382993|21003956|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
8521336|NCT00382993|21003957|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
8521337|NCT00382993|21003956|P2|STARTED|Migraine Attack 2 (Period 2)||67
8521338|NCT00382993|21003957|P1|STARTED|Migraine Attack 2 (Period 2)||70
8521339|NCT00382993|21003956|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
8521340|NCT00382993|21003957|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
8521341|NCT00382993|21003956|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
8521342|NCT00382993|21003957|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
8521343|NCT00382993|21003956|P2|STARTED|Migraine Attack 1 (Period 1)||85
8521344|NCT00382993|21003957|P1|STARTED|Migraine Attack 1 (Period 1)||84
8521345|NCT00382967|21004001|P2|NOT COMPLETED|Overall Study||1
8521346|NCT00382967|21004002|P1|NOT COMPLETED|Overall Study||1
8521347|NCT00382967|21004001|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
8521348|NCT00382967|21004002|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
8521349|NCT00382967|21004001|P2|STARTED|Overall Study||138
8521350|NCT00382967|21004002|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
8521351|NCT00382928|21004012|P2|NOT COMPLETED|Overall Study||0
8521352|NCT00382928|21004013|P1|NOT COMPLETED|Overall Study||0
8521353|NCT00382928|21004012|P2|COMPLETED|Overall Study||95
8521354|NCT00382928|21004013|P1|COMPLETED|Overall Study||97
8521355|NCT00382928|21004012|P2|STARTED|Overall Study||95
8521356|NCT00382928|21004013|P1|STARTED|Overall Study||97
8521357|NCT00382863|21004027|P2|NOT COMPLETED|Overall Study||36
8521358|NCT00382863|21004028|P1|NOT COMPLETED|Overall Study||15
8521359|NCT00382863|21004027|P2|COMPLETED|Overall Study||78
8521360|NCT00382863|21004028|P1|COMPLETED|Overall Study||81
8521361|NCT00382863|21004027|P2|STARTED|Overall Study||114
8521362|NCT00382863|21004028|P1|STARTED|Overall Study||96
8521363|NCT00382824|21004084|P2|NOT COMPLETED|Overall Study||13
8521364|NCT00382824|21004085|P1|NOT COMPLETED|Overall Study||12
8521365|NCT00382824|21004084|P2|COMPLETED|Overall Study||16
8521366|NCT00382824|21004085|P1|COMPLETED|Overall Study||20
8521367|NCT00382824|21004084|P2|STARTED|Overall Study||29
8521368|NCT00382824|21004085|P1|STARTED|Overall Study||32
8521369|NCT00382785|21004101|P2|NOT COMPLETED|Overall Study||0
8521370|NCT00382785|21004102|P1|NOT COMPLETED|Overall Study||0
8521371|NCT00382785|21004101|P2|COMPLETED|Overall Study||26
8521372|NCT00382785|21004102|P1|COMPLETED|Overall Study||25
8521373|NCT00382785|21004101|P2|STARTED|Overall Study||26
8521374|NCT00382785|21004102|P1|STARTED|Overall Study||25
8521375|NCT00382733|21004112|P5|NOT COMPLETED|Overall Study||0
8521376|NCT00382733|21004113|P4|NOT COMPLETED|Overall Study||0
8521377|NCT00382733|21004114|P3|NOT COMPLETED|Overall Study||0
8521378|NCT00382733|21004115|P2|NOT COMPLETED|Overall Study||1
8521379|NCT00382733|21004116|P1|NOT COMPLETED|Overall Study||0
8521380|NCT00382733|21004112|P5|COMPLETED|Overall Study||2
8521381|NCT00382733|21004113|P4|COMPLETED|Overall Study||14
8521382|NCT00382733|21004114|P3|COMPLETED|Overall Study||3
8521383|NCT00382733|21004115|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
8521384|NCT00382733|21004116|P1|COMPLETED|Overall Study||3
8521385|NCT00382733|21004112|P5|STARTED|Overall Study||2
8521386|NCT00382733|21004113|P4|STARTED|Overall Study||14
8521387|NCT00382733|21004114|P3|STARTED|Overall Study||3
8521388|NCT00382733|21004115|P2|STARTED|Overall Study||4
8521389|NCT00382733|21004116|P1|STARTED|Overall Study||3
8521390|NCT00382720|21004137|P3|NOT COMPLETED|Overall Study||86
8521391|NCT00382720|21004138|P2|NOT COMPLETED|Overall Study||89
8521392|NCT00382720|21004139|P1|NOT COMPLETED|Overall Study||79
8521393|NCT00382720|21004137|P3|COMPLETED|Overall Study||0
8521394|NCT00382720|21004138|P2|COMPLETED|Overall Study||0
8521395|NCT00382720|21004139|P1|COMPLETED|Overall Study||0
8521396|NCT00382720|21004137|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
8521397|NCT00382720|21004138|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
8521398|NCT00382720|21004139|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
8521399|NCT00382720|21004137|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
8521400|NCT00382720|21004138|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
8521401|NCT00382720|21004139|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
8521402|NCT00382720|21004137|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
8521403|NCT00382720|21004138|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
8521404|NCT00382720|21004139|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
8521405|NCT00382720|21004137|P3|STARTED|Overall Study||86
8521406|NCT00382720|21004138|P2|STARTED|Overall Study||89
8521407|NCT00382720|21004139|P1|STARTED|Overall Study||79
8521408|NCT00382590|21004155|P2|NOT COMPLETED|Overall Study||0
8521409|NCT00382590|21004156|P1|NOT COMPLETED|Overall Study||0
8521410|NCT00382590|21004155|P2|COMPLETED|Overall Study||6
8521411|NCT00382590|21004156|P1|COMPLETED|Overall Study||4
8521412|NCT00382590|21004155|P2|STARTED|Overall Study||6
8521413|NCT00382590|21004156|P1|STARTED|Overall Study||4
8521414|NCT00382408|21004164|P2|NOT COMPLETED|Overall Study||54
8521415|NCT00382408|21004165|P1|NOT COMPLETED|Overall Study||144
8521416|NCT00382408|21004164|P2|COMPLETED|Overall Study||955
8521417|NCT00382408|21004165|P1|COMPLETED|Overall Study||2887
8521418|NCT00382408|21004164|P2|STARTED|Overall Study||1009
8521419|NCT00382408|21004165|P1|STARTED|Overall Study||3031
8521420|NCT00382291|21004192|P3|NOT COMPLETED|Overall Study||8
8521421|NCT00382291|21004193|P2|NOT COMPLETED|Overall Study||7
8521422|NCT00382291|21004194|P1|NOT COMPLETED|Overall Study||4
8521423|NCT00382291|21004192|P3|COMPLETED|Overall Study||13
8521424|NCT00382291|21004193|P2|COMPLETED|Overall Study||10
8521425|NCT00382291|21004194|P1|COMPLETED|Overall Study||14
8521426|NCT00382291|21004192|P3|STARTED|Overall Study||21
8521427|NCT00382291|21004193|P2|STARTED|Overall Study||17
8521428|NCT00382291|21004194|P1|STARTED|Overall Study||18
8521429|NCT00382265|21004207|P2|NOT COMPLETED|Overall Study||6
8521430|NCT00382265|21004208|P1|NOT COMPLETED|Overall Study||9
8521431|NCT00382265|21004207|P2|COMPLETED|Overall Study||239
8521432|NCT00382265|21004208|P1|COMPLETED|Overall Study||258
8521433|NCT00382265|21004207|P2|STARTED|Overall Study||245
8521434|NCT00382265|21004208|P1|STARTED|Overall Study||267
8521435|NCT00382174|21004226|P3|NOT COMPLETED|Overall Study||21
8521436|NCT00382174|21004227|P2|NOT COMPLETED|Overall Study||17
8521437|NCT00382174|21004228|P1|NOT COMPLETED|Overall Study||4
8521438|NCT00382174|21004226|P3|COMPLETED|Overall Study||51
8521439|NCT00382174|21004227|P2|COMPLETED|Overall Study||37
8521440|NCT00382174|21004228|P1|COMPLETED|Overall Study||14
8521441|NCT00382174|21004226|P3|STARTED|Overall Study||72
8521442|NCT00382174|21004227|P2|STARTED|Overall Study||54
8521443|NCT00382174|21004228|P1|STARTED|Overall Study||18
8521444|NCT00382148|21004241|P2|NOT COMPLETED|Overall Study||0
8521445|NCT00382148|21004242|P1|NOT COMPLETED|Overall Study||1
8521446|NCT00382148|21004241|P2|COMPLETED|Overall Study||7
8521447|NCT00382148|21004242|P1|COMPLETED|Overall Study||3
8521448|NCT00382148|21004241|P2|STARTED|Overall Study||7
8521449|NCT00382148|21004242|P1|STARTED|Overall Study||4
8521450|NCT00382109|21004256|P2|NOT COMPLETED|Overall Study||4
8521451|NCT00382109|21004257|P1|NOT COMPLETED|Overall Study||12
8521452|NCT00382109|21004256|P2|COMPLETED|Overall Study||66
8521453|NCT00382109|21004257|P1|COMPLETED|Overall Study||64
8521454|NCT00382109|21004256|P2|STARTED|Overall Study||70
8521455|NCT00382109|21004257|P1|STARTED|Overall Study||76
8521456|NCT00382031|21004279|P2|NOT COMPLETED|Overall Study||0
8521457|NCT00382031|21004280|P1|NOT COMPLETED|Overall Study||0
8521458|NCT00382031|21004279|P2|COMPLETED|Overall Study||95
8521459|NCT00382031|21004280|P1|COMPLETED|Overall Study||191
8521460|NCT00382031|21004279|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
8521461|NCT00382031|21004280|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
8521462|NCT00382018|21004296|P4|NOT COMPLETED|Overall Study||59
8521463|NCT00382018|21004297|P3|NOT COMPLETED|Overall Study||64
8521464|NCT00382018|21004298|P2|NOT COMPLETED|Overall Study||165
8521465|NCT00382018|21004299|P1|NOT COMPLETED|Overall Study||0
8521466|NCT00382018|21004296|P4|COMPLETED|Overall Study||0
8521467|NCT00382018|21004297|P3|COMPLETED|Overall Study||0
8521468|NCT00382018|21004298|P2|COMPLETED|Overall Study||0
8521469|NCT00382018|21004299|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
8521470|NCT00382018|21004296|P4|STARTED|Overall Study||59
8521471|NCT00382018|21004297|P3|STARTED|Overall Study||64
8521472|NCT00382018|21004298|P2|STARTED|Overall Study||165
8521473|NCT00382018|21004299|P1|STARTED|Overall Study||276
8521474|NCT00381966|21004317|P1|NOT COMPLETED|Overall Study||0
8521475|NCT00381966|21004317|P1|COMPLETED|Overall Study||5
8521476|NCT00381966|21004317|P1|STARTED|Overall Study||5
8521477|NCT00381888|21004322|P1|NOT COMPLETED|Overall Study||17
8521478|NCT00381888|21004322|P1|COMPLETED|Overall Study||27
8521479|NCT00381888|21004322|P1|STARTED|Overall Study||44
8521480|NCT00381862|21004327|P1|NOT COMPLETED|Overall Study||10
8521481|NCT00381862|21004327|P1|COMPLETED|Overall Study||44
8521482|NCT00381862|21004327|P1|STARTED|Overall Study||54
8521483|NCT00381849|21004333|P2|NOT COMPLETED|Open-label||0
8521484|NCT00381849|21004334|P1|NOT COMPLETED|Open-label||0
8521485|NCT00381849|21004333|P2|COMPLETED|Open-label||9
8521486|NCT00381849|21004334|P1|COMPLETED|Open-label||10
8521487|NCT00381849|21004333|P2|STARTED|Open-label||9
8521488|NCT00381849|21004334|P1|STARTED|Open-label||10
8521489|NCT00381849|21004333|P2|NOT COMPLETED|Second Intervention||0
8521490|NCT00381849|21004334|P1|NOT COMPLETED|Second Intervention||0
8521491|NCT00381849|21004333|P2|COMPLETED|Second Intervention||9
8521492|NCT00381849|21004334|P1|COMPLETED|Second Intervention||10
8521493|NCT00381849|21004333|P2|STARTED|Second Intervention||9
8521494|NCT00381849|21004334|P1|STARTED|Second Intervention||10
8521495|NCT00381849|21004333|P2|NOT COMPLETED|Wash Out||1
8521496|NCT00381849|21004334|P1|NOT COMPLETED|Wash Out||0
8521497|NCT00381849|21004333|P2|COMPLETED|Wash Out||9
8521498|NCT00381849|21004334|P1|COMPLETED|Wash Out||10
8521499|NCT00381849|21004333|P2|STARTED|Wash Out||10
8521500|NCT00381849|21004334|P1|STARTED|Wash Out||10
8521501|NCT00381849|21004333|P2|NOT COMPLETED|First Intervention||0
8521502|NCT00381849|21004334|P1|NOT COMPLETED|First Intervention||0
8521503|NCT00381849|21004333|P2|COMPLETED|First Intervention||10
8521504|NCT00381849|21004334|P1|COMPLETED|First Intervention||10
8521505|NCT00381849|21004333|P2|STARTED|First Intervention||10
8521506|NCT00381849|21004334|P1|STARTED|First Intervention||10
8521507|NCT00381810|21004352|P1|NOT COMPLETED|B Cell Follow-up||7
8521508|NCT00381810|21004352|P1|COMPLETED|B Cell Follow-up||0
8521509|NCT00381810|21004352|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
8521510|NCT00381810|21004352|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
8521511|NCT00381810|21004352|P1|COMPLETED|Treatment and Safety Follow-up||16
8521512|NCT00381810|21004352|P1|STARTED|Treatment and Safety Follow-up||31
8521513|NCT00381797|21004361|P5|NOT COMPLETED|Overall Study||2
8521514|NCT00381797|21004362|P4|NOT COMPLETED|Overall Study||1
8521515|NCT00381797|21004363|P3|NOT COMPLETED|Overall Study||0
8521516|NCT00381797|21004364|P2|NOT COMPLETED|Overall Study||1
8521517|NCT00381797|21004365|P1|NOT COMPLETED|Overall Study||1
8521518|NCT00381797|21004361|P5|COMPLETED|Overall Study||35
8521519|NCT00381797|21004362|P4|COMPLETED|Overall Study||14
8521520|NCT00381797|21004363|P3|COMPLETED|Overall Study||10
8521521|NCT00381797|21004364|P2|COMPLETED|Overall Study||16
8521522|NCT00381797|21004365|P1|COMPLETED|Overall Study||17
8521523|NCT00381797|21004361|P5|STARTED|Overall Study||37
8521524|NCT00381797|21004362|P4|STARTED|Overall Study||15
8521525|NCT00381797|21004363|P3|STARTED|Overall Study||10
8521526|NCT00381797|21004364|P2|STARTED|Overall Study||17
8521527|NCT00381797|21004365|P1|STARTED|Overall Study||18
8521528|NCT00381706|21004440|P3|NOT COMPLETED|Overall Study||1
8521529|NCT00381706|21004441|P2|NOT COMPLETED|Overall Study||2
8521530|NCT00381706|21004442|P1|NOT COMPLETED|Overall Study||7
8521531|NCT00381706|21004440|P3|COMPLETED|Overall Study||79
8521532|NCT00381706|21004441|P2|COMPLETED|Overall Study||81
8521533|NCT00381706|21004442|P1|COMPLETED|Overall Study||75
8521534|NCT00381706|21004440|P3|STARTED|Overall Study||80
8521535|NCT00381706|21004441|P2|STARTED|Overall Study||83
8521536|NCT00381706|21004442|P1|STARTED|Overall Study||82
8521537|NCT00381693|21004465|P1|NOT COMPLETED|Overall Study||8
8521538|NCT00381693|21004465|P1|COMPLETED|Overall Study||2
8521539|NCT00381693|21004465|P1|STARTED|Overall Study||10
8521540|NCT00381680|21004474|P2|NOT COMPLETED|Overall Study||50
8521541|NCT00381680|21004475|P1|NOT COMPLETED|Overall Study||125
8521542|NCT00381680|21004474|P2|COMPLETED|Overall Study||19
8521543|NCT00381680|21004475|P1|COMPLETED|Overall Study||81
8521544|NCT00381680|21004474|P2|STARTED|Overall Study||69
8521545|NCT00381680|21004475|P1|STARTED|Overall Study||206
8521546|NCT00381641|21004492|P2|NOT COMPLETED|Overall Study||2
8521547|NCT00381641|21004493|P1|NOT COMPLETED|Overall Study||0
8521548|NCT00381641|21004492|P2|COMPLETED|Overall Study||23
8521549|NCT00381641|21004493|P1|COMPLETED|Overall Study||38
8521550|NCT00381641|21004492|P2|STARTED|Overall Study||25
8521551|NCT00381641|21004493|P1|STARTED|Overall Study||38
8521552|NCT00381628|21004509|P4|NOT COMPLETED|Overall Study||0
8521553|NCT00381628|21004510|P3|NOT COMPLETED|Overall Study||0
8521554|NCT00381628|21004511|P2|NOT COMPLETED|Overall Study||0
8521555|NCT00381628|21004512|P1|NOT COMPLETED|Overall Study||0
8521556|NCT00381628|21004509|P4|COMPLETED|Overall Study||14
8521557|NCT00381628|21004510|P3|COMPLETED|Overall Study||0
8521558|NCT00381628|21004511|P2|COMPLETED|Overall Study||27
8521559|NCT00381628|21004512|P1|COMPLETED|Overall Study||18
8521560|NCT00381628|21004509|P4|STARTED|Overall Study||14
8521561|NCT00381628|21004510|P3|STARTED|Overall Study||0
8521562|NCT00381628|21004511|P2|STARTED|Overall Study||27
8521563|NCT00381628|21004512|P1|STARTED|Overall Study||18
8521564|NCT00381615|21004526|P4|NOT COMPLETED|Overall Study||2
8521565|NCT00381615|21004527|P3|NOT COMPLETED|Overall Study||1
8521566|NCT00381615|21004528|P2|NOT COMPLETED|Overall Study||5
8521567|NCT00381615|21004529|P1|NOT COMPLETED|Overall Study||4
8521568|NCT00381615|21004526|P4|COMPLETED|Overall Study||22
8521569|NCT00381615|21004527|P3|COMPLETED|Overall Study||24
8521570|NCT00381615|21004528|P2|COMPLETED|Overall Study||45
8521571|NCT00381615|21004529|P1|COMPLETED|Overall Study||44
8521572|NCT00381615|21004526|P4|STARTED|Overall Study||24
8521573|NCT00381615|21004527|P3|STARTED|Overall Study||25
8521574|NCT00381615|21004528|P2|STARTED|Overall Study||50
8521575|NCT00381615|21004529|P1|STARTED|Overall Study||48
8521576|NCT00381563|21004581|P2|NOT COMPLETED|Overall Study||6
8521577|NCT00381563|21004582|P1|NOT COMPLETED|Overall Study||7
8521578|NCT00381563|21004581|P2|COMPLETED|Overall Study||33
8521579|NCT00381563|21004582|P1|COMPLETED|Overall Study||34
8521580|NCT00381563|21004581|P2|STARTED|Overall Study||39
8521581|NCT00381563|21004582|P1|STARTED|Overall Study||41
8521582|NCT00381550|21004589|P1|NOT COMPLETED|Overall Study||0
8521583|NCT00381550|21004589|P1|COMPLETED|Overall Study||35
8521584|NCT00381550|21004589|P1|STARTED|Overall Study||35
8521585|NCT00381485|21004597|P4|NOT COMPLETED|Double-Blind Treatment Period||33
8521586|NCT00381485|21004598|P3|NOT COMPLETED|Double-Blind Treatment Period||25
8521587|NCT00381485|21004599|P2|NOT COMPLETED|Double-Blind Treatment Period||27
8521588|NCT00381485|21004600|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8521589|NCT00381485|21004597|P4|COMPLETED|Double-Blind Treatment Period||207
8521590|NCT00381485|21004598|P3|COMPLETED|Double-Blind Treatment Period||208
8521591|NCT00381485|21004599|P2|COMPLETED|Double-Blind Treatment Period||228
8521592|NCT00381485|21004600|P1|COMPLETED|Double-Blind Treatment Period||0
8521593|NCT00381485|21004597|P4|STARTED|Double-Blind Treatment Period||240
8521594|NCT00381485|21004598|P3|STARTED|Double-Blind Treatment Period||233
8521595|NCT00381485|21004599|P2|STARTED|Double-Blind Treatment Period||255
8521596|NCT00381485|21004600|P1|STARTED|Double-Blind Treatment Period||0
8521597|NCT00381485|21004597|P4|NOT COMPLETED|Open-Label Run-In Period||0
8521598|NCT00381485|21004598|P3|NOT COMPLETED|Open-Label Run-In Period||0
8521599|NCT00381485|21004599|P2|NOT COMPLETED|Open-Label Run-In Period||0
8521600|NCT00381485|21004600|P1|NOT COMPLETED|Open-Label Run-In Period||106
8521601|NCT00381485|21004597|P4|COMPLETED|Open-Label Run-In Period||0
8521602|NCT00381485|21004598|P3|COMPLETED|Open-Label Run-In Period||0
8521603|NCT00381485|21004599|P2|COMPLETED|Open-Label Run-In Period||0
8521604|NCT00381485|21004600|P1|COMPLETED|Open-Label Run-In Period||728
8521605|NCT00381485|21004597|P4|STARTED|Open-Label Run-In Period||0
8521606|NCT00381485|21004598|P3|STARTED|Open-Label Run-In Period||0
8521607|NCT00381485|21004599|P2|STARTED|Open-Label Run-In Period||0
8521608|NCT00381485|21004600|P1|STARTED|Open-Label Run-In Period||834
8521609|NCT00381381|21004618|P1|NOT COMPLETED|Overall Study||64
8521610|NCT00381381|21004618|P1|COMPLETED|Overall Study||135
8521611|NCT00381381|21004618|P1|STARTED|Overall Study||199
8521612|NCT00381303|21004627|P2|NOT COMPLETED|Overall Study||33
8521613|NCT00381303|21004628|P1|NOT COMPLETED|Overall Study||94
8521614|NCT00381303|21004627|P2|COMPLETED|Overall Study||109
8521615|NCT00381303|21004628|P1|COMPLETED|Overall Study||193
8521616|NCT00381303|21004627|P2|STARTED|Overall Study||142
8521617|NCT00381303|21004628|P1|STARTED|Overall Study||287
8521618|NCT00381238|21004688|P1|NOT COMPLETED|Overall Study||12
8521619|NCT00381238|21004688|P1|COMPLETED|Overall Study||21
8521620|NCT00381238|21004688|P1|STARTED|Overall Study||33
8521621|NCT00381095|21004704|P2|NOT COMPLETED|Overall Study||21
8521622|NCT00381095|21004705|P1|NOT COMPLETED|Overall Study||13
8521623|NCT00381095|21004704|P2|COMPLETED|Overall Study||59
8521624|NCT00381095|21004705|P1|COMPLETED|Overall Study||59
8521625|NCT00381095|21004704|P2|STARTED|Overall Study||80
8521626|NCT00381095|21004705|P1|STARTED|Overall Study||72
8521627|NCT00381043|21004737|P2|NOT COMPLETED|Overall Study||8
8521628|NCT00381043|21004738|P1|NOT COMPLETED|Overall Study||12
8521629|NCT00381043|21004737|P2|COMPLETED|Overall Study||41
8521630|NCT00381043|21004738|P1|COMPLETED|Overall Study||39
8521631|NCT00381043|21004737|P2|STARTED|Overall Study||49
8521632|NCT00381043|21004738|P1|STARTED|Overall Study||51
8521633|NCT00381004|21004756|P1|NOT COMPLETED|Overall Study||0
8521634|NCT00381004|21004756|P1|COMPLETED|Overall Study||60
8521635|NCT00381004|21004756|P1|STARTED|Overall Study||60
8521636|NCT00380978|21004764|P2|NOT COMPLETED|Overall Study||10
8521637|NCT00380978|21004765|P1|NOT COMPLETED|Overall Study||2
8521638|NCT00380978|21004764|P2|COMPLETED|Overall Study||400
8521639|NCT00380978|21004765|P1|COMPLETED|Overall Study||406
8521640|NCT00380978|21004764|P2|STARTED|Overall Study||410
8521641|NCT00380978|21004765|P1|STARTED|Overall Study||408
8521648|NCT00380861|21004806|P2|NOT COMPLETED|Overall Study||17
8521649|NCT00380861|21004807|P1|NOT COMPLETED|Overall Study||18
8521650|NCT00380861|21004806|P2|COMPLETED|Overall Study||74
8521651|NCT00380861|21004807|P1|COMPLETED|Overall Study||75
8521652|NCT00380861|21004806|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
8521653|NCT00380861|21004807|P1|STARTED|Overall Study||93
8521654|NCT00380744|21004820|P7|NOT COMPLETED|Overall Study||1
8521655|NCT00380744|21004821|P6|NOT COMPLETED|Overall Study||0
8521656|NCT00380744|21004822|P5|NOT COMPLETED|Overall Study||0
8521657|NCT00380744|21004823|P4|NOT COMPLETED|Overall Study||0
8521658|NCT00380744|21004824|P3|NOT COMPLETED|Overall Study||0
8521659|NCT00380744|21004825|P2|NOT COMPLETED|Overall Study||0
8521660|NCT00380744|21004826|P1|NOT COMPLETED|Overall Study||1
8521661|NCT00380744|21004820|P7|COMPLETED|Overall Study||24
8521662|NCT00380744|21004821|P6|COMPLETED|Overall Study||25
8521663|NCT00380744|21004822|P5|COMPLETED|Overall Study||23
8521664|NCT00380744|21004823|P4|COMPLETED|Overall Study||4
8521665|NCT00380744|21004824|P3|COMPLETED|Overall Study||20
8521666|NCT00380744|21004825|P2|COMPLETED|Overall Study||4
8521667|NCT00380744|21004826|P1|COMPLETED|Overall Study||19
8521668|NCT00380744|21004820|P7|Received at Least 1 Dose of Study Drug|Overall Study||25
8521669|NCT00380744|21004821|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
8521670|NCT00380744|21004822|P5|Received at Least 1 Dose of Study Drug|Overall Study||23
8521671|NCT00380744|21004823|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8521672|NCT00380744|21004824|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
8521673|NCT00380744|21004825|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8521674|NCT00380744|21004826|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
8521675|NCT00380744|21004820|P7|STARTED|Overall Study||25
8521676|NCT00380744|21004821|P6|STARTED|Overall Study||25
8521677|NCT00380744|21004822|P5|STARTED|Overall Study||23
8521678|NCT00380744|21004823|P4|STARTED|Overall Study||4
8521679|NCT00380744|21004824|P3|STARTED|Overall Study||20
8521680|NCT00380744|21004825|P2|STARTED|Overall Study||4
8521681|NCT00380744|21004826|P1|STARTED|Overall Study||20
8521682|NCT00380718|21004876|P1|NOT COMPLETED|Overall Study||18
8521683|NCT00380718|21004876|P1|COMPLETED|Overall Study||15
8521684|NCT00380718|21004876|P1|Received Escalated Dose in Cycle 2|Overall Study||25
8521685|NCT00380718|21004876|P1|Received at Least One Dose of Study Drug|Overall Study||33
8521686|NCT00380718|21004876|P1|STARTED|Overall Study||33
8521687|NCT00380692|21004888|P2|NOT COMPLETED|Study Period III - Open Label||12
8521688|NCT00380692|21004889|P1|NOT COMPLETED|Study Period III - Open Label||6
8521689|NCT00380692|21004888|P2|COMPLETED|Study Period III - Open Label||34
8521690|NCT00380692|21004889|P1|COMPLETED|Study Period III - Open Label||36
8521691|NCT00380692|21004888|P2|STARTED|Study Period III - Open Label||46
8521692|NCT00380692|21004889|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
8521693|NCT00380692|21004888|P2|NOT COMPLETED|Study Period II - Double Blind||3
8521694|NCT00380692|21004889|P1|NOT COMPLETED|Study Period II - Double Blind||5
8521695|NCT00380692|21004888|P2|COMPLETED|Study Period II - Double Blind||46
8521696|NCT00380692|21004889|P1|COMPLETED|Study Period II - Double Blind||43
8521697|NCT00380692|21004888|P2|STARTED|Study Period II - Double Blind||49
8521698|NCT00380692|21004889|P1|STARTED|Study Period II - Double Blind||48
8521699|NCT00380588|21004937|P2|NOT COMPLETED|Overall Study||40
8521700|NCT00380588|21004938|P1|NOT COMPLETED|Overall Study||39
8521701|NCT00380588|21004937|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
8521702|NCT00380588|21004938|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
8521703|NCT00380588|21004937|P2|Received at Least One Dose of Study Drug|Overall Study||42
8521704|NCT00380588|21004938|P1|Received at Least One Dose of Study Drug|Overall Study||41
8521705|NCT00380588|21004937|P2|STARTED|Overall Study||42
8521706|NCT00380588|21004938|P1|STARTED|Overall Study||42
8521707|NCT00380393|21004952|P2|NOT COMPLETED|Month 14||56
8521708|NCT00380393|21004953|P1|NOT COMPLETED|Month 14||57
8521709|NCT00380393|21004952|P2|COMPLETED|Month 14||391
8521710|NCT00380393|21004953|P1|COMPLETED|Month 14||390
8521711|NCT00380393|21004952|P2|STARTED|Month 14||447
8521712|NCT00380393|21004953|P1|STARTED|Month 14||447
8521713|NCT00380393|21004952|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
8521714|NCT00380393|21004953|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
8521715|NCT00380393|21004952|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
8521716|NCT00380393|21004953|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
8521717|NCT00380393|21004952|P2|STARTED|Month 8 (Cross-sectional Visit)||447
8521718|NCT00380393|21004953|P1|STARTED|Month 8 (Cross-sectional Visit)||447
8521719|NCT00380367|21005001|P1|NOT COMPLETED|Overall Study||2
8521720|NCT00380367|21005001|P1|COMPLETED|Overall Study||108
8521721|NCT00380367|21005001|P1|STARTED|Overall Study||110
8521722|NCT00380250|21005008|P2|NOT COMPLETED|Overall Study||55
8521723|NCT00380250|21005009|P1|NOT COMPLETED|Overall Study||99
8521724|NCT00380250|21005008|P2|COMPLETED|Overall Study||139
8521725|NCT00380250|21005009|P1|COMPLETED|Overall Study||297
8521726|NCT00380250|21005008|P2|STARTED|Overall Study||194
8521727|NCT00380250|21005009|P1|STARTED|Overall Study||396
8521728|NCT00380081|21005077|P6|NOT COMPLETED|Overall Study||1
8521729|NCT00380081|21005078|P5|NOT COMPLETED|Overall Study||1
8521730|NCT00380081|21005079|P4|NOT COMPLETED|Overall Study||0
8521731|NCT00380081|21005080|P3|NOT COMPLETED|Overall Study||0
8521732|NCT00380081|21005081|P2|NOT COMPLETED|Overall Study||0
8521733|NCT00380081|21005082|P1|NOT COMPLETED|Overall Study||0
8521734|NCT00380081|21005077|P6|COMPLETED|Overall Study||13
8521735|NCT00380081|21005078|P5|COMPLETED|Overall Study||12
8521736|NCT00380081|21005079|P4|COMPLETED|Overall Study||15
8521737|NCT00380081|21005080|P3|COMPLETED|Overall Study||13
8521738|NCT00380081|21005081|P2|COMPLETED|Overall Study||13
8521739|NCT00380081|21005082|P1|COMPLETED|Overall Study||14
8521740|NCT00380081|21005077|P6|STARTED|Overall Study||14
8521741|NCT00380081|21005078|P5|STARTED|Overall Study||13
8521742|NCT00380081|21005079|P4|STARTED|Overall Study||15
8521743|NCT00380081|21005080|P3|STARTED|Overall Study||13
8521744|NCT00380081|21005081|P2|STARTED|Overall Study||13
8521745|NCT00380081|21005082|P1|STARTED|Overall Study||14
8521746|NCT00380068|21005132|P1|NOT COMPLETED|Overall Study||69
8521747|NCT00380068|21005132|P1|COMPLETED|Overall Study||155
8521748|NCT00380068|21005132|P1|STARTED|Overall Study||224
8521749|NCT00380029|21005152|P1|NOT COMPLETED|Overall Study||0
8521750|NCT00380029|21005152|P1|COMPLETED|Overall Study||20
8521751|NCT00380029|21005152|P1|STARTED|Overall Study||20
8521752|NCT00379912|21005164|P2|NOT COMPLETED|Overall Study||0
8521753|NCT00379912|21005165|P1|NOT COMPLETED|Overall Study||1
8521754|NCT00379912|21005164|P2|COMPLETED|Overall Study||8
8521755|NCT00379912|21005165|P1|COMPLETED|Overall Study||6
8521756|NCT00379912|21005164|P2|STARTED|Overall Study||8
8521757|NCT00379912|21005165|P1|STARTED|Overall Study||7
8521758|NCT00379899|21005187|P2|NOT COMPLETED|Overall Study||40
8521759|NCT00379899|21005188|P1|NOT COMPLETED|Overall Study||40
8521760|NCT00379899|21005187|P2|COMPLETED|Overall Study||140
8521761|NCT00379899|21005188|P1|COMPLETED|Overall Study||140
8521762|NCT00379899|21005187|P2|STARTED|Overall Study||180
8521763|NCT00379899|21005188|P1|STARTED|Overall Study||180
8521764|NCT00379834|21005216|P1|NOT COMPLETED|Overall Study||2
8521765|NCT00379834|21005216|P1|COMPLETED|Overall Study||8
8521766|NCT00379834|21005216|P1|STARTED|Overall Study||10
8521767|NCT00379821|21005224|P4|NOT COMPLETED|Overall Study||79
8521768|NCT00379821|21005225|P3|NOT COMPLETED|Overall Study||67
8521769|NCT00379821|21005226|P2|NOT COMPLETED|Overall Study||89
8521770|NCT00379821|21005227|P1|NOT COMPLETED|Overall Study||73
8521771|NCT00379821|21005224|P4|COMPLETED|Overall Study||81
8521772|NCT00379821|21005225|P3|COMPLETED|Overall Study||93
8521773|NCT00379821|21005226|P2|COMPLETED|Overall Study||71
8521774|NCT00379821|21005227|P1|COMPLETED|Overall Study||87
8521775|NCT00379821|21005224|P4|STARTED|Overall Study||160
8521776|NCT00379821|21005225|P3|STARTED|Overall Study||160
8521777|NCT00379821|21005226|P2|STARTED|Overall Study||160
8521778|NCT00379821|21005227|P1|STARTED|Overall Study||160
8521779|NCT00379808|21005368|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
8521780|NCT00379808|21005369|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
8521781|NCT00379808|21005368|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
8521782|NCT00379808|21005369|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
8521783|NCT00379808|21005368|P2|STARTED|Intervention Period 2 (4 Weeks)||11
8521784|NCT00379808|21005369|P1|STARTED|Intervention Period 2 (4 Weeks)||11
8521952|NCT00378898|21005818|P2|COMPLETED|Overall Study||11
8521785|NCT00379808|21005368|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
8521786|NCT00379808|21005369|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
8521787|NCT00379808|21005368|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
8521788|NCT00379808|21005369|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
8521789|NCT00379808|21005368|P2|STARTED|Intervention Period 1 (4 Weeks)||11
8521790|NCT00379808|21005369|P1|STARTED|Intervention Period 1 (4 Weeks)||11
8521791|NCT00379795|21005390|P5|NOT COMPLETED|Overall Study||49
8521792|NCT00379795|21005391|P4|NOT COMPLETED|Overall Study||68
8521793|NCT00379795|21005392|P3|NOT COMPLETED|Overall Study||93
8521794|NCT00379795|21005393|P2|NOT COMPLETED|Overall Study||51
8521795|NCT00379795|21005394|P1|NOT COMPLETED|Overall Study||476
8521796|NCT00379795|21005390|P5|COMPLETED|Overall Study||14
8521797|NCT00379795|21005391|P4|COMPLETED|Overall Study||6
8521798|NCT00379795|21005392|P3|COMPLETED|Overall Study||23
8521799|NCT00379795|21005393|P2|COMPLETED|Overall Study||23
8521800|NCT00379795|21005394|P1|COMPLETED|Overall Study||50
8521801|NCT00379795|21005390|P5|Received Ranibizumab in Extension Study|Overall Study||0
8521802|NCT00379795|21005391|P4|Received Ranibizumab in Extension Study|Overall Study||55
8521803|NCT00379795|21005392|P3|Received Ranibizumab in Extension Study|Overall Study||113
8521804|NCT00379795|21005393|P2|Received Ranibizumab in Extension Study|Overall Study||41
8521805|NCT00379795|21005394|P1|Received Ranibizumab in Extension Study|Overall Study||377
8521806|NCT00379795|21005390|P5|STARTED|Overall Study||63
8521807|NCT00379795|21005391|P4|STARTED|Overall Study||74
8521808|NCT00379795|21005392|P3|STARTED|Overall Study||116
8521809|NCT00379795|21005393|P2|STARTED|Overall Study||74
8521810|NCT00379795|21005394|P1|STARTED|Overall Study||526
8521811|NCT00379769|21005424|P6|NOT COMPLETED|Observational Follow-up||148
8521812|NCT00379769|21005425|P5|NOT COMPLETED|Observational Follow-up||149
8521813|NCT00379769|21005426|P4|NOT COMPLETED|Observational Follow-up||0
8521814|NCT00379769|21005427|P3|NOT COMPLETED|Observational Follow-up||0
8521815|NCT00379769|21005428|P2|NOT COMPLETED|Observational Follow-up||0
8521816|NCT00379769|21005429|P1|NOT COMPLETED|Observational Follow-up||0
8521817|NCT00379769|21005424|P6|COMPLETED|Observational Follow-up||1102
8521818|NCT00379769|21005425|P5|COMPLETED|Observational Follow-up||1131
8521819|NCT00379769|21005426|P4|COMPLETED|Observational Follow-up||0
8521820|NCT00379769|21005427|P3|COMPLETED|Observational Follow-up||0
8521821|NCT00379769|21005428|P2|COMPLETED|Observational Follow-up||0
8521822|NCT00379769|21005429|P1|COMPLETED|Observational Follow-up||0
8521823|NCT00379769|21005424|P6|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
8521824|NCT00379769|21005425|P5|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
8521825|NCT00379769|21005426|P4|STARTED|Observational Follow-up||0
8521826|NCT00379769|21005427|P3|STARTED|Observational Follow-up||0
8521827|NCT00379769|21005428|P2|STARTED|Observational Follow-up||0
8521828|NCT00379769|21005429|P1|STARTED|Observational Follow-up||0
8521829|NCT00379769|21005424|P6|NOT COMPLETED|Main Study||0
8521830|NCT00379769|21005425|P5|NOT COMPLETED|Main Study||0
8521831|NCT00379769|21005426|P4|NOT COMPLETED|Main Study||230
8521832|NCT00379769|21005427|P3|NOT COMPLETED|Main Study||207
8521833|NCT00379769|21005428|P2|NOT COMPLETED|Main Study||199
8521834|NCT00379769|21005429|P1|NOT COMPLETED|Main Study||178
8521835|NCT00379769|21005424|P6|COMPLETED|Main Study||0
8521836|NCT00379769|21005425|P5|COMPLETED|Main Study||0
8521837|NCT00379769|21005426|P4|COMPLETED|Main Study||892
8521838|NCT00379769|21005427|P3|COMPLETED|Main Study||896
8521839|NCT00379769|21005428|P2|COMPLETED|Main Study||906
8521840|NCT00379769|21005429|P1|COMPLETED|Main Study||939
8521841|NCT00379769|21005424|P6|STARTED|Main Study||0
8521842|NCT00379769|21005425|P5|STARTED|Main Study||0
8521843|NCT00379769|21005426|P4|STARTED|Main Study||1122
8521844|NCT00379769|21005427|P3|STARTED|Main Study||1103
8521845|NCT00379769|21005428|P2|STARTED|Main Study||1105
8521846|NCT00379769|21005429|P1|STARTED|Main Study||1117
8521847|NCT00379639|21005588|P5|NOT COMPLETED|Overall Study||6
8521848|NCT00379639|21005589|P4|NOT COMPLETED|Overall Study||6
8521849|NCT00379639|21005590|P3|NOT COMPLETED|Overall Study||9
8521850|NCT00379639|21005591|P2|NOT COMPLETED|Overall Study||5
8521851|NCT00379639|21005592|P1|NOT COMPLETED|Overall Study||3
8521852|NCT00379639|21005588|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
8521853|NCT00379639|21005589|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
8521854|NCT00379639|21005590|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
8521855|NCT00379639|21005591|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
8521856|NCT00379639|21005592|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
8521857|NCT00379639|21005588|P5|Completed 6 Cycles of Therapy|Overall Study||0
8521858|NCT00379639|21005589|P4|Completed 6 Cycles of Therapy|Overall Study||0
8521859|NCT00379639|21005590|P3|Completed 6 Cycles of Therapy|Overall Study||1
8521860|NCT00379639|21005591|P2|Completed 6 Cycles of Therapy|Overall Study||2
8521861|NCT00379639|21005592|P1|Completed 6 Cycles of Therapy|Overall Study||4
8521862|NCT00379639|21005588|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
8521863|NCT00379639|21005589|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
8521864|NCT00379639|21005590|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
8521953|NCT00378898|21005819|P1|COMPLETED|Overall Study||11
8521865|NCT00379639|21005591|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
8521866|NCT00379639|21005592|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
8521867|NCT00379639|21005588|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
8521868|NCT00379639|21005589|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
8521869|NCT00379639|21005590|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
8521870|NCT00379639|21005591|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
8521871|NCT00379639|21005592|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
8521872|NCT00379587|21005614|P1|NOT COMPLETED|Overall Study||2
8521873|NCT00379587|21005614|P1|COMPLETED|Overall Study||63
8521874|NCT00379587|21005614|P1|STARTED|Overall Study||65
8521875|NCT00379574|21005621|P1|NOT COMPLETED|Overall Study||0
8521876|NCT00379574|21005621|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
8521877|NCT00379574|21005621|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
8521878|NCT00379353|21005628|P2|NOT COMPLETED|Overall Study||6
8521879|NCT00379353|21005629|P1|NOT COMPLETED|Overall Study||11
8521880|NCT00379353|21005628|P2|COMPLETED|Overall Study||9
8521881|NCT00379353|21005629|P1|COMPLETED|Overall Study||5
8521882|NCT00379353|21005628|P2|STARTED|Overall Study||15
8521883|NCT00379353|21005629|P1|STARTED|Overall Study||16
8521884|NCT00379340|21005664|P5|NOT COMPLETED|Overall Study||14
8521885|NCT00379340|21005665|P4|NOT COMPLETED|Overall Study||13
8521886|NCT00379340|21005666|P3|NOT COMPLETED|Overall Study||2
8521887|NCT00379340|21005667|P2|NOT COMPLETED|Overall Study||3
8521888|NCT00379340|21005668|P1|NOT COMPLETED|Overall Study||13
8521889|NCT00379340|21005664|P5|COMPLETED|Overall Study||9
8521890|NCT00379340|21005665|P4|COMPLETED|Overall Study||37
8521891|NCT00379340|21005666|P3|COMPLETED|Overall Study||50
8521892|NCT00379340|21005667|P2|COMPLETED|Overall Study||132
8521893|NCT00379340|21005668|P1|COMPLETED|Overall Study||107
8521894|NCT00379340|21005664|P5|STARTED|Overall Study||23
8521895|NCT00379340|21005665|P4|STARTED|Overall Study||50
8521896|NCT00379340|21005666|P3|STARTED|Overall Study||52
8521897|NCT00379340|21005667|P2|STARTED|Overall Study||135
8521898|NCT00379340|21005668|P1|STARTED|Overall Study||120
8521899|NCT00379288|21005685|P4|NOT COMPLETED|Overall Study||8
8521900|NCT00379288|21005686|P3|NOT COMPLETED|Overall Study||10
8521901|NCT00379288|21005687|P2|NOT COMPLETED|Overall Study||22
8521902|NCT00379288|21005688|P1|NOT COMPLETED|Overall Study||19
8521903|NCT00379288|21005685|P4|COMPLETED|Overall Study||57
8521904|NCT00379288|21005686|P3|COMPLETED|Overall Study||58
8521905|NCT00379288|21005687|P2|COMPLETED|Overall Study||108
8521906|NCT00379288|21005688|P1|COMPLETED|Overall Study||122
8521907|NCT00379288|21005685|P4|STARTED|Overall Study||65
8521908|NCT00379288|21005686|P3|STARTED|Overall Study||68
8521909|NCT00379288|21005687|P2|STARTED|Overall Study||130
8521910|NCT00379288|21005688|P1|STARTED|Overall Study||141
8521911|NCT00379236|21005700|P3|NOT COMPLETED|Open-label Extension||55
8521912|NCT00379236|21005701|P2|NOT COMPLETED|Open-label Extension||0
8521913|NCT00379236|21005702|P1|NOT COMPLETED|Open-label Extension||0
8521914|NCT00379236|21005700|P3|COMPLETED|Open-label Extension||378
8521915|NCT00379236|21005701|P2|COMPLETED|Open-label Extension||0
8521916|NCT00379236|21005702|P1|COMPLETED|Open-label Extension||0
8521917|NCT00379236|21005700|P3|STARTED|Open-label Extension||433
8521918|NCT00379236|21005701|P2|STARTED|Open-label Extension||0
8521919|NCT00379236|21005702|P1|STARTED|Open-label Extension||0
8521920|NCT00379236|21005700|P3|NOT COMPLETED|Double-blind||0
8521921|NCT00379236|21005701|P2|NOT COMPLETED|Double-blind||36
8521922|NCT00379236|21005702|P1|NOT COMPLETED|Double-blind||36
8521923|NCT00379236|21005700|P3|COMPLETED|Double-blind||0
8521924|NCT00379236|21005701|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
8521925|NCT00379236|21005702|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
8521926|NCT00379236|21005700|P3|STARTED|Double-blind||0
8521927|NCT00379236|21005701|P2|STARTED|Double-blind||295
8521928|NCT00379236|21005702|P1|STARTED|Double-blind||293
8521929|NCT00379210|21005747|P2|NOT COMPLETED|Overall Study||7
8521930|NCT00379210|21005748|P1|NOT COMPLETED|Overall Study||10
8521931|NCT00379210|21005747|P2|COMPLETED|Overall Study||23
8521932|NCT00379210|21005748|P1|COMPLETED|Overall Study||20
8521933|NCT00379210|21005747|P2|STARTED|Overall Study||30
8521934|NCT00379210|21005748|P1|STARTED|Overall Study||30
8521935|NCT00379197|21005754|P1|NOT COMPLETED|Overall Study||5
8521936|NCT00379197|21005754|P1|COMPLETED|Overall Study||8
8521937|NCT00379197|21005754|P1|STARTED|Overall Study||13
8521938|NCT00379145|21005759|P1|NOT COMPLETED|Overall Study||0
8521939|NCT00379145|21005759|P1|COMPLETED|Overall Study||20
8521940|NCT00379145|21005759|P1|STARTED|Overall Study||20
8521941|NCT00379080|21005771|P3|NOT COMPLETED|Overall Study||0
8521942|NCT00379080|21005772|P2|NOT COMPLETED|Overall Study||4
8521943|NCT00379080|21005773|P1|NOT COMPLETED|Overall Study||0
8521944|NCT00379080|21005771|P3|COMPLETED|Overall Study||31
8521945|NCT00379080|21005772|P2|COMPLETED|Overall Study||15
8521946|NCT00379080|21005773|P1|COMPLETED|Overall Study||6
8521947|NCT00379080|21005771|P3|STARTED|Overall Study||31
8521948|NCT00379080|21005772|P2|STARTED|Overall Study||19
8521949|NCT00379080|21005773|P1|STARTED|Overall Study||6
8521950|NCT00378898|21005818|P2|NOT COMPLETED|Overall Study||6
8521951|NCT00378898|21005819|P1|NOT COMPLETED|Overall Study||11
8521954|NCT00378898|21005818|P2|STARTED|Overall Study||17
8521955|NCT00378898|21005819|P1|STARTED|Overall Study||22
8521956|NCT00378703|21005831|P4|NOT COMPLETED|Overall Study||91
8521957|NCT00378703|21005832|P3|NOT COMPLETED|Overall Study||90
8521958|NCT00378703|21005833|P2|NOT COMPLETED|Overall Study||91
8521959|NCT00378703|21005834|P1|NOT COMPLETED|Overall Study||89
8521960|NCT00378703|21005831|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521961|NCT00378703|21005832|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521962|NCT00378703|21005833|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521963|NCT00378703|21005834|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521964|NCT00378703|21005831|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
8521965|NCT00378703|21005832|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
8521966|NCT00378703|21005833|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
8521967|NCT00378703|21005834|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
8521968|NCT00378703|21005831|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
8521969|NCT00378703|21005832|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
8521970|NCT00378703|21005833|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
8521971|NCT00378703|21005834|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
8521972|NCT00378703|21005831|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
8521973|NCT00378703|21005832|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
8521974|NCT00378703|21005833|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
8521975|NCT00378703|21005834|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
8521976|NCT00378599|21005856|P1|NOT COMPLETED|Overall Study||52
8521977|NCT00378599|21005856|P1|COMPLETED|Overall Study||73
8521978|NCT00378599|21005856|P1|STARTED|Overall Study||125
8521979|NCT00378573|21005860|P1|NOT COMPLETED|Follow-up||14
8521980|NCT00378573|21005860|P1|COMPLETED|Follow-up||3
8521981|NCT00378573|21005860|P1|STARTED|Follow-up||17
8521982|NCT00378573|21005860|P1|NOT COMPLETED|Treatment Period||17
8521983|NCT00378573|21005860|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
8521984|NCT00378573|21005860|P1|STARTED|Treatment Period||17
8521985|NCT00378560|21005868|P2|NOT COMPLETED|Overall Study||58
8521986|NCT00378560|21005869|P1|NOT COMPLETED|Overall Study||56
8521987|NCT00378560|21005868|P2|COMPLETED|Overall Study||454
8521988|NCT00378560|21005869|P1|COMPLETED|Overall Study||453
8521989|NCT00378560|21005868|P2|Vaccinated|Overall Study||512
8521990|NCT00378560|21005869|P1|Vaccinated|Overall Study||509
8521991|NCT00378560|21005868|P2|STARTED|Overall Study||512
8521992|NCT00378560|21005869|P1|STARTED|Overall Study||509
8521993|NCT00378534|21005883|P1|NOT COMPLETED|Overall Study||60
8521994|NCT00378534|21005883|P1|COMPLETED|Overall Study|Transplantation Recipients|55
8521995|NCT00378534|21005883|P1|STARTED|Overall Study||115
8521996|NCT00378508|21005889|P2|NOT COMPLETED|Overall Study||3
8521997|NCT00378508|21005890|P1|NOT COMPLETED|Overall Study||2
8521998|NCT00378508|21005889|P2|COMPLETED|Overall Study||31
8521999|NCT00378508|21005890|P1|COMPLETED|Overall Study||27
8522000|NCT00378508|21005889|P2|Received Intervention/Placebo|Overall Study||31
8522001|NCT00378508|21005890|P1|Received Intervention/Placebo|Overall Study||28
8522002|NCT00378508|21005889|P2|Randomized|Overall Study||34
8522003|NCT00378508|21005890|P1|Randomized|Overall Study||29
8522004|NCT00378508|21005889|P2|STARTED|Overall Study||34
8522005|NCT00378508|21005890|P1|STARTED|Overall Study||29
8522006|NCT00378378|21005909|P3|NOT COMPLETED|Overall Study||2
8522007|NCT00378378|21005910|P2|NOT COMPLETED|Overall Study||1
8522008|NCT00378378|21005911|P1|NOT COMPLETED|Overall Study||0
8522009|NCT00378378|21005909|P3|COMPLETED|Overall Study||24
8522010|NCT00378378|21005910|P2|COMPLETED|Overall Study||49
8522011|NCT00378378|21005911|P1|COMPLETED|Overall Study||51
8522012|NCT00378378|21005909|P3|STARTED|Overall Study||26
8522013|NCT00378378|21005910|P2|STARTED|Overall Study||50
8522014|NCT00378378|21005911|P1|STARTED|Overall Study||51
8522015|NCT00378352|21005924|P6|NOT COMPLETED|Efficacy Phase||7
8522016|NCT00378352|21005925|P5|NOT COMPLETED|Efficacy Phase||11
8522017|NCT00378352|21005926|P4|NOT COMPLETED|Efficacy Phase||0
8522018|NCT00378352|21005927|P3|NOT COMPLETED|Efficacy Phase||0
8522019|NCT00378352|21005928|P2|NOT COMPLETED|Efficacy Phase||0
8522020|NCT00378352|21005929|P1|NOT COMPLETED|Efficacy Phase||0
8522021|NCT00378352|21005924|P6|COMPLETED|Efficacy Phase||59
8522022|NCT00378352|21005925|P5|COMPLETED|Efficacy Phase||54
8522023|NCT00378352|21005926|P4|COMPLETED|Efficacy Phase||0
8522024|NCT00378352|21005927|P3|COMPLETED|Efficacy Phase||0
8522025|NCT00378352|21005928|P2|COMPLETED|Efficacy Phase||0
8522026|NCT00378352|21005929|P1|COMPLETED|Efficacy Phase||0
8522027|NCT00378352|21005924|P6|Safety Analysis|Efficacy Phase||64
8522028|NCT00378352|21005925|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
8522029|NCT00378352|21005926|P4|Safety Analysis|Efficacy Phase||0
8522030|NCT00378352|21005927|P3|Safety Analysis|Efficacy Phase||0
8522031|NCT00378352|21005928|P2|Safety Analysis|Efficacy Phase||0
8522032|NCT00378352|21005929|P1|Safety Analysis|Efficacy Phase||0
8522033|NCT00378352|21005924|P6|STARTED|Efficacy Phase||66
8522034|NCT00378352|21005925|P5|STARTED|Efficacy Phase||65
8522035|NCT00378352|21005926|P4|STARTED|Efficacy Phase||0
8522036|NCT00378352|21005927|P3|STARTED|Efficacy Phase||0
8522037|NCT00378352|21005928|P2|STARTED|Efficacy Phase||0
8522038|NCT00378352|21005929|P1|STARTED|Efficacy Phase||0
8522039|NCT00378352|21005924|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522040|NCT00378352|21005925|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522041|NCT00378352|21005926|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
8522042|NCT00378352|21005927|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
8522043|NCT00378352|21005928|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522044|NCT00378352|21005929|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522045|NCT00378352|21005924|P6|COMPLETED|Dose Escalation 60,000 Units||0
8522046|NCT00378352|21005925|P5|COMPLETED|Dose Escalation 60,000 Units||0
8522047|NCT00378352|21005926|P4|COMPLETED|Dose Escalation 60,000 Units||10
8522048|NCT00378352|21005927|P3|COMPLETED|Dose Escalation 60,000 Units||17
8522049|NCT00378352|21005928|P2|COMPLETED|Dose Escalation 60,000 Units||0
8522050|NCT00378352|21005929|P1|COMPLETED|Dose Escalation 60,000 Units||0
8522051|NCT00378352|21005924|P6|Safety Analysis|Dose Escalation 60,000 Units||0
8522052|NCT00378352|21005925|P5|Safety Analysis|Dose Escalation 60,000 Units||0
8522053|NCT00378352|21005926|P4|Safety Analysis|Dose Escalation 60,000 Units||11
8522054|NCT00378352|21005927|P3|Safety Analysis|Dose Escalation 60,000 Units||19
8522055|NCT00378352|21005928|P2|Safety Analysis|Dose Escalation 60,000 Units||0
8522056|NCT00378352|21005929|P1|Safety Analysis|Dose Escalation 60,000 Units||0
8522057|NCT00378352|21005924|P6|STARTED|Dose Escalation 60,000 Units||0
8522058|NCT00378352|21005925|P5|STARTED|Dose Escalation 60,000 Units||0
8522059|NCT00378352|21005926|P4|STARTED|Dose Escalation 60,000 Units||11
8522060|NCT00378352|21005927|P3|STARTED|Dose Escalation 60,000 Units||20
8522061|NCT00378352|21005928|P2|STARTED|Dose Escalation 60,000 Units||0
8522062|NCT00378352|21005929|P1|STARTED|Dose Escalation 60,000 Units||0
8522063|NCT00378352|21005924|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522064|NCT00378352|21005925|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522065|NCT00378352|21005926|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
8522066|NCT00378352|21005927|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522067|NCT00378352|21005928|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
8522068|NCT00378352|21005929|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522069|NCT00378352|21005924|P6|COMPLETED|Dose Escalation 30,000 Units||0
8522070|NCT00378352|21005925|P5|COMPLETED|Dose Escalation 30,000 Units||0
8522071|NCT00378352|21005926|P4|COMPLETED|Dose Escalation 30,000 Units||9
8522072|NCT00378352|21005927|P3|COMPLETED|Dose Escalation 30,000 Units||0
8522073|NCT00378352|21005928|P2|COMPLETED|Dose Escalation 30,000 Units||16
8522074|NCT00378352|21005929|P1|COMPLETED|Dose Escalation 30,000 Units||0
8522075|NCT00378352|21005924|P6|Safety Analysis|Dose Escalation 30,000 Units||0
8522076|NCT00378352|21005925|P5|Safety Analysis|Dose Escalation 30,000 Units||0
8522077|NCT00378352|21005926|P4|Safety Analysis|Dose Escalation 30,000 Units||11
8522078|NCT00378352|21005927|P3|Safety Analysis|Dose Escalation 30,000 Units||0
8522079|NCT00378352|21005928|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
8522080|NCT00378352|21005929|P1|Safety Analysis|Dose Escalation 30,000 Units||0
8522081|NCT00378352|21005924|P6|STARTED|Dose Escalation 30,000 Units||0
8522082|NCT00378352|21005925|P5|STARTED|Dose Escalation 30,000 Units||0
8522083|NCT00378352|21005926|P4|STARTED|Dose Escalation 30,000 Units||11
8522084|NCT00378352|21005927|P3|STARTED|Dose Escalation 30,000 Units||0
8522085|NCT00378352|21005928|P2|STARTED|Dose Escalation 30,000 Units||19
8522086|NCT00378352|21005929|P1|STARTED|Dose Escalation 30,000 Units||0
8522087|NCT00378352|21005924|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522088|NCT00378352|21005925|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522089|NCT00378352|21005926|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
8522090|NCT00378352|21005927|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522091|NCT00378352|21005928|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522092|NCT00378352|21005929|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
8522093|NCT00378352|21005924|P6|COMPLETED|Dose Escalation 15,000 Units||0
8522094|NCT00378352|21005925|P5|COMPLETED|Dose Escalation 15,000 Units||0
8522095|NCT00378352|21005926|P4|COMPLETED|Dose Escalation 15,000 Units||10
8522096|NCT00378352|21005927|P3|COMPLETED|Dose Escalation 15,000 Units||0
8522097|NCT00378352|21005928|P2|COMPLETED|Dose Escalation 15,000 Units||0
8522098|NCT00378352|21005929|P1|COMPLETED|Dose Escalation 15,000 Units||15
8522099|NCT00378352|21005924|P6|Safety Analysis|Dose Escalation 15,000 Units||0
8522100|NCT00378352|21005925|P5|Safety Analysis|Dose Escalation 15,000 Units||0
8522101|NCT00378352|21005926|P4|Safety Analysis|Dose Escalation 15,000 Units||11
8522102|NCT00378352|21005927|P3|Safety Analysis|Dose Escalation 15,000 Units||0
8522103|NCT00378352|21005928|P2|Safety Analysis|Dose Escalation 15,000 Units||0
8522104|NCT00378352|21005929|P1|Safety Analysis|Dose Escalation 15,000 Units||19
8522105|NCT00378352|21005924|P6|STARTED|Dose Escalation 15,000 Units||0
8522106|NCT00378352|21005925|P5|STARTED|Dose Escalation 15,000 Units||0
8522107|NCT00378352|21005926|P4|STARTED|Dose Escalation 15,000 Units||11
8522108|NCT00378352|21005927|P3|STARTED|Dose Escalation 15,000 Units||0
8522109|NCT00378352|21005928|P2|STARTED|Dose Escalation 15,000 Units||0
8522110|NCT00378352|21005929|P1|STARTED|Dose Escalation 15,000 Units||20
8522111|NCT00378326|21005951|P1|NOT COMPLETED|Overall Study||0
8522112|NCT00378326|21005951|P1|COMPLETED|Overall Study||26
8522113|NCT00378326|21005951|P1|STARTED|Overall Study||26
8522114|NCT00378209|21005957|P1|NOT COMPLETED|Overall Study||22
8522199|NCT00377637|21006172|P1|COMPLETED|Maintenance Phase||0
8522200|NCT00377637|21006169|P4|STARTED|Maintenance Phase||111
8522115|NCT00378209|21005957|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
8522116|NCT00378209|21005957|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
8522123|NCT00378079|21005980|P3|NOT COMPLETED|Overall Study||0
8522124|NCT00378079|21005981|P2|NOT COMPLETED|Overall Study||1
8522125|NCT00378079|21005982|P1|NOT COMPLETED|Overall Study||6
8522126|NCT00378079|21005980|P3|COMPLETED|Overall Study||71
8522127|NCT00378079|21005981|P2|COMPLETED|Overall Study||69
8522128|NCT00378079|21005982|P1|COMPLETED|Overall Study||64
8522129|NCT00378079|21005980|P3|STARTED|Overall Study||71
8522130|NCT00378079|21005981|P2|STARTED|Overall Study||70
8522131|NCT00378079|21005982|P1|STARTED|Overall Study||70
8522132|NCT00378014|21006004|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
8522133|NCT00378014|21006005|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
8522134|NCT00378014|21006004|P2|COMPLETED|Extension (Month 12 to Month 59)||26
8522135|NCT00378014|21006005|P1|COMPLETED|Extension (Month 12 to Month 59)||27
8522136|NCT00378014|21006004|P2|STARTED|Extension (Month 12 to Month 59)||40
8522137|NCT00378014|21006005|P1|STARTED|Extension (Month 12 to Month 59)||41
8522138|NCT00378014|21006004|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
8522139|NCT00378014|21006005|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
8522140|NCT00378014|21006004|P2|COMPLETED|Core (Randomization to Month 11)||90
8522141|NCT00378014|21006005|P1|COMPLETED|Core (Randomization to Month 11)||87
8522142|NCT00378014|21006004|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
8522143|NCT00378014|21006005|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
8522144|NCT00378014|21006004|P2|STARTED|Core (Randomization to Month 11)||102
8522145|NCT00378014|21006005|P1|STARTED|Core (Randomization to Month 11)||101
8522146|NCT00377962|21006031|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
8522147|NCT00377962|21006032|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
8522148|NCT00377962|21006031|P2|COMPLETED|Extension Study: 12-24 Months||123
8522149|NCT00377962|21006032|P1|COMPLETED|Extension Study: 12-24 Months||98
8522150|NCT00377962|21006031|P2|STARTED|Extension Study: 12-24 Months||127
8522151|NCT00377962|21006032|P1|STARTED|Extension Study: 12-24 Months||108
8522152|NCT00377962|21006031|P2|NOT COMPLETED|Core Study: 0-12 Months||9
8522153|NCT00377962|21006032|P1|NOT COMPLETED|Core Study: 0-12 Months||28
8522154|NCT00377962|21006031|P2|COMPLETED|Core Study: 0-12 Months||133
8522155|NCT00377962|21006032|P1|COMPLETED|Core Study: 0-12 Months||112
8522156|NCT00377962|21006031|P2|STARTED|Core Study: 0-12 Months||142
8522157|NCT00377962|21006032|P1|STARTED|Core Study: 0-12 Months||140
8522158|NCT00377858|21006068|P2|NOT COMPLETED|Overall Study||27
8522159|NCT00377858|21006069|P1|NOT COMPLETED|Overall Study||31
8522160|NCT00377858|21006068|P2|COMPLETED|Overall Study||215
8522161|NCT00377858|21006069|P1|COMPLETED|Overall Study||211
8522162|NCT00377858|21006068|P2|Had at Least One Post-Baseline Value|Overall Study||240
8522163|NCT00377858|21006069|P1|Had at Least One Post-Baseline Value|Overall Study||239
8522164|NCT00377858|21006068|P2|STARTED|Overall Study||242
8522165|NCT00377858|21006069|P1|STARTED|Overall Study||242
8522166|NCT00377832|21006099|P2|NOT COMPLETED|Overall Study||0
8522167|NCT00377832|21006100|P1|NOT COMPLETED|Overall Study||0
8522168|NCT00377832|21006099|P2|COMPLETED|Overall Study||6
8522169|NCT00377832|21006100|P1|COMPLETED|Overall Study||7
8522170|NCT00377832|21006099|P2|STARTED|Overall Study||6
8522171|NCT00377832|21006100|P1|STARTED|Overall Study||7
8522172|NCT00377819|21006122|P2|NOT COMPLETED|Overall Study||10
8522173|NCT00377819|21006123|P1|NOT COMPLETED|Overall Study||13
8522174|NCT00377819|21006122|P2|COMPLETED|Overall Study||243
8522175|NCT00377819|21006123|P1|COMPLETED|Overall Study||238
8522176|NCT00377819|21006122|P2|Received Study Medication|Overall Study||253
8522177|NCT00377819|21006123|P1|Received Study Medication|Overall Study||249
8522178|NCT00377819|21006122|P2|STARTED|Overall Study||253
8522179|NCT00377819|21006123|P1|STARTED|Overall Study||251
8522180|NCT00377741|21006135|P2|NOT COMPLETED|Overall Study||0
8522181|NCT00377741|21006136|P1|NOT COMPLETED|Overall Study||0
8522182|NCT00377741|21006135|P2|COMPLETED|Overall Study||15
8522183|NCT00377741|21006136|P1|COMPLETED|Overall Study||16
8522184|NCT00377741|21006135|P2|STARTED|Overall Study||15
8522185|NCT00377741|21006136|P1|STARTED|Overall Study||16
8522186|NCT00377676|21006152|P2|NOT COMPLETED|Overall Study||322
8522187|NCT00377676|21006153|P1|NOT COMPLETED|Overall Study||961
8522188|NCT00377676|21006152|P2|COMPLETED|Overall Study||694
8522189|NCT00377676|21006153|P1|COMPLETED|Overall Study||1093
8522190|NCT00377676|21006152|P2|STARTED|Overall Study||1016
8522191|NCT00377676|21006153|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
8522192|NCT00377637|21006169|P4|NOT COMPLETED|Maintenance Phase||57
8522193|NCT00377637|21006170|P3|NOT COMPLETED|Maintenance Phase||43
8522194|NCT00377637|21006171|P2|NOT COMPLETED|Maintenance Phase||0
8522195|NCT00377637|21006172|P1|NOT COMPLETED|Maintenance Phase||0
8522196|NCT00377637|21006169|P4|COMPLETED|Maintenance Phase||54
8522197|NCT00377637|21006170|P3|COMPLETED|Maintenance Phase||73
8522198|NCT00377637|21006171|P2|COMPLETED|Maintenance Phase||0
8522201|NCT00377637|21006170|P3|STARTED|Maintenance Phase||116
8522202|NCT00377637|21006171|P2|STARTED|Maintenance Phase||0
8522203|NCT00377637|21006172|P1|STARTED|Maintenance Phase||0
8522204|NCT00377637|21006169|P4|NOT COMPLETED|Induction Phase||0
8522205|NCT00377637|21006170|P3|NOT COMPLETED|Induction Phase||0
8522206|NCT00377637|21006171|P2|NOT COMPLETED|Induction Phase||35
8522207|NCT00377637|21006172|P1|NOT COMPLETED|Induction Phase||29
8522208|NCT00377637|21006169|P4|COMPLETED|Induction Phase||0
8522209|NCT00377637|21006170|P3|COMPLETED|Induction Phase||0
8522210|NCT00377637|21006171|P2|COMPLETED|Induction Phase||150
8522211|NCT00377637|21006172|P1|COMPLETED|Induction Phase||156
8522212|NCT00377637|21006169|P4|Safety Population|Induction Phase||0
8522213|NCT00377637|21006170|P3|Safety Population|Induction Phase||0
8522214|NCT00377637|21006171|P2|Safety Population|Induction Phase||184
8522215|NCT00377637|21006172|P1|Safety Population|Induction Phase||180
8522216|NCT00377637|21006169|P4|STARTED|Induction Phase||0
8522217|NCT00377637|21006170|P3|STARTED|Induction Phase||0
8522218|NCT00377637|21006171|P2|STARTED|Induction Phase|Intent-To-Treat|185
8522219|NCT00377637|21006172|P1|STARTED|Induction Phase|Intent-To-Treat|185
8522220|NCT00377611|21006208|P2|NOT COMPLETED|Overall Study||33
8522221|NCT00377611|21006209|P1|NOT COMPLETED|Overall Study||22
8522222|NCT00377611|21006208|P2|COMPLETED|Overall Study||1974
8522223|NCT00377611|21006209|P1|COMPLETED|Overall Study||1025
8522224|NCT00377611|21006208|P2|STARTED|Overall Study||2007
8522225|NCT00377611|21006209|P1|STARTED|Overall Study||1047
8522226|NCT00377572|21006272|P2|NOT COMPLETED|Overall Study||54
8522227|NCT00377572|21006273|P1|NOT COMPLETED|Overall Study||53
8522228|NCT00377572|21006272|P2|COMPLETED|Overall Study||157
8522229|NCT00377572|21006273|P1|COMPLETED|Overall Study||155
8522230|NCT00377572|21006272|P2|STARTED|Overall Study||211
8522231|NCT00377572|21006273|P1|STARTED|Overall Study||208
8522232|NCT00377520|21006311|P1|NOT COMPLETED|Overall Study||1
8522233|NCT00377520|21006311|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
8522234|NCT00377520|21006311|P1|STARTED|Overall Study||27
8522235|NCT00377455|21006316|P1|NOT COMPLETED|Overall Study||1
8522236|NCT00377455|21006316|P1|COMPLETED|Overall Study||4
8522237|NCT00377455|21006316|P1|STARTED|Overall Study||5
8522238|NCT00377429|21006324|P1|NOT COMPLETED|Overall Study||15
8522239|NCT00377429|21006324|P1|COMPLETED|Overall Study|Completed main study|32
8522240|NCT00377429|21006324|P1|STARTED|Overall Study|Treated|47
8522241|NCT00377403|21006335|P2|NOT COMPLETED|Overall Study||7
8522242|NCT00377403|21006336|P1|NOT COMPLETED|Overall Study||4
8522243|NCT00377403|21006335|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
8522244|NCT00377403|21006336|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
8522245|NCT00377403|21006335|P2|Day 28 Assessment|Overall Study||77
8522246|NCT00377403|21006336|P1|Day 28 Assessment|Overall Study||82
8522247|NCT00377403|21006335|P2|Day 10 Assessment|Overall Study||71
8522248|NCT00377403|21006336|P1|Day 10 Assessment|Overall Study||81
8522249|NCT00377403|21006335|P2|Day 7 Assessment|Overall Study||75
8522250|NCT00377403|21006336|P1|Day 7 Assessment|Overall Study||80
8522251|NCT00377403|21006335|P2|Day -3 Assessment|Overall Study||74
8522252|NCT00377403|21006336|P1|Day -3 Assessment|Overall Study||81
8522253|NCT00377403|21006335|P2|STARTED|Overall Study||81
8522254|NCT00377403|21006336|P1|STARTED|Overall Study||85
8522255|NCT00377364|21006344|P2|NOT COMPLETED|Overall Study||0
8522256|NCT00377364|21006345|P1|NOT COMPLETED|Overall Study||2
8522257|NCT00377364|21006344|P2|COMPLETED|Overall Study||14
8522258|NCT00377364|21006345|P1|COMPLETED|Overall Study||14
8522259|NCT00377364|21006344|P2|STARTED|Overall Study||14
8522260|NCT00377364|21006345|P1|STARTED|Overall Study||16
8522261|NCT00377312|21006371|P2|NOT COMPLETED|Overall Study||1
8522262|NCT00377312|21006372|P1|NOT COMPLETED|Overall Study||1
8522263|NCT00377312|21006371|P2|COMPLETED|Overall Study||4
8522264|NCT00377312|21006372|P1|COMPLETED|Overall Study||5
8522265|NCT00377312|21006371|P2|STARTED|Overall Study||5
8522266|NCT00377312|21006372|P1|STARTED|Overall Study||6
8522267|NCT00377299|21006404|P2|NOT COMPLETED|Overall Study||24
8522268|NCT00377299|21006405|P1|NOT COMPLETED|Overall Study||19
8522269|NCT00377299|21006404|P2|COMPLETED|Overall Study||4
8522270|NCT00377299|21006405|P1|COMPLETED|Overall Study||13
8522271|NCT00377299|21006404|P2|STARTED|Overall Study||28
8522272|NCT00377299|21006405|P1|STARTED|Overall Study||32
8522273|NCT00377260|21006421|P2|NOT COMPLETED|Overall Study||5
8522274|NCT00377260|21006422|P1|NOT COMPLETED|Overall Study||2
8522275|NCT00377260|21006421|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
8522276|NCT00377260|21006422|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
8522277|NCT00377260|21006421|P2|STARTED|Overall Study||147
8522278|NCT00377260|21006422|P1|STARTED|Overall Study||144
8522279|NCT00377234|21006476|P2|NOT COMPLETED|Overall Study||31
8522280|NCT00377234|21006477|P1|NOT COMPLETED|Overall Study||34
8522281|NCT00377234|21006476|P2|COMPLETED|Overall Study||145
8522282|NCT00377234|21006477|P1|COMPLETED|Overall Study||146
8522283|NCT00377234|21006476|P2|Safety Analysis Set: Risedronate|Overall Study||174
8522284|NCT00377234|21006477|P1|Safety Analysis Set: Risedronate|Overall Study||153
8522285|NCT00377234|21006476|P2|Safety Analysis Set: Ibandronate|Overall Study||150
8522286|NCT00377234|21006477|P1|Safety Analysis Set: Ibandronate|Overall Study||177
8522287|NCT00377234|21006476|P2|Safety Analysis Set: Period 2|Overall Study||150
8522288|NCT00377234|21006477|P1|Safety Analysis Set: Period 2|Overall Study||153
8522289|NCT00377234|21006476|P2|Safety Analysis Set: Period 1|Overall Study||174
8522290|NCT00377234|21006477|P1|Safety Analysis Set: Period 1|Overall Study||177
8522291|NCT00377234|21006476|P2|Received Treatment|Overall Study||174
8522292|NCT00377234|21006477|P1|Received Treatment|Overall Study||177
8522293|NCT00377234|21006476|P2|Did Not Receive Study Treatment|Overall Study||2
8522294|NCT00377234|21006477|P1|Did Not Receive Study Treatment|Overall Study||3
8522295|NCT00377234|21006476|P2|Randomized|Overall Study||176
8522296|NCT00377234|21006477|P1|Randomized|Overall Study||180
8522297|NCT00377234|21006476|P2|STARTED|Overall Study||176
8522298|NCT00377234|21006477|P1|STARTED|Overall Study||180
8522299|NCT00377156|21006495|P2|NOT COMPLETED|Overall Study||54
8522300|NCT00377156|21006496|P1|NOT COMPLETED|Overall Study||48
8522301|NCT00377156|21006495|P2|COMPLETED|Overall Study||48
8522302|NCT00377156|21006496|P1|COMPLETED|Overall Study||63
8522303|NCT00377156|21006495|P2|STARTED|Overall Study||102
8522304|NCT00377156|21006496|P1|STARTED|Overall Study||111
8522305|NCT00376961|21006510|P2|NOT COMPLETED|Maintenance||23
8522306|NCT00376961|21006511|P1|NOT COMPLETED|Maintenance||0
8522307|NCT00376961|21006510|P2|COMPLETED|Maintenance||27
8522308|NCT00376961|21006511|P1|COMPLETED|Maintenance||0
8522309|NCT00376961|21006510|P2|Eligible|Maintenance||47
8522310|NCT00376961|21006511|P1|Eligible|Maintenance||0
8522311|NCT00376961|21006510|P2|STARTED|Maintenance||50
8522312|NCT00376961|21006511|P1|STARTED|Maintenance||0
8522313|NCT00376961|21006510|P2|NOT COMPLETED|Initial Registration||0
8522314|NCT00376961|21006511|P1|NOT COMPLETED|Initial Registration||7
8522315|NCT00376961|21006510|P2|COMPLETED|Initial Registration||0
8522316|NCT00376961|21006511|P1|COMPLETED|Initial Registration||61
8522317|NCT00376961|21006510|P2|Eligible|Initial Registration||0
8522318|NCT00376961|21006511|P1|Eligible|Initial Registration||65
8522319|NCT00376961|21006510|P2|STARTED|Initial Registration||0
8522320|NCT00376961|21006511|P1|STARTED|Initial Registration||68
8522324|NCT00376935|21006529|P4|NOT COMPLETED|Overall Study||0
8522325|NCT00376935|21006530|P3|NOT COMPLETED|Overall Study||0
8522326|NCT00376935|21006531|P2|NOT COMPLETED|Overall Study||0
8522327|NCT00376935|21006532|P1|NOT COMPLETED|Overall Study||0
8522328|NCT00376935|21006529|P4|COMPLETED|Overall Study||24
8522329|NCT00376935|21006530|P3|COMPLETED|Overall Study||25
8522330|NCT00376935|21006531|P2|COMPLETED|Overall Study||25
8522331|NCT00376935|21006532|P1|COMPLETED|Overall Study||25
8522332|NCT00376935|21006529|P4|STARTED|Overall Study||24
8522333|NCT00376935|21006530|P3|STARTED|Overall Study||25
8522334|NCT00376935|21006531|P2|STARTED|Overall Study||25
8522335|NCT00376935|21006532|P1|STARTED|Overall Study||25
8522336|NCT00376805|21006570|P1|NOT COMPLETED|Overall Study||0
8522337|NCT00376805|21006570|P1|COMPLETED|Overall Study||6
8522338|NCT00376805|21006570|P1|STARTED|Overall Study||6
8522339|NCT00376688|21006577|P1|NOT COMPLETED|Overall Study||4
8522340|NCT00376688|21006577|P1|COMPLETED|Overall Study||27
8522341|NCT00376688|21006577|P1|STARTED|Overall Study||31
8522342|NCT00376675|21006583|P2|NOT COMPLETED|Overall Study||14
8522343|NCT00376675|21006584|P1|NOT COMPLETED|Overall Study||20
8522344|NCT00376675|21006583|P2|COMPLETED|Overall Study||56
8522345|NCT00376675|21006584|P1|COMPLETED|Overall Study||49
8522346|NCT00376675|21006583|P2|STARTED|Overall Study||70
8522347|NCT00376675|21006584|P1|STARTED|Overall Study||69
8522348|NCT00376597|21006608|P2|NOT COMPLETED|Overall Study||3
8522349|NCT00376597|21006609|P1|NOT COMPLETED|Overall Study||11
8522350|NCT00376597|21006608|P2|COMPLETED|Overall Study||312
8522351|NCT00376597|21006609|P1|COMPLETED|Overall Study||242
8522352|NCT00376597|21006608|P2|STARTED|Overall Study||315
8522353|NCT00376597|21006609|P1|STARTED|Overall Study||253
8522354|NCT00376558|21006623|P2|NOT COMPLETED|Overall Study||0
8522355|NCT00376558|21006624|P1|NOT COMPLETED|Overall Study||0
8522356|NCT00376558|21006623|P2|COMPLETED|Overall Study||25
8522357|NCT00376558|21006624|P1|COMPLETED|Overall Study||25
8522358|NCT00376558|21006623|P2|STARTED|Overall Study||25
8522359|NCT00376558|21006624|P1|STARTED|Overall Study||25
8522360|NCT00376532|21006633|P2|NOT COMPLETED|Overall Study||6
8522361|NCT00376532|21006634|P1|NOT COMPLETED|Overall Study||6
8522362|NCT00376532|21006633|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
8522363|NCT00376532|21006634|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
8522364|NCT00376532|21006633|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
8522365|NCT00376532|21006634|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
8522366|NCT00376506|21006644|P2|NOT COMPLETED|Overall Study||2
8522367|NCT00376506|21006645|P1|NOT COMPLETED|Overall Study||0
8522368|NCT00376506|21006644|P2|COMPLETED|Overall Study||4
8522369|NCT00376506|21006645|P1|COMPLETED|Overall Study||4
8522370|NCT00376506|21006644|P2|STARTED|Overall Study||6
8522371|NCT00376506|21006645|P1|STARTED|Overall Study||4
8522372|NCT00376363|21006663|P2|NOT COMPLETED|Overall Study||46
8522373|NCT00376363|21006664|P1|NOT COMPLETED|Overall Study||56
8522374|NCT00376363|21006663|P2|COMPLETED|Overall Study||87
8522375|NCT00376363|21006664|P1|COMPLETED|Overall Study||87
8522376|NCT00376363|21006663|P2|STARTED|Overall Study||133
8522377|NCT00376363|21006664|P1|STARTED|Overall Study||143
8522378|NCT00376259|21006676|P2|NOT COMPLETED|Overall Study||21
8522379|NCT00376259|21006677|P1|NOT COMPLETED|Overall Study||22
8522380|NCT00376259|21006676|P2|COMPLETED|Overall Study||0
8522381|NCT00376259|21006677|P1|COMPLETED|Overall Study||0
8522382|NCT00376259|21006676|P2|Received Study Drug|Overall Study||21
8522383|NCT00376259|21006677|P1|Received Study Drug|Overall Study||21
8522384|NCT00376259|21006676|P2|STARTED|Overall Study||21
8522385|NCT00376259|21006677|P1|STARTED|Overall Study||22
8522386|NCT00376246|21006689|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8522387|NCT00376246|21006690|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8522388|NCT00376246|21006689|P2|COMPLETED|Second Intervention (2 Weeks)||12
8522389|NCT00376246|21006690|P1|COMPLETED|Second Intervention (2 Weeks)||10
8522390|NCT00376246|21006689|P2|STARTED|Second Intervention (2 Weeks)||12
8522391|NCT00376246|21006690|P1|STARTED|Second Intervention (2 Weeks)||10
8522392|NCT00376246|21006689|P2|NOT COMPLETED|Washout (2 Weeks)||0
8522393|NCT00376246|21006690|P1|NOT COMPLETED|Washout (2 Weeks)||0
8522394|NCT00376246|21006689|P2|COMPLETED|Washout (2 Weeks)||12
8522395|NCT00376246|21006690|P1|COMPLETED|Washout (2 Weeks)||10
8522396|NCT00376246|21006689|P2|STARTED|Washout (2 Weeks)||12
8522397|NCT00376246|21006690|P1|STARTED|Washout (2 Weeks)||10
8522398|NCT00376246|21006689|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
8522399|NCT00376246|21006690|P1|NOT COMPLETED|First Intervention (2 Weeks)||4
8522400|NCT00376246|21006689|P2|COMPLETED|First Intervention (2 Weeks)||12
8522401|NCT00376246|21006690|P1|COMPLETED|First Intervention (2 Weeks)||10
8522402|NCT00376246|21006689|P2|STARTED|First Intervention (2 Weeks)||14
8522403|NCT00376246|21006690|P1|STARTED|First Intervention (2 Weeks)||14
8522404|NCT00376220|21006700|P2|NOT COMPLETED|Overall Study||12
8522405|NCT00376220|21006701|P1|NOT COMPLETED|Overall Study||10
8522406|NCT00376220|21006700|P2|COMPLETED|Overall Study||35
8522407|NCT00376220|21006701|P1|COMPLETED|Overall Study||37
8522408|NCT00376220|21006700|P2|STARTED|Overall Study||47
8522409|NCT00376220|21006701|P1|STARTED|Overall Study||47
8522410|NCT00376168|21006709|P2|NOT COMPLETED|Overall Study||1
8522411|NCT00376168|21006710|P1|NOT COMPLETED|Overall Study||2
8522412|NCT00376168|21006709|P2|COMPLETED|Overall Study||15
8522413|NCT00376168|21006710|P1|COMPLETED|Overall Study||14
8522414|NCT00376168|21006709|P2|STARTED|Overall Study|One patient randomized but not treated|16
8522415|NCT00376168|21006710|P1|STARTED|Overall Study||16
8522416|NCT00375999|21006724|P1|NOT COMPLETED|Overall Study||2
8522417|NCT00375999|21006724|P1|COMPLETED|Overall Study||32
8522418|NCT00375999|21006724|P1|STARTED|Overall Study||34
8522419|NCT00375973|21006730|P2|NOT COMPLETED|Overall Study||2
8522420|NCT00375973|21006731|P1|NOT COMPLETED|Overall Study||10
8522421|NCT00375973|21006730|P2|COMPLETED|Overall Study||28
8522422|NCT00375973|21006731|P1|COMPLETED|Overall Study||20
8522423|NCT00375973|21006730|P2|STARTED|Overall Study||30
8522424|NCT00375973|21006731|P1|STARTED|Overall Study||30
8522425|NCT00375934|21006751|P2|NOT COMPLETED|Overall Study||6
8522426|NCT00375934|21006752|P1|NOT COMPLETED|Overall Study||3
8522427|NCT00375934|21006751|P2|COMPLETED|Overall Study||95
8522428|NCT00375934|21006752|P1|COMPLETED|Overall Study||96
8522429|NCT00375934|21006751|P2|STARTED|Overall Study||101
8522430|NCT00375934|21006752|P1|STARTED|Overall Study||99
8522431|NCT00375830|21006781|P3|NOT COMPLETED|Overall Study||0
8522432|NCT00375830|21006782|P2|NOT COMPLETED|Overall Study||0
8522433|NCT00375830|21006783|P1|NOT COMPLETED|Overall Study||0
8522434|NCT00375830|21006781|P3|COMPLETED|Overall Study||74
8522435|NCT00375830|21006782|P2|COMPLETED|Overall Study||30
8522436|NCT00375830|21006783|P1|COMPLETED|Overall Study||10
8522437|NCT00375830|21006781|P3|STARTED|Overall Study||74
8522438|NCT00375830|21006782|P2|STARTED|Overall Study||30
8522439|NCT00375830|21006783|P1|STARTED|Overall Study||10
8522440|NCT00375752|21006810|P2|NOT COMPLETED|Overall Study||15
8522441|NCT00375752|21006811|P1|NOT COMPLETED|Overall Study||12
8522442|NCT00375752|21006810|P2|COMPLETED|Overall Study||74
8522443|NCT00375752|21006811|P1|COMPLETED|Overall Study||67
8522444|NCT00375752|21006810|P2|STARTED|Overall Study||89
8522445|NCT00375752|21006811|P1|STARTED|Overall Study||79
8522446|NCT00375713|21006827|P2|NOT COMPLETED|Overall Study||23
8522447|NCT00375713|21006828|P1|NOT COMPLETED|Overall Study||20
8522448|NCT00375713|21006827|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
8522449|NCT00375713|21006828|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
8522450|NCT00375713|21006827|P2|STARTED|Overall Study|Randomized population (N=234).|234
8522451|NCT00375713|21006828|P1|STARTED|Overall Study|Randomized population (N=232).|232
8522452|NCT00375674|21006842|P2|NOT COMPLETED|Overall Study||141
8522453|NCT00375674|21006843|P1|NOT COMPLETED|Overall Study||144
8522454|NCT00375674|21006842|P2|COMPLETED|Overall Study||165
8522455|NCT00375674|21006843|P1|COMPLETED|Overall Study||165
8522456|NCT00375674|21006842|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
8522457|NCT00375674|21006843|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
8522458|NCT00375674|21006842|P2|Intent-to-Treat Population|Overall Study||306
8522459|NCT00375674|21006843|P1|Intent-to-Treat Population|Overall Study||309
8522460|NCT00375674|21006842|P2|STARTED|Overall Study||306
8522461|NCT00375674|21006843|P1|STARTED|Overall Study||309
8522462|NCT00375609|21006872|P3|NOT COMPLETED|Overall Study||1
8522463|NCT00375609|21006873|P2|NOT COMPLETED|Overall Study||7
8522464|NCT00375609|21006874|P1|NOT COMPLETED|Overall Study||4
8522465|NCT00375609|21006872|P3|COMPLETED|Overall Study||42
8522466|NCT00375609|21006873|P2|COMPLETED|Overall Study||77
8522467|NCT00375609|21006874|P1|COMPLETED|Overall Study||84
8522468|NCT00375609|21006872|P3|STARTED|Overall Study||43
8522469|NCT00375609|21006873|P2|STARTED|Overall Study||84
8522470|NCT00375609|21006874|P1|STARTED|Overall Study||88
8522471|NCT00375518|21006890|P2|NOT COMPLETED|Overall Study||17
8522472|NCT00375518|21006891|P1|NOT COMPLETED|Overall Study||8
8522473|NCT00375518|21006890|P2|COMPLETED|Overall Study||65
8522474|NCT00375518|21006891|P1|COMPLETED|Overall Study||72
8522475|NCT00375518|21006890|P2|STARTED|Overall Study||82
8522476|NCT00375518|21006891|P1|STARTED|Overall Study||80
8522477|NCT00375505|21006899|P2|NOT COMPLETED|Overall Study||2
8522478|NCT00375505|21006900|P1|NOT COMPLETED|Overall Study||1
8522479|NCT00375505|21006899|P2|COMPLETED|Overall Study||32
8522480|NCT00375505|21006900|P1|COMPLETED|Overall Study||35
8522481|NCT00375505|21006899|P2|STARTED|Overall Study||34
8522482|NCT00375505|21006900|P1|STARTED|Overall Study||36
8522483|NCT00375492|21006944|P2|NOT COMPLETED|Overall Study||26
8522484|NCT00375492|21006945|P1|NOT COMPLETED|Overall Study||26
8522485|NCT00375492|21006944|P2|COMPLETED|Overall Study||72
8522486|NCT00375492|21006945|P1|COMPLETED|Overall Study||70
8522487|NCT00375492|21006944|P2|STARTED|Overall Study||98
8522488|NCT00375492|21006945|P1|STARTED|Overall Study||96
8522489|NCT00375427|21006975|P2|NOT COMPLETED|Overall Study||74
8522490|NCT00375427|21006976|P1|NOT COMPLETED|Overall Study||60
8522491|NCT00375427|21006975|P2|COMPLETED|Overall Study||142
8522492|NCT00375427|21006976|P1|COMPLETED|Overall Study||149
8522493|NCT00375427|21006975|P2|STARTED|Overall Study||216
8522494|NCT00375427|21006976|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
8522495|NCT00375219|21007001|P3|NOT COMPLETED|Overall Study||21
8522496|NCT00375219|21007002|P2|NOT COMPLETED|Overall Study||20
8522497|NCT00375219|21007003|P1|NOT COMPLETED|Overall Study||59
8522498|NCT00375219|21007001|P3|COMPLETED|Overall Study||0
8522499|NCT00375219|21007002|P2|COMPLETED|Overall Study||0
8522500|NCT00375219|21007003|P1|COMPLETED|Overall Study||3
8522501|NCT00375219|21007001|P3|STARTED|Overall Study||21
8522502|NCT00375219|21007002|P2|STARTED|Overall Study||20
8522503|NCT00375219|21007003|P1|STARTED|Overall Study||62
8522504|NCT00375167|21007071|P2|NOT COMPLETED|Overall Study||0
8522505|NCT00375167|21007072|P1|NOT COMPLETED|Overall Study||0
8522506|NCT00375167|21007071|P2|COMPLETED|Overall Study||17
8522507|NCT00375167|21007072|P1|COMPLETED|Overall Study||16
8522508|NCT00375167|21007071|P2|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
8522509|NCT00375167|21007072|P1|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
8522510|NCT00374907|21007086|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
8522511|NCT00374907|21007087|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
8522512|NCT00374907|21007086|P2|COMPLETED|116-Week Short-term + Long-term Period||2
8522513|NCT00374907|21007087|P1|COMPLETED|116-Week Short-term + Long-term Period||7
8522514|NCT00374907|21007086|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
8522515|NCT00374907|21007087|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
8522516|NCT00374907|21007086|P2|STARTED|116-Week Short-term + Long-term Period||16
8522517|NCT00374907|21007087|P1|STARTED|116-Week Short-term + Long-term Period||20
8522518|NCT00374907|21007086|P2|NOT COMPLETED|12-Week Short-term Period||1
8522519|NCT00374907|21007087|P1|NOT COMPLETED|12-Week Short-term Period||3
8522520|NCT00374907|21007086|P2|COMPLETED|12-Week Short-term Period||15
8522521|NCT00374907|21007087|P1|COMPLETED|12-Week Short-term Period||17
8522522|NCT00374907|21007086|P2|STARTED|12-Week Short-term Period||16
8522523|NCT00374907|21007087|P1|STARTED|12-Week Short-term Period||20
8522524|NCT00374868|21007099|P1|NOT COMPLETED|Overall Study||36
8522525|NCT00374868|21007099|P1|COMPLETED|Overall Study||2
8522526|NCT00374868|21007099|P1|STARTED|Overall Study||38
8522527|NCT00374842|21007113|P3|NOT COMPLETED|Overall Study||0
8522528|NCT00374842|21007114|P2|NOT COMPLETED|Overall Study||0
8522529|NCT00374842|21007115|P1|NOT COMPLETED|Overall Study||0
8522530|NCT00374842|21007113|P3|COMPLETED|Overall Study||100
8522531|NCT00374842|21007114|P2|COMPLETED|Overall Study||100
8522532|NCT00374842|21007115|P1|COMPLETED|Overall Study||100
8522533|NCT00374842|21007113|P3|STARTED|Overall Study||100
8522534|NCT00374842|21007114|P2|STARTED|Overall Study||100
8522535|NCT00374842|21007115|P1|STARTED|Overall Study||100
8522536|NCT00374803|21007146|P2|NOT COMPLETED|Overall Study||0
8522537|NCT00374803|21007147|P1|NOT COMPLETED|Overall Study||0
8522538|NCT00374803|21007146|P2|COMPLETED|Overall Study||23
8522539|NCT00374803|21007147|P1|COMPLETED|Overall Study||22
8522540|NCT00374803|21007146|P2|STARTED|Overall Study||23
8522541|NCT00374803|21007147|P1|STARTED|Overall Study||22
8522542|NCT00374556|21007163|P2|NOT COMPLETED|Overall Study||1
8522543|NCT00374556|21007164|P1|NOT COMPLETED|Overall Study||1
8522544|NCT00374556|21007163|P2|COMPLETED|Overall Study||15
8522545|NCT00374556|21007164|P1|COMPLETED|Overall Study||13
8522546|NCT00374556|21007163|P2|STARTED|Overall Study||16
8522547|NCT00374556|21007164|P1|STARTED|Overall Study||14
8522548|NCT00374543|21007216|P2|NOT COMPLETED|Overall Study||0
8522549|NCT00374543|21007217|P1|NOT COMPLETED|Overall Study||0
8522550|NCT00374543|21007216|P2|COMPLETED|Overall Study||1
8522551|NCT00374543|21007217|P1|COMPLETED|Overall Study||2
8522552|NCT00374543|21007216|P2|STARTED|Overall Study||1
8522553|NCT00374543|21007217|P1|STARTED|Overall Study||2
8522554|NCT00374452|21007225|P2|NOT COMPLETED|Overall Study||5
8522555|NCT00374452|21007226|P1|NOT COMPLETED|Overall Study||5
8522556|NCT00374452|21007225|P2|COMPLETED|Overall Study||43
8522557|NCT00374452|21007226|P1|COMPLETED|Overall Study||29
8522558|NCT00374452|21007225|P2|Intervention Started|Overall Study||46
8522559|NCT00374452|21007226|P1|Intervention Started|Overall Study||30
8522560|NCT00374452|21007225|P2|STARTED|Overall Study||48
8522561|NCT00374452|21007226|P1|STARTED|Overall Study||34
8522562|NCT00374335|21007232|P1|NOT COMPLETED|Overall Study||0
8522563|NCT00374335|21007232|P1|COMPLETED|Overall Study||261
8522564|NCT00374335|21007232|P1|STARTED|Overall Study||261
8522565|NCT00374322|21007239|P2|NOT COMPLETED|Overall Study||1304
8522566|NCT00374322|21007240|P1|NOT COMPLETED|Overall Study||1257
8522567|NCT00374322|21007239|P2|COMPLETED|Overall Study||278
8522568|NCT00374322|21007240|P1|COMPLETED|Overall Study||322
8522569|NCT00374322|21007239|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
8522570|NCT00374322|21007240|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
8522571|NCT00374322|21007239|P2|STARTED|Overall Study||1582
8522572|NCT00374322|21007240|P1|STARTED|Overall Study||1579
8522573|NCT00374244|21007278|P2|NOT COMPLETED|Overall Study||0
8522574|NCT00374244|21007279|P1|NOT COMPLETED|Overall Study||0
8522575|NCT00374244|21007278|P2|COMPLETED|Overall Study||14
8522576|NCT00374244|21007279|P1|COMPLETED|Overall Study||14
8522577|NCT00374244|21007278|P2|STARTED|Overall Study||14
8522578|NCT00374244|21007279|P1|STARTED|Overall Study||14
8522579|NCT00374231|21007325|P1|NOT COMPLETED|Overall Study||0
8522580|NCT00374231|21007325|P1|COMPLETED|Overall Study||40
8522581|NCT00374231|21007325|P1|STARTED|Overall Study||40
8522582|NCT00374140|21007331|P1|NOT COMPLETED|Overall Study||2
8522583|NCT00374140|21007331|P1|COMPLETED|Overall Study||38
8522584|NCT00374140|21007331|P1|STARTED|Overall Study||40
8522585|NCT00374127|21007338|P1|NOT COMPLETED|Overall Study||11
8522586|NCT00374127|21007338|P1|COMPLETED|Overall Study||24
8522587|NCT00374127|21007338|P1|STARTED|Overall Study||35
8522588|NCT00374088|21007374|P2|NOT COMPLETED|Overall Study||1
8522589|NCT00374088|21007375|P1|NOT COMPLETED|Overall Study||1
8522590|NCT00374088|21007374|P2|COMPLETED|Overall Study||10
8522591|NCT00374088|21007375|P1|COMPLETED|Overall Study||9
8522592|NCT00374088|21007374|P2|STARTED|Overall Study||11
8522593|NCT00374088|21007375|P1|STARTED|Overall Study||10
8522594|NCT00373958|21007387|P2|NOT COMPLETED|Toddler Dose||38
8522595|NCT00373958|21007388|P1|NOT COMPLETED|Toddler Dose||30
8522596|NCT00373958|21007387|P2|COMPLETED|Toddler Dose||252
8522597|NCT00373958|21007388|P1|COMPLETED|Toddler Dose||264
8522598|NCT00373958|21007387|P2|Vaccinated Toddler Dose|Toddler Dose||265
8522599|NCT00373958|21007388|P1|Vaccinated Toddler Dose|Toddler Dose||272
8522600|NCT00373958|21007387|P2|Withdrawn After Infant Series|Toddler Dose||25
8522601|NCT00373958|21007388|P1|Withdrawn After Infant Series|Toddler Dose||22
8522602|NCT00373958|21007387|P2|STARTED|Toddler Dose||290
8522603|NCT00373958|21007388|P1|STARTED|Toddler Dose||294
8522604|NCT00373958|21007387|P2|NOT COMPLETED|Infant Series||42
8522605|NCT00373958|21007388|P1|NOT COMPLETED|Infant Series||40
8522606|NCT00373958|21007387|P2|COMPLETED|Infant Series||290
8522607|NCT00373958|21007388|P1|COMPLETED|Infant Series||294
8522608|NCT00373958|21007387|P2|Vaccinated Dose 3|Infant Series||300
8522609|NCT00373958|21007388|P1|Vaccinated Dose 3|Infant Series||298
8522610|NCT00373958|21007387|P2|Vaccinated Dose 2|Infant Series||305
8522611|NCT00373958|21007388|P1|Vaccinated Dose 2|Infant Series||309
8522612|NCT00373958|21007387|P2|Vaccinated Dose 1|Infant Series||331
8522613|NCT00373958|21007388|P1|Vaccinated Dose 1|Infant Series||332
8522614|NCT00373958|21007387|P2|STARTED|Infant Series||332
8522615|NCT00373958|21007388|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
8522616|NCT00373880|21007436|P1|NOT COMPLETED|Overall Study||18
8522617|NCT00373880|21007436|P1|COMPLETED|Overall Study||8
8522618|NCT00373880|21007436|P1|STARTED|Overall Study||26
8522619|NCT00373698|21007466|P2|NOT COMPLETED|Overall Study||0
8522620|NCT00373698|21007467|P1|NOT COMPLETED|Overall Study||11
8522621|NCT00373698|21007466|P2|COMPLETED|Overall Study||99
8522622|NCT00373698|21007467|P1|COMPLETED|Overall Study||85
8522623|NCT00373698|21007466|P2|STARTED|Overall Study||99
8522624|NCT00373698|21007467|P1|STARTED|Overall Study||96
8522625|NCT00373685|21007481|P2|NOT COMPLETED|Overall Study||1421
8522626|NCT00373685|21007482|P1|NOT COMPLETED|Overall Study||1439
8522627|NCT00373685|21007481|P2|COMPLETED|Overall Study||2611
8522628|NCT00373685|21007482|P1|COMPLETED|Overall Study||2596
8522629|NCT00373685|21007481|P2|Treated|Overall Study||3955
8522630|NCT00373685|21007482|P1|Treated|Overall Study||3984
8522631|NCT00373685|21007481|P2|STARTED|Overall Study||4032
8522632|NCT00373685|21007482|P1|STARTED|Overall Study||4035
8522633|NCT00373529|21007516|P1|NOT COMPLETED|Overall Study||108
8522634|NCT00373529|21007516|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
8522635|NCT00373529|21007516|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
8522636|NCT00373529|21007516|P1|STARTED|Overall Study||116
8522637|NCT00373490|21007528|P2|NOT COMPLETED|Overall Study||6
8522638|NCT00373490|21007529|P1|NOT COMPLETED|Overall Study||9
8522639|NCT00373490|21007528|P2|COMPLETED|Overall Study||0
8522640|NCT00373490|21007529|P1|COMPLETED|Overall Study||1
8522641|NCT00373490|21007528|P2|STARTED|Overall Study||6
8522642|NCT00373490|21007529|P1|STARTED|Overall Study||10
8522643|NCT00373425|21007552|P5|NOT COMPLETED|Overall Study||72
8522644|NCT00373425|21007553|P4|NOT COMPLETED|Overall Study||11
8522645|NCT00373425|21007554|P3|NOT COMPLETED|Overall Study||134
8522646|NCT00373425|21007555|P2|NOT COMPLETED|Overall Study||153
8522647|NCT00373425|21007556|P1|NOT COMPLETED|Overall Study||370
8522648|NCT00373425|21007552|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
8522649|NCT00373425|21007553|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
8522650|NCT00373425|21007554|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
8522651|NCT00373425|21007555|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
8522652|NCT00373425|21007556|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
8522653|NCT00373425|21007552|P5|Received Treatment|Overall Study||132
8522654|NCT00373425|21007553|P4|Received Treatment|Overall Study||7
8522655|NCT00373425|21007554|P3|Received Treatment|Overall Study||134
8522656|NCT00373425|21007555|P2|Received Treatment|Overall Study||342
8522657|NCT00373425|21007556|P1|Received Treatment|Overall Study||612
8522658|NCT00373425|21007552|P5|STARTED|Overall Study||132
8522659|NCT00373425|21007553|P4|STARTED|Overall Study||11
8522660|NCT00373425|21007554|P3|STARTED|Overall Study||134
8522661|NCT00373425|21007555|P2|STARTED|Overall Study||350
8522662|NCT00373425|21007556|P1|STARTED|Overall Study||623
8522663|NCT00373399|21007581|P6|NOT COMPLETED|Overall Study||0
8522664|NCT00373399|21007582|P5|NOT COMPLETED|Overall Study||0
8522665|NCT00373399|21007583|P4|NOT COMPLETED|Overall Study||0
8522666|NCT00373399|21007584|P3|NOT COMPLETED|Overall Study||0
8522667|NCT00373399|21007585|P2|NOT COMPLETED|Overall Study||0
8522668|NCT00373399|21007586|P1|NOT COMPLETED|Overall Study||0
8522669|NCT00373399|21007581|P6|COMPLETED|Overall Study||7
8522670|NCT00373399|21007582|P5|COMPLETED|Overall Study||7
8522671|NCT00373399|21007583|P4|COMPLETED|Overall Study||6
8522672|NCT00373399|21007584|P3|COMPLETED|Overall Study||4
8522673|NCT00373399|21007585|P2|COMPLETED|Overall Study||7
8522674|NCT00373399|21007586|P1|COMPLETED|Overall Study||5
8522675|NCT00373399|21007581|P6|STARTED|Overall Study||7
8522676|NCT00373399|21007582|P5|STARTED|Overall Study||7
8522677|NCT00373399|21007583|P4|STARTED|Overall Study||6
8522678|NCT00373399|21007584|P3|STARTED|Overall Study||4
8522679|NCT00373399|21007585|P2|STARTED|Overall Study||7
8522680|NCT00373399|21007586|P1|STARTED|Overall Study||5
8522681|NCT00373386|21007594|P1|NOT COMPLETED|Overall Study||0
8522682|NCT00373386|21007594|P1|COMPLETED|Overall Study||9
8522683|NCT00373386|21007594|P1|STARTED|Overall Study||9
8522684|NCT00373360|21007604|P1|NOT COMPLETED|Overall Study||0
8522685|NCT00373360|21007604|P1|COMPLETED|Overall Study||10
8522686|NCT00373360|21007604|P1|STARTED|Overall Study||10
8522687|NCT00373334|21007635|P3|NOT COMPLETED|Overall Study||13
8522688|NCT00373334|21007636|P2|NOT COMPLETED|Overall Study||18
8522689|NCT00373334|21007637|P1|NOT COMPLETED|Overall Study||10
8522690|NCT00373334|21007635|P3|COMPLETED|Overall Study||32
8522691|NCT00373334|21007636|P2|COMPLETED|Overall Study||32
8522692|NCT00373334|21007637|P1|COMPLETED|Overall Study||33
8522693|NCT00373334|21007635|P3|STARTED|Overall Study||45
8522694|NCT00373334|21007636|P2|STARTED|Overall Study||50
8522695|NCT00373334|21007637|P1|STARTED|Overall Study||43
8522696|NCT00373295|21007651|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
8522697|NCT00373295|21007652|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
8522698|NCT00373295|21007653|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
8522699|NCT00373295|21007654|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
8522700|NCT00373295|21007655|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
8522701|NCT00373295|21007656|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
8522702|NCT00373295|21007651|P6|COMPLETED|Intervention 3 (8 Days)||2
8522703|NCT00373295|21007652|P5|COMPLETED|Intervention 3 (8 Days)||2
8522704|NCT00373295|21007653|P4|COMPLETED|Intervention 3 (8 Days)||2
8522705|NCT00373295|21007654|P3|COMPLETED|Intervention 3 (8 Days)||1
8522706|NCT00373295|21007655|P2|COMPLETED|Intervention 3 (8 Days)||1
8522707|NCT00373295|21007656|P1|COMPLETED|Intervention 3 (8 Days)||2
8522708|NCT00373295|21007651|P6|STARTED|Intervention 3 (8 Days)||2
8522709|NCT00373295|21007652|P5|STARTED|Intervention 3 (8 Days)||2
8522710|NCT00373295|21007653|P4|STARTED|Intervention 3 (8 Days)||2
8522711|NCT00373295|21007654|P3|STARTED|Intervention 3 (8 Days)||1
8522712|NCT00373295|21007655|P2|STARTED|Intervention 3 (8 Days)||1
8522713|NCT00373295|21007656|P1|STARTED|Intervention 3 (8 Days)||2
8522714|NCT00373295|21007651|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
8522715|NCT00373295|21007652|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
8522716|NCT00373295|21007653|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
8522717|NCT00373295|21007654|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
8522718|NCT00373295|21007655|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
8522719|NCT00373295|21007656|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
8522720|NCT00373295|21007651|P6|COMPLETED|Intervention 2 (8 Days)||2
8522721|NCT00373295|21007652|P5|COMPLETED|Intervention 2 (8 Days)||2
8522722|NCT00373295|21007653|P4|COMPLETED|Intervention 2 (8 Days)||2
8522723|NCT00373295|21007654|P3|COMPLETED|Intervention 2 (8 Days)||1
8522724|NCT00373295|21007655|P2|COMPLETED|Intervention 2 (8 Days)||1
8522725|NCT00373295|21007656|P1|COMPLETED|Intervention 2 (8 Days)||2
8522726|NCT00373295|21007651|P6|STARTED|Intervention 2 (8 Days)||2
8522727|NCT00373295|21007652|P5|STARTED|Intervention 2 (8 Days)||2
8522728|NCT00373295|21007653|P4|STARTED|Intervention 2 (8 Days)||2
8522729|NCT00373295|21007654|P3|STARTED|Intervention 2 (8 Days)||1
8522730|NCT00373295|21007655|P2|STARTED|Intervention 2 (8 Days)||1
8522731|NCT00373295|21007656|P1|STARTED|Intervention 2 (8 Days)||2
8522732|NCT00373295|21007651|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
8522733|NCT00373295|21007652|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
8522734|NCT00373295|21007653|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
8522735|NCT00373295|21007654|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
8522736|NCT00373295|21007655|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
8522737|NCT00373295|21007656|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
8522738|NCT00373295|21007651|P6|COMPLETED|Intervention 1 (8 Days)||2
8522739|NCT00373295|21007652|P5|COMPLETED|Intervention 1 (8 Days)||2
8522740|NCT00373295|21007653|P4|COMPLETED|Intervention 1 (8 Days)||2
8522741|NCT00373295|21007654|P3|COMPLETED|Intervention 1 (8 Days)||1
8522742|NCT00373295|21007655|P2|COMPLETED|Intervention 1 (8 Days)||1
8522743|NCT00373295|21007656|P1|COMPLETED|Intervention 1 (8 Days)||2
8522744|NCT00373295|21007651|P6|STARTED|Intervention 1 (8 Days)||2
8522745|NCT00373295|21007652|P5|STARTED|Intervention 1 (8 Days)||3
8522746|NCT00373295|21007653|P4|STARTED|Intervention 1 (8 Days)||2
8522747|NCT00373295|21007654|P3|STARTED|Intervention 1 (8 Days)||1
8522748|NCT00373295|21007655|P2|STARTED|Intervention 1 (8 Days)||3
8522749|NCT00373295|21007656|P1|STARTED|Intervention 1 (8 Days)||2
8522750|NCT00373269|21007666|P2|NOT COMPLETED|Overall Study||0
8522751|NCT00373269|21007667|P1|NOT COMPLETED|Overall Study||0
8522752|NCT00373269|21007666|P2|COMPLETED|Overall Study||10
8522753|NCT00373269|21007667|P1|COMPLETED|Overall Study||11
8522754|NCT00373269|21007666|P2|STARTED|Overall Study||10
8522755|NCT00373269|21007667|P1|STARTED|Overall Study||11
8522756|NCT00373256|21007677|P2|NOT COMPLETED|Overall Study||247
8522757|NCT00373256|21007678|P1|NOT COMPLETED|Overall Study||241
8522758|NCT00373256|21007677|P2|COMPLETED|Overall Study||0
8522759|NCT00373256|21007678|P1|COMPLETED|Overall Study||0
8522760|NCT00373256|21007677|P2|Treated|Overall Study||236
8522761|NCT00373256|21007678|P1|Treated|Overall Study||235
8522762|NCT00373256|21007677|P2|STARTED|Overall Study||247
8522763|NCT00373256|21007678|P1|STARTED|Overall Study||241
8522764|NCT00373113|21007704|P2|NOT COMPLETED|Overall Study||244
8522765|NCT00373113|21007705|P1|NOT COMPLETED|Overall Study||238
8522766|NCT00373113|21007704|P2|COMPLETED|Overall Study||0
8522767|NCT00373113|21007705|P1|COMPLETED|Overall Study||0
8522768|NCT00373113|21007704|P2|Received Treatment|Overall Study||240
8522769|NCT00373113|21007705|P1|Received Treatment|Overall Study||238
8522770|NCT00373113|21007704|P2|STARTED|Overall Study||244
8522771|NCT00373113|21007705|P1|STARTED|Overall Study||238
8522772|NCT00372996|21007727|P4|NOT COMPLETED|Overall Study||20
8522773|NCT00372996|21007728|P3|NOT COMPLETED|Overall Study||28
8522774|NCT00372996|21007729|P2|NOT COMPLETED|Overall Study||14
8522775|NCT00372996|21007730|P1|NOT COMPLETED|Overall Study||37
8522776|NCT00372996|21007727|P4|COMPLETED|Overall Study||23
8522777|NCT00372996|21007728|P3|COMPLETED|Overall Study||33
8522778|NCT00372996|21007729|P2|COMPLETED|Overall Study||22
8522779|NCT00372996|21007730|P1|COMPLETED|Overall Study||42
8522780|NCT00372996|21007727|P4|STARTED|Overall Study||43
8522781|NCT00372996|21007728|P3|STARTED|Overall Study||61
8522782|NCT00372996|21007729|P2|STARTED|Overall Study||36
8522783|NCT00372996|21007730|P1|STARTED|Overall Study||79
8522784|NCT00372970|21007756|P2|NOT COMPLETED|Overall Study||0
8522785|NCT00372970|21007757|P1|NOT COMPLETED|Overall Study||0
8522786|NCT00372970|21007756|P2|COMPLETED|Overall Study||16
8522787|NCT00372970|21007757|P1|COMPLETED|Overall Study||16
8522788|NCT00372970|21007756|P2|STARTED|Overall Study||16
8522789|NCT00372970|21007757|P1|STARTED|Overall Study||16
8522790|NCT00372957|21007766|P3|NOT COMPLETED|Overall Study||0
8522791|NCT00372957|21007767|P2|NOT COMPLETED|Overall Study||0
8522792|NCT00372957|21007768|P1|NOT COMPLETED|Overall Study||0
8522793|NCT00372957|21007766|P3|COMPLETED|Overall Study||10
8522794|NCT00372957|21007767|P2|COMPLETED|Overall Study||10
8522795|NCT00372957|21007768|P1|COMPLETED|Overall Study||10
8522796|NCT00372957|21007766|P3|STARTED|Overall Study||10
8522797|NCT00372957|21007767|P2|STARTED|Overall Study||10
8522798|NCT00372957|21007768|P1|STARTED|Overall Study||10
8522799|NCT00372905|21007815|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
8522800|NCT00372905|21007816|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
8522801|NCT00372905|21007817|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
8522802|NCT00372905|21007818|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
8522803|NCT00372905|21007815|P4|COMPLETED|Follow up Until Relapse or Progression||5
8522804|NCT00372905|21007816|P3|COMPLETED|Follow up Until Relapse or Progression||3
8522805|NCT00372905|21007817|P2|COMPLETED|Follow up Until Relapse or Progression||2
8522806|NCT00372905|21007818|P1|COMPLETED|Follow up Until Relapse or Progression||3
8522807|NCT00372905|21007815|P4|STARTED|Follow up Until Relapse or Progression||8
8522808|NCT00372905|21007816|P3|STARTED|Follow up Until Relapse or Progression||3
8522809|NCT00372905|21007817|P2|STARTED|Follow up Until Relapse or Progression||3
8522810|NCT00372905|21007818|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
8522811|NCT00372905|21007815|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
8522812|NCT00372905|21007816|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522813|NCT00372905|21007817|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522814|NCT00372905|21007818|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522815|NCT00372905|21007815|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
8522816|NCT00372905|21007816|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522817|NCT00372905|21007817|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522818|NCT00372905|21007818|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522819|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
8522820|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8522821|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8522822|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8522823|NCT00372905|21007815|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
8522824|NCT00372905|21007816|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8522825|NCT00372905|21007817|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8522826|NCT00372905|21007818|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8522827|NCT00372905|21007815|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
8522828|NCT00372905|21007816|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
8522829|NCT00372905|21007817|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
8522830|NCT00372905|21007818|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
8522831|NCT00372905|21007815|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
8522832|NCT00372905|21007816|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8522833|NCT00372905|21007817|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8522834|NCT00372905|21007818|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8522835|NCT00372905|21007815|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522836|NCT00372905|21007816|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
8522837|NCT00372905|21007817|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522838|NCT00372905|21007818|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522839|NCT00372905|21007815|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522840|NCT00372905|21007816|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
8522841|NCT00372905|21007817|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522842|NCT00372905|21007818|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522843|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8522844|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
8522845|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8522846|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8522847|NCT00372905|21007815|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8522848|NCT00372905|21007816|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
8522849|NCT00372905|21007817|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8522850|NCT00372905|21007818|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8522851|NCT00372905|21007815|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8522852|NCT00372905|21007816|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
8522853|NCT00372905|21007817|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8522854|NCT00372905|21007818|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8522855|NCT00372905|21007815|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8522856|NCT00372905|21007816|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
8522857|NCT00372905|21007817|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8522858|NCT00372905|21007818|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8522859|NCT00372905|21007815|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522860|NCT00372905|21007816|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522861|NCT00372905|21007817|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522862|NCT00372905|21007818|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522863|NCT00372905|21007815|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522864|NCT00372905|21007816|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522865|NCT00372905|21007817|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
8522866|NCT00372905|21007818|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522867|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8522868|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8522869|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
8522870|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8522871|NCT00372905|21007815|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8522872|NCT00372905|21007816|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8522873|NCT00372905|21007817|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
8522874|NCT00372905|21007818|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8522875|NCT00372905|21007815|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8522876|NCT00372905|21007816|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8522877|NCT00372905|21007817|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
8522878|NCT00372905|21007818|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8522879|NCT00372905|21007815|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8522880|NCT00372905|21007816|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8522881|NCT00372905|21007817|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
8522882|NCT00372905|21007818|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8522883|NCT00372905|21007815|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522884|NCT00372905|21007816|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522885|NCT00372905|21007817|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522886|NCT00372905|21007818|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
8522887|NCT00372905|21007815|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522888|NCT00372905|21007816|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522889|NCT00372905|21007817|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522890|NCT00372905|21007818|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
8522891|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8522892|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8522893|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8522894|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
8522895|NCT00372905|21007815|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8522896|NCT00372905|21007816|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8522897|NCT00372905|21007817|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8522898|NCT00372905|21007818|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
8522899|NCT00372905|21007815|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8522900|NCT00372905|21007816|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8522901|NCT00372905|21007817|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8522902|NCT00372905|21007818|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
8522903|NCT00372905|21007815|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8522904|NCT00372905|21007816|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8522905|NCT00372905|21007817|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8522906|NCT00372905|21007818|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
8522907|NCT00372775|21007830|P1|NOT COMPLETED|Overall Study||63
8522908|NCT00372775|21007830|P1|COMPLETED|Overall Study||3
8522909|NCT00372775|21007830|P1|Received Treatment|Overall Study||64
8522910|NCT00372775|21007830|P1|STARTED|Overall Study||66
8522911|NCT00372697|21007852|P2|NOT COMPLETED|Overall Study||1
8522912|NCT00372697|21007853|P1|NOT COMPLETED|Overall Study||1
8522913|NCT00372697|21007852|P2|COMPLETED|Overall Study||11
8522914|NCT00372697|21007853|P1|COMPLETED|Overall Study||15
8522915|NCT00372697|21007852|P2|STARTED|Overall Study||12
8522916|NCT00372697|21007853|P1|STARTED|Overall Study||16
8522917|NCT00372619|21007878|P7|NOT COMPLETED|Overall Study||0
8522918|NCT00372619|21007879|P6|NOT COMPLETED|Overall Study||3
8522919|NCT00372619|21007880|P5|NOT COMPLETED|Overall Study||0
8522920|NCT00372619|21007881|P4|NOT COMPLETED|Overall Study||0
8522921|NCT00372619|21007882|P3|NOT COMPLETED|Overall Study||0
8522922|NCT00372619|21007883|P2|NOT COMPLETED|Overall Study||0
8522923|NCT00372619|21007884|P1|NOT COMPLETED|Overall Study||0
8522924|NCT00372619|21007878|P7|COMPLETED|Overall Study||2
8522925|NCT00372619|21007879|P6|COMPLETED|Overall Study||39
8522926|NCT00372619|21007880|P5|COMPLETED|Overall Study||7
8522927|NCT00372619|21007881|P4|COMPLETED|Overall Study||10
8522928|NCT00372619|21007882|P3|COMPLETED|Overall Study||3
8522929|NCT00372619|21007883|P2|COMPLETED|Overall Study||2
8522930|NCT00372619|21007884|P1|COMPLETED|Overall Study||8
8522931|NCT00372619|21007878|P7|STARTED|Overall Study||2
8522932|NCT00372619|21007879|P6|STARTED|Overall Study||42
8522933|NCT00372619|21007880|P5|STARTED|Overall Study||7
8522934|NCT00372619|21007881|P4|STARTED|Overall Study||10
8522935|NCT00372619|21007882|P3|STARTED|Overall Study||3
8522936|NCT00372619|21007883|P2|STARTED|Overall Study||2
8522937|NCT00372619|21007884|P1|STARTED|Overall Study||8
8522938|NCT00372593|21007917|P3|NOT COMPLETED|Overall Study||4
8522939|NCT00372593|21007918|P2|NOT COMPLETED|Overall Study||198
8522940|NCT00372593|21007919|P1|NOT COMPLETED|Overall Study||204
8522941|NCT00372593|21007917|P3|COMPLETED|Overall Study||3
8522942|NCT00372593|21007918|P2|COMPLETED|Overall Study||334
8522943|NCT00372593|21007919|P1|COMPLETED|Overall Study||327
8522944|NCT00372593|21007917|P3|STARTED|Overall Study||7
8522945|NCT00372593|21007918|P2|STARTED|Overall Study||532
8522946|NCT00372593|21007919|P1|STARTED|Overall Study||531
8522947|NCT00372567|21007948|P3|NOT COMPLETED|Phase 3 Study||12
8522948|NCT00372567|21007949|P2|NOT COMPLETED|Phase 3 Study||26
8522949|NCT00372567|21007950|P1|NOT COMPLETED|Phase 3 Study||31
8522950|NCT00372567|21007948|P3|COMPLETED|Phase 3 Study||0
8522951|NCT00372567|21007949|P2|COMPLETED|Phase 3 Study||0
8522952|NCT00372567|21007950|P1|COMPLETED|Phase 3 Study||0
8522953|NCT00372567|21007948|P3|Received Treatment|Phase 3 Study||12
8522954|NCT00372567|21007949|P2|Received Treatment|Phase 3 Study||25
8522955|NCT00372567|21007950|P1|Received Treatment|Phase 3 Study||31
8522956|NCT00372567|21007948|P3|STARTED|Phase 3 Study||12
8522957|NCT00372567|21007949|P2|STARTED|Phase 3 Study||26
8522958|NCT00372567|21007950|P1|STARTED|Phase 3 Study||31
8522959|NCT00372567|21007948|P3|NOT COMPLETED|Phase 1 Sub-study||0
8522960|NCT00372567|21007949|P2|NOT COMPLETED|Phase 1 Sub-study||0
8522961|NCT00372567|21007950|P1|NOT COMPLETED|Phase 1 Sub-study||0
8522962|NCT00372567|21007948|P3|COMPLETED|Phase 1 Sub-study||12
8522963|NCT00372567|21007949|P2|COMPLETED|Phase 1 Sub-study||0
8522964|NCT00372567|21007950|P1|COMPLETED|Phase 1 Sub-study||0
8522965|NCT00372567|21007948|P3|STARTED|Phase 1 Sub-study||12
8522966|NCT00372567|21007949|P2|STARTED|Phase 1 Sub-study||0
8522967|NCT00372567|21007950|P1|STARTED|Phase 1 Sub-study||0
8522968|NCT00372528|21007978|P1|NOT COMPLETED|Overall Study||21
8522969|NCT00372528|21007978|P1|COMPLETED|Overall Study||0
8522970|NCT00372528|21007978|P1|STARTED|Overall Study||21
8522971|NCT00372489|21007983|P1|NOT COMPLETED|Overall Study||79
8522972|NCT00372489|21007983|P1|COMPLETED|Overall Study||2
8522973|NCT00372489|21007983|P1|STARTED|Overall Study||81
8522974|NCT00372424|21007987|P1|NOT COMPLETED|Overall Study||26
8522975|NCT00372424|21007987|P1|COMPLETED|Overall Study||0
8522976|NCT00372424|21007987|P1|Treated|Overall Study||25
8522977|NCT00372424|21007987|P1|STARTED|Overall Study||26
8522978|NCT00372411|21008001|P3|NOT COMPLETED|Overall Study||3
8522979|NCT00372411|21008002|P2|NOT COMPLETED|Overall Study||8
8522980|NCT00372411|21008003|P1|NOT COMPLETED|Overall Study||5
8522981|NCT00372411|21008001|P3|COMPLETED|Overall Study||25
8522982|NCT00372411|21008002|P2|COMPLETED|Overall Study||42
8522983|NCT00372411|21008003|P1|COMPLETED|Overall Study||44
8522984|NCT00372411|21008001|P3|STARTED|Overall Study||28
8522985|NCT00372411|21008002|P2|STARTED|Overall Study||50
8522986|NCT00372411|21008003|P1|STARTED|Overall Study||49
8522987|NCT00372385|21008027|P4|NOT COMPLETED|Overall Study||8
8522988|NCT00372385|21008028|P3|NOT COMPLETED|Overall Study||10
8522989|NCT00372385|21008029|P2|NOT COMPLETED|Overall Study||20
8522990|NCT00372385|21008030|P1|NOT COMPLETED|Overall Study||33
8522991|NCT00372385|21008027|P4|COMPLETED|Overall Study||70
8522992|NCT00372385|21008028|P3|COMPLETED|Overall Study||72
8522993|NCT00372385|21008029|P2|COMPLETED|Overall Study||61
8522994|NCT00372385|21008030|P1|COMPLETED|Overall Study||49
8522995|NCT00372385|21008027|P4|STARTED|Overall Study||78
8522996|NCT00372385|21008028|P3|STARTED|Overall Study||82
8522997|NCT00372385|21008029|P2|STARTED|Overall Study||81
8522998|NCT00372385|21008030|P1|STARTED|Overall Study||82
8522999|NCT00372255|21008059|P2|NOT COMPLETED|Overall Study||1
8523000|NCT00372255|21008060|P1|NOT COMPLETED|Overall Study||2
8523001|NCT00372255|21008059|P2|COMPLETED|Overall Study||113
8523002|NCT00372255|21008060|P1|COMPLETED|Overall Study||108
8523003|NCT00372255|21008059|P2|STARTED|Overall Study||114
8523004|NCT00372255|21008060|P1|STARTED|Overall Study||110
8523005|NCT00372229|21008082|P2|NOT COMPLETED|Follow-Up Phase||52
8523006|NCT00372229|21008083|P1|NOT COMPLETED|Follow-Up Phase||46
8523007|NCT00372229|21008082|P2|COMPLETED|Follow-Up Phase||70
8523008|NCT00372229|21008083|P1|COMPLETED|Follow-Up Phase||71
8523009|NCT00372229|21008082|P2|STARTED|Follow-Up Phase||122
8523010|NCT00372229|21008083|P1|STARTED|Follow-Up Phase||117
8523011|NCT00372229|21008082|P2|NOT COMPLETED|Study Phase||29
8523012|NCT00372229|21008083|P1|NOT COMPLETED|Study Phase||31
8523013|NCT00372229|21008082|P2|COMPLETED|Study Phase||122
8523014|NCT00372229|21008083|P1|COMPLETED|Study Phase||117
8523015|NCT00372229|21008082|P2|STARTED|Study Phase||151
8523016|NCT00372229|21008083|P1|STARTED|Study Phase||148
8523017|NCT00372190|21008173|P2|NOT COMPLETED|Overall Study||1
8523018|NCT00372190|21008174|P1|NOT COMPLETED|Overall Study||3
8523019|NCT00372190|21008173|P2|COMPLETED|Overall Study||96
8523020|NCT00372190|21008174|P1|COMPLETED|Overall Study||90
8523021|NCT00372190|21008173|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
8523022|NCT00372190|21008174|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
8523023|NCT00372112|21008190|P4|NOT COMPLETED|Overall Study||4
8523024|NCT00372112|21008191|P3|NOT COMPLETED|Overall Study||4
8523025|NCT00372112|21008192|P2|NOT COMPLETED|Overall Study||1
8523026|NCT00372112|21008193|P1|NOT COMPLETED|Overall Study||1
8523027|NCT00372112|21008190|P4|COMPLETED|Overall Study||14
8523028|NCT00372112|21008191|P3|COMPLETED|Overall Study||13
8523029|NCT00372112|21008192|P2|COMPLETED|Overall Study||15
8523030|NCT00372112|21008193|P1|COMPLETED|Overall Study||16
8523031|NCT00372112|21008190|P4|STARTED|Overall Study||18
8523032|NCT00372112|21008191|P3|STARTED|Overall Study||17
8523033|NCT00372112|21008192|P2|STARTED|Overall Study||16
8523034|NCT00372112|21008193|P1|STARTED|Overall Study||17
8523035|NCT00372060|21008324|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
8523036|NCT00372060|21008325|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
8523037|NCT00372060|21008324|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
8523038|NCT00372060|21008325|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
8523039|NCT00372060|21008324|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
8523040|NCT00372060|21008325|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
8523041|NCT00372060|21008324|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
8523042|NCT00372060|21008325|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
8523043|NCT00372060|21008324|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
8523044|NCT00372060|21008325|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
8523045|NCT00372060|21008324|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
8523046|NCT00372060|21008325|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
8523047|NCT00371865|21008340|P2|NOT COMPLETED|Overall Study||14
8523048|NCT00371865|21008341|P1|NOT COMPLETED|Overall Study||15
8523049|NCT00371865|21008340|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
8523050|NCT00371865|21008341|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
8523051|NCT00371865|21008340|P2|STARTED|Overall Study||57
8523052|NCT00371865|21008341|P1|STARTED|Overall Study||57
8523053|NCT00371839|21008358|P3|NOT COMPLETED|Overall Study||2
8523054|NCT00371839|21008359|P2|NOT COMPLETED|Overall Study||7
8523055|NCT00371839|21008360|P1|NOT COMPLETED|Overall Study||17
8523056|NCT00371839|21008358|P3|COMPLETED|Overall Study||7
8523057|NCT00371839|21008359|P2|COMPLETED|Overall Study||13
8523058|NCT00371839|21008360|P1|COMPLETED|Overall Study||32
8523059|NCT00371839|21008358|P3|STARTED|Overall Study||9
8523060|NCT00371839|21008359|P2|STARTED|Overall Study||20
8523061|NCT00371839|21008360|P1|STARTED|Overall Study||49
8523062|NCT00371826|21008369|P3|NOT COMPLETED|Extension Phase (24 Months)||2
8523063|NCT00371826|21008370|P2|NOT COMPLETED|Extension Phase (24 Months)||10
8523064|NCT00371826|21008371|P1|NOT COMPLETED|Extension Phase (24 Months)||5
8523065|NCT00371826|21008369|P3|COMPLETED|Extension Phase (24 Months)||3
8523066|NCT00371826|21008370|P2|COMPLETED|Extension Phase (24 Months)||29
8523067|NCT00371826|21008371|P1|COMPLETED|Extension Phase (24 Months)||18
8523068|NCT00371826|21008369|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
8523069|NCT00371826|21008370|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
8523070|NCT00371826|21008371|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
8523071|NCT00371826|21008369|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
8523072|NCT00371826|21008370|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
8523073|NCT00371826|21008371|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
8523074|NCT00371826|21008369|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
8523075|NCT00371826|21008370|P2|STARTED|Extension Phase (24 Months)||39
8523076|NCT00371826|21008371|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
8523077|NCT00371826|21008369|P3|NOT COMPLETED|Core Phase (12 Months)||24
8523078|NCT00371826|21008370|P2|NOT COMPLETED|Core Phase (12 Months)||8
8523079|NCT00371826|21008371|P1|NOT COMPLETED|Core Phase (12 Months)||24
8523080|NCT00371826|21008369|P3|COMPLETED|Core Phase (12 Months)||6
8523081|NCT00371826|21008370|P2|COMPLETED|Core Phase (12 Months)||39
8523082|NCT00371826|21008371|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
8523083|NCT00371826|21008369|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
8523084|NCT00371826|21008370|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
8523085|NCT00371826|21008371|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
8523086|NCT00371826|21008369|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
8523087|NCT00371826|21008370|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
8523088|NCT00371826|21008371|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
8523089|NCT00371826|21008369|P3|STARTED|Core Phase (12 Months)||30
8523090|NCT00371826|21008370|P2|STARTED|Core Phase (12 Months)||47
8523091|NCT00371826|21008371|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
8523092|NCT00371787|21008495|P2|NOT COMPLETED|Overall Study||1
8523093|NCT00371787|21008496|P1|NOT COMPLETED|Overall Study||3
8523094|NCT00371787|21008495|P2|COMPLETED|Overall Study||11
8523095|NCT00371787|21008496|P1|COMPLETED|Overall Study||23
8523096|NCT00371787|21008495|P2|STARTED|Overall Study||12
8523097|NCT00371787|21008496|P1|STARTED|Overall Study||26
8523098|NCT00371761|21008510|P2|NOT COMPLETED|Overall Study||10
8523099|NCT00371761|21008511|P1|NOT COMPLETED|Overall Study||8
8523100|NCT00371761|21008510|P2|COMPLETED|Overall Study||2
8523101|NCT00371761|21008511|P1|COMPLETED|Overall Study||5
8523102|NCT00371761|21008510|P2|STARTED|Overall Study||12
8523103|NCT00371761|21008511|P1|STARTED|Overall Study||13
8523104|NCT00371683|21008519|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
8523105|NCT00371683|21008520|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
8523106|NCT00371683|21008519|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
8523107|NCT00371683|21008520|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
8523108|NCT00371683|21008519|P2|STARTED|Follow-Up Period - Randomized Patients||1533
8523109|NCT00371683|21008520|P1|STARTED|Follow-Up Period - Randomized Patients||1553
8523110|NCT00371683|21008519|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
8523111|NCT00371683|21008520|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
8523112|NCT00371683|21008519|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
8523113|NCT00371683|21008520|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
8523114|NCT00371683|21008519|P2|STARTED|DB Treatment Period-Randomized Patients||1596
8523115|NCT00371683|21008520|P1|STARTED|DB Treatment Period-Randomized Patients||1599
8523116|NCT00371644|21008574|P2|NOT COMPLETED|Overall Study||13
8523117|NCT00371644|21008575|P1|NOT COMPLETED|Overall Study||28
8523118|NCT00371644|21008574|P2|COMPLETED|Overall Study||44
8523119|NCT00371644|21008575|P1|COMPLETED|Overall Study||44
8523120|NCT00371644|21008574|P2|STARTED|Overall Study||57
8523121|NCT00371644|21008575|P1|STARTED|Overall Study||72
8523122|NCT00371631|21008581|P1|NOT COMPLETED|Overall Study||0
8523123|NCT00371631|21008581|P1|COMPLETED|Overall Study||13
8523124|NCT00371631|21008581|P1|STARTED|Overall Study||13
8523125|NCT00371566|21008588|P2|NOT COMPLETED|Follow Up Phase||7
8523126|NCT00371566|21008589|P1|NOT COMPLETED|Follow Up Phase||3
8523127|NCT00371566|21008588|P2|COMPLETED|Follow Up Phase||58
8523128|NCT00371566|21008589|P1|COMPLETED|Follow Up Phase||28
8523129|NCT00371566|21008588|P2|STARTED|Follow Up Phase||65
8523130|NCT00371566|21008589|P1|STARTED|Follow Up Phase||31
8523131|NCT00371566|21008588|P2|NOT COMPLETED|Chemoradiation Phase||3
8523132|NCT00371566|21008589|P1|NOT COMPLETED|Chemoradiation Phase||5
8523133|NCT00371566|21008588|P2|COMPLETED|Chemoradiation Phase||65
8523134|NCT00371566|21008589|P1|COMPLETED|Chemoradiation Phase||31
8523135|NCT00371566|21008588|P2|STARTED|Chemoradiation Phase||68
8523136|NCT00371566|21008589|P1|STARTED|Chemoradiation Phase||36
8523137|NCT00371566|21008588|P2|NOT COMPLETED|Treatment Phase||3
8523138|NCT00371566|21008589|P1|NOT COMPLETED|Treatment Phase||0
8523139|NCT00371566|21008588|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
8523140|NCT00371566|21008589|P1|COMPLETED|Treatment Phase||36
8523141|NCT00371566|21008588|P2|STARTED|Treatment Phase||71
8523142|NCT00371566|21008589|P1|STARTED|Treatment Phase||36
8523143|NCT00371540|21008661|P2|NOT COMPLETED|Overall Study||9
8523144|NCT00371540|21008662|P1|NOT COMPLETED|Overall Study||10
8523145|NCT00371540|21008661|P2|COMPLETED|Overall Study||87
8523146|NCT00371540|21008662|P1|COMPLETED|Overall Study||102
8523147|NCT00371540|21008661|P2|STARTED|Overall Study||96
8523148|NCT00371540|21008662|P1|STARTED|Overall Study||112
8523149|NCT00371462|21008674|P2|NOT COMPLETED|Overall Study||8
8523150|NCT00371462|21008675|P1|NOT COMPLETED|Overall Study||8
8523151|NCT00371462|21008674|P2|COMPLETED|Overall Study||27
8523152|NCT00371462|21008675|P1|COMPLETED|Overall Study||27
8523153|NCT00371462|21008674|P2|STARTED|Overall Study||35
8523154|NCT00371462|21008675|P1|STARTED|Overall Study||35
8523155|NCT00371449|21008681|P1|NOT COMPLETED|Overall Study||0
8523156|NCT00371449|21008681|P1|COMPLETED|Overall Study||120
8523157|NCT00371449|21008681|P1|STARTED|Overall Study||120
8523158|NCT00371436|21008692|P2|NOT COMPLETED|Overall Study||21
8523159|NCT00371436|21008693|P1|NOT COMPLETED|Overall Study||34
8523160|NCT00371436|21008692|P2|COMPLETED|Overall Study||68
8523161|NCT00371436|21008693|P1|COMPLETED|Overall Study||58
8523162|NCT00371436|21008692|P2|STARTED|Overall Study||89
8523163|NCT00371436|21008693|P1|STARTED|Overall Study||92
8523164|NCT00371397|21008699|P12|NOT COMPLETED|Session 3||0
8523165|NCT00371397|21008700|P11|NOT COMPLETED|Session 3||0
8523166|NCT00371397|21008701|P10|NOT COMPLETED|Session 3||0
8523167|NCT00371397|21008702|P9|NOT COMPLETED|Session 3||0
8523168|NCT00371397|21008703|P8|NOT COMPLETED|Session 3||0
8523169|NCT00371397|21008704|P7|NOT COMPLETED|Session 3||0
8523170|NCT00371397|21008705|P6|NOT COMPLETED|Session 3||0
8523171|NCT00371397|21008706|P5|NOT COMPLETED|Session 3||0
8523172|NCT00371397|21008707|P4|NOT COMPLETED|Session 3||0
8523173|NCT00371397|21008708|P3|NOT COMPLETED|Session 3||0
8523174|NCT00371397|21008709|P2|NOT COMPLETED|Session 3||0
8523175|NCT00371397|21008710|P1|NOT COMPLETED|Session 3||0
8523176|NCT00371397|21008699|P12|COMPLETED|Session 3||2
8523177|NCT00371397|21008700|P11|COMPLETED|Session 3||4
8523178|NCT00371397|21008701|P10|COMPLETED|Session 3||5
8523179|NCT00371397|21008702|P9|COMPLETED|Session 3||6
8523180|NCT00371397|21008703|P8|COMPLETED|Session 3||4
8523181|NCT00371397|21008704|P7|COMPLETED|Session 3||4
8523182|NCT00371397|21008705|P6|COMPLETED|Session 3||4
8523183|NCT00371397|21008706|P5|COMPLETED|Session 3||3
8523184|NCT00371397|21008707|P4|COMPLETED|Session 3||2
8523185|NCT00371397|21008708|P3|COMPLETED|Session 3||5
8523186|NCT00371397|21008709|P2|COMPLETED|Session 3||7
8523187|NCT00371397|21008710|P1|COMPLETED|Session 3||4
8523188|NCT00371397|21008699|P12|STARTED|Session 3||2
8523189|NCT00371397|21008700|P11|STARTED|Session 3||4
8523190|NCT00371397|21008701|P10|STARTED|Session 3||5
8523191|NCT00371397|21008702|P9|STARTED|Session 3||6
8523192|NCT00371397|21008703|P8|STARTED|Session 3||4
8523193|NCT00371397|21008704|P7|STARTED|Session 3||4
8523194|NCT00371397|21008705|P6|STARTED|Session 3||4
8523195|NCT00371397|21008706|P5|STARTED|Session 3||3
8523196|NCT00371397|21008707|P4|STARTED|Session 3||2
8523197|NCT00371397|21008708|P3|STARTED|Session 3||5
8523198|NCT00371397|21008709|P2|STARTED|Session 3||7
8523199|NCT00371397|21008710|P1|STARTED|Session 3||4
8523200|NCT00371397|21008699|P12|NOT COMPLETED|Session 2||0
8523201|NCT00371397|21008700|P11|NOT COMPLETED|Session 2||0
8523202|NCT00371397|21008701|P10|NOT COMPLETED|Session 2||0
8523203|NCT00371397|21008702|P9|NOT COMPLETED|Session 2||0
8523204|NCT00371397|21008703|P8|NOT COMPLETED|Session 2||0
8523205|NCT00371397|21008704|P7|NOT COMPLETED|Session 2||0
8523206|NCT00371397|21008705|P6|NOT COMPLETED|Session 2||0
8523207|NCT00371397|21008706|P5|NOT COMPLETED|Session 2||0
8523208|NCT00371397|21008707|P4|NOT COMPLETED|Session 2||0
8523209|NCT00371397|21008708|P3|NOT COMPLETED|Session 2||0
8523210|NCT00371397|21008709|P2|NOT COMPLETED|Session 2||0
8523211|NCT00371397|21008710|P1|NOT COMPLETED|Session 2||0
8523212|NCT00371397|21008699|P12|COMPLETED|Session 2||2
8523213|NCT00371397|21008700|P11|COMPLETED|Session 2||4
8523214|NCT00371397|21008701|P10|COMPLETED|Session 2||5
8523215|NCT00371397|21008702|P9|COMPLETED|Session 2||6
8523216|NCT00371397|21008703|P8|COMPLETED|Session 2||4
8523217|NCT00371397|21008704|P7|COMPLETED|Session 2||4
8523218|NCT00371397|21008705|P6|COMPLETED|Session 2||4
8523219|NCT00371397|21008706|P5|COMPLETED|Session 2||3
8523220|NCT00371397|21008707|P4|COMPLETED|Session 2||2
8523221|NCT00371397|21008708|P3|COMPLETED|Session 2||5
8523222|NCT00371397|21008709|P2|COMPLETED|Session 2||7
8523223|NCT00371397|21008710|P1|COMPLETED|Session 2||4
8523224|NCT00371397|21008699|P12|STARTED|Session 2||2
8523225|NCT00371397|21008700|P11|STARTED|Session 2||4
8523226|NCT00371397|21008701|P10|STARTED|Session 2||5
8523227|NCT00371397|21008702|P9|STARTED|Session 2||6
8523228|NCT00371397|21008703|P8|STARTED|Session 2||4
8523229|NCT00371397|21008704|P7|STARTED|Session 2||4
8523230|NCT00371397|21008705|P6|STARTED|Session 2||4
8523231|NCT00371397|21008706|P5|STARTED|Session 2||3
8523232|NCT00371397|21008707|P4|STARTED|Session 2||2
8523233|NCT00371397|21008708|P3|STARTED|Session 2||5
8523234|NCT00371397|21008709|P2|STARTED|Session 2||7
8523235|NCT00371397|21008710|P1|STARTED|Session 2||4
8523236|NCT00371397|21008699|P12|NOT COMPLETED|Session 1||0
8523237|NCT00371397|21008700|P11|NOT COMPLETED|Session 1||0
8523238|NCT00371397|21008701|P10|NOT COMPLETED|Session 1||0
8523239|NCT00371397|21008702|P9|NOT COMPLETED|Session 1||0
8523240|NCT00371397|21008703|P8|NOT COMPLETED|Session 1||1
8523241|NCT00371397|21008704|P7|NOT COMPLETED|Session 1||0
8523242|NCT00371397|21008705|P6|NOT COMPLETED|Session 1||0
8523243|NCT00371397|21008706|P5|NOT COMPLETED|Session 1||0
8523244|NCT00371397|21008707|P4|NOT COMPLETED|Session 1||0
8523245|NCT00371397|21008708|P3|NOT COMPLETED|Session 1||0
8523246|NCT00371397|21008709|P2|NOT COMPLETED|Session 1||0
8523247|NCT00371397|21008710|P1|NOT COMPLETED|Session 1||1
8523248|NCT00371397|21008699|P12|COMPLETED|Session 1||2
8523249|NCT00371397|21008700|P11|COMPLETED|Session 1||4
8523250|NCT00371397|21008701|P10|COMPLETED|Session 1||5
8523251|NCT00371397|21008702|P9|COMPLETED|Session 1||6
8523252|NCT00371397|21008703|P8|COMPLETED|Session 1||4
8523253|NCT00371397|21008704|P7|COMPLETED|Session 1||4
8523254|NCT00371397|21008705|P6|COMPLETED|Session 1||4
8523255|NCT00371397|21008706|P5|COMPLETED|Session 1||3
8523256|NCT00371397|21008707|P4|COMPLETED|Session 1||2
8523257|NCT00371397|21008708|P3|COMPLETED|Session 1||5
8523258|NCT00371397|21008709|P2|COMPLETED|Session 1||7
8523259|NCT00371397|21008710|P1|COMPLETED|Session 1||4
8523260|NCT00371397|21008699|P12|STARTED|Session 1||2
8523261|NCT00371397|21008700|P11|STARTED|Session 1||4
8523262|NCT00371397|21008701|P10|STARTED|Session 1||5
8523263|NCT00371397|21008702|P9|STARTED|Session 1||6
8523264|NCT00371397|21008703|P8|STARTED|Session 1||5
8523265|NCT00371397|21008704|P7|STARTED|Session 1||4
8523266|NCT00371397|21008705|P6|STARTED|Session 1||4
8523267|NCT00371397|21008706|P5|STARTED|Session 1||3
8523268|NCT00371397|21008707|P4|STARTED|Session 1||2
8523269|NCT00371397|21008708|P3|STARTED|Session 1||5
8523270|NCT00371397|21008709|P2|STARTED|Session 1||7
8523271|NCT00371397|21008710|P1|STARTED|Session 1||5
8523272|NCT00371345|21008718|P2|NOT COMPLETED|Overall Study||46
8523273|NCT00371345|21008719|P1|NOT COMPLETED|Overall Study||24
8523274|NCT00371345|21008718|P2|COMPLETED|Overall Study||0
8523275|NCT00371345|21008719|P1|COMPLETED|Overall Study||0
8523276|NCT00371345|21008718|P2|STARTED|Overall Study||46
8523277|NCT00371345|21008719|P1|STARTED|Overall Study||24
8523278|NCT00371293|21008779|P3|NOT COMPLETED|Overall Study||16
8523279|NCT00371293|21008780|P2|NOT COMPLETED|Overall Study||19
8523280|NCT00371293|21008781|P1|NOT COMPLETED|Overall Study||10
8523281|NCT00371293|21008779|P3|COMPLETED|Overall Study||46
8523282|NCT00371293|21008780|P2|COMPLETED|Overall Study||42
8523283|NCT00371293|21008781|P1|COMPLETED|Overall Study||48
8523284|NCT00371293|21008779|P3|STARTED|Overall Study||62
8523285|NCT00371293|21008780|P2|STARTED|Overall Study||61
8523286|NCT00371293|21008781|P1|STARTED|Overall Study||58
8523287|NCT00371267|21008803|P2|NOT COMPLETED|Overall Study||18
8523288|NCT00371267|21008804|P1|NOT COMPLETED|Overall Study||9
8523289|NCT00371267|21008803|P2|COMPLETED|Overall Study||32
8523290|NCT00371267|21008804|P1|COMPLETED|Overall Study||39
8523291|NCT00371267|21008803|P2|STARTED|Overall Study||50
8523292|NCT00371267|21008804|P1|STARTED|Overall Study||48
8523293|NCT00371254|21008820|P2|NOT COMPLETED|Overall Study||21
8523294|NCT00371254|21008821|P1|NOT COMPLETED|Overall Study||23
8523295|NCT00371254|21008820|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
8523296|NCT00371254|21008821|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
8523297|NCT00371254|21008820|P2|STARTED|Overall Study|Number of participants treated|21
8523298|NCT00371254|21008821|P1|STARTED|Overall Study|Number of participants treated|23
8523299|NCT00371176|21008873|P2|NOT COMPLETED|Overall Study||8
8523300|NCT00371176|21008874|P1|NOT COMPLETED|Overall Study||5
8523301|NCT00371176|21008873|P2|COMPLETED|Overall Study||5
8523302|NCT00371176|21008874|P1|COMPLETED|Overall Study||8
8523303|NCT00371176|21008873|P2|Completed Treatment|Overall Study||9
8523304|NCT00371176|21008874|P1|Completed Treatment|Overall Study||10
8523305|NCT00371176|21008873|P2|STARTED|Overall Study||13
8523306|NCT00371176|21008874|P1|STARTED|Overall Study||13
8523307|NCT00371150|21008904|P2|NOT COMPLETED|Overall Study||2
8523308|NCT00371150|21008905|P1|NOT COMPLETED|Overall Study||3
8523309|NCT00371150|21008904|P2|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
8523310|NCT00371150|21008905|P1|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
8523311|NCT00371150|21008904|P2|Discontinued at or After Week 48 Visit|Overall Study||1
8523312|NCT00371150|21008905|P1|Discontinued at or After Week 48 Visit|Overall Study||2
8523313|NCT00371150|21008904|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
8523314|NCT00371150|21008905|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
8523315|NCT00371150|21008904|P2|STARTED|Overall Study||6
8523316|NCT00371150|21008905|P1|STARTED|Overall Study||40
8523317|NCT00371137|21008940|P3|NOT COMPLETED|Overall Study||79
8523318|NCT00371137|21008941|P2|NOT COMPLETED|Overall Study||63
8523319|NCT00371137|21008942|P1|NOT COMPLETED|Overall Study||72
8523320|NCT00371137|21008940|P3|COMPLETED|Overall Study||104
8523321|NCT00371137|21008941|P2|COMPLETED|Overall Study||119
8523322|NCT00371137|21008942|P1|COMPLETED|Overall Study||111
8523323|NCT00371137|21008940|P3|Treated|Overall Study||182
8523324|NCT00371137|21008941|P2|Treated|Overall Study||182
8523325|NCT00371137|21008942|P1|Treated|Overall Study||183
8523326|NCT00371137|21008940|P3|STARTED|Overall Study||183
8523327|NCT00371137|21008941|P2|STARTED|Overall Study||182
8523328|NCT00371137|21008942|P1|STARTED|Overall Study||183
8523329|NCT00370994|21008952|P2|NOT COMPLETED|Overall Study||0
8523330|NCT00370994|21008953|P1|NOT COMPLETED|Overall Study||0
8523331|NCT00370994|21008952|P2|COMPLETED|Overall Study||60
8523332|NCT00370994|21008953|P1|COMPLETED|Overall Study||60
8523333|NCT00370994|21008952|P2|STARTED|Overall Study||60
8523334|NCT00370994|21008953|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
8523335|NCT00370838|21008963|P2|NOT COMPLETED|Taper||0
8523336|NCT00370838|21008964|P1|NOT COMPLETED|Taper||0
8523337|NCT00370838|21008963|P2|COMPLETED|Taper||3
8523338|NCT00370838|21008964|P1|COMPLETED|Taper||7
8523339|NCT00370838|21008963|P2|STARTED|Taper||3
8523340|NCT00370838|21008964|P1|STARTED|Taper||7
8523341|NCT00370838|21008963|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
8523342|NCT00370838|21008964|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
8523343|NCT00370838|21008963|P2|COMPLETED|Period 2 (Days 65-107)||3
8523344|NCT00370838|21008964|P1|COMPLETED|Period 2 (Days 65-107)||7
8523345|NCT00370838|21008963|P2|STARTED|Period 2 (Days 65-107)||3
8523346|NCT00370838|21008964|P1|STARTED|Period 2 (Days 65-107)||7
8523347|NCT00370838|21008963|P2|NOT COMPLETED|Washout (Days 51-64)||0
8523348|NCT00370838|21008964|P1|NOT COMPLETED|Washout (Days 51-64)||0
8523349|NCT00370838|21008963|P2|COMPLETED|Washout (Days 51-64)||3
8523350|NCT00370838|21008964|P1|COMPLETED|Washout (Days 51-64)||7
8523351|NCT00370838|21008963|P2|STARTED|Washout (Days 51-64)||3
8523352|NCT00370838|21008964|P1|STARTED|Washout (Days 51-64)||7
8523353|NCT00370838|21008963|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
8523354|NCT00370838|21008964|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
8523355|NCT00370838|21008963|P2|COMPLETED|Period 1 (Days 8-50)||3
8523356|NCT00370838|21008964|P1|COMPLETED|Period 1 (Days 8-50)||7
8523357|NCT00370838|21008963|P2|STARTED|Period 1 (Days 8-50)||3
8523358|NCT00370838|21008964|P1|STARTED|Period 1 (Days 8-50)||7
8523359|NCT00370695|21008982|P1|NOT COMPLETED|Overall Study||15
8523360|NCT00370695|21008982|P1|COMPLETED|Overall Study||0
8523361|NCT00370695|21008982|P1|12 Weeks Post-activation|Overall Study||2
8523362|NCT00370695|21008982|P1|STARTED|Overall Study||15
8523363|NCT00370682|21008989|P3|NOT COMPLETED|Overall Study||1
8523364|NCT00370682|21008990|P2|NOT COMPLETED|Overall Study||3
8523365|NCT00370682|21008991|P1|NOT COMPLETED|Overall Study||0
8523366|NCT00370682|21008989|P3|COMPLETED|Overall Study||39
8523367|NCT00370682|21008990|P2|COMPLETED|Overall Study||37
8523368|NCT00370682|21008991|P1|COMPLETED|Overall Study||40
8523369|NCT00370682|21008989|P3|STARTED|Overall Study||40
8523370|NCT00370682|21008990|P2|STARTED|Overall Study||40
8523371|NCT00370682|21008991|P1|STARTED|Overall Study||40
8523372|NCT00370552|21009033|P3|NOT COMPLETED|Overall Study||32
8523373|NCT00370552|21009034|P2|NOT COMPLETED|Overall Study||45
8523374|NCT00370552|21009035|P1|NOT COMPLETED|Overall Study||46
8523375|NCT00370552|21009033|P3|COMPLETED|Overall Study||0
8523376|NCT00370552|21009034|P2|COMPLETED|Overall Study||0
8523377|NCT00370552|21009035|P1|COMPLETED|Overall Study||0
8523378|NCT00370552|21009033|P3|STARTED|Overall Study|Randomized|32
8523379|NCT00370552|21009034|P2|STARTED|Overall Study|Randomized|45
8523380|NCT00370552|21009035|P1|STARTED|Overall Study|Randomized|46
8523381|NCT00370396|21009076|P3|NOT COMPLETED|Overall Study||1
8523382|NCT00370396|21009077|P2|NOT COMPLETED|Overall Study||1
8523383|NCT00370396|21009078|P1|NOT COMPLETED|Overall Study||11
8523384|NCT00370396|21009076|P3|COMPLETED|Overall Study||282
8523385|NCT00370396|21009077|P2|COMPLETED|Overall Study||91
8523386|NCT00370396|21009078|P1|COMPLETED|Overall Study||726
8523387|NCT00370396|21009076|P3|STARTED|Overall Study||283
8523388|NCT00370396|21009077|P2|STARTED|Overall Study||92
8523389|NCT00370396|21009078|P1|STARTED|Overall Study||737
8523390|NCT00370331|21009132|P2|NOT COMPLETED|Overall Study||23
8523391|NCT00370331|21009133|P1|NOT COMPLETED|Overall Study||7
8523392|NCT00370331|21009132|P2|COMPLETED|Overall Study||112
8523393|NCT00370331|21009133|P1|COMPLETED|Overall Study||55
8523394|NCT00370331|21009132|P2|STARTED|Overall Study||135
8523395|NCT00370331|21009133|P1|STARTED|Overall Study||62
8523396|NCT00370292|21009159|P1|NOT COMPLETED|Overall Study||13
8523397|NCT00370292|21009159|P1|COMPLETED|Overall Study||6
8523398|NCT00370292|21009159|P1|STARTED|Overall Study||19
8523399|NCT00370149|21009172|P2|NOT COMPLETED|Overall Study||19
8523400|NCT00370149|21009173|P1|NOT COMPLETED|Overall Study||19
8523401|NCT00370149|21009172|P2|COMPLETED|Overall Study||142
8523402|NCT00370149|21009173|P1|COMPLETED|Overall Study||146
8523403|NCT00370149|21009172|P2|STARTED|Overall Study||161
8523404|NCT00370149|21009173|P1|STARTED|Overall Study||165
8523405|NCT00370071|21009183|P1|NOT COMPLETED|Overall Study||2
8523406|NCT00370071|21009183|P1|COMPLETED|Overall Study||37
8523407|NCT00370071|21009183|P1|STARTED|Overall Study||39
8523408|NCT00370032|21009200|P2|NOT COMPLETED|Follow-up Period||0
8523409|NCT00370032|21009201|P1|NOT COMPLETED|Follow-up Period||1
8523410|NCT00370032|21009200|P2|COMPLETED|Follow-up Period||22
8523411|NCT00370032|21009201|P1|COMPLETED|Follow-up Period||22
8523412|NCT00370032|21009200|P2|STARTED|Follow-up Period||22
8523413|NCT00370032|21009201|P1|STARTED|Follow-up Period||23
8523414|NCT00370032|21009200|P2|NOT COMPLETED|Treatment Period 2||0
8523415|NCT00370032|21009201|P1|NOT COMPLETED|Treatment Period 2||0
8523416|NCT00370032|21009200|P2|COMPLETED|Treatment Period 2||22
8523417|NCT00370032|21009201|P1|COMPLETED|Treatment Period 2||23
8523418|NCT00370032|21009200|P2|STARTED|Treatment Period 2||22
8523419|NCT00370032|21009201|P1|STARTED|Treatment Period 2||23
8523420|NCT00370032|21009200|P2|NOT COMPLETED|Washout Period||2
8523421|NCT00370032|21009201|P1|NOT COMPLETED|Washout Period||1
8523422|NCT00370032|21009200|P2|COMPLETED|Washout Period||22
8523423|NCT00370032|21009201|P1|COMPLETED|Washout Period||23
8523424|NCT00370032|21009200|P2|STARTED|Washout Period||24
8523425|NCT00370032|21009201|P1|STARTED|Washout Period||24
8523426|NCT00370032|21009200|P2|NOT COMPLETED|Treatment Period 1||1
8523427|NCT00370032|21009201|P1|NOT COMPLETED|Treatment Period 1||0
8523428|NCT00370032|21009200|P2|COMPLETED|Treatment Period 1||24
8523429|NCT00370032|21009201|P1|COMPLETED|Treatment Period 1||24
8523430|NCT00370032|21009200|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
8523431|NCT00370032|21009201|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
8523432|NCT00369967|21009221|P2|NOT COMPLETED|Overall Study||12
8523433|NCT00369967|21009222|P1|NOT COMPLETED|Overall Study||23
8523434|NCT00369967|21009221|P2|COMPLETED|Overall Study||5
8523435|NCT00369967|21009222|P1|COMPLETED|Overall Study||8
8523436|NCT00369967|21009221|P2|STARTED|Overall Study||17
8523437|NCT00369967|21009222|P1|STARTED|Overall Study||31
8523438|NCT00369941|21009240|P2|NOT COMPLETED|Overall Study||100
8523439|NCT00369941|21009241|P1|NOT COMPLETED|Overall Study||72
8523440|NCT00369941|21009240|P2|COMPLETED|Overall Study||184
8523441|NCT00369941|21009241|P1|COMPLETED|Overall Study||210
8523442|NCT00369941|21009240|P2|Treated|Overall Study||282
8523443|NCT00369941|21009241|P1|Treated|Overall Study||281
8523444|NCT00369941|21009240|P2|STARTED|Overall Study||284
8523445|NCT00369941|21009241|P1|STARTED|Overall Study||282
8523446|NCT00369928|21009394|P3|NOT COMPLETED|Overall Study||20
8523447|NCT00369928|21009395|P2|NOT COMPLETED|Overall Study||16
8523448|NCT00369928|21009396|P1|NOT COMPLETED|Overall Study||8
8523449|NCT00369928|21009394|P3|COMPLETED|Overall Study||66
8523450|NCT00369928|21009395|P2|COMPLETED|Overall Study||69
8523451|NCT00369928|21009396|P1|COMPLETED|Overall Study||77
8523452|NCT00369928|21009394|P3|STARTED|Overall Study||86
8523453|NCT00369928|21009395|P2|STARTED|Overall Study||85
8523454|NCT00369928|21009396|P1|STARTED|Overall Study||85
8523455|NCT00369915|21009406|P2|NOT COMPLETED|Overall Study||3
8523456|NCT00369915|21009407|P1|NOT COMPLETED|Overall Study||6
8523457|NCT00369915|21009406|P2|COMPLETED|Overall Study||4
8523458|NCT00369915|21009407|P1|COMPLETED|Overall Study||4
8523459|NCT00369915|21009406|P2|STARTED|Overall Study||7
8523460|NCT00369915|21009407|P1|STARTED|Overall Study||10
8523461|NCT00369824|21009421|P6|NOT COMPLETED|Overall Study||11
8523462|NCT00369824|21009422|P5|NOT COMPLETED|Overall Study||18
8523463|NCT00369824|21009423|P4|NOT COMPLETED|Overall Study||15
8523464|NCT00369824|21009424|P3|NOT COMPLETED|Overall Study||12
8523465|NCT00369824|21009425|P2|NOT COMPLETED|Overall Study||19
8523466|NCT00369824|21009426|P1|NOT COMPLETED|Overall Study||15
8523467|NCT00369824|21009421|P6|COMPLETED|Overall Study||204
8523468|NCT00369824|21009422|P5|COMPLETED|Overall Study||196
8523469|NCT00369824|21009423|P4|COMPLETED|Overall Study||199
8523470|NCT00369824|21009424|P3|COMPLETED|Overall Study||202
8523471|NCT00369824|21009425|P2|COMPLETED|Overall Study||195
8523472|NCT00369824|21009426|P1|COMPLETED|Overall Study||197
8523473|NCT00369824|21009421|P6|STARTED|Overall Study||215
8523474|NCT00369824|21009422|P5|STARTED|Overall Study||214
8523475|NCT00369824|21009423|P4|STARTED|Overall Study||214
8523476|NCT00369824|21009424|P3|STARTED|Overall Study||214
8523477|NCT00369824|21009425|P2|STARTED|Overall Study||214
8523478|NCT00369824|21009426|P1|STARTED|Overall Study||212
8523479|NCT00369785|21009526|P2|NOT COMPLETED|Overall Study||25
8523480|NCT00369785|21009527|P1|NOT COMPLETED|Overall Study||27
8523481|NCT00369785|21009526|P2|COMPLETED|Overall Study||74
8523482|NCT00369785|21009527|P1|COMPLETED|Overall Study||72
8523483|NCT00369785|21009526|P2|STARTED|Overall Study||99
8523484|NCT00369785|21009527|P1|STARTED|Overall Study||99
8523485|NCT00369746|21009537|P2|NOT COMPLETED|Overall Study||0
8523486|NCT00369746|21009538|P1|NOT COMPLETED|Overall Study||0
8523487|NCT00369746|21009537|P2|COMPLETED|Overall Study||536
8523488|NCT00369746|21009538|P1|COMPLETED|Overall Study||138
8523489|NCT00369746|21009537|P2|STARTED|Overall Study||536
8523490|NCT00369746|21009538|P1|STARTED|Overall Study||138
8523491|NCT00369707|21009548|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
8523492|NCT00369707|21009548|P1|COMPLETED|Follow up for 2 Years After Treatment||38
8523493|NCT00369707|21009548|P1|STARTED|Follow up for 2 Years After Treatment||41
8523494|NCT00369707|21009548|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
8523495|NCT00369707|21009548|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
8523496|NCT00369707|21009548|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
8523497|NCT00369707|21009548|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
8523498|NCT00369707|21009548|P1|COMPLETED|Induction Part B (2 Cycles)||35
8523499|NCT00369707|21009548|P1|STARTED|Induction Part B (2 Cycles)||42
8523500|NCT00369707|21009548|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
8523501|NCT00369707|21009548|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
8523502|NCT00369707|21009548|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
8523503|NCT00369681|21009561|P1|NOT COMPLETED|Overall Study||1
8523504|NCT00369681|21009561|P1|COMPLETED|Overall Study||49
8523505|NCT00369681|21009561|P1|STARTED|Overall Study||50
8523506|NCT00369668|21009571|P3|NOT COMPLETED|Overall Study||7
8523507|NCT00369668|21009572|P2|NOT COMPLETED|Overall Study||5
8523508|NCT00369668|21009573|P1|NOT COMPLETED|Overall Study||4
8523509|NCT00369668|21009571|P3|COMPLETED|Overall Study||3
8523510|NCT00369668|21009572|P2|COMPLETED|Overall Study||5
8523511|NCT00369668|21009573|P1|COMPLETED|Overall Study||6
8523512|NCT00369668|21009571|P3|STARTED|Overall Study||10
8523513|NCT00369668|21009572|P2|STARTED|Overall Study||10
8523514|NCT00369668|21009573|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
8523515|NCT00369655|21009587|P1|NOT COMPLETED|Overall Study||2
8523516|NCT00369655|21009587|P1|COMPLETED|Overall Study||19
8523517|NCT00369655|21009587|P1|STARTED|Overall Study||21
8523518|NCT00369629|21009596|P4|NOT COMPLETED|Follow up for 1 Year||0
8523519|NCT00369629|21009597|P3|NOT COMPLETED|Follow up for 1 Year||3
8523520|NCT00369629|21009598|P2|NOT COMPLETED|Follow up for 1 Year||2
8523521|NCT00369629|21009599|P1|NOT COMPLETED|Follow up for 1 Year||2
8523522|NCT00369629|21009596|P4|COMPLETED|Follow up for 1 Year||0
8523523|NCT00369629|21009597|P3|COMPLETED|Follow up for 1 Year||2
8523524|NCT00369629|21009598|P2|COMPLETED|Follow up for 1 Year||1
8523525|NCT00369629|21009599|P1|COMPLETED|Follow up for 1 Year||4
8523526|NCT00369629|21009596|P4|STARTED|Follow up for 1 Year||0
8523527|NCT00369629|21009597|P3|STARTED|Follow up for 1 Year||5
8523528|NCT00369629|21009598|P2|STARTED|Follow up for 1 Year||3
8523529|NCT00369629|21009599|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
8523530|NCT00369629|21009596|P4|NOT COMPLETED|Completed 4 More Cycles||0
8523531|NCT00369629|21009597|P3|NOT COMPLETED|Completed 4 More Cycles||2
8523532|NCT00369629|21009598|P2|NOT COMPLETED|Completed 4 More Cycles||2
8523533|NCT00369629|21009599|P1|NOT COMPLETED|Completed 4 More Cycles||4
8523534|NCT00369629|21009596|P4|COMPLETED|Completed 4 More Cycles||0
8523535|NCT00369629|21009597|P3|COMPLETED|Completed 4 More Cycles||0
8523536|NCT00369629|21009598|P2|COMPLETED|Completed 4 More Cycles||0
8523537|NCT00369629|21009599|P1|COMPLETED|Completed 4 More Cycles||0
8523538|NCT00369629|21009596|P4|STARTED|Completed 4 More Cycles||0
8523539|NCT00369629|21009597|P3|STARTED|Completed 4 More Cycles||2
8523540|NCT00369629|21009598|P2|STARTED|Completed 4 More Cycles||2
8523541|NCT00369629|21009599|P1|STARTED|Completed 4 More Cycles||4
8523542|NCT00369629|21009596|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
8523543|NCT00369629|21009597|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
8523544|NCT00369629|21009598|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
8523545|NCT00369629|21009599|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
8523546|NCT00369629|21009596|P4|COMPLETED|Moved on to 4 More Cycles||0
8523547|NCT00369629|21009597|P3|COMPLETED|Moved on to 4 More Cycles||2
8523548|NCT00369629|21009598|P2|COMPLETED|Moved on to 4 More Cycles||2
8523549|NCT00369629|21009599|P1|COMPLETED|Moved on to 4 More Cycles||4
8523550|NCT00369629|21009596|P4|STARTED|Moved on to 4 More Cycles||0
8523551|NCT00369629|21009597|P3|STARTED|Moved on to 4 More Cycles||3
8523552|NCT00369629|21009598|P2|STARTED|Moved on to 4 More Cycles||2
8523553|NCT00369629|21009599|P1|STARTED|Moved on to 4 More Cycles||4
8523554|NCT00369629|21009596|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
8523555|NCT00369629|21009597|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
8523556|NCT00369629|21009598|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
8523557|NCT00369629|21009599|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
8523558|NCT00369629|21009596|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
8523559|NCT00369629|21009597|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
8523560|NCT00369629|21009598|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
8523561|NCT00369629|21009599|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
8523562|NCT00369629|21009596|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
8523563|NCT00369629|21009597|P3|STARTED|Treated 2 Cycles/Reached First Response||5
8523564|NCT00369629|21009598|P2|STARTED|Treated 2 Cycles/Reached First Response||3
8523565|NCT00369629|21009599|P1|STARTED|Treated 2 Cycles/Reached First Response||6
8523566|NCT00369590|21009611|P2|NOT COMPLETED|Overall Study||0
8523567|NCT00369590|21009612|P1|NOT COMPLETED|Overall Study||0
8523568|NCT00369590|21009611|P2|COMPLETED|Overall Study||42
8523569|NCT00369590|21009612|P1|COMPLETED|Overall Study||16
8523570|NCT00369590|21009611|P2|STARTED|Overall Study||42
8523571|NCT00369590|21009612|P1|STARTED|Overall Study||16
8523572|NCT00369577|21009630|P3|NOT COMPLETED|Overall Study||1
8523573|NCT00369577|21009631|P2|NOT COMPLETED|Overall Study||0
8523574|NCT00369577|21009632|P1|NOT COMPLETED|Overall Study||0
8523575|NCT00369577|21009630|P3|COMPLETED|Overall Study||40
8523576|NCT00369577|21009631|P2|COMPLETED|Overall Study||45
8523577|NCT00369577|21009632|P1|COMPLETED|Overall Study||43
8523578|NCT00369577|21009630|P3|STARTED|Overall Study||41
8523579|NCT00369577|21009631|P2|STARTED|Overall Study||45
8523580|NCT00369577|21009632|P1|STARTED|Overall Study||43
8523587|NCT00369512|21009658|P1|NOT COMPLETED|Overall Study||0
8523588|NCT00369512|21009658|P1|COMPLETED|Overall Study||15
8523589|NCT00369512|21009658|P1|STARTED|Overall Study||15
8523590|NCT00369486|21009669|P5|NOT COMPLETED|34-Week Visit||3
8523591|NCT00369486|21009670|P4|NOT COMPLETED|34-Week Visit||3
8523592|NCT00369486|21009671|P3|NOT COMPLETED|34-Week Visit||1
8523593|NCT00369486|21009672|P2|NOT COMPLETED|34-Week Visit||1
8523594|NCT00369486|21009673|P1|NOT COMPLETED|34-Week Visit||0
8523595|NCT00369486|21009669|P5|COMPLETED|34-Week Visit|Number of eyes|22
8523596|NCT00369486|21009670|P4|COMPLETED|34-Week Visit|Number of eyes|19
8523597|NCT00369486|21009671|P3|COMPLETED|34-Week Visit|Number of eyes|22
8523598|NCT00369486|21009672|P2|COMPLETED|34-Week Visit|Number of eyes|20
8523599|NCT00369486|21009673|P1|COMPLETED|34-Week Visit|Number of eyes|38
8523600|NCT00369486|21009669|P5|STARTED|34-Week Visit|Number of eyes that|25
8523601|NCT00369486|21009670|P4|STARTED|34-Week Visit|Number of eyes|22
8523602|NCT00369486|21009671|P3|STARTED|34-Week Visit|Number of eyes|23
8523603|NCT00369486|21009672|P2|STARTED|34-Week Visit|Number of eyes|21
8523604|NCT00369486|21009673|P1|STARTED|34-Week Visit|Number of eyes|38
8523605|NCT00369486|21009669|P5|NOT COMPLETED|17-Week Visit||1
8523606|NCT00369486|21009670|P4|NOT COMPLETED|17-Week Visit||1
8523607|NCT00369486|21009671|P3|NOT COMPLETED|17-Week Visit||1
8523608|NCT00369486|21009672|P2|NOT COMPLETED|17-Week Visit||0
8523609|NCT00369486|21009673|P1|NOT COMPLETED|17-Week Visit||0
8523610|NCT00369486|21009669|P5|COMPLETED|17-Week Visit|Number of eyes|24
8523611|NCT00369486|21009670|P4|COMPLETED|17-Week Visit|Number of eyes|21
8523612|NCT00369486|21009671|P3|COMPLETED|17-Week Visit|Number of eyes|22
8523613|NCT00369486|21009672|P2|COMPLETED|17-Week Visit|Number of eyes|21
8523614|NCT00369486|21009673|P1|COMPLETED|17-Week Visit|Number of eyes|38
8523615|NCT00369486|21009669|P5|STARTED|17-Week Visit|Number of eyes|25
8523616|NCT00369486|21009670|P4|STARTED|17-Week Visit|Number of eyes|22
8523617|NCT00369486|21009671|P3|STARTED|17-Week Visit|Number of eyes|23
8523618|NCT00369486|21009672|P2|STARTED|17-Week Visit|Number of eyes|21
8523619|NCT00369486|21009673|P1|STARTED|17-Week Visit|Number of eyes|38
8523620|NCT00369486|21009669|P5|NOT COMPLETED|8-Week Visit||1
8523621|NCT00369486|21009670|P4|NOT COMPLETED|8-Week Visit||1
8523622|NCT00369486|21009671|P3|NOT COMPLETED|8-Week Visit||0
8523623|NCT00369486|21009672|P2|NOT COMPLETED|8-Week Visit||1
8523624|NCT00369486|21009673|P1|NOT COMPLETED|8-Week Visit||0
8523625|NCT00369486|21009669|P5|COMPLETED|8-Week Visit|Number of eyes|24
8523626|NCT00369486|21009670|P4|COMPLETED|8-Week Visit|Number of eyes|21
8523627|NCT00369486|21009671|P3|COMPLETED|8-Week Visit|Number of eyes|22
8523628|NCT00369486|21009672|P2|COMPLETED|8-Week Visit|Number of eyes|20
8523629|NCT00369486|21009673|P1|COMPLETED|8-Week Visit|Number of eyes|38
8523630|NCT00369486|21009669|P5|STARTED|8-Week Visit|Number of eyes|25
8523631|NCT00369486|21009670|P4|STARTED|8-Week Visit|Number of eyes|22
8523632|NCT00369486|21009671|P3|STARTED|8-Week Visit|Number of eyes|22
8523633|NCT00369486|21009672|P2|STARTED|8-Week Visit|Number of eyes|21
8523634|NCT00369486|21009673|P1|STARTED|8-Week Visit|Number of eyes|38
8523635|NCT00369486|21009669|P5|NOT COMPLETED|4-Week Visit||1
8523636|NCT00369486|21009670|P4|NOT COMPLETED|4-Week Visit||2
8523637|NCT00369486|21009671|P3|NOT COMPLETED|4-Week Visit||1
8523638|NCT00369486|21009672|P2|NOT COMPLETED|4-Week Visit||2
8523639|NCT00369486|21009673|P1|NOT COMPLETED|4-Week Visit||2
8523640|NCT00369486|21009669|P5|COMPLETED|4-Week Visit|Number of eyes|24
8523641|NCT00369486|21009670|P4|COMPLETED|4-Week Visit|Number of eyes|20
8523642|NCT00369486|21009671|P3|COMPLETED|4-Week Visit|Number of eyes|22
8523643|NCT00369486|21009672|P2|COMPLETED|4-Week Visit|Number of eyes;|19
8523644|NCT00369486|21009673|P1|COMPLETED|4-Week Visit|Number of eyes|36
8523645|NCT00369486|21009669|P5|STARTED|4-Week Visit|Number of eyes|25
8523646|NCT00369486|21009670|P4|STARTED|4-Week Visit|Number of eyes|22
8523647|NCT00369486|21009671|P3|STARTED|4-Week Visit|Number of eyes|23
8523648|NCT00369486|21009672|P2|STARTED|4-Week Visit|Number of eyes|21
8523649|NCT00369486|21009673|P1|STARTED|4-Week Visit|Number of eyes|38
8523650|NCT00369382|21009712|P2|NOT COMPLETED|Overall Study||3
8523651|NCT00369382|21009713|P1|NOT COMPLETED|Overall Study||10
8523652|NCT00369382|21009712|P2|COMPLETED|Overall Study||54
8523653|NCT00369382|21009713|P1|COMPLETED|Overall Study||49
8523654|NCT00369382|21009712|P2|Completed Assigned Treatment Regimen|Overall Study||33
8523655|NCT00369382|21009713|P1|Completed Assigned Treatment Regimen|Overall Study||48
8523656|NCT00369382|21009712|P2|Received Treatment|Overall Study||57
8523657|NCT00369382|21009713|P1|Received Treatment|Overall Study||57
8523658|NCT00369382|21009712|P2|STARTED|Overall Study||57
8523659|NCT00369382|21009713|P1|STARTED|Overall Study||59
8523660|NCT00369343|21009746|P2|NOT COMPLETED|Open-label Phase||30
8523661|NCT00369343|21009747|P1|NOT COMPLETED|Open-label Phase||57
8523662|NCT00369343|21009746|P2|COMPLETED|Open-label Phase||79
8523663|NCT00369343|21009747|P1|COMPLETED|Open-label Phase||155
8523664|NCT00369343|21009746|P2|STARTED|Open-label Phase||109
8523665|NCT00369343|21009747|P1|STARTED|Open-label Phase||212
8523666|NCT00369343|21009746|P2|NOT COMPLETED|Double-blind Phase||16
8523667|NCT00369343|21009747|P1|NOT COMPLETED|Double-blind Phase||44
8523668|NCT00369343|21009746|P2|COMPLETED|Double-blind Phase||109
8523669|NCT00369343|21009747|P1|COMPLETED|Double-blind Phase||212
8523670|NCT00369343|21009746|P2|STARTED|Double-blind Phase||125
8523671|NCT00369343|21009747|P1|STARTED|Double-blind Phase||256
8523672|NCT00369317|21009780|P1|NOT COMPLETED|Overall Study||20
8523673|NCT00369317|21009780|P1|COMPLETED|Overall Study||185
8523674|NCT00369317|21009780|P1|STARTED|Overall Study||205
8523675|NCT00369278|21009796|P2|NOT COMPLETED|Overall Study||21
8523676|NCT00369278|21009797|P1|NOT COMPLETED|Overall Study||24
8523677|NCT00369278|21009796|P2|COMPLETED|Overall Study||44
8523678|NCT00369278|21009797|P1|COMPLETED|Overall Study||39
8523679|NCT00369278|21009796|P2|STARTED|Overall Study||65
8523680|NCT00369278|21009797|P1|STARTED|Overall Study||63
8523681|NCT00369265|21009813|P2|NOT COMPLETED|Overall Study||7
8523682|NCT00369265|21009814|P1|NOT COMPLETED|Overall Study||4
8523683|NCT00369265|21009813|P2|COMPLETED|Overall Study||0
8523684|NCT00369265|21009814|P1|COMPLETED|Overall Study||0
8523685|NCT00369265|21009813|P2|STARTED|Overall Study||7
8523686|NCT00369265|21009814|P1|STARTED|Overall Study||4
8523687|NCT00369226|21009822|P2|NOT COMPLETED|Phase II (45 Days)||0
8523688|NCT00369226|21009823|P1|NOT COMPLETED|Phase II (45 Days)||0
8523689|NCT00369226|21009822|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
8523690|NCT00369226|21009823|P1|COMPLETED|Phase II (45 Days)||0
8523691|NCT00369226|21009822|P2|STARTED|Phase II (45 Days)||32
8523692|NCT00369226|21009823|P1|STARTED|Phase II (45 Days)||0
8523693|NCT00369226|21009822|P2|NOT COMPLETED|Phase I (45 Days)||0
8523694|NCT00369226|21009823|P1|NOT COMPLETED|Phase I (45 Days)||0
8523695|NCT00369226|21009822|P2|COMPLETED|Phase I (45 Days)||0
8523696|NCT00369226|21009823|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
8523697|NCT00369226|21009822|P2|STARTED|Phase I (45 Days)||0
8523698|NCT00369226|21009823|P1|STARTED|Phase I (45 Days)||13
8523699|NCT00369161|21009835|P2|NOT COMPLETED|Overall Study||24
8523700|NCT00369161|21009836|P1|NOT COMPLETED|Overall Study||27
8523701|NCT00369161|21009835|P2|COMPLETED|Overall Study||95
8523702|NCT00369161|21009836|P1|COMPLETED|Overall Study||82
8523703|NCT00369161|21009835|P2|Intention to Treat (ITT)|Overall Study||117
8523704|NCT00369161|21009836|P1|Intention to Treat (ITT)|Overall Study||107
8523705|NCT00369161|21009835|P2|STARTED|Overall Study||119
8523706|NCT00369161|21009836|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
8523707|NCT00369122|21009846|P1|NOT COMPLETED|Overall Study||11
8523708|NCT00369122|21009846|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
8523709|NCT00369122|21009846|P1|STARTED|Overall Study||60
8523710|NCT00368992|21009853|P1|NOT COMPLETED|Overall Study||110
8523711|NCT00368992|21009853|P1|COMPLETED|Overall Study||0
8523712|NCT00368992|21009853|P1|STARTED|Overall Study||110
8523713|NCT00368979|21009862|P2|NOT COMPLETED|Overall Study||30
8523714|NCT00368979|21009863|P1|NOT COMPLETED|Overall Study||25
8523715|NCT00368979|21009862|P2|COMPLETED|Overall Study||163
8523716|NCT00368979|21009863|P1|COMPLETED|Overall Study||160
8523717|NCT00368979|21009862|P2|STARTED|Overall Study||193
8523718|NCT00368979|21009863|P1|STARTED|Overall Study||185
8523719|NCT00368966|21009879|P2|NOT COMPLETED|Toddler Dose||3
8523720|NCT00368966|21009880|P1|NOT COMPLETED|Toddler Dose||1
8523721|NCT00368966|21009879|P2|COMPLETED|Toddler Dose||286
8523722|NCT00368966|21009880|P1|COMPLETED|Toddler Dose||292
8523723|NCT00368966|21009879|P2|STARTED|Toddler Dose||289
8523724|NCT00368966|21009880|P1|STARTED|Toddler Dose||293
8523725|NCT00368966|21009879|P2|NOT COMPLETED|After Infant||5
8523726|NCT00368966|21009880|P1|NOT COMPLETED|After Infant||6
8523727|NCT00368966|21009879|P2|COMPLETED|After Infant||289
8523728|NCT00368966|21009880|P1|COMPLETED|After Infant||293
8523729|NCT00368966|21009879|P2|STARTED|After Infant||294
8523730|NCT00368966|21009880|P1|STARTED|After Infant||299
8523731|NCT00368966|21009879|P2|NOT COMPLETED|Infant Series||10
8523732|NCT00368966|21009880|P1|NOT COMPLETED|Infant Series||16
8523733|NCT00368966|21009879|P2|COMPLETED|Infant Series||294
8523734|NCT00368966|21009880|P1|COMPLETED|Infant Series||299
8523735|NCT00368966|21009879|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
8523736|NCT00368966|21009880|P1|Vaccinated Dose 3|Infant Series||301
8523737|NCT00368966|21009879|P2|Vaccinated Dose 2|Infant Series||298
8523738|NCT00368966|21009880|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
8523739|NCT00368966|21009879|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
8523740|NCT00368966|21009880|P1|Vaccinated Dose 1|Infant Series||314
8523741|NCT00368966|21009879|P2|STARTED|Infant Series||304
8523742|NCT00368966|21009880|P1|STARTED|Infant Series||315
8523743|NCT00368940|21009936|P2|NOT COMPLETED|Completed 12-wk Treatment||5
8523744|NCT00368940|21009937|P1|NOT COMPLETED|Completed 12-wk Treatment||6
8523745|NCT00368940|21009936|P2|COMPLETED|Completed 12-wk Treatment||32
8523746|NCT00368940|21009937|P1|COMPLETED|Completed 12-wk Treatment||31
8523747|NCT00368940|21009936|P2|STARTED|Completed 12-wk Treatment||37
8523748|NCT00368940|21009937|P1|STARTED|Completed 12-wk Treatment||37
8523749|NCT00368940|21009936|P2|NOT COMPLETED|Intention-to-Treat||0
8523750|NCT00368940|21009937|P1|NOT COMPLETED|Intention-to-Treat||0
8523751|NCT00368940|21009936|P2|COMPLETED|Intention-to-Treat||37
8523752|NCT00368940|21009937|P1|COMPLETED|Intention-to-Treat||37
8523753|NCT00368940|21009936|P2|STARTED|Intention-to-Treat||37
8523754|NCT00368940|21009937|P1|STARTED|Intention-to-Treat||37
8523755|NCT00368927|21009951|P2|NOT COMPLETED|Overall Study||3
8523756|NCT00368927|21009952|P1|NOT COMPLETED|Overall Study||5
8523757|NCT00368927|21009951|P2|COMPLETED|Overall Study||27
8523758|NCT00368927|21009952|P1|COMPLETED|Overall Study||26
8523759|NCT00368927|21009951|P2|STARTED|Overall Study||30
8523760|NCT00368927|21009952|P1|STARTED|Overall Study||31
8523761|NCT00368875|21009960|P2|NOT COMPLETED|Overall Study||48
8523762|NCT00368875|21009961|P1|NOT COMPLETED|Overall Study||6
8523763|NCT00368875|21009960|P2|COMPLETED|Overall Study||0
8523764|NCT00368875|21009961|P1|COMPLETED|Overall Study||0
8523765|NCT00368875|21009960|P2|STARTED|Overall Study||48
8523766|NCT00368875|21009961|P1|STARTED|Overall Study||6
8523767|NCT00368849|21009969|P2|NOT COMPLETED|Overall Study||2
8523768|NCT00368849|21009970|P1|NOT COMPLETED|Overall Study||0
8523769|NCT00368849|21009969|P2|COMPLETED|Overall Study||8
8523770|NCT00368849|21009970|P1|COMPLETED|Overall Study||10
8523771|NCT00368849|21009969|P2|STARTED|Overall Study||10
8523772|NCT00368849|21009970|P1|STARTED|Overall Study||10
8523785|NCT00368654|21010021|P4|NOT COMPLETED|Overall Study||3
8523786|NCT00368654|21010022|P3|NOT COMPLETED|Overall Study||3
8523787|NCT00368654|21010023|P2|NOT COMPLETED|Overall Study||3
8523788|NCT00368654|21010024|P1|NOT COMPLETED|Overall Study||3
8523789|NCT00368654|21010021|P4|COMPLETED|Overall Study||0
8523790|NCT00368654|21010022|P3|COMPLETED|Overall Study||0
8523791|NCT00368654|21010023|P2|COMPLETED|Overall Study||0
8523792|NCT00368654|21010024|P1|COMPLETED|Overall Study||0
8523793|NCT00368654|21010021|P4|STARTED|Overall Study||3
8523794|NCT00368654|21010022|P3|STARTED|Overall Study||3
8523795|NCT00368654|21010023|P2|STARTED|Overall Study||3
8523796|NCT00368654|21010024|P1|STARTED|Overall Study||3
8523797|NCT00368641|21010040|P2|NOT COMPLETED|Overall Study||6
8523798|NCT00368641|21010041|P1|NOT COMPLETED|Overall Study||6
8523799|NCT00368641|21010040|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
8523800|NCT00368641|21010041|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
8523801|NCT00368641|21010040|P2|STARTED|Overall Study||6
8523802|NCT00368641|21010041|P1|STARTED|Overall Study||6
8523803|NCT00368550|21010049|P2|NOT COMPLETED|Overall Study||23
8523804|NCT00368550|21010050|P1|NOT COMPLETED|Overall Study||28
8523805|NCT00368550|21010049|P2|COMPLETED|Overall Study||48
8523806|NCT00368550|21010050|P1|COMPLETED|Overall Study||35
8523807|NCT00368550|21010049|P2|STARTED|Overall Study||71
8523808|NCT00368550|21010050|P1|STARTED|Overall Study||63
8523809|NCT00368537|21010062|P2|NOT COMPLETED|Baseline Participants||24
8523810|NCT00368537|21010063|P1|NOT COMPLETED|Baseline Participants||24
8523811|NCT00368537|21010062|P2|COMPLETED|Baseline Participants||239
8523812|NCT00368537|21010063|P1|COMPLETED|Baseline Participants||244
8523813|NCT00368537|21010062|P2|STARTED|Baseline Participants||263
8523814|NCT00368537|21010063|P1|STARTED|Baseline Participants||268
8523815|NCT00368537|21010062|P2|NOT COMPLETED|Randomization||6
8523816|NCT00368537|21010063|P1|NOT COMPLETED|Randomization||13
8523817|NCT00368537|21010062|P2|COMPLETED|Randomization||263
8523818|NCT00368537|21010063|P1|COMPLETED|Randomization||268
8523819|NCT00368537|21010062|P2|STARTED|Randomization||269
8523820|NCT00368537|21010063|P1|STARTED|Randomization||281
8523821|NCT00368472|21010077|P1|NOT COMPLETED|Overall Study||105
8523822|NCT00368472|21010077|P1|COMPLETED|Overall Study||33
8523823|NCT00368472|21010077|P1|STARTED|Overall Study||138
8523824|NCT00368459|21010085|P2|NOT COMPLETED|Overall Study||1
8523825|NCT00368459|21010086|P1|NOT COMPLETED|Overall Study||2
8523826|NCT00368459|21010085|P2|COMPLETED|Overall Study||20
8523827|NCT00368459|21010086|P1|COMPLETED|Overall Study||19
8523828|NCT00368459|21010085|P2|STARTED|Overall Study||21
8523829|NCT00368459|21010086|P1|STARTED|Overall Study||21
8523830|NCT00368355|21010112|P2|NOT COMPLETED|Overall Study||17
8523831|NCT00368355|21010113|P1|NOT COMPLETED|Overall Study||11
8523832|NCT00368355|21010112|P2|COMPLETED|Overall Study||11
8523833|NCT00368355|21010113|P1|COMPLETED|Overall Study||7
8523834|NCT00368355|21010112|P2|STARTED|Overall Study||28
8523835|NCT00368355|21010113|P1|STARTED|Overall Study||18
8523836|NCT00368316|21010129|P2|NOT COMPLETED|Overall Study||46
8523837|NCT00368316|21010130|P1|NOT COMPLETED|Overall Study||42
8523838|NCT00368316|21010129|P2|COMPLETED|Overall Study||1319
8523839|NCT00368316|21010130|P1|COMPLETED|Overall Study||1392
8523840|NCT00368316|21010129|P2|STARTED|Overall Study||1365
8523841|NCT00368316|21010130|P1|STARTED|Overall Study||1434
8523842|NCT00368290|21010142|P2|NOT COMPLETED|Overall Study||10
8523843|NCT00368290|21010143|P1|NOT COMPLETED|Overall Study||13
8523844|NCT00368290|21010142|P2|COMPLETED|Overall Study||37
8523845|NCT00368290|21010143|P1|COMPLETED|Overall Study||34
8523846|NCT00368290|21010142|P2|STARTED|Overall Study||47
8523847|NCT00368290|21010143|P1|STARTED|Overall Study||47
8523848|NCT00368277|21010153|P2|NOT COMPLETED|Overall Study||108
8523849|NCT00368277|21010154|P1|NOT COMPLETED|Overall Study||113
8523850|NCT00368277|21010153|P2|COMPLETED|Overall Study||336
8523851|NCT00368277|21010154|P1|COMPLETED|Overall Study||344
8523852|NCT00368277|21010153|P2|STARTED|Overall Study||444
8523853|NCT00368277|21010154|P1|STARTED|Overall Study||457
8523854|NCT00368251|21010169|P3|NOT COMPLETED|Overall Study||1
8523855|NCT00368251|21010170|P2|NOT COMPLETED|Overall Study||0
8523856|NCT00368251|21010171|P1|NOT COMPLETED|Overall Study||1
8523857|NCT00368251|21010169|P3|COMPLETED|Overall Study||17
8523858|NCT00368251|21010170|P2|COMPLETED|Overall Study||20
8523859|NCT00368251|21010171|P1|COMPLETED|Overall Study||17
8523860|NCT00368251|21010169|P3|STARTED|Overall Study||18
8523861|NCT00368251|21010170|P2|STARTED|Overall Study||20
8523862|NCT00368251|21010171|P1|STARTED|Overall Study||18
8523863|NCT00368108|21010194|P3|NOT COMPLETED|Overall Study||68
8523864|NCT00368108|21010195|P2|NOT COMPLETED|Overall Study||53
8523865|NCT00368108|21010196|P1|NOT COMPLETED|Overall Study||64
8523866|NCT00368108|21010194|P3|COMPLETED|Overall Study||182
8523867|NCT00368108|21010195|P2|COMPLETED|Overall Study||198
8523868|NCT00368108|21010196|P1|COMPLETED|Overall Study||187
8523869|NCT00368108|21010194|P3|STARTED|Overall Study||250
8523870|NCT00368108|21010195|P2|STARTED|Overall Study||251
8523871|NCT00368108|21010196|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
8523872|NCT00368069|21010215|P2|NOT COMPLETED|Overall Study||7
8523873|NCT00368069|21010216|P1|NOT COMPLETED|Overall Study||8
8523874|NCT00368069|21010215|P2|COMPLETED|Overall Study||72
8523875|NCT00368069|21010216|P1|COMPLETED|Overall Study||71
8523876|NCT00368069|21010215|P2|STARTED|Overall Study||79
8523877|NCT00368069|21010216|P1|STARTED|Overall Study||79
8523878|NCT00367991|21010234|P2|NOT COMPLETED|Overall Study||2
8523879|NCT00367991|21010235|P1|NOT COMPLETED|Overall Study||2
8523880|NCT00367991|21010234|P2|COMPLETED|Overall Study||13
8523881|NCT00367991|21010235|P1|COMPLETED|Overall Study||27
8523882|NCT00367991|21010234|P2|STARTED|Overall Study||15
8523883|NCT00367991|21010235|P1|STARTED|Overall Study||29
8523884|NCT00367835|21010253|P2|NOT COMPLETED|Overall Study||31
8523885|NCT00367835|21010254|P1|NOT COMPLETED|Overall Study||29
8523886|NCT00367835|21010253|P2|COMPLETED|Overall Study||48
8523887|NCT00367835|21010254|P1|COMPLETED|Overall Study||109
8523888|NCT00367835|21010253|P2|STARTED|Overall Study||79
8523889|NCT00367835|21010254|P1|STARTED|Overall Study||138
8523890|NCT00367770|21010280|P1|NOT COMPLETED|Overall Study||2
8523891|NCT00367770|21010280|P1|COMPLETED|Overall Study||35
8523892|NCT00367770|21010280|P1|STARTED|Overall Study||37
8523893|NCT00367744|21010288|P2|NOT COMPLETED|Overall Study||5
8523894|NCT00367744|21010289|P1|NOT COMPLETED|Overall Study||4
8523895|NCT00367744|21010288|P2|COMPLETED|Overall Study||32
8523896|NCT00367744|21010289|P1|COMPLETED|Overall Study||30
8523897|NCT00367744|21010288|P2|STARTED|Overall Study||37
8523898|NCT00367744|21010289|P1|STARTED|Overall Study||34
8523899|NCT00367679|21010297|P1|NOT COMPLETED|Overall Study||0
8523900|NCT00367679|21010297|P1|COMPLETED|Overall Study||35
8523901|NCT00367679|21010297|P1|STARTED|Overall Study||35
8523902|NCT00367640|21010318|P4|NOT COMPLETED|Overall Study||10
8523903|NCT00367640|21010319|P3|NOT COMPLETED|Overall Study||19
8523904|NCT00367640|21010320|P2|NOT COMPLETED|Overall Study||22
8523905|NCT00367640|21010321|P1|NOT COMPLETED|Overall Study||18
8523906|NCT00367640|21010318|P4|COMPLETED|Overall Study||146
8523907|NCT00367640|21010319|P3|COMPLETED|Overall Study||141
8523908|NCT00367640|21010320|P2|COMPLETED|Overall Study||133
8523909|NCT00367640|21010321|P1|COMPLETED|Overall Study||139
8523910|NCT00367640|21010318|P4|STARTED|Overall Study||156
8523911|NCT00367640|21010319|P3|STARTED|Overall Study||160
8523912|NCT00367640|21010320|P2|STARTED|Overall Study||155
8523913|NCT00367640|21010321|P1|STARTED|Overall Study||157
8523914|NCT00367601|21010331|P1|NOT COMPLETED|Overall Study||0
8523915|NCT00367601|21010331|P1|COMPLETED|Overall Study||25
8523916|NCT00367601|21010331|P1|STARTED|Overall Study||25
8523917|NCT00367484|21010337|P1|NOT COMPLETED|Overall Study||17
8523918|NCT00367484|21010337|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
8523919|NCT00367484|21010337|P1|STARTED|Overall Study||460
8523920|NCT00367458|21010343|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
8523921|NCT00367458|21010344|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
8523922|NCT00367458|21010343|P2|COMPLETED|Second Intervention - 8 Weeks||12
8523923|NCT00367458|21010344|P1|COMPLETED|Second Intervention - 8 Weeks||10
8523924|NCT00367458|21010343|P2|STARTED|Second Intervention - 8 Weeks||12
8523925|NCT00367458|21010344|P1|STARTED|Second Intervention - 8 Weeks||10
8523926|NCT00367458|21010343|P2|NOT COMPLETED|Washout Period - 4-6 Weeks||0
8523927|NCT00367458|21010344|P1|NOT COMPLETED|Washout Period - 4-6 Weeks||0
8523928|NCT00367458|21010343|P2|COMPLETED|Washout Period - 4-6 Weeks||12
8523929|NCT00367458|21010344|P1|COMPLETED|Washout Period - 4-6 Weeks||10
8523930|NCT00367458|21010343|P2|STARTED|Washout Period - 4-6 Weeks||12
8523931|NCT00367458|21010344|P1|STARTED|Washout Period - 4-6 Weeks||10
8523932|NCT00367458|21010343|P2|NOT COMPLETED|First Intervention - 8 Weeks||0
8523933|NCT00367458|21010344|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
8523934|NCT00367458|21010343|P2|COMPLETED|First Intervention - 8 Weeks||12
8523935|NCT00367458|21010344|P1|COMPLETED|First Intervention - 8 Weeks||10
8523936|NCT00367458|21010343|P2|STARTED|First Intervention - 8 Weeks||12
8523937|NCT00367458|21010344|P1|STARTED|First Intervention - 8 Weeks||12
8523938|NCT00367432|21010358|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
8523939|NCT00367432|21010359|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
8523940|NCT00367432|21010358|P2|COMPLETED|Second Period (up to 54 Months)||69
8523941|NCT00367432|21010359|P1|COMPLETED|Second Period (up to 54 Months)||188
8523942|NCT00367432|21010358|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
8523943|NCT00367432|21010359|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
8523944|NCT00367432|21010358|P2|NOT COMPLETED|First Period (16 Weeks)||0
8523945|NCT00367432|21010359|P1|NOT COMPLETED|First Period (16 Weeks)||38
8523946|NCT00367432|21010358|P2|COMPLETED|First Period (16 Weeks)||0
8523947|NCT00367432|21010359|P1|COMPLETED|First Period (16 Weeks)||275
8523948|NCT00367432|21010358|P2|STARTED|First Period (16 Weeks)||0
8523949|NCT00367432|21010359|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
8523950|NCT00367380|21010374|P3|NOT COMPLETED|Overall Study||0
8523951|NCT00367380|21010375|P2|NOT COMPLETED|Overall Study||0
8523952|NCT00367380|21010376|P1|NOT COMPLETED|Overall Study||0
8523953|NCT00367380|21010374|P3|COMPLETED|Overall Study||6
8523954|NCT00367380|21010375|P2|COMPLETED|Overall Study||6
8523955|NCT00367380|21010376|P1|COMPLETED|Overall Study||6
8523956|NCT00367380|21010374|P3|STARTED|Overall Study||6
8523957|NCT00367380|21010375|P2|STARTED|Overall Study||6
8523958|NCT00367380|21010376|P1|STARTED|Overall Study||6
8523959|NCT00367341|21010386|P2|NOT COMPLETED|Overall Study||0
8523960|NCT00367341|21010387|P1|NOT COMPLETED|Overall Study||2
8523961|NCT00367341|21010386|P2|COMPLETED|Overall Study||40
8523962|NCT00367341|21010387|P1|COMPLETED|Overall Study||40
8523963|NCT00367341|21010386|P2|STARTED|Overall Study||40
8523964|NCT00367341|21010387|P1|STARTED|Overall Study||42
8523965|NCT00367237|21010397|P2|NOT COMPLETED|Overall Study||11
8523966|NCT00367237|21010398|P1|NOT COMPLETED|Overall Study||10
8523967|NCT00367237|21010397|P2|COMPLETED|Overall Study||47
8523968|NCT00367237|21010398|P1|COMPLETED|Overall Study||47
8523969|NCT00367237|21010397|P2|STARTED|Overall Study|Number of subjects randomized|58
8523970|NCT00367237|21010398|P1|STARTED|Overall Study|Number of subjects randomized|57
8523971|NCT00367133|21010407|P3|NOT COMPLETED|3 Years||18
8523972|NCT00367133|21010408|P2|NOT COMPLETED|3 Years||23
8523973|NCT00367133|21010409|P1|NOT COMPLETED|3 Years||28
8523974|NCT00367133|21010407|P3|COMPLETED|3 Years||98
8523975|NCT00367133|21010408|P2|COMPLETED|3 Years||93
8523976|NCT00367133|21010409|P1|COMPLETED|3 Years||115
8523977|NCT00367133|21010407|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
8523978|NCT00367133|21010408|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
8523979|NCT00367133|21010409|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
8523980|NCT00367133|21010407|P3|NOT COMPLETED|2 Years||49
8523981|NCT00367133|21010408|P2|NOT COMPLETED|2 Years||36
8523982|NCT00367133|21010409|P1|NOT COMPLETED|2 Years||58
8523983|NCT00367133|21010407|P3|COMPLETED|2 Years||205
8523984|NCT00367133|21010408|P2|COMPLETED|2 Years||220
8523985|NCT00367133|21010409|P1|COMPLETED|2 Years||272
8523986|NCT00367133|21010407|P3|STARTED|2 Years|Number of Eyes|254
8523987|NCT00367133|21010408|P2|STARTED|2 Years|Number of Eyes|256
8523988|NCT00367133|21010409|P1|STARTED|2 Years|Number of Eyes|330
8523989|NCT00367055|21010461|P2|NOT COMPLETED|Overall Study||11
8523990|NCT00367055|21010462|P1|NOT COMPLETED|Overall Study||11
8523991|NCT00367055|21010461|P2|COMPLETED|Overall Study||30
8523992|NCT00367055|21010462|P1|COMPLETED|Overall Study||32
8523993|NCT00367055|21010461|P2|STARTED|Overall Study||41
8523994|NCT00367055|21010462|P1|STARTED|Overall Study||43
8523995|NCT00367003|21010476|P1|NOT COMPLETED|Overall Study||9
8523996|NCT00367003|21010476|P1|COMPLETED|Overall Study||28
8523997|NCT00367003|21010476|P1|STARTED|Overall Study||37
8523998|NCT00366899|21010482|P2|NOT COMPLETED|Toddler Dose||1
8523999|NCT00366899|21010483|P1|NOT COMPLETED|Toddler Dose||2
8524000|NCT00366899|21010482|P2|COMPLETED|Toddler Dose||281
8524001|NCT00366899|21010483|P1|COMPLETED|Toddler Dose||285
8524002|NCT00366899|21010482|P2|STARTED|Toddler Dose||282
8524003|NCT00366899|21010483|P1|STARTED|Toddler Dose||287
8524004|NCT00366899|21010482|P2|NOT COMPLETED|After Infant Series||9
8524005|NCT00366899|21010483|P1|NOT COMPLETED|After Infant Series||7
8524006|NCT00366899|21010482|P2|COMPLETED|After Infant Series||282
8524007|NCT00366899|21010483|P1|COMPLETED|After Infant Series||287
8524008|NCT00366899|21010482|P2|STARTED|After Infant Series||291
8524009|NCT00366899|21010483|P1|STARTED|After Infant Series||294
8524010|NCT00366899|21010482|P2|NOT COMPLETED|Infant Series||12
8524011|NCT00366899|21010483|P1|NOT COMPLETED|Infant Series||9
8524012|NCT00366899|21010482|P2|COMPLETED|Infant Series||291
8524013|NCT00366899|21010483|P1|COMPLETED|Infant Series||294
8524014|NCT00366899|21010482|P2|Vaccinated Dose 2|Infant Series||293
8524015|NCT00366899|21010483|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
8524016|NCT00366899|21010482|P2|Vaccinated Dose 1|Infant Series||302
8524017|NCT00366899|21010483|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
8524018|NCT00366899|21010482|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
8524019|NCT00366899|21010483|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
8524020|NCT00366678|21010543|P3|NOT COMPLETED|Toddler Dose||0
8524021|NCT00366678|21010544|P2|NOT COMPLETED|Toddler Dose||1
8524022|NCT00366678|21010545|P1|NOT COMPLETED|Toddler Dose||5
8524023|NCT00366678|21010543|P3|COMPLETED|Toddler Dose||137
8524024|NCT00366678|21010544|P2|COMPLETED|Toddler Dose||151
8524025|NCT00366678|21010545|P1|COMPLETED|Toddler Dose||268
8524026|NCT00366678|21010543|P3|STARTED|Toddler Dose||137
8524027|NCT00366678|21010544|P2|STARTED|Toddler Dose||152
8524028|NCT00366678|21010545|P1|STARTED|Toddler Dose||273
8524029|NCT00366678|21010543|P3|NOT COMPLETED|After Infant||0
8524030|NCT00366678|21010544|P2|NOT COMPLETED|After Infant||10
8524031|NCT00366678|21010545|P1|NOT COMPLETED|After Infant||17
8524032|NCT00366678|21010543|P3|COMPLETED|After Infant||0
8524033|NCT00366678|21010544|P2|COMPLETED|After Infant||289
8524034|NCT00366678|21010545|P1|COMPLETED|After Infant||273
8524035|NCT00366678|21010543|P3|STARTED|After Infant||0
8524036|NCT00366678|21010544|P2|STARTED|After Infant||299
8524037|NCT00366678|21010545|P1|STARTED|After Infant||290
8524038|NCT00366678|21010543|P3|NOT COMPLETED|Infant Series||0
8524039|NCT00366678|21010544|P2|NOT COMPLETED|Infant Series||10
8524040|NCT00366678|21010545|P1|NOT COMPLETED|Infant Series||14
8524041|NCT00366678|21010543|P3|COMPLETED|Infant Series||0
8524042|NCT00366678|21010544|P2|COMPLETED|Infant Series||299
8524043|NCT00366678|21010545|P1|COMPLETED|Infant Series||290
8524044|NCT00366678|21010543|P3|Vaccinated Dose 3|Infant Series||0
8524045|NCT00366678|21010544|P2|Vaccinated Dose 3|Infant Series||302
8524046|NCT00366678|21010545|P1|Vaccinated Dose 3|Infant Series||291
8524047|NCT00366678|21010543|P3|Vaccinated Dose 2|Infant Series||0
8524048|NCT00366678|21010544|P2|Vaccinated Dose 2|Infant Series||304
8524049|NCT00366678|21010545|P1|Vaccinated Dose 2|Infant Series||295
8524050|NCT00366678|21010543|P3|Vaccinated Dose 1|Infant Series||0
8524051|NCT00366678|21010544|P2|Vaccinated Dose 1|Infant Series||309
8524052|NCT00366678|21010545|P1|Vaccinated Dose 1|Infant Series||302
8524053|NCT00366678|21010543|P3|STARTED|Infant Series||0
8524054|NCT00366678|21010544|P2|STARTED|Infant Series||309
8524055|NCT00366678|21010545|P1|STARTED|Infant Series||304
8524056|NCT00366626|21010612|P2|NOT COMPLETED|Overall Study||0
8524057|NCT00366626|21010613|P1|NOT COMPLETED|Overall Study||0
8524058|NCT00366626|21010612|P2|COMPLETED|Overall Study||45
8524059|NCT00366626|21010613|P1|COMPLETED|Overall Study||38
8524060|NCT00366626|21010612|P2|STARTED|Overall Study||45
8524061|NCT00366626|21010613|P1|STARTED|Overall Study||38
8524062|NCT00366548|21010627|P2|NOT COMPLETED|Toddler Dose||0
8524063|NCT00366548|21010628|P1|NOT COMPLETED|Toddler Dose||0
8524064|NCT00366548|21010627|P2|COMPLETED|Toddler Dose||244
8524065|NCT00366548|21010628|P1|COMPLETED|Toddler Dose||240
8524066|NCT00366548|21010627|P2|STARTED|Toddler Dose||244
8524067|NCT00366548|21010628|P1|STARTED|Toddler Dose||240
8524068|NCT00366548|21010627|P2|NOT COMPLETED|After Infant Series||1
8524069|NCT00366548|21010628|P1|NOT COMPLETED|After Infant Series||6
8524070|NCT00366548|21010627|P2|COMPLETED|After Infant Series||244
8524071|NCT00366548|21010628|P1|COMPLETED|After Infant Series||240
8524072|NCT00366548|21010627|P2|STARTED|After Infant Series||245
8524073|NCT00366548|21010628|P1|STARTED|After Infant Series||246
8524074|NCT00366548|21010627|P2|NOT COMPLETED|Infant Series||5
8524075|NCT00366548|21010628|P1|NOT COMPLETED|Infant Series||4
8524076|NCT00366548|21010627|P2|COMPLETED|Infant Series||245
8524077|NCT00366548|21010628|P1|COMPLETED|Infant Series||246
8524078|NCT00366548|21010627|P2|Vaccinated Dose 3|Infant Series||247
8524079|NCT00366548|21010628|P1|Vaccinated Dose 3|Infant Series||246
8524080|NCT00366548|21010627|P2|Vaccinated Dose 2|Infant Series||249
8524081|NCT00366548|21010628|P1|Vaccinated Dose 2|Infant Series||246
8524082|NCT00366548|21010627|P2|Vaccinated Dose 1|Infant Series||250
8524083|NCT00366548|21010628|P1|Vaccinated Dose 1|Infant Series||250
8524084|NCT00366548|21010627|P2|STARTED|Infant Series||250
8524085|NCT00366548|21010628|P1|STARTED|Infant Series||250
8524086|NCT00366535|21010664|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
8524087|NCT00366535|21010665|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
8524088|NCT00366535|21010664|P2|COMPLETED|Second Phase: 12 Weeks||18
8524089|NCT00366535|21010665|P1|COMPLETED|Second Phase: 12 Weeks||21
8524090|NCT00366535|21010664|P2|STARTED|Second Phase: 12 Weeks||21
8524091|NCT00366535|21010665|P1|STARTED|Second Phase: 12 Weeks||24
8524092|NCT00366535|21010664|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
8524093|NCT00366535|21010665|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
8524094|NCT00366535|21010664|P2|COMPLETED|Washout Period (at Least a Week)||21
8524095|NCT00366535|21010665|P1|COMPLETED|Washout Period (at Least a Week)||24
8524096|NCT00366535|21010664|P2|STARTED|Washout Period (at Least a Week)||21
8524097|NCT00366535|21010665|P1|STARTED|Washout Period (at Least a Week)||24
8524098|NCT00366535|21010664|P2|NOT COMPLETED|First Phase: 12 Weeks||8
8524099|NCT00366535|21010665|P1|NOT COMPLETED|First Phase: 12 Weeks||3
8524100|NCT00366535|21010664|P2|COMPLETED|First Phase: 12 Weeks||21
8524101|NCT00366535|21010665|P1|COMPLETED|First Phase: 12 Weeks||24
8524102|NCT00366535|21010664|P2|STARTED|First Phase: 12 Weeks||29
8524103|NCT00366535|21010665|P1|STARTED|First Phase: 12 Weeks||27
8524104|NCT00366457|21010679|P1|NOT COMPLETED|Overall Study||2
8524105|NCT00366457|21010679|P1|COMPLETED|Overall Study||30
8524106|NCT00366457|21010679|P1|STARTED|Overall Study||32
8524107|NCT00366444|21010688|P2|NOT COMPLETED|Overall Study||2
8524108|NCT00366444|21010689|P1|NOT COMPLETED|Overall Study||1
8524109|NCT00366444|21010688|P2|COMPLETED|Overall Study||97
8524110|NCT00366444|21010689|P1|COMPLETED|Overall Study||101
8524111|NCT00366444|21010688|P2|STARTED|Overall Study||99
8524112|NCT00366444|21010689|P1|STARTED|Overall Study||102
8524113|NCT00366340|21010717|P2|NOT COMPLETED|Toddler Dose||1
8524114|NCT00366340|21010718|P1|NOT COMPLETED|Toddler Dose||1
8524115|NCT00366340|21010717|P2|COMPLETED|Toddler Dose||286
8524116|NCT00366340|21010718|P1|COMPLETED|Toddler Dose||289
8524117|NCT00366340|21010717|P2|STARTED|Toddler Dose||287
8524118|NCT00366340|21010718|P1|STARTED|Toddler Dose||290
8524119|NCT00366340|21010717|P2|NOT COMPLETED|After the Infant Series||6
8524120|NCT00366340|21010718|P1|NOT COMPLETED|After the Infant Series||3
8524121|NCT00366340|21010717|P2|COMPLETED|After the Infant Series||287
8524122|NCT00366340|21010718|P1|COMPLETED|After the Infant Series||290
8524123|NCT00366340|21010717|P2|STARTED|After the Infant Series||293
8524124|NCT00366340|21010718|P1|STARTED|After the Infant Series||293
8524125|NCT00366340|21010717|P2|NOT COMPLETED|Infant Series||10
8524126|NCT00366340|21010718|P1|NOT COMPLETED|Infant Series||8
8524127|NCT00366340|21010717|P2|COMPLETED|Infant Series||293
8524128|NCT00366340|21010718|P1|COMPLETED|Infant Series||293
8524129|NCT00366340|21010717|P2|Vaccinated Dose 3|Infant Series||293
8524130|NCT00366340|21010718|P1|Vaccinated Dose 3|Infant Series||294
8524131|NCT00366340|21010717|P2|Vaccinated Dose 2|Infant Series||297
8524132|NCT00366340|21010718|P1|Vaccinated Dose 2|Infant Series||296
8524133|NCT00366340|21010717|P2|Vaccinated Dose 1|Infant Series||303
8524134|NCT00366340|21010718|P1|Vaccinated Dose 1|Infant Series||300
8524135|NCT00366340|21010717|P2|STARTED|Infant Series||303
8524136|NCT00366340|21010718|P1|STARTED|Infant Series||301
8524137|NCT00366301|21010776|P4|NOT COMPLETED|Overall Study||8
8524138|NCT00366301|21010777|P3|NOT COMPLETED|Overall Study||4
8524139|NCT00366301|21010778|P2|NOT COMPLETED|Overall Study||6
8524140|NCT00366301|21010779|P1|NOT COMPLETED|Overall Study||8
8524141|NCT00366301|21010776|P4|COMPLETED|Overall Study||116
8524142|NCT00366301|21010777|P3|COMPLETED|Overall Study||122
8524143|NCT00366301|21010778|P2|COMPLETED|Overall Study||120
8524144|NCT00366301|21010779|P1|COMPLETED|Overall Study||116
8524145|NCT00366301|21010776|P4|Either 6W or 14W CRP Obtained|Overall Study||119
8524146|NCT00366301|21010777|P3|Either 6W or 14W CRP Obtained|Overall Study||124
8524147|NCT00366301|21010778|P2|Either 6W or 14W CRP Obtained|Overall Study||124
8524148|NCT00366301|21010779|P1|Either 6W or 14W CRP Obtained|Overall Study||120
8524149|NCT00366301|21010776|P4|STARTED|Overall Study||124
8524150|NCT00366301|21010777|P3|STARTED|Overall Study||126
8524151|NCT00366301|21010778|P2|STARTED|Overall Study||126
8524152|NCT00366301|21010779|P1|STARTED|Overall Study||124
8524153|NCT00366275|21010789|P1|NOT COMPLETED|Overall Study||6
8524154|NCT00366275|21010789|P1|COMPLETED|Overall Study||58
8524155|NCT00366275|21010789|P1|STARTED|Overall Study||64
8524156|NCT00366249|21010795|P2|NOT COMPLETED|Overall Study||78
8524157|NCT00366249|21010796|P1|NOT COMPLETED|Overall Study||131
8524158|NCT00366249|21010795|P2|COMPLETED|Overall Study||430
8524159|NCT00366249|21010796|P1|COMPLETED|Overall Study||422
8524160|NCT00366249|21010795|P2|STARTED|Overall Study||508
8524161|NCT00366249|21010796|P1|STARTED|Overall Study||553
8524162|NCT00366106|21010810|P1|NOT COMPLETED|Overall Study||0
8524163|NCT00366106|21010810|P1|COMPLETED|Overall Study||32
8524164|NCT00366106|21010810|P1|STARTED|Overall Study||32
8524165|NCT00366028|21010819|P2|NOT COMPLETED|Overall Study||0
8524166|NCT00366028|21010820|P1|NOT COMPLETED|Overall Study||0
8524167|NCT00366028|21010819|P2|COMPLETED|Overall Study||735
8524168|NCT00366028|21010820|P1|COMPLETED|Overall Study||889
8524169|NCT00366028|21010819|P2|STARTED|Overall Study||735
8524170|NCT00366028|21010820|P1|STARTED|Overall Study||889
8524171|NCT00365989|21010828|P1|NOT COMPLETED|Overall Study||2
8524172|NCT00365989|21010828|P1|COMPLETED|Overall Study||48
8524173|NCT00365989|21010828|P1|STARTED|Overall Study||50
8524174|NCT00365976|21010836|P2|NOT COMPLETED|Overall Study||5
8524175|NCT00365976|21010837|P1|NOT COMPLETED|Overall Study||1
8524176|NCT00365976|21010836|P2|COMPLETED|Overall Study||20
8524177|NCT00365976|21010837|P1|COMPLETED|Overall Study||32
8524178|NCT00365976|21010836|P2|STARTED|Overall Study||25
8524179|NCT00365976|21010837|P1|STARTED|Overall Study||33
8524180|NCT00365872|21010868|P3|NOT COMPLETED|Overall Study||0
8524181|NCT00365872|21010869|P2|NOT COMPLETED|Overall Study||0
8524182|NCT00365872|21010870|P1|NOT COMPLETED|Overall Study||0
8524183|NCT00365872|21010868|P3|COMPLETED|Overall Study||6
8524184|NCT00365872|21010869|P2|COMPLETED|Overall Study||6
8524185|NCT00365872|21010870|P1|COMPLETED|Overall Study||5
8524186|NCT00365872|21010868|P3|STARTED|Overall Study||6
8524187|NCT00365872|21010869|P2|STARTED|Overall Study||6
8524188|NCT00365872|21010870|P1|STARTED|Overall Study||5
8524189|NCT00365859|21010883|P4|NOT COMPLETED|Overall Study||131
8524190|NCT00365859|21010884|P3|NOT COMPLETED|Overall Study||67
8524191|NCT00365859|21010885|P2|NOT COMPLETED|Overall Study||33
8524192|NCT00365859|21010886|P1|NOT COMPLETED|Overall Study||31
8524193|NCT00365859|21010883|P4|COMPLETED|Overall Study||199
8524194|NCT00365859|21010884|P3|COMPLETED|Overall Study||107
8524195|NCT00365859|21010885|P2|COMPLETED|Overall Study||37
8524196|NCT00365859|21010886|P1|COMPLETED|Overall Study||55
8524197|NCT00365859|21010883|P4|Efficacy Population|Overall Study||322
8524198|NCT00365859|21010884|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
8524199|NCT00365859|21010885|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
8524200|NCT00365859|21010886|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
8524201|NCT00365859|21010883|P4|Safety Population|Overall Study||330
8524202|NCT00365859|21010884|P3|Safety Population|Overall Study||174
8524203|NCT00365859|21010885|P2|Safety Population|Overall Study||70
8524204|NCT00365859|21010886|P1|Safety Population|Overall Study||86
8524205|NCT00365859|21010883|P4|STARTED|Overall Study||330
8524206|NCT00365859|21010884|P3|STARTED|Overall Study||174
8524207|NCT00365859|21010885|P2|STARTED|Overall Study||70
8524208|NCT00365859|21010886|P1|STARTED|Overall Study||86
8524209|NCT00365846|21010975|P1|NOT COMPLETED|Overall Study||1
8524210|NCT00365846|21010975|P1|COMPLETED|Overall Study||28
8524211|NCT00365846|21010975|P1|STARTED|Overall Study||29
8524212|NCT00365794|21010984|P1|NOT COMPLETED|Overall Study||2
8524213|NCT00365794|21010984|P1|COMPLETED|Overall Study||20
8524214|NCT00365794|21010984|P1|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
8524215|NCT00365768|21010999|P2|NOT COMPLETED|Overall Study||0
8524216|NCT00365768|21011000|P1|NOT COMPLETED|Overall Study||0
8524217|NCT00365768|21010999|P2|COMPLETED|Overall Study||25
8524218|NCT00365768|21011000|P1|COMPLETED|Overall Study||24
8524219|NCT00365768|21010999|P2|STARTED|Overall Study||25
8524220|NCT00365768|21011000|P1|STARTED|Overall Study||24
8524221|NCT00365716|21011013|P7|NOT COMPLETED|Extension 2||10
8524222|NCT00365716|21011014|P6|NOT COMPLETED|Extension 2||0
8524223|NCT00365716|21011015|P5|NOT COMPLETED|Extension 2||0
8524224|NCT00365716|21011016|P4|NOT COMPLETED|Extension 2||0
8524225|NCT00365716|21011017|P3|NOT COMPLETED|Extension 2||0
8524226|NCT00365716|21011018|P2|NOT COMPLETED|Extension 2||0
8524227|NCT00365716|21011019|P1|NOT COMPLETED|Extension 2||0
8524228|NCT00365716|21011013|P7|COMPLETED|Extension 2||7
8524229|NCT00365716|21011014|P6|COMPLETED|Extension 2||0
8524230|NCT00365716|21011015|P5|COMPLETED|Extension 2||0
8524231|NCT00365716|21011016|P4|COMPLETED|Extension 2||0
8524232|NCT00365716|21011017|P3|COMPLETED|Extension 2||0
8524233|NCT00365716|21011018|P2|COMPLETED|Extension 2||0
8524234|NCT00365716|21011019|P1|COMPLETED|Extension 2||0
8524235|NCT00365716|21011013|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
8524236|NCT00365716|21011014|P6|STARTED|Extension 2||0
8524237|NCT00365716|21011015|P5|STARTED|Extension 2||0
8524238|NCT00365716|21011016|P4|STARTED|Extension 2||0
8524239|NCT00365716|21011017|P3|STARTED|Extension 2||0
8524240|NCT00365716|21011018|P2|STARTED|Extension 2||0
8524241|NCT00365716|21011019|P1|STARTED|Extension 2||0
8524242|NCT00365716|21011013|P7|NOT COMPLETED|Extension 1||0
8524243|NCT00365716|21011014|P6|NOT COMPLETED|Extension 1||22
8524244|NCT00365716|21011015|P5|NOT COMPLETED|Extension 1||0
8524245|NCT00365716|21011016|P4|NOT COMPLETED|Extension 1||0
8524246|NCT00365716|21011017|P3|NOT COMPLETED|Extension 1||0
8524247|NCT00365716|21011018|P2|NOT COMPLETED|Extension 1||0
8524248|NCT00365716|21011019|P1|NOT COMPLETED|Extension 1||0
8524249|NCT00365716|21011013|P7|COMPLETED|Extension 1||0
8524250|NCT00365716|21011014|P6|COMPLETED|Extension 1||219
8524251|NCT00365716|21011015|P5|COMPLETED|Extension 1||0
8524252|NCT00365716|21011016|P4|COMPLETED|Extension 1||0
8524253|NCT00365716|21011017|P3|COMPLETED|Extension 1||0
8524254|NCT00365716|21011018|P2|COMPLETED|Extension 1||0
8524255|NCT00365716|21011019|P1|COMPLETED|Extension 1||0
8524256|NCT00365716|21011013|P7|STARTED|Extension 1||0
8524257|NCT00365716|21011014|P6|STARTED|Extension 1||241
8524258|NCT00365716|21011015|P5|STARTED|Extension 1||0
8524259|NCT00365716|21011016|P4|STARTED|Extension 1||0
8524260|NCT00365716|21011017|P3|STARTED|Extension 1||0
8524261|NCT00365716|21011018|P2|STARTED|Extension 1||0
8524262|NCT00365716|21011019|P1|STARTED|Extension 1||0
8524263|NCT00365716|21011013|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524264|NCT00365716|21011014|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524265|NCT00365716|21011015|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
8524266|NCT00365716|21011016|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
8524267|NCT00365716|21011017|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
8524268|NCT00365716|21011018|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
8524269|NCT00365716|21011019|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
8524270|NCT00365716|21011013|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524271|NCT00365716|21011014|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524272|NCT00365716|21011015|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
8524273|NCT00365716|21011016|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
8524274|NCT00365716|21011017|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
8524275|NCT00365716|21011018|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
8524276|NCT00365716|21011019|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
8524277|NCT00365716|21011013|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
8524278|NCT00365716|21011014|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
8524279|NCT00365716|21011015|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
8524280|NCT00365716|21011016|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
8524281|NCT00365716|21011017|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
8524282|NCT00365716|21011018|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
8524283|NCT00365716|21011019|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
8524284|NCT00365716|21011013|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
8524285|NCT00365716|21011014|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
8524286|NCT00365716|21011015|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
8524287|NCT00365716|21011016|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
8524288|NCT00365716|21011017|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
8524289|NCT00365716|21011018|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
8524290|NCT00365716|21011019|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
8524291|NCT00365716|21011013|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
8524292|NCT00365716|21011014|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
8524293|NCT00365716|21011015|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
8524294|NCT00365716|21011016|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
8524295|NCT00365716|21011017|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
8524296|NCT00365716|21011018|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
8524297|NCT00365716|21011019|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
8524298|NCT00365716|21011013|P7|STARTED|Base Study (Day 1 to Month 7)||0
8524299|NCT00365716|21011014|P6|STARTED|Base Study (Day 1 to Month 7)||0
8524300|NCT00365716|21011015|P5|STARTED|Base Study (Day 1 to Month 7)||146
8524301|NCT00365716|21011016|P4|STARTED|Base Study (Day 1 to Month 7)||146
8524302|NCT00365716|21011017|P3|STARTED|Base Study (Day 1 to Month 7)||292
8524303|NCT00365716|21011018|P2|STARTED|Base Study (Day 1 to Month 7)||284
8524304|NCT00365716|21011019|P1|STARTED|Base Study (Day 1 to Month 7)||290
8524305|NCT00365599|21011034|P1|NOT COMPLETED|Overall Study||0
8524306|NCT00365599|21011034|P1|COMPLETED|Overall Study||43
8524307|NCT00365599|21011034|P1|STARTED|Overall Study||43
8524308|NCT00365547|21011040|P1|NOT COMPLETED|Overall Study||3
8524309|NCT00365547|21011040|P1|COMPLETED|Overall Study||43
8524310|NCT00365547|21011040|P1|STARTED|Overall Study||46
8524311|NCT00365508|21011050|P2|NOT COMPLETED|Overall Study||154
8524312|NCT00365508|21011051|P1|NOT COMPLETED|Overall Study||139
8524313|NCT00365508|21011050|P2|COMPLETED|Overall Study||167
8524314|NCT00365508|21011051|P1|COMPLETED|Overall Study||182
8524315|NCT00365508|21011050|P2|STARTED|Overall Study||321
8524316|NCT00365508|21011051|P1|STARTED|Overall Study||321
8524317|NCT00365456|21011059|P2|NOT COMPLETED|Trial Period III (12 Months)||5
8524318|NCT00365456|21011060|P1|NOT COMPLETED|Trial Period III (12 Months)||18
8524319|NCT00365456|21011059|P2|COMPLETED|Trial Period III (12 Months)||127
8524320|NCT00365456|21011060|P1|COMPLETED|Trial Period III (12 Months)||118
8524321|NCT00365456|21011059|P2|STARTED|Trial Period III (12 Months)||132
8524322|NCT00365456|21011060|P1|STARTED|Trial Period III (12 Months)||136
8524323|NCT00365456|21011059|P2|NOT COMPLETED|Trial Period II (12 Months)||14
8524324|NCT00365456|21011060|P1|NOT COMPLETED|Trial Period II (12 Months)||0
8524325|NCT00365456|21011059|P2|COMPLETED|Trial Period II (12 Months)||268
8524326|NCT00365456|21011060|P1|COMPLETED|Trial Period II (12 Months)||0
8524327|NCT00365456|21011059|P2|STARTED|Trial Period II (12 Months)||282
8524328|NCT00365456|21011060|P1|STARTED|Trial Period II (12 Months)||0
8524329|NCT00365456|21011059|P2|NOT COMPLETED|Trial Period I (12 Months)||0
8524330|NCT00365456|21011060|P1|NOT COMPLETED|Trial Period I (12 Months)||125
8524331|NCT00365456|21011059|P2|COMPLETED|Trial Period I (12 Months)||0
8524332|NCT00365456|21011060|P1|COMPLETED|Trial Period I (12 Months)||282
8524333|NCT00365456|21011059|P2|STARTED|Trial Period I (12 Months)||0
8524334|NCT00365456|21011060|P1|STARTED|Trial Period I (12 Months)||407
8524335|NCT00365417|21011066|P1|NOT COMPLETED|Overall Study||0
8524336|NCT00365417|21011066|P1|COMPLETED|Overall Study||45
8524337|NCT00365417|21011066|P1|STARTED|Overall Study||45
8524338|NCT00365391|21011077|P1|NOT COMPLETED|Overall Study||0
8524339|NCT00365391|21011077|P1|COMPLETED|Overall Study||27
8524340|NCT00365391|21011077|P1|STARTED|Overall Study||27
8524341|NCT00365378|21011087|P3|NOT COMPLETED|Extension||197
8524342|NCT00365378|21011088|P2|NOT COMPLETED|Extension||0
8524343|NCT00365378|21011089|P1|NOT COMPLETED|Extension||0
8524344|NCT00365378|21011087|P3|COMPLETED|Extension||203
8524345|NCT00365378|21011088|P2|COMPLETED|Extension||0
8524346|NCT00365378|21011089|P1|COMPLETED|Extension||0
8524347|NCT00365378|21011087|P3|STARTED|Extension||400
8524348|NCT00365378|21011088|P2|STARTED|Extension||0
8524349|NCT00365378|21011089|P1|STARTED|Extension||0
8524350|NCT00365378|21011087|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
8524351|NCT00365378|21011088|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
8524352|NCT00365378|21011089|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
8524353|NCT00365378|21011087|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
8524354|NCT00365378|21011088|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
8524355|NCT00365378|21011089|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
8524356|NCT00365378|21011087|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
8524357|NCT00365378|21011088|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
8524358|NCT00365378|21011089|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
8524359|NCT00365378|21011087|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
8524360|NCT00365378|21011088|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
8524361|NCT00365378|21011089|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
8524362|NCT00365378|21011087|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
8524363|NCT00365378|21011088|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
8524364|NCT00365378|21011089|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
8524365|NCT00365378|21011087|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
8524366|NCT00365378|21011088|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
8524367|NCT00365378|21011089|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
8524368|NCT00365378|21011087|P3|STARTED|Vaccination (Day 1 to Month 7)||0
8524369|NCT00365378|21011088|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
8524370|NCT00365378|21011089|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
8524371|NCT00365365|21011103|P3|NOT COMPLETED|Overall Study||15
8524372|NCT00365365|21011104|P2|NOT COMPLETED|Overall Study||36
8524373|NCT00365365|21011105|P1|NOT COMPLETED|Overall Study||34
8524374|NCT00365365|21011103|P3|COMPLETED|Overall Study||44
8524375|NCT00365365|21011104|P2|COMPLETED|Overall Study||41
8524376|NCT00365365|21011105|P1|COMPLETED|Overall Study||44
8524377|NCT00365365|21011103|P3|COMPLETED TREATMENT|Overall Study||45
8524378|NCT00365365|21011104|P2|COMPLETED TREATMENT|Overall Study||36
8524379|NCT00365365|21011105|P1|COMPLETED TREATMENT|Overall Study||38
8524380|NCT00365365|21011103|P3|TREATED (SAFETY POPULATION)|Overall Study||59
8524381|NCT00365365|21011104|P2|TREATED (SAFETY POPULATION)|Overall Study||75
8524382|NCT00365365|21011105|P1|TREATED (SAFETY POPULATION)|Overall Study||78
8524383|NCT00365365|21011103|P3|STARTED|Overall Study||59
8524384|NCT00365365|21011104|P2|STARTED|Overall Study||77
8524385|NCT00365365|21011105|P1|STARTED|Overall Study||78
8524386|NCT00365352|21011122|P3|NOT COMPLETED|Overall Study||15
8524387|NCT00365352|21011123|P2|NOT COMPLETED|Overall Study||11
8524388|NCT00365352|21011124|P1|NOT COMPLETED|Overall Study||20
8524389|NCT00365352|21011122|P3|COMPLETED|Overall Study||98
8524390|NCT00365352|21011123|P2|COMPLETED|Overall Study||104
8524391|NCT00365352|21011124|P1|COMPLETED|Overall Study||77
8524392|NCT00365352|21011122|P3|Modified Intent-to-Treat Population|Overall Study||111
8524393|NCT00365352|21011123|P2|Modified Intent-to-Treat Population|Overall Study||114
8524394|NCT00365352|21011124|P1|Modified Intent-to-Treat Population|Overall Study||96
8524395|NCT00365352|21011122|P3|Safety Population|Overall Study||111
8524396|NCT00365352|21011123|P2|Safety Population|Overall Study||115
8524397|NCT00365352|21011124|P1|Safety Population|Overall Study||96
8524398|NCT00365352|21011122|P3|STARTED|Overall Study||113
8524399|NCT00365352|21011123|P2|STARTED|Overall Study||115
8524400|NCT00365352|21011124|P1|STARTED|Overall Study||97
8524401|NCT00365300|21011208|P2|NOT COMPLETED|Double-blind Phase||9
8524402|NCT00365300|21011209|P1|NOT COMPLETED|Double-blind Phase||11
8524403|NCT00365300|21011208|P2|COMPLETED|Double-blind Phase||45
8524404|NCT00365300|21011209|P1|COMPLETED|Double-blind Phase||43
8524405|NCT00365300|21011208|P2|STARTED|Double-blind Phase||54
8524406|NCT00365300|21011209|P1|STARTED|Double-blind Phase||54
8524407|NCT00365300|21011208|P2|NOT COMPLETED|Open-label Phase||0
8524408|NCT00365300|21011209|P1|NOT COMPLETED|Open-label Phase||22
8524409|NCT00365300|21011208|P2|COMPLETED|Open-label Phase||0
8524410|NCT00365300|21011209|P1|COMPLETED|Open-label Phase||107
8524411|NCT00365300|21011208|P2|STARTED|Open-label Phase||0
8524412|NCT00365300|21011209|P1|STARTED|Open-label Phase||129
8524413|NCT00365274|21011218|P1|NOT COMPLETED|Overall Study||0
8524414|NCT00365274|21011218|P1|COMPLETED|Overall Study||6
8524415|NCT00365274|21011218|P1|STARTED|Overall Study||6
8524416|NCT00365261|21011224|P2|NOT COMPLETED|Overall Study||3
8524417|NCT00365261|21011225|P1|NOT COMPLETED|Overall Study||3
8524418|NCT00365261|21011224|P2|COMPLETED|Overall Study||19
8524419|NCT00365261|21011225|P1|COMPLETED|Overall Study||20
8524420|NCT00365261|21011224|P2|STARTED|Overall Study||22
8524421|NCT00365261|21011225|P1|STARTED|Overall Study||23
8524422|NCT00365209|21011235|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
8524423|NCT00365209|21011235|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
8524424|NCT00365209|21011235|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
8524425|NCT00365209|21011235|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
8524426|NCT00365209|21011235|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
8524427|NCT00365209|21011235|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
8524428|NCT00365144|21011264|P1|NOT COMPLETED|Overall Study||0
8524429|NCT00365144|21011264|P1|COMPLETED|Overall Study||36
8524430|NCT00365144|21011264|P1|STARTED|Overall Study||36
8524431|NCT00365105|21011274|P2|NOT COMPLETED|Overall Study||8
8524432|NCT00365105|21011275|P1|NOT COMPLETED|Overall Study||5
8524433|NCT00365105|21011274|P2|COMPLETED|Overall Study||124
8524434|NCT00365105|21011275|P1|COMPLETED|Overall Study||124
8524435|NCT00365105|21011274|P2|Eligible With Adverse Event Data|Overall Study||124
8524436|NCT00365105|21011275|P1|Eligible With Adverse Event Data|Overall Study||123
8524437|NCT00365105|21011274|P2|Eligible|Overall Study||124
8524438|NCT00365105|21011275|P1|Eligible|Overall Study||124
8524439|NCT00365105|21011274|P2|STARTED|Overall Study||132
8524440|NCT00365105|21011275|P1|STARTED|Overall Study||129
8524441|NCT00365053|21011291|P1|NOT COMPLETED|Overall Study||0
8524442|NCT00365053|21011291|P1|COMPLETED|Overall Study||13
8524443|NCT00365053|21011291|P1|STARTED|Overall Study||13
8524444|NCT00364949|21011302|P2|NOT COMPLETED|Overall Study||0
8524445|NCT00364949|21011303|P1|NOT COMPLETED|Overall Study||0
8524446|NCT00364949|21011302|P2|COMPLETED|Overall Study||39
8524447|NCT00364949|21011303|P1|COMPLETED|Overall Study||31
8524448|NCT00364949|21011302|P2|STARTED|Overall Study||39
8524449|NCT00364949|21011303|P1|STARTED|Overall Study||31
8524450|NCT00364923|21011321|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
8524451|NCT00364923|21011321|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
8524452|NCT00364923|21011321|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
8524453|NCT00364923|21011321|P1|NOT COMPLETED|Treatment With Pralatrexate||4
8524454|NCT00364923|21011321|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
8524455|NCT00364923|21011321|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
8524456|NCT00364858|21011330|P2|NOT COMPLETED|Overall Study||22
8524457|NCT00364858|21011331|P1|NOT COMPLETED|Overall Study||7
8524458|NCT00364858|21011330|P2|COMPLETED|Overall Study||40
8524459|NCT00364858|21011331|P1|COMPLETED|Overall Study||26
8524460|NCT00364858|21011330|P2|STARTED|Overall Study||62
8524461|NCT00364858|21011331|P1|STARTED|Overall Study||33
8524462|NCT00364845|21011346|P2|NOT COMPLETED|Overall Study||11
8524463|NCT00364845|21011347|P1|NOT COMPLETED|Overall Study||11
8524464|NCT00364845|21011346|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
8524465|NCT00364845|21011347|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
8524466|NCT00364845|21011346|P2|STARTED|Overall Study||23
8524467|NCT00364845|21011347|P1|STARTED|Overall Study||28
8524468|NCT00364832|21011368|P12|NOT COMPLETED|Extension Year 2||3
8524469|NCT00364832|21011369|P11|NOT COMPLETED|Extension Year 2||5
8524470|NCT00364832|21011370|P10|NOT COMPLETED|Extension Year 2||5
8524471|NCT00364832|21011371|P9|NOT COMPLETED|Extension Year 2||0
8524472|NCT00364832|21011372|P8|NOT COMPLETED|Extension Year 2||0
8524473|NCT00364832|21011373|P7|NOT COMPLETED|Extension Year 2||0
8524474|NCT00364832|21011374|P6|NOT COMPLETED|Extension Year 2||0
8524475|NCT00364832|21011375|P5|NOT COMPLETED|Extension Year 2||0
8524476|NCT00364832|21011376|P4|NOT COMPLETED|Extension Year 2||0
8524477|NCT00364832|21011377|P3|NOT COMPLETED|Extension Year 2||0
8524478|NCT00364832|21011378|P2|NOT COMPLETED|Extension Year 2||0
8524479|NCT00364832|21011379|P1|NOT COMPLETED|Extension Year 2||0
8524480|NCT00364832|21011368|P12|COMPLETED|Extension Year 2||11
8524481|NCT00364832|21011369|P11|COMPLETED|Extension Year 2||9
8524482|NCT00364832|21011370|P10|COMPLETED|Extension Year 2||9
8524483|NCT00364832|21011371|P9|COMPLETED|Extension Year 2||0
8524484|NCT00364832|21011372|P8|COMPLETED|Extension Year 2||0
8524485|NCT00364832|21011373|P7|COMPLETED|Extension Year 2||0
8524486|NCT00364832|21011374|P6|COMPLETED|Extension Year 2||0
8524487|NCT00364832|21011375|P5|COMPLETED|Extension Year 2||0
8524488|NCT00364832|21011376|P4|COMPLETED|Extension Year 2||0
8524489|NCT00364832|21011377|P3|COMPLETED|Extension Year 2||0
8524490|NCT00364832|21011378|P2|COMPLETED|Extension Year 2||0
8524491|NCT00364832|21011379|P1|COMPLETED|Extension Year 2||0
8524492|NCT00364832|21011368|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8524493|NCT00364832|21011369|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8524494|NCT00364832|21011370|P10|STARTED|Extension Year 2||14
8524495|NCT00364832|21011371|P9|STARTED|Extension Year 2||0
8524496|NCT00364832|21011372|P8|STARTED|Extension Year 2||0
8524497|NCT00364832|21011373|P7|STARTED|Extension Year 2||0
8524498|NCT00364832|21011374|P6|STARTED|Extension Year 2||0
8524499|NCT00364832|21011375|P5|STARTED|Extension Year 2||0
8524500|NCT00364832|21011376|P4|STARTED|Extension Year 2||0
8524501|NCT00364832|21011377|P3|STARTED|Extension Year 2||0
8524502|NCT00364832|21011378|P2|STARTED|Extension Year 2||0
8524503|NCT00364832|21011379|P1|STARTED|Extension Year 2||0
8524504|NCT00364832|21011368|P12|NOT COMPLETED|Extension Year 1||10
8524505|NCT00364832|21011369|P11|NOT COMPLETED|Extension Year 1||2
8524506|NCT00364832|21011370|P10|NOT COMPLETED|Extension Year 1||4
8524507|NCT00364832|21011371|P9|NOT COMPLETED|Extension Year 1||0
8524508|NCT00364832|21011372|P8|NOT COMPLETED|Extension Year 1||0
8524509|NCT00364832|21011373|P7|NOT COMPLETED|Extension Year 1||0
8524510|NCT00364832|21011374|P6|NOT COMPLETED|Extension Year 1||0
8524511|NCT00364832|21011375|P5|NOT COMPLETED|Extension Year 1||0
8524512|NCT00364832|21011376|P4|NOT COMPLETED|Extension Year 1||0
8524513|NCT00364832|21011377|P3|NOT COMPLETED|Extension Year 1||0
8524514|NCT00364832|21011378|P2|NOT COMPLETED|Extension Year 1||0
8524515|NCT00364832|21011379|P1|NOT COMPLETED|Extension Year 1||0
8524516|NCT00364832|21011368|P12|COMPLETED|Extension Year 1||17
8524517|NCT00364832|21011369|P11|COMPLETED|Extension Year 1||15
8524518|NCT00364832|21011370|P10|COMPLETED|Extension Year 1||14
8524519|NCT00364832|21011371|P9|COMPLETED|Extension Year 1||0
8524520|NCT00364832|21011372|P8|COMPLETED|Extension Year 1||0
8524521|NCT00364832|21011373|P7|COMPLETED|Extension Year 1||0
8524522|NCT00364832|21011374|P6|COMPLETED|Extension Year 1||0
8524523|NCT00364832|21011375|P5|COMPLETED|Extension Year 1||0
8524524|NCT00364832|21011376|P4|COMPLETED|Extension Year 1||0
8524525|NCT00364832|21011377|P3|COMPLETED|Extension Year 1||0
8524526|NCT00364832|21011378|P2|COMPLETED|Extension Year 1||0
8524527|NCT00364832|21011379|P1|COMPLETED|Extension Year 1||0
8524528|NCT00364832|21011368|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
8524529|NCT00364832|21011369|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
8524530|NCT00364832|21011370|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
8524531|NCT00364832|21011371|P9|STARTED|Extension Year 1||0
8524532|NCT00364832|21011372|P8|STARTED|Extension Year 1||0
8524533|NCT00364832|21011373|P7|STARTED|Extension Year 1||0
8524534|NCT00364832|21011374|P6|STARTED|Extension Year 1||0
8524535|NCT00364832|21011375|P5|STARTED|Extension Year 1||0
8524536|NCT00364832|21011376|P4|STARTED|Extension Year 1||0
8524537|NCT00364832|21011377|P3|STARTED|Extension Year 1||0
8524538|NCT00364832|21011378|P2|STARTED|Extension Year 1||0
8524539|NCT00364832|21011379|P1|STARTED|Extension Year 1||0
8524540|NCT00364832|21011368|P12|NOT COMPLETED|Core Period||0
8524541|NCT00364832|21011369|P11|NOT COMPLETED|Core Period||0
8524542|NCT00364832|21011370|P10|NOT COMPLETED|Core Period||0
8524543|NCT00364832|21011371|P9|NOT COMPLETED|Core Period||0
8524544|NCT00364832|21011372|P8|NOT COMPLETED|Core Period||1
8524545|NCT00364832|21011373|P7|NOT COMPLETED|Core Period||4
8524546|NCT00364832|21011374|P6|NOT COMPLETED|Core Period||0
8524547|NCT00364832|21011375|P5|NOT COMPLETED|Core Period||0
8524548|NCT00364832|21011376|P4|NOT COMPLETED|Core Period||1
8524549|NCT00364832|21011377|P3|NOT COMPLETED|Core Period||1
8524550|NCT00364832|21011378|P2|NOT COMPLETED|Core Period||2
8524551|NCT00364832|21011379|P1|NOT COMPLETED|Core Period||2
8524552|NCT00364832|21011368|P12|COMPLETED|Core Period||0
8524553|NCT00364832|21011369|P11|COMPLETED|Core Period||0
8524554|NCT00364832|21011370|P10|COMPLETED|Core Period||0
8524555|NCT00364832|21011371|P9|COMPLETED|Core Period||16
8524556|NCT00364832|21011372|P8|COMPLETED|Core Period||14
8524557|NCT00364832|21011373|P7|COMPLETED|Core Period||12
8524558|NCT00364832|21011374|P6|COMPLETED|Core Period||12
8524559|NCT00364832|21011375|P5|COMPLETED|Core Period||16
8524560|NCT00364832|21011376|P4|COMPLETED|Core Period||15
8524561|NCT00364832|21011377|P3|COMPLETED|Core Period||14
8524562|NCT00364832|21011378|P2|COMPLETED|Core Period||13
8524563|NCT00364832|21011379|P1|COMPLETED|Core Period||14
8524564|NCT00364832|21011368|P12|STARTED|Core Period||0
8524565|NCT00364832|21011369|P11|STARTED|Core Period||0
8524566|NCT00364832|21011370|P10|STARTED|Core Period||0
8524567|NCT00364832|21011371|P9|STARTED|Core Period||16
8524568|NCT00364832|21011372|P8|STARTED|Core Period||15
8524569|NCT00364832|21011373|P7|STARTED|Core Period||16
8524570|NCT00364832|21011374|P6|STARTED|Core Period||12
8524571|NCT00364832|21011375|P5|STARTED|Core Period||16
8524572|NCT00364832|21011376|P4|STARTED|Core Period||16
8524573|NCT00364832|21011377|P3|STARTED|Core Period||15
8524574|NCT00364832|21011378|P2|STARTED|Core Period||15
8524575|NCT00364832|21011379|P1|STARTED|Core Period||16
8524576|NCT00364819|21011432|P1|NOT COMPLETED|Overall Study||0
8524577|NCT00364819|21011432|P1|COMPLETED|Overall Study||6
8524578|NCT00364819|21011432|P1|STARTED|Overall Study||6
8524579|NCT00364793|21011444|P4|NOT COMPLETED|Overall Study||3
8524580|NCT00364793|21011445|P3|NOT COMPLETED|Overall Study||4
8524581|NCT00364793|21011446|P2|NOT COMPLETED|Overall Study||5
8524582|NCT00364793|21011447|P1|NOT COMPLETED|Overall Study||8
8524583|NCT00364793|21011444|P4|COMPLETED|Overall Study||5
8524584|NCT00364793|21011445|P3|COMPLETED|Overall Study||0
8524585|NCT00364793|21011446|P2|COMPLETED|Overall Study||5
8524586|NCT00364793|21011447|P1|COMPLETED|Overall Study||7
8524587|NCT00364793|21011444|P4|STARTED|Overall Study||8
8524588|NCT00364793|21011445|P3|STARTED|Overall Study||4
8524589|NCT00364793|21011446|P2|STARTED|Overall Study||10
8524590|NCT00364793|21011447|P1|STARTED|Overall Study||15
8524591|NCT00364689|21011584|P1|NOT COMPLETED|Overall Study||1
8524592|NCT00364689|21011584|P1|COMPLETED|Overall Study||12
8524593|NCT00364689|21011584|P1|STARTED|Overall Study||13
8524594|NCT00364611|21011604|P2|NOT COMPLETED|Overall Study||21
8524595|NCT00364611|21011605|P1|NOT COMPLETED|Overall Study||51
8524596|NCT00364611|21011604|P2|COMPLETED|Overall Study||0
8524597|NCT00364611|21011605|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
8524598|NCT00364611|21011604|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
8524599|NCT00364611|21011605|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
8524600|NCT00364611|21011604|P2|STARTED|Overall Study||21
8524601|NCT00364611|21011605|P1|STARTED|Overall Study||52
8524602|NCT00364533|21011628|P5|NOT COMPLETED|Overall Study||51
8524603|NCT00364533|21011629|P4|NOT COMPLETED|Overall Study||31
8524604|NCT00364533|21011630|P3|NOT COMPLETED|Overall Study||45
8524605|NCT00364533|21011631|P2|NOT COMPLETED|Overall Study||40
8524606|NCT00364533|21011632|P1|NOT COMPLETED|Overall Study||42
8524607|NCT00364533|21011628|P5|COMPLETED|Overall Study||24
8524608|NCT00364533|21011629|P4|COMPLETED|Overall Study||36
8524609|NCT00364533|21011630|P3|COMPLETED|Overall Study||30
8524610|NCT00364533|21011631|P2|COMPLETED|Overall Study||31
8524611|NCT00364533|21011632|P1|COMPLETED|Overall Study||35
8524612|NCT00364533|21011628|P5|STARTED|Overall Study||75
8524613|NCT00364533|21011629|P4|STARTED|Overall Study||67
8524614|NCT00364533|21011630|P3|STARTED|Overall Study||75
8524615|NCT00364533|21011631|P2|STARTED|Overall Study||71
8524616|NCT00364533|21011632|P1|STARTED|Overall Study||77
8524617|NCT00364377|21011656|P2|NOT COMPLETED|Overall Study||0
8524618|NCT00364377|21011657|P1|NOT COMPLETED|Overall Study||0
8524619|NCT00364377|21011656|P2|COMPLETED|Overall Study||11
8524620|NCT00364377|21011657|P1|COMPLETED|Overall Study||11
8524621|NCT00364377|21011656|P2|STARTED|Overall Study||11
8524622|NCT00364377|21011657|P1|STARTED|Overall Study||11
8524623|NCT00364351|21011665|P2|NOT COMPLETED|Overall Study||583
8524624|NCT00364351|21011666|P1|NOT COMPLETED|Overall Study||592
8524625|NCT00364351|21011665|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
8524626|NCT00364351|21011666|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
8524627|NCT00364351|21011665|P2|STARTED|Overall Study|randomised patients|617
8524628|NCT00364351|21011666|P1|STARTED|Overall Study|randomised patients|623
8524629|NCT00364286|21011684|P1|NOT COMPLETED|Overall Study||3
8524630|NCT00364286|21011684|P1|COMPLETED|Overall Study||14
8524631|NCT00364286|21011684|P1|STARTED|Overall Study||17
8524632|NCT00364182|21011691|P3|NOT COMPLETED|Fourth Intervention||0
8524633|NCT00364182|21011692|P2|NOT COMPLETED|Fourth Intervention||0
8524634|NCT00364182|21011693|P1|NOT COMPLETED|Fourth Intervention||0
8524635|NCT00364182|21011691|P3|COMPLETED|Fourth Intervention||22
8524636|NCT00364182|21011692|P2|COMPLETED|Fourth Intervention||19
8524637|NCT00364182|21011693|P1|COMPLETED|Fourth Intervention||0
8524638|NCT00364182|21011691|P3|STARTED|Fourth Intervention||22
8524639|NCT00364182|21011692|P2|STARTED|Fourth Intervention||19
8524640|NCT00364182|21011693|P1|STARTED|Fourth Intervention||0
8524641|NCT00364182|21011691|P3|NOT COMPLETED|Third Intervention||1
8524642|NCT00364182|21011692|P2|NOT COMPLETED|Third Intervention||1
8524643|NCT00364182|21011693|P1|NOT COMPLETED|Third Intervention||0
8524644|NCT00364182|21011691|P3|COMPLETED|Third Intervention||22
8524645|NCT00364182|21011692|P2|COMPLETED|Third Intervention||19
8524646|NCT00364182|21011693|P1|COMPLETED|Third Intervention||0
8524647|NCT00364182|21011691|P3|STARTED|Third Intervention||23
8524648|NCT00364182|21011692|P2|STARTED|Third Intervention||20
8524649|NCT00364182|21011693|P1|STARTED|Third Intervention||0
8524650|NCT00364182|21011691|P3|NOT COMPLETED|Second Intervention||2
8524651|NCT00364182|21011692|P2|NOT COMPLETED|Second Intervention||2
8524652|NCT00364182|21011693|P1|NOT COMPLETED|Second Intervention||0
8524653|NCT00364182|21011691|P3|COMPLETED|Second Intervention||23
8524654|NCT00364182|21011692|P2|COMPLETED|Second Intervention||20
8524655|NCT00364182|21011693|P1|COMPLETED|Second Intervention||0
8524656|NCT00364182|21011691|P3|Randomized|Second Intervention||25
8524657|NCT00364182|21011692|P2|Randomized|Second Intervention||22
8524658|NCT00364182|21011693|P1|Randomized|Second Intervention||0
8524659|NCT00364182|21011691|P3|STARTED|Second Intervention||25
8524660|NCT00364182|21011692|P2|STARTED|Second Intervention||22
8524661|NCT00364182|21011693|P1|STARTED|Second Intervention||0
8524662|NCT00364182|21011691|P3|NOT COMPLETED|First Intervention||0
8524663|NCT00364182|21011692|P2|NOT COMPLETED|First Intervention||0
8524664|NCT00364182|21011693|P1|NOT COMPLETED|First Intervention||3
8524665|NCT00364182|21011691|P3|COMPLETED|First Intervention||25
8524666|NCT00364182|21011692|P2|COMPLETED|First Intervention||22
8524667|NCT00364182|21011693|P1|COMPLETED|First Intervention||0
8524668|NCT00364182|21011691|P3|STARTED|First Intervention||25
8524669|NCT00364182|21011692|P2|STARTED|First Intervention||22
8524670|NCT00364182|21011693|P1|STARTED|First Intervention||3
8524671|NCT00364156|21011727|P2|NOT COMPLETED|Overall Study||81
8524672|NCT00364156|21011728|P1|NOT COMPLETED|Overall Study||79
8524673|NCT00364156|21011727|P2|COMPLETED|Overall Study||205
8524674|NCT00364156|21011728|P1|COMPLETED|Overall Study||203
8524675|NCT00364156|21011727|P2|STARTED|Overall Study||286
8524676|NCT00364156|21011728|P1|STARTED|Overall Study||282
8524677|NCT00364130|21011736|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
8524678|NCT00364130|21011737|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
8524679|NCT00364130|21011736|P2|COMPLETED|Post Intervention Follow-up Period||50
8524680|NCT00364130|21011737|P1|COMPLETED|Post Intervention Follow-up Period||55
8524681|NCT00364130|21011736|P2|STARTED|Post Intervention Follow-up Period||61
8524682|NCT00364130|21011737|P1|STARTED|Post Intervention Follow-up Period||60
8524683|NCT00364130|21011736|P2|NOT COMPLETED|Intervention Period||8
8524684|NCT00364130|21011737|P1|NOT COMPLETED|Intervention Period||9
8524685|NCT00364130|21011736|P2|COMPLETED|Intervention Period||61
8524686|NCT00364130|21011737|P1|COMPLETED|Intervention Period||60
8524687|NCT00364130|21011736|P2|STARTED|Intervention Period||69
8524688|NCT00364130|21011737|P1|STARTED|Intervention Period||69
8524689|NCT00364013|21011759|P2|NOT COMPLETED|Overall Study||95
8524690|NCT00364013|21011760|P1|NOT COMPLETED|Overall Study||101
8524691|NCT00364013|21011759|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
8524692|NCT00364013|21011760|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
8524693|NCT00364013|21011759|P2|Received Study Drug|Overall Study||583
8524694|NCT00364013|21011760|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
8524695|NCT00364013|21011759|P2|STARTED|Overall Study||590
8524696|NCT00364013|21011760|P1|STARTED|Overall Study||593
8524697|NCT00363896|21011788|P2|NOT COMPLETED|Overall Study||47
8524698|NCT00363896|21011789|P1|NOT COMPLETED|Overall Study||89
8524699|NCT00363896|21011788|P2|COMPLETED|Overall Study||169
8524700|NCT00363896|21011789|P1|COMPLETED|Overall Study||538
8524701|NCT00363896|21011788|P2|STARTED|Overall Study||216
8524702|NCT00363896|21011789|P1|STARTED|Overall Study||627
8524703|NCT00363883|21011801|P1|NOT COMPLETED|Overall Study||0
8524704|NCT00363883|21011801|P1|COMPLETED|Overall Study||14
8524705|NCT00363883|21011801|P1|STARTED|Overall Study||14
8524706|NCT00363805|21011810|P3|NOT COMPLETED|Overall Study||3
8524707|NCT00363805|21011811|P2|NOT COMPLETED|Overall Study||6
8524708|NCT00363805|21011812|P1|NOT COMPLETED|Overall Study||4
8524709|NCT00363805|21011810|P3|COMPLETED|Overall Study||70
8524710|NCT00363805|21011811|P2|COMPLETED|Overall Study||57
8524711|NCT00363805|21011812|P1|COMPLETED|Overall Study||38
8524712|NCT00363805|21011810|P3|STARTED|Overall Study||73
8524713|NCT00363805|21011811|P2|STARTED|Overall Study||63
8524714|NCT00363805|21011812|P1|STARTED|Overall Study||42
8524715|NCT00363779|21011823|P1|NOT COMPLETED|Overall Study||0
8524716|NCT00363779|21011823|P1|COMPLETED|Overall Study||5
8524717|NCT00363779|21011823|P1|STARTED|Overall Study||5
8524718|NCT00363766|21011830|P2|NOT COMPLETED|Overall Study||20
8524719|NCT00363766|21011831|P1|NOT COMPLETED|Overall Study||32
8524720|NCT00363766|21011830|P2|COMPLETED|Overall Study||0
8524721|NCT00363766|21011831|P1|COMPLETED|Overall Study||0
8524722|NCT00363766|21011830|P2|STARTED|Overall Study||20
8524723|NCT00363766|21011831|P1|STARTED|Overall Study||32
8524724|NCT00363675|21011851|P1|NOT COMPLETED|Overall Study||0
8524725|NCT00363675|21011851|P1|COMPLETED|Overall Study||3
8524726|NCT00363675|21011851|P1|Completed Testing|Overall Study||3
8524727|NCT00363675|21011851|P1|STARTED|Overall Study||3
8524728|NCT00363649|21011860|P2|NOT COMPLETED|Overall Study||1
8524729|NCT00363649|21011861|P1|NOT COMPLETED|Overall Study||7
8524730|NCT00363649|21011860|P2|COMPLETED|Overall Study||15
8524731|NCT00363649|21011861|P1|COMPLETED|Overall Study||11
8524732|NCT00363649|21011860|P2|Did Not Cross Over|Overall Study||3
8524733|NCT00363649|21011861|P1|Did Not Cross Over|Overall Study||2
8524734|NCT00363649|21011860|P2|Crossed Over to Arm A|Overall Study||12
8524735|NCT00363649|21011861|P1|Crossed Over to Arm A|Overall Study||0
8524736|NCT00363649|21011860|P2|Crossed Over to Arm B|Overall Study||0
8524737|NCT00363649|21011861|P1|Crossed Over to Arm B|Overall Study||9
8524738|NCT00363649|21011860|P2|STARTED|Overall Study||16
8524739|NCT00363649|21011861|P1|STARTED|Overall Study||18
8524740|NCT00363545|21011877|P2|NOT COMPLETED|Overall Study||57
8524741|NCT00363545|21011878|P1|NOT COMPLETED|Overall Study||44
8524742|NCT00363545|21011877|P2|COMPLETED|Overall Study||581
8524743|NCT00363545|21011878|P1|COMPLETED|Overall Study||592
8524744|NCT00363545|21011877|P2|STARTED|Overall Study||638
8524745|NCT00363545|21011878|P1|STARTED|Overall Study||636
8524746|NCT00363480|21011896|P1|NOT COMPLETED|Overall Study||17
8524747|NCT00363480|21011896|P1|COMPLETED|Overall Study||204
8524748|NCT00363480|21011896|P1|STARTED|Overall Study||221
8524749|NCT00363467|21011916|P1|NOT COMPLETED|Overall Study||1
8524750|NCT00363467|21011916|P1|COMPLETED|Overall Study||2
8524751|NCT00363467|21011916|P1|STARTED|Overall Study||3
8524752|NCT00363415|21011926|P2|NOT COMPLETED|Overall Study||249
8524753|NCT00363415|21011927|P1|NOT COMPLETED|Overall Study||361
8524754|NCT00363415|21011926|P2|COMPLETED|Overall Study||206
8524755|NCT00363415|21011927|P1|COMPLETED|Overall Study||92
8524756|NCT00363415|21011926|P2|Received at Least One Dose of Study Drug|Overall Study||447
8524757|NCT00363415|21011927|P1|Received at Least One Dose of Study Drug|Overall Study||433
8524758|NCT00363415|21011926|P2|STARTED|Overall Study||455
8524759|NCT00363415|21011927|P1|STARTED|Overall Study||453
8524760|NCT00363311|21011945|P2|NOT COMPLETED|Overall Study||45
8524761|NCT00363311|21011946|P1|NOT COMPLETED|Overall Study||76
8524762|NCT00363311|21011945|P2|COMPLETED|Overall Study||102
8524763|NCT00363311|21011946|P1|COMPLETED|Overall Study||79
8524764|NCT00363311|21011945|P2|STARTED|Overall Study||147
8524765|NCT00363311|21011946|P1|STARTED|Overall Study||155
8524766|NCT00363298|21012012|P2|NOT COMPLETED|4-week Study Continuation Phase||0
8524767|NCT00363298|21012013|P1|NOT COMPLETED|4-week Study Continuation Phase||1
8524768|NCT00363298|21012012|P2|COMPLETED|4-week Study Continuation Phase||7
8524769|NCT00363298|21012013|P1|COMPLETED|4-week Study Continuation Phase||5
8524770|NCT00363298|21012012|P2|STARTED|4-week Study Continuation Phase||7
8524771|NCT00363298|21012013|P1|STARTED|4-week Study Continuation Phase||6
8524772|NCT00363298|21012012|P2|NOT COMPLETED|First Study Week||5
8524773|NCT00363298|21012013|P1|NOT COMPLETED|First Study Week||6
8524774|NCT00363298|21012012|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
8524775|NCT00363298|21012013|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
8524776|NCT00363298|21012012|P2|STARTED|First Study Week||12
8524777|NCT00363298|21012013|P1|STARTED|First Study Week||12
8524778|NCT00363246|21012021|P1|NOT COMPLETED|Overall Study||97
8524779|NCT00363246|21012021|P1|COMPLETED|Overall Study||669
8524780|NCT00363246|21012021|P1|STARTED|Overall Study||766
8524781|NCT00363168|21012028|P2|NOT COMPLETED|Overall Study||0
8524782|NCT00363168|21012029|P1|NOT COMPLETED|Overall Study||0
8524783|NCT00363168|21012028|P2|COMPLETED|Overall Study||2
8524784|NCT00363168|21012029|P1|COMPLETED|Overall Study||5
8524785|NCT00363168|21012028|P2|STARTED|Overall Study||2
8524786|NCT00363168|21012029|P1|STARTED|Overall Study||5
8524787|NCT00363142|21012039|P2|NOT COMPLETED|Overall Study||3
8524788|NCT00363142|21012040|P1|NOT COMPLETED|Overall Study||7
8524789|NCT00363142|21012039|P2|COMPLETED|Overall Study||66
8524790|NCT00363142|21012040|P1|COMPLETED|Overall Study||133
8524791|NCT00363142|21012039|P2|STARTED|Overall Study||69
8524792|NCT00363142|21012040|P1|STARTED|Overall Study||140
8524793|NCT00363129|21012069|P2|NOT COMPLETED|Overall Study||33
8524794|NCT00363129|21012070|P1|NOT COMPLETED|Overall Study||29
8524795|NCT00363129|21012069|P2|COMPLETED|Overall Study||60
8524796|NCT00363129|21012070|P1|COMPLETED|Overall Study||67
8524797|NCT00363129|21012069|P2|STARTED|Overall Study||93
8524798|NCT00363129|21012070|P1|STARTED|Overall Study||96
8524799|NCT00363077|21012086|P2|NOT COMPLETED|Overall Study||0
8524800|NCT00363077|21012087|P1|NOT COMPLETED|Overall Study||0
8524801|NCT00363077|21012086|P2|COMPLETED|Overall Study||75
8524802|NCT00363077|21012087|P1|COMPLETED|Overall Study||75
8524803|NCT00363077|21012086|P2|STARTED|Overall Study||75
8524804|NCT00363077|21012087|P1|STARTED|Overall Study||75
8524805|NCT00363051|21012113|P2|NOT COMPLETED|Overall Study||22
8524806|NCT00363051|21012114|P1|NOT COMPLETED|Overall Study||38
8524807|NCT00363051|21012113|P2|COMPLETED|Overall Study||23
8524808|NCT00363051|21012114|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
8524809|NCT00363051|21012113|P2|STARTED|Overall Study||45
8524810|NCT00363051|21012114|P1|STARTED|Overall Study||115
8524811|NCT00363038|21012131|P1|NOT COMPLETED|Overall Study||0
8524812|NCT00363038|21012131|P1|COMPLETED|Overall Study||16
8524813|NCT00363038|21012131|P1|STARTED|Overall Study||16
8524814|NCT00362882|21012137|P2|NOT COMPLETED|Overall Study||0
8524815|NCT00362882|21012138|P1|NOT COMPLETED|Overall Study||0
8524816|NCT00362882|21012137|P2|COMPLETED|Overall Study||41
8524817|NCT00362882|21012138|P1|COMPLETED|Overall Study||40
8524818|NCT00362882|21012137|P2|STARTED|Overall Study||41
8524819|NCT00362882|21012138|P1|STARTED|Overall Study||40
8524820|NCT00362817|21012150|P1|NOT COMPLETED|Overall Study||0
8524821|NCT00362817|21012150|P1|COMPLETED|Overall Study||17
8524822|NCT00362817|21012150|P1|STARTED|Overall Study||17
8524823|NCT00362648|21012163|P4|NOT COMPLETED|Overall Study||11
8524824|NCT00362648|21012164|P3|NOT COMPLETED|Overall Study||9
8524825|NCT00362648|21012165|P2|NOT COMPLETED|Overall Study||134
8524826|NCT00362648|21012166|P1|NOT COMPLETED|Overall Study||126
8524827|NCT00362648|21012163|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
8524828|NCT00362648|21012164|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
8524829|NCT00362648|21012165|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
8524830|NCT00362648|21012166|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
8524831|NCT00362648|21012163|P4|Vaccinated at Visit 3|Overall Study||1007
8524832|NCT00362648|21012164|P3|Vaccinated at Visit 3|Overall Study||1009
8524833|NCT00362648|21012165|P2|Vaccinated at Visit 3|Overall Study||2612
8524834|NCT00362648|21012166|P1|Vaccinated at Visit 3|Overall Study||2613
8524835|NCT00362648|21012163|P4|Vaccinated at Visit 2|Overall Study||1009
8524836|NCT00362648|21012164|P3|Vaccinated at Visit 2|Overall Study||1013
8524837|NCT00362648|21012165|P2|Vaccinated at Visit 2|Overall Study||2666
8524838|NCT00362648|21012166|P1|Vaccinated at Visit 2|Overall Study||2657
8524839|NCT00362648|21012163|P4|Vaccinated at Visit 1|Overall Study||1018
8524840|NCT00362648|21012164|P3|Vaccinated at Visit 1|Overall Study||1018
8524841|NCT00362648|21012165|P2|Vaccinated at Visit 1|Overall Study||2735
8524842|NCT00362648|21012166|P1|Vaccinated at Visit 1|Overall Study||2733
8524843|NCT00362648|21012163|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
8524844|NCT00362648|21012164|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
8524845|NCT00362648|21012165|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
8524846|NCT00362648|21012166|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
8524847|NCT00362609|21012184|P2|NOT COMPLETED|Overall Study||2
8524848|NCT00362609|21012185|P1|NOT COMPLETED|Overall Study||0
8524849|NCT00362609|21012184|P2|COMPLETED|Overall Study||38
8524850|NCT00362609|21012185|P1|COMPLETED|Overall Study||19
8524851|NCT00362609|21012184|P2|STARTED|Overall Study||40
8524852|NCT00362609|21012185|P1|STARTED|Overall Study||19
8524853|NCT00362466|21012199|P2|NOT COMPLETED|Overall Study||0
8524854|NCT00362466|21012200|P1|NOT COMPLETED|Overall Study||0
8524855|NCT00362466|21012199|P2|COMPLETED|Overall Study||1
8524856|NCT00362466|21012200|P1|COMPLETED|Overall Study||2
8524857|NCT00362466|21012199|P2|STARTED|Overall Study||1
8524858|NCT00362466|21012200|P1|STARTED|Overall Study||2
8524859|NCT00362453|21012222|P2|NOT COMPLETED|Overall Study||0
8524860|NCT00362453|21012223|P1|NOT COMPLETED|Overall Study||0
8524861|NCT00362453|21012222|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
8524862|NCT00362453|21012223|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
8524863|NCT00362453|21012222|P2|STARTED|Overall Study||20
8524864|NCT00362453|21012223|P1|STARTED|Overall Study||20
8524865|NCT00362440|21012255|P2|NOT COMPLETED|Overall Study||1
8524866|NCT00362440|21012256|P1|NOT COMPLETED|Overall Study||2
8524867|NCT00362440|21012255|P2|COMPLETED|Overall Study||3
8524868|NCT00362440|21012256|P1|COMPLETED|Overall Study||3
8524869|NCT00362440|21012255|P2|STARTED|Overall Study||4
8524870|NCT00362440|21012256|P1|STARTED|Overall Study||5
8524871|NCT00362414|21012266|P1|NOT COMPLETED|Overall Study||3
8524872|NCT00362414|21012266|P1|COMPLETED|Overall Study||12
8524873|NCT00362414|21012266|P1|STARTED|Overall Study||15
8524874|NCT00362401|21012286|P3|NOT COMPLETED|Overall Study||0
8524875|NCT00362401|21012287|P2|NOT COMPLETED|Overall Study||0
8524876|NCT00362401|21012288|P1|NOT COMPLETED|Overall Study||0
8524877|NCT00362401|21012286|P3|COMPLETED|Overall Study||40
8524878|NCT00362401|21012287|P2|COMPLETED|Overall Study||29
8524879|NCT00362401|21012288|P1|COMPLETED|Overall Study||15
8524880|NCT00362401|21012286|P3|STARTED|Overall Study||40
8524881|NCT00362401|21012287|P2|STARTED|Overall Study||29
8524882|NCT00362401|21012288|P1|STARTED|Overall Study||15
8524883|NCT00362375|21012295|P2|NOT COMPLETED|Overall Study||35
8524884|NCT00362375|21012296|P1|NOT COMPLETED|Overall Study||40
8524885|NCT00362375|21012295|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
8524886|NCT00362375|21012296|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
8524887|NCT00362375|21012295|P2|STARTED|Overall Study|Number eligible and randomized|152
8524888|NCT00362375|21012296|P1|STARTED|Overall Study|Number eligible and randomized|161
8524889|NCT00362336|21012313|P3|NOT COMPLETED|Overall Study||3
8524890|NCT00362336|21012314|P2|NOT COMPLETED|Overall Study||7
8524891|NCT00362336|21012315|P1|NOT COMPLETED|Overall Study||10
8524892|NCT00362336|21012313|P3|COMPLETED|Overall Study||134
8524893|NCT00362336|21012314|P2|COMPLETED|Overall Study||235
8524894|NCT00362336|21012315|P1|COMPLETED|Overall Study||233
8524895|NCT00362336|21012313|P3|STARTED|Overall Study||137
8524896|NCT00362336|21012314|P2|STARTED|Overall Study||242
8524897|NCT00362336|21012315|P1|STARTED|Overall Study||243
8524898|NCT00362297|21012343|P2|NOT COMPLETED|Treatment 2||0
8524899|NCT00362297|21012344|P1|NOT COMPLETED|Treatment 2||0
8524900|NCT00362297|21012343|P2|COMPLETED|Treatment 2||11
8524901|NCT00362297|21012344|P1|COMPLETED|Treatment 2||16
8524902|NCT00362297|21012343|P2|STARTED|Treatment 2||11
8524903|NCT00362297|21012344|P1|STARTED|Treatment 2||16
8524904|NCT00362297|21012343|P2|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
8524905|NCT00362297|21012344|P1|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
8524906|NCT00362297|21012343|P2|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
8524907|NCT00362297|21012344|P1|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
8524908|NCT00362297|21012343|P2|STARTED|Treatment 1 (Initial Drug Assignment)||15
8524909|NCT00362297|21012344|P1|STARTED|Treatment 1 (Initial Drug Assignment)||16
8524910|NCT00362232|21012352|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
8524911|NCT00362232|21012353|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
8524912|NCT00362232|21012352|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
8524913|NCT00362232|21012353|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
8524914|NCT00362232|21012352|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
8524915|NCT00362232|21012353|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
8524916|NCT00362232|21012352|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
8524917|NCT00362232|21012353|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
8524918|NCT00362232|21012352|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
8524919|NCT00362232|21012353|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
8524920|NCT00362232|21012352|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
8524921|NCT00362232|21012353|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
8524922|NCT00362232|21012352|P2|STARTED|Treatment (12 +/- 2 Days)||1564
8524923|NCT00362232|21012353|P1|STARTED|Treatment (12 +/- 2 Days)||1584
8524924|NCT00362180|21012398|P9|NOT COMPLETED|20 Week Safety Follow-up||0
8524925|NCT00362180|21012399|P8|NOT COMPLETED|20 Week Safety Follow-up||0
8524926|NCT00362180|21012400|P7|NOT COMPLETED|20 Week Safety Follow-up||0
8524927|NCT00362180|21012401|P6|NOT COMPLETED|20 Week Safety Follow-up||0
8524928|NCT00362180|21012402|P5|NOT COMPLETED|20 Week Safety Follow-up||0
8524929|NCT00362180|21012403|P4|NOT COMPLETED|20 Week Safety Follow-up||0
8524930|NCT00362180|21012404|P3|NOT COMPLETED|20 Week Safety Follow-up||0
8524931|NCT00362180|21012405|P2|NOT COMPLETED|20 Week Safety Follow-up||0
8524932|NCT00362180|21012406|P1|NOT COMPLETED|20 Week Safety Follow-up||0
8524933|NCT00362180|21012398|P9|COMPLETED|20 Week Safety Follow-up||1
8524934|NCT00362180|21012399|P8|COMPLETED|20 Week Safety Follow-up||3
8524935|NCT00362180|21012400|P7|COMPLETED|20 Week Safety Follow-up||0
8524936|NCT00362180|21012401|P6|COMPLETED|20 Week Safety Follow-up||9
8524937|NCT00362180|21012402|P5|COMPLETED|20 Week Safety Follow-up||11
8524938|NCT00362180|21012403|P4|COMPLETED|20 Week Safety Follow-up||0
8524939|NCT00362180|21012404|P3|COMPLETED|20 Week Safety Follow-up||1
8524940|NCT00362180|21012405|P2|COMPLETED|20 Week Safety Follow-up||2
8524941|NCT00362180|21012406|P1|COMPLETED|20 Week Safety Follow-up||3
8524942|NCT00362180|21012398|P9|STARTED|20 Week Safety Follow-up||1
8524943|NCT00362180|21012399|P8|STARTED|20 Week Safety Follow-up||3
8524944|NCT00362180|21012400|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
8524945|NCT00362180|21012401|P6|STARTED|20 Week Safety Follow-up||9
8524946|NCT00362180|21012402|P5|STARTED|20 Week Safety Follow-up||11
8524947|NCT00362180|21012403|P4|STARTED|20 Week Safety Follow-up||0
8524948|NCT00362180|21012404|P3|STARTED|20 Week Safety Follow-up||1
8524949|NCT00362180|21012405|P2|STARTED|20 Week Safety Follow-up||2
8524950|NCT00362180|21012406|P1|STARTED|20 Week Safety Follow-up||3
8524951|NCT00362180|21012398|P9|NOT COMPLETED|Treated Period||0
8524952|NCT00362180|21012399|P8|NOT COMPLETED|Treated Period||1
8524953|NCT00362180|21012400|P7|NOT COMPLETED|Treated Period||0
8524954|NCT00362180|21012401|P6|NOT COMPLETED|Treated Period||1
8524955|NCT00362180|21012402|P5|NOT COMPLETED|Treated Period||0
8524956|NCT00362180|21012403|P4|NOT COMPLETED|Treated Period||0
8524957|NCT00362180|21012404|P3|NOT COMPLETED|Treated Period||0
8524958|NCT00362180|21012405|P2|NOT COMPLETED|Treated Period||0
8524959|NCT00362180|21012406|P1|NOT COMPLETED|Treated Period||1
8524960|NCT00362180|21012398|P9|COMPLETED|Treated Period||1
8524961|NCT00362180|21012399|P8|COMPLETED|Treated Period||2
8524962|NCT00362180|21012400|P7|COMPLETED|Treated Period||6
8524963|NCT00362180|21012401|P6|COMPLETED|Treated Period||9
8524964|NCT00362180|21012402|P5|COMPLETED|Treated Period||11
8524965|NCT00362180|21012403|P4|COMPLETED|Treated Period||0
8524966|NCT00362180|21012404|P3|COMPLETED|Treated Period||1
8524967|NCT00362180|21012405|P2|COMPLETED|Treated Period||2
8524968|NCT00362180|21012406|P1|COMPLETED|Treated Period||3
8524969|NCT00362180|21012398|P9|STARTED|Treated Period||1
8524970|NCT00362180|21012399|P8|STARTED|Treated Period||3
8524971|NCT00362180|21012400|P7|STARTED|Treated Period||6
8524972|NCT00362180|21012401|P6|STARTED|Treated Period||10
8524973|NCT00362180|21012402|P5|STARTED|Treated Period||11
8524974|NCT00362180|21012403|P4|STARTED|Treated Period||0
8524975|NCT00362180|21012404|P3|STARTED|Treated Period||1
8524976|NCT00362180|21012405|P2|STARTED|Treated Period||2
8524977|NCT00362180|21012406|P1|STARTED|Treated Period||4
8524978|NCT00362128|21012467|P1|NOT COMPLETED|Overall Study||0
8524979|NCT00362128|21012467|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
8524980|NCT00362128|21012467|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
8524981|NCT00362115|21012478|P7|NOT COMPLETED|Overall Study||12
8524982|NCT00362115|21012479|P6|NOT COMPLETED|Overall Study||7
8524983|NCT00362115|21012480|P5|NOT COMPLETED|Overall Study||7
8524984|NCT00362115|21012481|P4|NOT COMPLETED|Overall Study||4
8524985|NCT00362115|21012482|P3|NOT COMPLETED|Overall Study||7
8524986|NCT00362115|21012483|P2|NOT COMPLETED|Overall Study||6
8524987|NCT00362115|21012484|P1|NOT COMPLETED|Overall Study||2
8524988|NCT00362115|21012478|P7|COMPLETED|Overall Study||52
8524989|NCT00362115|21012479|P6|COMPLETED|Overall Study||57
8524990|NCT00362115|21012480|P5|COMPLETED|Overall Study||57
8524991|NCT00362115|21012481|P4|COMPLETED|Overall Study||59
8524992|NCT00362115|21012482|P3|COMPLETED|Overall Study||57
8524993|NCT00362115|21012483|P2|COMPLETED|Overall Study||59
8524994|NCT00362115|21012484|P1|COMPLETED|Overall Study||63
8524995|NCT00362115|21012478|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
8524996|NCT00362115|21012479|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
8524997|NCT00362115|21012480|P5|STARTED|Overall Study||64
8524998|NCT00362115|21012481|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
8524999|NCT00362115|21012482|P3|STARTED|Overall Study||64
8525000|NCT00362115|21012483|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
8525001|NCT00362115|21012484|P1|STARTED|Overall Study||65
8525002|NCT00361972|21012635|P2|NOT COMPLETED|Overall Study||0
8525003|NCT00361972|21012636|P1|NOT COMPLETED|Overall Study||0
8525004|NCT00361972|21012635|P2|COMPLETED|Overall Study||9
8525005|NCT00361972|21012636|P1|COMPLETED|Overall Study||8
8525006|NCT00361972|21012635|P2|STARTED|Overall Study||9
8525007|NCT00361972|21012636|P1|STARTED|Overall Study||8
8525008|NCT00361712|21012646|P2|NOT COMPLETED|Overall Study||0
8525009|NCT00361712|21012647|P1|NOT COMPLETED|Overall Study||0
8525010|NCT00361712|21012646|P2|COMPLETED|Overall Study||21
8525011|NCT00361712|21012647|P1|COMPLETED|Overall Study||20
8525012|NCT00361712|21012646|P2|STARTED|Overall Study||21
8525013|NCT00361712|21012647|P1|STARTED|Overall Study||20
8525014|NCT00361634|21012657|P1|NOT COMPLETED|Overall Study||2
8525015|NCT00361634|21012657|P1|COMPLETED|Overall Study||12
8525016|NCT00361634|21012657|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
8525017|NCT00361634|21012657|P1|STARTED|Overall Study||14
8525018|NCT00361595|21012675|P1|NOT COMPLETED|Overall Study||0
8525019|NCT00361595|21012675|P1|COMPLETED|Overall Study||35
8525020|NCT00361595|21012675|P1|STARTED|Overall Study||35
8525021|NCT00361569|21012686|P4|NOT COMPLETED|Overall Study||21
8525022|NCT00361569|21012687|P3|NOT COMPLETED|Overall Study||18
8525023|NCT00361569|21012688|P2|NOT COMPLETED|Overall Study||11
8525024|NCT00361569|21012689|P1|NOT COMPLETED|Overall Study||12
8525025|NCT00361569|21012686|P4|COMPLETED|Overall Study||135
8525026|NCT00361569|21012687|P3|COMPLETED|Overall Study||137
8525027|NCT00361569|21012688|P2|COMPLETED|Overall Study||150
8525028|NCT00361569|21012689|P1|COMPLETED|Overall Study||138
8525029|NCT00361569|21012686|P4|STARTED|Overall Study||156
8525030|NCT00361569|21012687|P3|STARTED|Overall Study||155
8525031|NCT00361569|21012688|P2|STARTED|Overall Study||161
8525032|NCT00361569|21012689|P1|STARTED|Overall Study||150
8525033|NCT00361504|21012713|P2|NOT COMPLETED|Overall Study||145
8525034|NCT00361504|21012714|P1|NOT COMPLETED|Overall Study||481
8525035|NCT00361504|21012713|P2|COMPLETED|Overall Study||78
8525036|NCT00361504|21012714|P1|COMPLETED|Overall Study||413
8525037|NCT00361504|21012713|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
8525038|NCT00361504|21012714|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
8525039|NCT00361439|21012724|P2|NOT COMPLETED|Overall Study||0
8525040|NCT00361439|21012725|P1|NOT COMPLETED|Overall Study||0
8525041|NCT00361439|21012724|P2|COMPLETED|Overall Study||9
8525042|NCT00361439|21012725|P1|COMPLETED|Overall Study||8
8525043|NCT00361439|21012724|P2|STARTED|Overall Study||9
8525044|NCT00361439|21012725|P1|STARTED|Overall Study||8
8525045|NCT00361374|21012740|P3|NOT COMPLETED|Overall Study||12
8525046|NCT00361374|21012741|P2|NOT COMPLETED|Overall Study||15
8525047|NCT00361374|21012742|P1|NOT COMPLETED|Overall Study||15
8525048|NCT00361374|21012740|P3|COMPLETED|Overall Study||53
8525049|NCT00361374|21012741|P2|COMPLETED|Overall Study||50
8525050|NCT00361374|21012742|P1|COMPLETED|Overall Study||51
8525051|NCT00361374|21012740|P3|STARTED|Overall Study||65
8525052|NCT00361374|21012741|P2|STARTED|Overall Study||65
8525053|NCT00361374|21012742|P1|STARTED|Overall Study||66
8525054|NCT00361335|21012755|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
8525055|NCT00361335|21012756|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
8525056|NCT00361335|21012757|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
8525057|NCT00361335|21012758|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
8525058|NCT00361335|21012759|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
8525059|NCT00361335|21012760|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
8525060|NCT00361335|21012761|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
8525061|NCT00361335|21012755|P7|COMPLETED|SC Period: Week E0 to Week E24||164
8525062|NCT00361335|21012756|P6|COMPLETED|SC Period: Week E0 to Week E24||23
8525063|NCT00361335|21012757|P5|COMPLETED|SC Period: Week E0 to Week E24||3
8525064|NCT00361335|21012758|P4|COMPLETED|SC Period: Week E0 to Week E24||59
8525065|NCT00361335|21012759|P3|COMPLETED|SC Period: Week E0 to Week E24||99
8525066|NCT00361335|21012760|P2|COMPLETED|SC Period: Week E0 to Week E24||56
8525067|NCT00361335|21012761|P1|COMPLETED|SC Period: Week E0 to Week E24||80
8525068|NCT00361335|21012755|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
8525069|NCT00361335|21012756|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
8525070|NCT00361335|21012757|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
8525071|NCT00361335|21012758|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
8525072|NCT00361335|21012759|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
8525073|NCT00361335|21012760|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
8525074|NCT00361335|21012761|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
8525075|NCT00361335|21012755|P7|NOT COMPLETED|IV Period: Baseline to E0||0
8525076|NCT00361335|21012756|P6|NOT COMPLETED|IV Period: Baseline to E0||0
8525077|NCT00361335|21012757|P5|NOT COMPLETED|IV Period: Baseline to E0||24
8525078|NCT00361335|21012758|P4|NOT COMPLETED|IV Period: Baseline to E0||27
8525079|NCT00361335|21012759|P3|NOT COMPLETED|IV Period: Baseline to E0||21
8525080|NCT00361335|21012760|P2|NOT COMPLETED|IV Period: Baseline to E0||29
8525081|NCT00361335|21012761|P1|NOT COMPLETED|IV Period: Baseline to E0||20
8525082|NCT00361335|21012755|P7|COMPLETED|IV Period: Baseline to E0||0
8525083|NCT00361335|21012756|P6|COMPLETED|IV Period: Baseline to E0||0
8525084|NCT00361335|21012757|P5|COMPLETED|IV Period: Baseline to E0||105
8525085|NCT00361335|21012758|P4|COMPLETED|IV Period: Baseline to E0||102
8525086|NCT00361335|21012759|P3|COMPLETED|IV Period: Baseline to E0||107
8525087|NCT00361335|21012760|P2|COMPLETED|IV Period: Baseline to E0||99
8525088|NCT00361335|21012761|P1|COMPLETED|IV Period: Baseline to E0||109
8525089|NCT00361335|21012755|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
8525090|NCT00361335|21012756|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
8525091|NCT00361335|21012757|P5|STARTED|IV Period: Baseline to E0||129
8525092|NCT00361335|21012758|P4|STARTED|IV Period: Baseline to E0||129
8525093|NCT00361335|21012759|P3|STARTED|IV Period: Baseline to E0||128
8525094|NCT00361335|21012760|P2|STARTED|IV Period: Baseline to E0||128
8525095|NCT00361335|21012761|P1|STARTED|IV Period: Baseline to E0||129
8525096|NCT00361296|21012805|P1|NOT COMPLETED|Overall Study||3
8525097|NCT00361296|21012805|P1|COMPLETED|Overall Study||2
8525098|NCT00361296|21012805|P1|STARTED|Overall Study||5
8525099|NCT00361283|21012812|P1|NOT COMPLETED|Overall Study||27
8525100|NCT00361283|21012812|P1|COMPLETED|Overall Study||81
8525101|NCT00361283|21012812|P1|STARTED|Overall Study||108
8525102|NCT00361270|21012820|P4|NOT COMPLETED|Overall Study||13
8525103|NCT00361270|21012821|P3|NOT COMPLETED|Overall Study||10
8525104|NCT00361270|21012822|P2|NOT COMPLETED|Overall Study||14
8525105|NCT00361270|21012823|P1|NOT COMPLETED|Overall Study||24
8525106|NCT00361270|21012820|P4|COMPLETED|Overall Study||25
8525107|NCT00361270|21012821|P3|COMPLETED|Overall Study||25
8525108|NCT00361270|21012822|P2|COMPLETED|Overall Study||25
8525109|NCT00361270|21012823|P1|COMPLETED|Overall Study||25
8525110|NCT00361270|21012820|P4|STARTED|Overall Study||38
8525111|NCT00361270|21012821|P3|STARTED|Overall Study||35
8525112|NCT00361270|21012822|P2|STARTED|Overall Study||39
8525113|NCT00361270|21012823|P1|STARTED|Overall Study||49
8525114|NCT00361257|21012843|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
8525115|NCT00361257|21012844|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
8525116|NCT00361257|21012843|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
8525117|NCT00361257|21012844|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
8525118|NCT00361257|21012843|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
8525209|NCT00360490|21013188|P2|STARTED|Overall Study||83
8525119|NCT00361257|21012844|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
8525120|NCT00361257|21012843|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
8525121|NCT00361257|21012844|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
8525122|NCT00361257|21012843|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
8525123|NCT00361257|21012844|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
8525124|NCT00361257|21012843|P2|STARTED|Step 1: Minocycline vs. Placebo||55
8525125|NCT00361257|21012844|P1|STARTED|Step 1: Minocycline vs. Placebo||52
8525126|NCT00361231|21012896|P1|NOT COMPLETED|Overall Study||34
8525127|NCT00361231|21012896|P1|COMPLETED|Overall Study||1
8525128|NCT00361231|21012896|P1|STARTED|Overall Study||35
8525129|NCT00361218|21012901|P1|NOT COMPLETED|Overall Study||23
8525130|NCT00361218|21012901|P1|COMPLETED|Overall Study||30
8525131|NCT00361218|21012901|P1|Completed Baseline Assessment|Overall Study||47
8525132|NCT00361218|21012901|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
8525133|NCT00361140|21012909|P3|NOT COMPLETED|Overall Study||0
8525134|NCT00361140|21012910|P2|NOT COMPLETED|Overall Study||0
8525135|NCT00361140|21012911|P1|NOT COMPLETED|Overall Study||0
8525136|NCT00361140|21012909|P3|COMPLETED|Overall Study||3
8525137|NCT00361140|21012910|P2|COMPLETED|Overall Study||29
8525138|NCT00361140|21012911|P1|COMPLETED|Overall Study||40
8525139|NCT00361140|21012909|P3|STARTED|Overall Study||3
8525140|NCT00361140|21012910|P2|STARTED|Overall Study||29
8525141|NCT00361140|21012911|P1|STARTED|Overall Study||40
8525142|NCT00360971|21012924|P2|NOT COMPLETED|Overall Study||0
8525143|NCT00360971|21012925|P1|NOT COMPLETED|Overall Study||0
8525144|NCT00360971|21012924|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
8525145|NCT00360971|21012925|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
8525146|NCT00360971|21012924|P2|STARTED|Overall Study||11
8525147|NCT00360971|21012925|P1|STARTED|Overall Study||10
8525148|NCT00360828|21012941|P1|NOT COMPLETED|Overall Study||1
8525149|NCT00360828|21012941|P1|COMPLETED|Overall Study||9
8525150|NCT00360828|21012941|P1|STARTED|Overall Study||10
8525151|NCT00360724|21012951|P2|NOT COMPLETED|Overall Study||4
8525152|NCT00360724|21012952|P1|NOT COMPLETED|Overall Study||4
8525153|NCT00360724|21012951|P2|COMPLETED|Overall Study||28
8525154|NCT00360724|21012952|P1|COMPLETED|Overall Study||29
8525155|NCT00360724|21012951|P2|STARTED|Overall Study||32
8525156|NCT00360724|21012952|P1|STARTED|Overall Study||33
8525157|NCT00360698|21012980|P2|NOT COMPLETED|Treatment Period||1
8525158|NCT00360698|21012981|P1|NOT COMPLETED|Treatment Period||1
8525159|NCT00360698|21012980|P2|COMPLETED|Treatment Period||56
8525160|NCT00360698|21012981|P1|COMPLETED|Treatment Period||48
8525161|NCT00360698|21012980|P2|STARTED|Treatment Period||57
8525162|NCT00360698|21012981|P1|STARTED|Treatment Period||49
8525163|NCT00360698|21012980|P2|NOT COMPLETED|Run-In||10
8525164|NCT00360698|21012981|P1|NOT COMPLETED|Run-In||0
8525165|NCT00360698|21012980|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
8525166|NCT00360698|21012981|P1|COMPLETED|Run-In||0
8525167|NCT00360698|21012980|P2|STARTED|Run-In||135
8525168|NCT00360698|21012981|P1|STARTED|Run-In||0
8525169|NCT00360685|21013009|P2|NOT COMPLETED|Overall Study||0
8525170|NCT00360685|21013010|P1|NOT COMPLETED|Overall Study||0
8525171|NCT00360685|21013009|P2|COMPLETED|Overall Study||42
8525172|NCT00360685|21013010|P1|COMPLETED|Overall Study||47
8525173|NCT00360685|21013009|P2|STARTED|Overall Study||42
8525174|NCT00360685|21013010|P1|STARTED|Overall Study||47
8525175|NCT00360672|21013020|P1|NOT COMPLETED|Overall Study||0
8525176|NCT00360672|21013020|P1|COMPLETED|Overall Study||27
8525177|NCT00360672|21013020|P1|STARTED|Overall Study||27
8525178|NCT00360568|21013026|P2|NOT COMPLETED|Overall Study||5
8525179|NCT00360568|21013027|P1|NOT COMPLETED|Overall Study||2
8525180|NCT00360568|21013026|P2|COMPLETED|Overall Study||24
8525181|NCT00360568|21013027|P1|COMPLETED|Overall Study||31
8525182|NCT00360568|21013026|P2|STARTED|Overall Study||29
8525183|NCT00360568|21013027|P1|STARTED|Overall Study||33
8525184|NCT00360555|21013138|P4|NOT COMPLETED|Overall Study||112
8525185|NCT00360555|21013139|P3|NOT COMPLETED|Overall Study||145
8525186|NCT00360555|21013140|P2|NOT COMPLETED|Overall Study||134
8525187|NCT00360555|21013141|P1|NOT COMPLETED|Overall Study||122
8525188|NCT00360555|21013138|P4|COMPLETED|Overall Study||287
8525189|NCT00360555|21013139|P3|COMPLETED|Overall Study||251
8525190|NCT00360555|21013140|P2|COMPLETED|Overall Study||259
8525191|NCT00360555|21013141|P1|COMPLETED|Overall Study||274
8525192|NCT00360555|21013138|P4|STARTED|Overall Study||399
8525193|NCT00360555|21013139|P3|STARTED|Overall Study||396
8525194|NCT00360555|21013140|P2|STARTED|Overall Study||393
8525195|NCT00360555|21013141|P1|STARTED|Overall Study||396
8525196|NCT00360529|21013158|P3|NOT COMPLETED|Overall Study||91
8525197|NCT00360529|21013159|P2|NOT COMPLETED|Overall Study||65
8525198|NCT00360529|21013160|P1|NOT COMPLETED|Overall Study||61
8525199|NCT00360529|21013158|P3|COMPLETED|Overall Study||199
8525200|NCT00360529|21013159|P2|COMPLETED|Overall Study||230
8525201|NCT00360529|21013160|P1|COMPLETED|Overall Study||234
8525202|NCT00360529|21013158|P3|STARTED|Overall Study||290
8525203|NCT00360529|21013159|P2|STARTED|Overall Study||295
8525204|NCT00360529|21013160|P1|STARTED|Overall Study||295
8525205|NCT00360490|21013188|P2|NOT COMPLETED|Overall Study||11
8525206|NCT00360490|21013189|P1|NOT COMPLETED|Overall Study||9
8525207|NCT00360490|21013188|P2|COMPLETED|Overall Study||72
8525208|NCT00360490|21013189|P1|COMPLETED|Overall Study||73
8525210|NCT00360490|21013189|P1|STARTED|Overall Study||82
8525211|NCT00360412|21013224|P2|NOT COMPLETED|Overall Study||662
8525212|NCT00360412|21013225|P1|NOT COMPLETED|Overall Study||333
8525213|NCT00360412|21013224|P2|COMPLETED|Overall Study||2
8525214|NCT00360412|21013225|P1|COMPLETED|Overall Study||0
8525215|NCT00360412|21013224|P2|STARTED|Overall Study||664
8525216|NCT00360412|21013225|P1|STARTED|Overall Study||333
8525217|NCT00360399|21013240|P3|NOT COMPLETED|Overall Study||46
8525218|NCT00360399|21013241|P2|NOT COMPLETED|Overall Study||36
8525219|NCT00360399|21013242|P1|NOT COMPLETED|Overall Study||28
8525220|NCT00360399|21013240|P3|COMPLETED|Overall Study||69
8525221|NCT00360399|21013241|P2|COMPLETED|Overall Study||79
8525222|NCT00360399|21013242|P1|COMPLETED|Overall Study||86
8525223|NCT00360399|21013240|P3|Had Post-randomization Assessment|Overall Study||105
8525224|NCT00360399|21013241|P2|Had Post-randomization Assessment|Overall Study||106
8525225|NCT00360399|21013242|P1|Had Post-randomization Assessment|Overall Study||105
8525226|NCT00360399|21013240|P3|STARTED|Overall Study||115
8525227|NCT00360399|21013241|P2|STARTED|Overall Study||115
8525228|NCT00360399|21013242|P1|STARTED|Overall Study||114
8525229|NCT00360360|21013265|P1|NOT COMPLETED|Overall Study||6
8525230|NCT00360360|21013265|P1|COMPLETED|Overall Study||54
8525231|NCT00360360|21013265|P1|STARTED|Overall Study||60
8525232|NCT00360334|21013272|P2|NOT COMPLETED|Overall Study||13
8525233|NCT00360334|21013273|P1|NOT COMPLETED|Overall Study||19
8525234|NCT00360334|21013272|P2|COMPLETED|Overall Study||104
8525235|NCT00360334|21013273|P1|COMPLETED|Overall Study||99
8525236|NCT00360334|21013272|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
8525237|NCT00360334|21013273|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
8525238|NCT00360334|21013272|P2|STARTED|Overall Study||117
8525239|NCT00360334|21013273|P1|STARTED|Overall Study||118
8525240|NCT00360308|21013336|P3|NOT COMPLETED|Overall Study||88
8525241|NCT00360308|21013337|P2|NOT COMPLETED|Overall Study||79
8525242|NCT00360308|21013338|P1|NOT COMPLETED|Overall Study||76
8525243|NCT00360308|21013336|P3|COMPLETED|Overall Study||154
8525244|NCT00360308|21013337|P2|COMPLETED|Overall Study||155
8525245|NCT00360308|21013338|P1|COMPLETED|Overall Study||171
8525246|NCT00360308|21013336|P3|STARTED|Overall Study||242
8525247|NCT00360308|21013337|P2|STARTED|Overall Study||234
8525248|NCT00360308|21013338|P1|STARTED|Overall Study||247
8525249|NCT00360282|21013355|P4|NOT COMPLETED|Second Intervention||0
8525250|NCT00360282|21013356|P3|NOT COMPLETED|Second Intervention||0
8525251|NCT00360282|21013357|P2|NOT COMPLETED|Second Intervention||1
8525252|NCT00360282|21013358|P1|NOT COMPLETED|Second Intervention||0
8525253|NCT00360282|21013355|P4|COMPLETED|Second Intervention||6
8525254|NCT00360282|21013356|P3|COMPLETED|Second Intervention||6
8525255|NCT00360282|21013357|P2|COMPLETED|Second Intervention||7
8525256|NCT00360282|21013358|P1|COMPLETED|Second Intervention||6
8525257|NCT00360282|21013355|P4|STARTED|Second Intervention||6
8525258|NCT00360282|21013356|P3|STARTED|Second Intervention||6
8525259|NCT00360282|21013357|P2|STARTED|Second Intervention||8
8525260|NCT00360282|21013358|P1|STARTED|Second Intervention||6
8525261|NCT00360282|21013355|P4|NOT COMPLETED|Washout 1-3 Weeks||0
8525262|NCT00360282|21013356|P3|NOT COMPLETED|Washout 1-3 Weeks||1
8525263|NCT00360282|21013357|P2|NOT COMPLETED|Washout 1-3 Weeks||0
8525264|NCT00360282|21013358|P1|NOT COMPLETED|Washout 1-3 Weeks||0
8525265|NCT00360282|21013355|P4|COMPLETED|Washout 1-3 Weeks||6
8525266|NCT00360282|21013356|P3|COMPLETED|Washout 1-3 Weeks||6
8525267|NCT00360282|21013357|P2|COMPLETED|Washout 1-3 Weeks||8
8525268|NCT00360282|21013358|P1|COMPLETED|Washout 1-3 Weeks||6
8525269|NCT00360282|21013355|P4|STARTED|Washout 1-3 Weeks||6
8525270|NCT00360282|21013356|P3|STARTED|Washout 1-3 Weeks||7
8525271|NCT00360282|21013357|P2|STARTED|Washout 1-3 Weeks||8
8525272|NCT00360282|21013358|P1|STARTED|Washout 1-3 Weeks||6
8525273|NCT00360282|21013355|P4|NOT COMPLETED|First Intervention||0
8525274|NCT00360282|21013356|P3|NOT COMPLETED|First Intervention||0
8525275|NCT00360282|21013357|P2|NOT COMPLETED|First Intervention||0
8525276|NCT00360282|21013358|P1|NOT COMPLETED|First Intervention||0
8525277|NCT00360282|21013355|P4|COMPLETED|First Intervention||6
8525278|NCT00360282|21013356|P3|COMPLETED|First Intervention||7
8525279|NCT00360282|21013357|P2|COMPLETED|First Intervention||8
8525280|NCT00360282|21013358|P1|COMPLETED|First Intervention||6
8525281|NCT00360282|21013355|P4|STARTED|First Intervention||6
8525282|NCT00360282|21013356|P3|STARTED|First Intervention||7
8525283|NCT00360282|21013357|P2|STARTED|First Intervention||8
8525284|NCT00360282|21013358|P1|STARTED|First Intervention||6
8525285|NCT00360269|21013370|P2|NOT COMPLETED|Overall Study||12
8525286|NCT00360269|21013371|P1|NOT COMPLETED|Overall Study||10
8525287|NCT00360269|21013370|P2|COMPLETED|Overall Study||7
8525288|NCT00360269|21013371|P1|COMPLETED|Overall Study||9
8525289|NCT00360269|21013370|P2|STARTED|Overall Study||19
8525290|NCT00360269|21013371|P1|STARTED|Overall Study||19
8525291|NCT00360243|21013389|P4|NOT COMPLETED|Overall Study||125
8525292|NCT00360243|21013390|P3|NOT COMPLETED|Overall Study||156
8525293|NCT00360243|21013391|P2|NOT COMPLETED|Overall Study||120
8525294|NCT00360243|21013392|P1|NOT COMPLETED|Overall Study||102
8525295|NCT00360243|21013389|P4|COMPLETED|Overall Study||224
8525296|NCT00360243|21013390|P3|COMPLETED|Overall Study||180
8525297|NCT00360243|21013391|P2|COMPLETED|Overall Study||243
8525298|NCT00360243|21013392|P1|COMPLETED|Overall Study||235
8525299|NCT00360243|21013389|P4|STARTED|Overall Study||349
8525300|NCT00360243|21013390|P3|STARTED|Overall Study||336
8525301|NCT00360243|21013391|P2|STARTED|Overall Study||363
8525302|NCT00360243|21013392|P1|STARTED|Overall Study||337
8525303|NCT00360230|21013413|P7|NOT COMPLETED|Overall Study||2
8525304|NCT00360230|21013414|P6|NOT COMPLETED|Overall Study||4
8525305|NCT00360230|21013415|P5|NOT COMPLETED|Overall Study||5
8525306|NCT00360230|21013416|P4|NOT COMPLETED|Overall Study||2
8525307|NCT00360230|21013417|P3|NOT COMPLETED|Overall Study||3
8525308|NCT00360230|21013418|P2|NOT COMPLETED|Overall Study||3
8525309|NCT00360230|21013419|P1|NOT COMPLETED|Overall Study||6
8525310|NCT00360230|21013413|P7|COMPLETED|Overall Study||43
8525311|NCT00360230|21013414|P6|COMPLETED|Overall Study||86
8525312|NCT00360230|21013415|P5|COMPLETED|Overall Study||85
8525313|NCT00360230|21013416|P4|COMPLETED|Overall Study||88
8525314|NCT00360230|21013417|P3|COMPLETED|Overall Study||42
8525315|NCT00360230|21013418|P2|COMPLETED|Overall Study||87
8525316|NCT00360230|21013419|P1|COMPLETED|Overall Study||84
8525317|NCT00360230|21013413|P7|STARTED|Overall Study||45
8525318|NCT00360230|21013414|P6|STARTED|Overall Study||90
8525319|NCT00360230|21013415|P5|STARTED|Overall Study||90
8525320|NCT00360230|21013416|P4|STARTED|Overall Study||90
8525321|NCT00360230|21013417|P3|STARTED|Overall Study||45
8525322|NCT00360230|21013418|P2|STARTED|Overall Study||90
8525323|NCT00360230|21013419|P1|STARTED|Overall Study||90
8525324|NCT00360126|21013470|P1|NOT COMPLETED|Overall Study||0
8525325|NCT00360126|21013470|P1|COMPLETED|Overall Study||11
8525326|NCT00360126|21013470|P1|STARTED|Overall Study||11
8525327|NCT00360009|21013477|P3|NOT COMPLETED|Overall Study||3
8525328|NCT00360009|21013478|P2|NOT COMPLETED|Overall Study||4
8525329|NCT00360009|21013479|P1|NOT COMPLETED|Overall Study||0
8525330|NCT00360009|21013477|P3|COMPLETED|Overall Study||23
8525331|NCT00360009|21013478|P2|COMPLETED|Overall Study||22
8525332|NCT00360009|21013479|P1|COMPLETED|Overall Study||10
8525333|NCT00360009|21013477|P3|STARTED|Overall Study||26
8525334|NCT00360009|21013478|P2|STARTED|Overall Study||26
8525335|NCT00360009|21013479|P1|STARTED|Overall Study||10
8525336|NCT00359983|21013520|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
8525337|NCT00359983|21013521|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
8525338|NCT00359983|21013522|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
8525339|NCT00359983|21013520|P3|COMPLETED|Year 5 Persistence Follow-up||42
8525340|NCT00359983|21013521|P2|COMPLETED|Year 5 Persistence Follow-up||44
8525341|NCT00359983|21013522|P1|COMPLETED|Year 5 Persistence Follow-up||95
8525342|NCT00359983|21013520|P3|STARTED|Year 5 Persistence Follow-up||42
8525343|NCT00359983|21013521|P2|STARTED|Year 5 Persistence Follow-up||44
8525344|NCT00359983|21013522|P1|STARTED|Year 5 Persistence Follow-up||95
8525345|NCT00359983|21013520|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
8525346|NCT00359983|21013521|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
8525347|NCT00359983|21013522|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
8525348|NCT00359983|21013520|P3|COMPLETED|Year 3 Persistence Follow-up||51
8525349|NCT00359983|21013521|P2|COMPLETED|Year 3 Persistence Follow-up||47
8525350|NCT00359983|21013522|P1|COMPLETED|Year 3 Persistence Follow-up||103
8525351|NCT00359983|21013520|P3|STARTED|Year 3 Persistence Follow-up||51
8525352|NCT00359983|21013521|P2|STARTED|Year 3 Persistence Follow-up||47
8525353|NCT00359983|21013522|P1|STARTED|Year 3 Persistence Follow-up||103
8525354|NCT00359983|21013520|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
8525355|NCT00359983|21013521|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
8525356|NCT00359983|21013522|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
8525357|NCT00359983|21013520|P3|COMPLETED|Year 1 Persistence Follow-up||62
8525358|NCT00359983|21013521|P2|COMPLETED|Year 1 Persistence Follow-up||70
8525359|NCT00359983|21013522|P1|COMPLETED|Year 1 Persistence Follow-up||138
8525360|NCT00359983|21013520|P3|STARTED|Year 1 Persistence Follow-up||62
8525361|NCT00359983|21013521|P2|STARTED|Year 1 Persistence Follow-up||70
8525362|NCT00359983|21013522|P1|STARTED|Year 1 Persistence Follow-up||138
8525363|NCT00359944|21013557|P3|NOT COMPLETED|Overall Study||19
8525364|NCT00359944|21013558|P2|NOT COMPLETED|Overall Study||19
8525365|NCT00359944|21013559|P1|NOT COMPLETED|Overall Study||16
8525366|NCT00359944|21013557|P3|COMPLETED|Overall Study||38
8525367|NCT00359944|21013558|P2|COMPLETED|Overall Study||28
8525368|NCT00359944|21013559|P1|COMPLETED|Overall Study||34
8525369|NCT00359944|21013557|P3|STARTED|Overall Study||57
8525370|NCT00359944|21013558|P2|STARTED|Overall Study||47
8525371|NCT00359944|21013559|P1|STARTED|Overall Study||50
8525372|NCT00359801|21013575|P2|NOT COMPLETED|Overall Study||220
8525373|NCT00359801|21013576|P1|NOT COMPLETED|Overall Study||305
8525374|NCT00359801|21013575|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
8525375|NCT00359801|21013576|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
8525376|NCT00359801|21013575|P2|STARTED|Overall Study||989
8525377|NCT00359801|21013576|P1|STARTED|Overall Study||987
8525378|NCT00359788|21013610|P2|NOT COMPLETED|Overall Study||17
8525379|NCT00359788|21013611|P1|NOT COMPLETED|Overall Study||23
8525380|NCT00359788|21013610|P2|COMPLETED|Overall Study||159
8525381|NCT00359788|21013611|P1|COMPLETED|Overall Study||150
8525382|NCT00359788|21013610|P2|STARTED|Overall Study||176
8525383|NCT00359788|21013611|P1|STARTED|Overall Study||173
8525384|NCT00359762|21013845|P5|NOT COMPLETED|Period I||0
8525385|NCT00359762|21013846|P4|NOT COMPLETED|Period I||0
8525386|NCT00359762|21013847|P3|NOT COMPLETED|Period I||0
8525387|NCT00359762|21013848|P2|NOT COMPLETED|Period I||0
8525388|NCT00359762|21013849|P1|NOT COMPLETED|Period I||0
8525389|NCT00359762|21013845|P5|COMPLETED|Period I||0
8525390|NCT00359762|21013846|P4|COMPLETED|Period I||0
8525391|NCT00359762|21013847|P3|COMPLETED|Period I||0
8525392|NCT00359762|21013848|P2|COMPLETED|Period I||0
8525393|NCT00359762|21013849|P1|COMPLETED|Period I||0
8525394|NCT00359762|21013845|P5|STARTED|Period I||0
8525395|NCT00359762|21013846|P4|STARTED|Period I||0
8525396|NCT00359762|21013847|P3|STARTED|Period I||0
8525397|NCT00359762|21013848|P2|STARTED|Period I||0
8525398|NCT00359762|21013849|P1|STARTED|Period I||0
8525399|NCT00359762|21013845|P5|NOT COMPLETED|Period III||0
8525400|NCT00359762|21013846|P4|NOT COMPLETED|Period III||65
8525401|NCT00359762|21013847|P3|NOT COMPLETED|Period III||30
8525402|NCT00359762|21013848|P2|NOT COMPLETED|Period III||29
8525403|NCT00359762|21013849|P1|NOT COMPLETED|Period III||0
8525404|NCT00359762|21013845|P5|COMPLETED|Period III||0
8525405|NCT00359762|21013846|P4|COMPLETED|Period III||101
8525406|NCT00359762|21013847|P3|COMPLETED|Period III||47
8525407|NCT00359762|21013848|P2|COMPLETED|Period III||48
8525408|NCT00359762|21013849|P1|COMPLETED|Period III||0
8525409|NCT00359762|21013845|P5|Extension ITT Efficacy Population|Period III||0
8525410|NCT00359762|21013846|P4|Extension ITT Efficacy Population|Period III||164
8525411|NCT00359762|21013847|P3|Extension ITT Efficacy Population|Period III||75
8525412|NCT00359762|21013848|P2|Extension ITT Efficacy Population|Period III||73
8525413|NCT00359762|21013849|P1|Extension ITT Efficacy Population|Period III||0
8525414|NCT00359762|21013845|P5|Extension ITT Safety Population|Period III||0
8525415|NCT00359762|21013846|P4|Extension ITT Safety Population|Period III||166
8525416|NCT00359762|21013847|P3|Extension ITT Safety Population|Period III||76
8525417|NCT00359762|21013848|P2|Extension ITT Safety Population|Period III||74
8525418|NCT00359762|21013849|P1|Extension ITT Safety Population|Period III||0
8525419|NCT00359762|21013845|P5|STARTED|Period III||0
8525420|NCT00359762|21013846|P4|STARTED|Period III||166
8525421|NCT00359762|21013847|P3|STARTED|Period III||77
8525422|NCT00359762|21013848|P2|STARTED|Period III||77
8525423|NCT00359762|21013849|P1|STARTED|Period III||0
8525424|NCT00359762|21013845|P5|NOT COMPLETED|Period II||174
8525425|NCT00359762|21013846|P4|NOT COMPLETED|Period II||0
8525426|NCT00359762|21013847|P3|NOT COMPLETED|Period II||0
8525427|NCT00359762|21013848|P2|NOT COMPLETED|Period II||0
8525428|NCT00359762|21013849|P1|NOT COMPLETED|Period II||128
8525429|NCT00359762|21013845|P5|COMPLETED|Period II||341
8525430|NCT00359762|21013846|P4|COMPLETED|Period II||0
8525431|NCT00359762|21013847|P3|COMPLETED|Period II||0
8525432|NCT00359762|21013848|P2|COMPLETED|Period II||0
8525433|NCT00359762|21013849|P1|COMPLETED|Period II||386
8525434|NCT00359762|21013845|P5|Without Treatment Failure|Period II||138
8525435|NCT00359762|21013846|P4|Without Treatment Failure|Period II||0
8525436|NCT00359762|21013847|P3|Without Treatment Failure|Period II||0
8525437|NCT00359762|21013848|P2|Without Treatment Failure|Period II||0
8525438|NCT00359762|21013849|P1|Without Treatment Failure|Period II||124
8525439|NCT00359762|21013845|P5|Met Primary Endpoint|Period II||203
8525440|NCT00359762|21013846|P4|Met Primary Endpoint|Period II||0
8525441|NCT00359762|21013847|P3|Met Primary Endpoint|Period II||0
8525442|NCT00359762|21013848|P2|Met Primary Endpoint|Period II||0
8525443|NCT00359762|21013849|P1|Met Primary Endpoint|Period II||262
8525444|NCT00359762|21013845|P5|ITT Efficacy Population|Period II||490
8525445|NCT00359762|21013846|P4|ITT Efficacy Population|Period II||0
8525446|NCT00359762|21013847|P3|ITT Efficacy Population|Period II||0
8525447|NCT00359762|21013848|P2|ITT Efficacy Population|Period II||0
8525448|NCT00359762|21013849|P1|ITT Efficacy Population|Period II||487
8525449|NCT00359762|21013845|P5|Intent to Treat (ITT) Safety Population|Period II||511
8525450|NCT00359762|21013846|P4|Intent to Treat (ITT) Safety Population|Period II||0
8525451|NCT00359762|21013847|P3|Intent to Treat (ITT) Safety Population|Period II||0
8525452|NCT00359762|21013848|P2|Intent to Treat (ITT) Safety Population|Period II||0
8525453|NCT00359762|21013849|P1|Intent to Treat (ITT) Safety Population|Period II||508
8525454|NCT00359762|21013845|P5|STARTED|Period II||515
8525455|NCT00359762|21013846|P4|STARTED|Period II||0
8525456|NCT00359762|21013847|P3|STARTED|Period II||0
8525457|NCT00359762|21013848|P2|STARTED|Period II||0
8525458|NCT00359762|21013849|P1|STARTED|Period II||514
8525459|NCT00359736|21013912|P2|NOT COMPLETED|Overall Study||0
8525460|NCT00359736|21013913|P1|NOT COMPLETED|Overall Study||0
8525461|NCT00359736|21013912|P2|COMPLETED|Overall Study||15
8525462|NCT00359736|21013913|P1|COMPLETED|Overall Study||14
8525463|NCT00359736|21013912|P2|STARTED|Overall Study||15
8525464|NCT00359736|21013913|P1|STARTED|Overall Study||14
8525465|NCT00359632|21013923|P2|NOT COMPLETED|Overall Study||0
8525466|NCT00359632|21013924|P1|NOT COMPLETED|Overall Study||4
8525467|NCT00359632|21013923|P2|COMPLETED|Overall Study||9
8525468|NCT00359632|21013924|P1|COMPLETED|Overall Study||20
8525469|NCT00359632|21013923|P2|STARTED|Overall Study||9
8525470|NCT00359632|21013924|P1|STARTED|Overall Study||24
8525471|NCT00359619|21013938|P7|NOT COMPLETED|Overall Study||4
8525472|NCT00359619|21013939|P6|NOT COMPLETED|Overall Study||5
8525473|NCT00359619|21013940|P5|NOT COMPLETED|Overall Study||3
8525474|NCT00359619|21013941|P4|NOT COMPLETED|Overall Study||3
8525475|NCT00359619|21013942|P3|NOT COMPLETED|Overall Study||7
8525476|NCT00359619|21013943|P2|NOT COMPLETED|Overall Study||5
8525477|NCT00359619|21013944|P1|NOT COMPLETED|Overall Study||8
8525478|NCT00359619|21013938|P7|COMPLETED|Overall Study||46
8525479|NCT00359619|21013939|P6|COMPLETED|Overall Study||45
8525480|NCT00359619|21013940|P5|COMPLETED|Overall Study||45
8525481|NCT00359619|21013941|P4|COMPLETED|Overall Study||45
8525482|NCT00359619|21013942|P3|COMPLETED|Overall Study||42
8525483|NCT00359619|21013943|P2|COMPLETED|Overall Study||45
8525484|NCT00359619|21013944|P1|COMPLETED|Overall Study||80
8525485|NCT00359619|21013938|P7|STARTED|Overall Study||50
8525486|NCT00359619|21013939|P6|STARTED|Overall Study||50
8525487|NCT00359619|21013940|P5|STARTED|Overall Study||48
8525488|NCT00359619|21013941|P4|STARTED|Overall Study||48
8525489|NCT00359619|21013942|P3|STARTED|Overall Study||49
8525490|NCT00359619|21013943|P2|STARTED|Overall Study||50
8525491|NCT00359619|21013944|P1|STARTED|Overall Study||88
8525492|NCT00359424|21014074|P2|NOT COMPLETED|Overall Study||67
8525493|NCT00359424|21014075|P1|NOT COMPLETED|Overall Study||130
8525494|NCT00359424|21014074|P2|COMPLETED|Overall Study||155
8525495|NCT00359424|21014075|P1|COMPLETED|Overall Study||304
8525496|NCT00359424|21014074|P2|270 Day Follow up|Overall Study||159
8525497|NCT00359424|21014075|P1|270 Day Follow up|Overall Study||313
8525498|NCT00359424|21014074|P2|180 Day Follow up|Overall Study||167
8525499|NCT00359424|21014075|P1|180 Day Follow up|Overall Study||325
8525500|NCT00359424|21014074|P2|90 Day Follow up|Overall Study||172
8525501|NCT00359424|21014075|P1|90 Day Follow up|Overall Study||343
8525502|NCT00359424|21014074|P2|STARTED|Overall Study||222
8525503|NCT00359424|21014075|P1|STARTED|Overall Study||434
8525504|NCT00359281|21014114|P9|NOT COMPLETED|Overall Study||0
8525505|NCT00359281|21014115|P8|NOT COMPLETED|Overall Study||0
8525506|NCT00359281|21014116|P7|NOT COMPLETED|Overall Study||2
8525507|NCT00359281|21014117|P6|NOT COMPLETED|Overall Study||0
8525508|NCT00359281|21014118|P5|NOT COMPLETED|Overall Study||0
8525509|NCT00359281|21014119|P4|NOT COMPLETED|Overall Study||0
8525510|NCT00359281|21014120|P3|NOT COMPLETED|Overall Study||0
8525511|NCT00359281|21014121|P2|NOT COMPLETED|Overall Study||0
8525512|NCT00359281|21014122|P1|NOT COMPLETED|Overall Study||1
8525513|NCT00359281|21014114|P9|COMPLETED|Overall Study||20
8525514|NCT00359281|21014115|P8|COMPLETED|Overall Study||15
8525515|NCT00359281|21014116|P7|COMPLETED|Overall Study||16
8525516|NCT00359281|21014117|P6|COMPLETED|Overall Study||15
8525517|NCT00359281|21014118|P5|COMPLETED|Overall Study||10
8525518|NCT00359281|21014119|P4|COMPLETED|Overall Study||10
8525519|NCT00359281|21014120|P3|COMPLETED|Overall Study||10
8525520|NCT00359281|21014121|P2|COMPLETED|Overall Study||15
8525521|NCT00359281|21014122|P1|COMPLETED|Overall Study||15
8525522|NCT00359281|21014114|P9|STARTED|Overall Study||20
8525523|NCT00359281|21014115|P8|STARTED|Overall Study||15
8525524|NCT00359281|21014116|P7|STARTED|Overall Study||18
8525525|NCT00359281|21014117|P6|STARTED|Overall Study||15
8525526|NCT00359281|21014118|P5|STARTED|Overall Study||10
8525527|NCT00359281|21014119|P4|STARTED|Overall Study||10
8525528|NCT00359281|21014120|P3|STARTED|Overall Study||10
8525529|NCT00359281|21014121|P2|STARTED|Overall Study||15
8525530|NCT00359281|21014122|P1|STARTED|Overall Study||16
8525531|NCT00359216|21014154|P2|NOT COMPLETED|Overall Study||1
8525532|NCT00359216|21014155|P1|NOT COMPLETED|Overall Study||0
8525533|NCT00359216|21014154|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
8525534|NCT00359216|21014155|P1|COMPLETED|Overall Study||20
8525535|NCT00359216|21014154|P2|STARTED|Overall Study||10
8525536|NCT00359216|21014155|P1|STARTED|Overall Study||20
8525537|NCT00359203|21014163|P2|NOT COMPLETED|Overall Study||0
8525538|NCT00359203|21014164|P1|NOT COMPLETED|Overall Study||0
8525539|NCT00359203|21014163|P2|COMPLETED|Overall Study||38
8525540|NCT00359203|21014164|P1|COMPLETED|Overall Study||39
8525541|NCT00359203|21014163|P2|STARTED|Overall Study||38
8525542|NCT00359203|21014164|P1|STARTED|Overall Study||39
8525543|NCT00359138|21014173|P3|NOT COMPLETED|Overall Study||0
8525544|NCT00359138|21014174|P2|NOT COMPLETED|Overall Study||0
8525545|NCT00359138|21014175|P1|NOT COMPLETED|Overall Study||0
8525546|NCT00359138|21014173|P3|COMPLETED|Overall Study||12
8525547|NCT00359138|21014174|P2|COMPLETED|Overall Study||12
8525548|NCT00359138|21014175|P1|COMPLETED|Overall Study||12
8525549|NCT00359138|21014173|P3|STARTED|Overall Study||12
8525550|NCT00359138|21014174|P2|STARTED|Overall Study||12
8525551|NCT00359138|21014175|P1|STARTED|Overall Study||12
8525552|NCT00359073|21014185|P2|NOT COMPLETED|Overall Study||2
8525553|NCT00359073|21014186|P1|NOT COMPLETED|Overall Study||4
8525554|NCT00359073|21014185|P2|COMPLETED|Overall Study||11
8525555|NCT00359073|21014186|P1|COMPLETED|Overall Study||8
8525556|NCT00359073|21014185|P2|STARTED|Overall Study||13
8525557|NCT00359073|21014186|P1|STARTED|Overall Study||12
8525558|NCT00359021|21014198|P2|NOT COMPLETED|Overall Study||52
8525559|NCT00359021|21014199|P1|NOT COMPLETED|Overall Study||81
8525560|NCT00359021|21014198|P2|COMPLETED|Overall Study||195
8525561|NCT00359021|21014199|P1|COMPLETED|Overall Study||175
8525562|NCT00359021|21014198|P2|STARTED|Overall Study||247
8525563|NCT00359021|21014199|P1|STARTED|Overall Study||256
8525564|NCT00358956|21014211|P1|NOT COMPLETED|Overall Study||8
8525565|NCT00358956|21014211|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
8525566|NCT00358956|21014211|P1|STARTED|Overall Study||19
8525567|NCT00358917|21014223|P2|NOT COMPLETED|Overall Study||69
8525568|NCT00358917|21014224|P1|NOT COMPLETED|Overall Study||66
8525569|NCT00358917|21014223|P2|COMPLETED|Overall Study||230
8525570|NCT00358917|21014224|P1|COMPLETED|Overall Study||234
8525571|NCT00358917|21014223|P2|STARTED|Overall Study||299
8525572|NCT00358917|21014224|P1|STARTED|Overall Study||300
8525573|NCT00358826|21014242|P8|NOT COMPLETED|MDCT Substudy||0
8525574|NCT00358826|21014243|P7|NOT COMPLETED|MDCT Substudy||0
8525575|NCT00358826|21014244|P6|NOT COMPLETED|MDCT Substudy||2
8525576|NCT00358826|21014245|P5|NOT COMPLETED|MDCT Substudy||1
8525577|NCT00358826|21014246|P4|NOT COMPLETED|MDCT Substudy||0
8525578|NCT00358826|21014247|P3|NOT COMPLETED|MDCT Substudy||0
8525579|NCT00358826|21014248|P2|NOT COMPLETED|MDCT Substudy||0
8525580|NCT00358826|21014249|P1|NOT COMPLETED|MDCT Substudy||0
8525581|NCT00358826|21014242|P8|COMPLETED|MDCT Substudy||27
8525582|NCT00358826|21014243|P7|COMPLETED|MDCT Substudy||19
8525583|NCT00358826|21014244|P6|COMPLETED|MDCT Substudy||20
8525584|NCT00358826|21014245|P5|COMPLETED|MDCT Substudy||24
8525585|NCT00358826|21014246|P4|COMPLETED|MDCT Substudy||0
8525586|NCT00358826|21014247|P3|COMPLETED|MDCT Substudy||0
8525587|NCT00358826|21014248|P2|COMPLETED|MDCT Substudy||0
8525588|NCT00358826|21014249|P1|COMPLETED|MDCT Substudy||0
8525589|NCT00358826|21014242|P8|STARTED|MDCT Substudy||27
8525590|NCT00358826|21014243|P7|STARTED|MDCT Substudy||19
8525591|NCT00358826|21014244|P6|STARTED|MDCT Substudy||22
8525592|NCT00358826|21014245|P5|STARTED|MDCT Substudy||25
8525593|NCT00358826|21014246|P4|STARTED|MDCT Substudy||0
8525594|NCT00358826|21014247|P3|STARTED|MDCT Substudy||0
8525595|NCT00358826|21014248|P2|STARTED|MDCT Substudy||0
8525596|NCT00358826|21014249|P1|STARTED|MDCT Substudy||0
8525597|NCT00358826|21014242|P8|NOT COMPLETED|Core Study||0
8525598|NCT00358826|21014243|P7|NOT COMPLETED|Core Study||0
8525599|NCT00358826|21014244|P6|NOT COMPLETED|Core Study||0
8525600|NCT00358826|21014245|P5|NOT COMPLETED|Core Study||0
8525601|NCT00358826|21014246|P4|NOT COMPLETED|Core Study||2
8525602|NCT00358826|21014247|P3|NOT COMPLETED|Core Study||2
8525603|NCT00358826|21014248|P2|NOT COMPLETED|Core Study||5
8525604|NCT00358826|21014249|P1|NOT COMPLETED|Core Study||3
8525605|NCT00358826|21014242|P8|COMPLETED|Core Study||0
8525606|NCT00358826|21014243|P7|COMPLETED|Core Study||0
8525607|NCT00358826|21014244|P6|COMPLETED|Core Study||0
8525608|NCT00358826|21014245|P5|COMPLETED|Core Study||0
8525609|NCT00358826|21014246|P4|COMPLETED|Core Study||50
8525610|NCT00358826|21014247|P3|COMPLETED|Core Study||42
8525611|NCT00358826|21014248|P2|COMPLETED|Core Study||41
8525612|NCT00358826|21014249|P1|COMPLETED|Core Study||46
8525613|NCT00358826|21014242|P8|STARTED|Core Study||0
8525614|NCT00358826|21014243|P7|STARTED|Core Study||0
8525615|NCT00358826|21014244|P6|STARTED|Core Study||0
8525616|NCT00358826|21014245|P5|STARTED|Core Study||0
8525617|NCT00358826|21014246|P4|STARTED|Core Study||52
8525618|NCT00358826|21014247|P3|STARTED|Core Study||44
8525619|NCT00358826|21014248|P2|STARTED|Core Study||46
8525620|NCT00358826|21014249|P1|STARTED|Core Study||49
8525621|NCT00358735|21014285|P2|NOT COMPLETED|Overall Study||17
8525622|NCT00358735|21014286|P1|NOT COMPLETED|Overall Study||8
8525623|NCT00358735|21014285|P2|COMPLETED|Overall Study|Efficacy|190
8525624|NCT00358735|21014286|P1|COMPLETED|Overall Study|Efficacy|196
8525625|NCT00358735|21014285|P2|Not Completed Safety|Overall Study||13
8525626|NCT00358735|21014286|P1|Not Completed Safety|Overall Study||6
8525627|NCT00358735|21014285|P2|Completed Safety|Overall Study||194
8525628|NCT00358735|21014286|P1|Completed Safety|Overall Study||198
8525629|NCT00358735|21014285|P2|STARTED|Overall Study||207
8525630|NCT00358735|21014286|P1|STARTED|Overall Study||204
8525631|NCT00358670|21014316|P2|NOT COMPLETED|Overall Study||219
8525632|NCT00358670|21014317|P1|NOT COMPLETED|Overall Study||222
8525633|NCT00358670|21014316|P2|COMPLETED|Overall Study||0
8525634|NCT00358670|21014317|P1|COMPLETED|Overall Study||0
8525635|NCT00358670|21014316|P2|STARTED|Overall Study||219
8525636|NCT00358670|21014317|P1|STARTED|Overall Study||222
8525637|NCT00358657|21014331|P1|NOT COMPLETED|Overall Study||0
8525638|NCT00358657|21014331|P1|COMPLETED|Overall Study||14
8525639|NCT00358657|21014331|P1|STARTED|Overall Study||14
8525640|NCT00358644|21014343|P1|NOT COMPLETED|Overall Study||50
8525641|NCT00358644|21014343|P1|COMPLETED|Overall Study||5
8525642|NCT00358644|21014343|P1|STARTED|Overall Study||55
8525643|NCT00358579|21014349|P2|NOT COMPLETED|Overall Study||0
8525644|NCT00358579|21014350|P1|NOT COMPLETED|Overall Study||0
8525645|NCT00358579|21014349|P2|COMPLETED|Overall Study||374
8525646|NCT00358579|21014350|P1|COMPLETED|Overall Study||353
8525647|NCT00358579|21014349|P2|STARTED|Overall Study||374
8525648|NCT00358579|21014350|P1|STARTED|Overall Study||353
8525649|NCT00358527|21014366|P2|NOT COMPLETED|Overall Study||3
8525650|NCT00358527|21014367|P1|NOT COMPLETED|Overall Study||13
8525651|NCT00358527|21014366|P2|COMPLETED|Overall Study||131
8525652|NCT00358527|21014367|P1|COMPLETED|Overall Study||254
8525653|NCT00358527|21014366|P2|STARTED|Overall Study||134
8525654|NCT00358527|21014367|P1|STARTED|Overall Study||267
8525655|NCT00358501|21014377|P2|NOT COMPLETED|Overall Study||0
8525656|NCT00358501|21014378|P1|NOT COMPLETED|Overall Study||0
8525657|NCT00358501|21014377|P2|COMPLETED|Overall Study||32
8525658|NCT00358501|21014378|P1|COMPLETED|Overall Study||102
8525659|NCT00358501|21014377|P2|STARTED|Overall Study||32
8525660|NCT00358501|21014378|P1|STARTED|Overall Study||102
8525661|NCT00358462|21014393|P2|NOT COMPLETED|Overall Study||64
8525662|NCT00358462|21014394|P1|NOT COMPLETED|Overall Study||59
8525663|NCT00358462|21014393|P2|COMPLETED|Overall Study||238
8525664|NCT00358462|21014394|P1|COMPLETED|Overall Study||245
8525665|NCT00358462|21014393|P2|STARTED|Overall Study||302
8525666|NCT00358462|21014394|P1|STARTED|Overall Study||304
8525667|NCT00358449|21014417|P3|NOT COMPLETED|Overall Study||2
8525668|NCT00358449|21014418|P2|NOT COMPLETED|Overall Study||1
8525669|NCT00358449|21014419|P1|NOT COMPLETED|Overall Study||4
8525670|NCT00358449|21014417|P3|COMPLETED|Overall Study||18
8525671|NCT00358449|21014418|P2|COMPLETED|Overall Study||19
8525672|NCT00358449|21014419|P1|COMPLETED|Overall Study||15
8525673|NCT00358449|21014417|P3|STARTED|Overall Study||20
8525674|NCT00358449|21014418|P2|STARTED|Overall Study||20
8525675|NCT00358449|21014419|P1|STARTED|Overall Study||19
8525676|NCT00358436|21014522|P2|NOT COMPLETED|Overall Study||86
8525677|NCT00358436|21014523|P1|NOT COMPLETED|Overall Study||154
8525678|NCT00358436|21014522|P2|COMPLETED|Overall Study||118
8525679|NCT00358436|21014523|P1|COMPLETED|Overall Study||446
8525680|NCT00358436|21014522|P2|STARTED|Overall Study||204
8525681|NCT00358436|21014523|P1|STARTED|Overall Study||600
8525682|NCT00358332|21014539|P4|NOT COMPLETED|Overall Study||0
8525683|NCT00358332|21014540|P3|NOT COMPLETED|Overall Study||1
8525684|NCT00358332|21014541|P2|NOT COMPLETED|Overall Study||3
8525685|NCT00358332|21014542|P1|NOT COMPLETED|Overall Study||0
8525686|NCT00358332|21014539|P4|COMPLETED|Overall Study||25
8525687|NCT00358332|21014540|P3|COMPLETED|Overall Study||29
8525688|NCT00358332|21014541|P2|COMPLETED|Overall Study||27
8525689|NCT00358332|21014542|P1|COMPLETED|Overall Study||15
8525690|NCT00358332|21014539|P4|STARTED|Overall Study||25
8525691|NCT00358332|21014540|P3|STARTED|Overall Study||30
8525692|NCT00358332|21014541|P2|STARTED|Overall Study||30
8525693|NCT00358332|21014542|P1|STARTED|Overall Study||15
8525694|NCT00358215|21014594|P2|NOT COMPLETED|Overall Study||652
8525695|NCT00358215|21014595|P1|NOT COMPLETED|Overall Study||679
8525696|NCT00358215|21014594|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
8525697|NCT00358215|21014595|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
8525698|NCT00358215|21014594|P2|Received Investigational Product|Overall Study||1133
8525699|NCT00358215|21014595|P1|Received Investigational Product|Overall Study||1140
8525700|NCT00358215|21014594|P2|STARTED|Overall Study||1136
8525701|NCT00358215|21014595|P1|STARTED|Overall Study||1142
8525702|NCT00358150|21014609|P1|NOT COMPLETED|Overall Study||7
8525703|NCT00358150|21014609|P1|COMPLETED|Overall Study||19
8525704|NCT00358150|21014609|P1|STARTED|Overall Study||26
8525705|NCT00358007|21014631|P1|NOT COMPLETED|Overall Study||2
8525706|NCT00358007|21014631|P1|COMPLETED|Overall Study||28
8525707|NCT00358007|21014631|P1|STARTED|Overall Study||30
8525708|NCT00357994|21014638|P2|NOT COMPLETED|Overall Study||3
8525709|NCT00357994|21014639|P1|NOT COMPLETED|Overall Study||2
8525710|NCT00357994|21014638|P2|COMPLETED|Overall Study||31
8525711|NCT00357994|21014639|P1|COMPLETED|Overall Study||35
8525712|NCT00357994|21014638|P2|STARTED|Overall Study||34
8525713|NCT00357994|21014639|P1|STARTED|Overall Study||37
8525714|NCT00357968|21014693|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
8525715|NCT00357968|21014694|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
8525716|NCT00357968|21014693|P2|COMPLETED|Crossover Maintenance Dose Phase||55
8525717|NCT00357968|21014694|P1|COMPLETED|Crossover Maintenance Dose Phase||54
8525718|NCT00357968|21014693|P2|STARTED|Crossover Maintenance Dose Phase||55
8525719|NCT00357968|21014694|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
8525720|NCT00357968|21014693|P2|NOT COMPLETED|First Maintenance Dose Phase||44
8525721|NCT00357968|21014694|P1|NOT COMPLETED|First Maintenance Dose Phase||48
8525722|NCT00357968|21014693|P2|COMPLETED|First Maintenance Dose Phase||55
8525723|NCT00357968|21014694|P1|COMPLETED|First Maintenance Dose Phase||54
8525724|NCT00357968|21014693|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
8525725|NCT00357968|21014694|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
8525726|NCT00357968|21014693|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
8525727|NCT00357968|21014694|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
8525728|NCT00357968|21014693|P2|Received Loading Dose|First Maintenance Dose Phase||99
8525729|NCT00357968|21014694|P1|Received Loading Dose|First Maintenance Dose Phase||102
8525730|NCT00357968|21014693|P2|STARTED|First Maintenance Dose Phase||99
8525731|NCT00357968|21014694|P1|STARTED|First Maintenance Dose Phase||102
8525732|NCT00357955|21014738|P2|NOT COMPLETED|Overall Study||3
8525733|NCT00357955|21014739|P1|NOT COMPLETED|Overall Study||6
8525734|NCT00357955|21014738|P2|COMPLETED|Overall Study||51
8525735|NCT00357955|21014739|P1|COMPLETED|Overall Study||58
8525736|NCT00357955|21014738|P2|STARTED|Overall Study||54
8525737|NCT00357955|21014739|P1|STARTED|Overall Study||64
8525738|NCT00357903|21014747|P2|NOT COMPLETED|Overall Study||43
8525739|NCT00357903|21014748|P1|NOT COMPLETED|Overall Study||363
8525740|NCT00357903|21014747|P2|COMPLETED|Overall Study||15
8525741|NCT00357903|21014748|P1|COMPLETED|Overall Study||218
8525742|NCT00357903|21014747|P2|STARTED|Overall Study||58
8525743|NCT00357903|21014748|P1|STARTED|Overall Study||581
8525744|NCT00357877|21014788|P2|NOT COMPLETED|Overall Study||30
8525745|NCT00357877|21014789|P1|NOT COMPLETED|Overall Study||26
8525746|NCT00357877|21014788|P2|COMPLETED|Overall Study||460
8525747|NCT00357877|21014789|P1|COMPLETED|Overall Study||467
8525748|NCT00357877|21014788|P2|STARTED|Overall Study||490
8525749|NCT00357877|21014789|P1|STARTED|Overall Study||493
8525750|NCT00357760|21014803|P2|NOT COMPLETED|Overall Study||35
8525751|NCT00357760|21014804|P1|NOT COMPLETED|Overall Study||59
8525752|NCT00357760|21014803|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
8525753|NCT00357760|21014804|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
8525754|NCT00357760|21014803|P2|Patients Who Undergo Dose Escalation|Overall Study||16
8525755|NCT00357760|21014804|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
8525756|NCT00357760|21014803|P2|Eligible and Treated Patients|Overall Study||32
8525757|NCT00357760|21014804|P1|Eligible and Treated Patients|Overall Study||57
8525758|NCT00357760|21014803|P2|Patients Who Started Treatment|Overall Study||34
8525759|NCT00357760|21014804|P1|Patients Who Started Treatment|Overall Study||57
8525760|NCT00357760|21014803|P2|STARTED|Overall Study||35
8525761|NCT00357760|21014804|P1|STARTED|Overall Study||59
8525762|NCT00357734|21014814|P1|NOT COMPLETED|Overall Study||4
8525763|NCT00357734|21014814|P1|COMPLETED|Overall Study||10
8525764|NCT00357734|21014814|P1|Patient Received 500 mg of ZD1839|Overall Study||1
8525765|NCT00357734|21014814|P1|Patients Received 250 mg of ZD1839|Overall Study||13
8525766|NCT00357734|21014814|P1|STARTED|Overall Study||14
8525767|NCT00357656|21014825|P2|NOT COMPLETED|Overall Study||3
8525768|NCT00357656|21014826|P1|NOT COMPLETED|Overall Study||0
8525769|NCT00357656|21014825|P2|COMPLETED|Overall Study||29
8525770|NCT00357656|21014826|P1|COMPLETED|Overall Study||31
8525771|NCT00357656|21014825|P2|STARTED|Overall Study||32
8525772|NCT00357656|21014826|P1|STARTED|Overall Study||31
8525773|NCT00357552|21014877|P1|NOT COMPLETED|Weeks 24 to 104||5
8525774|NCT00357552|21014877|P1|COMPLETED|Weeks 24 to 104||117
8525775|NCT00357552|21014877|P1|STARTED|Weeks 24 to 104||122
8525776|NCT00357552|21014877|P1|NOT COMPLETED|Weeks 0 to 24||1
8525777|NCT00357552|21014877|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
8525778|NCT00357552|21014877|P1|STARTED|Weeks 0 to 24||123
8525779|NCT00357552|21014877|P1|NOT COMPLETED|Screening||84
8525780|NCT00357552|21014877|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
8525781|NCT00357552|21014877|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
8525782|NCT00357500|21014892|P1|NOT COMPLETED|Overall Study||77
8525783|NCT00357500|21014892|P1|COMPLETED|Overall Study||24
8525784|NCT00357500|21014892|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
8525785|NCT00357500|21014892|P1|STARTED|Overall Study||101
8525786|NCT00357396|21014901|P2|NOT COMPLETED|Overall Study||0
8525787|NCT00357396|21014902|P1|NOT COMPLETED|Overall Study||1
8525788|NCT00357396|21014901|P2|COMPLETED|Overall Study||4
8525789|NCT00357396|21014902|P1|COMPLETED|Overall Study||5
8525790|NCT00357396|21014901|P2|STARTED|Overall Study||4
8525791|NCT00357396|21014902|P1|STARTED|Overall Study||6
8525792|NCT00357370|21014910|P3|NOT COMPLETED|Cohort 2||2
8525793|NCT00357370|21014911|P2|NOT COMPLETED|Cohort 2||7
8525794|NCT00357370|21014912|P1|NOT COMPLETED|Cohort 2||2
8525795|NCT00357370|21014910|P3|COMPLETED|Cohort 2||22
8525796|NCT00357370|21014911|P2|COMPLETED|Cohort 2||16
8525797|NCT00357370|21014912|P1|COMPLETED|Cohort 2||22
8525798|NCT00357370|21014910|P3|STARTED|Cohort 2||24
8525799|NCT00357370|21014911|P2|STARTED|Cohort 2||23
8525800|NCT00357370|21014912|P1|STARTED|Cohort 2||24
8525801|NCT00357370|21014910|P3|NOT COMPLETED|Cohort 1||0
8525802|NCT00357370|21014911|P2|NOT COMPLETED|Cohort 1||0
8525803|NCT00357370|21014912|P1|NOT COMPLETED|Cohort 1||0
8525804|NCT00357370|21014910|P3|COMPLETED|Cohort 1||0
8525805|NCT00357370|21014911|P2|COMPLETED|Cohort 1||0
8525806|NCT00357370|21014912|P1|COMPLETED|Cohort 1||4
8525807|NCT00357370|21014910|P3|STARTED|Cohort 1||0
8525808|NCT00357370|21014911|P2|STARTED|Cohort 1||0
8525809|NCT00357370|21014912|P1|STARTED|Cohort 1||4
8525810|NCT00357331|21014937|P2|NOT COMPLETED|Overall Study||0
8525811|NCT00357331|21014938|P1|NOT COMPLETED|Overall Study||0
8525812|NCT00357331|21014937|P2|COMPLETED|Overall Study||41
8525813|NCT00357331|21014938|P1|COMPLETED|Overall Study||42
8525814|NCT00357331|21014937|P2|STARTED|Overall Study||41
8525815|NCT00357331|21014938|P1|STARTED|Overall Study||42
8525816|NCT00357214|21014952|P4|NOT COMPLETED|Overall Study||1
8525817|NCT00357214|21014953|P3|NOT COMPLETED|Overall Study||0
8525818|NCT00357214|21014954|P2|NOT COMPLETED|Overall Study||4
8525819|NCT00357214|21014955|P1|NOT COMPLETED|Overall Study||4
8525820|NCT00357214|21014952|P4|COMPLETED|Overall Study||42
8525821|NCT00357214|21014953|P3|COMPLETED|Overall Study||42
8525822|NCT00357214|21014954|P2|COMPLETED|Overall Study||39
8525823|NCT00357214|21014955|P1|COMPLETED|Overall Study||39
8525824|NCT00357214|21014952|P4|STARTED|Overall Study||43
8525825|NCT00357214|21014953|P3|STARTED|Overall Study||42
8525826|NCT00357214|21014954|P2|STARTED|Overall Study||43
8525827|NCT00357214|21014955|P1|STARTED|Overall Study||43
8525828|NCT00357162|21014965|P1|NOT COMPLETED|Overall Study||0
8525829|NCT00357162|21014965|P1|COMPLETED|Overall Study||21
8525830|NCT00357162|21014965|P1|STARTED|Overall Study||21
8525831|NCT00357110|21014975|P2|NOT COMPLETED|Overall Study||5
8525832|NCT00357110|21014976|P1|NOT COMPLETED|Overall Study||5
8525833|NCT00357110|21014975|P2|COMPLETED|Overall Study||2
8525834|NCT00357110|21014976|P1|COMPLETED|Overall Study||1
8525835|NCT00357110|21014975|P2|STARTED|Overall Study||7
8525836|NCT00357110|21014976|P1|STARTED|Overall Study||6
8525837|NCT00357097|21014984|P2|NOT COMPLETED|Overall Study||29
8525838|NCT00357097|21014985|P1|NOT COMPLETED|Overall Study||54
8525839|NCT00357097|21014984|P2|COMPLETED|Overall Study||38
8525840|NCT00357097|21014985|P1|COMPLETED|Overall Study||145
8525841|NCT00357097|21014984|P2|STARTED|Overall Study||67
8525842|NCT00357097|21014985|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
8525843|NCT00357032|21015029|P1|NOT COMPLETED|Overall Study||0
8525844|NCT00357032|21015029|P1|COMPLETED|Overall Study||12
8525845|NCT00357032|21015029|P1|STARTED|Overall Study||12
8525846|NCT00357006|21015039|P3|NOT COMPLETED|Overall Study||3
8525847|NCT00357006|21015040|P2|NOT COMPLETED|Overall Study||5
8525848|NCT00357006|21015041|P1|NOT COMPLETED|Overall Study||2
8525849|NCT00357006|21015039|P3|COMPLETED|Overall Study||59
8525850|NCT00357006|21015040|P2|COMPLETED|Overall Study||51
8525851|NCT00357006|21015041|P1|COMPLETED|Overall Study||60
8525852|NCT00357006|21015039|P3|STARTED|Overall Study||62
8525853|NCT00357006|21015040|P2|STARTED|Overall Study||56
8525854|NCT00357006|21015041|P1|STARTED|Overall Study||62
8525855|NCT00356993|21015049|P1|NOT COMPLETED|Overall Study||3921
8525856|NCT00356993|21015049|P1|COMPLETED|Overall Study||2088
8525857|NCT00356993|21015049|P1|STARTED|Overall Study||6009
8525858|NCT00356915|21015056|P3|NOT COMPLETED|Overall Study||42
8525859|NCT00356915|21015057|P2|NOT COMPLETED|Overall Study||94
8525860|NCT00356915|21015058|P1|NOT COMPLETED|Overall Study||76
8525861|NCT00356915|21015056|P3|COMPLETED|Overall Study||156
8525862|NCT00356915|21015057|P2|COMPLETED|Overall Study||496
8525863|NCT00356915|21015058|P1|COMPLETED|Overall Study||517
8525864|NCT00356915|21015056|P3|STARTED|Overall Study||198
8525865|NCT00356915|21015057|P2|STARTED|Overall Study||590
8525866|NCT00356915|21015058|P1|STARTED|Overall Study||593
8525867|NCT00356889|21015075|P1|NOT COMPLETED|Overall Study||3
8525868|NCT00356889|21015075|P1|COMPLETED|Overall Study||53
8525869|NCT00356889|21015075|P1|STARTED|Overall Study||56
8525870|NCT00356863|21015084|P2|NOT COMPLETED|Overall Study||75
8525871|NCT00356863|21015085|P1|NOT COMPLETED|Overall Study||92
8525872|NCT00356863|21015084|P2|COMPLETED|Overall Study||445
8525873|NCT00356863|21015085|P1|COMPLETED|Overall Study||412
8525874|NCT00356863|21015084|P2|STARTED|Overall Study||520
8525875|NCT00356863|21015085|P1|STARTED|Overall Study||504
8525876|NCT00356811|21015111|P1|NOT COMPLETED|Overall Study||49
8525877|NCT00356811|21015111|P1|COMPLETED|Overall Study||8
8525878|NCT00356811|21015111|P1|STARTED|Overall Study||57
8525879|NCT00356759|21015126|P2|NOT COMPLETED|Overall Study||10
8525880|NCT00356759|21015127|P1|NOT COMPLETED|Overall Study||14
8525881|NCT00356759|21015126|P2|COMPLETED|Overall Study||114
8525882|NCT00356759|21015127|P1|COMPLETED|Overall Study||112
8525883|NCT00356759|21015126|P2|STARTED|Overall Study||124
8525884|NCT00356759|21015127|P1|STARTED|Overall Study||126
8525885|NCT00356603|21015145|P2|NOT COMPLETED|Overall Study||3
8525886|NCT00356603|21015146|P1|NOT COMPLETED|Overall Study||6
8525887|NCT00356603|21015145|P2|COMPLETED|Overall Study||33
8525888|NCT00356603|21015146|P1|COMPLETED|Overall Study||33
8525889|NCT00356603|21015145|P2|STARTED|Overall Study||36
8525890|NCT00356603|21015146|P1|STARTED|Overall Study||39
8525891|NCT00356590|21015160|P1|NOT COMPLETED|Overall Study||274
8525892|NCT00356590|21015160|P1|COMPLETED|Overall Study||194
8525893|NCT00356590|21015160|P1|STARTED|Overall Study||468
8525894|NCT00356525|21015196|P4|NOT COMPLETED|Overall Study||9
8525895|NCT00356525|21015197|P3|NOT COMPLETED|Overall Study||7
8525896|NCT00356525|21015198|P2|NOT COMPLETED|Overall Study||11
8525897|NCT00356525|21015199|P1|NOT COMPLETED|Overall Study||14
8525898|NCT00356525|21015196|P4|COMPLETED|Overall Study||0
8525899|NCT00356525|21015197|P3|COMPLETED|Overall Study||0
8525900|NCT00356525|21015198|P2|COMPLETED|Overall Study||0
8525901|NCT00356525|21015199|P1|COMPLETED|Overall Study||0
8525902|NCT00356525|21015196|P4|STARTED|Overall Study||9
8525903|NCT00356525|21015197|P3|STARTED|Overall Study||7
8525904|NCT00356525|21015198|P2|STARTED|Overall Study||11
8525905|NCT00356525|21015199|P1|STARTED|Overall Study||14
8525906|NCT00356434|21015227|P2|NOT COMPLETED|Overall Study||0
8525907|NCT00356434|21015228|P1|NOT COMPLETED|Overall Study||0
8525908|NCT00356434|21015227|P2|COMPLETED|Overall Study||7
8525909|NCT00356434|21015228|P1|COMPLETED|Overall Study||4
8525910|NCT00356434|21015227|P2|STARTED|Overall Study||7
8525911|NCT00356434|21015228|P1|STARTED|Overall Study||4
8525912|NCT00356421|21015240|P2|NOT COMPLETED|Overall Study||17
8525913|NCT00356421|21015241|P1|NOT COMPLETED|Overall Study||32
8525914|NCT00356421|21015240|P2|COMPLETED|Overall Study||3
8525915|NCT00356421|21015241|P1|COMPLETED|Overall Study||6
8525916|NCT00356421|21015240|P2|STARTED|Overall Study||20
8525917|NCT00356421|21015241|P1|STARTED|Overall Study||38
8525918|NCT00356408|21015281|P1|NOT COMPLETED|Overall Study||60
8525919|NCT00356408|21015281|P1|COMPLETED|Overall Study||43
8525920|NCT00356408|21015281|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
8525921|NCT00356369|21015298|P2|NOT COMPLETED|Year 5||0
8525922|NCT00356369|21015299|P1|NOT COMPLETED|Year 5||0
8525923|NCT00356369|21015298|P2|COMPLETED|Year 5||105
8525924|NCT00356369|21015299|P1|COMPLETED|Year 5||299
8525925|NCT00356369|21015298|P2|STARTED|Year 5||105
8525926|NCT00356369|21015299|P1|STARTED|Year 5||299
8525927|NCT00356369|21015298|P2|NOT COMPLETED|Year 4||0
8525928|NCT00356369|21015299|P1|NOT COMPLETED|Year 4||0
8525929|NCT00356369|21015298|P2|COMPLETED|Year 4||109
8525930|NCT00356369|21015299|P1|COMPLETED|Year 4||317
8525931|NCT00356369|21015298|P2|STARTED|Year 4||109
8525932|NCT00356369|21015299|P1|STARTED|Year 4||317
8525933|NCT00356369|21015298|P2|NOT COMPLETED|Year 3||0
8525934|NCT00356369|21015299|P1|NOT COMPLETED|Year 3||0
8525935|NCT00356369|21015298|P2|COMPLETED|Year 3||116
8525936|NCT00356369|21015299|P1|COMPLETED|Year 3||344
8525937|NCT00356369|21015298|P2|STARTED|Year 3||116
8525938|NCT00356369|21015299|P1|STARTED|Year 3||344
8525939|NCT00356369|21015298|P2|NOT COMPLETED|Year 2||0
8525940|NCT00356369|21015299|P1|NOT COMPLETED|Year 2||0
8525941|NCT00356369|21015298|P2|COMPLETED|Year 2||117
8525942|NCT00356369|21015299|P1|COMPLETED|Year 2||354
8525943|NCT00356369|21015298|P2|STARTED|Year 2||117
8525944|NCT00356369|21015299|P1|STARTED|Year 2||354
8525945|NCT00356369|21015298|P2|NOT COMPLETED|Year 1||0
8525946|NCT00356369|21015299|P1|NOT COMPLETED|Year 1||0
8525947|NCT00356369|21015298|P2|COMPLETED|Year 1||121
8525948|NCT00356369|21015299|P1|COMPLETED|Year 1||364
8525949|NCT00356369|21015298|P2|STARTED|Year 1||121
8525950|NCT00356369|21015299|P1|STARTED|Year 1||364
8525951|NCT00356369|21015298|P2|NOT COMPLETED|Active Phase||1
8525952|NCT00356369|21015299|P1|NOT COMPLETED|Active Phase||2
8525953|NCT00356369|21015298|P2|COMPLETED|Active Phase||125
8525954|NCT00356369|21015299|P1|COMPLETED|Active Phase||372
8525955|NCT00356369|21015298|P2|STARTED|Active Phase||126
8525956|NCT00356369|21015299|P1|STARTED|Active Phase||374
8525957|NCT00356304|21015369|P2|NOT COMPLETED|Overall Study||4
8525958|NCT00356304|21015370|P1|NOT COMPLETED|Overall Study||2
8525959|NCT00356304|21015369|P2|COMPLETED|Overall Study||20
8525960|NCT00356304|21015370|P1|COMPLETED|Overall Study||24
8525961|NCT00356304|21015369|P2|STARTED|Overall Study||24
8525962|NCT00356304|21015370|P1|STARTED|Overall Study||26
8525963|NCT00356278|21015381|P3|NOT COMPLETED|Overall Study||19
8525964|NCT00356278|21015382|P2|NOT COMPLETED|Overall Study||15
8525965|NCT00356278|21015383|P1|NOT COMPLETED|Overall Study||25
8525966|NCT00356278|21015381|P3|COMPLETED|Overall Study||34
8525967|NCT00356278|21015382|P2|COMPLETED|Overall Study||35
8525968|NCT00356278|21015383|P1|COMPLETED|Overall Study||28
8525969|NCT00356278|21015381|P3|STARTED|Overall Study||53
8525970|NCT00356278|21015382|P2|STARTED|Overall Study||50
8525971|NCT00356278|21015383|P1|STARTED|Overall Study||53
8525972|NCT00356265|21015421|P3|NOT COMPLETED|Overall Study||1
8525973|NCT00356265|21015422|P2|NOT COMPLETED|Overall Study||0
8525974|NCT00356265|21015423|P1|NOT COMPLETED|Overall Study||0
8525975|NCT00356265|21015421|P3|COMPLETED|Overall Study||5
8525976|NCT00356265|21015422|P2|COMPLETED|Overall Study||2
8525977|NCT00356265|21015423|P1|COMPLETED|Overall Study||7
8525978|NCT00356265|21015421|P3|STARTED|Overall Study||6
8525979|NCT00356265|21015422|P2|STARTED|Overall Study||2
8525980|NCT00356265|21015423|P1|STARTED|Overall Study||7
8525981|NCT00356200|21015435|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
8525982|NCT00356200|21015436|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
8525983|NCT00356200|21015435|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
8525984|NCT00356200|21015436|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
8525985|NCT00356200|21015435|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
8525986|NCT00356200|21015436|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
8525987|NCT00356200|21015435|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
8525988|NCT00356200|21015436|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
8525989|NCT00356200|21015435|P2|COMPLETED|Cohort 1: 10 ug/ml||0
8525990|NCT00356200|21015436|P1|COMPLETED|Cohort 1: 10 ug/ml||4
8525991|NCT00356200|21015435|P2|STARTED|Cohort 1: 10 ug/ml||0
8525992|NCT00356200|21015436|P1|STARTED|Cohort 1: 10 ug/ml||5
8525993|NCT00356187|21015450|P2|NOT COMPLETED|Overall Study||0
8525994|NCT00356187|21015451|P1|NOT COMPLETED|Overall Study||0
8525995|NCT00356187|21015450|P2|COMPLETED|Overall Study||0
8525996|NCT00356187|21015451|P1|COMPLETED|Overall Study||0
8525997|NCT00356187|21015450|P2|STARTED|Overall Study||0
8525998|NCT00356187|21015451|P1|STARTED|Overall Study||0
8525999|NCT00356148|21015465|P2|NOT COMPLETED|Overall Study||1
8526000|NCT00356148|21015466|P1|NOT COMPLETED|Overall Study||2
8526001|NCT00356148|21015465|P2|COMPLETED|Overall Study||182
8526002|NCT00356148|21015466|P1|COMPLETED|Overall Study||187
8526003|NCT00356148|21015465|P2|STARTED|Overall Study||183
8526004|NCT00356148|21015466|P1|STARTED|Overall Study||189
8526005|NCT00356135|21015477|P3|NOT COMPLETED|Overall Study||5
8526006|NCT00356135|21015478|P2|NOT COMPLETED|Overall Study||2
8526007|NCT00356135|21015479|P1|NOT COMPLETED|Overall Study||4
8526008|NCT00356135|21015477|P3|COMPLETED|Overall Study||39
8526009|NCT00356135|21015478|P2|COMPLETED|Overall Study||46
8526010|NCT00356135|21015479|P1|COMPLETED|Overall Study||43
8526011|NCT00356135|21015477|P3|STARTED|Overall Study||44
8526012|NCT00356135|21015478|P2|STARTED|Overall Study||48
8526013|NCT00356135|21015479|P1|STARTED|Overall Study||47
8526014|NCT00356122|21015501|P1|NOT COMPLETED|FOLLOW-UP||41
8526015|NCT00356122|21015501|P1|COMPLETED|FOLLOW-UP||12
8526016|NCT00356122|21015501|P1|STARTED|FOLLOW-UP||53
8526017|NCT00356122|21015501|P1|NOT COMPLETED|TREATMENT||45
8526018|NCT00356122|21015501|P1|COMPLETED|TREATMENT||8
8526019|NCT00356122|21015501|P1|STARTED|TREATMENT||53
8526020|NCT00356057|21015512|P3|NOT COMPLETED|Overall Study||12
8526021|NCT00356057|21015513|P2|NOT COMPLETED|Overall Study||14
8526022|NCT00356057|21015514|P1|NOT COMPLETED|Overall Study||13
8526023|NCT00356057|21015512|P3|COMPLETED|Overall Study||22
8526024|NCT00356057|21015513|P2|COMPLETED|Overall Study||47
8526025|NCT00356057|21015514|P1|COMPLETED|Overall Study||45
8526026|NCT00356057|21015512|P3|IMPLANTED|Overall Study||25
8526027|NCT00356057|21015513|P2|IMPLANTED|Overall Study||52
8526028|NCT00356057|21015514|P1|IMPLANTED|Overall Study||49
8526029|NCT00356057|21015512|P3|STARTED|Overall Study||34
8526030|NCT00356057|21015513|P2|STARTED|Overall Study||61
8526031|NCT00356057|21015514|P1|STARTED|Overall Study||58
8526032|NCT00356031|21015552|P1|NOT COMPLETED|Overall Study||0
8526033|NCT00356031|21015552|P1|COMPLETED|Overall Study||20
8526034|NCT00356031|21015552|P1|STARTED|Overall Study||20
8526035|NCT00355914|21015563|P2|NOT COMPLETED|Overall Study||0
8526036|NCT00355914|21015564|P1|NOT COMPLETED|Overall Study||0
8526037|NCT00355914|21015563|P2|COMPLETED|Overall Study||60
8526038|NCT00355914|21015564|P1|COMPLETED|Overall Study||60
8526039|NCT00355914|21015563|P2|STARTED|Overall Study||60
8526040|NCT00355914|21015564|P1|STARTED|Overall Study||60
8526041|NCT00355797|21015575|P3|NOT COMPLETED|Overall Study||142
8526042|NCT00355797|21015576|P2|NOT COMPLETED|Overall Study||148
8526043|NCT00355797|21015577|P1|NOT COMPLETED|Overall Study||240
8526044|NCT00355797|21015575|P3|COMPLETED|Overall Study||239
8526045|NCT00355797|21015576|P2|COMPLETED|Overall Study||221
8526046|NCT00355797|21015577|P1|COMPLETED|Overall Study||501
8526047|NCT00355797|21015575|P3|STARTED|Overall Study||381
8526048|NCT00355797|21015576|P2|STARTED|Overall Study||369
8526049|NCT00355797|21015577|P1|STARTED|Overall Study||741
8526050|NCT00355784|21015609|P3|NOT COMPLETED|Overall Study||2
8526051|NCT00355784|21015610|P2|NOT COMPLETED|Overall Study||0
8526052|NCT00355784|21015611|P1|NOT COMPLETED|Overall Study||0
8526053|NCT00355784|21015609|P3|COMPLETED|Overall Study||5
8526054|NCT00355784|21015610|P2|COMPLETED|Overall Study||8
8526055|NCT00355784|21015611|P1|COMPLETED|Overall Study||9
8526056|NCT00355784|21015609|P3|STARTED|Overall Study||7
8526057|NCT00355784|21015610|P2|STARTED|Overall Study||8
8526058|NCT00355784|21015611|P1|STARTED|Overall Study||9
8526059|NCT00355706|21015645|P2|NOT COMPLETED|Overall Study||0
8526060|NCT00355706|21015646|P1|NOT COMPLETED|Overall Study||0
8526061|NCT00355706|21015645|P2|COMPLETED|Overall Study||50
8526062|NCT00355706|21015646|P1|COMPLETED|Overall Study||50
8526063|NCT00355706|21015645|P2|STARTED|Overall Study||50
8526064|NCT00355706|21015646|P1|STARTED|Overall Study||50
8526065|NCT00355615|21015660|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
8526066|NCT00355615|21015661|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526067|NCT00355615|21015662|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526068|NCT00355615|21015663|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526069|NCT00355615|21015664|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526070|NCT00355615|21015660|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
8526071|NCT00355615|21015661|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526072|NCT00355615|21015662|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526073|NCT00355615|21015663|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526074|NCT00355615|21015664|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526075|NCT00355615|21015660|P5|STARTED|40-week Rosuvastatin Open Label Period||173
8526076|NCT00355615|21015661|P4|STARTED|40-week Rosuvastatin Open Label Period||0
8526077|NCT00355615|21015662|P3|STARTED|40-week Rosuvastatin Open Label Period||0
8526078|NCT00355615|21015663|P2|STARTED|40-week Rosuvastatin Open Label Period||0
8526079|NCT00355615|21015664|P1|STARTED|40-week Rosuvastatin Open Label Period||0
8526080|NCT00355615|21015660|P5|NOT COMPLETED|Randomized Double Blind Period||0
8526081|NCT00355615|21015661|P4|NOT COMPLETED|Randomized Double Blind Period||1
8526082|NCT00355615|21015662|P3|NOT COMPLETED|Randomized Double Blind Period||1
8526083|NCT00355615|21015663|P2|NOT COMPLETED|Randomized Double Blind Period||0
8526084|NCT00355615|21015664|P1|NOT COMPLETED|Randomized Double Blind Period||1
8526085|NCT00355615|21015660|P5|COMPLETED|Randomized Double Blind Period||0
8526086|NCT00355615|21015661|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
8526087|NCT00355615|21015662|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
8526088|NCT00355615|21015663|P2|COMPLETED|Randomized Double Blind Period||44
8526089|NCT00355615|21015664|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
8526090|NCT00355615|21015660|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
8526091|NCT00355615|21015661|P4|STARTED|Randomized Double Blind Period||46
8526092|NCT00355615|21015662|P3|STARTED|Randomized Double Blind Period||45
8526093|NCT00355615|21015663|P2|STARTED|Randomized Double Blind Period||44
8526094|NCT00355615|21015664|P1|STARTED|Randomized Double Blind Period||42
8526095|NCT00355472|21015723|P1|NOT COMPLETED|Overall Study||1
8526096|NCT00355472|21015723|P1|COMPLETED|Overall Study||15
8526097|NCT00355472|21015723|P1|STARTED|Overall Study||16
8526098|NCT00355394|21015750|P2|NOT COMPLETED|Overall Study||0
8526099|NCT00355394|21015751|P1|NOT COMPLETED|Overall Study||0
8526100|NCT00355394|21015750|P2|COMPLETED|Overall Study||16
8526101|NCT00355394|21015751|P1|COMPLETED|Overall Study||15
8526102|NCT00355394|21015750|P2|STARTED|Overall Study||16
8526103|NCT00355394|21015751|P1|STARTED|Overall Study||15
8526104|NCT00355368|21015769|P2|NOT COMPLETED|Overall Study||9
8526105|NCT00355368|21015770|P1|NOT COMPLETED|Overall Study||10
8526106|NCT00355368|21015769|P2|COMPLETED|Overall Study||201
8526107|NCT00355368|21015770|P1|COMPLETED|Overall Study||200
8526108|NCT00355368|21015769|P2|STARTED|Overall Study||210
8526109|NCT00355368|21015770|P1|STARTED|Overall Study||210
8526110|NCT00355342|21015784|P2|NOT COMPLETED|Overall Study||36
8526111|NCT00355342|21015785|P1|NOT COMPLETED|Overall Study||39
8526112|NCT00355342|21015784|P2|COMPLETED|Overall Study||56
8526113|NCT00355342|21015785|P1|COMPLETED|Overall Study||55
8526114|NCT00355342|21015784|P2|STARTED|Overall Study||92
8526115|NCT00355342|21015785|P1|STARTED|Overall Study||94
8526116|NCT00355264|21015793|P1|NOT COMPLETED|Extension (Variable Duration)||2
8526117|NCT00355264|21015793|P1|COMPLETED|Extension (Variable Duration)||10
8526118|NCT00355264|21015793|P1|STARTED|Extension (Variable Duration)||12
8526119|NCT00355264|21015793|P1|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
8526120|NCT00355264|21015793|P1|COMPLETED|Part 3 (7 Weeks of Extension)||2
8526121|NCT00355264|21015793|P1|STARTED|Part 3 (7 Weeks of Extension)||2
8526122|NCT00355264|21015793|P1|NOT COMPLETED|Part 2 (8 Weeks)||0
8526123|NCT00355264|21015793|P1|COMPLETED|Part 2 (8 Weeks)||12
8526124|NCT00355264|21015793|P1|STARTED|Part 2 (8 Weeks)||12
8526125|NCT00355264|21015793|P1|NOT COMPLETED|Part 1 (2 Weeks)||0
8526126|NCT00355264|21015793|P1|COMPLETED|Part 1 (2 Weeks)||12
8526127|NCT00355264|21015793|P1|STARTED|Part 1 (2 Weeks)||12
8526128|NCT00355199|21015804|P2|NOT COMPLETED|Overall Study||4
8526129|NCT00355199|21015805|P1|NOT COMPLETED|Overall Study||7
8526130|NCT00355199|21015804|P2|COMPLETED|Overall Study||122
8526131|NCT00355199|21015805|P1|COMPLETED|Overall Study||113
8526132|NCT00355199|21015804|P2|STARTED|Overall Study||126
8526133|NCT00355199|21015805|P1|STARTED|Overall Study||120
8526134|NCT00355147|21015821|P2|NOT COMPLETED|Overall Study||20
8526135|NCT00355147|21015822|P1|NOT COMPLETED|Overall Study||18
8526136|NCT00355147|21015821|P2|COMPLETED|Overall Study||67
8526137|NCT00355147|21015822|P1|COMPLETED|Overall Study||69
8526138|NCT00355147|21015821|P2|STARTED|Overall Study||87
8526139|NCT00355147|21015822|P1|STARTED|Overall Study||87
8526140|NCT00355134|21015841|P5|NOT COMPLETED|Extension Phase||19
8526141|NCT00355134|21015842|P4|NOT COMPLETED|Extension Phase||16
8526142|NCT00355134|21015843|P3|NOT COMPLETED|Extension Phase||0
8526143|NCT00355134|21015844|P2|NOT COMPLETED|Extension Phase||37
8526144|NCT00355134|21015845|P1|NOT COMPLETED|Extension Phase||31
8526145|NCT00355134|21015841|P5|COMPLETED|Extension Phase||88
8526146|NCT00355134|21015842|P4|COMPLETED|Extension Phase||89
8526147|NCT00355134|21015843|P3|COMPLETED|Extension Phase||0
8526148|NCT00355134|21015844|P2|COMPLETED|Extension Phase||180
8526149|NCT00355134|21015845|P1|COMPLETED|Extension Phase||172
8526150|NCT00355134|21015841|P5|STARTED|Extension Phase||107
8526151|NCT00355134|21015842|P4|STARTED|Extension Phase||105
8526152|NCT00355134|21015843|P3|STARTED|Extension Phase||0
8526153|NCT00355134|21015844|P2|STARTED|Extension Phase||217
8526154|NCT00355134|21015845|P1|STARTED|Extension Phase||203
8526155|NCT00355134|21015841|P5|NOT COMPLETED|Core Phase||0
8526156|NCT00355134|21015842|P4|NOT COMPLETED|Core Phase||0
8526157|NCT00355134|21015843|P3|NOT COMPLETED|Core Phase||100
8526158|NCT00355134|21015844|P2|NOT COMPLETED|Core Phase||86
8526159|NCT00355134|21015845|P1|NOT COMPLETED|Core Phase||119
8526160|NCT00355134|21015841|P5|COMPLETED|Core Phase||0
8526161|NCT00355134|21015842|P4|COMPLETED|Core Phase||0
8526162|NCT00355134|21015843|P3|COMPLETED|Core Phase||255
8526163|NCT00355134|21015844|P2|COMPLETED|Core Phase||272
8526164|NCT00355134|21015845|P1|COMPLETED|Core Phase||251
8526165|NCT00355134|21015841|P5|STARTED|Core Phase||0
8526166|NCT00355134|21015842|P4|STARTED|Core Phase||0
8526167|NCT00355134|21015843|P3|STARTED|Core Phase||355
8526168|NCT00355134|21015844|P2|STARTED|Core Phase||358
8526169|NCT00355134|21015845|P1|STARTED|Core Phase||370
8526170|NCT00355121|21015888|P3|NOT COMPLETED|Overall Study||5
8526171|NCT00355121|21015889|P2|NOT COMPLETED|Overall Study||29
8526172|NCT00355121|21015890|P1|NOT COMPLETED|Overall Study||21
8526173|NCT00355121|21015888|P3|COMPLETED|Overall Study||170
8526174|NCT00355121|21015889|P2|COMPLETED|Overall Study||324
8526175|NCT00355121|21015890|P1|COMPLETED|Overall Study||332
8526176|NCT00355121|21015888|P3|STARTED|Overall Study||175
8526177|NCT00355121|21015889|P2|STARTED|Overall Study||353
8526178|NCT00355121|21015890|P1|STARTED|Overall Study||353
8526179|NCT00355082|21015921|P3|NOT COMPLETED|Continuation Phase||3
8526180|NCT00355082|21015922|P2|NOT COMPLETED|Continuation Phase||0
8526181|NCT00355082|21015923|P1|NOT COMPLETED|Continuation Phase||24
8526182|NCT00355082|21015921|P3|COMPLETED|Continuation Phase||8
8526183|NCT00355082|21015922|P2|COMPLETED|Continuation Phase||0
8526184|NCT00355082|21015923|P1|COMPLETED|Continuation Phase||160
8526185|NCT00355082|21015921|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
8526186|NCT00355082|21015922|P2|STARTED|Continuation Phase||0
8526187|NCT00355082|21015923|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
8526188|NCT00355082|21015921|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
8526189|NCT00355082|21015922|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
8526190|NCT00355082|21015923|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
8526191|NCT00355082|21015921|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
8526192|NCT00355082|21015922|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
8526193|NCT00355082|21015923|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
8526194|NCT00355082|21015921|P3|STARTED|Double-Blind (DB) Treatment Phase||0
8526195|NCT00355082|21015922|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
8526196|NCT00355082|21015923|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
8526197|NCT00355056|21015945|P2|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
8526198|NCT00355056|21015946|P1|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
8526199|NCT00355056|21015945|P2|COMPLETED|Optional Patent Foramen Ovale Closure||84
8526200|NCT00355056|21015946|P1|COMPLETED|Optional Patent Foramen Ovale Closure||0
8526201|NCT00355056|21015945|P2|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
8526202|NCT00355056|21015946|P1|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
8526203|NCT00355056|21015945|P2|NOT COMPLETED|Randomization Period||6
8526204|NCT00355056|21015946|P1|NOT COMPLETED|Randomization Period||4
8526205|NCT00355056|21015945|P2|COMPLETED|Randomization Period||117
8526206|NCT00355056|21015946|P1|COMPLETED|Randomization Period||103
8526207|NCT00355056|21015945|P2|STARTED|Randomization Period||123
8526208|NCT00355056|21015946|P1|STARTED|Randomization Period||107
8526209|NCT00355030|21015976|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
8526210|NCT00355030|21015977|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
8526211|NCT00355030|21015976|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
8526212|NCT00355030|21015977|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
8526213|NCT00355030|21015976|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
8526214|NCT00355030|21015977|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
8526215|NCT00355030|21015976|P2|NOT COMPLETED|Study Period 1 Treatment||44
8526216|NCT00355030|21015977|P1|NOT COMPLETED|Study Period 1 Treatment||45
8526217|NCT00355030|21015976|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
8526218|NCT00355030|21015977|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
8526219|NCT00355030|21015976|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
8526220|NCT00355030|21015977|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
8526221|NCT00355030|21015976|P2|STARTED|Study Period 1 Treatment||45
8526222|NCT00355030|21015977|P1|STARTED|Study Period 1 Treatment||46
8526223|NCT00354978|21015999|P1|NOT COMPLETED|Overall Study||0
8526224|NCT00354978|21015999|P1|COMPLETED|Overall Study||43
8526225|NCT00354978|21015999|P1|STARTED|Overall Study||43
8526226|NCT00354913|21016003|P1|NOT COMPLETED|Overall Study||0
8526227|NCT00354913|21016003|P1|COMPLETED|Overall Study||21
8526228|NCT00354913|21016003|P1|STARTED|Overall Study||21
8526229|NCT00354887|21016010|P1|NOT COMPLETED|Overall Study||1
8526230|NCT00354887|21016010|P1|COMPLETED|Overall Study||29
8526231|NCT00354887|21016010|P1|STARTED|Overall Study||30
8526232|NCT00354835|21016016|P2|NOT COMPLETED|Overall Study||61
8526233|NCT00354835|21016017|P1|NOT COMPLETED|Overall Study||52
8526234|NCT00354835|21016016|P2|COMPLETED|Overall Study||181
8526235|NCT00354835|21016017|P1|COMPLETED|Overall Study||187
8526236|NCT00354835|21016016|P2|STARTED|Overall Study||242
8526237|NCT00354835|21016017|P1|STARTED|Overall Study||239
8526238|NCT00354770|21016049|P2|NOT COMPLETED|Overall Study||3
8526239|NCT00354770|21016050|P1|NOT COMPLETED|Overall Study||3
8526240|NCT00354770|21016049|P2|COMPLETED|Overall Study||22
8526241|NCT00354770|21016050|P1|COMPLETED|Overall Study||22
8526242|NCT00354770|21016049|P2|STARTED|Overall Study||25
8526243|NCT00354770|21016050|P1|STARTED|Overall Study||25
8526244|NCT00354744|21016056|P1|NOT COMPLETED|Overall Study||42
8526245|NCT00354744|21016056|P1|COMPLETED|Overall Study||67
8526246|NCT00354744|21016056|P1|STARTED|Overall Study||109
8526247|NCT00354679|21016062|P1|NOT COMPLETED|Overall Study||1
8526248|NCT00354679|21016062|P1|COMPLETED|Overall Study||33
8526249|NCT00354679|21016062|P1|STARTED|Overall Study||34
8526250|NCT00354640|21016066|P1|NOT COMPLETED|Overall Study||0
8526251|NCT00354640|21016066|P1|COMPLETED|Overall Study||11
8526252|NCT00354640|21016066|P1|STARTED|Overall Study||11
8526253|NCT00354614|21016071|P1|NOT COMPLETED|Overall Study||28
8526254|NCT00354614|21016071|P1|COMPLETED|Overall Study||53
8526255|NCT00354614|21016071|P1|STARTED|Overall Study||81
8526256|NCT00354601|21016075|P1|NOT COMPLETED|Overall Study||2
8526257|NCT00354601|21016075|P1|COMPLETED|Overall Study||0
8526258|NCT00354601|21016075|P1|STARTED|Overall Study||2
8526259|NCT00354484|21016084|P2|NOT COMPLETED|Overall Study||3
8526260|NCT00354484|21016085|P1|NOT COMPLETED|Overall Study||4
8526261|NCT00354484|21016084|P2|COMPLETED|Overall Study||144
8526262|NCT00354484|21016085|P1|COMPLETED|Overall Study||138
8526263|NCT00354484|21016084|P2|STARTED|Overall Study||147
8526264|NCT00354484|21016085|P1|STARTED|Overall Study||142
8526265|NCT00354432|21016095|P4|NOT COMPLETED|Overall Study||10
8526266|NCT00354432|21016096|P3|NOT COMPLETED|Overall Study||10
8526267|NCT00354432|21016097|P2|NOT COMPLETED|Overall Study||8
8526268|NCT00354432|21016098|P1|NOT COMPLETED|Overall Study||6
8526269|NCT00354432|21016095|P4|COMPLETED|Overall Study||20
8526270|NCT00354432|21016096|P3|COMPLETED|Overall Study||20
8526271|NCT00354432|21016097|P2|COMPLETED|Overall Study||22
8526272|NCT00354432|21016098|P1|COMPLETED|Overall Study||24
8526273|NCT00354432|21016095|P4|STARTED|Overall Study||30
8526274|NCT00354432|21016096|P3|STARTED|Overall Study||30
8526275|NCT00354432|21016097|P2|STARTED|Overall Study||30
8526276|NCT00354432|21016098|P1|STARTED|Overall Study||30
8526277|NCT00354341|21016114|P2|NOT COMPLETED|Overall Study||7
8526278|NCT00354341|21016115|P1|NOT COMPLETED|Overall Study||3
8526279|NCT00354341|21016114|P2|COMPLETED|Overall Study||75
8526280|NCT00354341|21016115|P1|COMPLETED|Overall Study||85
8526281|NCT00354341|21016114|P2|STARTED|Overall Study||82
8526282|NCT00354341|21016115|P1|STARTED|Overall Study||88
8526283|NCT00354224|21016131|P1|NOT COMPLETED|Overall Study||0
8526284|NCT00354224|21016131|P1|COMPLETED|Overall Study||10
8526285|NCT00354224|21016131|P1|STARTED|Overall Study||10
8526286|NCT00354172|21016137|P1|NOT COMPLETED|Overall Study||1
8526287|NCT00354172|21016137|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
8526288|NCT00354172|21016137|P1|STARTED|Overall Study||16
8526289|NCT00354159|21016157|P2|NOT COMPLETED|Long-term Follow-up||176
8526290|NCT00354159|21016158|P1|NOT COMPLETED|Long-term Follow-up||180
8526291|NCT00354159|21016157|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
8526292|NCT00354159|21016158|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
8526293|NCT00354159|21016157|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
8526294|NCT00354159|21016158|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
8526295|NCT00354159|21016157|P2|NOT COMPLETED|Randomized Study Period||22
8526296|NCT00354159|21016158|P1|NOT COMPLETED|Randomized Study Period||22
8526297|NCT00354159|21016157|P2|COMPLETED|Randomized Study Period||176
8526298|NCT00354159|21016158|P1|COMPLETED|Randomized Study Period||180
8526299|NCT00354159|21016157|P2|STARTED|Randomized Study Period||198
8526300|NCT00354159|21016158|P1|STARTED|Randomized Study Period||202
8526301|NCT00354107|21016201|P1|NOT COMPLETED|Overall Study||5
8526302|NCT00354107|21016201|P1|COMPLETED|Overall Study||0
8526303|NCT00354107|21016201|P1|STARTED|Overall Study||5
8526304|NCT00354029|21016211|P2|NOT COMPLETED|Overall Study||2
8526305|NCT00354029|21016212|P1|NOT COMPLETED|Overall Study||4
8526306|NCT00354029|21016211|P2|COMPLETED|Overall Study||38
8526307|NCT00354029|21016212|P1|COMPLETED|Overall Study||39
8526308|NCT00354029|21016211|P2|STARTED|Overall Study||40
8526309|NCT00354029|21016212|P1|STARTED|Overall Study||43
8526310|NCT00353977|21016218|P1|NOT COMPLETED|Overall Study||0
8526311|NCT00353977|21016218|P1|COMPLETED|Overall Study||38
8526312|NCT00353977|21016218|P1|STARTED|Overall Study||38
8526313|NCT00353873|21016224|P2|NOT COMPLETED|Overall Study||3
8526314|NCT00353873|21016225|P1|NOT COMPLETED|Overall Study||6
8526315|NCT00353873|21016224|P2|COMPLETED|Overall Study||147
8526316|NCT00353873|21016225|P1|COMPLETED|Overall Study||147
8526317|NCT00353873|21016224|P2|STARTED|Overall Study||150
8526318|NCT00353873|21016225|P1|STARTED|Overall Study||153
8526319|NCT00353834|21016239|P2|NOT COMPLETED|Overall Study||0
8526320|NCT00353834|21016240|P1|NOT COMPLETED|Overall Study||0
8526321|NCT00353834|21016239|P2|COMPLETED|Overall Study||27
8526322|NCT00353834|21016240|P1|COMPLETED|Overall Study||26
8526323|NCT00353834|21016239|P2|STARTED|Overall Study||27
8526324|NCT00353834|21016240|P1|STARTED|Overall Study||26
8526325|NCT00353795|21016248|P1|NOT COMPLETED|Overall Study||0
8526326|NCT00353795|21016248|P1|COMPLETED|Overall Study||179
8526327|NCT00353795|21016248|P1|STARTED|Overall Study||179
8526328|NCT00353704|21016254|P2|NOT COMPLETED|Overall Study||1
8526329|NCT00353704|21016255|P1|NOT COMPLETED|Overall Study||3
8526330|NCT00353704|21016254|P2|COMPLETED|Overall Study||24
8526331|NCT00353704|21016255|P1|COMPLETED|Overall Study||22
8526332|NCT00353704|21016254|P2|STARTED|Overall Study||25
8526333|NCT00353704|21016255|P1|STARTED|Overall Study||25
8526334|NCT00353652|21016265|P8|NOT COMPLETED|Third Intervention - 3 Months||0
8526335|NCT00353652|21016266|P7|NOT COMPLETED|Third Intervention - 3 Months||0
8526336|NCT00353652|21016267|P6|NOT COMPLETED|Third Intervention - 3 Months||0
8526337|NCT00353652|21016268|P5|NOT COMPLETED|Third Intervention - 3 Months||0
8526338|NCT00353652|21016269|P4|NOT COMPLETED|Third Intervention - 3 Months||1
8526339|NCT00353652|21016270|P3|NOT COMPLETED|Third Intervention - 3 Months||0
8526340|NCT00353652|21016271|P2|NOT COMPLETED|Third Intervention - 3 Months||0
8526341|NCT00353652|21016272|P1|NOT COMPLETED|Third Intervention - 3 Months||0
8526342|NCT00353652|21016265|P8|COMPLETED|Third Intervention - 3 Months||0
8526343|NCT00353652|21016266|P7|COMPLETED|Third Intervention - 3 Months||1
8526344|NCT00353652|21016267|P6|COMPLETED|Third Intervention - 3 Months||0
8526345|NCT00353652|21016268|P5|COMPLETED|Third Intervention - 3 Months||3
8526346|NCT00353652|21016269|P4|COMPLETED|Third Intervention - 3 Months||6
8526347|NCT00353652|21016270|P3|COMPLETED|Third Intervention - 3 Months||6
8526348|NCT00353652|21016271|P2|COMPLETED|Third Intervention - 3 Months||0
8526349|NCT00353652|21016272|P1|COMPLETED|Third Intervention - 3 Months||0
8526350|NCT00353652|21016265|P8|STARTED|Third Intervention - 3 Months||0
8526351|NCT00353652|21016266|P7|STARTED|Third Intervention - 3 Months||1
8526352|NCT00353652|21016267|P6|STARTED|Third Intervention - 3 Months||0
8526353|NCT00353652|21016268|P5|STARTED|Third Intervention - 3 Months||3
8526354|NCT00353652|21016269|P4|STARTED|Third Intervention - 3 Months||7
8526355|NCT00353652|21016270|P3|STARTED|Third Intervention - 3 Months||6
8526356|NCT00353652|21016271|P2|STARTED|Third Intervention - 3 Months||0
8526357|NCT00353652|21016272|P1|STARTED|Third Intervention - 3 Months||0
8526358|NCT00353652|21016265|P8|NOT COMPLETED|Second Intervention - 3 Months||0
8526359|NCT00353652|21016266|P7|NOT COMPLETED|Second Intervention - 3 Months||0
8526360|NCT00353652|21016267|P6|NOT COMPLETED|Second Intervention - 3 Months||0
8526361|NCT00353652|21016268|P5|NOT COMPLETED|Second Intervention - 3 Months||0
8526362|NCT00353652|21016269|P4|NOT COMPLETED|Second Intervention - 3 Months||0
8526363|NCT00353652|21016270|P3|NOT COMPLETED|Second Intervention - 3 Months||0
8526364|NCT00353652|21016271|P2|NOT COMPLETED|Second Intervention - 3 Months||0
8526365|NCT00353652|21016272|P1|NOT COMPLETED|Second Intervention - 3 Months||0
8526366|NCT00353652|21016265|P8|COMPLETED|Second Intervention - 3 Months||0
8526367|NCT00353652|21016266|P7|COMPLETED|Second Intervention - 3 Months||1
8526368|NCT00353652|21016267|P6|COMPLETED|Second Intervention - 3 Months||0
8526369|NCT00353652|21016268|P5|COMPLETED|Second Intervention - 3 Months||3
8526370|NCT00353652|21016269|P4|COMPLETED|Second Intervention - 3 Months||7
8526371|NCT00353652|21016270|P3|COMPLETED|Second Intervention - 3 Months||6
8526372|NCT00353652|21016271|P2|COMPLETED|Second Intervention - 3 Months||11
8526373|NCT00353652|21016272|P1|COMPLETED|Second Intervention - 3 Months||12
8526374|NCT00353652|21016265|P8|STARTED|Second Intervention - 3 Months||0
8526375|NCT00353652|21016266|P7|STARTED|Second Intervention - 3 Months||1
8526376|NCT00353652|21016267|P6|STARTED|Second Intervention - 3 Months||0
8526377|NCT00353652|21016268|P5|STARTED|Second Intervention - 3 Months||3
8526378|NCT00353652|21016269|P4|STARTED|Second Intervention - 3 Months||7
8526379|NCT00353652|21016270|P3|STARTED|Second Intervention - 3 Months||6
8526380|NCT00353652|21016271|P2|STARTED|Second Intervention - 3 Months||11
8526381|NCT00353652|21016272|P1|STARTED|Second Intervention - 3 Months||12
8526382|NCT00353652|21016265|P8|NOT COMPLETED|First Intervention - 3 Months||0
8526383|NCT00353652|21016266|P7|NOT COMPLETED|First Intervention - 3 Months||0
8526384|NCT00353652|21016267|P6|NOT COMPLETED|First Intervention - 3 Months||0
8526385|NCT00353652|21016268|P5|NOT COMPLETED|First Intervention - 3 Months||0
8526386|NCT00353652|21016269|P4|NOT COMPLETED|First Intervention - 3 Months||0
8526387|NCT00353652|21016270|P3|NOT COMPLETED|First Intervention - 3 Months||0
8526388|NCT00353652|21016271|P2|NOT COMPLETED|First Intervention - 3 Months||4
8526389|NCT00353652|21016272|P1|NOT COMPLETED|First Intervention - 3 Months||3
8526390|NCT00353652|21016265|P8|COMPLETED|First Intervention - 3 Months||0
8526391|NCT00353652|21016266|P7|COMPLETED|First Intervention - 3 Months||1
8526392|NCT00353652|21016267|P6|COMPLETED|First Intervention - 3 Months||0
8526393|NCT00353652|21016268|P5|COMPLETED|First Intervention - 3 Months||3
8526394|NCT00353652|21016269|P4|COMPLETED|First Intervention - 3 Months||7
8526395|NCT00353652|21016270|P3|COMPLETED|First Intervention - 3 Months||6
8526396|NCT00353652|21016271|P2|COMPLETED|First Intervention - 3 Months||11
8526397|NCT00353652|21016272|P1|COMPLETED|First Intervention - 3 Months||12
8526398|NCT00353652|21016265|P8|STARTED|First Intervention - 3 Months||0
8526399|NCT00353652|21016266|P7|STARTED|First Intervention - 3 Months||1
8526400|NCT00353652|21016267|P6|STARTED|First Intervention - 3 Months||0
8526401|NCT00353652|21016268|P5|STARTED|First Intervention - 3 Months||3
8526402|NCT00353652|21016269|P4|STARTED|First Intervention - 3 Months||7
8526403|NCT00353652|21016270|P3|STARTED|First Intervention - 3 Months||6
8526404|NCT00353652|21016271|P2|STARTED|First Intervention - 3 Months||15
8526405|NCT00353652|21016272|P1|STARTED|First Intervention - 3 Months||15
8526406|NCT00353522|21016306|P2|NOT COMPLETED|Overall Study||9
8526407|NCT00353522|21016307|P1|NOT COMPLETED|Overall Study||15
8526408|NCT00353522|21016306|P2|COMPLETED|Overall Study||37
8526409|NCT00353522|21016307|P1|COMPLETED|Overall Study||74
8526410|NCT00353522|21016306|P2|STARTED|Overall Study||46
8526411|NCT00353522|21016307|P1|STARTED|Overall Study||89
8526412|NCT00353496|21016325|P2|NOT COMPLETED|Overall Study||17
8526413|NCT00353496|21016326|P1|NOT COMPLETED|Overall Study||16
8526414|NCT00353496|21016325|P2|COMPLETED|Overall Study||86
8526415|NCT00353496|21016326|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
8526416|NCT00353496|21016325|P2|STARTED|Overall Study||103
8526417|NCT00353496|21016326|P1|STARTED|Overall Study||101
8526418|NCT00353431|21016343|P2|NOT COMPLETED|Overall Study||0
8526419|NCT00353431|21016344|P1|NOT COMPLETED|Overall Study||0
8526420|NCT00353431|21016343|P2|COMPLETED|Overall Study||67
8526421|NCT00353431|21016344|P1|COMPLETED|Overall Study||63
8526422|NCT00353431|21016343|P2|STARTED|Overall Study||67
8526423|NCT00353431|21016344|P1|STARTED|Overall Study||63
8526424|NCT00353418|21016360|P2|NOT COMPLETED|Overall Study||158
8526425|NCT00353418|21016361|P1|NOT COMPLETED|Overall Study||83
8526426|NCT00353418|21016360|P2|COMPLETED|Overall Study||119
8526427|NCT00353418|21016361|P1|COMPLETED|Overall Study||55
8526428|NCT00353418|21016360|P2|STARTED|Overall Study||277
8526429|NCT00353418|21016361|P1|STARTED|Overall Study||138
8526430|NCT00353366|21016379|P1|NOT COMPLETED|Overall Study||143
8526431|NCT00353366|21016379|P1|COMPLETED|Overall Study||1289
8526432|NCT00353366|21016379|P1|STARTED|Overall Study||1432
8526433|NCT00353301|21016386|P1|NOT COMPLETED|Overall Study||0
8526434|NCT00353301|21016386|P1|COMPLETED|Overall Study||25
8526435|NCT00353301|21016386|P1|STARTED|Overall Study||25
8526436|NCT00353275|21016393|P2|NOT COMPLETED|Overall Study||0
8526437|NCT00353275|21016394|P1|NOT COMPLETED|Overall Study||0
8526438|NCT00353275|21016393|P2|COMPLETED|Overall Study||3
8526439|NCT00353275|21016394|P1|COMPLETED|Overall Study||2
8526440|NCT00353275|21016393|P2|STARTED|Overall Study||3
8526441|NCT00353275|21016394|P1|STARTED|Overall Study||2
8526442|NCT00353262|21016406|P1|NOT COMPLETED|Overall Study||29
8526443|NCT00353262|21016406|P1|COMPLETED|Overall Study||7
8526444|NCT00353262|21016406|P1|STARTED|Overall Study||36
8526445|NCT00353119|21016425|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
8526446|NCT00353119|21016426|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
8526447|NCT00353119|21016425|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
8526448|NCT00353119|21016426|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
8526449|NCT00353119|21016425|P2|STARTED|Second Intervention Week 12 to Week 28||10
8526450|NCT00353119|21016426|P1|STARTED|Second Intervention Week 12 to Week 28||5
8526451|NCT00353119|21016425|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
8526452|NCT00353119|21016426|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
8526453|NCT00353119|21016425|P2|COMPLETED|First Intervention Day 0 to Week 12||10
8526454|NCT00353119|21016426|P1|COMPLETED|First Intervention Day 0 to Week 12||5
8526455|NCT00353119|21016425|P2|STARTED|First Intervention Day 0 to Week 12||10
8526456|NCT00353119|21016426|P1|STARTED|First Intervention Day 0 to Week 12||5
8526457|NCT00352911|21016438|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
8526458|NCT00352911|21016439|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
8526459|NCT00352911|21016438|P2|COMPLETED|300mg Twice Daily (14 Days)||3
8526460|NCT00352911|21016439|P1|COMPLETED|300mg Twice Daily (14 Days)||15
8526461|NCT00352911|21016438|P2|STARTED|300mg Twice Daily (14 Days)||3
8526462|NCT00352911|21016439|P1|STARTED|300mg Twice Daily (14 Days)||16
8526463|NCT00352911|21016438|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
8526464|NCT00352911|21016439|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
8526465|NCT00352911|21016438|P2|COMPLETED|150mg Twice Daily (14 Days)||3
8526466|NCT00352911|21016439|P1|COMPLETED|150mg Twice Daily (14 Days)||16
8526467|NCT00352911|21016438|P2|STARTED|150mg Twice Daily (14 Days)||3
8526468|NCT00352911|21016439|P1|STARTED|150mg Twice Daily (14 Days)||16
8526469|NCT00352885|21016447|P2|NOT COMPLETED|Overall Study||7
8526470|NCT00352885|21016448|P1|NOT COMPLETED|Overall Study||6
8526471|NCT00352885|21016447|P2|COMPLETED|Overall Study||4
8526472|NCT00352885|21016448|P1|COMPLETED|Overall Study||3
8526473|NCT00352885|21016447|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
8526474|NCT00352885|21016448|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
8526475|NCT00352885|21016447|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
8526476|NCT00352885|21016448|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
8526477|NCT00352885|21016447|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
8526478|NCT00352885|21016448|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
8526479|NCT00352885|21016447|P2|STARTED|Overall Study||11
8526480|NCT00352885|21016448|P1|STARTED|Overall Study||9
8526481|NCT00352846|21016466|P2|NOT COMPLETED|Overall Study||13
8526482|NCT00352846|21016467|P1|NOT COMPLETED|Overall Study||8
8526483|NCT00352846|21016466|P2|COMPLETED|Overall Study||24
8526484|NCT00352846|21016467|P1|COMPLETED|Overall Study||29
8526485|NCT00352846|21016466|P2|STARTED|Overall Study||37
8526486|NCT00352846|21016467|P1|STARTED|Overall Study||37
8526487|NCT00352794|21016473|P1|NOT COMPLETED|Overall Study||0
8526488|NCT00352794|21016473|P1|COMPLETED|Overall Study||40
8526489|NCT00352794|21016473|P1|STARTED|Overall Study||40
8526490|NCT00352781|21016477|P1|NOT COMPLETED|Overall Study||883
8526491|NCT00352781|21016477|P1|COMPLETED|Overall Study||884
8526492|NCT00352781|21016477|P1|STARTED|Overall Study||1767
8526493|NCT00352755|21016482|P1|NOT COMPLETED|Overall Study||2
8526494|NCT00352755|21016482|P1|COMPLETED|Overall Study||16
8526495|NCT00352755|21016482|P1|STARTED|Overall Study||18
8526496|NCT00352690|21016492|P2|NOT COMPLETED|Overall Study||0
8526497|NCT00352690|21016493|P1|NOT COMPLETED|Overall Study||2
8526498|NCT00352690|21016492|P2|COMPLETED|Overall Study||0
8526499|NCT00352690|21016493|P1|COMPLETED|Overall Study||8
8526500|NCT00352690|21016492|P2|STARTED|Overall Study||0
8526501|NCT00352690|21016493|P1|STARTED|Overall Study||10
8526502|NCT00352664|21016513|P2|NOT COMPLETED|Overall Study||0
8526503|NCT00352664|21016514|P1|NOT COMPLETED|Overall Study||7
8526504|NCT00352664|21016513|P2|COMPLETED|Overall Study||0
8526505|NCT00352664|21016514|P1|COMPLETED|Overall Study||20
8526506|NCT00352664|21016513|P2|STARTED|Overall Study||0
8526507|NCT00352664|21016514|P1|STARTED|Overall Study||27
8526508|NCT00352612|21016522|P2|NOT COMPLETED|Overall Study||0
8526509|NCT00352612|21016523|P1|NOT COMPLETED|Overall Study||0
8526510|NCT00352612|21016522|P2|COMPLETED|Overall Study||100
8526511|NCT00352612|21016523|P1|COMPLETED|Overall Study||100
8526512|NCT00352612|21016522|P2|STARTED|Overall Study||100
8526513|NCT00352612|21016523|P1|STARTED|Overall Study||100
8526514|NCT00352534|21016531|P7|NOT COMPLETED|Final Risk Group Assignment||39
8526515|NCT00352534|21016532|P6|NOT COMPLETED|Final Risk Group Assignment||45
8526516|NCT00352534|21016533|P5|NOT COMPLETED|Final Risk Group Assignment||1
8526517|NCT00352534|21016534|P4|NOT COMPLETED|Final Risk Group Assignment||3
8526518|NCT00352534|21016535|P3|NOT COMPLETED|Final Risk Group Assignment||3
8526519|NCT00352534|21016536|P2|NOT COMPLETED|Final Risk Group Assignment||0
8526520|NCT00352534|21016537|P1|NOT COMPLETED|Final Risk Group Assignment||0
8526521|NCT00352534|21016531|P7|COMPLETED|Final Risk Group Assignment||1
8526522|NCT00352534|21016532|P6|COMPLETED|Final Risk Group Assignment||503
8526523|NCT00352534|21016533|P5|COMPLETED|Final Risk Group Assignment||31
8526524|NCT00352534|21016534|P4|COMPLETED|Final Risk Group Assignment||49
8526525|NCT00352534|21016535|P3|COMPLETED|Final Risk Group Assignment||116
8526526|NCT00352534|21016536|P2|COMPLETED|Final Risk Group Assignment||0
8526527|NCT00352534|21016537|P1|COMPLETED|Final Risk Group Assignment||0
8526528|NCT00352534|21016531|P7|STARTED|Final Risk Group Assignment||40
8526529|NCT00352534|21016532|P6|STARTED|Final Risk Group Assignment||548
8526530|NCT00352534|21016533|P5|STARTED|Final Risk Group Assignment||32
8526531|NCT00352534|21016534|P4|STARTED|Final Risk Group Assignment||52
8526532|NCT00352534|21016535|P3|STARTED|Final Risk Group Assignment||119
8526533|NCT00352534|21016536|P2|STARTED|Final Risk Group Assignment||0
8526534|NCT00352534|21016537|P1|STARTED|Final Risk Group Assignment||0
8526535|NCT00352534|21016531|P7|NOT COMPLETED|Initial Staging||0
8526536|NCT00352534|21016532|P6|NOT COMPLETED|Initial Staging||0
8526537|NCT00352534|21016533|P5|NOT COMPLETED|Initial Staging||0
8526538|NCT00352534|21016534|P4|NOT COMPLETED|Initial Staging||0
8526539|NCT00352534|21016535|P3|NOT COMPLETED|Initial Staging||0
8526540|NCT00352534|21016536|P2|NOT COMPLETED|Initial Staging||9
8526541|NCT00352534|21016537|P1|NOT COMPLETED|Initial Staging||8
8526542|NCT00352534|21016531|P7|COMPLETED|Initial Staging||0
8526543|NCT00352534|21016532|P6|COMPLETED|Initial Staging||0
8526544|NCT00352534|21016533|P5|COMPLETED|Initial Staging||0
8526545|NCT00352534|21016534|P4|COMPLETED|Initial Staging||0
8526546|NCT00352534|21016535|P3|COMPLETED|Initial Staging||0
8526547|NCT00352534|21016536|P2|COMPLETED|Initial Staging||588
8526548|NCT00352534|21016537|P1|COMPLETED|Initial Staging||203
8526549|NCT00352534|21016531|P7|STARTED|Initial Staging||0
8526550|NCT00352534|21016532|P6|STARTED|Initial Staging||0
8526551|NCT00352534|21016533|P5|STARTED|Initial Staging||0
8526552|NCT00352534|21016534|P4|STARTED|Initial Staging||0
8526553|NCT00352534|21016535|P3|STARTED|Initial Staging||0
8526554|NCT00352534|21016536|P2|STARTED|Initial Staging||597
8526555|NCT00352534|21016537|P1|STARTED|Initial Staging||211
8526556|NCT00352417|21016554|P2|NOT COMPLETED|Overall Study||5
8526557|NCT00352417|21016555|P1|NOT COMPLETED|Overall Study||5
8526558|NCT00352417|21016554|P2|COMPLETED|Overall Study||21
8526559|NCT00352417|21016555|P1|COMPLETED|Overall Study||19
8526560|NCT00352417|21016554|P2|STARTED|Overall Study||26
8526561|NCT00352417|21016555|P1|STARTED|Overall Study||24
8526562|NCT00352365|21016569|P1|NOT COMPLETED|Maintenance Therapy||12
8526563|NCT00352365|21016569|P1|COMPLETED|Maintenance Therapy||0
8526564|NCT00352365|21016569|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
8526565|NCT00352365|21016569|P1|STARTED|Maintenance Therapy||12
8526566|NCT00352365|21016569|P1|NOT COMPLETED|Induction Therapy||27
8526567|NCT00352365|21016569|P1|COMPLETED|Induction Therapy||14
8526568|NCT00352365|21016569|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
8526569|NCT00352365|21016569|P1|Eligible|Induction Therapy||38
8526570|NCT00352365|21016569|P1|STARTED|Induction Therapy||41
8526571|NCT00352118|21016579|P1|NOT COMPLETED|Overall Study||4
8526572|NCT00352118|21016579|P1|COMPLETED|Overall Study||0
8526573|NCT00352118|21016579|P1|STARTED|Overall Study||4
8526574|NCT00352105|21016589|P1|NOT COMPLETED|Overall Study||40
8526575|NCT00352105|21016589|P1|COMPLETED|Overall Study||20
8526576|NCT00352105|21016589|P1|STARTED|Overall Study||60
8526577|NCT00352053|21016600|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
8526578|NCT00352053|21016601|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
8526579|NCT00352053|21016600|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
8526580|NCT00352053|21016601|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
8526581|NCT00352053|21016600|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
8526582|NCT00352053|21016601|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
8526583|NCT00352053|21016600|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
8526584|NCT00352053|21016601|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
8526585|NCT00352053|21016600|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
8526586|NCT00352053|21016601|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
8526587|NCT00352053|21016600|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
8526588|NCT00352053|21016601|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
8526589|NCT00352053|21016600|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
8526590|NCT00352053|21016601|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
8526591|NCT00352053|21016600|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
8526592|NCT00352053|21016601|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
8526593|NCT00352053|21016600|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
8526594|NCT00352053|21016601|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
8526595|NCT00352053|21016600|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
8526596|NCT00352053|21016601|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
8526597|NCT00352053|21016600|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
8526598|NCT00352053|21016601|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
8526599|NCT00352053|21016600|P2|STARTED|Double-Blind Phase (Through Week 48)||42
8526600|NCT00352053|21016601|P1|STARTED|Double-Blind Phase (Through Week 48)||45
8526604|NCT00352001|21017037|P1|NOT COMPLETED|Overall Study||0
8526605|NCT00352001|21017037|P1|COMPLETED|Overall Study||37
8526606|NCT00352001|21017037|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
8526607|NCT00352001|21017037|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
8526608|NCT00352001|21017037|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
8526609|NCT00352001|21017037|P1|STARTED|Overall Study||37
8526610|NCT00351936|21017048|P1|NOT COMPLETED|Overall Study||0
8526611|NCT00351936|21017048|P1|COMPLETED|Overall Study||15
8526612|NCT00351936|21017048|P1|STARTED|Overall Study||15
8526613|NCT00351819|21017067|P2|NOT COMPLETED|Overall Study||12
8526614|NCT00351819|21017068|P1|NOT COMPLETED|Overall Study||7
8526615|NCT00351819|21017067|P2|COMPLETED|Overall Study||29
8526616|NCT00351819|21017068|P1|COMPLETED|Overall Study||36
8526617|NCT00351819|21017067|P2|STARTED|Overall Study||41
8526618|NCT00351819|21017068|P1|STARTED|Overall Study||43
8526619|NCT00351741|21017118|P2|NOT COMPLETED|Overall Study||0
8526620|NCT00351741|21017119|P1|NOT COMPLETED|Overall Study||0
8526621|NCT00351741|21017118|P2|COMPLETED|Overall Study||31
8526622|NCT00351741|21017119|P1|COMPLETED|Overall Study||31
8526623|NCT00351741|21017118|P2|STARTED|Overall Study||31
8526624|NCT00351741|21017119|P1|STARTED|Overall Study||31
8526625|NCT00351533|21017139|P2|NOT COMPLETED|Overall Study||5
8526626|NCT00351533|21017140|P1|NOT COMPLETED|Overall Study||2
8526627|NCT00351533|21017139|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
8526628|NCT00351533|21017140|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
8526629|NCT00351533|21017139|P2|STARTED|Overall Study||49
8526630|NCT00351533|21017140|P1|STARTED|Overall Study||41
8526631|NCT00351468|21017200|P1|NOT COMPLETED|Overall Study||167
8526632|NCT00351468|21017200|P1|COMPLETED|Overall Study||135
8526633|NCT00351468|21017200|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
8526634|NCT00351468|21017200|P1|Subjects From TRA108057 Repeat|Overall Study||43
8526635|NCT00351468|21017200|P1|Subjects From TRA102537 Raise|Overall Study||146
8526636|NCT00351468|21017200|P1|Subjects From TRA100773B|Overall Study||61
8526637|NCT00351468|21017200|P1|Subjects From TRA100773A|Overall Study||51
8526638|NCT00351468|21017200|P1|STARTED|Overall Study||302
8526639|NCT00351416|21017217|P2|NOT COMPLETED|Overall Study||0
8526640|NCT00351416|21017218|P1|NOT COMPLETED|Overall Study||0
8526641|NCT00351416|21017217|P2|COMPLETED|Overall Study||9
8526642|NCT00351416|21017218|P1|COMPLETED|Overall Study||6
8526643|NCT00351416|21017217|P2|STARTED|Overall Study||9
8526644|NCT00351416|21017218|P1|STARTED|Overall Study||6
8526645|NCT00351377|21017224|P1|NOT COMPLETED|Overall Study||7
8526646|NCT00351377|21017224|P1|COMPLETED|Overall Study||104
8526647|NCT00351377|21017224|P1|STARTED|Overall Study||111
8526648|NCT00351351|21017238|P2|NOT COMPLETED|Overall Study||4
8526649|NCT00351351|21017239|P1|NOT COMPLETED|Overall Study||9
8526650|NCT00351351|21017238|P2|COMPLETED|Overall Study||32
8526651|NCT00351351|21017239|P1|COMPLETED|Overall Study||25
8526652|NCT00351351|21017238|P2|STARTED|Overall Study||36
8526653|NCT00351351|21017239|P1|STARTED|Overall Study||34
8526654|NCT00351299|21017247|P2|NOT COMPLETED|Overall Study||0
8526655|NCT00351299|21017248|P1|NOT COMPLETED|Overall Study||0
8526656|NCT00351299|21017247|P2|COMPLETED|Overall Study||28
8526657|NCT00351299|21017248|P1|COMPLETED|Overall Study||25
8526658|NCT00351299|21017247|P2|STARTED|Overall Study||28
8526659|NCT00351299|21017248|P1|STARTED|Overall Study||25
8526660|NCT00351273|21017265|P3|NOT COMPLETED|Overall Study||5
8526661|NCT00351273|21017266|P2|NOT COMPLETED|Overall Study||2
8526662|NCT00351273|21017267|P1|NOT COMPLETED|Overall Study||1
8526663|NCT00351273|21017265|P3|COMPLETED|Overall Study||10
8526664|NCT00351273|21017266|P2|COMPLETED|Overall Study||10
8526665|NCT00351273|21017267|P1|COMPLETED|Overall Study||14
8526666|NCT00351273|21017265|P3|STARTED|Overall Study||15
8526667|NCT00351273|21017266|P2|STARTED|Overall Study||12
8526668|NCT00351273|21017267|P1|STARTED|Overall Study||15
8526669|NCT00351039|21017290|P1|NOT COMPLETED|Overall Study||0
8526670|NCT00351039|21017290|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
8526671|NCT00351039|21017290|P1|STARTED|Overall Study||8
8526672|NCT00351000|21017299|P1|NOT COMPLETED|Overall Study||3
8526673|NCT00351000|21017299|P1|COMPLETED|Overall Study||21
8526674|NCT00351000|21017299|P1|STARTED|Overall Study||24
8526675|NCT00350870|21017310|P4|NOT COMPLETED|Overall Study||15
8526676|NCT00350870|21017311|P3|NOT COMPLETED|Overall Study||16
8526677|NCT00350870|21017312|P2|NOT COMPLETED|Overall Study||17
8526678|NCT00350870|21017313|P1|NOT COMPLETED|Overall Study||22
8526679|NCT00350870|21017310|P4|COMPLETED|Overall Study||7
8526680|NCT00350870|21017311|P3|COMPLETED|Overall Study||6
8526681|NCT00350870|21017312|P2|COMPLETED|Overall Study||11
8526682|NCT00350870|21017313|P1|COMPLETED|Overall Study||5
8526683|NCT00350870|21017310|P4|Had at Least 1 Day of Med|Overall Study||19
8526684|NCT00350870|21017311|P3|Had at Least 1 Day of Med|Overall Study||18
8526685|NCT00350870|21017312|P2|Had at Least 1 Day of Med|Overall Study||24
8526686|NCT00350870|21017313|P1|Had at Least 1 Day of Med|Overall Study||19
8526687|NCT00350870|21017310|P4|STARTED|Overall Study||22
8526688|NCT00350870|21017311|P3|STARTED|Overall Study||22
8526689|NCT00350870|21017312|P2|STARTED|Overall Study||28
8526690|NCT00350870|21017313|P1|STARTED|Overall Study||27
8526691|NCT00350844|21017327|P1|NOT COMPLETED|Overall Study||1
8526692|NCT00350844|21017327|P1|COMPLETED|Overall Study||5
8526693|NCT00350844|21017327|P1|STARTED|Overall Study||6
8526694|NCT00350792|21017331|P1|NOT COMPLETED|Overall Study||33
8526695|NCT00350792|21017331|P1|COMPLETED|Overall Study||29
8526696|NCT00350792|21017331|P1|STARTED|Overall Study||62
8526697|NCT00350779|21017341|P2|NOT COMPLETED|Overall Study||21
8526698|NCT00350779|21017342|P1|NOT COMPLETED|Overall Study||22
8526699|NCT00350779|21017341|P2|COMPLETED|Overall Study||71
8526700|NCT00350779|21017342|P1|COMPLETED|Overall Study||148
8526701|NCT00350779|21017341|P2|STARTED|Overall Study||92
8526702|NCT00350779|21017342|P1|STARTED|Overall Study||170
8526703|NCT00350727|21017363|P3|NOT COMPLETED|Phase II||22
8526704|NCT00350727|21017364|P2|NOT COMPLETED|Phase II||19
8526705|NCT00350727|21017365|P1|NOT COMPLETED|Phase II||0
8526706|NCT00350727|21017363|P3|COMPLETED|Phase II||0
8526707|NCT00350727|21017364|P2|COMPLETED|Phase II||0
8526708|NCT00350727|21017365|P1|COMPLETED|Phase II||0
8526709|NCT00350727|21017363|P3|STARTED|Phase II||22
8526710|NCT00350727|21017364|P2|STARTED|Phase II||19
8526711|NCT00350727|21017365|P1|STARTED|Phase II||0
8526712|NCT00350727|21017363|P3|NOT COMPLETED|Phase I: Dose Escalation||0
8526713|NCT00350727|21017364|P2|NOT COMPLETED|Phase I: Dose Escalation||0
8526714|NCT00350727|21017365|P1|NOT COMPLETED|Phase I: Dose Escalation||34
8526715|NCT00350727|21017363|P3|COMPLETED|Phase I: Dose Escalation||0
8526716|NCT00350727|21017364|P2|COMPLETED|Phase I: Dose Escalation||0
8526717|NCT00350727|21017365|P1|COMPLETED|Phase I: Dose Escalation||0
8526718|NCT00350727|21017363|P3|STARTED|Phase I: Dose Escalation||0
8526719|NCT00350727|21017364|P2|STARTED|Phase I: Dose Escalation||0
8526720|NCT00350727|21017365|P1|STARTED|Phase I: Dose Escalation||34
8526721|NCT00350636|21017509|P2|NOT COMPLETED|Overall Study||45
8526722|NCT00350636|21017510|P1|NOT COMPLETED|Overall Study||43
8526723|NCT00350636|21017509|P2|COMPLETED|Overall Study||355
8526724|NCT00350636|21017510|P1|COMPLETED|Overall Study||346
8526725|NCT00350636|21017509|P2|STARTED|Overall Study||400
8526726|NCT00350636|21017510|P1|STARTED|Overall Study||389
8526727|NCT00350623|21017529|P3|NOT COMPLETED|Overall Study||6
8526728|NCT00350623|21017530|P2|NOT COMPLETED|Overall Study||4
8526729|NCT00350623|21017531|P1|NOT COMPLETED|Overall Study||8
8526730|NCT00350623|21017529|P3|COMPLETED|Overall Study||62
8526731|NCT00350623|21017530|P2|COMPLETED|Overall Study||67
8526732|NCT00350623|21017531|P1|COMPLETED|Overall Study||63
8526733|NCT00350623|21017529|P3|STARTED|Overall Study||68
8526734|NCT00350623|21017530|P2|STARTED|Overall Study||71
8526735|NCT00350623|21017531|P1|STARTED|Overall Study||71
8526736|NCT00350545|21017539|P1|NOT COMPLETED|Overall Study||2
8526737|NCT00350545|21017539|P1|COMPLETED|Overall Study||35
8526738|NCT00350545|21017539|P1|STARTED|Overall Study||37
8526739|NCT00350532|21017549|P2|NOT COMPLETED|Overall Study||0
8526740|NCT00350532|21017550|P1|NOT COMPLETED|Overall Study||0
8526741|NCT00350532|21017549|P2|COMPLETED|Overall Study||19
8526742|NCT00350532|21017550|P1|COMPLETED|Overall Study||24
8526743|NCT00350532|21017549|P2|STARTED|Overall Study||19
8526744|NCT00350532|21017550|P1|STARTED|Overall Study||24
8526745|NCT00350519|21017558|P2|NOT COMPLETED|Overall Study||6
8526746|NCT00350519|21017559|P1|NOT COMPLETED|Overall Study||4
8526747|NCT00350519|21017558|P2|COMPLETED|Overall Study||13
8526748|NCT00350519|21017559|P1|COMPLETED|Overall Study||14
8526749|NCT00350519|21017558|P2|STARTED|Overall Study||19
8526750|NCT00350519|21017559|P1|STARTED|Overall Study||18
8526751|NCT00350402|21017573|P2|NOT COMPLETED|Overall Study||1
8526752|NCT00350402|21017574|P1|NOT COMPLETED|Overall Study||1
8526753|NCT00350402|21017573|P2|COMPLETED|Overall Study||20
8526754|NCT00350402|21017574|P1|COMPLETED|Overall Study||20
8526755|NCT00350402|21017573|P2|STARTED|Overall Study||21
8526756|NCT00350402|21017574|P1|STARTED|Overall Study||21
8526757|NCT00350363|21017586|P1|NOT COMPLETED|Overall Study||0
8526758|NCT00350363|21017586|P1|COMPLETED|Overall Study||60
8526759|NCT00350363|21017586|P1|STARTED|Overall Study||60
8526772|NCT00350272|21017647|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
8526773|NCT00350272|21017648|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
8526774|NCT00350272|21017647|P2|COMPLETED|Open-Label 84 Week Treatment||27
8526775|NCT00350272|21017648|P1|COMPLETED|Open-Label 84 Week Treatment||21
8526776|NCT00350272|21017647|P2|STARTED|Open-Label 84 Week Treatment||35
8526777|NCT00350272|21017648|P1|STARTED|Open-Label 84 Week Treatment||30
8526778|NCT00350272|21017647|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
8526779|NCT00350272|21017648|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
8526780|NCT00350272|21017647|P2|COMPLETED|Blinded 12 Week Treatment||35
8526781|NCT00350272|21017648|P1|COMPLETED|Blinded 12 Week Treatment||30
8526782|NCT00350272|21017647|P2|STARTED|Blinded 12 Week Treatment||37
8526783|NCT00350272|21017648|P1|STARTED|Blinded 12 Week Treatment||39
8526784|NCT00350220|21017658|P2|NOT COMPLETED|Overall Study||0
8526785|NCT00350220|21017659|P1|NOT COMPLETED|Overall Study||0
8526786|NCT00350220|21017658|P2|COMPLETED|Overall Study||30
8526787|NCT00350220|21017659|P1|COMPLETED|Overall Study||30
8526788|NCT00350220|21017658|P2|STARTED|Overall Study||30
8526789|NCT00350220|21017659|P1|STARTED|Overall Study||30
8526790|NCT00350207|21017670|P3|NOT COMPLETED|Overall Study||7
8526791|NCT00350207|21017671|P2|NOT COMPLETED|Overall Study||6
8526792|NCT00350207|21017672|P1|NOT COMPLETED|Overall Study||8
8526793|NCT00350207|21017670|P3|COMPLETED|Overall Study||119
8526794|NCT00350207|21017671|P2|COMPLETED|Overall Study||128
8526795|NCT00350207|21017672|P1|COMPLETED|Overall Study||120
8526796|NCT00350207|21017670|P3|STARTED|Overall Study||126
8526797|NCT00350207|21017671|P2|STARTED|Overall Study||134
8526798|NCT00350207|21017672|P1|STARTED|Overall Study||128
8526799|NCT00350142|21017866|P1|NOT COMPLETED|Overall Study||0
8526800|NCT00350142|21017866|P1|COMPLETED|Overall Study||20
8526801|NCT00350142|21017866|P1|STARTED|Overall Study||20
8526802|NCT00350025|21017873|P2|NOT COMPLETED|Overall Study||2
8526803|NCT00350025|21017874|P1|NOT COMPLETED|Overall Study||0
8526804|NCT00350025|21017873|P2|COMPLETED|Overall Study||28
8526805|NCT00350025|21017874|P1|COMPLETED|Overall Study||11
8526806|NCT00350025|21017873|P2|STARTED|Overall Study||30
8526807|NCT00350025|21017874|P1|STARTED|Overall Study||11
8526808|NCT00349973|21017884|P2|NOT COMPLETED|Overall Study||3
8526809|NCT00349973|21017885|P1|NOT COMPLETED|Overall Study||4
8526810|NCT00349973|21017884|P2|COMPLETED|Overall Study||5
8526811|NCT00349973|21017885|P1|COMPLETED|Overall Study||8
8526812|NCT00349973|21017884|P2|STARTED|Overall Study||8
8526813|NCT00349973|21017885|P1|STARTED|Overall Study||12
8526814|NCT00349921|21017899|P4|NOT COMPLETED|Second Spinal Injection||0
8526815|NCT00349921|21017900|P3|NOT COMPLETED|Second Spinal Injection||0
8526816|NCT00349921|21017901|P2|NOT COMPLETED|Second Spinal Injection||0
8526817|NCT00349921|21017902|P1|NOT COMPLETED|Second Spinal Injection||0
8526818|NCT00349921|21017899|P4|COMPLETED|Second Spinal Injection||1
8526819|NCT00349921|21017900|P3|COMPLETED|Second Spinal Injection||0
8526820|NCT00349921|21017901|P2|COMPLETED|Second Spinal Injection||10
8526821|NCT00349921|21017902|P1|COMPLETED|Second Spinal Injection||9
8526822|NCT00349921|21017899|P4|STARTED|Second Spinal Injection||1
8526823|NCT00349921|21017900|P3|STARTED|Second Spinal Injection||0
8526824|NCT00349921|21017901|P2|STARTED|Second Spinal Injection||10
8526825|NCT00349921|21017902|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
8526826|NCT00349921|21017899|P4|NOT COMPLETED|First Spinal Injection||0
8526827|NCT00349921|21017900|P3|NOT COMPLETED|First Spinal Injection||1
8526828|NCT00349921|21017901|P2|NOT COMPLETED|First Spinal Injection||0
8526829|NCT00349921|21017902|P1|NOT COMPLETED|First Spinal Injection||1
8526830|NCT00349921|21017899|P4|COMPLETED|First Spinal Injection||1
8526831|NCT00349921|21017900|P3|COMPLETED|First Spinal Injection||0
8526832|NCT00349921|21017901|P2|COMPLETED|First Spinal Injection||10
8526833|NCT00349921|21017902|P1|COMPLETED|First Spinal Injection||9
8526834|NCT00349921|21017899|P4|STARTED|First Spinal Injection||1
8526835|NCT00349921|21017900|P3|STARTED|First Spinal Injection||1
8526836|NCT00349921|21017901|P2|STARTED|First Spinal Injection||10
8526837|NCT00349921|21017902|P1|STARTED|First Spinal Injection||10
8526838|NCT00349908|21017913|P2|NOT COMPLETED|Overall Study||4
8526839|NCT00349908|21017914|P1|NOT COMPLETED|Overall Study||0
8526840|NCT00349908|21017913|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
8526841|NCT00349908|21017914|P1|COMPLETED|Overall Study||10
8526842|NCT00349908|21017913|P2|STARTED|Overall Study||10
8526843|NCT00349908|21017914|P1|STARTED|Overall Study||10
8526844|NCT00349778|21017932|P1|NOT COMPLETED|Overall Study||0
8526845|NCT00349778|21017932|P1|COMPLETED|Overall Study||102
8526846|NCT00349778|21017932|P1|STARTED|Overall Study||102
8526847|NCT00349752|21017940|P2|NOT COMPLETED|Overall Study||64
8526848|NCT00349752|21017941|P1|NOT COMPLETED|Overall Study||59
8526849|NCT00349752|21017940|P2|COMPLETED|Overall Study||23
8526850|NCT00349752|21017941|P1|COMPLETED|Overall Study||28
8526851|NCT00349752|21017940|P2|STARTED|Overall Study||87
8526852|NCT00349752|21017941|P1|STARTED|Overall Study||87
8526853|NCT00349713|21017970|P3|NOT COMPLETED|Overall Study||0
8526854|NCT00349713|21017971|P2|NOT COMPLETED|Overall Study||0
8526855|NCT00349713|21017972|P1|NOT COMPLETED|Overall Study||0
8526856|NCT00349713|21017970|P3|COMPLETED|Overall Study||20
8526857|NCT00349713|21017971|P2|COMPLETED|Overall Study||20
8526858|NCT00349713|21017972|P1|COMPLETED|Overall Study||20
8526859|NCT00349713|21017970|P3|STARTED|Overall Study||20
8526860|NCT00349713|21017971|P2|STARTED|Overall Study||20
8526861|NCT00349713|21017972|P1|STARTED|Overall Study||20
8526862|NCT00349622|21017994|P2|NOT COMPLETED|Overall Study||96
8526863|NCT00349622|21017995|P1|NOT COMPLETED|Overall Study||178
8526864|NCT00349622|21017994|P2|COMPLETED|Overall Study||77
8526865|NCT00349622|21017995|P1|COMPLETED|Overall Study||162
8526866|NCT00349622|21017994|P2|STARTED|Overall Study||173
8526867|NCT00349622|21017995|P1|STARTED|Overall Study||340
8526868|NCT00349466|21018013|P2|NOT COMPLETED|Overall Study||3
8526869|NCT00349466|21018014|P1|NOT COMPLETED|Overall Study||9
8526870|NCT00349466|21018013|P2|COMPLETED|Overall Study||35
8526871|NCT00349466|21018014|P1|COMPLETED|Overall Study||33
8526872|NCT00349466|21018013|P2|STARTED|Overall Study||38
8526873|NCT00349466|21018014|P1|STARTED|Overall Study||42
8526874|NCT00349388|21018022|P2|NOT COMPLETED|Overall Study||0
8526875|NCT00349388|21018023|P1|NOT COMPLETED|Overall Study||0
8526876|NCT00349388|21018022|P2|COMPLETED|Overall Study||1
8526877|NCT00349388|21018023|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
8526878|NCT00349388|21018022|P2|STARTED|Overall Study||1
8526879|NCT00349388|21018023|P1|STARTED|Overall Study|no patients enrolled|0
8526880|NCT00349349|21018034|P3|NOT COMPLETED|Overall Study||6
8526881|NCT00349349|21018035|P2|NOT COMPLETED|Overall Study||62
8526882|NCT00349349|21018036|P1|NOT COMPLETED|Overall Study||53
8526883|NCT00349349|21018034|P3|COMPLETED|Overall Study||10
8526884|NCT00349349|21018035|P2|COMPLETED|Overall Study||50
8526885|NCT00349349|21018036|P1|COMPLETED|Overall Study||42
8526886|NCT00349349|21018034|P3|STARTED|Overall Study||16
8526887|NCT00349349|21018035|P2|STARTED|Overall Study||112
8526888|NCT00349349|21018036|P1|STARTED|Overall Study||95
8526889|NCT00349336|21018102|P2|NOT COMPLETED|Overall Study||14
8526890|NCT00349336|21018103|P1|NOT COMPLETED|Overall Study||13
8526891|NCT00349336|21018102|P2|COMPLETED|Overall Study||18
8526892|NCT00349336|21018103|P1|COMPLETED|Overall Study||19
8526893|NCT00349336|21018102|P2|STARTED|Overall Study||32
8526894|NCT00349336|21018103|P1|STARTED|Overall Study||32
8526895|NCT00348933|21018125|P1|NOT COMPLETED|Overall Study||25
8526896|NCT00348933|21018125|P1|COMPLETED|Overall Study||65
8526897|NCT00348933|21018125|P1|STARTED|Overall Study||90
8526898|NCT00348881|21018133|P2|NOT COMPLETED|Overall Study||12
8526899|NCT00348881|21018134|P1|NOT COMPLETED|Overall Study||17
8526900|NCT00348881|21018133|P2|COMPLETED|Overall Study||697
8526901|NCT00348881|21018134|P1|COMPLETED|Overall Study||1407
8526902|NCT00348881|21018133|P2|STARTED|Overall Study||709
8526903|NCT00348881|21018134|P1|STARTED|Overall Study||1424
8526904|NCT00348816|21018146|P1|NOT COMPLETED|Overall Study||1
8526905|NCT00348816|21018146|P1|COMPLETED|Overall Study||19
8526906|NCT00348816|21018146|P1|STARTED|Overall Study||20
8526907|NCT00348790|21018153|P1|NOT COMPLETED|Completed Treatment||25
8526908|NCT00348790|21018153|P1|COMPLETED|Completed Treatment||0
8526909|NCT00348790|21018153|P1|STARTED|Completed Treatment||25
8526910|NCT00348790|21018153|P1|NOT COMPLETED|Began Treatment||0
8526911|NCT00348790|21018153|P1|COMPLETED|Began Treatment||25
8526912|NCT00348790|21018153|P1|STARTED|Began Treatment||25
8526913|NCT00348686|21018165|P1|NOT COMPLETED|Overall Study||66
8526914|NCT00348686|21018165|P1|COMPLETED|Overall Study||249
8526915|NCT00348686|21018165|P1|STARTED|Overall Study||315
8526916|NCT00348673|21018182|P9|NOT COMPLETED|Stage 2||0
8526917|NCT00348673|21018183|P8|NOT COMPLETED|Stage 2||0
8526918|NCT00348673|21018184|P7|NOT COMPLETED|Stage 2||0
8526919|NCT00348673|21018185|P6|NOT COMPLETED|Stage 2||0
8526920|NCT00348673|21018186|P5|NOT COMPLETED|Stage 2||0
8526921|NCT00348673|21018187|P4|NOT COMPLETED|Stage 2||0
8526922|NCT00348673|21018188|P3|NOT COMPLETED|Stage 2||0
8526923|NCT00348673|21018189|P2|NOT COMPLETED|Stage 2||0
8526924|NCT00348673|21018190|P1|NOT COMPLETED|Stage 2||0
8526925|NCT00348673|21018182|P9|COMPLETED|Stage 2||2
8526926|NCT00348673|21018183|P8|COMPLETED|Stage 2||6
8526927|NCT00348673|21018184|P7|COMPLETED|Stage 2||6
8526928|NCT00348673|21018185|P6|COMPLETED|Stage 2||6
8526929|NCT00348673|21018186|P5|COMPLETED|Stage 2||0
8526930|NCT00348673|21018187|P4|COMPLETED|Stage 2||0
8526931|NCT00348673|21018188|P3|COMPLETED|Stage 2||0
8526932|NCT00348673|21018189|P2|COMPLETED|Stage 2||0
8526933|NCT00348673|21018190|P1|COMPLETED|Stage 2||0
8526934|NCT00348673|21018182|P9|STARTED|Stage 2||2
8526935|NCT00348673|21018183|P8|STARTED|Stage 2||6
8526936|NCT00348673|21018184|P7|STARTED|Stage 2||6
8526937|NCT00348673|21018185|P6|STARTED|Stage 2||6
8526938|NCT00348673|21018186|P5|STARTED|Stage 2||0
8526939|NCT00348673|21018187|P4|STARTED|Stage 2||0
8526940|NCT00348673|21018188|P3|STARTED|Stage 2||0
8526941|NCT00348673|21018189|P2|STARTED|Stage 2||0
8526942|NCT00348673|21018190|P1|STARTED|Stage 2||0
8526943|NCT00348673|21018182|P9|NOT COMPLETED|Stage 1||0
8526944|NCT00348673|21018183|P8|NOT COMPLETED|Stage 1||0
8526945|NCT00348673|21018184|P7|NOT COMPLETED|Stage 1||0
8526946|NCT00348673|21018185|P6|NOT COMPLETED|Stage 1||0
8526947|NCT00348673|21018186|P5|NOT COMPLETED|Stage 1||0
8526948|NCT00348673|21018187|P4|NOT COMPLETED|Stage 1||0
8526949|NCT00348673|21018188|P3|NOT COMPLETED|Stage 1||1
8526950|NCT00348673|21018189|P2|NOT COMPLETED|Stage 1||0
8526951|NCT00348673|21018190|P1|NOT COMPLETED|Stage 1||0
8526952|NCT00348673|21018182|P9|COMPLETED|Stage 1||0
8526953|NCT00348673|21018183|P8|COMPLETED|Stage 1||0
8526954|NCT00348673|21018184|P7|COMPLETED|Stage 1||0
8526955|NCT00348673|21018185|P6|COMPLETED|Stage 1||0
8526956|NCT00348673|21018186|P5|COMPLETED|Stage 1||4
8526957|NCT00348673|21018187|P4|COMPLETED|Stage 1||6
8526958|NCT00348673|21018188|P3|COMPLETED|Stage 1||6
8526959|NCT00348673|21018189|P2|COMPLETED|Stage 1||6
8526960|NCT00348673|21018190|P1|COMPLETED|Stage 1||6
8526961|NCT00348673|21018182|P9|Treated|Stage 1||0
8526962|NCT00348673|21018183|P8|Treated|Stage 1||0
8526963|NCT00348673|21018184|P7|Treated|Stage 1||0
8526964|NCT00348673|21018185|P6|Treated|Stage 1||0
8526965|NCT00348673|21018186|P5|Treated|Stage 1||4
8526966|NCT00348673|21018187|P4|Treated|Stage 1||6
8526967|NCT00348673|21018188|P3|Treated|Stage 1||6
8526968|NCT00348673|21018189|P2|Treated|Stage 1||6
8526969|NCT00348673|21018190|P1|Treated|Stage 1||6
8526970|NCT00348673|21018182|P9|STARTED|Stage 1||0
8526971|NCT00348673|21018183|P8|STARTED|Stage 1||0
8526972|NCT00348673|21018184|P7|STARTED|Stage 1||0
8526973|NCT00348673|21018185|P6|STARTED|Stage 1||0
8526974|NCT00348673|21018186|P5|STARTED|Stage 1||4
8526975|NCT00348673|21018187|P4|STARTED|Stage 1||6
8526976|NCT00348673|21018188|P3|STARTED|Stage 1||7
8526977|NCT00348673|21018189|P2|STARTED|Stage 1||6
8526978|NCT00348673|21018190|P1|STARTED|Stage 1||6
8526979|NCT00348595|21018239|P2|NOT COMPLETED|Overall Study||8
8526980|NCT00348595|21018240|P1|NOT COMPLETED|Overall Study||5
8526981|NCT00348595|21018239|P2|COMPLETED|Overall Study||26
8526982|NCT00348595|21018240|P1|COMPLETED|Overall Study||21
8526983|NCT00348595|21018239|P2|STARTED|Overall Study||34
8526984|NCT00348595|21018240|P1|STARTED|Overall Study||26
8526985|NCT00348556|21018252|P1|NOT COMPLETED|Overall Study||1
8526986|NCT00348556|21018252|P1|COMPLETED|Overall Study||3
8526987|NCT00348556|21018252|P1|STARTED|Overall Study||4
8526988|NCT00348374|21018259|P2|NOT COMPLETED|Overall Study||32
8526989|NCT00348374|21018260|P1|NOT COMPLETED|Overall Study||19
8526990|NCT00348374|21018259|P2|COMPLETED|Overall Study||71
8526991|NCT00348374|21018260|P1|COMPLETED|Overall Study||69
8526992|NCT00348374|21018259|P2|Received Study Treatment|Overall Study||96
8526993|NCT00348374|21018260|P1|Received Study Treatment|Overall Study||88
8526994|NCT00348374|21018259|P2|STARTED|Overall Study||103
8526995|NCT00348374|21018260|P1|STARTED|Overall Study||88
8526996|NCT00348348|21018307|P2|NOT COMPLETED|Overall Study||27
8526997|NCT00348348|21018308|P1|NOT COMPLETED|Overall Study||25
8526998|NCT00348348|21018307|P2|COMPLETED|Overall Study||555
8526999|NCT00348348|21018308|P1|COMPLETED|Overall Study||554
8527000|NCT00348348|21018307|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
8527001|NCT00348348|21018308|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
8527002|NCT00348309|21018323|P3|NOT COMPLETED|Overall Study||143
8527003|NCT00348309|21018324|P2|NOT COMPLETED|Overall Study||98
8527004|NCT00348309|21018325|P1|NOT COMPLETED|Overall Study||134
8527005|NCT00348309|21018323|P3|COMPLETED|Overall Study||346
8527006|NCT00348309|21018324|P2|COMPLETED|Overall Study||396
8527007|NCT00348309|21018325|P1|COMPLETED|Overall Study||362
8527008|NCT00348309|21018323|P3|STARTED|Overall Study||489
8527009|NCT00348309|21018324|P2|STARTED|Overall Study||494
8527010|NCT00348309|21018325|P1|STARTED|Overall Study||496
8527011|NCT00348283|21018398|P2|NOT COMPLETED|Open Label||34
8527012|NCT00348283|21018399|P1|NOT COMPLETED|Open Label||0
8527013|NCT00348283|21018398|P2|COMPLETED|Open Label||66
8527014|NCT00348283|21018399|P1|COMPLETED|Open Label||0
8527015|NCT00348283|21018398|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
8527016|NCT00348283|21018399|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
8527017|NCT00348283|21018398|P2|NOT COMPLETED|Double Blind||10
8527018|NCT00348283|21018399|P1|NOT COMPLETED|Double Blind||5
8527019|NCT00348283|21018398|P2|COMPLETED|Double Blind||54
8527020|NCT00348283|21018399|P1|COMPLETED|Double Blind||60
8527021|NCT00348283|21018398|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
8527022|NCT00348283|21018399|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
8527023|NCT00348283|21018398|P2|NOT COMPLETED|Induction||6
8527024|NCT00348283|21018399|P1|NOT COMPLETED|Induction||0
8527025|NCT00348283|21018398|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
8527026|NCT00348283|21018399|P1|COMPLETED|Induction||0
8527027|NCT00348283|21018398|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
8527028|NCT00348283|21018399|P1|STARTED|Induction||0
8527029|NCT00348205|21018415|P1|NOT COMPLETED|Overall Study||2
8527030|NCT00348205|21018415|P1|COMPLETED|Overall Study||78
8527031|NCT00348205|21018415|P1|STARTED|Overall Study||80
8527032|NCT00348140|21018428|P3|NOT COMPLETED|Overall Study||163
8527033|NCT00348140|21018429|P2|NOT COMPLETED|Overall Study||139
8527034|NCT00348140|21018430|P1|NOT COMPLETED|Overall Study||126
8527035|NCT00348140|21018428|P3|COMPLETED|Overall Study||328
8527036|NCT00348140|21018429|P2|COMPLETED|Overall Study||351
8527037|NCT00348140|21018430|P1|COMPLETED|Overall Study||361
8527038|NCT00348140|21018428|P3|STARTED|Overall Study||491
8527039|NCT00348140|21018429|P2|STARTED|Overall Study||490
8527040|NCT00348140|21018430|P1|STARTED|Overall Study||487
8527041|NCT00347958|21018528|P1|NOT COMPLETED|Overall Study||4
8527042|NCT00347958|21018528|P1|COMPLETED|Overall Study||540
8527043|NCT00347958|21018528|P1|STARTED|Overall Study||544
8527044|NCT00347932|21018537|P2|NOT COMPLETED|Overall Study||52
8527045|NCT00347932|21018538|P1|NOT COMPLETED|Overall Study||31
8527046|NCT00347932|21018537|P2|COMPLETED|Overall Study||430
8527047|NCT00347932|21018538|P1|COMPLETED|Overall Study||444
8527048|NCT00347932|21018537|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
8527049|NCT00347932|21018538|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
8527050|NCT00347919|21018553|P3|NOT COMPLETED|Overall Study||38
8527051|NCT00347919|21018554|P2|NOT COMPLETED|Overall Study||76
8527052|NCT00347919|21018555|P1|NOT COMPLETED|Overall Study||71
8527053|NCT00347919|21018553|P3|COMPLETED|Overall Study||2
8527054|NCT00347919|21018554|P2|COMPLETED|Overall Study||0
8527055|NCT00347919|21018555|P1|COMPLETED|Overall Study||2
8527056|NCT00347919|21018553|P3|STARTED|Overall Study|Safety Population|40
8527057|NCT00347919|21018554|P2|STARTED|Overall Study|Safety Population|76
8527058|NCT00347919|21018555|P1|STARTED|Overall Study|Safety Population|73
8527059|NCT00347776|21018578|P3|NOT COMPLETED|12 Month Follow-up||19
8527060|NCT00347776|21018579|P2|NOT COMPLETED|12 Month Follow-up||16
8527061|NCT00347776|21018580|P1|NOT COMPLETED|12 Month Follow-up||23
8527062|NCT00347776|21018578|P3|COMPLETED|12 Month Follow-up||436
8527063|NCT00347776|21018579|P2|COMPLETED|12 Month Follow-up||446
8527064|NCT00347776|21018580|P1|COMPLETED|12 Month Follow-up||425
8527065|NCT00347776|21018578|P3|STARTED|12 Month Follow-up||455
8527066|NCT00347776|21018579|P2|STARTED|12 Month Follow-up||462
8527067|NCT00347776|21018580|P1|STARTED|12 Month Follow-up||448
8527068|NCT00347776|21018578|P3|NOT COMPLETED|6 Month Follow-up||18
8527069|NCT00347776|21018579|P2|NOT COMPLETED|6 Month Follow-up||13
8527070|NCT00347776|21018580|P1|NOT COMPLETED|6 Month Follow-up||22
8527071|NCT00347776|21018578|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
8527072|NCT00347776|21018579|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
8527073|NCT00347776|21018580|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
8527074|NCT00347776|21018578|P3|STARTED|6 Month Follow-up||473
8527075|NCT00347776|21018579|P2|STARTED|6 Month Follow-up||475
8527076|NCT00347776|21018580|P1|STARTED|6 Month Follow-up||470
8527077|NCT00347776|21018578|P3|NOT COMPLETED|1.5 Month Follow-up||12
8527078|NCT00347776|21018579|P2|NOT COMPLETED|1.5 Month Follow-up||8
8527079|NCT00347776|21018580|P1|NOT COMPLETED|1.5 Month Follow-up||14
8527080|NCT00347776|21018578|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
8527081|NCT00347776|21018579|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
8527082|NCT00347776|21018580|P1|COMPLETED|1.5 Month Follow-up||470
8527083|NCT00347776|21018578|P3|STARTED|1.5 Month Follow-up||485
8527084|NCT00347776|21018579|P2|STARTED|1.5 Month Follow-up||483
8527085|NCT00347776|21018580|P1|STARTED|1.5 Month Follow-up||484
8527086|NCT00347438|21018592|P1|NOT COMPLETED|Overall Study||2
8527087|NCT00347438|21018592|P1|COMPLETED|Overall Study||16
8527088|NCT00347438|21018592|P1|STARTED|Overall Study||18
8527089|NCT00347360|21018614|P15|NOT COMPLETED|Overall Study||4
8527090|NCT00347360|21018615|P14|NOT COMPLETED|Overall Study||8
8527091|NCT00347360|21018616|P13|NOT COMPLETED|Overall Study||10
8527092|NCT00347360|21018617|P12|NOT COMPLETED|Overall Study||6
8527093|NCT00347360|21018618|P11|NOT COMPLETED|Overall Study||5
8527094|NCT00347360|21018619|P10|NOT COMPLETED|Overall Study||9
8527095|NCT00347360|21018620|P9|NOT COMPLETED|Overall Study||6
8527096|NCT00347360|21018621|P8|NOT COMPLETED|Overall Study||3
8527097|NCT00347360|21018622|P7|NOT COMPLETED|Overall Study||7
8527098|NCT00347360|21018623|P6|NOT COMPLETED|Overall Study||8
8527099|NCT00347360|21018624|P5|NOT COMPLETED|Overall Study||5
8527100|NCT00347360|21018625|P4|NOT COMPLETED|Overall Study||13
8527101|NCT00347360|21018626|P3|NOT COMPLETED|Overall Study||6
8527102|NCT00347360|21018627|P2|NOT COMPLETED|Overall Study||8
8527103|NCT00347360|21018628|P1|NOT COMPLETED|Overall Study||5
8527104|NCT00347360|21018614|P15|COMPLETED|Overall Study||39
8527105|NCT00347360|21018615|P14|COMPLETED|Overall Study||36
8527106|NCT00347360|21018616|P13|COMPLETED|Overall Study||34
8527107|NCT00347360|21018617|P12|COMPLETED|Overall Study||37
8527108|NCT00347360|21018618|P11|COMPLETED|Overall Study||39
8527109|NCT00347360|21018619|P10|COMPLETED|Overall Study||35
8527110|NCT00347360|21018620|P9|COMPLETED|Overall Study||38
8527111|NCT00347360|21018621|P8|COMPLETED|Overall Study||40
8527112|NCT00347360|21018622|P7|COMPLETED|Overall Study||37
8527113|NCT00347360|21018623|P6|COMPLETED|Overall Study||36
8527114|NCT00347360|21018624|P5|COMPLETED|Overall Study||39
8527115|NCT00347360|21018625|P4|COMPLETED|Overall Study||30
8527116|NCT00347360|21018626|P3|COMPLETED|Overall Study||37
8527117|NCT00347360|21018627|P2|COMPLETED|Overall Study||35
8527118|NCT00347360|21018628|P1|COMPLETED|Overall Study||39
8527119|NCT00347360|21018614|P15|STARTED|Overall Study||43
8527120|NCT00347360|21018615|P14|STARTED|Overall Study||44
8527121|NCT00347360|21018616|P13|STARTED|Overall Study||44
8527122|NCT00347360|21018617|P12|STARTED|Overall Study||43
8527123|NCT00347360|21018618|P11|STARTED|Overall Study||44
8527124|NCT00347360|21018619|P10|STARTED|Overall Study||44
8527125|NCT00347360|21018620|P9|STARTED|Overall Study||44
8527126|NCT00347360|21018621|P8|STARTED|Overall Study||43
8527127|NCT00347360|21018622|P7|STARTED|Overall Study||44
8527128|NCT00347360|21018623|P6|STARTED|Overall Study||44
8527129|NCT00347360|21018624|P5|STARTED|Overall Study||44
8527130|NCT00347360|21018625|P4|STARTED|Overall Study||43
8527131|NCT00347360|21018626|P3|STARTED|Overall Study||43
8527132|NCT00347360|21018627|P2|STARTED|Overall Study||43
8527133|NCT00347360|21018628|P1|STARTED|Overall Study||44
8527134|NCT00347308|21018810|P1|NOT COMPLETED|Overall Study||0
8527135|NCT00347308|21018810|P1|COMPLETED|Overall Study||40
8527136|NCT00347308|21018810|P1|STARTED|Overall Study||40
8527137|NCT00347269|21018816|P2|NOT COMPLETED|Overall Study||106
8527138|NCT00347269|21018817|P1|NOT COMPLETED|Overall Study||94
8527139|NCT00347269|21018816|P2|COMPLETED|Overall Study||395
8527140|NCT00347269|21018817|P1|COMPLETED|Overall Study||409
8527141|NCT00347269|21018816|P2|STARTED|Overall Study||501
8527142|NCT00347269|21018817|P1|STARTED|Overall Study||503
8527143|NCT00347022|21018825|P2|NOT COMPLETED|Overall Study||5
8527144|NCT00347022|21018826|P1|NOT COMPLETED|Overall Study||12
8527145|NCT00347022|21018825|P2|COMPLETED|Overall Study||66
8527146|NCT00347022|21018826|P1|COMPLETED|Overall Study||62
8527147|NCT00347022|21018825|P2|STARTED|Overall Study||71
8527148|NCT00347022|21018826|P1|STARTED|Overall Study||74
8527149|NCT00347009|21018832|P1|NOT COMPLETED|Overall Study||27
8527150|NCT00347009|21018832|P1|COMPLETED|Overall Study||128
8527151|NCT00347009|21018832|P1|STARTED|Overall Study||155
8527152|NCT00346905|21018849|P1|NOT COMPLETED|Overall Study||4
8527153|NCT00346905|21018849|P1|COMPLETED|Overall Study||12
8527154|NCT00346905|21018849|P1|STARTED|Overall Study||16
8527155|NCT00346775|21018853|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
8527156|NCT00346775|21018854|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
8527157|NCT00346775|21018853|P2|COMPLETED|Period 3: Intervention Period 2||45
8527158|NCT00346775|21018854|P1|COMPLETED|Period 3: Intervention Period 2||44
8527159|NCT00346775|21018853|P2|STARTED|Period 3: Intervention Period 2||45
8527160|NCT00346775|21018854|P1|STARTED|Period 3: Intervention Period 2||44
8527161|NCT00346775|21018853|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8527162|NCT00346775|21018854|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8527163|NCT00346775|21018853|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
8527164|NCT00346775|21018854|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
8527165|NCT00346775|21018853|P2|STARTED|Period 2: Washout Period (7 Days)||45
8527166|NCT00346775|21018854|P1|STARTED|Period 2: Washout Period (7 Days)||44
8527167|NCT00346775|21018853|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
8527168|NCT00346775|21018854|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
8527169|NCT00346775|21018853|P2|COMPLETED|Period 1: Intervention Period 1||45
8527170|NCT00346775|21018854|P1|COMPLETED|Period 1: Intervention Period 1||44
8527171|NCT00346775|21018853|P2|STARTED|Period 1: Intervention Period 1||48
8527172|NCT00346775|21018854|P1|STARTED|Period 1: Intervention Period 1||49
8527173|NCT00346697|21018866|P2|NOT COMPLETED|Overall Study||1
8527174|NCT00346697|21018867|P1|NOT COMPLETED|Overall Study||0
8527175|NCT00346697|21018866|P2|COMPLETED|Overall Study||23
8527176|NCT00346697|21018867|P1|COMPLETED|Overall Study||24
8527177|NCT00346697|21018866|P2|STARTED|Overall Study||24
8527178|NCT00346697|21018867|P1|STARTED|Overall Study||24
8527179|NCT00346632|21018903|P10|NOT COMPLETED|Overall Study||3
8527180|NCT00346632|21018904|P9|NOT COMPLETED|Overall Study||4
8527181|NCT00346632|21018905|P8|NOT COMPLETED|Overall Study||4
8527182|NCT00346632|21018906|P7|NOT COMPLETED|Overall Study||5
8527183|NCT00346632|21018907|P6|NOT COMPLETED|Overall Study||2
8527184|NCT00346632|21018908|P5|NOT COMPLETED|Overall Study||4
8527185|NCT00346632|21018909|P4|NOT COMPLETED|Overall Study||3
8527186|NCT00346632|21018910|P3|NOT COMPLETED|Overall Study||6
8527187|NCT00346632|21018911|P2|NOT COMPLETED|Overall Study||3
8527188|NCT00346632|21018912|P1|NOT COMPLETED|Overall Study||3
8527189|NCT00346632|21018903|P10|COMPLETED|Overall Study||0
8527190|NCT00346632|21018904|P9|COMPLETED|Overall Study||0
8527191|NCT00346632|21018905|P8|COMPLETED|Overall Study||0
8527192|NCT00346632|21018906|P7|COMPLETED|Overall Study||0
8527193|NCT00346632|21018907|P6|COMPLETED|Overall Study||0
8527194|NCT00346632|21018908|P5|COMPLETED|Overall Study||0
8527195|NCT00346632|21018909|P4|COMPLETED|Overall Study||0
8527196|NCT00346632|21018910|P3|COMPLETED|Overall Study||0
8527197|NCT00346632|21018911|P2|COMPLETED|Overall Study||0
8527198|NCT00346632|21018912|P1|COMPLETED|Overall Study||0
8527199|NCT00346632|21018903|P10|STARTED|Overall Study||3
8527200|NCT00346632|21018904|P9|STARTED|Overall Study||4
8527201|NCT00346632|21018905|P8|STARTED|Overall Study||4
8527202|NCT00346632|21018906|P7|STARTED|Overall Study||5
8527203|NCT00346632|21018907|P6|STARTED|Overall Study||2
8527204|NCT00346632|21018908|P5|STARTED|Overall Study||4
8527205|NCT00346632|21018909|P4|STARTED|Overall Study||3
8527206|NCT00346632|21018910|P3|STARTED|Overall Study||6
8527207|NCT00346632|21018911|P2|STARTED|Overall Study||3
8527208|NCT00346632|21018912|P1|STARTED|Overall Study||3
8527209|NCT00346476|21019055|P1|NOT COMPLETED|Overall Study||0
8527210|NCT00346476|21019055|P1|COMPLETED|Overall Study||1250
8527211|NCT00346476|21019055|P1|STARTED|Overall Study||1250
8527212|NCT00346398|21019062|P2|NOT COMPLETED|Overall Study||2
8527213|NCT00346398|21019063|P1|NOT COMPLETED|Overall Study||3
8527214|NCT00346398|21019062|P2|COMPLETED|Overall Study||24
8527215|NCT00346398|21019063|P1|COMPLETED|Overall Study||22
8527216|NCT00346398|21019062|P2|STARTED|Overall Study||26
8527217|NCT00346398|21019063|P1|STARTED|Overall Study||25
8527218|NCT00346333|21019075|P2|NOT COMPLETED|Overall Study||8
8527219|NCT00346333|21019076|P1|NOT COMPLETED|Overall Study||5
8527220|NCT00346333|21019075|P2|COMPLETED|Overall Study||111
8527221|NCT00346333|21019076|P1|COMPLETED|Overall Study||116
8527222|NCT00346333|21019075|P2|STARTED|Overall Study||119
8527223|NCT00346333|21019076|P1|STARTED|Overall Study||121
8527224|NCT00346268|21019092|P2|NOT COMPLETED|Overall Study||3
8527225|NCT00346268|21019093|P1|NOT COMPLETED|Overall Study||2
8527226|NCT00346268|21019092|P2|COMPLETED|Overall Study||50
8527227|NCT00346268|21019093|P1|COMPLETED|Overall Study||50
8527228|NCT00346268|21019092|P2|STARTED|Overall Study||53
8527229|NCT00346268|21019093|P1|STARTED|Overall Study||52
8527230|NCT00346216|21019128|P3|NOT COMPLETED|Overall Study||2348
8527231|NCT00346216|21019129|P2|NOT COMPLETED|Overall Study||2460
8527232|NCT00346216|21019130|P1|NOT COMPLETED|Overall Study||2408
8527233|NCT00346216|21019128|P3|COMPLETED|Overall Study||5621
8527234|NCT00346216|21019129|P2|COMPLETED|Overall Study||5580
8527235|NCT00346216|21019130|P1|COMPLETED|Overall Study||5664
8527236|NCT00346216|21019128|P3|STARTED|Overall Study||7969
8527237|NCT00346216|21019129|P2|STARTED|Overall Study||8040
8527238|NCT00346216|21019130|P1|STARTED|Overall Study||8072
8527239|NCT00346164|21019151|P4|NOT COMPLETED|Overall Study||106
8527240|NCT00346164|21019152|P3|NOT COMPLETED|Overall Study||26
8527241|NCT00346164|21019153|P2|NOT COMPLETED|Overall Study||7
8527242|NCT00346164|21019154|P1|NOT COMPLETED|Overall Study||17
8527243|NCT00346164|21019151|P4|COMPLETED|Overall Study||117
8527244|NCT00346164|21019152|P3|COMPLETED|Overall Study||96
8527245|NCT00346164|21019153|P2|COMPLETED|Overall Study||14
8527246|NCT00346164|21019154|P1|COMPLETED|Overall Study||205
8527247|NCT00346164|21019151|P4|STARTED|Overall Study||223
8527248|NCT00346164|21019152|P3|STARTED|Overall Study||122
8527249|NCT00346164|21019153|P2|STARTED|Overall Study||21
8527250|NCT00346164|21019154|P1|STARTED|Overall Study||222
8527251|NCT00346151|21019189|P1|NOT COMPLETED|Overall Study||3
8527252|NCT00346151|21019189|P1|COMPLETED|Overall Study||2
8527253|NCT00346151|21019189|P1|STARTED|Overall Study||5
8527254|NCT00346073|21019209|P2|NOT COMPLETED|Overall Study||24
8527255|NCT00346073|21019210|P1|NOT COMPLETED|Overall Study||41
8527256|NCT00346073|21019209|P2|COMPLETED|Overall Study||738
8527257|NCT00346073|21019210|P1|COMPLETED|Overall Study||1481
8527258|NCT00346073|21019209|P2|STARTED|Overall Study||762
8527259|NCT00346073|21019210|P1|STARTED|Overall Study||1522
8527260|NCT00346034|21019244|P1|NOT COMPLETED|Overall Study||57
8527261|NCT00346034|21019244|P1|COMPLETED|Overall Study||300
8527262|NCT00346034|21019244|P1|STARTED|Overall Study||357
8527263|NCT00345969|21019251|P2|NOT COMPLETED|Overall Study||2
8527264|NCT00345969|21019252|P1|NOT COMPLETED|Overall Study||1
8527265|NCT00345969|21019251|P2|COMPLETED|Overall Study||11
8527266|NCT00345969|21019252|P1|COMPLETED|Overall Study||11
8527267|NCT00345969|21019251|P2|STARTED|Overall Study||13
8527268|NCT00345969|21019252|P1|STARTED|Overall Study||12
8527269|NCT00345878|21019284|P2|NOT COMPLETED|Overall Study||1
8527270|NCT00345878|21019285|P1|NOT COMPLETED|Overall Study||4
8527271|NCT00345878|21019284|P2|COMPLETED|Overall Study||135
8527272|NCT00345878|21019285|P1|COMPLETED|Overall Study||131
8527273|NCT00345878|21019284|P2|STARTED|Overall Study||136
8527274|NCT00345878|21019285|P1|STARTED|Overall Study||135
8527275|NCT00345865|21019306|P5|NOT COMPLETED|Overall Study||0
8527276|NCT00345865|21019307|P4|NOT COMPLETED|Overall Study||0
8527277|NCT00345865|21019308|P3|NOT COMPLETED|Overall Study||0
8527278|NCT00345865|21019309|P2|NOT COMPLETED|Overall Study||0
8527279|NCT00345865|21019310|P1|NOT COMPLETED|Overall Study||0
8527280|NCT00345865|21019306|P5|COMPLETED|Overall Study||146
8527281|NCT00345865|21019307|P4|COMPLETED|Overall Study||5
8527282|NCT00345865|21019308|P3|COMPLETED|Overall Study||2
8527283|NCT00345865|21019309|P2|COMPLETED|Overall Study||149
8527284|NCT00345865|21019310|P1|COMPLETED|Overall Study||171
8527285|NCT00345865|21019306|P5|STARTED|Overall Study||146
8527286|NCT00345865|21019307|P4|STARTED|Overall Study||5
8527287|NCT00345865|21019308|P3|STARTED|Overall Study||2
8527288|NCT00345865|21019309|P2|STARTED|Overall Study||149
8527289|NCT00345865|21019310|P1|STARTED|Overall Study||171
8527290|NCT00345839|21019344|P2|NOT COMPLETED|Overall Study||159
8527291|NCT00345839|21019345|P1|NOT COMPLETED|Overall Study||149
8527384|NCT00345358|21019518|P3|NOT COMPLETED|Primary Vaccination Phase||8
8527292|NCT00345839|21019344|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
8527293|NCT00345839|21019345|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
8527294|NCT00345839|21019344|P2|STARTED|Overall Study|Randomized to placebo|1935
8527295|NCT00345839|21019345|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
8527296|NCT00345683|21019371|P2|NOT COMPLETED|Overall Study||9
8527297|NCT00345683|21019372|P1|NOT COMPLETED|Overall Study||25
8527298|NCT00345683|21019371|P2|COMPLETED|Overall Study||1001
8527299|NCT00345683|21019372|P1|COMPLETED|Overall Study||2985
8527300|NCT00345683|21019371|P2|STARTED|Overall Study||1010
8527301|NCT00345683|21019372|P1|STARTED|Overall Study||3010
8527302|NCT00345631|21019395|P3|NOT COMPLETED|Overall Study||6
8527303|NCT00345631|21019396|P2|NOT COMPLETED|Overall Study||8
8527304|NCT00345631|21019397|P1|NOT COMPLETED|Overall Study||4
8527305|NCT00345631|21019395|P3|COMPLETED|Overall Study||128
8527306|NCT00345631|21019396|P2|COMPLETED|Overall Study||259
8527307|NCT00345631|21019397|P1|COMPLETED|Overall Study||83
8527308|NCT00345631|21019395|P3|STARTED|Overall Study||134
8527309|NCT00345631|21019396|P2|STARTED|Overall Study||267
8527310|NCT00345631|21019397|P1|STARTED|Overall Study||87
8527311|NCT00345605|21019429|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
8527312|NCT00345605|21019430|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
8527313|NCT00345605|21019429|P2|COMPLETED|Arm 2, Opposite Treatment||6
8527314|NCT00345605|21019430|P1|COMPLETED|Arm 2, Opposite Treatment||5
8527315|NCT00345605|21019429|P2|STARTED|Arm 2, Opposite Treatment||6
8527316|NCT00345605|21019430|P1|STARTED|Arm 2, Opposite Treatment||6
8527317|NCT00345605|21019429|P2|NOT COMPLETED|Crossover Wash-out||0
8527318|NCT00345605|21019430|P1|NOT COMPLETED|Crossover Wash-out||0
8527319|NCT00345605|21019429|P2|COMPLETED|Crossover Wash-out||6
8527320|NCT00345605|21019430|P1|COMPLETED|Crossover Wash-out||6
8527321|NCT00345605|21019429|P2|STARTED|Crossover Wash-out||6
8527322|NCT00345605|21019430|P1|STARTED|Crossover Wash-out||6
8527323|NCT00345605|21019429|P2|NOT COMPLETED|Interval||0
8527324|NCT00345605|21019430|P1|NOT COMPLETED|Interval||0
8527325|NCT00345605|21019429|P2|COMPLETED|Interval||6
8527326|NCT00345605|21019430|P1|COMPLETED|Interval||6
8527327|NCT00345605|21019429|P2|STARTED|Interval||6
8527328|NCT00345605|21019430|P1|STARTED|Interval||6
8527329|NCT00345605|21019429|P2|NOT COMPLETED|Arm 1||1
8527330|NCT00345605|21019430|P1|NOT COMPLETED|Arm 1||0
8527331|NCT00345605|21019429|P2|COMPLETED|Arm 1||5
8527332|NCT00345605|21019430|P1|COMPLETED|Arm 1||6
8527333|NCT00345605|21019429|P2|STARTED|Arm 1||6
8527334|NCT00345605|21019430|P1|STARTED|Arm 1||6
8527335|NCT00345605|21019429|P2|NOT COMPLETED|Initial Washout||0
8527336|NCT00345605|21019430|P1|NOT COMPLETED|Initial Washout||0
8527337|NCT00345605|21019429|P2|COMPLETED|Initial Washout||6
8527338|NCT00345605|21019430|P1|COMPLETED|Initial Washout||6
8527339|NCT00345605|21019429|P2|STARTED|Initial Washout||6
8527340|NCT00345605|21019430|P1|STARTED|Initial Washout||6
8527341|NCT00345592|21019450|P2|NOT COMPLETED|Overall Study||24
8527342|NCT00345592|21019451|P1|NOT COMPLETED|Overall Study||25
8527343|NCT00345592|21019450|P2|COMPLETED|Overall Study||173
8527344|NCT00345592|21019451|P1|COMPLETED|Overall Study||174
8527345|NCT00345592|21019450|P2|STARTED|Overall Study||197
8527346|NCT00345592|21019451|P1|STARTED|Overall Study||199
8527347|NCT00345579|21019459|P2|NOT COMPLETED|Overall Study||65
8527348|NCT00345579|21019460|P1|NOT COMPLETED|Overall Study||164
8527349|NCT00345579|21019459|P2|COMPLETED|Overall Study||1048
8527350|NCT00345579|21019460|P1|COMPLETED|Overall Study||3114
8527351|NCT00345579|21019459|P2|STARTED|Overall Study||1113
8527352|NCT00345579|21019460|P1|STARTED|Overall Study||3278
8527353|NCT00345540|21019480|P1|NOT COMPLETED|Overall Study||1
8527354|NCT00345540|21019480|P1|COMPLETED|Overall Study||15
8527355|NCT00345540|21019480|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
8527356|NCT00345397|21019486|P1|NOT COMPLETED|Overall Study||1
8527357|NCT00345397|21019486|P1|COMPLETED|Overall Study||6
8527358|NCT00345397|21019486|P1|STARTED|Overall Study||7
8527359|NCT00345384|21019493|P2|NOT COMPLETED|Overall Study||0
8527360|NCT00345384|21019494|P1|NOT COMPLETED|Overall Study||0
8527361|NCT00345384|21019493|P2|COMPLETED|Overall Study||19
8527362|NCT00345384|21019494|P1|COMPLETED|Overall Study||19
8527363|NCT00345384|21019493|P2|STARTED|Overall Study||19
8527364|NCT00345384|21019494|P1|STARTED|Overall Study||19
8527365|NCT00345371|21019504|P2|NOT COMPLETED|Overall Study||33
8527366|NCT00345371|21019505|P1|NOT COMPLETED|Overall Study||30
8527367|NCT00345371|21019504|P2|COMPLETED|Overall Study||38
8527368|NCT00345371|21019505|P1|COMPLETED|Overall Study||39
8527369|NCT00345371|21019504|P2|STARTED|Overall Study||71
8527370|NCT00345371|21019505|P1|STARTED|Overall Study||69
8527371|NCT00345358|21019517|P4|NOT COMPLETED|Booster Vaccination Phase||0
8527372|NCT00345358|21019518|P3|NOT COMPLETED|Booster Vaccination Phase||0
8527373|NCT00345358|21019519|P2|NOT COMPLETED|Booster Vaccination Phase||0
8527374|NCT00345358|21019520|P1|NOT COMPLETED|Booster Vaccination Phase||4
8527375|NCT00345358|21019517|P4|COMPLETED|Booster Vaccination Phase||0
8527376|NCT00345358|21019518|P3|COMPLETED|Booster Vaccination Phase||0
8527377|NCT00345358|21019519|P2|COMPLETED|Booster Vaccination Phase||145
8527378|NCT00345358|21019520|P1|COMPLETED|Booster Vaccination Phase||141
8527379|NCT00345358|21019517|P4|STARTED|Booster Vaccination Phase||0
8527380|NCT00345358|21019518|P3|STARTED|Booster Vaccination Phase||0
8527381|NCT00345358|21019519|P2|STARTED|Booster Vaccination Phase||145
8527382|NCT00345358|21019520|P1|STARTED|Booster Vaccination Phase||145
8527383|NCT00345358|21019517|P4|NOT COMPLETED|Primary Vaccination Phase||2
8527385|NCT00345358|21019519|P2|NOT COMPLETED|Primary Vaccination Phase||4
8527386|NCT00345358|21019520|P1|NOT COMPLETED|Primary Vaccination Phase||5
8527387|NCT00345358|21019517|P4|COMPLETED|Primary Vaccination Phase||148
8527388|NCT00345358|21019518|P3|COMPLETED|Primary Vaccination Phase||142
8527389|NCT00345358|21019519|P2|COMPLETED|Primary Vaccination Phase||146
8527390|NCT00345358|21019520|P1|COMPLETED|Primary Vaccination Phase||145
8527391|NCT00345358|21019517|P4|STARTED|Primary Vaccination Phase||150
8527392|NCT00345358|21019518|P3|STARTED|Primary Vaccination Phase||150
8527393|NCT00345358|21019519|P2|STARTED|Primary Vaccination Phase||150
8527394|NCT00345358|21019520|P1|STARTED|Primary Vaccination Phase||150
8527395|NCT00345345|21019595|P1|NOT COMPLETED|Overall Study||2
8527396|NCT00345345|21019595|P1|COMPLETED|Overall Study||27
8527397|NCT00345345|21019595|P1|STARTED|Overall Study||29
8527398|NCT00345332|21019601|P2|NOT COMPLETED|Overall Study||0
8527399|NCT00345332|21019602|P1|NOT COMPLETED|Overall Study||0
8527400|NCT00345332|21019601|P2|COMPLETED|Overall Study||20
8527401|NCT00345332|21019602|P1|COMPLETED|Overall Study||11
8527402|NCT00345332|21019601|P2|STARTED|Overall Study||20
8527403|NCT00345332|21019602|P1|STARTED|Overall Study||11
8527404|NCT00345293|21019610|P2|NOT COMPLETED|Overall Study||0
8527405|NCT00345293|21019611|P1|NOT COMPLETED|Overall Study||2
8527406|NCT00345293|21019610|P2|COMPLETED|Overall Study||3
8527407|NCT00345293|21019611|P1|COMPLETED|Overall Study||8
8527408|NCT00345293|21019610|P2|STARTED|Overall Study||3
8527409|NCT00345293|21019611|P1|STARTED|Overall Study||10
8527410|NCT00345254|21019620|P2|NOT COMPLETED|Overall Study||0
8527411|NCT00345254|21019621|P1|NOT COMPLETED|Overall Study||0
8527412|NCT00345254|21019620|P2|COMPLETED|Overall Study||30
8527413|NCT00345254|21019621|P1|COMPLETED|Overall Study||30
8527414|NCT00345254|21019620|P2|STARTED|Overall Study||30
8527415|NCT00345254|21019621|P1|STARTED|Overall Study||30
8527416|NCT00345176|21019631|P4|NOT COMPLETED|Overall Study||10
8527417|NCT00345176|21019632|P3|NOT COMPLETED|Overall Study||6
8527418|NCT00345176|21019633|P2|NOT COMPLETED|Overall Study||6
8527419|NCT00345176|21019634|P1|NOT COMPLETED|Overall Study||5
8527420|NCT00345176|21019631|P4|COMPLETED|Overall Study||1069
8527421|NCT00345176|21019632|P3|COMPLETED|Overall Study||1062
8527422|NCT00345176|21019633|P2|COMPLETED|Overall Study||1038
8527423|NCT00345176|21019634|P1|COMPLETED|Overall Study||1007
8527424|NCT00345176|21019631|P4|STARTED|Overall Study||1079
8527425|NCT00345176|21019632|P3|STARTED|Overall Study||1068
8527426|NCT00345176|21019633|P2|STARTED|Overall Study||1044
8527427|NCT00345176|21019634|P1|STARTED|Overall Study||1012
8527428|NCT00345046|21019657|P3|NOT COMPLETED|Overall Study||2
8527429|NCT00345046|21019658|P2|NOT COMPLETED|Overall Study||1
8527430|NCT00345046|21019659|P1|NOT COMPLETED|Overall Study||1
8527431|NCT00345046|21019657|P3|COMPLETED|Overall Study||14
8527432|NCT00345046|21019658|P2|COMPLETED|Overall Study||21
8527433|NCT00345046|21019659|P1|COMPLETED|Overall Study||17
8527434|NCT00345046|21019657|P3|STARTED|Overall Study||16
8527435|NCT00345046|21019658|P2|STARTED|Overall Study||22
8527436|NCT00345046|21019659|P1|STARTED|Overall Study||18
8527437|NCT00345033|21019669|P2|NOT COMPLETED|Overall Study||4
8527438|NCT00345033|21019670|P1|NOT COMPLETED|Overall Study||4
8527439|NCT00345033|21019669|P2|COMPLETED|Overall Study||14
8527440|NCT00345033|21019670|P1|COMPLETED|Overall Study||16
8527441|NCT00345033|21019669|P2|STARTED|Overall Study||18
8527442|NCT00345033|21019670|P1|STARTED|Overall Study||20
8527443|NCT00344968|21019689|P3|NOT COMPLETED|Overall Study||116
8527444|NCT00344968|21019690|P2|NOT COMPLETED|Overall Study||102
8527445|NCT00344968|21019691|P1|NOT COMPLETED|Overall Study||59
8527446|NCT00344968|21019689|P3|COMPLETED|Overall Study||279
8527447|NCT00344968|21019690|P2|COMPLETED|Overall Study||274
8527448|NCT00344968|21019691|P1|COMPLETED|Overall Study||126
8527449|NCT00344968|21019689|P3|STARTED|Overall Study||395
8527450|NCT00344968|21019690|P2|STARTED|Overall Study||376
8527451|NCT00344968|21019691|P1|STARTED|Overall Study||185
8527452|NCT00344773|21019702|P1|NOT COMPLETED|Overall Study||21
8527453|NCT00344773|21019702|P1|COMPLETED|Overall Study||25
8527454|NCT00344773|21019702|P1|STARTED|Overall Study||46
8527455|NCT00344682|21019710|P2|NOT COMPLETED|Overall Study||1
8527456|NCT00344682|21019711|P1|NOT COMPLETED|Overall Study||4
8527457|NCT00344682|21019710|P2|COMPLETED|Overall Study||14
8527458|NCT00344682|21019711|P1|COMPLETED|Overall Study||12
8527459|NCT00344682|21019710|P2|STARTED|Overall Study||15
8527460|NCT00344682|21019711|P1|STARTED|Overall Study||16
8527461|NCT00344500|21019725|P3|NOT COMPLETED|Overall Study||2
8527462|NCT00344500|21019726|P2|NOT COMPLETED|Overall Study||35
8527463|NCT00344500|21019727|P1|NOT COMPLETED|Overall Study||23
8527464|NCT00344500|21019725|P3|COMPLETED|Overall Study||12
8527465|NCT00344500|21019726|P2|COMPLETED|Overall Study||25
8527466|NCT00344500|21019727|P1|COMPLETED|Overall Study||25
8527467|NCT00344500|21019725|P3|STARTED|Overall Study||14
8527468|NCT00344500|21019726|P2|STARTED|Overall Study||60
8527469|NCT00344500|21019727|P1|STARTED|Overall Study||48
8527470|NCT00344487|21019738|P1|NOT COMPLETED|Overall Study||1
8527471|NCT00344487|21019738|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
8527472|NCT00344487|21019738|P1|STARTED|Overall Study||3
8527473|NCT00344461|21019742|P1|NOT COMPLETED|Overall Study||21
8527474|NCT00344461|21019742|P1|COMPLETED|Overall Study||33
8527475|NCT00344461|21019742|P1|STARTED|Overall Study||54
8527476|NCT00344448|21019753|P2|NOT COMPLETED|Open Label||1
8527477|NCT00344448|21019754|P1|NOT COMPLETED|Open Label||2
8527478|NCT00344448|21019753|P2|COMPLETED|Open Label||2
8527479|NCT00344448|21019754|P1|COMPLETED|Open Label||2
8527480|NCT00344448|21019753|P2|STARTED|Open Label||3
8527481|NCT00344448|21019754|P1|STARTED|Open Label||4
8527482|NCT00344448|21019753|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
8527483|NCT00344448|21019754|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
8527484|NCT00344448|21019753|P2|COMPLETED|Double Blind, Placebo Controlled||3
8527485|NCT00344448|21019754|P1|COMPLETED|Double Blind, Placebo Controlled||4
8527486|NCT00344448|21019753|P2|STARTED|Double Blind, Placebo Controlled||3
8527487|NCT00344448|21019754|P1|STARTED|Double Blind, Placebo Controlled||6
8527488|NCT00344448|21019753|P2|NOT COMPLETED|Screening||1
8527489|NCT00344448|21019754|P1|NOT COMPLETED|Screening||0
8527490|NCT00344448|21019753|P2|COMPLETED|Screening||3
8527491|NCT00344448|21019754|P1|COMPLETED|Screening||6
8527492|NCT00344448|21019753|P2|STARTED|Screening||4
8527493|NCT00344448|21019754|P1|STARTED|Screening|No randomization during the screening phase|6
8527494|NCT00344370|21019762|P2|NOT COMPLETED|Overall Study||3
8527495|NCT00344370|21019763|P1|NOT COMPLETED|Overall Study||15
8527496|NCT00344370|21019762|P2|COMPLETED|Overall Study||68
8527497|NCT00344370|21019763|P1|COMPLETED|Overall Study||128
8527498|NCT00344370|21019762|P2|STARTED|Overall Study||71
8527499|NCT00344370|21019763|P1|STARTED|Overall Study||143
8527500|NCT00344318|21019775|P4|NOT COMPLETED|Overall Study||3
8527501|NCT00344318|21019776|P3|NOT COMPLETED|Overall Study||1
8527502|NCT00344318|21019777|P2|NOT COMPLETED|Overall Study||5
8527503|NCT00344318|21019778|P1|NOT COMPLETED|Overall Study||4
8527504|NCT00344318|21019775|P4|COMPLETED|Overall Study||100
8527505|NCT00344318|21019776|P3|COMPLETED|Overall Study||99
8527506|NCT00344318|21019777|P2|COMPLETED|Overall Study||298
8527507|NCT00344318|21019778|P1|COMPLETED|Overall Study||296
8527508|NCT00344318|21019775|P4|STARTED|Overall Study||103
8527509|NCT00344318|21019776|P3|STARTED|Overall Study||100
8527510|NCT00344318|21019777|P2|STARTED|Overall Study||303
8527511|NCT00344318|21019778|P1|STARTED|Overall Study||300
8527512|NCT00344305|21019900|P2|NOT COMPLETED|Overall Study||1
8527513|NCT00344305|21019901|P1|NOT COMPLETED|Overall Study||2
8527514|NCT00344305|21019900|P2|COMPLETED|Overall Study||99
8527515|NCT00344305|21019901|P1|COMPLETED|Overall Study||98
8527516|NCT00344305|21019900|P2|STARTED|Overall Study||100
8527517|NCT00344305|21019901|P1|STARTED|Overall Study||100
8527518|NCT00344175|21019938|P2|NOT COMPLETED|Overall Study||10
8527519|NCT00344175|21019939|P1|NOT COMPLETED|Overall Study||12
8527520|NCT00344175|21019938|P2|COMPLETED|Overall Study||47
8527521|NCT00344175|21019939|P1|COMPLETED|Overall Study||109
8527522|NCT00344175|21019938|P2|STARTED|Overall Study||57
8527523|NCT00344175|21019939|P1|STARTED|Overall Study||121
8527524|NCT00344032|21019951|P2|NOT COMPLETED|Overall Study||10
8527525|NCT00344032|21019952|P1|NOT COMPLETED|Overall Study||14
8527526|NCT00344032|21019951|P2|COMPLETED|Overall Study||168
8527527|NCT00344032|21019952|P1|COMPLETED|Overall Study||162
8527528|NCT00344032|21019951|P2|STARTED|Overall Study||178
8527529|NCT00344032|21019952|P1|STARTED|Overall Study||176
8527530|NCT00344019|21019971|P3|NOT COMPLETED|Overall Study||74
8527531|NCT00344019|21019972|P2|NOT COMPLETED|Overall Study||0
8527532|NCT00344019|21019973|P1|NOT COMPLETED|Overall Study||0
8527533|NCT00344019|21019971|P3|COMPLETED|Overall Study||0
8527534|NCT00344019|21019972|P2|COMPLETED|Overall Study||11
8527535|NCT00344019|21019973|P1|COMPLETED|Overall Study||12
8527536|NCT00344019|21019971|P3|STARTED|Overall Study||74
8527537|NCT00344019|21019972|P2|STARTED|Overall Study||11
8527538|NCT00344019|21019973|P1|STARTED|Overall Study||12
8527539|NCT00343915|21019991|P2|NOT COMPLETED|Month 66 Follow-up||0
8527540|NCT00343915|21019992|P1|NOT COMPLETED|Month 66 Follow-up||0
8527541|NCT00343915|21019991|P2|COMPLETED|Month 66 Follow-up||76
8527542|NCT00343915|21019992|P1|COMPLETED|Month 66 Follow-up||158
8527543|NCT00343915|21019991|P2|STARTED|Month 66 Follow-up||76
8527544|NCT00343915|21019992|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
8527545|NCT00343915|21019991|P2|NOT COMPLETED|Month 54 Follow-up||0
8527546|NCT00343915|21019992|P1|NOT COMPLETED|Month 54 Follow-up||0
8527547|NCT00343915|21019991|P2|COMPLETED|Month 54 Follow-up||79
8527548|NCT00343915|21019992|P1|COMPLETED|Month 54 Follow-up||166
8527549|NCT00343915|21019991|P2|STARTED|Month 54 Follow-up||79
8527550|NCT00343915|21019992|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
8527551|NCT00343915|21019991|P2|NOT COMPLETED|Month 42 Follow-up||0
8527552|NCT00343915|21019992|P1|NOT COMPLETED|Month 42 Follow-up||0
8527553|NCT00343915|21019991|P2|COMPLETED|Month 42 Follow-up||84
8527554|NCT00343915|21019992|P1|COMPLETED|Month 42 Follow-up||174
8527555|NCT00343915|21019991|P2|STARTED|Month 42 Follow-up||84
8527556|NCT00343915|21019992|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
8527557|NCT00343915|21019991|P2|NOT COMPLETED|Month 30 Follow-up||0
8527558|NCT00343915|21019992|P1|NOT COMPLETED|Month 30 Follow-up||0
8527559|NCT00343915|21019991|P2|COMPLETED|Month 30 Follow-up||88
8527560|NCT00343915|21019992|P1|COMPLETED|Month 30 Follow-up||179
8527561|NCT00343915|21019991|P2|STARTED|Month 30 Follow-up||88
8527562|NCT00343915|21019992|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
8527563|NCT00343915|21019991|P2|NOT COMPLETED|Primary Study||3
8527564|NCT00343915|21019992|P1|NOT COMPLETED|Primary Study||4
8527565|NCT00343915|21019991|P2|COMPLETED|Primary Study||123
8527566|NCT00343915|21019992|P1|COMPLETED|Primary Study||254
8527567|NCT00343915|21019991|P2|STARTED|Primary Study||126
8527568|NCT00343915|21019992|P1|STARTED|Primary Study||258
8527569|NCT00343889|21020018|P2|NOT COMPLETED|Overall Study||1
8527570|NCT00343889|21020019|P1|NOT COMPLETED|Overall Study||3
8527571|NCT00343889|21020018|P2|COMPLETED|Overall Study||188
8527572|NCT00343889|21020019|P1|COMPLETED|Overall Study||187
8527573|NCT00343889|21020018|P2|STARTED|Overall Study||189
8527574|NCT00343889|21020019|P1|STARTED|Overall Study||190
8527575|NCT00343863|21020037|P2|NOT COMPLETED|Overall Study||0
8527576|NCT00343863|21020038|P1|NOT COMPLETED|Overall Study||0
8527577|NCT00343863|21020037|P2|COMPLETED|Overall Study||34
8527578|NCT00343863|21020038|P1|COMPLETED|Overall Study||7
8527579|NCT00343863|21020037|P2|STARTED|Overall Study||34
8527580|NCT00343863|21020038|P1|STARTED|Overall Study||7
8527581|NCT00343785|21020060|P1|NOT COMPLETED|Overall Study||0
8527582|NCT00343785|21020060|P1|COMPLETED|Overall Study||21
8527583|NCT00343785|21020060|P1|STARTED|Overall Study||21
8527584|NCT00343564|21020077|P11|NOT COMPLETED|Overall Study||0
8527585|NCT00343564|21020078|P10|NOT COMPLETED|Overall Study||0
8527586|NCT00343564|21020079|P9|NOT COMPLETED|Overall Study||0
8527587|NCT00343564|21020080|P8|NOT COMPLETED|Overall Study||0
8527588|NCT00343564|21020081|P7|NOT COMPLETED|Overall Study||0
8527589|NCT00343564|21020082|P6|NOT COMPLETED|Overall Study||0
8527590|NCT00343564|21020083|P5|NOT COMPLETED|Overall Study||0
8527591|NCT00343564|21020084|P4|NOT COMPLETED|Overall Study||0
8527592|NCT00343564|21020085|P3|NOT COMPLETED|Overall Study||0
8527593|NCT00343564|21020086|P2|NOT COMPLETED|Overall Study||0
8527594|NCT00343564|21020087|P1|NOT COMPLETED|Overall Study||0
8527595|NCT00343564|21020077|P11|COMPLETED|Overall Study||8
8527596|NCT00343564|21020078|P10|COMPLETED|Overall Study||8
8527597|NCT00343564|21020079|P9|COMPLETED|Overall Study||3
8527598|NCT00343564|21020080|P8|COMPLETED|Overall Study||3
8527599|NCT00343564|21020081|P7|COMPLETED|Overall Study||4
8527600|NCT00343564|21020082|P6|COMPLETED|Overall Study||9
8527601|NCT00343564|21020083|P5|COMPLETED|Overall Study||10
8527602|NCT00343564|21020084|P4|COMPLETED|Overall Study||7
8527603|NCT00343564|21020085|P3|COMPLETED|Overall Study||3
8527604|NCT00343564|21020086|P2|COMPLETED|Overall Study||7
8527605|NCT00343564|21020087|P1|COMPLETED|Overall Study||6
8527606|NCT00343564|21020077|P11|STARTED|Overall Study||8
8527607|NCT00343564|21020078|P10|STARTED|Overall Study||8
8527608|NCT00343564|21020079|P9|STARTED|Overall Study||3
8527609|NCT00343564|21020080|P8|STARTED|Overall Study||3
8527610|NCT00343564|21020081|P7|STARTED|Overall Study||4
8527611|NCT00343564|21020082|P6|STARTED|Overall Study||9
8527612|NCT00343564|21020083|P5|STARTED|Overall Study||10
8527613|NCT00343564|21020084|P4|STARTED|Overall Study||7
8527614|NCT00343564|21020085|P3|STARTED|Overall Study||3
8527615|NCT00343564|21020086|P2|STARTED|Overall Study||7
8527616|NCT00343564|21020087|P1|STARTED|Overall Study||6
8527617|NCT00343512|21020183|P1|NOT COMPLETED|Overall Study||2
8527618|NCT00343512|21020183|P1|COMPLETED|Overall Study||32
8527619|NCT00343512|21020183|P1|STARTED|Overall Study||34
8527620|NCT00343460|21020195|P3|NOT COMPLETED|Cycle 2 - 4||0
8527621|NCT00343460|21020196|P2|NOT COMPLETED|Cycle 2 - 4||50
8527622|NCT00343460|21020197|P1|NOT COMPLETED|Cycle 2 - 4||56
8527623|NCT00343460|21020195|P3|COMPLETED|Cycle 2 - 4||0
8527624|NCT00343460|21020196|P2|COMPLETED|Cycle 2 - 4||515
8527625|NCT00343460|21020197|P1|COMPLETED|Cycle 2 - 4||528
8527626|NCT00343460|21020195|P3|STARTED|Cycle 2 - 4||0
8527627|NCT00343460|21020196|P2|STARTED|Cycle 2 - 4||565
8527628|NCT00343460|21020197|P1|STARTED|Cycle 2 - 4||584
8527629|NCT00343460|21020195|P3|NOT COMPLETED|Cycle 1||18
8527630|NCT00343460|21020196|P2|NOT COMPLETED|Cycle 1||22
8527631|NCT00343460|21020197|P1|NOT COMPLETED|Cycle 1||22
8527632|NCT00343460|21020195|P3|COMPLETED|Cycle 1||454
8527633|NCT00343460|21020196|P2|COMPLETED|Cycle 1||459
8527634|NCT00343460|21020197|P1|COMPLETED|Cycle 1||453
8527635|NCT00343460|21020195|P3|STARTED|Cycle 1||472
8527636|NCT00343460|21020196|P2|STARTED|Cycle 1||481
8527637|NCT00343460|21020197|P1|STARTED|Cycle 1||475
8527638|NCT00343382|21020271|P3|NOT COMPLETED|Overall Study||17
8527639|NCT00343382|21020272|P2|NOT COMPLETED|Overall Study||14
8527640|NCT00343382|21020273|P1|NOT COMPLETED|Overall Study||4
8527641|NCT00343382|21020271|P3|COMPLETED|Overall Study||49
8527642|NCT00343382|21020272|P2|COMPLETED|Overall Study||51
8527643|NCT00343382|21020273|P1|COMPLETED|Overall Study||60
8527644|NCT00343382|21020271|P3|STARTED|Overall Study||66
8527645|NCT00343382|21020272|P2|STARTED|Overall Study||65
8527646|NCT00343382|21020273|P1|STARTED|Overall Study||64
8527647|NCT00343291|21020292|P2|NOT COMPLETED|Overall Study||56
8527648|NCT00343291|21020293|P1|NOT COMPLETED|Overall Study||57
8527649|NCT00343291|21020292|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
8527650|NCT00343291|21020293|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
8527651|NCT00343291|21020292|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
8527652|NCT00343291|21020293|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
8527653|NCT00343291|21020292|P2|STARTED|Overall Study||61
8527654|NCT00343291|21020293|P1|STARTED|Overall Study||60
8527655|NCT00343252|21020309|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
8527656|NCT00343252|21020310|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
8527657|NCT00343252|21020309|P2|COMPLETED|18 Months (All Treated Participants)||269
8527658|NCT00343252|21020310|P1|COMPLETED|18 Months (All Treated Participants)||259
8527659|NCT00343252|21020309|P2|STARTED|18 Months (All Treated Participants)||350
8527660|NCT00343252|21020310|P1|STARTED|18 Months (All Treated Participants)||360
8527661|NCT00343252|21020309|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
8527662|NCT00343252|21020310|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
8527663|NCT00343252|21020309|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
8527664|NCT00343252|21020310|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
8527665|NCT00343252|21020309|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
8527666|NCT00343252|21020310|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
8527667|NCT00343252|21020309|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
8527668|NCT00343252|21020310|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
8527669|NCT00343252|21020309|P2|COMPLETED|6 Months (All Treated Participants)||306
8527670|NCT00343252|21020310|P1|COMPLETED|6 Months (All Treated Participants)||304
8527671|NCT00343252|21020309|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
8527672|NCT00343252|21020310|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
8527673|NCT00343252|21020309|P2|NOT COMPLETED|All Randomized Participants||82
8527674|NCT00343252|21020310|P1|NOT COMPLETED|All Randomized Participants||102
8527675|NCT00343252|21020309|P2|COMPLETED|All Randomized Participants||269
8527676|NCT00343252|21020310|P1|COMPLETED|All Randomized Participants||259
8527677|NCT00343252|21020309|P2|STARTED|All Randomized Participants||351
8527678|NCT00343252|21020310|P1|STARTED|All Randomized Participants||361
8527679|NCT00343083|21020356|P1|NOT COMPLETED|Overall Study||21
8527680|NCT00343083|21020356|P1|COMPLETED|Overall Study||22
8527681|NCT00343083|21020356|P1|STARTED|Overall Study||43
8527682|NCT00343044|21020365|P1|NOT COMPLETED|Overall Study||0
8527683|NCT00343044|21020365|P1|COMPLETED|Overall Study||40
8527684|NCT00343044|21020365|P1|STARTED|Overall Study||40
8527685|NCT00342628|21020375|P3|NOT COMPLETED|Overall Study||19
8527686|NCT00342628|21020376|P2|NOT COMPLETED|Overall Study||21
8527687|NCT00342628|21020377|P1|NOT COMPLETED|Overall Study||20
8527688|NCT00342628|21020375|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
8527689|NCT00342628|21020376|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
8527690|NCT00342628|21020377|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
8527691|NCT00342628|21020375|P3|STARTED|Overall Study||100
8527692|NCT00342628|21020376|P2|STARTED|Overall Study||101
8527693|NCT00342628|21020377|P1|STARTED|Overall Study||100
8527694|NCT00342563|21020398|P4|NOT COMPLETED|Overall Study||6
8527695|NCT00342563|21020399|P3|NOT COMPLETED|Overall Study||14
8527696|NCT00342563|21020400|P2|NOT COMPLETED|Overall Study||8
8527697|NCT00342563|21020401|P1|NOT COMPLETED|Overall Study||6
8527698|NCT00342563|21020398|P4|COMPLETED|Overall Study||22
8527699|NCT00342563|21020399|P3|COMPLETED|Overall Study||26
8527700|NCT00342563|21020400|P2|COMPLETED|Overall Study||19
8527701|NCT00342563|21020401|P1|COMPLETED|Overall Study||35
8527702|NCT00342563|21020398|P4|STARTED|Overall Study||28
8527703|NCT00342563|21020399|P3|STARTED|Overall Study||40
8527704|NCT00342563|21020400|P2|STARTED|Overall Study||27
8527705|NCT00342563|21020401|P1|STARTED|Overall Study||41
8527706|NCT00342355|21020421|P4|NOT COMPLETED|Overall Study||0
8527707|NCT00342355|21020422|P3|NOT COMPLETED|Overall Study||0
8527708|NCT00342355|21020423|P2|NOT COMPLETED|Overall Study||0
8527709|NCT00342355|21020424|P1|NOT COMPLETED|Overall Study||0
8527710|NCT00342355|21020421|P4|COMPLETED|Overall Study||443
8527711|NCT00342355|21020422|P3|COMPLETED|Overall Study||444
8527712|NCT00342355|21020423|P2|COMPLETED|Overall Study||440
8527713|NCT00342355|21020424|P1|COMPLETED|Overall Study||444
8527714|NCT00342355|21020421|P4|STARTED|Overall Study||443
8527715|NCT00342355|21020422|P3|STARTED|Overall Study||444
8527716|NCT00342355|21020423|P2|STARTED|Overall Study||440
8527717|NCT00342355|21020424|P1|STARTED|Overall Study||444
8527718|NCT00340834|21020443|P5|NOT COMPLETED|Extension Phase of Study||44
8527719|NCT00340834|21020444|P4|NOT COMPLETED|Extension Phase of Study||53
8527720|NCT00340834|21020445|P3|NOT COMPLETED|Extension Phase of Study||0
8527721|NCT00340834|21020446|P2|NOT COMPLETED|Extension Phase of Study||76
8527722|NCT00340834|21020447|P1|NOT COMPLETED|Extension Phase of Study||85
8527723|NCT00340834|21020443|P5|COMPLETED|Extension Phase of Study||123
8527724|NCT00340834|21020444|P4|COMPLETED|Extension Phase of Study||123
8527725|NCT00340834|21020445|P3|COMPLETED|Extension Phase of Study||0
8527726|NCT00340834|21020446|P2|COMPLETED|Extension Phase of Study||281
8527727|NCT00340834|21020447|P1|COMPLETED|Extension Phase of Study||245
8527728|NCT00340834|21020443|P5|Received Study Drug|Extension Phase of Study||167
8527729|NCT00340834|21020444|P4|Received Study Drug|Extension Phase of Study||174
8527730|NCT00340834|21020445|P3|Received Study Drug|Extension Phase of Study||0
8527731|NCT00340834|21020446|P2|Received Study Drug|Extension Phase of Study||356
8527732|NCT00340834|21020447|P1|Received Study Drug|Extension Phase of Study||330
8527733|NCT00340834|21020443|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
8527734|NCT00340834|21020444|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
8527735|NCT00340834|21020445|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
8527736|NCT00340834|21020446|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
8527737|NCT00340834|21020447|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
8527738|NCT00340834|21020443|P5|NOT COMPLETED|Core Phase of Study||0
8527739|NCT00340834|21020444|P4|NOT COMPLETED|Core Phase of Study||0
8527740|NCT00340834|21020445|P3|NOT COMPLETED|Core Phase of Study||49
8527741|NCT00340834|21020446|P2|NOT COMPLETED|Core Phase of Study||33
8527742|NCT00340834|21020447|P1|NOT COMPLETED|Core Phase of Study||57
8527743|NCT00340834|21020443|P5|COMPLETED|Core Phase of Study||0
8527744|NCT00340834|21020444|P4|COMPLETED|Core Phase of Study||0
8527745|NCT00340834|21020445|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
8527746|NCT00340834|21020446|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
8527747|NCT00340834|21020447|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
8527748|NCT00340834|21020443|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
8527749|NCT00340834|21020444|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
8527750|NCT00340834|21020445|P3|STARTED|Core Phase of Study||435
8527751|NCT00340834|21020446|P2|STARTED|Core Phase of Study||431
8527752|NCT00340834|21020447|P1|STARTED|Core Phase of Study||426
8527753|NCT00340704|21020481|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
8527754|NCT00340704|21020482|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
8527755|NCT00340704|21020483|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
8527756|NCT00340704|21020484|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
8527757|NCT00340704|21020485|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
8527758|NCT00340704|21020486|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
8527759|NCT00340704|21020487|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527760|NCT00340704|21020488|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527761|NCT00340704|21020489|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527762|NCT00340704|21020481|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527763|NCT00340704|21020482|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
8527764|NCT00340704|21020483|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
8527765|NCT00340704|21020484|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
8527766|NCT00340704|21020485|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
8527767|NCT00340704|21020486|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
8527768|NCT00340704|21020487|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527769|NCT00340704|21020488|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527770|NCT00340704|21020489|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527771|NCT00340704|21020481|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527772|NCT00340704|21020482|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527773|NCT00340704|21020483|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527774|NCT00340704|21020484|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
8527775|NCT00340704|21020485|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
8527776|NCT00340704|21020486|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
8527777|NCT00340704|21020487|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527778|NCT00340704|21020488|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527779|NCT00340704|21020489|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527780|NCT00340704|21020481|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
8527781|NCT00340704|21020482|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
8527782|NCT00340704|21020483|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
8527783|NCT00340704|21020484|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
8527784|NCT00340704|21020485|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
8527785|NCT00340704|21020486|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
8527786|NCT00340704|21020487|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8527787|NCT00340704|21020488|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8527788|NCT00340704|21020489|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8527789|NCT00340704|21020481|P9|NOT COMPLETED|PK Study||0
8527790|NCT00340704|21020482|P8|NOT COMPLETED|PK Study||0
8527791|NCT00340704|21020483|P7|NOT COMPLETED|PK Study||0
8527792|NCT00340704|21020484|P6|NOT COMPLETED|PK Study||0
8527793|NCT00340704|21020485|P5|NOT COMPLETED|PK Study||0
8527794|NCT00340704|21020486|P4|NOT COMPLETED|PK Study||0
8527795|NCT00340704|21020487|P3|NOT COMPLETED|PK Study||1
8527796|NCT00340704|21020488|P2|NOT COMPLETED|PK Study||1
8527797|NCT00340704|21020489|P1|NOT COMPLETED|PK Study||0
8527798|NCT00340704|21020481|P9|COMPLETED|PK Study||0
8527799|NCT00340704|21020482|P8|COMPLETED|PK Study||0
8527800|NCT00340704|21020483|P7|COMPLETED|PK Study||0
8527801|NCT00340704|21020484|P6|COMPLETED|PK Study||0
8527802|NCT00340704|21020485|P5|COMPLETED|PK Study||0
8527803|NCT00340704|21020486|P4|COMPLETED|PK Study||0
8527804|NCT00340704|21020487|P3|COMPLETED|PK Study||10
8527805|NCT00340704|21020488|P2|COMPLETED|PK Study||9
8527806|NCT00340704|21020489|P1|COMPLETED|PK Study||10
8527807|NCT00340704|21020481|P9|STARTED|PK Study||0
8527808|NCT00340704|21020482|P8|STARTED|PK Study||0
8527809|NCT00340704|21020483|P7|STARTED|PK Study||0
8527810|NCT00340704|21020484|P6|STARTED|PK Study||0
8527811|NCT00340704|21020485|P5|STARTED|PK Study||0
8527812|NCT00340704|21020486|P4|STARTED|PK Study||0
8527813|NCT00340704|21020487|P3|STARTED|PK Study||11
8527814|NCT00340704|21020488|P2|STARTED|PK Study||10
8527815|NCT00340704|21020489|P1|STARTED|PK Study||10
8527816|NCT00340678|21020595|P4|NOT COMPLETED|Overall Study||0
8527817|NCT00340678|21020596|P3|NOT COMPLETED|Overall Study||0
8527818|NCT00340678|21020597|P2|NOT COMPLETED|Overall Study||0
8527819|NCT00340678|21020598|P1|NOT COMPLETED|Overall Study||1
8527820|NCT00340678|21020595|P4|COMPLETED|Overall Study||39
8527821|NCT00340678|21020596|P3|COMPLETED|Overall Study||39
8527822|NCT00340678|21020597|P2|COMPLETED|Overall Study||46
8527823|NCT00340678|21020598|P1|COMPLETED|Overall Study||45
8527824|NCT00340678|21020595|P4|STARTED|Overall Study||39
8527825|NCT00340678|21020596|P3|STARTED|Overall Study||39
8527826|NCT00340678|21020597|P2|STARTED|Overall Study||46
8527827|NCT00340678|21020598|P1|STARTED|Overall Study||46
8527828|NCT00340379|21020612|P2|NOT COMPLETED|Overall Study||9
8527829|NCT00340379|21020613|P1|NOT COMPLETED|Overall Study||8
8527830|NCT00340379|21020612|P2|COMPLETED|Overall Study||28
8527831|NCT00340379|21020613|P1|COMPLETED|Overall Study||27
8527832|NCT00340379|21020612|P2|STARTED|Overall Study||37
8527833|NCT00340379|21020613|P1|STARTED|Overall Study||35
8527834|NCT00339833|21020625|P2|NOT COMPLETED|Overall Study||8
8527835|NCT00339833|21020626|P1|NOT COMPLETED|Overall Study||6
8527836|NCT00339833|21020625|P2|COMPLETED|Overall Study||18
8527837|NCT00339833|21020626|P1|COMPLETED|Overall Study||22
8527838|NCT00339833|21020625|P2|STARTED|Overall Study||26
8527839|NCT00339833|21020626|P1|STARTED|Overall Study||28
8527840|NCT00339183|21020636|P2|NOT COMPLETED|Overall Study||105
8527841|NCT00339183|21020637|P1|NOT COMPLETED|Overall Study||121
8527842|NCT00339183|21020636|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
8527843|NCT00339183|21020637|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
8527844|NCT00339183|21020636|P2|Received Study Drug|Overall Study||593
8527845|NCT00339183|21020637|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
8527846|NCT00339183|21020636|P2|STARTED|Overall Study||595
8527847|NCT00339183|21020637|P1|STARTED|Overall Study||591
8527848|NCT00339144|21020666|P3|NOT COMPLETED|Overall Study||4
8527849|NCT00339144|21020667|P2|NOT COMPLETED|Overall Study||3
8527850|NCT00339144|21020668|P1|NOT COMPLETED|Overall Study||9
8527851|NCT00339144|21020666|P3|COMPLETED|Overall Study||0
8527852|NCT00339144|21020667|P2|COMPLETED|Overall Study||0
8527853|NCT00339144|21020668|P1|COMPLETED|Overall Study||0
8527854|NCT00339144|21020666|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
8527855|NCT00339144|21020667|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
8527856|NCT00339144|21020668|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
8527857|NCT00339079|21020754|P4|NOT COMPLETED|Overall Study||24
8527858|NCT00339079|21020755|P3|NOT COMPLETED|Overall Study||18
8527859|NCT00339079|21020756|P2|NOT COMPLETED|Overall Study||23
8527860|NCT00339079|21020757|P1|NOT COMPLETED|Overall Study||33
8527861|NCT00339079|21020754|P4|COMPLETED|Overall Study||29
8527862|NCT00339079|21020755|P3|COMPLETED|Overall Study||27
8527863|NCT00339079|21020756|P2|COMPLETED|Overall Study||21
8527864|NCT00339079|21020757|P1|COMPLETED|Overall Study||20
8527865|NCT00339079|21020754|P4|STARTED|Overall Study||53
8527866|NCT00339079|21020755|P3|STARTED|Overall Study||45
8527867|NCT00339079|21020756|P2|STARTED|Overall Study||44
8527868|NCT00339079|21020757|P1|STARTED|Overall Study||53
8527869|NCT00339040|21020773|P2|NOT COMPLETED|Stage II||2
8527870|NCT00339040|21020774|P1|NOT COMPLETED|Stage II||10
8527871|NCT00339040|21020773|P2|COMPLETED|Stage II||27
8527872|NCT00339040|21020774|P1|COMPLETED|Stage II||84
8527873|NCT00339040|21020773|P2|Vaccination 6 at Week 120|Stage II||27
8527874|NCT00339040|21020774|P1|Vaccination 6 at Week 120|Stage II||0
8527875|NCT00339040|21020773|P2|Vaccination 5 at Week 104|Stage II||28
8527876|NCT00339040|21020774|P1|Vaccination 5 at Week 104|Stage II||0
8527877|NCT00339040|21020773|P2|Vaccination 4 at Week 96|Stage II||29
8527878|NCT00339040|21020774|P1|Vaccination 4 at Week 96|Stage II||84
8527879|NCT00339040|21020773|P2|STARTED|Stage II||29
8527880|NCT00339040|21020774|P1|STARTED|Stage II||94
8527881|NCT00339040|21020773|P2|NOT COMPLETED|Stage I||1
8527882|NCT00339040|21020774|P1|NOT COMPLETED|Stage I||2
8527883|NCT00339040|21020773|P2|COMPLETED|Stage I||29
8527884|NCT00339040|21020774|P1|COMPLETED|Stage I||94
8527885|NCT00339040|21020773|P2|Vaccination 3 at Week 24|Stage I||30
8527886|NCT00339040|21020774|P1|Vaccination 3 at Week 24|Stage I||94
8527887|NCT00339040|21020773|P2|Vaccination 2 at Week 8|Stage I||30
8527888|NCT00339040|21020774|P1|Vaccination 2 at Week 8|Stage I||95
8527889|NCT00339040|21020773|P2|Vaccination 1 at Week 0|Stage I||30
8527890|NCT00339040|21020774|P1|Vaccination 1 at Week 0|Stage I||96
8527891|NCT00339040|21020773|P2|STARTED|Stage I||30
8527892|NCT00339040|21020774|P1|STARTED|Stage I||96
8527893|NCT00338988|21020792|P1|NOT COMPLETED|Overall Study||1
8527894|NCT00338988|21020792|P1|COMPLETED|Overall Study||43
8527895|NCT00338988|21020792|P1|STARTED|Overall Study||44
8527896|NCT00338962|21020801|P4|NOT COMPLETED|Overall Study||3
8527897|NCT00338962|21020802|P3|NOT COMPLETED|Overall Study||6
8527898|NCT00338962|21020803|P2|NOT COMPLETED|Overall Study||4
8527899|NCT00338962|21020804|P1|NOT COMPLETED|Overall Study||8
8527900|NCT00338962|21020801|P4|COMPLETED|Overall Study||21
8527901|NCT00338962|21020802|P3|COMPLETED|Overall Study||16
8527902|NCT00338962|21020803|P2|COMPLETED|Overall Study||16
8527903|NCT00338962|21020804|P1|COMPLETED|Overall Study||14
8527904|NCT00338962|21020801|P4|STARTED|Overall Study||24
8527905|NCT00338962|21020802|P3|STARTED|Overall Study||22
8527906|NCT00338962|21020803|P2|STARTED|Overall Study||20
8527907|NCT00338962|21020804|P1|STARTED|Overall Study||22
8527908|NCT00338949|21020828|P2|NOT COMPLETED|Randomization||5
8527909|NCT00338949|21020829|P1|NOT COMPLETED|Randomization||1
8528004|NCT00337727|21021081|P1|COMPLETED|Overall Study||412
8527910|NCT00338949|21020828|P2|COMPLETED|Randomization|"Reasons for drop out:
~2- insomnia 2- symptom exacerbation
~1- akathisia"|25
8527911|NCT00338949|21020829|P1|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
8527912|NCT00338949|21020828|P2|STARTED|Randomization||30
8527913|NCT00338949|21020829|P1|STARTED|Randomization||25
8527914|NCT00338949|21020828|P2|NOT COMPLETED|Subject Screening||11
8527915|NCT00338949|21020829|P1|NOT COMPLETED|Subject Screening||11
8527916|NCT00338949|21020828|P2|COMPLETED|Subject Screening||30
8527917|NCT00338949|21020829|P1|COMPLETED|Subject Screening||25
8527918|NCT00338949|21020828|P2|STARTED|Subject Screening||41
8527919|NCT00338949|21020829|P1|STARTED|Subject Screening||36
8527920|NCT00338884|21020837|P1|NOT COMPLETED|Overall Study||78
8527921|NCT00338884|21020837|P1|COMPLETED|Overall Study||42
8527922|NCT00338884|21020837|P1|Received Treatment|Overall Study||119
8527923|NCT00338884|21020837|P1|STARTED|Overall Study||120
8527924|NCT00338806|21020871|P2|NOT COMPLETED|Follow-up||3
8527925|NCT00338806|21020872|P1|NOT COMPLETED|Follow-up||1
8527926|NCT00338806|21020871|P2|COMPLETED|Follow-up||1
8527927|NCT00338806|21020872|P1|COMPLETED|Follow-up||1
8527928|NCT00338806|21020871|P2|STARTED|Follow-up||4
8527929|NCT00338806|21020872|P1|STARTED|Follow-up||2
8527930|NCT00338806|21020871|P2|NOT COMPLETED|Acute Phase||1
8527931|NCT00338806|21020872|P1|NOT COMPLETED|Acute Phase||0
8527932|NCT00338806|21020871|P2|COMPLETED|Acute Phase||4
8527933|NCT00338806|21020872|P1|COMPLETED|Acute Phase||2
8527934|NCT00338806|21020871|P2|STARTED|Acute Phase||5
8527935|NCT00338806|21020872|P1|STARTED|Acute Phase||2
8527936|NCT00338741|21020934|P2|NOT COMPLETED|Overall Study||0
8527937|NCT00338741|21020935|P1|NOT COMPLETED|Overall Study||2
8527938|NCT00338741|21020934|P2|COMPLETED|Overall Study||2
8527939|NCT00338741|21020935|P1|COMPLETED|Overall Study||32
8527940|NCT00338741|21020934|P2|STARTED|Overall Study||2
8527941|NCT00338741|21020935|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
8527942|NCT00338728|21020943|P1|NOT COMPLETED|Overall Study||14
8527943|NCT00338728|21020943|P1|COMPLETED|Overall Study||45
8527944|NCT00338728|21020943|P1|STARTED|Overall Study||59
8527945|NCT00338598|21020950|P2|NOT COMPLETED|Overall Study||2
8527946|NCT00338598|21020951|P1|NOT COMPLETED|Overall Study||0
8527947|NCT00338598|21020950|P2|COMPLETED|Overall Study||8
8527948|NCT00338598|21020951|P1|COMPLETED|Overall Study||10
8527949|NCT00338598|21020950|P2|STARTED|Overall Study||10
8527950|NCT00338598|21020951|P1|STARTED|Overall Study||10
8527951|NCT00338455|21020971|P2|NOT COMPLETED|Overall Study||1
8527952|NCT00338455|21020972|P1|NOT COMPLETED|Overall Study||3
8527953|NCT00338455|21020971|P2|COMPLETED|Overall Study||6
8527954|NCT00338455|21020972|P1|COMPLETED|Overall Study||6
8527955|NCT00338455|21020971|P2|Administered Study Drug|Overall Study||7
8527956|NCT00338455|21020972|P1|Administered Study Drug|Overall Study||8
8527957|NCT00338455|21020971|P2|STARTED|Overall Study||7
8527958|NCT00338455|21020972|P1|STARTED|Overall Study||9
8527959|NCT00338286|21020986|P2|NOT COMPLETED|Overall Study||213
8527960|NCT00338286|21020987|P1|NOT COMPLETED|Overall Study||233
8527961|NCT00338286|21020986|P2|COMPLETED|Overall Study||837
8527962|NCT00338286|21020987|P1|COMPLETED|Overall Study||815
8527963|NCT00338286|21020986|P2|STARTED|Overall Study||1050
8527964|NCT00338286|21020987|P1|STARTED|Overall Study||1048
8527965|NCT00338104|21021004|P3|NOT COMPLETED|Overall Study||3
8527966|NCT00338104|21021005|P2|NOT COMPLETED|Overall Study||1
8527967|NCT00338104|21021006|P1|NOT COMPLETED|Overall Study||2
8527968|NCT00338104|21021004|P3|COMPLETED|Overall Study||22
8527969|NCT00338104|21021005|P2|COMPLETED|Overall Study||24
8527970|NCT00338104|21021006|P1|COMPLETED|Overall Study||23
8527971|NCT00338104|21021004|P3|STARTED|Overall Study||25
8527972|NCT00338104|21021005|P2|STARTED|Overall Study||25
8527973|NCT00338104|21021006|P1|STARTED|Overall Study||25
8527974|NCT00338039|21021017|P1|NOT COMPLETED|Overall Study||0
8527975|NCT00338039|21021017|P1|COMPLETED|Overall Study||69
8527976|NCT00338039|21021017|P1|STARTED|Overall Study||69
8527977|NCT00337987|21021022|P1|NOT COMPLETED|Overall Study||0
8527978|NCT00337987|21021022|P1|COMPLETED|Overall Study||49
8527979|NCT00337987|21021022|P1|STARTED|Overall Study||49
8527980|NCT00337935|21021029|P2|NOT COMPLETED|Overall Study||27
8527981|NCT00337935|21021030|P1|NOT COMPLETED|Overall Study||10
8527982|NCT00337935|21021029|P2|COMPLETED|Overall Study||91
8527983|NCT00337935|21021030|P1|COMPLETED|Overall Study||29
8527984|NCT00337935|21021029|P2|STARTED|Overall Study||118
8527985|NCT00337935|21021030|P1|STARTED|Overall Study||39
8527986|NCT00337818|21021043|P3|NOT COMPLETED|Overall Study||107
8527987|NCT00337818|21021044|P2|NOT COMPLETED|Overall Study||91
8527988|NCT00337818|21021045|P1|NOT COMPLETED|Overall Study||289
8527989|NCT00337818|21021043|P3|COMPLETED|Overall Study||51
8527990|NCT00337818|21021044|P2|COMPLETED|Overall Study||63
8527991|NCT00337818|21021045|P1|COMPLETED|Overall Study||169
8527992|NCT00337818|21021043|P3|STARTED|Overall Study||158
8527993|NCT00337818|21021044|P2|STARTED|Overall Study||154
8527994|NCT00337818|21021045|P1|STARTED|Overall Study||458
8527995|NCT00337779|21021067|P2|NOT COMPLETED|Overall Study||79
8527996|NCT00337779|21021068|P1|NOT COMPLETED|Overall Study||52
8527997|NCT00337779|21021067|P2|COMPLETED|Overall Study||490
8527998|NCT00337779|21021068|P1|COMPLETED|Overall Study||534
8527999|NCT00337779|21021067|P2|STARTED|Overall Study||569
8528000|NCT00337779|21021068|P1|STARTED|Overall Study||586
8528001|NCT00337727|21021080|P2|NOT COMPLETED|Overall Study||12
8528002|NCT00337727|21021081|P1|NOT COMPLETED|Overall Study||18
8528003|NCT00337727|21021080|P2|COMPLETED|Overall Study||406
8528005|NCT00337727|21021080|P2|STARTED|Overall Study||418
8528006|NCT00337727|21021081|P1|STARTED|Overall Study||430
8528007|NCT00337675|21021092|P3|NOT COMPLETED|Overall Study||99
8528008|NCT00337675|21021093|P2|NOT COMPLETED|Overall Study||103
8528009|NCT00337675|21021094|P1|NOT COMPLETED|Overall Study||97
8528010|NCT00337675|21021092|P3|COMPLETED|Overall Study||492
8528011|NCT00337675|21021093|P2|COMPLETED|Overall Study||488
8528012|NCT00337675|21021094|P1|COMPLETED|Overall Study||492
8528013|NCT00337675|21021092|P3|STARTED|Overall Study||591
8528014|NCT00337675|21021093|P2|STARTED|Overall Study||591
8528015|NCT00337675|21021094|P1|STARTED|Overall Study||589
8528016|NCT00337662|21021111|P4|NOT COMPLETED|Study Period III||0
8528017|NCT00337662|21021112|P3|NOT COMPLETED|Study Period III||44
8528018|NCT00337662|21021113|P2|NOT COMPLETED|Study Period III||58
8528019|NCT00337662|21021114|P1|NOT COMPLETED|Study Period III||60
8528020|NCT00337662|21021111|P4|COMPLETED|Study Period III||0
8528021|NCT00337662|21021112|P3|COMPLETED|Study Period III||100
8528022|NCT00337662|21021113|P2|COMPLETED|Study Period III||134
8528023|NCT00337662|21021114|P1|COMPLETED|Study Period III||126
8528024|NCT00337662|21021111|P4|STARTED|Study Period III||0
8528025|NCT00337662|21021112|P3|STARTED|Study Period III||144
8528026|NCT00337662|21021113|P2|STARTED|Study Period III||192
8528027|NCT00337662|21021114|P1|STARTED|Study Period III||186
8528028|NCT00337662|21021111|P4|NOT COMPLETED|Study Period II||106
8528029|NCT00337662|21021112|P3|NOT COMPLETED|Study Period II||0
8528030|NCT00337662|21021113|P2|NOT COMPLETED|Study Period II||0
8528031|NCT00337662|21021114|P1|NOT COMPLETED|Study Period II||0
8528032|NCT00337662|21021111|P4|COMPLETED|Study Period II||522
8528033|NCT00337662|21021112|P3|COMPLETED|Study Period II||0
8528034|NCT00337662|21021113|P2|COMPLETED|Study Period II||0
8528035|NCT00337662|21021114|P1|COMPLETED|Study Period II||0
8528036|NCT00337662|21021111|P4|STARTED|Study Period II||628
8528037|NCT00337662|21021112|P3|STARTED|Study Period II||0
8528038|NCT00337662|21021113|P2|STARTED|Study Period II||0
8528039|NCT00337662|21021114|P1|STARTED|Study Period II||0
8528040|NCT00337610|21021168|P2|NOT COMPLETED|Overall Study||14
8528041|NCT00337610|21021169|P1|NOT COMPLETED|Overall Study||17
8528042|NCT00337610|21021168|P2|COMPLETED|Overall Study||80
8528043|NCT00337610|21021169|P1|COMPLETED|Overall Study||79
8528044|NCT00337610|21021168|P2|Completed Week 18|Overall Study||82
8528045|NCT00337610|21021169|P1|Completed Week 18|Overall Study||89
8528046|NCT00337610|21021168|P2|STARTED|Overall Study||94
8528047|NCT00337610|21021169|P1|STARTED|Overall Study||96
8528048|NCT00337571|21021185|P4|NOT COMPLETED|Overall Study||7
8528049|NCT00337571|21021186|P3|NOT COMPLETED|Overall Study||10
8528050|NCT00337571|21021187|P2|NOT COMPLETED|Overall Study||9
8528051|NCT00337571|21021188|P1|NOT COMPLETED|Overall Study||14
8528052|NCT00337571|21021185|P4|COMPLETED|Overall Study||47
8528053|NCT00337571|21021186|P3|COMPLETED|Overall Study||49
8528054|NCT00337571|21021187|P2|COMPLETED|Overall Study||44
8528055|NCT00337571|21021188|P1|COMPLETED|Overall Study||38
8528056|NCT00337571|21021185|P4|STARTED|Overall Study||54
8528057|NCT00337571|21021186|P3|STARTED|Overall Study||59
8528058|NCT00337571|21021187|P2|STARTED|Overall Study||53
8528059|NCT00337571|21021188|P1|STARTED|Overall Study||52
8528060|NCT00337467|21021226|P1|NOT COMPLETED|Overall Study||10
8528061|NCT00337467|21021226|P1|COMPLETED|Overall Study||51
8528062|NCT00337467|21021226|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
8528063|NCT00337467|21021226|P1|STARTED|Overall Study||61
8528064|NCT00337428|21021245|P2|NOT COMPLETED|Overall Study||3
8528065|NCT00337428|21021246|P1|NOT COMPLETED|Overall Study||4
8528066|NCT00337428|21021245|P2|COMPLETED|Overall Study||421
8528067|NCT00337428|21021246|P1|COMPLETED|Overall Study||415
8528068|NCT00337428|21021245|P2|STARTED|Overall Study||424
8528069|NCT00337428|21021246|P1|STARTED|Overall Study||419
8528070|NCT00337350|21021286|P2|NOT COMPLETED|Overall Study||1
8528071|NCT00337350|21021287|P1|NOT COMPLETED|Overall Study||1
8528072|NCT00337350|21021286|P2|COMPLETED|Overall Study||10
8528073|NCT00337350|21021287|P1|COMPLETED|Overall Study||8
8528074|NCT00337350|21021286|P2|STARTED|Overall Study||11
8528075|NCT00337350|21021287|P1|STARTED|Overall Study||9
8528076|NCT00337285|21021297|P1|NOT COMPLETED|Overall Study||158
8528077|NCT00337285|21021297|P1|COMPLETED|Overall Study||191
8528078|NCT00337285|21021297|P1|STARTED|Overall Study||349
8528079|NCT00337272|21021305|P2|NOT COMPLETED|Withdrawal Period||1
8528080|NCT00337272|21021306|P1|NOT COMPLETED|Withdrawal Period||0
8528081|NCT00337272|21021305|P2|COMPLETED|Withdrawal Period||6
8528082|NCT00337272|21021306|P1|COMPLETED|Withdrawal Period||6
8528083|NCT00337272|21021305|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
8528084|NCT00337272|21021306|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
8528085|NCT00337272|21021305|P2|NOT COMPLETED|Treatment Period||2
8528086|NCT00337272|21021306|P1|NOT COMPLETED|Treatment Period||1
8528087|NCT00337272|21021305|P2|COMPLETED|Treatment Period||7
8528088|NCT00337272|21021306|P1|COMPLETED|Treatment Period||6
8528089|NCT00337272|21021305|P2|Randomization|Treatment Period||9
8528090|NCT00337272|21021306|P1|Randomization|Treatment Period||7
8528091|NCT00337272|21021305|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
8528092|NCT00337272|21021306|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
8528093|NCT00337272|21021305|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
8528094|NCT00337272|21021306|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
8528095|NCT00337272|21021305|P2|COMPLETED|Screening Period (Pre-randomization)||0
8528096|NCT00337272|21021306|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
8528097|NCT00337272|21021305|P2|STARTED|Screening Period (Pre-randomization)||0
8528098|NCT00337272|21021306|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
8528099|NCT00337207|21021326|P1|NOT COMPLETED|Overall Study||3
8528100|NCT00337207|21021326|P1|COMPLETED|Overall Study||52
8528101|NCT00337207|21021326|P1|STARTED|Overall Study||55
8528102|NCT00337194|21021334|P2|NOT COMPLETED|Overall Study||4
8528103|NCT00337194|21021335|P1|NOT COMPLETED|Overall Study||12
8528104|NCT00337194|21021334|P2|COMPLETED|Overall Study||3
8528105|NCT00337194|21021335|P1|COMPLETED|Overall Study||11
8528106|NCT00337194|21021334|P2|STARTED|Overall Study||7
8528107|NCT00337194|21021335|P1|STARTED|Overall Study||23
8528108|NCT00337181|21021352|P2|NOT COMPLETED|Overall Study||0
8528109|NCT00337181|21021353|P1|NOT COMPLETED|Overall Study||0
8528110|NCT00337181|21021352|P2|COMPLETED|Overall Study||65
8528111|NCT00337181|21021353|P1|COMPLETED|Overall Study||49
8528112|NCT00337181|21021352|P2|STARTED|Overall Study||65
8528113|NCT00337181|21021353|P1|STARTED|Overall Study||49
8528114|NCT00337168|21021359|P1|NOT COMPLETED|Overall Study||8
8528115|NCT00337168|21021359|P1|COMPLETED|Overall Study||29
8528116|NCT00337168|21021359|P1|Eligible and Treated|Overall Study||36
8528117|NCT00337168|21021359|P1|Eligible|Overall Study||37
8528118|NCT00337168|21021359|P1|STARTED|Overall Study||37
8528119|NCT00337129|21021366|P1|NOT COMPLETED|Overall Study||40
8528120|NCT00337129|21021366|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
8528121|NCT00337129|21021366|P1|STARTED|Overall Study||40
8528122|NCT00337103|21021375|P2|NOT COMPLETED|Overall Study||548
8528123|NCT00337103|21021376|P1|NOT COMPLETED|Overall Study||554
8528124|NCT00337103|21021375|P2|COMPLETED|Overall Study||0
8528125|NCT00337103|21021376|P1|COMPLETED|Overall Study||0
8528126|NCT00337103|21021375|P2|Treated (Safety Population)|Overall Study||546
8528127|NCT00337103|21021376|P1|Treated (Safety Population)|Overall Study||544
8528128|NCT00337103|21021375|P2|STARTED|Overall Study||548
8528129|NCT00337103|21021376|P1|STARTED|Overall Study||554
8528130|NCT00337077|21021410|P3|NOT COMPLETED|Overall Study||25
8528131|NCT00337077|21021411|P2|NOT COMPLETED|Overall Study||53
8528132|NCT00337077|21021412|P1|NOT COMPLETED|Overall Study||43
8528133|NCT00337077|21021410|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8528134|NCT00337077|21021411|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8528135|NCT00337077|21021412|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8528136|NCT00337077|21021410|P3|Patients With Measurable Disease|Overall Study||13
8528137|NCT00337077|21021411|P2|Patients With Measurable Disease|Overall Study||38
8528138|NCT00337077|21021412|P1|Patients With Measurable Disease|Overall Study||26
8528139|NCT00337077|21021410|P3|Eligible and Treated|Overall Study||24
8528140|NCT00337077|21021411|P2|Eligible and Treated|Overall Study||51
8528141|NCT00337077|21021412|P1|Eligible and Treated|Overall Study||41
8528142|NCT00337077|21021410|P3|Toxicity Assessed|Overall Study||25
8528143|NCT00337077|21021411|P2|Toxicity Assessed|Overall Study||51
8528144|NCT00337077|21021412|P1|Toxicity Assessed|Overall Study||42
8528145|NCT00337077|21021410|P3|Treated|Overall Study||25
8528146|NCT00337077|21021411|P2|Treated|Overall Study||52
8528147|NCT00337077|21021412|P1|Treated|Overall Study||42
8528148|NCT00337077|21021410|P3|STARTED|Overall Study||25
8528149|NCT00337077|21021411|P2|STARTED|Overall Study||53
8528150|NCT00337077|21021412|P1|STARTED|Overall Study||43
8528151|NCT00336973|21021421|P1|NOT COMPLETED|Overall Study||33
8528152|NCT00336973|21021421|P1|COMPLETED|Overall Study||33
8528153|NCT00336973|21021421|P1|STARTED|Overall Study||66
8528154|NCT00336895|21021427|P1|NOT COMPLETED|Overall Study||4
8528155|NCT00336895|21021427|P1|COMPLETED|Overall Study||26
8528156|NCT00336895|21021427|P1|STARTED|Overall Study||30
8528157|NCT00336856|21021433|P1|NOT COMPLETED|Overall Study||4
8528158|NCT00336856|21021433|P1|COMPLETED|Overall Study||31
8528159|NCT00336856|21021433|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
8528160|NCT00336817|21021441|P2|NOT COMPLETED|Overall Study||2
8528161|NCT00336817|21021442|P1|NOT COMPLETED|Overall Study||1
8528162|NCT00336817|21021441|P2|COMPLETED|Overall Study||13
8528163|NCT00336817|21021442|P1|COMPLETED|Overall Study||14
8528164|NCT00336817|21021441|P2|STARTED|Overall Study||15
8528165|NCT00336817|21021442|P1|STARTED|Overall Study||15
8528166|NCT00336700|21021472|P1|NOT COMPLETED|Overall Study||0
8528167|NCT00336700|21021472|P1|COMPLETED|Overall Study||25
8528168|NCT00336700|21021472|P1|STARTED|Overall Study||25
8528169|NCT00336583|21021481|P1|NOT COMPLETED|Overall Study||2
8528170|NCT00336583|21021481|P1|COMPLETED|Overall Study||25
8528171|NCT00336583|21021481|P1|STARTED|Overall Study||27
8528172|NCT00336544|21021488|P2|NOT COMPLETED|Overall Study||22
8528173|NCT00336544|21021489|P1|NOT COMPLETED|Overall Study||19
8528174|NCT00336544|21021488|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
8528175|NCT00336544|21021489|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
8528176|NCT00336544|21021488|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
8528177|NCT00336544|21021489|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
8528178|NCT00336505|21021503|P2|NOT COMPLETED|Overall Study||27
8528179|NCT00336505|21021504|P1|NOT COMPLETED|Overall Study||37
8528180|NCT00336505|21021503|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
8528181|NCT00336505|21021504|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
8528182|NCT00336505|21021503|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
8528183|NCT00336505|21021504|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
8528184|NCT00336492|21021519|P3|NOT COMPLETED|Overall Study||11
8528185|NCT00336492|21021520|P2|NOT COMPLETED|Overall Study||4
8528186|NCT00336492|21021521|P1|NOT COMPLETED|Overall Study||15
8528187|NCT00336492|21021519|P3|COMPLETED|Overall Study||12
8528188|NCT00336492|21021520|P2|COMPLETED|Overall Study||18
8528189|NCT00336492|21021521|P1|COMPLETED|Overall Study||0
8528190|NCT00336492|21021519|P3|STARTED|Overall Study||23
8528191|NCT00336492|21021520|P2|STARTED|Overall Study||22
8528192|NCT00336492|21021521|P1|STARTED|Overall Study||15
8528193|NCT00336479|21021533|P4|NOT COMPLETED|Overall Study||4
8528194|NCT00336479|21021534|P3|NOT COMPLETED|Overall Study||26
8528195|NCT00336479|21021535|P2|NOT COMPLETED|Overall Study||25
8528196|NCT00336479|21021536|P1|NOT COMPLETED|Overall Study||37
8528197|NCT00336479|21021533|P4|COMPLETED|Overall Study||13
8528198|NCT00336479|21021534|P3|COMPLETED|Overall Study||53
8528199|NCT00336479|21021535|P2|COMPLETED|Overall Study||54
8528200|NCT00336479|21021536|P1|COMPLETED|Overall Study||38
8528201|NCT00336479|21021533|P4|STARTED|Overall Study||17
8528202|NCT00336479|21021534|P3|STARTED|Overall Study||79
8528203|NCT00336479|21021535|P2|STARTED|Overall Study||79
8528204|NCT00336479|21021536|P1|STARTED|Overall Study||75
8528205|NCT00336323|21021564|P5|NOT COMPLETED|Overall Study||3
8528206|NCT00336323|21021565|P4|NOT COMPLETED|Overall Study||0
8528207|NCT00336323|21021566|P3|NOT COMPLETED|Overall Study||1
8528208|NCT00336323|21021567|P2|NOT COMPLETED|Overall Study||1
8528209|NCT00336323|21021568|P1|NOT COMPLETED|Overall Study||0
8528210|NCT00336323|21021564|P5|COMPLETED|Overall Study||19
8528211|NCT00336323|21021565|P4|COMPLETED|Overall Study||22
8528212|NCT00336323|21021566|P3|COMPLETED|Overall Study||23
8528213|NCT00336323|21021567|P2|COMPLETED|Overall Study||21
8528214|NCT00336323|21021568|P1|COMPLETED|Overall Study||19
8528215|NCT00336323|21021564|P5|24 Week Visit|Overall Study||19
8528216|NCT00336323|21021565|P4|24 Week Visit|Overall Study||22
8528217|NCT00336323|21021566|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
8528218|NCT00336323|21021567|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
8528219|NCT00336323|21021568|P1|24 Week Visit|Overall Study||18
8528220|NCT00336323|21021564|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
8528221|NCT00336323|21021565|P4|18 Week Visit|Overall Study||21
8528222|NCT00336323|21021566|P3|18 Week Visit|Overall Study||23
8528223|NCT00336323|21021567|P2|18 Week Visit|Overall Study||22
8528224|NCT00336323|21021568|P1|18 Week Visit|Overall Study||19
8528225|NCT00336323|21021564|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
8528226|NCT00336323|21021565|P4|12 Week Visit|Overall Study||22
8528227|NCT00336323|21021566|P3|12 Week Visit|Overall Study||24
8528228|NCT00336323|21021567|P2|12 Week Visit|Overall Study||21
8528229|NCT00336323|21021568|P1|12 Week Visit|Overall Study||19
8528230|NCT00336323|21021564|P5|9 Week Visit|Overall Study||19
8528231|NCT00336323|21021565|P4|9 Week Visit|Overall Study||21
8528232|NCT00336323|21021566|P3|9 Week Visit|Overall Study||23
8528233|NCT00336323|21021567|P2|9 Week Visit|Overall Study||21
8528234|NCT00336323|21021568|P1|9 Week Visit|Overall Study||18
8528235|NCT00336323|21021564|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
8528236|NCT00336323|21021565|P4|6 Week Visit|Overall Study||22
8528237|NCT00336323|21021566|P3|6 Week Visit|Overall Study||24
8528238|NCT00336323|21021567|P2|6 Week Visit|Overall Study||22
8528239|NCT00336323|21021568|P1|6 Week Visit|Overall Study||18
8528240|NCT00336323|21021564|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
8528241|NCT00336323|21021565|P4|3 Week Visit|Overall Study||22
8528242|NCT00336323|21021566|P3|3 Week Visit|Overall Study||24
8528243|NCT00336323|21021567|P2|3 Week Visit|Overall Study||21
8528244|NCT00336323|21021568|P1|3 Week Visit|Overall Study||18
8528245|NCT00336323|21021564|P5|STARTED|Overall Study||22
8528246|NCT00336323|21021565|P4|STARTED|Overall Study||22
8528247|NCT00336323|21021566|P3|STARTED|Overall Study||24
8528248|NCT00336323|21021567|P2|STARTED|Overall Study||22
8528249|NCT00336323|21021568|P1|STARTED|Overall Study||19
8528250|NCT00336284|21021625|P2|NOT COMPLETED|Overall Study||151
8528251|NCT00336284|21021626|P1|NOT COMPLETED|Overall Study||236
8528252|NCT00336284|21021625|P2|COMPLETED|Overall Study||322
8528253|NCT00336284|21021626|P1|COMPLETED|Overall Study||741
8528254|NCT00336284|21021625|P2|STARTED|Overall Study||473
8528255|NCT00336284|21021626|P1|STARTED|Overall Study||977
8528256|NCT00336232|21021638|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
8528257|NCT00336232|21021638|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
8528258|NCT00336232|21021638|P1|STARTED|High Vitamin K (500mcg Daily)||42
8528259|NCT00336232|21021638|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
8528260|NCT00336232|21021638|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
8528261|NCT00336232|21021638|P1|STARTED|Low Vitamin K (10mcg Daily)||42
8528262|NCT00336232|21021638|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
8528263|NCT00336232|21021638|P1|COMPLETED|Baseline (200mcg Daily)||42
8528264|NCT00336232|21021638|P1|STARTED|Baseline (200mcg Daily)||59
8528265|NCT00336024|21021644|P2|NOT COMPLETED|Overall Study||19
8528266|NCT00336024|21021645|P1|NOT COMPLETED|Overall Study||20
8528267|NCT00336024|21021644|P2|COMPLETED|Overall Study||26
8528268|NCT00336024|21021645|P1|COMPLETED|Overall Study||26
8528269|NCT00336024|21021644|P2|STARTED|Overall Study||45
8528270|NCT00336024|21021645|P1|STARTED|Overall Study||46
8528271|NCT00335972|21021681|P2|NOT COMPLETED|Overall Study||3
8528272|NCT00335972|21021682|P1|NOT COMPLETED|Overall Study||0
8528273|NCT00335972|21021681|P2|COMPLETED|Overall Study||68
8528274|NCT00335972|21021682|P1|COMPLETED|Overall Study||71
8528275|NCT00335972|21021681|P2|STARTED|Overall Study||71
8528276|NCT00335972|21021682|P1|STARTED|Overall Study||71
8528277|NCT00335959|21021692|P1|NOT COMPLETED|Overall Study||3
8528278|NCT00335959|21021692|P1|COMPLETED|Overall Study||4
8528279|NCT00335959|21021692|P1|Eligible and Began Protocol Therapy|Overall Study||6
8528280|NCT00335959|21021692|P1|Eligible|Overall Study||6
8528281|NCT00335959|21021692|P1|STARTED|Overall Study||7
8528282|NCT00335829|21021697|P1|NOT COMPLETED|Overall Study||3
8528283|NCT00335829|21021697|P1|COMPLETED|Overall Study||23
8528284|NCT00335829|21021697|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
8528285|NCT00335829|21021697|P1|Received Bevacizumab|Overall Study||26
8528286|NCT00335829|21021697|P1|STARTED|Overall Study||26
8528287|NCT00335777|21021711|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
8528288|NCT00335777|21021711|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
8528289|NCT00335777|21021711|P1|STARTED|Treated 2 Headaches Per Protocol||35
8528290|NCT00335777|21021711|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
8528291|NCT00335777|21021711|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
8528292|NCT00335777|21021711|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
8528293|NCT00335764|21021721|P5|NOT COMPLETED|Overall Study||1
8528294|NCT00335764|21021722|P4|NOT COMPLETED|Overall Study||0
8528295|NCT00335764|21021723|P3|NOT COMPLETED|Overall Study||0
8528296|NCT00335764|21021724|P2|NOT COMPLETED|Overall Study||0
8528297|NCT00335764|21021725|P1|NOT COMPLETED|Overall Study||1
8528298|NCT00335764|21021721|P5|COMPLETED|Overall Study||18
8528299|NCT00335764|21021722|P4|COMPLETED|Overall Study||19
8528300|NCT00335764|21021723|P3|COMPLETED|Overall Study||24
8528301|NCT00335764|21021724|P2|COMPLETED|Overall Study||13
8528302|NCT00335764|21021725|P1|COMPLETED|Overall Study||16
8528303|NCT00335764|21021721|P5|STARTED|Overall Study||19
8528304|NCT00335764|21021722|P4|STARTED|Overall Study||19
8528305|NCT00335764|21021723|P3|STARTED|Overall Study||24
8528306|NCT00335764|21021724|P2|STARTED|Overall Study||13
8528307|NCT00335764|21021725|P1|STARTED|Overall Study||17
8528314|NCT00335725|21021792|P2|NOT COMPLETED|Overall Study||5
8528315|NCT00335725|21021793|P1|NOT COMPLETED|Overall Study||4
8528316|NCT00335725|21021792|P2|COMPLETED|Overall Study||71
8528317|NCT00335725|21021793|P1|COMPLETED|Overall Study||71
8528318|NCT00335725|21021792|P2|STARTED|Overall Study||76
8528319|NCT00335725|21021793|P1|STARTED|Overall Study||75
8528320|NCT00335556|21021807|P6|NOT COMPLETED|Overall Study||1
8528321|NCT00335556|21021808|P5|NOT COMPLETED|Overall Study||1
8528322|NCT00335556|21021809|P4|NOT COMPLETED|Overall Study||5
8528323|NCT00335556|21021810|P3|NOT COMPLETED|Overall Study||5
8528324|NCT00335556|21021811|P2|NOT COMPLETED|Overall Study||34
8528325|NCT00335556|21021812|P1|NOT COMPLETED|Overall Study||2
8528326|NCT00335556|21021807|P6|COMPLETED|Overall Study||29
8528327|NCT00335556|21021808|P5|COMPLETED|Overall Study||77
8528328|NCT00335556|21021809|P4|COMPLETED|Overall Study||5
8528329|NCT00335556|21021810|P3|COMPLETED|Overall Study||2
8528330|NCT00335556|21021811|P2|COMPLETED|Overall Study||64
8528331|NCT00335556|21021812|P1|COMPLETED|Overall Study||66
8528332|NCT00335556|21021807|P6|STARTED|Overall Study||30
8528333|NCT00335556|21021808|P5|STARTED|Overall Study||78
8528334|NCT00335556|21021809|P4|STARTED|Overall Study||10
8528335|NCT00335556|21021810|P3|STARTED|Overall Study||7
8528336|NCT00335556|21021811|P2|STARTED|Overall Study||98
8528337|NCT00335556|21021812|P1|STARTED|Overall Study||68
8528338|NCT00335517|21021833|P1|NOT COMPLETED|Overall Study||2
8528339|NCT00335517|21021833|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
8528340|NCT00335517|21021833|P1|STARTED|Overall Study||100
8528341|NCT00335504|21021841|P4|NOT COMPLETED|Overall Study||0
8528342|NCT00335504|21021842|P3|NOT COMPLETED|Overall Study||0
8528343|NCT00335504|21021843|P2|NOT COMPLETED|Overall Study||0
8528344|NCT00335504|21021844|P1|NOT COMPLETED|Overall Study||0
8528345|NCT00335504|21021841|P4|COMPLETED|Overall Study||22
8528346|NCT00335504|21021842|P3|COMPLETED|Overall Study||20
8528347|NCT00335504|21021843|P2|COMPLETED|Overall Study||21
8528348|NCT00335504|21021844|P1|COMPLETED|Overall Study||22
8528349|NCT00335504|21021841|P4|STARTED|Overall Study||22
8528350|NCT00335504|21021842|P3|STARTED|Overall Study||20
8528351|NCT00335504|21021843|P2|STARTED|Overall Study||21
8528352|NCT00335504|21021844|P1|STARTED|Overall Study||22
8528353|NCT00335478|21021866|P1|NOT COMPLETED|Overall Study||24
8528354|NCT00335478|21021866|P1|COMPLETED|Overall Study||30
8528355|NCT00335478|21021866|P1|STARTED|Overall Study||54
8528356|NCT00335452|21021874|P4|NOT COMPLETED|Overall Study||131
8528357|NCT00335452|21021875|P3|NOT COMPLETED|Overall Study||159
8528358|NCT00335452|21021876|P2|NOT COMPLETED|Overall Study||147
8528359|NCT00335452|21021877|P1|NOT COMPLETED|Overall Study||158
8528360|NCT00335452|21021874|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
8528361|NCT00335452|21021875|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
8528362|NCT00335452|21021876|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
8528363|NCT00335452|21021877|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
8528364|NCT00335452|21021874|P4|TREATED WITH ASA|Overall Study||6247
8528365|NCT00335452|21021875|P3|TREATED WITH ASA|Overall Study||6261
8528366|NCT00335452|21021876|P2|TREATED WITH ASA|Overall Study||6251
8528367|NCT00335452|21021877|P1|TREATED WITH ASA|Overall Study||6302
8528368|NCT00335452|21021874|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
8528369|NCT00335452|21021875|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
8528370|NCT00335452|21021876|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
8528371|NCT00335452|21021877|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
8528372|NCT00335452|21021874|P4|STARTED|Overall Study|Randomized|6253
8528373|NCT00335452|21021875|P3|STARTED|Overall Study|Randomized|6267
8528374|NCT00335452|21021876|P2|STARTED|Overall Study|Randomized|6254
8528375|NCT00335452|21021877|P1|STARTED|Overall Study|Randomized|6312
8528376|NCT00335322|21021902|P3|NOT COMPLETED|Overall Study||2
8528377|NCT00335322|21021903|P2|NOT COMPLETED|Overall Study||2
8528378|NCT00335322|21021904|P1|NOT COMPLETED|Overall Study||1
8528379|NCT00335322|21021902|P3|COMPLETED|Overall Study||103
8528380|NCT00335322|21021903|P2|COMPLETED|Overall Study||105
8528381|NCT00335322|21021904|P1|COMPLETED|Overall Study||114
8528382|NCT00335322|21021902|P3|STARTED|Overall Study||105
8528383|NCT00335322|21021903|P2|STARTED|Overall Study||107
8528384|NCT00335322|21021904|P1|STARTED|Overall Study||115
8528385|NCT00335283|21021917|P2|NOT COMPLETED|Overall Study||5
8528386|NCT00335283|21021918|P1|NOT COMPLETED|Overall Study||6
8528387|NCT00335283|21021917|P2|COMPLETED|Overall Study||34
8528388|NCT00335283|21021918|P1|COMPLETED|Overall Study||30
8528389|NCT00335283|21021917|P2|STARTED|Overall Study||39
8528390|NCT00335283|21021918|P1|STARTED|Overall Study||36
8528391|NCT00335257|21021933|P3|NOT COMPLETED|Overall Study||0
8528392|NCT00335257|21021934|P2|NOT COMPLETED|Overall Study||0
8528393|NCT00335257|21021935|P1|NOT COMPLETED|Overall Study||0
8528394|NCT00335257|21021933|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
8528395|NCT00335257|21021934|P2|COMPLETED|Overall Study||9377
8528396|NCT00335257|21021935|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
8528397|NCT00335257|21021933|P3|STARTED|Overall Study||60190
8528398|NCT00335257|21021934|P2|STARTED|Overall Study||9377
8528399|NCT00335257|21021935|P1|STARTED|Overall Study||15542
8528400|NCT00335153|21021952|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
8528401|NCT00335153|21021952|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
8528402|NCT00335153|21021952|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
8528403|NCT00335153|21021952|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
8528404|NCT00335153|21021952|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
8528405|NCT00335153|21021952|P1|STARTED|Nasojejunal (NJ) Test Period||354
8528406|NCT00335140|21021989|P1|NOT COMPLETED|Overall Study||1
8528407|NCT00335140|21021989|P1|COMPLETED|Overall Study||25
8528408|NCT00335140|21021989|P1|Treated|Overall Study||25
8528409|NCT00335140|21021989|P1|Eligible|Overall Study||25
8528410|NCT00335140|21021989|P1|STARTED|Overall Study||26
8528411|NCT00334958|21021995|P2|NOT COMPLETED|Overall Study||24
8528412|NCT00334958|21021996|P1|NOT COMPLETED|Overall Study||37
8528413|NCT00334958|21021995|P2|COMPLETED|Overall Study||156
8528414|NCT00334958|21021996|P1|COMPLETED|Overall Study||139
8528415|NCT00334958|21021995|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
8528416|NCT00334958|21021996|P1|STARTED|Overall Study||176
8528417|NCT00334893|21022010|P2|NOT COMPLETED|Overall Study||0
8528418|NCT00334893|21022011|P1|NOT COMPLETED|Overall Study||1
8528419|NCT00334893|21022010|P2|COMPLETED|Overall Study||37
8528420|NCT00334893|21022011|P1|COMPLETED|Overall Study||36
8528421|NCT00334893|21022010|P2|STARTED|Overall Study||37
8528422|NCT00334893|21022011|P1|STARTED|Overall Study||37
8528429|NCT00334802|21022036|P2|NOT COMPLETED|Overall Study||40
8528430|NCT00334802|21022037|P1|NOT COMPLETED|Overall Study||6
8528431|NCT00334802|21022036|P2|COMPLETED|Overall Study||16
8528432|NCT00334802|21022037|P1|COMPLETED|Overall Study||0
8528433|NCT00334802|21022036|P2|STARTED|Overall Study||56
8528434|NCT00334802|21022037|P1|STARTED|Overall Study||6
8528435|NCT00334737|21022057|P3|NOT COMPLETED|Follow up Phase||6
8528436|NCT00334737|21022058|P2|NOT COMPLETED|Follow up Phase||3
8528437|NCT00334737|21022059|P1|NOT COMPLETED|Follow up Phase||5
8528438|NCT00334737|21022057|P3|COMPLETED|Follow up Phase||24
8528439|NCT00334737|21022058|P2|COMPLETED|Follow up Phase||29
8528440|NCT00334737|21022059|P1|COMPLETED|Follow up Phase||27
8528441|NCT00334737|21022057|P3|STARTED|Follow up Phase||30
8528442|NCT00334737|21022058|P2|STARTED|Follow up Phase||32
8528443|NCT00334737|21022059|P1|STARTED|Follow up Phase||32
8528444|NCT00334737|21022057|P3|NOT COMPLETED|Hospital Phase||4
8528445|NCT00334737|21022058|P2|NOT COMPLETED|Hospital Phase||2
8528446|NCT00334737|21022059|P1|NOT COMPLETED|Hospital Phase||2
8528447|NCT00334737|21022057|P3|COMPLETED|Hospital Phase||30
8528448|NCT00334737|21022058|P2|COMPLETED|Hospital Phase||32
8528449|NCT00334737|21022059|P1|COMPLETED|Hospital Phase||32
8528450|NCT00334737|21022057|P3|STARTED|Hospital Phase||34
8528451|NCT00334737|21022058|P2|STARTED|Hospital Phase||34
8528452|NCT00334737|21022059|P1|STARTED|Hospital Phase||34
8528453|NCT00334633|21022094|P3|NOT COMPLETED|Overall Study||82
8528454|NCT00334633|21022095|P2|NOT COMPLETED|Overall Study||82
8528455|NCT00334633|21022096|P1|NOT COMPLETED|Overall Study||80
8528456|NCT00334633|21022094|P3|COMPLETED|Overall Study||114
8528457|NCT00334633|21022095|P2|COMPLETED|Overall Study||118
8528458|NCT00334633|21022096|P1|COMPLETED|Overall Study||117
8528459|NCT00334633|21022094|P3|STARTED|Overall Study||196
8528460|NCT00334633|21022095|P2|STARTED|Overall Study||200
8528461|NCT00334633|21022096|P1|STARTED|Overall Study||197
8528462|NCT00334542|21022107|P1|NOT COMPLETED|Overall Study||5
8528463|NCT00334542|21022107|P1|COMPLETED|Overall Study||45
8528464|NCT00334542|21022107|P1|STARTED|Overall Study||50
8528465|NCT00334295|21022114|P1|NOT COMPLETED|Overall Study||5
8528466|NCT00334295|21022114|P1|COMPLETED|Overall Study||30
8528467|NCT00334295|21022114|P1|STARTED|Overall Study||35
8528468|NCT00334282|21022124|P2|NOT COMPLETED|Overall Study||108
8528469|NCT00334282|21022125|P1|NOT COMPLETED|Overall Study||222
8528470|NCT00334282|21022124|P2|COMPLETED|Overall Study||37
8528471|NCT00334282|21022125|P1|COMPLETED|Overall Study||68
8528472|NCT00334282|21022124|P2|STARTED|Overall Study||145
8528473|NCT00334282|21022125|P1|STARTED|Overall Study||290
8528474|NCT00334204|21022148|P1|NOT COMPLETED|Overall Study||2
8528475|NCT00334204|21022148|P1|COMPLETED|Overall Study||56
8528476|NCT00334204|21022148|P1|STARTED|Overall Study||58
8528477|NCT00334113|21022156|P2|NOT COMPLETED|Overall Study||3
8528478|NCT00334113|21022157|P1|NOT COMPLETED|Overall Study||2
8528479|NCT00334113|21022156|P2|COMPLETED|Overall Study||31
8528480|NCT00334113|21022157|P1|COMPLETED|Overall Study||30
8528481|NCT00334113|21022156|P2|STARTED|Overall Study||34
8528482|NCT00334113|21022157|P1|STARTED|Overall Study||32
8528483|NCT00334074|21022163|P1|NOT COMPLETED|Overall Study||0
8528484|NCT00334074|21022163|P1|COMPLETED|Overall Study||30
8528485|NCT00334074|21022163|P1|STARTED|Overall Study||30
8528486|NCT00334061|21022168|P1|NOT COMPLETED|Overall Study||0
8528487|NCT00334061|21022168|P1|COMPLETED|Overall Study|November 2007|125
8528488|NCT00334061|21022168|P1|STARTED|Overall Study|June 2006|125
8528489|NCT00333983|21022180|P3|NOT COMPLETED|Overall Study||2
8528490|NCT00333983|21022181|P2|NOT COMPLETED|Overall Study||5
8528491|NCT00333983|21022182|P1|NOT COMPLETED|Overall Study||3
8528492|NCT00333983|21022180|P3|COMPLETED|Overall Study||19
8528493|NCT00333983|21022181|P2|COMPLETED|Overall Study||16
8528494|NCT00333983|21022182|P1|COMPLETED|Overall Study||17
8528495|NCT00333983|21022180|P3|STARTED|Overall Study||21
8528496|NCT00333983|21022181|P2|STARTED|Overall Study||21
8528497|NCT00333983|21022182|P1|STARTED|Overall Study||20
8528498|NCT00333970|21022192|P2|NOT COMPLETED|Overall Study||7
8528499|NCT00333970|21022193|P1|NOT COMPLETED|Overall Study||13
8528500|NCT00333970|21022192|P2|COMPLETED|Overall Study||18
8528501|NCT00333970|21022193|P1|COMPLETED|Overall Study||37
8528502|NCT00333970|21022192|P2|STARTED|Overall Study||25
8528503|NCT00333970|21022193|P1|STARTED|Overall Study||50
8528504|NCT00333879|21022199|P1|NOT COMPLETED|Overall Study||0
8528505|NCT00333879|21022199|P1|COMPLETED|Overall Study||4
8528506|NCT00333879|21022199|P1|STARTED|Overall Study||4
8528523|NCT00333840|21022271|P4|NOT COMPLETED|Second-line Treatment Period||188
8528524|NCT00333840|21022272|P3|NOT COMPLETED|Second-line Treatment Period||14
8528525|NCT00333840|21022273|P2|NOT COMPLETED|Second-line Treatment Period||0
8528526|NCT00333840|21022274|P1|NOT COMPLETED|Second-line Treatment Period||0
8528527|NCT00333840|21022271|P4|COMPLETED|Second-line Treatment Period||175
8528528|NCT00333840|21022272|P3|COMPLETED|Second-line Treatment Period||0
8528529|NCT00333840|21022273|P2|COMPLETED|Second-line Treatment Period||0
8528530|NCT00333840|21022274|P1|COMPLETED|Second-line Treatment Period||0
8528531|NCT00333840|21022271|P4|STARTED|Second-line Treatment Period||363
8528532|NCT00333840|21022272|P3|STARTED|Second-line Treatment Period||14
8528533|NCT00333840|21022273|P2|STARTED|Second-line Treatment Period||0
8528534|NCT00333840|21022274|P1|STARTED|Second-line Treatment Period||0
8528535|NCT00333840|21022271|P4|NOT COMPLETED|First-line Treatment Period||0
8528536|NCT00333840|21022272|P3|NOT COMPLETED|First-line Treatment Period||0
8528537|NCT00333840|21022273|P2|NOT COMPLETED|First-line Treatment Period||546
8528538|NCT00333840|21022274|P1|NOT COMPLETED|First-line Treatment Period||286
8528539|NCT00333840|21022271|P4|COMPLETED|First-line Treatment Period||0
8528540|NCT00333840|21022272|P3|COMPLETED|First-line Treatment Period||0
8528541|NCT00333840|21022273|P2|COMPLETED|First-line Treatment Period||7
8528542|NCT00333840|21022274|P1|COMPLETED|First-line Treatment Period||267
8528543|NCT00333840|21022271|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
8528544|NCT00333840|21022272|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
8528545|NCT00333840|21022273|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
8528546|NCT00333840|21022274|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
8528547|NCT00333840|21022271|P4|STARTED|First-line Treatment Period||0
8528548|NCT00333840|21022272|P3|STARTED|First-line Treatment Period||0
8528549|NCT00333840|21022273|P2|STARTED|First-line Treatment Period||553
8528550|NCT00333840|21022274|P1|STARTED|First-line Treatment Period||553
8528551|NCT00333814|21022302|P3|NOT COMPLETED|Overall Study||5
8528552|NCT00333814|21022303|P2|NOT COMPLETED|Overall Study||4
8528553|NCT00333814|21022304|P1|NOT COMPLETED|Overall Study||3
8528554|NCT00333814|21022302|P3|COMPLETED|Overall Study||71
8528555|NCT00333814|21022303|P2|COMPLETED|Overall Study||73
8528556|NCT00333814|21022304|P1|COMPLETED|Overall Study||73
8528557|NCT00333814|21022302|P3|STARTED|Overall Study||76
8528558|NCT00333814|21022303|P2|STARTED|Overall Study||77
8528559|NCT00333814|21022304|P1|STARTED|Overall Study||76
8528560|NCT00333801|21022320|P2|NOT COMPLETED|Overall Study||6
8528561|NCT00333801|21022321|P1|NOT COMPLETED|Overall Study||8
8528562|NCT00333801|21022320|P2|COMPLETED|Overall Study||36
8528563|NCT00333801|21022321|P1|COMPLETED|Overall Study||35
8528564|NCT00333801|21022320|P2|STARTED|Overall Study||42
8528565|NCT00333801|21022321|P1|STARTED|Overall Study||43
8528566|NCT00333788|21022339|P1|NOT COMPLETED|Overall Study||162
8528567|NCT00333788|21022339|P1|COMPLETED|Overall Study||71
8528568|NCT00333788|21022339|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
8528569|NCT00333775|21022369|P3|NOT COMPLETED|Overall Study||247
8528570|NCT00333775|21022370|P2|NOT COMPLETED|Overall Study||248
8528571|NCT00333775|21022371|P1|NOT COMPLETED|Overall Study||241
8528572|NCT00333775|21022369|P3|COMPLETED|Overall Study||0
8528573|NCT00333775|21022370|P2|COMPLETED|Overall Study||0
8528574|NCT00333775|21022371|P1|COMPLETED|Overall Study||0
8528575|NCT00333775|21022369|P3|Received Treatment|Overall Study||245
8528576|NCT00333775|21022370|P2|Received Treatment|Overall Study||247
8528577|NCT00333775|21022371|P1|Received Treatment|Overall Study||238
8528578|NCT00333775|21022369|P3|STARTED|Overall Study||247
8528579|NCT00333775|21022370|P2|STARTED|Overall Study||248
8528580|NCT00333775|21022371|P1|STARTED|Overall Study||241
8528581|NCT00333762|21022391|P1|NOT COMPLETED|Overall Study||4
8528582|NCT00333762|21022391|P1|COMPLETED|Overall Study||0
8528583|NCT00333762|21022391|P1|STARTED|Overall Study||4
8528584|NCT00333710|21022398|P3|NOT COMPLETED|Overall Study||1
8528585|NCT00333710|21022399|P2|NOT COMPLETED|Overall Study||4
8528586|NCT00333710|21022400|P1|NOT COMPLETED|Overall Study||11
8528587|NCT00333710|21022398|P3|COMPLETED|Overall Study||15
8528588|NCT00333710|21022399|P2|COMPLETED|Overall Study||14
8528589|NCT00333710|21022400|P1|COMPLETED|Overall Study||8
8528590|NCT00333710|21022398|P3|STARTED|Overall Study||16
8528591|NCT00333710|21022399|P2|STARTED|Overall Study||18
8528592|NCT00333710|21022400|P1|STARTED|Overall Study||19
8528593|NCT00333619|21022410|P2|NOT COMPLETED|Overall Study||10
8528594|NCT00333619|21022411|P1|NOT COMPLETED|Overall Study||21
8528595|NCT00333619|21022410|P2|COMPLETED|Overall Study||99
8528596|NCT00333619|21022411|P1|COMPLETED|Overall Study||89
8528597|NCT00333619|21022410|P2|3-month Follow-up|Overall Study||105
8528598|NCT00333619|21022411|P1|3-month Follow-up|Overall Study||101
8528599|NCT00333619|21022410|P2|Post-treatment|Overall Study||109
8528600|NCT00333619|21022411|P1|Post-treatment|Overall Study||109
8528601|NCT00333619|21022410|P2|STARTED|Overall Study||109
8528602|NCT00333619|21022411|P1|STARTED|Overall Study||110
8528603|NCT00333606|21022421|P2|NOT COMPLETED|Overall Study||0
8528604|NCT00333606|21022422|P1|NOT COMPLETED|Overall Study||0
8528605|NCT00333606|21022421|P2|COMPLETED|Overall Study||30
8528606|NCT00333606|21022422|P1|COMPLETED|Overall Study||30
8528607|NCT00333606|21022421|P2|STARTED|Overall Study||30
8528608|NCT00333606|21022422|P1|STARTED|Overall Study||30
8528609|NCT00333437|21022430|P1|NOT COMPLETED|Overall Study||0
8528610|NCT00333437|21022430|P1|COMPLETED|Overall Study||7
8528611|NCT00333437|21022430|P1|STARTED|Overall Study||7
8528612|NCT00333359|21022440|P2|NOT COMPLETED|Overall Study||122
8528613|NCT00333359|21022441|P1|NOT COMPLETED|Overall Study||73
8528614|NCT00333359|21022440|P2|COMPLETED|Overall Study||260
8528615|NCT00333359|21022441|P1|COMPLETED|Overall Study||126
8528616|NCT00333359|21022440|P2|STARTED|Overall Study||382
8528617|NCT00333359|21022441|P1|STARTED|Overall Study||199
8528618|NCT00333229|21022484|P2|NOT COMPLETED|Overall Study||1
8528619|NCT00333229|21022485|P1|NOT COMPLETED|Overall Study||0
8528620|NCT00333229|21022484|P2|COMPLETED|Overall Study||4
8528621|NCT00333229|21022485|P1|COMPLETED|Overall Study||6
8528622|NCT00333229|21022484|P2|STARTED|Overall Study||5
8528623|NCT00333229|21022485|P1|STARTED|Overall Study||6
8528624|NCT00333177|21022503|P4|NOT COMPLETED|Overall Study||2
8528625|NCT00333177|21022504|P3|NOT COMPLETED|Overall Study||1
8528626|NCT00333177|21022505|P2|NOT COMPLETED|Overall Study||1
8528627|NCT00333177|21022506|P1|NOT COMPLETED|Overall Study||0
8528628|NCT00333177|21022503|P4|COMPLETED|Overall Study||12
8528629|NCT00333177|21022504|P3|COMPLETED|Overall Study||16
8528630|NCT00333177|21022505|P2|COMPLETED|Overall Study||16
8528631|NCT00333177|21022506|P1|COMPLETED|Overall Study||12
8528632|NCT00333177|21022503|P4|Received Intervention|Overall Study||12
8528633|NCT00333177|21022504|P3|Received Intervention|Overall Study||16
8528634|NCT00333177|21022505|P2|Received Intervention|Overall Study||16
8528635|NCT00333177|21022506|P1|Received Intervention|Overall Study||12
8528636|NCT00333177|21022503|P4|STARTED|Overall Study||14
8528637|NCT00333177|21022504|P3|STARTED|Overall Study||17
8528638|NCT00333177|21022505|P2|STARTED|Overall Study||17
8528639|NCT00333177|21022506|P1|STARTED|Overall Study||12
8528640|NCT00333138|21022555|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
8528641|NCT00333138|21022556|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
8528642|NCT00333138|21022557|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
8528643|NCT00333138|21022555|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
8528644|NCT00333138|21022556|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
8528645|NCT00333138|21022557|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
8528646|NCT00333138|21022555|P3|STARTED|Extension Study (Month6 to End of Study)||80
8528647|NCT00333138|21022556|P2|STARTED|Extension Study (Month6 to End of Study)||87
8528648|NCT00333138|21022557|P1|STARTED|Extension Study (Month6 to End of Study)||83
8528649|NCT00333138|21022555|P3|NOT COMPLETED|Core Study (6 Months)||12
8528650|NCT00333138|21022556|P2|NOT COMPLETED|Core Study (6 Months)||6
8528651|NCT00333138|21022557|P1|NOT COMPLETED|Core Study (6 Months)||7
8528652|NCT00333138|21022555|P3|COMPLETED|Core Study (6 Months)||82
8528653|NCT00333138|21022556|P2|COMPLETED|Core Study (6 Months)||88
8528654|NCT00333138|21022557|P1|COMPLETED|Core Study (6 Months)||86
8528655|NCT00333138|21022555|P3|STARTED|Core Study (6 Months)||94
8528656|NCT00333138|21022556|P2|STARTED|Core Study (6 Months)||94
8528657|NCT00333138|21022557|P1|STARTED|Core Study (6 Months)||93
8528658|NCT00332839|21022596|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
8528659|NCT00332839|21022597|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
8528660|NCT00332839|21022596|P2|COMPLETED|Follow-up (Months 12 - 60)||31
8528661|NCT00332839|21022597|P1|COMPLETED|Follow-up (Months 12 - 60)||29
8528662|NCT00332839|21022596|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
8528663|NCT00332839|21022597|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
8528664|NCT00332839|21022596|P2|NOT COMPLETED|Core (Months 0 - 12)||18
8528665|NCT00332839|21022597|P1|NOT COMPLETED|Core (Months 0 - 12)||10
8528666|NCT00332839|21022596|P2|COMPLETED|Core (Months 0 - 12)||28
8528667|NCT00332839|21022597|P1|COMPLETED|Core (Months 0 - 12)||37
8528668|NCT00332839|21022596|P2|Safety Set|Core (Months 0 - 12)||46
8528669|NCT00332839|21022597|P1|Safety Set|Core (Months 0 - 12)||47
8528670|NCT00332839|21022596|P2|STARTED|Core (Months 0 - 12)||46
8528671|NCT00332839|21022597|P1|STARTED|Core (Months 0 - 12)||47
8528672|NCT00332722|21022617|P2|NOT COMPLETED|Overall Study||0
8528673|NCT00332722|21022618|P1|NOT COMPLETED|Overall Study||0
8528674|NCT00332722|21022617|P2|COMPLETED|Overall Study||60
8528675|NCT00332722|21022618|P1|COMPLETED|Overall Study||60
8528676|NCT00332722|21022617|P2|STARTED|Overall Study||60
8528677|NCT00332722|21022618|P1|STARTED|Overall Study||60
8528678|NCT00332709|21022628|P2|NOT COMPLETED|Overall Study||20
8528679|NCT00332709|21022629|P1|NOT COMPLETED|Overall Study||16
8528680|NCT00332709|21022628|P2|COMPLETED|Overall Study||21
8528681|NCT00332709|21022629|P1|COMPLETED|Overall Study||24
8528682|NCT00332709|21022628|P2|STARTED|Overall Study||41
8528683|NCT00332709|21022629|P1|STARTED|Overall Study||40
8528684|NCT00332696|21022653|P2|NOT COMPLETED|Overall Study||30
8528685|NCT00332696|21022654|P1|NOT COMPLETED|Overall Study||30
8528686|NCT00332696|21022653|P2|COMPLETED|Overall Study||2
8528687|NCT00332696|21022654|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
8528688|NCT00332696|21022653|P2|Completed Day 14 Visit|Overall Study||15
8528689|NCT00332696|21022654|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
8528690|NCT00332696|21022653|P2|STARTED|Overall Study||32
8528691|NCT00332696|21022654|P1|STARTED|Overall Study||32
8528692|NCT00332644|21022686|P6|NOT COMPLETED|Overall Study||15
8528693|NCT00332644|21022687|P5|NOT COMPLETED|Overall Study||12
8528694|NCT00332644|21022688|P4|NOT COMPLETED|Overall Study||20
8528695|NCT00332644|21022689|P3|NOT COMPLETED|Overall Study||9
8528696|NCT00332644|21022690|P2|NOT COMPLETED|Overall Study||22
8528697|NCT00332644|21022691|P1|NOT COMPLETED|Overall Study||12
8528698|NCT00332644|21022686|P6|COMPLETED|Overall Study||174
8528699|NCT00332644|21022687|P5|COMPLETED|Overall Study||250
8528700|NCT00332644|21022688|P4|COMPLETED|Overall Study||244
8528701|NCT00332644|21022689|P3|COMPLETED|Overall Study||258
8528702|NCT00332644|21022690|P2|COMPLETED|Overall Study||238
8528703|NCT00332644|21022691|P1|COMPLETED|Overall Study||250
8528704|NCT00332644|21022686|P6|STARTED|Overall Study||189
8528705|NCT00332644|21022687|P5|STARTED|Overall Study||262
8528706|NCT00332644|21022688|P4|STARTED|Overall Study||264
8528707|NCT00332644|21022689|P3|STARTED|Overall Study||267
8528708|NCT00332644|21022690|P2|STARTED|Overall Study||260
8528709|NCT00332644|21022691|P1|STARTED|Overall Study||262
8528710|NCT00332605|21022708|P3|NOT COMPLETED|Overall Study||8
8528711|NCT00332605|21022709|P2|NOT COMPLETED|Overall Study||2
8528712|NCT00332605|21022710|P1|NOT COMPLETED|Overall Study||2
8528713|NCT00332605|21022708|P3|COMPLETED|Overall Study||9
8528714|NCT00332605|21022709|P2|COMPLETED|Overall Study||12
8528715|NCT00332605|21022710|P1|COMPLETED|Overall Study||12
8528716|NCT00332605|21022708|P3|STARTED|Overall Study||17
8528717|NCT00332605|21022709|P2|STARTED|Overall Study||14
8528718|NCT00332605|21022710|P1|STARTED|Overall Study||14
8528719|NCT00332579|21022720|P2|NOT COMPLETED|Overall Study||1
8528720|NCT00332579|21022721|P1|NOT COMPLETED|Overall Study||1
8528721|NCT00332579|21022720|P2|COMPLETED|Overall Study||12
8528722|NCT00332579|21022721|P1|COMPLETED|Overall Study||11
8528723|NCT00332579|21022720|P2|STARTED|Overall Study||13
8528724|NCT00332579|21022721|P1|STARTED|Overall Study||12
8528725|NCT00332488|21022730|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
8528726|NCT00332488|21022731|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
8528727|NCT00332488|21022732|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
8528728|NCT00332488|21022730|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
8528729|NCT00332488|21022731|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
8528730|NCT00332488|21022732|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
8528731|NCT00332488|21022730|P3|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
8528732|NCT00332488|21022731|P2|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
8528733|NCT00332488|21022732|P1|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
8528734|NCT00332488|21022730|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
8528735|NCT00332488|21022731|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
8528736|NCT00332488|21022732|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
8528737|NCT00332488|21022730|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
8528738|NCT00332488|21022731|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
8528739|NCT00332488|21022732|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
8528740|NCT00332488|21022730|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
8528741|NCT00332488|21022731|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
8528742|NCT00332488|21022732|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
8528743|NCT00332462|21022744|P1|NOT COMPLETED|Overall Study||16
8528744|NCT00332462|21022744|P1|COMPLETED|Overall Study||18
8528745|NCT00332462|21022744|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
8528746|NCT00332462|21022744|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
8528747|NCT00332462|21022744|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
8528748|NCT00332332|21022751|P1|NOT COMPLETED|Overall Study||68
8528749|NCT00332332|21022751|P1|COMPLETED|Overall Study||178
8528750|NCT00332332|21022751|P1|Received Study Medication|Overall Study||230
8528751|NCT00332332|21022751|P1|STARTED|Overall Study||246
8528752|NCT00332241|21022760|P2|NOT COMPLETED|Overall Study||8
8528753|NCT00332241|21022761|P1|NOT COMPLETED|Overall Study||15
8528754|NCT00332241|21022760|P2|COMPLETED|Overall Study||39
8528755|NCT00332241|21022761|P1|COMPLETED|Overall Study||36
8528756|NCT00332241|21022760|P2|STARTED|Overall Study||47
8528757|NCT00332241|21022761|P1|STARTED|Overall Study||51
8528758|NCT00332202|21022783|P2|NOT COMPLETED|Overall Study||125
8528759|NCT00332202|21022784|P1|NOT COMPLETED|Overall Study||241
8528760|NCT00332202|21022783|P2|COMPLETED|Overall Study||129
8528761|NCT00332202|21022784|P1|COMPLETED|Overall Study||263
8528762|NCT00332202|21022783|P2|Received At Least One Dose of Study Drug|Overall Study||249
8528763|NCT00332202|21022784|P1|Received At Least One Dose of Study Drug|Overall Study||493
8528764|NCT00332202|21022783|P2|STARTED|Overall Study||254
8528765|NCT00332202|21022784|P1|STARTED|Overall Study||504
8528766|NCT00332189|21022813|P1|NOT COMPLETED|Overall Study||21
8528767|NCT00332189|21022813|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
8528768|NCT00332189|21022813|P1|STARTED|Overall Study||111
8528769|NCT00332163|21022820|P2|NOT COMPLETED|Overall Study||0
8528770|NCT00332163|21022821|P1|NOT COMPLETED|Overall Study||0
8528771|NCT00332163|21022820|P2|COMPLETED|Overall Study||47
8528772|NCT00332163|21022821|P1|COMPLETED|Overall Study||48
8528773|NCT00332163|21022820|P2|Received Treatment|Overall Study||47
8528774|NCT00332163|21022821|P1|Received Treatment|Overall Study||48
8528775|NCT00332163|21022820|P2|STARTED|Overall Study||47
8528776|NCT00332163|21022821|P1|STARTED|Overall Study||48
8528777|NCT00331864|21022855|P2|NOT COMPLETED|Overall Study||4
8528778|NCT00331864|21022856|P1|NOT COMPLETED|Overall Study||58
8528779|NCT00331864|21022855|P2|COMPLETED|Overall Study||14
8528780|NCT00331864|21022856|P1|COMPLETED|Overall Study||455
8528781|NCT00331864|21022855|P2|STARTED|Overall Study||18
8528782|NCT00331864|21022856|P1|STARTED|Overall Study||513
8528783|NCT00331799|21022875|P1|NOT COMPLETED|Overall Study||3
8528784|NCT00331799|21022875|P1|COMPLETED|Overall Study||15
8528785|NCT00331799|21022875|P1|STARTED|Overall Study||18
8528786|NCT00331773|21022881|P2|NOT COMPLETED|Overall Study||7
8528787|NCT00331773|21022882|P1|NOT COMPLETED|Overall Study||16
8528788|NCT00331773|21022881|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
8528789|NCT00331773|21022882|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
8528790|NCT00331773|21022881|P2|STARTED|Overall Study||557
8528791|NCT00331773|21022882|P1|STARTED|Overall Study||558
8528792|NCT00331760|21022912|P2|NOT COMPLETED|Overall Study||8
8528793|NCT00331760|21022913|P1|NOT COMPLETED|Overall Study||15
8528794|NCT00331760|21022912|P2|COMPLETED|Overall Study||40
8528795|NCT00331760|21022913|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
8528796|NCT00331760|21022912|P2|STARTED|Overall Study||48
8528797|NCT00331760|21022913|P1|STARTED|Overall Study||58
8528798|NCT00331682|21022934|P1|NOT COMPLETED|Overall Study||1
8528799|NCT00331682|21022934|P1|COMPLETED|Overall Study||9
8528800|NCT00331682|21022934|P1|STARTED|Overall Study||10
8528801|NCT00331630|21022940|P1|NOT COMPLETED|Follow up for 5 Years||29
8528802|NCT00331630|21022940|P1|COMPLETED|Follow up for 5 Years||0
8528889|NCT00331344|21022992|P1|STARTED|Phase I||3
8528803|NCT00331630|21022940|P1|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
8528804|NCT00331630|21022940|P1|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
8528805|NCT00331630|21022940|P1|COMPLETED|Evaluated for and Completed SOC Surgery||28
8528806|NCT00331630|21022940|P1|STARTED|Evaluated for and Completed SOC Surgery||30
8528807|NCT00331630|21022940|P1|NOT COMPLETED|Treatment on Study||0
8528808|NCT00331630|21022940|P1|COMPLETED|Treatment on Study||30
8528809|NCT00331630|21022940|P1|Completed 4 Cycles|Treatment on Study||30
8528810|NCT00331630|21022940|P1|Completed 1st Cycle|Treatment on Study||30
8528811|NCT00331630|21022940|P1|STARTED|Treatment on Study||30
8528812|NCT00331552|21022952|P2|NOT COMPLETED|Period 3: Phase II||0
8528813|NCT00331552|21022953|P1|NOT COMPLETED|Period 3: Phase II||2
8528814|NCT00331552|21022952|P2|COMPLETED|Period 3: Phase II||0
8528815|NCT00331552|21022953|P1|COMPLETED|Period 3: Phase II||22
8528816|NCT00331552|21022952|P2|STARTED|Period 3: Phase II||0
8528817|NCT00331552|21022953|P1|STARTED|Period 3: Phase II||24
8528818|NCT00331552|21022952|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528819|NCT00331552|21022953|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528820|NCT00331552|21022952|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
8528821|NCT00331552|21022953|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528822|NCT00331552|21022952|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
8528823|NCT00331552|21022953|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528824|NCT00331552|21022952|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528825|NCT00331552|21022953|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528826|NCT00331552|21022952|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528827|NCT00331552|21022953|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
8528828|NCT00331552|21022952|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528829|NCT00331552|21022953|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
8528830|NCT00331422|21022967|P1|NOT COMPLETED|Overall Study||5
8528831|NCT00331422|21022967|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
8528832|NCT00331422|21022967|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
8528833|NCT00331409|21022976|P1|NOT COMPLETED|Overall Study||4
8528834|NCT00331409|21022976|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
8528835|NCT00331409|21022976|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
8528836|NCT00331344|21022984|P9|NOT COMPLETED|Phase II||4
8528837|NCT00331344|21022985|P8|NOT COMPLETED|Phase II||0
8528838|NCT00331344|21022986|P7|NOT COMPLETED|Phase II||0
8528839|NCT00331344|21022987|P6|NOT COMPLETED|Phase II||0
8528840|NCT00331344|21022988|P5|NOT COMPLETED|Phase II||0
8528841|NCT00331344|21022989|P4|NOT COMPLETED|Phase II||0
8528842|NCT00331344|21022990|P3|NOT COMPLETED|Phase II||0
8528843|NCT00331344|21022991|P2|NOT COMPLETED|Phase II||0
8528844|NCT00331344|21022992|P1|NOT COMPLETED|Phase II||0
8528845|NCT00331344|21022984|P9|COMPLETED|Phase II||48
8528846|NCT00331344|21022985|P8|COMPLETED|Phase II||6
8528847|NCT00331344|21022986|P7|COMPLETED|Phase II||0
8528848|NCT00331344|21022987|P6|COMPLETED|Phase II||0
8528849|NCT00331344|21022988|P5|COMPLETED|Phase II||0
8528850|NCT00331344|21022989|P4|COMPLETED|Phase II||0
8528851|NCT00331344|21022990|P3|COMPLETED|Phase II||0
8528852|NCT00331344|21022991|P2|COMPLETED|Phase II||0
8528853|NCT00331344|21022992|P1|COMPLETED|Phase II||0
8528854|NCT00331344|21022984|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
8528855|NCT00331344|21022985|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
8528856|NCT00331344|21022986|P7|STARTED|Phase II||0
8528857|NCT00331344|21022987|P6|STARTED|Phase II||0
8528858|NCT00331344|21022988|P5|STARTED|Phase II||0
8528859|NCT00331344|21022989|P4|STARTED|Phase II||0
8528860|NCT00331344|21022990|P3|STARTED|Phase II||0
8528861|NCT00331344|21022991|P2|STARTED|Phase II||0
8528862|NCT00331344|21022992|P1|STARTED|Phase II||0
8528863|NCT00331344|21022984|P9|NOT COMPLETED|Phase I||0
8528864|NCT00331344|21022985|P8|NOT COMPLETED|Phase I||1
8528865|NCT00331344|21022986|P7|NOT COMPLETED|Phase I||0
8528866|NCT00331344|21022987|P6|NOT COMPLETED|Phase I||2
8528867|NCT00331344|21022988|P5|NOT COMPLETED|Phase I||2
8528868|NCT00331344|21022989|P4|NOT COMPLETED|Phase I||1
8528869|NCT00331344|21022990|P3|NOT COMPLETED|Phase I||0
8528870|NCT00331344|21022991|P2|NOT COMPLETED|Phase I||0
8528871|NCT00331344|21022992|P1|NOT COMPLETED|Phase I||0
8528872|NCT00331344|21022984|P9|COMPLETED|Phase I||0
8528873|NCT00331344|21022985|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
8528874|NCT00331344|21022986|P7|COMPLETED|Phase I||4
8528875|NCT00331344|21022987|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
8528876|NCT00331344|21022988|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
8528877|NCT00331344|21022989|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
8528878|NCT00331344|21022990|P3|COMPLETED|Phase I||3
8528879|NCT00331344|21022991|P2|COMPLETED|Phase I||3
8528880|NCT00331344|21022992|P1|COMPLETED|Phase I||3
8528881|NCT00331344|21022984|P9|STARTED|Phase I||0
8528882|NCT00331344|21022985|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
8528883|NCT00331344|21022986|P7|STARTED|Phase I||4
8528884|NCT00331344|21022987|P6|STARTED|Phase I||5
8528885|NCT00331344|21022988|P5|STARTED|Phase I||6
8528886|NCT00331344|21022989|P4|STARTED|Phase I||6
8528887|NCT00331344|21022990|P3|STARTED|Phase I||3
8528888|NCT00331344|21022991|P2|STARTED|Phase I||3
8528890|NCT00331162|21023008|P2|NOT COMPLETED|Overall Study||0
8528891|NCT00331162|21023009|P1|NOT COMPLETED|Overall Study||0
8528892|NCT00331162|21023008|P2|COMPLETED|Overall Study||109
8528893|NCT00331162|21023009|P1|COMPLETED|Overall Study||113
8528894|NCT00331162|21023008|P2|STARTED|Overall Study||109
8528895|NCT00331162|21023009|P1|STARTED|Overall Study||113
8528896|NCT00331006|21023029|P1|NOT COMPLETED|Follow-Up Phase II||3
8528897|NCT00331006|21023029|P1|COMPLETED|Follow-Up Phase II||11
8528898|NCT00331006|21023029|P1|STARTED|Follow-Up Phase II||14
8528899|NCT00331006|21023029|P1|NOT COMPLETED|Follow-Up Phase I||1
8528900|NCT00331006|21023029|P1|COMPLETED|Follow-Up Phase I||14
8528901|NCT00331006|21023029|P1|STARTED|Follow-Up Phase I||15
8528902|NCT00331006|21023029|P1|NOT COMPLETED|Treatment Phase||1
8528903|NCT00331006|21023029|P1|COMPLETED|Treatment Phase||15
8528904|NCT00331006|21023029|P1|STARTED|Treatment Phase||16
8528905|NCT00331006|21023029|P1|NOT COMPLETED|Screening Phase||7
8528906|NCT00331006|21023029|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
8528907|NCT00331006|21023029|P1|STARTED|Screening Phase||23
8528908|NCT00330967|21023042|P2|NOT COMPLETED|Overall Study||14
8528909|NCT00330967|21023043|P1|NOT COMPLETED|Overall Study||0
8528910|NCT00330967|21023042|P2|COMPLETED|Overall Study||11
8528911|NCT00330967|21023043|P1|COMPLETED|Overall Study||0
8528912|NCT00330967|21023042|P2|STARTED|Overall Study||25
8528913|NCT00330967|21023043|P1|STARTED|Overall Study||0
8528914|NCT00330928|21023054|P1|NOT COMPLETED|Overall Study||17
8528915|NCT00330928|21023054|P1|COMPLETED|Overall Study||89
8528916|NCT00330928|21023054|P1|1 Year Phone Contact|Overall Study||89
8528917|NCT00330928|21023054|P1|7 Day Phone Contact|Overall Study||99
8528918|NCT00330928|21023054|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
8528919|NCT00330915|21023059|P1|NOT COMPLETED|Overall Study||0
8528920|NCT00330915|21023059|P1|COMPLETED|Overall Study||37
8528921|NCT00330915|21023059|P1|STARTED|Overall Study||37
8528922|NCT00330876|21023066|P2|NOT COMPLETED|Overall Study||13
8528923|NCT00330876|21023067|P1|NOT COMPLETED|Overall Study||71
8528924|NCT00330876|21023066|P2|COMPLETED|Overall Study||77
8528925|NCT00330876|21023067|P1|COMPLETED|Overall Study||378
8528926|NCT00330876|21023066|P2|STARTED|Overall Study||90
8528927|NCT00330876|21023067|P1|STARTED|Overall Study||449
8528928|NCT00330863|21023077|P2|NOT COMPLETED|Overall Study||80
8528929|NCT00330863|21023078|P1|NOT COMPLETED|Overall Study||81
8528930|NCT00330863|21023077|P2|COMPLETED|Overall Study||72
8528931|NCT00330863|21023078|P1|COMPLETED|Overall Study||72
8528932|NCT00330863|21023077|P2|STARTED|Overall Study||152
8528933|NCT00330863|21023078|P1|STARTED|Overall Study||153
8528934|NCT00330759|21023096|P2|NOT COMPLETED|Overall Study||706
8528935|NCT00330759|21023097|P1|NOT COMPLETED|Overall Study||712
8528936|NCT00330759|21023096|P2|COMPLETED|Overall Study||180
8528937|NCT00330759|21023097|P1|COMPLETED|Overall Study||178
8528938|NCT00330759|21023096|P2|Received Investigational Product|Overall Study||878
8528939|NCT00330759|21023097|P1|Received Investigational Product|Overall Study||878
8528940|NCT00330759|21023096|P2|STARTED|Overall Study||886
8528941|NCT00330759|21023097|P1|STARTED|Overall Study||890
8528942|NCT00330733|21023109|P2|NOT COMPLETED|Overall Study||5
8528943|NCT00330733|21023110|P1|NOT COMPLETED|Overall Study||7
8528944|NCT00330733|21023109|P2|COMPLETED|Overall Study||29
8528945|NCT00330733|21023110|P1|COMPLETED|Overall Study||30
8528946|NCT00330733|21023109|P2|Received Study Medication|Overall Study||34
8528947|NCT00330733|21023110|P1|Received Study Medication|Overall Study||36
8528948|NCT00330733|21023109|P2|STARTED|Overall Study||34
8528949|NCT00330733|21023110|P1|STARTED|Overall Study||37
8528950|NCT00330681|21023130|P2|NOT COMPLETED|Overall Study||14
8528951|NCT00330681|21023131|P1|NOT COMPLETED|Overall Study||9
8528952|NCT00330681|21023130|P2|COMPLETED|Overall Study||90
8528953|NCT00330681|21023131|P1|COMPLETED|Overall Study||93
8528954|NCT00330681|21023130|P2|STARTED|Overall Study||104
8528955|NCT00330681|21023131|P1|STARTED|Overall Study||102
8528956|NCT00330668|21023153|P1|NOT COMPLETED|QD Dosing Period||78
8528957|NCT00330668|21023153|P1|COMPLETED|QD Dosing Period||0
8528958|NCT00330668|21023153|P1|STARTED|QD Dosing Period||78
8528959|NCT00330668|21023153|P1|NOT COMPLETED|BID Dosing Period||36
8528960|NCT00330668|21023153|P1|COMPLETED|BID Dosing Period||78
8528961|NCT00330668|21023153|P1|STARTED|BID Dosing Period||114
8528962|NCT00330616|21023161|P1|NOT COMPLETED|Overall Study||21
8528963|NCT00330616|21023161|P1|COMPLETED|Overall Study||14
8528964|NCT00330616|21023161|P1|STARTED|Overall Study||35
8528965|NCT00330564|21023180|P1|NOT COMPLETED|Overall Study||0
8528966|NCT00330564|21023180|P1|COMPLETED|Overall Study||15
8528967|NCT00330564|21023180|P1|STARTED|Overall Study||15
8528968|NCT00330551|21023187|P2|NOT COMPLETED|Overall Study||16
8528969|NCT00330551|21023188|P1|NOT COMPLETED|Overall Study||10
8528970|NCT00330551|21023187|P2|COMPLETED|Overall Study||27
8528971|NCT00330551|21023188|P1|COMPLETED|Overall Study||30
8528972|NCT00330551|21023187|P2|STARTED|Overall Study||43
8528973|NCT00330551|21023188|P1|STARTED|Overall Study||40
8528974|NCT00330460|21023212|P2|NOT COMPLETED|Overall Study||33
8528975|NCT00330460|21023213|P1|NOT COMPLETED|Overall Study||42
8528976|NCT00330460|21023212|P2|COMPLETED|Overall Study||561
8528977|NCT00330460|21023213|P1|COMPLETED|Overall Study||553
8528978|NCT00330460|21023212|P2|STARTED|Overall Study||594
8528979|NCT00330460|21023213|P1|STARTED|Overall Study||595
8528980|NCT00330421|21023227|P2|NOT COMPLETED|Overall Study||0
8528981|NCT00330421|21023228|P1|NOT COMPLETED|Overall Study||0
8528982|NCT00330421|21023227|P2|COMPLETED|Overall Study||0
8528983|NCT00330421|21023228|P1|COMPLETED|Overall Study||15
8528984|NCT00330421|21023227|P2|STARTED|Overall Study||0
8528985|NCT00330421|21023228|P1|STARTED|Overall Study||15
8528986|NCT00330382|21023234|P2|NOT COMPLETED|Overall Study||17
8528987|NCT00330382|21023235|P1|NOT COMPLETED|Overall Study||24
8528988|NCT00330382|21023234|P2|COMPLETED|Overall Study||48
8528989|NCT00330382|21023235|P1|COMPLETED|Overall Study||43
8528990|NCT00330382|21023234|P2|STARTED|Overall Study||65
8528991|NCT00330382|21023235|P1|STARTED|Overall Study||67
8528992|NCT00330343|21023256|P1|NOT COMPLETED|Overall Study||5
8528993|NCT00330343|21023256|P1|COMPLETED|Overall Study||59
8528994|NCT00330343|21023256|P1|STARTED|Overall Study||64
8528995|NCT00330187|21023264|P4|NOT COMPLETED|Overall Study||14
8528996|NCT00330187|21023265|P3|NOT COMPLETED|Overall Study||18
8528997|NCT00330187|21023266|P2|NOT COMPLETED|Overall Study||18
8528998|NCT00330187|21023267|P1|NOT COMPLETED|Overall Study||20
8528999|NCT00330187|21023264|P4|COMPLETED|Overall Study||18
8529000|NCT00330187|21023265|P3|COMPLETED|Overall Study||11
8529001|NCT00330187|21023266|P2|COMPLETED|Overall Study||18
8529002|NCT00330187|21023267|P1|COMPLETED|Overall Study||17
8529003|NCT00330187|21023264|P4|STARTED|Overall Study||32
8529004|NCT00330187|21023265|P3|STARTED|Overall Study||29
8529005|NCT00330187|21023266|P2|STARTED|Overall Study||36
8529006|NCT00330187|21023267|P1|STARTED|Overall Study||37
8529007|NCT00330174|21023279|P2|NOT COMPLETED|Overall Study||19
8529008|NCT00330174|21023280|P1|NOT COMPLETED|Overall Study||22
8529009|NCT00330174|21023279|P2|COMPLETED|Overall Study||26
8529010|NCT00330174|21023280|P1|COMPLETED|Overall Study||23
8529011|NCT00330174|21023279|P2|STARTED|Overall Study||45
8529012|NCT00330174|21023280|P1|STARTED|Overall Study||45
8529013|NCT00330161|21023292|P1|NOT COMPLETED|Overall Study||0
8529014|NCT00330161|21023292|P1|COMPLETED|Overall Study||29
8529015|NCT00330161|21023292|P1|STARTED|Overall Study||29
8529016|NCT00329901|21023304|P3|NOT COMPLETED|Overall Study||4
8529017|NCT00329901|21023305|P2|NOT COMPLETED|Overall Study||5
8529018|NCT00329901|21023306|P1|NOT COMPLETED|Overall Study||9
8529019|NCT00329901|21023304|P3|COMPLETED|Overall Study||353
8529020|NCT00329901|21023305|P2|COMPLETED|Overall Study||349
8529021|NCT00329901|21023306|P1|COMPLETED|Overall Study||352
8529022|NCT00329901|21023304|P3|STARTED|Overall Study||357
8529023|NCT00329901|21023305|P2|STARTED|Overall Study||354
8529024|NCT00329901|21023306|P1|STARTED|Overall Study||361
8529025|NCT00329849|21023336|P2|NOT COMPLETED|Overall Study||4
8529026|NCT00329849|21023337|P1|NOT COMPLETED|Overall Study||6
8529027|NCT00329849|21023336|P2|COMPLETED|Overall Study||546
8529028|NCT00329849|21023337|P1|COMPLETED|Overall Study||944
8529029|NCT00329849|21023336|P2|STARTED|Overall Study||550
8529030|NCT00329849|21023337|P1|STARTED|Overall Study||950
8529031|NCT00329836|21023357|P1|NOT COMPLETED|Overall Study||0
8529032|NCT00329836|21023357|P1|COMPLETED|Overall Study||41
8529033|NCT00329836|21023357|P1|STARTED|Overall Study||41
8529034|NCT00329797|21023363|P2|NOT COMPLETED|Overall Study||6
8529035|NCT00329797|21023364|P1|NOT COMPLETED|Overall Study||7
8529036|NCT00329797|21023363|P2|COMPLETED|Overall Study||46
8529037|NCT00329797|21023364|P1|COMPLETED|Overall Study||50
8529038|NCT00329797|21023363|P2|STARTED|Overall Study||52
8529039|NCT00329797|21023364|P1|STARTED|Overall Study||57
8529040|NCT00329784|21023380|P4|NOT COMPLETED|Overall Study||0
8529041|NCT00329784|21023381|P3|NOT COMPLETED|Overall Study||0
8529042|NCT00329784|21023382|P2|NOT COMPLETED|Overall Study||5
8529043|NCT00329784|21023383|P1|NOT COMPLETED|Overall Study||5
8529044|NCT00329784|21023380|P4|COMPLETED|Overall Study||47
8529045|NCT00329784|21023381|P3|COMPLETED|Overall Study||51
8529046|NCT00329784|21023382|P2|COMPLETED|Overall Study||267
8529047|NCT00329784|21023383|P1|COMPLETED|Overall Study||265
8529048|NCT00329784|21023380|P4|STARTED|Overall Study||47
8529049|NCT00329784|21023381|P3|STARTED|Overall Study||51
8529050|NCT00329784|21023382|P2|STARTED|Overall Study||272
8529051|NCT00329784|21023383|P1|STARTED|Overall Study||270
8529052|NCT00329771|21023405|P1|NOT COMPLETED|Overall Study||3
8529053|NCT00329771|21023405|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
8529054|NCT00329771|21023405|P1|STARTED|Overall Study||28
8529055|NCT00329745|21023411|P2|NOT COMPLETED|Overall Study||102
8529056|NCT00329745|21023412|P1|NOT COMPLETED|Overall Study||87
8529057|NCT00329745|21023411|P2|COMPLETED|Overall Study||4226
8529058|NCT00329745|21023412|P1|COMPLETED|Overall Study||4272
8529059|NCT00329745|21023411|P2|STARTED|Overall Study||4328
8529060|NCT00329745|21023412|P1|STARTED|Overall Study||4359
8529061|NCT00329732|21023422|P2|NOT COMPLETED|Overall Study||0
8529062|NCT00329732|21023423|P1|NOT COMPLETED|Overall Study||0
8529063|NCT00329732|21023422|P2|COMPLETED|Overall Study||0
8529064|NCT00329732|21023423|P1|COMPLETED|Overall Study||2
8529065|NCT00329732|21023422|P2|STARTED|Overall Study||0
8529066|NCT00329732|21023423|P1|STARTED|Overall Study||2
8529067|NCT00329719|21023432|P4|NOT COMPLETED|Overall Study||1
8529068|NCT00329719|21023433|P3|NOT COMPLETED|Overall Study||0
8529069|NCT00329719|21023434|P2|NOT COMPLETED|Overall Study||0
8529070|NCT00329719|21023435|P1|NOT COMPLETED|Overall Study||0
8529071|NCT00329719|21023432|P4|COMPLETED|Overall Study||44
8529072|NCT00329719|21023433|P3|COMPLETED|Overall Study||9
8529073|NCT00329719|21023434|P2|COMPLETED|Overall Study||49
8529074|NCT00329719|21023435|P1|COMPLETED|Overall Study||12
8529075|NCT00329719|21023432|P4|STARTED|Overall Study||45
8529076|NCT00329719|21023433|P3|STARTED|Overall Study||9
8529077|NCT00329719|21023434|P2|STARTED|Overall Study||49
8529078|NCT00329719|21023435|P1|STARTED|Overall Study||12
8529079|NCT00329641|21023457|P1|NOT COMPLETED|Overall Study||6
8529080|NCT00329641|21023457|P1|COMPLETED|Overall Study||19
8529081|NCT00329641|21023457|P1|Eligible and Received Treatment|Overall Study||24
8529082|NCT00329641|21023457|P1|Eligible|Overall Study||25
8529083|NCT00329641|21023457|P1|STARTED|Overall Study||25
8529084|NCT00329602|21023466|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
8529085|NCT00329602|21023467|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
8529086|NCT00329602|21023468|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
8529087|NCT00329602|21023466|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
8529088|NCT00329602|21023467|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
8529089|NCT00329602|21023468|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
8529090|NCT00329602|21023466|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
8529091|NCT00329602|21023467|P2|STARTED|40-Week Open-Label Treatment Phase||0
8529092|NCT00329602|21023468|P1|STARTED|40-Week Open-Label Treatment Phase||0
8529093|NCT00329602|21023466|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
8529094|NCT00329602|21023467|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
8529095|NCT00329602|21023468|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
8529096|NCT00329602|21023466|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
8529097|NCT00329602|21023467|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
8529098|NCT00329602|21023468|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
8529099|NCT00329602|21023466|P3|STARTED|26-Week Double-Blind Treatment Phase||0
8529100|NCT00329602|21023467|P2|STARTED|26-Week Double-Blind Treatment Phase||197
8529101|NCT00329602|21023468|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
8529102|NCT00329550|21023506|P3|NOT COMPLETED|Overall Study||4
8529103|NCT00329550|21023507|P2|NOT COMPLETED|Overall Study||4
8529104|NCT00329550|21023508|P1|NOT COMPLETED|Overall Study||4
8529105|NCT00329550|21023506|P3|COMPLETED|Overall Study||12
8529106|NCT00329550|21023507|P2|COMPLETED|Overall Study||11
8529107|NCT00329550|21023508|P1|COMPLETED|Overall Study||5
8529108|NCT00329550|21023506|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
8529109|NCT00329550|21023507|P2|STARTED|Overall Study||15
8529110|NCT00329550|21023508|P1|STARTED|Overall Study||9
8529111|NCT00329524|21023755|P1|NOT COMPLETED|Overall Study||0
8529112|NCT00329524|21023755|P1|COMPLETED|Overall Study||5
8529113|NCT00329524|21023755|P1|STARTED|Overall Study||5
8529114|NCT00329433|21023763|P2|NOT COMPLETED|Overall Study||0
8529115|NCT00329433|21023764|P1|NOT COMPLETED|Overall Study||0
8529116|NCT00329433|21023763|P2|COMPLETED|Overall Study||59
8529117|NCT00329433|21023764|P1|COMPLETED|Overall Study||61
8529118|NCT00329433|21023763|P2|STARTED|Overall Study||59
8529119|NCT00329433|21023764|P1|STARTED|Overall Study||61
8529120|NCT00329420|21023777|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
8529121|NCT00329420|21023778|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
8529122|NCT00329420|21023779|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
8529123|NCT00329420|21023777|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
8529124|NCT00329420|21023778|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
8529125|NCT00329420|21023779|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
8529126|NCT00329420|21023777|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
8529127|NCT00329420|21023778|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
8529128|NCT00329420|21023779|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
8529129|NCT00329420|21023777|P3|NOT COMPLETED|Re-induction Phase||8
8529130|NCT00329420|21023778|P2|NOT COMPLETED|Re-induction Phase||6
8529131|NCT00329420|21023779|P1|NOT COMPLETED|Re-induction Phase||6
8529132|NCT00329420|21023777|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
8529133|NCT00329420|21023778|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
8529134|NCT00329420|21023779|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
8529135|NCT00329420|21023777|P3|STARTED|Re-induction Phase||15
8529136|NCT00329420|21023778|P2|STARTED|Re-induction Phase||13
8529137|NCT00329420|21023779|P1|STARTED|Re-induction Phase||18
8529138|NCT00329407|21024158|P1|NOT COMPLETED|Overall Study||1
8529139|NCT00329407|21024158|P1|COMPLETED|Overall Study||9
8529140|NCT00329407|21024158|P1|STARTED|Overall Study||10
8529141|NCT00329303|21024165|P2|NOT COMPLETED|Overall Study||2
8529142|NCT00329303|21024166|P1|NOT COMPLETED|Overall Study||2
8529143|NCT00329303|21024165|P2|COMPLETED|Overall Study||35
8529144|NCT00329303|21024166|P1|COMPLETED|Overall Study||32
8529145|NCT00329303|21024165|P2|STARTED|Overall Study||37
8529146|NCT00329303|21024166|P1|STARTED|Overall Study||34
8529147|NCT00329238|21024328|P2|NOT COMPLETED|Overall Study||281
8529148|NCT00329238|21024329|P1|NOT COMPLETED|Overall Study||276
8529149|NCT00329238|21024328|P2|COMPLETED|Overall Study||1145
8529150|NCT00329238|21024329|P1|COMPLETED|Overall Study||1154
8529151|NCT00329238|21024328|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
8529152|NCT00329238|21024329|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
8529153|NCT00329160|21024365|P1|NOT COMPLETED|Overall Study||88
8529154|NCT00329160|21024365|P1|COMPLETED|Overall Study||126
8529155|NCT00329160|21024365|P1|Treatment Period|Overall Study||214
8529156|NCT00329160|21024365|P1|Observation Period|Overall Study||214
8529157|NCT00329160|21024365|P1|STARTED|Overall Study||214
8529158|NCT00329108|21024374|P2|NOT COMPLETED|Overall Study||12
8529159|NCT00329108|21024375|P1|NOT COMPLETED|Overall Study||10
8529160|NCT00329108|21024374|P2|COMPLETED|Overall Study||2
8529161|NCT00329108|21024375|P1|COMPLETED|Overall Study||5
8529162|NCT00329108|21024374|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
8529163|NCT00329108|21024375|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
8529164|NCT00329030|21024383|P2|NOT COMPLETED|Overall Study||6
8529165|NCT00329030|21024384|P1|NOT COMPLETED|Overall Study||8
8529166|NCT00329030|21024383|P2|COMPLETED|Overall Study||107
8529167|NCT00329030|21024384|P1|COMPLETED|Overall Study||103
8529168|NCT00329030|21024383|P2|STARTED|Overall Study||113
8529169|NCT00329030|21024384|P1|STARTED|Overall Study||111
8529170|NCT00328926|21024415|P3|NOT COMPLETED|Overall Study||2
8529171|NCT00328926|21024416|P2|NOT COMPLETED|Overall Study||3
8529172|NCT00328926|21024417|P1|NOT COMPLETED|Overall Study||2
8529173|NCT00328926|21024415|P3|COMPLETED|Overall Study||1
8529174|NCT00328926|21024416|P2|COMPLETED|Overall Study||0
8529175|NCT00328926|21024417|P1|COMPLETED|Overall Study||3
8529176|NCT00328926|21024415|P3|STARTED|Overall Study||3
8529177|NCT00328926|21024416|P2|STARTED|Overall Study||3
8529178|NCT00328926|21024417|P1|STARTED|Overall Study||5
8529179|NCT00328861|21024433|P2|NOT COMPLETED|Overall Study||0
8529180|NCT00328861|21024434|P1|NOT COMPLETED|Overall Study||0
8529181|NCT00328861|21024433|P2|COMPLETED|Overall Study||1
8529182|NCT00328861|21024434|P1|COMPLETED|Overall Study||7
8529183|NCT00328861|21024433|P2|STARTED|Overall Study||1
8529184|NCT00328861|21024434|P1|STARTED|Overall Study||7
8529185|NCT00328783|21024442|P1|NOT COMPLETED|Overall Study||26
8529186|NCT00328783|21024442|P1|COMPLETED|Overall Study||86
8529187|NCT00328783|21024442|P1|STARTED|Overall Study||112
8529188|NCT00328770|21024450|P1|NOT COMPLETED|Overall Study||0
8529189|NCT00328770|21024450|P1|COMPLETED|Overall Study||70
8529190|NCT00328770|21024450|P1|STARTED|Overall Study||70
8529191|NCT00328627|21024468|P12|NOT COMPLETED|Overall Study||16
8529192|NCT00328627|21024469|P11|NOT COMPLETED|Overall Study||18
8529193|NCT00328627|21024470|P10|NOT COMPLETED|Overall Study||32
8529194|NCT00328627|21024471|P9|NOT COMPLETED|Overall Study||17
8529195|NCT00328627|21024472|P8|NOT COMPLETED|Overall Study||14
8529196|NCT00328627|21024473|P7|NOT COMPLETED|Overall Study||35
8529197|NCT00328627|21024474|P6|NOT COMPLETED|Overall Study||20
8529198|NCT00328627|21024475|P5|NOT COMPLETED|Overall Study||15
8529199|NCT00328627|21024476|P4|NOT COMPLETED|Overall Study||37
8529200|NCT00328627|21024477|P3|NOT COMPLETED|Overall Study||28
8529201|NCT00328627|21024478|P2|NOT COMPLETED|Overall Study||31
8529202|NCT00328627|21024479|P1|NOT COMPLETED|Overall Study||59
8529203|NCT00328627|21024468|P12|COMPLETED|Overall Study||114
8529204|NCT00328627|21024469|P11|COMPLETED|Overall Study||112
8529205|NCT00328627|21024470|P10|COMPLETED|Overall Study||97
8529206|NCT00328627|21024471|P9|COMPLETED|Overall Study||113
8529207|NCT00328627|21024472|P8|COMPLETED|Overall Study||116
8529208|NCT00328627|21024473|P7|COMPLETED|Overall Study||94
8529209|NCT00328627|21024474|P6|COMPLETED|Overall Study||110
8529210|NCT00328627|21024475|P5|COMPLETED|Overall Study||115
8529211|NCT00328627|21024476|P4|COMPLETED|Overall Study||93
8529212|NCT00328627|21024477|P3|COMPLETED|Overall Study||101
8529213|NCT00328627|21024478|P2|COMPLETED|Overall Study||97
8529214|NCT00328627|21024479|P1|COMPLETED|Overall Study||70
8529215|NCT00328627|21024468|P12|Safety Set|Overall Study||130
8529216|NCT00328627|21024469|P11|Safety Set|Overall Study||130
8529217|NCT00328627|21024470|P10|Safety Set|Overall Study||129
8529218|NCT00328627|21024471|P9|Safety Set|Overall Study||130
8529219|NCT00328627|21024472|P8|Safety Set|Overall Study||130
8529220|NCT00328627|21024473|P7|Safety Set|Overall Study||129
8529221|NCT00328627|21024474|P6|Safety Set|Overall Study||130
8529222|NCT00328627|21024475|P5|Safety Set|Overall Study||130
8529223|NCT00328627|21024476|P4|Safety Set|Overall Study||129
8529224|NCT00328627|21024477|P3|Safety Set|Overall Study||129
8529225|NCT00328627|21024478|P2|Safety Set|Overall Study||128
8529226|NCT00328627|21024479|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
8529227|NCT00328627|21024468|P12|STARTED|Overall Study||130
8529228|NCT00328627|21024469|P11|STARTED|Overall Study||130
8529229|NCT00328627|21024470|P10|STARTED|Overall Study||129
8529230|NCT00328627|21024471|P9|STARTED|Overall Study||130
8529231|NCT00328627|21024472|P8|STARTED|Overall Study||130
8529232|NCT00328627|21024473|P7|STARTED|Overall Study||129
8529233|NCT00328627|21024474|P6|STARTED|Overall Study||130
8529234|NCT00328627|21024475|P5|STARTED|Overall Study||130
8529235|NCT00328627|21024476|P4|STARTED|Overall Study||130
8529236|NCT00328627|21024477|P3|STARTED|Overall Study||129
8529237|NCT00328627|21024478|P2|STARTED|Overall Study||128
8529238|NCT00328627|21024479|P1|STARTED|Overall Study||129
8529239|NCT00328614|21026002|P6|NOT COMPLETED|Overall Study||1
8529240|NCT00328614|21026003|P5|NOT COMPLETED|Overall Study||1
8529241|NCT00328614|21026004|P4|NOT COMPLETED|Overall Study||1
8529242|NCT00328614|21026005|P3|NOT COMPLETED|Overall Study||0
8529243|NCT00328614|21026006|P2|NOT COMPLETED|Overall Study||0
8529244|NCT00328614|21026007|P1|NOT COMPLETED|Overall Study||0
8529245|NCT00328614|21026002|P6|COMPLETED|Overall Study||5
8529246|NCT00328614|21026003|P5|COMPLETED|Overall Study||5
8529247|NCT00328614|21026004|P4|COMPLETED|Overall Study||5
8529248|NCT00328614|21026005|P3|COMPLETED|Overall Study||6
8529249|NCT00328614|21026006|P2|COMPLETED|Overall Study||4
8529250|NCT00328614|21026007|P1|COMPLETED|Overall Study||4
8529251|NCT00328614|21026002|P6|STARTED|Overall Study||6
8529252|NCT00328614|21026003|P5|STARTED|Overall Study||6
8529253|NCT00328614|21026004|P4|STARTED|Overall Study||6
8529254|NCT00328614|21026005|P3|STARTED|Overall Study||6
8529255|NCT00328614|21026006|P2|STARTED|Overall Study||4
8529256|NCT00328614|21026007|P1|STARTED|Overall Study||4
8529257|NCT00328562|21026016|P1|NOT COMPLETED|Overall Study||1
8529258|NCT00328562|21026016|P1|COMPLETED|Overall Study||12
8529259|NCT00328562|21026016|P1|STARTED|Overall Study||13
8529260|NCT00328510|21026025|P2|NOT COMPLETED|Overall Study||4
8529261|NCT00328510|21026026|P1|NOT COMPLETED|Overall Study||10
8529262|NCT00328510|21026025|P2|COMPLETED|Overall Study||37
8529263|NCT00328510|21026026|P1|COMPLETED|Overall Study||32
8529264|NCT00328510|21026025|P2|STARTED|Overall Study||41
8529265|NCT00328510|21026026|P1|STARTED|Overall Study||42
8529266|NCT00328263|21026034|P2|NOT COMPLETED|Overall Study||4
8529267|NCT00328263|21026035|P1|NOT COMPLETED|Overall Study||3
8529268|NCT00328263|21026034|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
8529269|NCT00328263|21026035|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
8529270|NCT00328263|21026034|P2|STARTED|Overall Study||221
8529271|NCT00328263|21026035|P1|STARTED|Overall Study||216
8529272|NCT00328198|21026041|P1|NOT COMPLETED|Follow-up||35
8529273|NCT00328198|21026041|P1|COMPLETED|Follow-up||43
8529274|NCT00328198|21026041|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
8529275|NCT00328198|21026041|P1|NOT COMPLETED|Treatment||38
8529276|NCT00328198|21026041|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
8529277|NCT00328198|21026041|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
8529278|NCT00328172|21026056|P5|NOT COMPLETED|Overall Study||5
8529279|NCT00328172|21026057|P4|NOT COMPLETED|Overall Study||13
8529280|NCT00328172|21026058|P3|NOT COMPLETED|Overall Study||10
8529281|NCT00328172|21026059|P2|NOT COMPLETED|Overall Study||14
8529282|NCT00328172|21026060|P1|NOT COMPLETED|Overall Study||22
8529283|NCT00328172|21026056|P5|COMPLETED|Overall Study||60
8529284|NCT00328172|21026057|P4|COMPLETED|Overall Study||42
8529285|NCT00328172|21026058|P3|COMPLETED|Overall Study||47
8529286|NCT00328172|21026059|P2|COMPLETED|Overall Study||44
8529287|NCT00328172|21026060|P1|COMPLETED|Overall Study||45
8529288|NCT00328172|21026056|P5|STARTED|Overall Study||65
8529289|NCT00328172|21026057|P4|STARTED|Overall Study||55
8529290|NCT00328172|21026058|P3|STARTED|Overall Study||57
8529291|NCT00328172|21026059|P2|STARTED|Overall Study||58
8529292|NCT00328172|21026060|P1|STARTED|Overall Study||67
8529293|NCT00328094|21026084|P2|NOT COMPLETED|Overall Study||3
8529294|NCT00328094|21026085|P1|NOT COMPLETED|Overall Study||3
8529295|NCT00328094|21026084|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
8529296|NCT00328094|21026085|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
8529297|NCT00328094|21026084|P2|STARTED|Overall Study||125
8529298|NCT00328094|21026085|P1|STARTED|Overall Study||117
8529299|NCT00328042|21026095|P2|NOT COMPLETED|Overall Study||2
8529300|NCT00328042|21026096|P1|NOT COMPLETED|Overall Study||0
8529301|NCT00328042|21026095|P2|COMPLETED|Overall Study||63
8529302|NCT00328042|21026096|P1|COMPLETED|Overall Study||69
8529303|NCT00328042|21026095|P2|STARTED|Overall Study||65
8529304|NCT00328042|21026096|P1|STARTED|Overall Study||69
8529305|NCT00328016|21026106|P2|NOT COMPLETED|Overall Study||0
8529306|NCT00328016|21026107|P1|NOT COMPLETED|Overall Study||0
8529307|NCT00328016|21026106|P2|COMPLETED|Overall Study||21
8529308|NCT00328016|21026107|P1|COMPLETED|Overall Study||23
8529309|NCT00328016|21026106|P2|STARTED|Overall Study||21
8529310|NCT00328016|21026107|P1|STARTED|Overall Study||23
8529311|NCT00327717|21026119|P2|NOT COMPLETED|Overall Study||14
8529312|NCT00327717|21026120|P1|NOT COMPLETED|Overall Study||9
8529313|NCT00327717|21026119|P2|COMPLETED|Overall Study||106
8529314|NCT00327717|21026120|P1|COMPLETED|Overall Study||111
8529315|NCT00327717|21026119|P2|STARTED|Overall Study||120
8529316|NCT00327717|21026120|P1|STARTED|Overall Study||120
8529317|NCT00327470|21026146|P2|NOT COMPLETED|Overall Study||63
8529318|NCT00327470|21026147|P1|NOT COMPLETED|Overall Study||29
8529319|NCT00327470|21026146|P2|COMPLETED|Overall Study||118
8529320|NCT00327470|21026147|P1|COMPLETED|Overall Study||78
8529321|NCT00327470|21026146|P2|Treated|Overall Study||179
8529322|NCT00327470|21026147|P1|Treated|Overall Study||107
8529323|NCT00327470|21026146|P2|STARTED|Overall Study||181
8529324|NCT00327470|21026147|P1|STARTED|Overall Study||107
8529325|NCT00327444|21026167|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
8529326|NCT00327444|21026168|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
8529327|NCT00327444|21026167|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
8529328|NCT00327444|21026168|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
8529329|NCT00327444|21026167|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
8529330|NCT00327444|21026168|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
8529331|NCT00327444|21026167|P2|STARTED|Open Label Treatment (OL) Period||10
8529332|NCT00327444|21026168|P1|STARTED|Open Label Treatment (OL) Period||11
8529333|NCT00327444|21026167|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
8529334|NCT00327444|21026168|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
8529335|NCT00327444|21026167|P2|COMPLETED|Double Blind Treatment (DB) Period||0
8529336|NCT00327444|21026168|P1|COMPLETED|Double Blind Treatment (DB) Period||0
8529337|NCT00327444|21026167|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
8529338|NCT00327444|21026168|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
8529339|NCT00327444|21026167|P2|STARTED|Double Blind Treatment (DB) Period||29
8529340|NCT00327444|21026168|P1|STARTED|Double Blind Treatment (DB) Period||26
8529341|NCT00327392|21026180|P1|NOT COMPLETED|Overall Study||0
8529342|NCT00327392|21026180|P1|COMPLETED|Overall Study||123
8529343|NCT00327392|21026180|P1|STARTED|Overall Study||123
8529344|NCT00327340|21026186|P2|NOT COMPLETED|Overall Study||30
8529345|NCT00327340|21026187|P1|NOT COMPLETED|Overall Study||15
8529346|NCT00327340|21026186|P2|COMPLETED|Overall Study||16
8529347|NCT00327340|21026187|P1|COMPLETED|Overall Study||8
8529348|NCT00327340|21026186|P2|STARTED|Overall Study||46
8529349|NCT00327340|21026187|P1|STARTED|Overall Study||23
8529350|NCT00327171|21026201|P2|NOT COMPLETED|Overall Study||109
8529351|NCT00327171|21026202|P1|NOT COMPLETED|Overall Study||108
8529352|NCT00327171|21026201|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
8529353|NCT00327171|21026202|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
8529354|NCT00327171|21026201|P2|STARTED|Overall Study||109
8529355|NCT00327171|21026202|P1|STARTED|Overall Study||109
8529356|NCT00327015|21026234|P4|NOT COMPLETED|Overall Study||109
8529357|NCT00327015|21026235|P3|NOT COMPLETED|Overall Study||126
8529358|NCT00327015|21026236|P2|NOT COMPLETED|Overall Study||92
8529359|NCT00327015|21026237|P1|NOT COMPLETED|Overall Study||91
8529360|NCT00327015|21026234|P4|COMPLETED|Overall Study||219
8529361|NCT00327015|21026235|P3|COMPLETED|Overall Study||209
8529362|NCT00327015|21026236|P2|COMPLETED|Overall Study||231
8529363|NCT00327015|21026237|P1|COMPLETED|Overall Study||229
8529364|NCT00327015|21026234|P4|Completed Study Without Being Rescued|Overall Study||144
8529365|NCT00327015|21026235|P3|Completed Study Without Being Rescued|Overall Study||113
8529366|NCT00327015|21026236|P2|Completed Study Without Being Rescued|Overall Study||177
8529367|NCT00327015|21026237|P1|Completed Study Without Being Rescued|Overall Study||179
8529368|NCT00327015|21026234|P4|STARTED|Overall Study||328
8529369|NCT00327015|21026235|P3|STARTED|Overall Study||335
8529370|NCT00327015|21026236|P2|STARTED|Overall Study||323
8529371|NCT00327015|21026237|P1|STARTED|Overall Study||320
8529372|NCT00326963|21026279|P1|NOT COMPLETED|Overall Study||33
8529373|NCT00326963|21026279|P1|COMPLETED|Overall Study||107
8529374|NCT00326963|21026279|P1|STARTED|Overall Study||140
8529375|NCT00326950|21026299|P1|NOT COMPLETED|Overall Study||1
8529376|NCT00326950|21026299|P1|COMPLETED|Overall Study||14
8529377|NCT00326950|21026299|P1|STARTED|Overall Study||15
8529378|NCT00326924|21026306|P2|NOT COMPLETED|Overall Study||1
8529379|NCT00326924|21026307|P1|NOT COMPLETED|Overall Study||1
8529380|NCT00326924|21026306|P2|COMPLETED|Overall Study||188
8529381|NCT00326924|21026307|P1|COMPLETED|Overall Study||187
8529382|NCT00326924|21026306|P2|STARTED|Overall Study||189
8529383|NCT00326924|21026307|P1|STARTED|Overall Study||188
8529384|NCT00326911|21026321|P2|NOT COMPLETED|Overall Study||2
8529385|NCT00326911|21026322|P1|NOT COMPLETED|Overall Study||1
8529386|NCT00326911|21026321|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
8529387|NCT00326911|21026322|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
8529388|NCT00326911|21026321|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
8529389|NCT00326911|21026322|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
8529390|NCT00326898|21026375|P3|NOT COMPLETED|Overall Study||203
8529391|NCT00326898|21026376|P2|NOT COMPLETED|Overall Study||343
8529392|NCT00326898|21026377|P1|NOT COMPLETED|Overall Study||351
8529393|NCT00326898|21026375|P3|COMPLETED|Overall Study||444
8529394|NCT00326898|21026376|P2|COMPLETED|Overall Study||306
8529395|NCT00326898|21026377|P1|COMPLETED|Overall Study||296
8529396|NCT00326898|21026375|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
8529397|NCT00326898|21026376|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
8529398|NCT00326898|21026377|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
8529399|NCT00326898|21026375|P3|Patients With Clear Cell Histology|Overall Study||540
8529400|NCT00326898|21026376|P2|Patients With Clear Cell Histology|Overall Study||540
8529401|NCT00326898|21026377|P1|Patients With Clear Cell Histology|Overall Study||542
8529402|NCT00326898|21026375|P3|Patients With Toxicity Data|Overall Study||626
8529403|NCT00326898|21026376|P2|Patients With Toxicity Data|Overall Study||628
8529404|NCT00326898|21026377|P1|Patients With Toxicity Data|Overall Study||625
8529405|NCT00326898|21026375|P3|STARTED|Overall Study||647
8529406|NCT00326898|21026376|P2|STARTED|Overall Study||649
8529407|NCT00326898|21026377|P1|STARTED|Overall Study||647
8529408|NCT00326885|21026394|P1|NOT COMPLETED|Overall Study||7
8529409|NCT00326885|21026394|P1|COMPLETED|Overall Study||25
8529410|NCT00326885|21026394|P1|STARTED|Overall Study||32
8529411|NCT00326872|21026403|P1|NOT COMPLETED|Overall Study||0
8529412|NCT00326872|21026403|P1|COMPLETED|Overall Study||26
8529413|NCT00326872|21026403|P1|STARTED|Overall Study||26
8529414|NCT00326781|21026414|P2|NOT COMPLETED|Overall Study||32
8529415|NCT00326781|21026415|P1|NOT COMPLETED|Overall Study||42
8529416|NCT00326781|21026414|P2|COMPLETED|Overall Study||298
8529417|NCT00326781|21026415|P1|COMPLETED|Overall Study||302
8529418|NCT00326781|21026414|P2|STARTED|Overall Study||330
8529419|NCT00326781|21026415|P1|STARTED|Overall Study||344
8529420|NCT00326716|21026425|P4|NOT COMPLETED|Infants||0
8529421|NCT00326716|21026426|P3|NOT COMPLETED|Infants||0
8529422|NCT00326716|21026427|P2|NOT COMPLETED|Infants||0
8529423|NCT00326716|21026428|P1|NOT COMPLETED|Infants||0
8529424|NCT00326716|21026425|P4|COMPLETED|Infants||20
8529425|NCT00326716|21026426|P3|COMPLETED|Infants||20
8529426|NCT00326716|21026427|P2|COMPLETED|Infants||0
8529427|NCT00326716|21026428|P1|COMPLETED|Infants||0
8529428|NCT00326716|21026425|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
8529429|NCT00326716|21026426|P3|STARTED|Infants|All infants were followed.|20
8529430|NCT00326716|21026427|P2|STARTED|Infants||0
8529431|NCT00326716|21026428|P1|STARTED|Infants||0
8529432|NCT00326716|21026425|P4|NOT COMPLETED|Pre-Natal Mothers||0
8529433|NCT00326716|21026426|P3|NOT COMPLETED|Pre-Natal Mothers||0
8529434|NCT00326716|21026427|P2|NOT COMPLETED|Pre-Natal Mothers||2
8529435|NCT00326716|21026428|P1|NOT COMPLETED|Pre-Natal Mothers||1
8529436|NCT00326716|21026425|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
8529437|NCT00326716|21026426|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
8529438|NCT00326716|21026427|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
8529439|NCT00326716|21026428|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
8529440|NCT00326716|21026425|P4|STARTED|Pre-Natal Mothers||0
8529441|NCT00326716|21026426|P3|STARTED|Pre-Natal Mothers||0
8529442|NCT00326716|21026427|P2|STARTED|Pre-Natal Mothers||21
8529443|NCT00326716|21026428|P1|STARTED|Pre-Natal Mothers||20
8529444|NCT00326612|21026500|P2|NOT COMPLETED|Overall Study||137
8529445|NCT00326612|21026501|P1|NOT COMPLETED|Overall Study||129
8529446|NCT00326612|21026500|P2|COMPLETED|Overall Study||42
8529447|NCT00326612|21026501|P1|COMPLETED|Overall Study||50
8529448|NCT00326612|21026500|P2|STARTED|Overall Study||179
8529449|NCT00326612|21026501|P1|STARTED|Overall Study||179
8529450|NCT00326599|21026523|P4|NOT COMPLETED|Overall Study||19
8529451|NCT00326599|21026524|P3|NOT COMPLETED|Overall Study||53
8529452|NCT00326599|21026525|P2|NOT COMPLETED|Overall Study||1
8529453|NCT00326599|21026526|P1|NOT COMPLETED|Overall Study||6
8529454|NCT00326599|21026523|P4|COMPLETED|Overall Study||10
8529455|NCT00326599|21026524|P3|COMPLETED|Overall Study||5
8529456|NCT00326599|21026525|P2|COMPLETED|Overall Study||2
8529457|NCT00326599|21026526|P1|COMPLETED|Overall Study||0
8529458|NCT00326599|21026523|P4|STARTED|Overall Study||29
8529459|NCT00326599|21026524|P3|STARTED|Overall Study||58
8529460|NCT00326599|21026525|P2|STARTED|Overall Study||3
8529461|NCT00326599|21026526|P1|STARTED|Overall Study||6
8529462|NCT00326495|21026545|P1|NOT COMPLETED|Overall Study||5
8529463|NCT00326495|21026545|P1|COMPLETED|Overall Study||46
8529464|NCT00326495|21026545|P1|STARTED|Overall Study||51
8529465|NCT00326417|21026552|P4|NOT COMPLETED|Overall Study||3
8529466|NCT00326417|21026553|P3|NOT COMPLETED|Overall Study||1
8529467|NCT00326417|21026554|P2|NOT COMPLETED|Overall Study||0
8529468|NCT00326417|21026555|P1|NOT COMPLETED|Overall Study||14
8529469|NCT00326417|21026552|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
8529470|NCT00326417|21026553|P3|COMPLETED|Overall Study||38
8529471|NCT00326417|21026554|P2|COMPLETED|Overall Study||41
8529472|NCT00326417|21026555|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
8529473|NCT00326417|21026552|P4|Phase II|Overall Study||0
8529474|NCT00326417|21026553|P3|Phase II|Overall Study||33
8529475|NCT00326417|21026554|P2|Phase II|Overall Study||35
8529476|NCT00326417|21026555|P1|Phase II|Overall Study||8
8529477|NCT00326417|21026552|P4|Phase I|Overall Study||3
8529478|NCT00326417|21026553|P3|Phase I|Overall Study||6
8529479|NCT00326417|21026554|P2|Phase I|Overall Study||6
8529480|NCT00326417|21026555|P1|Phase I|Overall Study||6
8529481|NCT00326417|21026552|P4|STARTED|Overall Study||3
8529482|NCT00326417|21026553|P3|STARTED|Overall Study||39
8529483|NCT00326417|21026554|P2|STARTED|Overall Study||41
8529484|NCT00326417|21026555|P1|STARTED|Overall Study||14
8529485|NCT00326209|21026571|P1|NOT COMPLETED|Overall Study||282
8529486|NCT00326209|21026571|P1|COMPLETED|Overall Study||111
8529487|NCT00326209|21026571|P1|Safety Population|Overall Study||388
8529488|NCT00326209|21026571|P1|STARTED|Overall Study||393
8529489|NCT00326196|21026580|P2|NOT COMPLETED|Overall Study||0
8529490|NCT00326196|21026581|P1|NOT COMPLETED|Overall Study||0
8529491|NCT00326196|21026580|P2|COMPLETED|Overall Study||97
8529492|NCT00326196|21026581|P1|COMPLETED|Overall Study||101
8529493|NCT00326196|21026580|P2|STARTED|Overall Study||97
8529494|NCT00326196|21026581|P1|STARTED|Overall Study||101
8529495|NCT00326183|21026589|P2|NOT COMPLETED|Overall Study||83
8529496|NCT00326183|21026590|P1|NOT COMPLETED|Overall Study||200
8529497|NCT00326183|21026589|P2|COMPLETED|Overall Study||264
8529498|NCT00326183|21026590|P1|COMPLETED|Overall Study||1253
8529499|NCT00326183|21026589|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
8529500|NCT00326183|21026590|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
8529501|NCT00326183|21026589|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
8529502|NCT00326183|21026590|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
8529503|NCT00326183|21026589|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
8529504|NCT00326183|21026590|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
8529505|NCT00326183|21026589|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
8529506|NCT00326183|21026590|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
8529507|NCT00326183|21026589|P2|STARTED|Overall Study||347
8529508|NCT00326183|21026590|P1|STARTED|Overall Study||1453
8529509|NCT00326170|21026616|P1|NOT COMPLETED|Overall Study||0
8529510|NCT00326170|21026616|P1|COMPLETED|Overall Study||34
8529511|NCT00326170|21026616|P1|STARTED|Overall Study||34
8529512|NCT00326118|21026622|P2|NOT COMPLETED|Year 5 Follow up||0
8529513|NCT00326118|21026623|P1|NOT COMPLETED|Year 5 Follow up||0
8529514|NCT00326118|21026622|P2|COMPLETED|Year 5 Follow up||78
8529515|NCT00326118|21026623|P1|COMPLETED|Year 5 Follow up||217
8529516|NCT00326118|21026622|P2|STARTED|Year 5 Follow up||78
8529517|NCT00326118|21026623|P1|STARTED|Year 5 Follow up||217
8529518|NCT00326118|21026622|P2|NOT COMPLETED|Year 4 Follow-up||0
8529519|NCT00326118|21026623|P1|NOT COMPLETED|Year 4 Follow-up||0
8529520|NCT00326118|21026622|P2|COMPLETED|Year 4 Follow-up||80
8529521|NCT00326118|21026623|P1|COMPLETED|Year 4 Follow-up||228
8529522|NCT00326118|21026622|P2|STARTED|Year 4 Follow-up||80
8529523|NCT00326118|21026623|P1|STARTED|Year 4 Follow-up||228
8529524|NCT00326118|21026622|P2|NOT COMPLETED|Year 3 Follow-up||0
8529525|NCT00326118|21026623|P1|NOT COMPLETED|Year 3 Follow-up||0
8529526|NCT00326118|21026622|P2|COMPLETED|Year 3 Follow-up||89
8529527|NCT00326118|21026623|P1|COMPLETED|Year 3 Follow-up||256
8529528|NCT00326118|21026622|P2|STARTED|Year 3 Follow-up||89
8529529|NCT00326118|21026623|P1|STARTED|Year 3 Follow-up||256
8529530|NCT00326118|21026622|P2|NOT COMPLETED|Year 2 Follow-up||0
8529531|NCT00326118|21026623|P1|NOT COMPLETED|Year 2 Follow-up||0
8529532|NCT00326118|21026622|P2|COMPLETED|Year 2 Follow-up||92
8529533|NCT00326118|21026623|P1|COMPLETED|Year 2 Follow-up||270
8529534|NCT00326118|21026622|P2|STARTED|Year 2 Follow-up||92
8529535|NCT00326118|21026623|P1|STARTED|Year 2 Follow-up||270
8529536|NCT00326118|21026622|P2|NOT COMPLETED|Year 1 Follow-up||0
8529537|NCT00326118|21026623|P1|NOT COMPLETED|Year 1 Follow-up||0
8529538|NCT00326118|21026622|P2|COMPLETED|Year 1 Follow-up||100
8529539|NCT00326118|21026623|P1|COMPLETED|Year 1 Follow-up||295
8529540|NCT00326118|21026622|P2|STARTED|Year 1 Follow-up||100
8529541|NCT00326118|21026623|P1|STARTED|Year 1 Follow-up||295
8529542|NCT00326118|21026622|P2|NOT COMPLETED|Active Phase||1
8529543|NCT00326118|21026623|P1|NOT COMPLETED|Active Phase||4
8529544|NCT00326118|21026622|P2|COMPLETED|Active Phase||108
8529545|NCT00326118|21026623|P1|COMPLETED|Active Phase||320
8529546|NCT00326118|21026622|P2|STARTED|Active Phase||109
8529547|NCT00326118|21026623|P1|STARTED|Active Phase||324
8529548|NCT00326001|21026659|P2|NOT COMPLETED|Overall Study||8
8529549|NCT00326001|21026660|P1|NOT COMPLETED|Overall Study||7
8529550|NCT00326001|21026659|P2|COMPLETED|Overall Study||219
8529551|NCT00326001|21026660|P1|COMPLETED|Overall Study||229
8529552|NCT00326001|21026659|P2|STARTED|Overall Study||227
8529553|NCT00326001|21026660|P1|STARTED|Overall Study||236
8529554|NCT00325897|21026674|P2|NOT COMPLETED|Overall Study||13
8529555|NCT00325897|21026675|P1|NOT COMPLETED|Overall Study||12
8529556|NCT00325897|21026674|P2|COMPLETED|Overall Study||559
8529557|NCT00325897|21026675|P1|COMPLETED|Overall Study||558
8529558|NCT00325897|21026674|P2|STARTED|Overall Study||572
8529559|NCT00325897|21026675|P1|STARTED|Overall Study||570
8529560|NCT00325819|21026695|P2|NOT COMPLETED|Overall Study||13
8529561|NCT00325819|21026696|P1|NOT COMPLETED|Overall Study||9
8529562|NCT00325819|21026695|P2|COMPLETED|Overall Study||176
8529563|NCT00325819|21026696|P1|COMPLETED|Overall Study||176
8529564|NCT00325819|21026695|P2|STARTED|Overall Study||189
8529565|NCT00325819|21026696|P1|STARTED|Overall Study||185
8529566|NCT00325780|21026716|P1|NOT COMPLETED|Overall Study||155
8529567|NCT00325780|21026716|P1|COMPLETED|Overall Study||1200
8529568|NCT00325780|21026716|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
8529569|NCT00325780|21026716|P1|STARTED|Overall Study||1355
8529570|NCT00325754|21026723|P2|NOT COMPLETED|Overall Study||1
8529571|NCT00325754|21026724|P1|NOT COMPLETED|Overall Study||4
8529572|NCT00325754|21026723|P2|COMPLETED|Overall Study||10
8529573|NCT00325754|21026724|P1|COMPLETED|Overall Study||7
8529574|NCT00325754|21026723|P2|STARTED|Overall Study||11
8529575|NCT00325754|21026724|P1|STARTED|Overall Study||11
8529576|NCT00325598|21026740|P2|NOT COMPLETED|Overall Study||0
8529577|NCT00325598|21026741|P1|NOT COMPLETED|Overall Study||0
8529578|NCT00325598|21026740|P2|COMPLETED|Overall Study||50
8529579|NCT00325598|21026741|P1|COMPLETED|Overall Study||50
8529580|NCT00325598|21026740|P2|STARTED|Overall Study||50
8529581|NCT00325598|21026741|P1|STARTED|Overall Study||50
8529582|NCT00325572|21026767|P2|NOT COMPLETED|PHASE ii||0
8529583|NCT00325572|21026768|P1|NOT COMPLETED|PHASE ii||0
8529584|NCT00325572|21026767|P2|COMPLETED|PHASE ii||0
8529585|NCT00325572|21026768|P1|COMPLETED|PHASE ii||0
8529586|NCT00325572|21026767|P2|STARTED|PHASE ii||0
8529587|NCT00325572|21026768|P1|STARTED|PHASE ii||0
8529588|NCT00325572|21026767|P2|NOT COMPLETED|PHASE I||0
8529589|NCT00325572|21026768|P1|NOT COMPLETED|PHASE I||0
8529590|NCT00325572|21026767|P2|COMPLETED|PHASE I||44
8529591|NCT00325572|21026768|P1|COMPLETED|PHASE I||45
8529592|NCT00325572|21026767|P2|STARTED|PHASE I||44
8529593|NCT00325572|21026768|P1|STARTED|PHASE I||45
8529594|NCT00325468|21026779|P5|NOT COMPLETED|Overall Study||8
8529595|NCT00325468|21026780|P4|NOT COMPLETED|Overall Study||34
8529596|NCT00325468|21026781|P3|NOT COMPLETED|Overall Study||4
8529597|NCT00325468|21026782|P2|NOT COMPLETED|Overall Study||5
8529598|NCT00325468|21026783|P1|NOT COMPLETED|Overall Study||11
8529599|NCT00325468|21026779|P5|COMPLETED|Overall Study||14
8529600|NCT00325468|21026780|P4|COMPLETED|Overall Study||90
8529601|NCT00325468|21026781|P3|COMPLETED|Overall Study||10
8529602|NCT00325468|21026782|P2|COMPLETED|Overall Study||12
8529603|NCT00325468|21026783|P1|COMPLETED|Overall Study||12
8529604|NCT00325468|21026779|P5|STARTED|Overall Study||22
8529605|NCT00325468|21026780|P4|STARTED|Overall Study||124
8529606|NCT00325468|21026781|P3|STARTED|Overall Study||14
8529607|NCT00325468|21026782|P2|STARTED|Overall Study||17
8529608|NCT00325468|21026783|P1|STARTED|Overall Study||23
8529609|NCT00325442|21026818|P2|NOT COMPLETED|Overall Study||21
8529610|NCT00325442|21026819|P1|NOT COMPLETED|Overall Study||9
8529611|NCT00325442|21026818|P2|COMPLETED|Overall Study||153
8529612|NCT00325442|21026819|P1|COMPLETED|Overall Study||167
8529613|NCT00325442|21026818|P2|STARTED|Overall Study||174
8529614|NCT00325442|21026819|P1|STARTED|Overall Study||176
8529615|NCT00325416|21026866|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
8529616|NCT00325416|21026867|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
8529617|NCT00325416|21026866|P2|COMPLETED|Phase II: Treatment at MTD||40
8529618|NCT00325416|21026867|P1|COMPLETED|Phase II: Treatment at MTD||78
8529619|NCT00325416|21026866|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
8529620|NCT00325416|21026867|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
8529621|NCT00325416|21026866|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
8529622|NCT00325416|21026867|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
8529623|NCT00325416|21026866|P2|STARTED|Phase II: Treatment at MTD||42
8529624|NCT00325416|21026867|P1|STARTED|Phase II: Treatment at MTD||78
8529625|NCT00325416|21026866|P2|NOT COMPLETED|Phase I: Dose Escalation||16
8529626|NCT00325416|21026867|P1|NOT COMPLETED|Phase I: Dose Escalation||22
8529627|NCT00325416|21026866|P2|COMPLETED|Phase I: Dose Escalation||44
8529628|NCT00325416|21026867|P1|COMPLETED|Phase I: Dose Escalation||48
8529629|NCT00325416|21026866|P2|STARTED|Phase I: Dose Escalation||60
8529630|NCT00325416|21026867|P1|STARTED|Phase I: Dose Escalation||70
8529631|NCT00325403|21026881|P2|NOT COMPLETED|Overall Study||51
8529632|NCT00325403|21026882|P1|NOT COMPLETED|Overall Study||18
8529633|NCT00325403|21026881|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
8529634|NCT00325403|21026882|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
8529635|NCT00325403|21026881|P2|STARTED|Overall Study||233
8529636|NCT00325403|21026882|P1|STARTED|Overall Study||116
8529637|NCT00325234|21026920|P2|NOT COMPLETED|Overall Study||66
8529638|NCT00325234|21026921|P1|NOT COMPLETED|Overall Study||69
8529639|NCT00325234|21026920|P2|COMPLETED|Overall Study||0
8529640|NCT00325234|21026921|P1|COMPLETED|Overall Study||0
8529641|NCT00325234|21026920|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
8529642|NCT00325234|21026921|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
8529643|NCT00325234|21026920|P2|STARTED|Overall Study||66
8529644|NCT00325234|21026921|P1|STARTED|Overall Study||69
8529645|NCT00325195|21026940|P3|NOT COMPLETED|Received Intervention: ITT Population||4
8529646|NCT00325195|21026941|P2|NOT COMPLETED|Received Intervention: ITT Population||25
8529647|NCT00325195|21026942|P1|NOT COMPLETED|Received Intervention: ITT Population||26
8529648|NCT00325195|21026940|P3|COMPLETED|Received Intervention: ITT Population||39
8529649|NCT00325195|21026941|P2|COMPLETED|Received Intervention: ITT Population||59
8529650|NCT00325195|21026942|P1|COMPLETED|Received Intervention: ITT Population||59
8529651|NCT00325195|21026940|P3|STARTED|Received Intervention: ITT Population||43
8529652|NCT00325195|21026941|P2|STARTED|Received Intervention: ITT Population||84
8529653|NCT00325195|21026942|P1|STARTED|Received Intervention: ITT Population||85
8529654|NCT00325195|21026940|P3|NOT COMPLETED|Randomized||3
8529655|NCT00325195|21026941|P2|NOT COMPLETED|Randomized||5
8529656|NCT00325195|21026942|P1|NOT COMPLETED|Randomized||5
8529657|NCT00325195|21026940|P3|COMPLETED|Randomized||43
8529658|NCT00325195|21026941|P2|COMPLETED|Randomized||84
8529659|NCT00325195|21026942|P1|COMPLETED|Randomized||85
8529660|NCT00325195|21026940|P3|STARTED|Randomized||46
8529661|NCT00325195|21026941|P2|STARTED|Randomized||89
8529662|NCT00325195|21026942|P1|STARTED|Randomized||90
8529663|NCT00325156|21026965|P1|NOT COMPLETED|Overall Study||112
8529664|NCT00325156|21026965|P1|COMPLETED|Overall Study||2478
8529665|NCT00325156|21026965|P1|STARTED|Overall Study||2590
8529666|NCT00325143|21026972|P1|NOT COMPLETED|Overall Study||26
8529667|NCT00325143|21026972|P1|COMPLETED|Overall Study||676
8529668|NCT00325143|21026972|P1|STARTED|Overall Study||702
8529669|NCT00325130|21026982|P2|NOT COMPLETED|Overall Study||30
8529670|NCT00325130|21026983|P1|NOT COMPLETED|Overall Study||19
8529671|NCT00325130|21026982|P2|COMPLETED|Overall Study||494
8529672|NCT00325130|21026983|P1|COMPLETED|Overall Study||499
8529673|NCT00325130|21026982|P2|STARTED|Overall Study||524
8529674|NCT00325130|21026983|P1|STARTED|Overall Study||518
8529675|NCT00325078|21027026|P3|NOT COMPLETED|Overall Study||2
8529676|NCT00325078|21027027|P2|NOT COMPLETED|Overall Study||5
8529677|NCT00325078|21027028|P1|NOT COMPLETED|Overall Study||5
8529678|NCT00325078|21027026|P3|COMPLETED|Overall Study||23
8529679|NCT00325078|21027027|P2|COMPLETED|Overall Study||2
8529680|NCT00325078|21027028|P1|COMPLETED|Overall Study||3
8529681|NCT00325078|21027026|P3|STARTED|Overall Study||25
8529682|NCT00325078|21027027|P2|STARTED|Overall Study||7
8529683|NCT00325078|21027028|P1|STARTED|Overall Study||8
8529684|NCT00325039|21027040|P2|NOT COMPLETED|Overall Study||14
8529685|NCT00325039|21027041|P1|NOT COMPLETED|Overall Study||18
8529686|NCT00325039|21027040|P2|COMPLETED|Overall Study||285
8529687|NCT00325039|21027041|P1|COMPLETED|Overall Study||280
8529688|NCT00325039|21027040|P2|STARTED|Overall Study||299
8529689|NCT00325039|21027041|P1|STARTED|Overall Study||298
8529690|NCT00324987|21027057|P2|NOT COMPLETED|Overall Study||6
8529691|NCT00324987|21027058|P1|NOT COMPLETED|Overall Study||6
8529692|NCT00324987|21027057|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
8529693|NCT00324987|21027058|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
8529694|NCT00324987|21027057|P2|STARTED|Overall Study||6
8529695|NCT00324987|21027058|P1|STARTED|Overall Study||6
8529696|NCT00324961|21027072|P1|NOT COMPLETED|Overall Study||43
8529697|NCT00324961|21027072|P1|COMPLETED|Overall Study||490
8529698|NCT00324961|21027072|P1|STARTED|Overall Study||533
8529699|NCT00324896|21027087|P2|NOT COMPLETED|Overall Study||8
8529700|NCT00324896|21027088|P1|NOT COMPLETED|Overall Study||3
8529701|NCT00324896|21027087|P2|COMPLETED|Overall Study||7
8529702|NCT00324896|21027088|P1|COMPLETED|Overall Study||12
8529703|NCT00324896|21027087|P2|STARTED|Overall Study||15
8529704|NCT00324896|21027088|P1|STARTED|Overall Study||15
8529705|NCT00324870|21027096|P1|NOT COMPLETED|Overall Study||0
8529706|NCT00324870|21027096|P1|COMPLETED|Overall Study||37
8529707|NCT00324870|21027096|P1|STARTED|Overall Study||37
8529708|NCT00324857|21027104|P4|NOT COMPLETED|Overall Study||5
8529709|NCT00324857|21027105|P3|NOT COMPLETED|Overall Study||7
8529710|NCT00324857|21027106|P2|NOT COMPLETED|Overall Study||6
8529711|NCT00324857|21027107|P1|NOT COMPLETED|Overall Study||6
8529712|NCT00324857|21027104|P4|COMPLETED|Overall Study||158
8529713|NCT00324857|21027105|P3|COMPLETED|Overall Study||158
8529714|NCT00324857|21027106|P2|COMPLETED|Overall Study||162
8529715|NCT00324857|21027107|P1|COMPLETED|Overall Study||161
8529716|NCT00324857|21027104|P4|STARTED|Overall Study||163
8529717|NCT00324857|21027105|P3|STARTED|Overall Study||165
8529718|NCT00324857|21027106|P2|STARTED|Overall Study||168
8529719|NCT00324857|21027107|P1|STARTED|Overall Study||167
8529720|NCT00324805|21027123|P2|NOT COMPLETED|Overall Study||483
8529721|NCT00324805|21027124|P1|NOT COMPLETED|Overall Study||150
8529722|NCT00324805|21027123|P2|COMPLETED|Overall Study||269
8529723|NCT00324805|21027124|P1|COMPLETED|Overall Study||599
8529724|NCT00324805|21027123|P2|Started Assigned Therapy|Overall Study||735
8529725|NCT00324805|21027124|P1|Started Assigned Therapy|Overall Study||737
8529726|NCT00324805|21027123|P2|STARTED|Overall Study||752
8529727|NCT00324805|21027124|P1|STARTED|Overall Study||749
8529728|NCT00324753|21027138|P2|NOT COMPLETED|Overall Study||0
8529729|NCT00324753|21027139|P1|NOT COMPLETED|Overall Study||0
8529730|NCT00324753|21027138|P2|COMPLETED|Overall Study||264
8529731|NCT00324753|21027139|P1|COMPLETED|Overall Study||190
8529732|NCT00324753|21027138|P2|STARTED|Overall Study||264
8529733|NCT00324753|21027139|P1|STARTED|Overall Study||190
8529743|NCT00324701|21027160|P2|NOT COMPLETED|Overall Study||17
8529744|NCT00324701|21027161|P1|NOT COMPLETED|Overall Study||20
8529745|NCT00324701|21027160|P2|COMPLETED|Overall Study||104
8529746|NCT00324701|21027161|P1|COMPLETED|Overall Study||100
8529747|NCT00324701|21027160|P2|Week 8 Assessment|Overall Study||107
8529748|NCT00324701|21027161|P1|Week 8 Assessment|Overall Study||108
8529749|NCT00324701|21027160|P2|STARTED|Overall Study||121
8529750|NCT00324701|21027161|P1|STARTED|Overall Study||120
8529751|NCT00324675|21027171|P2|NOT COMPLETED|Overall Study||0
8529752|NCT00324675|21027172|P1|NOT COMPLETED|Overall Study||1
8529753|NCT00324675|21027171|P2|COMPLETED|Overall Study||14
8529754|NCT00324675|21027172|P1|COMPLETED|Overall Study||13
8529755|NCT00324675|21027171|P2|STARTED|Overall Study||14
8529756|NCT00324675|21027172|P1|STARTED|Overall Study||14
8529757|NCT00324649|21027180|P2|NOT COMPLETED|Overall Study||5
8529758|NCT00324649|21027181|P1|NOT COMPLETED|Overall Study||2
8529759|NCT00324649|21027180|P2|COMPLETED|Overall Study||36
8529760|NCT00324649|21027181|P1|COMPLETED|Overall Study||37
8529761|NCT00324649|21027180|P2|STARTED|Overall Study||41
8529762|NCT00324649|21027181|P1|STARTED|Overall Study||39
8529763|NCT00324415|21027221|P1|NOT COMPLETED|Overall Study||0
8529764|NCT00324415|21027221|P1|COMPLETED|Overall Study||45
8529765|NCT00324415|21027221|P1|STARTED|Overall Study||45
8529766|NCT00324350|21027236|P2|NOT COMPLETED|Overall Study||0
8529767|NCT00324350|21027237|P1|NOT COMPLETED|Overall Study||0
8529768|NCT00324350|21027236|P2|COMPLETED|Overall Study||3632
8529769|NCT00324350|21027237|P1|COMPLETED|Overall Study||3655
8529770|NCT00324350|21027236|P2|Falls Follow-Up|Overall Study||3418
8529771|NCT00324350|21027237|P1|Falls Follow-Up|Overall Study||3364
8529772|NCT00324350|21027236|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
8529773|NCT00324350|21027237|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
8529774|NCT00324350|21027236|P2|STARTED|Overall Study||3632
8529775|NCT00324350|21027237|P1|STARTED|Overall Study||3655
8529776|NCT00324272|21027251|P4|NOT COMPLETED|Overall Study||0
8529777|NCT00324272|21027252|P3|NOT COMPLETED|Overall Study||0
8529778|NCT00324272|21027253|P2|NOT COMPLETED|Overall Study||0
8529779|NCT00324272|21027254|P1|NOT COMPLETED|Overall Study||0
8529780|NCT00324272|21027251|P4|COMPLETED|Overall Study||18
8529781|NCT00324272|21027252|P3|COMPLETED|Overall Study||18
8529782|NCT00324272|21027253|P2|COMPLETED|Overall Study||20
8529783|NCT00324272|21027254|P1|COMPLETED|Overall Study||18
8529784|NCT00324272|21027251|P4|STARTED|Overall Study||18
8529785|NCT00324272|21027252|P3|STARTED|Overall Study||18
8529786|NCT00324272|21027253|P2|STARTED|Overall Study||20
8529787|NCT00324272|21027254|P1|STARTED|Overall Study||18
8529788|NCT00324259|21027290|P2|NOT COMPLETED|Overall Study||0
8529789|NCT00324259|21027291|P1|NOT COMPLETED|Overall Study||0
8529790|NCT00324259|21027290|P2|COMPLETED|Overall Study||32
8529791|NCT00324259|21027291|P1|COMPLETED|Overall Study||34
8529792|NCT00324259|21027290|P2|STARTED|Overall Study||32
8529793|NCT00324259|21027291|P1|STARTED|Overall Study||34
8529794|NCT00324233|21027312|P2|NOT COMPLETED|Second Period||7
8529795|NCT00324233|21027313|P1|NOT COMPLETED|Second Period||5
8529796|NCT00324233|21027312|P2|COMPLETED|Second Period||11
8529797|NCT00324233|21027313|P1|COMPLETED|Second Period||12
8529798|NCT00324233|21027312|P2|STARTED|Second Period||18
8529799|NCT00324233|21027313|P1|STARTED|Second Period||17
8529800|NCT00324233|21027312|P2|NOT COMPLETED|First Period||0
8529801|NCT00324233|21027313|P1|NOT COMPLETED|First Period||1
8529802|NCT00324233|21027312|P2|COMPLETED|First Period||18
8529803|NCT00324233|21027313|P1|COMPLETED|First Period||17
8529804|NCT00324233|21027312|P2|STARTED|First Period||18
8529805|NCT00324233|21027313|P1|STARTED|First Period||18
8529806|NCT00324168|21027321|P2|NOT COMPLETED|Overall Study||30
8529807|NCT00324168|21027322|P1|NOT COMPLETED|Overall Study||28
8529808|NCT00324168|21027321|P2|COMPLETED|Overall Study||220
8529809|NCT00324168|21027322|P1|COMPLETED|Overall Study||222
8529810|NCT00324168|21027321|P2|STARTED|Overall Study||250
8529811|NCT00324168|21027322|P1|STARTED|Overall Study||250
8529812|NCT00324155|21027350|P2|NOT COMPLETED|Follow-up Phase||6
8529813|NCT00324155|21027351|P1|NOT COMPLETED|Follow-up Phase||11
8529814|NCT00324155|21027350|P2|COMPLETED|Follow-up Phase||245
8529815|NCT00324155|21027351|P1|COMPLETED|Follow-up Phase||236
8529816|NCT00324155|21027350|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
8529817|NCT00324155|21027351|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
8529818|NCT00324155|21027350|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
8529819|NCT00324155|21027351|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
8529820|NCT00324155|21027350|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
8529821|NCT00324155|21027351|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
8529822|NCT00324155|21027350|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
8529823|NCT00324155|21027351|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
8529824|NCT00324155|21027350|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
8529825|NCT00324155|21027351|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
8529826|NCT00324155|21027350|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
8529827|NCT00324155|21027351|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
8529828|NCT00324155|21027350|P2|STARTED|Received Treatment in Induction Phase||251
8529829|NCT00324155|21027351|P1|STARTED|Received Treatment in Induction Phase||247
8529830|NCT00324155|21027350|P2|NOT COMPLETED|Enrolled and Randomized||1
8529831|NCT00324155|21027351|P1|NOT COMPLETED|Enrolled and Randomized||3
8529832|NCT00324155|21027350|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
8529833|NCT00324155|21027351|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
8529834|NCT00324155|21027350|P2|STARTED|Enrolled and Randomized||252
8529835|NCT00324155|21027351|P1|STARTED|Enrolled and Randomized||250
8529836|NCT00324116|21027381|P1|NOT COMPLETED|Overall Study||32
8529837|NCT00324116|21027381|P1|COMPLETED|Overall Study||49
8529838|NCT00324116|21027381|P1|STARTED|Overall Study|subjects received treatment|81
8529839|NCT00324038|21027393|P2|NOT COMPLETED|Overall Study||51
8529840|NCT00324038|21027394|P1|NOT COMPLETED|Overall Study||49
8529841|NCT00324038|21027393|P2|COMPLETED|Overall Study||58
8529842|NCT00324038|21027394|P1|COMPLETED|Overall Study||61
8529843|NCT00324038|21027393|P2|STARTED|Overall Study||109
8529844|NCT00324038|21027394|P1|STARTED|Overall Study||110
8529845|NCT00323882|21027405|P5|NOT COMPLETED|Overall Study||32
8529846|NCT00323882|21027406|P4|NOT COMPLETED|Overall Study||7
8529847|NCT00323882|21027407|P3|NOT COMPLETED|Overall Study||13
8529848|NCT00323882|21027408|P2|NOT COMPLETED|Overall Study||6
8529849|NCT00323882|21027409|P1|NOT COMPLETED|Overall Study||8
8529850|NCT00323882|21027405|P5|COMPLETED|Overall Study||2
8529851|NCT00323882|21027406|P4|COMPLETED|Overall Study||0
8529852|NCT00323882|21027407|P3|COMPLETED|Overall Study||3
8529853|NCT00323882|21027408|P2|COMPLETED|Overall Study||0
8529854|NCT00323882|21027409|P1|COMPLETED|Overall Study||0
8529855|NCT00323882|21027405|P5|STARTED|Overall Study||34
8529856|NCT00323882|21027406|P4|STARTED|Overall Study||7
8529857|NCT00323882|21027407|P3|STARTED|Overall Study||16
8529858|NCT00323882|21027408|P2|STARTED|Overall Study||6
8529859|NCT00323882|21027409|P1|STARTED|Overall Study||8
8529860|NCT00323869|21027480|P1|NOT COMPLETED|Overall Study||1
8529861|NCT00323869|21027480|P1|COMPLETED|Overall Study||47
8529862|NCT00323869|21027480|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
8529863|NCT00323869|21027480|P1|STARTED|Overall Study|Enrollment|48
8529864|NCT00323739|21027492|P1|NOT COMPLETED|Overall Study||0
8529865|NCT00323739|21027492|P1|COMPLETED|Overall Study||80
8529866|NCT00323739|21027492|P1|STARTED|Overall Study||80
8529867|NCT00323635|21027499|P2|NOT COMPLETED|Overall Study||0
8529868|NCT00323635|21027500|P1|NOT COMPLETED|Overall Study||0
8529869|NCT00323635|21027499|P2|COMPLETED|Overall Study||9
8529870|NCT00323635|21027500|P1|COMPLETED|Overall Study||10
8529871|NCT00323635|21027499|P2|STARTED|Overall Study||9
8529872|NCT00323635|21027500|P1|STARTED|Overall Study||10
8529873|NCT00323622|21027536|P8|NOT COMPLETED|Overall Study||15
8529874|NCT00323622|21027537|P7|NOT COMPLETED|Overall Study||5
8529875|NCT00323622|21027538|P6|NOT COMPLETED|Overall Study||74
8529876|NCT00323622|21027539|P5|NOT COMPLETED|Overall Study||39
8529877|NCT00323622|21027540|P4|NOT COMPLETED|Overall Study||12
8529878|NCT00323622|21027541|P3|NOT COMPLETED|Overall Study||4
8529879|NCT00323622|21027542|P2|NOT COMPLETED|Overall Study||92
8529880|NCT00323622|21027543|P1|NOT COMPLETED|Overall Study||31
8529881|NCT00323622|21027536|P8|COMPLETED|Overall Study||125
8529882|NCT00323622|21027537|P7|COMPLETED|Overall Study||38
8529883|NCT00323622|21027538|P6|COMPLETED|Overall Study||454
8529884|NCT00323622|21027539|P5|COMPLETED|Overall Study||120
8529885|NCT00323622|21027540|P4|COMPLETED|Overall Study||122
8529886|NCT00323622|21027541|P3|COMPLETED|Overall Study||38
8529887|NCT00323622|21027542|P2|COMPLETED|Overall Study||423
8529888|NCT00323622|21027543|P1|COMPLETED|Overall Study||145
8529889|NCT00323622|21027536|P8|STARTED|Overall Study||140
8529890|NCT00323622|21027537|P7|STARTED|Overall Study||43
8529891|NCT00323622|21027538|P6|STARTED|Overall Study||528
8529892|NCT00323622|21027539|P5|STARTED|Overall Study||159
8529893|NCT00323622|21027540|P4|STARTED|Overall Study||134
8529894|NCT00323622|21027541|P3|STARTED|Overall Study||42
8529895|NCT00323622|21027542|P2|STARTED|Overall Study||515
8529896|NCT00323622|21027543|P1|STARTED|Overall Study||176
8529897|NCT00323609|21027585|P4|NOT COMPLETED|Overall Study||15
8529898|NCT00323609|21027586|P3|NOT COMPLETED|Overall Study||8
8529899|NCT00323609|21027587|P2|NOT COMPLETED|Overall Study||99
8529900|NCT00323609|21027588|P1|NOT COMPLETED|Overall Study||91
8529901|NCT00323609|21027585|P4|COMPLETED|Overall Study||0
8529902|NCT00323609|21027586|P3|COMPLETED|Overall Study||0
8529903|NCT00323609|21027587|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
8529904|NCT00323609|21027588|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
8529905|NCT00323609|21027585|P4|STARTED|Overall Study||15
8529906|NCT00323609|21027586|P3|STARTED|Overall Study||8
8529907|NCT00323609|21027587|P2|STARTED|Overall Study||190
8529908|NCT00323609|21027588|P1|STARTED|Overall Study||191
8529909|NCT00323557|21027624|P2|NOT COMPLETED|Overall Study||0
8529910|NCT00323557|21027625|P1|NOT COMPLETED|Overall Study||1
8529911|NCT00323557|21027624|P2|COMPLETED|Overall Study||7
8529912|NCT00323557|21027625|P1|COMPLETED|Overall Study||24
8529913|NCT00323557|21027624|P2|STARTED|Overall Study||7
8529914|NCT00323557|21027625|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
8529915|NCT00323492|21027634|P3|NOT COMPLETED|Study Phase 2||1
8529916|NCT00323492|21027635|P2|NOT COMPLETED|Study Phase 2||1
8529917|NCT00323492|21027636|P1|NOT COMPLETED|Study Phase 2||4
8529918|NCT00323492|21027634|P3|COMPLETED|Study Phase 2||24
8529919|NCT00323492|21027635|P2|COMPLETED|Study Phase 2||17
8529920|NCT00323492|21027636|P1|COMPLETED|Study Phase 2||40
8529921|NCT00323492|21027634|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
8529922|NCT00323492|21027635|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
8529923|NCT00323492|21027636|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
8529924|NCT00323492|21027634|P3|NOT COMPLETED|Study Phase 1||0
8529925|NCT00323492|21027635|P2|NOT COMPLETED|Study Phase 1||0
8529926|NCT00323492|21027636|P1|NOT COMPLETED|Study Phase 1||2
8529927|NCT00323492|21027634|P3|COMPLETED|Study Phase 1||0
8529928|NCT00323492|21027635|P2|COMPLETED|Study Phase 1||45
8529929|NCT00323492|21027636|P1|COMPLETED|Study Phase 1||45
8529930|NCT00323492|21027634|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
8529931|NCT00323492|21027635|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
8529932|NCT00323492|21027636|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
8529933|NCT00323492|21027634|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
8529934|NCT00323492|21027635|P2|STARTED|Study Phase 1||45
8529935|NCT00323492|21027636|P1|STARTED|Study Phase 1||47
8529936|NCT00323479|21027667|P1|NOT COMPLETED|Overall Study||8
8529937|NCT00323479|21027667|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
8529938|NCT00323479|21027667|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
8529939|NCT00323479|21027667|P1|STARTED|Overall Study||114
8529940|NCT00323453|21027678|P2|NOT COMPLETED|Overall Study||0
8529941|NCT00323453|21027679|P1|NOT COMPLETED|Overall Study||0
8529942|NCT00323453|21027678|P2|COMPLETED|Overall Study||48
8529943|NCT00323453|21027679|P1|COMPLETED|Overall Study||61
8529944|NCT00323453|21027678|P2|STARTED|Overall Study||48
8529945|NCT00323453|21027679|P1|STARTED|Overall Study||61
8529946|NCT00323427|21027687|P2|NOT COMPLETED|Overall Study||23
8529947|NCT00323427|21027688|P1|NOT COMPLETED|Overall Study||31
8529948|NCT00323427|21027687|P2|COMPLETED|Overall Study||43
8529949|NCT00323427|21027688|P1|COMPLETED|Overall Study||38
8529950|NCT00323427|21027687|P2|STARTED|Overall Study||66
8529951|NCT00323427|21027688|P1|STARTED|Overall Study||69
8529952|NCT00323414|21027700|P2|NOT COMPLETED|Overall Study||1
8529953|NCT00323414|21027701|P1|NOT COMPLETED|Overall Study||0
8529954|NCT00323414|21027700|P2|COMPLETED|Overall Study||18
8529955|NCT00323414|21027701|P1|COMPLETED|Overall Study||18
8529956|NCT00323414|21027700|P2|STARTED|Overall Study||19
8529957|NCT00323414|21027701|P1|STARTED|Overall Study||18
8529958|NCT00323362|21027717|P1|NOT COMPLETED|Overall Study||0
8529959|NCT00323362|21027717|P1|COMPLETED|Overall Study||17
8529960|NCT00323362|21027717|P1|STARTED|Overall Study||17
8529961|NCT00323310|21027723|P1|NOT COMPLETED|Overall Study||3
8529962|NCT00323310|21027723|P1|COMPLETED|Overall Study||89
8529963|NCT00323310|21027723|P1|STARTED|Overall Study||92
8529976|NCT00323284|21027757|P2|NOT COMPLETED|24 Months Follow-up||22
8529977|NCT00323284|21027758|P1|NOT COMPLETED|24 Months Follow-up||18
8529978|NCT00323284|21027757|P2|COMPLETED|24 Months Follow-up||101
8529979|NCT00323284|21027758|P1|COMPLETED|24 Months Follow-up||98
8529980|NCT00323284|21027757|P2|STARTED|24 Months Follow-up||123
8529981|NCT00323284|21027758|P1|STARTED|24 Months Follow-up||116
8529982|NCT00323284|21027757|P2|NOT COMPLETED|12 Months Follow-up||9
8529983|NCT00323284|21027758|P1|NOT COMPLETED|12 Months Follow-up||5
8529984|NCT00323284|21027757|P2|COMPLETED|12 Months Follow-up||114
8529985|NCT00323284|21027758|P1|COMPLETED|12 Months Follow-up||111
8529986|NCT00323284|21027757|P2|STARTED|12 Months Follow-up||123
8529987|NCT00323284|21027758|P1|STARTED|12 Months Follow-up||116
8529988|NCT00323271|21027768|P2|NOT COMPLETED|Overall Study||3
8529989|NCT00323271|21027769|P1|NOT COMPLETED|Overall Study||2
8529990|NCT00323271|21027768|P2|COMPLETED|Overall Study||9
8529991|NCT00323271|21027769|P1|COMPLETED|Overall Study||11
8529992|NCT00323271|21027768|P2|STARTED|Overall Study||12
8529993|NCT00323271|21027769|P1|STARTED|Overall Study||13
8529994|NCT00323258|21027779|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
8529995|NCT00323258|21027780|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
8529996|NCT00323258|21027779|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
8529997|NCT00323258|21027780|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
8529998|NCT00323258|21027779|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
8529999|NCT00323258|21027780|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
8530000|NCT00323258|21027779|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
8530001|NCT00323258|21027780|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
8530002|NCT00323258|21027779|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
8530003|NCT00323258|21027780|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
8530004|NCT00323258|21027779|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
8530005|NCT00323258|21027780|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
8530006|NCT00323193|21027796|P2|NOT COMPLETED|Overall Study||15
8530007|NCT00323193|21027797|P1|NOT COMPLETED|Overall Study||23
8530008|NCT00323193|21027796|P2|COMPLETED|Overall Study||41
8530009|NCT00323193|21027797|P1|COMPLETED|Overall Study||30
8530010|NCT00323193|21027796|P2|STARTED|Overall Study||56
8530011|NCT00323193|21027797|P1|STARTED|Overall Study||53
8530012|NCT00323115|21027805|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
8530013|NCT00323115|21027805|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
8530014|NCT00323115|21027805|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
8530015|NCT00323115|21027805|P1|NOT COMPLETED|Vaccine Administration||1
8530016|NCT00323115|21027805|P1|COMPLETED|Vaccine Administration||10
8530017|NCT00323115|21027805|P1|STARTED|Vaccine Administration||11
8530018|NCT00323063|21027832|P2|NOT COMPLETED|Overall Study||0
8530019|NCT00323063|21027833|P1|NOT COMPLETED|Overall Study||2
8530020|NCT00323063|21027832|P2|COMPLETED|Overall Study||23
8530021|NCT00323063|21027833|P1|COMPLETED|Overall Study||24
8530022|NCT00323063|21027832|P2|STARTED|Overall Study||23
8530023|NCT00323063|21027833|P1|STARTED|Overall Study||26
8530024|NCT00323037|21027845|P2|NOT COMPLETED|Overall Study||27
8530025|NCT00323037|21027846|P1|NOT COMPLETED|Overall Study||33
8530026|NCT00323037|21027845|P2|COMPLETED|Overall Study||126
8530027|NCT00323037|21027846|P1|COMPLETED|Overall Study||132
8530028|NCT00323037|21027845|P2|STARTED|Overall Study|Number randomized|153
8530029|NCT00323037|21027846|P1|STARTED|Overall Study|Number randomized|165
8530030|NCT00322881|21027850|P1|NOT COMPLETED|Overall Study||5
8530031|NCT00322881|21027850|P1|COMPLETED|Overall Study||7
8530032|NCT00322881|21027850|P1|STARTED|Overall Study||12
8530033|NCT00322868|21027854|P1|NOT COMPLETED|Overall Study||1
8530034|NCT00322868|21027854|P1|COMPLETED|Overall Study||20
8530035|NCT00322868|21027854|P1|STARTED|Overall Study||21
8530036|NCT00322855|21027873|P1|NOT COMPLETED|Overall Study||0
8530037|NCT00322855|21027873|P1|COMPLETED|Overall Study||1
8530038|NCT00322855|21027873|P1|STARTED|Overall Study||1
8530039|NCT00322842|21027879|P2|NOT COMPLETED|Overall Study||2
8530040|NCT00322842|21027880|P1|NOT COMPLETED|Overall Study||2
8530041|NCT00322842|21027879|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
8530042|NCT00322842|21027880|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
8530043|NCT00322842|21027879|P2|STARTED|Overall Study||31
8530044|NCT00322842|21027880|P1|STARTED|Overall Study||4
8530045|NCT00322777|21027907|P2|NOT COMPLETED|Overall Study||0
8530046|NCT00322777|21027908|P1|NOT COMPLETED|Overall Study||0
8530047|NCT00322777|21027907|P2|COMPLETED|Overall Study||45
8530048|NCT00322777|21027908|P1|COMPLETED|Overall Study||39
8530049|NCT00322777|21027907|P2|Data Collection at Week 24|Overall Study||45
8530050|NCT00322777|21027908|P1|Data Collection at Week 24|Overall Study||39
8530051|NCT00322777|21027907|P2|Data Collection at Week 16|Overall Study||45
8530052|NCT00322777|21027908|P1|Data Collection at Week 16|Overall Study||39
8530053|NCT00322777|21027907|P2|Data Collection at Week 8|Overall Study||45
8530054|NCT00322777|21027908|P1|Data Collection at Week 8|Overall Study||39
8530055|NCT00322777|21027907|P2|"Data Collection at BASELINE|"|Overall Study||45
8530056|NCT00322777|21027908|P1|"Data Collection at BASELINE|"|Overall Study||39
8530057|NCT00322777|21027907|P2|STARTED|Overall Study||45
8530058|NCT00322777|21027908|P1|STARTED|Overall Study||39
8530059|NCT00322712|21027918|P1|NOT COMPLETED|Overall Study||1
8530060|NCT00322712|21027918|P1|COMPLETED|Overall Study||11
8530061|NCT00322712|21027918|P1|STARTED|Overall Study||12
8530062|NCT00322621|21027922|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
8530063|NCT00322621|21027923|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
8530064|NCT00322621|21027924|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
8530065|NCT00322621|21027922|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
8530066|NCT00322621|21027923|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
8530067|NCT00322621|21027924|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
8530068|NCT00322621|21027922|P3|STARTED|Period III - Maintenance / Rescue Phase||69
8530069|NCT00322621|21027923|P2|STARTED|Period III - Maintenance / Rescue Phase||115
8530070|NCT00322621|21027924|P1|STARTED|Period III - Maintenance / Rescue Phase||0
8530071|NCT00322621|21027922|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
8530072|NCT00322621|21027923|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
8530073|NCT00322621|21027924|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
8530074|NCT00322621|21027922|P3|COMPLETED|Period II - Acute Therapy Phase||0
8530075|NCT00322621|21027923|P2|COMPLETED|Period II - Acute Therapy Phase||0
8530076|NCT00322621|21027924|P1|COMPLETED|Period II - Acute Therapy Phase||184
8530077|NCT00322621|21027922|P3|STARTED|Period II - Acute Therapy Phase||0
8530078|NCT00322621|21027923|P2|STARTED|Period II - Acute Therapy Phase||0
8530079|NCT00322621|21027924|P1|STARTED|Period II - Acute Therapy Phase||216
8530080|NCT00322556|21027976|P1|NOT COMPLETED|Overall Study||12
8530081|NCT00322556|21027976|P1|COMPLETED|Overall Study||43
8530082|NCT00322556|21027976|P1|STARTED|Overall Study||55
8530083|NCT00322491|21027992|P2|NOT COMPLETED|Overall Study||2
8530084|NCT00322491|21027993|P1|NOT COMPLETED|Overall Study||2
8530085|NCT00322491|21027992|P2|COMPLETED|Overall Study||24
8530086|NCT00322491|21027993|P1|COMPLETED|Overall Study||21
8530087|NCT00322491|21027992|P2|STARTED|Overall Study||26
8530088|NCT00322491|21027993|P1|STARTED|Overall Study||23
8530089|NCT00322465|21028019|P4|NOT COMPLETED|Overall Study||26
8530090|NCT00322465|21028020|P3|NOT COMPLETED|Overall Study||26
8530091|NCT00322465|21028021|P2|NOT COMPLETED|Overall Study||24
8530092|NCT00322465|21028022|P1|NOT COMPLETED|Overall Study||20
8530093|NCT00322465|21028019|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
8530094|NCT00322465|21028020|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
8530095|NCT00322465|21028021|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
8530096|NCT00322465|21028022|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
8530097|NCT00322465|21028019|P4|STARTED|Overall Study|Randomized|79
8530098|NCT00322465|21028020|P3|STARTED|Overall Study|Randomized|77
8530099|NCT00322465|21028021|P2|STARTED|Overall Study|Randomized|73
8530100|NCT00322465|21028022|P1|STARTED|Overall Study|Randomized|76
8530101|NCT00322452|21028083|P2|NOT COMPLETED|Overall Study||276
8530102|NCT00322452|21028084|P1|NOT COMPLETED|Overall Study||247
8530103|NCT00322452|21028083|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
8530104|NCT00322452|21028084|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
8530105|NCT00322452|21028083|P2|STARTED|Overall Study|Number of patients randomized|608
8530106|NCT00322452|21028084|P1|STARTED|Overall Study|Number of patients randomized|609
8530107|NCT00322439|21028120|P1|NOT COMPLETED|Overall Study||1056
8530108|NCT00322439|21028120|P1|COMPLETED|Overall Study||1455
8530109|NCT00322439|21028120|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
8530110|NCT00322439|21028120|P1|STARTED|Overall Study||2511
8530111|NCT00322387|21028135|P2|NOT COMPLETED|Follow-up Period||3
8530112|NCT00322387|21028136|P1|NOT COMPLETED|Follow-up Period||2
8530113|NCT00322387|21028135|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
8530114|NCT00322387|21028136|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
8530115|NCT00322387|21028135|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
8530116|NCT00322387|21028136|P1|STARTED|Follow-up Period|Participants who had transplants|14
8530117|NCT00322387|21028135|P2|NOT COMPLETED|Treatment Period||1
8530118|NCT00322387|21028136|P1|NOT COMPLETED|Treatment Period||0
8530119|NCT00322387|21028135|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
8530120|NCT00322387|21028136|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
8530121|NCT00322387|21028135|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
8530122|NCT00322387|21028136|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
8530123|NCT00322374|21028170|P4|NOT COMPLETED|Second Escalation||0
8530124|NCT00322374|21028171|P3|NOT COMPLETED|Second Escalation||6
8530125|NCT00322374|21028172|P2|NOT COMPLETED|Second Escalation||0
8530126|NCT00322374|21028173|P1|NOT COMPLETED|Second Escalation||0
8530127|NCT00322374|21028170|P4|COMPLETED|Second Escalation||0
8530128|NCT00322374|21028171|P3|COMPLETED|Second Escalation||0
8530129|NCT00322374|21028172|P2|COMPLETED|Second Escalation||0
8530130|NCT00322374|21028173|P1|COMPLETED|Second Escalation||0
8530131|NCT00322374|21028170|P4|STARTED|Second Escalation||0
8530132|NCT00322374|21028171|P3|STARTED|Second Escalation||6
8530133|NCT00322374|21028172|P2|STARTED|Second Escalation||0
8530134|NCT00322374|21028173|P1|STARTED|Second Escalation||0
8530135|NCT00322374|21028170|P4|NOT COMPLETED|First Escalation||0
8530136|NCT00322374|21028171|P3|NOT COMPLETED|First Escalation||0
8530137|NCT00322374|21028172|P2|NOT COMPLETED|First Escalation||30
8530138|NCT00322374|21028173|P1|NOT COMPLETED|First Escalation||0
8530139|NCT00322374|21028170|P4|COMPLETED|First Escalation||0
8530140|NCT00322374|21028171|P3|COMPLETED|First Escalation||0
8530141|NCT00322374|21028172|P2|COMPLETED|First Escalation||0
8530142|NCT00322374|21028173|P1|COMPLETED|First Escalation||0
8530143|NCT00322374|21028170|P4|STARTED|First Escalation||0
8530144|NCT00322374|21028171|P3|STARTED|First Escalation||0
8530145|NCT00322374|21028172|P2|STARTED|First Escalation||30
8530146|NCT00322374|21028173|P1|STARTED|First Escalation||0
8530147|NCT00322374|21028170|P4|NOT COMPLETED|Starting Dose||0
8530148|NCT00322374|21028171|P3|NOT COMPLETED|Starting Dose||0
8530149|NCT00322374|21028172|P2|NOT COMPLETED|Starting Dose||0
8530150|NCT00322374|21028173|P1|NOT COMPLETED|Starting Dose||6
8530151|NCT00322374|21028170|P4|COMPLETED|Starting Dose||0
8530152|NCT00322374|21028171|P3|COMPLETED|Starting Dose||0
8530153|NCT00322374|21028172|P2|COMPLETED|Starting Dose||0
8530154|NCT00322374|21028173|P1|COMPLETED|Starting Dose||0
8530155|NCT00322374|21028170|P4|STARTED|Starting Dose||0
8530156|NCT00322374|21028171|P3|STARTED|Starting Dose||0
8530157|NCT00322374|21028172|P2|STARTED|Starting Dose||0
8530158|NCT00322374|21028173|P1|STARTED|Starting Dose||6
8530159|NCT00322374|21028170|P4|NOT COMPLETED|Enrollment||0
8530160|NCT00322374|21028171|P3|NOT COMPLETED|Enrollment||0
8530161|NCT00322374|21028172|P2|NOT COMPLETED|Enrollment||0
8530162|NCT00322374|21028173|P1|NOT COMPLETED|Enrollment||0
8530163|NCT00322374|21028170|P4|COMPLETED|Enrollment||42
8530164|NCT00322374|21028171|P3|COMPLETED|Enrollment||0
8530165|NCT00322374|21028172|P2|COMPLETED|Enrollment||0
8530166|NCT00322374|21028173|P1|COMPLETED|Enrollment||0
8530167|NCT00322374|21028170|P4|STARTED|Enrollment||42
8530168|NCT00322374|21028171|P3|STARTED|Enrollment||0
8530169|NCT00322374|21028172|P2|STARTED|Enrollment||0
8530170|NCT00322374|21028173|P1|STARTED|Enrollment||0
8530171|NCT00322348|21028223|P2|NOT COMPLETED|Overall Study||33
8530172|NCT00322348|21028224|P1|NOT COMPLETED|Overall Study||37
8530173|NCT00322348|21028223|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
8530174|NCT00322348|21028224|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
8530175|NCT00322348|21028223|P2|Received Study Treatment|Overall Study||48
8530176|NCT00322348|21028224|P1|Received Study Treatment|Overall Study||50
8530177|NCT00322348|21028223|P2|STARTED|Overall Study||49
8530178|NCT00322348|21028224|P1|STARTED|Overall Study||49
8530179|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8530180|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8530181|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8530182|NCT00322335|21028243|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
8530183|NCT00322335|21028244|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
8530184|NCT00322335|21028245|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
8530185|NCT00322335|21028243|P3|STARTED|Subjects 66 Months After Booster Dose||53
8530186|NCT00322335|21028244|P2|STARTED|Subjects 66 Months After Booster Dose||104
8530187|NCT00322335|21028245|P1|STARTED|Subjects 66 Months After Booster Dose||48
8530188|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8530189|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8530190|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8530191|NCT00322335|21028243|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
8530192|NCT00322335|21028244|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
8530193|NCT00322335|21028245|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
8530194|NCT00322335|21028243|P3|STARTED|Subjects 54 Months After Booster Dose||56
8530195|NCT00322335|21028244|P2|STARTED|Subjects 54 Months After Booster Dose||108
8530196|NCT00322335|21028245|P1|STARTED|Subjects 54 Months After Booster Dose||50
8530197|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8530198|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8530199|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8530200|NCT00322335|21028243|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
8530201|NCT00322335|21028244|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
8530202|NCT00322335|21028245|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
8530203|NCT00322335|21028243|P3|STARTED|Subjects 42 Months After Booster Dose||56
8530204|NCT00322335|21028244|P2|STARTED|Subjects 42 Months After Booster Dose||113
8530205|NCT00322335|21028245|P1|STARTED|Subjects 42 Months After Booster Dose||51
8530206|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8530207|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8530208|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8530209|NCT00322335|21028243|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
8530210|NCT00322335|21028244|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
8530211|NCT00322335|21028245|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
8530212|NCT00322335|21028243|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
8530213|NCT00322335|21028244|P2|STARTED|Subjects 30 Months After Booster Dose||119
8530214|NCT00322335|21028245|P1|STARTED|Subjects 30 Months After Booster Dose||54
8530215|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8530216|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8530217|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8530218|NCT00322335|21028243|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
8530219|NCT00322335|21028244|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
8530220|NCT00322335|21028245|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
8530221|NCT00322335|21028243|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
8530222|NCT00322335|21028244|P2|STARTED|Subjects 18 Months After Booster Dose||123
8530223|NCT00322335|21028245|P1|STARTED|Subjects 18 Months After Booster Dose||58
8530224|NCT00322309|21028285|P2|NOT COMPLETED|Overall Study||4
8530225|NCT00322309|21028286|P1|NOT COMPLETED|Overall Study||2
8530226|NCT00322309|21028285|P2|COMPLETED|Overall Study||9
8530227|NCT00322309|21028286|P1|COMPLETED|Overall Study||9
8530228|NCT00322309|21028285|P2|STARTED|Overall Study||13
8530229|NCT00322309|21028286|P1|STARTED|Overall Study||11
8530230|NCT00322231|21028302|P2|NOT COMPLETED|Period 2||0
8530231|NCT00322231|21028303|P1|NOT COMPLETED|Period 2||0
8530232|NCT00322231|21028302|P2|COMPLETED|Period 2||49
8530233|NCT00322231|21028303|P1|COMPLETED|Period 2||51
8530234|NCT00322231|21028302|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
8530235|NCT00322231|21028303|P1|STARTED|Period 2||51
8530236|NCT00322231|21028302|P2|NOT COMPLETED|Period 1||0
8530237|NCT00322231|21028303|P1|NOT COMPLETED|Period 1||0
8530238|NCT00322231|21028302|P2|COMPLETED|Period 1||50
8530239|NCT00322231|21028303|P1|COMPLETED|Period 1||51
8530240|NCT00322231|21028302|P2|STARTED|Period 1||50
8530241|NCT00322231|21028303|P1|STARTED|Period 1||51
8530242|NCT00322153|21028315|P2|NOT COMPLETED|Overall Study||69
8530243|NCT00322153|21028316|P1|NOT COMPLETED|Overall Study||63
8530244|NCT00322153|21028315|P2|COMPLETED|Overall Study||273
8530245|NCT00322153|21028316|P1|COMPLETED|Overall Study||272
8530246|NCT00322153|21028315|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
8530247|NCT00322153|21028316|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
8530248|NCT00322153|21028315|P2|STARTED|Overall Study|Randomized to Memantine ER|342
8530249|NCT00322153|21028316|P1|STARTED|Overall Study|Randomized to placebo|335
8530250|NCT00322101|21028328|P2|NOT COMPLETED|Overall Study||0
8530251|NCT00322101|21028329|P1|NOT COMPLETED|Overall Study||0
8530252|NCT00322101|21028328|P2|COMPLETED|Overall Study||11
8530253|NCT00322101|21028329|P1|COMPLETED|Overall Study||14
8530254|NCT00322101|21028328|P2|STARTED|Overall Study||11
8530255|NCT00322101|21028329|P1|STARTED|Overall Study||14
8530256|NCT00322049|21028349|P4|NOT COMPLETED|Overall Study||1
8530257|NCT00322049|21028350|P3|NOT COMPLETED|Overall Study||0
8530258|NCT00322049|21028351|P2|NOT COMPLETED|Overall Study||1
8530259|NCT00322049|21028352|P1|NOT COMPLETED|Overall Study||0
8530260|NCT00322049|21028349|P4|COMPLETED|Overall Study||16
8530261|NCT00322049|21028350|P3|COMPLETED|Overall Study||20
8530262|NCT00322049|21028351|P2|COMPLETED|Overall Study||9
8530263|NCT00322049|21028352|P1|COMPLETED|Overall Study||4
8530264|NCT00322049|21028349|P4|STARTED|Overall Study||17
8530265|NCT00322049|21028350|P3|STARTED|Overall Study||20
8530266|NCT00322049|21028351|P2|STARTED|Overall Study||10
8530267|NCT00322049|21028352|P1|STARTED|Overall Study||4
8530268|NCT00322023|21028385|P3|NOT COMPLETED|Overall Study||6
8530269|NCT00322023|21028386|P2|NOT COMPLETED|Overall Study||2
8530270|NCT00322023|21028387|P1|NOT COMPLETED|Overall Study||0
8530271|NCT00322023|21028385|P3|COMPLETED|Overall Study||16
8530272|NCT00322023|21028386|P2|COMPLETED|Overall Study||19
8530273|NCT00322023|21028387|P1|COMPLETED|Overall Study||12
8530274|NCT00322023|21028385|P3|STARTED|Overall Study||22
8530275|NCT00322023|21028386|P2|STARTED|Overall Study||21
8530276|NCT00322023|21028387|P1|STARTED|Overall Study||12
8530277|NCT00321984|21028404|P3|NOT COMPLETED|Overall Study||26
8530278|NCT00321984|21028405|P2|NOT COMPLETED|Overall Study||21
8530279|NCT00321984|21028406|P1|NOT COMPLETED|Overall Study||27
8530280|NCT00321984|21028404|P3|COMPLETED|Overall Study||289
8530281|NCT00321984|21028405|P2|COMPLETED|Overall Study||294
8530282|NCT00321984|21028406|P1|COMPLETED|Overall Study||290
8530283|NCT00321984|21028404|P3|STARTED|Overall Study||315
8530284|NCT00321984|21028405|P2|STARTED|Overall Study||315
8530285|NCT00321984|21028406|P1|STARTED|Overall Study||317
8530286|NCT00321971|21028425|P2|NOT COMPLETED|Overall Study||11
8530287|NCT00321971|21028426|P1|NOT COMPLETED|Overall Study||8
8530288|NCT00321971|21028425|P2|COMPLETED|Overall Study||26
8530289|NCT00321971|21028426|P1|COMPLETED|Overall Study||28
8530290|NCT00321971|21028425|P2|STARTED|Overall Study||37
8530291|NCT00321971|21028426|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
8530292|NCT00321932|21028434|P2|NOT COMPLETED|Overall Study||21
8530293|NCT00321932|21028435|P1|NOT COMPLETED|Overall Study||10
8530294|NCT00321932|21028434|P2|COMPLETED|Overall Study||11
8530295|NCT00321932|21028435|P1|COMPLETED|Overall Study||19
8530296|NCT00321932|21028434|P2|STARTED|Overall Study||32
8530297|NCT00321932|21028435|P1|STARTED|Overall Study||29
8530298|NCT00321919|21028459|P2|NOT COMPLETED|Overall Study||52
8530299|NCT00321919|21028460|P1|NOT COMPLETED|Overall Study||75
8530300|NCT00321919|21028459|P2|COMPLETED|Overall Study||250
8530301|NCT00321919|21028460|P1|COMPLETED|Overall Study||226
8530302|NCT00321919|21028459|P2|STARTED|Overall Study||302
8530303|NCT00321919|21028460|P1|STARTED|Overall Study||301
8530304|NCT00321906|21028502|P2|NOT COMPLETED|Overall Study||56
8530305|NCT00321906|21028503|P1|NOT COMPLETED|Overall Study||46
8530306|NCT00321906|21028502|P2|COMPLETED|Overall Study||31
8530307|NCT00321906|21028503|P1|COMPLETED|Overall Study||48
8530308|NCT00321906|21028502|P2|STARTED|Overall Study||87
8530309|NCT00321906|21028503|P1|STARTED|Overall Study||94
8530310|NCT00321893|21028525|P2|NOT COMPLETED|Overall Study||14
8530311|NCT00321893|21028526|P1|NOT COMPLETED|Overall Study||24
8530312|NCT00321893|21028525|P2|COMPLETED|Overall Study||87
8530313|NCT00321893|21028526|P1|COMPLETED|Overall Study||77
8530314|NCT00321893|21028525|P2|STARTED|Overall Study||101
8530315|NCT00321893|21028526|P1|STARTED|Overall Study||101
8530316|NCT00321854|21028540|P2|NOT COMPLETED|Overall Study||82
8530317|NCT00321854|21028541|P1|NOT COMPLETED|Overall Study||63
8530318|NCT00321854|21028540|P2|COMPLETED|Overall Study||192
8530319|NCT00321854|21028541|P1|COMPLETED|Overall Study||198
8530320|NCT00321854|21028540|P2|STARTED|Overall Study||274
8530321|NCT00321854|21028541|P1|STARTED|Overall Study||261
8530322|NCT00321828|21028659|P1|NOT COMPLETED|Overall Study||4
8530323|NCT00321828|21028659|P1|COMPLETED|Overall Study||86
8530324|NCT00321828|21028659|P1|STARTED|Overall Study||90
8530325|NCT00321789|21028665|P2|NOT COMPLETED|Overall Study||16
8530326|NCT00321789|21028666|P1|NOT COMPLETED|Overall Study||15
8530327|NCT00321789|21028665|P2|COMPLETED|Overall Study||112
8530328|NCT00321789|21028666|P1|COMPLETED|Overall Study||112
8530329|NCT00321789|21028665|P2|STARTED|Overall Study||128
8530330|NCT00321789|21028666|P1|STARTED|Overall Study||127
8530331|NCT00321763|21028698|P4|NOT COMPLETED|Overall Study||5
8530332|NCT00321763|21028699|P3|NOT COMPLETED|Overall Study||6
8530333|NCT00321763|21028700|P2|NOT COMPLETED|Overall Study||2
8530334|NCT00321763|21028701|P1|NOT COMPLETED|Overall Study||6
8530335|NCT00321763|21028698|P4|COMPLETED|Overall Study||565
8530336|NCT00321763|21028699|P3|COMPLETED|Overall Study||848
8530337|NCT00321763|21028700|P2|COMPLETED|Overall Study||848
8530338|NCT00321763|21028701|P1|COMPLETED|Overall Study||844
8530339|NCT00321763|21028698|P4|STARTED|Overall Study||570
8530340|NCT00321763|21028699|P3|STARTED|Overall Study||854
8530341|NCT00321763|21028700|P2|STARTED|Overall Study||850
8530342|NCT00321763|21028701|P1|STARTED|Overall Study||850
8530343|NCT00321737|21028761|P3|NOT COMPLETED|Overall Study||54
8530344|NCT00321737|21028762|P2|NOT COMPLETED|Overall Study||48
8530345|NCT00321737|21028763|P1|NOT COMPLETED|Overall Study||122
8530346|NCT00321737|21028761|P3|COMPLETED|Overall Study||104
8530347|NCT00321737|21028762|P2|COMPLETED|Overall Study||92
8530348|NCT00321737|21028763|P1|COMPLETED|Overall Study||25
8530349|NCT00321737|21028761|P3|STARTED|Overall Study||158
8530350|NCT00321737|21028762|P2|STARTED|Overall Study||140
8530351|NCT00321737|21028763|P1|STARTED|Overall Study||147
8530352|NCT00321711|21028791|P5|NOT COMPLETED|Part B||5
8530353|NCT00321711|21028792|P4|NOT COMPLETED|Part B||6
8530354|NCT00321711|21028793|P3|NOT COMPLETED|Part B||0
8530355|NCT00321711|21028794|P2|NOT COMPLETED|Part B||0
8530356|NCT00321711|21028795|P1|NOT COMPLETED|Part B||0
8530357|NCT00321711|21028791|P5|COMPLETED|Part B||10
8530358|NCT00321711|21028792|P4|COMPLETED|Part B||8
8530359|NCT00321711|21028793|P3|COMPLETED|Part B||0
8530360|NCT00321711|21028794|P2|COMPLETED|Part B||0
8530361|NCT00321711|21028795|P1|COMPLETED|Part B||0
8530362|NCT00321711|21028791|P5|STARTED|Part B||15
8530363|NCT00321711|21028792|P4|STARTED|Part B||14
8530364|NCT00321711|21028793|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8530365|NCT00321711|21028794|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8530366|NCT00321711|21028795|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8530367|NCT00321711|21028791|P5|NOT COMPLETED|Part A||0
8530368|NCT00321711|21028792|P4|NOT COMPLETED|Part A||0
8530369|NCT00321711|21028793|P3|NOT COMPLETED|Part A||11
8530370|NCT00321711|21028794|P2|NOT COMPLETED|Part A||10
8530371|NCT00321711|21028795|P1|NOT COMPLETED|Part A||5
8530372|NCT00321711|21028791|P5|COMPLETED|Part A||0
8530373|NCT00321711|21028792|P4|COMPLETED|Part A||0
8530374|NCT00321711|21028793|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
8530375|NCT00321711|21028794|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
8530376|NCT00321711|21028795|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
8530377|NCT00321711|21028791|P5|STARTED|Part A||0
8530378|NCT00321711|21028792|P4|STARTED|Part A||0
8530379|NCT00321711|21028793|P3|STARTED|Part A||14
8530380|NCT00321711|21028794|P2|STARTED|Part A||13
8530381|NCT00321711|21028795|P1|STARTED|Part A||13
8530382|NCT00321698|21028827|P5|NOT COMPLETED|Phase II, MTD Dose||0
8530383|NCT00321698|21028828|P4|NOT COMPLETED|Phase II, MTD Dose||0
8530384|NCT00321698|21028829|P3|NOT COMPLETED|Phase II, MTD Dose||0
8530385|NCT00321698|21028830|P2|NOT COMPLETED|Phase II, MTD Dose||0
8530386|NCT00321698|21028831|P1|NOT COMPLETED|Phase II, MTD Dose||0
8530387|NCT00321698|21028827|P5|COMPLETED|Phase II, MTD Dose||13
8530388|NCT00321698|21028828|P4|COMPLETED|Phase II, MTD Dose||0
8530389|NCT00321698|21028829|P3|COMPLETED|Phase II, MTD Dose||0
8530390|NCT00321698|21028830|P2|COMPLETED|Phase II, MTD Dose||0
8530391|NCT00321698|21028831|P1|COMPLETED|Phase II, MTD Dose||0
8530392|NCT00321698|21028827|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
8530393|NCT00321698|21028828|P4|STARTED|Phase II, MTD Dose||0
8530394|NCT00321698|21028829|P3|STARTED|Phase II, MTD Dose||0
8530395|NCT00321698|21028830|P2|STARTED|Phase II, MTD Dose||0
8530396|NCT00321698|21028831|P1|STARTED|Phase II, MTD Dose||0
8530397|NCT00321698|21028827|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530398|NCT00321698|21028828|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530399|NCT00321698|21028829|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530400|NCT00321698|21028830|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530401|NCT00321698|21028831|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530402|NCT00321698|21028827|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530403|NCT00321698|21028828|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530404|NCT00321698|21028829|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530405|NCT00321698|21028830|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530406|NCT00321698|21028831|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530407|NCT00321698|21028827|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
8530408|NCT00321698|21028828|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
8530409|NCT00321698|21028829|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
8530410|NCT00321698|21028830|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
8530411|NCT00321698|21028831|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
8530412|NCT00321685|21028845|P1|NOT COMPLETED|Overall Study||39
8530413|NCT00321685|21028845|P1|COMPLETED|Overall Study||18
8530414|NCT00321685|21028845|P1|Eligible and Treated|Overall Study||53
8530415|NCT00321685|21028845|P1|Started Protocol Therapy|Overall Study||55
8530416|NCT00321685|21028845|P1|Eligible|Overall Study||55
8530417|NCT00321685|21028845|P1|STARTED|Overall Study||57
8530418|NCT00321672|21028857|P4|NOT COMPLETED|Overall Study||2
8530419|NCT00321672|21028858|P3|NOT COMPLETED|Overall Study||11
8530420|NCT00321672|21028859|P2|NOT COMPLETED|Overall Study||8
8530421|NCT00321672|21028860|P1|NOT COMPLETED|Overall Study||12
8530422|NCT00321672|21028857|P4|COMPLETED|Overall Study||71
8530423|NCT00321672|21028858|P3|COMPLETED|Overall Study||156
8530424|NCT00321672|21028859|P2|COMPLETED|Overall Study||81
8530425|NCT00321672|21028860|P1|COMPLETED|Overall Study||153
8530426|NCT00321672|21028857|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
8530427|NCT00321672|21028858|P3|STARTED|Overall Study||167
8530428|NCT00321672|21028859|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
8530429|NCT00321672|21028860|P1|STARTED|Overall Study||165
8530430|NCT00321646|21028886|P1|NOT COMPLETED|Prostatectomy||0
8530431|NCT00321646|21028886|P1|COMPLETED|Prostatectomy||37
8530432|NCT00321646|21028886|P1|STARTED|Prostatectomy||37
8530433|NCT00321646|21028886|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
8530434|NCT00321646|21028886|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
8530435|NCT00321646|21028886|P1|STARTED|Neoadjuvant Chemotherapy||42
8530436|NCT00321620|21028893|P2|NOT COMPLETED|Overall Study||722
8530437|NCT00321620|21028894|P1|NOT COMPLETED|Overall Study||743
8530438|NCT00321620|21028893|P2|COMPLETED|Overall Study||228
8530439|NCT00321620|21028894|P1|COMPLETED|Overall Study||208
8530440|NCT00321620|21028893|P2|Received Investigational Product|Overall Study||942
8530441|NCT00321620|21028894|P1|Received Investigational Product|Overall Study||946
8530442|NCT00321620|21028893|P2|STARTED|Overall Study||950
8530443|NCT00321620|21028894|P1|STARTED|Overall Study||951
8530444|NCT00321594|21028906|P5|NOT COMPLETED|Phase II, MTD Dose||0
8530445|NCT00321594|21028907|P4|NOT COMPLETED|Phase II, MTD Dose||0
8530446|NCT00321594|21028908|P3|NOT COMPLETED|Phase II, MTD Dose||0
8530447|NCT00321594|21028909|P2|NOT COMPLETED|Phase II, MTD Dose||0
8530448|NCT00321594|21028910|P1|NOT COMPLETED|Phase II, MTD Dose||0
8530449|NCT00321594|21028906|P5|COMPLETED|Phase II, MTD Dose||36
8530450|NCT00321594|21028907|P4|COMPLETED|Phase II, MTD Dose||6
8530451|NCT00321594|21028908|P3|COMPLETED|Phase II, MTD Dose||0
8530452|NCT00321594|21028909|P2|COMPLETED|Phase II, MTD Dose||0
8530453|NCT00321594|21028910|P1|COMPLETED|Phase II, MTD Dose||0
8530454|NCT00321594|21028906|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
8530455|NCT00321594|21028907|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
8530456|NCT00321594|21028908|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8530457|NCT00321594|21028909|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8530458|NCT00321594|21028910|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8530459|NCT00321594|21028906|P5|NOT COMPLETED|Phase I, Level 1-4||0
8530460|NCT00321594|21028907|P4|NOT COMPLETED|Phase I, Level 1-4||0
8530461|NCT00321594|21028908|P3|NOT COMPLETED|Phase I, Level 1-4||0
8530462|NCT00321594|21028909|P2|NOT COMPLETED|Phase I, Level 1-4||0
8530463|NCT00321594|21028910|P1|NOT COMPLETED|Phase I, Level 1-4||0
8530464|NCT00321594|21028906|P5|COMPLETED|Phase I, Level 1-4||0
8530465|NCT00321594|21028907|P4|COMPLETED|Phase I, Level 1-4||6
8530466|NCT00321594|21028908|P3|COMPLETED|Phase I, Level 1-4||6
8530467|NCT00321594|21028909|P2|COMPLETED|Phase I, Level 1-4||3
8530468|NCT00321594|21028910|P1|COMPLETED|Phase I, Level 1-4||3
8530469|NCT00321594|21028906|P5|STARTED|Phase I, Level 1-4||0
8530470|NCT00321594|21028907|P4|STARTED|Phase I, Level 1-4||6
8530471|NCT00321594|21028908|P3|STARTED|Phase I, Level 1-4||6
8530472|NCT00321594|21028909|P2|STARTED|Phase I, Level 1-4||3
8530473|NCT00321594|21028910|P1|STARTED|Phase I, Level 1-4||3
8530474|NCT00321555|21028922|P1|NOT COMPLETED|Overall Study||6
8530475|NCT00321555|21028922|P1|COMPLETED|Overall Study||9
8530476|NCT00321555|21028922|P1|STARTED|Overall Study||15
8530477|NCT00321464|21028930|P2|NOT COMPLETED|Overall Study||558
8530478|NCT00321464|21028931|P1|NOT COMPLETED|Overall Study||559
8530479|NCT00321464|21028930|P2|COMPLETED|Overall Study||468
8530480|NCT00321464|21028931|P1|COMPLETED|Overall Study||461
8530481|NCT00321464|21028930|P2|Received Investigational Product|Overall Study||1019
8530482|NCT00321464|21028931|P1|Received Investigational Product|Overall Study||1014
8530483|NCT00321464|21028930|P2|STARTED|Overall Study||1026
8530484|NCT00321464|21028931|P1|STARTED|Overall Study||1020
8530485|NCT00321373|21028944|P3|NOT COMPLETED|Overall Study||3
8530486|NCT00321373|21028945|P2|NOT COMPLETED|Overall Study||0
8530487|NCT00321373|21028946|P1|NOT COMPLETED|Overall Study||2
8530488|NCT00321373|21028944|P3|COMPLETED|Overall Study||404
8530489|NCT00321373|21028945|P2|COMPLETED|Overall Study||406
8530490|NCT00321373|21028946|P1|COMPLETED|Overall Study||405
8530491|NCT00321373|21028944|P3|STARTED|Overall Study||407
8530492|NCT00321373|21028945|P2|STARTED|Overall Study||406
8530493|NCT00321373|21028946|P1|STARTED|Overall Study||407
8530494|NCT00321321|21028969|P1|NOT COMPLETED|Overall Study||0
8530495|NCT00321321|21028969|P1|COMPLETED|Overall Study||12
8530496|NCT00321321|21028969|P1|STARTED|Overall Study||12
8530497|NCT00321269|21028975|P2|NOT COMPLETED|Overall Study||6
8530498|NCT00321269|21028976|P1|NOT COMPLETED|Overall Study||8
8530499|NCT00321269|21028975|P2|COMPLETED|Overall Study||68
8530500|NCT00321269|21028976|P1|COMPLETED|Overall Study||66
8530501|NCT00321269|21028975|P2|STARTED|Overall Study||74
8530502|NCT00321269|21028976|P1|STARTED|Overall Study||74
8530503|NCT00321048|21028986|P2|NOT COMPLETED|Overall Study||8
8530504|NCT00321048|21028987|P1|NOT COMPLETED|Overall Study||6
8530505|NCT00321048|21028986|P2|COMPLETED|Overall Study||21
8530506|NCT00321048|21028987|P1|COMPLETED|Overall Study||22
8530507|NCT00321048|21028986|P2|STARTED|Overall Study||29
8530508|NCT00321048|21028987|P1|STARTED|Overall Study||28
8530509|NCT00320801|21028995|P4|NOT COMPLETED|Extension Phase||48
8530510|NCT00320801|21028996|P3|NOT COMPLETED|Extension Phase||0
8530511|NCT00320801|21028997|P2|NOT COMPLETED|Extension Phase||0
8530512|NCT00320801|21028998|P1|NOT COMPLETED|Extension Phase||0
8530513|NCT00320801|21028995|P4|COMPLETED|Extension Phase||7
8530514|NCT00320801|21028996|P3|COMPLETED|Extension Phase||0
8530515|NCT00320801|21028997|P2|COMPLETED|Extension Phase||0
8530516|NCT00320801|21028998|P1|COMPLETED|Extension Phase||0
8530517|NCT00320801|21028995|P4|STARTED|Extension Phase||55
8530518|NCT00320801|21028996|P3|STARTED|Extension Phase||0
8530519|NCT00320801|21028997|P2|STARTED|Extension Phase||0
8530520|NCT00320801|21028998|P1|STARTED|Extension Phase||0
8530521|NCT00320801|21028995|P4|NOT COMPLETED|Double-blind Phase||0
8530522|NCT00320801|21028996|P3|NOT COMPLETED|Double-blind Phase||14
8530523|NCT00320801|21028997|P2|NOT COMPLETED|Double-blind Phase||11
8530524|NCT00320801|21028998|P1|NOT COMPLETED|Double-blind Phase||0
8530525|NCT00320801|21028995|P4|COMPLETED|Double-blind Phase||0
8530526|NCT00320801|21028996|P3|COMPLETED|Double-blind Phase||35
8530527|NCT00320801|21028997|P2|COMPLETED|Double-blind Phase||36
8530528|NCT00320801|21028998|P1|COMPLETED|Double-blind Phase||0
8530529|NCT00320801|21028995|P4|STARTED|Double-blind Phase||0
8530530|NCT00320801|21028996|P3|STARTED|Double-blind Phase||49
8530531|NCT00320801|21028997|P2|STARTED|Double-blind Phase||47
8530532|NCT00320801|21028998|P1|STARTED|Double-blind Phase||0
8530533|NCT00320801|21028995|P4|NOT COMPLETED|Open-label Run-in Period||0
8530534|NCT00320801|21028996|P3|NOT COMPLETED|Open-label Run-in Period||0
8530535|NCT00320801|21028997|P2|NOT COMPLETED|Open-label Run-in Period||0
8530536|NCT00320801|21028998|P1|NOT COMPLETED|Open-label Run-in Period||92
8530537|NCT00320801|21028995|P4|COMPLETED|Open-label Run-in Period||0
8530538|NCT00320801|21028996|P3|COMPLETED|Open-label Run-in Period||0
8530539|NCT00320801|21028997|P2|COMPLETED|Open-label Run-in Period||0
8530540|NCT00320801|21028998|P1|COMPLETED|Open-label Run-in Period||96
8530541|NCT00320801|21028995|P4|STARTED|Open-label Run-in Period||0
8530542|NCT00320801|21028996|P3|STARTED|Open-label Run-in Period||0
8530543|NCT00320801|21028997|P2|STARTED|Open-label Run-in Period||0
8530544|NCT00320801|21028998|P1|STARTED|Open-label Run-in Period||188
8530545|NCT00320788|21029013|P5|NOT COMPLETED|Overall Study||5
8530546|NCT00320788|21029014|P4|NOT COMPLETED|Overall Study||5
8530547|NCT00320788|21029015|P3|NOT COMPLETED|Overall Study||3
8530548|NCT00320788|21029016|P2|NOT COMPLETED|Overall Study||6
8530549|NCT00320788|21029017|P1|NOT COMPLETED|Overall Study||6
8530550|NCT00320788|21029013|P5|COMPLETED|Overall Study||26
8530551|NCT00320788|21029014|P4|COMPLETED|Overall Study||27
8530552|NCT00320788|21029015|P3|COMPLETED|Overall Study||29
8530553|NCT00320788|21029016|P2|COMPLETED|Overall Study||26
8530554|NCT00320788|21029017|P1|COMPLETED|Overall Study||26
8530555|NCT00320788|21029013|P5|Participants Received Treatment (SAF)|Overall Study||31
8530556|NCT00320788|21029014|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
8530557|NCT00320788|21029015|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
8530558|NCT00320788|21029016|P2|Participants Received Treatment (SAF)|Overall Study||32
8530559|NCT00320788|21029017|P1|Participants Received Treatment (SAF)|Overall Study||32
8530560|NCT00320788|21029013|P5|STARTED|Overall Study||31
8530561|NCT00320788|21029014|P4|STARTED|Overall Study|Participants Randomized|32
8530562|NCT00320788|21029015|P3|STARTED|Overall Study||32
8530563|NCT00320788|21029016|P2|STARTED|Overall Study||32
8530564|NCT00320788|21029017|P1|STARTED|Overall Study||32
8530565|NCT00320749|21029060|P3|NOT COMPLETED|Overall Study||9
8530566|NCT00320749|21029061|P2|NOT COMPLETED|Overall Study||2
8530567|NCT00320749|21029062|P1|NOT COMPLETED|Overall Study||0
8530568|NCT00320749|21029060|P3|COMPLETED|Overall Study||1
8530569|NCT00320749|21029061|P2|COMPLETED|Overall Study||6
8530570|NCT00320749|21029062|P1|COMPLETED|Overall Study||3
8530571|NCT00320749|21029060|P3|STARTED|Overall Study||10
8530572|NCT00320749|21029061|P2|STARTED|Overall Study||8
8530573|NCT00320749|21029062|P1|STARTED|Overall Study||3
8530574|NCT00320710|21029071|P3|NOT COMPLETED|Overall Study||5
8530575|NCT00320710|21029072|P2|NOT COMPLETED|Overall Study||76
8530576|NCT00320710|21029073|P1|NOT COMPLETED|Overall Study||94
8530577|NCT00320710|21029071|P3|COMPLETED|Overall Study||8
8530578|NCT00320710|21029072|P2|COMPLETED|Overall Study||127
8530579|NCT00320710|21029073|P1|COMPLETED|Overall Study||106
8530580|NCT00320710|21029071|P3|Treated (Safety Set)|Overall Study||13
8530581|NCT00320710|21029072|P2|Treated (Safety Set)|Overall Study||202
8530582|NCT00320710|21029073|P1|Treated (Safety Set)|Overall Study||198
8530583|NCT00320710|21029071|P3|STARTED|Overall Study||13
8530584|NCT00320710|21029072|P2|STARTED|Overall Study||203
8530585|NCT00320710|21029073|P1|STARTED|Overall Study||200
8530586|NCT00320671|21029096|P2|NOT COMPLETED|Overall Study||38
8530587|NCT00320671|21029097|P1|NOT COMPLETED|Overall Study||33
8530588|NCT00320671|21029096|P2|COMPLETED|Overall Study||58
8530589|NCT00320671|21029097|P1|COMPLETED|Overall Study||69
8530590|NCT00320671|21029096|P2|STARTED|Overall Study||96
8530591|NCT00320671|21029097|P1|STARTED|Overall Study||102
8530592|NCT00320606|21029103|P1|NOT COMPLETED|Overall Study||3
8530593|NCT00320606|21029103|P1|COMPLETED|Overall Study||17
8530594|NCT00320606|21029103|P1|STARTED|Overall Study||20
8530595|NCT00320593|21029119|P2|NOT COMPLETED|Overall Study||1
8530596|NCT00320593|21029120|P1|NOT COMPLETED|Overall Study||7
8530597|NCT00320593|21029119|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
8530598|NCT00320593|21029120|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
8530599|NCT00320593|21029119|P2|STARTED|Overall Study||59
8530600|NCT00320593|21029120|P1|STARTED|Overall Study||59
8530601|NCT00320541|21029144|P2|NOT COMPLETED|Overall Study||57
8530602|NCT00320541|21029145|P1|NOT COMPLETED|Overall Study||50
8530603|NCT00320541|21029144|P2|COMPLETED|Overall Study||36
8530604|NCT00320541|21029145|P1|COMPLETED|Overall Study||44
8530605|NCT00320541|21029144|P2|STARTED|Overall Study||93
8530606|NCT00320541|21029145|P1|STARTED|Overall Study||94
8530607|NCT00320528|21029172|P3|NOT COMPLETED|Study Period III||106
8530608|NCT00320528|21029173|P2|NOT COMPLETED|Study Period III||31
8530609|NCT00320528|21029174|P1|NOT COMPLETED|Study Period III||87
8530610|NCT00320528|21029172|P3|COMPLETED|Study Period III||2
8530611|NCT00320528|21029173|P2|COMPLETED|Study Period III||0
8530612|NCT00320528|21029174|P1|COMPLETED|Study Period III||0
8530613|NCT00320528|21029172|P3|STARTED|Study Period III||108
8530614|NCT00320528|21029173|P2|STARTED|Study Period III||31
8530615|NCT00320528|21029174|P1|STARTED|Study Period III||87
8530616|NCT00320528|21029172|P3|NOT COMPLETED|Study Period II||22
8530617|NCT00320528|21029173|P2|NOT COMPLETED|Study Period II||10
8530618|NCT00320528|21029174|P1|NOT COMPLETED|Study Period II||11
8530619|NCT00320528|21029172|P3|COMPLETED|Study Period II||108
8530620|NCT00320528|21029173|P2|COMPLETED|Study Period II||31
8530621|NCT00320528|21029174|P1|COMPLETED|Study Period II||87
8530622|NCT00320528|21029172|P3|Received at Least One Dose of Study Drug|Study Period II||128
8530623|NCT00320528|21029173|P2|Received at Least One Dose of Study Drug|Study Period II||38
8530624|NCT00320528|21029174|P1|Received at Least One Dose of Study Drug|Study Period II||97
8530625|NCT00320528|21029172|P3|STARTED|Study Period II||130
8530626|NCT00320528|21029173|P2|STARTED|Study Period II||41
8530627|NCT00320528|21029174|P1|STARTED|Study Period II||98
8530628|NCT00320515|21029209|P1|NOT COMPLETED|Overall Study||49
8530629|NCT00320515|21029209|P1|COMPLETED|Overall Study||20
8530630|NCT00320515|21029209|P1|STARTED|Overall Study||69
8530631|NCT00320489|21029218|P2|NOT COMPLETED|Overall Study||136
8530632|NCT00320489|21029219|P1|NOT COMPLETED|Overall Study||145
8530633|NCT00320489|21029218|P2|COMPLETED|Overall Study||124
8530634|NCT00320489|21029219|P1|COMPLETED|Overall Study||119
8530635|NCT00320489|21029218|P2|STARTED|Overall Study||260
8530636|NCT00320489|21029219|P1|STARTED|Overall Study||264
8530637|NCT00320424|21029275|P1|NOT COMPLETED|Overall Study||6
8530638|NCT00320424|21029275|P1|COMPLETED|Overall Study||42
8530639|NCT00320424|21029275|P1|STARTED|Overall Study||48
8530640|NCT00320411|21029289|P1|NOT COMPLETED|Overall Study||4
8530641|NCT00320411|21029289|P1|COMPLETED|Overall Study||58
8530642|NCT00320411|21029289|P1|STARTED|Overall Study||62
8530643|NCT00320398|21029312|P2|NOT COMPLETED|Overall Study||4
8530644|NCT00320398|21029313|P1|NOT COMPLETED|Overall Study||2
8530645|NCT00320398|21029312|P2|COMPLETED|Overall Study||52
8530646|NCT00320398|21029313|P1|COMPLETED|Overall Study||56
8530647|NCT00320398|21029312|P2|STARTED|Overall Study||56
8530648|NCT00320398|21029313|P1|STARTED|Overall Study||58
8530649|NCT00320385|21029341|P2|NOT COMPLETED|Overall Study||22
8530650|NCT00320385|21029342|P1|NOT COMPLETED|Overall Study||18
8530651|NCT00320385|21029341|P2|COMPLETED|Overall Study||126
8530652|NCT00320385|21029342|P1|COMPLETED|Overall Study||130
8530653|NCT00320385|21029341|P2|STARTED|Overall Study||148
8530654|NCT00320385|21029342|P1|STARTED|Overall Study||148
8530655|NCT00320372|21029365|P2|NOT COMPLETED|Overall Study||163
8530656|NCT00320372|21029366|P1|NOT COMPLETED|Overall Study||195
8530657|NCT00320372|21029365|P2|COMPLETED|Overall Study||138
8530658|NCT00320372|21029366|P1|COMPLETED|Overall Study||299
8530659|NCT00320372|21029365|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
8530660|NCT00320372|21029366|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
8530661|NCT00320372|21029365|P2|VNS Therapy D-23 Original|Overall Study||0
8530662|NCT00320372|21029366|P1|VNS Therapy D-23 Original|Overall Study||335
8530663|NCT00320372|21029365|P2|STARTED|Overall Study||301
8530664|NCT00320372|21029366|P1|STARTED|Overall Study||494
8530665|NCT00320281|21029393|P2|NOT COMPLETED|Overall Study||0
8530666|NCT00320281|21029394|P1|NOT COMPLETED|Overall Study||0
8530667|NCT00320281|21029393|P2|COMPLETED|Overall Study||9
8530668|NCT00320281|21029394|P1|COMPLETED|Overall Study||10
8530669|NCT00320281|21029393|P2|STARTED|Overall Study||9
8530670|NCT00320281|21029394|P1|STARTED|Overall Study||10
8530671|NCT00320255|21029408|P6|NOT COMPLETED|Overall Study||0
8530672|NCT00320255|21029409|P5|NOT COMPLETED|Overall Study||0
8530673|NCT00320255|21029410|P4|NOT COMPLETED|Overall Study||8
8530674|NCT00320255|21029411|P3|NOT COMPLETED|Overall Study||6
8530675|NCT00320255|21029412|P2|NOT COMPLETED|Overall Study||7
8530676|NCT00320255|21029413|P1|NOT COMPLETED|Overall Study||11
8530677|NCT00320255|21029408|P6|COMPLETED|Overall Study||3
8530678|NCT00320255|21029409|P5|COMPLETED|Overall Study||2
8530679|NCT00320255|21029410|P4|COMPLETED|Overall Study||25
8530680|NCT00320255|21029411|P3|COMPLETED|Overall Study||24
8530681|NCT00320255|21029412|P2|COMPLETED|Overall Study||25
8530682|NCT00320255|21029413|P1|COMPLETED|Overall Study||19
8530683|NCT00320255|21029408|P6|Received Treatment|Overall Study||3
8530684|NCT00320255|21029409|P5|Received Treatment|Overall Study||2
8530685|NCT00320255|21029410|P4|Received Treatment|Overall Study||32
8530686|NCT00320255|21029411|P3|Received Treatment|Overall Study||29
8530687|NCT00320255|21029412|P2|Received Treatment|Overall Study||32
8530688|NCT00320255|21029413|P1|Received Treatment|Overall Study||29
8530689|NCT00320255|21029408|P6|STARTED|Overall Study||3
8530690|NCT00320255|21029409|P5|STARTED|Overall Study||2
8530691|NCT00320255|21029410|P4|STARTED|Overall Study||33
8530692|NCT00320255|21029411|P3|STARTED|Overall Study||30
8530693|NCT00320255|21029412|P2|STARTED|Overall Study||32
8530694|NCT00320255|21029413|P1|STARTED|Overall Study||30
8530695|NCT00320242|21029493|P2|NOT COMPLETED|Overall Study||4
8530696|NCT00320242|21029494|P1|NOT COMPLETED|Overall Study||2
8530697|NCT00320242|21029493|P2|COMPLETED|Overall Study||12
8530698|NCT00320242|21029494|P1|COMPLETED|Overall Study||14
8530699|NCT00320242|21029493|P2|STARTED|Overall Study||16
8530700|NCT00320242|21029494|P1|STARTED|Overall Study||16
8530701|NCT00320216|21029506|P5|NOT COMPLETED|Overall Study||6
8530702|NCT00320216|21029507|P4|NOT COMPLETED|Overall Study||3
8530703|NCT00320216|21029508|P3|NOT COMPLETED|Overall Study||6
8530704|NCT00320216|21029509|P2|NOT COMPLETED|Overall Study||10
8530705|NCT00320216|21029510|P1|NOT COMPLETED|Overall Study||16
8530706|NCT00320216|21029506|P5|COMPLETED|Overall Study||58
8530707|NCT00320216|21029507|P4|COMPLETED|Overall Study||61
8530708|NCT00320216|21029508|P3|COMPLETED|Overall Study||58
8530709|NCT00320216|21029509|P2|COMPLETED|Overall Study||54
8530710|NCT00320216|21029510|P1|COMPLETED|Overall Study||48
8530711|NCT00320216|21029506|P5|STARTED|Overall Study||64
8530712|NCT00320216|21029507|P4|STARTED|Overall Study||64
8530713|NCT00320216|21029508|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
8530714|NCT00320216|21029509|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
8530715|NCT00320216|21029510|P1|STARTED|Overall Study||64
8530716|NCT00320190|21029544|P2|NOT COMPLETED|Long-term (12-month) Extension||2
8530717|NCT00320190|21029545|P1|NOT COMPLETED|Long-term (12-month) Extension||9
8530718|NCT00320190|21029544|P2|COMPLETED|Long-term (12-month) Extension||1
8530719|NCT00320190|21029545|P1|COMPLETED|Long-term (12-month) Extension||2
8530720|NCT00320190|21029544|P2|STARTED|Long-term (12-month) Extension||3
8530721|NCT00320190|21029545|P1|STARTED|Long-term (12-month) Extension||11
8530722|NCT00320190|21029544|P2|NOT COMPLETED|First 12 Months||10
8530723|NCT00320190|21029545|P1|NOT COMPLETED|First 12 Months||8
8530724|NCT00320190|21029544|P2|COMPLETED|First 12 Months||3
8530725|NCT00320190|21029545|P1|COMPLETED|First 12 Months||11
8530726|NCT00320190|21029544|P2|STARTED|First 12 Months||13
8530727|NCT00320190|21029545|P1|STARTED|First 12 Months||19
8530728|NCT00320112|21029565|P2|NOT COMPLETED|Overall Study||5
8530729|NCT00320112|21029566|P1|NOT COMPLETED|Overall Study||8
8530730|NCT00320112|21029565|P2|COMPLETED|Overall Study||114
8530731|NCT00320112|21029566|P1|COMPLETED|Overall Study||117
8530732|NCT00320112|21029565|P2|STARTED|Overall Study||119
8530733|NCT00320112|21029566|P1|STARTED|Overall Study||125
8530734|NCT00319982|21029580|P2|NOT COMPLETED|Overall Study||0
8530735|NCT00319982|21029581|P1|NOT COMPLETED|Overall Study||1
8530736|NCT00319982|21029580|P2|COMPLETED|Overall Study||20
8530737|NCT00319982|21029581|P1|COMPLETED|Overall Study||18
8530738|NCT00319982|21029580|P2|STARTED|Overall Study||20
8530739|NCT00319982|21029581|P1|STARTED|Overall Study||19
8530740|NCT00319956|21029601|P2|NOT COMPLETED|Overall Study||24
8530741|NCT00319956|21029602|P1|NOT COMPLETED|Overall Study||20
8530742|NCT00319956|21029601|P2|COMPLETED|Overall Study||85
8530743|NCT00319956|21029602|P1|COMPLETED|Overall Study||91
8530744|NCT00319956|21029601|P2|STARTED|Overall Study||109
8530745|NCT00319956|21029602|P1|STARTED|Overall Study||111
8530746|NCT00319839|21029614|P1|NOT COMPLETED|Overall Study||6
8530747|NCT00319839|21029614|P1|COMPLETED|Overall Study||1
8530748|NCT00319839|21029614|P1|STARTED|Overall Study||7
8530749|NCT00319748|21029620|P1|NOT COMPLETED|Overall Study||0
8530750|NCT00319748|21029620|P1|COMPLETED|Overall Study||13
8530751|NCT00319748|21029620|P1|STARTED|Overall Study||13
8530752|NCT00319735|21029630|P1|NOT COMPLETED|Overall Study||2
8530753|NCT00319735|21029630|P1|COMPLETED|Overall Study||39
8530754|NCT00319735|21029630|P1|STARTED|Overall Study||41
8530755|NCT00319696|21029643|P1|NOT COMPLETED|Overall Study||60
8530756|NCT00319696|21029643|P1|COMPLETED|Overall Study||56
8530757|NCT00319696|21029643|P1|STARTED|Overall Study||116
8530758|NCT00319644|21029669|P2|NOT COMPLETED|Overall Study||0
8530759|NCT00319644|21029670|P1|NOT COMPLETED|Overall Study||0
8530760|NCT00319644|21029669|P2|COMPLETED|Overall Study||16
8530761|NCT00319644|21029670|P1|COMPLETED|Overall Study||21
8530762|NCT00319644|21029669|P2|STARTED|Overall Study||16
8530763|NCT00319644|21029670|P1|STARTED|Overall Study||21
8530764|NCT00319592|21029680|P2|NOT COMPLETED|Overall Study||1
8530765|NCT00319592|21029681|P1|NOT COMPLETED|Overall Study||1
8530766|NCT00319592|21029680|P2|COMPLETED|Overall Study||29
8530767|NCT00319592|21029681|P1|COMPLETED|Overall Study||29
8530768|NCT00319592|21029680|P2|STARTED|Overall Study||30
8530769|NCT00319592|21029681|P1|STARTED|Overall Study||30
8530770|NCT00319553|21029697|P2|NOT COMPLETED|Overall Study||4
8530771|NCT00319553|21029698|P1|NOT COMPLETED|Overall Study||4
8530772|NCT00319553|21029697|P2|COMPLETED|Overall Study||317
8530773|NCT00319553|21029698|P1|COMPLETED|Overall Study||319
8530774|NCT00319553|21029697|P2|STARTED|Overall Study||321
8530775|NCT00319553|21029698|P1|STARTED|Overall Study||323
8530776|NCT00319501|21029712|P2|NOT COMPLETED|Open-label Extension Period||0
8530777|NCT00319501|21029713|P1|NOT COMPLETED|Open-label Extension Period||51
8530778|NCT00319501|21029712|P2|COMPLETED|Open-label Extension Period||0
8530779|NCT00319501|21029713|P1|COMPLETED|Open-label Extension Period||0
8530780|NCT00319501|21029712|P2|Received Treatment|Open-label Extension Period||0
8530781|NCT00319501|21029713|P1|Received Treatment|Open-label Extension Period||33
8530782|NCT00319501|21029712|P2|STARTED|Open-label Extension Period||0
8530783|NCT00319501|21029713|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
8530784|NCT00319501|21029712|P2|NOT COMPLETED|Open-label Period||0
8530785|NCT00319501|21029713|P1|NOT COMPLETED|Open-label Period||116
8530786|NCT00319501|21029712|P2|COMPLETED|Open-label Period||0
8530787|NCT00319501|21029713|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
8530788|NCT00319501|21029712|P2|Received Treatment|Open-label Period||0
8530789|NCT00319501|21029713|P1|Received Treatment|Open-label Period||128
8530790|NCT00319501|21029712|P2|STARTED|Open-label Period||0
8530791|NCT00319501|21029713|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
8530792|NCT00319501|21029712|P2|NOT COMPLETED|Double-blind Period||32
8530793|NCT00319501|21029713|P1|NOT COMPLETED|Double-blind Period||43
8530794|NCT00319501|21029712|P2|COMPLETED|Double-blind Period||78
8530795|NCT00319501|21029713|P1|COMPLETED|Double-blind Period||81
8530796|NCT00319501|21029712|P2|Received Treatment|Double-blind Period||81
8530797|NCT00319501|21029713|P1|Received Treatment|Double-blind Period||82
8530798|NCT00319501|21029712|P2|STARTED|Double-blind Period|Randomized participants|110
8530799|NCT00319501|21029713|P1|STARTED|Double-blind Period|Randomized participants|124
8530800|NCT00319449|21029739|P2|NOT COMPLETED|Overall Study||0
8530801|NCT00319449|21029740|P1|NOT COMPLETED|Overall Study||2
8530802|NCT00319449|21029739|P2|COMPLETED|Overall Study||12
8530803|NCT00319449|21029740|P1|COMPLETED|Overall Study||8
8530804|NCT00319449|21029739|P2|STARTED|Overall Study||12
8530805|NCT00319449|21029740|P1|STARTED|Overall Study||10
8530806|NCT00319436|21029752|P2|NOT COMPLETED|Overall Study||7
8530807|NCT00319436|21029753|P1|NOT COMPLETED|Overall Study||6
8530808|NCT00319436|21029752|P2|COMPLETED|Overall Study||17
8530809|NCT00319436|21029753|P1|COMPLETED|Overall Study||17
8530810|NCT00319436|21029752|P2|STARTED|Overall Study||24
8530811|NCT00319436|21029753|P1|STARTED|Overall Study||23
8530812|NCT00319254|21029771|P1|NOT COMPLETED|Overall Study||54
8530813|NCT00319254|21029771|P1|COMPLETED|Overall Study||21
8530814|NCT00319254|21029771|P1|Treated|Overall Study||73
8530815|NCT00319254|21029771|P1|STARTED|Overall Study||75
8530816|NCT00319111|21029784|P1|NOT COMPLETED|Overall Study||47
8530817|NCT00319111|21029784|P1|COMPLETED|Overall Study||104
8530818|NCT00319111|21029784|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
8530819|NCT00319098|21029798|P2|NOT COMPLETED|Overall Study||32
8530820|NCT00319098|21029799|P1|NOT COMPLETED|Overall Study||135
8530821|NCT00319098|21029798|P2|COMPLETED|Overall Study||1237
8530822|NCT00319098|21029799|P1|COMPLETED|Overall Study||3667
8530823|NCT00319098|21029798|P2|STARTED|Overall Study||1269
8530824|NCT00319098|21029799|P1|STARTED|Overall Study||3802
8530825|NCT00319046|21029857|P1|NOT COMPLETED|Overall Study||8
8530826|NCT00319046|21029857|P1|COMPLETED|Overall Study||34
8530827|NCT00319046|21029857|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
8530828|NCT00319020|21029866|P2|NOT COMPLETED|Overall Study||13
8530829|NCT00319020|21029867|P1|NOT COMPLETED|Overall Study||7
8530830|NCT00319020|21029866|P2|COMPLETED|Overall Study||8
8530831|NCT00319020|21029867|P1|COMPLETED|Overall Study||8
8530832|NCT00319020|21029866|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
8530833|NCT00319020|21029867|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
8530834|NCT00319020|21029866|P2|STARTED|Overall Study||21
8530835|NCT00319020|21029867|P1|STARTED|Overall Study||15
8530836|NCT00318929|21029896|P1|NOT COMPLETED|Overall Study||0
8530837|NCT00318929|21029896|P1|COMPLETED|Overall Study||14
8530838|NCT00318929|21029896|P1|STARTED|Overall Study||14
8530839|NCT00318812|21029905|P2|NOT COMPLETED|Overall Study||0
8530840|NCT00318812|21029906|P1|NOT COMPLETED|Overall Study||0
8530841|NCT00318812|21029905|P2|COMPLETED|Overall Study||22
8530842|NCT00318812|21029906|P1|COMPLETED|Overall Study||18
8530843|NCT00318812|21029905|P2|STARTED|Overall Study||22
8530844|NCT00318812|21029906|P1|STARTED|Overall Study||18
8530845|NCT00318708|21029918|P2|NOT COMPLETED|Overall Study||5
8530846|NCT00318708|21029919|P1|NOT COMPLETED|Overall Study||8
8530847|NCT00318708|21029918|P2|COMPLETED|Overall Study||40
8530848|NCT00318708|21029919|P1|COMPLETED|Overall Study||39
8530849|NCT00318708|21029918|P2|8-week Milestone|Overall Study||42
8530850|NCT00318708|21029919|P1|8-week Milestone|Overall Study||42
8530851|NCT00318708|21029918|P2|STARTED|Overall Study||45
8530852|NCT00318708|21029919|P1|STARTED|Overall Study||47
8530853|NCT00318656|21029939|P2|NOT COMPLETED|Overall Study||2
8530854|NCT00318656|21029940|P1|NOT COMPLETED|Overall Study||0
8530855|NCT00318656|21029939|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
8530856|NCT00318656|21029940|P1|COMPLETED|Overall Study||12
8530857|NCT00318656|21029939|P2|STARTED|Overall Study||11
8530858|NCT00318656|21029940|P1|STARTED|Overall Study||12
8530865|NCT00318565|21029997|P1|NOT COMPLETED|Overall Study||24
8530866|NCT00318565|21029997|P1|COMPLETED|Overall Study||267
8530867|NCT00318565|21029997|P1|STARTED|Overall Study||291
8530868|NCT00318474|21030004|P2|NOT COMPLETED|Overall Study||17
8530869|NCT00318474|21030005|P1|NOT COMPLETED|Overall Study||18
8530870|NCT00318474|21030004|P2|COMPLETED|Overall Study||10
8530871|NCT00318474|21030005|P1|COMPLETED|Overall Study||7
8530872|NCT00318474|21030004|P2|STARTED|Overall Study||27
8530873|NCT00318474|21030005|P1|STARTED|Overall Study||25
8530874|NCT00318461|21030016|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
8530875|NCT00318461|21030017|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
8530876|NCT00318461|21030018|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
8530877|NCT00318461|21030019|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
8530878|NCT00318461|21030020|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
8530879|NCT00318461|21030016|P5|COMPLETED|Open-Label Extension, 18 Months||113
8530880|NCT00318461|21030017|P4|COMPLETED|Open-Label Extension, 18 Months||31
8530881|NCT00318461|21030018|P3|COMPLETED|Open-Label Extension, 18 Months||118
8530882|NCT00318461|21030019|P2|COMPLETED|Open-Label Extension, 18 Months||137
8530883|NCT00318461|21030020|P1|COMPLETED|Open-Label Extension, 18 Months||130
8530884|NCT00318461|21030016|P5|STARTED|Open-Label Extension, 18 Months||210
8530885|NCT00318461|21030017|P4|STARTED|Open-Label Extension, 18 Months||74
8530886|NCT00318461|21030018|P3|STARTED|Open-Label Extension, 18 Months||191
8530887|NCT00318461|21030019|P2|STARTED|Open-Label Extension, 18 Months||197
8530888|NCT00318461|21030020|P1|STARTED|Open-Label Extension, 18 Months||208
8530889|NCT00318461|21030016|P5|NOT COMPLETED|Double-Blind, 6 Months||34
8530890|NCT00318461|21030017|P4|NOT COMPLETED|Double-Blind, 6 Months||48
8530891|NCT00318461|21030018|P3|NOT COMPLETED|Double-Blind, 6 Months||51
8530892|NCT00318461|21030019|P2|NOT COMPLETED|Double-Blind, 6 Months||44
8530893|NCT00318461|21030020|P1|NOT COMPLETED|Double-Blind, 6 Months||34
8530894|NCT00318461|21030016|P5|COMPLETED|Double-Blind, 6 Months||210
8530895|NCT00318461|21030017|P4|COMPLETED|Double-Blind, 6 Months||74
8530896|NCT00318461|21030018|P3|COMPLETED|Double-Blind, 6 Months||191
8530897|NCT00318461|21030019|P2|COMPLETED|Double-Blind, 6 Months||197
8530898|NCT00318461|21030020|P1|COMPLETED|Double-Blind, 6 Months||208
8530899|NCT00318461|21030016|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
8530900|NCT00318461|21030017|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
8530901|NCT00318461|21030018|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
8530902|NCT00318461|21030019|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
8530903|NCT00318461|21030020|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
8530904|NCT00318461|21030016|P5|STARTED|Double-Blind, 6 Months|Randomised|244
8530905|NCT00318461|21030017|P4|STARTED|Double-Blind, 6 Months|Randomised|122
8530906|NCT00318461|21030018|P3|STARTED|Double-Blind, 6 Months|Randomised|242
8530907|NCT00318461|21030019|P2|STARTED|Double-Blind, 6 Months|Randomised|241
8530908|NCT00318461|21030020|P1|STARTED|Double-Blind, 6 Months|Randomised|242
8530909|NCT00318409|21030099|P2|NOT COMPLETED|Overall Study||1
8530910|NCT00318409|21030100|P1|NOT COMPLETED|Overall Study||2
8530911|NCT00318409|21030099|P2|COMPLETED|Overall Study||9
8530912|NCT00318409|21030100|P1|COMPLETED|Overall Study||18
8530913|NCT00318409|21030099|P2|STARTED|Overall Study||10
8530914|NCT00318409|21030100|P1|STARTED|Overall Study||20
8530915|NCT00318370|21030119|P3|NOT COMPLETED|Period 3||33
8530916|NCT00318370|21030120|P2|NOT COMPLETED|Period 3||0
8530917|NCT00318370|21030121|P1|NOT COMPLETED|Period 3||0
8530918|NCT00318370|21030119|P3|COMPLETED|Period 3||3
8530919|NCT00318370|21030120|P2|COMPLETED|Period 3||0
8530920|NCT00318370|21030121|P1|COMPLETED|Period 3||0
8530921|NCT00318370|21030119|P3|STARTED|Period 3||36
8530922|NCT00318370|21030120|P2|STARTED|Period 3||0
8530923|NCT00318370|21030121|P1|STARTED|Period 3||0
8530924|NCT00318370|21030119|P3|NOT COMPLETED|Period 2||0
8530925|NCT00318370|21030120|P2|NOT COMPLETED|Period 2||11
8530926|NCT00318370|21030121|P1|NOT COMPLETED|Period 2||0
8530927|NCT00318370|21030119|P3|COMPLETED|Period 2||0
8530928|NCT00318370|21030120|P2|COMPLETED|Period 2||36
8530929|NCT00318370|21030121|P1|COMPLETED|Period 2||0
8530930|NCT00318370|21030119|P3|STARTED|Period 2||0
8530931|NCT00318370|21030120|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
8530932|NCT00318370|21030121|P1|STARTED|Period 2||0
8530933|NCT00318370|21030119|P3|NOT COMPLETED|Period 1||0
8530934|NCT00318370|21030120|P2|NOT COMPLETED|Period 1||0
8530935|NCT00318370|21030121|P1|NOT COMPLETED|Period 1||7
8530936|NCT00318370|21030119|P3|COMPLETED|Period 1||0
8530937|NCT00318370|21030120|P2|COMPLETED|Period 1||0
8530938|NCT00318370|21030121|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
8530939|NCT00318370|21030119|P3|STARTED|Period 1||0
8530940|NCT00318370|21030120|P2|STARTED|Period 1||0
8530941|NCT00318370|21030121|P1|STARTED|Period 1||28
8530942|NCT00318357|21030133|P2|NOT COMPLETED|Overall Study||32
8530943|NCT00318357|21030134|P1|NOT COMPLETED|Overall Study||39
8530944|NCT00318357|21030133|P2|COMPLETED|Overall Study||104
8530945|NCT00318357|21030134|P1|COMPLETED|Overall Study||134
8530946|NCT00318357|21030133|P2|STARTED|Overall Study||136
8530947|NCT00318357|21030134|P1|STARTED|Overall Study||173
8530948|NCT00318292|21030142|P2|NOT COMPLETED|Overall Study||0
8530949|NCT00318292|21030143|P1|NOT COMPLETED|Overall Study||0
8530950|NCT00318292|21030142|P2|COMPLETED|Overall Study||45
8530951|NCT00318292|21030143|P1|COMPLETED|Overall Study||45
8530952|NCT00318292|21030142|P2|STARTED|Overall Study||45
8530953|NCT00318292|21030143|P1|STARTED|Overall Study||45
8530954|NCT00318149|21030155|P6|NOT COMPLETED|Overall Study||2
8530955|NCT00318149|21030156|P5|NOT COMPLETED|Overall Study||0
8530956|NCT00318149|21030157|P4|NOT COMPLETED|Overall Study||0
8530957|NCT00318149|21030158|P3|NOT COMPLETED|Overall Study||0
8530958|NCT00318149|21030159|P2|NOT COMPLETED|Overall Study||0
8530959|NCT00318149|21030160|P1|NOT COMPLETED|Overall Study||0
8530960|NCT00318149|21030155|P6|COMPLETED|Overall Study||73
8530961|NCT00318149|21030156|P5|COMPLETED|Overall Study||75
8530962|NCT00318149|21030157|P4|COMPLETED|Overall Study||75
8530963|NCT00318149|21030158|P3|COMPLETED|Overall Study||75
8530964|NCT00318149|21030159|P2|COMPLETED|Overall Study||50
8530965|NCT00318149|21030160|P1|COMPLETED|Overall Study||75
8530966|NCT00318149|21030155|P6|STARTED|Overall Study||75
8530967|NCT00318149|21030156|P5|STARTED|Overall Study||75
8530968|NCT00318149|21030157|P4|STARTED|Overall Study||75
8530969|NCT00318149|21030158|P3|STARTED|Overall Study||75
8530970|NCT00318149|21030159|P2|STARTED|Overall Study||50
8530971|NCT00318149|21030160|P1|STARTED|Overall Study||75
8530972|NCT00318136|21030246|P1|NOT COMPLETED|Overall Study||45
8530973|NCT00318136|21030246|P1|COMPLETED|Overall Study||2
8530974|NCT00318136|21030246|P1|STARTED|Overall Study||47
8530975|NCT00317941|21030255|P3|NOT COMPLETED|Overall Study||8
8530976|NCT00317941|21030256|P2|NOT COMPLETED|Overall Study||5
8530977|NCT00317941|21030257|P1|NOT COMPLETED|Overall Study||7
8530978|NCT00317941|21030255|P3|COMPLETED|Overall Study||60
8530979|NCT00317941|21030256|P2|COMPLETED|Overall Study||74
8530980|NCT00317941|21030257|P1|COMPLETED|Overall Study||66
8530981|NCT00317941|21030255|P3|Fulfilled Requirements PP Population|Overall Study||63
8530982|NCT00317941|21030256|P2|Fulfilled Requirements PP Population|Overall Study||76
8530983|NCT00317941|21030257|P1|Fulfilled Requirements PP Population|Overall Study||66
8530984|NCT00317941|21030255|P3|Fulfilled Requirement Safety Population|Overall Study||65
8530985|NCT00317941|21030256|P2|Fulfilled Requirement Safety Population|Overall Study||77
8530986|NCT00317941|21030257|P1|Fulfilled Requirement Safety Population|Overall Study||73
8530987|NCT00317941|21030255|P3|Participants Received Treatment|Overall Study||68
8530988|NCT00317941|21030256|P2|Participants Received Treatment|Overall Study||79
8530989|NCT00317941|21030257|P1|Participants Received Treatment|Overall Study||73
8530990|NCT00317941|21030255|P3|STARTED|Overall Study||68
8530991|NCT00317941|21030256|P2|STARTED|Overall Study||79
8530992|NCT00317941|21030257|P1|STARTED|Overall Study||73
8530993|NCT00317720|21030298|P2|NOT COMPLETED|Overall Study||0
8530994|NCT00317720|21030299|P1|NOT COMPLETED|Overall Study||0
8530995|NCT00317720|21030298|P2|COMPLETED|Overall Study||7
8530996|NCT00317720|21030299|P1|COMPLETED|Overall Study||40
8530997|NCT00317720|21030298|P2|STARTED|Overall Study||7
8530998|NCT00317720|21030299|P1|STARTED|Overall Study||40
8530999|NCT00317642|21030306|P2|NOT COMPLETED|Overall Study||135
8531000|NCT00317642|21030307|P1|NOT COMPLETED|Overall Study||122
8531001|NCT00317642|21030306|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
8531002|NCT00317642|21030307|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
8531003|NCT00317642|21030306|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
8531004|NCT00317642|21030307|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
8531005|NCT00317642|21030306|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
8531006|NCT00317642|21030307|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
8531007|NCT00317642|21030306|P2|STARTED|Overall Study||163
8531008|NCT00317642|21030307|P1|STARTED|Overall Study||163
8531009|NCT00317473|21030386|P6|NOT COMPLETED|Overall Study||3
8531010|NCT00317473|21030387|P5|NOT COMPLETED|Overall Study||8
8531011|NCT00317473|21030388|P4|NOT COMPLETED|Overall Study||2
8531012|NCT00317473|21030389|P3|NOT COMPLETED|Overall Study||3
8531013|NCT00317473|21030390|P2|NOT COMPLETED|Overall Study||3
8531014|NCT00317473|21030391|P1|NOT COMPLETED|Overall Study||4
8531015|NCT00317473|21030386|P6|COMPLETED|Overall Study||12
8531016|NCT00317473|21030387|P5|COMPLETED|Overall Study||22
8531017|NCT00317473|21030388|P4|COMPLETED|Overall Study||13
8531018|NCT00317473|21030389|P3|COMPLETED|Overall Study||27
8531019|NCT00317473|21030390|P2|COMPLETED|Overall Study||12
8531020|NCT00317473|21030391|P1|COMPLETED|Overall Study||26
8531021|NCT00317473|21030386|P6|STARTED|Overall Study||15
8531022|NCT00317473|21030387|P5|STARTED|Overall Study||30
8531023|NCT00317473|21030388|P4|STARTED|Overall Study||15
8531024|NCT00317473|21030389|P3|STARTED|Overall Study||30
8531025|NCT00317473|21030390|P2|STARTED|Overall Study||15
8531026|NCT00317473|21030391|P1|STARTED|Overall Study||30
8531027|NCT00317239|21030417|P2|NOT COMPLETED|Overall Study||19
8531028|NCT00317239|21030418|P1|NOT COMPLETED|Overall Study||13
8531029|NCT00317239|21030417|P2|COMPLETED|Overall Study||84
8531030|NCT00317239|21030418|P1|COMPLETED|Overall Study||134
8531031|NCT00317239|21030417|P2|STARTED|Overall Study||103
8531032|NCT00317239|21030418|P1|STARTED|Overall Study||147
8531033|NCT00317226|21030424|P1|NOT COMPLETED|Overall Study||23
8531034|NCT00317226|21030424|P1|COMPLETED|Overall Study||104
8531035|NCT00317226|21030424|P1|STARTED|Overall Study||127
8531036|NCT00317109|21030430|P2|NOT COMPLETED|Overall Study||0
8531037|NCT00317109|21030431|P1|NOT COMPLETED|Overall Study||3
8531038|NCT00317109|21030430|P2|COMPLETED|Overall Study||84
8531039|NCT00317109|21030431|P1|COMPLETED|Overall Study||81
8531040|NCT00317109|21030430|P2|STARTED|Overall Study||84
8531041|NCT00317109|21030431|P1|STARTED|Overall Study||84
8531042|NCT00317044|21030468|P3|NOT COMPLETED|Overall Study||45
8531043|NCT00317044|21030469|P2|NOT COMPLETED|Overall Study||40
8531044|NCT00317044|21030470|P1|NOT COMPLETED|Overall Study||48
8531045|NCT00317044|21030468|P3|COMPLETED|Overall Study||283
8531046|NCT00317044|21030469|P2|COMPLETED|Overall Study||273
8531047|NCT00317044|21030470|P1|COMPLETED|Overall Study||272
8531048|NCT00317044|21030468|P3|STARTED|Overall Study||328
8531049|NCT00317044|21030469|P2|STARTED|Overall Study||313
8531050|NCT00317044|21030470|P1|STARTED|Overall Study||320
8531051|NCT00316914|21030516|P2|NOT COMPLETED|Overall Study||36
8531052|NCT00316914|21030517|P1|NOT COMPLETED|Overall Study||33
8531053|NCT00316914|21030516|P2|COMPLETED|Overall Study||16
8531054|NCT00316914|21030517|P1|COMPLETED|Overall Study||17
8531055|NCT00316914|21030516|P2|STARTED|Overall Study||52
8531056|NCT00316914|21030517|P1|STARTED|Overall Study||50
8531057|NCT00316888|21030547|P2|NOT COMPLETED|Overall Study||8
8531058|NCT00316888|21030548|P1|NOT COMPLETED|Overall Study||6
8531059|NCT00316888|21030547|P2|COMPLETED|Overall Study||27
8531060|NCT00316888|21030548|P1|COMPLETED|Overall Study||22
8531061|NCT00316888|21030547|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
8531062|NCT00316888|21030548|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
8531063|NCT00316888|21030547|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
8531064|NCT00316888|21030548|P1|Started Induction Chemotherapy|Overall Study||28
8531065|NCT00316888|21030547|P2|Treated|Overall Study||34
8531066|NCT00316888|21030548|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
8531067|NCT00316888|21030547|P2|Eligible|Overall Study||35
8531068|NCT00316888|21030548|P1|Eligible|Overall Study||28
8531069|NCT00316888|21030547|P2|STARTED|Overall Study||35
8531070|NCT00316888|21030548|P1|STARTED|Overall Study||28
8531071|NCT00316862|21030562|P1|NOT COMPLETED|Overall Study||0
8531072|NCT00316862|21030562|P1|COMPLETED|Overall Study||82
8531073|NCT00316862|21030562|P1|STARTED|Overall Study||82
8531074|NCT00316719|21030570|P2|NOT COMPLETED|Overall Study||6
8531075|NCT00316719|21030571|P1|NOT COMPLETED|Overall Study||2
8531076|NCT00316719|21030570|P2|COMPLETED|Overall Study||47
8531077|NCT00316719|21030571|P1|COMPLETED|Overall Study||50
8531078|NCT00316719|21030570|P2|STARTED|Overall Study||53
8531079|NCT00316719|21030571|P1|STARTED|Overall Study||52
8531080|NCT00316706|21030597|P2|NOT COMPLETED|Overall Study||48
8531081|NCT00316706|21030598|P1|NOT COMPLETED|Overall Study||38
8531082|NCT00316706|21030597|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
8531083|NCT00316706|21030598|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
8531084|NCT00316706|21030597|P2|STARTED|Overall Study||619
8531085|NCT00316706|21030598|P1|STARTED|Overall Study||626
8531086|NCT00316693|21030614|P2|NOT COMPLETED|Overall Study||85
8531087|NCT00316693|21030615|P1|NOT COMPLETED|Overall Study||77
8531088|NCT00316693|21030614|P2|COMPLETED|Overall Study||436
8531089|NCT00316693|21030615|P1|COMPLETED|Overall Study||442
8531090|NCT00316693|21030614|P2|STARTED|Overall Study||521
8531091|NCT00316693|21030615|P1|STARTED|Overall Study||519
8531092|NCT00316602|21030657|P2|NOT COMPLETED|Overall Study||25
8531093|NCT00316602|21030658|P1|NOT COMPLETED|Overall Study||10
8531094|NCT00316602|21030657|P2|COMPLETED|Overall Study||325
8531095|NCT00316602|21030658|P1|COMPLETED|Overall Study||272
8531096|NCT00316602|21030657|P2|STARTED|Overall Study||350
8531097|NCT00316602|21030658|P1|STARTED|Overall Study||282
8531098|NCT00316589|21030690|P4|NOT COMPLETED|Overall Study||5
8531099|NCT00316589|21030691|P3|NOT COMPLETED|Overall Study||1
8531100|NCT00316589|21030692|P2|NOT COMPLETED|Overall Study||24
8531101|NCT00316589|21030693|P1|NOT COMPLETED|Overall Study||1
8531102|NCT00316589|21030690|P4|COMPLETED|Overall Study||127
8531103|NCT00316589|21030691|P3|COMPLETED|Overall Study||8
8531104|NCT00316589|21030692|P2|COMPLETED|Overall Study||328
8531105|NCT00316589|21030693|P1|COMPLETED|Overall Study||87
8531106|NCT00316589|21030690|P4|STARTED|Overall Study||132
8531107|NCT00316589|21030691|P3|STARTED|Overall Study||9
8531108|NCT00316589|21030692|P2|STARTED|Overall Study||352
8531109|NCT00316589|21030693|P1|STARTED|Overall Study||88
8531110|NCT00316524|21030761|P4|NOT COMPLETED|Overall Study||0
8531111|NCT00316524|21030762|P3|NOT COMPLETED|Overall Study||6
8531112|NCT00316524|21030763|P2|NOT COMPLETED|Overall Study||8
8531113|NCT00316524|21030764|P1|NOT COMPLETED|Overall Study||8
8531114|NCT00316524|21030761|P4|COMPLETED|Overall Study||200
8531115|NCT00316524|21030762|P3|COMPLETED|Overall Study||175
8531116|NCT00316524|21030763|P2|COMPLETED|Overall Study||173
8531117|NCT00316524|21030764|P1|COMPLETED|Overall Study||175
8531118|NCT00316524|21030761|P4|STARTED|Overall Study||200
8531119|NCT00316524|21030762|P3|STARTED|Overall Study||181
8531120|NCT00316524|21030763|P2|STARTED|Overall Study||181
8531121|NCT00316524|21030764|P1|STARTED|Overall Study||183
8531122|NCT00316355|21030816|P2|NOT COMPLETED|Overall Study||7
8531123|NCT00316355|21030817|P1|NOT COMPLETED|Overall Study||5
8531124|NCT00316355|21030816|P2|COMPLETED|Overall Study||12
8531125|NCT00316355|21030817|P1|COMPLETED|Overall Study||10
8531126|NCT00316355|21030816|P2|Started Treatment|Overall Study||18
8531127|NCT00316355|21030817|P1|Started Treatment|Overall Study||12
8531128|NCT00316355|21030816|P2|STARTED|Overall Study||19
8531129|NCT00316355|21030817|P1|STARTED|Overall Study||15
8531130|NCT00316303|21030827|P2|NOT COMPLETED|Overall Study||16
8531131|NCT00316303|21030828|P1|NOT COMPLETED|Overall Study||11
8531132|NCT00316303|21030827|P2|COMPLETED|Overall Study||102
8531133|NCT00316303|21030828|P1|COMPLETED|Overall Study||107
8531134|NCT00316303|21030827|P2|STARTED|Overall Study||118
8531135|NCT00316303|21030828|P1|STARTED|Overall Study||118
8531136|NCT00316277|21030844|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
8531137|NCT00316277|21030845|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
8531138|NCT00316277|21030844|P2|COMPLETED|Phase 2 (24 Weeks)||161
8531139|NCT00316277|21030845|P1|COMPLETED|Phase 2 (24 Weeks)||161
8531140|NCT00316277|21030844|P2|STARTED|Phase 2 (24 Weeks)||180
8531141|NCT00316277|21030845|P1|STARTED|Phase 2 (24 Weeks)||180
8531142|NCT00316277|21030844|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
8531143|NCT00316277|21030845|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
8531144|NCT00316277|21030844|P2|COMPLETED|Phase 1 (12 Weeks)||24
8531145|NCT00316277|21030845|P1|COMPLETED|Phase 1 (12 Weeks)||19
8531146|NCT00316277|21030844|P2|STARTED|Phase 1 (12 Weeks)||324
8531147|NCT00316277|21030845|P1|STARTED|Phase 1 (12 Weeks)||329
8531148|NCT00316264|21030866|P3|NOT COMPLETED|Overall Study||6
8531149|NCT00316264|21030867|P2|NOT COMPLETED|Overall Study||7
8531150|NCT00316264|21030868|P1|NOT COMPLETED|Overall Study||6
8531151|NCT00316264|21030866|P3|COMPLETED|Overall Study||87
8531152|NCT00316264|21030867|P2|COMPLETED|Overall Study||77
8531153|NCT00316264|21030868|P1|COMPLETED|Overall Study||77
8531154|NCT00316264|21030866|P3|STARTED|Overall Study||93
8531155|NCT00316264|21030867|P2|STARTED|Overall Study||84
8531156|NCT00316264|21030868|P1|STARTED|Overall Study||83
8531157|NCT00316225|21030936|P1|NOT COMPLETED|Overall Study||25
8531158|NCT00316225|21030936|P1|COMPLETED|Overall Study||6
8531159|NCT00316225|21030936|P1|STARTED|Overall Study||31
8531160|NCT00316199|21030945|P1|NOT COMPLETED|Overall Study||12
8531161|NCT00316199|21030945|P1|COMPLETED|Overall Study||48
8531162|NCT00316199|21030945|P1|STARTED|Overall Study||60
8531163|NCT00316186|21030953|P1|NOT COMPLETED|Overall Study||12
8531164|NCT00316186|21030953|P1|COMPLETED|Overall Study||21
8531165|NCT00316186|21030953|P1|STARTED|Overall Study||33
8531166|NCT00316173|21030967|P2|NOT COMPLETED|Treatment Phase||42
8531167|NCT00316173|21030968|P1|NOT COMPLETED|Treatment Phase||0
8531168|NCT00316173|21030967|P2|COMPLETED|Treatment Phase||13
8531169|NCT00316173|21030968|P1|COMPLETED|Treatment Phase||0
8531170|NCT00316173|21030967|P2|STARTED|Treatment Phase||55
8531171|NCT00316173|21030968|P1|STARTED|Treatment Phase||0
8531172|NCT00316173|21030967|P2|NOT COMPLETED|Run-in Phase||0
8531173|NCT00316173|21030968|P1|NOT COMPLETED|Run-in Phase||7
8531174|NCT00316173|21030967|P2|COMPLETED|Run-in Phase||0
8531175|NCT00316173|21030968|P1|COMPLETED|Run-in Phase||15
8531176|NCT00316173|21030967|P2|STARTED|Run-in Phase||0
8531177|NCT00316173|21030968|P1|STARTED|Run-in Phase||22
8531178|NCT00316121|21030981|P2|NOT COMPLETED|Overall Study||9
8531179|NCT00316121|21030982|P1|NOT COMPLETED|Overall Study||22
8531180|NCT00316121|21030981|P2|COMPLETED|Overall Study||37
8531181|NCT00316121|21030982|P1|COMPLETED|Overall Study||70
8531182|NCT00316121|21030981|P2|STARTED|Overall Study||46
8531183|NCT00316121|21030982|P1|STARTED|Overall Study||92
8531184|NCT00316082|21030993|P5|NOT COMPLETED|Overall Study||26
8531185|NCT00316082|21030994|P4|NOT COMPLETED|Overall Study||26
8531186|NCT00316082|21030995|P3|NOT COMPLETED|Overall Study||27
8531187|NCT00316082|21030996|P2|NOT COMPLETED|Overall Study||22
8531188|NCT00316082|21030997|P1|NOT COMPLETED|Overall Study||33
8531189|NCT00316082|21030993|P5|COMPLETED|Overall Study||48
8531190|NCT00316082|21030994|P4|COMPLETED|Overall Study||46
8531191|NCT00316082|21030995|P3|COMPLETED|Overall Study||44
8531192|NCT00316082|21030996|P2|COMPLETED|Overall Study||52
8531193|NCT00316082|21030997|P1|COMPLETED|Overall Study||41
8531194|NCT00316082|21030993|P5|Completed Study Without Being Rescued|Overall Study||31
8531195|NCT00316082|21030994|P4|Completed Study Without Being Rescued|Overall Study||27
8531196|NCT00316082|21030995|P3|Completed Study Without Being Rescued|Overall Study||29
8531197|NCT00316082|21030996|P2|Completed Study Without Being Rescued|Overall Study||35
8531198|NCT00316082|21030997|P1|Completed Study Without Being Rescued|Overall Study||25
8531199|NCT00316082|21030993|P5|STARTED|Overall Study||74
8531200|NCT00316082|21030994|P4|STARTED|Overall Study||72
8531201|NCT00316082|21030995|P3|STARTED|Overall Study||71
8531202|NCT00316082|21030996|P2|STARTED|Overall Study||74
8531203|NCT00316082|21030997|P1|STARTED|Overall Study||74
8531204|NCT00316017|21031028|P3|NOT COMPLETED|Overall Study||19
8531205|NCT00316017|21031029|P2|NOT COMPLETED|Overall Study||13
8531206|NCT00316017|21031030|P1|NOT COMPLETED|Overall Study||11
8531207|NCT00316017|21031028|P3|COMPLETED|Overall Study||376
8531208|NCT00316017|21031029|P2|COMPLETED|Overall Study||256
8531209|NCT00316017|21031030|P1|COMPLETED|Overall Study||220
8531210|NCT00316017|21031028|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
8531211|NCT00316017|21031029|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
8531212|NCT00316017|21031030|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
8531213|NCT00316004|21031104|P3|NOT COMPLETED|Overall Study||21
8531214|NCT00316004|21031105|P2|NOT COMPLETED|Overall Study||14
8531215|NCT00316004|21031106|P1|NOT COMPLETED|Overall Study||14
8531216|NCT00316004|21031104|P3|COMPLETED|Overall Study||582
8531217|NCT00316004|21031105|P2|COMPLETED|Overall Study||341
8531218|NCT00316004|21031106|P1|COMPLETED|Overall Study||359
8531219|NCT00316004|21031104|P3|STARTED|Overall Study||603
8531220|NCT00316004|21031105|P2|STARTED|Overall Study||355
8531221|NCT00316004|21031106|P1|STARTED|Overall Study||373
8531222|NCT00315939|21031161|P2|NOT COMPLETED|Admission 3 (3 Months)||2
8531223|NCT00315939|21031162|P1|NOT COMPLETED|Admission 3 (3 Months)||4
8531224|NCT00315939|21031161|P2|COMPLETED|Admission 3 (3 Months)||49
8531225|NCT00315939|21031162|P1|COMPLETED|Admission 3 (3 Months)||48
8531226|NCT00315939|21031161|P2|STARTED|Admission 3 (3 Months)||51
8531227|NCT00315939|21031162|P1|STARTED|Admission 3 (3 Months)||52
8531228|NCT00315939|21031161|P2|NOT COMPLETED|Admission 2 (3 Months)||4
8531229|NCT00315939|21031162|P1|NOT COMPLETED|Admission 2 (3 Months)||4
8531230|NCT00315939|21031161|P2|COMPLETED|Admission 2 (3 Months)||51
8531231|NCT00315939|21031162|P1|COMPLETED|Admission 2 (3 Months)||52
8531232|NCT00315939|21031161|P2|STARTED|Admission 2 (3 Months)||55
8531233|NCT00315939|21031162|P1|STARTED|Admission 2 (3 Months)||56
8531234|NCT00315939|21031161|P2|NOT COMPLETED|Admission 1 (3 Months)||6
8531235|NCT00315939|21031162|P1|NOT COMPLETED|Admission 1 (3 Months)||3
8531236|NCT00315939|21031161|P2|COMPLETED|Admission 1 (3 Months)||55
8531237|NCT00315939|21031162|P1|COMPLETED|Admission 1 (3 Months)||56
8531238|NCT00315939|21031161|P2|STARTED|Admission 1 (3 Months)||61
8531239|NCT00315939|21031162|P1|STARTED|Admission 1 (3 Months)||59
8531240|NCT00315822|21031170|P2|NOT COMPLETED|Overall Study||0
8531241|NCT00315822|21031171|P1|NOT COMPLETED|Overall Study||0
8531242|NCT00315822|21031170|P2|COMPLETED|Overall Study||202
8531243|NCT00315822|21031171|P1|COMPLETED|Overall Study||198
8531244|NCT00315822|21031170|P2|STARTED|Overall Study||202
8531245|NCT00315822|21031171|P1|STARTED|Overall Study||198
8531246|NCT00315731|21031177|P1|NOT COMPLETED|Overall Study||6
8531247|NCT00315731|21031177|P1|COMPLETED|Overall Study||9
8531248|NCT00315731|21031177|P1|STARTED|Overall Study||15
8531249|NCT00315705|21031205|P1|NOT COMPLETED|Phase 2||25
8531250|NCT00315705|21031205|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
8531251|NCT00315705|21031205|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
8531252|NCT00315705|21031205|P1|NOT COMPLETED|Phase 1||25
8531253|NCT00315705|21031205|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
8531254|NCT00315705|21031205|P1|STARTED|Phase 1||25
8531255|NCT00315627|21031242|P1|NOT COMPLETED|Overall Study||0
8531256|NCT00315627|21031242|P1|COMPLETED|Overall Study||3
8531257|NCT00315627|21031242|P1|STARTED|Overall Study||3
8531258|NCT00315614|21031250|P1|NOT COMPLETED|Overall Study||0
8531259|NCT00315614|21031250|P1|COMPLETED|Overall Study||3
8531260|NCT00315614|21031250|P1|STARTED|Overall Study||3
8531261|NCT00315588|21031257|P1|NOT COMPLETED|Overall Study||0
8531262|NCT00315588|21031257|P1|COMPLETED|Overall Study||7
8531263|NCT00315588|21031257|P1|STARTED|Overall Study||7
8531264|NCT00315458|21031266|P4|NOT COMPLETED|Overall Study||29
8531265|NCT00315458|21031267|P3|NOT COMPLETED|Overall Study||52
8531266|NCT00315458|21031268|P2|NOT COMPLETED|Overall Study||12
8531267|NCT00315458|21031269|P1|NOT COMPLETED|Overall Study||3
8531268|NCT00315458|21031266|P4|COMPLETED|Overall Study||10
8531269|NCT00315458|21031267|P3|COMPLETED|Overall Study||107
8531270|NCT00315458|21031268|P2|COMPLETED|Overall Study||44
8531271|NCT00315458|21031269|P1|COMPLETED|Overall Study||48
8531272|NCT00315458|21031266|P4|STARTED|Overall Study||39
8531273|NCT00315458|21031267|P3|STARTED|Overall Study||159
8531274|NCT00315458|21031268|P2|STARTED|Overall Study||56
8531275|NCT00315458|21031269|P1|STARTED|Overall Study||51
8531276|NCT00315445|21031282|P3|NOT COMPLETED|Overall Study||24
8531277|NCT00315445|21031283|P2|NOT COMPLETED|Overall Study||16
8531278|NCT00315445|21031284|P1|NOT COMPLETED|Overall Study||27
8531279|NCT00315445|21031282|P3|COMPLETED|Overall Study||22
8531280|NCT00315445|21031283|P2|COMPLETED|Overall Study||27
8531281|NCT00315445|21031284|P1|COMPLETED|Overall Study||18
8531282|NCT00315445|21031282|P3|STARTED|Overall Study||46
8531283|NCT00315445|21031283|P2|STARTED|Overall Study||43
8531284|NCT00315445|21031284|P1|STARTED|Overall Study||45
8531285|NCT00315341|21031357|P2|NOT COMPLETED|Overall Study||138
8531286|NCT00315341|21031358|P1|NOT COMPLETED|Overall Study||400
8531287|NCT00315341|21031357|P2|COMPLETED|Overall Study||391
8531288|NCT00315341|21031358|P1|COMPLETED|Overall Study||340
8531289|NCT00315341|21031357|P2|STARTED|Overall Study||529
8531290|NCT00315341|21031358|P1|STARTED|Overall Study||740
8531291|NCT00315328|21031368|P4|NOT COMPLETED|Overall Study||2
8531292|NCT00315328|21031369|P3|NOT COMPLETED|Overall Study||5
8531293|NCT00315328|21031370|P2|NOT COMPLETED|Overall Study||7
8531294|NCT00315328|21031371|P1|NOT COMPLETED|Overall Study||14
8531295|NCT00315328|21031368|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
8531296|NCT00315328|21031369|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
8531297|NCT00315328|21031370|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
8531298|NCT00315328|21031371|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
8531299|NCT00315328|21031368|P4|5 Week Visit|Overall Study||19
8531300|NCT00315328|21031369|P3|5 Week Visit|Overall Study||17
8531301|NCT00315328|21031370|P2|5 Week Visit|Overall Study||89
8531302|NCT00315328|21031371|P1|5 Week Visit|Overall Study||91
8531303|NCT00315328|21031368|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
8531304|NCT00315328|21031369|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
8531305|NCT00315328|21031370|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
8531306|NCT00315328|21031371|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
8531307|NCT00315302|21031441|P4|NOT COMPLETED|Overall Study||3
8531308|NCT00315302|21031442|P3|NOT COMPLETED|Overall Study||2
8531309|NCT00315302|21031443|P2|NOT COMPLETED|Overall Study||2
8531310|NCT00315302|21031444|P1|NOT COMPLETED|Overall Study||6
8531311|NCT00315302|21031441|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
8531312|NCT00315302|21031442|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
8531313|NCT00315302|21031443|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
8531314|NCT00315302|21031444|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
8531315|NCT00315302|21031441|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
8531316|NCT00315302|21031442|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
8531317|NCT00315302|21031443|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
8531318|NCT00315302|21031444|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
8531319|NCT00315302|21031441|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
8531320|NCT00315302|21031442|P3|18 Week Primary Outcome Visit|Overall Study||24
8531321|NCT00315302|21031443|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
8531322|NCT00315302|21031444|P1|18 Week Primary Outcome Visit|Overall Study||84
8531323|NCT00315302|21031441|P4|10 Week Visit|Overall Study||29
8531324|NCT00315302|21031442|P3|10 Week Visit|Overall Study||24
8531325|NCT00315302|21031443|P2|10 Week Visit|Overall Study||85
8531326|NCT00315302|21031444|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
8531327|NCT00315302|21031441|P4|5 Week Visit|Overall Study||30
8531328|NCT00315302|21031442|P3|5 Week Visit|Overall Study||26
8531329|NCT00315302|21031443|P2|5 Week Visit|Overall Study||86
8531330|NCT00315302|21031444|P1|5 Week Visit|Overall Study||85
8531331|NCT00315302|21031441|P4|STARTED|Overall Study||34
8531332|NCT00315302|21031442|P3|STARTED|Overall Study||26
8531333|NCT00315302|21031443|P2|STARTED|Overall Study||90
8531334|NCT00315302|21031444|P1|STARTED|Overall Study||90
8531335|NCT00315146|21031490|P4|NOT COMPLETED|Overall Study||0
8531336|NCT00315146|21031491|P3|NOT COMPLETED|Overall Study||2
8531337|NCT00315146|21031492|P2|NOT COMPLETED|Overall Study||3
8531338|NCT00315146|21031493|P1|NOT COMPLETED|Overall Study||2
8531339|NCT00315146|21031490|P4|COMPLETED|Overall Study||22
8531340|NCT00315146|21031491|P3|COMPLETED|Overall Study||20
8531341|NCT00315146|21031492|P2|COMPLETED|Overall Study||19
8531342|NCT00315146|21031493|P1|COMPLETED|Overall Study||20
8531343|NCT00315146|21031490|P4|STARTED|Overall Study||22
8531344|NCT00315146|21031491|P3|STARTED|Overall Study||22
8531345|NCT00315146|21031492|P2|STARTED|Overall Study||22
8531346|NCT00315146|21031493|P1|STARTED|Overall Study||22
8531347|NCT00315120|21031511|P4|NOT COMPLETED|Overall Study||0
8531348|NCT00315120|21031512|P3|NOT COMPLETED|Overall Study||0
8531349|NCT00315120|21031513|P2|NOT COMPLETED|Overall Study||0
8531350|NCT00315120|21031514|P1|NOT COMPLETED|Overall Study||0
8531351|NCT00315120|21031511|P4|COMPLETED|Overall Study||107
8531352|NCT00315120|21031512|P3|COMPLETED|Overall Study||115
8531353|NCT00315120|21031513|P2|COMPLETED|Overall Study||118
8531354|NCT00315120|21031514|P1|COMPLETED|Overall Study||115
8531355|NCT00315120|21031511|P4|STARTED|Overall Study||107
8531356|NCT00315120|21031512|P3|STARTED|Overall Study||115
8531357|NCT00315120|21031513|P2|STARTED|Overall Study||118
8531358|NCT00315120|21031514|P1|STARTED|Overall Study||115
8531359|NCT00315055|21031574|P2|NOT COMPLETED|Overall Study||5
8531360|NCT00315055|21031575|P1|NOT COMPLETED|Overall Study||3
8531361|NCT00315055|21031574|P2|COMPLETED|Overall Study||150
8531362|NCT00315055|21031575|P1|COMPLETED|Overall Study||152
8531363|NCT00315055|21031574|P2|STARTED|Overall Study||155
8531364|NCT00315055|21031575|P1|STARTED|Overall Study||155
8531365|NCT00314951|21031593|P2|NOT COMPLETED|Follow-up||34
8531366|NCT00314951|21031594|P1|NOT COMPLETED|Follow-up||44
8531367|NCT00314951|21031593|P2|COMPLETED|Follow-up||255
8531368|NCT00314951|21031594|P1|COMPLETED|Follow-up||263
8531369|NCT00314951|21031593|P2|STARTED|Follow-up||289
8531370|NCT00314951|21031594|P1|STARTED|Follow-up||307
8531371|NCT00314951|21031593|P2|NOT COMPLETED|Treatment||11
8531372|NCT00314951|21031594|P1|NOT COMPLETED|Treatment||16
8531373|NCT00314951|21031593|P2|COMPLETED|Treatment||289
8531374|NCT00314951|21031594|P1|COMPLETED|Treatment||307
8531375|NCT00314951|21031593|P2|STARTED|Treatment||300
8531376|NCT00314951|21031594|P1|STARTED|Treatment||323
8531377|NCT00314951|21031593|P2|NOT COMPLETED|Enrollment||6
8531378|NCT00314951|21031594|P1|NOT COMPLETED|Enrollment||0
8531379|NCT00314951|21031593|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
8531380|NCT00314951|21031594|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
8531381|NCT00314951|21031593|P2|STARTED|Enrollment||306
8531382|NCT00314951|21031594|P1|STARTED|Enrollment||323
8531383|NCT00314808|21031604|P1|NOT COMPLETED|Overall Study||8
8531384|NCT00314808|21031604|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
8531385|NCT00314808|21031604|P1|STARTED|Overall Study||33
8531386|NCT00314795|21031612|P1|NOT COMPLETED|Overall Study||20
8531387|NCT00314795|21031612|P1|COMPLETED|Overall Study||2
8531388|NCT00314795|21031612|P1|STARTED|Overall Study||22
8531389|NCT00314574|21031622|P2|NOT COMPLETED|Overall Study||83
8531390|NCT00314574|21031623|P1|NOT COMPLETED|Overall Study||94
8531391|NCT00314574|21031622|P2|COMPLETED|Overall Study||344
8531392|NCT00314574|21031623|P1|COMPLETED|Overall Study||329
8531393|NCT00314574|21031622|P2|Safety Population|Overall Study||428
8531394|NCT00314574|21031623|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
8531395|NCT00314574|21031622|P2|Received at Least One Dose of Study Drug|Overall Study||427
8531396|NCT00314574|21031623|P1|Received at Least One Dose of Study Drug|Overall Study||421
8531397|NCT00314574|21031622|P2|STARTED|Overall Study||427
8531398|NCT00314574|21031623|P1|STARTED|Overall Study||423
8531399|NCT00314366|21031639|P2|NOT COMPLETED|Overall Study||0
8531400|NCT00314366|21031640|P1|NOT COMPLETED|Overall Study||1
8531401|NCT00314366|21031639|P2|COMPLETED|Overall Study||10
8531402|NCT00314366|21031640|P1|COMPLETED|Overall Study||10
8531403|NCT00314366|21031639|P2|STARTED|Overall Study||10
8531404|NCT00314366|21031640|P1|STARTED|Overall Study||11
8531405|NCT00314353|21031670|P2|NOT COMPLETED|Follow-up||0
8531406|NCT00314353|21031671|P1|NOT COMPLETED|Follow-up||0
8531407|NCT00314353|21031670|P2|COMPLETED|Follow-up||0
8531408|NCT00314353|21031671|P1|COMPLETED|Follow-up||3
8531409|NCT00314353|21031670|P2|STARTED|Follow-up||0
8531410|NCT00314353|21031671|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
8531411|NCT00314353|21031670|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
8531412|NCT00314353|21031671|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
8531413|NCT00314353|21031670|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
8531414|NCT00314353|21031671|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
8531415|NCT00314353|21031670|P2|STARTED|Protocol Therapy (8 Cycles)||3
8531416|NCT00314353|21031671|P1|STARTED|Protocol Therapy (8 Cycles)||4
8531417|NCT00314340|21031685|P1|NOT COMPLETED|Overall Study||1
8531418|NCT00314340|21031685|P1|COMPLETED|Overall Study||11
8531419|NCT00314340|21031685|P1|Placebo|Overall Study||12
8531420|NCT00314340|21031685|P1|Hydrocodone Plus APAP|Overall Study||12
8531421|NCT00314340|21031685|P1|ER Morphine|Overall Study||11
8531422|NCT00314340|21031685|P1|STARTED|Overall Study||12
8531423|NCT00314327|21031691|P1|NOT COMPLETED|Overall Study||1
8531424|NCT00314327|21031691|P1|COMPLETED|Overall Study||0
8531425|NCT00314327|21031691|P1|STARTED|Overall Study||1
8531426|NCT00314262|21031696|P1|NOT COMPLETED|Overall Study||5
8531427|NCT00314262|21031696|P1|COMPLETED|Overall Study||7
8531428|NCT00314262|21031696|P1|STARTED|Overall Study||12
8531429|NCT00314249|21031704|P2|NOT COMPLETED|Overall Study||163
8531430|NCT00314249|21031705|P1|NOT COMPLETED|Overall Study||152
8531431|NCT00314249|21031704|P2|COMPLETED|Overall Study||353
8531432|NCT00314249|21031705|P1|COMPLETED|Overall Study||357
8531433|NCT00314249|21031704|P2|STARTED|Overall Study||516
8531434|NCT00314249|21031705|P1|STARTED|Overall Study||509
8531435|NCT00314236|21031723|P2|NOT COMPLETED|Overall Study||2
8531436|NCT00314236|21031724|P1|NOT COMPLETED|Overall Study||0
8531437|NCT00314236|21031723|P2|COMPLETED|Overall Study||37
8531438|NCT00314236|21031724|P1|COMPLETED|Overall Study||41
8531439|NCT00314236|21031723|P2|STARTED|Overall Study||39
8531440|NCT00314236|21031724|P1|STARTED|Overall Study||41
8531441|NCT00314145|21031738|P2|NOT COMPLETED|Overall Study||29
8531442|NCT00314145|21031739|P1|NOT COMPLETED|Overall Study||21
8531443|NCT00314145|21031738|P2|COMPLETED|Overall Study||381
8531444|NCT00314145|21031739|P1|COMPLETED|Overall Study||389
8531445|NCT00314145|21031738|P2|STARTED|Overall Study||410
8531446|NCT00314145|21031739|P1|STARTED|Overall Study||410
8531447|NCT00314132|21031753|P2|NOT COMPLETED|Overall Study||18
8531448|NCT00314132|21031754|P1|NOT COMPLETED|Overall Study||8
8531449|NCT00314132|21031753|P2|COMPLETED|Overall Study||1583
8531450|NCT00314132|21031754|P1|COMPLETED|Overall Study||395
8531451|NCT00314132|21031753|P2|STARTED|Overall Study||1601
8531452|NCT00314132|21031754|P1|STARTED|Overall Study||403
8531453|NCT00314106|21031764|P2|NOT COMPLETED|Overall Study||0
8531454|NCT00314106|21031765|P1|NOT COMPLETED|Overall Study||0
8531455|NCT00314106|21031764|P2|COMPLETED|Overall Study||8
8531456|NCT00314106|21031765|P1|COMPLETED|Overall Study||18
8531457|NCT00314106|21031764|P2|STARTED|Overall Study||8
8531458|NCT00314106|21031765|P1|STARTED|Overall Study||18
8531459|NCT00314093|21031773|P1|NOT COMPLETED|Overall Study||0
8531460|NCT00314093|21031773|P1|COMPLETED|Overall Study||0
8531461|NCT00314093|21031773|P1|STARTED|Overall Study||0
8531462|NCT00313911|21031781|P2|NOT COMPLETED|Overall Study||41
8531463|NCT00313911|21031782|P1|NOT COMPLETED|Overall Study||94
8531464|NCT00313911|21031781|P2|COMPLETED|Overall Study||670
8531465|NCT00313911|21031782|P1|COMPLETED|Overall Study||1328
8531466|NCT00313911|21031781|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
8531467|NCT00313911|21031782|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
8531468|NCT00313846|21031796|P2|NOT COMPLETED|Overall Study||11
8531469|NCT00313846|21031797|P1|NOT COMPLETED|Overall Study||5
8531470|NCT00313846|21031796|P2|COMPLETED|Overall Study||153
8531471|NCT00313846|21031797|P1|COMPLETED|Overall Study||157
8531472|NCT00313846|21031796|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
8531473|NCT00313846|21031797|P1|STARTED|Overall Study||162
8531486|NCT00313781|21031847|P3|NOT COMPLETED|After Crossover||27
8531487|NCT00313781|21031848|P2|NOT COMPLETED|After Crossover||0
8531488|NCT00313781|21031849|P1|NOT COMPLETED|After Crossover||0
8531489|NCT00313781|21031847|P3|COMPLETED|After Crossover||10
8531490|NCT00313781|21031848|P2|COMPLETED|After Crossover||0
8531491|NCT00313781|21031849|P1|COMPLETED|After Crossover||0
8531492|NCT00313781|21031847|P3|STARTED|After Crossover||37
8531493|NCT00313781|21031848|P2|STARTED|After Crossover||0
8531494|NCT00313781|21031849|P1|STARTED|After Crossover||0
8531495|NCT00313781|21031847|P3|NOT COMPLETED|Before Crossover||0
8531496|NCT00313781|21031848|P2|NOT COMPLETED|Before Crossover||79
8531497|NCT00313781|21031849|P1|NOT COMPLETED|Before Crossover||75
8531498|NCT00313781|21031847|P3|COMPLETED|Before Crossover||0
8531499|NCT00313781|21031848|P2|COMPLETED|Before Crossover||23
8531500|NCT00313781|21031849|P1|COMPLETED|Before Crossover||27
8531501|NCT00313781|21031847|P3|Treated|Before Crossover||0
8531502|NCT00313781|21031848|P2|Treated|Before Crossover||102
8531503|NCT00313781|21031849|P1|Treated|Before Crossover||97
8531504|NCT00313781|21031847|P3|STARTED|Before Crossover||0
8531505|NCT00313781|21031848|P2|STARTED|Before Crossover||102
8531506|NCT00313781|21031849|P1|STARTED|Before Crossover||102
8531507|NCT00313729|21031883|P1|NOT COMPLETED|Overall Study||0
8531508|NCT00313729|21031883|P1|COMPLETED|Overall Study||120
8531509|NCT00313729|21031883|P1|STARTED|Overall Study||120
8531510|NCT00313716|21031895|P6|NOT COMPLETED|Overall Study||13
8531511|NCT00313716|21031896|P5|NOT COMPLETED|Overall Study||6
8531512|NCT00313716|21031897|P4|NOT COMPLETED|Overall Study||4
8531513|NCT00313716|21031898|P3|NOT COMPLETED|Overall Study||12
8531514|NCT00313716|21031899|P2|NOT COMPLETED|Overall Study||8
8531515|NCT00313716|21031900|P1|NOT COMPLETED|Overall Study||5
8531516|NCT00313716|21031895|P6|COMPLETED|Overall Study||35
8531517|NCT00313716|21031896|P5|COMPLETED|Overall Study||27
8531518|NCT00313716|21031897|P4|COMPLETED|Overall Study||16
8531519|NCT00313716|21031898|P3|COMPLETED|Overall Study||38
8531520|NCT00313716|21031899|P2|COMPLETED|Overall Study||23
8531521|NCT00313716|21031900|P1|COMPLETED|Overall Study||13
8531522|NCT00313716|21031895|P6|STARTED|Overall Study||48
8531523|NCT00313716|21031896|P5|STARTED|Overall Study||33
8531524|NCT00313716|21031897|P4|STARTED|Overall Study||20
8531525|NCT00313716|21031898|P3|STARTED|Overall Study||50
8531526|NCT00313716|21031899|P2|STARTED|Overall Study||31
8531527|NCT00313716|21031900|P1|STARTED|Overall Study||18
8531528|NCT00313703|21031927|P4|NOT COMPLETED|Overall Study||12
8531529|NCT00313703|21031928|P3|NOT COMPLETED|Overall Study||5
8531530|NCT00313703|21031929|P2|NOT COMPLETED|Overall Study||2
8531531|NCT00313703|21031930|P1|NOT COMPLETED|Overall Study||11
8531532|NCT00313703|21031927|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
8531533|NCT00313703|21031928|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
8531534|NCT00313703|21031929|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
8531535|NCT00313703|21031930|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
8531536|NCT00313703|21031927|P4|STARTED|Overall Study||12
8531537|NCT00313703|21031928|P3|STARTED|Overall Study||77
8531538|NCT00313703|21031929|P2|STARTED|Overall Study||34
8531539|NCT00313703|21031930|P1|STARTED|Overall Study||186
8531540|NCT00313612|21031946|P2|NOT COMPLETED|Overall Study||1
8531541|NCT00313612|21031947|P1|NOT COMPLETED|Overall Study||0
8531542|NCT00313612|21031946|P2|COMPLETED|Overall Study||19
8531543|NCT00313612|21031947|P1|COMPLETED|Overall Study||19
8531544|NCT00313612|21031946|P2|STARTED|Overall Study||20
8531545|NCT00313612|21031947|P1|STARTED|Overall Study||19
8531546|NCT00313586|21031959|P4|NOT COMPLETED|Overall Study||23
8531547|NCT00313586|21031960|P3|NOT COMPLETED|Overall Study||24
8531548|NCT00313586|21031961|P2|NOT COMPLETED|Overall Study||70
8531549|NCT00313586|21031962|P1|NOT COMPLETED|Overall Study||70
8531550|NCT00313586|21031959|P4|COMPLETED|Overall Study||0
8531551|NCT00313586|21031960|P3|COMPLETED|Overall Study||0
8531552|NCT00313586|21031961|P2|COMPLETED|Overall Study||5
8531553|NCT00313586|21031962|P1|COMPLETED|Overall Study||5
8531554|NCT00313586|21031959|P4|Treated|Overall Study||23
8531555|NCT00313586|21031960|P3|Treated|Overall Study||24
8531556|NCT00313586|21031961|P2|Treated|Overall Study||75
8531557|NCT00313586|21031962|P1|Treated|Overall Study||74
8531558|NCT00313586|21031959|P4|STARTED|Overall Study||23
8531559|NCT00313586|21031960|P3|STARTED|Overall Study||24
8531560|NCT00313586|21031961|P2|STARTED|Overall Study||75
8531561|NCT00313586|21031962|P1|STARTED|Overall Study||75
8531562|NCT00313560|21031970|P1|NOT COMPLETED|Overall Study||0
8531563|NCT00313560|21031970|P1|COMPLETED|Overall Study||48
8531564|NCT00313560|21031970|P1|STARTED|Overall Study||48
8531565|NCT00313443|21031979|P1|NOT COMPLETED|Overall Study||0
8531566|NCT00313443|21031979|P1|COMPLETED|Overall Study||30
8531567|NCT00313443|21031979|P1|STARTED|Overall Study||30
8531568|NCT00313313|21031990|P3|NOT COMPLETED|Overall Study||82
8531569|NCT00313313|21031991|P2|NOT COMPLETED|Overall Study||66
8531570|NCT00313313|21031992|P1|NOT COMPLETED|Overall Study||63
8531571|NCT00313313|21031990|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
8531572|NCT00313313|21031991|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
8531573|NCT00313313|21031992|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
8531574|NCT00313313|21031990|P3|STARTED|Overall Study||267
8531575|NCT00313313|21031991|P2|STARTED|Overall Study||253
8531576|NCT00313313|21031992|P1|STARTED|Overall Study||248
8531577|NCT00313300|21032014|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
8531578|NCT00313300|21032015|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
8531579|NCT00313300|21032016|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
8531580|NCT00313300|21032017|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
8531581|NCT00313300|21032018|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
8531582|NCT00313300|21032014|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
8531583|NCT00313300|21032015|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
8531584|NCT00313300|21032016|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
8531585|NCT00313300|21032017|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
8531586|NCT00313300|21032018|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
8531587|NCT00313300|21032014|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
8531588|NCT00313300|21032015|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
8531589|NCT00313300|21032016|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
8531590|NCT00313300|21032017|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
8531591|NCT00313300|21032018|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
8531592|NCT00313300|21032014|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531593|NCT00313300|21032015|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531594|NCT00313300|21032016|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
8531595|NCT00313300|21032017|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
8531596|NCT00313300|21032018|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
8531597|NCT00313300|21032014|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531598|NCT00313300|21032015|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531599|NCT00313300|21032016|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
8531600|NCT00313300|21032017|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
8531601|NCT00313300|21032018|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
8531602|NCT00313300|21032014|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
8531603|NCT00313300|21032015|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
8531604|NCT00313300|21032016|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
8531605|NCT00313300|21032017|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
8531606|NCT00313300|21032018|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
8531607|NCT00313300|21032014|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
8531608|NCT00313300|21032015|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
8531609|NCT00313300|21032016|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
8531610|NCT00313300|21032017|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
8531611|NCT00313300|21032018|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
8531612|NCT00313300|21032014|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
8531613|NCT00313300|21032015|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
8531614|NCT00313300|21032016|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
8531615|NCT00313300|21032017|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
8531616|NCT00313300|21032018|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
8531617|NCT00313300|21032014|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
8531618|NCT00313300|21032015|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
8531619|NCT00313300|21032016|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
8531620|NCT00313300|21032017|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
8531621|NCT00313300|21032018|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
8531622|NCT00313300|21032014|P5|STARTED|Randomized in Phase B (26 Weeks)||221
8531623|NCT00313300|21032015|P4|STARTED|Randomized in Phase B (26 Weeks)||248
8531624|NCT00313300|21032016|P3|STARTED|Randomized in Phase B (26 Weeks)||134
8531625|NCT00313300|21032017|P2|STARTED|Randomized in Phase B (26 Weeks)||138
8531626|NCT00313300|21032018|P1|STARTED|Randomized in Phase B (26 Weeks)||427
8531627|NCT00313300|21032014|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
8531628|NCT00313300|21032015|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
8531629|NCT00313300|21032016|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
8531630|NCT00313300|21032017|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
8531631|NCT00313300|21032018|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
8531632|NCT00313300|21032014|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
8531633|NCT00313300|21032015|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
8531634|NCT00313300|21032016|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
8531635|NCT00313300|21032017|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
8531636|NCT00313300|21032018|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
8531637|NCT00313300|21032014|P5|STARTED|Randomized in Phase A (26 Weeks)||0
8531638|NCT00313300|21032015|P4|STARTED|Randomized in Phase A (26 Weeks)||0
8531639|NCT00313300|21032016|P3|STARTED|Randomized in Phase A (26 Weeks)||184
8531640|NCT00313300|21032017|P2|STARTED|Randomized in Phase A (26 Weeks)||179
8531641|NCT00313300|21032018|P1|STARTED|Randomized in Phase A (26 Weeks)||184
8531642|NCT00313209|21032070|P2|NOT COMPLETED|Overall Study||82
8531643|NCT00313209|21032071|P1|NOT COMPLETED|Overall Study||107
8531644|NCT00313209|21032070|P2|COMPLETED|Overall Study||385
8531645|NCT00313209|21032071|P1|COMPLETED|Overall Study||359
8531646|NCT00313209|21032070|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
8531647|NCT00313209|21032071|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
8531648|NCT00313170|21032088|P3|NOT COMPLETED|Overall Study||32
8531649|NCT00313170|21032089|P2|NOT COMPLETED|Overall Study||34
8531650|NCT00313170|21032090|P1|NOT COMPLETED|Overall Study||36
8531651|NCT00313170|21032088|P3|COMPLETED|Overall Study||14
8531652|NCT00313170|21032089|P2|COMPLETED|Overall Study||17
8531653|NCT00313170|21032090|P1|COMPLETED|Overall Study||11
8531654|NCT00313170|21032088|P3|STARTED|Overall Study||46
8531655|NCT00313170|21032089|P2|STARTED|Overall Study||51
8531656|NCT00313170|21032090|P1|STARTED|Overall Study||47
8531657|NCT00313144|21032109|P1|NOT COMPLETED|Overall Study||110
8531658|NCT00313144|21032109|P1|COMPLETED|Overall Study||17
8531659|NCT00313144|21032109|P1|STARTED|Overall Study||127
8531660|NCT00313014|21032196|P3|NOT COMPLETED|Overall Study||61
8531661|NCT00313014|21032197|P2|NOT COMPLETED|Overall Study||73
8531662|NCT00313014|21032198|P1|NOT COMPLETED|Overall Study||93
8531663|NCT00313014|21032196|P3|COMPLETED|Overall Study||159
8531664|NCT00313014|21032197|P2|COMPLETED|Overall Study||146
8531665|NCT00313014|21032198|P1|COMPLETED|Overall Study||128
8531666|NCT00313014|21032196|P3|STARTED|Overall Study||220
8531667|NCT00313014|21032197|P2|STARTED|Overall Study||219
8531668|NCT00313014|21032198|P1|STARTED|Overall Study||221
8531669|NCT00312923|21032218|P2|NOT COMPLETED|Overall Study||6
8531670|NCT00312923|21032219|P1|NOT COMPLETED|Overall Study||9
8531671|NCT00312923|21032218|P2|COMPLETED|Overall Study||20
8531672|NCT00312923|21032219|P1|COMPLETED|Overall Study||19
8531673|NCT00312923|21032218|P2|STARTED|Overall Study||26
8531674|NCT00312923|21032219|P1|STARTED|Overall Study||28
8531675|NCT00312897|21032229|P2|NOT COMPLETED|Overall Study||6
8531676|NCT00312897|21032230|P1|NOT COMPLETED|Overall Study||6
8531677|NCT00312897|21032229|P2|COMPLETED|Overall Study||18
8531678|NCT00312897|21032230|P1|COMPLETED|Overall Study||21
8531679|NCT00312897|21032229|P2|STARTED|Overall Study||24
8531680|NCT00312897|21032230|P1|STARTED|Overall Study||27
8531681|NCT00312884|21032240|P2|NOT COMPLETED|Overall Study||12
8531682|NCT00312884|21032241|P1|NOT COMPLETED|Overall Study||17
8531683|NCT00312884|21032240|P2|COMPLETED|Overall Study||79
8531684|NCT00312884|21032241|P1|COMPLETED|Overall Study||74
8531685|NCT00312884|21032240|P2|STARTED|Overall Study||91
8531686|NCT00312884|21032241|P1|STARTED|Overall Study||91
8531687|NCT00312858|21032255|P2|NOT COMPLETED|Overall Study||93
8531688|NCT00312858|21032256|P1|NOT COMPLETED|Overall Study||68
8531689|NCT00312858|21032255|P2|COMPLETED|Overall Study||230
8531690|NCT00312858|21032256|P1|COMPLETED|Overall Study||262
8531691|NCT00312858|21032255|P2|Visit 4|Overall Study||240
8531692|NCT00312858|21032256|P1|Visit 4|Overall Study||262
8531693|NCT00312858|21032255|P2|Visit 3|Overall Study||261
8531694|NCT00312858|21032256|P1|Visit 3|Overall Study||273
8531695|NCT00312858|21032255|P2|Visit 2|Overall Study||294
8531696|NCT00312858|21032256|P1|Visit 2|Overall Study||305
8531697|NCT00312858|21032255|P2|Visit 1|Overall Study||323
8531698|NCT00312858|21032256|P1|Visit 1|Overall Study||330
8531699|NCT00312858|21032255|P2|STARTED|Overall Study||323
8531700|NCT00312858|21032256|P1|STARTED|Overall Study||330
8531701|NCT00312845|21032310|P2|NOT COMPLETED|Overall Study||95
8531702|NCT00312845|21032311|P1|NOT COMPLETED|Overall Study||99
8531703|NCT00312845|21032310|P2|COMPLETED|Overall Study||245
8531704|NCT00312845|21032311|P1|COMPLETED|Overall Study||237
8531705|NCT00312845|21032310|P2|STARTED|Overall Study||340
8531706|NCT00312845|21032311|P1|STARTED|Overall Study||336
8531707|NCT00312728|21032319|P1|NOT COMPLETED|Overall Study||110
8531708|NCT00312728|21032319|P1|COMPLETED|Overall Study||5
8531709|NCT00312728|21032319|P1|STARTED|Overall Study||115
8531710|NCT00312702|21032331|P3|NOT COMPLETED|Challenge Phase||0
8531711|NCT00312702|21032332|P2|NOT COMPLETED|Challenge Phase||0
8531712|NCT00312702|21032333|P1|NOT COMPLETED|Challenge Phase||0
8531713|NCT00312702|21032331|P3|COMPLETED|Challenge Phase||1
8531714|NCT00312702|21032332|P2|COMPLETED|Challenge Phase||12
8531715|NCT00312702|21032333|P1|COMPLETED|Challenge Phase||0
8531716|NCT00312702|21032331|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
8531717|NCT00312702|21032332|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
8531891|NCT00310856|21032754|P2|NOT COMPLETED|Overall Study||5
8531718|NCT00312702|21032333|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
8531719|NCT00312702|21032331|P3|NOT COMPLETED|Immunization Phase||0
8531720|NCT00312702|21032332|P2|NOT COMPLETED|Immunization Phase||1
8531721|NCT00312702|21032333|P1|NOT COMPLETED|Immunization Phase||0
8531722|NCT00312702|21032331|P3|COMPLETED|Immunization Phase||0
8531723|NCT00312702|21032332|P2|COMPLETED|Immunization Phase||12
8531724|NCT00312702|21032333|P1|COMPLETED|Immunization Phase||5
8531725|NCT00312702|21032331|P3|STARTED|Immunization Phase||0
8531726|NCT00312702|21032332|P2|STARTED|Immunization Phase||13
8531727|NCT00312702|21032333|P1|STARTED|Immunization Phase||5
8531728|NCT00312663|21032346|P3|NOT COMPLETED|Challenge Phase||0
8531729|NCT00312663|21032347|P2|NOT COMPLETED|Challenge Phase||0
8531730|NCT00312663|21032348|P1|NOT COMPLETED|Challenge Phase||0
8531731|NCT00312663|21032346|P3|COMPLETED|Challenge Phase||6
8531732|NCT00312663|21032347|P2|COMPLETED|Challenge Phase||10
8531733|NCT00312663|21032348|P1|COMPLETED|Challenge Phase||0
8531734|NCT00312663|21032346|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
8531735|NCT00312663|21032347|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
8531736|NCT00312663|21032348|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
8531737|NCT00312663|21032346|P3|NOT COMPLETED|Immunization Phase||0
8531738|NCT00312663|21032347|P2|NOT COMPLETED|Immunization Phase||1
8531739|NCT00312663|21032348|P1|NOT COMPLETED|Immunization Phase||0
8531740|NCT00312663|21032346|P3|COMPLETED|Immunization Phase||0
8531741|NCT00312663|21032347|P2|COMPLETED|Immunization Phase||12
8531742|NCT00312663|21032348|P1|COMPLETED|Immunization Phase||5
8531743|NCT00312663|21032346|P3|STARTED|Immunization Phase||0
8531744|NCT00312663|21032347|P2|STARTED|Immunization Phase||13
8531745|NCT00312663|21032348|P1|STARTED|Immunization Phase||5
8531746|NCT00312572|21032361|P2|NOT COMPLETED|Overall Study||21
8531747|NCT00312572|21032362|P1|NOT COMPLETED|Overall Study||16
8531748|NCT00312572|21032361|P2|COMPLETED|Overall Study||82
8531749|NCT00312572|21032362|P1|COMPLETED|Overall Study||85
8531750|NCT00312572|21032361|P2|STARTED|Overall Study||103
8531751|NCT00312572|21032362|P1|STARTED|Overall Study||101
8531752|NCT00312494|21032373|P3|NOT COMPLETED|Overall Study||43
8531753|NCT00312494|21032374|P2|NOT COMPLETED|Overall Study||58
8531754|NCT00312494|21032375|P1|NOT COMPLETED|Overall Study||71
8531755|NCT00312494|21032373|P3|COMPLETED|Overall Study||179
8531756|NCT00312494|21032374|P2|COMPLETED|Overall Study||168
8531757|NCT00312494|21032375|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
8531758|NCT00312494|21032373|P3|Received Study Treatment|Overall Study||217
8531759|NCT00312494|21032374|P2|Received Study Treatment|Overall Study||216
8531760|NCT00312494|21032375|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
8531761|NCT00312494|21032373|P3|STARTED|Overall Study||222
8531762|NCT00312494|21032374|P2|STARTED|Overall Study||226
8531763|NCT00312494|21032375|P1|STARTED|Overall Study||232
8531764|NCT00312377|21032409|P2|NOT COMPLETED|Overall Study||668
8531765|NCT00312377|21032410|P1|NOT COMPLETED|Overall Study||644
8531766|NCT00312377|21032409|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
8531767|NCT00312377|21032410|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
8531768|NCT00312377|21032409|P2|STARTED|Overall Study|randomised patients|697
8531769|NCT00312377|21032410|P1|STARTED|Overall Study|randomised patients|694
8531770|NCT00312338|21032434|P2|NOT COMPLETED|Overall Study||3
8531771|NCT00312338|21032435|P1|NOT COMPLETED|Overall Study||22
8531772|NCT00312338|21032434|P2|COMPLETED|Overall Study||54
8531773|NCT00312338|21032435|P1|COMPLETED|Overall Study||83
8531774|NCT00312338|21032434|P2|STARTED|Overall Study||57
8531775|NCT00312338|21032435|P1|STARTED|Overall Study||105
8531776|NCT00312221|21032448|P4|NOT COMPLETED|Double-blind Phase||70
8531777|NCT00312221|21032449|P3|NOT COMPLETED|Double-blind Phase||72
8531778|NCT00312221|21032450|P2|NOT COMPLETED|Double-blind Phase||59
8531779|NCT00312221|21032451|P1|NOT COMPLETED|Double-blind Phase||0
8531780|NCT00312221|21032448|P4|COMPLETED|Double-blind Phase||63
8531781|NCT00312221|21032449|P3|COMPLETED|Double-blind Phase||77
8531782|NCT00312221|21032450|P2|COMPLETED|Double-blind Phase||77
8531783|NCT00312221|21032451|P1|COMPLETED|Double-blind Phase||0
8531784|NCT00312221|21032448|P4|STARTED|Double-blind Phase||133
8531785|NCT00312221|21032449|P3|STARTED|Double-blind Phase||149
8531786|NCT00312221|21032450|P2|STARTED|Double-blind Phase||136
8531787|NCT00312221|21032451|P1|STARTED|Double-blind Phase||0
8531788|NCT00312221|21032448|P4|NOT COMPLETED|Open-label Run-in Period||0
8531789|NCT00312221|21032449|P3|NOT COMPLETED|Open-label Run-in Period||0
8531790|NCT00312221|21032450|P2|NOT COMPLETED|Open-label Run-in Period||0
8531791|NCT00312221|21032451|P1|NOT COMPLETED|Open-label Run-in Period||234
8531792|NCT00312221|21032448|P4|COMPLETED|Open-label Run-in Period||0
8531793|NCT00312221|21032449|P3|COMPLETED|Open-label Run-in Period||0
8531794|NCT00312221|21032450|P2|COMPLETED|Open-label Run-in Period||0
8531795|NCT00312221|21032451|P1|COMPLETED|Open-label Run-in Period||418
8531796|NCT00312221|21032448|P4|STARTED|Open-label Run-in Period||0
8531797|NCT00312221|21032449|P3|STARTED|Open-label Run-in Period||0
8531798|NCT00312221|21032450|P2|STARTED|Open-label Run-in Period||0
8531799|NCT00312221|21032451|P1|STARTED|Open-label Run-in Period||652
8531800|NCT00312208|21032471|P2|NOT COMPLETED|Overall Study||123
8531801|NCT00312208|21032472|P1|NOT COMPLETED|Overall Study||172
8531802|NCT00312208|21032471|P2|COMPLETED|Overall Study||1526
8531803|NCT00312208|21032472|P1|COMPLETED|Overall Study||1477
8531804|NCT00312208|21032471|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
8531805|NCT00312208|21032472|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
8531806|NCT00312195|21032482|P2|NOT COMPLETED|Overall Study||6
8531807|NCT00312195|21032483|P1|NOT COMPLETED|Overall Study||6
8531808|NCT00312195|21032482|P2|COMPLETED|Overall Study||123
8531809|NCT00312195|21032483|P1|COMPLETED|Overall Study||132
8531810|NCT00312195|21032482|P2|STARTED|Overall Study||129
8531811|NCT00312195|21032483|P1|STARTED|Overall Study||138
8531812|NCT00311766|21032499|P2|NOT COMPLETED|Overall Study||5
8531813|NCT00311766|21032500|P1|NOT COMPLETED|Overall Study||0
8531814|NCT00311766|21032499|P2|COMPLETED|Overall Study||17
8531815|NCT00311766|21032500|P1|COMPLETED|Overall Study||8
8531816|NCT00311766|21032499|P2|STARTED|Overall Study||22
8531817|NCT00311766|21032500|P1|STARTED|Overall Study||8
8531818|NCT00311623|21032511|P3|NOT COMPLETED|Overall Study||2
8531819|NCT00311623|21032512|P2|NOT COMPLETED|Overall Study||0
8531820|NCT00311623|21032513|P1|NOT COMPLETED|Overall Study||0
8531821|NCT00311623|21032511|P3|COMPLETED|Overall Study||0
8531822|NCT00311623|21032512|P2|COMPLETED|Overall Study||20
8531823|NCT00311623|21032513|P1|COMPLETED|Overall Study||10
8531824|NCT00311623|21032511|P3|STARTED|Overall Study||2
8531825|NCT00311623|21032512|P2|STARTED|Overall Study||20
8531826|NCT00311623|21032513|P1|STARTED|Overall Study||10
8531827|NCT00311584|21032555|P2|NOT COMPLETED|Overall Study||23
8531828|NCT00311584|21032556|P1|NOT COMPLETED|Overall Study||20
8531829|NCT00311584|21032555|P2|COMPLETED|Overall Study||7
8531830|NCT00311584|21032556|P1|COMPLETED|Overall Study||9
8531831|NCT00311584|21032555|P2|STARTED|Overall Study||30
8531832|NCT00311584|21032556|P1|STARTED|Overall Study||29
8531833|NCT00311402|21032564|P2|NOT COMPLETED|Overall Study||177
8531834|NCT00311402|21032565|P1|NOT COMPLETED|Overall Study||210
8531835|NCT00311402|21032564|P2|COMPLETED|Overall Study||462
8531836|NCT00311402|21032565|P1|COMPLETED|Overall Study||445
8531837|NCT00311402|21032564|P2|STARTED|Overall Study||639
8531838|NCT00311402|21032565|P1|STARTED|Overall Study||655
8531839|NCT00311376|21032592|P3|NOT COMPLETED|Treatment Cycle 2||0
8531840|NCT00311376|21032593|P2|NOT COMPLETED|Treatment Cycle 2||13
8531841|NCT00311376|21032594|P1|NOT COMPLETED|Treatment Cycle 2||9
8531842|NCT00311376|21032592|P3|COMPLETED|Treatment Cycle 2||0
8531843|NCT00311376|21032593|P2|COMPLETED|Treatment Cycle 2||112
8531844|NCT00311376|21032594|P1|COMPLETED|Treatment Cycle 2||106
8531845|NCT00311376|21032592|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
8531846|NCT00311376|21032593|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
8531847|NCT00311376|21032594|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
8531848|NCT00311376|21032592|P3|NOT COMPLETED|Treatment Cycle 1||17
8531849|NCT00311376|21032593|P2|NOT COMPLETED|Treatment Cycle 1||17
8531850|NCT00311376|21032594|P1|NOT COMPLETED|Treatment Cycle 1||27
8531851|NCT00311376|21032592|P3|COMPLETED|Treatment Cycle 1||132
8531852|NCT00311376|21032593|P2|COMPLETED|Treatment Cycle 1||118
8531853|NCT00311376|21032594|P1|COMPLETED|Treatment Cycle 1||105
8531854|NCT00311376|21032592|P3|STARTED|Treatment Cycle 1||149
8531855|NCT00311376|21032593|P2|STARTED|Treatment Cycle 1||135
8531856|NCT00311376|21032594|P1|STARTED|Treatment Cycle 1||132
8531857|NCT00311363|21032614|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
8531858|NCT00311363|21032615|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
8531859|NCT00311363|21032616|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
8531860|NCT00311363|21032614|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
8531861|NCT00311363|21032615|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
8531862|NCT00311363|21032616|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
8531863|NCT00311363|21032614|P3|STARTED|12-Week Double-Blind Treatment Period||96
8531864|NCT00311363|21032615|P2|STARTED|12-Week Double-Blind Treatment Period||98
8531865|NCT00311363|21032616|P1|STARTED|12-Week Double-Blind Treatment Period||0
8531866|NCT00311363|21032614|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
8531867|NCT00311363|21032615|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
8531868|NCT00311363|21032616|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
8531869|NCT00311363|21032614|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
8531870|NCT00311363|21032615|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
8531871|NCT00311363|21032616|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
8531872|NCT00311363|21032614|P3|STARTED|24-Week Single-Blind Treatment Period||0
8531873|NCT00311363|21032615|P2|STARTED|24-Week Single-Blind Treatment Period||0
8531874|NCT00311363|21032616|P1|STARTED|24-Week Single-Blind Treatment Period||327
8531875|NCT00311311|21032676|P2|NOT COMPLETED|Overall Study||9
8531876|NCT00311311|21032677|P1|NOT COMPLETED|Overall Study||8
8531877|NCT00311311|21032676|P2|COMPLETED|Overall Study||26
8531878|NCT00311311|21032677|P1|COMPLETED|Overall Study||29
8531879|NCT00311311|21032676|P2|STARTED|Overall Study||35
8531880|NCT00311311|21032677|P1|STARTED|Overall Study||37
8531881|NCT00311246|21032727|P1|NOT COMPLETED|Overall Study||0
8531882|NCT00311246|21032727|P1|COMPLETED|Overall Study||11
8531883|NCT00311246|21032727|P1|STARTED|Overall Study||11
8531884|NCT00311181|21032735|P1|NOT COMPLETED|Overall Study||96
8531885|NCT00311181|21032735|P1|COMPLETED|Overall Study||121
8531886|NCT00311181|21032735|P1|STARTED|Overall Study||217
8531887|NCT00311155|21032741|P1|NOT COMPLETED|Overall Study||93
8531888|NCT00311155|21032741|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
8531889|NCT00311155|21032741|P1|STARTED|Overall Study||694
8531890|NCT00310856|21032753|P3|NOT COMPLETED|Overall Study||8
8531892|NCT00310856|21032755|P1|NOT COMPLETED|Overall Study||5
8531893|NCT00310856|21032753|P3|COMPLETED|Overall Study||42
8531894|NCT00310856|21032754|P2|COMPLETED|Overall Study||56
8531895|NCT00310856|21032755|P1|COMPLETED|Overall Study||59
8531896|NCT00310856|21032753|P3|STARTED|Overall Study||50
8531897|NCT00310856|21032754|P2|STARTED|Overall Study||61
8531898|NCT00310856|21032755|P1|STARTED|Overall Study||64
8531899|NCT00310817|21032779|P4|NOT COMPLETED|Overall Study||8
8531900|NCT00310817|21032780|P3|NOT COMPLETED|Overall Study||8
8531901|NCT00310817|21032781|P2|NOT COMPLETED|Overall Study||8
8531902|NCT00310817|21032782|P1|NOT COMPLETED|Overall Study||11
8531903|NCT00310817|21032779|P4|COMPLETED|Overall Study||74
8531904|NCT00310817|21032780|P3|COMPLETED|Overall Study||120
8531905|NCT00310817|21032781|P2|COMPLETED|Overall Study||198
8531906|NCT00310817|21032782|P1|COMPLETED|Overall Study||196
8531907|NCT00310817|21032779|P4|STARTED|Overall Study||82
8531908|NCT00310817|21032780|P3|STARTED|Overall Study||128
8531909|NCT00310817|21032781|P2|STARTED|Overall Study||206
8531910|NCT00310817|21032782|P1|STARTED|Overall Study||207
8531911|NCT00310804|21032870|P2|NOT COMPLETED|Overall Study||0
8531912|NCT00310804|21032871|P1|NOT COMPLETED|Overall Study||5
8531913|NCT00310804|21032870|P2|COMPLETED|Overall Study||171
8531914|NCT00310804|21032871|P1|COMPLETED|Overall Study||1024
8531915|NCT00310804|21032870|P2|STARTED|Overall Study||171
8531916|NCT00310804|21032871|P1|STARTED|Overall Study||1029
8531917|NCT00310791|21032906|P2|NOT COMPLETED|Overall Study||10
8531918|NCT00310791|21032907|P1|NOT COMPLETED|Overall Study||10
8531919|NCT00310791|21032906|P2|COMPLETED|Overall Study||30
8531920|NCT00310791|21032907|P1|COMPLETED|Overall Study||30
8531921|NCT00310791|21032906|P2|STARTED|Overall Study||40
8531922|NCT00310791|21032907|P1|STARTED|Overall Study||40
8531923|NCT00310466|21032915|P2|NOT COMPLETED|Overall Study||12
8531924|NCT00310466|21032916|P1|NOT COMPLETED|Overall Study||18
8531925|NCT00310466|21032915|P2|COMPLETED|Overall Study||101
8531926|NCT00310466|21032916|P1|COMPLETED|Overall Study||95
8531927|NCT00310466|21032915|P2|STARTED|Overall Study||113
8531928|NCT00310466|21032916|P1|STARTED|Overall Study||113
8531929|NCT00310440|21032930|P2|NOT COMPLETED|Overall Study||13
8531930|NCT00310440|21032931|P1|NOT COMPLETED|Overall Study||26
8531931|NCT00310440|21032930|P2|COMPLETED|Overall Study||141
8531932|NCT00310440|21032931|P1|COMPLETED|Overall Study||139
8531933|NCT00310440|21032930|P2|STARTED|Overall Study||154
8531934|NCT00310440|21032931|P1|STARTED|Overall Study||165
8531935|NCT00310427|21032957|P2|NOT COMPLETED|Overall Study||1
8531936|NCT00310427|21032958|P1|NOT COMPLETED|Overall Study||2
8531937|NCT00310427|21032957|P2|COMPLETED|Overall Study||25
8531938|NCT00310427|21032958|P1|COMPLETED|Overall Study||25
8531939|NCT00310427|21032957|P2|STARTED|Overall Study||26
8531940|NCT00310427|21032958|P1|STARTED|Overall Study||27
8531941|NCT00310401|21032980|P2|NOT COMPLETED|Overall Study||0
8531942|NCT00310401|21032981|P1|NOT COMPLETED|Overall Study||0
8531943|NCT00310401|21032980|P2|COMPLETED|Overall Study||246
8531944|NCT00310401|21032981|P1|COMPLETED|Overall Study||260
8531945|NCT00310401|21032980|P2|STARTED|Overall Study||246
8531946|NCT00310401|21032981|P1|STARTED|Overall Study||260
8531947|NCT00310388|21032995|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
8531948|NCT00310388|21032996|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8531949|NCT00310388|21032995|P2|COMPLETED|Safety Follow-up Continuation Phase||13
8531950|NCT00310388|21032996|P1|COMPLETED|Safety Follow-up Continuation Phase||0
8531951|NCT00310388|21032995|P2|STARTED|Safety Follow-up Continuation Phase||26
8531952|NCT00310388|21032996|P1|STARTED|Safety Follow-up Continuation Phase||0
8531953|NCT00310388|21032995|P2|NOT COMPLETED|Primary Reporting Phase||0
8531954|NCT00310388|21032996|P1|NOT COMPLETED|Primary Reporting Phase||346
8531955|NCT00310388|21032995|P2|COMPLETED|Primary Reporting Phase||0
8531956|NCT00310388|21032996|P1|COMPLETED|Primary Reporting Phase||30
8531957|NCT00310388|21032995|P2|STARTED|Primary Reporting Phase||0
8531958|NCT00310388|21032996|P1|STARTED|Primary Reporting Phase||376
8531959|NCT00310375|21033038|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
8531960|NCT00310375|21033039|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8531961|NCT00310375|21033040|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8531962|NCT00310375|21033038|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
8531963|NCT00310375|21033039|P2|COMPLETED|Safety Follow-up Continuation Phase||0
8531964|NCT00310375|21033040|P1|COMPLETED|Safety Follow-up Continuation Phase||0
8531965|NCT00310375|21033038|P3|STARTED|Safety Follow-up Continuation Phase||19
8531966|NCT00310375|21033039|P2|STARTED|Safety Follow-up Continuation Phase||0
8531967|NCT00310375|21033040|P1|STARTED|Safety Follow-up Continuation Phase||0
8531968|NCT00310375|21033038|P3|NOT COMPLETED|Primary Reporting Phase||0
8531969|NCT00310375|21033039|P2|NOT COMPLETED|Primary Reporting Phase||68
8531970|NCT00310375|21033040|P1|NOT COMPLETED|Primary Reporting Phase||91
8531971|NCT00310375|21033038|P3|COMPLETED|Primary Reporting Phase||0
8531972|NCT00310375|21033039|P2|COMPLETED|Primary Reporting Phase||11
8531973|NCT00310375|21033040|P1|COMPLETED|Primary Reporting Phase||11
8531974|NCT00310375|21033038|P3|STARTED|Primary Reporting Phase||0
8531975|NCT00310375|21033039|P2|STARTED|Primary Reporting Phase||79
8531976|NCT00310375|21033040|P1|STARTED|Primary Reporting Phase||102
8531977|NCT00310362|21033085|P3|NOT COMPLETED|Overall Study||0
8531978|NCT00310362|21033086|P2|NOT COMPLETED|Overall Study||0
8531979|NCT00310362|21033087|P1|NOT COMPLETED|Overall Study||0
8531980|NCT00310362|21033085|P3|COMPLETED|Overall Study||1206
8531981|NCT00310362|21033086|P2|COMPLETED|Overall Study||1205
8531982|NCT00310362|21033087|P1|COMPLETED|Overall Study||1199
8531983|NCT00310362|21033085|P3|STARTED|Overall Study||1206
8531984|NCT00310362|21033086|P2|STARTED|Overall Study||1205
8531985|NCT00310362|21033087|P1|STARTED|Overall Study||1199
8531986|NCT00310310|21033106|P2|NOT COMPLETED|Overall Study||20
8531987|NCT00310310|21033107|P1|NOT COMPLETED|Overall Study||30
8531988|NCT00310310|21033106|P2|COMPLETED|Overall Study||100
8531989|NCT00310310|21033107|P1|COMPLETED|Overall Study||90
8531990|NCT00310310|21033106|P2|STARTED|Overall Study||120
8531991|NCT00310310|21033107|P1|STARTED|Overall Study||120
8532016|NCT00310076|21033168|P1|NOT COMPLETED|Overall Study||3
8532017|NCT00310076|21033168|P1|COMPLETED|Overall Study||26
8532018|NCT00310076|21033168|P1|STARTED|Overall Study||29
8532019|NCT00310050|21033174|P1|NOT COMPLETED|Overall Study||1
8532020|NCT00310050|21033174|P1|COMPLETED|Overall Study||3
8532021|NCT00310050|21033174|P1|STARTED|Overall Study||4
8532022|NCT00310037|21033185|P2|NOT COMPLETED|Overall Study||17
8532023|NCT00310037|21033186|P1|NOT COMPLETED|Overall Study||18
8532024|NCT00310037|21033185|P2|COMPLETED|Overall Study||33
8532025|NCT00310037|21033186|P1|COMPLETED|Overall Study||34
8532026|NCT00310037|21033185|P2|STARTED|Overall Study||50
8532027|NCT00310037|21033186|P1|STARTED|Overall Study||52
8532028|NCT00309985|21033200|P2|NOT COMPLETED|Overall Study||1
8532029|NCT00309985|21033201|P1|NOT COMPLETED|Overall Study||62
8532030|NCT00309985|21033200|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
8532031|NCT00309985|21033201|P1|COMPLETED|Overall Study||335
8532032|NCT00309985|21033200|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
8532033|NCT00309985|21033201|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
8532034|NCT00309985|21033200|P2|Toxicity Analysis|Overall Study||392
8532035|NCT00309985|21033201|P1|Toxicity Analysis|Overall Study||390
8532036|NCT00309985|21033200|P2|STARTED|Overall Study||393
8532037|NCT00309985|21033201|P1|STARTED|Overall Study||397
8532038|NCT00309959|21033217|P1|NOT COMPLETED|Overall Study||2
8532039|NCT00309959|21033217|P1|COMPLETED|Overall Study||35
8532040|NCT00309959|21033217|P1|STARTED|Overall Study||37
8532041|NCT00309946|21033226|P1|NOT COMPLETED|Overall Study||1
8532042|NCT00309946|21033226|P1|COMPLETED|Overall Study||50
8532043|NCT00309946|21033226|P1|STARTED|Overall Study||51
8532044|NCT00309907|21033232|P1|NOT COMPLETED|Overall Study||20
8532045|NCT00309907|21033232|P1|COMPLETED|Overall Study||19
8532046|NCT00309907|21033232|P1|STARTED|Overall Study||39
8532047|NCT00309842|21033241|P1|NOT COMPLETED|Overall Study||1
8532048|NCT00309842|21033241|P1|COMPLETED|Overall Study||212
8532049|NCT00309842|21033241|P1|STARTED|Overall Study||213
8532050|NCT00309777|21033259|P4|NOT COMPLETED|Overall Study||4
8532051|NCT00309777|21033260|P3|NOT COMPLETED|Overall Study||19
8532052|NCT00309777|21033261|P2|NOT COMPLETED|Overall Study||9
8532053|NCT00309777|21033262|P1|NOT COMPLETED|Overall Study||23
8532054|NCT00309777|21033259|P4|COMPLETED|Overall Study||107
8532055|NCT00309777|21033260|P3|COMPLETED|Overall Study||304
8532056|NCT00309777|21033261|P2|COMPLETED|Overall Study||99
8532057|NCT00309777|21033262|P1|COMPLETED|Overall Study||292
8532058|NCT00309777|21033259|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
8532059|NCT00309777|21033260|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
8532060|NCT00309777|21033261|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
8532061|NCT00309777|21033262|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
8532062|NCT00309777|21033259|P4|STARTED|Overall Study||111
8532063|NCT00309777|21033260|P3|STARTED|Overall Study||323
8532064|NCT00309777|21033261|P2|STARTED|Overall Study||108
8532065|NCT00309777|21033262|P1|STARTED|Overall Study||315
8532066|NCT00309751|21033278|P2|NOT COMPLETED|Overall Study||15
8532067|NCT00309751|21033279|P1|NOT COMPLETED|Overall Study||31
8532068|NCT00309751|21033278|P2|COMPLETED|Overall Study||124
8532069|NCT00309751|21033279|P1|COMPLETED|Overall Study||248
8532070|NCT00309751|21033278|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
8532071|NCT00309751|21033279|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
8532072|NCT00309751|21033278|P2|STARTED|Overall Study||139
8532073|NCT00309751|21033279|P1|STARTED|Overall Study||279
8532074|NCT00309738|21033289|P2|NOT COMPLETED|Overall Study||12
8532075|NCT00309738|21033290|P1|NOT COMPLETED|Overall Study||13
8532076|NCT00309738|21033289|P2|COMPLETED|Overall Study||107
8532077|NCT00309738|21033290|P1|COMPLETED|Overall Study||223
8532078|NCT00309738|21033289|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
8532079|NCT00309738|21033290|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
8532080|NCT00309738|21033289|P2|STARTED|Overall Study||119
8532081|NCT00309738|21033290|P1|STARTED|Overall Study||236
8532082|NCT00309608|21033303|P5|NOT COMPLETED|Overall Study||4
8532083|NCT00309608|21033304|P4|NOT COMPLETED|Overall Study||6
8532084|NCT00309608|21033305|P3|NOT COMPLETED|Overall Study||10
8532085|NCT00309608|21033306|P2|NOT COMPLETED|Overall Study||13
8532086|NCT00309608|21033307|P1|NOT COMPLETED|Overall Study||14
8532087|NCT00309608|21033303|P5|COMPLETED|Overall Study||61
8532088|NCT00309608|21033304|P4|COMPLETED|Overall Study||60
8532089|NCT00309608|21033305|P3|COMPLETED|Overall Study||56
8532090|NCT00309608|21033306|P2|COMPLETED|Overall Study||52
8532091|NCT00309608|21033307|P1|COMPLETED|Overall Study||57
8532092|NCT00309608|21033303|P5|STARTED|Overall Study||65
8532093|NCT00309608|21033304|P4|STARTED|Overall Study||66
8532094|NCT00309608|21033305|P3|STARTED|Overall Study||66
8532095|NCT00309608|21033306|P2|STARTED|Overall Study||65
8532096|NCT00309608|21033307|P1|STARTED|Overall Study||71
8532097|NCT00309465|21033334|P6|NOT COMPLETED|Overall Study||0
8532098|NCT00309465|21033335|P5|NOT COMPLETED|Overall Study||0
8532099|NCT00309465|21033336|P4|NOT COMPLETED|Overall Study||1
8532100|NCT00309465|21033337|P3|NOT COMPLETED|Overall Study||0
8532101|NCT00309465|21033338|P2|NOT COMPLETED|Overall Study||0
8532102|NCT00309465|21033339|P1|NOT COMPLETED|Overall Study||0
8532103|NCT00309465|21033334|P6|COMPLETED|Overall Study||76
8532104|NCT00309465|21033335|P5|COMPLETED|Overall Study||76
8532105|NCT00309465|21033336|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
8532106|NCT00309465|21033337|P3|COMPLETED|Overall Study||58
8532107|NCT00309465|21033338|P2|COMPLETED|Overall Study||58
8532108|NCT00309465|21033339|P1|COMPLETED|Overall Study||58
8532109|NCT00309465|21033334|P6|STARTED|Overall Study||76
8532110|NCT00309465|21033335|P5|STARTED|Overall Study||76
8532111|NCT00309465|21033336|P4|STARTED|Overall Study||76
8532112|NCT00309465|21033337|P3|STARTED|Overall Study||58
8532113|NCT00309465|21033338|P2|STARTED|Overall Study||58
8532114|NCT00309465|21033339|P1|STARTED|Overall Study||58
8532115|NCT00309452|21033355|P2|NOT COMPLETED|Overall Study||0
8532116|NCT00309452|21033356|P1|NOT COMPLETED|Overall Study||3
8532117|NCT00309452|21033355|P2|COMPLETED|Overall Study||60
8532118|NCT00309452|21033356|P1|COMPLETED|Overall Study||57
8532119|NCT00309452|21033355|P2|STARTED|Overall Study||60
8532120|NCT00309452|21033356|P1|STARTED|Overall Study||60
8532121|NCT00309387|21033384|P2|NOT COMPLETED|Overall Study||159
8532122|NCT00309387|21033385|P1|NOT COMPLETED|Overall Study||142
8532123|NCT00309387|21033384|P2|COMPLETED|Overall Study||351
8532124|NCT00309387|21033385|P1|COMPLETED|Overall Study||368
8532125|NCT00309387|21033384|P2|STARTED|Overall Study||510
8532126|NCT00309387|21033385|P1|STARTED|Overall Study||510
8532127|NCT00309244|21033403|P2|NOT COMPLETED|Overall Study||97
8532128|NCT00309244|21033404|P1|NOT COMPLETED|Overall Study||118
8532129|NCT00309244|21033403|P2|COMPLETED|Overall Study||246
8532130|NCT00309244|21033404|P1|COMPLETED|Overall Study||216
8532131|NCT00309244|21033403|P2|STARTED|Overall Study||343
8532132|NCT00309244|21033404|P1|STARTED|Overall Study||334
8532133|NCT00309166|21033426|P2|NOT COMPLETED|Overall Study||3
8532134|NCT00309166|21033427|P1|NOT COMPLETED|Overall Study||5
8532135|NCT00309166|21033426|P2|COMPLETED|Overall Study||86
8532136|NCT00309166|21033427|P1|COMPLETED|Overall Study||176
8532137|NCT00309166|21033426|P2|STARTED|Overall Study||89
8532138|NCT00309166|21033427|P1|STARTED|Overall Study||181
8532139|NCT00309140|21033453|P1|NOT COMPLETED|Overall Study||0
8532140|NCT00309140|21033453|P1|COMPLETED|Overall Study||23
8532141|NCT00309140|21033453|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
8532142|NCT00309140|21033453|P1|STARTED|Overall Study||23
8532143|NCT00308997|21033461|P2|NOT COMPLETED|Overall Study||1
8532144|NCT00308997|21033462|P1|NOT COMPLETED|Overall Study||1
8532145|NCT00308997|21033461|P2|COMPLETED|Overall Study||28
8532146|NCT00308997|21033462|P1|COMPLETED|Overall Study||55
8532147|NCT00308997|21033461|P2|STARTED|Overall Study||29
8532148|NCT00308997|21033462|P1|STARTED|Overall Study||56
8532149|NCT00308737|21033481|P3|NOT COMPLETED|Overall Study||37
8532150|NCT00308737|21033482|P2|NOT COMPLETED|Overall Study||289
8532151|NCT00308737|21033483|P1|NOT COMPLETED|Overall Study||463
8532152|NCT00308737|21033481|P3|COMPLETED|Overall Study||127
8532153|NCT00308737|21033482|P2|COMPLETED|Overall Study||662
8532154|NCT00308737|21033483|P1|COMPLETED|Overall Study||475
8532155|NCT00308737|21033481|P3|STARTED|Overall Study||164
8532156|NCT00308737|21033482|P2|STARTED|Overall Study||951
8532157|NCT00308737|21033483|P1|STARTED|Overall Study||938
8532158|NCT00308711|21033523|P3|NOT COMPLETED|Overall Study||5
8532159|NCT00308711|21033524|P2|NOT COMPLETED|Overall Study||4
8532160|NCT00308711|21033525|P1|NOT COMPLETED|Overall Study||2
8532161|NCT00308711|21033523|P3|COMPLETED|Overall Study||431
8532162|NCT00308711|21033524|P2|COMPLETED|Overall Study||440
8532163|NCT00308711|21033525|P1|COMPLETED|Overall Study||426
8532164|NCT00308711|21033523|P3|STARTED|Overall Study||436
8532165|NCT00308711|21033524|P2|STARTED|Overall Study||444
8532166|NCT00308711|21033525|P1|STARTED|Overall Study||428
8532167|NCT00308620|21033560|P3|NOT COMPLETED|Overall Study||1
8532168|NCT00308620|21033561|P2|NOT COMPLETED|Overall Study||1
8532169|NCT00308620|21033562|P1|NOT COMPLETED|Overall Study||1
8532170|NCT00308620|21033560|P3|COMPLETED|Overall Study||5
8532171|NCT00308620|21033561|P2|COMPLETED|Overall Study||3
8532172|NCT00308620|21033562|P1|COMPLETED|Overall Study||2
8532173|NCT00308620|21033560|P3|STARTED|Overall Study||6
8532174|NCT00308620|21033561|P2|STARTED|Overall Study||4
8532175|NCT00308620|21033562|P1|STARTED|Overall Study||3
8532176|NCT00308581|21033571|P3|NOT COMPLETED|Randomized Maintenance Phase||0
8532177|NCT00308581|21033572|P2|NOT COMPLETED|Randomized Maintenance Phase||103
8532178|NCT00308581|21033573|P1|NOT COMPLETED|Randomized Maintenance Phase||105
8532179|NCT00308581|21033571|P3|COMPLETED|Randomized Maintenance Phase||0
8532180|NCT00308581|21033572|P2|COMPLETED|Randomized Maintenance Phase||83
8532181|NCT00308581|21033573|P1|COMPLETED|Randomized Maintenance Phase||82
8532182|NCT00308581|21033571|P3|STARTED|Randomized Maintenance Phase||0
8532183|NCT00308581|21033572|P2|STARTED|Randomized Maintenance Phase||186
8532184|NCT00308581|21033573|P1|STARTED|Randomized Maintenance Phase||187
8532185|NCT00308581|21033571|P3|NOT COMPLETED|Induction Phase||166
8532186|NCT00308581|21033572|P2|NOT COMPLETED|Induction Phase||0
8532187|NCT00308581|21033573|P1|NOT COMPLETED|Induction Phase||0
8532188|NCT00308581|21033571|P3|COMPLETED|Induction Phase||373
8532189|NCT00308581|21033572|P2|COMPLETED|Induction Phase|Not applicable in this period|0
8532190|NCT00308581|21033573|P1|COMPLETED|Induction Phase|Not applicable in this period|0
8532191|NCT00308581|21033571|P3|STARTED|Induction Phase||539
8532192|NCT00308581|21033572|P2|STARTED|Induction Phase|Not applicable in this period|0
8532193|NCT00308581|21033573|P1|STARTED|Induction Phase|Not applicable in this period|0
8532194|NCT00308555|21033699|P2|NOT COMPLETED|Overall Study||0
8532195|NCT00308555|21033700|P1|NOT COMPLETED|Overall Study||3
8532196|NCT00308555|21033699|P2|COMPLETED|Overall Study||11
8532197|NCT00308555|21033700|P1|COMPLETED|Overall Study||10
8532198|NCT00308555|21033699|P2|STARTED|Overall Study||11
8532199|NCT00308555|21033700|P1|STARTED|Overall Study||13
8532200|NCT00308516|21033708|P2|NOT COMPLETED|Overall Study||21
8532201|NCT00308516|21033709|P1|NOT COMPLETED|Overall Study||29
8532202|NCT00308516|21033708|P2|COMPLETED|Overall Study||10
8532203|NCT00308516|21033709|P1|COMPLETED|Overall Study||6
8532204|NCT00308516|21033708|P2|STARTED|Overall Study||31
8532205|NCT00308516|21033709|P1|STARTED|Overall Study||35
8532206|NCT00308308|21033717|P2|NOT COMPLETED|Overall Study||68
8532207|NCT00308308|21033718|P1|NOT COMPLETED|Overall Study||103
8532208|NCT00308308|21033717|P2|COMPLETED|Overall Study||220
8532209|NCT00308308|21033718|P1|COMPLETED|Overall Study||198
8532210|NCT00308308|21033717|P2|STARTED|Overall Study||288
8532211|NCT00308308|21033718|P1|STARTED|Overall Study||301
8532212|NCT00308282|21033742|P4|NOT COMPLETED|Overall Study||2
8532213|NCT00308282|21033743|P3|NOT COMPLETED|Overall Study||1
8532214|NCT00308282|21033744|P2|NOT COMPLETED|Overall Study||4
8532215|NCT00308282|21033745|P1|NOT COMPLETED|Overall Study||3
8532216|NCT00308282|21033742|P4|COMPLETED|Overall Study||32
8532217|NCT00308282|21033743|P3|COMPLETED|Overall Study||33
8532218|NCT00308282|21033744|P2|COMPLETED|Overall Study||30
8532219|NCT00308282|21033745|P1|COMPLETED|Overall Study||31
8532220|NCT00308282|21033742|P4|Received at Least One Dose of Study Drug|Overall Study||34
8532221|NCT00308282|21033743|P3|Received at Least One Dose of Study Drug|Overall Study||34
8532222|NCT00308282|21033744|P2|Received at Least One Dose of Study Drug|Overall Study||34
8532223|NCT00308282|21033745|P1|Received at Least One Dose of Study Drug|Overall Study||34
8532224|NCT00308282|21033742|P4|STARTED|Overall Study||34
8532225|NCT00308282|21033743|P3|STARTED|Overall Study||34
8532226|NCT00308282|21033744|P2|STARTED|Overall Study||34
8532227|NCT00308282|21033745|P1|STARTED|Overall Study||34
8532228|NCT00308230|21033785|P3|NOT COMPLETED|Overall Study||0
8532229|NCT00308230|21033786|P2|NOT COMPLETED|Overall Study||0
8532230|NCT00308230|21033787|P1|NOT COMPLETED|Overall Study||0
8532231|NCT00308230|21033785|P3|COMPLETED|Overall Study||20
8532232|NCT00308230|21033786|P2|COMPLETED|Overall Study||8
8532233|NCT00308230|21033787|P1|COMPLETED|Overall Study||6
8532234|NCT00308230|21033785|P3|STARTED|Overall Study||20
8532235|NCT00308230|21033786|P2|STARTED|Overall Study||8
8532236|NCT00308230|21033787|P1|STARTED|Overall Study||6
8532237|NCT00308139|21033797|P2|NOT COMPLETED|Overall Study||87
8532238|NCT00308139|21033798|P1|NOT COMPLETED|Overall Study||94
8532239|NCT00308139|21033797|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
8532240|NCT00308139|21033798|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
8532241|NCT00308139|21033797|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
8532242|NCT00308139|21033798|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
8532243|NCT00308139|21033797|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
8532244|NCT00308139|21033798|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
8532245|NCT00308139|21033797|P2|Pharmacokinetics Population|Overall Study||0
8532246|NCT00308139|21033798|P1|Pharmacokinetics Population|Overall Study||129
8532247|NCT00308139|21033797|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
8532248|NCT00308139|21033798|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
8532249|NCT00308139|21033797|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
8532413|NCT00307125|21034293|P1|COMPLETED|Pilot Phase||0
8532250|NCT00308139|21033798|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
8532251|NCT00308139|21033797|P2|STARTED|Overall Study||151
8532252|NCT00308139|21033798|P1|STARTED|Overall Study||152
8532253|NCT00308113|21033872|P4|NOT COMPLETED|Overall Study||1
8532254|NCT00308113|21033873|P3|NOT COMPLETED|Overall Study||0
8532255|NCT00308113|21033874|P2|NOT COMPLETED|Overall Study||0
8532256|NCT00308113|21033875|P1|NOT COMPLETED|Overall Study||0
8532257|NCT00308113|21033872|P4|COMPLETED|Overall Study||1
8532258|NCT00308113|21033873|P3|COMPLETED|Overall Study||1
8532259|NCT00308113|21033874|P2|COMPLETED|Overall Study||0
8532260|NCT00308113|21033875|P1|COMPLETED|Overall Study||0
8532261|NCT00308113|21033872|P4|STARTED|Overall Study||2
8532262|NCT00308113|21033873|P3|STARTED|Overall Study||1
8532263|NCT00308113|21033874|P2|STARTED|Overall Study||0
8532264|NCT00308113|21033875|P1|STARTED|Overall Study||0
8532265|NCT00308087|21033895|P2|NOT COMPLETED|Overall Study||37
8532266|NCT00308087|21033896|P1|NOT COMPLETED|Overall Study||36
8532267|NCT00308087|21033895|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
8532268|NCT00308087|21033896|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
8532269|NCT00308087|21033895|P2|STARTED|Overall Study||38
8532270|NCT00308087|21033896|P1|STARTED|Overall Study||37
8532271|NCT00308074|21033912|P1|NOT COMPLETED|Overall Study||1
8532272|NCT00308074|21033912|P1|COMPLETED|Overall Study||13
8532273|NCT00308074|21033912|P1|STARTED|Overall Study||14
8532274|NCT00308061|21033921|P2|NOT COMPLETED|Overall Study||0
8532275|NCT00308061|21033922|P1|NOT COMPLETED|Overall Study||0
8532276|NCT00308061|21033921|P2|COMPLETED|Overall Study||20
8532277|NCT00308061|21033922|P1|COMPLETED|Overall Study||20
8532278|NCT00308061|21033921|P2|STARTED|Overall Study||20
8532279|NCT00308061|21033922|P1|STARTED|Overall Study||20
8532280|NCT00307931|21033929|P1|NOT COMPLETED|Overall Study||1
8532281|NCT00307931|21033929|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
8532282|NCT00307931|21033929|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
8532283|NCT00307801|21033946|P2|NOT COMPLETED|Overall Study||17
8532284|NCT00307801|21033947|P1|NOT COMPLETED|Overall Study||32
8532285|NCT00307801|21033946|P2|COMPLETED|Overall Study||65
8532286|NCT00307801|21033947|P1|COMPLETED|Overall Study||117
8532287|NCT00307801|21033946|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
8532288|NCT00307801|21033947|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
8532289|NCT00307801|21033946|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
8532290|NCT00307801|21033947|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
8532291|NCT00307801|21033946|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
8532292|NCT00307801|21033947|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
8532293|NCT00307801|21033946|P2|Subjects Received Treatment|Overall Study||81
8532294|NCT00307801|21033947|P1|Subjects Received Treatment|Overall Study||145
8532295|NCT00307801|21033946|P2|STARTED|Overall Study||82
8532296|NCT00307801|21033947|P1|STARTED|Overall Study||149
8532297|NCT00307736|21034059|P4|NOT COMPLETED|Overall Study||3
8532298|NCT00307736|21034060|P3|NOT COMPLETED|Overall Study||3
8532299|NCT00307736|21034061|P2|NOT COMPLETED|Overall Study||0
8532300|NCT00307736|21034062|P1|NOT COMPLETED|Overall Study||0
8532301|NCT00307736|21034059|P4|COMPLETED|Overall Study||20
8532302|NCT00307736|21034060|P3|COMPLETED|Overall Study||0
8532303|NCT00307736|21034061|P2|COMPLETED|Overall Study||3
8532304|NCT00307736|21034062|P1|COMPLETED|Overall Study||3
8532305|NCT00307736|21034059|P4|STARTED|Overall Study||23
8532306|NCT00307736|21034060|P3|STARTED|Overall Study||3
8532307|NCT00307736|21034061|P2|STARTED|Overall Study||3
8532308|NCT00307736|21034062|P1|STARTED|Overall Study||3
8532309|NCT00307684|21034073|P3|NOT COMPLETED|Double Blind Phase||0
8532310|NCT00307684|21034074|P2|NOT COMPLETED|Double Blind Phase||5
8532311|NCT00307684|21034075|P1|NOT COMPLETED|Double Blind Phase||2
8532312|NCT00307684|21034073|P3|COMPLETED|Double Blind Phase||0
8532313|NCT00307684|21034074|P2|COMPLETED|Double Blind Phase||17
8532314|NCT00307684|21034075|P1|COMPLETED|Double Blind Phase||21
8532315|NCT00307684|21034073|P3|STARTED|Double Blind Phase||0
8532316|NCT00307684|21034074|P2|STARTED|Double Blind Phase||22
8532317|NCT00307684|21034075|P1|STARTED|Double Blind Phase||23
8532318|NCT00307684|21034073|P3|NOT COMPLETED|Open Label Phase||56
8532319|NCT00307684|21034074|P2|NOT COMPLETED|Open Label Phase||0
8532320|NCT00307684|21034075|P1|NOT COMPLETED|Open Label Phase||0
8532321|NCT00307684|21034073|P3|COMPLETED|Open Label Phase||99
8532322|NCT00307684|21034074|P2|COMPLETED|Open Label Phase||0
8532323|NCT00307684|21034075|P1|COMPLETED|Open Label Phase||0
8532324|NCT00307684|21034073|P3|STARTED|Open Label Phase|1 screening failure|155
8532325|NCT00307684|21034074|P2|STARTED|Open Label Phase||0
8532326|NCT00307684|21034075|P1|STARTED|Open Label Phase||0
8532327|NCT00307489|21034103|P2|NOT COMPLETED|Week 48 Through Week 168||6
8532328|NCT00307489|21034104|P1|NOT COMPLETED|Week 48 Through Week 168||6
8532329|NCT00307489|21034103|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
8532330|NCT00307489|21034104|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
8532331|NCT00307489|21034103|P2|STARTED|Week 48 Through Week 168||50
8532332|NCT00307489|21034104|P1|STARTED|Week 48 Through Week 168||52
8532333|NCT00307489|21034103|P2|NOT COMPLETED|Baseline Through Week 48||2
8532334|NCT00307489|21034104|P1|NOT COMPLETED|Baseline Through Week 48||1
8532335|NCT00307489|21034103|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
8532336|NCT00307489|21034104|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
8532337|NCT00307489|21034103|P2|STARTED|Baseline Through Week 48||52
8532338|NCT00307489|21034104|P1|STARTED|Baseline Through Week 48||53
8532339|NCT00307437|21034149|P7|NOT COMPLETED|After Controlled Period||113
8532340|NCT00307437|21034150|P6|NOT COMPLETED|After Controlled Period||122
8532341|NCT00307437|21034151|P5|NOT COMPLETED|After Controlled Period||55
8532342|NCT00307437|21034152|P4|NOT COMPLETED|After Controlled Period||58
8532343|NCT00307437|21034153|P3|NOT COMPLETED|After Controlled Period||0
8532344|NCT00307437|21034154|P2|NOT COMPLETED|After Controlled Period||0
8532345|NCT00307437|21034155|P1|NOT COMPLETED|After Controlled Period||0
8532346|NCT00307437|21034149|P7|COMPLETED|After Controlled Period||289
8532347|NCT00307437|21034150|P6|COMPLETED|After Controlled Period||281
8532348|NCT00307437|21034151|P5|COMPLETED|After Controlled Period||140
8532349|NCT00307437|21034152|P4|COMPLETED|After Controlled Period||139
8532350|NCT00307437|21034153|P3|COMPLETED|After Controlled Period||0
8532351|NCT00307437|21034154|P2|COMPLETED|After Controlled Period||0
8532352|NCT00307437|21034155|P1|COMPLETED|After Controlled Period||0
8532353|NCT00307437|21034149|P7|STARTED|After Controlled Period||402
8532354|NCT00307437|21034150|P6|STARTED|After Controlled Period||403
8532355|NCT00307437|21034151|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
8532356|NCT00307437|21034152|P4|STARTED|After Controlled Period||197
8532357|NCT00307437|21034153|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8532358|NCT00307437|21034154|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8532359|NCT00307437|21034155|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8532360|NCT00307437|21034149|P7|NOT COMPLETED|Controlled Period||0
8532361|NCT00307437|21034150|P6|NOT COMPLETED|Controlled Period||0
8532362|NCT00307437|21034151|P5|NOT COMPLETED|Controlled Period||0
8532363|NCT00307437|21034152|P4|NOT COMPLETED|Controlled Period||0
8532364|NCT00307437|21034153|P3|NOT COMPLETED|Controlled Period||9
8532365|NCT00307437|21034154|P2|NOT COMPLETED|Controlled Period||6
8532366|NCT00307437|21034155|P1|NOT COMPLETED|Controlled Period||16
8532367|NCT00307437|21034149|P7|COMPLETED|Controlled Period||0
8532368|NCT00307437|21034150|P6|COMPLETED|Controlled Period||0
8532369|NCT00307437|21034151|P5|COMPLETED|Controlled Period||0
8532370|NCT00307437|21034152|P4|COMPLETED|Controlled Period||0
8532371|NCT00307437|21034153|P3|COMPLETED|Controlled Period||402
8532372|NCT00307437|21034154|P2|COMPLETED|Controlled Period||403
8532373|NCT00307437|21034155|P1|COMPLETED|Controlled Period||394
8532374|NCT00307437|21034149|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532375|NCT00307437|21034150|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532376|NCT00307437|21034151|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532377|NCT00307437|21034152|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532378|NCT00307437|21034153|P3|STARTED|Controlled Period||411
8532379|NCT00307437|21034154|P2|STARTED|Controlled Period||409
8532380|NCT00307437|21034155|P1|STARTED|Controlled Period||410
8532381|NCT00307333|21034181|P2|NOT COMPLETED|Overall Study||3
8532382|NCT00307333|21034182|P1|NOT COMPLETED|Overall Study||11
8532383|NCT00307333|21034181|P2|COMPLETED|Overall Study||1489
8532384|NCT00307333|21034182|P1|COMPLETED|Overall Study||1500
8532385|NCT00307333|21034181|P2|STARTED|Overall Study||1492
8532386|NCT00307333|21034182|P1|STARTED|Overall Study||1511
8532387|NCT00307294|21034194|P1|NOT COMPLETED|Overall Study||1
8532388|NCT00307294|21034194|P1|COMPLETED|Overall Study||39
8532389|NCT00307294|21034194|P1|STARTED|Overall Study||40
8532390|NCT00307164|21034203|P2|NOT COMPLETED|Overall Study||14
8532391|NCT00307164|21034204|P1|NOT COMPLETED|Overall Study||15
8532392|NCT00307164|21034203|P2|COMPLETED|Overall Study||68
8532393|NCT00307164|21034204|P1|COMPLETED|Overall Study||68
8532394|NCT00307164|21034203|P2|STARTED|Overall Study||82
8532395|NCT00307164|21034204|P1|STARTED|Overall Study||83
8532396|NCT00307151|21034244|P4|NOT COMPLETED|Overall Study||11
8532397|NCT00307151|21034245|P3|NOT COMPLETED|Overall Study||20
8532398|NCT00307151|21034246|P2|NOT COMPLETED|Overall Study||7
8532399|NCT00307151|21034247|P1|NOT COMPLETED|Overall Study||11
8532400|NCT00307151|21034244|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
8532401|NCT00307151|21034245|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
8532402|NCT00307151|21034246|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
8532403|NCT00307151|21034247|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
8532404|NCT00307151|21034244|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
8532405|NCT00307151|21034245|P3|STARTED|Overall Study||147
8532406|NCT00307151|21034246|P2|STARTED|Overall Study||82
8532407|NCT00307151|21034247|P1|STARTED|Overall Study||82
8532408|NCT00307125|21034291|P3|NOT COMPLETED|Pilot Phase||1
8532409|NCT00307125|21034292|P2|NOT COMPLETED|Pilot Phase||2
8532410|NCT00307125|21034293|P1|NOT COMPLETED|Pilot Phase||0
8532411|NCT00307125|21034291|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
8532412|NCT00307125|21034292|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
8532414|NCT00307125|21034291|P3|STARTED|Pilot Phase||7
8532415|NCT00307125|21034292|P2|STARTED|Pilot Phase||15
8532416|NCT00307125|21034293|P1|STARTED|Pilot Phase||0
8532417|NCT00307125|21034291|P3|NOT COMPLETED|Screening Phase||0
8532418|NCT00307125|21034292|P2|NOT COMPLETED|Screening Phase||0
8532419|NCT00307125|21034293|P1|NOT COMPLETED|Screening Phase||454
8532420|NCT00307125|21034291|P3|COMPLETED|Screening Phase||0
8532421|NCT00307125|21034292|P2|COMPLETED|Screening Phase||0
8532422|NCT00307125|21034293|P1|COMPLETED|Screening Phase||303
8532423|NCT00307125|21034291|P3|STARTED|Screening Phase||0
8532424|NCT00307125|21034292|P2|STARTED|Screening Phase||0
8532425|NCT00307125|21034293|P1|STARTED|Screening Phase||757
8532426|NCT00307086|21034315|P1|NOT COMPLETED|Overall Study||5
8532427|NCT00307086|21034315|P1|COMPLETED|Overall Study||25
8532428|NCT00307086|21034315|P1|STARTED|Overall Study||30
8532429|NCT00307047|21034321|P2|NOT COMPLETED|Overall Study||49
8532430|NCT00307047|21034322|P1|NOT COMPLETED|Overall Study||69
8532431|NCT00307047|21034321|P2|COMPLETED|Overall Study||1180
8532432|NCT00307047|21034322|P1|COMPLETED|Overall Study||2389
8532433|NCT00307047|21034321|P2|STARTED|Overall Study||1229
8532434|NCT00307047|21034322|P1|STARTED|Overall Study||2458
8532435|NCT00307034|21034460|P2|NOT COMPLETED|Overall Study||7
8532436|NCT00307034|21034461|P1|NOT COMPLETED|Overall Study||2
8532437|NCT00307034|21034460|P2|COMPLETED|Overall Study||169
8532438|NCT00307034|21034461|P1|COMPLETED|Overall Study||173
8532439|NCT00307034|21034460|P2|STARTED|Overall Study||176
8532440|NCT00307034|21034461|P1|STARTED|Overall Study||175
8532441|NCT00306995|21034506|P7|NOT COMPLETED|Study Part II for Subset 2||0
8532442|NCT00306995|21034507|P6|NOT COMPLETED|Study Part II for Subset 2||0
8532443|NCT00306995|21034508|P5|NOT COMPLETED|Study Part II for Subset 2||0
8532444|NCT00306995|21034509|P4|NOT COMPLETED|Study Part II for Subset 2||0
8532445|NCT00306995|21034510|P3|NOT COMPLETED|Study Part II for Subset 2||0
8532446|NCT00306995|21034511|P2|NOT COMPLETED|Study Part II for Subset 2||1
8532447|NCT00306995|21034512|P1|NOT COMPLETED|Study Part II for Subset 2||0
8532448|NCT00306995|21034506|P7|COMPLETED|Study Part II for Subset 2||24
8532449|NCT00306995|21034507|P6|COMPLETED|Study Part II for Subset 2||26
8532450|NCT00306995|21034508|P5|COMPLETED|Study Part II for Subset 2||23
8532451|NCT00306995|21034509|P4|COMPLETED|Study Part II for Subset 2||22
8532452|NCT00306995|21034510|P3|COMPLETED|Study Part II for Subset 2||23
8532453|NCT00306995|21034511|P2|COMPLETED|Study Part II for Subset 2||23
8532454|NCT00306995|21034512|P1|COMPLETED|Study Part II for Subset 2||23
8532455|NCT00306995|21034506|P7|STARTED|Study Part II for Subset 2||24
8532456|NCT00306995|21034507|P6|STARTED|Study Part II for Subset 2||26
8532457|NCT00306995|21034508|P5|STARTED|Study Part II for Subset 2||23
8532458|NCT00306995|21034509|P4|STARTED|Study Part II for Subset 2||22
8532459|NCT00306995|21034510|P3|STARTED|Study Part II for Subset 2||23
8532460|NCT00306995|21034511|P2|STARTED|Study Part II for Subset 2||24
8532461|NCT00306995|21034512|P1|STARTED|Study Part II for Subset 2||23
8532462|NCT00306995|21034506|P7|NOT COMPLETED|Study Part II for Subset 1||0
8532463|NCT00306995|21034507|P6|NOT COMPLETED|Study Part II for Subset 1||0
8532464|NCT00306995|21034508|P5|NOT COMPLETED|Study Part II for Subset 1||0
8532465|NCT00306995|21034509|P4|NOT COMPLETED|Study Part II for Subset 1||0
8532466|NCT00306995|21034510|P3|NOT COMPLETED|Study Part II for Subset 1||0
8532467|NCT00306995|21034511|P2|NOT COMPLETED|Study Part II for Subset 1||0
8532468|NCT00306995|21034512|P1|NOT COMPLETED|Study Part II for Subset 1||0
8532469|NCT00306995|21034506|P7|COMPLETED|Study Part II for Subset 1||23
8532470|NCT00306995|21034507|P6|COMPLETED|Study Part II for Subset 1||26
8532471|NCT00306995|21034508|P5|COMPLETED|Study Part II for Subset 1||27
8532472|NCT00306995|21034509|P4|COMPLETED|Study Part II for Subset 1||27
8532473|NCT00306995|21034510|P3|COMPLETED|Study Part II for Subset 1||27
8532474|NCT00306995|21034511|P2|COMPLETED|Study Part II for Subset 1||26
8532475|NCT00306995|21034512|P1|COMPLETED|Study Part II for Subset 1||27
8532476|NCT00306995|21034506|P7|STARTED|Study Part II for Subset 1||23
8532477|NCT00306995|21034507|P6|STARTED|Study Part II for Subset 1||26
8532478|NCT00306995|21034508|P5|STARTED|Study Part II for Subset 1||27
8532479|NCT00306995|21034509|P4|STARTED|Study Part II for Subset 1||27
8532480|NCT00306995|21034510|P3|STARTED|Study Part II for Subset 1||27
8532481|NCT00306995|21034511|P2|STARTED|Study Part II for Subset 1||26
8532482|NCT00306995|21034512|P1|STARTED|Study Part II for Subset 1||27
8532483|NCT00306995|21034506|P7|NOT COMPLETED|Study Part I||1
8532484|NCT00306995|21034507|P6|NOT COMPLETED|Study Part I||0
8532485|NCT00306995|21034508|P5|NOT COMPLETED|Study Part I||0
8532486|NCT00306995|21034509|P4|NOT COMPLETED|Study Part I||0
8532487|NCT00306995|21034510|P3|NOT COMPLETED|Study Part I||0
8532488|NCT00306995|21034511|P2|NOT COMPLETED|Study Part I||0
8532489|NCT00306995|21034512|P1|NOT COMPLETED|Study Part I||0
8532490|NCT00306995|21034506|P7|COMPLETED|Study Part I||54
8532491|NCT00306995|21034507|P6|COMPLETED|Study Part I||55
8532492|NCT00306995|21034508|P5|COMPLETED|Study Part I||55
8532493|NCT00306995|21034509|P4|COMPLETED|Study Part I||55
8532494|NCT00306995|21034510|P3|COMPLETED|Study Part I||55
8532495|NCT00306995|21034511|P2|COMPLETED|Study Part I||55
8532496|NCT00306995|21034512|P1|COMPLETED|Study Part I||55
8532497|NCT00306995|21034506|P7|STARTED|Study Part I||55
8532498|NCT00306995|21034507|P6|STARTED|Study Part I||55
8532499|NCT00306995|21034508|P5|STARTED|Study Part I||55
8532500|NCT00306995|21034509|P4|STARTED|Study Part I||55
8532501|NCT00306995|21034510|P3|STARTED|Study Part I||55
8532502|NCT00306995|21034511|P2|STARTED|Study Part I||55
8532503|NCT00306995|21034512|P1|STARTED|Study Part I||55
8532504|NCT00306917|21034894|P2|NOT COMPLETED|Overall Study||109
8532505|NCT00306917|21034895|P1|NOT COMPLETED|Overall Study||108
8532506|NCT00306917|21034894|P2|COMPLETED|Overall Study||15
8532507|NCT00306917|21034895|P1|COMPLETED|Overall Study||13
8532508|NCT00306917|21034894|P2|60 Month Follow up|Overall Study||15
8532509|NCT00306917|21034895|P1|60 Month Follow up|Overall Study||13
8532510|NCT00306917|21034894|P2|48 Month Follow up|Overall Study||22
8532511|NCT00306917|21034895|P1|48 Month Follow up|Overall Study||29
8532512|NCT00306917|21034894|P2|36 Month Follow up|Overall Study||42
8532513|NCT00306917|21034895|P1|36 Month Follow up|Overall Study||56
8532514|NCT00306917|21034894|P2|24 Month Follow up|Overall Study||71
8532515|NCT00306917|21034895|P1|24 Month Follow up|Overall Study||60
8532516|NCT00306917|21034894|P2|12 Month Follow|Overall Study||94
8532517|NCT00306917|21034895|P1|12 Month Follow|Overall Study||86
8532518|NCT00306917|21034894|P2|Postoperative to 6 Month Follow up|Overall Study||100
8532519|NCT00306917|21034895|P1|Postoperative to 6 Month Follow up|Overall Study||93
8532520|NCT00306917|21034894|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
8532521|NCT00306917|21034895|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
8532522|NCT00306891|21034905|P4|NOT COMPLETED|Part B||17
8532523|NCT00306891|21034906|P3|NOT COMPLETED|Part B||11
8532524|NCT00306891|21034907|P2|NOT COMPLETED|Part B||0
8532525|NCT00306891|21034908|P1|NOT COMPLETED|Part B||0
8532526|NCT00306891|21034905|P4|COMPLETED|Part B||14
8532527|NCT00306891|21034906|P3|COMPLETED|Part B||5
8532528|NCT00306891|21034907|P2|COMPLETED|Part B||0
8532529|NCT00306891|21034908|P1|COMPLETED|Part B||0
8532530|NCT00306891|21034905|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
8532531|NCT00306891|21034906|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
8532532|NCT00306891|21034907|P2|STARTED|Part B||0
8532533|NCT00306891|21034908|P1|STARTED|Part B||0
8532534|NCT00306891|21034905|P4|NOT COMPLETED|Part A||0
8532535|NCT00306891|21034906|P3|NOT COMPLETED|Part A||0
8532536|NCT00306891|21034907|P2|NOT COMPLETED|Part A||6
8532537|NCT00306891|21034908|P1|NOT COMPLETED|Part A||5
8532538|NCT00306891|21034905|P4|COMPLETED|Part A||0
8532539|NCT00306891|21034906|P3|COMPLETED|Part A||0
8532540|NCT00306891|21034907|P2|COMPLETED|Part A||16
8532541|NCT00306891|21034908|P1|COMPLETED|Part A||18
8532542|NCT00306891|21034905|P4|STARTED|Part A||0
8532543|NCT00306891|21034906|P3|STARTED|Part A||0
8532544|NCT00306891|21034907|P2|STARTED|Part A||22
8532545|NCT00306891|21034908|P1|STARTED|Part A||23
8532546|NCT00306852|21034931|P2|NOT COMPLETED|Overall Study||38
8532547|NCT00306852|21034932|P1|NOT COMPLETED|Overall Study||29
8532548|NCT00306852|21034931|P2|COMPLETED|Overall Study||69
8532549|NCT00306852|21034932|P1|COMPLETED|Overall Study||76
8532550|NCT00306852|21034931|P2|STARTED|Overall Study||107
8532551|NCT00306852|21034932|P1|STARTED|Overall Study||105
8532552|NCT00306787|21034950|P2|NOT COMPLETED|Overall Study||241
8532553|NCT00306787|21034951|P1|NOT COMPLETED|Overall Study||234
8532554|NCT00306787|21034950|P2|COMPLETED|Overall Study||359
8532555|NCT00306787|21034951|P1|COMPLETED|Overall Study||345
8532556|NCT00306787|21034950|P2|Intent to Treat (ITT) Population|Overall Study||381
8532557|NCT00306787|21034951|P1|Intent to Treat (ITT) Population|Overall Study||370
8532558|NCT00306787|21034950|P2|Received Study Drug (Safety Population)|Overall Study||385
8532559|NCT00306787|21034951|P1|Received Study Drug (Safety Population)|Overall Study||371
8532560|NCT00306787|21034950|P2|STARTED|Overall Study||600
8532561|NCT00306787|21034951|P1|STARTED|Overall Study||579
8532562|NCT00306670|21034969|P2|NOT COMPLETED|Overall Study||2
8532563|NCT00306670|21034970|P1|NOT COMPLETED|Overall Study||0
8532564|NCT00306670|21034969|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
8532565|NCT00306670|21034970|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
8532566|NCT00306670|21034969|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
8532567|NCT00306670|21034970|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
8532568|NCT00306592|21034976|P2|NOT COMPLETED|Overall Study||58
8532569|NCT00306592|21034977|P1|NOT COMPLETED|Overall Study||31
8532570|NCT00306592|21034976|P2|COMPLETED|Overall Study||632
8532571|NCT00306592|21034977|P1|COMPLETED|Overall Study||373
8532572|NCT00306592|21034976|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
8532573|NCT00306592|21034977|P1|Entered 101-MS-321 Extension Study|Overall Study||22
8532574|NCT00306592|21034976|P2|Completed at 48 Weeks|Overall Study||632
8532575|NCT00306592|21034977|P1|Completed at 48 Weeks|Overall Study||81
8532576|NCT00306592|21034976|P2|Completed Between 24 and 48 Weeks|Overall Study||0
8532577|NCT00306592|21034977|P1|Completed Between 24 and 48 Weeks|Overall Study||85
8532578|NCT00306592|21034976|P2|Completed at 24 Weeks|Overall Study||0
8532579|NCT00306592|21034977|P1|Completed at 24 Weeks|Overall Study||207
8532580|NCT00306592|21034976|P2|STARTED|Overall Study||690
8532581|NCT00306592|21034977|P1|STARTED|Overall Study||404
8532582|NCT00306527|21034987|P4|NOT COMPLETED|Overall Study||6
8532583|NCT00306527|21034988|P3|NOT COMPLETED|Overall Study||5
8532584|NCT00306527|21034989|P2|NOT COMPLETED|Overall Study||7
8532585|NCT00306527|21034990|P1|NOT COMPLETED|Overall Study||6
8532586|NCT00306527|21034987|P4|COMPLETED|Overall Study||590
8532587|NCT00306527|21034988|P3|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
8532588|NCT00306527|21034989|P2|COMPLETED|Overall Study||527
8532589|NCT00306527|21034990|P1|COMPLETED|Overall Study||527
8532590|NCT00306527|21034987|P4|STARTED|Overall Study||596
8532591|NCT00306527|21034988|P3|STARTED|Overall Study||572
8532592|NCT00306527|21034989|P2|STARTED|Overall Study||534
8532593|NCT00306527|21034990|P1|STARTED|Overall Study||533
8532594|NCT00306488|21035044|P1|NOT COMPLETED|Overall Study||1
8532595|NCT00306488|21035044|P1|COMPLETED|Overall Study||10
8532596|NCT00306488|21035044|P1|STARTED|Overall Study||11
8532597|NCT00306384|21035062|P3|NOT COMPLETED|Overall Study||277
8532598|NCT00306384|21035063|P2|NOT COMPLETED|Overall Study||508
8532599|NCT00306384|21035064|P1|NOT COMPLETED|Overall Study||542
8532600|NCT00306384|21035062|P3|COMPLETED|Overall Study||251
8532601|NCT00306384|21035063|P2|COMPLETED|Overall Study||891
8532602|NCT00306384|21035064|P1|COMPLETED|Overall Study||854
8532603|NCT00306384|21035062|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
8532604|NCT00306384|21035063|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
8532605|NCT00306384|21035064|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
8532606|NCT00306384|21035062|P3|STARTED|Overall Study||528
8532607|NCT00306384|21035063|P2|STARTED|Overall Study||1399
8532608|NCT00306384|21035064|P1|STARTED|Overall Study||1396
8532609|NCT00306293|21035096|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
8532610|NCT00306293|21035097|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
8532611|NCT00306293|21035096|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
8532612|NCT00306293|21035097|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
8532613|NCT00306293|21035096|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
8532614|NCT00306293|21035097|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
8532615|NCT00306293|21035096|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
8532616|NCT00306293|21035097|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
8532617|NCT00306293|21035096|P2|COMPLETED|Washout (Day 61 to Day 66)||27
8532618|NCT00306293|21035097|P1|COMPLETED|Washout (Day 61 to Day 66)||27
8532619|NCT00306293|21035096|P2|STARTED|Washout (Day 61 to Day 66)||27
8532620|NCT00306293|21035097|P1|STARTED|Washout (Day 61 to Day 66)||27
8532621|NCT00306293|21035096|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
8532622|NCT00306293|21035097|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
8532623|NCT00306293|21035096|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
8532624|NCT00306293|21035097|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
8532625|NCT00306293|21035096|P2|STARTED|Period 1 (Day 1 to Day 60)||35
8532626|NCT00306293|21035097|P1|STARTED|Period 1 (Day 1 to Day 60)||35
8532636|NCT00306189|21035280|P4|NOT COMPLETED|Overall Study||5
8532637|NCT00306189|21035281|P3|NOT COMPLETED|Overall Study||11
8532638|NCT00306189|21035282|P2|NOT COMPLETED|Overall Study||6
8532639|NCT00306189|21035283|P1|NOT COMPLETED|Overall Study||9
8532640|NCT00306189|21035280|P4|COMPLETED|Overall Study||52
8532641|NCT00306189|21035281|P3|COMPLETED|Overall Study||45
8532642|NCT00306189|21035282|P2|COMPLETED|Overall Study||50
8532643|NCT00306189|21035283|P1|COMPLETED|Overall Study||48
8532644|NCT00306189|21035280|P4|STARTED|Overall Study||57
8532645|NCT00306189|21035281|P3|STARTED|Overall Study||56
8532646|NCT00306189|21035282|P2|STARTED|Overall Study||56
8532647|NCT00306189|21035283|P1|STARTED|Overall Study||57
8532648|NCT00306163|21035295|P2|NOT COMPLETED|Overall Study||0
8532649|NCT00306163|21035296|P1|NOT COMPLETED|Overall Study||0
8532650|NCT00306163|21035295|P2|COMPLETED|Overall Study||18
8532651|NCT00306163|21035296|P1|COMPLETED|Overall Study||19
8532652|NCT00306163|21035295|P2|STARTED|Overall Study||18
8532653|NCT00306163|21035296|P1|STARTED|Overall Study||19
8532654|NCT00305942|21035302|P1|NOT COMPLETED|Overall Study||38
8532655|NCT00305942|21035302|P1|COMPLETED|Overall Study||23
8532656|NCT00305942|21035302|P1|STARTED|Overall Study||61
8532657|NCT00305877|21035310|P2|NOT COMPLETED|Overall Study||34
8532658|NCT00305877|21035311|P1|NOT COMPLETED|Overall Study||24
8532659|NCT00305877|21035310|P2|COMPLETED|Overall Study||34
8532660|NCT00305877|21035311|P1|COMPLETED|Overall Study||45
8532661|NCT00305877|21035310|P2|Included in Efficacy Analysis|Overall Study||62
8532662|NCT00305877|21035311|P1|Included in Efficacy Analysis|Overall Study||65
8532663|NCT00305877|21035310|P2|Eligible|Overall Study||66
8532664|NCT00305877|21035311|P1|Eligible|Overall Study||66
8532665|NCT00305877|21035310|P2|Treated|Overall Study||63
8532666|NCT00305877|21035311|P1|Treated|Overall Study||67
8532667|NCT00305877|21035310|P2|STARTED|Overall Study||68
8532668|NCT00305877|21035311|P1|STARTED|Overall Study||69
8532669|NCT00305864|21035325|P4|NOT COMPLETED|Overall Study||13
8532670|NCT00305864|21035326|P3|NOT COMPLETED|Overall Study||1
8532671|NCT00305864|21035327|P2|NOT COMPLETED|Overall Study||1
8532672|NCT00305864|21035328|P1|NOT COMPLETED|Overall Study||0
8532673|NCT00305864|21035325|P4|COMPLETED|Overall Study||81
8532674|NCT00305864|21035326|P3|COMPLETED|Overall Study||6
8532675|NCT00305864|21035327|P2|COMPLETED|Overall Study||9
8532676|NCT00305864|21035328|P1|COMPLETED|Overall Study||7
8532677|NCT00305864|21035325|P4|STARTED|Overall Study||94
8532678|NCT00305864|21035326|P3|STARTED|Overall Study||7
8532679|NCT00305864|21035327|P2|STARTED|Overall Study||10
8532680|NCT00305864|21035328|P1|STARTED|Overall Study||7
8532681|NCT00305773|21035341|P2|NOT COMPLETED|Overall Study||18
8532682|NCT00305773|21035342|P1|NOT COMPLETED|Overall Study||14
8532683|NCT00305773|21035341|P2|COMPLETED|Overall Study||4
8532684|NCT00305773|21035342|P1|COMPLETED|Overall Study||1
8532685|NCT00305773|21035341|P2|STARTED|Overall Study||22
8532686|NCT00305773|21035342|P1|STARTED|Overall Study||15
8532687|NCT00305760|21035356|P1|NOT COMPLETED|Overall Study||47
8532688|NCT00305760|21035356|P1|COMPLETED|Overall Study||13
8532689|NCT00305760|21035356|P1|STARTED|Overall Study||60
8532690|NCT00305695|21035362|P2|NOT COMPLETED|Overall Study||27
8532691|NCT00305695|21035363|P1|NOT COMPLETED|Overall Study||41
8532692|NCT00305695|21035362|P2|COMPLETED|Overall Study||52
8532693|NCT00305695|21035363|P1|COMPLETED|Overall Study||40
8532694|NCT00305695|21035362|P2|STARTED|Overall Study||79
8532695|NCT00305695|21035363|P1|STARTED|Overall Study||81
8532696|NCT00305682|21035381|P6|NOT COMPLETED|Overall Study||0
8532697|NCT00305682|21035382|P5|NOT COMPLETED|Overall Study||0
8532698|NCT00305682|21035383|P4|NOT COMPLETED|Overall Study||0
8532699|NCT00305682|21035384|P3|NOT COMPLETED|Overall Study||0
8532700|NCT00305682|21035385|P2|NOT COMPLETED|Overall Study||0
8532701|NCT00305682|21035386|P1|NOT COMPLETED|Overall Study||0
8532702|NCT00305682|21035381|P6|COMPLETED|Overall Study||35
8532703|NCT00305682|21035382|P5|COMPLETED|Overall Study||39
8532704|NCT00305682|21035383|P4|COMPLETED|Overall Study||34
8532705|NCT00305682|21035384|P3|COMPLETED|Overall Study||7
8532706|NCT00305682|21035385|P2|COMPLETED|Overall Study||71
8532707|NCT00305682|21035386|P1|COMPLETED|Overall Study||98
8532708|NCT00305682|21035381|P6|STARTED|Overall Study||35
8532709|NCT00305682|21035382|P5|STARTED|Overall Study||39
8532710|NCT00305682|21035383|P4|STARTED|Overall Study||34
8532711|NCT00305682|21035384|P3|STARTED|Overall Study||7
8532712|NCT00305682|21035385|P2|STARTED|Overall Study||71
8532713|NCT00305682|21035386|P1|STARTED|Overall Study||98
8532714|NCT00305643|21035486|P2|NOT COMPLETED|Overall Study||0
8532715|NCT00305643|21035487|P1|NOT COMPLETED|Overall Study||0
8532716|NCT00305643|21035486|P2|COMPLETED|Overall Study||5
8532717|NCT00305643|21035487|P1|COMPLETED|Overall Study||6
8532718|NCT00305643|21035486|P2|STARTED|Overall Study||5
8532719|NCT00305643|21035487|P1|STARTED|Overall Study||6
8532720|NCT00305604|21035497|P2|NOT COMPLETED|Overall Study||47
8532721|NCT00305604|21035498|P1|NOT COMPLETED|Overall Study||32
8532722|NCT00305604|21035497|P2|COMPLETED|Overall Study||57
8532723|NCT00305604|21035498|P1|COMPLETED|Overall Study||70
8532724|NCT00305604|21035497|P2|STARTED|Overall Study||104
8532725|NCT00305604|21035498|P1|STARTED|Overall Study||102
8532726|NCT00305578|21035512|P2|NOT COMPLETED|Overall Study||2
8532727|NCT00305578|21035513|P1|NOT COMPLETED|Overall Study||3
8532728|NCT00305578|21035512|P2|COMPLETED|Overall Study||12
8532729|NCT00305578|21035513|P1|COMPLETED|Overall Study||12
8532730|NCT00305578|21035512|P2|STARTED|Overall Study||14
8532731|NCT00305578|21035513|P1|STARTED|Overall Study||15
8532732|NCT00305565|21035522|P3|NOT COMPLETED|Overall Study (ITT Population)||5
8532733|NCT00305565|21035523|P2|NOT COMPLETED|Overall Study (ITT Population)||11
8532734|NCT00305565|21035524|P1|NOT COMPLETED|Overall Study (ITT Population)||13
8532735|NCT00305565|21035522|P3|COMPLETED|Overall Study (ITT Population)||102
8532736|NCT00305565|21035523|P2|COMPLETED|Overall Study (ITT Population)||90
8532737|NCT00305565|21035524|P1|COMPLETED|Overall Study (ITT Population)||89
8532738|NCT00305565|21035522|P3|STARTED|Overall Study (ITT Population)||107
8532739|NCT00305565|21035523|P2|STARTED|Overall Study (ITT Population)||101
8532740|NCT00305565|21035524|P1|STARTED|Overall Study (ITT Population)||102
8532741|NCT00305565|21035522|P3|NOT COMPLETED|Overall Study (Safety Population)||7
8532742|NCT00305565|21035523|P2|NOT COMPLETED|Overall Study (Safety Population)||12
8532743|NCT00305565|21035524|P1|NOT COMPLETED|Overall Study (Safety Population)||14
8532744|NCT00305565|21035522|P3|COMPLETED|Overall Study (Safety Population)||106
8532745|NCT00305565|21035523|P2|COMPLETED|Overall Study (Safety Population)||95
8532746|NCT00305565|21035524|P1|COMPLETED|Overall Study (Safety Population)||97
8532747|NCT00305565|21035522|P3|STARTED|Overall Study (Safety Population)||113
8532748|NCT00305565|21035523|P2|STARTED|Overall Study (Safety Population)||107
8532749|NCT00305565|21035524|P1|STARTED|Overall Study (Safety Population)||111
8532750|NCT00305448|21035642|P3|NOT COMPLETED|Overall Study||33
8532751|NCT00305448|21035643|P2|NOT COMPLETED|Overall Study||34
8532752|NCT00305448|21035644|P1|NOT COMPLETED|Overall Study||31
8532753|NCT00305448|21035642|P3|COMPLETED|Overall Study||14
8532754|NCT00305448|21035643|P2|COMPLETED|Overall Study||17
8532755|NCT00305448|21035644|P1|COMPLETED|Overall Study||14
8532756|NCT00305448|21035642|P3|STARTED|Overall Study||47
8532757|NCT00305448|21035643|P2|STARTED|Overall Study||51
8532758|NCT00305448|21035644|P1|STARTED|Overall Study||45
8532759|NCT00305344|21035660|P1|NOT COMPLETED|Overall Study||0
8532760|NCT00305344|21035660|P1|COMPLETED|Overall Study||23
8532761|NCT00305344|21035660|P1|STARTED|Overall Study||23
8532762|NCT00305253|21035666|P2|NOT COMPLETED|Overall Study||1
8532763|NCT00305253|21035667|P1|NOT COMPLETED|Overall Study||0
8532764|NCT00305253|21035666|P2|COMPLETED|Overall Study||558
8532765|NCT00305253|21035667|P1|COMPLETED|Overall Study||432
8532766|NCT00305253|21035666|P2|STARTED|Overall Study||559
8532767|NCT00305253|21035667|P1|STARTED|Overall Study||432
8532768|NCT00305227|21035679|P2|NOT COMPLETED|Overall Study||6
8532769|NCT00305227|21035680|P1|NOT COMPLETED|Overall Study||7
8532770|NCT00305227|21035679|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
8532771|NCT00305227|21035680|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
8532772|NCT00305227|21035679|P2|STARTED|Overall Study||50
8532773|NCT00305227|21035680|P1|STARTED|Overall Study||50
8532774|NCT00305162|21035688|P2|NOT COMPLETED|1 Year Follow-up Period||65
8532775|NCT00305162|21035689|P1|NOT COMPLETED|1 Year Follow-up Period||55
8532776|NCT00305162|21035688|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
8532777|NCT00305162|21035689|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
8532778|NCT00305162|21035688|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
8532779|NCT00305162|21035689|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
8532780|NCT00305162|21035688|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
8532781|NCT00305162|21035689|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
8532782|NCT00305162|21035688|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
8532783|NCT00305162|21035689|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
8532784|NCT00305162|21035688|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
8532785|NCT00305162|21035689|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
8532786|NCT00305162|21035688|P2|STARTED|1 Year Follow-up Period||4447
8532787|NCT00305162|21035689|P1|STARTED|1 Year Follow-up Period||4435
8532788|NCT00305162|21035688|P2|NOT COMPLETED|30-day Follow-up Period||63
8532789|NCT00305162|21035689|P1|NOT COMPLETED|30-day Follow-up Period||62
8532790|NCT00305162|21035688|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
8532791|NCT00305162|21035689|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
8532792|NCT00305162|21035688|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
8532793|NCT00305162|21035689|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
8532794|NCT00305162|21035688|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
8532795|NCT00305162|21035689|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
8532796|NCT00305162|21035688|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
8532797|NCT00305162|21035689|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
8532798|NCT00305162|21035688|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
8532799|NCT00305162|21035689|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
8532800|NCT00305162|21035688|P2|STARTED|30-day Follow-up Period||4447
8532801|NCT00305162|21035689|P1|STARTED|30-day Follow-up Period||4435
8532802|NCT00305162|21035688|P2|NOT COMPLETED|48 Hour Follow-up Period||16
8532803|NCT00305162|21035689|P1|NOT COMPLETED|48 Hour Follow-up Period||20
8532804|NCT00305162|21035688|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
8532805|NCT00305162|21035689|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
8532806|NCT00305162|21035688|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
8532807|NCT00305162|21035689|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
8532808|NCT00305162|21035688|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
8532809|NCT00305162|21035689|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
8532810|NCT00305162|21035688|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
8532811|NCT00305162|21035689|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
8532812|NCT00305162|21035688|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
8532813|NCT00305162|21035689|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
8532814|NCT00305162|21035688|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
8532815|NCT00305162|21035689|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
8532816|NCT00305162|21035688|P2|STARTED|48 Hour Follow-up Period||4447
8532817|NCT00305162|21035689|P1|STARTED|48 Hour Follow-up Period||4435
8532818|NCT00305110|21035727|P1|NOT COMPLETED|Overall Study||29
8532819|NCT00305110|21035727|P1|COMPLETED|Overall Study||269
8532820|NCT00305110|21035727|P1|All Necessary Data Collected|Overall Study||269
8532821|NCT00305110|21035727|P1|STARTED|Overall Study||298
8532822|NCT00305084|21035741|P5|NOT COMPLETED|Overall Study||0
8532823|NCT00305084|21035742|P4|NOT COMPLETED|Overall Study||0
8532824|NCT00305084|21035743|P3|NOT COMPLETED|Overall Study||0
8532825|NCT00305084|21035744|P2|NOT COMPLETED|Overall Study||0
8532826|NCT00305084|21035745|P1|NOT COMPLETED|Overall Study||0
8532827|NCT00305084|21035741|P5|COMPLETED|Overall Study||3
8532828|NCT00305084|21035742|P4|COMPLETED|Overall Study||3
8532829|NCT00305084|21035743|P3|COMPLETED|Overall Study||3
8532830|NCT00305084|21035744|P2|COMPLETED|Overall Study||3
8532831|NCT00305084|21035745|P1|COMPLETED|Overall Study||3
8532832|NCT00305084|21035741|P5|STARTED|Overall Study||3
8532833|NCT00305084|21035742|P4|STARTED|Overall Study||3
8532834|NCT00305084|21035743|P3|STARTED|Overall Study||3
8532835|NCT00305084|21035744|P2|STARTED|Overall Study||3
8532836|NCT00305084|21035745|P1|STARTED|Overall Study||3
8532837|NCT00305058|21035800|P2|NOT COMPLETED|Overall Study||4
8532838|NCT00305058|21035801|P1|NOT COMPLETED|Overall Study||7
8532839|NCT00305058|21035800|P2|COMPLETED|Overall Study||93
8532840|NCT00305058|21035801|P1|COMPLETED|Overall Study||90
8532841|NCT00305058|21035800|P2|Data Collection Forms Filed for Analysis|Overall Study||93
8532842|NCT00305058|21035801|P1|Data Collection Forms Filed for Analysis|Overall Study||90
8532843|NCT00305058|21035800|P2|All Outcome Data Collected|Overall Study||95
8532844|NCT00305058|21035801|P1|All Outcome Data Collected|Overall Study||93
8532845|NCT00305058|21035800|P2|Inclusion/Exclusion Verification|Overall Study||97
8532846|NCT00305058|21035801|P1|Inclusion/Exclusion Verification|Overall Study||96
8532847|NCT00305058|21035800|P2|STARTED|Overall Study||97
8532848|NCT00305058|21035801|P1|STARTED|Overall Study||97
8532849|NCT00304954|21035817|P4|NOT COMPLETED|Overall Study||0
8532850|NCT00304954|21035818|P3|NOT COMPLETED|Overall Study||1
8532851|NCT00304954|21035819|P2|NOT COMPLETED|Overall Study||0
8532852|NCT00304954|21035820|P1|NOT COMPLETED|Overall Study||1
8532853|NCT00304954|21035817|P4|COMPLETED|Overall Study||3
8532854|NCT00304954|21035818|P3|COMPLETED|Overall Study||2
8532855|NCT00304954|21035819|P2|COMPLETED|Overall Study||3
8532856|NCT00304954|21035820|P1|COMPLETED|Overall Study||3
8532857|NCT00304954|21035817|P4|STARTED|Overall Study||3
8532858|NCT00304954|21035818|P3|STARTED|Overall Study||3
8532859|NCT00304954|21035819|P2|STARTED|Overall Study||3
8532860|NCT00304954|21035820|P1|STARTED|Overall Study||4
8532861|NCT00304915|21035840|P2|NOT COMPLETED|Overall Study||16
8532862|NCT00304915|21035841|P1|NOT COMPLETED|Overall Study||18
8532863|NCT00304915|21035840|P2|COMPLETED|Overall Study||110
8532864|NCT00304915|21035841|P1|COMPLETED|Overall Study||105
8532865|NCT00304915|21035840|P2|STARTED|Overall Study||126
8532866|NCT00304915|21035841|P1|STARTED|Overall Study||123
8532867|NCT00304746|21035849|P2|NOT COMPLETED|Overall Study||0
8532868|NCT00304746|21035850|P1|NOT COMPLETED|Overall Study||0
8532869|NCT00304746|21035849|P2|COMPLETED|Overall Study||50
8532870|NCT00304746|21035850|P1|COMPLETED|Overall Study||50
8532871|NCT00304746|21035849|P2|STARTED|Overall Study||50
8532872|NCT00304746|21035850|P1|STARTED|Overall Study||50
8532873|NCT00304707|21035860|P2|NOT COMPLETED|Overall Study||6
8532874|NCT00304707|21035861|P1|NOT COMPLETED|Overall Study||7
8532875|NCT00304707|21035860|P2|COMPLETED|Overall Study||64
8532876|NCT00304707|21035861|P1|COMPLETED|Overall Study||66
8532877|NCT00304707|21035860|P2|STARTED|Overall Study||70
8532878|NCT00304707|21035861|P1|STARTED|Overall Study||73
8532879|NCT00304512|21035870|P3|NOT COMPLETED|Extension Period||0
8532880|NCT00304512|21035871|P2|NOT COMPLETED|Extension Period||0
8532881|NCT00304512|21035872|P1|NOT COMPLETED|Extension Period||0
8532882|NCT00304512|21035870|P3|COMPLETED|Extension Period||3
8532883|NCT00304512|21035871|P2|COMPLETED|Extension Period||4
8532884|NCT00304512|21035872|P1|COMPLETED|Extension Period||2
8532885|NCT00304512|21035870|P3|STARTED|Extension Period||3
8532886|NCT00304512|21035871|P2|STARTED|Extension Period||4
8532887|NCT00304512|21035872|P1|STARTED|Extension Period||2
8532888|NCT00304512|21035870|P3|NOT COMPLETED|Treatment Period||0
8532889|NCT00304512|21035871|P2|NOT COMPLETED|Treatment Period||0
8532890|NCT00304512|21035872|P1|NOT COMPLETED|Treatment Period||0
8532891|NCT00304512|21035870|P3|COMPLETED|Treatment Period||3
8532892|NCT00304512|21035871|P2|COMPLETED|Treatment Period||4
8532893|NCT00304512|21035872|P1|COMPLETED|Treatment Period||2
8532894|NCT00304512|21035870|P3|Pharmacodynamic (PD) Population|Treatment Period||3
8532895|NCT00304512|21035871|P2|Pharmacodynamic (PD) Population|Treatment Period||4
8532896|NCT00304512|21035872|P1|Pharmacodynamic (PD) Population|Treatment Period||2
8532897|NCT00304512|21035870|P3|Pharmacokinetic (PK) Population|Treatment Period||3
8532898|NCT00304512|21035871|P2|Pharmacokinetic (PK) Population|Treatment Period||4
8532899|NCT00304512|21035872|P1|Pharmacokinetic (PK) Population|Treatment Period||2
8532900|NCT00304512|21035870|P3|Safety Population|Treatment Period||3
8532901|NCT00304512|21035871|P2|Safety Population|Treatment Period||4
8532902|NCT00304512|21035872|P1|Safety Population|Treatment Period||2
8532903|NCT00304512|21035870|P3|STARTED|Treatment Period||3
8532904|NCT00304512|21035871|P2|STARTED|Treatment Period||4
8532905|NCT00304512|21035872|P1|STARTED|Treatment Period||2
8532906|NCT00304356|21035886|P1|NOT COMPLETED|Nitazoxanide||5
8532907|NCT00304356|21035886|P1|COMPLETED|Nitazoxanide||22
8532908|NCT00304356|21035886|P1|STARTED|Nitazoxanide||27
8532909|NCT00304356|21035886|P1|NOT COMPLETED|Nitazoxanide||5
8532910|NCT00304356|21035886|P1|COMPLETED|Nitazoxanide||22
8532911|NCT00304356|21035886|P1|STARTED|Nitazoxanide||27
8532912|NCT00304278|21035890|P1|NOT COMPLETED|Overall Study||2
8532913|NCT00304278|21035890|P1|COMPLETED|Overall Study||19
8532914|NCT00304278|21035890|P1|STARTED|Overall Study||21
8532915|NCT00304265|21035897|P2|NOT COMPLETED|Overall Study||0
8532916|NCT00304265|21035898|P1|NOT COMPLETED|Overall Study||0
8532917|NCT00304265|21035897|P2|COMPLETED|Overall Study||98
8532918|NCT00304265|21035898|P1|COMPLETED|Overall Study||117
8532919|NCT00304265|21035897|P2|STARTED|Overall Study||98
8532920|NCT00304265|21035898|P1|STARTED|Overall Study||117
8532921|NCT00304187|21035906|P2|NOT COMPLETED|Overall Study||1
8532922|NCT00304187|21035907|P1|NOT COMPLETED|Overall Study||2
8532923|NCT00304187|21035906|P2|COMPLETED|Overall Study||13
8532924|NCT00304187|21035907|P1|COMPLETED|Overall Study||13
8532925|NCT00304187|21035906|P2|STARTED|Overall Study||14
8532926|NCT00304187|21035907|P1|STARTED|Overall Study||15
8532927|NCT00304161|21035917|P2|NOT COMPLETED|Overall Study||6
8532928|NCT00304161|21035918|P1|NOT COMPLETED|Overall Study||6
8532929|NCT00304161|21035917|P2|COMPLETED|Overall Study||21
8532930|NCT00304161|21035918|P1|COMPLETED|Overall Study||22
8532931|NCT00304161|21035917|P2|STARTED|Overall Study||27
8532932|NCT00304161|21035918|P1|STARTED|Overall Study||28
8532933|NCT00304096|21035928|P2|NOT COMPLETED|Overall Study||0
8532934|NCT00304096|21035929|P1|NOT COMPLETED|Overall Study||0
8532935|NCT00304096|21035928|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
8532936|NCT00304096|21035929|P1|COMPLETED|Overall Study||6
8532937|NCT00304096|21035928|P2|STARTED|Overall Study||5
8532938|NCT00304096|21035929|P1|STARTED|Overall Study||6
8532939|NCT00304083|21035939|P2|NOT COMPLETED|Overall Study||8
8532940|NCT00304083|21035940|P1|NOT COMPLETED|Overall Study||22
8532941|NCT00304083|21035939|P2|COMPLETED|Overall Study||6
8532942|NCT00304083|21035940|P1|COMPLETED|Overall Study||12
8532943|NCT00304083|21035939|P2|Patients Had Neither RT or Surgery|Overall Study||1
8532944|NCT00304083|21035940|P1|Patients Had Neither RT or Surgery|Overall Study||6
8532945|NCT00304083|21035939|P2|Patients Treated With RT Only|Overall Study||2
8532946|NCT00304083|21035940|P1|Patients Treated With RT Only|Overall Study||4
8532947|NCT00304083|21035939|P2|Patients Treated With Surgery and RT|Overall Study||1
8532948|NCT00304083|21035940|P1|Patients Treated With Surgery and RT|Overall Study||5
8532949|NCT00304083|21035939|P2|Patients Treated With Surgery|Overall Study||3
8532950|NCT00304083|21035940|P1|Patients Treated With Surgery|Overall Study||7
8532951|NCT00304083|21035939|P2|Completed 4 Cycles|Overall Study||7
8532952|NCT00304083|21035940|P1|Completed 4 Cycles|Overall Study||22
8532953|NCT00304083|21035939|P2|STARTED|Overall Study||14
8532954|NCT00304083|21035940|P1|STARTED|Overall Study||34
8532955|NCT00304070|21035959|P3|NOT COMPLETED|Overall Study||12
8532956|NCT00304070|21035960|P2|NOT COMPLETED|Overall Study||7
8532957|NCT00304070|21035961|P1|NOT COMPLETED|Overall Study||3
8532958|NCT00304070|21035959|P3|COMPLETED|Overall Study||27
8532959|NCT00304070|21035960|P2|COMPLETED|Overall Study||8
8532960|NCT00304070|21035961|P1|COMPLETED|Overall Study||21
8532961|NCT00304070|21035959|P3|STARTED|Overall Study||39
8532962|NCT00304070|21035960|P2|STARTED|Overall Study||15
8532963|NCT00304070|21035961|P1|STARTED|Overall Study||24
8532964|NCT00304031|21035976|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
8532965|NCT00304031|21035977|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
8532966|NCT00304031|21035978|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
8532967|NCT00304031|21035976|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
8532968|NCT00304031|21035977|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
8532969|NCT00304031|21035978|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
8532970|NCT00304031|21035976|P3|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
8532971|NCT00304031|21035977|P2|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
8532972|NCT00304031|21035978|P1|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
8532973|NCT00304031|21035976|P3|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
8532974|NCT00304031|21035977|P2|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
8532975|NCT00304031|21035978|P1|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
8532976|NCT00304031|21035976|P3|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
8532977|NCT00304031|21035977|P2|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
8532978|NCT00304031|21035978|P1|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
8532979|NCT00304031|21035976|P3|Eligible Population|Randomization to Adjuvant TMZ Arm||420
8532980|NCT00304031|21035977|P2|Eligible Population|Randomization to Adjuvant TMZ Arm||411
8532981|NCT00304031|21035978|P1|Eligible Population|Randomization to Adjuvant TMZ Arm||0
8532982|NCT00304031|21035976|P3|STARTED|Randomization to Adjuvant TMZ Arm||422
8532983|NCT00304031|21035977|P2|STARTED|Randomization to Adjuvant TMZ Arm||411
8532984|NCT00304031|21035978|P1|STARTED|Randomization to Adjuvant TMZ Arm||0
8532985|NCT00304031|21035976|P3|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532986|NCT00304031|21035977|P2|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532987|NCT00304031|21035978|P1|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
8532988|NCT00304031|21035976|P3|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532989|NCT00304031|21035977|P2|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532990|NCT00304031|21035978|P1|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
8532991|NCT00304031|21035976|P3|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
8532992|NCT00304031|21035977|P2|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
8532993|NCT00304031|21035978|P1|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
8532994|NCT00304031|21035976|P3|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
8532995|NCT00304031|21035977|P2|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
8532996|NCT00304031|21035978|P1|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
8533084|NCT00303472|21036240|P3|STARTED|Treatment Extension (Optional)||11
8532997|NCT00304031|21035976|P3|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
8532998|NCT00304031|21035977|P2|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
8532999|NCT00304031|21035978|P1|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
8533000|NCT00303979|21036031|P3|NOT COMPLETED|Overall Study||0
8533001|NCT00303979|21036032|P2|NOT COMPLETED|Overall Study||0
8533002|NCT00303979|21036033|P1|NOT COMPLETED|Overall Study||7572
8533003|NCT00303979|21036031|P3|COMPLETED|Overall Study|at 18 months|9641
8533004|NCT00303979|21036032|P2|COMPLETED|Overall Study|at 6 months|9992
8533005|NCT00303979|21036033|P1|COMPLETED|Overall Study|at 24 Months|7605
8533006|NCT00303979|21036031|P3|STARTED|Overall Study|at 18 months|9641
8533007|NCT00303979|21036032|P2|STARTED|Overall Study|at 6 months|9992
8533008|NCT00303979|21036033|P1|STARTED|Overall Study|at baseline|15177
8533009|NCT00303966|21036051|P1|NOT COMPLETED|Overall Study||0
8533010|NCT00303966|21036051|P1|COMPLETED|Overall Study||5
8533011|NCT00303966|21036051|P1|STARTED|Overall Study||5
8533012|NCT00303953|21036060|P1|NOT COMPLETED|Overall Study||19
8533013|NCT00303953|21036060|P1|COMPLETED|Overall Study||3
8533014|NCT00303953|21036060|P1|Eligible and Treated|Overall Study||20
8533015|NCT00303953|21036060|P1|Eligible|Overall Study||21
8533016|NCT00303953|21036060|P1|STARTED|Overall Study||22
8533017|NCT00303901|21036066|P1|NOT COMPLETED|Overall Study||0
8533018|NCT00303901|21036066|P1|COMPLETED|Overall Study||40
8533019|NCT00303901|21036066|P1|STARTED|Overall Study||40
8533020|NCT00303862|21036072|P1|NOT COMPLETED|Overall Study||0
8533021|NCT00303862|21036072|P1|COMPLETED|Overall Study||10
8533022|NCT00303862|21036072|P1|STARTED|Overall Study||10
8533023|NCT00303823|21036081|P2|NOT COMPLETED|Overall Study||10
8533024|NCT00303823|21036082|P1|NOT COMPLETED|Overall Study||15
8533025|NCT00303823|21036081|P2|COMPLETED|Overall Study||38
8533026|NCT00303823|21036082|P1|COMPLETED|Overall Study||35
8533027|NCT00303823|21036081|P2|STARTED|Overall Study||48
8533028|NCT00303823|21036082|P1|STARTED|Overall Study||50
8533029|NCT00303719|21036096|P2|NOT COMPLETED|Overall Study||37
8533030|NCT00303719|21036097|P1|NOT COMPLETED|Overall Study||0
8533031|NCT00303719|21036096|P2|COMPLETED|Overall Study||292
8533032|NCT00303719|21036097|P1|COMPLETED|Overall Study||13
8533033|NCT00303719|21036096|P2|STARTED|Overall Study||329
8533034|NCT00303719|21036097|P1|STARTED|Overall Study||13
8533035|NCT00303667|21036113|P2|NOT COMPLETED|Overall Study||4
8533036|NCT00303667|21036114|P1|NOT COMPLETED|Overall Study||0
8533037|NCT00303667|21036113|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
8533038|NCT00303667|21036114|P1|COMPLETED|Overall Study||8
8533039|NCT00303667|21036113|P2|STARTED|Overall Study||39
8533040|NCT00303667|21036114|P1|STARTED|Overall Study||8
8533041|NCT00303628|21036138|P2|NOT COMPLETED|Overall Study||73
8533042|NCT00303628|21036139|P1|NOT COMPLETED|Overall Study||50
8533043|NCT00303628|21036138|P2|COMPLETED|Overall Study||106
8533044|NCT00303628|21036139|P1|COMPLETED|Overall Study||126
8533045|NCT00303628|21036138|P2|Treated|Overall Study||174
8533046|NCT00303628|21036139|P1|Treated|Overall Study||173
8533047|NCT00303628|21036138|P2|Eligible|Overall Study||177
8533048|NCT00303628|21036139|P1|Eligible|Overall Study||171
8533049|NCT00303628|21036138|P2|STARTED|Overall Study||179
8533050|NCT00303628|21036139|P1|STARTED|Overall Study||176
8533051|NCT00303602|21036157|P2|NOT COMPLETED|Overall Study||15
8533052|NCT00303602|21036158|P1|NOT COMPLETED|Overall Study||19
8533053|NCT00303602|21036157|P2|COMPLETED|Overall Study||50
8533054|NCT00303602|21036158|P1|COMPLETED|Overall Study||65
8533055|NCT00303602|21036157|P2|STARTED|Overall Study||65
8533056|NCT00303602|21036158|P1|STARTED|Overall Study||84
8533057|NCT00303511|21036198|P1|NOT COMPLETED|Overall Study||0
8533058|NCT00303511|21036198|P1|COMPLETED|Overall Study||10
8533059|NCT00303511|21036198|P1|STARTED|Overall Study||10
8533060|NCT00303485|21036204|P2|NOT COMPLETED|Overall Study||2
8533061|NCT00303485|21036205|P1|NOT COMPLETED|Overall Study||1
8533062|NCT00303485|21036204|P2|COMPLETED|Overall Study||15
8533063|NCT00303485|21036205|P1|COMPLETED|Overall Study||48
8533064|NCT00303485|21036204|P2|STARTED|Overall Study||17
8533065|NCT00303485|21036205|P1|STARTED|Overall Study||49
8533066|NCT00303472|21036236|P7|NOT COMPLETED|Treatment Extension (Optional)||0
8533067|NCT00303472|21036237|P6|NOT COMPLETED|Treatment Extension (Optional)||1
8533068|NCT00303472|21036238|P5|NOT COMPLETED|Treatment Extension (Optional)||4
8533069|NCT00303472|21036239|P4|NOT COMPLETED|Treatment Extension (Optional)||8
8533070|NCT00303472|21036240|P3|NOT COMPLETED|Treatment Extension (Optional)||9
8533071|NCT00303472|21036241|P2|NOT COMPLETED|Treatment Extension (Optional)||6
8533072|NCT00303472|21036242|P1|NOT COMPLETED|Treatment Extension (Optional)||5
8533073|NCT00303472|21036236|P7|COMPLETED|Treatment Extension (Optional)||1
8533074|NCT00303472|21036237|P6|COMPLETED|Treatment Extension (Optional)||4
8533075|NCT00303472|21036238|P5|COMPLETED|Treatment Extension (Optional)||1
8533076|NCT00303472|21036239|P4|COMPLETED|Treatment Extension (Optional)||5
8533077|NCT00303472|21036240|P3|COMPLETED|Treatment Extension (Optional)||2
8533078|NCT00303472|21036241|P2|COMPLETED|Treatment Extension (Optional)||5
8533079|NCT00303472|21036242|P1|COMPLETED|Treatment Extension (Optional)||1
8533080|NCT00303472|21036236|P7|STARTED|Treatment Extension (Optional)||1
8533081|NCT00303472|21036237|P6|STARTED|Treatment Extension (Optional)||5
8533082|NCT00303472|21036238|P5|STARTED|Treatment Extension (Optional)||5
8533083|NCT00303472|21036239|P4|STARTED|Treatment Extension (Optional)||13
8533085|NCT00303472|21036241|P2|STARTED|Treatment Extension (Optional)||11
8533086|NCT00303472|21036242|P1|STARTED|Treatment Extension (Optional)||6
8533087|NCT00303472|21036236|P7|NOT COMPLETED|Treatment Period||2
8533088|NCT00303472|21036237|P6|NOT COMPLETED|Treatment Period||1
8533089|NCT00303472|21036238|P5|NOT COMPLETED|Treatment Period||3
8533090|NCT00303472|21036239|P4|NOT COMPLETED|Treatment Period||2
8533091|NCT00303472|21036240|P3|NOT COMPLETED|Treatment Period||0
8533092|NCT00303472|21036241|P2|NOT COMPLETED|Treatment Period||0
8533093|NCT00303472|21036242|P1|NOT COMPLETED|Treatment Period||0
8533094|NCT00303472|21036236|P7|COMPLETED|Treatment Period||3
8533095|NCT00303472|21036237|P6|COMPLETED|Treatment Period||11
8533096|NCT00303472|21036238|P5|COMPLETED|Treatment Period||8
8533097|NCT00303472|21036239|P4|COMPLETED|Treatment Period||14
8533098|NCT00303472|21036240|P3|COMPLETED|Treatment Period||11
8533099|NCT00303472|21036241|P2|COMPLETED|Treatment Period||11
8533100|NCT00303472|21036242|P1|COMPLETED|Treatment Period||6
8533101|NCT00303472|21036236|P7|STARTED|Treatment Period||5
8533102|NCT00303472|21036237|P6|STARTED|Treatment Period||12
8533103|NCT00303472|21036238|P5|STARTED|Treatment Period||11
8533104|NCT00303472|21036239|P4|STARTED|Treatment Period||16
8533105|NCT00303472|21036240|P3|STARTED|Treatment Period||11
8533106|NCT00303472|21036241|P2|STARTED|Treatment Period||11
8533107|NCT00303472|21036242|P1|STARTED|Treatment Period||6
8533108|NCT00303459|21036302|P2|NOT COMPLETED|Overall Study||89
8533109|NCT00303459|21036303|P1|NOT COMPLETED|Overall Study||83
8533110|NCT00303459|21036302|P2|COMPLETED|Overall Study||86
8533111|NCT00303459|21036303|P1|COMPLETED|Overall Study||76
8533112|NCT00303459|21036302|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
8533113|NCT00303459|21036303|P1|STARTED|Overall Study||159
8533114|NCT00303446|21036329|P2|NOT COMPLETED|Overall Study||4
8533115|NCT00303446|21036330|P1|NOT COMPLETED|Overall Study||2
8533116|NCT00303446|21036329|P2|COMPLETED|Overall Study||21
8533117|NCT00303446|21036330|P1|COMPLETED|Overall Study||23
8533118|NCT00303446|21036329|P2|STARTED|Overall Study||25
8533119|NCT00303446|21036330|P1|STARTED|Overall Study||25
8533120|NCT00303329|21036366|P2|NOT COMPLETED|Overall Study||62
8533121|NCT00303329|21036367|P1|NOT COMPLETED|Overall Study||35
8533122|NCT00303329|21036366|P2|COMPLETED|Overall Study||37
8533123|NCT00303329|21036367|P1|COMPLETED|Overall Study||50
8533124|NCT00303329|21036366|P2|STARTED|Overall Study||99
8533125|NCT00303329|21036367|P1|STARTED|Overall Study||85
8533126|NCT00303316|21036381|P2|NOT COMPLETED|Overall Study||3
8533127|NCT00303316|21036382|P1|NOT COMPLETED|Overall Study||2
8533128|NCT00303316|21036381|P2|COMPLETED|Overall Study||223
8533129|NCT00303316|21036382|P1|COMPLETED|Overall Study||230
8533130|NCT00303316|21036381|P2|STARTED|Overall Study||226
8533131|NCT00303316|21036382|P1|STARTED|Overall Study||232
8533132|NCT00303186|21036394|P1|NOT COMPLETED|Overall Study||52
8533133|NCT00303186|21036394|P1|COMPLETED|Overall Study||55
8533134|NCT00303186|21036394|P1|STARTED|Overall Study||107
8533135|NCT00303108|21036428|P3|NOT COMPLETED|Overall Study||16
8533136|NCT00303108|21036429|P2|NOT COMPLETED|Overall Study||9
8533137|NCT00303108|21036430|P1|NOT COMPLETED|Overall Study||12
8533138|NCT00303108|21036428|P3|COMPLETED|Overall Study||31
8533139|NCT00303108|21036429|P2|COMPLETED|Overall Study||37
8533140|NCT00303108|21036430|P1|COMPLETED|Overall Study||31
8533141|NCT00303108|21036428|P3|STARTED|Overall Study||47
8533142|NCT00303108|21036429|P2|STARTED|Overall Study||46
8533143|NCT00303108|21036430|P1|STARTED|Overall Study||43
8533144|NCT00303069|21036450|P4|NOT COMPLETED|Overall Study||2
8533145|NCT00303069|21036451|P3|NOT COMPLETED|Overall Study||1
8533146|NCT00303069|21036452|P2|NOT COMPLETED|Overall Study||0
8533147|NCT00303069|21036453|P1|NOT COMPLETED|Overall Study||2
8533148|NCT00303069|21036450|P4|COMPLETED|Overall Study||29
8533149|NCT00303069|21036451|P3|COMPLETED|Overall Study||33
8533150|NCT00303069|21036452|P2|COMPLETED|Overall Study||28
8533151|NCT00303069|21036453|P1|COMPLETED|Overall Study||29
8533152|NCT00303069|21036450|P4|STARTED|Overall Study||31
8533153|NCT00303069|21036451|P3|STARTED|Overall Study||34
8533154|NCT00303069|21036452|P2|STARTED|Overall Study||28
8533155|NCT00303069|21036453|P1|STARTED|Overall Study||31
8533156|NCT00302952|21036473|P2|NOT COMPLETED|Overall Study||5
8533157|NCT00302952|21036474|P1|NOT COMPLETED|Overall Study||3
8533158|NCT00302952|21036473|P2|COMPLETED|Overall Study||25
8533159|NCT00302952|21036474|P1|COMPLETED|Overall Study||31
8533160|NCT00302952|21036473|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
8533161|NCT00302952|21036474|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
8533162|NCT00302952|21036473|P2|Started Intent-to-Treat (ITT)|Overall Study||30
8533163|NCT00302952|21036474|P1|Started Intent-to-Treat (ITT)|Overall Study||34
8533164|NCT00302952|21036473|P2|STARTED|Overall Study||30
8533165|NCT00302952|21036474|P1|STARTED|Overall Study||34
8533166|NCT00302848|21036511|P3|NOT COMPLETED|Overall Study||579
8533167|NCT00302848|21036512|P2|NOT COMPLETED|Overall Study||419
8533168|NCT00302848|21036513|P1|NOT COMPLETED|Overall Study||401
8533169|NCT00302848|21036511|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
8533170|NCT00302848|21036512|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
8533171|NCT00302848|21036513|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
8533172|NCT00302848|21036511|P3|STARTED|Overall Study||26341
8533173|NCT00302848|21036512|P2|STARTED|Overall Study||15428
8533174|NCT00302848|21036513|P1|STARTED|Overall Study||16534
8533175|NCT00302731|21036524|P4|NOT COMPLETED|Overall Study||0
8533176|NCT00302731|21036525|P3|NOT COMPLETED|Overall Study||3
8533177|NCT00302731|21036526|P2|NOT COMPLETED|Overall Study||5
8533178|NCT00302731|21036527|P1|NOT COMPLETED|Overall Study||4
8533179|NCT00302731|21036524|P4|COMPLETED|Overall Study||4
8533180|NCT00302731|21036525|P3|COMPLETED|Overall Study||2
8533181|NCT00302731|21036526|P2|COMPLETED|Overall Study||1
8533182|NCT00302731|21036527|P1|COMPLETED|Overall Study||2
8533183|NCT00302731|21036524|P4|STARTED|Overall Study||4
8533184|NCT00302731|21036525|P3|STARTED|Overall Study||5
8533185|NCT00302731|21036526|P2|STARTED|Overall Study||6
8533186|NCT00302731|21036527|P1|STARTED|Overall Study||6
8533187|NCT00302718|21036553|P4|NOT COMPLETED|Overall Study||2
8533188|NCT00302718|21036554|P3|NOT COMPLETED|Overall Study||2
8533189|NCT00302718|21036555|P2|NOT COMPLETED|Overall Study||1
8533190|NCT00302718|21036556|P1|NOT COMPLETED|Overall Study||1
8533191|NCT00302718|21036553|P4|COMPLETED|Overall Study||19
8533192|NCT00302718|21036554|P3|COMPLETED|Overall Study||19
8533193|NCT00302718|21036555|P2|COMPLETED|Overall Study||20
8533194|NCT00302718|21036556|P1|COMPLETED|Overall Study||19
8533195|NCT00302718|21036553|P4|STARTED|Overall Study||21
8533196|NCT00302718|21036554|P3|STARTED|Overall Study||21
8533197|NCT00302718|21036555|P2|STARTED|Overall Study||21
8533198|NCT00302718|21036556|P1|STARTED|Overall Study||20
8533199|NCT00302458|21036622|P1|NOT COMPLETED|Overall Study||3
8533200|NCT00302458|21036622|P1|COMPLETED|Overall Study||26
8533201|NCT00302458|21036622|P1|STARTED|Overall Study||29
8533202|NCT00302328|21036633|P3|NOT COMPLETED|Overall Study||0
8533203|NCT00302328|21036634|P2|NOT COMPLETED|Overall Study||1
8533204|NCT00302328|21036635|P1|NOT COMPLETED|Overall Study||0
8533205|NCT00302328|21036633|P3|COMPLETED|Overall Study||18
8533206|NCT00302328|21036634|P2|COMPLETED|Overall Study|developed cancer during the study|34
8533207|NCT00302328|21036635|P1|COMPLETED|Overall Study||25
8533208|NCT00302328|21036633|P3|STARTED|Overall Study||18
8533209|NCT00302328|21036634|P2|STARTED|Overall Study||35
8533210|NCT00302328|21036635|P1|STARTED|Overall Study||25
8533211|NCT00302211|21036652|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
8533212|NCT00302211|21036653|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
8533213|NCT00302211|21036654|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8533214|NCT00302211|21036655|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8533215|NCT00302211|21036656|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8533216|NCT00302211|21036652|P5|COMPLETED|Open Label-Patients From Double-Blind||24
8533217|NCT00302211|21036653|P4|COMPLETED|Open Label-Patients From Double-Blind||18
8533218|NCT00302211|21036654|P3|COMPLETED|Open Label-Patients From Double-Blind||0
8533219|NCT00302211|21036655|P2|COMPLETED|Open Label-Patients From Double-Blind||0
8533220|NCT00302211|21036656|P1|COMPLETED|Open Label-Patients From Double-Blind||0
8533221|NCT00302211|21036652|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
8533222|NCT00302211|21036653|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
8533223|NCT00302211|21036654|P3|STARTED|Open Label-Patients From Double-Blind||0
8533224|NCT00302211|21036655|P2|STARTED|Open Label-Patients From Double-Blind||0
8533225|NCT00302211|21036656|P1|STARTED|Open Label-Patients From Double-Blind||0
8533226|NCT00302211|21036652|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
8533227|NCT00302211|21036653|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
8533228|NCT00302211|21036654|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
8533229|NCT00302211|21036655|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
8533230|NCT00302211|21036656|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
8533231|NCT00302211|21036652|P5|COMPLETED|Double Blind Period (New Patients)||0
8533232|NCT00302211|21036653|P4|COMPLETED|Double Blind Period (New Patients)||0
8533233|NCT00302211|21036654|P3|COMPLETED|Double Blind Period (New Patients)||10
8533234|NCT00302211|21036655|P2|COMPLETED|Double Blind Period (New Patients)||25
8533235|NCT00302211|21036656|P1|COMPLETED|Double Blind Period (New Patients)||23
8533236|NCT00302211|21036652|P5|STARTED|Double Blind Period (New Patients)||0
8533237|NCT00302211|21036653|P4|STARTED|Double Blind Period (New Patients)||0
8533238|NCT00302211|21036654|P3|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
8533239|NCT00302211|21036655|P2|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
8533240|NCT00302211|21036656|P1|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
8533241|NCT00302159|21036682|P1|NOT COMPLETED|Overall Study||2
8533242|NCT00302159|21036682|P1|COMPLETED|Overall Study||41
8533243|NCT00302159|21036682|P1|STARTED|Overall Study||43
8533244|NCT00302133|21036693|P2|NOT COMPLETED|Overall Study||4
8533245|NCT00302133|21036694|P1|NOT COMPLETED|Overall Study||4
8533246|NCT00302133|21036693|P2|COMPLETED|Overall Study||5
8533247|NCT00302133|21036694|P1|COMPLETED|Overall Study||5
8533248|NCT00302133|21036693|P2|STARTED|Overall Study||9
8533249|NCT00302133|21036694|P1|STARTED|Overall Study||9
8533250|NCT00302107|21036704|P2|NOT COMPLETED|Overall Study||9
8533251|NCT00302107|21036705|P1|NOT COMPLETED|Overall Study||8
8533252|NCT00302107|21036704|P2|COMPLETED|Overall Study||30
8533253|NCT00302107|21036705|P1|COMPLETED|Overall Study||31
8533254|NCT00302107|21036704|P2|STARTED|Overall Study||39
8533255|NCT00302107|21036705|P1|STARTED|Overall Study||39
8533256|NCT00302081|21036714|P3|NOT COMPLETED|Overall Study||52
8533257|NCT00302081|21036715|P2|NOT COMPLETED|Overall Study||43
8533258|NCT00302081|21036716|P1|NOT COMPLETED|Overall Study||56
8533259|NCT00302081|21036714|P3|COMPLETED|Overall Study||178
8533260|NCT00302081|21036715|P2|COMPLETED|Overall Study||186
8533261|NCT00302081|21036716|P1|COMPLETED|Overall Study||181
8533262|NCT00302081|21036714|P3|STARTED|Overall Study||230
8533263|NCT00302081|21036715|P2|STARTED|Overall Study||229
8533264|NCT00302081|21036716|P1|STARTED|Overall Study||237
8533265|NCT00302068|21036727|P3|NOT COMPLETED|Overall Study||1
8533266|NCT00302068|21036728|P2|NOT COMPLETED|Overall Study||4
8533267|NCT00302068|21036729|P1|NOT COMPLETED|Overall Study||1
8533268|NCT00302068|21036727|P3|COMPLETED|Overall Study||23
8533269|NCT00302068|21036728|P2|COMPLETED|Overall Study||36
8533270|NCT00302068|21036729|P1|COMPLETED|Overall Study||36
8533271|NCT00302068|21036727|P3|STARTED|Overall Study||24
8533272|NCT00302068|21036728|P2|STARTED|Overall Study||40
8533273|NCT00302068|21036729|P1|STARTED|Overall Study||37
8533274|NCT00302055|21036757|P2|NOT COMPLETED|Overall Study||13
8533275|NCT00302055|21036758|P1|NOT COMPLETED|Overall Study||9
8533276|NCT00302055|21036757|P2|COMPLETED|Overall Study||36
8533277|NCT00302055|21036758|P1|COMPLETED|Overall Study||14
8533278|NCT00302055|21036757|P2|STARTED|Overall Study||49
8533279|NCT00302055|21036758|P1|STARTED|Overall Study||23
8533280|NCT00302042|21036766|P2|NOT COMPLETED|Overall Study||8
8533281|NCT00302042|21036767|P1|NOT COMPLETED|Overall Study||7
8533282|NCT00302042|21036766|P2|COMPLETED|Overall Study||38
8533283|NCT00302042|21036767|P1|COMPLETED|Overall Study||39
8533284|NCT00302042|21036766|P2|STARTED|Overall Study||46
8533285|NCT00302042|21036767|P1|STARTED|Overall Study||46
8533286|NCT00302003|21036773|P1|NOT COMPLETED|Overall Study||80
8533287|NCT00302003|21036773|P1|COMPLETED|Overall Study||207
8533288|NCT00302003|21036773|P1|STARTED|Overall Study||287
8533289|NCT00301964|21036780|P1|NOT COMPLETED|Overall Study||4
8533290|NCT00301964|21036780|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
8533291|NCT00301964|21036780|P1|STARTED|Overall Study||56
8533292|NCT00301873|21036795|P1|NOT COMPLETED|Overall Study||0
8533293|NCT00301873|21036795|P1|COMPLETED|Overall Study||59
8533294|NCT00301873|21036795|P1|STARTED|Overall Study||59
8533295|NCT00301834|21036801|P1|NOT COMPLETED|Overall Study||1
8533296|NCT00301834|21036801|P1|COMPLETED|Overall Study||34
8533297|NCT00301834|21036801|P1|STARTED|Overall Study||35
8533298|NCT00301821|21036810|P1|NOT COMPLETED|Overall Study||26
8533299|NCT00301821|21036810|P1|COMPLETED|Overall Study||81
8533300|NCT00301821|21036810|P1|STARTED|Overall Study||107
8533301|NCT00301808|21036817|P1|NOT COMPLETED|Overall Study||12
8533302|NCT00301808|21036817|P1|COMPLETED|Overall Study||17
8533303|NCT00301808|21036817|P1|STARTED|Overall Study||29
8533304|NCT00301756|21036824|P1|NOT COMPLETED|Overall Study||0
8533305|NCT00301756|21036824|P1|COMPLETED|Overall Study||32
8533306|NCT00301756|21036824|P1|STARTED|Overall Study||32
8533307|NCT00301418|21036836|P1|NOT COMPLETED|Overall Study||0
8533308|NCT00301418|21036836|P1|COMPLETED|Overall Study||11
8533309|NCT00301418|21036836|P1|STARTED|Overall Study||11
8533310|NCT00301366|21036842|P1|NOT COMPLETED|Overall Study||1
8533311|NCT00301366|21036842|P1|COMPLETED|Overall Study||37
8533312|NCT00301366|21036842|P1|STARTED|Overall Study||38
8533325|NCT00301080|21037007|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533326|NCT00301080|21037008|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533327|NCT00301080|21037009|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533328|NCT00301080|21037010|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533329|NCT00301080|21037011|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533330|NCT00301080|21037007|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533331|NCT00301080|21037008|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533332|NCT00301080|21037009|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533333|NCT00301080|21037010|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533334|NCT00301080|21037011|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533335|NCT00301080|21037007|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
8533336|NCT00301080|21037008|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
8533337|NCT00301080|21037009|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
8533338|NCT00301080|21037010|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
8533339|NCT00301080|21037011|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
8533340|NCT00301080|21037007|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533341|NCT00301080|21037008|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533342|NCT00301080|21037009|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533343|NCT00301080|21037010|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533344|NCT00301080|21037011|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
8533345|NCT00301080|21037007|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533346|NCT00301080|21037008|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533347|NCT00301080|21037009|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533348|NCT00301080|21037010|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
8533349|NCT00301080|21037011|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
8533350|NCT00301080|21037007|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
8533351|NCT00301080|21037008|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
8533352|NCT00301080|21037009|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
8533353|NCT00301080|21037010|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
8533354|NCT00301080|21037011|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
8533355|NCT00301080|21037007|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
8533356|NCT00301080|21037008|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
8533357|NCT00301080|21037009|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
8533358|NCT00301080|21037010|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
8533359|NCT00301080|21037011|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
8533360|NCT00301080|21037007|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
8533361|NCT00301080|21037008|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
8533362|NCT00301080|21037009|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
8533363|NCT00301080|21037010|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
8533364|NCT00301080|21037011|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
8533365|NCT00301067|21037040|P4|NOT COMPLETED|Follow up Until Death||1
8533366|NCT00301067|21037041|P3|NOT COMPLETED|Follow up Until Death||0
8533367|NCT00301067|21037042|P2|NOT COMPLETED|Follow up Until Death||0
8533368|NCT00301067|21037043|P1|NOT COMPLETED|Follow up Until Death||1
8533369|NCT00301067|21037040|P4|COMPLETED|Follow up Until Death||2
8533370|NCT00301067|21037041|P3|COMPLETED|Follow up Until Death||3
8533371|NCT00301067|21037042|P2|COMPLETED|Follow up Until Death||3
8533372|NCT00301067|21037043|P1|COMPLETED|Follow up Until Death||3
8533373|NCT00301067|21037040|P4|STARTED|Follow up Until Death||3
8533374|NCT00301067|21037041|P3|STARTED|Follow up Until Death||3
8533375|NCT00301067|21037042|P2|STARTED|Follow up Until Death||3
8533376|NCT00301067|21037043|P1|STARTED|Follow up Until Death||4
8533377|NCT00301067|21037040|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
8533378|NCT00301067|21037041|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
8533379|NCT00301067|21037042|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
8533380|NCT00301067|21037043|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
8533381|NCT00301067|21037040|P4|COMPLETED|Completed 12 Cycles of Treatment||0
8533382|NCT00301067|21037041|P3|COMPLETED|Completed 12 Cycles of Treatment||0
8533383|NCT00301067|21037042|P2|COMPLETED|Completed 12 Cycles of Treatment||0
8533384|NCT00301067|21037043|P1|COMPLETED|Completed 12 Cycles of Treatment||0
8533385|NCT00301067|21037040|P4|STARTED|Completed 12 Cycles of Treatment||2
8533386|NCT00301067|21037041|P3|STARTED|Completed 12 Cycles of Treatment||0
8533387|NCT00301067|21037042|P2|STARTED|Completed 12 Cycles of Treatment||1
8533388|NCT00301067|21037043|P1|STARTED|Completed 12 Cycles of Treatment||0
8533389|NCT00301067|21037040|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
8533390|NCT00301067|21037041|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
8533391|NCT00301067|21037042|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8533392|NCT00301067|21037043|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8533393|NCT00301067|21037040|P4|COMPLETED|Completed 4 Cycles of Treatment||2
8533394|NCT00301067|21037041|P3|COMPLETED|Completed 4 Cycles of Treatment||0
8533395|NCT00301067|21037042|P2|COMPLETED|Completed 4 Cycles of Treatment||1
8533396|NCT00301067|21037043|P1|COMPLETED|Completed 4 Cycles of Treatment||0
8533397|NCT00301067|21037040|P4|STARTED|Completed 4 Cycles of Treatment||7
8533398|NCT00301067|21037041|P3|STARTED|Completed 4 Cycles of Treatment||2
8533399|NCT00301067|21037042|P2|STARTED|Completed 4 Cycles of Treatment||2
8533400|NCT00301067|21037043|P1|STARTED|Completed 4 Cycles of Treatment||1
8533401|NCT00301067|21037040|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8533402|NCT00301067|21037041|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
8533403|NCT00301067|21037042|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
8533404|NCT00301067|21037043|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8533405|NCT00301067|21037040|P4|COMPLETED|Reached 1st Response/2 Cycles||7
8533406|NCT00301067|21037041|P3|COMPLETED|Reached 1st Response/2 Cycles||2
8533407|NCT00301067|21037042|P2|COMPLETED|Reached 1st Response/2 Cycles||2
8533408|NCT00301067|21037043|P1|COMPLETED|Reached 1st Response/2 Cycles||1
8533409|NCT00301067|21037040|P4|STARTED|Reached 1st Response/2 Cycles||9
8533410|NCT00301067|21037041|P3|STARTED|Reached 1st Response/2 Cycles||3
8533411|NCT00301067|21037042|P2|STARTED|Reached 1st Response/2 Cycles||3
8533412|NCT00301067|21037043|P1|STARTED|Reached 1st Response/2 Cycles||3
8533413|NCT00301067|21037040|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
8533414|NCT00301067|21037041|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
8533415|NCT00301067|21037042|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
8533416|NCT00301067|21037043|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
8533417|NCT00301067|21037040|P4|COMPLETED|Completed DLT Period/1st Cycle||9
8533418|NCT00301067|21037041|P3|COMPLETED|Completed DLT Period/1st Cycle||3
8533419|NCT00301067|21037042|P2|COMPLETED|Completed DLT Period/1st Cycle||3
8533420|NCT00301067|21037043|P1|COMPLETED|Completed DLT Period/1st Cycle||3
8533512|NCT00300456|21037289|P5|COMPLETED|Overall Study||99
8533421|NCT00301067|21037040|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
8533422|NCT00301067|21037041|P3|STARTED|Completed DLT Period/1st Cycle||3
8533423|NCT00301067|21037042|P2|STARTED|Completed DLT Period/1st Cycle||3
8533424|NCT00301067|21037043|P1|STARTED|Completed DLT Period/1st Cycle||4
8533425|NCT00301028|21037062|P1|NOT COMPLETED|Overall Study||0
8533426|NCT00301028|21037062|P1|COMPLETED|Overall Study||47
8533427|NCT00301028|21037062|P1|STARTED|Overall Study||47
8533428|NCT00300885|21037068|P2|NOT COMPLETED|Follow-up||195
8533429|NCT00300885|21037069|P1|NOT COMPLETED|Follow-up||178
8533430|NCT00300885|21037068|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
8533431|NCT00300885|21037069|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
8533432|NCT00300885|21037068|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
8533433|NCT00300885|21037069|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
8533434|NCT00300885|21037068|P2|NOT COMPLETED|Treatment||374
8533435|NCT00300885|21037069|P1|NOT COMPLETED|Treatment||373
8533436|NCT00300885|21037068|P2|COMPLETED|Treatment||88
8533437|NCT00300885|21037069|P1|COMPLETED|Treatment||91
8533438|NCT00300885|21037068|P2|Received Treatment|Treatment||459
8533439|NCT00300885|21037069|P1|Received Treatment|Treatment||463
8533440|NCT00300885|21037068|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
8533441|NCT00300885|21037069|P1|STARTED|Treatment||464
8533442|NCT00300781|21037087|P2|NOT COMPLETED|Overall Study||62
8533443|NCT00300781|21037088|P1|NOT COMPLETED|Overall Study||63
8533444|NCT00300781|21037087|P2|COMPLETED|Overall Study||8
8533445|NCT00300781|21037088|P1|COMPLETED|Overall Study||3
8533446|NCT00300781|21037087|P2|STARTED|Overall Study||70
8533447|NCT00300781|21037088|P1|STARTED|Overall Study||66
8533448|NCT00300755|21037103|P3|NOT COMPLETED|Overall Study||2
8533449|NCT00300755|21037104|P2|NOT COMPLETED|Overall Study||4
8533450|NCT00300755|21037105|P1|NOT COMPLETED|Overall Study||1
8533451|NCT00300755|21037103|P3|COMPLETED|Overall Study||19
8533452|NCT00300755|21037104|P2|COMPLETED|Overall Study||17
8533453|NCT00300755|21037105|P1|COMPLETED|Overall Study||17
8533454|NCT00300755|21037103|P3|STARTED|Overall Study||21
8533455|NCT00300755|21037104|P2|STARTED|Overall Study||21
8533456|NCT00300755|21037105|P1|STARTED|Overall Study||18
8533457|NCT00300742|21037122|P1|NOT COMPLETED|Overall Study||2
8533458|NCT00300742|21037122|P1|COMPLETED|Overall Study||3
8533459|NCT00300742|21037122|P1|STARTED|Overall Study||5
8533460|NCT00300677|21037130|P1|NOT COMPLETED|Overall Study||0
8533461|NCT00300677|21037130|P1|COMPLETED|Overall Study||12
8533462|NCT00300677|21037130|P1|STARTED|Overall Study||12
8533463|NCT00300495|21037139|P2|NOT COMPLETED|Overall Study||1
8533464|NCT00300495|21037140|P1|NOT COMPLETED|Overall Study||4
8533465|NCT00300495|21037139|P2|COMPLETED|Overall Study||8
8533466|NCT00300495|21037140|P1|COMPLETED|Overall Study||6
8533467|NCT00300495|21037139|P2|STARTED|Overall Study||9
8533468|NCT00300495|21037140|P1|STARTED|Overall Study||10
8533469|NCT00300482|21037154|P6|NOT COMPLETED|Overall Study||16
8533470|NCT00300482|21037155|P5|NOT COMPLETED|Overall Study||23
8533471|NCT00300482|21037156|P4|NOT COMPLETED|Overall Study||24
8533472|NCT00300482|21037157|P3|NOT COMPLETED|Overall Study||51
8533473|NCT00300482|21037158|P2|NOT COMPLETED|Overall Study||41
8533474|NCT00300482|21037159|P1|NOT COMPLETED|Overall Study||41
8533475|NCT00300482|21037154|P6|COMPLETED|Overall Study||115
8533476|NCT00300482|21037155|P5|COMPLETED|Overall Study||243
8533477|NCT00300482|21037156|P4|COMPLETED|Overall Study||237
8533478|NCT00300482|21037157|P3|COMPLETED|Overall Study||208
8533479|NCT00300482|21037158|P2|COMPLETED|Overall Study||220
8533480|NCT00300482|21037159|P1|COMPLETED|Overall Study||220
8533481|NCT00300482|21037154|P6|STARTED|Overall Study||131
8533482|NCT00300482|21037155|P5|STARTED|Overall Study||266
8533483|NCT00300482|21037156|P4|STARTED|Overall Study||261
8533484|NCT00300482|21037157|P3|STARTED|Overall Study||259
8533485|NCT00300482|21037158|P2|STARTED|Overall Study||261
8533486|NCT00300482|21037159|P1|STARTED|Overall Study|"For all arms, started means treated."|261
8533487|NCT00300469|21037221|P6|NOT COMPLETED|Overall Study||9
8533488|NCT00300469|21037222|P5|NOT COMPLETED|Overall Study||14
8533489|NCT00300469|21037223|P4|NOT COMPLETED|Overall Study||9
8533490|NCT00300469|21037224|P3|NOT COMPLETED|Overall Study||17
8533491|NCT00300469|21037225|P2|NOT COMPLETED|Overall Study||21
8533492|NCT00300469|21037226|P1|NOT COMPLETED|Overall Study||21
8533493|NCT00300469|21037221|P6|COMPLETED|Overall Study||46
8533494|NCT00300469|21037222|P5|COMPLETED|Overall Study||95
8533495|NCT00300469|21037223|P4|COMPLETED|Overall Study||104
8533496|NCT00300469|21037224|P3|COMPLETED|Overall Study||95
8533497|NCT00300469|21037225|P2|COMPLETED|Overall Study||89
8533498|NCT00300469|21037226|P1|COMPLETED|Overall Study||89
8533499|NCT00300469|21037221|P6|STARTED|Overall Study||55
8533500|NCT00300469|21037222|P5|STARTED|Overall Study||109
8533501|NCT00300469|21037223|P4|STARTED|Overall Study||113
8533502|NCT00300469|21037224|P3|STARTED|Overall Study||112
8533503|NCT00300469|21037225|P2|STARTED|Overall Study||110
8533504|NCT00300469|21037226|P1|STARTED|Overall Study|"For all arms, started means treated."|110
8533505|NCT00300456|21037288|P6|NOT COMPLETED|Overall Study||11
8533506|NCT00300456|21037289|P5|NOT COMPLETED|Overall Study||17
8533507|NCT00300456|21037290|P4|NOT COMPLETED|Overall Study||14
8533508|NCT00300456|21037291|P3|NOT COMPLETED|Overall Study||21
8533509|NCT00300456|21037292|P2|NOT COMPLETED|Overall Study||16
8533510|NCT00300456|21037293|P1|NOT COMPLETED|Overall Study||16
8533511|NCT00300456|21037288|P6|COMPLETED|Overall Study||48
8533513|NCT00300456|21037290|P4|COMPLETED|Overall Study||105
8533514|NCT00300456|21037291|P3|COMPLETED|Overall Study||98
8533515|NCT00300456|21037292|P2|COMPLETED|Overall Study||102
8533516|NCT00300456|21037293|P1|COMPLETED|Overall Study||103
8533517|NCT00300456|21037288|P6|STARTED|Overall Study||59
8533518|NCT00300456|21037289|P5|STARTED|Overall Study||116
8533519|NCT00300456|21037290|P4|STARTED|Overall Study||119
8533520|NCT00300456|21037291|P3|STARTED|Overall Study||119
8533521|NCT00300456|21037292|P2|STARTED|Overall Study||118
8533522|NCT00300456|21037293|P1|STARTED|Overall Study|"For all arms, started means treated."|119
8533523|NCT00300430|21037352|P3|NOT COMPLETED|Overall Study||151
8533524|NCT00300430|21037353|P2|NOT COMPLETED|Overall Study||169
8533525|NCT00300430|21037354|P1|NOT COMPLETED|Overall Study||367
8533526|NCT00300430|21037352|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
8533527|NCT00300430|21037353|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
8533528|NCT00300430|21037354|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
8533529|NCT00300430|21037352|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
8533530|NCT00300430|21037353|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
8533531|NCT00300430|21037354|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
8533532|NCT00300391|21037388|P2|NOT COMPLETED|Overall Study||0
8533533|NCT00300391|21037389|P1|NOT COMPLETED|Overall Study||0
8533534|NCT00300391|21037388|P2|COMPLETED|Overall Study||14
8533535|NCT00300391|21037389|P1|COMPLETED|Overall Study||16
8533536|NCT00300391|21037388|P2|STARTED|Overall Study||14
8533537|NCT00300391|21037389|P1|STARTED|Overall Study||16
8533538|NCT00300365|21037407|P2|NOT COMPLETED|Overall Study||2
8533539|NCT00300365|21037408|P1|NOT COMPLETED|Overall Study||4
8533540|NCT00300365|21037407|P2|COMPLETED|Overall Study||38
8533541|NCT00300365|21037408|P1|COMPLETED|Overall Study||34
8533542|NCT00300365|21037407|P2|STARTED|Overall Study||40
8533543|NCT00300365|21037408|P1|STARTED|Overall Study||38
8533544|NCT00300274|21037417|P3|NOT COMPLETED|Overall Study||45
8533545|NCT00300274|21037418|P2|NOT COMPLETED|Overall Study||27
8533546|NCT00300274|21037419|P1|NOT COMPLETED|Overall Study||46
8533547|NCT00300274|21037417|P3|COMPLETED|Overall Study||226
8533548|NCT00300274|21037418|P2|COMPLETED|Overall Study||141
8533549|NCT00300274|21037419|P1|COMPLETED|Overall Study||236
8533550|NCT00300274|21037417|P3|Completed 12 Month|Overall Study||248
8533551|NCT00300274|21037418|P2|Completed 12 Month|Overall Study||149
8533552|NCT00300274|21037419|P1|Completed 12 Month|Overall Study||250
8533553|NCT00300274|21037417|P3|STARTED|Overall Study||271
8533554|NCT00300274|21037418|P2|STARTED|Overall Study||168
8533555|NCT00300274|21037419|P1|STARTED|Overall Study||282
8533556|NCT00300235|21037459|P5|NOT COMPLETED|Overall Study||0
8533557|NCT00300235|21037460|P4|NOT COMPLETED|Overall Study||0
8533558|NCT00300235|21037461|P3|NOT COMPLETED|Overall Study||0
8533559|NCT00300235|21037462|P2|NOT COMPLETED|Overall Study||0
8533560|NCT00300235|21037463|P1|NOT COMPLETED|Overall Study||0
8533561|NCT00300235|21037459|P5|COMPLETED|Overall Study||251
8533562|NCT00300235|21037460|P4|COMPLETED|Overall Study||362
8533563|NCT00300235|21037461|P3|COMPLETED|Overall Study||398
8533564|NCT00300235|21037462|P2|COMPLETED|Overall Study||240
8533565|NCT00300235|21037463|P1|COMPLETED|Overall Study||208
8533566|NCT00300235|21037459|P5|STARTED|Overall Study||251
8533567|NCT00300235|21037460|P4|STARTED|Overall Study||362
8533568|NCT00300235|21037461|P3|STARTED|Overall Study||398
8533569|NCT00300235|21037462|P2|STARTED|Overall Study||240
8533570|NCT00300235|21037463|P1|STARTED|Overall Study||208
8533571|NCT00300053|21037478|P3|NOT COMPLETED|Overall Study||6
8533572|NCT00300053|21037479|P2|NOT COMPLETED|Overall Study||3
8533573|NCT00300053|21037480|P1|NOT COMPLETED|Overall Study||2
8533574|NCT00300053|21037478|P3|COMPLETED|Overall Study||50
8533575|NCT00300053|21037479|P2|COMPLETED|Overall Study||53
8533576|NCT00300053|21037480|P1|COMPLETED|Overall Study||53
8533577|NCT00300053|21037478|P3|6-Month Evaluation|Overall Study||53
8533578|NCT00300053|21037479|P2|6-Month Evaluation|Overall Study||55
8533579|NCT00300053|21037480|P1|6-Month Evaluation|Overall Study||54
8533580|NCT00300053|21037478|P3|3-Month Evaluation|Overall Study||54
8533581|NCT00300053|21037479|P2|3-Month Evaluation|Overall Study||56
8533582|NCT00300053|21037480|P1|3-Month Evaluation|Overall Study||55
8533583|NCT00300053|21037478|P3|STARTED|Overall Study|started = randomized and treated/injected|56
8533584|NCT00300053|21037479|P2|STARTED|Overall Study|started = randomized and treated/injected|56
8533585|NCT00300053|21037480|P1|STARTED|Overall Study|started = randomized and treated/injected|55
8533586|NCT00299988|21037506|P2|NOT COMPLETED|Overall Study||0
8533587|NCT00299988|21037507|P1|NOT COMPLETED|Overall Study||0
8533588|NCT00299988|21037506|P2|COMPLETED|Overall Study||8
8533589|NCT00299988|21037507|P1|COMPLETED|Overall Study||16
8533590|NCT00299988|21037506|P2|STARTED|Overall Study||8
8533591|NCT00299988|21037507|P1|STARTED|Overall Study||16
8533592|NCT00299975|21037518|P3|NOT COMPLETED|Overall Study||8
8533593|NCT00299975|21037519|P2|NOT COMPLETED|Overall Study||1
8533594|NCT00299975|21037520|P1|NOT COMPLETED|Overall Study||3
8533595|NCT00299975|21037518|P3|COMPLETED|Overall Study||25
8533596|NCT00299975|21037519|P2|COMPLETED|Overall Study||31
8533597|NCT00299975|21037520|P1|COMPLETED|Overall Study||29
8533598|NCT00299975|21037518|P3|Received Allocated Intervention|Overall Study||32
8533599|NCT00299975|21037519|P2|Received Allocated Intervention|Overall Study||32
8533600|NCT00299975|21037520|P1|Received Allocated Intervention|Overall Study||32
8533601|NCT00299975|21037518|P3|STARTED|Overall Study||33
8533602|NCT00299975|21037519|P2|STARTED|Overall Study||32
8533603|NCT00299975|21037520|P1|STARTED|Overall Study||32
8533604|NCT00299741|21037570|P1|NOT COMPLETED|Overall Study||0
8533605|NCT00299741|21037570|P1|COMPLETED|Overall Study||36
8533606|NCT00299741|21037570|P1|STARTED|Overall Study||36
8533607|NCT00299702|21037577|P2|NOT COMPLETED|Overall Study||50
8533608|NCT00299702|21037578|P1|NOT COMPLETED|Overall Study||53
8533609|NCT00299702|21037577|P2|COMPLETED|Overall Study||126
8533610|NCT00299702|21037578|P1|COMPLETED|Overall Study||126
8533611|NCT00299702|21037577|P2|STARTED|Overall Study||176
8533612|NCT00299702|21037578|P1|STARTED|Overall Study||179
8533613|NCT00299689|21037586|P1|NOT COMPLETED|Overall Study||0
8533614|NCT00299689|21037586|P1|COMPLETED|Overall Study||69
8533615|NCT00299689|21037586|P1|STARTED|Overall Study||69
8533616|NCT00299546|21037593|P3|NOT COMPLETED|Overall Study||86
8533617|NCT00299546|21037594|P2|NOT COMPLETED|Overall Study||92
8533618|NCT00299546|21037595|P1|NOT COMPLETED|Overall Study||100
8533619|NCT00299546|21037593|P3|COMPLETED|Overall Study||67
8533620|NCT00299546|21037594|P2|COMPLETED|Overall Study||61
8533621|NCT00299546|21037595|P1|COMPLETED|Overall Study||55
8533622|NCT00299546|21037593|P3|STARTED|Overall Study||153
8533623|NCT00299546|21037594|P2|STARTED|Overall Study||153
8533624|NCT00299546|21037595|P1|STARTED|Overall Study||155
8533625|NCT00299494|21037626|P6|NOT COMPLETED|Overall Study||26
8533626|NCT00299494|21037627|P5|NOT COMPLETED|Overall Study||27
8533627|NCT00299494|21037628|P4|NOT COMPLETED|Overall Study||10
8533628|NCT00299494|21037629|P3|NOT COMPLETED|Overall Study||4
8533629|NCT00299494|21037630|P2|NOT COMPLETED|Overall Study||1
8533630|NCT00299494|21037631|P1|NOT COMPLETED|Overall Study||3
8533631|NCT00299494|21037626|P6|COMPLETED|Overall Study||4
8533632|NCT00299494|21037627|P5|COMPLETED|Overall Study||13
8533633|NCT00299494|21037628|P4|COMPLETED|Overall Study||24
8533634|NCT00299494|21037629|P3|COMPLETED|Overall Study||3
8533635|NCT00299494|21037630|P2|COMPLETED|Overall Study||2
8533636|NCT00299494|21037631|P1|COMPLETED|Overall Study||2
8533637|NCT00299494|21037626|P6|STARTED|Overall Study||30
8533638|NCT00299494|21037627|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
8533639|NCT00299494|21037628|P4|STARTED|Overall Study||34
8533640|NCT00299494|21037629|P3|STARTED|Overall Study||7
8533641|NCT00299494|21037630|P2|STARTED|Overall Study||3
8533642|NCT00299494|21037631|P1|STARTED|Overall Study||5
8533643|NCT00299416|21037734|P1|NOT COMPLETED|Overall Study||0
8533644|NCT00299416|21037734|P1|COMPLETED|Overall Study||30
8533645|NCT00299416|21037734|P1|STARTED|Overall Study||30
8533646|NCT00299221|21037742|P2|NOT COMPLETED|Overall Study||0
8533647|NCT00299221|21037743|P1|NOT COMPLETED|Overall Study||0
8533648|NCT00299221|21037742|P2|COMPLETED|Overall Study||71
8533649|NCT00299221|21037743|P1|COMPLETED|Overall Study||79
8533650|NCT00299221|21037742|P2|STARTED|Overall Study||71
8533651|NCT00299221|21037743|P1|STARTED|Overall Study||79
8533652|NCT00299195|21037759|P2|NOT COMPLETED|Overall Study||0
8533653|NCT00299195|21037760|P1|NOT COMPLETED|Overall Study||0
8533654|NCT00299195|21037759|P2|COMPLETED|Overall Study||33
8533655|NCT00299195|21037760|P1|COMPLETED|Overall Study||30
8533656|NCT00299195|21037759|P2|STARTED|Overall Study||33
8533657|NCT00299195|21037760|P1|STARTED|Overall Study||30
8533658|NCT00299156|21037777|P3|NOT COMPLETED|Period 2 (Randomized)||0
8533659|NCT00299156|21037778|P2|NOT COMPLETED|Period 2 (Randomized)||1
8533660|NCT00299156|21037779|P1|NOT COMPLETED|Period 2 (Randomized)||0
8533661|NCT00299156|21037777|P3|COMPLETED|Period 2 (Randomized)||16
8533662|NCT00299156|21037778|P2|COMPLETED|Period 2 (Randomized)||16
8533663|NCT00299156|21037779|P1|COMPLETED|Period 2 (Randomized)||0
8533664|NCT00299156|21037777|P3|STARTED|Period 2 (Randomized)||16
8533665|NCT00299156|21037778|P2|STARTED|Period 2 (Randomized)||17
8533666|NCT00299156|21037779|P1|STARTED|Period 2 (Randomized)||0
8533667|NCT00299156|21037777|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
8533668|NCT00299156|21037778|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
8533669|NCT00299156|21037779|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
8533670|NCT00299156|21037777|P3|COMPLETED|Period 1 (Non-Randomized)||0
8533671|NCT00299156|21037778|P2|COMPLETED|Period 1 (Non-Randomized)||0
8533672|NCT00299156|21037779|P1|COMPLETED|Period 1 (Non-Randomized)||32
8533673|NCT00299156|21037777|P3|STARTED|Period 1 (Non-Randomized)||0
8533674|NCT00299156|21037778|P2|STARTED|Period 1 (Non-Randomized)||0
8533675|NCT00299156|21037779|P1|STARTED|Period 1 (Non-Randomized)||32
8533676|NCT00299130|21037790|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
8533677|NCT00299130|21037791|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
8533678|NCT00299130|21037792|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
8533679|NCT00299130|21037790|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
8533680|NCT00299130|21037791|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
8533681|NCT00299130|21037792|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
8533682|NCT00299130|21037790|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
8533683|NCT00299130|21037791|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
8533684|NCT00299130|21037792|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
8533685|NCT00299130|21037790|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8533686|NCT00299130|21037791|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8533687|NCT00299130|21037792|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8533688|NCT00299130|21037790|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
8533689|NCT00299130|21037791|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
8533690|NCT00299130|21037792|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
8533691|NCT00299130|21037790|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
8533692|NCT00299130|21037791|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
8533693|NCT00299130|21037792|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
8533694|NCT00299130|21037790|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
8533695|NCT00299130|21037791|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
8533696|NCT00299130|21037792|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
8533697|NCT00299130|21037790|P3|COMPLETED|Treatment Period (up to 5 Years)||121
8533698|NCT00299130|21037791|P2|COMPLETED|Treatment Period (up to 5 Years)||125
8533699|NCT00299130|21037792|P1|COMPLETED|Treatment Period (up to 5 Years)||119
8533700|NCT00299130|21037790|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
8533701|NCT00299130|21037791|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
8533702|NCT00299130|21037792|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
8533703|NCT00299130|21037790|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
8533704|NCT00299130|21037791|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
8533705|NCT00299130|21037792|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
8533706|NCT00299130|21037790|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
8533707|NCT00299130|21037791|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
8533708|NCT00299130|21037792|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
8533709|NCT00299130|21037790|P3|Treated|Treatment Period (up to 5 Years)||170
8533710|NCT00299130|21037791|P2|Treated|Treatment Period (up to 5 Years)||167
8533711|NCT00299130|21037792|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
8533712|NCT00299130|21037790|P3|STARTED|Treatment Period (up to 5 Years)||171
8533713|NCT00299130|21037791|P2|STARTED|Treatment Period (up to 5 Years)||168
8533714|NCT00299130|21037792|P1|STARTED|Treatment Period (up to 5 Years)||172
8533715|NCT00299104|21037897|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
8533716|NCT00299104|21037898|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
8533717|NCT00299104|21037899|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
8533718|NCT00299104|21037897|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
8533719|NCT00299104|21037898|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
8533720|NCT00299104|21037899|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
8533721|NCT00299104|21037897|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
8533722|NCT00299104|21037898|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
8533723|NCT00299104|21037899|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
8533724|NCT00299104|21037897|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
8533725|NCT00299104|21037898|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
8533726|NCT00299104|21037899|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
8533727|NCT00299104|21037897|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
8533728|NCT00299104|21037898|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
8533729|NCT00299104|21037899|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
8533730|NCT00299104|21037897|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
8533731|NCT00299104|21037898|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
8533732|NCT00299104|21037899|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
8533733|NCT00299104|21037897|P3|NOT COMPLETED|Treatment Period||172
8533734|NCT00299104|21037898|P2|NOT COMPLETED|Treatment Period||175
8533735|NCT00299104|21037899|P1|NOT COMPLETED|Treatment Period||189
8533736|NCT00299104|21037897|P3|COMPLETED|Treatment Period||80
8533737|NCT00299104|21037898|P2|COMPLETED|Treatment Period||77
8533738|NCT00299104|21037899|P1|COMPLETED|Treatment Period|Completed Week 152|62
8533739|NCT00299104|21037897|P3|Completed Week 104|Treatment Period||216
8533740|NCT00299104|21037898|P2|Completed Week 104|Treatment Period||213
8533741|NCT00299104|21037899|P1|Completed Week 104|Treatment Period||178
8533742|NCT00299104|21037897|P3|Completed Week 52|Treatment Period||232
8533743|NCT00299104|21037898|P2|Completed Week 52|Treatment Period||227
8533744|NCT00299104|21037899|P1|Completed Week 52|Treatment Period||213
8533745|NCT00299104|21037897|P3|Completed Week 24|Treatment Period||241
8533746|NCT00299104|21037898|P2|Completed Week 24|Treatment Period||240
8533747|NCT00299104|21037899|P1|Completed Week 24|Treatment Period||227
8533748|NCT00299104|21037897|P3|Safety/ITT: Received Study Drug|Treatment Period||250
8533749|NCT00299104|21037898|P2|Safety/ITT: Received Study Drug|Treatment Period||249
8533750|NCT00299104|21037899|P1|Safety/ITT: Received Study Drug|Treatment Period||249
8533751|NCT00299104|21037897|P3|STARTED|Treatment Period||252
8533752|NCT00299104|21037898|P2|STARTED|Treatment Period||252
8533753|NCT00299104|21037899|P1|STARTED|Treatment Period||251
8533754|NCT00299000|21037996|P2|NOT COMPLETED|Overall Study||0
8533755|NCT00299000|21037997|P1|NOT COMPLETED|Overall Study||0
8533756|NCT00299000|21037996|P2|COMPLETED|Overall Study||2
8533757|NCT00299000|21037997|P1|COMPLETED|Overall Study||2
8533758|NCT00299000|21037996|P2|STARTED|Overall Study||2
8533759|NCT00299000|21037997|P1|STARTED|Overall Study||2
8533760|NCT00298896|21038009|P1|NOT COMPLETED|Overall Study||50
8533761|NCT00298896|21038009|P1|COMPLETED|Overall Study||5
8533762|NCT00298896|21038009|P1|STARTED|Overall Study||55
8533763|NCT00298831|21038014|P1|NOT COMPLETED|Overall Study||32
8533764|NCT00298831|21038014|P1|COMPLETED|Overall Study||192
8533765|NCT00298831|21038014|P1|Treated|Overall Study||197
8533766|NCT00298831|21038014|P1|STARTED|Overall Study||224
8533767|NCT00298766|21038023|P1|NOT COMPLETED|Overall Study||46
8533768|NCT00298766|21038023|P1|COMPLETED|Overall Study||24
8533769|NCT00298766|21038023|P1|STARTED|Overall Study||70
8533770|NCT00298740|21038032|P1|NOT COMPLETED|Overall Study||9
8533771|NCT00298740|21038032|P1|COMPLETED|Overall Study||3
8533772|NCT00298740|21038032|P1|STARTED|Overall Study||12
8533773|NCT00298610|21038036|P1|NOT COMPLETED|Overall Study||0
8533774|NCT00298610|21038036|P1|COMPLETED|Overall Study||30
8533775|NCT00298610|21038036|P1|STARTED|Overall Study||30
8533776|NCT00298558|21038050|P4|NOT COMPLETED|10th Annual (A10)||163
8533777|NCT00298558|21038051|P3|NOT COMPLETED|10th Annual (A10)||171
8533778|NCT00298558|21038052|P2|NOT COMPLETED|10th Annual (A10)||153
8533779|NCT00298558|21038053|P1|NOT COMPLETED|10th Annual (A10)||172
8533780|NCT00298558|21038050|P4|COMPLETED|10th Annual (A10)||285
8533781|NCT00298558|21038051|P3|COMPLETED|10th Annual (A10)||319
8533782|NCT00298558|21038052|P2|COMPLETED|10th Annual (A10)||316
8533783|NCT00298558|21038053|P1|COMPLETED|10th Annual (A10)||300
8533784|NCT00298558|21038050|P4|STARTED|10th Annual (A10)||448
8533785|NCT00298558|21038051|P3|STARTED|10th Annual (A10)||490
8533786|NCT00298558|21038052|P2|STARTED|10th Annual (A10)||469
8533787|NCT00298558|21038053|P1|STARTED|10th Annual (A10)||472
8533788|NCT00298558|21038050|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
8533789|NCT00298558|21038051|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
8533790|NCT00298558|21038052|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
8533791|NCT00298558|21038053|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
8533792|NCT00298558|21038050|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
8533793|NCT00298558|21038051|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
8533794|NCT00298558|21038052|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
8533795|NCT00298558|21038053|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
8533796|NCT00298558|21038050|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
8533797|NCT00298558|21038051|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
8533798|NCT00298558|21038052|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
8533799|NCT00298558|21038053|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
8533800|NCT00298558|21038050|P4|NOT COMPLETED|3rd Annual Booster||0
8533801|NCT00298558|21038051|P3|NOT COMPLETED|3rd Annual Booster||140
8533802|NCT00298558|21038052|P2|NOT COMPLETED|3rd Annual Booster||128
8533803|NCT00298558|21038053|P1|NOT COMPLETED|3rd Annual Booster||122
8533804|NCT00298558|21038050|P4|COMPLETED|3rd Annual Booster||0
8533805|NCT00298558|21038051|P3|COMPLETED|3rd Annual Booster||230
8533806|NCT00298558|21038052|P2|COMPLETED|3rd Annual Booster||243
8533807|NCT00298558|21038053|P1|COMPLETED|3rd Annual Booster||250
8533808|NCT00298558|21038050|P4|STARTED|3rd Annual Booster||0
8533809|NCT00298558|21038051|P3|STARTED|3rd Annual Booster||370
8533810|NCT00298558|21038052|P2|STARTED|3rd Annual Booster||371
8533811|NCT00298558|21038053|P1|STARTED|3rd Annual Booster||372
8533812|NCT00298558|21038050|P4|NOT COMPLETED|2nd Annual (A2)||32
8533813|NCT00298558|21038051|P3|NOT COMPLETED|2nd Annual (A2)||27
8533814|NCT00298558|21038052|P2|NOT COMPLETED|2nd Annual (A2)||11
8533815|NCT00298558|21038053|P1|NOT COMPLETED|2nd Annual (A2)||22
8533816|NCT00298558|21038050|P4|COMPLETED|2nd Annual (A2)||552
8533817|NCT00298558|21038051|P3|COMPLETED|2nd Annual (A2)||574
8533818|NCT00298558|21038052|P2|COMPLETED|2nd Annual (A2)||555
8533819|NCT00298558|21038053|P1|COMPLETED|2nd Annual (A2)||563
8533820|NCT00298558|21038050|P4|STARTED|2nd Annual (A2)||584
8533821|NCT00298558|21038051|P3|STARTED|2nd Annual (A2)||601
8533822|NCT00298558|21038052|P2|STARTED|2nd Annual (A2)||566
8533823|NCT00298558|21038053|P1|STARTED|2nd Annual (A2)||585
8533824|NCT00298558|21038050|P4|NOT COMPLETED|1st Annual (A1)||55
8533825|NCT00298558|21038051|P3|NOT COMPLETED|1st Annual (A1)||52
8533826|NCT00298558|21038052|P2|NOT COMPLETED|1st Annual (A1)||63
8533827|NCT00298558|21038053|P1|NOT COMPLETED|1st Annual (A1)||55
8533828|NCT00298558|21038050|P4|COMPLETED|1st Annual (A1)||584
8533829|NCT00298558|21038051|P3|COMPLETED|1st Annual (A1)||601
8533830|NCT00298558|21038052|P2|COMPLETED|1st Annual (A1)||566
8533831|NCT00298558|21038053|P1|COMPLETED|1st Annual (A1)||585
8533832|NCT00298558|21038050|P4|STARTED|1st Annual (A1)||639
8533833|NCT00298558|21038051|P3|STARTED|1st Annual (A1)||653
8533834|NCT00298558|21038052|P2|STARTED|1st Annual (A1)||629
8533835|NCT00298558|21038053|P1|STARTED|1st Annual (A1)||640
8533836|NCT00298558|21038050|P4|NOT COMPLETED|Booster||0
8533837|NCT00298558|21038051|P3|NOT COMPLETED|Booster||75
8533838|NCT00298558|21038052|P2|NOT COMPLETED|Booster||70
8533839|NCT00298558|21038053|P1|NOT COMPLETED|Booster||89
8533840|NCT00298558|21038050|P4|COMPLETED|Booster||0
8533841|NCT00298558|21038051|P3|COMPLETED|Booster||295
8533842|NCT00298558|21038052|P2|COMPLETED|Booster||301
8533843|NCT00298558|21038053|P1|COMPLETED|Booster||283
8533844|NCT00298558|21038050|P4|STARTED|Booster||0
8533845|NCT00298558|21038051|P3|STARTED|Booster||370
8533846|NCT00298558|21038052|P2|STARTED|Booster||371
8533847|NCT00298558|21038053|P1|STARTED|Booster||372
8533848|NCT00298558|21038050|P4|NOT COMPLETED|Immediate Post Test||65
8533849|NCT00298558|21038051|P3|NOT COMPLETED|Immediate Post Test||59
8533850|NCT00298558|21038052|P2|NOT COMPLETED|Immediate Post Test||76
8533851|NCT00298558|21038053|P1|NOT COMPLETED|Immediate Post Test||71
8533852|NCT00298558|21038050|P4|COMPLETED|Immediate Post Test||639
8533853|NCT00298558|21038051|P3|COMPLETED|Immediate Post Test||653
8533854|NCT00298558|21038052|P2|COMPLETED|Immediate Post Test||629
8533855|NCT00298558|21038053|P1|COMPLETED|Immediate Post Test||640
8533856|NCT00298558|21038050|P4|STARTED|Immediate Post Test||704
8533857|NCT00298558|21038051|P3|STARTED|Immediate Post Test||712
8533858|NCT00298558|21038052|P2|STARTED|Immediate Post Test||705
8533859|NCT00298558|21038053|P1|STARTED|Immediate Post Test||711
8533860|NCT00298558|21038050|P4|NOT COMPLETED|Intervention||419
8533861|NCT00298558|21038051|P3|NOT COMPLETED|Intervention||75
8533862|NCT00298558|21038052|P2|NOT COMPLETED|Intervention||78
8533863|NCT00298558|21038053|P1|NOT COMPLETED|Intervention||91
8533864|NCT00298558|21038050|P4|COMPLETED|Intervention||285
8533865|NCT00298558|21038051|P3|COMPLETED|Intervention||637
8533866|NCT00298558|21038052|P2|COMPLETED|Intervention||627
8533867|NCT00298558|21038053|P1|COMPLETED|Intervention||620
8533868|NCT00298558|21038050|P4|STARTED|Intervention||704
8533869|NCT00298558|21038051|P3|STARTED|Intervention||712
8533870|NCT00298558|21038052|P2|STARTED|Intervention||705
8533871|NCT00298558|21038053|P1|STARTED|Intervention||711
8533872|NCT00298558|21038050|P4|NOT COMPLETED|Baseline||0
8533873|NCT00298558|21038051|P3|NOT COMPLETED|Baseline||0
8533874|NCT00298558|21038052|P2|NOT COMPLETED|Baseline||0
8533875|NCT00298558|21038053|P1|NOT COMPLETED|Baseline||0
8533876|NCT00298558|21038050|P4|COMPLETED|Baseline||704
8533877|NCT00298558|21038051|P3|COMPLETED|Baseline||712
8533878|NCT00298558|21038052|P2|COMPLETED|Baseline||705
8533879|NCT00298558|21038053|P1|COMPLETED|Baseline||711
8533880|NCT00298558|21038050|P4|STARTED|Baseline||704
8533881|NCT00298558|21038051|P3|STARTED|Baseline||712
8533882|NCT00298558|21038052|P2|STARTED|Baseline||705
8533883|NCT00298558|21038053|P1|STARTED|Baseline||711
8533884|NCT00298389|21038086|P3|NOT COMPLETED|Overall Study||0
8533885|NCT00298389|21038087|P2|NOT COMPLETED|Overall Study||0
8533886|NCT00298389|21038088|P1|NOT COMPLETED|Overall Study||0
8533887|NCT00298389|21038086|P3|COMPLETED|Overall Study||19
8533888|NCT00298389|21038087|P2|COMPLETED|Overall Study||17
8533889|NCT00298389|21038088|P1|COMPLETED|Overall Study||20
8533890|NCT00298389|21038086|P3|STARTED|Overall Study||19
8533891|NCT00298389|21038087|P2|STARTED|Overall Study||17
8533892|NCT00298389|21038088|P1|STARTED|Overall Study||20
8533893|NCT00298363|21038102|P3|NOT COMPLETED|Overall Study||6
8533894|NCT00298363|21038103|P2|NOT COMPLETED|Overall Study||8
8533895|NCT00298363|21038104|P1|NOT COMPLETED|Overall Study||17
8533896|NCT00298363|21038102|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
8533897|NCT00298363|21038103|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
8533898|NCT00298363|21038104|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
8533899|NCT00298363|21038102|P3|STARTED|Overall Study||22
8533900|NCT00298363|21038103|P2|STARTED|Overall Study||45
8533901|NCT00298363|21038104|P1|STARTED|Overall Study||45
8533902|NCT00298272|21038262|P2|NOT COMPLETED|Safety Follow-up Phase||4
8533903|NCT00298272|21038263|P1|NOT COMPLETED|Safety Follow-up Phase||4
8533904|NCT00298272|21038262|P2|COMPLETED|Safety Follow-up Phase||13
8533905|NCT00298272|21038263|P1|COMPLETED|Safety Follow-up Phase||18
8533906|NCT00298272|21038262|P2|STARTED|Safety Follow-up Phase||17
8533907|NCT00298272|21038263|P1|STARTED|Safety Follow-up Phase||22
8533908|NCT00298272|21038262|P2|NOT COMPLETED|Open Label Retreatment Phase||4
8533909|NCT00298272|21038263|P1|NOT COMPLETED|Open Label Retreatment Phase||9
8533910|NCT00298272|21038262|P2|COMPLETED|Open Label Retreatment Phase||12
8533911|NCT00298272|21038263|P1|COMPLETED|Open Label Retreatment Phase||13
8533912|NCT00298272|21038262|P2|Completed to Week 56|Open Label Retreatment Phase||12
8533913|NCT00298272|21038263|P1|Completed to Week 56|Open Label Retreatment Phase||13
8533914|NCT00298272|21038262|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
8533915|NCT00298272|21038263|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
8533916|NCT00298272|21038262|P2|STARTED|Open Label Retreatment Phase||16
8533917|NCT00298272|21038263|P1|STARTED|Open Label Retreatment Phase||22
8533918|NCT00298272|21038262|P2|NOT COMPLETED|Double-blind Phase||0
8533919|NCT00298272|21038263|P1|NOT COMPLETED|Double-blind Phase||8
8533920|NCT00298272|21038262|P2|COMPLETED|Double-blind Phase||18
8533921|NCT00298272|21038263|P1|COMPLETED|Double-blind Phase||28
8533922|NCT00298272|21038262|P2|Completed to Week 56|Double-blind Phase||3
8533923|NCT00298272|21038263|P1|Completed to Week 56|Double-blind Phase||8
8533924|NCT00298272|21038262|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
8533925|NCT00298272|21038263|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
8533926|NCT00298272|21038262|P2|Safety Population|Double-blind Phase||18
8533927|NCT00298272|21038263|P1|Safety Population|Double-blind Phase|received treatment|33
8533928|NCT00298272|21038262|P2|STARTED|Double-blind Phase||18
8533929|NCT00298272|21038263|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
8533930|NCT00298233|21038286|P4|NOT COMPLETED|Overall Study||0
8533931|NCT00298233|21038287|P3|NOT COMPLETED|Overall Study||0
8533932|NCT00298233|21038288|P2|NOT COMPLETED|Overall Study||0
8533933|NCT00298233|21038289|P1|NOT COMPLETED|Overall Study||0
8533934|NCT00298233|21038286|P4|COMPLETED|Overall Study||124
8533935|NCT00298233|21038287|P3|COMPLETED|Overall Study||122
8533936|NCT00298233|21038288|P2|COMPLETED|Overall Study||41
8533937|NCT00298233|21038289|P1|COMPLETED|Overall Study||39
8533938|NCT00298233|21038286|P4|STARTED|Overall Study||124
8533939|NCT00298233|21038287|P3|STARTED|Overall Study||122
8533940|NCT00298233|21038288|P2|STARTED|Overall Study||41
8533941|NCT00298233|21038289|P1|STARTED|Overall Study||39
8533942|NCT00298155|21038308|P3|NOT COMPLETED|Overall Study||0
8533943|NCT00298155|21038309|P2|NOT COMPLETED|Overall Study||0
8533944|NCT00298155|21038310|P1|NOT COMPLETED|Overall Study||0
8533945|NCT00298155|21038308|P3|COMPLETED|Overall Study||13
8533946|NCT00298155|21038309|P2|COMPLETED|Overall Study||10
8533947|NCT00298155|21038310|P1|COMPLETED|Overall Study||12
8533948|NCT00298155|21038308|P3|STARTED|Overall Study||13
8533949|NCT00298155|21038309|P2|STARTED|Overall Study||10
8533950|NCT00298155|21038310|P1|STARTED|Overall Study||12
8533951|NCT00298090|21038321|P1|NOT COMPLETED|Overall Study||18
8533952|NCT00298090|21038321|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
8533953|NCT00298090|21038321|P1|STARTED|Overall Study||47
8533954|NCT00298038|21038327|P2|NOT COMPLETED|Overall Study||93
8533955|NCT00298038|21038328|P1|NOT COMPLETED|Overall Study||52
8533956|NCT00298038|21038327|P2|COMPLETED|Overall Study||66
8533957|NCT00298038|21038328|P1|COMPLETED|Overall Study||88
8533958|NCT00298038|21038327|P2|Received At Least 1 Dose Of Study Drug|Overall Study||159
8533959|NCT00298038|21038328|P1|Received At Least 1 Dose Of Study Drug|Overall Study||140
8533960|NCT00298038|21038327|P2|STARTED|Overall Study||159
8533961|NCT00298038|21038328|P1|STARTED|Overall Study||140
8533962|NCT00297830|21038347|P3|NOT COMPLETED|12 Month Visit||0
8533963|NCT00297830|21038348|P2|NOT COMPLETED|12 Month Visit||6
8533964|NCT00297830|21038349|P1|NOT COMPLETED|12 Month Visit||1
8533965|NCT00297830|21038347|P3|COMPLETED|12 Month Visit||24
8533966|NCT00297830|21038348|P2|COMPLETED|12 Month Visit||35
8533967|NCT00297830|21038349|P1|COMPLETED|12 Month Visit||37
8533968|NCT00297830|21038347|P3|STARTED|12 Month Visit||24
8533969|NCT00297830|21038348|P2|STARTED|12 Month Visit||41
8533970|NCT00297830|21038349|P1|STARTED|12 Month Visit||38
8533971|NCT00297830|21038347|P3|NOT COMPLETED|6 Month Visit||3
8533972|NCT00297830|21038348|P2|NOT COMPLETED|6 Month Visit||2
8533973|NCT00297830|21038349|P1|NOT COMPLETED|6 Month Visit||3
8533974|NCT00297830|21038347|P3|COMPLETED|6 Month Visit||24
8533975|NCT00297830|21038348|P2|COMPLETED|6 Month Visit||41
8533976|NCT00297830|21038349|P1|COMPLETED|6 Month Visit||38
8533977|NCT00297830|21038347|P3|STARTED|6 Month Visit||27
8533978|NCT00297830|21038348|P2|STARTED|6 Month Visit||43
8533979|NCT00297830|21038349|P1|STARTED|6 Month Visit||41
8533980|NCT00297830|21038347|P3|NOT COMPLETED|Baseline||0
8533981|NCT00297830|21038348|P2|NOT COMPLETED|Baseline||0
8533982|NCT00297830|21038349|P1|NOT COMPLETED|Baseline||0
8533983|NCT00297830|21038347|P3|COMPLETED|Baseline||27
8533984|NCT00297830|21038348|P2|COMPLETED|Baseline||43
8533985|NCT00297830|21038349|P1|COMPLETED|Baseline||41
8533986|NCT00297830|21038347|P3|STARTED|Baseline||27
8533987|NCT00297830|21038348|P2|STARTED|Baseline||43
8533988|NCT00297830|21038349|P1|STARTED|Baseline||41
8533989|NCT00297778|21038368|P2|NOT COMPLETED|Overall Study||20
8533990|NCT00297778|21038369|P1|NOT COMPLETED|Overall Study||19
8533991|NCT00297778|21038368|P2|COMPLETED|Overall Study||124
8533992|NCT00297778|21038369|P1|COMPLETED|Overall Study||133
8533993|NCT00297778|21038368|P2|STARTED|Overall Study||144
8533994|NCT00297778|21038369|P1|STARTED|Overall Study||152
8533995|NCT00297648|21038403|P1|NOT COMPLETED|Overall Study||36
8533996|NCT00297648|21038403|P1|COMPLETED|Overall Study||53
8533997|NCT00297648|21038403|P1|STARTED|Overall Study||89
8533998|NCT00297596|21038442|P1|NOT COMPLETED|Overall Study||0
8533999|NCT00297596|21038442|P1|COMPLETED|Overall Study||25
8534000|NCT00297596|21038442|P1|STARTED|Overall Study||25
8534001|NCT00297492|21038449|P3|NOT COMPLETED|6 Month Follow-up||27
8534002|NCT00297492|21038450|P2|NOT COMPLETED|6 Month Follow-up||49
8534003|NCT00297492|21038451|P1|NOT COMPLETED|6 Month Follow-up||63
8534004|NCT00297492|21038449|P3|COMPLETED|6 Month Follow-up||118
8534005|NCT00297492|21038450|P2|COMPLETED|6 Month Follow-up||237
8534006|NCT00297492|21038451|P1|COMPLETED|6 Month Follow-up||227
8534007|NCT00297492|21038449|P3|STARTED|6 Month Follow-up||145
8534008|NCT00297492|21038450|P2|STARTED|6 Month Follow-up||286
8534009|NCT00297492|21038451|P1|STARTED|6 Month Follow-up||290
8534010|NCT00297492|21038449|P3|NOT COMPLETED|Set Quit Date||5
8534011|NCT00297492|21038450|P2|NOT COMPLETED|Set Quit Date||13
8534012|NCT00297492|21038451|P1|NOT COMPLETED|Set Quit Date||7
8534013|NCT00297492|21038449|P3|COMPLETED|Set Quit Date||145
8534014|NCT00297492|21038450|P2|COMPLETED|Set Quit Date||286
8534015|NCT00297492|21038451|P1|COMPLETED|Set Quit Date||290
8534016|NCT00297492|21038449|P3|STARTED|Set Quit Date||150
8534017|NCT00297492|21038450|P2|STARTED|Set Quit Date||299
8534018|NCT00297492|21038451|P1|STARTED|Set Quit Date||297
8534019|NCT00297479|21038462|P3|NOT COMPLETED|Overall Study||51
8534020|NCT00297479|21038463|P2|NOT COMPLETED|Overall Study||54
8534021|NCT00297479|21038464|P1|NOT COMPLETED|Overall Study||37
8534022|NCT00297479|21038462|P3|COMPLETED|Overall Study||103
8534023|NCT00297479|21038463|P2|COMPLETED|Overall Study||101
8534024|NCT00297479|21038464|P1|COMPLETED|Overall Study||66
8534025|NCT00297479|21038462|P3|26- Week Follow Up|Overall Study||103
8534026|NCT00297479|21038463|P2|26- Week Follow Up|Overall Study||101
8534027|NCT00297479|21038464|P1|26- Week Follow Up|Overall Study||66
8534028|NCT00297479|21038462|P3|4-Week Follow Up|Overall Study||128
8534029|NCT00297479|21038463|P2|4-Week Follow Up|Overall Study||132
8534030|NCT00297479|21038464|P1|4-Week Follow Up|Overall Study||78
8534031|NCT00297479|21038462|P3|STARTED|Overall Study||154
8534032|NCT00297479|21038463|P2|STARTED|Overall Study||155
8534033|NCT00297479|21038464|P1|STARTED|Overall Study||103
8534034|NCT00297427|21038483|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
8534035|NCT00297427|21038484|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
8534036|NCT00297427|21038483|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
8534196|NCT00296504|21038713|P5|COMPLETED|Interim Analysis||36
8534037|NCT00297427|21038484|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
8534038|NCT00297427|21038483|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
8534039|NCT00297427|21038484|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
8534040|NCT00297427|21038483|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
8534041|NCT00297427|21038484|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
8534042|NCT00297427|21038483|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8534043|NCT00297427|21038484|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
8534044|NCT00297427|21038483|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8534045|NCT00297427|21038484|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
8534046|NCT00297427|21038483|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8534047|NCT00297427|21038484|P1|STARTED|Phase 2: Optional Crossover for Sham||54
8534048|NCT00297427|21038483|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
8534049|NCT00297427|21038484|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
8534050|NCT00297427|21038483|P2|COMPLETED|Phase 1: Initial Intervention||54
8534051|NCT00297427|21038484|P1|COMPLETED|Phase 1: Initial Intervention||56
8534052|NCT00297427|21038483|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
8534053|NCT00297427|21038484|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
8534054|NCT00297258|21038525|P1|NOT COMPLETED|Overall Study||142
8534055|NCT00297258|21038525|P1|COMPLETED|Overall Study||0
8534056|NCT00297258|21038525|P1|STARTED|Overall Study||142
8534057|NCT00297232|21038544|P1|NOT COMPLETED|Overall Study||605
8534058|NCT00297232|21038544|P1|COMPLETED|Overall Study||489
8534059|NCT00297232|21038544|P1|STARTED|Overall Study||1094
8534060|NCT00297167|21038550|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8534061|NCT00297167|21038551|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8534062|NCT00297167|21038552|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8534063|NCT00297167|21038550|P3|COMPLETED|Open-label Dose Normalization Period 2||31
8534064|NCT00297167|21038551|P2|COMPLETED|Open-label Dose Normalization Period 2||0
8534065|NCT00297167|21038552|P1|COMPLETED|Open-label Dose Normalization Period 2||0
8534066|NCT00297167|21038550|P3|STARTED|Open-label Dose Normalization Period 2||31
8534067|NCT00297167|21038551|P2|STARTED|Open-label Dose Normalization Period 2||0
8534068|NCT00297167|21038552|P1|STARTED|Open-label Dose Normalization Period 2||0
8534069|NCT00297167|21038550|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
8534070|NCT00297167|21038551|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
8534071|NCT00297167|21038552|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
8534072|NCT00297167|21038550|P3|COMPLETED|Second Double-blind Intervention Period||0
8534073|NCT00297167|21038551|P2|COMPLETED|Second Double-blind Intervention Period||15
8534074|NCT00297167|21038552|P1|COMPLETED|Second Double-blind Intervention Period||16
8534075|NCT00297167|21038550|P3|STARTED|Second Double-blind Intervention Period||0
8534076|NCT00297167|21038551|P2|STARTED|Second Double-blind Intervention Period||15
8534077|NCT00297167|21038552|P1|STARTED|Second Double-blind Intervention Period||17
8534078|NCT00297167|21038550|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
8534079|NCT00297167|21038551|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
8534080|NCT00297167|21038552|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
8534081|NCT00297167|21038550|P3|COMPLETED|Open-label Dose Normalization Period 1||32
8534082|NCT00297167|21038551|P2|COMPLETED|Open-label Dose Normalization Period 1||0
8534083|NCT00297167|21038552|P1|COMPLETED|Open-label Dose Normalization Period 1||0
8534084|NCT00297167|21038550|P3|STARTED|Open-label Dose Normalization Period 1||33
8534085|NCT00297167|21038551|P2|STARTED|Open-label Dose Normalization Period 1||0
8534086|NCT00297167|21038552|P1|STARTED|Open-label Dose Normalization Period 1||0
8534087|NCT00297167|21038550|P3|NOT COMPLETED|First Double-blind Intervention Period||0
8534088|NCT00297167|21038551|P2|NOT COMPLETED|First Double-blind Intervention Period||0
8534089|NCT00297167|21038552|P1|NOT COMPLETED|First Double-blind Intervention Period||0
8534090|NCT00297167|21038550|P3|COMPLETED|First Double-blind Intervention Period||0
8534091|NCT00297167|21038551|P2|COMPLETED|First Double-blind Intervention Period||16
8534092|NCT00297167|21038552|P1|COMPLETED|First Double-blind Intervention Period||17
8534093|NCT00297167|21038550|P3|STARTED|First Double-blind Intervention Period||0
8534094|NCT00297167|21038551|P2|STARTED|First Double-blind Intervention Period||16
8534095|NCT00297167|21038552|P1|STARTED|First Double-blind Intervention Period||17
8534096|NCT00297115|21038578|P2|NOT COMPLETED|Overall Study||246
8534097|NCT00297115|21038579|P1|NOT COMPLETED|Overall Study||245
8534098|NCT00297115|21038578|P2|COMPLETED|Overall Study||550
8534099|NCT00297115|21038579|P1|COMPLETED|Overall Study||527
8534100|NCT00297115|21038578|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
8534101|NCT00297115|21038579|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
8534102|NCT00297102|21038597|P2|NOT COMPLETED|Overall Study||233
8534103|NCT00297102|21038598|P1|NOT COMPLETED|Overall Study||263
8534104|NCT00297102|21038597|P2|COMPLETED|Overall Study||525
8534105|NCT00297102|21038598|P1|COMPLETED|Overall Study||502
8534106|NCT00297102|21038597|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
8534107|NCT00297102|21038598|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
8534108|NCT00297037|21038616|P2|NOT COMPLETED|Overall Study||0
8534109|NCT00297037|21038617|P1|NOT COMPLETED|Overall Study||2
8534110|NCT00297037|21038616|P2|COMPLETED|Overall Study||11
8534111|NCT00297037|21038617|P1|COMPLETED|Overall Study||8
8534112|NCT00297037|21038616|P2|STARTED|Overall Study||11
8534113|NCT00297037|21038617|P1|STARTED|Overall Study||10
8534114|NCT00296816|21038629|P1|NOT COMPLETED|Overall Study||74
8534115|NCT00296816|21038629|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
8534116|NCT00296816|21038629|P1|STARTED|Overall Study||132
8534117|NCT00296725|21038641|P1|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
8534118|NCT00296725|21038641|P1|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
8534119|NCT00296725|21038641|P1|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
8534120|NCT00296725|21038641|P1|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
8534121|NCT00296725|21038641|P1|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
8534122|NCT00296725|21038641|P1|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
8534123|NCT00296647|21038654|P5|NOT COMPLETED|Overall Study||20
8534124|NCT00296647|21038655|P4|NOT COMPLETED|Overall Study||17
8534125|NCT00296647|21038656|P3|NOT COMPLETED|Overall Study||34
8534126|NCT00296647|21038657|P2|NOT COMPLETED|Overall Study||28
8534127|NCT00296647|21038658|P1|NOT COMPLETED|Overall Study||32
8534128|NCT00296647|21038654|P5|COMPLETED|Overall Study||248
8534129|NCT00296647|21038655|P4|COMPLETED|Overall Study||262
8534130|NCT00296647|21038656|P3|COMPLETED|Overall Study||222
8534131|NCT00296647|21038657|P2|COMPLETED|Overall Study||233
8534132|NCT00296647|21038658|P1|COMPLETED|Overall Study||250
8534133|NCT00296647|21038654|P5|STARTED|Overall Study||268
8534134|NCT00296647|21038655|P4|STARTED|Overall Study||279
8534135|NCT00296647|21038656|P3|STARTED|Overall Study||256
8534136|NCT00296647|21038657|P2|STARTED|Overall Study||261
8534137|NCT00296647|21038658|P1|STARTED|Overall Study||282
8534138|NCT00296517|21038672|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
8534139|NCT00296517|21038673|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
8534140|NCT00296517|21038672|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
8534141|NCT00296517|21038673|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
8534142|NCT00296517|21038672|P2|STARTED|Dose Level 3 - Weeks 3-12||161
8534143|NCT00296517|21038673|P1|STARTED|Dose Level 3 - Weeks 3-12||157
8534144|NCT00296517|21038672|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
8534145|NCT00296517|21038673|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
8534146|NCT00296517|21038672|P2|COMPLETED|Dose Level 2 - Week 2||161
8534147|NCT00296517|21038673|P1|COMPLETED|Dose Level 2 - Week 2||157
8534148|NCT00296517|21038672|P2|STARTED|Dose Level 2 - Week 2||166
8534149|NCT00296517|21038673|P1|STARTED|Dose Level 2 - Week 2||159
8534150|NCT00296517|21038672|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
8534151|NCT00296517|21038673|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
8534152|NCT00296517|21038672|P2|COMPLETED|Dose Level 1 - Week 1||166
8534153|NCT00296517|21038673|P1|COMPLETED|Dose Level 1 - Week 1||159
8534154|NCT00296517|21038672|P2|STARTED|Dose Level 1 - Week 1||166
8534155|NCT00296517|21038673|P1|STARTED|Dose Level 1 - Week 1||159
8534156|NCT00296504|21038709|P9|NOT COMPLETED|Final Analysis||21
8534157|NCT00296504|21038710|P8|NOT COMPLETED|Final Analysis||0
8534158|NCT00296504|21038711|P7|NOT COMPLETED|Final Analysis||0
8534159|NCT00296504|21038712|P6|NOT COMPLETED|Final Analysis||0
8534160|NCT00296504|21038713|P5|NOT COMPLETED|Final Analysis||0
8534161|NCT00296504|21038714|P4|NOT COMPLETED|Final Analysis||0
8534162|NCT00296504|21038715|P3|NOT COMPLETED|Final Analysis||0
8534163|NCT00296504|21038716|P2|NOT COMPLETED|Final Analysis||0
8534164|NCT00296504|21038717|P1|NOT COMPLETED|Final Analysis||0
8534165|NCT00296504|21038709|P9|COMPLETED|Final Analysis||90
8534166|NCT00296504|21038710|P8|COMPLETED|Final Analysis||0
8534167|NCT00296504|21038711|P7|COMPLETED|Final Analysis||0
8534168|NCT00296504|21038712|P6|COMPLETED|Final Analysis||0
8534169|NCT00296504|21038713|P5|COMPLETED|Final Analysis||0
8534170|NCT00296504|21038714|P4|COMPLETED|Final Analysis||0
8534171|NCT00296504|21038715|P3|COMPLETED|Final Analysis||0
8534172|NCT00296504|21038716|P2|COMPLETED|Final Analysis||0
8534173|NCT00296504|21038717|P1|COMPLETED|Final Analysis||0
8534174|NCT00296504|21038709|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
8534175|NCT00296504|21038710|P8|STARTED|Final Analysis||0
8534176|NCT00296504|21038711|P7|STARTED|Final Analysis||0
8534177|NCT00296504|21038712|P6|STARTED|Final Analysis||0
8534178|NCT00296504|21038713|P5|STARTED|Final Analysis||0
8534179|NCT00296504|21038714|P4|STARTED|Final Analysis||0
8534180|NCT00296504|21038715|P3|STARTED|Final Analysis||0
8534181|NCT00296504|21038716|P2|STARTED|Final Analysis||0
8534182|NCT00296504|21038717|P1|STARTED|Final Analysis||0
8534183|NCT00296504|21038709|P9|NOT COMPLETED|Interim Analysis||0
8534184|NCT00296504|21038710|P8|NOT COMPLETED|Interim Analysis||49
8534185|NCT00296504|21038711|P7|NOT COMPLETED|Interim Analysis||74
8534186|NCT00296504|21038712|P6|NOT COMPLETED|Interim Analysis||37
8534187|NCT00296504|21038713|P5|NOT COMPLETED|Interim Analysis||37
8534188|NCT00296504|21038714|P4|NOT COMPLETED|Interim Analysis||43
8534189|NCT00296504|21038715|P3|NOT COMPLETED|Interim Analysis||105
8534190|NCT00296504|21038716|P2|NOT COMPLETED|Interim Analysis||18
8534191|NCT00296504|21038717|P1|NOT COMPLETED|Interim Analysis||76
8534192|NCT00296504|21038709|P9|COMPLETED|Interim Analysis||0
8534193|NCT00296504|21038710|P8|COMPLETED|Interim Analysis||37
8534194|NCT00296504|21038711|P7|COMPLETED|Interim Analysis||30
8534195|NCT00296504|21038712|P6|COMPLETED|Interim Analysis||41
8534197|NCT00296504|21038714|P4|COMPLETED|Interim Analysis||11
8534198|NCT00296504|21038715|P3|COMPLETED|Interim Analysis||116
8534199|NCT00296504|21038716|P2|COMPLETED|Interim Analysis||0
8534200|NCT00296504|21038717|P1|COMPLETED|Interim Analysis||43
8534201|NCT00296504|21038709|P9|Ongoing|Interim Analysis||0
8534202|NCT00296504|21038710|P8|Ongoing|Interim Analysis||1
8534203|NCT00296504|21038711|P7|Ongoing|Interim Analysis||30
8534204|NCT00296504|21038712|P6|Ongoing|Interim Analysis||0
8534205|NCT00296504|21038713|P5|Ongoing|Interim Analysis||0
8534206|NCT00296504|21038714|P4|Ongoing|Interim Analysis||22
8534207|NCT00296504|21038715|P3|Ongoing|Interim Analysis||16
8534208|NCT00296504|21038716|P2|Ongoing|Interim Analysis||12
8534209|NCT00296504|21038717|P1|Ongoing|Interim Analysis||32
8534210|NCT00296504|21038709|P9|STARTED|Interim Analysis||0
8534211|NCT00296504|21038710|P8|STARTED|Interim Analysis||86
8534212|NCT00296504|21038711|P7|STARTED|Interim Analysis||104
8534213|NCT00296504|21038712|P6|STARTED|Interim Analysis||78
8534214|NCT00296504|21038713|P5|STARTED|Interim Analysis||73
8534215|NCT00296504|21038714|P4|STARTED|Interim Analysis||54
8534216|NCT00296504|21038715|P3|STARTED|Interim Analysis||221
8534217|NCT00296504|21038716|P2|STARTED|Interim Analysis||18
8534218|NCT00296504|21038717|P1|STARTED|Interim Analysis||119
8534219|NCT00296491|21038810|P4|NOT COMPLETED|Overall Study||43
8534220|NCT00296491|21038811|P3|NOT COMPLETED|Overall Study||43
8534221|NCT00296491|21038812|P2|NOT COMPLETED|Overall Study||53
8534222|NCT00296491|21038813|P1|NOT COMPLETED|Overall Study||42
8534223|NCT00296491|21038810|P4|COMPLETED|Overall Study||138
8534224|NCT00296491|21038811|P3|COMPLETED|Overall Study||137
8534225|NCT00296491|21038812|P2|COMPLETED|Overall Study||129
8534226|NCT00296491|21038813|P1|COMPLETED|Overall Study||140
8534227|NCT00296491|21038810|P4|STARTED|Overall Study||181
8534228|NCT00296491|21038811|P3|STARTED|Overall Study||180
8534229|NCT00296491|21038812|P2|STARTED|Overall Study||182
8534230|NCT00296491|21038813|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
8534231|NCT00296400|21038842|P3|NOT COMPLETED|Overall Study||13
8534232|NCT00296400|21038843|P2|NOT COMPLETED|Overall Study||18
8534233|NCT00296400|21038844|P1|NOT COMPLETED|Overall Study||17
8534234|NCT00296400|21038842|P3|COMPLETED|Overall Study||67
8534235|NCT00296400|21038843|P2|COMPLETED|Overall Study||69
8534236|NCT00296400|21038844|P1|COMPLETED|Overall Study||53
8534237|NCT00296400|21038842|P3|STARTED|Overall Study||80
8534238|NCT00296400|21038843|P2|STARTED|Overall Study||87
8534239|NCT00296400|21038844|P1|STARTED|Overall Study||70
8534240|NCT00296374|21039068|P3|NOT COMPLETED|Overall Study||29
8534241|NCT00296374|21039069|P2|NOT COMPLETED|Overall Study||23
8534242|NCT00296374|21039070|P1|NOT COMPLETED|Overall Study||25
8534243|NCT00296374|21039068|P3|COMPLETED|Overall Study||82
8534244|NCT00296374|21039069|P2|COMPLETED|Overall Study||101
8534245|NCT00296374|21039070|P1|COMPLETED|Overall Study||93
8534246|NCT00296374|21039068|P3|STARTED|Overall Study||111
8534247|NCT00296374|21039069|P2|STARTED|Overall Study||124
8534248|NCT00296374|21039070|P1|STARTED|Overall Study||118
8534249|NCT00296335|21039293|P2|NOT COMPLETED|Overall Study||122
8534250|NCT00296335|21039294|P1|NOT COMPLETED|Overall Study||30
8534251|NCT00296335|21039293|P2|COMPLETED|Overall Study||309
8534252|NCT00296335|21039294|P1|COMPLETED|Overall Study||394
8534253|NCT00296335|21039293|P2|STARTED|Overall Study||431
8534254|NCT00296335|21039294|P1|STARTED|Overall Study||424
8534255|NCT00296322|21039306|P2|NOT COMPLETED|Overall Study||79
8534256|NCT00296322|21039307|P1|NOT COMPLETED|Overall Study||21
8534257|NCT00296322|21039306|P2|COMPLETED|Overall Study||184
8534258|NCT00296322|21039307|P1|COMPLETED|Overall Study||237
8534259|NCT00296322|21039306|P2|STARTED|Overall Study||263
8534260|NCT00296322|21039307|P1|STARTED|Overall Study||258
8534261|NCT00296296|21039319|P2|NOT COMPLETED|Overall Study||13
8534262|NCT00296296|21039320|P1|NOT COMPLETED|Overall Study||2
8534263|NCT00296296|21039319|P2|COMPLETED|Overall Study||5
8534264|NCT00296296|21039320|P1|COMPLETED|Overall Study||9
8534265|NCT00296296|21039319|P2|STARTED|Overall Study||18
8534266|NCT00296296|21039320|P1|STARTED|Overall Study||11
8534267|NCT00296244|21039334|P2|NOT COMPLETED|Overall Study||1
8534268|NCT00296244|21039335|P1|NOT COMPLETED|Overall Study||0
8534269|NCT00296244|21039334|P2|COMPLETED|Overall Study||19
8534270|NCT00296244|21039335|P1|COMPLETED|Overall Study||20
8534271|NCT00296244|21039334|P2|STARTED|Overall Study||20
8534272|NCT00296244|21039335|P1|STARTED|Overall Study||20
8534273|NCT00296231|21039351|P1|NOT COMPLETED|Overall Study||0
8534274|NCT00296231|21039351|P1|COMPLETED|Overall Study||14
8534275|NCT00296231|21039351|P1|STARTED|Overall Study||14
8534276|NCT00296192|21039361|P5|NOT COMPLETED|Overall Study||0
8534277|NCT00296192|21039362|P4|NOT COMPLETED|Overall Study||0
8534278|NCT00296192|21039363|P3|NOT COMPLETED|Overall Study||0
8534279|NCT00296192|21039364|P2|NOT COMPLETED|Overall Study||0
8534280|NCT00296192|21039365|P1|NOT COMPLETED|Overall Study||0
8534281|NCT00296192|21039361|P5|COMPLETED|Overall Study||16
8534282|NCT00296192|21039362|P4|COMPLETED|Overall Study||17
8534283|NCT00296192|21039363|P3|COMPLETED|Overall Study||16
8534284|NCT00296192|21039364|P2|COMPLETED|Overall Study||16
8534285|NCT00296192|21039365|P1|COMPLETED|Overall Study||17
8534286|NCT00296192|21039361|P5|STARTED|Overall Study||16
8534287|NCT00296192|21039362|P4|STARTED|Overall Study||17
8534288|NCT00296192|21039363|P3|STARTED|Overall Study||16
8534289|NCT00296192|21039364|P2|STARTED|Overall Study||16
8534290|NCT00296192|21039365|P1|STARTED|Overall Study||17
8534291|NCT00296140|21039399|P2|NOT COMPLETED|Overall Study||0
8534292|NCT00296140|21039400|P1|NOT COMPLETED|Overall Study||3
8534293|NCT00296140|21039399|P2|COMPLETED|Overall Study||33
8534294|NCT00296140|21039400|P1|COMPLETED|Overall Study||30
8534295|NCT00296140|21039399|P2|STARTED|Overall Study||33
8534296|NCT00296140|21039400|P1|STARTED|Overall Study||33
8534297|NCT00296036|21039412|P6|NOT COMPLETED|Overall Study||4
8534298|NCT00296036|21039413|P5|NOT COMPLETED|Overall Study||2
8534299|NCT00296036|21039414|P4|NOT COMPLETED|Overall Study||1
8534300|NCT00296036|21039415|P3|NOT COMPLETED|Overall Study||2
8534301|NCT00296036|21039416|P2|NOT COMPLETED|Overall Study||0
8534302|NCT00296036|21039417|P1|NOT COMPLETED|Overall Study||1
8534303|NCT00296036|21039412|P6|COMPLETED|Overall Study||28
8534304|NCT00296036|21039413|P5|COMPLETED|Overall Study||31
8534305|NCT00296036|21039414|P4|COMPLETED|Overall Study||16
8534306|NCT00296036|21039415|P3|COMPLETED|Overall Study||16
8534307|NCT00296036|21039416|P2|COMPLETED|Overall Study||18
8534308|NCT00296036|21039417|P1|COMPLETED|Overall Study||18
8534309|NCT00296036|21039412|P6|STARTED|Overall Study||32
8534310|NCT00296036|21039413|P5|STARTED|Overall Study||33
8534311|NCT00296036|21039414|P4|STARTED|Overall Study||17
8534312|NCT00296036|21039415|P3|STARTED|Overall Study||18
8534313|NCT00296036|21039416|P2|STARTED|Overall Study||18
8534314|NCT00296036|21039417|P1|STARTED|Overall Study||19
8534315|NCT00295932|21039454|P11|NOT COMPLETED|Overall Study||1
8534316|NCT00295932|21039455|P10|NOT COMPLETED|Overall Study||0
8534317|NCT00295932|21039456|P9|NOT COMPLETED|Overall Study||0
8534318|NCT00295932|21039457|P8|NOT COMPLETED|Overall Study||0
8534319|NCT00295932|21039458|P7|NOT COMPLETED|Overall Study||0
8534320|NCT00295932|21039459|P6|NOT COMPLETED|Overall Study||0
8534321|NCT00295932|21039460|P5|NOT COMPLETED|Overall Study||0
8534322|NCT00295932|21039461|P4|NOT COMPLETED|Overall Study||0
8534323|NCT00295932|21039462|P3|NOT COMPLETED|Overall Study||0
8534324|NCT00295932|21039463|P2|NOT COMPLETED|Overall Study||0
8534325|NCT00295932|21039464|P1|NOT COMPLETED|Overall Study||0
8534326|NCT00295932|21039454|P11|COMPLETED|Overall Study||12
8534327|NCT00295932|21039455|P10|COMPLETED|Overall Study||12
8534328|NCT00295932|21039456|P9|COMPLETED|Overall Study||10
8534329|NCT00295932|21039457|P8|COMPLETED|Overall Study||4
8534330|NCT00295932|21039458|P7|COMPLETED|Overall Study||3
8534331|NCT00295932|21039459|P6|COMPLETED|Overall Study||18
8534332|NCT00295932|21039460|P5|COMPLETED|Overall Study||2
8534333|NCT00295932|21039461|P4|COMPLETED|Overall Study||4
8534334|NCT00295932|21039462|P3|COMPLETED|Overall Study||3
8534335|NCT00295932|21039463|P2|COMPLETED|Overall Study||6
8534336|NCT00295932|21039464|P1|COMPLETED|Overall Study||4
8534337|NCT00295932|21039454|P11|STARTED|Overall Study||13
8534338|NCT00295932|21039455|P10|STARTED|Overall Study||12
8534339|NCT00295932|21039456|P9|STARTED|Overall Study||10
8534340|NCT00295932|21039457|P8|STARTED|Overall Study||4
8534341|NCT00295932|21039458|P7|STARTED|Overall Study||3
8534342|NCT00295932|21039459|P6|STARTED|Overall Study||18
8534343|NCT00295932|21039460|P5|STARTED|Overall Study||2
8534344|NCT00295932|21039461|P4|STARTED|Overall Study||4
8534345|NCT00295932|21039462|P3|STARTED|Overall Study||3
8534346|NCT00295932|21039463|P2|STARTED|Overall Study||6
8534347|NCT00295932|21039464|P1|STARTED|Overall Study||4
8534348|NCT00295880|21039498|P1|NOT COMPLETED|Overall Study||2
8534349|NCT00295880|21039498|P1|COMPLETED|Overall Study||10
8534350|NCT00295880|21039498|P1|STARTED|Overall Study||12
8534351|NCT00295867|21039509|P1|NOT COMPLETED|Overall Study||11
8534352|NCT00295867|21039509|P1|COMPLETED|Overall Study||34
8534353|NCT00295867|21039509|P1|STARTED|Overall Study||45
8534354|NCT00295854|21039518|P3|NOT COMPLETED|Overall Study||15
8534355|NCT00295854|21039519|P2|NOT COMPLETED|Overall Study||21
8534356|NCT00295854|21039520|P1|NOT COMPLETED|Overall Study||18
8534357|NCT00295854|21039518|P3|COMPLETED|Overall Study||87
8534358|NCT00295854|21039519|P2|COMPLETED|Overall Study||87
8534359|NCT00295854|21039520|P1|COMPLETED|Overall Study||77
8534360|NCT00295854|21039518|P3|ITT Population (N=296)|Overall Study||99
8534361|NCT00295854|21039519|P2|ITT Population (N=296)|Overall Study||105
8534362|NCT00295854|21039520|P1|ITT Population (N=296)|Overall Study||92
8534363|NCT00295854|21039518|P3|Safety Population (N=304)|Overall Study||101
8534364|NCT00295854|21039519|P2|Safety Population (N=304)|Overall Study||108
8534365|NCT00295854|21039520|P1|Safety Population (N=304)|Overall Study||95
8534366|NCT00295854|21039518|P3|STARTED|Overall Study||102
8534367|NCT00295854|21039519|P2|STARTED|Overall Study||108
8534368|NCT00295854|21039520|P1|STARTED|Overall Study||95
8534369|NCT00295750|21039534|P3|NOT COMPLETED|Overall Study||32
8534370|NCT00295750|21039535|P2|NOT COMPLETED|Overall Study||41
8534371|NCT00295750|21039536|P1|NOT COMPLETED|Overall Study||43
8534372|NCT00295750|21039534|P3|COMPLETED|Overall Study||172
8534373|NCT00295750|21039535|P2|COMPLETED|Overall Study||169
8534374|NCT00295750|21039536|P1|COMPLETED|Overall Study||163
8534375|NCT00295750|21039534|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
8534376|NCT00295750|21039535|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
8534377|NCT00295750|21039536|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
8534378|NCT00295750|21039534|P3|STARTED|Overall Study|randomized|204
8534379|NCT00295750|21039535|P2|STARTED|Overall Study|randomized|210
8534380|NCT00295750|21039536|P1|STARTED|Overall Study|randomized|206
8534381|NCT00295633|21039571|P3|NOT COMPLETED|Overall Study||76
8534382|NCT00295633|21039572|P2|NOT COMPLETED|Overall Study||67
8534383|NCT00295633|21039573|P1|NOT COMPLETED|Overall Study||62
8534384|NCT00295633|21039571|P3|COMPLETED|Overall Study||108
8534385|NCT00295633|21039572|P2|COMPLETED|Overall Study||119
8534386|NCT00295633|21039573|P1|COMPLETED|Overall Study||133
8534387|NCT00295633|21039571|P3|Completed Study Without Being Rescued|Overall Study||51
8534388|NCT00295633|21039572|P2|Completed Study Without Being Rescued|Overall Study||82
8534389|NCT00295633|21039573|P1|Completed Study Without Being Rescued|Overall Study||88
8534390|NCT00295633|21039571|P3|STARTED|Overall Study||184
8534391|NCT00295633|21039572|P2|STARTED|Overall Study||186
8534392|NCT00295633|21039573|P1|STARTED|Overall Study||195
8534393|NCT00295620|21039592|P2|NOT COMPLETED|Overall Study||896
8534394|NCT00295620|21039593|P1|NOT COMPLETED|Overall Study||872
8534395|NCT00295620|21039592|P2|COMPLETED|Overall Study||842
8534396|NCT00295620|21039593|P1|COMPLETED|Overall Study||860
8534397|NCT00295620|21039592|P2|Safety Analysis Set|Overall Study||1710
8534398|NCT00295620|21039593|P1|Safety Analysis Set|Overall Study||1705
8534399|NCT00295620|21039592|P2|STARTED|Overall Study||1738
8534400|NCT00295620|21039593|P1|STARTED|Overall Study||1732
8534401|NCT00295503|21039607|P1|NOT COMPLETED|Overall Study||0
8534402|NCT00295503|21039607|P1|COMPLETED|Overall Study||53
8534403|NCT00295503|21039607|P1|STARTED|Overall Study||53
8534404|NCT00295490|21039617|P4|NOT COMPLETED|Overall Study||5
8534405|NCT00295490|21039618|P3|NOT COMPLETED|Overall Study||4
8534406|NCT00295490|21039619|P2|NOT COMPLETED|Overall Study||4
8534407|NCT00295490|21039620|P1|NOT COMPLETED|Overall Study||1
8534408|NCT00295490|21039617|P4|COMPLETED|Overall Study||12
8534409|NCT00295490|21039618|P3|COMPLETED|Overall Study||12
8534410|NCT00295490|21039619|P2|COMPLETED|Overall Study||15
8534411|NCT00295490|21039620|P1|COMPLETED|Overall Study||14
8534412|NCT00295490|21039617|P4|STARTED|Overall Study||17
8534413|NCT00295490|21039618|P3|STARTED|Overall Study||16
8534414|NCT00295490|21039619|P2|STARTED|Overall Study||19
8534415|NCT00295490|21039620|P1|STARTED|Overall Study||15
8534416|NCT00295061|21039660|P2|NOT COMPLETED|Overall Study||0
8534417|NCT00295061|21039661|P1|NOT COMPLETED|Overall Study||0
8534418|NCT00295061|21039660|P2|COMPLETED|Overall Study||12
8534419|NCT00295061|21039661|P1|COMPLETED|Overall Study||12
8534420|NCT00295061|21039660|P2|STARTED|Overall Study||12
8534421|NCT00295061|21039661|P1|STARTED|Overall Study||12
8534422|NCT00295022|21039670|P3|NOT COMPLETED|Overall Study||5
8534423|NCT00295022|21039671|P2|NOT COMPLETED|Overall Study||1
8534424|NCT00295022|21039672|P1|NOT COMPLETED|Overall Study||1
8534425|NCT00295022|21039670|P3|COMPLETED|Overall Study||151
8534426|NCT00295022|21039671|P2|COMPLETED|Overall Study||156
8534427|NCT00295022|21039672|P1|COMPLETED|Overall Study||104
8534428|NCT00295022|21039670|P3|STARTED|Overall Study||156
8534429|NCT00295022|21039671|P2|STARTED|Overall Study||157
8534430|NCT00295022|21039672|P1|STARTED|Overall Study||105
8534431|NCT00295009|21039761|P6|NOT COMPLETED|Overall Study||269
8534432|NCT00295009|21039762|P5|NOT COMPLETED|Overall Study||58
8534433|NCT00295009|21039763|P4|NOT COMPLETED|Overall Study||25
8534434|NCT00295009|21039764|P3|NOT COMPLETED|Overall Study||12
8534435|NCT00295009|21039765|P2|NOT COMPLETED|Overall Study||49
8534436|NCT00295009|21039766|P1|NOT COMPLETED|Overall Study||41
8534437|NCT00295009|21039761|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
8534438|NCT00295009|21039762|P5|COMPLETED|Overall Study|Completed 60 month visit|116
8534439|NCT00295009|21039763|P4|COMPLETED|Overall Study|Completed 60 month visit|57
8534440|NCT00295009|21039764|P3|COMPLETED|Overall Study|Completed 60 month visit|39
8534441|NCT00295009|21039765|P2|COMPLETED|Overall Study|Completed 60 month visit|134
8534442|NCT00295009|21039766|P1|COMPLETED|Overall Study|Completed 60 month visit|52
8534443|NCT00295009|21039761|P6|Completed 24 Month Analysis|Overall Study||198
8534444|NCT00295009|21039762|P5|Completed 24 Month Analysis|Overall Study||133
8534445|NCT00295009|21039763|P4|Completed 24 Month Analysis|Overall Study||60
8534446|NCT00295009|21039764|P3|Completed 24 Month Analysis|Overall Study||45
8534447|NCT00295009|21039765|P2|Completed 24 Month Analysis|Overall Study||148
8534448|NCT00295009|21039766|P1|Completed 24 Month Analysis|Overall Study||71
8534449|NCT00295009|21039761|P6|Treated|Overall Study||259
8534450|NCT00295009|21039762|P5|Treated|Overall Study||165
8534451|NCT00295009|21039763|P4|Treated|Overall Study||72
8534452|NCT00295009|21039764|P3|Treated|Overall Study||50
8534453|NCT00295009|21039765|P2|Treated|Overall Study||162
8534454|NCT00295009|21039766|P1|Treated|Overall Study||80
8534455|NCT00295009|21039761|P6|STARTED|Overall Study||269
8534456|NCT00295009|21039762|P5|STARTED|Overall Study||174
8534457|NCT00295009|21039763|P4|STARTED|Overall Study||82
8534458|NCT00295009|21039764|P3|STARTED|Overall Study||51
8534459|NCT00295009|21039765|P2|STARTED|Overall Study||183
8534460|NCT00295009|21039766|P1|STARTED|Overall Study||93
8534461|NCT00294762|21039788|P2|NOT COMPLETED|Overall Study||3
8534462|NCT00294762|21039789|P1|NOT COMPLETED|Overall Study||3
8534463|NCT00294762|21039788|P2|COMPLETED|Overall Study||68
8534464|NCT00294762|21039789|P1|COMPLETED|Overall Study||69
8534465|NCT00294762|21039788|P2|STARTED|Overall Study||71
8534466|NCT00294762|21039789|P1|STARTED|Overall Study||72
8534467|NCT00294723|21039808|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
8534468|NCT00294723|21039809|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
8534469|NCT00294723|21039810|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
8534470|NCT00294723|21039808|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
8534471|NCT00294723|21039809|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
8534472|NCT00294723|21039810|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
8534473|NCT00294723|21039808|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
8534555|NCT00294398|21040067|P2|COMPLETED|Overall Study||48
8534474|NCT00294723|21039809|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
8534475|NCT00294723|21039810|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
8534476|NCT00294723|21039808|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
8534477|NCT00294723|21039809|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
8534478|NCT00294723|21039810|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
8534479|NCT00294723|21039808|P3|COMPLETED|Open-Label Extension 52 Weeks||97
8534480|NCT00294723|21039809|P2|COMPLETED|Open-Label Extension 52 Weeks||110
8534481|NCT00294723|21039810|P1|COMPLETED|Open-Label Extension 52 Weeks||114
8534482|NCT00294723|21039808|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
8534483|NCT00294723|21039809|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
8534484|NCT00294723|21039810|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
8534485|NCT00294723|21039808|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
8534486|NCT00294723|21039809|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
8534487|NCT00294723|21039810|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
8534488|NCT00294723|21039808|P3|COMPLETED|Double-Blind Period 52 Weeks||152
8534489|NCT00294723|21039809|P2|COMPLETED|Double-Blind Period 52 Weeks||162
8534490|NCT00294723|21039810|P1|COMPLETED|Double-Blind Period 52 Weeks||173
8534491|NCT00294723|21039808|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
8534492|NCT00294723|21039809|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
8534493|NCT00294723|21039810|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
8534494|NCT00294723|21039808|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
8534495|NCT00294723|21039809|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
8534496|NCT00294723|21039810|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
8534497|NCT00294684|21039871|P2|NOT COMPLETED|Overall Study||8
8534498|NCT00294684|21039872|P1|NOT COMPLETED|Overall Study||5
8534499|NCT00294684|21039871|P2|COMPLETED|Overall Study||62
8534500|NCT00294684|21039872|P1|COMPLETED|Overall Study||65
8534501|NCT00294684|21039871|P2|STARTED|Overall Study||70
8534502|NCT00294684|21039872|P1|STARTED|Overall Study||70
8534503|NCT00294671|21039912|P2|NOT COMPLETED|Overall Study||40
8534504|NCT00294671|21039913|P1|NOT COMPLETED|Overall Study||27
8534505|NCT00294671|21039912|P2|COMPLETED|Overall Study||26
8534506|NCT00294671|21039913|P1|COMPLETED|Overall Study||37
8534507|NCT00294671|21039912|P2|STARTED|Overall Study||66
8534508|NCT00294671|21039913|P1|STARTED|Overall Study||64
8534509|NCT00294658|21039929|P2|NOT COMPLETED|Overall Study||9
8534510|NCT00294658|21039930|P1|NOT COMPLETED|Overall Study||6
8534511|NCT00294658|21039929|P2|COMPLETED|Overall Study||51
8534512|NCT00294658|21039930|P1|COMPLETED|Overall Study||60
8534513|NCT00294658|21039929|P2|STARTED|Overall Study||60
8534514|NCT00294658|21039930|P1|STARTED|Overall Study||66
8534515|NCT00294645|21039994|P2|NOT COMPLETED|Overall Study||92
8534516|NCT00294645|21039995|P1|NOT COMPLETED|Overall Study||48
8534517|NCT00294645|21039994|P2|COMPLETED|Overall Study||510
8534518|NCT00294645|21039995|P1|COMPLETED|Overall Study||247
8534519|NCT00294645|21039994|P2|STARTED|Overall Study||602
8534520|NCT00294645|21039995|P1|STARTED|Overall Study||295
8534521|NCT00294632|21040029|P2|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
8534522|NCT00294632|21040030|P1|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
8534523|NCT00294632|21040029|P2|COMPLETED|Phase II: 20 mg Lenalidomide||38
8534524|NCT00294632|21040030|P1|COMPLETED|Phase II: 20 mg Lenalidomide||6
8534525|NCT00294632|21040029|P2|STARTED|Phase II: 20 mg Lenalidomide||38
8534526|NCT00294632|21040030|P1|STARTED|Phase II: 20 mg Lenalidomide||6
8534527|NCT00294632|21040029|P2|NOT COMPLETED|Phase I Dose Escalation Period||0
8534528|NCT00294632|21040030|P1|NOT COMPLETED|Phase I Dose Escalation Period||0
8534529|NCT00294632|21040029|P2|COMPLETED|Phase I Dose Escalation Period||0
8534530|NCT00294632|21040030|P1|COMPLETED|Phase I Dose Escalation Period||14
8534531|NCT00294632|21040029|P2|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
8534532|NCT00294632|21040030|P1|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
8534533|NCT00294632|21040029|P2|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
8534534|NCT00294632|21040030|P1|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
8534535|NCT00294632|21040029|P2|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
8534536|NCT00294632|21040030|P1|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
8534537|NCT00294632|21040029|P2|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
8534538|NCT00294632|21040030|P1|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
8534539|NCT00294632|21040029|P2|STARTED|Phase I Dose Escalation Period||0
8534540|NCT00294632|21040030|P1|STARTED|Phase I Dose Escalation Period||14
8534541|NCT00294554|21040039|P2|NOT COMPLETED|Overall Study||2
8534542|NCT00294554|21040040|P1|NOT COMPLETED|Overall Study||0
8534543|NCT00294554|21040039|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit
~1 S withdrawn @ 13 wks b/o extreme agitation"|8
8534544|NCT00294554|21040040|P1|COMPLETED|Overall Study||10
8534545|NCT00294554|21040039|P2|STARTED|Overall Study||10
8534546|NCT00294554|21040040|P1|STARTED|Overall Study||10
8534547|NCT00294515|21040050|P2|NOT COMPLETED|Overall Study||28
8534548|NCT00294515|21040051|P1|NOT COMPLETED|Overall Study||34
8534549|NCT00294515|21040050|P2|COMPLETED|Overall Study||132
8534550|NCT00294515|21040051|P1|COMPLETED|Overall Study||132
8534551|NCT00294515|21040050|P2|STARTED|Overall Study|Randomized|160
8534552|NCT00294515|21040051|P1|STARTED|Overall Study|Randomized|166
8534553|NCT00294398|21040067|P2|NOT COMPLETED|Overall Study||26
8534554|NCT00294398|21040068|P1|NOT COMPLETED|Overall Study||21
8534556|NCT00294398|21040068|P1|COMPLETED|Overall Study||57
8534557|NCT00294398|21040067|P2|STARTED|Overall Study||74
8534558|NCT00294398|21040068|P1|STARTED|Overall Study||78
8534559|NCT00294060|21040076|P1|NOT COMPLETED|Overall Study||1173
8534560|NCT00294060|21040076|P1|COMPLETED|Overall Study||840
8534561|NCT00294060|21040076|P1|STARTED|Overall Study||2013
8534562|NCT00294047|21040084|P2|NOT COMPLETED|Month 84||989
8534563|NCT00294047|21040085|P1|NOT COMPLETED|Month 84||973
8534564|NCT00294047|21040084|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
8534565|NCT00294047|21040085|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
8534566|NCT00294047|21040084|P2|STARTED|Month 84||2870
8534567|NCT00294047|21040085|P1|STARTED|Month 84||2877
8534568|NCT00294047|21040084|P2|NOT COMPLETED|Month 48||433
8534569|NCT00294047|21040085|P1|NOT COMPLETED|Month 48||425
8534570|NCT00294047|21040084|P2|COMPLETED|Month 48||2438
8534571|NCT00294047|21040085|P1|COMPLETED|Month 48||2456
8534572|NCT00294047|21040084|P2|Participated up to Month 48|Month 48||2281
8534573|NCT00294047|21040085|P1|Participated up to Month 48|Month 48||2305
8534574|NCT00294047|21040084|P2|STARTED|Month 48||2871
8534575|NCT00294047|21040085|P1|STARTED|Month 48||2881
8534576|NCT00293813|21040190|P3|NOT COMPLETED|Overall Study||8
8534577|NCT00293813|21040191|P2|NOT COMPLETED|Overall Study||9
8534578|NCT00293813|21040192|P1|NOT COMPLETED|Overall Study||13
8534579|NCT00293813|21040190|P3|COMPLETED|Overall Study||74
8534580|NCT00293813|21040191|P2|COMPLETED|Overall Study||74
8534581|NCT00293813|21040192|P1|COMPLETED|Overall Study||69
8534582|NCT00293813|21040190|P3|STARTED|Overall Study||82
8534583|NCT00293813|21040191|P2|STARTED|Overall Study||83
8534584|NCT00293813|21040192|P1|STARTED|Overall Study||82
8534585|NCT00293722|21040203|P1|NOT COMPLETED|Overall Study||427
8534586|NCT00293722|21040203|P1|COMPLETED|Overall Study||864
8534587|NCT00293722|21040203|P1|STARTED|Overall Study||1291
8534588|NCT00293709|21040217|P1|NOT COMPLETED|Overall Study||47
8534589|NCT00293709|21040217|P1|COMPLETED|Overall Study||102
8534590|NCT00293709|21040217|P1|STARTED|Overall Study||149
8534591|NCT00293579|21040231|P1|NOT COMPLETED|Overall Study||1
8534592|NCT00293579|21040231|P1|COMPLETED|Overall Study||4
8534593|NCT00293579|21040231|P1|STARTED|Overall Study||5
8534594|NCT00293540|21040240|P2|NOT COMPLETED|Overall Study||8
8534595|NCT00293540|21040241|P1|NOT COMPLETED|Overall Study||7
8534596|NCT00293540|21040240|P2|COMPLETED|Overall Study||119
8534597|NCT00293540|21040241|P1|COMPLETED|Overall Study||115
8534598|NCT00293540|21040240|P2|STARTED|Overall Study||127
8534599|NCT00293540|21040241|P1|STARTED|Overall Study||122
8534600|NCT00293462|21040250|P3|NOT COMPLETED|Overall Study||10
8534601|NCT00293462|21040251|P2|NOT COMPLETED|Overall Study||8
8534602|NCT00293462|21040252|P1|NOT COMPLETED|Overall Study||7
8534603|NCT00293462|21040250|P3|COMPLETED|Overall Study||21
8534604|NCT00293462|21040251|P2|COMPLETED|Overall Study||21
8534605|NCT00293462|21040252|P1|COMPLETED|Overall Study||24
8534606|NCT00293462|21040250|P3|STARTED|Overall Study||31
8534607|NCT00293462|21040251|P2|STARTED|Overall Study||29
8534608|NCT00293462|21040252|P1|STARTED|Overall Study||31
8534609|NCT00293397|21040271|P1|NOT COMPLETED|Overall Study||2
8534610|NCT00293397|21040271|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
8534611|NCT00293397|21040271|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
8534612|NCT00293397|21040271|P1|STARTED|Overall Study||20
8534613|NCT00293384|21040281|P1|NOT COMPLETED|Overall Study||5
8534614|NCT00293384|21040281|P1|COMPLETED|Overall Study||35
8534615|NCT00293384|21040281|P1|STARTED|Overall Study||40
8534616|NCT00293293|21040290|P2|NOT COMPLETED|Overall Study||2
8534617|NCT00293293|21040291|P1|NOT COMPLETED|Overall Study||2
8534618|NCT00293293|21040290|P2|COMPLETED|Overall Study||21
8534619|NCT00293293|21040291|P1|COMPLETED|Overall Study||18
8534620|NCT00293293|21040290|P2|STARTED|Overall Study||23
8534621|NCT00293293|21040291|P1|STARTED|Overall Study||20
8534622|NCT00293267|21040319|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
8534623|NCT00293267|21040320|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
8534624|NCT00293267|21040319|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
8534625|NCT00293267|21040320|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
8534626|NCT00293267|21040319|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
8534627|NCT00293267|21040320|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
8534628|NCT00293267|21040319|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
8534629|NCT00293267|21040320|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
8534630|NCT00293267|21040319|P2|COMPLETED|Extension - Open-Label Week 157-240||26
8534631|NCT00293267|21040320|P1|COMPLETED|Extension - Open-Label Week 157-240||111
8534632|NCT00293267|21040319|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
8534633|NCT00293267|21040320|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
8534634|NCT00293267|21040319|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
8534635|NCT00293267|21040320|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
8534636|NCT00293267|21040319|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
8534637|NCT00293267|21040320|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
8534638|NCT00293267|21040319|P2|STARTED|Extension - Double-Blind Week 49-156||50
8534639|NCT00293267|21040320|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
8534640|NCT00293267|21040319|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
8534641|NCT00293267|21040320|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
8534642|NCT00293267|21040319|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
8534643|NCT00293267|21040320|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
8534644|NCT00293267|21040319|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
8534645|NCT00293267|21040320|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
8534646|NCT00293267|21040319|P2|Treated|Primary Study - Double-Blind Week 0-48||118
8534647|NCT00293267|21040320|P1|Treated|Primary Study - Double-Blind Week 0-48||232
8534648|NCT00293267|21040319|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
8534649|NCT00293267|21040320|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
8534650|NCT00293254|21040360|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
8534651|NCT00293254|21040361|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
8534652|NCT00293254|21040360|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
8534653|NCT00293254|21040361|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
8534654|NCT00293254|21040360|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
8534655|NCT00293254|21040361|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
8534656|NCT00293254|21040360|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
8534657|NCT00293254|21040361|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
8534658|NCT00293254|21040360|P2|COMPLETED|Extension - Open-Label Week 157-240||18
8534659|NCT00293254|21040361|P1|COMPLETED|Extension - Open-Label Week 157-240||110
8534660|NCT00293254|21040360|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
8534661|NCT00293254|21040361|P1|STARTED|Extension - Open-Label Week 157-240||120
8534662|NCT00293254|21040360|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
8534663|NCT00293254|21040361|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
8534664|NCT00293254|21040360|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
8534665|NCT00293254|21040361|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
8534666|NCT00293254|21040360|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
8534667|NCT00293254|21040361|P1|STARTED|Extension - Double-Blind Week 49-156||177
8534668|NCT00293254|21040360|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
8534669|NCT00293254|21040361|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
8534670|NCT00293254|21040360|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
8534671|NCT00293254|21040361|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
8534672|NCT00293254|21040360|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
8534673|NCT00293254|21040361|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
8534674|NCT00293254|21040360|P2|Treated|Primary Study - Double-Blind Week 0-48||119
8534675|NCT00293254|21040361|P1|Treated|Primary Study - Double-Blind Week 0-48||230
8534676|NCT00293254|21040360|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
8534677|NCT00293254|21040361|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
8534678|NCT00293241|21040401|P2|NOT COMPLETED|Overall Study||41
8534679|NCT00293241|21040402|P1|NOT COMPLETED|Overall Study||36
8534680|NCT00293241|21040401|P2|COMPLETED|Overall Study||265
8534681|NCT00293241|21040402|P1|COMPLETED|Overall Study||263
8534682|NCT00293241|21040401|P2|STARTED|Overall Study||306
8534683|NCT00293241|21040402|P1|STARTED|Overall Study||299
8534684|NCT00293215|21040446|P2|NOT COMPLETED|Overall Study||3
8534685|NCT00293215|21040447|P1|NOT COMPLETED|Overall Study||5
8534686|NCT00293215|21040446|P2|COMPLETED|Overall Study||0
8534687|NCT00293215|21040447|P1|COMPLETED|Overall Study||1
8534688|NCT00293215|21040446|P2|STARTED|Overall Study||3
8534689|NCT00293215|21040447|P1|STARTED|Overall Study||6
8534690|NCT00293059|21040469|P2|NOT COMPLETED|Overall Study||19
8534691|NCT00293059|21040470|P1|NOT COMPLETED|Overall Study||35
8534692|NCT00293059|21040469|P2|COMPLETED|Overall Study||51
8534693|NCT00293059|21040470|P1|COMPLETED|Overall Study||85
8534694|NCT00293059|21040469|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
8534695|NCT00293059|21040470|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
8534696|NCT00293059|21040469|P2|Cycle 3/Treatment Day 84|Overall Study||55
8534697|NCT00293059|21040470|P1|Cycle 3/Treatment Day 84|Overall Study||100
8534698|NCT00293059|21040469|P2|Cycle 1/Treatment Day 28|Overall Study||64
8534699|NCT00293059|21040470|P1|Cycle 1/Treatment Day 28|Overall Study||115
8534700|NCT00293059|21040469|P2|Subjects Received Treatment|Overall Study||66
8534701|NCT00293059|21040470|P1|Subjects Received Treatment|Overall Study||119
8534702|NCT00293059|21040469|P2|STARTED|Overall Study||70
8534703|NCT00293059|21040470|P1|STARTED|Overall Study||120
8534704|NCT00293033|21040582|P1|NOT COMPLETED|Double-blind Treatment Period||12
8534705|NCT00293033|21040582|P1|COMPLETED|Double-blind Treatment Period||70
8534706|NCT00293033|21040582|P1|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
8534707|NCT00293033|21040582|P1|NOT COMPLETED|Open-label Titration Period||69
8534708|NCT00293033|21040582|P1|COMPLETED|Open-label Titration Period||82
8534709|NCT00293033|21040582|P1|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
8534710|NCT00293020|21040685|P1|NOT COMPLETED|Overall Study||162
8534711|NCT00293020|21040685|P1|COMPLETED|Overall Study||82
8534712|NCT00293020|21040685|P1|STARTED|Overall Study||244
8534713|NCT00292981|21040689|P1|NOT COMPLETED|Overall Study||39
8534714|NCT00292981|21040689|P1|COMPLETED|Overall Study||18
8534715|NCT00292981|21040689|P1|STARTED|Overall Study||57
8534716|NCT00292942|21040700|P4|NOT COMPLETED|Overall Study||1
8534717|NCT00292942|21040701|P3|NOT COMPLETED|Overall Study||1
8534718|NCT00292942|21040702|P2|NOT COMPLETED|Overall Study||0
8534719|NCT00292942|21040703|P1|NOT COMPLETED|Overall Study||0
8534720|NCT00292942|21040700|P4|COMPLETED|Overall Study||6
8534721|NCT00292942|21040701|P3|COMPLETED|Overall Study||6
8534722|NCT00292942|21040702|P2|COMPLETED|Overall Study||6
8534723|NCT00292942|21040703|P1|COMPLETED|Overall Study||6
8534724|NCT00292942|21040700|P4|STARTED|Overall Study||7
8534725|NCT00292942|21040701|P3|STARTED|Overall Study||7
8534726|NCT00292942|21040702|P2|STARTED|Overall Study||6
8534727|NCT00292942|21040703|P1|STARTED|Overall Study||6
8534728|NCT00292591|21040737|P3|NOT COMPLETED|Overall Study||58
8534729|NCT00292591|21040738|P2|NOT COMPLETED|Overall Study||56
8534730|NCT00292591|21040739|P1|NOT COMPLETED|Overall Study||64
8534731|NCT00292591|21040737|P3|COMPLETED|Overall Study||110
8534732|NCT00292591|21040738|P2|COMPLETED|Overall Study||111
8534733|NCT00292591|21040739|P1|COMPLETED|Overall Study||102
8534734|NCT00292591|21040737|P3|STARTED|Overall Study||168
8534735|NCT00292591|21040738|P2|STARTED|Overall Study||167
8534736|NCT00292591|21040739|P1|STARTED|Overall Study||166
8534737|NCT00292461|21040749|P2|NOT COMPLETED|Overall Study||6
8534738|NCT00292461|21040750|P1|NOT COMPLETED|Overall Study||10
8534739|NCT00292461|21040749|P2|COMPLETED|Overall Study||24
8534740|NCT00292461|21040750|P1|COMPLETED|Overall Study||24
8534741|NCT00292461|21040749|P2|STARTED|Overall Study||30
8534742|NCT00292461|21040750|P1|STARTED|Overall Study||34
8534743|NCT00292370|21040765|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
8534744|NCT00292370|21040766|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
8534745|NCT00292370|21040767|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
8534746|NCT00292370|21040765|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
8534747|NCT00292370|21040766|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
8534748|NCT00292370|21040767|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
8534749|NCT00292370|21040765|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
8534750|NCT00292370|21040766|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
8534751|NCT00292370|21040767|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I
~28 Excluded Ph II:
~20 responded
~7 declined
~1 medical
~50 to Arm 2 & 3"|0
8534752|NCT00292370|21040765|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534753|NCT00292370|21040766|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534754|NCT00292370|21040767|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
8534755|NCT00292370|21040765|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534756|NCT00292370|21040766|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534757|NCT00292370|21040767|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
8534758|NCT00292370|21040765|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
8534759|NCT00292370|21040766|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
8534760|NCT00292370|21040767|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
8534761|NCT00292318|21040792|P2|NOT COMPLETED|Overall Study||1
8534762|NCT00292318|21040793|P1|NOT COMPLETED|Overall Study||2
8534763|NCT00292318|21040792|P2|COMPLETED|Overall Study||2
8534764|NCT00292318|21040793|P1|COMPLETED|Overall Study||2
8534765|NCT00292318|21040792|P2|STARTED|Overall Study||3
8534766|NCT00292318|21040793|P1|STARTED|Overall Study||4
8534767|NCT00292227|21040803|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8534768|NCT00292227|21040804|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8534769|NCT00292227|21040805|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8534770|NCT00292227|21040803|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
8534771|NCT00292227|21040804|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
8534772|NCT00292227|21040805|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
8534773|NCT00292227|21040803|P3|STARTED|Cross-over Period 2 (Day 39)||30
8534774|NCT00292227|21040804|P2|STARTED|Cross-over Period 2 (Day 39)||31
8534775|NCT00292227|21040805|P1|STARTED|Cross-over Period 2 (Day 39)||65
8534776|NCT00292227|21040803|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8534777|NCT00292227|21040804|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8534778|NCT00292227|21040805|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8534779|NCT00292227|21040803|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
8534780|NCT00292227|21040804|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
8534781|NCT00292227|21040805|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
8534782|NCT00292227|21040803|P3|STARTED|Cross-over Period 1 (Day 32)||30
8534783|NCT00292227|21040804|P2|STARTED|Cross-over Period 1 (Day 32)||31
8534784|NCT00292227|21040805|P1|STARTED|Cross-over Period 1 (Day 32)||65
8534785|NCT00292227|21040803|P3|NOT COMPLETED|Patch Period||3
8534786|NCT00292227|21040804|P2|NOT COMPLETED|Patch Period||0
8534787|NCT00292227|21040805|P1|NOT COMPLETED|Patch Period||1
8534788|NCT00292227|21040803|P3|COMPLETED|Patch Period||30
8534789|NCT00292227|21040804|P2|COMPLETED|Patch Period||31
8534790|NCT00292227|21040805|P1|COMPLETED|Patch Period||65
8534791|NCT00292227|21040803|P3|STARTED|Patch Period||33
8534792|NCT00292227|21040804|P2|STARTED|Patch Period||31
8534793|NCT00292227|21040805|P1|STARTED|Patch Period||66
8534815|NCT00292162|21040950|P2|NOT COMPLETED|Overall Study||2
8534816|NCT00292162|21040951|P1|NOT COMPLETED|Overall Study||1
8534817|NCT00292162|21040950|P2|COMPLETED|Overall Study||20
8534818|NCT00292162|21040951|P1|COMPLETED|Overall Study||18
8534819|NCT00292162|21040950|P2|STARTED|Overall Study||22
8534820|NCT00292162|21040951|P1|STARTED|Overall Study||19
8534821|NCT00292045|21040967|P1|NOT COMPLETED|Extended Treatment Beyond Week 13||0
8534822|NCT00292045|21040967|P1|COMPLETED|Extended Treatment Beyond Week 13||10
8534823|NCT00292045|21040967|P1|STARTED|Extended Treatment Beyond Week 13||10
8534824|NCT00292045|21040967|P1|NOT COMPLETED|Core Study (Through Week 13)||2
8534825|NCT00292045|21040967|P1|COMPLETED|Core Study (Through Week 13)||13
8534826|NCT00292045|21040967|P1|STARTED|Core Study (Through Week 13)||15
8534827|NCT00291876|21040974|P1|NOT COMPLETED|Month 246||0
8534828|NCT00291876|21040974|P1|COMPLETED|Month 246||116
8534829|NCT00291876|21040974|P1|STARTED|Month 246||116
8534830|NCT00291876|21040974|P1|NOT COMPLETED|Month 234||0
8534831|NCT00291876|21040974|P1|COMPLETED|Month 234||110
8534832|NCT00291876|21040974|P1|STARTED|Month 234||110
8534833|NCT00291876|21040974|P1|NOT COMPLETED|Month 222||0
8534834|NCT00291876|21040974|P1|COMPLETED|Month 222||114
8534835|NCT00291876|21040974|P1|STARTED|Month 222||114
8534836|NCT00291876|21040974|P1|NOT COMPLETED|Month 210||0
8534837|NCT00291876|21040974|P1|COMPLETED|Month 210||124
8534838|NCT00291876|21040974|P1|STARTED|Month 210||124
8534839|NCT00291876|21040974|P1|NOT COMPLETED|Month 198||0
8534840|NCT00291876|21040974|P1|COMPLETED|Month 198||135
8534841|NCT00291876|21040974|P1|STARTED|Month 198||135
8534842|NCT00291876|21040974|P1|NOT COMPLETED|Month 186||0
8534843|NCT00291876|21040974|P1|COMPLETED|Month 186||129
8534844|NCT00291876|21040974|P1|STARTED|Month 186||129
8534845|NCT00291876|21040974|P1|NOT COMPLETED|Month 174||0
8534846|NCT00291876|21040974|P1|COMPLETED|Month 174||127
8534847|NCT00291876|21040974|P1|STARTED|Month 174||127
8534848|NCT00291876|21040974|P1|NOT COMPLETED|Month 162||0
8534849|NCT00291876|21040974|P1|COMPLETED|Month 162||127
8534850|NCT00291876|21040974|P1|STARTED|Month 162||127
8534851|NCT00291876|21040974|P1|NOT COMPLETED|Month 150||0
8534852|NCT00291876|21040974|P1|COMPLETED|Month 150||117
8534853|NCT00291876|21040974|P1|STARTED|Month 150||117
8534854|NCT00291876|21040974|P1|NOT COMPLETED|Month 138||0
8534855|NCT00291876|21040974|P1|COMPLETED|Month 138||107
8534856|NCT00291876|21040974|P1|STARTED|Month 138||107
8534857|NCT00291694|21040988|P2|NOT COMPLETED|Overall Study||5
8534858|NCT00291694|21040989|P1|NOT COMPLETED|Overall Study||3
8534859|NCT00291694|21040988|P2|COMPLETED|Overall Study||43
8534860|NCT00291694|21040989|P1|COMPLETED|Overall Study||21
8534861|NCT00291694|21040988|P2|STARTED|Overall Study||48
8534862|NCT00291694|21040989|P1|STARTED|Overall Study||24
8534863|NCT00291668|21041006|P3|NOT COMPLETED|Overall Study||1
8534864|NCT00291668|21041007|P2|NOT COMPLETED|Overall Study||1
8534865|NCT00291668|21041008|P1|NOT COMPLETED|Overall Study||4
8534866|NCT00291668|21041006|P3|COMPLETED|Overall Study||31
8534867|NCT00291668|21041007|P2|COMPLETED|Overall Study||29
8534868|NCT00291668|21041008|P1|COMPLETED|Overall Study||28
8534869|NCT00291668|21041006|P3|STARTED|Overall Study||32
8534870|NCT00291668|21041007|P2|STARTED|Overall Study||30
8534871|NCT00291668|21041008|P1|STARTED|Overall Study||32
8534872|NCT00291655|21041094|P1|NOT COMPLETED|Overall Study||15
8534873|NCT00291655|21041094|P1|COMPLETED|Overall Study||115
8534874|NCT00291655|21041094|P1|STARTED|Overall Study||130
8534875|NCT00291642|21041104|P5|NOT COMPLETED|Overall Study||1
8534876|NCT00291642|21041105|P4|NOT COMPLETED|Overall Study||0
8534877|NCT00291642|21041106|P3|NOT COMPLETED|Overall Study||2
8534878|NCT00291642|21041107|P2|NOT COMPLETED|Overall Study||0
8534879|NCT00291642|21041108|P1|NOT COMPLETED|Overall Study||2
8534880|NCT00291642|21041104|P5|COMPLETED|Overall Study||118
8534881|NCT00291642|21041105|P4|COMPLETED|Overall Study||119
8534882|NCT00291642|21041106|P3|COMPLETED|Overall Study||117
8534883|NCT00291642|21041107|P2|COMPLETED|Overall Study||116
8534884|NCT00291642|21041108|P1|COMPLETED|Overall Study||76
8534885|NCT00291642|21041104|P5|STARTED|Overall Study||119
8534886|NCT00291642|21041105|P4|STARTED|Overall Study||119
8534887|NCT00291642|21041106|P3|STARTED|Overall Study||119
8534888|NCT00291642|21041107|P2|STARTED|Overall Study||116
8534889|NCT00291642|21041108|P1|STARTED|Overall Study||78
8534890|NCT00291577|21041160|P1|NOT COMPLETED|Overall Study||21
8534891|NCT00291577|21041160|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
8534892|NCT00291577|21041160|P1|STARTED|Overall Study||22
8534893|NCT00291551|21041179|P1|NOT COMPLETED|Overall Study||13
8534894|NCT00291551|21041179|P1|COMPLETED|Overall Study||26
8534895|NCT00291551|21041179|P1|STARTED|Overall Study||39
8534896|NCT00291343|21041196|P2|NOT COMPLETED|Overall Study||0
8534897|NCT00291343|21041197|P1|NOT COMPLETED|Overall Study||0
8534898|NCT00291343|21041196|P2|COMPLETED|Overall Study||93
8534899|NCT00291343|21041197|P1|COMPLETED|Overall Study||203
8534900|NCT00291343|21041196|P2|STARTED|Overall Study||93
8534901|NCT00291343|21041197|P1|STARTED|Overall Study||203
8534902|NCT00291330|21041227|P2|NOT COMPLETED|Overall Study||97
8534903|NCT00291330|21041228|P1|NOT COMPLETED|Overall Study||101
8534904|NCT00291330|21041227|P2|COMPLETED|Overall Study|Completed planned observation time|1169
8534905|NCT00291330|21041228|P1|COMPLETED|Overall Study|Completed planned observation time|1172
8534906|NCT00291330|21041227|P2|STARTED|Overall Study|Started Treatment|1266
8534907|NCT00291330|21041228|P1|STARTED|Overall Study|Started Treatment|1273
8534908|NCT00291317|21041250|P1|NOT COMPLETED|Overall Study||0
8534909|NCT00291317|21041250|P1|COMPLETED|Overall Study||6
8534910|NCT00291317|21041250|P1|STARTED|Overall Study||6
8534911|NCT00291226|21041257|P2|NOT COMPLETED|Overall Study||1
8534912|NCT00291226|21041258|P1|NOT COMPLETED|Overall Study||1
8534913|NCT00291226|21041257|P2|COMPLETED|Overall Study||3
8534914|NCT00291226|21041258|P1|COMPLETED|Overall Study||3
8534915|NCT00291226|21041257|P2|STARTED|Overall Study||4
8534916|NCT00291226|21041258|P1|STARTED|Overall Study||4
8534917|NCT00291187|21041270|P4|NOT COMPLETED|Overall Study||0
8534918|NCT00291187|21041271|P3|NOT COMPLETED|Overall Study||1
8534919|NCT00291187|21041272|P2|NOT COMPLETED|Overall Study||0
8534920|NCT00291187|21041273|P1|NOT COMPLETED|Overall Study||0
8534921|NCT00291187|21041270|P4|COMPLETED|Overall Study||106
8534922|NCT00291187|21041271|P3|COMPLETED|Overall Study||102
8534923|NCT00291187|21041272|P2|COMPLETED|Overall Study||100
8534924|NCT00291187|21041273|P1|COMPLETED|Overall Study||103
8534925|NCT00291187|21041270|P4|STARTED|Overall Study||106
8534926|NCT00291187|21041271|P3|STARTED|Overall Study||103
8534927|NCT00291187|21041272|P2|STARTED|Overall Study||100
8534928|NCT00291187|21041273|P1|STARTED|Overall Study||103
8534929|NCT00291161|21041299|P4|NOT COMPLETED|Overall Study||65
8534930|NCT00291161|21041300|P3|NOT COMPLETED|Overall Study||93
8534931|NCT00291161|21041301|P2|NOT COMPLETED|Overall Study||58
8534932|NCT00291161|21041302|P1|NOT COMPLETED|Overall Study||81
8534933|NCT00291161|21041299|P4|COMPLETED|Overall Study||122
8534934|NCT00291161|21041300|P3|COMPLETED|Overall Study||206
8534935|NCT00291161|21041301|P2|COMPLETED|Overall Study||134
8534936|NCT00291161|21041302|P1|COMPLETED|Overall Study||235
8534937|NCT00291161|21041299|P4|STARTED|Overall Study||187
8534938|NCT00291161|21041300|P3|STARTED|Overall Study||299
8534939|NCT00291161|21041301|P2|STARTED|Overall Study||192
8534940|NCT00291161|21041302|P1|STARTED|Overall Study||316
8534941|NCT00291135|21041310|P1|NOT COMPLETED|Overall Study||0
8534942|NCT00291135|21041310|P1|COMPLETED|Overall Study||42
8534943|NCT00291135|21041310|P1|STARTED|Overall Study||42
8534944|NCT00291018|21041317|P3|NOT COMPLETED|Overall Study||43
8534945|NCT00291018|21041318|P2|NOT COMPLETED|Overall Study||42
8534946|NCT00291018|21041319|P1|NOT COMPLETED|Overall Study||25
8534947|NCT00291018|21041317|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
8534948|NCT00291018|21041318|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
8534949|NCT00291018|21041319|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
8534950|NCT00291018|21041317|P3|Evaluated at 24 Months|Overall Study||105
8534951|NCT00291018|21041318|P2|Evaluated at 24 Months|Overall Study||92
8534952|NCT00291018|21041319|P1|Evaluated at 24 Months|Overall Study||99
8534953|NCT00291018|21041317|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
8534954|NCT00291018|21041318|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
8534955|NCT00291018|21041319|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
8534956|NCT00290888|21041359|P2|NOT COMPLETED|Overall Study||1
8534957|NCT00290888|21041360|P1|NOT COMPLETED|Overall Study||3
8534958|NCT00290888|21041359|P2|COMPLETED|Overall Study||44
8534959|NCT00290888|21041360|P1|COMPLETED|Overall Study||38
8534960|NCT00290888|21041359|P2|STARTED|Overall Study||45
8534961|NCT00290888|21041360|P1|STARTED|Overall Study||41
8534962|NCT00290810|21041368|P1|NOT COMPLETED|Overall Study||0
8534963|NCT00290810|21041368|P1|COMPLETED|Overall Study||12
8534964|NCT00290810|21041368|P1|STARTED|Overall Study||12
8534965|NCT00290771|21041377|P2|NOT COMPLETED|Overall Study||97
8534966|NCT00290771|21041378|P1|NOT COMPLETED|Overall Study||127
8534967|NCT00290771|21041377|P2|COMPLETED|Overall Study||3
8534968|NCT00290771|21041378|P1|COMPLETED|Overall Study||4
8534969|NCT00290771|21041377|P2|STARTED|Overall Study||100
8534970|NCT00290771|21041378|P1|STARTED|Overall Study||131
8534971|NCT00290758|21041402|P2|NOT COMPLETED|Post Intervention rFNA||5
8534972|NCT00290758|21041403|P1|NOT COMPLETED|Post Intervention rFNA||6
8534973|NCT00290758|21041402|P2|COMPLETED|Post Intervention rFNA||49
8534974|NCT00290758|21041403|P1|COMPLETED|Post Intervention rFNA||49
8534975|NCT00290758|21041402|P2|STARTED|Post Intervention rFNA||54
8534976|NCT00290758|21041403|P1|STARTED|Post Intervention rFNA||55
8534977|NCT00290758|21041402|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
8534978|NCT00290758|21041403|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
8534979|NCT00290758|21041402|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
8534980|NCT00290758|21041403|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
8534981|NCT00290758|21041402|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
8534982|NCT00290758|21041403|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
8534983|NCT00290758|21041402|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
8534984|NCT00290758|21041403|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
8534985|NCT00290758|21041402|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
8534986|NCT00290758|21041403|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
8534987|NCT00290758|21041402|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
8534988|NCT00290758|21041403|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
8534989|NCT00290758|21041402|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
8534990|NCT00290758|21041403|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
8534991|NCT00290745|21041423|P1|NOT COMPLETED|Overall Study||12
8534992|NCT00290745|21041423|P1|COMPLETED|Overall Study||67
8534993|NCT00290745|21041423|P1|STARTED|Overall Study||79
8534994|NCT00290732|21041437|P5|NOT COMPLETED|Overall Study||0
8534995|NCT00290732|21041438|P4|NOT COMPLETED|Overall Study||0
8534996|NCT00290732|21041439|P3|NOT COMPLETED|Overall Study||1
8534997|NCT00290732|21041440|P2|NOT COMPLETED|Overall Study||1
8534998|NCT00290732|21041441|P1|NOT COMPLETED|Overall Study||0
8534999|NCT00290732|21041437|P5|COMPLETED|Overall Study||3
8535000|NCT00290732|21041438|P4|COMPLETED|Overall Study||6
8535001|NCT00290732|21041439|P3|COMPLETED|Overall Study||3
8535002|NCT00290732|21041440|P2|COMPLETED|Overall Study||3
8535003|NCT00290732|21041441|P1|COMPLETED|Overall Study||3
8535004|NCT00290732|21041437|P5|STARTED|Overall Study||3
8535005|NCT00290732|21041438|P4|STARTED|Overall Study||6
8535006|NCT00290732|21041439|P3|STARTED|Overall Study||4
8535007|NCT00290732|21041440|P2|STARTED|Overall Study||4
8535008|NCT00290732|21041441|P1|STARTED|Overall Study||3
8535009|NCT00290706|21041463|P4|NOT COMPLETED|Overall Study||12
8535010|NCT00290706|21041464|P3|NOT COMPLETED|Overall Study||6
8535011|NCT00290706|21041465|P2|NOT COMPLETED|Overall Study||6
8535012|NCT00290706|21041466|P1|NOT COMPLETED|Overall Study||5
8535013|NCT00290706|21041463|P4|COMPLETED|Overall Study||2
8535014|NCT00290706|21041464|P3|COMPLETED|Overall Study||1
8535015|NCT00290706|21041465|P2|COMPLETED|Overall Study||0
8535016|NCT00290706|21041466|P1|COMPLETED|Overall Study||0
8535017|NCT00290706|21041463|P4|Reached 1st Response/Cycle 3|Overall Study||2
8535018|NCT00290706|21041464|P3|Reached 1st Response/Cycle 3|Overall Study||1
8535019|NCT00290706|21041465|P2|Reached 1st Response/Cycle 3|Overall Study||0
8535020|NCT00290706|21041466|P1|Reached 1st Response/Cycle 3|Overall Study||0
8535021|NCT00290706|21041463|P4|Attempted1st Cycle|Overall Study||14
8535022|NCT00290706|21041464|P3|Attempted1st Cycle|Overall Study||7
8535023|NCT00290706|21041465|P2|Attempted1st Cycle|Overall Study||6
8535024|NCT00290706|21041466|P1|Attempted1st Cycle|Overall Study||5
8535025|NCT00290706|21041463|P4|STARTED|Overall Study||14
8535026|NCT00290706|21041464|P3|STARTED|Overall Study||7
8535027|NCT00290706|21041465|P2|STARTED|Overall Study||6
8535028|NCT00290706|21041466|P1|STARTED|Overall Study||5
8535029|NCT00290693|21041485|P1|NOT COMPLETED|Overall Study||2
8535030|NCT00290693|21041485|P1|COMPLETED|Overall Study||43
8535031|NCT00290693|21041485|P1|STARTED|Overall Study||45
8535032|NCT00290654|21041493|P1|NOT COMPLETED|Overall Study||0
8535033|NCT00290654|21041493|P1|COMPLETED|Overall Study||41
8535034|NCT00290654|21041493|P1|STARTED|Overall Study||41
8535035|NCT00290615|21041504|P1|NOT COMPLETED|Overall Study||0
8535036|NCT00290615|21041504|P1|COMPLETED|Overall Study||30
8535037|NCT00290615|21041504|P1|STARTED|Overall Study||30
8535038|NCT00290589|21041513|P2|NOT COMPLETED|Overall Study||2
8535039|NCT00290589|21041514|P1|NOT COMPLETED|Overall Study||2
8535040|NCT00290589|21041513|P2|COMPLETED|Overall Study||41
8535041|NCT00290589|21041514|P1|COMPLETED|Overall Study||37
8535042|NCT00290589|21041513|P2|STARTED|Overall Study||43
8535043|NCT00290589|21041514|P1|STARTED|Overall Study||39
8535044|NCT00290537|21041524|P2|NOT COMPLETED|Overall Study||0
8535045|NCT00290537|21041525|P1|NOT COMPLETED|Overall Study||0
8535046|NCT00290537|21041524|P2|COMPLETED|Overall Study||0
8535047|NCT00290537|21041525|P1|COMPLETED|Overall Study||4
8535048|NCT00290537|21041524|P2|STARTED|Overall Study||0
8535049|NCT00290537|21041525|P1|STARTED|Overall Study||4
8535050|NCT00290498|21041532|P2|NOT COMPLETED|Overall Study||0
8535051|NCT00290498|21041533|P1|NOT COMPLETED|Overall Study||8
8535052|NCT00290498|21041532|P2|COMPLETED|Overall Study||10
8535053|NCT00290498|21041533|P1|COMPLETED|Overall Study||41
8535054|NCT00290498|21041532|P2|STARTED|Overall Study||10
8535055|NCT00290498|21041533|P1|STARTED|Overall Study||49
8535056|NCT00290472|21041544|P3|NOT COMPLETED|Overall Study||0
8535057|NCT00290472|21041545|P2|NOT COMPLETED|Overall Study||0
8535058|NCT00290472|21041546|P1|NOT COMPLETED|Overall Study||0
8535059|NCT00290472|21041544|P3|COMPLETED|Overall Study||18
8535060|NCT00290472|21041545|P2|COMPLETED|Overall Study||39
8535061|NCT00290472|21041546|P1|COMPLETED|Overall Study||32
8535062|NCT00290472|21041544|P3|STARTED|Overall Study||18
8535063|NCT00290472|21041545|P2|STARTED|Overall Study||39
8535064|NCT00290472|21041546|P1|STARTED|Overall Study||32
8535065|NCT00290433|21041558|P1|NOT COMPLETED|Overall Study||36
8535066|NCT00290433|21041558|P1|COMPLETED|Overall Study||17
8535067|NCT00290433|21041558|P1|STARTED|Overall Study||53
8535068|NCT00290407|21041562|P1|NOT COMPLETED|Overall Study||2
8535069|NCT00290407|21041562|P1|COMPLETED|Overall Study||0
8535070|NCT00290407|21041562|P1|STARTED|Overall Study||2
8535071|NCT00290355|21041569|P2|NOT COMPLETED|Overall Study||5
8535072|NCT00290355|21041570|P1|NOT COMPLETED|Overall Study||17
8535073|NCT00290355|21041569|P2|COMPLETED|Overall Study||55
8535074|NCT00290355|21041570|P1|COMPLETED|Overall Study||105
8535075|NCT00290355|21041569|P2|STARTED|Overall Study||60
8535076|NCT00290355|21041570|P1|STARTED|Overall Study||122
8535077|NCT00290342|21041614|P2|NOT COMPLETED|Overall Study||5
8535078|NCT00290342|21041615|P1|NOT COMPLETED|Overall Study||7
8535079|NCT00290342|21041614|P2|COMPLETED|Overall Study||223
8535080|NCT00290342|21041615|P1|COMPLETED|Overall Study||217
8535081|NCT00290342|21041614|P2|STARTED|Overall Study||228
8535082|NCT00290342|21041615|P1|STARTED|Overall Study||224
8535083|NCT00290329|21041646|P3|NOT COMPLETED|Overall Study||0
8535084|NCT00290329|21041647|P2|NOT COMPLETED|Overall Study||0
8535085|NCT00290329|21041648|P1|NOT COMPLETED|Overall Study||0
8535086|NCT00290329|21041646|P3|COMPLETED|Overall Study||61
8535087|NCT00290329|21041647|P2|COMPLETED|Overall Study||86
8535088|NCT00290329|21041648|P1|COMPLETED|Overall Study||102
8535089|NCT00290329|21041646|P3|STARTED|Overall Study||61
8535090|NCT00290329|21041647|P2|STARTED|Overall Study||86
8535091|NCT00290329|21041648|P1|STARTED|Overall Study||102
8535092|NCT00290290|21041670|P2|NOT COMPLETED|Overall Study||18
8535093|NCT00290290|21041671|P1|NOT COMPLETED|Overall Study||18
8535094|NCT00290290|21041670|P2|COMPLETED|Overall Study||391
8535095|NCT00290290|21041671|P1|COMPLETED|Overall Study||422
8535096|NCT00290290|21041670|P2|STARTED|Overall Study||409
8535097|NCT00290290|21041671|P1|STARTED|Overall Study||440
8535098|NCT00290251|21041677|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
8535099|NCT00290251|21041678|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
8535100|NCT00290251|21041679|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
8535101|NCT00290251|21041677|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
8535102|NCT00290251|21041678|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
8535103|NCT00290251|21041679|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
8535104|NCT00290251|21041677|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
8535105|NCT00290251|21041678|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
8535106|NCT00290251|21041679|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
8535107|NCT00290251|21041677|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
8535108|NCT00290251|21041678|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
8535109|NCT00290251|21041679|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
8535110|NCT00290251|21041677|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
8535111|NCT00290251|21041678|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
8535112|NCT00290251|21041679|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
8535113|NCT00290251|21041677|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
8535114|NCT00290251|21041678|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
8535115|NCT00290251|21041679|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
8535116|NCT00290251|21041677|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
8535117|NCT00290251|21041678|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
8535118|NCT00290251|21041679|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
8535119|NCT00290251|21041677|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
8535120|NCT00290251|21041678|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
8535121|NCT00290251|21041679|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
8535122|NCT00290251|21041677|P3|STARTED|Treatment 1 (Months 1 - 3)||14
8535123|NCT00290251|21041678|P2|STARTED|Treatment 1 (Months 1 - 3)||14
8535124|NCT00290251|21041679|P1|STARTED|Treatment 1 (Months 1 - 3)||14
8535125|NCT00290238|21041691|P2|NOT COMPLETED|Overall Study||41
8535126|NCT00290238|21041692|P1|NOT COMPLETED|Overall Study||42
8535127|NCT00290238|21041691|P2|COMPLETED|Overall Study||24
8535128|NCT00290238|21041692|P1|COMPLETED|Overall Study||15
8535129|NCT00290238|21041691|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
8535130|NCT00290238|21041692|P1|STARTED|Overall Study||57
8535131|NCT00290199|21041702|P2|NOT COMPLETED|Overall Study||0
8535132|NCT00290199|21041703|P1|NOT COMPLETED|Overall Study||0
8535133|NCT00290199|21041702|P2|COMPLETED|Overall Study||82
8535134|NCT00290199|21041703|P1|COMPLETED|Overall Study||87
8535135|NCT00290199|21041702|P2|STARTED|Overall Study||82
8535136|NCT00290199|21041703|P1|STARTED|Overall Study||87
8535137|NCT00290186|21041717|P2|NOT COMPLETED|Overall Study||5
8535138|NCT00290186|21041718|P1|NOT COMPLETED|Overall Study||5
8535139|NCT00290186|21041717|P2|COMPLETED|Overall Study||19
8535140|NCT00290186|21041718|P1|COMPLETED|Overall Study||20
8535141|NCT00290186|21041717|P2|Completed 6-month Followup Assessments|Overall Study||19
8535142|NCT00290186|21041718|P1|Completed 6-month Followup Assessments|Overall Study||20
8535143|NCT00290186|21041717|P2|Completed 3-month Followup Assessments|Overall Study||21
8535144|NCT00290186|21041718|P1|Completed 3-month Followup Assessments|Overall Study||20
8535145|NCT00290186|21041717|P2|Completed Post-treatment Assessments|Overall Study||22
8535146|NCT00290186|21041718|P1|Completed Post-treatment Assessments|Overall Study||24
8535147|NCT00290186|21041717|P2|Completed 8 Weeks of Treatment|Overall Study||22
8535148|NCT00290186|21041718|P1|Completed 8 Weeks of Treatment|Overall Study||24
8535149|NCT00290186|21041717|P2|Completed Baseline Assessments|Overall Study||24
8535150|NCT00290186|21041718|P1|Completed Baseline Assessments|Overall Study||25
8535151|NCT00290186|21041717|P2|STARTED|Overall Study||24
8535152|NCT00290186|21041718|P1|STARTED|Overall Study||25
8535153|NCT00290147|21041758|P2|NOT COMPLETED|Overall Study||0
8535154|NCT00290147|21041759|P1|NOT COMPLETED|Overall Study||0
8535155|NCT00290147|21041758|P2|COMPLETED|Overall Study||12
8535156|NCT00290147|21041759|P1|COMPLETED|Overall Study||10
8535157|NCT00290147|21041758|P2|STARTED|Overall Study||12
8535158|NCT00290147|21041759|P1|STARTED|Overall Study||10
8535159|NCT00289991|21041769|P2|NOT COMPLETED|Overall Study||80
8535160|NCT00289991|21041770|P1|NOT COMPLETED|Overall Study||58
8535161|NCT00289991|21041769|P2|COMPLETED|Overall Study||175
8535162|NCT00289991|21041770|P1|COMPLETED|Overall Study||176
8535163|NCT00289991|21041769|P2|STARTED|Overall Study||255
8535164|NCT00289991|21041770|P1|STARTED|Overall Study||234
8535165|NCT00289978|21041795|P3|NOT COMPLETED|Overall Study||86
8535166|NCT00289978|21041796|P2|NOT COMPLETED|Overall Study||56
8535167|NCT00289978|21041797|P1|NOT COMPLETED|Overall Study||97
8535168|NCT00289978|21041795|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
8535169|NCT00289978|21041796|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
8535170|NCT00289978|21041797|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
8535171|NCT00289978|21041795|P3|STARTED|Overall Study||418
8535172|NCT00289978|21041796|P2|STARTED|Overall Study||425
8535173|NCT00289978|21041797|P1|STARTED|Overall Study||429
8535174|NCT00289913|21041816|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535175|NCT00289913|21041817|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535176|NCT00289913|21041818|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535177|NCT00289913|21041819|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535178|NCT00289913|21041820|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535179|NCT00289913|21041816|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
8535180|NCT00289913|21041817|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
8535181|NCT00289913|21041818|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
8535182|NCT00289913|21041819|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
8535183|NCT00289913|21041820|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
8535184|NCT00289913|21041816|P5|STARTED|Visit 4 (Stage I and Stage II)||597
8535185|NCT00289913|21041817|P4|STARTED|Visit 4 (Stage I and Stage II)||131
8535186|NCT00289913|21041818|P3|STARTED|Visit 4 (Stage I and Stage II)||138
8535187|NCT00289913|21041819|P2|STARTED|Visit 4 (Stage I and Stage II)||106
8535188|NCT00289913|21041820|P1|STARTED|Visit 4 (Stage I and Stage II)||122
8535189|NCT00289913|21041816|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
8535190|NCT00289913|21041817|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
8535191|NCT00289913|21041818|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
8535192|NCT00289913|21041819|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
8535193|NCT00289913|21041820|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
8535194|NCT00289913|21041816|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
8535195|NCT00289913|21041817|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
8535196|NCT00289913|21041818|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
8535197|NCT00289913|21041819|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
8535198|NCT00289913|21041820|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
8535199|NCT00289913|21041816|P5|STARTED|Visit 3 (Stage I and Stage II)||605
8535200|NCT00289913|21041817|P4|STARTED|Visit 3 (Stage I and Stage II)||135
8535201|NCT00289913|21041818|P3|STARTED|Visit 3 (Stage I and Stage II)||140
8535202|NCT00289913|21041819|P2|STARTED|Visit 3 (Stage I and Stage II)||114
8535203|NCT00289913|21041820|P1|STARTED|Visit 3 (Stage I and Stage II)||131
8535204|NCT00289913|21041816|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
8535205|NCT00289913|21041817|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
8535206|NCT00289913|21041818|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
8535207|NCT00289913|21041819|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
8535208|NCT00289913|21041820|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
8535209|NCT00289913|21041816|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
8535210|NCT00289913|21041817|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
8535211|NCT00289913|21041818|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
8535212|NCT00289913|21041819|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
8535213|NCT00289913|21041820|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
8535214|NCT00289913|21041816|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
8535215|NCT00289913|21041817|P4|STARTED|Visit 2 (Stage I and Stage II)||141
8535216|NCT00289913|21041818|P3|STARTED|Visit 2 (Stage I and Stage II)||150
8535217|NCT00289913|21041819|P2|STARTED|Visit 2 (Stage I and Stage II)||135
8535218|NCT00289913|21041820|P1|STARTED|Visit 2 (Stage I and Stage II)||146
8535219|NCT00289913|21041816|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8535220|NCT00289913|21041817|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
8535221|NCT00289913|21041818|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8535222|NCT00289913|21041819|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
8535223|NCT00289913|21041820|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8535224|NCT00289913|21041816|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
8535225|NCT00289913|21041817|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
8535226|NCT00289913|21041818|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
8535227|NCT00289913|21041819|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
8535228|NCT00289913|21041820|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
8535229|NCT00289913|21041816|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
8535230|NCT00289913|21041817|P4|STARTED|Visit 1 (Stage I and Stage II)||152
8535231|NCT00289913|21041818|P3|STARTED|Visit 1 (Stage I and Stage II)||159
8535232|NCT00289913|21041819|P2|STARTED|Visit 1 (Stage I and Stage II)||151
8535233|NCT00289913|21041820|P1|STARTED|Visit 1 (Stage I and Stage II)||155
8535234|NCT00289900|21041851|P6|NOT COMPLETED|Overall Study||61
8535235|NCT00289900|21041852|P5|NOT COMPLETED|Overall Study||45
8535236|NCT00289900|21041853|P4|NOT COMPLETED|Overall Study||59
8535237|NCT00289900|21041854|P3|NOT COMPLETED|Overall Study||33
8535238|NCT00289900|21041855|P2|NOT COMPLETED|Overall Study||120
8535239|NCT00289900|21041856|P1|NOT COMPLETED|Overall Study||68
8535240|NCT00289900|21041851|P6|COMPLETED|Overall Study||372
8535241|NCT00289900|21041852|P5|COMPLETED|Overall Study||392
8535242|NCT00289900|21041853|P4|COMPLETED|Overall Study||380
8535243|NCT00289900|21041854|P3|COMPLETED|Overall Study||265
8535244|NCT00289900|21041855|P2|COMPLETED|Overall Study||316
8535245|NCT00289900|21041856|P1|COMPLETED|Overall Study||229
8535246|NCT00289900|21041851|P6|Treated|Overall Study||433
8535247|NCT00289900|21041852|P5|Treated|Overall Study||437
8535248|NCT00289900|21041853|P4|Treated|Overall Study||439
8535249|NCT00289900|21041854|P3|Treated|Overall Study||298
8535250|NCT00289900|21041855|P2|Treated|Overall Study||435
8535251|NCT00289900|21041856|P1|Treated|Overall Study||297
8535252|NCT00289900|21041851|P6|STARTED|Overall Study||433
8535253|NCT00289900|21041852|P5|STARTED|Overall Study||437
8535254|NCT00289900|21041853|P4|STARTED|Overall Study||439
8535255|NCT00289900|21041854|P3|STARTED|Overall Study||298
8535256|NCT00289900|21041855|P2|STARTED|Overall Study||436
8535257|NCT00289900|21041856|P1|STARTED|Overall Study||297
8535258|NCT00289887|21041960|P2|NOT COMPLETED|Overall Study||29
8535259|NCT00289887|21041961|P1|NOT COMPLETED|Overall Study||22
8535260|NCT00289887|21041960|P2|COMPLETED|Overall Study||105
8535261|NCT00289887|21041961|P1|COMPLETED|Overall Study||105
8535262|NCT00289887|21041960|P2|STARTED|Overall Study||134
8535263|NCT00289887|21041961|P1|STARTED|Overall Study||127
8535264|NCT00289874|21041979|P2|NOT COMPLETED|Overall Study||8
8535265|NCT00289874|21041980|P1|NOT COMPLETED|Overall Study||6
8535266|NCT00289874|21041979|P2|COMPLETED|Overall Study||210
8535267|NCT00289874|21041980|P1|COMPLETED|Overall Study||197
8535268|NCT00289874|21041979|P2|STARTED|Overall Study||218
8535269|NCT00289874|21041980|P1|STARTED|Overall Study||203
8535270|NCT00289848|21041990|P2|NOT COMPLETED|Overall Study||45
8535271|NCT00289848|21041991|P1|NOT COMPLETED|Overall Study||46
8535272|NCT00289848|21041990|P2|COMPLETED|Overall Study||133
8535273|NCT00289848|21041991|P1|COMPLETED|Overall Study||306
8535274|NCT00289848|21041990|P2|STARTED|Overall Study||178
8535275|NCT00289848|21041991|P1|STARTED|Overall Study||352
8535276|NCT00289783|21042003|P2|NOT COMPLETED|Fourth Dose Phase||24
8535277|NCT00289783|21042004|P1|NOT COMPLETED|Fourth Dose Phase||87
8535278|NCT00289783|21042003|P2|COMPLETED|Fourth Dose Phase||899
8535279|NCT00289783|21042004|P1|COMPLETED|Fourth Dose Phase||2682
8535280|NCT00289783|21042003|P2|STARTED|Fourth Dose Phase||923
8535281|NCT00289783|21042004|P1|STARTED|Fourth Dose Phase||2769
8535282|NCT00289783|21042003|P2|NOT COMPLETED|Primary Phase||83
8535283|NCT00289783|21042004|P1|NOT COMPLETED|Primary Phase||248
8535284|NCT00289783|21042003|P2|COMPLETED|Primary Phase||961
8535285|NCT00289783|21042004|P1|COMPLETED|Primary Phase||2888
8535286|NCT00289783|21042003|P2|STARTED|Primary Phase||1044
8535287|NCT00289783|21042004|P1|STARTED|Primary Phase||3136
8535288|NCT00289770|21042182|P1|NOT COMPLETED|Year 15||1
8535289|NCT00289770|21042182|P1|COMPLETED|Year 15||49
8535290|NCT00289770|21042182|P1|STARTED|Year 15||50
8535291|NCT00289770|21042182|P1|NOT COMPLETED|Year 14||0
8535292|NCT00289770|21042182|P1|COMPLETED|Year 14||43
8535293|NCT00289770|21042182|P1|STARTED|Year 14||43
8535294|NCT00289770|21042182|P1|NOT COMPLETED|Year 13||0
8535295|NCT00289770|21042182|P1|COMPLETED|Year 13||37
8535296|NCT00289770|21042182|P1|STARTED|Year 13||37
8535297|NCT00289770|21042182|P1|NOT COMPLETED|Year 12||0
8535298|NCT00289770|21042182|P1|COMPLETED|Year 12||40
8535299|NCT00289770|21042182|P1|STARTED|Year 12||40
8535300|NCT00289770|21042182|P1|NOT COMPLETED|Year 11||0
8535301|NCT00289770|21042182|P1|COMPLETED|Year 11||37
8535302|NCT00289770|21042182|P1|STARTED|Year 11||37
8535303|NCT00289757|21042194|P1|NOT COMPLETED|Overall Study||0
8535304|NCT00289757|21042194|P1|COMPLETED|Overall Study||78
8535305|NCT00289757|21042194|P1|STARTED|Overall Study||78
8535306|NCT00289744|21042205|P3|NOT COMPLETED|Additional Dose Phase||0
8535307|NCT00289744|21042206|P2|NOT COMPLETED|Additional Dose Phase||0
8535308|NCT00289744|21042207|P1|NOT COMPLETED|Additional Dose Phase||0
8535309|NCT00289744|21042205|P3|COMPLETED|Additional Dose Phase||6
8535310|NCT00289744|21042206|P2|COMPLETED|Additional Dose Phase||19
8535311|NCT00289744|21042207|P1|COMPLETED|Additional Dose Phase||0
8535312|NCT00289744|21042205|P3|STARTED|Additional Dose Phase||6
8535313|NCT00289744|21042206|P2|STARTED|Additional Dose Phase||19
8535314|NCT00289744|21042207|P1|STARTED|Additional Dose Phase||0
8535315|NCT00289744|21042205|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
8535316|NCT00289744|21042206|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
8535317|NCT00289744|21042207|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
8535318|NCT00289744|21042205|P3|COMPLETED|Year 10 Long-term Follow-up||0
8535319|NCT00289744|21042206|P2|COMPLETED|Year 10 Long-term Follow-up||0
8535320|NCT00289744|21042207|P1|COMPLETED|Year 10 Long-term Follow-up||171
8535321|NCT00289744|21042205|P3|STARTED|Year 10 Long-term Follow-up||0
8535322|NCT00289744|21042206|P2|STARTED|Year 10 Long-term Follow-up||0
8535323|NCT00289744|21042207|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
8535324|NCT00289744|21042205|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
8535325|NCT00289744|21042206|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
8535326|NCT00289744|21042207|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
8535327|NCT00289744|21042205|P3|COMPLETED|Year 9 Long-term Follow-up||0
8535328|NCT00289744|21042206|P2|COMPLETED|Year 9 Long-term Follow-up||0
8535329|NCT00289744|21042207|P1|COMPLETED|Year 9 Long-term Follow-up||173
8535330|NCT00289744|21042205|P3|STARTED|Year 9 Long-term Follow-up||0
8535331|NCT00289744|21042206|P2|STARTED|Year 9 Long-term Follow-up||0
8535332|NCT00289744|21042207|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
8535333|NCT00289744|21042205|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
8535334|NCT00289744|21042206|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
8535335|NCT00289744|21042207|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
8535336|NCT00289744|21042205|P3|COMPLETED|Year 8 Long-term Follow-up||0
8535337|NCT00289744|21042206|P2|COMPLETED|Year 8 Long-term Follow-up||0
8535338|NCT00289744|21042207|P1|COMPLETED|Year 8 Long-term Follow-up||174
8535339|NCT00289744|21042205|P3|STARTED|Year 8 Long-term Follow-up||0
8535340|NCT00289744|21042206|P2|STARTED|Year 8 Long-term Follow-up||0
8535341|NCT00289744|21042207|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
8535342|NCT00289744|21042205|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
8535343|NCT00289744|21042206|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
8535344|NCT00289744|21042207|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
8535345|NCT00289744|21042205|P3|COMPLETED|Year 7 Long-term Follow-up||0
8535346|NCT00289744|21042206|P2|COMPLETED|Year 7 Long-term Follow-up||0
8535347|NCT00289744|21042207|P1|COMPLETED|Year 7 Long-term Follow-up||175
8535348|NCT00289744|21042205|P3|STARTED|Year 7 Long-term Follow-up||0
8535349|NCT00289744|21042206|P2|STARTED|Year 7 Long-term Follow-up||0
8535350|NCT00289744|21042207|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
8535351|NCT00289744|21042205|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
8535352|NCT00289744|21042206|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
8535353|NCT00289744|21042207|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
8535354|NCT00289744|21042205|P3|COMPLETED|Year 6 Long-term Follow-up||0
8535355|NCT00289744|21042206|P2|COMPLETED|Year 6 Long-term Follow-up||0
8535356|NCT00289744|21042207|P1|COMPLETED|Year 6 Long-term Follow-up||178
8535357|NCT00289744|21042205|P3|STARTED|Year 6 Long-term Follow-up||0
8535358|NCT00289744|21042206|P2|STARTED|Year 6 Long-term Follow-up||0
8535359|NCT00289744|21042207|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
8535360|NCT00289731|21042228|P3|NOT COMPLETED|Overall Study||2
8535361|NCT00289731|21042229|P2|NOT COMPLETED|Overall Study||2
8535362|NCT00289731|21042230|P1|NOT COMPLETED|Overall Study||2
8535363|NCT00289731|21042228|P3|COMPLETED|Overall Study||195
8535364|NCT00289731|21042229|P2|COMPLETED|Overall Study||198
8535365|NCT00289731|21042230|P1|COMPLETED|Overall Study||197
8535366|NCT00289731|21042228|P3|STARTED|Overall Study||197
8535367|NCT00289731|21042229|P2|STARTED|Overall Study||200
8535368|NCT00289731|21042230|P1|STARTED|Overall Study||199
8535369|NCT00289718|21042322|P1|NOT COMPLETED|Overall Study||0
8535370|NCT00289718|21042322|P1|COMPLETED|Overall Study||51
8535371|NCT00289718|21042322|P1|STARTED|Overall Study||51
8535372|NCT00289653|21042337|P1|NOT COMPLETED|Overall Study||11
8535373|NCT00289653|21042337|P1|COMPLETED|Overall Study||12
8535374|NCT00289653|21042337|P1|STARTED|Overall Study||23
8535375|NCT00289536|21042342|P3|NOT COMPLETED|Period 3||1
8535376|NCT00289536|21042343|P2|NOT COMPLETED|Period 3||0
8535377|NCT00289536|21042344|P1|NOT COMPLETED|Period 3||0
8535378|NCT00289536|21042342|P3|COMPLETED|Period 3||9
8535379|NCT00289536|21042343|P2|COMPLETED|Period 3||9
8535380|NCT00289536|21042344|P1|COMPLETED|Period 3||7
8535381|NCT00289536|21042342|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
8535382|NCT00289536|21042343|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
8535383|NCT00289536|21042344|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
8535384|NCT00289536|21042342|P3|NOT COMPLETED|Period 2||0
8535385|NCT00289536|21042343|P2|NOT COMPLETED|Period 2||0
8535386|NCT00289536|21042344|P1|NOT COMPLETED|Period 2||0
8535387|NCT00289536|21042342|P3|COMPLETED|Period 2||7
8535388|NCT00289536|21042343|P2|COMPLETED|Period 2||9
8535389|NCT00289536|21042344|P1|COMPLETED|Period 2||10
8535390|NCT00289536|21042342|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
8535391|NCT00289536|21042343|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
8535392|NCT00289536|21042344|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
8535393|NCT00289536|21042342|P3|NOT COMPLETED|Period 1||0
8535394|NCT00289536|21042343|P2|NOT COMPLETED|Period 1||0
8535395|NCT00289536|21042344|P1|NOT COMPLETED|Period 1||0
8535396|NCT00289536|21042342|P3|COMPLETED|Period 1||9
8535397|NCT00289536|21042343|P2|COMPLETED|Period 1||8
8535398|NCT00289536|21042344|P1|COMPLETED|Period 1||9
8535399|NCT00289536|21042342|P3|STARTED|Period 1||9
8535400|NCT00289536|21042343|P2|STARTED|Period 1||8
8535401|NCT00289536|21042344|P1|STARTED|Period 1||9
8535402|NCT00289471|21042383|P1|NOT COMPLETED|Overall Study||0
8535403|NCT00289471|21042383|P1|COMPLETED|Overall Study||630
8535404|NCT00289471|21042383|P1|STARTED|Overall Study||630
8535405|NCT00289458|21042390|P3|NOT COMPLETED|Overall Study||6
8535406|NCT00289458|21042391|P2|NOT COMPLETED|Overall Study||6
8535407|NCT00289458|21042392|P1|NOT COMPLETED|Overall Study||6
8535408|NCT00289458|21042390|P3|COMPLETED|Overall Study||22
8535409|NCT00289458|21042391|P2|COMPLETED|Overall Study||20
8535410|NCT00289458|21042392|P1|COMPLETED|Overall Study||19
8535411|NCT00289458|21042390|P3|STARTED|Overall Study||28
8535412|NCT00289458|21042391|P2|STARTED|Overall Study||26
8535413|NCT00289458|21042392|P1|STARTED|Overall Study||25
8535414|NCT00289341|21042417|P2|NOT COMPLETED|Overall Study||0
8535415|NCT00289341|21042418|P1|NOT COMPLETED|Overall Study||0
8535416|NCT00289341|21042417|P2|COMPLETED|Overall Study||12
8535417|NCT00289341|21042418|P1|COMPLETED|Overall Study||12
8535418|NCT00289341|21042417|P2|STARTED|Overall Study||12
8535419|NCT00289341|21042418|P1|STARTED|Overall Study||12
8535420|NCT00289315|21042431|P3|NOT COMPLETED|Overall Study||140
8535421|NCT00289315|21042432|P2|NOT COMPLETED|Overall Study||122
8535422|NCT00289315|21042433|P1|NOT COMPLETED|Overall Study||101
8535423|NCT00289315|21042431|P3|COMPLETED|Overall Study||447
8535424|NCT00289315|21042432|P2|COMPLETED|Overall Study||638
8535425|NCT00289315|21042433|P1|COMPLETED|Overall Study||612
8535426|NCT00289315|21042431|P3|STARTED|Overall Study||587
8535427|NCT00289315|21042432|P2|STARTED|Overall Study||760
8535428|NCT00289315|21042433|P1|STARTED|Overall Study||713
8535429|NCT00289289|21042453|P3|NOT COMPLETED|Overall Study||49
8535430|NCT00289289|21042454|P2|NOT COMPLETED|Overall Study||10
8535431|NCT00289289|21042455|P1|NOT COMPLETED|Overall Study||19
8535432|NCT00289289|21042453|P3|COMPLETED|Overall Study||95
8535433|NCT00289289|21042454|P2|COMPLETED|Overall Study||114
8535434|NCT00289289|21042455|P1|COMPLETED|Overall Study||113
8535435|NCT00289289|21042453|P3|STARTED|Overall Study||144
8535436|NCT00289289|21042454|P2|STARTED|Overall Study||124
8535437|NCT00289289|21042455|P1|STARTED|Overall Study||132
8535438|NCT00289276|21042470|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
8535439|NCT00289276|21042471|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
8535440|NCT00289276|21042470|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
8535441|NCT00289276|21042471|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
8535442|NCT00289276|21042470|P2|STARTED|Second Part of FAST Study (Expansion)||109
8535443|NCT00289276|21042471|P1|STARTED|Second Part of FAST Study (Expansion)||0
8535444|NCT00289276|21042470|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
8535445|NCT00289276|21042471|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
8535446|NCT00289276|21042470|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
8535447|NCT00289276|21042471|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
8535448|NCT00289276|21042470|P2|STARTED|First Part of FAST Study (Pivotal)||0
8535449|NCT00289276|21042471|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
8535450|NCT00289211|21042486|P3|NOT COMPLETED|Overall Study||10
8535451|NCT00289211|21042487|P2|NOT COMPLETED|Overall Study||1
8535452|NCT00289211|21042488|P1|NOT COMPLETED|Overall Study||0
8535453|NCT00289211|21042486|P3|COMPLETED|Overall Study||2
8535454|NCT00289211|21042487|P2|COMPLETED|Overall Study||34
8535455|NCT00289211|21042488|P1|COMPLETED|Overall Study||36
8535456|NCT00289211|21042486|P3|STARTED|Overall Study||12
8535457|NCT00289211|21042487|P2|STARTED|Overall Study||35
8535458|NCT00289211|21042488|P1|STARTED|Overall Study||36
8535459|NCT00289198|21042506|P2|NOT COMPLETED|Overall Study||30
8535460|NCT00289198|21042507|P1|NOT COMPLETED|Overall Study||31
8535461|NCT00289198|21042506|P2|COMPLETED|Overall Study||121
8535462|NCT00289198|21042507|P1|COMPLETED|Overall Study||120
8535463|NCT00289198|21042506|P2|STARTED|Overall Study||151
8535464|NCT00289198|21042507|P1|STARTED|Overall Study||151
8535465|NCT00289185|21042557|P2|NOT COMPLETED|Overall Study||26
8535466|NCT00289185|21042558|P1|NOT COMPLETED|Overall Study||28
8535467|NCT00289185|21042557|P2|COMPLETED|Overall Study||144
8535468|NCT00289185|21042558|P1|COMPLETED|Overall Study||142
8535469|NCT00289185|21042557|P2|STARTED|Overall Study||170
8535470|NCT00289185|21042558|P1|STARTED|Overall Study||170
8535471|NCT00289133|21042605|P2|NOT COMPLETED|Overall Study||298
8535472|NCT00289133|21042606|P1|NOT COMPLETED|Overall Study||272
8535473|NCT00289133|21042605|P2|COMPLETED|Overall Study||179
8535474|NCT00289133|21042606|P1|COMPLETED|Overall Study||189
8535475|NCT00289133|21042605|P2|STARTED|Overall Study||477
8535476|NCT00289133|21042606|P1|STARTED|Overall Study||461
8535477|NCT00289120|21042628|P1|NOT COMPLETED|Overall Study||0
8535478|NCT00289120|21042628|P1|COMPLETED|Overall Study||13
8535479|NCT00289120|21042628|P1|STARTED|Overall Study||13
8535480|NCT00289107|21042646|P2|NOT COMPLETED|Overall Study||44
8535481|NCT00289107|21042647|P1|NOT COMPLETED|Overall Study||53
8535482|NCT00289107|21042646|P2|COMPLETED|Overall Study||28
8535483|NCT00289107|21042647|P1|COMPLETED|Overall Study||24
8535484|NCT00289107|21042646|P2|STARTED|Overall Study||72
8535485|NCT00289107|21042647|P1|STARTED|Overall Study||77
8535486|NCT00289094|21042655|P2|NOT COMPLETED|Overall Study||47
8535487|NCT00289094|21042656|P1|NOT COMPLETED|Overall Study||47
8535488|NCT00289094|21042655|P2|COMPLETED|Overall Study||2
8535489|NCT00289094|21042656|P1|COMPLETED|Overall Study||3
8535490|NCT00289094|21042655|P2|STARTED|Overall Study||49
8535491|NCT00289094|21042656|P1|STARTED|Overall Study||50
8535492|NCT00289016|21042662|P1|NOT COMPLETED|Overall Study||37
8535493|NCT00289016|21042662|P1|COMPLETED|Overall Study||13
8535494|NCT00289016|21042662|P1|STARTED|Overall Study||50
8535495|NCT00288912|21042674|P3|NOT COMPLETED|Overall Study||28
8535496|NCT00288912|21042675|P2|NOT COMPLETED|Overall Study||17
8535497|NCT00288912|21042676|P1|NOT COMPLETED|Overall Study||17
8535498|NCT00288912|21042674|P3|COMPLETED|Overall Study||146
8535499|NCT00288912|21042675|P2|COMPLETED|Overall Study||157
8535500|NCT00288912|21042676|P1|COMPLETED|Overall Study||158
8535501|NCT00288912|21042674|P3|STARTED|Overall Study||174
8535502|NCT00288912|21042675|P2|STARTED|Overall Study||174
8535503|NCT00288912|21042676|P1|STARTED|Overall Study||175
8535504|NCT00288886|21042695|P2|NOT COMPLETED|Overall Study||11
8535505|NCT00288886|21042696|P1|NOT COMPLETED|Overall Study||11
8535506|NCT00288886|21042695|P2|COMPLETED|Overall Study||81
8535507|NCT00288886|21042696|P1|COMPLETED|Overall Study||80
8535508|NCT00288886|21042695|P2|12-month Follow Up|Overall Study||81
8535509|NCT00288886|21042696|P1|12-month Follow Up|Overall Study||80
8535510|NCT00288886|21042695|P2|6-month Follow Up|Overall Study||84
8535511|NCT00288886|21042696|P1|6-month Follow Up|Overall Study||85
8535512|NCT00288886|21042695|P2|3-month Follow Up|Overall Study||85
8535513|NCT00288886|21042696|P1|3-month Follow Up|Overall Study||82
8535514|NCT00288886|21042695|P2|STARTED|Overall Study||92
8535515|NCT00288886|21042696|P1|STARTED|Overall Study||91
8535516|NCT00288860|21042716|P2|NOT COMPLETED|Overall Study||97
8535517|NCT00288860|21042717|P1|NOT COMPLETED|Overall Study||102
8535518|NCT00288860|21042716|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
8535519|NCT00288860|21042717|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
8535520|NCT00288860|21042716|P2|Completed 12 Month fu Survey|Overall Study||281
8535521|NCT00288860|21042717|P1|Completed 12 Month fu Survey|Overall Study||257
8535522|NCT00288860|21042716|P2|Completed 4 Month fu Survey|Overall Study||299
8535523|NCT00288860|21042717|P1|Completed 4 Month fu Survey|Overall Study||275
8535524|NCT00288860|21042716|P2|Completed Intake Survey|Overall Study||417
8535525|NCT00288860|21042717|P1|Completed Intake Survey|Overall Study||408
8535526|NCT00288860|21042716|P2|STARTED|Overall Study||425
8535527|NCT00288860|21042717|P1|STARTED|Overall Study||412
8535528|NCT00288704|21042730|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
8535529|NCT00288704|21042731|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535530|NCT00288704|21042732|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535531|NCT00288704|21042730|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
8535532|NCT00288704|21042731|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535533|NCT00288704|21042732|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535534|NCT00288704|21042730|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
8535535|NCT00288704|21042731|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
8535536|NCT00288704|21042732|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
8535537|NCT00288704|21042730|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8535538|NCT00288704|21042731|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
8535539|NCT00288704|21042732|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8535540|NCT00288704|21042730|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8535541|NCT00288704|21042731|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
8535542|NCT00288704|21042732|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
8535543|NCT00288704|21042730|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
8535544|NCT00288704|21042731|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
8535545|NCT00288704|21042732|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
8535546|NCT00288704|21042730|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
8535547|NCT00288704|21042731|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
8535548|NCT00288704|21042732|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
8535549|NCT00288704|21042730|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
8535550|NCT00288704|21042731|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
8535551|NCT00288704|21042732|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
8535552|NCT00288704|21042730|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
8535553|NCT00288704|21042731|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
8535554|NCT00288704|21042732|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
8535555|NCT00288639|21042759|P1|NOT COMPLETED|Overall Study||12
8535556|NCT00288639|21042759|P1|COMPLETED|Overall Study||86
8535557|NCT00288639|21042759|P1|STARTED|Overall Study||98
8535558|NCT00288626|21042776|P1|NOT COMPLETED|Overall Study||7
8535559|NCT00288626|21042776|P1|COMPLETED|Overall Study||17
8535560|NCT00288626|21042776|P1|STARTED|Overall Study||24
8535561|NCT00288600|21042801|P2|NOT COMPLETED|Overall Study||0
8535562|NCT00288600|21042802|P1|NOT COMPLETED|Overall Study||0
8535563|NCT00288600|21042801|P2|COMPLETED|Overall Study||46
8535564|NCT00288600|21042802|P1|COMPLETED|Overall Study||46
8535565|NCT00288600|21042801|P2|STARTED|Overall Study||46
8535566|NCT00288600|21042802|P1|STARTED|Overall Study||46
8535567|NCT00288587|21042810|P2|NOT COMPLETED|Overall Study||10
8535568|NCT00288587|21042811|P1|NOT COMPLETED|Overall Study||5
8535569|NCT00288587|21042810|P2|COMPLETED|Overall Study||7
8535570|NCT00288587|21042811|P1|COMPLETED|Overall Study||14
8535571|NCT00288587|21042810|P2|STARTED|Overall Study||17
8535572|NCT00288587|21042811|P1|STARTED|Overall Study||19
8535573|NCT00288574|21042827|P2|NOT COMPLETED|Overall Study||0
8535574|NCT00288574|21042828|P1|NOT COMPLETED|Overall Study||0
8535575|NCT00288574|21042827|P2|COMPLETED|Overall Study||44
8535576|NCT00288574|21042828|P1|COMPLETED|Overall Study||49
8535577|NCT00288574|21042827|P2|STARTED|Overall Study||44
8535578|NCT00288574|21042828|P1|STARTED|Overall Study||49
8535579|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 4||8
8535580|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 4||80
8535581|NCT00288509|21042854|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
8535582|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 3||5
8535583|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 3||91
8535584|NCT00288509|21042854|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
8535585|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 2||3
8535586|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 2||97
8535587|NCT00288509|21042854|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
8535588|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 1||6
8535589|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 1||102
8535590|NCT00288509|21042854|P1|STARTED|Treatment Cycle 1||108
8535591|NCT00288366|21042863|P2|NOT COMPLETED|Overall Study||0
8535592|NCT00288366|21042864|P1|NOT COMPLETED|Overall Study||0
8535593|NCT00288366|21042863|P2|COMPLETED|Overall Study||26
8535594|NCT00288366|21042864|P1|COMPLETED|Overall Study||23
8535595|NCT00288366|21042863|P2|STARTED|Overall Study||26
8535596|NCT00288366|21042864|P1|STARTED|Overall Study||23
8535597|NCT00288080|21042872|P2|NOT COMPLETED|Overall Study||23
8535598|NCT00288080|21042873|P1|NOT COMPLETED|Overall Study||26
8535599|NCT00288080|21042872|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
8535600|NCT00288080|21042873|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
8535601|NCT00288080|21042872|P2|STARTED|Overall Study||305
8535602|NCT00288080|21042873|P1|STARTED|Overall Study||307
8535603|NCT00288067|21042889|P1|NOT COMPLETED|Overall Study||0
8535604|NCT00288067|21042889|P1|COMPLETED|Overall Study||32
8535605|NCT00288067|21042889|P1|STARTED|Overall Study||32
8535606|NCT00288054|21042895|P1|NOT COMPLETED|Overall Study||24
8535607|NCT00288054|21042895|P1|COMPLETED|Overall Study||0
8535608|NCT00288054|21042895|P1|STARTED|Overall Study||24
8535609|NCT00288015|21042903|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
8535610|NCT00288015|21042903|P1|COMPLETED|Follow up for Survival x 2 Years||3
8535611|NCT00288015|21042903|P1|STARTED|Follow up for Survival x 2 Years||29
8535612|NCT00288015|21042903|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
8535613|NCT00288015|21042903|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
8535614|NCT00288015|21042903|P1|STARTED|Continued Bevacizumab Cycle 3+||26
8535615|NCT00288015|21042903|P1|NOT COMPLETED|First Response Assessment||4
8535616|NCT00288015|21042903|P1|COMPLETED|First Response Assessment||26
8535617|NCT00288015|21042903|P1|STARTED|First Response Assessment||30
8535618|NCT00288015|21042903|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
8535619|NCT00288015|21042903|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
8535620|NCT00288015|21042903|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
8535621|NCT00288015|21042903|P1|NOT COMPLETED|Registered to Study||0
8535622|NCT00288015|21042903|P1|COMPLETED|Registered to Study||32
8535623|NCT00288015|21042903|P1|STARTED|Registered to Study||32
8535624|NCT00287989|21042915|P3|NOT COMPLETED|Overall Study||0
8535625|NCT00287989|21042916|P2|NOT COMPLETED|Overall Study||0
8535626|NCT00287989|21042917|P1|NOT COMPLETED|Overall Study||0
8535627|NCT00287989|21042915|P3|COMPLETED|Overall Study||29
8535628|NCT00287989|21042916|P2|COMPLETED|Overall Study||29
8535629|NCT00287989|21042917|P1|COMPLETED|Overall Study||28
8535630|NCT00287989|21042915|P3|STARTED|Overall Study||29
8535631|NCT00287989|21042916|P2|STARTED|Overall Study||29
8535632|NCT00287989|21042917|P1|STARTED|Overall Study||28
8535633|NCT00287872|21042928|P1|NOT COMPLETED|Overall Study||0
8535634|NCT00287872|21042928|P1|COMPLETED|Overall Study||30
8535635|NCT00287872|21042928|P1|STARTED|Overall Study||30
8535636|NCT00287729|21042938|P2|NOT COMPLETED|Overall Study||31
8535637|NCT00287729|21042939|P1|NOT COMPLETED|Overall Study||34
8535638|NCT00287729|21042938|P2|COMPLETED|Overall Study||142
8535639|NCT00287729|21042939|P1|COMPLETED|Overall Study||137
8535640|NCT00287729|21042938|P2|STARTED|Overall Study||173
8535641|NCT00287729|21042939|P1|STARTED|Overall Study||171
8535642|NCT00287716|21042962|P3|NOT COMPLETED|Overall Study||31
8535643|NCT00287716|21042963|P2|NOT COMPLETED|Overall Study||17
8535644|NCT00287716|21042964|P1|NOT COMPLETED|Overall Study||38
8535645|NCT00287716|21042962|P3|COMPLETED|Overall Study||143
8535646|NCT00287716|21042963|P2|COMPLETED|Overall Study||70
8535647|NCT00287716|21042964|P1|COMPLETED|Overall Study||136
8535648|NCT00287716|21042962|P3|STARTED|Overall Study||174
8535649|NCT00287716|21042963|P2|STARTED|Overall Study||87
8535650|NCT00287716|21042964|P1|STARTED|Overall Study||174
8535651|NCT00287690|21042995|P2|NOT COMPLETED|Overall Study||26
8535652|NCT00287690|21042996|P1|NOT COMPLETED|Overall Study||20
8535653|NCT00287690|21042995|P2|COMPLETED|Overall Study||12
8535654|NCT00287690|21042996|P1|COMPLETED|Overall Study||13
8535655|NCT00287690|21042995|P2|STARTED|Overall Study||38
8535656|NCT00287690|21042996|P1|STARTED|Overall Study||33
8535657|NCT00287586|21043008|P2|NOT COMPLETED|Overall Study||52
8535658|NCT00287586|21043009|P1|NOT COMPLETED|Overall Study||45
8535659|NCT00287586|21043008|P2|COMPLETED|Overall Study||100
8535660|NCT00287586|21043009|P1|COMPLETED|Overall Study||111
8535661|NCT00287586|21043008|P2|Intent-to-treat: Received Study Drug|Overall Study||151
8535662|NCT00287586|21043009|P1|Intent-to-treat: Received Study Drug|Overall Study||155
8535663|NCT00287586|21043008|P2|STARTED|Overall Study||152
8535664|NCT00287586|21043009|P1|STARTED|Overall Study||156
8535665|NCT00287469|21043047|P2|NOT COMPLETED|Overall Study||214
8535666|NCT00287469|21043048|P1|NOT COMPLETED|Overall Study||220
8535667|NCT00287469|21043047|P2|COMPLETED|Overall Study||786
8535668|NCT00287469|21043048|P1|COMPLETED|Overall Study||780
8535669|NCT00287469|21043047|P2|STARTED|Overall Study||1000
8535670|NCT00287469|21043048|P1|STARTED|Overall Study||1000
8535671|NCT00287365|21043058|P1|NOT COMPLETED|Overall Study||13
8535672|NCT00287365|21043058|P1|COMPLETED|Overall Study||12
8535673|NCT00287365|21043058|P1|STARTED|Overall Study||25
8535674|NCT00287339|21043069|P2|NOT COMPLETED|Overall Study||0
8535675|NCT00287339|21043070|P1|NOT COMPLETED|Overall Study||0
8535676|NCT00287339|21043069|P2|COMPLETED|Overall Study||18
8535677|NCT00287339|21043070|P1|COMPLETED|Overall Study||22
8535678|NCT00287339|21043069|P2|STARTED|Overall Study||18
8535679|NCT00287339|21043070|P1|STARTED|Overall Study||22
8535680|NCT00287287|21043076|P1|NOT COMPLETED|Overall Study||0
8535681|NCT00287287|21043076|P1|COMPLETED|Overall Study||25
8535682|NCT00287287|21043076|P1|STARTED|Overall Study||25
8535683|NCT00287222|21043080|P1|NOT COMPLETED|Overall Study||0
8535684|NCT00287222|21043080|P1|COMPLETED|Overall Study||21
8535685|NCT00287222|21043080|P1|STARTED|Overall Study||21
8535686|NCT00287118|21043084|P1|NOT COMPLETED|Overall Study||52
8535687|NCT00287118|21043084|P1|COMPLETED|Overall Study||137
8535688|NCT00287118|21043084|P1|STARTED|Overall Study||189
8535689|NCT00287079|21043090|P2|NOT COMPLETED|Overall Study||1
8535690|NCT00287079|21043091|P1|NOT COMPLETED|Overall Study||22
8535691|NCT00287079|21043090|P2|COMPLETED|Overall Study||2
8535692|NCT00287079|21043091|P1|COMPLETED|Overall Study||10
8535693|NCT00287079|21043090|P2|STARTED|Overall Study||3
8535694|NCT00287079|21043091|P1|STARTED|Overall Study||32
8535695|NCT00287053|21043103|P2|NOT COMPLETED|Overall Study||1
8535696|NCT00287053|21043104|P1|NOT COMPLETED|Overall Study||4
8535697|NCT00287053|21043103|P2|COMPLETED|Overall Study||26
8535698|NCT00287053|21043104|P1|COMPLETED|Overall Study||26
8535699|NCT00287053|21043103|P2|STARTED|Overall Study||27
8535700|NCT00287053|21043104|P1|STARTED|Overall Study||30
8535701|NCT00286949|21043110|P1|NOT COMPLETED|Overall Study||0
8535702|NCT00286949|21043110|P1|COMPLETED|Overall Study||12
8535703|NCT00286949|21043110|P1|STARTED|Overall Study||12
8535704|NCT00286754|21043119|P3|NOT COMPLETED|Overall Study||10
8535705|NCT00286754|21043120|P2|NOT COMPLETED|Overall Study||18
8535706|NCT00286754|21043121|P1|NOT COMPLETED|Overall Study||20
8535707|NCT00286754|21043119|P3|COMPLETED|Overall Study||170
8535708|NCT00286754|21043120|P2|COMPLETED|Overall Study||159
8535709|NCT00286754|21043121|P1|COMPLETED|Overall Study||156
8535710|NCT00286754|21043119|P3|STARTED|Overall Study||180
8535711|NCT00286754|21043120|P2|STARTED|Overall Study||177
8535712|NCT00286754|21043121|P1|STARTED|Overall Study||176
8535713|NCT00286741|21043155|P2|NOT COMPLETED|Overall Study||17
8535714|NCT00286741|21043156|P1|NOT COMPLETED|Overall Study||11
8535715|NCT00286741|21043155|P2|COMPLETED|Overall Study||89
8535716|NCT00286741|21043156|P1|COMPLETED|Overall Study||122
8535717|NCT00286741|21043155|P2|STARTED|Overall Study||106
8535718|NCT00286741|21043156|P1|STARTED|Overall Study||133
8535719|NCT00286728|21043168|P2|NOT COMPLETED|Overall Study||29
8535720|NCT00286728|21043169|P1|NOT COMPLETED|Overall Study||36
8535721|NCT00286728|21043168|P2|COMPLETED|Overall Study||116
8535722|NCT00286728|21043169|P1|COMPLETED|Overall Study||106
8535723|NCT00286728|21043168|P2|STARTED|Overall Study||145
8535724|NCT00286728|21043169|P1|STARTED|Overall Study||142
8535725|NCT00286494|21043180|P3|NOT COMPLETED|Overall Study||39
8535726|NCT00286494|21043181|P2|NOT COMPLETED|Overall Study||44
8535727|NCT00286494|21043182|P1|NOT COMPLETED|Overall Study||26
8535728|NCT00286494|21043180|P3|COMPLETED|Overall Study||160
8535729|NCT00286494|21043181|P2|COMPLETED|Overall Study||153
8535730|NCT00286494|21043182|P1|COMPLETED|Overall Study||71
8535731|NCT00286494|21043180|P3|STARTED|Overall Study||199
8535732|NCT00286494|21043181|P2|STARTED|Overall Study||197
8535733|NCT00286494|21043182|P1|STARTED|Overall Study||97
8535734|NCT00286468|21043343|P3|NOT COMPLETED|Overall Study||50
8535735|NCT00286468|21043344|P2|NOT COMPLETED|Overall Study||50
8535736|NCT00286468|21043345|P1|NOT COMPLETED|Overall Study||37
8535737|NCT00286468|21043343|P3|COMPLETED|Overall Study||148
8535738|NCT00286468|21043344|P2|COMPLETED|Overall Study||153
8535739|NCT00286468|21043345|P1|COMPLETED|Overall Study||62
8535740|NCT00286468|21043343|P3|STARTED|Overall Study||198
8535741|NCT00286468|21043344|P2|STARTED|Overall Study||203
8535742|NCT00286468|21043345|P1|STARTED|Overall Study||99
8535743|NCT00286455|21043506|P3|NOT COMPLETED|Overall Study||24
8535744|NCT00286455|21043507|P2|NOT COMPLETED|Overall Study||28
8535745|NCT00286455|21043508|P1|NOT COMPLETED|Overall Study||25
8535746|NCT00286455|21043506|P3|COMPLETED|Overall Study||107
8535747|NCT00286455|21043507|P2|COMPLETED|Overall Study||105
8535748|NCT00286455|21043508|P1|COMPLETED|Overall Study||40
8535749|NCT00286455|21043506|P3|STARTED|Overall Study||131
8535750|NCT00286455|21043507|P2|STARTED|Overall Study||133
8535751|NCT00286455|21043508|P1|STARTED|Overall Study||65
8535752|NCT00286442|21043687|P3|NOT COMPLETED|Overall Study||32
8535753|NCT00286442|21043688|P2|NOT COMPLETED|Overall Study||45
8535754|NCT00286442|21043689|P1|NOT COMPLETED|Overall Study||37
8535755|NCT00286442|21043687|P3|COMPLETED|Overall Study||72
8535756|NCT00286442|21043688|P2|COMPLETED|Overall Study||165
8535757|NCT00286442|21043689|P1|COMPLETED|Overall Study||176
8535758|NCT00286442|21043687|P3|STARTED|Overall Study||104
8535759|NCT00286442|21043688|P2|STARTED|Overall Study||210
8535760|NCT00286442|21043689|P1|STARTED|Overall Study||213
8535761|NCT00286429|21043850|P3|NOT COMPLETED|Overall Study||52
8535762|NCT00286429|21043851|P2|NOT COMPLETED|Overall Study||48
8535763|NCT00286429|21043852|P1|NOT COMPLETED|Overall Study||75
8535764|NCT00286429|21043850|P3|COMPLETED|Overall Study||77
8535765|NCT00286429|21043851|P2|COMPLETED|Overall Study||83
8535766|NCT00286429|21043852|P1|COMPLETED|Overall Study||55
8535767|NCT00286429|21043850|P3|STARTED|Overall Study||129
8535768|NCT00286429|21043851|P2|STARTED|Overall Study||131
8535769|NCT00286429|21043852|P1|STARTED|Overall Study||130
8535770|NCT00286325|21043956|P1|NOT COMPLETED|Overall Study||0
8535771|NCT00286325|21043956|P1|COMPLETED|Overall Study||8
8535772|NCT00286325|21043956|P1|STARTED|Overall Study||8
8535773|NCT00286221|21043968|P4|NOT COMPLETED|Overall Study||6
8535774|NCT00286221|21043969|P3|NOT COMPLETED|Overall Study||9
8535775|NCT00286221|21043970|P2|NOT COMPLETED|Overall Study||5
8535776|NCT00286221|21043971|P1|NOT COMPLETED|Overall Study||10
8535777|NCT00286221|21043968|P4|COMPLETED|Overall Study||34
8535778|NCT00286221|21043969|P3|COMPLETED|Overall Study||31
8535779|NCT00286221|21043970|P2|COMPLETED|Overall Study||35
8535780|NCT00286221|21043971|P1|COMPLETED|Overall Study||29
8535781|NCT00286221|21043968|P4|STARTED|Overall Study||40
8535782|NCT00286221|21043969|P3|STARTED|Overall Study||40
8535783|NCT00286221|21043970|P2|STARTED|Overall Study||40
8535784|NCT00286221|21043971|P1|STARTED|Overall Study||39
8535785|NCT00286182|21043987|P2|NOT COMPLETED|Overall Study||3
8535786|NCT00286182|21043988|P1|NOT COMPLETED|Overall Study||5
8535787|NCT00286182|21043987|P2|COMPLETED|Overall Study||25
8535788|NCT00286182|21043988|P1|COMPLETED|Overall Study||23
8535789|NCT00286182|21043987|P2|STARTED|Overall Study||28
8535790|NCT00286182|21043988|P1|STARTED|Overall Study||28
8535791|NCT00286156|21043997|P3|NOT COMPLETED|Overall Study||1
8535792|NCT00286156|21043998|P2|NOT COMPLETED|Overall Study||1
8535793|NCT00286156|21043999|P1|NOT COMPLETED|Overall Study||2
8535794|NCT00286156|21043997|P3|COMPLETED|Overall Study||9
8535795|NCT00286156|21043998|P2|COMPLETED|Overall Study||9
8535796|NCT00286156|21043999|P1|COMPLETED|Overall Study||8
8535797|NCT00286156|21043997|P3|STARTED|Overall Study||10
8535798|NCT00286156|21043998|P2|STARTED|Overall Study||10
8535799|NCT00286156|21043999|P1|STARTED|Overall Study||10
8535800|NCT00286091|21044012|P2|NOT COMPLETED|Open-label Treatment Phase||71
8535801|NCT00286091|21044013|P1|NOT COMPLETED|Open-label Treatment Phase||77
8535802|NCT00286091|21044012|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
8535803|NCT00286091|21044013|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
8535804|NCT00286091|21044012|P2|Received Treatment|Open-label Treatment Phase||101
8535805|NCT00286091|21044013|P1|Received Treatment|Open-label Treatment Phase||109
8535806|NCT00286091|21044012|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
8535807|NCT00286091|21044013|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
8535808|NCT00286091|21044012|P2|NOT COMPLETED|Double-blind Treatment Phase||593
8535809|NCT00286091|21044013|P1|NOT COMPLETED|Double-blind Treatment Phase||584
8535810|NCT00286091|21044012|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
8535811|NCT00286091|21044013|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
8535812|NCT00286091|21044012|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
8535813|NCT00286091|21044013|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
8535814|NCT00286091|21044012|P2|Received Treatment|Double-blind Treatment Phase||716
8535815|NCT00286091|21044013|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
8535816|NCT00286091|21044012|P2|STARTED|Double-blind Treatment Phase||716
8535817|NCT00286091|21044013|P1|STARTED|Double-blind Treatment Phase||716
8535818|NCT00286078|21044027|P2|NOT COMPLETED|Overall Study||34
8535819|NCT00286078|21044028|P1|NOT COMPLETED|Overall Study||32
8535820|NCT00286078|21044027|P2|COMPLETED|Overall Study||34
8535821|NCT00286078|21044028|P1|COMPLETED|Overall Study||40
8535822|NCT00286078|21044027|P2|12 Weeks|Overall Study||62
8535823|NCT00286078|21044028|P1|12 Weeks|Overall Study||63
8535824|NCT00286078|21044027|P2|STARTED|Overall Study||68
8535825|NCT00286078|21044028|P1|STARTED|Overall Study||72
8535826|NCT00285857|21044036|P1|NOT COMPLETED|Overall Study||4
8535827|NCT00285857|21044036|P1|COMPLETED|Overall Study||26
8535828|NCT00285857|21044036|P1|STARTED|Overall Study||30
8535829|NCT00285818|21044049|P2|NOT COMPLETED|Overall Study||2
8535830|NCT00285818|21044050|P1|NOT COMPLETED|Overall Study||4
8535831|NCT00285818|21044049|P2|COMPLETED|Overall Study||3
8535832|NCT00285818|21044050|P1|COMPLETED|Overall Study||2
8535833|NCT00285818|21044049|P2|STARTED|Overall Study||5
8535834|NCT00285818|21044050|P1|STARTED|Overall Study||6
8535835|NCT00285779|21044058|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
8535836|NCT00285779|21044059|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
8535837|NCT00285779|21044058|P2|COMPLETED|Follow-up Period (wk 24-32)||10
8535838|NCT00285779|21044059|P1|COMPLETED|Follow-up Period (wk 24-32)||8
8535839|NCT00285779|21044058|P2|STARTED|Follow-up Period (wk 24-32)||10
8535840|NCT00285779|21044059|P1|STARTED|Follow-up Period (wk 24-32)||9
8535841|NCT00285779|21044058|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
8535842|NCT00285779|21044059|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
8535843|NCT00285779|21044058|P2|COMPLETED|Open Label Period (wk 12-24)||10
8535844|NCT00285779|21044059|P1|COMPLETED|Open Label Period (wk 12-24)||9
8535845|NCT00285779|21044058|P2|STARTED|Open Label Period (wk 12-24)||12
8535846|NCT00285779|21044059|P1|STARTED|Open Label Period (wk 12-24)||11
8535847|NCT00285779|21044058|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
8535848|NCT00285779|21044059|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
8535849|NCT00285779|21044058|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
8535850|NCT00285779|21044059|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
8535851|NCT00285779|21044058|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
8535852|NCT00285779|21044059|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
8535853|NCT00285649|21044095|P3|NOT COMPLETED|Overall Study||6
8535854|NCT00285649|21044096|P2|NOT COMPLETED|Overall Study||6
8535855|NCT00285649|21044097|P1|NOT COMPLETED|Overall Study||9
8535856|NCT00285649|21044095|P3|COMPLETED|Overall Study||42
8535857|NCT00285649|21044096|P2|COMPLETED|Overall Study||66
8535858|NCT00285649|21044097|P1|COMPLETED|Overall Study||63
8535859|NCT00285649|21044095|P3|STARTED|Overall Study||48
8535860|NCT00285649|21044096|P2|STARTED|Overall Study||72
8535861|NCT00285649|21044097|P1|STARTED|Overall Study||72
8535862|NCT00285584|21044107|P2|NOT COMPLETED|Month 9||3
8535863|NCT00285584|21044108|P1|NOT COMPLETED|Month 9||1
8535864|NCT00285584|21044107|P2|COMPLETED|Month 9||14
8535865|NCT00285584|21044108|P1|COMPLETED|Month 9||15
8535866|NCT00285584|21044107|P2|STARTED|Month 9||17
8535867|NCT00285584|21044108|P1|STARTED|Month 9||16
8535868|NCT00285584|21044107|P2|NOT COMPLETED|Month 6||1
8535869|NCT00285584|21044108|P1|NOT COMPLETED|Month 6||0
8535870|NCT00285584|21044107|P2|COMPLETED|Month 6||17
8535871|NCT00285584|21044108|P1|COMPLETED|Month 6||16
8535872|NCT00285584|21044107|P2|STARTED|Month 6||18
8535873|NCT00285584|21044108|P1|STARTED|Month 6||16
8535874|NCT00285584|21044107|P2|NOT COMPLETED|Month 3||3
8535875|NCT00285584|21044108|P1|NOT COMPLETED|Month 3||4
8535876|NCT00285584|21044107|P2|COMPLETED|Month 3||18
8535877|NCT00285584|21044108|P1|COMPLETED|Month 3||16
8535878|NCT00285584|21044107|P2|STARTED|Month 3||21
8535879|NCT00285584|21044108|P1|STARTED|Month 3||20
8535880|NCT00285584|21044107|P2|NOT COMPLETED|Enrollment (Month 0)||0
8535881|NCT00285584|21044108|P1|NOT COMPLETED|Enrollment (Month 0)||0
8535882|NCT00285584|21044107|P2|COMPLETED|Enrollment (Month 0)||21
8535883|NCT00285584|21044108|P1|COMPLETED|Enrollment (Month 0)||20
8535884|NCT00285584|21044107|P2|STARTED|Enrollment (Month 0)||21
8535885|NCT00285584|21044108|P1|STARTED|Enrollment (Month 0)||20
8535886|NCT00285467|21044122|P2|NOT COMPLETED|Overall Study||0
8535887|NCT00285467|21044123|P1|NOT COMPLETED|Overall Study||0
8535888|NCT00285467|21044122|P2|COMPLETED|Overall Study||22
8535889|NCT00285467|21044123|P1|COMPLETED|Overall Study||25
8535890|NCT00285467|21044122|P2|STARTED|Overall Study||22
8535891|NCT00285467|21044123|P1|STARTED|Overall Study||25
8535892|NCT00285246|21044131|P1|NOT COMPLETED|Overall Study||48
8535893|NCT00285246|21044131|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
8535894|NCT00285246|21044131|P1|STARTED|Overall Study||838
8535895|NCT00285207|21044140|P2|NOT COMPLETED|Overall Study||6
8535896|NCT00285207|21044141|P1|NOT COMPLETED|Overall Study||9
8535897|NCT00285207|21044140|P2|COMPLETED|Overall Study||71
8535898|NCT00285207|21044141|P1|COMPLETED|Overall Study||61
8535899|NCT00285207|21044140|P2|Treated|Overall Study||75
8535900|NCT00285207|21044141|P1|Treated|Overall Study||63
8535901|NCT00285207|21044140|P2|STARTED|Overall Study||77
8535902|NCT00285207|21044141|P1|STARTED|Overall Study||70
8535903|NCT00285012|21044149|P2|NOT COMPLETED|Received Study Tx||94
8535904|NCT00285012|21044150|P1|NOT COMPLETED|Received Study Tx||72
8535905|NCT00285012|21044149|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
8535906|NCT00285012|21044150|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
8535907|NCT00285012|21044149|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
8535908|NCT00285012|21044150|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
8535909|NCT00285012|21044149|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
8535910|NCT00285012|21044150|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
8535911|NCT00285012|21044149|P2|STARTED|Received Study Tx||251
8535912|NCT00285012|21044150|P1|STARTED|Received Study Tx||248
8535913|NCT00285012|21044149|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
8535914|NCT00285012|21044150|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
8535915|NCT00285012|21044149|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
8535916|NCT00285012|21044150|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
8535917|NCT00285012|21044149|P2|STARTED|Assigned to Study Treatment (Tx)||254
8535918|NCT00285012|21044150|P1|STARTED|Assigned to Study Treatment (Tx)||250
8535919|NCT00284934|21044176|P2|NOT COMPLETED|Overall Study||3
8535920|NCT00284934|21044177|P1|NOT COMPLETED|Overall Study||4
8535921|NCT00284934|21044176|P2|COMPLETED|Overall Study||43
8535922|NCT00284934|21044177|P1|COMPLETED|Overall Study||44
8535923|NCT00284934|21044176|P2|Intent-to-treat Population (ITT)|Overall Study||45
8535924|NCT00284934|21044177|P1|Intent-to-treat Population (ITT)|Overall Study||47
8535925|NCT00284934|21044176|P2|STARTED|Overall Study||46
8535926|NCT00284934|21044177|P1|STARTED|Overall Study||48
8535927|NCT00284856|21044192|P3|NOT COMPLETED|Overall Study||60
8535928|NCT00284856|21044193|P2|NOT COMPLETED|Overall Study||50
8535929|NCT00284856|21044194|P1|NOT COMPLETED|Overall Study||51
8535930|NCT00284856|21044192|P3|COMPLETED|Overall Study||276
8535931|NCT00284856|21044193|P2|COMPLETED|Overall Study||286
8535932|NCT00284856|21044194|P1|COMPLETED|Overall Study||296
8535933|NCT00284856|21044192|P3|STARTED|Overall Study||336
8535934|NCT00284856|21044193|P2|STARTED|Overall Study||336
8535935|NCT00284856|21044194|P1|STARTED|Overall Study||347
8535936|NCT00284739|21044210|P2|NOT COMPLETED|Overall Study||0
8535937|NCT00284739|21044211|P1|NOT COMPLETED|Overall Study||0
8535938|NCT00284739|21044210|P2|COMPLETED|Overall Study||9
8535939|NCT00284739|21044211|P1|COMPLETED|Overall Study||11
8535940|NCT00284739|21044210|P2|STARTED|Overall Study||9
8535941|NCT00284739|21044211|P1|STARTED|Overall Study||11
8535942|NCT00284557|21044223|P2|NOT COMPLETED|Overall Study||13
8535943|NCT00284557|21044224|P1|NOT COMPLETED|Overall Study||9
8535944|NCT00284557|21044223|P2|COMPLETED|Overall Study||50
8535945|NCT00284557|21044224|P1|COMPLETED|Overall Study||58
8535946|NCT00284557|21044223|P2|STARTED|Overall Study||63
8535947|NCT00284557|21044224|P1|STARTED|Overall Study||67
8535948|NCT00284518|21044236|P4|NOT COMPLETED|Overall Study||33
8535949|NCT00284518|21044237|P3|NOT COMPLETED|Overall Study||28
8535950|NCT00284518|21044238|P2|NOT COMPLETED|Overall Study||28
8535951|NCT00284518|21044239|P1|NOT COMPLETED|Overall Study||26
8535952|NCT00284518|21044236|P4|COMPLETED|Overall Study||61
8535953|NCT00284518|21044237|P3|COMPLETED|Overall Study||67
8535954|NCT00284518|21044238|P2|COMPLETED|Overall Study||66
8535955|NCT00284518|21044239|P1|COMPLETED|Overall Study||71
8535956|NCT00284518|21044236|P4|STARTED|Overall Study||94
8535957|NCT00284518|21044237|P3|STARTED|Overall Study||95
8535958|NCT00284518|21044238|P2|STARTED|Overall Study||94
8535959|NCT00284518|21044239|P1|STARTED|Overall Study||97
8535960|NCT00284180|21044279|P2|NOT COMPLETED|Overall Study||4
8535961|NCT00284180|21044280|P1|NOT COMPLETED|Overall Study||0
8535962|NCT00284180|21044279|P2|COMPLETED|Overall Study||17
8535963|NCT00284180|21044280|P1|COMPLETED|Overall Study||11
8535964|NCT00284180|21044279|P2|STARTED|Overall Study||21
8535965|NCT00284180|21044280|P1|STARTED|Overall Study||11
8535966|NCT00284154|21044286|P1|NOT COMPLETED|Overall Study||42
8535967|NCT00284154|21044286|P1|COMPLETED|Overall Study||9
8535968|NCT00284154|21044286|P1|STARTED|Overall Study||51
8535969|NCT00284141|21044293|P1|NOT COMPLETED|Overall Study||98
8535970|NCT00284141|21044293|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
8535971|NCT00284141|21044293|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
8535972|NCT00284141|21044293|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
8535973|NCT00284141|21044293|P1|STARTED|Overall Study||98
8535974|NCT00284089|21044316|P4|NOT COMPLETED|Extension Phase||12
8535975|NCT00284089|21044317|P3|NOT COMPLETED|Extension Phase||6
8535976|NCT00284089|21044318|P2|NOT COMPLETED|Extension Phase||0
8535977|NCT00284089|21044319|P1|NOT COMPLETED|Extension Phase||2
8535978|NCT00284089|21044316|P4|COMPLETED|Extension Phase||21
8535979|NCT00284089|21044317|P3|COMPLETED|Extension Phase||22
8535980|NCT00284089|21044318|P2|COMPLETED|Extension Phase||6
8535981|NCT00284089|21044319|P1|COMPLETED|Extension Phase||1
8535982|NCT00284089|21044316|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
8535983|NCT00284089|21044317|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
8535984|NCT00284089|21044318|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
8535985|NCT00284089|21044319|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
8535986|NCT00284089|21044316|P4|NOT COMPLETED|Multiple Dose Phase||4
8535987|NCT00284089|21044317|P3|NOT COMPLETED|Multiple Dose Phase||4
8535988|NCT00284089|21044318|P2|NOT COMPLETED|Multiple Dose Phase||0
8535989|NCT00284089|21044319|P1|NOT COMPLETED|Multiple Dose Phase||1
8535990|NCT00284089|21044316|P4|COMPLETED|Multiple Dose Phase||37
8535991|NCT00284089|21044317|P3|COMPLETED|Multiple Dose Phase||31
8535992|NCT00284089|21044318|P2|COMPLETED|Multiple Dose Phase||6
8535993|NCT00284089|21044319|P1|COMPLETED|Multiple Dose Phase||4
8535994|NCT00284089|21044316|P4|STARTED|Multiple Dose Phase||41
8535995|NCT00284089|21044317|P3|STARTED|Multiple Dose Phase||35
8535996|NCT00284089|21044318|P2|STARTED|Multiple Dose Phase||6
8535997|NCT00284089|21044319|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
8535998|NCT00284089|21044316|P4|NOT COMPLETED|Single Dose Phase||0
8535999|NCT00284089|21044317|P3|NOT COMPLETED|Single Dose Phase||0
8536000|NCT00284089|21044318|P2|NOT COMPLETED|Single Dose Phase||0
8536001|NCT00284089|21044319|P1|NOT COMPLETED|Single Dose Phase||0
8536002|NCT00284089|21044316|P4|COMPLETED|Single Dose Phase||0
8536003|NCT00284089|21044317|P3|COMPLETED|Single Dose Phase||0
8536004|NCT00284089|21044318|P2|COMPLETED|Single Dose Phase||6
8536005|NCT00284089|21044319|P1|COMPLETED|Single Dose Phase||6
8536006|NCT00284089|21044316|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
8536007|NCT00284089|21044317|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
8536008|NCT00284089|21044318|P2|STARTED|Single Dose Phase||6
8536009|NCT00284089|21044319|P1|STARTED|Single Dose Phase||6
8536010|NCT00284050|21044348|P3|NOT COMPLETED|Overall Study||9
8536011|NCT00284050|21044349|P2|NOT COMPLETED|Overall Study||5
8536012|NCT00284050|21044350|P1|NOT COMPLETED|Overall Study||5
8536013|NCT00284050|21044348|P3|COMPLETED|Overall Study||40
8536014|NCT00284050|21044349|P2|COMPLETED|Overall Study||46
8536015|NCT00284050|21044350|P1|COMPLETED|Overall Study||46
8536016|NCT00284050|21044348|P3|STARTED|Overall Study||49
8536017|NCT00284050|21044349|P2|STARTED|Overall Study||51
8536018|NCT00284050|21044350|P1|STARTED|Overall Study||51
8536019|NCT00283959|21044364|P1|NOT COMPLETED|Extension Period||1
8536020|NCT00283959|21044364|P1|COMPLETED|Extension Period||3
8536021|NCT00283959|21044364|P1|STARTED|Extension Period||4
8536022|NCT00283959|21044364|P1|NOT COMPLETED|Treatment Period||0
8536023|NCT00283959|21044364|P1|COMPLETED|Treatment Period||4
8536024|NCT00283959|21044364|P1|Pharmacodynamics (PD) Population|Treatment Period||4
8536025|NCT00283959|21044364|P1|Safety Population|Treatment Period||4
8536026|NCT00283959|21044364|P1|STARTED|Treatment Period||4
8536027|NCT00283933|21044369|P1|NOT COMPLETED|Extension Period||0
8536028|NCT00283933|21044369|P1|COMPLETED|Extension Period||5
8536029|NCT00283933|21044369|P1|STARTED|Extension Period||5
8536030|NCT00283933|21044369|P1|NOT COMPLETED|Treatment Period||0
8536031|NCT00283933|21044369|P1|COMPLETED|Treatment Period||5
8536032|NCT00283933|21044369|P1|Pharmacodynamic (PD) Population|Treatment Period||5
8536033|NCT00283933|21044369|P1|Safety Population|Treatment Period||5
8536034|NCT00283933|21044369|P1|STARTED|Treatment Period||5
8536035|NCT00283868|21044376|P2|NOT COMPLETED|Overall Study||8
8536036|NCT00283868|21044377|P1|NOT COMPLETED|Overall Study||7
8536037|NCT00283868|21044376|P2|COMPLETED|Overall Study||103
8536038|NCT00283868|21044377|P1|COMPLETED|Overall Study||104
8536039|NCT00283868|21044376|P2|STARTED|Overall Study||111
8536040|NCT00283868|21044377|P1|STARTED|Overall Study||111
8536041|NCT00283842|21044394|P5|NOT COMPLETED|Overall Study||15
8536042|NCT00283842|21044395|P4|NOT COMPLETED|Overall Study||27
8536043|NCT00283842|21044396|P3|NOT COMPLETED|Overall Study||31
8536044|NCT00283842|21044397|P2|NOT COMPLETED|Overall Study||18
8536045|NCT00283842|21044398|P1|NOT COMPLETED|Overall Study||12
8536046|NCT00283842|21044394|P5|COMPLETED|Overall Study||75
8536047|NCT00283842|21044395|P4|COMPLETED|Overall Study||42
8536048|NCT00283842|21044396|P3|COMPLETED|Overall Study||68
8536049|NCT00283842|21044397|P2|COMPLETED|Overall Study||69
8536050|NCT00283842|21044398|P1|COMPLETED|Overall Study||51
8536051|NCT00283842|21044394|P5|STARTED|Overall Study||90
8536052|NCT00283842|21044395|P4|STARTED|Overall Study||69
8536053|NCT00283842|21044396|P3|STARTED|Overall Study||99
8536054|NCT00283842|21044397|P2|STARTED|Overall Study||87
8536055|NCT00283842|21044398|P1|STARTED|Overall Study||63
8536056|NCT00283816|21044417|P2|NOT COMPLETED|Overall Study||2
8536057|NCT00283816|21044418|P1|NOT COMPLETED|Overall Study||2
8536058|NCT00283816|21044417|P2|COMPLETED|Overall Study||16
8536059|NCT00283816|21044418|P1|COMPLETED|Overall Study||16
8536060|NCT00283816|21044417|P2|STARTED|Overall Study||18
8536061|NCT00283816|21044418|P1|STARTED|Overall Study||18
8536062|NCT00283803|21044430|P1|NOT COMPLETED|Overall Study||13
8536063|NCT00283803|21044430|P1|COMPLETED|Overall Study||19
8536064|NCT00283803|21044430|P1|STARTED|Overall Study||32
8536065|NCT00283712|21044438|P2|NOT COMPLETED|Overall Study||1
8536066|NCT00283712|21044439|P1|NOT COMPLETED|Overall Study||0
8536067|NCT00283712|21044438|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
8536068|NCT00283712|21044439|P1|COMPLETED|Overall Study||10
8536069|NCT00283712|21044438|P2|Per-Protocol Sample|Overall Study||7
8536070|NCT00283712|21044439|P1|Per-Protocol Sample|Overall Study||6
8536071|NCT00283712|21044438|P2|Safety Sample|Overall Study||10
8536072|NCT00283712|21044439|P1|Safety Sample|Overall Study||10
8536073|NCT00283712|21044438|P2|Intent-to-treat Sample|Overall Study||10
8536074|NCT00283712|21044439|P1|Intent-to-treat Sample|Overall Study||10
8536075|NCT00283712|21044438|P2|STARTED|Overall Study||10
8536076|NCT00283712|21044439|P1|STARTED|Overall Study||10
8536077|NCT00283686|21044477|P4|NOT COMPLETED|Overall Study||32
8536078|NCT00283686|21044478|P3|NOT COMPLETED|Overall Study||33
8536079|NCT00283686|21044479|P2|NOT COMPLETED|Overall Study||41
8536080|NCT00283686|21044480|P1|NOT COMPLETED|Overall Study||29
8536081|NCT00283686|21044477|P4|COMPLETED|Overall Study||109
8536082|NCT00283686|21044478|P3|COMPLETED|Overall Study||111
8536083|NCT00283686|21044479|P2|COMPLETED|Overall Study||92
8536084|NCT00283686|21044480|P1|COMPLETED|Overall Study||111
8536085|NCT00283686|21044477|P4|STARTED|Overall Study||141
8536086|NCT00283686|21044478|P3|STARTED|Overall Study||144
8536087|NCT00283686|21044479|P2|STARTED|Overall Study||133
8536088|NCT00283686|21044480|P1|STARTED|Overall Study||140
8536089|NCT00283595|21044524|P2|NOT COMPLETED|Overall Study||2
8536090|NCT00283595|21044525|P1|NOT COMPLETED|Overall Study||1
8536091|NCT00283595|21044524|P2|COMPLETED|Overall Study||9
8536092|NCT00283595|21044525|P1|COMPLETED|Overall Study||9
8536093|NCT00283595|21044524|P2|STARTED|Overall Study||11
8536094|NCT00283595|21044525|P1|STARTED|Overall Study||10
8536095|NCT00283504|21044535|P2|NOT COMPLETED|Overall Study||0
8536096|NCT00283504|21044536|P1|NOT COMPLETED|Overall Study||0
8536097|NCT00283504|21044535|P2|COMPLETED|Overall Study||6
8536098|NCT00283504|21044536|P1|COMPLETED|Overall Study||7
8536099|NCT00283504|21044535|P2|STARTED|Overall Study||6
8536100|NCT00283504|21044536|P1|STARTED|Overall Study||7
8536101|NCT00283439|21044550|P4|NOT COMPLETED|Overall Study||9
8536102|NCT00283439|21044551|P3|NOT COMPLETED|Overall Study||11
8536103|NCT00283439|21044552|P2|NOT COMPLETED|Overall Study||11
8536104|NCT00283439|21044553|P1|NOT COMPLETED|Overall Study||8
8536105|NCT00283439|21044550|P4|COMPLETED|Overall Study||0
8536106|NCT00283439|21044551|P3|COMPLETED|Overall Study||0
8536107|NCT00283439|21044552|P2|COMPLETED|Overall Study||0
8536108|NCT00283439|21044553|P1|COMPLETED|Overall Study||0
8536109|NCT00283439|21044550|P4|STARTED|Overall Study||9
8536110|NCT00283439|21044551|P3|STARTED|Overall Study||11
8536111|NCT00283439|21044552|P2|STARTED|Overall Study||11
8536112|NCT00283439|21044553|P1|STARTED|Overall Study||8
8536113|NCT00283400|21044579|P4|NOT COMPLETED|Overall Study||0
8536114|NCT00283400|21044580|P3|NOT COMPLETED|Overall Study||1
8536115|NCT00283400|21044581|P2|NOT COMPLETED|Overall Study||1
8536116|NCT00283400|21044582|P1|NOT COMPLETED|Overall Study||2
8536117|NCT00283400|21044579|P4|COMPLETED|Overall Study||0
8536118|NCT00283400|21044580|P3|COMPLETED|Overall Study||6
8536119|NCT00283400|21044581|P2|COMPLETED|Overall Study||19
8536120|NCT00283400|21044582|P1|COMPLETED|Overall Study||18
8536121|NCT00283400|21044579|P4|STARTED|Overall Study||0
8536122|NCT00283400|21044580|P3|STARTED|Overall Study||7
8536123|NCT00283400|21044581|P2|STARTED|Overall Study||20
8536124|NCT00283400|21044582|P1|STARTED|Overall Study||20
8536125|NCT00283387|21044600|P2|NOT COMPLETED|Second Intervention||0
8536126|NCT00283387|21044601|P1|NOT COMPLETED|Second Intervention||0
8536127|NCT00283387|21044600|P2|COMPLETED|Second Intervention||5
8536128|NCT00283387|21044601|P1|COMPLETED|Second Intervention||5
8536129|NCT00283387|21044600|P2|STARTED|Second Intervention||5
8536130|NCT00283387|21044601|P1|STARTED|Second Intervention||5
8536131|NCT00283387|21044600|P2|NOT COMPLETED|Washout Period of 2 Months||0
8536132|NCT00283387|21044601|P1|NOT COMPLETED|Washout Period of 2 Months||0
8536133|NCT00283387|21044600|P2|COMPLETED|Washout Period of 2 Months||5
8536134|NCT00283387|21044601|P1|COMPLETED|Washout Period of 2 Months||5
8536135|NCT00283387|21044600|P2|STARTED|Washout Period of 2 Months||5
8536136|NCT00283387|21044601|P1|STARTED|Washout Period of 2 Months||5
8536137|NCT00283387|21044600|P2|NOT COMPLETED|First Intervention||2
8536138|NCT00283387|21044601|P1|NOT COMPLETED|First Intervention||1
8536139|NCT00283387|21044600|P2|COMPLETED|First Intervention||5
8536140|NCT00283387|21044601|P1|COMPLETED|First Intervention||5
8536141|NCT00283387|21044600|P2|STARTED|First Intervention||7
8536142|NCT00283387|21044601|P1|STARTED|First Intervention||6
8536143|NCT00283296|21044607|P1|NOT COMPLETED|Overall Study||5
8536144|NCT00283296|21044607|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
8536145|NCT00283296|21044607|P1|STARTED|Overall Study||14
8536158|NCT00283244|21044638|P3|NOT COMPLETED|Overall Study||51
8536159|NCT00283244|21044639|P2|NOT COMPLETED|Overall Study||51
8536160|NCT00283244|21044640|P1|NOT COMPLETED|Overall Study||18
8536161|NCT00283244|21044638|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
8536162|NCT00283244|21044639|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
8536163|NCT00283244|21044640|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
8536164|NCT00283244|21044638|P3|STARTED|Overall Study||51
8536165|NCT00283244|21044639|P2|STARTED|Overall Study||51
8536166|NCT00283244|21044640|P1|STARTED|Overall Study||44
8536167|NCT00283075|21044660|P2|NOT COMPLETED|Overall Study||0
8536168|NCT00283075|21044661|P1|NOT COMPLETED|Overall Study||0
8536169|NCT00283075|21044660|P2|COMPLETED|Overall Study||6
8536170|NCT00283075|21044661|P1|COMPLETED|Overall Study||25
8536171|NCT00283075|21044660|P2|STARTED|Overall Study||6
8536172|NCT00283075|21044661|P1|STARTED|Overall Study||25
8536173|NCT00283062|21044676|P4|NOT COMPLETED|Overall Study||49
8536174|NCT00283062|21044677|P3|NOT COMPLETED|Overall Study||41
8536175|NCT00283062|21044678|P2|NOT COMPLETED|Overall Study||7
8536176|NCT00283062|21044679|P1|NOT COMPLETED|Overall Study||12
8536177|NCT00283062|21044676|P4|COMPLETED|Overall Study||13
8536178|NCT00283062|21044677|P3|COMPLETED|Overall Study||15
8536179|NCT00283062|21044678|P2|COMPLETED|Overall Study||48
8536180|NCT00283062|21044679|P1|COMPLETED|Overall Study||43
8536181|NCT00283062|21044676|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
8536182|NCT00283062|21044677|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
8536183|NCT00283062|21044678|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
8536184|NCT00283062|21044679|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
8536185|NCT00283062|21044676|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
8536186|NCT00283062|21044677|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
8536187|NCT00283062|21044678|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
8536188|NCT00283062|21044679|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
8536189|NCT00283062|21044676|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
8536190|NCT00283062|21044677|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
8536191|NCT00283062|21044678|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
8536192|NCT00283062|21044679|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
8536193|NCT00283062|21044676|P4|STARTED|Overall Study||62
8536194|NCT00283062|21044677|P3|STARTED|Overall Study||56
8536195|NCT00283062|21044678|P2|STARTED|Overall Study||55
8536196|NCT00283062|21044679|P1|STARTED|Overall Study||55
8536197|NCT00283049|21044712|P3|NOT COMPLETED|Overall Study||54
8536198|NCT00283049|21044713|P2|NOT COMPLETED|Overall Study||45
8536199|NCT00283049|21044714|P1|NOT COMPLETED|Overall Study||58
8536200|NCT00283049|21044712|P3|COMPLETED|Overall Study||76
8536201|NCT00283049|21044713|P2|COMPLETED|Overall Study||83
8536202|NCT00283049|21044714|P1|COMPLETED|Overall Study||70
8536203|NCT00283049|21044712|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
8536204|NCT00283049|21044713|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
8536205|NCT00283049|21044714|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
8536206|NCT00282984|21044742|P2|NOT COMPLETED|Overall Study||61
8536207|NCT00282984|21044743|P1|NOT COMPLETED|Overall Study||51
8536208|NCT00282984|21044742|P2|COMPLETED|Overall Study||289
8536209|NCT00282984|21044743|P1|COMPLETED|Overall Study||302
8536210|NCT00282984|21044742|P2|STARTED|Overall Study||350
8536211|NCT00282984|21044743|P1|STARTED|Overall Study||353
8536212|NCT00282971|21044769|P2|NOT COMPLETED|Overall Study||22
8536213|NCT00282971|21044770|P1|NOT COMPLETED|Overall Study||34
8536214|NCT00282971|21044769|P2|COMPLETED|Overall Study||149
8536215|NCT00282971|21044770|P1|COMPLETED|Overall Study||146
8536216|NCT00282971|21044769|P2|STARTED|Overall Study||171
8536217|NCT00282971|21044770|P1|STARTED|Overall Study||180
8536218|NCT00282919|21044780|P1|NOT COMPLETED|Overall Study||7
8536219|NCT00282919|21044780|P1|COMPLETED|Overall Study||103
8536220|NCT00282919|21044780|P1|STARTED|Overall Study||110
8536221|NCT00282867|21044795|P3|NOT COMPLETED|Overall Study||0
8536222|NCT00282867|21044796|P2|NOT COMPLETED|Overall Study||1
8536223|NCT00282867|21044797|P1|NOT COMPLETED|Overall Study||1
8536224|NCT00282867|21044795|P3|COMPLETED|Overall Study||25
8536225|NCT00282867|21044796|P2|COMPLETED|Overall Study||24
8536226|NCT00282867|21044797|P1|COMPLETED|Overall Study||23
8536227|NCT00282867|21044795|P3|STARTED|Overall Study||25
8536228|NCT00282867|21044796|P2|STARTED|Overall Study||25
8536229|NCT00282867|21044797|P1|STARTED|Overall Study||24
8536230|NCT00282841|21044811|P1|NOT COMPLETED|Overall Study||0
8536231|NCT00282841|21044811|P1|COMPLETED|Overall Study||61
8536232|NCT00282841|21044811|P1|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
8536233|NCT00282828|21044819|P3|NOT COMPLETED|Overall Study||9
8536234|NCT00282828|21044820|P2|NOT COMPLETED|Overall Study||12
8536235|NCT00282828|21044821|P1|NOT COMPLETED|Overall Study||6
8536236|NCT00282828|21044819|P3|COMPLETED|Overall Study||50
8536237|NCT00282828|21044820|P2|COMPLETED|Overall Study||47
8536238|NCT00282828|21044821|P1|COMPLETED|Overall Study||57
8536239|NCT00282828|21044819|P3|STARTED|Overall Study||59
8536240|NCT00282828|21044820|P2|STARTED|Overall Study||59
8536241|NCT00282828|21044821|P1|STARTED|Overall Study||63
8536242|NCT00282815|21044834|P2|NOT COMPLETED|Overall Study||6
8536243|NCT00282815|21044835|P1|NOT COMPLETED|Overall Study||7
8536244|NCT00282815|21044834|P2|COMPLETED|Overall Study||11
8536245|NCT00282815|21044835|P1|COMPLETED|Overall Study||8
8536246|NCT00282815|21044834|P2|STARTED|Overall Study||17
8536247|NCT00282815|21044835|P1|STARTED|Overall Study||15
8536248|NCT00282672|21044848|P4|NOT COMPLETED|5 Year: Follow up||5
8536249|NCT00282672|21044849|P3|NOT COMPLETED|5 Year: Follow up||0
8536250|NCT00282672|21044850|P2|NOT COMPLETED|5 Year: Follow up||5
8536251|NCT00282672|21044851|P1|NOT COMPLETED|5 Year: Follow up||1
8536252|NCT00282672|21044848|P4|COMPLETED|5 Year: Follow up||20
8536253|NCT00282672|21044849|P3|COMPLETED|5 Year: Follow up||12
8536254|NCT00282672|21044850|P2|COMPLETED|5 Year: Follow up||27
8536255|NCT00282672|21044851|P1|COMPLETED|5 Year: Follow up||14
8536256|NCT00282672|21044848|P4|STARTED|5 Year: Follow up|11 withdrew|25
8536257|NCT00282672|21044849|P3|STARTED|5 Year: Follow up|3 withdrew|12
8536258|NCT00282672|21044850|P2|STARTED|5 Year: Follow up|7 withdrew|32
8536259|NCT00282672|21044851|P1|STARTED|5 Year: Follow up|1 withdrew|15
8536260|NCT00282672|21044848|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
8536261|NCT00282672|21044849|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
8536262|NCT00282672|21044850|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
8536263|NCT00282672|21044851|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
8536264|NCT00282672|21044848|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
8536265|NCT00282672|21044849|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
8536266|NCT00282672|21044850|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
8536267|NCT00282672|21044851|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
8536268|NCT00282672|21044848|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
8536269|NCT00282672|21044849|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
8536270|NCT00282672|21044850|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
8536271|NCT00282672|21044851|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
8536272|NCT00282672|21044848|P4|NOT COMPLETED|1 Year||4
8536273|NCT00282672|21044849|P3|NOT COMPLETED|1 Year||1
8536274|NCT00282672|21044850|P2|NOT COMPLETED|1 Year||2
8536275|NCT00282672|21044851|P1|NOT COMPLETED|1 Year||3
8536276|NCT00282672|21044848|P4|COMPLETED|1 Year||38
8536277|NCT00282672|21044849|P3|COMPLETED|1 Year||20
8536278|NCT00282672|21044850|P2|COMPLETED|1 Year||40
8536279|NCT00282672|21044851|P1|COMPLETED|1 Year||19
8536280|NCT00282672|21044848|P4|STARTED|1 Year||42
8536281|NCT00282672|21044849|P3|STARTED|1 Year||21
8536282|NCT00282672|21044850|P2|STARTED|1 Year||42
8536283|NCT00282672|21044851|P1|STARTED|1 Year||22
8536284|NCT00282568|21044899|P1|NOT COMPLETED|Extended Treatment Period||24
8536285|NCT00282568|21044899|P1|COMPLETED|Extended Treatment Period||42
8536286|NCT00282568|21044899|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
8536287|NCT00282568|21044899|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
8536288|NCT00282568|21044899|P1|COMPLETED|Pharmacokinetic Treatment Period||67
8536289|NCT00282568|21044899|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
8536290|NCT00282568|21044899|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
8536291|NCT00282568|21044899|P1|STARTED|Pharmacokinetic Treatment Period||70
8536292|NCT00282464|21044925|P2|NOT COMPLETED|Overall Study||62
8536293|NCT00282464|21044926|P1|NOT COMPLETED|Overall Study||73
8536294|NCT00282464|21044925|P2|COMPLETED|Overall Study||134
8536295|NCT00282464|21044926|P1|COMPLETED|Overall Study||112
8536296|NCT00282464|21044925|P2|STARTED|Overall Study||196
8536297|NCT00282464|21044926|P1|STARTED|Overall Study||185
8536298|NCT00282438|21044976|P2|NOT COMPLETED|Overall Study||1
8536299|NCT00282438|21044977|P1|NOT COMPLETED|Overall Study||1
8536300|NCT00282438|21044976|P2|COMPLETED|Overall Study||0
8536301|NCT00282438|21044977|P1|COMPLETED|Overall Study||0
8536302|NCT00282438|21044976|P2|STARTED|Overall Study||1
8536303|NCT00282438|21044977|P1|STARTED|Overall Study||1
8536304|NCT00282412|21044987|P1|NOT COMPLETED|Overall Study||2
8536305|NCT00282412|21044987|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
8536306|NCT00282412|21044987|P1|STARTED|Overall Study||4
8536307|NCT00282347|21044993|P2|NOT COMPLETED|B Cell Follow-up Period||0
8536308|NCT00282347|21044994|P1|NOT COMPLETED|B Cell Follow-up Period||5
8536309|NCT00282347|21044993|P2|COMPLETED|B Cell Follow-up Period||4
8536310|NCT00282347|21044994|P1|COMPLETED|B Cell Follow-up Period||15
8536311|NCT00282347|21044993|P2|STARTED|B Cell Follow-up Period||4
8536312|NCT00282347|21044994|P1|STARTED|B Cell Follow-up Period||20
8536313|NCT00282347|21044993|P2|NOT COMPLETED|Safety Follow-up Period||6
8536314|NCT00282347|21044994|P1|NOT COMPLETED|Safety Follow-up Period||3
8536315|NCT00282347|21044993|P2|COMPLETED|Safety Follow-up Period||57
8536316|NCT00282347|21044994|P1|COMPLETED|Safety Follow-up Period||64
8536317|NCT00282347|21044993|P2|STARTED|Safety Follow-up Period||63
8536318|NCT00282347|21044994|P1|STARTED|Safety Follow-up Period||67
8536319|NCT00282347|21044993|P2|NOT COMPLETED|Treatment Period||9
8536320|NCT00282347|21044994|P1|NOT COMPLETED|Treatment Period||5
8536321|NCT00282347|21044993|P2|COMPLETED|Treatment Period||63
8536322|NCT00282347|21044994|P1|COMPLETED|Treatment Period||67
8536323|NCT00282347|21044993|P2|STARTED|Treatment Period||72
8536324|NCT00282347|21044994|P1|STARTED|Treatment Period||72
8536325|NCT00282334|21045020|P2|NOT COMPLETED|Overall Study||5
8536326|NCT00282334|21045021|P1|NOT COMPLETED|Overall Study||8
8536327|NCT00282334|21045020|P2|COMPLETED|Overall Study||118
8536328|NCT00282334|21045021|P1|COMPLETED|Overall Study||105
8536329|NCT00282334|21045020|P2|STARTED|Overall Study||123
8536330|NCT00282334|21045021|P1|STARTED|Overall Study||113
8536331|NCT00282308|21045029|P3|NOT COMPLETED|Safety Follow-up Period||19
8536332|NCT00282308|21045030|P2|NOT COMPLETED|Safety Follow-up Period||0
8536333|NCT00282308|21045031|P1|NOT COMPLETED|Safety Follow-up Period||0
8536334|NCT00282308|21045029|P3|COMPLETED|Safety Follow-up Period||81
8536335|NCT00282308|21045030|P2|COMPLETED|Safety Follow-up Period||0
8536336|NCT00282308|21045031|P1|COMPLETED|Safety Follow-up Period||0
8536337|NCT00282308|21045029|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
8536338|NCT00282308|21045030|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536339|NCT00282308|21045031|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536340|NCT00282308|21045029|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
8536341|NCT00282308|21045030|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
8536342|NCT00282308|21045031|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
8536343|NCT00282308|21045029|P3|COMPLETED|Optional Extension Re-treatment Period||72
8536344|NCT00282308|21045030|P2|COMPLETED|Optional Extension Re-treatment Period||0
8536345|NCT00282308|21045031|P1|COMPLETED|Optional Extension Re-treatment Period||0
8536346|NCT00282308|21045029|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
8536347|NCT00282308|21045030|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536348|NCT00282308|21045031|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536349|NCT00282308|21045029|P3|NOT COMPLETED|Treatment Period||0
8536350|NCT00282308|21045030|P2|NOT COMPLETED|Treatment Period||6
8536351|NCT00282308|21045031|P1|NOT COMPLETED|Treatment Period||4
8536352|NCT00282308|21045029|P3|COMPLETED|Treatment Period||0
8536353|NCT00282308|21045030|P2|COMPLETED|Treatment Period||28
8536354|NCT00282308|21045031|P1|COMPLETED|Treatment Period||65
8536355|NCT00282308|21045029|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
8536356|NCT00282308|21045030|P2|STARTED|Treatment Period||34
8536357|NCT00282308|21045031|P1|STARTED|Treatment Period||69
8536358|NCT00282295|21045061|P3|NOT COMPLETED|Overall Study||8
8536359|NCT00282295|21045062|P2|NOT COMPLETED|Overall Study||17
8536360|NCT00282295|21045063|P1|NOT COMPLETED|Overall Study||3
8536361|NCT00282295|21045061|P3|COMPLETED|Overall Study||441
8536362|NCT00282295|21045062|P2|COMPLETED|Overall Study||429
8536363|NCT00282295|21045063|P1|COMPLETED|Overall Study||443
8536364|NCT00282295|21045061|P3|STARTED|Overall Study||449
8536365|NCT00282295|21045062|P2|STARTED|Overall Study||446
8536366|NCT00282295|21045063|P1|STARTED|Overall Study||446
8536367|NCT00282282|21045112|P1|NOT COMPLETED|Overall Study||0
8536368|NCT00282282|21045112|P1|COMPLETED|Overall Study||29
8536369|NCT00282282|21045112|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
8536370|NCT00282256|21045118|P1|NOT COMPLETED|Extension Treatment Period||2
8536371|NCT00282256|21045118|P1|COMPLETED|Extension Treatment Period||16
8536372|NCT00282256|21045118|P1|STARTED|Extension Treatment Period||18
8536373|NCT00282256|21045118|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
8536374|NCT00282256|21045118|P1|COMPLETED|Pharmacokinetic Treatment Period||18
8536375|NCT00282256|21045118|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
8536376|NCT00282256|21045118|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
8536377|NCT00282256|21045118|P1|STARTED|Pharmacokinetic Treatment Period||19
8536378|NCT00282243|21045139|P1|NOT COMPLETED|Extension Treatment Period||22
8536379|NCT00282243|21045139|P1|COMPLETED|Extension Treatment Period||43
8536380|NCT00282243|21045139|P1|STARTED|Extension Treatment Period||65
8536381|NCT00282243|21045139|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
8536382|NCT00282243|21045139|P1|COMPLETED|Pharmacokinetic Treatment Period||65
8536383|NCT00282243|21045139|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
8536384|NCT00282243|21045139|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
8536385|NCT00282243|21045139|P1|STARTED|Pharmacokinetic Treatment Period||70
8536386|NCT00282152|21045165|P2|NOT COMPLETED|Overall Study||0
8536387|NCT00282152|21045166|P1|NOT COMPLETED|Overall Study||1
8536388|NCT00282152|21045165|P2|COMPLETED|Overall Study||15
8536389|NCT00282152|21045166|P1|COMPLETED|Overall Study||14
8536390|NCT00282152|21045165|P2|STARTED|Overall Study||15
8536391|NCT00282152|21045166|P1|STARTED|Overall Study||15
8536392|NCT00282113|21045187|P3|NOT COMPLETED|Overall Study||0
8536393|NCT00282113|21045188|P2|NOT COMPLETED|Overall Study||0
8536394|NCT00282113|21045189|P1|NOT COMPLETED|Overall Study||1
8536395|NCT00282113|21045187|P3|COMPLETED|Overall Study||29
8536396|NCT00282113|21045188|P2|COMPLETED|Overall Study||30
8536397|NCT00282113|21045189|P1|COMPLETED|Overall Study||30
8536398|NCT00282113|21045187|P3|STARTED|Overall Study||29
8536399|NCT00282113|21045188|P2|STARTED|Overall Study||30
8536400|NCT00282113|21045189|P1|STARTED|Overall Study||31
8536401|NCT00282087|21045203|P1|NOT COMPLETED|Overall Study||1
8536402|NCT00282087|21045203|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
8536403|NCT00282087|21045203|P1|STARTED|Overall Study||47
8536404|NCT00282048|21045216|P1|NOT COMPLETED|Overall Study||62
8536405|NCT00282048|21045216|P1|COMPLETED|Overall Study||0
8536406|NCT00282048|21045216|P1|STARTED|Overall Study||62
8536407|NCT00281957|21045230|P2|NOT COMPLETED|Overall Study||42
8536408|NCT00281957|21045231|P1|NOT COMPLETED|Overall Study||67
8536409|NCT00281957|21045230|P2|COMPLETED|Overall Study||0
8536410|NCT00281957|21045231|P1|COMPLETED|Overall Study||0
8536411|NCT00281957|21045230|P2|Eligible and Received Treatment|Overall Study||39
8536412|NCT00281957|21045231|P1|Eligible and Received Treatment|Overall Study||63
8536413|NCT00281957|21045230|P2|Eligible|Overall Study||40
8536414|NCT00281957|21045231|P1|Eligible|Overall Study||66
8536415|NCT00281957|21045230|P2|STARTED|Overall Study||42
8536416|NCT00281957|21045231|P1|STARTED|Overall Study||67
8536417|NCT00281918|21045245|P2|NOT COMPLETED|Overall Study||108
8536418|NCT00281918|21045246|P1|NOT COMPLETED|Overall Study||142
8536419|NCT00281918|21045245|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
8536420|NCT00281918|21045246|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
8536421|NCT00281918|21045245|P2|Safety Population; Received Study Drug|Overall Study||402
8536422|NCT00281918|21045246|P1|Safety Population; Received Study Drug|Overall Study||398
8536423|NCT00281918|21045245|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
8536424|NCT00281918|21045246|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
8536425|NCT00281879|21045280|P8|NOT COMPLETED|Overall Study||1
8536426|NCT00281879|21045281|P7|NOT COMPLETED|Overall Study||0
8536427|NCT00281879|21045282|P6|NOT COMPLETED|Overall Study||9
8536428|NCT00281879|21045283|P5|NOT COMPLETED|Overall Study||6
8536429|NCT00281879|21045284|P4|NOT COMPLETED|Overall Study||0
8536430|NCT00281879|21045285|P3|NOT COMPLETED|Overall Study||20
8536431|NCT00281879|21045286|P2|NOT COMPLETED|Overall Study||36
8536432|NCT00281879|21045287|P1|NOT COMPLETED|Overall Study||128
8536433|NCT00281879|21045280|P8|COMPLETED|Overall Study||0
8536434|NCT00281879|21045281|P7|COMPLETED|Overall Study||0
8536435|NCT00281879|21045282|P6|COMPLETED|Overall Study||0
8536436|NCT00281879|21045283|P5|COMPLETED|Overall Study||0
8536437|NCT00281879|21045284|P4|COMPLETED|Overall Study||0
8536438|NCT00281879|21045285|P3|COMPLETED|Overall Study||0
8536439|NCT00281879|21045286|P2|COMPLETED|Overall Study||0
8536440|NCT00281879|21045287|P1|COMPLETED|Overall Study||0
8536441|NCT00281879|21045280|P8|STARTED|Overall Study||1
8536442|NCT00281879|21045281|P7|STARTED|Overall Study||0
8536443|NCT00281879|21045282|P6|STARTED|Overall Study||9
8536444|NCT00281879|21045283|P5|STARTED|Overall Study||6
8536445|NCT00281879|21045284|P4|STARTED|Overall Study||0
8536446|NCT00281879|21045285|P3|STARTED|Overall Study||20
8536447|NCT00281879|21045286|P2|STARTED|Overall Study||36
8536448|NCT00281879|21045287|P1|STARTED|Overall Study||128
8536449|NCT00281840|21045305|P1|NOT COMPLETED|Overall Study||25
8536450|NCT00281840|21045305|P1|COMPLETED|Overall Study||5
8536451|NCT00281840|21045305|P1|STARTED|Overall Study||30
8536452|NCT00281827|21045310|P1|NOT COMPLETED|Overall Study||0
8536453|NCT00281827|21045310|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
8536454|NCT00281827|21045310|P1|STARTED|Overall Study||22
8536455|NCT00281697|21045321|P2|NOT COMPLETED|Overall Study||197
8536456|NCT00281697|21045322|P1|NOT COMPLETED|Overall Study||401
8536457|NCT00281697|21045321|P2|COMPLETED|Overall Study||28
8536458|NCT00281697|21045322|P1|COMPLETED|Overall Study||58
8536459|NCT00281697|21045321|P2|STARTED|Overall Study||225
8536460|NCT00281697|21045322|P1|STARTED|Overall Study||459
8536461|NCT00281684|21045342|P4|NOT COMPLETED|Overall Study||0
8536462|NCT00281684|21045343|P3|NOT COMPLETED|Overall Study||1
8536463|NCT00281684|21045344|P2|NOT COMPLETED|Overall Study||0
8536464|NCT00281684|21045345|P1|NOT COMPLETED|Overall Study||1
8536465|NCT00281684|21045342|P4|COMPLETED|Overall Study||38
8536466|NCT00281684|21045343|P3|COMPLETED|Overall Study||33
8536467|NCT00281684|21045344|P2|COMPLETED|Overall Study||36
8536468|NCT00281684|21045345|P1|COMPLETED|Overall Study||36
8536469|NCT00281684|21045342|P4|STARTED|Overall Study||38
8536470|NCT00281684|21045343|P3|STARTED|Overall Study||34
8536471|NCT00281684|21045344|P2|STARTED|Overall Study||36
8536472|NCT00281684|21045345|P1|STARTED|Overall Study||37
8536473|NCT00281671|21045417|P2|NOT COMPLETED|Overall Study||0
8536474|NCT00281671|21045418|P1|NOT COMPLETED|Overall Study||0
8536475|NCT00281671|21045417|P2|COMPLETED|Overall Study||4
8536476|NCT00281671|21045418|P1|COMPLETED|Overall Study||5
8536477|NCT00281671|21045417|P2|STARTED|Overall Study||4
8536478|NCT00281671|21045418|P1|STARTED|Overall Study||5
8536479|NCT00281658|21045432|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
8536480|NCT00281658|21045433|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
8536481|NCT00281658|21045434|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
8536482|NCT00281658|21045432|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
8536483|NCT00281658|21045433|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
8536484|NCT00281658|21045434|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
8536485|NCT00281658|21045432|P3|STARTED|Open-label Monotherapy Extension Phase||149
8536486|NCT00281658|21045433|P2|STARTED|Open-label Monotherapy Extension Phase||0
8536487|NCT00281658|21045434|P1|STARTED|Open-label Monotherapy Extension Phase||0
8536488|NCT00281658|21045432|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
8536489|NCT00281658|21045433|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
8536490|NCT00281658|21045434|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
8536491|NCT00281658|21045432|P3|COMPLETED|Double-blind, Randomized Phase||0
8536492|NCT00281658|21045433|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
8536493|NCT00281658|21045434|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
8536494|NCT00281658|21045432|P3|STARTED|Double-blind, Randomized Phase||0
8536495|NCT00281658|21045433|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
8536496|NCT00281658|21045434|P1|STARTED|Double-blind, Randomized Phase||222
8536497|NCT00281632|21045451|P1|NOT COMPLETED|Overall Study||36
8536498|NCT00281632|21045451|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
8536499|NCT00281632|21045451|P1|STARTED|Overall Study||36
8536500|NCT00281580|21045493|P16|NOT COMPLETED|Overall Study||13
8536501|NCT00281580|21045494|P15|NOT COMPLETED|Overall Study||7
8536502|NCT00281580|21045495|P14|NOT COMPLETED|Overall Study||7
8536503|NCT00281580|21045496|P13|NOT COMPLETED|Overall Study||13
8536504|NCT00281580|21045497|P12|NOT COMPLETED|Overall Study||10
8536505|NCT00281580|21045498|P11|NOT COMPLETED|Overall Study||4
8536506|NCT00281580|21045499|P10|NOT COMPLETED|Overall Study||12
8536507|NCT00281580|21045500|P9|NOT COMPLETED|Overall Study||8
8536508|NCT00281580|21045501|P8|NOT COMPLETED|Overall Study||1
8536509|NCT00281580|21045502|P7|NOT COMPLETED|Overall Study||5
8536510|NCT00281580|21045503|P6|NOT COMPLETED|Overall Study||3
8536511|NCT00281580|21045504|P5|NOT COMPLETED|Overall Study||4
8536512|NCT00281580|21045505|P4|NOT COMPLETED|Overall Study||17
8536513|NCT00281580|21045506|P3|NOT COMPLETED|Overall Study||5
8536514|NCT00281580|21045507|P2|NOT COMPLETED|Overall Study||1
8536515|NCT00281580|21045508|P1|NOT COMPLETED|Overall Study||7
8536516|NCT00281580|21045493|P16|COMPLETED|Overall Study||116
8536517|NCT00281580|21045494|P15|COMPLETED|Overall Study||133
8536518|NCT00281580|21045495|P14|COMPLETED|Overall Study||43
8536519|NCT00281580|21045496|P13|COMPLETED|Overall Study||129
8536520|NCT00281580|21045497|P12|COMPLETED|Overall Study||136
8536521|NCT00281580|21045498|P11|COMPLETED|Overall Study||44
8536522|NCT00281580|21045499|P10|COMPLETED|Overall Study||117
8536523|NCT00281580|21045500|P9|COMPLETED|Overall Study||135
8536524|NCT00281580|21045501|P8|COMPLETED|Overall Study||46
8536525|NCT00281580|21045502|P7|COMPLETED|Overall Study||39
8536526|NCT00281580|21045503|P6|COMPLETED|Overall Study||43
8536527|NCT00281580|21045504|P5|COMPLETED|Overall Study||40
8536528|NCT00281580|21045505|P4|COMPLETED|Overall Study||118
8536529|NCT00281580|21045506|P3|COMPLETED|Overall Study||125
8536530|NCT00281580|21045507|P2|COMPLETED|Overall Study||41
8536531|NCT00281580|21045508|P1|COMPLETED|Overall Study||39
8536532|NCT00281580|21045493|P16|STARTED|Overall Study||129
8536533|NCT00281580|21045494|P15|STARTED|Overall Study||140
8536534|NCT00281580|21045495|P14|STARTED|Overall Study||50
8536535|NCT00281580|21045496|P13|STARTED|Overall Study||142
8536536|NCT00281580|21045497|P12|STARTED|Overall Study||146
8536537|NCT00281580|21045498|P11|STARTED|Overall Study||48
8536538|NCT00281580|21045499|P10|STARTED|Overall Study||129
8536539|NCT00281580|21045500|P9|STARTED|Overall Study||143
8536540|NCT00281580|21045501|P8|STARTED|Overall Study||47
8536541|NCT00281580|21045502|P7|STARTED|Overall Study||44
8536542|NCT00281580|21045503|P6|STARTED|Overall Study||46
8536543|NCT00281580|21045504|P5|STARTED|Overall Study||44
8536544|NCT00281580|21045505|P4|STARTED|Overall Study||135
8536545|NCT00281580|21045506|P3|STARTED|Overall Study||130
8536546|NCT00281580|21045507|P2|STARTED|Overall Study||42
8536547|NCT00281580|21045508|P1|STARTED|Overall Study||46
8536548|NCT00281528|21045855|P3|NOT COMPLETED|Overall Study||79
8536549|NCT00281528|21045856|P2|NOT COMPLETED|Overall Study||54
8536550|NCT00281528|21045857|P1|NOT COMPLETED|Overall Study||75
8536551|NCT00281528|21045855|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8536552|NCT00281528|21045856|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8536553|NCT00281528|21045857|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8536554|NCT00281528|21045855|P3|STARTED|Overall Study||79
8536555|NCT00281528|21045856|P2|STARTED|Overall Study||54
8536556|NCT00281528|21045857|P1|STARTED|Overall Study||75
8536557|NCT00281463|21045901|P1|NOT COMPLETED|Overall Study||0
8536558|NCT00281463|21045901|P1|COMPLETED|Overall Study||45
8536559|NCT00281463|21045901|P1|STARTED|Overall Study||45
8536560|NCT00281320|21045908|P2|NOT COMPLETED|Overall Study||21
8536561|NCT00281320|21045909|P1|NOT COMPLETED|Overall Study||25
8536562|NCT00281320|21045908|P2|COMPLETED|Overall Study||40
8536563|NCT00281320|21045909|P1|COMPLETED|Overall Study||36
8536564|NCT00281320|21045908|P2|STARTED|Overall Study||61
8536565|NCT00281320|21045909|P1|STARTED|Overall Study||61
8536566|NCT00281099|21045931|P2|NOT COMPLETED|Overall Study||222
8536567|NCT00281099|21045932|P1|NOT COMPLETED|Overall Study||205
8536568|NCT00281099|21045931|P2|COMPLETED|Overall Study||296
8536569|NCT00281099|21045932|P1|COMPLETED|Overall Study||308
8536570|NCT00281099|21045931|P2|STARTED|Overall Study||518
8536571|NCT00281099|21045932|P1|STARTED|Overall Study||513
8536572|NCT00281021|21045973|P1|NOT COMPLETED|Overall Study||2
8536573|NCT00281021|21045973|P1|COMPLETED|Overall Study||24
8536574|NCT00281021|21045973|P1|STARTED|Overall Study||26
8536575|NCT00280917|21045981|P4|NOT COMPLETED|Overall Study||2
8536576|NCT00280917|21045982|P3|NOT COMPLETED|Overall Study||6
8536577|NCT00280917|21045983|P2|NOT COMPLETED|Overall Study||6
8536578|NCT00280917|21045984|P1|NOT COMPLETED|Overall Study||2
8536579|NCT00280917|21045981|P4|COMPLETED|Overall Study||61
8536580|NCT00280917|21045982|P3|COMPLETED|Overall Study||57
8536581|NCT00280917|21045983|P2|COMPLETED|Overall Study||57
8536582|NCT00280917|21045984|P1|COMPLETED|Overall Study||63
8536583|NCT00280917|21045981|P4|STARTED|Overall Study||63
8536584|NCT00280917|21045982|P3|STARTED|Overall Study||63
8536585|NCT00280917|21045983|P2|STARTED|Overall Study||63
8536586|NCT00280917|21045984|P1|STARTED|Overall Study||65
8536587|NCT00280904|21045994|P1|NOT COMPLETED|Overall Study||0
8536588|NCT00280904|21045994|P1|COMPLETED|Overall Study||433
8536589|NCT00280904|21045994|P1|STARTED|Overall Study||433
8536590|NCT00280826|21045999|P1|NOT COMPLETED|Overall Study||0
8536591|NCT00280826|21045999|P1|COMPLETED|Overall Study||6
8536592|NCT00280826|21045999|P1|STARTED|Overall Study||6
8536593|NCT00280748|21046007|P1|NOT COMPLETED|Overall Study||4
8536594|NCT00280748|21046007|P1|COMPLETED|Overall Study||6
8536595|NCT00280748|21046007|P1|STARTED|Overall Study||10
8536596|NCT00280735|21046017|P1|NOT COMPLETED|Overall Study||18
8536597|NCT00280735|21046017|P1|COMPLETED|Overall Study||57
8536598|NCT00280735|21046017|P1|Received Adequate Exposure|Overall Study||57
8536599|NCT00280735|21046017|P1|Received Treatment|Overall Study||72
8536600|NCT00280735|21046017|P1|STARTED|Overall Study||75
8536601|NCT00280683|21046029|P2|NOT COMPLETED|Overall Study||3
8536602|NCT00280683|21046030|P1|NOT COMPLETED|Overall Study||2
8536603|NCT00280683|21046029|P2|COMPLETED|Overall Study||7
8536604|NCT00280683|21046030|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
8536605|NCT00280683|21046029|P2|STARTED|Overall Study||10
8536606|NCT00280683|21046030|P1|STARTED|Overall Study||10
8536607|NCT00280566|21046040|P3|NOT COMPLETED|Period 2 Double Blind||57
8536608|NCT00280566|21046041|P2|NOT COMPLETED|Period 2 Double Blind||43
8536609|NCT00280566|21046042|P1|NOT COMPLETED|Period 2 Double Blind||0
8536610|NCT00280566|21046040|P3|COMPLETED|Period 2 Double Blind||54
8536611|NCT00280566|21046041|P2|COMPLETED|Period 2 Double Blind||84
8536612|NCT00280566|21046042|P1|COMPLETED|Period 2 Double Blind||0
8536613|NCT00280566|21046040|P3|STARTED|Period 2 Double Blind||111
8536614|NCT00280566|21046041|P2|STARTED|Period 2 Double Blind||127
8536615|NCT00280566|21046042|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
8536616|NCT00280566|21046040|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
8536617|NCT00280566|21046041|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
8536618|NCT00280566|21046042|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
8536619|NCT00280566|21046040|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
8536620|NCT00280566|21046041|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
8536621|NCT00280566|21046042|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
8536622|NCT00280566|21046040|P3|STARTED|Period 1 Open Label Ziprasidone||0
8536623|NCT00280566|21046041|P2|STARTED|Period 1 Open Label Ziprasidone||0
8536624|NCT00280566|21046042|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
8536625|NCT00280397|21046067|P1|NOT COMPLETED|Overall Study||1
8536626|NCT00280397|21046067|P1|COMPLETED|Overall Study||26
8536627|NCT00280397|21046067|P1|STARTED|Overall Study||27
8536628|NCT00280384|21046082|P8|NOT COMPLETED|Overall Study||0
8536629|NCT00280384|21046083|P7|NOT COMPLETED|Overall Study||0
8536630|NCT00280384|21046084|P6|NOT COMPLETED|Overall Study||0
8536631|NCT00280384|21046085|P5|NOT COMPLETED|Overall Study||0
8536632|NCT00280384|21046086|P4|NOT COMPLETED|Overall Study||0
8536633|NCT00280384|21046087|P3|NOT COMPLETED|Overall Study||0
8536634|NCT00280384|21046088|P2|NOT COMPLETED|Overall Study||0
8536635|NCT00280384|21046089|P1|NOT COMPLETED|Overall Study||0
8536636|NCT00280384|21046082|P8|COMPLETED|Overall Study||6
8536637|NCT00280384|21046083|P7|COMPLETED|Overall Study||6
8536638|NCT00280384|21046084|P6|COMPLETED|Overall Study||6
8536639|NCT00280384|21046085|P5|COMPLETED|Overall Study||6
8536640|NCT00280384|21046086|P4|COMPLETED|Overall Study||6
8536641|NCT00280384|21046087|P3|COMPLETED|Overall Study||6
8536642|NCT00280384|21046088|P2|COMPLETED|Overall Study||6
8536643|NCT00280384|21046089|P1|COMPLETED|Overall Study||6
8536644|NCT00280384|21046082|P8|STARTED|Overall Study||6
8536645|NCT00280384|21046083|P7|STARTED|Overall Study||6
8536646|NCT00280384|21046084|P6|STARTED|Overall Study||6
8536647|NCT00280384|21046085|P5|STARTED|Overall Study||6
8536648|NCT00280384|21046086|P4|STARTED|Overall Study||6
8536649|NCT00280384|21046087|P3|STARTED|Overall Study||6
8536650|NCT00280384|21046088|P2|STARTED|Overall Study||6
8536651|NCT00280384|21046089|P1|STARTED|Overall Study||6
8536652|NCT00280293|21046133|P2|NOT COMPLETED|Overall Study||23
8536653|NCT00280293|21046134|P1|NOT COMPLETED|Overall Study||26
8536654|NCT00280293|21046133|P2|COMPLETED|Overall Study||34
8536655|NCT00280293|21046134|P1|COMPLETED|Overall Study||29
8536656|NCT00280293|21046133|P2|STARTED|Overall Study||57
8536657|NCT00280293|21046134|P1|STARTED|Overall Study||55
8536658|NCT00280241|21046146|P1|NOT COMPLETED|Overall Study||10
8536659|NCT00280241|21046146|P1|COMPLETED|Overall Study||55
8536660|NCT00280241|21046146|P1|STARTED|Overall Study||65
8536661|NCT00280150|21046157|P4|NOT COMPLETED|Overall Study||10
8536662|NCT00280150|21046158|P3|NOT COMPLETED|Overall Study||5
8536663|NCT00280150|21046159|P2|NOT COMPLETED|Overall Study||1
8536664|NCT00280150|21046160|P1|NOT COMPLETED|Overall Study||3
8536665|NCT00280150|21046157|P4|COMPLETED|Overall Study||20
8536666|NCT00280150|21046158|P3|COMPLETED|Overall Study||1
8536667|NCT00280150|21046159|P2|COMPLETED|Overall Study||4
8536668|NCT00280150|21046160|P1|COMPLETED|Overall Study||2
8536669|NCT00280150|21046157|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
8536670|NCT00280150|21046158|P3|Consolidation Therapy|Overall Study||3
8536671|NCT00280150|21046159|P2|Consolidation Therapy|Overall Study||5
8536672|NCT00280150|21046160|P1|Consolidation Therapy|Overall Study||2
8536673|NCT00280150|21046157|P4|Cohort Induction|Overall Study||30
8536674|NCT00280150|21046158|P3|Cohort Induction|Overall Study||6
8536675|NCT00280150|21046159|P2|Cohort Induction|Overall Study||5
8536676|NCT00280150|21046160|P1|Cohort Induction|Overall Study||5
8536677|NCT00280150|21046157|P4|STARTED|Overall Study||30
8536678|NCT00280150|21046158|P3|STARTED|Overall Study||6
8536679|NCT00280150|21046159|P2|STARTED|Overall Study||5
8536680|NCT00280150|21046160|P1|STARTED|Overall Study||5
8536681|NCT00279955|21046176|P3|NOT COMPLETED|Overall Study||0
8536682|NCT00279955|21046177|P2|NOT COMPLETED|Overall Study||0
8536683|NCT00279955|21046178|P1|NOT COMPLETED|Overall Study||0
8536684|NCT00279955|21046176|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
8536685|NCT00279955|21046177|P2|COMPLETED|Overall Study||486
8536686|NCT00279955|21046178|P1|COMPLETED|Overall Study||157
8536687|NCT00279955|21046176|P3|STARTED|Overall Study||358
8536688|NCT00279955|21046177|P2|STARTED|Overall Study||486
8536689|NCT00279955|21046178|P1|STARTED|Overall Study||157
8536690|NCT00279916|21046191|P2|NOT COMPLETED|Overall Study||5
8536691|NCT00279916|21046192|P1|NOT COMPLETED|Overall Study||7
8536692|NCT00279916|21046191|P2|COMPLETED|Overall Study||41
8536693|NCT00279916|21046192|P1|COMPLETED|Overall Study||38
8536694|NCT00279916|21046191|P2|STARTED|Overall Study||46
8536695|NCT00279916|21046192|P1|STARTED|Overall Study||45
8536696|NCT00279812|21046218|P6|NOT COMPLETED|Overall Study||1
8536697|NCT00279812|21046219|P5|NOT COMPLETED|Overall Study||3
8536698|NCT00279812|21046220|P4|NOT COMPLETED|Overall Study||0
8536699|NCT00279812|21046221|P3|NOT COMPLETED|Overall Study||3
8536700|NCT00279812|21046222|P2|NOT COMPLETED|Overall Study||6
8536701|NCT00279812|21046223|P1|NOT COMPLETED|Overall Study||1
8536702|NCT00279812|21046218|P6|COMPLETED|Overall Study||18
8536703|NCT00279812|21046219|P5|COMPLETED|Overall Study||17
8536704|NCT00279812|21046220|P4|COMPLETED|Overall Study||23
8536705|NCT00279812|21046221|P3|COMPLETED|Overall Study||21
8536706|NCT00279812|21046222|P2|COMPLETED|Overall Study||20
8536707|NCT00279812|21046223|P1|COMPLETED|Overall Study||20
8536708|NCT00279812|21046218|P6|STARTED|Overall Study||19
8536709|NCT00279812|21046219|P5|STARTED|Overall Study||20
8536710|NCT00279812|21046220|P4|STARTED|Overall Study||23
8536711|NCT00279812|21046221|P3|STARTED|Overall Study||24
8536712|NCT00279812|21046222|P2|STARTED|Overall Study||26
8536713|NCT00279812|21046223|P1|STARTED|Overall Study||21
8536714|NCT00279708|21046251|P2|NOT COMPLETED|Overall Study||4
8536715|NCT00279708|21046252|P1|NOT COMPLETED|Overall Study||3
8536716|NCT00279708|21046251|P2|COMPLETED|Overall Study||24
8536717|NCT00279708|21046252|P1|COMPLETED|Overall Study||24
8536718|NCT00279708|21046251|P2|STARTED|Overall Study||28
8536719|NCT00279708|21046252|P1|STARTED|Overall Study|"Started meaning randomized"|27
8536720|NCT00279591|21046260|P2|NOT COMPLETED|Overall Study||0
8536721|NCT00279591|21046261|P1|NOT COMPLETED|Overall Study||0
8536722|NCT00279591|21046260|P2|COMPLETED|Overall Study||46
8536723|NCT00279591|21046261|P1|COMPLETED|Overall Study||48
8536724|NCT00279591|21046260|P2|STARTED|Overall Study||46
8536725|NCT00279591|21046261|P1|STARTED|Overall Study||48
8536726|NCT00279500|21046275|P1|NOT COMPLETED|Overall Study||0
8536727|NCT00279500|21046275|P1|COMPLETED|Overall Study|6 patients treated|6
8536728|NCT00279500|21046275|P1|STARTED|Overall Study|6 patients treated|6
8536729|NCT00279409|21046281|P2|NOT COMPLETED|Overall Study||0
8536730|NCT00279409|21046282|P1|NOT COMPLETED|Overall Study||0
8536731|NCT00279409|21046281|P2|COMPLETED|Overall Study||0
8536732|NCT00279409|21046282|P1|COMPLETED|Overall Study||0
8536733|NCT00279409|21046281|P2|STARTED|Overall Study||0
8536734|NCT00279409|21046282|P1|STARTED|Overall Study||0
8536735|NCT00279305|21046290|P2|NOT COMPLETED|Overall Study||1
8536736|NCT00279305|21046291|P1|NOT COMPLETED|Overall Study||8
8536737|NCT00279305|21046290|P2|COMPLETED|Overall Study||29
8536738|NCT00279305|21046291|P1|COMPLETED|Overall Study||49
8536739|NCT00279305|21046290|P2|STARTED|Overall Study||30
8536740|NCT00279305|21046291|P1|STARTED|Overall Study||57
8536741|NCT00279214|21046299|P2|NOT COMPLETED|Overall Study||2
8536742|NCT00279214|21046300|P1|NOT COMPLETED|Overall Study||3
8536743|NCT00279214|21046299|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
8536744|NCT00279214|21046300|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
8536745|NCT00279214|21046299|P2|STARTED|Overall Study||21
8536746|NCT00279214|21046300|P1|STARTED|Overall Study||22
8536747|NCT00279201|21046330|P6|NOT COMPLETED|Intensification Addendum||37
8536748|NCT00279201|21046331|P5|NOT COMPLETED|Intensification Addendum||29
8536749|NCT00279201|21046332|P4|NOT COMPLETED|Intensification Addendum||28
8536750|NCT00279201|21046333|P3|NOT COMPLETED|Intensification Addendum||23
8536751|NCT00279201|21046334|P2|NOT COMPLETED|Intensification Addendum||0
8536752|NCT00279201|21046335|P1|NOT COMPLETED|Intensification Addendum||0
8536753|NCT00279201|21046330|P6|COMPLETED|Intensification Addendum||162
8536754|NCT00279201|21046331|P5|COMPLETED|Intensification Addendum||142
8536755|NCT00279201|21046332|P4|COMPLETED|Intensification Addendum||172
8536756|NCT00279201|21046333|P3|COMPLETED|Intensification Addendum||151
8536757|NCT00279201|21046334|P2|COMPLETED|Intensification Addendum||0
8536758|NCT00279201|21046335|P1|COMPLETED|Intensification Addendum||0
8536759|NCT00279201|21046330|P6|STARTED|Intensification Addendum||199
8536760|NCT00279201|21046331|P5|STARTED|Intensification Addendum||171
8536761|NCT00279201|21046332|P4|STARTED|Intensification Addendum||200
8536762|NCT00279201|21046333|P3|STARTED|Intensification Addendum||174
8536763|NCT00279201|21046334|P2|STARTED|Intensification Addendum||0
8536764|NCT00279201|21046335|P1|STARTED|Intensification Addendum||0
8536765|NCT00279201|21046330|P6|NOT COMPLETED|Maintenance||0
8536766|NCT00279201|21046331|P5|NOT COMPLETED|Maintenance||0
8536767|NCT00279201|21046332|P4|NOT COMPLETED|Maintenance||0
8536768|NCT00279201|21046333|P3|NOT COMPLETED|Maintenance||0
8536769|NCT00279201|21046334|P2|NOT COMPLETED|Maintenance||234
8536770|NCT00279201|21046335|P1|NOT COMPLETED|Maintenance||231
8536771|NCT00279201|21046330|P6|COMPLETED|Maintenance||0
8536772|NCT00279201|21046331|P5|COMPLETED|Maintenance||0
8536773|NCT00279201|21046332|P4|COMPLETED|Maintenance||0
8536774|NCT00279201|21046333|P3|COMPLETED|Maintenance||0
8536775|NCT00279201|21046334|P2|COMPLETED|Maintenance||239
8536776|NCT00279201|21046335|P1|COMPLETED|Maintenance||188
8536777|NCT00279201|21046330|P6|STARTED|Maintenance||0
8536778|NCT00279201|21046331|P5|STARTED|Maintenance||0
8536779|NCT00279201|21046332|P4|STARTED|Maintenance||0
8536780|NCT00279201|21046333|P3|STARTED|Maintenance||0
8536781|NCT00279201|21046334|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
8536782|NCT00279201|21046335|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
8536783|NCT00279201|21046330|P6|NOT COMPLETED|Initiation||0
8536784|NCT00279201|21046331|P5|NOT COMPLETED|Initiation||0
8536785|NCT00279201|21046332|P4|NOT COMPLETED|Initiation||0
8536786|NCT00279201|21046333|P3|NOT COMPLETED|Initiation||0
8536787|NCT00279201|21046334|P2|NOT COMPLETED|Initiation||145
8536788|NCT00279201|21046335|P1|NOT COMPLETED|Initiation||128
8536789|NCT00279201|21046330|P6|COMPLETED|Initiation||0
8536790|NCT00279201|21046331|P5|COMPLETED|Initiation||0
8536791|NCT00279201|21046332|P4|COMPLETED|Initiation||0
8536792|NCT00279201|21046333|P3|COMPLETED|Initiation||0
8536793|NCT00279201|21046334|P2|COMPLETED|Initiation||900
8536794|NCT00279201|21046335|P1|COMPLETED|Initiation||918
8536795|NCT00279201|21046330|P6|STARTED|Initiation||0
8536796|NCT00279201|21046331|P5|STARTED|Initiation||0
8536797|NCT00279201|21046332|P4|STARTED|Initiation||0
8536798|NCT00279201|21046333|P3|STARTED|Initiation||0
8536799|NCT00279201|21046334|P2|STARTED|Initiation||1045
8536800|NCT00279201|21046335|P1|STARTED|Initiation||1046
8536801|NCT00278993|21046479|P1|NOT COMPLETED|Overall Study||107
8536802|NCT00278993|21046479|P1|COMPLETED|Overall Study||1
8536803|NCT00278993|21046479|P1|STARTED|Overall Study||108
8536804|NCT00278954|21046487|P1|NOT COMPLETED|Overall Study||5
8536805|NCT00278954|21046487|P1|COMPLETED|Overall Study||45
8536806|NCT00278954|21046487|P1|STARTED|Overall Study||50
8536807|NCT00278915|21046495|P1|NOT COMPLETED|Overall Study||1
8536808|NCT00278915|21046495|P1|COMPLETED|Overall Study||29
8536809|NCT00278915|21046495|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
8536810|NCT00278889|21046531|P3|NOT COMPLETED|Overall Study||20
8536811|NCT00278889|21046532|P2|NOT COMPLETED|Overall Study||27
8536812|NCT00278889|21046533|P1|NOT COMPLETED|Overall Study||25
8536813|NCT00278889|21046531|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
8536814|NCT00278889|21046532|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
8536815|NCT00278889|21046533|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
8536816|NCT00278889|21046531|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
8536817|NCT00278889|21046532|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
8536818|NCT00278889|21046533|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
8536819|NCT00278889|21046531|P3|STARTED|Overall Study|Randomised|68
8536820|NCT00278889|21046532|P2|STARTED|Overall Study|Randomised|74
8536821|NCT00278889|21046533|P1|STARTED|Overall Study|Randomised|73
8536822|NCT00278876|21046559|P1|NOT COMPLETED|Overall Study||9
8536823|NCT00278876|21046559|P1|COMPLETED|Overall Study||38
8536824|NCT00278876|21046559|P1|STARTED|Overall Study||47
8536825|NCT00278863|21046567|P2|NOT COMPLETED|Overall Study||2
8536826|NCT00278863|21046568|P1|NOT COMPLETED|Overall Study||5
8536827|NCT00278863|21046567|P2|COMPLETED|Overall Study||45
8536828|NCT00278863|21046568|P1|COMPLETED|Overall Study||44
8536829|NCT00278863|21046567|P2|STARTED|Overall Study||47
8536830|NCT00278863|21046568|P1|STARTED|Overall Study||49
8536831|NCT00278655|21046576|P1|NOT COMPLETED|Overall Study||0
8536832|NCT00278655|21046576|P1|COMPLETED|Overall Study||21
8536833|NCT00278655|21046576|P1|STARTED|Overall Study||21
8536834|NCT00278629|21046581|P1|NOT COMPLETED|Overall Study||14
8536835|NCT00278629|21046581|P1|COMPLETED|Overall Study||66
8536836|NCT00278629|21046581|P1|STARTED|Overall Study||80
8536837|NCT00278564|21046588|P1|NOT COMPLETED|Overall Study||4
8536838|NCT00278564|21046588|P1|COMPLETED|Overall Study||3
8536839|NCT00278564|21046588|P1|STARTED|Overall Study||7
8536840|NCT00278538|21046592|P1|NOT COMPLETED|Overall Study||2
8536841|NCT00278538|21046592|P1|COMPLETED|Overall Study||30
8536842|NCT00278538|21046592|P1|STARTED|Overall Study||32
8536843|NCT00278525|21046598|P2|NOT COMPLETED|Overall Study||0
8536844|NCT00278525|21046599|P1|NOT COMPLETED|Overall Study||0
8536845|NCT00278525|21046598|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
8536846|NCT00278525|21046599|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
8536847|NCT00278525|21046598|P2|STARTED|Overall Study||10
8536848|NCT00278525|21046599|P1|STARTED|Overall Study||9
8536849|NCT00278512|21046609|P2|NOT COMPLETED|Overall Study||0
8536850|NCT00278512|21046610|P1|NOT COMPLETED|Overall Study||1
8536851|NCT00278512|21046609|P2|COMPLETED|Overall Study||0
8536852|NCT00278512|21046610|P1|COMPLETED|Overall Study||6
8536853|NCT00278512|21046609|P2|STARTED|Overall Study||0
8536854|NCT00278512|21046610|P1|STARTED|Overall Study||7
8536855|NCT00278473|21046618|P2|NOT COMPLETED|Overall Study||3
8536856|NCT00278473|21046619|P1|NOT COMPLETED|Overall Study||4
8536857|NCT00278473|21046618|P2|COMPLETED|Overall Study||40
8536858|NCT00278473|21046619|P1|COMPLETED|Overall Study||41
8536859|NCT00278473|21046618|P2|STARTED|Overall Study||43
8536860|NCT00278473|21046619|P1|STARTED|Overall Study||45
8536861|NCT00278395|21046635|P1|NOT COMPLETED|Overall Study||3
8536862|NCT00278395|21046635|P1|COMPLETED|Overall Study||11
8536863|NCT00278395|21046635|P1|STARTED|Overall Study||14
8536864|NCT00278343|21046642|P1|NOT COMPLETED|Overall Study||0
8536865|NCT00278343|21046642|P1|COMPLETED|Overall Study||74
8536866|NCT00278343|21046642|P1|STARTED|Overall Study||74
8536867|NCT00278200|21046653|P2|NOT COMPLETED|Overall Study||4
8536868|NCT00278200|21046654|P1|NOT COMPLETED|Overall Study||1
8536869|NCT00278200|21046653|P2|COMPLETED|Overall Study||8
8536870|NCT00278200|21046654|P1|COMPLETED|Overall Study||1
8536871|NCT00278200|21046653|P2|STARTED|Overall Study||12
8536872|NCT00278200|21046654|P1|STARTED|Overall Study||2
8536873|NCT00278161|21046663|P1|NOT COMPLETED|Overall Study||11
8536874|NCT00278161|21046663|P1|COMPLETED|Overall Study||70
8536875|NCT00278161|21046663|P1|STARTED|Overall Study||81
8536876|NCT00278148|21046669|P3|NOT COMPLETED|Phase II - Expansion Phase||6
8536877|NCT00278148|21046670|P2|NOT COMPLETED|Phase II - Expansion Phase||0
8536878|NCT00278148|21046671|P1|NOT COMPLETED|Phase II - Expansion Phase||0
8536879|NCT00278148|21046669|P3|COMPLETED|Phase II - Expansion Phase||20
8536880|NCT00278148|21046670|P2|COMPLETED|Phase II - Expansion Phase||0
8536881|NCT00278148|21046671|P1|COMPLETED|Phase II - Expansion Phase||0
8536882|NCT00278148|21046669|P3|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
8536883|NCT00278148|21046670|P2|STARTED|Phase II - Expansion Phase||0
8536884|NCT00278148|21046671|P1|STARTED|Phase II - Expansion Phase||0
8536885|NCT00278148|21046669|P3|NOT COMPLETED|Phase I - Dose Escalation||0
8536886|NCT00278148|21046670|P2|NOT COMPLETED|Phase I - Dose Escalation||0
8536887|NCT00278148|21046671|P1|NOT COMPLETED|Phase I - Dose Escalation||0
8536888|NCT00278148|21046669|P3|COMPLETED|Phase I - Dose Escalation||3
8536889|NCT00278148|21046670|P2|COMPLETED|Phase I - Dose Escalation||2
8536890|NCT00278148|21046671|P1|COMPLETED|Phase I - Dose Escalation||4
8536891|NCT00278148|21046669|P3|STARTED|Phase I - Dose Escalation||3
8536892|NCT00278148|21046670|P2|STARTED|Phase I - Dose Escalation||2
8536893|NCT00278148|21046671|P1|STARTED|Phase I - Dose Escalation||4
8536894|NCT00278109|21046683|P1|NOT COMPLETED|Overall Study||4
8536895|NCT00278109|21046683|P1|COMPLETED|Overall Study||21
8536896|NCT00278109|21046683|P1|Completed 3 Cycles of Chemotherapy|Overall Study||25
8536897|NCT00278109|21046683|P1|STARTED|Overall Study||25
8536898|NCT00277524|21046687|P4|NOT COMPLETED|Overall Study||0
8536899|NCT00277524|21046688|P3|NOT COMPLETED|Overall Study||0
8536900|NCT00277524|21046689|P2|NOT COMPLETED|Overall Study||0
8536901|NCT00277524|21046690|P1|NOT COMPLETED|Overall Study||0
8536902|NCT00277524|21046687|P4|COMPLETED|Overall Study||850
8536903|NCT00277524|21046688|P3|COMPLETED|Overall Study||1088
8536904|NCT00277524|21046689|P2|COMPLETED|Overall Study||324
8536905|NCT00277524|21046690|P1|COMPLETED|Overall Study||621
8536906|NCT00277524|21046687|P4|STARTED|Overall Study||850
8536907|NCT00277524|21046688|P3|STARTED|Overall Study||1088
8536908|NCT00277524|21046689|P2|STARTED|Overall Study||324
8536909|NCT00277524|21046690|P1|STARTED|Overall Study||621
8536910|NCT00277446|21046708|P1|NOT COMPLETED|Overall Study||0
8536911|NCT00277446|21046708|P1|COMPLETED|Overall Study||13
8536912|NCT00277446|21046708|P1|STARTED|Overall Study||13
8536913|NCT00277394|21046716|P2|NOT COMPLETED|Overall Study||24
8536914|NCT00277394|21046717|P1|NOT COMPLETED|Overall Study||37
8536915|NCT00277394|21046716|P2|COMPLETED|Overall Study||246
8536916|NCT00277394|21046717|P1|COMPLETED|Overall Study||232
8536917|NCT00277394|21046716|P2|STARTED|Overall Study||270
8536918|NCT00277394|21046717|P1|STARTED|Overall Study||269
8536919|NCT00277355|21046729|P2|NOT COMPLETED|Overall Study||5
8536920|NCT00277355|21046730|P1|NOT COMPLETED|Overall Study||14
8536921|NCT00277355|21046729|P2|COMPLETED|Overall Study||22
8536922|NCT00277355|21046730|P1|COMPLETED|Overall Study||73
8536923|NCT00277355|21046729|P2|STARTED|Overall Study||27
8536924|NCT00277355|21046730|P1|STARTED|Overall Study||87
8536925|NCT00277212|21046738|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
8536926|NCT00277212|21046739|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
8536927|NCT00277212|21046740|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
8536928|NCT00277212|21046738|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
8536929|NCT00277212|21046739|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
8536930|NCT00277212|21046740|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
8536931|NCT00277212|21046738|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
8536932|NCT00277212|21046739|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
8536933|NCT00277212|21046740|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
8536934|NCT00277212|21046738|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
8536935|NCT00277212|21046739|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
8536936|NCT00277212|21046740|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
8536937|NCT00277212|21046738|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
8536938|NCT00277212|21046739|P2|STARTED|Phase 2 - Double-Blind Treatment||173
8536939|NCT00277212|21046740|P1|STARTED|Phase 2 - Double-Blind Treatment||0
8536940|NCT00277212|21046738|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
8536941|NCT00277212|21046739|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
8536942|NCT00277212|21046740|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
8536943|NCT00277212|21046738|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
8536944|NCT00277212|21046739|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
8536945|NCT00277212|21046740|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
8536946|NCT00277212|21046738|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
8536947|NCT00277212|21046739|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
8536948|NCT00277212|21046740|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
8536949|NCT00277212|21046738|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
8536950|NCT00277212|21046739|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
8536951|NCT00277212|21046740|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
8536952|NCT00277212|21046738|P3|STARTED|Phase 1 - Single-Blind Treatment||0
8536953|NCT00277212|21046739|P2|STARTED|Phase 1 - Single-Blind Treatment||0
8536954|NCT00277212|21046740|P1|STARTED|Phase 1 - Single-Blind Treatment||787
8536955|NCT00277095|21046778|P1|NOT COMPLETED|Overall Study||21
8536956|NCT00277095|21046778|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
8536957|NCT00277095|21046778|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
8536958|NCT00276861|21046782|P1|NOT COMPLETED|Overall Study||0
8536959|NCT00276861|21046782|P1|COMPLETED|Overall Study||10
8536960|NCT00276861|21046782|P1|STARTED|Overall Study||10
8536961|NCT00276744|21046787|P1|NOT COMPLETED|PART B||0
8536962|NCT00276744|21046787|P1|COMPLETED|PART B||0
8536963|NCT00276744|21046787|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
8536964|NCT00276744|21046787|P1|NOT COMPLETED|PART A||98
8536965|NCT00276744|21046787|P1|COMPLETED|PART A||142
8536966|NCT00276744|21046787|P1|STARTED|PART A||240
8536967|NCT00276614|21046791|P1|NOT COMPLETED|Overall Study||3
8536968|NCT00276614|21046791|P1|COMPLETED|Overall Study||1
8536969|NCT00276614|21046791|P1|STARTED|Overall Study||4
8536970|NCT00276549|21046795|P1|NOT COMPLETED|Overall Study||0
8536971|NCT00276549|21046795|P1|COMPLETED|Overall Study||35
8536972|NCT00276549|21046795|P1|STARTED|Overall Study||35
8536973|NCT00276484|21046802|P2|NOT COMPLETED|Overall Study||13
8536974|NCT00276484|21046803|P1|NOT COMPLETED|Overall Study||9
8536975|NCT00276484|21046802|P2|COMPLETED|Overall Study||278
8536976|NCT00276484|21046803|P1|COMPLETED|Overall Study||279
8536977|NCT00276484|21046802|P2|STARTED|Overall Study||291
8536978|NCT00276484|21046803|P1|STARTED|Overall Study||288
8536979|NCT00276458|21046835|P2|NOT COMPLETED|Overall Study||7
8536980|NCT00276458|21046836|P1|NOT COMPLETED|Overall Study||6
8536981|NCT00276458|21046835|P2|COMPLETED|Overall Study||91
8536982|NCT00276458|21046836|P1|COMPLETED|Overall Study||92
8536983|NCT00276458|21046835|P2|STARTED|Overall Study||98
8536984|NCT00276458|21046836|P1|STARTED|Overall Study||98
8536985|NCT00276419|21046870|P2|NOT COMPLETED|Second Intervention||0
8536986|NCT00276419|21046871|P1|NOT COMPLETED|Second Intervention||0
8536987|NCT00276419|21046870|P2|COMPLETED|Second Intervention||8
8536988|NCT00276419|21046871|P1|COMPLETED|Second Intervention||7
8536989|NCT00276419|21046870|P2|STARTED|Second Intervention||8
8536990|NCT00276419|21046871|P1|STARTED|Second Intervention||7
8536991|NCT00276419|21046870|P2|NOT COMPLETED|Wash-out Phase||0
8536992|NCT00276419|21046871|P1|NOT COMPLETED|Wash-out Phase||0
8536993|NCT00276419|21046870|P2|COMPLETED|Wash-out Phase||8
8536994|NCT00276419|21046871|P1|COMPLETED|Wash-out Phase||7
8536995|NCT00276419|21046870|P2|STARTED|Wash-out Phase||8
8536996|NCT00276419|21046871|P1|STARTED|Wash-out Phase||7
8536997|NCT00276419|21046870|P2|NOT COMPLETED|First Intervention||2
8536998|NCT00276419|21046871|P1|NOT COMPLETED|First Intervention||1
8536999|NCT00276419|21046870|P2|COMPLETED|First Intervention||8
8537000|NCT00276419|21046871|P1|COMPLETED|First Intervention||7
8537001|NCT00276419|21046870|P2|STARTED|First Intervention||10
8537002|NCT00276419|21046871|P1|STARTED|First Intervention||8
8537003|NCT00276406|21046883|P2|NOT COMPLETED|Overall Study||0
8537004|NCT00276406|21046884|P1|NOT COMPLETED|Overall Study||0
8537005|NCT00276406|21046883|P2|COMPLETED|Overall Study||14
8537006|NCT00276406|21046884|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
8537007|NCT00276406|21046883|P2|STARTED|Overall Study||14
8537008|NCT00276406|21046884|P1|STARTED|Overall Study||16
8537009|NCT00276380|21046914|P2|NOT COMPLETED|Overall Study||14
8537010|NCT00276380|21046915|P1|NOT COMPLETED|Overall Study||14
8537011|NCT00276380|21046914|P2|COMPLETED|Overall Study||88
8537012|NCT00276380|21046915|P1|COMPLETED|Overall Study||88
8537013|NCT00276380|21046914|P2|STARTED|Overall Study||102
8537014|NCT00276380|21046915|P1|STARTED|Overall Study||102
8537015|NCT00276250|21046936|P3|NOT COMPLETED|Overall Study||0
8537016|NCT00276250|21046937|P2|NOT COMPLETED|Overall Study||0
8537017|NCT00276250|21046938|P1|NOT COMPLETED|Overall Study||0
8537018|NCT00276250|21046936|P3|COMPLETED|Overall Study||0
8537019|NCT00276250|21046937|P2|COMPLETED|Overall Study||1
8537020|NCT00276250|21046938|P1|COMPLETED|Overall Study||4
8537021|NCT00276250|21046936|P3|STARTED|Overall Study||0
8537022|NCT00276250|21046937|P2|STARTED|Overall Study||1
8537023|NCT00276250|21046938|P1|STARTED|Overall Study||4
8537024|NCT00276159|21046970|P1|NOT COMPLETED|Overall Study||6
8537025|NCT00276159|21046970|P1|COMPLETED|Overall Study||0
8537026|NCT00276159|21046970|P1|STARTED|Overall Study||6
8537027|NCT00276094|21046980|P3|NOT COMPLETED|Overall Study||38
8537028|NCT00276094|21046981|P2|NOT COMPLETED|Overall Study||42
8537029|NCT00276094|21046982|P1|NOT COMPLETED|Overall Study||57
8537030|NCT00276094|21046980|P3|COMPLETED|Overall Study||230
8537031|NCT00276094|21046981|P2|COMPLETED|Overall Study||234
8537032|NCT00276094|21046982|P1|COMPLETED|Overall Study||225
8537033|NCT00276094|21046980|P3|STARTED|Overall Study||268
8537034|NCT00276094|21046981|P2|STARTED|Overall Study||276
8537035|NCT00276094|21046982|P1|STARTED|Overall Study||282
8537036|NCT00276016|21047035|P6|NOT COMPLETED|Intervention 3||0
8537037|NCT00276016|21047036|P5|NOT COMPLETED|Intervention 3||0
8537038|NCT00276016|21047037|P4|NOT COMPLETED|Intervention 3||0
8537039|NCT00276016|21047038|P3|NOT COMPLETED|Intervention 3||0
8537040|NCT00276016|21047039|P2|NOT COMPLETED|Intervention 3||0
8537041|NCT00276016|21047040|P1|NOT COMPLETED|Intervention 3||0
8537042|NCT00276016|21047035|P6|COMPLETED|Intervention 3||6
8537043|NCT00276016|21047036|P5|COMPLETED|Intervention 3||6
8537044|NCT00276016|21047037|P4|COMPLETED|Intervention 3||6
8537045|NCT00276016|21047038|P3|COMPLETED|Intervention 3||7
8537046|NCT00276016|21047039|P2|COMPLETED|Intervention 3||6
8537047|NCT00276016|21047040|P1|COMPLETED|Intervention 3||7
8537048|NCT00276016|21047035|P6|STARTED|Intervention 3||6
8537049|NCT00276016|21047036|P5|STARTED|Intervention 3||6
8537050|NCT00276016|21047037|P4|STARTED|Intervention 3||6
8537051|NCT00276016|21047038|P3|STARTED|Intervention 3||7
8537052|NCT00276016|21047039|P2|STARTED|Intervention 3||6
8537053|NCT00276016|21047040|P1|STARTED|Intervention 3||7
8537054|NCT00276016|21047035|P6|NOT COMPLETED|Wash Out 2||0
8537055|NCT00276016|21047036|P5|NOT COMPLETED|Wash Out 2||0
8537056|NCT00276016|21047037|P4|NOT COMPLETED|Wash Out 2||0
8537057|NCT00276016|21047038|P3|NOT COMPLETED|Wash Out 2||0
8537058|NCT00276016|21047039|P2|NOT COMPLETED|Wash Out 2||0
8537059|NCT00276016|21047040|P1|NOT COMPLETED|Wash Out 2||0
8537060|NCT00276016|21047035|P6|COMPLETED|Wash Out 2||6
8537061|NCT00276016|21047036|P5|COMPLETED|Wash Out 2||6
8537062|NCT00276016|21047037|P4|COMPLETED|Wash Out 2||6
8537063|NCT00276016|21047038|P3|COMPLETED|Wash Out 2||7
8537064|NCT00276016|21047039|P2|COMPLETED|Wash Out 2||6
8537065|NCT00276016|21047040|P1|COMPLETED|Wash Out 2||7
8537066|NCT00276016|21047035|P6|STARTED|Wash Out 2||6
8537067|NCT00276016|21047036|P5|STARTED|Wash Out 2||6
8537068|NCT00276016|21047037|P4|STARTED|Wash Out 2||6
8537069|NCT00276016|21047038|P3|STARTED|Wash Out 2||7
8537070|NCT00276016|21047039|P2|STARTED|Wash Out 2||6
8537071|NCT00276016|21047040|P1|STARTED|Wash Out 2||7
8537072|NCT00276016|21047035|P6|NOT COMPLETED|Intervention 2||0
8537073|NCT00276016|21047036|P5|NOT COMPLETED|Intervention 2||0
8537074|NCT00276016|21047037|P4|NOT COMPLETED|Intervention 2||0
8537075|NCT00276016|21047038|P3|NOT COMPLETED|Intervention 2||0
8537076|NCT00276016|21047039|P2|NOT COMPLETED|Intervention 2||0
8537077|NCT00276016|21047040|P1|NOT COMPLETED|Intervention 2||0
8537078|NCT00276016|21047035|P6|COMPLETED|Intervention 2||6
8537079|NCT00276016|21047036|P5|COMPLETED|Intervention 2||6
8537080|NCT00276016|21047037|P4|COMPLETED|Intervention 2||6
8537081|NCT00276016|21047038|P3|COMPLETED|Intervention 2||7
8537082|NCT00276016|21047039|P2|COMPLETED|Intervention 2||6
8537083|NCT00276016|21047040|P1|COMPLETED|Intervention 2||7
8537084|NCT00276016|21047035|P6|STARTED|Intervention 2||6
8537085|NCT00276016|21047036|P5|STARTED|Intervention 2||6
8537086|NCT00276016|21047037|P4|STARTED|Intervention 2||6
8537087|NCT00276016|21047038|P3|STARTED|Intervention 2||7
8537088|NCT00276016|21047039|P2|STARTED|Intervention 2||6
8537089|NCT00276016|21047040|P1|STARTED|Intervention 2||7
8537090|NCT00276016|21047035|P6|NOT COMPLETED|Wash Out 1||0
8537091|NCT00276016|21047036|P5|NOT COMPLETED|Wash Out 1||0
8537092|NCT00276016|21047037|P4|NOT COMPLETED|Wash Out 1||0
8537093|NCT00276016|21047038|P3|NOT COMPLETED|Wash Out 1||0
8537094|NCT00276016|21047039|P2|NOT COMPLETED|Wash Out 1||0
8537095|NCT00276016|21047040|P1|NOT COMPLETED|Wash Out 1||0
8537096|NCT00276016|21047035|P6|COMPLETED|Wash Out 1||6
8537097|NCT00276016|21047036|P5|COMPLETED|Wash Out 1||6
8537098|NCT00276016|21047037|P4|COMPLETED|Wash Out 1||6
8537099|NCT00276016|21047038|P3|COMPLETED|Wash Out 1||7
8537100|NCT00276016|21047039|P2|COMPLETED|Wash Out 1||6
8537101|NCT00276016|21047040|P1|COMPLETED|Wash Out 1||7
8537102|NCT00276016|21047035|P6|STARTED|Wash Out 1||6
8537103|NCT00276016|21047036|P5|STARTED|Wash Out 1||6
8537104|NCT00276016|21047037|P4|STARTED|Wash Out 1||6
8537105|NCT00276016|21047038|P3|STARTED|Wash Out 1||7
8537106|NCT00276016|21047039|P2|STARTED|Wash Out 1||6
8537107|NCT00276016|21047040|P1|STARTED|Wash Out 1||7
8537108|NCT00276016|21047035|P6|NOT COMPLETED|Intervention 1||0
8537109|NCT00276016|21047036|P5|NOT COMPLETED|Intervention 1||0
8537110|NCT00276016|21047037|P4|NOT COMPLETED|Intervention 1||0
8537111|NCT00276016|21047038|P3|NOT COMPLETED|Intervention 1||0
8537112|NCT00276016|21047039|P2|NOT COMPLETED|Intervention 1||1
8537113|NCT00276016|21047040|P1|NOT COMPLETED|Intervention 1||0
8537114|NCT00276016|21047035|P6|COMPLETED|Intervention 1||6
8537115|NCT00276016|21047036|P5|COMPLETED|Intervention 1||6
8537116|NCT00276016|21047037|P4|COMPLETED|Intervention 1||6
8537117|NCT00276016|21047038|P3|COMPLETED|Intervention 1||7
8537118|NCT00276016|21047039|P2|COMPLETED|Intervention 1||6
8537119|NCT00276016|21047040|P1|COMPLETED|Intervention 1||7
8537120|NCT00276016|21047035|P6|STARTED|Intervention 1||6
8537121|NCT00276016|21047036|P5|STARTED|Intervention 1||6
8537122|NCT00276016|21047037|P4|STARTED|Intervention 1||6
8537123|NCT00276016|21047038|P3|STARTED|Intervention 1||7
8537124|NCT00276016|21047039|P2|STARTED|Intervention 1||7
8537125|NCT00276016|21047040|P1|STARTED|Intervention 1||7
8537126|NCT00275834|21047052|P3|NOT COMPLETED|Overall Study||1
8537127|NCT00275834|21047053|P2|NOT COMPLETED|Overall Study||3
8537128|NCT00275834|21047054|P1|NOT COMPLETED|Overall Study||3
8537129|NCT00275834|21047052|P3|COMPLETED|Overall Study||74
8537130|NCT00275834|21047053|P2|COMPLETED|Overall Study||73
8537131|NCT00275834|21047054|P1|COMPLETED|Overall Study||71
8537132|NCT00275834|21047052|P3|Completed Study While on Study Drug|Overall Study||62
8537133|NCT00275834|21047053|P2|Completed Study While on Study Drug|Overall Study||51
8537134|NCT00275834|21047054|P1|Completed Study While on Study Drug|Overall Study||54
8537135|NCT00275834|21047052|P3|STARTED|Overall Study||75
8537136|NCT00275834|21047053|P2|STARTED|Overall Study||76
8537137|NCT00275834|21047054|P1|STARTED|Overall Study||74
8537138|NCT00275821|21047086|P3|NOT COMPLETED|Overall Study||12
8537139|NCT00275821|21047087|P2|NOT COMPLETED|Overall Study||23
8537140|NCT00275821|21047088|P1|NOT COMPLETED|Overall Study||14
8537141|NCT00275821|21047086|P3|COMPLETED|Overall Study||103
8537142|NCT00275821|21047087|P2|COMPLETED|Overall Study||95
8537143|NCT00275821|21047088|P1|COMPLETED|Overall Study||106
8537144|NCT00275821|21047086|P3|STARTED|Overall Study||115
8537145|NCT00275821|21047087|P2|STARTED|Overall Study||118
8537146|NCT00275821|21047088|P1|STARTED|Overall Study||120
8537147|NCT00275561|21047107|P2|NOT COMPLETED|Overall Study||6
8537148|NCT00275561|21047108|P1|NOT COMPLETED|Overall Study||2
8537149|NCT00275561|21047107|P2|COMPLETED|Overall Study||15
8537150|NCT00275561|21047108|P1|COMPLETED|Overall Study||19
8537151|NCT00275561|21047107|P2|STARTED|Overall Study||21
8537152|NCT00275561|21047108|P1|STARTED|Overall Study||21
8537153|NCT00275509|21047120|P2|NOT COMPLETED|Overall Study||1
8537154|NCT00275509|21047121|P1|NOT COMPLETED|Overall Study||0
8537155|NCT00275509|21047120|P2|COMPLETED|Overall Study||25
8537156|NCT00275509|21047121|P1|COMPLETED|Overall Study||30
8537157|NCT00275509|21047120|P2|STARTED|Overall Study||26
8537158|NCT00275509|21047121|P1|STARTED|Overall Study||30
8537159|NCT00275392|21047133|P2|NOT COMPLETED|Overall Study||2
8537160|NCT00275392|21047134|P1|NOT COMPLETED|Overall Study||0
8537161|NCT00275392|21047133|P2|COMPLETED|Overall Study||17
8537162|NCT00275392|21047134|P1|COMPLETED|Overall Study||20
8537163|NCT00275392|21047133|P2|STARTED|Overall Study||19
8537164|NCT00275392|21047134|P1|STARTED|Overall Study||20
8537165|NCT00275340|21047144|P2|NOT COMPLETED|Overall Study||4
8537166|NCT00275340|21047145|P1|NOT COMPLETED|Overall Study||2
8537167|NCT00275340|21047144|P2|COMPLETED|Overall Study||45
8537168|NCT00275340|21047145|P1|COMPLETED|Overall Study||50
8537169|NCT00275340|21047144|P2|STARTED|Overall Study||49
8537170|NCT00275340|21047145|P1|STARTED|Overall Study||52
8537171|NCT00275301|21047149|P1|NOT COMPLETED|Overall Study||5
8537172|NCT00275301|21047149|P1|COMPLETED|Overall Study||14
8537173|NCT00275301|21047149|P1|STARTED|Overall Study||19
8537174|NCT00275275|21047156|P3|NOT COMPLETED|Overall Study||6
8537175|NCT00275275|21047157|P2|NOT COMPLETED|Overall Study||2
8537176|NCT00275275|21047158|P1|NOT COMPLETED|Overall Study||6
8537177|NCT00275275|21047156|P3|COMPLETED|Overall Study||15
8537178|NCT00275275|21047157|P2|COMPLETED|Overall Study||18
8537179|NCT00275275|21047158|P1|COMPLETED|Overall Study||14
8537180|NCT00275275|21047156|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
8537181|NCT00275275|21047157|P2|STARTED|Overall Study||20
8537182|NCT00275275|21047158|P1|STARTED|Overall Study||20
8537183|NCT00275262|21047168|P2|NOT COMPLETED|Overall Study||9
8537184|NCT00275262|21047169|P1|NOT COMPLETED|Overall Study||6
8537185|NCT00275262|21047168|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
8537186|NCT00275262|21047169|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
8537187|NCT00275262|21047168|P2|STARTED|Overall Study||13
8537188|NCT00275262|21047169|P1|STARTED|Overall Study||12
8537189|NCT00275028|21047183|P1|NOT COMPLETED|Overall Study||47
8537190|NCT00275028|21047183|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
8537191|NCT00275028|21047183|P1|STARTED|Overall Study||47
8537192|NCT00275002|21047190|P2|NOT COMPLETED|Overall Study||16
8537193|NCT00275002|21047191|P1|NOT COMPLETED|Overall Study||22
8537194|NCT00275002|21047190|P2|COMPLETED|Overall Study||0
8537195|NCT00275002|21047191|P1|COMPLETED|Overall Study||3
8537196|NCT00275002|21047190|P2|STARTED|Overall Study||16
8537197|NCT00275002|21047191|P1|STARTED|Overall Study||25
8537198|NCT00274937|21047199|P1|NOT COMPLETED|Overall Study||20
8537199|NCT00274937|21047199|P1|COMPLETED|Overall Study||91
8537200|NCT00274937|21047199|P1|STARTED|Overall Study||111
8537201|NCT00274924|21047211|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
8537202|NCT00274924|21047212|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
8537203|NCT00274924|21047213|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
8537204|NCT00274924|21047211|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
8537205|NCT00274924|21047212|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
8537206|NCT00274924|21047213|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
8537207|NCT00274924|21047211|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
8537208|NCT00274924|21047212|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
8537209|NCT00274924|21047213|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
8537210|NCT00274924|21047211|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
8537211|NCT00274924|21047212|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
8537212|NCT00274924|21047213|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
8537213|NCT00274924|21047211|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
8537214|NCT00274924|21047212|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
8537215|NCT00274924|21047213|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
8537216|NCT00274924|21047211|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
8537217|NCT00274924|21047212|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
8537218|NCT00274924|21047213|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
8537219|NCT00274924|21047211|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
8537220|NCT00274924|21047212|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
8537221|NCT00274924|21047213|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
8537222|NCT00274924|21047211|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
8537223|NCT00274924|21047212|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
8537224|NCT00274924|21047213|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
8537225|NCT00274924|21047211|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
8537226|NCT00274924|21047212|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
8537227|NCT00274924|21047213|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
8537228|NCT00274846|21047222|P1|NOT COMPLETED|Overall Study||1
8537229|NCT00274846|21047222|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
8537230|NCT00274846|21047222|P1|STARTED|Overall Study||21
8537231|NCT00274781|21047230|P1|NOT COMPLETED|Overall Study||0
8537232|NCT00274781|21047230|P1|COMPLETED|Overall Study||30
8537233|NCT00274781|21047230|P1|STARTED|Overall Study||30
8537234|NCT00274768|21047236|P1|NOT COMPLETED|Overall Study||0
8537235|NCT00274768|21047236|P1|COMPLETED|Overall Study||26
8537236|NCT00274768|21047236|P1|STARTED|Overall Study||26
8537237|NCT00274742|21047251|P6|NOT COMPLETED|Overall Study||3
8537238|NCT00274742|21047252|P5|NOT COMPLETED|Overall Study||16
8537239|NCT00274742|21047253|P4|NOT COMPLETED|Overall Study||5
8537240|NCT00274742|21047254|P3|NOT COMPLETED|Overall Study||2
8537241|NCT00274742|21047255|P2|NOT COMPLETED|Overall Study||8
8537242|NCT00274742|21047256|P1|NOT COMPLETED|Overall Study||0
8537243|NCT00274742|21047251|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
8537244|NCT00274742|21047252|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
8537245|NCT00274742|21047253|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
8537246|NCT00274742|21047254|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
8537247|NCT00274742|21047255|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
8537248|NCT00274742|21047256|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
8537249|NCT00274742|21047251|P6|STARTED|Overall Study||4
8537250|NCT00274742|21047252|P5|STARTED|Overall Study||32
8537251|NCT00274742|21047253|P4|STARTED|Overall Study||9
8537252|NCT00274742|21047254|P3|STARTED|Overall Study||6
8537253|NCT00274742|21047255|P2|STARTED|Overall Study||13
8537254|NCT00274742|21047256|P1|STARTED|Overall Study||12
8537255|NCT00274716|21047294|P6|NOT COMPLETED|Phase B||1
8537256|NCT00274716|21047295|P5|NOT COMPLETED|Phase B||0
8537257|NCT00274716|21047296|P4|NOT COMPLETED|Phase B||1
8537258|NCT00274716|21047297|P3|NOT COMPLETED|Phase B||3
8537259|NCT00274716|21047298|P2|NOT COMPLETED|Phase B||4
8537260|NCT00274716|21047299|P1|NOT COMPLETED|Phase B||1
8537261|NCT00274716|21047294|P6|COMPLETED|Phase B||14
8537262|NCT00274716|21047295|P5|COMPLETED|Phase B||16
8537263|NCT00274716|21047296|P4|COMPLETED|Phase B||41
8537264|NCT00274716|21047297|P3|COMPLETED|Phase B||41
8537265|NCT00274716|21047298|P2|COMPLETED|Phase B||40
8537266|NCT00274716|21047299|P1|COMPLETED|Phase B||42
8537267|NCT00274716|21047294|P6|STARTED|Phase B||15
8537268|NCT00274716|21047295|P5|STARTED|Phase B||16
8537269|NCT00274716|21047296|P4|STARTED|Phase B||42
8537270|NCT00274716|21047297|P3|STARTED|Phase B||44
8537271|NCT00274716|21047298|P2|STARTED|Phase B||44
8537272|NCT00274716|21047299|P1|STARTED|Phase B||43
8537273|NCT00274716|21047294|P6|NOT COMPLETED|Phase A||4
8537274|NCT00274716|21047295|P5|NOT COMPLETED|Phase A||3
8537275|NCT00274716|21047296|P4|NOT COMPLETED|Phase A||9
8537276|NCT00274716|21047297|P3|NOT COMPLETED|Phase A||8
8537277|NCT00274716|21047298|P2|NOT COMPLETED|Phase A||10
8537278|NCT00274716|21047299|P1|NOT COMPLETED|Phase A||11
8537279|NCT00274716|21047294|P6|COMPLETED|Phase A||15
8537280|NCT00274716|21047295|P5|COMPLETED|Phase A||16
8537281|NCT00274716|21047296|P4|COMPLETED|Phase A||42
8537282|NCT00274716|21047297|P3|COMPLETED|Phase A||44
8537283|NCT00274716|21047298|P2|COMPLETED|Phase A||44
8537284|NCT00274716|21047299|P1|COMPLETED|Phase A||43
8537285|NCT00274716|21047294|P6|STARTED|Phase A||19
8537286|NCT00274716|21047295|P5|STARTED|Phase A||19
8537287|NCT00274716|21047296|P4|STARTED|Phase A||51
8537288|NCT00274716|21047297|P3|STARTED|Phase A||52
8537289|NCT00274716|21047298|P2|STARTED|Phase A||54
8537290|NCT00274716|21047299|P1|STARTED|Phase A||54
8537291|NCT00274651|21047361|P2|NOT COMPLETED|Overall Study||20
8537292|NCT00274651|21047362|P1|NOT COMPLETED|Overall Study||28
8537293|NCT00274651|21047361|P2|COMPLETED|Overall Study||4
8537294|NCT00274651|21047362|P1|COMPLETED|Overall Study||1
8537295|NCT00274651|21047361|P2|STARTED|Overall Study||24
8537296|NCT00274651|21047362|P1|STARTED|Overall Study||29
8537297|NCT00274625|21047377|P2|NOT COMPLETED|Overall Study||62
8537298|NCT00274625|21047378|P1|NOT COMPLETED|Overall Study||60
8537299|NCT00274625|21047377|P2|COMPLETED|Overall Study||141
8537300|NCT00274625|21047378|P1|COMPLETED|Overall Study||139
8537301|NCT00274625|21047377|P2|STARTED|Overall Study||203
8537302|NCT00274625|21047378|P1|STARTED|Overall Study||199
8537303|NCT00274469|21047386|P2|NOT COMPLETED|Overall Study||93
8537304|NCT00274469|21047387|P1|NOT COMPLETED|Overall Study||79
8537305|NCT00274469|21047386|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
8537306|NCT00274469|21047387|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
8537307|NCT00274469|21047386|P2|STARTED|Overall Study|Number of patients randomized|103
8537308|NCT00274469|21047387|P1|STARTED|Overall Study|Number of patients randomized|102
8537309|NCT00274456|21047407|P4|NOT COMPLETED|Overall Study||45
8537310|NCT00274456|21047408|P3|NOT COMPLETED|Overall Study||35
8537311|NCT00274456|21047409|P2|NOT COMPLETED|Overall Study||27
8537312|NCT00274456|21047410|P1|NOT COMPLETED|Overall Study||37
8537313|NCT00274456|21047407|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
8537314|NCT00274456|21047408|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
8537315|NCT00274456|21047409|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
8537316|NCT00274456|21047410|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
8537317|NCT00274456|21047407|P4|At Least One Response Assessment|Overall Study||70
8537318|NCT00274456|21047408|P3|At Least One Response Assessment|Overall Study||73
8537319|NCT00274456|21047409|P2|At Least One Response Assessment|Overall Study||76
8537320|NCT00274456|21047410|P1|At Least One Response Assessment|Overall Study||73
8537321|NCT00274456|21047407|P4|STARTED|Overall Study||74
8537322|NCT00274456|21047408|P3|STARTED|Overall Study||74
8537323|NCT00274456|21047409|P2|STARTED|Overall Study||76
8537324|NCT00274456|21047410|P1|STARTED|Overall Study||76
8537325|NCT00274287|21047452|P1|NOT COMPLETED|Overall Study||2
8537326|NCT00274287|21047452|P1|COMPLETED|Overall Study||13
8537327|NCT00274287|21047452|P1|STARTED|Overall Study||15
8537328|NCT00274261|21047462|P2|NOT COMPLETED|Overall Study||337
8537329|NCT00274261|21047463|P1|NOT COMPLETED|Overall Study||489
8537330|NCT00274261|21047462|P2|COMPLETED|Overall Study||296
8537331|NCT00274261|21047463|P1|COMPLETED|Overall Study||443
8537332|NCT00274261|21047462|P2|STARTED|Overall Study||633
8537333|NCT00274261|21047463|P1|STARTED|Overall Study||932
8537334|NCT00273910|21047477|P6|NOT COMPLETED|Overall Study||0
8537335|NCT00273910|21047478|P5|NOT COMPLETED|Overall Study||0
8537336|NCT00273910|21047479|P4|NOT COMPLETED|Overall Study||0
8537337|NCT00273910|21047480|P3|NOT COMPLETED|Overall Study||0
8537338|NCT00273910|21047481|P2|NOT COMPLETED|Overall Study||0
8537339|NCT00273910|21047482|P1|NOT COMPLETED|Overall Study||0
8537340|NCT00273910|21047477|P6|COMPLETED|Overall Study||14
8537341|NCT00273910|21047478|P5|COMPLETED|Overall Study||15
8537342|NCT00273910|21047479|P4|COMPLETED|Overall Study||19
8537343|NCT00273910|21047480|P3|COMPLETED|Overall Study||18
8537344|NCT00273910|21047481|P2|COMPLETED|Overall Study||19
8537345|NCT00273910|21047482|P1|COMPLETED|Overall Study||19
8537346|NCT00273910|21047477|P6|STARTED|Overall Study||14
8537347|NCT00273910|21047478|P5|STARTED|Overall Study||15
8537348|NCT00273910|21047479|P4|STARTED|Overall Study||19
8537349|NCT00273910|21047480|P3|STARTED|Overall Study||18
8537350|NCT00273910|21047481|P2|STARTED|Overall Study||19
8537351|NCT00273910|21047482|P1|STARTED|Overall Study||19
8537352|NCT00273858|21047502|P1|NOT COMPLETED|Overall Study||537
8537353|NCT00273858|21047502|P1|COMPLETED|Overall Study||343
8537354|NCT00273858|21047502|P1|STARTED|Overall Study||880
8537355|NCT00273793|21047517|P6|NOT COMPLETED|Overall Study||0
8537356|NCT00273793|21047518|P5|NOT COMPLETED|Overall Study||0
8537357|NCT00273793|21047519|P4|NOT COMPLETED|Overall Study||0
8537358|NCT00273793|21047520|P3|NOT COMPLETED|Overall Study||0
8537359|NCT00273793|21047521|P2|NOT COMPLETED|Overall Study||0
8537360|NCT00273793|21047522|P1|NOT COMPLETED|Overall Study||0
8537361|NCT00273793|21047517|P6|COMPLETED|Overall Study||29
8537362|NCT00273793|21047518|P5|COMPLETED|Overall Study||58
8537363|NCT00273793|21047519|P4|COMPLETED|Overall Study||60
8537364|NCT00273793|21047520|P3|COMPLETED|Overall Study||18
8537365|NCT00273793|21047521|P2|COMPLETED|Overall Study||38
8537366|NCT00273793|21047522|P1|COMPLETED|Overall Study||36
8537367|NCT00273793|21047517|P6|STARTED|Overall Study||29
8537368|NCT00273793|21047518|P5|STARTED|Overall Study||58
8537369|NCT00273793|21047519|P4|STARTED|Overall Study||60
8537370|NCT00273793|21047520|P3|STARTED|Overall Study||18
8537371|NCT00273793|21047521|P2|STARTED|Overall Study||38
8537372|NCT00273793|21047522|P1|STARTED|Overall Study||36
8537373|NCT00273754|21047544|P2|NOT COMPLETED|Overall Study||0
8537374|NCT00273754|21047545|P1|NOT COMPLETED|Overall Study||0
8537375|NCT00273754|21047544|P2|COMPLETED|Overall Study||36
8537376|NCT00273754|21047545|P1|COMPLETED|Overall Study||36
8537377|NCT00273754|21047544|P2|STARTED|Overall Study||36
8537378|NCT00273754|21047545|P1|STARTED|Overall Study||36
8537379|NCT00273364|21047563|P2|NOT COMPLETED|Overall Study||0
8537380|NCT00273364|21047564|P1|NOT COMPLETED|Overall Study||0
8537381|NCT00273364|21047563|P2|COMPLETED|Overall Study||55
8537382|NCT00273364|21047564|P1|COMPLETED|Overall Study||55
8537383|NCT00273364|21047563|P2|STARTED|Overall Study||55
8537384|NCT00273364|21047564|P1|STARTED|Overall Study||55
8537385|NCT00273182|21047570|P1|NOT COMPLETED|Overall Study||985
8537386|NCT00273182|21047570|P1|COMPLETED|Overall Study||1014
8537387|NCT00273182|21047570|P1|STARTED|Overall Study||1999
8537388|NCT00273052|21047580|P2|NOT COMPLETED|Overall Study||88
8537389|NCT00273052|21047581|P1|NOT COMPLETED|Overall Study||69
8537390|NCT00273052|21047580|P2|COMPLETED|Overall Study||190
8537391|NCT00273052|21047581|P1|COMPLETED|Overall Study||221
8537392|NCT00273052|21047580|P2|STARTED|Overall Study||278
8537393|NCT00273052|21047581|P1|STARTED|Overall Study||290
8537394|NCT00272987|21047616|P3|NOT COMPLETED|Overall Study||11
8537395|NCT00272987|21047617|P2|NOT COMPLETED|Overall Study||4
8537396|NCT00272987|21047618|P1|NOT COMPLETED|Overall Study||9
8537397|NCT00272987|21047616|P3|COMPLETED|Overall Study||9
8537398|NCT00272987|21047617|P2|COMPLETED|Overall Study||10
8537399|NCT00272987|21047618|P1|COMPLETED|Overall Study||20
8537400|NCT00272987|21047616|P3|STARTED|Overall Study||20
8537401|NCT00272987|21047617|P2|STARTED|Overall Study||14
8537402|NCT00272987|21047618|P1|STARTED|Overall Study||29
8537403|NCT00272961|21047688|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537404|NCT00272961|21047689|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
8537405|NCT00272961|21047690|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537406|NCT00272961|21047691|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537407|NCT00272961|21047692|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
8537408|NCT00272961|21047688|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
8537409|NCT00272961|21047689|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
8537410|NCT00272961|21047690|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
8537411|NCT00272961|21047691|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537412|NCT00272961|21047692|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
8537413|NCT00272961|21047688|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8537414|NCT00272961|21047689|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8537415|NCT00272961|21047690|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
8537416|NCT00272961|21047691|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
8537417|NCT00272961|21047692|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8537418|NCT00272961|21047688|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537419|NCT00272961|21047689|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537420|NCT00272961|21047690|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537421|NCT00272961|21047691|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537422|NCT00272961|21047692|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
8537423|NCT00272961|21047688|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537424|NCT00272961|21047689|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537425|NCT00272961|21047690|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537426|NCT00272961|21047691|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537427|NCT00272961|21047692|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
8537428|NCT00272961|21047688|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537429|NCT00272961|21047689|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537430|NCT00272961|21047690|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537431|NCT00272961|21047691|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537432|NCT00272961|21047692|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
8537433|NCT00272844|21047749|P1|NOT COMPLETED|Overall Study||5
8537434|NCT00272844|21047749|P1|COMPLETED|Overall Study||18
8537435|NCT00272844|21047749|P1|STARTED|Overall Study||23
8537436|NCT00272792|21047757|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
8537437|NCT00272792|21047758|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
8537438|NCT00272792|21047757|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
8537439|NCT00272792|21047758|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
8537440|NCT00272792|21047757|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
8537441|NCT00272792|21047758|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
8537442|NCT00272792|21047757|P2|NOT COMPLETED|Part 1: Responsiveness||0
8537443|NCT00272792|21047758|P1|NOT COMPLETED|Part 1: Responsiveness||1
8537444|NCT00272792|21047757|P2|COMPLETED|Part 1: Responsiveness||0
8537445|NCT00272792|21047758|P1|COMPLETED|Part 1: Responsiveness||89
8537446|NCT00272792|21047757|P2|STARTED|Part 1: Responsiveness||0
8537447|NCT00272792|21047758|P1|STARTED|Part 1: Responsiveness||90
8537448|NCT00272779|21047768|P2|NOT COMPLETED|Baseline Through Week 96||136
8537449|NCT00272779|21047769|P1|NOT COMPLETED|Baseline Through Week 96||139
8537450|NCT00272779|21047768|P2|COMPLETED|Baseline Through Week 96||307
8537451|NCT00272779|21047769|P1|COMPLETED|Baseline Through Week 96||301
8537452|NCT00272779|21047768|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
8537453|NCT00272779|21047769|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
8537454|NCT00272779|21047768|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
8537455|NCT00272779|21047769|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
8537456|NCT00272779|21047768|P2|NOT COMPLETED|Baseline Through Week 48||443
8537457|NCT00272779|21047769|P1|NOT COMPLETED|Baseline Through Week 48||440
8537458|NCT00272779|21047768|P2|COMPLETED|Baseline Through Week 48||0
8537459|NCT00272779|21047769|P1|COMPLETED|Baseline Through Week 48||0
8537460|NCT00272779|21047768|P2|STILL ON TREATMENT|Baseline Through Week 48||368
8537461|NCT00272779|21047769|P1|STILL ON TREATMENT|Baseline Through Week 48||385
8537462|NCT00272779|21047768|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
8537463|NCT00272779|21047769|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
8537464|NCT00272779|21047768|P2|Discontinued Before Week 48|Baseline Through Week 48||58
8537465|NCT00272779|21047769|P1|Discontinued Before Week 48|Baseline Through Week 48||39
8537466|NCT00272779|21047768|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
8537467|NCT00272779|21047769|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
8537468|NCT00272779|21047768|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
8537469|NCT00272779|21047769|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
8537470|NCT00272779|21047768|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
8537471|NCT00272779|21047769|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
8537472|NCT00272337|21047953|P5|NOT COMPLETED|Overall Study||0
8537473|NCT00272337|21047954|P4|NOT COMPLETED|Overall Study||0
8537474|NCT00272337|21047955|P3|NOT COMPLETED|Overall Study||0
8537475|NCT00272337|21047956|P2|NOT COMPLETED|Overall Study||0
8537476|NCT00272337|21047957|P1|NOT COMPLETED|Overall Study||0
8537477|NCT00272337|21047953|P5|COMPLETED|Overall Study||8
8537478|NCT00272337|21047954|P4|COMPLETED|Overall Study||7
8537479|NCT00272337|21047955|P3|COMPLETED|Overall Study||7
8537480|NCT00272337|21047956|P2|COMPLETED|Overall Study||7
8537481|NCT00272337|21047957|P1|COMPLETED|Overall Study||8
8537482|NCT00272337|21047953|P5|STARTED|Overall Study||8
8537483|NCT00272337|21047954|P4|STARTED|Overall Study||7
8537484|NCT00272337|21047955|P3|STARTED|Overall Study||7
8537485|NCT00272337|21047956|P2|STARTED|Overall Study||7
8537486|NCT00272337|21047957|P1|STARTED|Overall Study||8
8537487|NCT00272311|21047984|P5|NOT COMPLETED|Overall Study||0
8537488|NCT00272311|21047985|P4|NOT COMPLETED|Overall Study||0
8537489|NCT00272311|21047986|P3|NOT COMPLETED|Overall Study||0
8537490|NCT00272311|21047987|P2|NOT COMPLETED|Overall Study||0
8537491|NCT00272311|21047988|P1|NOT COMPLETED|Overall Study||0
8537492|NCT00272311|21047984|P5|COMPLETED|Overall Study||14
8537493|NCT00272311|21047985|P4|COMPLETED|Overall Study||14
8537494|NCT00272311|21047986|P3|COMPLETED|Overall Study||14
8537495|NCT00272311|21047987|P2|COMPLETED|Overall Study||14
8537496|NCT00272311|21047988|P1|COMPLETED|Overall Study||14
8537497|NCT00272311|21047984|P5|STARTED|Overall Study||14
8537498|NCT00272311|21047985|P4|STARTED|Overall Study||14
8537499|NCT00272311|21047986|P3|STARTED|Overall Study||14
8537500|NCT00272311|21047987|P2|STARTED|Overall Study||14
8537501|NCT00272311|21047988|P1|STARTED|Overall Study||14
8537502|NCT00272168|21048012|P2|NOT COMPLETED|Overall Study||10
8537503|NCT00272168|21048013|P1|NOT COMPLETED|Overall Study||10
8537504|NCT00272168|21048012|P2|COMPLETED|Overall Study||31
8537505|NCT00272168|21048013|P1|COMPLETED|Overall Study||37
8537506|NCT00272168|21048012|P2|STARTED|Overall Study||41
8537507|NCT00272168|21048013|P1|STARTED|Overall Study||47
8537508|NCT00272038|21048029|P1|NOT COMPLETED|Overall Study||7
8537509|NCT00272038|21048029|P1|COMPLETED|Overall Study||22
8537510|NCT00272038|21048029|P1|STARTED|Overall Study||29
8537511|NCT00271947|21048035|P1|NOT COMPLETED|Overall Study||1
8537512|NCT00271947|21048035|P1|COMPLETED|Overall Study||0
8537513|NCT00271947|21048035|P1|STARTED|Overall Study||1
8537514|NCT00271856|21048041|P2|NOT COMPLETED|Overall Study||18
8537515|NCT00271856|21048042|P1|NOT COMPLETED|Overall Study||11
8537516|NCT00271856|21048041|P2|COMPLETED|Overall Study||70
8537517|NCT00271856|21048042|P1|COMPLETED|Overall Study||78
8537518|NCT00271856|21048041|P2|STARTED|Overall Study||88
8537519|NCT00271856|21048042|P1|STARTED|Overall Study||89
8537520|NCT00271817|21048061|P3|NOT COMPLETED|Part 2||84
8537521|NCT00271817|21048062|P2|NOT COMPLETED|Part 2||32
8537522|NCT00271817|21048063|P1|NOT COMPLETED|Part 2||0
8537523|NCT00271817|21048061|P3|COMPLETED|Part 2||401
8537524|NCT00271817|21048062|P2|COMPLETED|Part 2||234
8537525|NCT00271817|21048063|P1|COMPLETED|Part 2||0
8537526|NCT00271817|21048061|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
8537527|NCT00271817|21048062|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
8537528|NCT00271817|21048063|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
8537529|NCT00271817|21048061|P3|NOT COMPLETED|Part 1||285
8537530|NCT00271817|21048062|P2|NOT COMPLETED|Part 1||59
8537531|NCT00271817|21048063|P1|NOT COMPLETED|Part 1||106
8537532|NCT00271817|21048061|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
8537533|NCT00271817|21048062|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
8537534|NCT00271817|21048063|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
8537535|NCT00271817|21048061|P3|STARTED|Part 1||676
8537536|NCT00271817|21048062|P2|STARTED|Part 1||272
8537537|NCT00271817|21048063|P1|STARTED|Part 1||272
8537538|NCT00271739|21048092|P2|NOT COMPLETED|Overall Study||105
8537539|NCT00271739|21048093|P1|NOT COMPLETED|Overall Study||115
8537540|NCT00271739|21048092|P2|COMPLETED|Overall Study||716
8537541|NCT00271739|21048093|P1|COMPLETED|Overall Study||729
8537542|NCT00271739|21048092|P2|STARTED|Overall Study||821
8537543|NCT00271739|21048093|P1|STARTED|Overall Study||844
8537544|NCT00271609|21048105|P2|NOT COMPLETED|Overall Study||3
8537545|NCT00271609|21048106|P1|NOT COMPLETED|Overall Study||13
8537546|NCT00271609|21048105|P2|COMPLETED|Overall Study||29
8537547|NCT00271609|21048106|P1|COMPLETED|Overall Study||43
8537548|NCT00271609|21048105|P2|STARTED|Overall Study||32
8537549|NCT00271609|21048106|P1|STARTED|Overall Study||56
8537550|NCT00271596|21048116|P2|NOT COMPLETED|Overall Study||1
8537551|NCT00271596|21048117|P1|NOT COMPLETED|Overall Study||1
8537552|NCT00271596|21048116|P2|COMPLETED|Overall Study||15
8537553|NCT00271596|21048117|P1|COMPLETED|Overall Study||16
8537554|NCT00271596|21048116|P2|STARTED|Overall Study||16
8537555|NCT00271596|21048117|P1|STARTED|Overall Study||17
8537556|NCT00271570|21048143|P2|NOT COMPLETED|Overall Study||0
8537557|NCT00271570|21048144|P1|NOT COMPLETED|Overall Study||0
8537558|NCT00271570|21048143|P2|COMPLETED|Overall Study||12
8537559|NCT00271570|21048144|P1|COMPLETED|Overall Study||12
8537560|NCT00271570|21048143|P2|STARTED|Overall Study||12
8537561|NCT00271570|21048144|P1|STARTED|Overall Study||12
8537562|NCT00271544|21048152|P1|NOT COMPLETED|Overall Study||20
8537563|NCT00271544|21048152|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
8537564|NCT00271544|21048152|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
8537565|NCT00271544|21048152|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
8537566|NCT00271544|21048152|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
8537567|NCT00271505|21048173|P1|NOT COMPLETED|Overall Study||5
8537568|NCT00271505|21048173|P1|COMPLETED|Overall Study||38
8537569|NCT00271505|21048173|P1|STARTED|Overall Study||43
8537570|NCT00271375|21048182|P3|NOT COMPLETED|Overall Study||0
8537571|NCT00271375|21048183|P2|NOT COMPLETED|Overall Study||0
8537572|NCT00271375|21048184|P1|NOT COMPLETED|Overall Study||0
8537573|NCT00271375|21048182|P3|COMPLETED|Overall Study||57
8537574|NCT00271375|21048183|P2|COMPLETED|Overall Study||83
8537575|NCT00271375|21048184|P1|COMPLETED|Overall Study||114
8537576|NCT00271375|21048182|P3|STARTED|Overall Study||57
8537577|NCT00271375|21048183|P2|STARTED|Overall Study||83
8537578|NCT00271375|21048184|P1|STARTED|Overall Study||114
8537579|NCT00271219|21048222|P2|NOT COMPLETED|Overall Study||28
8537580|NCT00271219|21048223|P1|NOT COMPLETED|Overall Study||16
8537581|NCT00271219|21048222|P2|COMPLETED|Overall Study||58
8537582|NCT00271219|21048223|P1|COMPLETED|Overall Study||73
8537583|NCT00271219|21048222|P2|STARTED|Overall Study||86
8537584|NCT00271219|21048223|P1|STARTED|Overall Study||89
8537585|NCT00271154|21048249|P2|NOT COMPLETED|Overall Study||0
8537586|NCT00271154|21048250|P1|NOT COMPLETED|Overall Study||0
8537587|NCT00271154|21048249|P2|COMPLETED|Overall Study||419
8537588|NCT00271154|21048250|P1|COMPLETED|Overall Study||191
8537589|NCT00271154|21048249|P2|STARTED|Overall Study||419
8537590|NCT00271154|21048250|P1|STARTED|Overall Study||191
8537591|NCT00271102|21048261|P2|NOT COMPLETED|Overall Study||5
8537592|NCT00271102|21048262|P1|NOT COMPLETED|Overall Study||5
8537593|NCT00271102|21048261|P2|COMPLETED|Overall Study||30
8537594|NCT00271102|21048262|P1|COMPLETED|Overall Study||30
8537595|NCT00271102|21048261|P2|STARTED|Overall Study||35
8537596|NCT00271102|21048262|P1|STARTED|Overall Study||35
8537597|NCT00271024|21048272|P4|NOT COMPLETED|Overall Study||24
8537598|NCT00271024|21048273|P3|NOT COMPLETED|Overall Study||23
8537599|NCT00271024|21048274|P2|NOT COMPLETED|Overall Study||26
8537600|NCT00271024|21048275|P1|NOT COMPLETED|Overall Study||22
8537601|NCT00271024|21048272|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
8537602|NCT00271024|21048273|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
8537603|NCT00271024|21048274|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
8537604|NCT00271024|21048275|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
8537694|NCT00270231|21048524|P2|COMPLETED|Second Intervention||30
8537605|NCT00271024|21048272|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
8537606|NCT00271024|21048273|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
8537607|NCT00271024|21048274|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
8537608|NCT00271024|21048275|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
8537609|NCT00271024|21048272|P4|STARTED|Overall Study||88
8537610|NCT00271024|21048273|P3|STARTED|Overall Study||88
8537611|NCT00271024|21048274|P2|STARTED|Overall Study||77
8537612|NCT00271024|21048275|P1|STARTED|Overall Study||80
8537613|NCT00271011|21048317|P1|NOT COMPLETED|Overall Study||0
8537614|NCT00271011|21048317|P1|COMPLETED|Overall Study||13
8537615|NCT00271011|21048317|P1|STARTED|Overall Study||13
8537616|NCT00270998|21048325|P3|NOT COMPLETED|12 Month Follow-up||21
8537617|NCT00270998|21048326|P2|NOT COMPLETED|12 Month Follow-up||25
8537618|NCT00270998|21048327|P1|NOT COMPLETED|12 Month Follow-up||14
8537619|NCT00270998|21048325|P3|COMPLETED|12 Month Follow-up||111
8537620|NCT00270998|21048326|P2|COMPLETED|12 Month Follow-up||99
8537621|NCT00270998|21048327|P1|COMPLETED|12 Month Follow-up||96
8537622|NCT00270998|21048325|P3|STARTED|12 Month Follow-up||132
8537623|NCT00270998|21048326|P2|STARTED|12 Month Follow-up||124
8537624|NCT00270998|21048327|P1|STARTED|12 Month Follow-up||110
8537625|NCT00270998|21048325|P3|NOT COMPLETED|3 Month Follow-up||18
8537626|NCT00270998|21048326|P2|NOT COMPLETED|3 Month Follow-up||22
8537627|NCT00270998|21048327|P1|NOT COMPLETED|3 Month Follow-up||39
8537628|NCT00270998|21048325|P3|COMPLETED|3 Month Follow-up||132
8537629|NCT00270998|21048326|P2|COMPLETED|3 Month Follow-up||124
8537630|NCT00270998|21048327|P1|COMPLETED|3 Month Follow-up||110
8537631|NCT00270998|21048325|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
8537632|NCT00270998|21048326|P2|STARTED|3 Month Follow-up||146
8537633|NCT00270998|21048327|P1|STARTED|3 Month Follow-up||149
8537634|NCT00270894|21048356|P1|NOT COMPLETED|Overall Study||2
8537635|NCT00270894|21048356|P1|COMPLETED|Overall Study||28
8537636|NCT00270894|21048356|P1|STARTED|Overall Study||30
8537637|NCT00270855|21048368|P2|NOT COMPLETED|Overall Study||8
8537638|NCT00270855|21048369|P1|NOT COMPLETED|Overall Study||8
8537639|NCT00270855|21048368|P2|COMPLETED|Overall Study||6
8537640|NCT00270855|21048369|P1|COMPLETED|Overall Study||7
8537641|NCT00270855|21048368|P2|STARTED|Overall Study||14
8537642|NCT00270855|21048369|P1|STARTED|Overall Study||15
8537643|NCT00270842|21048428|P3|NOT COMPLETED|Overall Study||16
8537644|NCT00270842|21048429|P2|NOT COMPLETED|Overall Study||16
8537645|NCT00270842|21048430|P1|NOT COMPLETED|Overall Study||15
8537646|NCT00270842|21048428|P3|COMPLETED|Overall Study||18
8537647|NCT00270842|21048429|P2|COMPLETED|Overall Study||18
8537648|NCT00270842|21048430|P1|COMPLETED|Overall Study||18
8537649|NCT00270842|21048428|P3|STARTED|Overall Study||34
8537650|NCT00270842|21048429|P2|STARTED|Overall Study||34
8537651|NCT00270842|21048430|P1|STARTED|Overall Study||33
8537652|NCT00270790|21048441|P1|NOT COMPLETED|Overall Study||5
8537653|NCT00270790|21048441|P1|COMPLETED|Overall Study||16
8537654|NCT00270790|21048441|P1|STARTED|Overall Study||21
8537655|NCT00270634|21048450|P4|NOT COMPLETED|Overall Study||5
8537656|NCT00270634|21048451|P3|NOT COMPLETED|Overall Study||22
8537657|NCT00270634|21048452|P2|NOT COMPLETED|Overall Study||13
8537658|NCT00270634|21048453|P1|NOT COMPLETED|Overall Study||17
8537659|NCT00270634|21048450|P4|COMPLETED|Overall Study||81
8537660|NCT00270634|21048451|P3|COMPLETED|Overall Study||62
8537661|NCT00270634|21048452|P2|COMPLETED|Overall Study||64
8537662|NCT00270634|21048453|P1|COMPLETED|Overall Study||70
8537663|NCT00270634|21048450|P4|STARTED|Overall Study||86
8537664|NCT00270634|21048451|P3|STARTED|Overall Study||84
8537665|NCT00270634|21048452|P2|STARTED|Overall Study||77
8537666|NCT00270634|21048453|P1|STARTED|Overall Study||87
8537667|NCT00270296|21048490|P3|NOT COMPLETED|Overall Study||61
8537668|NCT00270296|21048491|P2|NOT COMPLETED|Overall Study||90
8537669|NCT00270296|21048492|P1|NOT COMPLETED|Overall Study||99
8537670|NCT00270296|21048490|P3|COMPLETED|Overall Study||109
8537671|NCT00270296|21048491|P2|COMPLETED|Overall Study||185
8537672|NCT00270296|21048492|P1|COMPLETED|Overall Study||186
8537673|NCT00270296|21048490|P3|STARTED|Overall Study||170
8537674|NCT00270296|21048491|P2|STARTED|Overall Study||275
8537675|NCT00270296|21048492|P1|STARTED|Overall Study||285
8537676|NCT00270257|21048505|P2|NOT COMPLETED|Overall Study||424
8537677|NCT00270257|21048506|P1|NOT COMPLETED|Overall Study||412
8537678|NCT00270257|21048505|P2|COMPLETED|Overall Study||204
8537679|NCT00270257|21048506|P1|COMPLETED|Overall Study||211
8537680|NCT00270257|21048505|P2|Visit 104|Overall Study||204
8537681|NCT00270257|21048506|P1|Visit 104|Overall Study||211
8537682|NCT00270257|21048505|P2|Week 78|Overall Study||285
8537683|NCT00270257|21048506|P1|Week 78|Overall Study||283
8537684|NCT00270257|21048505|P2|Week 52|Overall Study||340
8537685|NCT00270257|21048506|P1|Week 52|Overall Study||362
8537686|NCT00270257|21048505|P2|Week 26|Overall Study||440
8537687|NCT00270257|21048506|P1|Week 26|Overall Study||460
8537688|NCT00270257|21048505|P2|Week 8|Overall Study||443
8537689|NCT00270257|21048506|P1|Week 8|Overall Study||510
8537690|NCT00270257|21048505|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
8537691|NCT00270257|21048506|P1|STARTED|Overall Study||623
8537692|NCT00270231|21048524|P2|NOT COMPLETED|Second Intervention||1
8537693|NCT00270231|21048525|P1|NOT COMPLETED|Second Intervention||0
8537695|NCT00270231|21048525|P1|COMPLETED|Second Intervention||30
8537696|NCT00270231|21048524|P2|STARTED|Second Intervention||31
8537697|NCT00270231|21048525|P1|STARTED|Second Intervention||30
8537698|NCT00270231|21048524|P2|NOT COMPLETED|Washout Period||0
8537699|NCT00270231|21048525|P1|NOT COMPLETED|Washout Period||1
8537700|NCT00270231|21048524|P2|COMPLETED|Washout Period||31
8537701|NCT00270231|21048525|P1|COMPLETED|Washout Period||30
8537702|NCT00270231|21048524|P2|STARTED|Washout Period||31
8537703|NCT00270231|21048525|P1|STARTED|Washout Period||31
8537704|NCT00270231|21048524|P2|NOT COMPLETED|First Intervention||1
8537705|NCT00270231|21048525|P1|NOT COMPLETED|First Intervention||1
8537706|NCT00270231|21048524|P2|COMPLETED|First Intervention||31
8537707|NCT00270231|21048525|P1|COMPLETED|First Intervention||31
8537708|NCT00270231|21048524|P2|STARTED|First Intervention||32
8537709|NCT00270231|21048525|P1|STARTED|First Intervention||32
8537710|NCT00270205|21048535|P4|NOT COMPLETED|Overall Study||1
8537711|NCT00270205|21048536|P3|NOT COMPLETED|Overall Study||0
8537712|NCT00270205|21048537|P2|NOT COMPLETED|Overall Study||0
8537713|NCT00270205|21048538|P1|NOT COMPLETED|Overall Study||1
8537714|NCT00270205|21048535|P4|COMPLETED|Overall Study||6
8537715|NCT00270205|21048536|P3|COMPLETED|Overall Study||6
8537716|NCT00270205|21048537|P2|COMPLETED|Overall Study||6
8537717|NCT00270205|21048538|P1|COMPLETED|Overall Study||5
8537718|NCT00270205|21048535|P4|STARTED|Overall Study||7
8537719|NCT00270205|21048536|P3|STARTED|Overall Study||6
8537720|NCT00270205|21048537|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
8537721|NCT00270205|21048538|P1|STARTED|Overall Study||6
8537722|NCT00269919|21048656|P1|NOT COMPLETED|Overall Study||27
8537723|NCT00269919|21048656|P1|COMPLETED|Overall Study||13
8537724|NCT00269919|21048656|P1|Treated|Overall Study||39
8537725|NCT00269919|21048656|P1|STARTED|Overall Study||40
8537726|NCT00269633|21048675|P2|NOT COMPLETED|Overall Study||0
8537727|NCT00269633|21048676|P1|NOT COMPLETED|Overall Study||1
8537728|NCT00269633|21048675|P2|COMPLETED|Overall Study||5
8537729|NCT00269633|21048676|P1|COMPLETED|Overall Study||3
8537730|NCT00269633|21048675|P2|STARTED|Overall Study||5
8537731|NCT00269633|21048676|P1|STARTED|Overall Study||4
8537732|NCT00269477|21048686|P4|NOT COMPLETED|Overall Study||0
8537733|NCT00269477|21048687|P3|NOT COMPLETED|Overall Study||1
8537734|NCT00269477|21048688|P2|NOT COMPLETED|Overall Study||6
8537735|NCT00269477|21048689|P1|NOT COMPLETED|Overall Study||5
8537736|NCT00269477|21048686|P4|COMPLETED|Overall Study||60
8537737|NCT00269477|21048687|P3|COMPLETED|Overall Study||57
8537738|NCT00269477|21048688|P2|COMPLETED|Overall Study||12
8537739|NCT00269477|21048689|P1|COMPLETED|Overall Study||4
8537740|NCT00269477|21048686|P4|STARTED|Overall Study||60
8537741|NCT00269477|21048687|P3|STARTED|Overall Study||58
8537742|NCT00269477|21048688|P2|STARTED|Overall Study||18
8537743|NCT00269477|21048689|P1|STARTED|Overall Study||9
8537744|NCT00269399|21048705|P2|NOT COMPLETED|Overall Study||27
8537745|NCT00269399|21048706|P1|NOT COMPLETED|Overall Study||41
8537746|NCT00269399|21048705|P2|COMPLETED|Overall Study||91
8537747|NCT00269399|21048706|P1|COMPLETED|Overall Study||78
8537748|NCT00269399|21048705|P2|STARTED|Overall Study||118
8537749|NCT00269399|21048706|P1|STARTED|Overall Study||119
8537750|NCT00269152|21048716|P2|NOT COMPLETED|Overall Study||10
8537751|NCT00269152|21048717|P1|NOT COMPLETED|Overall Study||18
8537752|NCT00269152|21048716|P2|COMPLETED|Overall Study||49
8537753|NCT00269152|21048717|P1|COMPLETED|Overall Study||45
8537754|NCT00269152|21048716|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
8537755|NCT00269152|21048717|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
8537756|NCT00269113|21048733|P2|NOT COMPLETED|Overall Study||37
8537757|NCT00269113|21048734|P1|NOT COMPLETED|Overall Study||74
8537758|NCT00269113|21048733|P2|COMPLETED|Overall Study||146
8537759|NCT00269113|21048734|P1|COMPLETED|Overall Study||103
8537760|NCT00269113|21048733|P2|STARTED|Overall Study||183
8537761|NCT00269113|21048734|P1|STARTED|Overall Study||177
8537762|NCT00269087|21048752|P1|NOT COMPLETED|Overall Study||34
8537763|NCT00269087|21048752|P1|COMPLETED|Overall Study||88
8537764|NCT00269087|21048752|P1|STARTED|Overall Study||122
8537765|NCT00268996|21048782|P2|NOT COMPLETED|Overall Study||20
8537766|NCT00268996|21048783|P1|NOT COMPLETED|Overall Study||21
8537767|NCT00268996|21048782|P2|COMPLETED|Overall Study||152
8537768|NCT00268996|21048783|P1|COMPLETED|Overall Study||130
8537769|NCT00268996|21048782|P2|STARTED|Overall Study||172
8537770|NCT00268996|21048783|P1|STARTED|Overall Study||151
8537771|NCT00268983|21048827|P2|NOT COMPLETED|Overall Study||0
8537772|NCT00268983|21048828|P1|NOT COMPLETED|Overall Study||3
8537773|NCT00268983|21048827|P2|COMPLETED|Overall Study||8
8537774|NCT00268983|21048828|P1|COMPLETED|Overall Study||3
8537775|NCT00268983|21048827|P2|STARTED|Overall Study||8
8537776|NCT00268983|21048828|P1|STARTED|Overall Study||6
8537777|NCT00268905|21048871|P3|NOT COMPLETED|Overall Study||12
8537778|NCT00268905|21048872|P2|NOT COMPLETED|Overall Study||9
8537779|NCT00268905|21048873|P1|NOT COMPLETED|Overall Study||43
8537780|NCT00268905|21048871|P3|COMPLETED|Overall Study||0
8537781|NCT00268905|21048872|P2|COMPLETED|Overall Study||0
8537782|NCT00268905|21048873|P1|COMPLETED|Overall Study||0
8537783|NCT00268905|21048871|P3|STARTED|Overall Study||12
8537784|NCT00268905|21048872|P2|STARTED|Overall Study||9
8537785|NCT00268905|21048873|P1|STARTED|Overall Study||43
8537786|NCT00268892|21048890|P3|NOT COMPLETED|Overall Study||39
8537787|NCT00268892|21048891|P2|NOT COMPLETED|Overall Study||42
8537788|NCT00268892|21048892|P1|NOT COMPLETED|Overall Study||39
8537789|NCT00268892|21048890|P3|COMPLETED|Overall Study||54
8537790|NCT00268892|21048891|P2|COMPLETED|Overall Study||53
8537791|NCT00268892|21048892|P1|COMPLETED|Overall Study||51
8537792|NCT00268892|21048890|P3|Switched to Higher Dose|Overall Study||76
8537793|NCT00268892|21048891|P2|Switched to Higher Dose|Overall Study||68
8537794|NCT00268892|21048892|P1|Switched to Higher Dose|Overall Study||59
8537795|NCT00268892|21048890|P3|STARTED|Overall Study||93
8537796|NCT00268892|21048891|P2|STARTED|Overall Study||95
8537797|NCT00268892|21048892|P1|STARTED|Overall Study||90
8537798|NCT00268762|21048903|P1|NOT COMPLETED|Overall Study||0
8537799|NCT00268762|21048903|P1|COMPLETED|Overall Study||65
8537800|NCT00268762|21048903|P1|STARTED|Overall Study||65
8537801|NCT00268463|21048911|P2|NOT COMPLETED|Overall Study||12
8537802|NCT00268463|21048912|P1|NOT COMPLETED|Overall Study||10
8537803|NCT00268463|21048911|P2|COMPLETED|Overall Study||0
8537804|NCT00268463|21048912|P1|COMPLETED|Overall Study||0
8537805|NCT00268463|21048911|P2|STARTED|Overall Study||12
8537806|NCT00268463|21048912|P1|STARTED|Overall Study||10
8537807|NCT00268450|21048918|P1|NOT COMPLETED|Overall Study||0
8537808|NCT00268450|21048918|P1|COMPLETED|Overall Study||21
8537809|NCT00268450|21048918|P1|STARTED|Overall Study||21
8537810|NCT00268437|21048928|P1|NOT COMPLETED|Overall Study||1
8537811|NCT00268437|21048928|P1|COMPLETED|Overall Study||26
8537812|NCT00268437|21048928|P1|STARTED|Overall Study||27
8537813|NCT00268346|21048935|P2|NOT COMPLETED|Overall Study||3
8537814|NCT00268346|21048936|P1|NOT COMPLETED|Overall Study||0
8537815|NCT00268346|21048935|P2|COMPLETED|Overall Study||37
8537816|NCT00268346|21048936|P1|COMPLETED|Overall Study||18
8537817|NCT00268346|21048935|P2|Started Treatment|Overall Study||40
8537818|NCT00268346|21048936|P1|Started Treatment|Overall Study||18
8537819|NCT00268346|21048935|P2|STARTED|Overall Study||40
8537820|NCT00268346|21048936|P1|STARTED|Overall Study||18
8537821|NCT00268242|21048942|P1|NOT COMPLETED|Overall Study||1
8537822|NCT00268242|21048942|P1|COMPLETED|Overall Study||23
8537823|NCT00268242|21048942|P1|STARTED|Overall Study||24
8537824|NCT00268203|21048951|P1|NOT COMPLETED|Overall Study||647
8537825|NCT00268203|21048951|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
8537826|NCT00268203|21048951|P1|Completed 2 Years of Follow-up|Overall Study||62
8537827|NCT00268203|21048951|P1|STARTED|Overall Study||765
8537828|NCT00267969|21048965|P7|NOT COMPLETED|After Controlled Period||72
8537829|NCT00267969|21048966|P6|NOT COMPLETED|After Controlled Period||82
8537830|NCT00267969|21048967|P5|NOT COMPLETED|After Controlled Period||35
8537831|NCT00267969|21048968|P4|NOT COMPLETED|After Controlled Period||36
8537832|NCT00267969|21048969|P3|NOT COMPLETED|After Controlled Period||0
8537833|NCT00267969|21048970|P2|NOT COMPLETED|After Controlled Period||0
8537834|NCT00267969|21048971|P1|NOT COMPLETED|After Controlled Period||0
8537835|NCT00267969|21048965|P7|COMPLETED|After Controlled Period||173
8537836|NCT00267969|21048966|P6|COMPLETED|After Controlled Period||172
8537837|NCT00267969|21048967|P5|COMPLETED|After Controlled Period||85
8537838|NCT00267969|21048968|P4|COMPLETED|After Controlled Period||87
8537839|NCT00267969|21048969|P3|COMPLETED|After Controlled Period||0
8537840|NCT00267969|21048970|P2|COMPLETED|After Controlled Period||0
8537841|NCT00267969|21048971|P1|COMPLETED|After Controlled Period||0
8537842|NCT00267969|21048965|P7|STARTED|After Controlled Period||245
8537843|NCT00267969|21048966|P6|STARTED|After Controlled Period||254
8537844|NCT00267969|21048967|P5|STARTED|After Controlled Period||120
8537845|NCT00267969|21048968|P4|STARTED|After Controlled Period||123
8537846|NCT00267969|21048969|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537847|NCT00267969|21048970|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537848|NCT00267969|21048971|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537849|NCT00267969|21048965|P7|NOT COMPLETED|Controlled Period||0
8537850|NCT00267969|21048966|P6|NOT COMPLETED|Controlled Period||0
8537851|NCT00267969|21048967|P5|NOT COMPLETED|Controlled Period||0
8537852|NCT00267969|21048968|P4|NOT COMPLETED|Controlled Period||0
8537853|NCT00267969|21048969|P3|NOT COMPLETED|Controlled Period||11
8537854|NCT00267969|21048970|P2|NOT COMPLETED|Controlled Period||1
8537855|NCT00267969|21048971|P1|NOT COMPLETED|Controlled Period||12
8537856|NCT00267969|21048965|P7|COMPLETED|Controlled Period||0
8537857|NCT00267969|21048966|P6|COMPLETED|Controlled Period||0
8537858|NCT00267969|21048967|P5|COMPLETED|Controlled Period||0
8537859|NCT00267969|21048968|P4|COMPLETED|Controlled Period||0
8537860|NCT00267969|21048969|P3|COMPLETED|Controlled Period||245
8537861|NCT00267969|21048970|P2|COMPLETED|Controlled Period||254
8537862|NCT00267969|21048971|P1|COMPLETED|Controlled Period||243
8537863|NCT00267969|21048965|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537864|NCT00267969|21048966|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537865|NCT00267969|21048967|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537866|NCT00267969|21048968|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537867|NCT00267969|21048969|P3|STARTED|Controlled Period|Number of patients randomized|256
8537868|NCT00267969|21048970|P2|STARTED|Controlled Period|Number of patients randomized|255
8537869|NCT00267969|21048971|P1|STARTED|Controlled Period|Number of patients randomized|255
8537870|NCT00267956|21048997|P4|NOT COMPLETED|After Controlled Period||2
8537871|NCT00267956|21048998|P3|NOT COMPLETED|After Controlled Period||5
8537872|NCT00267956|21048999|P2|NOT COMPLETED|After Controlled Period||0
8537873|NCT00267956|21049000|P1|NOT COMPLETED|After Controlled Period||0
8537874|NCT00267956|21048997|P4|COMPLETED|After Controlled Period||70
8537875|NCT00267956|21048998|P3|COMPLETED|After Controlled Period||52
8537876|NCT00267956|21048999|P2|COMPLETED|After Controlled Period||0
8537877|NCT00267956|21049000|P1|COMPLETED|After Controlled Period||0
8537878|NCT00267956|21048997|P4|STARTED|After Controlled Period||72
8537879|NCT00267956|21048998|P3|STARTED|After Controlled Period||57
8537880|NCT00267956|21048999|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537881|NCT00267956|21049000|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537882|NCT00267956|21048997|P4|NOT COMPLETED|Controlled Period||0
8537883|NCT00267956|21048998|P3|NOT COMPLETED|Controlled Period||0
8537884|NCT00267956|21048999|P2|NOT COMPLETED|Controlled Period||4
8537885|NCT00267956|21049000|P1|NOT COMPLETED|Controlled Period||13
8537886|NCT00267956|21048997|P4|COMPLETED|Controlled Period||0
8537887|NCT00267956|21048998|P3|COMPLETED|Controlled Period||0
8537888|NCT00267956|21048999|P2|COMPLETED|Controlled Period||72
8537889|NCT00267956|21049000|P1|COMPLETED|Controlled Period||57
8537890|NCT00267956|21048997|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537891|NCT00267956|21048998|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537892|NCT00267956|21048999|P2|STARTED|Controlled Period||76
8537893|NCT00267956|21049000|P1|STARTED|Controlled Period||70
8537894|NCT00267865|21049018|P1|NOT COMPLETED|Consolidation Treatment||0
8537895|NCT00267865|21049018|P1|COMPLETED|Consolidation Treatment||5
8537896|NCT00267865|21049018|P1|STARTED|Consolidation Treatment||5
8537897|NCT00267865|21049018|P1|NOT COMPLETED|Induction Treatment||3
8537898|NCT00267865|21049018|P1|COMPLETED|Induction Treatment||9
8537899|NCT00267865|21049018|P1|STARTED|Induction Treatment||12
8537900|NCT00267774|21049029|P2|NOT COMPLETED|Overall Study||0
8537901|NCT00267774|21049030|P1|NOT COMPLETED|Overall Study||0
8537902|NCT00267774|21049029|P2|COMPLETED|Overall Study||496
8537903|NCT00267774|21049030|P1|COMPLETED|Overall Study||509
8537904|NCT00267774|21049029|P2|STARTED|Overall Study||496
8537905|NCT00267774|21049030|P1|STARTED|Overall Study||509
8537906|NCT00267748|21049041|P3|NOT COMPLETED|Randomized Period||132
8537907|NCT00267748|21049042|P2|NOT COMPLETED|Randomized Period||127
8537908|NCT00267748|21049043|P1|NOT COMPLETED|Randomized Period||0
8537909|NCT00267748|21049041|P3|COMPLETED|Randomized Period||14
8537910|NCT00267748|21049042|P2|COMPLETED|Randomized Period||19
8537911|NCT00267748|21049043|P1|COMPLETED|Randomized Period||0
8537912|NCT00267748|21049041|P3|Treated|Randomized Period||143
8537913|NCT00267748|21049042|P2|Treated|Randomized Period||146
8537914|NCT00267748|21049043|P1|Treated|Randomized Period||0
8537915|NCT00267748|21049041|P3|STARTED|Randomized Period||146
8537916|NCT00267748|21049042|P2|STARTED|Randomized Period||146
8537917|NCT00267748|21049043|P1|STARTED|Randomized Period||0
8537918|NCT00267748|21049041|P3|NOT COMPLETED|Non-randomized Period||0
8537919|NCT00267748|21049042|P2|NOT COMPLETED|Non-randomized Period||0
8537920|NCT00267748|21049043|P1|NOT COMPLETED|Non-randomized Period||23
8537921|NCT00267748|21049041|P3|COMPLETED|Non-randomized Period||0
8537922|NCT00267748|21049042|P2|COMPLETED|Non-randomized Period||0
8537923|NCT00267748|21049043|P1|COMPLETED|Non-randomized Period||2
8537924|NCT00267748|21049041|P3|STARTED|Non-randomized Period||0
8537925|NCT00267748|21049042|P2|STARTED|Non-randomized Period||0
8537926|NCT00267748|21049043|P1|STARTED|Non-randomized Period||25
8537927|NCT00267696|21049060|P1|NOT COMPLETED|Overall Study||0
8537928|NCT00267696|21049060|P1|COMPLETED|Overall Study||45
8537929|NCT00267696|21049060|P1|STARTED|Overall Study||45
8537930|NCT00267670|21049067|P2|NOT COMPLETED|Overall Study||0
8537931|NCT00267670|21049068|P1|NOT COMPLETED|Overall Study||4
8537932|NCT00267670|21049067|P2|COMPLETED|Overall Study||7
8537933|NCT00267670|21049068|P1|COMPLETED|Overall Study||15
8537934|NCT00267670|21049067|P2|STARTED|Overall Study||7
8537935|NCT00267670|21049068|P1|STARTED|Overall Study||19
8537936|NCT00267644|21049082|P2|NOT COMPLETED|Overall Study||0
8537937|NCT00267644|21049083|P1|NOT COMPLETED|Overall Study||0
8537938|NCT00267644|21049082|P2|COMPLETED|Overall Study||63
8537939|NCT00267644|21049083|P1|COMPLETED|Overall Study||13
8537940|NCT00267644|21049082|P2|STARTED|Overall Study||63
8537941|NCT00267644|21049083|P1|STARTED|Overall Study||13
8537942|NCT00267631|21049093|P2|NOT COMPLETED|Overall Study||0
8537943|NCT00267631|21049094|P1|NOT COMPLETED|Overall Study||0
8537944|NCT00267631|21049093|P2|COMPLETED|Overall Study||3031
8537945|NCT00267631|21049094|P1|COMPLETED|Overall Study||2361
8537946|NCT00267631|21049093|P2|STARTED|Overall Study||3031
8537947|NCT00267631|21049094|P1|STARTED|Overall Study||2361
8537948|NCT00267488|21049100|P1|NOT COMPLETED|Overall Study||11
8537949|NCT00267488|21049100|P1|COMPLETED|Overall Study||26
8537950|NCT00267488|21049100|P1|STARTED|Overall Study||37
8537951|NCT00267293|21049112|P3|NOT COMPLETED|Overall Study||0
8537952|NCT00267293|21049113|P2|NOT COMPLETED|Overall Study||0
8537953|NCT00267293|21049114|P1|NOT COMPLETED|Overall Study||0
8537954|NCT00267293|21049112|P3|COMPLETED|Overall Study||20
8537955|NCT00267293|21049113|P2|COMPLETED|Overall Study||20
8537956|NCT00267293|21049114|P1|COMPLETED|Overall Study||20
8537957|NCT00267293|21049112|P3|STARTED|Overall Study||20
8537958|NCT00267293|21049113|P2|STARTED|Overall Study||20
8537959|NCT00267293|21049114|P1|STARTED|Overall Study||20
8537960|NCT00267202|21049124|P2|NOT COMPLETED|Overall Study||34
8537961|NCT00267202|21049125|P1|NOT COMPLETED|Overall Study||53
8537962|NCT00267202|21049124|P2|COMPLETED|Overall Study||105
8537963|NCT00267202|21049125|P1|COMPLETED|Overall Study||83
8537964|NCT00267202|21049124|P2|STARTED|Overall Study||139
8537965|NCT00267202|21049125|P1|STARTED|Overall Study||136
8537966|NCT00267189|21049146|P2|NOT COMPLETED|Overall Study||1
8537967|NCT00267189|21049147|P1|NOT COMPLETED|Overall Study||5
8537968|NCT00267189|21049146|P2|COMPLETED|Overall Study||72
8537969|NCT00267189|21049147|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
8537970|NCT00267189|21049146|P2|Completed Study Medication|Overall Study||72
8537971|NCT00267189|21049147|P1|Completed Study Medication|Overall Study||54
8537972|NCT00267189|21049146|P2|STARTED|Overall Study||73
8537973|NCT00267189|21049147|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
8537974|NCT00267150|21049157|P1|NOT COMPLETED|Overall Study||1
8537975|NCT00267150|21049157|P1|COMPLETED|Overall Study||30
8537976|NCT00267150|21049157|P1|STARTED|Overall Study||31
8537977|NCT00267111|21049164|P2|NOT COMPLETED|Overall Study||0
8537978|NCT00267111|21049165|P1|NOT COMPLETED|Overall Study||0
8537979|NCT00267111|21049164|P2|COMPLETED|Overall Study||55
8537980|NCT00267111|21049165|P1|COMPLETED|Overall Study||55
8537981|NCT00267111|21049164|P2|STARTED|Overall Study||55
8537982|NCT00267111|21049165|P1|STARTED|Overall Study||55
8537983|NCT00267098|21049181|P8|NOT COMPLETED|Overall Study||15
8537984|NCT00267098|21049182|P7|NOT COMPLETED|Overall Study||46
8537985|NCT00267098|21049183|P6|NOT COMPLETED|Overall Study||40
8537986|NCT00267098|21049184|P5|NOT COMPLETED|Overall Study||37
8537987|NCT00267098|21049185|P4|NOT COMPLETED|Overall Study||106
8537988|NCT00267098|21049186|P3|NOT COMPLETED|Overall Study||94
8537989|NCT00267098|21049187|P2|NOT COMPLETED|Overall Study||51
8537990|NCT00267098|21049188|P1|NOT COMPLETED|Overall Study||109
8537991|NCT00267098|21049181|P8|COMPLETED|Overall Study||5
8537992|NCT00267098|21049182|P7|COMPLETED|Overall Study||55
8537993|NCT00267098|21049183|P6|COMPLETED|Overall Study||66
8537994|NCT00267098|21049184|P5|COMPLETED|Overall Study||10
8537995|NCT00267098|21049185|P4|COMPLETED|Overall Study||135
8537996|NCT00267098|21049186|P3|COMPLETED|Overall Study||149
8537997|NCT00267098|21049187|P2|COMPLETED|Overall Study||0
8537998|NCT00267098|21049188|P1|COMPLETED|Overall Study||0
8537999|NCT00267098|21049181|P8|STARTED|Overall Study||20
8538000|NCT00267098|21049182|P7|STARTED|Overall Study||101
8538001|NCT00267098|21049183|P6|STARTED|Overall Study||106
8538002|NCT00267098|21049184|P5|STARTED|Overall Study||47
8538003|NCT00267098|21049185|P4|STARTED|Overall Study||241
8538004|NCT00267098|21049186|P3|STARTED|Overall Study||243
8538005|NCT00267098|21049187|P2|STARTED|Overall Study||51
8538006|NCT00267098|21049188|P1|STARTED|Overall Study||109
8538007|NCT00267085|21049321|P1|NOT COMPLETED|Overall Study||0
8538008|NCT00267085|21049321|P1|COMPLETED|Overall Study||10
8538009|NCT00267085|21049321|P1|STARTED|Overall Study||10
8538010|NCT00267059|21049325|P1|NOT COMPLETED|Overall Study||0
8538011|NCT00267059|21049325|P1|COMPLETED|Overall Study||44
8538012|NCT00267059|21049325|P1|STARTED|Overall Study||44
8538013|NCT00267046|21049331|P2|NOT COMPLETED|Overall Study||11
8538014|NCT00267046|21049332|P1|NOT COMPLETED|Overall Study||12
8538015|NCT00267046|21049331|P2|COMPLETED|Overall Study||5
8538016|NCT00267046|21049332|P1|COMPLETED|Overall Study||20
8538017|NCT00267046|21049331|P2|STARTED|Overall Study||16
8538018|NCT00267046|21049332|P1|STARTED|Overall Study||32
8538019|NCT00267020|21049342|P2|NOT COMPLETED|Overall Study||43
8538020|NCT00267020|21049343|P1|NOT COMPLETED|Overall Study||86
8538021|NCT00267020|21049342|P2|COMPLETED|Overall Study||1
8538022|NCT00267020|21049343|P1|COMPLETED|Overall Study||0
8538023|NCT00267020|21049342|P2|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
8538024|NCT00267020|21049343|P1|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
8538025|NCT00267020|21049342|P2|Received at Least 1 Dose|Overall Study||39
8538026|NCT00267020|21049343|P1|Received at Least 1 Dose|Overall Study||82
8538027|NCT00267020|21049342|P2|STARTED|Overall Study||44
8538028|NCT00267020|21049343|P1|STARTED|Overall Study||86
8538029|NCT00267007|21049365|P2|NOT COMPLETED|Overall Study||1
8538030|NCT00267007|21049366|P1|NOT COMPLETED|Overall Study||8
8538031|NCT00267007|21049365|P2|COMPLETED|Overall Study||10
8538032|NCT00267007|21049366|P1|COMPLETED|Overall Study||11
8538033|NCT00267007|21049365|P2|STARTED|Overall Study||11
8538034|NCT00267007|21049366|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
8538035|NCT00266877|21049377|P3|NOT COMPLETED|Overall Study||28
8538036|NCT00266877|21049378|P2|NOT COMPLETED|Overall Study||48
8538037|NCT00266877|21049379|P1|NOT COMPLETED|Overall Study||91
8538038|NCT00266877|21049377|P3|COMPLETED|Overall Study||0
8538039|NCT00266877|21049378|P2|COMPLETED|Overall Study||0
8538040|NCT00266877|21049379|P1|COMPLETED|Overall Study||0
8538041|NCT00266877|21049377|P3|STARTED|Overall Study||28
8538042|NCT00266877|21049378|P2|STARTED|Overall Study||48
8538043|NCT00266877|21049379|P1|STARTED|Overall Study||91
8538044|NCT00266864|21049398|P2|NOT COMPLETED|Overall Study||2
8538045|NCT00266864|21049399|P1|NOT COMPLETED|Overall Study||5
8538046|NCT00266864|21049398|P2|COMPLETED|Overall Study||11
8538047|NCT00266864|21049399|P1|COMPLETED|Overall Study||13
8538048|NCT00266864|21049398|P2|STARTED|Overall Study||13
8538049|NCT00266864|21049399|P1|STARTED|Overall Study||18
8538050|NCT00266851|21049409|P3|NOT COMPLETED|Overall Study||0
8538051|NCT00266851|21049410|P2|NOT COMPLETED|Overall Study||0
8538052|NCT00266851|21049411|P1|NOT COMPLETED|Overall Study||0
8538053|NCT00266851|21049409|P3|COMPLETED|Overall Study||22
8538054|NCT00266851|21049410|P2|COMPLETED|Overall Study||38
8538055|NCT00266851|21049411|P1|COMPLETED|Overall Study||37
8538056|NCT00266851|21049409|P3|Completed 12 Month Follow up|Overall Study||13
8538057|NCT00266851|21049410|P2|Completed 12 Month Follow up|Overall Study||19
8538058|NCT00266851|21049411|P1|Completed 12 Month Follow up|Overall Study||25
8538059|NCT00266851|21049409|P3|Completed 9 Month Follow up|Overall Study||15
8538060|NCT00266851|21049410|P2|Completed 9 Month Follow up|Overall Study||23
8538061|NCT00266851|21049411|P1|Completed 9 Month Follow up|Overall Study||22
8538062|NCT00266851|21049409|P3|Completed 6 Month Follow up|Overall Study||17
8538063|NCT00266851|21049410|P2|Completed 6 Month Follow up|Overall Study||22
8538064|NCT00266851|21049411|P1|Completed 6 Month Follow up|Overall Study||27
8538065|NCT00266851|21049409|P3|Completed 3 Month Follow up|Overall Study||15
8538066|NCT00266851|21049410|P2|Completed 3 Month Follow up|Overall Study||22
8538067|NCT00266851|21049411|P1|Completed 3 Month Follow up|Overall Study||26
8538068|NCT00266851|21049409|P3|STARTED|Overall Study||22
8538069|NCT00266851|21049410|P2|STARTED|Overall Study||38
8538070|NCT00266851|21049411|P1|STARTED|Overall Study||37
8538071|NCT00266825|21049430|P2|NOT COMPLETED|Completed Follow-Up||24
8538072|NCT00266825|21049431|P1|NOT COMPLETED|Completed Follow-Up||25
8538073|NCT00266825|21049430|P2|COMPLETED|Completed Follow-Up||154
8538074|NCT00266825|21049431|P1|COMPLETED|Completed Follow-Up||147
8538075|NCT00266825|21049430|P2|STARTED|Completed Follow-Up||178
8538076|NCT00266825|21049431|P1|STARTED|Completed Follow-Up||172
8538077|NCT00266825|21049430|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
8538078|NCT00266825|21049431|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
8538079|NCT00266825|21049430|P2|COMPLETED|Enrolled and Allocated Intervention||178
8538080|NCT00266825|21049431|P1|COMPLETED|Enrolled and Allocated Intervention||172
8538081|NCT00266825|21049430|P2|STARTED|Enrolled and Allocated Intervention||178
8538082|NCT00266825|21049431|P1|STARTED|Enrolled and Allocated Intervention||172
8538083|NCT00266812|21049457|P2|NOT COMPLETED|Overall Study||11
8538084|NCT00266812|21049458|P1|NOT COMPLETED|Overall Study||21
8538085|NCT00266812|21049457|P2|COMPLETED|Overall Study||2
8538086|NCT00266812|21049458|P1|COMPLETED|Overall Study||1
8538087|NCT00266812|21049457|P2|STARTED|Overall Study||13
8538088|NCT00266812|21049458|P1|STARTED|Overall Study||22
8538089|NCT00266799|21049466|P2|NOT COMPLETED|Overall Study||34
8538090|NCT00266799|21049467|P1|NOT COMPLETED|Overall Study||36
8538091|NCT00266799|21049466|P2|COMPLETED|Overall Study||68
8538092|NCT00266799|21049467|P1|COMPLETED|Overall Study||62
8538093|NCT00266799|21049466|P2|STARTED|Overall Study||102
8538094|NCT00266799|21049467|P1|STARTED|Overall Study||98
8538095|NCT00266708|21049483|P2|NOT COMPLETED|Overall Study||9
8538096|NCT00266708|21049484|P1|NOT COMPLETED|Overall Study||4
8538097|NCT00266708|21049483|P2|COMPLETED|Overall Study||13
8538098|NCT00266708|21049484|P1|COMPLETED|Overall Study||16
8538099|NCT00266708|21049483|P2|STARTED|Overall Study||22
8538100|NCT00266708|21049484|P1|STARTED|Overall Study||20
8538101|NCT00266695|21049524|P1|NOT COMPLETED|Overall Study||29
8538102|NCT00266695|21049524|P1|COMPLETED|Overall Study||174
8538103|NCT00266695|21049524|P1|STARTED|Overall Study||203
8538104|NCT00266656|21049536|P2|NOT COMPLETED|Overall Study||13
8538105|NCT00266656|21049537|P1|NOT COMPLETED|Overall Study||14
8538106|NCT00266656|21049536|P2|COMPLETED|Overall Study||20
8538107|NCT00266656|21049537|P1|COMPLETED|Overall Study||22
8538108|NCT00266656|21049536|P2|STARTED|Overall Study||33
8538109|NCT00266656|21049537|P1|STARTED|Overall Study||36
8538110|NCT00266630|21049561|P2|NOT COMPLETED|Overall Study||28
8538111|NCT00266630|21049562|P1|NOT COMPLETED|Overall Study||42
8538112|NCT00266630|21049561|P2|COMPLETED|Overall Study||11
8538113|NCT00266630|21049562|P1|COMPLETED|Overall Study||58
8538114|NCT00266630|21049561|P2|STARTED|Overall Study||39
8538115|NCT00266630|21049562|P1|STARTED|Overall Study||100
8538116|NCT00266409|21049604|P4|NOT COMPLETED|Overall Study||22
8538117|NCT00266409|21049605|P3|NOT COMPLETED|Overall Study||17
8538118|NCT00266409|21049606|P2|NOT COMPLETED|Overall Study||46
8538119|NCT00266409|21049607|P1|NOT COMPLETED|Overall Study||45
8538120|NCT00266409|21049604|P4|COMPLETED|Overall Study||49
8538121|NCT00266409|21049605|P3|COMPLETED|Overall Study||55
8538122|NCT00266409|21049606|P2|COMPLETED|Overall Study||92
8538123|NCT00266409|21049607|P1|COMPLETED|Overall Study||92
8538124|NCT00266409|21049604|P4|STARTED|Overall Study||71
8538125|NCT00266409|21049605|P3|STARTED|Overall Study||72
8538126|NCT00266409|21049606|P2|STARTED|Overall Study||138
8538127|NCT00266409|21049607|P1|STARTED|Overall Study||137
8538128|NCT00266279|21049889|P1|NOT COMPLETED|Overall Study||2
8538129|NCT00266279|21049889|P1|COMPLETED|Overall Study||15
8538130|NCT00266279|21049889|P1|STARTED|Overall Study||17
8538131|NCT00266227|21049896|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
8538132|NCT00266227|21049897|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
8538133|NCT00266227|21049898|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
8538134|NCT00266227|21049896|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
8538135|NCT00266227|21049897|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
8538136|NCT00266227|21049898|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
8538137|NCT00266227|21049896|P3|STARTED|Retreatment: Week 48 to Week 72||0
8538138|NCT00266227|21049897|P2|STARTED|Retreatment: Week 48 to Week 72||134
8538139|NCT00266227|21049898|P1|STARTED|Retreatment: Week 48 to Week 72||291
8538140|NCT00266227|21049896|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
8538141|NCT00266227|21049897|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
8538142|NCT00266227|21049898|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
8538143|NCT00266227|21049896|P3|COMPLETED|Retreatment: Up to Week 48||0
8538144|NCT00266227|21049897|P2|COMPLETED|Retreatment: Up to Week 48||134
8538145|NCT00266227|21049898|P1|COMPLETED|Retreatment: Up to Week 48||291
8538146|NCT00266227|21049896|P3|STARTED|Retreatment: Up to Week 48||0
8538147|NCT00266227|21049897|P2|STARTED|Retreatment: Up to Week 48||157
8538148|NCT00266227|21049898|P1|STARTED|Retreatment: Up to Week 48||318
8538149|NCT00266227|21049896|P3|NOT COMPLETED|Initial Treatment||77
8538150|NCT00266227|21049897|P2|NOT COMPLETED|Initial Treatment||0
8538151|NCT00266227|21049898|P1|NOT COMPLETED|Initial Treatment||0
8538152|NCT00266227|21049896|P3|COMPLETED|Initial Treatment||482
8538153|NCT00266227|21049897|P2|COMPLETED|Initial Treatment||0
8538154|NCT00266227|21049898|P1|COMPLETED|Initial Treatment||0
8538155|NCT00266227|21049896|P3|STARTED|Initial Treatment||559
8538156|NCT00266227|21049897|P2|STARTED|Initial Treatment||0
8538157|NCT00266227|21049898|P1|STARTED|Initial Treatment||0
8538158|NCT00266110|21049943|P1|NOT COMPLETED|Overall Study||7
8538159|NCT00266110|21049943|P1|COMPLETED|Overall Study||10
8538160|NCT00266110|21049943|P1|STARTED|Overall Study||17
8538161|NCT00266032|21049952|P3|NOT COMPLETED|Open-label Safety Extension||25
8538162|NCT00266032|21049953|P2|NOT COMPLETED|Open-label Safety Extension||14
8538163|NCT00266032|21049954|P1|NOT COMPLETED|Open-label Safety Extension||41
8538164|NCT00266032|21049952|P3|COMPLETED|Open-label Safety Extension||140
8538165|NCT00266032|21049953|P2|COMPLETED|Open-label Safety Extension||115
8538166|NCT00266032|21049954|P1|COMPLETED|Open-label Safety Extension||448
8538167|NCT00266032|21049952|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
8538168|NCT00266032|21049953|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
8538169|NCT00266032|21049954|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
8538170|NCT00266032|21049952|P3|NOT COMPLETED|Treatment||47
8538171|NCT00266032|21049953|P2|NOT COMPLETED|Treatment||64
8538172|NCT00266032|21049954|P1|NOT COMPLETED|Treatment||111
8538173|NCT00266032|21049952|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
8538174|NCT00266032|21049953|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
8538175|NCT00266032|21049954|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
8538176|NCT00266032|21049952|P3|Patients Treated and in FAS|Treatment|FAS|216
8538177|NCT00266032|21049953|P2|Patients Treated and in FAS|Treatment|FAS|209
8538178|NCT00266032|21049954|P1|Patients Treated and in FAS|Treatment|FAS|642
8538179|NCT00266032|21049952|P3|Patients Treated|Treatment||229
8538180|NCT00266032|21049953|P2|Patients Treated|Treatment||221
8538181|NCT00266032|21049954|P1|Patients Treated|Treatment||684
8538182|NCT00266032|21049952|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
8538183|NCT00266032|21049953|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
8538184|NCT00266032|21049954|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
8538185|NCT00265980|21049982|P1|NOT COMPLETED|Overall Study||0
8538186|NCT00265980|21049982|P1|COMPLETED|Overall Study||22
8538187|NCT00265980|21049982|P1|Weight -10% Leptin|Overall Study||22
8538188|NCT00265980|21049982|P1|Weight -10% Placebo|Overall Study||22
8538189|NCT00265980|21049982|P1|Weight Initial|Overall Study||22
8538190|NCT00265980|21049982|P1|STARTED|Overall Study||22
8538191|NCT00265941|21049989|P2|NOT COMPLETED|Overall Study||26
8538192|NCT00265941|21049990|P1|NOT COMPLETED|Overall Study||23
8538193|NCT00265941|21049989|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
8538194|NCT00265941|21049990|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
8538195|NCT00265941|21049989|P2|STARTED|Overall Study||470
8538196|NCT00265941|21049990|P1|STARTED|Overall Study||470
8538197|NCT00265889|21050022|P1|NOT COMPLETED|Overall Study||5
8538198|NCT00265889|21050022|P1|COMPLETED|Overall Study||37
8538199|NCT00265889|21050022|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
8538200|NCT00265889|21050022|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
8538201|NCT00265889|21050022|P1|STARTED|Overall Study||42
8538202|NCT00265850|21050031|P3|NOT COMPLETED|Overall Study||0
8538203|NCT00265850|21050032|P2|NOT COMPLETED|Overall Study||0
8538204|NCT00265850|21050033|P1|NOT COMPLETED|Overall Study||0
8538205|NCT00265850|21050031|P3|COMPLETED|Overall Study||533
8538206|NCT00265850|21050032|P2|COMPLETED|Overall Study||902
8538207|NCT00265850|21050033|P1|COMPLETED|Overall Study||899
8538208|NCT00265850|21050031|P3|STARTED|Overall Study||533
8538209|NCT00265850|21050032|P2|STARTED|Overall Study||902
8538210|NCT00265850|21050033|P1|STARTED|Overall Study||899
8538211|NCT00265798|21050043|P1|NOT COMPLETED|Overall Study||0
8538212|NCT00265798|21050043|P1|COMPLETED|Overall Study||38
8538213|NCT00265798|21050043|P1|STARTED|Overall Study||38
8538214|NCT00265785|21050049|P1|NOT COMPLETED|Overall Study||27
8538215|NCT00265785|21050049|P1|COMPLETED|Overall Study||0
8538216|NCT00265785|21050049|P1|Eligible and Began Protocol Treatment|Overall Study||24
8538217|NCT00265785|21050049|P1|Eligible|Overall Study||26
8538218|NCT00265785|21050049|P1|STARTED|Overall Study||27
8538219|NCT00265759|21050062|P4|NOT COMPLETED|Overall Study||9
8538220|NCT00265759|21050063|P3|NOT COMPLETED|Overall Study||2
8538221|NCT00265759|21050064|P2|NOT COMPLETED|Overall Study||1
8538222|NCT00265759|21050065|P1|NOT COMPLETED|Overall Study||0
8538223|NCT00265759|21050062|P4|COMPLETED|Overall Study||236
8538224|NCT00265759|21050063|P3|COMPLETED|Overall Study||123
8538225|NCT00265759|21050064|P2|COMPLETED|Overall Study||127
8538226|NCT00265759|21050065|P1|COMPLETED|Overall Study||124
8538227|NCT00265759|21050062|P4|STARTED|Overall Study||245
8538228|NCT00265759|21050063|P3|STARTED|Overall Study||125
8538229|NCT00265759|21050064|P2|STARTED|Overall Study||128
8538230|NCT00265759|21050065|P1|STARTED|Overall Study||124
8538231|NCT00265616|21050096|P2|NOT COMPLETED|Overall Study||0
8538232|NCT00265616|21050097|P1|NOT COMPLETED|Overall Study||0
8538233|NCT00265616|21050096|P2|COMPLETED|Overall Study||9
8538234|NCT00265616|21050097|P1|COMPLETED|Overall Study||14
8538235|NCT00265616|21050096|P2|STARTED|Overall Study||9
8538236|NCT00265616|21050097|P1|STARTED|Overall Study||14
8538237|NCT00265564|21050115|P2|NOT COMPLETED|Overall Study||9
8538238|NCT00265564|21050116|P1|NOT COMPLETED|Overall Study||10
8538239|NCT00265564|21050115|P2|COMPLETED|Overall Study||49
8538240|NCT00265564|21050116|P1|COMPLETED|Overall Study||49
8538241|NCT00265564|21050115|P2|STARTED|Overall Study||58
8538242|NCT00265564|21050116|P1|STARTED|Overall Study||59
8538243|NCT00265538|21050128|P4|NOT COMPLETED|Overall Study||19
8538244|NCT00265538|21050129|P3|NOT COMPLETED|Overall Study||11
8538245|NCT00265538|21050130|P2|NOT COMPLETED|Overall Study||9
8538246|NCT00265538|21050131|P1|NOT COMPLETED|Overall Study||10
8538247|NCT00265538|21050128|P4|COMPLETED|Overall Study||267
8538248|NCT00265538|21050129|P3|COMPLETED|Overall Study||171
8538249|NCT00265538|21050130|P2|COMPLETED|Overall Study||161
8538250|NCT00265538|21050131|P1|COMPLETED|Overall Study||186
8538251|NCT00265538|21050128|P4|STARTED|Overall Study||286
8538252|NCT00265538|21050129|P3|STARTED|Overall Study||182
8538253|NCT00265538|21050130|P2|STARTED|Overall Study||170
8538254|NCT00265538|21050131|P1|STARTED|Overall Study||196
8538255|NCT00265512|21050145|P2|NOT COMPLETED|Overall Study||95
8538256|NCT00265512|21050146|P1|NOT COMPLETED|Overall Study||45
8538257|NCT00265512|21050145|P2|COMPLETED|Overall Study||359
8538258|NCT00265512|21050146|P1|COMPLETED|Overall Study||168
8538259|NCT00265512|21050145|P2|STARTED|Overall Study||454
8538260|NCT00265512|21050146|P1|STARTED|Overall Study||213
8538261|NCT00265473|21050156|P1|NOT COMPLETED|Overall Study||0
8538262|NCT00265473|21050156|P1|COMPLETED|Overall Study||5
8538263|NCT00265473|21050156|P1|STARTED|Overall Study||5
8538264|NCT00265395|21050166|P2|NOT COMPLETED|Overall Study||17
8538265|NCT00265395|21050167|P1|NOT COMPLETED|Overall Study||8
8538266|NCT00265395|21050166|P2|COMPLETED|Overall Study||56
8538267|NCT00265395|21050167|P1|COMPLETED|Overall Study||78
8538268|NCT00265395|21050166|P2|STARTED|Overall Study||73
8538269|NCT00265395|21050167|P1|STARTED|Overall Study||86
8538270|NCT00265382|21050172|P1|NOT COMPLETED|Overall Study||145
8538271|NCT00265382|21050172|P1|COMPLETED|Overall Study||76
8538272|NCT00265382|21050172|P1|STARTED|Overall Study||221
8538273|NCT00265343|21050192|P2|NOT COMPLETED|Overall Study||19
8538274|NCT00265343|21050193|P1|NOT COMPLETED|Overall Study||21
8538275|NCT00265343|21050192|P2|COMPLETED|Overall Study||153
8538276|NCT00265343|21050193|P1|COMPLETED|Overall Study||113
8538277|NCT00265343|21050192|P2|STARTED|Overall Study||172
8538278|NCT00265343|21050193|P1|STARTED|Overall Study||134
8538279|NCT00265330|21050201|P1|NOT COMPLETED|Overall Study||95
8538280|NCT00265330|21050201|P1|COMPLETED|Overall Study||67
8538281|NCT00265330|21050201|P1|STARTED|Overall Study||162
8538282|NCT00265317|21050227|P4|NOT COMPLETED|Phase 2||65
8538283|NCT00265317|21050228|P3|NOT COMPLETED|Phase 2||64
8538284|NCT00265317|21050229|P2|NOT COMPLETED|Phase 2||0
8538285|NCT00265317|21050230|P1|NOT COMPLETED|Phase 2||0
8538286|NCT00265317|21050227|P4|COMPLETED|Phase 2||2
8538287|NCT00265317|21050228|P3|COMPLETED|Phase 2||1
8538288|NCT00265317|21050229|P2|COMPLETED|Phase 2||0
8538289|NCT00265317|21050230|P1|COMPLETED|Phase 2||0
8538290|NCT00265317|21050227|P4|STARTED|Phase 2||67
8538291|NCT00265317|21050228|P3|STARTED|Phase 2||65
8538292|NCT00265317|21050229|P2|STARTED|Phase 2||0
8538293|NCT00265317|21050230|P1|STARTED|Phase 2||0
8538294|NCT00265317|21050227|P4|NOT COMPLETED|Lead-In||0
8538295|NCT00265317|21050228|P3|NOT COMPLETED|Lead-In||0
8538296|NCT00265317|21050229|P2|NOT COMPLETED|Lead-In||17
8538297|NCT00265317|21050230|P1|NOT COMPLETED|Lead-In||12
8538298|NCT00265317|21050227|P4|COMPLETED|Lead-In||0
8538299|NCT00265317|21050228|P3|COMPLETED|Lead-In||0
8538300|NCT00265317|21050229|P2|COMPLETED|Lead-In||0
8538301|NCT00265317|21050230|P1|COMPLETED|Lead-In||1
8538302|NCT00265317|21050227|P4|STARTED|Lead-In||0
8538303|NCT00265317|21050228|P3|STARTED|Lead-In||0
8538304|NCT00265317|21050229|P2|STARTED|Lead-In||17
8538305|NCT00265317|21050230|P1|STARTED|Lead-In||13
8538306|NCT00265239|21050345|P2|NOT COMPLETED|Overall Study||1
8538307|NCT00265239|21050346|P1|NOT COMPLETED|Overall Study||2
8538308|NCT00265239|21050345|P2|COMPLETED|Overall Study||51
8538309|NCT00265239|21050346|P1|COMPLETED|Overall Study||50
8538310|NCT00265239|21050345|P2|STARTED|Overall Study||52
8538311|NCT00265239|21050346|P1|STARTED|Overall Study||52
8538312|NCT00265200|21050358|P1|NOT COMPLETED|Overall Study||4
8538313|NCT00265200|21050358|P1|COMPLETED|Overall Study||24
8538314|NCT00265200|21050358|P1|STARTED|Overall Study||28
8538315|NCT00265148|21050364|P2|NOT COMPLETED|Overall Study||9
8538316|NCT00265148|21050365|P1|NOT COMPLETED|Overall Study||9
8538317|NCT00265148|21050364|P2|COMPLETED|Overall Study||31
8538318|NCT00265148|21050365|P1|COMPLETED|Overall Study||31
8538319|NCT00265148|21050364|P2|STARTED|Overall Study||40
8538320|NCT00265148|21050365|P1|STARTED|Overall Study||40
8538321|NCT00265122|21050429|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
8538322|NCT00265122|21050430|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
8538323|NCT00265122|21050431|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
8538324|NCT00265122|21050432|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
8538325|NCT00265122|21050433|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
8538326|NCT00265122|21050434|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
8538327|NCT00265122|21050429|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
8538328|NCT00265122|21050430|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
8538329|NCT00265122|21050431|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
8538330|NCT00265122|21050432|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
8538331|NCT00265122|21050433|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
8538332|NCT00265122|21050434|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
8538333|NCT00265122|21050429|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
8538334|NCT00265122|21050430|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
8538335|NCT00265122|21050431|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
8538336|NCT00265122|21050432|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
8538337|NCT00265122|21050433|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
8538338|NCT00265122|21050434|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
8538339|NCT00265122|21050429|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
8538340|NCT00265122|21050430|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
8538341|NCT00265122|21050431|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8538342|NCT00265122|21050432|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
8538343|NCT00265122|21050433|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8538344|NCT00265122|21050434|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8538345|NCT00265122|21050429|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
8538346|NCT00265122|21050430|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
8538347|NCT00265122|21050431|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
8538348|NCT00265122|21050432|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
8538349|NCT00265122|21050433|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
8538350|NCT00265122|21050434|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
8538351|NCT00265122|21050429|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
8538352|NCT00265122|21050430|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
8538353|NCT00265122|21050431|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
8538354|NCT00265122|21050432|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
8538355|NCT00265122|21050433|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
8538356|NCT00265122|21050434|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
8538357|NCT00265109|21050456|P1|NOT COMPLETED|Overall Study||6
8538358|NCT00265109|21050456|P1|COMPLETED|Overall Study||11
8538359|NCT00265109|21050456|P1|STARTED|Overall Study||17
8538360|NCT00265096|21050475|P3|NOT COMPLETED|Overall Study||39
8538361|NCT00265096|21050476|P2|NOT COMPLETED|Overall Study||51
8538362|NCT00265096|21050477|P1|NOT COMPLETED|Overall Study||36
8538363|NCT00265096|21050475|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
8538364|NCT00265096|21050476|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
8538365|NCT00265096|21050477|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
8538366|NCT00265096|21050475|P3|STARTED|Overall Study||146
8538367|NCT00265096|21050476|P2|STARTED|Overall Study||146
8538368|NCT00265096|21050477|P1|STARTED|Overall Study||113
8538369|NCT00265083|21050509|P3|NOT COMPLETED|Overall Study||42
8538370|NCT00265083|21050510|P2|NOT COMPLETED|Overall Study||42
8538371|NCT00265083|21050511|P1|NOT COMPLETED|Overall Study||17
8538372|NCT00265083|21050509|P3|COMPLETED|Overall Study||98
8538373|NCT00265083|21050510|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
8538374|NCT00265083|21050511|P1|COMPLETED|Overall Study||61
8538375|NCT00265083|21050509|P3|STARTED|Overall Study||140
8538376|NCT00265083|21050510|P2|STARTED|Overall Study|One patient did not receive study agent.|138
8538377|NCT00265083|21050511|P1|STARTED|Overall Study||78
8538378|NCT00264875|21050532|P1|NOT COMPLETED|Overall Study||30
8538379|NCT00264875|21050532|P1|COMPLETED|Overall Study||190
8538380|NCT00264875|21050532|P1|STARTED|Overall Study||220
8538381|NCT00264849|21050538|P2|NOT COMPLETED|Overall Study||25
8538382|NCT00264849|21050539|P1|NOT COMPLETED|Overall Study||22
8538383|NCT00264849|21050538|P2|COMPLETED|Overall Study||106
8538384|NCT00264849|21050539|P1|COMPLETED|Overall Study||253
8538385|NCT00264849|21050538|P2|STARTED|Overall Study||131
8538386|NCT00264849|21050539|P1|STARTED|Overall Study||275
8538387|NCT00264810|21050573|P2|NOT COMPLETED|Open Label Evaluation Period||6
8538388|NCT00264810|21050574|P1|NOT COMPLETED|Open Label Evaluation Period||6
8538389|NCT00264810|21050573|P2|COMPLETED|Open Label Evaluation Period||86
8538390|NCT00264810|21050574|P1|COMPLETED|Open Label Evaluation Period||89
8538391|NCT00264810|21050573|P2|1-year Post-implant|Open Label Evaluation Period||90
8538392|NCT00264810|21050574|P1|1-year Post-implant|Open Label Evaluation Period||92
8538393|NCT00264810|21050573|P2|STARTED|Open Label Evaluation Period||92
8538394|NCT00264810|21050574|P1|STARTED|Open Label Evaluation Period||95
8538395|NCT00264810|21050573|P2|NOT COMPLETED|Blinded Evaluation Period||1
8538396|NCT00264810|21050574|P1|NOT COMPLETED|Blinded Evaluation Period||1
8538397|NCT00264810|21050573|P2|COMPLETED|Blinded Evaluation Period||92
8538398|NCT00264810|21050574|P1|COMPLETED|Blinded Evaluation Period||95
8538399|NCT00264810|21050573|P2|STARTED|Blinded Evaluation Period||93
8538400|NCT00264810|21050574|P1|STARTED|Blinded Evaluation Period||96
8538401|NCT00264810|21050573|P2|NOT COMPLETED|Stimulation Optimization Period||1
8538402|NCT00264810|21050574|P1|NOT COMPLETED|Stimulation Optimization Period||1
8538403|NCT00264810|21050573|P2|COMPLETED|Stimulation Optimization Period||93
8538404|NCT00264810|21050574|P1|COMPLETED|Stimulation Optimization Period||96
8538405|NCT00264810|21050573|P2|STARTED|Stimulation Optimization Period||94
8538406|NCT00264810|21050574|P1|STARTED|Stimulation Optimization Period||97
8538407|NCT00264810|21050573|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
8538408|NCT00264810|21050574|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
8538409|NCT00264810|21050573|P2|COMPLETED|Post-Operative Stabilization Period||94
8538410|NCT00264810|21050574|P1|COMPLETED|Post-Operative Stabilization Period||97
8538411|NCT00264810|21050573|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
8538412|NCT00264810|21050574|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
8538413|NCT00264810|21050573|P2|NOT COMPLETED|Baseline||26
8538414|NCT00264810|21050574|P1|NOT COMPLETED|Baseline||23
8538415|NCT00264810|21050573|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
8538416|NCT00264810|21050574|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
8538417|NCT00264810|21050573|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
8538418|NCT00264810|21050574|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
8538419|NCT00264797|21050584|P2|NOT COMPLETED|Overall Study||43
8538420|NCT00264797|21050585|P1|NOT COMPLETED|Overall Study||33
8538421|NCT00264797|21050584|P2|COMPLETED|Overall Study||109
8538422|NCT00264797|21050585|P1|COMPLETED|Overall Study||118
8538423|NCT00264797|21050584|P2|STARTED|Overall Study||152
8538424|NCT00264797|21050585|P1|STARTED|Overall Study||151
8538425|NCT00264641|21050599|P2|NOT COMPLETED|Overall Study||0
8538426|NCT00264641|21050600|P1|NOT COMPLETED|Overall Study||0
8538427|NCT00264641|21050599|P2|COMPLETED|Overall Study||10
8538428|NCT00264641|21050600|P1|COMPLETED|Overall Study||10
8538429|NCT00264641|21050599|P2|Initiation of the Study|Overall Study||10
8538430|NCT00264641|21050600|P1|Initiation of the Study|Overall Study||10
8538431|NCT00264641|21050599|P2|STARTED|Overall Study||10
8538432|NCT00264641|21050600|P1|STARTED|Overall Study||10
8538433|NCT00264576|21050607|P2|NOT COMPLETED|Overall Study||1
8538434|NCT00264576|21050608|P1|NOT COMPLETED|Overall Study||1
8538435|NCT00264576|21050607|P2|COMPLETED|Overall Study||304
8538436|NCT00264576|21050608|P1|COMPLETED|Overall Study||307
8538437|NCT00264576|21050607|P2|STARTED|Overall Study||305
8538438|NCT00264576|21050608|P1|STARTED|Overall Study||308
8538439|NCT00264550|21050632|P4|NOT COMPLETED|Overall Study||30
8538440|NCT00264550|21050633|P3|NOT COMPLETED|Overall Study||17
8538441|NCT00264550|21050634|P2|NOT COMPLETED|Overall Study||41
8538442|NCT00264550|21050635|P1|NOT COMPLETED|Overall Study||43
8538443|NCT00264550|21050632|P4|COMPLETED|Overall Study||59
8538444|NCT00264550|21050633|P3|COMPLETED|Overall Study||72
8538445|NCT00264550|21050634|P2|COMPLETED|Overall Study||92
8538446|NCT00264550|21050635|P1|COMPLETED|Overall Study||90
8538447|NCT00264550|21050632|P4|STARTED|Overall Study||89
8538448|NCT00264550|21050633|P3|STARTED|Overall Study||89
8538449|NCT00264550|21050634|P2|STARTED|Overall Study||133
8538450|NCT00264550|21050635|P1|STARTED|Overall Study||133
8538451|NCT00264537|21050674|P4|NOT COMPLETED|Overall Study||60
8538452|NCT00264537|21050675|P3|NOT COMPLETED|Overall Study||50
8538453|NCT00264537|21050676|P2|NOT COMPLETED|Overall Study||58
8538454|NCT00264537|21050677|P1|NOT COMPLETED|Overall Study||50
8538455|NCT00264537|21050674|P4|COMPLETED|Overall Study||99
8538456|NCT00264537|21050675|P3|COMPLETED|Overall Study||109
8538457|NCT00264537|21050676|P2|COMPLETED|Overall Study||101
8538458|NCT00264537|21050677|P1|COMPLETED|Overall Study||110
8538459|NCT00264537|21050674|P4|STARTED|Overall Study||159
8538460|NCT00264537|21050675|P3|STARTED|Overall Study||159
8538461|NCT00264537|21050676|P2|STARTED|Overall Study||159
8538462|NCT00264537|21050677|P1|STARTED|Overall Study||160
8538463|NCT00264498|21050709|P2|NOT COMPLETED|Crossover Treatment||9
8538464|NCT00264498|21050710|P1|NOT COMPLETED|Crossover Treatment||6
8538465|NCT00264498|21050709|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538466|NCT00264498|21050710|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538467|NCT00264498|21050709|P2|STARTED|Crossover Treatment||9
8538468|NCT00264498|21050710|P1|STARTED|Crossover Treatment||6
8538469|NCT00264498|21050709|P2|NOT COMPLETED|Randomized Treatment||18
8538470|NCT00264498|21050710|P1|NOT COMPLETED|Randomized Treatment||17
8538471|NCT00264498|21050709|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538472|NCT00264498|21050710|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538473|NCT00264498|21050709|P2|STARTED|Randomized Treatment||18
8538474|NCT00264498|21050710|P1|STARTED|Randomized Treatment||17
8538475|NCT00264381|21050718|P2|NOT COMPLETED|Overall Study||0
8538476|NCT00264381|21050719|P1|NOT COMPLETED|Overall Study||0
8538477|NCT00264381|21050718|P2|COMPLETED|Overall Study||37
8538478|NCT00264381|21050719|P1|COMPLETED|Overall Study||35
8538479|NCT00264381|21050718|P2|STARTED|Overall Study||37
8538480|NCT00264381|21050719|P1|STARTED|Overall Study||35
8538481|NCT00264303|21050733|P2|NOT COMPLETED|Overall Study||29
8538482|NCT00264303|21050734|P1|NOT COMPLETED|Overall Study||25
8538483|NCT00264303|21050733|P2|COMPLETED|Overall Study||419
8538484|NCT00264303|21050734|P1|COMPLETED|Overall Study||413
8538485|NCT00264303|21050733|P2|STARTED|Overall Study||448
8538486|NCT00264303|21050734|P1|STARTED|Overall Study||438
8538487|NCT00264290|21050752|P2|NOT COMPLETED|Observation (4 Weeks)||0
8538488|NCT00264290|21050753|P1|NOT COMPLETED|Observation (4 Weeks)||0
8538489|NCT00264290|21050752|P2|COMPLETED|Observation (4 Weeks)||14
8538490|NCT00264290|21050753|P1|COMPLETED|Observation (4 Weeks)||15
8538491|NCT00264290|21050752|P2|STARTED|Observation (4 Weeks)||14
8538492|NCT00264290|21050753|P1|STARTED|Observation (4 Weeks)||15
8538493|NCT00264290|21050752|P2|NOT COMPLETED|Intervention (8 Weeks)||0
8538494|NCT00264290|21050753|P1|NOT COMPLETED|Intervention (8 Weeks)||1
8538495|NCT00264290|21050752|P2|COMPLETED|Intervention (8 Weeks)||14
8538496|NCT00264290|21050753|P1|COMPLETED|Intervention (8 Weeks)||15
8538497|NCT00264290|21050752|P2|STARTED|Intervention (8 Weeks)||14
8538498|NCT00264290|21050753|P1|STARTED|Intervention (8 Weeks)||16
8538499|NCT00264238|21050769|P1|NOT COMPLETED|Overall Study||1
8538500|NCT00264238|21050769|P1|COMPLETED|Overall Study||14
8538501|NCT00264238|21050769|P1|STARTED|Overall Study||15
8538502|NCT00264147|21050781|P6|NOT COMPLETED|Treatment II Period||33
8538503|NCT00264147|21050782|P5|NOT COMPLETED|Treatment II Period||33
8538504|NCT00264147|21050783|P4|NOT COMPLETED|Treatment II Period||0
8538505|NCT00264147|21050784|P3|NOT COMPLETED|Treatment II Period||0
8538506|NCT00264147|21050785|P2|NOT COMPLETED|Treatment II Period||0
8538507|NCT00264147|21050786|P1|NOT COMPLETED|Treatment II Period||0
8538508|NCT00264147|21050781|P6|COMPLETED|Treatment II Period||116
8538509|NCT00264147|21050782|P5|COMPLETED|Treatment II Period||147
8538510|NCT00264147|21050783|P4|COMPLETED|Treatment II Period||0
8538511|NCT00264147|21050784|P3|COMPLETED|Treatment II Period||0
8538512|NCT00264147|21050785|P2|COMPLETED|Treatment II Period||0
8538513|NCT00264147|21050786|P1|COMPLETED|Treatment II Period||0
8538514|NCT00264147|21050781|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
8538515|NCT00264147|21050782|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
8538516|NCT00264147|21050783|P4|STARTED|Treatment II Period||0
8538517|NCT00264147|21050784|P3|STARTED|Treatment II Period||0
8538518|NCT00264147|21050785|P2|STARTED|Treatment II Period||0
8538519|NCT00264147|21050786|P1|STARTED|Treatment II Period||0
8538520|NCT00264147|21050781|P6|NOT COMPLETED|Treatment I Period||0
8538521|NCT00264147|21050782|P5|NOT COMPLETED|Treatment I Period||56
8538522|NCT00264147|21050783|P4|NOT COMPLETED|Treatment I Period||72
8538523|NCT00264147|21050784|P3|NOT COMPLETED|Treatment I Period||77
8538524|NCT00264147|21050785|P2|NOT COMPLETED|Treatment I Period||83
8538525|NCT00264147|21050786|P1|NOT COMPLETED|Treatment I Period||98
8538526|NCT00264147|21050781|P6|COMPLETED|Treatment I Period||0
8538527|NCT00264147|21050782|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
8538528|NCT00264147|21050783|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
8538529|NCT00264147|21050784|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
8538530|NCT00264147|21050785|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
8538531|NCT00264147|21050786|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
8538532|NCT00264147|21050781|P6|STARTED|Treatment I Period||0
8538533|NCT00264147|21050782|P5|STARTED|Treatment I Period||155
8538534|NCT00264147|21050783|P4|STARTED|Treatment I Period||140
8538535|NCT00264147|21050784|P3|STARTED|Treatment I Period||151
8538536|NCT00264147|21050785|P2|STARTED|Treatment I Period||154
8538537|NCT00264147|21050786|P1|STARTED|Treatment I Period||161
8538538|NCT00264004|21050829|P4|NOT COMPLETED|Overall Study||15
8538539|NCT00264004|21050830|P3|NOT COMPLETED|Overall Study||14
8538540|NCT00264004|21050831|P2|NOT COMPLETED|Overall Study||11
8538541|NCT00264004|21050832|P1|NOT COMPLETED|Overall Study||17
8538542|NCT00264004|21050829|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
8538543|NCT00264004|21050830|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
8538544|NCT00264004|21050831|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
8538545|NCT00264004|21050832|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
8538546|NCT00264004|21050829|P4|STARTED|Overall Study|Randomised|34
8538547|NCT00264004|21050830|P3|STARTED|Overall Study|Randomised|30
8538548|NCT00264004|21050831|P2|STARTED|Overall Study|Randomised|32
8538549|NCT00264004|21050832|P1|STARTED|Overall Study|Randomised|30
8538550|NCT00263887|21050860|P2|NOT COMPLETED|Overall Study||7
8538551|NCT00263887|21050861|P1|NOT COMPLETED|Overall Study||3
8538552|NCT00263887|21050860|P2|COMPLETED|Overall Study||32
8538553|NCT00263887|21050861|P1|COMPLETED|Overall Study||35
8538554|NCT00263887|21050860|P2|STARTED|Overall Study||39
8538555|NCT00263887|21050861|P1|STARTED|Overall Study||38
8538556|NCT00263757|21050869|P2|NOT COMPLETED|Overall Study||8
8538557|NCT00263757|21050870|P1|NOT COMPLETED|Overall Study||8
8538558|NCT00263757|21050869|P2|COMPLETED|Overall Study||5
8538559|NCT00263757|21050870|P1|COMPLETED|Overall Study||4
8538560|NCT00263757|21050869|P2|STARTED|Overall Study||13
8538561|NCT00263757|21050870|P1|STARTED|Overall Study||12
8538562|NCT00263666|21050882|P2|NOT COMPLETED|Overall Study||11
8538563|NCT00263666|21050883|P1|NOT COMPLETED|Overall Study||7
8538564|NCT00263666|21050882|P2|COMPLETED|Overall Study||39
8538565|NCT00263666|21050883|P1|COMPLETED|Overall Study||43
8538566|NCT00263666|21050882|P2|STARTED|Overall Study||50
8538567|NCT00263666|21050883|P1|STARTED|Overall Study||50
8538568|NCT00263588|21050936|P2|NOT COMPLETED|Overall Study||132
8538569|NCT00263588|21050937|P1|NOT COMPLETED|Overall Study||81
8538570|NCT00263588|21050936|P2|COMPLETED|Overall Study||15
8538571|NCT00263588|21050937|P1|COMPLETED|Overall Study||14
8538572|NCT00263588|21050936|P2|STARTED|Overall Study||147
8538573|NCT00263588|21050937|P1|STARTED|Overall Study||95
8538574|NCT00263575|21050960|P1|NOT COMPLETED|Maintence Period||77
8538575|NCT00263575|21050960|P1|COMPLETED|Maintence Period||19
8538576|NCT00263575|21050960|P1|STARTED|Maintence Period||96
8538577|NCT00263575|21050960|P1|NOT COMPLETED|Titration Period||43
8538578|NCT00263575|21050960|P1|COMPLETED|Titration Period||96
8538579|NCT00263575|21050960|P1|STARTED|Titration Period||139
8538580|NCT00263562|21050968|P2|NOT COMPLETED|Overall Study||0
8538581|NCT00263562|21050969|P1|NOT COMPLETED|Overall Study||3
8538582|NCT00263562|21050968|P2|COMPLETED|Overall Study||9
8538583|NCT00263562|21050969|P1|COMPLETED|Overall Study||6
8538584|NCT00263562|21050968|P2|STARTED|Overall Study||9
8538585|NCT00263562|21050969|P1|STARTED|Overall Study||9
8538586|NCT00263328|21050986|P3|NOT COMPLETED|Overall Study||7
8538587|NCT00263328|21050987|P2|NOT COMPLETED|Overall Study||2
8538588|NCT00263328|21050988|P1|NOT COMPLETED|Overall Study||8
8538589|NCT00263328|21050986|P3|COMPLETED|Overall Study||6
8538590|NCT00263328|21050987|P2|COMPLETED|Overall Study||12
8538591|NCT00263328|21050988|P1|COMPLETED|Overall Study||10
8538592|NCT00263328|21050986|P3|STARTED|Overall Study||13
8538593|NCT00263328|21050987|P2|STARTED|Overall Study||14
8538594|NCT00263328|21050988|P1|STARTED|Overall Study||18
8538595|NCT00263211|21051146|P2|NOT COMPLETED|Overall Study||1
8538596|NCT00263211|21051147|P1|NOT COMPLETED|Overall Study||5
8538597|NCT00263211|21051146|P2|COMPLETED|Overall Study||23
8538598|NCT00263211|21051147|P1|COMPLETED|Overall Study||19
8538599|NCT00263211|21051146|P2|STARTED|Overall Study||24
8538600|NCT00263211|21051147|P1|STARTED|Overall Study||24
8538601|NCT00262964|21051165|P4|NOT COMPLETED|Overall Study||0
8538602|NCT00262964|21051166|P3|NOT COMPLETED|Overall Study||0
8538603|NCT00262964|21051167|P2|NOT COMPLETED|Overall Study||0
8538604|NCT00262964|21051168|P1|NOT COMPLETED|Overall Study||0
8538605|NCT00262964|21051165|P4|COMPLETED|Overall Study||12
8538606|NCT00262964|21051166|P3|COMPLETED|Overall Study||17
8538607|NCT00262964|21051167|P2|COMPLETED|Overall Study||11
8538608|NCT00262964|21051168|P1|COMPLETED|Overall Study||11
8538609|NCT00262964|21051165|P4|STARTED|Overall Study||12
8538610|NCT00262964|21051166|P3|STARTED|Overall Study||17
8538611|NCT00262964|21051167|P2|STARTED|Overall Study||11
8538612|NCT00262964|21051168|P1|STARTED|Overall Study||11
8538613|NCT00262951|21051198|P1|NOT COMPLETED|Overall Study||16
8538614|NCT00262951|21051198|P1|COMPLETED|Overall Study||7
8538615|NCT00262951|21051198|P1|STARTED|Overall Study||23
8538616|NCT00262925|21051203|P1|NOT COMPLETED|Overall Study||11
8538617|NCT00262925|21051203|P1|COMPLETED|Overall Study||1
8538618|NCT00262925|21051203|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
8538619|NCT00262873|21051209|P1|NOT COMPLETED|Overall Study||8
8538620|NCT00262873|21051209|P1|COMPLETED|Overall Study||0
8538621|NCT00262873|21051209|P1|STARTED|Overall Study||8
8538622|NCT00262860|21051220|P1|NOT COMPLETED|Overall Study||2
8538623|NCT00262860|21051220|P1|COMPLETED|Overall Study||16
8538624|NCT00262860|21051220|P1|STARTED|Overall Study||18
8538625|NCT00262847|21051229|P3|NOT COMPLETED|Overall Study||396
8538626|NCT00262847|21051230|P2|NOT COMPLETED|Overall Study||513
8538627|NCT00262847|21051231|P1|NOT COMPLETED|Overall Study||518
8538628|NCT00262847|21051229|P3|COMPLETED|Overall Study||227
8538629|NCT00262847|21051230|P2|COMPLETED|Overall Study||112
8538630|NCT00262847|21051231|P1|COMPLETED|Overall Study||107
8538631|NCT00262847|21051229|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
8538632|NCT00262847|21051230|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
8538633|NCT00262847|21051231|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
8538634|NCT00262834|21051250|P2|NOT COMPLETED|Overall Study||4
8538635|NCT00262834|21051251|P1|NOT COMPLETED|Overall Study||1
8538636|NCT00262834|21051250|P2|COMPLETED|Overall Study||25
8538637|NCT00262834|21051251|P1|COMPLETED|Overall Study||24
8538638|NCT00262834|21051250|P2|STARTED|Overall Study||29
8538639|NCT00262834|21051251|P1|STARTED|Overall Study||25
8538640|NCT00262821|21051264|P2|NOT COMPLETED|Overall Study||19
8538641|NCT00262821|21051265|P1|NOT COMPLETED|Overall Study||4
8538642|NCT00262821|21051264|P2|COMPLETED|Overall Study||185
8538643|NCT00262821|21051265|P1|COMPLETED|Overall Study||194
8538644|NCT00262821|21051264|P2|STARTED|Overall Study||204
8538645|NCT00262821|21051265|P1|STARTED|Overall Study||198
8538646|NCT00262743|21051277|P2|NOT COMPLETED|Overall Study||12
8538647|NCT00262743|21051278|P1|NOT COMPLETED|Overall Study||0
8538648|NCT00262743|21051277|P2|COMPLETED|Overall Study||30
8538649|NCT00262743|21051278|P1|COMPLETED|Overall Study||27
8538650|NCT00262743|21051277|P2|STARTED|Overall Study||42
8538651|NCT00262743|21051278|P1|STARTED|Overall Study||27
8538652|NCT00262730|21051285|P1|NOT COMPLETED|Overall Study||0
8538653|NCT00262730|21051285|P1|COMPLETED|Overall Study||97
8538654|NCT00262730|21051285|P1|STARTED|Overall Study||97
8538655|NCT00262639|21051293|P4|NOT COMPLETED|Overall Study||0
8538656|NCT00262639|21051294|P3|NOT COMPLETED|Overall Study||0
8538657|NCT00262639|21051295|P2|NOT COMPLETED|Overall Study||0
8538658|NCT00262639|21051296|P1|NOT COMPLETED|Overall Study||0
8538659|NCT00262639|21051293|P4|COMPLETED|Overall Study||7
8538660|NCT00262639|21051294|P3|COMPLETED|Overall Study||9
8538661|NCT00262639|21051295|P2|COMPLETED|Overall Study||26
8538662|NCT00262639|21051296|P1|COMPLETED|Overall Study||18
8538663|NCT00262639|21051293|P4|STARTED|Overall Study||7
8538664|NCT00262639|21051294|P3|STARTED|Overall Study||9
8538665|NCT00262639|21051295|P2|STARTED|Overall Study||26
8538666|NCT00262639|21051296|P1|STARTED|Overall Study||18
8538667|NCT00262600|21051313|P3|NOT COMPLETED|Overall Study||266
8538668|NCT00262600|21051314|P2|NOT COMPLETED|Overall Study||252
8538669|NCT00262600|21051315|P1|NOT COMPLETED|Overall Study||235
8538670|NCT00262600|21051313|P3|COMPLETED|Overall Study||5756
8538671|NCT00262600|21051314|P2|COMPLETED|Overall Study||5824
8538672|NCT00262600|21051315|P1|COMPLETED|Overall Study||5780
8538673|NCT00262600|21051313|P3|STARTED|Overall Study||6022
8538674|NCT00262600|21051314|P2|STARTED|Overall Study||6076
8538675|NCT00262600|21051315|P1|STARTED|Overall Study||6015
8538676|NCT00262522|21051342|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
8538677|NCT00262522|21051343|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
8538678|NCT00262522|21051344|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
8538679|NCT00262522|21051345|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
8538680|NCT00262522|21051342|P4|COMPLETED|Study Start Through 96 Weeks||0
8538681|NCT00262522|21051343|P3|COMPLETED|Study Start Through 96 Weeks||254
8538682|NCT00262522|21051344|P2|COMPLETED|Study Start Through 96 Weeks||0
8538683|NCT00262522|21051345|P1|COMPLETED|Study Start Through 96 Weeks||256
8538684|NCT00262522|21051342|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
8538685|NCT00262522|21051343|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
8538686|NCT00262522|21051344|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
8538687|NCT00262522|21051345|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
8538688|NCT00262522|21051342|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
8538689|NCT00262522|21051343|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
8538690|NCT00262522|21051344|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
8538691|NCT00262522|21051345|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
8538692|NCT00262522|21051342|P4|COMPLETED|Study Start Through 48 Weeks||0
8538693|NCT00262522|21051343|P3|COMPLETED|Study Start Through 48 Weeks||276
8538694|NCT00262522|21051344|P2|COMPLETED|Study Start Through 48 Weeks||0
8538695|NCT00262522|21051345|P1|COMPLETED|Study Start Through 48 Weeks||284
8538696|NCT00262522|21051342|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
8538697|NCT00262522|21051343|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
8538698|NCT00262522|21051344|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
8538699|NCT00262522|21051345|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
8538700|NCT00262522|21051342|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
8538701|NCT00262522|21051343|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
8538702|NCT00262522|21051344|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
8538703|NCT00262522|21051345|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
8538704|NCT00262522|21051342|P4|COMPLETED|Study Start Through 8 Weeks||160
8538705|NCT00262522|21051343|P3|COMPLETED|Study Start Through 8 Weeks||155
8538706|NCT00262522|21051344|P2|COMPLETED|Study Start Through 8 Weeks||161
8538707|NCT00262522|21051345|P1|COMPLETED|Study Start Through 8 Weeks||163
8538708|NCT00262522|21051342|P4|STARTED|Study Start Through 8 Weeks||165
8538709|NCT00262522|21051343|P3|STARTED|Study Start Through 8 Weeks||166
8538710|NCT00262522|21051344|P2|STARTED|Study Start Through 8 Weeks||166
8538711|NCT00262522|21051345|P1|STARTED|Study Start Through 8 Weeks||167
8538712|NCT00262509|21051367|P2|NOT COMPLETED|Overall Study||0
8538713|NCT00262509|21051368|P1|NOT COMPLETED|Overall Study||0
8538714|NCT00262509|21051367|P2|COMPLETED|Overall Study||9
8538715|NCT00262509|21051368|P1|COMPLETED|Overall Study||8
8538716|NCT00262509|21051367|P2|STARTED|Overall Study||9
8538717|NCT00262509|21051368|P1|STARTED|Overall Study||8
8538718|NCT00262314|21051374|P1|NOT COMPLETED|Overall Study||337
8538719|NCT00262314|21051374|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
8538720|NCT00262314|21051374|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
8538721|NCT00262301|21051392|P3|NOT COMPLETED|Open-label Phase||0
8538722|NCT00262301|21051393|P2|NOT COMPLETED|Open-label Phase||0
8538723|NCT00262301|21051394|P1|NOT COMPLETED|Open-label Phase||0
8538724|NCT00262301|21051392|P3|COMPLETED|Open-label Phase||57
8538725|NCT00262301|21051393|P2|COMPLETED|Open-label Phase||0
8538726|NCT00262301|21051394|P1|COMPLETED|Open-label Phase||0
8538727|NCT00262301|21051392|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
8538728|NCT00262301|21051393|P2|STARTED|Open-label Phase||0
8538729|NCT00262301|21051394|P1|STARTED|Open-label Phase||0
8538730|NCT00262301|21051392|P3|NOT COMPLETED|Double-blind Phase||0
8538731|NCT00262301|21051393|P2|NOT COMPLETED|Double-blind Phase||1
8538732|NCT00262301|21051394|P1|NOT COMPLETED|Double-blind Phase||1
8538733|NCT00262301|21051392|P3|COMPLETED|Double-blind Phase||0
8538734|NCT00262301|21051393|P2|COMPLETED|Double-blind Phase||15
8538735|NCT00262301|21051394|P1|COMPLETED|Double-blind Phase||15
8538736|NCT00262301|21051392|P3|STARTED|Double-blind Phase||0
8538737|NCT00262301|21051393|P2|STARTED|Double-blind Phase||16
8538738|NCT00262301|21051394|P1|STARTED|Double-blind Phase||16
8538739|NCT00262223|21051407|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
8538740|NCT00262223|21051408|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
8538741|NCT00262223|21051407|P2|COMPLETED|12-month Post-treatment Follow-up||22
8538742|NCT00262223|21051408|P1|COMPLETED|12-month Post-treatment Follow-up||21
8538743|NCT00262223|21051407|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
8538744|NCT00262223|21051408|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
8538745|NCT00262223|21051407|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
8538746|NCT00262223|21051408|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
8538747|NCT00262223|21051407|P2|COMPLETED|6-month Post-treatment Follow-up||28
8538748|NCT00262223|21051408|P1|COMPLETED|6-month Post-treatment Follow-up||22
8538749|NCT00262223|21051407|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
8538750|NCT00262223|21051408|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
8538751|NCT00262223|21051407|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
8538752|NCT00262223|21051408|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
8538753|NCT00262223|21051407|P2|COMPLETED|1-week Post-treatment Follow-up||25
8538754|NCT00262223|21051408|P1|COMPLETED|1-week Post-treatment Follow-up||24
8538755|NCT00262223|21051407|P2|STARTED|1-week Post-treatment Follow-up||29
8538756|NCT00262223|21051408|P1|STARTED|1-week Post-treatment Follow-up||28
8538757|NCT00262223|21051407|P2|NOT COMPLETED|Treatment Phase||8
8538758|NCT00262223|21051408|P1|NOT COMPLETED|Treatment Phase||4
8538759|NCT00262223|21051407|P2|COMPLETED|Treatment Phase||29
8538760|NCT00262223|21051408|P1|COMPLETED|Treatment Phase||28
8538761|NCT00262223|21051407|P2|STARTED|Treatment Phase||37
8538762|NCT00262223|21051408|P1|STARTED|Treatment Phase||32
8538763|NCT00262119|21051419|P3|NOT COMPLETED|Overall Study||58
8538764|NCT00262119|21051420|P2|NOT COMPLETED|Overall Study||70
8538765|NCT00262119|21051421|P1|NOT COMPLETED|Overall Study||58
8538766|NCT00262119|21051419|P3|COMPLETED|Overall Study||325
8538767|NCT00262119|21051420|P2|COMPLETED|Overall Study||328
8538768|NCT00262119|21051421|P1|COMPLETED|Overall Study||327
8538769|NCT00262119|21051419|P3|STARTED|Overall Study||383
8538770|NCT00262119|21051420|P2|STARTED|Overall Study||398
8538771|NCT00262119|21051421|P1|STARTED|Overall Study||385
8538772|NCT00262080|21051441|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
8538773|NCT00262080|21051442|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
8538774|NCT00262080|21051443|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
8538775|NCT00262080|21051441|P3|COMPLETED|Repeat Dose Treatment Period||14
8538776|NCT00262080|21051442|P2|COMPLETED|Repeat Dose Treatment Period||25
8538777|NCT00262080|21051443|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
8538778|NCT00262080|21051441|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
8538779|NCT00262080|21051442|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
8538780|NCT00262080|21051443|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
8538781|NCT00262080|21051441|P3|NOT COMPLETED|Double Blind Treatment Period||0
8538782|NCT00262080|21051442|P2|NOT COMPLETED|Double Blind Treatment Period||0
8538783|NCT00262080|21051443|P1|NOT COMPLETED|Double Blind Treatment Period||1
8538784|NCT00262080|21051441|P3|COMPLETED|Double Blind Treatment Period||0
8538785|NCT00262080|21051442|P2|COMPLETED|Double Blind Treatment Period||36
8538786|NCT00262080|21051443|P1|COMPLETED|Double Blind Treatment Period||35
8538787|NCT00262080|21051441|P3|STARTED|Double Blind Treatment Period||0
8538788|NCT00262080|21051442|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
8538789|NCT00262080|21051443|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
8538790|NCT00262067|21051463|P4|NOT COMPLETED|Overall Study||113
8538791|NCT00262067|21051464|P3|NOT COMPLETED|Overall Study||216
8538792|NCT00262067|21051465|P2|NOT COMPLETED|Overall Study||100
8538793|NCT00262067|21051466|P1|NOT COMPLETED|Overall Study||219
8538794|NCT00262067|21051463|P4|COMPLETED|Overall Study||93
8538795|NCT00262067|21051464|P3|COMPLETED|Overall Study||193
8538796|NCT00262067|21051465|P2|COMPLETED|Overall Study||107
8538797|NCT00262067|21051466|P1|COMPLETED|Overall Study||196
8538798|NCT00262067|21051463|P4|STARTED|Overall Study||206
8538799|NCT00262067|21051464|P3|STARTED|Overall Study||409
8538800|NCT00262067|21051465|P2|STARTED|Overall Study||207
8538801|NCT00262067|21051466|P1|STARTED|Overall Study||415
8538802|NCT00262041|21051500|P3|NOT COMPLETED|Overall Study||6
8538803|NCT00262041|21051501|P2|NOT COMPLETED|Overall Study||4
8538804|NCT00262041|21051502|P1|NOT COMPLETED|Overall Study||2
8538805|NCT00262041|21051500|P3|COMPLETED|Overall Study||203
8538806|NCT00262041|21051501|P2|COMPLETED|Overall Study||147
8538807|NCT00262041|21051502|P1|COMPLETED|Overall Study||162
8538808|NCT00262041|21051500|P3|STARTED|Overall Study||209
8538809|NCT00262041|21051501|P2|STARTED|Overall Study||151
8538810|NCT00262041|21051502|P1|STARTED|Overall Study||164
8538811|NCT00262028|21051531|P9|NOT COMPLETED|Overall Study||19
8538812|NCT00262028|21051532|P8|NOT COMPLETED|Overall Study||18
8538813|NCT00262028|21051533|P7|NOT COMPLETED|Overall Study||12
8538814|NCT00262028|21051534|P6|NOT COMPLETED|Overall Study||13
8538815|NCT00262028|21051535|P5|NOT COMPLETED|Overall Study||12
8538816|NCT00262028|21051536|P4|NOT COMPLETED|Overall Study||23
8538817|NCT00262028|21051537|P3|NOT COMPLETED|Overall Study||20
8538818|NCT00262028|21051538|P2|NOT COMPLETED|Overall Study||27
8538819|NCT00262028|21051539|P1|NOT COMPLETED|Overall Study||24
8538820|NCT00262028|21051531|P9|COMPLETED|Overall Study||81
8538821|NCT00262028|21051532|P8|COMPLETED|Overall Study||55
8538822|NCT00262028|21051533|P7|COMPLETED|Overall Study||59
8538823|NCT00262028|21051534|P6|COMPLETED|Overall Study||60
8538824|NCT00262028|21051535|P5|COMPLETED|Overall Study||62
8538825|NCT00262028|21051536|P4|COMPLETED|Overall Study||134
8538826|NCT00262028|21051537|P3|COMPLETED|Overall Study||137
8538827|NCT00262028|21051538|P2|COMPLETED|Overall Study||126
8538828|NCT00262028|21051539|P1|COMPLETED|Overall Study||128
8538829|NCT00262028|21051531|P9|STARTED|Overall Study||100
8538830|NCT00262028|21051532|P8|STARTED|Overall Study||73
8538831|NCT00262028|21051533|P7|STARTED|Overall Study||71
8538832|NCT00262028|21051534|P6|STARTED|Overall Study||73
8538833|NCT00262028|21051535|P5|STARTED|Overall Study||74
8538834|NCT00262028|21051536|P4|STARTED|Overall Study||157
8538835|NCT00262028|21051537|P3|STARTED|Overall Study||157
8538836|NCT00262028|21051538|P2|STARTED|Overall Study||153
8538837|NCT00262028|21051539|P1|STARTED|Overall Study||152
8538838|NCT00262002|21051601|P7|NOT COMPLETED|Overall Study||6
8538839|NCT00262002|21051602|P6|NOT COMPLETED|Overall Study||7
8538840|NCT00262002|21051603|P5|NOT COMPLETED|Overall Study||7
8538841|NCT00262002|21051604|P4|NOT COMPLETED|Overall Study||5
8538842|NCT00262002|21051605|P3|NOT COMPLETED|Overall Study||0
8538843|NCT00262002|21051606|P2|NOT COMPLETED|Overall Study||6
8538844|NCT00262002|21051607|P1|NOT COMPLETED|Overall Study||11
8538845|NCT00262002|21051601|P7|COMPLETED|Overall Study||84
8538846|NCT00262002|21051602|P6|COMPLETED|Overall Study||83
8538847|NCT00262002|21051603|P5|COMPLETED|Overall Study||91
8538848|NCT00262002|21051604|P4|COMPLETED|Overall Study||93
8538849|NCT00262002|21051605|P3|COMPLETED|Overall Study||45
8538850|NCT00262002|21051606|P2|COMPLETED|Overall Study||84
8538851|NCT00262002|21051607|P1|COMPLETED|Overall Study||79
8538852|NCT00262002|21051601|P7|STARTED|Overall Study||90
8538853|NCT00262002|21051602|P6|STARTED|Overall Study||90
8538854|NCT00262002|21051603|P5|STARTED|Overall Study||98
8538855|NCT00262002|21051604|P4|STARTED|Overall Study||98
8538856|NCT00262002|21051605|P3|STARTED|Overall Study||45
8538857|NCT00262002|21051606|P2|STARTED|Overall Study||90
8538858|NCT00262002|21051607|P1|STARTED|Overall Study||90
8538859|NCT00261950|21051700|P1|NOT COMPLETED|Overall Study||26
8538860|NCT00261950|21051700|P1|COMPLETED|Overall Study||84
8538861|NCT00261950|21051700|P1|STARTED|Overall Study||110
8538862|NCT00261846|21051725|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
8538863|NCT00261846|21051726|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
8538864|NCT00261846|21051727|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
8538865|NCT00261846|21051728|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
8538866|NCT00261846|21051729|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
8538867|NCT00261846|21051730|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
8538868|NCT00261846|21051731|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
8538869|NCT00261846|21051732|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
8538870|NCT00261846|21051733|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
8538871|NCT00261846|21051734|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8538872|NCT00261846|21051735|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8538873|NCT00261846|21051736|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8538874|NCT00261846|21051725|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
8538875|NCT00261846|21051726|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
8538876|NCT00261846|21051727|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
8538877|NCT00261846|21051728|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
8538878|NCT00261846|21051729|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
8538879|NCT00261846|21051730|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
8538880|NCT00261846|21051731|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
8538881|NCT00261846|21051732|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
8538882|NCT00261846|21051733|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
8538883|NCT00261846|21051734|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
8538884|NCT00261846|21051735|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
8538885|NCT00261846|21051736|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
8538886|NCT00261846|21051725|P12|STARTED|Period 2: Part 2 (Efficacy)||24
8538887|NCT00261846|21051726|P11|STARTED|Period 2: Part 2 (Efficacy)||64
8538888|NCT00261846|21051727|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
8538889|NCT00261846|21051728|P9|STARTED|Period 2: Part 2 (Efficacy)||26
8538890|NCT00261846|21051729|P8|STARTED|Period 2: Part 2 (Efficacy)||50
8538891|NCT00261846|21051730|P7|STARTED|Period 2: Part 2 (Efficacy)||38
8538892|NCT00261846|21051731|P6|STARTED|Period 2: Part 2 (Efficacy)||5
8538893|NCT00261846|21051732|P5|STARTED|Period 2: Part 2 (Efficacy)||89
8538894|NCT00261846|21051733|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
8538895|NCT00261846|21051734|P3|STARTED|Period 2: Part 2 (Efficacy)||0
8538896|NCT00261846|21051735|P2|STARTED|Period 2: Part 2 (Efficacy)||0
8538897|NCT00261846|21051736|P1|STARTED|Period 2: Part 2 (Efficacy)||0
8538898|NCT00261846|21051725|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538899|NCT00261846|21051726|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538900|NCT00261846|21051727|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538901|NCT00261846|21051728|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538902|NCT00261846|21051729|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538903|NCT00261846|21051730|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538904|NCT00261846|21051731|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538905|NCT00261846|21051732|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538906|NCT00261846|21051733|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538907|NCT00261846|21051734|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
8538908|NCT00261846|21051735|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
8538909|NCT00261846|21051736|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
8538910|NCT00261846|21051725|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538911|NCT00261846|21051726|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538912|NCT00261846|21051727|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538913|NCT00261846|21051728|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538914|NCT00261846|21051729|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538915|NCT00261846|21051730|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538916|NCT00261846|21051731|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538917|NCT00261846|21051732|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538918|NCT00261846|21051733|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538919|NCT00261846|21051734|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538920|NCT00261846|21051735|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538921|NCT00261846|21051736|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538922|NCT00261846|21051725|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538923|NCT00261846|21051726|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538924|NCT00261846|21051727|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538925|NCT00261846|21051728|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538926|NCT00261846|21051729|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538927|NCT00261846|21051730|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538928|NCT00261846|21051731|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538929|NCT00261846|21051732|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538930|NCT00261846|21051733|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538931|NCT00261846|21051734|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
8538932|NCT00261846|21051735|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
8538933|NCT00261846|21051736|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
8538934|NCT00261833|21051995|P2|NOT COMPLETED|Overall Study||18
8538935|NCT00261833|21051996|P1|NOT COMPLETED|Overall Study||9
8538936|NCT00261833|21051995|P2|COMPLETED|Overall Study||69
8538937|NCT00261833|21051996|P1|COMPLETED|Overall Study||84
8538938|NCT00261833|21051995|P2|STARTED|Overall Study||87
8538939|NCT00261833|21051996|P1|STARTED|Overall Study||93
8538940|NCT00261716|21052030|P2|NOT COMPLETED|Overall Study||10
8538941|NCT00261716|21052031|P1|NOT COMPLETED|Overall Study||6
8538942|NCT00261716|21052030|P2|COMPLETED|Overall Study||11
8538943|NCT00261716|21052031|P1|COMPLETED|Overall Study||11
8538944|NCT00261716|21052030|P2|STARTED|Overall Study||21
8538945|NCT00261716|21052031|P1|STARTED|Overall Study||17
8538946|NCT00261495|21052051|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8538947|NCT00261495|21052052|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
8538948|NCT00261495|21052051|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
8538949|NCT00261495|21052052|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
8538950|NCT00261495|21052051|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
8538951|NCT00261495|21052052|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
8538952|NCT00261495|21052051|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
8538953|NCT00261495|21052052|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
8538954|NCT00261495|21052051|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
8538955|NCT00261495|21052052|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
8538956|NCT00261495|21052051|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
8538957|NCT00261495|21052052|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
8538958|NCT00261495|21052051|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
8538959|NCT00261495|21052052|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
8538960|NCT00261495|21052051|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
8538961|NCT00261495|21052052|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
8538962|NCT00261495|21052051|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
8538963|NCT00261495|21052052|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
8538964|NCT00261443|21052216|P3|NOT COMPLETED|4: Extension Phase||2
8538965|NCT00261443|21052217|P2|NOT COMPLETED|4: Extension Phase||3
8538966|NCT00261443|21052218|P1|NOT COMPLETED|4: Extension Phase||0
8538967|NCT00261443|21052216|P3|COMPLETED|4: Extension Phase||21
8538968|NCT00261443|21052217|P2|COMPLETED|4: Extension Phase||16
8538969|NCT00261443|21052218|P1|COMPLETED|4: Extension Phase||0
8538970|NCT00261443|21052216|P3|STARTED|4: Extension Phase||23
8538971|NCT00261443|21052217|P2|STARTED|4: Extension Phase||19
8538972|NCT00261443|21052218|P1|STARTED|4: Extension Phase||0
8538973|NCT00261443|21052216|P3|NOT COMPLETED|3: Assessment of Relapse||65
8538974|NCT00261443|21052217|P2|NOT COMPLETED|3: Assessment of Relapse||80
8538975|NCT00261443|21052218|P1|NOT COMPLETED|3: Assessment of Relapse||0
8538976|NCT00261443|21052216|P3|COMPLETED|3: Assessment of Relapse||103
8538977|NCT00261443|21052217|P2|COMPLETED|3: Assessment of Relapse||89
8538978|NCT00261443|21052218|P1|COMPLETED|3: Assessment of Relapse||0
8538979|NCT00261443|21052216|P3|STARTED|3: Assessment of Relapse||168
8538980|NCT00261443|21052217|P2|STARTED|3: Assessment of Relapse||169
8538981|NCT00261443|21052218|P1|STARTED|3: Assessment of Relapse||0
8538982|NCT00261443|21052216|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
8538983|NCT00261443|21052217|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
8538984|NCT00261443|21052218|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
8538985|NCT00261443|21052216|P3|COMPLETED|2: Stability & Maintenance of Stability||0
8538986|NCT00261443|21052217|P2|COMPLETED|2: Stability & Maintenance of Stability||0
8538987|NCT00261443|21052218|P1|COMPLETED|2: Stability & Maintenance of Stability||346
8538988|NCT00261443|21052216|P3|STARTED|2: Stability & Maintenance of Stability||0
8538989|NCT00261443|21052217|P2|STARTED|2: Stability & Maintenance of Stability||0
8538990|NCT00261443|21052218|P1|STARTED|2: Stability & Maintenance of Stability||686
8538991|NCT00261443|21052216|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
8538992|NCT00261443|21052217|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
8538993|NCT00261443|21052218|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
8538994|NCT00261443|21052216|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
8538995|NCT00261443|21052217|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
8538996|NCT00261443|21052218|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
8538997|NCT00261443|21052216|P3|STARTED|1: Confirmation of Partial Nonresponse||0
8538998|NCT00261443|21052217|P2|STARTED|1: Confirmation of Partial Nonresponse||0
8538999|NCT00261443|21052218|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
8539000|NCT00261040|21052475|P2|NOT COMPLETED|Overall Study||0
8539001|NCT00261040|21052476|P1|NOT COMPLETED|Overall Study||1
8539002|NCT00261040|21052475|P2|COMPLETED|Overall Study||20
8539003|NCT00261040|21052476|P1|COMPLETED|Overall Study||19
8539004|NCT00261040|21052475|P2|STARTED|Overall Study||20
8539005|NCT00261040|21052476|P1|STARTED|Overall Study||20
8539006|NCT00260962|21052492|P2|NOT COMPLETED|Overall Study||2
8539007|NCT00260962|21052493|P1|NOT COMPLETED|Overall Study||4
8539008|NCT00260962|21052492|P2|COMPLETED|Overall Study||14
8539009|NCT00260962|21052493|P1|COMPLETED|Overall Study||14
8539010|NCT00260962|21052492|P2|STARTED|Overall Study||16
8539011|NCT00260962|21052493|P1|STARTED|Overall Study||18
8539012|NCT00260832|21052503|P2|NOT COMPLETED|Overall Study||211
8539013|NCT00260832|21052504|P1|NOT COMPLETED|Overall Study||228
8539014|NCT00260832|21052503|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
8539015|NCT00260832|21052504|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
8539016|NCT00260832|21052503|P2|STARTED|Overall Study||242
8539017|NCT00260832|21052504|P1|STARTED|Overall Study||243
8539018|NCT00260689|21052515|P3|NOT COMPLETED|Overall Study||15
8539019|NCT00260689|21052516|P2|NOT COMPLETED|Overall Study||49
8539020|NCT00260689|21052517|P1|NOT COMPLETED|Overall Study||41
8539021|NCT00260689|21052515|P3|COMPLETED|Overall Study||1
8539022|NCT00260689|21052516|P2|COMPLETED|Overall Study||11
8539023|NCT00260689|21052517|P1|COMPLETED|Overall Study||19
8539024|NCT00260689|21052515|P3|STARTED|Overall Study||16
8539025|NCT00260689|21052516|P2|STARTED|Overall Study||60
8539026|NCT00260689|21052517|P1|STARTED|Overall Study||60
8539027|NCT00260533|21052533|P2|NOT COMPLETED|Overall Study||3
8539028|NCT00260533|21052534|P1|NOT COMPLETED|Overall Study||3
8539029|NCT00260533|21052533|P2|COMPLETED|Overall Study||10
8539030|NCT00260533|21052534|P1|COMPLETED|Overall Study||11
8539031|NCT00260533|21052533|P2|STARTED|Overall Study||13
8539032|NCT00260533|21052534|P1|STARTED|Overall Study||14
8539033|NCT00260429|21052542|P2|NOT COMPLETED|Overall Study||0
8539034|NCT00260429|21052543|P1|NOT COMPLETED|Overall Study||2
8539035|NCT00260429|21052542|P2|COMPLETED|Overall Study||12
8539036|NCT00260429|21052543|P1|COMPLETED|Overall Study||21
8539037|NCT00260429|21052542|P2|STARTED|Overall Study||12
8539038|NCT00260429|21052543|P1|STARTED|Overall Study||23
8539039|NCT00260208|21052551|P2|NOT COMPLETED|Overall Study||34
8539040|NCT00260208|21052552|P1|NOT COMPLETED|Overall Study||47
8539041|NCT00260208|21052551|P2|COMPLETED|Overall Study||138
8539042|NCT00260208|21052552|P1|COMPLETED|Overall Study||137
8539043|NCT00260208|21052551|P2|Modified ITT|Overall Study||96
8539044|NCT00260208|21052552|P1|Modified ITT|Overall Study||101
8539045|NCT00260208|21052551|P2|Intent to Treat (ITT) Population|Overall Study||169
8539046|NCT00260208|21052552|P1|Intent to Treat (ITT) Population|Overall Study||182
8539047|NCT00260208|21052551|P2|STARTED|Overall Study||172
8539048|NCT00260208|21052552|P1|STARTED|Overall Study|"Started indicates safety population."|184
8539049|NCT00260195|21052582|P2|NOT COMPLETED|Overall Study||0
8539050|NCT00260195|21052583|P1|NOT COMPLETED|Overall Study||0
8539051|NCT00260195|21052582|P2|COMPLETED|Overall Study||37
8539052|NCT00260195|21052583|P1|COMPLETED|Overall Study||39
8539053|NCT00260195|21052582|P2|STARTED|Overall Study||37
8539054|NCT00260195|21052583|P1|STARTED|Overall Study||39
8539055|NCT00260065|21052595|P1|NOT COMPLETED|Overall Study||93
8539056|NCT00260065|21052595|P1|COMPLETED|Overall Study||6
8539057|NCT00260065|21052595|P1|STARTED|Overall Study||99
8539058|NCT00259857|21052602|P2|NOT COMPLETED|24 Months Treatment||3
8539059|NCT00259857|21052603|P1|NOT COMPLETED|24 Months Treatment||0
8539060|NCT00259857|21052602|P2|COMPLETED|24 Months Treatment||6
8539061|NCT00259857|21052603|P1|COMPLETED|24 Months Treatment||10
8539062|NCT00259857|21052602|P2|STARTED|24 Months Treatment||9
8539063|NCT00259857|21052603|P1|STARTED|24 Months Treatment||10
8539064|NCT00259857|21052602|P2|NOT COMPLETED|12 Months Treatment||2
8539065|NCT00259857|21052603|P1|NOT COMPLETED|12 Months Treatment||1
8539066|NCT00259857|21052602|P2|COMPLETED|12 Months Treatment||9
8539067|NCT00259857|21052603|P1|COMPLETED|12 Months Treatment||10
8539068|NCT00259857|21052602|P2|STARTED|12 Months Treatment||11
8539069|NCT00259857|21052603|P1|STARTED|12 Months Treatment||11
8539070|NCT00259740|21052621|P2|NOT COMPLETED|Overall Study||53
8539071|NCT00259740|21052622|P1|NOT COMPLETED|Overall Study||43
8539072|NCT00259740|21052621|P2|COMPLETED|Overall Study||0
8539073|NCT00259740|21052622|P1|COMPLETED|Overall Study||0
8539074|NCT00259740|21052621|P2|Received Study Medication|Overall Study||53
8539075|NCT00259740|21052622|P1|Received Study Medication|Overall Study||42
8539076|NCT00259740|21052621|P2|STARTED|Overall Study||53
8539077|NCT00259740|21052622|P1|STARTED|Overall Study||43
8539078|NCT00259649|21052632|P1|NOT COMPLETED|Overall Study||10
8539079|NCT00259649|21052632|P1|COMPLETED|Overall Study||61
8539080|NCT00259649|21052632|P1|STARTED|Overall Study||71
8539081|NCT00259610|21052640|P4|NOT COMPLETED|Overall Study||43
8539082|NCT00259610|21052641|P3|NOT COMPLETED|Overall Study||73
8539083|NCT00259610|21052642|P2|NOT COMPLETED|Overall Study||46
8539084|NCT00259610|21052643|P1|NOT COMPLETED|Overall Study||76
8539085|NCT00259610|21052640|P4|COMPLETED|Overall Study||81
8539086|NCT00259610|21052641|P3|COMPLETED|Overall Study||182
8539087|NCT00259610|21052642|P2|COMPLETED|Overall Study||86
8539088|NCT00259610|21052643|P1|COMPLETED|Overall Study||168
8539089|NCT00259610|21052640|P4|STARTED|Overall Study||124
8539090|NCT00259610|21052641|P3|STARTED|Overall Study||255
8539091|NCT00259610|21052642|P2|STARTED|Overall Study||132
8539092|NCT00259610|21052643|P1|STARTED|Overall Study||244
8539093|NCT00259298|21052657|P1|NOT COMPLETED|Overall Study||3
8539094|NCT00259298|21052657|P1|COMPLETED|Overall Study||9
8539095|NCT00259298|21052657|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
8539096|NCT00259298|21052657|P1|STARTED|Overall Study||12
8539097|NCT00259285|21052665|P1|NOT COMPLETED|Overall Study||0
8539098|NCT00259285|21052665|P1|COMPLETED|Overall Study||10
8539099|NCT00259285|21052665|P1|STARTED|Overall Study||10
8539100|NCT00259272|21052675|P4|NOT COMPLETED|Overall Study||21
8539101|NCT00259272|21052676|P3|NOT COMPLETED|Overall Study||5
8539102|NCT00259272|21052677|P2|NOT COMPLETED|Overall Study||7
8539103|NCT00259272|21052678|P1|NOT COMPLETED|Overall Study||15
8539104|NCT00259272|21052675|P4|COMPLETED|Overall Study||27
8539105|NCT00259272|21052676|P3|COMPLETED|Overall Study||21
8539106|NCT00259272|21052677|P2|COMPLETED|Overall Study||24
8539107|NCT00259272|21052678|P1|COMPLETED|Overall Study||21
8539108|NCT00259272|21052675|P4|STARTED|Overall Study||48
8539109|NCT00259272|21052676|P3|STARTED|Overall Study||26
8539110|NCT00259272|21052677|P2|STARTED|Overall Study||31
8539111|NCT00259272|21052678|P1|STARTED|Overall Study||36
8539112|NCT00259090|21052756|P3|NOT COMPLETED|Overall Study||0
8539113|NCT00259090|21052757|P2|NOT COMPLETED|Overall Study||0
8539114|NCT00259090|21052758|P1|NOT COMPLETED|Overall Study||0
8539115|NCT00259090|21052756|P3|COMPLETED|Overall Study||37
8539116|NCT00259090|21052757|P2|COMPLETED|Overall Study||31
8539117|NCT00259090|21052758|P1|COMPLETED|Overall Study||35
8539118|NCT00259090|21052756|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
8539119|NCT00259090|21052757|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
8539120|NCT00259090|21052758|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
8539121|NCT00259012|21052774|P2|NOT COMPLETED|Overall Study||4
8539122|NCT00259012|21052775|P1|NOT COMPLETED|Overall Study||2
8539123|NCT00259012|21052774|P2|COMPLETED|Overall Study||30
8539124|NCT00259012|21052775|P1|COMPLETED|Overall Study||31
8539125|NCT00259012|21052774|P2|STARTED|Overall Study||34
8539126|NCT00259012|21052775|P1|STARTED|Overall Study||33
8539127|NCT00258960|21052807|P1|NOT COMPLETED|Overall Study||17
8539128|NCT00258960|21052807|P1|COMPLETED|Overall Study||32
8539129|NCT00258960|21052807|P1|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
8539130|NCT00258908|21052815|P1|NOT COMPLETED|Overall Study||0
8539131|NCT00258908|21052815|P1|COMPLETED|Overall Study||112
8539132|NCT00258908|21052815|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
8539133|NCT00258895|21052823|P2|NOT COMPLETED|Overall Study||3
8539134|NCT00258895|21052824|P1|NOT COMPLETED|Overall Study||10
8539135|NCT00258895|21052823|P2|COMPLETED|Overall Study||159
8539136|NCT00258895|21052824|P1|COMPLETED|Overall Study||477
8539137|NCT00258895|21052823|P2|STARTED|Overall Study||162
8539138|NCT00258895|21052824|P1|STARTED|Overall Study||487
8539139|NCT00258882|21052840|P2|NOT COMPLETED|Pregnancy Surveillance||0
8539140|NCT00258882|21052841|P1|NOT COMPLETED|Pregnancy Surveillance||0
8539141|NCT00258882|21052840|P2|COMPLETED|Pregnancy Surveillance||675
8539142|NCT00258882|21052841|P1|COMPLETED|Pregnancy Surveillance||225
8539143|NCT00258882|21052840|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
8539144|NCT00258882|21052841|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
8539145|NCT00258882|21052840|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
8539146|NCT00258882|21052841|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
8539147|NCT00258882|21052840|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
8539148|NCT00258882|21052841|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
8539149|NCT00258882|21052840|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
8539150|NCT00258882|21052841|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
8539151|NCT00258882|21052840|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
8539152|NCT00258882|21052841|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
8539153|NCT00258882|21052840|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
8539154|NCT00258882|21052841|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
8539155|NCT00258882|21052840|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
8539156|NCT00258882|21052841|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
8539157|NCT00258856|21052860|P4|NOT COMPLETED|Overall Study||1
8539158|NCT00258856|21052861|P3|NOT COMPLETED|Overall Study||2
8539159|NCT00258856|21052862|P2|NOT COMPLETED|Overall Study||0
8539160|NCT00258856|21052863|P1|NOT COMPLETED|Overall Study||3
8539161|NCT00258856|21052860|P4|COMPLETED|Overall Study||58
8539162|NCT00258856|21052861|P3|COMPLETED|Overall Study||56
8539163|NCT00258856|21052862|P2|COMPLETED|Overall Study||58
8539164|NCT00258856|21052863|P1|COMPLETED|Overall Study||56
8539165|NCT00258856|21052860|P4|STARTED|Overall Study||59
8539166|NCT00258856|21052861|P3|STARTED|Overall Study||58
8539167|NCT00258856|21052862|P2|STARTED|Overall Study||58
8539168|NCT00258856|21052863|P1|STARTED|Overall Study||59
8539169|NCT00258830|21052875|P2|NOT COMPLETED|Overall Study||0
8539170|NCT00258830|21052876|P1|NOT COMPLETED|Overall Study||0
8539171|NCT00258830|21052875|P2|COMPLETED|Overall Study||60
8539172|NCT00258830|21052876|P1|COMPLETED|Overall Study||60
8539173|NCT00258830|21052875|P2|STARTED|Overall Study||60
8539174|NCT00258830|21052876|P1|STARTED|Overall Study||60
8539175|NCT00258817|21052890|P2|NOT COMPLETED|Overall Study||0
8539176|NCT00258817|21052891|P1|NOT COMPLETED|Overall Study||0
8539177|NCT00258817|21052890|P2|COMPLETED|Overall Study||15
8539178|NCT00258817|21052891|P1|COMPLETED|Overall Study||15
8539179|NCT00258817|21052890|P2|STARTED|Overall Study||15
8539180|NCT00258817|21052891|P1|STARTED|Overall Study||15
8539181|NCT00258674|21052904|P3|NOT COMPLETED|Overall Study||34
8539182|NCT00258674|21052905|P2|NOT COMPLETED|Overall Study||53
8539183|NCT00258674|21052906|P1|NOT COMPLETED|Overall Study||32
8539184|NCT00258674|21052904|P3|COMPLETED|Overall Study||568
8539185|NCT00258674|21052905|P2|COMPLETED|Overall Study||758
8539186|NCT00258674|21052906|P1|COMPLETED|Overall Study||565
8539187|NCT00258674|21052904|P3|STARTED|Overall Study||602
8539188|NCT00258674|21052905|P2|STARTED|Overall Study||811
8539189|NCT00258674|21052906|P1|STARTED|Overall Study||597
8539190|NCT00258440|21052965|P3|NOT COMPLETED|Overall Study||1
8539191|NCT00258440|21052966|P2|NOT COMPLETED|Overall Study||0
8539192|NCT00258440|21052967|P1|NOT COMPLETED|Overall Study||0
8539193|NCT00258440|21052965|P3|COMPLETED|Overall Study||5
8539194|NCT00258440|21052966|P2|COMPLETED|Overall Study||0
8539195|NCT00258440|21052967|P1|COMPLETED|Overall Study||1
8539196|NCT00258440|21052965|P3|STARTED|Overall Study||6
8539197|NCT00258440|21052966|P2|STARTED|Overall Study||0
8539198|NCT00258440|21052967|P1|STARTED|Overall Study||1
8539199|NCT00258362|21052978|P1|NOT COMPLETED|Overall Study||0
8539200|NCT00258362|21052978|P1|COMPLETED|Overall Study||41
8539201|NCT00258362|21052978|P1|STARTED|Overall Study||41
8539202|NCT00258349|21052983|P1|NOT COMPLETED|Overall Study||0
8539203|NCT00258349|21052983|P1|COMPLETED|Overall Study||16
8539204|NCT00258349|21052983|P1|HER2-positive by Central Review|Overall Study||10
8539205|NCT00258349|21052983|P1|STARTED|Overall Study||16
8539206|NCT00258310|21052990|P1|NOT COMPLETED|Overall Study||0
8539207|NCT00258310|21052990|P1|COMPLETED|Overall Study||35
8539208|NCT00258310|21052990|P1|STARTED|Overall Study||35
8539209|NCT00258206|21052994|P1|NOT COMPLETED|Overall Study||0
8539210|NCT00258206|21052994|P1|COMPLETED|Overall Study||21
8539211|NCT00258206|21052994|P1|STARTED|Overall Study||21
8539212|NCT00258180|21052998|P1|NOT COMPLETED|Overall Study||0
8539213|NCT00258180|21052998|P1|COMPLETED|Overall Study||2
8539214|NCT00258180|21052998|P1|STARTED|Overall Study||2
8539215|NCT00258154|21053005|P2|NOT COMPLETED|Overall Study||7
8539216|NCT00258154|21053006|P1|NOT COMPLETED|Overall Study||9
8539217|NCT00258154|21053005|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
8539218|NCT00258154|21053006|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
8539219|NCT00258154|21053005|P2|Vaccinated at Visit 3|Overall Study||197
8539220|NCT00258154|21053006|P1|Vaccinated at Visit 3|Overall Study||195
8539221|NCT00258154|21053005|P2|Vaccinated at Visit 2|Overall Study||198
8539222|NCT00258154|21053006|P1|Vaccinated at Visit 2|Overall Study||198
8539223|NCT00258154|21053005|P2|Vaccinated at Visit 1|Overall Study||202
8539224|NCT00258154|21053006|P1|Vaccinated at Visit 1|Overall Study||201
8539225|NCT00258154|21053005|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
8539226|NCT00258154|21053006|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
8539227|NCT00258128|21053076|P2|NOT COMPLETED|Overall Study||0
8539228|NCT00258128|21053077|P1|NOT COMPLETED|Overall Study||0
8539229|NCT00258128|21053076|P2|COMPLETED|Overall Study||9
8539230|NCT00258128|21053077|P1|COMPLETED|Overall Study||8
8539231|NCT00258128|21053076|P2|STARTED|Overall Study||9
8539232|NCT00258128|21053077|P1|STARTED|Overall Study||8
8539233|NCT00258011|21053085|P1|NOT COMPLETED|Overall Study||0
8539234|NCT00258011|21053085|P1|COMPLETED|Overall Study||3
8539235|NCT00258011|21053085|P1|STARTED|Overall Study||3
8539236|NCT00257933|21053092|P2|NOT COMPLETED|Overall Study||0
8539237|NCT00257933|21053093|P1|NOT COMPLETED|Overall Study||0
8539238|NCT00257933|21053092|P2|COMPLETED|Overall Study||78
8539239|NCT00257933|21053093|P1|COMPLETED|Overall Study||74
8539240|NCT00257933|21053092|P2|STARTED|Overall Study||78
8539241|NCT00257933|21053093|P1|STARTED|Overall Study||74
8539242|NCT00257920|21053101|P2|NOT COMPLETED|Period: Second Intervention||1
8539243|NCT00257920|21053102|P1|NOT COMPLETED|Period: Second Intervention||2
8539244|NCT00257920|21053101|P2|COMPLETED|Period: Second Intervention||18
8539245|NCT00257920|21053102|P1|COMPLETED|Period: Second Intervention||19
8539246|NCT00257920|21053101|P2|STARTED|Period: Second Intervention||19
8539247|NCT00257920|21053102|P1|STARTED|Period: Second Intervention||21
8539248|NCT00257920|21053101|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
8539249|NCT00257920|21053102|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
8539250|NCT00257920|21053101|P2|COMPLETED|Period: Washout Period of Two Weeks||19
8539251|NCT00257920|21053102|P1|COMPLETED|Period: Washout Period of Two Weeks||21
8539252|NCT00257920|21053101|P2|STARTED|Period: Washout Period of Two Weeks||20
8539253|NCT00257920|21053102|P1|STARTED|Period: Washout Period of Two Weeks||21
8539254|NCT00257920|21053101|P2|NOT COMPLETED|Period: First Intervention||0
8539255|NCT00257920|21053102|P1|NOT COMPLETED|Period: First Intervention||0
8539256|NCT00257920|21053101|P2|COMPLETED|Period: First Intervention||20
8539257|NCT00257920|21053102|P1|COMPLETED|Period: First Intervention||21
8539258|NCT00257920|21053101|P2|STARTED|Period: First Intervention||20
8539259|NCT00257920|21053102|P1|STARTED|Period: First Intervention||21
8539260|NCT00257894|21053112|P2|NOT COMPLETED|Overall Study||5
8539261|NCT00257894|21053113|P1|NOT COMPLETED|Overall Study||4
8539262|NCT00257894|21053112|P2|COMPLETED|Overall Study||15
8539263|NCT00257894|21053113|P1|COMPLETED|Overall Study||17
8539264|NCT00257894|21053112|P2|STARTED|Overall Study||20
8539265|NCT00257894|21053113|P1|STARTED|Overall Study||21
8539266|NCT00257725|21053125|P1|NOT COMPLETED|Overall Study||3
8539267|NCT00257725|21053125|P1|COMPLETED|Overall Study||8
8539268|NCT00257725|21053125|P1|STARTED|Overall Study||11
8539269|NCT00257686|21053137|P6|NOT COMPLETED|Overall Study||9
8539270|NCT00257686|21053138|P5|NOT COMPLETED|Overall Study||22
8539271|NCT00257686|21053139|P4|NOT COMPLETED|Overall Study||11
8539272|NCT00257686|21053140|P3|NOT COMPLETED|Overall Study||18
8539273|NCT00257686|21053141|P2|NOT COMPLETED|Overall Study||19
8539274|NCT00257686|21053142|P1|NOT COMPLETED|Overall Study||21
8539275|NCT00257686|21053137|P6|COMPLETED|Overall Study||95
8539276|NCT00257686|21053138|P5|COMPLETED|Overall Study||194
8539277|NCT00257686|21053139|P4|COMPLETED|Overall Study||88
8539278|NCT00257686|21053140|P3|COMPLETED|Overall Study||208
8539279|NCT00257686|21053141|P2|COMPLETED|Overall Study||89
8539280|NCT00257686|21053142|P1|COMPLETED|Overall Study||188
8539281|NCT00257686|21053137|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
8539282|NCT00257686|21053138|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
8539283|NCT00257686|21053139|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
8539284|NCT00257686|21053140|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
8539285|NCT00257686|21053141|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
8539286|NCT00257686|21053142|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
8539287|NCT00257686|21053137|P6|STARTED|Overall Study||104
8539288|NCT00257686|21053138|P5|STARTED|Overall Study||216
8539289|NCT00257686|21053139|P4|STARTED|Overall Study||99
8539290|NCT00257686|21053140|P3|STARTED|Overall Study||226
8539291|NCT00257686|21053141|P2|STARTED|Overall Study||108
8539292|NCT00257686|21053142|P1|STARTED|Overall Study||209
8539293|NCT00257660|21053164|P2|NOT COMPLETED|Overall Study||23
8539294|NCT00257660|21053165|P1|NOT COMPLETED|Overall Study||10
8539295|NCT00257660|21053164|P2|COMPLETED|Overall Study||38
8539296|NCT00257660|21053165|P1|COMPLETED|Overall Study||45
8539297|NCT00257660|21053164|P2|STARTED|Overall Study||61
8539298|NCT00257660|21053165|P1|STARTED|Overall Study||55
8539299|NCT00257608|21053195|P3|NOT COMPLETED|Post Chemotherapy Phase||244
8539300|NCT00257608|21053196|P2|NOT COMPLETED|Post Chemotherapy Phase||264
8539301|NCT00257608|21053197|P1|NOT COMPLETED|Post Chemotherapy Phase||0
8539302|NCT00257608|21053195|P3|COMPLETED|Post Chemotherapy Phase||126
8539303|NCT00257608|21053196|P2|COMPLETED|Post Chemotherapy Phase||109
8539304|NCT00257608|21053197|P1|COMPLETED|Post Chemotherapy Phase||0
8539305|NCT00257608|21053195|P3|STARTED|Post Chemotherapy Phase||370
8539306|NCT00257608|21053196|P2|STARTED|Post Chemotherapy Phase||373
8539307|NCT00257608|21053197|P1|STARTED|Post Chemotherapy Phase||0
8539308|NCT00257608|21053195|P3|NOT COMPLETED|Chemotherapy Phase||0
8539309|NCT00257608|21053196|P2|NOT COMPLETED|Chemotherapy Phase||0
8539310|NCT00257608|21053197|P1|NOT COMPLETED|Chemotherapy Phase||376
8539311|NCT00257608|21053195|P3|COMPLETED|Chemotherapy Phase||0
8539312|NCT00257608|21053196|P2|COMPLETED|Chemotherapy Phase||0
8539313|NCT00257608|21053197|P1|COMPLETED|Chemotherapy Phase||769
8539314|NCT00257608|21053195|P3|STARTED|Chemotherapy Phase||0
8539315|NCT00257608|21053196|P2|STARTED|Chemotherapy Phase||0
8539316|NCT00257608|21053197|P1|STARTED|Chemotherapy Phase||1145
8539317|NCT00257556|21053223|P2|NOT COMPLETED|Overall Study||10
8539318|NCT00257556|21053224|P1|NOT COMPLETED|Overall Study||14
8539319|NCT00257556|21053223|P2|COMPLETED|Overall Study||32
8539320|NCT00257556|21053224|P1|COMPLETED|Overall Study||24
8539321|NCT00257556|21053223|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
8539322|NCT00257556|21053224|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
8539323|NCT00257556|21053223|P2|STARTED|Overall Study||42
8539324|NCT00257556|21053224|P1|STARTED|Overall Study||38
8539325|NCT00257322|21053250|P1|NOT COMPLETED|Overall Study||4
8539326|NCT00257322|21053250|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
8539327|NCT00257322|21053250|P1|STARTED|Overall Study|20 subjects accrued.|20
8539328|NCT00257309|21053257|P2|NOT COMPLETED|Overall Study||2
8539329|NCT00257309|21053258|P1|NOT COMPLETED|Overall Study||2
8539330|NCT00257309|21053257|P2|COMPLETED|Overall Study||130
8539331|NCT00257309|21053258|P1|COMPLETED|Overall Study||132
8539332|NCT00257309|21053257|P2|STARTED|Overall Study||132
8539333|NCT00257309|21053258|P1|STARTED|Overall Study||134
8539334|NCT00257192|21053268|P2|NOT COMPLETED|Overall Study||39
8539335|NCT00257192|21053269|P1|NOT COMPLETED|Overall Study||58
8539336|NCT00257192|21053268|P2|COMPLETED|Overall Study||52
8539337|NCT00257192|21053269|P1|COMPLETED|Overall Study||135
8539338|NCT00257192|21053268|P2|Received Study Treatment|Overall Study||90
8539339|NCT00257192|21053269|P1|Received Study Treatment|Overall Study||193
8539340|NCT00257192|21053268|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
8539341|NCT00257192|21053269|P1|STARTED|Overall Study||193
8539342|NCT00257166|21053313|P2|NOT COMPLETED|Overall Study||37
8539343|NCT00257166|21053314|P1|NOT COMPLETED|Overall Study||53
8539344|NCT00257166|21053313|P2|COMPLETED|Overall Study||51
8539345|NCT00257166|21053314|P1|COMPLETED|Overall Study||97
8539346|NCT00257166|21053313|P2|Treated|Overall Study||88
8539347|NCT00257166|21053314|P1|Treated|Overall Study||149
8539348|NCT00257166|21053313|P2|STARTED|Overall Study||88
8539349|NCT00257166|21053314|P1|STARTED|Overall Study||150
8539350|NCT00257010|21053326|P1|NOT COMPLETED|Overall Study||128
8539351|NCT00257010|21053326|P1|COMPLETED|Overall Study||319
8539352|NCT00257010|21053326|P1|STARTED|Overall Study||447
8539353|NCT00256997|21053337|P2|NOT COMPLETED|Overall Study||55
8539354|NCT00256997|21053338|P1|NOT COMPLETED|Overall Study||48
8539355|NCT00256997|21053337|P2|COMPLETED|Overall Study||31
8539356|NCT00256997|21053338|P1|COMPLETED|Overall Study||33
8539357|NCT00256997|21053337|P2|Treated|Overall Study||86
8539358|NCT00256997|21053338|P1|Treated|Overall Study||79
8539359|NCT00256997|21053337|P2|STARTED|Overall Study||86
8539360|NCT00256997|21053338|P1|STARTED|Overall Study||81
8539361|NCT00256984|21053362|P1|NOT COMPLETED|Overall Study||16
8539362|NCT00256984|21053362|P1|COMPLETED|Overall Study||59
8539363|NCT00256984|21053362|P1|STARTED|Overall Study||75
8539364|NCT00256867|21053380|P8|NOT COMPLETED|Overall Study||11
8539365|NCT00256867|21053381|P7|NOT COMPLETED|Overall Study||5
8539366|NCT00256867|21053382|P6|NOT COMPLETED|Overall Study||6
8539367|NCT00256867|21053383|P5|NOT COMPLETED|Overall Study||7
8539368|NCT00256867|21053384|P4|NOT COMPLETED|Overall Study||6
8539369|NCT00256867|21053385|P3|NOT COMPLETED|Overall Study||5
8539370|NCT00256867|21053386|P2|NOT COMPLETED|Overall Study||5
8539371|NCT00256867|21053387|P1|NOT COMPLETED|Overall Study||2
8539372|NCT00256867|21053380|P8|COMPLETED|Overall Study||36
8539373|NCT00256867|21053381|P7|COMPLETED|Overall Study||41
8539374|NCT00256867|21053382|P6|COMPLETED|Overall Study||40
8539375|NCT00256867|21053383|P5|COMPLETED|Overall Study||41
8539376|NCT00256867|21053384|P4|COMPLETED|Overall Study||40
8539377|NCT00256867|21053385|P3|COMPLETED|Overall Study||40
8539378|NCT00256867|21053386|P2|COMPLETED|Overall Study||39
8539379|NCT00256867|21053387|P1|COMPLETED|Overall Study||45
8539380|NCT00256867|21053380|P8|STARTED|Overall Study||47
8539381|NCT00256867|21053381|P7|STARTED|Overall Study||46
8539382|NCT00256867|21053382|P6|STARTED|Overall Study||46
8539383|NCT00256867|21053383|P5|STARTED|Overall Study||48
8539384|NCT00256867|21053384|P4|STARTED|Overall Study||46
8539385|NCT00256867|21053385|P3|STARTED|Overall Study||45
8539386|NCT00256867|21053386|P2|STARTED|Overall Study||44
8539387|NCT00256867|21053387|P1|STARTED|Overall Study||47
8539388|NCT00256854|21053477|P6|NOT COMPLETED|Overall Study||1
8539389|NCT00256854|21053478|P5|NOT COMPLETED|Overall Study||1
8539390|NCT00256854|21053479|P4|NOT COMPLETED|Overall Study||3
8539391|NCT00256854|21053480|P3|NOT COMPLETED|Overall Study||3
8539392|NCT00256854|21053481|P2|NOT COMPLETED|Overall Study||4
8539393|NCT00256854|21053482|P1|NOT COMPLETED|Overall Study||3
8539394|NCT00256854|21053477|P6|COMPLETED|Overall Study||13
8539395|NCT00256854|21053478|P5|COMPLETED|Overall Study||15
8539396|NCT00256854|21053479|P4|COMPLETED|Overall Study||24
8539397|NCT00256854|21053480|P3|COMPLETED|Overall Study||23
8539398|NCT00256854|21053481|P2|COMPLETED|Overall Study||22
8539399|NCT00256854|21053482|P1|COMPLETED|Overall Study||23
8539400|NCT00256854|21053477|P6|STARTED|Overall Study||14
8539401|NCT00256854|21053478|P5|STARTED|Overall Study||16
8539402|NCT00256854|21053479|P4|STARTED|Overall Study||27
8539403|NCT00256854|21053480|P3|STARTED|Overall Study||26
8539404|NCT00256854|21053481|P2|STARTED|Overall Study||26
8539405|NCT00256854|21053482|P1|STARTED|Overall Study||26
8539406|NCT00256750|21053541|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
8539407|NCT00256750|21053542|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
8539408|NCT00256750|21053543|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
8539409|NCT00256750|21053541|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
8539410|NCT00256750|21053542|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
8539411|NCT00256750|21053543|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
8539412|NCT00256750|21053541|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
8539413|NCT00256750|21053542|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
8539414|NCT00256750|21053543|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
8539415|NCT00256750|21053541|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
8539416|NCT00256750|21053542|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
8539417|NCT00256750|21053543|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
8539418|NCT00256750|21053541|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
8539419|NCT00256750|21053542|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
8539420|NCT00256750|21053543|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
8539421|NCT00256750|21053541|P3|STARTED|Post-Transplant Treated (36 Months)||164
8539422|NCT00256750|21053542|P2|STARTED|Post-Transplant Treated (36 Months)||176
8539423|NCT00256750|21053543|P1|STARTED|Post-Transplant Treated (36 Months)||153
8539424|NCT00256750|21053541|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
8539425|NCT00256750|21053542|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
8539426|NCT00256750|21053543|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
8539427|NCT00256750|21053541|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
8539428|NCT00256750|21053542|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
8539429|NCT00256750|21053543|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
8539430|NCT00256750|21053541|P3|STARTED|Post-Transplant Treated (24 Months)||173
8539431|NCT00256750|21053542|P2|STARTED|Post-Transplant Treated (24 Months)||183
8539432|NCT00256750|21053543|P1|STARTED|Post-Transplant Treated (24 Months)||174
8539433|NCT00256750|21053541|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
8539434|NCT00256750|21053542|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
8539435|NCT00256750|21053543|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
8539436|NCT00256750|21053541|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
8539437|NCT00256750|21053542|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
8539438|NCT00256750|21053543|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
8539439|NCT00256750|21053541|P3|STARTED|Post-Transplant Treated (12 Months)||219
8539440|NCT00256750|21053542|P2|STARTED|Post-Transplant Treated (12 Months)||226
8539441|NCT00256750|21053543|P1|STARTED|Post-Transplant Treated (12 Months)||215
8539442|NCT00256750|21053541|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
8539443|NCT00256750|21053542|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
8539444|NCT00256750|21053543|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
8539445|NCT00256750|21053541|P3|COMPLETED|Transplanted Pre-Treatment||219
8539446|NCT00256750|21053542|P2|COMPLETED|Transplanted Pre-Treatment||226
8539447|NCT00256750|21053543|P1|COMPLETED|Transplanted Pre-Treatment||215
8539448|NCT00256750|21053541|P3|STARTED|Transplanted Pre-Treatment||219
8539449|NCT00256750|21053542|P2|STARTED|Transplanted Pre-Treatment||226
8539450|NCT00256750|21053543|P1|STARTED|Transplanted Pre-Treatment||221
8539451|NCT00256724|21053679|P2|NOT COMPLETED|Overall Study||8
8539452|NCT00256724|21053680|P1|NOT COMPLETED|Overall Study||5
8539453|NCT00256724|21053679|P2|COMPLETED|Overall Study||16
8539454|NCT00256724|21053680|P1|COMPLETED|Overall Study||18
8539455|NCT00256724|21053679|P2|STARTED|Overall Study||24
8539456|NCT00256724|21053680|P1|STARTED|Overall Study||23
8539457|NCT00256698|21053690|P2|NOT COMPLETED|Overall Study||172
8539458|NCT00256698|21053691|P1|NOT COMPLETED|Overall Study||167
8539459|NCT00256698|21053690|P2|COMPLETED|Overall Study||84
8539460|NCT00256698|21053691|P1|COMPLETED|Overall Study||91
8539461|NCT00256698|21053690|P2|STARTED|Overall Study||256
8539462|NCT00256698|21053691|P1|STARTED|Overall Study||258
8539463|NCT00256451|21053709|P4|NOT COMPLETED|Session4||0
8539464|NCT00256451|21053710|P3|NOT COMPLETED|Session4||0
8539465|NCT00256451|21053711|P2|NOT COMPLETED|Session4||0
8539466|NCT00256451|21053712|P1|NOT COMPLETED|Session4||0
8539467|NCT00256451|21053709|P4|COMPLETED|Session4||8
8539468|NCT00256451|21053710|P3|COMPLETED|Session4||10
8539469|NCT00256451|21053711|P2|COMPLETED|Session4||8
8539470|NCT00256451|21053712|P1|COMPLETED|Session4||9
8539471|NCT00256451|21053709|P4|STARTED|Session4||8
8539472|NCT00256451|21053710|P3|STARTED|Session4||10
8539473|NCT00256451|21053711|P2|STARTED|Session4||8
8539474|NCT00256451|21053712|P1|STARTED|Session4||9
8539475|NCT00256451|21053709|P4|NOT COMPLETED|Session3||0
8539476|NCT00256451|21053710|P3|NOT COMPLETED|Session3||0
8539477|NCT00256451|21053711|P2|NOT COMPLETED|Session3||0
8539478|NCT00256451|21053712|P1|NOT COMPLETED|Session3||0
8539479|NCT00256451|21053709|P4|COMPLETED|Session3||9
8539480|NCT00256451|21053710|P3|COMPLETED|Session3||10
8539481|NCT00256451|21053711|P2|COMPLETED|Session3||9
8539482|NCT00256451|21053712|P1|COMPLETED|Session3||9
8539483|NCT00256451|21053709|P4|STARTED|Session3||9
8539484|NCT00256451|21053710|P3|STARTED|Session3||10
8539485|NCT00256451|21053711|P2|STARTED|Session3||9
8539486|NCT00256451|21053712|P1|STARTED|Session3||9
8539487|NCT00256451|21053709|P4|NOT COMPLETED|Session2||0
8539488|NCT00256451|21053710|P3|NOT COMPLETED|Session2||0
8539489|NCT00256451|21053711|P2|NOT COMPLETED|Session2||0
8539490|NCT00256451|21053712|P1|NOT COMPLETED|Session2||0
8539491|NCT00256451|21053709|P4|COMPLETED|Session2||10
8539492|NCT00256451|21053710|P3|COMPLETED|Session2||10
8539493|NCT00256451|21053711|P2|COMPLETED|Session2||11
8539494|NCT00256451|21053712|P1|COMPLETED|Session2||9
8539495|NCT00256451|21053709|P4|STARTED|Session2||10
8539496|NCT00256451|21053710|P3|STARTED|Session2||10
8539497|NCT00256451|21053711|P2|STARTED|Session2||11
8539498|NCT00256451|21053712|P1|STARTED|Session2||9
8539499|NCT00256451|21053709|P4|NOT COMPLETED|Session1||0
8539500|NCT00256451|21053710|P3|NOT COMPLETED|Session1||0
8539501|NCT00256451|21053711|P2|NOT COMPLETED|Session1||0
8539502|NCT00256451|21053712|P1|NOT COMPLETED|Session1||0
8539503|NCT00256451|21053709|P4|COMPLETED|Session1||11
8539504|NCT00256451|21053710|P3|COMPLETED|Session1||11
8539505|NCT00256451|21053711|P2|COMPLETED|Session1||11
8539506|NCT00256451|21053712|P1|COMPLETED|Session1||10
8539507|NCT00256451|21053709|P4|STARTED|Session1||11
8539508|NCT00256451|21053710|P3|STARTED|Session1||11
8539509|NCT00256451|21053711|P2|STARTED|Session1||11
8539510|NCT00256451|21053712|P1|STARTED|Session1||10
8539511|NCT00256308|21053738|P1|NOT COMPLETED|Overall Study||2
8539512|NCT00256308|21053738|P1|COMPLETED|Overall Study||4
8539513|NCT00256308|21053738|P1|STARTED|Overall Study||6
8539514|NCT00256295|21053746|P1|NOT COMPLETED|Overall Study||4
8539515|NCT00256295|21053746|P1|COMPLETED|Overall Study||3
8539516|NCT00256295|21053746|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
8539517|NCT00256282|21053752|P1|NOT COMPLETED|Overall Study||16
8539518|NCT00256282|21053752|P1|COMPLETED|Overall Study||36
8539519|NCT00256282|21053752|P1|STARTED|Overall Study||52
8539520|NCT00256243|21053757|P1|NOT COMPLETED|Overall Study||10
8539521|NCT00256243|21053757|P1|COMPLETED|Overall Study||38
8539522|NCT00256243|21053757|P1|STARTED|Overall Study||48
8539523|NCT00256204|21053766|P4|NOT COMPLETED|Overall Study||49
8539524|NCT00256204|21053767|P3|NOT COMPLETED|Overall Study||54
8539525|NCT00256204|21053768|P2|NOT COMPLETED|Overall Study||50
8539526|NCT00256204|21053769|P1|NOT COMPLETED|Overall Study||67
8539527|NCT00256204|21053766|P4|COMPLETED|Overall Study||244
8539528|NCT00256204|21053767|P3|COMPLETED|Overall Study||241
8539529|NCT00256204|21053768|P2|COMPLETED|Overall Study||238
8539530|NCT00256204|21053769|P1|COMPLETED|Overall Study||231
8539531|NCT00256204|21053766|P4|STARTED|Overall Study||293
8539532|NCT00256204|21053767|P3|STARTED|Overall Study||295
8539533|NCT00256204|21053768|P2|STARTED|Overall Study||288
8539534|NCT00256204|21053769|P1|STARTED|Overall Study||298
8539535|NCT00256126|21053784|P2|NOT COMPLETED|Overall Study||2
8539536|NCT00256126|21053785|P1|NOT COMPLETED|Overall Study||2
8539537|NCT00256126|21053784|P2|COMPLETED|Overall Study||167
8539538|NCT00256126|21053785|P1|COMPLETED|Overall Study||147
8539539|NCT00256126|21053784|P2|STARTED|Overall Study||169
8539540|NCT00256126|21053785|P1|STARTED|Overall Study||149
8539541|NCT00255970|21053803|P2|NOT COMPLETED|Overall Study||0
8539542|NCT00255970|21053804|P1|NOT COMPLETED|Overall Study||0
8539543|NCT00255970|21053803|P2|COMPLETED|Overall Study||19
8539544|NCT00255970|21053804|P1|COMPLETED|Overall Study||21
8539545|NCT00255970|21053803|P2|Final Visit Week 24|Overall Study||19
8539546|NCT00255970|21053804|P1|Final Visit Week 24|Overall Study||21
8539547|NCT00255970|21053803|P2|Screening Visit|Overall Study||19
8539548|NCT00255970|21053804|P1|Screening Visit|Overall Study||21
8539549|NCT00255970|21053803|P2|STARTED|Overall Study||19
8539550|NCT00255970|21053804|P1|STARTED|Overall Study||21
8539551|NCT00255944|21053824|P2|NOT COMPLETED|Overall Study||834
8539552|NCT00255944|21053825|P1|NOT COMPLETED|Overall Study||797
8539553|NCT00255944|21053824|P2|COMPLETED|Overall Study||477
8539554|NCT00255944|21053825|P1|COMPLETED|Overall Study||514
8539555|NCT00255944|21053824|P2|STARTED|Overall Study||1311
8539556|NCT00255944|21053825|P1|STARTED|Overall Study||1311
8539557|NCT00255840|21053833|P2|NOT COMPLETED|Overall Study||70
8539558|NCT00255840|21053834|P1|NOT COMPLETED|Overall Study||63
8539559|NCT00255840|21053833|P2|COMPLETED|Overall Study||334
8539560|NCT00255840|21053834|P1|COMPLETED|Overall Study||345
8539561|NCT00255840|21053833|P2|STARTED|Overall Study||404
8539562|NCT00255840|21053834|P1|STARTED|Overall Study||408
8539563|NCT00255801|21053840|P1|NOT COMPLETED|Overall Study||0
8539564|NCT00255801|21053840|P1|COMPLETED|Overall Study||37
8539565|NCT00255801|21053840|P1|STARTED|Overall Study||37
8539566|NCT00255723|21053847|P2|NOT COMPLETED|Overall Study||2
8539567|NCT00255723|21053848|P1|NOT COMPLETED|Overall Study||2
8539568|NCT00255723|21053847|P2|COMPLETED|Overall Study||39
8539569|NCT00255723|21053848|P1|COMPLETED|Overall Study||54
8539570|NCT00255723|21053847|P2|STARTED|Overall Study||41
8539571|NCT00255723|21053848|P1|STARTED|Overall Study||56
8539572|NCT00255684|21053854|P1|NOT COMPLETED|Overall Study||0
8539573|NCT00255684|21053854|P1|COMPLETED|Overall Study||16
8539574|NCT00255684|21053854|P1|STARTED|Overall Study||16
8539575|NCT00255346|21053864|P5|NOT COMPLETED|Overall Study||0
8539576|NCT00255346|21053865|P4|NOT COMPLETED|Overall Study||0
8539577|NCT00255346|21053866|P3|NOT COMPLETED|Overall Study||0
8539578|NCT00255346|21053867|P2|NOT COMPLETED|Overall Study||0
8539579|NCT00255346|21053868|P1|NOT COMPLETED|Overall Study||1
8539580|NCT00255346|21053864|P5|COMPLETED|Overall Study||33
8539581|NCT00255346|21053865|P4|COMPLETED|Overall Study||11
8539582|NCT00255346|21053866|P3|COMPLETED|Overall Study||8
8539583|NCT00255346|21053867|P2|COMPLETED|Overall Study||6
8539584|NCT00255346|21053868|P1|COMPLETED|Overall Study||9
8539585|NCT00255346|21053864|P5|STARTED|Overall Study||33
8539586|NCT00255346|21053865|P4|STARTED|Overall Study||11
8539587|NCT00255346|21053866|P3|STARTED|Overall Study||8
8539588|NCT00255346|21053867|P2|STARTED|Overall Study||6
8539589|NCT00255346|21053868|P1|STARTED|Overall Study||10
8539590|NCT00255190|21053883|P2|NOT COMPLETED|Overall Study||157
8539591|NCT00255190|21053884|P1|NOT COMPLETED|Overall Study||50
8539592|NCT00255190|21053883|P2|COMPLETED|Overall Study||281
8539593|NCT00255190|21053884|P1|COMPLETED|Overall Study||103
8539594|NCT00255190|21053883|P2|STARTED|Overall Study||438
8539595|NCT00255190|21053884|P1|STARTED|Overall Study||153
8539596|NCT00255177|21053952|P4|NOT COMPLETED|Overall Study||2
8539597|NCT00255177|21053953|P3|NOT COMPLETED|Overall Study||1
8539598|NCT00255177|21053954|P2|NOT COMPLETED|Overall Study||1
8539599|NCT00255177|21053955|P1|NOT COMPLETED|Overall Study||2
8539600|NCT00255177|21053952|P4|COMPLETED|Overall Study||4
8539601|NCT00255177|21053953|P3|COMPLETED|Overall Study||12
8539602|NCT00255177|21053954|P2|COMPLETED|Overall Study||13
8539603|NCT00255177|21053955|P1|COMPLETED|Overall Study||9
8539604|NCT00255177|21053952|P4|STARTED|Overall Study||6
8539605|NCT00255177|21053953|P3|STARTED|Overall Study||13
8539606|NCT00255177|21053954|P2|STARTED|Overall Study||14
8539607|NCT00255177|21053955|P1|STARTED|Overall Study||11
8539608|NCT00255164|21053968|P3|NOT COMPLETED|Overall Study||49
8539609|NCT00255164|21053969|P2|NOT COMPLETED|Overall Study||49
8539610|NCT00255164|21053970|P1|NOT COMPLETED|Overall Study||123
8539611|NCT00255164|21053968|P3|COMPLETED|Overall Study||103
8539612|NCT00255164|21053969|P2|COMPLETED|Overall Study||110
8539613|NCT00255164|21053970|P1|COMPLETED|Overall Study||17
8539614|NCT00255164|21053968|P3|STARTED|Overall Study||152
8539615|NCT00255164|21053969|P2|STARTED|Overall Study||159
8539616|NCT00255164|21053970|P1|STARTED|Overall Study||140
8539617|NCT00255151|21053996|P3|NOT COMPLETED|Overall Study||49
8539618|NCT00255151|21053997|P2|NOT COMPLETED|Overall Study||49
8539619|NCT00255151|21053998|P1|NOT COMPLETED|Overall Study||123
8539620|NCT00255151|21053996|P3|COMPLETED|Overall Study||103
8539621|NCT00255151|21053997|P2|COMPLETED|Overall Study||110
8539622|NCT00255151|21053998|P1|COMPLETED|Overall Study||17
8539623|NCT00255151|21053996|P3|STARTED|Overall Study||152
8539624|NCT00255151|21053997|P2|STARTED|Overall Study||159
8539625|NCT00255151|21053998|P1|STARTED|Overall Study||140
8539626|NCT00255125|21054023|P2|NOT COMPLETED|Overall Study||0
8539627|NCT00255125|21054024|P1|NOT COMPLETED|Overall Study||0
8539628|NCT00255125|21054023|P2|COMPLETED|Overall Study||44
8539629|NCT00255125|21054024|P1|COMPLETED|Overall Study||42
8539630|NCT00255125|21054023|P2|STARTED|Overall Study||44
8539631|NCT00255125|21054024|P1|STARTED|Overall Study||42
8539632|NCT00255086|21054036|P2|NOT COMPLETED|Overall Study||2
8539633|NCT00255086|21054037|P1|NOT COMPLETED|Overall Study||2
8539634|NCT00255086|21054036|P2|COMPLETED|Overall Study||6
8539635|NCT00255086|21054037|P1|COMPLETED|Overall Study||7
8539636|NCT00255086|21054036|P2|STARTED|Overall Study||8
8539637|NCT00255086|21054037|P1|STARTED|Overall Study||9
8539638|NCT00255047|21054049|P4|NOT COMPLETED|Overall Study||46
8539639|NCT00255047|21054050|P3|NOT COMPLETED|Overall Study||50
8539640|NCT00255047|21054051|P2|NOT COMPLETED|Overall Study||48
8539641|NCT00255047|21054052|P1|NOT COMPLETED|Overall Study||48
8539642|NCT00255047|21054049|P4|COMPLETED|Overall Study||502
8539643|NCT00255047|21054050|P3|COMPLETED|Overall Study||496
8539644|NCT00255047|21054051|P2|COMPLETED|Overall Study||487
8539645|NCT00255047|21054052|P1|COMPLETED|Overall Study||490
8539646|NCT00255047|21054049|P4|STARTED|Overall Study||548
8539647|NCT00255047|21054050|P3|STARTED|Overall Study||546
8539648|NCT00255047|21054051|P2|STARTED|Overall Study||535
8539649|NCT00255047|21054052|P1|STARTED|Overall Study||538
8539650|NCT00255034|21054076|P2|NOT COMPLETED|Overall Study||38
8539651|NCT00255034|21054077|P1|NOT COMPLETED|Overall Study||15
8539652|NCT00255034|21054076|P2|COMPLETED|Overall Study||26
8539653|NCT00255034|21054077|P1|COMPLETED|Overall Study||64
8539654|NCT00255034|21054076|P2|STARTED|Overall Study||64
8539655|NCT00255034|21054077|P1|STARTED|Overall Study||79
8539656|NCT00255008|21054087|P4|NOT COMPLETED|Overall Study||22
8539657|NCT00255008|21054088|P3|NOT COMPLETED|Overall Study||16
8539658|NCT00255008|21054089|P2|NOT COMPLETED|Overall Study||9
8539659|NCT00255008|21054090|P1|NOT COMPLETED|Overall Study||32
8539660|NCT00255008|21054087|P4|COMPLETED|Overall Study||12
8539661|NCT00255008|21054088|P3|COMPLETED|Overall Study||17
8539662|NCT00255008|21054089|P2|COMPLETED|Overall Study||0
8539663|NCT00255008|21054090|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
8539664|NCT00255008|21054087|P4|STARTED|Overall Study||34
8539665|NCT00255008|21054088|P3|STARTED|Overall Study||33
8539666|NCT00255008|21054089|P2|STARTED|Overall Study||9
8539667|NCT00255008|21054090|P1|STARTED|Overall Study||45
8539668|NCT00254995|21054102|P2|NOT COMPLETED|Overall Study||0
8539669|NCT00254995|21054103|P1|NOT COMPLETED|Overall Study||0
8539670|NCT00254995|21054102|P2|COMPLETED|Overall Study||31065
8539671|NCT00254995|21054103|P1|COMPLETED|Overall Study||31561
8539672|NCT00254995|21054102|P2|STARTED|Overall Study||31065
8539673|NCT00254995|21054103|P1|STARTED|Overall Study||31561
8539674|NCT00254982|21054126|P2|NOT COMPLETED|Overall Study||31
8539675|NCT00254982|21054127|P1|NOT COMPLETED|Overall Study||36
8539676|NCT00254982|21054126|P2|COMPLETED|Overall Study||265
8539677|NCT00254982|21054127|P1|COMPLETED|Overall Study||261
8539678|NCT00254982|21054126|P2|STARTED|Overall Study||296
8539679|NCT00254982|21054127|P1|STARTED|Overall Study||297
8539680|NCT00254592|21054133|P1|NOT COMPLETED|Overall Study||2
8539681|NCT00254592|21054133|P1|COMPLETED|Overall Study||41
8539682|NCT00254592|21054133|P1|STARTED|Overall Study||43
8539683|NCT00254566|21054139|P2|NOT COMPLETED|Overall Study||26
8539684|NCT00254566|21054140|P1|NOT COMPLETED|Overall Study||31
8539685|NCT00254566|21054139|P2|COMPLETED|Overall Study||172
8539686|NCT00254566|21054140|P1|COMPLETED|Overall Study||167
8539687|NCT00254566|21054139|P2|STARTED|Overall Study||198
8539688|NCT00254566|21054140|P1|STARTED|Overall Study||198
8539689|NCT00254540|21054164|P2|NOT COMPLETED|Overall Study||22
8539690|NCT00254540|21054165|P1|NOT COMPLETED|Overall Study||19
8539691|NCT00254540|21054164|P2|COMPLETED|Overall Study||4
8539692|NCT00254540|21054165|P1|COMPLETED|Overall Study||6
8539693|NCT00254540|21054164|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
8539694|NCT00254540|21054165|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
8539695|NCT00254501|21054194|P2|NOT COMPLETED|Overall Study||1
8539696|NCT00254501|21054195|P1|NOT COMPLETED|Overall Study||1
8539697|NCT00254501|21054194|P2|COMPLETED|Overall Study||36
8539698|NCT00254501|21054195|P1|COMPLETED|Overall Study||31
8539699|NCT00254501|21054194|P2|STARTED|Overall Study||37
8539700|NCT00254501|21054195|P1|STARTED|Overall Study||32
8539701|NCT00254488|21054209|P2|NOT COMPLETED|Overall Study||49
8539702|NCT00254488|21054210|P1|NOT COMPLETED|Overall Study||57
8539703|NCT00254488|21054209|P2|COMPLETED|Overall Study||63
8539704|NCT00254488|21054210|P1|COMPLETED|Overall Study||55
8539705|NCT00254488|21054209|P2|STARTED|Overall Study||112
8539706|NCT00254488|21054210|P1|STARTED|Overall Study||112
8539707|NCT00254462|21054220|P2|NOT COMPLETED|Overall Study||10
8539708|NCT00254462|21054221|P1|NOT COMPLETED|Overall Study||8
8539709|NCT00254462|21054220|P2|COMPLETED|Overall Study||39
8539710|NCT00254462|21054221|P1|COMPLETED|Overall Study||36
8539711|NCT00254462|21054220|P2|STARTED|Overall Study||49
8539712|NCT00254462|21054221|P1|STARTED|Overall Study||44
8539713|NCT00254410|21054229|P1|NOT COMPLETED|Overall Study||0
8539714|NCT00254410|21054229|P1|COMPLETED|Overall Study||30
8539715|NCT00254410|21054229|P1|STARTED|Overall Study||30
8539716|NCT00254397|21054240|P4|NOT COMPLETED|Overall Study||25
8539717|NCT00254397|21054241|P3|NOT COMPLETED|Overall Study||19
8539718|NCT00254397|21054242|P2|NOT COMPLETED|Overall Study||1
8539719|NCT00254397|21054243|P1|NOT COMPLETED|Overall Study||6
8539720|NCT00254397|21054240|P4|COMPLETED|Overall Study||20
8539721|NCT00254397|21054241|P3|COMPLETED|Overall Study||18
8539722|NCT00254397|21054242|P2|COMPLETED|Overall Study||5
8539723|NCT00254397|21054243|P1|COMPLETED|Overall Study||4
8539724|NCT00254397|21054240|P4|STARTED|Overall Study||45
8539725|NCT00254397|21054241|P3|STARTED|Overall Study||37
8539726|NCT00254397|21054242|P2|STARTED|Overall Study||6
8539727|NCT00254397|21054243|P1|STARTED|Overall Study||10
8539728|NCT00254293|21054267|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
8539729|NCT00254293|21054268|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539730|NCT00254293|21054269|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539731|NCT00254293|21054270|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539732|NCT00254293|21054271|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539733|NCT00254293|21054272|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539734|NCT00254293|21054273|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539735|NCT00254293|21054267|P7|COMPLETED|LTE Open Label Fixed Dosing||35
8539736|NCT00254293|21054268|P6|COMPLETED|LTE Open Label Fixed Dosing||0
8539737|NCT00254293|21054269|P5|COMPLETED|LTE Open Label Fixed Dosing||0
8539738|NCT00254293|21054270|P4|COMPLETED|LTE Open Label Fixed Dosing||0
8539739|NCT00254293|21054271|P3|COMPLETED|LTE Open Label Fixed Dosing||0
8539740|NCT00254293|21054272|P2|COMPLETED|LTE Open Label Fixed Dosing||0
8539741|NCT00254293|21054273|P1|COMPLETED|LTE Open Label Fixed Dosing||0
8539742|NCT00254293|21054267|P7|STARTED|LTE Open Label Fixed Dosing||48
8539743|NCT00254293|21054268|P6|STARTED|LTE Open Label Fixed Dosing||0
8539744|NCT00254293|21054269|P5|STARTED|LTE Open Label Fixed Dosing||0
8539745|NCT00254293|21054270|P4|STARTED|LTE Open Label Fixed Dosing||0
8539746|NCT00254293|21054271|P3|STARTED|LTE Open Label Fixed Dosing||0
8539747|NCT00254293|21054272|P2|STARTED|LTE Open Label Fixed Dosing||0
8539748|NCT00254293|21054273|P1|STARTED|LTE Open Label Fixed Dosing||0
8539749|NCT00254293|21054267|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539750|NCT00254293|21054268|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539751|NCT00254293|21054269|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
8539752|NCT00254293|21054270|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539753|NCT00254293|21054271|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
8539754|NCT00254293|21054272|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539755|NCT00254293|21054273|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
8539756|NCT00254293|21054267|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
8539757|NCT00254293|21054268|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
8539758|NCT00254293|21054269|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
8539759|NCT00254293|21054270|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
8539760|NCT00254293|21054271|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
8539761|NCT00254293|21054272|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
8539762|NCT00254293|21054273|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
8539763|NCT00254293|21054267|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
8539764|NCT00254293|21054268|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
8539765|NCT00254293|21054269|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
8539766|NCT00254293|21054270|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
8539767|NCT00254293|21054271|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
8539768|NCT00254293|21054272|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
8539769|NCT00254293|21054273|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
8539770|NCT00254293|21054267|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539771|NCT00254293|21054268|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539772|NCT00254293|21054269|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539773|NCT00254293|21054270|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
8539774|NCT00254293|21054271|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
8539775|NCT00254293|21054272|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
8539776|NCT00254293|21054273|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539777|NCT00254293|21054267|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539778|NCT00254293|21054268|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
8539779|NCT00254293|21054269|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
8539780|NCT00254293|21054270|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
8539781|NCT00254293|21054271|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
8539782|NCT00254293|21054272|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
8539783|NCT00254293|21054273|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
8539784|NCT00254293|21054267|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
8539785|NCT00254293|21054268|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
8539786|NCT00254293|21054269|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
8539787|NCT00254293|21054270|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
8539788|NCT00254293|21054271|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
8539789|NCT00254293|21054272|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
8539790|NCT00254293|21054273|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
8539791|NCT00254163|21054356|P2|NOT COMPLETED|Overall Study||46
8539792|NCT00254163|21054357|P1|NOT COMPLETED|Overall Study||45
8539793|NCT00254163|21054356|P2|COMPLETED|Overall Study||46
8539794|NCT00254163|21054357|P1|COMPLETED|Overall Study||47
8539795|NCT00254163|21054356|P2|STARTED|Overall Study||92
8539796|NCT00254163|21054357|P1|STARTED|Overall Study||92
8539797|NCT00254072|21054381|P2|NOT COMPLETED|Overall Study||0
8539798|NCT00254072|21054382|P1|NOT COMPLETED|Overall Study||0
8539799|NCT00254072|21054381|P2|COMPLETED|Overall Study||175
8539800|NCT00254072|21054382|P1|COMPLETED|Overall Study||180
8539801|NCT00254072|21054381|P2|STARTED|Overall Study||175
8539802|NCT00254072|21054382|P1|STARTED|Overall Study||180
8539803|NCT00253981|21054390|P2|NOT COMPLETED|Overall Study||0
8539804|NCT00253981|21054391|P1|NOT COMPLETED|Overall Study||0
8539805|NCT00253981|21054390|P2|COMPLETED|Overall Study||14
8539806|NCT00253981|21054391|P1|COMPLETED|Overall Study||16
8539807|NCT00253981|21054390|P2|STARTED|Overall Study||14
8539808|NCT00253981|21054391|P1|STARTED|Overall Study||16
8539809|NCT00253890|21054399|P2|NOT COMPLETED|Overall Study||7
8539810|NCT00253890|21054400|P1|NOT COMPLETED|Overall Study||7
8539811|NCT00253890|21054399|P2|COMPLETED|Overall Study||61
8539812|NCT00253890|21054400|P1|COMPLETED|Overall Study||62
8539813|NCT00253890|21054399|P2|STARTED|Overall Study||68
8539814|NCT00253890|21054400|P1|STARTED|Overall Study||69
8539815|NCT00253747|21054408|P2|NOT COMPLETED|Overall Study||27
8539816|NCT00253747|21054409|P1|NOT COMPLETED|Overall Study||24
8539817|NCT00253747|21054408|P2|COMPLETED|Overall Study||101
8539818|NCT00253747|21054409|P1|COMPLETED|Overall Study||103
8539819|NCT00253747|21054408|P2|STARTED|Overall Study||128
8539820|NCT00253747|21054409|P1|STARTED|Overall Study||127
8539821|NCT00253708|21054430|P3|NOT COMPLETED|Overall Study||1
8539822|NCT00253708|21054431|P2|NOT COMPLETED|Overall Study||0
8539823|NCT00253708|21054432|P1|NOT COMPLETED|Overall Study||0
8539824|NCT00253708|21054430|P3|COMPLETED|Overall Study||8
8539825|NCT00253708|21054431|P2|COMPLETED|Overall Study||10
8539826|NCT00253708|21054432|P1|COMPLETED|Overall Study||20
8539827|NCT00253708|21054430|P3|STARTED|Overall Study||9
8539828|NCT00253708|21054431|P2|STARTED|Overall Study||10
8539829|NCT00253708|21054432|P1|STARTED|Overall Study||20
8539830|NCT00253643|21054462|P4|NOT COMPLETED|Overall Study||3
8539831|NCT00253643|21054463|P3|NOT COMPLETED|Overall Study||1
8539832|NCT00253643|21054464|P2|NOT COMPLETED|Overall Study||0
8539833|NCT00253643|21054465|P1|NOT COMPLETED|Overall Study||0
8539834|NCT00253643|21054462|P4|COMPLETED|Overall Study||28
8539835|NCT00253643|21054463|P3|COMPLETED|Overall Study||28
8539836|NCT00253643|21054464|P2|COMPLETED|Overall Study||15
8539837|NCT00253643|21054465|P1|COMPLETED|Overall Study||14
8539838|NCT00253643|21054462|P4|STARTED|Overall Study||31
8539839|NCT00253643|21054463|P3|STARTED|Overall Study||29
8539840|NCT00253643|21054464|P2|STARTED|Overall Study||15
8539841|NCT00253643|21054465|P1|STARTED|Overall Study||14
8539842|NCT00253630|21054479|P1|NOT COMPLETED|Overall Study||2
8539843|NCT00253630|21054479|P1|COMPLETED|Overall Study||35
8539844|NCT00253630|21054479|P1|STARTED|Overall Study||37
8539845|NCT00253513|21054488|P1|NOT COMPLETED|Overall Study||0
8539846|NCT00253513|21054488|P1|COMPLETED|Overall Study||60
8539847|NCT00253513|21054488|P1|STARTED|Overall Study||60
8539848|NCT00253448|21054495|P1|NOT COMPLETED|Overall Study||1
8539849|NCT00253448|21054495|P1|COMPLETED|Overall Study||34
8539850|NCT00253448|21054495|P1|STARTED|Overall Study||35
8539851|NCT00253435|21054501|P2|NOT COMPLETED|Overall Study||0
8539852|NCT00253435|21054502|P1|NOT COMPLETED|Overall Study||0
8539853|NCT00253435|21054501|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
8539854|NCT00253435|21054502|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
8539855|NCT00253435|21054501|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
8539856|NCT00253435|21054502|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
8539857|NCT00253435|21054501|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
8539858|NCT00253435|21054502|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
8539859|NCT00253435|21054501|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
8539860|NCT00253435|21054502|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
8539861|NCT00253435|21054501|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
8539862|NCT00253435|21054502|P1|STARTED|Overall Study|Total number is 42|42
8539863|NCT00253370|21054514|P1|NOT COMPLETED|Overall Study||43
8539864|NCT00253370|21054514|P1|COMPLETED|Overall Study||1
8539865|NCT00253370|21054514|P1|STARTED|Overall Study||44
8539866|NCT00253019|21054523|P3|NOT COMPLETED|Overall Study||18
8539867|NCT00253019|21054524|P2|NOT COMPLETED|Overall Study||31
8539868|NCT00253019|21054525|P1|NOT COMPLETED|Overall Study||29
8539869|NCT00253019|21054523|P3|COMPLETED|Overall Study||83
8539870|NCT00253019|21054524|P2|COMPLETED|Overall Study||78
8539871|NCT00253019|21054525|P1|COMPLETED|Overall Study||82
8539872|NCT00253019|21054523|P3|STARTED|Overall Study||101
8539873|NCT00253019|21054524|P2|STARTED|Overall Study||109
8539874|NCT00253019|21054525|P1|STARTED|Overall Study||111
8539875|NCT00252967|21054535|P2|NOT COMPLETED|Overall Study||0
8539876|NCT00252967|21054536|P1|NOT COMPLETED|Overall Study||0
8539877|NCT00252967|21054535|P2|COMPLETED|Overall Study||33
8539878|NCT00252967|21054536|P1|COMPLETED|Overall Study||31
8539879|NCT00252967|21054535|P2|STARTED|Overall Study||33
8539880|NCT00252967|21054536|P1|STARTED|Overall Study||31
8539881|NCT00252733|21054560|P2|NOT COMPLETED|Overall Study||92
8539882|NCT00252733|21054561|P1|NOT COMPLETED|Overall Study||106
8539883|NCT00252733|21054560|P2|COMPLETED|Overall Study||618
8539884|NCT00252733|21054561|P1|COMPLETED|Overall Study||605
8539885|NCT00252733|21054560|P2|STARTED|Overall Study||710
8539886|NCT00252733|21054561|P1|STARTED|Overall Study||711
8539887|NCT00252720|21054571|P2|NOT COMPLETED|Overall Study||165
8539888|NCT00252720|21054572|P1|NOT COMPLETED|Overall Study||132
8539889|NCT00252720|21054571|P2|COMPLETED|Overall Study||789
8539890|NCT00252720|21054572|P1|COMPLETED|Overall Study||819
8539891|NCT00252720|21054571|P2|STARTED|Overall Study||954
8539892|NCT00252720|21054572|P1|STARTED|Overall Study||951
8539893|NCT00252694|21054586|P2|NOT COMPLETED|Overall Study||154
8539894|NCT00252694|21054587|P1|NOT COMPLETED|Overall Study||144
8539895|NCT00252694|21054586|P2|COMPLETED|Overall Study||800
8539896|NCT00252694|21054587|P1|COMPLETED|Overall Study||807
8539897|NCT00252694|21054586|P2|STARTED|Overall Study||954
8539898|NCT00252694|21054587|P1|STARTED|Overall Study||951
8539899|NCT00252629|21054602|P3|NOT COMPLETED|Overall Study||0
8539900|NCT00252629|21054603|P2|NOT COMPLETED|Overall Study||0
8539901|NCT00252629|21054604|P1|NOT COMPLETED|Overall Study||1
8539902|NCT00252629|21054602|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
8539903|NCT00252629|21054603|P2|COMPLETED|Overall Study||9
8539904|NCT00252629|21054604|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
8539905|NCT00252629|21054602|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
8539906|NCT00252629|21054603|P2|STARTED|Overall Study||9
8539907|NCT00252629|21054604|P1|STARTED|Overall Study||9
8539908|NCT00252590|21054620|P3|NOT COMPLETED|Overall Study||3
8539909|NCT00252590|21054621|P2|NOT COMPLETED|Overall Study||2
8539910|NCT00252590|21054622|P1|NOT COMPLETED|Overall Study||2
8539911|NCT00252590|21054620|P3|COMPLETED|Overall Study||31
8539912|NCT00252590|21054621|P2|COMPLETED|Overall Study||28
8539913|NCT00252590|21054622|P1|COMPLETED|Overall Study||33
8539914|NCT00252590|21054620|P3|STARTED|Overall Study||34
8539915|NCT00252590|21054621|P2|STARTED|Overall Study||30
8539916|NCT00252590|21054622|P1|STARTED|Overall Study||35
8539917|NCT00252577|21054633|P1|NOT COMPLETED|Overall Study||20
8539918|NCT00252577|21054633|P1|COMPLETED|Overall Study||110
8539919|NCT00252577|21054633|P1|STARTED|Overall Study||130
8539920|NCT00252564|21054639|P2|NOT COMPLETED|Overall Study||44
8539921|NCT00252564|21054640|P1|NOT COMPLETED|Overall Study||39
8539922|NCT00252564|21054639|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
8539923|NCT00252564|21054640|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
8539924|NCT00252564|21054639|P2|STARTED|Overall Study|From randomization|123
8539925|NCT00252564|21054640|P1|STARTED|Overall Study|From randomization|124
8539926|NCT00252538|21054652|P2|NOT COMPLETED|Overall Study||0
8539927|NCT00252538|21054653|P1|NOT COMPLETED|Overall Study||0
8539928|NCT00252538|21054652|P2|COMPLETED|Overall Study||114
8539929|NCT00252538|21054653|P1|COMPLETED|Overall Study||19
8539930|NCT00252538|21054652|P2|STARTED|Overall Study||114
8539931|NCT00252538|21054653|P1|STARTED|Overall Study||19
8539932|NCT00252512|21054660|P2|NOT COMPLETED|12 Month Follow up||1
8539933|NCT00252512|21054661|P1|NOT COMPLETED|12 Month Follow up||9
8539934|NCT00252512|21054660|P2|COMPLETED|12 Month Follow up||121
8539935|NCT00252512|21054661|P1|COMPLETED|12 Month Follow up||123
8539936|NCT00252512|21054660|P2|STARTED|12 Month Follow up||122
8539937|NCT00252512|21054661|P1|STARTED|12 Month Follow up||132
8539938|NCT00252512|21054660|P2|NOT COMPLETED|Six Month Follow up||12
8539939|NCT00252512|21054661|P1|NOT COMPLETED|Six Month Follow up||4
8539940|NCT00252512|21054660|P2|COMPLETED|Six Month Follow up||122
8539941|NCT00252512|21054661|P1|COMPLETED|Six Month Follow up||132
8539942|NCT00252512|21054660|P2|STARTED|Six Month Follow up||134
8539943|NCT00252512|21054661|P1|STARTED|Six Month Follow up||136
8539944|NCT00252512|21054660|P2|NOT COMPLETED|Intervention||31
8539945|NCT00252512|21054661|P1|NOT COMPLETED|Intervention||29
8539946|NCT00252512|21054660|P2|COMPLETED|Intervention||134
8539947|NCT00252512|21054661|P1|COMPLETED|Intervention||136
8539948|NCT00252512|21054660|P2|STARTED|Intervention||165
8539949|NCT00252512|21054661|P1|STARTED|Intervention||165
8539950|NCT00252499|21054680|P3|NOT COMPLETED|Overall Study||0
8539951|NCT00252499|21054681|P2|NOT COMPLETED|Overall Study||0
8539952|NCT00252499|21054682|P1|NOT COMPLETED|Overall Study||1
8539953|NCT00252499|21054680|P3|COMPLETED|Overall Study||6
8539954|NCT00252499|21054681|P2|COMPLETED|Overall Study||2
8539955|NCT00252499|21054682|P1|COMPLETED|Overall Study||4
8539956|NCT00252499|21054680|P3|STARTED|Overall Study||6
8539957|NCT00252499|21054681|P2|STARTED|Overall Study||2
8539958|NCT00252499|21054682|P1|STARTED|Overall Study||5
8539959|NCT00252382|21054705|P1|NOT COMPLETED|Overall Study||26
8539960|NCT00252382|21054705|P1|COMPLETED|Overall Study||5
8539961|NCT00252382|21054705|P1|STARTED|Overall Study||31
8539962|NCT00252239|21054714|P4|NOT COMPLETED|Overall Study||1
8539963|NCT00252239|21054715|P3|NOT COMPLETED|Overall Study||2
8539964|NCT00252239|21054716|P2|NOT COMPLETED|Overall Study||0
8539965|NCT00252239|21054717|P1|NOT COMPLETED|Overall Study||1
8539966|NCT00252239|21054714|P4|COMPLETED|Overall Study||30
8539967|NCT00252239|21054715|P3|COMPLETED|Overall Study||17
8539968|NCT00252239|21054716|P2|COMPLETED|Overall Study||31
8539969|NCT00252239|21054717|P1|COMPLETED|Overall Study||30
8539970|NCT00252239|21054714|P4|STARTED|Overall Study||31
8539971|NCT00252239|21054715|P3|STARTED|Overall Study||19
8539972|NCT00252239|21054716|P2|STARTED|Overall Study||31
8539973|NCT00252239|21054717|P1|STARTED|Overall Study||31
8539974|NCT00252187|21054729|P2|NOT COMPLETED|Overall Study||1
8539975|NCT00252187|21054730|P1|NOT COMPLETED|Overall Study||4
8539976|NCT00252187|21054729|P2|COMPLETED|Overall Study||20
8539977|NCT00252187|21054730|P1|COMPLETED|Overall Study||20
8539978|NCT00252187|21054729|P2|STARTED|Overall Study||21
8539979|NCT00252187|21054730|P1|STARTED|Overall Study||24
8539980|NCT00252174|21054753|P3|NOT COMPLETED|Overall Study||0
8539981|NCT00252174|21054754|P2|NOT COMPLETED|Overall Study||1
8539982|NCT00252174|21054755|P1|NOT COMPLETED|Overall Study||0
8539983|NCT00252174|21054753|P3|COMPLETED|Overall Study||0
8539984|NCT00252174|21054754|P2|COMPLETED|Overall Study||1
8539985|NCT00252174|21054755|P1|COMPLETED|Overall Study||0
8539986|NCT00252174|21054753|P3|STARTED|Overall Study|No subjects entered Stage 2|0
8539987|NCT00252174|21054754|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
8539988|NCT00252174|21054755|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
8539989|NCT00252057|21054795|P2|NOT COMPLETED|Overall Study||8
8539990|NCT00252057|21054796|P1|NOT COMPLETED|Overall Study||3
8539991|NCT00252057|21054795|P2|COMPLETED|Overall Study||368
8539992|NCT00252057|21054796|P1|COMPLETED|Overall Study||370
8539993|NCT00252057|21054795|P2|STARTED|Overall Study||376
8539994|NCT00252057|21054796|P1|STARTED|Overall Study||373
8539995|NCT00251979|21054804|P2|NOT COMPLETED|Overall Study||40
8539996|NCT00251979|21054805|P1|NOT COMPLETED|Overall Study||38
8539997|NCT00251979|21054804|P2|COMPLETED|Overall Study||349
8539998|NCT00251979|21054805|P1|COMPLETED|Overall Study||337
8539999|NCT00251979|21054804|P2|STARTED|Overall Study|ITT population|389
8540000|NCT00251979|21054805|P1|STARTED|Overall Study|ITT population|375
8540001|NCT00251927|21054837|P2|NOT COMPLETED|Overall Study||74
8540002|NCT00251927|21054838|P1|NOT COMPLETED|Overall Study||108
8540003|NCT00251927|21054837|P2|COMPLETED|Overall Study|Completed 5 year visit|192
8540004|NCT00251927|21054838|P1|COMPLETED|Overall Study|Completed 5 year visit|180
8540005|NCT00251927|21054837|P2|STARTED|Overall Study|Randomised|266
8540006|NCT00251927|21054838|P1|STARTED|Overall Study|Randomised|288
8540007|NCT00251862|21054868|P3|NOT COMPLETED|Overall Study||0
8540008|NCT00251862|21054869|P2|NOT COMPLETED|Overall Study||0
8540009|NCT00251862|21054870|P1|NOT COMPLETED|Overall Study||0
8540010|NCT00251862|21054868|P3|COMPLETED|Overall Study||276
8540011|NCT00251862|21054869|P2|COMPLETED|Overall Study||269
8540012|NCT00251862|21054870|P1|COMPLETED|Overall Study||280
8540013|NCT00251862|21054868|P3|STARTED|Overall Study||276
8540014|NCT00251862|21054869|P2|STARTED|Overall Study||269
8540015|NCT00251862|21054870|P1|STARTED|Overall Study||280
8540016|NCT00251758|21054890|P3|NOT COMPLETED|Overall Study||27
8540017|NCT00251758|21054891|P2|NOT COMPLETED|Overall Study||27
8540018|NCT00251758|21054892|P1|NOT COMPLETED|Overall Study||28
8540019|NCT00251758|21054890|P3|COMPLETED|Overall Study||277
8540020|NCT00251758|21054891|P2|COMPLETED|Overall Study||285
8540021|NCT00251758|21054892|P1|COMPLETED|Overall Study||264
8540022|NCT00251758|21054890|P3|STARTED|Overall Study||304
8540023|NCT00251758|21054891|P2|STARTED|Overall Study||312
8540024|NCT00251758|21054892|P1|STARTED|Overall Study||292
8540025|NCT00251745|21054912|P3|NOT COMPLETED|Overall Study||27
8540026|NCT00251745|21054913|P2|NOT COMPLETED|Overall Study||27
8540027|NCT00251745|21054914|P1|NOT COMPLETED|Overall Study||28
8540028|NCT00251745|21054912|P3|COMPLETED|Overall Study||277
8540029|NCT00251745|21054913|P2|COMPLETED|Overall Study||285
8540030|NCT00251745|21054914|P1|COMPLETED|Overall Study||264
8540031|NCT00251745|21054912|P3|STARTED|Overall Study||304
8540032|NCT00251745|21054913|P2|STARTED|Overall Study||312
8540033|NCT00251745|21054914|P1|STARTED|Overall Study||292
8540034|NCT00251719|21054934|P3|NOT COMPLETED|Overall Study||30
8540035|NCT00251719|21054935|P2|NOT COMPLETED|Overall Study||45
8540036|NCT00251719|21054936|P1|NOT COMPLETED|Overall Study||53
8540037|NCT00251719|21054934|P3|COMPLETED|Overall Study||643
8540038|NCT00251719|21054935|P2|COMPLETED|Overall Study||642
8540039|NCT00251719|21054936|P1|COMPLETED|Overall Study||641
8540040|NCT00251719|21054934|P3|STARTED|Overall Study||673
8540041|NCT00251719|21054935|P2|STARTED|Overall Study||687
8540042|NCT00251719|21054936|P1|STARTED|Overall Study||694
8540043|NCT00251693|21054962|P3|NOT COMPLETED|Overall Study||46
8540044|NCT00251693|21054963|P2|NOT COMPLETED|Overall Study||44
8540045|NCT00251693|21054964|P1|NOT COMPLETED|Overall Study||51
8540046|NCT00251693|21054962|P3|COMPLETED|Overall Study||644
8540047|NCT00251693|21054963|P2|COMPLETED|Overall Study||624
8540048|NCT00251693|21054964|P1|COMPLETED|Overall Study||629
8540049|NCT00251693|21054962|P3|STARTED|Overall Study||690
8540050|NCT00251693|21054963|P2|STARTED|Overall Study||668
8540051|NCT00251693|21054964|P1|STARTED|Overall Study||680
8540052|NCT00251641|21054989|P2|NOT COMPLETED|Overall Study||88
8540053|NCT00251641|21054990|P1|NOT COMPLETED|Overall Study||112
8540054|NCT00251641|21054989|P2|COMPLETED|Overall Study||127
8540055|NCT00251641|21054990|P1|COMPLETED|Overall Study||541
8540056|NCT00251641|21054989|P2|STARTED|Overall Study||215
8540057|NCT00251641|21054990|P1|STARTED|Overall Study||653
8540058|NCT00251589|21055008|P4|NOT COMPLETED|Overall Study||2
8540059|NCT00251589|21055009|P3|NOT COMPLETED|Overall Study||2
8540060|NCT00251589|21055010|P2|NOT COMPLETED|Overall Study||3
8540061|NCT00251589|21055011|P1|NOT COMPLETED|Overall Study||15
8540062|NCT00251589|21055008|P4|COMPLETED|Overall Study||0
8540063|NCT00251589|21055009|P3|COMPLETED|Overall Study||0
8540064|NCT00251589|21055010|P2|COMPLETED|Overall Study||0
8540065|NCT00251589|21055011|P1|COMPLETED|Overall Study||1
8540066|NCT00251589|21055008|P4|STARTED|Overall Study||2
8540067|NCT00251589|21055009|P3|STARTED|Overall Study||2
8540068|NCT00251589|21055010|P2|STARTED|Overall Study||3
8540069|NCT00251589|21055011|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
8540070|NCT00251316|21055048|P2|NOT COMPLETED|Overall Study||3
8540071|NCT00251316|21055049|P1|NOT COMPLETED|Overall Study||2
8540072|NCT00251316|21055048|P2|COMPLETED|Overall Study||14
8540073|NCT00251316|21055049|P1|COMPLETED|Overall Study||15
8540074|NCT00251316|21055048|P2|STARTED|Overall Study||17
8540075|NCT00251316|21055049|P1|STARTED|Overall Study||17
8540076|NCT00251303|21055057|P2|NOT COMPLETED|Overall Study||1
8540077|NCT00251303|21055058|P1|NOT COMPLETED|Overall Study||8
8540078|NCT00251303|21055057|P2|COMPLETED|Overall Study||29
8540079|NCT00251303|21055058|P1|COMPLETED|Overall Study||22
8540080|NCT00251303|21055057|P2|STARTED|Overall Study||30
8540081|NCT00251303|21055058|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
8540082|NCT00251238|21055068|P2|NOT COMPLETED|Overall Study||0
8540083|NCT00251238|21055069|P1|NOT COMPLETED|Overall Study||0
8540084|NCT00251238|21055068|P2|COMPLETED|Overall Study||20
8540085|NCT00251238|21055069|P1|COMPLETED|Overall Study||21
8540086|NCT00251238|21055068|P2|STARTED|Overall Study||20
8540087|NCT00251238|21055069|P1|STARTED|Overall Study||21
8540088|NCT00251225|21055079|P1|NOT COMPLETED|Overall Study||0
8540089|NCT00251225|21055079|P1|COMPLETED|Overall Study||49
8540090|NCT00251225|21055079|P1|STARTED|Overall Study||49
8540091|NCT00251004|21055088|P3|NOT COMPLETED|Overall Study||31
8540092|NCT00251004|21055089|P2|NOT COMPLETED|Overall Study||41
8540093|NCT00251004|21055090|P1|NOT COMPLETED|Overall Study||45
8540094|NCT00251004|21055088|P3|COMPLETED|Overall Study||246
8540095|NCT00251004|21055089|P2|COMPLETED|Overall Study||238
8540096|NCT00251004|21055090|P1|COMPLETED|Overall Study||232
8540097|NCT00251004|21055088|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
8540098|NCT00251004|21055089|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
8540099|NCT00251004|21055090|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
8540100|NCT00251004|21055088|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
8540101|NCT00251004|21055089|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
8540102|NCT00251004|21055090|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
8540103|NCT00251004|21055088|P3|STARTED|Overall Study||277
8540104|NCT00251004|21055089|P2|STARTED|Overall Study||279
8540105|NCT00251004|21055090|P1|STARTED|Overall Study||277
8540106|NCT00250926|21055107|P1|NOT COMPLETED|Overall Study||0
8540107|NCT00250926|21055107|P1|COMPLETED|Overall Study||23
8540108|NCT00250926|21055107|P1|STARTED|Overall Study||23
8540109|NCT00250835|21055114|P1|NOT COMPLETED|Overall Study||1
8540110|NCT00250835|21055114|P1|COMPLETED|Overall Study||37
8540111|NCT00250835|21055114|P1|STARTED|Overall Study||38
8540112|NCT00250718|21055123|P1|NOT COMPLETED|Overall Study||3
8540113|NCT00250718|21055123|P1|COMPLETED|Overall Study||14
8540114|NCT00250718|21055123|P1|Received Treatment|Overall Study||16
8540115|NCT00250718|21055123|P1|STARTED|Overall Study||17
8540116|NCT00250705|21055128|P1|NOT COMPLETED|Overall Study||2
8540117|NCT00250705|21055128|P1|COMPLETED|Overall Study||10
8540118|NCT00250705|21055128|P1|STARTED|Overall Study||12
8540119|NCT00250679|21055139|P3|NOT COMPLETED|Overall Study||44
8540120|NCT00250679|21055140|P2|NOT COMPLETED|Overall Study||49
8540121|NCT00250679|21055141|P1|NOT COMPLETED|Overall Study||39
8540122|NCT00250679|21055139|P3|COMPLETED|Overall Study||103
8540123|NCT00250679|21055140|P2|COMPLETED|Overall Study||100
8540124|NCT00250679|21055141|P1|COMPLETED|Overall Study||108
8540125|NCT00250679|21055139|P3|STARTED|Overall Study||147
8540126|NCT00250679|21055140|P2|STARTED|Overall Study||149
8540127|NCT00250679|21055141|P1|STARTED|Overall Study||147
8540128|NCT00250588|21055242|P3|NOT COMPLETED|Overall Study||13
8540129|NCT00250588|21055243|P2|NOT COMPLETED|Overall Study||19
8540130|NCT00250588|21055244|P1|NOT COMPLETED|Overall Study||9
8540131|NCT00250588|21055242|P3|COMPLETED|Overall Study||74
8540132|NCT00250588|21055243|P2|COMPLETED|Overall Study||65
8540133|NCT00250588|21055244|P1|COMPLETED|Overall Study||72
8540134|NCT00250588|21055242|P3|STARTED|Overall Study||87
8540135|NCT00250588|21055243|P2|STARTED|Overall Study||84
8540136|NCT00250588|21055244|P1|STARTED|Overall Study||81
8540137|NCT00250497|21055260|P2|NOT COMPLETED|Overall Study||15
8540138|NCT00250497|21055261|P1|NOT COMPLETED|Overall Study||5
8540139|NCT00250497|21055260|P2|COMPLETED|Overall Study||159
8540140|NCT00250497|21055261|P1|COMPLETED|Overall Study||177
8540141|NCT00250497|21055260|P2|STARTED|Overall Study||174
8540142|NCT00250497|21055261|P1|STARTED|Overall Study||182
8540143|NCT00250484|21055279|P2|NOT COMPLETED|Overall Study||0
8540144|NCT00250484|21055280|P1|NOT COMPLETED|Overall Study||0
8540145|NCT00250484|21055279|P2|COMPLETED|Overall Study||8
8540146|NCT00250484|21055280|P1|COMPLETED|Overall Study||9
8540147|NCT00250484|21055279|P2|STARTED|Overall Study||8
8540148|NCT00250484|21055280|P1|STARTED|Overall Study||9
8540149|NCT00250458|21055292|P2|NOT COMPLETED|Overall Study||17
8540150|NCT00250458|21055293|P1|NOT COMPLETED|Overall Study||32
8540151|NCT00250458|21055292|P2|COMPLETED|Overall Study||97
8540152|NCT00250458|21055293|P1|COMPLETED|Overall Study||200
8540153|NCT00250458|21055292|P2|STARTED|Overall Study||114
8540154|NCT00250458|21055293|P1|STARTED|Overall Study||232
8540155|NCT00250432|21055303|P2|NOT COMPLETED|Overall Study||47
8540156|NCT00250432|21055304|P1|NOT COMPLETED|Overall Study||45
8540157|NCT00250432|21055303|P2|COMPLETED|Overall Study||53
8540158|NCT00250432|21055304|P1|COMPLETED|Overall Study||59
8540159|NCT00250432|21055303|P2|STARTED|Overall Study||100
8540160|NCT00250432|21055304|P1|STARTED|Overall Study||104
8540161|NCT00250276|21055316|P4|NOT COMPLETED|Overall Study||19
8540162|NCT00250276|21055317|P3|NOT COMPLETED|Overall Study||19
8540163|NCT00250276|21055318|P2|NOT COMPLETED|Overall Study||21
8540164|NCT00250276|21055319|P1|NOT COMPLETED|Overall Study||17
8540165|NCT00250276|21055316|P4|COMPLETED|Overall Study||181
8540166|NCT00250276|21055317|P3|COMPLETED|Overall Study||182
8540167|NCT00250276|21055318|P2|COMPLETED|Overall Study||177
8540168|NCT00250276|21055319|P1|COMPLETED|Overall Study||182
8540169|NCT00250276|21055316|P4|STARTED|Overall Study||200
8540170|NCT00250276|21055317|P3|STARTED|Overall Study||201
8540171|NCT00250276|21055318|P2|STARTED|Overall Study||198
8540172|NCT00250276|21055319|P1|STARTED|Overall Study||199
8540173|NCT00249873|21055399|P2|NOT COMPLETED|Overall Study||1254
8540174|NCT00249873|21055400|P1|NOT COMPLETED|Overall Study||1330
8540175|NCT00249873|21055399|P2|COMPLETED|Overall Study|started and completed study drug|2528
8540176|NCT00249873|21055400|P1|COMPLETED|Overall Study|started and completed study drug|2442
8540177|NCT00249873|21055399|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
8540178|NCT00249873|21055400|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
8540179|NCT00249834|21055420|P8|NOT COMPLETED|Overall Study||0
8540180|NCT00249834|21055421|P7|NOT COMPLETED|Overall Study||1
8540181|NCT00249834|21055422|P6|NOT COMPLETED|Overall Study||2
8540182|NCT00249834|21055423|P5|NOT COMPLETED|Overall Study||5
8540183|NCT00249834|21055424|P4|NOT COMPLETED|Overall Study||8
8540184|NCT00249834|21055425|P3|NOT COMPLETED|Overall Study||14
8540185|NCT00249834|21055426|P2|NOT COMPLETED|Overall Study||19
8540186|NCT00249834|21055427|P1|NOT COMPLETED|Overall Study||1
8540187|NCT00249834|21055420|P8|COMPLETED|Overall Study||2
8540188|NCT00249834|21055421|P7|COMPLETED|Overall Study||1
8540189|NCT00249834|21055422|P6|COMPLETED|Overall Study||8
8540190|NCT00249834|21055423|P5|COMPLETED|Overall Study||19
8540191|NCT00249834|21055424|P4|COMPLETED|Overall Study||26
8540192|NCT00249834|21055425|P3|COMPLETED|Overall Study||31
8540193|NCT00249834|21055426|P2|COMPLETED|Overall Study||29
8540194|NCT00249834|21055427|P1|COMPLETED|Overall Study||0
8540195|NCT00249834|21055420|P8|STARTED|Overall Study||2
8540196|NCT00249834|21055421|P7|STARTED|Overall Study||2
8540197|NCT00249834|21055422|P6|STARTED|Overall Study||10
8540198|NCT00249834|21055423|P5|STARTED|Overall Study||24
8540199|NCT00249834|21055424|P4|STARTED|Overall Study||34
8540200|NCT00249834|21055425|P3|STARTED|Overall Study||45
8540201|NCT00249834|21055426|P2|STARTED|Overall Study||48
8540202|NCT00249834|21055427|P1|STARTED|Overall Study||1
8540203|NCT00249821|21055476|P2|NOT COMPLETED|Overall Study||1
8540204|NCT00249821|21055477|P1|NOT COMPLETED|Overall Study||0
8540205|NCT00249821|21055476|P2|COMPLETED|Overall Study||11
8540206|NCT00249821|21055477|P1|COMPLETED|Overall Study||10
8540207|NCT00249821|21055476|P2|STARTED|Overall Study||12
8540208|NCT00249821|21055477|P1|STARTED|Overall Study||10
8540209|NCT00249808|21055497|P1|NOT COMPLETED|Overall Study||182
8540210|NCT00249808|21055497|P1|COMPLETED|Overall Study||1084
8540211|NCT00249808|21055497|P1|STARTED|Overall Study||1266
8540212|NCT00249795|21055505|P2|NOT COMPLETED|Overall Study||1390
8540213|NCT00249795|21055506|P1|NOT COMPLETED|Overall Study||1394
8540214|NCT00249795|21055505|P2|COMPLETED|Overall Study|started and completed study drug|3108
8540215|NCT00249795|21055506|P1|COMPLETED|Overall Study|started and completed study drug|3124
8540216|NCT00249795|21055505|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
8540217|NCT00249795|21055506|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
8540218|NCT00249769|21055527|P3|NOT COMPLETED|Overall Study||28
8540219|NCT00249769|21055528|P2|NOT COMPLETED|Overall Study||15
8540220|NCT00249769|21055529|P1|NOT COMPLETED|Overall Study||2
8540221|NCT00249769|21055527|P3|COMPLETED|Overall Study||222
8540222|NCT00249769|21055528|P2|COMPLETED|Overall Study||235
8540223|NCT00249769|21055529|P1|COMPLETED|Overall Study||98
8540224|NCT00249769|21055527|P3|Received Measles Vaccine|Overall Study||235
8540225|NCT00249769|21055528|P2|Received Measles Vaccine|Overall Study||236
8540226|NCT00249769|21055529|P1|Received Measles Vaccine|Overall Study||97
8540227|NCT00249769|21055527|P3|Received LJEV|Overall Study||224
8540228|NCT00249769|21055528|P2|Received LJEV|Overall Study||236
8540229|NCT00249769|21055529|P1|Received LJEV|Overall Study||100
8540230|NCT00249769|21055527|P3|STARTED|Overall Study||250
8540231|NCT00249769|21055528|P2|STARTED|Overall Study||250
8540232|NCT00249769|21055529|P1|STARTED|Overall Study||100
8540233|NCT00249613|21055557|P2|NOT COMPLETED|12 Month Follow-up||15
8540234|NCT00249613|21055558|P1|NOT COMPLETED|12 Month Follow-up||17
8540235|NCT00249613|21055557|P2|COMPLETED|12 Month Follow-up||124
8540236|NCT00249613|21055558|P1|COMPLETED|12 Month Follow-up||135
8540237|NCT00249613|21055557|P2|STARTED|12 Month Follow-up||139
8540238|NCT00249613|21055558|P1|STARTED|12 Month Follow-up||152
8540239|NCT00249613|21055557|P2|NOT COMPLETED|Baseline||0
8540240|NCT00249613|21055558|P1|NOT COMPLETED|Baseline||0
8540241|NCT00249613|21055557|P2|COMPLETED|Baseline||139
8540242|NCT00249613|21055558|P1|COMPLETED|Baseline||152
8540243|NCT00249613|21055557|P2|STARTED|Baseline||139
8540244|NCT00249613|21055558|P1|STARTED|Baseline||152
8540245|NCT00249496|21055569|P2|NOT COMPLETED|Overall Study||1
8540246|NCT00249496|21055570|P1|NOT COMPLETED|Overall Study||0
8540247|NCT00249496|21055569|P2|COMPLETED|Overall Study||26
8540248|NCT00249496|21055570|P1|COMPLETED|Overall Study||24
8540249|NCT00249496|21055569|P2|STARTED|Overall Study||27
8540250|NCT00249496|21055570|P1|STARTED|Overall Study||24
8540251|NCT00249470|21055586|P2|NOT COMPLETED|Overall Study||0
8540252|NCT00249470|21055587|P1|NOT COMPLETED|Overall Study||0
8540253|NCT00249470|21055586|P2|COMPLETED|Overall Study||28
8540254|NCT00249470|21055587|P1|COMPLETED|Overall Study||28
8540255|NCT00249470|21055586|P2|STARTED|Overall Study||28
8540256|NCT00249470|21055587|P1|STARTED|Overall Study||28
8540257|NCT00249444|21055599|P2|NOT COMPLETED|Overall Study||15
8540258|NCT00249444|21055600|P1|NOT COMPLETED|Overall Study||12
8540259|NCT00249444|21055599|P2|COMPLETED|Overall Study||29
8540260|NCT00249444|21055600|P1|COMPLETED|Overall Study||30
8540261|NCT00249444|21055599|P2|STARTED|Overall Study||44
8540262|NCT00249444|21055600|P1|STARTED|Overall Study||42
8540263|NCT00249379|21055610|P2|NOT COMPLETED|Overall Study||8
8540264|NCT00249379|21055611|P1|NOT COMPLETED|Overall Study||8
8540265|NCT00249379|21055610|P2|COMPLETED|Overall Study||4
8540266|NCT00249379|21055611|P1|COMPLETED|Overall Study||6
8540267|NCT00249379|21055610|P2|STARTED|Overall Study||12
8540268|NCT00249379|21055611|P1|STARTED|Overall Study||14
8540269|NCT00249288|21055625|P2|NOT COMPLETED|Overall Study||5
8540270|NCT00249288|21055626|P1|NOT COMPLETED|Overall Study||5
8540271|NCT00249288|21055625|P2|COMPLETED|Overall Study||14
8540272|NCT00249288|21055626|P1|COMPLETED|Overall Study||14
8540273|NCT00249288|21055625|P2|Initiated Treatment|Overall Study||15
8540274|NCT00249288|21055626|P1|Initiated Treatment|Overall Study||17
8540275|NCT00249288|21055625|P2|STARTED|Overall Study||19
8540276|NCT00249288|21055626|P1|STARTED|Overall Study||19
8540277|NCT00249249|21055661|P4|NOT COMPLETED|Overall Study||3
8540278|NCT00249249|21055662|P3|NOT COMPLETED|Overall Study||15
8540279|NCT00249249|21055663|P2|NOT COMPLETED|Overall Study||5
8540280|NCT00249249|21055664|P1|NOT COMPLETED|Overall Study||20
8540281|NCT00249249|21055661|P4|COMPLETED|Overall Study||100
8540282|NCT00249249|21055662|P3|COMPLETED|Overall Study||288
8540283|NCT00249249|21055663|P2|COMPLETED|Overall Study||98
8540284|NCT00249249|21055664|P1|COMPLETED|Overall Study||301
8540285|NCT00249249|21055661|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
8540286|NCT00249249|21055662|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
8540287|NCT00249249|21055663|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
8540288|NCT00249249|21055664|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
8540289|NCT00249249|21055661|P4|STARTED|Overall Study||103
8540290|NCT00249249|21055662|P3|STARTED|Overall Study||303
8540291|NCT00249249|21055663|P2|STARTED|Overall Study||103
8540292|NCT00249249|21055664|P1|STARTED|Overall Study||321
8540293|NCT00249002|21055718|P1|NOT COMPLETED|Overall Study||7
8540294|NCT00249002|21055718|P1|COMPLETED|Overall Study||2
8540295|NCT00249002|21055718|P1|STARTED|Overall Study||9
8540296|NCT00248833|21055737|P3|NOT COMPLETED|Overall Study||2
8540297|NCT00248833|21055738|P2|NOT COMPLETED|Overall Study||3
8540298|NCT00248833|21055739|P1|NOT COMPLETED|Overall Study||3
8540299|NCT00248833|21055737|P3|COMPLETED|Overall Study||9
8540300|NCT00248833|21055738|P2|COMPLETED|Overall Study||8
8540301|NCT00248833|21055739|P1|COMPLETED|Overall Study||9
8540302|NCT00248833|21055737|P3|STARTED|Overall Study||11
8540303|NCT00248833|21055738|P2|STARTED|Overall Study||11
8540304|NCT00248833|21055739|P1|STARTED|Overall Study||12
8540305|NCT00248807|21055757|P2|NOT COMPLETED|Overall Study||0
8540306|NCT00248807|21055758|P1|NOT COMPLETED|Overall Study||0
8540307|NCT00248807|21055757|P2|COMPLETED|Overall Study||11
8540308|NCT00248807|21055758|P1|COMPLETED|Overall Study||19
8540309|NCT00248807|21055757|P2|STARTED|Overall Study||11
8540310|NCT00248807|21055758|P1|STARTED|Overall Study||19
8540311|NCT00248794|21055775|P3|NOT COMPLETED|Overall Study||3
8540312|NCT00248794|21055776|P2|NOT COMPLETED|Overall Study||8
8540313|NCT00248794|21055777|P1|NOT COMPLETED|Overall Study||6
8540314|NCT00248794|21055775|P3|COMPLETED|Overall Study||7
8540315|NCT00248794|21055776|P2|COMPLETED|Overall Study||16
8540316|NCT00248794|21055777|P1|COMPLETED|Overall Study||19
8540317|NCT00248794|21055775|P3|STARTED|Overall Study||10
8540318|NCT00248794|21055776|P2|STARTED|Overall Study||24
8540319|NCT00248794|21055777|P1|STARTED|Overall Study||25
8540320|NCT00248781|21055799|P2|NOT COMPLETED|Overall Study||4
8540321|NCT00248781|21055800|P1|NOT COMPLETED|Overall Study||10
8540322|NCT00248781|21055799|P2|COMPLETED|Overall Study||47
8540323|NCT00248781|21055800|P1|COMPLETED|Overall Study||42
8540324|NCT00248781|21055799|P2|STARTED|Overall Study||51
8540325|NCT00248781|21055800|P1|STARTED|Overall Study||52
8540326|NCT00248651|21055827|P3|NOT COMPLETED|Overall Study||32
8540327|NCT00248651|21055828|P2|NOT COMPLETED|Overall Study||40
8540328|NCT00248651|21055829|P1|NOT COMPLETED|Overall Study||28
8540329|NCT00248651|21055827|P3|COMPLETED|Overall Study||65
8540330|NCT00248651|21055828|P2|COMPLETED|Overall Study||58
8540331|NCT00248651|21055829|P1|COMPLETED|Overall Study||69
8540332|NCT00248651|21055827|P3|Completed 12 Weeks of Treatment|Overall Study||75
8540333|NCT00248651|21055828|P2|Completed 12 Weeks of Treatment|Overall Study||66
8540334|NCT00248651|21055829|P1|Completed 12 Weeks of Treatment|Overall Study||78
8540335|NCT00248651|21055827|P3|STARTED|Overall Study||97
8540336|NCT00248651|21055828|P2|STARTED|Overall Study||98
8540337|NCT00248651|21055829|P1|STARTED|Overall Study||97
8540338|NCT00248638|21055848|P2|NOT COMPLETED|Overall Study||0
8540339|NCT00248638|21055849|P1|NOT COMPLETED|Overall Study||0
8540340|NCT00248638|21055848|P2|COMPLETED|Overall Study||75
8540341|NCT00248638|21055849|P1|COMPLETED|Overall Study||75
8540342|NCT00248638|21055848|P2|STARTED|Overall Study||75
8540343|NCT00248638|21055849|P1|STARTED|Overall Study||75
8540344|NCT00248625|21055865|P2|NOT COMPLETED|Overall Study||2
8540345|NCT00248625|21055866|P1|NOT COMPLETED|Overall Study||0
8540346|NCT00248625|21055865|P2|COMPLETED|Overall Study||90
8540347|NCT00248625|21055866|P1|COMPLETED|Overall Study||92
8540348|NCT00248625|21055865|P2|STARTED|Overall Study||92
8540349|NCT00248625|21055866|P1|STARTED|Overall Study||92
8540350|NCT00248612|21055890|P4|NOT COMPLETED|Overall Study||0
8540351|NCT00248612|21055891|P3|NOT COMPLETED|Overall Study||0
8540352|NCT00248612|21055892|P2|NOT COMPLETED|Overall Study||0
8540353|NCT00248612|21055893|P1|NOT COMPLETED|Overall Study||0
8540354|NCT00248612|21055890|P4|COMPLETED|Overall Study||22
8540355|NCT00248612|21055891|P3|COMPLETED|Overall Study||14
8540356|NCT00248612|21055892|P2|COMPLETED|Overall Study||21
8540357|NCT00248612|21055893|P1|COMPLETED|Overall Study||24
8540358|NCT00248612|21055890|P4|STARTED|Overall Study||22
8540359|NCT00248612|21055891|P3|STARTED|Overall Study||14
8540360|NCT00248612|21055892|P2|STARTED|Overall Study||21
8540361|NCT00248612|21055893|P1|STARTED|Overall Study||24
8540362|NCT00248560|21055935|P1|NOT COMPLETED|Overall Study||0
8540363|NCT00248560|21055935|P1|COMPLETED|Overall Study||36
8540364|NCT00248560|21055935|P1|STARTED|Overall Study||36
8540365|NCT00248547|21055944|P2|NOT COMPLETED|Overall Study||0
8540366|NCT00248547|21055945|P1|NOT COMPLETED|Overall Study||0
8540367|NCT00248547|21055944|P2|COMPLETED|Overall Study||20
8540368|NCT00248547|21055945|P1|COMPLETED|Overall Study||20
8540369|NCT00248547|21055944|P2|STARTED|Overall Study||20
8540370|NCT00248547|21055945|P1|STARTED|Overall Study||20
8540371|NCT00248534|21055951|P1|NOT COMPLETED|Overall Study||0
8540372|NCT00248534|21055951|P1|COMPLETED|Overall Study||16
8540373|NCT00248534|21055951|P1|STARTED|Overall Study||16
8540374|NCT00248495|21055958|P1|NOT COMPLETED|Overall Study||1
8540375|NCT00248495|21055958|P1|COMPLETED|Overall Study||37
8540376|NCT00248495|21055958|P1|STARTED|Overall Study||38
8540377|NCT00248287|21055969|P2|NOT COMPLETED|Overall Study||19
8540378|NCT00248287|21055970|P1|NOT COMPLETED|Overall Study||24
8540379|NCT00248287|21055969|P2|COMPLETED|Overall Study||60
8540380|NCT00248287|21055970|P1|COMPLETED|Overall Study||51
8540381|NCT00248287|21055969|P2|STARTED|Overall Study||79
8540382|NCT00248287|21055970|P1|STARTED|Overall Study||75
8540383|NCT00248170|21055984|P2|NOT COMPLETED|Overall Study||808
8540384|NCT00248170|21055985|P1|NOT COMPLETED|Overall Study||761
8540385|NCT00248170|21055984|P2|COMPLETED|Overall Study||1286
8540386|NCT00248170|21055985|P1|COMPLETED|Overall Study||1317
8540387|NCT00248170|21055984|P2|Safety Set|Overall Study||2062
8540388|NCT00248170|21055985|P1|Safety Set|Overall Study||2049
8540389|NCT00248170|21055984|P2|Intent-to-treat (ITT)|Overall Study||2075
8540390|NCT00248170|21055985|P1|Intent-to-treat (ITT)|Overall Study||2061
8540391|NCT00248170|21055984|P2|STARTED|Overall Study||2094
8540392|NCT00248170|21055985|P1|STARTED|Overall Study||2078
8540393|NCT00248040|21056008|P3|NOT COMPLETED|Overall Study||4
8540394|NCT00248040|21056009|P2|NOT COMPLETED|Overall Study||1
8540395|NCT00248040|21056010|P1|NOT COMPLETED|Overall Study||3
8540396|NCT00248040|21056008|P3|COMPLETED|Overall Study||22
8540397|NCT00248040|21056009|P2|COMPLETED|Overall Study||22
8540398|NCT00248040|21056010|P1|COMPLETED|Overall Study||22
8540399|NCT00248040|21056008|P3|STARTED|Overall Study||26
8540400|NCT00248040|21056009|P2|STARTED|Overall Study||23
8540401|NCT00248040|21056010|P1|STARTED|Overall Study||25
8540402|NCT00247962|21056059|P2|NOT COMPLETED|Overall Study||19
8540403|NCT00247962|21056060|P1|NOT COMPLETED|Overall Study||26
8540404|NCT00247962|21056059|P2|COMPLETED|Overall Study||168
8540405|NCT00247962|21056060|P1|COMPLETED|Overall Study||353
8540406|NCT00247962|21056059|P2|STARTED|Overall Study||187
8540407|NCT00247962|21056060|P1|STARTED|Overall Study||379
8540408|NCT00247728|21056071|P3|NOT COMPLETED|Overall Study||14
8540409|NCT00247728|21056072|P2|NOT COMPLETED|Overall Study||6
8540410|NCT00247728|21056073|P1|NOT COMPLETED|Overall Study||3
8540411|NCT00247728|21056071|P3|COMPLETED|Overall Study||43
8540412|NCT00247728|21056072|P2|COMPLETED|Overall Study||51
8540413|NCT00247728|21056073|P1|COMPLETED|Overall Study||55
8540414|NCT00247728|21056071|P3|STARTED|Overall Study||57
8540415|NCT00247728|21056072|P2|STARTED|Overall Study||57
8540416|NCT00247728|21056073|P1|STARTED|Overall Study||58
8540417|NCT00247676|21056087|P1|NOT COMPLETED|Overall Study||36
8540418|NCT00247676|21056087|P1|COMPLETED|Overall Study||1
8540419|NCT00247676|21056087|P1|STARTED|Overall Study||37
8540420|NCT00247624|21056117|P2|NOT COMPLETED|Overall Study||4
8540421|NCT00247624|21056118|P1|NOT COMPLETED|Overall Study||5
8540422|NCT00247624|21056117|P2|COMPLETED|Overall Study||26
8540423|NCT00247624|21056118|P1|COMPLETED|Overall Study||25
8540424|NCT00247624|21056117|P2|STARTED|Overall Study||30
8540425|NCT00247624|21056118|P1|STARTED|Overall Study||30
8540426|NCT00247611|21056132|P2|NOT COMPLETED|On Protocol Sample||125
8540427|NCT00247611|21056133|P1|NOT COMPLETED|On Protocol Sample||111
8540428|NCT00247611|21056132|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
8540429|NCT00247611|21056133|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
8540430|NCT00247611|21056132|P2|STARTED|On Protocol Sample|ITT sample participants|277
8540431|NCT00247611|21056133|P1|STARTED|On Protocol Sample|ITT sample participants|287
8540432|NCT00247611|21056132|P2|NOT COMPLETED|Intention to Treat Sample||13
8540433|NCT00247611|21056133|P1|NOT COMPLETED|Intention to Treat Sample||17
8540434|NCT00247611|21056132|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
8540435|NCT00247611|21056133|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
8540436|NCT00247611|21056132|P2|STARTED|Intention to Treat Sample|Participants randomized|290
8540437|NCT00247611|21056133|P1|STARTED|Intention to Treat Sample|Participants randomized|304
8540438|NCT00247611|21056132|P2|NOT COMPLETED|Baselined||13
8540439|NCT00247611|21056133|P1|NOT COMPLETED|Baselined||17
8540440|NCT00247611|21056132|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
8540441|NCT00247611|21056133|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
8540442|NCT00247611|21056132|P2|STARTED|Baselined|Participants randomized|290
8540443|NCT00247611|21056133|P1|STARTED|Baselined|Participants randomized|304
8540444|NCT00247416|21056151|P2|NOT COMPLETED|Overall Study||2
8540445|NCT00247416|21056152|P1|NOT COMPLETED|Overall Study||1
8540446|NCT00247416|21056151|P2|COMPLETED|Overall Study||31
8540447|NCT00247416|21056152|P1|COMPLETED|Overall Study||25
8540448|NCT00247416|21056151|P2|STARTED|Overall Study||33
8540449|NCT00247416|21056152|P1|STARTED|Overall Study||26
8540450|NCT00247377|21056166|P2|NOT COMPLETED|Overall Study||0
8540451|NCT00247377|21056167|P1|NOT COMPLETED|Overall Study||0
8540452|NCT00247377|21056166|P2|COMPLETED|Overall Study||86
8540453|NCT00247377|21056167|P1|COMPLETED|Overall Study||111
8540454|NCT00247377|21056166|P2|STARTED|Overall Study||86
8540455|NCT00247377|21056167|P1|STARTED|Overall Study||111
8540456|NCT00247273|21056193|P2|NOT COMPLETED|Overall Study||137
8540457|NCT00247273|21056194|P1|NOT COMPLETED|Overall Study||146
8540458|NCT00247273|21056193|P2|COMPLETED|Overall Study||513
8540459|NCT00247273|21056194|P1|COMPLETED|Overall Study||498
8540460|NCT00247273|21056193|P2|Intent to Treat Population|Overall Study||650
8540461|NCT00247273|21056194|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
8540462|NCT00247273|21056193|P2|STARTED|Overall Study||650
8540463|NCT00247273|21056194|P1|STARTED|Overall Study||644
8540464|NCT00246805|21056240|P2|NOT COMPLETED|Phase 2||0
8540465|NCT00246805|21056241|P1|NOT COMPLETED|Phase 2||0
8540466|NCT00246805|21056240|P2|COMPLETED|Phase 2||33
8540467|NCT00246805|21056241|P1|COMPLETED|Phase 2||33
8540468|NCT00246805|21056240|P2|STARTED|Phase 2||33
8540469|NCT00246805|21056241|P1|STARTED|Phase 2||33
8540470|NCT00246805|21056240|P2|NOT COMPLETED|Phase 1||0
8540471|NCT00246805|21056241|P1|NOT COMPLETED|Phase 1||1
8540472|NCT00246805|21056240|P2|COMPLETED|Phase 1||33
8540473|NCT00246805|21056241|P1|COMPLETED|Phase 1||33
8540474|NCT00246805|21056240|P2|STARTED|Phase 1||33
8540475|NCT00246805|21056241|P1|STARTED|Phase 1||34
8540476|NCT00246753|21056247|P1|NOT COMPLETED|Overall Study||8
8540477|NCT00246753|21056247|P1|COMPLETED|Overall Study||21
8540478|NCT00246753|21056247|P1|STARTED|Overall Study||29
8540479|NCT00246740|21056255|P2|NOT COMPLETED|Experimental Phase||0
8540480|NCT00246740|21056256|P1|NOT COMPLETED|Experimental Phase||0
8540481|NCT00246740|21056255|P2|COMPLETED|Experimental Phase||20
8540482|NCT00246740|21056256|P1|COMPLETED|Experimental Phase||22
8540483|NCT00246740|21056255|P2|STARTED|Experimental Phase||20
8540484|NCT00246740|21056256|P1|STARTED|Experimental Phase||22
8540485|NCT00246740|21056255|P2|NOT COMPLETED|Initial Enrollment||8
8540486|NCT00246740|21056256|P1|NOT COMPLETED|Initial Enrollment||6
8540487|NCT00246740|21056255|P2|COMPLETED|Initial Enrollment||20
8540488|NCT00246740|21056256|P1|COMPLETED|Initial Enrollment||22
8540489|NCT00246740|21056255|P2|STARTED|Initial Enrollment||28
8540490|NCT00246740|21056256|P1|STARTED|Initial Enrollment||28
8540491|NCT00246571|21056280|P2|NOT COMPLETED|Overall Study||104
8540492|NCT00246571|21056281|P1|NOT COMPLETED|Overall Study||113
8540493|NCT00246571|21056280|P2|COMPLETED|Overall Study||0
8540494|NCT00246571|21056281|P1|COMPLETED|Overall Study||0
8540495|NCT00246571|21056280|P2|Randomized But Not Treated|Overall Study||1
8540496|NCT00246571|21056281|P1|Randomized But Not Treated|Overall Study||3
8540497|NCT00246571|21056280|P2|STARTED|Overall Study||104
8540498|NCT00246571|21056281|P1|STARTED|Overall Study||113
8540499|NCT00246519|21056321|P2|NOT COMPLETED|Overall Study||64
8540500|NCT00246519|21056322|P1|NOT COMPLETED|Overall Study||56
8540501|NCT00246519|21056321|P2|COMPLETED|Overall Study||382
8540502|NCT00246519|21056322|P1|COMPLETED|Overall Study||386
8540503|NCT00246519|21056321|P2|STARTED|Overall Study||446
8540504|NCT00246519|21056322|P1|STARTED|Overall Study||442
8540505|NCT00246441|21056330|P2|NOT COMPLETED|Overall Study||0
8540506|NCT00246441|21056331|P1|NOT COMPLETED|Overall Study||1
8540507|NCT00246441|21056330|P2|COMPLETED|Overall Study||22
8540508|NCT00246441|21056331|P1|COMPLETED|Overall Study||19
8540509|NCT00246441|21056330|P2|STARTED|Overall Study||22
8540510|NCT00246441|21056331|P1|STARTED|Overall Study||20
8540511|NCT00246376|21056346|P5|NOT COMPLETED|Overall Study||17
8540512|NCT00246376|21056347|P4|NOT COMPLETED|Overall Study||26
8540513|NCT00246376|21056348|P3|NOT COMPLETED|Overall Study||16
8540514|NCT00246376|21056349|P2|NOT COMPLETED|Overall Study||19
8540515|NCT00246376|21056350|P1|NOT COMPLETED|Overall Study||15
8540516|NCT00246376|21056346|P5|COMPLETED|Overall Study||28
8540517|NCT00246376|21056347|P4|COMPLETED|Overall Study||21
8540518|NCT00246376|21056348|P3|COMPLETED|Overall Study||29
8540519|NCT00246376|21056349|P2|COMPLETED|Overall Study||24
8540520|NCT00246376|21056350|P1|COMPLETED|Overall Study||26
8540521|NCT00246376|21056346|P5|After Dietary run-in at Two Weeks|Overall Study||42
8540522|NCT00246376|21056347|P4|After Dietary run-in at Two Weeks|Overall Study||40
8540523|NCT00246376|21056348|P3|After Dietary run-in at Two Weeks|Overall Study||41
8540524|NCT00246376|21056349|P2|After Dietary run-in at Two Weeks|Overall Study||38
8540525|NCT00246376|21056350|P1|After Dietary run-in at Two Weeks|Overall Study||30
8540526|NCT00246376|21056346|P5|STARTED|Overall Study||45
8540527|NCT00246376|21056347|P4|STARTED|Overall Study||47
8540528|NCT00246376|21056348|P3|STARTED|Overall Study||45
8540529|NCT00246376|21056349|P2|STARTED|Overall Study||43
8540530|NCT00246376|21056350|P1|STARTED|Overall Study||41
8540531|NCT00246337|21056401|P9|NOT COMPLETED|Overall Study||11
8540532|NCT00246337|21056402|P8|NOT COMPLETED|Overall Study||13
8540533|NCT00246337|21056403|P7|NOT COMPLETED|Overall Study||9
8540534|NCT00246337|21056404|P6|NOT COMPLETED|Overall Study||15
8540535|NCT00246337|21056405|P5|NOT COMPLETED|Overall Study||4
8540536|NCT00246337|21056406|P4|NOT COMPLETED|Overall Study||1
8540537|NCT00246337|21056407|P3|NOT COMPLETED|Overall Study||3
8540538|NCT00246337|21056408|P2|NOT COMPLETED|Overall Study||2
8540539|NCT00246337|21056409|P1|NOT COMPLETED|Overall Study||32
8540540|NCT00246337|21056401|P9|COMPLETED|Overall Study||34
8540541|NCT00246337|21056402|P8|COMPLETED|Overall Study||40
8540542|NCT00246337|21056403|P7|COMPLETED|Overall Study||45
8540543|NCT00246337|21056404|P6|COMPLETED|Overall Study||39
8540544|NCT00246337|21056405|P5|COMPLETED|Overall Study||12
8540545|NCT00246337|21056406|P4|COMPLETED|Overall Study||16
8540546|NCT00246337|21056407|P3|COMPLETED|Overall Study||15
8540547|NCT00246337|21056408|P2|COMPLETED|Overall Study||14
8540548|NCT00246337|21056409|P1|COMPLETED|Overall Study||115
8540549|NCT00246337|21056401|P9|Completed Period (Both Doses)|Overall Study||15
8540550|NCT00246337|21056402|P8|Completed Period (Both Doses)|Overall Study||13
8540551|NCT00246337|21056403|P7|Completed Period (Both Doses)|Overall Study||16
8540552|NCT00246337|21056404|P6|Completed Period (Both Doses)|Overall Study||10
8540553|NCT00246337|21056405|P5|Completed Period (Both Doses)|Overall Study||4
8540554|NCT00246337|21056406|P4|Completed Period (Both Doses)|Overall Study||11
8540555|NCT00246337|21056407|P3|Completed Period (Both Doses)|Overall Study||6
8540556|NCT00246337|21056408|P2|Completed Period (Both Doses)|Overall Study||10
8540557|NCT00246337|21056409|P1|Completed Period (Both Doses)|Overall Study||69
8540558|NCT00246337|21056401|P9|Completed Period (Initial Dose)|Overall Study||19
8540559|NCT00246337|21056402|P8|Completed Period (Initial Dose)|Overall Study||27
8540560|NCT00246337|21056403|P7|Completed Period (Initial Dose)|Overall Study||29
8540561|NCT00246337|21056404|P6|Completed Period (Initial Dose)|Overall Study||29
8540562|NCT00246337|21056405|P5|Completed Period (Initial Dose)|Overall Study||8
8540563|NCT00246337|21056406|P4|Completed Period (Initial Dose)|Overall Study||5
8540564|NCT00246337|21056407|P3|Completed Period (Initial Dose)|Overall Study||9
8540565|NCT00246337|21056408|P2|Completed Period (Initial Dose)|Overall Study||4
8540566|NCT00246337|21056409|P1|Completed Period (Initial Dose)|Overall Study||46
8540567|NCT00246337|21056401|P9|STARTED|Overall Study||45
8540568|NCT00246337|21056402|P8|STARTED|Overall Study||53
8540569|NCT00246337|21056403|P7|STARTED|Overall Study||54
8540570|NCT00246337|21056404|P6|STARTED|Overall Study||54
8540571|NCT00246337|21056405|P5|STARTED|Overall Study||16
8540572|NCT00246337|21056406|P4|STARTED|Overall Study||17
8540573|NCT00246337|21056407|P3|STARTED|Overall Study||18
8540574|NCT00246337|21056408|P2|STARTED|Overall Study||16
8540575|NCT00246337|21056409|P1|STARTED|Overall Study||147
8540576|NCT00246324|21056456|P1|NOT COMPLETED|Overall Study||1
8540577|NCT00246324|21056456|P1|COMPLETED|Overall Study||15
8540578|NCT00246324|21056456|P1|STARTED|Overall Study||16
8540579|NCT00246259|21056463|P2|NOT COMPLETED|Overall Study||26
8540580|NCT00246259|21056464|P1|NOT COMPLETED|Overall Study||28
8540581|NCT00246259|21056463|P2|COMPLETED|Overall Study||15
8540582|NCT00246259|21056464|P1|COMPLETED|Overall Study||16
8540583|NCT00246259|21056463|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
8540584|NCT00246259|21056464|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
8540585|NCT00246259|21056463|P2|STARTED|Overall Study||41
8540586|NCT00246259|21056464|P1|STARTED|Overall Study||44
8540587|NCT00246090|21056498|P1|NOT COMPLETED|Overall Study||295
8540588|NCT00246090|21056498|P1|COMPLETED|Overall Study||3
8540589|NCT00246090|21056498|P1|STARTED|Overall Study||298
8540590|NCT00246025|21056507|P4|NOT COMPLETED|Overall Study||13
8540591|NCT00246025|21056508|P3|NOT COMPLETED|Overall Study||10
8540592|NCT00246025|21056509|P2|NOT COMPLETED|Overall Study||9
8540593|NCT00246025|21056510|P1|NOT COMPLETED|Overall Study||10
8540594|NCT00246025|21056507|P4|COMPLETED|Overall Study||116
8540595|NCT00246025|21056508|P3|COMPLETED|Overall Study||116
8540596|NCT00246025|21056509|P2|COMPLETED|Overall Study||124
8540597|NCT00246025|21056510|P1|COMPLETED|Overall Study||114
8540598|NCT00246025|21056507|P4|STARTED|Overall Study||129
8540599|NCT00246025|21056508|P3|STARTED|Overall Study||126
8540600|NCT00246025|21056509|P2|STARTED|Overall Study||133
8540601|NCT00246025|21056510|P1|STARTED|Overall Study||124
8540602|NCT00246012|21056569|P9|NOT COMPLETED|Overall Study||28
8540603|NCT00246012|21056570|P8|NOT COMPLETED|Overall Study||28
8540604|NCT00246012|21056571|P7|NOT COMPLETED|Overall Study||31
8540605|NCT00246012|21056572|P6|NOT COMPLETED|Overall Study||28
8540606|NCT00246012|21056573|P5|NOT COMPLETED|Overall Study||3
8540607|NCT00246012|21056574|P4|NOT COMPLETED|Overall Study||3
8540608|NCT00246012|21056575|P3|NOT COMPLETED|Overall Study||2
8540609|NCT00246012|21056576|P2|NOT COMPLETED|Overall Study||1
8540610|NCT00246012|21056577|P1|NOT COMPLETED|Overall Study||3
8540611|NCT00246012|21056569|P9|COMPLETED|Overall Study||4
8540612|NCT00246012|21056570|P8|COMPLETED|Overall Study||5
8540613|NCT00246012|21056571|P7|COMPLETED|Overall Study||1
8540614|NCT00246012|21056572|P6|COMPLETED|Overall Study||4
8540615|NCT00246012|21056573|P5|COMPLETED|Overall Study||0
8540616|NCT00246012|21056574|P4|COMPLETED|Overall Study||0
8540617|NCT00246012|21056575|P3|COMPLETED|Overall Study||1
8540618|NCT00246012|21056576|P2|COMPLETED|Overall Study||2
8540619|NCT00246012|21056577|P1|COMPLETED|Overall Study||0
8540620|NCT00246012|21056569|P9|Treated|Overall Study||32
8540621|NCT00246012|21056570|P8|Treated|Overall Study||33
8540622|NCT00246012|21056571|P7|Treated|Overall Study||31
8540623|NCT00246012|21056572|P6|Treated|Overall Study||31
8540624|NCT00246012|21056573|P5|Treated|Overall Study||3
8540625|NCT00246012|21056574|P4|Treated|Overall Study||3
8540626|NCT00246012|21056575|P3|Treated|Overall Study||3
8540627|NCT00246012|21056576|P2|Treated|Overall Study||3
8540628|NCT00246012|21056577|P1|Treated|Overall Study||3
8540629|NCT00246012|21056569|P9|STARTED|Overall Study||32
8540630|NCT00246012|21056570|P8|STARTED|Overall Study||33
8540631|NCT00246012|21056571|P7|STARTED|Overall Study||32
8540632|NCT00246012|21056572|P6|STARTED|Overall Study||32
8540633|NCT00246012|21056573|P5|STARTED|Overall Study||3
8540634|NCT00246012|21056574|P4|STARTED|Overall Study||3
8540635|NCT00246012|21056575|P3|STARTED|Overall Study||3
8540636|NCT00246012|21056576|P2|STARTED|Overall Study||3
8540637|NCT00246012|21056577|P1|STARTED|Overall Study||3
8540638|NCT00245960|21056672|P2|NOT COMPLETED|Overall Study||28
8540639|NCT00245960|21056673|P1|NOT COMPLETED|Overall Study||29
8540640|NCT00245960|21056672|P2|COMPLETED|Overall Study||345
8540641|NCT00245960|21056673|P1|COMPLETED|Overall Study||350
8540642|NCT00245960|21056672|P2|STARTED|Overall Study||373
8540643|NCT00245960|21056673|P1|STARTED|Overall Study||379
8540644|NCT00245856|21056681|P2|NOT COMPLETED|Period Two||1
8540645|NCT00245856|21056682|P1|NOT COMPLETED|Period Two||0
8540646|NCT00245856|21056681|P2|COMPLETED|Period Two||38
8540647|NCT00245856|21056682|P1|COMPLETED|Period Two||0
8540648|NCT00245856|21056681|P2|STARTED|Period Two||39
8540649|NCT00245856|21056682|P1|STARTED|Period Two||0
8540650|NCT00245856|21056681|P2|NOT COMPLETED|Period One||0
8540651|NCT00245856|21056682|P1|NOT COMPLETED|Period One||0
8540652|NCT00245856|21056681|P2|COMPLETED|Period One||0
8540653|NCT00245856|21056682|P1|COMPLETED|Period One||28
8540654|NCT00245856|21056681|P2|STARTED|Period One||0
8540655|NCT00245856|21056682|P1|STARTED|Period One||28
8540656|NCT00245765|21056692|P3|NOT COMPLETED|Overall Study||8
8540657|NCT00245765|21056693|P2|NOT COMPLETED|Overall Study||14
8540658|NCT00245765|21056694|P1|NOT COMPLETED|Overall Study||32
8540659|NCT00245765|21056692|P3|COMPLETED|Overall Study||50
8540660|NCT00245765|21056693|P2|COMPLETED|Overall Study||45
8540661|NCT00245765|21056694|P1|COMPLETED|Overall Study||27
8540662|NCT00245765|21056692|P3|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
8540663|NCT00245765|21056693|P2|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
8540664|NCT00245765|21056694|P1|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
8540665|NCT00245765|21056692|P3|STARTED|Overall Study||58
8540666|NCT00245765|21056693|P2|STARTED|Overall Study||59
8540667|NCT00245765|21056694|P1|STARTED|Overall Study||59
8540668|NCT00245635|21056734|P2|NOT COMPLETED|Overall Study||0
8540669|NCT00245635|21056735|P1|NOT COMPLETED|Overall Study||0
8540670|NCT00245635|21056734|P2|COMPLETED|Overall Study||18
8540671|NCT00245635|21056735|P1|COMPLETED|Overall Study||25
8540672|NCT00245635|21056734|P2|STARTED|Overall Study||18
8540673|NCT00245635|21056735|P1|STARTED|Overall Study||25
8540674|NCT00245583|21056743|P2|NOT COMPLETED|Overall Study||9
8540675|NCT00245583|21056744|P1|NOT COMPLETED|Overall Study||6
8540676|NCT00245583|21056743|P2|COMPLETED|Overall Study||13
8540677|NCT00245583|21056744|P1|COMPLETED|Overall Study||14
8540678|NCT00245583|21056743|P2|STARTED|Overall Study||22
8540679|NCT00245583|21056744|P1|STARTED|Overall Study||20
8540680|NCT00245570|21056764|P6|NOT COMPLETED|Treatment Period IV||0
8540681|NCT00245570|21056765|P5|NOT COMPLETED|Treatment Period IV||0
8540682|NCT00245570|21056766|P4|NOT COMPLETED|Treatment Period IV||0
8540683|NCT00245570|21056767|P3|NOT COMPLETED|Treatment Period IV||0
8540684|NCT00245570|21056768|P2|NOT COMPLETED|Treatment Period IV||0
8540685|NCT00245570|21056769|P1|NOT COMPLETED|Treatment Period IV||0
8540686|NCT00245570|21056764|P6|COMPLETED|Treatment Period IV||8
8540687|NCT00245570|21056765|P5|COMPLETED|Treatment Period IV||8
8540688|NCT00245570|21056766|P4|COMPLETED|Treatment Period IV||8
8540689|NCT00245570|21056767|P3|COMPLETED|Treatment Period IV||8
8540690|NCT00245570|21056768|P2|COMPLETED|Treatment Period IV||7
8540691|NCT00245570|21056769|P1|COMPLETED|Treatment Period IV||7
8540692|NCT00245570|21056764|P6|STARTED|Treatment Period IV||8
8540693|NCT00245570|21056765|P5|STARTED|Treatment Period IV||8
8540694|NCT00245570|21056766|P4|STARTED|Treatment Period IV||8
8540695|NCT00245570|21056767|P3|STARTED|Treatment Period IV||8
8540696|NCT00245570|21056768|P2|STARTED|Treatment Period IV||7
8540697|NCT00245570|21056769|P1|STARTED|Treatment Period IV||7
8540698|NCT00245570|21056764|P6|NOT COMPLETED|Washout Between Periods III and IV||0
8540699|NCT00245570|21056765|P5|NOT COMPLETED|Washout Between Periods III and IV||0
8540700|NCT00245570|21056766|P4|NOT COMPLETED|Washout Between Periods III and IV||0
8540701|NCT00245570|21056767|P3|NOT COMPLETED|Washout Between Periods III and IV||0
8540702|NCT00245570|21056768|P2|NOT COMPLETED|Washout Between Periods III and IV||1
8540703|NCT00245570|21056769|P1|NOT COMPLETED|Washout Between Periods III and IV||0
8540704|NCT00245570|21056764|P6|COMPLETED|Washout Between Periods III and IV||8
8540705|NCT00245570|21056765|P5|COMPLETED|Washout Between Periods III and IV||8
8540706|NCT00245570|21056766|P4|COMPLETED|Washout Between Periods III and IV||8
8540707|NCT00245570|21056767|P3|COMPLETED|Washout Between Periods III and IV||8
8540708|NCT00245570|21056768|P2|COMPLETED|Washout Between Periods III and IV||7
8540709|NCT00245570|21056769|P1|COMPLETED|Washout Between Periods III and IV||7
8540710|NCT00245570|21056764|P6|STARTED|Washout Between Periods III and IV||8
8540711|NCT00245570|21056765|P5|STARTED|Washout Between Periods III and IV||8
8540712|NCT00245570|21056766|P4|STARTED|Washout Between Periods III and IV||8
8540713|NCT00245570|21056767|P3|STARTED|Washout Between Periods III and IV||8
8540714|NCT00245570|21056768|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
8540715|NCT00245570|21056769|P1|STARTED|Washout Between Periods III and IV||7
8540716|NCT00245570|21056764|P6|NOT COMPLETED|Treatment Period III||0
8540717|NCT00245570|21056765|P5|NOT COMPLETED|Treatment Period III||0
8540718|NCT00245570|21056766|P4|NOT COMPLETED|Treatment Period III||0
8540719|NCT00245570|21056767|P3|NOT COMPLETED|Treatment Period III||0
8540720|NCT00245570|21056768|P2|NOT COMPLETED|Treatment Period III||0
8540721|NCT00245570|21056769|P1|NOT COMPLETED|Treatment Period III||0
8540722|NCT00245570|21056764|P6|COMPLETED|Treatment Period III||8
8540723|NCT00245570|21056765|P5|COMPLETED|Treatment Period III||8
8540724|NCT00245570|21056766|P4|COMPLETED|Treatment Period III||8
8540725|NCT00245570|21056767|P3|COMPLETED|Treatment Period III||8
8540726|NCT00245570|21056768|P2|COMPLETED|Treatment Period III||8
8540727|NCT00245570|21056769|P1|COMPLETED|Treatment Period III||7
8540728|NCT00245570|21056764|P6|STARTED|Treatment Period III||8
8540729|NCT00245570|21056765|P5|STARTED|Treatment Period III||8
8540730|NCT00245570|21056766|P4|STARTED|Treatment Period III||8
8540731|NCT00245570|21056767|P3|STARTED|Treatment Period III||8
8540732|NCT00245570|21056768|P2|STARTED|Treatment Period III||8
8540733|NCT00245570|21056769|P1|STARTED|Treatment Period III||7
8540734|NCT00245570|21056764|P6|NOT COMPLETED|Washout Between Periods II and III||0
8540735|NCT00245570|21056765|P5|NOT COMPLETED|Washout Between Periods II and III||0
8540736|NCT00245570|21056766|P4|NOT COMPLETED|Washout Between Periods II and III||0
8540737|NCT00245570|21056767|P3|NOT COMPLETED|Washout Between Periods II and III||0
8540738|NCT00245570|21056768|P2|NOT COMPLETED|Washout Between Periods II and III||0
8540739|NCT00245570|21056769|P1|NOT COMPLETED|Washout Between Periods II and III||0
8540740|NCT00245570|21056764|P6|COMPLETED|Washout Between Periods II and III||8
8540741|NCT00245570|21056765|P5|COMPLETED|Washout Between Periods II and III||8
8540742|NCT00245570|21056766|P4|COMPLETED|Washout Between Periods II and III||8
8540743|NCT00245570|21056767|P3|COMPLETED|Washout Between Periods II and III||8
8540744|NCT00245570|21056768|P2|COMPLETED|Washout Between Periods II and III||8
8540745|NCT00245570|21056769|P1|COMPLETED|Washout Between Periods II and III||7
8540746|NCT00245570|21056764|P6|STARTED|Washout Between Periods II and III||8
8540747|NCT00245570|21056765|P5|STARTED|Washout Between Periods II and III||8
8540748|NCT00245570|21056766|P4|STARTED|Washout Between Periods II and III||8
8540749|NCT00245570|21056767|P3|STARTED|Washout Between Periods II and III||8
8540750|NCT00245570|21056768|P2|STARTED|Washout Between Periods II and III||8
8540751|NCT00245570|21056769|P1|STARTED|Washout Between Periods II and III||7
8540752|NCT00245570|21056764|P6|NOT COMPLETED|Treatment Period II||0
8540753|NCT00245570|21056765|P5|NOT COMPLETED|Treatment Period II||0
8540754|NCT00245570|21056766|P4|NOT COMPLETED|Treatment Period II||0
8540755|NCT00245570|21056767|P3|NOT COMPLETED|Treatment Period II||0
8540756|NCT00245570|21056768|P2|NOT COMPLETED|Treatment Period II||0
8540757|NCT00245570|21056769|P1|NOT COMPLETED|Treatment Period II||0
8540758|NCT00245570|21056764|P6|COMPLETED|Treatment Period II||8
8540759|NCT00245570|21056765|P5|COMPLETED|Treatment Period II||8
8540760|NCT00245570|21056766|P4|COMPLETED|Treatment Period II||8
8540761|NCT00245570|21056767|P3|COMPLETED|Treatment Period II||8
8540762|NCT00245570|21056768|P2|COMPLETED|Treatment Period II||8
8540763|NCT00245570|21056769|P1|COMPLETED|Treatment Period II||7
8540764|NCT00245570|21056764|P6|STARTED|Treatment Period II||8
8540765|NCT00245570|21056765|P5|STARTED|Treatment Period II||8
8540766|NCT00245570|21056766|P4|STARTED|Treatment Period II||8
8540767|NCT00245570|21056767|P3|STARTED|Treatment Period II||8
8540768|NCT00245570|21056768|P2|STARTED|Treatment Period II||8
8540769|NCT00245570|21056769|P1|STARTED|Treatment Period II||7
8540770|NCT00245557|21056815|P2|NOT COMPLETED|Overall Study||16
8540771|NCT00245557|21056816|P1|NOT COMPLETED|Overall Study||6
8540772|NCT00245557|21056815|P2|COMPLETED|Overall Study||10
8540773|NCT00245557|21056816|P1|COMPLETED|Overall Study||11
8540774|NCT00245557|21056815|P2|STARTED|Overall Study||26
8540775|NCT00245557|21056816|P1|STARTED|Overall Study||17
8540776|NCT00245518|21056829|P2|NOT COMPLETED|Overall Study||0
8540777|NCT00245518|21056830|P1|NOT COMPLETED|Overall Study||0
8540778|NCT00245518|21056829|P2|COMPLETED|Overall Study||16
8540779|NCT00245518|21056830|P1|COMPLETED|Overall Study||17
8540780|NCT00245518|21056829|P2|STARTED|Overall Study||16
8540781|NCT00245518|21056830|P1|STARTED|Overall Study||17
8540782|NCT00245466|21056903|P3|NOT COMPLETED|Overall Study||37
8540783|NCT00245466|21056904|P2|NOT COMPLETED|Overall Study||44
8540784|NCT00245466|21056905|P1|NOT COMPLETED|Overall Study||36
8540785|NCT00245466|21056903|P3|COMPLETED|Overall Study||3
8540786|NCT00245466|21056904|P2|COMPLETED|Overall Study||2
8540787|NCT00245466|21056905|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
8540788|NCT00245466|21056903|P3|Started FE200486 CS02A|Overall Study||26
8540789|NCT00245466|21056904|P2|Started FE200486 CS02A|Overall Study||30
8540790|NCT00245466|21056905|P1|Started FE200486 CS02A|Overall Study||32
8540791|NCT00245466|21056903|P3|STARTED|Overall Study||40
8540792|NCT00245466|21056904|P2|STARTED|Overall Study||46
8540793|NCT00245466|21056905|P1|STARTED|Overall Study||43
8540794|NCT00245219|21056922|P3|NOT COMPLETED|Overall Study||2
8540795|NCT00245219|21056923|P2|NOT COMPLETED|Overall Study||6
8540796|NCT00245219|21056924|P1|NOT COMPLETED|Overall Study||6
8540797|NCT00245219|21056922|P3|COMPLETED|Overall Study||58
8540798|NCT00245219|21056923|P2|COMPLETED|Overall Study||88
8540799|NCT00245219|21056924|P1|COMPLETED|Overall Study||85
8540800|NCT00245219|21056922|P3|STARTED|Overall Study||60
8540801|NCT00245219|21056923|P2|STARTED|Overall Study||94
8540802|NCT00245219|21056924|P1|STARTED|Overall Study||91
8540803|NCT00245128|21056938|P1|NOT COMPLETED|Overall Study||10
8540804|NCT00245128|21056938|P1|COMPLETED|Overall Study||0
8540805|NCT00245128|21056938|P1|STARTED|Overall Study||10
8540806|NCT00245102|21056948|P6|NOT COMPLETED|Overall Study||4
8540807|NCT00245102|21056949|P5|NOT COMPLETED|Overall Study||0
8540808|NCT00245102|21056950|P4|NOT COMPLETED|Overall Study||3
8540809|NCT00245102|21056951|P3|NOT COMPLETED|Overall Study||7
8540810|NCT00245102|21056952|P2|NOT COMPLETED|Overall Study||4
8540811|NCT00245102|21056953|P1|NOT COMPLETED|Overall Study||7
8540812|NCT00245102|21056948|P6|COMPLETED|Overall Study||19
8540813|NCT00245102|21056949|P5|COMPLETED|Overall Study||5
8540814|NCT00245102|21056950|P4|COMPLETED|Overall Study||10
8540815|NCT00245102|21056951|P3|COMPLETED|Overall Study||39
8540816|NCT00245102|21056952|P2|COMPLETED|Overall Study||12
8540817|NCT00245102|21056953|P1|COMPLETED|Overall Study||37
8540818|NCT00245102|21056948|P6|STARTED|Overall Study||23
8540819|NCT00245102|21056949|P5|STARTED|Overall Study||5
8540820|NCT00245102|21056950|P4|STARTED|Overall Study||13
8540821|NCT00245102|21056951|P3|STARTED|Overall Study||46
8540822|NCT00245102|21056952|P2|STARTED|Overall Study||16
8540823|NCT00245102|21056953|P1|STARTED|Overall Study||44
8540824|NCT00245063|21056969|P2|NOT COMPLETED|Overall Study||5
8540825|NCT00245063|21056970|P1|NOT COMPLETED|Overall Study||7
8540826|NCT00245063|21056969|P2|COMPLETED|Overall Study||8
8540827|NCT00245063|21056970|P1|COMPLETED|Overall Study||5
8540828|NCT00245063|21056969|P2|STARTED|Overall Study||13
8540829|NCT00245063|21056970|P1|STARTED|Overall Study||12
8540830|NCT00245050|21056978|P2|NOT COMPLETED|Overall Study||2
8540831|NCT00245050|21056979|P1|NOT COMPLETED|Overall Study||3
8540832|NCT00245050|21056978|P2|COMPLETED|Overall Study||14
8540833|NCT00245050|21056979|P1|COMPLETED|Overall Study||15
8540834|NCT00245050|21056978|P2|STARTED|Overall Study||16
8540835|NCT00245050|21056979|P1|STARTED|Overall Study||18
8540836|NCT00245037|21056987|P1|NOT COMPLETED|Overall Study||17
8540837|NCT00245037|21056987|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
8540838|NCT00245037|21056987|P1|STARTED|Overall Study||147
8540839|NCT00245011|21056997|P1|NOT COMPLETED|Overall Study||1
8540840|NCT00245011|21056997|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
8540841|NCT00245011|21056997|P1|STARTED|Overall Study||11
8540842|NCT00244985|21057006|P1|NOT COMPLETED|Overall Study||0
8540843|NCT00244985|21057006|P1|COMPLETED|Overall Study||42
8540844|NCT00244985|21057006|P1|STARTED|Overall Study||42
8540848|NCT00244881|21057018|P1|NOT COMPLETED|Overall Study||3
8540849|NCT00244881|21057018|P1|COMPLETED|Overall Study||23
8540850|NCT00244881|21057018|P1|STARTED|Overall Study||26
8540851|NCT00244855|21057026|P2|NOT COMPLETED|Overall Study||1
8540852|NCT00244855|21057027|P1|NOT COMPLETED|Overall Study||0
8540853|NCT00244855|21057026|P2|COMPLETED|Overall Study||24
8540854|NCT00244855|21057027|P1|COMPLETED|Overall Study||7
8540855|NCT00244855|21057026|P2|STARTED|Overall Study||25
8540856|NCT00244855|21057027|P1|STARTED|Overall Study||7
8540857|NCT00244764|21057035|P1|NOT COMPLETED|Overall Study||96
8540858|NCT00244764|21057035|P1|COMPLETED|Overall Study||129
8540859|NCT00244764|21057035|P1|STARTED|Overall Study||225
8540860|NCT00244751|21057045|P3|NOT COMPLETED|Overall Study||10
8540861|NCT00244751|21057046|P2|NOT COMPLETED|Overall Study||15
8540862|NCT00244751|21057047|P1|NOT COMPLETED|Overall Study||16
8540863|NCT00244751|21057045|P3|COMPLETED|Overall Study||78
8540864|NCT00244751|21057046|P2|COMPLETED|Overall Study||74
8540865|NCT00244751|21057047|P1|COMPLETED|Overall Study||72
8540866|NCT00244751|21057045|P3|STARTED|Overall Study||88
8540867|NCT00244751|21057046|P2|STARTED|Overall Study||89
8540868|NCT00244751|21057047|P1|STARTED|Overall Study||88
8540869|NCT00244725|21057148|P4|NOT COMPLETED|Overall Study||21
8540870|NCT00244725|21057149|P3|NOT COMPLETED|Overall Study||24
8540871|NCT00244725|21057150|P2|NOT COMPLETED|Overall Study||19
8540872|NCT00244725|21057151|P1|NOT COMPLETED|Overall Study||23
8540873|NCT00244725|21057148|P4|COMPLETED|Overall Study||216
8540874|NCT00244725|21057149|P3|COMPLETED|Overall Study||215
8540875|NCT00244725|21057150|P2|COMPLETED|Overall Study||226
8540876|NCT00244725|21057151|P1|COMPLETED|Overall Study||214
8540877|NCT00244725|21057148|P4|STARTED|Overall Study||237
8540878|NCT00244725|21057149|P3|STARTED|Overall Study||239
8540879|NCT00244725|21057150|P2|STARTED|Overall Study||245
8540880|NCT00244725|21057151|P1|STARTED|Overall Study||237
8540881|NCT00244712|21057207|P2|NOT COMPLETED|Overall Study||124
8540882|NCT00244712|21057208|P1|NOT COMPLETED|Overall Study||109
8540883|NCT00244712|21057207|P2|COMPLETED|Overall Study||221
8540884|NCT00244712|21057208|P1|COMPLETED|Overall Study||234
8540885|NCT00244712|21057207|P2|STARTED|Overall Study||345
8540886|NCT00244712|21057208|P1|STARTED|Overall Study||343
8540887|NCT00244621|21057243|P3|NOT COMPLETED|Open-label Treatment Period||2
8540888|NCT00244621|21057244|P2|NOT COMPLETED|Open-label Treatment Period||1
8540889|NCT00244621|21057245|P1|NOT COMPLETED|Open-label Treatment Period||1
8540890|NCT00244621|21057243|P3|COMPLETED|Open-label Treatment Period||28
8540891|NCT00244621|21057244|P2|COMPLETED|Open-label Treatment Period||28
8540892|NCT00244621|21057245|P1|COMPLETED|Open-label Treatment Period||25
8540893|NCT00244621|21057243|P3|STARTED|Open-label Treatment Period||30
8540894|NCT00244621|21057244|P2|STARTED|Open-label Treatment Period||29
8540895|NCT00244621|21057245|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
8540896|NCT00244621|21057243|P3|NOT COMPLETED|Double-blind Treatment Period||2
8540897|NCT00244621|21057244|P2|NOT COMPLETED|Double-blind Treatment Period||3
8540898|NCT00244621|21057245|P1|NOT COMPLETED|Double-blind Treatment Period||2
8540899|NCT00244621|21057243|P3|COMPLETED|Double-blind Treatment Period||30
8540900|NCT00244621|21057244|P2|COMPLETED|Double-blind Treatment Period||29
8540901|NCT00244621|21057245|P1|COMPLETED|Double-blind Treatment Period||27
8540902|NCT00244621|21057243|P3|STARTED|Double-blind Treatment Period||32
8540903|NCT00244621|21057244|P2|STARTED|Double-blind Treatment Period||32
8540904|NCT00244621|21057245|P1|STARTED|Double-blind Treatment Period||29
8540905|NCT00244374|21057262|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
8540906|NCT00244374|21057263|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
8540907|NCT00244374|21057264|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
8540908|NCT00244374|21057265|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
8540909|NCT00244374|21057266|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
8540910|NCT00244374|21057262|P5|COMPLETED|Vaccine Adherence Cohort||41
8540911|NCT00244374|21057263|P4|COMPLETED|Vaccine Adherence Cohort||36
8540912|NCT00244374|21057264|P3|COMPLETED|Vaccine Adherence Cohort||43
8540913|NCT00244374|21057265|P2|COMPLETED|Vaccine Adherence Cohort||47
8540914|NCT00244374|21057266|P1|COMPLETED|Vaccine Adherence Cohort||0
8540915|NCT00244374|21057262|P5|STARTED|Vaccine Adherence Cohort||41
8540916|NCT00244374|21057263|P4|STARTED|Vaccine Adherence Cohort||36
8540917|NCT00244374|21057264|P3|STARTED|Vaccine Adherence Cohort||43
8540918|NCT00244374|21057265|P2|STARTED|Vaccine Adherence Cohort||47
8540919|NCT00244374|21057266|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
8540920|NCT00244374|21057262|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540921|NCT00244374|21057263|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540922|NCT00244374|21057264|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540923|NCT00244374|21057265|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540924|NCT00244374|21057266|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
8540925|NCT00244374|21057262|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540926|NCT00244374|21057263|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540927|NCT00244374|21057264|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540928|NCT00244374|21057265|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540929|NCT00244374|21057266|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
8540930|NCT00244374|21057262|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540931|NCT00244374|21057263|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540932|NCT00244374|21057264|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540933|NCT00244374|21057265|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540934|NCT00244374|21057266|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
8540935|NCT00244374|21057262|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540936|NCT00244374|21057263|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540937|NCT00244374|21057264|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540938|NCT00244374|21057265|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540939|NCT00244374|21057266|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
8540940|NCT00244374|21057262|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540941|NCT00244374|21057263|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540942|NCT00244374|21057264|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540943|NCT00244374|21057265|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540944|NCT00244374|21057266|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
8540945|NCT00244374|21057262|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540946|NCT00244374|21057263|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540947|NCT00244374|21057264|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540948|NCT00244374|21057265|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540949|NCT00244374|21057266|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
8540950|NCT00244374|21057262|P5|STARTED|Pre-Randomization Cross-sectional Study||0
8540951|NCT00244374|21057263|P4|STARTED|Pre-Randomization Cross-sectional Study||0
8540952|NCT00244374|21057264|P3|STARTED|Pre-Randomization Cross-sectional Study||0
8540953|NCT00244374|21057265|P2|STARTED|Pre-Randomization Cross-sectional Study||0
8540954|NCT00244374|21057266|P1|STARTED|Pre-Randomization Cross-sectional Study||546
8540955|NCT00244140|21057284|P2|NOT COMPLETED|Overall Study||0
8540956|NCT00244140|21057285|P1|NOT COMPLETED|Overall Study||0
8540957|NCT00244140|21057284|P2|COMPLETED|Overall Study||22
8540958|NCT00244140|21057285|P1|COMPLETED|Overall Study||412
8540959|NCT00244140|21057284|P2|STARTED|Overall Study||22
8540960|NCT00244140|21057285|P1|STARTED|Overall Study||412
8540961|NCT00244101|21057300|P3|NOT COMPLETED|Overall Study||0
8540962|NCT00244101|21057301|P2|NOT COMPLETED|Overall Study||0
8540963|NCT00244101|21057302|P1|NOT COMPLETED|Overall Study||0
8540964|NCT00244101|21057300|P3|COMPLETED|Overall Study||216
8540965|NCT00244101|21057301|P2|COMPLETED|Overall Study||223
8540966|NCT00244101|21057302|P1|COMPLETED|Overall Study||209
8540967|NCT00244101|21057300|P3|STARTED|Overall Study||216
8540968|NCT00244101|21057301|P2|STARTED|Overall Study||223
8540969|NCT00244101|21057302|P1|STARTED|Overall Study||209
8540970|NCT00244010|21057312|P2|NOT COMPLETED|Overall Study||0
8540971|NCT00244010|21057313|P1|NOT COMPLETED|Overall Study||0
8540972|NCT00244010|21057312|P2|COMPLETED|Overall Study||2
8540973|NCT00244010|21057313|P1|COMPLETED|Overall Study||2
8540974|NCT00244010|21057312|P2|STARTED|Overall Study||2
8540975|NCT00244010|21057313|P1|STARTED|Overall Study||2
8540976|NCT00243932|21057322|P3|NOT COMPLETED|Stage 2: Efficacy||0
8540977|NCT00243932|21057323|P2|NOT COMPLETED|Stage 2: Efficacy||0
8540978|NCT00243932|21057324|P1|NOT COMPLETED|Stage 2: Efficacy||0
8540979|NCT00243932|21057322|P3|COMPLETED|Stage 2: Efficacy||0
8540980|NCT00243932|21057323|P2|COMPLETED|Stage 2: Efficacy||40
8540981|NCT00243932|21057324|P1|COMPLETED|Stage 2: Efficacy||40
8540982|NCT00243932|21057322|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
8540983|NCT00243932|21057323|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
8540984|NCT00243932|21057324|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
8540985|NCT00243932|21057322|P3|NOT COMPLETED|Stage 1: Dose Selection||0
8540986|NCT00243932|21057323|P2|NOT COMPLETED|Stage 1: Dose Selection||0
8540987|NCT00243932|21057324|P1|NOT COMPLETED|Stage 1: Dose Selection||2
8540988|NCT00243932|21057322|P3|COMPLETED|Stage 1: Dose Selection||35
8540989|NCT00243932|21057323|P2|COMPLETED|Stage 1: Dose Selection||35
8540990|NCT00243932|21057324|P1|COMPLETED|Stage 1: Dose Selection||33
8540991|NCT00243932|21057322|P3|STARTED|Stage 1: Dose Selection||35
8540992|NCT00243932|21057323|P2|STARTED|Stage 1: Dose Selection||35
8540993|NCT00243932|21057324|P1|STARTED|Stage 1: Dose Selection||35
8540994|NCT00243919|21057335|P3|NOT COMPLETED|Overall Study||11
8540995|NCT00243919|21057336|P2|NOT COMPLETED|Overall Study||18
8540996|NCT00243919|21057337|P1|NOT COMPLETED|Overall Study||17
8540997|NCT00243919|21057335|P3|COMPLETED|Overall Study||115
8540998|NCT00243919|21057336|P2|COMPLETED|Overall Study||125
8540999|NCT00243919|21057337|P1|COMPLETED|Overall Study||122
8541000|NCT00243919|21057335|P3|STARTED|Overall Study||126
8541001|NCT00243919|21057336|P2|STARTED|Overall Study||143
8541002|NCT00243919|21057337|P1|STARTED|Overall Study||139
8541003|NCT00243841|21057381|P6|NOT COMPLETED|Overall Study||2
8541004|NCT00243841|21057382|P5|NOT COMPLETED|Overall Study||0
8541005|NCT00243841|21057383|P4|NOT COMPLETED|Overall Study||0
8541006|NCT00243841|21057384|P3|NOT COMPLETED|Overall Study||1
8541007|NCT00243841|21057385|P2|NOT COMPLETED|Overall Study||0
8541008|NCT00243841|21057386|P1|NOT COMPLETED|Overall Study||0
8541009|NCT00243841|21057381|P6|COMPLETED|Overall Study||19
8541010|NCT00243841|21057382|P5|COMPLETED|Overall Study||39
8541011|NCT00243841|21057383|P4|COMPLETED|Overall Study||3
8541012|NCT00243841|21057384|P3|COMPLETED|Overall Study||4
8541013|NCT00243841|21057385|P2|COMPLETED|Overall Study||6
8541014|NCT00243841|21057386|P1|COMPLETED|Overall Study||3
8541015|NCT00243841|21057381|P6|STARTED|Overall Study||21
8541016|NCT00243841|21057382|P5|STARTED|Overall Study||39
8541017|NCT00243841|21057383|P4|STARTED|Overall Study||3
8541018|NCT00243841|21057384|P3|STARTED|Overall Study||5
8541019|NCT00243841|21057385|P2|STARTED|Overall Study||6
8541020|NCT00243841|21057386|P1|STARTED|Overall Study||3
8541021|NCT00243659|21057408|P2|NOT COMPLETED|Overall Study||3
8541022|NCT00243659|21057409|P1|NOT COMPLETED|Overall Study||2
8541023|NCT00243659|21057408|P2|COMPLETED|Overall Study||5
8541024|NCT00243659|21057409|P1|COMPLETED|Overall Study||20
8541025|NCT00243659|21057408|P2|STARTED|Overall Study||8
8541026|NCT00243659|21057409|P1|STARTED|Overall Study||22
8541027|NCT00243503|21057417|P1|NOT COMPLETED|Overall Study||58
8541028|NCT00243503|21057417|P1|COMPLETED|Overall Study||2
8541029|NCT00243503|21057417|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
8541030|NCT00243412|21057434|P2|NOT COMPLETED|Overall Study||11
8541031|NCT00243412|21057435|P1|NOT COMPLETED|Overall Study||10
8541032|NCT00243412|21057434|P2|COMPLETED|Overall Study|Completed Week 104|10
8541033|NCT00243412|21057435|P1|COMPLETED|Overall Study|Completed Week 104|11
8541034|NCT00243412|21057434|P2|Safety Evaluable|Overall Study||20
8541035|NCT00243412|21057435|P1|Safety Evaluable|Overall Study||21
8541036|NCT00243412|21057434|P2|STARTED|Overall Study|Intent to treat|21
8541037|NCT00243412|21057435|P1|STARTED|Overall Study|Intent to treat|21
8541038|NCT00243386|21057461|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
8541039|NCT00243386|21057462|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
8541040|NCT00243386|21057463|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
8541041|NCT00243386|21057461|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
8541042|NCT00243386|21057462|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
8541043|NCT00243386|21057463|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
8541044|NCT00243386|21057461|P3|STARTED|PK-Driven or Standard Prophylaxis||32
8541045|NCT00243386|21057462|P2|STARTED|PK-Driven or Standard Prophylaxis||34
8541046|NCT00243386|21057463|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8541047|NCT00243386|21057461|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8541048|NCT00243386|21057462|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8541049|NCT00243386|21057463|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
8541050|NCT00243386|21057461|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8541051|NCT00243386|21057462|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8541052|NCT00243386|21057463|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
8541053|NCT00243386|21057461|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8541054|NCT00243386|21057462|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8541055|NCT00243386|21057463|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
8541056|NCT00243386|21057461|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
8541057|NCT00243386|21057462|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
8541058|NCT00243386|21057463|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
8541059|NCT00243386|21057461|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
8541060|NCT00243386|21057462|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
8541061|NCT00243386|21057463|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
8541062|NCT00243386|21057461|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8541063|NCT00243386|21057462|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8541064|NCT00243386|21057463|P1|STARTED|On-Demand Regimen (Study Part 1)||73
8541065|NCT00243347|21057528|P1|NOT COMPLETED|Overall Study||19
8541066|NCT00243347|21057528|P1|COMPLETED|Overall Study|Completed study|0
8541067|NCT00243347|21057528|P1|STARTED|Overall Study|Treated|19
8541068|NCT00243269|21057537|P4|NOT COMPLETED|Overall Study||4
8541069|NCT00243269|21057538|P3|NOT COMPLETED|Overall Study||1
8541070|NCT00243269|21057539|P2|NOT COMPLETED|Overall Study||1
8541071|NCT00243269|21057540|P1|NOT COMPLETED|Overall Study||3
8541072|NCT00243269|21057537|P4|COMPLETED|Overall Study||25
8541073|NCT00243269|21057538|P3|COMPLETED|Overall Study||11
8541074|NCT00243269|21057539|P2|COMPLETED|Overall Study||10
8541075|NCT00243269|21057540|P1|COMPLETED|Overall Study||28
8541076|NCT00243269|21057537|P4|STARTED|Overall Study||29
8541077|NCT00243269|21057538|P3|STARTED|Overall Study||12
8541078|NCT00243269|21057539|P2|STARTED|Overall Study||11
8541079|NCT00243269|21057540|P1|STARTED|Overall Study||31
8541080|NCT00243243|21057556|P2|NOT COMPLETED|Overall Study||0
8541081|NCT00243243|21057557|P1|NOT COMPLETED|Overall Study||0
8541082|NCT00243243|21057556|P2|COMPLETED|Overall Study||10
8541083|NCT00243243|21057557|P1|COMPLETED|Overall Study||10
8541084|NCT00243243|21057556|P2|STARTED|Overall Study||10
8541085|NCT00243243|21057557|P1|STARTED|Overall Study||10
8541086|NCT00243191|21057563|P1|NOT COMPLETED|Overall Study||0
8541087|NCT00243191|21057563|P1|COMPLETED|Overall Study||18
8541088|NCT00243191|21057563|P1|STARTED|Overall Study||18
8541089|NCT00243152|21057567|P2|NOT COMPLETED|Overall Study||0
8541090|NCT00243152|21057568|P1|NOT COMPLETED|Overall Study||0
8541091|NCT00243152|21057567|P2|COMPLETED|Overall Study||3
8541092|NCT00243152|21057568|P1|COMPLETED|Overall Study||3
8541093|NCT00243152|21057567|P2|Scan 2: Placebo or Drug|Overall Study||3
8541094|NCT00243152|21057568|P1|Scan 2: Placebo or Drug|Overall Study||3
8541095|NCT00243152|21057567|P2|Scan 1: Drug or Placebo|Overall Study||3
8541096|NCT00243152|21057568|P1|Scan 1: Drug or Placebo|Overall Study||3
8541097|NCT00243152|21057567|P2|STARTED|Overall Study||3
8541098|NCT00243152|21057568|P1|STARTED|Overall Study||3
8541099|NCT00243074|21057575|P1|NOT COMPLETED|Overall Study||54
8541100|NCT00243074|21057575|P1|COMPLETED|Overall Study||0
8541101|NCT00243074|21057575|P1|STARTED|Overall Study||54
8541102|NCT00243061|21057585|P1|NOT COMPLETED|Overall Study||0
8541103|NCT00243061|21057585|P1|COMPLETED|Overall Study||24
8541104|NCT00243061|21057585|P1|STARTED|Overall Study||24
8541105|NCT00243022|21057601|P2|NOT COMPLETED|Overall Study||1
8541106|NCT00243022|21057602|P1|NOT COMPLETED|Overall Study||2
8541107|NCT00243022|21057601|P2|COMPLETED|Overall Study||4
8541108|NCT00243022|21057602|P1|COMPLETED|Overall Study||5
8541109|NCT00243022|21057601|P2|STARTED|Overall Study||5
8541110|NCT00243022|21057602|P1|STARTED|Overall Study||7
8541111|NCT00242710|21057626|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
8541112|NCT00242710|21057627|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
8541113|NCT00242710|21057628|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
8541114|NCT00242710|21057629|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
8541115|NCT00242710|21057626|P4|COMPLETED|Study Extension (up to Year 2)||84
8541116|NCT00242710|21057627|P3|COMPLETED|Study Extension (up to Year 2)||69
8541117|NCT00242710|21057628|P2|COMPLETED|Study Extension (up to Year 2)||148
8541118|NCT00242710|21057629|P1|COMPLETED|Study Extension (up to Year 2)||141
8541119|NCT00242710|21057626|P4|STARTED|Study Extension (up to Year 2)||94
8541120|NCT00242710|21057627|P3|STARTED|Study Extension (up to Year 2)||84
8541121|NCT00242710|21057628|P2|STARTED|Study Extension (up to Year 2)||177
8541122|NCT00242710|21057629|P1|STARTED|Study Extension (up to Year 2)||168
8541123|NCT00242710|21057626|P4|NOT COMPLETED|Period Between Core Study and Extension||49
8541124|NCT00242710|21057627|P3|NOT COMPLETED|Period Between Core Study and Extension||48
8541125|NCT00242710|21057628|P2|NOT COMPLETED|Period Between Core Study and Extension||112
8541126|NCT00242710|21057629|P1|NOT COMPLETED|Period Between Core Study and Extension||119
8541127|NCT00242710|21057626|P4|COMPLETED|Period Between Core Study and Extension||94
8541128|NCT00242710|21057627|P3|COMPLETED|Period Between Core Study and Extension||84
8541129|NCT00242710|21057628|P2|COMPLETED|Period Between Core Study and Extension||177
8541130|NCT00242710|21057629|P1|COMPLETED|Period Between Core Study and Extension||168
8541131|NCT00242710|21057626|P4|STARTED|Period Between Core Study and Extension||143
8541132|NCT00242710|21057627|P3|STARTED|Period Between Core Study and Extension||132
8541133|NCT00242710|21057628|P2|STARTED|Period Between Core Study and Extension||289
8541134|NCT00242710|21057629|P1|STARTED|Period Between Core Study and Extension||287
8541135|NCT00242710|21057626|P4|NOT COMPLETED|Core Study (up to Year 1)||31
8541136|NCT00242710|21057627|P3|NOT COMPLETED|Core Study (up to Year 1)||51
8541137|NCT00242710|21057628|P2|NOT COMPLETED|Core Study (up to Year 1)||64
8541138|NCT00242710|21057629|P1|NOT COMPLETED|Core Study (up to Year 1)||86
8541139|NCT00242710|21057626|P4|COMPLETED|Core Study (up to Year 1)||143
8541140|NCT00242710|21057627|P3|COMPLETED|Core Study (up to Year 1)||132
8541141|NCT00242710|21057628|P2|COMPLETED|Core Study (up to Year 1)||289
8541142|NCT00242710|21057629|P1|COMPLETED|Core Study (up to Year 1)||287
8541143|NCT00242710|21057626|P4|Treated|Core Study (up to Year 1)||172
8541144|NCT00242710|21057627|P3|Treated|Core Study (up to Year 1)||179
8541145|NCT00242710|21057628|P2|Treated|Core Study (up to Year 1)||349
8541146|NCT00242710|21057629|P1|Treated|Core Study (up to Year 1)||361
8541147|NCT00242710|21057626|P4|STARTED|Core Study (up to Year 1)||174
8541148|NCT00242710|21057627|P3|STARTED|Core Study (up to Year 1)||183
8541149|NCT00242710|21057628|P2|STARTED|Core Study (up to Year 1)||353
8541150|NCT00242710|21057629|P1|STARTED|Core Study (up to Year 1)||373
8541151|NCT00242684|21057679|P1|NOT COMPLETED|Overall Study||0
8541152|NCT00242684|21057679|P1|COMPLETED|Overall Study||446
8541153|NCT00242684|21057679|P1|STARTED|Overall Study||446
8541154|NCT00242658|21057686|P2|NOT COMPLETED|Overall Study||19
8541155|NCT00242658|21057687|P1|NOT COMPLETED|Overall Study||22
8541156|NCT00242658|21057686|P2|COMPLETED|Overall Study||188
8541157|NCT00242658|21057687|P1|COMPLETED|Overall Study||165
8541158|NCT00242658|21057686|P2|STARTED|Overall Study||207
8541159|NCT00242658|21057687|P1|STARTED|Overall Study||187
8541160|NCT00242632|21057697|P2|NOT COMPLETED|Overall Study||0
8541161|NCT00242632|21057698|P1|NOT COMPLETED|Overall Study||0
8541162|NCT00242632|21057697|P2|COMPLETED|Overall Study||11
8541163|NCT00242632|21057698|P1|COMPLETED|Overall Study||11
8541164|NCT00242632|21057697|P2|STARTED|Overall Study||11
8541165|NCT00242632|21057698|P1|STARTED|Overall Study||11
8541166|NCT00242619|21057706|P2|NOT COMPLETED|Overall Study||0
8541167|NCT00242619|21057707|P1|NOT COMPLETED|Overall Study||0
8541168|NCT00242619|21057706|P2|COMPLETED|Overall Study||4
8541169|NCT00242619|21057707|P1|COMPLETED|Overall Study||8
8541170|NCT00242619|21057706|P2|STARTED|Overall Study||4
8541171|NCT00242619|21057707|P1|STARTED|Overall Study||8
8541172|NCT00242580|21057718|P3|NOT COMPLETED|Overall Study||14
8541173|NCT00242580|21057719|P2|NOT COMPLETED|Overall Study||12
8541174|NCT00242580|21057720|P1|NOT COMPLETED|Overall Study||10
8541175|NCT00242580|21057718|P3|COMPLETED|Overall Study||24
8541176|NCT00242580|21057719|P2|COMPLETED|Overall Study||29
8541177|NCT00242580|21057720|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
8541178|NCT00242580|21057718|P3|STARTED|Overall Study||38
8541179|NCT00242580|21057719|P2|STARTED|Overall Study||41
8541180|NCT00242580|21057720|P1|STARTED|Overall Study||32
8541181|NCT00242567|21057745|P2|NOT COMPLETED|Overall Study||140
8541182|NCT00242567|21057746|P1|NOT COMPLETED|Overall Study||166
8541183|NCT00242567|21057745|P2|COMPLETED|Overall Study||123
8541184|NCT00242567|21057746|P1|COMPLETED|Overall Study||93
8541185|NCT00242567|21057745|P2|Never Received Study Drug|Overall Study||191
8541186|NCT00242567|21057746|P1|Never Received Study Drug|Overall Study||0
8541187|NCT00242567|21057745|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
8541188|NCT00242567|21057746|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
8541189|NCT00242567|21057745|P2|STARTED|Overall Study||263
8541190|NCT00242567|21057746|P1|STARTED|Overall Study||259
8541191|NCT00242502|21057762|P1|NOT COMPLETED|Overall Study||0
8541192|NCT00242502|21057762|P1|COMPLETED|Overall Study||59
8541193|NCT00242502|21057762|P1|STARTED|Overall Study||59
8541194|NCT00242385|21057766|P2|NOT COMPLETED|Period 2||0
8541195|NCT00242385|21057767|P1|NOT COMPLETED|Period 2||0
8541196|NCT00242385|21057766|P2|COMPLETED|Period 2||11
8541197|NCT00242385|21057767|P1|COMPLETED|Period 2||14
8541198|NCT00242385|21057766|P2|STARTED|Period 2||11
8541199|NCT00242385|21057767|P1|STARTED|Period 2||14
8541200|NCT00242385|21057766|P2|NOT COMPLETED|Period 1||0
8541201|NCT00242385|21057767|P1|NOT COMPLETED|Period 1||0
8541202|NCT00242385|21057766|P2|COMPLETED|Period 1||11
8541203|NCT00242385|21057767|P1|COMPLETED|Period 1||14
8541204|NCT00242385|21057766|P2|STARTED|Period 1||11
8541205|NCT00242385|21057767|P1|STARTED|Period 1||14
8541206|NCT00242216|21057793|P2|NOT COMPLETED|Overall Study||22
8541207|NCT00242216|21057794|P1|NOT COMPLETED|Overall Study||18
8541208|NCT00242216|21057793|P2|COMPLETED|Overall Study||15
8541209|NCT00242216|21057794|P1|COMPLETED|Overall Study||21
8541210|NCT00242216|21057793|P2|STARTED|Overall Study||37
8541211|NCT00242216|21057794|P1|STARTED|Overall Study||39
8541212|NCT00241969|21057804|P2|NOT COMPLETED|Overall Study||0
8541213|NCT00241969|21057805|P1|NOT COMPLETED|Overall Study||0
8541214|NCT00241969|21057804|P2|COMPLETED|Overall Study||42
8541215|NCT00241969|21057805|P1|COMPLETED|Overall Study||36
8541216|NCT00241969|21057804|P2|STARTED|Overall Study||42
8541217|NCT00241969|21057805|P1|STARTED|Overall Study||36
8541218|NCT00241904|21057817|P2|NOT COMPLETED|Overall Study||24
8541219|NCT00241904|21057818|P1|NOT COMPLETED|Overall Study||34
8541220|NCT00241904|21057817|P2|COMPLETED|Overall Study||240
8541221|NCT00241904|21057818|P1|COMPLETED|Overall Study||227
8541222|NCT00241904|21057817|P2|STARTED|Overall Study||264
8541223|NCT00241904|21057818|P1|STARTED|Overall Study||261
8541224|NCT00241839|21057832|P2|NOT COMPLETED|Overall Study||18
8541225|NCT00241839|21057833|P1|NOT COMPLETED|Overall Study||19
8541226|NCT00241839|21057832|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
8541227|NCT00241839|21057833|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
8541228|NCT00241839|21057832|P2|STARTED|Overall Study||71
8541229|NCT00241839|21057833|P1|STARTED|Overall Study||71
8541230|NCT00241644|21057849|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
8541231|NCT00241644|21057850|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
8541232|NCT00241644|21057851|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
8541233|NCT00241644|21057852|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
8541234|NCT00241644|21057849|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
8541235|NCT00241644|21057850|P3|COMPLETED|Second Efficacy Period (Year 2)||682
8541236|NCT00241644|21057851|P2|COMPLETED|Second Efficacy Period (Year 2)||697
8541237|NCT00241644|21057852|P1|COMPLETED|Second Efficacy Period (Year 2)||710
8541238|NCT00241644|21057849|P4|STARTED|Second Efficacy Period (Year 2)||1525
8541239|NCT00241644|21057850|P3|STARTED|Second Efficacy Period (Year 2)||746
8541240|NCT00241644|21057851|P2|STARTED|Second Efficacy Period (Year 2)||754
8541241|NCT00241644|21057852|P1|STARTED|Second Efficacy Period (Year 2)||771
8541242|NCT00241644|21057849|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
8541243|NCT00241644|21057850|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
8541244|NCT00241644|21057851|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
8541245|NCT00241644|21057852|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
8541246|NCT00241644|21057849|P4|COMPLETED|First Efficacy Period (Year 1)||2803
8541247|NCT00241644|21057850|P3|COMPLETED|First Efficacy Period (Year 1)||1392
8541248|NCT00241644|21057851|P2|COMPLETED|First Efficacy Period (Year 1)||1383
8541249|NCT00241644|21057852|P1|COMPLETED|First Efficacy Period (Year 1)||1420
8541250|NCT00241644|21057849|P4|STARTED|First Efficacy Period (Year 1)||3298
8541251|NCT00241644|21057850|P3|STARTED|First Efficacy Period (Year 1)||1641
8541252|NCT00241644|21057851|P2|STARTED|First Efficacy Period (Year 1)||1651
8541253|NCT00241644|21057852|P1|STARTED|First Efficacy Period (Year 1)||1647
8541254|NCT00241631|21057936|P2|NOT COMPLETED|Phase 2 (4 Weeks)||0
8541255|NCT00241631|21057937|P1|NOT COMPLETED|Phase 2 (4 Weeks)||0
8541256|NCT00241631|21057936|P2|COMPLETED|Phase 2 (4 Weeks)||16
8541257|NCT00241631|21057937|P1|COMPLETED|Phase 2 (4 Weeks)||14
8541258|NCT00241631|21057936|P2|STARTED|Phase 2 (4 Weeks)||16
8541259|NCT00241631|21057937|P1|STARTED|Phase 2 (4 Weeks)||14
8541260|NCT00241631|21057936|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
8541261|NCT00241631|21057937|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
8541262|NCT00241631|21057936|P2|COMPLETED|Wash Out (2 Weeks)||16
8541263|NCT00241631|21057937|P1|COMPLETED|Wash Out (2 Weeks)||14
8541264|NCT00241631|21057936|P2|STARTED|Wash Out (2 Weeks)||16
8541265|NCT00241631|21057937|P1|STARTED|Wash Out (2 Weeks)||14
8541266|NCT00241631|21057936|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
8541267|NCT00241631|21057937|P1|NOT COMPLETED|Phase 1 (4 Weeks)||8
8541268|NCT00241631|21057936|P2|COMPLETED|Phase 1 (4 Weeks)||16
8541269|NCT00241631|21057937|P1|COMPLETED|Phase 1 (4 Weeks)||14
8541270|NCT00241631|21057936|P2|STARTED|Phase 1 (4 Weeks)||21
8541271|NCT00241631|21057937|P1|STARTED|Phase 1 (4 Weeks)||22
8541272|NCT00241631|21057936|P2|NOT COMPLETED|Run in (2 Weeks)||3
8541273|NCT00241631|21057937|P1|NOT COMPLETED|Run in (2 Weeks)||3
8541274|NCT00241631|21057936|P2|COMPLETED|Run in (2 Weeks)||21
8541275|NCT00241631|21057937|P1|COMPLETED|Run in (2 Weeks)||22
8541276|NCT00241631|21057936|P2|STARTED|Run in (2 Weeks)||24
8541277|NCT00241631|21057937|P1|STARTED|Run in (2 Weeks)||25
8541278|NCT00241358|21057950|P3|NOT COMPLETED|Overall Study||1
8541279|NCT00241358|21057951|P2|NOT COMPLETED|Overall Study||1
8541280|NCT00241358|21057952|P1|NOT COMPLETED|Overall Study||0
8541281|NCT00241358|21057950|P3|COMPLETED|Overall Study||20
8541282|NCT00241358|21057951|P2|COMPLETED|Overall Study||45
8541283|NCT00241358|21057952|P1|COMPLETED|Overall Study||25
8541284|NCT00241358|21057950|P3|STARTED|Overall Study||21
8541285|NCT00241358|21057951|P2|STARTED|Overall Study||46
8541286|NCT00241358|21057952|P1|STARTED|Overall Study||25
8541287|NCT00241280|21057985|P2|NOT COMPLETED|Overall Study||68
8541288|NCT00241280|21057986|P1|NOT COMPLETED|Overall Study||48
8541289|NCT00241280|21057985|P2|COMPLETED|Overall Study||186
8541290|NCT00241280|21057986|P1|COMPLETED|Overall Study||199
8541291|NCT00241280|21057985|P2|STARTED|Overall Study||254
8541292|NCT00241280|21057986|P1|STARTED|Overall Study||247
8541293|NCT00241176|21057994|P1|NOT COMPLETED|Overall Study||0
8541294|NCT00241176|21057994|P1|COMPLETED|Overall Study||11
8541295|NCT00241176|21057994|P1|STARTED|Overall Study||11
8541296|NCT00240994|21058001|P1|NOT COMPLETED|Overall Study||3
8541297|NCT00240994|21058001|P1|COMPLETED|Overall Study||32
8541298|NCT00240994|21058001|P1|STARTED|Overall Study||35
8541299|NCT00240981|21058007|P2|NOT COMPLETED|Overall Study||33
8541300|NCT00240981|21058008|P1|NOT COMPLETED|Overall Study||38
8541301|NCT00240981|21058007|P2|COMPLETED|Overall Study||70
8541302|NCT00240981|21058008|P1|COMPLETED|Overall Study||68
8541303|NCT00240981|21058007|P2|Intent to Treat Sample|Overall Study||83
8541304|NCT00240981|21058008|P1|Intent to Treat Sample|Overall Study||82
8541305|NCT00240981|21058007|P2|STARTED|Overall Study||103
8541306|NCT00240981|21058008|P1|STARTED|Overall Study||106
8541307|NCT00240539|21058036|P4|NOT COMPLETED|Overall Study||0
8541308|NCT00240539|21058037|P3|NOT COMPLETED|Overall Study||0
8541309|NCT00240539|21058038|P2|NOT COMPLETED|Overall Study||0
8541310|NCT00240539|21058039|P1|NOT COMPLETED|Overall Study||0
8541311|NCT00240539|21058036|P4|COMPLETED|Overall Study||1
8541312|NCT00240539|21058037|P3|COMPLETED|Overall Study||31
8541313|NCT00240539|21058038|P2|COMPLETED|Overall Study||2
8541314|NCT00240539|21058039|P1|COMPLETED|Overall Study||2
8541315|NCT00240539|21058036|P4|STARTED|Overall Study||1
8541316|NCT00240539|21058037|P3|STARTED|Overall Study||31
8541317|NCT00240539|21058038|P2|STARTED|Overall Study||2
8541318|NCT00240539|21058039|P1|STARTED|Overall Study||2
8541319|NCT00240526|21058061|P4|NOT COMPLETED|Year 20||0
8541320|NCT00240526|21058062|P3|NOT COMPLETED|Year 20||0
8541321|NCT00240526|21058063|P2|NOT COMPLETED|Year 20||0
8541322|NCT00240526|21058064|P1|NOT COMPLETED|Year 20||0
8541323|NCT00240526|21058061|P4|COMPLETED|Year 20||20
8541324|NCT00240526|21058062|P3|COMPLETED|Year 20||13
8541325|NCT00240526|21058063|P2|COMPLETED|Year 20||17
8541326|NCT00240526|21058064|P1|COMPLETED|Year 20||19
8541327|NCT00240526|21058061|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
8541328|NCT00240526|21058062|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
8541329|NCT00240526|21058063|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
8541330|NCT00240526|21058064|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
8541331|NCT00240526|21058061|P4|NOT COMPLETED|Year 19||0
8541332|NCT00240526|21058062|P3|NOT COMPLETED|Year 19||0
8541333|NCT00240526|21058063|P2|NOT COMPLETED|Year 19||0
8541334|NCT00240526|21058064|P1|NOT COMPLETED|Year 19||0
8541335|NCT00240526|21058061|P4|COMPLETED|Year 19||18
8541336|NCT00240526|21058062|P3|COMPLETED|Year 19||12
8541337|NCT00240526|21058063|P2|COMPLETED|Year 19||16
8541338|NCT00240526|21058064|P1|COMPLETED|Year 19||17
8541339|NCT00240526|21058061|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
8541340|NCT00240526|21058062|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
8541341|NCT00240526|21058063|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
8541342|NCT00240526|21058064|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
8541343|NCT00240526|21058061|P4|NOT COMPLETED|Year 18||0
8541344|NCT00240526|21058062|P3|NOT COMPLETED|Year 18||0
8541345|NCT00240526|21058063|P2|NOT COMPLETED|Year 18||0
8541346|NCT00240526|21058064|P1|NOT COMPLETED|Year 18||0
8541347|NCT00240526|21058061|P4|COMPLETED|Year 18||20
8541348|NCT00240526|21058062|P3|COMPLETED|Year 18||14
8541349|NCT00240526|21058063|P2|COMPLETED|Year 18||17
8541350|NCT00240526|21058064|P1|COMPLETED|Year 18||16
8541351|NCT00240526|21058061|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
8541352|NCT00240526|21058062|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
8541353|NCT00240526|21058063|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
8541354|NCT00240526|21058064|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
8541355|NCT00240526|21058061|P4|NOT COMPLETED|Year 17||0
8541356|NCT00240526|21058062|P3|NOT COMPLETED|Year 17||0
8541357|NCT00240526|21058063|P2|NOT COMPLETED|Year 17||0
8541358|NCT00240526|21058064|P1|NOT COMPLETED|Year 17||0
8541359|NCT00240526|21058061|P4|COMPLETED|Year 17||20
8541360|NCT00240526|21058062|P3|COMPLETED|Year 17||13
8541361|NCT00240526|21058063|P2|COMPLETED|Year 17||17
8541362|NCT00240526|21058064|P1|COMPLETED|Year 17||19
8541363|NCT00240526|21058061|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
8541364|NCT00240526|21058062|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
8541365|NCT00240526|21058063|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
8541366|NCT00240526|21058064|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
8541367|NCT00240526|21058061|P4|NOT COMPLETED|Year 16||0
8541368|NCT00240526|21058062|P3|NOT COMPLETED|Year 16||0
8541369|NCT00240526|21058063|P2|NOT COMPLETED|Year 16||0
8541370|NCT00240526|21058064|P1|NOT COMPLETED|Year 16||0
8541371|NCT00240526|21058061|P4|COMPLETED|Year 16||22
8541372|NCT00240526|21058062|P3|COMPLETED|Year 16||16
8541373|NCT00240526|21058063|P2|COMPLETED|Year 16||19
8541374|NCT00240526|21058064|P1|COMPLETED|Year 16||17
8541375|NCT00240526|21058061|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
8541463|NCT00239681|21058254|P1|NOT COMPLETED|Overall Study||693
8541376|NCT00240526|21058062|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
8541377|NCT00240526|21058063|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
8541378|NCT00240526|21058064|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
8541379|NCT00240526|21058061|P4|NOT COMPLETED|Year 15||0
8541380|NCT00240526|21058062|P3|NOT COMPLETED|Year 15||0
8541381|NCT00240526|21058063|P2|NOT COMPLETED|Year 15||0
8541382|NCT00240526|21058064|P1|NOT COMPLETED|Year 15||0
8541383|NCT00240526|21058061|P4|COMPLETED|Year 15||21
8541384|NCT00240526|21058062|P3|COMPLETED|Year 15||14
8541385|NCT00240526|21058063|P2|COMPLETED|Year 15||19
8541386|NCT00240526|21058064|P1|COMPLETED|Year 15||19
8541387|NCT00240526|21058061|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
8541388|NCT00240526|21058062|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
8541389|NCT00240526|21058063|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
8541390|NCT00240526|21058064|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
8541391|NCT00240500|21058100|P6|NOT COMPLETED|Overall Study||1
8541392|NCT00240500|21058101|P5|NOT COMPLETED|Overall Study||3
8541393|NCT00240500|21058102|P4|NOT COMPLETED|Overall Study||4
8541394|NCT00240500|21058103|P3|NOT COMPLETED|Overall Study||3
8541395|NCT00240500|21058104|P2|NOT COMPLETED|Overall Study||3
8541396|NCT00240500|21058105|P1|NOT COMPLETED|Overall Study||1
8541397|NCT00240500|21058100|P6|COMPLETED|Overall Study||2
8541398|NCT00240500|21058101|P5|COMPLETED|Overall Study||26
8541399|NCT00240500|21058102|P4|COMPLETED|Overall Study||19
8541400|NCT00240500|21058103|P3|COMPLETED|Overall Study||14
8541401|NCT00240500|21058104|P2|COMPLETED|Overall Study||17
8541402|NCT00240500|21058105|P1|COMPLETED|Overall Study||16
8541403|NCT00240500|21058100|P6|STARTED|Overall Study||3
8541404|NCT00240500|21058101|P5|STARTED|Overall Study||29
8541405|NCT00240500|21058102|P4|STARTED|Overall Study||23
8541406|NCT00240500|21058103|P3|STARTED|Overall Study||17
8541407|NCT00240500|21058104|P2|STARTED|Overall Study||20
8541408|NCT00240500|21058105|P1|STARTED|Overall Study||17
8541409|NCT00240487|21058127|P2|NOT COMPLETED|Overall Study||0
8541410|NCT00240487|21058128|P1|NOT COMPLETED|Overall Study||0
8541411|NCT00240487|21058127|P2|COMPLETED|Overall Study||28
8541412|NCT00240487|21058128|P1|COMPLETED|Overall Study||24
8541413|NCT00240487|21058127|P2|STARTED|Overall Study||28
8541414|NCT00240487|21058128|P1|STARTED|Overall Study||24
8541415|NCT00240331|21058136|P2|NOT COMPLETED|Overall Study||134
8541416|NCT00240331|21058137|P1|NOT COMPLETED|Overall Study||126
8541417|NCT00240331|21058136|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
8541418|NCT00240331|21058137|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
8541419|NCT00240331|21058136|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
8541420|NCT00240331|21058137|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
8541421|NCT00240227|21058155|P1|NOT COMPLETED|Overall Study||0
8541422|NCT00240227|21058155|P1|COMPLETED|Overall Study||8
8541423|NCT00240227|21058155|P1|STARTED|Overall Study||8
8541424|NCT00240162|21058171|P1|NOT COMPLETED|Overall Study||0
8541425|NCT00240162|21058171|P1|COMPLETED|Overall Study||21
8541426|NCT00240162|21058171|P1|STARTED|Overall Study||21
8541427|NCT00240110|21058180|P2|NOT COMPLETED|Overall Study||7
8541428|NCT00240110|21058181|P1|NOT COMPLETED|Overall Study||6
8541429|NCT00240110|21058180|P2|COMPLETED|Overall Study||6
8541430|NCT00240110|21058181|P1|COMPLETED|Overall Study||7
8541431|NCT00240110|21058180|P2|STARTED|Overall Study||13
8541432|NCT00240110|21058181|P1|STARTED|Overall Study||13
8541433|NCT00240097|21058189|P1|NOT COMPLETED|Part II||23
8541434|NCT00240097|21058189|P1|COMPLETED|Part II||3
8541435|NCT00240097|21058189|P1|STARTED|Part II||26
8541436|NCT00240097|21058189|P1|NOT COMPLETED|Part I||4
8541437|NCT00240097|21058189|P1|COMPLETED|Part I||26
8541438|NCT00240097|21058189|P1|STARTED|Part I||30
8541439|NCT00240071|21058199|P1|NOT COMPLETED|Overall Study||3
8541440|NCT00240071|21058199|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
8541441|NCT00240071|21058199|P1|STARTED|Overall Study||30
8541442|NCT00239928|21058204|P1|NOT COMPLETED|Overall Study||10
8541443|NCT00239928|21058204|P1|COMPLETED|Overall Study||51
8541444|NCT00239928|21058204|P1|STARTED|Overall Study||61
8541445|NCT00239837|21058216|P2|NOT COMPLETED|Overall Study||7
8541446|NCT00239837|21058217|P1|NOT COMPLETED|Overall Study||3
8541447|NCT00239837|21058216|P2|COMPLETED|Overall Study|3-year follow-up|45
8541448|NCT00239837|21058217|P1|COMPLETED|Overall Study|3-year follow-up|45
8541449|NCT00239837|21058216|P2|6 Months|Overall Study||50
8541450|NCT00239837|21058217|P1|6 Months|Overall Study||48
8541451|NCT00239837|21058216|P2|STARTED|Overall Study||52
8541452|NCT00239837|21058217|P1|STARTED|Overall Study||48
8541453|NCT00239733|21058237|P1|NOT COMPLETED|Overall Study||0
8541454|NCT00239733|21058237|P1|COMPLETED|Overall Study||6
8541455|NCT00239733|21058237|P1|STARTED|Overall Study||6
8541456|NCT00239720|21058244|P2|NOT COMPLETED|Overall Study||1
8541457|NCT00239720|21058245|P1|NOT COMPLETED|Overall Study||1
8541458|NCT00239720|21058244|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
8541459|NCT00239720|21058245|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
8541460|NCT00239720|21058244|P2|STARTED|Overall Study||1
8541461|NCT00239720|21058245|P1|STARTED|Overall Study||3
8541462|NCT00239681|21058253|P2|NOT COMPLETED|Overall Study||715
8541464|NCT00239681|21058253|P2|COMPLETED|Overall Study||8186
8541465|NCT00239681|21058254|P1|COMPLETED|Overall Study||8208
8541466|NCT00239681|21058253|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
8541467|NCT00239681|21058254|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
8541468|NCT00239681|21058253|P2|STARTED|Overall Study||8901
8541469|NCT00239681|21058254|P1|STARTED|Overall Study||8901
8541470|NCT00239642|21058273|P3|NOT COMPLETED|Overall Study||2
8541471|NCT00239642|21058274|P2|NOT COMPLETED|Overall Study||0
8541472|NCT00239642|21058275|P1|NOT COMPLETED|Overall Study||2
8541473|NCT00239642|21058273|P3|COMPLETED|Overall Study||47
8541474|NCT00239642|21058274|P2|COMPLETED|Overall Study||47
8541475|NCT00239642|21058275|P1|COMPLETED|Overall Study||47
8541476|NCT00239642|21058273|P3|STARTED|Overall Study||49
8541477|NCT00239642|21058274|P2|STARTED|Overall Study||47
8541478|NCT00239642|21058275|P1|STARTED|Overall Study||49
8541479|NCT00239590|21058307|P2|NOT COMPLETED|Completed Study Protocol||2
8541480|NCT00239590|21058308|P1|NOT COMPLETED|Completed Study Protocol||1
8541481|NCT00239590|21058307|P2|COMPLETED|Completed Study Protocol||10
8541482|NCT00239590|21058308|P1|COMPLETED|Completed Study Protocol||13
8541483|NCT00239590|21058307|P2|STARTED|Completed Study Protocol||12
8541484|NCT00239590|21058308|P1|STARTED|Completed Study Protocol||14
8541485|NCT00239590|21058307|P2|NOT COMPLETED|Started Intervention After Randomization||0
8541486|NCT00239590|21058308|P1|NOT COMPLETED|Started Intervention After Randomization||0
8541487|NCT00239590|21058307|P2|COMPLETED|Started Intervention After Randomization||12
8541488|NCT00239590|21058308|P1|COMPLETED|Started Intervention After Randomization||14
8541489|NCT00239590|21058307|P2|STARTED|Started Intervention After Randomization||12
8541490|NCT00239590|21058308|P1|STARTED|Started Intervention After Randomization||14
8541491|NCT00239590|21058307|P2|NOT COMPLETED|Randomized||2
8541492|NCT00239590|21058308|P1|NOT COMPLETED|Randomized||0
8541493|NCT00239590|21058307|P2|COMPLETED|Randomized||12
8541494|NCT00239590|21058308|P1|COMPLETED|Randomized||14
8541495|NCT00239590|21058307|P2|STARTED|Randomized||14
8541496|NCT00239590|21058308|P1|STARTED|Randomized||14
8541497|NCT00239577|21058320|P4|NOT COMPLETED|Booster Phase||0
8541498|NCT00239577|21058321|P3|NOT COMPLETED|Booster Phase||0
8541499|NCT00239577|21058322|P2|NOT COMPLETED|Booster Phase||0
8541500|NCT00239577|21058323|P1|NOT COMPLETED|Booster Phase||0
8541501|NCT00239577|21058320|P4|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
8541502|NCT00239577|21058321|P3|COMPLETED|Booster Phase||12
8541503|NCT00239577|21058322|P2|COMPLETED|Booster Phase||9
8541504|NCT00239577|21058323|P1|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
8541505|NCT00239577|21058320|P4|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
8541506|NCT00239577|21058321|P3|STARTED|Booster Phase||12
8541507|NCT00239577|21058322|P2|STARTED|Booster Phase||9
8541508|NCT00239577|21058323|P1|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
8541509|NCT00239577|21058320|P4|NOT COMPLETED|Primary Phase||0
8541510|NCT00239577|21058321|P3|NOT COMPLETED|Primary Phase||3
8541511|NCT00239577|21058322|P2|NOT COMPLETED|Primary Phase||3
8541512|NCT00239577|21058323|P1|NOT COMPLETED|Primary Phase||5
8541513|NCT00239577|21058320|P4|COMPLETED|Primary Phase||21
8541514|NCT00239577|21058321|P3|COMPLETED|Primary Phase||18
8541515|NCT00239577|21058322|P2|COMPLETED|Primary Phase||19
8541516|NCT00239577|21058323|P1|COMPLETED|Primary Phase||17
8541517|NCT00239577|21058320|P4|STARTED|Primary Phase||21
8541518|NCT00239577|21058321|P3|STARTED|Primary Phase||21
8541519|NCT00239577|21058322|P2|STARTED|Primary Phase||22
8541520|NCT00239577|21058323|P1|STARTED|Primary Phase||22
8541521|NCT00239356|21058427|P2|NOT COMPLETED|Overall Study||9
8541522|NCT00239356|21058428|P1|NOT COMPLETED|Overall Study||39
8541523|NCT00239356|21058427|P2|COMPLETED|Overall Study||11
8541524|NCT00239356|21058428|P1|COMPLETED|Overall Study||58
8541525|NCT00239356|21058427|P2|STARTED|Overall Study||20
8541526|NCT00239356|21058428|P1|STARTED|Overall Study||97
8541527|NCT00239226|21058450|P4|NOT COMPLETED|Overall Study||3
8541528|NCT00239226|21058451|P3|NOT COMPLETED|Overall Study||1
8541529|NCT00239226|21058452|P2|NOT COMPLETED|Overall Study||0
8541530|NCT00239226|21058453|P1|NOT COMPLETED|Overall Study||1
8541531|NCT00239226|21058450|P4|COMPLETED|Overall Study||14
8541532|NCT00239226|21058451|P3|COMPLETED|Overall Study||36
8541533|NCT00239226|21058452|P2|COMPLETED|Overall Study||18
8541534|NCT00239226|21058453|P1|COMPLETED|Overall Study||29
8541535|NCT00239226|21058450|P4|STARTED|Overall Study||17
8541536|NCT00239226|21058451|P3|STARTED|Overall Study||37
8541537|NCT00239226|21058452|P2|STARTED|Overall Study||18
8541538|NCT00239226|21058453|P1|STARTED|Overall Study||30
8541539|NCT00239005|21058465|P2|NOT COMPLETED|Overall Study||12
8541540|NCT00239005|21058466|P1|NOT COMPLETED|Overall Study||12
8541541|NCT00239005|21058465|P2|COMPLETED|Overall Study||53
8541542|NCT00239005|21058466|P1|COMPLETED|Overall Study||57
8541543|NCT00239005|21058465|P2|Intention-to-treat Population (ITT)|Overall Study||61
8541544|NCT00239005|21058466|P1|Intention-to-treat Population (ITT)|Overall Study||68
8541545|NCT00239005|21058465|P2|STARTED|Overall Study||65
8541546|NCT00239005|21058466|P1|STARTED|Overall Study||69
8541547|NCT00238615|21058476|P1|NOT COMPLETED|Overall Study||0
8541548|NCT00238615|21058476|P1|COMPLETED|Overall Study||13
8541549|NCT00238615|21058476|P1|STARTED|Overall Study||13
8541550|NCT00238433|21058482|P1|NOT COMPLETED|Overall Study||3
8541551|NCT00238433|21058482|P1|COMPLETED|Overall Study||34
8541552|NCT00238433|21058482|P1|STARTED|Overall Study||37
8541553|NCT00238420|21058489|P2|NOT COMPLETED|Overall Study||1
8541554|NCT00238420|21058490|P1|NOT COMPLETED|Overall Study||1
8541555|NCT00238420|21058489|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
8541556|NCT00238420|21058490|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
8541557|NCT00238420|21058489|P2|STARTED|Overall Study||48
8541558|NCT00238420|21058490|P1|STARTED|Overall Study||22
8541559|NCT00238355|21058500|P1|NOT COMPLETED|Overall Study||3
8541560|NCT00238355|21058500|P1|COMPLETED|Overall Study||10
8541561|NCT00238355|21058500|P1|STARTED|Overall Study||13
8541562|NCT00238303|21058507|P3|NOT COMPLETED|Overall Study||9
8541563|NCT00238303|21058508|P2|NOT COMPLETED|Overall Study||2
8541564|NCT00238303|21058509|P1|NOT COMPLETED|Overall Study||15
8541565|NCT00238303|21058507|P3|COMPLETED|Overall Study||11
8541566|NCT00238303|21058508|P2|COMPLETED|Overall Study||13
8541567|NCT00238303|21058509|P1|COMPLETED|Overall Study||53
8541568|NCT00238303|21058507|P3|STARTED|Overall Study||20
8541569|NCT00238303|21058508|P2|STARTED|Overall Study||15
8541570|NCT00238303|21058509|P1|STARTED|Overall Study||68
8541571|NCT00238264|21058526|P1|NOT COMPLETED|Overall Study||36
8541572|NCT00238264|21058526|P1|COMPLETED|Overall Study||56
8541573|NCT00238264|21058526|P1|STARTED|Overall Study||92
8541574|NCT00238238|21058539|P3|NOT COMPLETED|Overall Study||0
8541575|NCT00238238|21058540|P2|NOT COMPLETED|Overall Study||3
8541576|NCT00238238|21058541|P1|NOT COMPLETED|Overall Study||0
8541577|NCT00238238|21058539|P3|COMPLETED|Overall Study||46
8541578|NCT00238238|21058540|P2|COMPLETED|Overall Study||45
8541579|NCT00238238|21058541|P1|COMPLETED|Overall Study||3
8541580|NCT00238238|21058539|P3|STARTED|Overall Study||46
8541581|NCT00238238|21058540|P2|STARTED|Overall Study||48
8541582|NCT00238238|21058541|P1|STARTED|Overall Study||3
8541583|NCT00238121|21058554|P2|NOT COMPLETED|Overall Study||2
8541584|NCT00238121|21058555|P1|NOT COMPLETED|Overall Study||3
8541585|NCT00238121|21058554|P2|COMPLETED|Overall Study||14
8541586|NCT00238121|21058555|P1|COMPLETED|Overall Study||37
8541587|NCT00238121|21058554|P2|STARTED|Overall Study||16
8541588|NCT00238121|21058555|P1|STARTED|Overall Study||40
8541589|NCT00238108|21058568|P2|NOT COMPLETED|Overall Study||0
8541590|NCT00238108|21058569|P1|NOT COMPLETED|Overall Study||0
8541591|NCT00238108|21058568|P2|COMPLETED|Overall Study||8
8541592|NCT00238108|21058569|P1|COMPLETED|Overall Study||8
8541593|NCT00238108|21058568|P2|STARTED|Overall Study||8
8541594|NCT00238108|21058569|P1|STARTED|Overall Study||8
8541595|NCT00237809|21058581|P4|NOT COMPLETED|Overall Study||9
8541596|NCT00237809|21058582|P3|NOT COMPLETED|Overall Study||9
8541597|NCT00237809|21058583|P2|NOT COMPLETED|Overall Study||10
8541598|NCT00237809|21058584|P1|NOT COMPLETED|Overall Study||11
8541599|NCT00237809|21058581|P4|COMPLETED|Overall Study||17
8541600|NCT00237809|21058582|P3|COMPLETED|Overall Study||15
8541601|NCT00237809|21058583|P2|COMPLETED|Overall Study||17
8541602|NCT00237809|21058584|P1|COMPLETED|Overall Study||16
8541603|NCT00237809|21058581|P4|STARTED|Overall Study||26
8541604|NCT00237809|21058582|P3|STARTED|Overall Study||24
8541605|NCT00237809|21058583|P2|STARTED|Overall Study||27
8541606|NCT00237809|21058584|P1|STARTED|Overall Study||27
8541607|NCT00237796|21058620|P2|NOT COMPLETED|Overall Study||5
8541608|NCT00237796|21058621|P1|NOT COMPLETED|Overall Study||10
8541609|NCT00237796|21058620|P2|COMPLETED|Overall Study||33
8541610|NCT00237796|21058621|P1|COMPLETED|Overall Study||31
8541611|NCT00237796|21058620|P2|STARTED|Overall Study||38
8541612|NCT00237796|21058621|P1|STARTED|Overall Study||41
8541613|NCT00237770|21058641|P2|NOT COMPLETED|Overall Study||0
8541614|NCT00237770|21058642|P1|NOT COMPLETED|Overall Study||0
8541615|NCT00237770|21058641|P2|COMPLETED|Overall Study||7
8541616|NCT00237770|21058642|P1|COMPLETED|Overall Study||9
8541617|NCT00237770|21058641|P2|STARTED|Overall Study||7
8541618|NCT00237770|21058642|P1|STARTED|Overall Study||9
8541619|NCT00237744|21058655|P3|NOT COMPLETED|Overall Study||0
8541620|NCT00237744|21058656|P2|NOT COMPLETED|Overall Study||1
8541621|NCT00237744|21058657|P1|NOT COMPLETED|Overall Study||3
8541622|NCT00237744|21058655|P3|COMPLETED|Overall Study||18
8541623|NCT00237744|21058656|P2|COMPLETED|Overall Study||10
8541624|NCT00237744|21058657|P1|COMPLETED|Overall Study||8
8541625|NCT00237744|21058655|P3|STARTED|Overall Study||18
8541626|NCT00237744|21058656|P2|STARTED|Overall Study||11
8541627|NCT00237744|21058657|P1|STARTED|Overall Study||11
8541628|NCT00237718|21058670|P2|NOT COMPLETED|Overall Study||41
8541629|NCT00237718|21058671|P1|NOT COMPLETED|Overall Study||46
8541630|NCT00237718|21058670|P2|COMPLETED|Overall Study||124
8541631|NCT00237718|21058671|P1|COMPLETED|Overall Study||114
8541632|NCT00237718|21058670|P2|STARTED|Overall Study||165
8541633|NCT00237718|21058671|P1|STARTED|Overall Study||160
8541634|NCT00237692|21058683|P4|NOT COMPLETED|Overall Study||19
8541635|NCT00237692|21058684|P3|NOT COMPLETED|Overall Study||22
8541636|NCT00237692|21058685|P2|NOT COMPLETED|Overall Study||14
8541637|NCT00237692|21058686|P1|NOT COMPLETED|Overall Study||18
8541638|NCT00237692|21058683|P4|COMPLETED|Overall Study||128
8541639|NCT00237692|21058684|P3|COMPLETED|Overall Study||127
8541640|NCT00237692|21058685|P2|COMPLETED|Overall Study||134
8541641|NCT00237692|21058686|P1|COMPLETED|Overall Study||129
8541642|NCT00237692|21058683|P4|18 Month f/u|Overall Study||122
8541643|NCT00237692|21058684|P3|18 Month f/u|Overall Study||126
8541644|NCT00237692|21058685|P2|18 Month f/u|Overall Study||131
8541645|NCT00237692|21058686|P1|18 Month f/u|Overall Study||124
8541646|NCT00237692|21058683|P4|12 Month f/u|Overall Study||127
8541647|NCT00237692|21058684|P3|12 Month f/u|Overall Study||132
8541648|NCT00237692|21058685|P2|12 Month f/u|Overall Study||127
8541649|NCT00237692|21058686|P1|12 Month f/u|Overall Study||137
8541650|NCT00237692|21058683|P4|6 Month f/u|Overall Study||134
8541651|NCT00237692|21058684|P3|6 Month f/u|Overall Study||135
8541652|NCT00237692|21058685|P2|6 Month f/u|Overall Study||134
8541653|NCT00237692|21058686|P1|6 Month f/u|Overall Study||132
8541654|NCT00237692|21058683|P4|STARTED|Overall Study||147
8541655|NCT00237692|21058684|P3|STARTED|Overall Study||149
8541656|NCT00237692|21058685|P2|STARTED|Overall Study||148
8541657|NCT00237692|21058686|P1|STARTED|Overall Study||147
8541658|NCT00237666|21058716|P1|NOT COMPLETED|Overall Study||6
8541659|NCT00237666|21058716|P1|COMPLETED|Overall Study||24
8541660|NCT00237666|21058716|P1|STARTED|Overall Study||30
8541661|NCT00237458|21058726|P1|NOT COMPLETED|Overall Study||3
8541662|NCT00237458|21058726|P1|COMPLETED|Overall Study||4
8541663|NCT00237458|21058726|P1|STARTED|Overall Study||7
8541664|NCT00237185|21058744|P2|NOT COMPLETED|Extension||19
8541665|NCT00237185|21058745|P1|NOT COMPLETED|Extension||16
8541666|NCT00237185|21058744|P2|COMPLETED|Extension||13
8541667|NCT00237185|21058745|P1|COMPLETED|Extension||8
8541668|NCT00237185|21058744|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
8541669|NCT00237185|21058745|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
8541670|NCT00237185|21058744|P2|NOT COMPLETED|Core||37
8541671|NCT00237185|21058745|P1|NOT COMPLETED|Core||44
8541672|NCT00237185|21058744|P2|COMPLETED|Core||37
8541673|NCT00237185|21058745|P1|COMPLETED|Core||30
8541674|NCT00237185|21058744|P2|Treated Participants|Core||74
8541675|NCT00237185|21058745|P1|Treated Participants|Core||73
8541676|NCT00237185|21058744|P2|STARTED|Core||74
8541677|NCT00237185|21058745|P1|STARTED|Core||74
8541678|NCT00237042|21058776|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
8541679|NCT00237042|21058777|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
8541680|NCT00237042|21058778|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
8541681|NCT00237042|21058776|P3|COMPLETED|Long Term (12 Month) Follow up||48
8541682|NCT00237042|21058777|P2|COMPLETED|Long Term (12 Month) Follow up||46
8541683|NCT00237042|21058778|P1|COMPLETED|Long Term (12 Month) Follow up||48
8541684|NCT00237042|21058776|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
8541685|NCT00237042|21058777|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
8541686|NCT00237042|21058778|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
8541687|NCT00237042|21058776|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
8541688|NCT00237042|21058777|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
8541689|NCT00237042|21058778|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
8541690|NCT00237042|21058776|P3|COMPLETED|Short Term (6 Month) Follow up||46
8541691|NCT00237042|21058777|P2|COMPLETED|Short Term (6 Month) Follow up||47
8541692|NCT00237042|21058778|P1|COMPLETED|Short Term (6 Month) Follow up||50
8541693|NCT00237042|21058776|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
8541694|NCT00237042|21058777|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
8541695|NCT00237042|21058778|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
8541696|NCT00237042|21058776|P3|NOT COMPLETED|Treatment||38
8541697|NCT00237042|21058777|P2|NOT COMPLETED|Treatment||7
8541698|NCT00237042|21058778|P1|NOT COMPLETED|Treatment||6
8541699|NCT00237042|21058776|P3|COMPLETED|Treatment||36
8541700|NCT00237042|21058777|P2|COMPLETED|Treatment||50
8541701|NCT00237042|21058778|P1|COMPLETED|Treatment||54
8541702|NCT00237042|21058776|P3|STARTED|Treatment||74
8541703|NCT00237042|21058777|P2|STARTED|Treatment||57
8541704|NCT00237042|21058778|P1|STARTED|Treatment||60
8541705|NCT00236977|21058797|P2|NOT COMPLETED|Overall Study||19
8541706|NCT00236977|21058798|P1|NOT COMPLETED|Overall Study||21
8541707|NCT00236977|21058797|P2|COMPLETED|Overall Study||72
8541708|NCT00236977|21058798|P1|COMPLETED|Overall Study||70
8541709|NCT00236977|21058797|P2|STARTED|Overall Study||91
8541710|NCT00236977|21058798|P1|STARTED|Overall Study||91
8541711|NCT00236951|21058820|P4|NOT COMPLETED|Overall Study||31
8541712|NCT00236951|21058821|P3|NOT COMPLETED|Overall Study||19
8541713|NCT00236951|21058822|P2|NOT COMPLETED|Overall Study||31
8541714|NCT00236951|21058823|P1|NOT COMPLETED|Overall Study||26
8541715|NCT00236951|21058820|P4|COMPLETED|Overall Study||17
8541716|NCT00236951|21058821|P3|COMPLETED|Overall Study||21
8541717|NCT00236951|21058822|P2|COMPLETED|Overall Study||46
8541718|NCT00236951|21058823|P1|COMPLETED|Overall Study||33
8541719|NCT00236951|21058820|P4|STARTED|Overall Study||48
8541720|NCT00236951|21058821|P3|STARTED|Overall Study||40
8541721|NCT00236951|21058822|P2|STARTED|Overall Study||77
8541722|NCT00236951|21058823|P1|STARTED|Overall Study||59
8541723|NCT00236938|21058835|P2|NOT COMPLETED|Overall Study||20
8541724|NCT00236938|21058836|P1|NOT COMPLETED|Overall Study||13
8541725|NCT00236938|21058835|P2|COMPLETED|Overall Study||26
8541726|NCT00236938|21058836|P1|COMPLETED|Overall Study||62
8541727|NCT00236938|21058835|P2|STARTED|Overall Study||46
8541728|NCT00236938|21058836|P1|STARTED|Overall Study||75
8541729|NCT00236899|21058852|P4|NOT COMPLETED|Overall Study||40
8541730|NCT00236899|21058853|P3|NOT COMPLETED|Overall Study||44
8541731|NCT00236899|21058854|P2|NOT COMPLETED|Overall Study||40
8541732|NCT00236899|21058855|P1|NOT COMPLETED|Overall Study||42
8541733|NCT00236899|21058852|P4|COMPLETED|Overall Study||19
8541734|NCT00236899|21058853|P3|COMPLETED|Overall Study||14
8541735|NCT00236899|21058854|P2|COMPLETED|Overall Study||24
8541736|NCT00236899|21058855|P1|COMPLETED|Overall Study||18
8541737|NCT00236899|21058852|P4|STARTED|Overall Study||59
8541738|NCT00236899|21058853|P3|STARTED|Overall Study||58
8541739|NCT00236899|21058854|P2|STARTED|Overall Study||64
8541740|NCT00236899|21058855|P1|STARTED|Overall Study||60
8541741|NCT00236197|21058887|P2|NOT COMPLETED|Overall Study||14
8541742|NCT00236197|21058888|P1|NOT COMPLETED|Overall Study||5
8541743|NCT00236197|21058887|P2|COMPLETED|Overall Study||293
8541744|NCT00236197|21058888|P1|COMPLETED|Overall Study||307
8541745|NCT00236197|21058887|P2|STARTED|Overall Study||307
8541746|NCT00236197|21058888|P1|STARTED|Overall Study||312
8541747|NCT00236184|21058896|P2|NOT COMPLETED|Overall Study||11
8541748|NCT00236184|21058897|P1|NOT COMPLETED|Overall Study||18
8541749|NCT00236184|21058896|P2|COMPLETED|Overall Study||308
8541750|NCT00236184|21058897|P1|COMPLETED|Overall Study||292
8541751|NCT00236184|21058896|P2|STARTED|Overall Study||319
8541752|NCT00236184|21058897|P1|STARTED|Overall Study||310
8541753|NCT00236080|21058908|P5|NOT COMPLETED|Overall Study||1
8541754|NCT00236080|21058909|P4|NOT COMPLETED|Overall Study||2
8541755|NCT00236080|21058910|P3|NOT COMPLETED|Overall Study||5
8541756|NCT00236080|21058911|P2|NOT COMPLETED|Overall Study||1
8541757|NCT00236080|21058912|P1|NOT COMPLETED|Overall Study||2
8541758|NCT00236080|21058908|P5|COMPLETED|Overall Study||26
8541759|NCT00236080|21058909|P4|COMPLETED|Overall Study||23
8541760|NCT00236080|21058910|P3|COMPLETED|Overall Study||22
8541761|NCT00236080|21058911|P2|COMPLETED|Overall Study||27
8541762|NCT00236080|21058912|P1|COMPLETED|Overall Study||27
8541763|NCT00236080|21058908|P5|STARTED|Overall Study||27
8541764|NCT00236080|21058909|P4|STARTED|Overall Study||25
8541765|NCT00236080|21058910|P3|STARTED|Overall Study||27
8541766|NCT00236080|21058911|P2|STARTED|Overall Study||28
8541767|NCT00236080|21058912|P1|STARTED|Overall Study||29
8541768|NCT00235989|21058933|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
8541769|NCT00235989|21058934|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
8541770|NCT00235989|21058935|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
8541771|NCT00235989|21058936|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
8541772|NCT00235989|21058937|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
8541773|NCT00235989|21058938|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
8541774|NCT00235989|21058933|P6|COMPLETED|Extension Treatment Period (ET)||0
8541775|NCT00235989|21058934|P5|COMPLETED|Extension Treatment Period (ET)||0
8541776|NCT00235989|21058935|P4|COMPLETED|Extension Treatment Period (ET)||14
8541777|NCT00235989|21058936|P3|COMPLETED|Extension Treatment Period (ET)||14
8541778|NCT00235989|21058937|P2|COMPLETED|Extension Treatment Period (ET)||2
8541779|NCT00235989|21058938|P1|COMPLETED|Extension Treatment Period (ET)||8
8541780|NCT00235989|21058933|P6|STARTED|Extension Treatment Period (ET)||0
8541781|NCT00235989|21058934|P5|STARTED|Extension Treatment Period (ET)||0
8541782|NCT00235989|21058935|P4|STARTED|Extension Treatment Period (ET)||20
8541783|NCT00235989|21058936|P3|STARTED|Extension Treatment Period (ET)||19
8541784|NCT00235989|21058937|P2|STARTED|Extension Treatment Period (ET)||6
8541785|NCT00235989|21058938|P1|STARTED|Extension Treatment Period (ET)||16
8541786|NCT00235989|21058933|P6|NOT COMPLETED|Core Treatment Period (CT)||2
8541787|NCT00235989|21058934|P5|NOT COMPLETED|Core Treatment Period (CT)||0
8541788|NCT00235989|21058935|P4|NOT COMPLETED|Core Treatment Period (CT)||0
8541789|NCT00235989|21058936|P3|NOT COMPLETED|Core Treatment Period (CT)||0
8541790|NCT00235989|21058937|P2|NOT COMPLETED|Core Treatment Period (CT)||0
8541791|NCT00235989|21058938|P1|NOT COMPLETED|Core Treatment Period (CT)||0
8541792|NCT00235989|21058933|P6|COMPLETED|Core Treatment Period (CT)||25
8541793|NCT00235989|21058934|P5|COMPLETED|Core Treatment Period (CT)||36
8541794|NCT00235989|21058935|P4|COMPLETED|Core Treatment Period (CT)||0
8541795|NCT00235989|21058936|P3|COMPLETED|Core Treatment Period (CT)||0
8541796|NCT00235989|21058937|P2|COMPLETED|Core Treatment Period (CT)||0
8541797|NCT00235989|21058938|P1|COMPLETED|Core Treatment Period (CT)||0
8541798|NCT00235989|21058933|P6|STARTED|Core Treatment Period (CT)||27
8541799|NCT00235989|21058934|P5|STARTED|Core Treatment Period (CT)||36
8541800|NCT00235989|21058935|P4|STARTED|Core Treatment Period (CT)||0
8541801|NCT00235989|21058936|P3|STARTED|Core Treatment Period (CT)||0
8541802|NCT00235989|21058937|P2|STARTED|Core Treatment Period (CT)||0
8541803|NCT00235989|21058938|P1|STARTED|Core Treatment Period (CT)||0
8541804|NCT00235872|21058952|P1|NOT COMPLETED|Overall Study||147
8541805|NCT00235872|21058952|P1|COMPLETED|Overall Study||162
8541806|NCT00235872|21058952|P1|STARTED|Overall Study||309
8541807|NCT00235833|21058967|P1|NOT COMPLETED|Overall Study||16
8541808|NCT00235833|21058967|P1|COMPLETED|Overall Study||9
8541809|NCT00235833|21058967|P1|STARTED|Overall Study||25
8541810|NCT00235755|21058983|P3|NOT COMPLETED|12-Week Maintenance Phase||31
8541811|NCT00235755|21058984|P2|NOT COMPLETED|12-Week Maintenance Phase||27
8541812|NCT00235755|21058985|P1|NOT COMPLETED|12-Week Maintenance Phase||16
8541813|NCT00235755|21058983|P3|COMPLETED|12-Week Maintenance Phase||122
8541814|NCT00235755|21058984|P2|COMPLETED|12-Week Maintenance Phase||135
8541815|NCT00235755|21058985|P1|COMPLETED|12-Week Maintenance Phase||152
8541816|NCT00235755|21058983|P3|STARTED|12-Week Maintenance Phase||153
8541817|NCT00235755|21058984|P2|STARTED|12-Week Maintenance Phase||162
8541818|NCT00235755|21058985|P1|STARTED|12-Week Maintenance Phase||168
8541819|NCT00235755|21058983|P3|NOT COMPLETED|4-Week Titration Phase||26
8541820|NCT00235755|21058984|P2|NOT COMPLETED|4-Week Titration Phase||19
8541821|NCT00235755|21058985|P1|NOT COMPLETED|4-Week Titration Phase||11
8541822|NCT00235755|21058983|P3|COMPLETED|4-Week Titration Phase||153
8541823|NCT00235755|21058984|P2|COMPLETED|4-Week Titration Phase||162
8541824|NCT00235755|21058985|P1|COMPLETED|4-Week Titration Phase||168
8541825|NCT00235755|21058983|P3|STARTED|4-Week Titration Phase||179
8541826|NCT00235755|21058984|P2|STARTED|4-Week Titration Phase||181
8541827|NCT00235755|21058985|P1|STARTED|4-Week Titration Phase||179
8541828|NCT00235716|21059063|P4|NOT COMPLETED|Overall Study||62
8541829|NCT00235716|21059064|P3|NOT COMPLETED|Overall Study||65
8541830|NCT00235716|21059065|P2|NOT COMPLETED|Overall Study||67
8541831|NCT00235716|21059066|P1|NOT COMPLETED|Overall Study||62
8541832|NCT00235716|21059063|P4|COMPLETED|Overall Study||90
8541833|NCT00235716|21059064|P3|COMPLETED|Overall Study||89
8541834|NCT00235716|21059065|P2|COMPLETED|Overall Study||88
8541835|NCT00235716|21059066|P1|COMPLETED|Overall Study||90
8541836|NCT00235716|21059063|P4|STARTED|Overall Study||152
8541837|NCT00235716|21059064|P3|STARTED|Overall Study||154
8541838|NCT00235716|21059065|P2|STARTED|Overall Study||155
8541839|NCT00235716|21059066|P1|STARTED|Overall Study||152
8541840|NCT00235573|21059100|P1|NOT COMPLETED|Overall Study||0
8541841|NCT00235573|21059100|P1|COMPLETED|Overall Study||21
8541842|NCT00235573|21059100|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
8541843|NCT00235547|21059106|P2|NOT COMPLETED|6 Month Follow-up Survey||68
8541844|NCT00235547|21059107|P1|NOT COMPLETED|6 Month Follow-up Survey||71
8541845|NCT00235547|21059106|P2|COMPLETED|6 Month Follow-up Survey||76
8541846|NCT00235547|21059107|P1|COMPLETED|6 Month Follow-up Survey||83
8541847|NCT00235547|21059106|P2|STARTED|6 Month Follow-up Survey||144
8541848|NCT00235547|21059107|P1|STARTED|6 Month Follow-up Survey||154
8541849|NCT00235547|21059106|P2|NOT COMPLETED|2 Month Follow-up Survey||40
8541850|NCT00235547|21059107|P1|NOT COMPLETED|2 Month Follow-up Survey||46
8541851|NCT00235547|21059106|P2|COMPLETED|2 Month Follow-up Survey||104
8541852|NCT00235547|21059107|P1|COMPLETED|2 Month Follow-up Survey||108
8541853|NCT00235547|21059106|P2|STARTED|2 Month Follow-up Survey||144
8541854|NCT00235547|21059107|P1|STARTED|2 Month Follow-up Survey||154
8541855|NCT00235495|21059117|P2|NOT COMPLETED|Overall Study||68
8541856|NCT00235495|21059118|P1|NOT COMPLETED|Overall Study||68
8541857|NCT00235495|21059117|P2|COMPLETED|Overall Study||351
8541858|NCT00235495|21059118|P1|COMPLETED|Overall Study||354
8541859|NCT00235495|21059117|P2|STARTED|Overall Study||419
8541860|NCT00235495|21059118|P1|STARTED|Overall Study||422
8541861|NCT00235456|21059168|P2|NOT COMPLETED|Overall Study||7
8541862|NCT00235456|21059169|P1|NOT COMPLETED|Overall Study||2
8541863|NCT00235456|21059168|P2|COMPLETED|Overall Study||143
8541864|NCT00235456|21059169|P1|COMPLETED|Overall Study||148
8541865|NCT00235456|21059168|P2|STARTED|Overall Study||150
8541866|NCT00235456|21059169|P1|STARTED|Overall Study||150
8541867|NCT00235443|21059191|P6|NOT COMPLETED|Overall Study||45
8541868|NCT00235443|21059192|P5|NOT COMPLETED|Overall Study||30
8541869|NCT00235443|21059193|P4|NOT COMPLETED|Overall Study||97
8541870|NCT00235443|21059194|P3|NOT COMPLETED|Overall Study||62
8541871|NCT00235443|21059195|P2|NOT COMPLETED|Overall Study||38
8541872|NCT00235443|21059196|P1|NOT COMPLETED|Overall Study||8
8541873|NCT00235443|21059191|P6|COMPLETED|Overall Study||9
8541874|NCT00235443|21059192|P5|COMPLETED|Overall Study||9
8541875|NCT00235443|21059193|P4|COMPLETED|Overall Study||108
8541876|NCT00235443|21059194|P3|COMPLETED|Overall Study||23
8541877|NCT00235443|21059195|P2|COMPLETED|Overall Study||19
8541878|NCT00235443|21059196|P1|COMPLETED|Overall Study||3
8541879|NCT00235443|21059191|P6|STARTED|Overall Study||54
8541880|NCT00235443|21059192|P5|STARTED|Overall Study||39
8541881|NCT00235443|21059193|P4|STARTED|Overall Study||205
8541882|NCT00235443|21059194|P3|STARTED|Overall Study||85
8541883|NCT00235443|21059195|P2|STARTED|Overall Study||57
8541884|NCT00235443|21059196|P1|STARTED|Overall Study||11
8541885|NCT00235391|21059337|P6|NOT COMPLETED|Overall Study||4
8541886|NCT00235391|21059338|P5|NOT COMPLETED|Overall Study||12
8541887|NCT00235391|21059339|P4|NOT COMPLETED|Overall Study||220
8541888|NCT00235391|21059340|P3|NOT COMPLETED|Overall Study||24
8541889|NCT00235391|21059341|P2|NOT COMPLETED|Overall Study||18
8541890|NCT00235391|21059342|P1|NOT COMPLETED|Overall Study||12
8541891|NCT00235391|21059337|P6|COMPLETED|Overall Study||3
8541892|NCT00235391|21059338|P5|COMPLETED|Overall Study||31
8541893|NCT00235391|21059339|P4|COMPLETED|Overall Study||944
8541894|NCT00235391|21059340|P3|COMPLETED|Overall Study||148
8541895|NCT00235391|21059341|P2|COMPLETED|Overall Study||182
8541896|NCT00235391|21059342|P1|COMPLETED|Overall Study||85
8541897|NCT00235391|21059337|P6|Deferasirox Treatment|Overall Study||7
8541898|NCT00235391|21059338|P5|Deferasirox Treatment|Overall Study||43
8541899|NCT00235391|21059339|P4|Deferasirox Treatment|Overall Study||1164
8541900|NCT00235391|21059340|P3|Deferasirox Treatment|Overall Study||172
8541901|NCT00235391|21059341|P2|Deferasirox Treatment|Overall Study||200
8541902|NCT00235391|21059342|P1|Deferasirox Treatment|Overall Study||97
8541903|NCT00235391|21059337|P6|STARTED|Overall Study||7
8541904|NCT00235391|21059338|P5|STARTED|Overall Study||43
8541905|NCT00235391|21059339|P4|STARTED|Overall Study||1164
8541906|NCT00235391|21059340|P3|STARTED|Overall Study||172
8541907|NCT00235391|21059341|P2|STARTED|Overall Study||200
8541908|NCT00235391|21059342|P1|STARTED|Overall Study||97
8541909|NCT00235326|21059359|P2|NOT COMPLETED|Overall Study||1400
8541910|NCT00235326|21059360|P1|NOT COMPLETED|Overall Study||746
8541911|NCT00235326|21059359|P2|COMPLETED|Overall Study||1586
8541912|NCT00235326|21059360|P1|COMPLETED|Overall Study||829
8541913|NCT00235326|21059359|P2|STARTED|Overall Study||2986
8541914|NCT00235326|21059360|P1|STARTED|Overall Study||1575
8541915|NCT00234884|21059364|P1|NOT COMPLETED|Overall Study||1630
8541916|NCT00234884|21059364|P1|COMPLETED|Overall Study||1805
8541917|NCT00234884|21059364|P1|STARTED|Overall Study||3435
8541918|NCT00234832|21059374|P2|NOT COMPLETED|Overall Study||996
8541919|NCT00234832|21059375|P1|NOT COMPLETED|Overall Study||1016
8541920|NCT00234832|21059374|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
8541921|NCT00234832|21059375|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
8541922|NCT00234832|21059374|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
8541923|NCT00234832|21059375|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
8541924|NCT00234533|21059400|P1|NOT COMPLETED|Overall Study||11
8541925|NCT00234533|21059400|P1|COMPLETED|Overall Study||240
8541926|NCT00234533|21059400|P1|STARTED|Overall Study||251
8541927|NCT00234494|21059419|P1|NOT COMPLETED|Overall Study||2
8541928|NCT00234494|21059419|P1|COMPLETED|Overall Study||43
8541929|NCT00234494|21059419|P1|STARTED|Overall Study||45
8541930|NCT00234286|21059426|P1|NOT COMPLETED|Overall Study||0
8541931|NCT00234286|21059426|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
8541932|NCT00234286|21059426|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
8541933|NCT00234104|21059465|P4|NOT COMPLETED|Overall Study||8
8541934|NCT00234104|21059466|P3|NOT COMPLETED|Overall Study||5
8541935|NCT00234104|21059467|P2|NOT COMPLETED|Overall Study||1
8541936|NCT00234104|21059468|P1|NOT COMPLETED|Overall Study||4
8541937|NCT00234104|21059465|P4|COMPLETED|Overall Study||21
8541938|NCT00234104|21059466|P3|COMPLETED|Overall Study||29
8541939|NCT00234104|21059467|P2|COMPLETED|Overall Study||28
8541940|NCT00234104|21059468|P1|COMPLETED|Overall Study||26
8541941|NCT00234104|21059465|P4|STARTED|Overall Study||29
8541942|NCT00234104|21059466|P3|STARTED|Overall Study||34
8541943|NCT00234104|21059467|P2|STARTED|Overall Study||29
8541944|NCT00234104|21059468|P1|STARTED|Overall Study||30
8541945|NCT00234078|21059482|P4|NOT COMPLETED|Overall Study||4
8541946|NCT00234078|21059483|P3|NOT COMPLETED|Overall Study||10
8541947|NCT00234078|21059484|P2|NOT COMPLETED|Overall Study||9
8541948|NCT00234078|21059485|P1|NOT COMPLETED|Overall Study||6
8541949|NCT00234078|21059482|P4|COMPLETED|Overall Study||68
8541950|NCT00234078|21059483|P3|COMPLETED|Overall Study||64
8541951|NCT00234078|21059484|P2|COMPLETED|Overall Study||63
8541952|NCT00234078|21059485|P1|COMPLETED|Overall Study||66
8541953|NCT00234078|21059482|P4|STARTED|Overall Study||72
8541954|NCT00234078|21059483|P3|STARTED|Overall Study||74
8541955|NCT00234078|21059484|P2|STARTED|Overall Study||72
8541956|NCT00234078|21059485|P1|STARTED|Overall Study||72
8541957|NCT00234065|21059509|P2|NOT COMPLETED|Overall Study||356
8541958|NCT00234065|21059510|P1|NOT COMPLETED|Overall Study||475
8541959|NCT00234065|21059509|P2|COMPLETED|Overall Study||1004
8541960|NCT00234065|21059510|P1|COMPLETED|Overall Study||881
8541961|NCT00234065|21059509|P2|STARTED|Overall Study||1360
8541962|NCT00234065|21059510|P1|STARTED|Overall Study||1356
8541963|NCT00234052|21059526|P1|NOT COMPLETED|Follow-up for 5 Years||49
8541964|NCT00234052|21059526|P1|COMPLETED|Follow-up for 5 Years||1
8541965|NCT00234052|21059526|P1|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
8541966|NCT00234052|21059526|P1|NOT COMPLETED|Treatment||21
8541967|NCT00234052|21059526|P1|COMPLETED|Treatment||30
8541968|NCT00234052|21059526|P1|Went Into Maintenance Phase|Treatment||30
8541969|NCT00234052|21059526|P1|Completed 6 Cycles|Treatment||33
8541970|NCT00234052|21059526|P1|Started Treatment|Treatment||50
8541971|NCT00234052|21059526|P1|STARTED|Treatment||51
8541972|NCT00234039|21059536|P1|NOT COMPLETED|Overall Study||50
8541973|NCT00234039|21059536|P1|COMPLETED|Overall Study||8
8541974|NCT00234039|21059536|P1|Eligible and Began Protocol Therapy|Overall Study||47
8541975|NCT00234039|21059536|P1|Eligible|Overall Study||49
8541976|NCT00234039|21059536|P1|STARTED|Overall Study||58
8541977|NCT00233987|21059543|P1|NOT COMPLETED|Overall Study||15
8541978|NCT00233987|21059543|P1|COMPLETED|Overall Study||83
8541979|NCT00233987|21059543|P1|Eligible and Treated|Overall Study||92
8541980|NCT00233987|21059543|P1|Eligible|Overall Study||94
8541981|NCT00233987|21059543|P1|STARTED|Overall Study||98
8541982|NCT00233948|21059552|P6|NOT COMPLETED|Overall Study||0
8541983|NCT00233948|21059553|P5|NOT COMPLETED|Overall Study||0
8541984|NCT00233948|21059554|P4|NOT COMPLETED|Overall Study||0
8541985|NCT00233948|21059555|P3|NOT COMPLETED|Overall Study||0
8541986|NCT00233948|21059556|P2|NOT COMPLETED|Overall Study||0
8541987|NCT00233948|21059557|P1|NOT COMPLETED|Overall Study||1
8541988|NCT00233948|21059552|P6|COMPLETED|Overall Study||12
8541989|NCT00233948|21059553|P5|COMPLETED|Overall Study||4
8541990|NCT00233948|21059554|P4|COMPLETED|Overall Study||3
8541991|NCT00233948|21059555|P3|COMPLETED|Overall Study||3
8541992|NCT00233948|21059556|P2|COMPLETED|Overall Study||3
8541993|NCT00233948|21059557|P1|COMPLETED|Overall Study||3
8541994|NCT00233948|21059552|P6|STARTED|Overall Study||12
8541995|NCT00233948|21059553|P5|STARTED|Overall Study||4
8541996|NCT00233948|21059554|P4|STARTED|Overall Study||3
8541997|NCT00233948|21059555|P3|STARTED|Overall Study||3
8541998|NCT00233948|21059556|P2|STARTED|Overall Study||3
8541999|NCT00233948|21059557|P1|STARTED|Overall Study||4
8542000|NCT00233519|21059574|P2|NOT COMPLETED|Overall Study||1
8542001|NCT00233519|21059575|P1|NOT COMPLETED|Overall Study||1
8542002|NCT00233519|21059574|P2|COMPLETED|Overall Study||9
8542003|NCT00233519|21059575|P1|COMPLETED|Overall Study||6
8542004|NCT00233519|21059574|P2|STARTED|Overall Study||10
8542005|NCT00233519|21059575|P1|STARTED|Overall Study||7
8542006|NCT00233480|21059583|P2|NOT COMPLETED|Overall Study||1
8542007|NCT00233480|21059584|P1|NOT COMPLETED|Overall Study||0
8542008|NCT00233480|21059583|P2|COMPLETED|Overall Study||12
8542009|NCT00233480|21059584|P1|COMPLETED|Overall Study||14
8542010|NCT00233480|21059583|P2|STARTED|Overall Study||13
8542011|NCT00233480|21059584|P1|STARTED|Overall Study||14
8542012|NCT00233454|21059600|P1|NOT COMPLETED|Overall Study||6
8542013|NCT00233454|21059600|P1|COMPLETED|Overall Study||20
8542014|NCT00233454|21059600|P1|2 Months (for Response Rate)|Overall Study||26
8542015|NCT00233454|21059600|P1|STARTED|Overall Study||26
8542016|NCT00233402|21059608|P2|NOT COMPLETED|Overall Study||124
8542017|NCT00233402|21059609|P1|NOT COMPLETED|Overall Study||104
8542018|NCT00233402|21059608|P2|COMPLETED|Overall Study||271
8542019|NCT00233402|21059609|P1|COMPLETED|Overall Study||280
8542020|NCT00233402|21059608|P2|STARTED|Overall Study||395
8542021|NCT00233402|21059609|P1|STARTED|Overall Study||384
8542022|NCT00233324|21059624|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
8542023|NCT00233324|21059625|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
8542024|NCT00233324|21059626|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
8542025|NCT00233324|21059627|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
8542026|NCT00233324|21059624|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
8542027|NCT00233324|21059625|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
8542028|NCT00233324|21059626|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
8542029|NCT00233324|21059627|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
8542030|NCT00233324|21059624|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
8542031|NCT00233324|21059625|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
8542032|NCT00233324|21059626|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
8542033|NCT00233324|21059627|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
8542034|NCT00233324|21059624|P4|NOT COMPLETED|Main Study||47
8542035|NCT00233324|21059625|P3|NOT COMPLETED|Main Study||62
8542036|NCT00233324|21059626|P2|NOT COMPLETED|Main Study||60
8542037|NCT00233324|21059627|P1|NOT COMPLETED|Main Study||68
8542038|NCT00233324|21059624|P4|COMPLETED|Main Study||280
8542039|NCT00233324|21059625|P3|COMPLETED|Main Study||274
8542040|NCT00233324|21059626|P2|COMPLETED|Main Study||275
8542041|NCT00233324|21059627|P1|COMPLETED|Main Study||250
8542042|NCT00233324|21059624|P4|STARTED|Main Study||327
8542043|NCT00233324|21059625|P3|STARTED|Main Study||336
8542044|NCT00233324|21059626|P2|STARTED|Main Study||335
8542045|NCT00233324|21059627|P1|STARTED|Main Study||318
8542046|NCT00233103|21059711|P2|NOT COMPLETED|Overall Study||6
8542047|NCT00233103|21059712|P1|NOT COMPLETED|Overall Study||5
8542048|NCT00233103|21059711|P2|COMPLETED|Overall Study||19
8542049|NCT00233103|21059712|P1|COMPLETED|Overall Study||22
8542050|NCT00233103|21059711|P2|STARTED|Overall Study||25
8542051|NCT00233103|21059712|P1|STARTED|Overall Study||27
8542052|NCT00233090|21059726|P2|NOT COMPLETED|Overall Study||0
8542053|NCT00233090|21059727|P1|NOT COMPLETED|Overall Study||0
8542054|NCT00233090|21059726|P2|COMPLETED|Overall Study||9
8542055|NCT00233090|21059727|P1|COMPLETED|Overall Study||12
8542056|NCT00233090|21059726|P2|STARTED|Overall Study||9
8542057|NCT00233090|21059727|P1|STARTED|Overall Study||12
8542058|NCT00233064|21059749|P2|NOT COMPLETED|Overall Study||12
8542059|NCT00233064|21059750|P1|NOT COMPLETED|Overall Study||14
8542060|NCT00233064|21059749|P2|COMPLETED|Overall Study||190
8542061|NCT00233064|21059750|P1|COMPLETED|Overall Study||197
8542062|NCT00233064|21059749|P2|STARTED|Overall Study||202
8542063|NCT00233064|21059750|P1|STARTED|Overall Study||211
8542064|NCT00232739|21059757|P1|NOT COMPLETED|Overall Study||9
8542065|NCT00232739|21059757|P1|COMPLETED|Overall Study||91
8542066|NCT00232739|21059757|P1|STARTED|Overall Study||100
8542067|NCT00232596|21059776|P2|NOT COMPLETED|12-Week Maintenance Phase||28
8542068|NCT00232596|21059777|P1|NOT COMPLETED|12-Week Maintenance Phase||12
8542069|NCT00232596|21059776|P2|COMPLETED|12-Week Maintenance Phase||97
8542070|NCT00232596|21059777|P1|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
8542071|NCT00232596|21059776|P2|STARTED|12-Week Maintenance Phase||125
8542072|NCT00232596|21059777|P1|STARTED|12-Week Maintenance Phase||138
8542073|NCT00232596|21059776|P2|NOT COMPLETED|6-Week Titration Phase||29
8542074|NCT00232596|21059777|P1|NOT COMPLETED|6-Week Titration Phase||14
8542075|NCT00232596|21059776|P2|COMPLETED|6-Week Titration Phase||125
8542076|NCT00232596|21059777|P1|COMPLETED|6-Week Titration Phase||138
8542077|NCT00232596|21059776|P2|STARTED|6-Week Titration Phase||154
8542078|NCT00232596|21059777|P1|STARTED|6-Week Titration Phase||152
8542079|NCT00232583|21059829|P2|NOT COMPLETED|Overall Study||13
8542080|NCT00232583|21059830|P1|NOT COMPLETED|Overall Study||10
8542081|NCT00232583|21059829|P2|COMPLETED|Overall Study||16
8542082|NCT00232583|21059830|P1|COMPLETED|Overall Study||19
8542083|NCT00232583|21059829|P2|STARTED|Overall Study||29
8542084|NCT00232583|21059830|P1|STARTED|Overall Study||29
8542085|NCT00232557|21059868|P2|NOT COMPLETED|Overall Study||5
8542086|NCT00232557|21059869|P1|NOT COMPLETED|Overall Study||3
8542087|NCT00232557|21059868|P2|COMPLETED|Overall Study||60
8542088|NCT00232557|21059869|P1|COMPLETED|Overall Study||68
8542089|NCT00232557|21059868|P2|STARTED|Overall Study||65
8542090|NCT00232557|21059869|P1|STARTED|Overall Study||71
8542091|NCT00232544|21059879|P2|NOT COMPLETED|Overall Study||15
8542092|NCT00232544|21059880|P1|NOT COMPLETED|Overall Study||20
8542093|NCT00232544|21059879|P2|COMPLETED|Overall Study||111
8542094|NCT00232544|21059880|P1|COMPLETED|Overall Study||104
8542095|NCT00232544|21059879|P2|STARTED|Overall Study||126
8542096|NCT00232544|21059880|P1|STARTED|Overall Study||124
8542097|NCT00232505|21059890|P2|NOT COMPLETED|Overall Study||11
8542098|NCT00232505|21059891|P1|NOT COMPLETED|Overall Study||5
8542099|NCT00232505|21059890|P2|COMPLETED|Overall Study||60
8542100|NCT00232505|21059891|P1|COMPLETED|Overall Study||26
8542101|NCT00232505|21059890|P2|Off Protocol|Overall Study||0
8542102|NCT00232505|21059891|P1|Off Protocol|Overall Study||5
8542103|NCT00232505|21059890|P2|Early Progressors|Overall Study||5
8542104|NCT00232505|21059891|P1|Early Progressors|Overall Study||2
8542105|NCT00232505|21059890|P2|Not Evaluable|Overall Study||6
8542106|NCT00232505|21059891|P1|Not Evaluable|Overall Study||0
8542107|NCT00232505|21059890|P2|STARTED|Overall Study||71
8542108|NCT00232505|21059891|P1|STARTED|Overall Study||31
8542109|NCT00232479|21059904|P1|NOT COMPLETED|Overall Study||0
8542110|NCT00232479|21059904|P1|COMPLETED|Overall Study||44
8542111|NCT00232479|21059904|P1|STARTED|Overall Study||44
8542112|NCT00232180|21059911|P3|NOT COMPLETED|Open Label Phase||148
8542113|NCT00232180|21059912|P2|NOT COMPLETED|Open Label Phase||0
8542114|NCT00232180|21059913|P1|NOT COMPLETED|Open Label Phase||0
8542115|NCT00232180|21059911|P3|COMPLETED|Open Label Phase||1098
8542116|NCT00232180|21059912|P2|COMPLETED|Open Label Phase||0
8542117|NCT00232180|21059913|P1|COMPLETED|Open Label Phase||0
8542118|NCT00232180|21059911|P3|Treated|Open Label Phase||1245
8542119|NCT00232180|21059912|P2|Treated|Open Label Phase||0
8542120|NCT00232180|21059913|P1|Treated|Open Label Phase||0
8542121|NCT00232180|21059911|P3|STARTED|Open Label Phase||1246
8542122|NCT00232180|21059912|P2|STARTED|Open Label Phase||0
8542123|NCT00232180|21059913|P1|STARTED|Open Label Phase||0
8542124|NCT00232180|21059911|P3|NOT COMPLETED|Double-blind (DB) Phase||0
8542125|NCT00232180|21059912|P2|NOT COMPLETED|Double-blind (DB) Phase||605
8542126|NCT00232180|21059913|P1|NOT COMPLETED|Double-blind (DB) Phase||541
8542127|NCT00232180|21059911|P3|COMPLETED|Double-blind (DB) Phase||0
8542128|NCT00232180|21059912|P2|COMPLETED|Double-blind (DB) Phase||771
8542129|NCT00232180|21059913|P1|COMPLETED|Double-blind (DB) Phase||826
8542130|NCT00232180|21059911|P3|Treated|Double-blind (DB) Phase||0
8542131|NCT00232180|21059912|P2|Treated|Double-blind (DB) Phase||1372
8542132|NCT00232180|21059913|P1|Treated|Double-blind (DB) Phase||1364
8542133|NCT00232180|21059911|P3|STARTED|Double-blind (DB) Phase||0
8542134|NCT00232180|21059912|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
8542135|NCT00232180|21059913|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
8542142|NCT00231894|21060029|P2|NOT COMPLETED|Overall Study||1
8542143|NCT00231894|21060030|P1|NOT COMPLETED|Overall Study||1
8542144|NCT00231894|21060029|P2|COMPLETED|Overall Study||24
8542145|NCT00231894|21060030|P1|COMPLETED|Overall Study||30
8542146|NCT00231894|21060029|P2|STARTED|Overall Study||25
8542147|NCT00231894|21060030|P1|STARTED|Overall Study||31
8542148|NCT00231868|21060052|P1|NOT COMPLETED|Overall Study||16
8542149|NCT00231868|21060052|P1|COMPLETED|Overall Study||65
8542150|NCT00231868|21060052|P1|STARTED|Overall Study||81
8542151|NCT00231842|21060056|P1|NOT COMPLETED|Overall Study||11
8542152|NCT00231842|21060056|P1|COMPLETED|Overall Study||19
8542153|NCT00231842|21060056|P1|Completed Full Prescribed Therapy|Overall Study||19
8542154|NCT00231842|21060056|P1|Completed Prescribed RT|Overall Study||27
8542155|NCT00231842|21060056|P1|Completed First 3 Cycles|Overall Study||27
8542156|NCT00231842|21060056|P1|Initiated Therapy|Overall Study||27
8542157|NCT00231842|21060056|P1|STARTED|Overall Study||30
8542158|NCT00231816|21060063|P2|NOT COMPLETED|Overall Study||12
8542159|NCT00231816|21060064|P1|NOT COMPLETED|Overall Study||16
8542160|NCT00231816|21060063|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
8542161|NCT00231816|21060064|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
8542162|NCT00231816|21060063|P2|Vaccinated at Visit 2|Overall Study||371
8542163|NCT00231816|21060064|P1|Vaccinated at Visit 2|Overall Study||369
8542164|NCT00231816|21060063|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
8542165|NCT00231816|21060064|P1|Vaccinated at Visit 1|Overall Study||382
8542166|NCT00231816|21060063|P2|STARTED|Overall Study||381
8542167|NCT00231816|21060064|P1|STARTED|Overall Study||382
8542168|NCT00231777|21060079|P2|NOT COMPLETED|Overall Study||2
8542169|NCT00231777|21060080|P1|NOT COMPLETED|Overall Study||6
8542170|NCT00231777|21060079|P2|COMPLETED|Overall Study||44
8542171|NCT00231777|21060080|P1|COMPLETED|Overall Study||164
8542172|NCT00231777|21060079|P2|STARTED|Overall Study||46
8542173|NCT00231777|21060080|P1|STARTED|Overall Study||170
8542174|NCT00231478|21060094|P2|NOT COMPLETED|Overall Study||6
8542175|NCT00231478|21060095|P1|NOT COMPLETED|Overall Study||8
8542176|NCT00231478|21060094|P2|COMPLETED|Overall Study||78
8542177|NCT00231478|21060095|P1|COMPLETED|Overall Study||79
8542178|NCT00231478|21060094|P2|STARTED|Overall Study||84
8542179|NCT00231478|21060095|P1|STARTED|Overall Study||87
8542180|NCT00231465|21060107|P1|NOT COMPLETED|Overall Study||2
8542181|NCT00231465|21060107|P1|COMPLETED|Overall Study||42
8542182|NCT00231465|21060107|P1|STARTED|Overall Study||44
8542183|NCT00231413|21060120|P7|NOT COMPLETED|Overall Study||4
8542184|NCT00231413|21060121|P6|NOT COMPLETED|Overall Study||5
8542185|NCT00231413|21060122|P5|NOT COMPLETED|Overall Study||3
8542186|NCT00231413|21060123|P4|NOT COMPLETED|Overall Study||3
8542187|NCT00231413|21060124|P3|NOT COMPLETED|Overall Study||7
8542188|NCT00231413|21060125|P2|NOT COMPLETED|Overall Study||5
8542189|NCT00231413|21060126|P1|NOT COMPLETED|Overall Study||8
8542190|NCT00231413|21060120|P7|COMPLETED|Overall Study||46
8542191|NCT00231413|21060121|P6|COMPLETED|Overall Study||45
8542192|NCT00231413|21060122|P5|COMPLETED|Overall Study||45
8542193|NCT00231413|21060123|P4|COMPLETED|Overall Study||45
8542194|NCT00231413|21060124|P3|COMPLETED|Overall Study||42
8542195|NCT00231413|21060125|P2|COMPLETED|Overall Study||45
8542196|NCT00231413|21060126|P1|COMPLETED|Overall Study||80
8542197|NCT00231413|21060120|P7|STARTED|Overall Study||50
8542198|NCT00231413|21060121|P6|STARTED|Overall Study||50
8542199|NCT00231413|21060122|P5|STARTED|Overall Study||48
8542200|NCT00231413|21060123|P4|STARTED|Overall Study||48
8542201|NCT00231413|21060124|P3|STARTED|Overall Study||49
8542202|NCT00231413|21060125|P2|STARTED|Overall Study||50
8542203|NCT00231413|21060126|P1|STARTED|Overall Study||88
8542204|NCT00231309|21060282|P1|NOT COMPLETED|Overall Study||0
8542205|NCT00231309|21060282|P1|COMPLETED|Overall Study||10
8542206|NCT00231309|21060282|P1|STARTED|Overall Study||10
8542207|NCT00231283|21060287|P1|NOT COMPLETED|Overall Study||5
8542208|NCT00231283|21060287|P1|COMPLETED|Overall Study||95
8542209|NCT00231283|21060287|P1|STARTED|Overall Study||100
8542210|NCT00231179|21060296|P2|NOT COMPLETED|Overall Study||24
8542211|NCT00231179|21060297|P1|NOT COMPLETED|Overall Study||24
8542212|NCT00231179|21060296|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
8542213|NCT00231179|21060297|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
8542214|NCT00231179|21060296|P2|STARTED|Overall Study||150
8542215|NCT00231179|21060297|P1|STARTED|Overall Study||152
8542216|NCT00231153|21060313|P2|NOT COMPLETED|Overall Study||188
8542217|NCT00231153|21060314|P1|NOT COMPLETED|Overall Study||217
8542218|NCT00231153|21060313|P2|COMPLETED|Overall Study||720
8542219|NCT00231153|21060314|P1|COMPLETED|Overall Study||690
8542220|NCT00231153|21060313|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
8542221|NCT00231153|21060314|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
8542222|NCT00231114|21060324|P2|NOT COMPLETED|Post-Treatment Period||1
8542223|NCT00231114|21060325|P1|NOT COMPLETED|Post-Treatment Period||8
8542224|NCT00231114|21060324|P2|COMPLETED|Post-Treatment Period||97
8542225|NCT00231114|21060325|P1|COMPLETED|Post-Treatment Period||181
8542226|NCT00231114|21060324|P2|STARTED|Post-Treatment Period||98
8542227|NCT00231114|21060325|P1|STARTED|Post-Treatment Period||189
8542228|NCT00231114|21060324|P2|NOT COMPLETED|Treatment Period||0
8542229|NCT00231114|21060325|P1|NOT COMPLETED|Treatment Period||1
8542230|NCT00231114|21060324|P2|COMPLETED|Treatment Period||98
8542231|NCT00231114|21060325|P1|COMPLETED|Treatment Period||189
8542232|NCT00231114|21060324|P2|STARTED|Treatment Period||98
8542233|NCT00231114|21060325|P1|STARTED|Treatment Period||190
8542234|NCT00231114|21060324|P2|NOT COMPLETED|Randomized||3
8542235|NCT00231114|21060325|P1|NOT COMPLETED|Randomized||6
8542236|NCT00231114|21060324|P2|COMPLETED|Randomized||98
8542237|NCT00231114|21060325|P1|COMPLETED|Randomized||190
8542238|NCT00231114|21060324|P2|STARTED|Randomized||101
8542239|NCT00231114|21060325|P1|STARTED|Randomized||196
8542240|NCT00231062|21060361|P1|NOT COMPLETED|Overall Study||6
8542241|NCT00231062|21060361|P1|COMPLETED|Overall Study||109
8542242|NCT00231062|21060361|P1|STARTED|Overall Study||115
8542243|NCT00230971|21060369|P2|NOT COMPLETED|Baseline Participants||19
8542244|NCT00230971|21060370|P1|NOT COMPLETED|Baseline Participants||22
8542245|NCT00230971|21060369|P2|COMPLETED|Baseline Participants||216
8542246|NCT00230971|21060370|P1|COMPLETED|Baseline Participants||210
8542247|NCT00230971|21060369|P2|STARTED|Baseline Participants||235
8542248|NCT00230971|21060370|P1|STARTED|Baseline Participants||232
8542249|NCT00230971|21060369|P2|NOT COMPLETED|Randomization||3
8542250|NCT00230971|21060370|P1|NOT COMPLETED|Randomization||3
8542251|NCT00230971|21060369|P2|COMPLETED|Randomization||235
8542252|NCT00230971|21060370|P1|COMPLETED|Randomization||232
8542253|NCT00230971|21060369|P2|STARTED|Randomization||238
8542254|NCT00230971|21060370|P1|STARTED|Randomization||235
8542255|NCT00230802|21060384|P2|NOT COMPLETED|Overall Study||0
8542256|NCT00230802|21060385|P1|NOT COMPLETED|Overall Study||0
8542257|NCT00230802|21060384|P2|COMPLETED|Overall Study||23
8542258|NCT00230802|21060385|P1|COMPLETED|Overall Study||25
8542259|NCT00230802|21060384|P2|STARTED|Overall Study||23
8542260|NCT00230802|21060385|P1|STARTED|Overall Study||25
8542261|NCT00230737|21060398|P3|NOT COMPLETED|Overall Study||0
8542262|NCT00230737|21060399|P2|NOT COMPLETED|Overall Study||0
8542263|NCT00230737|21060400|P1|NOT COMPLETED|Overall Study||0
8542264|NCT00230737|21060398|P3|COMPLETED|Overall Study||8
8542265|NCT00230737|21060399|P2|COMPLETED|Overall Study||10
8542266|NCT00230737|21060400|P1|COMPLETED|Overall Study||9
8542267|NCT00230737|21060398|P3|STARTED|Overall Study||8
8542268|NCT00230737|21060399|P2|STARTED|Overall Study||10
8542269|NCT00230737|21060400|P1|STARTED|Overall Study||9
8542270|NCT00230282|21060408|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
8542271|NCT00230282|21060408|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
8542272|NCT00230282|21060408|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
8542273|NCT00230282|21060408|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
8542274|NCT00230282|21060408|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
8542275|NCT00230282|21060408|P1|STARTED|Fludarabine + Cyclophosphamide||25
8542276|NCT00230178|21060416|P3|NOT COMPLETED|Overall Study||7
8542277|NCT00230178|21060417|P2|NOT COMPLETED|Overall Study||7
8542278|NCT00230178|21060418|P1|NOT COMPLETED|Overall Study||4
8542279|NCT00230178|21060416|P3|COMPLETED|Overall Study||86
8542280|NCT00230178|21060417|P2|COMPLETED|Overall Study||86
8542281|NCT00230178|21060418|P1|COMPLETED|Overall Study||90
8542282|NCT00230178|21060416|P3|Treated|Overall Study||91
8542283|NCT00230178|21060417|P2|Treated|Overall Study||92
8542284|NCT00230178|21060418|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
8542285|NCT00230178|21060416|P3|STARTED|Overall Study||93
8542286|NCT00230178|21060417|P2|STARTED|Overall Study||93
8542287|NCT00230178|21060418|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
8542288|NCT00230126|21060434|P2|NOT COMPLETED|Overall Study||1
8542289|NCT00230126|21060435|P1|NOT COMPLETED|Overall Study||2
8542290|NCT00230126|21060434|P2|COMPLETED|Overall Study||27
8542291|NCT00230126|21060435|P1|COMPLETED|Overall Study||28
8542292|NCT00230126|21060434|P2|STARTED|Overall Study||28
8542293|NCT00230126|21060435|P1|STARTED|Overall Study||30
8542294|NCT00230100|21060447|P2|NOT COMPLETED|Overall Study||0
8542295|NCT00230100|21060448|P1|NOT COMPLETED|Overall Study||0
8542296|NCT00230100|21060447|P2|COMPLETED|Overall Study||17
8542297|NCT00230100|21060448|P1|COMPLETED|Overall Study||29
8542298|NCT00230100|21060447|P2|STARTED|Overall Study||17
8542299|NCT00230100|21060448|P1|STARTED|Overall Study||29
8542300|NCT00230048|21060470|P2|NOT COMPLETED|Overall Study||18
8542301|NCT00230048|21060471|P1|NOT COMPLETED|Overall Study||13
8542302|NCT00230048|21060470|P2|COMPLETED|Overall Study||37
8542303|NCT00230048|21060471|P1|COMPLETED|Overall Study||39
8542304|NCT00230048|21060470|P2|Completed Intervention/Control Session|Overall Study||55
8542305|NCT00230048|21060471|P1|Completed Intervention/Control Session|Overall Study||52
8542306|NCT00230048|21060470|P2|STARTED|Overall Study||55
8542307|NCT00230048|21060471|P1|STARTED|Overall Study||52
8542308|NCT00230022|21060481|P2|NOT COMPLETED|Overall Study||0
8542309|NCT00230022|21060482|P1|NOT COMPLETED|Overall Study||0
8542310|NCT00230022|21060481|P2|COMPLETED|Overall Study||15
8542311|NCT00230022|21060482|P1|COMPLETED|Overall Study||15
8542312|NCT00230022|21060481|P2|STARTED|Overall Study||15
8542313|NCT00230022|21060482|P1|STARTED|Overall Study||15
8542314|NCT00230009|21060490|P2|NOT COMPLETED|Follow-up||26
8542315|NCT00230009|21060491|P1|NOT COMPLETED|Follow-up||31
8542316|NCT00230009|21060490|P2|COMPLETED|Follow-up||24
8542317|NCT00230009|21060491|P1|COMPLETED|Follow-up||19
8542318|NCT00230009|21060490|P2|STARTED|Follow-up||50
8542319|NCT00230009|21060491|P1|STARTED|Follow-up||50
8542320|NCT00230009|21060490|P2|NOT COMPLETED|Single Session Intervention/Control||0
8542321|NCT00230009|21060491|P1|NOT COMPLETED|Single Session Intervention/Control||0
8542322|NCT00230009|21060490|P2|COMPLETED|Single Session Intervention/Control||50
8542323|NCT00230009|21060491|P1|COMPLETED|Single Session Intervention/Control||50
8542324|NCT00230009|21060490|P2|STARTED|Single Session Intervention/Control||50
8542325|NCT00230009|21060491|P1|STARTED|Single Session Intervention/Control||50
8542326|NCT00229970|21060508|P3|NOT COMPLETED|Overall Study||0
8542327|NCT00229970|21060509|P2|NOT COMPLETED|Overall Study||0
8542328|NCT00229970|21060510|P1|NOT COMPLETED|Overall Study||0
8542329|NCT00229970|21060508|P3|COMPLETED|Overall Study||75
8542330|NCT00229970|21060509|P2|COMPLETED|Overall Study||72
8542331|NCT00229970|21060510|P1|COMPLETED|Overall Study||78
8542332|NCT00229970|21060508|P3|STARTED|Overall Study||75
8542333|NCT00229970|21060509|P2|STARTED|Overall Study||72
8542334|NCT00229970|21060510|P1|STARTED|Overall Study||78
8542335|NCT00229957|21060520|P2|NOT COMPLETED|Overall Study||12
8542336|NCT00229957|21060521|P1|NOT COMPLETED|Overall Study||20
8542337|NCT00229957|21060520|P2|COMPLETED|Overall Study||139
8542338|NCT00229957|21060521|P1|COMPLETED|Overall Study||132
8542339|NCT00229957|21060520|P2|STARTED|Overall Study||151
8542340|NCT00229957|21060521|P1|STARTED|Overall Study||152
8542341|NCT00229931|21060529|P2|NOT COMPLETED|Overall Study||2
8542342|NCT00229931|21060530|P1|NOT COMPLETED|Overall Study||4
8542343|NCT00229931|21060529|P2|COMPLETED|Overall Study||3
8542344|NCT00229931|21060530|P1|COMPLETED|Overall Study||2
8542345|NCT00229931|21060529|P2|STARTED|Overall Study||5
8542346|NCT00229931|21060530|P1|STARTED|Overall Study||6
8542347|NCT00229723|21060545|P7|NOT COMPLETED|Maintenance Phase||10
8542348|NCT00229723|21060546|P6|NOT COMPLETED|Maintenance Phase||19
8542349|NCT00229723|21060547|P5|NOT COMPLETED|Maintenance Phase||15
8542350|NCT00229723|21060548|P4|NOT COMPLETED|Maintenance Phase||17
8542351|NCT00229723|21060549|P3|NOT COMPLETED|Maintenance Phase||9
8542352|NCT00229723|21060550|P2|NOT COMPLETED|Maintenance Phase||14
8542353|NCT00229723|21060551|P1|NOT COMPLETED|Maintenance Phase||25
8542354|NCT00229723|21060545|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
8542355|NCT00229723|21060546|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
8542356|NCT00229723|21060547|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
8542357|NCT00229723|21060548|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
8542358|NCT00229723|21060549|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
8542359|NCT00229723|21060550|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
8542360|NCT00229723|21060551|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
8542361|NCT00229723|21060545|P7|STARTED|Maintenance Phase||19
8542362|NCT00229723|21060546|P6|STARTED|Maintenance Phase||31
8542363|NCT00229723|21060547|P5|STARTED|Maintenance Phase||22
8542364|NCT00229723|21060548|P4|STARTED|Maintenance Phase||26
8542365|NCT00229723|21060549|P3|STARTED|Maintenance Phase||25
8542366|NCT00229723|21060550|P2|STARTED|Maintenance Phase||19
8542367|NCT00229723|21060551|P1|STARTED|Maintenance Phase||50
8542368|NCT00229723|21060545|P7|NOT COMPLETED|Concomitant Phase||3
8542369|NCT00229723|21060546|P6|NOT COMPLETED|Concomitant Phase||3
8542370|NCT00229723|21060547|P5|NOT COMPLETED|Concomitant Phase||2
8542371|NCT00229723|21060548|P4|NOT COMPLETED|Concomitant Phase||5
8542372|NCT00229723|21060549|P3|NOT COMPLETED|Concomitant Phase||6
8542373|NCT00229723|21060550|P2|NOT COMPLETED|Concomitant Phase||5
8542374|NCT00229723|21060551|P1|NOT COMPLETED|Concomitant Phase||10
8542375|NCT00229723|21060545|P7|COMPLETED|Concomitant Phase||19
8542376|NCT00229723|21060546|P6|COMPLETED|Concomitant Phase||31
8542377|NCT00229723|21060547|P5|COMPLETED|Concomitant Phase||22
8542378|NCT00229723|21060548|P4|COMPLETED|Concomitant Phase||26
8542379|NCT00229723|21060549|P3|COMPLETED|Concomitant Phase||25
8542380|NCT00229723|21060550|P2|COMPLETED|Concomitant Phase||19
8542381|NCT00229723|21060551|P1|COMPLETED|Concomitant Phase||50
8542382|NCT00229723|21060545|P7|STARTED|Concomitant Phase|Received randomized treatment|22
8542383|NCT00229723|21060546|P6|STARTED|Concomitant Phase|Received randomized treatment|34
8542384|NCT00229723|21060547|P5|STARTED|Concomitant Phase|Received randomized treatment|24
8542385|NCT00229723|21060548|P4|STARTED|Concomitant Phase|Received randomized treatment|31
8542386|NCT00229723|21060549|P3|STARTED|Concomitant Phase|Received randomized treatment|31
8542387|NCT00229723|21060550|P2|STARTED|Concomitant Phase|Received randomized treatment|24
8542388|NCT00229723|21060551|P1|STARTED|Concomitant Phase|Received randomized treatment|60
8542389|NCT00229658|21060604|P2|NOT COMPLETED|Overall Study||167
8542390|NCT00229658|21060605|P1|NOT COMPLETED|Overall Study||225
8542391|NCT00229658|21060604|P2|COMPLETED|Overall Study||364
8542392|NCT00229658|21060605|P1|COMPLETED|Overall Study||541
8542393|NCT00229658|21060604|P2|STARTED|Overall Study||531
8542394|NCT00229658|21060605|P1|STARTED|Overall Study||766
8542395|NCT00229619|21060633|P1|NOT COMPLETED|Overall Study||0
8542396|NCT00229619|21060633|P1|COMPLETED|Overall Study||11
8542397|NCT00229619|21060633|P1|STARTED|Overall Study||11
8542398|NCT00229203|21060641|P2|NOT COMPLETED|Overall Study||19
8542399|NCT00229203|21060642|P1|NOT COMPLETED|Overall Study||32
8542400|NCT00229203|21060641|P2|COMPLETED|Overall Study||0
8542401|NCT00229203|21060642|P1|COMPLETED|Overall Study||0
8542402|NCT00229203|21060641|P2|STARTED|Overall Study||19
8542403|NCT00229203|21060642|P1|STARTED|Overall Study||32
8542404|NCT00228943|21060654|P1|NOT COMPLETED|Week 2||1
8542405|NCT00228943|21060654|P1|COMPLETED|Week 2||27
8542406|NCT00228943|21060654|P1|STARTED|Week 2||28
8542407|NCT00228943|21060654|P1|NOT COMPLETED|Week 1||0
8542408|NCT00228943|21060654|P1|COMPLETED|Week 1||28
8542409|NCT00228943|21060654|P1|STARTED|Week 1||28
8542410|NCT00228917|21060670|P8|NOT COMPLETED|Overall Study||0
8542411|NCT00228917|21060671|P7|NOT COMPLETED|Overall Study||0
8542412|NCT00228917|21060672|P6|NOT COMPLETED|Overall Study||2
8542413|NCT00228917|21060673|P5|NOT COMPLETED|Overall Study||0
8542414|NCT00228917|21060674|P4|NOT COMPLETED|Overall Study||0
8542415|NCT00228917|21060675|P3|NOT COMPLETED|Overall Study||0
8542416|NCT00228917|21060676|P2|NOT COMPLETED|Overall Study||0
8542417|NCT00228917|21060677|P1|NOT COMPLETED|Overall Study||0
8542418|NCT00228917|21060670|P8|COMPLETED|Overall Study||33
8542419|NCT00228917|21060671|P7|COMPLETED|Overall Study||69
8542420|NCT00228917|21060672|P6|COMPLETED|Overall Study||102
8542421|NCT00228917|21060673|P5|COMPLETED|Overall Study||205
8542422|NCT00228917|21060674|P4|COMPLETED|Overall Study||33
8542423|NCT00228917|21060675|P3|COMPLETED|Overall Study||65
8542424|NCT00228917|21060676|P2|COMPLETED|Overall Study||96
8542425|NCT00228917|21060677|P1|COMPLETED|Overall Study||193
8542426|NCT00228917|21060670|P8|STARTED|Overall Study||33
8542427|NCT00228917|21060671|P7|STARTED|Overall Study||69
8542428|NCT00228917|21060672|P6|STARTED|Overall Study||104
8542429|NCT00228917|21060673|P5|STARTED|Overall Study||205
8542430|NCT00228917|21060674|P4|STARTED|Overall Study||33
8542431|NCT00228917|21060675|P3|STARTED|Overall Study||65
8542432|NCT00228917|21060676|P2|STARTED|Overall Study||96
8542433|NCT00228917|21060677|P1|STARTED|Overall Study||193
8542434|NCT00228813|21060723|P1|NOT COMPLETED|Overall Study||4
8542435|NCT00228813|21060723|P1|COMPLETED|Overall Study||4
8542436|NCT00228813|21060723|P1|STARTED|Overall Study||8
8542437|NCT00228566|21060729|P1|NOT COMPLETED|Overall Study||71
8542438|NCT00228566|21060729|P1|COMPLETED|Overall Study||176
8542439|NCT00228566|21060729|P1|STARTED|Overall Study||247
8542440|NCT00228553|21060733|P1|NOT COMPLETED|Overall Study||430
8542441|NCT00228553|21060733|P1|COMPLETED|Overall Study||313
8542442|NCT00228553|21060733|P1|STARTED|Overall Study||743
8542443|NCT00228384|21060739|P2|NOT COMPLETED|Overall Study||29
8542444|NCT00228384|21060740|P1|NOT COMPLETED|Overall Study||29
8542445|NCT00228384|21060739|P2|COMPLETED|Overall Study||47
8542446|NCT00228384|21060740|P1|COMPLETED|Overall Study||43
8542447|NCT00228384|21060739|P2|Three Year Follow-up (Final)|Overall Study||47
8542448|NCT00228384|21060740|P1|Three Year Follow-up (Final)|Overall Study||43
8542449|NCT00228384|21060739|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
8542450|NCT00228384|21060740|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
8542451|NCT00228384|21060739|P2|Baseline|Overall Study||76
8542452|NCT00228384|21060740|P1|Baseline|Overall Study||72
8542453|NCT00228384|21060739|P2|STARTED|Overall Study||76
8542454|NCT00228384|21060740|P1|STARTED|Overall Study||72
8542455|NCT00227994|21060780|P2|NOT COMPLETED|Overall Study||7
8542456|NCT00227994|21060781|P1|NOT COMPLETED|Overall Study||7
8542457|NCT00227994|21060780|P2|COMPLETED|Overall Study||13
8542458|NCT00227994|21060781|P1|COMPLETED|Overall Study||13
8542459|NCT00227994|21060780|P2|STARTED|Overall Study||20
8542460|NCT00227994|21060781|P1|STARTED|Overall Study||20
8542461|NCT00227903|21060791|P2|NOT COMPLETED|Overall Study||10
8542462|NCT00227903|21060792|P1|NOT COMPLETED|Overall Study||5
8542463|NCT00227903|21060791|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
8542464|NCT00227903|21060792|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
8542465|NCT00227903|21060791|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
8542466|NCT00227903|21060792|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
8542467|NCT00227903|21060791|P2|STARTED|Overall Study||92
8542468|NCT00227903|21060792|P1|STARTED|Overall Study||91
8542469|NCT00227877|21060856|P4|NOT COMPLETED|12-months Follow-up||26
8542470|NCT00227877|21060857|P3|NOT COMPLETED|12-months Follow-up||31
8542471|NCT00227877|21060858|P2|NOT COMPLETED|12-months Follow-up||263
8542472|NCT00227877|21060859|P1|NOT COMPLETED|12-months Follow-up||310
8542473|NCT00227877|21060856|P4|COMPLETED|12-months Follow-up||266
8542474|NCT00227877|21060857|P3|COMPLETED|12-months Follow-up||266
8542475|NCT00227877|21060858|P2|COMPLETED|12-months Follow-up||765
8542476|NCT00227877|21060859|P1|COMPLETED|12-months Follow-up||758
8542477|NCT00227877|21060856|P4|STARTED|12-months Follow-up||292
8542478|NCT00227877|21060857|P3|STARTED|12-months Follow-up||297
8542479|NCT00227877|21060858|P2|STARTED|12-months Follow-up||1028
8542480|NCT00227877|21060859|P1|STARTED|12-months Follow-up||1068
8542481|NCT00227877|21060856|P4|NOT COMPLETED|3-months Follow-up||21
8542482|NCT00227877|21060857|P3|NOT COMPLETED|3-months Follow-up||52
8542483|NCT00227877|21060858|P2|NOT COMPLETED|3-months Follow-up||267
8542484|NCT00227877|21060859|P1|NOT COMPLETED|3-months Follow-up||313
8542485|NCT00227877|21060856|P4|COMPLETED|3-months Follow-up||271
8542486|NCT00227877|21060857|P3|COMPLETED|3-months Follow-up||245
8542487|NCT00227877|21060858|P2|COMPLETED|3-months Follow-up||761
8542488|NCT00227877|21060859|P1|COMPLETED|3-months Follow-up||755
8542489|NCT00227877|21060856|P4|STARTED|3-months Follow-up||292
8542490|NCT00227877|21060857|P3|STARTED|3-months Follow-up||297
8542491|NCT00227877|21060858|P2|STARTED|3-months Follow-up||1028
8542492|NCT00227877|21060859|P1|STARTED|3-months Follow-up||1068
8542493|NCT00227877|21060856|P4|NOT COMPLETED|Post-visit Checklist||0
8542494|NCT00227877|21060857|P3|NOT COMPLETED|Post-visit Checklist||1
8542495|NCT00227877|21060858|P2|NOT COMPLETED|Post-visit Checklist||13
8542496|NCT00227877|21060859|P1|NOT COMPLETED|Post-visit Checklist||24
8542497|NCT00227877|21060856|P4|COMPLETED|Post-visit Checklist||292
8542498|NCT00227877|21060857|P3|COMPLETED|Post-visit Checklist||296
8542499|NCT00227877|21060858|P2|COMPLETED|Post-visit Checklist||1015
8542500|NCT00227877|21060859|P1|COMPLETED|Post-visit Checklist||1044
8542501|NCT00227877|21060856|P4|STARTED|Post-visit Checklist||292
8542502|NCT00227877|21060857|P3|STARTED|Post-visit Checklist||297
8542503|NCT00227877|21060858|P2|STARTED|Post-visit Checklist||1028
8542504|NCT00227877|21060859|P1|STARTED|Post-visit Checklist||1068
8542505|NCT00227877|21060856|P4|NOT COMPLETED|Pre-visit Assessment||0
8542506|NCT00227877|21060857|P3|NOT COMPLETED|Pre-visit Assessment||0
8542507|NCT00227877|21060858|P2|NOT COMPLETED|Pre-visit Assessment||3
8542508|NCT00227877|21060859|P1|NOT COMPLETED|Pre-visit Assessment||7
8542509|NCT00227877|21060856|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
8542510|NCT00227877|21060857|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
8542511|NCT00227877|21060858|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
8542512|NCT00227877|21060859|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
8542513|NCT00227877|21060856|P4|STARTED|Pre-visit Assessment||292
8542514|NCT00227877|21060857|P3|STARTED|Pre-visit Assessment||297
8542515|NCT00227877|21060858|P2|STARTED|Pre-visit Assessment||1031
8542516|NCT00227877|21060859|P1|STARTED|Pre-visit Assessment||1075
8542517|NCT00227760|21060889|P1|NOT COMPLETED|Overall Study||0
8542518|NCT00227760|21060889|P1|COMPLETED|Overall Study||44
8542519|NCT00227760|21060889|P1|STARTED|Overall Study||44
8542520|NCT00227721|21060895|P1|NOT COMPLETED|Overall Study||1
8542521|NCT00227721|21060895|P1|COMPLETED|Overall Study||29
8542522|NCT00227721|21060895|P1|STARTED|Overall Study||30
8542523|NCT00227617|21060900|P3|NOT COMPLETED|Stage 2||0
8542524|NCT00227617|21060901|P2|NOT COMPLETED|Stage 2||0
8542525|NCT00227617|21060902|P1|NOT COMPLETED|Stage 2||0
8542526|NCT00227617|21060900|P3|COMPLETED|Stage 2||0
8542527|NCT00227617|21060901|P2|COMPLETED|Stage 2||0
8542528|NCT00227617|21060902|P1|COMPLETED|Stage 2||0
8542529|NCT00227617|21060900|P3|STARTED|Stage 2||0
8542530|NCT00227617|21060901|P2|STARTED|Stage 2||0
8542531|NCT00227617|21060902|P1|STARTED|Stage 2||0
8542532|NCT00227617|21060900|P3|NOT COMPLETED|Stage 1||0
8542533|NCT00227617|21060901|P2|NOT COMPLETED|Stage 1||0
8542534|NCT00227617|21060902|P1|NOT COMPLETED|Stage 1||0
8542535|NCT00227617|21060900|P3|COMPLETED|Stage 1||2
8542536|NCT00227617|21060901|P2|COMPLETED|Stage 1||12
8542537|NCT00227617|21060902|P1|COMPLETED|Stage 1||22
8542538|NCT00227617|21060900|P3|STARTED|Stage 1||2
8542539|NCT00227617|21060901|P2|STARTED|Stage 1||12
8542540|NCT00227617|21060902|P1|STARTED|Stage 1||22
8542541|NCT00227591|21060918|P1|NOT COMPLETED|Overall Study||1
8542542|NCT00227591|21060918|P1|COMPLETED|Overall Study||47
8542543|NCT00227591|21060918|P1|Began Treatment|Overall Study||47
8542544|NCT00227591|21060918|P1|STARTED|Overall Study|48 pts registered to the study|48
8542545|NCT00227539|21060922|P1|NOT COMPLETED|Overall Study||1
8542546|NCT00227539|21060922|P1|COMPLETED|Overall Study||24
8542547|NCT00227539|21060922|P1|STARTED|Overall Study||25
8542548|NCT00227370|21060930|P2|NOT COMPLETED|Overall Study||24
8542549|NCT00227370|21060931|P1|NOT COMPLETED|Overall Study||21
8542550|NCT00227370|21060930|P2|COMPLETED|Overall Study||46
8542551|NCT00227370|21060931|P1|COMPLETED|Overall Study||45
8542552|NCT00227370|21060930|P2|STARTED|Overall Study|Treatment Group|70
8542553|NCT00227370|21060931|P1|STARTED|Overall Study|Placebo Group|66
8542554|NCT00227344|21060951|P2|NOT COMPLETED|Overall Study||5
8542555|NCT00227344|21060952|P1|NOT COMPLETED|Overall Study||12
8542556|NCT00227344|21060951|P2|COMPLETED|Overall Study||37
8542557|NCT00227344|21060952|P1|COMPLETED|Overall Study||75
8542558|NCT00227344|21060951|P2|STARTED|Overall Study||42
8542559|NCT00227344|21060952|P1|STARTED|Overall Study||87
8542560|NCT00227305|21060972|P1|NOT COMPLETED|Overall Study||144
8542561|NCT00227305|21060972|P1|COMPLETED|Overall Study|Completed 26 weeks|237
8542562|NCT00227305|21060972|P1|Drug Received|Overall Study|safety population|380
8542563|NCT00227305|21060972|P1|STARTED|Overall Study|enrolled|381
8542564|NCT00227266|21060989|P3|NOT COMPLETED|Overall Study||4
8542565|NCT00227266|21060990|P2|NOT COMPLETED|Overall Study||0
8542566|NCT00227266|21060991|P1|NOT COMPLETED|Overall Study||1
8542567|NCT00227266|21060989|P3|COMPLETED|Overall Study||29
8542568|NCT00227266|21060990|P2|COMPLETED|Overall Study||30
8542569|NCT00227266|21060991|P1|COMPLETED|Overall Study||30
8542570|NCT00227266|21060989|P3|STARTED|Overall Study||33
8542571|NCT00227266|21060990|P2|STARTED|Overall Study||30
8542572|NCT00227266|21060991|P1|STARTED|Overall Study||31
8542573|NCT00227019|21061011|P1|NOT COMPLETED|Overall Study||0
8542574|NCT00227019|21061011|P1|COMPLETED|Overall Study||16
8542575|NCT00227019|21061011|P1|STARTED|Overall Study||16
8542576|NCT00226941|21061021|P4|NOT COMPLETED|Overall Study||2
8542577|NCT00226941|21061022|P3|NOT COMPLETED|Overall Study||0
8542578|NCT00226941|21061023|P2|NOT COMPLETED|Overall Study||0
8542579|NCT00226941|21061024|P1|NOT COMPLETED|Overall Study||0
8542580|NCT00226941|21061021|P4|COMPLETED|Overall Study||5
8542581|NCT00226941|21061022|P3|COMPLETED|Overall Study||4
8542582|NCT00226941|21061023|P2|COMPLETED|Overall Study||6
8542583|NCT00226941|21061024|P1|COMPLETED|Overall Study||6
8542584|NCT00226941|21061021|P4|STARTED|Overall Study||7
8542585|NCT00226941|21061022|P3|STARTED|Overall Study||4
8542586|NCT00226941|21061023|P2|STARTED|Overall Study||6
8542587|NCT00226941|21061024|P1|STARTED|Overall Study||6
8542588|NCT00226811|21061058|P1|NOT COMPLETED|Overall Study||76
8542589|NCT00226811|21061058|P1|COMPLETED|Overall Study||2
8542590|NCT00226811|21061058|P1|STARTED|Overall Study||78
8542591|NCT00226655|21061068|P1|NOT COMPLETED|Overall Study||79
8542592|NCT00226655|21061068|P1|COMPLETED|Overall Study||33
8542593|NCT00226655|21061068|P1|STARTED|Overall Study||112
8542594|NCT00226590|21061072|P1|NOT COMPLETED|Overall Study||0
8542595|NCT00226590|21061072|P1|COMPLETED|Overall Study||39
8542596|NCT00226590|21061072|P1|STARTED|Overall Study||39
8542597|NCT00226577|21061079|P1|NOT COMPLETED|Overall Study||0
8542598|NCT00226577|21061079|P1|COMPLETED|Overall Study||52
8542599|NCT00226577|21061079|P1|STARTED|Overall Study||52
8542600|NCT00226499|21061090|P3|NOT COMPLETED|Overall Study||359
8542601|NCT00226499|21061091|P2|NOT COMPLETED|Overall Study||1072
8542602|NCT00226499|21061092|P1|NOT COMPLETED|Overall Study||1074
8542603|NCT00226499|21061090|P3|COMPLETED|Overall Study||468
8542604|NCT00226499|21061091|P2|COMPLETED|Overall Study||1415
8542605|NCT00226499|21061092|P1|COMPLETED|Overall Study||1415
8542606|NCT00226499|21061090|P3|STARTED|Overall Study||827
8542607|NCT00226499|21061091|P2|STARTED|Overall Study||2487
8542608|NCT00226499|21061092|P1|STARTED|Overall Study||2489
8542609|NCT00226239|21061207|P1|NOT COMPLETED|Maintenance Cetuximab||14
8542610|NCT00226239|21061207|P1|COMPLETED|Maintenance Cetuximab||17
8542611|NCT00226239|21061207|P1|STARTED|Maintenance Cetuximab||31
8542612|NCT00226239|21061207|P1|NOT COMPLETED|XPE, Definitive Therapy||4
8542613|NCT00226239|21061207|P1|COMPLETED|XPE, Definitive Therapy||33
8542614|NCT00226239|21061207|P1|STARTED|XPE, Definitive Therapy||37
8542615|NCT00226239|21061207|P1|NOT COMPLETED|TPE, Induction Therapy||2
8542616|NCT00226239|21061207|P1|COMPLETED|TPE, Induction Therapy||37
8542617|NCT00226239|21061207|P1|STARTED|TPE, Induction Therapy||39
8542618|NCT00225784|21061216|P1|NOT COMPLETED|Overall Study||4
8542619|NCT00225784|21061216|P1|COMPLETED|Overall Study||33
8542620|NCT00225784|21061216|P1|STARTED|Overall Study||37
8542621|NCT00225758|21061227|P1|NOT COMPLETED|Overall Study||4
8542622|NCT00225758|21061227|P1|COMPLETED|Overall Study||23
8542623|NCT00225758|21061227|P1|STARTED|Overall Study||27
8542624|NCT00225732|21061237|P2|NOT COMPLETED|Overall Study||0
8542625|NCT00225732|21061238|P1|NOT COMPLETED|Overall Study||0
8542626|NCT00225732|21061237|P2|COMPLETED|Overall Study||166
8542627|NCT00225732|21061238|P1|COMPLETED|Overall Study||153
8542628|NCT00225732|21061237|P2|STARTED|Overall Study||166
8542629|NCT00225732|21061238|P1|STARTED|Overall Study||153
8542630|NCT00225498|21061244|P1|NOT COMPLETED|Overall Study||0
8542631|NCT00225498|21061244|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
8542632|NCT00225498|21061244|P1|STARTED|Overall Study||10
8542633|NCT00225420|21061248|P3|NOT COMPLETED|Overall Study||0
8542634|NCT00225420|21061249|P2|NOT COMPLETED|Overall Study||0
8542635|NCT00225420|21061250|P1|NOT COMPLETED|Overall Study||0
8542636|NCT00225420|21061248|P3|COMPLETED|Overall Study||3
8542637|NCT00225420|21061249|P2|COMPLETED|Overall Study||6
8542638|NCT00225420|21061250|P1|COMPLETED|Overall Study||9
8542639|NCT00225420|21061248|P3|STARTED|Overall Study||3
8542640|NCT00225420|21061249|P2|STARTED|Overall Study||6
8542641|NCT00225420|21061250|P1|STARTED|Overall Study||9
8542642|NCT00225277|21061259|P2|NOT COMPLETED|Overall Study||95
8542643|NCT00225277|21061260|P1|NOT COMPLETED|Overall Study||97
8542644|NCT00225277|21061259|P2|COMPLETED|Overall Study||178
8542645|NCT00225277|21061260|P1|COMPLETED|Overall Study||177
8542646|NCT00225277|21061259|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
8542647|NCT00225277|21061260|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
8542648|NCT00225251|21061278|P2|NOT COMPLETED|Overall Study||1
8542649|NCT00225251|21061279|P1|NOT COMPLETED|Overall Study||1
8542650|NCT00225251|21061278|P2|COMPLETED|Overall Study||6
8542651|NCT00225251|21061279|P1|COMPLETED|Overall Study||10
8542652|NCT00225251|21061278|P2|STARTED|Overall Study||7
8542653|NCT00225251|21061279|P1|STARTED|Overall Study||11
8542654|NCT00225212|21061293|P1|NOT COMPLETED|Overall Study||6
8542655|NCT00225212|21061293|P1|COMPLETED|Overall Study||29
8542656|NCT00225212|21061293|P1|STARTED|Overall Study||35
8542657|NCT00225147|21061302|P4|NOT COMPLETED|Open-label Phase||10
8542658|NCT00225147|21061303|P3|NOT COMPLETED|Open-label Phase||0
8542659|NCT00225147|21061304|P2|NOT COMPLETED|Open-label Phase||0
8542660|NCT00225147|21061305|P1|NOT COMPLETED|Open-label Phase||0
8542661|NCT00225147|21061302|P4|COMPLETED|Open-label Phase||52
8542662|NCT00225147|21061303|P3|COMPLETED|Open-label Phase||0
8542663|NCT00225147|21061304|P2|COMPLETED|Open-label Phase||0
8542664|NCT00225147|21061305|P1|COMPLETED|Open-label Phase||0
8542665|NCT00225147|21061302|P4|STARTED|Open-label Phase||62
8542666|NCT00225147|21061303|P3|STARTED|Open-label Phase||0
8542667|NCT00225147|21061304|P2|STARTED|Open-label Phase||0
8542668|NCT00225147|21061305|P1|STARTED|Open-label Phase||0
8542669|NCT00225147|21061302|P4|NOT COMPLETED|Double-blind Phase||0
8542670|NCT00225147|21061303|P3|NOT COMPLETED|Double-blind Phase||0
8542671|NCT00225147|21061304|P2|NOT COMPLETED|Double-blind Phase||0
8542672|NCT00225147|21061305|P1|NOT COMPLETED|Double-blind Phase||0
8542673|NCT00225147|21061302|P4|COMPLETED|Double-blind Phase||0
8542674|NCT00225147|21061303|P3|COMPLETED|Double-blind Phase||13
8542675|NCT00225147|21061304|P2|COMPLETED|Double-blind Phase||12
8542676|NCT00225147|21061305|P1|COMPLETED|Double-blind Phase||13
8542677|NCT00225147|21061302|P4|STARTED|Double-blind Phase||0
8542678|NCT00225147|21061303|P3|STARTED|Double-blind Phase||13
8542679|NCT00225147|21061304|P2|STARTED|Double-blind Phase||12
8542680|NCT00225147|21061305|P1|STARTED|Double-blind Phase||13
8542681|NCT00225017|21061321|P2|NOT COMPLETED|Overall Study||1
8542682|NCT00225017|21061322|P1|NOT COMPLETED|Overall Study||0
8542683|NCT00225017|21061321|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
8542684|NCT00225017|21061322|P1|COMPLETED|Overall Study||26
8542685|NCT00225017|21061321|P2|STARTED|Overall Study||24
8542686|NCT00225017|21061322|P1|STARTED|Overall Study||26
8542687|NCT00224952|21061335|P3|NOT COMPLETED|Overall Study||0
8542688|NCT00224952|21061336|P2|NOT COMPLETED|Overall Study||0
8542689|NCT00224952|21061337|P1|NOT COMPLETED|Overall Study||0
8542690|NCT00224952|21061335|P3|COMPLETED|Overall Study||134
8542691|NCT00224952|21061336|P2|COMPLETED|Overall Study||87
8542692|NCT00224952|21061337|P1|COMPLETED|Overall Study||53
8542693|NCT00224952|21061335|P3|STARTED|Overall Study||134
8542694|NCT00224952|21061336|P2|STARTED|Overall Study||87
8542695|NCT00224952|21061337|P1|STARTED|Overall Study||53
8542696|NCT00224874|21061352|P4|NOT COMPLETED|Overall Study||0
8542697|NCT00224874|21061353|P3|NOT COMPLETED|Overall Study||1
8542698|NCT00224874|21061354|P2|NOT COMPLETED|Overall Study||0
8542699|NCT00224874|21061355|P1|NOT COMPLETED|Overall Study||0
8542700|NCT00224874|21061352|P4|COMPLETED|Overall Study||42
8542701|NCT00224874|21061353|P3|COMPLETED|Overall Study||46
8542702|NCT00224874|21061354|P2|COMPLETED|Overall Study||45
8542703|NCT00224874|21061355|P1|COMPLETED|Overall Study||46
8542704|NCT00224874|21061352|P4|STARTED|Overall Study||42
8542705|NCT00224874|21061353|P3|STARTED|Overall Study||47
8542706|NCT00224874|21061354|P2|STARTED|Overall Study||45
8542707|NCT00224874|21061355|P1|STARTED|Overall Study||46
8542708|NCT00224770|21061400|P3|NOT COMPLETED|Overall Study||0
8542709|NCT00224770|21061401|P2|NOT COMPLETED|Overall Study||2
8542710|NCT00224770|21061402|P1|NOT COMPLETED|Overall Study||4
8542711|NCT00224770|21061400|P3|COMPLETED|Overall Study||14
8542712|NCT00224770|21061401|P2|COMPLETED|Overall Study||52
8542713|NCT00224770|21061402|P1|COMPLETED|Overall Study||38
8542714|NCT00224770|21061400|P3|STARTED|Overall Study||14
8542715|NCT00224770|21061401|P2|STARTED|Overall Study||54
8542716|NCT00224770|21061402|P1|STARTED|Overall Study||42
8542717|NCT00224484|21061437|P3|NOT COMPLETED|Overall Study||62
8542718|NCT00224484|21061438|P2|NOT COMPLETED|Overall Study||65
8542719|NCT00224484|21061439|P1|NOT COMPLETED|Overall Study||146
8542720|NCT00224484|21061437|P3|COMPLETED|Overall Study||1425
8542721|NCT00224484|21061438|P2|COMPLETED|Overall Study||1426
8542722|NCT00224484|21061439|P1|COMPLETED|Overall Study||2831
8542723|NCT00224484|21061437|P3|STARTED|Overall Study||1487
8542724|NCT00224484|21061438|P2|STARTED|Overall Study||1491
8542725|NCT00224484|21061439|P1|STARTED|Overall Study||2977
8542726|NCT00224289|21061498|P1|NOT COMPLETED|Overall Study||0
8542727|NCT00224289|21061498|P1|COMPLETED|Overall Study||17
8542728|NCT00224289|21061498|P1|STARTED|Overall Study||17
8542729|NCT00224133|21061503|P1|NOT COMPLETED|Overall Study||226
8542730|NCT00224133|21061503|P1|COMPLETED|Overall Study||435
8542731|NCT00224133|21061503|P1|STARTED|Overall Study||661
8542732|NCT00224120|21061509|P2|NOT COMPLETED|Overall Study||24
8542733|NCT00224120|21061510|P1|NOT COMPLETED|Overall Study||22
8542734|NCT00224120|21061509|P2|COMPLETED|Overall Study||205
8542735|NCT00224120|21061510|P1|COMPLETED|Overall Study||211
8542736|NCT00224120|21061509|P2|STARTED|Overall Study||229
8542737|NCT00224120|21061510|P1|STARTED|Overall Study||233
8542738|NCT00224107|21061520|P2|NOT COMPLETED|Overall Study||14
8542739|NCT00224107|21061521|P1|NOT COMPLETED|Overall Study||31
8542740|NCT00224107|21061520|P2|COMPLETED|Overall Study||214
8542741|NCT00224107|21061521|P1|COMPLETED|Overall Study||202
8542742|NCT00224107|21061520|P2|STARTED|Overall Study||228
8542743|NCT00224107|21061521|P1|STARTED|Overall Study||233
8542744|NCT00224055|21061531|P2|NOT COMPLETED|Overall Study||14
8542745|NCT00224055|21061532|P1|NOT COMPLETED|Overall Study||15
8542746|NCT00224055|21061531|P2|COMPLETED|Overall Study||31
8542747|NCT00224055|21061532|P1|COMPLETED|Overall Study||29
8542748|NCT00224055|21061531|P2|STARTED|Overall Study||45
8542749|NCT00224055|21061532|P1|STARTED|Overall Study||44
8542750|NCT00224042|21061542|P2|NOT COMPLETED|Overall Study||6
8542751|NCT00224042|21061543|P1|NOT COMPLETED|Overall Study||6
8542752|NCT00224042|21061542|P2|COMPLETED|Overall Study||20
8542753|NCT00224042|21061543|P1|COMPLETED|Overall Study||20
8542754|NCT00224042|21061542|P2|STARTED|Overall Study||26
8542755|NCT00224042|21061543|P1|STARTED|Overall Study||26
8542756|NCT00224029|21061555|P1|NOT COMPLETED|Overall Study||6
8542757|NCT00224029|21061555|P1|COMPLETED|Overall Study||18
8542758|NCT00224029|21061555|P1|STARTED|Overall Study||24
8542759|NCT00224016|21061561|P2|NOT COMPLETED|Follow-Up Period||0
8542760|NCT00224016|21061562|P1|NOT COMPLETED|Follow-Up Period||0
8542761|NCT00224016|21061561|P2|COMPLETED|Follow-Up Period||0
8542762|NCT00224016|21061562|P1|COMPLETED|Follow-Up Period||35
8542763|NCT00224016|21061561|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
8542764|NCT00224016|21061562|P1|STARTED|Follow-Up Period||35
8542765|NCT00224016|21061561|P2|NOT COMPLETED|Maintenance Period||1
8542766|NCT00224016|21061562|P1|NOT COMPLETED|Maintenance Period||2
8542767|NCT00224016|21061561|P2|COMPLETED|Maintenance Period||14
8542768|NCT00224016|21061562|P1|COMPLETED|Maintenance Period||36
8542769|NCT00224016|21061561|P2|STARTED|Maintenance Period||15
8542770|NCT00224016|21061562|P1|STARTED|Maintenance Period||38
8542771|NCT00224016|21061561|P2|NOT COMPLETED|Titration Period||1
8542772|NCT00224016|21061562|P1|NOT COMPLETED|Titration Period||1
8542773|NCT00224016|21061561|P2|COMPLETED|Titration Period||15
8542774|NCT00224016|21061562|P1|COMPLETED|Titration Period||38
8542775|NCT00224016|21061561|P2|STARTED|Titration Period||16
8542776|NCT00224016|21061562|P1|STARTED|Titration Period||39
8542777|NCT00224003|21061570|P1|NOT COMPLETED|Overall Study||7
8542778|NCT00224003|21061570|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
8542779|NCT00224003|21061570|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
8542786|NCT00223977|21061602|P3|NOT COMPLETED|Overall Study||3
8542787|NCT00223977|21061603|P2|NOT COMPLETED|Overall Study||11
8542788|NCT00223977|21061604|P1|NOT COMPLETED|Overall Study||9
8542789|NCT00223977|21061602|P3|COMPLETED|Overall Study||39
8542790|NCT00223977|21061603|P2|COMPLETED|Overall Study||47
8542791|NCT00223977|21061604|P1|COMPLETED|Overall Study||37
8542792|NCT00223977|21061602|P3|STARTED|Overall Study||42
8542793|NCT00223977|21061603|P2|STARTED|Overall Study||58
8542794|NCT00223977|21061604|P1|STARTED|Overall Study||46
8542795|NCT00223821|21061626|P2|NOT COMPLETED|Overall Study||10
8542796|NCT00223821|21061627|P1|NOT COMPLETED|Overall Study||4
8542797|NCT00223821|21061626|P2|COMPLETED|Overall Study||22
8542798|NCT00223821|21061627|P1|COMPLETED|Overall Study||28
8542799|NCT00223821|21061626|P2|Completed 6-month Follow-up|Overall Study||25
8542800|NCT00223821|21061627|P1|Completed 6-month Follow-up|Overall Study||28
8542801|NCT00223821|21061626|P2|Completed Post-treatment Assessment|Overall Study||27
8542802|NCT00223821|21061627|P1|Completed Post-treatment Assessment|Overall Study||31
8542803|NCT00223821|21061626|P2|Completed Therapy|Overall Study||28
8542804|NCT00223821|21061627|P1|Completed Therapy|Overall Study||31
8542805|NCT00223821|21061626|P2|STARTED|Overall Study||32
8542806|NCT00223821|21061627|P1|STARTED|Overall Study||32
8542807|NCT00223808|21061638|P3|NOT COMPLETED|Overall Study||5
8542808|NCT00223808|21061639|P2|NOT COMPLETED|Overall Study||5
8542809|NCT00223808|21061640|P1|NOT COMPLETED|Overall Study||3
8542810|NCT00223808|21061638|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
8542811|NCT00223808|21061639|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
8542812|NCT00223808|21061640|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
8542813|NCT00223808|21061638|P3|STARTED|Overall Study||23
8542814|NCT00223808|21061639|P2|STARTED|Overall Study||22
8542815|NCT00223808|21061640|P1|STARTED|Overall Study||22
8542816|NCT00223795|21061657|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
8542817|NCT00223795|21061658|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
8542818|NCT00223795|21061657|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
8542819|NCT00223795|21061658|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
8542820|NCT00223795|21061657|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
8542821|NCT00223795|21061658|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
8542822|NCT00223795|21061657|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
8542823|NCT00223795|21061658|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
8542824|NCT00223795|21061657|P2|COMPLETED|First Intervention - Eight Weeks||18
8542825|NCT00223795|21061658|P1|COMPLETED|First Intervention - Eight Weeks||19
8542826|NCT00223795|21061657|P2|STARTED|First Intervention - Eight Weeks||27
8542827|NCT00223795|21061658|P1|STARTED|First Intervention - Eight Weeks||26
8542828|NCT00223704|21061668|P3|NOT COMPLETED|Overall Study||0
8542829|NCT00223704|21061669|P2|NOT COMPLETED|Overall Study||0
8542830|NCT00223704|21061670|P1|NOT COMPLETED|Overall Study||0
8542831|NCT00223704|21061668|P3|COMPLETED|Overall Study||40
8542832|NCT00223704|21061669|P2|COMPLETED|Overall Study||37
8542833|NCT00223704|21061670|P1|COMPLETED|Overall Study||38
8542834|NCT00223704|21061668|P3|STARTED|Overall Study||40
8542835|NCT00223704|21061669|P2|STARTED|Overall Study||37
8542836|NCT00223704|21061670|P1|STARTED|Overall Study||38
8542837|NCT00223678|21061692|P2|NOT COMPLETED|Overall Study||0
8542838|NCT00223678|21061693|P1|NOT COMPLETED|Overall Study||0
8542839|NCT00223678|21061692|P2|COMPLETED|Overall Study||7
8542840|NCT00223678|21061693|P1|COMPLETED|Overall Study||13
8542841|NCT00223678|21061692|P2|STARTED|Overall Study||7
8542842|NCT00223678|21061693|P1|STARTED|Overall Study||13
8542843|NCT00223665|21061699|P1|NOT COMPLETED|Overall Study||0
8542844|NCT00223665|21061699|P1|COMPLETED|Overall Study||102
8542845|NCT00223665|21061699|P1|STARTED|Overall Study||102
8542846|NCT00223652|21061719|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
8542847|NCT00223652|21061720|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
8542848|NCT00223652|21061719|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
8542849|NCT00223652|21061720|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
8542850|NCT00223652|21061719|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
8542851|NCT00223652|21061720|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
8542852|NCT00223652|21061719|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
8542853|NCT00223652|21061720|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
8542854|NCT00223652|21061719|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
8542855|NCT00223652|21061720|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
8542856|NCT00223652|21061719|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
8542857|NCT00223652|21061720|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
8542858|NCT00223652|21061719|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
8542859|NCT00223652|21061720|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
8542860|NCT00223652|21061719|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
8542861|NCT00223652|21061720|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
8542862|NCT00223652|21061719|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
8542863|NCT00223652|21061720|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
8542864|NCT00223496|21061736|P1|NOT COMPLETED|Overall Study||22
8542865|NCT00223496|21061736|P1|COMPLETED|Overall Study||10
8542866|NCT00223496|21061736|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
8542867|NCT00223262|21061742|P2|NOT COMPLETED|Overall Study||1
8542868|NCT00223262|21061743|P1|NOT COMPLETED|Overall Study||8
8542869|NCT00223262|21061742|P2|COMPLETED|Overall Study||11
8542870|NCT00223262|21061743|P1|COMPLETED|Overall Study||8
8542871|NCT00223262|21061742|P2|STARTED|Overall Study||12
8542872|NCT00223262|21061743|P1|STARTED|Overall Study||16
8542873|NCT00223236|21061751|P2|NOT COMPLETED|Overall Study||14
8542874|NCT00223236|21061752|P1|NOT COMPLETED|Overall Study||7
8542875|NCT00223236|21061751|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
8542876|NCT00223236|21061752|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
8542877|NCT00223236|21061751|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
8542878|NCT00223236|21061752|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
8542879|NCT00223080|21061766|P2|NOT COMPLETED|Overall Study||797
8542880|NCT00223080|21061767|P1|NOT COMPLETED|Overall Study||796
8542881|NCT00223080|21061766|P2|COMPLETED|Overall Study||7401
8542882|NCT00223080|21061767|P1|COMPLETED|Overall Study||7401
8542883|NCT00223080|21061766|P2|STARTED|Overall Study||8198
8542884|NCT00223080|21061767|P1|STARTED|Overall Study||8197
8542885|NCT00222729|21061785|P1|NOT COMPLETED|Overall Study||3
8542886|NCT00222729|21061785|P1|COMPLETED|Overall Study||37
8542887|NCT00222729|21061785|P1|STARTED|Overall Study||40
8542888|NCT00222131|21061794|P2|NOT COMPLETED|Overall Study||0
8542889|NCT00222131|21061795|P1|NOT COMPLETED|Overall Study||0
8542890|NCT00222131|21061794|P2|COMPLETED|Overall Study||35
8542891|NCT00222131|21061795|P1|COMPLETED|Overall Study||38
8542892|NCT00222131|21061794|P2|STARTED|Overall Study||35
8542893|NCT00222131|21061795|P1|STARTED|Overall Study||38
8542894|NCT00222105|21061803|P1|NOT COMPLETED|Overall Study||14
8542895|NCT00222105|21061803|P1|COMPLETED|Overall Study||11
8542896|NCT00222105|21061803|P1|STARTED|Overall Study||25
8542897|NCT00221403|21061811|P3|NOT COMPLETED|Overall Study||0
8542898|NCT00221403|21061812|P2|NOT COMPLETED|Overall Study||5
8542899|NCT00221403|21061813|P1|NOT COMPLETED|Overall Study||2
8542900|NCT00221403|21061811|P3|COMPLETED|Overall Study||7
8542901|NCT00221403|21061812|P2|COMPLETED|Overall Study||16
8542902|NCT00221403|21061813|P1|COMPLETED|Overall Study||16
8542903|NCT00221403|21061811|P3|STARTED|Overall Study||7
8542904|NCT00221403|21061812|P2|STARTED|Overall Study||21
8542905|NCT00221403|21061813|P1|STARTED|Overall Study||18
8542906|NCT00221338|21061823|P2|NOT COMPLETED|Overall Study||29
8542907|NCT00221338|21061824|P1|NOT COMPLETED|Overall Study||24
8542908|NCT00221338|21061823|P2|COMPLETED|Overall Study||347
8542909|NCT00221338|21061824|P1|COMPLETED|Overall Study||350
8542910|NCT00221338|21061823|P2|STARTED|Overall Study||376
8542911|NCT00221338|21061824|P1|STARTED|Overall Study||374
8542912|NCT00221299|21061843|P4|NOT COMPLETED|Overall Study||1
8542913|NCT00221299|21061844|P3|NOT COMPLETED|Overall Study||0
8542914|NCT00221299|21061845|P2|NOT COMPLETED|Overall Study||2
8542915|NCT00221299|21061846|P1|NOT COMPLETED|Overall Study||1
8542916|NCT00221299|21061843|P4|COMPLETED|Overall Study||10
8542917|NCT00221299|21061844|P3|COMPLETED|Overall Study||14
8542918|NCT00221299|21061845|P2|COMPLETED|Overall Study||11
8542919|NCT00221299|21061846|P1|COMPLETED|Overall Study||10
8542920|NCT00221299|21061843|P4|STARTED|Overall Study||11
8542921|NCT00221299|21061844|P3|STARTED|Overall Study||14
8542922|NCT00221299|21061845|P2|STARTED|Overall Study||13
8542923|NCT00221299|21061846|P1|STARTED|Overall Study||11
8542924|NCT00221195|21061856|P2|NOT COMPLETED|Therapy 2 (Months 10-15)||0
8542925|NCT00221195|21061857|P1|NOT COMPLETED|Therapy 2 (Months 10-15)||2
8542926|NCT00221195|21061856|P2|COMPLETED|Therapy 2 (Months 10-15)||14
8542927|NCT00221195|21061857|P1|COMPLETED|Therapy 2 (Months 10-15)||12
8542928|NCT00221195|21061856|P2|STARTED|Therapy 2 (Months 10-15)||14
8542929|NCT00221195|21061857|P1|STARTED|Therapy 2 (Months 10-15)||14
8542930|NCT00221195|21061856|P2|NOT COMPLETED|Washout Period (Months 7-9)||1
8542931|NCT00221195|21061857|P1|NOT COMPLETED|Washout Period (Months 7-9)||0
8542932|NCT00221195|21061856|P2|COMPLETED|Washout Period (Months 7-9)||14
8542933|NCT00221195|21061857|P1|COMPLETED|Washout Period (Months 7-9)||14
8542934|NCT00221195|21061856|P2|STARTED|Washout Period (Months 7-9)||15
8542935|NCT00221195|21061857|P1|STARTED|Washout Period (Months 7-9)||14
8542936|NCT00221195|21061856|P2|NOT COMPLETED|Therapy 1 (Months 1-6)||2
8542937|NCT00221195|21061857|P1|NOT COMPLETED|Therapy 1 (Months 1-6)||3
8542938|NCT00221195|21061856|P2|COMPLETED|Therapy 1 (Months 1-6)||15
8542939|NCT00221195|21061857|P1|COMPLETED|Therapy 1 (Months 1-6)||14
8542940|NCT00221195|21061856|P2|STARTED|Therapy 1 (Months 1-6)||17
8542941|NCT00221195|21061857|P1|STARTED|Therapy 1 (Months 1-6)||17
8542942|NCT00221117|21061866|P2|NOT COMPLETED|Overall Study||0
8542943|NCT00221117|21061867|P1|NOT COMPLETED|Overall Study||0
8542944|NCT00221117|21061866|P2|COMPLETED|Overall Study||9
8542945|NCT00221117|21061867|P1|COMPLETED|Overall Study||12
8542946|NCT00221117|21061866|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
8542947|NCT00221117|21061867|P1|STARTED|Overall Study||12
8542948|NCT00221104|21061879|P2|NOT COMPLETED|Overall Study||76
8542949|NCT00221104|21061880|P1|NOT COMPLETED|Overall Study||83
8542950|NCT00221104|21061879|P2|COMPLETED|Overall Study||709
8542951|NCT00221104|21061880|P1|COMPLETED|Overall Study||710
8542952|NCT00221104|21061879|P2|STARTED|Overall Study||785
8542953|NCT00221104|21061880|P1|STARTED|Overall Study||793
8542954|NCT00220961|21061896|P2|NOT COMPLETED|Overall Study||90
8542955|NCT00220961|21061897|P1|NOT COMPLETED|Overall Study||71
8542956|NCT00220961|21061896|P2|COMPLETED|Overall Study||213
8542957|NCT00220961|21061897|P1|COMPLETED|Overall Study||228
8542958|NCT00220961|21061896|P2|STARTED|Overall Study||303
8542959|NCT00220961|21061897|P1|STARTED|Overall Study||299
8542960|NCT00220805|21061913|P2|NOT COMPLETED|Overall Study||11
8542961|NCT00220805|21061914|P1|NOT COMPLETED|Overall Study||8
8542962|NCT00220805|21061913|P2|COMPLETED|Overall Study||16
8542963|NCT00220805|21061914|P1|COMPLETED|Overall Study||22
8542964|NCT00220805|21061913|P2|STARTED|Overall Study||27
8542965|NCT00220805|21061914|P1|STARTED|Overall Study||30
8542966|NCT00220779|21061935|P3|NOT COMPLETED|Overall Study||4
8542967|NCT00220779|21061936|P2|NOT COMPLETED|Overall Study||4
8542968|NCT00220779|21061937|P1|NOT COMPLETED|Overall Study||7
8542969|NCT00220779|21061935|P3|COMPLETED|Overall Study||37
8542970|NCT00220779|21061936|P2|COMPLETED|Overall Study||38
8542971|NCT00220779|21061937|P1|COMPLETED|Overall Study||38
8542972|NCT00220779|21061935|P3|STARTED|Overall Study||41
8542973|NCT00220779|21061936|P2|STARTED|Overall Study||42
8542974|NCT00220779|21061937|P1|STARTED|Overall Study||45
8542975|NCT00220740|21061947|P2|NOT COMPLETED|Withdrawal Period||15
8542976|NCT00220740|21061948|P1|NOT COMPLETED|Withdrawal Period||6
8542977|NCT00220740|21061947|P2|COMPLETED|Withdrawal Period||16
8542978|NCT00220740|21061948|P1|COMPLETED|Withdrawal Period||37
8542979|NCT00220740|21061947|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
8542980|NCT00220740|21061948|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
8542981|NCT00220740|21061947|P2|NOT COMPLETED|Rescue Treatment||18
8542982|NCT00220740|21061948|P1|NOT COMPLETED|Rescue Treatment||19
8542983|NCT00220740|21061947|P2|COMPLETED|Rescue Treatment||5
8542984|NCT00220740|21061948|P1|COMPLETED|Rescue Treatment||26
8542985|NCT00220740|21061947|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
8542986|NCT00220740|21061948|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
8542987|NCT00220740|21061947|P2|NOT COMPLETED|Efficacy Period||46
8542988|NCT00220740|21061948|P1|NOT COMPLETED|Efficacy Period||26
8542989|NCT00220740|21061947|P2|COMPLETED|Efficacy Period||12
8542990|NCT00220740|21061948|P1|COMPLETED|Efficacy Period||33
8542991|NCT00220740|21061947|P2|STARTED|Efficacy Period||58
8542992|NCT00220740|21061948|P1|STARTED|Efficacy Period||59
8542993|NCT00220727|21061962|P2|NOT COMPLETED|Second Infusion (Week <6)||0
8542994|NCT00220727|21061963|P1|NOT COMPLETED|Second Infusion (Week <6)||1
8542995|NCT00220727|21061962|P2|COMPLETED|Second Infusion (Week <6)||4
8542996|NCT00220727|21061963|P1|COMPLETED|Second Infusion (Week <6)||3
8542997|NCT00220727|21061962|P2|STARTED|Second Infusion (Week <6)||4
8542998|NCT00220727|21061963|P1|STARTED|Second Infusion (Week <6)||4
8542999|NCT00220727|21061962|P2|NOT COMPLETED|First Infusion (Week 0)||0
8543000|NCT00220727|21061963|P1|NOT COMPLETED|First Infusion (Week 0)||0
8543001|NCT00220727|21061962|P2|COMPLETED|First Infusion (Week 0)||4
8543002|NCT00220727|21061963|P1|COMPLETED|First Infusion (Week 0)||4
8543003|NCT00220727|21061962|P2|STARTED|First Infusion (Week 0)||4
8543004|NCT00220727|21061963|P1|STARTED|First Infusion (Week 0)||4
8543005|NCT00220701|21061979|P2|NOT COMPLETED|Overall Study||4
8543006|NCT00220701|21061980|P1|NOT COMPLETED|Overall Study||5
8543007|NCT00220701|21061979|P2|COMPLETED|Overall Study||13
8543008|NCT00220701|21061980|P1|COMPLETED|Overall Study||12
8543009|NCT00220701|21061979|P2|STARTED|Overall Study||17
8543010|NCT00220701|21061980|P1|STARTED|Overall Study||17
8543011|NCT00220636|21061996|P1|NOT COMPLETED|Overall Study||4
8543012|NCT00220636|21061996|P1|COMPLETED|Overall Study||11
8543013|NCT00220636|21061996|P1|STARTED|Overall Study||15
8543014|NCT00219557|21062006|P3|NOT COMPLETED|Phase 2||33
8543015|NCT00219557|21062007|P2|NOT COMPLETED|Phase 2||69
8543016|NCT00219557|21062008|P1|NOT COMPLETED|Phase 2||0
8543017|NCT00219557|21062006|P3|COMPLETED|Phase 2||1
8543018|NCT00219557|21062007|P2|COMPLETED|Phase 2||0
8543019|NCT00219557|21062008|P1|COMPLETED|Phase 2||0
8543020|NCT00219557|21062006|P3|Treated|Phase 2||31
8543021|NCT00219557|21062007|P2|Treated|Phase 2||68
8543022|NCT00219557|21062008|P1|Treated|Phase 2||0
8543023|NCT00219557|21062006|P3|STARTED|Phase 2||34
8543024|NCT00219557|21062007|P2|STARTED|Phase 2||69
8543025|NCT00219557|21062008|P1|STARTED|Phase 2||0
8543026|NCT00219557|21062006|P3|NOT COMPLETED|Phase 1||0
8543027|NCT00219557|21062007|P2|NOT COMPLETED|Phase 1||0
8543028|NCT00219557|21062008|P1|NOT COMPLETED|Phase 1||7
8543029|NCT00219557|21062006|P3|COMPLETED|Phase 1||0
8543030|NCT00219557|21062007|P2|COMPLETED|Phase 1||0
8543031|NCT00219557|21062008|P1|COMPLETED|Phase 1||1
8543032|NCT00219557|21062006|P3|STARTED|Phase 1||0
8543033|NCT00219557|21062007|P2|STARTED|Phase 1||0
8543034|NCT00219557|21062008|P1|STARTED|Phase 1||8
8543035|NCT00219544|21062036|P2|NOT COMPLETED|Double Blind Treatment Period||0
8543036|NCT00219544|21062037|P1|NOT COMPLETED|Double Blind Treatment Period||0
8543037|NCT00219544|21062036|P2|COMPLETED|Double Blind Treatment Period||77
8543038|NCT00219544|21062037|P1|COMPLETED|Double Blind Treatment Period||80
8543039|NCT00219544|21062036|P2|STARTED|Double Blind Treatment Period||77
8543040|NCT00219544|21062037|P1|STARTED|Double Blind Treatment Period||80
8543041|NCT00219544|21062036|P2|NOT COMPLETED|Single Blind Treatment Period||0
8543042|NCT00219544|21062037|P1|NOT COMPLETED|Single Blind Treatment Period||22
8543043|NCT00219544|21062036|P2|COMPLETED|Single Blind Treatment Period||0
8543044|NCT00219544|21062037|P1|COMPLETED|Single Blind Treatment Period||234
8543045|NCT00219544|21062036|P2|STARTED|Single Blind Treatment Period||0
8543046|NCT00219544|21062037|P1|STARTED|Single Blind Treatment Period||256
8543047|NCT00219349|21062075|P1|NOT COMPLETED|Escitalopram Phase||3
8543048|NCT00219349|21062075|P1|COMPLETED|Escitalopram Phase||4
8543049|NCT00219349|21062075|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
8543050|NCT00219349|21062075|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
8543051|NCT00219349|21062075|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
8543052|NCT00219349|21062075|P1|STARTED|Cognitive Behavioral Therapy Phase||25
8543053|NCT00219284|21062088|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
8543054|NCT00219284|21062089|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
8543055|NCT00219284|21062088|P2|COMPLETED|Extension Phase - 8 Weeks||99
8543056|NCT00219284|21062089|P1|COMPLETED|Extension Phase - 8 Weeks||112
8543057|NCT00219284|21062088|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
8543058|NCT00219284|21062089|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
8543059|NCT00219284|21062088|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
8543060|NCT00219284|21062089|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
8543061|NCT00219284|21062088|P2|COMPLETED|Treatment Phase - 16 Weeks||128
8543062|NCT00219284|21062089|P1|COMPLETED|Treatment Phase - 16 Weeks||136
8543063|NCT00219284|21062088|P2|STARTED|Treatment Phase - 16 Weeks||179
8543064|NCT00219284|21062089|P1|STARTED|Treatment Phase - 16 Weeks||180
8543065|NCT00219141|21062114|P3|NOT COMPLETED|Overall Study||12
8543066|NCT00219141|21062115|P2|NOT COMPLETED|Overall Study||21
8543067|NCT00219141|21062116|P1|NOT COMPLETED|Overall Study||14
8543068|NCT00219141|21062114|P3|COMPLETED|Overall Study||142
8543069|NCT00219141|21062115|P2|COMPLETED|Overall Study||131
8543070|NCT00219141|21062116|P1|COMPLETED|Overall Study||140
8543071|NCT00219141|21062114|P3|STARTED|Overall Study||154
8543072|NCT00219141|21062115|P2|STARTED|Overall Study||152
8543073|NCT00219141|21062116|P1|STARTED|Overall Study||154
8543074|NCT00218634|21062162|P2|NOT COMPLETED|Overall Study||15
8543075|NCT00218634|21062163|P1|NOT COMPLETED|Overall Study||8
8543076|NCT00218634|21062162|P2|COMPLETED|Overall Study||30
8543077|NCT00218634|21062163|P1|COMPLETED|Overall Study||36
8543078|NCT00218634|21062162|P2|STARTED|Overall Study||45
8543079|NCT00218634|21062163|P1|STARTED|Overall Study||44
8543080|NCT00218543|21062183|P1|NOT COMPLETED|Overall Study||15
8543081|NCT00218543|21062183|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
8543082|NCT00218543|21062183|P1|STARTED|Overall Study||20
8543083|NCT00218491|21062191|P3|NOT COMPLETED|Overall Study||0
8543084|NCT00218491|21062192|P2|NOT COMPLETED|Overall Study||0
8543085|NCT00218491|21062193|P1|NOT COMPLETED|Overall Study||0
8543086|NCT00218491|21062191|P3|COMPLETED|Overall Study||38
8543087|NCT00218491|21062192|P2|COMPLETED|Overall Study||33
8543088|NCT00218491|21062193|P1|COMPLETED|Overall Study||40
8543089|NCT00218491|21062191|P3|STARTED|Overall Study||38
8543090|NCT00218491|21062192|P2|STARTED|Overall Study||33
8543091|NCT00218491|21062193|P1|STARTED|Overall Study||40
8543092|NCT00218465|21062203|P2|NOT COMPLETED|Overall Study||18
8543093|NCT00218465|21062204|P1|NOT COMPLETED|Overall Study||17
8543094|NCT00218465|21062203|P2|COMPLETED|Overall Study||30
8543095|NCT00218465|21062204|P1|COMPLETED|Overall Study||33
8543096|NCT00218465|21062203|P2|STARTED|Overall Study||48
8543097|NCT00218465|21062204|P1|STARTED|Overall Study||50
8543098|NCT00218439|21062216|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
8543099|NCT00218439|21062217|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
8543100|NCT00218439|21062216|P2|COMPLETED|Second Intervention (4 Weeks)||30
8543101|NCT00218439|21062217|P1|COMPLETED|Second Intervention (4 Weeks)||33
8543102|NCT00218439|21062216|P2|STARTED|Second Intervention (4 Weeks)||35
8543103|NCT00218439|21062217|P1|STARTED|Second Intervention (4 Weeks)||40
8543104|NCT00218439|21062216|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
8543105|NCT00218439|21062217|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
8543106|NCT00218439|21062216|P2|COMPLETED|First Intervention (4 Weeks)||35
8543107|NCT00218439|21062217|P1|COMPLETED|First Intervention (4 Weeks)||40
8543108|NCT00218439|21062216|P2|STARTED|First Intervention (4 Weeks)||47
8543109|NCT00218439|21062217|P1|STARTED|First Intervention (4 Weeks)||58
8543110|NCT00218426|21062234|P3|NOT COMPLETED|Overall Study||91
8543111|NCT00218426|21062235|P2|NOT COMPLETED|Overall Study||86
8543112|NCT00218426|21062236|P1|NOT COMPLETED|Overall Study||48
8543113|NCT00218426|21062234|P3|COMPLETED|Overall Study||11
8543114|NCT00218426|21062235|P2|COMPLETED|Overall Study||16
8543115|NCT00218426|21062236|P1|COMPLETED|Overall Study||54
8543116|NCT00218426|21062234|P3|STARTED|Overall Study||102
8543117|NCT00218426|21062235|P2|STARTED|Overall Study||102
8543118|NCT00218426|21062236|P1|STARTED|Overall Study||102
8543119|NCT00218387|21062277|P3|NOT COMPLETED|Overall Study||23
8543120|NCT00218387|21062278|P2|NOT COMPLETED|Overall Study||18
8543121|NCT00218387|21062279|P1|NOT COMPLETED|Overall Study||15
8543122|NCT00218387|21062277|P3|COMPLETED|Overall Study||17
8543123|NCT00218387|21062278|P2|COMPLETED|Overall Study||25
8543124|NCT00218387|21062279|P1|COMPLETED|Overall Study||25
8543125|NCT00218387|21062277|P3|STARTED|Overall Study||40
8543126|NCT00218387|21062278|P2|STARTED|Overall Study||43
8543127|NCT00218387|21062279|P1|STARTED|Overall Study||40
8543128|NCT00218335|21062294|P4|NOT COMPLETED|Overall Study||36
8543129|NCT00218335|21062295|P3|NOT COMPLETED|Overall Study||54
8543130|NCT00218335|21062296|P2|NOT COMPLETED|Overall Study||3
8543131|NCT00218335|21062297|P1|NOT COMPLETED|Overall Study||6
8543132|NCT00218335|21062294|P4|COMPLETED|Overall Study||388
8543133|NCT00218335|21062295|P3|COMPLETED|Overall Study||319
8543134|NCT00218335|21062296|P2|COMPLETED|Overall Study||110
8543135|NCT00218335|21062297|P1|COMPLETED|Overall Study||108
8543136|NCT00218335|21062294|P4|18 Month Follow-up|Overall Study||368
8543137|NCT00218335|21062295|P3|18 Month Follow-up|Overall Study||296
8543138|NCT00218335|21062296|P2|18 Month Follow-up|Overall Study||108
8543139|NCT00218335|21062297|P1|18 Month Follow-up|Overall Study||101
8543140|NCT00218335|21062294|P4|12 Month Follow-up|Overall Study||303
8543141|NCT00218335|21062295|P3|12 Month Follow-up|Overall Study||244
8543142|NCT00218335|21062296|P2|12 Month Follow-up|Overall Study||102
8543143|NCT00218335|21062297|P1|12 Month Follow-up|Overall Study||95
8543144|NCT00218335|21062294|P4|6 Month Follow-up|Overall Study||301
8543145|NCT00218335|21062295|P3|6 Month Follow-up|Overall Study||219
8543146|NCT00218335|21062296|P2|6 Month Follow-up|Overall Study||99
8543147|NCT00218335|21062297|P1|6 Month Follow-up|Overall Study||103
8543148|NCT00218335|21062294|P4|STARTED|Overall Study||424
8543149|NCT00218335|21062295|P3|STARTED|Overall Study||373
8543150|NCT00218335|21062296|P2|STARTED|Overall Study||113
8543151|NCT00218335|21062297|P1|STARTED|Overall Study||114
8543152|NCT00218296|21062361|P2|NOT COMPLETED|Overall Study||121
8543153|NCT00218296|21062362|P1|NOT COMPLETED|Overall Study||111
8543154|NCT00218296|21062361|P2|COMPLETED|Overall Study||48
8543155|NCT00218296|21062362|P1|COMPLETED|Overall Study||52
8543156|NCT00218296|21062361|P2|Attended Visti|Overall Study||102
8543157|NCT00218296|21062362|P1|Attended Visti|Overall Study||97
8543158|NCT00218296|21062361|P2|STARTED|Overall Study||169
8543159|NCT00218296|21062362|P1|STARTED|Overall Study||163
8543160|NCT00218257|21062378|P2|NOT COMPLETED|Intervention 2||0
8543161|NCT00218257|21062379|P1|NOT COMPLETED|Intervention 2||0
8543162|NCT00218257|21062378|P2|COMPLETED|Intervention 2||19
8543163|NCT00218257|21062379|P1|COMPLETED|Intervention 2||19
8543164|NCT00218257|21062378|P2|STARTED|Intervention 2||19
8543165|NCT00218257|21062379|P1|STARTED|Intervention 2||19
8543166|NCT00218257|21062378|P2|NOT COMPLETED|Period Between Visit 1 and 2||3
8543167|NCT00218257|21062379|P1|NOT COMPLETED|Period Between Visit 1 and 2||4
8543168|NCT00218257|21062378|P2|COMPLETED|Period Between Visit 1 and 2||19
8543169|NCT00218257|21062379|P1|COMPLETED|Period Between Visit 1 and 2||19
8543170|NCT00218257|21062378|P2|STARTED|Period Between Visit 1 and 2||22
8543171|NCT00218257|21062379|P1|STARTED|Period Between Visit 1 and 2||23
8543172|NCT00218257|21062378|P2|NOT COMPLETED|Intervention 1||0
8543173|NCT00218257|21062379|P1|NOT COMPLETED|Intervention 1||0
8543174|NCT00218257|21062378|P2|COMPLETED|Intervention 1||22
8543175|NCT00218257|21062379|P1|COMPLETED|Intervention 1||23
8543176|NCT00218257|21062378|P2|STARTED|Intervention 1||22
8543177|NCT00218257|21062379|P1|STARTED|Intervention 1||23
8543178|NCT00218062|21062397|P4|NOT COMPLETED|Overall Study||13
8543179|NCT00218062|21062398|P3|NOT COMPLETED|Overall Study||12
8543180|NCT00218062|21062399|P2|NOT COMPLETED|Overall Study||16
8543181|NCT00218062|21062400|P1|NOT COMPLETED|Overall Study||15
8543182|NCT00218062|21062397|P4|COMPLETED|Overall Study||3
8543183|NCT00218062|21062398|P3|COMPLETED|Overall Study||3
8543184|NCT00218062|21062399|P2|COMPLETED|Overall Study||4
8543185|NCT00218062|21062400|P1|COMPLETED|Overall Study||7
8543186|NCT00218062|21062397|P4|Received First Dose of Study Medication|Overall Study||12
8543187|NCT00218062|21062398|P3|Received First Dose of Study Medication|Overall Study||10
8543188|NCT00218062|21062399|P2|Received First Dose of Study Medication|Overall Study||11
8543189|NCT00218062|21062400|P1|Received First Dose of Study Medication|Overall Study||16
8543190|NCT00218062|21062397|P4|STARTED|Overall Study||16
8543191|NCT00218062|21062398|P3|STARTED|Overall Study||15
8543192|NCT00218062|21062399|P2|STARTED|Overall Study||20
8543193|NCT00218062|21062400|P1|STARTED|Overall Study||22
8543194|NCT00218036|21062431|P5|NOT COMPLETED|Overall Study||6
8543195|NCT00218036|21062432|P4|NOT COMPLETED|Overall Study||6
8543196|NCT00218036|21062433|P3|NOT COMPLETED|Overall Study||8
8543197|NCT00218036|21062434|P2|NOT COMPLETED|Overall Study||3
8543198|NCT00218036|21062435|P1|NOT COMPLETED|Overall Study||5
8543199|NCT00218036|21062431|P5|COMPLETED|Overall Study||3
8543200|NCT00218036|21062432|P4|COMPLETED|Overall Study||6
8543201|NCT00218036|21062433|P3|COMPLETED|Overall Study||5
8543202|NCT00218036|21062434|P2|COMPLETED|Overall Study||3
8543203|NCT00218036|21062435|P1|COMPLETED|Overall Study||6
8543204|NCT00218036|21062431|P5|STARTED|Overall Study||9
8543205|NCT00218036|21062432|P4|STARTED|Overall Study||12
8543206|NCT00218036|21062433|P3|STARTED|Overall Study||13
8543207|NCT00218036|21062434|P2|STARTED|Overall Study||6
8543208|NCT00218036|21062435|P1|STARTED|Overall Study||11
8543209|NCT00218023|21062461|P4|NOT COMPLETED|Overall Study||7
8543210|NCT00218023|21062462|P3|NOT COMPLETED|Overall Study||10
8543211|NCT00218023|21062463|P2|NOT COMPLETED|Overall Study||15
8543212|NCT00218023|21062464|P1|NOT COMPLETED|Overall Study||13
8543213|NCT00218023|21062461|P4|COMPLETED|Overall Study||11
8543214|NCT00218023|21062462|P3|COMPLETED|Overall Study||6
8543215|NCT00218023|21062463|P2|COMPLETED|Overall Study||10
8543216|NCT00218023|21062464|P1|COMPLETED|Overall Study||9
8543217|NCT00218023|21062461|P4|Received Drug or Placebo in Phase II|Overall Study||18
8543218|NCT00218023|21062462|P3|Received Drug or Placebo in Phase II|Overall Study||15
8543219|NCT00218023|21062463|P2|Received Drug or Placebo in Phase II|Overall Study||24
8543220|NCT00218023|21062464|P1|Received Drug or Placebo in Phase II|Overall Study||18
8543221|NCT00218023|21062461|P4|STARTED|Overall Study||18
8543222|NCT00218023|21062462|P3|STARTED|Overall Study||16
8543223|NCT00218023|21062463|P2|STARTED|Overall Study||25
8543224|NCT00218023|21062464|P1|STARTED|Overall Study||22
8543225|NCT00217971|21062480|P2|NOT COMPLETED|Overall Study||33
8543226|NCT00217971|21062481|P1|NOT COMPLETED|Overall Study||24
8543227|NCT00217971|21062480|P2|COMPLETED|Overall Study||44
8543228|NCT00217971|21062481|P1|COMPLETED|Overall Study||55
8543229|NCT00217971|21062480|P2|STARTED|Overall Study||77
8543230|NCT00217971|21062481|P1|STARTED|Overall Study||79
8543231|NCT00217724|21062487|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
8543232|NCT00217724|21062488|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
8543233|NCT00217724|21062487|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
8543234|NCT00217724|21062488|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
8543235|NCT00217724|21062487|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
8543236|NCT00217724|21062488|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
8543237|NCT00217724|21062487|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
8543238|NCT00217724|21062488|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
8543239|NCT00217724|21062487|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
8543240|NCT00217724|21062488|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
8543241|NCT00217724|21062487|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
8543242|NCT00217724|21062488|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
8543243|NCT00217672|21062496|P2|NOT COMPLETED|Follow-up||0
8543244|NCT00217672|21062497|P1|NOT COMPLETED|Follow-up||5
8543245|NCT00217672|21062496|P2|COMPLETED|Follow-up||0
8543246|NCT00217672|21062497|P1|COMPLETED|Follow-up||69
8543247|NCT00217672|21062496|P2|STARTED|Follow-up||0
8543248|NCT00217672|21062497|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
8543249|NCT00217672|21062496|P2|NOT COMPLETED|Treatment||7
8543250|NCT00217672|21062497|P1|NOT COMPLETED|Treatment||67
8543251|NCT00217672|21062496|P2|COMPLETED|Treatment||0
8543252|NCT00217672|21062497|P1|COMPLETED|Treatment||0
8543253|NCT00217672|21062496|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
8543254|NCT00217672|21062497|P1|STARTED|Treatment||67
8543255|NCT00217672|21062496|P2|NOT COMPLETED|Allocation||0
8543256|NCT00217672|21062497|P1|NOT COMPLETED|Allocation||2
8543257|NCT00217672|21062496|P2|COMPLETED|Allocation||7
8543258|NCT00217672|21062497|P1|COMPLETED|Allocation||67
8543259|NCT00217672|21062496|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
8543260|NCT00217672|21062497|P1|STARTED|Allocation||69
8543261|NCT00217620|21062503|P1|NOT COMPLETED|Overall Study||51
8543262|NCT00217620|21062503|P1|COMPLETED|Overall Study||0
8543263|NCT00217620|21062503|P1|Eligible and Began Protocol Therapy|Overall Study||37
8543264|NCT00217620|21062503|P1|Eligible|Overall Study||38
8543265|NCT00217620|21062503|P1|STARTED|Overall Study||51
8543266|NCT00217594|21062514|P1|NOT COMPLETED|Overall Study||0
8543267|NCT00217594|21062514|P1|COMPLETED|Overall Study||31
8543268|NCT00217594|21062514|P1|STARTED|Overall Study||31
8543269|NCT00217581|21062518|P1|NOT COMPLETED|Overall Study||1
8543270|NCT00217581|21062518|P1|COMPLETED|Overall Study||38
8543271|NCT00217581|21062518|P1|STARTED|Overall Study||39
8543272|NCT00217490|21062530|P4|NOT COMPLETED|Overall Study||23
8543273|NCT00217490|21062531|P3|NOT COMPLETED|Overall Study||24
8543274|NCT00217490|21062532|P2|NOT COMPLETED|Overall Study||25
8543275|NCT00217490|21062533|P1|NOT COMPLETED|Overall Study||17
8543276|NCT00217490|21062530|P4|COMPLETED|Overall Study||130
8543277|NCT00217490|21062531|P3|COMPLETED|Overall Study||131
8543278|NCT00217490|21062532|P2|COMPLETED|Overall Study||128
8543279|NCT00217490|21062533|P1|COMPLETED|Overall Study||137
8543280|NCT00217490|21062530|P4|STARTED|Overall Study||153
8543281|NCT00217490|21062531|P3|STARTED|Overall Study||155
8543282|NCT00217490|21062532|P2|STARTED|Overall Study||153
8543283|NCT00217490|21062533|P1|STARTED|Overall Study||154
8543284|NCT00217464|21062547|P1|NOT COMPLETED|Overall Study||17
8543285|NCT00217464|21062547|P1|COMPLETED|Overall Study||0
8543286|NCT00217464|21062547|P1|STARTED|Overall Study||17
8543287|NCT00217438|21062554|P2|NOT COMPLETED|Overall Study||1
8543288|NCT00217438|21062555|P1|NOT COMPLETED|Overall Study||0
8543289|NCT00217438|21062554|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
8543290|NCT00217438|21062555|P1|COMPLETED|Overall Study||66
8543291|NCT00217438|21062554|P2|STARTED|Overall Study||64
8543292|NCT00217438|21062555|P1|STARTED|Overall Study||66
8543293|NCT00217425|21062563|P1|NOT COMPLETED|Overall Study||37
8543294|NCT00217425|21062563|P1|COMPLETED|Overall Study||9
8543295|NCT00217425|21062563|P1|Eligible and Treated|Overall Study||39
8543296|NCT00217425|21062563|P1|Treated|Overall Study||44
8543297|NCT00217425|21062563|P1|STARTED|Overall Study||46
8543298|NCT00217399|21062569|P1|NOT COMPLETED|Overall Study||0
8543299|NCT00217399|21062569|P1|COMPLETED|Overall Study||35
8543300|NCT00217399|21062569|P1|STARTED|Overall Study||35
8543301|NCT00217087|21062577|P2|NOT COMPLETED|Overall Study||20
8543302|NCT00217087|21062578|P1|NOT COMPLETED|Overall Study||11
8543303|NCT00217087|21062577|P2|COMPLETED|Overall Study||17
8543304|NCT00217087|21062578|P1|COMPLETED|Overall Study||25
8543305|NCT00217087|21062577|P2|STARTED|Overall Study||37
8543306|NCT00217087|21062578|P1|STARTED|Overall Study||36
8543307|NCT00217022|21062592|P2|NOT COMPLETED|Overall Study||1
8543308|NCT00217022|21062593|P1|NOT COMPLETED|Overall Study||1
8543309|NCT00217022|21062592|P2|COMPLETED|Overall Study||3
8543310|NCT00217022|21062593|P1|COMPLETED|Overall Study||11
8543311|NCT00217022|21062592|P2|STARTED|Overall Study||4
8543312|NCT00217022|21062593|P1|STARTED|Overall Study||12
8543313|NCT00216736|21062603|P2|NOT COMPLETED|Overall Study||1
8543314|NCT00216736|21062604|P1|NOT COMPLETED|Overall Study||1
8543315|NCT00216736|21062603|P2|COMPLETED|Overall Study||30
8543316|NCT00216736|21062604|P1|COMPLETED|Overall Study||31
8543317|NCT00216736|21062603|P2|STARTED|Overall Study||31
8543318|NCT00216736|21062604|P1|STARTED|Overall Study||32
8543319|NCT00216671|21062618|P2|NOT COMPLETED|Overall Study||50
8543320|NCT00216671|21062619|P1|NOT COMPLETED|Overall Study||35
8543321|NCT00216671|21062618|P2|COMPLETED|Overall Study||60
8543322|NCT00216671|21062619|P1|COMPLETED|Overall Study||75
8543323|NCT00216671|21062618|P2|STARTED|Overall Study||110
8543324|NCT00216671|21062619|P1|STARTED|Overall Study||110
8543325|NCT00216476|21062637|P3|NOT COMPLETED|Overall Study||17
8543326|NCT00216476|21062638|P2|NOT COMPLETED|Overall Study||107
8543327|NCT00216476|21062639|P1|NOT COMPLETED|Overall Study||105
8543328|NCT00216476|21062637|P3|COMPLETED|Overall Study||28
8543329|NCT00216476|21062638|P2|COMPLETED|Overall Study||230
8543330|NCT00216476|21062639|P1|COMPLETED|Overall Study||224
8543331|NCT00216476|21062637|P3|STARTED|Overall Study||45
8543332|NCT00216476|21062638|P2|STARTED|Overall Study||337
8543333|NCT00216476|21062639|P1|STARTED|Overall Study||329
8543334|NCT00216320|21062659|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
8543335|NCT00216320|21062660|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
8543336|NCT00216320|21062661|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
8543337|NCT00216320|21062659|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
8543338|NCT00216320|21062660|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
8543339|NCT00216320|21062661|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
8543340|NCT00216320|21062659|P3|STARTED|Phase 2 (Weeks 6 -12)||25
8543341|NCT00216320|21062660|P2|STARTED|Phase 2 (Weeks 6 -12)||35
8543342|NCT00216320|21062661|P1|STARTED|Phase 2 (Weeks 6 -12)||43
8543343|NCT00216320|21062659|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
8543344|NCT00216320|21062660|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
8543345|NCT00216320|21062661|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
8543346|NCT00216320|21062659|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
8543347|NCT00216320|21062660|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
8543348|NCT00216320|21062661|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
8543349|NCT00216320|21062659|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
8543350|NCT00216320|21062660|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
8543351|NCT00216320|21062661|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
8543352|NCT00216203|21062676|P1|NOT COMPLETED|Overall Study||2
8543353|NCT00216203|21062676|P1|COMPLETED|Overall Study||34
8543354|NCT00216203|21062676|P1|STARTED|Overall Study||36
8543355|NCT00216125|21062684|P3|NOT COMPLETED|Randomization Phase||8
8543356|NCT00216125|21062685|P2|NOT COMPLETED|Randomization Phase||11
8543357|NCT00216125|21062686|P1|NOT COMPLETED|Randomization Phase||0
8543358|NCT00216125|21062684|P3|COMPLETED|Randomization Phase||74
8543359|NCT00216125|21062685|P2|COMPLETED|Randomization Phase||73
8543360|NCT00216125|21062686|P1|COMPLETED|Randomization Phase||0
8543361|NCT00216125|21062684|P3|DSMB Cohort for Futility|Randomization Phase||74
8543362|NCT00216125|21062685|P2|DSMB Cohort for Futility|Randomization Phase||73
8543363|NCT00216125|21062686|P1|DSMB Cohort for Futility|Randomization Phase||0
8543364|NCT00216125|21062684|P3|STARTED|Randomization Phase||82
8543365|NCT00216125|21062685|P2|STARTED|Randomization Phase||84
8543366|NCT00216125|21062686|P1|STARTED|Randomization Phase||0
8543367|NCT00216125|21062684|P3|NOT COMPLETED|Pre-Randomization Phase||0
8543368|NCT00216125|21062685|P2|NOT COMPLETED|Pre-Randomization Phase||0
8543369|NCT00216125|21062686|P1|NOT COMPLETED|Pre-Randomization Phase||77
8543370|NCT00216125|21062684|P3|COMPLETED|Pre-Randomization Phase||0
8543371|NCT00216125|21062685|P2|COMPLETED|Pre-Randomization Phase||0
8543372|NCT00216125|21062686|P1|COMPLETED|Pre-Randomization Phase||166
8543373|NCT00216125|21062684|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
8543374|NCT00216125|21062685|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
8543375|NCT00216125|21062686|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
8543376|NCT00216125|21062684|P3|STARTED|Pre-Randomization Phase||0
8543377|NCT00216125|21062685|P2|STARTED|Pre-Randomization Phase||0
8543378|NCT00216125|21062686|P1|STARTED|Pre-Randomization Phase||243
8543379|NCT00216099|21062695|P1|NOT COMPLETED|Overall Study||1
8543380|NCT00216099|21062695|P1|COMPLETED|Overall Study||48
8543381|NCT00216099|21062695|P1|Response Analysis|Overall Study||48
8543382|NCT00216099|21062695|P1|Toxicity Analysis|Overall Study||49
8543383|NCT00216099|21062695|P1|STARTED|Overall Study||49
8543384|NCT00216086|21062706|P1|NOT COMPLETED|Overall Study||4
8543385|NCT00216086|21062706|P1|COMPLETED|Overall Study||18
8543386|NCT00216086|21062706|P1|STARTED|Overall Study||22
8543387|NCT00216060|21062715|P2|NOT COMPLETED|Overall Study||0
8543388|NCT00216060|21062716|P1|NOT COMPLETED|Overall Study||0
8543389|NCT00216060|21062715|P2|COMPLETED|Overall Study||31
8543390|NCT00216060|21062716|P1|COMPLETED|Overall Study||32
8543391|NCT00216060|21062715|P2|STARTED|Overall Study||31
8543392|NCT00216060|21062716|P1|STARTED|Overall Study||32
8543393|NCT00215943|21062738|P2|NOT COMPLETED|Overall Study||14
8543394|NCT00215943|21062739|P1|NOT COMPLETED|Overall Study||9
8543395|NCT00215943|21062738|P2|COMPLETED|Overall Study||23
8543396|NCT00215943|21062739|P1|COMPLETED|Overall Study||27
8543397|NCT00215943|21062738|P2|STARTED|Overall Study||37
8543398|NCT00215943|21062739|P1|STARTED|Overall Study||36
8543399|NCT00215930|21062751|P1|NOT COMPLETED|Overall Study||0
8543400|NCT00215930|21062751|P1|COMPLETED|Overall Study||53
8543401|NCT00215930|21062751|P1|STARTED|Overall Study||53
8543402|NCT00215787|21062757|P1|NOT COMPLETED|Overall Study||0
8543403|NCT00215787|21062757|P1|COMPLETED|Overall Study||20
8543404|NCT00215787|21062757|P1|STARTED|Overall Study||20
8543405|NCT00215683|21062764|P3|NOT COMPLETED|Overall Study||32
8543406|NCT00215683|21062765|P2|NOT COMPLETED|Overall Study||26
8543407|NCT00215683|21062766|P1|NOT COMPLETED|Overall Study||29
8543408|NCT00215683|21062764|P3|COMPLETED|Overall Study||12
8543409|NCT00215683|21062765|P2|COMPLETED|Overall Study||22
8543410|NCT00215683|21062766|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
8543411|NCT00215683|21062764|P3|Switched to 160 mg|Overall Study||36
8543412|NCT00215683|21062765|P2|Switched to 160 mg|Overall Study||41
8543413|NCT00215683|21062766|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
8543414|NCT00215683|21062764|P3|STARTED|Overall Study||44
8543415|NCT00215683|21062765|P2|STARTED|Overall Study||48
8543416|NCT00215683|21062766|P1|STARTED|Overall Study|Safety analysis set|45
8543417|NCT00215657|21062785|P8|NOT COMPLETED|Overall Study||16
8543418|NCT00215657|21062786|P7|NOT COMPLETED|Overall Study||23
8543419|NCT00215657|21062787|P6|NOT COMPLETED|Overall Study||20
8543420|NCT00215657|21062788|P5|NOT COMPLETED|Overall Study||23
8543421|NCT00215657|21062789|P4|NOT COMPLETED|Overall Study||18
8543422|NCT00215657|21062790|P3|NOT COMPLETED|Overall Study||11
8543423|NCT00215657|21062791|P2|NOT COMPLETED|Overall Study||11
8543424|NCT00215657|21062792|P1|NOT COMPLETED|Overall Study||22
8543425|NCT00215657|21062785|P8|COMPLETED|Overall Study||11
8543426|NCT00215657|21062786|P7|COMPLETED|Overall Study||4
8543427|NCT00215657|21062787|P6|COMPLETED|Overall Study||4
8543428|NCT00215657|21062788|P5|COMPLETED|Overall Study||4
8543429|NCT00215657|21062789|P4|COMPLETED|Overall Study||6
8543430|NCT00215657|21062790|P3|COMPLETED|Overall Study||2
8543431|NCT00215657|21062791|P2|COMPLETED|Overall Study||1
8543432|NCT00215657|21062792|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
8543433|NCT00215657|21062785|P8|Started FE200486 CS07A|Overall Study||23
8543434|NCT00215657|21062786|P7|Started FE200486 CS07A|Overall Study||14
8543435|NCT00215657|21062787|P6|Started FE200486 CS07A|Overall Study||20
8543436|NCT00215657|21062788|P5|Started FE200486 CS07A|Overall Study||17
8543437|NCT00215657|21062789|P4|Started FE200486 CS07A|Overall Study||24
8543438|NCT00215657|21062790|P3|Started FE200486 CS07A|Overall Study||7
8543439|NCT00215657|21062791|P2|Started FE200486 CS07A|Overall Study||6
8543440|NCT00215657|21062792|P1|Started FE200486 CS07A|Overall Study||20
8543441|NCT00215657|21062785|P8|Intention-to-treat Population|Overall Study||27
8543442|NCT00215657|21062786|P7|Intention-to-treat Population|Overall Study||24
8543443|NCT00215657|21062787|P6|Intention-to-treat Population|Overall Study||24
8543444|NCT00215657|21062788|P5|Intention-to-treat Population|Overall Study||24
8543445|NCT00215657|21062789|P4|Intention-to-treat Population|Overall Study||24
8543446|NCT00215657|21062790|P3|Intention-to-treat Population|Overall Study||12
8543447|NCT00215657|21062791|P2|Intention-to-treat Population|Overall Study||12
8543448|NCT00215657|21062792|P1|Intention-to-treat Population|Overall Study||25
8543449|NCT00215657|21062785|P8|STARTED|Overall Study||27
8543450|NCT00215657|21062786|P7|STARTED|Overall Study||27
8543451|NCT00215657|21062787|P6|STARTED|Overall Study||24
8543452|NCT00215657|21062788|P5|STARTED|Overall Study||27
8543453|NCT00215657|21062789|P4|STARTED|Overall Study||24
8543454|NCT00215657|21062790|P3|STARTED|Overall Study||13
8543455|NCT00215657|21062791|P2|STARTED|Overall Study||12
8543456|NCT00215657|21062792|P1|STARTED|Overall Study||26
8543457|NCT00215644|21062820|P2|NOT COMPLETED|Overall Study||36
8543458|NCT00215644|21062821|P1|NOT COMPLETED|Overall Study||36
8543459|NCT00215644|21062820|P2|COMPLETED|Overall Study||0
8543460|NCT00215644|21062821|P1|COMPLETED|Overall Study||0
8543461|NCT00215644|21062820|P2|Treated|Overall Study||36
8543462|NCT00215644|21062821|P1|Treated|Overall Study||35
8543463|NCT00215644|21062820|P2|STARTED|Overall Study||36
8543464|NCT00215644|21062821|P1|STARTED|Overall Study||36
8543465|NCT00215553|21062848|P7|NOT COMPLETED|Overall Study||0
8543466|NCT00215553|21062849|P6|NOT COMPLETED|Overall Study||6
8543467|NCT00215553|21062850|P5|NOT COMPLETED|Overall Study||2
8543468|NCT00215553|21062851|P4|NOT COMPLETED|Overall Study||1
8543469|NCT00215553|21062852|P3|NOT COMPLETED|Overall Study||2
8543470|NCT00215553|21062853|P2|NOT COMPLETED|Overall Study||1
8543471|NCT00215553|21062854|P1|NOT COMPLETED|Overall Study||0
8543472|NCT00215553|21062848|P7|COMPLETED|Overall Study||36
8543473|NCT00215553|21062849|P6|COMPLETED|Overall Study||32
8543474|NCT00215553|21062850|P5|COMPLETED|Overall Study||26
8543475|NCT00215553|21062851|P4|COMPLETED|Overall Study||4
8543476|NCT00215553|21062852|P3|COMPLETED|Overall Study||4
8543477|NCT00215553|21062853|P2|COMPLETED|Overall Study||5
8543478|NCT00215553|21062854|P1|COMPLETED|Overall Study||5
8543479|NCT00215553|21062848|P7|STARTED|Overall Study||36
8543480|NCT00215553|21062849|P6|STARTED|Overall Study||38
8543481|NCT00215553|21062850|P5|STARTED|Overall Study||28
8543482|NCT00215553|21062851|P4|STARTED|Overall Study||5
8543483|NCT00215553|21062852|P3|STARTED|Overall Study||6
8543484|NCT00215553|21062853|P2|STARTED|Overall Study||6
8543485|NCT00215553|21062854|P1|STARTED|Overall Study||5
8543486|NCT00215540|21062887|P3|NOT COMPLETED|Overall Study||0
8543487|NCT00215540|21062888|P2|NOT COMPLETED|Overall Study||0
8543488|NCT00215540|21062889|P1|NOT COMPLETED|Overall Study||1
8543489|NCT00215540|21062887|P3|COMPLETED|Overall Study||44
8543490|NCT00215540|21062888|P2|COMPLETED|Overall Study||47
8543491|NCT00215540|21062889|P1|COMPLETED|Overall Study||44
8543492|NCT00215540|21062887|P3|STARTED|Overall Study||44
8543493|NCT00215540|21062888|P2|STARTED|Overall Study||47
8543494|NCT00215540|21062889|P1|STARTED|Overall Study||45
8543495|NCT00215150|21062924|P1|NOT COMPLETED|Randomization Phase Placebo||1
8543496|NCT00215150|21062924|P1|COMPLETED|Randomization Phase Placebo||10
8543497|NCT00215150|21062924|P1|STARTED|Randomization Phase Placebo||11
8543498|NCT00215150|21062924|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
8543499|NCT00215150|21062924|P1|COMPLETED|Randomization Phase Ziprasidone||7
8543500|NCT00215150|21062924|P1|STARTED|Randomization Phase Ziprasidone||10
8543501|NCT00215150|21062924|P1|NOT COMPLETED|Open Label Phase||30
8543502|NCT00215150|21062924|P1|COMPLETED|Open Label Phase||21
8543503|NCT00215150|21062924|P1|STARTED|Open Label Phase|Number of subjects consented|51
8543504|NCT00215137|21062932|P3|NOT COMPLETED|Randomization Period||0
8543505|NCT00215137|21062933|P2|NOT COMPLETED|Randomization Period||2
8543506|NCT00215137|21062934|P1|NOT COMPLETED|Randomization Period||0
8543507|NCT00215137|21062932|P3|COMPLETED|Randomization Period||5
8543508|NCT00215137|21062933|P2|COMPLETED|Randomization Period||5
8543509|NCT00215137|21062934|P1|COMPLETED|Randomization Period||0
8543510|NCT00215137|21062932|P3|STARTED|Randomization Period||5
8543511|NCT00215137|21062933|P2|STARTED|Randomization Period||7
8543512|NCT00215137|21062934|P1|STARTED|Randomization Period||0
8543513|NCT00215137|21062932|P3|NOT COMPLETED|Open Label Escitalopram||0
8543514|NCT00215137|21062933|P2|NOT COMPLETED|Open Label Escitalopram||0
8543515|NCT00215137|21062934|P1|NOT COMPLETED|Open Label Escitalopram||1
8543516|NCT00215137|21062932|P3|COMPLETED|Open Label Escitalopram||0
8543517|NCT00215137|21062933|P2|COMPLETED|Open Label Escitalopram||0
8543518|NCT00215137|21062934|P1|COMPLETED|Open Label Escitalopram||13
8543519|NCT00215137|21062932|P3|STARTED|Open Label Escitalopram||0
8543520|NCT00215137|21062933|P2|STARTED|Open Label Escitalopram||0
8543521|NCT00215137|21062934|P1|STARTED|Open Label Escitalopram||14
8543522|NCT00214903|21062946|P4|NOT COMPLETED|Overall Study||0
8543523|NCT00214903|21062947|P3|NOT COMPLETED|Overall Study||0
8543524|NCT00214903|21062948|P2|NOT COMPLETED|Overall Study||0
8543525|NCT00214903|21062949|P1|NOT COMPLETED|Overall Study||0
8543526|NCT00214903|21062946|P4|COMPLETED|Overall Study||3057
8543527|NCT00214903|21062947|P3|COMPLETED|Overall Study||4113
8543528|NCT00214903|21062948|P2|COMPLETED|Overall Study||13384
8543529|NCT00214903|21062949|P1|COMPLETED|Overall Study||10043
8543530|NCT00214903|21062946|P4|STARTED|Overall Study||3057
8543531|NCT00214903|21062947|P3|STARTED|Overall Study||4113
8543532|NCT00214903|21062948|P2|STARTED|Overall Study||13384
8543533|NCT00214903|21062949|P1|STARTED|Overall Study||10043
8543534|NCT00214786|21062963|P1|NOT COMPLETED|Overall Study||3
8543535|NCT00214786|21062963|P1|COMPLETED|Overall Study||1
8543536|NCT00214786|21062963|P1|STARTED|Overall Study||4
8543561|NCT00214526|21063005|P2|NOT COMPLETED|Post-Treatment Period||0
8543562|NCT00214526|21063006|P1|NOT COMPLETED|Post-Treatment Period||1
8543563|NCT00214526|21063005|P2|COMPLETED|Post-Treatment Period||49
8543564|NCT00214526|21063006|P1|COMPLETED|Post-Treatment Period||52
8543565|NCT00214526|21063005|P2|STARTED|Post-Treatment Period||49
8543566|NCT00214526|21063006|P1|STARTED|Post-Treatment Period||53
8543567|NCT00214526|21063005|P2|NOT COMPLETED|Treatment Period||5
8543568|NCT00214526|21063006|P1|NOT COMPLETED|Treatment Period||2
8543569|NCT00214526|21063005|P2|COMPLETED|Treatment Period||49
8543570|NCT00214526|21063006|P1|COMPLETED|Treatment Period||53
8543571|NCT00214526|21063005|P2|STARTED|Treatment Period||54
8543572|NCT00214526|21063006|P1|STARTED|Treatment Period||55
8543573|NCT00214526|21063005|P2|NOT COMPLETED|Randomized||2
8543574|NCT00214526|21063006|P1|NOT COMPLETED|Randomized||1
8543575|NCT00214526|21063005|P2|COMPLETED|Randomized||54
8543576|NCT00214526|21063006|P1|COMPLETED|Randomized||55
8543577|NCT00214526|21063005|P2|STARTED|Randomized||56
8543578|NCT00214526|21063006|P1|STARTED|Randomized||56
8543579|NCT00214500|21063032|P1|NOT COMPLETED|Extension Period||2
8543580|NCT00214500|21063032|P1|COMPLETED|Extension Period||6
8543581|NCT00214500|21063032|P1|STARTED|Extension Period||8
8543582|NCT00214500|21063032|P1|NOT COMPLETED|Treatment Period||1
8543583|NCT00214500|21063032|P1|COMPLETED|Treatment Period||8
8543584|NCT00214500|21063032|P1|Pharmacodynamic (PD) Population|Treatment Period||9
8543585|NCT00214500|21063032|P1|Pharmacokinetic (PK) Population|Treatment Period||9
8543586|NCT00214500|21063032|P1|Safety Population|Treatment Period||9
8543587|NCT00214500|21063032|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
8543588|NCT00214487|21063042|P2|NOT COMPLETED|Overall Study||3
8543589|NCT00214487|21063043|P1|NOT COMPLETED|Overall Study||5
8543590|NCT00214487|21063042|P2|COMPLETED|Overall Study||40
8543591|NCT00214487|21063043|P1|COMPLETED|Overall Study||38
8543592|NCT00214487|21063042|P2|STARTED|Overall Study||43
8543593|NCT00214487|21063043|P1|STARTED|Overall Study||43
8543594|NCT00214461|21063053|P4|NOT COMPLETED|Overall Study||1
8543595|NCT00214461|21063054|P3|NOT COMPLETED|Overall Study||2
8543596|NCT00214461|21063055|P2|NOT COMPLETED|Overall Study||0
8543597|NCT00214461|21063056|P1|NOT COMPLETED|Overall Study||0
8543598|NCT00214461|21063053|P4|COMPLETED|Overall Study||11
8543599|NCT00214461|21063054|P3|COMPLETED|Overall Study||10
8543600|NCT00214461|21063055|P2|COMPLETED|Overall Study||12
8543601|NCT00214461|21063056|P1|COMPLETED|Overall Study||12
8543602|NCT00214461|21063053|P4|STARTED|Overall Study||12
8543603|NCT00214461|21063054|P3|STARTED|Overall Study||12
8543604|NCT00214461|21063055|P2|STARTED|Overall Study||12
8543605|NCT00214461|21063056|P1|STARTED|Overall Study||12
8543606|NCT00214422|21063073|P3|NOT COMPLETED|Overall Study||1
8543607|NCT00214422|21063074|P2|NOT COMPLETED|Overall Study||1
8543608|NCT00214422|21063075|P1|NOT COMPLETED|Overall Study||5
8543609|NCT00214422|21063073|P3|COMPLETED|Overall Study||3
8543610|NCT00214422|21063074|P2|COMPLETED|Overall Study||2
8543611|NCT00214422|21063075|P1|COMPLETED|Overall Study||7
8543612|NCT00214422|21063073|P3|STARTED|Overall Study||4
8543613|NCT00214422|21063074|P2|STARTED|Overall Study||3
8543614|NCT00214422|21063075|P1|STARTED|Overall Study||12
8543615|NCT00214383|21063098|P2|NOT COMPLETED|Overall Study||26
8543616|NCT00214383|21063099|P1|NOT COMPLETED|Overall Study||16
8543617|NCT00214383|21063098|P2|COMPLETED|Overall Study||127
8543618|NCT00214383|21063099|P1|COMPLETED|Overall Study||132
8543619|NCT00214383|21063098|P2|STARTED|Overall Study||153
8543620|NCT00214383|21063099|P1|STARTED|Overall Study||148
8543621|NCT00214201|21063111|P2|NOT COMPLETED|Overall Study||2
8543622|NCT00214201|21063112|P1|NOT COMPLETED|Overall Study||2
8543623|NCT00214201|21063111|P2|COMPLETED|Overall Study||18
8543624|NCT00214201|21063112|P1|COMPLETED|Overall Study||18
8543625|NCT00214201|21063111|P2|STARTED|Overall Study||20
8543626|NCT00214201|21063112|P1|STARTED|Overall Study||20
8543627|NCT00214149|21063122|P1|NOT COMPLETED|Overall Study||127
8543720|NCT00213135|21063242|P1|STARTED|Overall Study||456
8543628|NCT00214149|21063122|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
8543629|NCT00214149|21063122|P1|STARTED|Overall Study||127
8543630|NCT00214136|21063127|P1|NOT COMPLETED|Overall Study||5
8543631|NCT00214136|21063127|P1|COMPLETED|Overall Study||25
8543632|NCT00214136|21063127|P1|STARTED|Overall Study||30
8543633|NCT00214097|21063135|P3|NOT COMPLETED|Overall Study||0
8543634|NCT00214097|21063136|P2|NOT COMPLETED|Overall Study||0
8543635|NCT00214097|21063137|P1|NOT COMPLETED|Overall Study||0
8543636|NCT00214097|21063135|P3|COMPLETED|Overall Study||135
8543637|NCT00214097|21063136|P2|COMPLETED|Overall Study||111
8543638|NCT00214097|21063137|P1|COMPLETED|Overall Study||101
8543639|NCT00214097|21063135|P3|STARTED|Overall Study||135
8543640|NCT00214097|21063136|P2|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
8543641|NCT00214097|21063137|P1|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
8543642|NCT00214045|21063165|P2|NOT COMPLETED|Overall Study||0
8543643|NCT00214045|21063166|P1|NOT COMPLETED|Overall Study||0
8543644|NCT00214045|21063165|P2|COMPLETED|Overall Study||18
8543645|NCT00214045|21063166|P1|COMPLETED|Overall Study||18
8543646|NCT00214045|21063165|P2|STARTED|Overall Study||18
8543647|NCT00214045|21063166|P1|STARTED|Overall Study||18
8543648|NCT00214019|21063172|P1|NOT COMPLETED|Overall Study||30
8543649|NCT00214019|21063172|P1|COMPLETED|Overall Study||6
8543650|NCT00214019|21063172|P1|Fluticason/Salmeterol Arm|Overall Study||6
8543651|NCT00214019|21063172|P1|Fluticasone/Placebo Arm|Overall Study||6
8543652|NCT00214019|21063172|P1|Placebo/Salmeterol Arm|Overall Study||6
8543653|NCT00214019|21063172|P1|Placebo/Placebo Arm|Overall Study||6
8543654|NCT00214019|21063172|P1|STARTED|Overall Study||36
8543655|NCT00213980|21063181|P2|NOT COMPLETED|Overall Study||7
8543656|NCT00213980|21063182|P1|NOT COMPLETED|Overall Study||6
8543657|NCT00213980|21063181|P2|COMPLETED|Overall Study||29
8543658|NCT00213980|21063182|P1|COMPLETED|Overall Study||26
8543659|NCT00213980|21063181|P2|STARTED|Overall Study||36
8543660|NCT00213980|21063182|P1|STARTED|Overall Study||32
8543661|NCT00213239|21063196|P2|NOT COMPLETED|Overall Study||0
8543662|NCT00213239|21063197|P1|NOT COMPLETED|Overall Study||0
8543663|NCT00213239|21063196|P2|COMPLETED|Overall Study||32
8543664|NCT00213239|21063197|P1|COMPLETED|Overall Study||32
8543665|NCT00213239|21063196|P2|STARTED|Overall Study||32
8543666|NCT00213239|21063197|P1|STARTED|Overall Study||32
8543667|NCT00213148|21063209|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
8543668|NCT00213148|21063210|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
8543669|NCT00213148|21063211|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
8543670|NCT00213148|21063212|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
8543671|NCT00213148|21063213|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
8543672|NCT00213148|21063209|P5|COMPLETED|Cycle 3 (1 Month)||21
8543673|NCT00213148|21063210|P4|COMPLETED|Cycle 3 (1 Month)||23
8543674|NCT00213148|21063211|P3|COMPLETED|Cycle 3 (1 Month)||25
8543675|NCT00213148|21063212|P2|COMPLETED|Cycle 3 (1 Month)||8
8543676|NCT00213148|21063213|P1|COMPLETED|Cycle 3 (1 Month)||23
8543677|NCT00213148|21063209|P5|STARTED|Cycle 3 (1 Month)||22
8543678|NCT00213148|21063210|P4|STARTED|Cycle 3 (1 Month)||24
8543679|NCT00213148|21063211|P3|STARTED|Cycle 3 (1 Month)||26
8543680|NCT00213148|21063212|P2|STARTED|Cycle 3 (1 Month)||10
8543681|NCT00213148|21063213|P1|STARTED|Cycle 3 (1 Month)||23
8543682|NCT00213148|21063209|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
8543683|NCT00213148|21063210|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
8543684|NCT00213148|21063211|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
8543685|NCT00213148|21063212|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
8543686|NCT00213148|21063213|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
8543687|NCT00213148|21063209|P5|COMPLETED|Cycle 2 (1 Month)||11
8543688|NCT00213148|21063210|P4|COMPLETED|Cycle 2 (1 Month)||33
8543689|NCT00213148|21063211|P3|COMPLETED|Cycle 2 (1 Month)||28
8543690|NCT00213148|21063212|P2|COMPLETED|Cycle 2 (1 Month)||4
8543691|NCT00213148|21063213|P1|COMPLETED|Cycle 2 (1 Month)||29
8543692|NCT00213148|21063209|P5|STARTED|Cycle 2 (1 Month)||41
8543693|NCT00213148|21063210|P4|STARTED|Cycle 2 (1 Month)||52
8543694|NCT00213148|21063211|P3|STARTED|Cycle 2 (1 Month)||42
8543695|NCT00213148|21063212|P2|STARTED|Cycle 2 (1 Month)||10
8543696|NCT00213148|21063213|P1|STARTED|Cycle 2 (1 Month)||43
8543697|NCT00213148|21063209|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
8543698|NCT00213148|21063210|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
8543699|NCT00213148|21063211|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
8543700|NCT00213148|21063212|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
8543701|NCT00213148|21063213|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
8543702|NCT00213148|21063209|P5|COMPLETED|Cycle 1 (1 Month)||17
8543703|NCT00213148|21063210|P4|COMPLETED|Cycle 1 (1 Month)||58
8543704|NCT00213148|21063211|P3|COMPLETED|Cycle 1 (1 Month)||60
8543705|NCT00213148|21063212|P2|COMPLETED|Cycle 1 (1 Month)||0
8543706|NCT00213148|21063213|P1|COMPLETED|Cycle 1 (1 Month)||53
8543707|NCT00213148|21063209|P5|STARTED|Cycle 1 (1 Month)||39
8543708|NCT00213148|21063210|P4|STARTED|Cycle 1 (1 Month)||76
8543709|NCT00213148|21063211|P3|STARTED|Cycle 1 (1 Month)||79
8543710|NCT00213148|21063212|P2|STARTED|Cycle 1 (1 Month)||0
8543711|NCT00213148|21063213|P1|STARTED|Cycle 1 (1 Month)||77
8543712|NCT00213135|21063240|P3|NOT COMPLETED|Overall Study||57
8543713|NCT00213135|21063241|P2|NOT COMPLETED|Overall Study||35
8543714|NCT00213135|21063242|P1|NOT COMPLETED|Overall Study||50
8543715|NCT00213135|21063240|P3|COMPLETED|Overall Study||380
8543716|NCT00213135|21063241|P2|COMPLETED|Overall Study||398
8543717|NCT00213135|21063242|P1|COMPLETED|Overall Study||406
8543718|NCT00213135|21063240|P3|STARTED|Overall Study||437
8543719|NCT00213135|21063241|P2|STARTED|Overall Study||433
8543721|NCT00212888|21063262|P3|NOT COMPLETED|Overall Study||1
8543722|NCT00212888|21063263|P2|NOT COMPLETED|Overall Study||0
8543723|NCT00212888|21063264|P1|NOT COMPLETED|Overall Study||3
8543724|NCT00212888|21063262|P3|COMPLETED|Overall Study||14
8543725|NCT00212888|21063263|P2|COMPLETED|Overall Study||18
8543726|NCT00212888|21063264|P1|COMPLETED|Overall Study||16
8543727|NCT00212888|21063262|P3|STARTED|Overall Study||15
8543728|NCT00212888|21063263|P2|STARTED|Overall Study||18
8543729|NCT00212888|21063264|P1|STARTED|Overall Study||19
8543730|NCT00212758|21063285|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
8543731|NCT00212758|21063286|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
8543732|NCT00212758|21063285|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
8543733|NCT00212758|21063286|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
8543734|NCT00212758|21063285|P2|STARTED|Standard Therapy of GH (12 Months)||9
8543735|NCT00212758|21063286|P1|STARTED|Standard Therapy of GH (12 Months)||8
8543736|NCT00212758|21063285|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8543737|NCT00212758|21063286|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8543738|NCT00212758|21063285|P2|COMPLETED|Second Intervention (7 Days)||9
8543739|NCT00212758|21063286|P1|COMPLETED|Second Intervention (7 Days)||8
8543740|NCT00212758|21063285|P2|STARTED|Second Intervention (7 Days)||9
8543741|NCT00212758|21063286|P1|STARTED|Second Intervention (7 Days)||8
8543742|NCT00212758|21063285|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
8543743|NCT00212758|21063286|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
8543744|NCT00212758|21063285|P2|COMPLETED|Wash Out Period (2 Weeks)||9
8543745|NCT00212758|21063286|P1|COMPLETED|Wash Out Period (2 Weeks)||8
8543746|NCT00212758|21063285|P2|STARTED|Wash Out Period (2 Weeks)||9
8543747|NCT00212758|21063286|P1|STARTED|Wash Out Period (2 Weeks)||8
8543748|NCT00212758|21063285|P2|NOT COMPLETED|First Intervention (7 Days)||0
8543749|NCT00212758|21063286|P1|NOT COMPLETED|First Intervention (7 Days)||0
8543750|NCT00212758|21063285|P2|COMPLETED|First Intervention (7 Days)||9
8543751|NCT00212758|21063286|P1|COMPLETED|First Intervention (7 Days)||8
8543752|NCT00212758|21063285|P2|STARTED|First Intervention (7 Days)||9
8543753|NCT00212758|21063286|P1|STARTED|First Intervention (7 Days)||8
8543754|NCT00212446|21063292|P1|NOT COMPLETED|Overall Study||0
8543755|NCT00212446|21063292|P1|COMPLETED|Overall Study||8
8543756|NCT00212446|21063292|P1|STARTED|Overall Study||8
8543757|NCT00212355|21063302|P1|NOT COMPLETED|Overall Study||3
8543758|NCT00212355|21063302|P1|COMPLETED|Overall Study||34
8543759|NCT00212355|21063302|P1|STARTED|Overall Study||37
8543760|NCT00212264|21063309|P3|NOT COMPLETED|Overall Study||4
8543761|NCT00212264|21063310|P2|NOT COMPLETED|Overall Study||16
8543762|NCT00212264|21063311|P1|NOT COMPLETED|Overall Study||12
8543763|NCT00212264|21063309|P3|COMPLETED|Overall Study||64
8543764|NCT00212264|21063310|P2|COMPLETED|Overall Study||54
8543765|NCT00212264|21063311|P1|COMPLETED|Overall Study||58
8543766|NCT00212264|21063309|P3|STARTED|Overall Study||68
8543767|NCT00212264|21063310|P2|STARTED|Overall Study||70
8543768|NCT00212264|21063311|P1|STARTED|Overall Study||70
8543769|NCT00212134|21063323|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
8543770|NCT00212134|21063324|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
8543771|NCT00212134|21063323|P2|COMPLETED|Phase 3 (Age 10 Years)||35
8543772|NCT00212134|21063324|P1|COMPLETED|Phase 3 (Age 10 Years)||36
8543773|NCT00212134|21063323|P2|STARTED|Phase 3 (Age 10 Years)||56
8543774|NCT00212134|21063324|P1|STARTED|Phase 3 (Age 10 Years)||57
8543775|NCT00212134|21063323|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
8543776|NCT00212134|21063324|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
8543777|NCT00212134|21063323|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
8543778|NCT00212134|21063324|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
8543779|NCT00212134|21063323|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
8543780|NCT00212134|21063324|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
8543781|NCT00212134|21063323|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
8543782|NCT00212134|21063324|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
8543783|NCT00212134|21063323|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
8543784|NCT00212134|21063324|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
8543785|NCT00212134|21063323|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
8543786|NCT00212134|21063324|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
8543787|NCT00212134|21063323|P2|STARTED|Phase 1 (to Age 1 Year)||57
8543788|NCT00212134|21063324|P1|STARTED|Phase 1 (to Age 1 Year)||57
8543789|NCT00211887|21063345|P3|NOT COMPLETED|Overall Study||36
8543790|NCT00211887|21063346|P2|NOT COMPLETED|Overall Study||56
8543791|NCT00211887|21063347|P1|NOT COMPLETED|Overall Study||102
8543792|NCT00211887|21063345|P3|COMPLETED|Overall Study||223
8543793|NCT00211887|21063346|P2|COMPLETED|Overall Study||194
8543794|NCT00211887|21063347|P1|COMPLETED|Overall Study||397
8543795|NCT00211887|21063345|P3|STARTED|Overall Study||259
8543796|NCT00211887|21063346|P2|STARTED|Overall Study||250
8543797|NCT00211887|21063347|P1|STARTED|Overall Study||499
8543798|NCT00211809|21063364|P1|NOT COMPLETED|Overall Study||6
8543799|NCT00211809|21063364|P1|COMPLETED|Overall Study||11
8543800|NCT00211809|21063364|P1|STARTED|Overall Study||17
8543801|NCT00211757|21063380|P2|NOT COMPLETED|Overall Study||2
8543802|NCT00211757|21063381|P1|NOT COMPLETED|Overall Study||1
8543803|NCT00211757|21063380|P2|COMPLETED|Overall Study||14
8543804|NCT00211757|21063381|P1|COMPLETED|Overall Study||10
8543805|NCT00211757|21063380|P2|STARTED|Overall Study||16
8543806|NCT00211757|21063381|P1|STARTED|Overall Study||11
8543807|NCT00211692|21063391|P2|NOT COMPLETED|Overall Study||0
8543808|NCT00211692|21063392|P1|NOT COMPLETED|Overall Study||0
8543809|NCT00211692|21063391|P2|COMPLETED|Overall Study||31
8543810|NCT00211692|21063392|P1|COMPLETED|Overall Study||33
8543811|NCT00211692|21063391|P2|STARTED|Overall Study||31
8543812|NCT00211692|21063392|P1|STARTED|Overall Study||33
8543813|NCT00211536|21063402|P2|NOT COMPLETED|Overall Study||7
8543814|NCT00211536|21063403|P1|NOT COMPLETED|Overall Study||4
8543815|NCT00211536|21063402|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
8543816|NCT00211536|21063403|P1|COMPLETED|Overall Study||49
8543817|NCT00211536|21063402|P2|As Treated Data Analysis Set|Overall Study||48
8543818|NCT00211536|21063403|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
8543819|NCT00211536|21063402|P2|STARTED|Overall Study||54
8543820|NCT00211536|21063403|P1|STARTED|Overall Study||53
8543821|NCT00211510|21063419|P2|NOT COMPLETED|Overall Study||2
8543822|NCT00211510|21063420|P1|NOT COMPLETED|Overall Study||6
8543823|NCT00211510|21063419|P2|COMPLETED|Overall Study||72
8543824|NCT00211510|21063420|P1|COMPLETED|Overall Study||66
8543825|NCT00211510|21063419|P2|STARTED|Overall Study||74
8543826|NCT00211510|21063420|P1|STARTED|Overall Study||72
8543827|NCT00211237|21063438|P3|NOT COMPLETED|12 Months||6
8543828|NCT00211237|21063439|P2|NOT COMPLETED|12 Months||2
8543829|NCT00211237|21063440|P1|NOT COMPLETED|12 Months||9
8543830|NCT00211237|21063438|P3|COMPLETED|12 Months||28
8543831|NCT00211237|21063439|P2|COMPLETED|12 Months||6
8543832|NCT00211237|21063440|P1|COMPLETED|12 Months||40
8543833|NCT00211237|21063438|P3|STARTED|12 Months||34
8543834|NCT00211237|21063439|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
8543835|NCT00211237|21063440|P1|STARTED|12 Months||49
8543836|NCT00211237|21063438|P3|NOT COMPLETED|6 Months||3
8543837|NCT00211237|21063439|P2|NOT COMPLETED|6 Months||2
8543838|NCT00211237|21063440|P1|NOT COMPLETED|6 Months||8
8543839|NCT00211237|21063438|P3|COMPLETED|6 Months||33
8543840|NCT00211237|21063439|P2|COMPLETED|6 Months||9
8543841|NCT00211237|21063440|P1|COMPLETED|6 Months||49
8543842|NCT00211237|21063438|P3|STARTED|6 Months||36
8543843|NCT00211237|21063439|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
8543844|NCT00211237|21063440|P1|STARTED|6 Months||57
8543845|NCT00211237|21063438|P3|NOT COMPLETED|3 Months||1
8543846|NCT00211237|21063439|P2|NOT COMPLETED|3 Months||4
8543847|NCT00211237|21063440|P1|NOT COMPLETED|3 Months||8
8543848|NCT00211237|21063438|P3|COMPLETED|3 Months||33
8543849|NCT00211237|21063439|P2|COMPLETED|3 Months||14
8543850|NCT00211237|21063440|P1|COMPLETED|3 Months||57
8543851|NCT00211237|21063438|P3|STARTED|3 Months||34
8543852|NCT00211237|21063439|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
8543853|NCT00211237|21063440|P1|STARTED|3 Months||65
8543854|NCT00211237|21063438|P3|NOT COMPLETED|1 Month||0
8543855|NCT00211237|21063439|P2|NOT COMPLETED|1 Month||9
8543856|NCT00211237|21063440|P1|NOT COMPLETED|1 Month||3
8543857|NCT00211237|21063438|P3|COMPLETED|1 Month||0
8543858|NCT00211237|21063439|P2|COMPLETED|1 Month||52
8543859|NCT00211237|21063440|P1|COMPLETED|1 Month||65
8543860|NCT00211237|21063438|P3|STARTED|1 Month||0
8543861|NCT00211237|21063439|P2|STARTED|1 Month||61
8543862|NCT00211237|21063440|P1|STARTED|1 Month||68
8543863|NCT00211237|21063438|P3|NOT COMPLETED|Baseline||0
8543864|NCT00211237|21063439|P2|NOT COMPLETED|Baseline||3
8543865|NCT00211237|21063440|P1|NOT COMPLETED|Baseline||2
8543866|NCT00211237|21063438|P3|COMPLETED|Baseline||0
8543867|NCT00211237|21063439|P2|COMPLETED|Baseline||61
8543868|NCT00211237|21063440|P1|COMPLETED|Baseline||68
8543869|NCT00211237|21063438|P3|STARTED|Baseline||0
8543870|NCT00211237|21063439|P2|STARTED|Baseline||64
8543871|NCT00211237|21063440|P1|STARTED|Baseline||70
8543872|NCT00211185|21063530|P1|NOT COMPLETED|Overall Study||20
8543873|NCT00211185|21063530|P1|COMPLETED|Overall Study||29
8543874|NCT00211185|21063530|P1|STARTED|Overall Study||49
8543875|NCT00211172|21063544|P2|NOT COMPLETED|Overall Study||32
8543876|NCT00211172|21063545|P1|NOT COMPLETED|Overall Study||39
8543877|NCT00211172|21063544|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
8543878|NCT00211172|21063545|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
8543879|NCT00211172|21063544|P2|STARTED|Overall Study||458
8543880|NCT00211172|21063545|P1|STARTED|Overall Study||449
8543881|NCT00211081|21063551|P1|NOT COMPLETED|Overall Study||2
8543882|NCT00211081|21063551|P1|COMPLETED|Overall Study||10
8543883|NCT00211081|21063551|P1|STARTED|Overall Study||12
8543884|NCT00210639|21063563|P2|NOT COMPLETED|Overall Study||42
8543885|NCT00210639|21063564|P1|NOT COMPLETED|Overall Study||63
8543886|NCT00210639|21063563|P2|COMPLETED|Overall Study||41
8543887|NCT00210639|21063564|P1|COMPLETED|Overall Study||61
8543888|NCT00210639|21063563|P2|STARTED|Overall Study||83
8543889|NCT00210639|21063564|P1|STARTED|Overall Study||124
8543890|NCT00210626|21063572|P2|NOT COMPLETED|Overall Study||45
8543891|NCT00210626|21063573|P1|NOT COMPLETED|Overall Study||48
8543892|NCT00210626|21063572|P2|COMPLETED|Overall Study||50
8543893|NCT00210626|21063573|P1|COMPLETED|Overall Study||49
8543894|NCT00210626|21063572|P2|STARTED|Overall Study||95
8543895|NCT00210626|21063573|P1|STARTED|Overall Study||97
8543896|NCT00210470|21063581|P1|NOT COMPLETED|Overall Study||0
8543897|NCT00210470|21063581|P1|COMPLETED|Overall Study||27
8543898|NCT00210470|21063581|P1|STARTED|Overall Study||27
8543899|NCT00210353|21063596|P3|NOT COMPLETED|Overall Study||26
8543900|NCT00210353|21063597|P2|NOT COMPLETED|Overall Study||45
8543901|NCT00210353|21063598|P1|NOT COMPLETED|Overall Study||38
8543902|NCT00210353|21063596|P3|COMPLETED|Overall Study||125
8543903|NCT00210353|21063597|P2|COMPLETED|Overall Study||107
8543904|NCT00210353|21063598|P1|COMPLETED|Overall Study||113
8543905|NCT00210353|21063596|P3|STARTED|Overall Study||151
8543906|NCT00210353|21063597|P2|STARTED|Overall Study||152
8543907|NCT00210353|21063598|P1|STARTED|Overall Study||151
8543908|NCT00209560|21063620|P2|NOT COMPLETED|Overall Study||0
8543909|NCT00209560|21063621|P1|NOT COMPLETED|Overall Study||1
8543910|NCT00209560|21063620|P2|COMPLETED|Overall Study||42
8543911|NCT00209560|21063621|P1|COMPLETED|Overall Study||120
8543912|NCT00209560|21063620|P2|STARTED|Overall Study||42
8543913|NCT00209560|21063621|P1|STARTED|Overall Study||121
8543914|NCT00209417|21063631|P2|NOT COMPLETED|Overall Study||0
8543915|NCT00209417|21063632|P1|NOT COMPLETED|Overall Study||0
8543916|NCT00209417|21063631|P2|COMPLETED|Overall Study||327
8543917|NCT00209417|21063632|P1|COMPLETED|Overall Study||321
8543918|NCT00209417|21063631|P2|STARTED|Overall Study||327
8543919|NCT00209417|21063632|P1|STARTED|Overall Study||321
8543920|NCT00209339|21063640|P1|NOT COMPLETED|At 5 Years Follow-up||8
8543921|NCT00209339|21063640|P1|COMPLETED|At 5 Years Follow-up||15
8543922|NCT00209339|21063640|P1|STARTED|At 5 Years Follow-up||23
8543923|NCT00209339|21063640|P1|NOT COMPLETED|At 4 Years Follow-up||5
8543924|NCT00209339|21063640|P1|COMPLETED|At 4 Years Follow-up||23
8543925|NCT00209339|21063640|P1|STARTED|At 4 Years Follow-up||28
8543926|NCT00209339|21063640|P1|NOT COMPLETED|At 3 Years Follow-up||1
8543927|NCT00209339|21063640|P1|COMPLETED|At 3 Years Follow-up||28
8543928|NCT00209339|21063640|P1|STARTED|At 3 Years Follow-up||29
8543929|NCT00209339|21063640|P1|NOT COMPLETED|At 24 Months Follow-up||11
8543930|NCT00209339|21063640|P1|COMPLETED|At 24 Months Follow-up||29
8543931|NCT00209339|21063640|P1|STARTED|At 24 Months Follow-up||40
8543932|NCT00209339|21063640|P1|NOT COMPLETED|At 12 Months Follow-up||15
8543933|NCT00209339|21063640|P1|COMPLETED|At 12 Months Follow-up||40
8543934|NCT00209339|21063640|P1|STARTED|At 12 Months Follow-up||55
8543935|NCT00209274|21063724|P2|NOT COMPLETED|Overall Study||47
8543936|NCT00209274|21063725|P1|NOT COMPLETED|Overall Study||71
8543937|NCT00209274|21063724|P2|COMPLETED|Overall Study||48
8543938|NCT00209274|21063725|P1|COMPLETED|Overall Study||113
8543939|NCT00209274|21063724|P2|STARTED|Overall Study||95
8543940|NCT00209274|21063725|P1|STARTED|Overall Study||184
8543941|NCT00209170|21064045|P2|NOT COMPLETED|Overall Study||3
8543942|NCT00209170|21064046|P1|NOT COMPLETED|Overall Study||2
8543943|NCT00209170|21064045|P2|COMPLETED|Overall Study||4
8543944|NCT00209170|21064046|P1|COMPLETED|Overall Study||5
8543945|NCT00209170|21064045|P2|STARTED|Overall Study||7
8543946|NCT00209170|21064046|P1|STARTED|Overall Study||7
8543947|NCT00209131|21064054|P2|NOT COMPLETED|Overall Study||11
8543948|NCT00209131|21064055|P1|NOT COMPLETED|Overall Study||15
8543949|NCT00209131|21064054|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
8543950|NCT00209131|21064055|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
8543951|NCT00209131|21064054|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
8543952|NCT00209131|21064055|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
8543953|NCT00209092|21064065|P2|NOT COMPLETED|Overall Study||2
8543954|NCT00209092|21064066|P1|NOT COMPLETED|Overall Study||8
8543955|NCT00209092|21064065|P2|COMPLETED|Overall Study||24
8543956|NCT00209092|21064066|P1|COMPLETED|Overall Study||17
8543957|NCT00209092|21064065|P2|STARTED|Overall Study||26
8543958|NCT00209092|21064066|P1|STARTED|Overall Study||25
8543959|NCT00209027|21064076|P2|NOT COMPLETED|Overall Study||0
8543960|NCT00209027|21064077|P1|NOT COMPLETED|Overall Study||10
8543961|NCT00209027|21064076|P2|COMPLETED|Overall Study||10
8543962|NCT00209027|21064077|P1|COMPLETED|Overall Study||0
8543963|NCT00209027|21064076|P2|STARTED|Overall Study||10
8543964|NCT00209027|21064077|P1|STARTED|Overall Study||10
8543965|NCT00208975|21064083|P1|NOT COMPLETED|Overall Study||0
8543966|NCT00208975|21064083|P1|COMPLETED|Overall Study||15
8543967|NCT00208975|21064083|P1|STARTED|Overall Study||15
8543968|NCT00208949|21064090|P2|NOT COMPLETED|Overall Study||0
8543969|NCT00208949|21064091|P1|NOT COMPLETED|Overall Study||0
8543970|NCT00208949|21064090|P2|COMPLETED|Overall Study||25
8543971|NCT00208949|21064091|P1|COMPLETED|Overall Study||25
8543972|NCT00208949|21064090|P2|STARTED|Overall Study||25
8543973|NCT00208949|21064091|P1|STARTED|Overall Study||25
8543974|NCT00208767|21064101|P2|NOT COMPLETED|Overall Study||7
8543975|NCT00208767|21064102|P1|NOT COMPLETED|Overall Study||27
8543976|NCT00208767|21064101|P2|COMPLETED|Overall Study||33
8543977|NCT00208767|21064102|P1|COMPLETED|Overall Study||53
8543978|NCT00208767|21064101|P2|STARTED|Overall Study||40
8543979|NCT00208767|21064102|P1|STARTED|Overall Study||80
8543980|NCT00208507|21064110|P2|NOT COMPLETED|Overall Study||8
8543981|NCT00208507|21064111|P1|NOT COMPLETED|Overall Study||14
8543982|NCT00208507|21064110|P2|COMPLETED|Overall Study||79
8543983|NCT00208507|21064111|P1|COMPLETED|Overall Study||163
8543984|NCT00208507|21064110|P2|STARTED|Overall Study||87
8543985|NCT00208507|21064111|P1|STARTED|Overall Study||177
8543986|NCT00208494|21064119|P2|NOT COMPLETED|Overall Study||34
8543987|NCT00208494|21064120|P1|NOT COMPLETED|Overall Study||30
8543988|NCT00208494|21064119|P2|COMPLETED|Overall Study||162
8543989|NCT00208494|21064120|P1|COMPLETED|Overall Study||164
8543990|NCT00208494|21064119|P2|STARTED|Overall Study||196
8543991|NCT00208494|21064120|P1|STARTED|Overall Study||194
8543992|NCT00208325|21064130|P4|NOT COMPLETED|Overall Study||14
8543993|NCT00208325|21064131|P3|NOT COMPLETED|Overall Study||14
8543994|NCT00208325|21064132|P2|NOT COMPLETED|Overall Study||54
8543995|NCT00208325|21064133|P1|NOT COMPLETED|Overall Study||51
8543996|NCT00208325|21064130|P4|COMPLETED|Overall Study||147
8543997|NCT00208325|21064131|P3|COMPLETED|Overall Study||156
8543998|NCT00208325|21064132|P2|COMPLETED|Overall Study||142
8543999|NCT00208325|21064133|P1|COMPLETED|Overall Study||142
8544000|NCT00208325|21064130|P4|STARTED|Overall Study||161
8544001|NCT00208325|21064131|P3|STARTED|Overall Study||170
8544002|NCT00208325|21064132|P2|STARTED|Overall Study||196
8544003|NCT00208325|21064133|P1|STARTED|Overall Study||193
8544004|NCT00208091|21064241|P1|NOT COMPLETED|Overall Study||0
8544005|NCT00208091|21064241|P1|COMPLETED|Overall Study||16
8544006|NCT00208091|21064241|P1|STARTED|Overall Study||16
8544007|NCT00208026|21064249|P1|NOT COMPLETED|Overall Study||0
8544008|NCT00208026|21064249|P1|COMPLETED|Overall Study||3
8544009|NCT00208026|21064249|P1|STARTED|Overall Study||3
8544010|NCT00207883|21064257|P2|NOT COMPLETED|Overall Study||0
8544011|NCT00207883|21064258|P1|NOT COMPLETED|Overall Study||0
8544012|NCT00207883|21064257|P2|COMPLETED|Overall Study||119
8544013|NCT00207883|21064258|P1|COMPLETED|Overall Study||93
8544014|NCT00207883|21064257|P2|STARTED|Overall Study||119
8544015|NCT00207883|21064258|P1|STARTED|Overall Study||93
8544016|NCT00207740|21064270|P4|NOT COMPLETED|Overall Study||43
8544017|NCT00207740|21064271|P3|NOT COMPLETED|Overall Study||40
8544018|NCT00207740|21064272|P2|NOT COMPLETED|Overall Study||41
8544019|NCT00207740|21064273|P1|NOT COMPLETED|Overall Study||29
8544020|NCT00207740|21064270|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
8544021|NCT00207740|21064271|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
8544022|NCT00207740|21064272|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
8544023|NCT00207740|21064273|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
8544024|NCT00207740|21064270|P4|STARTED|Overall Study||78
8544025|NCT00207740|21064271|P3|STARTED|Overall Study||76
8544026|NCT00207740|21064272|P2|STARTED|Overall Study||77
8544027|NCT00207740|21064273|P1|STARTED|Overall Study||78
8544028|NCT00207727|21064319|P5|NOT COMPLETED|Overall Study||34
8544029|NCT00207727|21064320|P4|NOT COMPLETED|Overall Study||37
8544030|NCT00207727|21064321|P3|NOT COMPLETED|Overall Study||41
8544031|NCT00207727|21064322|P2|NOT COMPLETED|Overall Study||42
8544032|NCT00207727|21064323|P1|NOT COMPLETED|Overall Study||38
8544033|NCT00207727|21064319|P5|COMPLETED|Overall Study||16
8544034|NCT00207727|21064320|P4|COMPLETED|Overall Study||13
8544035|NCT00207727|21064321|P3|COMPLETED|Overall Study||9
8544036|NCT00207727|21064322|P2|COMPLETED|Overall Study||8
8544037|NCT00207727|21064323|P1|COMPLETED|Overall Study||11
8544038|NCT00207727|21064319|P5|STARTED|Overall Study||50
8544039|NCT00207727|21064320|P4|STARTED|Overall Study||50
8544040|NCT00207727|21064321|P3|STARTED|Overall Study||50
8544041|NCT00207727|21064322|P2|STARTED|Overall Study||50
8544042|NCT00207727|21064323|P1|STARTED|Overall Study||49
8544043|NCT00207714|21064350|P5|NOT COMPLETED|Overall Study||5
8544044|NCT00207714|21064351|P4|NOT COMPLETED|Overall Study||8
8544045|NCT00207714|21064352|P3|NOT COMPLETED|Overall Study||10
8544046|NCT00207714|21064353|P2|NOT COMPLETED|Overall Study||7
8544047|NCT00207714|21064354|P1|NOT COMPLETED|Overall Study||14
8544048|NCT00207714|21064350|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
8544049|NCT00207714|21064351|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
8544050|NCT00207714|21064352|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
8544051|NCT00207714|21064353|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
8544052|NCT00207714|21064354|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
8544053|NCT00207714|21064350|P5|STARTED|Overall Study||34
8544054|NCT00207714|21064351|P4|STARTED|Overall Study||34
8544055|NCT00207714|21064352|P3|STARTED|Overall Study||34
8544056|NCT00207714|21064353|P2|STARTED|Overall Study||35
8544057|NCT00207714|21064354|P1|STARTED|Overall Study||35
8544058|NCT00207142|21064376|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
8544059|NCT00207142|21064377|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
8544060|NCT00207142|21064378|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
8544061|NCT00207142|21064379|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
8544062|NCT00207142|21064376|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
8544063|NCT00207142|21064377|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
8544064|NCT00207142|21064378|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
8544065|NCT00207142|21064379|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
8544066|NCT00207142|21064376|P4|STARTED|Maintenance Phase/Rescue Phase||50
8544067|NCT00207142|21064377|P3|STARTED|Maintenance Phase/Rescue Phase||85
8544068|NCT00207142|21064378|P2|STARTED|Maintenance Phase/Rescue Phase||87
8544069|NCT00207142|21064379|P1|STARTED|Maintenance Phase/Rescue Phase||0
8544070|NCT00207142|21064376|P4|NOT COMPLETED|Induction Phase||0
8544071|NCT00207142|21064377|P3|NOT COMPLETED|Induction Phase||0
8544072|NCT00207142|21064378|P2|NOT COMPLETED|Induction Phase||0
8544073|NCT00207142|21064379|P1|NOT COMPLETED|Induction Phase||30
8544074|NCT00207142|21064376|P4|COMPLETED|Induction Phase||0
8544075|NCT00207142|21064377|P3|COMPLETED|Induction Phase||0
8544076|NCT00207142|21064378|P2|COMPLETED|Induction Phase||0
8544167|NCT00205777|21064632|P4|NOT COMPLETED|Study Extension II||149
8544077|NCT00207142|21064379|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
8544078|NCT00207142|21064376|P4|STARTED|Induction Phase||0
8544079|NCT00207142|21064377|P3|STARTED|Induction Phase||0
8544080|NCT00207142|21064378|P2|STARTED|Induction Phase||0
8544081|NCT00207142|21064379|P1|STARTED|Induction Phase||252
8544082|NCT00207090|21064416|P1|NOT COMPLETED|Overall Study||7
8544083|NCT00207090|21064416|P1|COMPLETED|Overall Study||8
8544084|NCT00207090|21064416|P1|STARTED|Overall Study|Number of participants treated|15
8544085|NCT00206726|21064445|P1|NOT COMPLETED|Overall Study||51
8544086|NCT00206726|21064445|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
8544087|NCT00206726|21064445|P1|4 Cycles Completed|Overall Study|per protocol population|41
8544088|NCT00206726|21064445|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
8544089|NCT00206726|21064445|P1|STARTED|Overall Study||60
8544090|NCT00206518|21064456|P2|NOT COMPLETED|Overall Study||6
8544091|NCT00206518|21064457|P1|NOT COMPLETED|Overall Study||10
8544092|NCT00206518|21064456|P2|COMPLETED|Overall Study||78
8544093|NCT00206518|21064457|P1|COMPLETED|Overall Study||73
8544094|NCT00206518|21064456|P2|STARTED|Overall Study||84
8544095|NCT00206518|21064457|P1|STARTED|Overall Study||83
8544096|NCT00206440|21064469|P2|NOT COMPLETED|Overall Study||4
8544097|NCT00206440|21064470|P1|NOT COMPLETED|Overall Study||5
8544098|NCT00206440|21064469|P2|COMPLETED|Overall Study||18
8544099|NCT00206440|21064470|P1|COMPLETED|Overall Study||16
8544100|NCT00206440|21064469|P2|STARTED|Overall Study||22
8544101|NCT00206440|21064470|P1|STARTED|Overall Study||21
8544102|NCT00206427|21064476|P1|NOT COMPLETED|Overall Study||2
8544103|NCT00206427|21064476|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
8544104|NCT00206427|21064476|P1|STARTED|Overall Study|Received First Dose|49
8544105|NCT00206375|21064483|P3|NOT COMPLETED|Overall Study||4
8544106|NCT00206375|21064484|P2|NOT COMPLETED|Overall Study||2
8544107|NCT00206375|21064485|P1|NOT COMPLETED|Overall Study||3
8544108|NCT00206375|21064483|P3|COMPLETED|Overall Study||3
8544109|NCT00206375|21064484|P2|COMPLETED|Overall Study||1
8544110|NCT00206375|21064485|P1|COMPLETED|Overall Study||3
8544111|NCT00206375|21064483|P3|STARTED|Overall Study||7
8544112|NCT00206375|21064484|P2|STARTED|Overall Study||3
8544113|NCT00206375|21064485|P1|STARTED|Overall Study||6
8544114|NCT00206336|21064499|P1|NOT COMPLETED|Overall Study||0
8544115|NCT00206336|21064499|P1|COMPLETED|Overall Study||20
8544116|NCT00206336|21064499|P1|STARTED|Overall Study||20
8544117|NCT00206323|21064505|P2|NOT COMPLETED|Overall Study||3
8544118|NCT00206323|21064506|P1|NOT COMPLETED|Overall Study||6
8544119|NCT00206323|21064505|P2|COMPLETED|Overall Study||12
8544120|NCT00206323|21064506|P1|COMPLETED|Overall Study||8
8544121|NCT00206323|21064505|P2|STARTED|Overall Study||15
8544122|NCT00206323|21064506|P1|STARTED|Overall Study||14
8544123|NCT00206102|21064514|P2|NOT COMPLETED|Overall Study||315
8544124|NCT00206102|21064515|P1|NOT COMPLETED|Overall Study||408
8544125|NCT00206102|21064514|P2|COMPLETED|Overall Study||187
8544126|NCT00206102|21064515|P1|COMPLETED|Overall Study||188
8544127|NCT00206102|21064514|P2|STARTED|Overall Study||502
8544128|NCT00206102|21064515|P1|STARTED|Overall Study||596
8544129|NCT00206076|21064551|P2|NOT COMPLETED|Overall Study||1
8544130|NCT00206076|21064552|P1|NOT COMPLETED|Overall Study||3
8544131|NCT00206076|21064551|P2|COMPLETED|Overall Study||9
8544132|NCT00206076|21064552|P1|COMPLETED|Overall Study||6
8544133|NCT00206076|21064551|P2|STARTED|Overall Study||10
8544134|NCT00206076|21064552|P1|STARTED|Overall Study||9
8544135|NCT00205881|21064562|P1|NOT COMPLETED|Overall Study||16
8544136|NCT00205881|21064562|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
8544137|NCT00205881|21064562|P1|STARTED|Overall Study||32
8544138|NCT00205855|21064567|P1|NOT COMPLETED|Overall Study||21
8544139|NCT00205855|21064567|P1|COMPLETED|Overall Study||44
8544140|NCT00205855|21064567|P1|STARTED|Overall Study||65
8544141|NCT00205803|21064573|P2|NOT COMPLETED|Toddler Dose||3
8544142|NCT00205803|21064574|P1|NOT COMPLETED|Toddler Dose||2
8544143|NCT00205803|21064573|P2|COMPLETED|Toddler Dose||100
8544144|NCT00205803|21064574|P1|COMPLETED|Toddler Dose||84
8544145|NCT00205803|21064573|P2|STARTED|Toddler Dose||103
8544146|NCT00205803|21064574|P1|STARTED|Toddler Dose||86
8544147|NCT00205803|21064573|P2|NOT COMPLETED|After Infant Series||13
8544148|NCT00205803|21064574|P1|NOT COMPLETED|After Infant Series||18
8544149|NCT00205803|21064573|P2|COMPLETED|After Infant Series||103
8544150|NCT00205803|21064574|P1|COMPLETED|After Infant Series||86
8544151|NCT00205803|21064573|P2|STARTED|After Infant Series||116
8544152|NCT00205803|21064574|P1|STARTED|After Infant Series||104
8544153|NCT00205803|21064573|P2|NOT COMPLETED|Infant Series||11
8544154|NCT00205803|21064574|P1|NOT COMPLETED|Infant Series||18
8544155|NCT00205803|21064573|P2|COMPLETED|Infant Series||116
8544156|NCT00205803|21064574|P1|COMPLETED|Infant Series||104
8544157|NCT00205803|21064573|P2|Vaccinated Dose 3|Infant Series||118
8544158|NCT00205803|21064574|P1|Vaccinated Dose 3|Infant Series||110
8544159|NCT00205803|21064573|P2|Vaccinated Dose 2|Infant Series||122
8544160|NCT00205803|21064574|P1|Vaccinated Dose 2|Infant Series||115
8544161|NCT00205803|21064573|P2|Vaccinated Dose 1|Infant Series||126
8544162|NCT00205803|21064574|P1|Vaccinated Dose 1|Infant Series||121
8544163|NCT00205803|21064573|P2|STARTED|Infant Series||127
8544164|NCT00205803|21064574|P1|STARTED|Infant Series||122
8544165|NCT00205777|21064630|P6|NOT COMPLETED|Study Extension II||282
8544166|NCT00205777|21064631|P5|NOT COMPLETED|Study Extension II||0
8544168|NCT00205777|21064633|P3|NOT COMPLETED|Study Extension II||0
8544169|NCT00205777|21064634|P2|NOT COMPLETED|Study Extension II||0
8544170|NCT00205777|21064635|P1|NOT COMPLETED|Study Extension II||0
8544171|NCT00205777|21064630|P6|COMPLETED|Study Extension II||860
8544172|NCT00205777|21064631|P5|COMPLETED|Study Extension II||0
8544173|NCT00205777|21064632|P4|COMPLETED|Study Extension II||441
8544174|NCT00205777|21064633|P3|COMPLETED|Study Extension II||0
8544175|NCT00205777|21064634|P2|COMPLETED|Study Extension II||0
8544176|NCT00205777|21064635|P1|COMPLETED|Study Extension II||0
8544177|NCT00205777|21064630|P6|TREATED|Study Extension II||1011
8544178|NCT00205777|21064631|P5|TREATED|Study Extension II||0
8544179|NCT00205777|21064632|P4|TREATED|Study Extension II||519
8544180|NCT00205777|21064633|P3|TREATED|Study Extension II||0
8544181|NCT00205777|21064634|P2|TREATED|Study Extension II||0
8544182|NCT00205777|21064635|P1|TREATED|Study Extension II||0
8544183|NCT00205777|21064630|P6|STARTED|Study Extension II||1142
8544184|NCT00205777|21064631|P5|STARTED|Study Extension II||0
8544185|NCT00205777|21064632|P4|STARTED|Study Extension II||590
8544186|NCT00205777|21064633|P3|STARTED|Study Extension II||0
8544187|NCT00205777|21064634|P2|STARTED|Study Extension II||0
8544188|NCT00205777|21064635|P1|STARTED|Study Extension II||0
8544189|NCT00205777|21064630|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8544190|NCT00205777|21064631|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
8544191|NCT00205777|21064632|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
8544192|NCT00205777|21064633|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8544193|NCT00205777|21064634|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8544194|NCT00205777|21064635|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
8544195|NCT00205777|21064630|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
8544196|NCT00205777|21064631|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
8544197|NCT00205777|21064632|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
8544198|NCT00205777|21064633|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
8544199|NCT00205777|21064634|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
8544200|NCT00205777|21064635|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
8544201|NCT00205777|21064630|P6|STARTED|Completed SE I, Entered Extension SE II||0
8544202|NCT00205777|21064631|P5|STARTED|Completed SE I, Entered Extension SE II||840
8544203|NCT00205777|21064632|P4|STARTED|Completed SE I, Entered Extension SE II||830
8544204|NCT00205777|21064633|P3|STARTED|Completed SE I, Entered Extension SE II||0
8544205|NCT00205777|21064634|P2|STARTED|Completed SE I, Entered Extension SE II||0
8544206|NCT00205777|21064635|P1|STARTED|Completed SE I, Entered Extension SE II||833
8544207|NCT00205777|21064630|P6|NOT COMPLETED|Study Extension I||0
8544208|NCT00205777|21064631|P5|NOT COMPLETED|Study Extension I||201
8544209|NCT00205777|21064632|P4|NOT COMPLETED|Study Extension I||228
8544210|NCT00205777|21064633|P3|NOT COMPLETED|Study Extension I||1070
8544211|NCT00205777|21064634|P2|NOT COMPLETED|Study Extension I||0
8544212|NCT00205777|21064635|P1|NOT COMPLETED|Study Extension I||214
8544213|NCT00205777|21064630|P6|COMPLETED|Study Extension I||0
8544214|NCT00205777|21064631|P5|COMPLETED|Study Extension I||840
8544215|NCT00205777|21064632|P4|COMPLETED|Study Extension I||830
8544216|NCT00205777|21064633|P3|COMPLETED|Study Extension I||0
8544217|NCT00205777|21064634|P2|COMPLETED|Study Extension I||0
8544218|NCT00205777|21064635|P1|COMPLETED|Study Extension I||833
8544219|NCT00205777|21064630|P6|STARTED|Study Extension I||0
8544220|NCT00205777|21064631|P5|STARTED|Study Extension I||1041
8544221|NCT00205777|21064632|P4|STARTED|Study Extension I||1058
8544222|NCT00205777|21064633|P3|STARTED|Study Extension I||1070
8544223|NCT00205777|21064634|P2|STARTED|Study Extension I||0
8544224|NCT00205777|21064635|P1|STARTED|Study Extension I||1047
8544225|NCT00205777|21064630|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
8544226|NCT00205777|21064631|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
8544227|NCT00205777|21064632|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
8544228|NCT00205777|21064633|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
8544229|NCT00205777|21064634|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
8544230|NCT00205777|21064635|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
8544231|NCT00205777|21064630|P6|COMPLETED|Completed Core Study, Entered SE I||0
8544232|NCT00205777|21064631|P5|COMPLETED|Completed Core Study, Entered SE I||0
8544233|NCT00205777|21064632|P4|COMPLETED|Completed Core Study, Entered SE I||1058
8544234|NCT00205777|21064633|P3|COMPLETED|Completed Core Study, Entered SE I||1070
8544235|NCT00205777|21064634|P2|COMPLETED|Completed Core Study, Entered SE I||1041
8544236|NCT00205777|21064635|P1|COMPLETED|Completed Core Study, Entered SE I||1047
8544237|NCT00205777|21064630|P6|STARTED|Completed Core Study, Entered SE I||0
8544238|NCT00205777|21064631|P5|STARTED|Completed Core Study, Entered SE I||0
8544239|NCT00205777|21064632|P4|STARTED|Completed Core Study, Entered SE I||1282
8544240|NCT00205777|21064633|P3|STARTED|Completed Core Study, Entered SE I||1277
8544241|NCT00205777|21064634|P2|STARTED|Completed Core Study, Entered SE I||1245
8544242|NCT00205777|21064635|P1|STARTED|Completed Core Study, Entered SE I||1279
8544243|NCT00205777|21064630|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
8544244|NCT00205777|21064631|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
8544245|NCT00205777|21064632|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
8544246|NCT00205777|21064633|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
8544247|NCT00205777|21064634|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
8544248|NCT00205777|21064635|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
8544249|NCT00205777|21064630|P6|COMPLETED|Core Study (Up to 3 Years)||0
8544250|NCT00205777|21064631|P5|COMPLETED|Core Study (Up to 3 Years)||0
8544251|NCT00205777|21064632|P4|COMPLETED|Core Study (Up to 3 Years)||1282
8544252|NCT00205777|21064633|P3|COMPLETED|Core Study (Up to 3 Years)||1277
8544253|NCT00205777|21064634|P2|COMPLETED|Core Study (Up to 3 Years)||1245
8544254|NCT00205777|21064635|P1|COMPLETED|Core Study (Up to 3 Years)||1279
8544255|NCT00205777|21064630|P6|TREATED|Core Study (Up to 3 Years)||0
8544256|NCT00205777|21064631|P5|TREATED|Core Study (Up to 3 Years)||0
8544257|NCT00205777|21064632|P4|TREATED|Core Study (Up to 3 Years)||1885
8544258|NCT00205777|21064633|P3|TREATED|Core Study (Up to 3 Years)||1849
8544259|NCT00205777|21064634|P2|TREATED|Core Study (Up to 3 Years)||1872
8544260|NCT00205777|21064635|P1|TREATED|Core Study (Up to 3 Years)||1886
8544261|NCT00205777|21064630|P6|STARTED|Core Study (Up to 3 Years)||0
8544262|NCT00205777|21064631|P5|STARTED|Core Study (Up to 3 Years)||0
8544263|NCT00205777|21064632|P4|STARTED|Core Study (Up to 3 Years)||1914
8544264|NCT00205777|21064633|P3|STARTED|Core Study (Up to 3 Years)||1884
8544265|NCT00205777|21064634|P2|STARTED|Core Study (Up to 3 Years)||1904
8544266|NCT00205777|21064635|P1|STARTED|Core Study (Up to 3 Years)||1907
8544267|NCT00205712|21064844|P2|NOT COMPLETED|Overall Study||1
8544268|NCT00205712|21064845|P1|NOT COMPLETED|Overall Study||0
8544269|NCT00205712|21064844|P2|COMPLETED|Overall Study||19
8544270|NCT00205712|21064845|P1|COMPLETED|Overall Study||20
8544271|NCT00205712|21064844|P2|STARTED|Overall Study||20
8544272|NCT00205712|21064845|P1|STARTED|Overall Study||20
8544273|NCT00205699|21064858|P3|NOT COMPLETED|Overall Study||6
8544274|NCT00205699|21064859|P2|NOT COMPLETED|Overall Study||6
8544275|NCT00205699|21064860|P1|NOT COMPLETED|Overall Study||3
8544276|NCT00205699|21064858|P3|COMPLETED|Overall Study||43
8544277|NCT00205699|21064859|P2|COMPLETED|Overall Study||40
8544278|NCT00205699|21064860|P1|COMPLETED|Overall Study||46
8544279|NCT00205699|21064858|P3|STARTED|Overall Study||49
8544280|NCT00205699|21064859|P2|STARTED|Overall Study||46
8544281|NCT00205699|21064860|P1|STARTED|Overall Study||49
8544282|NCT00205660|21064885|P2|NOT COMPLETED|Overall Study||2
8544283|NCT00205660|21064886|P1|NOT COMPLETED|Overall Study||2
8544284|NCT00205660|21064885|P2|COMPLETED|Overall Study||35
8544285|NCT00205660|21064886|P1|COMPLETED|Overall Study||12
8544286|NCT00205660|21064885|P2|STARTED|Overall Study||37
8544287|NCT00205660|21064886|P1|STARTED|Overall Study||14
8544288|NCT00205504|21064898|P2|NOT COMPLETED|Overall Study||0
8544289|NCT00205504|21064899|P1|NOT COMPLETED|Overall Study||7
8544290|NCT00205504|21064898|P2|COMPLETED|Overall Study||15
8544291|NCT00205504|21064899|P1|COMPLETED|Overall Study||14
8544292|NCT00205504|21064898|P2|STARTED|Overall Study||15
8544293|NCT00205504|21064899|P1|STARTED|Overall Study||21
8544294|NCT00205374|21064925|P2|NOT COMPLETED|Overall Study||0
8544295|NCT00205374|21064926|P1|NOT COMPLETED|Overall Study||0
8544296|NCT00205374|21064925|P2|COMPLETED|Overall Study||9
8544297|NCT00205374|21064926|P1|COMPLETED|Overall Study||10
8544298|NCT00205374|21064925|P2|STARTED|Overall Study||9
8544299|NCT00205374|21064926|P1|STARTED|Overall Study||10
8544300|NCT00205348|21064934|P1|NOT COMPLETED|Overall Study||30
8544301|NCT00205348|21064934|P1|COMPLETED|Overall Study||116
8544302|NCT00205348|21064934|P1|STARTED|Overall Study||146
8544303|NCT00205179|21064940|P2|NOT COMPLETED|Overall Study||4
8544304|NCT00205179|21064941|P1|NOT COMPLETED|Overall Study||2
8544305|NCT00205179|21064940|P2|COMPLETED|Overall Study||29
8544306|NCT00205179|21064941|P1|COMPLETED|Overall Study||30
8544307|NCT00205179|21064940|P2|STARTED|Overall Study||33
8544308|NCT00205179|21064941|P1|STARTED|Overall Study||32
8544309|NCT00205049|21065005|P2|NOT COMPLETED|Overall Study||0
8544310|NCT00205049|21065006|P1|NOT COMPLETED|Overall Study||0
8544311|NCT00205049|21065005|P2|COMPLETED|Overall Study||0
8544312|NCT00205049|21065006|P1|COMPLETED|Overall Study||0
8544313|NCT00205049|21065005|P2|STARTED|Overall Study||0
8544314|NCT00205049|21065006|P1|STARTED|Overall Study||0
8544315|NCT00204932|21065014|P2|NOT COMPLETED|Overall Study||6
8544316|NCT00204932|21065015|P1|NOT COMPLETED|Overall Study||2
8544317|NCT00204932|21065014|P2|COMPLETED|Overall Study||18
8544318|NCT00204932|21065015|P1|COMPLETED|Overall Study||22
8544319|NCT00204932|21065014|P2|STARTED|Overall Study||24
8544320|NCT00204932|21065015|P1|STARTED|Overall Study||24
8544321|NCT00204737|21065023|P2|NOT COMPLETED|Overall Study||0
8544322|NCT00204737|21065024|P1|NOT COMPLETED|Overall Study||0
8544323|NCT00204737|21065023|P2|COMPLETED|Overall Study||6
8544324|NCT00204737|21065024|P1|COMPLETED|Overall Study||6
8544325|NCT00204737|21065023|P2|STARTED|Overall Study||6
8544326|NCT00204737|21065024|P1|STARTED|Overall Study||6
8544327|NCT00204373|21065048|P1|NOT COMPLETED|Overall Study||0
8544328|NCT00204373|21065048|P1|COMPLETED|Overall Study||72
8544329|NCT00204373|21065048|P1|STARTED|Overall Study||72
8544330|NCT00203996|21065059|P10|NOT COMPLETED|Overall Study||1
8544331|NCT00203996|21065060|P9|NOT COMPLETED|Overall Study||0
8544332|NCT00203996|21065061|P8|NOT COMPLETED|Overall Study||2
8544333|NCT00203996|21065062|P7|NOT COMPLETED|Overall Study||0
8544334|NCT00203996|21065063|P6|NOT COMPLETED|Overall Study||0
8544335|NCT00203996|21065064|P5|NOT COMPLETED|Overall Study||1
8544336|NCT00203996|21065065|P4|NOT COMPLETED|Overall Study||10
8544337|NCT00203996|21065066|P3|NOT COMPLETED|Overall Study||0
8544338|NCT00203996|21065067|P2|NOT COMPLETED|Overall Study||0
8544339|NCT00203996|21065068|P1|NOT COMPLETED|Overall Study||0
8544340|NCT00203996|21065059|P10|COMPLETED|Overall Study||2
8544341|NCT00203996|21065060|P9|COMPLETED|Overall Study||2
8544342|NCT00203996|21065061|P8|COMPLETED|Overall Study||2
8544343|NCT00203996|21065062|P7|COMPLETED|Overall Study||2
8544344|NCT00203996|21065063|P6|COMPLETED|Overall Study||3
8544345|NCT00203996|21065064|P5|COMPLETED|Overall Study||3
8544346|NCT00203996|21065065|P4|COMPLETED|Overall Study||9
8544347|NCT00203996|21065066|P3|COMPLETED|Overall Study||0
8544348|NCT00203996|21065067|P2|COMPLETED|Overall Study||0
8544349|NCT00203996|21065068|P1|COMPLETED|Overall Study||0
8544350|NCT00203996|21065059|P10|Aim 3 Only: Third Intervention|Overall Study||2
8544351|NCT00203996|21065060|P9|Aim 3 Only: Third Intervention|Overall Study||2
8544352|NCT00203996|21065061|P8|Aim 3 Only: Third Intervention|Overall Study||2
8544353|NCT00203996|21065062|P7|Aim 3 Only: Third Intervention|Overall Study||2
8544354|NCT00203996|21065063|P6|Aim 3 Only: Third Intervention|Overall Study||3
8544355|NCT00203996|21065064|P5|Aim 3 Only: Third Intervention|Overall Study||0
8544356|NCT00203996|21065065|P4|Aim 3 Only: Third Intervention|Overall Study||0
8544357|NCT00203996|21065066|P3|Aim 3 Only: Third Intervention|Overall Study||0
8544358|NCT00203996|21065067|P2|Aim 3 Only: Third Intervention|Overall Study||0
8544359|NCT00203996|21065068|P1|Aim 3 Only: Third Intervention|Overall Study||0
8544360|NCT00203996|21065059|P10|Aim 3 Only: Second Washout|Overall Study||2
8544361|NCT00203996|21065060|P9|Aim 3 Only: Second Washout|Overall Study||2
8544362|NCT00203996|21065061|P8|Aim 3 Only: Second Washout|Overall Study||2
8544363|NCT00203996|21065062|P7|Aim 3 Only: Second Washout|Overall Study||2
8544364|NCT00203996|21065063|P6|Aim 3 Only: Second Washout|Overall Study||3
8544365|NCT00203996|21065064|P5|Aim 3 Only: Second Washout|Overall Study||0
8544366|NCT00203996|21065065|P4|Aim 3 Only: Second Washout|Overall Study||0
8544367|NCT00203996|21065066|P3|Aim 3 Only: Second Washout|Overall Study||0
8544368|NCT00203996|21065067|P2|Aim 3 Only: Second Washout|Overall Study||0
8544369|NCT00203996|21065068|P1|Aim 3 Only: Second Washout|Overall Study||0
8544370|NCT00203996|21065059|P10|Aim 3 Only: Second Intervention|Overall Study||2
8544371|NCT00203996|21065060|P9|Aim 3 Only: Second Intervention|Overall Study||2
8544372|NCT00203996|21065061|P8|Aim 3 Only: Second Intervention|Overall Study||2
8544373|NCT00203996|21065062|P7|Aim 3 Only: Second Intervention|Overall Study||2
8544374|NCT00203996|21065063|P6|Aim 3 Only: Second Intervention|Overall Study||3
8544375|NCT00203996|21065064|P5|Aim 3 Only: Second Intervention|Overall Study||0
8544376|NCT00203996|21065065|P4|Aim 3 Only: Second Intervention|Overall Study||0
8544377|NCT00203996|21065066|P3|Aim 3 Only: Second Intervention|Overall Study||0
8544378|NCT00203996|21065067|P2|Aim 3 Only: Second Intervention|Overall Study||0
8544379|NCT00203996|21065068|P1|Aim 3 Only: Second Intervention|Overall Study||0
8544380|NCT00203996|21065059|P10|Aim 3 Only: Washout|Overall Study||2
8544381|NCT00203996|21065060|P9|Aim 3 Only: Washout|Overall Study||2
8544382|NCT00203996|21065061|P8|Aim 3 Only: Washout|Overall Study||2
8544383|NCT00203996|21065062|P7|Aim 3 Only: Washout|Overall Study||2
8544384|NCT00203996|21065063|P6|Aim 3 Only: Washout|Overall Study||3
8544385|NCT00203996|21065064|P5|Aim 3 Only: Washout|Overall Study||0
8544386|NCT00203996|21065065|P4|Aim 3 Only: Washout|Overall Study||0
8544387|NCT00203996|21065066|P3|Aim 3 Only: Washout|Overall Study||0
8544388|NCT00203996|21065067|P2|Aim 3 Only: Washout|Overall Study||0
8544389|NCT00203996|21065068|P1|Aim 3 Only: Washout|Overall Study||0
8544390|NCT00203996|21065059|P10|Aim 3 Only: First Intervention|Overall Study||3
8544391|NCT00203996|21065060|P9|Aim 3 Only: First Intervention|Overall Study||2
8544392|NCT00203996|21065061|P8|Aim 3 Only: First Intervention|Overall Study||4
8544393|NCT00203996|21065062|P7|Aim 3 Only: First Intervention|Overall Study||2
8544394|NCT00203996|21065063|P6|Aim 3 Only: First Intervention|Overall Study||3
8544395|NCT00203996|21065064|P5|Aim 3 Only: First Intervention|Overall Study||0
8544396|NCT00203996|21065065|P4|Aim 3 Only: First Intervention|Overall Study||0
8544397|NCT00203996|21065066|P3|Aim 3 Only: First Intervention|Overall Study||0
8544398|NCT00203996|21065067|P2|Aim 3 Only: First Intervention|Overall Study||0
8544399|NCT00203996|21065068|P1|Aim 3 Only: First Intervention|Overall Study||0
8544400|NCT00203996|21065059|P10|STARTED|Overall Study||3
8544401|NCT00203996|21065060|P9|STARTED|Overall Study||2
8544402|NCT00203996|21065061|P8|STARTED|Overall Study||4
8544403|NCT00203996|21065062|P7|STARTED|Overall Study||2
8544404|NCT00203996|21065063|P6|STARTED|Overall Study||3
8544405|NCT00203996|21065064|P5|STARTED|Overall Study||4
8544406|NCT00203996|21065065|P4|STARTED|Overall Study||19
8544407|NCT00203996|21065066|P3|STARTED|Overall Study||0
8544408|NCT00203996|21065067|P2|STARTED|Overall Study||0
8544409|NCT00203996|21065068|P1|STARTED|Overall Study||0
8544410|NCT00203931|21065117|P2|NOT COMPLETED|Overall Study||5
8544411|NCT00203931|21065118|P1|NOT COMPLETED|Overall Study||7
8544412|NCT00203931|21065117|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
8544413|NCT00203931|21065118|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
8544414|NCT00203931|21065117|P2|STARTED|Overall Study||28
8544415|NCT00203931|21065118|P1|STARTED|Overall Study||27
8544416|NCT00203892|21065135|P3|NOT COMPLETED|Overall Study||0
8544417|NCT00203892|21065136|P2|NOT COMPLETED|Overall Study||2
8544418|NCT00203892|21065137|P1|NOT COMPLETED|Overall Study||2
8544419|NCT00203892|21065135|P3|COMPLETED|Overall Study||6
8544420|NCT00203892|21065136|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
8544421|NCT00203892|21065137|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
8544422|NCT00203892|21065135|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
8544423|NCT00203892|21065136|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
8544424|NCT00203892|21065137|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
8544425|NCT00203892|21065135|P3|STARTED|Overall Study||6
8544426|NCT00203892|21065136|P2|STARTED|Overall Study||10
8544427|NCT00203892|21065137|P1|STARTED|Overall Study||7
8544428|NCT00203502|21065148|P1|NOT COMPLETED|Overall Study||1
8544429|NCT00203502|21065148|P1|COMPLETED|Overall Study||39
8544430|NCT00203502|21065148|P1|STARTED|Overall Study||40
8544431|NCT00203476|21065159|P3|NOT COMPLETED|Overall Study||0
8544432|NCT00203476|21065160|P2|NOT COMPLETED|Overall Study||1
8544433|NCT00203476|21065161|P1|NOT COMPLETED|Overall Study||1
8544434|NCT00203476|21065159|P3|COMPLETED|Overall Study||10
8544435|NCT00203476|21065160|P2|COMPLETED|Overall Study||9
8544436|NCT00203476|21065161|P1|COMPLETED|Overall Study||9
8544437|NCT00203476|21065159|P3|STARTED|Overall Study||10
8544438|NCT00203476|21065160|P2|STARTED|Overall Study||10
8544439|NCT00203476|21065161|P1|STARTED|Overall Study||10
8544440|NCT00203424|21065178|P1|NOT COMPLETED|Follow-up Period||6
8544441|NCT00203424|21065178|P1|COMPLETED|Follow-up Period||10
8544442|NCT00203424|21065178|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
8544443|NCT00203424|21065178|P1|NOT COMPLETED|Treatment Period||11
8544444|NCT00203424|21065178|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
8544445|NCT00203424|21065178|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
8544446|NCT00203411|21065185|P1|NOT COMPLETED|Follow-up||4
8544447|NCT00203411|21065185|P1|COMPLETED|Follow-up||41
8544448|NCT00203411|21065185|P1|STARTED|Follow-up||45
8544449|NCT00203411|21065185|P1|NOT COMPLETED|Treatment Period||0
8544450|NCT00203411|21065185|P1|COMPLETED|Treatment Period||45
8544451|NCT00203411|21065185|P1|STARTED|Treatment Period||45
8544452|NCT00203307|21065194|P2|NOT COMPLETED|Second Intervention||0
8544453|NCT00203307|21065195|P1|NOT COMPLETED|Second Intervention||0
8544454|NCT00203307|21065194|P2|COMPLETED|Second Intervention||0
8544455|NCT00203307|21065195|P1|COMPLETED|Second Intervention||1
8544456|NCT00203307|21065194|P2|STARTED|Second Intervention||0
8544457|NCT00203307|21065195|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
8544458|NCT00203307|21065194|P2|NOT COMPLETED|First Intervention||0
8544459|NCT00203307|21065195|P1|NOT COMPLETED|First Intervention||2
8544460|NCT00203307|21065194|P2|COMPLETED|First Intervention||0
8544461|NCT00203307|21065195|P1|COMPLETED|First Intervention||1
8544462|NCT00203307|21065194|P2|STARTED|First Intervention||0
8544463|NCT00203307|21065195|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
8544464|NCT00203294|21065203|P2|NOT COMPLETED|Overall Study||13
8544465|NCT00203294|21065204|P1|NOT COMPLETED|Overall Study||8
8544466|NCT00203294|21065203|P2|COMPLETED|Overall Study||10
8544467|NCT00203294|21065204|P1|COMPLETED|Overall Study||14
8544468|NCT00203294|21065203|P2|STARTED|Overall Study||23
8544469|NCT00203294|21065204|P1|STARTED|Overall Study||22
8544470|NCT00203268|21065210|P1|NOT COMPLETED|Late Treatment||0
8544471|NCT00203268|21065210|P1|COMPLETED|Late Treatment||9
8544472|NCT00203268|21065210|P1|STARTED|Late Treatment||9
8544473|NCT00203268|21065210|P1|NOT COMPLETED|Early Treatment||4
8544474|NCT00203268|21065210|P1|COMPLETED|Early Treatment||9
8544475|NCT00203268|21065210|P1|STARTED|Early Treatment||13
8544476|NCT00203242|21065216|P1|NOT COMPLETED|Overall Study||1
8544477|NCT00203242|21065216|P1|COMPLETED|Overall Study||14
8544478|NCT00203242|21065216|P1|STARTED|Overall Study||15
8544479|NCT00203229|21065222|P2|NOT COMPLETED|Overall Study||3
8544480|NCT00203229|21065223|P1|NOT COMPLETED|Overall Study||3
8544481|NCT00203229|21065222|P2|COMPLETED|Overall Study||7
8544482|NCT00203229|21065223|P1|COMPLETED|Overall Study||7
8544483|NCT00203229|21065222|P2|STARTED|Overall Study||10
8544484|NCT00203229|21065223|P1|STARTED|Overall Study||10
8544485|NCT00203216|21065229|P1|NOT COMPLETED|Overall Study||4
8544486|NCT00203216|21065229|P1|COMPLETED|Overall Study||27
8544487|NCT00203216|21065229|P1|STARTED|Overall Study||31
8544488|NCT00203203|21065235|P2|NOT COMPLETED|Overall Study||0
8544489|NCT00203203|21065236|P1|NOT COMPLETED|Overall Study||1
8544490|NCT00203203|21065235|P2|COMPLETED|Overall Study||20
8544491|NCT00203203|21065236|P1|COMPLETED|Overall Study||9
8544492|NCT00203203|21065235|P2|STARTED|Overall Study||20
8544493|NCT00203203|21065236|P1|STARTED|Overall Study||10
8544494|NCT00203047|21065268|P2|NOT COMPLETED|Overall Study||203
8544495|NCT00203047|21065269|P1|NOT COMPLETED|Overall Study||191
8544496|NCT00203047|21065268|P2|COMPLETED|Overall Study||7
8544497|NCT00203047|21065269|P1|COMPLETED|Overall Study||13
8544498|NCT00203047|21065268|P2|In Database as of January 29, 2009|Overall Study||209
8544499|NCT00203047|21065269|P1|In Database as of January 29, 2009|Overall Study||199
8544500|NCT00203047|21065268|P2|STARTED|Overall Study||210
8544501|NCT00203047|21065269|P1|STARTED|Overall Study||204
8544502|NCT00203021|21065283|P2|NOT COMPLETED|Overall Study||77
8544503|NCT00203021|21065284|P1|NOT COMPLETED|Overall Study||79
8544504|NCT00203021|21065283|P2|COMPLETED|Overall Study||24
8544505|NCT00203021|21065284|P1|COMPLETED|Overall Study||28
8544506|NCT00203021|21065283|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
8544507|NCT00203021|21065284|P1|Received at Least 1 Dose of Study Drug|Overall Study||107
8544508|NCT00203021|21065283|P2|STARTED|Overall Study||101
8544509|NCT00203021|21065284|P1|STARTED|Overall Study||107
8544510|NCT00202930|21065292|P1|NOT COMPLETED|Overall Study||0
8544511|NCT00202930|21065292|P1|COMPLETED|Overall Study||4
8544512|NCT00202930|21065292|P1|STARTED|Overall Study||4
8544513|NCT00202878|21065302|P2|NOT COMPLETED|Overall Study||2217
8544514|NCT00202878|21065303|P1|NOT COMPLETED|Overall Study||2199
8544515|NCT00202878|21065302|P2|COMPLETED|Overall Study||6860
8544516|NCT00202878|21065303|P1|COMPLETED|Overall Study||6868
8544517|NCT00202878|21065302|P2|STARTED|Overall Study||9077
8544518|NCT00202878|21065303|P1|STARTED|Overall Study||9067
8544519|NCT00202839|21065317|P2|NOT COMPLETED|Overall Study||10
8544520|NCT00202839|21065318|P1|NOT COMPLETED|Overall Study||24
8544521|NCT00202839|21065317|P2|COMPLETED|Overall Study||72
8544522|NCT00202839|21065318|P1|COMPLETED|Overall Study||54
8544523|NCT00202839|21065317|P2|STARTED|Overall Study||82
8544524|NCT00202839|21065318|P1|STARTED|Overall Study||78
8544525|NCT00202722|21065326|P1|NOT COMPLETED|Overall Study||0
8544526|NCT00202722|21065326|P1|COMPLETED|Overall Study||41
8544527|NCT00202722|21065326|P1|STARTED|Overall Study||41
8544528|NCT00202644|21065333|P2|NOT COMPLETED|Overall Study||27
8544529|NCT00202644|21065334|P1|NOT COMPLETED|Overall Study||35
8544530|NCT00202644|21065333|P2|COMPLETED|Overall Study||43
8544531|NCT00202644|21065334|P1|COMPLETED|Overall Study||41
8544532|NCT00202644|21065333|P2|STARTED|Overall Study||70
8544533|NCT00202644|21065334|P1|STARTED|Overall Study|One participant not randomized but treated.|76
8544534|NCT00202449|21065361|P3|NOT COMPLETED|Overall Study||12
8544535|NCT00202449|21065362|P2|NOT COMPLETED|Overall Study||11
8544536|NCT00202449|21065363|P1|NOT COMPLETED|Overall Study||11
8544537|NCT00202449|21065361|P3|COMPLETED|Overall Study||9
8544538|NCT00202449|21065362|P2|COMPLETED|Overall Study||9
8544539|NCT00202449|21065363|P1|COMPLETED|Overall Study||7
8544540|NCT00202449|21065361|P3|STARTED|Overall Study||21
8544541|NCT00202449|21065362|P2|STARTED|Overall Study||20
8544542|NCT00202449|21065363|P1|STARTED|Overall Study||18
8544543|NCT00201877|21065377|P1|NOT COMPLETED|Overall Study||0
8544544|NCT00201877|21065377|P1|COMPLETED|Overall Study||25
8544545|NCT00201877|21065377|P1|STARTED|Overall Study||25
8544546|NCT00201864|21065384|P1|NOT COMPLETED|Overall Study||0
8544547|NCT00201864|21065384|P1|COMPLETED|Overall Study||40
8544548|NCT00201864|21065384|P1|STARTED|Overall Study||40
8544549|NCT00201851|21065395|P3|NOT COMPLETED|Overall Study||1
8544550|NCT00201851|21065396|P2|NOT COMPLETED|Overall Study||2
8544551|NCT00201851|21065397|P1|NOT COMPLETED|Overall Study||8
8544552|NCT00201851|21065395|P3|COMPLETED|Overall Study||230
8544553|NCT00201851|21065396|P2|COMPLETED|Overall Study||255
8544554|NCT00201851|21065397|P1|COMPLETED|Overall Study||244
8544555|NCT00201851|21065395|P3|STARTED|Overall Study||231
8544556|NCT00201851|21065396|P2|STARTED|Overall Study||257
8544557|NCT00201851|21065397|P1|STARTED|Overall Study||252
8544558|NCT00201838|21065407|P2|NOT COMPLETED|Overall Study||0
8544559|NCT00201838|21065408|P1|NOT COMPLETED|Overall Study||0
8544560|NCT00201838|21065407|P2|COMPLETED|Overall Study||8
8544561|NCT00201838|21065408|P1|COMPLETED|Overall Study||30
8544562|NCT00201838|21065407|P2|Treatment Cohort|Overall Study||8
8544563|NCT00201838|21065408|P1|Treatment Cohort|Overall Study||30
8544564|NCT00201838|21065407|P2|STARTED|Overall Study||8
8544565|NCT00201838|21065408|P1|STARTED|Overall Study||30
8544566|NCT00201825|21065422|P1|NOT COMPLETED|Overall Study||0
8544567|NCT00201825|21065422|P1|COMPLETED|Overall Study||29
8544568|NCT00201825|21065422|P1|STARTED|Overall Study||29
8544569|NCT00201773|21065429|P1|NOT COMPLETED|Overall Study||6
8544570|NCT00201773|21065429|P1|COMPLETED|Overall Study||16
8544571|NCT00201773|21065429|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
8544572|NCT00201773|21065429|P1|Received All Exemestane Therapy|Overall Study||5
8544573|NCT00201773|21065429|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
8544574|NCT00201773|21065429|P1|STARTED|Overall Study||22
8544575|NCT00201760|21065438|P2|NOT COMPLETED|Overall Study||0
8544576|NCT00201760|21065439|P1|NOT COMPLETED|Overall Study||0
8544577|NCT00201760|21065438|P2|COMPLETED|Overall Study||5
8544578|NCT00201760|21065439|P1|COMPLETED|Overall Study||5
8544579|NCT00201760|21065438|P2|STARTED|Overall Study||5
8544580|NCT00201760|21065439|P1|STARTED|Overall Study||5
8544581|NCT00201734|21065451|P2|NOT COMPLETED|Overall Study||0
8544582|NCT00201734|21065452|P1|NOT COMPLETED|Overall Study||3
8544583|NCT00201734|21065451|P2|COMPLETED|Overall Study||25
8544584|NCT00201734|21065452|P1|COMPLETED|Overall Study||29
8544585|NCT00201734|21065451|P2|Patients Not Evaluable|Overall Study||0
8544586|NCT00201734|21065452|P1|Patients Not Evaluable|Overall Study||3
8544587|NCT00201734|21065451|P2|STARTED|Overall Study||25
8544588|NCT00201734|21065452|P1|STARTED|Overall Study||32
8544589|NCT00201643|21065469|P2|NOT COMPLETED|Overall Study||4
8544590|NCT00201643|21065470|P1|NOT COMPLETED|Overall Study||5
8544591|NCT00201643|21065469|P2|COMPLETED|Overall Study||210
8544592|NCT00201643|21065470|P1|COMPLETED|Overall Study||218
8544593|NCT00201643|21065469|P2|STARTED|Overall Study||214
8544594|NCT00201643|21065470|P1|STARTED|Overall Study||223
8544595|NCT00201448|21065494|P2|NOT COMPLETED|Overall Study||0
8544596|NCT00201448|21065495|P1|NOT COMPLETED|Overall Study||0
8544597|NCT00201448|21065494|P2|COMPLETED|Overall Study||40
8544598|NCT00201448|21065495|P1|COMPLETED|Overall Study||42
8544599|NCT00201448|21065494|P2|STARTED|Overall Study||40
8544600|NCT00201448|21065495|P1|STARTED|Overall Study||42
8544601|NCT00201409|21065505|P2|NOT COMPLETED|Overall Study||1
8544602|NCT00201409|21065506|P1|NOT COMPLETED|Overall Study||1
8544603|NCT00201409|21065505|P2|COMPLETED|Overall Study||66
8544604|NCT00201409|21065506|P1|COMPLETED|Overall Study||64
8544605|NCT00201409|21065505|P2|STARTED|Overall Study||67
8544606|NCT00201409|21065506|P1|STARTED|Overall Study||65
8544607|NCT00201240|21065516|P1|NOT COMPLETED|Overall Study||3
8544608|NCT00201240|21065516|P1|COMPLETED|Overall Study||44
8544609|NCT00201240|21065516|P1|STARTED|Overall Study||47
8544610|NCT00201201|21065534|P2|NOT COMPLETED|Overall Study||7
8544611|NCT00201201|21065535|P1|NOT COMPLETED|Overall Study||5
8544612|NCT00201201|21065534|P2|COMPLETED|Overall Study||66
8544613|NCT00201201|21065535|P1|COMPLETED|Overall Study||82
8544614|NCT00201201|21065534|P2|STARTED|Overall Study||73
8544615|NCT00201201|21065535|P1|STARTED|Overall Study||87
8544616|NCT00201123|21065554|P3|NOT COMPLETED|Overall Study||9
8544617|NCT00201123|21065555|P2|NOT COMPLETED|Overall Study||4
8544618|NCT00201123|21065556|P1|NOT COMPLETED|Overall Study||6
8544619|NCT00201123|21065554|P3|COMPLETED|Overall Study||23
8544620|NCT00201123|21065555|P2|COMPLETED|Overall Study||28
8544621|NCT00201123|21065556|P1|COMPLETED|Overall Study||26
8544622|NCT00201123|21065554|P3|Did Not Meet Continuation Criteria|Overall Study||5
8544623|NCT00201123|21065555|P2|Did Not Meet Continuation Criteria|Overall Study||0
8544624|NCT00201123|21065556|P1|Did Not Meet Continuation Criteria|Overall Study||2
8544625|NCT00201123|21065554|P3|STARTED|Overall Study||32
8544626|NCT00201123|21065555|P2|STARTED|Overall Study||32
8544627|NCT00201123|21065556|P1|STARTED|Overall Study||32
8544628|NCT00201006|21065573|P3|NOT COMPLETED|Overall Study||4
8544629|NCT00201006|21065574|P2|NOT COMPLETED|Overall Study||2
8544630|NCT00201006|21065575|P1|NOT COMPLETED|Overall Study||8
8544631|NCT00201006|21065573|P3|COMPLETED|Overall Study||75
8544632|NCT00201006|21065574|P2|COMPLETED|Overall Study||70
8544633|NCT00201006|21065575|P1|COMPLETED|Overall Study||75
8544634|NCT00201006|21065573|P3|STARTED|Overall Study||79
8544635|NCT00201006|21065574|P2|STARTED|Overall Study||72
8544636|NCT00201006|21065575|P1|STARTED|Overall Study||83
8544637|NCT00200967|21065585|P2|NOT COMPLETED|Run-out Period||0
8544638|NCT00200967|21065586|P1|NOT COMPLETED|Run-out Period||1
8544639|NCT00200967|21065585|P2|COMPLETED|Run-out Period||41
8544640|NCT00200967|21065586|P1|COMPLETED|Run-out Period||34
8544641|NCT00200967|21065585|P2|STARTED|Run-out Period||41
8544642|NCT00200967|21065586|P1|STARTED|Run-out Period||35
8544643|NCT00200967|21065585|P2|NOT COMPLETED|Second Treatment Period||2
8544644|NCT00200967|21065586|P1|NOT COMPLETED|Second Treatment Period||1
8544645|NCT00200967|21065585|P2|COMPLETED|Second Treatment Period||41
8544646|NCT00200967|21065586|P1|COMPLETED|Second Treatment Period||35
8544647|NCT00200967|21065585|P2|STARTED|Second Treatment Period||43
8544648|NCT00200967|21065586|P1|STARTED|Second Treatment Period||36
8544649|NCT00200967|21065585|P2|NOT COMPLETED|Wash-out Period||1
8544650|NCT00200967|21065586|P1|NOT COMPLETED|Wash-out Period||0
8544651|NCT00200967|21065585|P2|COMPLETED|Wash-out Period||43
8544652|NCT00200967|21065586|P1|COMPLETED|Wash-out Period||36
8544653|NCT00200967|21065585|P2|STARTED|Wash-out Period||44
8544654|NCT00200967|21065586|P1|STARTED|Wash-out Period||36
8544655|NCT00200967|21065585|P2|NOT COMPLETED|First Treatment Period||1
8544656|NCT00200967|21065586|P1|NOT COMPLETED|First Treatment Period||6
8544657|NCT00200967|21065585|P2|COMPLETED|First Treatment Period||44
8544658|NCT00200967|21065586|P1|COMPLETED|First Treatment Period||36
8544659|NCT00200967|21065585|P2|First Treatment Period|First Treatment Period||45
8544660|NCT00200967|21065586|P1|First Treatment Period|First Treatment Period||42
8544661|NCT00200967|21065585|P2|STARTED|First Treatment Period||45
8544662|NCT00200967|21065586|P1|STARTED|First Treatment Period||42
8544663|NCT00200902|21065617|P3|NOT COMPLETED|Overall Study||8
8544664|NCT00200902|21065618|P2|NOT COMPLETED|Overall Study||3
8544665|NCT00200902|21065619|P1|NOT COMPLETED|Overall Study||10
8544666|NCT00200902|21065617|P3|COMPLETED|Overall Study||12
8544667|NCT00200902|21065618|P2|COMPLETED|Overall Study||26
8544668|NCT00200902|21065619|P1|COMPLETED|Overall Study||29
8544669|NCT00200902|21065617|P3|STARTED|Overall Study||20
8544670|NCT00200902|21065618|P2|STARTED|Overall Study||29
8544671|NCT00200902|21065619|P1|STARTED|Overall Study||39
8544672|NCT00200850|21065636|P3|NOT COMPLETED|Overall Study||6
8544673|NCT00200850|21065637|P2|NOT COMPLETED|Overall Study||1
8544674|NCT00200850|21065638|P1|NOT COMPLETED|Overall Study||3
8544675|NCT00200850|21065636|P3|COMPLETED|Overall Study||5
8544676|NCT00200850|21065637|P2|COMPLETED|Overall Study||9
8544677|NCT00200850|21065638|P1|COMPLETED|Overall Study||7
8544678|NCT00200850|21065636|P3|STARTED|Overall Study||11
8544679|NCT00200850|21065637|P2|STARTED|Overall Study||10
8544680|NCT00200850|21065638|P1|STARTED|Overall Study||10
8544681|NCT00200785|21065648|P2|NOT COMPLETED|Second Intervention||0
8544682|NCT00200785|21065649|P1|NOT COMPLETED|Second Intervention||0
8544683|NCT00200785|21065648|P2|COMPLETED|Second Intervention||6
8544684|NCT00200785|21065649|P1|COMPLETED|Second Intervention||9
8544685|NCT00200785|21065648|P2|STARTED|Second Intervention||6
8544686|NCT00200785|21065649|P1|STARTED|Second Intervention||9
8544687|NCT00200785|21065648|P2|NOT COMPLETED|Washout Period of 1 Week||0
8544688|NCT00200785|21065649|P1|NOT COMPLETED|Washout Period of 1 Week||0
8544689|NCT00200785|21065648|P2|COMPLETED|Washout Period of 1 Week||6
8544690|NCT00200785|21065649|P1|COMPLETED|Washout Period of 1 Week||9
8544691|NCT00200785|21065648|P2|STARTED|Washout Period of 1 Week||6
8544692|NCT00200785|21065649|P1|STARTED|Washout Period of 1 Week||9
8544693|NCT00200785|21065648|P2|NOT COMPLETED|First Intervention||0
8544694|NCT00200785|21065649|P1|NOT COMPLETED|First Intervention||0
8544695|NCT00200785|21065648|P2|COMPLETED|First Intervention||6
8544696|NCT00200785|21065649|P1|COMPLETED|First Intervention||9
8544697|NCT00200785|21065648|P2|STARTED|First Intervention||6
8544698|NCT00200785|21065649|P1|STARTED|First Intervention||9
8544699|NCT00200356|21065659|P2|NOT COMPLETED|Overall Study||7
8544700|NCT00200356|21065660|P1|NOT COMPLETED|Overall Study||8
8544701|NCT00200356|21065659|P2|COMPLETED|Overall Study||195
8544702|NCT00200356|21065660|P1|COMPLETED|Overall Study||191
8544703|NCT00200356|21065659|P2|Safety Analysis Set|Overall Study||198
8544704|NCT00200356|21065660|P1|Safety Analysis Set|Overall Study||194
8544705|NCT00200356|21065659|P2|STARTED|Overall Study||202
8544706|NCT00200356|21065660|P1|STARTED|Overall Study||199
8544707|NCT00200343|21065687|P3|NOT COMPLETED|Overall Study||13
8544708|NCT00200343|21065688|P2|NOT COMPLETED|Overall Study||8
8544709|NCT00200343|21065689|P1|NOT COMPLETED|Overall Study||16
8544710|NCT00200343|21065687|P3|COMPLETED|Overall Study||184
8544711|NCT00200343|21065688|P2|COMPLETED|Overall Study||192
8544712|NCT00200343|21065689|P1|COMPLETED|Overall Study||183
8544713|NCT00200343|21065687|P3|STARTED|Overall Study||197
8544714|NCT00200343|21065688|P2|STARTED|Overall Study||200
8544715|NCT00200343|21065689|P1|STARTED|Overall Study||199
8544716|NCT00200161|21065714|P2|NOT COMPLETED|Overall Study||0
8544717|NCT00200161|21065715|P1|NOT COMPLETED|Overall Study||0
8544718|NCT00200161|21065714|P2|COMPLETED|Overall Study||42
8544719|NCT00200161|21065715|P1|COMPLETED|Overall Study||43
8544720|NCT00200161|21065714|P2|STARTED|Overall Study||42
8544721|NCT00200161|21065715|P1|STARTED|Overall Study||43
8544722|NCT00200057|21065727|P1|NOT COMPLETED|Overall Study||9
8544723|NCT00200057|21065727|P1|COMPLETED|Overall Study||111
8544724|NCT00200057|21065727|P1|12 Month Follow-up|Overall Study||111
8544725|NCT00200057|21065727|P1|6 Month Follow-up|Overall Study||114
8544726|NCT00200057|21065727|P1|3 Month Follow-up|Overall Study||116
8544727|NCT00200057|21065727|P1|1 Month Follow-up|Overall Study||117
8544728|NCT00200057|21065727|P1|STARTED|Overall Study||120
8544729|NCT00199914|21065739|P2|NOT COMPLETED|Overall Study||6
8544730|NCT00199914|21065740|P1|NOT COMPLETED|Overall Study||3
8544731|NCT00199914|21065739|P2|COMPLETED|Overall Study||54
8544732|NCT00199914|21065740|P1|COMPLETED|Overall Study||50
8544733|NCT00199914|21065739|P2|STARTED|Overall Study||60
8544734|NCT00199914|21065740|P1|STARTED|Overall Study||53
8544735|NCT00199875|21065751|P5|NOT COMPLETED|Overall Study||1
8544736|NCT00199875|21065752|P4|NOT COMPLETED|Overall Study||0
8544737|NCT00199875|21065753|P3|NOT COMPLETED|Overall Study||0
8544738|NCT00199875|21065754|P2|NOT COMPLETED|Overall Study||0
8544739|NCT00199875|21065755|P1|NOT COMPLETED|Overall Study||0
8544740|NCT00199875|21065751|P5|COMPLETED|Overall Study||2
8544741|NCT00199875|21065752|P4|COMPLETED|Overall Study||3
8544742|NCT00199875|21065753|P3|COMPLETED|Overall Study||6
8544743|NCT00199875|21065754|P2|COMPLETED|Overall Study||3
8544744|NCT00199875|21065755|P1|COMPLETED|Overall Study||3
8544745|NCT00199875|21065751|P5|STARTED|Overall Study||3
8544746|NCT00199875|21065752|P4|STARTED|Overall Study||3
8544747|NCT00199875|21065753|P3|STARTED|Overall Study||6
8544748|NCT00199875|21065754|P2|STARTED|Overall Study||3
8544749|NCT00199875|21065755|P1|STARTED|Overall Study||3
8544750|NCT00199381|21065777|P1|NOT COMPLETED|Overall Study||504
8544751|NCT00199381|21065777|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
8544752|NCT00199381|21065777|P1|STARTED|Overall Study||504
8544753|NCT00198822|21065784|P3|NOT COMPLETED|Overall Study||21
8544754|NCT00198822|21065785|P2|NOT COMPLETED|Overall Study||20
8544755|NCT00198822|21065786|P1|NOT COMPLETED|Overall Study||14
8544756|NCT00198822|21065784|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
8544757|NCT00198822|21065785|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
8544758|NCT00198822|21065786|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
8544759|NCT00198822|21065784|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
8544760|NCT00198822|21065785|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
8544761|NCT00198822|21065786|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
8544762|NCT00198133|21065805|P2|NOT COMPLETED|Overall Study||8
8544763|NCT00198133|21065806|P1|NOT COMPLETED|Overall Study||5
8544764|NCT00198133|21065805|P2|COMPLETED|Overall Study||3
8544765|NCT00198133|21065806|P1|COMPLETED|Overall Study||11
8544766|NCT00198133|21065805|P2|STARTED|Overall Study||11
8544767|NCT00198133|21065806|P1|STARTED|Overall Study||16
8544768|NCT00198107|21065818|P3|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
8544769|NCT00198107|21065819|P2|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544770|NCT00198107|21065820|P1|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544771|NCT00198107|21065818|P3|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
8544772|NCT00198107|21065819|P2|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544773|NCT00198107|21065820|P1|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544774|NCT00198107|21065818|P3|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
8544775|NCT00198107|21065819|P2|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544776|NCT00198107|21065820|P1|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544777|NCT00198107|21065818|P3|NOT COMPLETED|Double-Blind Period||0
8544778|NCT00198107|21065819|P2|NOT COMPLETED|Double-Blind Period||3
8544779|NCT00198107|21065820|P1|NOT COMPLETED|Double-Blind Period||6
8544780|NCT00198107|21065818|P3|COMPLETED|Double-Blind Period||0
8544781|NCT00198107|21065819|P2|COMPLETED|Double-Blind Period||37
8544782|NCT00198107|21065820|P1|COMPLETED|Double-Blind Period||35
8544783|NCT00198107|21065818|P3|1 or More Follow-up Visits|Double-Blind Period||0
8544784|NCT00198107|21065819|P2|1 or More Follow-up Visits|Double-Blind Period||38
8544785|NCT00198107|21065820|P1|1 or More Follow-up Visits|Double-Blind Period||40
8544786|NCT00198107|21065818|P3|STARTED|Double-Blind Period||0
8544787|NCT00198107|21065819|P2|STARTED|Double-Blind Period||40
8544788|NCT00198107|21065820|P1|STARTED|Double-Blind Period||41
8544789|NCT00198081|21065857|P2|NOT COMPLETED|Overall Study||0
8544790|NCT00198081|21065858|P1|NOT COMPLETED|Overall Study||1
8544791|NCT00198081|21065857|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
8544792|NCT00198081|21065858|P1|COMPLETED|Overall Study||4
8544793|NCT00198081|21065857|P2|STARTED|Overall Study|No enrollment on this arm.|0
8544794|NCT00198081|21065858|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
8544795|NCT00198042|21065884|P1|NOT COMPLETED|Overall Study||0
8544796|NCT00198042|21065884|P1|COMPLETED|Overall Study||18
8544797|NCT00198042|21065884|P1|STARTED|Overall Study||18
8544798|NCT00198029|21065888|P1|NOT COMPLETED|Overall Study||4
8544799|NCT00198029|21065888|P1|COMPLETED|Overall Study||28
8544800|NCT00198029|21065888|P1|STARTED|Overall Study||32
8544801|NCT00197496|21065895|P2|NOT COMPLETED|Follow-up||1
8544802|NCT00197496|21065896|P1|NOT COMPLETED|Follow-up||2
8544803|NCT00197496|21065895|P2|COMPLETED|Follow-up||4
8544804|NCT00197496|21065896|P1|COMPLETED|Follow-up||10
8544805|NCT00197496|21065895|P2|STARTED|Follow-up||5
8544806|NCT00197496|21065896|P1|STARTED|Follow-up||12
8544807|NCT00197496|21065895|P2|NOT COMPLETED|Baseline to Discharge||2
8544808|NCT00197496|21065896|P1|NOT COMPLETED|Baseline to Discharge||2
8544809|NCT00197496|21065895|P2|COMPLETED|Baseline to Discharge||5
8544810|NCT00197496|21065896|P1|COMPLETED|Baseline to Discharge||12
8544811|NCT00197496|21065895|P2|STARTED|Baseline to Discharge||7
8544812|NCT00197496|21065896|P1|STARTED|Baseline to Discharge||14
8544813|NCT00197392|21065911|P2|NOT COMPLETED|Overall Study||86
8544814|NCT00197392|21065912|P1|NOT COMPLETED|Overall Study||88
8544815|NCT00197392|21065911|P2|COMPLETED|Overall Study||134
8544816|NCT00197392|21065912|P1|COMPLETED|Overall Study||126
8544817|NCT00197392|21065911|P2|Per Protocol|Overall Study||134
8544818|NCT00197392|21065912|P1|Per Protocol|Overall Study||126
8544819|NCT00197392|21065911|P2|Evaluable|Overall Study||181
8544820|NCT00197392|21065912|P1|Evaluable|Overall Study||176
8544821|NCT00197392|21065911|P2|Modified Intent to Treat|Overall Study||210
8544822|NCT00197392|21065912|P1|Modified Intent to Treat|Overall Study||209
8544823|NCT00197392|21065911|P2|Safety Population|Overall Study||220
8544824|NCT00197392|21065912|P1|Safety Population|Overall Study||214
8544825|NCT00197392|21065911|P2|STARTED|Overall Study||220
8544826|NCT00197392|21065912|P1|STARTED|Overall Study||214
8544827|NCT00197236|21065944|P3|NOT COMPLETED|Overall Study||23
8544828|NCT00197236|21065945|P2|NOT COMPLETED|Overall Study||17
8544829|NCT00197236|21065946|P1|NOT COMPLETED|Overall Study||14
8544830|NCT00197236|21065944|P3|COMPLETED|Overall Study||109
8544831|NCT00197236|21065945|P2|COMPLETED|Overall Study||110
8544832|NCT00197236|21065946|P1|COMPLETED|Overall Study||121
8544833|NCT00197236|21065944|P3|STARTED|Overall Study||132
8544834|NCT00197236|21065945|P2|STARTED|Overall Study||127
8544835|NCT00197236|21065946|P1|STARTED|Overall Study||135
8544836|NCT00197184|21065995|P2|NOT COMPLETED|Overall Study||0
8544837|NCT00197184|21065996|P1|NOT COMPLETED|Overall Study||0
8544838|NCT00197184|21065995|P2|COMPLETED|Overall Study||137
8544839|NCT00197184|21065996|P1|COMPLETED|Overall Study||139
8544840|NCT00197184|21065995|P2|STARTED|Overall Study||137
8544841|NCT00197184|21065996|P1|STARTED|Overall Study||139
8544842|NCT00197145|21066020|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
8544843|NCT00197145|21066021|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
8544844|NCT00197145|21066020|P2|COMPLETED|Period 2 : Open Label Phase||0
8544845|NCT00197145|21066021|P1|COMPLETED|Period 2 : Open Label Phase||0
8544846|NCT00197145|21066020|P2|STARTED|Period 2 : Open Label Phase||0
8544847|NCT00197145|21066021|P1|STARTED|Period 2 : Open Label Phase||10
8544848|NCT00197145|21066020|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
8544849|NCT00197145|21066021|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
8544850|NCT00197145|21066020|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
8544851|NCT00197145|21066021|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
8544852|NCT00197145|21066020|P2|STARTED|Period 1: Randomized Treatment Phase||11
8544853|NCT00197145|21066021|P1|STARTED|Period 1: Randomized Treatment Phase||13
8544854|NCT00197119|21066079|P2|NOT COMPLETED|Year 10||0
8544855|NCT00197119|21066080|P1|NOT COMPLETED|Year 10||0
8544856|NCT00197119|21066079|P2|COMPLETED|Year 10||108
8544857|NCT00197119|21066080|P1|COMPLETED|Year 10||120
8544858|NCT00197119|21066079|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
8544859|NCT00197119|21066080|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
8544860|NCT00197119|21066079|P2|NOT COMPLETED|Year 9||0
8544861|NCT00197119|21066080|P1|NOT COMPLETED|Year 9||0
8544862|NCT00197119|21066079|P2|COMPLETED|Year 9||114
8544863|NCT00197119|21066080|P1|COMPLETED|Year 9||121
8544864|NCT00197119|21066079|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
8544865|NCT00197119|21066080|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
8544866|NCT00197119|21066079|P2|NOT COMPLETED|Year 8||0
8544867|NCT00197119|21066080|P1|NOT COMPLETED|Year 8||0
8544868|NCT00197119|21066079|P2|COMPLETED|Year 8||115
8544869|NCT00197119|21066080|P1|COMPLETED|Year 8||122
8544870|NCT00197119|21066079|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
8544871|NCT00197119|21066080|P1|STARTED|Year 8||122
8544872|NCT00197119|21066079|P2|NOT COMPLETED|Year 7||0
8544873|NCT00197119|21066080|P1|NOT COMPLETED|Year 7||0
8544874|NCT00197119|21066079|P2|COMPLETED|Year 7||114
8544875|NCT00197119|21066080|P1|COMPLETED|Year 7||122
8544876|NCT00197119|21066079|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
8544877|NCT00197119|21066080|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
8544878|NCT00197119|21066079|P2|NOT COMPLETED|Year 6||0
8544879|NCT00197119|21066080|P1|NOT COMPLETED|Year 6||0
8544880|NCT00197119|21066079|P2|COMPLETED|Year 6||118
8544881|NCT00197119|21066080|P1|COMPLETED|Year 6||126
8544882|NCT00197119|21066079|P2|STARTED|Year 6||118
8544883|NCT00197119|21066080|P1|STARTED|Year 6||126
8544884|NCT00197106|21066092|P3|NOT COMPLETED|Overall Treatment Period||6
8544885|NCT00197106|21066093|P2|NOT COMPLETED|Overall Treatment Period||1
8544886|NCT00197106|21066094|P1|NOT COMPLETED|Overall Treatment Period||0
8544887|NCT00197106|21066092|P3|COMPLETED|Overall Treatment Period||74
8544888|NCT00197106|21066093|P2|COMPLETED|Overall Treatment Period||77
8544889|NCT00197106|21066094|P1|COMPLETED|Overall Treatment Period||0
8544890|NCT00197106|21066092|P3|STARTED|Overall Treatment Period||80
8544891|NCT00197106|21066093|P2|STARTED|Overall Treatment Period||78
8544892|NCT00197106|21066094|P1|STARTED|Overall Treatment Period||0
8544893|NCT00197106|21066092|P3|NOT COMPLETED|4-Week Run-In Period||0
8544894|NCT00197106|21066093|P2|NOT COMPLETED|4-Week Run-In Period||0
8544895|NCT00197106|21066094|P1|NOT COMPLETED|4-Week Run-In Period||99
8544896|NCT00197106|21066092|P3|COMPLETED|4-Week Run-In Period||0
8544897|NCT00197106|21066093|P2|COMPLETED|4-Week Run-In Period||0
8544898|NCT00197106|21066094|P1|COMPLETED|4-Week Run-In Period||158
8544899|NCT00197106|21066092|P3|STARTED|4-Week Run-In Period||0
8544900|NCT00197106|21066093|P2|STARTED|4-Week Run-In Period||0
8544901|NCT00197106|21066094|P1|STARTED|4-Week Run-In Period||257
8544911|NCT00197028|21066243|P2|NOT COMPLETED|Overall Study||21
8544912|NCT00197028|21066244|P1|NOT COMPLETED|Overall Study||16
8544913|NCT00197028|21066243|P2|COMPLETED|Overall Study||86
8544914|NCT00197028|21066244|P1|COMPLETED|Overall Study||91
8544915|NCT00197028|21066243|P2|STARTED|Overall Study||107
8544916|NCT00197028|21066244|P1|STARTED|Overall Study||107
8544917|NCT00197015|21066287|P3|NOT COMPLETED|Overall Study||77
8544918|NCT00197015|21066288|P2|NOT COMPLETED|Overall Study||89
8544919|NCT00197015|21066289|P1|NOT COMPLETED|Overall Study||50
8544920|NCT00197015|21066287|P3|COMPLETED|Overall Study||385
8544921|NCT00197015|21066288|P2|COMPLETED|Overall Study||366
8544922|NCT00197015|21066289|P1|COMPLETED|Overall Study||274
8544923|NCT00197015|21066287|P3|STARTED|Overall Study||462
8544924|NCT00197015|21066288|P2|STARTED|Overall Study||455
8544925|NCT00197015|21066289|P1|STARTED|Overall Study||324
8544926|NCT00197002|21066348|P3|NOT COMPLETED|Overall Study||17
8544927|NCT00197002|21066349|P2|NOT COMPLETED|Overall Study||18
8544928|NCT00197002|21066350|P1|NOT COMPLETED|Overall Study||22
8544929|NCT00197002|21066348|P3|COMPLETED|Overall Study||132
8544930|NCT00197002|21066349|P2|COMPLETED|Overall Study||119
8544931|NCT00197002|21066350|P1|COMPLETED|Overall Study||125
8544932|NCT00197002|21066348|P3|STARTED|Overall Study||149
8544933|NCT00197002|21066349|P2|STARTED|Overall Study||137
8544934|NCT00197002|21066350|P1|STARTED|Overall Study||147
8544935|NCT00196976|21066401|P14|NOT COMPLETED|Booster Study||0
8544936|NCT00196976|21066402|P13|NOT COMPLETED|Booster Study||0
8544937|NCT00196976|21066403|P12|NOT COMPLETED|Booster Study||2
8544938|NCT00196976|21066404|P11|NOT COMPLETED|Booster Study||2
8544939|NCT00196976|21066405|P10|NOT COMPLETED|Booster Study||0
8544940|NCT00196976|21066406|P9|NOT COMPLETED|Booster Study||0
8544941|NCT00196976|21066407|P8|NOT COMPLETED|Booster Study||0
8544942|NCT00196976|21066408|P7|NOT COMPLETED|Booster Study||0
8544943|NCT00196976|21066409|P6|NOT COMPLETED|Booster Study||0
8544944|NCT00196976|21066410|P5|NOT COMPLETED|Booster Study||0
8544945|NCT00196976|21066411|P4|NOT COMPLETED|Booster Study||0
8544946|NCT00196976|21066412|P3|NOT COMPLETED|Booster Study||0
8544947|NCT00196976|21066413|P2|NOT COMPLETED|Booster Study||0
8544948|NCT00196976|21066414|P1|NOT COMPLETED|Booster Study||0
8544949|NCT00196976|21066401|P14|COMPLETED|Booster Study||43
8544950|NCT00196976|21066402|P13|COMPLETED|Booster Study||45
8544951|NCT00196976|21066403|P12|COMPLETED|Booster Study||30
8544952|NCT00196976|21066404|P11|COMPLETED|Booster Study||31
8544953|NCT00196976|21066405|P10|COMPLETED|Booster Study||0
8544954|NCT00196976|21066406|P9|COMPLETED|Booster Study||0
8544955|NCT00196976|21066407|P8|COMPLETED|Booster Study||0
8544956|NCT00196976|21066408|P7|COMPLETED|Booster Study||0
8544957|NCT00196976|21066409|P6|COMPLETED|Booster Study||0
8544958|NCT00196976|21066410|P5|COMPLETED|Booster Study||0
8544959|NCT00196976|21066411|P4|COMPLETED|Booster Study||0
8544960|NCT00196976|21066412|P3|COMPLETED|Booster Study||0
8544961|NCT00196976|21066413|P2|COMPLETED|Booster Study||0
8544962|NCT00196976|21066414|P1|COMPLETED|Booster Study||0
8544963|NCT00196976|21066401|P14|STARTED|Booster Study||43
8544964|NCT00196976|21066402|P13|STARTED|Booster Study||45
8544965|NCT00196976|21066403|P12|STARTED|Booster Study||32
8544966|NCT00196976|21066404|P11|STARTED|Booster Study||33
8544967|NCT00196976|21066405|P10|STARTED|Booster Study||0
8544968|NCT00196976|21066406|P9|STARTED|Booster Study||0
8544969|NCT00196976|21066407|P8|STARTED|Booster Study||0
8544970|NCT00196976|21066408|P7|STARTED|Booster Study||0
8544971|NCT00196976|21066409|P6|STARTED|Booster Study||0
8544972|NCT00196976|21066410|P5|STARTED|Booster Study||0
8544973|NCT00196976|21066411|P4|STARTED|Booster Study||0
8544974|NCT00196976|21066412|P3|STARTED|Booster Study||0
8544975|NCT00196976|21066413|P2|STARTED|Booster Study||0
8544976|NCT00196976|21066414|P1|STARTED|Booster Study||0
8544977|NCT00196976|21066401|P14|NOT COMPLETED|Primary Study||0
8544978|NCT00196976|21066402|P13|NOT COMPLETED|Primary Study||0
8544979|NCT00196976|21066403|P12|NOT COMPLETED|Primary Study||0
8544980|NCT00196976|21066404|P11|NOT COMPLETED|Primary Study||0
8544981|NCT00196976|21066405|P10|NOT COMPLETED|Primary Study||1
8544982|NCT00196976|21066406|P9|NOT COMPLETED|Primary Study||0
8544983|NCT00196976|21066407|P8|NOT COMPLETED|Primary Study||3
8544984|NCT00196976|21066408|P7|NOT COMPLETED|Primary Study||0
8544985|NCT00196976|21066409|P6|NOT COMPLETED|Primary Study||2
8544986|NCT00196976|21066410|P5|NOT COMPLETED|Primary Study||3
8544987|NCT00196976|21066411|P4|NOT COMPLETED|Primary Study||1
8544988|NCT00196976|21066412|P3|NOT COMPLETED|Primary Study||4
8544989|NCT00196976|21066413|P2|NOT COMPLETED|Primary Study||1
8544990|NCT00196976|21066414|P1|NOT COMPLETED|Primary Study||1
8544991|NCT00196976|21066401|P14|COMPLETED|Primary Study||0
8544992|NCT00196976|21066402|P13|COMPLETED|Primary Study||0
8544993|NCT00196976|21066403|P12|COMPLETED|Primary Study||0
8544994|NCT00196976|21066404|P11|COMPLETED|Primary Study||0
8544995|NCT00196976|21066405|P10|COMPLETED|Primary Study||51
8544996|NCT00196976|21066406|P9|COMPLETED|Primary Study||52
8544997|NCT00196976|21066407|P8|COMPLETED|Primary Study||49
8544998|NCT00196976|21066408|P7|COMPLETED|Primary Study||50
8544999|NCT00196976|21066409|P6|COMPLETED|Primary Study||52
8545000|NCT00196976|21066410|P5|COMPLETED|Primary Study||37
8545001|NCT00196976|21066411|P4|COMPLETED|Primary Study||39
8545002|NCT00196976|21066412|P3|COMPLETED|Primary Study||37
8545003|NCT00196976|21066413|P2|COMPLETED|Primary Study||40
8545004|NCT00196976|21066414|P1|COMPLETED|Primary Study||38
8545005|NCT00196976|21066401|P14|STARTED|Primary Study||0
8545006|NCT00196976|21066402|P13|STARTED|Primary Study||0
8545007|NCT00196976|21066403|P12|STARTED|Primary Study||0
8545008|NCT00196976|21066404|P11|STARTED|Primary Study||0
8545009|NCT00196976|21066405|P10|STARTED|Primary Study||52
8545010|NCT00196976|21066406|P9|STARTED|Primary Study||52
8545011|NCT00196976|21066407|P8|STARTED|Primary Study||52
8545012|NCT00196976|21066408|P7|STARTED|Primary Study||50
8545013|NCT00196976|21066409|P6|STARTED|Primary Study||54
8545014|NCT00196976|21066410|P5|STARTED|Primary Study||40
8545015|NCT00196976|21066411|P4|STARTED|Primary Study||40
8545016|NCT00196976|21066412|P3|STARTED|Primary Study||41
8545017|NCT00196976|21066413|P2|STARTED|Primary Study||41
8545018|NCT00196976|21066414|P1|STARTED|Primary Study||39
8545019|NCT00196937|21066610|P3|NOT COMPLETED|Overall Study||7
8545020|NCT00196937|21066611|P2|NOT COMPLETED|Overall Study||5
8545021|NCT00196937|21066612|P1|NOT COMPLETED|Overall Study||9
8545022|NCT00196937|21066610|P3|COMPLETED|Overall Study||204
8545023|NCT00196937|21066611|P2|COMPLETED|Overall Study||221
8545024|NCT00196937|21066612|P1|COMPLETED|Overall Study||220
8545025|NCT00196937|21066610|P3|STARTED|Overall Study||211
8545026|NCT00196937|21066611|P2|STARTED|Overall Study||226
8545027|NCT00196937|21066612|P1|STARTED|Overall Study||229
8545028|NCT00196716|21066656|P1|NOT COMPLETED|0.3 mg/kg Period||0
8545029|NCT00196716|21066656|P1|COMPLETED|0.3 mg/kg Period||21
8545030|NCT00196716|21066656|P1|STARTED|0.3 mg/kg Period||21
8545031|NCT00196716|21066656|P1|NOT COMPLETED|1.0 mg/kg Period||0
8545032|NCT00196716|21066656|P1|COMPLETED|1.0 mg/kg Period||21
8545033|NCT00196716|21066656|P1|STARTED|1.0 mg/kg Period||21
8545034|NCT00196326|21066666|P1|NOT COMPLETED|Overall Study||986
8545035|NCT00196326|21066666|P1|COMPLETED|Overall Study||1249
8545036|NCT00196326|21066666|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
8545037|NCT00196326|21066666|P1|Safety Population|Overall Study|Treated participants|2185
8545038|NCT00196326|21066666|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
8545039|NCT00196313|21066674|P2|NOT COMPLETED|Overall Study||8
8545040|NCT00196313|21066675|P1|NOT COMPLETED|Overall Study||11
8545041|NCT00196313|21066674|P2|COMPLETED|Overall Study||40
8545042|NCT00196313|21066675|P1|COMPLETED|Overall Study||36
8545043|NCT00196313|21066674|P2|STARTED|Overall Study||48
8545044|NCT00196313|21066675|P1|STARTED|Overall Study||47
8545045|NCT00196196|21066689|P1|NOT COMPLETED|Overall Study||7
8545046|NCT00196196|21066689|P1|COMPLETED|Overall Study||267
8545047|NCT00196196|21066689|P1|STARTED|Overall Study||274
8545048|NCT00196105|21066697|P3|NOT COMPLETED|Overall Study||7
8545049|NCT00196105|21066698|P2|NOT COMPLETED|Overall Study||5
8545050|NCT00196105|21066699|P1|NOT COMPLETED|Overall Study||4
8545051|NCT00196105|21066697|P3|COMPLETED|Overall Study||82
8545052|NCT00196105|21066698|P2|COMPLETED|Overall Study||83
8545053|NCT00196105|21066699|P1|COMPLETED|Overall Study||60
8545054|NCT00196105|21066697|P3|STARTED|Overall Study||89
8545055|NCT00196105|21066698|P2|STARTED|Overall Study||88
8545056|NCT00196105|21066699|P1|STARTED|Overall Study||64
8545057|NCT00195819|21066719|P2|NOT COMPLETED|Open-label||20
8545058|NCT00195819|21066720|P1|NOT COMPLETED|Open-label||0
8545059|NCT00195819|21066719|P2|COMPLETED|Open-label||62
8545060|NCT00195819|21066720|P1|COMPLETED|Open-label||0
8545061|NCT00195819|21066719|P2|STARTED|Open-label||82
8545062|NCT00195819|21066720|P1|STARTED|Open-label||0
8545063|NCT00195819|21066719|P2|NOT COMPLETED|Double-Blind||0
8545064|NCT00195819|21066720|P1|NOT COMPLETED|Double-Blind||2
8545065|NCT00195819|21066719|P2|COMPLETED|Double-Blind||38
8545066|NCT00195819|21066720|P1|COMPLETED|Double-Blind||42
8545067|NCT00195819|21066719|P2|STARTED|Double-Blind||38
8545068|NCT00195819|21066720|P1|STARTED|Double-Blind||44
8545069|NCT00195715|21066770|P1|NOT COMPLETED|Overall Study||377
8545070|NCT00195715|21066770|P1|COMPLETED|Overall Study||400
8545071|NCT00195715|21066770|P1|STARTED|Overall Study||777
8545072|NCT00195702|21066801|P6|NOT COMPLETED|Open-label Extension Phase||78
8545073|NCT00195702|21066802|P5|NOT COMPLETED|Open-label Extension Phase||78
8545074|NCT00195702|21066803|P4|NOT COMPLETED|Open-label Extension Phase||99
8545075|NCT00195702|21066804|P3|NOT COMPLETED|Open-label Extension Phase||0
8545076|NCT00195702|21066805|P2|NOT COMPLETED|Open-label Extension Phase||0
8545077|NCT00195702|21066806|P1|NOT COMPLETED|Open-label Extension Phase||0
8545078|NCT00195702|21066801|P6|COMPLETED|Open-label Extension Phase||56
8545079|NCT00195702|21066802|P5|COMPLETED|Open-label Extension Phase||80
8545080|NCT00195702|21066803|P4|COMPLETED|Open-label Extension Phase||66
8545081|NCT00195702|21066804|P3|COMPLETED|Open-label Extension Phase||0
8545082|NCT00195702|21066805|P2|COMPLETED|Open-label Extension Phase||0
8545083|NCT00195702|21066806|P1|COMPLETED|Open-label Extension Phase||0
8545084|NCT00195702|21066801|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
8545085|NCT00195702|21066802|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
8545086|NCT00195702|21066803|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
8545087|NCT00195702|21066804|P3|STARTED|Open-label Extension Phase||0
8545088|NCT00195702|21066805|P2|STARTED|Open-label Extension Phase||0
8545089|NCT00195702|21066806|P1|STARTED|Open-label Extension Phase||0
8545090|NCT00195702|21066801|P6|NOT COMPLETED|Double-blind Phase||0
8545091|NCT00195702|21066802|P5|NOT COMPLETED|Double-blind Phase||0
8545092|NCT00195702|21066803|P4|NOT COMPLETED|Double-blind Phase||0
8545093|NCT00195702|21066804|P3|NOT COMPLETED|Double-blind Phase||60
8545094|NCT00195702|21066805|P2|NOT COMPLETED|Double-blind Phase||48
8545095|NCT00195702|21066806|P1|NOT COMPLETED|Double-blind Phase||44
8545096|NCT00195702|21066801|P6|COMPLETED|Double-blind Phase||0
8545097|NCT00195702|21066802|P5|COMPLETED|Double-blind Phase||0
8545098|NCT00195702|21066803|P4|COMPLETED|Double-blind Phase||0
8545099|NCT00195702|21066804|P3|COMPLETED|Double-blind Phase||140
8545100|NCT00195702|21066805|P2|COMPLETED|Double-blind Phase||159
8545101|NCT00195702|21066806|P1|COMPLETED|Double-blind Phase||168
8545102|NCT00195702|21066801|P6|STARTED|Double-blind Phase||0
8545103|NCT00195702|21066802|P5|STARTED|Double-blind Phase||0
8545104|NCT00195702|21066803|P4|STARTED|Double-blind Phase||0
8545105|NCT00195702|21066804|P3|STARTED|Double-blind Phase||200
8545106|NCT00195702|21066805|P2|STARTED|Double-blind Phase||207
8545107|NCT00195702|21066806|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
8545108|NCT00195676|21066870|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
8545109|NCT00195676|21066870|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
8545110|NCT00195676|21066870|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
8545111|NCT00195676|21066870|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
8545112|NCT00195676|21066870|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
8545113|NCT00195676|21066870|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
8545114|NCT00195676|21066870|P1|NOT COMPLETED|Period O - Open-label Treatment||606
8545115|NCT00195676|21066870|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
8545116|NCT00195676|21066870|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
8545117|NCT00195663|21066884|P3|NOT COMPLETED|Open-Label Extension Period||97
8545118|NCT00195663|21066885|P2|NOT COMPLETED|Open-Label Extension Period||74
8545119|NCT00195663|21066886|P1|NOT COMPLETED|Open-Label Extension Period||76
8545120|NCT00195663|21066884|P3|COMPLETED|Open-Label Extension Period||86
8545121|NCT00195663|21066885|P2|COMPLETED|Open-Label Extension Period||85
8545122|NCT00195663|21066886|P1|COMPLETED|Open-Label Extension Period||79
8545123|NCT00195663|21066884|P3|STARTED|Open-Label Extension Period||183
8545124|NCT00195663|21066885|P2|STARTED|Open-Label Extension Period||159
8545125|NCT00195663|21066886|P1|STARTED|Open-Label Extension Period||155
8545126|NCT00195663|21066884|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
8545127|NCT00195663|21066885|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
8545128|NCT00195663|21066886|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
8545129|NCT00195663|21066884|P3|COMPLETED|2-year Double-blind Treatment Period||196
8545130|NCT00195663|21066885|P2|COMPLETED|2-year Double-blind Treatment Period||166
8545131|NCT00195663|21066886|P1|COMPLETED|2-year Double-blind Treatment Period||164
8545132|NCT00195663|21066884|P3|STARTED|2-year Double-blind Treatment Period||268
8545133|NCT00195663|21066885|P2|STARTED|2-year Double-blind Treatment Period||274
8545134|NCT00195663|21066886|P1|STARTED|2-year Double-blind Treatment Period||257
8545135|NCT00195650|21066980|P1|NOT COMPLETED|Overall Study||525
8545136|NCT00195650|21066980|P1|COMPLETED|Overall Study||321
8545227|NCT00195260|21067118|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545137|NCT00195650|21066980|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
8545138|NCT00195624|21066996|P2|NOT COMPLETED|Overall Study||0
8545139|NCT00195624|21066997|P1|NOT COMPLETED|Overall Study||0
8545140|NCT00195624|21066996|P2|COMPLETED|Overall Study||42
8545141|NCT00195624|21066997|P1|COMPLETED|Overall Study||5
8545142|NCT00195624|21066996|P2|STARTED|Overall Study||42
8545143|NCT00195624|21066997|P1|STARTED|Overall Study||5
8545144|NCT00195507|21067005|P2|NOT COMPLETED|Overall Study||118
8545145|NCT00195507|21067006|P1|NOT COMPLETED|Overall Study||99
8545146|NCT00195507|21067005|P2|COMPLETED|Overall Study||245
8545147|NCT00195507|21067006|P1|COMPLETED|Overall Study||258
8545148|NCT00195507|21067005|P2|STARTED|Overall Study||363
8545149|NCT00195507|21067006|P1|STARTED|Overall Study||357
8545150|NCT00195494|21067020|P6|NOT COMPLETED|Year 2||0
8545151|NCT00195494|21067021|P5|NOT COMPLETED|Year 2||0
8545152|NCT00195494|21067022|P4|NOT COMPLETED|Year 2||23
8545153|NCT00195494|21067023|P3|NOT COMPLETED|Year 2||18
8545154|NCT00195494|21067024|P2|NOT COMPLETED|Year 2||16
8545155|NCT00195494|21067025|P1|NOT COMPLETED|Year 2||7
8545156|NCT00195494|21067020|P6|COMPLETED|Year 2||0
8545157|NCT00195494|21067021|P5|COMPLETED|Year 2||0
8545158|NCT00195494|21067022|P4|COMPLETED|Year 2||76
8545159|NCT00195494|21067023|P3|COMPLETED|Year 2||93
8545160|NCT00195494|21067024|P2|COMPLETED|Year 2||74
8545161|NCT00195494|21067025|P1|COMPLETED|Year 2||104
8545162|NCT00195494|21067020|P6|STARTED|Year 2||0
8545163|NCT00195494|21067021|P5|STARTED|Year 2||0
8545164|NCT00195494|21067022|P4|STARTED|Year 2||99
8545165|NCT00195494|21067023|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
8545166|NCT00195494|21067024|P2|STARTED|Year 2||90
8545167|NCT00195494|21067025|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
8545168|NCT00195494|21067020|P6|NOT COMPLETED|Year 1||53
8545169|NCT00195494|21067021|P5|NOT COMPLETED|Year 1||79
8545170|NCT00195494|21067022|P4|NOT COMPLETED|Year 1||0
8545171|NCT00195494|21067023|P3|NOT COMPLETED|Year 1||0
8545172|NCT00195494|21067024|P2|NOT COMPLETED|Year 1||0
8545173|NCT00195494|21067025|P1|NOT COMPLETED|Year 1||0
8545174|NCT00195494|21067020|P6|COMPLETED|Year 1||221
8545175|NCT00195494|21067021|P5|COMPLETED|Year 1||189
8545176|NCT00195494|21067022|P4|COMPLETED|Year 1||0
8545177|NCT00195494|21067023|P3|COMPLETED|Year 1||0
8545178|NCT00195494|21067024|P2|COMPLETED|Year 1||0
8545179|NCT00195494|21067025|P1|COMPLETED|Year 1||0
8545180|NCT00195494|21067020|P6|STARTED|Year 1||274
8545181|NCT00195494|21067021|P5|STARTED|Year 1||268
8545182|NCT00195494|21067022|P4|STARTED|Year 1||0
8545183|NCT00195494|21067023|P3|STARTED|Year 1||0
8545184|NCT00195494|21067024|P2|STARTED|Year 1||0
8545185|NCT00195494|21067025|P1|STARTED|Year 1||0
8545186|NCT00195442|21067043|P1|NOT COMPLETED|Overall Study||136
8545187|NCT00195442|21067043|P1|COMPLETED|Overall Study||152
8545188|NCT00195442|21067043|P1|STARTED|Overall Study||288
8545189|NCT00195429|21067062|P2|NOT COMPLETED|Overall Study||5
8545190|NCT00195429|21067063|P1|NOT COMPLETED|Overall Study||5
8545191|NCT00195429|21067062|P2|COMPLETED|Overall Study||18
8545192|NCT00195429|21067063|P1|COMPLETED|Overall Study||19
8545193|NCT00195429|21067062|P2|STARTED|Overall Study||23
8545194|NCT00195429|21067063|P1|STARTED|Overall Study||24
8545195|NCT00195403|21067071|P1|NOT COMPLETED|Overall Study||0
8545196|NCT00195403|21067071|P1|COMPLETED|Overall Study||1014
8545197|NCT00195403|21067071|P1|STARTED|Overall Study||1014
8545198|NCT00195351|21067079|P2|NOT COMPLETED|Overall Study||16
8545199|NCT00195351|21067080|P1|NOT COMPLETED|Overall Study||21
8545200|NCT00195351|21067079|P2|COMPLETED|Overall Study||215
8545201|NCT00195351|21067080|P1|COMPLETED|Overall Study||215
8545202|NCT00195351|21067079|P2|STARTED|Overall Study||231
8545203|NCT00195351|21067080|P1|STARTED|Overall Study||236
8545204|NCT00195338|21067090|P1|NOT COMPLETED|Overall Study||12
8545205|NCT00195338|21067090|P1|COMPLETED|Overall Study||13
8545206|NCT00195338|21067090|P1|STARTED|Overall Study||25
8545207|NCT00195273|21067100|P2|NOT COMPLETED|Overall Study||14
8545208|NCT00195273|21067101|P1|NOT COMPLETED|Overall Study||21
8545209|NCT00195273|21067100|P2|COMPLETED|Overall Study||16
8545210|NCT00195273|21067101|P1|COMPLETED|Overall Study||10
8545211|NCT00195273|21067100|P2|STARTED|Overall Study||30
8545212|NCT00195273|21067101|P1|STARTED|Overall Study||31
8545213|NCT00195260|21067115|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
8545214|NCT00195260|21067116|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
8545215|NCT00195260|21067117|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
8545216|NCT00195260|21067118|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545217|NCT00195260|21067119|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545218|NCT00195260|21067120|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545219|NCT00195260|21067121|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545220|NCT00195260|21067122|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545221|NCT00195260|21067123|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545222|NCT00195260|21067124|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545223|NCT00195260|21067125|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545224|NCT00195260|21067115|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
8545225|NCT00195260|21067116|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545226|NCT00195260|21067117|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
8545228|NCT00195260|21067119|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545229|NCT00195260|21067120|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545230|NCT00195260|21067121|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545231|NCT00195260|21067122|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545232|NCT00195260|21067123|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545233|NCT00195260|21067124|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545234|NCT00195260|21067125|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545235|NCT00195260|21067115|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
8545236|NCT00195260|21067116|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
8545237|NCT00195260|21067117|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
8545238|NCT00195260|21067118|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545239|NCT00195260|21067119|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545240|NCT00195260|21067120|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545241|NCT00195260|21067121|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545242|NCT00195260|21067122|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545243|NCT00195260|21067123|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545244|NCT00195260|21067124|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545245|NCT00195260|21067125|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545246|NCT00195260|21067115|P11|NOT COMPLETED|Part 1: Dose Escalation||0
8545247|NCT00195260|21067116|P10|NOT COMPLETED|Part 1: Dose Escalation||0
8545248|NCT00195260|21067117|P9|NOT COMPLETED|Part 1: Dose Escalation||0
8545249|NCT00195260|21067118|P8|NOT COMPLETED|Part 1: Dose Escalation||6
8545250|NCT00195260|21067119|P7|NOT COMPLETED|Part 1: Dose Escalation||10
8545251|NCT00195260|21067120|P6|NOT COMPLETED|Part 1: Dose Escalation||7
8545252|NCT00195260|21067121|P5|NOT COMPLETED|Part 1: Dose Escalation||7
8545253|NCT00195260|21067122|P4|NOT COMPLETED|Part 1: Dose Escalation||7
8545254|NCT00195260|21067123|P3|NOT COMPLETED|Part 1: Dose Escalation||6
8545255|NCT00195260|21067124|P2|NOT COMPLETED|Part 1: Dose Escalation||4
8545256|NCT00195260|21067125|P1|NOT COMPLETED|Part 1: Dose Escalation||4
8545257|NCT00195260|21067115|P11|COMPLETED|Part 1: Dose Escalation||0
8545258|NCT00195260|21067116|P10|COMPLETED|Part 1: Dose Escalation||0
8545259|NCT00195260|21067117|P9|COMPLETED|Part 1: Dose Escalation||0
8545260|NCT00195260|21067118|P8|COMPLETED|Part 1: Dose Escalation||0
8545261|NCT00195260|21067119|P7|COMPLETED|Part 1: Dose Escalation||0
8545262|NCT00195260|21067120|P6|COMPLETED|Part 1: Dose Escalation||0
8545263|NCT00195260|21067121|P5|COMPLETED|Part 1: Dose Escalation||0
8545264|NCT00195260|21067122|P4|COMPLETED|Part 1: Dose Escalation||0
8545265|NCT00195260|21067123|P3|COMPLETED|Part 1: Dose Escalation||0
8545266|NCT00195260|21067124|P2|COMPLETED|Part 1: Dose Escalation||0
8545267|NCT00195260|21067125|P1|COMPLETED|Part 1: Dose Escalation||0
8545268|NCT00195260|21067115|P11|STARTED|Part 1: Dose Escalation||0
8545269|NCT00195260|21067116|P10|STARTED|Part 1: Dose Escalation||0
8545270|NCT00195260|21067117|P9|STARTED|Part 1: Dose Escalation||0
8545271|NCT00195260|21067118|P8|STARTED|Part 1: Dose Escalation||6
8545272|NCT00195260|21067119|P7|STARTED|Part 1: Dose Escalation||10
8545273|NCT00195260|21067120|P6|STARTED|Part 1: Dose Escalation||7
8545274|NCT00195260|21067121|P5|STARTED|Part 1: Dose Escalation||7
8545275|NCT00195260|21067122|P4|STARTED|Part 1: Dose Escalation||7
8545276|NCT00195260|21067123|P3|STARTED|Part 1: Dose Escalation||6
8545277|NCT00195260|21067124|P2|STARTED|Part 1: Dose Escalation||4
8545278|NCT00195260|21067125|P1|STARTED|Part 1: Dose Escalation||4
8545279|NCT00195039|21067271|P1|NOT COMPLETED|Overall Study||0
8545280|NCT00195039|21067271|P1|COMPLETED|Overall Study||47
8545281|NCT00195039|21067271|P1|STARTED|Overall Study||47
8545282|NCT00195013|21067284|P2|NOT COMPLETED|Overall Study||1
8545283|NCT00195013|21067285|P1|NOT COMPLETED|Overall Study||2
8545284|NCT00195013|21067284|P2|COMPLETED|Overall Study||15
8545285|NCT00195013|21067285|P1|COMPLETED|Overall Study||12
8545286|NCT00195013|21067284|P2|STARTED|Overall Study||16
8545287|NCT00195013|21067285|P1|STARTED|Overall Study||14
8545288|NCT00194987|21067293|P2|NOT COMPLETED|Overall Study||3
8545289|NCT00194987|21067294|P1|NOT COMPLETED|Overall Study||0
8545290|NCT00194987|21067293|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
8545291|NCT00194987|21067294|P1|COMPLETED|Overall Study||51
8545292|NCT00194987|21067293|P2|STARTED|Overall Study||51
8545293|NCT00194987|21067294|P1|STARTED|Overall Study||51
8545294|NCT00194896|21067310|P4|NOT COMPLETED|Overall Study||12
8545295|NCT00194896|21067311|P3|NOT COMPLETED|Overall Study||6
8545296|NCT00194896|21067312|P2|NOT COMPLETED|Overall Study||5
8545297|NCT00194896|21067313|P1|NOT COMPLETED|Overall Study||11
8545298|NCT00194896|21067310|P4|COMPLETED|Overall Study||9
8545299|NCT00194896|21067311|P3|COMPLETED|Overall Study||7
8545300|NCT00194896|21067312|P2|COMPLETED|Overall Study||10
8545301|NCT00194896|21067313|P1|COMPLETED|Overall Study||4
8545302|NCT00194896|21067310|P4|STARTED|Overall Study||21
8545303|NCT00194896|21067311|P3|STARTED|Overall Study||13
8545304|NCT00194896|21067312|P2|STARTED|Overall Study||15
8545305|NCT00194896|21067313|P1|STARTED|Overall Study||15
8545306|NCT00194792|21067327|P1|NOT COMPLETED|Overall Study||1
8545307|NCT00194792|21067327|P1|COMPLETED|Overall Study||27
8545308|NCT00194792|21067327|P1|STARTED|Overall Study||28
8545309|NCT00194779|21067337|P1|NOT COMPLETED|Overall Study||0
8545310|NCT00194779|21067337|P1|COMPLETED|Overall Study||50
8545311|NCT00194779|21067337|P1|STARTED|Overall Study||50
8545312|NCT00194675|21067351|P2|NOT COMPLETED|Overall Study||2
8545313|NCT00194675|21067352|P1|NOT COMPLETED|Overall Study||5
8545314|NCT00194675|21067351|P2|COMPLETED|Overall Study||24
8545315|NCT00194675|21067352|P1|COMPLETED|Overall Study||22
8545316|NCT00194675|21067351|P2|STARTED|Overall Study||26
8545317|NCT00194675|21067352|P1|STARTED|Overall Study||27
8545318|NCT00194610|21067370|P2|NOT COMPLETED|Overall Study||0
8545319|NCT00194610|21067371|P1|NOT COMPLETED|Overall Study||0
8545320|NCT00194610|21067370|P2|COMPLETED|Overall Study||9
8545321|NCT00194610|21067371|P1|COMPLETED|Overall Study||11
8545322|NCT00194610|21067370|P2|STARTED|Overall Study||9
8545323|NCT00194610|21067371|P1|STARTED|Overall Study||11
8545324|NCT00194532|21067379|P2|NOT COMPLETED|Overall Study||0
8545325|NCT00194532|21067380|P1|NOT COMPLETED|Overall Study||0
8545326|NCT00194532|21067379|P2|COMPLETED|Overall Study||150
8545327|NCT00194532|21067380|P1|COMPLETED|Overall Study||150
8545328|NCT00194532|21067379|P2|STARTED|Overall Study||150
8545329|NCT00194532|21067380|P1|STARTED|Overall Study||150
8545330|NCT00194129|21067390|P2|NOT COMPLETED|Overall Study||13
8545331|NCT00194129|21067391|P1|NOT COMPLETED|Overall Study||10
8545332|NCT00194129|21067390|P2|COMPLETED|Overall Study||3
8545333|NCT00194129|21067391|P1|COMPLETED|Overall Study||5
8545334|NCT00194129|21067390|P2|STARTED|Overall Study||16
8545335|NCT00194129|21067391|P1|STARTED|Overall Study||15
8545336|NCT00194116|21067406|P2|NOT COMPLETED|Overall Study||15
8545337|NCT00194116|21067407|P1|NOT COMPLETED|Overall Study||13
8545338|NCT00194116|21067406|P2|COMPLETED|Overall Study||13
8545339|NCT00194116|21067407|P1|COMPLETED|Overall Study||13
8545340|NCT00194116|21067406|P2|STARTED|Overall Study||28
8545341|NCT00194116|21067407|P1|STARTED|Overall Study||26
8545342|NCT00194077|21067427|P2|NOT COMPLETED|Overall Study||30
8545343|NCT00194077|21067428|P1|NOT COMPLETED|Overall Study||24
8545344|NCT00194077|21067427|P2|COMPLETED|Overall Study|"Lack of efficacy:
~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
8545345|NCT00194077|21067428|P1|COMPLETED|Overall Study|"Lack of efficacy:
~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
8545346|NCT00194077|21067427|P2|STARTED|Overall Study||30
8545347|NCT00194077|21067428|P1|STARTED|Overall Study||30
8545348|NCT00194025|21067434|P1|NOT COMPLETED|Overall Study||5
8545349|NCT00194025|21067434|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
8545350|NCT00194025|21067434|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
8545351|NCT00194012|21067449|P2|NOT COMPLETED|Open Label Extension (OLE)||6
8545352|NCT00194012|21067450|P1|NOT COMPLETED|Open Label Extension (OLE)||5
8545353|NCT00194012|21067449|P2|COMPLETED|Open Label Extension (OLE)||15
8545354|NCT00194012|21067450|P1|COMPLETED|Open Label Extension (OLE)||17
8545355|NCT00194012|21067449|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
8545356|NCT00194012|21067450|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
8545357|NCT00194012|21067449|P2|NOT COMPLETED|Randomized Phase||25
8545358|NCT00194012|21067450|P1|NOT COMPLETED|Randomized Phase||16
8545359|NCT00194012|21067449|P2|COMPLETED|Randomized Phase||6
8545360|NCT00194012|21067450|P1|COMPLETED|Randomized Phase||15
8545361|NCT00194012|21067449|P2|Received More Than One Dose|Randomized Phase||29
8545362|NCT00194012|21067450|P1|Received More Than One Dose|Randomized Phase||30
8545363|NCT00194012|21067449|P2|STARTED|Randomized Phase||31
8545364|NCT00194012|21067450|P1|STARTED|Randomized Phase||31
8545365|NCT00193609|21067486|P1|NOT COMPLETED|Overall Study||4
8545366|NCT00193609|21067486|P1|COMPLETED|Overall Study||44
8545367|NCT00193609|21067486|P1|STARTED|Overall Study||48
8545368|NCT00193596|21067493|P2|NOT COMPLETED|Overall Study||66
8545369|NCT00193596|21067494|P1|NOT COMPLETED|Overall Study||56
8545370|NCT00193596|21067493|P2|COMPLETED|Overall Study||39
8545371|NCT00193596|21067494|P1|COMPLETED|Overall Study||37
8545372|NCT00193596|21067493|P2|STARTED|Overall Study||105
8545373|NCT00193596|21067494|P1|STARTED|Overall Study||93
8545374|NCT00193492|21067504|P2|NOT COMPLETED|Overall Study||15
8545375|NCT00193492|21067505|P1|NOT COMPLETED|Overall Study||17
8545376|NCT00193492|21067504|P2|COMPLETED|Overall Study||14
8545377|NCT00193492|21067505|P1|COMPLETED|Overall Study||14
8545378|NCT00193492|21067504|P2|STARTED|Overall Study||29
8545379|NCT00193492|21067505|P1|STARTED|Overall Study||31
8545380|NCT00193479|21067513|P1|NOT COMPLETED|Maintenance Rituximab||0
8545381|NCT00193479|21067513|P1|COMPLETED|Maintenance Rituximab||44
8545382|NCT00193479|21067513|P1|STARTED|Maintenance Rituximab||44
8545383|NCT00193479|21067513|P1|NOT COMPLETED|Induction Chemotherapy||3
8545384|NCT00193479|21067513|P1|COMPLETED|Induction Chemotherapy||48
8545385|NCT00193479|21067513|P1|STARTED|Induction Chemotherapy||51
8545386|NCT00193453|21067517|P1|NOT COMPLETED|Overall Study||48
8545387|NCT00193453|21067517|P1|COMPLETED|Overall Study||21
8545388|NCT00193453|21067517|P1|STARTED|Overall Study||69
8545389|NCT00193427|21067523|P1|NOT COMPLETED|Overall Study||49
8545390|NCT00193427|21067523|P1|COMPLETED|Overall Study||26
8545391|NCT00193427|21067523|P1|STARTED|Overall Study||75
8545392|NCT00193414|21067530|P1|NOT COMPLETED|Overall Study||58
8545393|NCT00193414|21067530|P1|COMPLETED|Overall Study||14
8545394|NCT00193414|21067530|P1|STARTED|Overall Study||72
8545395|NCT00193375|21067536|P1|NOT COMPLETED|Overall Study||19
8545396|NCT00193375|21067536|P1|COMPLETED|Overall Study||41
8545397|NCT00193375|21067536|P1|STARTED|Overall Study||60
8545398|NCT00193258|21067542|P1|NOT COMPLETED|Overall Study||0
8545399|NCT00193258|21067542|P1|COMPLETED|Overall Study||94
8545400|NCT00193258|21067542|P1|STARTED|Overall Study||94
8545401|NCT00193219|21067548|P1|NOT COMPLETED|Overall Study||30
8545402|NCT00193219|21067548|P1|COMPLETED|Overall Study||6
8545403|NCT00193219|21067548|P1|STARTED|Overall Study||36
8545404|NCT00193206|21067554|P1|NOT COMPLETED|Postoperative Therapy||14
8545405|NCT00193206|21067554|P1|COMPLETED|Postoperative Therapy||102
8545406|NCT00193206|21067554|P1|STARTED|Postoperative Therapy||116
8545407|NCT00193206|21067554|P1|NOT COMPLETED|Surgery||0
8545408|NCT00193206|21067554|P1|COMPLETED|Surgery||116
8545409|NCT00193206|21067554|P1|STARTED|Surgery||116
8545410|NCT00193206|21067554|P1|NOT COMPLETED|Preoperative Therapy||7
8545411|NCT00193206|21067554|P1|COMPLETED|Preoperative Therapy||116
8545412|NCT00193206|21067554|P1|STARTED|Preoperative Therapy||123
8545413|NCT00193180|21067558|P1|NOT COMPLETED|Overall Study||10
8545414|NCT00193180|21067558|P1|COMPLETED|Overall Study||27
8545415|NCT00193180|21067558|P1|STARTED|Overall Study||37
8545416|NCT00193128|21067566|P2|NOT COMPLETED|Overall Study||10
8545417|NCT00193128|21067567|P1|NOT COMPLETED|Overall Study||0
8545418|NCT00193128|21067566|P2|COMPLETED|Overall Study||39
8545419|NCT00193128|21067567|P1|COMPLETED|Overall Study||10
8545420|NCT00193128|21067566|P2|STARTED|Overall Study||49
8545421|NCT00193128|21067567|P1|STARTED|Overall Study||10
8545422|NCT00193063|21067573|P1|NOT COMPLETED|Overall Study||4
8545423|NCT00193063|21067573|P1|COMPLETED|Overall Study||37
8545424|NCT00193063|21067573|P1|STARTED|Overall Study||41
8545425|NCT00193050|21067579|P1|NOT COMPLETED|Adjuvant||10
8545426|NCT00193050|21067579|P1|COMPLETED|Adjuvant||77
8545427|NCT00193050|21067579|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
8545428|NCT00193050|21067579|P1|NOT COMPLETED|Surgery||0
8545429|NCT00193050|21067579|P1|COMPLETED|Surgery||103
8545430|NCT00193050|21067579|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
8545431|NCT00193050|21067579|P1|NOT COMPLETED|Neoadjuvant Treatment||9
8545432|NCT00193050|21067579|P1|COMPLETED|Neoadjuvant Treatment||101
8545433|NCT00193050|21067579|P1|STARTED|Neoadjuvant Treatment||110
8545434|NCT00193037|21067585|P2|NOT COMPLETED|Crossover Treatment||0
8545435|NCT00193037|21067586|P1|NOT COMPLETED|Crossover Treatment||0
8545436|NCT00193037|21067585|P2|COMPLETED|Crossover Treatment||24
8545437|NCT00193037|21067586|P1|COMPLETED|Crossover Treatment||32
8545438|NCT00193037|21067585|P2|STARTED|Crossover Treatment||24
8545439|NCT00193037|21067586|P1|STARTED|Crossover Treatment||32
8545440|NCT00193037|21067585|P2|NOT COMPLETED|Randomized Treatment||28
8545441|NCT00193037|21067586|P1|NOT COMPLETED|Randomized Treatment||18
8545442|NCT00193037|21067585|P2|COMPLETED|Randomized Treatment||24
8545443|NCT00193037|21067586|P1|COMPLETED|Randomized Treatment||32
8545444|NCT00193037|21067585|P2|STARTED|Randomized Treatment||52
8545445|NCT00193037|21067586|P1|STARTED|Randomized Treatment||50
8545446|NCT00192647|21067596|P2|NOT COMPLETED|Overall Study||146
8545447|NCT00192647|21067597|P1|NOT COMPLETED|Overall Study||128
8545448|NCT00192647|21067596|P2|COMPLETED|Overall Study||302
8545449|NCT00192647|21067597|P1|COMPLETED|Overall Study||320
8545450|NCT00192647|21067596|P2|Treated|Overall Study||438
8545451|NCT00192647|21067597|P1|Treated|Overall Study||433
8545452|NCT00192647|21067596|P2|STARTED|Overall Study||448
8545453|NCT00192647|21067597|P1|STARTED|Overall Study||448
8545454|NCT00192296|21067617|P4|NOT COMPLETED|Overall Study||0
8545455|NCT00192296|21067618|P3|NOT COMPLETED|Overall Study||0
8545456|NCT00192296|21067619|P2|NOT COMPLETED|Overall Study||1
8545457|NCT00192296|21067620|P1|NOT COMPLETED|Overall Study||0
8545458|NCT00192296|21067617|P4|COMPLETED|Overall Study||6
8545459|NCT00192296|21067618|P3|COMPLETED|Overall Study||6
8545460|NCT00192296|21067619|P2|COMPLETED|Overall Study||5
8545461|NCT00192296|21067620|P1|COMPLETED|Overall Study||6
8545462|NCT00192296|21067617|P4|STARTED|Overall Study||6
8545463|NCT00192296|21067618|P3|STARTED|Overall Study||6
8545464|NCT00192296|21067619|P2|STARTED|Overall Study||6
8545465|NCT00192296|21067620|P1|STARTED|Overall Study||6
8545466|NCT00192114|21067674|P1|NOT COMPLETED|Overall Study||24
8545467|NCT00192114|21067674|P1|COMPLETED|Overall Study||4
8545468|NCT00192114|21067674|P1|Received at Least 1 Dose of Study Drug|Overall Study||28
8545469|NCT00192114|21067674|P1|STARTED|Overall Study||28
8545470|NCT00192075|21067691|P2|NOT COMPLETED|Overall Study||19
8545471|NCT00192075|21067692|P1|NOT COMPLETED|Overall Study||39
8545472|NCT00192075|21067691|P2|COMPLETED|Overall Study||23
8545473|NCT00192075|21067692|P1|COMPLETED|Overall Study||3
8545474|NCT00192075|21067691|P2|STARTED|Overall Study||42
8545475|NCT00192075|21067692|P1|STARTED|Overall Study||42
8545476|NCT00192036|21067717|P1|NOT COMPLETED|Overall Study||21
8545477|NCT00192036|21067717|P1|COMPLETED|Overall Study||28
8545478|NCT00192036|21067717|P1|STARTED|Overall Study||49
8545479|NCT00192023|21067727|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
8545480|NCT00192023|21067728|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
8545481|NCT00192023|21067727|P2|COMPLETED|Period IV - Optional Open-Label||0
8545482|NCT00192023|21067728|P1|COMPLETED|Period IV - Optional Open-Label||49
8545483|NCT00192023|21067727|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
8545484|NCT00192023|21067728|P1|STARTED|Period IV - Optional Open-Label||124
8545485|NCT00192023|21067727|P2|NOT COMPLETED|Period III - Double-Blind||0
8545486|NCT00192023|21067728|P1|NOT COMPLETED|Period III - Double-Blind||7
8545487|NCT00192023|21067727|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
8545488|NCT00192023|21067728|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
8545489|NCT00192023|21067727|P2|STARTED|Period III - Double-Blind||32
8545490|NCT00192023|21067728|P1|STARTED|Period III - Double-Blind||107
8545491|NCT00191984|21067750|P1|NOT COMPLETED|Overall Study||39
8545492|NCT00191984|21067750|P1|COMPLETED|Overall Study||7
8545493|NCT00191984|21067750|P1|STARTED|Overall Study||46
8545494|NCT00191945|21067760|P2|NOT COMPLETED|Open-Label Treatment Extension||0
8545495|NCT00191945|21067761|P1|NOT COMPLETED|Open-Label Treatment Extension||0
8545496|NCT00191945|21067760|P2|COMPLETED|Open-Label Treatment Extension||48
8545497|NCT00191945|21067761|P1|COMPLETED|Open-Label Treatment Extension||94
8545498|NCT00191945|21067760|P2|STARTED|Open-Label Treatment Extension||48
8545499|NCT00191945|21067761|P1|STARTED|Open-Label Treatment Extension||94
8545500|NCT00191945|21067760|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
8545501|NCT00191945|21067761|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
8545502|NCT00191945|21067760|P2|COMPLETED|Double-Blind Acute Treatment||48
8545503|NCT00191945|21067761|P1|COMPLETED|Double-Blind Acute Treatment||94
8545504|NCT00191945|21067760|P2|STARTED|Double-Blind Acute Treatment||51
8545505|NCT00191945|21067761|P1|STARTED|Double-Blind Acute Treatment||100
8545506|NCT00191906|21067797|P4|NOT COMPLETED|Study Period III||0
8545507|NCT00191906|21067798|P3|NOT COMPLETED|Study Period III||0
8545508|NCT00191906|21067799|P2|NOT COMPLETED|Study Period III||4
8545509|NCT00191906|21067800|P1|NOT COMPLETED|Study Period III||5
8545510|NCT00191906|21067797|P4|COMPLETED|Study Period III||0
8545511|NCT00191906|21067798|P3|COMPLETED|Study Period III||0
8545512|NCT00191906|21067799|P2|COMPLETED|Study Period III||7
8545513|NCT00191906|21067800|P1|COMPLETED|Study Period III||9
8545514|NCT00191906|21067797|P4|STARTED|Study Period III||0
8545515|NCT00191906|21067798|P3|STARTED|Study Period III||0
8545516|NCT00191906|21067799|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
8545517|NCT00191906|21067800|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
8545518|NCT00191906|21067797|P4|NOT COMPLETED|Study Period II||0
8545519|NCT00191906|21067798|P3|NOT COMPLETED|Study Period II||1
8545520|NCT00191906|21067799|P2|NOT COMPLETED|Study Period II||5
8545521|NCT00191906|21067800|P1|NOT COMPLETED|Study Period II||0
8545522|NCT00191906|21067797|P4|COMPLETED|Study Period II||18
8545523|NCT00191906|21067798|P3|COMPLETED|Study Period II||26
8545524|NCT00191906|21067799|P2|COMPLETED|Study Period II||32
8545525|NCT00191906|21067800|P1|COMPLETED|Study Period II||39
8545526|NCT00191906|21067797|P4|STARTED|Study Period II||18
8545527|NCT00191906|21067798|P3|STARTED|Study Period II||27
8545528|NCT00191906|21067799|P2|STARTED|Study Period II||37
8545529|NCT00191906|21067800|P1|STARTED|Study Period II||39
8545530|NCT00191854|21067843|P3|NOT COMPLETED|Overall Study||39
8545531|NCT00191854|21067844|P2|NOT COMPLETED|Overall Study||30
8545532|NCT00191854|21067845|P1|NOT COMPLETED|Overall Study||37
8545533|NCT00191854|21067843|P3|COMPLETED|Overall Study||12
8545534|NCT00191854|21067844|P2|COMPLETED|Overall Study||17
8545535|NCT00191854|21067845|P1|COMPLETED|Overall Study||12
8545536|NCT00191854|21067843|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
8545537|NCT00191854|21067844|P2|Received at Least One Dose of Study Drug|Overall Study||47
8545538|NCT00191854|21067845|P1|Received at Least One Dose of Study Drug|Overall Study||49
8545539|NCT00191854|21067843|P3|STARTED|Overall Study||51
8545540|NCT00191854|21067844|P2|STARTED|Overall Study||47
8545541|NCT00191854|21067845|P1|STARTED|Overall Study||49
8545542|NCT00191815|21067865|P1|NOT COMPLETED|Overall Study||40
8545543|NCT00191815|21067865|P1|COMPLETED|Overall Study||30
8545544|NCT00191815|21067865|P1|Treated|Overall Study||67
8545545|NCT00191815|21067865|P1|STARTED|Overall Study||70
8545546|NCT00191789|21067877|P1|NOT COMPLETED|Overall Study||25
8545547|NCT00191789|21067877|P1|COMPLETED|Overall Study||40
8545548|NCT00191789|21067877|P1|STARTED|Overall Study||65
8545549|NCT00191724|21067894|P5|NOT COMPLETED|Overall Study||3
8545550|NCT00191724|21067895|P4|NOT COMPLETED|Overall Study||3
8545551|NCT00191724|21067896|P3|NOT COMPLETED|Overall Study||1
8545552|NCT00191724|21067897|P2|NOT COMPLETED|Overall Study||1
8545553|NCT00191724|21067898|P1|NOT COMPLETED|Overall Study||1
8545554|NCT00191724|21067894|P5|COMPLETED|Overall Study||12
8545555|NCT00191724|21067895|P4|COMPLETED|Overall Study||5
8545556|NCT00191724|21067896|P3|COMPLETED|Overall Study||8
8545557|NCT00191724|21067897|P2|COMPLETED|Overall Study||8
8545558|NCT00191724|21067898|P1|COMPLETED|Overall Study||5
8545559|NCT00191724|21067894|P5|STARTED|Overall Study||15
8545560|NCT00191724|21067895|P4|STARTED|Overall Study||8
8545561|NCT00191724|21067896|P3|STARTED|Overall Study||9
8545562|NCT00191724|21067897|P2|STARTED|Overall Study||9
8545563|NCT00191724|21067898|P1|STARTED|Overall Study||6
8545564|NCT00191646|21067927|P2|NOT COMPLETED|Overall Study||153
8545565|NCT00191646|21067928|P1|NOT COMPLETED|Overall Study||171
8545566|NCT00191646|21067927|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
8545567|NCT00191646|21067928|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
8545568|NCT00191646|21067927|P2|Received Crossover Therapy|Overall Study||78
8545569|NCT00191646|21067928|P1|Received Crossover Therapy|Overall Study||77
8545570|NCT00191646|21067927|P2|Received Consolidation Therapy|Overall Study||183
8545571|NCT00191646|21067928|P1|Received Consolidation Therapy|Overall Study||169
8545572|NCT00191646|21067927|P2|Received Induction Therapy|Overall Study||409
8545573|NCT00191646|21067928|P1|Received Induction Therapy|Overall Study||411
8545574|NCT00191646|21067927|P2|STARTED|Overall Study||414
8545575|NCT00191646|21067928|P1|STARTED|Overall Study||417
8545576|NCT00191477|21067948|P2|NOT COMPLETED|Overall Study||129
8545577|NCT00191477|21067949|P1|NOT COMPLETED|Overall Study||138
8545578|NCT00191477|21067948|P2|COMPLETED|Overall Study||47
8545579|NCT00191477|21067949|P1|COMPLETED|Overall Study||41
8545580|NCT00191477|21067948|P2|Received Study Drug|Overall Study||162
8545581|NCT00191477|21067949|P1|Received Study Drug|Overall Study||166
8545582|NCT00191477|21067948|P2|STARTED|Overall Study||176
8545583|NCT00191477|21067949|P1|STARTED|Overall Study||179
8545584|NCT00191451|21067968|P3|NOT COMPLETED|Overall Study||14
8545585|NCT00191451|21067969|P2|NOT COMPLETED|Overall Study||14
8545586|NCT00191451|21067970|P1|NOT COMPLETED|Overall Study||7
8545587|NCT00191451|21067968|P3|COMPLETED|Overall Study||35
8545588|NCT00191451|21067969|P2|COMPLETED|Overall Study||37
8545589|NCT00191451|21067970|P1|COMPLETED|Overall Study||43
8545590|NCT00191451|21067968|P3|Received at Least One Dose of Study Drug|Overall Study||47
8545591|NCT00191451|21067969|P2|Received at Least One Dose of Study Drug|Overall Study||48
8545592|NCT00191451|21067970|P1|Received at Least One Dose of Study Drug|Overall Study||50
8545593|NCT00191451|21067968|P3|STARTED|Overall Study||49
8545594|NCT00191451|21067969|P2|STARTED|Overall Study||51
8545595|NCT00191451|21067970|P1|STARTED|Overall Study||50
8545596|NCT00191386|21067990|P1|NOT COMPLETED|Overall Study||160
8545597|NCT00191386|21067990|P1|COMPLETED|Overall Study||68
8545598|NCT00191386|21067990|P1|3 Years|Overall Study||65
8545599|NCT00191386|21067990|P1|2 Years|Overall Study||105
8545600|NCT00191386|21067990|P1|12 Months|Overall Study||149
8545601|NCT00191386|21067990|P1|6 Months|Overall Study||183
8545602|NCT00191386|21067990|P1|STARTED|Overall Study||228
8545603|NCT00191334|21067997|P1|NOT COMPLETED|Overall Study||17
8545604|NCT00191334|21067997|P1|COMPLETED|Overall Study||33
8545605|NCT00191334|21067997|P1|STARTED|Overall Study||50
8545606|NCT00191308|21068005|P1|NOT COMPLETED|Overall Study||1
8545607|NCT00191308|21068005|P1|COMPLETED|Overall Study||29
8545608|NCT00191308|21068005|P1|STARTED|Overall Study||30
8545609|NCT00191282|21068015|P2|NOT COMPLETED|Overall Study||212
8545610|NCT00191282|21068016|P1|NOT COMPLETED|Overall Study||220
8545611|NCT00191282|21068015|P2|COMPLETED|Overall Study||346
8545612|NCT00191282|21068016|P1|COMPLETED|Overall Study||338
8545613|NCT00191282|21068015|P2|STARTED|Overall Study||558
8545614|NCT00191282|21068016|P1|STARTED|Overall Study||558
8545615|NCT00191269|21068076|P2|NOT COMPLETED|Overall Study||58
8545616|NCT00191269|21068077|P1|NOT COMPLETED|Overall Study||6
8545617|NCT00191269|21068076|P2|COMPLETED|Overall Study||4
8545618|NCT00191269|21068077|P1|COMPLETED|Overall Study||0
8545619|NCT00191269|21068076|P2|STARTED|Overall Study||62
8545620|NCT00191269|21068077|P1|STARTED|Overall Study||6
8545621|NCT00191191|21068093|P2|NOT COMPLETED|Overall Study||112
8545622|NCT00191191|21068094|P1|NOT COMPLETED|Overall Study||114
8545623|NCT00191191|21068093|P2|COMPLETED|Overall Study||0
8545624|NCT00191191|21068094|P1|COMPLETED|Overall Study||0
8545625|NCT00191191|21068093|P2|Full Analysis Set Population|Overall Study||108
8545626|NCT00191191|21068094|P1|Full Analysis Set Population|Overall Study||108
8545627|NCT00191191|21068093|P2|Safety Analysis Population|Overall Study||111
8545628|NCT00191191|21068094|P1|Safety Analysis Population|Overall Study||114
8545629|NCT00191191|21068093|P2|STARTED|Overall Study||112
8545630|NCT00191191|21068094|P1|STARTED|Overall Study||114
8545631|NCT00191165|21068110|P2|NOT COMPLETED|Overall Study||2
8545632|NCT00191165|21068111|P1|NOT COMPLETED|Overall Study||2
8545633|NCT00191165|21068110|P2|COMPLETED|Overall Study||11
8545634|NCT00191165|21068111|P1|COMPLETED|Overall Study||12
8545635|NCT00191165|21068110|P2|STARTED|Overall Study||13
8545636|NCT00191165|21068111|P1|STARTED|Overall Study||14
8545637|NCT00191152|21068123|P2|NOT COMPLETED|Crossover Treatment||28
8545638|NCT00191152|21068124|P1|NOT COMPLETED|Crossover Treatment||27
8545639|NCT00191152|21068123|P2|COMPLETED|Crossover Treatment||53
8545640|NCT00191152|21068124|P1|COMPLETED|Crossover Treatment||50
8545641|NCT00191152|21068123|P2|Received Treatment|Crossover Treatment||80
8545642|NCT00191152|21068124|P1|Received Treatment|Crossover Treatment||76
8545643|NCT00191152|21068123|P2|STARTED|Crossover Treatment||81
8545644|NCT00191152|21068124|P1|STARTED|Crossover Treatment||77
8545645|NCT00191152|21068123|P2|NOT COMPLETED|Initial Treatment||153
8545646|NCT00191152|21068124|P1|NOT COMPLETED|Initial Treatment||141
8545647|NCT00191152|21068123|P2|COMPLETED|Initial Treatment||83
8545648|NCT00191152|21068124|P1|COMPLETED|Initial Treatment||98
8545649|NCT00191152|21068123|P2|Received Initial Treatment|Initial Treatment||227
8545650|NCT00191152|21068124|P1|Received Initial Treatment|Initial Treatment||236
8545651|NCT00191152|21068123|P2|STARTED|Initial Treatment||236
8545652|NCT00191152|21068124|P1|STARTED|Initial Treatment||239
8545653|NCT00191139|21068156|P2|NOT COMPLETED|Overall Study||12
8545654|NCT00191139|21068157|P1|NOT COMPLETED|Overall Study||5
8545655|NCT00191139|21068156|P2|COMPLETED|Overall Study||20
8545656|NCT00191139|21068157|P1|COMPLETED|Overall Study||27
8545657|NCT00191139|21068156|P2|STARTED|Overall Study||32
8545658|NCT00191139|21068157|P1|STARTED|Overall Study||32
8545659|NCT00191113|21068173|P2|NOT COMPLETED|Addendum 3||0
8545660|NCT00191113|21068174|P1|NOT COMPLETED|Addendum 3||0
8545661|NCT00191113|21068173|P2|COMPLETED|Addendum 3||37
8545662|NCT00191113|21068174|P1|COMPLETED|Addendum 3||20
8545663|NCT00191113|21068173|P2|STARTED|Addendum 3||37
8545664|NCT00191113|21068174|P1|STARTED|Addendum 3||20
8545665|NCT00191113|21068173|P2|NOT COMPLETED|Addendum 2||17
8545666|NCT00191113|21068174|P1|NOT COMPLETED|Addendum 2||10
8545667|NCT00191113|21068173|P2|COMPLETED|Addendum 2||31
8545668|NCT00191113|21068174|P1|COMPLETED|Addendum 2||18
8545669|NCT00191113|21068173|P2|STARTED|Addendum 2||48
8545670|NCT00191113|21068174|P1|STARTED|Addendum 2||28
8545671|NCT00191113|21068173|P2|NOT COMPLETED|Addendum 1||0
8545672|NCT00191113|21068174|P1|NOT COMPLETED|Addendum 1||0
8545673|NCT00191113|21068173|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
8545674|NCT00191113|21068174|P1|COMPLETED|Addendum 1||2
8545675|NCT00191113|21068173|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
8545676|NCT00191113|21068174|P1|STARTED|Addendum 1||2
8545677|NCT00191113|21068173|P2|NOT COMPLETED|Core Study||15
8545678|NCT00191113|21068174|P1|NOT COMPLETED|Core Study||35
8545679|NCT00191113|21068173|P2|COMPLETED|Core Study||61
8545680|NCT00191113|21068174|P1|COMPLETED|Core Study||43
8545681|NCT00191113|21068173|P2|STARTED|Core Study||76
8545682|NCT00191113|21068174|P1|STARTED|Core Study||78
8545683|NCT00191100|21068216|P2|NOT COMPLETED|Overall Study||12
8545684|NCT00191100|21068217|P1|NOT COMPLETED|Overall Study||42
8545685|NCT00191100|21068216|P2|COMPLETED|Overall Study||244
8545686|NCT00191100|21068217|P1|COMPLETED|Overall Study||217
8545687|NCT00191100|21068216|P2|STARTED|Overall Study||256
8545688|NCT00191100|21068217|P1|STARTED|Overall Study||259
8545689|NCT00190983|21068233|P1|NOT COMPLETED|Overall Study||2
8545690|NCT00190983|21068233|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
8545691|NCT00190983|21068233|P1|STARTED|Overall Study||29
8545692|NCT00190775|21068242|P2|NOT COMPLETED|Overall Study||100
8545693|NCT00190775|21068243|P1|NOT COMPLETED|Overall Study||149
8545694|NCT00190775|21068242|P2|COMPLETED|Overall Study||134
8545695|NCT00190775|21068243|P1|COMPLETED|Overall Study||119
8545696|NCT00190775|21068242|P2|Received Study Drug|Overall Study||234
8545697|NCT00190775|21068243|P1|Received Study Drug|Overall Study||266
8545698|NCT00190775|21068242|P2|STARTED|Overall Study||234
8545699|NCT00190775|21068243|P1|STARTED|Overall Study||268
8545700|NCT00190749|21068314|P2|NOT COMPLETED|Overall Study||31
8545701|NCT00190749|21068315|P1|NOT COMPLETED|Overall Study||26
8545702|NCT00190749|21068314|P2|COMPLETED|Overall Study||31
8545703|NCT00190749|21068315|P1|COMPLETED|Overall Study||42
8545704|NCT00190749|21068314|P2|STARTED|Overall Study||62
8545705|NCT00190749|21068315|P1|STARTED|Overall Study||68
8545706|NCT00190684|21068379|P1|NOT COMPLETED|Overall Study||1489
8545707|NCT00190684|21068379|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
8545708|NCT00190684|21068379|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
8545709|NCT00190684|21068379|P1|STARTED|Overall Study||1553
8545710|NCT00190671|21068400|P2|NOT COMPLETED|Overall Study||42
8545711|NCT00190671|21068401|P1|NOT COMPLETED|Overall Study||27
8545712|NCT00190671|21068400|P2|COMPLETED|Overall Study||19
8545713|NCT00190671|21068401|P1|COMPLETED|Overall Study||15
8545714|NCT00190671|21068400|P2|STARTED|Overall Study||61
8545715|NCT00190671|21068401|P1|STARTED|Overall Study||42
8545716|NCT00189540|21068421|P2|NOT COMPLETED|Overall Study||1
8545717|NCT00189540|21068422|P1|NOT COMPLETED|Overall Study||7
8545718|NCT00189540|21068421|P2|COMPLETED|Overall Study||5
8545719|NCT00189540|21068422|P1|COMPLETED|Overall Study||14
8545720|NCT00189540|21068421|P2|STARTED|Overall Study||6
8545721|NCT00189540|21068422|P1|STARTED|Overall Study||21
8545722|NCT00189488|21068440|P2|NOT COMPLETED|Overall Study||22
8545723|NCT00189488|21068441|P1|NOT COMPLETED|Overall Study||15
8545724|NCT00189488|21068440|P2|COMPLETED|Overall Study||55
8545725|NCT00189488|21068441|P1|COMPLETED|Overall Study||63
8545726|NCT00189488|21068440|P2|Received Palifermin/Placebo|Overall Study||76
8545727|NCT00189488|21068441|P1|Received Palifermin/Placebo|Overall Study||75
8545728|NCT00189488|21068440|P2|STARTED|Overall Study||77
8545729|NCT00189488|21068441|P1|STARTED|Overall Study||78
8545730|NCT00189475|21068463|P2|NOT COMPLETED|Overall Study||0
8545731|NCT00189475|21068464|P1|NOT COMPLETED|Overall Study||0
8545732|NCT00189475|21068463|P2|COMPLETED|Overall Study||42
8545733|NCT00189475|21068464|P1|COMPLETED|Overall Study||42
8545734|NCT00189475|21068463|P2|STARTED|Overall Study||42
8545735|NCT00189475|21068464|P1|STARTED|Overall Study||42
8545736|NCT00189462|21068472|P2|NOT COMPLETED|Overall Study||21
8545737|NCT00189462|21068473|P1|NOT COMPLETED|Overall Study||23
8545738|NCT00189462|21068472|P2|COMPLETED|Overall Study||28
8545739|NCT00189462|21068473|P1|COMPLETED|Overall Study||27
8545740|NCT00189462|21068472|P2|STARTED|Overall Study||49
8545741|NCT00189462|21068473|P1|STARTED|Overall Study||50
8545748|NCT00189423|21068490|P2|NOT COMPLETED|Overall Study||766
8545749|NCT00189423|21068491|P1|NOT COMPLETED|Overall Study||765
8545750|NCT00189423|21068490|P2|COMPLETED|Overall Study||74
8545751|NCT00189423|21068491|P1|COMPLETED|Overall Study||48
8545752|NCT00189423|21068490|P2|STARTED|Overall Study||840
8545753|NCT00189423|21068491|P1|STARTED|Overall Study||813
8545754|NCT00189306|21068513|P1|NOT COMPLETED|Long-Term Follow-up||38
8545755|NCT00189306|21068513|P1|COMPLETED|Long-Term Follow-up||119
8545756|NCT00189306|21068513|P1|STARTED|Long-Term Follow-up||157
8545757|NCT00189306|21068513|P1|NOT COMPLETED|Posttreatment Period||12
8545758|NCT00189306|21068513|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
8545759|NCT00189306|21068513|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
8545760|NCT00189306|21068513|P1|NOT COMPLETED|Treatment Period||5
8545856|NCT00187200|21068709|P1|STARTED|Overall Study||49
8545761|NCT00189306|21068513|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
8545762|NCT00189306|21068513|P1|STARTED|Treatment Period||169
8545763|NCT00189228|21068518|P1|NOT COMPLETED|Overall Study||0
8545764|NCT00189228|21068518|P1|COMPLETED|Overall Study||18
8545765|NCT00189228|21068518|P1|STARTED|Overall Study||18
8545766|NCT00189202|21068522|P1|NOT COMPLETED|Overall Study||5
8545767|NCT00189202|21068522|P1|COMPLETED|Overall Study||44
8545768|NCT00189202|21068522|P1|STARTED|Overall Study||49
8545769|NCT00189137|21068533|P2|NOT COMPLETED|Overall Study||0
8545770|NCT00189137|21068534|P1|NOT COMPLETED|Overall Study||0
8545771|NCT00189137|21068533|P2|COMPLETED|Overall Study||43
8545772|NCT00189137|21068534|P1|COMPLETED|Overall Study||37
8545773|NCT00189137|21068533|P2|STARTED|Overall Study||43
8545774|NCT00189137|21068534|P1|STARTED|Overall Study||37
8545775|NCT00189098|21068544|P2|NOT COMPLETED|Overall Study||6
8545776|NCT00189098|21068545|P1|NOT COMPLETED|Overall Study||5
8545777|NCT00189098|21068544|P2|COMPLETED|Overall Study||44
8545778|NCT00189098|21068545|P1|COMPLETED|Overall Study||46
8545779|NCT00189098|21068544|P2|STARTED|Overall Study||50
8545780|NCT00189098|21068545|P1|STARTED|Overall Study||51
8545781|NCT00187889|21068563|P2|NOT COMPLETED|Overall Study||4
8545782|NCT00187889|21068564|P1|NOT COMPLETED|Overall Study||6
8545783|NCT00187889|21068563|P2|COMPLETED|Overall Study||22
8545784|NCT00187889|21068564|P1|COMPLETED|Overall Study||19
8545785|NCT00187889|21068563|P2|STARTED|Overall Study||26
8545786|NCT00187889|21068564|P1|STARTED|Overall Study||25
8545787|NCT00187876|21068574|P2|NOT COMPLETED|Overall Study||0
8545788|NCT00187876|21068575|P1|NOT COMPLETED|Overall Study||0
8545789|NCT00187876|21068574|P2|COMPLETED|Overall Study||43
8545790|NCT00187876|21068575|P1|COMPLETED|Overall Study||24
8545791|NCT00187876|21068574|P2|STARTED|Overall Study||43
8545792|NCT00187876|21068575|P1|STARTED|Overall Study||24
8545793|NCT00187720|21068583|P2|NOT COMPLETED|Overall Study||0
8545794|NCT00187720|21068584|P1|NOT COMPLETED|Overall Study||0
8545795|NCT00187720|21068583|P2|COMPLETED|Overall Study||14
8545796|NCT00187720|21068584|P1|COMPLETED|Overall Study||9
8545797|NCT00187720|21068583|P2|STARTED|Overall Study||14
8545798|NCT00187720|21068584|P1|STARTED|Overall Study||9
8545799|NCT00187681|21068592|P2|NOT COMPLETED|Overall Study||0
8545800|NCT00187681|21068593|P1|NOT COMPLETED|Overall Study||0
8545801|NCT00187681|21068592|P2|COMPLETED|Overall Study||8
8545802|NCT00187681|21068593|P1|COMPLETED|Overall Study||12
8545803|NCT00187681|21068592|P2|STARTED|Overall Study||8
8545804|NCT00187681|21068593|P1|STARTED|Overall Study||12
8545805|NCT00187655|21068601|P1|NOT COMPLETED|Overall Study||0
8545806|NCT00187655|21068601|P1|COMPLETED|Overall Study||24
8545807|NCT00187655|21068601|P1|STARTED|Overall Study||24
8545808|NCT00187486|21068606|P1|NOT COMPLETED|Overall Study||1
8545809|NCT00187486|21068606|P1|COMPLETED|Overall Study||65
8545810|NCT00187486|21068606|P1|STARTED|Overall Study||66
8545811|NCT00187369|21068613|P2|NOT COMPLETED|Fetuses or Infants||30
8545812|NCT00187369|21068614|P1|NOT COMPLETED|Fetuses or Infants||12
8545813|NCT00187369|21068613|P2|COMPLETED|Fetuses or Infants||2782
8545814|NCT00187369|21068614|P1|COMPLETED|Fetuses or Infants||2783
8545815|NCT00187369|21068613|P2|Included in the Study|Fetuses or Infants||2786
8545816|NCT00187369|21068614|P1|Included in the Study|Fetuses or Infants||2785
8545817|NCT00187369|21068613|P2|STARTED|Fetuses or Infants||2812
8545818|NCT00187369|21068614|P1|STARTED|Fetuses or Infants||2795
8545819|NCT00187369|21068613|P2|NOT COMPLETED|Mothers||14
8545820|NCT00187369|21068614|P1|NOT COMPLETED|Mothers||6
8545821|NCT00187369|21068613|P2|COMPLETED|Mothers||1392
8545822|NCT00187369|21068614|P1|COMPLETED|Mothers||1392
8545823|NCT00187369|21068613|P2|Included in the Study|Mothers||1393
8545824|NCT00187369|21068614|P1|Included in the Study|Mothers||1393
8545825|NCT00187369|21068613|P2|STARTED|Mothers||1406
8545826|NCT00187369|21068614|P1|STARTED|Mothers||1398
8545827|NCT00187278|21068642|P2|NOT COMPLETED|Overall Study||13
8545828|NCT00187278|21068643|P1|NOT COMPLETED|Overall Study||10
8545829|NCT00187278|21068642|P2|COMPLETED|Overall Study||902
8545830|NCT00187278|21068643|P1|COMPLETED|Overall Study||908
8545831|NCT00187278|21068642|P2|STARTED|Overall Study||915
8545832|NCT00187278|21068643|P1|STARTED|Overall Study||918
8545833|NCT00187226|21068687|P6|NOT COMPLETED|Overall Study||0
8545834|NCT00187226|21068688|P5|NOT COMPLETED|Overall Study||0
8545835|NCT00187226|21068689|P4|NOT COMPLETED|Overall Study||0
8545836|NCT00187226|21068690|P3|NOT COMPLETED|Overall Study||0
8545837|NCT00187226|21068691|P2|NOT COMPLETED|Overall Study||0
8545838|NCT00187226|21068692|P1|NOT COMPLETED|Overall Study||0
8545839|NCT00187226|21068687|P6|COMPLETED|Overall Study||1
8545840|NCT00187226|21068688|P5|COMPLETED|Overall Study||34
8545841|NCT00187226|21068689|P4|COMPLETED|Overall Study||2
8545842|NCT00187226|21068690|P3|COMPLETED|Overall Study||28
8545843|NCT00187226|21068691|P2|COMPLETED|Overall Study||49
8545844|NCT00187226|21068692|P1|COMPLETED|Overall Study||88
8545845|NCT00187226|21068687|P6|STARTED|Overall Study||1
8545846|NCT00187226|21068688|P5|STARTED|Overall Study||34
8545847|NCT00187226|21068689|P4|STARTED|Overall Study||2
8545848|NCT00187226|21068690|P3|STARTED|Overall Study||28
8545849|NCT00187226|21068691|P2|STARTED|Overall Study||49
8545850|NCT00187226|21068692|P1|STARTED|Overall Study||88
8545851|NCT00187200|21068708|P2|NOT COMPLETED|Overall Study||18
8545852|NCT00187200|21068709|P1|NOT COMPLETED|Overall Study||18
8545853|NCT00187200|21068708|P2|COMPLETED|Overall Study||26
8545854|NCT00187200|21068709|P1|COMPLETED|Overall Study||31
8545855|NCT00187200|21068708|P2|STARTED|Overall Study||44
8545857|NCT00187135|21068727|P6|NOT COMPLETED|Visit Three||6
8545858|NCT00187135|21068728|P5|NOT COMPLETED|Visit Three||8
8545859|NCT00187135|21068729|P4|NOT COMPLETED|Visit Three||9
8545860|NCT00187135|21068730|P3|NOT COMPLETED|Visit Three||9
8545861|NCT00187135|21068731|P2|NOT COMPLETED|Visit Three||7
8545862|NCT00187135|21068732|P1|NOT COMPLETED|Visit Three||7
8545863|NCT00187135|21068727|P6|COMPLETED|Visit Three||12
8545864|NCT00187135|21068728|P5|COMPLETED|Visit Three||11
8545865|NCT00187135|21068729|P4|COMPLETED|Visit Three||9
8545866|NCT00187135|21068730|P3|COMPLETED|Visit Three||14
8545867|NCT00187135|21068731|P2|COMPLETED|Visit Three||17
8545868|NCT00187135|21068732|P1|COMPLETED|Visit Three||14
8545869|NCT00187135|21068727|P6|STARTED|Visit Three||18
8545870|NCT00187135|21068728|P5|STARTED|Visit Three||19
8545871|NCT00187135|21068729|P4|STARTED|Visit Three||18
8545872|NCT00187135|21068730|P3|STARTED|Visit Three||23
8545873|NCT00187135|21068731|P2|STARTED|Visit Three||24
8545874|NCT00187135|21068732|P1|STARTED|Visit Three||21
8545875|NCT00187135|21068727|P6|NOT COMPLETED|Visit Two||8
8545876|NCT00187135|21068728|P5|NOT COMPLETED|Visit Two||6
8545877|NCT00187135|21068729|P4|NOT COMPLETED|Visit Two||8
8545878|NCT00187135|21068730|P3|NOT COMPLETED|Visit Two||2
8545879|NCT00187135|21068731|P2|NOT COMPLETED|Visit Two||3
8545880|NCT00187135|21068732|P1|NOT COMPLETED|Visit Two||5
8545881|NCT00187135|21068727|P6|COMPLETED|Visit Two||18
8545882|NCT00187135|21068728|P5|COMPLETED|Visit Two||19
8545883|NCT00187135|21068729|P4|COMPLETED|Visit Two||18
8545884|NCT00187135|21068730|P3|COMPLETED|Visit Two||23
8545885|NCT00187135|21068731|P2|COMPLETED|Visit Two||24
8545886|NCT00187135|21068732|P1|COMPLETED|Visit Two||21
8545887|NCT00187135|21068727|P6|STARTED|Visit Two||26
8545888|NCT00187135|21068728|P5|STARTED|Visit Two||25
8545889|NCT00187135|21068729|P4|STARTED|Visit Two||26
8545890|NCT00187135|21068730|P3|STARTED|Visit Two||25
8545891|NCT00187135|21068731|P2|STARTED|Visit Two||27
8545892|NCT00187135|21068732|P1|STARTED|Visit Two||26
8545893|NCT00187135|21068727|P6|NOT COMPLETED|Visit One||2
8545894|NCT00187135|21068728|P5|NOT COMPLETED|Visit One||0
8545895|NCT00187135|21068729|P4|NOT COMPLETED|Visit One||0
8545896|NCT00187135|21068730|P3|NOT COMPLETED|Visit One||0
8545897|NCT00187135|21068731|P2|NOT COMPLETED|Visit One||1
8545898|NCT00187135|21068732|P1|NOT COMPLETED|Visit One||4
8545899|NCT00187135|21068727|P6|COMPLETED|Visit One||26
8545900|NCT00187135|21068728|P5|COMPLETED|Visit One||25
8545901|NCT00187135|21068729|P4|COMPLETED|Visit One||26
8545902|NCT00187135|21068730|P3|COMPLETED|Visit One||25
8545903|NCT00187135|21068731|P2|COMPLETED|Visit One||27
8545904|NCT00187135|21068732|P1|COMPLETED|Visit One||26
8545905|NCT00187135|21068727|P6|STARTED|Visit One||28
8545906|NCT00187135|21068728|P5|STARTED|Visit One||25
8545907|NCT00187135|21068729|P4|STARTED|Visit One||26
8545908|NCT00187135|21068730|P3|STARTED|Visit One||25
8545909|NCT00187135|21068731|P2|STARTED|Visit One||28
8545910|NCT00187135|21068732|P1|STARTED|Visit One||30
8545911|NCT00187096|21068755|P3|NOT COMPLETED|Overall Study||1
8545912|NCT00187096|21068756|P2|NOT COMPLETED|Overall Study||0
8545913|NCT00187096|21068757|P1|NOT COMPLETED|Overall Study||0
8545914|NCT00187096|21068755|P3|COMPLETED|Overall Study||11
8545915|NCT00187096|21068756|P2|COMPLETED|Overall Study||3
8545916|NCT00187096|21068757|P1|COMPLETED|Overall Study||10
8545917|NCT00187096|21068755|P3|STARTED|Overall Study||12
8545918|NCT00187096|21068756|P2|STARTED|Overall Study||3
8545919|NCT00187096|21068757|P1|STARTED|Overall Study||10
8545920|NCT00186901|21068795|P3|NOT COMPLETED|Overall Study||149
8545921|NCT00186901|21068796|P2|NOT COMPLETED|Overall Study||45
8545922|NCT00186901|21068797|P1|NOT COMPLETED|Overall Study||49
8545923|NCT00186901|21068795|P3|COMPLETED|Overall Study||0
8545924|NCT00186901|21068796|P2|COMPLETED|Overall Study||96
8545925|NCT00186901|21068797|P1|COMPLETED|Overall Study||85
8545926|NCT00186901|21068795|P3|24 Month Follow-up|Overall Study||0
8545927|NCT00186901|21068796|P2|24 Month Follow-up|Overall Study||107
8545928|NCT00186901|21068797|P1|24 Month Follow-up|Overall Study||106
8545929|NCT00186901|21068795|P3|12 Month Follow-up|Overall Study||0
8545930|NCT00186901|21068796|P2|12 Month Follow-up|Overall Study||122
8545931|NCT00186901|21068797|P1|12 Month Follow-up|Overall Study||117
8545932|NCT00186901|21068795|P3|Baseline|Overall Study||0
8545933|NCT00186901|21068796|P2|Baseline|Overall Study||141
8545934|NCT00186901|21068797|P1|Baseline|Overall Study||134
8545935|NCT00186901|21068795|P3|STARTED|Overall Study||149
8545936|NCT00186901|21068796|P2|STARTED|Overall Study||141
8545937|NCT00186901|21068797|P1|STARTED|Overall Study||134
8545950|NCT00186875|21068916|P2|NOT COMPLETED|Overall Study||0
8545951|NCT00186875|21068917|P1|NOT COMPLETED|Overall Study||0
8545952|NCT00186875|21068916|P2|COMPLETED|Overall Study||14
8545953|NCT00186875|21068917|P1|COMPLETED|Overall Study||26
8545954|NCT00186875|21068916|P2|STARTED|Overall Study||14
8545955|NCT00186875|21068917|P1|STARTED|Overall Study||26
8545956|NCT00186628|21068931|P1|NOT COMPLETED|Overall Study||3
8545957|NCT00186628|21068931|P1|COMPLETED|Overall Study||33
8545958|NCT00186628|21068931|P1|STARTED|Overall Study||36
8545959|NCT00186537|21068942|P3|NOT COMPLETED|Overall Study||3
8545960|NCT00186537|21068943|P2|NOT COMPLETED|Overall Study||0
8545961|NCT00186537|21068944|P1|NOT COMPLETED|Overall Study||7
8545962|NCT00186537|21068942|P3|COMPLETED|Overall Study||13
8545963|NCT00186537|21068943|P2|COMPLETED|Overall Study||12
8545964|NCT00186537|21068944|P1|COMPLETED|Overall Study||12
8545965|NCT00186537|21068942|P3|STARTED|Overall Study||16
8545966|NCT00186537|21068943|P2|STARTED|Overall Study||12
8545967|NCT00186537|21068944|P1|STARTED|Overall Study||19
8545968|NCT00186498|21068960|P2|NOT COMPLETED|Overall Study||2
8545969|NCT00186498|21068961|P1|NOT COMPLETED|Overall Study||2
8545970|NCT00186498|21068960|P2|COMPLETED|Overall Study||3
8545971|NCT00186498|21068961|P1|COMPLETED|Overall Study||4
8545972|NCT00186498|21068960|P2|STARTED|Overall Study||5
8545973|NCT00186498|21068961|P1|STARTED|Overall Study||6
8545974|NCT00186485|21068967|P1|NOT COMPLETED|Overall Study||3
8545975|NCT00186485|21068967|P1|COMPLETED|Overall Study||25
8545976|NCT00186485|21068967|P1|STARTED|Overall Study||28
8545977|NCT00186446|21068973|P1|NOT COMPLETED|Overall Study||9
8545978|NCT00186446|21068973|P1|COMPLETED|Overall Study||11
8545979|NCT00186446|21068973|P1|STARTED|Overall Study||20
8545980|NCT00186186|21068979|P1|NOT COMPLETED|Overall Study||8
8545981|NCT00186186|21068979|P1|COMPLETED|Overall Study||20
8545982|NCT00186186|21068979|P1|STARTED|Overall Study||28
8545983|NCT00186121|21068984|P1|NOT COMPLETED|Overall Study||3
8545984|NCT00186121|21068984|P1|COMPLETED|Overall Study||32
8545985|NCT00186121|21068984|P1|STARTED|Overall Study||35
8545986|NCT00186069|21068996|P2|NOT COMPLETED|Overall Study||0
8545987|NCT00186069|21068997|P1|NOT COMPLETED|Overall Study||0
8545988|NCT00186069|21068996|P2|COMPLETED|Overall Study||15
8545989|NCT00186069|21068997|P1|COMPLETED|Overall Study||15
8545990|NCT00186069|21068996|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
8545991|NCT00186069|21068997|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
8545992|NCT00186056|21069009|P2|NOT COMPLETED|Overall Study||1
8545993|NCT00186056|21069010|P1|NOT COMPLETED|Overall Study||2
8545994|NCT00186056|21069009|P2|COMPLETED|Overall Study||16
8545995|NCT00186056|21069010|P1|COMPLETED|Overall Study||12
8545996|NCT00186056|21069009|P2|STARTED|Overall Study||17
8545997|NCT00186056|21069010|P1|STARTED|Overall Study||14
8545998|NCT00186043|21069018|P2|NOT COMPLETED|Overall Study||13
8545999|NCT00186043|21069019|P1|NOT COMPLETED|Overall Study||15
8546000|NCT00186043|21069018|P2|COMPLETED|Overall Study||12
8546001|NCT00186043|21069019|P1|COMPLETED|Overall Study||15
8546002|NCT00186043|21069018|P2|STARTED|Overall Study||25
8546003|NCT00186043|21069019|P1|STARTED|Overall Study||30
8546004|NCT00186017|21069031|P2|NOT COMPLETED|Overall Study||3
8546005|NCT00186017|21069032|P1|NOT COMPLETED|Overall Study||2
8546006|NCT00186017|21069031|P2|COMPLETED|Overall Study||22
8546007|NCT00186017|21069032|P1|COMPLETED|Overall Study||23
8546008|NCT00186017|21069031|P2|STARTED|Overall Study||25
8546009|NCT00186017|21069032|P1|STARTED|Overall Study||25
8546010|NCT00185965|21069046|P2|NOT COMPLETED|Overall Study||1
8546011|NCT00185965|21069047|P1|NOT COMPLETED|Overall Study||0
8546012|NCT00185965|21069046|P2|COMPLETED|Overall Study||14
8546013|NCT00185965|21069047|P1|COMPLETED|Overall Study||15
8546014|NCT00185965|21069046|P2|STARTED|Overall Study||15
8546015|NCT00185965|21069047|P1|STARTED|Overall Study||15
8546016|NCT00185900|21069055|P2|NOT COMPLETED|Overall Study||0
8546017|NCT00185900|21069056|P1|NOT COMPLETED|Overall Study||0
8546018|NCT00185900|21069055|P2|COMPLETED|Overall Study||100
8546019|NCT00185900|21069056|P1|COMPLETED|Overall Study||92
8546020|NCT00185900|21069055|P2|STARTED|Overall Study||100
8546021|NCT00185900|21069056|P1|STARTED|Overall Study||92
8546022|NCT00185731|21069072|P1|NOT COMPLETED|Overall Study||2
8546023|NCT00185731|21069072|P1|COMPLETED|Overall Study||23
8546024|NCT00185731|21069072|P1|STARTED|Overall Study||25
8546025|NCT00185692|21069078|P1|NOT COMPLETED|Overall Study||16
8546026|NCT00185692|21069078|P1|COMPLETED|Overall Study||0
8546027|NCT00185692|21069078|P1|STARTED|Overall Study||16
8546028|NCT00185679|21069083|P1|NOT COMPLETED|Overall Study||0
8546029|NCT00185679|21069083|P1|COMPLETED|Overall Study||13
8546030|NCT00185679|21069083|P1|STARTED|Overall Study||13
8546031|NCT00185640|21069089|P1|NOT COMPLETED|Overall Study||145
8546032|NCT00185640|21069089|P1|COMPLETED|Overall Study||158
8546033|NCT00185640|21069089|P1|90 Days Post-transplant|Overall Study||161
8546034|NCT00185640|21069089|P1|Transplanted|Overall Study||296
8546035|NCT00185640|21069089|P1|STARTED|Overall Study||303
8546036|NCT00185614|21069098|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
8546037|NCT00185614|21069098|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
8546038|NCT00185614|21069098|P1|STARTED|Allogenic HCT (Allo-HCT)||59
8546039|NCT00185614|21069098|P1|NOT COMPLETED|Inter-treatment Period||4
8546040|NCT00185614|21069098|P1|COMPLETED|Inter-treatment Period||59
8546041|NCT00185614|21069098|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
8546042|NCT00185614|21069098|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
8546043|NCT00185614|21069098|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
8546044|NCT00185614|21069098|P1|STARTED|Autologous HCT (Auto-HCT)||63
8546045|NCT00185588|21069110|P4|NOT COMPLETED|Overall Study||4
8546046|NCT00185588|21069111|P3|NOT COMPLETED|Overall Study||6
8546047|NCT00185588|21069112|P2|NOT COMPLETED|Overall Study||2
8546048|NCT00185588|21069113|P1|NOT COMPLETED|Overall Study||3
8546049|NCT00185588|21069110|P4|COMPLETED|Overall Study||13
8546050|NCT00185588|21069111|P3|COMPLETED|Overall Study||0
8546051|NCT00185588|21069112|P2|COMPLETED|Overall Study||2
8546052|NCT00185588|21069113|P1|COMPLETED|Overall Study||3
8546053|NCT00185588|21069110|P4|STARTED|Overall Study||17
8546054|NCT00185588|21069111|P3|STARTED|Overall Study||6
8546055|NCT00185588|21069112|P2|STARTED|Overall Study||4
8546056|NCT00185588|21069113|P1|STARTED|Overall Study||6
8546057|NCT00185458|21069127|P1|NOT COMPLETED|HRT Phase||27
8546058|NCT00185458|21069127|P1|COMPLETED|HRT Phase||141
8546059|NCT00185458|21069127|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
8546060|NCT00185458|21069127|P1|NOT COMPLETED|Contraception Phase||58
8546061|NCT00185458|21069127|P1|COMPLETED|Contraception Phase||336
8546062|NCT00185458|21069127|P1|STARTED|Contraception Phase||394
8546063|NCT00185380|21069190|P3|NOT COMPLETED|Overall Study||74
8546064|NCT00185380|21069191|P2|NOT COMPLETED|Overall Study||72
8546065|NCT00185380|21069192|P1|NOT COMPLETED|Overall Study||66
8546066|NCT00185380|21069190|P3|COMPLETED|Overall Study||182
8546067|NCT00185380|21069191|P2|COMPLETED|Overall Study||174
8546068|NCT00185380|21069192|P1|COMPLETED|Overall Study||174
8546069|NCT00185380|21069190|P3|Subjects Received Treatment|Overall Study||254
8546070|NCT00185380|21069191|P2|Subjects Received Treatment|Overall Study||245
8546071|NCT00185380|21069192|P1|Subjects Received Treatment|Overall Study||239
8546072|NCT00185380|21069190|P3|STARTED|Overall Study||256
8546073|NCT00185380|21069191|P2|STARTED|Overall Study||246
8546074|NCT00185380|21069192|P1|STARTED|Overall Study||240
8546075|NCT00185211|21069220|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
8546076|NCT00185211|21069221|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
8546077|NCT00185211|21069220|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
8546078|NCT00185211|21069221|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
8546079|NCT00185211|21069220|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
8546080|NCT00185211|21069221|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
8546081|NCT00185211|21069220|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
8546082|NCT00185211|21069221|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
8546083|NCT00185211|21069220|P2|COMPLETED|Placebo-controlled Study (92012)||166
8546084|NCT00185211|21069221|P1|COMPLETED|Placebo-controlled Study (92012)||271
8546085|NCT00185211|21069220|P2|STARTED|Placebo-controlled Study (92012)||176
8546086|NCT00185211|21069221|P1|STARTED|Placebo-controlled Study (92012)||292
8546087|NCT00184717|21069249|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
8546088|NCT00184717|21069250|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
8546089|NCT00184717|21069251|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
8546090|NCT00184717|21069252|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
8546091|NCT00184717|21069253|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
8546092|NCT00184717|21069249|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
8546093|NCT00184717|21069250|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
8546094|NCT00184717|21069251|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
8546095|NCT00184717|21069252|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
8546096|NCT00184717|21069253|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
8546097|NCT00184717|21069249|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
8546098|NCT00184717|21069250|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
8546099|NCT00184717|21069251|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
8546100|NCT00184717|21069252|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
8546101|NCT00184717|21069253|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
8546102|NCT00184717|21069249|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
8546103|NCT00184717|21069250|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
8546104|NCT00184717|21069251|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
8546105|NCT00184717|21069252|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
8546106|NCT00184717|21069253|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
8546107|NCT00184717|21069249|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
8546108|NCT00184717|21069250|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
8546109|NCT00184717|21069251|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
8546110|NCT00184717|21069252|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
8546111|NCT00184717|21069253|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
8546112|NCT00184717|21069249|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
8546113|NCT00184717|21069250|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
8546114|NCT00184717|21069251|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
8546115|NCT00184717|21069252|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
8546116|NCT00184717|21069253|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
8546117|NCT00184717|21069249|P5|STARTED|Main Period (GHLIQUID-1516)||0
8546118|NCT00184717|21069250|P4|STARTED|Main Period (GHLIQUID-1516)||0
8546119|NCT00184717|21069251|P3|STARTED|Main Period (GHLIQUID-1516)||21
8546120|NCT00184717|21069252|P2|STARTED|Main Period (GHLIQUID-1516)||38
8546121|NCT00184717|21069253|P1|STARTED|Main Period (GHLIQUID-1516)||39
8546122|NCT00184600|21069294|P3|NOT COMPLETED|Overall Study||34
8546123|NCT00184600|21069295|P2|NOT COMPLETED|Overall Study||51
8546124|NCT00184600|21069296|P1|NOT COMPLETED|Overall Study||45
8546125|NCT00184600|21069294|P3|COMPLETED|Overall Study||201
8546126|NCT00184600|21069295|P2|COMPLETED|Overall Study||188
8546127|NCT00184600|21069296|P1|COMPLETED|Overall Study||189
8546128|NCT00184600|21069294|P3|STARTED|Overall Study||235
8546129|NCT00184600|21069295|P2|STARTED|Overall Study||239
8546130|NCT00184600|21069296|P1|STARTED|Overall Study||234
8546131|NCT00184548|21069350|P4|NOT COMPLETED|Overall Study||7
8546132|NCT00184548|21069351|P3|NOT COMPLETED|Overall Study||3
8546133|NCT00184548|21069352|P2|NOT COMPLETED|Overall Study||13
8546134|NCT00184548|21069353|P1|NOT COMPLETED|Overall Study||8
8546135|NCT00184548|21069350|P4|COMPLETED|Overall Study||38
8546136|NCT00184548|21069351|P3|COMPLETED|Overall Study||44
8546137|NCT00184548|21069352|P2|COMPLETED|Overall Study||242
8546138|NCT00184548|21069353|P1|COMPLETED|Overall Study||218
8546139|NCT00184548|21069350|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
8546140|NCT00184548|21069351|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
8546141|NCT00184548|21069352|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
8546142|NCT00184548|21069353|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
8546143|NCT00184548|21069350|P4|STARTED|Overall Study||45
8546144|NCT00184548|21069351|P3|STARTED|Overall Study||47
8546145|NCT00184548|21069352|P2|STARTED|Overall Study||255
8546146|NCT00184548|21069353|P1|STARTED|Overall Study||226
8546147|NCT00184093|21069387|P1|NOT COMPLETED|Overall Study||9
8546148|NCT00184093|21069387|P1|COMPLETED|Overall Study||26
8546149|NCT00184093|21069387|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
8546150|NCT00184054|21069392|P1|NOT COMPLETED|Overall Study||1
8546151|NCT00184054|21069392|P1|COMPLETED|Overall Study||10
8546152|NCT00184054|21069392|P1|STARTED|Overall Study||11
8546153|NCT00184028|21069397|P1|NOT COMPLETED|Overall Study||10
8546154|NCT00184028|21069397|P1|COMPLETED|Overall Study||2
8546155|NCT00184028|21069397|P1|STARTED|Overall Study||12
8546156|NCT00184002|21069402|P1|NOT COMPLETED|Overall Study||17
8546157|NCT00184002|21069402|P1|COMPLETED|Overall Study||51
8546158|NCT00184002|21069402|P1|STARTED|Overall Study||68
8546159|NCT00183963|21069411|P4|NOT COMPLETED|Overall Study||1
8546160|NCT00183963|21069412|P3|NOT COMPLETED|Overall Study||1
8546161|NCT00183963|21069413|P2|NOT COMPLETED|Overall Study||1
8546162|NCT00183963|21069414|P1|NOT COMPLETED|Overall Study||1
8546163|NCT00183963|21069411|P4|COMPLETED|Overall Study||0
8546164|NCT00183963|21069412|P3|COMPLETED|Overall Study||0
8546165|NCT00183963|21069413|P2|COMPLETED|Overall Study||0
8546166|NCT00183963|21069414|P1|COMPLETED|Overall Study||0
8546167|NCT00183963|21069411|P4|STARTED|Overall Study||1
8546168|NCT00183963|21069412|P3|STARTED|Overall Study||1
8546169|NCT00183963|21069413|P2|STARTED|Overall Study||1
8546170|NCT00183963|21069414|P1|STARTED|Overall Study||1
8546171|NCT00183872|21069428|P1|NOT COMPLETED|Overall Study||16
8546172|NCT00183872|21069428|P1|COMPLETED|Overall Study||24
8546173|NCT00183872|21069428|P1|STARTED|Overall Study||40
8546174|NCT00183794|21069433|P1|NOT COMPLETED|Overall Study||0
8546175|NCT00183794|21069433|P1|COMPLETED|Overall Study||20
8546176|NCT00183794|21069433|P1|STARTED|Overall Study||20
8546177|NCT00183729|21069440|P2|NOT COMPLETED|Overall Study||5
8546178|NCT00183729|21069441|P1|NOT COMPLETED|Overall Study||3
8546179|NCT00183729|21069440|P2|COMPLETED|Overall Study||13
8546180|NCT00183729|21069441|P1|COMPLETED|Overall Study||14
8546181|NCT00183729|21069440|P2|STARTED|Overall Study||18
8546182|NCT00183729|21069441|P1|STARTED|Overall Study||17
8546183|NCT00183677|21069451|P1|NOT COMPLETED|Overall Study||44
8546184|NCT00183677|21069451|P1|COMPLETED|Overall Study||53
8546185|NCT00183677|21069451|P1|STARTED|Overall Study||97
8546186|NCT00183625|21069457|P4|NOT COMPLETED|Overall Study||14
8546187|NCT00183625|21069458|P3|NOT COMPLETED|Overall Study||19
8546188|NCT00183625|21069459|P2|NOT COMPLETED|Overall Study||18
8546189|NCT00183625|21069460|P1|NOT COMPLETED|Overall Study||18
8546190|NCT00183625|21069457|P4|COMPLETED|Overall Study||10
8546191|NCT00183625|21069458|P3|COMPLETED|Overall Study||9
8546192|NCT00183625|21069459|P2|COMPLETED|Overall Study||10
8546193|NCT00183625|21069460|P1|COMPLETED|Overall Study||9
8546194|NCT00183625|21069457|P4|Obtained Employment|Overall Study||14
8546195|NCT00183625|21069458|P3|Obtained Employment|Overall Study||14
8546196|NCT00183625|21069459|P2|Obtained Employment|Overall Study||18
8546197|NCT00183625|21069460|P1|Obtained Employment|Overall Study||21
8546198|NCT00183625|21069457|P4|STARTED|Overall Study||24
8546199|NCT00183625|21069458|P3|STARTED|Overall Study||28
8546200|NCT00183625|21069459|P2|STARTED|Overall Study||28
8546201|NCT00183625|21069460|P1|STARTED|Overall Study||27
8546202|NCT00183469|21069470|P2|NOT COMPLETED|Overall Study||29
8546203|NCT00183469|21069471|P1|NOT COMPLETED|Overall Study||28
8546204|NCT00183469|21069470|P2|COMPLETED|Overall Study||16
8546205|NCT00183469|21069471|P1|COMPLETED|Overall Study||13
8546206|NCT00183469|21069470|P2|STARTED|Overall Study||45
8546207|NCT00183469|21069471|P1|STARTED|Overall Study||41
8546208|NCT00183456|21069481|P4|NOT COMPLETED|Overall Study||28
8546209|NCT00183456|21069482|P3|NOT COMPLETED|Overall Study||16
8546210|NCT00183456|21069483|P2|NOT COMPLETED|Overall Study||1
8546211|NCT00183456|21069484|P1|NOT COMPLETED|Overall Study||3
8546212|NCT00183456|21069481|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
8546213|NCT00183456|21069482|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
8546214|NCT00183456|21069483|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
8546215|NCT00183456|21069484|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
8546216|NCT00183456|21069481|P4|18 Month Follow-up|Overall Study||207
8546217|NCT00183456|21069482|P3|18 Month Follow-up|Overall Study||303
8546218|NCT00183456|21069483|P2|18 Month Follow-up|Overall Study||81
8546219|NCT00183456|21069484|P1|18 Month Follow-up|Overall Study||80
8546220|NCT00183456|21069481|P4|12 Month Follow-up|Overall Study||186
8546221|NCT00183456|21069482|P3|12 Month Follow-up|Overall Study||267
8546222|NCT00183456|21069483|P2|12 Month Follow-up|Overall Study||74
8546223|NCT00183456|21069484|P1|12 Month Follow-up|Overall Study||76
8546224|NCT00183456|21069481|P4|6 Month Follow-up|Overall Study||175
8546225|NCT00183456|21069482|P3|6 Month Follow-up|Overall Study||278
8546226|NCT00183456|21069483|P2|6 Month Follow-up|Overall Study||77
8546227|NCT00183456|21069484|P1|6 Month Follow-up|Overall Study||74
8546228|NCT00183456|21069481|P4|STARTED|Overall Study||248
8546229|NCT00183456|21069482|P3|STARTED|Overall Study||329
8546230|NCT00183456|21069483|P2|STARTED|Overall Study||84
8546231|NCT00183456|21069484|P1|STARTED|Overall Study||85
8546232|NCT00183443|21069533|P3|NOT COMPLETED|Overall Study||0
8546233|NCT00183443|21069534|P2|NOT COMPLETED|Overall Study||0
8546234|NCT00183443|21069535|P1|NOT COMPLETED|Overall Study||0
8546235|NCT00183443|21069533|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
8546236|NCT00183443|21069534|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
8546237|NCT00183443|21069535|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
8546238|NCT00183443|21069533|P3|STARTED|Overall Study||25
8546239|NCT00183443|21069534|P2|STARTED|Overall Study||26
8546240|NCT00183443|21069535|P1|STARTED|Overall Study||24
8546241|NCT00183430|21069557|P2|NOT COMPLETED|Overall Study||0
8546242|NCT00183430|21069558|P1|NOT COMPLETED|Overall Study||6
8546243|NCT00183430|21069557|P2|COMPLETED|Overall Study||11
8546244|NCT00183430|21069558|P1|COMPLETED|Overall Study||3
8546245|NCT00183430|21069557|P2|STARTED|Overall Study||11
8546246|NCT00183430|21069558|P1|STARTED|Overall Study||9
8546247|NCT00183391|21069570|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
8546248|NCT00183391|21069571|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
8546249|NCT00183391|21069570|P2|COMPLETED|Block 2 - 5 Weeks||108
8546250|NCT00183391|21069571|P1|COMPLETED|Block 2 - 5 Weeks||91
8546251|NCT00183391|21069570|P2|STARTED|Block 2 - 5 Weeks||110
8546252|NCT00183391|21069571|P1|STARTED|Block 2 - 5 Weeks||95
8546253|NCT00183391|21069570|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
8546254|NCT00183391|21069571|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
8546255|NCT00183391|21069570|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
8546256|NCT00183391|21069571|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
8546257|NCT00183391|21069570|P2|STARTED|Crossover Placebo - 2 Weeks||110
8546258|NCT00183391|21069571|P1|STARTED|Crossover Placebo - 2 Weeks||95
8546259|NCT00183391|21069570|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
8546260|NCT00183391|21069571|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
8546261|NCT00183391|21069570|P2|COMPLETED|Block 1 - 5 Weeks||110
8546262|NCT00183391|21069571|P1|COMPLETED|Block 1 - 5 Weeks||95
8546263|NCT00183391|21069570|P2|STARTED|Block 1 - 5 Weeks||124
8546264|NCT00183391|21069571|P1|STARTED|Block 1 - 5 Weeks||108
8546265|NCT00183339|21069631|P2|NOT COMPLETED|Overall Study||4
8546266|NCT00183339|21069632|P1|NOT COMPLETED|Overall Study||6
8546267|NCT00183339|21069631|P2|COMPLETED|Overall Study||4
8546268|NCT00183339|21069632|P1|COMPLETED|Overall Study||4
8546269|NCT00183339|21069631|P2|STARTED|Overall Study||8
8546270|NCT00183339|21069632|P1|STARTED|Overall Study||10
8546271|NCT00183274|21069644|P6|NOT COMPLETED|Phase 3: Double-Blind||4
8546272|NCT00183274|21069645|P5|NOT COMPLETED|Phase 3: Double-Blind||20
8546273|NCT00183274|21069646|P4|NOT COMPLETED|Phase 3: Double-Blind||2
8546274|NCT00183274|21069647|P3|NOT COMPLETED|Phase 3: Double-Blind||0
8546275|NCT00183274|21069648|P2|NOT COMPLETED|Phase 3: Double-Blind||0
8546276|NCT00183274|21069649|P1|NOT COMPLETED|Phase 3: Double-Blind||0
8546277|NCT00183274|21069644|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
8546278|NCT00183274|21069645|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
8546279|NCT00183274|21069646|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
8546280|NCT00183274|21069647|P3|COMPLETED|Phase 3: Double-Blind||0
8546281|NCT00183274|21069648|P2|COMPLETED|Phase 3: Double-Blind||0
8546282|NCT00183274|21069649|P1|COMPLETED|Phase 3: Double-Blind||0
8546283|NCT00183274|21069644|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
8546284|NCT00183274|21069645|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
8546285|NCT00183274|21069646|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
8546286|NCT00183274|21069647|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
8546287|NCT00183274|21069648|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
8546288|NCT00183274|21069649|P1|STARTED|Phase 3: Double-Blind||0
8546289|NCT00183274|21069644|P6|NOT COMPLETED|Phase 2: Double-Blind||0
8546290|NCT00183274|21069645|P5|NOT COMPLETED|Phase 2: Double-Blind||0
8546291|NCT00183274|21069646|P4|NOT COMPLETED|Phase 2: Double-Blind||0
8546292|NCT00183274|21069647|P3|NOT COMPLETED|Phase 2: Double-Blind||43
8546293|NCT00183274|21069648|P2|NOT COMPLETED|Phase 2: Double-Blind||26
8546294|NCT00183274|21069649|P1|NOT COMPLETED|Phase 2: Double-Blind||0
8546295|NCT00183274|21069644|P6|COMPLETED|Phase 2: Double-Blind||0
8546296|NCT00183274|21069645|P5|COMPLETED|Phase 2: Double-Blind||0
8546297|NCT00183274|21069646|P4|COMPLETED|Phase 2: Double-Blind||0
8546298|NCT00183274|21069647|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
8546299|NCT00183274|21069648|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
8546300|NCT00183274|21069649|P1|COMPLETED|Phase 2: Double-Blind||0
8546301|NCT00183274|21069644|P6|STARTED|Phase 2: Double-Blind||0
8546302|NCT00183274|21069645|P5|STARTED|Phase 2: Double-Blind||0
8546303|NCT00183274|21069646|P4|STARTED|Phase 2: Double-Blind||0
8546304|NCT00183274|21069647|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
8546305|NCT00183274|21069648|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
8546306|NCT00183274|21069649|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
8546307|NCT00183274|21069644|P6|NOT COMPLETED|Phase 1: Open-Label||0
8546308|NCT00183274|21069645|P5|NOT COMPLETED|Phase 1: Open-Label||0
8546309|NCT00183274|21069646|P4|NOT COMPLETED|Phase 1: Open-Label||0
8546310|NCT00183274|21069647|P3|NOT COMPLETED|Phase 1: Open-Label||0
8546311|NCT00183274|21069648|P2|NOT COMPLETED|Phase 1: Open-Label||0
8546312|NCT00183274|21069649|P1|NOT COMPLETED|Phase 1: Open-Label||110
8546313|NCT00183274|21069644|P6|COMPLETED|Phase 1: Open-Label||0
8546314|NCT00183274|21069645|P5|COMPLETED|Phase 1: Open-Label||0
8546315|NCT00183274|21069646|P4|COMPLETED|Phase 1: Open-Label||0
8546316|NCT00183274|21069647|P3|COMPLETED|Phase 1: Open-Label||0
8546317|NCT00183274|21069648|P2|COMPLETED|Phase 1: Open-Label||0
8546318|NCT00183274|21069649|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
8546319|NCT00183274|21069644|P6|STARTED|Phase 1: Open-Label||0
8546320|NCT00183274|21069645|P5|STARTED|Phase 1: Open-Label||0
8546321|NCT00183274|21069646|P4|STARTED|Phase 1: Open-Label||0
8546322|NCT00183274|21069647|P3|STARTED|Phase 1: Open-Label||0
8546323|NCT00183274|21069648|P2|STARTED|Phase 1: Open-Label||0
8546324|NCT00183274|21069649|P1|STARTED|Phase 1: Open-Label||268
8546325|NCT00183248|21069666|P2|NOT COMPLETED|Overall Study||1
8546326|NCT00183248|21069667|P1|NOT COMPLETED|Overall Study||1
8546327|NCT00183248|21069666|P2|COMPLETED|Overall Study||4
8546328|NCT00183248|21069667|P1|COMPLETED|Overall Study||3
8546329|NCT00183248|21069666|P2|STARTED|Overall Study||5
8546330|NCT00183248|21069667|P1|STARTED|Overall Study||4
8546331|NCT00183196|21069688|P3|NOT COMPLETED|Overall Study||18
8546332|NCT00183196|21069689|P2|NOT COMPLETED|Overall Study||15
8546333|NCT00183196|21069690|P1|NOT COMPLETED|Overall Study||20
8546334|NCT00183196|21069688|P3|COMPLETED|Overall Study||32
8546335|NCT00183196|21069689|P2|COMPLETED|Overall Study||35
8546336|NCT00183196|21069690|P1|COMPLETED|Overall Study||30
8546337|NCT00183196|21069688|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
8546338|NCT00183196|21069689|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
8546339|NCT00183196|21069690|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
8546340|NCT00183170|21069700|P2|NOT COMPLETED|Second Intervention||2
8546341|NCT00183170|21069701|P1|NOT COMPLETED|Second Intervention||1
8546342|NCT00183170|21069700|P2|COMPLETED|Second Intervention||99
8546343|NCT00183170|21069701|P1|COMPLETED|Second Intervention||94
8546344|NCT00183170|21069700|P2|STARTED|Second Intervention||101
8546345|NCT00183170|21069701|P1|STARTED|Second Intervention||95
8546346|NCT00183170|21069700|P2|NOT COMPLETED|Washout 1 Week||8
8546347|NCT00183170|21069701|P1|NOT COMPLETED|Washout 1 Week||6
8546348|NCT00183170|21069700|P2|COMPLETED|Washout 1 Week||101
8546349|NCT00183170|21069701|P1|COMPLETED|Washout 1 Week||95
8546350|NCT00183170|21069700|P2|STARTED|Washout 1 Week||109
8546351|NCT00183170|21069701|P1|STARTED|Washout 1 Week||101
8546352|NCT00183170|21069700|P2|NOT COMPLETED|First Intervention||0
8546353|NCT00183170|21069701|P1|NOT COMPLETED|First Intervention||2
8546354|NCT00183170|21069700|P2|COMPLETED|First Intervention||109
8546355|NCT00183170|21069701|P1|COMPLETED|First Intervention||101
8546356|NCT00183170|21069700|P2|STARTED|First Intervention||109
8546357|NCT00183170|21069701|P1|STARTED|First Intervention||103
8546358|NCT00183092|21069717|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
8546359|NCT00183092|21069718|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
8546360|NCT00183092|21069719|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
8546361|NCT00183092|21069720|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
8546362|NCT00183092|21069717|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546363|NCT00183092|21069718|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546364|NCT00183092|21069719|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546365|NCT00183092|21069720|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546366|NCT00183092|21069717|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
8546367|NCT00183092|21069718|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
8546368|NCT00183092|21069719|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
8546369|NCT00183092|21069720|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
8546370|NCT00183092|21069717|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
8546371|NCT00183092|21069718|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
8546372|NCT00183092|21069719|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
8546373|NCT00183092|21069720|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
8546374|NCT00183092|21069717|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
8546375|NCT00183092|21069718|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
8546376|NCT00183092|21069719|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
8546377|NCT00183092|21069720|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
8546378|NCT00183092|21069717|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
8546379|NCT00183092|21069718|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
8546380|NCT00183092|21069719|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
8546381|NCT00183092|21069720|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
8546382|NCT00183092|21069717|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
8546383|NCT00183092|21069718|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
8546384|NCT00183092|21069719|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
8546385|NCT00183092|21069720|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
8546386|NCT00183092|21069717|P4|STARTED|Double-blind (Baseline - Month 2)||0
8546387|NCT00183092|21069718|P3|STARTED|Double-blind (Baseline - Month 2)||0
8546388|NCT00183092|21069719|P2|STARTED|Double-blind (Baseline - Month 2)||28
8546389|NCT00183092|21069720|P1|STARTED|Double-blind (Baseline - Month 2)||23
8546390|NCT00182793|21069741|P1|NOT COMPLETED|Overall Study||0
8546391|NCT00182793|21069741|P1|COMPLETED|Overall Study||32
8546392|NCT00182793|21069741|P1|STARTED|Overall Study||32
8546393|NCT00182767|21069746|P5|NOT COMPLETED|Overall Study||0
8546394|NCT00182767|21069747|P4|NOT COMPLETED|Overall Study||0
8546395|NCT00182767|21069748|P3|NOT COMPLETED|Overall Study||0
8546396|NCT00182767|21069749|P2|NOT COMPLETED|Overall Study||0
8546397|NCT00182767|21069750|P1|NOT COMPLETED|Overall Study||0
8546398|NCT00182767|21069746|P5|COMPLETED|Overall Study||24
8546399|NCT00182767|21069747|P4|COMPLETED|Overall Study||3
8546400|NCT00182767|21069748|P3|COMPLETED|Overall Study||6
8546401|NCT00182767|21069749|P2|COMPLETED|Overall Study||6
8546402|NCT00182767|21069750|P1|COMPLETED|Overall Study||6
8546403|NCT00182767|21069746|P5|STARTED|Overall Study||24
8546404|NCT00182767|21069747|P4|STARTED|Overall Study||3
8546405|NCT00182767|21069748|P3|STARTED|Overall Study||6
8546406|NCT00182767|21069749|P2|STARTED|Overall Study||6
8546407|NCT00182767|21069750|P1|STARTED|Overall Study||6
8546408|NCT00182754|21069767|P2|NOT COMPLETED|Overall Study||0
8546409|NCT00182754|21069768|P1|NOT COMPLETED|Overall Study||0
8546410|NCT00182754|21069767|P2|COMPLETED|Overall Study||17
8546411|NCT00182754|21069768|P1|COMPLETED|Overall Study||16
8546412|NCT00182754|21069767|P2|STARTED|Overall Study||17
8546413|NCT00182754|21069768|P1|STARTED|Overall Study||16
8546414|NCT00182728|21069778|P1|NOT COMPLETED|Overall Study||0
8546415|NCT00182728|21069778|P1|COMPLETED|Overall Study||71
8546416|NCT00182728|21069778|P1|STARTED|Overall Study||71
8546417|NCT00182689|21069790|P2|NOT COMPLETED|Overall Study||49
8546418|NCT00182689|21069791|P1|NOT COMPLETED|Overall Study||40
8546419|NCT00182689|21069790|P2|COMPLETED|Overall Study||0
8546420|NCT00182689|21069791|P1|COMPLETED|Overall Study||0
8546421|NCT00182689|21069790|P2|Eligible and Began Protocol Therapy|Overall Study||45
8546422|NCT00182689|21069791|P1|Eligible and Began Protocol Therapy|Overall Study||38
8546423|NCT00182689|21069790|P2|Eligible|Overall Study||45
8546424|NCT00182689|21069791|P1|Eligible|Overall Study||39
8546425|NCT00182689|21069790|P2|STARTED|Overall Study||49
8546426|NCT00182689|21069791|P1|STARTED|Overall Study||40
8546427|NCT00182637|21069801|P1|NOT COMPLETED|Overall Study||3
8546428|NCT00182637|21069801|P1|COMPLETED|Overall Study|off study date|2
8546429|NCT00182637|21069801|P1|STARTED|Overall Study|active/on treatment date|5
8546430|NCT00182325|21069809|P2|NOT COMPLETED|Overall Study||53
8546431|NCT00182325|21069810|P1|NOT COMPLETED|Overall Study||34
8546432|NCT00182325|21069809|P2|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
8546433|NCT00182325|21069810|P1|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
8546434|NCT00182325|21069809|P2|STARTED|Overall Study||96
8546435|NCT00182325|21069810|P1|STARTED|Overall Study||97
8546436|NCT00182091|21069838|P4|NOT COMPLETED|Overall Study||0
8546437|NCT00182091|21069839|P3|NOT COMPLETED|Overall Study||0
8546438|NCT00182091|21069840|P2|NOT COMPLETED|Overall Study||0
8546439|NCT00182091|21069841|P1|NOT COMPLETED|Overall Study||1
8546440|NCT00182091|21069838|P4|COMPLETED|Overall Study||20
8546441|NCT00182091|21069839|P3|COMPLETED|Overall Study||25
8546442|NCT00182091|21069840|P2|COMPLETED|Overall Study||15
8546443|NCT00182091|21069841|P1|COMPLETED|Overall Study||14
8546444|NCT00182091|21069838|P4|STARTED|Overall Study||20
8546445|NCT00182091|21069839|P3|STARTED|Overall Study||25
8546446|NCT00182091|21069840|P2|STARTED|Overall Study||15
8546447|NCT00182091|21069841|P1|STARTED|Overall Study||15
8546448|NCT00182078|21069857|P2|NOT COMPLETED|Overall Study||0
8546449|NCT00182078|21069858|P1|NOT COMPLETED|Overall Study||1
8546450|NCT00182078|21069857|P2|COMPLETED|Overall Study||17
8546451|NCT00182078|21069858|P1|COMPLETED|Overall Study||8
8546452|NCT00182078|21069857|P2|STARTED|Overall Study||17
8546453|NCT00182078|21069858|P1|STARTED|Overall Study||9
8546454|NCT00182000|21069870|P2|NOT COMPLETED|Overall Study||2
8546455|NCT00182000|21069871|P1|NOT COMPLETED|Overall Study||5
8546456|NCT00182000|21069870|P2|COMPLETED|Overall Study||13
8546457|NCT00182000|21069871|P1|COMPLETED|Overall Study||9
8546458|NCT00182000|21069870|P2|STARTED|Overall Study||15
8546459|NCT00182000|21069871|P1|STARTED|Overall Study||14
8546460|NCT00181961|21069879|P2|NOT COMPLETED|Overall Study||5
8546461|NCT00181961|21069880|P1|NOT COMPLETED|Overall Study||1
8546462|NCT00181961|21069879|P2|COMPLETED|Overall Study||4
8546463|NCT00181961|21069880|P1|COMPLETED|Overall Study||6
8546464|NCT00181961|21069879|P2|STARTED|Overall Study||9
8546465|NCT00181961|21069880|P1|STARTED|Overall Study||7
8546466|NCT00181883|21069886|P1|NOT COMPLETED|Overall Study||10
8546467|NCT00181883|21069886|P1|COMPLETED|Overall Study||20
8546468|NCT00181883|21069886|P1|STARTED|Overall Study||30
8546469|NCT00181844|21069890|P1|NOT COMPLETED|Exposed to Study Medication||17
8546470|NCT00181844|21069890|P1|COMPLETED|Exposed to Study Medication||22
8546471|NCT00181844|21069890|P1|STARTED|Exposed to Study Medication||39
8546472|NCT00181844|21069890|P1|NOT COMPLETED|Signed Consent||12
8546473|NCT00181844|21069890|P1|COMPLETED|Signed Consent||39
8546474|NCT00181844|21069890|P1|STARTED|Signed Consent||51
8546475|NCT00181766|21069894|P1|NOT COMPLETED|Overall Study||12
8546476|NCT00181766|21069894|P1|COMPLETED|Overall Study|Completed the trial.|33
8546477|NCT00181766|21069894|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
8546478|NCT00181714|21069899|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
8546479|NCT00181714|21069899|P1|COMPLETED|Began Treatment With OROS-MPH||30
8546480|NCT00181714|21069899|P1|STARTED|Began Treatment With OROS-MPH||154
8546481|NCT00181714|21069899|P1|NOT COMPLETED|Signed Consent/Enrolled||49
8546482|NCT00181714|21069899|P1|COMPLETED|Signed Consent/Enrolled||154
8546483|NCT00181714|21069899|P1|STARTED|Signed Consent/Enrolled||203
8546484|NCT00181623|21069903|P1|NOT COMPLETED|Overall Study||1
8546485|NCT00181623|21069903|P1|COMPLETED|Overall Study||5
8546486|NCT00181623|21069903|P1|STARTED|Overall Study||6
8546487|NCT00181610|21069911|P3|NOT COMPLETED|Overall Study||0
8546488|NCT00181610|21069912|P2|NOT COMPLETED|Overall Study||1
8546489|NCT00181610|21069913|P1|NOT COMPLETED|Overall Study||0
8546490|NCT00181610|21069911|P3|COMPLETED|Overall Study||3
8546491|NCT00181610|21069912|P2|COMPLETED|Overall Study||3
8546492|NCT00181610|21069913|P1|COMPLETED|Overall Study||4
8546493|NCT00181610|21069911|P3|STARTED|Overall Study||3
8546494|NCT00181610|21069912|P2|STARTED|Overall Study||4
8546495|NCT00181610|21069913|P1|STARTED|Overall Study||4
8546496|NCT00181363|21069924|P1|NOT COMPLETED|Overall Study||0
8546497|NCT00181363|21069924|P1|COMPLETED|Overall Study||10
8546498|NCT00181363|21069924|P1|STARTED|Overall Study|10|10
8546499|NCT00181285|21069939|P2|NOT COMPLETED|Overall Study||0
8546500|NCT00181285|21069940|P1|NOT COMPLETED|Overall Study||0
8546501|NCT00181285|21069939|P2|COMPLETED|Overall Study||25
8546502|NCT00181285|21069940|P1|COMPLETED|Overall Study||27
8546503|NCT00181285|21069939|P2|STARTED|Overall Study||25
8546504|NCT00181285|21069940|P1|STARTED|Overall Study||27
8546505|NCT00181207|21069950|P2|NOT COMPLETED|Overall Study||0
8546506|NCT00181207|21069951|P1|NOT COMPLETED|Overall Study||0
8546507|NCT00181207|21069950|P2|COMPLETED|Overall Study||26
8546508|NCT00181207|21069951|P1|COMPLETED|Overall Study||24
8546509|NCT00181207|21069950|P2|STARTED|Overall Study||26
8546510|NCT00181207|21069951|P1|STARTED|Overall Study||24
8546511|NCT00181168|21069961|P2|NOT COMPLETED|Overall Study||0
8546512|NCT00181168|21069962|P1|NOT COMPLETED|Overall Study||0
8546513|NCT00181168|21069961|P2|COMPLETED|Overall Study||33
8546514|NCT00181168|21069962|P1|COMPLETED|Overall Study||30
8546515|NCT00181168|21069961|P2|STARTED|Overall Study||33
8546516|NCT00181168|21069962|P1|STARTED|Overall Study||30
8546517|NCT00181155|21069968|P2|NOT COMPLETED|Overall Study||0
8546518|NCT00181155|21069969|P1|NOT COMPLETED|Overall Study||2
8546519|NCT00181155|21069968|P2|COMPLETED|Overall Study||3
8546520|NCT00181155|21069969|P1|COMPLETED|Overall Study||13
8546521|NCT00181155|21069968|P2|STARTED|Overall Study||3
8546522|NCT00181155|21069969|P1|STARTED|Overall Study||15
8546523|NCT00180713|21069979|P2|NOT COMPLETED|Overall Study||3
8546524|NCT00180713|21069980|P1|NOT COMPLETED|Overall Study||5
8546525|NCT00180713|21069979|P2|COMPLETED|Overall Study||16
8546526|NCT00180713|21069980|P1|COMPLETED|Overall Study||18
8546527|NCT00180713|21069979|P2|STARTED|Overall Study||19
8546528|NCT00180713|21069980|P1|STARTED|Overall Study||23
8546529|NCT00180687|21069998|P4|NOT COMPLETED|Overall Study||0
8546530|NCT00180687|21069999|P3|NOT COMPLETED|Overall Study||0
8546531|NCT00180687|21070000|P2|NOT COMPLETED|Overall Study||0
8546532|NCT00180687|21070001|P1|NOT COMPLETED|Overall Study||0
8546533|NCT00180687|21069998|P4|COMPLETED|Overall Study||20
8546534|NCT00180687|21069999|P3|COMPLETED|Overall Study||20
8546535|NCT00180687|21070000|P2|COMPLETED|Overall Study||20
8546536|NCT00180687|21070001|P1|COMPLETED|Overall Study||20
8546537|NCT00180687|21069998|P4|STARTED|Overall Study||20
8546538|NCT00180687|21069999|P3|STARTED|Overall Study||20
8546539|NCT00180687|21070000|P2|STARTED|Overall Study||20
8546540|NCT00180687|21070001|P1|STARTED|Overall Study||20
8546541|NCT00180674|21070023|P1|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
8546542|NCT00180674|21070023|P1|COMPLETED|Phase 2, Warfarin Treatment Period||9
8546543|NCT00180674|21070023|P1|STARTED|Phase 2, Warfarin Treatment Period||10
8546544|NCT00180674|21070023|P1|NOT COMPLETED|Phase 1, Observation Period||4
8546545|NCT00180674|21070023|P1|COMPLETED|Phase 1, Observation Period||10
8546546|NCT00180674|21070023|P1|STARTED|Phase 1, Observation Period||14
8546547|NCT00180661|21070033|P2|NOT COMPLETED|Overall Study||0
8546548|NCT00180661|21070034|P1|NOT COMPLETED|Overall Study||0
8546549|NCT00180661|21070033|P2|COMPLETED|Overall Study||20
8546550|NCT00180661|21070034|P1|COMPLETED|Overall Study||19
8546551|NCT00180661|21070033|P2|STARTED|Overall Study||20
8546552|NCT00180661|21070034|P1|STARTED|Overall Study||19
8546553|NCT00180479|21070052|P2|NOT COMPLETED|Overall Study||13
8546554|NCT00180479|21070053|P1|NOT COMPLETED|Overall Study||16
8546555|NCT00180479|21070052|P2|COMPLETED|Overall Study||320
8546556|NCT00180479|21070053|P1|COMPLETED|Overall Study||653
8546557|NCT00180479|21070052|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
8546558|NCT00180479|21070053|P1|STARTED|Overall Study||669
8546562|NCT00180271|21070154|P2|NOT COMPLETED|Overall Study||0
8546563|NCT00180271|21070155|P1|NOT COMPLETED|Overall Study||0
8546564|NCT00180271|21070154|P2|COMPLETED|Overall Study||731
8546565|NCT00180271|21070155|P1|COMPLETED|Overall Study||1089
8546566|NCT00180271|21070154|P2|STARTED|Overall Study||731
8546567|NCT00180271|21070155|P1|STARTED|Overall Study||1089
8546568|NCT00179998|21070165|P2|NOT COMPLETED|Crossover Period - 6 Months||2
8546569|NCT00179998|21070166|P1|NOT COMPLETED|Crossover Period - 6 Months||0
8546570|NCT00179998|21070165|P2|COMPLETED|Crossover Period - 6 Months||10
8546571|NCT00179998|21070166|P1|COMPLETED|Crossover Period - 6 Months||12
8546572|NCT00179998|21070165|P2|STARTED|Crossover Period - 6 Months||12
8546573|NCT00179998|21070166|P1|STARTED|Crossover Period - 6 Months||12
8546574|NCT00179998|21070165|P2|NOT COMPLETED|Initial Period - 6 Months||0
8546575|NCT00179998|21070166|P1|NOT COMPLETED|Initial Period - 6 Months||0
8546576|NCT00179998|21070165|P2|COMPLETED|Initial Period - 6 Months||12
8546577|NCT00179998|21070166|P1|COMPLETED|Initial Period - 6 Months||12
8546578|NCT00179998|21070165|P2|STARTED|Initial Period - 6 Months||12
8546579|NCT00179998|21070166|P1|STARTED|Initial Period - 6 Months||12
8546580|NCT00179959|21070178|P2|NOT COMPLETED|Overall Study||3
8546581|NCT00179959|21070179|P1|NOT COMPLETED|Overall Study||6
8546582|NCT00179959|21070178|P2|COMPLETED|Overall Study||13
8546583|NCT00179959|21070179|P1|COMPLETED|Overall Study||9
8546584|NCT00179959|21070178|P2|STARTED|Overall Study||16
8546585|NCT00179959|21070179|P1|STARTED|Overall Study||15
8546586|NCT00179673|21070185|P1|NOT COMPLETED|Overall Study||43
8546587|NCT00179673|21070185|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
8546588|NCT00179673|21070185|P1|Received Study Drug|Overall Study||43
8546589|NCT00179673|21070185|P1|STARTED|Overall Study||43
8546590|NCT00179660|21070193|P1|NOT COMPLETED|Overall Study||50
8546591|NCT00179660|21070193|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
8546592|NCT00179660|21070193|P1|Completed 12 Cycles of Treatment|Overall Study||12
8546593|NCT00179660|21070193|P1|Received Study Drug|Overall Study||49
8546594|NCT00179660|21070193|P1|STARTED|Overall Study||50
8546595|NCT00179647|21070202|P1|NOT COMPLETED|Overall Study||1913
8546596|NCT00179647|21070202|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
8546597|NCT00179647|21070202|P1|STARTED|Overall Study||1913
8546598|NCT00179621|21070209|P4|NOT COMPLETED|Open-Label Period||43
8546599|NCT00179621|21070210|P3|NOT COMPLETED|Open-Label Period||28
8546600|NCT00179621|21070211|P2|NOT COMPLETED|Open-Label Period||28
8546601|NCT00179621|21070212|P1|NOT COMPLETED|Open-Label Period||0
8546602|NCT00179621|21070209|P4|COMPLETED|Open-Label Period||13
8546603|NCT00179621|21070210|P3|COMPLETED|Open-Label Period||19
8546604|NCT00179621|21070211|P2|COMPLETED|Open-Label Period||14
8546605|NCT00179621|21070212|P1|COMPLETED|Open-Label Period||0
8546606|NCT00179621|21070209|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
8546607|NCT00179621|21070210|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
8546608|NCT00179621|21070211|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
8546609|NCT00179621|21070212|P1|STARTED|Open-Label Period||0
8546610|NCT00179621|21070209|P4|NOT COMPLETED|Double-Blind Period||0
8546611|NCT00179621|21070210|P3|NOT COMPLETED|Double-Blind Period||30
8546612|NCT00179621|21070211|P2|NOT COMPLETED|Double-Blind Period||46
8546613|NCT00179621|21070212|P1|NOT COMPLETED|Double-Blind Period||64
8546614|NCT00179621|21070209|P4|COMPLETED|Double-Blind Period||0
8546615|NCT00179621|21070210|P3|COMPLETED|Double-Blind Period||39
8546616|NCT00179621|21070211|P2|COMPLETED|Double-Blind Period||23
8546617|NCT00179621|21070212|P1|COMPLETED|Double-Blind Period||3
8546618|NCT00179621|21070209|P4|STARTED|Double-Blind Period||0
8546619|NCT00179621|21070210|P3|STARTED|Double-Blind Period||69
8546620|NCT00179621|21070211|P2|STARTED|Double-Blind Period||69
8546621|NCT00179621|21070212|P1|STARTED|Double-Blind Period||67
8546622|NCT00179517|21070265|P2|NOT COMPLETED|Overall Study||1
8546623|NCT00179517|21070266|P1|NOT COMPLETED|Overall Study||2
8546624|NCT00179517|21070265|P2|COMPLETED|Overall Study||19
8546625|NCT00179517|21070266|P1|COMPLETED|Overall Study||18
8546626|NCT00179517|21070265|P2|STARTED|Overall Study||20
8546627|NCT00179517|21070266|P1|STARTED|Overall Study||20
8546628|NCT00179478|21070290|P2|NOT COMPLETED|Overall Study||15
8546629|NCT00179478|21070291|P1|NOT COMPLETED|Overall Study||13
8546630|NCT00179478|21070290|P2|COMPLETED|Overall Study||59
8546631|NCT00179478|21070291|P1|COMPLETED|Overall Study||68
8546632|NCT00179478|21070290|P2|STARTED|Overall Study||74
8546633|NCT00179478|21070291|P1|STARTED|Overall Study||81
8546634|NCT00179413|21070304|P2|NOT COMPLETED|Overall Study||115
8546635|NCT00179413|21070305|P1|NOT COMPLETED|Overall Study||125
8546636|NCT00179413|21070304|P2|COMPLETED|Overall Study||152
8546637|NCT00179413|21070305|P1|COMPLETED|Overall Study||157
8546638|NCT00179413|21070304|P2|STARTED|Overall Study||267
8546639|NCT00179413|21070305|P1|STARTED|Overall Study||282
8546640|NCT00179309|21070317|P2|NOT COMPLETED|Crossover||0
8546641|NCT00179309|21070318|P1|NOT COMPLETED|Crossover||0
8546642|NCT00179309|21070317|P2|COMPLETED|Crossover||3
8546643|NCT00179309|21070318|P1|COMPLETED|Crossover||0
8546644|NCT00179309|21070317|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
8546645|NCT00179309|21070318|P1|STARTED|Crossover||0
8546646|NCT00179309|21070317|P2|NOT COMPLETED|Treatment||5
8546647|NCT00179309|21070318|P1|NOT COMPLETED|Treatment||4
8546648|NCT00179309|21070317|P2|COMPLETED|Treatment||18
8546649|NCT00179309|21070318|P1|COMPLETED|Treatment||21
8546650|NCT00179309|21070317|P2|STARTED|Treatment||23
8546651|NCT00179309|21070318|P1|STARTED|Treatment||25
8546652|NCT00179127|21070328|P2|NOT COMPLETED|Overall Study||0
8546653|NCT00179127|21070329|P1|NOT COMPLETED|Overall Study||0
8546654|NCT00179127|21070328|P2|COMPLETED|Overall Study||0
8546655|NCT00179127|21070329|P1|COMPLETED|Overall Study||0
8546656|NCT00179127|21070328|P2|STARTED|Overall Study||0
8546657|NCT00179127|21070329|P1|STARTED|Overall Study||0
8546658|NCT00179010|21070341|P2|NOT COMPLETED|Overall Study||2
8546659|NCT00179010|21070342|P1|NOT COMPLETED|Overall Study||1
8546660|NCT00179010|21070341|P2|COMPLETED|Overall Study||5
8546661|NCT00179010|21070342|P1|COMPLETED|Overall Study||5
8546662|NCT00179010|21070341|P2|STARTED|Overall Study||7
8546663|NCT00179010|21070342|P1|STARTED|Overall Study||6
8546664|NCT00178919|21070352|P2|NOT COMPLETED|Overall Study||25
8546665|NCT00178919|21070353|P1|NOT COMPLETED|Overall Study||0
8546666|NCT00178919|21070352|P2|COMPLETED|Overall Study||68
8546667|NCT00178919|21070353|P1|COMPLETED|Overall Study||19
8546668|NCT00178919|21070352|P2|STARTED|Overall Study||93
8546669|NCT00178919|21070353|P1|STARTED|Overall Study||19
8546670|NCT00178841|21070361|P1|NOT COMPLETED|Overall Study||0
8546671|NCT00178841|21070361|P1|COMPLETED|Overall Study||4
8546672|NCT00178841|21070361|P1|STARTED|Overall Study||4
8546673|NCT00178711|21070369|P2|NOT COMPLETED|Overall Study||0
8546674|NCT00178711|21070370|P1|NOT COMPLETED|Overall Study||0
8546675|NCT00178711|21070369|P2|COMPLETED|Overall Study||45
8546676|NCT00178711|21070370|P1|COMPLETED|Overall Study||52
8546677|NCT00178711|21070369|P2|STARTED|Overall Study||45
8546678|NCT00178711|21070370|P1|STARTED|Overall Study||52
8546679|NCT00178685|21070381|P3|NOT COMPLETED|Overall Study||196
8546680|NCT00178685|21070382|P2|NOT COMPLETED|Overall Study||204
8546681|NCT00178685|21070383|P1|NOT COMPLETED|Overall Study||111
8546682|NCT00178685|21070381|P3|COMPLETED|Overall Study||128
8546683|NCT00178685|21070382|P2|COMPLETED|Overall Study||120
8546684|NCT00178685|21070383|P1|COMPLETED|Overall Study||61
8546685|NCT00178685|21070381|P3|STARTED|Overall Study||324
8546686|NCT00178685|21070382|P2|STARTED|Overall Study||324
8546687|NCT00178685|21070383|P1|STARTED|Overall Study||172
8546688|NCT00178646|21070397|P3|NOT COMPLETED|Overall Study||1
8546689|NCT00178646|21070398|P2|NOT COMPLETED|Overall Study||1
8546690|NCT00178646|21070399|P1|NOT COMPLETED|Overall Study||0
8546691|NCT00178646|21070397|P3|COMPLETED|Overall Study||10
8546692|NCT00178646|21070398|P2|COMPLETED|Overall Study||8
8546693|NCT00178646|21070399|P1|COMPLETED|Overall Study||12
8546694|NCT00178646|21070397|P3|STARTED|Overall Study||11
8546695|NCT00178646|21070398|P2|STARTED|Overall Study||9
8546696|NCT00178646|21070399|P1|STARTED|Overall Study||12
8546697|NCT00178633|21070425|P1|NOT COMPLETED|Overall Study||6
8546698|NCT00178633|21070425|P1|COMPLETED|Overall Study||37
8546699|NCT00178633|21070425|P1|STARTED|Overall Study||43
8546700|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: High Dose||0
8546701|NCT00178503|21070433|P1|COMPLETED|MPH Trial: High Dose||24
8546702|NCT00178503|21070433|P1|STARTED|MPH Trial: High Dose||24
8546703|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: Med Dose||0
8546704|NCT00178503|21070433|P1|COMPLETED|MPH Trial: Med Dose||24
8546705|NCT00178503|21070433|P1|STARTED|MPH Trial: Med Dose||24
8546706|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: Low Dose||0
8546707|NCT00178503|21070433|P1|COMPLETED|MPH Trial: Low Dose||24
8546708|NCT00178503|21070433|P1|STARTED|MPH Trial: Low Dose||24
8546709|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: Placebo||0
8546710|NCT00178503|21070433|P1|COMPLETED|MPH Trial: Placebo||24
8546711|NCT00178503|21070433|P1|STARTED|MPH Trial: Placebo||24
8546712|NCT00178477|21070451|P1|NOT COMPLETED|Overall Study||5
8546713|NCT00178477|21070451|P1|COMPLETED|Overall Study||5
8546714|NCT00178477|21070451|P1|STARTED|Overall Study||10
8546715|NCT00178464|21070455|P1|NOT COMPLETED|Overall Study||2
8546716|NCT00178464|21070455|P1|COMPLETED|Overall Study||9
8546717|NCT00178464|21070455|P1|STARTED|Overall Study||11
8546718|NCT00178399|21070460|P1|NOT COMPLETED|Overall Study||13
8546719|NCT00178399|21070460|P1|COMPLETED|Overall Study||115
8546720|NCT00178399|21070460|P1|STARTED|Overall Study||128
8546721|NCT00178256|21070467|P4|NOT COMPLETED|Overall Study||2
8546722|NCT00178256|21070468|P3|NOT COMPLETED|Overall Study||0
8546723|NCT00178256|21070469|P2|NOT COMPLETED|Overall Study||1
8546724|NCT00178256|21070470|P1|NOT COMPLETED|Overall Study||4
8546725|NCT00178256|21070467|P4|COMPLETED|Overall Study||16
8546726|NCT00178256|21070468|P3|COMPLETED|Overall Study||6
8546727|NCT00178256|21070469|P2|COMPLETED|Overall Study||6
8546728|NCT00178256|21070470|P1|COMPLETED|Overall Study||6
8546729|NCT00178256|21070467|P4|STARTED|Overall Study||18
8546730|NCT00178256|21070468|P3|STARTED|Overall Study||6
8546731|NCT00178256|21070469|P2|STARTED|Overall Study||7
8546732|NCT00178256|21070470|P1|STARTED|Overall Study||10
8546733|NCT00178191|21070480|P3|NOT COMPLETED|Overall Study||0
8546734|NCT00178191|21070481|P2|NOT COMPLETED|Overall Study||0
8546735|NCT00178191|21070482|P1|NOT COMPLETED|Overall Study||0
8546736|NCT00178191|21070480|P3|COMPLETED|Overall Study||7
8546737|NCT00178191|21070481|P2|COMPLETED|Overall Study||10
8546738|NCT00178191|21070482|P1|COMPLETED|Overall Study||11
8546739|NCT00178191|21070480|P3|STARTED|Overall Study||7
8546740|NCT00178191|21070481|P2|STARTED|Overall Study||10
8546741|NCT00178191|21070482|P1|STARTED|Overall Study||11
8546742|NCT00178178|21070494|P4|NOT COMPLETED|Overall Study||0
8546743|NCT00178178|21070495|P3|NOT COMPLETED|Overall Study||0
8546744|NCT00178178|21070496|P2|NOT COMPLETED|Overall Study||0
8546745|NCT00178178|21070497|P1|NOT COMPLETED|Overall Study||0
8546746|NCT00178178|21070494|P4|COMPLETED|Overall Study||24
8546747|NCT00178178|21070495|P3|COMPLETED|Overall Study||24
8546748|NCT00178178|21070496|P2|COMPLETED|Overall Study||24
8546749|NCT00178178|21070497|P1|COMPLETED|Overall Study||24
8546750|NCT00178178|21070494|P4|STARTED|Overall Study||24
8546751|NCT00178178|21070495|P3|STARTED|Overall Study||24
8546752|NCT00178178|21070496|P2|STARTED|Overall Study||24
8546753|NCT00178178|21070497|P1|STARTED|Overall Study||24
8546754|NCT00178126|21070509|P2|NOT COMPLETED|Overall Study||27
8546755|NCT00178126|21070510|P1|NOT COMPLETED|Overall Study||25
8546756|NCT00178126|21070509|P2|COMPLETED|Overall Study||86
8546757|NCT00178126|21070510|P1|COMPLETED|Overall Study||94
8546758|NCT00178126|21070509|P2|STARTED|Overall Study||113
8546759|NCT00178126|21070510|P1|STARTED|Overall Study||119
8546760|NCT00177970|21070518|P2|NOT COMPLETED|Overall Study||0
8546761|NCT00177970|21070519|P1|NOT COMPLETED|Overall Study||0
8546762|NCT00177970|21070518|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546763|NCT00177970|21070519|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546764|NCT00177970|21070518|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546765|NCT00177970|21070519|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546766|NCT00177866|21070541|P2|NOT COMPLETED|Overall Study||0
8546767|NCT00177866|21070542|P1|NOT COMPLETED|Overall Study||0
8546768|NCT00177866|21070541|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546769|NCT00177866|21070542|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546770|NCT00177866|21070541|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546771|NCT00177866|21070542|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546772|NCT00177671|21070552|P2|NOT COMPLETED|Overall Study||14
8546773|NCT00177671|21070553|P1|NOT COMPLETED|Overall Study||25
8546774|NCT00177671|21070552|P2|COMPLETED|Overall Study||49
8546775|NCT00177671|21070553|P1|COMPLETED|Overall Study||42
8546776|NCT00177671|21070552|P2|Month 24|Overall Study||49
8546777|NCT00177671|21070553|P1|Month 24|Overall Study||42
8546778|NCT00177671|21070552|P2|Month 12|Overall Study||57
8546779|NCT00177671|21070553|P1|Month 12|Overall Study||45
8546780|NCT00177671|21070552|P2|STARTED|Overall Study||63
8546781|NCT00177671|21070553|P1|STARTED|Overall Study||67
8546782|NCT00177307|21070565|P1|NOT COMPLETED|Overall Study||1
8546783|NCT00177307|21070565|P1|COMPLETED|Overall Study||39
8546784|NCT00177307|21070565|P1|STARTED|Overall Study||40
8546785|NCT00177294|21070574|P2|NOT COMPLETED|Overall Study||5
8546786|NCT00177294|21070575|P1|NOT COMPLETED|Overall Study||7
8546787|NCT00177294|21070574|P2|COMPLETED|Overall Study||59
8546788|NCT00177294|21070575|P1|COMPLETED|Overall Study||53
8546789|NCT00177294|21070574|P2|STARTED|Overall Study||64
8546790|NCT00177294|21070575|P1|STARTED|Overall Study||60
8546791|NCT00177255|21070581|P1|NOT COMPLETED|Overall Study||0
8546792|NCT00177255|21070581|P1|COMPLETED|Overall Study||39
8546793|NCT00177255|21070581|P1|STARTED|Overall Study||39
8546794|NCT00177216|21070589|P3|NOT COMPLETED|Overall Study||1
8546795|NCT00177216|21070590|P2|NOT COMPLETED|Overall Study||3
8546796|NCT00177216|21070591|P1|NOT COMPLETED|Overall Study||6
8546797|NCT00177216|21070589|P3|COMPLETED|Overall Study||19
8546798|NCT00177216|21070590|P2|COMPLETED|Overall Study||20
8546799|NCT00177216|21070591|P1|COMPLETED|Overall Study||20
8546800|NCT00177216|21070589|P3|STARTED|Overall Study||20
8546801|NCT00177216|21070590|P2|STARTED|Overall Study||23
8546802|NCT00177216|21070591|P1|STARTED|Overall Study||26
8546803|NCT00177164|21070607|P2|NOT COMPLETED|Overall Study||16
8546804|NCT00177164|21070608|P1|NOT COMPLETED|Overall Study||9
8546805|NCT00177164|21070607|P2|COMPLETED|Overall Study||9
8546806|NCT00177164|21070608|P1|COMPLETED|Overall Study||14
8546807|NCT00177164|21070607|P2|STARTED|Overall Study||25
8546808|NCT00177164|21070608|P1|STARTED|Overall Study||23
8546809|NCT00176930|21070628|P8|NOT COMPLETED|Overall Study||0
8546810|NCT00176930|21070629|P7|NOT COMPLETED|Overall Study||0
8546811|NCT00176930|21070630|P6|NOT COMPLETED|Overall Study||0
8546812|NCT00176930|21070631|P5|NOT COMPLETED|Overall Study||0
8546813|NCT00176930|21070632|P4|NOT COMPLETED|Overall Study||0
8546814|NCT00176930|21070633|P3|NOT COMPLETED|Overall Study||0
8546815|NCT00176930|21070634|P2|NOT COMPLETED|Overall Study||0
8546816|NCT00176930|21070635|P1|NOT COMPLETED|Overall Study||0
8546817|NCT00176930|21070628|P8|COMPLETED|Overall Study||2
8546818|NCT00176930|21070629|P7|COMPLETED|Overall Study||2
8546819|NCT00176930|21070630|P6|COMPLETED|Overall Study||85
8546820|NCT00176930|21070631|P5|COMPLETED|Overall Study||213
8546821|NCT00176930|21070632|P4|COMPLETED|Overall Study||1
8546822|NCT00176930|21070633|P3|COMPLETED|Overall Study||1
8546823|NCT00176930|21070634|P2|COMPLETED|Overall Study||13
8546824|NCT00176930|21070635|P1|COMPLETED|Overall Study||12
8546825|NCT00176930|21070628|P8|STARTED|Overall Study||2
8546826|NCT00176930|21070629|P7|STARTED|Overall Study||2
8546827|NCT00176930|21070630|P6|STARTED|Overall Study||85
8546828|NCT00176930|21070631|P5|STARTED|Overall Study||213
8546829|NCT00176930|21070632|P4|STARTED|Overall Study||1
8546830|NCT00176930|21070633|P3|STARTED|Overall Study||1
8546831|NCT00176930|21070634|P2|STARTED|Overall Study||13
8546832|NCT00176930|21070635|P1|STARTED|Overall Study||12
8546833|NCT00176917|21070725|P1|NOT COMPLETED|Overall Study||0
8546834|NCT00176917|21070725|P1|COMPLETED|Overall Study||41
8546835|NCT00176917|21070725|P1|STARTED|Overall Study||41
8546836|NCT00176904|21070732|P1|NOT COMPLETED|Overall Study||0
8546837|NCT00176904|21070732|P1|COMPLETED|Overall Study||135
8546838|NCT00176904|21070732|P1|STARTED|Overall Study||135
8546839|NCT00176891|21070740|P1|NOT COMPLETED|Overall Study||3
8546840|NCT00176891|21070740|P1|COMPLETED|Overall Study||22
8546841|NCT00176891|21070740|P1|STARTED|Overall Study||25
8546842|NCT00176878|21070751|P1|NOT COMPLETED|Overall Study||0
8546843|NCT00176878|21070751|P1|COMPLETED|Overall Study||10
8546844|NCT00176878|21070751|P1|STARTED|Overall Study||10
8546845|NCT00176865|21070763|P3|NOT COMPLETED|Overall Study||0
8546846|NCT00176865|21070764|P2|NOT COMPLETED|Overall Study||0
8546847|NCT00176865|21070765|P1|NOT COMPLETED|Overall Study||0
8546848|NCT00176865|21070763|P3|COMPLETED|Overall Study||6
8546849|NCT00176865|21070764|P2|COMPLETED|Overall Study||10
8546850|NCT00176865|21070765|P1|COMPLETED|Overall Study||3
8546851|NCT00176865|21070763|P3|STARTED|Overall Study||6
8546852|NCT00176865|21070764|P2|STARTED|Overall Study||10
8546853|NCT00176865|21070765|P1|STARTED|Overall Study||3
8546854|NCT00176852|21070803|P3|NOT COMPLETED|Overall Study||0
8546855|NCT00176852|21070804|P2|NOT COMPLETED|Overall Study||0
8546856|NCT00176852|21070805|P1|NOT COMPLETED|Overall Study||0
8546857|NCT00176852|21070803|P3|COMPLETED|Overall Study||14
8546858|NCT00176852|21070804|P2|COMPLETED|Overall Study||5
8546859|NCT00176852|21070805|P1|COMPLETED|Overall Study||3
8546860|NCT00176852|21070803|P3|STARTED|Overall Study||14
8546861|NCT00176852|21070804|P2|STARTED|Overall Study||5
8546862|NCT00176852|21070805|P1|STARTED|Overall Study||3
8546863|NCT00176839|21070861|P1|NOT COMPLETED|Overall Study||0
8546864|NCT00176839|21070861|P1|COMPLETED|Overall Study||11
8546865|NCT00176839|21070861|P1|STARTED|Overall Study||11
8546866|NCT00176826|21070870|P1|NOT COMPLETED|Overall Study||0
8546867|NCT00176826|21070870|P1|COMPLETED|Overall Study||22
8546868|NCT00176826|21070870|P1|STARTED|Overall Study||22
8546869|NCT00176800|21070880|P1|NOT COMPLETED|Overall Study||0
8546870|NCT00176800|21070880|P1|COMPLETED|Overall Study||69
8546871|NCT00176800|21070880|P1|STARTED|Overall Study||69
8546872|NCT00176644|21070886|P1|NOT COMPLETED|Overall Study||1
8546873|NCT00176644|21070886|P1|COMPLETED|Overall Study||22
8546874|NCT00176644|21070886|P1|STARTED|Overall Study||23
8546875|NCT00176631|21070894|P1|NOT COMPLETED|Overall Study||0
8546876|NCT00176631|21070894|P1|COMPLETED|Overall Study||10
8546877|NCT00176631|21070894|P1|STARTED|Overall Study||10
8546878|NCT00176605|21070899|P1|NOT COMPLETED|Overall Study||2
8546879|NCT00176605|21070899|P1|COMPLETED|Overall Study||13
8546880|NCT00176605|21070899|P1|STARTED|Overall Study||15
8546881|NCT00176501|21070904|P1|NOT COMPLETED|Overall Study||0
8546882|NCT00176501|21070904|P1|COMPLETED|Overall Study||3
8546883|NCT00176501|21070904|P1|STARTED|Overall Study||3
8546884|NCT00176488|21070910|P1|NOT COMPLETED|Overall Study||1
8546885|NCT00176488|21070910|P1|COMPLETED|Overall Study||30
8546886|NCT00176488|21070910|P1|STARTED|Overall Study||31
8546887|NCT00176462|21070918|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
8546888|NCT00176462|21070919|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
8546889|NCT00176462|21070918|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
8546890|NCT00176462|21070919|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
8546891|NCT00176462|21070918|P2|STARTED|Continuation -up to 30mos Post Remission||26
8546892|NCT00176462|21070919|P1|STARTED|Continuation -up to 30mos Post Remission||19
8546893|NCT00176462|21070918|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
8546894|NCT00176462|21070919|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
8546895|NCT00176462|21070918|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
8546896|NCT00176462|21070919|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
8546897|NCT00176462|21070918|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
8546898|NCT00176462|21070919|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
8546899|NCT00176462|21070918|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
8546900|NCT00176462|21070919|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
8546901|NCT00176462|21070918|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
8546902|NCT00176462|21070919|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
8546903|NCT00176462|21070918|P2|STARTED|Delayed Intensification (8 Weeks)||29
8546904|NCT00176462|21070919|P1|STARTED|Delayed Intensification (8 Weeks)||20
8546905|NCT00176462|21070918|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
8546906|NCT00176462|21070919|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
8546907|NCT00176462|21070918|P2|COMPLETED|Consolidation (12 Weeks)||29
8546908|NCT00176462|21070919|P1|COMPLETED|Consolidation (12 Weeks)||20
8546909|NCT00176462|21070918|P2|STARTED|Consolidation (12 Weeks)||34
8546910|NCT00176462|21070919|P1|STARTED|Consolidation (12 Weeks)||20
8546911|NCT00176462|21070918|P2|NOT COMPLETED|Induction (4 Weeks)||5
8546912|NCT00176462|21070919|P1|NOT COMPLETED|Induction (4 Weeks)||1
8546913|NCT00176462|21070918|P2|COMPLETED|Induction (4 Weeks)||34
8546914|NCT00176462|21070919|P1|COMPLETED|Induction (4 Weeks)||20
8546915|NCT00176462|21070918|P2|STARTED|Induction (4 Weeks)||39
8546916|NCT00176462|21070919|P1|STARTED|Induction (4 Weeks)||21
8546917|NCT00176436|21070928|P2|NOT COMPLETED|Overall Study||5
8546918|NCT00176436|21070929|P1|NOT COMPLETED|Overall Study||6
8546919|NCT00176436|21070928|P2|COMPLETED|Overall Study||12
8546920|NCT00176436|21070929|P1|COMPLETED|Overall Study||14
8546921|NCT00176436|21070928|P2|STARTED|Overall Study||17
8546922|NCT00176436|21070929|P1|STARTED|Overall Study||20
8546923|NCT00176423|21070937|P2|NOT COMPLETED|Overall Study||6
8546924|NCT00176423|21070938|P1|NOT COMPLETED|Overall Study||7
8546925|NCT00176423|21070937|P2|COMPLETED|Overall Study||38
8546926|NCT00176423|21070938|P1|COMPLETED|Overall Study||35
8546927|NCT00176423|21070937|P2|STARTED|Overall Study||44
8546928|NCT00176423|21070938|P1|STARTED|Overall Study||42
8546929|NCT00176306|21070950|P1|NOT COMPLETED|Overall Study||0
8546930|NCT00176306|21070950|P1|COMPLETED|Overall Study||15
8546931|NCT00176306|21070950|P1|STARTED|Overall Study||15
8546932|NCT00176254|21070954|P1|NOT COMPLETED|Overall Study||1
8546933|NCT00176254|21070954|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
8546934|NCT00176254|21070954|P1|STARTED|Overall Study||40
8546935|NCT00176228|21070962|P1|NOT COMPLETED|Overall Study||2
8546936|NCT00176228|21070962|P1|COMPLETED|Overall Study|Study ended|46
8546937|NCT00176228|21070962|P1|STARTED|Overall Study|When study began|48
8546938|NCT00176202|21070969|P2|NOT COMPLETED|Overall Study||16
8546939|NCT00176202|21070970|P1|NOT COMPLETED|Overall Study||5
8546940|NCT00176202|21070969|P2|COMPLETED|Overall Study||17
8546941|NCT00176202|21070970|P1|COMPLETED|Overall Study||27
8546942|NCT00176202|21070969|P2|STARTED|Overall Study||33
8546943|NCT00176202|21070970|P1|STARTED|Overall Study||32
8546944|NCT00175916|21070982|P1|NOT COMPLETED|Overall Study||619
8546945|NCT00175916|21070982|P1|COMPLETED|Overall Study||234
8546946|NCT00175916|21070982|P1|STARTED|Overall Study||853
8546947|NCT00175877|21070991|P1|NOT COMPLETED|Overall Study||349
8546948|NCT00175877|21070991|P1|COMPLETED|Overall Study||497
8546949|NCT00175877|21070991|P1|STARTED|Overall Study||846
8546950|NCT00175825|21071026|P4|NOT COMPLETED|Overall Study||1
8546951|NCT00175825|21071027|P3|NOT COMPLETED|Overall Study||1
8546952|NCT00175825|21071028|P2|NOT COMPLETED|Overall Study||4
8546953|NCT00175825|21071029|P1|NOT COMPLETED|Overall Study||5
8546954|NCT00175825|21071026|P4|COMPLETED|Overall Study||51
8546955|NCT00175825|21071027|P3|COMPLETED|Overall Study||51
8546956|NCT00175825|21071028|P2|COMPLETED|Overall Study||46
8546957|NCT00175825|21071029|P1|COMPLETED|Overall Study||49
8546958|NCT00175825|21071026|P4|STARTED|Overall Study||52
8546959|NCT00175825|21071027|P3|STARTED|Overall Study||52
8546960|NCT00175825|21071028|P2|STARTED|Overall Study||50
8546961|NCT00175825|21071029|P1|STARTED|Overall Study||54
8546962|NCT00175019|21071082|P3|NOT COMPLETED|Overall Study||57
8546963|NCT00175019|21071083|P2|NOT COMPLETED|Overall Study||171
8546964|NCT00175019|21071084|P1|NOT COMPLETED|Overall Study||194
8546965|NCT00175019|21071082|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
8546966|NCT00175019|21071083|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
8546967|NCT00175019|21071084|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
8546968|NCT00175019|21071082|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
8546969|NCT00175019|21071083|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
8546970|NCT00175019|21071084|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
8546971|NCT00175006|21071128|P1|NOT COMPLETED|Overall Study||0
8546972|NCT00175006|21071128|P1|COMPLETED|Overall Study||13
8546973|NCT00175006|21071128|P1|STARTED|Overall Study||13
8546974|NCT00174967|21071137|P4|NOT COMPLETED|Overall Study||2
8546975|NCT00174967|21071138|P3|NOT COMPLETED|Overall Study||2
8546976|NCT00174967|21071139|P2|NOT COMPLETED|Overall Study||3
8546977|NCT00174967|21071140|P1|NOT COMPLETED|Overall Study||1
8546978|NCT00174967|21071137|P4|COMPLETED|Overall Study||36
8546979|NCT00174967|21071138|P3|COMPLETED|Overall Study||36
8546980|NCT00174967|21071139|P2|COMPLETED|Overall Study||37
8546981|NCT00174967|21071140|P1|COMPLETED|Overall Study||36
8546982|NCT00174967|21071137|P4|STARTED|Overall Study||38
8546983|NCT00174967|21071138|P3|STARTED|Overall Study||38
8546984|NCT00174967|21071139|P2|STARTED|Overall Study||40
8546985|NCT00174967|21071140|P1|STARTED|Overall Study||37
8546986|NCT00174954|21071186|P1|NOT COMPLETED|Overall Study||4
8546987|NCT00174954|21071186|P1|COMPLETED|Overall Study||28
8546988|NCT00174954|21071186|P1|STARTED|Overall Study||32
8546989|NCT00174941|21071194|P4|NOT COMPLETED|Overall Study||58
8546990|NCT00174941|21071195|P3|NOT COMPLETED|Overall Study||18
8546991|NCT00174941|21071196|P2|NOT COMPLETED|Overall Study||38
8546992|NCT00174941|21071197|P1|NOT COMPLETED|Overall Study||2
8546993|NCT00174941|21071194|P4|COMPLETED|Overall Study||58
8546994|NCT00174941|21071195|P3|COMPLETED|Overall Study||11
8546995|NCT00174941|21071196|P2|COMPLETED|Overall Study||41
8546996|NCT00174941|21071197|P1|COMPLETED|Overall Study||6
8546997|NCT00174941|21071194|P4|STARTED|Overall Study||116
8546998|NCT00174941|21071195|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
8546999|NCT00174941|21071196|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
8547000|NCT00174941|21071197|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
8547001|NCT00174915|21071272|P5|NOT COMPLETED|Overall Study||33
8547002|NCT00174915|21071273|P4|NOT COMPLETED|Overall Study||57
8547003|NCT00174915|21071274|P3|NOT COMPLETED|Overall Study||48
8547004|NCT00174915|21071275|P2|NOT COMPLETED|Overall Study||69
8547005|NCT00174915|21071276|P1|NOT COMPLETED|Overall Study||93
8547006|NCT00174915|21071272|P5|COMPLETED|Overall Study||101
8547007|NCT00174915|21071273|P4|COMPLETED|Overall Study||211
8547008|NCT00174915|21071274|P3|COMPLETED|Overall Study||86
8547009|NCT00174915|21071275|P2|COMPLETED|Overall Study||200
8547010|NCT00174915|21071276|P1|COMPLETED|Overall Study||174
8547011|NCT00174915|21071272|P5|STARTED|Overall Study||134
8547012|NCT00174915|21071273|P4|STARTED|Overall Study||268
8547013|NCT00174915|21071274|P3|STARTED|Overall Study||134
8547014|NCT00174915|21071275|P2|STARTED|Overall Study||269
8547015|NCT00174915|21071276|P1|STARTED|Overall Study||267
8547016|NCT00174785|21071335|P2|NOT COMPLETED|Overall Study||716
8547017|NCT00174785|21071336|P1|NOT COMPLETED|Overall Study||696
8547018|NCT00174785|21071335|P2|COMPLETED|Overall Study|completed study drug|1611
8547019|NCT00174785|21071336|P1|COMPLETED|Overall Study|completed study drug|1605
8547020|NCT00174785|21071335|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
8547021|NCT00174785|21071336|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
8547022|NCT00174460|21071352|P2|NOT COMPLETED|Overall Study||1
8547023|NCT00174460|21071353|P1|NOT COMPLETED|Overall Study||0
8547024|NCT00174460|21071352|P2|COMPLETED|Overall Study||14
8547025|NCT00174460|21071353|P1|COMPLETED|Overall Study||18
8547026|NCT00174460|21071352|P2|Received Study Treatment|Overall Study||14
8547027|NCT00174460|21071353|P1|Received Study Treatment|Overall Study||18
8547028|NCT00174460|21071352|P2|STARTED|Overall Study||15
8547029|NCT00174460|21071353|P1|STARTED|Overall Study||18
8547030|NCT00174447|21071399|P1|NOT COMPLETED|Overall Study||38
8547031|NCT00174447|21071399|P1|COMPLETED|Overall Study||5
8547032|NCT00174447|21071399|P1|STARTED|Overall Study||43
8547033|NCT00174382|21071408|P1|NOT COMPLETED|Overall Study||33
8547034|NCT00174382|21071408|P1|COMPLETED|Overall Study||116
8547035|NCT00174382|21071408|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
8547036|NCT00174291|21071427|P2|NOT COMPLETED|Overall Study||6
8547037|NCT00174291|21071428|P1|NOT COMPLETED|Overall Study||5
8547038|NCT00174291|21071427|P2|COMPLETED|Overall Study||4
8547039|NCT00174291|21071428|P1|COMPLETED|Overall Study||6
8547040|NCT00174291|21071427|P2|STARTED|Overall Study||10
8547041|NCT00174291|21071428|P1|STARTED|Overall Study||11
8547042|NCT00174265|21071458|P2|NOT COMPLETED|Overall Study||21
8547043|NCT00174265|21071459|P1|NOT COMPLETED|Overall Study||29
8547044|NCT00174265|21071458|P2|COMPLETED|Overall Study||89
8547045|NCT00174265|21071459|P1|COMPLETED|Overall Study||57
8547046|NCT00174265|21071458|P2|STARTED|Overall Study||110
8547047|NCT00174265|21071459|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
8547048|NCT00174252|21071467|P1|NOT COMPLETED|Overall Study||2
8547049|NCT00174252|21071467|P1|COMPLETED|Overall Study||55
8547050|NCT00174252|21071467|P1|STARTED|Overall Study||57
8547051|NCT00174187|21071502|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
8547052|NCT00174187|21071503|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
8547053|NCT00174187|21071504|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
8547054|NCT00174187|21071502|P3|COMPLETED|Period 2 (After 3 Years)||13
8547055|NCT00174187|21071503|P2|COMPLETED|Period 2 (After 3 Years)||0
8547056|NCT00174187|21071504|P1|COMPLETED|Period 2 (After 3 Years)||0
8547057|NCT00174187|21071502|P3|STARTED|Period 2 (After 3 Years)||21
8547058|NCT00174187|21071503|P2|STARTED|Period 2 (After 3 Years)||0
8547059|NCT00174187|21071504|P1|STARTED|Period 2 (After 3 Years)||0
8547060|NCT00174187|21071502|P3|NOT COMPLETED|Between Period 1 and Period 2||5
8547061|NCT00174187|21071503|P2|NOT COMPLETED|Between Period 1 and Period 2||0
8547062|NCT00174187|21071504|P1|NOT COMPLETED|Between Period 1 and Period 2||0
8547063|NCT00174187|21071502|P3|COMPLETED|Between Period 1 and Period 2||21
8547064|NCT00174187|21071503|P2|COMPLETED|Between Period 1 and Period 2||0
8547065|NCT00174187|21071504|P1|COMPLETED|Between Period 1 and Period 2||0
8547066|NCT00174187|21071502|P3|Consented|Between Period 1 and Period 2||24
8547067|NCT00174187|21071503|P2|Consented|Between Period 1 and Period 2||0
8547068|NCT00174187|21071504|P1|Consented|Between Period 1 and Period 2||0
8547069|NCT00174187|21071502|P3|STARTED|Between Period 1 and Period 2||26
8547070|NCT00174187|21071503|P2|STARTED|Between Period 1 and Period 2||0
8547071|NCT00174187|21071504|P1|STARTED|Between Period 1 and Period 2||0
8547072|NCT00174187|21071502|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
8547073|NCT00174187|21071503|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
8547074|NCT00174187|21071504|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
8547075|NCT00174187|21071502|P3|COMPLETED|Period 1 (up to 3 Years)||0
8547076|NCT00174187|21071503|P2|COMPLETED|Period 1 (up to 3 Years)||11
8547077|NCT00174187|21071504|P1|COMPLETED|Period 1 (up to 3 Years)||15
8547078|NCT00174187|21071502|P3|STARTED|Period 1 (up to 3 Years)||0
8547079|NCT00174187|21071503|P2|STARTED|Period 1 (up to 3 Years)||15
8547080|NCT00174187|21071504|P1|STARTED|Period 1 (up to 3 Years)||15
8547081|NCT00172185|21071569|P4|NOT COMPLETED|Overall Study||4
8547082|NCT00172185|21071570|P3|NOT COMPLETED|Overall Study||5
8547083|NCT00172185|21071571|P2|NOT COMPLETED|Overall Study||2
8547084|NCT00172185|21071572|P1|NOT COMPLETED|Overall Study||0
8547085|NCT00172185|21071569|P4|COMPLETED|Overall Study||23
8547086|NCT00172185|21071570|P3|COMPLETED|Overall Study||20
8547087|NCT00172185|21071571|P2|COMPLETED|Overall Study||5
8547088|NCT00172185|21071572|P1|COMPLETED|Overall Study||6
8547089|NCT00172185|21071569|P4|STARTED|Overall Study||27
8547090|NCT00172185|21071570|P3|STARTED|Overall Study||25
8547091|NCT00172185|21071571|P2|STARTED|Overall Study||7
8547092|NCT00172185|21071572|P1|STARTED|Overall Study||6
8547093|NCT00172042|21071588|P2|NOT COMPLETED|Overall Study||125
8547094|NCT00172042|21071589|P1|NOT COMPLETED|Overall Study||158
8547095|NCT00172042|21071588|P2|COMPLETED|Overall Study||86
8547096|NCT00172042|21071589|P1|COMPLETED|Overall Study||68
8547097|NCT00172042|21071588|P2|STARTED|Overall Study||211
8547098|NCT00172042|21071589|P1|STARTED|Overall Study||226
8547099|NCT00171925|21071611|P2|NOT COMPLETED|Overall Study||31
8547100|NCT00171925|21071612|P1|NOT COMPLETED|Overall Study||30
8547101|NCT00171925|21071611|P2|COMPLETED|Overall Study||40
8547102|NCT00171925|21071612|P1|COMPLETED|Overall Study||42
8547103|NCT00171925|21071611|P2|STARTED|Overall Study||71
8547104|NCT00171925|21071612|P1|STARTED|Overall Study||72
8547105|NCT00171873|21071624|P2|NOT COMPLETED|Overall Study||3
8547106|NCT00171873|21071625|P1|NOT COMPLETED|Overall Study||9
8547107|NCT00171873|21071624|P2|COMPLETED|Overall Study||40
8547108|NCT00171873|21071625|P1|COMPLETED|Overall Study||33
8547109|NCT00171873|21071624|P2|STARTED|Overall Study||43
8547110|NCT00171873|21071625|P1|STARTED|Overall Study||42
8547111|NCT00171834|21071638|P7|NOT COMPLETED|Overall Study||4
8547112|NCT00171834|21071639|P6|NOT COMPLETED|Overall Study||35
8547113|NCT00171834|21071640|P5|NOT COMPLETED|Overall Study||8
8547114|NCT00171834|21071641|P4|NOT COMPLETED|Overall Study||12
8547115|NCT00171834|21071642|P3|NOT COMPLETED|Overall Study||12
8547116|NCT00171834|21071643|P2|NOT COMPLETED|Overall Study||12
8547117|NCT00171834|21071644|P1|NOT COMPLETED|Overall Study||6
8547118|NCT00171834|21071638|P7|COMPLETED|Overall Study||0
8547119|NCT00171834|21071639|P6|COMPLETED|Overall Study||0
8547120|NCT00171834|21071640|P5|COMPLETED|Overall Study||0
8547121|NCT00171834|21071641|P4|COMPLETED|Overall Study||0
8547122|NCT00171834|21071642|P3|COMPLETED|Overall Study||0
8547123|NCT00171834|21071643|P2|COMPLETED|Overall Study||0
8547124|NCT00171834|21071644|P1|COMPLETED|Overall Study||0
8547125|NCT00171834|21071638|P7|Completed 6 Cycles of Treatment|Overall Study||0
8547126|NCT00171834|21071639|P6|Completed 6 Cycles of Treatment|Overall Study||1
8547127|NCT00171834|21071640|P5|Completed 6 Cycles of Treatment|Overall Study||2
8547128|NCT00171834|21071641|P4|Completed 6 Cycles of Treatment|Overall Study||0
8547129|NCT00171834|21071642|P3|Completed 6 Cycles of Treatment|Overall Study||1
8547130|NCT00171834|21071643|P2|Completed 6 Cycles of Treatment|Overall Study||0
8547131|NCT00171834|21071644|P1|Completed 6 Cycles of Treatment|Overall Study||0
8547132|NCT00171834|21071638|P7|STARTED|Overall Study||4
8547133|NCT00171834|21071639|P6|STARTED|Overall Study||35
8547134|NCT00171834|21071640|P5|STARTED|Overall Study||8
8547135|NCT00171834|21071641|P4|STARTED|Overall Study||12
8547136|NCT00171834|21071642|P3|STARTED|Overall Study||12
8547137|NCT00171834|21071643|P2|STARTED|Overall Study||12
8547138|NCT00171834|21071644|P1|STARTED|Overall Study||6
8547139|NCT00171704|21071684|P2|NOT COMPLETED|Overall Study||49
8547140|NCT00171704|21071685|P1|NOT COMPLETED|Overall Study||44
8547141|NCT00171704|21071684|P2|COMPLETED|Overall Study||81
8547142|NCT00171704|21071685|P1|COMPLETED|Overall Study||89
8547143|NCT00171704|21071684|P2|STARTED|Overall Study||130
8547144|NCT00171704|21071685|P1|STARTED|Overall Study||133
8547145|NCT00171340|21071707|P2|NOT COMPLETED|Overall Study||135
8547146|NCT00171340|21071708|P1|NOT COMPLETED|Overall Study||124
8547147|NCT00171340|21071707|P2|COMPLETED|Overall Study||398
8547148|NCT00171340|21071708|P1|COMPLETED|Overall Study||408
8547149|NCT00171340|21071707|P2|STARTED|Overall Study||533
8547150|NCT00171340|21071708|P1|STARTED|Overall Study||532
8547151|NCT00171314|21071724|P2|NOT COMPLETED|Overall Study||78
8547152|NCT00171314|21071725|P1|NOT COMPLETED|Overall Study||91
8547153|NCT00171314|21071724|P2|COMPLETED|Overall Study||186
8547154|NCT00171314|21071725|P1|COMPLETED|Overall Study||172
8547155|NCT00171314|21071724|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
8547156|NCT00171314|21071725|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
8547157|NCT00171314|21071724|P2|STARTED|Overall Study||264
8547158|NCT00171314|21071725|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
8547159|NCT00171301|21071741|P2|NOT COMPLETED|Overall Study||9
8547160|NCT00171301|21071742|P1|NOT COMPLETED|Overall Study||8
8547161|NCT00171301|21071741|P2|COMPLETED|Overall Study||62
8547162|NCT00171301|21071742|P1|COMPLETED|Overall Study||154
8547163|NCT00171301|21071741|P2|Received Deferasirox|Overall Study||69
8547164|NCT00171301|21071742|P1|Received Deferasirox|Overall Study||162
8547165|NCT00171301|21071741|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
8547166|NCT00171301|21071742|P1|STARTED|Overall Study||162
8547167|NCT00171210|21071755|P2|NOT COMPLETED|Overall Study||115
8547168|NCT00171210|21071756|P1|NOT COMPLETED|Overall Study||69
8547169|NCT00171210|21071755|P2|COMPLETED|Overall Study||181
8547170|NCT00171210|21071756|P1|COMPLETED|Overall Study||190
8547171|NCT00171210|21071755|P2|STARTED EXTENSION STUDY|Overall Study||247
8547172|NCT00171210|21071756|P1|STARTED EXTENSION STUDY|Overall Study||259
8547173|NCT00171210|21071755|P2|STARTED|Overall Study||296
8547174|NCT00171210|21071756|P1|STARTED|Overall Study||259
8547175|NCT00171054|21071786|P2|NOT COMPLETED|Overall Study||12
8547176|NCT00171054|21071787|P1|NOT COMPLETED|Overall Study||10
8547177|NCT00171054|21071786|P2|COMPLETED|Overall Study||50
8547178|NCT00171054|21071787|P1|COMPLETED|Overall Study||53
8547179|NCT00171054|21071786|P2|STARTED|Overall Study||62
8547180|NCT00171054|21071787|P1|STARTED|Overall Study||63
8547181|NCT00170950|21071819|P2|NOT COMPLETED|Overall Study||910
8547182|NCT00170950|21071820|P1|NOT COMPLETED|Overall Study||885
8547183|NCT00170950|21071819|P2|COMPLETED|Overall Study||4852
8547184|NCT00170950|21071820|P1|COMPLETED|Overall Study||4859
8547185|NCT00170950|21071819|P2|STARTED|Overall Study||5762
8547186|NCT00170950|21071820|P1|STARTED|Overall Study||5744
8547187|NCT00170846|21071833|P3|NOT COMPLETED|Overall Study||13
8547188|NCT00170846|21071834|P2|NOT COMPLETED|Overall Study||19
8547189|NCT00170846|21071835|P1|NOT COMPLETED|Overall Study||11
8547190|NCT00170846|21071833|P3|COMPLETED|Overall Study||131
8547191|NCT00170846|21071834|P2|COMPLETED|Overall Study||108
8547192|NCT00170846|21071835|P1|COMPLETED|Overall Study||112
8547193|NCT00170846|21071833|P3|STARTED|Overall Study||144
8547194|NCT00170846|21071834|P2|STARTED|Overall Study||127
8547195|NCT00170846|21071835|P1|STARTED|Overall Study||123
8547196|NCT00170625|21071849|P1|NOT COMPLETED|Overall Study||0
8547197|NCT00170625|21071849|P1|COMPLETED|Overall Study||26
8547198|NCT00170625|21071849|P1|STARTED|Overall Study||26
8547199|NCT00170157|21071854|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
8547200|NCT00170157|21071855|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
8547201|NCT00170157|21071854|P2|COMPLETED|Treatment Period 2 Crossover||41
8547202|NCT00170157|21071855|P1|COMPLETED|Treatment Period 2 Crossover||0
8547203|NCT00170157|21071854|P2|STARTED|Treatment Period 2 Crossover||41
8547204|NCT00170157|21071855|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
8547205|NCT00170157|21071854|P2|NOT COMPLETED|Washout Period of 14 Days||17
8547206|NCT00170157|21071855|P1|NOT COMPLETED|Washout Period of 14 Days||0
8547207|NCT00170157|21071854|P2|COMPLETED|Washout Period of 14 Days||41
8547208|NCT00170157|21071855|P1|COMPLETED|Washout Period of 14 Days||0
8547209|NCT00170157|21071854|P2|STARTED|Washout Period of 14 Days||58
8547210|NCT00170157|21071855|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
8547211|NCT00170157|21071854|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
8547212|NCT00170157|21071855|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
8547213|NCT00170157|21071854|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
8547214|NCT00170157|21071855|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
8547215|NCT00170157|21071854|P2|STARTED|Treatment Period 1 Initial Randomization||58
8547216|NCT00170157|21071855|P1|STARTED|Treatment Period 1 Initial Randomization||54
8547217|NCT00169442|21071867|P6|NOT COMPLETED|Overall Study||2
8547218|NCT00169442|21071868|P5|NOT COMPLETED|Overall Study||1
8547219|NCT00169442|21071869|P4|NOT COMPLETED|Overall Study||0
8547220|NCT00169442|21071870|P3|NOT COMPLETED|Overall Study||1
8547221|NCT00169442|21071871|P2|NOT COMPLETED|Overall Study||1
8547222|NCT00169442|21071872|P1|NOT COMPLETED|Overall Study||0
8547223|NCT00169442|21071867|P6|COMPLETED|Overall Study||41
8547224|NCT00169442|21071868|P5|COMPLETED|Overall Study||41
8547225|NCT00169442|21071869|P4|COMPLETED|Overall Study||250
8547226|NCT00169442|21071870|P3|COMPLETED|Overall Study||166
8547227|NCT00169442|21071871|P2|COMPLETED|Overall Study||123
8547228|NCT00169442|21071872|P1|COMPLETED|Overall Study||119
8547229|NCT00169442|21071867|P6|STARTED|Overall Study||43
8547230|NCT00169442|21071868|P5|STARTED|Overall Study||42
8547231|NCT00169442|21071869|P4|STARTED|Overall Study||250
8547232|NCT00169442|21071870|P3|STARTED|Overall Study||167
8547233|NCT00169442|21071871|P2|STARTED|Overall Study||124
8547234|NCT00169442|21071872|P1|STARTED|Overall Study||119
8547235|NCT00169104|21071981|P2|NOT COMPLETED|Overall Study||2
8547236|NCT00169104|21071982|P1|NOT COMPLETED|Overall Study||2
8547237|NCT00169104|21071981|P2|COMPLETED|Overall Study||8
8547238|NCT00169104|21071982|P1|COMPLETED|Overall Study||11
8547239|NCT00169104|21071981|P2|STARTED|Overall Study||10
8547240|NCT00169104|21071982|P1|STARTED|Overall Study||13
8547241|NCT00168844|21071996|P3|NOT COMPLETED|Overall Study||91
8547242|NCT00168844|21071997|P2|NOT COMPLETED|Overall Study||55
8547243|NCT00168844|21071998|P1|NOT COMPLETED|Overall Study||55
8547244|NCT00168844|21071996|P3|COMPLETED|Overall Study||228
8547245|NCT00168844|21071997|P2|COMPLETED|Overall Study||277
8547246|NCT00168844|21071998|P1|COMPLETED|Overall Study||277
8547247|NCT00168844|21071996|P3|STARTED|Overall Study||319
8547248|NCT00168844|21071997|P2|STARTED|Overall Study||332
8547249|NCT00168844|21071998|P1|STARTED|Overall Study||332
8547250|NCT00168831|21072180|P3|NOT COMPLETED|Overall Study||114
8547251|NCT00168831|21072181|P2|NOT COMPLETED|Overall Study||81
8547252|NCT00168831|21072182|P1|NOT COMPLETED|Overall Study||60
8547253|NCT00168831|21072180|P3|COMPLETED|Overall Study||220
8547254|NCT00168831|21072181|P2|COMPLETED|Overall Study||254
8547255|NCT00168831|21072182|P1|COMPLETED|Overall Study||278
8547256|NCT00168831|21072180|P3|STARTED|Overall Study||334
8547257|NCT00168831|21072181|P2|STARTED|Overall Study||335
8547258|NCT00168831|21072182|P1|STARTED|Overall Study||338
8547259|NCT00168818|21072364|P3|NOT COMPLETED|Treatment||133
8547260|NCT00168818|21072365|P2|NOT COMPLETED|Treatment||151
8547261|NCT00168818|21072366|P1|NOT COMPLETED|Treatment||133
8547262|NCT00168818|21072364|P3|COMPLETED|Treatment||1021
8547263|NCT00168818|21072365|P2|COMPLETED|Treatment||1012
8547264|NCT00168818|21072366|P1|COMPLETED|Treatment||1013
8547265|NCT00168818|21072364|P3|STARTED|Treatment||1154
8547266|NCT00168818|21072365|P2|STARTED|Treatment||1163
8547267|NCT00168818|21072366|P1|STARTED|Treatment||1146
8547268|NCT00168818|21072364|P3|NOT COMPLETED|Overall Study||124
8547269|NCT00168818|21072365|P2|NOT COMPLETED|Overall Study||109
8547270|NCT00168818|21072366|P1|NOT COMPLETED|Overall Study||117
8547271|NCT00168818|21072364|P3|COMPLETED|Overall Study||1030
8547272|NCT00168818|21072365|P2|COMPLETED|Overall Study||1054
8547273|NCT00168818|21072366|P1|COMPLETED|Overall Study||1029
8547274|NCT00168818|21072364|P3|STARTED|Overall Study||1154
8547275|NCT00168818|21072365|P2|STARTED|Overall Study||1163
8547276|NCT00168818|21072366|P1|STARTED|Overall Study||1146
8547277|NCT00168805|21072410|P3|NOT COMPLETED|Treatment||62
8547278|NCT00168805|21072411|P2|NOT COMPLETED|Treatment||56
8547279|NCT00168805|21072412|P1|NOT COMPLETED|Treatment||49
8547280|NCT00168805|21072410|P3|COMPLETED|Treatment||632
8547281|NCT00168805|21072411|P2|COMPLETED|Treatment||647
8547282|NCT00168805|21072412|P1|COMPLETED|Treatment||630
8547283|NCT00168805|21072410|P3|STARTED|Treatment||694
8547284|NCT00168805|21072411|P2|STARTED|Treatment||703
8547285|NCT00168805|21072412|P1|STARTED|Treatment||679
8547286|NCT00168805|21072410|P3|NOT COMPLETED|Overall Study||78
8547287|NCT00168805|21072411|P2|NOT COMPLETED|Overall Study||78
8547288|NCT00168805|21072412|P1|NOT COMPLETED|Overall Study||71
8547289|NCT00168805|21072410|P3|COMPLETED|Overall Study||616
8547290|NCT00168805|21072411|P2|COMPLETED|Overall Study||625
8547291|NCT00168805|21072412|P1|COMPLETED|Overall Study||608
8547292|NCT00168805|21072410|P3|STARTED|Overall Study||694
8547293|NCT00168805|21072411|P2|STARTED|Overall Study||703
8547294|NCT00168805|21072412|P1|STARTED|Overall Study||679
8547295|NCT00168454|21072459|P6|NOT COMPLETED|Overall Study||6
8547296|NCT00168454|21072460|P5|NOT COMPLETED|Overall Study||6
8547297|NCT00168454|21072461|P4|NOT COMPLETED|Overall Study||9
8547298|NCT00168454|21072462|P3|NOT COMPLETED|Overall Study||6
8547299|NCT00168454|21072463|P2|NOT COMPLETED|Overall Study||7
8547300|NCT00168454|21072464|P1|NOT COMPLETED|Overall Study||7
8547301|NCT00168454|21072459|P6|COMPLETED|Overall Study||50
8547302|NCT00168454|21072460|P5|COMPLETED|Overall Study||47
8547303|NCT00168454|21072461|P4|COMPLETED|Overall Study||40
8547304|NCT00168454|21072462|P3|COMPLETED|Overall Study||48
8547305|NCT00168454|21072463|P2|COMPLETED|Overall Study||50
8547306|NCT00168454|21072464|P1|COMPLETED|Overall Study||37
8547307|NCT00168454|21072459|P6|STARTED|Overall Study||56
8547308|NCT00168454|21072460|P5|STARTED|Overall Study||53
8547309|NCT00168454|21072461|P4|STARTED|Overall Study||49
8547310|NCT00168454|21072462|P3|STARTED|Overall Study||54
8547311|NCT00168454|21072463|P2|STARTED|Overall Study||57
8547312|NCT00168454|21072464|P1|STARTED|Overall Study||44
8547313|NCT00168428|21072510|P2|NOT COMPLETED|Open-Label Phase (OL)||68
8547314|NCT00168428|21072511|P1|NOT COMPLETED|Open-Label Phase (OL)||44
8547315|NCT00168428|21072510|P2|COMPLETED|Open-Label Phase (OL)||261
8547316|NCT00168428|21072511|P1|COMPLETED|Open-Label Phase (OL)||261
8547317|NCT00168428|21072510|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
8547318|NCT00168428|21072511|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
8547319|NCT00168428|21072510|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
8547320|NCT00168428|21072511|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
8547321|NCT00168428|21072510|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
8547322|NCT00168428|21072511|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
8547323|NCT00168428|21072510|P2|STARTED|Double-Blind Phase (DB)||358
8547324|NCT00168428|21072511|P1|STARTED|Double-Blind Phase (DB)||347
8547325|NCT00168389|21072530|P3|NOT COMPLETED|Overall Study||95
8547326|NCT00168389|21072531|P2|NOT COMPLETED|Overall Study||48
8547327|NCT00168389|21072532|P1|NOT COMPLETED|Overall Study||56
8547328|NCT00168389|21072530|P3|COMPLETED|Overall Study||70
8547329|NCT00168389|21072531|P2|COMPLETED|Overall Study||118
8547330|NCT00168389|21072532|P1|COMPLETED|Overall Study||107
8547331|NCT00168389|21072530|P3|STARTED|Overall Study||165
8547332|NCT00168389|21072531|P2|STARTED|Overall Study||166
8547333|NCT00168389|21072532|P1|STARTED|Overall Study||163
8547334|NCT00168337|21072561|P3|NOT COMPLETED|Overall Study||103
8547335|NCT00168337|21072562|P2|NOT COMPLETED|Overall Study||69
8547336|NCT00168337|21072563|P1|NOT COMPLETED|Overall Study||70
8547337|NCT00168337|21072561|P3|COMPLETED|Overall Study||82
8547338|NCT00168337|21072562|P2|COMPLETED|Overall Study||112
8547339|NCT00168337|21072563|P1|COMPLETED|Overall Study||118
8547340|NCT00168337|21072561|P3|STARTED|Overall Study||185
8547341|NCT00168337|21072562|P2|STARTED|Overall Study||181
8547342|NCT00168337|21072563|P1|STARTED|Overall Study||188
8547343|NCT00168324|21072592|P3|NOT COMPLETED|Open-Label Period||6
8547344|NCT00168324|21072593|P2|NOT COMPLETED|Open-Label Period||8
8547345|NCT00168324|21072594|P1|NOT COMPLETED|Open-Label Period||4
8547346|NCT00168324|21072592|P3|COMPLETED|Open-Label Period||152
8547347|NCT00168324|21072593|P2|COMPLETED|Open-Label Period||147
8547348|NCT00168324|21072594|P1|COMPLETED|Open-Label Period||160
8547349|NCT00168324|21072592|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
8547350|NCT00168324|21072593|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
8547351|NCT00168324|21072594|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
8547352|NCT00168324|21072592|P3|NOT COMPLETED|Double-Blind Period||13
8547353|NCT00168324|21072593|P2|NOT COMPLETED|Double-Blind Period||7
8547354|NCT00168324|21072594|P1|NOT COMPLETED|Double-Blind Period||12
8547355|NCT00168324|21072592|P3|COMPLETED|Double-Blind Period||189
8547356|NCT00168324|21072593|P2|COMPLETED|Double-Blind Period||189
8547357|NCT00168324|21072594|P1|COMPLETED|Double-Blind Period||189
8547358|NCT00168324|21072592|P3|STARTED|Double-Blind Period||202
8547359|NCT00168324|21072593|P2|STARTED|Double-Blind Period||196
8547360|NCT00168324|21072594|P1|STARTED|Double-Blind Period||201
8547361|NCT00168311|21072616|P2|NOT COMPLETED|Overall Study||2
8547362|NCT00168311|21072617|P1|NOT COMPLETED|Overall Study||0
8547363|NCT00168311|21072616|P2|COMPLETED|Overall Study||8
8547364|NCT00168311|21072617|P1|COMPLETED|Overall Study||12
8547365|NCT00168311|21072616|P2|STARTED|Overall Study||10
8547366|NCT00168311|21072617|P1|STARTED|Overall Study||12
8547367|NCT00168298|21072626|P3|NOT COMPLETED|Open-Label Period||8
8547368|NCT00168298|21072627|P2|NOT COMPLETED|Open-Label Period||5
8547369|NCT00168298|21072628|P1|NOT COMPLETED|Open-Label Period||7
8547370|NCT00168298|21072626|P3|COMPLETED|Open-Label Period||160
8547371|NCT00168298|21072627|P2|COMPLETED|Open-Label Period||168
8547372|NCT00168298|21072628|P1|COMPLETED|Open-Label Period||172
8547373|NCT00168298|21072626|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
8547374|NCT00168298|21072627|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
8547375|NCT00168298|21072628|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
8547376|NCT00168298|21072626|P3|NOT COMPLETED|Double-Blind Period||15
8547377|NCT00168298|21072627|P2|NOT COMPLETED|Double-Blind Period||12
8547378|NCT00168298|21072628|P1|NOT COMPLETED|Double-Blind Period||12
8547379|NCT00168298|21072626|P3|COMPLETED|Double-Blind Period||209
8547380|NCT00168298|21072627|P2|COMPLETED|Double-Blind Period||206
8547381|NCT00168298|21072628|P1|COMPLETED|Double-Blind Period||214
8547382|NCT00168298|21072626|P3|STARTED|Double-Blind Period||224
8547383|NCT00168298|21072627|P2|STARTED|Double-Blind Period||218
8547384|NCT00168298|21072628|P1|STARTED|Double-Blind Period||226
8547385|NCT00168103|21072648|P4|NOT COMPLETED|Overall Study||0
8547386|NCT00168103|21072649|P3|NOT COMPLETED|Overall Study||1
8547387|NCT00168103|21072650|P2|NOT COMPLETED|Overall Study||5
8547388|NCT00168103|21072651|P1|NOT COMPLETED|Overall Study||2
8547389|NCT00168103|21072648|P4|COMPLETED|Overall Study||1
8547390|NCT00168103|21072649|P3|COMPLETED|Overall Study||41
8547391|NCT00168103|21072650|P2|COMPLETED|Overall Study||38
8547392|NCT00168103|21072651|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
8547393|NCT00168103|21072648|P4|STARTED|Overall Study||1
8547394|NCT00168103|21072649|P3|STARTED|Overall Study||42
8547395|NCT00168103|21072650|P2|STARTED|Overall Study||43
8547396|NCT00168103|21072651|P1|STARTED|Overall Study||40
8547397|NCT00168064|21072673|P2|NOT COMPLETED|Overall Study||44
8547398|NCT00168064|21072674|P1|NOT COMPLETED|Overall Study||49
8547399|NCT00168064|21072673|P2|COMPLETED|Overall Study||86
8547400|NCT00168064|21072674|P1|COMPLETED|Overall Study||81
8547401|NCT00168064|21072673|P2|STARTED|Overall Study|127 participants received AP formulation|130
8547402|NCT00168064|21072674|P1|STARTED|Overall Study|128 participants received PG formulation|130
8547403|NCT00168038|21072682|P1|NOT COMPLETED|Overall Study||2
8547404|NCT00168038|21072682|P1|COMPLETED|Overall Study||55
8547405|NCT00168038|21072682|P1|STARTED|Overall Study||57
8547406|NCT00167934|21072696|P2|NOT COMPLETED|Overall Study||0
8547407|NCT00167934|21072697|P1|NOT COMPLETED|Overall Study||0
8547408|NCT00167934|21072696|P2|COMPLETED|Overall Study||82
8547409|NCT00167934|21072697|P1|COMPLETED|Overall Study||82
8547410|NCT00167934|21072696|P2|STARTED|Overall Study||82
8547411|NCT00167934|21072697|P1|STARTED|Overall Study||82
8547412|NCT00167778|21072705|P1|NOT COMPLETED|Overall Study||1
8547413|NCT00167778|21072705|P1|COMPLETED|Overall Study||10
8547414|NCT00167778|21072705|P1|STARTED|Overall Study||11
8547415|NCT00167661|21072754|P1|NOT COMPLETED|Overall Study||0
8547416|NCT00167661|21072754|P1|COMPLETED|Overall Study||33
8547417|NCT00167661|21072754|P1|STARTED|Overall Study||33
8547418|NCT00167544|21072769|P2|NOT COMPLETED|Overall Study||0
8547419|NCT00167544|21072770|P1|NOT COMPLETED|Overall Study||1
8547420|NCT00167544|21072769|P2|COMPLETED|Overall Study||33
8547421|NCT00167544|21072770|P1|COMPLETED|Overall Study||30
8547422|NCT00167544|21072769|P2|STARTED|Overall Study||33
8547423|NCT00167544|21072770|P1|STARTED|Overall Study||31
8547424|NCT00167414|21072784|P1|NOT COMPLETED|Overall Study||10
8547425|NCT00167414|21072784|P1|COMPLETED|Overall Study||39
8547426|NCT00167414|21072784|P1|STARTED|Overall Study||49
8547427|NCT00167388|21072796|P4|NOT COMPLETED|Overall Study||0
8547428|NCT00167388|21072797|P3|NOT COMPLETED|Overall Study||0
8547429|NCT00167388|21072798|P2|NOT COMPLETED|Overall Study||0
8547430|NCT00167388|21072799|P1|NOT COMPLETED|Overall Study||0
8547431|NCT00167388|21072796|P4|COMPLETED|Overall Study||6
8547432|NCT00167388|21072797|P3|COMPLETED|Overall Study||6
8547433|NCT00167388|21072798|P2|COMPLETED|Overall Study||5
8547434|NCT00167388|21072799|P1|COMPLETED|Overall Study||5
8547435|NCT00167388|21072796|P4|Completed Doppler Study|Overall Study||6
8547436|NCT00167388|21072797|P3|Completed Doppler Study|Overall Study||6
8547437|NCT00167388|21072798|P2|Completed Doppler Study|Overall Study||5
8547438|NCT00167388|21072799|P1|Completed Doppler Study|Overall Study||5
8547439|NCT00167388|21072796|P4|STARTED|Overall Study||6
8547440|NCT00167388|21072797|P3|STARTED|Overall Study||6
8547441|NCT00167388|21072798|P2|STARTED|Overall Study||5
8547442|NCT00167388|21072799|P1|STARTED|Overall Study||5
8547443|NCT00167310|21072809|P2|NOT COMPLETED|Overall Study||10
8547444|NCT00167310|21072810|P1|NOT COMPLETED|Overall Study||8
8547445|NCT00167310|21072809|P2|COMPLETED|Overall Study||18
8547446|NCT00167310|21072810|P1|COMPLETED|Overall Study||21
8547447|NCT00167310|21072809|P2|STARTED|Overall Study||28
8547448|NCT00167310|21072810|P1|STARTED|Overall Study||29
8547449|NCT00167245|21072820|P2|NOT COMPLETED|Overall Study||41
8547450|NCT00167245|21072821|P1|NOT COMPLETED|Overall Study||29
8547451|NCT00167245|21072820|P2|COMPLETED|Overall Study||46
8547452|NCT00167245|21072821|P1|COMPLETED|Overall Study||54
8547453|NCT00167245|21072820|P2|STARTED|Overall Study||87
8547454|NCT00167245|21072821|P1|STARTED|Overall Study||83
8547455|NCT00167206|21072833|P1|NOT COMPLETED|Overall Study||0
8547456|NCT00167206|21072833|P1|COMPLETED|Overall Study||16
8547457|NCT00167206|21072833|P1|STARTED|Overall Study||16
8547458|NCT00167180|21072847|P2|NOT COMPLETED|Overall Study||0
8547459|NCT00167180|21072848|P1|NOT COMPLETED|Overall Study||0
8547460|NCT00167180|21072847|P2|COMPLETED|Overall Study||57
8547461|NCT00167180|21072848|P1|COMPLETED|Overall Study||0
8547462|NCT00167180|21072847|P2|STARTED|Overall Study||57
8547463|NCT00167180|21072848|P1|STARTED|Overall Study||0
8547464|NCT00167102|21072864|P2|NOT COMPLETED|Overall Study||0
8547465|NCT00167102|21072865|P1|NOT COMPLETED|Overall Study||0
8547466|NCT00167102|21072864|P2|COMPLETED|Overall Study||22
8547467|NCT00167102|21072865|P1|COMPLETED|Overall Study||23
8547468|NCT00167102|21072864|P2|STARTED|Overall Study||22
8547469|NCT00167102|21072865|P1|STARTED|Overall Study||23
8547470|NCT00166712|21072875|P2|NOT COMPLETED|Overall Study||5
8547471|NCT00166712|21072876|P1|NOT COMPLETED|Overall Study||2
8547472|NCT00166712|21072875|P2|COMPLETED|Overall Study|Completed study participation.|11
8547473|NCT00166712|21072876|P1|COMPLETED|Overall Study|Completed study participation.|22
8547474|NCT00166712|21072875|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
8547475|NCT00166712|21072876|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
8547476|NCT00166712|21072875|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
8547477|NCT00166712|21072876|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
8547478|NCT00166712|21072875|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
8547479|NCT00166712|21072876|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
8547480|NCT00166712|21072875|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
8547481|NCT00166712|21072876|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
8547482|NCT00166712|21072875|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
8547483|NCT00166712|21072876|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
8547484|NCT00166517|21072893|P2|NOT COMPLETED|Overall Study||2
8547485|NCT00166517|21072894|P1|NOT COMPLETED|Overall Study||5
8547486|NCT00166517|21072893|P2|COMPLETED|Overall Study||61
8547487|NCT00166517|21072894|P1|COMPLETED|Overall Study||110
8547488|NCT00166517|21072893|P2|Vaccinated at Visit 3|Overall Study||61
8547489|NCT00166517|21072894|P1|Vaccinated at Visit 3|Overall Study||110
8547490|NCT00166517|21072893|P2|Vaccinated at Visit 2|Overall Study||61
8547491|NCT00166517|21072894|P1|Vaccinated at Visit 2|Overall Study||112
8547492|NCT00166517|21072893|P2|Vaccinated at Visit 1|Overall Study||63
8547493|NCT00166517|21072894|P1|Vaccinated at Visit 1|Overall Study||115
8547494|NCT00166517|21072893|P2|STARTED|Overall Study||63
8547495|NCT00166517|21072894|P1|STARTED|Overall Study||115
8547496|NCT00166504|21072904|P2|NOT COMPLETED|Overall Study||4
8547497|NCT00166504|21072905|P1|NOT COMPLETED|Overall Study||5
8547498|NCT00166504|21072904|P2|COMPLETED|Overall Study||91
8547499|NCT00166504|21072905|P1|COMPLETED|Overall Study||103
8547500|NCT00166504|21072904|P2|STARTED|Overall Study||95
8547501|NCT00166504|21072905|P1|STARTED|Overall Study||108
8547502|NCT00166439|21072911|P1|NOT COMPLETED|Overall Study||5
8547503|NCT00166439|21072911|P1|COMPLETED|Overall Study||45
8547504|NCT00166439|21072911|P1|STARTED|Overall Study||50
8547505|NCT00166361|21072919|P2|NOT COMPLETED|Overall Study||0
8547506|NCT00166361|21072920|P1|NOT COMPLETED|Overall Study||0
8547507|NCT00166361|21072919|P2|COMPLETED|Overall Study||10
8547508|NCT00166361|21072920|P1|COMPLETED|Overall Study||14
8547509|NCT00166361|21072919|P2|STARTED|Overall Study||10
8547510|NCT00166361|21072920|P1|STARTED|Overall Study||14
8547511|NCT00166296|21072928|P2|NOT COMPLETED|Overall Study||9
8547512|NCT00166296|21072929|P1|NOT COMPLETED|Overall Study||7
8547513|NCT00166296|21072928|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
8547514|NCT00166296|21072929|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
8547515|NCT00166296|21072928|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
8547516|NCT00166296|21072929|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
8547517|NCT00166296|21072928|P2|STARTED|Overall Study|Randomized patients|66
8547518|NCT00166296|21072929|P1|STARTED|Overall Study|Randomized patients|67
8547519|NCT00166205|21072941|P1|NOT COMPLETED|Overall Study||48
8547520|NCT00166205|21072941|P1|COMPLETED|Overall Study||228
8547521|NCT00166205|21072941|P1|Intervention - SAGB Surgery|Overall Study||276
8547522|NCT00166205|21072941|P1|STARTED|Overall Study||276
8547523|NCT00166166|21072957|P2|NOT COMPLETED|Overall Study||0
8547524|NCT00166166|21072958|P1|NOT COMPLETED|Overall Study||0
8547525|NCT00166166|21072957|P2|COMPLETED|Overall Study||71
8547526|NCT00166166|21072958|P1|COMPLETED|Overall Study||103
8547527|NCT00166166|21072957|P2|STARTED|Overall Study||71
8547528|NCT00166166|21072958|P1|STARTED|Overall Study||103
8547529|NCT00166114|21072981|P2|NOT COMPLETED|Overall Study||6
8547530|NCT00166114|21072982|P1|NOT COMPLETED|Overall Study||14
8547531|NCT00166114|21072981|P2|COMPLETED|Overall Study||13
8547532|NCT00166114|21072982|P1|COMPLETED|Overall Study||7
8547533|NCT00166114|21072981|P2|STARTED|Overall Study||19
8547534|NCT00166114|21072982|P1|STARTED|Overall Study||21
8547535|NCT00166036|21072990|P2|NOT COMPLETED|Overall Study||0
8547536|NCT00166036|21072991|P1|NOT COMPLETED|Overall Study||0
8547537|NCT00166036|21072990|P2|COMPLETED|Overall Study||19
8547538|NCT00166036|21072991|P1|COMPLETED|Overall Study||17
8547539|NCT00166036|21072990|P2|STARTED|Overall Study||19
8547540|NCT00166036|21072991|P1|STARTED|Overall Study||17
8547541|NCT00165984|21072999|P1|NOT COMPLETED|Overall Study||15
8547542|NCT00165984|21072999|P1|COMPLETED|Overall Study||150
8547543|NCT00165984|21072999|P1|STARTED|Overall Study||165
8547544|NCT00165958|21073008|P2|NOT COMPLETED|Overall Study||2
8547545|NCT00165958|21073009|P1|NOT COMPLETED|Overall Study||1
8547546|NCT00165958|21073008|P2|COMPLETED|Overall Study||19
8547547|NCT00165958|21073009|P1|COMPLETED|Overall Study||18
8547548|NCT00165958|21073008|P2|STARTED|Overall Study||21
8547549|NCT00165958|21073009|P1|STARTED|Overall Study||19
8547550|NCT00165841|21073017|P2|NOT COMPLETED|Overall Study||62
8547551|NCT00165841|21073018|P1|NOT COMPLETED|Overall Study||30
8547552|NCT00165841|21073017|P2|COMPLETED|Overall Study||35
8547553|NCT00165841|21073018|P1|COMPLETED|Overall Study||73
8547554|NCT00165841|21073017|P2|STARTED|Overall Study||97
8547555|NCT00165841|21073018|P1|STARTED|Overall Study||103
8547556|NCT00165789|21073028|P4|NOT COMPLETED|Overall Study||14
8547557|NCT00165789|21073029|P3|NOT COMPLETED|Overall Study||1
8547558|NCT00165789|21073030|P2|NOT COMPLETED|Overall Study||4
8547559|NCT00165789|21073031|P1|NOT COMPLETED|Overall Study||0
8547560|NCT00165789|21073028|P4|COMPLETED|Overall Study||21
8547561|NCT00165789|21073029|P3|COMPLETED|Overall Study||11
8547562|NCT00165789|21073030|P2|COMPLETED|Overall Study||16
8547563|NCT00165789|21073031|P1|COMPLETED|Overall Study||8
8547564|NCT00165789|21073028|P4|STARTED|Overall Study||35
8547565|NCT00165789|21073029|P3|STARTED|Overall Study||12
8547566|NCT00165789|21073030|P2|STARTED|Overall Study||20
8547567|NCT00165789|21073031|P1|STARTED|Overall Study||8
8547568|NCT00165776|21073085|P4|NOT COMPLETED|Overall Study||2
8547569|NCT00165776|21073086|P3|NOT COMPLETED|Overall Study||2
8547570|NCT00165776|21073087|P2|NOT COMPLETED|Overall Study||1
8547571|NCT00165776|21073088|P1|NOT COMPLETED|Overall Study||4
8547572|NCT00165776|21073085|P4|COMPLETED|Overall Study||29
8547573|NCT00165776|21073086|P3|COMPLETED|Overall Study||31
8547574|NCT00165776|21073087|P2|COMPLETED|Overall Study||33
8547575|NCT00165776|21073088|P1|COMPLETED|Overall Study||31
8547576|NCT00165776|21073085|P4|STARTED|Overall Study||31
8547577|NCT00165776|21073086|P3|STARTED|Overall Study||33
8547578|NCT00165776|21073087|P2|STARTED|Overall Study||34
8547579|NCT00165776|21073088|P1|STARTED|Overall Study||35
8547580|NCT00165698|21073124|P2|NOT COMPLETED|Overall Study||15
8547581|NCT00165698|21073125|P1|NOT COMPLETED|Overall Study||8
8547582|NCT00165698|21073124|P2|COMPLETED|Overall Study||105
8547583|NCT00165698|21073125|P1|COMPLETED|Overall Study||112
8547584|NCT00165698|21073124|P2|STARTED|Overall Study||120
8547585|NCT00165698|21073125|P1|STARTED|Overall Study||120
8547586|NCT00165672|21073151|P2|NOT COMPLETED|Overall Study||1
8547587|NCT00165672|21073152|P1|NOT COMPLETED|Overall Study||0
8547588|NCT00165672|21073151|P2|COMPLETED|Overall Study||12
8547589|NCT00165672|21073152|P1|COMPLETED|Overall Study||13
8547590|NCT00165672|21073151|P2|STARTED|Overall Study||13
8547591|NCT00165672|21073152|P1|STARTED|Overall Study||13
8547592|NCT00165646|21073161|P3|NOT COMPLETED|Overall Study||4
8547593|NCT00165646|21073162|P2|NOT COMPLETED|Overall Study||5
8547594|NCT00165646|21073163|P1|NOT COMPLETED|Overall Study||5
8547595|NCT00165646|21073161|P3|COMPLETED|Overall Study||98
8547596|NCT00165646|21073162|P2|COMPLETED|Overall Study||88
8547597|NCT00165646|21073163|P1|COMPLETED|Overall Study||88
8547598|NCT00165646|21073161|P3|STARTED|Overall Study||102
8547599|NCT00165646|21073162|P2|STARTED|Overall Study||93
8547600|NCT00165646|21073163|P1|STARTED|Overall Study||93
8547601|NCT00165503|21073171|P1|NOT COMPLETED|Overall Study||16
8547602|NCT00165503|21073171|P1|COMPLETED|Overall Study||0
8547603|NCT00165503|21073171|P1|STARTED|Overall Study||16
8547604|NCT00163657|21073178|P3|NOT COMPLETED|Overall Study||37
8547605|NCT00163657|21073179|P2|NOT COMPLETED|Overall Study||23
8547606|NCT00163657|21073180|P1|NOT COMPLETED|Overall Study||20
8547607|NCT00163657|21073178|P3|COMPLETED|Overall Study||116
8547608|NCT00163657|21073179|P2|COMPLETED|Overall Study||56
8547609|NCT00163657|21073180|P1|COMPLETED|Overall Study||60
8547610|NCT00163657|21073178|P3|STARTED|Overall Study||153
8547611|NCT00163657|21073179|P2|STARTED|Overall Study||79
8547612|NCT00163657|21073180|P1|STARTED|Overall Study||80
8547613|NCT00163293|21073194|P3|NOT COMPLETED|Overall Study||19
8547614|NCT00163293|21073195|P2|NOT COMPLETED|Overall Study||7
8547615|NCT00163293|21073196|P1|NOT COMPLETED|Overall Study||13
8547616|NCT00163293|21073194|P3|COMPLETED|Overall Study||66
8547617|NCT00163293|21073195|P2|COMPLETED|Overall Study||69
8547618|NCT00163293|21073196|P1|COMPLETED|Overall Study||66
8547619|NCT00163293|21073194|P3|STARTED|Overall Study||85
8547620|NCT00163293|21073195|P2|STARTED|Overall Study||76
8547621|NCT00163293|21073196|P1|STARTED|Overall Study||79
8547622|NCT00163215|21073270|P1|NOT COMPLETED|Overall Study||15
8547623|NCT00163215|21073270|P1|COMPLETED|Overall Study||31
8547624|NCT00163215|21073270|P1|STARTED|Overall Study||46
8547625|NCT00163189|21073290|P1|NOT COMPLETED|Overall Study||63
8547626|NCT00163189|21073290|P1|COMPLETED|Overall Study||35
8547627|NCT00163189|21073290|P1|STARTED|Overall Study||98
8547628|NCT00163020|21073314|P2|NOT COMPLETED|Overall Study||2
8547629|NCT00163020|21073315|P1|NOT COMPLETED|Overall Study||0
8547630|NCT00163020|21073314|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
8547631|NCT00163020|21073315|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
8547632|NCT00163020|21073314|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
8547633|NCT00163020|21073315|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
8547634|NCT00162981|21073355|P2|NOT COMPLETED|Overall Study||6
8547635|NCT00162981|21073356|P1|NOT COMPLETED|Overall Study||4
8547636|NCT00162981|21073355|P2|COMPLETED|Overall Study||30
8547637|NCT00162981|21073356|P1|COMPLETED|Overall Study||28
8547638|NCT00162981|21073355|P2|STARTED|Overall Study||36
8547639|NCT00162981|21073356|P1|STARTED|Overall Study||32
8547640|NCT00162942|21073372|P2|NOT COMPLETED|Overall Study||52
8547641|NCT00162942|21073373|P1|NOT COMPLETED|Overall Study||106
8547642|NCT00162942|21073372|P2|COMPLETED|Overall Study||26
8547643|NCT00162942|21073373|P1|COMPLETED|Overall Study||51
8547644|NCT00162942|21073372|P2|Week 12|Overall Study||61
8547645|NCT00162942|21073373|P1|Week 12|Overall Study||127
8547646|NCT00162942|21073372|P2|STARTED|Overall Study||78
8547647|NCT00162942|21073373|P1|STARTED|Overall Study||157
8547648|NCT00162773|21073421|P1|NOT COMPLETED|Overall Study||22
8547649|NCT00162773|21073421|P1|COMPLETED|Overall Study||7
8547650|NCT00162773|21073421|P1|STARTED|Overall Study||29
8547651|NCT00162370|21073425|P1|NOT COMPLETED|Efficacy Population||51
8547652|NCT00162370|21073425|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
8547653|NCT00162370|21073425|P1|STARTED|Efficacy Population||366
8547654|NCT00162370|21073425|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
8547655|NCT00162370|21073425|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
8547656|NCT00162370|21073425|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
8547657|NCT00162266|21073433|P4|NOT COMPLETED|Open-Label Period||137
8547658|NCT00162266|21073434|P3|NOT COMPLETED|Open-Label Period||0
8547659|NCT00162266|21073435|P2|NOT COMPLETED|Open-Label Period||0
8547660|NCT00162266|21073436|P1|NOT COMPLETED|Open-Label Period||0
8547661|NCT00162266|21073433|P4|COMPLETED|Open-Label Period||82
8547662|NCT00162266|21073434|P3|COMPLETED|Open-Label Period||0
8547663|NCT00162266|21073435|P2|COMPLETED|Open-Label Period||0
8547664|NCT00162266|21073436|P1|COMPLETED|Open-Label Period||0
8547665|NCT00162266|21073433|P4|STARTED|Open-Label Period||219
8547666|NCT00162266|21073434|P3|STARTED|Open-Label Period||0
8547667|NCT00162266|21073435|P2|STARTED|Open-Label Period||0
8547668|NCT00162266|21073436|P1|STARTED|Open-Label Period||0
8547669|NCT00162266|21073433|P4|NOT COMPLETED|Double-Blind Period||0
8547670|NCT00162266|21073434|P3|NOT COMPLETED|Double-Blind Period||48
8547671|NCT00162266|21073435|P2|NOT COMPLETED|Double-Blind Period||31
8547672|NCT00162266|21073436|P1|NOT COMPLETED|Double-Blind Period||25
8547673|NCT00162266|21073433|P4|COMPLETED|Double-Blind Period||0
8547674|NCT00162266|21073434|P3|COMPLETED|Double-Blind Period||71
8547675|NCT00162266|21073435|P2|COMPLETED|Double-Blind Period||74
8547676|NCT00162266|21073436|P1|COMPLETED|Double-Blind Period||90
8547677|NCT00162266|21073433|P4|Completed Day 1 to Day 181|Double-Blind Period||0
8547678|NCT00162266|21073434|P3|Completed Day 1 to Day 181|Double-Blind Period||78
8547679|NCT00162266|21073435|P2|Completed Day 1 to Day 181|Double-Blind Period||80
8547680|NCT00162266|21073436|P1|Completed Day 1 to Day 181|Double-Blind Period||98
8547681|NCT00162266|21073433|P4|STARTED|Double-Blind Period||0
8547682|NCT00162266|21073434|P3|STARTED|Double-Blind Period||119
8547683|NCT00162266|21073435|P2|STARTED|Double-Blind Period||105
8547684|NCT00162266|21073436|P1|STARTED|Double-Blind Period||115
8547685|NCT00162136|21073637|P1|NOT COMPLETED|Overall Study||35
8547686|NCT00162136|21073637|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
8547687|NCT00162136|21073637|P1|STARTED|Overall Study||35
8547688|NCT00162123|21073669|P8|NOT COMPLETED|Overall Study||58
8547689|NCT00162123|21073670|P7|NOT COMPLETED|Overall Study||4
8547690|NCT00162123|21073671|P6|NOT COMPLETED|Overall Study||9
8547691|NCT00162123|21073672|P5|NOT COMPLETED|Overall Study||31
8547692|NCT00162123|21073673|P4|NOT COMPLETED|Overall Study||8
8547693|NCT00162123|21073674|P3|NOT COMPLETED|Overall Study||21
8547694|NCT00162123|21073675|P2|NOT COMPLETED|Overall Study||29
8547695|NCT00162123|21073676|P1|NOT COMPLETED|Overall Study||44
8547696|NCT00162123|21073669|P8|COMPLETED|Overall Study|Still on treatment|0
8547697|NCT00162123|21073670|P7|COMPLETED|Overall Study|Still on treatment|0
8547698|NCT00162123|21073671|P6|COMPLETED|Overall Study|Still on treatment|4
8547699|NCT00162123|21073672|P5|COMPLETED|Overall Study|Still on treatment|14
8547700|NCT00162123|21073673|P4|COMPLETED|Overall Study|Still on treatment|3
8547701|NCT00162123|21073674|P3|COMPLETED|Overall Study|Still on treatment|3
8547702|NCT00162123|21073675|P2|COMPLETED|Overall Study|Still on treatment|5
8547703|NCT00162123|21073676|P1|COMPLETED|Overall Study|Still on treatment|9
8547704|NCT00162123|21073669|P8|Received Treatment|Overall Study||0
8547705|NCT00162123|21073670|P7|Received Treatment|Overall Study||4
8547706|NCT00162123|21073671|P6|Received Treatment|Overall Study||12
8547707|NCT00162123|21073672|P5|Received Treatment|Overall Study||33
8547708|NCT00162123|21073673|P4|Received Treatment|Overall Study||11
8547709|NCT00162123|21073674|P3|Received Treatment|Overall Study||24
8547710|NCT00162123|21073675|P2|Received Treatment|Overall Study||34
8547711|NCT00162123|21073676|P1|Received Treatment|Overall Study||53
8547712|NCT00162123|21073669|P8|STARTED|Overall Study|Enrolled|58
8547713|NCT00162123|21073670|P7|STARTED|Overall Study|Enrolled|4
8547714|NCT00162123|21073671|P6|STARTED|Overall Study|Enrolled|13
8547715|NCT00162123|21073672|P5|STARTED|Overall Study|Enrolled|45
8547716|NCT00162123|21073673|P4|STARTED|Overall Study|Enrolled|11
8547717|NCT00162123|21073674|P3|STARTED|Overall Study|Enrolled|24
8547718|NCT00162123|21073675|P2|STARTED|Overall Study|Enrolled|34
8547719|NCT00162123|21073676|P1|STARTED|Overall Study|Enrolled|53
8547720|NCT00162097|21073709|P4|NOT COMPLETED|Overall Study||1
8547721|NCT00162097|21073710|P3|NOT COMPLETED|Overall Study||0
8547722|NCT00162097|21073711|P2|NOT COMPLETED|Overall Study||0
8547723|NCT00162097|21073712|P1|NOT COMPLETED|Overall Study||0
8547724|NCT00162097|21073709|P4|COMPLETED|Overall Study||6
8547725|NCT00162097|21073710|P3|COMPLETED|Overall Study||1
8547726|NCT00162097|21073711|P2|COMPLETED|Overall Study||2
8547727|NCT00162097|21073712|P1|COMPLETED|Overall Study||6
8547728|NCT00162097|21073709|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
8547729|NCT00162097|21073710|P3|STARTED|Overall Study|Treated on Day 1|1
8547730|NCT00162097|21073711|P2|STARTED|Overall Study|Treated on Day 1|2
8547731|NCT00162097|21073712|P1|STARTED|Overall Study|Treated on Day 1|6
8547732|NCT00162032|21073774|P2|NOT COMPLETED|Overall Study||2
8547733|NCT00162032|21073775|P1|NOT COMPLETED|Overall Study||5
8547734|NCT00162032|21073774|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
8547735|NCT00162032|21073775|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
8547736|NCT00162032|21073774|P2|STARTED|Overall Study||116
8547737|NCT00162032|21073775|P1|STARTED|Overall Study||329
8547738|NCT00161616|21073796|P2|NOT COMPLETED|Overall Study||19
8547739|NCT00161616|21073797|P1|NOT COMPLETED|Overall Study||26
8547740|NCT00161616|21073796|P2|COMPLETED|Overall Study||119
8547741|NCT00161616|21073797|P1|COMPLETED|Overall Study||113
8547742|NCT00161616|21073796|P2|STARTED|Overall Study||138
8547743|NCT00161616|21073797|P1|STARTED|Overall Study||139
8547744|NCT00161473|21073807|P2|NOT COMPLETED|Overall Study||6
8547745|NCT00161473|21073808|P1|NOT COMPLETED|Overall Study||5
8547746|NCT00161473|21073807|P2|COMPLETED|Overall Study||6
8547747|NCT00161473|21073808|P1|COMPLETED|Overall Study||7
8547748|NCT00161473|21073807|P2|STARTED|Overall Study||12
8547749|NCT00161473|21073808|P1|STARTED|Overall Study||12
8547750|NCT00161382|21073822|P2|NOT COMPLETED|Overall Study||289
8547751|NCT00161382|21073823|P1|NOT COMPLETED|Overall Study||249
8547752|NCT00161382|21073822|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
8547753|NCT00161382|21073823|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
8547754|NCT00161382|21073822|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
8547755|NCT00161382|21073823|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
8547756|NCT00161213|21073829|P1|NOT COMPLETED|Overall Study||2
8547757|NCT00161213|21073829|P1|COMPLETED|Overall Study||42
8547758|NCT00161213|21073829|P1|STARTED|Overall Study||44
8547759|NCT00160706|21073836|P1|NOT COMPLETED|Overall Study||286
8547760|NCT00160706|21073836|P1|COMPLETED|Overall Study||24
8547761|NCT00160706|21073836|P1|STARTED|Overall Study||310
8547762|NCT00160693|21073848|P1|NOT COMPLETED|Overall Study||235
8547763|NCT00160693|21073848|P1|COMPLETED|Overall Study||167
8547764|NCT00160693|21073848|P1|STARTED|Overall Study||402
8547765|NCT00160680|21073867|P2|NOT COMPLETED|Overall Study||13
8547766|NCT00160680|21073868|P1|NOT COMPLETED|Overall Study||9
8547767|NCT00160680|21073867|P2|COMPLETED|Overall Study||18
8547768|NCT00160680|21073868|P1|COMPLETED|Overall Study||22
8547769|NCT00160680|21073867|P2|STARTED|Overall Study||31
8547770|NCT00160680|21073868|P1|STARTED|Overall Study||31
8547771|NCT00160667|21073903|P3|NOT COMPLETED|Overall Study||6
8547772|NCT00160667|21073904|P2|NOT COMPLETED|Overall Study||3
8547773|NCT00160667|21073905|P1|NOT COMPLETED|Overall Study||5
8547774|NCT00160667|21073903|P3|COMPLETED|Overall Study||45
8547775|NCT00160667|21073904|P2|COMPLETED|Overall Study||48
8547776|NCT00160667|21073905|P1|COMPLETED|Overall Study||45
8547777|NCT00160667|21073903|P3|STARTED|Overall Study||51
8547778|NCT00160667|21073904|P2|STARTED|Overall Study||51
8547779|NCT00160667|21073905|P1|STARTED|Overall Study||50
8547780|NCT00160654|21073952|P1|NOT COMPLETED|Overall Study||33
8547781|NCT00160654|21073952|P1|COMPLETED|Overall Study||218
8547782|NCT00160654|21073952|P1|STARTED|Overall Study||251
8547783|NCT00160641|21073962|P1|NOT COMPLETED|Overall Study||221
8547784|NCT00160641|21073962|P1|COMPLETED|Overall Study||346
8547785|NCT00160641|21073962|P1|STARTED|Overall Study||567
8547786|NCT00160615|21073995|P2|NOT COMPLETED|Overall Study||45
8547787|NCT00160615|21073996|P1|NOT COMPLETED|Overall Study||18
8547788|NCT00160615|21073995|P2|COMPLETED|Overall Study||56
8547789|NCT00160615|21073996|P1|COMPLETED|Overall Study||32
8547790|NCT00160615|21073995|P2|STARTED|Overall Study||101
8547791|NCT00160615|21073996|P1|STARTED|Overall Study||50
8547792|NCT00160563|21074019|P3|NOT COMPLETED|Overall Study||90
8547793|NCT00160563|21074020|P2|NOT COMPLETED|Overall Study||45
8547794|NCT00160563|21074021|P1|NOT COMPLETED|Overall Study||51
8547795|NCT00160563|21074019|P3|COMPLETED|Overall Study||11
8547796|NCT00160563|21074020|P2|COMPLETED|Overall Study||2
8547797|NCT00160563|21074021|P1|COMPLETED|Overall Study||8
8547798|NCT00160563|21074019|P3|STARTED|Overall Study||101
8547799|NCT00160563|21074020|P2|STARTED|Overall Study||47
8547800|NCT00160563|21074021|P1|STARTED|Overall Study||59
8547801|NCT00160524|21074033|P1|NOT COMPLETED|Overall Study||478
8547802|NCT00160524|21074033|P1|COMPLETED|Overall Study||117
8547803|NCT00160524|21074033|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
8547804|NCT00160251|21074050|P8|NOT COMPLETED|Post-amendment 2||55
8547805|NCT00160251|21074051|P7|NOT COMPLETED|Post-amendment 2||0
8547806|NCT00160251|21074052|P6|NOT COMPLETED|Post-amendment 2||0
8547807|NCT00160251|21074053|P5|NOT COMPLETED|Post-amendment 2||0
8547808|NCT00160251|21074054|P4|NOT COMPLETED|Post-amendment 2||0
8547809|NCT00160251|21074055|P3|NOT COMPLETED|Post-amendment 2||0
8547810|NCT00160251|21074056|P2|NOT COMPLETED|Post-amendment 2||0
8547811|NCT00160251|21074057|P1|NOT COMPLETED|Post-amendment 2||0
8547812|NCT00160251|21074050|P8|COMPLETED|Post-amendment 2||88
8547813|NCT00160251|21074051|P7|COMPLETED|Post-amendment 2||0
8547814|NCT00160251|21074052|P6|COMPLETED|Post-amendment 2||0
8547815|NCT00160251|21074053|P5|COMPLETED|Post-amendment 2||0
8547816|NCT00160251|21074054|P4|COMPLETED|Post-amendment 2||0
8547817|NCT00160251|21074055|P3|COMPLETED|Post-amendment 2||0
8547818|NCT00160251|21074056|P2|COMPLETED|Post-amendment 2||0
8547819|NCT00160251|21074057|P1|COMPLETED|Post-amendment 2||0
8547820|NCT00160251|21074050|P8|STARTED|Post-amendment 2||143
8547821|NCT00160251|21074051|P7|STARTED|Post-amendment 2||0
8547822|NCT00160251|21074052|P6|STARTED|Post-amendment 2||0
8547823|NCT00160251|21074053|P5|STARTED|Post-amendment 2||0
8547824|NCT00160251|21074054|P4|STARTED|Post-amendment 2||0
8547825|NCT00160251|21074055|P3|STARTED|Post-amendment 2||0
8547826|NCT00160251|21074056|P2|STARTED|Post-amendment 2||0
8547827|NCT00160251|21074057|P1|STARTED|Post-amendment 2||0
8547828|NCT00160251|21074050|P8|NOT COMPLETED|Prior to Amendment 2||0
8547829|NCT00160251|21074051|P7|NOT COMPLETED|Prior to Amendment 2||4
8547830|NCT00160251|21074052|P6|NOT COMPLETED|Prior to Amendment 2||83
8547831|NCT00160251|21074053|P5|NOT COMPLETED|Prior to Amendment 2||28
8547832|NCT00160251|21074054|P4|NOT COMPLETED|Prior to Amendment 2||40
8547833|NCT00160251|21074055|P3|NOT COMPLETED|Prior to Amendment 2||44
8547834|NCT00160251|21074056|P2|NOT COMPLETED|Prior to Amendment 2||6
8547835|NCT00160251|21074057|P1|NOT COMPLETED|Prior to Amendment 2||9
8547836|NCT00160251|21074050|P8|COMPLETED|Prior to Amendment 2||0
8547837|NCT00160251|21074051|P7|COMPLETED|Prior to Amendment 2||61
8547838|NCT00160251|21074052|P6|COMPLETED|Prior to Amendment 2||14
8547839|NCT00160251|21074053|P5|COMPLETED|Prior to Amendment 2||21
8547840|NCT00160251|21074054|P4|COMPLETED|Prior to Amendment 2||9
8547841|NCT00160251|21074055|P3|COMPLETED|Prior to Amendment 2||4
8547842|NCT00160251|21074056|P2|COMPLETED|Prior to Amendment 2||28
8547843|NCT00160251|21074057|P1|COMPLETED|Prior to Amendment 2||6
8547844|NCT00160251|21074050|P8|STARTED|Prior to Amendment 2||0
8547845|NCT00160251|21074051|P7|STARTED|Prior to Amendment 2||65
8547846|NCT00160251|21074052|P6|STARTED|Prior to Amendment 2||97
8547847|NCT00160251|21074053|P5|STARTED|Prior to Amendment 2||49
8547848|NCT00160251|21074054|P4|STARTED|Prior to Amendment 2||49
8547849|NCT00160251|21074055|P3|STARTED|Prior to Amendment 2||48
8547850|NCT00160251|21074056|P2|STARTED|Prior to Amendment 2||34
8547851|NCT00160251|21074057|P1|STARTED|Prior to Amendment 2||15
8547852|NCT00160199|21074133|P2|NOT COMPLETED|Overall Study||37
8547853|NCT00160199|21074134|P1|NOT COMPLETED|Overall Study||24
8547854|NCT00160199|21074133|P2|COMPLETED|Overall Study||81
8547855|NCT00160199|21074134|P1|COMPLETED|Overall Study||98
8547856|NCT00160199|21074133|P2|STARTED|Overall Study||118
8547857|NCT00160199|21074134|P1|STARTED|Overall Study||122
8547858|NCT00159965|21074154|P2|NOT COMPLETED|Overall Study||5
8547859|NCT00159965|21074155|P1|NOT COMPLETED|Overall Study||7
8547860|NCT00159965|21074154|P2|COMPLETED|Overall Study||14
8547861|NCT00159965|21074155|P1|COMPLETED|Overall Study||12
8547862|NCT00159965|21074154|P2|STARTED|Overall Study||19
8547863|NCT00159965|21074155|P1|STARTED|Overall Study||19
8547920|NCT00159822|21074466|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
8547921|NCT00159822|21074466|P1|COMPLETED|Post-treatment Follow-up Period||23
8547922|NCT00159822|21074466|P1|STARTED|Post-treatment Follow-up Period||26
8547923|NCT00159822|21074466|P1|NOT COMPLETED|Voriconazole Treatment Period||22
8547924|NCT00159822|21074466|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
8547925|NCT00159822|21074466|P1|STARTED|Voriconazole Treatment Period||48
8547926|NCT00159783|21074484|P3|NOT COMPLETED|Overall Study||39
8547927|NCT00159783|21074485|P2|NOT COMPLETED|Overall Study||27
8547928|NCT00159783|21074486|P1|NOT COMPLETED|Overall Study||19
8547929|NCT00159783|21074484|P3|COMPLETED|Overall Study||68
8547930|NCT00159783|21074485|P2|COMPLETED|Overall Study||52
8547931|NCT00159783|21074486|P1|COMPLETED|Overall Study||13
8547932|NCT00159783|21074484|P3|STARTED|Overall Study||107
8547933|NCT00159783|21074485|P2|STARTED|Overall Study||79
8547934|NCT00159783|21074486|P1|STARTED|Overall Study||32
8547935|NCT00159432|21074516|P1|NOT COMPLETED|Overall Study||10
8547936|NCT00159432|21074516|P1|COMPLETED|Overall Study||53
8547937|NCT00159432|21074516|P1|STARTED|Overall Study||63
8547938|NCT00159419|21074523|P2|NOT COMPLETED|Overall Study||0
8547939|NCT00159419|21074524|P1|NOT COMPLETED|Overall Study||0
8547940|NCT00159419|21074523|P2|COMPLETED|Overall Study||9
8547941|NCT00159419|21074524|P1|COMPLETED|Overall Study||9
8547942|NCT00159419|21074523|P2|STARTED|Overall Study||9
8547943|NCT00159419|21074524|P1|STARTED|Overall Study||9
8547944|NCT00159263|21074530|P6|NOT COMPLETED|Sixth Intervention||0
8547945|NCT00159263|21074531|P5|NOT COMPLETED|Sixth Intervention||0
8547946|NCT00159263|21074532|P4|NOT COMPLETED|Sixth Intervention||0
8547947|NCT00159263|21074533|P3|NOT COMPLETED|Sixth Intervention||0
8547948|NCT00159263|21074534|P2|NOT COMPLETED|Sixth Intervention||0
8547949|NCT00159263|21074535|P1|NOT COMPLETED|Sixth Intervention||0
8547950|NCT00159263|21074530|P6|COMPLETED|Sixth Intervention||2
8547951|NCT00159263|21074531|P5|COMPLETED|Sixth Intervention||2
8547952|NCT00159263|21074532|P4|COMPLETED|Sixth Intervention||2
8547953|NCT00159263|21074533|P3|COMPLETED|Sixth Intervention||2
8547954|NCT00159263|21074534|P2|COMPLETED|Sixth Intervention||1
8547955|NCT00159263|21074535|P1|COMPLETED|Sixth Intervention||1
8547956|NCT00159263|21074530|P6|STARTED|Sixth Intervention||2
8547957|NCT00159263|21074531|P5|STARTED|Sixth Intervention||2
8547958|NCT00159263|21074532|P4|STARTED|Sixth Intervention||2
8547959|NCT00159263|21074533|P3|STARTED|Sixth Intervention||2
8547960|NCT00159263|21074534|P2|STARTED|Sixth Intervention||1
8547961|NCT00159263|21074535|P1|STARTED|Sixth Intervention||1
8547962|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8547963|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8547964|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8547965|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8547966|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8547967|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8547968|NCT00159263|21074530|P6|COMPLETED|Washout||2
8547969|NCT00159263|21074531|P5|COMPLETED|Washout||2
8547970|NCT00159263|21074532|P4|COMPLETED|Washout||2
8547971|NCT00159263|21074533|P3|COMPLETED|Washout||2
8547972|NCT00159263|21074534|P2|COMPLETED|Washout||1
8547973|NCT00159263|21074535|P1|COMPLETED|Washout||1
8547974|NCT00159263|21074530|P6|STARTED|Washout||2
8547975|NCT00159263|21074531|P5|STARTED|Washout||2
8547976|NCT00159263|21074532|P4|STARTED|Washout||2
8547977|NCT00159263|21074533|P3|STARTED|Washout||2
8547978|NCT00159263|21074534|P2|STARTED|Washout||1
8547979|NCT00159263|21074535|P1|STARTED|Washout||1
8547980|NCT00159263|21074530|P6|NOT COMPLETED|Fifth Intervention||0
8547981|NCT00159263|21074531|P5|NOT COMPLETED|Fifth Intervention||0
8547982|NCT00159263|21074532|P4|NOT COMPLETED|Fifth Intervention||0
8547983|NCT00159263|21074533|P3|NOT COMPLETED|Fifth Intervention||0
8547984|NCT00159263|21074534|P2|NOT COMPLETED|Fifth Intervention||0
8547985|NCT00159263|21074535|P1|NOT COMPLETED|Fifth Intervention||0
8547986|NCT00159263|21074530|P6|COMPLETED|Fifth Intervention||2
8547987|NCT00159263|21074531|P5|COMPLETED|Fifth Intervention||2
8547988|NCT00159263|21074532|P4|COMPLETED|Fifth Intervention||2
8547989|NCT00159263|21074533|P3|COMPLETED|Fifth Intervention||2
8547990|NCT00159263|21074534|P2|COMPLETED|Fifth Intervention||1
8547991|NCT00159263|21074535|P1|COMPLETED|Fifth Intervention||1
8547992|NCT00159263|21074530|P6|STARTED|Fifth Intervention||2
8547993|NCT00159263|21074531|P5|STARTED|Fifth Intervention||2
8547994|NCT00159263|21074532|P4|STARTED|Fifth Intervention||2
8547995|NCT00159263|21074533|P3|STARTED|Fifth Intervention||2
8547996|NCT00159263|21074534|P2|STARTED|Fifth Intervention||1
8547997|NCT00159263|21074535|P1|STARTED|Fifth Intervention||1
8547998|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8547999|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548000|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548001|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548002|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548003|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548004|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548005|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548006|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548007|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548008|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548009|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548010|NCT00159263|21074530|P6|STARTED|Washout||2
8548011|NCT00159263|21074531|P5|STARTED|Washout||2
8548012|NCT00159263|21074532|P4|STARTED|Washout||2
8548013|NCT00159263|21074533|P3|STARTED|Washout||2
8548014|NCT00159263|21074534|P2|STARTED|Washout||1
8548015|NCT00159263|21074535|P1|STARTED|Washout||1
8548016|NCT00159263|21074530|P6|NOT COMPLETED|Fourth Intervention||0
8548017|NCT00159263|21074531|P5|NOT COMPLETED|Fourth Intervention||0
8548018|NCT00159263|21074532|P4|NOT COMPLETED|Fourth Intervention||0
8548019|NCT00159263|21074533|P3|NOT COMPLETED|Fourth Intervention||0
8548020|NCT00159263|21074534|P2|NOT COMPLETED|Fourth Intervention||0
8548021|NCT00159263|21074535|P1|NOT COMPLETED|Fourth Intervention||0
8548022|NCT00159263|21074530|P6|COMPLETED|Fourth Intervention||2
8548023|NCT00159263|21074531|P5|COMPLETED|Fourth Intervention||2
8548024|NCT00159263|21074532|P4|COMPLETED|Fourth Intervention||2
8548025|NCT00159263|21074533|P3|COMPLETED|Fourth Intervention||2
8548026|NCT00159263|21074534|P2|COMPLETED|Fourth Intervention||1
8548027|NCT00159263|21074535|P1|COMPLETED|Fourth Intervention||1
8548028|NCT00159263|21074530|P6|STARTED|Fourth Intervention||2
8548029|NCT00159263|21074531|P5|STARTED|Fourth Intervention||2
8548030|NCT00159263|21074532|P4|STARTED|Fourth Intervention||2
8548031|NCT00159263|21074533|P3|STARTED|Fourth Intervention||2
8548032|NCT00159263|21074534|P2|STARTED|Fourth Intervention||1
8548033|NCT00159263|21074535|P1|STARTED|Fourth Intervention||1
8548034|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8548035|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548036|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548037|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548038|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548039|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548040|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548041|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548042|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548043|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548044|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548045|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548046|NCT00159263|21074530|P6|STARTED|Washout||2
8548047|NCT00159263|21074531|P5|STARTED|Washout||2
8548048|NCT00159263|21074532|P4|STARTED|Washout||2
8548049|NCT00159263|21074533|P3|STARTED|Washout||2
8548050|NCT00159263|21074534|P2|STARTED|Washout||1
8548051|NCT00159263|21074535|P1|STARTED|Washout||1
8548052|NCT00159263|21074530|P6|NOT COMPLETED|Third Intervention||0
8548053|NCT00159263|21074531|P5|NOT COMPLETED|Third Intervention||0
8548054|NCT00159263|21074532|P4|NOT COMPLETED|Third Intervention||0
8548055|NCT00159263|21074533|P3|NOT COMPLETED|Third Intervention||0
8548056|NCT00159263|21074534|P2|NOT COMPLETED|Third Intervention||0
8548057|NCT00159263|21074535|P1|NOT COMPLETED|Third Intervention||0
8548058|NCT00159263|21074530|P6|COMPLETED|Third Intervention||2
8548059|NCT00159263|21074531|P5|COMPLETED|Third Intervention||2
8548060|NCT00159263|21074532|P4|COMPLETED|Third Intervention||2
8548061|NCT00159263|21074533|P3|COMPLETED|Third Intervention||2
8548062|NCT00159263|21074534|P2|COMPLETED|Third Intervention||1
8548063|NCT00159263|21074535|P1|COMPLETED|Third Intervention||1
8548064|NCT00159263|21074530|P6|STARTED|Third Intervention||2
8548065|NCT00159263|21074531|P5|STARTED|Third Intervention||2
8548066|NCT00159263|21074532|P4|STARTED|Third Intervention||2
8548067|NCT00159263|21074533|P3|STARTED|Third Intervention||2
8548068|NCT00159263|21074534|P2|STARTED|Third Intervention||1
8548069|NCT00159263|21074535|P1|STARTED|Third Intervention||1
8548070|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8548071|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548072|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548073|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548074|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548075|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548076|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548077|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548078|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548079|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548080|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548081|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548082|NCT00159263|21074530|P6|STARTED|Washout||2
8548083|NCT00159263|21074531|P5|STARTED|Washout||2
8548084|NCT00159263|21074532|P4|STARTED|Washout||2
8548085|NCT00159263|21074533|P3|STARTED|Washout||2
8548086|NCT00159263|21074534|P2|STARTED|Washout||1
8548087|NCT00159263|21074535|P1|STARTED|Washout||1
8548088|NCT00159263|21074530|P6|NOT COMPLETED|Second Intervention||0
8548089|NCT00159263|21074531|P5|NOT COMPLETED|Second Intervention||0
8548090|NCT00159263|21074532|P4|NOT COMPLETED|Second Intervention||0
8548091|NCT00159263|21074533|P3|NOT COMPLETED|Second Intervention||0
8548092|NCT00159263|21074534|P2|NOT COMPLETED|Second Intervention||0
8548093|NCT00159263|21074535|P1|NOT COMPLETED|Second Intervention||0
8548094|NCT00159263|21074530|P6|COMPLETED|Second Intervention||2
8548095|NCT00159263|21074531|P5|COMPLETED|Second Intervention||2
8548096|NCT00159263|21074532|P4|COMPLETED|Second Intervention||2
8548097|NCT00159263|21074533|P3|COMPLETED|Second Intervention||2
8548098|NCT00159263|21074534|P2|COMPLETED|Second Intervention||1
8548099|NCT00159263|21074535|P1|COMPLETED|Second Intervention||1
8548100|NCT00159263|21074530|P6|STARTED|Second Intervention||2
8548101|NCT00159263|21074531|P5|STARTED|Second Intervention||2
8548102|NCT00159263|21074532|P4|STARTED|Second Intervention||2
8548103|NCT00159263|21074533|P3|STARTED|Second Intervention||2
8548104|NCT00159263|21074534|P2|STARTED|Second Intervention||1
8548105|NCT00159263|21074535|P1|STARTED|Second Intervention||1
8548106|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8548107|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548108|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548109|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548110|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548111|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548112|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548113|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548114|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548115|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548116|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548117|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548118|NCT00159263|21074530|P6|STARTED|Washout||2
8548119|NCT00159263|21074531|P5|STARTED|Washout||2
8548120|NCT00159263|21074532|P4|STARTED|Washout||2
8548121|NCT00159263|21074533|P3|STARTED|Washout||2
8548122|NCT00159263|21074534|P2|STARTED|Washout||1
8548123|NCT00159263|21074535|P1|STARTED|Washout||1
8548124|NCT00159263|21074530|P6|NOT COMPLETED|First Intervention||0
8548125|NCT00159263|21074531|P5|NOT COMPLETED|First Intervention||0
8548126|NCT00159263|21074532|P4|NOT COMPLETED|First Intervention||0
8548127|NCT00159263|21074533|P3|NOT COMPLETED|First Intervention||0
8548128|NCT00159263|21074534|P2|NOT COMPLETED|First Intervention||0
8548129|NCT00159263|21074535|P1|NOT COMPLETED|First Intervention||0
8548130|NCT00159263|21074530|P6|COMPLETED|First Intervention||2
8548131|NCT00159263|21074531|P5|COMPLETED|First Intervention||2
8548132|NCT00159263|21074532|P4|COMPLETED|First Intervention||2
8548133|NCT00159263|21074533|P3|COMPLETED|First Intervention||2
8548134|NCT00159263|21074534|P2|COMPLETED|First Intervention||1
8548135|NCT00159263|21074535|P1|COMPLETED|First Intervention||1
8548136|NCT00159263|21074530|P6|STARTED|First Intervention||2
8548137|NCT00159263|21074531|P5|STARTED|First Intervention||2
8548138|NCT00159263|21074532|P4|STARTED|First Intervention||2
8548139|NCT00159263|21074533|P3|STARTED|First Intervention||2
8548140|NCT00159263|21074534|P2|STARTED|First Intervention||1
8548141|NCT00159263|21074535|P1|STARTED|First Intervention||1
8548142|NCT00159250|21074563|P2|NOT COMPLETED|Overall Study||0
8548143|NCT00159250|21074564|P1|NOT COMPLETED|Overall Study||0
8548144|NCT00159250|21074563|P2|COMPLETED|Overall Study||5
8548145|NCT00159250|21074564|P1|COMPLETED|Overall Study||2
8548146|NCT00159250|21074563|P2|STARTED|Overall Study||5
8548147|NCT00159250|21074564|P1|STARTED|Overall Study||2
8548148|NCT00158925|21074580|P1|NOT COMPLETED|Overall Study||12
8548149|NCT00158925|21074580|P1|COMPLETED|Overall Study||84
8548150|NCT00158925|21074580|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
8548151|NCT00158860|21074590|P2|NOT COMPLETED|Overall Study||71
8548152|NCT00158860|21074591|P1|NOT COMPLETED|Overall Study||35
8548153|NCT00158860|21074590|P2|COMPLETED|Overall Study||184
8548154|NCT00158860|21074591|P1|COMPLETED|Overall Study||93
8548155|NCT00158860|21074590|P2|STARTED|Overall Study||255
8548156|NCT00158860|21074591|P1|STARTED|Overall Study||128
8548157|NCT00158756|21074610|P5|NOT COMPLETED|Overall Study||3
8548158|NCT00158756|21074611|P4|NOT COMPLETED|Overall Study||1
8548159|NCT00158756|21074612|P3|NOT COMPLETED|Overall Study||8
8548160|NCT00158756|21074613|P2|NOT COMPLETED|Overall Study||0
8548161|NCT00158756|21074614|P1|NOT COMPLETED|Overall Study||5
8548162|NCT00158756|21074610|P5|COMPLETED|Overall Study||96
8548163|NCT00158756|21074611|P4|COMPLETED|Overall Study||22
8548164|NCT00158756|21074612|P3|COMPLETED|Overall Study||73
8548165|NCT00158756|21074613|P2|COMPLETED|Overall Study||25
8548166|NCT00158756|21074614|P1|COMPLETED|Overall Study||75
8548167|NCT00158756|21074610|P5|STARTED|Overall Study||99
8548168|NCT00158756|21074611|P4|STARTED|Overall Study||23
8548169|NCT00158756|21074612|P3|STARTED|Overall Study||81
8548170|NCT00158756|21074613|P2|STARTED|Overall Study||25
8548171|NCT00158756|21074614|P1|STARTED|Overall Study||80
8548172|NCT00158743|21074711|P2|NOT COMPLETED|Overall Study||7
8548173|NCT00158743|21074712|P1|NOT COMPLETED|Overall Study||9
8548174|NCT00158743|21074711|P2|COMPLETED|Overall Study||20
8548175|NCT00158743|21074712|P1|COMPLETED|Overall Study||15
8548176|NCT00158743|21074711|P2|STARTED|Overall Study||27
8548177|NCT00158743|21074712|P1|STARTED|Overall Study||24
8548178|NCT00158600|21074720|P2|NOT COMPLETED|Overall Study||4
8548179|NCT00158600|21074721|P1|NOT COMPLETED|Overall Study||5
8548180|NCT00158600|21074720|P2|COMPLETED|Overall Study||26
8548181|NCT00158600|21074721|P1|COMPLETED|Overall Study||55
8548182|NCT00158600|21074720|P2|STARTED|Overall Study||30
8548183|NCT00158600|21074721|P1|STARTED|Overall Study||60
8548184|NCT00158379|21074739|P1|NOT COMPLETED|Overall Study||0
8548185|NCT00158379|21074739|P1|COMPLETED|Overall Study||105
8548186|NCT00158379|21074739|P1|STARTED|Overall Study||105
8548187|NCT00158262|21074746|P2|NOT COMPLETED|Overall Study||1
8548188|NCT00158262|21074747|P1|NOT COMPLETED|Overall Study||1
8548189|NCT00158262|21074746|P2|COMPLETED|Overall Study||21
8548190|NCT00158262|21074747|P1|COMPLETED|Overall Study||20
8548191|NCT00158262|21074746|P2|STARTED|Overall Study||22
8548192|NCT00158262|21074747|P1|STARTED|Overall Study||21
8548193|NCT00158249|21074759|P2|NOT COMPLETED|Overall Study||0
8548194|NCT00158249|21074760|P1|NOT COMPLETED|Overall Study||2
8548195|NCT00158249|21074759|P2|COMPLETED|Overall Study||10
8548196|NCT00158249|21074760|P1|COMPLETED|Overall Study||9
8548197|NCT00158249|21074759|P2|STARTED|Overall Study||10
8548198|NCT00158249|21074760|P1|STARTED|Overall Study||11
8548199|NCT00158223|21074770|P2|NOT COMPLETED|Overall Study||3
8548200|NCT00158223|21074771|P1|NOT COMPLETED|Overall Study||5
8548201|NCT00158223|21074770|P2|COMPLETED|Overall Study||22
8548202|NCT00158223|21074771|P1|COMPLETED|Overall Study||23
8548203|NCT00158223|21074770|P2|STARTED|Overall Study||25
8548204|NCT00158223|21074771|P1|STARTED|Overall Study||28
8548205|NCT00158197|21074785|P4|NOT COMPLETED|Overall Study||0
8548206|NCT00158197|21074786|P3|NOT COMPLETED|Overall Study||0
8548207|NCT00158197|21074787|P2|NOT COMPLETED|Overall Study||0
8548208|NCT00158197|21074788|P1|NOT COMPLETED|Overall Study||0
8548209|NCT00158197|21074785|P4|COMPLETED|Overall Study||29
8548210|NCT00158197|21074786|P3|COMPLETED|Overall Study||28
8548211|NCT00158197|21074787|P2|COMPLETED|Overall Study||30
8548212|NCT00158197|21074788|P1|COMPLETED|Overall Study||32
8548213|NCT00158197|21074785|P4|STARTED|Overall Study||29
8548214|NCT00158197|21074786|P3|STARTED|Overall Study||28
8548215|NCT00158197|21074787|P2|STARTED|Overall Study||30
8548216|NCT00158197|21074788|P1|STARTED|Overall Study||32
8548217|NCT00158184|21074808|P2|NOT COMPLETED|Overall Study||2
8548218|NCT00158184|21074809|P1|NOT COMPLETED|Overall Study||6
8548219|NCT00158184|21074808|P2|COMPLETED|Overall Study||9
8548220|NCT00158184|21074809|P1|COMPLETED|Overall Study||10
8548221|NCT00158184|21074808|P2|STARTED|Overall Study||11
8548222|NCT00158184|21074809|P1|STARTED|Overall Study||16
8548223|NCT00158054|21074819|P2|NOT COMPLETED|Overall Study||3
8548224|NCT00158054|21074820|P1|NOT COMPLETED|Overall Study||10
8548225|NCT00158054|21074819|P2|COMPLETED|Overall Study||74
8548226|NCT00158054|21074820|P1|COMPLETED|Overall Study||70
8548227|NCT00158054|21074819|P2|STARTED|Overall Study||77
8548228|NCT00158054|21074820|P1|STARTED|Overall Study||80
8548229|NCT00157950|21074834|P2|NOT COMPLETED|Overall Study||0
8548230|NCT00157950|21074835|P1|NOT COMPLETED|Overall Study||1
8548231|NCT00157950|21074834|P2|COMPLETED|Overall Study||59
8548232|NCT00157950|21074835|P1|COMPLETED|Overall Study||116
8548233|NCT00157950|21074834|P2|Vaccinated at Dose 3|Overall Study||59
8548234|NCT00157950|21074835|P1|Vaccinated at Dose 3|Overall Study||116
8548235|NCT00157950|21074834|P2|Vaccinated at Dose 2|Overall Study||59
8548236|NCT00157950|21074835|P1|Vaccinated at Dose 2|Overall Study||117
8548237|NCT00157950|21074834|P2|Vaccinated at Dose 1|Overall Study||59
8548238|NCT00157950|21074835|P1|Vaccinated at Dose 1|Overall Study||117
8548239|NCT00157950|21074834|P2|STARTED|Overall Study||59
8548240|NCT00157950|21074835|P1|STARTED|Overall Study||117
8548241|NCT00157820|21074852|P3|NOT COMPLETED|2nd 8 Months||14
8548242|NCT00157820|21074853|P2|NOT COMPLETED|2nd 8 Months||13
8548243|NCT00157820|21074854|P1|NOT COMPLETED|2nd 8 Months||5
8548244|NCT00157820|21074852|P3|COMPLETED|2nd 8 Months||94
8548245|NCT00157820|21074853|P2|COMPLETED|2nd 8 Months||88
8548246|NCT00157820|21074854|P1|COMPLETED|2nd 8 Months||98
8548247|NCT00157820|21074852|P3|STARTED|2nd 8 Months||108
8548248|NCT00157820|21074853|P2|STARTED|2nd 8 Months||101
8548249|NCT00157820|21074854|P1|STARTED|2nd 8 Months||103
8548250|NCT00157820|21074852|P3|NOT COMPLETED|1 Month Wash Out Period||0
8548251|NCT00157820|21074853|P2|NOT COMPLETED|1 Month Wash Out Period||0
8548252|NCT00157820|21074854|P1|NOT COMPLETED|1 Month Wash Out Period||0
8548253|NCT00157820|21074852|P3|COMPLETED|1 Month Wash Out Period||108
8548254|NCT00157820|21074853|P2|COMPLETED|1 Month Wash Out Period||101
8548255|NCT00157820|21074854|P1|COMPLETED|1 Month Wash Out Period||103
8548256|NCT00157820|21074852|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
8548257|NCT00157820|21074853|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
8548258|NCT00157820|21074854|P1|STARTED|1 Month Wash Out Period||103
8548259|NCT00157820|21074852|P3|NOT COMPLETED|1st 8 Month||6
8548260|NCT00157820|21074853|P2|NOT COMPLETED|1st 8 Month||12
8548261|NCT00157820|21074854|P1|NOT COMPLETED|1st 8 Month||8
8548262|NCT00157820|21074852|P3|COMPLETED|1st 8 Month||106
8548263|NCT00157820|21074853|P2|COMPLETED|1st 8 Month||99
8548264|NCT00157820|21074854|P1|COMPLETED|1st 8 Month||103
8548265|NCT00157820|21074852|P3|STARTED|1st 8 Month||112
8548266|NCT00157820|21074853|P2|STARTED|1st 8 Month||111
8548267|NCT00157820|21074854|P1|STARTED|1st 8 Month||111
8548268|NCT00157820|21074852|P3|NOT COMPLETED|Randomized||8
8548269|NCT00157820|21074853|P2|NOT COMPLETED|Randomized||5
8548270|NCT00157820|21074854|P1|NOT COMPLETED|Randomized||7
8548271|NCT00157820|21074852|P3|COMPLETED|Randomized||112
8548272|NCT00157820|21074853|P2|COMPLETED|Randomized||111
8548273|NCT00157820|21074854|P1|COMPLETED|Randomized||111
8548274|NCT00157820|21074852|P3|STARTED|Randomized||120
8548275|NCT00157820|21074853|P2|STARTED|Randomized||116
8548276|NCT00157820|21074854|P1|STARTED|Randomized||118
8548277|NCT00157755|21074867|P6|NOT COMPLETED|Overall Study||5
8548278|NCT00157755|21074868|P5|NOT COMPLETED|Overall Study||2
8548279|NCT00157755|21074869|P4|NOT COMPLETED|Overall Study||4
8548280|NCT00157755|21074870|P3|NOT COMPLETED|Overall Study||7
8548281|NCT00157755|21074871|P2|NOT COMPLETED|Overall Study||4
8548282|NCT00157755|21074872|P1|NOT COMPLETED|Overall Study||2
8548283|NCT00157755|21074867|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
8548284|NCT00157755|21074868|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
8548285|NCT00157755|21074869|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
8548286|NCT00157755|21074870|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
8548287|NCT00157755|21074871|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
8548288|NCT00157755|21074872|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
8548289|NCT00157755|21074867|P6|STARTED|Overall Study||5
8548290|NCT00157755|21074868|P5|STARTED|Overall Study||12
8548291|NCT00157755|21074869|P4|STARTED|Overall Study||15
8548292|NCT00157755|21074870|P3|STARTED|Overall Study||10
8548293|NCT00157755|21074871|P2|STARTED|Overall Study||19
8548294|NCT00157755|21074872|P1|STARTED|Overall Study||26
8548295|NCT00157573|21074894|P2|NOT COMPLETED|Overall Study||0
8548296|NCT00157573|21074895|P1|NOT COMPLETED|Overall Study||0
8548297|NCT00157573|21074894|P2|COMPLETED|Overall Study||37
8548298|NCT00157573|21074895|P1|COMPLETED|Overall Study||35
8548299|NCT00157573|21074894|P2|STARTED|Overall Study||37
8548300|NCT00157573|21074895|P1|STARTED|Overall Study||35
8548301|NCT00157248|21074908|P4|NOT COMPLETED|Overall Study||47
8548302|NCT00157248|21074909|P3|NOT COMPLETED|Overall Study||21
8548303|NCT00157248|21074910|P2|NOT COMPLETED|Overall Study||37
8548304|NCT00157248|21074911|P1|NOT COMPLETED|Overall Study||48
8548305|NCT00157248|21074908|P4|COMPLETED|Overall Study||77
8548306|NCT00157248|21074909|P3|COMPLETED|Overall Study||29
8548307|NCT00157248|21074910|P2|COMPLETED|Overall Study||52
8548308|NCT00157248|21074911|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
8548309|NCT00157248|21074908|P4|STARTED|Overall Study||124
8548310|NCT00157248|21074909|P3|STARTED|Overall Study||50
8548311|NCT00157248|21074910|P2|STARTED|Overall Study||89
8548312|NCT00157248|21074911|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
8548313|NCT00157209|21075017|P2|NOT COMPLETED|Overall Study||0
8548314|NCT00157209|21075018|P1|NOT COMPLETED|Overall Study||10
8548315|NCT00157209|21075017|P2|COMPLETED|Overall Study||83
8548316|NCT00157209|21075018|P1|COMPLETED|Overall Study||78
8548317|NCT00157209|21075017|P2|STARTED|Overall Study||83
8548318|NCT00157209|21075018|P1|STARTED|Overall Study||88
8548319|NCT00157196|21075032|P1|NOT COMPLETED|Overall Study||9
8548320|NCT00157196|21075032|P1|COMPLETED|Overall Study||13
8548321|NCT00157196|21075032|P1|STARTED|Overall Study||22
8548322|NCT00157157|21075038|P1|NOT COMPLETED|Overall Study||11
8548323|NCT00157157|21075038|P1|COMPLETED|Overall Study||44
8548324|NCT00157157|21075038|P1|STARTED|Overall Study||55
8548325|NCT00157014|21075065|P4|NOT COMPLETED|Overall Study||1
8548326|NCT00157014|21075066|P3|NOT COMPLETED|Overall Study||1
8548327|NCT00157014|21075067|P2|NOT COMPLETED|Overall Study||5
8548328|NCT00157014|21075068|P1|NOT COMPLETED|Overall Study||7
8548329|NCT00157014|21075065|P4|COMPLETED|Overall Study||5
8548330|NCT00157014|21075066|P3|COMPLETED|Overall Study||4
8548331|NCT00157014|21075067|P2|COMPLETED|Overall Study||41
8548332|NCT00157014|21075068|P1|COMPLETED|Overall Study||45
8548333|NCT00157014|21075065|P4|STARTED|Overall Study||6
8548334|NCT00157014|21075066|P3|STARTED|Overall Study||5
8548335|NCT00157014|21075067|P2|STARTED|Overall Study||46
8548336|NCT00157014|21075068|P1|STARTED|Overall Study||52
8548337|NCT00156936|21075148|P2|NOT COMPLETED|Overall Study||11
8548338|NCT00156936|21075149|P1|NOT COMPLETED|Overall Study||72
8548339|NCT00156936|21075148|P2|COMPLETED|Overall Study||5
8548340|NCT00156936|21075149|P1|COMPLETED|Overall Study||20
8548341|NCT00156936|21075148|P2|STARTED|Overall Study||16
8548342|NCT00156936|21075149|P1|STARTED|Overall Study||92
8548343|NCT00156923|21075157|P2|NOT COMPLETED|Overall Study||32
8548344|NCT00156923|21075158|P1|NOT COMPLETED|Overall Study||34
8548345|NCT00156923|21075157|P2|COMPLETED|Overall Study||20
8548346|NCT00156923|21075158|P1|COMPLETED|Overall Study||22
8548347|NCT00156923|21075157|P2|STARTED|Overall Study||52
8548348|NCT00156923|21075158|P1|STARTED|Overall Study||56
8548349|NCT00156910|21075166|P2|NOT COMPLETED|Open-Label Phase (OL)||55
8548350|NCT00156910|21075167|P1|NOT COMPLETED|Open-Label Phase (OL)||33
8548351|NCT00156910|21075166|P2|COMPLETED|Open-Label Phase (OL)||231
8548352|NCT00156910|21075167|P1|COMPLETED|Open-Label Phase (OL)||252
8548353|NCT00156910|21075166|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
8548354|NCT00156910|21075167|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
8548355|NCT00156910|21075166|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
8548356|NCT00156910|21075167|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
8548357|NCT00156910|21075166|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
8548358|NCT00156910|21075167|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
8548359|NCT00156910|21075166|P2|STARTED|Double-Blind Phase (DB)||338
8548360|NCT00156910|21075167|P1|STARTED|Double-Blind Phase (DB)||341
8548361|NCT00156819|21075184|P3|NOT COMPLETED|Overall Study||3
8548362|NCT00156819|21075185|P2|NOT COMPLETED|Overall Study||1
8548363|NCT00156819|21075186|P1|NOT COMPLETED|Overall Study||1
8548364|NCT00156819|21075184|P3|COMPLETED|Overall Study||162
8548365|NCT00156819|21075185|P2|COMPLETED|Overall Study||165
8548366|NCT00156819|21075186|P1|COMPLETED|Overall Study||168
8548367|NCT00156819|21075184|P3|STARTED|Overall Study||165
8548368|NCT00156819|21075185|P2|STARTED|Overall Study||166
8548369|NCT00156819|21075186|P1|STARTED|Overall Study||169
8548370|NCT00156715|21075194|P1|NOT COMPLETED|Overall Study||7
8548371|NCT00156715|21075194|P1|COMPLETED|Overall Study||16
8548372|NCT00156715|21075194|P1|STARTED|Overall Study||23
8548373|NCT00156533|21075203|P4|NOT COMPLETED|Overall Study||2
8548374|NCT00156533|21075204|P3|NOT COMPLETED|Overall Study||2
8548375|NCT00156533|21075205|P2|NOT COMPLETED|Overall Study||2
8548376|NCT00156533|21075206|P1|NOT COMPLETED|Overall Study||2
8548377|NCT00156533|21075203|P4|COMPLETED|Overall Study||3
8548378|NCT00156533|21075204|P3|COMPLETED|Overall Study||3
8548379|NCT00156533|21075205|P2|COMPLETED|Overall Study||3
8548380|NCT00156533|21075206|P1|COMPLETED|Overall Study||3
8548381|NCT00156533|21075203|P4|STARTED|Overall Study||5
8548382|NCT00156533|21075204|P3|STARTED|Overall Study||5
8548383|NCT00156533|21075205|P2|STARTED|Overall Study||5
8548384|NCT00156533|21075206|P1|STARTED|Overall Study||5
8548385|NCT00156390|21075222|P2|NOT COMPLETED|Overall Study||8
8548386|NCT00156390|21075223|P1|NOT COMPLETED|Overall Study||14
8548387|NCT00156390|21075222|P2|COMPLETED|Overall Study||69
8548388|NCT00156390|21075223|P1|COMPLETED|Overall Study||96
8548389|NCT00156390|21075222|P2|STARTED|Overall Study||77
8548390|NCT00156390|21075223|P1|STARTED|Overall Study||110
8548391|NCT00156247|21075231|P1|NOT COMPLETED|Overall Study||4
8548392|NCT00156247|21075231|P1|COMPLETED|Overall Study||5
8548393|NCT00156247|21075231|P1|STARTED|Overall Study||9
8548394|NCT00156065|21075240|P3|NOT COMPLETED|Overall Study||27
8548395|NCT00156065|21075241|P2|NOT COMPLETED|Overall Study||63
8548396|NCT00156065|21075242|P1|NOT COMPLETED|Overall Study||31
8548397|NCT00156065|21075240|P3|COMPLETED|Overall Study||16
8548398|NCT00156065|21075241|P2|COMPLETED|Overall Study||30
8548399|NCT00156065|21075242|P1|COMPLETED|Overall Study||20
8548400|NCT00156065|21075240|P3|STARTED|Overall Study||43
8548401|NCT00156065|21075241|P2|STARTED|Overall Study||93
8548402|NCT00156065|21075242|P1|STARTED|Overall Study||51
8548403|NCT00156013|21075253|P1|NOT COMPLETED|Overall Study||2
8548404|NCT00156013|21075253|P1|COMPLETED|Overall Study||31
8548405|NCT00156013|21075253|P1|STARTED|Overall Study||33
8548406|NCT00154466|21075262|P3|NOT COMPLETED|Overall Study||0
8548407|NCT00154466|21075263|P2|NOT COMPLETED|Overall Study||0
8548408|NCT00154466|21075264|P1|NOT COMPLETED|Overall Study||0
8548409|NCT00154466|21075262|P3|COMPLETED|Overall Study||19
8548410|NCT00154466|21075263|P2|COMPLETED|Overall Study||19
8548411|NCT00154466|21075264|P1|COMPLETED|Overall Study||20
8548412|NCT00154466|21075262|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
8548413|NCT00154466|21075263|P2|STARTED|Overall Study||19
8548414|NCT00154466|21075264|P1|STARTED|Overall Study||20
8548415|NCT00154375|21075276|P2|NOT COMPLETED|Overall Study||106
8548416|NCT00154375|21075277|P1|NOT COMPLETED|Overall Study||113
8548417|NCT00154375|21075276|P2|COMPLETED|Overall Study||14
8548418|NCT00154375|21075277|P1|COMPLETED|Overall Study||7
8548419|NCT00154375|21075276|P2|Not Exposed to Study Treatment|Overall Study||2
8548420|NCT00154375|21075277|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
8548421|NCT00154375|21075276|P2|Discontinued Study Treatment|Overall Study||104
8548422|NCT00154375|21075277|P1|Discontinued Study Treatment|Overall Study||111
8548423|NCT00154375|21075276|P2|STARTED|Overall Study||120
8548424|NCT00154375|21075277|P1|STARTED|Overall Study||120
8548425|NCT00154310|21075288|P2|NOT COMPLETED|Overall Study||28
8548426|NCT00154310|21075289|P1|NOT COMPLETED|Overall Study||37
8548427|NCT00154310|21075288|P2|COMPLETED|Overall Study||117
8548428|NCT00154310|21075289|P1|COMPLETED|Overall Study||118
8548429|NCT00154310|21075288|P2|STARTED|Overall Study||145
8548430|NCT00154310|21075289|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
8548431|NCT00154297|21075305|P2|NOT COMPLETED|Overall Study||7
8548432|NCT00154297|21075306|P1|NOT COMPLETED|Overall Study||8
8548433|NCT00154297|21075305|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
8548434|NCT00154297|21075306|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
8548435|NCT00154297|21075305|P2|STARTED|Overall Study|Randomized population.|74
8548436|NCT00154297|21075306|P1|STARTED|Overall Study|Randomized population.|65
8548437|NCT00154284|21075324|P2|NOT COMPLETED|Overall Study||13
8548438|NCT00154284|21075325|P1|NOT COMPLETED|Overall Study||7
8548439|NCT00154284|21075324|P2|COMPLETED|Overall Study||42
8548440|NCT00154284|21075325|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
8548441|NCT00154284|21075324|P2|Intent to Treat (ITT) Population|Overall Study||53
8548442|NCT00154284|21075325|P1|Intent to Treat (ITT) Population|Overall Study||57
8548443|NCT00154284|21075324|P2|STARTED|Overall Study||55
8548444|NCT00154284|21075325|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
8548445|NCT00154102|21075339|P2|NOT COMPLETED|Overall Study||2
8548446|NCT00154102|21075340|P1|NOT COMPLETED|Overall Study||7
8548447|NCT00154102|21075339|P2|COMPLETED|Overall Study||597
8548448|NCT00154102|21075340|P1|COMPLETED|Overall Study||592
8548449|NCT00154102|21075339|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
8548450|NCT00154102|21075340|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
8548451|NCT00154063|21075376|P2|NOT COMPLETED|Overall Study||22
8548452|NCT00154063|21075377|P1|NOT COMPLETED|Overall Study||12
8548453|NCT00154063|21075376|P2|COMPLETED|Overall Study||80
8548454|NCT00154063|21075377|P1|COMPLETED|Overall Study||92
8548455|NCT00154063|21075376|P2|STARTED|Overall Study||102
8548456|NCT00154063|21075377|P1|STARTED|Overall Study||104
8548457|NCT00153985|21075433|P1|NOT COMPLETED|Overall Study||0
8548458|NCT00153985|21075433|P1|COMPLETED|Overall Study||2
8548459|NCT00153985|21075433|P1|STARTED|Overall Study||2
8548460|NCT00153920|21075439|P1|NOT COMPLETED|Overall Study||30
8548461|NCT00153920|21075439|P1|COMPLETED|Overall Study||36
8548462|NCT00153920|21075439|P1|Eligible and Treated|Overall Study||64
8548463|NCT00153920|21075439|P1|STARTED|Overall Study||66
8548464|NCT00153842|21075450|P2|NOT COMPLETED|Overall Study||0
8548465|NCT00153842|21075451|P1|NOT COMPLETED|Overall Study||0
8548466|NCT00153842|21075450|P2|COMPLETED|Overall Study||7
8548467|NCT00153842|21075451|P1|COMPLETED|Overall Study||26
8548468|NCT00153842|21075450|P2|STARTED|Overall Study||7
8548469|NCT00153842|21075451|P1|STARTED|Overall Study||26
8548470|NCT00153816|21075465|P6|NOT COMPLETED|Overall Study||27
8548471|NCT00153816|21075466|P5|NOT COMPLETED|Overall Study||17
8548472|NCT00153816|21075467|P4|NOT COMPLETED|Overall Study||31
8548473|NCT00153816|21075468|P3|NOT COMPLETED|Overall Study||32
8548474|NCT00153816|21075469|P2|NOT COMPLETED|Overall Study||32
8548475|NCT00153816|21075470|P1|NOT COMPLETED|Overall Study||32
8548476|NCT00153816|21075465|P6|COMPLETED|Overall Study||262
8548477|NCT00153816|21075466|P5|COMPLETED|Overall Study||278
8548478|NCT00153816|21075467|P4|COMPLETED|Overall Study||390
8548479|NCT00153816|21075468|P3|COMPLETED|Overall Study||388
8548480|NCT00153816|21075469|P2|COMPLETED|Overall Study||387
8548481|NCT00153816|21075470|P1|COMPLETED|Overall Study||383
8548482|NCT00153816|21075465|P6|STARTED|Overall Study||289
8548483|NCT00153816|21075466|P5|STARTED|Overall Study||295
8548484|NCT00153816|21075467|P4|STARTED|Overall Study||421
8548485|NCT00153816|21075468|P3|STARTED|Overall Study||420
8548486|NCT00153816|21075469|P2|STARTED|Overall Study||419
8548487|NCT00153816|21075470|P1|STARTED|Overall Study||415
8548488|NCT00153803|21075492|P2|NOT COMPLETED|Investigational Drug||42
8548489|NCT00153803|21075493|P1|NOT COMPLETED|Investigational Drug||41
8548490|NCT00153803|21075492|P2|COMPLETED|Investigational Drug||75
8548491|NCT00153803|21075493|P1|COMPLETED|Investigational Drug||77
8548492|NCT00153803|21075492|P2|Investigational Drug Dispensed|Investigational Drug||75
8548493|NCT00153803|21075493|P1|Investigational Drug Dispensed|Investigational Drug||77
8548494|NCT00153803|21075492|P2|STARTED|Investigational Drug||117
8548495|NCT00153803|21075493|P1|STARTED|Investigational Drug||118
8548496|NCT00153803|21075492|P2|NOT COMPLETED|Concurrent Chemoradiation||5
8548497|NCT00153803|21075493|P1|NOT COMPLETED|Concurrent Chemoradiation||5
8548498|NCT00153803|21075492|P2|COMPLETED|Concurrent Chemoradiation||117
8548499|NCT00153803|21075493|P1|COMPLETED|Concurrent Chemoradiation||118
8548500|NCT00153803|21075492|P2|Received Chemoradiation|Concurrent Chemoradiation||117
8548501|NCT00153803|21075493|P1|Received Chemoradiation|Concurrent Chemoradiation||118
8548502|NCT00153803|21075492|P2|STARTED|Concurrent Chemoradiation||122
8548503|NCT00153803|21075493|P1|STARTED|Concurrent Chemoradiation||123
8548504|NCT00153179|21075511|P4|NOT COMPLETED|Study Visit Day 2||2
8548505|NCT00153179|21075512|P3|NOT COMPLETED|Study Visit Day 2||2
8548506|NCT00153179|21075513|P2|NOT COMPLETED|Study Visit Day 2||0
8548507|NCT00153179|21075514|P1|NOT COMPLETED|Study Visit Day 2||1
8548508|NCT00153179|21075511|P4|COMPLETED|Study Visit Day 2||7
8548509|NCT00153179|21075512|P3|COMPLETED|Study Visit Day 2||11
8548510|NCT00153179|21075513|P2|COMPLETED|Study Visit Day 2||8
8548511|NCT00153179|21075514|P1|COMPLETED|Study Visit Day 2||9
8548512|NCT00153179|21075511|P4|STARTED|Study Visit Day 2||9
8548513|NCT00153179|21075512|P3|STARTED|Study Visit Day 2||13
8548514|NCT00153179|21075513|P2|STARTED|Study Visit Day 2||8
8548515|NCT00153179|21075514|P1|STARTED|Study Visit Day 2||10
8548516|NCT00153179|21075511|P4|NOT COMPLETED|Study Visit Day 1||0
8548517|NCT00153179|21075512|P3|NOT COMPLETED|Study Visit Day 1||0
8548518|NCT00153179|21075513|P2|NOT COMPLETED|Study Visit Day 1||0
8548519|NCT00153179|21075514|P1|NOT COMPLETED|Study Visit Day 1||0
8548520|NCT00153179|21075511|P4|COMPLETED|Study Visit Day 1||9
8548521|NCT00153179|21075512|P3|COMPLETED|Study Visit Day 1||13
8548522|NCT00153179|21075513|P2|COMPLETED|Study Visit Day 1||8
8548523|NCT00153179|21075514|P1|COMPLETED|Study Visit Day 1||10
8548524|NCT00153179|21075511|P4|STARTED|Study Visit Day 1||9
8548525|NCT00153179|21075512|P3|STARTED|Study Visit Day 1||13
8548526|NCT00153179|21075513|P2|STARTED|Study Visit Day 1||8
8548527|NCT00153179|21075514|P1|STARTED|Study Visit Day 1||10
8548528|NCT00153166|21075527|P3|NOT COMPLETED|Overall Study||0
8548529|NCT00153166|21075528|P2|NOT COMPLETED|Overall Study||0
8548530|NCT00153166|21075529|P1|NOT COMPLETED|Overall Study||0
8548531|NCT00153166|21075527|P3|COMPLETED|Overall Study||28
8548532|NCT00153166|21075528|P2|COMPLETED|Overall Study||37
8548533|NCT00153166|21075529|P1|COMPLETED|Overall Study||11
8548534|NCT00153166|21075527|P3|Received Placebo and Placebo|Overall Study||7
8548535|NCT00153166|21075528|P2|Received Placebo and Placebo|Overall Study||9
8548536|NCT00153166|21075529|P1|Received Placebo and Placebo|Overall Study||3
8548537|NCT00153166|21075527|P3|Received Placebo and Pioglitazone|Overall Study||7
8548538|NCT00153166|21075528|P2|Received Placebo and Pioglitazone|Overall Study||10
8548539|NCT00153166|21075529|P1|Received Placebo and Pioglitazone|Overall Study||3
8548540|NCT00153166|21075527|P3|Received Atorvastatin and Placebo|Overall Study||7
8548541|NCT00153166|21075528|P2|Received Atorvastatin and Placebo|Overall Study||9
8548542|NCT00153166|21075529|P1|Received Atorvastatin and Placebo|Overall Study||2
8548543|NCT00153166|21075527|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
8548544|NCT00153166|21075528|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
8548545|NCT00153166|21075529|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
8548546|NCT00153166|21075527|P3|STARTED|Overall Study||28
8548547|NCT00153166|21075528|P2|STARTED|Overall Study||37
8548548|NCT00153166|21075529|P1|STARTED|Overall Study||11
8548549|NCT00153101|21075546|P5|NOT COMPLETED|Overall Study||10
8548550|NCT00153101|21075547|P4|NOT COMPLETED|Overall Study||8
8548551|NCT00153101|21075548|P3|NOT COMPLETED|Overall Study||15
8548552|NCT00153101|21075549|P2|NOT COMPLETED|Overall Study||18
8548553|NCT00153101|21075550|P1|NOT COMPLETED|Overall Study||17
8548554|NCT00153101|21075546|P5|COMPLETED|Overall Study||2962
8548555|NCT00153101|21075547|P4|COMPLETED|Overall Study||2946
8548556|NCT00153101|21075548|P3|COMPLETED|Overall Study||8561
8548557|NCT00153101|21075549|P2|COMPLETED|Overall Study||8524
8548558|NCT00153101|21075550|P1|COMPLETED|Overall Study||8485
8548559|NCT00153101|21075546|P5|STARTED|Overall Study||2972
8548560|NCT00153101|21075547|P4|STARTED|Overall Study||2954
8548561|NCT00153101|21075548|P3|STARTED|Overall Study||8576
8548562|NCT00153101|21075549|P2|STARTED|Overall Study||8542
8548563|NCT00153101|21075550|P1|STARTED|Overall Study||8502
8548564|NCT00153062|21075658|P4|NOT COMPLETED|Overall Study||411
8548565|NCT00153062|21075659|P3|NOT COMPLETED|Overall Study||415
8548566|NCT00153062|21075660|P2|NOT COMPLETED|Overall Study||406
8548567|NCT00153062|21075661|P1|NOT COMPLETED|Overall Study||387
8548568|NCT00153062|21075658|P4|COMPLETED|Overall Study||4680
8548569|NCT00153062|21075659|P3|COMPLETED|Overall Study||4645
8548570|NCT00153062|21075660|P2|COMPLETED|Overall Study||4689
8548571|NCT00153062|21075661|P1|COMPLETED|Overall Study||4699
8548572|NCT00153062|21075658|P4|STARTED|Overall Study||5091
8548573|NCT00153062|21075659|P3|STARTED|Overall Study||5060
8548574|NCT00153062|21075660|P2|STARTED|Overall Study||5095
8548575|NCT00153062|21075661|P1|STARTED|Overall Study||5086
8548576|NCT00152971|21075680|P3|NOT COMPLETED|Treatment||80
8548577|NCT00152971|21075681|P2|NOT COMPLETED|Treatment||63
8548578|NCT00152971|21075682|P1|NOT COMPLETED|Treatment||71
8548579|NCT00152971|21075680|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
8548580|NCT00152971|21075681|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
8548581|NCT00152971|21075682|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
8548582|NCT00152971|21075680|P3|STARTED|Treatment||868
8548583|NCT00152971|21075681|P2|STARTED|Treatment||871
8548584|NCT00152971|21075682|P1|STARTED|Treatment||857
8548585|NCT00152971|21075680|P3|NOT COMPLETED|Overall Study||49
8548586|NCT00152971|21075681|P2|NOT COMPLETED|Overall Study||48
8548587|NCT00152971|21075682|P1|NOT COMPLETED|Overall Study||51
8548588|NCT00152971|21075680|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
8548589|NCT00152971|21075681|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
8548590|NCT00152971|21075682|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
8548591|NCT00152971|21075680|P3|STARTED|Overall Study||868
8548592|NCT00152971|21075681|P2|STARTED|Overall Study||871
8548593|NCT00152971|21075682|P1|STARTED|Overall Study||857
8548594|NCT00152763|21075718|P4|NOT COMPLETED|Overall Study||14
8548595|NCT00152763|21075719|P3|NOT COMPLETED|Overall Study||4
8548596|NCT00152763|21075720|P2|NOT COMPLETED|Overall Study||5
8548597|NCT00152763|21075721|P1|NOT COMPLETED|Overall Study||10
8548598|NCT00152763|21075718|P4|COMPLETED|Overall Study||63
8548599|NCT00152763|21075719|P3|COMPLETED|Overall Study||16
8548600|NCT00152763|21075720|P2|COMPLETED|Overall Study||14
8548601|NCT00152763|21075721|P1|COMPLETED|Overall Study||67
8548602|NCT00152763|21075718|P4|STARTED|Overall Study||77
8548603|NCT00152763|21075719|P3|STARTED|Overall Study||20
8548604|NCT00152763|21075720|P2|STARTED|Overall Study||19
8548605|NCT00152763|21075721|P1|STARTED|Overall Study||77
8548606|NCT00152516|21075837|P1|NOT COMPLETED|Overall Study||75
8548607|NCT00152516|21075837|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
8548608|NCT00152516|21075837|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
8548609|NCT00152464|21075863|P2|NOT COMPLETED|Overall Study||36
8548610|NCT00152464|21075864|P1|NOT COMPLETED|Overall Study||40
8548611|NCT00152464|21075863|P2|COMPLETED|Overall Study||219
8548612|NCT00152464|21075864|P1|COMPLETED|Overall Study||215
8548613|NCT00152464|21075863|P2|STARTED|Overall Study||255
8548614|NCT00152464|21075864|P1|STARTED|Overall Study||255
8548615|NCT00152009|21075892|P4|NOT COMPLETED|Overall Study||33
8548616|NCT00152009|21075893|P3|NOT COMPLETED|Overall Study||37
8548617|NCT00152009|21075894|P2|NOT COMPLETED|Overall Study||31
8548618|NCT00152009|21075895|P1|NOT COMPLETED|Overall Study||29
8548619|NCT00152009|21075892|P4|COMPLETED|Overall Study||53
8548620|NCT00152009|21075893|P3|COMPLETED|Overall Study||49
8548621|NCT00152009|21075894|P2|COMPLETED|Overall Study||55
8548622|NCT00152009|21075895|P1|COMPLETED|Overall Study||58
8548623|NCT00152009|21075892|P4|STARTED|Overall Study||86
8548624|NCT00152009|21075893|P3|STARTED|Overall Study||86
8548625|NCT00152009|21075894|P2|STARTED|Overall Study||86
8548626|NCT00152009|21075895|P1|STARTED|Overall Study||87
8548627|NCT00151996|21075927|P2|NOT COMPLETED|Overall Study||7
8548628|NCT00151996|21075928|P1|NOT COMPLETED|Overall Study||5
8548629|NCT00151996|21075927|P2|COMPLETED|Overall Study||26
8548630|NCT00151996|21075928|P1|COMPLETED|Overall Study||37
8548631|NCT00151996|21075927|P2|STARTED|Overall Study||33
8548632|NCT00151996|21075928|P1|STARTED|Overall Study||42
8548633|NCT00151892|21075944|P2|NOT COMPLETED|Overall Study||83
8548634|NCT00151892|21075945|P1|NOT COMPLETED|Overall Study||76
8548635|NCT00151892|21075944|P2|COMPLETED|Overall Study||330
8548636|NCT00151892|21075945|P1|COMPLETED|Overall Study||340
8548637|NCT00151892|21075944|P2|STARTED|Overall Study||413
8548638|NCT00151892|21075945|P1|STARTED|Overall Study||416
8548639|NCT00151814|21075962|P3|NOT COMPLETED|Overall Study||0
8548640|NCT00151814|21075963|P2|NOT COMPLETED|Overall Study||0
8548641|NCT00151814|21075964|P1|NOT COMPLETED|Overall Study||0
8548642|NCT00151814|21075962|P3|COMPLETED|Overall Study||10
8548643|NCT00151814|21075963|P2|COMPLETED|Overall Study||10
8548644|NCT00151814|21075964|P1|COMPLETED|Overall Study||4
8548645|NCT00151814|21075962|P3|STARTED|Overall Study||10
8548646|NCT00151814|21075963|P2|STARTED|Overall Study||10
8548647|NCT00151814|21075964|P1|STARTED|Overall Study||4
8548648|NCT00151775|21075990|P12|NOT COMPLETED|Period 4: Open Label||0
8548649|NCT00151775|21075991|P11|NOT COMPLETED|Period 4: Open Label||0
8548650|NCT00151775|21075992|P10|NOT COMPLETED|Period 4: Open Label||21
8548651|NCT00151775|21075993|P9|NOT COMPLETED|Period 4: Open Label||0
8548652|NCT00151775|21075994|P8|NOT COMPLETED|Period 4: Open Label||0
8548653|NCT00151775|21075995|P7|NOT COMPLETED|Period 4: Open Label||0
8548654|NCT00151775|21075996|P6|NOT COMPLETED|Period 4: Open Label||0
8548655|NCT00151775|21075997|P5|NOT COMPLETED|Period 4: Open Label||30
8548656|NCT00151775|21075998|P4|NOT COMPLETED|Period 4: Open Label||0
8548657|NCT00151775|21075999|P3|NOT COMPLETED|Period 4: Open Label||0
8548658|NCT00151775|21076000|P2|NOT COMPLETED|Period 4: Open Label||0
8548659|NCT00151775|21076001|P1|NOT COMPLETED|Period 4: Open Label||0
8548660|NCT00151775|21075990|P12|COMPLETED|Period 4: Open Label||0
8548661|NCT00151775|21075991|P11|COMPLETED|Period 4: Open Label||57
8548662|NCT00151775|21075992|P10|COMPLETED|Period 4: Open Label||83
8548663|NCT00151775|21075993|P9|COMPLETED|Period 4: Open Label||0
8548664|NCT00151775|21075994|P8|COMPLETED|Period 4: Open Label||0
8548665|NCT00151775|21075995|P7|COMPLETED|Period 4: Open Label||0
8548666|NCT00151775|21075996|P6|COMPLETED|Period 4: Open Label||0
8548667|NCT00151775|21075997|P5|COMPLETED|Period 4: Open Label||149
8548668|NCT00151775|21075998|P4|COMPLETED|Period 4: Open Label||0
8548669|NCT00151775|21075999|P3|COMPLETED|Period 4: Open Label||0
8548670|NCT00151775|21076000|P2|COMPLETED|Period 4: Open Label||0
8548671|NCT00151775|21076001|P1|COMPLETED|Period 4: Open Label||0
8548672|NCT00151775|21075990|P12|STARTED|Period 4: Open Label||0
8548673|NCT00151775|21075991|P11|STARTED|Period 4: Open Label||57
8548674|NCT00151775|21075992|P10|STARTED|Period 4: Open Label||104
8548675|NCT00151775|21075993|P9|STARTED|Period 4: Open Label||0
8548676|NCT00151775|21075994|P8|STARTED|Period 4: Open Label||0
8548677|NCT00151775|21075995|P7|STARTED|Period 4: Open Label||0
8548678|NCT00151775|21075996|P6|STARTED|Period 4: Open Label||0
8548679|NCT00151775|21075997|P5|STARTED|Period 4: Open Label||179
8548680|NCT00151775|21075998|P4|STARTED|Period 4: Open Label||0
8548681|NCT00151775|21075999|P3|STARTED|Period 4: Open Label||0
8548682|NCT00151775|21076000|P2|STARTED|Period 4: Open Label||0
8548683|NCT00151775|21076001|P1|STARTED|Period 4: Open Label||0
8548684|NCT00151775|21075990|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548685|NCT00151775|21075991|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548686|NCT00151775|21075992|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548687|NCT00151775|21075993|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548688|NCT00151775|21075994|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548689|NCT00151775|21075995|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548690|NCT00151775|21075996|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548691|NCT00151775|21075997|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548692|NCT00151775|21075998|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548693|NCT00151775|21075999|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
8548694|NCT00151775|21076000|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548695|NCT00151775|21076001|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548696|NCT00151775|21075990|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
8548697|NCT00151775|21075991|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
8548698|NCT00151775|21075992|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
8548699|NCT00151775|21075993|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
8548700|NCT00151775|21075994|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
8548701|NCT00151775|21075995|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
8548702|NCT00151775|21075996|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
8548703|NCT00151775|21075997|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
8548704|NCT00151775|21075998|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
8548705|NCT00151775|21075999|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
8548706|NCT00151775|21076000|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
8548707|NCT00151775|21076001|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
8548708|NCT00151775|21075990|P12|STARTED|Period 3: Double-blind, Withdrawal||29
8548709|NCT00151775|21075991|P11|STARTED|Period 3: Double-blind, Withdrawal||29
8548710|NCT00151775|21075992|P10|STARTED|Period 3: Double-blind, Withdrawal||0
8548711|NCT00151775|21075993|P9|STARTED|Period 3: Double-blind, Withdrawal||26
8548712|NCT00151775|21075994|P8|STARTED|Period 3: Double-blind, Withdrawal||28
8548713|NCT00151775|21075995|P7|STARTED|Period 3: Double-blind, Withdrawal||27
8548714|NCT00151775|21075996|P6|STARTED|Period 3: Double-blind, Withdrawal||26
8548715|NCT00151775|21075997|P5|STARTED|Period 3: Double-blind, Withdrawal||0
8548716|NCT00151775|21075998|P4|STARTED|Period 3: Double-blind, Withdrawal||44
8548717|NCT00151775|21075999|P3|STARTED|Period 3: Double-blind, Withdrawal||45
8548718|NCT00151775|21076000|P2|STARTED|Period 3: Double-blind, Withdrawal||45
8548719|NCT00151775|21076001|P1|STARTED|Period 3: Double-blind, Withdrawal||48
8548720|NCT00151775|21075990|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548805|NCT00150618|21076193|P4|NOT COMPLETED|Overall Study||26
8548721|NCT00151775|21075991|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
8548722|NCT00151775|21075992|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548723|NCT00151775|21075993|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548724|NCT00151775|21075994|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548725|NCT00151775|21075995|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
8548726|NCT00151775|21075996|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
8548727|NCT00151775|21075997|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548728|NCT00151775|21075998|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548729|NCT00151775|21075999|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548730|NCT00151775|21076000|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
8548731|NCT00151775|21076001|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
8548732|NCT00151775|21075990|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548733|NCT00151775|21075991|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
8548734|NCT00151775|21075992|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548735|NCT00151775|21075993|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548736|NCT00151775|21075994|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548737|NCT00151775|21075995|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
8548738|NCT00151775|21075996|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
8548739|NCT00151775|21075997|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548740|NCT00151775|21075998|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548741|NCT00151775|21075999|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548742|NCT00151775|21076000|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
8548743|NCT00151775|21076001|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
8548744|NCT00151775|21075990|P12|STARTED|Period 2 - Double-Blind Dose Response||0
8548745|NCT00151775|21075991|P11|STARTED|Period 2 - Double-Blind Dose Response||60
8548746|NCT00151775|21075992|P10|STARTED|Period 2 - Double-Blind Dose Response||0
8548747|NCT00151775|21075993|P9|STARTED|Period 2 - Double-Blind Dose Response||0
8548748|NCT00151775|21075994|P8|STARTED|Period 2 - Double-Blind Dose Response||0
8548749|NCT00151775|21075995|P7|STARTED|Period 2 - Double-Blind Dose Response||56
8548750|NCT00151775|21075996|P6|STARTED|Period 2 - Double-Blind Dose Response||56
8548751|NCT00151775|21075997|P5|STARTED|Period 2 - Double-Blind Dose Response||0
8548752|NCT00151775|21075998|P4|STARTED|Period 2 - Double-Blind Dose Response||0
8548753|NCT00151775|21075999|P3|STARTED|Period 2 - Double-Blind Dose Response||0
8548754|NCT00151775|21076000|P2|STARTED|Period 2 - Double-Blind Dose Response||95
8548755|NCT00151775|21076001|P1|STARTED|Period 2 - Double-Blind Dose Response||95
8548756|NCT00151476|21076045|P2|NOT COMPLETED|FAP Analyzed Subjects||3
8548757|NCT00151476|21076046|P1|NOT COMPLETED|FAP Analyzed Subjects||0
8548758|NCT00151476|21076045|P2|COMPLETED|FAP Analyzed Subjects||51
8548759|NCT00151476|21076046|P1|COMPLETED|FAP Analyzed Subjects||13
8548760|NCT00151476|21076045|P2|STARTED|FAP Analyzed Subjects||54
8548761|NCT00151476|21076046|P1|STARTED|FAP Analyzed Subjects||13
8548762|NCT00151476|21076045|P2|NOT COMPLETED|FAP Identified Subjects||1
8548763|NCT00151476|21076046|P1|NOT COMPLETED|FAP Identified Subjects||0
8548764|NCT00151476|21076045|P2|COMPLETED|FAP Identified Subjects||54
8548765|NCT00151476|21076046|P1|COMPLETED|FAP Identified Subjects||13
8548766|NCT00151476|21076045|P2|STARTED|FAP Identified Subjects||55
8548767|NCT00151476|21076046|P1|STARTED|FAP Identified Subjects||13
8548768|NCT00151411|21076103|P2|NOT COMPLETED|Overall Study||43
8548769|NCT00151411|21076104|P1|NOT COMPLETED|Overall Study||33
8548770|NCT00151411|21076103|P2|COMPLETED|Overall Study||16
8548771|NCT00151411|21076104|P1|COMPLETED|Overall Study||22
8548772|NCT00151411|21076103|P2|STARTED|Overall Study||59
8548773|NCT00151411|21076104|P1|STARTED|Overall Study||55
8548774|NCT00151372|21076116|P2|NOT COMPLETED|Overall Study||29
8548775|NCT00151372|21076117|P1|NOT COMPLETED|Overall Study||29
8548776|NCT00151372|21076116|P2|COMPLETED|Overall Study||45
8548777|NCT00151372|21076117|P1|COMPLETED|Overall Study||38
8548778|NCT00151372|21076116|P2|STARTED|Overall Study||74
8548779|NCT00151372|21076117|P1|STARTED|Overall Study||67
8548780|NCT00151320|21076127|P1|NOT COMPLETED|Overall Study||0
8548781|NCT00151320|21076127|P1|COMPLETED|Overall Study||76
8548782|NCT00151320|21076127|P1|STARTED|Overall Study||76
8548783|NCT00151281|21076132|P1|NOT COMPLETED|Overall Study||3
8548784|NCT00151281|21076132|P1|COMPLETED|Overall Study||22
8548785|NCT00151281|21076132|P1|STARTED|Overall Study||25
8548786|NCT00150969|21076141|P2|NOT COMPLETED|24-48 Month Extension||100
8548787|NCT00150969|21076142|P1|NOT COMPLETED|24-48 Month Extension||88
8548788|NCT00150969|21076141|P2|COMPLETED|24-48 Month Extension||40
8548789|NCT00150969|21076142|P1|COMPLETED|24-48 Month Extension||33
8548790|NCT00150969|21076141|P2|STARTED|24-48 Month Extension||140
8548791|NCT00150969|21076142|P1|STARTED|24-48 Month Extension||121
8548792|NCT00150969|21076141|P2|NOT COMPLETED|24 Month Main Study||21
8548793|NCT00150969|21076142|P1|NOT COMPLETED|24 Month Main Study||19
8548794|NCT00150969|21076141|P2|COMPLETED|24 Month Main Study||202
8548795|NCT00150969|21076142|P1|COMPLETED|24 Month Main Study||198
8548796|NCT00150969|21076141|P2|STARTED|24 Month Main Study||223
8548797|NCT00150969|21076142|P1|STARTED|24 Month Main Study||217
8548798|NCT00150813|21076174|P1|NOT COMPLETED|Overall Study||18
8548799|NCT00150813|21076174|P1|COMPLETED|Overall Study||48
8548800|NCT00150813|21076174|P1|STARTED|Overall Study||66
8548801|NCT00150800|21076178|P1|NOT COMPLETED|Overall Study||496
8548802|NCT00150800|21076178|P1|COMPLETED|Overall Study||171
8548803|NCT00150800|21076178|P1|STARTED|Overall Study||667
8548804|NCT00150618|21076192|P5|NOT COMPLETED|Overall Study||25
8548806|NCT00150618|21076194|P3|NOT COMPLETED|Overall Study||27
8548807|NCT00150618|21076195|P2|NOT COMPLETED|Overall Study||18
8548808|NCT00150618|21076196|P1|NOT COMPLETED|Overall Study||17
8548809|NCT00150618|21076192|P5|COMPLETED|Overall Study||41
8548810|NCT00150618|21076193|P4|COMPLETED|Overall Study||40
8548811|NCT00150618|21076194|P3|COMPLETED|Overall Study||38
8548812|NCT00150618|21076195|P2|COMPLETED|Overall Study||47
8548813|NCT00150618|21076196|P1|COMPLETED|Overall Study||45
8548814|NCT00150618|21076192|P5|STARTED|Overall Study||66
8548815|NCT00150618|21076193|P4|STARTED|Overall Study||66
8548816|NCT00150618|21076194|P3|STARTED|Overall Study||65
8548817|NCT00150618|21076195|P2|STARTED|Overall Study||65
8548818|NCT00150618|21076196|P1|STARTED|Overall Study||62
8548819|NCT00150592|21076230|P2|NOT COMPLETED|Overall Study||3
8548820|NCT00150592|21076231|P1|NOT COMPLETED|Overall Study||7
8548821|NCT00150592|21076230|P2|COMPLETED|Overall Study||54
8548822|NCT00150592|21076231|P1|COMPLETED|Overall Study||114
8548823|NCT00150592|21076230|P2|STARTED|Overall Study||57
8548824|NCT00150592|21076231|P1|STARTED|Overall Study||121
8548825|NCT00150462|21076262|P11|NOT COMPLETED|Overall Study||3
8548826|NCT00150462|21076263|P10|NOT COMPLETED|Overall Study||6
8548827|NCT00150462|21076264|P9|NOT COMPLETED|Overall Study||6
8548828|NCT00150462|21076265|P8|NOT COMPLETED|Overall Study||8
8548829|NCT00150462|21076266|P7|NOT COMPLETED|Overall Study||3
8548830|NCT00150462|21076267|P6|NOT COMPLETED|Overall Study||4
8548831|NCT00150462|21076268|P5|NOT COMPLETED|Overall Study||3
8548832|NCT00150462|21076269|P4|NOT COMPLETED|Overall Study||3
8548833|NCT00150462|21076270|P3|NOT COMPLETED|Overall Study||4
8548834|NCT00150462|21076271|P2|NOT COMPLETED|Overall Study||3
8548835|NCT00150462|21076272|P1|NOT COMPLETED|Overall Study||3
8548836|NCT00150462|21076262|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
8548837|NCT00150462|21076263|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
8548838|NCT00150462|21076264|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548839|NCT00150462|21076265|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548840|NCT00150462|21076266|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548841|NCT00150462|21076267|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548842|NCT00150462|21076268|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548843|NCT00150462|21076269|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548844|NCT00150462|21076270|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548845|NCT00150462|21076271|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548846|NCT00150462|21076272|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548847|NCT00150462|21076262|P11|STARTED|Overall Study||4
8548848|NCT00150462|21076263|P10|STARTED|Overall Study||7
8548849|NCT00150462|21076264|P9|STARTED|Overall Study||6
8548850|NCT00150462|21076265|P8|STARTED|Overall Study||8
8548851|NCT00150462|21076266|P7|STARTED|Overall Study||3
8548852|NCT00150462|21076267|P6|STARTED|Overall Study||4
8548853|NCT00150462|21076268|P5|STARTED|Overall Study||3
8548854|NCT00150462|21076269|P4|STARTED|Overall Study||3
8548855|NCT00150462|21076270|P3|STARTED|Overall Study||4
8548856|NCT00150462|21076271|P2|STARTED|Overall Study||3
8548857|NCT00150462|21076272|P1|STARTED|Overall Study||3
8548858|NCT00150345|21076382|P2|NOT COMPLETED|Overall Study||32
8548859|NCT00150345|21076383|P1|NOT COMPLETED|Overall Study||34
8548860|NCT00150345|21076382|P2|COMPLETED|Overall Study||34
8548861|NCT00150345|21076383|P1|COMPLETED|Overall Study||47
8548862|NCT00150345|21076382|P2|STARTED|Overall Study||66
8548863|NCT00150345|21076383|P1|STARTED|Overall Study||81
8548864|NCT00150176|21076447|P2|NOT COMPLETED|Overall Study||120
8548865|NCT00150176|21076448|P1|NOT COMPLETED|Overall Study||59
8548866|NCT00150176|21076447|P2|COMPLETED|Overall Study||72
8548867|NCT00150176|21076448|P1|COMPLETED|Overall Study||135
8548868|NCT00150176|21076447|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
8548869|NCT00150176|21076448|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
8548870|NCT00149994|21076459|P2|NOT COMPLETED|Overall Study||1
8548871|NCT00149994|21076460|P1|NOT COMPLETED|Overall Study||1
8548872|NCT00149994|21076459|P2|COMPLETED|Overall Study||85
8548873|NCT00149994|21076460|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
8548874|NCT00149994|21076459|P2|STARTED|Overall Study||86
8548875|NCT00149994|21076460|P1|STARTED|Overall Study|"Started indicates Safety population."|85
8548876|NCT00149890|21076468|P2|NOT COMPLETED|Overall Study||18
8548877|NCT00149890|21076469|P1|NOT COMPLETED|Overall Study||13
8548878|NCT00149890|21076468|P2|COMPLETED|Overall Study||20
8548879|NCT00149890|21076469|P1|COMPLETED|Overall Study||26
8548880|NCT00149890|21076468|P2|STARTED|Overall Study||38
8548881|NCT00149890|21076469|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
8548882|NCT00149838|21076489|P4|NOT COMPLETED|Phase III||24
8548883|NCT00149838|21076490|P3|NOT COMPLETED|Phase III||0
8548884|NCT00149838|21076491|P2|NOT COMPLETED|Phase III||0
8548885|NCT00149838|21076492|P1|NOT COMPLETED|Phase III||0
8548886|NCT00149838|21076489|P4|COMPLETED|Phase III||37
8548887|NCT00149838|21076490|P3|COMPLETED|Phase III||0
8548888|NCT00149838|21076491|P2|COMPLETED|Phase III||0
8548889|NCT00149838|21076492|P1|COMPLETED|Phase III||0
8548890|NCT00149838|21076489|P4|STARTED|Phase III||61
8548891|NCT00149838|21076490|P3|STARTED|Phase III||0
8548892|NCT00149838|21076491|P2|STARTED|Phase III||0
8548893|NCT00149838|21076492|P1|STARTED|Phase III||0
8548894|NCT00149838|21076489|P4|NOT COMPLETED|Phase II||0
8548895|NCT00149838|21076490|P3|NOT COMPLETED|Phase II||0
8548896|NCT00149838|21076491|P2|NOT COMPLETED|Phase II||0
8548897|NCT00149838|21076492|P1|NOT COMPLETED|Phase II||0
8548898|NCT00149838|21076489|P4|COMPLETED|Phase II||0
8548899|NCT00149838|21076490|P3|COMPLETED|Phase II||144
8548900|NCT00149838|21076491|P2|COMPLETED|Phase II||0
8548901|NCT00149838|21076492|P1|COMPLETED|Phase II||0
8548902|NCT00149838|21076489|P4|STARTED|Phase II||0
8548903|NCT00149838|21076490|P3|STARTED|Phase II||144
8548904|NCT00149838|21076491|P2|STARTED|Phase II||0
8548905|NCT00149838|21076492|P1|STARTED|Phase II||0
8548906|NCT00149838|21076489|P4|NOT COMPLETED|Phase I||0
8548907|NCT00149838|21076490|P3|NOT COMPLETED|Phase I||0
8548908|NCT00149838|21076491|P2|NOT COMPLETED|Phase I||16
8548909|NCT00149838|21076492|P1|NOT COMPLETED|Phase I||20
8548910|NCT00149838|21076489|P4|COMPLETED|Phase I||0
8548911|NCT00149838|21076490|P3|COMPLETED|Phase I||0
8548912|NCT00149838|21076491|P2|COMPLETED|Phase I||82
8548913|NCT00149838|21076492|P1|COMPLETED|Phase I||72
8548914|NCT00149838|21076489|P4|STARTED|Phase I||0
8548915|NCT00149838|21076490|P3|STARTED|Phase I||0
8548916|NCT00149838|21076491|P2|STARTED|Phase I||98
8548917|NCT00149838|21076492|P1|STARTED|Phase I||92
8548918|NCT00149825|21076504|P2|NOT COMPLETED|Overall Study||3
8548919|NCT00149825|21076505|P1|NOT COMPLETED|Overall Study||5
8548920|NCT00149825|21076504|P2|COMPLETED|Overall Study||12
8548921|NCT00149825|21076505|P1|COMPLETED|Overall Study||10
8548922|NCT00149825|21076504|P2|STARTED|Overall Study||15
8548923|NCT00149825|21076505|P1|STARTED|Overall Study||15
8548924|NCT00149799|21076515|P3|NOT COMPLETED|Discontinuation (Phase II)||9
8548925|NCT00149799|21076516|P2|NOT COMPLETED|Discontinuation (Phase II)||3
8548926|NCT00149799|21076517|P1|NOT COMPLETED|Discontinuation (Phase II)||0
8548927|NCT00149799|21076515|P3|COMPLETED|Discontinuation (Phase II)||21
8548928|NCT00149799|21076516|P2|COMPLETED|Discontinuation (Phase II)||25
8548929|NCT00149799|21076517|P1|COMPLETED|Discontinuation (Phase II)||0
8548930|NCT00149799|21076515|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
8548931|NCT00149799|21076516|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
8548932|NCT00149799|21076517|P1|STARTED|Discontinuation (Phase II)||0
8548933|NCT00149799|21076515|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
8548934|NCT00149799|21076516|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
8548935|NCT00149799|21076517|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
8548936|NCT00149799|21076515|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
8548937|NCT00149799|21076516|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
8548938|NCT00149799|21076517|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
8548939|NCT00149799|21076515|P3|STARTED|Open Label Escitalopram (Phase I)||0
8548940|NCT00149799|21076516|P2|STARTED|Open Label Escitalopram (Phase I)||0
8548941|NCT00149799|21076517|P1|STARTED|Open Label Escitalopram (Phase I)||100
8548942|NCT00149747|21076533|P2|NOT COMPLETED|Overall Study||3
8548943|NCT00149747|21076534|P1|NOT COMPLETED|Overall Study||4
8548944|NCT00149747|21076533|P2|COMPLETED|Overall Study||27
8548945|NCT00149747|21076534|P1|COMPLETED|Overall Study||32
8548946|NCT00149747|21076533|P2|STARTED|Overall Study||30
8548947|NCT00149747|21076534|P1|STARTED|Overall Study||36
8548948|NCT00149669|21076546|P2|NOT COMPLETED|Overall Study||5
8548949|NCT00149669|21076547|P1|NOT COMPLETED|Overall Study||3
8548950|NCT00149669|21076546|P2|COMPLETED|Overall Study||30
8548951|NCT00149669|21076547|P1|COMPLETED|Overall Study||29
8548952|NCT00149669|21076546|P2|STARTED|Overall Study||35
8548953|NCT00149669|21076547|P1|STARTED|Overall Study||32
8548954|NCT00149643|21076567|P2|NOT COMPLETED|Overall Study||36
8548955|NCT00149643|21076568|P1|NOT COMPLETED|Overall Study||34
8548956|NCT00149643|21076567|P2|COMPLETED|Overall Study||0
8548957|NCT00149643|21076568|P1|COMPLETED|Overall Study||0
8548958|NCT00149643|21076567|P2|STARTED|Overall Study||36
8548959|NCT00149643|21076568|P1|STARTED|Overall Study||34
8548960|NCT00149630|21076580|P2|NOT COMPLETED|Overall Study||5
8548961|NCT00149630|21076581|P1|NOT COMPLETED|Overall Study||8
8548962|NCT00149630|21076580|P2|COMPLETED|Overall Study||35
8548963|NCT00149630|21076581|P1|COMPLETED|Overall Study||26
8548964|NCT00149630|21076580|P2|STARTED|Overall Study||40
8548965|NCT00149630|21076581|P1|STARTED|Overall Study||34
8548966|NCT00149396|21076591|P1|NOT COMPLETED|Overall Study||23
8548967|NCT00149396|21076591|P1|COMPLETED|Overall Study||9
8548968|NCT00149396|21076591|P1|Completed NV1020 and Chemotherapy|Overall Study||9
8548969|NCT00149396|21076591|P1|Completed NV1020 Therapy|Overall Study||29
8548970|NCT00149396|21076591|P1|STARTED|Overall Study||32
8548971|NCT00149227|21076634|P2|NOT COMPLETED|Overall Study||0
8548972|NCT00149227|21076635|P1|NOT COMPLETED|Overall Study||0
8548973|NCT00149227|21076634|P2|COMPLETED|Overall Study||1514
8548974|NCT00149227|21076635|P1|COMPLETED|Overall Study||1517
8548975|NCT00149227|21076634|P2|STARTED|Overall Study||1514
8548976|NCT00149227|21076635|P1|STARTED|Overall Study||1517
8548977|NCT00149214|21076661|P2|NOT COMPLETED|Overall Study||17
8548978|NCT00149214|21076662|P1|NOT COMPLETED|Overall Study||26
8548979|NCT00149214|21076661|P2|COMPLETED|Overall Study||105
8548980|NCT00149214|21076662|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
8548981|NCT00149214|21076661|P2|STARTED|Overall Study||122
8549072|NCT00147823|21076883|P2|STARTED|Overall Study||31
8548982|NCT00149214|21076662|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
8548983|NCT00148954|21076678|P2|NOT COMPLETED|Overall Study||300
8548984|NCT00148954|21076679|P1|NOT COMPLETED|Overall Study||307
8548985|NCT00148954|21076678|P2|COMPLETED|Overall Study||677
8548986|NCT00148954|21076679|P1|COMPLETED|Overall Study||678
8548987|NCT00148954|21076678|P2|STARTED|Overall Study||977
8548988|NCT00148954|21076679|P1|STARTED|Overall Study||985
8548989|NCT00148941|21076689|P4|NOT COMPLETED|Overall Study||24
8548990|NCT00148941|21076690|P3|NOT COMPLETED|Overall Study||20
8548991|NCT00148941|21076691|P2|NOT COMPLETED|Overall Study||24
8548992|NCT00148941|21076692|P1|NOT COMPLETED|Overall Study||18
8548993|NCT00148941|21076689|P4|COMPLETED|Overall Study||1029
8548994|NCT00148941|21076690|P3|COMPLETED|Overall Study||1032
8548995|NCT00148941|21076691|P2|COMPLETED|Overall Study||1027
8548996|NCT00148941|21076692|P1|COMPLETED|Overall Study||1035
8548997|NCT00148941|21076689|P4|STARTED|Overall Study||1053
8548998|NCT00148941|21076690|P3|STARTED|Overall Study||1052
8548999|NCT00148941|21076691|P2|STARTED|Overall Study||1051
8549000|NCT00148941|21076692|P1|STARTED|Overall Study||1053
8549001|NCT00148798|21076784|P2|NOT COMPLETED|Overall Study||0
8549002|NCT00148798|21076785|P1|NOT COMPLETED|Overall Study||0
8549003|NCT00148798|21076784|P2|COMPLETED|Overall Study||568
8549004|NCT00148798|21076785|P1|COMPLETED|Overall Study||557
8549005|NCT00148798|21076784|P2|STARTED|Overall Study|ITT Population|568
8549006|NCT00148798|21076785|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
8549007|NCT00148759|21076807|P2|NOT COMPLETED|Overall Study||1
8549008|NCT00148759|21076808|P1|NOT COMPLETED|Overall Study||2
8549009|NCT00148759|21076807|P2|COMPLETED|Overall Study||11
8549010|NCT00148759|21076808|P1|COMPLETED|Overall Study||9
8549011|NCT00148759|21076807|P2|24-hr PK Sampling|Overall Study||11
8549012|NCT00148759|21076808|P1|24-hr PK Sampling|Overall Study||9
8549013|NCT00148759|21076807|P2|STARTED|Overall Study||12
8549014|NCT00148759|21076808|P1|STARTED|Overall Study||11
8549021|NCT00148668|21076827|P2|NOT COMPLETED|Overall Study||0
8549022|NCT00148668|21076828|P1|NOT COMPLETED|Overall Study||0
8549023|NCT00148668|21076827|P2|COMPLETED|Overall Study||40
8549024|NCT00148668|21076828|P1|COMPLETED|Overall Study||41
8549025|NCT00148668|21076827|P2|STARTED|Overall Study||40
8549026|NCT00148668|21076828|P1|STARTED|Overall Study||41
8549027|NCT00148343|21076836|P2|NOT COMPLETED|Overall Study||11
8549028|NCT00148343|21076837|P1|NOT COMPLETED|Overall Study||15
8549029|NCT00148343|21076836|P2|COMPLETED|Overall Study||45
8549030|NCT00148343|21076837|P1|COMPLETED|Overall Study||39
8549031|NCT00148343|21076836|P2|STARTED|Overall Study||56
8549032|NCT00148343|21076837|P1|STARTED|Overall Study||54
8549033|NCT00148317|21076851|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
8549034|NCT00148317|21076851|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
8549035|NCT00148317|21076851|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
8549036|NCT00148317|21076851|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
8549037|NCT00148317|21076851|P1|COMPLETED|Consolidation (VEL + DEX)||38
8549038|NCT00148317|21076851|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
8549039|NCT00148317|21076851|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
8549040|NCT00148317|21076851|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
8549041|NCT00148317|21076851|P1|STARTED|Consolidation (VEL + DEX)||38
8549042|NCT00148122|21076858|P1|NOT COMPLETED|Overall Study||2
8549043|NCT00148122|21076858|P1|COMPLETED|Overall Study||38
8549044|NCT00148122|21076858|P1|STARTED|Overall Study||40
8549045|NCT00148109|21076866|P2|NOT COMPLETED|Overall Study||20
8549046|NCT00148109|21076867|P1|NOT COMPLETED|Overall Study||12
8549047|NCT00148109|21076866|P2|COMPLETED|Overall Study||1
8549048|NCT00148109|21076867|P1|COMPLETED|Overall Study||3
8549049|NCT00148109|21076866|P2|STARTED|Overall Study||21
8549050|NCT00148109|21076867|P1|STARTED|Overall Study||15
8549051|NCT00147966|21076877|P1|NOT COMPLETED|Overall Study||0
8549052|NCT00147966|21076877|P1|COMPLETED|Overall Study||24
8549053|NCT00147966|21076877|P1|STARTED|Overall Study||24
8549054|NCT00147823|21076883|P2|NOT COMPLETED|Overall Study||15
8549055|NCT00147823|21076884|P1|NOT COMPLETED|Overall Study||13
8549056|NCT00147823|21076883|P2|COMPLETED|Overall Study||16
8549057|NCT00147823|21076884|P1|COMPLETED|Overall Study||19
8549058|NCT00147823|21076883|P2|Month 24 Visit|Overall Study||18
8549059|NCT00147823|21076884|P1|Month 24 Visit|Overall Study||21
8549060|NCT00147823|21076883|P2|Month 18 Visit|Overall Study||20
8549061|NCT00147823|21076884|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
8549062|NCT00147823|21076883|P2|Month 12 CT Scan|Overall Study||25
8549063|NCT00147823|21076884|P1|Month 12 CT Scan|Overall Study||20
8549064|NCT00147823|21076883|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
8549065|NCT00147823|21076884|P1|Month 12 Visit|Overall Study||21
8549066|NCT00147823|21076883|P2|Month 6 Visit|Overall Study||21
8549067|NCT00147823|21076884|P1|Month 6 Visit|Overall Study||25
8549068|NCT00147823|21076883|P2|Month 3 Visit|Overall Study||24
8549069|NCT00147823|21076884|P1|Month 3 Visit|Overall Study||25
8549070|NCT00147823|21076883|P2|Week 6 Visit|Overall Study||28
8549071|NCT00147823|21076884|P1|Week 6 Visit|Overall Study||26
8549073|NCT00147823|21076884|P1|STARTED|Overall Study||32
8549074|NCT00147745|21076915|P3|NOT COMPLETED|Overall Study||0
8549075|NCT00147745|21076916|P2|NOT COMPLETED|Overall Study||0
8549076|NCT00147745|21076917|P1|NOT COMPLETED|Overall Study||1
8549077|NCT00147745|21076915|P3|COMPLETED|Overall Study||6
8549078|NCT00147745|21076916|P2|COMPLETED|Overall Study||14
8549079|NCT00147745|21076917|P1|COMPLETED|Overall Study||15
8549080|NCT00147745|21076915|P3|STARTED|Overall Study||6
8549081|NCT00147745|21076916|P2|STARTED|Overall Study||14
8549082|NCT00147745|21076917|P1|STARTED|Overall Study||16
8549083|NCT00147537|21076939|P11|NOT COMPLETED|Phase 2||52
8549084|NCT00147537|21076940|P10|NOT COMPLETED|Phase 2||161
8549085|NCT00147537|21076941|P9|NOT COMPLETED|Phase 2||0
8549086|NCT00147537|21076942|P8|NOT COMPLETED|Phase 2||0
8549087|NCT00147537|21076943|P7|NOT COMPLETED|Phase 2||0
8549088|NCT00147537|21076944|P6|NOT COMPLETED|Phase 2||0
8549089|NCT00147537|21076945|P5|NOT COMPLETED|Phase 2||0
8549090|NCT00147537|21076946|P4|NOT COMPLETED|Phase 2||0
8549091|NCT00147537|21076947|P3|NOT COMPLETED|Phase 2||0
8549092|NCT00147537|21076948|P2|NOT COMPLETED|Phase 2||0
8549093|NCT00147537|21076949|P1|NOT COMPLETED|Phase 2||0
8549094|NCT00147537|21076939|P11|COMPLETED|Phase 2||3
8549095|NCT00147537|21076940|P10|COMPLETED|Phase 2||5
8549096|NCT00147537|21076941|P9|COMPLETED|Phase 2||0
8549097|NCT00147537|21076942|P8|COMPLETED|Phase 2||0
8549098|NCT00147537|21076943|P7|COMPLETED|Phase 2||0
8549099|NCT00147537|21076944|P6|COMPLETED|Phase 2||0
8549100|NCT00147537|21076945|P5|COMPLETED|Phase 2||0
8549101|NCT00147537|21076946|P4|COMPLETED|Phase 2||0
8549102|NCT00147537|21076947|P3|COMPLETED|Phase 2||0
8549103|NCT00147537|21076948|P2|COMPLETED|Phase 2||0
8549104|NCT00147537|21076949|P1|COMPLETED|Phase 2||0
8549105|NCT00147537|21076939|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
8549106|NCT00147537|21076940|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
8549107|NCT00147537|21076941|P9|STARTED|Phase 2||0
8549108|NCT00147537|21076942|P8|STARTED|Phase 2||0
8549109|NCT00147537|21076943|P7|STARTED|Phase 2||0
8549110|NCT00147537|21076944|P6|STARTED|Phase 2||0
8549111|NCT00147537|21076945|P5|STARTED|Phase 2||0
8549112|NCT00147537|21076946|P4|STARTED|Phase 2||0
8549113|NCT00147537|21076947|P3|STARTED|Phase 2||0
8549114|NCT00147537|21076948|P2|STARTED|Phase 2||0
8549115|NCT00147537|21076949|P1|STARTED|Phase 2||0
8549116|NCT00147537|21076939|P11|NOT COMPLETED|Phase 1b||0
8549117|NCT00147537|21076940|P10|NOT COMPLETED|Phase 1b||0
8549118|NCT00147537|21076941|P9|NOT COMPLETED|Phase 1b||17
8549119|NCT00147537|21076942|P8|NOT COMPLETED|Phase 1b||7
8549120|NCT00147537|21076943|P7|NOT COMPLETED|Phase 1b||18
8549121|NCT00147537|21076944|P6|NOT COMPLETED|Phase 1b||3
8549122|NCT00147537|21076945|P5|NOT COMPLETED|Phase 1b||3
8549123|NCT00147537|21076946|P4|NOT COMPLETED|Phase 1b||2
8549124|NCT00147537|21076947|P3|NOT COMPLETED|Phase 1b||4
8549125|NCT00147537|21076948|P2|NOT COMPLETED|Phase 1b||2
8549126|NCT00147537|21076949|P1|NOT COMPLETED|Phase 1b||2
8549127|NCT00147537|21076939|P11|COMPLETED|Phase 1b||0
8549128|NCT00147537|21076940|P10|COMPLETED|Phase 1b||0
8549129|NCT00147537|21076941|P9|COMPLETED|Phase 1b||1
8549130|NCT00147537|21076942|P8|COMPLETED|Phase 1b||0
8549131|NCT00147537|21076943|P7|COMPLETED|Phase 1b||0
8549132|NCT00147537|21076944|P6|COMPLETED|Phase 1b||0
8549133|NCT00147537|21076945|P5|COMPLETED|Phase 1b||0
8549134|NCT00147537|21076946|P4|COMPLETED|Phase 1b||1
8549135|NCT00147537|21076947|P3|COMPLETED|Phase 1b||0
8549136|NCT00147537|21076948|P2|COMPLETED|Phase 1b||0
8549137|NCT00147537|21076949|P1|COMPLETED|Phase 1b||1
8549138|NCT00147537|21076939|P11|STARTED|Phase 1b||0
8549139|NCT00147537|21076940|P10|STARTED|Phase 1b||0
8549140|NCT00147537|21076941|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
8549141|NCT00147537|21076942|P8|STARTED|Phase 1b||7
8549142|NCT00147537|21076943|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
8549143|NCT00147537|21076944|P6|STARTED|Phase 1b||3
8549144|NCT00147537|21076945|P5|STARTED|Phase 1b||3
8549145|NCT00147537|21076946|P4|STARTED|Phase 1b||3
8549146|NCT00147537|21076947|P3|STARTED|Phase 1b||4
8549147|NCT00147537|21076948|P2|STARTED|Phase 1b||2
8549148|NCT00147537|21076949|P1|STARTED|Phase 1b||3
8549149|NCT00147498|21077132|P4|NOT COMPLETED|Overall Study||17
8549150|NCT00147498|21077133|P3|NOT COMPLETED|Overall Study||17
8549151|NCT00147498|21077134|P2|NOT COMPLETED|Overall Study||9
8549152|NCT00147498|21077135|P1|NOT COMPLETED|Overall Study||3
8549153|NCT00147498|21077132|P4|COMPLETED|Overall Study||48
8549154|NCT00147498|21077133|P3|COMPLETED|Overall Study||52
8549155|NCT00147498|21077134|P2|COMPLETED|Overall Study||60
8549156|NCT00147498|21077135|P1|COMPLETED|Overall Study||58
8549157|NCT00147498|21077132|P4|STARTED|Overall Study||65
8549158|NCT00147498|21077133|P3|STARTED|Overall Study||69
8549159|NCT00147498|21077134|P2|STARTED|Overall Study||69
8549160|NCT00147498|21077135|P1|STARTED|Overall Study||61
8549161|NCT00147446|21077231|P2|NOT COMPLETED|Overall Study||0
8549162|NCT00147446|21077232|P1|NOT COMPLETED|Overall Study||0
8549163|NCT00147446|21077231|P2|COMPLETED|Overall Study||61
8549164|NCT00147446|21077232|P1|COMPLETED|Overall Study||60
8549165|NCT00147446|21077231|P2|STARTED|Overall Study||61
8549166|NCT00147446|21077232|P1|STARTED|Overall Study||60
8549167|NCT00147316|21077240|P1|NOT COMPLETED|Overall Study||0
8549168|NCT00147316|21077240|P1|COMPLETED|Overall Study||103
8549169|NCT00147316|21077240|P1|STARTED|Overall Study||103
8549170|NCT00147290|21077247|P2|NOT COMPLETED|Overall Study||0
8549171|NCT00147290|21077248|P1|NOT COMPLETED|Overall Study||0
8549172|NCT00147290|21077247|P2|COMPLETED|Overall Study||260
8549173|NCT00147290|21077248|P1|COMPLETED|Overall Study||266
8549174|NCT00147290|21077247|P2|STARTED|Overall Study||260
8549175|NCT00147290|21077248|P1|STARTED|Overall Study||266
8549176|NCT00147277|21077254|P2|NOT COMPLETED|Overall Study||0
8549177|NCT00147277|21077255|P1|NOT COMPLETED|Overall Study||0
8549178|NCT00147277|21077254|P2|COMPLETED|Overall Study||450
8549179|NCT00147277|21077255|P1|COMPLETED|Overall Study||475
8549180|NCT00147277|21077254|P2|STARTED|Overall Study||450
8549181|NCT00147277|21077255|P1|STARTED|Overall Study||475
8549182|NCT00147238|21077259|P1|NOT COMPLETED|Overall Study||8
8549183|NCT00147238|21077259|P1|COMPLETED|Overall Study||2
8549184|NCT00147238|21077259|P1|STARTED|Overall Study||10
8549185|NCT00147225|21077269|P6|NOT COMPLETED|Overall Study||2
8549186|NCT00147225|21077270|P5|NOT COMPLETED|Overall Study||1
8549187|NCT00147225|21077271|P4|NOT COMPLETED|Overall Study||1
8549188|NCT00147225|21077272|P3|NOT COMPLETED|Overall Study||2
8549189|NCT00147225|21077273|P2|NOT COMPLETED|Overall Study||0
8549190|NCT00147225|21077274|P1|NOT COMPLETED|Overall Study||1
8549191|NCT00147225|21077269|P6|COMPLETED|Overall Study||10
8549192|NCT00147225|21077270|P5|COMPLETED|Overall Study||10
8549193|NCT00147225|21077271|P4|COMPLETED|Overall Study||10
8549194|NCT00147225|21077272|P3|COMPLETED|Overall Study||6
8549195|NCT00147225|21077273|P2|COMPLETED|Overall Study||6
8549196|NCT00147225|21077274|P1|COMPLETED|Overall Study||6
8549197|NCT00147225|21077269|P6|STARTED|Overall Study||12
8549198|NCT00147225|21077270|P5|STARTED|Overall Study||11
8549199|NCT00147225|21077271|P4|STARTED|Overall Study||11
8549200|NCT00147225|21077272|P3|STARTED|Overall Study||8
8549201|NCT00147225|21077273|P2|STARTED|Overall Study||6
8549202|NCT00147225|21077274|P1|STARTED|Overall Study||7
8549203|NCT00147212|21077294|P1|NOT COMPLETED|Overall Study||0
8549204|NCT00147212|21077294|P1|COMPLETED|Overall Study||50
8549205|NCT00147212|21077294|P1|STARTED|Overall Study||50
8549206|NCT00147199|21077300|P2|NOT COMPLETED|Overall Study||10
8549207|NCT00147199|21077301|P1|NOT COMPLETED|Overall Study||13
8549208|NCT00147199|21077300|P2|COMPLETED|Overall Study||110
8549209|NCT00147199|21077301|P1|COMPLETED|Overall Study||102
8549210|NCT00147199|21077300|P2|STARTED|Overall Study||120
8549211|NCT00147199|21077301|P1|STARTED|Overall Study||115
8549212|NCT00147082|21077326|P3|NOT COMPLETED|Overall Study||0
8549213|NCT00147082|21077327|P2|NOT COMPLETED|Overall Study||0
8549214|NCT00147082|21077328|P1|NOT COMPLETED|Overall Study||0
8549215|NCT00147082|21077326|P3|COMPLETED|Overall Study||30
8549216|NCT00147082|21077327|P2|COMPLETED|Overall Study||33
8549217|NCT00147082|21077328|P1|COMPLETED|Overall Study||37
8549218|NCT00147082|21077326|P3|STARTED|Overall Study||30
8549219|NCT00147082|21077327|P2|STARTED|Overall Study||33
8549220|NCT00147082|21077328|P1|STARTED|Overall Study||37
8549221|NCT00147069|21077346|P4|NOT COMPLETED|Overall Study||0
8549222|NCT00147069|21077347|P3|NOT COMPLETED|Overall Study||0
8549223|NCT00147069|21077348|P2|NOT COMPLETED|Overall Study||0
8549224|NCT00147069|21077349|P1|NOT COMPLETED|Overall Study||0
8549225|NCT00147069|21077346|P4|COMPLETED|Overall Study||15
8549226|NCT00147069|21077347|P3|COMPLETED|Overall Study||15
8549227|NCT00147069|21077348|P2|COMPLETED|Overall Study||15
8549228|NCT00147069|21077349|P1|COMPLETED|Overall Study||15
8549229|NCT00147069|21077346|P4|STARTED|Overall Study||15
8549230|NCT00147069|21077347|P3|STARTED|Overall Study||15
8549231|NCT00147069|21077348|P2|STARTED|Overall Study||15
8549232|NCT00147069|21077349|P1|STARTED|Overall Study||15
8549233|NCT00147043|21077371|P1|NOT COMPLETED|Overall Study||0
8549234|NCT00147043|21077371|P1|COMPLETED|Overall Study||5
8549235|NCT00147043|21077371|P1|STARTED|Overall Study||5
8549236|NCT00147030|21077378|P2|NOT COMPLETED|Overall Study||0
8549237|NCT00147030|21077379|P1|NOT COMPLETED|Overall Study||0
8549238|NCT00147030|21077378|P2|COMPLETED|Overall Study||162
8549239|NCT00147030|21077379|P1|COMPLETED|Overall Study||163
8549240|NCT00147030|21077378|P2|STARTED|Overall Study||162
8549241|NCT00147030|21077379|P1|STARTED|Overall Study||163
8549242|NCT00147017|21077430|P3|NOT COMPLETED|Overall Study||0
8549243|NCT00147017|21077431|P2|NOT COMPLETED|Overall Study||0
8549244|NCT00147017|21077432|P1|NOT COMPLETED|Overall Study||0
8549245|NCT00147017|21077430|P3|COMPLETED|Overall Study||4
8549246|NCT00147017|21077431|P2|COMPLETED|Overall Study||7
8549247|NCT00147017|21077432|P1|COMPLETED|Overall Study||6
8549248|NCT00147017|21077430|P3|STARTED|Overall Study||4
8549249|NCT00147017|21077431|P2|STARTED|Overall Study||7
8549250|NCT00147017|21077432|P1|STARTED|Overall Study||6
8549251|NCT00146848|21077449|P3|NOT COMPLETED|Post-randomization||39
8549252|NCT00146848|21077450|P2|NOT COMPLETED|Post-randomization||47
8549253|NCT00146848|21077451|P1|NOT COMPLETED|Post-randomization||38
8549254|NCT00146848|21077449|P3|COMPLETED|Post-randomization||431
8549255|NCT00146848|21077450|P2|COMPLETED|Post-randomization||441
8549256|NCT00146848|21077451|P1|COMPLETED|Post-randomization||437
8549257|NCT00146848|21077449|P3|STARTED|Post-randomization||470
8549258|NCT00146848|21077450|P2|STARTED|Post-randomization||488
8549259|NCT00146848|21077451|P1|STARTED|Post-randomization||475
8549260|NCT00146848|21077449|P3|NOT COMPLETED|Pre-randomization||0
8549261|NCT00146848|21077450|P2|NOT COMPLETED|Pre-randomization||0
8549262|NCT00146848|21077451|P1|NOT COMPLETED|Pre-randomization||309
8549263|NCT00146848|21077449|P3|COMPLETED|Pre-randomization||0
8549264|NCT00146848|21077450|P2|COMPLETED|Pre-randomization||0
8549265|NCT00146848|21077451|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
8549266|NCT00146848|21077449|P3|STARTED|Pre-randomization||0
8549267|NCT00146848|21077450|P2|STARTED|Pre-randomization||0
8549268|NCT00146848|21077451|P1|STARTED|Pre-randomization|Registered|1742
8549269|NCT00146770|21077467|P2|NOT COMPLETED|Overall Study||0
8549270|NCT00146770|21077468|P1|NOT COMPLETED|Overall Study||5
8549271|NCT00146770|21077467|P2|COMPLETED|Overall Study||22
8549272|NCT00146770|21077468|P1|COMPLETED|Overall Study||18
8549273|NCT00146770|21077467|P2|STARTED|Overall Study||22
8549274|NCT00146770|21077468|P1|STARTED|Overall Study||23
8549275|NCT00146757|21077486|P2|NOT COMPLETED|Overall Study||0
8549276|NCT00146757|21077487|P1|NOT COMPLETED|Overall Study||2
8549277|NCT00146757|21077486|P2|COMPLETED|Overall Study||4
8549278|NCT00146757|21077487|P1|COMPLETED|Overall Study||14
8549279|NCT00146757|21077486|P2|STARTED|Overall Study||4
8549280|NCT00146757|21077487|P1|STARTED|Overall Study||16
8549281|NCT00146640|21077506|P2|NOT COMPLETED|Overall Study||14
8549282|NCT00146640|21077507|P1|NOT COMPLETED|Overall Study||23
8549283|NCT00146640|21077506|P2|COMPLETED|Overall Study||130
8549284|NCT00146640|21077507|P1|COMPLETED|Overall Study||121
8549285|NCT00146640|21077506|P2|STARTED|Overall Study||144
8549286|NCT00146640|21077507|P1|STARTED|Overall Study||144
8549287|NCT00146328|21077530|P3|NOT COMPLETED|Overall Study||291
8549288|NCT00146328|21077531|P2|NOT COMPLETED|Overall Study||154
8549289|NCT00146328|21077532|P1|NOT COMPLETED|Overall Study||141
8549290|NCT00146328|21077530|P3|COMPLETED|Overall Study||158
8549291|NCT00146328|21077531|P2|COMPLETED|Overall Study||101
8549292|NCT00146328|21077532|P1|COMPLETED|Overall Study||150
8549293|NCT00146328|21077530|P3|STARTED|Overall Study||449
8549294|NCT00146328|21077531|P2|STARTED|Overall Study||255
8549295|NCT00146328|21077532|P1|STARTED|Overall Study||291
8549296|NCT00146172|21077623|P8|NOT COMPLETED|Overall Study||40
8549297|NCT00146172|21077624|P7|NOT COMPLETED|Overall Study||6
8549298|NCT00146172|21077625|P6|NOT COMPLETED|Overall Study||7
8549299|NCT00146172|21077626|P5|NOT COMPLETED|Overall Study||3
8549300|NCT00146172|21077627|P4|NOT COMPLETED|Overall Study||6
8549301|NCT00146172|21077628|P3|NOT COMPLETED|Overall Study||4
8549302|NCT00146172|21077629|P2|NOT COMPLETED|Overall Study||4
8549303|NCT00146172|21077630|P1|NOT COMPLETED|Overall Study||3
8549304|NCT00146172|21077623|P8|COMPLETED|Overall Study||0
8549305|NCT00146172|21077624|P7|COMPLETED|Overall Study||0
8549306|NCT00146172|21077625|P6|COMPLETED|Overall Study||0
8549307|NCT00146172|21077626|P5|COMPLETED|Overall Study||0
8549308|NCT00146172|21077627|P4|COMPLETED|Overall Study||0
8549309|NCT00146172|21077628|P3|COMPLETED|Overall Study||0
8549310|NCT00146172|21077629|P2|COMPLETED|Overall Study||0
8549311|NCT00146172|21077630|P1|COMPLETED|Overall Study||0
8549312|NCT00146172|21077623|P8|Received Drug|Overall Study||39
8549313|NCT00146172|21077624|P7|Received Drug|Overall Study||6
8549314|NCT00146172|21077625|P6|Received Drug|Overall Study||7
8549315|NCT00146172|21077626|P5|Received Drug|Overall Study||3
8549316|NCT00146172|21077627|P4|Received Drug|Overall Study||6
8549317|NCT00146172|21077628|P3|Received Drug|Overall Study||4
8549318|NCT00146172|21077629|P2|Received Drug|Overall Study||4
8549319|NCT00146172|21077630|P1|Received Drug|Overall Study||3
8549320|NCT00146172|21077623|P8|STARTED|Overall Study||40
8549321|NCT00146172|21077624|P7|STARTED|Overall Study||6
8549322|NCT00146172|21077625|P6|STARTED|Overall Study||7
8549323|NCT00146172|21077626|P5|STARTED|Overall Study||3
8549324|NCT00146172|21077627|P4|STARTED|Overall Study||6
8549325|NCT00146172|21077628|P3|STARTED|Overall Study||4
8549326|NCT00146172|21077629|P2|STARTED|Overall Study||4
8549327|NCT00146172|21077630|P1|STARTED|Overall Study||3
8549328|NCT00145977|21077665|P2|NOT COMPLETED|Overall Study||4
8549329|NCT00145977|21077666|P1|NOT COMPLETED|Overall Study||2
8549330|NCT00145977|21077665|P2|COMPLETED|Overall Study||13
8549331|NCT00145977|21077666|P1|COMPLETED|Overall Study||17
8549332|NCT00145977|21077665|P2|STARTED|Overall Study||17
8549333|NCT00145977|21077666|P1|STARTED|Overall Study||19
8549334|NCT00145795|21077692|P2|NOT COMPLETED|Overall Study||0
8549335|NCT00145795|21077693|P1|NOT COMPLETED|Overall Study||1
8549336|NCT00145795|21077692|P2|COMPLETED|Overall Study||10
8549337|NCT00145795|21077693|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
8549338|NCT00145795|21077692|P2|STARTED|Overall Study||10
8549339|NCT00145795|21077693|P1|STARTED|Overall Study||10
8549340|NCT00145704|21077719|P2|NOT COMPLETED|Overall Study||3
8549341|NCT00145704|21077720|P1|NOT COMPLETED|Overall Study||3
8549342|NCT00145704|21077719|P2|COMPLETED|Overall Study||0
8549343|NCT00145704|21077720|P1|COMPLETED|Overall Study||0
8549344|NCT00145704|21077719|P2|STARTED|Overall Study||3
8549345|NCT00145704|21077720|P1|STARTED|Overall Study||3
8549346|NCT00145626|21077728|P1|NOT COMPLETED|Overall Study||5
8549347|NCT00145626|21077728|P1|COMPLETED|Overall Study||14
8549348|NCT00145626|21077728|P1|STARTED|Overall Study||19
8549349|NCT00145600|21077774|P4|NOT COMPLETED|Overall Study||16
8549350|NCT00145600|21077775|P3|NOT COMPLETED|Overall Study||5
8549351|NCT00145600|21077776|P2|NOT COMPLETED|Overall Study||10
8549352|NCT00145600|21077777|P1|NOT COMPLETED|Overall Study||8
8549353|NCT00145600|21077774|P4|COMPLETED|Overall Study||130
8549354|NCT00145600|21077775|P3|COMPLETED|Overall Study||8
8549355|NCT00145600|21077776|P2|COMPLETED|Overall Study||36
8549356|NCT00145600|21077777|P1|COMPLETED|Overall Study||83
8549357|NCT00145600|21077774|P4|STARTED|Overall Study||146
8549358|NCT00145600|21077775|P3|STARTED|Overall Study||13
8549359|NCT00145600|21077776|P2|STARTED|Overall Study||46
8549360|NCT00145600|21077777|P1|STARTED|Overall Study||91
8549361|NCT00145587|21077891|P2|NOT COMPLETED|Overall Study||0
8549362|NCT00145587|21077892|P1|NOT COMPLETED|Overall Study||0
8549363|NCT00145587|21077891|P2|COMPLETED|Overall Study||1
8549364|NCT00145587|21077892|P1|COMPLETED|Overall Study||5
8549365|NCT00145587|21077891|P2|STARTED|Overall Study||1
8549366|NCT00145587|21077892|P1|STARTED|Overall Study||5
8549367|NCT00145574|21077901|P3|NOT COMPLETED|Open Label Long-term Extension||11
8549368|NCT00145574|21077902|P2|NOT COMPLETED|Open Label Long-term Extension||0
8549369|NCT00145574|21077903|P1|NOT COMPLETED|Open Label Long-term Extension||0
8549370|NCT00145574|21077901|P3|COMPLETED|Open Label Long-term Extension||173
8549371|NCT00145574|21077902|P2|COMPLETED|Open Label Long-term Extension||0
8549372|NCT00145574|21077903|P1|COMPLETED|Open Label Long-term Extension||0
8549373|NCT00145574|21077901|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
8549374|NCT00145574|21077902|P2|STARTED|Open Label Long-term Extension||0
8549375|NCT00145574|21077903|P1|STARTED|Open Label Long-term Extension||0
8549376|NCT00145574|21077901|P3|NOT COMPLETED|Double Blind||2
8549377|NCT00145574|21077902|P2|NOT COMPLETED|Double Blind||5
8549378|NCT00145574|21077903|P1|NOT COMPLETED|Double Blind||1
8549379|NCT00145574|21077901|P3|COMPLETED|Double Blind||62
8549380|NCT00145574|21077902|P2|COMPLETED|Double Blind||60
8549381|NCT00145574|21077903|P1|COMPLETED|Double Blind||64
8549382|NCT00145574|21077901|P3|STARTED|Double Blind||64
8549383|NCT00145574|21077902|P2|STARTED|Double Blind||65
8549384|NCT00145574|21077903|P1|STARTED|Double Blind||65
8549385|NCT00145509|21077960|P2|NOT COMPLETED|Overall Study||21
8549386|NCT00145509|21077961|P1|NOT COMPLETED|Overall Study||22
8549387|NCT00145509|21077960|P2|COMPLETED|Overall Study||15
8549388|NCT00145509|21077961|P1|COMPLETED|Overall Study||19
8549389|NCT00145509|21077960|P2|STARTED|Overall Study||36
8549390|NCT00145509|21077961|P1|STARTED|Overall Study||41
8549391|NCT00145496|21077975|P2|NOT COMPLETED|Overall Study||81
8549392|NCT00145496|21077976|P1|NOT COMPLETED|Overall Study||123
8549393|NCT00145496|21077975|P2|COMPLETED|Overall Study||143
8549394|NCT00145496|21077976|P1|COMPLETED|Overall Study||121
8549395|NCT00145496|21077975|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
8549396|NCT00145496|21077976|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
8549397|NCT00145470|21077988|P2|NOT COMPLETED|Overall Study||98
8549398|NCT00145470|21077989|P1|NOT COMPLETED|Overall Study||112
8549399|NCT00145470|21077988|P2|COMPLETED|Overall Study||61
8549400|NCT00145470|21077989|P1|COMPLETED|Overall Study||55
8549401|NCT00145470|21077988|P2|Treated|Overall Study||158
8549402|NCT00145470|21077989|P1|Treated|Overall Study||166
8549403|NCT00145470|21077988|P2|STARTED|Overall Study||159
8549404|NCT00145470|21077989|P1|STARTED|Overall Study||167
8549405|NCT00145418|21078049|P1|NOT COMPLETED|Overall Study||0
8549406|NCT00145418|21078049|P1|COMPLETED|Overall Study||15
8549407|NCT00145418|21078049|P1|STARTED|Overall Study||15
8549408|NCT00145327|21078059|P3|NOT COMPLETED|Overall Study||248
8549409|NCT00145327|21078060|P2|NOT COMPLETED|Overall Study||124
8549410|NCT00145327|21078061|P1|NOT COMPLETED|Overall Study||142
8549411|NCT00145327|21078059|P3|COMPLETED|Overall Study||975
8549412|NCT00145327|21078060|P2|COMPLETED|Overall Study||493
8549413|NCT00145327|21078061|P1|COMPLETED|Overall Study||474
8549414|NCT00145327|21078059|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
8549415|NCT00145327|21078060|P2|STARTED|Overall Study||617
8549416|NCT00145327|21078061|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
8549417|NCT00145249|21078117|P3|NOT COMPLETED|Overall Study||17
8549418|NCT00145249|21078118|P2|NOT COMPLETED|Overall Study||15
8549419|NCT00145249|21078119|P1|NOT COMPLETED|Overall Study||11
8549420|NCT00145249|21078117|P3|COMPLETED|Overall Study||31
8549421|NCT00145249|21078118|P2|COMPLETED|Overall Study||33
8549422|NCT00145249|21078119|P1|COMPLETED|Overall Study||36
8549423|NCT00145249|21078117|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
8549424|NCT00145249|21078118|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
8549425|NCT00145249|21078119|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
8549426|NCT00145119|21078160|P1|NOT COMPLETED|Overall Study||45
8549427|NCT00145119|21078160|P1|COMPLETED|Overall Study||267
8549428|NCT00145119|21078160|P1|STARTED|Overall Study||312
8549429|NCT00145041|21078164|P1|NOT COMPLETED|Overall Study||0
8549430|NCT00145041|21078164|P1|COMPLETED|Overall Study||7
8549431|NCT00145041|21078164|P1|STARTED|Overall Study||7
8549432|NCT00144963|21078170|P1|NOT COMPLETED|Overall Study||0
8549433|NCT00144963|21078170|P1|COMPLETED|Overall Study||36
8549434|NCT00144963|21078170|P1|STARTED|Overall Study||36
8549435|NCT00144781|21078178|P4|NOT COMPLETED|Overall Study||0
8549436|NCT00144781|21078179|P3|NOT COMPLETED|Overall Study||0
8549437|NCT00144781|21078180|P2|NOT COMPLETED|Overall Study||2
8549438|NCT00144781|21078181|P1|NOT COMPLETED|Overall Study||0
8549439|NCT00144781|21078178|P4|COMPLETED|Overall Study||9
8549440|NCT00144781|21078179|P3|COMPLETED|Overall Study||8
8549441|NCT00144781|21078180|P2|COMPLETED|Overall Study||7
8549442|NCT00144781|21078181|P1|COMPLETED|Overall Study||8
8549443|NCT00144781|21078178|P4|STARTED|Overall Study||9
8549444|NCT00144781|21078179|P3|STARTED|Overall Study||8
8549445|NCT00144781|21078180|P2|STARTED|Overall Study||9
8549446|NCT00144781|21078181|P1|STARTED|Overall Study||8
8549447|NCT00144391|21078201|P2|NOT COMPLETED|Overall Study||0
8549448|NCT00144391|21078202|P1|NOT COMPLETED|Overall Study||0
8549449|NCT00144391|21078201|P2|COMPLETED|Overall Study||9
8549450|NCT00144391|21078202|P1|COMPLETED|Overall Study||11
8549451|NCT00144391|21078201|P2|STARTED|Overall Study||9
8549452|NCT00144391|21078202|P1|STARTED|Overall Study||11
8549453|NCT00144339|21078210|P2|NOT COMPLETED|Overall Study||1099
8549454|NCT00144339|21078211|P1|NOT COMPLETED|Overall Study||1358
8549455|NCT00144339|21078210|P2|COMPLETED|Overall Study||1887
8549456|NCT00144339|21078211|P1|COMPLETED|Overall Study||1648
8549457|NCT00144339|21078210|P2|STARTED|Overall Study||2986
8549458|NCT00144339|21078211|P1|STARTED|Overall Study||3006
8549459|NCT00144300|21078419|P2|NOT COMPLETED|Overall Study||28
8549460|NCT00144300|21078420|P1|NOT COMPLETED|Overall Study||29
8549461|NCT00144300|21078419|P2|COMPLETED|Overall Study||97
8549462|NCT00144300|21078420|P1|COMPLETED|Overall Study||92
8549463|NCT00144300|21078419|P2|STARTED|Overall Study||125
8549464|NCT00144300|21078420|P1|STARTED|Overall Study||121
8549465|NCT00144170|21078468|P2|NOT COMPLETED|Overall Study||396
8549466|NCT00144170|21078469|P1|NOT COMPLETED|Overall Study||352
8549467|NCT00144170|21078468|P2|COMPLETED|Overall Study||32
8549468|NCT00144170|21078469|P1|COMPLETED|Overall Study||86
8549469|NCT00144170|21078468|P2|STARTED|Overall Study||428
8549470|NCT00144170|21078469|P1|STARTED|Overall Study||438
8549471|NCT00144027|21078659|P2|NOT COMPLETED|Overall Study||11
8549472|NCT00144027|21078660|P1|NOT COMPLETED|Overall Study||3
8549473|NCT00144027|21078659|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
8549474|NCT00144027|21078660|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
8549475|NCT00144027|21078659|P2|Completed 6 Month Assessment|Overall Study||24
8549476|NCT00144027|21078660|P1|Completed 6 Month Assessment|Overall Study||37
8549477|NCT00144027|21078659|P2|Completed Baseline Assessment|Overall Study||29
8549478|NCT00144027|21078660|P1|Completed Baseline Assessment|Overall Study||39
8549479|NCT00144027|21078659|P2|STARTED|Overall Study|participants who consented|36
8549480|NCT00144027|21078660|P1|STARTED|Overall Study|participants who consented|39
8549481|NCT00143845|21078666|P1|NOT COMPLETED|Overall Study||0
8549482|NCT00143845|21078666|P1|COMPLETED|Overall Study||54
8549483|NCT00143845|21078666|P1|STARTED|Overall Study||54
8549484|NCT00143819|21078674|P2|NOT COMPLETED|Overall Study||3
8549485|NCT00143819|21078675|P1|NOT COMPLETED|Overall Study||2
8549486|NCT00143819|21078674|P2|COMPLETED|Overall Study||5
8549487|NCT00143819|21078675|P1|COMPLETED|Overall Study||3
8549488|NCT00143819|21078674|P2|STARTED|Overall Study||8
8549489|NCT00143819|21078675|P1|STARTED|Overall Study||5
8549490|NCT00143598|21078690|P2|NOT COMPLETED|Overall Study||94
8549491|NCT00143598|21078691|P1|NOT COMPLETED|Overall Study||92
8549492|NCT00143598|21078690|P2|COMPLETED|Overall Study||302
8549493|NCT00143598|21078691|P1|COMPLETED|Overall Study||318
8549494|NCT00143598|21078690|P2|STARTED|Overall Study||396
8549495|NCT00143598|21078691|P1|STARTED|Overall Study||410
8549496|NCT00143507|21078705|P2|NOT COMPLETED|Overall Study||652
8549497|NCT00143507|21078706|P1|NOT COMPLETED|Overall Study||687
8549498|NCT00143507|21078705|P2|COMPLETED|Overall Study||4786
8549499|NCT00143507|21078706|P1|COMPLETED|Overall Study||4792
8549500|NCT00143507|21078705|P2|STARTED|Overall Study||5438
8549501|NCT00143507|21078706|P1|STARTED|Overall Study||5479
8549502|NCT00143455|21078740|P4|NOT COMPLETED|Cohort 2||93
8549503|NCT00143455|21078741|P3|NOT COMPLETED|Cohort 2||106
8549504|NCT00143455|21078742|P2|NOT COMPLETED|Cohort 2||0
8549505|NCT00143455|21078743|P1|NOT COMPLETED|Cohort 2||0
8549506|NCT00143455|21078740|P4|COMPLETED|Cohort 2||111
8549507|NCT00143455|21078741|P3|COMPLETED|Cohort 2||97
8549508|NCT00143455|21078742|P2|COMPLETED|Cohort 2||0
8549509|NCT00143455|21078743|P1|COMPLETED|Cohort 2||0
8549510|NCT00143455|21078740|P4|Received Treatment|Cohort 2||203
8549511|NCT00143455|21078741|P3|Received Treatment|Cohort 2||202
8549512|NCT00143455|21078742|P2|Received Treatment|Cohort 2||0
8549513|NCT00143455|21078743|P1|Received Treatment|Cohort 2||0
8549514|NCT00143455|21078740|P4|STARTED|Cohort 2||204
8549515|NCT00143455|21078741|P3|STARTED|Cohort 2||203
8549516|NCT00143455|21078742|P2|STARTED|Cohort 2||0
8549517|NCT00143455|21078743|P1|STARTED|Cohort 2||0
8549518|NCT00143455|21078740|P4|NOT COMPLETED|Cohort 1||0
8549519|NCT00143455|21078741|P3|NOT COMPLETED|Cohort 1||0
8549520|NCT00143455|21078742|P2|NOT COMPLETED|Cohort 1||17
8549521|NCT00143455|21078743|P1|NOT COMPLETED|Cohort 1||14
8549522|NCT00143455|21078740|P4|COMPLETED|Cohort 1||0
8549523|NCT00143455|21078741|P3|COMPLETED|Cohort 1||0
8549524|NCT00143455|21078742|P2|COMPLETED|Cohort 1||22
8549525|NCT00143455|21078743|P1|COMPLETED|Cohort 1||25
8549526|NCT00143455|21078740|P4|Received Treatment|Cohort 1||0
8549527|NCT00143455|21078741|P3|Received Treatment|Cohort 1||0
8549528|NCT00143455|21078742|P2|Received Treatment|Cohort 1||38
8549529|NCT00143455|21078743|P1|Received Treatment|Cohort 1||39
8549530|NCT00143455|21078740|P4|STARTED|Cohort 1||0
8549531|NCT00143455|21078741|P3|STARTED|Cohort 1||0
8549532|NCT00143455|21078742|P2|STARTED|Cohort 1||39
8549533|NCT00143455|21078743|P1|STARTED|Cohort 1||39
8549534|NCT00143403|21078777|P2|NOT COMPLETED|Overall Study||46
8549535|NCT00143403|21078778|P1|NOT COMPLETED|Overall Study||35
8549536|NCT00143403|21078777|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
8549537|NCT00143403|21078778|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
8549538|NCT00143403|21078777|P2|Treated|Overall Study||153
8549539|NCT00143403|21078778|P1|Treated|Overall Study||153
8549540|NCT00143403|21078777|P2|STARTED|Overall Study||161
8549541|NCT00143403|21078778|P1|STARTED|Overall Study||160
8549542|NCT00143390|21078788|P2|NOT COMPLETED|Overall Study||149
8549543|NCT00143390|21078789|P1|NOT COMPLETED|Overall Study||149
8549544|NCT00143390|21078788|P2|COMPLETED|Overall Study||0
8549545|NCT00143390|21078789|P1|COMPLETED|Overall Study||0
8549546|NCT00143390|21078788|P2|STARTED|Overall Study||149
8549547|NCT00143390|21078789|P1|STARTED|Overall Study||149
8549548|NCT00143312|21078805|P1|NOT COMPLETED|Overall Study||16
8549549|NCT00143312|21078805|P1|COMPLETED|Overall Study||29
8549550|NCT00143312|21078805|P1|STARTED|Overall Study||45
8549551|NCT00143247|21078815|P1|NOT COMPLETED|Overall Study||156
8549552|NCT00143247|21078815|P1|COMPLETED|Overall Study||17
8549553|NCT00143247|21078815|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
8549554|NCT00142935|21078832|P3|NOT COMPLETED|Overall Study||7
8549555|NCT00142935|21078833|P2|NOT COMPLETED|Overall Study||8
8549556|NCT00142935|21078834|P1|NOT COMPLETED|Overall Study||3
8549557|NCT00142935|21078832|P3|COMPLETED|Overall Study||23
8549558|NCT00142935|21078833|P2|COMPLETED|Overall Study||20
8549559|NCT00142935|21078834|P1|COMPLETED|Overall Study||26
8549560|NCT00142935|21078832|P3|STARTED|Overall Study||30
8549561|NCT00142935|21078833|P2|STARTED|Overall Study||28
8549562|NCT00142935|21078834|P1|STARTED|Overall Study||29
8549563|NCT00142909|21078859|P2|NOT COMPLETED|Medications Begin||3
8549564|NCT00142909|21078860|P1|NOT COMPLETED|Medications Begin||9
8549565|NCT00142909|21078859|P2|COMPLETED|Medications Begin||31
8549566|NCT00142909|21078860|P1|COMPLETED|Medications Begin||26
8549567|NCT00142909|21078859|P2|STARTED|Medications Begin||34
8549568|NCT00142909|21078860|P1|STARTED|Medications Begin||35
8549569|NCT00142909|21078859|P2|NOT COMPLETED|Randomization||10
8549570|NCT00142909|21078860|P1|NOT COMPLETED|Randomization||7
8549571|NCT00142909|21078859|P2|COMPLETED|Randomization||34
8549572|NCT00142909|21078860|P1|COMPLETED|Randomization||35
8549573|NCT00142909|21078859|P2|STARTED|Randomization||44
8549574|NCT00142909|21078860|P1|STARTED|Randomization||42
8549575|NCT00142818|21078880|P4|NOT COMPLETED|Overall Study||22
8549576|NCT00142818|21078881|P3|NOT COMPLETED|Overall Study||13
8549577|NCT00142818|21078882|P2|NOT COMPLETED|Overall Study||21
8549578|NCT00142818|21078883|P1|NOT COMPLETED|Overall Study||17
8549579|NCT00142818|21078880|P4|COMPLETED|Overall Study||20
8549580|NCT00142818|21078881|P3|COMPLETED|Overall Study||24
8549581|NCT00142818|21078882|P2|COMPLETED|Overall Study||19
8549582|NCT00142818|21078883|P1|COMPLETED|Overall Study||28
8549583|NCT00142818|21078880|P4|STARTED|Overall Study||42
8549584|NCT00142818|21078881|P3|STARTED|Overall Study||37
8549585|NCT00142818|21078882|P2|STARTED|Overall Study||40
8549586|NCT00142818|21078883|P1|STARTED|Overall Study||45
8549587|NCT00142792|21078900|P3|NOT COMPLETED|Overall Study||12
8549588|NCT00142792|21078901|P2|NOT COMPLETED|Overall Study||15
8549589|NCT00142792|21078902|P1|NOT COMPLETED|Overall Study||12
8549590|NCT00142792|21078900|P3|COMPLETED|Overall Study||30
8549591|NCT00142792|21078901|P2|COMPLETED|Overall Study||26
8549592|NCT00142792|21078902|P1|COMPLETED|Overall Study||27
8549593|NCT00142792|21078900|P3|Completed Intervention|Overall Study||37
8549594|NCT00142792|21078901|P2|Completed Intervention|Overall Study||37
8549595|NCT00142792|21078902|P1|Completed Intervention|Overall Study||35
8549596|NCT00142792|21078900|P3|STARTED|Overall Study||42
8549597|NCT00142792|21078901|P2|STARTED|Overall Study||41
8549598|NCT00142792|21078902|P1|STARTED|Overall Study||39
8549599|NCT00142597|21078915|P2|NOT COMPLETED|Overall Study||1
8549600|NCT00142597|21078916|P1|NOT COMPLETED|Overall Study||3
8549601|NCT00142597|21078915|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
8549602|NCT00142597|21078916|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
8549603|NCT00142597|21078915|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
8549604|NCT00142597|21078916|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
8549605|NCT00142519|21078924|P2|NOT COMPLETED|Overall Study||16
8549606|NCT00142519|21078925|P1|NOT COMPLETED|Overall Study||18
8549607|NCT00142519|21078924|P2|COMPLETED|Overall Study||9
8549608|NCT00142519|21078925|P1|COMPLETED|Overall Study||7
8549609|NCT00142519|21078924|P2|STARTED|Overall Study||25
8549610|NCT00142519|21078925|P1|STARTED|Overall Study||25
8549611|NCT00142506|21078935|P2|NOT COMPLETED|Overall Study||29
8549612|NCT00142506|21078936|P1|NOT COMPLETED|Overall Study||72
8549613|NCT00142506|21078935|P2|COMPLETED|Overall Study||77
8549614|NCT00142506|21078936|P1|COMPLETED|Overall Study||112
8549615|NCT00142506|21078935|P2|STARTED|Overall Study||106
8549616|NCT00142506|21078936|P1|STARTED|Overall Study||184
8549617|NCT00142454|21078942|P1|NOT COMPLETED|Overall Study||0
8549618|NCT00142454|21078942|P1|COMPLETED|Overall Study||9
8549619|NCT00142454|21078942|P1|STARTED|Overall Study||9
8549620|NCT00142415|21078954|P6|NOT COMPLETED|Overall Study||2
8549621|NCT00142415|21078955|P5|NOT COMPLETED|Overall Study||1
8549622|NCT00142415|21078956|P4|NOT COMPLETED|Overall Study||0
8549623|NCT00142415|21078957|P3|NOT COMPLETED|Overall Study||0
8549624|NCT00142415|21078958|P2|NOT COMPLETED|Overall Study||0
8549625|NCT00142415|21078959|P1|NOT COMPLETED|Overall Study||0
8549626|NCT00142415|21078954|P6|COMPLETED|Overall Study||6
8549627|NCT00142415|21078955|P5|COMPLETED|Overall Study||2
8549628|NCT00142415|21078956|P4|COMPLETED|Overall Study||3
8549629|NCT00142415|21078957|P3|COMPLETED|Overall Study||6
8549630|NCT00142415|21078958|P2|COMPLETED|Overall Study||3
8549631|NCT00142415|21078959|P1|COMPLETED|Overall Study||3
8549632|NCT00142415|21078954|P6|STARTED|Overall Study||8
8549633|NCT00142415|21078955|P5|STARTED|Overall Study||3
8549634|NCT00142415|21078956|P4|STARTED|Overall Study||3
8549635|NCT00142415|21078957|P3|STARTED|Overall Study||6
8549636|NCT00142415|21078958|P2|STARTED|Overall Study||3
8549637|NCT00142415|21078959|P1|STARTED|Overall Study||3
8549638|NCT00142298|21078997|P10|NOT COMPLETED|Overall Study||0
8549639|NCT00142298|21078998|P9|NOT COMPLETED|Overall Study||5
8549640|NCT00142298|21078999|P8|NOT COMPLETED|Overall Study||8
8549641|NCT00142298|21079000|P7|NOT COMPLETED|Overall Study||8
8549642|NCT00142298|21079001|P6|NOT COMPLETED|Overall Study||16
8549643|NCT00142298|21079002|P5|NOT COMPLETED|Overall Study||10
8549644|NCT00142298|21079003|P4|NOT COMPLETED|Overall Study||85
8549645|NCT00142298|21079004|P3|NOT COMPLETED|Overall Study||33
8549646|NCT00142298|21079005|P2|NOT COMPLETED|Overall Study||176
8549647|NCT00142298|21079006|P1|NOT COMPLETED|Overall Study||160
8549648|NCT00142298|21078997|P10|COMPLETED|Overall Study||13
8549649|NCT00142298|21078998|P9|COMPLETED|Overall Study||52
8549650|NCT00142298|21078999|P8|COMPLETED|Overall Study||58
8549651|NCT00142298|21079000|P7|COMPLETED|Overall Study||15
8549652|NCT00142298|21079001|P6|COMPLETED|Overall Study||10
8549653|NCT00142298|21079002|P5|COMPLETED|Overall Study||46
8549654|NCT00142298|21079003|P4|COMPLETED|Overall Study||121
8549655|NCT00142298|21079004|P3|COMPLETED|Overall Study||90
8549656|NCT00142298|21079005|P2|COMPLETED|Overall Study||456
8549657|NCT00142298|21079006|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
8549658|NCT00142298|21078997|P10|Per Protocol Population|Overall Study||13
8549659|NCT00142298|21078998|P9|Per Protocol Population|Overall Study||56
8549660|NCT00142298|21078999|P8|Per Protocol Population|Overall Study||64
8549661|NCT00142298|21079000|P7|Per Protocol Population|Overall Study||19
8549662|NCT00142298|21079001|P6|Per Protocol Population|Overall Study||25
8549663|NCT00142298|21079002|P5|Per Protocol Population|Overall Study||50
8549664|NCT00142298|21079003|P4|Per Protocol Population|Overall Study||202
8549665|NCT00142298|21079004|P3|Per Protocol Population|Overall Study||120
8549666|NCT00142298|21079005|P2|Per Protocol Population|Overall Study||606
8549667|NCT00142298|21079006|P1|Per Protocol Population|Overall Study||635
8549668|NCT00142298|21078997|P10|Safety Population|Overall Study||13
8549669|NCT00142298|21078998|P9|Safety Population|Overall Study||57
8549670|NCT00142298|21078999|P8|Safety Population|Overall Study||66
8549671|NCT00142298|21079000|P7|Safety Population|Overall Study||23
8549672|NCT00142298|21079001|P6|Safety Population|Overall Study||26
8549673|NCT00142298|21079002|P5|Safety Population|Overall Study||50
8549674|NCT00142298|21079003|P4|Safety Population|Overall Study||206
8549675|NCT00142298|21079004|P3|Safety Population|Overall Study||122
8549676|NCT00142298|21079005|P2|Safety Population|Overall Study||626
8549677|NCT00142298|21079006|P1|Safety Population|Overall Study||655
8549678|NCT00142298|21078997|P10|STARTED|Overall Study||13
8549679|NCT00142298|21078998|P9|STARTED|Overall Study||57
8549680|NCT00142298|21078999|P8|STARTED|Overall Study||66
8549681|NCT00142298|21079000|P7|STARTED|Overall Study||23
8549682|NCT00142298|21079001|P6|STARTED|Overall Study||26
8549683|NCT00142298|21079002|P5|STARTED|Overall Study||56
8549684|NCT00142298|21079003|P4|STARTED|Overall Study||206
8549685|NCT00142298|21079004|P3|STARTED|Overall Study||123
8549686|NCT00142298|21079005|P2|STARTED|Overall Study||632
8549687|NCT00142298|21079006|P1|STARTED|Overall Study||667
8549688|NCT00142168|21079028|P1|NOT COMPLETED|Overall Study||0
8549689|NCT00142168|21079028|P1|COMPLETED|Overall Study||16
8549690|NCT00142168|21079028|P1|STARTED|Overall Study||16
8549691|NCT00142116|21079035|P1|NOT COMPLETED|Overall Study||0
8549692|NCT00142116|21079035|P1|COMPLETED|Overall Study||25
8549693|NCT00142116|21079035|P1|STARTED|Overall Study||25
8549694|NCT00141921|21079040|P1|NOT COMPLETED|Overall Study||141
8549695|NCT00141921|21079040|P1|COMPLETED|Overall Study||41
8549696|NCT00141921|21079040|P1|Received Treatment|Overall Study||181
8549697|NCT00141921|21079040|P1|STARTED|Overall Study||182
8549698|NCT00141817|21079066|P4|NOT COMPLETED|Overall Study||0
8549699|NCT00141817|21079067|P3|NOT COMPLETED|Overall Study||1
8549700|NCT00141817|21079068|P2|NOT COMPLETED|Overall Study||0
8549701|NCT00141817|21079069|P1|NOT COMPLETED|Overall Study||1
8549702|NCT00141817|21079066|P4|COMPLETED|Overall Study||13
8549703|NCT00141817|21079067|P3|COMPLETED|Overall Study||10
8549704|NCT00141817|21079068|P2|COMPLETED|Overall Study||10
8549705|NCT00141817|21079069|P1|COMPLETED|Overall Study||6
8549706|NCT00141817|21079066|P4|STARTED|Overall Study||13
8549707|NCT00141817|21079067|P3|STARTED|Overall Study||11
8549708|NCT00141817|21079068|P2|STARTED|Overall Study||10
8549709|NCT00141817|21079069|P1|STARTED|Overall Study||7
8549710|NCT00141778|21079110|P3|NOT COMPLETED|Started Study Medication||4
8549711|NCT00141778|21079111|P2|NOT COMPLETED|Started Study Medication||7
8549712|NCT00141778|21079112|P1|NOT COMPLETED|Started Study Medication||2
8549713|NCT00141778|21079110|P3|COMPLETED|Started Study Medication||143
8549714|NCT00141778|21079111|P2|COMPLETED|Started Study Medication||144
8549715|NCT00141778|21079112|P1|COMPLETED|Started Study Medication||145
8549716|NCT00141778|21079110|P3|STARTED|Started Study Medication||147
8549717|NCT00141778|21079111|P2|STARTED|Started Study Medication||151
8549718|NCT00141778|21079112|P1|STARTED|Started Study Medication||147
8549719|NCT00141778|21079110|P3|NOT COMPLETED|Randomization Prior to Study Med||6
8549720|NCT00141778|21079111|P2|NOT COMPLETED|Randomization Prior to Study Med||2
8549721|NCT00141778|21079112|P1|NOT COMPLETED|Randomization Prior to Study Med||5
8549722|NCT00141778|21079110|P3|COMPLETED|Randomization Prior to Study Med||147
8549723|NCT00141778|21079111|P2|COMPLETED|Randomization Prior to Study Med||151
8549724|NCT00141778|21079112|P1|COMPLETED|Randomization Prior to Study Med||147
8549725|NCT00141778|21079110|P3|STARTED|Randomization Prior to Study Med||153
8549726|NCT00141778|21079111|P2|STARTED|Randomization Prior to Study Med||153
8549727|NCT00141778|21079112|P1|STARTED|Randomization Prior to Study Med||152
8549728|NCT00141765|21079150|P1|NOT COMPLETED|Overall Study||0
8549729|NCT00141765|21079150|P1|COMPLETED|Overall Study||25
8549730|NCT00141765|21079150|P1|STARTED|Overall Study||25
8549731|NCT00141739|21079154|P1|NOT COMPLETED|Overall Study||0
8549732|NCT00141739|21079154|P1|COMPLETED|Overall Study||100
8549733|NCT00141739|21079154|P1|STARTED|Overall Study|Number of evaluable patients|100
8549734|NCT00141726|21079165|P1|NOT COMPLETED|Overall Study||3
8549735|NCT00141726|21079165|P1|COMPLETED|Overall Study||31
8549736|NCT00141726|21079165|P1|STARTED|Overall Study||34
8549737|NCT00141518|21079173|P3|NOT COMPLETED|Overall Study||6
8549738|NCT00141518|21079174|P2|NOT COMPLETED|Overall Study||6
8549739|NCT00141518|21079175|P1|NOT COMPLETED|Overall Study||16
8549740|NCT00141518|21079173|P3|COMPLETED|Overall Study||12
8549741|NCT00141518|21079174|P2|COMPLETED|Overall Study||16
8549742|NCT00141518|21079175|P1|COMPLETED|Overall Study||21
8549743|NCT00141518|21079173|P3|Full Analysis Sample|Overall Study||18
8549744|NCT00141518|21079174|P2|Full Analysis Sample|Overall Study||22
8549745|NCT00141518|21079175|P1|Full Analysis Sample|Overall Study||27
8549746|NCT00141518|21079173|P3|Safety Sample|Overall Study||18
8549747|NCT00141518|21079174|P2|Safety Sample|Overall Study||22
8549748|NCT00141518|21079175|P1|Safety Sample|Overall Study||36
8549749|NCT00141518|21079173|P3|STARTED|Overall Study||18
8549750|NCT00141518|21079174|P2|STARTED|Overall Study||22
8549751|NCT00141518|21079175|P1|STARTED|Overall Study||37
8549752|NCT00141453|21079364|P2|NOT COMPLETED|Overall Study||5
8549753|NCT00141453|21079365|P1|NOT COMPLETED|Overall Study||6
8549754|NCT00141453|21079364|P2|COMPLETED|Overall Study||284
8549755|NCT00141453|21079365|P1|COMPLETED|Overall Study||282
8549756|NCT00141453|21079364|P2|STARTED|Overall Study||289
8549757|NCT00141453|21079365|P1|STARTED|Overall Study||288
8549758|NCT00141297|21079379|P10|NOT COMPLETED|Overall Study||6
8549759|NCT00141297|21079380|P9|NOT COMPLETED|Overall Study||20
8549760|NCT00141297|21079381|P8|NOT COMPLETED|Overall Study||4
8549761|NCT00141297|21079382|P7|NOT COMPLETED|Overall Study||3
8549762|NCT00141297|21079383|P6|NOT COMPLETED|Overall Study||3
8549763|NCT00141297|21079384|P5|NOT COMPLETED|Overall Study||22
8549764|NCT00141297|21079385|P4|NOT COMPLETED|Overall Study||3
8549765|NCT00141297|21079386|P3|NOT COMPLETED|Overall Study||7
8549766|NCT00141297|21079387|P2|NOT COMPLETED|Overall Study||3
8549767|NCT00141297|21079388|P1|NOT COMPLETED|Overall Study||3
8549768|NCT00141297|21079379|P10|COMPLETED|Overall Study||0
8549769|NCT00141297|21079380|P9|COMPLETED|Overall Study||0
8549770|NCT00141297|21079381|P8|COMPLETED|Overall Study||0
8549771|NCT00141297|21079382|P7|COMPLETED|Overall Study||0
8549772|NCT00141297|21079383|P6|COMPLETED|Overall Study||0
8549773|NCT00141297|21079384|P5|COMPLETED|Overall Study||0
8549774|NCT00141297|21079385|P4|COMPLETED|Overall Study||0
8549775|NCT00141297|21079386|P3|COMPLETED|Overall Study||0
8549776|NCT00141297|21079387|P2|COMPLETED|Overall Study||0
8549777|NCT00141297|21079388|P1|COMPLETED|Overall Study||0
8549778|NCT00141297|21079379|P10|STARTED|Overall Study||6
8549779|NCT00141297|21079380|P9|STARTED|Overall Study||20
8549780|NCT00141297|21079381|P8|STARTED|Overall Study||4
8549781|NCT00141297|21079382|P7|STARTED|Overall Study||3
8549782|NCT00141297|21079383|P6|STARTED|Overall Study||3
8549783|NCT00141297|21079384|P5|STARTED|Overall Study||22
8549784|NCT00141297|21079385|P4|STARTED|Overall Study||3
8549785|NCT00141297|21079386|P3|STARTED|Overall Study||7
8549786|NCT00141297|21079387|P2|STARTED|Overall Study||3
8549787|NCT00141297|21079388|P1|STARTED|Overall Study||3
8549788|NCT00141271|21079666|P3|NOT COMPLETED|Overall Study||57
8549789|NCT00141271|21079667|P2|NOT COMPLETED|Overall Study||63
8549790|NCT00141271|21079668|P1|NOT COMPLETED|Overall Study||80
8549791|NCT00141271|21079666|P3|COMPLETED|Overall Study||111
8549792|NCT00141271|21079667|P2|COMPLETED|Overall Study||102
8549793|NCT00141271|21079668|P1|COMPLETED|Overall Study||91
8549794|NCT00141271|21079666|P3|STARTED|Overall Study||168
8549795|NCT00141271|21079667|P2|STARTED|Overall Study||165
8549796|NCT00141271|21079668|P1|STARTED|Overall Study||171
8549803|NCT00141115|21079840|P1|NOT COMPLETED|Overall Study||1
8549804|NCT00141115|21079840|P1|COMPLETED|Overall Study||2
8549805|NCT00141115|21079840|P1|STARTED|Overall Study||3
8549806|NCT00141102|21079847|P2|NOT COMPLETED|Overall Study||625
8549807|NCT00141102|21079848|P1|NOT COMPLETED|Overall Study||508
8549808|NCT00141102|21079847|P2|COMPLETED|Overall Study||1621
8549809|NCT00141102|21079848|P1|COMPLETED|Overall Study||1730
8549810|NCT00141102|21079847|P2|Received Treatment|Overall Study||2237
8549811|NCT00141102|21079848|P1|Received Treatment|Overall Study||2223
8549812|NCT00141102|21079847|P2|STARTED|Overall Study||2246
8549813|NCT00141102|21079848|P1|STARTED|Overall Study||2238
8549814|NCT00141037|21079888|P2|NOT COMPLETED|Overall Study||18
8549815|NCT00141037|21079889|P1|NOT COMPLETED|Overall Study||10
8549816|NCT00141037|21079888|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
8549817|NCT00141037|21079889|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
8549818|NCT00141037|21079888|P2|STARTED|Overall Study||70
8549819|NCT00141037|21079889|P1|STARTED|Overall Study||60
8549820|NCT00140842|21079899|P2|NOT COMPLETED|Overall Study||0
8549821|NCT00140842|21079900|P1|NOT COMPLETED|Overall Study||0
8549822|NCT00140842|21079899|P2|COMPLETED|Overall Study||15
8549823|NCT00140842|21079900|P1|COMPLETED|Overall Study||15
8549824|NCT00140842|21079899|P2|STARTED|Overall Study||15
8549825|NCT00140842|21079900|P1|STARTED|Overall Study||15
8549826|NCT00140621|21079908|P1|NOT COMPLETED|Overall Study||0
8549827|NCT00140621|21079908|P1|COMPLETED|Overall Study||6
8549828|NCT00140621|21079908|P1|STARTED|Overall Study||6
8549829|NCT00140556|21079918|P1|NOT COMPLETED|Chemoradiotherapy Period||0
8549830|NCT00140556|21079918|P1|COMPLETED|Chemoradiotherapy Period||28
8549831|NCT00140556|21079918|P1|STARTED|Chemoradiotherapy Period||28
8549832|NCT00140556|21079918|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
8549833|NCT00140556|21079918|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
8549834|NCT00140556|21079918|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
8549835|NCT00140426|21079924|P2|NOT COMPLETED|Overall Study||3
8549836|NCT00140426|21079925|P1|NOT COMPLETED|Overall Study||0
8549837|NCT00140426|21079924|P2|COMPLETED|Overall Study||16
8549838|NCT00140426|21079925|P1|COMPLETED|Overall Study||22
8549839|NCT00140426|21079924|P2|STARTED|Overall Study||19
8549840|NCT00140426|21079925|P1|STARTED|Overall Study||22
8549841|NCT00140413|21079958|P2|NOT COMPLETED|Overall Study||0
8549842|NCT00140413|21079959|P1|NOT COMPLETED|Overall Study||3
8549843|NCT00140413|21079958|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
8549844|NCT00140413|21079959|P1|COMPLETED|Overall Study||10
8549845|NCT00140413|21079958|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
8549846|NCT00140413|21079959|P1|Received at Least One Dose of GH|Overall Study||13
8549847|NCT00140413|21079958|P2|STARTED|Overall Study||7
8549848|NCT00140413|21079959|P1|STARTED|Overall Study||13
8549849|NCT00140244|21079966|P2|NOT COMPLETED|Intervention 2||2
8549850|NCT00140244|21079967|P1|NOT COMPLETED|Intervention 2||0
8549851|NCT00140244|21079966|P2|COMPLETED|Intervention 2||2
8549852|NCT00140244|21079967|P1|COMPLETED|Intervention 2||3
8549853|NCT00140244|21079966|P2|STARTED|Intervention 2||4
8549854|NCT00140244|21079967|P1|STARTED|Intervention 2||3
8549855|NCT00140244|21079966|P2|NOT COMPLETED|Washout||0
8549856|NCT00140244|21079967|P1|NOT COMPLETED|Washout||0
8549857|NCT00140244|21079966|P2|COMPLETED|Washout||4
8549858|NCT00140244|21079967|P1|COMPLETED|Washout||3
8549859|NCT00140244|21079966|P2|STARTED|Washout||4
8549860|NCT00140244|21079967|P1|STARTED|Washout||3
8549861|NCT00140244|21079966|P2|NOT COMPLETED|Intervention 1||0
8549862|NCT00140244|21079967|P1|NOT COMPLETED|Intervention 1||0
8549863|NCT00140244|21079966|P2|COMPLETED|Intervention 1||4
8549864|NCT00140244|21079967|P1|COMPLETED|Intervention 1||3
8549865|NCT00140244|21079966|P2|STARTED|Intervention 1||4
8549866|NCT00140244|21079967|P1|STARTED|Intervention 1||3
8549867|NCT00140231|21079999|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
8549868|NCT00140231|21080000|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
8549869|NCT00140231|21079999|P2|COMPLETED|Fasting State With Leptin and Crossover||6
8549870|NCT00140231|21080000|P1|COMPLETED|Fasting State With Leptin and Crossover||7
8549871|NCT00140231|21079999|P2|STARTED|Fasting State With Leptin and Crossover||6
8549872|NCT00140231|21080000|P1|STARTED|Fasting State With Leptin and Crossover||7
8549873|NCT00140231|21079999|P2|NOT COMPLETED|Washout 8 Weeks||0
8549874|NCT00140231|21080000|P1|NOT COMPLETED|Washout 8 Weeks||0
8549875|NCT00140231|21079999|P2|COMPLETED|Washout 8 Weeks||6
8549876|NCT00140231|21080000|P1|COMPLETED|Washout 8 Weeks||7
8549877|NCT00140231|21079999|P2|STARTED|Washout 8 Weeks||6
8549878|NCT00140231|21080000|P1|STARTED|Washout 8 Weeks||7
8549879|NCT00140231|21079999|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
8549880|NCT00140231|21080000|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
8549881|NCT00140231|21079999|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
8549882|NCT00140231|21080000|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
8549883|NCT00140231|21079999|P2|STARTED|First Fasting State 3 Days With Placebo||6
8549884|NCT00140231|21080000|P1|STARTED|First Fasting State 3 Days With Placebo||7
8549885|NCT00140231|21079999|P2|NOT COMPLETED|Washout 8weeks||0
8549886|NCT00140231|21080000|P1|NOT COMPLETED|Washout 8weeks||0
8549887|NCT00140231|21079999|P2|COMPLETED|Washout 8weeks||6
8549888|NCT00140231|21080000|P1|COMPLETED|Washout 8weeks||7
8549889|NCT00140231|21079999|P2|STARTED|Washout 8weeks||6
8549890|NCT00140231|21080000|P1|STARTED|Washout 8weeks||7
8549891|NCT00140231|21079999|P2|NOT COMPLETED|Fed State 1 Day- day5||0
8549892|NCT00140231|21080000|P1|NOT COMPLETED|Fed State 1 Day- day5||0
8549893|NCT00140231|21079999|P2|COMPLETED|Fed State 1 Day- day5||6
8549894|NCT00140231|21080000|P1|COMPLETED|Fed State 1 Day- day5||7
8549895|NCT00140231|21079999|P2|STARTED|Fed State 1 Day- day5||6
8549896|NCT00140231|21080000|P1|STARTED|Fed State 1 Day- day5||7
8549897|NCT00140205|21080019|P3|NOT COMPLETED|Overall Study||0
8549898|NCT00140205|21080020|P2|NOT COMPLETED|Overall Study||0
8549899|NCT00140205|21080021|P1|NOT COMPLETED|Overall Study||0
8549900|NCT00140205|21080019|P3|COMPLETED|Overall Study||5
8549901|NCT00140205|21080020|P2|COMPLETED|Overall Study||5
8549902|NCT00140205|21080021|P1|COMPLETED|Overall Study||5
8549903|NCT00140205|21080019|P3|STARTED|Overall Study||5
8549904|NCT00140205|21080020|P2|STARTED|Overall Study||5
8549905|NCT00140205|21080021|P1|STARTED|Overall Study||5
8549906|NCT00140140|21080090|P3|NOT COMPLETED|Overall Study||2
8549907|NCT00140140|21080091|P2|NOT COMPLETED|Overall Study||2
8549908|NCT00140140|21080092|P1|NOT COMPLETED|Overall Study||2
8549909|NCT00140140|21080090|P3|COMPLETED|Overall Study|Progressive disease|4
8549910|NCT00140140|21080091|P2|COMPLETED|Overall Study|Progressive disease|4
8549911|NCT00140140|21080092|P1|COMPLETED|Overall Study|Progressive disease|2
8549912|NCT00140140|21080090|P3|STARTED|Overall Study||6
8549913|NCT00140140|21080091|P2|STARTED|Overall Study||6
8549914|NCT00140140|21080092|P1|STARTED|Overall Study||4
8549915|NCT00139997|21080131|P2|NOT COMPLETED|Overall Study||2
8549916|NCT00139997|21080132|P1|NOT COMPLETED|Overall Study||1
8549917|NCT00139997|21080131|P2|COMPLETED|Overall Study||9
8549918|NCT00139997|21080132|P1|COMPLETED|Overall Study||14
8549919|NCT00139997|21080131|P2|STARTED|Overall Study||11
8549920|NCT00139997|21080132|P1|STARTED|Overall Study||15
8549921|NCT00139776|21080142|P4|NOT COMPLETED|Period III||106
8549922|NCT00139776|21080143|P3|NOT COMPLETED|Period III||76
8549923|NCT00139776|21080144|P2|NOT COMPLETED|Period III||0
8549924|NCT00139776|21080145|P1|NOT COMPLETED|Period III||0
8549925|NCT00139776|21080142|P4|COMPLETED|Period III||321
8549926|NCT00139776|21080143|P3|COMPLETED|Period III||355
8549927|NCT00139776|21080144|P2|COMPLETED|Period III||0
8549928|NCT00139776|21080145|P1|COMPLETED|Period III||0
8549929|NCT00139776|21080142|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
8549930|NCT00139776|21080143|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
8549931|NCT00139776|21080144|P2|STARTED|Period III||0
8549932|NCT00139776|21080145|P1|STARTED|Period III||0
8549933|NCT00139776|21080142|P4|NOT COMPLETED|Period II||0
8549934|NCT00139776|21080143|P3|NOT COMPLETED|Period II||0
8549935|NCT00139776|21080144|P2|NOT COMPLETED|Period II||322
8549936|NCT00139776|21080145|P1|NOT COMPLETED|Period II||0
8549937|NCT00139776|21080142|P4|COMPLETED|Period II||0
8549938|NCT00139776|21080143|P3|COMPLETED|Period II||0
8549939|NCT00139776|21080144|P2|COMPLETED|Period II||875
8549940|NCT00139776|21080145|P1|COMPLETED|Period II||0
8549941|NCT00139776|21080142|P4|STARTED|Period II||0
8549942|NCT00139776|21080143|P3|STARTED|Period II||0
8549943|NCT00139776|21080144|P2|STARTED|Period II||1197
8549944|NCT00139776|21080145|P1|STARTED|Period II||0
8549945|NCT00139776|21080142|P4|NOT COMPLETED|Period I||0
8549946|NCT00139776|21080143|P3|NOT COMPLETED|Period I||0
8549947|NCT00139776|21080144|P2|NOT COMPLETED|Period I||0
8549948|NCT00139776|21080145|P1|NOT COMPLETED|Period I||575
8549949|NCT00139776|21080142|P4|COMPLETED|Period I||0
8549950|NCT00139776|21080143|P3|COMPLETED|Period I||0
8549951|NCT00139776|21080144|P2|COMPLETED|Period I||0
8549952|NCT00139776|21080145|P1|COMPLETED|Period I||1197
8549953|NCT00139776|21080142|P4|STARTED|Period I||0
8549954|NCT00139776|21080143|P3|STARTED|Period I||0
8549955|NCT00139776|21080144|P2|STARTED|Period I||0
8549956|NCT00139776|21080145|P1|STARTED|Period I||1772
8549957|NCT00139737|21080180|P1|NOT COMPLETED|Overall Study||341
8549958|NCT00139737|21080180|P1|COMPLETED|Overall Study||3
8549959|NCT00139737|21080180|P1|Received Treatment|Overall Study||331
8549960|NCT00139737|21080180|P1|STARTED|Overall Study||344
8549961|NCT00139659|21080186|P2|NOT COMPLETED|Overall Study||18
8549962|NCT00139659|21080187|P1|NOT COMPLETED|Overall Study||40
8549963|NCT00139659|21080186|P2|COMPLETED|Overall Study||123
8549964|NCT00139659|21080187|P1|COMPLETED|Overall Study||106
8549965|NCT00139659|21080186|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
8549966|NCT00139659|21080187|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
8549967|NCT00139477|21080265|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
8549968|NCT00139477|21080266|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
8549969|NCT00139477|21080265|P2|COMPLETED|Second Intervention -6Months to 12Months||18
8549970|NCT00139477|21080266|P1|COMPLETED|Second Intervention -6Months to 12Months||14
8549971|NCT00139477|21080265|P2|STARTED|Second Intervention -6Months to 12Months||23
8549972|NCT00139477|21080266|P1|STARTED|Second Intervention -6Months to 12Months||19
8549973|NCT00139477|21080265|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
8549974|NCT00139477|21080266|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
8549975|NCT00139477|21080265|P2|COMPLETED|First Intervention -Baseline to 6Months||23
8549976|NCT00139477|21080266|P1|COMPLETED|First Intervention -Baseline to 6Months||19
8549977|NCT00139477|21080265|P2|STARTED|First Intervention -Baseline to 6Months||35
8549978|NCT00139477|21080266|P1|STARTED|First Intervention -Baseline to 6Months||31
8549979|NCT00139399|21080288|P2|NOT COMPLETED|Overall Study||23
8549980|NCT00139399|21080289|P1|NOT COMPLETED|Overall Study||16
8549981|NCT00139399|21080288|P2|COMPLETED|Overall Study||59
8549982|NCT00139399|21080289|P1|COMPLETED|Overall Study||44
8549983|NCT00139399|21080288|P2|STARTED|Overall Study||82
8549984|NCT00139399|21080289|P1|STARTED|Overall Study||60
8549985|NCT00138671|21080301|P2|NOT COMPLETED|Overall Study||16
8549986|NCT00138671|21080302|P1|NOT COMPLETED|Overall Study||13
8549987|NCT00138671|21080301|P2|COMPLETED|Overall Study||30
8549988|NCT00138671|21080302|P1|COMPLETED|Overall Study||46
8549989|NCT00138671|21080301|P2|STARTED|Overall Study||46
8549990|NCT00138671|21080302|P1|STARTED|Overall Study||59
8549991|NCT00138658|21080352|P1|NOT COMPLETED|Overall Study||61
8549992|NCT00138658|21080352|P1|COMPLETED|Overall Study||20
8549993|NCT00138658|21080352|P1|STARTED|Overall Study||81
8549994|NCT00138645|21080364|P2|NOT COMPLETED|Overall Study||7
8549995|NCT00138645|21080365|P1|NOT COMPLETED|Overall Study||6
8549996|NCT00138645|21080364|P2|COMPLETED|Overall Study||23
8549997|NCT00138645|21080365|P1|COMPLETED|Overall Study||24
8549998|NCT00138645|21080364|P2|STARTED|Overall Study||30
8549999|NCT00138645|21080365|P1|STARTED|Overall Study||30
8550000|NCT00138424|21080375|P4|NOT COMPLETED|Overall Study||0
8550001|NCT00138424|21080376|P3|NOT COMPLETED|Overall Study||0
8550002|NCT00138424|21080377|P2|NOT COMPLETED|Overall Study||1
8550003|NCT00138424|21080378|P1|NOT COMPLETED|Overall Study||0
8550004|NCT00138424|21080375|P4|COMPLETED|Overall Study||3
8550005|NCT00138424|21080376|P3|COMPLETED|Overall Study||5
8550006|NCT00138424|21080377|P2|COMPLETED|Overall Study||4
8550007|NCT00138424|21080378|P1|COMPLETED|Overall Study||9
8550008|NCT00138424|21080375|P4|STARTED|Overall Study||3
8550009|NCT00138424|21080376|P3|STARTED|Overall Study||5
8550010|NCT00138424|21080377|P2|STARTED|Overall Study||5
8550011|NCT00138424|21080378|P1|STARTED|Overall Study||9
8550012|NCT00138294|21080444|P1|NOT COMPLETED|Overall Study||0
8550013|NCT00138294|21080444|P1|COMPLETED|Overall Study||29255
8550014|NCT00138294|21080444|P1|STARTED|Overall Study||29255
8550015|NCT00138203|21080454|P1|NOT COMPLETED|Overall Study||0
8550016|NCT00138203|21080454|P1|COMPLETED|Overall Study||16
8550017|NCT00138203|21080454|P1|STARTED|Overall Study||16
8550018|NCT00138151|21080461|P1|NOT COMPLETED|Overall Study||4
8550019|NCT00138151|21080461|P1|COMPLETED|Overall Study||29
8550020|NCT00138151|21080461|P1|STARTED|Overall Study||33
8550021|NCT00138125|21080467|P1|NOT COMPLETED|Overall Study||0
8550022|NCT00138125|21080467|P1|COMPLETED|Overall Study||2
8550023|NCT00138125|21080467|P1|STARTED|Overall Study||2
8550024|NCT00138073|21080476|P1|NOT COMPLETED|Overall Study||55
8550025|NCT00138073|21080476|P1|COMPLETED|Overall Study||0
8550026|NCT00138073|21080476|P1|Pre-intervention Testing|Overall Study||55
8550027|NCT00138073|21080476|P1|STARTED|Overall Study||55
8550028|NCT00138034|21080483|P2|NOT COMPLETED|Overall Study||3
8550029|NCT00138034|21080484|P1|NOT COMPLETED|Overall Study||3
8550030|NCT00138034|21080483|P2|COMPLETED|Overall Study||20
8550031|NCT00138034|21080484|P1|COMPLETED|Overall Study||23
8550032|NCT00138034|21080483|P2|STARTED|Overall Study||23
8550033|NCT00138034|21080484|P1|STARTED|Overall Study||26
8550034|NCT00137969|21080494|P2|NOT COMPLETED|Overall Study||21
8550035|NCT00137969|21080495|P1|NOT COMPLETED|Overall Study||67
8550036|NCT00137969|21080494|P2|COMPLETED|Overall Study||67
8550037|NCT00137969|21080495|P1|COMPLETED|Overall Study||107
8550038|NCT00137969|21080494|P2|Received Study Drug|Overall Study||88
8550039|NCT00137969|21080495|P1|Received Study Drug|Overall Study||169
8550040|NCT00137969|21080494|P2|STARTED|Overall Study||88
8550041|NCT00137969|21080495|P1|STARTED|Overall Study||174
8550042|NCT00137839|21080515|P1|NOT COMPLETED|Overall Study||84
8550043|NCT00137839|21080515|P1|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
8550044|NCT00137839|21080515|P1|Treated|Overall Study||83
8550045|NCT00137839|21080515|P1|STARTED|Overall Study||84
8550046|NCT00137631|21080528|P2|NOT COMPLETED|Overall Study||41
8550047|NCT00137631|21080529|P1|NOT COMPLETED|Overall Study||37
8550048|NCT00137631|21080528|P2|COMPLETED|Overall Study||133
8550049|NCT00137631|21080529|P1|COMPLETED|Overall Study||127
8550050|NCT00137631|21080528|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
8550051|NCT00137631|21080529|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
8550052|NCT00137631|21080528|P2|Complete 3-month Follow-up|Overall Study||125
8550053|NCT00137631|21080529|P1|Complete 3-month Follow-up|Overall Study||120
8550054|NCT00137631|21080528|P2|STARTED|Overall Study||174
8550055|NCT00137631|21080529|P1|STARTED|Overall Study||164
8550056|NCT00137449|21080545|P2|NOT COMPLETED|Overall Study||18
8550057|NCT00137449|21080546|P1|NOT COMPLETED|Overall Study||16
8550058|NCT00137449|21080545|P2|COMPLETED|Overall Study||12
8550059|NCT00137449|21080546|P1|COMPLETED|Overall Study||14
8550060|NCT00137449|21080545|P2|STARTED|Overall Study||30
8550061|NCT00137449|21080546|P1|STARTED|Overall Study||30
8550062|NCT00137436|21080583|P1|NOT COMPLETED|Overall Study||43
8550063|NCT00137436|21080583|P1|COMPLETED|Overall Study||12
8550064|NCT00137436|21080583|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
8550065|NCT00137423|21080602|P2|NOT COMPLETED|Overall Study||44
8550066|NCT00137423|21080603|P1|NOT COMPLETED|Overall Study||39
8550067|NCT00137423|21080602|P2|COMPLETED|Overall Study||9
8550068|NCT00137423|21080603|P1|COMPLETED|Overall Study||15
8550069|NCT00137423|21080602|P2|STARTED|Overall Study||53
8550070|NCT00137423|21080603|P1|STARTED|Overall Study||54
8550071|NCT00137280|21080625|P2|NOT COMPLETED|Overall Study||55
8550072|NCT00137280|21080626|P1|NOT COMPLETED|Overall Study||84
8550073|NCT00137280|21080625|P2|COMPLETED|Overall Study||357
8550074|NCT00137280|21080626|P1|COMPLETED|Overall Study||305
8550075|NCT00137280|21080625|P2|STARTED|Overall Study||412
8550076|NCT00137280|21080626|P1|STARTED|Overall Study||389
8550077|NCT00137267|21080640|P2|NOT COMPLETED|Overall Study||21
8550078|NCT00137267|21080641|P1|NOT COMPLETED|Overall Study||15
8550079|NCT00137267|21080640|P2|COMPLETED|Overall Study||26
8550080|NCT00137267|21080641|P1|COMPLETED|Overall Study||40
8550081|NCT00137267|21080640|P2|STARTED|Overall Study||47
8550082|NCT00137267|21080641|P1|STARTED|Overall Study||55
8550083|NCT00137111|21080653|P4|NOT COMPLETED|Total Therapy||0
8550084|NCT00137111|21080654|P3|NOT COMPLETED|Total Therapy||0
8550085|NCT00137111|21080655|P2|NOT COMPLETED|Total Therapy||0
8550086|NCT00137111|21080656|P1|NOT COMPLETED|Total Therapy||40
8550087|NCT00137111|21080653|P4|COMPLETED|Total Therapy||0
8550088|NCT00137111|21080654|P3|COMPLETED|Total Therapy||0
8550089|NCT00137111|21080655|P2|COMPLETED|Total Therapy||0
8550090|NCT00137111|21080656|P1|COMPLETED|Total Therapy||458
8550091|NCT00137111|21080653|P4|STARTED|Total Therapy||0
8550092|NCT00137111|21080654|P3|STARTED|Total Therapy||0
8550093|NCT00137111|21080655|P2|STARTED|Total Therapy||0
8550094|NCT00137111|21080656|P1|STARTED|Total Therapy||498
8550095|NCT00137111|21080653|P4|NOT COMPLETED|Window Therapy||0
8550096|NCT00137111|21080654|P3|NOT COMPLETED|Window Therapy||0
8550097|NCT00137111|21080655|P2|NOT COMPLETED|Window Therapy||0
8550098|NCT00137111|21080656|P1|NOT COMPLETED|Window Therapy||0
8550099|NCT00137111|21080653|P4|COMPLETED|Window Therapy||142
8550100|NCT00137111|21080654|P3|COMPLETED|Window Therapy||180
8550101|NCT00137111|21080655|P2|COMPLETED|Window Therapy||176
8550102|NCT00137111|21080656|P1|COMPLETED|Window Therapy||0
8550103|NCT00137111|21080653|P4|STARTED|Window Therapy||142
8550104|NCT00137111|21080654|P3|STARTED|Window Therapy||180
8550105|NCT00137111|21080655|P2|STARTED|Window Therapy||176
8550106|NCT00137111|21080656|P1|STARTED|Window Therapy||0
8550107|NCT00137046|21080670|P2|NOT COMPLETED|Overall Study||93
8550108|NCT00137046|21080671|P1|NOT COMPLETED|Overall Study||99
8550109|NCT00137046|21080670|P2|COMPLETED|Overall Study||198
8550110|NCT00137046|21080671|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
8550111|NCT00137046|21080670|P2|Received Study Treatment|Overall Study||290
8550112|NCT00137046|21080671|P1|Received Study Treatment|Overall Study||290
8550113|NCT00137046|21080670|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
8550114|NCT00137046|21080671|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
8550115|NCT00136955|21080719|P1|NOT COMPLETED|Overall Study||23
8550116|NCT00136955|21080719|P1|COMPLETED|Overall Study||18
8550117|NCT00136955|21080719|P1|STARTED|Overall Study||41
8550118|NCT00136916|21080728|P2|NOT COMPLETED|Overall Study||104
8550119|NCT00136916|21080729|P1|NOT COMPLETED|Overall Study||125
8550120|NCT00136916|21080728|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
8550121|NCT00136916|21080729|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
8550122|NCT00136916|21080728|P2|Received Treatment|Overall Study||311
8550123|NCT00136916|21080729|P1|Received Treatment|Overall Study||316
8550124|NCT00136916|21080728|P2|STARTED|Overall Study||316
8550125|NCT00136916|21080729|P1|STARTED|Overall Study||319
8550126|NCT00136838|21080783|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
8550127|NCT00136838|21080784|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
8550128|NCT00136838|21080783|P2|COMPLETED|Second Intervention ( 5 Days)||6
8550129|NCT00136838|21080784|P1|COMPLETED|Second Intervention ( 5 Days)||6
8550130|NCT00136838|21080783|P2|STARTED|Second Intervention ( 5 Days)||6
8550131|NCT00136838|21080784|P1|STARTED|Second Intervention ( 5 Days)||6
8550132|NCT00136838|21080783|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
8550133|NCT00136838|21080784|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
8550134|NCT00136838|21080783|P2|COMPLETED|First Intervention ( 5 Days)||6
8550135|NCT00136838|21080784|P1|COMPLETED|First Intervention ( 5 Days)||6
8550136|NCT00136838|21080783|P2|STARTED|First Intervention ( 5 Days)||6
8550137|NCT00136838|21080784|P1|STARTED|First Intervention ( 5 Days)||6
8550138|NCT00136812|21080794|P2|NOT COMPLETED|Overall Study||0
8550139|NCT00136812|21080795|P1|NOT COMPLETED|Overall Study||0
8550140|NCT00136812|21080794|P2|COMPLETED|Overall Study||113
8550141|NCT00136812|21080795|P1|COMPLETED|Overall Study||111
8550142|NCT00136812|21080794|P2|STARTED|Overall Study||113
8550143|NCT00136812|21080795|P1|STARTED|Overall Study||111
8550144|NCT00136760|21080805|P4|NOT COMPLETED|Overall Study||0
8550145|NCT00136760|21080806|P3|NOT COMPLETED|Overall Study||0
8550146|NCT00136760|21080807|P2|NOT COMPLETED|Overall Study||0
8550147|NCT00136760|21080808|P1|NOT COMPLETED|Overall Study||0
8550148|NCT00136760|21080805|P4|COMPLETED|Overall Study||13
8550149|NCT00136760|21080806|P3|COMPLETED|Overall Study||11
8550150|NCT00136760|21080807|P2|COMPLETED|Overall Study||16
8550151|NCT00136760|21080808|P1|COMPLETED|Overall Study||12
8550152|NCT00136760|21080805|P4|STARTED|Overall Study||13
8550153|NCT00136760|21080806|P3|STARTED|Overall Study||11
8550154|NCT00136760|21080807|P2|STARTED|Overall Study||16
8550155|NCT00136760|21080808|P1|STARTED|Overall Study||12
8550156|NCT00136695|21080824|P2|NOT COMPLETED|Overall Study||8
8550157|NCT00136695|21080825|P1|NOT COMPLETED|Overall Study||11
8550158|NCT00136695|21080824|P2|COMPLETED|Overall Study||35
8550159|NCT00136695|21080825|P1|COMPLETED|Overall Study||34
8550160|NCT00136695|21080824|P2|STARTED|Overall Study||43
8550161|NCT00136695|21080825|P1|STARTED|Overall Study||45
8550162|NCT00136604|21080836|P5|NOT COMPLETED|Overall Study||1
8550163|NCT00136604|21080837|P4|NOT COMPLETED|Overall Study||0
8550164|NCT00136604|21080838|P3|NOT COMPLETED|Overall Study||0
8550165|NCT00136604|21080839|P2|NOT COMPLETED|Overall Study||1
8550166|NCT00136604|21080840|P1|NOT COMPLETED|Overall Study||1
8550167|NCT00136604|21080836|P5|COMPLETED|Overall Study||124
8550168|NCT00136604|21080837|P4|COMPLETED|Overall Study||41
8550169|NCT00136604|21080838|P3|COMPLETED|Overall Study||79
8550170|NCT00136604|21080839|P2|COMPLETED|Overall Study||122
8550171|NCT00136604|21080840|P1|COMPLETED|Overall Study||248
8550172|NCT00136604|21080836|P5|STARTED|Overall Study||125
8550173|NCT00136604|21080837|P4|STARTED|Overall Study||41
8550174|NCT00136604|21080838|P3|STARTED|Overall Study||79
8550175|NCT00136604|21080839|P2|STARTED|Overall Study||123
8550176|NCT00136604|21080840|P1|STARTED|Overall Study||249
8550177|NCT00136357|21080948|P2|NOT COMPLETED|Overall Study||2
8550178|NCT00136357|21080949|P1|NOT COMPLETED|Overall Study||3
8550179|NCT00136357|21080948|P2|COMPLETED|Overall Study||39
8550180|NCT00136357|21080949|P1|COMPLETED|Overall Study||38
8550181|NCT00136357|21080948|P2|STARTED|Overall Study||41
8550182|NCT00136357|21080949|P1|STARTED|Overall Study||41
8550183|NCT00136318|21080957|P2|NOT COMPLETED|Overall Study||7
8550184|NCT00136318|21080958|P1|NOT COMPLETED|Overall Study||7
8550185|NCT00136318|21080957|P2|COMPLETED|Overall Study||84
8550186|NCT00136318|21080958|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
8550187|NCT00136318|21080957|P2|STARTED|Overall Study|Took first dose of study medication|91
8550188|NCT00136318|21080958|P1|STARTED|Overall Study|Took first dose of study medication|90
8550189|NCT00136214|21080974|P2|NOT COMPLETED|Overall Study||0
8550190|NCT00136214|21080975|P1|NOT COMPLETED|Overall Study||0
8550191|NCT00136214|21080974|P2|COMPLETED|Overall Study||7
8550192|NCT00136214|21080975|P1|COMPLETED|Overall Study||15
8550193|NCT00136214|21080974|P2|STARTED|Overall Study||7
8550194|NCT00136214|21080975|P1|STARTED|Overall Study||15
8550195|NCT00136084|21080985|P2|NOT COMPLETED|Overall Study||42
8550196|NCT00136084|21080986|P1|NOT COMPLETED|Overall Study||48
8550197|NCT00136084|21080985|P2|COMPLETED|Overall Study||72
8550198|NCT00136084|21080986|P1|COMPLETED|Overall Study||61
8550199|NCT00136084|21080985|P2|STARTED|Overall Study||114
8550200|NCT00136084|21080986|P1|STARTED|Overall Study||109
8550201|NCT00135798|21081002|P3|NOT COMPLETED|Overall Study||0
8550202|NCT00135798|21081003|P2|NOT COMPLETED|Overall Study||0
8550203|NCT00135798|21081004|P1|NOT COMPLETED|Overall Study||0
8550204|NCT00135798|21081002|P3|COMPLETED|Overall Study||32
8550205|NCT00135798|21081003|P2|COMPLETED|Overall Study||31
8550206|NCT00135798|21081004|P1|COMPLETED|Overall Study||16
8550207|NCT00135798|21081002|P3|STARTED|Overall Study||32
8550208|NCT00135798|21081003|P2|STARTED|Overall Study||31
8550209|NCT00135798|21081004|P1|STARTED|Overall Study||16
8550210|NCT00135707|21081022|P2|NOT COMPLETED|Overall Study||90
8550211|NCT00135707|21081023|P1|NOT COMPLETED|Overall Study||95
8550212|NCT00135707|21081022|P2|COMPLETED|Overall Study||4976
8550213|NCT00135707|21081023|P1|COMPLETED|Overall Study||4993
8550214|NCT00135707|21081022|P2|STARTED|Overall Study||5066
8550215|NCT00135707|21081023|P1|STARTED|Overall Study||5088
8550216|NCT00135694|21081106|P3|NOT COMPLETED|Overall Study||7
8550217|NCT00135694|21081107|P2|NOT COMPLETED|Overall Study||21
8550218|NCT00135694|21081108|P1|NOT COMPLETED|Overall Study||180
8550219|NCT00135694|21081106|P3|COMPLETED|Overall Study||11
8550220|NCT00135694|21081107|P2|COMPLETED|Overall Study||56
8550221|NCT00135694|21081108|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
8550222|NCT00135694|21081106|P3|STARTED|Overall Study||18
8550223|NCT00135694|21081107|P2|STARTED|Overall Study||77
8550224|NCT00135694|21081108|P1|STARTED|Overall Study||180
8550225|NCT00135512|21081126|P1|NOT COMPLETED|Overall Study||123
8550226|NCT00135512|21081126|P1|COMPLETED|Overall Study||111
8550227|NCT00135512|21081126|P1|STARTED|Overall Study||234
8550228|NCT00135356|21081138|P2|NOT COMPLETED|Overall Study||9
8550229|NCT00135356|21081139|P1|NOT COMPLETED|Overall Study||17
8550230|NCT00135356|21081138|P2|COMPLETED|Overall Study||60
8550231|NCT00135356|21081139|P1|COMPLETED|Overall Study||114
8550232|NCT00135356|21081138|P2|Discontinued on or After Week 96 Visit|Overall Study||0
8550233|NCT00135356|21081139|P1|Discontinued on or After Week 96 Visit|Overall Study||1
8550234|NCT00135356|21081138|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
8550235|NCT00135356|21081139|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
8550236|NCT00135356|21081138|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
8550237|NCT00135356|21081139|P1|STARTED|Overall Study|Number randomized and treated|131
8550238|NCT00135330|21081182|P3|NOT COMPLETED|Overall Study||11
8550239|NCT00135330|21081183|P2|NOT COMPLETED|Overall Study||13
8550240|NCT00135330|21081184|P1|NOT COMPLETED|Overall Study||12
8550241|NCT00135330|21081182|P3|COMPLETED|Overall Study||34
8550242|NCT00135330|21081183|P2|COMPLETED|Overall Study||34
8550243|NCT00135330|21081184|P1|COMPLETED|Overall Study||33
8550244|NCT00135330|21081182|P3|STARTED|Overall Study||45
8550245|NCT00135330|21081183|P2|STARTED|Overall Study||47
8550246|NCT00135330|21081184|P1|STARTED|Overall Study||45
8550247|NCT00135226|21081280|P4|NOT COMPLETED|Overall Study||36
8550248|NCT00135226|21081281|P3|NOT COMPLETED|Overall Study||34
8550249|NCT00135226|21081282|P2|NOT COMPLETED|Overall Study||35
8550250|NCT00135226|21081283|P1|NOT COMPLETED|Overall Study||34
8550251|NCT00135226|21081280|P4|COMPLETED|Overall Study||3834
8550252|NCT00135226|21081281|P3|COMPLETED|Overall Study||3836
8550253|NCT00135226|21081282|P2|COMPLETED|Overall Study||3835
8550254|NCT00135226|21081283|P1|COMPLETED|Overall Study||3836
8550255|NCT00135226|21081280|P4|STARTED|Overall Study||3870
8550256|NCT00135226|21081281|P3|STARTED|Overall Study||3870
8550257|NCT00135226|21081282|P2|STARTED|Overall Study||3870
8550258|NCT00135226|21081283|P1|STARTED|Overall Study||3870
8550262|NCT00134901|21081382|P2|NOT COMPLETED|Overall Study||15
8550263|NCT00134901|21081383|P1|NOT COMPLETED|Overall Study||17
8550264|NCT00134901|21081382|P2|COMPLETED|Overall Study||27
8550265|NCT00134901|21081383|P1|COMPLETED|Overall Study||22
8550266|NCT00134901|21081382|P2|STARTED|Overall Study||42
8550267|NCT00134901|21081383|P1|STARTED|Overall Study||39
8550268|NCT00134784|21081395|P4|NOT COMPLETED|Overall Study||1
8550269|NCT00134784|21081396|P3|NOT COMPLETED|Overall Study||2
8550270|NCT00134784|21081397|P2|NOT COMPLETED|Overall Study||2
8550271|NCT00134784|21081398|P1|NOT COMPLETED|Overall Study||2
8550272|NCT00134784|21081395|P4|COMPLETED|Overall Study||37
8550273|NCT00134784|21081396|P3|COMPLETED|Overall Study||35
8550274|NCT00134784|21081397|P2|COMPLETED|Overall Study||36
8550275|NCT00134784|21081398|P1|COMPLETED|Overall Study||27
8550276|NCT00134784|21081395|P4|STARTED|Overall Study||38
8550277|NCT00134784|21081396|P3|STARTED|Overall Study||37
8550278|NCT00134784|21081397|P2|STARTED|Overall Study||38
8550279|NCT00134784|21081398|P1|STARTED|Overall Study||29
8550280|NCT00134719|21081408|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
8550281|NCT00134719|21081409|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
8550282|NCT00134719|21081410|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
8550283|NCT00134719|21081408|P3|COMPLETED|Fourth Dose Vaccination Phase||203
8550284|NCT00134719|21081409|P2|COMPLETED|Fourth Dose Vaccination Phase||203
8550285|NCT00134719|21081410|P1|COMPLETED|Fourth Dose Vaccination Phase||623
8550286|NCT00134719|21081408|P3|STARTED|Fourth Dose Vaccination Phase||204
8550287|NCT00134719|21081409|P2|STARTED|Fourth Dose Vaccination Phase||206
8550288|NCT00134719|21081410|P1|STARTED|Fourth Dose Vaccination Phase||625
8550289|NCT00134719|21081408|P3|NOT COMPLETED|Primary Vaccination Phase||5
8550290|NCT00134719|21081409|P2|NOT COMPLETED|Primary Vaccination Phase||6
8550291|NCT00134719|21081410|P1|NOT COMPLETED|Primary Vaccination Phase||14
8550292|NCT00134719|21081408|P3|COMPLETED|Primary Vaccination Phase||216
8550293|NCT00134719|21081409|P2|COMPLETED|Primary Vaccination Phase||215
8550294|NCT00134719|21081410|P1|COMPLETED|Primary Vaccination Phase||647
8550295|NCT00134719|21081408|P3|STARTED|Primary Vaccination Phase||221
8550296|NCT00134719|21081409|P2|STARTED|Primary Vaccination Phase||221
8550297|NCT00134719|21081410|P1|STARTED|Primary Vaccination Phase||661
8550298|NCT00134563|21081541|P3|NOT COMPLETED|Overall Study||96
8550299|NCT00134563|21081542|P2|NOT COMPLETED|Overall Study||92
8550300|NCT00134563|21081543|P1|NOT COMPLETED|Overall Study||104
8550301|NCT00134563|21081541|P3|COMPLETED|Overall Study|completed treatment period|263
8550302|NCT00134563|21081542|P2|COMPLETED|Overall Study|completed treatment period|274
8550303|NCT00134563|21081543|P1|COMPLETED|Overall Study|completed treatment period|259
8550304|NCT00134563|21081541|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
8550305|NCT00134563|21081542|P2|Treated|Overall Study||365
8550306|NCT00134563|21081543|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
8550307|NCT00134563|21081541|P3|STARTED|Overall Study|Randomized|359
8550308|NCT00134563|21081542|P2|STARTED|Overall Study|Randomized|366
8550309|NCT00134563|21081543|P1|STARTED|Overall Study|Randomized|363
8550310|NCT00134381|21081566|P6|NOT COMPLETED|Overall Study||2
8550311|NCT00134381|21081567|P5|NOT COMPLETED|Overall Study||0
8550312|NCT00134381|21081568|P4|NOT COMPLETED|Overall Study||0
8550313|NCT00134381|21081569|P3|NOT COMPLETED|Overall Study||0
8550314|NCT00134381|21081570|P2|NOT COMPLETED|Overall Study||0
8550315|NCT00134381|21081571|P1|NOT COMPLETED|Overall Study||0
8550316|NCT00134381|21081566|P6|COMPLETED|Overall Study||29
8550317|NCT00134381|21081567|P5|COMPLETED|Overall Study||31
8550318|NCT00134381|21081568|P4|COMPLETED|Overall Study||2
8550319|NCT00134381|21081569|P3|COMPLETED|Overall Study||1
8550320|NCT00134381|21081570|P2|COMPLETED|Overall Study||2
8550321|NCT00134381|21081571|P1|COMPLETED|Overall Study||1
8550322|NCT00134381|21081566|P6|STARTED|Overall Study||31
8550323|NCT00134381|21081567|P5|STARTED|Overall Study||31
8550324|NCT00134381|21081568|P4|STARTED|Overall Study||2
8550325|NCT00134381|21081569|P3|STARTED|Overall Study||1
8550326|NCT00134381|21081570|P2|STARTED|Overall Study||2
8550327|NCT00134381|21081571|P1|STARTED|Overall Study||1
8550328|NCT00134082|21081604|P1|NOT COMPLETED|Overall Study||3
8550329|NCT00134082|21081604|P1|COMPLETED|Overall Study||27
8550330|NCT00134082|21081604|P1|STARTED|Overall Study||30
8550331|NCT00134056|21081613|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
8550332|NCT00134056|21081614|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
8550333|NCT00134056|21081613|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
8550334|NCT00134056|21081614|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
8550335|NCT00134056|21081613|P2|STARTED|Eligible for Protocol Assigned Treatment||500
8550336|NCT00134056|21081614|P1|STARTED|Eligible for Protocol Assigned Treatment||496
8550337|NCT00134056|21081613|P2|NOT COMPLETED|Randomization||20
8550338|NCT00134056|21081614|P1|NOT COMPLETED|Randomization||22
8550339|NCT00134056|21081613|P2|COMPLETED|Randomization||500
8550340|NCT00134056|21081614|P1|COMPLETED|Randomization||496
8550341|NCT00134056|21081613|P2|STARTED|Randomization||520
8550342|NCT00134056|21081614|P1|STARTED|Randomization||518
8550343|NCT00134043|21081636|P2|NOT COMPLETED|Overall Study||0
8550344|NCT00134043|21081637|P1|NOT COMPLETED|Overall Study||0
8550345|NCT00134043|21081636|P2|COMPLETED|Overall Study||3
8550346|NCT00134043|21081637|P1|COMPLETED|Overall Study||16
8550347|NCT00134043|21081636|P2|STARTED|Overall Study||3
8550348|NCT00134043|21081637|P1|STARTED|Overall Study||16
8550349|NCT00134017|21081642|P1|NOT COMPLETED|Overall Study||0
8550350|NCT00134017|21081642|P1|COMPLETED|Overall Study||142
8550351|NCT00134017|21081642|P1|STARTED|Overall Study||142
8550352|NCT00134004|21081650|P1|NOT COMPLETED|Overall Study||0
8550353|NCT00134004|21081650|P1|COMPLETED|Overall Study||210
8550354|NCT00134004|21081650|P1|STARTED|Overall Study||210
8550355|NCT00133991|21081658|P1|NOT COMPLETED|Overall Study||4
8550356|NCT00133991|21081658|P1|COMPLETED|Overall Study||17
8550357|NCT00133991|21081658|P1|STARTED|Overall Study||21
8550358|NCT00133978|21081670|P4|NOT COMPLETED|Overall Study||2
8550359|NCT00133978|21081671|P3|NOT COMPLETED|Overall Study||0
8550360|NCT00133978|21081672|P2|NOT COMPLETED|Overall Study||1
8550361|NCT00133978|21081673|P1|NOT COMPLETED|Overall Study||2
8550362|NCT00133978|21081670|P4|COMPLETED|Overall Study||300
8550363|NCT00133978|21081671|P3|COMPLETED|Overall Study||310
8550364|NCT00133978|21081672|P2|COMPLETED|Overall Study||307
8550365|NCT00133978|21081673|P1|COMPLETED|Overall Study||301
8550366|NCT00133978|21081670|P4|STARTED|Overall Study||302
8550367|NCT00133978|21081671|P3|STARTED|Overall Study||310
8550368|NCT00133978|21081672|P2|STARTED|Overall Study||308
8550369|NCT00133978|21081673|P1|STARTED|Overall Study||303
8550370|NCT00133952|21081697|P2|NOT COMPLETED|Overall Study||28
8550371|NCT00133952|21081698|P1|NOT COMPLETED|Overall Study||42
8550372|NCT00133952|21081697|P2|COMPLETED|Overall Study||124
8550373|NCT00133952|21081698|P1|COMPLETED|Overall Study||115
8550374|NCT00133952|21081697|P2|Received at Least One Dose of Study Drug|Overall Study||149
8550375|NCT00133952|21081698|P1|Received at Least One Dose of Study Drug|Overall Study||153
8550376|NCT00133952|21081697|P2|STARTED|Overall Study||152
8550377|NCT00133952|21081698|P1|STARTED|Overall Study||157
8550378|NCT00133809|21081720|P1|NOT COMPLETED|Overall Study||0
8550379|NCT00133809|21081720|P1|COMPLETED|Overall Study||8
8550380|NCT00133809|21081720|P1|STARTED|Overall Study||8
8550381|NCT00133705|21081729|P2|NOT COMPLETED|Overall Study||3
8550382|NCT00133705|21081730|P1|NOT COMPLETED|Overall Study||2
8550383|NCT00133705|21081729|P2|COMPLETED|Overall Study||17
8550384|NCT00133705|21081730|P1|COMPLETED|Overall Study||20
8550385|NCT00133705|21081729|P2|STARTED|Overall Study||20
8550386|NCT00133705|21081730|P1|STARTED|Overall Study||22
8550387|NCT00133679|21081738|P2|NOT COMPLETED|Overall Study||0
8550388|NCT00133679|21081739|P1|NOT COMPLETED|Overall Study||0
8550389|NCT00133679|21081738|P2|COMPLETED|Overall Study||0
8550390|NCT00133679|21081739|P1|COMPLETED|Overall Study||0
8550391|NCT00133679|21081738|P2|STARTED|Overall Study||0
8550392|NCT00133679|21081739|P1|STARTED|Overall Study||0
8550393|NCT00133575|21081762|P7|NOT COMPLETED|Overall Study||3
8550394|NCT00133575|21081763|P6|NOT COMPLETED|Overall Study||1
8550395|NCT00133575|21081764|P5|NOT COMPLETED|Overall Study||4
8550396|NCT00133575|21081765|P4|NOT COMPLETED|Overall Study||1
8550397|NCT00133575|21081766|P3|NOT COMPLETED|Overall Study||2
8550398|NCT00133575|21081767|P2|NOT COMPLETED|Overall Study||0
8550399|NCT00133575|21081768|P1|NOT COMPLETED|Overall Study||0
8550400|NCT00133575|21081762|P7|COMPLETED|Overall Study||9
8550401|NCT00133575|21081763|P6|COMPLETED|Overall Study||9
8550402|NCT00133575|21081764|P5|COMPLETED|Overall Study||6
8550403|NCT00133575|21081765|P4|COMPLETED|Overall Study||9
8550404|NCT00133575|21081766|P3|COMPLETED|Overall Study||8
8550405|NCT00133575|21081767|P2|COMPLETED|Overall Study||10
8550406|NCT00133575|21081768|P1|COMPLETED|Overall Study||10
8550407|NCT00133575|21081762|P7|STARTED|Overall Study||12
8550408|NCT00133575|21081763|P6|STARTED|Overall Study||10
8550409|NCT00133575|21081764|P5|STARTED|Overall Study||10
8550410|NCT00133575|21081765|P4|STARTED|Overall Study||10
8550411|NCT00133575|21081766|P3|STARTED|Overall Study||10
8550412|NCT00133575|21081767|P2|STARTED|Overall Study||10
8550413|NCT00133575|21081768|P1|STARTED|Overall Study||10
8550414|NCT00132964|21081877|P2|NOT COMPLETED|Overall Study||3
8550415|NCT00132964|21081878|P1|NOT COMPLETED|Overall Study||4
8550416|NCT00132964|21081877|P2|COMPLETED|Overall Study||54
8550417|NCT00132964|21081878|P1|COMPLETED|Overall Study||50
8550418|NCT00132964|21081877|P2|STARTED|Overall Study||57
8550419|NCT00132964|21081878|P1|STARTED|Overall Study||54
8550420|NCT00132873|21081884|P1|NOT COMPLETED|Overall Study||9
8550421|NCT00132873|21081884|P1|COMPLETED|Overall Study||50
8550422|NCT00132873|21081884|P1|STARTED|Overall Study||59
8550423|NCT00132808|21081892|P3|NOT COMPLETED|Stratum II||9
8550424|NCT00132808|21081893|P2|NOT COMPLETED|Stratum II||15
8550425|NCT00132808|21081894|P1|NOT COMPLETED|Stratum II||8
8550426|NCT00132808|21081892|P3|COMPLETED|Stratum II||116
8550427|NCT00132808|21081893|P2|COMPLETED|Stratum II||96
8550428|NCT00132808|21081894|P1|COMPLETED|Stratum II||113
8550429|NCT00132808|21081892|P3|STARTED|Stratum II||125
8550430|NCT00132808|21081893|P2|STARTED|Stratum II||111
8550431|NCT00132808|21081894|P1|STARTED|Stratum II||121
8550432|NCT00132808|21081892|P3|NOT COMPLETED|Stratum I||5
8550433|NCT00132808|21081893|P2|NOT COMPLETED|Stratum I||12
8550434|NCT00132808|21081894|P1|NOT COMPLETED|Stratum I||9
8550435|NCT00132808|21081892|P3|COMPLETED|Stratum I||72
8550436|NCT00132808|21081893|P2|COMPLETED|Stratum I||58
8550437|NCT00132808|21081894|P1|COMPLETED|Stratum I||68
8550438|NCT00132808|21081892|P3|STARTED|Stratum I||77
8550439|NCT00132808|21081893|P2|STARTED|Stratum I||70
8550440|NCT00132808|21081894|P1|STARTED|Stratum I||77
8550441|NCT00132769|21081919|P2|NOT COMPLETED|Overall Study||11
8550442|NCT00132769|21081920|P1|NOT COMPLETED|Overall Study||11
8550443|NCT00132769|21081919|P2|COMPLETED|Overall Study||42
8550444|NCT00132769|21081920|P1|COMPLETED|Overall Study||42
8550445|NCT00132769|21081919|P2|STARTED|Overall Study||53
8550446|NCT00132769|21081920|P1|STARTED|Overall Study||53
8550447|NCT00132730|21081946|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
8550448|NCT00132730|21081947|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
8550449|NCT00132730|21081948|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550450|NCT00132730|21081949|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550451|NCT00132730|21081950|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550452|NCT00132730|21081951|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550453|NCT00132730|21081946|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550454|NCT00132730|21081947|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550455|NCT00132730|21081948|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550527|NCT00132730|21081948|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
8550456|NCT00132730|21081949|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550457|NCT00132730|21081950|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550458|NCT00132730|21081951|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550459|NCT00132730|21081946|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
8550460|NCT00132730|21081947|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
8550461|NCT00132730|21081948|P4|STARTED|Period V - Open-label Extension (EXT2)||0
8550462|NCT00132730|21081949|P3|STARTED|Period V - Open-label Extension (EXT2)||0
8550463|NCT00132730|21081950|P2|STARTED|Period V - Open-label Extension (EXT2)||0
8550464|NCT00132730|21081951|P1|STARTED|Period V - Open-label Extension (EXT2)||0
8550465|NCT00132730|21081946|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
8550466|NCT00132730|21081947|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
8550467|NCT00132730|21081948|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550468|NCT00132730|21081949|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550469|NCT00132730|21081950|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550470|NCT00132730|21081951|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550471|NCT00132730|21081946|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
8550472|NCT00132730|21081947|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
8550473|NCT00132730|21081948|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550474|NCT00132730|21081949|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550475|NCT00132730|21081950|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550476|NCT00132730|21081951|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550477|NCT00132730|21081946|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
8550478|NCT00132730|21081947|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
8550479|NCT00132730|21081948|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
8550480|NCT00132730|21081949|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
8550481|NCT00132730|21081950|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
8550482|NCT00132730|21081951|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
8550483|NCT00132730|21081946|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550484|NCT00132730|21081947|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550485|NCT00132730|21081948|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
8550486|NCT00132730|21081949|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
8550487|NCT00132730|21081950|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550488|NCT00132730|21081951|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550489|NCT00132730|21081946|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550490|NCT00132730|21081947|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550491|NCT00132730|21081948|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
8550492|NCT00132730|21081949|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
8550493|NCT00132730|21081950|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550494|NCT00132730|21081951|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550495|NCT00132730|21081946|P6|STARTED|Period III - Blinded Extension (EXT1)||0
8550496|NCT00132730|21081947|P5|STARTED|Period III - Blinded Extension (EXT1)||0
8550497|NCT00132730|21081948|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
8550498|NCT00132730|21081949|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
8550499|NCT00132730|21081950|P2|STARTED|Period III - Blinded Extension (EXT1)||0
8550500|NCT00132730|21081951|P1|STARTED|Period III - Blinded Extension (EXT1)||0
8550501|NCT00132730|21081946|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
8550502|NCT00132730|21081947|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
8550503|NCT00132730|21081948|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
8550504|NCT00132730|21081949|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
8550505|NCT00132730|21081950|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
8550506|NCT00132730|21081951|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
8550507|NCT00132730|21081946|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
8550508|NCT00132730|21081947|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
8550509|NCT00132730|21081948|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
8550510|NCT00132730|21081949|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
8550511|NCT00132730|21081950|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
8550512|NCT00132730|21081951|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
8550513|NCT00132730|21081946|P6|STARTED|Period II - 12-week Treatment (Base)||0
8550514|NCT00132730|21081947|P5|STARTED|Period II - 12-week Treatment (Base)||0
8550515|NCT00132730|21081948|P4|STARTED|Period II - 12-week Treatment (Base)||153
8550516|NCT00132730|21081949|P3|STARTED|Period II - 12-week Treatment (Base)||153
8550517|NCT00132730|21081950|P2|STARTED|Period II - 12-week Treatment (Base)||148
8550518|NCT00132730|21081951|P1|STARTED|Period II - 12-week Treatment (Base)||150
8550519|NCT00132730|21081946|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550520|NCT00132730|21081947|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550521|NCT00132730|21081948|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550522|NCT00132730|21081949|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550523|NCT00132730|21081950|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550524|NCT00132730|21081951|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550525|NCT00132730|21081946|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
8550526|NCT00132730|21081947|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
8550528|NCT00132730|21081949|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
8550529|NCT00132730|21081950|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
8550530|NCT00132730|21081951|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
8550531|NCT00132730|21081946|P6|STARTED|Period I - Placebo Run-in (Base)||0
8550532|NCT00132730|21081947|P5|STARTED|Period I - Placebo Run-in (Base)||0
8550533|NCT00132730|21081948|P4|STARTED|Period I - Placebo Run-in (Base)||153
8550534|NCT00132730|21081949|P3|STARTED|Period I - Placebo Run-in (Base)||153
8550535|NCT00132730|21081950|P2|STARTED|Period I - Placebo Run-in (Base)||148
8550536|NCT00132730|21081951|P1|STARTED|Period I - Placebo Run-in (Base)||150
8550537|NCT00132691|21081995|P2|NOT COMPLETED|Overall Study||12
8550538|NCT00132691|21081996|P1|NOT COMPLETED|Overall Study||11
8550539|NCT00132691|21081995|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
8550540|NCT00132691|21081996|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
8550541|NCT00132691|21081995|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
8550542|NCT00132691|21081996|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
8550543|NCT00132678|21082036|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
8550544|NCT00132678|21082037|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
8550545|NCT00132678|21082038|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
8550546|NCT00132678|21082036|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
8550547|NCT00132678|21082037|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
8550548|NCT00132678|21082038|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
8550549|NCT00132678|21082036|P3|STARTED|Period IV (Double-Blind Treatment)||0
8550550|NCT00132678|21082037|P2|STARTED|Period IV (Double-Blind Treatment)||149
8550551|NCT00132678|21082038|P1|STARTED|Period IV (Double-Blind Treatment)||154
8550552|NCT00132678|21082036|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
8550553|NCT00132678|21082037|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
8550554|NCT00132678|21082038|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
8550555|NCT00132678|21082036|P3|COMPLETED|Period III (Open-Label Stabilization)||0
8550556|NCT00132678|21082037|P2|COMPLETED|Period III (Open-Label Stabilization)||0
8550557|NCT00132678|21082038|P1|COMPLETED|Period III (Open-Label Stabilization)||303
8550558|NCT00132678|21082036|P3|STARTED|Period III (Open-Label Stabilization)||0
8550559|NCT00132678|21082037|P2|STARTED|Period III (Open-Label Stabilization)||0
8550560|NCT00132678|21082038|P1|STARTED|Period III (Open-Label Stabilization)||501
8550561|NCT00132678|21082036|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
8550562|NCT00132678|21082037|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550563|NCT00132678|21082038|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550564|NCT00132678|21082036|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
8550565|NCT00132678|21082037|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550566|NCT00132678|21082038|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550567|NCT00132678|21082036|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
8550568|NCT00132678|21082037|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
8550569|NCT00132678|21082038|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
8550570|NCT00132496|21082052|P2|NOT COMPLETED|Overall Study||2
8550571|NCT00132496|21082053|P1|NOT COMPLETED|Overall Study||2
8550572|NCT00132496|21082052|P2|COMPLETED|Overall Study||55
8550573|NCT00132496|21082053|P1|COMPLETED|Overall Study||52
8550574|NCT00132496|21082052|P2|STARTED|Overall Study||57
8550575|NCT00132496|21082053|P1|STARTED|Overall Study||54
8550576|NCT00132314|21082061|P2|NOT COMPLETED|Overall Study||72
8550577|NCT00132314|21082062|P1|NOT COMPLETED|Overall Study||73
8550578|NCT00132314|21082061|P2|COMPLETED|Overall Study||120
8550579|NCT00132314|21082062|P1|COMPLETED|Overall Study||117
8550580|NCT00132314|21082061|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
8550581|NCT00132314|21082062|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
8550582|NCT00132314|21082061|P2|Received Treatment|Overall Study||185
8550583|NCT00132314|21082062|P1|Received Treatment|Overall Study||188
8550584|NCT00132314|21082061|P2|STARTED|Overall Study||192
8550585|NCT00132314|21082062|P1|STARTED|Overall Study||190
8550586|NCT00132301|21082072|P2|NOT COMPLETED|Overall Study||13
8550587|NCT00132301|21082073|P1|NOT COMPLETED|Overall Study||20
8550588|NCT00132301|21082072|P2|COMPLETED|Overall Study||144
8550589|NCT00132301|21082073|P1|COMPLETED|Overall Study||121
8550590|NCT00132301|21082072|P2|STARTED|Overall Study||157
8550591|NCT00132301|21082073|P1|STARTED|Overall Study||141
8550592|NCT00132132|21082081|P2|NOT COMPLETED|Overall Study||2
8550593|NCT00132132|21082082|P1|NOT COMPLETED|Overall Study||7
8550594|NCT00132132|21082081|P2|COMPLETED|Overall Study||13
8550595|NCT00132132|21082082|P1|COMPLETED|Overall Study||8
8550596|NCT00132132|21082081|P2|STARTED|Overall Study||15
8550597|NCT00132132|21082082|P1|STARTED|Overall Study||15
8550598|NCT00132041|21082090|P1|NOT COMPLETED|18 Months Post Ablation||6
8550599|NCT00132041|21082090|P1|COMPLETED|18 Months Post Ablation||12
8550600|NCT00132041|21082090|P1|STARTED|18 Months Post Ablation||18
8550601|NCT00132041|21082090|P1|NOT COMPLETED|15 Months Post Ablation||8
8550602|NCT00132041|21082090|P1|COMPLETED|15 Months Post Ablation||18
8550603|NCT00132041|21082090|P1|STARTED|15 Months Post Ablation||26
8550604|NCT00132041|21082090|P1|NOT COMPLETED|12 Months Post Ablation||4
8550605|NCT00132041|21082090|P1|COMPLETED|12 Months Post Ablation||26
8550606|NCT00132041|21082090|P1|STARTED|12 Months Post Ablation||30
8550607|NCT00132041|21082090|P1|NOT COMPLETED|9 Months Post Ablation||2
8550608|NCT00132041|21082090|P1|COMPLETED|9 Months Post Ablation||30
8550609|NCT00132041|21082090|P1|STARTED|9 Months Post Ablation||32
8550610|NCT00132041|21082090|P1|NOT COMPLETED|6 Months Post Ablation||10
8550611|NCT00132041|21082090|P1|COMPLETED|6 Months Post Ablation||32
8550612|NCT00132041|21082090|P1|STARTED|6 Months Post Ablation||42
8550613|NCT00132041|21082090|P1|NOT COMPLETED|3 Months Post Ablation||3
8550614|NCT00132041|21082090|P1|COMPLETED|3 Months Post Ablation||42
8550615|NCT00132041|21082090|P1|STARTED|3 Months Post Ablation||45
8550616|NCT00132041|21082090|P1|NOT COMPLETED|Baseline||6
8550617|NCT00132041|21082090|P1|COMPLETED|Baseline||45
8550618|NCT00132041|21082090|P1|Eligible|Baseline||45
8550619|NCT00132041|21082090|P1|STARTED|Baseline||51
8550620|NCT00132028|21082105|P1|NOT COMPLETED|Overall Study||27
8550621|NCT00132028|21082105|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
8550622|NCT00132028|21082105|P1|Eligible and Began Protocol Therapy|Overall Study||25
8550623|NCT00132028|21082105|P1|Eligible|Overall Study||25
8550624|NCT00132028|21082105|P1|STARTED|Overall Study||27
8550625|NCT00132002|21082111|P1|NOT COMPLETED|Overall Study||0
8550626|NCT00132002|21082111|P1|COMPLETED|Overall Study||14
8550627|NCT00132002|21082111|P1|STARTED|Overall Study||14
8550628|NCT00131937|21082117|P1|NOT COMPLETED|Overall Study||14
8550629|NCT00131937|21082117|P1|COMPLETED|Overall Study||0
8550630|NCT00131937|21082117|P1|STARTED|Overall Study||14
8550631|NCT00131911|21082125|P2|NOT COMPLETED|Overall Study||0
8550632|NCT00131911|21082126|P1|NOT COMPLETED|Overall Study||1
8550633|NCT00131911|21082125|P2|COMPLETED|Overall Study||42
8550634|NCT00131911|21082126|P1|COMPLETED|Overall Study||50
8550635|NCT00131911|21082125|P2|STARTED|Overall Study||42
8550636|NCT00131911|21082126|P1|STARTED|Overall Study||51
8550637|NCT00131885|21082143|P4|NOT COMPLETED|Time 2: Second Intervention||0
8550638|NCT00131885|21082144|P3|NOT COMPLETED|Time 2: Second Intervention||0
8550639|NCT00131885|21082145|P2|NOT COMPLETED|Time 2: Second Intervention||0
8550640|NCT00131885|21082146|P1|NOT COMPLETED|Time 2: Second Intervention||0
8550641|NCT00131885|21082143|P4|COMPLETED|Time 2: Second Intervention||9
8550642|NCT00131885|21082144|P3|COMPLETED|Time 2: Second Intervention||9
8550643|NCT00131885|21082145|P2|COMPLETED|Time 2: Second Intervention||9
8550644|NCT00131885|21082146|P1|COMPLETED|Time 2: Second Intervention||9
8550645|NCT00131885|21082143|P4|STARTED|Time 2: Second Intervention||9
8550646|NCT00131885|21082144|P3|STARTED|Time 2: Second Intervention||9
8550647|NCT00131885|21082145|P2|STARTED|Time 2: Second Intervention||9
8550648|NCT00131885|21082146|P1|STARTED|Time 2: Second Intervention||9
8550649|NCT00131885|21082143|P4|NOT COMPLETED|Time 1: First Intervention||0
8550650|NCT00131885|21082144|P3|NOT COMPLETED|Time 1: First Intervention||0
8550651|NCT00131885|21082145|P2|NOT COMPLETED|Time 1: First Intervention||0
8550652|NCT00131885|21082146|P1|NOT COMPLETED|Time 1: First Intervention||0
8550653|NCT00131885|21082143|P4|COMPLETED|Time 1: First Intervention||9
8550654|NCT00131885|21082144|P3|COMPLETED|Time 1: First Intervention||9
8550655|NCT00131885|21082145|P2|COMPLETED|Time 1: First Intervention||9
8550656|NCT00131885|21082146|P1|COMPLETED|Time 1: First Intervention||9
8550657|NCT00131885|21082143|P4|STARTED|Time 1: First Intervention||9
8550658|NCT00131885|21082144|P3|STARTED|Time 1: First Intervention||9
8550659|NCT00131885|21082145|P2|STARTED|Time 1: First Intervention||9
8550660|NCT00131885|21082146|P1|STARTED|Time 1: First Intervention||9
8550661|NCT00131677|21082178|P2|NOT COMPLETED|Overall Study||39
8550662|NCT00131677|21082179|P1|NOT COMPLETED|Overall Study||30
8550663|NCT00131677|21082178|P2|COMPLETED|Overall Study||160
8550664|NCT00131677|21082179|P1|COMPLETED|Overall Study||171
8550665|NCT00131677|21082178|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
8550666|NCT00131677|21082179|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
8550667|NCT00131664|21082196|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
8550668|NCT00131664|21082197|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
8550669|NCT00131664|21082198|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
8550670|NCT00131664|21082199|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
8550671|NCT00131664|21082200|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
8550672|NCT00131664|21082201|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
8550673|NCT00131664|21082196|P6|COMPLETED|Second Period (Additional Drug Added)||22
8550674|NCT00131664|21082197|P5|COMPLETED|Second Period (Additional Drug Added)||15
8550675|NCT00131664|21082198|P4|COMPLETED|Second Period (Additional Drug Added)||19
8550676|NCT00131664|21082199|P3|COMPLETED|Second Period (Additional Drug Added)||76
8550677|NCT00131664|21082200|P2|COMPLETED|Second Period (Additional Drug Added)||97
8550678|NCT00131664|21082201|P1|COMPLETED|Second Period (Additional Drug Added)||81
8550679|NCT00131664|21082196|P6|STARTED|Second Period (Additional Drug Added)||25
8550680|NCT00131664|21082197|P5|STARTED|Second Period (Additional Drug Added)||16
8550681|NCT00131664|21082198|P4|STARTED|Second Period (Additional Drug Added)||21
8550682|NCT00131664|21082199|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
8550683|NCT00131664|21082200|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
8550684|NCT00131664|21082201|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
8550685|NCT00131664|21082196|P6|NOT COMPLETED|First Period (First 6 Months)||0
8550686|NCT00131664|21082197|P5|NOT COMPLETED|First Period (First 6 Months)||0
8550687|NCT00131664|21082198|P4|NOT COMPLETED|First Period (First 6 Months)||0
8550688|NCT00131664|21082199|P3|NOT COMPLETED|First Period (First 6 Months)||16
8550689|NCT00131664|21082200|P2|NOT COMPLETED|First Period (First 6 Months)||18
8550690|NCT00131664|21082201|P1|NOT COMPLETED|First Period (First 6 Months)||25
8550691|NCT00131664|21082196|P6|COMPLETED|First Period (First 6 Months)||0
8550692|NCT00131664|21082197|P5|COMPLETED|First Period (First 6 Months)||0
8550693|NCT00131664|21082198|P4|COMPLETED|First Period (First 6 Months)||0
8550694|NCT00131664|21082199|P3|COMPLETED|First Period (First 6 Months)||104
8550695|NCT00131664|21082200|P2|COMPLETED|First Period (First 6 Months)||117
8550696|NCT00131664|21082201|P1|COMPLETED|First Period (First 6 Months)||111
8550697|NCT00131664|21082196|P6|STARTED|First Period (First 6 Months)||0
8550698|NCT00131664|21082197|P5|STARTED|First Period (First 6 Months)||0
8550699|NCT00131664|21082198|P4|STARTED|First Period (First 6 Months)||0
8550700|NCT00131664|21082199|P3|STARTED|First Period (First 6 Months)||120
8550701|NCT00131664|21082200|P2|STARTED|First Period (First 6 Months)||135
8550702|NCT00131664|21082201|P1|STARTED|First Period (First 6 Months)||136
8550703|NCT00131573|21082262|P2|NOT COMPLETED|Overall Study||26
8550704|NCT00131573|21082263|P1|NOT COMPLETED|Overall Study||33
8550705|NCT00131573|21082262|P2|COMPLETED|Overall Study||13
8550706|NCT00131573|21082263|P1|COMPLETED|Overall Study||13
8550707|NCT00131573|21082262|P2|STARTED|Overall Study||39
8550708|NCT00131573|21082263|P1|STARTED|Overall Study||46
8550709|NCT00131508|21082273|P2|NOT COMPLETED|Overall Study||8
8550710|NCT00131508|21082274|P1|NOT COMPLETED|Overall Study||3
8550711|NCT00131508|21082273|P2|COMPLETED|Overall Study||5
8550712|NCT00131508|21082274|P1|COMPLETED|Overall Study||9
8550713|NCT00131508|21082273|P2|STARTED|Overall Study||13
8550714|NCT00131508|21082274|P1|STARTED|Overall Study||12
8550715|NCT00131469|21082298|P2|NOT COMPLETED|Overall Study||13
8550716|NCT00131469|21082299|P1|NOT COMPLETED|Overall Study||9
8550717|NCT00131469|21082298|P2|COMPLETED|Overall Study||27
8550718|NCT00131469|21082299|P1|COMPLETED|Overall Study||29
8550719|NCT00131469|21082298|P2|STARTED|Overall Study||40
8550720|NCT00131469|21082299|P1|STARTED|Overall Study||38
8550721|NCT00131456|21082309|P2|NOT COMPLETED|Overall Study||20
8550722|NCT00131456|21082310|P1|NOT COMPLETED|Overall Study||19
8550723|NCT00131456|21082309|P2|COMPLETED|Overall Study||31
8550724|NCT00131456|21082310|P1|COMPLETED|Overall Study||33
8550725|NCT00131456|21082309|P2|STARTED|Overall Study||51
8550726|NCT00131456|21082310|P1|STARTED|Overall Study||52
8550727|NCT00131378|21082320|P4|NOT COMPLETED|Overall Study||9
8550728|NCT00131378|21082321|P3|NOT COMPLETED|Overall Study||10
8550729|NCT00131378|21082322|P2|NOT COMPLETED|Overall Study||18
8550730|NCT00131378|21082323|P1|NOT COMPLETED|Overall Study||11
8550731|NCT00131378|21082320|P4|COMPLETED|Overall Study||21
8550732|NCT00131378|21082321|P3|COMPLETED|Overall Study||22
8550733|NCT00131378|21082322|P2|COMPLETED|Overall Study||22
8550734|NCT00131378|21082323|P1|COMPLETED|Overall Study||29
8550735|NCT00131378|21082320|P4|STARTED|Overall Study||30
8550736|NCT00131378|21082321|P3|STARTED|Overall Study||32
8550737|NCT00131378|21082322|P2|STARTED|Overall Study||40
8550738|NCT00131378|21082323|P1|STARTED|Overall Study||40
8550739|NCT00131365|21082345|P1|NOT COMPLETED|Overall Study||4
8550740|NCT00131365|21082345|P1|COMPLETED|Overall Study||5
8550741|NCT00131365|21082345|P1|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
8550742|NCT00131352|21082352|P2|NOT COMPLETED|Repeat Treatment Period||0
8550743|NCT00131352|21082353|P1|NOT COMPLETED|Repeat Treatment Period||2
8550744|NCT00131352|21082352|P2|COMPLETED|Repeat Treatment Period||0
8550745|NCT00131352|21082353|P1|COMPLETED|Repeat Treatment Period||158
8550746|NCT00131352|21082352|P2|STARTED|Repeat Treatment Period||0
8550747|NCT00131352|21082353|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
8550748|NCT00131352|21082352|P2|NOT COMPLETED|Initial Treatment Period||12
8550749|NCT00131352|21082353|P1|NOT COMPLETED|Initial Treatment Period||9
8550750|NCT00131352|21082352|P2|COMPLETED|Initial Treatment Period||118
8550751|NCT00131352|21082353|P1|COMPLETED|Initial Treatment Period||114
8550752|NCT00131352|21082352|P2|Intent to Treat Population|Initial Treatment Period||129
8550753|NCT00131352|21082353|P1|Intent to Treat Population|Initial Treatment Period||124
8550754|NCT00131352|21082352|P2|STARTED|Initial Treatment Period|Safety population|130
8550755|NCT00131352|21082353|P1|STARTED|Initial Treatment Period|Safety population|123
8550756|NCT00131248|21082375|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
8550757|NCT00131248|21082376|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
8550758|NCT00131248|21082375|P2|COMPLETED|Intervention 3 (4-day Course)||9
8550759|NCT00131248|21082376|P1|COMPLETED|Intervention 3 (4-day Course)||8
8550760|NCT00131248|21082375|P2|STARTED|Intervention 3 (4-day Course)||9
8550761|NCT00131248|21082376|P1|STARTED|Intervention 3 (4-day Course)||8
8550762|NCT00131248|21082375|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
8550763|NCT00131248|21082376|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
8550764|NCT00131248|21082375|P2|COMPLETED|Washout 2 (24 Hours)||9
8550765|NCT00131248|21082376|P1|COMPLETED|Washout 2 (24 Hours)||8
8550766|NCT00131248|21082375|P2|STARTED|Washout 2 (24 Hours)||9
8550767|NCT00131248|21082376|P1|STARTED|Washout 2 (24 Hours)||8
8550768|NCT00131248|21082375|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
8550769|NCT00131248|21082376|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
8550770|NCT00131248|21082375|P2|COMPLETED|Intervention 2 (7-day Course)||9
8550771|NCT00131248|21082376|P1|COMPLETED|Intervention 2 (7-day Course)||8
8550772|NCT00131248|21082375|P2|STARTED|Intervention 2 (7-day Course)||9
8550773|NCT00131248|21082376|P1|STARTED|Intervention 2 (7-day Course)||8
8550774|NCT00131248|21082375|P2|NOT COMPLETED|Washout (24 Hour)||0
8550775|NCT00131248|21082376|P1|NOT COMPLETED|Washout (24 Hour)||0
8550776|NCT00131248|21082375|P2|COMPLETED|Washout (24 Hour)||9
8550777|NCT00131248|21082376|P1|COMPLETED|Washout (24 Hour)||8
8550778|NCT00131248|21082375|P2|STARTED|Washout (24 Hour)||9
8550779|NCT00131248|21082376|P1|STARTED|Washout (24 Hour)||8
8550780|NCT00131248|21082375|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
8550781|NCT00131248|21082376|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
8550782|NCT00131248|21082375|P2|COMPLETED|Intervention 1 (3-day Course)||9
8550783|NCT00131248|21082376|P1|COMPLETED|Intervention 1 (3-day Course)||8
8550784|NCT00131248|21082375|P2|STARTED|Intervention 1 (3-day Course)||9
8550785|NCT00131248|21082376|P1|STARTED|Intervention 1 (3-day Course)||9
8550786|NCT00130923|21082384|P2|NOT COMPLETED|Overall Study||14
8550787|NCT00130923|21082385|P1|NOT COMPLETED|Overall Study||13
8550788|NCT00130923|21082384|P2|COMPLETED|Overall Study||32
8550789|NCT00130923|21082385|P1|COMPLETED|Overall Study||36
8550790|NCT00130923|21082384|P2|STARTED|Overall Study||46
8550791|NCT00130923|21082385|P1|STARTED|Overall Study||49
8550792|NCT00130832|21082403|P2|NOT COMPLETED|Overall Study||17
8550793|NCT00130832|21082404|P1|NOT COMPLETED|Overall Study||16
8550794|NCT00130832|21082403|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
8550795|NCT00130832|21082404|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
8550796|NCT00130832|21082403|P2|STARTED|Overall Study||363
8550797|NCT00130832|21082404|P1|STARTED|Overall Study||372
8550798|NCT00130793|21082416|P2|NOT COMPLETED|Overall Study||4
8550799|NCT00130793|21082417|P1|NOT COMPLETED|Overall Study||3
8550800|NCT00130793|21082416|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
8550801|NCT00130793|21082417|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
8550802|NCT00130793|21082416|P2|Vaccinated|Overall Study||185
8550803|NCT00130793|21082417|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
8550804|NCT00130793|21082416|P2|STARTED|Overall Study||185
8550805|NCT00130793|21082417|P1|STARTED|Overall Study||183
8550806|NCT00130780|21082429|P2|NOT COMPLETED|Overall Study||0
8550807|NCT00130780|21082430|P1|NOT COMPLETED|Overall Study||0
8550808|NCT00130780|21082429|P2|COMPLETED|Overall Study||20
8550809|NCT00130780|21082430|P1|COMPLETED|Overall Study||51
8550810|NCT00130780|21082429|P2|STARTED|Overall Study||20
8550811|NCT00130780|21082430|P1|STARTED|Overall Study||51
8550812|NCT00130728|21082438|P2|NOT COMPLETED|Overall Study||260
8550813|NCT00130728|21082439|P1|NOT COMPLETED|Overall Study||262
8550814|NCT00130728|21082438|P2|COMPLETED|Overall Study||57
8550815|NCT00130728|21082439|P1|COMPLETED|Overall Study||57
8550816|NCT00130728|21082438|P2|Received Study Drug (Safety Population)|Overall Study||313
8550817|NCT00130728|21082439|P1|Received Study Drug (Safety Population)|Overall Study||313
8550818|NCT00130728|21082438|P2|STARTED|Overall Study||317
8550819|NCT00130728|21082439|P1|STARTED|Overall Study||319
8550820|NCT00130689|21082451|P1|NOT COMPLETED|Overall Study||43
8550821|NCT00130689|21082451|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8550822|NCT00130689|21082451|P1|Treated|Overall Study||35
8550823|NCT00130689|21082451|P1|Eligible|Overall Study||37
8550824|NCT00130689|21082451|P1|STARTED|Overall Study||43
8550825|NCT00130637|21082455|P1|NOT COMPLETED|Overall Study||3
8550826|NCT00130637|21082455|P1|COMPLETED|Overall Study||3
8550827|NCT00130637|21082455|P1|STARTED|Overall Study||6
8550828|NCT00130533|21082462|P2|NOT COMPLETED|Overall Study||30
8550829|NCT00130533|21082463|P1|NOT COMPLETED|Overall Study||111
8550830|NCT00130533|21082462|P2|COMPLETED|Overall Study||398
8550831|NCT00130533|21082463|P1|COMPLETED|Overall Study||337
8550832|NCT00130533|21082462|P2|STARTED|Overall Study||428
8550833|NCT00130533|21082463|P1|STARTED|Overall Study||448
8550834|NCT00130520|21082475|P1|NOT COMPLETED|Overall Study||39
8550835|NCT00130520|21082475|P1|COMPLETED|Overall Study||1
8550836|NCT00130520|21082475|P1|Completion of at Least One Cycle|Overall Study||39
8550837|NCT00130520|21082475|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
8550838|NCT00130442|21082483|P2|NOT COMPLETED|Overall Study||2
8550839|NCT00130442|21082484|P1|NOT COMPLETED|Overall Study||1
8550840|NCT00130442|21082483|P2|COMPLETED|Overall Study||66
8550841|NCT00130442|21082484|P1|COMPLETED|Overall Study||65
8550842|NCT00130442|21082483|P2|STARTED|Overall Study||68
8550843|NCT00130442|21082484|P1|STARTED|Overall Study||66
8550844|NCT00130286|21082502|P4|NOT COMPLETED|Overall Study||2
8550845|NCT00130286|21082503|P3|NOT COMPLETED|Overall Study||4
8550846|NCT00130286|21082504|P2|NOT COMPLETED|Overall Study||3
8550847|NCT00130286|21082505|P1|NOT COMPLETED|Overall Study||0
8550848|NCT00130286|21082502|P4|COMPLETED|Overall Study||17
8550849|NCT00130286|21082503|P3|COMPLETED|Overall Study||13
8550850|NCT00130286|21082504|P2|COMPLETED|Overall Study||16
8550851|NCT00130286|21082505|P1|COMPLETED|Overall Study||22
8550852|NCT00130286|21082502|P4|STARTED|Overall Study||19
8550853|NCT00130286|21082503|P3|STARTED|Overall Study||17
8550854|NCT00130286|21082504|P2|STARTED|Overall Study||19
8550855|NCT00130286|21082505|P1|STARTED|Overall Study||22
8550856|NCT00130247|21082525|P2|NOT COMPLETED|Overall Study||4
8550857|NCT00130247|21082526|P1|NOT COMPLETED|Overall Study||2
8550858|NCT00130247|21082525|P2|COMPLETED|Overall Study||194
8550859|NCT00130247|21082526|P1|COMPLETED|Overall Study||194
8550860|NCT00130247|21082525|P2|STARTED|Overall Study||198
8550861|NCT00130247|21082526|P1|STARTED|Overall Study||196
8550862|NCT00130208|21082544|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
8550863|NCT00130208|21082545|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
8550864|NCT00130208|21082544|P2|COMPLETED|Washout Period (8 Weeks)||490
8550865|NCT00130208|21082545|P1|COMPLETED|Washout Period (8 Weeks)||494
8550866|NCT00130208|21082544|P2|STARTED|Washout Period (8 Weeks)||502
8550867|NCT00130208|21082545|P1|STARTED|Washout Period (8 Weeks)||500
8550868|NCT00130208|21082544|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
8550869|NCT00130208|21082545|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
8550870|NCT00130208|21082544|P2|COMPLETED|Maintenance Period (26 Weeks)||502
8550871|NCT00130208|21082545|P1|COMPLETED|Maintenance Period (26 Weeks)||500
8550872|NCT00130208|21082544|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
8550873|NCT00130208|21082545|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
8550874|NCT00130208|21082544|P2|STARTED|Maintenance Period (26 Weeks)||532
8550875|NCT00130208|21082545|P1|STARTED|Maintenance Period (26 Weeks)||524
8550876|NCT00130117|21082557|P2|NOT COMPLETED|Overall Study||3
8550877|NCT00130117|21082558|P1|NOT COMPLETED|Overall Study||4
8550878|NCT00130117|21082557|P2|COMPLETED|Overall Study||6
8550879|NCT00130117|21082558|P1|COMPLETED|Overall Study||7
8550880|NCT00130117|21082557|P2|STARTED|Overall Study||9
8550881|NCT00130117|21082558|P1|STARTED|Overall Study||11
8550882|NCT00130039|21082581|P2|NOT COMPLETED|Overall Study||18
8550883|NCT00130039|21082582|P1|NOT COMPLETED|Overall Study||30
8550884|NCT00130039|21082581|P2|COMPLETED|Overall Study|full analysis set|207
8550885|NCT00130039|21082582|P1|COMPLETED|Overall Study|full analysis set|202
8550886|NCT00130039|21082581|P2|STARTED|Overall Study||225
8550887|NCT00130039|21082582|P1|STARTED|Overall Study||232
8550888|NCT00129987|21082600|P2|NOT COMPLETED|1 Year||21
8550889|NCT00129987|21082601|P1|NOT COMPLETED|1 Year||32
8550890|NCT00129987|21082600|P2|COMPLETED|1 Year||150
8550891|NCT00129987|21082601|P1|COMPLETED|1 Year||114
8550892|NCT00129987|21082600|P2|STARTED|1 Year||171
8550893|NCT00129987|21082601|P1|STARTED|1 Year||146
8550894|NCT00129987|21082600|P2|NOT COMPLETED|1st Educational Session||109
8550895|NCT00129987|21082601|P1|NOT COMPLETED|1st Educational Session||141
8550896|NCT00129987|21082600|P2|COMPLETED|1st Educational Session||171
8550897|NCT00129987|21082601|P1|COMPLETED|1st Educational Session||146
8550898|NCT00129987|21082600|P2|STARTED|1st Educational Session||280
8550899|NCT00129987|21082601|P1|STARTED|1st Educational Session||287
8550900|NCT00129974|21082613|P1|NOT COMPLETED|Overall Study||1
8550901|NCT00129974|21082613|P1|COMPLETED|Overall Study||0
8550902|NCT00129974|21082613|P1|STARTED|Overall Study||1
8550903|NCT00129961|21082620|P2|NOT COMPLETED|Overall Study||23
8550904|NCT00129961|21082621|P1|NOT COMPLETED|Overall Study||19
8550905|NCT00129961|21082620|P2|COMPLETED|Overall Study||24
8550906|NCT00129961|21082621|P1|COMPLETED|Overall Study||20
8550907|NCT00129961|21082620|P2|STARTED|Overall Study||47
8550908|NCT00129961|21082621|P1|STARTED|Overall Study||39
8550909|NCT00129935|21082657|P2|NOT COMPLETED|Overall Study||92
8550910|NCT00129935|21082658|P1|NOT COMPLETED|Overall Study||36
8550911|NCT00129935|21082657|P2|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
8550912|NCT00129935|21082658|P1|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
8550913|NCT00129935|21082657|P2|STARTED|Overall Study||715
8550914|NCT00129935|21082658|P1|STARTED|Overall Study||669
8550915|NCT00129766|21082676|P2|NOT COMPLETED|Overall Study||59
8550916|NCT00129766|21082677|P1|NOT COMPLETED|Overall Study||60
8550917|NCT00129766|21082676|P2|COMPLETED|Overall Study||3270
8550918|NCT00129766|21082677|P1|COMPLETED|Overall Study||3246
8550919|NCT00129766|21082676|P2|STARTED|Overall Study||3329
8550920|NCT00129766|21082677|P1|STARTED|Overall Study||3306
8550921|NCT00129740|21082715|P1|NOT COMPLETED|Overall Study||0
8550922|NCT00129740|21082715|P1|COMPLETED|Overall Study||148
8550923|NCT00129740|21082715|P1|STARTED|Overall Study||148
8550924|NCT00129727|21082720|P1|NOT COMPLETED|Overall Study||5
8550925|NCT00129727|21082720|P1|COMPLETED|Overall Study||57
8550926|NCT00129727|21082720|P1|STARTED|Overall Study||62
8550927|NCT00129701|21082726|P1|NOT COMPLETED|Overall Study||33
8550928|NCT00129701|21082726|P1|COMPLETED|Overall Study||71
8550929|NCT00129701|21082726|P1|STARTED|Overall Study||104
8550930|NCT00129649|21082735|P2|NOT COMPLETED|Overall Study||65
8550931|NCT00129649|21082736|P1|NOT COMPLETED|Overall Study||76
8550932|NCT00129649|21082735|P2|COMPLETED|Overall Study||181
8550933|NCT00129649|21082736|P1|COMPLETED|Overall Study||182
8550934|NCT00129649|21082735|P2|STARTED|Overall Study||246
8550935|NCT00129649|21082736|P1|STARTED|Overall Study||258
8550936|NCT00129623|21082744|P2|NOT COMPLETED|Overall Study||12
8550937|NCT00129623|21082745|P1|NOT COMPLETED|Overall Study||10
8550938|NCT00129623|21082744|P2|COMPLETED|Overall Study||65
8550939|NCT00129623|21082745|P1|COMPLETED|Overall Study||73
8550940|NCT00129623|21082744|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
8550941|NCT00129623|21082745|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
8550942|NCT00129623|21082744|P2|STARTED|Overall Study||77
8550943|NCT00129623|21082745|P1|STARTED|Overall Study||83
8550944|NCT00129545|21082770|P3|NOT COMPLETED|Overall Study||111
8550945|NCT00129545|21082771|P2|NOT COMPLETED|Overall Study||164
8550946|NCT00129545|21082772|P1|NOT COMPLETED|Overall Study||26
8550947|NCT00129545|21082770|P3|COMPLETED|Overall Study||133
8550948|NCT00129545|21082771|P2|COMPLETED|Overall Study||299
8550949|NCT00129545|21082772|P1|COMPLETED|Overall Study||67
8550950|NCT00129545|21082770|P3|STARTED|Overall Study||244
8550951|NCT00129545|21082771|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
8550952|NCT00129545|21082772|P1|STARTED|Overall Study||93
8550953|NCT00129480|21082784|P2|NOT COMPLETED|Overall Study||0
8550954|NCT00129480|21082785|P1|NOT COMPLETED|Overall Study||0
8550955|NCT00129480|21082784|P2|COMPLETED|Overall Study||214
8550956|NCT00129480|21082785|P1|COMPLETED|Overall Study||187
8550957|NCT00129480|21082784|P2|STARTED|Overall Study||214
8550958|NCT00129480|21082785|P1|STARTED|Overall Study||187
8550959|NCT00129467|21082801|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
8550960|NCT00129467|21082802|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
8550961|NCT00129467|21082801|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
8550962|NCT00129467|21082802|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
8550963|NCT00129467|21082801|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
8550964|NCT00129467|21082802|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
8550965|NCT00129467|21082801|P2|NOT COMPLETED|Received Intervention||4
8550966|NCT00129467|21082802|P1|NOT COMPLETED|Received Intervention||6
8550967|NCT00129467|21082801|P2|COMPLETED|Received Intervention||13
8550968|NCT00129467|21082802|P1|COMPLETED|Received Intervention||9
8550969|NCT00129467|21082801|P2|STARTED|Received Intervention||17
8550970|NCT00129467|21082802|P1|STARTED|Received Intervention||15
8550971|NCT00129441|21082810|P2|NOT COMPLETED|Overall Study||0
8550972|NCT00129441|21082811|P1|NOT COMPLETED|Overall Study||0
8550973|NCT00129441|21082810|P2|COMPLETED|Overall Study||6
8550974|NCT00129441|21082811|P1|COMPLETED|Overall Study||9
8550975|NCT00129441|21082810|P2|Year 1, Visit 8|Overall Study||6
8550976|NCT00129441|21082811|P1|Year 1, Visit 8|Overall Study||9
8550977|NCT00129441|21082810|P2|Week 26, Visit 7|Overall Study||6
8550978|NCT00129441|21082811|P1|Week 26, Visit 7|Overall Study||9
8550979|NCT00129441|21082810|P2|Week 5, Visit 6|Overall Study||6
8550980|NCT00129441|21082811|P1|Week 5, Visit 6|Overall Study||9
8550981|NCT00129441|21082810|P2|Week 4, Visit 5|Overall Study||6
8550982|NCT00129441|21082811|P1|Week 4, Visit 5|Overall Study||9
8550983|NCT00129441|21082810|P2|Week 3, Visit 4|Overall Study||6
8550984|NCT00129441|21082811|P1|Week 3, Visit 4|Overall Study||9
8550985|NCT00129441|21082810|P2|Week 2, Visit 3|Overall Study||6
8550986|NCT00129441|21082811|P1|Week 2, Visit 3|Overall Study||9
8550987|NCT00129441|21082810|P2|Week 1, Visit 2|Overall Study||6
8550988|NCT00129441|21082811|P1|Week 1, Visit 2|Overall Study||9
8550989|NCT00129441|21082810|P2|Baseline, Visit 1|Overall Study||6
8550990|NCT00129441|21082811|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
8550991|NCT00129441|21082810|P2|STARTED|Overall Study||6
8550992|NCT00129441|21082811|P1|STARTED|Overall Study||9
8550993|NCT00129402|21082833|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
8550994|NCT00129402|21082834|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550995|NCT00129402|21082835|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550996|NCT00129402|21082836|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550997|NCT00129402|21082837|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550998|NCT00129402|21082838|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550999|NCT00129402|21082839|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551000|NCT00129402|21082833|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
8551001|NCT00129402|21082834|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551002|NCT00129402|21082835|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551003|NCT00129402|21082836|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551004|NCT00129402|21082837|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551005|NCT00129402|21082838|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551006|NCT00129402|21082839|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551007|NCT00129402|21082833|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
8551008|NCT00129402|21082834|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551009|NCT00129402|21082835|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551010|NCT00129402|21082836|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551011|NCT00129402|21082837|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551012|NCT00129402|21082838|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551013|NCT00129402|21082839|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551014|NCT00129402|21082833|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551015|NCT00129402|21082834|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
8551016|NCT00129402|21082835|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551017|NCT00129402|21082836|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551018|NCT00129402|21082837|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
8551019|NCT00129402|21082838|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551020|NCT00129402|21082839|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551021|NCT00129402|21082833|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551022|NCT00129402|21082834|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
8551023|NCT00129402|21082835|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551024|NCT00129402|21082836|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551025|NCT00129402|21082837|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
8551026|NCT00129402|21082838|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551027|NCT00129402|21082839|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551028|NCT00129402|21082833|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551109|NCT00129220|21082948|P2|STARTED|Study Period III||8
8551029|NCT00129402|21082834|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
8551030|NCT00129402|21082835|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551031|NCT00129402|21082836|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551032|NCT00129402|21082837|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
8551033|NCT00129402|21082838|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551034|NCT00129402|21082839|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551035|NCT00129402|21082833|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551036|NCT00129402|21082834|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
8551037|NCT00129402|21082835|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551038|NCT00129402|21082836|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551039|NCT00129402|21082837|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
8551040|NCT00129402|21082838|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551041|NCT00129402|21082839|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551042|NCT00129402|21082833|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551043|NCT00129402|21082834|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
8551044|NCT00129402|21082835|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551045|NCT00129402|21082836|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551046|NCT00129402|21082837|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
8551047|NCT00129402|21082838|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551048|NCT00129402|21082839|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
8551049|NCT00129402|21082833|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
8551050|NCT00129402|21082834|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
8551051|NCT00129402|21082835|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551052|NCT00129402|21082836|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551053|NCT00129402|21082837|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
8551054|NCT00129402|21082838|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551055|NCT00129402|21082839|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
8551056|NCT00129389|21082858|P2|NOT COMPLETED|Overall Study||140
8551057|NCT00129389|21082859|P1|NOT COMPLETED|Overall Study||33
8551058|NCT00129389|21082858|P2|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
8551059|NCT00129389|21082859|P1|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
8551060|NCT00129389|21082858|P2|STARTED|Overall Study||951
8551061|NCT00129389|21082859|P1|STARTED|Overall Study||974
8551062|NCT00129376|21082867|P1|NOT COMPLETED|Overall Study||2
8551063|NCT00129376|21082867|P1|COMPLETED|Overall Study||61
8551064|NCT00129376|21082867|P1|STARTED|Overall Study||63
8551065|NCT00129311|21082877|P2|NOT COMPLETED|Overall Study||19
8551066|NCT00129311|21082878|P1|NOT COMPLETED|Overall Study||12
8551067|NCT00129311|21082877|P2|COMPLETED|Overall Study||31
8551068|NCT00129311|21082878|P1|COMPLETED|Overall Study||39
8551069|NCT00129311|21082877|P2|STARTED|Overall Study||50
8551070|NCT00129311|21082878|P1|STARTED|Overall Study||51
8551071|NCT00129285|21082889|P3|NOT COMPLETED|Overall Study||38
8551072|NCT00129285|21082890|P2|NOT COMPLETED|Overall Study||27
8551073|NCT00129285|21082891|P1|NOT COMPLETED|Overall Study||25
8551074|NCT00129285|21082889|P3|COMPLETED|Overall Study||37
8551075|NCT00129285|21082890|P2|COMPLETED|Overall Study||43
8551076|NCT00129285|21082891|P1|COMPLETED|Overall Study||40
8551077|NCT00129285|21082889|P3|STARTED|Overall Study||75
8551078|NCT00129285|21082890|P2|STARTED|Overall Study||70
8551079|NCT00129285|21082891|P1|STARTED|Overall Study||65
8551080|NCT00129272|21082907|P2|NOT COMPLETED|Overall Study||22
8551081|NCT00129272|21082908|P1|NOT COMPLETED|Overall Study||17
8551082|NCT00129272|21082907|P2|COMPLETED|Overall Study||51
8551083|NCT00129272|21082908|P1|COMPLETED|Overall Study||54
8551084|NCT00129272|21082907|P2|STARTED|Overall Study||73
8551085|NCT00129272|21082908|P1|STARTED|Overall Study||71
8551086|NCT00129259|21082918|P2|NOT COMPLETED|Overall Study||3
8551087|NCT00129259|21082919|P1|NOT COMPLETED|Overall Study||3
8551088|NCT00129259|21082918|P2|COMPLETED|Overall Study||22
8551089|NCT00129259|21082919|P1|COMPLETED|Overall Study||49
8551090|NCT00129259|21082918|P2|Received All or Part of Cycle 2|Overall Study||0
8551091|NCT00129259|21082919|P1|Received All or Part of Cycle 2|Overall Study||40
8551092|NCT00129259|21082918|P2|Received All or Part of Cycle 1|Overall Study||0
8551093|NCT00129259|21082919|P1|Received All or Part of Cycle 1|Overall Study||52
8551094|NCT00129259|21082918|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
8551095|NCT00129259|21082919|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
8551096|NCT00129246|21082931|P2|NOT COMPLETED|Overall Study||0
8551097|NCT00129246|21082932|P1|NOT COMPLETED|Overall Study||0
8551098|NCT00129246|21082931|P2|COMPLETED|Overall Study||20
8551099|NCT00129246|21082932|P1|COMPLETED|Overall Study||20
8551100|NCT00129246|21082931|P2|STARTED|Overall Study||20
8551101|NCT00129246|21082932|P1|STARTED|Overall Study||20
8551102|NCT00129220|21082947|P3|NOT COMPLETED|Study Period III||10
8551103|NCT00129220|21082948|P2|NOT COMPLETED|Study Period III||1
8551104|NCT00129220|21082949|P1|NOT COMPLETED|Study Period III||13
8551105|NCT00129220|21082947|P3|COMPLETED|Study Period III||42
8551106|NCT00129220|21082948|P2|COMPLETED|Study Period III||7
8551107|NCT00129220|21082949|P1|COMPLETED|Study Period III||59
8551108|NCT00129220|21082947|P3|STARTED|Study Period III||52
8551110|NCT00129220|21082949|P1|STARTED|Study Period III||72
8551111|NCT00129220|21082947|P3|NOT COMPLETED|Study Period II||47
8551112|NCT00129220|21082948|P2|NOT COMPLETED|Study Period II||12
8551113|NCT00129220|21082949|P1|NOT COMPLETED|Study Period II||33
8551114|NCT00129220|21082947|P3|COMPLETED|Study Period II||52
8551115|NCT00129220|21082948|P2|COMPLETED|Study Period II||8
8551116|NCT00129220|21082949|P1|COMPLETED|Study Period II||72
8551117|NCT00129220|21082947|P3|Received at Least One Dose of Study Drug|Study Period II||97
8551118|NCT00129220|21082948|P2|Received at Least One Dose of Study Drug|Study Period II||20
8551119|NCT00129220|21082949|P1|Received at Least One Dose of Study Drug|Study Period II||104
8551120|NCT00129220|21082947|P3|STARTED|Study Period II||99
8551121|NCT00129220|21082948|P2|STARTED|Study Period II||20
8551122|NCT00129220|21082949|P1|STARTED|Study Period II||105
8551123|NCT00129129|21082989|P5|NOT COMPLETED|Fourth Dose Phase||6
8551124|NCT00129129|21082990|P4|NOT COMPLETED|Fourth Dose Phase||4
8551125|NCT00129129|21082991|P3|NOT COMPLETED|Fourth Dose Phase||0
8551126|NCT00129129|21082992|P2|NOT COMPLETED|Fourth Dose Phase||0
8551127|NCT00129129|21082993|P1|NOT COMPLETED|Fourth Dose Phase||4
8551128|NCT00129129|21082989|P5|COMPLETED|Fourth Dose Phase||124
8551129|NCT00129129|21082990|P4|COMPLETED|Fourth Dose Phase||128
8551130|NCT00129129|21082991|P3|COMPLETED|Fourth Dose Phase||0
8551131|NCT00129129|21082992|P2|COMPLETED|Fourth Dose Phase||0
8551132|NCT00129129|21082993|P1|COMPLETED|Fourth Dose Phase||232
8551133|NCT00129129|21082989|P5|STARTED|Fourth Dose Phase||130
8551134|NCT00129129|21082990|P4|STARTED|Fourth Dose Phase||132
8551135|NCT00129129|21082991|P3|STARTED|Fourth Dose Phase||0
8551136|NCT00129129|21082992|P2|STARTED|Fourth Dose Phase||0
8551137|NCT00129129|21082993|P1|STARTED|Fourth Dose Phase||236
8551138|NCT00129129|21082989|P5|NOT COMPLETED|Primary Phase||0
8551139|NCT00129129|21082990|P4|NOT COMPLETED|Primary Phase||0
8551140|NCT00129129|21082991|P3|NOT COMPLETED|Primary Phase||0
8551141|NCT00129129|21082992|P2|NOT COMPLETED|Primary Phase||25
8551142|NCT00129129|21082993|P1|NOT COMPLETED|Primary Phase||25
8551143|NCT00129129|21082989|P5|COMPLETED|Primary Phase||0
8551144|NCT00129129|21082990|P4|COMPLETED|Primary Phase||0
8551145|NCT00129129|21082991|P3|COMPLETED|Primary Phase||150
8551146|NCT00129129|21082992|P2|COMPLETED|Primary Phase||294
8551147|NCT00129129|21082993|P1|COMPLETED|Primary Phase||262
8551148|NCT00129129|21082989|P5|STARTED|Primary Phase||0
8551149|NCT00129129|21082990|P4|STARTED|Primary Phase||0
8551150|NCT00129129|21082991|P3|STARTED|Primary Phase||150
8551151|NCT00129129|21082992|P2|STARTED|Primary Phase||319
8551152|NCT00129129|21082993|P1|STARTED|Primary Phase||287
8551153|NCT00129116|21083200|P5|NOT COMPLETED|Booster Phase||1
8551154|NCT00129116|21083201|P4|NOT COMPLETED|Booster Phase||0
8551155|NCT00129116|21083202|P3|NOT COMPLETED|Booster Phase||0
8551156|NCT00129116|21083203|P2|NOT COMPLETED|Booster Phase||0
8551157|NCT00129116|21083204|P1|NOT COMPLETED|Booster Phase||2
8551158|NCT00129116|21083200|P5|COMPLETED|Booster Phase||43
8551159|NCT00129116|21083201|P4|COMPLETED|Booster Phase||44
8551160|NCT00129116|21083202|P3|COMPLETED|Booster Phase||44
8551161|NCT00129116|21083203|P2|COMPLETED|Booster Phase||42
8551162|NCT00129116|21083204|P1|COMPLETED|Booster Phase||45
8551163|NCT00129116|21083200|P5|STARTED|Booster Phase||44
8551164|NCT00129116|21083201|P4|STARTED|Booster Phase||44
8551165|NCT00129116|21083202|P3|STARTED|Booster Phase||44
8551166|NCT00129116|21083203|P2|STARTED|Booster Phase||42
8551167|NCT00129116|21083204|P1|STARTED|Booster Phase||47
8551168|NCT00129116|21083200|P5|NOT COMPLETED|Primary Phase||1
8551169|NCT00129116|21083201|P4|NOT COMPLETED|Primary Phase||1
8551170|NCT00129116|21083202|P3|NOT COMPLETED|Primary Phase||1
8551171|NCT00129116|21083203|P2|NOT COMPLETED|Primary Phase||4
8551172|NCT00129116|21083204|P1|NOT COMPLETED|Primary Phase||2
8551173|NCT00129116|21083200|P5|COMPLETED|Primary Phase||76
8551174|NCT00129116|21083201|P4|COMPLETED|Primary Phase||77
8551175|NCT00129116|21083202|P3|COMPLETED|Primary Phase||77
8551176|NCT00129116|21083203|P2|COMPLETED|Primary Phase||73
8551177|NCT00129116|21083204|P1|COMPLETED|Primary Phase||76
8551178|NCT00129116|21083200|P5|STARTED|Primary Phase||77
8551179|NCT00129116|21083201|P4|STARTED|Primary Phase||78
8551180|NCT00129116|21083202|P3|STARTED|Primary Phase||78
8551181|NCT00129116|21083203|P2|STARTED|Primary Phase||77
8551182|NCT00129116|21083204|P1|STARTED|Primary Phase||78
8551183|NCT00128921|21083469|P3|NOT COMPLETED|Overall Study||0
8551184|NCT00128921|21083470|P2|NOT COMPLETED|Overall Study||5
8551185|NCT00128921|21083471|P1|NOT COMPLETED|Overall Study||5
8551186|NCT00128921|21083469|P3|COMPLETED|Overall Study||0
8551187|NCT00128921|21083470|P2|COMPLETED|Overall Study||3
8551188|NCT00128921|21083471|P1|COMPLETED|Overall Study||5
8551189|NCT00128921|21083469|P3|Received Bortezomib|Overall Study||0
8551190|NCT00128921|21083470|P2|Received Bortezomib|Overall Study||6
8551191|NCT00128921|21083471|P1|Received Bortezomib|Overall Study||10
8551192|NCT00128921|21083469|P3|STARTED|Overall Study||0
8551193|NCT00128921|21083470|P2|STARTED|Overall Study||8
8551194|NCT00128921|21083471|P1|STARTED|Overall Study||10
8551195|NCT00128830|21083488|P1|NOT COMPLETED|Overall Study||72
8551196|NCT00128830|21083488|P1|COMPLETED|Overall Study||139
8551197|NCT00128830|21083488|P1|STARTED|Overall Study||211
8551198|NCT00128713|21083506|P3|NOT COMPLETED|Overall Study||0
8551199|NCT00128713|21083507|P2|NOT COMPLETED|Overall Study||0
8551200|NCT00128713|21083508|P1|NOT COMPLETED|Overall Study||0
8551201|NCT00128713|21083506|P3|COMPLETED|Overall Study||449
8551202|NCT00128713|21083507|P2|COMPLETED|Overall Study||449
8551203|NCT00128713|21083508|P1|COMPLETED|Overall Study||453
8551204|NCT00128713|21083506|P3|STARTED|Overall Study||449
8551205|NCT00128713|21083507|P2|STARTED|Overall Study||449
8551206|NCT00128713|21083508|P1|STARTED|Overall Study||453
8551207|NCT00128661|21083530|P2|NOT COMPLETED|Overall Study||258
8551208|NCT00128661|21083531|P1|NOT COMPLETED|Overall Study||274
8551209|NCT00128661|21083530|P2|COMPLETED|Overall Study||3481
8551210|NCT00128661|21083531|P1|COMPLETED|Overall Study||3453
8551211|NCT00128661|21083530|P2|STARTED|Overall Study||3739
8551212|NCT00128661|21083531|P1|STARTED|Overall Study||3727
8551213|NCT00128492|21083577|P2|NOT COMPLETED|Overall Study||59
8551214|NCT00128492|21083578|P1|NOT COMPLETED|Overall Study||20
8551215|NCT00128492|21083577|P2|COMPLETED|Overall Study||130
8551216|NCT00128492|21083578|P1|COMPLETED|Overall Study||65
8551217|NCT00128492|21083577|P2|STARTED|Overall Study||189
8551218|NCT00128492|21083578|P1|STARTED|Overall Study||85
8551219|NCT00128401|21083638|P2|NOT COMPLETED|Overall Study||4
8551220|NCT00128401|21083639|P1|NOT COMPLETED|Overall Study||6
8551221|NCT00128401|21083638|P2|COMPLETED|Overall Study||15
8551222|NCT00128401|21083639|P1|COMPLETED|Overall Study||14
8551223|NCT00128401|21083638|P2|STARTED|Overall Study||19
8551224|NCT00128401|21083639|P1|STARTED|Overall Study||20
8551225|NCT00128219|21083650|P2|NOT COMPLETED|Overall Study||71
8551226|NCT00128219|21083651|P1|NOT COMPLETED|Overall Study||69
8551227|NCT00128219|21083650|P2|COMPLETED|Overall Study||263
8551228|NCT00128219|21083651|P1|COMPLETED|Overall Study||264
8551229|NCT00128219|21083650|P2|STARTED|Overall Study||334
8551230|NCT00128219|21083651|P1|STARTED|Overall Study||333
8551231|NCT00128206|21083735|P2|NOT COMPLETED|Overall Study||120
8551232|NCT00128206|21083736|P1|NOT COMPLETED|Overall Study||137
8551233|NCT00128206|21083735|P2|COMPLETED|Overall Study||60
8551234|NCT00128206|21083736|P1|COMPLETED|Overall Study||47
8551235|NCT00128206|21083735|P2|STARTED|Overall Study||180
8551236|NCT00128206|21083736|P1|STARTED|Overall Study||184
8551237|NCT00128193|21083758|P12|NOT COMPLETED|Overall Study||2
8551238|NCT00128193|21083759|P11|NOT COMPLETED|Overall Study||3
8551239|NCT00128193|21083760|P10|NOT COMPLETED|Overall Study||2
8551240|NCT00128193|21083761|P9|NOT COMPLETED|Overall Study||2
8551241|NCT00128193|21083762|P8|NOT COMPLETED|Overall Study||0
8551242|NCT00128193|21083763|P7|NOT COMPLETED|Overall Study||4
8551243|NCT00128193|21083764|P6|NOT COMPLETED|Overall Study||3
8551244|NCT00128193|21083765|P5|NOT COMPLETED|Overall Study||2
8551245|NCT00128193|21083766|P4|NOT COMPLETED|Overall Study||1
8551246|NCT00128193|21083767|P3|NOT COMPLETED|Overall Study||3
8551247|NCT00128193|21083768|P2|NOT COMPLETED|Overall Study||0
8551248|NCT00128193|21083769|P1|NOT COMPLETED|Overall Study||0
8551249|NCT00128193|21083758|P12|COMPLETED|Overall Study||18
8551250|NCT00128193|21083759|P11|COMPLETED|Overall Study||17
8551251|NCT00128193|21083760|P10|COMPLETED|Overall Study||18
8551252|NCT00128193|21083761|P9|COMPLETED|Overall Study||18
8551253|NCT00128193|21083762|P8|COMPLETED|Overall Study||20
8551254|NCT00128193|21083763|P7|COMPLETED|Overall Study||16
8551255|NCT00128193|21083764|P6|COMPLETED|Overall Study||17
8551256|NCT00128193|21083765|P5|COMPLETED|Overall Study||18
8551257|NCT00128193|21083766|P4|COMPLETED|Overall Study||44
8551258|NCT00128193|21083767|P3|COMPLETED|Overall Study||42
8551259|NCT00128193|21083768|P2|COMPLETED|Overall Study||5
8551260|NCT00128193|21083769|P1|COMPLETED|Overall Study||5
8551261|NCT00128193|21083758|P12|STARTED|Overall Study||20
8551262|NCT00128193|21083759|P11|STARTED|Overall Study||20
8551263|NCT00128193|21083760|P10|STARTED|Overall Study||20
8551264|NCT00128193|21083761|P9|STARTED|Overall Study||20
8551265|NCT00128193|21083762|P8|STARTED|Overall Study||20
8551266|NCT00128193|21083763|P7|STARTED|Overall Study||20
8551267|NCT00128193|21083764|P6|STARTED|Overall Study||20
8551268|NCT00128193|21083765|P5|STARTED|Overall Study||20
8551269|NCT00128193|21083766|P4|STARTED|Overall Study||45
8551270|NCT00128193|21083767|P3|STARTED|Overall Study||45
8551271|NCT00128193|21083768|P2|STARTED|Overall Study||5
8551272|NCT00128193|21083769|P1|STARTED|Overall Study||5
8551273|NCT00128180|21084005|P2|NOT COMPLETED|Overall Study||0
8551274|NCT00128180|21084006|P1|NOT COMPLETED|Overall Study||0
8551275|NCT00128180|21084005|P2|COMPLETED|Overall Study||34
8551276|NCT00128180|21084006|P1|COMPLETED|Overall Study||32
8551277|NCT00128180|21084005|P2|STARTED|Overall Study||34
8551278|NCT00128180|21084006|P1|STARTED|Overall Study||32
8551279|NCT00128102|21084032|P2|NOT COMPLETED|Overall Study||332
8551280|NCT00128102|21084033|P1|NOT COMPLETED|Overall Study||328
8551281|NCT00128102|21084032|P2|COMPLETED|Overall Study||0
8551282|NCT00128102|21084033|P1|COMPLETED|Overall Study||1
8551283|NCT00128102|21084032|P2|Treated|Overall Study||329
8551284|NCT00128102|21084033|P1|Treated|Overall Study||329
8551285|NCT00128102|21084032|P2|STARTED|Overall Study||332
8551286|NCT00128102|21084033|P1|STARTED|Overall Study||329
8551287|NCT00127933|21084059|P2|NOT COMPLETED|Overall Study||0
8551288|NCT00127933|21084060|P1|NOT COMPLETED|Overall Study||1
8551289|NCT00127933|21084059|P2|COMPLETED|Overall Study||34
8551290|NCT00127933|21084060|P1|COMPLETED|Overall Study||122
8551291|NCT00127933|21084059|P2|Postoperative|Overall Study||27
8551292|NCT00127933|21084060|P1|Postoperative|Overall Study||98
8551293|NCT00127933|21084059|P2|Quality of Life Population|Overall Study||33
8551294|NCT00127933|21084060|P1|Quality of Life Population|Overall Study||118
8551295|NCT00127933|21084059|P2|Safety Population|Overall Study||34
8551296|NCT00127933|21084060|P1|Safety Population|Overall Study||122
8551297|NCT00127933|21084059|P2|Clinical Response|Overall Study||34
8551298|NCT00127933|21084060|P1|Clinical Response|Overall Study||122
8551299|NCT00127933|21084059|P2|Pathological Response|Overall Study||28
8551300|NCT00127933|21084060|P1|Pathological Response|Overall Study||101
8551301|NCT00127933|21084059|P2|STARTED|Overall Study||34
8551302|NCT00127933|21084060|P1|STARTED|Overall Study||123
8551303|NCT00127855|21084081|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551304|NCT00127855|21084082|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551305|NCT00127855|21084083|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551306|NCT00127855|21084084|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551307|NCT00127855|21084085|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551308|NCT00127855|21084081|P5|COMPLETED|Polysaccharide Challenge Dose||77
8551309|NCT00127855|21084082|P4|COMPLETED|Polysaccharide Challenge Dose||81
8551310|NCT00127855|21084083|P3|COMPLETED|Polysaccharide Challenge Dose||77
8551311|NCT00127855|21084084|P2|COMPLETED|Polysaccharide Challenge Dose||79
8551312|NCT00127855|21084085|P1|COMPLETED|Polysaccharide Challenge Dose||80
8551313|NCT00127855|21084081|P5|STARTED|Polysaccharide Challenge Dose||77
8551314|NCT00127855|21084082|P4|STARTED|Polysaccharide Challenge Dose||81
8551315|NCT00127855|21084083|P3|STARTED|Polysaccharide Challenge Dose||77
8551316|NCT00127855|21084084|P2|STARTED|Polysaccharide Challenge Dose||79
8551317|NCT00127855|21084085|P1|STARTED|Polysaccharide Challenge Dose||80
8551318|NCT00127855|21084081|P5|NOT COMPLETED|Primary Vaccination Course||4
8551319|NCT00127855|21084082|P4|NOT COMPLETED|Primary Vaccination Course||0
8551320|NCT00127855|21084083|P3|NOT COMPLETED|Primary Vaccination Course||2
8551321|NCT00127855|21084084|P2|NOT COMPLETED|Primary Vaccination Course||1
8551322|NCT00127855|21084085|P1|NOT COMPLETED|Primary Vaccination Course||2
8551323|NCT00127855|21084081|P5|COMPLETED|Primary Vaccination Course||78
8551324|NCT00127855|21084082|P4|COMPLETED|Primary Vaccination Course||81
8551325|NCT00127855|21084083|P3|COMPLETED|Primary Vaccination Course||78
8551326|NCT00127855|21084084|P2|COMPLETED|Primary Vaccination Course||81
8551327|NCT00127855|21084085|P1|COMPLETED|Primary Vaccination Course||80
8551328|NCT00127855|21084081|P5|STARTED|Primary Vaccination Course||82
8551329|NCT00127855|21084082|P4|STARTED|Primary Vaccination Course||81
8551330|NCT00127855|21084083|P3|STARTED|Primary Vaccination Course||80
8551331|NCT00127855|21084084|P2|STARTED|Primary Vaccination Course||82
8551332|NCT00127855|21084085|P1|STARTED|Primary Vaccination Course||82
8551333|NCT00127842|21084267|P1|NOT COMPLETED|Overall Study||39
8551334|NCT00127842|21084267|P1|COMPLETED|Overall Study||71
8551335|NCT00127842|21084267|P1|STARTED|Overall Study||110
8551336|NCT00127803|21084285|P4|NOT COMPLETED|Overall Study||1
8551337|NCT00127803|21084286|P3|NOT COMPLETED|Overall Study||0
8551338|NCT00127803|21084287|P2|NOT COMPLETED|Overall Study||0
8551339|NCT00127803|21084288|P1|NOT COMPLETED|Overall Study||3
8551340|NCT00127803|21084285|P4|COMPLETED|Overall Study||11
8551341|NCT00127803|21084286|P3|COMPLETED|Overall Study||12
8551342|NCT00127803|21084287|P2|COMPLETED|Overall Study||13
8551343|NCT00127803|21084288|P1|COMPLETED|Overall Study||10
8551344|NCT00127803|21084285|P4|STARTED|Overall Study||12
8551345|NCT00127803|21084286|P3|STARTED|Overall Study||12
8551346|NCT00127803|21084287|P2|STARTED|Overall Study||13
8551347|NCT00127803|21084288|P1|STARTED|Overall Study||13
8551348|NCT00127790|21084310|P4|NOT COMPLETED|Post-Treatment||0
8551349|NCT00127790|21084311|P3|NOT COMPLETED|Post-Treatment||0
8551350|NCT00127790|21084312|P2|NOT COMPLETED|Post-Treatment||0
8551351|NCT00127790|21084313|P1|NOT COMPLETED|Post-Treatment||0
8551352|NCT00127790|21084310|P4|COMPLETED|Post-Treatment||4
8551353|NCT00127790|21084311|P3|COMPLETED|Post-Treatment||6
8551354|NCT00127790|21084312|P2|COMPLETED|Post-Treatment||5
8551355|NCT00127790|21084313|P1|COMPLETED|Post-Treatment||6
8551356|NCT00127790|21084310|P4|STARTED|Post-Treatment||4
8551357|NCT00127790|21084311|P3|STARTED|Post-Treatment||6
8551358|NCT00127790|21084312|P2|STARTED|Post-Treatment||5
8551359|NCT00127790|21084313|P1|STARTED|Post-Treatment||6
8551360|NCT00127790|21084310|P4|NOT COMPLETED|Pre-Treatment||0
8551361|NCT00127790|21084311|P3|NOT COMPLETED|Pre-Treatment||0
8551362|NCT00127790|21084312|P2|NOT COMPLETED|Pre-Treatment||0
8551363|NCT00127790|21084313|P1|NOT COMPLETED|Pre-Treatment||0
8551364|NCT00127790|21084310|P4|COMPLETED|Pre-Treatment||4
8551365|NCT00127790|21084311|P3|COMPLETED|Pre-Treatment||6
8551366|NCT00127790|21084312|P2|COMPLETED|Pre-Treatment||5
8551367|NCT00127790|21084313|P1|COMPLETED|Pre-Treatment||6
8551368|NCT00127790|21084310|P4|STARTED|Pre-Treatment||4
8551369|NCT00127790|21084311|P3|STARTED|Pre-Treatment||6
8551370|NCT00127790|21084312|P2|STARTED|Pre-Treatment||5
8551371|NCT00127790|21084313|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
8551372|NCT00127712|21084337|P2|NOT COMPLETED|Overall Study||0
8551373|NCT00127712|21084338|P1|NOT COMPLETED|Overall Study||5
8551374|NCT00127712|21084337|P2|COMPLETED|Overall Study||65
8551375|NCT00127712|21084338|P1|COMPLETED|Overall Study||60
8551376|NCT00127712|21084337|P2|STARTED|Overall Study||65
8551377|NCT00127712|21084338|P1|STARTED|Overall Study||65
8551378|NCT00127660|21084354|P4|NOT COMPLETED|Overall Study||0
8551379|NCT00127660|21084355|P3|NOT COMPLETED|Overall Study||5
8551380|NCT00127660|21084356|P2|NOT COMPLETED|Overall Study||3
8551381|NCT00127660|21084357|P1|NOT COMPLETED|Overall Study||3
8551382|NCT00127660|21084354|P4|COMPLETED|Overall Study||150
8551383|NCT00127660|21084355|P3|COMPLETED|Overall Study||143
8551384|NCT00127660|21084356|P2|COMPLETED|Overall Study||151
8551385|NCT00127660|21084357|P1|COMPLETED|Overall Study||150
8551386|NCT00127660|21084354|P4|STARTED|Overall Study||150
8551387|NCT00127660|21084355|P3|STARTED|Overall Study||148
8551388|NCT00127660|21084356|P2|STARTED|Overall Study||154
8551389|NCT00127660|21084357|P1|STARTED|Overall Study||153
8551390|NCT00127608|21084367|P1|NOT COMPLETED|Overall Study||1
8551391|NCT00127608|21084367|P1|COMPLETED|Overall Study||35
8551392|NCT00127608|21084367|P1|STARTED|Overall Study||36
8551393|NCT00127530|21084375|P2|NOT COMPLETED|Overall Study||21
8551394|NCT00127530|21084376|P1|NOT COMPLETED|Overall Study||1
8551395|NCT00127530|21084375|P2|COMPLETED|Overall Study||207
8551396|NCT00127530|21084376|P1|COMPLETED|Overall Study||71
8551397|NCT00127530|21084375|P2|STARTED|Overall Study||228
8551398|NCT00127530|21084376|P1|STARTED|Overall Study||72
8551399|NCT00127439|21084384|P2|NOT COMPLETED|Overall Study||0
8551400|NCT00127439|21084385|P1|NOT COMPLETED|Overall Study||0
8551401|NCT00127439|21084384|P2|COMPLETED|Overall Study||10
8551402|NCT00127439|21084385|P1|COMPLETED|Overall Study||9
8551403|NCT00127439|21084384|P2|STARTED|Overall Study||10
8551404|NCT00127439|21084385|P1|STARTED|Overall Study||9
8551405|NCT00127413|21084411|P4|NOT COMPLETED|Overall Study||2
8551406|NCT00127413|21084412|P3|NOT COMPLETED|Overall Study||8
8551407|NCT00127413|21084413|P2|NOT COMPLETED|Overall Study||4
8551408|NCT00127413|21084414|P1|NOT COMPLETED|Overall Study||6
8551409|NCT00127413|21084411|P4|COMPLETED|Overall Study||5
8551410|NCT00127413|21084412|P3|COMPLETED|Overall Study||5
8551411|NCT00127413|21084413|P2|COMPLETED|Overall Study||6
8551412|NCT00127413|21084414|P1|COMPLETED|Overall Study||6
8551413|NCT00127413|21084411|P4|STARTED|Overall Study||7
8551414|NCT00127413|21084412|P3|STARTED|Overall Study||13
8551415|NCT00127413|21084413|P2|STARTED|Overall Study||10
8551416|NCT00127413|21084414|P1|STARTED|Overall Study||12
8551417|NCT00127231|21084426|P2|NOT COMPLETED|Overall Study||6
8551418|NCT00127231|21084427|P1|NOT COMPLETED|Overall Study||6
8551419|NCT00127231|21084426|P2|COMPLETED|Overall Study||68
8551420|NCT00127231|21084427|P1|COMPLETED|Overall Study||68
8551421|NCT00127231|21084426|P2|STARTED|Overall Study||74
8551422|NCT00127231|21084427|P1|STARTED|Overall Study||74
8551423|NCT00127218|21084443|P2|NOT COMPLETED|Overall Study||15
8551424|NCT00127218|21084444|P1|NOT COMPLETED|Overall Study||13
8551425|NCT00127218|21084443|P2|COMPLETED|Overall Study||58
8551426|NCT00127218|21084444|P1|COMPLETED|Overall Study||59
8551427|NCT00127218|21084443|P2|STARTED|Overall Study||73
8551428|NCT00127218|21084444|P1|STARTED|Overall Study||72
8551429|NCT00127205|21084455|P3|NOT COMPLETED|Overall Study||617
8551430|NCT00127205|21084456|P2|NOT COMPLETED|Overall Study||980
8551431|NCT00127205|21084457|P1|NOT COMPLETED|Overall Study||835
8551432|NCT00127205|21084455|P3|COMPLETED|Overall Study||950
8551433|NCT00127205|21084456|P2|COMPLETED|Overall Study||1288
8551434|NCT00127205|21084457|P1|COMPLETED|Overall Study||1427
8551435|NCT00127205|21084455|P3|STARTED|Overall Study||1567
8551436|NCT00127205|21084456|P2|STARTED|Overall Study||2268
8551437|NCT00127205|21084457|P1|STARTED|Overall Study||2262
8551438|NCT00127192|21084479|P5|NOT COMPLETED|Overall Study||5
8551439|NCT00127192|21084480|P4|NOT COMPLETED|Overall Study||1
8551440|NCT00127192|21084481|P3|NOT COMPLETED|Overall Study||2
8551441|NCT00127192|21084482|P2|NOT COMPLETED|Overall Study||1
8551442|NCT00127192|21084483|P1|NOT COMPLETED|Overall Study||3
8551443|NCT00127192|21084479|P5|COMPLETED|Overall Study||68
8551444|NCT00127192|21084480|P4|COMPLETED|Overall Study||67
8551445|NCT00127192|21084481|P3|COMPLETED|Overall Study||68
8551446|NCT00127192|21084482|P2|COMPLETED|Overall Study||71
8551447|NCT00127192|21084483|P1|COMPLETED|Overall Study||77
8551448|NCT00127192|21084479|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
8551449|NCT00127192|21084480|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
8551450|NCT00127192|21084481|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
8551451|NCT00127192|21084482|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
8551452|NCT00127192|21084483|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
8551453|NCT00127166|21084507|P2|NOT COMPLETED|Period II||0
8551454|NCT00127166|21084508|P1|NOT COMPLETED|Period II||3
8551455|NCT00127166|21084507|P2|COMPLETED|Period II||73
8551456|NCT00127166|21084508|P1|COMPLETED|Period II||72
8551457|NCT00127166|21084507|P2|STARTED|Period II||73
8551458|NCT00127166|21084508|P1|STARTED|Period II||75
8551459|NCT00127166|21084507|P2|NOT COMPLETED|Washout Period||1
8551460|NCT00127166|21084508|P1|NOT COMPLETED|Washout Period||0
8551461|NCT00127166|21084507|P2|COMPLETED|Washout Period||73
8551462|NCT00127166|21084508|P1|COMPLETED|Washout Period||75
8551463|NCT00127166|21084507|P2|STARTED|Washout Period||74
8551464|NCT00127166|21084508|P1|STARTED|Washout Period||75
8551465|NCT00127166|21084507|P2|NOT COMPLETED|Period I||2
8551466|NCT00127166|21084508|P1|NOT COMPLETED|Period I||3
8551467|NCT00127166|21084507|P2|COMPLETED|Period I||74
8551468|NCT00127166|21084508|P1|COMPLETED|Period I||75
8551469|NCT00127166|21084507|P2|STARTED|Period I||76
8551470|NCT00127166|21084508|P1|STARTED|Period I||78
8551471|NCT00127101|21084528|P6|NOT COMPLETED|Continuation Phase||3
8551472|NCT00127101|21084529|P5|NOT COMPLETED|Continuation Phase||3
8551473|NCT00127101|21084530|P4|NOT COMPLETED|Continuation Phase||0
8551474|NCT00127101|21084531|P3|NOT COMPLETED|Continuation Phase||1
8551475|NCT00127101|21084532|P2|NOT COMPLETED|Continuation Phase||0
8551476|NCT00127101|21084533|P1|NOT COMPLETED|Continuation Phase||0
8551477|NCT00127101|21084528|P6|COMPLETED|Continuation Phase||0
8551478|NCT00127101|21084529|P5|COMPLETED|Continuation Phase||0
8551479|NCT00127101|21084530|P4|COMPLETED|Continuation Phase||0
8551480|NCT00127101|21084531|P3|COMPLETED|Continuation Phase||0
8551481|NCT00127101|21084532|P2|COMPLETED|Continuation Phase||0
8551482|NCT00127101|21084533|P1|COMPLETED|Continuation Phase||0
8551483|NCT00127101|21084528|P6|STARTED|Continuation Phase||3
8551484|NCT00127101|21084529|P5|STARTED|Continuation Phase||3
8551485|NCT00127101|21084530|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
8551486|NCT00127101|21084531|P3|STARTED|Continuation Phase||1
8551487|NCT00127101|21084532|P2|STARTED|Continuation Phase||0
8551488|NCT00127101|21084533|P1|STARTED|Continuation Phase||0
8551489|NCT00127101|21084528|P6|NOT COMPLETED|Base Protocol||1
8551490|NCT00127101|21084529|P5|NOT COMPLETED|Base Protocol||2
8551491|NCT00127101|21084530|P4|NOT COMPLETED|Base Protocol||0
8551492|NCT00127101|21084531|P3|NOT COMPLETED|Base Protocol||2
8551493|NCT00127101|21084532|P2|NOT COMPLETED|Base Protocol||4
8551494|NCT00127101|21084533|P1|NOT COMPLETED|Base Protocol||2
8551495|NCT00127101|21084528|P6|COMPLETED|Base Protocol||3
8551496|NCT00127101|21084529|P5|COMPLETED|Base Protocol||3
8551497|NCT00127101|21084530|P4|COMPLETED|Base Protocol||3
8551498|NCT00127101|21084531|P3|COMPLETED|Base Protocol||1
8551499|NCT00127101|21084532|P2|COMPLETED|Base Protocol||1
8551500|NCT00127101|21084533|P1|COMPLETED|Base Protocol||1
8551501|NCT00127101|21084528|P6|STARTED|Base Protocol||4
8551502|NCT00127101|21084529|P5|STARTED|Base Protocol||5
8551503|NCT00127101|21084530|P4|STARTED|Base Protocol||3
8551504|NCT00127101|21084531|P3|STARTED|Base Protocol||3
8551505|NCT00127101|21084532|P2|STARTED|Base Protocol||5
8551506|NCT00127101|21084533|P1|STARTED|Base Protocol||3
8551507|NCT00127062|21084555|P2|NOT COMPLETED|Second intervention_Hyde Park||0
8551508|NCT00127062|21084556|P1|NOT COMPLETED|Second intervention_Hyde Park||0
8551509|NCT00127062|21084555|P2|COMPLETED|Second intervention_Hyde Park||29
8551510|NCT00127062|21084556|P1|COMPLETED|Second intervention_Hyde Park||31
8551511|NCT00127062|21084555|P2|STARTED|Second intervention_Hyde Park||29
8551512|NCT00127062|21084556|P1|STARTED|Second intervention_Hyde Park||31
8551513|NCT00127062|21084555|P2|NOT COMPLETED|First intervention_Oxford Street||0
8551514|NCT00127062|21084556|P1|NOT COMPLETED|First intervention_Oxford Street||0
8551515|NCT00127062|21084555|P2|COMPLETED|First intervention_Oxford Street||29
8551516|NCT00127062|21084556|P1|COMPLETED|First intervention_Oxford Street||31
8551517|NCT00127062|21084555|P2|STARTED|First intervention_Oxford Street||29
8551518|NCT00127062|21084556|P1|STARTED|First intervention_Oxford Street||31
8551519|NCT00127036|21084568|P2|NOT COMPLETED|Overall Study||11
8551520|NCT00127036|21084569|P1|NOT COMPLETED|Overall Study||8
8551521|NCT00127036|21084568|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
8551522|NCT00127036|21084569|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
8551523|NCT00127036|21084568|P2|STARTED|Overall Study||31
8551524|NCT00127036|21084569|P1|STARTED|Overall Study||34
8551525|NCT00126776|21084581|P2|NOT COMPLETED|Overall Study||0
8551526|NCT00126776|21084582|P1|NOT COMPLETED|Overall Study||0
8551527|NCT00126776|21084581|P2|COMPLETED|Overall Study||371
8551528|NCT00126776|21084582|P1|COMPLETED|Overall Study||372
8551529|NCT00126776|21084581|P2|STARTED|Overall Study||371
8551530|NCT00126776|21084582|P1|STARTED|Overall Study||372
8551531|NCT00126750|21084588|P2|NOT COMPLETED|Overall Study||266
8551532|NCT00126750|21084589|P1|NOT COMPLETED|Overall Study||180
8551533|NCT00126750|21084588|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
8551534|NCT00126750|21084589|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
8551535|NCT00126750|21084588|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
8551536|NCT00126750|21084589|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
8551537|NCT00126737|21084599|P4|NOT COMPLETED|Overall Study||7
8551538|NCT00126737|21084600|P3|NOT COMPLETED|Overall Study||6
8551539|NCT00126737|21084601|P2|NOT COMPLETED|Overall Study||3
8551540|NCT00126737|21084602|P1|NOT COMPLETED|Overall Study||6
8551541|NCT00126737|21084599|P4|COMPLETED|Overall Study||18
8551542|NCT00126737|21084600|P3|COMPLETED|Overall Study||24
8551543|NCT00126737|21084601|P2|COMPLETED|Overall Study||24
8551544|NCT00126737|21084602|P1|COMPLETED|Overall Study||22
8551545|NCT00126737|21084599|P4|STARTED|Overall Study||25
8551546|NCT00126737|21084600|P3|STARTED|Overall Study||30
8551547|NCT00126737|21084601|P2|STARTED|Overall Study||27
8551548|NCT00126737|21084602|P1|STARTED|Overall Study||28
8551549|NCT00126659|21084631|P3|NOT COMPLETED|Overall Study||2
8551550|NCT00126659|21084632|P2|NOT COMPLETED|Overall Study||0
8551551|NCT00126659|21084633|P1|NOT COMPLETED|Overall Study||0
8551552|NCT00126659|21084631|P3|COMPLETED|Overall Study||2
8551553|NCT00126659|21084632|P2|COMPLETED|Overall Study||3
8551554|NCT00126659|21084633|P1|COMPLETED|Overall Study||3
8551555|NCT00126659|21084631|P3|STARTED|Overall Study||4
8551556|NCT00126659|21084632|P2|STARTED|Overall Study||3
8551557|NCT00126659|21084633|P1|STARTED|Overall Study||3
8551558|NCT00126594|21084641|P2|NOT COMPLETED|Overall Study||37
8551559|NCT00126594|21084642|P1|NOT COMPLETED|Overall Study||39
8551560|NCT00126594|21084641|P2|COMPLETED|Overall Study||3
8551561|NCT00126594|21084642|P1|COMPLETED|Overall Study||1
8551562|NCT00126594|21084641|P2|STARTED|Overall Study||40
8551563|NCT00126594|21084642|P1|STARTED|Overall Study||40
8551564|NCT00126581|21084659|P2|NOT COMPLETED|Overall Study||20
8551565|NCT00126581|21084660|P1|NOT COMPLETED|Overall Study||13
8551566|NCT00126581|21084659|P2|COMPLETED|Overall Study||80
8551567|NCT00126581|21084660|P1|COMPLETED|Overall Study||68
8551568|NCT00126581|21084659|P2|STARTED|Overall Study||100
8551569|NCT00126581|21084660|P1|STARTED|Overall Study||81
8551570|NCT00126568|21084680|P1|NOT COMPLETED|Overall Study||2
8551571|NCT00126568|21084680|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
8551572|NCT00126568|21084680|P1|STARTED|Overall Study||20
8551573|NCT00126555|21084687|P1|NOT COMPLETED|Overall Study||6
8551574|NCT00126555|21084687|P1|COMPLETED|Overall Study||17
8551575|NCT00126555|21084687|P1|Stratum 2- Unresectable|Overall Study||4
8551576|NCT00126555|21084687|P1|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
8551577|NCT00126555|21084687|P1|STARTED|Overall Study||23
8551578|NCT00126503|21084709|P2|NOT COMPLETED|Overall Study||21
8551579|NCT00126503|21084710|P1|NOT COMPLETED|Overall Study||47
8551580|NCT00126503|21084709|P2|COMPLETED|Overall Study||0
8551581|NCT00126503|21084710|P1|COMPLETED|Overall Study||1
8551582|NCT00126503|21084709|P2|STARTED|Overall Study||21
8551583|NCT00126503|21084710|P1|STARTED|Overall Study||48
8551584|NCT00126490|21084722|P1|NOT COMPLETED|Overall Study||1
8551585|NCT00126490|21084722|P1|COMPLETED|Overall Study||18
8551586|NCT00126490|21084722|P1|STARTED|Overall Study||19
8551587|NCT00126438|21084732|P2|NOT COMPLETED|Overall Study||10
8551588|NCT00126438|21084733|P1|NOT COMPLETED|Overall Study||34
8551589|NCT00126438|21084732|P2|COMPLETED|Overall Study||52
8551590|NCT00126438|21084733|P1|COMPLETED|Overall Study||419
8551591|NCT00126438|21084732|P2|STARTED|Overall Study||62
8551592|NCT00126438|21084733|P1|STARTED|Overall Study||453
8551593|NCT00126425|21084741|P2|NOT COMPLETED|Overall Study||11
8551594|NCT00126425|21084742|P1|NOT COMPLETED|Overall Study||41
8551595|NCT00126425|21084741|P2|COMPLETED|Overall Study||37
8551596|NCT00126425|21084742|P1|COMPLETED|Overall Study||498
8551597|NCT00126425|21084741|P2|STARTED|Overall Study||48
8551598|NCT00126425|21084742|P1|STARTED|Overall Study||539
8551599|NCT00126191|21084750|P2|NOT COMPLETED|Overall Study||2
8551600|NCT00126191|21084751|P1|NOT COMPLETED|Overall Study||0
8551601|NCT00126191|21084750|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
8551602|NCT00126191|21084751|P1|COMPLETED|Overall Study||2
8551603|NCT00126191|21084750|P2|STARTED|Overall Study||8
8551604|NCT00126191|21084751|P1|STARTED|Overall Study||2
8551605|NCT00126126|21084761|P2|NOT COMPLETED|Overall Study||2
8551606|NCT00126126|21084762|P1|NOT COMPLETED|Overall Study||0
8551607|NCT00126126|21084761|P2|COMPLETED|Overall Study||7
8551608|NCT00126126|21084762|P1|COMPLETED|Overall Study||9
8551609|NCT00126126|21084761|P2|STARTED|Overall Study||9
8551610|NCT00126126|21084762|P1|STARTED|Overall Study||9
8551611|NCT00126113|21084772|P2|NOT COMPLETED|Overall Study||2
8551612|NCT00126113|21084773|P1|NOT COMPLETED|Overall Study||3
8551613|NCT00126113|21084772|P2|COMPLETED|Overall Study||35
8551614|NCT00126113|21084773|P1|COMPLETED|Overall Study||34
8551615|NCT00126113|21084772|P2|STARTED|Overall Study||37
8551616|NCT00126113|21084773|P1|STARTED|Overall Study||37
8551617|NCT00125957|21084787|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8551618|NCT00125957|21084788|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8551619|NCT00125957|21084787|P2|COMPLETED|Second Intervention (3 Weeks)||17
8551620|NCT00125957|21084788|P1|COMPLETED|Second Intervention (3 Weeks)||15
8551621|NCT00125957|21084787|P2|STARTED|Second Intervention (3 Weeks)||17
8551622|NCT00125957|21084788|P1|STARTED|Second Intervention (3 Weeks)||15
8551623|NCT00125957|21084787|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8551624|NCT00125957|21084788|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8551625|NCT00125957|21084787|P2|COMPLETED|First Intervention (3 Weeks)||17
8551626|NCT00125957|21084788|P1|COMPLETED|First Intervention (3 Weeks)||15
8551627|NCT00125957|21084787|P2|STARTED|First Intervention (3 Weeks)||17
8551628|NCT00125957|21084788|P1|STARTED|First Intervention (3 Weeks)||15
8551629|NCT00125931|21084796|P1|NOT COMPLETED|Overall Study||0
8551630|NCT00125931|21084796|P1|COMPLETED|Overall Study||10
8551631|NCT00125931|21084796|P1|STARTED|Overall Study||10
8551632|NCT00125853|21084801|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8551633|NCT00125853|21084802|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8551634|NCT00125853|21084801|P2|COMPLETED|Second Intervention (8 Weeks)||20
8551635|NCT00125853|21084802|P1|COMPLETED|Second Intervention (8 Weeks)||24
8551636|NCT00125853|21084801|P2|STARTED|Second Intervention (8 Weeks)||20
8551637|NCT00125853|21084802|P1|STARTED|Second Intervention (8 Weeks)||24
8551638|NCT00125853|21084801|P2|NOT COMPLETED|Wash-out (4 Weeks)||7
8551639|NCT00125853|21084802|P1|NOT COMPLETED|Wash-out (4 Weeks)||3
8551640|NCT00125853|21084801|P2|COMPLETED|Wash-out (4 Weeks)||20
8551641|NCT00125853|21084802|P1|COMPLETED|Wash-out (4 Weeks)||24
8551642|NCT00125853|21084801|P2|STARTED|Wash-out (4 Weeks)||27
8551643|NCT00125853|21084802|P1|STARTED|Wash-out (4 Weeks)||27
8551644|NCT00125853|21084801|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8551645|NCT00125853|21084802|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8551646|NCT00125853|21084801|P2|COMPLETED|First Intervention (8 Weeks)||27
8551647|NCT00125853|21084802|P1|COMPLETED|First Intervention (8 Weeks)||27
8551648|NCT00125853|21084801|P2|STARTED|First Intervention (8 Weeks)||27
8551649|NCT00125853|21084802|P1|STARTED|First Intervention (8 Weeks)||27
8551650|NCT00125853|21084801|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
8551651|NCT00125853|21084802|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
8551652|NCT00125853|21084801|P2|COMPLETED|Wash-out (4 Weeks)||27
8551653|NCT00125853|21084802|P1|COMPLETED|Wash-out (4 Weeks)||27
8551654|NCT00125853|21084801|P2|STARTED|Wash-out (4 Weeks)||27
8551655|NCT00125853|21084802|P1|STARTED|Wash-out (4 Weeks)||27
8551656|NCT00125762|21084816|P1|NOT COMPLETED|Overall Study||159
8551657|NCT00125762|21084816|P1|COMPLETED|Overall Study||748
8551658|NCT00125762|21084816|P1|STARTED|Overall Study||907
8551659|NCT00125658|21084823|P2|NOT COMPLETED|Overall Study||0
8551660|NCT00125658|21084824|P1|NOT COMPLETED|Overall Study||0
8551661|NCT00125658|21084823|P2|COMPLETED|Overall Study||6
8551662|NCT00125658|21084824|P1|COMPLETED|Overall Study||8
8551663|NCT00125658|21084823|P2|STARTED|Overall Study||6
8551664|NCT00125658|21084824|P1|STARTED|Overall Study||8
8551665|NCT00125619|21084844|P2|NOT COMPLETED|Overall Study||0
8551666|NCT00125619|21084845|P1|NOT COMPLETED|Overall Study||0
8551667|NCT00125619|21084844|P2|COMPLETED|Overall Study||8
8551668|NCT00125619|21084845|P1|COMPLETED|Overall Study||8
8551669|NCT00125619|21084844|P2|STARTED|Overall Study||8
8551670|NCT00125619|21084845|P1|STARTED|Overall Study||8
8551671|NCT00125593|21084865|P2|NOT COMPLETED|Overall Study||103
8551672|NCT00125593|21084866|P1|NOT COMPLETED|Overall Study||101
8551673|NCT00125593|21084865|P2|COMPLETED|Overall Study||4517
8551674|NCT00125593|21084866|P1|COMPLETED|Overall Study||4549
8551675|NCT00125593|21084865|P2|STARTED|Overall Study||4620
8551676|NCT00125593|21084866|P1|STARTED|Overall Study||4650
8551677|NCT00125528|21084886|P2|NOT COMPLETED|Overall Study||1
8551678|NCT00125528|21084887|P1|NOT COMPLETED|Overall Study||2
8551679|NCT00125528|21084886|P2|COMPLETED|Overall Study||20
8551680|NCT00125528|21084887|P1|COMPLETED|Overall Study||18
8551681|NCT00125528|21084886|P2|STARTED|Overall Study||21
8551682|NCT00125528|21084887|P1|STARTED|Overall Study||20
8551683|NCT00125515|21084898|P3|NOT COMPLETED|Overall Study||21
8551684|NCT00125515|21084899|P2|NOT COMPLETED|Overall Study||20
8551685|NCT00125515|21084900|P1|NOT COMPLETED|Overall Study||20
8551686|NCT00125515|21084898|P3|COMPLETED|Overall Study||6
8551687|NCT00125515|21084899|P2|COMPLETED|Overall Study||7
8551688|NCT00125515|21084900|P1|COMPLETED|Overall Study||7
8551689|NCT00125515|21084898|P3|STARTED|Overall Study||27
8551690|NCT00125515|21084899|P2|STARTED|Overall Study||27
8551691|NCT00125515|21084900|P1|STARTED|Overall Study||27
8551692|NCT00125372|21084908|P1|NOT COMPLETED|Overall Study||2
8551693|NCT00125372|21084908|P1|COMPLETED|Overall Study||10
8551694|NCT00125372|21084908|P1|STARTED|Overall Study||12
8551695|NCT00125359|21084916|P1|NOT COMPLETED|Overall Study||23
8551696|NCT00125359|21084916|P1|COMPLETED|Overall Study||19
8551697|NCT00125359|21084916|P1|STARTED|Overall Study||42
8551698|NCT00125268|21084925|P2|NOT COMPLETED|Overall Study||1
8551699|NCT00125268|21084926|P1|NOT COMPLETED|Overall Study||1
8551700|NCT00125268|21084925|P2|COMPLETED|Overall Study||13
8551701|NCT00125268|21084926|P1|COMPLETED|Overall Study||15
8551702|NCT00125268|21084925|P2|STARTED|Overall Study||14
8551703|NCT00125268|21084926|P1|STARTED|Overall Study||16
8551704|NCT00125242|21084938|P2|NOT COMPLETED|Overall Study||2
8551705|NCT00125242|21084939|P1|NOT COMPLETED|Overall Study||7
8551706|NCT00125242|21084938|P2|COMPLETED|Overall Study||14
8551707|NCT00125242|21084939|P1|COMPLETED|Overall Study||87
8551708|NCT00125242|21084938|P2|STARTED|Overall Study||16
8551709|NCT00125242|21084939|P1|STARTED|Overall Study||94
8551710|NCT00125190|21084944|P1|NOT COMPLETED|Overall Study||15
8551711|NCT00125190|21084944|P1|COMPLETED|Overall Study||30
8551712|NCT00125190|21084944|P1|Completed 34 Weeks of Study|Overall Study||43
8551713|NCT00125190|21084944|P1|STARTED|Overall Study||45
8551714|NCT00125164|21084960|P4|NOT COMPLETED|Overall Study||6
8551715|NCT00125164|21084961|P3|NOT COMPLETED|Overall Study||4
8551716|NCT00125164|21084962|P2|NOT COMPLETED|Overall Study||0
8551717|NCT00125164|21084963|P1|NOT COMPLETED|Overall Study||2
8551718|NCT00125164|21084960|P4|COMPLETED|Overall Study||45
8551719|NCT00125164|21084961|P3|COMPLETED|Overall Study||40
8551720|NCT00125164|21084962|P2|COMPLETED|Overall Study||16
8551721|NCT00125164|21084963|P1|COMPLETED|Overall Study||23
8551722|NCT00125164|21084960|P4|STARTED|Overall Study||51
8551723|NCT00125164|21084961|P3|STARTED|Overall Study||44
8551724|NCT00125164|21084962|P2|STARTED|Overall Study||16
8551725|NCT00125164|21084963|P1|STARTED|Overall Study||25
8551726|NCT00125138|21085017|P4|NOT COMPLETED|Overall Study||5
8551727|NCT00125138|21085018|P3|NOT COMPLETED|Overall Study||4
8551728|NCT00125138|21085019|P2|NOT COMPLETED|Overall Study||3
8551729|NCT00125138|21085020|P1|NOT COMPLETED|Overall Study||3
8551730|NCT00125138|21085017|P4|COMPLETED|Overall Study||25
8551731|NCT00125138|21085018|P3|COMPLETED|Overall Study||21
8551732|NCT00125138|21085019|P2|COMPLETED|Overall Study||17
8551733|NCT00125138|21085020|P1|COMPLETED|Overall Study||12
8551734|NCT00125138|21085017|P4|STARTED|Overall Study||30
8551735|NCT00125138|21085018|P3|STARTED|Overall Study||25
8551736|NCT00125138|21085019|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
8551737|NCT00125138|21085020|P1|STARTED|Overall Study||15
8551738|NCT00125034|21085036|P2|NOT COMPLETED|Overall Study||0
8551739|NCT00125034|21085037|P1|NOT COMPLETED|Overall Study||0
8551740|NCT00125034|21085036|P2|COMPLETED|Overall Study||168
8551741|NCT00125034|21085037|P1|COMPLETED|Overall Study||170
8551742|NCT00125034|21085036|P2|STARTED|Overall Study|Randomized & treated|168
8551743|NCT00125034|21085037|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
8551744|NCT00124982|21085069|P3|NOT COMPLETED|Long-term Period||89
8551745|NCT00124982|21085070|P2|NOT COMPLETED|Long-term Period||0
8551746|NCT00124982|21085071|P1|NOT COMPLETED|Long-term Period||0
8551747|NCT00124982|21085069|P3|COMPLETED|Long-term Period||441
8551748|NCT00124982|21085070|P2|COMPLETED|Long-term Period||0
8551749|NCT00124982|21085071|P1|COMPLETED|Long-term Period||0
8551750|NCT00124982|21085069|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
8551751|NCT00124982|21085070|P2|STARTED|Long-term Period||0
8551752|NCT00124982|21085071|P1|STARTED|Long-term Period||0
8551753|NCT00124982|21085069|P3|NOT COMPLETED|Short-term Period||0
8551754|NCT00124982|21085070|P2|NOT COMPLETED|Short-term Period||114
8551755|NCT00124982|21085071|P1|NOT COMPLETED|Short-term Period||72
8551756|NCT00124982|21085069|P3|COMPLETED|Short-term Period||0
8551757|NCT00124982|21085070|P2|COMPLETED|Short-term Period||483
8551758|NCT00124982|21085071|P1|COMPLETED|Short-term Period||377
8551759|NCT00124982|21085069|P3|STARTED|Short-term Period||0
8551760|NCT00124982|21085070|P2|STARTED|Short-term Period||597
8551761|NCT00124982|21085071|P1|STARTED|Short-term Period||449
8551762|NCT00124943|21085153|P4|NOT COMPLETED|Phase II||5
8551763|NCT00124943|21085154|P3|NOT COMPLETED|Phase II||0
8551764|NCT00124943|21085155|P2|NOT COMPLETED|Phase II||2
8551765|NCT00124943|21085156|P1|NOT COMPLETED|Phase II||0
8551766|NCT00124943|21085153|P4|COMPLETED|Phase II||50
8551767|NCT00124943|21085154|P3|COMPLETED|Phase II||3
8551768|NCT00124943|21085155|P2|COMPLETED|Phase II||49
8551769|NCT00124943|21085156|P1|COMPLETED|Phase II||3
8551770|NCT00124943|21085153|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
8551771|NCT00124943|21085154|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
8551772|NCT00124943|21085155|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
8551773|NCT00124943|21085156|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
8551774|NCT00124943|21085153|P4|NOT COMPLETED|Phase I||0
8551775|NCT00124943|21085154|P3|NOT COMPLETED|Phase I||0
8551776|NCT00124943|21085155|P2|NOT COMPLETED|Phase I||0
8551777|NCT00124943|21085156|P1|NOT COMPLETED|Phase I||0
8551778|NCT00124943|21085153|P4|COMPLETED|Phase I||3
8551779|NCT00124943|21085154|P3|COMPLETED|Phase I||3
8551780|NCT00124943|21085155|P2|COMPLETED|Phase I||3
8551781|NCT00124943|21085156|P1|COMPLETED|Phase I||3
8551782|NCT00124943|21085153|P4|STARTED|Phase I||3
8551783|NCT00124943|21085154|P3|STARTED|Phase I||3
8551784|NCT00124943|21085155|P2|STARTED|Phase I||3
8551785|NCT00124943|21085156|P1|STARTED|Phase I||3
8551786|NCT00124917|21085194|P1|NOT COMPLETED|Overall Study||3
8551787|NCT00124917|21085194|P1|COMPLETED|Overall Study||3
8551788|NCT00124917|21085194|P1|STARTED|Overall Study||6
8551789|NCT00124748|21085204|P2|NOT COMPLETED|Overall Study||284
8551790|NCT00124748|21085205|P1|NOT COMPLETED|Overall Study||143
8551791|NCT00124748|21085204|P2|COMPLETED|Overall Study||35
8551792|NCT00124748|21085205|P1|COMPLETED|Overall Study||14
8551793|NCT00124748|21085204|P2|Safety Population|Overall Study||316
8551794|NCT00124748|21085205|P1|Safety Population|Overall Study||157
8551795|NCT00124748|21085204|P2|STARTED|Overall Study||319
8551796|NCT00124748|21085205|P1|STARTED|Overall Study||157
8551797|NCT00124735|21085257|P10|NOT COMPLETED|Overall Study||2
8551798|NCT00124735|21085258|P9|NOT COMPLETED|Overall Study||3
8551799|NCT00124735|21085259|P8|NOT COMPLETED|Overall Study||1
8551800|NCT00124735|21085260|P7|NOT COMPLETED|Overall Study||0
8551801|NCT00124735|21085261|P6|NOT COMPLETED|Overall Study||2
8551802|NCT00124735|21085262|P5|NOT COMPLETED|Overall Study||2
8551803|NCT00124735|21085263|P4|NOT COMPLETED|Overall Study||3
8551804|NCT00124735|21085264|P3|NOT COMPLETED|Overall Study||0
8551805|NCT00124735|21085265|P2|NOT COMPLETED|Overall Study||2
8551806|NCT00124735|21085266|P1|NOT COMPLETED|Overall Study||1
8551807|NCT00124735|21085257|P10|COMPLETED|Overall Study||18
8551808|NCT00124735|21085258|P9|COMPLETED|Overall Study||22
8551809|NCT00124735|21085259|P8|COMPLETED|Overall Study||19
8551810|NCT00124735|21085260|P7|COMPLETED|Overall Study||6
8551811|NCT00124735|21085261|P6|COMPLETED|Overall Study||5
8551812|NCT00124735|21085262|P5|COMPLETED|Overall Study||17
8551813|NCT00124735|21085263|P4|COMPLETED|Overall Study||18
8551814|NCT00124735|21085264|P3|COMPLETED|Overall Study||18
8551815|NCT00124735|21085265|P2|COMPLETED|Overall Study||6
8551816|NCT00124735|21085266|P1|COMPLETED|Overall Study||4
8551817|NCT00124735|21085257|P10|STARTED|Overall Study||20
8551818|NCT00124735|21085258|P9|STARTED|Overall Study||25
8551819|NCT00124735|21085259|P8|STARTED|Overall Study||20
8551820|NCT00124735|21085260|P7|STARTED|Overall Study||6
8551821|NCT00124735|21085261|P6|STARTED|Overall Study||7
8551822|NCT00124735|21085262|P5|STARTED|Overall Study||19
8551823|NCT00124735|21085263|P4|STARTED|Overall Study||21
8551824|NCT00124735|21085264|P3|STARTED|Overall Study||18
8551825|NCT00124735|21085265|P2|STARTED|Overall Study||8
8551826|NCT00124735|21085266|P1|STARTED|Overall Study||5
8551827|NCT00124709|21085312|P2|NOT COMPLETED|Overall Study||272
8551828|NCT00124709|21085313|P1|NOT COMPLETED|Overall Study||255
8551829|NCT00124709|21085312|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
8551830|NCT00124709|21085313|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
8551831|NCT00124709|21085312|P2|Patients Who Received Study Medication|Overall Study||544
8551832|NCT00124709|21085313|P1|Patients Who Received Study Medication|Overall Study||543
8551833|NCT00124709|21085312|P2|STARTED|Overall Study||545
8551834|NCT00124709|21085313|P1|STARTED|Overall Study||546
8551835|NCT00124657|21085330|P3|NOT COMPLETED|Overall Study||32
8551836|NCT00124657|21085331|P2|NOT COMPLETED|Overall Study||5
8551837|NCT00124657|21085332|P1|NOT COMPLETED|Overall Study||16
8551838|NCT00124657|21085330|P3|COMPLETED|Overall Study||7
8551839|NCT00124657|21085331|P2|COMPLETED|Overall Study||0
8551840|NCT00124657|21085332|P1|COMPLETED|Overall Study||2
8551841|NCT00124657|21085330|P3|STARTED|Overall Study||39
8551842|NCT00124657|21085331|P2|STARTED|Overall Study||5
8551843|NCT00124657|21085332|P1|STARTED|Overall Study||18
8551844|NCT00124618|21085367|P1|NOT COMPLETED|Overall Study||1
8551845|NCT00124618|21085367|P1|COMPLETED|Overall Study||57
8551846|NCT00124618|21085367|P1|STARTED|Overall Study||58
8551847|NCT00124579|21085374|P1|NOT COMPLETED|Maintenance||2
8551848|NCT00124579|21085374|P1|COMPLETED|Maintenance||0
8551849|NCT00124579|21085374|P1|STARTED|Maintenance||2
8551850|NCT00124579|21085374|P1|NOT COMPLETED|Induction||5
8551851|NCT00124579|21085374|P1|COMPLETED|Induction||2
8551852|NCT00124579|21085374|P1|STARTED|Induction||7
8551853|NCT00124514|21085385|P5|NOT COMPLETED|Overall Study||1
8551854|NCT00124514|21085386|P4|NOT COMPLETED|Overall Study||1
8551855|NCT00124514|21085387|P3|NOT COMPLETED|Overall Study||1
8551856|NCT00124514|21085388|P2|NOT COMPLETED|Overall Study||2
8551857|NCT00124514|21085389|P1|NOT COMPLETED|Overall Study||4
8551858|NCT00124514|21085385|P5|COMPLETED|Overall Study||1
8551859|NCT00124514|21085386|P4|COMPLETED|Overall Study||5
8551860|NCT00124514|21085387|P3|COMPLETED|Overall Study||7
8551861|NCT00124514|21085388|P2|COMPLETED|Overall Study||7
8551862|NCT00124514|21085389|P1|COMPLETED|Overall Study||2
8551863|NCT00124514|21085385|P5|STARTED|Overall Study||2
8551864|NCT00124514|21085386|P4|STARTED|Overall Study||6
8551865|NCT00124514|21085387|P3|STARTED|Overall Study||8
8551866|NCT00124514|21085388|P2|STARTED|Overall Study||9
8551867|NCT00124514|21085389|P1|STARTED|Overall Study||6
8551868|NCT00124462|21085399|P2|NOT COMPLETED|Overall Study||13
8551869|NCT00124462|21085400|P1|NOT COMPLETED|Overall Study||11
8551870|NCT00124462|21085399|P2|COMPLETED|Overall Study||27
8551871|NCT00124462|21085400|P1|COMPLETED|Overall Study||29
8551872|NCT00124462|21085399|P2|STARTED|Overall Study||40
8551873|NCT00124462|21085400|P1|STARTED|Overall Study||40
8551874|NCT00124449|21085410|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
8551875|NCT00124449|21085411|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
8551876|NCT00124449|21085410|P2|COMPLETED|18-Month Untreated Observation Period||4
8551877|NCT00124449|21085411|P1|COMPLETED|18-Month Untreated Observation Period||7
8551878|NCT00124449|21085410|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
8551879|NCT00124449|21085411|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
8551880|NCT00124449|21085410|P2|STARTED|18-Month Untreated Observation Period||17
8551881|NCT00124449|21085411|P1|STARTED|18-Month Untreated Observation Period||22
8551882|NCT00124449|21085410|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
8551883|NCT00124449|21085411|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
8551884|NCT00124449|21085410|P2|COMPLETED|6-month Double-Blind Treatment Period||17
8551885|NCT00124449|21085411|P1|COMPLETED|6-month Double-Blind Treatment Period||22
8551886|NCT00124449|21085410|P2|STARTED|6-month Double-Blind Treatment Period||28
8551887|NCT00124449|21085411|P1|STARTED|6-month Double-Blind Treatment Period||28
8551888|NCT00124176|21085446|P2|NOT COMPLETED|Overall Study||0
8551889|NCT00124176|21085447|P1|NOT COMPLETED|Overall Study||0
8551890|NCT00124176|21085446|P2|COMPLETED|Overall Study||41
8551891|NCT00124176|21085447|P1|COMPLETED|Overall Study||40
8551892|NCT00124176|21085446|P2|Received Study Drug|Overall Study||41
8551893|NCT00124176|21085447|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
8551894|NCT00124176|21085446|P2|STARTED|Overall Study||41
8551895|NCT00124176|21085447|P1|STARTED|Overall Study||40
8551896|NCT00124072|21085465|P4|NOT COMPLETED|Overall Study||500
8551897|NCT00124072|21085466|P3|NOT COMPLETED|Overall Study||492
8551898|NCT00124072|21085467|P2|NOT COMPLETED|Overall Study||512
8551899|NCT00124072|21085468|P1|NOT COMPLETED|Overall Study||514
8551900|NCT00124072|21085465|P4|COMPLETED|Overall Study||2515
8551901|NCT00124072|21085466|P3|COMPLETED|Overall Study||2524
8551902|NCT00124072|21085467|P2|COMPLETED|Overall Study||2504
8551903|NCT00124072|21085468|P1|COMPLETED|Overall Study||2503
8551904|NCT00124072|21085465|P4|STARTED|Overall Study||3015
8551905|NCT00124072|21085466|P3|STARTED|Overall Study||3016
8551906|NCT00124072|21085467|P2|STARTED|Overall Study||3016
8551907|NCT00124072|21085468|P1|STARTED|Overall Study||3017
8551908|NCT00124020|21085480|P2|NOT COMPLETED|Overall Study||91
8551909|NCT00124020|21085481|P1|NOT COMPLETED|Overall Study||88
8551910|NCT00124020|21085480|P2|COMPLETED|Overall Study||289
8551911|NCT00124020|21085481|P1|COMPLETED|Overall Study||289
8551912|NCT00124020|21085480|P2|STARTED|Overall Study||380
8551913|NCT00124020|21085481|P1|STARTED|Overall Study||377
8551914|NCT00123955|21085489|P2|NOT COMPLETED|Overall Study||4
8551915|NCT00123955|21085490|P1|NOT COMPLETED|Overall Study||5
8551916|NCT00123955|21085489|P2|COMPLETED|Overall Study||34
8551917|NCT00123955|21085490|P1|COMPLETED|Overall Study||37
8551918|NCT00123955|21085489|P2|STARTED|Overall Study||38
8551919|NCT00123955|21085490|P1|STARTED|Overall Study||42
8551920|NCT00123734|21085502|P1|NOT COMPLETED|Overall Study||8
8551921|NCT00123734|21085502|P1|COMPLETED|Overall Study||74
8551922|NCT00123734|21085502|P1|STARTED|Overall Study||82
8551923|NCT00123682|21085537|P4|NOT COMPLETED|Overall Study||95
8551924|NCT00123682|21085538|P3|NOT COMPLETED|Overall Study||154
8551925|NCT00123682|21085539|P2|NOT COMPLETED|Overall Study||203
8551926|NCT00123682|21085540|P1|NOT COMPLETED|Overall Study||320
8551927|NCT00123682|21085537|P4|COMPLETED|Overall Study||430
8551928|NCT00123682|21085538|P3|COMPLETED|Overall Study||438
8551929|NCT00123682|21085539|P2|COMPLETED|Overall Study||731
8551930|NCT00123682|21085540|P1|COMPLETED|Overall Study||749
8551931|NCT00123682|21085537|P4|STARTED|Overall Study||525
8551932|NCT00123682|21085538|P3|STARTED|Overall Study||592
8551933|NCT00123682|21085539|P2|STARTED|Overall Study||934
8551934|NCT00123682|21085540|P1|STARTED|Overall Study||1069
8551935|NCT00123643|21085560|P2|NOT COMPLETED|Overall Study||0
8551936|NCT00123643|21085561|P1|NOT COMPLETED|Overall Study||0
8551937|NCT00123643|21085560|P2|COMPLETED|Overall Study||16
8551938|NCT00123643|21085561|P1|COMPLETED|Overall Study||20
8551939|NCT00123643|21085560|P2|STARTED|Overall Study||16
8551940|NCT00123643|21085561|P1|STARTED|Overall Study||20
8551941|NCT00123630|21085569|P2|NOT COMPLETED|Overall Study||0
8551942|NCT00123630|21085570|P1|NOT COMPLETED|Overall Study||0
8551943|NCT00123630|21085569|P2|COMPLETED|Overall Study||15
8551944|NCT00123630|21085570|P1|COMPLETED|Overall Study||15
8551945|NCT00123630|21085569|P2|STARTED|Overall Study||15
8551946|NCT00123630|21085570|P1|STARTED|Overall Study||15
8551947|NCT00123604|21085578|P2|NOT COMPLETED|Overall Study||1
8551948|NCT00123604|21085579|P1|NOT COMPLETED|Overall Study||1
8551949|NCT00123604|21085578|P2|COMPLETED|Overall Study||16
8551950|NCT00123604|21085579|P1|COMPLETED|Overall Study||18
8551951|NCT00123604|21085578|P2|STARTED|Overall Study||17
8551952|NCT00123604|21085579|P1|STARTED|Overall Study||19
8551953|NCT00123487|21085587|P2|NOT COMPLETED|Treated With Study Drug||305
8551954|NCT00123487|21085588|P1|NOT COMPLETED|Treated With Study Drug||304
8551955|NCT00123487|21085587|P2|COMPLETED|Treated With Study Drug||0
8551956|NCT00123487|21085588|P1|COMPLETED|Treated With Study Drug||0
8551957|NCT00123487|21085587|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
8551958|NCT00123487|21085588|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
8551959|NCT00123487|21085587|P2|NOT COMPLETED|Randomized||1
8551960|NCT00123487|21085588|P1|NOT COMPLETED|Randomized||1
8551961|NCT00123487|21085587|P2|COMPLETED|Randomized||304
8551962|NCT00123487|21085588|P1|COMPLETED|Randomized||305
8551963|NCT00123487|21085587|P2|STARTED|Randomized||305
8551964|NCT00123487|21085588|P1|STARTED|Randomized||306
8551965|NCT00123474|21085632|P4|NOT COMPLETED|As Treated at Study Closure||167
8551966|NCT00123474|21085633|P3|NOT COMPLETED|As Treated at Study Closure||167
8551967|NCT00123474|21085634|P2|NOT COMPLETED|As Treated at Study Closure||163
8551968|NCT00123474|21085635|P1|NOT COMPLETED|As Treated at Study Closure||165
8551969|NCT00123474|21085632|P4|COMPLETED|As Treated at Study Closure||0
8551970|NCT00123474|21085633|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
8551971|NCT00123474|21085634|P2|COMPLETED|As Treated at Study Closure||0
8551972|NCT00123474|21085635|P1|COMPLETED|As Treated at Study Closure||0
8551973|NCT00123474|21085632|P4|STARTED|As Treated at Study Closure||167
8551974|NCT00123474|21085633|P3|STARTED|As Treated at Study Closure||167
8551975|NCT00123474|21085634|P2|STARTED|As Treated at Study Closure||163
8551976|NCT00123474|21085635|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
8551977|NCT00123474|21085632|P4|NOT COMPLETED|Randomized to Treatment||1
8551978|NCT00123474|21085633|P3|NOT COMPLETED|Randomized to Treatment||2
8551979|NCT00123474|21085634|P2|NOT COMPLETED|Randomized to Treatment||4
8551980|NCT00123474|21085635|P1|NOT COMPLETED|Randomized to Treatment||1
8551981|NCT00123474|21085632|P4|COMPLETED|Randomized to Treatment||167
8551982|NCT00123474|21085633|P3|COMPLETED|Randomized to Treatment||166
8551983|NCT00123474|21085634|P2|COMPLETED|Randomized to Treatment||163
8551984|NCT00123474|21085635|P1|COMPLETED|Randomized to Treatment||166
8551985|NCT00123474|21085632|P4|STARTED|Randomized to Treatment||168
8551986|NCT00123474|21085633|P3|STARTED|Randomized to Treatment||168
8551987|NCT00123474|21085634|P2|STARTED|Randomized to Treatment||167
8551988|NCT00123474|21085635|P1|STARTED|Randomized to Treatment||167
8551989|NCT00123422|21085729|P3|NOT COMPLETED|Overall Study||10
8551990|NCT00123422|21085730|P2|NOT COMPLETED|Overall Study||6
8551991|NCT00123422|21085731|P1|NOT COMPLETED|Overall Study||4
8551992|NCT00123422|21085729|P3|COMPLETED|Overall Study||25
8551993|NCT00123422|21085730|P2|COMPLETED|Overall Study||27
8551994|NCT00123422|21085731|P1|COMPLETED|Overall Study||31
8551995|NCT00123422|21085729|P3|8-week Testing|Overall Study||27
8551996|NCT00123422|21085730|P2|8-week Testing|Overall Study||30
8551997|NCT00123422|21085731|P1|8-week Testing|Overall Study||32
8551998|NCT00123422|21085729|P3|STARTED|Overall Study||35
8551999|NCT00123422|21085730|P2|STARTED|Overall Study||33
8552000|NCT00123422|21085731|P1|STARTED|Overall Study||35
8552001|NCT00123409|21085744|P2|NOT COMPLETED|Overall Study||3
8552002|NCT00123409|21085745|P1|NOT COMPLETED|Overall Study||4
8552003|NCT00123409|21085744|P2|COMPLETED|Overall Study||71
8552004|NCT00123409|21085745|P1|COMPLETED|Overall Study||68
8552005|NCT00123409|21085744|P2|STARTED|Overall Study||74
8552006|NCT00123409|21085745|P1|STARTED|Overall Study||72
8552007|NCT00123162|21085755|P2|NOT COMPLETED|Overall Study||0
8552008|NCT00123162|21085756|P1|NOT COMPLETED|Overall Study||0
8552009|NCT00123162|21085755|P2|COMPLETED|Overall Study||12
8552010|NCT00123162|21085756|P1|COMPLETED|Overall Study||13
8552011|NCT00123162|21085755|P2|STARTED|Overall Study||12
8552012|NCT00123162|21085756|P1|STARTED|Overall Study||13
8552013|NCT00123123|21085767|P3|NOT COMPLETED|Overall Study||0
8552014|NCT00123123|21085768|P2|NOT COMPLETED|Overall Study||0
8552015|NCT00123123|21085769|P1|NOT COMPLETED|Overall Study||0
8552016|NCT00123123|21085767|P3|COMPLETED|Overall Study||58
8552017|NCT00123123|21085768|P2|COMPLETED|Overall Study||58
8552018|NCT00123123|21085769|P1|COMPLETED|Overall Study||59
8552019|NCT00123123|21085767|P3|STARTED|Overall Study||58
8552020|NCT00123123|21085768|P2|STARTED|Overall Study||58
8552021|NCT00123123|21085769|P1|STARTED|Overall Study||59
8552022|NCT00123110|21085783|P3|NOT COMPLETED|Overall Study||0
8552023|NCT00123110|21085784|P2|NOT COMPLETED|Overall Study||0
8552024|NCT00123110|21085785|P1|NOT COMPLETED|Overall Study||0
8552025|NCT00123110|21085783|P3|COMPLETED|Overall Study||11
8552026|NCT00123110|21085784|P2|COMPLETED|Overall Study||12
8552027|NCT00123110|21085785|P1|COMPLETED|Overall Study||12
8552028|NCT00123110|21085783|P3|STARTED|Overall Study||11
8552029|NCT00123110|21085784|P2|STARTED|Overall Study||12
8552030|NCT00123110|21085785|P1|STARTED|Overall Study||12
8552031|NCT00122980|21085819|P2|NOT COMPLETED|Overall Study||40
8552032|NCT00122980|21085820|P1|NOT COMPLETED|Overall Study||43
8552033|NCT00122980|21085819|P2|COMPLETED|Overall Study|Study terminated early|26
8552034|NCT00122980|21085820|P1|COMPLETED|Overall Study|Study terminated early|24
8552035|NCT00122980|21085819|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
8552036|NCT00122980|21085820|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
8552037|NCT00122954|21085844|P2|NOT COMPLETED|Overall Study||3
8552038|NCT00122954|21085845|P1|NOT COMPLETED|Overall Study||2
8552039|NCT00122954|21085844|P2|COMPLETED|Overall Study||18
8552040|NCT00122954|21085845|P1|COMPLETED|Overall Study||16
8552041|NCT00122954|21085844|P2|STARTED|Overall Study||21
8552042|NCT00122954|21085845|P1|STARTED|Overall Study||18
8552043|NCT00122681|21085855|P2|NOT COMPLETED|Overall Study||1521
8552044|NCT00122681|21085856|P1|NOT COMPLETED|Overall Study||1514
8552045|NCT00122681|21085855|P2|COMPLETED|Overall Study||7798
8552046|NCT00122681|21085856|P1|COMPLETED|Overall Study||7811
8552047|NCT00122681|21085855|P2|STARTED|Overall Study||9319
8552048|NCT00122681|21085856|P1|STARTED|Overall Study||9325
8552049|NCT00122460|21085930|P2|NOT COMPLETED|Overall Study||1
8552050|NCT00122460|21085931|P1|NOT COMPLETED|Overall Study||7
8552051|NCT00122460|21085930|P2|COMPLETED|Overall Study||219
8552052|NCT00122460|21085931|P1|COMPLETED|Overall Study||215
8552053|NCT00122460|21085930|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
8552054|NCT00122460|21085931|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
8552055|NCT00122447|21085957|P4|NOT COMPLETED|Overall Study||3
8552056|NCT00122447|21085958|P3|NOT COMPLETED|Overall Study||1
8552057|NCT00122447|21085959|P2|NOT COMPLETED|Overall Study||5
8552058|NCT00122447|21085960|P1|NOT COMPLETED|Overall Study||1
8552059|NCT00122447|21085957|P4|COMPLETED|Overall Study||14
8552060|NCT00122447|21085958|P3|COMPLETED|Overall Study||16
8552061|NCT00122447|21085959|P2|COMPLETED|Overall Study||13
8552062|NCT00122447|21085960|P1|COMPLETED|Overall Study||17
8552063|NCT00122447|21085957|P4|STARTED|Overall Study||17
8552064|NCT00122447|21085958|P3|STARTED|Overall Study||17
8552065|NCT00122447|21085959|P2|STARTED|Overall Study||18
8552066|NCT00122447|21085960|P1|STARTED|Overall Study||18
8552067|NCT00122382|21085980|P3|NOT COMPLETED|Open-Label Study||26
8552068|NCT00122382|21085981|P2|NOT COMPLETED|Open-Label Study||0
8552069|NCT00122382|21085982|P1|NOT COMPLETED|Open-Label Study||0
8552070|NCT00122382|21085980|P3|COMPLETED|Open-Label Study||433
8552071|NCT00122382|21085981|P2|COMPLETED|Open-Label Study||0
8552072|NCT00122382|21085982|P1|COMPLETED|Open-Label Study||0
8552073|NCT00122382|21085980|P3|STARTED|Open-Label Study||459
8552074|NCT00122382|21085981|P2|STARTED|Open-Label Study||0
8552075|NCT00122382|21085982|P1|STARTED|Open-Label Study||0
8552076|NCT00122382|21085980|P3|NOT COMPLETED|Double-Blind Study||0
8552077|NCT00122382|21085981|P2|NOT COMPLETED|Double-Blind Study||28
8552078|NCT00122382|21085982|P1|NOT COMPLETED|Double-Blind Study||24
8552079|NCT00122382|21085980|P3|COMPLETED|Double-Blind Study||0
8552080|NCT00122382|21085981|P2|COMPLETED|Double-Blind Study||227
8552081|NCT00122382|21085982|P1|COMPLETED|Double-Blind Study||232
8552082|NCT00122382|21085980|P3|Treated|Double-Blind Study||0
8552083|NCT00122382|21085981|P2|Treated|Double-Blind Study||253
8552084|NCT00122382|21085982|P1|Treated|Double-Blind Study||256
8552085|NCT00122382|21085980|P3|STARTED|Double-Blind Study||0
8552086|NCT00122382|21085981|P2|STARTED|Double-Blind Study|participants randomized|255
8552087|NCT00122382|21085982|P1|STARTED|Double-Blind Study|participants randomized|256
8552088|NCT00122369|21086035|P3|NOT COMPLETED|Overall Study||0
8552089|NCT00122369|21086036|P2|NOT COMPLETED|Overall Study||0
8552090|NCT00122369|21086037|P1|NOT COMPLETED|Overall Study||0
8552091|NCT00122369|21086035|P3|COMPLETED|Overall Study||78
8552092|NCT00122369|21086036|P2|COMPLETED|Overall Study||82
8552093|NCT00122369|21086037|P1|COMPLETED|Overall Study||76
8552094|NCT00122369|21086035|P3|STARTED|Overall Study||78
8552095|NCT00122369|21086036|P2|STARTED|Overall Study||82
8552096|NCT00122369|21086037|P1|STARTED|Overall Study||76
8552097|NCT00122317|21086126|P1|NOT COMPLETED|Overall Study||11
8552098|NCT00122317|21086126|P1|COMPLETED|Overall Study||176
8552099|NCT00122317|21086126|P1|STARTED|Overall Study||187
8552100|NCT00122278|21086135|P2|NOT COMPLETED|Overall Study||0
8552101|NCT00122278|21086136|P1|NOT COMPLETED|Overall Study||2
8552102|NCT00122278|21086135|P2|COMPLETED|Overall Study||99
8552103|NCT00122278|21086136|P1|COMPLETED|Overall Study||104
8552104|NCT00122278|21086135|P2|STARTED|Overall Study||99
8552105|NCT00122278|21086136|P1|STARTED|Overall Study||106
8552106|NCT00122187|21086146|P2|NOT COMPLETED|Overall Study||2
8552107|NCT00122187|21086147|P1|NOT COMPLETED|Overall Study||2
8552108|NCT00122187|21086146|P2|COMPLETED|Overall Study||2
8552109|NCT00122187|21086147|P1|COMPLETED|Overall Study||2
8552110|NCT00122187|21086146|P2|Post-intervention Data Collection|Overall Study||2
8552111|NCT00122187|21086147|P1|Post-intervention Data Collection|Overall Study||2
8552112|NCT00122187|21086146|P2|Intervention Implemented|Overall Study||4
8552113|NCT00122187|21086147|P1|Intervention Implemented|Overall Study||3
8552114|NCT00122187|21086146|P2|Randomized to Intervention or Usual Care|Overall Study||4
8552115|NCT00122187|21086147|P1|Randomized to Intervention or Usual Care|Overall Study||4
8552116|NCT00122187|21086146|P2|Matched by Colonoscopy Volume|Overall Study||4
8552117|NCT00122187|21086147|P1|Matched by Colonoscopy Volume|Overall Study||4
8552118|NCT00122187|21086146|P2|STARTED|Overall Study||4
8552119|NCT00122187|21086147|P1|STARTED|Overall Study||4
8552120|NCT00122135|21086161|P2|NOT COMPLETED|Overall Study||0
8552121|NCT00122135|21086162|P1|NOT COMPLETED|Overall Study||3
8552122|NCT00122135|21086161|P2|COMPLETED|Overall Study||60
8552123|NCT00122135|21086162|P1|COMPLETED|Overall Study||57
8552124|NCT00122135|21086161|P2|STARTED|Overall Study||60
8552125|NCT00122135|21086162|P1|STARTED|Overall Study||60
8552126|NCT00122109|21086170|P2|NOT COMPLETED|Overall Study||7
8552127|NCT00122109|21086171|P1|NOT COMPLETED|Overall Study||6
8552128|NCT00122109|21086170|P2|COMPLETED|Overall Study||57
8552129|NCT00122109|21086171|P1|COMPLETED|Overall Study||55
8552130|NCT00122109|21086170|P2|STARTED|Overall Study|ITT|64
8552131|NCT00122109|21086171|P1|STARTED|Overall Study|ITT|61
8552132|NCT00121992|21086197|P2|NOT COMPLETED|Overall Study||11
8552133|NCT00121992|21086198|P1|NOT COMPLETED|Overall Study||2
8552134|NCT00121992|21086197|P2|COMPLETED|Overall Study||528
8552135|NCT00121992|21086198|P1|COMPLETED|Overall Study||519
8552136|NCT00121992|21086197|P2|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
8552137|NCT00121992|21086198|P1|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
8552138|NCT00121992|21086197|P2|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
8552139|NCT00121992|21086198|P1|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
8552140|NCT00121992|21086197|P2|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
8552141|NCT00121992|21086198|P1|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
8552142|NCT00121992|21086197|P2|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
8552143|NCT00121992|21086198|P1|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
8552144|NCT00121992|21086197|P2|STARTED|Overall Study||539
8552145|NCT00121992|21086198|P1|STARTED|Overall Study||521
8552146|NCT00121836|21086218|P1|NOT COMPLETED|Overall Study||55
8552147|NCT00121836|21086218|P1|COMPLETED|Overall Study||54
8552148|NCT00121836|21086218|P1|STARTED|Overall Study||109
8552149|NCT00121810|21086229|P2|NOT COMPLETED|Overall Study||39
8552150|NCT00121810|21086230|P1|NOT COMPLETED|Overall Study||30
8552151|NCT00121810|21086229|P2|COMPLETED|Overall Study||115
8552152|NCT00121810|21086230|P1|COMPLETED|Overall Study||121
8552153|NCT00121810|21086229|P2|Intent-to-Treat (ITT) Population|Overall Study||151
8552154|NCT00121810|21086230|P1|Intent-to-Treat (ITT) Population|Overall Study||148
8552155|NCT00121810|21086229|P2|Safety Population|Overall Study||153
8552156|NCT00121810|21086230|P1|Safety Population|Overall Study||148
8552157|NCT00121810|21086229|P2|STARTED|Overall Study||154
8552158|NCT00121810|21086230|P1|STARTED|Overall Study||151
8552159|NCT00121719|21086256|P14|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552160|NCT00121719|21086257|P13|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552161|NCT00121719|21086258|P12|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552162|NCT00121719|21086259|P11|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552163|NCT00121719|21086260|P10|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552164|NCT00121719|21086261|P9|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552165|NCT00121719|21086262|P8|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552166|NCT00121719|21086263|P7|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552167|NCT00121719|21086264|P6|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552168|NCT00121719|21086265|P5|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552169|NCT00121719|21086266|P4|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552170|NCT00121719|21086267|P3|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552171|NCT00121719|21086268|P2|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552172|NCT00121719|21086269|P1|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552173|NCT00121719|21086256|P14|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552174|NCT00121719|21086257|P13|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552175|NCT00121719|21086258|P12|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
8552176|NCT00121719|21086259|P11|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
8552177|NCT00121719|21086260|P10|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552178|NCT00121719|21086261|P9|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552179|NCT00121719|21086262|P8|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552180|NCT00121719|21086263|P7|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552181|NCT00121719|21086264|P6|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552182|NCT00121719|21086265|P5|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552183|NCT00121719|21086266|P4|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552184|NCT00121719|21086267|P3|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552185|NCT00121719|21086268|P2|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552186|NCT00121719|21086269|P1|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552187|NCT00121719|21086256|P14|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552188|NCT00121719|21086257|P13|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552189|NCT00121719|21086258|P12|STARTED|Food-Effect Pilot Study (4 Weeks)||5
8552190|NCT00121719|21086259|P11|STARTED|Food-Effect Pilot Study (4 Weeks)||6
8552191|NCT00121719|21086260|P10|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552192|NCT00121719|21086261|P9|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552193|NCT00121719|21086262|P8|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552194|NCT00121719|21086263|P7|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552195|NCT00121719|21086264|P6|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552196|NCT00121719|21086265|P5|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552197|NCT00121719|21086266|P4|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552198|NCT00121719|21086267|P3|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552199|NCT00121719|21086268|P2|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552200|NCT00121719|21086269|P1|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552201|NCT00121719|21086256|P14|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552202|NCT00121719|21086257|P13|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552203|NCT00121719|21086258|P12|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552204|NCT00121719|21086259|P11|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552205|NCT00121719|21086260|P10|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552206|NCT00121719|21086261|P9|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552207|NCT00121719|21086262|P8|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552208|NCT00121719|21086263|P7|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552209|NCT00121719|21086264|P6|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552210|NCT00121719|21086265|P5|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552211|NCT00121719|21086266|P4|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552212|NCT00121719|21086267|P3|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552213|NCT00121719|21086268|P2|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552214|NCT00121719|21086269|P1|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552215|NCT00121719|21086256|P14|COMPLETED|Dose Escalation (4 Weeks)||7
8552216|NCT00121719|21086257|P13|COMPLETED|Dose Escalation (4 Weeks)||24
8552217|NCT00121719|21086258|P12|COMPLETED|Dose Escalation (4 Weeks)||0
8552218|NCT00121719|21086259|P11|COMPLETED|Dose Escalation (4 Weeks)||0
8552219|NCT00121719|21086260|P10|COMPLETED|Dose Escalation (4 Weeks)||3
8552220|NCT00121719|21086261|P9|COMPLETED|Dose Escalation (4 Weeks)||6
8552221|NCT00121719|21086262|P8|COMPLETED|Dose Escalation (4 Weeks)||9
8552222|NCT00121719|21086263|P7|COMPLETED|Dose Escalation (4 Weeks)||12
8552223|NCT00121719|21086264|P6|COMPLETED|Dose Escalation (4 Weeks)||3
8552224|NCT00121719|21086265|P5|COMPLETED|Dose Escalation (4 Weeks)||3
8552225|NCT00121719|21086266|P4|COMPLETED|Dose Escalation (4 Weeks)||3
8552226|NCT00121719|21086267|P3|COMPLETED|Dose Escalation (4 Weeks)||4
8552227|NCT00121719|21086268|P2|COMPLETED|Dose Escalation (4 Weeks)||4
8552228|NCT00121719|21086269|P1|COMPLETED|Dose Escalation (4 Weeks)||4
8552229|NCT00121719|21086256|P14|STARTED|Dose Escalation (4 Weeks)||7
8552230|NCT00121719|21086257|P13|STARTED|Dose Escalation (4 Weeks)||24
8552231|NCT00121719|21086258|P12|STARTED|Dose Escalation (4 Weeks)||0
8552232|NCT00121719|21086259|P11|STARTED|Dose Escalation (4 Weeks)||0
8552233|NCT00121719|21086260|P10|STARTED|Dose Escalation (4 Weeks)||3
8552234|NCT00121719|21086261|P9|STARTED|Dose Escalation (4 Weeks)||6
8552235|NCT00121719|21086262|P8|STARTED|Dose Escalation (4 Weeks)||9
8552236|NCT00121719|21086263|P7|STARTED|Dose Escalation (4 Weeks)||12
8552237|NCT00121719|21086264|P6|STARTED|Dose Escalation (4 Weeks)||3
8552238|NCT00121719|21086265|P5|STARTED|Dose Escalation (4 Weeks)||3
8552239|NCT00121719|21086266|P4|STARTED|Dose Escalation (4 Weeks)||3
8552240|NCT00121719|21086267|P3|STARTED|Dose Escalation (4 Weeks)||4
8552241|NCT00121719|21086268|P2|STARTED|Dose Escalation (4 Weeks)||4
8552242|NCT00121719|21086269|P1|STARTED|Dose Escalation (4 Weeks)||4
8552243|NCT00121667|21086460|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
8552244|NCT00121667|21086461|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
8552245|NCT00121667|21086462|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
8552246|NCT00121667|21086463|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
8552247|NCT00121667|21086460|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
8552248|NCT00121667|21086461|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
8552249|NCT00121667|21086462|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
8552250|NCT00121667|21086463|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
8552251|NCT00121667|21086460|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
8552252|NCT00121667|21086461|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
8552253|NCT00121667|21086462|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
8552254|NCT00121667|21086463|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
8552255|NCT00121667|21086460|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
8552256|NCT00121667|21086461|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
8552257|NCT00121667|21086462|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
8552258|NCT00121667|21086463|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
8552259|NCT00121667|21086460|P4|NOT COMPLETED|Short Term (ST) Period||67
8552260|NCT00121667|21086461|P3|NOT COMPLETED|Short Term (ST) Period||41
8552261|NCT00121667|21086462|P2|NOT COMPLETED|Short Term (ST) Period||48
8552262|NCT00121667|21086463|P1|NOT COMPLETED|Short Term (ST) Period||44
8552263|NCT00121667|21086460|P4|COMPLETED|Short Term (ST) Period||112
8552264|NCT00121667|21086461|P3|COMPLETED|Short Term (ST) Period||140
8552265|NCT00121667|21086462|P2|COMPLETED|Short Term (ST) Period||143
8552266|NCT00121667|21086463|P1|COMPLETED|Short Term (ST) Period||148
8552267|NCT00121667|21086460|P4|STARTED|Short Term (ST) Period||179
8552268|NCT00121667|21086461|P3|STARTED|Short Term (ST) Period||181
8552269|NCT00121667|21086462|P2|STARTED|Short Term (ST) Period||191
8552270|NCT00121667|21086463|P1|STARTED|Short Term (ST) Period||192
8552271|NCT00121641|21086561|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
8552272|NCT00121641|21086562|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
8552273|NCT00121641|21086563|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
8552274|NCT00121641|21086564|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
8552275|NCT00121641|21086565|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
8552276|NCT00121641|21086561|P5|COMPLETED|48-month Short Term + Long Term Period||8
8552277|NCT00121641|21086562|P4|COMPLETED|48-month Short Term + Long Term Period||24
8552278|NCT00121641|21086563|P3|COMPLETED|48-month Short Term + Long Term Period||28
8552279|NCT00121641|21086564|P2|COMPLETED|48-month Short Term + Long Term Period||24
8552280|NCT00121641|21086565|P1|COMPLETED|48-month Short Term + Long Term Period||23
8552281|NCT00121641|21086561|P5|STARTED|48-month Short Term + Long Term Period||66
8552282|NCT00121641|21086562|P4|STARTED|48-month Short Term + Long Term Period||95
8552283|NCT00121641|21086563|P3|STARTED|48-month Short Term + Long Term Period||98
8552284|NCT00121641|21086564|P2|STARTED|48-month Short Term + Long Term Period||106
8552285|NCT00121641|21086565|P1|STARTED|48-month Short Term + Long Term Period||102
8552286|NCT00121641|21086561|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
8552287|NCT00121641|21086562|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
8552288|NCT00121641|21086563|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
8552289|NCT00121641|21086564|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
8552290|NCT00121641|21086565|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
8552291|NCT00121641|21086561|P5|COMPLETED|24-week Short-term Treatment Period||25
8552292|NCT00121641|21086562|P4|COMPLETED|24-week Short-term Treatment Period||55
8552293|NCT00121641|21086563|P3|COMPLETED|24-week Short-term Treatment Period||69
8552294|NCT00121641|21086564|P2|COMPLETED|24-week Short-term Treatment Period||68
8552295|NCT00121641|21086565|P1|COMPLETED|24-week Short-term Treatment Period||73
8552296|NCT00121641|21086561|P5|STARTED|24-week Short-term Treatment Period||66
8552297|NCT00121641|21086562|P4|STARTED|24-week Short-term Treatment Period||95
8552298|NCT00121641|21086563|P3|STARTED|24-week Short-term Treatment Period||98
8552299|NCT00121641|21086564|P2|STARTED|24-week Short-term Treatment Period||106
8552300|NCT00121641|21086565|P1|STARTED|24-week Short-term Treatment Period||102
8552301|NCT00121485|21086678|P2|NOT COMPLETED|Overall Study||7
8552302|NCT00121485|21086679|P1|NOT COMPLETED|Overall Study||1
8552303|NCT00121485|21086678|P2|COMPLETED|Overall Study||59
8552304|NCT00121485|21086679|P1|COMPLETED|Overall Study||133
8552305|NCT00121485|21086678|P2|STARTED|Overall Study||66
8552306|NCT00121485|21086679|P1|STARTED|Overall Study||134
8552307|NCT00121472|21086713|P1|NOT COMPLETED|Overall Study||0
8552308|NCT00121472|21086713|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
8552309|NCT00121472|21086713|P1|STARTED|Overall Study||194
8552310|NCT00121238|21086724|P1|NOT COMPLETED|Overall Study||3
8552311|NCT00121238|21086724|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
8552312|NCT00121238|21086724|P1|STARTED|Overall Study||16
8552313|NCT00121225|21086732|P1|NOT COMPLETED|Overall Study||0
8552314|NCT00121225|21086732|P1|COMPLETED|Overall Study||32
8552315|NCT00121225|21086732|P1|STARTED|Overall Study||32
8552316|NCT00121199|21086740|P1|NOT COMPLETED|Overall Study||28
8552317|NCT00121199|21086740|P1|COMPLETED|Overall Study||45
8552318|NCT00121199|21086740|P1|Eligible and Began Protocol Therapy|Overall Study||64
8552319|NCT00121199|21086740|P1|Eligible|Overall Study||64
8552320|NCT00121199|21086740|P1|STARTED|Overall Study||73
8552321|NCT00121186|21086747|P1|NOT COMPLETED|Overall Study||0
8552322|NCT00121186|21086747|P1|COMPLETED|Overall Study||1
8552323|NCT00121186|21086747|P1|STARTED|Overall Study||1
8552324|NCT00121173|21086755|P3|NOT COMPLETED|Overall Study||0
8552325|NCT00121173|21086756|P2|NOT COMPLETED|Overall Study||0
8552326|NCT00121173|21086757|P1|NOT COMPLETED|Overall Study||1
8552327|NCT00121173|21086755|P3|COMPLETED|Overall Study||9
8552328|NCT00121173|21086756|P2|COMPLETED|Overall Study||3
8552329|NCT00121173|21086757|P1|COMPLETED|Overall Study||3
8552330|NCT00121173|21086755|P3|STARTED|Overall Study||9
8552331|NCT00121173|21086756|P2|STARTED|Overall Study||3
8552332|NCT00121173|21086757|P1|STARTED|Overall Study||4
8552333|NCT00121134|21086784|P4|NOT COMPLETED|Overall Study||9
8552334|NCT00121134|21086785|P3|NOT COMPLETED|Overall Study||21
8552335|NCT00121134|21086786|P2|NOT COMPLETED|Overall Study||15
8552336|NCT00121134|21086787|P1|NOT COMPLETED|Overall Study||16
8552337|NCT00121134|21086784|P4|COMPLETED|Overall Study||31
8552338|NCT00121134|21086785|P3|COMPLETED|Overall Study||20
8552339|NCT00121134|21086786|P2|COMPLETED|Overall Study||26
8552340|NCT00121134|21086787|P1|COMPLETED|Overall Study||24
8552341|NCT00121134|21086784|P4|STARTED|Overall Study||40
8552342|NCT00121134|21086785|P3|STARTED|Overall Study||41
8552343|NCT00121134|21086786|P2|STARTED|Overall Study||41
8552344|NCT00121134|21086787|P1|STARTED|Overall Study||40
8552345|NCT00120874|21086799|P2|NOT COMPLETED|Overall Study||1
8552346|NCT00120874|21086800|P1|NOT COMPLETED|Overall Study||0
8552347|NCT00120874|21086799|P2|COMPLETED|Overall Study||9
8552348|NCT00120874|21086800|P1|COMPLETED|Overall Study||10
8552349|NCT00120874|21086799|P2|Completed Study; Started Extension Study|Overall Study||10
8552350|NCT00120874|21086800|P1|Completed Study; Started Extension Study|Overall Study||10
8552351|NCT00120874|21086799|P2|STARTED|Overall Study||10
8552352|NCT00120874|21086800|P1|STARTED|Overall Study||10
8552353|NCT00120627|21086838|P2|NOT COMPLETED|Overall Study||5
8552354|NCT00120627|21086839|P1|NOT COMPLETED|Overall Study||5
8552355|NCT00120627|21086838|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
8552356|NCT00120627|21086839|P1|COMPLETED|Overall Study||66
8552357|NCT00120627|21086838|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
8552358|NCT00120627|21086839|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
8552359|NCT00120627|21086838|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
8552360|NCT00120627|21086839|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
8552361|NCT00120627|21086838|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
8552450|NCT00119158|21087049|P2|COMPLETED|Placebo Treatment||45
8552362|NCT00120627|21086839|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
8552363|NCT00120523|21086865|P2|NOT COMPLETED|Follow-Up Period||24
8552364|NCT00120523|21086866|P1|NOT COMPLETED|Follow-Up Period||30
8552365|NCT00120523|21086865|P2|COMPLETED|Follow-Up Period||46
8552366|NCT00120523|21086866|P1|COMPLETED|Follow-Up Period||90
8552367|NCT00120523|21086865|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
8552368|NCT00120523|21086866|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
8552369|NCT00120523|21086865|P2|NOT COMPLETED|Treatment Period||339
8552370|NCT00120523|21086866|P1|NOT COMPLETED|Treatment Period||369
8552371|NCT00120523|21086865|P2|COMPLETED|Treatment Period||874
8552372|NCT00120523|21086866|P1|COMPLETED|Treatment Period||836
8552373|NCT00120523|21086865|P2|STARTED|Treatment Period||1213
8552374|NCT00120523|21086866|P1|STARTED|Treatment Period||1205
8552375|NCT00120406|21086890|P2|NOT COMPLETED|Overall Study||16
8552376|NCT00120406|21086891|P1|NOT COMPLETED|Overall Study||19
8552377|NCT00120406|21086890|P2|COMPLETED|Overall Study||222
8552378|NCT00120406|21086891|P1|COMPLETED|Overall Study||217
8552379|NCT00120406|21086890|P2|STARTED|Overall Study||238
8552380|NCT00120406|21086891|P1|STARTED|Overall Study||236
8552381|NCT00120289|21086901|P2|NOT COMPLETED|Overall Study||109
8552382|NCT00120289|21086902|P1|NOT COMPLETED|Overall Study||121
8552383|NCT00120289|21086901|P2|COMPLETED|Overall Study||1587
8552384|NCT00120289|21086902|P1|COMPLETED|Overall Study||1597
8552385|NCT00120289|21086901|P2|STARTED|Overall Study||1696
8552386|NCT00120289|21086902|P1|STARTED|Overall Study||1718
8552387|NCT00120250|21086914|P2|NOT COMPLETED|Overall Study||2
8552388|NCT00120250|21086915|P1|NOT COMPLETED|Overall Study||1
8552389|NCT00120250|21086914|P2|COMPLETED|Overall Study||12
8552390|NCT00120250|21086915|P1|COMPLETED|Overall Study||12
8552391|NCT00120250|21086914|P2|STARTED|Overall Study||14
8552392|NCT00120250|21086915|P1|STARTED|Overall Study||13
8552393|NCT00120042|21086931|P3|NOT COMPLETED|Overall Study||0
8552394|NCT00120042|21086932|P2|NOT COMPLETED|Overall Study||0
8552395|NCT00120042|21086933|P1|NOT COMPLETED|Overall Study||0
8552396|NCT00120042|21086931|P3|COMPLETED|Overall Study||83
8552397|NCT00120042|21086932|P2|COMPLETED|Overall Study||83
8552398|NCT00120042|21086933|P1|COMPLETED|Overall Study||85
8552399|NCT00120042|21086931|P3|STARTED|Overall Study||83
8552400|NCT00120042|21086932|P2|STARTED|Overall Study||83
8552401|NCT00120042|21086933|P1|STARTED|Overall Study||85
8552402|NCT00119847|21086943|P2|NOT COMPLETED|Overall Study||32
8552403|NCT00119847|21086944|P1|NOT COMPLETED|Overall Study||31
8552404|NCT00119847|21086943|P2|COMPLETED|Overall Study||119
8552405|NCT00119847|21086944|P1|COMPLETED|Overall Study||118
8552406|NCT00119847|21086943|P2|STARTED|Overall Study||151
8552407|NCT00119847|21086944|P1|STARTED|Overall Study||149
8552408|NCT00119678|21086956|P2|NOT COMPLETED|Open-label Treatment Period||0
8552409|NCT00119678|21086957|P1|NOT COMPLETED|Open-label Treatment Period||110
8552410|NCT00119678|21086956|P2|COMPLETED|Open-label Treatment Period||0
8552411|NCT00119678|21086957|P1|COMPLETED|Open-label Treatment Period||0
8552412|NCT00119678|21086956|P2|STARTED|Open-label Treatment Period||0
8552413|NCT00119678|21086957|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
8552414|NCT00119678|21086956|P2|NOT COMPLETED|Double-blind Treatment Period||26
8552415|NCT00119678|21086957|P1|NOT COMPLETED|Double-blind Treatment Period||41
8552416|NCT00119678|21086956|P2|COMPLETED|Double-blind Treatment Period||35
8552417|NCT00119678|21086957|P1|COMPLETED|Double-blind Treatment Period||81
8552418|NCT00119678|21086956|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
8552419|NCT00119678|21086957|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
8552420|NCT00119678|21086956|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
8552421|NCT00119678|21086957|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
8552422|NCT00119678|21086956|P2|STARTED|Double-blind Treatment Period||61
8552423|NCT00119678|21086957|P1|STARTED|Double-blind Treatment Period||122
8552424|NCT00119405|21087003|P1|NOT COMPLETED|Overall Study||1
8552425|NCT00119405|21087003|P1|COMPLETED|Overall Study||17
8552426|NCT00119405|21087003|P1|STARTED|Overall Study||18
8552427|NCT00119392|21087007|P1|NOT COMPLETED|Overall Study||5
8552428|NCT00119392|21087007|P1|COMPLETED|Overall Study||40
8552429|NCT00119392|21087007|P1|STARTED|Overall Study||45
8552430|NCT00119379|21087017|P2|NOT COMPLETED|Overall Study||1
8552431|NCT00119379|21087018|P1|NOT COMPLETED|Overall Study||4
8552432|NCT00119379|21087017|P2|COMPLETED|Overall Study||23
8552433|NCT00119379|21087018|P1|COMPLETED|Overall Study||22
8552434|NCT00119379|21087017|P2|STARTED|Overall Study||24
8552435|NCT00119379|21087018|P1|STARTED|Overall Study||26
8552436|NCT00119262|21087036|P2|NOT COMPLETED|Overall Study||58
8552437|NCT00119262|21087037|P1|NOT COMPLETED|Overall Study||46
8552438|NCT00119262|21087036|P2|COMPLETED|Overall Study||64
8552439|NCT00119262|21087037|P1|COMPLETED|Overall Study||58
8552440|NCT00119262|21087036|P2|Eligible and Treated|Overall Study||119
8552441|NCT00119262|21087037|P1|Eligible and Treated|Overall Study||102
8552442|NCT00119262|21087036|P2|Treated|Overall Study||120
8552443|NCT00119262|21087037|P1|Treated|Overall Study||103
8552444|NCT00119262|21087036|P2|Eligible|Overall Study||120
8552445|NCT00119262|21087037|P1|Eligible|Overall Study||103
8552446|NCT00119262|21087036|P2|STARTED|Overall Study||122
8552447|NCT00119262|21087037|P1|STARTED|Overall Study||104
8552448|NCT00119158|21087049|P2|NOT COMPLETED|Placebo Treatment||0
8552449|NCT00119158|21087050|P1|NOT COMPLETED|Placebo Treatment||0
8552451|NCT00119158|21087050|P1|COMPLETED|Placebo Treatment||45
8552452|NCT00119158|21087049|P2|STARTED|Placebo Treatment||45
8552453|NCT00119158|21087050|P1|STARTED|Placebo Treatment||45
8552454|NCT00119158|21087049|P2|NOT COMPLETED|Active Treatment||0
8552455|NCT00119158|21087050|P1|NOT COMPLETED|Active Treatment||0
8552456|NCT00119158|21087049|P2|COMPLETED|Active Treatment||45
8552457|NCT00119158|21087050|P1|COMPLETED|Active Treatment||45
8552458|NCT00119158|21087049|P2|STARTED|Active Treatment||45
8552459|NCT00119158|21087050|P1|STARTED|Active Treatment|patients are self controls|45
8552466|NCT00119041|21087084|P3|NOT COMPLETED|Overall Study||0
8552467|NCT00119041|21087085|P2|NOT COMPLETED|Overall Study||0
8552468|NCT00119041|21087086|P1|NOT COMPLETED|Overall Study||0
8552469|NCT00119041|21087084|P3|COMPLETED|Overall Study||22
8552470|NCT00119041|21087085|P2|COMPLETED|Overall Study||83
8552471|NCT00119041|21087086|P1|COMPLETED|Overall Study||199
8552472|NCT00119041|21087084|P3|STARTED|Overall Study||22
8552473|NCT00119041|21087085|P2|STARTED|Overall Study||83
8552474|NCT00119041|21087086|P1|STARTED|Overall Study||199
8552475|NCT00119015|21087097|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552476|NCT00119015|21087098|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552477|NCT00119015|21087099|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552478|NCT00119015|21087097|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
8552479|NCT00119015|21087098|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
8552480|NCT00119015|21087099|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552481|NCT00119015|21087097|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
8552482|NCT00119015|21087098|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
8552483|NCT00119015|21087099|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
8552484|NCT00119015|21087097|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
8552485|NCT00119015|21087098|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
8552486|NCT00119015|21087099|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
8552487|NCT00119015|21087097|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
8552488|NCT00119015|21087098|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
8552489|NCT00119015|21087099|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
8552490|NCT00119015|21087097|P3|STARTED|Open-Label Phase (2 Weeks)||0
8552491|NCT00119015|21087098|P2|STARTED|Open-Label Phase (2 Weeks)||0
8552492|NCT00119015|21087099|P1|STARTED|Open-Label Phase (2 Weeks)||102
8552493|NCT00118911|21087115|P2|NOT COMPLETED|Overall Study||5
8552494|NCT00118911|21087116|P1|NOT COMPLETED|Overall Study||2
8552495|NCT00118911|21087115|P2|COMPLETED|Overall Study||38
8552496|NCT00118911|21087116|P1|COMPLETED|Overall Study||41
8552497|NCT00118911|21087115|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
8552498|NCT00118911|21087116|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
8552499|NCT00118911|21087115|P2|6 Month Follow-up|Overall Study||30
8552500|NCT00118911|21087116|P1|6 Month Follow-up|Overall Study||37
8552501|NCT00118911|21087115|P2|Completed Post-Treatment Assessment|Overall Study||37
8552502|NCT00118911|21087116|P1|Completed Post-Treatment Assessment|Overall Study||41
8552503|NCT00118911|21087115|P2|Received Intervention as Assigned|Overall Study||38
8552504|NCT00118911|21087116|P1|Received Intervention as Assigned|Overall Study||41
8552505|NCT00118911|21087115|P2|STARTED|Overall Study||43
8552506|NCT00118911|21087116|P1|STARTED|Overall Study||43
8552507|NCT00118898|21087128|P4|NOT COMPLETED|Overall Study||141
8552508|NCT00118898|21087129|P3|NOT COMPLETED|Overall Study||123
8552509|NCT00118898|21087130|P2|NOT COMPLETED|Overall Study||141
8552510|NCT00118898|21087131|P1|NOT COMPLETED|Overall Study||121
8552511|NCT00118898|21087128|P4|COMPLETED|Overall Study||322
8552512|NCT00118898|21087129|P3|COMPLETED|Overall Study||342
8552513|NCT00118898|21087130|P2|COMPLETED|Overall Study||324
8552514|NCT00118898|21087131|P1|COMPLETED|Overall Study||343
8552515|NCT00118898|21087128|P4|Initiated Treatment|Overall Study||462
8552516|NCT00118898|21087129|P3|Initiated Treatment|Overall Study||464
8552517|NCT00118898|21087130|P2|Initiated Treatment|Overall Study||461
8552518|NCT00118898|21087131|P1|Initiated Treatment|Overall Study||461
8552519|NCT00118898|21087128|P4|STARTED|Overall Study||463
8552520|NCT00118898|21087129|P3|STARTED|Overall Study||465
8552521|NCT00118898|21087130|P2|STARTED|Overall Study||465
8552522|NCT00118898|21087131|P1|STARTED|Overall Study||464
8552523|NCT00118755|21087227|P2|NOT COMPLETED|Overall Study||215
8552524|NCT00118755|21087228|P1|NOT COMPLETED|Overall Study||210
8552525|NCT00118755|21087227|P2|COMPLETED|Overall Study||3
8552526|NCT00118755|21087228|P1|COMPLETED|Overall Study||7
8552527|NCT00118755|21087227|P2|Safety Population|Overall Study||211
8552528|NCT00118755|21087228|P1|Safety Population|Overall Study||208
8552529|NCT00118755|21087227|P2|STARTED|Overall Study||218
8552530|NCT00118755|21087228|P1|STARTED|Overall Study||217
8552531|NCT00118742|21087242|P2|NOT COMPLETED|Overall Study||66
8552532|NCT00118742|21087243|P1|NOT COMPLETED|Overall Study||49
8552533|NCT00118742|21087242|P2|COMPLETED|Overall Study||82
8552534|NCT00118742|21087243|P1|COMPLETED|Overall Study||96
8552535|NCT00118742|21087242|P2|STARTED|Overall Study||148
8552536|NCT00118742|21087243|P1|STARTED|Overall Study||145
8552537|NCT00118716|21087257|P2|NOT COMPLETED|Overall Study||22
8552538|NCT00118716|21087258|P1|NOT COMPLETED|Overall Study||13
8552539|NCT00118716|21087257|P2|COMPLETED|Overall Study||102
8552540|NCT00118716|21087258|P1|COMPLETED|Overall Study||111
8552541|NCT00118716|21087257|P2|STARTED|Overall Study||124
8552542|NCT00118716|21087258|P1|STARTED|Overall Study||124
8552543|NCT00118703|21087278|P2|NOT COMPLETED|Overall Study||9
8552544|NCT00118703|21087279|P1|NOT COMPLETED|Overall Study||5
8552545|NCT00118703|21087278|P2|COMPLETED|Overall Study||165
8552546|NCT00118703|21087279|P1|COMPLETED|Overall Study||168
8552547|NCT00118703|21087278|P2|STARTED|Overall Study||174
8552548|NCT00118703|21087279|P1|STARTED|Overall Study||173
8552549|NCT00118534|21087291|P2|NOT COMPLETED|Overall Study||0
8552550|NCT00118534|21087292|P1|NOT COMPLETED|Overall Study||0
8552551|NCT00118534|21087291|P2|COMPLETED|Overall Study||471
8552552|NCT00118534|21087292|P1|COMPLETED|Overall Study||472
8552553|NCT00118534|21087291|P2|STARTED|Overall Study||471
8552554|NCT00118534|21087292|P1|STARTED|Overall Study||472
8552555|NCT00118482|21087376|P2|NOT COMPLETED|Overall Study||29
8552556|NCT00118482|21087377|P1|NOT COMPLETED|Overall Study||30
8552557|NCT00118482|21087376|P2|COMPLETED|Overall Study||76
8552558|NCT00118482|21087377|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
8552559|NCT00118482|21087376|P2|STARTED|Overall Study||105
8552560|NCT00118482|21087377|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
8552561|NCT00118430|21087392|P3|NOT COMPLETED|Overall Study||28
8552562|NCT00118430|21087393|P2|NOT COMPLETED|Overall Study||24
8552563|NCT00118430|21087394|P1|NOT COMPLETED|Overall Study||21
8552564|NCT00118430|21087392|P3|COMPLETED|Overall Study||222
8552565|NCT00118430|21087393|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
8552566|NCT00118430|21087394|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
8552567|NCT00118430|21087392|P3|STARTED|Overall Study||250
8552568|NCT00118430|21087393|P2|STARTED|Overall Study||127
8552569|NCT00118430|21087394|P1|STARTED|Overall Study||123
8552570|NCT00118417|21087409|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
8552571|NCT00118417|21087410|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
8552572|NCT00118417|21087409|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
8552573|NCT00118417|21087410|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
8552574|NCT00118417|21087409|P2|STARTED|Phase III (Weeks 12 to 24)||10
8552575|NCT00118417|21087410|P1|STARTED|Phase III (Weeks 12 to 24)||9
8552576|NCT00118417|21087409|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
8552577|NCT00118417|21087410|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
8552578|NCT00118417|21087409|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
8552579|NCT00118417|21087410|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
8552580|NCT00118417|21087409|P2|STARTED|Phase II (Weeks 6 to 12)||13
8552581|NCT00118417|21087410|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
8552582|NCT00118417|21087409|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
8552583|NCT00118417|21087410|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
8552584|NCT00118417|21087409|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
8552585|NCT00118417|21087410|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
8552586|NCT00118417|21087409|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
8552587|NCT00118417|21087410|P1|STARTED|Phase I (Weeks 0 to 6)||39
8552588|NCT00118404|21087423|P3|NOT COMPLETED|Overall Study||20
8552589|NCT00118404|21087424|P2|NOT COMPLETED|Overall Study||16
8552590|NCT00118404|21087425|P1|NOT COMPLETED|Overall Study||24
8552591|NCT00118404|21087423|P3|COMPLETED|Overall Study||49
8552592|NCT00118404|21087424|P2|COMPLETED|Overall Study||70
8552593|NCT00118404|21087425|P1|COMPLETED|Overall Study||62
8552594|NCT00118404|21087423|P3|STARTED|Overall Study||69
8552595|NCT00118404|21087424|P2|STARTED|Overall Study||86
8552596|NCT00118404|21087425|P1|STARTED|Overall Study||86
8552597|NCT00118378|21087441|P2|NOT COMPLETED|Overall Study||8
8552598|NCT00118378|21087442|P1|NOT COMPLETED|Overall Study||2
8552599|NCT00118378|21087441|P2|COMPLETED|Overall Study||45
8552600|NCT00118378|21087442|P1|COMPLETED|Overall Study||60
8552601|NCT00118378|21087441|P2|STARTED|Overall Study||53
8552602|NCT00118378|21087442|P1|STARTED|Overall Study||62
8552603|NCT00118365|21087456|P2|NOT COMPLETED|Overall Study||60
8552604|NCT00118365|21087457|P1|NOT COMPLETED|Overall Study||59
8552605|NCT00118365|21087456|P2|COMPLETED|Overall Study||124
8552606|NCT00118365|21087457|P1|COMPLETED|Overall Study||132
8552607|NCT00118365|21087456|P2|STARTED|Overall Study||184
8552608|NCT00118365|21087457|P1|STARTED|Overall Study||191
8552609|NCT00118352|21087526|P3|NOT COMPLETED|Overall Study||0
8552610|NCT00118352|21087527|P2|NOT COMPLETED|Overall Study||0
8552611|NCT00118352|21087528|P1|NOT COMPLETED|Overall Study||0
8552612|NCT00118352|21087526|P3|COMPLETED|Overall Study||0
8552613|NCT00118352|21087527|P2|COMPLETED|Overall Study||0
8552614|NCT00118352|21087528|P1|COMPLETED|Overall Study||12
8552615|NCT00118352|21087526|P3|STARTED|Overall Study||0
8552616|NCT00118352|21087527|P2|STARTED|Overall Study||0
8552617|NCT00118352|21087528|P1|STARTED|Overall Study||12
8552618|NCT00118287|21087554|P1|NOT COMPLETED|Overall Study||2
8552619|NCT00118287|21087554|P1|COMPLETED|Overall Study||30
8552620|NCT00118287|21087554|P1|STARTED|Overall Study||32
8552621|NCT00118248|21087560|P2|NOT COMPLETED|Overall Study||0
8552622|NCT00118248|21087561|P1|NOT COMPLETED|Overall Study||0
8552623|NCT00118248|21087560|P2|COMPLETED|Overall Study||24
8552624|NCT00118248|21087561|P1|COMPLETED|Overall Study||17
8552625|NCT00118248|21087560|P2|STARTED|Overall Study||24
8552626|NCT00118248|21087561|P1|STARTED|Overall Study||17
8552627|NCT00118209|21087576|P2|NOT COMPLETED|Overall Study||21
8552628|NCT00118209|21087577|P1|NOT COMPLETED|Overall Study||12
8552629|NCT00118209|21087576|P2|COMPLETED|Overall Study||241
8552630|NCT00118209|21087577|P1|COMPLETED|Overall Study||250
8552631|NCT00118209|21087576|P2|Evaluable for Safety Analysis|Overall Study||237
8552632|NCT00118209|21087577|P1|Evaluable for Safety Analysis|Overall Study||243
8552633|NCT00118209|21087576|P2|Evaluable for Primary Endpoint|Overall Study||241
8552634|NCT00118209|21087577|P1|Evaluable for Primary Endpoint|Overall Study||250
8552635|NCT00118209|21087576|P2|STARTED|Overall Study||262
8552636|NCT00118209|21087577|P1|STARTED|Overall Study||262
8552637|NCT00118157|21087587|P1|NOT COMPLETED|Overall Study||12
8552638|NCT00118157|21087587|P1|COMPLETED|Overall Study||7
8552639|NCT00118157|21087587|P1|STARTED|Overall Study||19
8552640|NCT00118144|21087592|P1|NOT COMPLETED|Overall Study||1
8552641|NCT00118144|21087592|P1|COMPLETED|Overall Study||41
8552642|NCT00118144|21087592|P1|STARTED|Overall Study||42
8552643|NCT00118131|21087598|P1|NOT COMPLETED|Overall Study||0
8552644|NCT00118131|21087598|P1|COMPLETED|Overall Study||49
8552645|NCT00118131|21087598|P1|STARTED|Overall Study||49
8552646|NCT00118092|21087605|P1|NOT COMPLETED|Overall Study||2
8552647|NCT00118092|21087605|P1|COMPLETED|Overall Study||15
8552648|NCT00118092|21087605|P1|STARTED|Overall Study||17
8552649|NCT00118053|21087613|P1|NOT COMPLETED|Overall Study||0
8552650|NCT00118053|21087613|P1|COMPLETED|Overall Study||5
8552651|NCT00118053|21087613|P1|STARTED|Overall Study||5
8552652|NCT00118040|21087623|P3|NOT COMPLETED|Overall Study||6
8552653|NCT00118040|21087624|P2|NOT COMPLETED|Overall Study||2
8552654|NCT00118040|21087625|P1|NOT COMPLETED|Overall Study||1
8552655|NCT00118040|21087623|P3|COMPLETED|Overall Study||14
8552656|NCT00118040|21087624|P2|COMPLETED|Overall Study||18
8552657|NCT00118040|21087625|P1|COMPLETED|Overall Study||19
8552658|NCT00118040|21087623|P3|STARTED|Overall Study||20
8552659|NCT00118040|21087624|P2|STARTED|Overall Study||20
8552660|NCT00118040|21087625|P1|STARTED|Overall Study||20
8552661|NCT00117988|21087686|P1|NOT COMPLETED|Overall Study||4
8552662|NCT00117988|21087686|P1|COMPLETED|Overall Study||18
8552663|NCT00117988|21087686|P1|STARTED|Overall Study||22
8552664|NCT00117962|21087692|P2|NOT COMPLETED|Overall Study||25
8552665|NCT00117962|21087693|P1|NOT COMPLETED|Overall Study||22
8552666|NCT00117962|21087692|P2|COMPLETED|Overall Study||28
8552667|NCT00117962|21087693|P1|COMPLETED|Overall Study||26
8552668|NCT00117962|21087692|P2|STARTED|Overall Study||53
8552669|NCT00117962|21087693|P1|STARTED|Overall Study||48
8552670|NCT00117949|21087709|P4|NOT COMPLETED|Overall Study||24
8552671|NCT00117949|21087710|P3|NOT COMPLETED|Overall Study||24
8552672|NCT00117949|21087711|P2|NOT COMPLETED|Overall Study||24
8552673|NCT00117949|21087712|P1|NOT COMPLETED|Overall Study||10
8552674|NCT00117949|21087709|P4|COMPLETED|Overall Study||0
8552675|NCT00117949|21087710|P3|COMPLETED|Overall Study||0
8552676|NCT00117949|21087711|P2|COMPLETED|Overall Study||0
8552677|NCT00117949|21087712|P1|COMPLETED|Overall Study||0
8552678|NCT00117949|21087709|P4|STARTED|Overall Study||24
8552679|NCT00117949|21087710|P3|STARTED|Overall Study||24
8552680|NCT00117949|21087711|P2|STARTED|Overall Study||24
8552681|NCT00117949|21087712|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
8552682|NCT00117845|21087746|P1|NOT COMPLETED|Overall Study||1
8552683|NCT00117845|21087746|P1|COMPLETED|Overall Study||16
8552684|NCT00117845|21087746|P1|STARTED|Overall Study||17
8552685|NCT00117806|21087753|P2|NOT COMPLETED|Overall Study||16
8552686|NCT00117806|21087754|P1|NOT COMPLETED|Overall Study||38
8552687|NCT00117806|21087753|P2|COMPLETED|Overall Study||60
8552688|NCT00117806|21087754|P1|COMPLETED|Overall Study||43
8552689|NCT00117806|21087753|P2|STARTED|Overall Study||76
8552690|NCT00117806|21087754|P1|STARTED|Overall Study||81
8552691|NCT00117793|21087764|P1|NOT COMPLETED|Overall Study||12
8552692|NCT00117793|21087764|P1|COMPLETED|Overall Study||5
8552693|NCT00117793|21087764|P1|STARTED|Overall Study||17
8552694|NCT00117715|21087779|P1|NOT COMPLETED|Overall Study||72
8552695|NCT00117715|21087779|P1|COMPLETED|Overall Study||49
8552696|NCT00117715|21087779|P1|5 Year|Overall Study||49
8552697|NCT00117715|21087779|P1|4.5 Year|Overall Study||55
8552698|NCT00117715|21087779|P1|4 Year|Overall Study||58
8552699|NCT00117715|21087779|P1|3.5 Year|Overall Study||60
8552700|NCT00117715|21087779|P1|3 Year|Overall Study||61
8552701|NCT00117715|21087779|P1|2.5 Year|Overall Study||70
8552702|NCT00117715|21087779|P1|2 Year|Overall Study||76
8552703|NCT00117715|21087779|P1|1.5 Year|Overall Study||85
8552704|NCT00117715|21087779|P1|1 Year|Overall Study||88
8552705|NCT00117715|21087779|P1|STARTED|Overall Study||121
8552706|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
8552707|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
8552708|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
8552709|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
8552710|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
8552711|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 433 - 480||82
8552712|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
8552713|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
8552714|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
8552715|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
8552790|NCT00117598|21087956|P2|COMPLETED|After Treament Cross Over||0
8552716|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
8552717|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
8552718|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
8552719|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
8552720|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
8552721|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
8552722|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 337 - 384||93
8552723|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 337 - 384||183
8552724|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
8552725|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
8552726|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
8552727|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
8552728|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 289 - 336||100
8552729|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 289 - 336||192
8552730|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
8552731|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
8552732|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
8552733|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
8552734|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 241 - 288||103
8552735|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 241 - 288||202
8552736|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
8552737|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
8552738|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
8552739|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
8552740|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 193 - 240||106
8552741|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 193 - 240||209
8552742|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
8552743|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
8552744|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
8552745|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
8552746|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 145 - 192||109
8552747|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 145 - 192||219
8552748|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
8552749|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
8552750|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
8552751|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
8552752|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 97 - 144||110
8552753|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 97 - 144||225
8552754|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
8552755|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
8552756|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
8552757|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
8552758|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
8552759|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
8552760|NCT00117676|21087787|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
8552761|NCT00117676|21087788|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
8552762|NCT00117676|21087787|P2|COMPLETED|Double-blind Period Through Week 48||121
8552763|NCT00117676|21087788|P1|COMPLETED|Double-blind Period Through Week 48||244
8552764|NCT00117676|21087787|P2|STARTED|Double-blind Period Through Week 48||128
8552765|NCT00117676|21087788|P1|STARTED|Double-blind Period Through Week 48||254
8552766|NCT00117637|21087877|P2|NOT COMPLETED|Second Intervention (Period 2)||22
8552767|NCT00117637|21087878|P1|NOT COMPLETED|Second Intervention (Period 2)||10
8552768|NCT00117637|21087877|P2|COMPLETED|Second Intervention (Period 2)||39
8552769|NCT00117637|21087878|P1|COMPLETED|Second Intervention (Period 2)||39
8552770|NCT00117637|21087877|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
8552771|NCT00117637|21087878|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
8552772|NCT00117637|21087877|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
8552773|NCT00117637|21087878|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
8552774|NCT00117637|21087877|P2|NOT COMPLETED|First Intervention (Period 1)||25
8552775|NCT00117637|21087878|P1|NOT COMPLETED|First Intervention (Period 1)||18
8552776|NCT00117637|21087877|P2|COMPLETED|First Intervention (Period 1)||67
8552777|NCT00117637|21087878|P1|COMPLETED|First Intervention (Period 1)||79
8552778|NCT00117637|21087877|P2|Subjects Received Treatment|First Intervention (Period 1)||90
8552779|NCT00117637|21087878|P1|Subjects Received Treatment|First Intervention (Period 1)||97
8552780|NCT00117637|21087877|P2|STARTED|First Intervention (Period 1)||92
8552781|NCT00117637|21087878|P1|STARTED|First Intervention (Period 1)||97
8552782|NCT00117598|21087953|P5|NOT COMPLETED|After Treament Cross Over||4
8552783|NCT00117598|21087954|P4|NOT COMPLETED|After Treament Cross Over||3
8552784|NCT00117598|21087955|P3|NOT COMPLETED|After Treament Cross Over||0
8552785|NCT00117598|21087956|P2|NOT COMPLETED|After Treament Cross Over||0
8552786|NCT00117598|21087957|P1|NOT COMPLETED|After Treament Cross Over||0
8552787|NCT00117598|21087953|P5|COMPLETED|After Treament Cross Over||0
8552788|NCT00117598|21087954|P4|COMPLETED|After Treament Cross Over||0
8552789|NCT00117598|21087955|P3|COMPLETED|After Treament Cross Over||0
8552791|NCT00117598|21087957|P1|COMPLETED|After Treament Cross Over||0
8552792|NCT00117598|21087953|P5|STARTED|After Treament Cross Over||4
8552793|NCT00117598|21087954|P4|STARTED|After Treament Cross Over||3
8552794|NCT00117598|21087955|P3|STARTED|After Treament Cross Over||0
8552795|NCT00117598|21087956|P2|STARTED|After Treament Cross Over||0
8552796|NCT00117598|21087957|P1|STARTED|After Treament Cross Over||0
8552797|NCT00117598|21087953|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
8552798|NCT00117598|21087954|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
8552799|NCT00117598|21087955|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
8552800|NCT00117598|21087956|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
8552801|NCT00117598|21087957|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
8552802|NCT00117598|21087953|P5|COMPLETED|Prior to Treatment Cross Over||0
8552803|NCT00117598|21087954|P4|COMPLETED|Prior to Treatment Cross Over||0
8552804|NCT00117598|21087955|P3|COMPLETED|Prior to Treatment Cross Over||4
8552805|NCT00117598|21087956|P2|COMPLETED|Prior to Treatment Cross Over||3
8552806|NCT00117598|21087957|P1|COMPLETED|Prior to Treatment Cross Over||0
8552807|NCT00117598|21087953|P5|STARTED|Prior to Treatment Cross Over||0
8552808|NCT00117598|21087954|P4|STARTED|Prior to Treatment Cross Over||0
8552809|NCT00117598|21087955|P3|STARTED|Prior to Treatment Cross Over||56
8552810|NCT00117598|21087956|P2|STARTED|Prior to Treatment Cross Over||56
8552811|NCT00117598|21087957|P1|STARTED|Prior to Treatment Cross Over||57
8552812|NCT00117585|21087985|P1|NOT COMPLETED|Overall Study||0
8552813|NCT00117585|21087985|P1|COMPLETED|Overall Study||341
8552814|NCT00117585|21087985|P1|STARTED|Overall Study||341
8552815|NCT00117572|21087991|P2|NOT COMPLETED|Overall Study||6
8552816|NCT00117572|21087992|P1|NOT COMPLETED|Overall Study||6
8552817|NCT00117572|21087991|P2|COMPLETED|Overall Study||135
8552818|NCT00117572|21087992|P1|COMPLETED|Overall Study||138
8552819|NCT00117572|21087991|P2|STARTED|Overall Study||141
8552820|NCT00117572|21087992|P1|STARTED|Overall Study||144
8552821|NCT00117559|21088024|P2|NOT COMPLETED|Overall Study||1
8552822|NCT00117559|21088025|P1|NOT COMPLETED|Overall Study||1
8552823|NCT00117559|21088024|P2|COMPLETED|Overall Study||9
8552824|NCT00117559|21088025|P1|COMPLETED|Overall Study||8
8552825|NCT00117559|21088024|P2|STARTED|Overall Study||10
8552826|NCT00117559|21088025|P1|STARTED|Overall Study||9
8552827|NCT00117338|21088033|P2|NOT COMPLETED|Overall Study||4
8552828|NCT00117338|21088034|P1|NOT COMPLETED|Overall Study||5
8552829|NCT00117338|21088033|P2|COMPLETED|Overall Study||127
8552830|NCT00117338|21088034|P1|COMPLETED|Overall Study||140
8552831|NCT00117338|21088033|P2|STARTED|Overall Study||131
8552832|NCT00117338|21088034|P1|STARTED|Overall Study||145
8552833|NCT00117325|21088054|P2|NOT COMPLETED|Overall Study||12
8552834|NCT00117325|21088055|P1|NOT COMPLETED|Overall Study||13
8552835|NCT00117325|21088054|P2|COMPLETED|Overall Study||167
8552836|NCT00117325|21088055|P1|COMPLETED|Overall Study||160
8552837|NCT00117325|21088054|P2|STARTED|Overall Study||179
8552838|NCT00117325|21088055|P1|STARTED|Overall Study||173
8552839|NCT00117312|21088087|P4|NOT COMPLETED|Overall Study||21
8552840|NCT00117312|21088088|P3|NOT COMPLETED|Overall Study||24
8552841|NCT00117312|21088089|P2|NOT COMPLETED|Overall Study||20
8552842|NCT00117312|21088090|P1|NOT COMPLETED|Overall Study||10
8552843|NCT00117312|21088087|P4|COMPLETED|Overall Study||3
8552844|NCT00117312|21088088|P3|COMPLETED|Overall Study||0
8552845|NCT00117312|21088089|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
8552846|NCT00117312|21088090|P1|COMPLETED|Overall Study||0
8552847|NCT00117312|21088087|P4|Started FE200486 CS06A|Overall Study||9
8552848|NCT00117312|21088088|P3|Started FE200486 CS06A|Overall Study||16
8552849|NCT00117312|21088089|P2|Started FE200486 CS06A|Overall Study||11
8552850|NCT00117312|21088090|P1|Started FE200486 CS06A|Overall Study||1
8552851|NCT00117312|21088087|P4|STARTED|Overall Study||24
8552852|NCT00117312|21088088|P3|STARTED|Overall Study||24
8552853|NCT00117312|21088089|P2|STARTED|Overall Study||24
8552854|NCT00117312|21088090|P1|STARTED|Overall Study||10
8552855|NCT00117286|21088106|P2|NOT COMPLETED|Overall Study||21
8552856|NCT00117286|21088107|P1|NOT COMPLETED|Overall Study||28
8552857|NCT00117286|21088106|P2|COMPLETED|Overall Study||6
8552858|NCT00117286|21088107|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
8552859|NCT00117286|21088106|P2|Switched to Higher Dose|Overall Study||17
8552860|NCT00117286|21088107|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
8552861|NCT00117286|21088106|P2|STARTED|Overall Study||27
8552862|NCT00117286|21088107|P1|STARTED|Overall Study|Safety analysis set|30
8552863|NCT00117156|21088115|P1|NOT COMPLETED|Overall Study||11
8552864|NCT00117156|21088115|P1|COMPLETED|Overall Study||15
8552865|NCT00117156|21088115|P1|STARTED|Overall Study||26
8552866|NCT00117143|21088127|P4|NOT COMPLETED|Overall Study||0
8552867|NCT00117143|21088128|P3|NOT COMPLETED|Overall Study||0
8552868|NCT00117143|21088129|P2|NOT COMPLETED|Overall Study||0
8552869|NCT00117143|21088130|P1|NOT COMPLETED|Overall Study||0
8552870|NCT00117143|21088127|P4|COMPLETED|Overall Study||1
8552871|NCT00117143|21088128|P3|COMPLETED|Overall Study||7
8552872|NCT00117143|21088129|P2|COMPLETED|Overall Study||4
8552873|NCT00117143|21088130|P1|COMPLETED|Overall Study||4
8552874|NCT00117143|21088127|P4|Received Second Dose|Overall Study||0
8552875|NCT00117143|21088128|P3|Received Second Dose|Overall Study||6
8552876|NCT00117143|21088129|P2|Received Second Dose|Overall Study||4
8552877|NCT00117143|21088130|P1|Received Second Dose|Overall Study||4
8552878|NCT00117143|21088127|P4|Received First Dose|Overall Study||1
8552879|NCT00117143|21088128|P3|Received First Dose|Overall Study||7
8552880|NCT00117143|21088129|P2|Received First Dose|Overall Study||4
8552881|NCT00117143|21088130|P1|Received First Dose|Overall Study||4
8552882|NCT00117143|21088127|P4|STARTED|Overall Study||1
8552883|NCT00117143|21088128|P3|STARTED|Overall Study||7
8552884|NCT00117143|21088129|P2|STARTED|Overall Study||4
8552885|NCT00117143|21088130|P1|STARTED|Overall Study||4
8552886|NCT00116857|21088174|P2|NOT COMPLETED|Overall Study||4
8552887|NCT00116857|21088175|P1|NOT COMPLETED|Overall Study||3
8552888|NCT00116857|21088174|P2|COMPLETED|Overall Study||56
8552889|NCT00116857|21088175|P1|COMPLETED|Overall Study||59
8552890|NCT00116857|21088174|P2|STARTED|Overall Study||60
8552891|NCT00116857|21088175|P1|STARTED|Overall Study||62
8552892|NCT00116844|21088183|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
8552893|NCT00116844|21088184|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
8552894|NCT00116844|21088183|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
8552895|NCT00116844|21088184|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
8552896|NCT00116844|21088183|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
8552897|NCT00116844|21088184|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
8552898|NCT00116844|21088183|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8552899|NCT00116844|21088184|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8552900|NCT00116844|21088183|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
8552901|NCT00116844|21088184|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
8552902|NCT00116844|21088183|P2|STARTED|Period 2: Washout Period (7 Days)||33
8552903|NCT00116844|21088184|P1|STARTED|Period 2: Washout Period (7 Days)||28
8552904|NCT00116844|21088183|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
8552905|NCT00116844|21088184|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
8552906|NCT00116844|21088183|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
8552907|NCT00116844|21088184|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
8552908|NCT00116844|21088183|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
8552909|NCT00116844|21088184|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
8552910|NCT00116831|21088202|P2|NOT COMPLETED|Overall Study||72
8552911|NCT00116831|21088203|P1|NOT COMPLETED|Overall Study||73
8552912|NCT00116831|21088202|P2|COMPLETED|Overall Study||259
8552913|NCT00116831|21088203|P1|COMPLETED|Overall Study||264
8552914|NCT00116831|21088202|P2|STARTED|Overall Study||331
8552915|NCT00116831|21088203|P1|STARTED|Overall Study||337
8552916|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
8552917|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
8552918|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
8552919|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
8552920|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
8552921|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 433 - 480||57
8552922|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
8552923|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
8552924|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
8552925|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
8552926|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
8552927|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
8552928|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
8552929|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
8552930|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
8552931|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
8552932|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 337 - 384||57
8552933|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 337 - 384||98
8552934|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
8552935|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
8552936|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
8552937|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
8552938|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 289 - 336||64
8552939|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 289 - 336||104
8552940|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
8552941|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
8552942|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
8552943|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
8552944|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 241 - 288||64
8552945|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 241 - 288||110
8552946|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
8552947|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
8552948|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
8552949|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
8552950|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 193 - 240||68
8552951|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 193 - 240||123
8552952|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
8552953|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
8552954|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
8552955|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
8552956|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 145 - 192||74
8552957|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 145 - 192||133
8552958|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
8552959|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
8552960|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
8552961|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
8552962|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 97 - 144||83
8552963|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 97 - 144||144
8552964|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
8552965|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
8552966|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
8552967|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
8552968|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
8552969|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
8552970|NCT00116805|21088281|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
8552971|NCT00116805|21088282|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
8552972|NCT00116805|21088281|P2|COMPLETED|Double-blind Period Through Week 48||85
8552973|NCT00116805|21088282|P1|COMPLETED|Double-blind Period Through Week 48||165
8552974|NCT00116805|21088281|P2|STARTED|Double-blind Period Through Week 48||90
8552975|NCT00116805|21088282|P1|STARTED|Double-blind Period Through Week 48||176
8552976|NCT00116779|21088375|P2|NOT COMPLETED|Overall Study||19
8552977|NCT00116779|21088376|P1|NOT COMPLETED|Overall Study||21
8552978|NCT00116779|21088375|P2|COMPLETED|Overall Study||45
8552979|NCT00116779|21088376|P1|COMPLETED|Overall Study||42
8552980|NCT00116779|21088375|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
8552981|NCT00116779|21088376|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
8552982|NCT00116753|21088409|P3|NOT COMPLETED|Overall Study||24
8552983|NCT00116753|21088410|P2|NOT COMPLETED|Overall Study||30
8552984|NCT00116753|21088411|P1|NOT COMPLETED|Overall Study||32
8552985|NCT00116753|21088409|P3|COMPLETED|Overall Study||128
8552986|NCT00116753|21088410|P2|COMPLETED|Overall Study||125
8552987|NCT00116753|21088411|P1|COMPLETED|Overall Study||121
8552988|NCT00116753|21088409|P3|ITT Population|Overall Study||147
8552989|NCT00116753|21088410|P2|ITT Population|Overall Study||150
8552990|NCT00116753|21088411|P1|ITT Population|Overall Study||150
8552991|NCT00116753|21088409|P3|STARTED|Overall Study||152
8552992|NCT00116753|21088410|P2|STARTED|Overall Study||155
8552993|NCT00116753|21088411|P1|STARTED|Overall Study|Randomised.|153
8552994|NCT00116688|21088433|P2|NOT COMPLETED|Overall Study||4
8552995|NCT00116688|21088434|P1|NOT COMPLETED|Overall Study||92
8552996|NCT00116688|21088433|P2|COMPLETED|Overall Study||17
8552997|NCT00116688|21088434|P1|COMPLETED|Overall Study||200
8552998|NCT00116688|21088433|P2|Received Study Medication|Overall Study||20
8552999|NCT00116688|21088434|P1|Received Study Medication|Overall Study||291
8553000|NCT00116688|21088433|P2|STARTED|Overall Study||21
8553001|NCT00116688|21088434|P1|STARTED|Overall Study||292
8553002|NCT00116649|21088449|P1|NOT COMPLETED|Overall Study||155
8553003|NCT00116649|21088449|P1|COMPLETED|Overall Study||396
8553004|NCT00116649|21088449|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
8553005|NCT00116584|21088456|P2|NOT COMPLETED|Overall Study||1
8553006|NCT00116584|21088457|P1|NOT COMPLETED|Overall Study||2
8553007|NCT00116584|21088456|P2|COMPLETED|Overall Study||35
8553008|NCT00116584|21088457|P1|COMPLETED|Overall Study||34
8553009|NCT00116584|21088456|P2|STARTED|Overall Study||36
8553010|NCT00116584|21088457|P1|STARTED|Overall Study||36
8553011|NCT00116558|21088470|P3|NOT COMPLETED|Overall Study||33
8553012|NCT00116558|21088471|P2|NOT COMPLETED|Overall Study||15
8553013|NCT00116558|21088472|P1|NOT COMPLETED|Overall Study||31
8553014|NCT00116558|21088470|P3|COMPLETED|Overall Study||14
8553015|NCT00116558|21088471|P2|COMPLETED|Overall Study||11
8553016|NCT00116558|21088472|P1|COMPLETED|Overall Study||49
8553017|NCT00116558|21088470|P3|STARTED|Overall Study||47
8553018|NCT00116558|21088471|P2|STARTED|Overall Study||26
8553019|NCT00116558|21088472|P1|STARTED|Overall Study||80
8553020|NCT00116428|21088483|P2|NOT COMPLETED|Overall Study||5
8553021|NCT00116428|21088484|P1|NOT COMPLETED|Overall Study||3
8553022|NCT00116428|21088483|P2|COMPLETED|Overall Study||56
8553023|NCT00116428|21088484|P1|COMPLETED|Overall Study||103
8553024|NCT00116428|21088483|P2|Underwent Study Ablation Procedure|Overall Study||36
8553025|NCT00116428|21088484|P1|Underwent Study Ablation Procedure|Overall Study||103
8553026|NCT00116428|21088483|P2|STARTED|Overall Study||61
8553027|NCT00116428|21088484|P1|STARTED|Overall Study||106
8553028|NCT00116337|21088500|P1|NOT COMPLETED|Overall Study||0
8553029|NCT00116337|21088500|P1|COMPLETED|Overall Study||17
8553030|NCT00116337|21088500|P1|STARTED|Overall Study||17
8553031|NCT00116272|21088513|P2|NOT COMPLETED|Overall Study||6
8553032|NCT00116272|21088514|P1|NOT COMPLETED|Overall Study||11
8553033|NCT00116272|21088513|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
8553034|NCT00116272|21088514|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
8553035|NCT00116272|21088513|P2|STARTED|Overall Study||164
8553036|NCT00116272|21088514|P1|STARTED|Overall Study||370
8553037|NCT00116207|21088566|P2|NOT COMPLETED|Overall Study||4
8553038|NCT00116207|21088567|P1|NOT COMPLETED|Overall Study||9
8553039|NCT00116207|21088566|P2|COMPLETED|Overall Study||18
8553040|NCT00116207|21088567|P1|COMPLETED|Overall Study||13
8553041|NCT00116207|21088566|P2|STARTED|Overall Study||22
8553042|NCT00116207|21088567|P1|STARTED|Overall Study||22
8553043|NCT00116168|21088583|P4|NOT COMPLETED|Overall Study||0
8553044|NCT00116168|21088584|P3|NOT COMPLETED|Overall Study||0
8553045|NCT00116168|21088585|P2|NOT COMPLETED|Overall Study||5
8553046|NCT00116168|21088586|P1|NOT COMPLETED|Overall Study||6
8553047|NCT00116168|21088583|P4|COMPLETED|Overall Study||6
8553048|NCT00116168|21088584|P3|COMPLETED|Overall Study||6
8553049|NCT00116168|21088585|P2|COMPLETED|Overall Study||6
8553050|NCT00116168|21088586|P1|COMPLETED|Overall Study||0
8553051|NCT00116168|21088583|P4|STARTED|Overall Study||6
8553052|NCT00116168|21088584|P3|STARTED|Overall Study||6
8553053|NCT00116168|21088585|P2|STARTED|Overall Study||11
8553054|NCT00116168|21088586|P1|STARTED|Overall Study||6
8553055|NCT00115934|21088650|P2|NOT COMPLETED|Overall Study||2
8553056|NCT00115934|21088651|P1|NOT COMPLETED|Overall Study||4
8553057|NCT00115934|21088650|P2|COMPLETED|Overall Study||274
8553058|NCT00115934|21088651|P1|COMPLETED|Overall Study||275
8553059|NCT00115934|21088650|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
8553060|NCT00115934|21088651|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
8553061|NCT00115869|21088691|P2|NOT COMPLETED|Overall Study||296
8553062|NCT00115869|21088692|P1|NOT COMPLETED|Overall Study||317
8553063|NCT00115869|21088691|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
8553064|NCT00115869|21088692|P1|COMPLETED|Overall Study||3894
8553065|NCT00115869|21088691|P2|Completed Data Collection at 12th Grade|Overall Study||3847
8553066|NCT00115869|21088692|P1|Completed Data Collection at 12th Grade|Overall Study||3876
8553067|NCT00115869|21088691|P2|STARTED|Overall Study||4177
8553068|NCT00115869|21088692|P1|STARTED|Overall Study||4211
8553069|NCT00115804|21088700|P1|NOT COMPLETED|Overall Study||2
8553070|NCT00115804|21088700|P1|COMPLETED|Overall Study||4
8553071|NCT00115804|21088700|P1|STARTED|Overall Study||6
8553072|NCT00115778|21088711|P2|NOT COMPLETED|Overall Study||1
8553073|NCT00115778|21088712|P1|NOT COMPLETED|Overall Study||0
8553074|NCT00115778|21088711|P2|COMPLETED|Overall Study||4
8553075|NCT00115778|21088712|P1|COMPLETED|Overall Study||6
8553076|NCT00115778|21088711|P2|STARTED|Overall Study||5
8553077|NCT00115778|21088712|P1|STARTED|Overall Study||6
8553078|NCT00115765|21088732|P4|NOT COMPLETED|Overall Study||31
8553079|NCT00115765|21088733|P3|NOT COMPLETED|Overall Study||121
8553080|NCT00115765|21088734|P2|NOT COMPLETED|Overall Study||100
8553081|NCT00115765|21088735|P1|NOT COMPLETED|Overall Study||35
8553082|NCT00115765|21088732|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
8553083|NCT00115765|21088733|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
8553084|NCT00115765|21088734|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
8553085|NCT00115765|21088735|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
8553086|NCT00115765|21088732|P4|STARTED|Overall Study||115
8553087|NCT00115765|21088733|P3|STARTED|Overall Study||410
8553088|NCT00115765|21088734|P2|STARTED|Overall Study||413
8553089|NCT00115765|21088735|P1|STARTED|Overall Study||115
8553090|NCT00115739|21088773|P1|NOT COMPLETED|Overall Study||3
8553091|NCT00115739|21088773|P1|COMPLETED|Overall Study||8
8553092|NCT00115739|21088773|P1|STARTED|Overall Study||11
8553093|NCT00115349|21088782|P2|NOT COMPLETED|Overall Study||9
8553094|NCT00115349|21088783|P1|NOT COMPLETED|Overall Study||11
8553095|NCT00115349|21088782|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
8553096|NCT00115349|21088783|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
8553097|NCT00115349|21088782|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
8553098|NCT00115349|21088783|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
8553099|NCT00115336|21088791|P2|NOT COMPLETED|Overall Study||1
8553100|NCT00115336|21088792|P1|NOT COMPLETED|Overall Study||0
8553101|NCT00115336|21088791|P2|COMPLETED|Overall Study||3
8553102|NCT00115336|21088792|P1|COMPLETED|Overall Study||6
8553103|NCT00115336|21088791|P2|STARTED|Overall Study||4
8553104|NCT00115336|21088792|P1|STARTED|Overall Study||6
8553105|NCT00115297|21088816|P2|NOT COMPLETED|Overall Study||0
8553106|NCT00115297|21088817|P1|NOT COMPLETED|Overall Study||0
8553107|NCT00115297|21088816|P2|COMPLETED|Overall Study||32
8553108|NCT00115297|21088817|P1|COMPLETED|Overall Study||30
8553109|NCT00115297|21088816|P2|STARTED|Overall Study||32
8553110|NCT00115297|21088817|P1|STARTED|Overall Study||30
8553111|NCT00115063|21088829|P2|NOT COMPLETED|Overall Study||104
8553112|NCT00115063|21088830|P1|NOT COMPLETED|Overall Study||99
8553113|NCT00115063|21088829|P2|COMPLETED|Overall Study||86
8553114|NCT00115063|21088830|P1|COMPLETED|Overall Study||101
8553115|NCT00115063|21088829|P2|STARTED|Overall Study||190
8553116|NCT00115063|21088830|P1|STARTED|Overall Study||200
8553117|NCT00115037|21088848|P6|NOT COMPLETED|Phase2||12
8553118|NCT00115037|21088849|P5|NOT COMPLETED|Phase2||6
8553119|NCT00115037|21088850|P4|NOT COMPLETED|Phase2||15
8553120|NCT00115037|21088851|P3|NOT COMPLETED|Phase2||15
8553121|NCT00115037|21088852|P2|NOT COMPLETED|Phase2||0
8553122|NCT00115037|21088853|P1|NOT COMPLETED|Phase2||0
8553123|NCT00115037|21088848|P6|COMPLETED|Phase2||21
8553124|NCT00115037|21088849|P5|COMPLETED|Phase2||28
8553125|NCT00115037|21088850|P4|COMPLETED|Phase2||77
8553126|NCT00115037|21088851|P3|COMPLETED|Phase2||76
8553127|NCT00115037|21088852|P2|COMPLETED|Phase2||0
8553128|NCT00115037|21088853|P1|COMPLETED|Phase2||0
8553129|NCT00115037|21088848|P6|STARTED|Phase2||33
8553130|NCT00115037|21088849|P5|STARTED|Phase2||34
8553131|NCT00115037|21088850|P4|STARTED|Phase2||92
8553132|NCT00115037|21088851|P3|STARTED|Phase2||91
8553133|NCT00115037|21088852|P2|STARTED|Phase2||0
8553134|NCT00115037|21088853|P1|STARTED|Phase2||0
8553135|NCT00115037|21088848|P6|NOT COMPLETED|Phase1||0
8553136|NCT00115037|21088849|P5|NOT COMPLETED|Phase1||0
8553137|NCT00115037|21088850|P4|NOT COMPLETED|Phase1||0
8553138|NCT00115037|21088851|P3|NOT COMPLETED|Phase1||0
8553139|NCT00115037|21088852|P2|NOT COMPLETED|Phase1||27
8553140|NCT00115037|21088853|P1|NOT COMPLETED|Phase1||25
8553141|NCT00115037|21088848|P6|COMPLETED|Phase1||0
8553142|NCT00115037|21088849|P5|COMPLETED|Phase1||0
8553143|NCT00115037|21088850|P4|COMPLETED|Phase1||0
8553144|NCT00115037|21088851|P3|COMPLETED|Phase1||0
8553145|NCT00115037|21088852|P2|COMPLETED|Phase1||123
8553146|NCT00115037|21088853|P1|COMPLETED|Phase1||127
8553147|NCT00115037|21088848|P6|STARTED|Phase1||0
8553148|NCT00115037|21088849|P5|STARTED|Phase1||0
8553149|NCT00115037|21088850|P4|STARTED|Phase1||0
8553150|NCT00115037|21088851|P3|STARTED|Phase1||0
8553151|NCT00115037|21088852|P2|STARTED|Phase1||150
8553152|NCT00115037|21088853|P1|STARTED|Phase1||152
8553153|NCT00114972|21088869|P2|NOT COMPLETED|Overall Study||12
8553154|NCT00114972|21088870|P1|NOT COMPLETED|Overall Study||48
8553155|NCT00114972|21088869|P2|COMPLETED|Overall Study||891
8553156|NCT00114972|21088870|P1|COMPLETED|Overall Study||849
8553157|NCT00114972|21088869|P2|STARTED|Overall Study||903
8553158|NCT00114972|21088870|P1|STARTED|Overall Study||897
8553159|NCT00114959|21088890|P1|NOT COMPLETED|Overall Study||8
8553160|NCT00114959|21088890|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
8553161|NCT00114959|21088890|P1|STARTED|Overall Study||15
8553162|NCT00114777|21088900|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
8553163|NCT00114777|21088901|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
8553164|NCT00114777|21088902|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
8553165|NCT00114777|21088900|P3|COMPLETED|Long-Term Extension to Month 84||57
8553166|NCT00114777|21088901|P2|COMPLETED|Long-Term Extension to Month 84||84
8553167|NCT00114777|21088902|P1|COMPLETED|Long-Term Extension to Month 84||74
8553168|NCT00114777|21088900|P3|STARTED|Long-Term Extension to Month 84||87
8553169|NCT00114777|21088901|P2|STARTED|Long-Term Extension to Month 84||113
8553170|NCT00114777|21088902|P1|STARTED|Long-Term Extension to Month 84||104
8553171|NCT00114777|21088900|P3|NOT COMPLETED|Randomization to Month 36||84
8553172|NCT00114777|21088901|P2|NOT COMPLETED|Randomization to Month 36||61
8553173|NCT00114777|21088902|P1|NOT COMPLETED|Randomization to Month 36||75
8553174|NCT00114777|21088900|P3|COMPLETED|Randomization to Month 36||100
8553175|NCT00114777|21088901|P2|COMPLETED|Randomization to Month 36||114
8553176|NCT00114777|21088902|P1|COMPLETED|Randomization to Month 36||109
8553177|NCT00114777|21088900|P3|STARTED|Randomization to Month 36||184
8553178|NCT00114777|21088901|P2|STARTED|Randomization to Month 36||175
8553179|NCT00114777|21088902|P1|STARTED|Randomization to Month 36||184
8553180|NCT00114738|21088976|P3|NOT COMPLETED|Randomization||0
8553181|NCT00114738|21088977|P2|NOT COMPLETED|Randomization||0
8553182|NCT00114738|21088978|P1|NOT COMPLETED|Randomization||0
8553183|NCT00114738|21088976|P3|COMPLETED|Randomization||16
8553184|NCT00114738|21088977|P2|COMPLETED|Randomization||14
8553185|NCT00114738|21088978|P1|COMPLETED|Randomization||0
8553186|NCT00114738|21088976|P3|STARTED|Randomization||16
8553187|NCT00114738|21088977|P2|STARTED|Randomization||14
8553188|NCT00114738|21088978|P1|STARTED|Randomization||0
8553189|NCT00114738|21088976|P3|NOT COMPLETED|Screening for Randomization||0
8553190|NCT00114738|21088977|P2|NOT COMPLETED|Screening for Randomization||0
8553191|NCT00114738|21088978|P1|NOT COMPLETED|Screening for Randomization||21
8553192|NCT00114738|21088976|P3|COMPLETED|Screening for Randomization||0
8553193|NCT00114738|21088977|P2|COMPLETED|Screening for Randomization||0
8553194|NCT00114738|21088978|P1|COMPLETED|Screening for Randomization||30
8553195|NCT00114738|21088976|P3|STARTED|Screening for Randomization||0
8553196|NCT00114738|21088977|P2|STARTED|Screening for Randomization||0
8553197|NCT00114738|21088978|P1|STARTED|Screening for Randomization||51
8553198|NCT00114738|21088976|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553199|NCT00114738|21088977|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553200|NCT00114738|21088978|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
8553201|NCT00114738|21088976|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553202|NCT00114738|21088977|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553203|NCT00114738|21088978|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
8553204|NCT00114738|21088976|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553205|NCT00114738|21088977|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553206|NCT00114738|21088978|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
8553207|NCT00114738|21088976|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553208|NCT00114738|21088977|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553209|NCT00114738|21088978|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
8553210|NCT00114738|21088976|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
8553211|NCT00114738|21088977|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
8553212|NCT00114738|21088978|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
8553213|NCT00114634|21088991|P1|NOT COMPLETED|Overall Study||3
8553214|NCT00114634|21088991|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
8553215|NCT00114634|21088991|P1|STARTED|Overall Study||13
8553216|NCT00114530|21089007|P2|NOT COMPLETED|Overall Study||20
8553217|NCT00114530|21089008|P1|NOT COMPLETED|Overall Study||9
8553218|NCT00114530|21089007|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
8553313|NCT00113763|21089351|P1|NOT COMPLETED|Overall Study||73
8553219|NCT00114530|21089008|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
8553220|NCT00114530|21089007|P2|STARTED|Overall Study||39
8553221|NCT00114530|21089008|P1|STARTED|Overall Study||36
8553222|NCT00114517|21089117|P4|NOT COMPLETED|Overall Study||10
8553223|NCT00114517|21089118|P3|NOT COMPLETED|Overall Study||14
8553224|NCT00114517|21089119|P2|NOT COMPLETED|Overall Study||11
8553225|NCT00114517|21089120|P1|NOT COMPLETED|Overall Study||12
8553226|NCT00114517|21089117|P4|COMPLETED|Overall Study||176
8553227|NCT00114517|21089118|P3|COMPLETED|Overall Study||172
8553228|NCT00114517|21089119|P2|COMPLETED|Overall Study||123
8553229|NCT00114517|21089120|P1|COMPLETED|Overall Study||125
8553230|NCT00114517|21089117|P4|STARTED|Overall Study||186
8553231|NCT00114517|21089118|P3|STARTED|Overall Study||186
8553232|NCT00114517|21089119|P2|STARTED|Overall Study||134
8553233|NCT00114517|21089120|P1|STARTED|Overall Study||137
8553234|NCT00114504|21089132|P2|NOT COMPLETED|Overall Study||0
8553235|NCT00114504|21089133|P1|NOT COMPLETED|Overall Study||0
8553236|NCT00114504|21089132|P2|COMPLETED|Overall Study||22
8553237|NCT00114504|21089133|P1|COMPLETED|Overall Study||21
8553238|NCT00114504|21089132|P2|STARTED|Overall Study||22
8553239|NCT00114504|21089133|P1|STARTED|Overall Study||21
8553240|NCT00114244|21089145|P2|NOT COMPLETED|Overall Study||7
8553241|NCT00114244|21089146|P1|NOT COMPLETED|Overall Study||2
8553242|NCT00114244|21089145|P2|COMPLETED|Overall Study||30
8553243|NCT00114244|21089146|P1|COMPLETED|Overall Study||13
8553244|NCT00114244|21089145|P2|STARTED|Overall Study||37
8553245|NCT00114244|21089146|P1|STARTED|Overall Study||15
8553246|NCT00114231|21089158|P2|NOT COMPLETED|Overall Study||2
8553247|NCT00114231|21089159|P1|NOT COMPLETED|Overall Study||9
8553248|NCT00114231|21089158|P2|COMPLETED|Overall Study||26
8553249|NCT00114231|21089159|P1|COMPLETED|Overall Study||53
8553250|NCT00114231|21089158|P2|STARTED|Overall Study||28
8553251|NCT00114231|21089159|P1|STARTED|Overall Study||62
8553252|NCT00114218|21089168|P1|NOT COMPLETED|Overall Study||4
8553253|NCT00114218|21089168|P1|COMPLETED|Overall Study||24
8553254|NCT00114218|21089168|P1|STARTED|Overall Study||28
8553255|NCT00114166|21089175|P2|NOT COMPLETED|Overall Study||1
8553256|NCT00114166|21089176|P1|NOT COMPLETED|Overall Study||0
8553257|NCT00114166|21089175|P2|COMPLETED|Overall Study||65
8553258|NCT00114166|21089176|P1|COMPLETED|Overall Study||15
8553259|NCT00114166|21089175|P2|STARTED|Overall Study||66
8553260|NCT00114166|21089176|P1|STARTED|Overall Study||15
8553261|NCT00114140|21089186|P1|NOT COMPLETED|Overall Study||7
8553262|NCT00114140|21089186|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
8553263|NCT00114140|21089186|P1|STARTED|Overall Study||136
8553264|NCT00114127|21089200|P2|NOT COMPLETED|Overall Study||4
8553265|NCT00114127|21089201|P1|NOT COMPLETED|Overall Study||4
8553266|NCT00114127|21089200|P2|COMPLETED|Overall Study||11
8553267|NCT00114127|21089201|P1|COMPLETED|Overall Study||9
8553268|NCT00114127|21089200|P2|STARTED|Overall Study||15
8553269|NCT00114127|21089201|P1|STARTED|Overall Study||13
8553270|NCT00114114|21089215|P6|NOT COMPLETED|Overall Study||1
8553271|NCT00114114|21089216|P5|NOT COMPLETED|Overall Study||2
8553272|NCT00114114|21089217|P4|NOT COMPLETED|Overall Study||4
8553273|NCT00114114|21089218|P3|NOT COMPLETED|Overall Study||1
8553274|NCT00114114|21089219|P2|NOT COMPLETED|Overall Study||1
8553275|NCT00114114|21089220|P1|NOT COMPLETED|Overall Study||5
8553276|NCT00114114|21089215|P6|COMPLETED|Overall Study||30
8553277|NCT00114114|21089216|P5|COMPLETED|Overall Study||27
8553278|NCT00114114|21089217|P4|COMPLETED|Overall Study||31
8553279|NCT00114114|21089218|P3|COMPLETED|Overall Study||30
8553280|NCT00114114|21089219|P2|COMPLETED|Overall Study||24
8553281|NCT00114114|21089220|P1|COMPLETED|Overall Study||21
8553282|NCT00114114|21089215|P6|STARTED|Overall Study||31
8553283|NCT00114114|21089216|P5|STARTED|Overall Study||29
8553284|NCT00114114|21089217|P4|STARTED|Overall Study||35
8553285|NCT00114114|21089218|P3|STARTED|Overall Study||31
8553286|NCT00114114|21089219|P2|STARTED|Overall Study||25
8553287|NCT00114114|21089220|P1|STARTED|Overall Study||26
8553288|NCT00114101|21089260|P2|NOT COMPLETED|Overall Study||0
8553289|NCT00114101|21089261|P1|NOT COMPLETED|Overall Study||0
8553290|NCT00114101|21089260|P2|COMPLETED|Overall Study||229
8553291|NCT00114101|21089261|P1|COMPLETED|Overall Study||231
8553292|NCT00114101|21089260|P2|STARTED|Overall Study||229
8553293|NCT00114101|21089261|P1|STARTED|Overall Study||231
8553294|NCT00113919|21089273|P1|NOT COMPLETED|Overall Study||14
8553295|NCT00113919|21089273|P1|COMPLETED|Overall Study||0
8553296|NCT00113919|21089273|P1|STARTED|Overall Study||14
8553297|NCT00113880|21089280|P3|NOT COMPLETED|Overall Study||0
8553298|NCT00113880|21089281|P2|NOT COMPLETED|Overall Study||0
8553299|NCT00113880|21089282|P1|NOT COMPLETED|Overall Study||0
8553300|NCT00113880|21089280|P3|COMPLETED|Overall Study||62492
8553301|NCT00113880|21089281|P2|COMPLETED|Overall Study||71949
8553302|NCT00113880|21089282|P1|COMPLETED|Overall Study||63061
8553303|NCT00113880|21089280|P3|STARTED|Overall Study||62492
8553304|NCT00113880|21089281|P2|STARTED|Overall Study||71949
8553305|NCT00113880|21089282|P1|STARTED|Overall Study||63061
8553306|NCT00113841|21089341|P2|NOT COMPLETED|Overall Study||2
8553307|NCT00113841|21089342|P1|NOT COMPLETED|Overall Study||1
8553308|NCT00113841|21089341|P2|COMPLETED|Overall Study||15
8553309|NCT00113841|21089342|P1|COMPLETED|Overall Study||15
8553310|NCT00113841|21089341|P2|STARTED|Overall Study||17
8553311|NCT00113841|21089342|P1|STARTED|Overall Study||16
8553312|NCT00113763|21089350|P2|NOT COMPLETED|Overall Study||26
8553314|NCT00113763|21089350|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
8553315|NCT00113763|21089351|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
8553316|NCT00113763|21089350|P2|Received Study Drug|Overall Study||0
8553317|NCT00113763|21089351|P1|Received Study Drug|Overall Study||229
8553318|NCT00113763|21089350|P2|STARTED|Overall Study||232
8553319|NCT00113763|21089351|P1|STARTED|Overall Study||231
8553320|NCT00113607|21089377|P2|NOT COMPLETED|Overall Study||337
8553321|NCT00113607|21089378|P1|NOT COMPLETED|Overall Study||335
8553322|NCT00113607|21089377|P2|COMPLETED|Overall Study||0
8553323|NCT00113607|21089378|P1|COMPLETED|Overall Study||0
8553324|NCT00113607|21089377|P2|STARTED|Overall Study|Number of randomized participants|337
8553325|NCT00113607|21089378|P1|STARTED|Overall Study|Number of randomized participants|335
8553326|NCT00113568|21089392|P1|NOT COMPLETED|Overall Study||545
8553327|NCT00113568|21089392|P1|COMPLETED|Overall Study||239
8553328|NCT00113568|21089392|P1|Intent to Treat Population|Overall Study||723
8553329|NCT00113568|21089392|P1|STARTED|Overall Study||784
8553330|NCT00113555|21089404|P1|NOT COMPLETED|Overall Study||79
8553331|NCT00113555|21089404|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
8553332|NCT00113555|21089404|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
8553333|NCT00113555|21089404|P1|STARTED|Overall Study||221
8553334|NCT00113529|21089414|P1|NOT COMPLETED|Overall Study||34
8553335|NCT00113529|21089414|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
8553336|NCT00113529|21089414|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
8553337|NCT00113516|21089447|P2|NOT COMPLETED|Part 2||66
8553338|NCT00113516|21089448|P1|NOT COMPLETED|Part 2||0
8553339|NCT00113516|21089447|P2|COMPLETED|Part 2||0
8553340|NCT00113516|21089448|P1|COMPLETED|Part 2||0
8553341|NCT00113516|21089447|P2|STARTED|Part 2||66
8553342|NCT00113516|21089448|P1|STARTED|Part 2||0
8553343|NCT00113516|21089447|P2|NOT COMPLETED|Part 1||0
8553344|NCT00113516|21089448|P1|NOT COMPLETED|Part 1||84
8553345|NCT00113516|21089447|P2|COMPLETED|Part 1||0
8553346|NCT00113516|21089448|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
8553347|NCT00113516|21089447|P2|STARTED|Part 1||0
8553348|NCT00113516|21089448|P1|STARTED|Part 1||84
8553349|NCT00113490|21089491|P2|NOT COMPLETED|Overall Study||3
8553350|NCT00113490|21089492|P1|NOT COMPLETED|Overall Study||2
8553351|NCT00113490|21089491|P2|COMPLETED|Overall Study||67
8553352|NCT00113490|21089492|P1|COMPLETED|Overall Study||64
8553353|NCT00113490|21089491|P2|STARTED|Overall Study||70
8553354|NCT00113490|21089492|P1|STARTED|Overall Study||66
8553355|NCT00113425|21089505|P1|NOT COMPLETED|Overall Study||15
8553356|NCT00113425|21089505|P1|COMPLETED|Overall Study||29
8553357|NCT00113425|21089505|P1|STARTED|Overall Study||44
8553358|NCT00113399|21089525|P2|NOT COMPLETED|Overall Study||5
8553359|NCT00113399|21089526|P1|NOT COMPLETED|Overall Study||2
8553360|NCT00113399|21089525|P2|COMPLETED|Overall Study||3
8553361|NCT00113399|21089526|P1|COMPLETED|Overall Study||5
8553362|NCT00113399|21089525|P2|STARTED|Overall Study||8
8553363|NCT00113399|21089526|P1|STARTED|Overall Study||7
8553364|NCT00113386|21089534|P2|NOT COMPLETED|Overall Study||4
8553365|NCT00113386|21089535|P1|NOT COMPLETED|Overall Study||7
8553366|NCT00113386|21089534|P2|COMPLETED|Overall Study||5
8553367|NCT00113386|21089535|P1|COMPLETED|Overall Study||3
8553368|NCT00113386|21089534|P2|STARTED|Overall Study||9
8553369|NCT00113386|21089535|P1|STARTED|Overall Study||10
8553370|NCT00113373|21089541|P1|NOT COMPLETED|Overall Study||3
8553371|NCT00113373|21089541|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
8553372|NCT00113373|21089541|P1|STARTED|Overall Study||28
8553373|NCT00113360|21089556|P1|NOT COMPLETED|Overall Study||7
8553374|NCT00113360|21089556|P1|COMPLETED|Overall Study||60
8553375|NCT00113360|21089556|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
8553376|NCT00113334|21089560|P1|NOT COMPLETED|Overall Study||0
8553377|NCT00113334|21089560|P1|COMPLETED|Overall Study||6
8553378|NCT00113334|21089560|P1|STARTED|Overall Study||6
8553379|NCT00113321|21089564|P1|NOT COMPLETED|Overall Study||0
8553380|NCT00113321|21089564|P1|COMPLETED|Overall Study||16
8553381|NCT00113321|21089564|P1|STARTED|Overall Study||16
8553382|NCT00113295|21089570|P2|NOT COMPLETED|Overall Study||1
8553383|NCT00113295|21089571|P1|NOT COMPLETED|Overall Study||5
8553384|NCT00113295|21089570|P2|COMPLETED|Overall Study||10
8553385|NCT00113295|21089571|P1|COMPLETED|Overall Study||6
8553386|NCT00113295|21089570|P2|STARTED|Overall Study||11
8553387|NCT00113295|21089571|P1|STARTED|Overall Study||11
8553388|NCT00113269|21089590|P4|NOT COMPLETED|Overall Study||40
8553389|NCT00113269|21089591|P3|NOT COMPLETED|Overall Study||41
8553390|NCT00113269|21089592|P2|NOT COMPLETED|Overall Study||22
8553391|NCT00113269|21089593|P1|NOT COMPLETED|Overall Study||25
8553392|NCT00113269|21089590|P4|COMPLETED|Overall Study||140
8553393|NCT00113269|21089591|P3|COMPLETED|Overall Study||134
8553394|NCT00113269|21089592|P2|COMPLETED|Overall Study||48
8553395|NCT00113269|21089593|P1|COMPLETED|Overall Study||51
8553396|NCT00113269|21089590|P4|Received Treatment|Overall Study||171
8553397|NCT00113269|21089591|P3|Received Treatment|Overall Study||164
8553398|NCT00113269|21089592|P2|Received Treatment|Overall Study||69
8553399|NCT00113269|21089593|P1|Received Treatment|Overall Study||70
8553400|NCT00113269|21089590|P4|STARTED|Overall Study||180
8553401|NCT00113269|21089591|P3|STARTED|Overall Study||175
8553402|NCT00113269|21089592|P2|STARTED|Overall Study||70
8553403|NCT00113269|21089593|P1|STARTED|Overall Study||76
8553404|NCT00113230|21089643|P1|NOT COMPLETED|Overall Study||0
8553405|NCT00113230|21089643|P1|COMPLETED|Overall Study||25
8553406|NCT00113230|21089643|P1|STARTED|Overall Study||25
8553407|NCT00113217|21089647|P1|NOT COMPLETED|Overall Study||0
8553408|NCT00113217|21089647|P1|COMPLETED|Overall Study||50
8553409|NCT00113217|21089647|P1|STARTED|Overall Study||50
8553410|NCT00113087|21089653|P2|NOT COMPLETED|Overall Study||21
8553411|NCT00113087|21089654|P1|NOT COMPLETED|Overall Study||24
8553412|NCT00113087|21089653|P2|COMPLETED|Overall Study||94
8553413|NCT00113087|21089654|P1|COMPLETED|Overall Study||91
8553414|NCT00113087|21089653|P2|STARTED|Overall Study||115
8553415|NCT00113087|21089654|P1|STARTED|Overall Study||115
8553416|NCT00113022|21089718|P2|NOT COMPLETED|Overall Study||2
8553417|NCT00113022|21089719|P1|NOT COMPLETED|Overall Study||3
8553418|NCT00113022|21089718|P2|COMPLETED|Overall Study||2
8553419|NCT00113022|21089719|P1|COMPLETED|Overall Study||2
8553420|NCT00113022|21089718|P2|STARTED|Overall Study||4
8553421|NCT00113022|21089719|P1|STARTED|Overall Study||5
8553422|NCT00112957|21089725|P1|NOT COMPLETED|Overall Study||19
8553423|NCT00112957|21089725|P1|COMPLETED|Overall Study||4
8553424|NCT00112957|21089725|P1|STARTED|Overall Study||23
8553425|NCT00112918|21089740|P3|NOT COMPLETED|Overall Study||299
8553426|NCT00112918|21089741|P2|NOT COMPLETED|Overall Study||345
8553427|NCT00112918|21089742|P1|NOT COMPLETED|Overall Study||297
8553428|NCT00112918|21089740|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
8553429|NCT00112918|21089741|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
8553430|NCT00112918|21089742|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
8553431|NCT00112918|21089740|P3|Stage III Disease Population|Overall Study||952
8553432|NCT00112918|21089741|P2|Stage III Disease Population|Overall Study||960
8553433|NCT00112918|21089742|P1|Stage III Disease Population|Overall Study||955
8553434|NCT00112918|21089740|P3|Received Treatment|Overall Study||1135
8553435|NCT00112918|21089741|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
8553436|NCT00112918|21089742|P1|Received Treatment|Overall Study||1126
8553437|NCT00112918|21089740|P3|STARTED|Overall Study||1145
8553438|NCT00112918|21089741|P2|STARTED|Overall Study||1155
8553439|NCT00112918|21089742|P1|STARTED|Overall Study||1151
8553440|NCT00112905|21089765|P1|NOT COMPLETED|Overall Study||12
8553441|NCT00112905|21089765|P1|COMPLETED|Overall Study||15
8553442|NCT00112905|21089765|P1|Eligible and Treated|Overall Study||22
8553443|NCT00112905|21089765|P1|STARTED|Overall Study||27
8553444|NCT00112866|21089774|P2|NOT COMPLETED|Overall Study||2
8553445|NCT00112866|21089775|P1|NOT COMPLETED|Overall Study||2
8553446|NCT00112866|21089774|P2|COMPLETED|Overall Study||13
8553447|NCT00112866|21089775|P1|COMPLETED|Overall Study||13
8553448|NCT00112866|21089774|P2|STARTED|Overall Study||15
8553449|NCT00112866|21089775|P1|STARTED|Overall Study||15
8553450|NCT00112840|21089797|P3|NOT COMPLETED|Overall Study||6
8553451|NCT00112840|21089798|P2|NOT COMPLETED|Overall Study||0
8553452|NCT00112840|21089799|P1|NOT COMPLETED|Overall Study||2
8553453|NCT00112840|21089797|P3|COMPLETED|Overall Study||40
8553454|NCT00112840|21089798|P2|COMPLETED|Overall Study||6
8553455|NCT00112840|21089799|P1|COMPLETED|Overall Study||6
8553456|NCT00112840|21089797|P3|STARTED|Overall Study||46
8553457|NCT00112840|21089798|P2|STARTED|Overall Study||6
8553458|NCT00112840|21089799|P1|STARTED|Overall Study||8
8553459|NCT00112736|21089818|P2|NOT COMPLETED|Overall Study||0
8553460|NCT00112736|21089819|P1|NOT COMPLETED|Overall Study||1
8553461|NCT00112736|21089818|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
8553462|NCT00112736|21089819|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
8553463|NCT00112736|21089818|P2|STARTED|Overall Study||47
8553464|NCT00112736|21089819|P1|STARTED|Overall Study||22
8553465|NCT00112723|21089832|P3|NOT COMPLETED|Overall Study||2
8553466|NCT00112723|21089833|P2|NOT COMPLETED|Overall Study||7
8553467|NCT00112723|21089834|P1|NOT COMPLETED|Overall Study||2
8553468|NCT00112723|21089832|P3|COMPLETED|Overall Study||12
8553469|NCT00112723|21089833|P2|COMPLETED|Overall Study||12
8553470|NCT00112723|21089834|P1|COMPLETED|Overall Study||11
8553471|NCT00112723|21089832|P3|Patients Evaluable for Toxicity|Overall Study||12
8553472|NCT00112723|21089833|P2|Patients Evaluable for Toxicity|Overall Study||12
8553473|NCT00112723|21089834|P1|Patients Evaluable for Toxicity|Overall Study||11
8553474|NCT00112723|21089832|P3|STARTED|Overall Study||14
8553475|NCT00112723|21089833|P2|STARTED|Overall Study||19
8553476|NCT00112723|21089834|P1|STARTED|Overall Study||13
8553477|NCT00112671|21089859|P1|NOT COMPLETED|Overall Study||0
8553478|NCT00112671|21089859|P1|COMPLETED|Overall Study||17
8553479|NCT00112671|21089859|P1|STARTED|Overall Study||17
8553480|NCT00112593|21089867|P1|NOT COMPLETED|Overall Study||0
8553481|NCT00112593|21089867|P1|COMPLETED|Overall Study||5
8553482|NCT00112593|21089867|P1|STARTED|Overall Study||5
8553483|NCT00112489|21089876|P1|NOT COMPLETED|Overall Study||40
8553484|NCT00112489|21089876|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
8553485|NCT00112489|21089876|P1|STARTED|Overall Study|All patients enrolled on study|55
8553486|NCT00112463|21089886|P1|NOT COMPLETED|Overall Study||39
8553487|NCT00112463|21089886|P1|COMPLETED|Overall Study||1
8553488|NCT00112463|21089886|P1|STARTED|Overall Study||40
8553489|NCT00112437|21089898|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
8553490|NCT00112437|21089899|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
8553491|NCT00112437|21089900|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
8553492|NCT00112437|21089901|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
8553493|NCT00112437|21089902|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553494|NCT00112437|21089903|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553495|NCT00112437|21089904|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553496|NCT00112437|21089905|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553497|NCT00112437|21089906|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553498|NCT00112437|21089907|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553499|NCT00112437|21089908|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553500|NCT00112437|21089909|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553501|NCT00112437|21089910|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553502|NCT00112437|21089911|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553503|NCT00112437|21089912|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553504|NCT00112437|21089913|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553505|NCT00112437|21089914|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553506|NCT00112437|21089915|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553507|NCT00112437|21089916|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553508|NCT00112437|21089917|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553509|NCT00112437|21089918|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553510|NCT00112437|21089919|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553511|NCT00112437|21089920|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553512|NCT00112437|21089921|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553513|NCT00112437|21089922|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553514|NCT00112437|21089923|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553515|NCT00112437|21089898|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
8553516|NCT00112437|21089899|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
8553517|NCT00112437|21089900|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
8553518|NCT00112437|21089901|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
8553519|NCT00112437|21089902|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
8553520|NCT00112437|21089903|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
8553521|NCT00112437|21089904|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
8553522|NCT00112437|21089905|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
8553523|NCT00112437|21089906|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
8553524|NCT00112437|21089907|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
8553525|NCT00112437|21089908|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
8553526|NCT00112437|21089909|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
8553527|NCT00112437|21089910|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
8553528|NCT00112437|21089911|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
8553529|NCT00112437|21089912|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
8553530|NCT00112437|21089913|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
8553531|NCT00112437|21089914|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
8553532|NCT00112437|21089915|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
8553533|NCT00112437|21089916|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
8553534|NCT00112437|21089917|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
8553535|NCT00112437|21089918|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
8553536|NCT00112437|21089919|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
8553537|NCT00112437|21089920|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
8553538|NCT00112437|21089921|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
8553539|NCT00112437|21089922|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
8553540|NCT00112437|21089923|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
8553541|NCT00112437|21089898|P26|STARTED|Years 6-10 (60-Month Extension)||32
8553542|NCT00112437|21089899|P25|STARTED|Years 6-10 (60-Month Extension)||23
8553543|NCT00112437|21089900|P24|STARTED|Years 6-10 (60-Month Extension)||34
8553544|NCT00112437|21089901|P23|STARTED|Years 6-10 (60-Month Extension)||28
8553545|NCT00112437|21089902|P22|STARTED|Years 6-10 (60-Month Extension)||0
8553546|NCT00112437|21089903|P21|STARTED|Years 6-10 (60-Month Extension)||0
8553547|NCT00112437|21089904|P20|STARTED|Years 6-10 (60-Month Extension)||0
8553548|NCT00112437|21089905|P19|STARTED|Years 6-10 (60-Month Extension)||0
8553549|NCT00112437|21089906|P18|STARTED|Years 6-10 (60-Month Extension)||0
8553550|NCT00112437|21089907|P17|STARTED|Years 6-10 (60-Month Extension)||0
8553551|NCT00112437|21089908|P16|STARTED|Years 6-10 (60-Month Extension)||0
8553552|NCT00112437|21089909|P15|STARTED|Years 6-10 (60-Month Extension)||0
8553553|NCT00112437|21089910|P14|STARTED|Years 6-10 (60-Month Extension)||0
8553554|NCT00112437|21089911|P13|STARTED|Years 6-10 (60-Month Extension)||0
8553555|NCT00112437|21089912|P12|STARTED|Years 6-10 (60-Month Extension)||0
8553556|NCT00112437|21089913|P11|STARTED|Years 6-10 (60-Month Extension)||0
8553557|NCT00112437|21089914|P10|STARTED|Years 6-10 (60-Month Extension)||0
8553558|NCT00112437|21089915|P9|STARTED|Years 6-10 (60-Month Extension)||0
8553559|NCT00112437|21089916|P8|STARTED|Years 6-10 (60-Month Extension)||0
8553560|NCT00112437|21089917|P7|STARTED|Years 6-10 (60-Month Extension)||0
8553561|NCT00112437|21089918|P6|STARTED|Years 6-10 (60-Month Extension)||0
8553562|NCT00112437|21089919|P5|STARTED|Years 6-10 (60-Month Extension)||0
8553563|NCT00112437|21089920|P4|STARTED|Years 6-10 (60-Month Extension)||0
8553564|NCT00112437|21089921|P3|STARTED|Years 6-10 (60-Month Extension)||0
8553565|NCT00112437|21089922|P2|STARTED|Years 6-10 (60-Month Extension)||0
8553566|NCT00112437|21089923|P1|STARTED|Years 6-10 (60-Month Extension)||0
8553567|NCT00112437|21089898|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553568|NCT00112437|21089899|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553569|NCT00112437|21089900|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553570|NCT00112437|21089901|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553571|NCT00112437|21089902|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
8553572|NCT00112437|21089903|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
8553573|NCT00112437|21089904|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553574|NCT00112437|21089905|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553575|NCT00112437|21089906|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553576|NCT00112437|21089907|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553577|NCT00112437|21089908|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553578|NCT00112437|21089909|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553579|NCT00112437|21089910|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553580|NCT00112437|21089911|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553581|NCT00112437|21089912|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553582|NCT00112437|21089913|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553583|NCT00112437|21089914|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553584|NCT00112437|21089915|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553585|NCT00112437|21089916|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553586|NCT00112437|21089917|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553587|NCT00112437|21089918|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553588|NCT00112437|21089919|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553589|NCT00112437|21089920|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553590|NCT00112437|21089921|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553591|NCT00112437|21089922|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553592|NCT00112437|21089923|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553593|NCT00112437|21089898|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
8553594|NCT00112437|21089899|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
8553595|NCT00112437|21089900|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
8553596|NCT00112437|21089901|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
8553597|NCT00112437|21089902|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
8553598|NCT00112437|21089903|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
8553599|NCT00112437|21089904|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
8553600|NCT00112437|21089905|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
8553601|NCT00112437|21089906|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
8553602|NCT00112437|21089907|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
8553603|NCT00112437|21089908|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
8553604|NCT00112437|21089909|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
8553605|NCT00112437|21089910|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
8553606|NCT00112437|21089911|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
8553607|NCT00112437|21089912|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
8553608|NCT00112437|21089913|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
8553609|NCT00112437|21089914|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
8553610|NCT00112437|21089915|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
8553611|NCT00112437|21089916|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
8553612|NCT00112437|21089917|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
8553613|NCT00112437|21089918|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
8553614|NCT00112437|21089919|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
8553615|NCT00112437|21089920|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
8553616|NCT00112437|21089921|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
8553617|NCT00112437|21089922|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
8553618|NCT00112437|21089923|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
8553619|NCT00112437|21089898|P26|STARTED|Years 4-5 (24-Month Extension)||0
8553620|NCT00112437|21089899|P25|STARTED|Years 4-5 (24-Month Extension)||0
8553621|NCT00112437|21089900|P24|STARTED|Years 4-5 (24-Month Extension)||0
8553622|NCT00112437|21089901|P23|STARTED|Years 4-5 (24-Month Extension)||0
8553623|NCT00112437|21089902|P22|STARTED|Years 4-5 (24-Month Extension)||100
8553624|NCT00112437|21089903|P21|STARTED|Years 4-5 (24-Month Extension)||41
8553625|NCT00112437|21089904|P20|STARTED|Years 4-5 (24-Month Extension)||0
8553626|NCT00112437|21089905|P19|STARTED|Years 4-5 (24-Month Extension)||0
8553627|NCT00112437|21089906|P18|STARTED|Years 4-5 (24-Month Extension)||0
8553628|NCT00112437|21089907|P17|STARTED|Years 4-5 (24-Month Extension)||0
8553629|NCT00112437|21089908|P16|STARTED|Years 4-5 (24-Month Extension)||0
8553630|NCT00112437|21089909|P15|STARTED|Years 4-5 (24-Month Extension)||0
8553631|NCT00112437|21089910|P14|STARTED|Years 4-5 (24-Month Extension)||0
8553632|NCT00112437|21089911|P13|STARTED|Years 4-5 (24-Month Extension)||0
8553633|NCT00112437|21089912|P12|STARTED|Years 4-5 (24-Month Extension)||0
8553634|NCT00112437|21089913|P11|STARTED|Years 4-5 (24-Month Extension)||0
8553635|NCT00112437|21089914|P10|STARTED|Years 4-5 (24-Month Extension)||0
8553636|NCT00112437|21089915|P9|STARTED|Years 4-5 (24-Month Extension)||0
8553637|NCT00112437|21089916|P8|STARTED|Years 4-5 (24-Month Extension)||0
8553638|NCT00112437|21089917|P7|STARTED|Years 4-5 (24-Month Extension)||0
8553639|NCT00112437|21089918|P6|STARTED|Years 4-5 (24-Month Extension)||0
8553640|NCT00112437|21089919|P5|STARTED|Years 4-5 (24-Month Extension)||0
8553641|NCT00112437|21089920|P4|STARTED|Years 4-5 (24-Month Extension)||0
8553642|NCT00112437|21089921|P3|STARTED|Years 4-5 (24-Month Extension)||0
8553643|NCT00112437|21089922|P2|STARTED|Years 4-5 (24-Month Extension)||0
8553644|NCT00112437|21089923|P1|STARTED|Years 4-5 (24-Month Extension)||0
8553645|NCT00112437|21089898|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553646|NCT00112437|21089899|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553647|NCT00112437|21089900|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553648|NCT00112437|21089901|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553649|NCT00112437|21089902|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553650|NCT00112437|21089903|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553651|NCT00112437|21089904|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553652|NCT00112437|21089905|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
8553653|NCT00112437|21089906|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553654|NCT00112437|21089907|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
8553655|NCT00112437|21089908|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
8553656|NCT00112437|21089909|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553657|NCT00112437|21089910|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553658|NCT00112437|21089911|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553659|NCT00112437|21089912|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
8553660|NCT00112437|21089913|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
8553661|NCT00112437|21089914|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553662|NCT00112437|21089915|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553663|NCT00112437|21089916|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553664|NCT00112437|21089917|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553665|NCT00112437|21089918|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553666|NCT00112437|21089919|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553667|NCT00112437|21089920|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553668|NCT00112437|21089921|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553669|NCT00112437|21089922|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553670|NCT00112437|21089923|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553671|NCT00112437|21089898|P26|COMPLETED|Year 3 (12-Month Extension)||0
8553672|NCT00112437|21089899|P25|COMPLETED|Year 3 (12-Month Extension)||0
8553673|NCT00112437|21089900|P24|COMPLETED|Year 3 (12-Month Extension)||0
8553674|NCT00112437|21089901|P23|COMPLETED|Year 3 (12-Month Extension)||0
8553675|NCT00112437|21089902|P22|COMPLETED|Year 3 (12-Month Extension)||0
8553676|NCT00112437|21089903|P21|COMPLETED|Year 3 (12-Month Extension)||0
8553677|NCT00112437|21089904|P20|COMPLETED|Year 3 (12-Month Extension)||19
8553678|NCT00112437|21089905|P19|COMPLETED|Year 3 (12-Month Extension)||16
8553679|NCT00112437|21089906|P18|COMPLETED|Year 3 (12-Month Extension)||20
8553680|NCT00112437|21089907|P17|COMPLETED|Year 3 (12-Month Extension)||16
8553681|NCT00112437|21089908|P16|COMPLETED|Year 3 (12-Month Extension)||13
8553682|NCT00112437|21089909|P15|COMPLETED|Year 3 (12-Month Extension)||17
8553683|NCT00112437|21089910|P14|COMPLETED|Year 3 (12-Month Extension)||16
8553684|NCT00112437|21089911|P13|COMPLETED|Year 3 (12-Month Extension)||18
8553685|NCT00112437|21089912|P12|COMPLETED|Year 3 (12-Month Extension)||17
8553686|NCT00112437|21089913|P11|COMPLETED|Year 3 (12-Month Extension)||17
8553687|NCT00112437|21089914|P10|COMPLETED|Year 3 (12-Month Extension)||0
8553688|NCT00112437|21089915|P9|COMPLETED|Year 3 (12-Month Extension)||0
8553689|NCT00112437|21089916|P8|COMPLETED|Year 3 (12-Month Extension)||0
8553690|NCT00112437|21089917|P7|COMPLETED|Year 3 (12-Month Extension)||0
8553691|NCT00112437|21089918|P6|COMPLETED|Year 3 (12-Month Extension)||0
8553692|NCT00112437|21089919|P5|COMPLETED|Year 3 (12-Month Extension)||0
8553693|NCT00112437|21089920|P4|COMPLETED|Year 3 (12-Month Extension)||0
8553694|NCT00112437|21089921|P3|COMPLETED|Year 3 (12-Month Extension)||0
8553695|NCT00112437|21089922|P2|COMPLETED|Year 3 (12-Month Extension)||0
8553696|NCT00112437|21089923|P1|COMPLETED|Year 3 (12-Month Extension)||0
8553697|NCT00112437|21089898|P26|STARTED|Year 3 (12-Month Extension)||0
8553698|NCT00112437|21089899|P25|STARTED|Year 3 (12-Month Extension)||0
8553699|NCT00112437|21089900|P24|STARTED|Year 3 (12-Month Extension)||0
8553700|NCT00112437|21089901|P23|STARTED|Year 3 (12-Month Extension)||0
8553701|NCT00112437|21089902|P22|STARTED|Year 3 (12-Month Extension)||0
8553702|NCT00112437|21089903|P21|STARTED|Year 3 (12-Month Extension)||0
8553703|NCT00112437|21089904|P20|STARTED|Year 3 (12-Month Extension)||20
8553704|NCT00112437|21089905|P19|STARTED|Year 3 (12-Month Extension)||18
8553705|NCT00112437|21089906|P18|STARTED|Year 3 (12-Month Extension)||21
8553706|NCT00112437|21089907|P17|STARTED|Year 3 (12-Month Extension)||19
8553707|NCT00112437|21089908|P16|STARTED|Year 3 (12-Month Extension)||17
8553708|NCT00112437|21089909|P15|STARTED|Year 3 (12-Month Extension)||18
8553709|NCT00112437|21089910|P14|STARTED|Year 3 (12-Month Extension)||17
8553710|NCT00112437|21089911|P13|STARTED|Year 3 (12-Month Extension)||18
8553711|NCT00112437|21089912|P12|STARTED|Year 3 (12-Month Extension)||22
8553712|NCT00112437|21089913|P11|STARTED|Year 3 (12-Month Extension)||19
8553713|NCT00112437|21089914|P10|STARTED|Year 3 (12-Month Extension)||0
8553714|NCT00112437|21089915|P9|STARTED|Year 3 (12-Month Extension)||0
8553715|NCT00112437|21089916|P8|STARTED|Year 3 (12-Month Extension)||0
8553716|NCT00112437|21089917|P7|STARTED|Year 3 (12-Month Extension)||0
8553717|NCT00112437|21089918|P6|STARTED|Year 3 (12-Month Extension)||0
8553718|NCT00112437|21089919|P5|STARTED|Year 3 (12-Month Extension)||0
8553719|NCT00112437|21089920|P4|STARTED|Year 3 (12-Month Extension)||0
8553720|NCT00112437|21089921|P3|STARTED|Year 3 (12-Month Extension)||0
8553721|NCT00112437|21089922|P2|STARTED|Year 3 (12-Month Extension)||0
8553722|NCT00112437|21089923|P1|STARTED|Year 3 (12-Month Extension)||0
8553723|NCT00112437|21089898|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553724|NCT00112437|21089899|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553725|NCT00112437|21089900|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553726|NCT00112437|21089901|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553727|NCT00112437|21089902|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553728|NCT00112437|21089903|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553729|NCT00112437|21089904|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553730|NCT00112437|21089905|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553731|NCT00112437|21089906|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553732|NCT00112437|21089907|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553733|NCT00112437|21089908|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553734|NCT00112437|21089909|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553735|NCT00112437|21089910|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553736|NCT00112437|21089911|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553737|NCT00112437|21089912|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553738|NCT00112437|21089913|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553739|NCT00112437|21089914|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
8553740|NCT00112437|21089915|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
8553741|NCT00112437|21089916|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
8553742|NCT00112437|21089917|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
8553743|NCT00112437|21089918|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
8553744|NCT00112437|21089919|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553745|NCT00112437|21089920|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553746|NCT00112437|21089921|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553747|NCT00112437|21089922|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553748|NCT00112437|21089923|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553749|NCT00112437|21089898|P26|COMPLETED|Year 2 (12-Month Extension)||0
8553750|NCT00112437|21089899|P25|COMPLETED|Year 2 (12-Month Extension)||0
8553751|NCT00112437|21089900|P24|COMPLETED|Year 2 (12-Month Extension)||0
8553752|NCT00112437|21089901|P23|COMPLETED|Year 2 (12-Month Extension)||0
8553753|NCT00112437|21089902|P22|COMPLETED|Year 2 (12-Month Extension)||0
8553754|NCT00112437|21089903|P21|COMPLETED|Year 2 (12-Month Extension)||0
8553755|NCT00112437|21089904|P20|COMPLETED|Year 2 (12-Month Extension)||0
8553756|NCT00112437|21089905|P19|COMPLETED|Year 2 (12-Month Extension)||0
8553757|NCT00112437|21089906|P18|COMPLETED|Year 2 (12-Month Extension)||0
8553758|NCT00112437|21089907|P17|COMPLETED|Year 2 (12-Month Extension)||0
8553759|NCT00112437|21089908|P16|COMPLETED|Year 2 (12-Month Extension)||0
8553760|NCT00112437|21089909|P15|COMPLETED|Year 2 (12-Month Extension)||0
8553761|NCT00112437|21089910|P14|COMPLETED|Year 2 (12-Month Extension)||0
8553762|NCT00112437|21089911|P13|COMPLETED|Year 2 (12-Month Extension)||0
8553763|NCT00112437|21089912|P12|COMPLETED|Year 2 (12-Month Extension)||0
8553764|NCT00112437|21089913|P11|COMPLETED|Year 2 (12-Month Extension)||0
8553765|NCT00112437|21089914|P10|COMPLETED|Year 2 (12-Month Extension)||50
8553766|NCT00112437|21089915|P9|COMPLETED|Year 2 (12-Month Extension)||62
8553767|NCT00112437|21089916|P8|COMPLETED|Year 2 (12-Month Extension)||55
8553768|NCT00112437|21089917|P7|COMPLETED|Year 2 (12-Month Extension)||53
8553769|NCT00112437|21089918|P6|COMPLETED|Year 2 (12-Month Extension)||60
8553770|NCT00112437|21089919|P5|COMPLETED|Year 2 (12-Month Extension)||0
8553771|NCT00112437|21089920|P4|COMPLETED|Year 2 (12-Month Extension)||0
8553772|NCT00112437|21089921|P3|COMPLETED|Year 2 (12-Month Extension)||0
8553773|NCT00112437|21089922|P2|COMPLETED|Year 2 (12-Month Extension)||0
8553774|NCT00112437|21089923|P1|COMPLETED|Year 2 (12-Month Extension)||0
8553775|NCT00112437|21089898|P26|STARTED|Year 2 (12-Month Extension)||0
8553776|NCT00112437|21089899|P25|STARTED|Year 2 (12-Month Extension)||0
8553777|NCT00112437|21089900|P24|STARTED|Year 2 (12-Month Extension)||0
8553778|NCT00112437|21089901|P23|STARTED|Year 2 (12-Month Extension)||0
8553779|NCT00112437|21089902|P22|STARTED|Year 2 (12-Month Extension)||0
8553780|NCT00112437|21089903|P21|STARTED|Year 2 (12-Month Extension)||0
8553781|NCT00112437|21089904|P20|STARTED|Year 2 (12-Month Extension)||0
8553782|NCT00112437|21089905|P19|STARTED|Year 2 (12-Month Extension)||0
8553783|NCT00112437|21089906|P18|STARTED|Year 2 (12-Month Extension)||0
8553784|NCT00112437|21089907|P17|STARTED|Year 2 (12-Month Extension)||0
8553785|NCT00112437|21089908|P16|STARTED|Year 2 (12-Month Extension)||0
8553786|NCT00112437|21089909|P15|STARTED|Year 2 (12-Month Extension)||0
8553787|NCT00112437|21089910|P14|STARTED|Year 2 (12-Month Extension)||0
8553788|NCT00112437|21089911|P13|STARTED|Year 2 (12-Month Extension)||0
8553789|NCT00112437|21089912|P12|STARTED|Year 2 (12-Month Extension)||0
8553790|NCT00112437|21089913|P11|STARTED|Year 2 (12-Month Extension)||0
8553791|NCT00112437|21089914|P10|STARTED|Year 2 (12-Month Extension)||63
8553792|NCT00112437|21089915|P9|STARTED|Year 2 (12-Month Extension)||69
8553793|NCT00112437|21089916|P8|STARTED|Year 2 (12-Month Extension)||63
8553794|NCT00112437|21089917|P7|STARTED|Year 2 (12-Month Extension)||62
8553795|NCT00112437|21089918|P6|STARTED|Year 2 (12-Month Extension)||63
8553796|NCT00112437|21089919|P5|STARTED|Year 2 (12-Month Extension)||0
8553797|NCT00112437|21089920|P4|STARTED|Year 2 (12-Month Extension)||0
8553798|NCT00112437|21089921|P3|STARTED|Year 2 (12-Month Extension)||0
8553799|NCT00112437|21089922|P2|STARTED|Year 2 (12-Month Extension)||0
8553800|NCT00112437|21089923|P1|STARTED|Year 2 (12-Month Extension)||0
8553801|NCT00112437|21089898|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553802|NCT00112437|21089899|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553803|NCT00112437|21089900|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553804|NCT00112437|21089901|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553805|NCT00112437|21089902|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553806|NCT00112437|21089903|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553807|NCT00112437|21089904|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553808|NCT00112437|21089905|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553809|NCT00112437|21089906|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553810|NCT00112437|21089907|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553811|NCT00112437|21089908|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553812|NCT00112437|21089909|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553813|NCT00112437|21089910|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553814|NCT00112437|21089911|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553815|NCT00112437|21089912|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553816|NCT00112437|21089913|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553817|NCT00112437|21089914|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553818|NCT00112437|21089915|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553819|NCT00112437|21089916|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553820|NCT00112437|21089917|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553821|NCT00112437|21089918|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553822|NCT00112437|21089919|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
8553823|NCT00112437|21089920|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
8553824|NCT00112437|21089921|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
8553825|NCT00112437|21089922|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
8553826|NCT00112437|21089923|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
8553827|NCT00112437|21089898|P26|COMPLETED|Year 1 (12-Month Base Study)||0
8553828|NCT00112437|21089899|P25|COMPLETED|Year 1 (12-Month Base Study)||0
8553829|NCT00112437|21089900|P24|COMPLETED|Year 1 (12-Month Base Study)||0
8553830|NCT00112437|21089901|P23|COMPLETED|Year 1 (12-Month Base Study)||0
8553831|NCT00112437|21089902|P22|COMPLETED|Year 1 (12-Month Base Study)||0
8553832|NCT00112437|21089903|P21|COMPLETED|Year 1 (12-Month Base Study)||0
8553833|NCT00112437|21089904|P20|COMPLETED|Year 1 (12-Month Base Study)||0
8553834|NCT00112437|21089905|P19|COMPLETED|Year 1 (12-Month Base Study)||0
8553835|NCT00112437|21089906|P18|COMPLETED|Year 1 (12-Month Base Study)||0
8553836|NCT00112437|21089907|P17|COMPLETED|Year 1 (12-Month Base Study)||0
8553837|NCT00112437|21089908|P16|COMPLETED|Year 1 (12-Month Base Study)||0
8553838|NCT00112437|21089909|P15|COMPLETED|Year 1 (12-Month Base Study)||0
8553839|NCT00112437|21089910|P14|COMPLETED|Year 1 (12-Month Base Study)||0
8553840|NCT00112437|21089911|P13|COMPLETED|Year 1 (12-Month Base Study)||0
8553841|NCT00112437|21089912|P12|COMPLETED|Year 1 (12-Month Base Study)||0
8553842|NCT00112437|21089913|P11|COMPLETED|Year 1 (12-Month Base Study)||0
8553843|NCT00112437|21089914|P10|COMPLETED|Year 1 (12-Month Base Study)||0
8553844|NCT00112437|21089915|P9|COMPLETED|Year 1 (12-Month Base Study)||0
8553845|NCT00112437|21089916|P8|COMPLETED|Year 1 (12-Month Base Study)||0
8553846|NCT00112437|21089917|P7|COMPLETED|Year 1 (12-Month Base Study)||0
8553847|NCT00112437|21089918|P6|COMPLETED|Year 1 (12-Month Base Study)||0
8553848|NCT00112437|21089919|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
8553849|NCT00112437|21089920|P4|COMPLETED|Year 1 (12-Month Base Study)||71
8553850|NCT00112437|21089921|P3|COMPLETED|Year 1 (12-Month Base Study)||65
8553851|NCT00112437|21089922|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
8553852|NCT00112437|21089923|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
8553853|NCT00112437|21089898|P26|STARTED|Year 1 (12-Month Base Study)||0
8553854|NCT00112437|21089899|P25|STARTED|Year 1 (12-Month Base Study)||0
8553855|NCT00112437|21089900|P24|STARTED|Year 1 (12-Month Base Study)||0
8553856|NCT00112437|21089901|P23|STARTED|Year 1 (12-Month Base Study)||0
8553857|NCT00112437|21089902|P22|STARTED|Year 1 (12-Month Base Study)||0
8553858|NCT00112437|21089903|P21|STARTED|Year 1 (12-Month Base Study)||0
8553859|NCT00112437|21089904|P20|STARTED|Year 1 (12-Month Base Study)||0
8553860|NCT00112437|21089905|P19|STARTED|Year 1 (12-Month Base Study)||0
8553861|NCT00112437|21089906|P18|STARTED|Year 1 (12-Month Base Study)||0
8553862|NCT00112437|21089907|P17|STARTED|Year 1 (12-Month Base Study)||0
8553863|NCT00112437|21089908|P16|STARTED|Year 1 (12-Month Base Study)||0
8553864|NCT00112437|21089909|P15|STARTED|Year 1 (12-Month Base Study)||0
8553865|NCT00112437|21089910|P14|STARTED|Year 1 (12-Month Base Study)||0
8553866|NCT00112437|21089911|P13|STARTED|Year 1 (12-Month Base Study)||0
8553867|NCT00112437|21089912|P12|STARTED|Year 1 (12-Month Base Study)||0
8553868|NCT00112437|21089913|P11|STARTED|Year 1 (12-Month Base Study)||0
8553869|NCT00112437|21089914|P10|STARTED|Year 1 (12-Month Base Study)||0
8553870|NCT00112437|21089915|P9|STARTED|Year 1 (12-Month Base Study)||0
8553871|NCT00112437|21089916|P8|STARTED|Year 1 (12-Month Base Study)||0
8553872|NCT00112437|21089917|P7|STARTED|Year 1 (12-Month Base Study)||0
8553873|NCT00112437|21089918|P6|STARTED|Year 1 (12-Month Base Study)||0
8553874|NCT00112437|21089919|P5|STARTED|Year 1 (12-Month Base Study)||78
8553875|NCT00112437|21089920|P4|STARTED|Year 1 (12-Month Base Study)||79
8553876|NCT00112437|21089921|P3|STARTED|Year 1 (12-Month Base Study)||77
8553877|NCT00112437|21089922|P2|STARTED|Year 1 (12-Month Base Study)||82
8553878|NCT00112437|21089923|P1|STARTED|Year 1 (12-Month Base Study)||83
8553879|NCT00112385|21090203|P2|NOT COMPLETED|Overall Study||1
8553880|NCT00112385|21090204|P1|NOT COMPLETED|Overall Study||1
8553881|NCT00112385|21090203|P2|COMPLETED|Overall Study||4
8553882|NCT00112385|21090204|P1|COMPLETED|Overall Study||10
8553883|NCT00112385|21090203|P2|STARTED|Overall Study||5
8553884|NCT00112385|21090204|P1|STARTED|Overall Study||11
8553885|NCT00112359|21090294|P2|NOT COMPLETED|Overall Study||13
8553886|NCT00112359|21090295|P1|NOT COMPLETED|Overall Study||27
8553887|NCT00112359|21090294|P2|COMPLETED|Overall Study||67
8553888|NCT00112359|21090295|P1|COMPLETED|Overall Study||57
8553889|NCT00112359|21090294|P2|STARTED|Overall Study||80
8553890|NCT00112359|21090295|P1|STARTED|Overall Study||84
8553891|NCT00112294|21090321|P2|NOT COMPLETED|Overall Study||0
8553892|NCT00112294|21090322|P1|NOT COMPLETED|Overall Study||5
8553893|NCT00112294|21090321|P2|COMPLETED|Overall Study|Off all study therapies.|320
8553894|NCT00112294|21090322|P1|COMPLETED|Overall Study|Off all study therapies.|320
8553895|NCT00112294|21090321|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
8553896|NCT00112294|21090322|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
8553897|NCT00112294|21090321|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
8553898|NCT00112294|21090322|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
8553899|NCT00112242|21090365|P5|NOT COMPLETED|Overall Study||7
8553900|NCT00112242|21090366|P4|NOT COMPLETED|Overall Study||6
8553901|NCT00112242|21090367|P3|NOT COMPLETED|Overall Study||1
8553902|NCT00112242|21090368|P2|NOT COMPLETED|Overall Study||2
8553903|NCT00112242|21090369|P1|NOT COMPLETED|Overall Study||5
8553904|NCT00112242|21090365|P5|COMPLETED|Overall Study||2
8553905|NCT00112242|21090366|P4|COMPLETED|Overall Study||4
8553906|NCT00112242|21090367|P3|COMPLETED|Overall Study||4
8553907|NCT00112242|21090368|P2|COMPLETED|Overall Study||3
8553908|NCT00112242|21090369|P1|COMPLETED|Overall Study||5
8553909|NCT00112242|21090365|P5|Cycle 3 Completed|Overall Study||2
8553910|NCT00112242|21090366|P4|Cycle 3 Completed|Overall Study||4
8553911|NCT00112242|21090367|P3|Cycle 3 Completed|Overall Study||4
8553912|NCT00112242|21090368|P2|Cycle 3 Completed|Overall Study||3
8553913|NCT00112242|21090369|P1|Cycle 3 Completed|Overall Study||5
8553914|NCT00112242|21090365|P5|Cycle 2 Completed|Overall Study||4
8553915|NCT00112242|21090366|P4|Cycle 2 Completed|Overall Study||8
8553916|NCT00112242|21090367|P3|Cycle 2 Completed|Overall Study||4
8553917|NCT00112242|21090368|P2|Cycle 2 Completed|Overall Study||3
8553918|NCT00112242|21090369|P1|Cycle 2 Completed|Overall Study||8
8553919|NCT00112242|21090365|P5|Cycle 1 Completed|Overall Study||7
8553920|NCT00112242|21090366|P4|Cycle 1 Completed|Overall Study||9
8553921|NCT00112242|21090367|P3|Cycle 1 Completed|Overall Study||5
8553922|NCT00112242|21090368|P2|Cycle 1 Completed|Overall Study||5
8553923|NCT00112242|21090369|P1|Cycle 1 Completed|Overall Study||10
8553924|NCT00112242|21090365|P5|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
8553925|NCT00112242|21090366|P4|STARTED|Overall Study||10
8553926|NCT00112242|21090367|P3|STARTED|Overall Study||5
8553927|NCT00112242|21090368|P2|STARTED|Overall Study||5
8553928|NCT00112242|21090369|P1|STARTED|Overall Study||10
8553929|NCT00112151|21090432|P6|NOT COMPLETED|Overall Study||3
8553930|NCT00112151|21090433|P5|NOT COMPLETED|Overall Study||6
8553931|NCT00112151|21090434|P4|NOT COMPLETED|Overall Study||3
8553932|NCT00112151|21090435|P3|NOT COMPLETED|Overall Study||3
8553933|NCT00112151|21090436|P2|NOT COMPLETED|Overall Study||5
8553934|NCT00112151|21090437|P1|NOT COMPLETED|Overall Study||4
8553935|NCT00112151|21090432|P6|COMPLETED|Overall Study||25
8553936|NCT00112151|21090433|P5|COMPLETED|Overall Study||22
8553937|NCT00112151|21090434|P4|COMPLETED|Overall Study||24
8553938|NCT00112151|21090435|P3|COMPLETED|Overall Study||25
8553939|NCT00112151|21090436|P2|COMPLETED|Overall Study||23
8553940|NCT00112151|21090437|P1|COMPLETED|Overall Study||24
8553941|NCT00112151|21090432|P6|STARTED|Overall Study||28
8553942|NCT00112151|21090433|P5|STARTED|Overall Study||28
8553943|NCT00112151|21090434|P4|STARTED|Overall Study||27
8553944|NCT00112151|21090435|P3|STARTED|Overall Study||28
8553945|NCT00112151|21090436|P2|STARTED|Overall Study||28
8553946|NCT00112151|21090437|P1|STARTED|Overall Study||28
8553947|NCT00112125|21090468|P2|NOT COMPLETED|Overall Study||22
8553948|NCT00112125|21090469|P1|NOT COMPLETED|Overall Study||24
8553949|NCT00112125|21090468|P2|COMPLETED|Overall Study||193
8553950|NCT00112125|21090469|P1|COMPLETED|Overall Study||189
8553951|NCT00112125|21090468|P2|STARTED|Overall Study||215
8553952|NCT00112125|21090469|P1|STARTED|Overall Study||213
8553953|NCT00112112|21090487|P2|NOT COMPLETED|Overall Study||0
8553954|NCT00112112|21090488|P1|NOT COMPLETED|Overall Study||0
8553955|NCT00112112|21090487|P2|COMPLETED|Overall Study||10
8553956|NCT00112112|21090488|P1|COMPLETED|Overall Study||10
8553957|NCT00112112|21090487|P2|STARTED|Overall Study||10
8553958|NCT00112112|21090488|P1|STARTED|Overall Study||10
8553959|NCT00112047|21090630|P2|NOT COMPLETED|Atripla Phase||20
8553960|NCT00112047|21090631|P1|NOT COMPLETED|Atripla Phase||18
8553961|NCT00112047|21090630|P2|COMPLETED|Atripla Phase||106
8553962|NCT00112047|21090631|P1|COMPLETED|Atripla Phase||142
8553963|NCT00112047|21090630|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
8553964|NCT00112047|21090631|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
8553965|NCT00112047|21090630|P2|NOT COMPLETED|Randomized Phase||88
8553966|NCT00112047|21090631|P1|NOT COMPLETED|Randomized Phase||70
8553967|NCT00112047|21090630|P2|COMPLETED|Randomized Phase||166
8553968|NCT00112047|21090631|P1|COMPLETED|Randomized Phase||187
8553969|NCT00112047|21090630|P2|STARTED|Randomized Phase|ITT analysis population|254
8553970|NCT00112047|21090631|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
8553971|NCT00111917|21090731|P2|NOT COMPLETED|Overall Study||1
8553972|NCT00111917|21090732|P1|NOT COMPLETED|Overall Study||1
8553973|NCT00111917|21090731|P2|COMPLETED|Overall Study||3
8553974|NCT00111917|21090732|P1|COMPLETED|Overall Study||8
8553975|NCT00111917|21090731|P2|STARTED|Overall Study||4
8553976|NCT00111917|21090732|P1|STARTED|Overall Study||9
8553977|NCT00111839|21090747|P3|NOT COMPLETED|Overall Study||49
8553978|NCT00111839|21090748|P2|NOT COMPLETED|Overall Study||46
8553979|NCT00111839|21090749|P1|NOT COMPLETED|Overall Study||48
8553980|NCT00111839|21090747|P3|COMPLETED|Overall Study||0
8553981|NCT00111839|21090748|P2|COMPLETED|Overall Study||5
8553982|NCT00111839|21090749|P1|COMPLETED|Overall Study||2
8553983|NCT00111839|21090747|P3|Treated|Overall Study||47
8553984|NCT00111839|21090748|P2|Treated|Overall Study||51
8553985|NCT00111839|21090749|P1|Treated|Overall Study||50
8553986|NCT00111839|21090747|P3|STARTED|Overall Study||49
8553987|NCT00111839|21090748|P2|STARTED|Overall Study||51
8553988|NCT00111839|21090749|P1|STARTED|Overall Study||50
8553989|NCT00111813|21090769|P6|NOT COMPLETED|Overall Study||6
8553990|NCT00111813|21090770|P5|NOT COMPLETED|Overall Study||6
8553991|NCT00111813|21090771|P4|NOT COMPLETED|Overall Study||5
8553992|NCT00111813|21090772|P3|NOT COMPLETED|Overall Study||10
8553993|NCT00111813|21090773|P2|NOT COMPLETED|Overall Study||3
8553994|NCT00111813|21090774|P1|NOT COMPLETED|Overall Study||3
8553995|NCT00111813|21090769|P6|COMPLETED|Overall Study||0
8553996|NCT00111813|21090770|P5|COMPLETED|Overall Study||0
8553997|NCT00111813|21090771|P4|COMPLETED|Overall Study||1
8553998|NCT00111813|21090772|P3|COMPLETED|Overall Study||0
8553999|NCT00111813|21090773|P2|COMPLETED|Overall Study||0
8554000|NCT00111813|21090774|P1|COMPLETED|Overall Study||0
8554001|NCT00111813|21090769|P6|STARTED|Overall Study||6
8554002|NCT00111813|21090770|P5|STARTED|Overall Study||6
8554003|NCT00111813|21090771|P4|STARTED|Overall Study||6
8554004|NCT00111813|21090772|P3|STARTED|Overall Study||10
8554005|NCT00111813|21090773|P2|STARTED|Overall Study||3
8554006|NCT00111813|21090774|P1|STARTED|Overall Study||3
8554007|NCT00111800|21090813|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
8554008|NCT00111800|21090814|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
8554009|NCT00111800|21090815|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
8554010|NCT00111800|21090816|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
8554011|NCT00111800|21090817|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
8554012|NCT00111800|21090818|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
8554013|NCT00111800|21090813|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
8554014|NCT00111800|21090814|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
8554015|NCT00111800|21090815|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
8554016|NCT00111800|21090816|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
8554017|NCT00111800|21090817|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
8554018|NCT00111800|21090818|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
8554019|NCT00111800|21090813|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
8554020|NCT00111800|21090814|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
8554021|NCT00111800|21090815|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
8554022|NCT00111800|21090816|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
8554023|NCT00111800|21090817|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
8554024|NCT00111800|21090818|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
8554025|NCT00111800|21090813|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
8554026|NCT00111800|21090814|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
8554027|NCT00111800|21090815|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
8554028|NCT00111800|21090816|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
8554029|NCT00111800|21090817|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
8554030|NCT00111800|21090818|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
8554031|NCT00111800|21090813|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
8554032|NCT00111800|21090814|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
8554033|NCT00111800|21090815|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
8554034|NCT00111800|21090816|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
8554035|NCT00111800|21090817|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
8554036|NCT00111800|21090818|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
8554037|NCT00111800|21090813|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
8554038|NCT00111800|21090814|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
8554039|NCT00111800|21090815|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
8554040|NCT00111800|21090816|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
8554041|NCT00111800|21090817|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
8554042|NCT00111800|21090818|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
8554043|NCT00111761|21090988|P2|NOT COMPLETED|Part 2||0
8554044|NCT00111761|21090989|P1|NOT COMPLETED|Part 2||8
8554045|NCT00111761|21090988|P2|COMPLETED|Part 2||0
8554046|NCT00111761|21090989|P1|COMPLETED|Part 2||16
8554047|NCT00111761|21090988|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
8554048|NCT00111761|21090989|P1|STARTED|Part 2||24
8554049|NCT00111761|21090988|P2|NOT COMPLETED|Part 1||5
8554050|NCT00111761|21090989|P1|NOT COMPLETED|Part 1||0
8554051|NCT00111761|21090988|P2|COMPLETED|Part 1|Completed through safety followup|14
8554052|NCT00111761|21090989|P1|COMPLETED|Part 1||0
8554053|NCT00111761|21090988|P2|STARTED|Part 1||19
8554054|NCT00111761|21090989|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
8554055|NCT00111657|21091006|P1|NOT COMPLETED|Overall Study||16
8554056|NCT00111657|21091006|P1|COMPLETED|Overall Study|Completed all intended doses.|21
8554057|NCT00111657|21091006|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
8554058|NCT00111475|21091026|P10|NOT COMPLETED|Overall Study||0
8554059|NCT00111475|21091027|P9|NOT COMPLETED|Overall Study||0
8554060|NCT00111475|21091028|P8|NOT COMPLETED|Overall Study||0
8554061|NCT00111475|21091029|P7|NOT COMPLETED|Overall Study||0
8554062|NCT00111475|21091030|P6|NOT COMPLETED|Overall Study||1
8554063|NCT00111475|21091031|P5|NOT COMPLETED|Overall Study||0
8554064|NCT00111475|21091032|P4|NOT COMPLETED|Overall Study||0
8554065|NCT00111475|21091033|P3|NOT COMPLETED|Overall Study||0
8554066|NCT00111475|21091034|P2|NOT COMPLETED|Overall Study||0
8554067|NCT00111475|21091035|P1|NOT COMPLETED|Overall Study||0
8554068|NCT00111475|21091026|P10|COMPLETED|Overall Study||1
8554069|NCT00111475|21091027|P9|COMPLETED|Overall Study||8
8554070|NCT00111475|21091028|P8|COMPLETED|Overall Study||8
8554071|NCT00111475|21091029|P7|COMPLETED|Overall Study||4
8554072|NCT00111475|21091030|P6|COMPLETED|Overall Study||3
8554073|NCT00111475|21091031|P5|COMPLETED|Overall Study||4
8554074|NCT00111475|21091032|P4|COMPLETED|Overall Study||4
8554075|NCT00111475|21091033|P3|COMPLETED|Overall Study||4
8554076|NCT00111475|21091034|P2|COMPLETED|Overall Study||4
8554077|NCT00111475|21091035|P1|COMPLETED|Overall Study||4
8554078|NCT00111475|21091026|P10|STARTED|Overall Study||1
8554079|NCT00111475|21091027|P9|STARTED|Overall Study||8
8554080|NCT00111475|21091028|P8|STARTED|Overall Study||8
8554081|NCT00111475|21091029|P7|STARTED|Overall Study||4
8554082|NCT00111475|21091030|P6|STARTED|Overall Study||4
8554083|NCT00111475|21091031|P5|STARTED|Overall Study||4
8554084|NCT00111475|21091032|P4|STARTED|Overall Study||4
8554085|NCT00111475|21091033|P3|STARTED|Overall Study||4
8554086|NCT00111475|21091034|P2|STARTED|Overall Study||4
8554087|NCT00111475|21091035|P1|STARTED|Overall Study||4
8554088|NCT00111241|21091153|P2|NOT COMPLETED|Overall Study||8
8554089|NCT00111241|21091154|P1|NOT COMPLETED|Overall Study||15
8554090|NCT00111241|21091153|P2|COMPLETED|Overall Study||62
8554091|NCT00111241|21091154|P1|COMPLETED|Overall Study||30
8554092|NCT00111241|21091153|P2|STARTED|Overall Study||70
8554093|NCT00111241|21091154|P1|STARTED|Overall Study||45
8554094|NCT00111228|21091165|P3|NOT COMPLETED|Overall Study||0
8554095|NCT00111228|21091166|P2|NOT COMPLETED|Overall Study||1
8554096|NCT00111228|21091167|P1|NOT COMPLETED|Overall Study||5
8554097|NCT00111228|21091165|P3|COMPLETED|Overall Study||54
8554098|NCT00111228|21091166|P2|COMPLETED|Overall Study||53
8554099|NCT00111228|21091167|P1|COMPLETED|Overall Study||49
8554100|NCT00111228|21091165|P3|STARTED|Overall Study||54
8554101|NCT00111228|21091166|P2|STARTED|Overall Study||54
8554102|NCT00111228|21091167|P1|STARTED|Overall Study||54
8554103|NCT00111007|21091180|P2|NOT COMPLETED|Long Term Follow-up||45
8554104|NCT00111007|21091181|P1|NOT COMPLETED|Long Term Follow-up||47
8554105|NCT00111007|21091180|P2|COMPLETED|Long Term Follow-up||62
8554106|NCT00111007|21091181|P1|COMPLETED|Long Term Follow-up||54
8554107|NCT00111007|21091180|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
8554108|NCT00111007|21091181|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
8554109|NCT00111007|21091180|P2|NOT COMPLETED|Active Follow-up||2
8554110|NCT00111007|21091181|P1|NOT COMPLETED|Active Follow-up||6
8554111|NCT00111007|21091180|P2|COMPLETED|Active Follow-up||2
8554112|NCT00111007|21091181|P1|COMPLETED|Active Follow-up||0
8554113|NCT00111007|21091180|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
8554114|NCT00111007|21091181|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
8554115|NCT00111007|21091180|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
8554116|NCT00111007|21091181|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
8554117|NCT00111007|21091180|P2|COMPLETED|Double-blind (DB) Treatment||24
8554118|NCT00111007|21091181|P1|COMPLETED|Double-blind (DB) Treatment||27
8554119|NCT00111007|21091180|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
8554120|NCT00111007|21091181|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
8554121|NCT00111007|21091180|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
8554122|NCT00111007|21091181|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
8554123|NCT00110994|21091197|P2|NOT COMPLETED|Long Term Follow-up||17
8554124|NCT00110994|21091198|P1|NOT COMPLETED|Long Term Follow-up||19
8554125|NCT00110994|21091197|P2|COMPLETED|Long Term Follow-up||30
8554126|NCT00110994|21091198|P1|COMPLETED|Long Term Follow-up||22
8554127|NCT00110994|21091197|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
8554128|NCT00110994|21091198|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
8554129|NCT00110994|21091197|P2|NOT COMPLETED|Active Follow-up||2
8554130|NCT00110994|21091198|P1|NOT COMPLETED|Active Follow-up||1
8554131|NCT00110994|21091197|P2|COMPLETED|Active Follow-up||0
8554132|NCT00110994|21091198|P1|COMPLETED|Active Follow-up||0
8554133|NCT00110994|21091197|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
8554134|NCT00110994|21091198|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
8554135|NCT00110994|21091197|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
8554136|NCT00110994|21091198|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
8554137|NCT00110994|21091197|P2|COMPLETED|Double-blind (DB) Treatment||3
8554138|NCT00110994|21091198|P1|COMPLETED|Double-blind (DB) Treatment||9
8554139|NCT00110994|21091197|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
8554140|NCT00110994|21091198|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
8554141|NCT00110994|21091197|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
8554142|NCT00110994|21091198|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
8554143|NCT00110890|21091224|P2|NOT COMPLETED|Overall Study||179
8554144|NCT00110890|21091225|P1|NOT COMPLETED|Overall Study||361
8554145|NCT00110890|21091224|P2|COMPLETED|Overall Study|Follow-up Phase|5
8554146|NCT00110890|21091225|P1|COMPLETED|Overall Study|Follow-up Phase|7
8554147|NCT00110890|21091224|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
8554148|NCT00110890|21091225|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
8554149|NCT00110890|21091224|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
8554150|NCT00110890|21091225|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
8554151|NCT00110890|21091224|P2|STARTED|Overall Study||184
8554152|NCT00110890|21091225|P1|STARTED|Overall Study||368
8554153|NCT00110812|21091242|P3|NOT COMPLETED|Extended Follow-up||4
8554154|NCT00110812|21091243|P2|NOT COMPLETED|Extended Follow-up||4
8554155|NCT00110812|21091244|P1|NOT COMPLETED|Extended Follow-up||2
8554156|NCT00110812|21091242|P3|COMPLETED|Extended Follow-up||69
8554157|NCT00110812|21091243|P2|COMPLETED|Extended Follow-up||65
8554158|NCT00110812|21091244|P1|COMPLETED|Extended Follow-up||78
8554159|NCT00110812|21091242|P3|STARTED|Extended Follow-up||73
8554160|NCT00110812|21091243|P2|STARTED|Extended Follow-up||69
8554161|NCT00110812|21091244|P1|STARTED|Extended Follow-up||80
8554162|NCT00110812|21091242|P3|NOT COMPLETED|Main Study||13
8554163|NCT00110812|21091243|P2|NOT COMPLETED|Main Study||11
8554164|NCT00110812|21091244|P1|NOT COMPLETED|Main Study||8
8554165|NCT00110812|21091242|P3|COMPLETED|Main Study||74
8554166|NCT00110812|21091243|P2|COMPLETED|Main Study||78
8554167|NCT00110812|21091244|P1|COMPLETED|Main Study||83
8554168|NCT00110812|21091242|P3|STARTED|Main Study||87
8554169|NCT00110812|21091243|P2|STARTED|Main Study||89
8554170|NCT00110812|21091244|P1|STARTED|Main Study||91
8554171|NCT00110617|21091289|P2|NOT COMPLETED|Overall Study||29
8554172|NCT00110617|21091290|P1|NOT COMPLETED|Overall Study||39
8554173|NCT00110617|21091289|P2|COMPLETED|Overall Study||39
8554174|NCT00110617|21091290|P1|COMPLETED|Overall Study||96
8554175|NCT00110617|21091289|P2|On Going at Week 24|Overall Study||53
8554176|NCT00110617|21091290|P1|On Going at Week 24|Overall Study||126
8554177|NCT00110617|21091289|P2|Full Analysis 2; Received ICL670|Overall Study||53
8554178|NCT00110617|21091290|P1|Full Analysis 2; Received ICL670|Overall Study||135
8554179|NCT00110617|21091289|P2|Safety Set 1; Received Study Drug|Overall Study||56
8554180|NCT00110617|21091290|P1|Safety Set 1; Received Study Drug|Overall Study||135
8554181|NCT00110617|21091289|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
8554182|NCT00110617|21091290|P1|STARTED|Overall Study||135
8554183|NCT00110513|21091303|P1|NOT COMPLETED|Overall Study||0
8554184|NCT00110513|21091303|P1|COMPLETED|Overall Study||18
8554185|NCT00110513|21091303|P1|STARTED|Overall Study||18
8554186|NCT00110461|21091310|P3|NOT COMPLETED|Acute Phase||23
8554187|NCT00110461|21091311|P2|NOT COMPLETED|Acute Phase||22
8554188|NCT00110461|21091312|P1|NOT COMPLETED|Acute Phase||14
8554189|NCT00110461|21091310|P3|COMPLETED|Acute Phase||76
8554190|NCT00110461|21091311|P2|COMPLETED|Acute Phase||77
8554191|NCT00110461|21091312|P1|COMPLETED|Acute Phase||84
8554192|NCT00110461|21091310|P3|STARTED|Acute Phase||99
8554193|NCT00110461|21091311|P2|STARTED|Acute Phase||99
8554194|NCT00110461|21091312|P1|STARTED|Acute Phase||98
8554195|NCT00110461|21091310|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
8554196|NCT00110461|21091311|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
8554197|NCT00110461|21091312|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
8554198|NCT00110461|21091310|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
8554199|NCT00110461|21091311|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
8554200|NCT00110461|21091312|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
8554201|NCT00110461|21091310|P3|STARTED|30-Week, Double-blind Treatment Phase||99
8554202|NCT00110461|21091311|P2|STARTED|30-Week, Double-blind Treatment Phase||99
8554203|NCT00110461|21091312|P1|STARTED|30-Week, Double-blind Treatment Phase||98
8554204|NCT00110396|21091407|P1|NOT COMPLETED|Overall Study||36
8554205|NCT00110396|21091407|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
8554206|NCT00110396|21091407|P1|STARTED|Overall Study||260
8554207|NCT00110357|21091415|P2|NOT COMPLETED|Overall Study||19
8554208|NCT00110357|21091416|P1|NOT COMPLETED|Overall Study||27
8554209|NCT00110357|21091415|P2|COMPLETED|Overall Study|Number Still on Study|0
8554210|NCT00110357|21091416|P1|COMPLETED|Overall Study|Number Still on Study|0
8554211|NCT00110357|21091415|P2|STARTED|Overall Study||19
8554212|NCT00110357|21091416|P1|STARTED|Overall Study||27
8554213|NCT00110305|21091504|P2|NOT COMPLETED|Overall Study||32
8554214|NCT00110305|21091505|P1|NOT COMPLETED|Overall Study||114
8554215|NCT00110305|21091504|P2|COMPLETED|Overall Study||57
8554216|NCT00110305|21091505|P1|COMPLETED|Overall Study||165
8554217|NCT00110305|21091504|P2|STARTED|Overall Study||89
8554218|NCT00110305|21091505|P1|STARTED|Overall Study||279
8554219|NCT00110214|21091558|P2|NOT COMPLETED|Overall Study||503
8554220|NCT00110214|21091559|P1|NOT COMPLETED|Overall Study||509
8554221|NCT00110214|21091558|P2|COMPLETED|Overall Study||21
8554222|NCT00110214|21091559|P1|COMPLETED|Overall Study||17
8554223|NCT00110214|21091558|P2|STARTED|Overall Study||524
8554224|NCT00110214|21091559|P1|STARTED|Overall Study||526
8554225|NCT00110149|21091571|P1|NOT COMPLETED|Overall Study||3
8554226|NCT00110149|21091571|P1|COMPLETED|Overall Study||9
8554227|NCT00110149|21091571|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
8554228|NCT00110149|21091571|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
8554229|NCT00110136|21091576|P1|NOT COMPLETED|Overall Study||0
8554230|NCT00110136|21091576|P1|COMPLETED|Overall Study||9
8554231|NCT00110136|21091576|P1|STARTED|Overall Study||9
8554232|NCT00110084|21091585|P1|NOT COMPLETED|Overall Study||28
8554233|NCT00110084|21091585|P1|COMPLETED|Overall Study||22
8554234|NCT00110084|21091585|P1|STARTED|Overall Study||50
8554235|NCT00110019|21091594|P2|NOT COMPLETED|Overall Study||413
8554236|NCT00110019|21091595|P1|NOT COMPLETED|Overall Study||406
8554237|NCT00110019|21091594|P2|COMPLETED|Overall Study||0
8554238|NCT00110019|21091595|P1|COMPLETED|Overall Study||4
8554239|NCT00110019|21091594|P2|Treated|Overall Study||397
8554240|NCT00110019|21091595|P1|Treated|Overall Study||393
8554241|NCT00110019|21091594|P2|Eligible|Overall Study||398
8554242|NCT00110019|21091595|P1|Eligible|Overall Study||395
8554243|NCT00110019|21091594|P2|STARTED|Overall Study||413
8554244|NCT00110019|21091595|P1|STARTED|Overall Study||410
8554245|NCT00109967|21091607|P2|NOT COMPLETED|Overall Study||6
8554246|NCT00109967|21091608|P1|NOT COMPLETED|Overall Study||20
8554247|NCT00109967|21091607|P2|COMPLETED|Overall Study||15
8554248|NCT00109967|21091608|P1|COMPLETED|Overall Study||30
8554249|NCT00109967|21091607|P2|STARTED|Overall Study||21
8554250|NCT00109967|21091608|P1|STARTED|Overall Study||50
8554251|NCT00109928|21091622|P1|NOT COMPLETED|Overall Study||13
8554252|NCT00109928|21091622|P1|COMPLETED|Overall Study||21
8554253|NCT00109928|21091622|P1|Eligible and Began Protocol Therapy|Overall Study||33
8554254|NCT00109928|21091622|P1|Eligible|Overall Study||33
8554255|NCT00109928|21091622|P1|STARTED|Overall Study||34
8554256|NCT00109876|21091629|P1|NOT COMPLETED|Overall Study||0
8554257|NCT00109876|21091629|P1|COMPLETED|Overall Study||51
8554258|NCT00109876|21091629|P1|STARTED|Overall Study||51
8554259|NCT00109850|21091639|P1|NOT COMPLETED|Overall Study||4
8554260|NCT00109850|21091639|P1|COMPLETED|Overall Study||18
8554261|NCT00109850|21091639|P1|Eligible and Began Protocol Therapy|Overall Study||21
8554262|NCT00109850|21091639|P1|Eligible|Overall Study||21
8554263|NCT00109850|21091639|P1|STARTED|Overall Study||22
8554264|NCT00109837|21091646|P1|NOT COMPLETED|Overall Study||23
8554265|NCT00109837|21091646|P1|COMPLETED|Overall Study||56
8554266|NCT00109837|21091646|P1|Eligible and Ph- and Treated|Overall Study||60
8554267|NCT00109837|21091646|P1|Eligible and Ph-|Overall Study||61
8554268|NCT00109837|21091646|P1|Eligible|Overall Study||78
8554269|NCT00109837|21091646|P1|STARTED|Overall Study||79
8554270|NCT00109772|21091656|P2|NOT COMPLETED|Open-label Extension||49
8554271|NCT00109772|21091657|P1|NOT COMPLETED|Open-label Extension||45
8554272|NCT00109772|21091656|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
8554273|NCT00109772|21091657|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
8554274|NCT00109772|21091656|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
8554275|NCT00109772|21091657|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
8554276|NCT00109772|21091656|P2|NOT COMPLETED|Double-blind Treatment||15
8554277|NCT00109772|21091657|P1|NOT COMPLETED|Double-blind Treatment||22
8554278|NCT00109772|21091656|P2|COMPLETED|Double-blind Treatment||79
8554279|NCT00109772|21091657|P1|COMPLETED|Double-blind Treatment||68
8554280|NCT00109772|21091656|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
8554281|NCT00109772|21091657|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
8554282|NCT00109772|21091656|P2|STARTED|Double-blind Treatment||94
8554283|NCT00109772|21091657|P1|STARTED|Double-blind Treatment||90
8554284|NCT00109733|21091697|P2|NOT COMPLETED|Overall Study||4
8554285|NCT00109733|21091698|P1|NOT COMPLETED|Overall Study||2
8554286|NCT00109733|21091697|P2|COMPLETED|Overall Study||12
8554287|NCT00109733|21091698|P1|COMPLETED|Overall Study||13
8554288|NCT00109733|21091697|P2|STARTED|Overall Study||16
8554289|NCT00109733|21091698|P1|STARTED|Overall Study||15
8554290|NCT00109590|21091715|P3|NOT COMPLETED|Overall Study||4
8554291|NCT00109590|21091716|P2|NOT COMPLETED|Overall Study||2
8554292|NCT00109590|21091717|P1|NOT COMPLETED|Overall Study||2
8554293|NCT00109590|21091715|P3|COMPLETED|Overall Study||56
8554294|NCT00109590|21091716|P2|COMPLETED|Overall Study||56
8554295|NCT00109590|21091717|P1|COMPLETED|Overall Study||55
8554296|NCT00109590|21091715|P3|RECEIVED TREATMENT|Overall Study||57
8554297|NCT00109590|21091716|P2|RECEIVED TREATMENT|Overall Study||56
8554298|NCT00109590|21091717|P1|RECEIVED TREATMENT|Overall Study||56
8554299|NCT00109590|21091715|P3|STARTED|Overall Study||60
8554300|NCT00109590|21091716|P2|STARTED|Overall Study||58
8554301|NCT00109590|21091717|P1|STARTED|Overall Study||57
8554302|NCT00109577|21091759|P2|NOT COMPLETED|Overall Study||3
8554303|NCT00109577|21091760|P1|NOT COMPLETED|Overall Study||3
8554304|NCT00109577|21091759|P2|COMPLETED|Overall Study||17
8554305|NCT00109577|21091760|P1|COMPLETED|Overall Study||17
8554306|NCT00109577|21091759|P2|STARTED|Overall Study||20
8554307|NCT00109577|21091760|P1|STARTED|Overall Study||20
8554308|NCT00109473|21091768|P2|NOT COMPLETED|52 Week Extension Phase||5
8554309|NCT00109473|21091769|P1|NOT COMPLETED|52 Week Extension Phase||4
8554310|NCT00109473|21091768|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
8554311|NCT00109473|21091769|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
8554312|NCT00109473|21091768|P2|Analyzed|52 Week Extension Phase||8
8554313|NCT00109473|21091769|P1|Analyzed|52 Week Extension Phase||9
8554314|NCT00109473|21091768|P2|STARTED|52 Week Extension Phase||8
8554315|NCT00109473|21091769|P1|STARTED|52 Week Extension Phase||9
8554316|NCT00109473|21091768|P2|NOT COMPLETED|Week 12 to Week 24||0
8554317|NCT00109473|21091769|P1|NOT COMPLETED|Week 12 to Week 24||1
8554318|NCT00109473|21091768|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
8554319|NCT00109473|21091769|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
8554320|NCT00109473|21091768|P2|Analyzed|Week 12 to Week 24||9
8554321|NCT00109473|21091769|P1|Analyzed|Week 12 to Week 24||9
8554322|NCT00109473|21091768|P2|STARTED|Week 12 to Week 24||9
8554323|NCT00109473|21091769|P1|STARTED|Week 12 to Week 24||10
8554324|NCT00109473|21091768|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
8554325|NCT00109473|21091769|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
8554326|NCT00109473|21091768|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
8554327|NCT00109473|21091769|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
8554328|NCT00109473|21091768|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
8554329|NCT00109473|21091769|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
8554330|NCT00109473|21091768|P2|STARTED|Baseline (0 Through 12 Weeks)||10
8554331|NCT00109473|21091769|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
8554332|NCT00109343|21091793|P3|NOT COMPLETED|Overall Study||30
8554333|NCT00109343|21091794|P2|NOT COMPLETED|Overall Study||37
8554334|NCT00109343|21091795|P1|NOT COMPLETED|Overall Study||64
8554335|NCT00109343|21091793|P3|COMPLETED|Overall Study||229
8554336|NCT00109343|21091794|P2|COMPLETED|Overall Study||221
8554337|NCT00109343|21091795|P1|COMPLETED|Overall Study||446
8554338|NCT00109343|21091793|P3|Vaccinated at Visit 4|Overall Study||240
8554339|NCT00109343|21091794|P2|Vaccinated at Visit 4|Overall Study||235
8554340|NCT00109343|21091795|P1|Vaccinated at Visit 4|Overall Study||466
8554341|NCT00109343|21091793|P3|Vaccinated at Visit 2|Overall Study||246
8554342|NCT00109343|21091794|P2|Vaccinated at Visit 2|Overall Study||246
8554343|NCT00109343|21091795|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
8554344|NCT00109343|21091793|P3|Vaccinated at Visit 1|Overall Study||259
8554345|NCT00109343|21091794|P2|Vaccinated at Visit 1|Overall Study||258
8554346|NCT00109343|21091795|P1|Vaccinated at Visit 1|Overall Study||510
8554347|NCT00109343|21091793|P3|STARTED|Overall Study||259
8554348|NCT00109343|21091794|P2|STARTED|Overall Study||258
8554349|NCT00109343|21091795|P1|STARTED|Overall Study||510
8554350|NCT00109031|21091840|P4|NOT COMPLETED|Overall Study||0
8554351|NCT00109031|21091841|P3|NOT COMPLETED|Overall Study||2
8554352|NCT00109031|21091842|P2|NOT COMPLETED|Overall Study||2
8554353|NCT00109031|21091843|P1|NOT COMPLETED|Overall Study||0
8554354|NCT00109031|21091840|P4|COMPLETED|Overall Study||12
8554355|NCT00109031|21091841|P3|COMPLETED|Overall Study||12
8554356|NCT00109031|21091842|P2|COMPLETED|Overall Study||8
8554357|NCT00109031|21091843|P1|COMPLETED|Overall Study||11
8554358|NCT00109031|21091840|P4|STARTED|Overall Study||12
8554359|NCT00109031|21091841|P3|STARTED|Overall Study||14
8554360|NCT00109031|21091842|P2|STARTED|Overall Study||10
8554361|NCT00109031|21091843|P1|STARTED|Overall Study||11
8554362|NCT00109005|21091879|P2|NOT COMPLETED|Overall Study||0
8554363|NCT00109005|21091880|P1|NOT COMPLETED|Overall Study||0
8554364|NCT00109005|21091879|P2|COMPLETED|Overall Study||9
8554365|NCT00109005|21091880|P1|COMPLETED|Overall Study||8
8554366|NCT00109005|21091879|P2|STARTED|Overall Study||9
8554367|NCT00109005|21091880|P1|STARTED|Overall Study||8
8554368|NCT00108953|21091894|P2|NOT COMPLETED|Follow-up||33
8554369|NCT00108953|21091895|P1|NOT COMPLETED|Follow-up||29
8554370|NCT00108953|21091894|P2|COMPLETED|Follow-up||12
8554371|NCT00108953|21091895|P1|COMPLETED|Follow-up||11
8554372|NCT00108953|21091894|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
8554373|NCT00108953|21091895|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
8554374|NCT00108953|21091894|P2|NOT COMPLETED|Treatment Period||0
8554375|NCT00108953|21091895|P1|NOT COMPLETED|Treatment Period||0
8554376|NCT00108953|21091894|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
8554377|NCT00108953|21091895|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
8554378|NCT00108953|21091894|P2|STARTED|Treatment Period|ITT population|49
8554379|NCT00108953|21091895|P1|STARTED|Treatment Period|ITT population|47
8554380|NCT00108862|21091917|P2|NOT COMPLETED|Overall Study||62
8554381|NCT00108862|21091918|P1|NOT COMPLETED|Overall Study||68
8554382|NCT00108862|21091917|P2|COMPLETED|Overall Study||339
8554383|NCT00108862|21091918|P1|COMPLETED|Overall Study||337
8554384|NCT00108862|21091917|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
8554385|NCT00108862|21091918|P1|STARTED|Overall Study||405
8554386|NCT00108732|21091946|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
8554387|NCT00108732|21091946|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
8554388|NCT00108732|21091946|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
8554389|NCT00108732|21091946|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
8554390|NCT00108732|21091946|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
8554391|NCT00108732|21091946|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
8554392|NCT00108732|21091946|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
8554393|NCT00108628|21091955|P2|NOT COMPLETED|Overall Study||10
8554394|NCT00108628|21091956|P1|NOT COMPLETED|Overall Study||20
8554395|NCT00108628|21091955|P2|COMPLETED|Overall Study||53
8554396|NCT00108628|21091956|P1|COMPLETED|Overall Study||41
8554397|NCT00108628|21091955|P2|Completed Treatment|Overall Study||57
8554398|NCT00108628|21091956|P1|Completed Treatment|Overall Study||42
8554399|NCT00108628|21091955|P2|Received One or More Sessions|Overall Study||58
8554400|NCT00108628|21091956|P1|Received One or More Sessions|Overall Study||53
8554401|NCT00108628|21091955|P2|STARTED|Overall Study||63
8554402|NCT00108628|21091956|P1|STARTED|Overall Study||61
8554403|NCT00108550|21091982|P2|NOT COMPLETED|Overall Study||16
8554404|NCT00108550|21091983|P1|NOT COMPLETED|Overall Study||16
8554405|NCT00108550|21091982|P2|COMPLETED|Overall Study||37
8554406|NCT00108550|21091983|P1|COMPLETED|Overall Study||39
8554407|NCT00108550|21091982|P2|STARTED|Overall Study||53
8554408|NCT00108550|21091983|P1|STARTED|Overall Study||55
8554409|NCT00108524|21091993|P2|NOT COMPLETED|Overall Study||18
8554410|NCT00108524|21091994|P1|NOT COMPLETED|Overall Study||29
8554411|NCT00108524|21091993|P2|COMPLETED|Overall Study||61
8554412|NCT00108524|21091994|P1|COMPLETED|Overall Study||52
8554413|NCT00108524|21091993|P2|STARTED|Overall Study||79
8554414|NCT00108524|21091994|P1|STARTED|Overall Study||81
8554415|NCT00108485|21092006|P2|NOT COMPLETED|Overall Study||2
8554416|NCT00108485|21092007|P1|NOT COMPLETED|Overall Study||3
8554417|NCT00108485|21092006|P2|COMPLETED|Overall Study||2
8554418|NCT00108485|21092007|P1|COMPLETED|Overall Study||2
8554419|NCT00108485|21092006|P2|STARTED|Overall Study||4
8554420|NCT00108485|21092007|P1|STARTED|Overall Study||5
8554421|NCT00108433|21092015|P2|NOT COMPLETED|Overall Study||17
8554422|NCT00108433|21092016|P1|NOT COMPLETED|Overall Study||21
8554423|NCT00108433|21092015|P2|COMPLETED|Overall Study||14
8554424|NCT00108433|21092016|P1|COMPLETED|Overall Study||9
8554425|NCT00108433|21092015|P2|STARTED|Overall Study||31
8554426|NCT00108433|21092016|P1|STARTED|Overall Study||30
8554427|NCT00108355|21092032|P2|NOT COMPLETED|Overall Study||2
8554428|NCT00108355|21092033|P1|NOT COMPLETED|Overall Study||2
8554429|NCT00108355|21092032|P2|COMPLETED|Overall Study||12
8554430|NCT00108355|21092033|P1|COMPLETED|Overall Study||13
8554431|NCT00108355|21092032|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
8554432|NCT00108355|21092033|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
8554433|NCT00108342|21092043|P2|NOT COMPLETED|Overall Study||0
8554434|NCT00108342|21092044|P1|NOT COMPLETED|Overall Study||1
8554435|NCT00108342|21092043|P2|COMPLETED|Overall Study||9
8554436|NCT00108342|21092044|P1|COMPLETED|Overall Study||7
8554437|NCT00108342|21092043|P2|STARTED|Overall Study||9
8554438|NCT00108342|21092044|P1|STARTED|Overall Study||8
8554439|NCT00108303|21092053|P3|NOT COMPLETED|Overall Study||0
8554440|NCT00108303|21092054|P2|NOT COMPLETED|Overall Study||0
8554441|NCT00108303|21092055|P1|NOT COMPLETED|Overall Study||0
8554442|NCT00108303|21092053|P3|COMPLETED|Overall Study||180
8554443|NCT00108303|21092054|P2|COMPLETED|Overall Study||179
8554444|NCT00108303|21092055|P1|COMPLETED|Overall Study||179
8554445|NCT00108303|21092053|P3|STARTED|Overall Study||180
8554446|NCT00108303|21092054|P2|STARTED|Overall Study||179
8554447|NCT00108303|21092055|P1|STARTED|Overall Study||179
8554448|NCT00108277|21092070|P3|NOT COMPLETED|Overall Study||16
8554449|NCT00108277|21092071|P2|NOT COMPLETED|Overall Study||12
8554450|NCT00108277|21092072|P1|NOT COMPLETED|Overall Study||10
8554451|NCT00108277|21092070|P3|COMPLETED|Overall Study||19
8554452|NCT00108277|21092071|P2|COMPLETED|Overall Study||16
8554453|NCT00108277|21092072|P1|COMPLETED|Overall Study||19
8554454|NCT00108277|21092070|P3|STARTED|Overall Study||35
8554455|NCT00108277|21092071|P2|STARTED|Overall Study||28
8554456|NCT00108277|21092072|P1|STARTED|Overall Study||29
8554457|NCT00108160|21092082|P2|NOT COMPLETED|Overall Study||21
8554458|NCT00108160|21092083|P1|NOT COMPLETED|Overall Study||39
8554459|NCT00108160|21092082|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
8554460|NCT00108160|21092083|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
8554461|NCT00108160|21092082|P2|Completed Visit 7 (18 mo)|Overall Study||31
8554462|NCT00108160|21092083|P1|Completed Visit 7 (18 mo)|Overall Study||34
8554463|NCT00108160|21092082|P2|Completed Visit 6 (15 mo)|Overall Study||33
8554464|NCT00108160|21092083|P1|Completed Visit 6 (15 mo)|Overall Study||36
8554465|NCT00108160|21092082|P2|Completed Visit 5 (12 mo)|Overall Study||37
8554466|NCT00108160|21092083|P1|Completed Visit 5 (12 mo)|Overall Study||37
8554467|NCT00108160|21092082|P2|Completed Visit 4 (9 mo)|Overall Study||37
8554468|NCT00108160|21092083|P1|Completed Visit 4 (9 mo)|Overall Study||38
8554469|NCT00108160|21092082|P2|Completed Visit 3 (6 mo)|Overall Study||38
8554470|NCT00108160|21092083|P1|Completed Visit 3 (6 mo)|Overall Study||44
8554471|NCT00108160|21092082|P2|Completed Visit 2 (3 mo)|Overall Study||46
8554472|NCT00108160|21092083|P1|Completed Visit 2 (3 mo)|Overall Study||54
8554473|NCT00108160|21092082|P2|Completed Visit 1 (2 Wks)|Overall Study||54
8554474|NCT00108160|21092083|P1|Completed Visit 1 (2 Wks)|Overall Study||72
8554475|NCT00108160|21092082|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
8554476|NCT00108160|21092083|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
8554477|NCT00108160|21092082|P2|STARTED|Overall Study||63
8554478|NCT00108160|21092083|P1|STARTED|Overall Study||83
8554479|NCT00108082|21092096|P3|NOT COMPLETED|Overall Study||43
8554480|NCT00108082|21092097|P2|NOT COMPLETED|Overall Study||32
8554481|NCT00108082|21092098|P1|NOT COMPLETED|Overall Study||38
8554482|NCT00108082|21092096|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
8554483|NCT00108082|21092097|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
8554484|NCT00108082|21092098|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
8554485|NCT00108082|21092096|P3|STARTED|Overall Study||96
8554486|NCT00108082|21092097|P2|STARTED|Overall Study||100
8554487|NCT00108082|21092098|P1|STARTED|Overall Study||91
8554488|NCT00108069|21092147|P2|NOT COMPLETED|Overall Study||13
8554489|NCT00108069|21092148|P1|NOT COMPLETED|Overall Study||30
8554490|NCT00108069|21092147|P2|COMPLETED|Overall Study||0
8554491|NCT00108069|21092148|P1|COMPLETED|Overall Study||0
8554492|NCT00108069|21092147|P2|STARTED|Overall Study||13
8554493|NCT00108069|21092148|P1|STARTED|Overall Study||30
8554494|NCT00107991|21092162|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
8554495|NCT00107991|21092162|P1|COMPLETED|18-Week Post Treatment Assessment||8
8554496|NCT00107991|21092162|P1|STARTED|18-Week Post Treatment Assessment||10
8554497|NCT00107991|21092162|P1|NOT COMPLETED|12 Week Treatment Period||5
8554498|NCT00107991|21092162|P1|COMPLETED|12 Week Treatment Period||10
8554499|NCT00107991|21092162|P1|STARTED|12 Week Treatment Period||15
8554500|NCT00107991|21092162|P1|NOT COMPLETED|Eligibility Assessment||23
8554501|NCT00107991|21092162|P1|COMPLETED|Eligibility Assessment||15
8554502|NCT00107991|21092162|P1|STARTED|Eligibility Assessment||38
8554503|NCT00107978|21092172|P2|NOT COMPLETED|Overall Study||50
8554504|NCT00107978|21092173|P1|NOT COMPLETED|Overall Study||33
8554505|NCT00107978|21092172|P2|COMPLETED|Overall Study||431
8554506|NCT00107978|21092173|P1|COMPLETED|Overall Study||425
8554507|NCT00107978|21092172|P2|STARTED|Overall Study||481
8554508|NCT00107978|21092173|P1|STARTED|Overall Study||458
8554509|NCT00107952|21092181|P2|NOT COMPLETED|Overall Study||81
8554510|NCT00107952|21092182|P1|NOT COMPLETED|Overall Study||95
8554511|NCT00107952|21092181|P2|COMPLETED|Overall Study||299
8554512|NCT00107952|21092182|P1|COMPLETED|Overall Study||286
8554513|NCT00107952|21092181|P2|STARTED|Overall Study||380
8554514|NCT00107952|21092182|P1|STARTED|Overall Study||381
8554515|NCT00107900|21092194|P6|NOT COMPLETED|Overall Study||9
8554516|NCT00107900|21092195|P5|NOT COMPLETED|Overall Study||21
8554517|NCT00107900|21092196|P4|NOT COMPLETED|Overall Study||12
8554518|NCT00107900|21092197|P3|NOT COMPLETED|Overall Study||25
8554519|NCT00107900|21092198|P2|NOT COMPLETED|Overall Study||3
8554520|NCT00107900|21092199|P1|NOT COMPLETED|Overall Study||10
8554521|NCT00107900|21092194|P6|COMPLETED|Overall Study||94
8554522|NCT00107900|21092195|P5|COMPLETED|Overall Study||94
8554523|NCT00107900|21092196|P4|COMPLETED|Overall Study||87
8554524|NCT00107900|21092197|P3|COMPLETED|Overall Study||104
8554525|NCT00107900|21092198|P2|COMPLETED|Overall Study||72
8554526|NCT00107900|21092199|P1|COMPLETED|Overall Study||75
8554527|NCT00107900|21092194|P6|STARTED|Overall Study||103
8554528|NCT00107900|21092195|P5|STARTED|Overall Study||115
8554529|NCT00107900|21092196|P4|STARTED|Overall Study||99
8554530|NCT00107900|21092197|P3|STARTED|Overall Study||129
8554531|NCT00107900|21092198|P2|STARTED|Overall Study||75
8554532|NCT00107900|21092199|P1|STARTED|Overall Study||85
8554533|NCT00107783|21092233|P2|NOT COMPLETED|Overall Study||4
8554534|NCT00107783|21092234|P1|NOT COMPLETED|Overall Study||3
8554535|NCT00107783|21092233|P2|COMPLETED|Overall Study||16
8554536|NCT00107783|21092234|P1|COMPLETED|Overall Study||17
8554537|NCT00107783|21092233|P2|STARTED|Overall Study||20
8554538|NCT00107783|21092234|P1|STARTED|Overall Study||20
8554539|NCT00107744|21092251|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8554540|NCT00107744|21092252|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8554541|NCT00107744|21092253|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8554542|NCT00107744|21092251|P3|COMPLETED|Intervention 3 (8 Weeks)||88
8554543|NCT00107744|21092252|P2|COMPLETED|Intervention 3 (8 Weeks)||92
8554544|NCT00107744|21092253|P1|COMPLETED|Intervention 3 (8 Weeks)||93
8554545|NCT00107744|21092251|P3|STARTED|Intervention 3 (8 Weeks)||88
8554546|NCT00107744|21092252|P2|STARTED|Intervention 3 (8 Weeks)||92
8554547|NCT00107744|21092253|P1|STARTED|Intervention 3 (8 Weeks)||93
8554548|NCT00107744|21092251|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
8554549|NCT00107744|21092252|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
8554550|NCT00107744|21092253|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
8554551|NCT00107744|21092251|P3|COMPLETED|Intervention 2 (8 Weeks)||88
8554552|NCT00107744|21092252|P2|COMPLETED|Intervention 2 (8 Weeks)||92
8554553|NCT00107744|21092253|P1|COMPLETED|Intervention 2 (8 Weeks)||93
8554554|NCT00107744|21092251|P3|STARTED|Intervention 2 (8 Weeks)||101
8554555|NCT00107744|21092252|P2|STARTED|Intervention 2 (8 Weeks)||104
8554556|NCT00107744|21092253|P1|STARTED|Intervention 2 (8 Weeks)||101
8554557|NCT00107744|21092251|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
8554558|NCT00107744|21092252|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
8554559|NCT00107744|21092253|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
8554560|NCT00107744|21092251|P3|COMPLETED|Intervention 1 (8 Weeks)||101
8554561|NCT00107744|21092252|P2|COMPLETED|Intervention 1 (8 Weeks)||104
8554562|NCT00107744|21092253|P1|COMPLETED|Intervention 1 (8 Weeks)||101
8554563|NCT00107744|21092251|P3|STARTED|Intervention 1 (8 Weeks)||118
8554564|NCT00107744|21092252|P2|STARTED|Intervention 1 (8 Weeks)||117
8554565|NCT00107744|21092253|P1|STARTED|Intervention 1 (8 Weeks)||117
8554566|NCT00107653|21092269|P2|NOT COMPLETED|Overall Study||76
8554567|NCT00107653|21092270|P1|NOT COMPLETED|Overall Study||79
8554568|NCT00107653|21092269|P2|COMPLETED|Overall Study||224
8554569|NCT00107653|21092270|P1|COMPLETED|Overall Study||190
8554570|NCT00107653|21092269|P2|STARTED|Overall Study||300
8554571|NCT00107653|21092270|P1|STARTED|Overall Study||269
8554572|NCT00107614|21092316|P1|NOT COMPLETED|Overall Study||12
8554573|NCT00107614|21092316|P1|COMPLETED|Overall Study||0
8554574|NCT00107614|21092316|P1|STARTED|Overall Study||12
8554575|NCT00107575|21092322|P2|NOT COMPLETED|Overall Study||10
8554576|NCT00107575|21092323|P1|NOT COMPLETED|Overall Study||11
8554577|NCT00107575|21092322|P2|COMPLETED|Overall Study||107
8554578|NCT00107575|21092323|P1|COMPLETED|Overall Study||108
8554579|NCT00107575|21092322|P2|STARTED|Overall Study||117
8554580|NCT00107575|21092323|P1|STARTED|Overall Study||119
8554581|NCT00107536|21092337|P1|NOT COMPLETED|Overall Study||0
8554582|NCT00107536|21092337|P1|COMPLETED|Overall Study||26
8554583|NCT00107536|21092337|P1|STARTED|Overall Study||26
8554584|NCT00107380|21092347|P1|NOT COMPLETED|Overall Study||30
8554585|NCT00107380|21092347|P1|COMPLETED|Overall Study||56
8554586|NCT00107380|21092347|P1|Eligible|Overall Study||84
8554587|NCT00107380|21092347|P1|STARTED|Overall Study||86
8554588|NCT00107315|21092353|P1|NOT COMPLETED|Overall Study||15
8554589|NCT00107315|21092353|P1|COMPLETED|Overall Study||1
8554590|NCT00107315|21092353|P1|STARTED|Overall Study||16
8554591|NCT00107276|21092360|P1|NOT COMPLETED|Overall Study||72
8554592|NCT00107276|21092360|P1|COMPLETED|Overall Study||40
8554593|NCT00107276|21092360|P1|Eligible|Overall Study||96
8554594|NCT00107276|21092360|P1|STARTED|Overall Study||112
8554595|NCT00107198|21092366|P1|NOT COMPLETED|Overall Study||52
8554596|NCT00107198|21092366|P1|COMPLETED|Overall Study||136
8554597|NCT00107198|21092366|P1|STARTED|Overall Study||188
8554598|NCT00107172|21092376|P2|NOT COMPLETED|Overall Study||5
8554599|NCT00107172|21092377|P1|NOT COMPLETED|Overall Study||5
8554600|NCT00107172|21092376|P2|COMPLETED|Overall Study||103
8554601|NCT00107172|21092377|P1|COMPLETED|Overall Study||109
8554602|NCT00107172|21092376|P2|STARTED|Overall Study||108
8554603|NCT00107172|21092377|P1|STARTED|Overall Study||114
8554604|NCT00107120|21092407|P2|NOT COMPLETED|Overall Study||24
8554605|NCT00107120|21092408|P1|NOT COMPLETED|Overall Study||29
8554606|NCT00107120|21092407|P2|COMPLETED|Overall Study||133
8554607|NCT00107120|21092408|P1|COMPLETED|Overall Study||126
8554608|NCT00107120|21092407|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
8554609|NCT00107120|21092408|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
8554610|NCT00107042|21092420|P2|NOT COMPLETED|Overall Study||16
8554611|NCT00107042|21092421|P1|NOT COMPLETED|Overall Study||22
8554612|NCT00107042|21092420|P2|COMPLETED|Overall Study||47
8554613|NCT00107042|21092421|P1|COMPLETED|Overall Study||38
8554614|NCT00107042|21092420|P2|STARTED|Overall Study||63
8554615|NCT00107042|21092421|P1|STARTED|Overall Study||60
8554616|NCT00106964|21092487|P3|NOT COMPLETED|Overall Study||7
8554617|NCT00106964|21092488|P2|NOT COMPLETED|Overall Study||15
8554618|NCT00106964|21092489|P1|NOT COMPLETED|Overall Study||13
8554619|NCT00106964|21092487|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
8554620|NCT00106964|21092488|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
8554621|NCT00106964|21092489|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
8554622|NCT00106964|21092487|P3|STARTED|Overall Study||127
8554623|NCT00106964|21092488|P2|STARTED|Overall Study||126
8554624|NCT00106964|21092489|P1|STARTED|Overall Study||118
8554625|NCT00106938|21092514|P2|NOT COMPLETED|Overall Study||71
8554626|NCT00106938|21092515|P1|NOT COMPLETED|Overall Study||176
8554627|NCT00106938|21092514|P2|COMPLETED|Overall Study||293
8554628|NCT00106938|21092515|P1|COMPLETED|Overall Study||913
8554629|NCT00106938|21092514|P2|STARTED|Overall Study||364
8554630|NCT00106938|21092515|P1|STARTED|Overall Study||1089
8554631|NCT00106704|21092584|P2|NOT COMPLETED|Overall Study||151
8554632|NCT00106704|21092585|P1|NOT COMPLETED|Overall Study||131
8554633|NCT00106704|21092584|P2|COMPLETED|Overall Study||68
8554634|NCT00106704|21092585|P1|COMPLETED|Overall Study||91
8554635|NCT00106704|21092584|P2|STARTED|Overall Study||219
8554636|NCT00106704|21092585|P1|STARTED|Overall Study||222
8554637|NCT00106639|21092596|P3|NOT COMPLETED|Overall Study||2
8554638|NCT00106639|21092597|P2|NOT COMPLETED|Overall Study||7
8554639|NCT00106639|21092598|P1|NOT COMPLETED|Overall Study||3
8554640|NCT00106639|21092596|P3|COMPLETED|Overall Study||19
8554641|NCT00106639|21092597|P2|COMPLETED|Overall Study||13
8554642|NCT00106639|21092598|P1|COMPLETED|Overall Study||17
8554643|NCT00106639|21092596|P3|STARTED|Overall Study||21
8554644|NCT00106639|21092597|P2|STARTED|Overall Study||20
8554645|NCT00106639|21092598|P1|STARTED|Overall Study||20
8554646|NCT00106626|21092725|P4|NOT COMPLETED|Overall Study||13
8554647|NCT00106626|21092726|P3|NOT COMPLETED|Overall Study||12
8554648|NCT00106626|21092727|P2|NOT COMPLETED|Overall Study||6
8554649|NCT00106626|21092728|P1|NOT COMPLETED|Overall Study||10
8554650|NCT00106626|21092725|P4|COMPLETED|Overall Study||3
8554651|NCT00106626|21092726|P3|COMPLETED|Overall Study||2
8554652|NCT00106626|21092727|P2|COMPLETED|Overall Study||3
8554653|NCT00106626|21092728|P1|COMPLETED|Overall Study||3
8554654|NCT00106626|21092725|P4|STARTED|Overall Study||16
8554655|NCT00106626|21092726|P3|STARTED|Overall Study||14
8554656|NCT00106626|21092727|P2|STARTED|Overall Study||9
8554657|NCT00106626|21092728|P1|STARTED|Overall Study||13
8554658|NCT00106535|21092746|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
8554659|NCT00106535|21092747|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554660|NCT00106535|21092748|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554661|NCT00106535|21092749|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554662|NCT00106535|21092746|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
8554663|NCT00106535|21092747|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554664|NCT00106535|21092748|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554665|NCT00106535|21092749|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554666|NCT00106535|21092746|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
8554667|NCT00106535|21092747|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
8554668|NCT00106535|21092748|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
8554669|NCT00106535|21092749|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
8554670|NCT00106535|21092746|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
8554671|NCT00106535|21092747|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
8554672|NCT00106535|21092748|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
8554673|NCT00106535|21092749|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
8554674|NCT00106535|21092746|P4|COMPLETED|2-year Placebo Controlled Period||0
8554675|NCT00106535|21092747|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
8554676|NCT00106535|21092748|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
8554677|NCT00106535|21092749|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
8554678|NCT00106535|21092746|P4|Completed Week 52|2-year Placebo Controlled Period||0
8554679|NCT00106535|21092747|P3|Completed Week 52|2-year Placebo Controlled Period||338
8554680|NCT00106535|21092748|P2|Completed Week 52|2-year Placebo Controlled Period||342
8554681|NCT00106535|21092749|P1|Completed Week 52|2-year Placebo Controlled Period||326
8554682|NCT00106535|21092746|P4|Completed Week 24|2-year Placebo Controlled Period||0
8554683|NCT00106535|21092747|P3|Completed Week 24|2-year Placebo Controlled Period||366
8554684|NCT00106535|21092748|P2|Completed Week 24|2-year Placebo Controlled Period||373
8554685|NCT00106535|21092749|P1|Completed Week 24|2-year Placebo Controlled Period||356
8554686|NCT00106535|21092746|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
8554687|NCT00106535|21092747|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
8554688|NCT00106535|21092748|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
8554689|NCT00106535|21092749|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
8554690|NCT00106535|21092746|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
8554691|NCT00106535|21092747|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
8554692|NCT00106535|21092748|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
8554693|NCT00106535|21092749|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
8554694|NCT00106535|21092746|P4|STARTED|2-year Placebo Controlled Period||0
8554695|NCT00106535|21092747|P3|STARTED|2-year Placebo Controlled Period||401
8554696|NCT00106535|21092748|P2|STARTED|2-year Placebo Controlled Period||401
8554697|NCT00106535|21092749|P1|STARTED|2-year Placebo Controlled Period||394
8554698|NCT00106431|21093042|P1|NOT COMPLETED|Overall Study||65
8554699|NCT00106431|21093042|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
8554700|NCT00106431|21093042|P1|STARTED|Overall Study||102
8554701|NCT00106392|21093054|P2|NOT COMPLETED|Overall Study||27
8554702|NCT00106392|21093055|P1|NOT COMPLETED|Overall Study||26
8554703|NCT00106392|21093054|P2|COMPLETED|Overall Study||42
8554704|NCT00106392|21093055|P1|COMPLETED|Overall Study||36
8554705|NCT00106392|21093054|P2|Full Analysis Set (FAS)|Overall Study||61
8554706|NCT00106392|21093055|P1|Full Analysis Set (FAS)|Overall Study||53
8554707|NCT00106392|21093054|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
8554708|NCT00106392|21093055|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
8554709|NCT00106392|21093054|P2|STARTED|Overall Study||69
8554710|NCT00106392|21093055|P1|STARTED|Overall Study||62
8554711|NCT00106353|21093073|P7|NOT COMPLETED|Part 2||16
8554712|NCT00106353|21093074|P6|NOT COMPLETED|Part 2||18
8554713|NCT00106353|21093075|P5|NOT COMPLETED|Part 2||16
8554714|NCT00106353|21093076|P4|NOT COMPLETED|Part 2||0
8554715|NCT00106353|21093077|P3|NOT COMPLETED|Part 2||0
8554716|NCT00106353|21093078|P2|NOT COMPLETED|Part 2||0
8554717|NCT00106353|21093079|P1|NOT COMPLETED|Part 2||0
8554718|NCT00106353|21093073|P7|COMPLETED|Part 2||0
8554719|NCT00106353|21093074|P6|COMPLETED|Part 2||1
8554720|NCT00106353|21093075|P5|COMPLETED|Part 2||1
8554721|NCT00106353|21093076|P4|COMPLETED|Part 2||0
8554722|NCT00106353|21093077|P3|COMPLETED|Part 2||0
8554723|NCT00106353|21093078|P2|COMPLETED|Part 2||0
8554724|NCT00106353|21093079|P1|COMPLETED|Part 2||0
8554725|NCT00106353|21093073|P7|STARTED|Part 2||16
8554726|NCT00106353|21093074|P6|STARTED|Part 2||19
8554727|NCT00106353|21093075|P5|STARTED|Part 2||17
8554728|NCT00106353|21093076|P4|STARTED|Part 2||0
8554729|NCT00106353|21093077|P3|STARTED|Part 2||0
8554730|NCT00106353|21093078|P2|STARTED|Part 2||0
8554731|NCT00106353|21093079|P1|STARTED|Part 2||0
8554732|NCT00106353|21093073|P7|NOT COMPLETED|Part 1||0
8554733|NCT00106353|21093074|P6|NOT COMPLETED|Part 1||0
8554734|NCT00106353|21093075|P5|NOT COMPLETED|Part 1||0
8554735|NCT00106353|21093076|P4|NOT COMPLETED|Part 1||7
8554736|NCT00106353|21093077|P3|NOT COMPLETED|Part 1||3
8554737|NCT00106353|21093078|P2|NOT COMPLETED|Part 1||5
8554738|NCT00106353|21093079|P1|NOT COMPLETED|Part 1||4
8554739|NCT00106353|21093073|P7|COMPLETED|Part 1||0
8554740|NCT00106353|21093074|P6|COMPLETED|Part 1||0
8554741|NCT00106353|21093075|P5|COMPLETED|Part 1||0
8554742|NCT00106353|21093076|P4|COMPLETED|Part 1||0
8554743|NCT00106353|21093077|P3|COMPLETED|Part 1||0
8554744|NCT00106353|21093078|P2|COMPLETED|Part 1||0
8554745|NCT00106353|21093079|P1|COMPLETED|Part 1||0
8554746|NCT00106353|21093073|P7|STARTED|Part 1||0
8554747|NCT00106353|21093074|P6|STARTED|Part 1||0
8554748|NCT00106353|21093075|P5|STARTED|Part 1||0
8554749|NCT00106353|21093076|P4|STARTED|Part 1||7
8554750|NCT00106353|21093077|P3|STARTED|Part 1||3
8554751|NCT00106353|21093078|P2|STARTED|Part 1||5
8554752|NCT00106353|21093079|P1|STARTED|Part 1||4
8554753|NCT00106249|21093206|P2|NOT COMPLETED|Overall Study||2
8554754|NCT00106249|21093207|P1|NOT COMPLETED|Overall Study||3
8554755|NCT00106249|21093206|P2|COMPLETED|Overall Study||11
8554756|NCT00106249|21093207|P1|COMPLETED|Overall Study||11
8554757|NCT00106249|21093206|P2|STARTED|Overall Study||13
8554758|NCT00106249|21093207|P1|STARTED|Overall Study||14
8554759|NCT00106184|21093219|P2|NOT COMPLETED|Overall Study||2
8554760|NCT00106184|21093220|P1|NOT COMPLETED|Overall Study||3
8554761|NCT00106184|21093219|P2|COMPLETED|Overall Study||102
8554762|NCT00106184|21093220|P1|COMPLETED|Overall Study||93
8554763|NCT00106184|21093219|P2|Treated|Overall Study|104 subjects were randomized.|102
8554764|NCT00106184|21093220|P1|Treated|Overall Study|96 subjects were randomized.|93
8554765|NCT00106184|21093219|P2|STARTED|Overall Study||104
8554766|NCT00106184|21093220|P1|STARTED|Overall Study||96
8554767|NCT00106119|21093230|P2|NOT COMPLETED|Second Intervention||0
8554768|NCT00106119|21093231|P1|NOT COMPLETED|Second Intervention||0
8554769|NCT00106119|21093230|P2|COMPLETED|Second Intervention||7
8554770|NCT00106119|21093231|P1|COMPLETED|Second Intervention||7
8554771|NCT00106119|21093230|P2|STARTED|Second Intervention||7
8554772|NCT00106119|21093231|P1|STARTED|Second Intervention||7
8554773|NCT00106119|21093230|P2|NOT COMPLETED|Washout Period of 30 Days||0
8554774|NCT00106119|21093231|P1|NOT COMPLETED|Washout Period of 30 Days||0
8554775|NCT00106119|21093230|P2|COMPLETED|Washout Period of 30 Days||7
8554776|NCT00106119|21093231|P1|COMPLETED|Washout Period of 30 Days||7
8554777|NCT00106119|21093230|P2|STARTED|Washout Period of 30 Days||7
8554778|NCT00106119|21093231|P1|STARTED|Washout Period of 30 Days||7
8554779|NCT00106119|21093230|P2|NOT COMPLETED|First Intervention||0
8554780|NCT00106119|21093231|P1|NOT COMPLETED|First Intervention||0
8554781|NCT00106119|21093230|P2|COMPLETED|First Intervention||7
8554782|NCT00106119|21093231|P1|COMPLETED|First Intervention||7
8554783|NCT00106119|21093230|P2|STARTED|First Intervention||7
8554784|NCT00106119|21093231|P1|STARTED|First Intervention||7
8554785|NCT00106106|21093251|P2|NOT COMPLETED|Overall Study||4
8554786|NCT00106106|21093252|P1|NOT COMPLETED|Overall Study||4
8554787|NCT00106106|21093251|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
8554788|NCT00106106|21093252|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
8554789|NCT00106106|21093251|P2|Completed Both MRS Scans|Overall Study||15
8554790|NCT00106106|21093252|P1|Completed Both MRS Scans|Overall Study||18
8554791|NCT00106106|21093251|P2|STARTED|Overall Study||23
8554792|NCT00106106|21093252|P1|STARTED|Overall Study||26
8554793|NCT00106080|21093262|P2|NOT COMPLETED|Overall Study||27
8554794|NCT00106080|21093263|P1|NOT COMPLETED|Overall Study||43
8554795|NCT00106080|21093262|P2|COMPLETED|Overall Study||155
8554796|NCT00106080|21093263|P1|COMPLETED|Overall Study||151
8554797|NCT00106080|21093262|P2|STARTED|Overall Study||182
8554798|NCT00106080|21093263|P1|STARTED|Overall Study||194
8554799|NCT00106028|21093273|P2|NOT COMPLETED|Overall Study||12
8554800|NCT00106028|21093274|P1|NOT COMPLETED|Overall Study||6
8554801|NCT00106028|21093273|P2|COMPLETED|Overall Study|Completed Month 36|82
8554802|NCT00106028|21093274|P1|COMPLETED|Overall Study|Completed Month 36|43
8554803|NCT00106028|21093273|P2|Month 12 Completed/Started Open Label|Overall Study||87
8554804|NCT00106028|21093274|P1|Month 12 Completed/Started Open Label|Overall Study||49
8554805|NCT00106028|21093273|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
8554806|NCT00106028|21093274|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
8554807|NCT00106002|21093368|P1|NOT COMPLETED|Overall Study||2
8554808|NCT00106002|21093368|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
8554809|NCT00106002|21093368|P1|STARTED|Overall Study||37
8554810|NCT00105989|21093376|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
8554811|NCT00105989|21093377|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
8554812|NCT00105989|21093376|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
8554813|NCT00105989|21093377|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
8554814|NCT00105989|21093376|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
8554815|NCT00105989|21093377|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
8554816|NCT00105989|21093376|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
8554817|NCT00105989|21093377|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
8554818|NCT00105989|21093376|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
8554819|NCT00105989|21093377|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
8554820|NCT00105989|21093376|P2|STARTED|Continuation - Open Label:Week 10-34||0
8554821|NCT00105989|21093377|P1|STARTED|Continuation - Open Label:Week 10-34||413
8554822|NCT00105989|21093376|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
8554823|NCT00105989|21093377|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
8554824|NCT00105989|21093376|P2|COMPLETED|Acute - Open Label: Week 0-10||0
8554825|NCT00105989|21093377|P1|COMPLETED|Acute - Open Label: Week 0-10||413
8554826|NCT00105989|21093376|P2|STARTED|Acute - Open Label: Week 0-10||0
8554827|NCT00105989|21093377|P1|STARTED|Acute - Open Label: Week 0-10||514
8554828|NCT00105586|21093493|P2|NOT COMPLETED|Overall Study||16
8554829|NCT00105586|21093494|P1|NOT COMPLETED|Overall Study||17
8554830|NCT00105586|21093493|P2|COMPLETED|Overall Study||69
8554831|NCT00105586|21093494|P1|COMPLETED|Overall Study||75
8554832|NCT00105586|21093493|P2|STARTED|Overall Study||85
8554833|NCT00105586|21093494|P1|STARTED|Overall Study||92
8554834|NCT00105560|21093502|P1|NOT COMPLETED|Overall Study||1
8554835|NCT00105560|21093502|P1|COMPLETED|Overall Study||58
8554836|NCT00105560|21093502|P1|STARTED|Overall Study||59
8554837|NCT00105534|21093524|P2|NOT COMPLETED|Overall Study||33
8554838|NCT00105534|21093525|P1|NOT COMPLETED|Overall Study||22
8554839|NCT00105534|21093524|P2|COMPLETED|Overall Study||317
8554840|NCT00105534|21093525|P1|COMPLETED|Overall Study||313
8554841|NCT00105534|21093524|P2|STARTED|Overall Study||350
8554842|NCT00105534|21093525|P1|STARTED|Overall Study||335
8554843|NCT00105521|21093537|P4|NOT COMPLETED|Overall Study||17
8554844|NCT00105521|21093538|P3|NOT COMPLETED|Overall Study||17
8554845|NCT00105521|21093539|P2|NOT COMPLETED|Overall Study||11
8554846|NCT00105521|21093540|P1|NOT COMPLETED|Overall Study||15
8554847|NCT00105521|21093537|P4|COMPLETED|Overall Study||85
8554848|NCT00105521|21093538|P3|COMPLETED|Overall Study||80
8554849|NCT00105521|21093539|P2|COMPLETED|Overall Study||90
8554850|NCT00105521|21093540|P1|COMPLETED|Overall Study||83
8554851|NCT00105521|21093537|P4|STARTED|Overall Study||102
8554852|NCT00105521|21093538|P3|STARTED|Overall Study||97
8554853|NCT00105521|21093539|P2|STARTED|Overall Study||101
8554854|NCT00105521|21093540|P1|STARTED|Overall Study||98
8554855|NCT00105508|21093564|P2|NOT COMPLETED|Overall Study||36
8554856|NCT00105508|21093565|P1|NOT COMPLETED|Overall Study||40
8554857|NCT00105508|21093564|P2|COMPLETED|Overall Study||217
8554858|NCT00105508|21093565|P1|COMPLETED|Overall Study||213
8554859|NCT00105508|21093564|P2|STARTED|Overall Study||253
8554860|NCT00105508|21093565|P1|STARTED|Overall Study||253
8554861|NCT00105482|21093579|P2|NOT COMPLETED|Overall Study||55
8554862|NCT00105482|21093580|P1|NOT COMPLETED|Overall Study||59
8554863|NCT00105482|21093579|P2|COMPLETED|Overall Study||30
8554864|NCT00105482|21093580|P1|COMPLETED|Overall Study||28
8554865|NCT00105482|21093579|P2|STARTED|Overall Study||85
8554866|NCT00105482|21093580|P1|STARTED|Overall Study||87
8554867|NCT00105469|21093596|P2|NOT COMPLETED|Overall Study||11
8554868|NCT00105469|21093597|P1|NOT COMPLETED|Overall Study||22
8554869|NCT00105469|21093596|P2|COMPLETED|Overall Study||367
8554870|NCT00105469|21093597|P1|COMPLETED|Overall Study||343
8554871|NCT00105469|21093596|P2|STARTED|Overall Study||378
8554872|NCT00105469|21093597|P1|STARTED|Overall Study||365
8554873|NCT00105443|21093607|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
8554874|NCT00105443|21093608|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
8554875|NCT00105443|21093609|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
8554876|NCT00105443|21093610|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
8554877|NCT00105443|21093607|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
8554878|NCT00105443|21093608|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
8554879|NCT00105443|21093609|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
8554880|NCT00105443|21093610|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
8554881|NCT00105443|21093607|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
8554882|NCT00105443|21093608|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
8554883|NCT00105443|21093609|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
8554884|NCT00105443|21093610|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
8554885|NCT00105443|21093607|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
8554886|NCT00105443|21093608|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
8554887|NCT00105443|21093609|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
8554888|NCT00105443|21093610|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
8554889|NCT00105443|21093607|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
8554890|NCT00105443|21093608|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
8554891|NCT00105443|21093609|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
8554892|NCT00105443|21093610|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
8554893|NCT00105443|21093607|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
8554894|NCT00105443|21093608|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
8554895|NCT00105443|21093609|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
8554896|NCT00105443|21093610|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
8554897|NCT00105443|21093607|P4|NOT COMPLETED|Double-Blind Treatment||0
8554898|NCT00105443|21093608|P3|NOT COMPLETED|Double-Blind Treatment||11
8554899|NCT00105443|21093609|P2|NOT COMPLETED|Double-Blind Treatment||0
8554900|NCT00105443|21093610|P1|NOT COMPLETED|Double-Blind Treatment||14
8554901|NCT00105443|21093607|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
8554902|NCT00105443|21093608|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
8554903|NCT00105443|21093609|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
8554904|NCT00105443|21093610|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
8554905|NCT00105443|21093607|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
8554906|NCT00105443|21093608|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
8554907|NCT00105443|21093609|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
8554908|NCT00105443|21093610|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
8554909|NCT00105443|21093607|P4|STARTED|Double-Blind Treatment||47
8554910|NCT00105443|21093608|P3|STARTED|Double-Blind Treatment||256
8554911|NCT00105443|21093609|P2|STARTED|Double-Blind Treatment||57
8554912|NCT00105443|21093610|P1|STARTED|Double-Blind Treatment||242
8554913|NCT00105235|21093637|P1|NOT COMPLETED|Overall Study||7
8554914|NCT00105235|21093637|P1|COMPLETED|Overall Study||20
8554915|NCT00105235|21093637|P1|STARTED|Overall Study||27
8554916|NCT00105196|21093650|P2|NOT COMPLETED|Overall Study||23
8554917|NCT00105196|21093651|P1|NOT COMPLETED|Overall Study||30
8554918|NCT00105196|21093650|P2|COMPLETED|Overall Study||149
8554919|NCT00105196|21093651|P1|COMPLETED|Overall Study||147
8554920|NCT00105196|21093650|P2|STARTED|Overall Study||172
8554921|NCT00105196|21093651|P1|STARTED|Overall Study||177
8554922|NCT00105183|21093674|P3|NOT COMPLETED|Overall Study||23
8554923|NCT00105183|21093675|P2|NOT COMPLETED|Overall Study||19
8554924|NCT00105183|21093676|P1|NOT COMPLETED|Overall Study||22
8554925|NCT00105183|21093674|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
8554926|NCT00105183|21093675|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
8554927|NCT00105183|21093676|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
8554928|NCT00105183|21093674|P3|STARTED|Overall Study|Randomized|62
8554929|NCT00105183|21093675|P2|STARTED|Overall Study|Randomized|79
8554930|NCT00105183|21093676|P1|STARTED|Overall Study|Randomized|82
8554931|NCT00105157|21093712|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
8554932|NCT00105157|21093713|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
8554933|NCT00105157|21093714|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
8554934|NCT00105157|21093715|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
8554935|NCT00105157|21093712|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
8554936|NCT00105157|21093713|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
8554937|NCT00105157|21093714|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
8554938|NCT00105157|21093715|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
8554939|NCT00105157|21093712|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
8554940|NCT00105157|21093713|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
8554941|NCT00105157|21093714|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
8554942|NCT00105157|21093715|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
8554943|NCT00105157|21093712|P4|NOT COMPLETED|Open-Label Continuation of DB||1
8554944|NCT00105157|21093713|P3|NOT COMPLETED|Open-Label Continuation of DB||9
8554945|NCT00105157|21093714|P2|NOT COMPLETED|Open-Label Continuation of DB||10
8554946|NCT00105157|21093715|P1|NOT COMPLETED|Open-Label Continuation of DB||7
8554947|NCT00105157|21093712|P4|COMPLETED|Open-Label Continuation of DB||5
8554948|NCT00105157|21093713|P3|COMPLETED|Open-Label Continuation of DB||24
8554949|NCT00105157|21093714|P2|COMPLETED|Open-Label Continuation of DB||21
8554950|NCT00105157|21093715|P1|COMPLETED|Open-Label Continuation of DB||23
8554951|NCT00105157|21093712|P4|STARTED|Open-Label Continuation of DB||6
8554952|NCT00105157|21093713|P3|STARTED|Open-Label Continuation of DB||33
8554953|NCT00105157|21093714|P2|STARTED|Open-Label Continuation of DB||31
8554954|NCT00105157|21093715|P1|STARTED|Open-Label Continuation of DB||30
8554955|NCT00105157|21093712|P4|NOT COMPLETED|Double-Blind (DB)||39
8554956|NCT00105157|21093713|P3|NOT COMPLETED|Double-Blind (DB)||12
8554957|NCT00105157|21093714|P2|NOT COMPLETED|Double-Blind (DB)||14
8554958|NCT00105157|21093715|P1|NOT COMPLETED|Double-Blind (DB)||14
8554959|NCT00105157|21093712|P4|COMPLETED|Double-Blind (DB)||6
8554960|NCT00105157|21093713|P3|COMPLETED|Double-Blind (DB)||33
8554961|NCT00105157|21093714|P2|COMPLETED|Double-Blind (DB)||31
8554962|NCT00105157|21093715|P1|COMPLETED|Double-Blind (DB)||30
8554963|NCT00105157|21093712|P4|Treated|Double-Blind (DB)||45
8554964|NCT00105157|21093713|P3|Treated|Double-Blind (DB)||45
8554965|NCT00105157|21093714|P2|Treated|Double-Blind (DB)||45
8554966|NCT00105157|21093715|P1|Treated|Double-Blind (DB)||43
8554967|NCT00105157|21093712|P4|STARTED|Double-Blind (DB)||45
8554968|NCT00105157|21093713|P3|STARTED|Double-Blind (DB)||45
8554969|NCT00105157|21093714|P2|STARTED|Double-Blind (DB)||45
8554970|NCT00105157|21093715|P1|STARTED|Double-Blind (DB)||44
8554971|NCT00105079|21093909|P2|NOT COMPLETED|Overall Study||35
8554972|NCT00105079|21093910|P1|NOT COMPLETED|Overall Study||39
8554973|NCT00105079|21093909|P2|COMPLETED|Overall Study||135
8554974|NCT00105079|21093910|P1|COMPLETED|Overall Study||128
8554975|NCT00105079|21093909|P2|Safety Population|Overall Study||168
8554976|NCT00105079|21093910|P1|Safety Population|Overall Study||163
8554977|NCT00105079|21093909|P2|STARTED|Overall Study||170
8554978|NCT00105079|21093910|P1|STARTED|Overall Study||167
8554979|NCT00105066|21093928|P2|NOT COMPLETED|Overall Study||5
8554980|NCT00105066|21093929|P1|NOT COMPLETED|Overall Study||2
8554981|NCT00105066|21093928|P2|COMPLETED|Overall Study||45
8554982|NCT00105066|21093929|P1|COMPLETED|Overall Study||25
8554983|NCT00105066|21093928|P2|STARTED|Overall Study||50
8554984|NCT00105066|21093929|P1|STARTED|Overall Study||27
8554985|NCT00105027|21093945|P6|NOT COMPLETED|Overall Study||13
8554986|NCT00105027|21093946|P5|NOT COMPLETED|Overall Study||15
8554987|NCT00105027|21093947|P4|NOT COMPLETED|Overall Study||16
8554988|NCT00105027|21093948|P3|NOT COMPLETED|Overall Study||9
8554989|NCT00105027|21093949|P2|NOT COMPLETED|Overall Study||9
8554990|NCT00105027|21093950|P1|NOT COMPLETED|Overall Study||15
8554991|NCT00105027|21093945|P6|COMPLETED|Overall Study||125
8554992|NCT00105027|21093946|P5|COMPLETED|Overall Study||121
8554993|NCT00105027|21093947|P4|COMPLETED|Overall Study||121
8554994|NCT00105027|21093948|P3|COMPLETED|Overall Study||82
8554995|NCT00105027|21093949|P2|COMPLETED|Overall Study||83
8554996|NCT00105027|21093950|P1|COMPLETED|Overall Study||73
8554997|NCT00105027|21093945|P6|STARTED|Overall Study||138
8554998|NCT00105027|21093946|P5|STARTED|Overall Study||136
8554999|NCT00105027|21093947|P4|STARTED|Overall Study||137
8555000|NCT00105027|21093948|P3|STARTED|Overall Study||91
8555001|NCT00105027|21093949|P2|STARTED|Overall Study||92
8555002|NCT00105027|21093950|P1|STARTED|Overall Study||88
8555003|NCT00105001|21093985|P3|NOT COMPLETED|Overall Study||0
8555004|NCT00105001|21093986|P2|NOT COMPLETED|Overall Study||0
8555005|NCT00105001|21093987|P1|NOT COMPLETED|Overall Study||0
8555006|NCT00105001|21093985|P3|COMPLETED|Overall Study||69
8555007|NCT00105001|21093986|P2|COMPLETED|Overall Study||71
8555008|NCT00105001|21093987|P1|COMPLETED|Overall Study||70
8555009|NCT00105001|21093985|P3|STARTED|Overall Study||69
8555010|NCT00105001|21093986|P2|STARTED|Overall Study||71
8555011|NCT00105001|21093987|P1|STARTED|Overall Study||70
8555012|NCT00104884|21094007|P1|NOT COMPLETED|Overall Study||4
8555013|NCT00104884|21094007|P1|COMPLETED|Overall Study||0
8555014|NCT00104884|21094007|P1|STARTED|Overall Study||4
8555015|NCT00104871|21094011|P1|NOT COMPLETED|Overall Study||1
8555016|NCT00104871|21094011|P1|COMPLETED|Overall Study||21
8555017|NCT00104871|21094011|P1|STARTED|Overall Study||22
8555018|NCT00104858|21094017|P1|NOT COMPLETED|Overall Study||0
8555019|NCT00104858|21094017|P1|COMPLETED|Overall Study||52
8555020|NCT00104858|21094017|P1|STARTED|Overall Study||52
8555021|NCT00104728|21094032|P1|NOT COMPLETED|Overall Study||19
8555022|NCT00104728|21094032|P1|COMPLETED|Overall Study||23
8555023|NCT00104728|21094032|P1|STARTED|Overall Study|42 consented on study|42
8555024|NCT00104650|21094040|P3|NOT COMPLETED|Follow-up Period||10
8555025|NCT00104650|21094041|P2|NOT COMPLETED|Follow-up Period||13
8555026|NCT00104650|21094042|P1|NOT COMPLETED|Follow-up Period||11
8555027|NCT00104650|21094040|P3|COMPLETED|Follow-up Period||18
8555028|NCT00104650|21094041|P2|COMPLETED|Follow-up Period||12
8555029|NCT00104650|21094042|P1|COMPLETED|Follow-up Period||14
8555030|NCT00104650|21094040|P3|STARTED|Follow-up Period||28
8555031|NCT00104650|21094041|P2|STARTED|Follow-up Period||25
8555032|NCT00104650|21094042|P1|STARTED|Follow-up Period||25
8555033|NCT00104650|21094040|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
8555034|NCT00104650|21094041|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
8555035|NCT00104650|21094042|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
8555036|NCT00104650|21094040|P3|COMPLETED|Treatment Period (25 Weeks)||28
8555037|NCT00104650|21094041|P2|COMPLETED|Treatment Period (25 Weeks)||25
8555038|NCT00104650|21094042|P1|COMPLETED|Treatment Period (25 Weeks)||25
8555039|NCT00104650|21094040|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
8555040|NCT00104650|21094041|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
8555041|NCT00104650|21094042|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
8555042|NCT00104650|21094040|P3|STARTED|Treatment Period (25 Weeks)||38
8555043|NCT00104650|21094041|P2|STARTED|Treatment Period (25 Weeks)||36
8555044|NCT00104650|21094042|P1|STARTED|Treatment Period (25 Weeks)||37
8555045|NCT00104637|21094074|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
8555046|NCT00104637|21094075|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
8555047|NCT00104637|21094074|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
8555048|NCT00104637|21094075|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
8555049|NCT00104637|21094074|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
8555050|NCT00104637|21094075|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
8555051|NCT00104637|21094074|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
8555052|NCT00104637|21094075|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
8555053|NCT00104637|21094074|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
8555054|NCT00104637|21094075|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
8555055|NCT00104637|21094074|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
8555056|NCT00104637|21094075|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
8555057|NCT00104637|21094074|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
8555058|NCT00104637|21094075|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
8555059|NCT00104637|21094074|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
8555060|NCT00104637|21094075|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
8555061|NCT00104637|21094074|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
8555062|NCT00104637|21094075|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
8555063|NCT00104572|21094104|P3|NOT COMPLETED|Overall Study||0
8555064|NCT00104572|21094105|P2|NOT COMPLETED|Overall Study||3
8555065|NCT00104572|21094106|P1|NOT COMPLETED|Overall Study||3
8555066|NCT00104572|21094104|P3|COMPLETED|Overall Study||9
8555067|NCT00104572|21094105|P2|COMPLETED|Overall Study||10
8555068|NCT00104572|21094106|P1|COMPLETED|Overall Study||10
8555069|NCT00104572|21094104|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
8555070|NCT00104572|21094105|P2|STARTED|Overall Study|These are the analysed subjects|13
8555071|NCT00104572|21094106|P1|STARTED|Overall Study|These are the analysed subjects|13
8555072|NCT00104520|21094125|P2|NOT COMPLETED|Overall Study||71
8555073|NCT00104520|21094126|P1|NOT COMPLETED|Overall Study||50
8555074|NCT00104520|21094125|P2|COMPLETED|Overall Study||64
8555075|NCT00104520|21094126|P1|COMPLETED|Overall Study||26
8555076|NCT00104520|21094125|P2|STARTED|Overall Study||135
8555077|NCT00104520|21094126|P1|STARTED|Overall Study||76
8555078|NCT00104416|21094146|P5|NOT COMPLETED|Continuation Phase||5
8555079|NCT00104416|21094147|P4|NOT COMPLETED|Continuation Phase||2
8555080|NCT00104416|21094148|P3|NOT COMPLETED|Continuation Phase||6
8555081|NCT00104416|21094149|P2|NOT COMPLETED|Continuation Phase||0
8555082|NCT00104416|21094150|P1|NOT COMPLETED|Continuation Phase||0
8555083|NCT00104416|21094146|P5|COMPLETED|Continuation Phase||27
8555084|NCT00104416|21094147|P4|COMPLETED|Continuation Phase||65
8555085|NCT00104416|21094148|P3|COMPLETED|Continuation Phase||63
8555086|NCT00104416|21094149|P2|COMPLETED|Continuation Phase||0
8555087|NCT00104416|21094150|P1|COMPLETED|Continuation Phase||0
8555088|NCT00104416|21094146|P5|STARTED|Continuation Phase||32
8555089|NCT00104416|21094147|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
8555090|NCT00104416|21094148|P3|STARTED|Continuation Phase||69
8555091|NCT00104416|21094149|P2|STARTED|Continuation Phase||0
8555092|NCT00104416|21094150|P1|STARTED|Continuation Phase||0
8555093|NCT00104416|21094146|P5|NOT COMPLETED|Double-Blind Phase||0
8555094|NCT00104416|21094147|P4|NOT COMPLETED|Double-Blind Phase||0
8555095|NCT00104416|21094148|P3|NOT COMPLETED|Double-Blind Phase||0
8555096|NCT00104416|21094149|P2|NOT COMPLETED|Double-Blind Phase||10
8555097|NCT00104416|21094150|P1|NOT COMPLETED|Double-Blind Phase||8
8555098|NCT00104416|21094146|P5|COMPLETED|Double-Blind Phase||0
8555099|NCT00104416|21094147|P4|COMPLETED|Double-Blind Phase||0
8555100|NCT00104416|21094148|P3|COMPLETED|Double-Blind Phase||0
8555101|NCT00104416|21094149|P2|COMPLETED|Double-Blind Phase||66
8555102|NCT00104416|21094150|P1|COMPLETED|Double-Blind Phase||69
8555103|NCT00104416|21094146|P5|STARTED|Double-Blind Phase||0
8555104|NCT00104416|21094147|P4|STARTED|Double-Blind Phase||0
8555105|NCT00104416|21094148|P3|STARTED|Double-Blind Phase||0
8555106|NCT00104416|21094149|P2|STARTED|Double-Blind Phase||76
8555107|NCT00104416|21094150|P1|STARTED|Double-Blind Phase||77
8555108|NCT00104299|21094195|P2|NOT COMPLETED|Overall Study||10
8555109|NCT00104299|21094196|P1|NOT COMPLETED|Overall Study||9
8555110|NCT00104299|21094195|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
8555111|NCT00104299|21094196|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
8555112|NCT00104299|21094195|P2|STARTED|Overall Study||98
8555113|NCT00104299|21094196|P1|STARTED|Overall Study||99
8555114|NCT00104247|21094218|P2|NOT COMPLETED|Overall Study||1
8555115|NCT00104247|21094219|P1|NOT COMPLETED|Overall Study||1
8555116|NCT00104247|21094218|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
8555117|NCT00104247|21094219|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
8555118|NCT00104247|21094218|P2|STARTED|Overall Study||47
8555119|NCT00104247|21094219|P1|STARTED|Overall Study||42
8555120|NCT00104234|21094227|P2|NOT COMPLETED|Overall Study||1
8555121|NCT00104234|21094228|P1|NOT COMPLETED|Overall Study||0
8555122|NCT00104234|21094227|P2|COMPLETED|Overall Study||19
8555123|NCT00104234|21094228|P1|COMPLETED|Overall Study||19
8555124|NCT00104234|21094227|P2|STARTED|Overall Study||20
8555125|NCT00104234|21094228|P1|STARTED|Overall Study||19
8555126|NCT00104104|21094238|P2|NOT COMPLETED|Overall Study||72
8555127|NCT00104104|21094239|P1|NOT COMPLETED|Overall Study||75
8555128|NCT00104104|21094238|P2|COMPLETED|Overall Study||17
8555129|NCT00104104|21094239|P1|COMPLETED|Overall Study||15
8555130|NCT00104104|21094238|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
8555131|NCT00104104|21094239|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
8555132|NCT00104104|21094238|P2|Safety Population (Including Site 74)|Overall Study||88
8555133|NCT00104104|21094239|P1|Safety Population (Including Site 74)|Overall Study||88
8555134|NCT00104104|21094238|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
8555135|NCT00104104|21094239|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
8555136|NCT00104052|21094253|P1|NOT COMPLETED|Overall Study||29
8555137|NCT00104052|21094253|P1|COMPLETED|Overall Study||78
8555138|NCT00104052|21094253|P1|STARTED|Overall Study||107
8555139|NCT00103857|21094264|P7|NOT COMPLETED|50-Week Extension Study||0
8555140|NCT00103857|21094265|P6|NOT COMPLETED|50-Week Extension Study||20
8555141|NCT00103857|21094266|P5|NOT COMPLETED|50-Week Extension Study||21
8555142|NCT00103857|21094267|P4|NOT COMPLETED|50-Week Extension Study||36
8555143|NCT00103857|21094268|P3|NOT COMPLETED|50-Week Extension Study||26
8555144|NCT00103857|21094269|P2|NOT COMPLETED|50-Week Extension Study||27
8555145|NCT00103857|21094270|P1|NOT COMPLETED|50-Week Extension Study||38
8555146|NCT00103857|21094264|P7|COMPLETED|50-Week Extension Study||0
8555147|NCT00103857|21094265|P6|COMPLETED|50-Week Extension Study||78
8555148|NCT00103857|21094266|P5|COMPLETED|50-Week Extension Study||101
8555149|NCT00103857|21094267|P4|COMPLETED|50-Week Extension Study||98
8555150|NCT00103857|21094268|P3|COMPLETED|50-Week Extension Study||95
8555151|NCT00103857|21094269|P2|COMPLETED|50-Week Extension Study||80
8555152|NCT00103857|21094270|P1|COMPLETED|50-Week Extension Study||65
8555153|NCT00103857|21094264|P7|STARTED|50-Week Extension Study||0
8555154|NCT00103857|21094265|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
8555155|NCT00103857|21094266|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
8555156|NCT00103857|21094267|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
8555157|NCT00103857|21094268|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
8555158|NCT00103857|21094269|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
8555159|NCT00103857|21094270|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
8555160|NCT00103857|21094264|P7|NOT COMPLETED|54-Week Base Study||38
8555161|NCT00103857|21094265|P6|NOT COMPLETED|54-Week Base Study||61
8555162|NCT00103857|21094266|P5|NOT COMPLETED|54-Week Base Study||41
8555163|NCT00103857|21094267|P4|NOT COMPLETED|54-Week Base Study||42
8555164|NCT00103857|21094268|P3|NOT COMPLETED|54-Week Base Study||47
8555165|NCT00103857|21094269|P2|NOT COMPLETED|54-Week Base Study||56
8555166|NCT00103857|21094270|P1|NOT COMPLETED|54-Week Base Study||57
8555167|NCT00103857|21094264|P7|COMPLETED|54-Week Base Study||79
8555168|NCT00103857|21094265|P6|COMPLETED|54-Week Base Study||115
8555169|NCT00103857|21094266|P5|COMPLETED|54-Week Base Study||141
8555170|NCT00103857|21094267|P4|COMPLETED|54-Week Base Study||148
8555171|NCT00103857|21094268|P3|COMPLETED|54-Week Base Study||135
8555172|NCT00103857|21094269|P2|COMPLETED|54-Week Base Study||126
8555173|NCT00103857|21094270|P1|COMPLETED|54-Week Base Study||122
8555174|NCT00103857|21094264|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
8555175|NCT00103857|21094265|P6|STARTED|54-Week Base Study||176
8555176|NCT00103857|21094266|P5|STARTED|54-Week Base Study||182
8555177|NCT00103857|21094267|P4|STARTED|54-Week Base Study||190
8555178|NCT00103857|21094268|P3|STARTED|54-Week Base Study||182
8555179|NCT00103857|21094269|P2|STARTED|54-Week Base Study||182
8555180|NCT00103857|21094270|P1|STARTED|54-Week Base Study||179
8555181|NCT00103844|21094335|P2|NOT COMPLETED|Overall Study||0
8555182|NCT00103844|21094336|P1|NOT COMPLETED|Overall Study||0
8555183|NCT00103844|21094335|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
8555184|NCT00103844|21094336|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
8555185|NCT00103844|21094335|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
8555186|NCT00103844|21094336|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
8555187|NCT00103844|21094335|P2|STARTED|Overall Study||49
8555188|NCT00103844|21094336|P1|STARTED|Overall Study||101
8555189|NCT00103740|21094369|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
8555190|NCT00103740|21094370|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
8555191|NCT00103740|21094369|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
8555192|NCT00103740|21094370|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
8555193|NCT00103740|21094369|P2|STARTED|Period 2 - Extended Observation Period||63
8555194|NCT00103740|21094370|P1|STARTED|Period 2 - Extended Observation Period||78
8555195|NCT00103740|21094369|P2|NOT COMPLETED|Period 1 - Core||4
8555196|NCT00103740|21094370|P1|NOT COMPLETED|Period 1 - Core||7
8555197|NCT00103740|21094369|P2|COMPLETED|Period 1 - Core||89
8555198|NCT00103740|21094370|P1|COMPLETED|Period 1 - Core||85
8555199|NCT00103740|21094369|P2|STARTED|Period 1 - Core||93
8555200|NCT00103740|21094370|P1|STARTED|Period 1 - Core||92
8555201|NCT00103662|21094398|P2|NOT COMPLETED|Overall Study||33
8555202|NCT00103662|21094399|P1|NOT COMPLETED|Overall Study||19
8555203|NCT00103662|21094398|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
8555204|NCT00103662|21094399|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
8555205|NCT00103662|21094398|P2|STARTED|Overall Study||154
8555206|NCT00103662|21094399|P1|STARTED|Overall Study||148
8555207|NCT00103610|21094425|P2|NOT COMPLETED|Overall Study||80
8555208|NCT00103610|21094426|P1|NOT COMPLETED|Overall Study||38
8555209|NCT00103610|21094425|P2|COMPLETED|Overall Study||68
8555210|NCT00103610|21094426|P1|COMPLETED|Overall Study||112
8555211|NCT00103610|21094425|P2|STARTED|Overall Study||148
8555212|NCT00103610|21094426|P1|STARTED|Overall Study||150
8555213|NCT00103506|21094450|P2|NOT COMPLETED|Overall Study||324
8555214|NCT00103506|21094451|P1|NOT COMPLETED|Overall Study||322
8555215|NCT00103506|21094450|P2|COMPLETED|Overall Study||0
8555216|NCT00103506|21094451|P1|COMPLETED|Overall Study||0
8555217|NCT00103506|21094450|P2|STARTED|Overall Study||324
8555218|NCT00103506|21094451|P1|STARTED|Overall Study||322
8555219|NCT00103402|21094463|P2|NOT COMPLETED|Overall Study||17
8555220|NCT00103402|21094464|P1|NOT COMPLETED|Overall Study||22
8555221|NCT00103402|21094463|P2|COMPLETED|Overall Study||117
8555222|NCT00103402|21094464|P1|COMPLETED|Overall Study||116
8555223|NCT00103402|21094463|P2|STARTED|Overall Study||134
8555224|NCT00103402|21094464|P1|STARTED|Overall Study||138
8555225|NCT00103376|21094487|P3|NOT COMPLETED|Overall Study||0
8555226|NCT00103376|21094488|P2|NOT COMPLETED|Overall Study||0
8555227|NCT00103376|21094489|P1|NOT COMPLETED|Overall Study||0
8555228|NCT00103376|21094487|P3|COMPLETED|Overall Study||8
8555229|NCT00103376|21094488|P2|COMPLETED|Overall Study||7
8555230|NCT00103376|21094489|P1|COMPLETED|Overall Study||8
8555231|NCT00103376|21094487|P3|STARTED|Overall Study||8
8555232|NCT00103376|21094488|P2|STARTED|Overall Study||7
8555233|NCT00103376|21094489|P1|STARTED|Overall Study||8
8555234|NCT00103311|21094505|P2|NOT COMPLETED|Overall Study||1
8555235|NCT00103311|21094506|P1|NOT COMPLETED|Overall Study||4
8555236|NCT00103311|21094505|P2|COMPLETED|Overall Study||30
8555237|NCT00103311|21094506|P1|COMPLETED|Overall Study||29
8555238|NCT00103311|21094505|P2|STARTED|Overall Study||31
8555239|NCT00103311|21094506|P1|STARTED|Overall Study||33
8555240|NCT00103285|21094516|P8|NOT COMPLETED|Response Assignment||120
8555241|NCT00103285|21094517|P7|NOT COMPLETED|Response Assignment||49
8555242|NCT00103285|21094518|P6|NOT COMPLETED|Response Assignment||48
8555243|NCT00103285|21094519|P5|NOT COMPLETED|Response Assignment||84
8555244|NCT00103285|21094520|P4|NOT COMPLETED|Response Assignment||62
8555245|NCT00103285|21094521|P3|NOT COMPLETED|Response Assignment||84
8555246|NCT00103285|21094522|P2|NOT COMPLETED|Response Assignment||132
8555247|NCT00103285|21094523|P1|NOT COMPLETED|Response Assignment||0
8555248|NCT00103285|21094516|P8|COMPLETED|Response Assignment||523
8555249|NCT00103285|21094517|P7|COMPLETED|Response Assignment||199
8555250|NCT00103285|21094518|P6|COMPLETED|Response Assignment||201
8555251|NCT00103285|21094519|P5|COMPLETED|Response Assignment||425
8555252|NCT00103285|21094520|P4|COMPLETED|Response Assignment||441
8555253|NCT00103285|21094521|P3|COMPLETED|Response Assignment||853
8555254|NCT00103285|21094522|P2|COMPLETED|Response Assignment||807
8555255|NCT00103285|21094523|P1|COMPLETED|Response Assignment||0
8555256|NCT00103285|21094516|P8|STARTED|Response Assignment||643
8555257|NCT00103285|21094517|P7|STARTED|Response Assignment||248
8555258|NCT00103285|21094518|P6|STARTED|Response Assignment||249
8555259|NCT00103285|21094519|P5|STARTED|Response Assignment||509
8555260|NCT00103285|21094520|P4|STARTED|Response Assignment||503
8555261|NCT00103285|21094521|P3|STARTED|Response Assignment||937
8555262|NCT00103285|21094522|P2|STARTED|Response Assignment||939
8555263|NCT00103285|21094523|P1|STARTED|Response Assignment||0
8555264|NCT00103285|21094516|P8|NOT COMPLETED|Induction||0
8555265|NCT00103285|21094517|P7|NOT COMPLETED|Induction||0
8555266|NCT00103285|21094518|P6|NOT COMPLETED|Induction||0
8555267|NCT00103285|21094519|P5|NOT COMPLETED|Induction||0
8555268|NCT00103285|21094520|P4|NOT COMPLETED|Induction||0
8555269|NCT00103285|21094521|P3|NOT COMPLETED|Induction||0
8555270|NCT00103285|21094522|P2|NOT COMPLETED|Induction||0
8555271|NCT00103285|21094523|P1|NOT COMPLETED|Induction||1349
8555272|NCT00103285|21094516|P8|COMPLETED|Induction||0
8555273|NCT00103285|21094517|P7|COMPLETED|Induction||0
8555274|NCT00103285|21094518|P6|COMPLETED|Induction||0
8555275|NCT00103285|21094519|P5|COMPLETED|Induction||0
8555276|NCT00103285|21094520|P4|COMPLETED|Induction||0
8555277|NCT00103285|21094521|P3|COMPLETED|Induction||0
8555278|NCT00103285|21094522|P2|COMPLETED|Induction||0
8555279|NCT00103285|21094523|P1|COMPLETED|Induction||4028
8555280|NCT00103285|21094516|P8|STARTED|Induction||0
8555281|NCT00103285|21094517|P7|STARTED|Induction||0
8555282|NCT00103285|21094518|P6|STARTED|Induction||0
8555283|NCT00103285|21094519|P5|STARTED|Induction||0
8555284|NCT00103285|21094520|P4|STARTED|Induction||0
8555285|NCT00103285|21094521|P3|STARTED|Induction||0
8555286|NCT00103285|21094522|P2|STARTED|Induction||0
8555287|NCT00103285|21094523|P1|STARTED|Induction||5377
8555288|NCT00103259|21094552|P2|NOT COMPLETED|Overall Study||12
8555289|NCT00103259|21094553|P1|NOT COMPLETED|Overall Study||12
8555290|NCT00103259|21094552|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
8555291|NCT00103259|21094553|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
8555292|NCT00103259|21094552|P2|Eligible Patients Who Cross Over|Overall Study||10
8555293|NCT00103259|21094553|P1|Eligible Patients Who Cross Over|Overall Study||0
8555294|NCT00103259|21094552|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
8555295|NCT00103259|21094553|P1|Cross Over to the Other Arm|Overall Study||0
8555296|NCT00103259|21094552|P2|Eligible and Treated|Overall Study||38
8555297|NCT00103259|21094553|P1|Eligible and Treated|Overall Study||23
8555298|NCT00103259|21094552|P2|Treated|Overall Study||41
8555299|NCT00103259|21094553|P1|Treated|Overall Study||23
8555300|NCT00103259|21094552|P2|Eligible|Overall Study||41
8555301|NCT00103259|21094553|P1|Eligible|Overall Study||27
8555302|NCT00103259|21094552|P2|STARTED|Overall Study||44
8555303|NCT00103259|21094553|P1|STARTED|Overall Study||27
8555304|NCT00103207|21094565|P1|NOT COMPLETED|Overall Study||38
8555305|NCT00103207|21094565|P1|COMPLETED|Overall Study||34
8555306|NCT00103207|21094565|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
8555307|NCT00103207|21094565|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
8555308|NCT00103207|21094565|P1|STARTED|Overall Study||72
8555309|NCT00103194|21094575|P1|NOT COMPLETED|Overall Study||31
8555310|NCT00103194|21094575|P1|COMPLETED|Overall Study||18
8555311|NCT00103194|21094575|P1|Eligible and Treated|Overall Study||35
8555312|NCT00103194|21094575|P1|Eligible|Overall Study||35
8555313|NCT00103194|21094575|P1|Treated|Overall Study||49
8555314|NCT00103194|21094575|P1|STARTED|Overall Study||49
8555315|NCT00103142|21094584|P2|NOT COMPLETED|Overall Study||1
8555316|NCT00103142|21094585|P1|NOT COMPLETED|Overall Study||3
8555317|NCT00103142|21094584|P2|COMPLETED|Overall Study||36
8555318|NCT00103142|21094585|P1|COMPLETED|Overall Study||33
8555319|NCT00103142|21094584|P2|STARTED|Overall Study||37
8555320|NCT00103142|21094585|P1|STARTED|Overall Study||36
8555321|NCT00103116|21094593|P1|NOT COMPLETED|Overall Study||0
8555322|NCT00103116|21094593|P1|COMPLETED|Overall Study||32
8555323|NCT00103116|21094593|P1|STARTED|Overall Study||32
8555324|NCT00103012|21094601|P3|NOT COMPLETED|Overall Study||4
8555325|NCT00103012|21094602|P2|NOT COMPLETED|Overall Study||1
8555326|NCT00103012|21094603|P1|NOT COMPLETED|Overall Study||3
8555327|NCT00103012|21094601|P3|COMPLETED|Overall Study||12
8555328|NCT00103012|21094602|P2|COMPLETED|Overall Study||13
8555329|NCT00103012|21094603|P1|COMPLETED|Overall Study||14
8555330|NCT00103012|21094601|P3|STARTED|Overall Study||16
8555331|NCT00103012|21094602|P2|STARTED|Overall Study||14
8555332|NCT00103012|21094603|P1|STARTED|Overall Study||17
8555333|NCT00102960|21094614|P3|NOT COMPLETED|Overall Study||28
8555334|NCT00102960|21094615|P2|NOT COMPLETED|Overall Study||23
8555335|NCT00102960|21094616|P1|NOT COMPLETED|Overall Study||30
8555336|NCT00102960|21094614|P3|COMPLETED|Overall Study||98
8555337|NCT00102960|21094615|P2|COMPLETED|Overall Study||103
8555338|NCT00102960|21094616|P1|COMPLETED|Overall Study||95
8555339|NCT00102960|21094614|P3|STARTED|Overall Study||126
8555340|NCT00102960|21094615|P2|STARTED|Overall Study||126
8555341|NCT00102960|21094616|P1|STARTED|Overall Study||125
8555342|NCT00102804|21094665|P2|NOT COMPLETED|Overall Study||222
8555343|NCT00102804|21094666|P1|NOT COMPLETED|Overall Study||441
8555344|NCT00102804|21094665|P2|COMPLETED|Overall Study||0
8555345|NCT00102804|21094666|P1|COMPLETED|Overall Study||0
8555346|NCT00102804|21094665|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
8555347|NCT00102804|21094666|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
8555348|NCT00102804|21094665|P2|STARTED|Overall Study||222
8555349|NCT00102804|21094666|P1|STARTED|Overall Study||441
8555350|NCT00102687|21094687|P5|NOT COMPLETED|Maintenance Period||13
8555351|NCT00102687|21094688|P4|NOT COMPLETED|Maintenance Period||10
8555352|NCT00102687|21094689|P3|NOT COMPLETED|Maintenance Period||6
8555353|NCT00102687|21094690|P2|NOT COMPLETED|Maintenance Period||4
8555354|NCT00102687|21094691|P1|NOT COMPLETED|Maintenance Period||7
8555355|NCT00102687|21094687|P5|COMPLETED|Maintenance Period||8
8555356|NCT00102687|21094688|P4|COMPLETED|Maintenance Period||12
8555357|NCT00102687|21094689|P3|COMPLETED|Maintenance Period||2
8555358|NCT00102687|21094690|P2|COMPLETED|Maintenance Period||2
8555359|NCT00102687|21094691|P1|COMPLETED|Maintenance Period||6
8555360|NCT00102687|21094687|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
8555361|NCT00102687|21094688|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
8555362|NCT00102687|21094689|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
8555363|NCT00102687|21094690|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
8555364|NCT00102687|21094691|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
8555365|NCT00102687|21094687|P5|NOT COMPLETED|Initial Period||0
8555366|NCT00102687|21094688|P4|NOT COMPLETED|Initial Period||0
8555367|NCT00102687|21094689|P3|NOT COMPLETED|Initial Period||26
8555368|NCT00102687|21094690|P2|NOT COMPLETED|Initial Period||28
8555369|NCT00102687|21094691|P1|NOT COMPLETED|Initial Period||18
8555370|NCT00102687|21094687|P5|COMPLETED|Initial Period||0
8555371|NCT00102687|21094688|P4|COMPLETED|Initial Period||0
8555372|NCT00102687|21094689|P3|COMPLETED|Initial Period||25
8555373|NCT00102687|21094690|P2|COMPLETED|Initial Period||22
8555374|NCT00102687|21094691|P1|COMPLETED|Initial Period||32
8555375|NCT00102687|21094687|P5|STARTED|Initial Period||0
8555376|NCT00102687|21094688|P4|STARTED|Initial Period||0
8555377|NCT00102687|21094689|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
8555378|NCT00102687|21094690|P2|STARTED|Initial Period||50
8555379|NCT00102687|21094691|P1|STARTED|Initial Period||50
8555380|NCT00102596|21094755|P2|NOT COMPLETED|Part C||0
8555381|NCT00102596|21094756|P1|NOT COMPLETED|Part C||0
8555382|NCT00102596|21094755|P2|COMPLETED|Part C||2
8555383|NCT00102596|21094756|P1|COMPLETED|Part C||0
8555384|NCT00102596|21094755|P2|STARTED|Part C|Only 2 patients participated in Part C|2
8555385|NCT00102596|21094756|P1|STARTED|Part C||0
8555386|NCT00102596|21094755|P2|NOT COMPLETED|Part B||0
8555387|NCT00102596|21094756|P1|NOT COMPLETED|Part B||0
8555388|NCT00102596|21094755|P2|COMPLETED|Part B||10
8555389|NCT00102596|21094756|P1|COMPLETED|Part B||0
8555390|NCT00102596|21094755|P2|STARTED|Part B||10
8555391|NCT00102596|21094756|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
8555392|NCT00102596|21094755|P2|NOT COMPLETED|Part A||0
8555393|NCT00102596|21094756|P1|NOT COMPLETED|Part A||7
8555394|NCT00102596|21094755|P2|COMPLETED|Part A||0
8555395|NCT00102596|21094756|P1|COMPLETED|Part A||4
8555396|NCT00102596|21094755|P2|Participants Assigned Treatment|Part A||0
8555397|NCT00102596|21094756|P1|Participants Assigned Treatment|Part A||5
8555398|NCT00102596|21094755|P2|STARTED|Part A||0
8555399|NCT00102596|21094756|P1|STARTED|Part A||11
8555400|NCT00102531|21094767|P2|NOT COMPLETED|Overall Study||11
8555401|NCT00102531|21094768|P1|NOT COMPLETED|Overall Study||5
8555402|NCT00102531|21094767|P2|COMPLETED|Overall Study||1
8555403|NCT00102531|21094768|P1|COMPLETED|Overall Study||2
8555404|NCT00102531|21094767|P2|STARTED|Overall Study||12
8555405|NCT00102531|21094768|P1|STARTED|Overall Study||7
8555406|NCT00102518|21094774|P1|NOT COMPLETED|Overall Study||87
8555407|NCT00102518|21094774|P1|COMPLETED|Overall Study||238
8555408|NCT00102518|21094774|P1|STARTED|Overall Study||325
8555409|NCT00102440|21094783|P3|NOT COMPLETED|Overall Study||66
8555410|NCT00102440|21094784|P2|NOT COMPLETED|Overall Study||98
8555411|NCT00102440|21094785|P1|NOT COMPLETED|Overall Study||88
8555412|NCT00102440|21094783|P3|COMPLETED|Overall Study||187
8555413|NCT00102440|21094784|P2|COMPLETED|Overall Study||153
8555414|NCT00102440|21094785|P1|COMPLETED|Overall Study||168
8555415|NCT00102440|21094783|P3|STARTED|Overall Study||253
8555416|NCT00102440|21094784|P2|STARTED|Overall Study||251
8555417|NCT00102440|21094785|P1|STARTED|Overall Study||256
8555418|NCT00102063|21094835|P3|NOT COMPLETED|Overall Study||10
8555419|NCT00102063|21094836|P2|NOT COMPLETED|Overall Study||18
8555420|NCT00102063|21094837|P1|NOT COMPLETED|Overall Study||16
8555421|NCT00102063|21094835|P3|COMPLETED|Overall Study||90
8555422|NCT00102063|21094836|P2|COMPLETED|Overall Study||84
8555423|NCT00102063|21094837|P1|COMPLETED|Overall Study||84
8555424|NCT00102063|21094835|P3|STARTED|Overall Study||100
8555425|NCT00102063|21094836|P2|STARTED|Overall Study||102
8555426|NCT00102063|21094837|P1|STARTED|Overall Study||100
8555427|NCT00101933|21094868|P2|NOT COMPLETED|Overall Study||0
8555428|NCT00101933|21094869|P1|NOT COMPLETED|Overall Study||0
8555429|NCT00101933|21094868|P2|COMPLETED|Overall Study||55
8555430|NCT00101933|21094869|P1|COMPLETED|Overall Study||54
8555431|NCT00101933|21094868|P2|STARTED|Overall Study||55
8555432|NCT00101933|21094869|P1|STARTED|Overall Study||54
8555433|NCT00101907|21094895|P6|NOT COMPLETED|Overall Study||0
8555434|NCT00101907|21094896|P5|NOT COMPLETED|Overall Study||5
8555435|NCT00101907|21094897|P4|NOT COMPLETED|Overall Study||1
8555436|NCT00101907|21094898|P3|NOT COMPLETED|Overall Study||1
8555437|NCT00101907|21094899|P2|NOT COMPLETED|Overall Study||1
8555438|NCT00101907|21094900|P1|NOT COMPLETED|Overall Study||2
8555439|NCT00101907|21094895|P6|COMPLETED|Overall Study||2
8555440|NCT00101907|21094896|P5|COMPLETED|Overall Study||6
8555441|NCT00101907|21094897|P4|COMPLETED|Overall Study||5
8555442|NCT00101907|21094898|P3|COMPLETED|Overall Study||5
8555443|NCT00101907|21094899|P2|COMPLETED|Overall Study||7
8555444|NCT00101907|21094900|P1|COMPLETED|Overall Study||6
8555445|NCT00101907|21094895|P6|STARTED|Overall Study||2
8555446|NCT00101907|21094896|P5|STARTED|Overall Study||11
8555447|NCT00101907|21094897|P4|STARTED|Overall Study||6
8555448|NCT00101907|21094898|P3|STARTED|Overall Study||6
8555449|NCT00101907|21094899|P2|STARTED|Overall Study||8
8555450|NCT00101907|21094900|P1|STARTED|Overall Study||8
8555451|NCT00101868|21094942|P2|NOT COMPLETED|Overall Study||32
8555452|NCT00101868|21094943|P1|NOT COMPLETED|Overall Study||29
8555453|NCT00101868|21094942|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
8555454|NCT00101868|21094943|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
8555455|NCT00101868|21094942|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
8555456|NCT00101868|21094943|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
8555457|NCT00101816|21094955|P2|NOT COMPLETED|Overall Study||0
8555458|NCT00101816|21094956|P1|NOT COMPLETED|Overall Study||0
8555459|NCT00101816|21094955|P2|COMPLETED|Overall Study||99
8555460|NCT00101816|21094956|P1|COMPLETED|Overall Study||10
8555461|NCT00101816|21094955|P2|STARTED|Overall Study||99
8555462|NCT00101816|21094956|P1|STARTED|Overall Study||10
8555463|NCT00101686|21095013|P10|NOT COMPLETED|Overall Study||30
8555464|NCT00101686|21095014|P9|NOT COMPLETED|Overall Study||30
8555465|NCT00101686|21095015|P8|NOT COMPLETED|Overall Study||30
8555466|NCT00101686|21095016|P7|NOT COMPLETED|Overall Study||27
8555467|NCT00101686|21095017|P6|NOT COMPLETED|Overall Study||72
8555468|NCT00101686|21095018|P5|NOT COMPLETED|Overall Study||73
8555469|NCT00101686|21095019|P4|NOT COMPLETED|Overall Study||72
8555470|NCT00101686|21095020|P3|NOT COMPLETED|Overall Study||69
8555471|NCT00101686|21095021|P2|NOT COMPLETED|Overall Study||73
8555472|NCT00101686|21095022|P1|NOT COMPLETED|Overall Study||71
8555473|NCT00101686|21095013|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555474|NCT00101686|21095014|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555475|NCT00101686|21095015|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555476|NCT00101686|21095016|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555477|NCT00101686|21095017|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555478|NCT00101686|21095018|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555479|NCT00101686|21095019|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555480|NCT00101686|21095020|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555481|NCT00101686|21095021|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555482|NCT00101686|21095022|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555483|NCT00101686|21095013|P10|Received Treatment|Overall Study||29
8555484|NCT00101686|21095014|P9|Received Treatment|Overall Study||30
8555485|NCT00101686|21095015|P8|Received Treatment|Overall Study||29
8555486|NCT00101686|21095016|P7|Received Treatment|Overall Study||27
8555487|NCT00101686|21095017|P6|Received Treatment|Overall Study||70
8555488|NCT00101686|21095018|P5|Received Treatment|Overall Study||71
8555489|NCT00101686|21095019|P4|Received Treatment|Overall Study||70
8555490|NCT00101686|21095020|P3|Received Treatment|Overall Study||67
8555491|NCT00101686|21095021|P2|Received Treatment|Overall Study||67
8555492|NCT00101686|21095022|P1|Received Treatment|Overall Study||70
8555493|NCT00101686|21095013|P10|STARTED|Overall Study||30
8555494|NCT00101686|21095014|P9|STARTED|Overall Study||30
8555495|NCT00101686|21095015|P8|STARTED|Overall Study||30
8555496|NCT00101686|21095016|P7|STARTED|Overall Study||27
8555497|NCT00101686|21095017|P6|STARTED|Overall Study||72
8555498|NCT00101686|21095018|P5|STARTED|Overall Study||73
8555499|NCT00101686|21095019|P4|STARTED|Overall Study||72
8555500|NCT00101686|21095020|P3|STARTED|Overall Study||69
8555501|NCT00101686|21095021|P2|STARTED|Overall Study||73
8555502|NCT00101686|21095022|P1|STARTED|Overall Study||71
8555503|NCT00101660|21095069|P2|NOT COMPLETED|Overall Study||0
8555504|NCT00101660|21095070|P1|NOT COMPLETED|Overall Study||0
8555505|NCT00101660|21095069|P2|COMPLETED|Overall Study||288
8555506|NCT00101660|21095070|P1|COMPLETED|Overall Study||99
8555507|NCT00101660|21095069|P2|STARTED|Overall Study||288
8555508|NCT00101660|21095070|P1|STARTED|Overall Study||99
8555509|NCT00101647|21095088|P2|NOT COMPLETED|Overall Study||0
8555510|NCT00101647|21095089|P1|NOT COMPLETED|Overall Study||0
8555511|NCT00101647|21095088|P2|COMPLETED|Overall Study||161
8555512|NCT00101647|21095089|P1|COMPLETED|Overall Study||13
8555513|NCT00101647|21095088|P2|STARTED|Overall Study|Randomized|161
8555514|NCT00101647|21095089|P1|STARTED|Overall Study|Randomized|13
8555515|NCT00101582|21095139|P2|NOT COMPLETED|Overall Study||15
8555516|NCT00101582|21095140|P1|NOT COMPLETED|Overall Study||11
8555517|NCT00101582|21095139|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
8555518|NCT00101582|21095140|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
8555519|NCT00101582|21095139|P2|Received Study Drug|Overall Study||94
8555520|NCT00101582|21095140|P1|Received Study Drug|Overall Study||91
8555521|NCT00101582|21095139|P2|STARTED|Overall Study||94
8555522|NCT00101582|21095140|P1|STARTED|Overall Study||94
8555523|NCT00101452|21095163|P3|NOT COMPLETED|Overall Study||43
8555524|NCT00101452|21095164|P2|NOT COMPLETED|Overall Study||43
8555525|NCT00101452|21095165|P1|NOT COMPLETED|Overall Study||44
8555526|NCT00101452|21095163|P3|COMPLETED|Overall Study||22
8555527|NCT00101452|21095164|P2|COMPLETED|Overall Study||26
8555528|NCT00101452|21095165|P1|COMPLETED|Overall Study||21
8555529|NCT00101452|21095163|P3|STARTED|Overall Study||65
8555530|NCT00101452|21095164|P2|STARTED|Overall Study||69
8555531|NCT00101452|21095165|P1|STARTED|Overall Study||65
8555532|NCT00101439|21095179|P2|NOT COMPLETED|Period 2||2
8555533|NCT00101439|21095180|P1|NOT COMPLETED|Period 2||0
8555534|NCT00101439|21095179|P2|COMPLETED|Period 2||28
8555535|NCT00101439|21095180|P1|COMPLETED|Period 2||28
8555536|NCT00101439|21095179|P2|STARTED|Period 2||30
8555537|NCT00101439|21095180|P1|STARTED|Period 2||28
8555538|NCT00101439|21095179|P2|NOT COMPLETED|Period 1||0
8555539|NCT00101439|21095180|P1|NOT COMPLETED|Period 1||0
8555540|NCT00101439|21095179|P2|COMPLETED|Period 1||30
8555541|NCT00101439|21095180|P1|COMPLETED|Period 1||28
8555542|NCT00101439|21095179|P2|STARTED|Period 1||30
8555543|NCT00101439|21095180|P1|STARTED|Period 1||28
8555544|NCT00101413|21095188|P1|NOT COMPLETED|Overall Study||0
8555545|NCT00101413|21095188|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
8555546|NCT00101413|21095188|P1|STARTED|Overall Study||52
8555547|NCT00101400|21095196|P1|NOT COMPLETED|Survival Follow-Up||7
8555548|NCT00101400|21095196|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
8555549|NCT00101400|21095196|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
8555550|NCT00101400|21095196|P1|NOT COMPLETED|Treatment||0
8555551|NCT00101400|21095196|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
8555552|NCT00101400|21095196|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
8555553|NCT00101361|21095207|P2|NOT COMPLETED|Overall Study||0
8555554|NCT00101361|21095208|P1|NOT COMPLETED|Overall Study||0
8555555|NCT00101361|21095207|P2|COMPLETED|Overall Study||104
8555556|NCT00101361|21095208|P1|COMPLETED|Overall Study||108
8555557|NCT00101361|21095207|P2|STARTED|Overall Study||104
8555558|NCT00101361|21095208|P1|STARTED|Overall Study||108
8555559|NCT00101283|21095216|P2|NOT COMPLETED|Overall Study||3
8555560|NCT00101283|21095217|P1|NOT COMPLETED|Overall Study||0
8555561|NCT00101283|21095216|P2|COMPLETED|Overall Study||13
8555562|NCT00101283|21095217|P1|COMPLETED|Overall Study||16
8555563|NCT00101283|21095216|P2|Began Treatment|Overall Study||13
8555564|NCT00101283|21095217|P1|Began Treatment|Overall Study||16
8555565|NCT00101283|21095216|P2|STARTED|Overall Study||16
8555566|NCT00101283|21095217|P1|STARTED|Overall Study||16
8555567|NCT00101192|21095227|P1|NOT COMPLETED|Overall Study||7
8555568|NCT00101192|21095227|P1|COMPLETED|Overall Study||69
8555569|NCT00101192|21095227|P1|STARTED|Overall Study||76
8555570|NCT00101166|21095231|P1|NOT COMPLETED|Overall Study||10
8555571|NCT00101166|21095231|P1|COMPLETED|Overall Study||18
8555572|NCT00101166|21095231|P1|STARTED|Overall Study||28
8555573|NCT00101101|21095239|P1|NOT COMPLETED|Overall Study||20
8555574|NCT00101101|21095239|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
8555575|NCT00101101|21095239|P1|STARTED|Overall Study||43
8555576|NCT00101036|21095247|P2|NOT COMPLETED|Overall Study||0
8555577|NCT00101036|21095248|P1|NOT COMPLETED|Overall Study||0
8555578|NCT00101036|21095247|P2|COMPLETED|Overall Study||40
8555579|NCT00101036|21095248|P1|COMPLETED|Overall Study||17
8555580|NCT00101036|21095247|P2|STARTED|Overall Study||40
8555581|NCT00101036|21095248|P1|STARTED|Overall Study||17
8555582|NCT00101010|21095260|P1|NOT COMPLETED|Overall Study||1
8555583|NCT00101010|21095260|P1|COMPLETED|Overall Study||79
8555584|NCT00101010|21095260|P1|STARTED|Overall Study||80
8555585|NCT00100932|21095267|P2|NOT COMPLETED|Overall Study||27
8555586|NCT00100932|21095268|P1|NOT COMPLETED|Overall Study||73
8555587|NCT00100932|21095267|P2|COMPLETED|Overall Study||1
8555588|NCT00100932|21095268|P1|COMPLETED|Overall Study||5
8555589|NCT00100932|21095267|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
8555590|NCT00100932|21095268|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
8555591|NCT00100841|21095278|P1|NOT COMPLETED|Overall Study||0
8555592|NCT00100841|21095278|P1|COMPLETED|Overall Study||66
8555593|NCT00100841|21095278|P1|STARTED|Overall Study||66
8555594|NCT00100828|21095283|P1|NOT COMPLETED|Overall Study||6
8555595|NCT00100828|21095283|P1|COMPLETED|Overall Study||0
8555596|NCT00100828|21095283|P1|STARTED|Overall Study||6
8555597|NCT00100815|21095287|P1|NOT COMPLETED|Overall Study||49
8555598|NCT00100815|21095287|P1|COMPLETED|Overall Study||1
8555599|NCT00100815|21095287|P1|STARTED|Overall Study||50
8555600|NCT00100802|21095295|P1|NOT COMPLETED|Overall Study||80
8555601|NCT00100802|21095295|P1|COMPLETED|Overall Study||38
8555602|NCT00100802|21095295|P1|STARTED|Overall Study||118
8555603|NCT00100789|21095300|P1|NOT COMPLETED|Overall Study||64
8555604|NCT00100789|21095300|P1|COMPLETED|Overall Study||3
8555605|NCT00100789|21095300|P1|Eligible and Began Protocol Therapy|Overall Study||63
8555606|NCT00100789|21095300|P1|Eligible|Overall Study||64
8555607|NCT00100789|21095300|P1|STARTED|Overall Study||67
8555608|NCT00100698|21095309|P2|NOT COMPLETED|Overall Study||2
8555609|NCT00100698|21095310|P1|NOT COMPLETED|Overall Study||6
8555610|NCT00100698|21095309|P2|COMPLETED|Overall Study||27
8555611|NCT00100698|21095310|P1|COMPLETED|Overall Study||21
8555612|NCT00100698|21095309|P2|STARTED|Overall Study||29
8555613|NCT00100698|21095310|P1|STARTED|Overall Study||27
8555614|NCT00100659|21095352|P2|NOT COMPLETED|Overall Study||2
8555615|NCT00100659|21095353|P1|NOT COMPLETED|Overall Study||3
8555616|NCT00100659|21095352|P2|COMPLETED|Overall Study||57
8555617|NCT00100659|21095353|P1|COMPLETED|Overall Study||52
8555618|NCT00100659|21095352|P2|STARTED|Overall Study||59
8555619|NCT00100659|21095353|P1|STARTED|Overall Study||55
8555620|NCT00100230|21095363|P2|NOT COMPLETED|Overall Study||15
8555621|NCT00100230|21095364|P1|NOT COMPLETED|Overall Study||12
8555622|NCT00100230|21095363|P2|COMPLETED|Overall Study||22
8555623|NCT00100230|21095364|P1|COMPLETED|Overall Study||29
8555624|NCT00100230|21095363|P2|STARTED|Overall Study||37
8555625|NCT00100230|21095364|P1|STARTED|Overall Study||41
8555626|NCT00100178|21095377|P3|NOT COMPLETED|Overall Study||10
8555627|NCT00100178|21095378|P2|NOT COMPLETED|Overall Study||10
8555628|NCT00100178|21095379|P1|NOT COMPLETED|Overall Study||9
8555629|NCT00100178|21095377|P3|COMPLETED|Overall Study||32
8555630|NCT00100178|21095378|P2|COMPLETED|Overall Study||21
8555631|NCT00100178|21095379|P1|COMPLETED|Overall Study||32
8555632|NCT00100178|21095377|P3|STARTED|Overall Study||42
8555633|NCT00100178|21095378|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
8555634|NCT00100178|21095379|P1|STARTED|Overall Study||41
8555635|NCT00100165|21095390|P3|NOT COMPLETED|Third Intervention (4 Weeks)||0
8555636|NCT00100165|21095391|P2|NOT COMPLETED|Third Intervention (4 Weeks)||0
8555637|NCT00100165|21095392|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
8555638|NCT00100165|21095390|P3|COMPLETED|Third Intervention (4 Weeks)||9
8555639|NCT00100165|21095391|P2|COMPLETED|Third Intervention (4 Weeks)||10
8555640|NCT00100165|21095392|P1|COMPLETED|Third Intervention (4 Weeks)||10
8555641|NCT00100165|21095390|P3|STARTED|Third Intervention (4 Weeks)||9
8555642|NCT00100165|21095391|P2|STARTED|Third Intervention (4 Weeks)||10
8555643|NCT00100165|21095392|P1|STARTED|Third Intervention (4 Weeks)||10
8555644|NCT00100165|21095390|P3|NOT COMPLETED|Washout (1 Week)||0
8555645|NCT00100165|21095391|P2|NOT COMPLETED|Washout (1 Week)||0
8555646|NCT00100165|21095392|P1|NOT COMPLETED|Washout (1 Week)||0
8555647|NCT00100165|21095390|P3|COMPLETED|Washout (1 Week)||9
8555648|NCT00100165|21095391|P2|COMPLETED|Washout (1 Week)||10
8555649|NCT00100165|21095392|P1|COMPLETED|Washout (1 Week)||10
8555650|NCT00100165|21095390|P3|STARTED|Washout (1 Week)||9
8555651|NCT00100165|21095391|P2|STARTED|Washout (1 Week)||10
8555652|NCT00100165|21095392|P1|STARTED|Washout (1 Week)||10
8555653|NCT00100165|21095390|P3|NOT COMPLETED|Second Intervention (4 Weeks)||0
8555654|NCT00100165|21095391|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8555655|NCT00100165|21095392|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8555656|NCT00100165|21095390|P3|COMPLETED|Second Intervention (4 Weeks)||9
8555657|NCT00100165|21095391|P2|COMPLETED|Second Intervention (4 Weeks)||10
8555658|NCT00100165|21095392|P1|COMPLETED|Second Intervention (4 Weeks)||10
8555659|NCT00100165|21095390|P3|STARTED|Second Intervention (4 Weeks)||9
8555660|NCT00100165|21095391|P2|STARTED|Second Intervention (4 Weeks)||10
8555661|NCT00100165|21095392|P1|STARTED|Second Intervention (4 Weeks)||10
8555662|NCT00100165|21095390|P3|NOT COMPLETED|Washout (1 Week)||0
8555663|NCT00100165|21095391|P2|NOT COMPLETED|Washout (1 Week)||0
8555664|NCT00100165|21095392|P1|NOT COMPLETED|Washout (1 Week)||0
8555665|NCT00100165|21095390|P3|COMPLETED|Washout (1 Week)||9
8555666|NCT00100165|21095391|P2|COMPLETED|Washout (1 Week)||10
8555667|NCT00100165|21095392|P1|COMPLETED|Washout (1 Week)||10
8555668|NCT00100165|21095390|P3|STARTED|Washout (1 Week)||9
8555669|NCT00100165|21095391|P2|STARTED|Washout (1 Week)||10
8555670|NCT00100165|21095392|P1|STARTED|Washout (1 Week)||10
8555671|NCT00100165|21095390|P3|NOT COMPLETED|First Intervention (4 Weeks)||0
8555672|NCT00100165|21095391|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8555673|NCT00100165|21095392|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8555674|NCT00100165|21095390|P3|COMPLETED|First Intervention (4 Weeks)||9
8555675|NCT00100165|21095391|P2|COMPLETED|First Intervention (4 Weeks)||10
8555676|NCT00100165|21095392|P1|COMPLETED|First Intervention (4 Weeks)||10
8555677|NCT00100165|21095390|P3|STARTED|First Intervention (4 Weeks)||9
8555678|NCT00100165|21095391|P2|STARTED|First Intervention (4 Weeks)||10
8555679|NCT00100165|21095392|P1|STARTED|First Intervention (4 Weeks)||10
8555680|NCT00100165|21095390|P3|NOT COMPLETED|Baseline||0
8555681|NCT00100165|21095391|P2|NOT COMPLETED|Baseline||0
8555682|NCT00100165|21095392|P1|NOT COMPLETED|Baseline||0
8555683|NCT00100165|21095390|P3|COMPLETED|Baseline||9
8555684|NCT00100165|21095391|P2|COMPLETED|Baseline||10
8555685|NCT00100165|21095392|P1|COMPLETED|Baseline||10
8555686|NCT00100165|21095390|P3|STARTED|Baseline||9
8555687|NCT00100165|21095391|P2|STARTED|Baseline||10
8555688|NCT00100165|21095392|P1|STARTED|Baseline||10
8555689|NCT00100048|21095408|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
8555690|NCT00100048|21095409|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
8555691|NCT00100048|21095410|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
8555692|NCT00100048|21095411|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
8555693|NCT00100048|21095412|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
8555694|NCT00100048|21095413|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
8555695|NCT00100048|21095408|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
8555696|NCT00100048|21095409|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
8555697|NCT00100048|21095410|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
8555698|NCT00100048|21095411|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
8555699|NCT00100048|21095412|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
8555700|NCT00100048|21095413|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
8555701|NCT00100048|21095408|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
8555702|NCT00100048|21095409|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555703|NCT00100048|21095410|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555704|NCT00100048|21095411|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555705|NCT00100048|21095412|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555706|NCT00100048|21095413|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
8555707|NCT00100048|21095408|P6|Treated|Cohort I & II-Combination Therapy Phase||38
8555708|NCT00100048|21095409|P5|Treated|Cohort I & II-Combination Therapy Phase||0
8555709|NCT00100048|21095410|P4|Treated|Cohort I & II-Combination Therapy Phase||40
8555710|NCT00100048|21095411|P3|Treated|Cohort I & II-Combination Therapy Phase||41
8555711|NCT00100048|21095412|P2|Treated|Cohort I & II-Combination Therapy Phase||40
8555712|NCT00100048|21095413|P1|Treated|Cohort I & II-Combination Therapy Phase||39
8555713|NCT00100048|21095408|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
8555714|NCT00100048|21095409|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
8555715|NCT00100048|21095410|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
8555716|NCT00100048|21095411|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
8555717|NCT00100048|21095412|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
8555718|NCT00100048|21095413|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
8555719|NCT00100048|21095408|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555720|NCT00100048|21095409|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555721|NCT00100048|21095410|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555722|NCT00100048|21095411|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555723|NCT00100048|21095412|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555724|NCT00100048|21095413|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555725|NCT00100048|21095408|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555726|NCT00100048|21095409|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
8555727|NCT00100048|21095410|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
8555728|NCT00100048|21095411|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
8555729|NCT00100048|21095412|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
8555730|NCT00100048|21095413|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
8555731|NCT00100048|21095408|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
8555732|NCT00100048|21095409|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
8555733|NCT00100048|21095410|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
8555734|NCT00100048|21095411|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
8555735|NCT00100048|21095412|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
8555736|NCT00100048|21095413|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
8555737|NCT00100048|21095408|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
8555738|NCT00100048|21095409|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8555739|NCT00100048|21095410|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
8555740|NCT00100048|21095411|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
8555741|NCT00100048|21095412|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8555742|NCT00100048|21095413|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8555743|NCT00099983|21095522|P2|NOT COMPLETED|Overall Study||25
8555744|NCT00099983|21095523|P1|NOT COMPLETED|Overall Study||24
8555745|NCT00099983|21095522|P2|COMPLETED|Overall Study||124
8555746|NCT00099983|21095523|P1|COMPLETED|Overall Study||123
8555747|NCT00099983|21095522|P2|STARTED|Overall Study||149
8555748|NCT00099983|21095523|P1|STARTED|Overall Study||147
8555749|NCT00099632|21095535|P6|NOT COMPLETED|Overall Study||2
8555750|NCT00099632|21095536|P5|NOT COMPLETED|Overall Study||1
8555751|NCT00099632|21095537|P4|NOT COMPLETED|Overall Study||1
8555752|NCT00099632|21095538|P3|NOT COMPLETED|Overall Study||3
8555753|NCT00099632|21095539|P2|NOT COMPLETED|Overall Study||1
8555754|NCT00099632|21095540|P1|NOT COMPLETED|Overall Study||1
8555755|NCT00099632|21095535|P6|COMPLETED|Overall Study||66
8555756|NCT00099632|21095536|P5|COMPLETED|Overall Study||70
8555757|NCT00099632|21095537|P4|COMPLETED|Overall Study||66
8555758|NCT00099632|21095538|P3|COMPLETED|Overall Study||72
8555759|NCT00099632|21095539|P2|COMPLETED|Overall Study||67
8555760|NCT00099632|21095540|P1|COMPLETED|Overall Study||72
8555761|NCT00099632|21095535|P6|STARTED|Overall Study||68
8555762|NCT00099632|21095536|P5|STARTED|Overall Study||71
8555763|NCT00099632|21095537|P4|STARTED|Overall Study||67
8555764|NCT00099632|21095538|P3|STARTED|Overall Study||75
8555765|NCT00099632|21095539|P2|STARTED|Overall Study||68
8555766|NCT00099632|21095540|P1|STARTED|Overall Study||73
8555767|NCT00099437|21095580|P2|NOT COMPLETED|Overall Study||349
8555768|NCT00099437|21095581|P1|NOT COMPLETED|Overall Study||366
8555769|NCT00099437|21095580|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
8555770|NCT00099437|21095581|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
8555771|NCT00099437|21095580|P2|STARTED|Overall Study|randomised patients|362
8555772|NCT00099437|21095581|P1|STARTED|Overall Study|randomised patients|374
8555773|NCT00099359|21095604|P3|NOT COMPLETED|Overall Study||68
8555774|NCT00099359|21095605|P2|NOT COMPLETED|Overall Study||65
8555775|NCT00099359|21095606|P1|NOT COMPLETED|Overall Study||54
8555776|NCT00099359|21095604|P3|COMPLETED|Overall Study||506
8555777|NCT00099359|21095605|P2|COMPLETED|Overall Study||515
8555778|NCT00099359|21095606|P1|COMPLETED|Overall Study||527
8555779|NCT00099359|21095604|P3|STARTED|Overall Study||574
8555780|NCT00099359|21095605|P2|STARTED|Overall Study||580
8555781|NCT00099359|21095606|P1|STARTED|Overall Study||581
8555782|NCT00099268|21095629|P2|NOT COMPLETED|Overall Study||82
8555783|NCT00099268|21095630|P1|NOT COMPLETED|Overall Study||92
8555784|NCT00099268|21095629|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
8555785|NCT00099268|21095630|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
8555786|NCT00099268|21095629|P2|Intent-to-Treat|Overall Study||372
8555787|NCT00099268|21095630|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
8555788|NCT00099268|21095629|P2|STARTED|Overall Study||373
8555789|NCT00099268|21095630|P1|STARTED|Overall Study||374
8555790|NCT00099047|21095648|P2|NOT COMPLETED|Overall Study||0
8555791|NCT00099047|21095649|P1|NOT COMPLETED|Overall Study||0
8555792|NCT00099047|21095648|P2|COMPLETED|Overall Study||12
8555793|NCT00099047|21095649|P1|COMPLETED|Overall Study||11
8555794|NCT00099047|21095648|P2|STARTED|Overall Study||12
8555795|NCT00099047|21095649|P1|STARTED|Overall Study||11
8555796|NCT00099021|21095655|P1|NOT COMPLETED|Overall Study||0
8555797|NCT00099021|21095655|P1|COMPLETED|Overall Study||21
8555798|NCT00099021|21095655|P1|STARTED|Overall Study||21
8555799|NCT00098956|21095661|P1|NOT COMPLETED|Overall Study||0
8555800|NCT00098956|21095661|P1|COMPLETED|Overall Study||19
8555801|NCT00098956|21095661|P1|STARTED|Overall Study||19
8555802|NCT00098865|21095670|P1|NOT COMPLETED|Overall Study||9
8555803|NCT00098865|21095670|P1|COMPLETED|Overall Study||6
8555804|NCT00098865|21095670|P1|STARTED|Overall Study||15
8555805|NCT00098839|21095678|P2|NOT COMPLETED|Overall Study||33
8555806|NCT00098839|21095679|P1|NOT COMPLETED|Overall Study||32
8555807|NCT00098839|21095678|P2|COMPLETED|Overall Study||27
8555808|NCT00098839|21095679|P1|COMPLETED|Overall Study||24
8555809|NCT00098839|21095678|P2|STARTED|Overall Study||60
8555810|NCT00098839|21095679|P1|STARTED|Overall Study||56
8555811|NCT00098813|21095690|P1|NOT COMPLETED|Overall Study||19
8555812|NCT00098813|21095690|P1|COMPLETED|Overall Study||1
8555813|NCT00098813|21095690|P1|STARTED|Overall Study||20
8555814|NCT00098787|21095697|P3|NOT COMPLETED|Overall Study||63
8555815|NCT00098787|21095698|P2|NOT COMPLETED|Overall Study||75
8555816|NCT00098787|21095699|P1|NOT COMPLETED|Overall Study||73
8555817|NCT00098787|21095697|P3|COMPLETED|Overall Study||0
8555818|NCT00098787|21095698|P2|COMPLETED|Overall Study||0
8555819|NCT00098787|21095699|P1|COMPLETED|Overall Study||0
8555820|NCT00098787|21095697|P3|Eligible and Treated|Overall Study||59
8555821|NCT00098787|21095698|P2|Eligible and Treated|Overall Study||66
8555822|NCT00098787|21095699|P1|Eligible and Treated|Overall Study||61
8555823|NCT00098787|21095697|P3|Treated|Overall Study||62
8555824|NCT00098787|21095698|P2|Treated|Overall Study||73
8555825|NCT00098787|21095699|P1|Treated|Overall Study||70
8555826|NCT00098787|21095697|P3|STARTED|Overall Study||63
8555827|NCT00098787|21095698|P2|STARTED|Overall Study||75
8555828|NCT00098787|21095699|P1|STARTED|Overall Study||73
8555829|NCT00098774|21095713|P1|NOT COMPLETED|Overall Study||18
8555830|NCT00098774|21095713|P1|COMPLETED|Overall Study||26
8555831|NCT00098774|21095713|P1|STARTED|Overall Study||44
8555832|NCT00098748|21095723|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
8555833|NCT00098748|21095724|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
8555834|NCT00098748|21095725|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
8555835|NCT00098748|21095723|P3|COMPLETED|Continued on Open-Label Treatment||0
8555836|NCT00098748|21095724|P2|COMPLETED|Continued on Open-Label Treatment||10
8555837|NCT00098748|21095725|P1|COMPLETED|Continued on Open-Label Treatment||7
8555838|NCT00098748|21095723|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
8555839|NCT00098748|21095724|P2|STARTED|Continued on Open-Label Treatment||25
8555840|NCT00098748|21095725|P1|STARTED|Continued on Open-Label Treatment||15
8555841|NCT00098748|21095723|P3|NOT COMPLETED|Received Study Treatment||44
8555842|NCT00098748|21095724|P2|NOT COMPLETED|Received Study Treatment||36
8555843|NCT00098748|21095725|P1|NOT COMPLETED|Received Study Treatment||48
8555844|NCT00098748|21095723|P3|COMPLETED|Received Study Treatment||18
8555845|NCT00098748|21095724|P2|COMPLETED|Received Study Treatment||25
8555846|NCT00098748|21095725|P1|COMPLETED|Received Study Treatment||15
8555847|NCT00098748|21095723|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
8555848|NCT00098748|21095724|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
8555849|NCT00098748|21095725|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
8555850|NCT00098748|21095723|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
8555851|NCT00098748|21095724|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
8555852|NCT00098748|21095725|P1|STARTED|Received Study Treatment||63
8555853|NCT00098748|21095723|P3|NOT COMPLETED|Assigned to Study Treatment||2
8555854|NCT00098748|21095724|P2|NOT COMPLETED|Assigned to Study Treatment||2
8555855|NCT00098748|21095725|P1|NOT COMPLETED|Assigned to Study Treatment||0
8555856|NCT00098748|21095723|P3|COMPLETED|Assigned to Study Treatment||62
8555857|NCT00098748|21095724|P2|COMPLETED|Assigned to Study Treatment||61
8555858|NCT00098748|21095725|P1|COMPLETED|Assigned to Study Treatment||63
8555859|NCT00098748|21095723|P3|STARTED|Assigned to Study Treatment||64
8555860|NCT00098748|21095724|P2|STARTED|Assigned to Study Treatment||63
8555861|NCT00098748|21095725|P1|STARTED|Assigned to Study Treatment||63
8555862|NCT00098722|21095781|P7|NOT COMPLETED|Observation Phase||17
8555863|NCT00098722|21095782|P6|NOT COMPLETED|Observation Phase||45
8555864|NCT00098722|21095783|P5|NOT COMPLETED|Observation Phase||0
8555865|NCT00098722|21095784|P4|NOT COMPLETED|Observation Phase||0
8555866|NCT00098722|21095785|P3|NOT COMPLETED|Observation Phase||0
8555867|NCT00098722|21095786|P2|NOT COMPLETED|Observation Phase||0
8555868|NCT00098722|21095787|P1|NOT COMPLETED|Observation Phase||0
8555869|NCT00098722|21095781|P7|COMPLETED|Observation Phase||48
8555870|NCT00098722|21095782|P6|COMPLETED|Observation Phase||160
8555871|NCT00098722|21095783|P5|COMPLETED|Observation Phase||0
8555872|NCT00098722|21095784|P4|COMPLETED|Observation Phase||0
8555873|NCT00098722|21095785|P3|COMPLETED|Observation Phase||0
8555874|NCT00098722|21095786|P2|COMPLETED|Observation Phase||0
8555875|NCT00098722|21095787|P1|COMPLETED|Observation Phase||0
8555876|NCT00098722|21095781|P7|STARTED|Observation Phase||65
8555877|NCT00098722|21095782|P6|STARTED|Observation Phase||205
8555878|NCT00098722|21095783|P5|STARTED|Observation Phase||0
8555879|NCT00098722|21095784|P4|STARTED|Observation Phase||0
8555880|NCT00098722|21095785|P3|STARTED|Observation Phase||0
8555881|NCT00098722|21095786|P2|STARTED|Observation Phase||0
8555882|NCT00098722|21095787|P1|STARTED|Observation Phase||0
8555883|NCT00098722|21095781|P7|NOT COMPLETED|Open Label Phase||0
8555884|NCT00098722|21095782|P6|NOT COMPLETED|Open Label Phase||0
8555885|NCT00098722|21095783|P5|NOT COMPLETED|Open Label Phase||50
8555886|NCT00098722|21095784|P4|NOT COMPLETED|Open Label Phase||272
8555887|NCT00098722|21095785|P3|NOT COMPLETED|Open Label Phase||0
8555888|NCT00098722|21095786|P2|NOT COMPLETED|Open Label Phase||0
8555889|NCT00098722|21095787|P1|NOT COMPLETED|Open Label Phase||0
8555890|NCT00098722|21095781|P7|COMPLETED|Open Label Phase||0
8555891|NCT00098722|21095782|P6|COMPLETED|Open Label Phase||0
8555892|NCT00098722|21095783|P5|COMPLETED|Open Label Phase||0
8555893|NCT00098722|21095784|P4|COMPLETED|Open Label Phase||0
8555894|NCT00098722|21095785|P3|COMPLETED|Open Label Phase||0
8555895|NCT00098722|21095786|P2|COMPLETED|Open Label Phase||0
8555896|NCT00098722|21095787|P1|COMPLETED|Open Label Phase||0
8555897|NCT00098722|21095781|P7|STARTED|Open Label Phase||0
8555898|NCT00098722|21095782|P6|STARTED|Open Label Phase||0
8555899|NCT00098722|21095783|P5|STARTED|Open Label Phase||50
8555900|NCT00098722|21095784|P4|STARTED|Open Label Phase||272
8555901|NCT00098722|21095785|P3|STARTED|Open Label Phase||0
8555902|NCT00098722|21095786|P2|STARTED|Open Label Phase||0
8555903|NCT00098722|21095787|P1|STARTED|Open Label Phase||0
8555904|NCT00098722|21095781|P7|NOT COMPLETED|Double Blind Phase||0
8555905|NCT00098722|21095782|P6|NOT COMPLETED|Double Blind Phase||0
8555906|NCT00098722|21095783|P5|NOT COMPLETED|Double Blind Phase||0
8555907|NCT00098722|21095784|P4|NOT COMPLETED|Double Blind Phase||0
8555908|NCT00098722|21095785|P3|NOT COMPLETED|Double Blind Phase||94
8555909|NCT00098722|21095786|P2|NOT COMPLETED|Double Blind Phase||194
8555910|NCT00098722|21095787|P1|NOT COMPLETED|Double Blind Phase||186
8555911|NCT00098722|21095781|P7|COMPLETED|Double Blind Phase||0
8555912|NCT00098722|21095782|P6|COMPLETED|Double Blind Phase||0
8555913|NCT00098722|21095783|P5|COMPLETED|Double Blind Phase||0
8555914|NCT00098722|21095784|P4|COMPLETED|Double Blind Phase||0
8555915|NCT00098722|21095785|P3|COMPLETED|Double Blind Phase||0
8555916|NCT00098722|21095786|P2|COMPLETED|Double Blind Phase||0
8555917|NCT00098722|21095787|P1|COMPLETED|Double Blind Phase||0
8555918|NCT00098722|21095781|P7|Treated|Double Blind Phase||0
8555919|NCT00098722|21095782|P6|Treated|Double Blind Phase||0
8555920|NCT00098722|21095783|P5|Treated|Double Blind Phase||0
8555921|NCT00098722|21095784|P4|Treated|Double Blind Phase||0
8555922|NCT00098722|21095785|P3|Treated|Double Blind Phase||91
8555923|NCT00098722|21095786|P2|Treated|Double Blind Phase||191
8555924|NCT00098722|21095787|P1|Treated|Double Blind Phase||182
8555925|NCT00098722|21095781|P7|STARTED|Double Blind Phase||0
8555926|NCT00098722|21095782|P6|STARTED|Double Blind Phase||0
8555927|NCT00098722|21095783|P5|STARTED|Double Blind Phase||0
8555928|NCT00098722|21095784|P4|STARTED|Double Blind Phase||0
8555929|NCT00098722|21095785|P3|STARTED|Double Blind Phase||94
8555930|NCT00098722|21095786|P2|STARTED|Double Blind Phase||194
8555931|NCT00098722|21095787|P1|STARTED|Double Blind Phase||186
8555932|NCT00098670|21095850|P1|NOT COMPLETED|Overall Study||0
8555933|NCT00098670|21095850|P1|COMPLETED|Overall Study||102
8555934|NCT00098670|21095850|P1|STARTED|Overall Study||102
8555935|NCT00098475|21095861|P4|NOT COMPLETED|Step 2||0
8555936|NCT00098475|21095862|P3|NOT COMPLETED|Step 2||0
8555937|NCT00098475|21095863|P2|NOT COMPLETED|Step 2||10
8555938|NCT00098475|21095864|P1|NOT COMPLETED|Step 2||5
8555939|NCT00098475|21095861|P4|COMPLETED|Step 2||0
8555940|NCT00098475|21095862|P3|COMPLETED|Step 2||0
8555941|NCT00098475|21095863|P2|COMPLETED|Step 2||5
8555942|NCT00098475|21095864|P1|COMPLETED|Step 2||0
8555943|NCT00098475|21095861|P4|Eligible|Step 2||0
8555944|NCT00098475|21095862|P3|Eligible|Step 2||0
8555945|NCT00098475|21095863|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
8555946|NCT00098475|21095864|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
8555947|NCT00098475|21095861|P4|Treated|Step 2||0
8555948|NCT00098475|21095862|P3|Treated|Step 2||0
8555949|NCT00098475|21095863|P2|Treated|Step 2||14
8555950|NCT00098475|21095864|P1|Treated|Step 2||4
8555951|NCT00098475|21095861|P4|STARTED|Step 2||0
8555952|NCT00098475|21095862|P3|STARTED|Step 2||0
8555953|NCT00098475|21095863|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
8555954|NCT00098475|21095864|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
8555955|NCT00098475|21095861|P4|NOT COMPLETED|Step 1||3
8555956|NCT00098475|21095862|P3|NOT COMPLETED|Step 1||4
8555957|NCT00098475|21095863|P2|NOT COMPLETED|Step 1||173
8555958|NCT00098475|21095864|P1|NOT COMPLETED|Step 1||171
8555959|NCT00098475|21095861|P4|COMPLETED|Step 1||0
8555960|NCT00098475|21095862|P3|COMPLETED|Step 1||0
8555961|NCT00098475|21095863|P2|COMPLETED|Step 1||49
8555962|NCT00098475|21095864|P1|COMPLETED|Step 1||52
8555963|NCT00098475|21095861|P4|Eligible|Step 1||3
8555964|NCT00098475|21095862|P3|Eligible|Step 1||4
8555965|NCT00098475|21095863|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
8555966|NCT00098475|21095864|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
8555967|NCT00098475|21095861|P4|Treated|Step 1||3
8555968|NCT00098475|21095862|P3|Treated|Step 1||4
8555969|NCT00098475|21095863|P2|Treated|Step 1||220
8555970|NCT00098475|21095864|P1|Treated|Step 1||223
8555971|NCT00098475|21095861|P4|STARTED|Step 1||3
8555972|NCT00098475|21095862|P3|STARTED|Step 1||4
8555973|NCT00098475|21095863|P2|STARTED|Step 1||222
8555974|NCT00098475|21095864|P1|STARTED|Step 1||223
8555975|NCT00098371|21095876|P1|NOT COMPLETED|Overall Study||0
8555976|NCT00098371|21095876|P1|COMPLETED|Overall Study||64
8555977|NCT00098371|21095876|P1|STARTED|Overall Study||64
8555978|NCT00098345|21095901|P1|NOT COMPLETED|Overall Study||13
8555979|NCT00098345|21095901|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
8555980|NCT00098345|21095901|P1|STARTED|Overall Study||30
8555981|NCT00098306|21095914|P7|NOT COMPLETED|Observational Phase||26
8555982|NCT00098306|21095915|P6|NOT COMPLETED|Observational Phase||46
8555983|NCT00098306|21095916|P5|NOT COMPLETED|Observational Phase||0
8555984|NCT00098306|21095917|P4|NOT COMPLETED|Observational Phase||0
8555985|NCT00098306|21095918|P3|NOT COMPLETED|Observational Phase||0
8555986|NCT00098306|21095919|P2|NOT COMPLETED|Observational Phase||0
8555987|NCT00098306|21095920|P1|NOT COMPLETED|Observational Phase||0
8555988|NCT00098306|21095914|P7|COMPLETED|Observational Phase||55
8555989|NCT00098306|21095915|P6|COMPLETED|Observational Phase||204
8555990|NCT00098306|21095916|P5|COMPLETED|Observational Phase||0
8555991|NCT00098306|21095917|P4|COMPLETED|Observational Phase||0
8555992|NCT00098306|21095918|P3|COMPLETED|Observational Phase||0
8555993|NCT00098306|21095919|P2|COMPLETED|Observational Phase||0
8555994|NCT00098306|21095920|P1|COMPLETED|Observational Phase||0
8555995|NCT00098306|21095914|P7|STARTED|Observational Phase||81
8555996|NCT00098306|21095915|P6|STARTED|Observational Phase||250
8555997|NCT00098306|21095916|P5|STARTED|Observational Phase||0
8555998|NCT00098306|21095917|P4|STARTED|Observational Phase||0
8555999|NCT00098306|21095918|P3|STARTED|Observational Phase||0
8556000|NCT00098306|21095919|P2|STARTED|Observational Phase||0
8556001|NCT00098306|21095920|P1|STARTED|Observational Phase||0
8556002|NCT00098306|21095914|P7|NOT COMPLETED|Open Label||0
8556003|NCT00098306|21095915|P6|NOT COMPLETED|Open Label||0
8556004|NCT00098306|21095916|P5|NOT COMPLETED|Open Label||62
8556005|NCT00098306|21095917|P4|NOT COMPLETED|Open Label||327
8556006|NCT00098306|21095918|P3|NOT COMPLETED|Open Label||0
8556007|NCT00098306|21095919|P2|NOT COMPLETED|Open Label||0
8556008|NCT00098306|21095920|P1|NOT COMPLETED|Open Label||0
8556009|NCT00098306|21095914|P7|COMPLETED|Open Label||0
8556010|NCT00098306|21095915|P6|COMPLETED|Open Label||0
8556011|NCT00098306|21095916|P5|COMPLETED|Open Label||0
8556012|NCT00098306|21095917|P4|COMPLETED|Open Label||0
8556013|NCT00098306|21095918|P3|COMPLETED|Open Label||0
8556014|NCT00098306|21095919|P2|COMPLETED|Open Label||0
8556015|NCT00098306|21095920|P1|COMPLETED|Open Label||0
8556016|NCT00098306|21095914|P7|STARTED|Open Label||0
8556017|NCT00098306|21095915|P6|STARTED|Open Label||0
8556018|NCT00098306|21095916|P5|STARTED|Open Label||62
8556019|NCT00098306|21095917|P4|STARTED|Open Label||327
8556020|NCT00098306|21095918|P3|STARTED|Open Label||0
8556021|NCT00098306|21095919|P2|STARTED|Open Label||0
8556022|NCT00098306|21095920|P1|STARTED|Open Label||0
8556023|NCT00098306|21095914|P7|NOT COMPLETED|Double Blind||0
8556024|NCT00098306|21095915|P6|NOT COMPLETED|Double Blind||0
8556025|NCT00098306|21095916|P5|NOT COMPLETED|Double Blind||0
8556026|NCT00098306|21095917|P4|NOT COMPLETED|Double Blind||0
8556027|NCT00098306|21095918|P3|NOT COMPLETED|Double Blind||120
8556028|NCT00098306|21095919|P2|NOT COMPLETED|Double Blind||240
8556029|NCT00098306|21095920|P1|NOT COMPLETED|Double Blind||241
8556030|NCT00098306|21095914|P7|COMPLETED|Double Blind||0
8556031|NCT00098306|21095915|P6|COMPLETED|Double Blind||0
8556032|NCT00098306|21095916|P5|COMPLETED|Double Blind||0
8556033|NCT00098306|21095917|P4|COMPLETED|Double Blind||0
8556034|NCT00098306|21095918|P3|COMPLETED|Double Blind||0
8556035|NCT00098306|21095919|P2|COMPLETED|Double Blind||0
8556036|NCT00098306|21095920|P1|COMPLETED|Double Blind||0
8556037|NCT00098306|21095914|P7|Treated|Double Blind||0
8556038|NCT00098306|21095915|P6|Treated|Double Blind||0
8556039|NCT00098306|21095916|P5|Treated|Double Blind||0
8556040|NCT00098306|21095917|P4|Treated|Double Blind||0
8556041|NCT00098306|21095918|P3|Treated|Double Blind||118
8556042|NCT00098306|21095919|P2|Treated|Double Blind||235
8556043|NCT00098306|21095920|P1|Treated|Double Blind||232
8556044|NCT00098306|21095914|P7|STARTED|Double Blind||0
8556045|NCT00098306|21095915|P6|STARTED|Double Blind||0
8556046|NCT00098306|21095916|P5|STARTED|Double Blind||0
8556047|NCT00098306|21095917|P4|STARTED|Double Blind||0
8556048|NCT00098306|21095918|P3|STARTED|Double Blind||120
8556049|NCT00098306|21095919|P2|STARTED|Double Blind||240
8556050|NCT00098306|21095920|P1|STARTED|Double Blind||241
8556051|NCT00098293|21095986|P5|NOT COMPLETED|Supplemental Phase (SP)||33
8556052|NCT00098293|21095987|P4|NOT COMPLETED|Supplemental Phase (SP)||0
8556053|NCT00098293|21095988|P3|NOT COMPLETED|Supplemental Phase (SP)||0
8556054|NCT00098293|21095989|P2|NOT COMPLETED|Supplemental Phase (SP)||0
8556055|NCT00098293|21095990|P1|NOT COMPLETED|Supplemental Phase (SP)||0
8556056|NCT00098293|21095986|P5|COMPLETED|Supplemental Phase (SP)||94
8556057|NCT00098293|21095987|P4|COMPLETED|Supplemental Phase (SP)||0
8556058|NCT00098293|21095988|P3|COMPLETED|Supplemental Phase (SP)||0
8556059|NCT00098293|21095989|P2|COMPLETED|Supplemental Phase (SP)||0
8556060|NCT00098293|21095990|P1|COMPLETED|Supplemental Phase (SP)||0
8556061|NCT00098293|21095986|P5|STARTED|Supplemental Phase (SP)||127
8556062|NCT00098293|21095987|P4|STARTED|Supplemental Phase (SP)||0
8556063|NCT00098293|21095988|P3|STARTED|Supplemental Phase (SP)||0
8556064|NCT00098293|21095989|P2|STARTED|Supplemental Phase (SP)||0
8556065|NCT00098293|21095990|P1|STARTED|Supplemental Phase (SP)||0
8556066|NCT00098293|21095986|P5|NOT COMPLETED|Open-label (OL) Phase||0
8556067|NCT00098293|21095987|P4|NOT COMPLETED|Open-label (OL) Phase||65
8556068|NCT00098293|21095988|P3|NOT COMPLETED|Open-label (OL) Phase||41
8556069|NCT00098293|21095989|P2|NOT COMPLETED|Open-label (OL) Phase||25
8556070|NCT00098293|21095990|P1|NOT COMPLETED|Open-label (OL) Phase||0
8556071|NCT00098293|21095986|P5|COMPLETED|Open-label (OL) Phase||0
8556072|NCT00098293|21095987|P4|COMPLETED|Open-label (OL) Phase||65
8556073|NCT00098293|21095988|P3|COMPLETED|Open-label (OL) Phase||158
8556074|NCT00098293|21095989|P2|COMPLETED|Open-label (OL) Phase||177
8556075|NCT00098293|21095990|P1|COMPLETED|Open-label (OL) Phase||0
8556076|NCT00098293|21095986|P5|STARTED|Open-label (OL) Phase||0
8556077|NCT00098293|21095987|P4|STARTED|Open-label (OL) Phase||130
8556078|NCT00098293|21095988|P3|STARTED|Open-label (OL) Phase||199
8556079|NCT00098293|21095989|P2|STARTED|Open-label (OL) Phase||202
8556080|NCT00098293|21095990|P1|STARTED|Open-label (OL) Phase||0
8556081|NCT00098293|21095986|P5|NOT COMPLETED|Between DB and OL Phase||0
8556082|NCT00098293|21095987|P4|NOT COMPLETED|Between DB and OL Phase||0
8556083|NCT00098293|21095988|P3|NOT COMPLETED|Between DB and OL Phase||3
8556084|NCT00098293|21095989|P2|NOT COMPLETED|Between DB and OL Phase||0
8556085|NCT00098293|21095990|P1|NOT COMPLETED|Between DB and OL Phase||0
8556086|NCT00098293|21095986|P5|COMPLETED|Between DB and OL Phase||0
8556087|NCT00098293|21095987|P4|COMPLETED|Between DB and OL Phase||0
8556088|NCT00098293|21095988|P3|COMPLETED|Between DB and OL Phase||199
8556089|NCT00098293|21095989|P2|COMPLETED|Between DB and OL Phase||202
8556090|NCT00098293|21095990|P1|COMPLETED|Between DB and OL Phase||0
8556091|NCT00098293|21095986|P5|STARTED|Between DB and OL Phase||0
8556092|NCT00098293|21095987|P4|STARTED|Between DB and OL Phase||0
8556093|NCT00098293|21095988|P3|STARTED|Between DB and OL Phase||202
8556094|NCT00098293|21095989|P2|STARTED|Between DB and OL Phase||202
8556095|NCT00098293|21095990|P1|STARTED|Between DB and OL Phase||0
8556096|NCT00098293|21095986|P5|NOT COMPLETED|Double-blind (DB) Phase||0
8556097|NCT00098293|21095987|P4|NOT COMPLETED|Double-blind (DB) Phase||0
8556098|NCT00098293|21095988|P3|NOT COMPLETED|Double-blind (DB) Phase||170
8556099|NCT00098293|21095989|P2|NOT COMPLETED|Double-blind (DB) Phase||166
8556100|NCT00098293|21095990|P1|NOT COMPLETED|Double-blind (DB) Phase||177
8556101|NCT00098293|21095986|P5|COMPLETED|Double-blind (DB) Phase||0
8556102|NCT00098293|21095987|P4|COMPLETED|Double-blind (DB) Phase||0
8556103|NCT00098293|21095988|P3|COMPLETED|Double-blind (DB) Phase||202
8556104|NCT00098293|21095989|P2|COMPLETED|Double-blind (DB) Phase||202
8556105|NCT00098293|21095990|P1|COMPLETED|Double-blind (DB) Phase||0
8556106|NCT00098293|21095986|P5|Treated|Double-blind (DB) Phase||0
8556107|NCT00098293|21095987|P4|Treated|Double-blind (DB) Phase||0
8556108|NCT00098293|21095988|P3|Treated|Double-blind (DB) Phase||361
8556109|NCT00098293|21095989|P2|Treated|Double-blind (DB) Phase||360
8556110|NCT00098293|21095990|P1|Treated|Double-blind (DB) Phase||174
8556111|NCT00098293|21095986|P5|STARTED|Double-blind (DB) Phase||0
8556112|NCT00098293|21095987|P4|STARTED|Double-blind (DB) Phase||0
8556113|NCT00098293|21095988|P3|STARTED|Double-blind (DB) Phase||372
8556114|NCT00098293|21095989|P2|STARTED|Double-blind (DB) Phase||368
8556115|NCT00098293|21095990|P1|STARTED|Double-blind (DB) Phase||177
8556116|NCT00098254|21096043|P1|NOT COMPLETED|Overall Study||3
8556117|NCT00098254|21096043|P1|COMPLETED|Overall Study||34
8556118|NCT00098254|21096043|P1|STARTED|Overall Study||37
8556119|NCT00098059|21096064|P2|NOT COMPLETED|Overall Study||1
8556120|NCT00098059|21096065|P1|NOT COMPLETED|Overall Study||0
8556121|NCT00098059|21096064|P2|COMPLETED|Overall Study||46
8556122|NCT00098059|21096065|P1|COMPLETED|Overall Study||27
8556123|NCT00098059|21096064|P2|STARTED|Overall Study||47
8556124|NCT00098059|21096065|P1|STARTED|Overall Study||27
8556125|NCT00098020|21096109|P1|NOT COMPLETED|Overall Study||6
8556126|NCT00098020|21096109|P1|COMPLETED|Overall Study||6
8556127|NCT00098020|21096109|P1|Started Isotretinoin|Overall Study||8
8556128|NCT00098020|21096109|P1|STARTED|Overall Study||12
8556129|NCT00097981|21096116|P2|NOT COMPLETED|Overall Study||100
8556130|NCT00097981|21096117|P1|NOT COMPLETED|Overall Study||106
8556131|NCT00097981|21096116|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
8556132|NCT00097981|21096117|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
8556133|NCT00097981|21096116|P2|Received Study Medication|Overall Study||106
8556134|NCT00097981|21096117|P1|Received Study Medication|Overall Study||110
8556135|NCT00097981|21096116|P2|STARTED|Overall Study|Enrollment at randomization|112
8556136|NCT00097981|21096117|P1|STARTED|Overall Study|Enrollment at randomization|113
8556137|NCT00097786|21096139|P4|NOT COMPLETED|Overall Study||310
8556138|NCT00097786|21096140|P3|NOT COMPLETED|Overall Study||313
8556139|NCT00097786|21096141|P2|NOT COMPLETED|Overall Study||292
8556140|NCT00097786|21096142|P1|NOT COMPLETED|Overall Study||296
8556141|NCT00097786|21096139|P4|COMPLETED|Overall Study||2036
8556142|NCT00097786|21096140|P3|COMPLETED|Overall Study||2016
8556143|NCT00097786|21096141|P2|COMPLETED|Overall Study||2023
8556144|NCT00097786|21096142|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
8556145|NCT00097786|21096139|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
8556146|NCT00097786|21096140|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
8556147|NCT00097786|21096141|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
8556148|NCT00097786|21096142|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
8556149|NCT00097786|21096139|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
8556150|NCT00097786|21096140|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
8556151|NCT00097786|21096141|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
8556152|NCT00097786|21096142|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
8556153|NCT00097786|21096139|P4|Complete FU for Progression to Diabetes|Overall Study||1762
8556154|NCT00097786|21096140|P3|Complete FU for Progression to Diabetes|Overall Study||1734
8556155|NCT00097786|21096141|P2|Complete FU for Progression to Diabetes|Overall Study||1712
8556156|NCT00097786|21096142|P1|Complete FU for Progression to Diabetes|Overall Study||1709
8556157|NCT00097786|21096139|P4|STARTED|Overall Study||2346
8556158|NCT00097786|21096140|P3|STARTED|Overall Study||2329
8556159|NCT00097786|21096141|P2|STARTED|Overall Study||2315
8556160|NCT00097786|21096142|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
8556161|NCT00097773|21096164|P4|NOT COMPLETED|Overall Study||3
8556162|NCT00097773|21096165|P3|NOT COMPLETED|Overall Study||8
8556163|NCT00097773|21096166|P2|NOT COMPLETED|Overall Study||8
8556164|NCT00097773|21096167|P1|NOT COMPLETED|Overall Study||8
8556165|NCT00097773|21096164|P4|COMPLETED|Overall Study||73
8556166|NCT00097773|21096165|P3|COMPLETED|Overall Study||68
8556167|NCT00097773|21096166|P2|COMPLETED|Overall Study||68
8556168|NCT00097773|21096167|P1|COMPLETED|Overall Study||68
8556169|NCT00097773|21096164|P4|STARTED|Overall Study||76
8556170|NCT00097773|21096165|P3|STARTED|Overall Study||76
8556171|NCT00097773|21096166|P2|STARTED|Overall Study||76
8556172|NCT00097773|21096167|P1|STARTED|Overall Study||76
8556173|NCT00097721|21096187|P2|NOT COMPLETED|Overall Study||33
8556174|NCT00097721|21096188|P1|NOT COMPLETED|Overall Study||71
8556175|NCT00097721|21096187|P2|COMPLETED|Overall Study||0
8556176|NCT00097721|21096188|P1|COMPLETED|Overall Study||0
8556177|NCT00097721|21096187|P2|STARTED|Overall Study||33
8556178|NCT00097721|21096188|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
8556179|NCT00097708|21096205|P3|NOT COMPLETED|Overall Study||65
8556180|NCT00097708|21096206|P2|NOT COMPLETED|Overall Study||56
8556181|NCT00097708|21096207|P1|NOT COMPLETED|Overall Study||64
8556182|NCT00097708|21096205|P3|COMPLETED|Overall Study||97
8556183|NCT00097708|21096206|P2|COMPLETED|Overall Study||120
8556184|NCT00097708|21096207|P1|COMPLETED|Overall Study||109
8556185|NCT00097708|21096205|P3|Treated|Overall Study||160
8556186|NCT00097708|21096206|P2|Treated|Overall Study||176
8556187|NCT00097708|21096207|P1|Treated|Overall Study||171
8556188|NCT00097708|21096205|P3|Intent-to-Treat (ITT)|Overall Study||149
8556189|NCT00097708|21096206|P2|Intent-to-Treat (ITT)|Overall Study||169
8556190|NCT00097708|21096207|P1|Intent-to-Treat (ITT)|Overall Study||165
8556191|NCT00097708|21096205|P3|STARTED|Overall Study||162
8556192|NCT00097708|21096206|P2|STARTED|Overall Study||176
8556193|NCT00097708|21096207|P1|STARTED|Overall Study||173
8556194|NCT00097695|21096219|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
8556195|NCT00097695|21096220|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
8556196|NCT00097695|21096221|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
8556197|NCT00097695|21096222|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
8556198|NCT00097695|21096219|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
8556199|NCT00097695|21096220|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
8556200|NCT00097695|21096221|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
8556201|NCT00097695|21096222|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
8556202|NCT00097695|21096219|P4|STARTED|The Open Label Extension (OLE) Phase||20
8556203|NCT00097695|21096220|P3|STARTED|The Open Label Extension (OLE) Phase||3
8556204|NCT00097695|21096221|P2|STARTED|The Open Label Extension (OLE) Phase||26
8556205|NCT00097695|21096222|P1|STARTED|The Open Label Extension (OLE) Phase||23
8556206|NCT00097695|21096219|P4|NOT COMPLETED|The Controlled Phase||20
8556207|NCT00097695|21096220|P3|NOT COMPLETED|The Controlled Phase||5
8556208|NCT00097695|21096221|P2|NOT COMPLETED|The Controlled Phase||3
8556209|NCT00097695|21096222|P1|NOT COMPLETED|The Controlled Phase||4
8556210|NCT00097695|21096219|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
8556211|NCT00097695|21096220|P3|COMPLETED|The Controlled Phase||3
8556212|NCT00097695|21096221|P2|COMPLETED|The Controlled Phase||26
8556213|NCT00097695|21096222|P1|COMPLETED|The Controlled Phase||23
8556214|NCT00097695|21096219|P4|STARTED|The Controlled Phase||20
8556215|NCT00097695|21096220|P3|STARTED|The Controlled Phase||8
8556216|NCT00097695|21096221|P2|STARTED|The Controlled Phase||29
8556217|NCT00097695|21096222|P1|STARTED|The Controlled Phase||27
8556218|NCT00097669|21096238|P2|NOT COMPLETED|Overall Study||0
8556219|NCT00097669|21096239|P1|NOT COMPLETED|Overall Study||0
8556220|NCT00097669|21096238|P2|COMPLETED|Overall Study||4075
8556221|NCT00097669|21096239|P1|COMPLETED|Overall Study||4089
8556222|NCT00097669|21096238|P2|STARTED|Overall Study||4075
8556223|NCT00097669|21096239|P1|STARTED|Overall Study||4089
8556224|NCT00097591|21096247|P2|NOT COMPLETED|Overall Study||394
8556225|NCT00097591|21096248|P1|NOT COMPLETED|Overall Study||410
8556226|NCT00097591|21096247|P2|COMPLETED|Overall Study||6401
8556227|NCT00097591|21096248|P1|COMPLETED|Overall Study||6403
8556228|NCT00097591|21096247|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
8556229|NCT00097591|21096248|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
8556230|NCT00097539|21096271|P7|NOT COMPLETED|Overall Study||171
8556231|NCT00097539|21096272|P6|NOT COMPLETED|Overall Study||5892
8556232|NCT00097539|21096273|P5|NOT COMPLETED|Overall Study||1758
8556233|NCT00097539|21096274|P4|NOT COMPLETED|Overall Study||3585
8556234|NCT00097539|21096275|P3|NOT COMPLETED|Overall Study||9108
8556235|NCT00097539|21096276|P2|NOT COMPLETED|Overall Study||6531
8556236|NCT00097539|21096277|P1|NOT COMPLETED|Overall Study||19066
8556237|NCT00097539|21096271|P7|COMPLETED|Overall Study||68
8556238|NCT00097539|21096272|P6|COMPLETED|Overall Study||2118
8556239|NCT00097539|21096273|P5|COMPLETED|Overall Study||386
8556240|NCT00097539|21096274|P4|COMPLETED|Overall Study||2066
8556241|NCT00097539|21096275|P3|COMPLETED|Overall Study||3411
8556242|NCT00097539|21096276|P2|COMPLETED|Overall Study||2825
8556243|NCT00097539|21096277|P1|COMPLETED|Overall Study||8220
8556244|NCT00097539|21096271|P7|STARTED|Overall Study||239
8556245|NCT00097539|21096272|P6|STARTED|Overall Study||8010
8556246|NCT00097539|21096273|P5|STARTED|Overall Study||2144
8556247|NCT00097539|21096274|P4|STARTED|Overall Study||5651
8556248|NCT00097539|21096275|P3|STARTED|Overall Study||12519
8556249|NCT00097539|21096276|P2|STARTED|Overall Study||9356
8556250|NCT00097539|21096277|P1|STARTED|Overall Study||27286
8556251|NCT00097500|21096323|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
8556252|NCT00097500|21096324|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
8556253|NCT00097500|21096323|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
8556254|NCT00097500|21096324|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
8556255|NCT00097500|21096323|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
8556256|NCT00097500|21096324|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
8556257|NCT00097500|21096323|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
8556258|NCT00097500|21096324|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
8556259|NCT00097500|21096323|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
8556260|NCT00097500|21096324|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
8556261|NCT00097500|21096323|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
8556262|NCT00097500|21096324|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
8556263|NCT00097448|21096348|P2|NOT COMPLETED|Overall Study||1
8556264|NCT00097448|21096349|P1|NOT COMPLETED|Overall Study||4
8556265|NCT00097448|21096348|P2|COMPLETED|Overall Study||129
8556266|NCT00097448|21096349|P1|COMPLETED|Overall Study||121
8556267|NCT00097448|21096348|P2|STARTED|Overall Study||130
8556268|NCT00097448|21096349|P1|STARTED|Overall Study||125
8556269|NCT00097370|21096355|P1|NOT COMPLETED|Stage 3||59
8556270|NCT00097370|21096355|P1|COMPLETED|Stage 3||0
8556271|NCT00097370|21096355|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
8556272|NCT00097370|21096355|P1|NOT COMPLETED|Stage 2||13
8556273|NCT00097370|21096355|P1|COMPLETED|Stage 2||59
8556274|NCT00097370|21096355|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
8556275|NCT00097370|21096355|P1|NOT COMPLETED|Stage 1||6
8556276|NCT00097370|21096355|P1|COMPLETED|Stage 1||31
8556277|NCT00097370|21096355|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
8556278|NCT00097253|21096372|P1|NOT COMPLETED|Water (Control)||0
8556279|NCT00097253|21096372|P1|COMPLETED|Water (Control)||56
8556280|NCT00097253|21096372|P1|STARTED|Water (Control)||56
8556281|NCT00097253|21096372|P1|NOT COMPLETED|Lemon||0
8556282|NCT00097253|21096372|P1|COMPLETED|Lemon||56
8556283|NCT00097253|21096372|P1|STARTED|Lemon||56
8556284|NCT00097253|21096372|P1|NOT COMPLETED|Lavender||0
8556285|NCT00097253|21096372|P1|COMPLETED|Lavender||56
8556286|NCT00097253|21096372|P1|STARTED|Lavender||56
8556287|NCT00096993|21096389|P2|NOT COMPLETED|Overall Study||65
8556288|NCT00096993|21096390|P1|NOT COMPLETED|Overall Study||65
8556289|NCT00096993|21096389|P2|COMPLETED|Overall Study||0
8556290|NCT00096993|21096390|P1|COMPLETED|Overall Study||1
8556291|NCT00096993|21096389|P2|STARTED|Overall Study||65
8556292|NCT00096993|21096390|P1|STARTED|Overall Study||66
8556293|NCT00096954|21096406|P2|NOT COMPLETED|Overall Study||20
8556294|NCT00096954|21096407|P1|NOT COMPLETED|Overall Study||24
8556295|NCT00096954|21096406|P2|COMPLETED|Overall Study||154
8556296|NCT00096954|21096407|P1|COMPLETED|Overall Study||135
8556297|NCT00096954|21096406|P2|Received Study Drug|Overall Study||171
8556298|NCT00096954|21096407|P1|Received Study Drug|Overall Study||157
8556299|NCT00096954|21096406|P2|STARTED|Overall Study||174
8556300|NCT00096954|21096407|P1|STARTED|Overall Study||159
8556301|NCT00096941|21096419|P1|NOT COMPLETED|Overall Study||3
8556302|NCT00096941|21096419|P1|COMPLETED|Overall Study||0
8556303|NCT00096941|21096419|P1|STARTED|Overall Study||3
8556304|NCT00096785|21096426|P2|NOT COMPLETED|Overall Study||1
8556305|NCT00096785|21096427|P1|NOT COMPLETED|Overall Study||2
8556306|NCT00096785|21096426|P2|COMPLETED|Overall Study|As randomized cohort|33
8556307|NCT00096785|21096427|P1|COMPLETED|Overall Study|As randomized cohort|33
8556308|NCT00096785|21096426|P2|As-Treated Population|Overall Study||33
8556309|NCT00096785|21096427|P1|As-Treated Population|Overall Study||36
8556310|NCT00096785|21096426|P2|As-Randomized Population|Overall Study||34
8556311|NCT00096785|21096427|P1|As-Randomized Population|Overall Study||35
8556312|NCT00096785|21096426|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
8556313|NCT00096785|21096427|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
8556314|NCT00096681|21096451|P1|NOT COMPLETED|Overall Study||0
8556315|NCT00096681|21096451|P1|COMPLETED|Overall Study||762
8556316|NCT00096681|21096451|P1|STARTED|Overall Study||762
8556317|NCT00096538|21096456|P1|NOT COMPLETED|Overall Study||1
8556318|NCT00096538|21096456|P1|COMPLETED|Overall Study||5
8556319|NCT00096538|21096456|P1|STARTED|Overall Study||6
8556320|NCT00096486|21096464|P4|NOT COMPLETED|Overall Study||2
8556321|NCT00096486|21096465|P3|NOT COMPLETED|Overall Study||2
8556322|NCT00096486|21096466|P2|NOT COMPLETED|Overall Study||0
8556323|NCT00096486|21096467|P1|NOT COMPLETED|Overall Study||0
8556324|NCT00096486|21096464|P4|COMPLETED|Overall Study||36
8556325|NCT00096486|21096465|P3|COMPLETED|Overall Study||24
8556326|NCT00096486|21096466|P2|COMPLETED|Overall Study||6
8556327|NCT00096486|21096467|P1|COMPLETED|Overall Study||4
8556328|NCT00096486|21096464|P4|STARTED|Overall Study||38
8556329|NCT00096486|21096465|P3|STARTED|Overall Study||26
8556330|NCT00096486|21096466|P2|STARTED|Overall Study||6
8556331|NCT00096486|21096467|P1|STARTED|Overall Study||4
8556332|NCT00096460|21096479|P2|NOT COMPLETED|Overall Study||1
8556333|NCT00096460|21096480|P1|NOT COMPLETED|Overall Study||7
8556334|NCT00096460|21096479|P2|COMPLETED|Overall Study||7
8556335|NCT00096460|21096480|P1|COMPLETED|Overall Study||15
8556336|NCT00096460|21096479|P2|STARTED|Overall Study||8
8556337|NCT00096460|21096480|P1|STARTED|Overall Study||22
8556338|NCT00096447|21096486|P1|NOT COMPLETED|Overall Study||1
8556339|NCT00096447|21096486|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
8556340|NCT00096447|21096486|P1|STARTED|Overall Study||31
8556341|NCT00096382|21096502|P2|NOT COMPLETED|Overall Study||0
8556342|NCT00096382|21096503|P1|NOT COMPLETED|Overall Study||2
8556343|NCT00096382|21096502|P2|COMPLETED|Overall Study||3
8556344|NCT00096382|21096503|P1|COMPLETED|Overall Study||21
8556345|NCT00096382|21096502|P2|STARTED|Overall Study||3
8556346|NCT00096382|21096503|P1|STARTED|Overall Study||23
8556347|NCT00096356|21096513|P2|NOT COMPLETED|Overall Study||53
8556348|NCT00096356|21096514|P1|NOT COMPLETED|Overall Study||44
8556349|NCT00096356|21096513|P2|COMPLETED|Overall Study||61
8556350|NCT00096356|21096514|P1|COMPLETED|Overall Study||78
8556351|NCT00096356|21096513|P2|STARTED|Overall Study||114
8556352|NCT00096356|21096514|P1|STARTED|Overall Study||122
8556353|NCT00096278|21096526|P2|NOT COMPLETED|Overall Study||20
8556354|NCT00096278|21096527|P1|NOT COMPLETED|Overall Study||18
8556355|NCT00096278|21096526|P2|COMPLETED|Overall Study||1334
8556356|NCT00096278|21096527|P1|COMPLETED|Overall Study||1338
8556357|NCT00096278|21096526|P2|STARTED|Overall Study||1354
8556358|NCT00096278|21096527|P1|STARTED|Overall Study||1356
8556359|NCT00096265|21096546|P3|NOT COMPLETED|Overall Study||0
8556360|NCT00096265|21096547|P2|NOT COMPLETED|Overall Study||0
8556361|NCT00096265|21096548|P1|NOT COMPLETED|Overall Study||1
8556362|NCT00096265|21096546|P3|COMPLETED|Overall Study||41
8556363|NCT00096265|21096547|P2|COMPLETED|Overall Study||40
8556364|NCT00096265|21096548|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8556365|NCT00096265|21096546|P3|STARTED|Overall Study||41
8556366|NCT00096265|21096547|P2|STARTED|Overall Study||40
8556367|NCT00096265|21096548|P1|STARTED|Overall Study||45
8556368|NCT00096226|21096574|P1|NOT COMPLETED|Overall Study||3
8556369|NCT00096226|21096574|P1|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
8556370|NCT00096226|21096574|P1|Eligible and Underwent Surgery|Overall Study||37
8556371|NCT00096226|21096574|P1|Eligible|Overall Study||57
8556372|NCT00096226|21096574|P1|STARTED|Overall Study||60
8556373|NCT00096200|21096588|P3|NOT COMPLETED|Overall Study||0
8556374|NCT00096200|21096589|P2|NOT COMPLETED|Overall Study||7
8556375|NCT00096200|21096590|P1|NOT COMPLETED|Overall Study||1
8556376|NCT00096200|21096588|P3|COMPLETED|Overall Study||5
8556377|NCT00096200|21096589|P2|COMPLETED|Overall Study||23
8556378|NCT00096200|21096590|P1|COMPLETED|Overall Study||8
8556379|NCT00096200|21096588|P3|STARTED|Overall Study||5
8556380|NCT00096200|21096589|P2|STARTED|Overall Study||30
8556381|NCT00096200|21096590|P1|STARTED|Overall Study||9
8556382|NCT00096174|21096604|P1|NOT COMPLETED|Overall Study||62
8556383|NCT00096174|21096604|P1|COMPLETED|Overall Study||7
8556384|NCT00096174|21096604|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
8556385|NCT00096174|21096604|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
8556386|NCT00096174|21096604|P1|STARTED|Overall Study||69
8556387|NCT00096161|21096614|P4|NOT COMPLETED|Overall Study||0
8556388|NCT00096161|21096615|P3|NOT COMPLETED|Overall Study||0
8556389|NCT00096161|21096616|P2|NOT COMPLETED|Overall Study||0
8556390|NCT00096161|21096617|P1|NOT COMPLETED|Overall Study||0
8556391|NCT00096161|21096614|P4|COMPLETED|Overall Study||0
8556392|NCT00096161|21096615|P3|COMPLETED|Overall Study||6
8556393|NCT00096161|21096616|P2|COMPLETED|Overall Study||10
8556394|NCT00096161|21096617|P1|COMPLETED|Overall Study||20
8556395|NCT00096161|21096614|P4|STARTED|Overall Study||0
8556396|NCT00096161|21096615|P3|STARTED|Overall Study||6
8556397|NCT00096161|21096616|P2|STARTED|Overall Study||10
8556398|NCT00096161|21096617|P1|STARTED|Overall Study||20
8556399|NCT00096135|21096649|P2|NOT COMPLETED|Overall Study||15
8556400|NCT00096135|21096650|P1|NOT COMPLETED|Overall Study||63
8556401|NCT00096135|21096649|P2|COMPLETED|Overall Study||27
8556402|NCT00096135|21096650|P1|COMPLETED|Overall Study||63
8556403|NCT00096135|21096649|P2|STARTED|Overall Study||42
8556404|NCT00096135|21096650|P1|STARTED|Overall Study||126
8556405|NCT00096122|21096656|P1|NOT COMPLETED|Overall Study||0
8556406|NCT00096122|21096656|P1|COMPLETED|Overall Study||95
8556407|NCT00096122|21096656|P1|STARTED|Overall Study||95
8556408|NCT00096109|21096660|P1|NOT COMPLETED|Overall Study||0
8556409|NCT00096109|21096660|P1|COMPLETED|Overall Study||11
8556410|NCT00096109|21096660|P1|STARTED|Overall Study||11
8556411|NCT00096044|21096666|P1|NOT COMPLETED|Overall Study||34
8556412|NCT00096044|21096666|P1|COMPLETED|Overall Study||11
8556413|NCT00096044|21096666|P1|STARTED|Overall Study||45
8556414|NCT00096031|21096675|P1|NOT COMPLETED|Overall Study||63
8556415|NCT00096031|21096675|P1|COMPLETED|Overall Study||0
8556416|NCT00096031|21096675|P1|Eligible and Began Protocol Therapy|Overall Study||55
8556417|NCT00096031|21096675|P1|Eligible|Overall Study||57
8556418|NCT00096031|21096675|P1|STARTED|Overall Study||63
8556419|NCT00096018|21096683|P2|NOT COMPLETED|Overall Study||14
8556420|NCT00096018|21096684|P1|NOT COMPLETED|Overall Study||2
8556421|NCT00096018|21096683|P2|COMPLETED|Overall Study||16
8556422|NCT00096018|21096684|P1|COMPLETED|Overall Study||11
8556423|NCT00096018|21096683|P2|Treated With Study Therapy|Overall Study||25
8556424|NCT00096018|21096684|P1|Treated With Study Therapy|Overall Study||13
8556425|NCT00096018|21096683|P2|STARTED|Overall Study||30
8556426|NCT00096018|21096684|P1|STARTED|Overall Study||13
8556427|NCT00095979|21096692|P1|NOT COMPLETED|Overall Study||2
8556428|NCT00095979|21096692|P1|COMPLETED|Overall Study||50
8556429|NCT00095979|21096692|P1|STARTED|Overall Study||52
8556430|NCT00095940|21096710|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
8556431|NCT00095940|21096711|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556432|NCT00095940|21096712|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556433|NCT00095940|21096713|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
8556434|NCT00095940|21096714|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
8556435|NCT00095940|21096715|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
8556436|NCT00095940|21096716|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
8556437|NCT00095940|21096717|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556438|NCT00095940|21096718|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556439|NCT00095940|21096710|P9|COMPLETED|Lapatinib Continuation/Phase II||1
8556440|NCT00095940|21096711|P8|COMPLETED|Lapatinib Continuation/Phase II||0
8556441|NCT00095940|21096712|P7|COMPLETED|Lapatinib Continuation/Phase II||0
8556442|NCT00095940|21096713|P6|COMPLETED|Lapatinib Continuation/Phase II||0
8556443|NCT00095940|21096714|P5|COMPLETED|Lapatinib Continuation/Phase II||0
8556444|NCT00095940|21096715|P4|COMPLETED|Lapatinib Continuation/Phase II||0
8556445|NCT00095940|21096716|P3|COMPLETED|Lapatinib Continuation/Phase II||1
8556446|NCT00095940|21096717|P2|COMPLETED|Lapatinib Continuation/Phase II||0
8556447|NCT00095940|21096718|P1|COMPLETED|Lapatinib Continuation/Phase II||0
8556448|NCT00095940|21096710|P9|STARTED|Lapatinib Continuation/Phase II||14
8556449|NCT00095940|21096711|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
8556450|NCT00095940|21096712|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
8556451|NCT00095940|21096713|P6|STARTED|Lapatinib Continuation/Phase II||13
8556452|NCT00095940|21096714|P5|STARTED|Lapatinib Continuation/Phase II||0
8556453|NCT00095940|21096715|P4|STARTED|Lapatinib Continuation/Phase II||0
8556454|NCT00095940|21096716|P3|STARTED|Lapatinib Continuation/Phase II||17
8556455|NCT00095940|21096717|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
8556456|NCT00095940|21096718|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
8556457|NCT00095940|21096710|P9|NOT COMPLETED|Molecular Biology Phase||0
8556458|NCT00095940|21096711|P8|NOT COMPLETED|Molecular Biology Phase||0
8556459|NCT00095940|21096712|P7|NOT COMPLETED|Molecular Biology Phase||0
8556460|NCT00095940|21096713|P6|NOT COMPLETED|Molecular Biology Phase||0
8556461|NCT00095940|21096714|P5|NOT COMPLETED|Molecular Biology Phase||0
8556462|NCT00095940|21096715|P4|NOT COMPLETED|Molecular Biology Phase||0
8556463|NCT00095940|21096716|P3|NOT COMPLETED|Molecular Biology Phase||0
8556464|NCT00095940|21096717|P2|NOT COMPLETED|Molecular Biology Phase||0
8556465|NCT00095940|21096718|P1|NOT COMPLETED|Molecular Biology Phase||0
8556466|NCT00095940|21096710|P9|COMPLETED|Molecular Biology Phase||0
8556467|NCT00095940|21096711|P8|COMPLETED|Molecular Biology Phase||2
8556468|NCT00095940|21096712|P7|COMPLETED|Molecular Biology Phase||2
8556469|NCT00095940|21096713|P6|COMPLETED|Molecular Biology Phase||0
8556470|NCT00095940|21096714|P5|COMPLETED|Molecular Biology Phase||0
8556471|NCT00095940|21096715|P4|COMPLETED|Molecular Biology Phase||0
8556472|NCT00095940|21096716|P3|COMPLETED|Molecular Biology Phase||0
8556473|NCT00095940|21096717|P2|COMPLETED|Molecular Biology Phase||2
8556474|NCT00095940|21096718|P1|COMPLETED|Molecular Biology Phase||2
8556475|NCT00095940|21096710|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8556476|NCT00095940|21096711|P8|STARTED|Molecular Biology Phase||2
8556477|NCT00095940|21096712|P7|STARTED|Molecular Biology Phase||2
8556478|NCT00095940|21096713|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8556479|NCT00095940|21096714|P5|STARTED|Molecular Biology Phase||0
8556480|NCT00095940|21096715|P4|STARTED|Molecular Biology Phase||0
8556481|NCT00095940|21096716|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8556482|NCT00095940|21096717|P2|STARTED|Molecular Biology Phase||2
8556483|NCT00095940|21096718|P1|STARTED|Molecular Biology Phase||2
8556484|NCT00095875|21096742|P2|NOT COMPLETED|Overall Study||9
8556485|NCT00095875|21096743|P1|NOT COMPLETED|Overall Study||14
8556486|NCT00095875|21096742|P2|COMPLETED|Overall Study||66
8556487|NCT00095875|21096743|P1|COMPLETED|Overall Study||56
8556488|NCT00095875|21096742|P2|STARTED|Overall Study||75
8556489|NCT00095875|21096743|P1|STARTED|Overall Study||70
8556490|NCT00095836|21096751|P1|NOT COMPLETED|Overall Study||4
8556491|NCT00095836|21096751|P1|COMPLETED|Overall Study||23
8556492|NCT00095836|21096751|P1|STARTED|Overall Study||27
8556493|NCT00095784|21096758|P1|NOT COMPLETED|Overall Study||0
8556494|NCT00095784|21096758|P1|COMPLETED|Overall Study||21
8556495|NCT00095784|21096758|P1|STARTED|Overall Study||21
8556496|NCT00095628|21096781|P1|NOT COMPLETED|Overall Study||1
8556497|NCT00095628|21096781|P1|COMPLETED|Overall Study||20
8556498|NCT00095628|21096781|P1|STARTED|Overall Study||21
8556499|NCT00095576|21096792|P2|NOT COMPLETED|Overall Study||1481
8556500|NCT00095576|21096793|P1|NOT COMPLETED|Overall Study||1475
8556501|NCT00095576|21096792|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
8556502|NCT00095576|21096793|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
8556503|NCT00095576|21096792|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
8556504|NCT00095576|21096793|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
8556505|NCT00095576|21096792|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
8556506|NCT00095576|21096793|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
8556507|NCT00095576|21096792|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
8556508|NCT00095576|21096793|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
8556509|NCT00095576|21096792|P2|STARTED|Overall Study||1495
8556510|NCT00095576|21096793|P1|STARTED|Overall Study||1484
8556511|NCT00095563|21096805|P1|NOT COMPLETED|Overall Study||0
8556512|NCT00095563|21096805|P1|COMPLETED|Overall Study||39
8556513|NCT00095563|21096805|P1|STARTED|Overall Study||39
8556514|NCT00095498|21096817|P3|NOT COMPLETED|Overall Study||39
8556515|NCT00095498|21096818|P2|NOT COMPLETED|Overall Study||35
8556516|NCT00095498|21096819|P1|NOT COMPLETED|Overall Study||37
8556517|NCT00095498|21096817|P3|COMPLETED|Overall Study||39
8556518|NCT00095498|21096818|P2|COMPLETED|Overall Study||38
8556519|NCT00095498|21096819|P1|COMPLETED|Overall Study||39
8556520|NCT00095498|21096817|P3|Received Investigational Product|Overall Study||75
8556521|NCT00095498|21096818|P2|Received Investigational Product|Overall Study||71
8556522|NCT00095498|21096819|P1|Received Investigational Product|Overall Study||72
8556523|NCT00095498|21096817|P3|STARTED|Overall Study||78
8556524|NCT00095498|21096818|P2|STARTED|Overall Study||73
8556525|NCT00095498|21096819|P1|STARTED|Overall Study||76
8556526|NCT00095303|21097246|P2|NOT COMPLETED|Follow Up Study||58
8556527|NCT00095303|21097247|P1|NOT COMPLETED|Follow Up Study||59
8556528|NCT00095303|21097246|P2|COMPLETED|Follow Up Study||121
8556529|NCT00095303|21097247|P1|COMPLETED|Follow Up Study||140
8556530|NCT00095303|21097246|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
8556531|NCT00095303|21097247|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
8556532|NCT00095303|21097246|P2|NOT COMPLETED|Main Study||87
8556533|NCT00095303|21097247|P1|NOT COMPLETED|Main Study||91
8556534|NCT00095303|21097246|P2|COMPLETED|Main Study||148
8556535|NCT00095303|21097247|P1|COMPLETED|Main Study||154
8556536|NCT00095303|21097246|P2|STARTED|Main Study||235
8556537|NCT00095303|21097247|P1|STARTED|Main Study||245
8556538|NCT00095238|21097315|P2|NOT COMPLETED|Overall Study||852
8556539|NCT00095238|21097316|P1|NOT COMPLETED|Overall Study||857
8556540|NCT00095238|21097315|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
8556541|NCT00095238|21097316|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
8556542|NCT00095238|21097315|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
8556543|NCT00095238|21097316|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
8556544|NCT00095238|21097315|P2|STARTED|Overall Study|number randomized|2061
8556545|NCT00095238|21097316|P1|STARTED|Overall Study|number randomized|2067
8556546|NCT00095212|21097378|P2|NOT COMPLETED|Overall Study||3
8556547|NCT00095212|21097379|P1|NOT COMPLETED|Overall Study||1
8556548|NCT00095212|21097378|P2|COMPLETED|Overall Study||9
8556549|NCT00095212|21097379|P1|COMPLETED|Overall Study||12
8556550|NCT00095212|21097378|P2|STARTED|Overall Study||12
8556551|NCT00095212|21097379|P1|STARTED|Overall Study||13
8556552|NCT00095199|21097409|P4|NOT COMPLETED|Overall Study||143
8556553|NCT00095199|21097410|P3|NOT COMPLETED|Overall Study||160
8556554|NCT00095199|21097411|P2|NOT COMPLETED|Overall Study||242
8556555|NCT00095199|21097412|P1|NOT COMPLETED|Overall Study||296
8556556|NCT00095199|21097409|P4|COMPLETED|Overall Study||23
8556557|NCT00095199|21097410|P3|COMPLETED|Overall Study||7
8556558|NCT00095199|21097411|P2|COMPLETED|Overall Study||62
8556559|NCT00095199|21097412|P1|COMPLETED|Overall Study||6
8556560|NCT00095199|21097409|P4|STARTED|Overall Study||166
8556561|NCT00095199|21097410|P3|STARTED|Overall Study||167
8556562|NCT00095199|21097411|P2|STARTED|Overall Study||304
8556563|NCT00095199|21097412|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
8556564|NCT00095173|21097450|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
8556565|NCT00095173|21097451|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
8556566|NCT00095173|21097452|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
8556567|NCT00095173|21097453|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8556568|NCT00095173|21097454|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8556569|NCT00095173|21097455|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8556570|NCT00095173|21097450|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
8556571|NCT00095173|21097451|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
8556572|NCT00095173|21097452|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
8556573|NCT00095173|21097453|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
8556574|NCT00095173|21097454|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
8556575|NCT00095173|21097455|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
8556576|NCT00095173|21097450|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
8556577|NCT00095173|21097451|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
8556578|NCT00095173|21097452|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
8556579|NCT00095173|21097453|P3|STARTED|Open-Label Extension Phase (Period C)||0
8556580|NCT00095173|21097454|P2|STARTED|Open-Label Extension Phase (Period C)||0
8556581|NCT00095173|21097455|P1|STARTED|Open-Label Extension Phase (Period C)||0
8556582|NCT00095173|21097450|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556583|NCT00095173|21097451|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556584|NCT00095173|21097452|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556585|NCT00095173|21097453|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
8556586|NCT00095173|21097454|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
8556587|NCT00095173|21097455|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556588|NCT00095173|21097450|P6|COMPLETED|Double-Blind Phase (Period B)||0
8556589|NCT00095173|21097451|P5|COMPLETED|Double-Blind Phase (Period B)||0
8556590|NCT00095173|21097452|P4|COMPLETED|Double-Blind Phase (Period B)||0
8556591|NCT00095173|21097453|P3|COMPLETED|Double-Blind Phase (Period B)||31
8556592|NCT00095173|21097454|P2|COMPLETED|Double-Blind Phase (Period B)||49
8556593|NCT00095173|21097455|P1|COMPLETED|Double-Blind Phase (Period B)||0
8556594|NCT00095173|21097450|P6|STARTED|Double-Blind Phase (Period B)||0
8556595|NCT00095173|21097451|P5|STARTED|Double-Blind Phase (Period B)||0
8556596|NCT00095173|21097452|P4|STARTED|Double-Blind Phase (Period B)||0
8556597|NCT00095173|21097453|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
8556598|NCT00095173|21097454|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
8556599|NCT00095173|21097455|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
8556600|NCT00095173|21097450|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556601|NCT00095173|21097451|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556602|NCT00095173|21097452|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556603|NCT00095173|21097453|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556604|NCT00095173|21097454|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556605|NCT00095173|21097455|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
8556606|NCT00095173|21097450|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556607|NCT00095173|21097451|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556608|NCT00095173|21097452|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556609|NCT00095173|21097453|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556610|NCT00095173|21097454|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556611|NCT00095173|21097455|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
8556612|NCT00095173|21097450|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
8556613|NCT00095173|21097451|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
8556614|NCT00095173|21097452|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
8556615|NCT00095173|21097453|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
8556616|NCT00095173|21097454|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
8556617|NCT00095173|21097455|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
8556618|NCT00095147|21097493|P5|NOT COMPLETED|Long-term Extension Period||45
8556619|NCT00095147|21097494|P4|NOT COMPLETED|Long-term Extension Period||0
8556620|NCT00095147|21097495|P3|NOT COMPLETED|Long-term Extension Period||0
8556621|NCT00095147|21097496|P2|NOT COMPLETED|Long-term Extension Period||0
8556622|NCT00095147|21097497|P1|NOT COMPLETED|Long-term Extension Period||0
8556623|NCT00095147|21097493|P5|COMPLETED|Long-term Extension Period||327
8556624|NCT00095147|21097494|P4|COMPLETED|Long-term Extension Period||0
8556625|NCT00095147|21097495|P3|COMPLETED|Long-term Extension Period||0
8556626|NCT00095147|21097496|P2|COMPLETED|Long-term Extension Period||0
8556627|NCT00095147|21097497|P1|COMPLETED|Long-term Extension Period||0
8556628|NCT00095147|21097493|P5|STARTED|Long-term Extension Period||372
8556629|NCT00095147|21097494|P4|STARTED|Long-term Extension Period||0
8556630|NCT00095147|21097495|P3|STARTED|Long-term Extension Period||0
8556631|NCT00095147|21097496|P2|STARTED|Long-term Extension Period||0
8556632|NCT00095147|21097497|P1|STARTED|Long-term Extension Period||0
8556633|NCT00095147|21097493|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556634|NCT00095147|21097494|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
8556635|NCT00095147|21097495|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556636|NCT00095147|21097496|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
8556637|NCT00095147|21097497|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
8556638|NCT00095147|21097493|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556639|NCT00095147|21097494|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
8556640|NCT00095147|21097495|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556641|NCT00095147|21097496|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
8556642|NCT00095147|21097497|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
8556643|NCT00095147|21097493|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
8556644|NCT00095147|21097494|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
8556645|NCT00095147|21097495|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
8556646|NCT00095147|21097496|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
8556647|NCT00095147|21097497|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
8556648|NCT00095147|21097493|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556649|NCT00095147|21097494|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556650|NCT00095147|21097495|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
8556651|NCT00095147|21097496|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
8556652|NCT00095147|21097497|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
8556653|NCT00095147|21097493|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556654|NCT00095147|21097494|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556655|NCT00095147|21097495|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
8556656|NCT00095147|21097496|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
8556657|NCT00095147|21097497|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
8556658|NCT00095147|21097493|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
8556659|NCT00095147|21097494|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
8556660|NCT00095147|21097495|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
8556661|NCT00095147|21097496|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
8556662|NCT00095147|21097497|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
8556663|NCT00095121|21097692|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
8556664|NCT00095121|21097693|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
8556665|NCT00095121|21097692|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
8556666|NCT00095121|21097693|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
8556667|NCT00095121|21097692|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
8556668|NCT00095121|21097693|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
8556669|NCT00095121|21097692|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
8556670|NCT00095121|21097693|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
8556671|NCT00095121|21097692|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
8556672|NCT00095121|21097693|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
8556673|NCT00095121|21097692|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
8556674|NCT00095121|21097693|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
8556675|NCT00095121|21097692|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
8556676|NCT00095121|21097693|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
8556677|NCT00095056|21097739|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
8556678|NCT00095056|21097740|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
8556679|NCT00095056|21097739|P2|COMPLETED|Phase B (Weeks 12-54)||20
8556680|NCT00095056|21097740|P1|COMPLETED|Phase B (Weeks 12-54)||46
8556681|NCT00095056|21097739|P2|STARTED|Phase B (Weeks 12-54)||25
8556682|NCT00095056|21097740|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
8556683|NCT00095056|21097739|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
8556684|NCT00095056|21097740|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
8556685|NCT00095056|21097739|P2|COMPLETED|Phase A (Weeks 0-12)||25
8556686|NCT00095056|21097740|P1|COMPLETED|Phase A (Weeks 0-12)||58
8556687|NCT00095056|21097739|P2|STARTED|Phase A (Weeks 0-12)||26
8556688|NCT00095056|21097740|P1|STARTED|Phase A (Weeks 0-12)||65
8556689|NCT00094900|21097748|P1|NOT COMPLETED|Overall Study||1
8556690|NCT00094900|21097748|P1|COMPLETED|Overall Study||10
8556691|NCT00094900|21097748|P1|STARTED|Overall Study||11
8556692|NCT00094887|21097850|P2|NOT COMPLETED|Overall Study||4
8556693|NCT00094887|21097851|P1|NOT COMPLETED|Overall Study||4
8556694|NCT00094887|21097850|P2|COMPLETED|Overall Study||71
8556695|NCT00094887|21097851|P1|COMPLETED|Overall Study||71
8556696|NCT00094887|21097850|P2|Primary Efficacy Population|Overall Study||64
8556697|NCT00094887|21097851|P1|Primary Efficacy Population|Overall Study||65
8556698|NCT00094887|21097850|P2|Per Protocol Analysis Set|Overall Study||71
8556699|NCT00094887|21097851|P1|Per Protocol Analysis Set|Overall Study||71
8556700|NCT00094887|21097850|P2|Intent to Treat Population|Overall Study||75
8556701|NCT00094887|21097851|P1|Intent to Treat Population|Overall Study||75
8556702|NCT00094887|21097850|P2|Safety Population|Overall Study||75
8556703|NCT00094887|21097851|P1|Safety Population|Overall Study||75
8556704|NCT00094887|21097850|P2|STARTED|Overall Study||75
8556705|NCT00094887|21097851|P1|STARTED|Overall Study||75
8556706|NCT00094861|21097869|P2|NOT COMPLETED|Overall Study||9
8556707|NCT00094861|21097870|P1|NOT COMPLETED|Overall Study||18
8556708|NCT00094861|21097869|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
8556709|NCT00094861|21097870|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
8556710|NCT00094861|21097869|P2|Participants Treated|Overall Study||48
8556711|NCT00094861|21097870|P1|Participants Treated|Overall Study||46
8556712|NCT00094861|21097869|P2|STARTED|Overall Study||49
8556713|NCT00094861|21097870|P1|STARTED|Overall Study||46
8556714|NCT00094835|21097897|P7|NOT COMPLETED|Overall Study||2
8556715|NCT00094835|21097898|P6|NOT COMPLETED|Overall Study||3
8556716|NCT00094835|21097899|P5|NOT COMPLETED|Overall Study||4
8556717|NCT00094835|21097900|P4|NOT COMPLETED|Overall Study||1
8556718|NCT00094835|21097901|P3|NOT COMPLETED|Overall Study||3
8556719|NCT00094835|21097902|P2|NOT COMPLETED|Overall Study||3
8556720|NCT00094835|21097903|P1|NOT COMPLETED|Overall Study||4
8556721|NCT00094835|21097897|P7|COMPLETED|Overall Study||4
8556722|NCT00094835|21097898|P6|COMPLETED|Overall Study||3
8556723|NCT00094835|21097899|P5|COMPLETED|Overall Study||3
8556724|NCT00094835|21097900|P4|COMPLETED|Overall Study||4
8556725|NCT00094835|21097901|P3|COMPLETED|Overall Study||4
8556726|NCT00094835|21097902|P2|COMPLETED|Overall Study||8
8556727|NCT00094835|21097903|P1|COMPLETED|Overall Study||5
8556728|NCT00094835|21097897|P7|Treated With Motesanib|Overall Study||6
8556729|NCT00094835|21097898|P6|Treated With Motesanib|Overall Study||5
8556730|NCT00094835|21097899|P5|Treated With Motesanib|Overall Study||7
8556731|NCT00094835|21097900|P4|Treated With Motesanib|Overall Study||4
8556732|NCT00094835|21097901|P3|Treated With Motesanib|Overall Study||6
8556733|NCT00094835|21097902|P2|Treated With Motesanib|Overall Study||11
8556734|NCT00094835|21097903|P1|Treated With Motesanib|Overall Study||6
8556735|NCT00094835|21097897|P7|STARTED|Overall Study||6
8556736|NCT00094835|21097898|P6|STARTED|Overall Study||6
8556737|NCT00094835|21097899|P5|STARTED|Overall Study||7
8556738|NCT00094835|21097900|P4|STARTED|Overall Study||5
8556739|NCT00094835|21097901|P3|STARTED|Overall Study||7
8556740|NCT00094835|21097902|P2|STARTED|Overall Study||11
8556741|NCT00094835|21097903|P1|STARTED|Overall Study||9
8556742|NCT00094809|21097981|P2|NOT COMPLETED|Overall Study||65
8556743|NCT00094809|21097982|P1|NOT COMPLETED|Overall Study||52
8556744|NCT00094809|21097981|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
8556745|NCT00094809|21097982|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
8556746|NCT00094809|21097981|P2|Completed All 4 Cycles of Treatment|Overall Study||90
8556747|NCT00094809|21097982|P1|Completed All 4 Cycles of Treatment|Overall Study||98
8556748|NCT00094809|21097981|P2|Properly Consented; Received Study Drug|Overall Study||118
8556749|NCT00094809|21097982|P1|Properly Consented; Received Study Drug|Overall Study||123
8556750|NCT00094809|21097981|P2|Received Study Drug|Overall Study||118
8556751|NCT00094809|21097982|P1|Received Study Drug|Overall Study||124
8556752|NCT00094809|21097981|P2|STARTED|Overall Study||126
8556753|NCT00094809|21097982|P1|STARTED|Overall Study||126
8556754|NCT00094770|21098008|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
8556755|NCT00094770|21098009|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
8556756|NCT00094770|21098008|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
8556757|NCT00094770|21098009|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
8556758|NCT00094770|21098008|P2|STARTED|Year 2 (Week 0 to Week 104)||584
8556759|NCT00094770|21098009|P1|STARTED|Year 2 (Week 0 to Week 104)||588
8556760|NCT00094770|21098008|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
8556761|NCT00094770|21098009|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
8556762|NCT00094770|21098008|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
8556763|NCT00094770|21098009|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
8556764|NCT00094770|21098008|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
8556765|NCT00094770|21098009|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
8556766|NCT00094757|21098040|P3|NOT COMPLETED|Overall Study||30
8556767|NCT00094757|21098041|P2|NOT COMPLETED|Overall Study||62
8556768|NCT00094757|21098042|P1|NOT COMPLETED|Overall Study||53
8556769|NCT00094757|21098040|P3|COMPLETED|Overall Study||80
8556770|NCT00094757|21098041|P2|COMPLETED|Overall Study||144
8556771|NCT00094757|21098042|P1|COMPLETED|Overall Study||152
8556772|NCT00094757|21098040|P3|STARTED|Overall Study||110
8556773|NCT00094757|21098041|P2|STARTED|Overall Study||206
8556774|NCT00094757|21098042|P1|STARTED|Overall Study||205
8556775|NCT00094653|21098062|P3|NOT COMPLETED|Overall Study||126
8556776|NCT00094653|21098063|P2|NOT COMPLETED|Overall Study||106
8556777|NCT00094653|21098064|P1|NOT COMPLETED|Overall Study||321
8556778|NCT00094653|21098062|P3|COMPLETED|Overall Study||10
8556779|NCT00094653|21098063|P2|COMPLETED|Overall Study||31
8556780|NCT00094653|21098064|P1|COMPLETED|Overall Study||82
8556781|NCT00094653|21098062|P3|Treated|Overall Study||131
8556782|NCT00094653|21098063|P2|Treated|Overall Study||131
8556783|NCT00094653|21098064|P1|Treated|Overall Study||381
8556784|NCT00094653|21098062|P3|STARTED|Overall Study||136
8556785|NCT00094653|21098063|P2|STARTED|Overall Study||137
8556786|NCT00094653|21098064|P1|STARTED|Overall Study||403
8556787|NCT00094575|21098127|P2|NOT COMPLETED|Overall Study||146
8556788|NCT00094575|21098128|P1|NOT COMPLETED|Overall Study||146
8556789|NCT00094575|21098127|P2|COMPLETED|Overall Study||291
8556790|NCT00094575|21098128|P1|COMPLETED|Overall Study||298
8556791|NCT00094575|21098127|P2|STARTED|Overall Study||437
8556792|NCT00094575|21098128|P1|STARTED|Overall Study||444
8556793|NCT00094536|21098148|P1|NOT COMPLETED|Treatment and Follow-up||31
8556794|NCT00094536|21098148|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
8556795|NCT00094536|21098148|P1|36 Month Follow-up|Treatment and Follow-up||51
8556796|NCT00094536|21098148|P1|24 Month Follow-up|Treatment and Follow-up||53
8556797|NCT00094536|21098148|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
8556798|NCT00094536|21098148|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
8556799|NCT00094536|21098148|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
8556800|NCT00094536|21098148|P1|COMPLETED|Inclusion Exclusion Evaluation||82
8556801|NCT00094536|21098148|P1|STARTED|Inclusion Exclusion Evaluation||106
8556802|NCT00094497|21098154|P2|NOT COMPLETED|Overall Study||0
8556803|NCT00094497|21098155|P1|NOT COMPLETED|Overall Study||0
8556804|NCT00094497|21098154|P2|COMPLETED|Overall Study||153
8556805|NCT00094497|21098155|P1|COMPLETED|Overall Study||151
8556806|NCT00094497|21098154|P2|Received Second Line Therapy|Overall Study||101
8556807|NCT00094497|21098155|P1|Received Second Line Therapy|Overall Study||84
8556808|NCT00094497|21098154|P2|Treated|Overall Study||149
8556809|NCT00094497|21098155|P1|Treated|Overall Study||148
8556810|NCT00094497|21098154|P2|STARTED|Overall Study||153
8556811|NCT00094497|21098155|P1|STARTED|Overall Study||151
8556812|NCT00094458|21098172|P6|NOT COMPLETED|OLE: Open-Label Extension||4
8556813|NCT00094458|21098173|P5|NOT COMPLETED|OLE: Open-Label Extension||5
8556814|NCT00094458|21098174|P4|NOT COMPLETED|OLE: Open-Label Extension||1
8556815|NCT00094458|21098175|P3|NOT COMPLETED|OLE: Open-Label Extension||0
8556816|NCT00094458|21098176|P2|NOT COMPLETED|OLE: Open-Label Extension||0
8556817|NCT00094458|21098177|P1|NOT COMPLETED|OLE: Open-Label Extension||0
8556818|NCT00094458|21098172|P6|COMPLETED|OLE: Open-Label Extension||13
8556819|NCT00094458|21098173|P5|COMPLETED|OLE: Open-Label Extension||13
8556820|NCT00094458|21098174|P4|COMPLETED|OLE: Open-Label Extension||7
8556821|NCT00094458|21098175|P3|COMPLETED|OLE: Open-Label Extension||0
8556822|NCT00094458|21098176|P2|COMPLETED|OLE: Open-Label Extension||0
8556823|NCT00094458|21098177|P1|COMPLETED|OLE: Open-Label Extension||0
8556824|NCT00094458|21098172|P6|STARTED|OLE: Open-Label Extension||17
8556825|NCT00094458|21098173|P5|STARTED|OLE: Open-Label Extension||18
8556826|NCT00094458|21098174|P4|STARTED|OLE: Open-Label Extension||8
8556827|NCT00094458|21098175|P3|STARTED|OLE: Open-Label Extension||0
8556828|NCT00094458|21098176|P2|STARTED|OLE: Open-Label Extension||0
8556829|NCT00094458|21098177|P1|STARTED|OLE: Open-Label Extension||0
8556830|NCT00094458|21098172|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8556831|NCT00094458|21098173|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8556832|NCT00094458|21098174|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8556833|NCT00094458|21098175|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
8556834|NCT00094458|21098176|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
8556835|NCT00094458|21098177|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
8556836|NCT00094458|21098172|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
8556837|NCT00094458|21098173|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
8556838|NCT00094458|21098174|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
8556839|NCT00094458|21098175|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
8556840|NCT00094458|21098176|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
8556841|NCT00094458|21098177|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
8556842|NCT00094458|21098172|P6|STARTED|Study Extension: Week 30 Through Week 50||0
8556843|NCT00094458|21098173|P5|STARTED|Study Extension: Week 30 Through Week 50||0
8556844|NCT00094458|21098174|P4|STARTED|Study Extension: Week 30 Through Week 50||0
8556845|NCT00094458|21098175|P3|STARTED|Study Extension: Week 30 Through Week 50||108
8556846|NCT00094458|21098176|P2|STARTED|Study Extension: Week 30 Through Week 50||97
8556847|NCT00094458|21098177|P1|STARTED|Study Extension: Week 30 Through Week 50||75
8556848|NCT00094458|21098172|P6|NOT COMPLETED|Main Study: Through Week 30||0
8556849|NCT00094458|21098173|P5|NOT COMPLETED|Main Study: Through Week 30||0
8556850|NCT00094458|21098174|P4|NOT COMPLETED|Main Study: Through Week 30||0
8556851|NCT00094458|21098175|P3|NOT COMPLETED|Main Study: Through Week 30||48
8556852|NCT00094458|21098176|P2|NOT COMPLETED|Main Study: Through Week 30||58
8556853|NCT00094458|21098177|P1|NOT COMPLETED|Main Study: Through Week 30||84
8556854|NCT00094458|21098172|P6|COMPLETED|Main Study: Through Week 30||0
8556855|NCT00094458|21098173|P5|COMPLETED|Main Study: Through Week 30||0
8556856|NCT00094458|21098174|P4|COMPLETED|Main Study: Through Week 30||0
8556857|NCT00094458|21098175|P3|COMPLETED|Main Study: Through Week 30||121
8556858|NCT00094458|21098176|P2|COMPLETED|Main Study: Through Week 30||111
8556859|NCT00094458|21098177|P1|COMPLETED|Main Study: Through Week 30||86
8556860|NCT00094458|21098172|P6|STARTED|Main Study: Through Week 30||0
8556861|NCT00094458|21098173|P5|STARTED|Main Study: Through Week 30||0
8556862|NCT00094458|21098174|P4|STARTED|Main Study: Through Week 30||0
8556863|NCT00094458|21098175|P3|STARTED|Main Study: Through Week 30||169
8556864|NCT00094458|21098176|P2|STARTED|Main Study: Through Week 30||169
8556865|NCT00094458|21098177|P1|STARTED|Main Study: Through Week 30||170
8556866|NCT00094445|21098215|P1|NOT COMPLETED|Overall Study||6
8556867|NCT00094445|21098215|P1|COMPLETED|Overall Study||44
8556868|NCT00094445|21098215|P1|STARTED|Overall Study||50
8556869|NCT00094328|21098219|P1|NOT COMPLETED|Overall Study||1
8556870|NCT00094328|21098219|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
8556871|NCT00094328|21098219|P1|STARTED|Overall Study|Received treatment|14
8556872|NCT00094302|21098233|P2|NOT COMPLETED|Overall Study||406
8556873|NCT00094302|21098234|P1|NOT COMPLETED|Overall Study||417
8556874|NCT00094302|21098233|P2|COMPLETED|Overall Study||1316
8556875|NCT00094302|21098234|P1|COMPLETED|Overall Study||1306
8556876|NCT00094302|21098233|P2|STARTED|Overall Study||1722
8556877|NCT00094302|21098234|P1|STARTED|Overall Study||1723
8556878|NCT00094211|21098292|P4|NOT COMPLETED|Overall Study||7
8556879|NCT00094211|21098293|P3|NOT COMPLETED|Overall Study||10
8556880|NCT00094211|21098294|P2|NOT COMPLETED|Overall Study||8
8556881|NCT00094211|21098295|P1|NOT COMPLETED|Overall Study||9
8556882|NCT00094211|21098292|P4|COMPLETED|Overall Study||179
8556883|NCT00094211|21098293|P3|COMPLETED|Overall Study||220
8556884|NCT00094211|21098294|P2|COMPLETED|Overall Study||251
8556885|NCT00094211|21098295|P1|COMPLETED|Overall Study||212
8556886|NCT00094211|21098292|P4|STARTED|Overall Study||186
8556887|NCT00094211|21098293|P3|STARTED|Overall Study||230
8556888|NCT00094211|21098294|P2|STARTED|Overall Study||259
8556889|NCT00094211|21098295|P1|STARTED|Overall Study||221
8556890|NCT00094172|21098323|P2|NOT COMPLETED|Overall Study||7
8556891|NCT00094172|21098324|P1|NOT COMPLETED|Overall Study||14
8556892|NCT00094172|21098323|P2|COMPLETED|Overall Study||25
8556893|NCT00094172|21098324|P1|COMPLETED|Overall Study||36
8556894|NCT00094172|21098323|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
8556895|NCT00094172|21098324|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
8556896|NCT00094107|21098334|P1|NOT COMPLETED|Overall Study||32
8556897|NCT00094107|21098334|P1|COMPLETED|Overall Study||0
8556898|NCT00094107|21098334|P1|STARTED|Overall Study||32
8556899|NCT00094094|21098343|P1|NOT COMPLETED|Overall Study||32
8556900|NCT00094094|21098343|P1|COMPLETED|Overall Study||0
8556901|NCT00094094|21098343|P1|STARTED|Overall Study||32
8556902|NCT00094055|21098352|P1|NOT COMPLETED|Overall Study||60
8556903|NCT00094055|21098352|P1|COMPLETED|Overall Study||0
8556904|NCT00094055|21098352|P1|STARTED|Overall Study||60
8556905|NCT00093964|21098363|P2|NOT COMPLETED|Overall Study||0
8556906|NCT00093964|21098364|P1|NOT COMPLETED|Overall Study||0
8556907|NCT00093964|21098363|P2|COMPLETED|Overall Study||40
8556908|NCT00093964|21098364|P1|COMPLETED|Overall Study||41
8556909|NCT00093964|21098363|P2|STARTED|Overall Study||40
8556910|NCT00093964|21098364|P1|STARTED|Overall Study||41
8556911|NCT00093847|21098400|P2|NOT COMPLETED|Overall Study||10
8556912|NCT00093847|21098401|P1|NOT COMPLETED|Overall Study||8
8556913|NCT00093847|21098400|P2|COMPLETED|Overall Study||24
8556914|NCT00093847|21098401|P1|COMPLETED|Overall Study||31
8556915|NCT00093847|21098400|P2|STARTED|Overall Study||34
8556916|NCT00093847|21098401|P1|STARTED|Overall Study||39
8556917|NCT00093808|21098409|P1|NOT COMPLETED|Overall Study||2
8556918|NCT00093808|21098409|P1|COMPLETED|Overall Study||45
8556919|NCT00093808|21098409|P1|STARTED|Overall Study||47
8556920|NCT00093795|21098419|P3|NOT COMPLETED|Overall Study||17
8556921|NCT00093795|21098420|P2|NOT COMPLETED|Overall Study||16
8556922|NCT00093795|21098421|P1|NOT COMPLETED|Overall Study||20
8556923|NCT00093795|21098419|P3|COMPLETED|Overall Study||1613
8556924|NCT00093795|21098420|P2|COMPLETED|Overall Study||1618
8556925|NCT00093795|21098421|P1|COMPLETED|Overall Study||1610
8556926|NCT00093795|21098419|P3|STARTED|Overall Study||1630
8556927|NCT00093795|21098420|P2|STARTED|Overall Study||1634
8556928|NCT00093795|21098421|P1|STARTED|Overall Study||1630
8556929|NCT00093782|21098441|P1|NOT COMPLETED|Overall Study||0
8556930|NCT00093782|21098441|P1|COMPLETED|Overall Study||36
8556931|NCT00093782|21098441|P1|STARTED|Overall Study||36
8556932|NCT00093756|21098453|P2|NOT COMPLETED|Overall Study||0
8556933|NCT00093756|21098454|P1|NOT COMPLETED|Overall Study||0
8556934|NCT00093756|21098453|P2|COMPLETED|Overall Study||21
8556935|NCT00093756|21098454|P1|COMPLETED|Overall Study||27
8556936|NCT00093756|21098453|P2|STARTED|Overall Study||21
8556937|NCT00093756|21098454|P1|STARTED|Overall Study||27
8556938|NCT00093496|21098466|P2|NOT COMPLETED|Overall Study||3
8556939|NCT00093496|21098467|P1|NOT COMPLETED|Overall Study||1
8556940|NCT00093496|21098466|P2|COMPLETED|Overall Study||11
8556941|NCT00093496|21098467|P1|COMPLETED|Overall Study||14
8556942|NCT00093496|21098466|P2|STARTED|Overall Study||14
8556943|NCT00093496|21098467|P1|STARTED|Overall Study||15
8556944|NCT00093470|21098480|P2|NOT COMPLETED|Overall Study||0
8556945|NCT00093470|21098481|P1|NOT COMPLETED|Overall Study||73
8556946|NCT00093470|21098480|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
8556947|NCT00093470|21098481|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8556948|NCT00093470|21098480|P2|Patients With Toxicity Assessment|Overall Study||69
8556949|NCT00093470|21098481|P1|Patients With Toxicity Assessment|Overall Study||72
8556950|NCT00093470|21098480|P2|Treated|Overall Study||71
8556951|NCT00093470|21098481|P1|Treated|Overall Study||72
8556952|NCT00093470|21098480|P2|STARTED|Overall Study||71
8556953|NCT00093470|21098481|P1|STARTED|Overall Study||73
8556954|NCT00093379|21098489|P1|NOT COMPLETED|Overall Study||0
8556955|NCT00093379|21098489|P1|COMPLETED|Overall Study||20
8556956|NCT00093379|21098489|P1|STARTED|Overall Study||20
8556957|NCT00093145|21098495|P1|NOT COMPLETED|Overall Study||17
8556958|NCT00093145|21098495|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
8556959|NCT00093145|21098495|P1|At Least One Response Assessment|Overall Study||31
8556960|NCT00093145|21098495|P1|STARTED|Overall Study||32
8556961|NCT00093041|21098510|P6|NOT COMPLETED|Overall Study||3
8556962|NCT00093041|21098511|P5|NOT COMPLETED|Overall Study||1
8556963|NCT00093041|21098512|P4|NOT COMPLETED|Overall Study||1
8556964|NCT00093041|21098513|P3|NOT COMPLETED|Overall Study||2
8556965|NCT00093041|21098514|P2|NOT COMPLETED|Overall Study||3
8556966|NCT00093041|21098515|P1|NOT COMPLETED|Overall Study||2
8556967|NCT00093041|21098510|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
8556968|NCT00093041|21098511|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
8556969|NCT00093041|21098512|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
8556970|NCT00093041|21098513|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
8556971|NCT00093041|21098514|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
8556972|NCT00093041|21098515|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
8556973|NCT00093041|21098510|P6|STARTED|Overall Study||7
8556974|NCT00093041|21098511|P5|STARTED|Overall Study||4
8556975|NCT00093041|21098512|P4|STARTED|Overall Study||4
8556976|NCT00093041|21098513|P3|STARTED|Overall Study||5
8556977|NCT00093041|21098514|P2|STARTED|Overall Study||4
8556978|NCT00093041|21098515|P1|STARTED|Overall Study||4
8556979|NCT00093015|21098537|P2|NOT COMPLETED|Overall Study||664
8556980|NCT00093015|21098538|P1|NOT COMPLETED|Overall Study||665
8556981|NCT00093015|21098537|P2|COMPLETED|Overall Study||1348
8556982|NCT00093015|21098538|P1|COMPLETED|Overall Study||1361
8556983|NCT00093015|21098537|P2|Received Study Medication|Overall Study||2004
8556984|NCT00093015|21098538|P1|Received Study Medication|Overall Study||2019
8556985|NCT00093015|21098537|P2|STARTED|Overall Study||2012
8556986|NCT00093015|21098538|P1|STARTED|Overall Study||2026
8556987|NCT00092677|21098566|P2|NOT COMPLETED|Overall Study||11
8556988|NCT00092677|21098567|P1|NOT COMPLETED|Overall Study||5
8556989|NCT00092677|21098566|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
8556990|NCT00092677|21098567|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
8556991|NCT00092677|21098566|P2|STARTED|Overall Study||929
8556992|NCT00092677|21098567|P1|STARTED|Overall Study||944
8556993|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556994|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556995|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556996|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
8556997|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556998|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
8556999|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
8557000|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
8557001|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
8557002|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557003|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557004|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557005|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
8557006|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557007|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
8557008|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
8557009|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
8557010|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
8557011|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557012|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557013|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557014|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
8557015|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557016|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
8557017|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
8557018|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
8557019|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
8557020|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8557021|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8557022|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
8557023|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
8557024|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8557025|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
8557026|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
8557027|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
8557028|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
8557029|NCT00092547|21098611|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
8557030|NCT00092547|21098612|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
8557031|NCT00092547|21098613|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
8557032|NCT00092547|21098611|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
8557033|NCT00092547|21098612|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
8557034|NCT00092547|21098613|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
8557035|NCT00092547|21098611|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
8557036|NCT00092547|21098612|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
8557037|NCT00092547|21098613|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
8557038|NCT00092547|21098611|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
8557039|NCT00092547|21098612|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
8557040|NCT00092547|21098613|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
8557041|NCT00092547|21098611|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
8557042|NCT00092547|21098612|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
8557043|NCT00092547|21098613|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
8557044|NCT00092547|21098611|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
8557045|NCT00092547|21098612|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
8557046|NCT00092547|21098613|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
8557047|NCT00092547|21098611|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
8557048|NCT00092547|21098612|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
8557049|NCT00092547|21098613|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
8557050|NCT00092547|21098611|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
8557051|NCT00092547|21098612|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
8557052|NCT00092547|21098613|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
8557053|NCT00092547|21098611|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
8557054|NCT00092547|21098612|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
8557055|NCT00092547|21098613|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
8557056|NCT00092547|21098611|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
8557057|NCT00092547|21098612|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
8557058|NCT00092547|21098613|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
8557059|NCT00092547|21098611|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
8557060|NCT00092547|21098612|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
8557061|NCT00092547|21098613|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
8557062|NCT00092547|21098611|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
8557063|NCT00092547|21098612|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
8557064|NCT00092547|21098613|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
8557065|NCT00092547|21098611|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
8557066|NCT00092547|21098612|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
8557067|NCT00092547|21098613|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
8557068|NCT00092547|21098611|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
8557069|NCT00092547|21098612|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
8557070|NCT00092547|21098613|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
8557071|NCT00092534|21098657|P5|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557072|NCT00092534|21098658|P4|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
8557073|NCT00092534|21098659|P3|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557074|NCT00092534|21098660|P2|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557075|NCT00092534|21098661|P1|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557076|NCT00092534|21098657|P5|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
8557077|NCT00092534|21098658|P4|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
8557078|NCT00092534|21098659|P3|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557079|NCT00092534|21098660|P2|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557080|NCT00092534|21098661|P1|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557081|NCT00092534|21098657|P5|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
8557082|NCT00092534|21098658|P4|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
8557083|NCT00092534|21098659|P3|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8557084|NCT00092534|21098660|P2|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8557085|NCT00092534|21098661|P1|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8557086|NCT00092534|21098657|P5|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
8557087|NCT00092534|21098658|P4|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
8557088|NCT00092534|21098659|P3|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8557089|NCT00092534|21098660|P2|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8557090|NCT00092534|21098661|P1|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8557091|NCT00092534|21098657|P5|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
8557092|NCT00092534|21098658|P4|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
8557093|NCT00092534|21098659|P3|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8557094|NCT00092534|21098660|P2|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8557095|NCT00092534|21098661|P1|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8557096|NCT00092534|21098657|P5|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
8557097|NCT00092534|21098658|P4|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
8557098|NCT00092534|21098659|P3|STARTED|Long-Term Follow-Up (LTFU) Study||0
8557099|NCT00092534|21098660|P2|STARTED|Long-Term Follow-Up (LTFU) Study||0
8557100|NCT00092534|21098661|P1|STARTED|Long-Term Follow-Up (LTFU) Study||0
8557101|NCT00092534|21098657|P5|NOT COMPLETED|Base Study EXT||0
8557102|NCT00092534|21098658|P4|NOT COMPLETED|Base Study EXT||0
8557103|NCT00092534|21098659|P3|NOT COMPLETED|Base Study EXT||145
8557104|NCT00092534|21098660|P2|NOT COMPLETED|Base Study EXT||0
8557105|NCT00092534|21098661|P1|NOT COMPLETED|Base Study EXT||0
8557106|NCT00092534|21098657|P5|COMPLETED|Base Study EXT||0
8557107|NCT00092534|21098658|P4|COMPLETED|Base Study EXT||0
8557108|NCT00092534|21098659|P3|COMPLETED|Base Study EXT||449
8557109|NCT00092534|21098660|P2|COMPLETED|Base Study EXT||0
8557110|NCT00092534|21098661|P1|COMPLETED|Base Study EXT||0
8557111|NCT00092534|21098657|P5|STARTED|Base Study EXT||0
8557112|NCT00092534|21098658|P4|STARTED|Base Study EXT||0
8557113|NCT00092534|21098659|P3|STARTED|Base Study EXT||594
8557114|NCT00092534|21098660|P2|STARTED|Base Study EXT||0
8557115|NCT00092534|21098661|P1|STARTED|Base Study EXT||0
8557116|NCT00092534|21098657|P5|NOT COMPLETED|Base Study Follow-Up Period||0
8557117|NCT00092534|21098658|P4|NOT COMPLETED|Base Study Follow-Up Period||0
8557118|NCT00092534|21098659|P3|NOT COMPLETED|Base Study Follow-Up Period||0
8557119|NCT00092534|21098660|P2|NOT COMPLETED|Base Study Follow-Up Period||694
8557120|NCT00092534|21098661|P1|NOT COMPLETED|Base Study Follow-Up Period||316
8557121|NCT00092534|21098657|P5|COMPLETED|Base Study Follow-Up Period||0
8557122|NCT00092534|21098658|P4|COMPLETED|Base Study Follow-Up Period||0
8557123|NCT00092534|21098659|P3|COMPLETED|Base Study Follow-Up Period||0
8557124|NCT00092534|21098660|P2|COMPLETED|Base Study Follow-Up Period||5277
8557125|NCT00092534|21098661|P1|COMPLETED|Base Study Follow-Up Period||5626
8557126|NCT00092534|21098657|P5|STARTED|Base Study Follow-Up Period||0
8557127|NCT00092534|21098658|P4|STARTED|Base Study Follow-Up Period||0
8557128|NCT00092534|21098659|P3|STARTED|Base Study Follow-Up Period||0
8557129|NCT00092534|21098660|P2|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
8557130|NCT00092534|21098661|P1|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
8557131|NCT00092534|21098657|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557132|NCT00092534|21098658|P4|NOT COMPLETED|Base Study Vaccination Period||0
8557133|NCT00092534|21098659|P3|NOT COMPLETED|Base Study Vaccination Period||0
8557134|NCT00092534|21098660|P2|NOT COMPLETED|Base Study Vaccination Period||126
8557135|NCT00092534|21098661|P1|NOT COMPLETED|Base Study Vaccination Period||171
8557136|NCT00092534|21098657|P5|COMPLETED|Base Study Vaccination Period||0
8557137|NCT00092534|21098658|P4|COMPLETED|Base Study Vaccination Period||0
8557138|NCT00092534|21098659|P3|COMPLETED|Base Study Vaccination Period||0
8557139|NCT00092534|21098660|P2|COMPLETED|Base Study Vaccination Period||5954
8557140|NCT00092534|21098661|P1|COMPLETED|Base Study Vaccination Period||5916
8557141|NCT00092534|21098657|P5|STARTED|Base Study Vaccination Period||0
8557142|NCT00092534|21098658|P4|STARTED|Base Study Vaccination Period||0
8557143|NCT00092534|21098659|P3|STARTED|Base Study Vaccination Period||0
8557144|NCT00092534|21098660|P2|STARTED|Base Study Vaccination Period||6080
8557145|NCT00092534|21098661|P1|STARTED|Base Study Vaccination Period||6087
8557146|NCT00092521|21098692|P4|NOT COMPLETED|Extension Study (Group 4)||209
8557147|NCT00092521|21098693|P3|NOT COMPLETED|Extension Study (Group 4)||0
8557148|NCT00092521|21098694|P2|NOT COMPLETED|Extension Study (Group 4)||0
8557149|NCT00092521|21098695|P1|NOT COMPLETED|Extension Study (Group 4)||0
8557150|NCT00092521|21098692|P4|COMPLETED|Extension Study (Group 4)||635
8557151|NCT00092521|21098693|P3|COMPLETED|Extension Study (Group 4)||0
8557152|NCT00092521|21098694|P2|COMPLETED|Extension Study (Group 4)||0
8557153|NCT00092521|21098695|P1|COMPLETED|Extension Study (Group 4)||0
8557154|NCT00092521|21098692|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
8557155|NCT00092521|21098693|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8557156|NCT00092521|21098694|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8557157|NCT00092521|21098695|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8557158|NCT00092521|21098692|P4|Initiated Extension Study|Extension Study (Group 4)||829
8557159|NCT00092521|21098693|P3|Initiated Extension Study|Extension Study (Group 4)||0
8557160|NCT00092521|21098694|P2|Initiated Extension Study|Extension Study (Group 4)||0
8557161|NCT00092521|21098695|P1|Initiated Extension Study|Extension Study (Group 4)||0
8557162|NCT00092521|21098692|P4|STARTED|Extension Study (Group 4)||844
8557163|NCT00092521|21098693|P3|STARTED|Extension Study (Group 4)||0
8557164|NCT00092521|21098694|P2|STARTED|Extension Study (Group 4)||0
8557165|NCT00092521|21098695|P1|STARTED|Extension Study (Group 4)||0
8557166|NCT00092521|21098692|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
8557167|NCT00092521|21098693|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
8557168|NCT00092521|21098694|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
8557169|NCT00092521|21098695|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
8557170|NCT00092521|21098692|P4|COMPLETED|Follow-Up (After Month 7)||0
8557171|NCT00092521|21098693|P3|COMPLETED|Follow-Up (After Month 7)||1959
8557172|NCT00092521|21098694|P2|COMPLETED|Follow-Up (After Month 7)||155
8557173|NCT00092521|21098695|P1|COMPLETED|Follow-Up (After Month 7)||2353
8557174|NCT00092521|21098692|P4|STARTED|Follow-Up (After Month 7)||0
8557175|NCT00092521|21098693|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
8557176|NCT00092521|21098694|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
8557177|NCT00092521|21098695|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
8557178|NCT00092521|21098692|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
8557179|NCT00092521|21098693|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
8557180|NCT00092521|21098694|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
8557181|NCT00092521|21098695|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
8557182|NCT00092521|21098692|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
8557183|NCT00092521|21098693|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
8557184|NCT00092521|21098694|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
8557185|NCT00092521|21098695|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
8557186|NCT00092521|21098692|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
8557187|NCT00092521|21098693|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
8557188|NCT00092521|21098694|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
8557189|NCT00092521|21098695|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
8557190|NCT00092495|21098709|P5|NOT COMPLETED|Extension Study||0
8557191|NCT00092495|21098710|P4|NOT COMPLETED|Extension Study||0
8557192|NCT00092495|21098711|P3|NOT COMPLETED|Extension Study||0
8557193|NCT00092495|21098712|P2|NOT COMPLETED|Extension Study||0
8557194|NCT00092495|21098713|P1|NOT COMPLETED|Extension Study||0
8557195|NCT00092495|21098709|P5|COMPLETED|Extension Study||12
8557196|NCT00092495|21098710|P4|COMPLETED|Extension Study||0
8557197|NCT00092495|21098711|P3|COMPLETED|Extension Study||0
8557198|NCT00092495|21098712|P2|COMPLETED|Extension Study||0
8557199|NCT00092495|21098713|P1|COMPLETED|Extension Study||0
8557200|NCT00092495|21098709|P5|STARTED|Extension Study||12
8557201|NCT00092495|21098710|P4|STARTED|Extension Study||0
8557202|NCT00092495|21098711|P3|STARTED|Extension Study||0
8557203|NCT00092495|21098712|P2|STARTED|Extension Study||0
8557204|NCT00092495|21098713|P1|STARTED|Extension Study||0
8557205|NCT00092495|21098709|P5|NOT COMPLETED|Base Study Follow-up Period||0
8557206|NCT00092495|21098710|P4|NOT COMPLETED|Base Study Follow-up Period||14
8557207|NCT00092495|21098711|P3|NOT COMPLETED|Base Study Follow-up Period||4
8557208|NCT00092495|21098712|P2|NOT COMPLETED|Base Study Follow-up Period||3
8557209|NCT00092495|21098713|P1|NOT COMPLETED|Base Study Follow-up Period||3
8557210|NCT00092495|21098709|P5|COMPLETED|Base Study Follow-up Period||0
8557211|NCT00092495|21098710|P4|COMPLETED|Base Study Follow-up Period||446
8557212|NCT00092495|21098711|P3|COMPLETED|Base Study Follow-up Period||126
8557213|NCT00092495|21098712|P2|COMPLETED|Base Study Follow-up Period||122
8557214|NCT00092495|21098713|P1|COMPLETED|Base Study Follow-up Period||112
8557215|NCT00092495|21098709|P5|STARTED|Base Study Follow-up Period||0
8557216|NCT00092495|21098710|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
8557217|NCT00092495|21098711|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
8557218|NCT00092495|21098712|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
8557219|NCT00092495|21098713|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
8557220|NCT00092495|21098709|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557221|NCT00092495|21098710|P4|NOT COMPLETED|Base Study Vaccination Period||88
8557222|NCT00092495|21098711|P3|NOT COMPLETED|Base Study Vaccination Period||34
8557223|NCT00092495|21098712|P2|NOT COMPLETED|Base Study Vaccination Period||22
8557224|NCT00092495|21098713|P1|NOT COMPLETED|Base Study Vaccination Period||37
8557225|NCT00092495|21098709|P5|COMPLETED|Base Study Vaccination Period||0
8557226|NCT00092495|21098710|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
8557227|NCT00092495|21098711|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
8557228|NCT00092495|21098712|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
8557229|NCT00092495|21098713|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
8557230|NCT00092495|21098709|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
8557231|NCT00092495|21098710|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
8557232|NCT00092495|21098711|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
8557233|NCT00092495|21098712|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
8557234|NCT00092495|21098713|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
8557235|NCT00092495|21098709|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
8557236|NCT00092495|21098710|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
8557237|NCT00092495|21098711|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
8557238|NCT00092495|21098712|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
8557239|NCT00092495|21098713|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
8557240|NCT00092495|21098709|P5|STARTED|Base Study Vaccination Period||0
8557241|NCT00092495|21098710|P4|STARTED|Base Study Vaccination Period||1529
8557242|NCT00092495|21098711|P3|STARTED|Base Study Vaccination Period||508
8557243|NCT00092495|21098712|P2|STARTED|Base Study Vaccination Period||514
8557244|NCT00092495|21098713|P1|STARTED|Base Study Vaccination Period||504
8557245|NCT00092456|21098779|P4|NOT COMPLETED|Overall Study||16
8557246|NCT00092456|21098780|P3|NOT COMPLETED|Overall Study||29
8557247|NCT00092456|21098781|P2|NOT COMPLETED|Overall Study||17
8557248|NCT00092456|21098782|P1|NOT COMPLETED|Overall Study||25
8557249|NCT00092456|21098779|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
8557250|NCT00092456|21098780|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
8557251|NCT00092456|21098781|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
8557252|NCT00092456|21098782|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
8557253|NCT00092456|21098779|P4|Vaccinated at Visit 3|Overall Study||98
8557254|NCT00092456|21098780|P3|Vaccinated at Visit 3|Overall Study||200
8557255|NCT00092456|21098781|P2|Vaccinated at Visit 3|Overall Study||210
8557256|NCT00092456|21098782|P1|Vaccinated at Visit 3|Overall Study||202
8557257|NCT00092456|21098779|P4|Vaccinated at Visit 2|Overall Study||104
8557258|NCT00092456|21098780|P3|Vaccinated at Visit 2|Overall Study||210
8557259|NCT00092456|21098781|P2|Vaccinated at Visit 2|Overall Study||217
8557260|NCT00092456|21098782|P1|Vaccinated at Visit 2|Overall Study||208
8557261|NCT00092456|21098779|P4|Vaccinated at Visit 1|Overall Study||113
8557262|NCT00092456|21098780|P3|Vaccinated at Visit 1|Overall Study||229
8557263|NCT00092456|21098781|P2|Vaccinated at Visit 1|Overall Study||225
8557264|NCT00092456|21098782|P1|Vaccinated at Visit 1|Overall Study||226
8557265|NCT00092456|21098779|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
8557266|NCT00092456|21098780|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
8557267|NCT00092456|21098781|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
8557268|NCT00092456|21098782|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
8557269|NCT00092443|21098830|P2|NOT COMPLETED|Overall Study||54
8557270|NCT00092443|21098831|P1|NOT COMPLETED|Overall Study||58
8557271|NCT00092443|21098830|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
8557272|NCT00092443|21098831|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
8557273|NCT00092443|21098830|P2|Vaccinated at Visit 3|Overall Study||608
8557274|NCT00092443|21098831|P1|Vaccinated at Visit 3|Overall Study||593
8557275|NCT00092443|21098830|P2|Vaccinated at Visit 2|Overall Study||627
8557276|NCT00092443|21098831|P1|Vaccinated at Visit 2|Overall Study||618
8557277|NCT00092443|21098830|P2|Vaccinated at Visit 1|Overall Study||660
8557278|NCT00092443|21098831|P1|Vaccinated at Visit 1|Overall Study||650
8557279|NCT00092443|21098830|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
8557280|NCT00092443|21098831|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
8557281|NCT00092417|21098849|P2|NOT COMPLETED|Overall Study||1
8557282|NCT00092417|21098850|P1|NOT COMPLETED|Overall Study||5
8557283|NCT00092417|21098849|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
8557284|NCT00092417|21098850|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
8557285|NCT00092417|21098849|P2|Vaccinated|Overall Study||234
8557286|NCT00092417|21098850|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
8557287|NCT00092417|21098849|P2|STARTED|Overall Study|Started Period Group 2|234
8557288|NCT00092417|21098850|P1|STARTED|Overall Study|Started Period Group 1|464
8557289|NCT00092131|21098864|P2|NOT COMPLETED|Treatment Period II||1
8557290|NCT00092131|21098865|P1|NOT COMPLETED|Treatment Period II||0
8557291|NCT00092131|21098864|P2|COMPLETED|Treatment Period II||25
8557292|NCT00092131|21098865|P1|COMPLETED|Treatment Period II||24
8557293|NCT00092131|21098864|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
8557294|NCT00092131|21098865|P1|STARTED|Treatment Period II||24
8557295|NCT00092131|21098864|P2|NOT COMPLETED|Treatment Period I||0
8557296|NCT00092131|21098865|P1|NOT COMPLETED|Treatment Period I||1
8557297|NCT00092131|21098864|P2|COMPLETED|Treatment Period I||26
8557298|NCT00092131|21098865|P1|COMPLETED|Treatment Period I||24
8557299|NCT00092131|21098864|P2|STARTED|Treatment Period I||26
8557300|NCT00092131|21098865|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
8557301|NCT00092118|21098895|P2|NOT COMPLETED|Overall Study||89
8557302|NCT00092118|21098896|P1|NOT COMPLETED|Overall Study||84
8557303|NCT00092118|21098895|P2|COMPLETED|Overall Study||913
8557304|NCT00092118|21098896|P1|COMPLETED|Overall Study||906
8557305|NCT00092118|21098895|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
8557395|NCT00091026|21099199|P2|NOT COMPLETED|Overall Study||3
8557306|NCT00092118|21098896|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
8557307|NCT00091962|21098909|P3|NOT COMPLETED|Overall Study||0
8557308|NCT00091962|21098910|P2|NOT COMPLETED|Overall Study||0
8557309|NCT00091962|21098911|P1|NOT COMPLETED|Overall Study||0
8557310|NCT00091962|21098909|P3|COMPLETED|Overall Study||151
8557311|NCT00091962|21098910|P2|COMPLETED|Overall Study||152
8557312|NCT00091962|21098911|P1|COMPLETED|Overall Study||150
8557313|NCT00091962|21098909|P3|STARTED|Overall Study||151
8557314|NCT00091962|21098910|P2|STARTED|Overall Study||152
8557315|NCT00091962|21098911|P1|STARTED|Overall Study||150
8557316|NCT00091949|21098930|P2|NOT COMPLETED|Overall Study||151
8557317|NCT00091949|21098931|P1|NOT COMPLETED|Overall Study||175
8557318|NCT00091949|21098930|P2|COMPLETED|Overall Study||1786
8557319|NCT00091949|21098931|P1|COMPLETED|Overall Study||1764
8557320|NCT00091949|21098930|P2|STARTED|Overall Study||1937
8557321|NCT00091949|21098931|P1|STARTED|Overall Study||1939
8557322|NCT00091832|21098955|P6|NOT COMPLETED|Overall Study||11
8557323|NCT00091832|21098956|P5|NOT COMPLETED|Overall Study||15
8557324|NCT00091832|21098957|P4|NOT COMPLETED|Overall Study||14
8557325|NCT00091832|21098958|P3|NOT COMPLETED|Overall Study||12
8557326|NCT00091832|21098959|P2|NOT COMPLETED|Overall Study||11
8557327|NCT00091832|21098960|P1|NOT COMPLETED|Overall Study||14
8557328|NCT00091832|21098955|P6|COMPLETED|Overall Study||32
8557329|NCT00091832|21098956|P5|COMPLETED|Overall Study||27
8557330|NCT00091832|21098957|P4|COMPLETED|Overall Study||29
8557331|NCT00091832|21098958|P3|COMPLETED|Overall Study||30
8557332|NCT00091832|21098959|P2|COMPLETED|Overall Study||31
8557333|NCT00091832|21098960|P1|COMPLETED|Overall Study||29
8557334|NCT00091832|21098955|P6|Received Study Medication|Overall Study||43
8557335|NCT00091832|21098956|P5|Received Study Medication|Overall Study||42
8557336|NCT00091832|21098957|P4|Received Study Medication|Overall Study||43
8557337|NCT00091832|21098958|P3|Received Study Medication|Overall Study||41
8557338|NCT00091832|21098959|P2|Received Study Medication|Overall Study||42
8557339|NCT00091832|21098960|P1|Received Study Medication|Overall Study||43
8557340|NCT00091832|21098955|P6|STARTED|Overall Study||43
8557341|NCT00091832|21098956|P5|STARTED|Overall Study||42
8557342|NCT00091832|21098957|P4|STARTED|Overall Study||43
8557343|NCT00091832|21098958|P3|STARTED|Overall Study||42
8557344|NCT00091832|21098959|P2|STARTED|Overall Study||42
8557345|NCT00091832|21098960|P1|STARTED|Overall Study||43
8557346|NCT00091819|21099078|P2|NOT COMPLETED|Overall Study||46
8557347|NCT00091819|21099079|P1|NOT COMPLETED|Overall Study||42
8557348|NCT00091819|21099078|P2|COMPLETED|Overall Study||387
8557349|NCT00091819|21099079|P1|COMPLETED|Overall Study||387
8557350|NCT00091819|21099078|P2|STARTED|Overall Study||433
8557351|NCT00091819|21099079|P1|STARTED|Overall Study||429
8557352|NCT00091793|21099087|P2|NOT COMPLETED|Overall Study||22
8557353|NCT00091793|21099088|P1|NOT COMPLETED|Overall Study||24
8557354|NCT00091793|21099087|P2|COMPLETED|Overall Study||144
8557355|NCT00091793|21099088|P1|COMPLETED|Overall Study||142
8557356|NCT00091793|21099087|P2|STARTED|Overall Study||166
8557357|NCT00091793|21099088|P1|STARTED|Overall Study||166
8557358|NCT00091572|21099112|P2|NOT COMPLETED|Overall Study||82
8557359|NCT00091572|21099113|P1|NOT COMPLETED|Overall Study||95
8557360|NCT00091572|21099112|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
8557361|NCT00091572|21099113|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
8557362|NCT00091572|21099112|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
8557363|NCT00091572|21099113|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
8557364|NCT00091507|21099127|P2|NOT COMPLETED|Overall Study||19
8557365|NCT00091507|21099128|P1|NOT COMPLETED|Overall Study||21
8557366|NCT00091507|21099127|P2|COMPLETED|Overall Study||460
8557367|NCT00091507|21099128|P1|COMPLETED|Overall Study||411
8557368|NCT00091507|21099127|P2|STARTED|Overall Study||479
8557369|NCT00091507|21099128|P1|STARTED|Overall Study||432
8557370|NCT00091442|21099144|P2|NOT COMPLETED|Overall Study||373
8557371|NCT00091442|21099145|P1|NOT COMPLETED|Overall Study||369
8557372|NCT00091442|21099144|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
8557373|NCT00091442|21099145|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
8557374|NCT00091442|21099144|P2|STARTED|Overall Study||378
8557375|NCT00091442|21099145|P1|STARTED|Overall Study||373
8557376|NCT00091390|21099155|P1|NOT COMPLETED|Overall Study||4
8557377|NCT00091390|21099155|P1|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
8557378|NCT00091390|21099155|P1|Eligible, Started Treatment, Has AE Data|Overall Study||115
8557379|NCT00091390|21099155|P1|Eligible and Started Study Treatment|Overall Study||125
8557380|NCT00091390|21099155|P1|STARTED|Overall Study||129
8557381|NCT00091273|21099166|P1|NOT COMPLETED|Overall Study||0
8557382|NCT00091273|21099166|P1|COMPLETED|Overall Study||9
8557383|NCT00091273|21099166|P1|STARTED|Overall Study||9
8557384|NCT00091260|21099172|P1|NOT COMPLETED|Overall Study||0
8557385|NCT00091260|21099172|P1|COMPLETED|Overall Study||82
8557386|NCT00091260|21099172|P1|STARTED|Overall Study||82
8557387|NCT00091169|21099180|P2|NOT COMPLETED|Overall Study||53
8557388|NCT00091169|21099181|P1|NOT COMPLETED|Overall Study||57
8557389|NCT00091169|21099180|P2|COMPLETED|Overall Study||134
8557390|NCT00091169|21099181|P1|COMPLETED|Overall Study||132
8557391|NCT00091169|21099180|P2|Treated|Overall Study||170
8557392|NCT00091169|21099181|P1|Treated|Overall Study||163
8557393|NCT00091169|21099180|P2|STARTED|Overall Study||187
8557394|NCT00091169|21099181|P1|STARTED|Overall Study||189
8557396|NCT00091026|21099200|P1|NOT COMPLETED|Overall Study||1
8557397|NCT00091026|21099199|P2|COMPLETED|Overall Study||68
8557398|NCT00091026|21099200|P1|COMPLETED|Overall Study||71
8557399|NCT00091026|21099199|P2|STARTED|Overall Study||71
8557400|NCT00091026|21099200|P1|STARTED|Overall Study||72
8557401|NCT00090987|21099210|P1|NOT COMPLETED|Overall Study||21
8557402|NCT00090987|21099210|P1|COMPLETED|Overall Study||9
8557403|NCT00090987|21099210|P1|STARTED|Overall Study||30
8557404|NCT00090870|21099214|P1|NOT COMPLETED|Overall Study||0
8557405|NCT00090870|21099214|P1|COMPLETED|Overall Study||10
8557406|NCT00090870|21099214|P1|STARTED|Overall Study||10
8557407|NCT00090857|21099223|P2|NOT COMPLETED|Overall Study||3
8557408|NCT00090857|21099224|P1|NOT COMPLETED|Overall Study||4
8557409|NCT00090857|21099223|P2|COMPLETED|Overall Study||13
8557410|NCT00090857|21099224|P1|COMPLETED|Overall Study||29
8557411|NCT00090857|21099223|P2|STARTED|Overall Study||16
8557412|NCT00090857|21099224|P1|STARTED|Overall Study||33
8557413|NCT00090779|21099254|P2|NOT COMPLETED|Step 3||5
8557414|NCT00090779|21099255|P1|NOT COMPLETED|Step 3||7
8557415|NCT00090779|21099254|P2|COMPLETED|Step 3||0
8557416|NCT00090779|21099255|P1|COMPLETED|Step 3||0
8557417|NCT00090779|21099254|P2|STARTED|Step 3||5
8557418|NCT00090779|21099255|P1|STARTED|Step 3||7
8557419|NCT00090779|21099254|P2|NOT COMPLETED|Step 2||18
8557420|NCT00090779|21099255|P1|NOT COMPLETED|Step 2||6
8557421|NCT00090779|21099254|P2|COMPLETED|Step 2||1
8557422|NCT00090779|21099255|P1|COMPLETED|Step 2||0
8557423|NCT00090779|21099254|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
8557424|NCT00090779|21099255|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
8557425|NCT00090779|21099254|P2|NOT COMPLETED|Step 1||15
8557426|NCT00090779|21099255|P1|NOT COMPLETED|Step 1||11
8557427|NCT00090779|21099254|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
8557428|NCT00090779|21099255|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
8557429|NCT00090779|21099254|P2|STARTED|Step 1||64
8557430|NCT00090779|21099255|P1|STARTED|Step 1||66
8557431|NCT00090766|21099279|P3|NOT COMPLETED|Overall Study||3
8557432|NCT00090766|21099280|P2|NOT COMPLETED|Overall Study||2
8557433|NCT00090766|21099281|P1|NOT COMPLETED|Overall Study||3
8557434|NCT00090766|21099279|P3|COMPLETED|Overall Study||22
8557435|NCT00090766|21099280|P2|COMPLETED|Overall Study||19
8557436|NCT00090766|21099281|P1|COMPLETED|Overall Study||14
8557437|NCT00090766|21099279|P3|STARTED|Overall Study||25
8557438|NCT00090766|21099280|P2|STARTED|Overall Study||21
8557439|NCT00090766|21099281|P1|STARTED|Overall Study||17
8557440|NCT00090753|21099323|P2|NOT COMPLETED|Extended Treatment Period||191
8557441|NCT00090753|21099324|P1|NOT COMPLETED|Extended Treatment Period||359
8557442|NCT00090753|21099323|P2|COMPLETED|Extended Treatment Period||59
8557443|NCT00090753|21099324|P1|COMPLETED|Extended Treatment Period||94
8557444|NCT00090753|21099323|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
8557445|NCT00090753|21099324|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
8557446|NCT00090753|21099323|P2|NOT COMPLETED|First Treatment Period||178
8557447|NCT00090753|21099324|P1|NOT COMPLETED|First Treatment Period||256
8557448|NCT00090753|21099323|P2|COMPLETED|First Treatment Period||302
8557449|NCT00090753|21099324|P1|COMPLETED|First Treatment Period||492
8557450|NCT00090753|21099323|P2|STARTED|First Treatment Period||480
8557451|NCT00090753|21099324|P1|STARTED|First Treatment Period||748
8557452|NCT00090610|21099334|P2|NOT COMPLETED|Overall Study||1
8557453|NCT00090610|21099335|P1|NOT COMPLETED|Overall Study||1
8557454|NCT00090610|21099334|P2|COMPLETED|Overall Study||74
8557455|NCT00090610|21099335|P1|COMPLETED|Overall Study||74
8557456|NCT00090610|21099334|P2|STARTED|Overall Study||75
8557457|NCT00090610|21099335|P1|STARTED|Overall Study||75
8557458|NCT00090584|21099351|P2|NOT COMPLETED|Baseline to 8 Months||41
8557459|NCT00090584|21099352|P1|NOT COMPLETED|Baseline to 8 Months||44
8557460|NCT00090584|21099351|P2|COMPLETED|Baseline to 8 Months||112
8557461|NCT00090584|21099352|P1|COMPLETED|Baseline to 8 Months||110
8557462|NCT00090584|21099351|P2|STARTED|Baseline to 8 Months||153
8557463|NCT00090584|21099352|P1|STARTED|Baseline to 8 Months||154
8557464|NCT00090584|21099351|P2|NOT COMPLETED|Baseline to 10 Weeks||12
8557465|NCT00090584|21099352|P1|NOT COMPLETED|Baseline to 10 Weeks||15
8557466|NCT00090584|21099351|P2|COMPLETED|Baseline to 10 Weeks||141
8557467|NCT00090584|21099352|P1|COMPLETED|Baseline to 10 Weeks||139
8557468|NCT00090584|21099351|P2|STARTED|Baseline to 10 Weeks||153
8557469|NCT00090584|21099352|P1|STARTED|Baseline to 10 Weeks||154
8557470|NCT00090519|21099384|P2|NOT COMPLETED|Overall Study||75
8557471|NCT00090519|21099385|P1|NOT COMPLETED|Overall Study||73
8557472|NCT00090519|21099384|P2|COMPLETED|Overall Study||285
8557473|NCT00090519|21099385|P1|COMPLETED|Overall Study||298
8557474|NCT00090519|21099384|P2|STARTED|Overall Study||360
8557475|NCT00090519|21099385|P1|STARTED|Overall Study||371
8557476|NCT00090493|21099409|P1|NOT COMPLETED|Overall Study||2
8557477|NCT00090493|21099409|P1|COMPLETED|Overall Study||2
8557478|NCT00090493|21099409|P1|STARTED|Overall Study||4
8557479|NCT00090363|21099416|P3|NOT COMPLETED|Overall Study||96
8557480|NCT00090363|21099417|P2|NOT COMPLETED|Overall Study||107
8557481|NCT00090363|21099418|P1|NOT COMPLETED|Overall Study||106
8557482|NCT00090363|21099416|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
8557483|NCT00090363|21099417|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
8557484|NCT00090363|21099418|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
8557485|NCT00090363|21099416|P3|Received Study Treatment.|Overall Study||98
8557486|NCT00090363|21099417|P2|Received Study Treatment.|Overall Study||107
8557487|NCT00090363|21099418|P1|Received Study Treatment.|Overall Study||107
8557488|NCT00090363|21099416|P3|STARTED|Overall Study||98
8557489|NCT00090363|21099417|P2|STARTED|Overall Study||107
8557490|NCT00090363|21099418|P1|STARTED|Overall Study||107
8557491|NCT00090545|21099440|P2|NOT COMPLETED|Overall Study||24
8557492|NCT00090545|21099441|P1|NOT COMPLETED|Overall Study||22
8557493|NCT00090545|21099440|P2|COMPLETED|Overall Study||0
8557494|NCT00090545|21099441|P1|COMPLETED|Overall Study||0
8557495|NCT00090545|21099440|P2|STARTED|Overall Study||24
8557496|NCT00090545|21099441|P1|STARTED|Overall Study||22
8557497|NCT00090285|21099461|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
8557498|NCT00090285|21099462|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
8557499|NCT00090285|21099463|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557500|NCT00090285|21099464|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557501|NCT00090285|21099465|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557502|NCT00090285|21099466|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557503|NCT00090285|21099461|P6|COMPLETED|Long-term Follow-up (EXT2)||664
8557504|NCT00090285|21099462|P5|COMPLETED|Long-term Follow-up (EXT2)||709
8557505|NCT00090285|21099463|P4|COMPLETED|Long-term Follow-up (EXT2)||0
8557506|NCT00090285|21099464|P3|COMPLETED|Long-term Follow-up (EXT2)||0
8557507|NCT00090285|21099465|P2|COMPLETED|Long-term Follow-up (EXT2)||0
8557508|NCT00090285|21099466|P1|COMPLETED|Long-term Follow-up (EXT2)||0
8557509|NCT00090285|21099461|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
8557510|NCT00090285|21099462|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
8557511|NCT00090285|21099463|P4|STARTED|Long-term Follow-up (EXT2)||0
8557512|NCT00090285|21099464|P3|STARTED|Long-term Follow-up (EXT2)||0
8557513|NCT00090285|21099465|P2|STARTED|Long-term Follow-up (EXT2)||0
8557514|NCT00090285|21099466|P1|STARTED|Long-term Follow-up (EXT2)||0
8557515|NCT00090285|21099461|P6|NOT COMPLETED|Extension 1||0
8557516|NCT00090285|21099462|P5|NOT COMPLETED|Extension 1||0
8557517|NCT00090285|21099463|P4|NOT COMPLETED|Extension 1||1
8557518|NCT00090285|21099464|P3|NOT COMPLETED|Extension 1||57
8557519|NCT00090285|21099465|P2|NOT COMPLETED|Extension 1||0
8557520|NCT00090285|21099466|P1|NOT COMPLETED|Extension 1||0
8557521|NCT00090285|21099461|P6|COMPLETED|Extension 1||0
8557522|NCT00090285|21099462|P5|COMPLETED|Extension 1||0
8557523|NCT00090285|21099463|P4|COMPLETED|Extension 1||15
8557524|NCT00090285|21099464|P3|COMPLETED|Extension 1||1041
8557525|NCT00090285|21099465|P2|COMPLETED|Extension 1||0
8557526|NCT00090285|21099466|P1|COMPLETED|Extension 1||0
8557527|NCT00090285|21099461|P6|STARTED|Extension 1||0
8557528|NCT00090285|21099462|P5|STARTED|Extension 1||0
8557529|NCT00090285|21099463|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
8557530|NCT00090285|21099464|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
8557531|NCT00090285|21099465|P2|STARTED|Extension 1||0
8557532|NCT00090285|21099466|P1|STARTED|Extension 1||0
8557533|NCT00090285|21099461|P6|NOT COMPLETED|Base Study Follow-up Period||0
8557534|NCT00090285|21099462|P5|NOT COMPLETED|Base Study Follow-up Period||0
8557535|NCT00090285|21099463|P4|NOT COMPLETED|Base Study Follow-up Period||0
8557536|NCT00090285|21099464|P3|NOT COMPLETED|Base Study Follow-up Period||0
8557537|NCT00090285|21099465|P2|NOT COMPLETED|Base Study Follow-up Period||342
8557538|NCT00090285|21099466|P1|NOT COMPLETED|Base Study Follow-up Period||335
8557539|NCT00090285|21099461|P6|COMPLETED|Base Study Follow-up Period||0
8557540|NCT00090285|21099462|P5|COMPLETED|Base Study Follow-up Period||0
8557541|NCT00090285|21099463|P4|COMPLETED|Base Study Follow-up Period||0
8557542|NCT00090285|21099464|P3|COMPLETED|Base Study Follow-up Period||0
8557543|NCT00090285|21099465|P2|COMPLETED|Base Study Follow-up Period||1479
8557544|NCT00090285|21099466|P1|COMPLETED|Base Study Follow-up Period||1487
8557545|NCT00090285|21099461|P6|STARTED|Base Study Follow-up Period||0
8557546|NCT00090285|21099462|P5|STARTED|Base Study Follow-up Period||0
8557547|NCT00090285|21099463|P4|STARTED|Base Study Follow-up Period||0
8557548|NCT00090285|21099464|P3|STARTED|Base Study Follow-up Period||0
8557549|NCT00090285|21099465|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
8557550|NCT00090285|21099466|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
8557551|NCT00090285|21099461|P6|NOT COMPLETED|Base Study Vaccination Period||0
8557552|NCT00090285|21099462|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557553|NCT00090285|21099463|P4|NOT COMPLETED|Base Study Vaccination Period||0
8557554|NCT00090285|21099464|P3|NOT COMPLETED|Base Study Vaccination Period||0
8557555|NCT00090285|21099465|P2|NOT COMPLETED|Base Study Vaccination Period||219
8557556|NCT00090285|21099466|P1|NOT COMPLETED|Base Study Vaccination Period||214
8557557|NCT00090285|21099461|P6|COMPLETED|Base Study Vaccination Period||0
8557558|NCT00090285|21099462|P5|COMPLETED|Base Study Vaccination Period||0
8557559|NCT00090285|21099463|P4|COMPLETED|Base Study Vaccination Period||0
8557560|NCT00090285|21099464|P3|COMPLETED|Base Study Vaccination Period||0
8557561|NCT00090285|21099465|P2|COMPLETED|Base Study Vaccination Period||1814
8557562|NCT00090285|21099466|P1|COMPLETED|Base Study Vaccination Period||1818
8557563|NCT00090285|21099461|P6|Vaccinated|Base Study Vaccination Period||0
8557564|NCT00090285|21099462|P5|Vaccinated|Base Study Vaccination Period||0
8557565|NCT00090285|21099463|P4|Vaccinated|Base Study Vaccination Period||0
8557566|NCT00090285|21099464|P3|Vaccinated|Base Study Vaccination Period||0
8557567|NCT00090285|21099465|P2|Vaccinated|Base Study Vaccination Period||2030
8557568|NCT00090285|21099466|P1|Vaccinated|Base Study Vaccination Period||2025
8557569|NCT00090285|21099461|P6|STARTED|Base Study Vaccination Period||0
8557570|NCT00090285|21099462|P5|STARTED|Base Study Vaccination Period||0
8557571|NCT00090285|21099463|P4|STARTED|Base Study Vaccination Period||0
8557572|NCT00090285|21099464|P3|STARTED|Base Study Vaccination Period||0
8557573|NCT00090285|21099465|P2|STARTED|Base Study Vaccination Period||2033
8557574|NCT00090285|21099466|P1|STARTED|Base Study Vaccination Period||2032
8557575|NCT00090259|21099503|P2|NOT COMPLETED|Overall Study||48
8557576|NCT00090259|21099504|P1|NOT COMPLETED|Overall Study||62
8557577|NCT00090259|21099503|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
8557578|NCT00090259|21099504|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
8557579|NCT00090259|21099503|P2|STARTED|Overall Study||1921
8557580|NCT00090259|21099504|P1|STARTED|Overall Study||1913
8557581|NCT00090233|21099520|P2|NOT COMPLETED|Overall Study||5065
8557582|NCT00090233|21099521|P1|NOT COMPLETED|Overall Study||4999
8557583|NCT00090233|21099520|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
8557584|NCT00090233|21099521|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
8557585|NCT00090233|21099520|P2|Vaccinated at Visit 3|Overall Study||29598
8557586|NCT00090233|21099521|P1|Vaccinated at Visit 3|Overall Study||29667
8557587|NCT00090233|21099520|P2|Vaccinated at Visit 2|Overall Study||31066
8557588|NCT00090233|21099521|P1|Vaccinated at Visit 2|Overall Study||31052
8557589|NCT00090233|21099520|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
8557590|NCT00090233|21099521|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
8557591|NCT00090233|21099520|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
8557592|NCT00090233|21099521|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
8557593|NCT00090220|21099545|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
8557594|NCT00090220|21099546|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
8557595|NCT00090220|21099547|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557596|NCT00090220|21099548|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557597|NCT00090220|21099549|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557598|NCT00090220|21099550|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557599|NCT00090220|21099545|P6|COMPLETED|Long-term Follow-up (EXT2)||623
8557600|NCT00090220|21099546|P5|COMPLETED|Long-term Follow-up (EXT2)||641
8557601|NCT00090220|21099547|P4|COMPLETED|Long-term Follow-up (EXT2)||0
8557602|NCT00090220|21099548|P3|COMPLETED|Long-term Follow-up (EXT2)||0
8557603|NCT00090220|21099549|P2|COMPLETED|Long-term Follow-up (EXT2)||0
8557604|NCT00090220|21099550|P1|COMPLETED|Long-term Follow-up (EXT2)||0
8557605|NCT00090220|21099545|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
8557606|NCT00090220|21099546|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
8557607|NCT00090220|21099547|P4|STARTED|Long-term Follow-up (EXT2)||0
8557608|NCT00090220|21099548|P3|STARTED|Long-term Follow-up (EXT2)||0
8557609|NCT00090220|21099549|P2|STARTED|Long-term Follow-up (EXT2)||0
8557610|NCT00090220|21099550|P1|STARTED|Long-term Follow-up (EXT2)||0
8557611|NCT00090220|21099545|P6|NOT COMPLETED|Extension 1 (EXT1)||0
8557612|NCT00090220|21099546|P5|NOT COMPLETED|Extension 1 (EXT1)||0
8557613|NCT00090220|21099547|P4|NOT COMPLETED|Extension 1 (EXT1)||2
8557614|NCT00090220|21099548|P3|NOT COMPLETED|Extension 1 (EXT1)||55
8557615|NCT00090220|21099549|P2|NOT COMPLETED|Extension 1 (EXT1)||0
8557616|NCT00090220|21099550|P1|NOT COMPLETED|Extension 1 (EXT1)||0
8557617|NCT00090220|21099545|P6|COMPLETED|Extension 1 (EXT1)||0
8557618|NCT00090220|21099546|P5|COMPLETED|Extension 1 (EXT1)||0
8557619|NCT00090220|21099547|P4|COMPLETED|Extension 1 (EXT1)||5
8557620|NCT00090220|21099548|P3|COMPLETED|Extension 1 (EXT1)||1267
8557621|NCT00090220|21099549|P2|COMPLETED|Extension 1 (EXT1)||0
8557622|NCT00090220|21099550|P1|COMPLETED|Extension 1 (EXT1)||0
8557623|NCT00090220|21099545|P6|Vaccinated|Extension 1 (EXT1)||0
8557624|NCT00090220|21099546|P5|Vaccinated|Extension 1 (EXT1)||0
8557625|NCT00090220|21099547|P4|Vaccinated|Extension 1 (EXT1)||7
8557626|NCT00090220|21099548|P3|Vaccinated|Extension 1 (EXT1)||1321
8557627|NCT00090220|21099549|P2|Vaccinated|Extension 1 (EXT1)||0
8557628|NCT00090220|21099550|P1|Vaccinated|Extension 1 (EXT1)||0
8557629|NCT00090220|21099545|P6|STARTED|Extension 1 (EXT1)||0
8557630|NCT00090220|21099546|P5|STARTED|Extension 1 (EXT1)||0
8557631|NCT00090220|21099547|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
8557632|NCT00090220|21099548|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
8557633|NCT00090220|21099549|P2|STARTED|Extension 1 (EXT1)||0
8557634|NCT00090220|21099550|P1|STARTED|Extension 1 (EXT1)||0
8557635|NCT00090220|21099545|P6|NOT COMPLETED|Base Study Follow-up Period||0
8557636|NCT00090220|21099546|P5|NOT COMPLETED|Base Study Follow-up Period||0
8557637|NCT00090220|21099547|P4|NOT COMPLETED|Base Study Follow-up Period||0
8557638|NCT00090220|21099548|P3|NOT COMPLETED|Base Study Follow-up Period||0
8557639|NCT00090220|21099549|P2|NOT COMPLETED|Base Study Follow-up Period||164
8557640|NCT00090220|21099550|P1|NOT COMPLETED|Base Study Follow-up Period||160
8557641|NCT00090220|21099545|P6|COMPLETED|Base Study Follow-up Period||0
8557642|NCT00090220|21099546|P5|COMPLETED|Base Study Follow-up Period||0
8557643|NCT00090220|21099547|P4|COMPLETED|Base Study Follow-up Period||0
8557644|NCT00090220|21099548|P3|COMPLETED|Base Study Follow-up Period||0
8557645|NCT00090220|21099549|P2|COMPLETED|Base Study Follow-up Period||1687
8557646|NCT00090220|21099550|P1|COMPLETED|Base Study Follow-up Period||1695
8557647|NCT00090220|21099545|P6|STARTED|Base Study Follow-up Period||0
8557648|NCT00090220|21099546|P5|STARTED|Base Study Follow-up Period||0
8557649|NCT00090220|21099547|P4|STARTED|Base Study Follow-up Period||0
8557650|NCT00090220|21099548|P3|STARTED|Base Study Follow-up Period||0
8557651|NCT00090220|21099549|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
8557652|NCT00090220|21099550|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
8557653|NCT00090220|21099545|P6|NOT COMPLETED|Base Study Vaccination Period||0
8557654|NCT00090220|21099546|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557655|NCT00090220|21099547|P4|NOT COMPLETED|Base Study Vaccination Period||0
8557656|NCT00090220|21099548|P3|NOT COMPLETED|Base Study Vaccination Period||0
8557657|NCT00090220|21099549|P2|NOT COMPLETED|Base Study Vaccination Period||63
8557658|NCT00090220|21099550|P1|NOT COMPLETED|Base Study Vaccination Period||64
8557659|NCT00090220|21099545|P6|COMPLETED|Base Study Vaccination Period||0
8557660|NCT00090220|21099546|P5|COMPLETED|Base Study Vaccination Period||0
8557661|NCT00090220|21099547|P4|COMPLETED|Base Study Vaccination Period||0
8557662|NCT00090220|21099548|P3|COMPLETED|Base Study Vaccination Period||0
8557663|NCT00090220|21099549|P2|COMPLETED|Base Study Vaccination Period||1845
8557664|NCT00090220|21099550|P1|COMPLETED|Base Study Vaccination Period||1847
8557665|NCT00090220|21099545|P6|Vaccinated|Base Study Vaccination Period||0
8557666|NCT00090220|21099546|P5|Vaccinated|Base Study Vaccination Period||0
8557667|NCT00090220|21099547|P4|Vaccinated|Base Study Vaccination Period||0
8557668|NCT00090220|21099548|P3|Vaccinated|Base Study Vaccination Period||0
8557669|NCT00090220|21099549|P2|Vaccinated|Base Study Vaccination Period||1907
8557670|NCT00090220|21099550|P1|Vaccinated|Base Study Vaccination Period||1910
8557671|NCT00090220|21099545|P6|STARTED|Base Study Vaccination Period||0
8557672|NCT00090220|21099546|P5|STARTED|Base Study Vaccination Period||0
8557673|NCT00090220|21099547|P4|STARTED|Base Study Vaccination Period||0
8557674|NCT00090220|21099548|P3|STARTED|Base Study Vaccination Period||0
8557675|NCT00090220|21099549|P2|STARTED|Base Study Vaccination Period||1908
8557676|NCT00090220|21099550|P1|STARTED|Base Study Vaccination Period||1911
8557677|NCT00090402|21099645|P3|NOT COMPLETED|Overall Study||1
8557678|NCT00090402|21099646|P2|NOT COMPLETED|Overall Study||2
8557679|NCT00090402|21099647|P1|NOT COMPLETED|Overall Study||2
8557680|NCT00090402|21099645|P3|COMPLETED|Overall Study||12
8557681|NCT00090402|21099646|P2|COMPLETED|Overall Study||11
8557682|NCT00090402|21099647|P1|COMPLETED|Overall Study||11
8557683|NCT00090402|21099645|P3|STARTED|Overall Study||13
8557684|NCT00090402|21099646|P2|STARTED|Overall Study||13
8557685|NCT00090402|21099647|P1|STARTED|Overall Study||13
8557686|NCT00090142|21099661|P2|NOT COMPLETED|Treatment Period II||0
8557687|NCT00090142|21099662|P1|NOT COMPLETED|Treatment Period II||1
8557688|NCT00090142|21099661|P2|COMPLETED|Treatment Period II||28
8557689|NCT00090142|21099662|P1|COMPLETED|Treatment Period II||25
8557690|NCT00090142|21099661|P2|STARTED|Treatment Period II||28
8557691|NCT00090142|21099662|P1|STARTED|Treatment Period II||26
8557692|NCT00090142|21099661|P2|NOT COMPLETED|Treatment Period I||3
8557693|NCT00090142|21099662|P1|NOT COMPLETED|Treatment Period I||5
8557694|NCT00090142|21099661|P2|COMPLETED|Treatment Period I||28
8557695|NCT00090142|21099662|P1|COMPLETED|Treatment Period I||26
8557696|NCT00090142|21099661|P2|STARTED|Treatment Period I||31
8557697|NCT00090142|21099662|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
8557698|NCT00090103|21099693|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
8557699|NCT00090103|21099694|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
8557700|NCT00090103|21099695|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
8557701|NCT00090103|21099693|P3|COMPLETED|16-Week Safety Follow-up Period||1143
8557702|NCT00090103|21099694|P2|COMPLETED|16-Week Safety Follow-up Period||1205
8557703|NCT00090103|21099695|P1|COMPLETED|16-Week Safety Follow-up Period||1224
8557704|NCT00090103|21099693|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
8557705|NCT00090103|21099694|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
8557706|NCT00090103|21099695|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
8557707|NCT00090103|21099693|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
8557708|NCT00090103|21099694|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
8557709|NCT00090103|21099695|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
8557710|NCT00090103|21099693|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
8557711|NCT00090103|21099694|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
8557712|NCT00090103|21099695|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
8557713|NCT00090103|21099693|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
8557714|NCT00090103|21099694|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
8557715|NCT00090103|21099695|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
8557716|NCT00090051|21099795|P2|NOT COMPLETED|Overall Study||95
8557717|NCT00090051|21099796|P1|NOT COMPLETED|Overall Study||109
8557718|NCT00090051|21099795|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
8557719|NCT00090051|21099796|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
8557720|NCT00090051|21099795|P2|Safety Population; Received Study Drug|Overall Study||274
8557721|NCT00090051|21099796|P1|Safety Population; Received Study Drug|Overall Study||272
8557722|NCT00090051|21099795|P2|STARTED|Overall Study||276
8557723|NCT00090051|21099796|P1|STARTED|Overall Study||276
8557724|NCT00003224|21099836|P6|NOT COMPLETED|Overall Study||0
8557725|NCT00003224|21099837|P5|NOT COMPLETED|Overall Study||0
8557726|NCT00003224|21099838|P4|NOT COMPLETED|Overall Study||0
8557727|NCT00003224|21099839|P3|NOT COMPLETED|Overall Study||0
8557728|NCT00003224|21099840|P2|NOT COMPLETED|Overall Study||0
8557729|NCT00003224|21099841|P1|NOT COMPLETED|Overall Study||0
8557730|NCT00003224|21099836|P6|COMPLETED|Overall Study||3
8557731|NCT00003224|21099837|P5|COMPLETED|Overall Study||4
8557732|NCT00003224|21099838|P4|COMPLETED|Overall Study||2
8557733|NCT00003224|21099839|P3|COMPLETED|Overall Study||4
8557734|NCT00003224|21099840|P2|COMPLETED|Overall Study||5
8557735|NCT00003224|21099841|P1|COMPLETED|Overall Study||4
8557736|NCT00003224|21099836|P6|STARTED|Overall Study||3
8557737|NCT00003224|21099837|P5|STARTED|Overall Study||4
8557738|NCT00003224|21099838|P4|STARTED|Overall Study||2
8557739|NCT00003224|21099839|P3|STARTED|Overall Study||4
8557740|NCT00003224|21099840|P2|STARTED|Overall Study||5
8557741|NCT00003224|21099841|P1|STARTED|Overall Study||4
8557742|NCT00089999|21099861|P2|NOT COMPLETED|Overall Study||69
8557743|NCT00089999|21099862|P1|NOT COMPLETED|Overall Study||69
8557744|NCT00089999|21099861|P2|COMPLETED|Overall Study||0
8557745|NCT00089999|21099862|P1|COMPLETED|Overall Study||0
8557746|NCT00089999|21099861|P2|STARTED|Overall Study||69
8557747|NCT00089999|21099862|P1|STARTED|Overall Study||69
8557748|NCT00089986|21099885|P3|NOT COMPLETED|Overall Study||10
8557749|NCT00089986|21099886|P2|NOT COMPLETED|Overall Study||24
8557750|NCT00089986|21099887|P1|NOT COMPLETED|Overall Study||15
8557751|NCT00089986|21099885|P3|COMPLETED|Overall Study||172
8557752|NCT00089986|21099886|P2|COMPLETED|Overall Study||574
8557753|NCT00089986|21099887|P1|COMPLETED|Overall Study||584
8557754|NCT00089986|21099885|P3|STARTED|Overall Study||182
8557755|NCT00089986|21099886|P2|STARTED|Overall Study||598
8557756|NCT00089986|21099887|P1|STARTED|Overall Study||599
8557757|NCT00089973|21099904|P1|NOT COMPLETED|Overall Study||50
8557758|NCT00089973|21099904|P1|COMPLETED|Overall Study||0
8557759|NCT00089973|21099904|P1|STARTED|Overall Study||50
8557760|NCT00089895|21099919|P2|NOT COMPLETED|Overall Study||42
8557761|NCT00089895|21099920|P1|NOT COMPLETED|Overall Study||35
8557762|NCT00089895|21099919|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
8557763|NCT00089895|21099920|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
8557764|NCT00089895|21099919|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
8557765|NCT00089895|21099920|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
8557766|NCT00089843|21099932|P4|NOT COMPLETED|Overall Study||7
8557767|NCT00089843|21099933|P3|NOT COMPLETED|Overall Study||5
8557768|NCT00089843|21099934|P2|NOT COMPLETED|Overall Study||4
8557769|NCT00089843|21099935|P1|NOT COMPLETED|Overall Study||2
8557770|NCT00089843|21099932|P4|COMPLETED|Overall Study||11
8557771|NCT00089843|21099933|P3|COMPLETED|Overall Study||15
8557772|NCT00089843|21099934|P2|COMPLETED|Overall Study||16
8557773|NCT00089843|21099935|P1|COMPLETED|Overall Study||17
8557774|NCT00089843|21099932|P4|STARTED|Overall Study||18
8557775|NCT00089843|21099933|P3|STARTED|Overall Study||20
8557776|NCT00089843|21099934|P2|STARTED|Overall Study||20
8557777|NCT00089843|21099935|P1|STARTED|Overall Study||19
8557778|NCT00089791|21099947|P2|NOT COMPLETED|Overall Study||630
8557779|NCT00089791|21099948|P1|NOT COMPLETED|Overall Study||700
8557780|NCT00089791|21099947|P2|COMPLETED|Overall Study||3272
8557781|NCT00089791|21099948|P1|COMPLETED|Overall Study||3206
8557782|NCT00089791|21099947|P2|Safety Analysis Set|Overall Study||3886
8557783|NCT00089791|21099948|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
8557784|NCT00089791|21099947|P2|Received Study Medication|Overall Study||3879
8557785|NCT00089791|21099948|P1|Received Study Medication|Overall Study||3883
8557786|NCT00089791|21099947|P2|STARTED|Overall Study||3902
8557787|NCT00089791|21099948|P1|STARTED|Overall Study||3906
8557788|NCT00089752|21099960|P2|NOT COMPLETED|Overall Study||22
8557789|NCT00089752|21099961|P1|NOT COMPLETED|Overall Study||20
8557790|NCT00089752|21099960|P2|COMPLETED|Overall Study||118
8557791|NCT00089752|21099961|P1|COMPLETED|Overall Study||121
8557792|NCT00089752|21099960|P2|STARTED|Overall Study||140
8557793|NCT00089752|21099961|P1|STARTED|Overall Study||141
8557794|NCT00089778|21099982|P3|NOT COMPLETED|Overall Study||1
8557795|NCT00089778|21099983|P2|NOT COMPLETED|Overall Study||0
8557796|NCT00089778|21099984|P1|NOT COMPLETED|Overall Study||0
8557797|NCT00089778|21099982|P3|COMPLETED|Overall Study||7
8557798|NCT00089778|21099983|P2|COMPLETED|Overall Study||1
8557799|NCT00089778|21099984|P1|COMPLETED|Overall Study||2
8557800|NCT00089778|21099982|P3|STARTED|Overall Study||8
8557801|NCT00089778|21099983|P2|STARTED|Overall Study||1
8557802|NCT00089778|21099984|P1|STARTED|Overall Study||2
8557803|NCT00089674|21099997|P2|NOT COMPLETED|Overall Study||267
8557804|NCT00089674|21099998|P1|NOT COMPLETED|Overall Study||289
8557805|NCT00089674|21099997|P2|COMPLETED|Overall Study||467
8557806|NCT00089674|21099998|P1|COMPLETED|Overall Study||445
8557807|NCT00089674|21099997|P2|Received Study Drug|Overall Study||726
8557808|NCT00089674|21099998|P1|Received Study Drug|Overall Study||730
8557809|NCT00089674|21099997|P2|STARTED|Overall Study||734
8557810|NCT00089674|21099998|P1|STARTED|Overall Study||734
8557811|NCT00089661|21100024|P2|NOT COMPLETED|Overall Study||26
8557812|NCT00089661|21100025|P1|NOT COMPLETED|Overall Study||21
8557813|NCT00089661|21100024|P2|COMPLETED|Overall Study||99
8557814|NCT00089661|21100025|P1|COMPLETED|Overall Study||106
8557815|NCT00089661|21100024|P2|STARTED|Overall Study||125
8557816|NCT00089661|21100025|P1|STARTED|Overall Study||127
8557817|NCT00089648|21100041|P1|NOT COMPLETED|Overall Study||41
8557818|NCT00089648|21100041|P1|COMPLETED|Overall Study||20
8557819|NCT00089648|21100041|P1|STARTED|Overall Study||61
8557820|NCT00089635|21100057|P1|NOT COMPLETED|Overall Study||43
8557821|NCT00089635|21100057|P1|COMPLETED|Overall Study||160
8557822|NCT00089635|21100057|P1|STARTED|Overall Study||203
8557823|NCT00089583|21100071|P2|NOT COMPLETED|Overall Study||38
8557824|NCT00089583|21100072|P1|NOT COMPLETED|Overall Study||7
8557825|NCT00089583|21100071|P2|COMPLETED|Overall Study||51
8557826|NCT00089583|21100072|P1|COMPLETED|Overall Study||13
8557827|NCT00089583|21100071|P2|STARTED|Overall Study||89
8557828|NCT00089583|21100072|P1|STARTED|Overall Study||20
8557829|NCT00089609|21100166|P2|NOT COMPLETED|Overall Study||1
8557830|NCT00089609|21100167|P1|NOT COMPLETED|Overall Study||3
8557831|NCT00089609|21100166|P2|COMPLETED|Overall Study||12
8557832|NCT00089609|21100167|P1|COMPLETED|Overall Study||57
8557833|NCT00089609|21100166|P2|STARTED|Overall Study||13
8557834|NCT00089609|21100167|P1|STARTED|Overall Study||60
8557835|NCT00089544|21100186|P2|NOT COMPLETED|Overall Study||0
8557836|NCT00089544|21100187|P1|NOT COMPLETED|Overall Study||1
8557837|NCT00089544|21100186|P2|COMPLETED|Overall Study||7
8557838|NCT00089544|21100187|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
8557839|NCT00089544|21100186|P2|STARTED|Overall Study||7
8557840|NCT00089544|21100187|P1|STARTED|Overall Study||16
8557841|NCT00089505|21100201|P4|NOT COMPLETED|Overall Study||21
8557842|NCT00089505|21100202|P3|NOT COMPLETED|Overall Study||21
8557843|NCT00089505|21100203|P2|NOT COMPLETED|Overall Study||2
8557844|NCT00089505|21100204|P1|NOT COMPLETED|Overall Study||9
8557845|NCT00089505|21100201|P4|COMPLETED|Overall Study||230
8557846|NCT00089505|21100202|P3|COMPLETED|Overall Study||228
8557847|NCT00089505|21100203|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
8557848|NCT00089505|21100204|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
8557849|NCT00089505|21100201|P4|STARTED|Overall Study||251
8557850|NCT00089505|21100202|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
8557851|NCT00089505|21100203|P2|STARTED|Overall Study||120
8557852|NCT00089505|21100204|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
8557853|NCT00089479|21100248|P2|NOT COMPLETED|Overall Study||289
8557854|NCT00089479|21100249|P1|NOT COMPLETED|Overall Study||331
8557855|NCT00089479|21100248|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
8557856|NCT00089479|21100249|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
8557857|NCT00089479|21100248|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
8557858|NCT00089479|21100249|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
8557859|NCT00089479|21100248|P2|STARTED|Overall Study||1307
8557860|NCT00089479|21100249|P1|STARTED|Overall Study||1304
8557861|NCT00089414|21100276|P3|NOT COMPLETED|Overall Study||0
8557862|NCT00089414|21100277|P2|NOT COMPLETED|Overall Study||0
8557863|NCT00089414|21100278|P1|NOT COMPLETED|Overall Study||0
8557864|NCT00089414|21100276|P3|COMPLETED|Overall Study||2
8557865|NCT00089414|21100277|P2|COMPLETED|Overall Study||1
8557866|NCT00089414|21100278|P1|COMPLETED|Overall Study||2
8557867|NCT00089414|21100276|P3|STARTED|Overall Study||2
8557868|NCT00089414|21100277|P2|STARTED|Overall Study||1
8557869|NCT00089414|21100278|P1|STARTED|Overall Study||2
8557870|NCT00089297|21100292|P1|NOT COMPLETED|Overall Study||38
8557871|NCT00089297|21100292|P1|COMPLETED|Overall Study||36
8557872|NCT00089297|21100292|P1|Eligible|Overall Study||63
8557873|NCT00089297|21100292|P1|Treated|Overall Study||70
8557874|NCT00089297|21100292|P1|STARTED|Overall Study||74
8557875|NCT00089284|21100304|P7|NOT COMPLETED|Overall Study||1
8557876|NCT00089284|21100305|P6|NOT COMPLETED|Overall Study||0
8557877|NCT00089284|21100306|P5|NOT COMPLETED|Overall Study||0
8557878|NCT00089284|21100307|P4|NOT COMPLETED|Overall Study||0
8557879|NCT00089284|21100308|P3|NOT COMPLETED|Overall Study||0
8557880|NCT00089284|21100309|P2|NOT COMPLETED|Overall Study||0
8557881|NCT00089284|21100310|P1|NOT COMPLETED|Overall Study||0
8557882|NCT00089284|21100304|P7|COMPLETED|Overall Study||7
8557883|NCT00089284|21100305|P6|COMPLETED|Overall Study||0
8557884|NCT00089284|21100306|P5|COMPLETED|Overall Study||0
8557885|NCT00089284|21100307|P4|COMPLETED|Overall Study||6
8557886|NCT00089284|21100308|P3|COMPLETED|Overall Study||6
8557887|NCT00089284|21100309|P2|COMPLETED|Overall Study||3
8557888|NCT00089284|21100310|P1|COMPLETED|Overall Study||7
8557889|NCT00089284|21100304|P7|STARTED|Overall Study||8
8557890|NCT00089284|21100305|P6|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
8557891|NCT00089284|21100306|P5|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
8557892|NCT00089284|21100307|P4|STARTED|Overall Study||6
8557893|NCT00089284|21100308|P3|STARTED|Overall Study||6
8557894|NCT00089284|21100309|P2|STARTED|Overall Study||3
8557895|NCT00089284|21100310|P1|STARTED|Overall Study||7
8557896|NCT00089141|21100347|P2|NOT COMPLETED|Overall Study||24
8557897|NCT00089141|21100348|P1|NOT COMPLETED|Overall Study||18
8557898|NCT00089141|21100347|P2|COMPLETED|Overall Study||53
8557899|NCT00089141|21100348|P1|COMPLETED|Overall Study||56
8557900|NCT00089141|21100347|P2|STARTED|Overall Study||77
8557901|NCT00089141|21100348|P1|STARTED|Overall Study||74
8557902|NCT00089128|21100370|P1|NOT COMPLETED|Overall Study||0
8557903|NCT00089128|21100370|P1|COMPLETED|Overall Study||16
8557904|NCT00089128|21100370|P1|STARTED|Overall Study||16
8557905|NCT00089102|21100377|P1|NOT COMPLETED|Overall Study||0
8557906|NCT00089102|21100377|P1|COMPLETED|Overall Study||9
8557907|NCT00089102|21100377|P1|STARTED|Overall Study||9
8557908|NCT00089076|21100384|P1|NOT COMPLETED|Overall Study||10
8557909|NCT00089076|21100384|P1|COMPLETED|Overall Study||8
8557910|NCT00089076|21100384|P1|STARTED|Overall Study||18
8557911|NCT00089024|21100395|P1|NOT COMPLETED|Overall Study||5
8557912|NCT00089024|21100395|P1|COMPLETED|Overall Study||24
8557913|NCT00089024|21100395|P1|Treated Subjects|Overall Study||29
8557914|NCT00089024|21100395|P1|STARTED|Overall Study||29
8557915|NCT00089011|21100402|P2|NOT COMPLETED|Overall Study||0
8557916|NCT00089011|21100403|P1|NOT COMPLETED|Overall Study||0
8557917|NCT00089011|21100402|P2|COMPLETED|Overall Study||50
8557918|NCT00089011|21100403|P1|COMPLETED|Overall Study||100
8557919|NCT00089011|21100402|P2|STARTED|Overall Study||50
8557920|NCT00089011|21100403|P1|STARTED|Overall Study||100
8557921|NCT00088985|21100423|P1|NOT COMPLETED|Overall Study||3
8557922|NCT00088985|21100423|P1|COMPLETED|Overall Study||4
8557923|NCT00088985|21100423|P1|STARTED|Overall Study||7
8557924|NCT00088972|21100430|P2|NOT COMPLETED|Overall Study||4
8557925|NCT00088972|21100431|P1|NOT COMPLETED|Overall Study||2
8557926|NCT00088972|21100430|P2|COMPLETED|Overall Study||1
8557927|NCT00088972|21100431|P1|COMPLETED|Overall Study||1
8557928|NCT00088972|21100430|P2|STARTED|Overall Study||5
8557929|NCT00088972|21100431|P1|STARTED|Overall Study||3
8557930|NCT00088907|21100441|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
8557931|NCT00088907|21100442|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
8557932|NCT00088907|21100441|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
8557933|NCT00088907|21100442|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
8557934|NCT00088907|21100441|P2|Treated|Single Gefitinib Treatment (Step 2)||0
8557935|NCT00088907|21100442|P1|Treated|Single Gefitinib Treatment (Step 2)||19
8557936|NCT00088907|21100441|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
8557937|NCT00088907|21100442|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
8557938|NCT00088907|21100441|P2|NOT COMPLETED|Randomized Study (Step 1)||134
8557939|NCT00088907|21100442|P1|NOT COMPLETED|Randomized Study (Step 1)||136
8557940|NCT00088907|21100441|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
8557941|NCT00088907|21100442|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
8557942|NCT00088907|21100441|P2|Eligible and Treated|Randomized Study (Step 1)||122
8557943|NCT00088907|21100442|P1|Eligible and Treated|Randomized Study (Step 1)||117
8557944|NCT00088907|21100441|P2|Eligible|Randomized Study (Step 1)||122
8557945|NCT00088907|21100442|P1|Eligible|Randomized Study (Step 1)||117
8557946|NCT00088907|21100441|P2|Treated|Randomized Study (Step 1)||124
8557947|NCT00088907|21100442|P1|Treated|Randomized Study (Step 1)||129
8557948|NCT00088907|21100441|P2|STARTED|Randomized Study (Step 1)||134
8557949|NCT00088907|21100442|P1|STARTED|Randomized Study (Step 1)||136
8557950|NCT00088881|21100453|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
8557951|NCT00088881|21100453|P1|COMPLETED|Step 3 - Radiation Therapy||1
8557952|NCT00088881|21100453|P1|STARTED|Step 3 - Radiation Therapy||1
8557953|NCT00088881|21100453|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
8557954|NCT00088881|21100453|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
8557955|NCT00088881|21100453|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
8557956|NCT00088881|21100453|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
8557957|NCT00088881|21100453|P1|NOT COMPLETED|Step 1 - R-CHOP||14
8557958|NCT00088881|21100453|P1|COMPLETED|Step 1 - R-CHOP||48
8557959|NCT00088881|21100453|P1|Eligible and Treated|Step 1 - R-CHOP||53
8557960|NCT00088881|21100453|P1|STARTED|Step 1 - R-CHOP||62
8557961|NCT00088829|21100462|P1|NOT COMPLETED|Overall Study||22
8557962|NCT00088829|21100462|P1|COMPLETED|Overall Study||0
8557963|NCT00088829|21100462|P1|STARTED|Overall Study||22
8557964|NCT00088699|21100468|P4|NOT COMPLETED|Infusion 2||1
8557965|NCT00088699|21100469|P3|NOT COMPLETED|Infusion 2||0
8557966|NCT00088699|21100470|P2|NOT COMPLETED|Infusion 2||0
8557967|NCT00088699|21100471|P1|NOT COMPLETED|Infusion 2||0
8557968|NCT00088699|21100468|P4|COMPLETED|Infusion 2||10
8557969|NCT00088699|21100469|P3|COMPLETED|Infusion 2||11
8557970|NCT00088699|21100470|P2|COMPLETED|Infusion 2||18
8557971|NCT00088699|21100471|P1|COMPLETED|Infusion 2||19
8557972|NCT00088699|21100468|P4|STARTED|Infusion 2||11
8557973|NCT00088699|21100469|P3|STARTED|Infusion 2||11
8557974|NCT00088699|21100470|P2|STARTED|Infusion 2||18
8557975|NCT00088699|21100471|P1|STARTED|Infusion 2||19
8557976|NCT00088699|21100468|P4|NOT COMPLETED|Infusion 1||2
8557977|NCT00088699|21100469|P3|NOT COMPLETED|Infusion 1||1
8557978|NCT00088699|21100470|P2|NOT COMPLETED|Infusion 1||0
8557979|NCT00088699|21100471|P1|NOT COMPLETED|Infusion 1||1
8557980|NCT00088699|21100468|P4|COMPLETED|Infusion 1||10
8557981|NCT00088699|21100469|P3|COMPLETED|Infusion 1||12
8557982|NCT00088699|21100470|P2|COMPLETED|Infusion 1||19
8557983|NCT00088699|21100471|P1|COMPLETED|Infusion 1||22
8557984|NCT00088699|21100468|P4|STARTED|Infusion 1||12
8557985|NCT00088699|21100469|P3|STARTED|Infusion 1||13
8557986|NCT00088699|21100470|P2|STARTED|Infusion 1||19
8557987|NCT00088699|21100471|P1|STARTED|Infusion 1||23
8557988|NCT00088634|21100487|P2|NOT COMPLETED|Overall Study||43
8557989|NCT00088634|21100488|P1|NOT COMPLETED|Overall Study||38
8557990|NCT00088634|21100487|P2|COMPLETED|Overall Study||47
8557991|NCT00088634|21100488|P1|COMPLETED|Overall Study||52
8557992|NCT00088634|21100487|P2|STARTED|Overall Study||90
8557993|NCT00088634|21100488|P1|STARTED|Overall Study||90
8557994|NCT00088621|21100500|P1|NOT COMPLETED|Overall Study||54
8557995|NCT00088621|21100500|P1|COMPLETED|Overall Study||7
8557996|NCT00088621|21100500|P1|STARTED|Overall Study||61
8557997|NCT00088595|21100504|P1|NOT COMPLETED|Overall Study||28
8557998|NCT00088595|21100504|P1|COMPLETED|Overall Study||17
8557999|NCT00088595|21100504|P1|STARTED|Overall Study||45
8558000|NCT00088530|21100522|P2|NOT COMPLETED|Overall Study||54
8558001|NCT00088530|21100523|P1|NOT COMPLETED|Overall Study||50
8558002|NCT00088530|21100522|P2|COMPLETED|Overall Study||16
8558003|NCT00088530|21100523|P1|COMPLETED|Overall Study||20
8558004|NCT00088530|21100522|P2|STARTED|Overall Study||70
8558005|NCT00088530|21100523|P1|STARTED|Overall Study||70
8558006|NCT00088465|21100535|P1|NOT COMPLETED|Overall Study||561
8558007|NCT00088465|21100535|P1|COMPLETED|Overall Study||370
8558008|NCT00088465|21100535|P1|STARTED|Overall Study||931
8558009|NCT00088452|21100561|P3|NOT COMPLETED|Overall Study||1
8558010|NCT00088452|21100562|P2|NOT COMPLETED|Overall Study||0
8558011|NCT00088452|21100563|P1|NOT COMPLETED|Overall Study||1
8558012|NCT00088452|21100561|P3|COMPLETED|Overall Study||147
8558013|NCT00088452|21100562|P2|COMPLETED|Overall Study||149
8558014|NCT00088452|21100563|P1|COMPLETED|Overall Study||155
8558015|NCT00088452|21100561|P3|STARTED|Overall Study||148
8558016|NCT00088452|21100562|P2|STARTED|Overall Study||149
8558017|NCT00088452|21100563|P1|STARTED|Overall Study||156
8558018|NCT00088413|21100581|P4|NOT COMPLETED|Overall Study||14
8558019|NCT00088413|21100582|P3|NOT COMPLETED|Overall Study||12
8558020|NCT00088413|21100583|P2|NOT COMPLETED|Overall Study||15
8558021|NCT00088413|21100584|P1|NOT COMPLETED|Overall Study||10
8558022|NCT00088413|21100581|P4|COMPLETED|Overall Study||0
8558023|NCT00088413|21100582|P3|COMPLETED|Overall Study||0
8558024|NCT00088413|21100583|P2|COMPLETED|Overall Study||0
8558025|NCT00088413|21100584|P1|COMPLETED|Overall Study||0
8558026|NCT00088413|21100581|P4|STARTED|Overall Study||14
8558027|NCT00088413|21100582|P3|STARTED|Overall Study||12
8558028|NCT00088413|21100583|P2|STARTED|Overall Study||15
8558029|NCT00088413|21100584|P1|STARTED|Overall Study||10
8558030|NCT00088374|21100598|P1|NOT COMPLETED|Overall Study||2
8558031|NCT00088374|21100598|P1|COMPLETED|Overall Study||7
8558032|NCT00088374|21100598|P1|STARTED|Overall Study||9
8558033|NCT00088218|21100609|P2|NOT COMPLETED|Overall Study||0
8558034|NCT00088218|21100610|P1|NOT COMPLETED|Overall Study||0
8558035|NCT00088218|21100609|P2|COMPLETED|Overall Study||79
8558036|NCT00088218|21100610|P1|COMPLETED|Overall Study||16
8558037|NCT00088218|21100609|P2|STARTED|Overall Study||79
8558038|NCT00088218|21100610|P1|STARTED|Overall Study||16
8558039|NCT00088205|21100616|P1|NOT COMPLETED|Overall Study||60
8558040|NCT00088205|21100616|P1|COMPLETED|Overall Study||0
8558041|NCT00088205|21100616|P1|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
8558042|NCT00088205|21100616|P1|Received at Least 1 Dose of Study Drug|Overall Study||60
8558043|NCT00088205|21100616|P1|STARTED|Overall Study||60
8558044|NCT00088166|21100633|P2|NOT COMPLETED|Overall Study||61
8558045|NCT00088166|21100634|P1|NOT COMPLETED|Overall Study||53
8558046|NCT00088166|21100633|P2|COMPLETED|Overall Study||39
8558047|NCT00088166|21100634|P1|COMPLETED|Overall Study||47
8558048|NCT00088166|21100633|P2|STARTED|Overall Study||100
8558049|NCT00088166|21100634|P1|STARTED|Overall Study||100
8558050|NCT00088153|21100658|P2|NOT COMPLETED|Overall Study||25
8558051|NCT00088153|21100659|P1|NOT COMPLETED|Overall Study||24
8558052|NCT00088153|21100658|P2|COMPLETED|Overall Study||30
8558053|NCT00088153|21100659|P1|COMPLETED|Overall Study||31
8558054|NCT00088153|21100658|P2|STARTED|Overall Study||55
8558055|NCT00088153|21100659|P1|STARTED|Overall Study||55
8558056|NCT00087698|21100669|P1|NOT COMPLETED|Overall Study||36
8558057|NCT00087698|21100669|P1|COMPLETED|Overall Study||41
8558058|NCT00087698|21100669|P1|STARTED|Overall Study||77
8558059|NCT00087685|21100678|P1|NOT COMPLETED|Overall Study||14
8558060|NCT00087685|21100678|P1|COMPLETED|Overall Study||21
8558061|NCT00087685|21100678|P1|STARTED|Overall Study||35
8558062|NCT00087672|21100683|P1|NOT COMPLETED|Overall Study||0
8558063|NCT00087672|21100683|P1|COMPLETED|Overall Study||41
8558064|NCT00087672|21100683|P1|STARTED|Overall Study||41
8558065|NCT00087646|21100691|P4|NOT COMPLETED|Overall Study||84
8558066|NCT00087646|21100692|P3|NOT COMPLETED|Overall Study||65
8558067|NCT00087646|21100693|P2|NOT COMPLETED|Overall Study||42
8558068|NCT00087646|21100694|P1|NOT COMPLETED|Overall Study||135
8558069|NCT00087646|21100691|P4|COMPLETED|Overall Study||229
8558070|NCT00087646|21100692|P3|COMPLETED|Overall Study||91
8558071|NCT00087646|21100693|P2|COMPLETED|Overall Study||114
8558072|NCT00087646|21100694|P1|COMPLETED|Overall Study||182
8558073|NCT00087646|21100691|P4|STARTED|Overall Study||313
8558074|NCT00087646|21100692|P3|STARTED|Overall Study||156
8558075|NCT00087646|21100693|P2|STARTED|Overall Study||156
8558076|NCT00087646|21100694|P1|STARTED|Overall Study||317
8558077|NCT00087633|21100722|P2|NOT COMPLETED|Overall Study||17
8558078|NCT00087633|21100723|P1|NOT COMPLETED|Overall Study||24
8558079|NCT00087633|21100722|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
8558080|NCT00087633|21100723|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
8558081|NCT00087633|21100722|P2|STARTED|Overall Study|Randomized|60
8558082|NCT00087633|21100723|P1|STARTED|Overall Study|Randomized|55
8558083|NCT00087607|21100733|P2|NOT COMPLETED|Overall Study||122
8558084|NCT00087607|21100734|P1|NOT COMPLETED|Overall Study||122
8558085|NCT00087607|21100733|P2|COMPLETED|Overall Study||71
8558086|NCT00087607|21100734|P1|COMPLETED|Overall Study||70
8558087|NCT00087607|21100733|P2|STARTED|Overall Study||193
8558088|NCT00087607|21100734|P1|STARTED|Overall Study||192
8558089|NCT00087594|21100774|P2|NOT COMPLETED|Overall Study||12
8558090|NCT00087594|21100775|P1|NOT COMPLETED|Overall Study||8
8558091|NCT00087594|21100774|P2|COMPLETED|Overall Study||12
8558092|NCT00087594|21100775|P1|COMPLETED|Overall Study||16
8558093|NCT00087594|21100774|P2|STARTED|Overall Study||24
8558094|NCT00087594|21100775|P1|STARTED|Overall Study||24
8558095|NCT00087568|21100809|P2|NOT COMPLETED|Overall Study||2
8558096|NCT00087568|21100810|P1|NOT COMPLETED|Overall Study||30
8558097|NCT00087568|21100809|P2|COMPLETED|Overall Study||23
8558098|NCT00087568|21100810|P1|COMPLETED|Overall Study||2
8558099|NCT00087568|21100809|P2|STARTED|Overall Study||25
8558100|NCT00087568|21100810|P1|STARTED|Overall Study||32
8558101|NCT00087555|21100837|P3|NOT COMPLETED|Overall Study||21
8558102|NCT00087555|21100838|P2|NOT COMPLETED|Overall Study||11
8558103|NCT00087555|21100839|P1|NOT COMPLETED|Overall Study||12
8558104|NCT00087555|21100837|P3|COMPLETED|Overall Study||46
8558105|NCT00087555|21100838|P2|COMPLETED|Overall Study||51
8558106|NCT00087555|21100839|P1|COMPLETED|Overall Study||54
8558107|NCT00087555|21100837|P3|Treated|Overall Study||67
8558108|NCT00087555|21100838|P2|Treated|Overall Study||60
8558109|NCT00087555|21100839|P1|Treated|Overall Study||65
8558110|NCT00087555|21100837|P3|STARTED|Overall Study||67
8558111|NCT00087555|21100838|P2|STARTED|Overall Study||62
8558112|NCT00087555|21100839|P1|STARTED|Overall Study||66
8558113|NCT00087529|21100849|P2|NOT COMPLETED|Overall Study||68
8558114|NCT00087529|21100850|P1|NOT COMPLETED|Overall Study||31
8558115|NCT00087529|21100849|P2|COMPLETED|Overall Study||224
8558116|NCT00087529|21100850|P1|COMPLETED|Overall Study||116
8558117|NCT00087529|21100849|P2|STARTED|Overall Study||292
8558118|NCT00087529|21100850|P1|STARTED|Overall Study||147
8558119|NCT00087516|21100865|P4|NOT COMPLETED|Overall Study||85
8558120|NCT00087516|21100866|P3|NOT COMPLETED|Overall Study||97
8558121|NCT00087516|21100867|P2|NOT COMPLETED|Overall Study||169
8558122|NCT00087516|21100868|P1|NOT COMPLETED|Overall Study||161
8558123|NCT00087516|21100865|P4|COMPLETED|Overall Study||38
8558124|NCT00087516|21100866|P3|COMPLETED|Overall Study||33
8558125|NCT00087516|21100867|P2|COMPLETED|Overall Study||81
8558126|NCT00087516|21100868|P1|COMPLETED|Overall Study||77
8558127|NCT00087516|21100865|P4|STARTED|Overall Study||123
8558128|NCT00087516|21100866|P3|STARTED|Overall Study||130
8558129|NCT00087516|21100867|P2|STARTED|Overall Study||250
8558130|NCT00087516|21100868|P1|STARTED|Overall Study||238
8558131|NCT00087490|21100897|P2|NOT COMPLETED|Overall Study||269
8558132|NCT00087490|21100898|P1|NOT COMPLETED|Overall Study||258
8558133|NCT00087490|21100897|P2|COMPLETED|Overall Study||264
8558134|NCT00087490|21100898|P1|COMPLETED|Overall Study||286
8558135|NCT00087490|21100897|P2|Treated|Overall Study||515
8558136|NCT00087490|21100898|P1|Treated|Overall Study||537
8558137|NCT00087490|21100897|P2|STARTED|Overall Study||533
8558138|NCT00087490|21100898|P1|STARTED|Overall Study||544
8558139|NCT00087438|21100932|P1|NOT COMPLETED|Overall Study||4
8558140|NCT00087438|21100932|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
8558141|NCT00087438|21100932|P1|STARTED|Overall Study||59
8558142|NCT00087152|21100942|P1|NOT COMPLETED|Overall Study||6
8558143|NCT00087152|21100942|P1|COMPLETED|Overall Study||21
8558144|NCT00087152|21100942|P1|STARTED|Overall Study||27
8558145|NCT00087139|21100951|P3|NOT COMPLETED|Overall Study||36
8558146|NCT00087139|21100952|P2|NOT COMPLETED|Overall Study||49
8558147|NCT00087139|21100953|P1|NOT COMPLETED|Overall Study||39
8558148|NCT00087139|21100951|P3|COMPLETED|Overall Study||0
8558149|NCT00087139|21100952|P2|COMPLETED|Overall Study||0
8558150|NCT00087139|21100953|P1|COMPLETED|Overall Study||0
8558151|NCT00087139|21100951|P3|Patients w/ Measurable Disease Response|Overall Study||0
8558152|NCT00087139|21100952|P2|Patients w/ Measurable Disease Response|Overall Study||2
8558153|NCT00087139|21100953|P1|Patients w/ Measurable Disease Response|Overall Study||5
8558154|NCT00087139|21100951|P3|Patients With PSA Response|Overall Study||4
8558155|NCT00087139|21100952|P2|Patients With PSA Response|Overall Study||8
8558156|NCT00087139|21100953|P1|Patients With PSA Response|Overall Study||10
8558157|NCT00087139|21100951|P3|Patients With Measurable Disease|Overall Study||24
8558158|NCT00087139|21100952|P2|Patients With Measurable Disease|Overall Study||25
8558159|NCT00087139|21100953|P1|Patients With Measurable Disease|Overall Study||22
8558160|NCT00087139|21100951|P3|Patients for the Analysis of PSA Respons|Overall Study||22
8558161|NCT00087139|21100952|P2|Patients for the Analysis of PSA Respons|Overall Study||34
8558162|NCT00087139|21100953|P1|Patients for the Analysis of PSA Respons|Overall Study||30
8558163|NCT00087139|21100951|P3|Eligible and Treated|Overall Study||32
8558164|NCT00087139|21100952|P2|Eligible and Treated|Overall Study||42
8558165|NCT00087139|21100953|P1|Eligible and Treated|Overall Study||35
8558166|NCT00087139|21100951|P3|Treated|Overall Study||36
8558167|NCT00087139|21100952|P2|Treated|Overall Study||48
8558168|NCT00087139|21100953|P1|Treated|Overall Study||39
8558169|NCT00087139|21100951|P3|STARTED|Overall Study||36
8558170|NCT00087139|21100952|P2|STARTED|Overall Study||49
8558171|NCT00087139|21100953|P1|STARTED|Overall Study||39
8558172|NCT00087126|21100968|P1|NOT COMPLETED|Overall Study||2
8558173|NCT00087126|21100968|P1|COMPLETED|Overall Study||25
8558174|NCT00087126|21100968|P1|STARTED|Overall Study||27
8558175|NCT00087022|21100979|P2|NOT COMPLETED|Overall Study||55
8558176|NCT00087022|21100980|P1|NOT COMPLETED|Overall Study||54
8558177|NCT00087022|21100979|P2|COMPLETED|Overall Study||376
8558178|NCT00087022|21100980|P1|COMPLETED|Overall Study||379
8558179|NCT00087022|21100979|P2|Treated (Safety Population)|Overall Study||424
8558180|NCT00087022|21100980|P1|Treated (Safety Population)|Overall Study||431
8558181|NCT00087022|21100979|P2|STARTED|Overall Study||431
8558182|NCT00087022|21100980|P1|STARTED|Overall Study||433
8558183|NCT00086996|21100993|P1|NOT COMPLETED|Overall Study||64
8558184|NCT00086996|21100993|P1|COMPLETED|Overall Study||34
8558185|NCT00086996|21100993|P1|Eligible and Began Protocol Therapy|Overall Study||93
8558186|NCT00086996|21100993|P1|Eligible|Overall Study||93
8558187|NCT00086996|21100993|P1|STARTED|Overall Study||98
8558188|NCT00086957|21101000|P3|NOT COMPLETED|Overall Study||0
8558189|NCT00086957|21101001|P2|NOT COMPLETED|Overall Study||0
8558190|NCT00086957|21101002|P1|NOT COMPLETED|Overall Study||0
8558191|NCT00086957|21101000|P3|COMPLETED|Overall Study||22
8558192|NCT00086957|21101001|P2|COMPLETED|Overall Study||7
8558193|NCT00086957|21101002|P1|COMPLETED|Overall Study||2
8558194|NCT00086957|21101000|P3|STARTED|Overall Study||22
8558195|NCT00086957|21101001|P2|STARTED|Overall Study||7
8558196|NCT00086957|21101002|P1|STARTED|Overall Study||2
8558197|NCT00086684|21101015|P3|NOT COMPLETED|Overall Study||53
8558198|NCT00086684|21101016|P2|NOT COMPLETED|Overall Study||55
8558199|NCT00086684|21101017|P1|NOT COMPLETED|Overall Study||55
8558200|NCT00086684|21101015|P3|COMPLETED|Overall Study||69
8558201|NCT00086684|21101016|P2|COMPLETED|Overall Study||74
8558202|NCT00086684|21101017|P1|COMPLETED|Overall Study||63
8558203|NCT00086684|21101015|P3|STARTED|Overall Study||122
8558204|NCT00086684|21101016|P2|STARTED|Overall Study||129
8558205|NCT00086684|21101017|P1|STARTED|Overall Study||118
8558206|NCT00086619|21101030|P2|NOT COMPLETED|Overall Study||17
8558207|NCT00086619|21101031|P1|NOT COMPLETED|Overall Study||15
8558208|NCT00086619|21101030|P2|COMPLETED|Overall Study||23
8558209|NCT00086619|21101031|P1|COMPLETED|Overall Study||25
8558210|NCT00086619|21101030|P2|Completed 12 Month Visit|Overall Study||26
8558211|NCT00086619|21101031|P1|Completed 12 Month Visit|Overall Study||26
8558212|NCT00086619|21101030|P2|Completed Baseline Visit|Overall Study||36
8558213|NCT00086619|21101031|P1|Completed Baseline Visit|Overall Study||34
8558214|NCT00086619|21101030|P2|STARTED|Overall Study||40
8558215|NCT00086619|21101031|P1|STARTED|Overall Study||40
8558216|NCT00086580|21101041|P2|NOT COMPLETED|Observation Period||65
8558217|NCT00086580|21101042|P1|NOT COMPLETED|Observation Period||46
8558218|NCT00086580|21101041|P2|COMPLETED|Observation Period||56
8558219|NCT00086580|21101042|P1|COMPLETED|Observation Period||49
8558220|NCT00086580|21101041|P2|STARTED|Observation Period||121
8558221|NCT00086580|21101042|P1|STARTED|Observation Period||95
8558222|NCT00086580|21101041|P2|NOT COMPLETED|Follow-up Period||119
8558223|NCT00086580|21101042|P1|NOT COMPLETED|Follow-up Period||104
8558224|NCT00086580|21101041|P2|COMPLETED|Follow-up Period||18
8558225|NCT00086580|21101042|P1|COMPLETED|Follow-up Period||37
8558226|NCT00086580|21101041|P2|STARTED|Follow-up Period||137
8558227|NCT00086580|21101042|P1|STARTED|Follow-up Period||141
8558228|NCT00086580|21101041|P2|NOT COMPLETED|Treatment Period||60
8558229|NCT00086580|21101042|P1|NOT COMPLETED|Treatment Period||65
8558230|NCT00086580|21101041|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
8558231|NCT00086580|21101042|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
8558232|NCT00086580|21101041|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
8558233|NCT00086580|21101042|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
8558234|NCT00086580|21101041|P2|STARTED|Treatment Period||167
8558235|NCT00086580|21101042|P1|STARTED|Treatment Period||168
8558236|NCT00086411|21101090|P4|NOT COMPLETED|Overall Study||12
8558237|NCT00086411|21101091|P3|NOT COMPLETED|Overall Study||13
8558238|NCT00086411|21101092|P2|NOT COMPLETED|Overall Study||11
8558239|NCT00086411|21101093|P1|NOT COMPLETED|Overall Study||11
8558240|NCT00086411|21101090|P4|COMPLETED|Overall Study||53
8558241|NCT00086411|21101091|P3|COMPLETED|Overall Study||49
8558242|NCT00086411|21101092|P2|COMPLETED|Overall Study||52
8558243|NCT00086411|21101093|P1|COMPLETED|Overall Study||59
8558244|NCT00086411|21101090|P4|STARTED|Overall Study||65
8558245|NCT00086411|21101091|P3|STARTED|Overall Study||62
8558246|NCT00086411|21101092|P2|STARTED|Overall Study||63
8558247|NCT00086411|21101093|P1|STARTED|Overall Study||70
8558248|NCT00086385|21101111|P4|NOT COMPLETED|Overall Study||1
8558249|NCT00086385|21101112|P3|NOT COMPLETED|Overall Study||1
8558250|NCT00086385|21101113|P2|NOT COMPLETED|Overall Study||2
8558251|NCT00086385|21101114|P1|NOT COMPLETED|Overall Study||2
8558252|NCT00086385|21101111|P4|COMPLETED|Overall Study||98
8558253|NCT00086385|21101112|P3|COMPLETED|Overall Study||103
8558254|NCT00086385|21101113|P2|COMPLETED|Overall Study||97
8558255|NCT00086385|21101114|P1|COMPLETED|Overall Study||98
8558256|NCT00086385|21101111|P4|STARTED|Overall Study||99
8558257|NCT00086385|21101112|P3|STARTED|Overall Study||104
8558258|NCT00086385|21101113|P2|STARTED|Overall Study||99
8558259|NCT00086385|21101114|P1|STARTED|Overall Study||100
8558260|NCT00086515|21101126|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
8558261|NCT00086515|21101127|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
8558262|NCT00086515|21101126|P2|COMPLETED|Phase B (Weeks 24-104)||109
8558263|NCT00086515|21101127|P1|COMPLETED|Phase B (Weeks 24-104)||201
8558264|NCT00086515|21101126|P2|STARTED|Phase B (Weeks 24-104)||164
8558265|NCT00086515|21101127|P1|STARTED|Phase B (Weeks 24-104)||391
8558266|NCT00086515|21101126|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
8558267|NCT00086515|21101127|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
8558268|NCT00086515|21101126|P2|COMPLETED|Phase A to Phase B Transition Period||164
8558269|NCT00086515|21101127|P1|COMPLETED|Phase A to Phase B Transition Period||391
8558270|NCT00086515|21101126|P2|STARTED|Phase A to Phase B Transition Period||192
8558271|NCT00086515|21101127|P1|STARTED|Phase A to Phase B Transition Period||415
8558272|NCT00086515|21101126|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
8558273|NCT00086515|21101127|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
8558274|NCT00086515|21101126|P2|COMPLETED|Phase A (Weeks 0-24)||192
8558275|NCT00086515|21101127|P1|COMPLETED|Phase A (Weeks 0-24)||415
8558276|NCT00086515|21101126|P2|STARTED|Phase A (Weeks 0-24)||237
8558277|NCT00086515|21101127|P1|STARTED|Phase A (Weeks 0-24)||464
8558278|NCT00086502|21101139|P2|NOT COMPLETED|Overall Study||20
8558279|NCT00086502|21101140|P1|NOT COMPLETED|Overall Study||26
8558280|NCT00086502|21101139|P2|COMPLETED|Overall Study||158
8558281|NCT00086502|21101140|P1|COMPLETED|Overall Study||149
8558282|NCT00086502|21101139|P2|STARTED|Overall Study||178
8558283|NCT00086502|21101140|P1|STARTED|Overall Study||175
8558284|NCT00086450|21101150|P2|NOT COMPLETED|Overall Study||0
8558285|NCT00086450|21101151|P1|NOT COMPLETED|Overall Study||0
8558286|NCT00086450|21101150|P2|COMPLETED|Overall Study||947
8558287|NCT00086450|21101151|P1|COMPLETED|Overall Study||953
8558288|NCT00086450|21101150|P2|STARTED|Overall Study||947
8558289|NCT00086450|21101151|P1|STARTED|Overall Study||953
8558290|NCT00086346|21101165|P2|NOT COMPLETED|Patients Dosed With Test Article||23
8558291|NCT00086346|21101166|P1|NOT COMPLETED|Patients Dosed With Test Article||140
8558292|NCT00086346|21101165|P2|COMPLETED|Patients Dosed With Test Article||187
8558293|NCT00086346|21101166|P1|COMPLETED|Patients Dosed With Test Article||249
8558294|NCT00086346|21101165|P2|STARTED|Patients Dosed With Test Article||210
8558295|NCT00086346|21101166|P1|STARTED|Patients Dosed With Test Article||389
8558296|NCT00086346|21101165|P2|NOT COMPLETED|Randomization||4
8558297|NCT00086346|21101166|P1|NOT COMPLETED|Randomization||4
8558298|NCT00086346|21101165|P2|COMPLETED|Randomization||210
8558299|NCT00086346|21101166|P1|COMPLETED|Randomization||389
8558300|NCT00086346|21101165|P2|STARTED|Randomization||214
8558301|NCT00086346|21101166|P1|STARTED|Randomization||393
8558302|NCT00086281|21101193|P15|NOT COMPLETED|Phase 2||0
8558303|NCT00086281|21101194|P14|NOT COMPLETED|Phase 2||1
8558304|NCT00086281|21101195|P13|NOT COMPLETED|Phase 2||1
8558305|NCT00086281|21101196|P12|NOT COMPLETED|Phase 2||0
8558306|NCT00086281|21101197|P11|NOT COMPLETED|Phase 2||0
8558307|NCT00086281|21101198|P10|NOT COMPLETED|Phase 2||0
8558308|NCT00086281|21101199|P9|NOT COMPLETED|Phase 2||0
8558309|NCT00086281|21101200|P8|NOT COMPLETED|Phase 2||0
8558310|NCT00086281|21101201|P7|NOT COMPLETED|Phase 2||0
8558311|NCT00086281|21101202|P6|NOT COMPLETED|Phase 2||0
8558312|NCT00086281|21101203|P5|NOT COMPLETED|Phase 2||0
8558313|NCT00086281|21101204|P4|NOT COMPLETED|Phase 2||0
8558314|NCT00086281|21101205|P3|NOT COMPLETED|Phase 2||0
8558315|NCT00086281|21101206|P2|NOT COMPLETED|Phase 2||0
8558316|NCT00086281|21101207|P1|NOT COMPLETED|Phase 2||0
8558317|NCT00086281|21101193|P15|COMPLETED|Phase 2||0
8558318|NCT00086281|21101194|P14|COMPLETED|Phase 2||26
8558319|NCT00086281|21101195|P13|COMPLETED|Phase 2||22
8558320|NCT00086281|21101196|P12|COMPLETED|Phase 2||0
8558321|NCT00086281|21101197|P11|COMPLETED|Phase 2||0
8558322|NCT00086281|21101198|P10|COMPLETED|Phase 2||0
8558323|NCT00086281|21101199|P9|COMPLETED|Phase 2||0
8558324|NCT00086281|21101200|P8|COMPLETED|Phase 2||0
8558325|NCT00086281|21101201|P7|COMPLETED|Phase 2||0
8558326|NCT00086281|21101202|P6|COMPLETED|Phase 2||0
8558327|NCT00086281|21101203|P5|COMPLETED|Phase 2||0
8558328|NCT00086281|21101204|P4|COMPLETED|Phase 2||0
8558329|NCT00086281|21101205|P3|COMPLETED|Phase 2||0
8558330|NCT00086281|21101206|P2|COMPLETED|Phase 2||0
8558331|NCT00086281|21101207|P1|COMPLETED|Phase 2||0
8558332|NCT00086281|21101193|P15|STARTED|Phase 2||0
8558333|NCT00086281|21101194|P14|STARTED|Phase 2||27
8558334|NCT00086281|21101195|P13|STARTED|Phase 2||23
8558335|NCT00086281|21101196|P12|STARTED|Phase 2||0
8558336|NCT00086281|21101197|P11|STARTED|Phase 2||0
8558337|NCT00086281|21101198|P10|STARTED|Phase 2||0
8558338|NCT00086281|21101199|P9|STARTED|Phase 2||0
8558339|NCT00086281|21101200|P8|STARTED|Phase 2||0
8558340|NCT00086281|21101201|P7|STARTED|Phase 2||0
8558341|NCT00086281|21101202|P6|STARTED|Phase 2||0
8558342|NCT00086281|21101203|P5|STARTED|Phase 2||0
8558343|NCT00086281|21101204|P4|STARTED|Phase 2||0
8558344|NCT00086281|21101205|P3|STARTED|Phase 2||0
8558345|NCT00086281|21101206|P2|STARTED|Phase 2||0
8558346|NCT00086281|21101207|P1|STARTED|Phase 2||0
8558347|NCT00086281|21101193|P15|NOT COMPLETED|Phase 1||3
8558348|NCT00086281|21101194|P14|NOT COMPLETED|Phase 1||1
8558349|NCT00086281|21101195|P13|NOT COMPLETED|Phase 1||1
8558350|NCT00086281|21101196|P12|NOT COMPLETED|Phase 1||1
8558351|NCT00086281|21101197|P11|NOT COMPLETED|Phase 1||3
8558352|NCT00086281|21101198|P10|NOT COMPLETED|Phase 1||1
8558353|NCT00086281|21101199|P9|NOT COMPLETED|Phase 1||0
8558354|NCT00086281|21101200|P8|NOT COMPLETED|Phase 1||0
8558355|NCT00086281|21101201|P7|NOT COMPLETED|Phase 1||0
8558356|NCT00086281|21101202|P6|NOT COMPLETED|Phase 1||0
8558357|NCT00086281|21101203|P5|NOT COMPLETED|Phase 1||0
8558358|NCT00086281|21101204|P4|NOT COMPLETED|Phase 1||0
8558359|NCT00086281|21101205|P3|NOT COMPLETED|Phase 1||0
8558360|NCT00086281|21101206|P2|NOT COMPLETED|Phase 1||0
8558361|NCT00086281|21101207|P1|NOT COMPLETED|Phase 1||0
8558362|NCT00086281|21101193|P15|COMPLETED|Phase 1||0
8558363|NCT00086281|21101194|P14|COMPLETED|Phase 1||0
8558364|NCT00086281|21101195|P13|COMPLETED|Phase 1||0
8558365|NCT00086281|21101196|P12|COMPLETED|Phase 1||0
8558366|NCT00086281|21101197|P11|COMPLETED|Phase 1||0
8558367|NCT00086281|21101198|P10|COMPLETED|Phase 1||0
8558368|NCT00086281|21101199|P9|COMPLETED|Phase 1||2
8558369|NCT00086281|21101200|P8|COMPLETED|Phase 1||1
8558370|NCT00086281|21101201|P7|COMPLETED|Phase 1||1
8558371|NCT00086281|21101202|P6|COMPLETED|Phase 1||3
8558372|NCT00086281|21101203|P5|COMPLETED|Phase 1||1
8558373|NCT00086281|21101204|P4|COMPLETED|Phase 1||11
8558374|NCT00086281|21101205|P3|COMPLETED|Phase 1||8
8558375|NCT00086281|21101206|P2|COMPLETED|Phase 1||12
8558376|NCT00086281|21101207|P1|COMPLETED|Phase 1||11
8558377|NCT00086281|21101193|P15|STARTED|Phase 1||3
8558378|NCT00086281|21101194|P14|STARTED|Phase 1||1
8558379|NCT00086281|21101195|P13|STARTED|Phase 1||1
8558380|NCT00086281|21101196|P12|STARTED|Phase 1||1
8558381|NCT00086281|21101197|P11|STARTED|Phase 1||3
8558382|NCT00086281|21101198|P10|STARTED|Phase 1||1
8558383|NCT00086281|21101199|P9|STARTED|Phase 1||2
8558384|NCT00086281|21101200|P8|STARTED|Phase 1||1
8558385|NCT00086281|21101201|P7|STARTED|Phase 1||1
8558386|NCT00086281|21101202|P6|STARTED|Phase 1||3
8558387|NCT00086281|21101203|P5|STARTED|Phase 1||1
8558388|NCT00086281|21101204|P4|STARTED|Phase 1||11
8558389|NCT00086281|21101205|P3|STARTED|Phase 1||8
8558390|NCT00086281|21101206|P2|STARTED|Phase 1||12
8558391|NCT00086281|21101207|P1|STARTED|Phase 1||11
8558392|NCT00086307|21101220|P3|NOT COMPLETED|Overall Study||8
8558393|NCT00086307|21101221|P2|NOT COMPLETED|Overall Study||1
8558394|NCT00086307|21101222|P1|NOT COMPLETED|Overall Study||2
8558395|NCT00086307|21101220|P3|COMPLETED|Overall Study||5
8558396|NCT00086307|21101221|P2|COMPLETED|Overall Study||12
8558397|NCT00086307|21101222|P1|COMPLETED|Overall Study||11
8558398|NCT00086307|21101220|P3|STARTED|Overall Study||13
8558399|NCT00086307|21101221|P2|STARTED|Overall Study||13
8558400|NCT00086307|21101222|P1|STARTED|Overall Study||13
8558401|NCT00086190|21101233|P3|NOT COMPLETED|Overall Study||6
8558402|NCT00086190|21101234|P2|NOT COMPLETED|Overall Study||4
8558403|NCT00086190|21101235|P1|NOT COMPLETED|Overall Study||8
8558404|NCT00086190|21101233|P3|COMPLETED|Overall Study||33
8558405|NCT00086190|21101234|P2|COMPLETED|Overall Study||30
8558406|NCT00086190|21101235|P1|COMPLETED|Overall Study||34
8558407|NCT00086190|21101233|P3|STARTED|Overall Study||39
8558408|NCT00086190|21101234|P2|STARTED|Overall Study||34
8558409|NCT00086190|21101235|P1|STARTED|Overall Study||42
8558410|NCT00086138|21101293|P2|NOT COMPLETED|Overall Study||3
8558411|NCT00086138|21101294|P1|NOT COMPLETED|Overall Study||4
8558412|NCT00086138|21101293|P2|COMPLETED|Overall Study||64
8558413|NCT00086138|21101294|P1|COMPLETED|Overall Study||60
8558414|NCT00086138|21101293|P2|STARTED|Overall Study||67
8558415|NCT00086138|21101294|P1|STARTED|Overall Study||64
8558416|NCT00086047|21101304|P2|NOT COMPLETED|Overall Study||7
8558417|NCT00086047|21101305|P1|NOT COMPLETED|Overall Study||7
8558418|NCT00086047|21101304|P2|COMPLETED|Overall Study||50
8558419|NCT00086047|21101305|P1|COMPLETED|Overall Study||50
8558420|NCT00086047|21101304|P2|STARTED|Overall Study||57
8558421|NCT00086047|21101305|P1|STARTED|Overall Study||57
8558422|NCT00085917|21101313|P2|NOT COMPLETED|Overall Study||3
8558423|NCT00085917|21101314|P1|NOT COMPLETED|Overall Study||4
8558424|NCT00085917|21101313|P2|COMPLETED|Overall Study||11
8558425|NCT00085917|21101314|P1|COMPLETED|Overall Study||11
8558426|NCT00085917|21101313|P2|STARTED|Overall Study||14
8558427|NCT00085917|21101314|P1|STARTED|Overall Study||15
8558428|NCT00085839|21101326|P2|NOT COMPLETED|Overall Study||0
8558429|NCT00085839|21101327|P1|NOT COMPLETED|Overall Study||0
8558430|NCT00085839|21101326|P2|COMPLETED|Overall Study||51
8558431|NCT00085839|21101327|P1|COMPLETED|Overall Study||52
8558432|NCT00085839|21101326|P2|STARTED|Overall Study||51
8558433|NCT00085839|21101327|P1|STARTED|Overall Study||52
8558452|NCT00085709|21101403|P2|NOT COMPLETED|Overall Study||50
8558453|NCT00085709|21101404|P1|NOT COMPLETED|Overall Study||53
8558454|NCT00085709|21101403|P2|COMPLETED|Overall Study||270
8558455|NCT00085709|21101404|P1|COMPLETED|Overall Study||264
8558456|NCT00085709|21101403|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
8558457|NCT00085709|21101404|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
8558458|NCT00085709|21101403|P2|Eligible|Overall Study||301
8558459|NCT00085709|21101404|P1|Eligible|Overall Study||298
8558460|NCT00085709|21101403|P2|STARTED|Overall Study||320
8558461|NCT00085709|21101404|P1|STARTED|Overall Study||317
8558462|NCT00085644|21101420|P3|NOT COMPLETED|Open-Label Period||109
8558463|NCT00085644|21101421|P2|NOT COMPLETED|Open-Label Period||0
8558464|NCT00085644|21101422|P1|NOT COMPLETED|Open-Label Period||0
8558465|NCT00085644|21101420|P3|COMPLETED|Open-Label Period||202
8558466|NCT00085644|21101421|P2|COMPLETED|Open-Label Period||0
8558467|NCT00085644|21101422|P1|COMPLETED|Open-Label Period||0
8558468|NCT00085644|21101420|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
8558469|NCT00085644|21101421|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
8558470|NCT00085644|21101422|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
8558471|NCT00085644|21101420|P3|NOT COMPLETED|Double-Blind Period||0
8558472|NCT00085644|21101421|P2|NOT COMPLETED|Double-Blind Period||6
8558473|NCT00085644|21101422|P1|NOT COMPLETED|Double-Blind Period||13
8558474|NCT00085644|21101420|P3|COMPLETED|Double-Blind Period||0
8558475|NCT00085644|21101421|P2|COMPLETED|Double-Blind Period||101
8558476|NCT00085644|21101422|P1|COMPLETED|Double-Blind Period||195
8558477|NCT00085644|21101420|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
8558478|NCT00085644|21101421|P2|STARTED|Double-Blind Period||107
8558479|NCT00085644|21101422|P1|STARTED|Double-Blind Period||208
8558480|NCT00085631|21101463|P3|NOT COMPLETED|Overall Study||7
8558481|NCT00085631|21101464|P2|NOT COMPLETED|Overall Study||11
8558482|NCT00085631|21101465|P1|NOT COMPLETED|Overall Study||4
8558483|NCT00085631|21101463|P3|COMPLETED|Overall Study||32
8558484|NCT00085631|21101464|P2|COMPLETED|Overall Study||38
8558485|NCT00085631|21101465|P1|COMPLETED|Overall Study||9
8558486|NCT00085631|21101463|P3|STARTED|Overall Study||39
8558487|NCT00085631|21101464|P2|STARTED|Overall Study||49
8558488|NCT00085631|21101465|P1|STARTED|Overall Study||13
8558489|NCT00085566|21101475|P3|NOT COMPLETED|Overall Study||14
8558490|NCT00085566|21101476|P2|NOT COMPLETED|Overall Study||0
8558491|NCT00085566|21101477|P1|NOT COMPLETED|Overall Study||0
8558492|NCT00085566|21101475|P3|COMPLETED|Overall Study||43
8558493|NCT00085566|21101476|P2|COMPLETED|Overall Study||3
8558494|NCT00085566|21101477|P1|COMPLETED|Overall Study||3
8558495|NCT00085566|21101475|P3|STARTED|Overall Study||57
8558496|NCT00085566|21101476|P2|STARTED|Overall Study||3
8558497|NCT00085566|21101477|P1|STARTED|Overall Study||3
8558498|NCT00085540|21101487|P2|NOT COMPLETED|Overall Study||2
8558499|NCT00085540|21101488|P1|NOT COMPLETED|Overall Study||0
8558500|NCT00085540|21101487|P2|COMPLETED|Overall Study||40
8558501|NCT00085540|21101488|P1|COMPLETED|Overall Study||8
8558502|NCT00085540|21101487|P2|STARTED|Overall Study||42
8558503|NCT00085540|21101488|P1|STARTED|Overall Study||8
8558504|NCT00085436|21101495|P1|NOT COMPLETED|Overall Study||0
8558505|NCT00085436|21101495|P1|COMPLETED|Overall Study||18
8558506|NCT00085436|21101495|P1|STARTED|Overall Study||18
8558507|NCT00085423|21101500|P1|NOT COMPLETED|Overall Study||2
8558508|NCT00085423|21101500|P1|COMPLETED|Overall Study||18
8558509|NCT00085423|21101500|P1|STARTED|Overall Study||20
8558510|NCT00085410|21101506|P1|NOT COMPLETED|Overall Study||0
8558511|NCT00085410|21101506|P1|COMPLETED|Overall Study||20
8558512|NCT00085410|21101506|P1|STARTED|Overall Study||20
8558513|NCT00085293|21101520|P1|NOT COMPLETED|Overall Study||0
8558514|NCT00085293|21101520|P1|COMPLETED|Overall Study||12
8558515|NCT00085293|21101520|P1|STARTED|Overall Study||12
8558516|NCT00085254|21101533|P3|NOT COMPLETED|Overall Study||0
8558517|NCT00085254|21101534|P2|NOT COMPLETED|Overall Study||0
8558518|NCT00085254|21101535|P1|NOT COMPLETED|Overall Study||0
8558519|NCT00085254|21101533|P3|COMPLETED|Overall Study||48
8558520|NCT00085254|21101534|P2|COMPLETED|Overall Study||46
8558521|NCT00085254|21101535|P1|COMPLETED|Overall Study||18
8558522|NCT00085254|21101533|P3|STARTED|Overall Study||48
8558523|NCT00085254|21101534|P2|STARTED|Overall Study||46
8558524|NCT00085254|21101535|P1|STARTED|Overall Study||18
8558525|NCT00085202|21101551|P2|NOT COMPLETED|Overall Study||24
8558526|NCT00085202|21101552|P1|NOT COMPLETED|Overall Study||18
8558527|NCT00085202|21101551|P2|COMPLETED|Overall Study||120
8558528|NCT00085202|21101552|P1|COMPLETED|Overall Study||251
8558529|NCT00085202|21101551|P2|STARTED|Overall Study||144
8558530|NCT00085202|21101552|P1|STARTED|Overall Study||269
8558531|NCT00085098|21101573|P2|NOT COMPLETED|Overall Study||2
8558532|NCT00085098|21101574|P1|NOT COMPLETED|Overall Study||1
8558533|NCT00085098|21101573|P2|COMPLETED|Overall Study||11
8558534|NCT00085098|21101574|P1|COMPLETED|Overall Study||10
8558535|NCT00085098|21101573|P2|STARTED|Overall Study||13
8558536|NCT00085098|21101574|P1|STARTED|Overall Study||11
8558537|NCT00084929|21101584|P1|NOT COMPLETED|Overall Study||69
8558538|NCT00084929|21101584|P1|COMPLETED|Overall Study||2531
8558539|NCT00084929|21101584|P1|STARTED|Overall Study||2600
8558540|NCT00084864|21101606|P4|NOT COMPLETED|Overall Study||0
8558541|NCT00084864|21101607|P3|NOT COMPLETED|Overall Study||0
8558542|NCT00084864|21101608|P2|NOT COMPLETED|Overall Study||0
8558543|NCT00084864|21101609|P1|NOT COMPLETED|Overall Study||1
8558544|NCT00084864|21101606|P4|COMPLETED|Overall Study||4
8558545|NCT00084864|21101607|P3|COMPLETED|Overall Study||4
8558546|NCT00084864|21101608|P2|COMPLETED|Overall Study||7
8558547|NCT00084864|21101609|P1|COMPLETED|Overall Study||9
8558548|NCT00084864|21101606|P4|STARTED|Overall Study||4
8558549|NCT00084864|21101607|P3|STARTED|Overall Study||4
8558550|NCT00084864|21101608|P2|STARTED|Overall Study||7
8558551|NCT00084864|21101609|P1|STARTED|Overall Study||10
8558552|NCT00084838|21101635|P1|NOT COMPLETED|Overall Study||13
8558553|NCT00084838|21101635|P1|COMPLETED|Overall Study||12
8558554|NCT00084838|21101635|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
8558555|NCT00084838|21101635|P1|STARTED|Overall Study||25
8558556|NCT00084747|21101657|P1|NOT COMPLETED|Overall Study||13
8558557|NCT00084747|21101657|P1|COMPLETED|Overall Study||17
8558558|NCT00084747|21101657|P1|STARTED|Overall Study||30
8558559|NCT00084682|21101662|P1|NOT COMPLETED|Overall Study||1
8558560|NCT00084682|21101662|P1|COMPLETED|Overall Study||13
8558561|NCT00084682|21101662|P1|STARTED|Overall Study||14
8558562|NCT00084617|21101666|P1|NOT COMPLETED|Overall Study||9
8558563|NCT00084617|21101666|P1|COMPLETED|Overall Study||30
8558564|NCT00084617|21101666|P1|STARTED|Overall Study||39
8558565|NCT00084487|21101672|P1|NOT COMPLETED|Overall Study||1
8558566|NCT00084487|21101672|P1|COMPLETED|Overall Study||20
8558567|NCT00084487|21101672|P1|STARTED|Overall Study||21
8558568|NCT00084409|21101682|P2|NOT COMPLETED|Overall Study||12
8558569|NCT00084409|21101683|P1|NOT COMPLETED|Overall Study||15
8558570|NCT00084409|21101682|P2|COMPLETED|Overall Study|4 Current, 8 former|65
8558571|NCT00084409|21101683|P1|COMPLETED|Overall Study|9 current, 6 former|60
8558572|NCT00084409|21101682|P2|STARTED|Overall Study|41 current, 36 former|77
8558573|NCT00084409|21101683|P1|STARTED|Overall Study|40 Current, 35 former|75
8558574|NCT00084383|21101709|P1|NOT COMPLETED|Overall Study||47
8558575|NCT00084383|21101709|P1|COMPLETED|Overall Study||13
8558576|NCT00084383|21101709|P1|STARTED|Overall Study||60
8558577|NCT00084318|21101716|P2|NOT COMPLETED|Overall Study||13
8558578|NCT00084318|21101717|P1|NOT COMPLETED|Overall Study||22
8558579|NCT00084318|21101716|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
8558580|NCT00084318|21101717|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
8558581|NCT00084318|21101716|P2|STARTED|Overall Study||119
8558582|NCT00084318|21101717|P1|STARTED|Overall Study||119
8558583|NCT00084266|21101737|P2|NOT COMPLETED|Overall Study||423
8558584|NCT00084266|21101738|P1|NOT COMPLETED|Overall Study||441
8558585|NCT00084266|21101737|P2|COMPLETED|Overall Study||184
8558586|NCT00084266|21101738|P1|COMPLETED|Overall Study||177
8558587|NCT00084266|21101737|P2|Treated|Overall Study||587
8558588|NCT00084266|21101738|P1|Treated|Overall Study||597
8558589|NCT00084266|21101737|P2|STARTED|Overall Study||607
8558590|NCT00084266|21101738|P1|STARTED|Overall Study||618
8558591|NCT00084149|21101774|P2|NOT COMPLETED|Overall Study||5
8558592|NCT00084149|21101775|P1|NOT COMPLETED|Overall Study||8
8558593|NCT00084149|21101774|P2|COMPLETED|Overall Study||13
8558594|NCT00084149|21101775|P1|COMPLETED|Overall Study||28
8558595|NCT00084149|21101774|P2|STARTED|Overall Study||18
8558596|NCT00084149|21101775|P1|STARTED|Overall Study||36
8558597|NCT00084136|21101796|P3|NOT COMPLETED|NRTI Comparison||82
8558598|NCT00084136|21101797|P2|NOT COMPLETED|NRTI Comparison||0
8558599|NCT00084136|21101798|P1|NOT COMPLETED|NRTI Comparison||101
8558600|NCT00084136|21101796|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
8558601|NCT00084136|21101797|P2|COMPLETED|NRTI Comparison||0
8558602|NCT00084136|21101798|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
8558603|NCT00084136|21101796|P3|STARTED|NRTI Comparison||526
8558604|NCT00084136|21101797|P2|STARTED|NRTI Comparison||0
8558605|NCT00084136|21101798|P1|STARTED|NRTI Comparison||519
8558606|NCT00084136|21101796|P3|NOT COMPLETED|PI Comparison||0
8558607|NCT00084136|21101797|P2|NOT COMPLETED|PI Comparison||47
8558608|NCT00084136|21101798|P1|NOT COMPLETED|PI Comparison||55
8558609|NCT00084136|21101796|P3|COMPLETED|PI Comparison||0
8558610|NCT00084136|21101797|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
8558611|NCT00084136|21101798|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
8558612|NCT00084136|21101796|P3|STARTED|PI Comparison||0
8558613|NCT00084136|21101797|P2|STARTED|PI Comparison||526
8558614|NCT00084136|21101798|P1|STARTED|PI Comparison||519
8558615|NCT00084084|21101857|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
8558616|NCT00084084|21101857|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
8558617|NCT00084084|21101857|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
8558618|NCT00084084|21101857|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
8558619|NCT00084084|21101857|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
8558620|NCT00084084|21101857|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
8558621|NCT00083915|21101867|P2|NOT COMPLETED|Overall Study||37
8558622|NCT00083915|21101868|P1|NOT COMPLETED|Overall Study||50
8558623|NCT00083915|21101867|P2|COMPLETED|Overall Study||8
8558624|NCT00083915|21101868|P1|COMPLETED|Overall Study||2
8558625|NCT00083915|21101867|P2|STARTED|Overall Study||45
8558626|NCT00083915|21101868|P1|STARTED|Overall Study||52
8558627|NCT00083889|21101876|P2|NOT COMPLETED|Overall Study||375
8558628|NCT00083889|21101877|P1|NOT COMPLETED|Overall Study||375
8558629|NCT00083889|21101876|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
8558630|NCT00083889|21101877|P1|COMPLETED|Overall Study||0
8558798|NCT00082017|21102222|P2|COMPLETED|Overall Study||9
8558631|NCT00083889|21101876|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
8558632|NCT00083889|21101877|P1|Received Treatment|Overall Study||375
8558633|NCT00083889|21101876|P2|STARTED|Overall Study||375
8558634|NCT00083889|21101877|P1|STARTED|Overall Study||375
8558635|NCT00004146|21101926|P1|NOT COMPLETED|Overall Study||0
8558636|NCT00004146|21101926|P1|COMPLETED|Overall Study||55
8558637|NCT00004146|21101926|P1|STARTED|Overall Study||55
8558638|NCT00083759|21101935|P2|NOT COMPLETED|Overall Study||83
8558639|NCT00083759|21101936|P1|NOT COMPLETED|Overall Study||84
8558640|NCT00083759|21101935|P2|COMPLETED|Overall Study||66
8558641|NCT00083759|21101936|P1|COMPLETED|Overall Study||66
8558642|NCT00083759|21101935|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
8558643|NCT00083759|21101936|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
8558644|NCT00083720|21101944|P1|NOT COMPLETED|Overall Study||0
8558645|NCT00083720|21101944|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
8558646|NCT00083720|21101944|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
8558647|NCT00083616|21101954|P1|NOT COMPLETED|Overall Study||31
8558648|NCT00083616|21101954|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
8558649|NCT00083616|21101954|P1|Received Study Medication|Overall Study||182
8558650|NCT00083616|21101954|P1|STARTED|Overall Study||185
8558651|NCT00083551|21101968|P2|NOT COMPLETED|Overall Study||0
8558652|NCT00083551|21101969|P1|NOT COMPLETED|Overall Study||0
8558653|NCT00083551|21101968|P2|COMPLETED|Overall Study||345
8558654|NCT00083551|21101969|P1|COMPLETED|Overall Study||323
8558655|NCT00083551|21101968|P2|STARTED|Overall Study||345
8558656|NCT00083551|21101969|P1|STARTED|Overall Study||323
8558657|NCT00083382|21101975|P1|NOT COMPLETED|Overall Study||0
8558658|NCT00083382|21101975|P1|COMPLETED|Overall Study||83
8558659|NCT00083382|21101975|P1|STARTED|Overall Study||83
8558660|NCT00082888|21101982|P3|NOT COMPLETED|Overall Study||0
8558661|NCT00082888|21101983|P2|NOT COMPLETED|Overall Study||0
8558662|NCT00082888|21101984|P1|NOT COMPLETED|Overall Study||1
8558663|NCT00082888|21101982|P3|COMPLETED|Overall Study||36
8558664|NCT00082888|21101983|P2|COMPLETED|Overall Study||15
8558665|NCT00082888|21101984|P1|COMPLETED|Overall Study||41
8558666|NCT00082888|21101982|P3|STARTED|Overall Study||36
8558667|NCT00082888|21101983|P2|STARTED|Overall Study||15
8558668|NCT00082888|21101984|P1|STARTED|Overall Study||42
8558669|NCT00082810|21102004|P1|NOT COMPLETED|Overall Study||31
8558670|NCT00082810|21102004|P1|COMPLETED|Overall Study||2
8558671|NCT00082810|21102004|P1|STARTED|Overall Study||33
8558672|NCT00082758|21102015|P3|NOT COMPLETED|Overall Study||0
8558673|NCT00082758|21102016|P2|NOT COMPLETED|Overall Study||17
8558674|NCT00082758|21102017|P1|NOT COMPLETED|Overall Study||15
8558675|NCT00082758|21102015|P3|COMPLETED|Overall Study||0
8558676|NCT00082758|21102016|P2|COMPLETED|Overall Study||7
8558677|NCT00082758|21102017|P1|COMPLETED|Overall Study||0
8558678|NCT00082758|21102015|P3|STARTED|Overall Study||0
8558679|NCT00082758|21102016|P2|STARTED|Overall Study||24
8558680|NCT00082758|21102017|P1|STARTED|Overall Study||15
8558681|NCT00082641|21102027|P2|NOT COMPLETED|Overall Study||0
8558682|NCT00082641|21102028|P1|NOT COMPLETED|Overall Study||0
8558683|NCT00082641|21102027|P2|COMPLETED|Overall Study||12
8558684|NCT00082641|21102028|P1|COMPLETED|Overall Study||11
8558685|NCT00082641|21102027|P2|STARTED|Overall Study||12
8558686|NCT00082641|21102028|P1|STARTED|Overall Study||11
8558687|NCT00083226|21102037|P1|NOT COMPLETED|Overall Study||42
8558688|NCT00083226|21102037|P1|COMPLETED|Overall Study||0
8558689|NCT00083226|21102037|P1|STARTED|Overall Study||42
8558690|NCT00083174|21102045|P3|NOT COMPLETED|Open-label Extension||0
8558691|NCT00083174|21102046|P2|NOT COMPLETED|Open-label Extension||0
8558692|NCT00083174|21102047|P1|NOT COMPLETED|Open-label Extension||0
8558693|NCT00083174|21102045|P3|COMPLETED|Open-label Extension||2831
8558694|NCT00083174|21102046|P2|COMPLETED|Open-label Extension||0
8558695|NCT00083174|21102047|P1|COMPLETED|Open-label Extension||0
8558696|NCT00083174|21102045|P3|STARTED|Open-label Extension||2831
8558697|NCT00083174|21102046|P2|STARTED|Open-label Extension||0
8558698|NCT00083174|21102047|P1|STARTED|Open-label Extension||0
8558699|NCT00083174|21102045|P3|NOT COMPLETED|Randomization Period||0
8558700|NCT00083174|21102046|P2|NOT COMPLETED|Randomization Period||0
8558701|NCT00083174|21102047|P1|NOT COMPLETED|Randomization Period||0
8558702|NCT00083174|21102045|P3|COMPLETED|Randomization Period||0
8558703|NCT00083174|21102046|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
8558704|NCT00083174|21102047|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
8558705|NCT00083174|21102045|P3|STARTED|Randomization Period||0
8558706|NCT00083174|21102046|P2|STARTED|Randomization Period||2275
8558707|NCT00083174|21102047|P1|STARTED|Randomization Period||2285
8558708|NCT00083122|21102069|P2|NOT COMPLETED|Overall Study||0
8558709|NCT00083122|21102070|P1|NOT COMPLETED|Overall Study||0
8558710|NCT00083122|21102069|P2|COMPLETED|Overall Study||5
8558711|NCT00083122|21102070|P1|COMPLETED|Overall Study||40
8558712|NCT00083122|21102069|P2|STARTED|Overall Study||5
8558713|NCT00083122|21102070|P1|STARTED|Overall Study||40
8558714|NCT00082628|21102081|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
8558715|NCT00082628|21102082|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
8558716|NCT00082628|21102083|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
8558717|NCT00082628|21102084|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558718|NCT00082628|21102085|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558719|NCT00082628|21102081|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
8558720|NCT00082628|21102082|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
8558721|NCT00082628|21102083|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
8558722|NCT00082628|21102084|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558723|NCT00082628|21102085|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558724|NCT00082628|21102081|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
8558725|NCT00082628|21102082|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
8558726|NCT00082628|21102083|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
8558727|NCT00082628|21102084|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
8558728|NCT00082628|21102085|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
8558729|NCT00082628|21102081|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558730|NCT00082628|21102082|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558731|NCT00082628|21102083|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558732|NCT00082628|21102084|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
8558733|NCT00082628|21102085|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
8558734|NCT00082628|21102081|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558735|NCT00082628|21102082|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558736|NCT00082628|21102083|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558737|NCT00082628|21102084|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
8558738|NCT00082628|21102085|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
8558739|NCT00082628|21102081|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
8558740|NCT00082628|21102082|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
8558741|NCT00082628|21102083|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
8558742|NCT00082628|21102084|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
8558743|NCT00082628|21102085|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
8558744|NCT00082433|21102105|P2|NOT COMPLETED|Overall Study||597
8558745|NCT00082433|21102106|P1|NOT COMPLETED|Overall Study||594
8558746|NCT00082433|21102105|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
8558747|NCT00082433|21102106|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
8558748|NCT00082433|21102105|P2|STARTED|Overall Study||612
8558749|NCT00082433|21102106|P1|STARTED|Overall Study||609
8558750|NCT00082381|21102126|P2|NOT COMPLETED|Overall Study||26
8558751|NCT00082381|21102127|P1|NOT COMPLETED|Overall Study||55
8558752|NCT00082381|21102126|P2|COMPLETED|Overall Study||242
8558753|NCT00082381|21102127|P1|COMPLETED|Overall Study||228
8558754|NCT00082381|21102126|P2|Received Treatment (Intent to Treat)|Overall Study||267
8558755|NCT00082381|21102127|P1|Received Treatment (Intent to Treat)|Overall Study||282
8558756|NCT00082381|21102126|P2|STARTED|Overall Study||268
8558757|NCT00082381|21102127|P1|STARTED|Overall Study||283
8558758|NCT00082407|21102147|P2|NOT COMPLETED|Overall Study||27
8558759|NCT00082407|21102148|P1|NOT COMPLETED|Overall Study||56
8558760|NCT00082407|21102147|P2|COMPLETED|Overall Study||223
8558761|NCT00082407|21102148|P1|COMPLETED|Overall Study||199
8558762|NCT00082407|21102147|P2|Received Treatment (Intent to Treat)|Overall Study||248
8558763|NCT00082407|21102148|P1|Received Treatment (Intent to Treat)|Overall Study||253
8558764|NCT00082407|21102147|P2|STARTED|Overall Study||250
8558765|NCT00082407|21102148|P1|STARTED|Overall Study||255
8558766|NCT00082368|21102166|P1|NOT COMPLETED|Overall Study||1
8558767|NCT00082368|21102166|P1|COMPLETED|Overall Study||11
8558768|NCT00082368|21102166|P1|STARTED|Overall Study||12
8558769|NCT00082355|21102171|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
8558770|NCT00082355|21102171|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
8558771|NCT00082355|21102171|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
8558772|NCT00082355|21102171|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
8558773|NCT00082355|21102171|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
8558774|NCT00082355|21102171|P1|STARTED|Initial Results of Thrombolytic Therapy||30
8558775|NCT00082342|21102178|P2|NOT COMPLETED|Overall Study||0
8558776|NCT00082342|21102179|P1|NOT COMPLETED|Overall Study||0
8558777|NCT00082342|21102178|P2|COMPLETED|Overall Study||12
8558778|NCT00082342|21102179|P1|COMPLETED|Overall Study||13
8558779|NCT00082342|21102178|P2|STARTED|Overall Study||12
8558780|NCT00082342|21102179|P1|STARTED|Overall Study||13
8558781|NCT00082329|21102199|P1|NOT COMPLETED|Overall Study||0
8558782|NCT00082329|21102199|P1|COMPLETED|Overall Study||9
8558783|NCT00082329|21102199|P1|STARTED|Overall Study||9
8558784|NCT00082173|21102205|P2|NOT COMPLETED|Overall Study||11
8558785|NCT00082173|21102206|P1|NOT COMPLETED|Overall Study||10
8558786|NCT00082173|21102205|P2|COMPLETED|Overall Study||61
8558787|NCT00082173|21102206|P1|COMPLETED|Overall Study||64
8558788|NCT00082173|21102205|P2|STARTED|Overall Study||72
8558789|NCT00082173|21102206|P1|STARTED|Overall Study||74
8558790|NCT00003726|21102214|P1|NOT COMPLETED|Overall Study||1
8558791|NCT00003726|21102214|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
8558792|NCT00003726|21102214|P1|STARTED|Overall Study||1
8558793|NCT00081939|21102218|P1|NOT COMPLETED|Overall Study||0
8558794|NCT00081939|21102218|P1|COMPLETED|Overall Study||303
8558795|NCT00081939|21102218|P1|STARTED|Overall Study||303
8558796|NCT00082017|21102222|P2|NOT COMPLETED|Overall Study||0
8558797|NCT00082017|21102223|P1|NOT COMPLETED|Overall Study||0
8558799|NCT00082017|21102223|P1|COMPLETED|Overall Study||11
8558800|NCT00082017|21102222|P2|STARTED|Overall Study||9
8558801|NCT00082017|21102223|P1|STARTED|Overall Study||11
8558802|NCT00081861|21102239|P1|NOT COMPLETED|Overall Study||0
8558803|NCT00081861|21102239|P1|COMPLETED|Overall Study||13
8558804|NCT00081861|21102239|P1|STARTED|Overall Study||13
8558805|NCT00003270|21102243|P1|NOT COMPLETED|Overall Study||0
8558806|NCT00003270|21102243|P1|COMPLETED|Overall Study||20
8558807|NCT00003270|21102243|P1|STARTED|Overall Study||20
8558808|NCT00081770|21102251|P3|NOT COMPLETED|Overall Study||456
8558809|NCT00081770|21102252|P2|NOT COMPLETED|Overall Study||546
8558810|NCT00081770|21102253|P1|NOT COMPLETED|Overall Study||502
8558811|NCT00081770|21102251|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
8558812|NCT00081770|21102252|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
8558813|NCT00081770|21102253|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
8558814|NCT00081770|21102251|P3|STARTED|Overall Study||1035
8558815|NCT00081770|21102252|P2|STARTED|Overall Study||1016
8558816|NCT00081770|21102253|P1|STARTED|Overall Study||1019
8558817|NCT00081731|21102272|P2|NOT COMPLETED|Overall Study||8
8558818|NCT00081731|21102273|P1|NOT COMPLETED|Overall Study||8
8558819|NCT00081731|21102272|P2|COMPLETED|Overall Study||459
8558820|NCT00081731|21102273|P1|COMPLETED|Overall Study||472
8558821|NCT00081731|21102272|P2|STARTED|Overall Study||467
8558822|NCT00081731|21102273|P1|STARTED|Overall Study||480
8558823|NCT00081653|21102293|P2|NOT COMPLETED|Overall Study||37
8558824|NCT00081653|21102294|P1|NOT COMPLETED|Overall Study||47
8558825|NCT00081653|21102293|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
8558826|NCT00081653|21102294|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
8558827|NCT00081653|21102293|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
8558828|NCT00081653|21102294|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
8558829|NCT00081497|21102312|P2|NOT COMPLETED|Overall Study||2
8558830|NCT00081497|21102313|P1|NOT COMPLETED|Overall Study||3
8558831|NCT00081497|21102312|P2|COMPLETED|Overall Study||37
8558832|NCT00081497|21102313|P1|COMPLETED|Overall Study||25
8558833|NCT00081497|21102312|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
8558834|NCT00081497|21102313|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
8558835|NCT00081458|21102331|P3|NOT COMPLETED|Overall Study||4
8558836|NCT00081458|21102332|P2|NOT COMPLETED|Overall Study||8
8558837|NCT00081458|21102333|P1|NOT COMPLETED|Overall Study||1
8558838|NCT00081458|21102331|P3|COMPLETED|Overall Study||29
8558839|NCT00081458|21102332|P2|COMPLETED|Overall Study||27
8558840|NCT00081458|21102333|P1|COMPLETED|Overall Study||15
8558841|NCT00081458|21102331|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
8558842|NCT00081458|21102332|P2|Received Treatment|Overall Study||35
8558843|NCT00081458|21102333|P1|Received Treatment|Overall Study||16
8558844|NCT00081458|21102331|P3|STARTED|Overall Study||33
8558845|NCT00081458|21102332|P2|STARTED|Overall Study||35
8558846|NCT00081458|21102333|P1|STARTED|Overall Study||16
8558847|NCT00081328|21102347|P3|NOT COMPLETED|Overall Study||0
8558848|NCT00081328|21102348|P2|NOT COMPLETED|Overall Study||0
8558849|NCT00081328|21102349|P1|NOT COMPLETED|Overall Study||0
8558850|NCT00081328|21102347|P3|COMPLETED|Overall Study||234
8558851|NCT00081328|21102348|P2|COMPLETED|Overall Study||233
8558852|NCT00081328|21102349|P1|COMPLETED|Overall Study||232
8558853|NCT00081328|21102347|P3|STARTED|Overall Study||234
8558854|NCT00081328|21102348|P2|STARTED|Overall Study||233
8558855|NCT00081328|21102349|P1|STARTED|Overall Study||232
8558856|NCT00081289|21102389|P2|NOT COMPLETED|Overall Study||21
8558857|NCT00081289|21102390|P1|NOT COMPLETED|Overall Study||21
8558858|NCT00081289|21102389|P2|COMPLETED|Overall Study||52
8558859|NCT00081289|21102390|P1|COMPLETED|Overall Study||52
8558860|NCT00081289|21102389|P2|Defecation Symptom Score at Two Years|Overall Study||15
8558861|NCT00081289|21102390|P1|Defecation Symptom Score at Two Years|Overall Study||13
8558862|NCT00081289|21102389|P2|DS Score at End of Post-op CT|Overall Study||14
8558863|NCT00081289|21102390|P1|DS Score at End of Post-op CT|Overall Study||12
8558864|NCT00081289|21102389|P2|Defecation Symptom Score at End of CR|Overall Study||32
8558865|NCT00081289|21102390|P1|Defecation Symptom Score at End of CR|Overall Study||32
8558866|NCT00081289|21102389|P2|GI Symptom Score at Two Years|Overall Study||20
8558867|NCT00081289|21102390|P1|GI Symptom Score at Two Years|Overall Study||21
8558868|NCT00081289|21102389|P2|GI Symptom Score at End of Post-op CT|Overall Study||27
8558869|NCT00081289|21102390|P1|GI Symptom Score at End of Post-op CT|Overall Study||22
8558870|NCT00081289|21102389|P2|GI Symptom Score at End of CR|Overall Study||33
8558871|NCT00081289|21102390|P1|GI Symptom Score at End of CR|Overall Study||34
8558872|NCT00081289|21102389|P2|GHS at Two Years|Overall Study||20
8558873|NCT00081289|21102390|P1|GHS at Two Years|Overall Study||21
8558874|NCT00081289|21102389|P2|GHS at End of Post-op CT|Overall Study||28
8558875|NCT00081289|21102390|P1|GHS at End of Post-op CT|Overall Study||20
8558876|NCT00081289|21102389|P2|Global Health Status Score at End of CR|Overall Study||32
8558877|NCT00081289|21102390|P1|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
8558878|NCT00081289|21102389|P2|Surgery|Overall Study||51
8558879|NCT00081289|21102390|P1|Surgery|Overall Study||47
8558880|NCT00081289|21102389|P2|Full AE Population|Overall Study||68
8558881|NCT00081289|21102390|P1|Full AE Population|Overall Study||70
8558882|NCT00081289|21102389|P2|General Analysis Population|Overall Study||52
8558883|NCT00081289|21102390|P1|General Analysis Population|Overall Study||52
8558884|NCT00081289|21102389|P2|Primary Endpoint Population|Overall Study||48
8558885|NCT00081289|21102390|P1|Primary Endpoint Population|Overall Study||48
8558886|NCT00081289|21102389|P2|STARTED|Overall Study||73
8558887|NCT00081289|21102390|P1|STARTED|Overall Study||73
8558888|NCT00081263|21102434|P2|NOT COMPLETED|Overall Study||22
8558889|NCT00081263|21102435|P1|NOT COMPLETED|Overall Study||17
8558890|NCT00081263|21102434|P2|COMPLETED|Overall Study||41
8558891|NCT00081263|21102435|P1|COMPLETED|Overall Study||50
8558892|NCT00081263|21102434|P2|STARTED|Overall Study||63
8558893|NCT00081263|21102435|P1|STARTED|Overall Study||67
8558894|NCT00081159|21102445|P2|NOT COMPLETED|Overall Study||5
8558895|NCT00081159|21102446|P1|NOT COMPLETED|Overall Study||2
8558896|NCT00081159|21102445|P2|COMPLETED|Overall Study||35
8558897|NCT00081159|21102446|P1|COMPLETED|Overall Study||37
8558898|NCT00081159|21102445|P2|STARTED|Overall Study||40
8558899|NCT00081159|21102446|P1|STARTED|Overall Study||39
8558900|NCT00080938|21102456|P1|NOT COMPLETED|Overall Study||24
8558901|NCT00080938|21102456|P1|COMPLETED|Overall Study||2
8558902|NCT00080938|21102456|P1|Eligible and Treated|Overall Study||21
8558903|NCT00080938|21102456|P1|Began Protocol Therapy|Overall Study||25
8558904|NCT00080938|21102456|P1|STARTED|Overall Study||26
8558905|NCT00080912|21102465|P2|NOT COMPLETED|Overall Study||0
8558906|NCT00080912|21102466|P1|NOT COMPLETED|Overall Study||0
8558907|NCT00080912|21102465|P2|COMPLETED|Overall Study||425
8558908|NCT00080912|21102466|P1|COMPLETED|Overall Study||425
8558909|NCT00080912|21102465|P2|STARTED|Overall Study||425
8558910|NCT00080912|21102466|P1|STARTED|Overall Study||425
8558911|NCT00080899|21102472|P1|NOT COMPLETED|Overall Study||1
8558912|NCT00080899|21102472|P1|COMPLETED|Overall Study||22
8558913|NCT00080899|21102472|P1|STARTED|Overall Study||23
8558914|NCT00080535|21102477|P1|NOT COMPLETED|Overall Study||0
8558915|NCT00080535|21102477|P1|COMPLETED|Overall Study||10
8558916|NCT00080535|21102477|P1|STARTED|Overall Study||10
8558917|NCT00080483|21102484|P2|NOT COMPLETED|Overall Study||2
8558918|NCT00080483|21102485|P1|NOT COMPLETED|Overall Study||2
8558919|NCT00080483|21102484|P2|COMPLETED|Overall Study||16
8558920|NCT00080483|21102485|P1|COMPLETED|Overall Study||15
8558921|NCT00080483|21102484|P2|STARTED|Overall Study||18
8558922|NCT00080483|21102485|P1|STARTED|Overall Study||17
8558923|NCT00002525|21102493|P2|NOT COMPLETED|Overall Study||0
8558924|NCT00002525|21102494|P1|NOT COMPLETED|Overall Study||186
8558925|NCT00002525|21102493|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
8558926|NCT00002525|21102494|P1|COMPLETED|Overall Study||241
8558927|NCT00002525|21102493|P2|Dukes' B2 Stage|Overall Study||139
8558928|NCT00002525|21102494|P1|Dukes' B2 Stage|Overall Study||150
8558929|NCT00002525|21102493|P2|Dukes' B3 or C Stage|Overall Study||158
8558930|NCT00002525|21102494|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
8558931|NCT00002525|21102493|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
8558932|NCT00002525|21102494|P1|Treated|Overall Study||419
8558933|NCT00002525|21102493|P2|STARTED|Overall Study||428
8558934|NCT00002525|21102494|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
8558935|NCT00080470|21102510|P2|NOT COMPLETED|Overall Study||28
8558936|NCT00080470|21102511|P1|NOT COMPLETED|Overall Study||34
8558937|NCT00080470|21102510|P2|COMPLETED|Overall Study||14
8558938|NCT00080470|21102511|P1|COMPLETED|Overall Study||11
8558939|NCT00080470|21102510|P2|STARTED|Overall Study||42
8558940|NCT00080470|21102511|P1|STARTED|Overall Study||45
8558941|NCT00080301|21102521|P2|NOT COMPLETED|Overall Study||11
8558942|NCT00080301|21102522|P1|NOT COMPLETED|Overall Study||5
8558943|NCT00080301|21102521|P2|COMPLETED|Overall Study|Participants who are off treatment|366
8558944|NCT00080301|21102522|P1|COMPLETED|Overall Study|Participants who are off treatment|370
8558945|NCT00080301|21102521|P2|Still on Treatment|Overall Study||1
8558946|NCT00080301|21102522|P1|Still on Treatment|Overall Study||0
8558947|NCT00080301|21102521|P2|Never Treated|Overall Study||10
8558948|NCT00080301|21102522|P1|Never Treated|Overall Study||5
8558949|NCT00080301|21102521|P2|STARTED|Overall Study||377
8558950|NCT00080301|21102522|P1|STARTED|Overall Study||375
8558951|NCT00080288|21102542|P2|NOT COMPLETED|Overall Study||38
8558952|NCT00080288|21102543|P1|NOT COMPLETED|Overall Study||30
8558953|NCT00080288|21102542|P2|COMPLETED|Overall Study||89
8558954|NCT00080288|21102543|P1|COMPLETED|Overall Study||97
8558955|NCT00080288|21102542|P2|STARTED|Overall Study||127
8558956|NCT00080288|21102543|P1|STARTED|Overall Study||127
8558957|NCT00080223|21102551|P1|NOT COMPLETED|Overall Study||76
8558958|NCT00080223|21102551|P1|COMPLETED|Overall Study||7
8558959|NCT00080223|21102551|P1|STARTED|Overall Study||83
8558960|NCT00002540|21102561|P2|NOT COMPLETED|Overall Study||2464
8558961|NCT00002540|21102562|P1|NOT COMPLETED|Overall Study||801
8558962|NCT00002540|21102561|P2|COMPLETED|Overall Study||35876
8558963|NCT00002540|21102562|P1|COMPLETED|Overall Study||37544
8558964|NCT00002540|21102561|P2|STARTED|Overall Study||38340
8558965|NCT00002540|21102562|P1|STARTED|Overall Study||38345
8558966|NCT00080119|21102592|P4|NOT COMPLETED|Overall Study||163
8558967|NCT00080119|21102593|P3|NOT COMPLETED|Overall Study||165
8558968|NCT00080119|21102594|P2|NOT COMPLETED|Overall Study||62
8558969|NCT00080119|21102595|P1|NOT COMPLETED|Overall Study||56
8558970|NCT00080119|21102592|P4|COMPLETED|Overall Study||111
8558971|NCT00080119|21102593|P3|COMPLETED|Overall Study||108
8558972|NCT00080119|21102594|P2|COMPLETED|Overall Study||339
8558973|NCT00080119|21102595|P1|COMPLETED|Overall Study||347
8558974|NCT00080119|21102592|P4|STARTED|Overall Study||274
8558975|NCT00080119|21102593|P3|STARTED|Overall Study||273
8558976|NCT00080119|21102594|P2|STARTED|Overall Study||401
8558977|NCT00080119|21102595|P1|STARTED|Overall Study||403
8558978|NCT00079937|21102629|P2|NOT COMPLETED|Overall Study||32
8558979|NCT00079937|21102630|P1|NOT COMPLETED|Overall Study||69
8558980|NCT00079937|21102629|P2|COMPLETED|Overall Study||175
8558981|NCT00079937|21102630|P1|COMPLETED|Overall Study||352
8558982|NCT00079937|21102629|P2|STARTED|Overall Study||207
8558983|NCT00079937|21102630|P1|STARTED|Overall Study||421
8558984|NCT00009737|21102648|P2|NOT COMPLETED|Overall Study||123
8558985|NCT00009737|21102649|P1|NOT COMPLETED|Overall Study||170
8558986|NCT00009737|21102648|P2|COMPLETED|Overall Study||860
8558987|NCT00009737|21102649|P1|COMPLETED|Overall Study||834
8558988|NCT00009737|21102648|P2|STARTED|Overall Study||983
8558989|NCT00009737|21102649|P1|STARTED|Overall Study||1004
8558990|NCT00079781|21102668|P3|NOT COMPLETED|Follow-up Period||2
8558991|NCT00079781|21102669|P2|NOT COMPLETED|Follow-up Period||0
8558992|NCT00079781|21102670|P1|NOT COMPLETED|Follow-up Period||4
8558993|NCT00079781|21102668|P3|COMPLETED|Follow-up Period||12
8558994|NCT00079781|21102669|P2|COMPLETED|Follow-up Period||9
8558995|NCT00079781|21102670|P1|COMPLETED|Follow-up Period||38
8558996|NCT00079781|21102668|P3|STARTED|Follow-up Period||14
8558997|NCT00079781|21102669|P2|STARTED|Follow-up Period||9
8558998|NCT00079781|21102670|P1|STARTED|Follow-up Period||42
8558999|NCT00079781|21102668|P3|NOT COMPLETED|Evaluation Period||0
8559000|NCT00079781|21102669|P2|NOT COMPLETED|Evaluation Period||0
8559001|NCT00079781|21102670|P1|NOT COMPLETED|Evaluation Period||0
8559002|NCT00079781|21102668|P3|COMPLETED|Evaluation Period||14
8559003|NCT00079781|21102669|P2|COMPLETED|Evaluation Period||9
8559004|NCT00079781|21102670|P1|COMPLETED|Evaluation Period||42
8559005|NCT00079781|21102668|P3|STARTED|Evaluation Period||14
8559006|NCT00079781|21102669|P2|STARTED|Evaluation Period||9
8559007|NCT00079781|21102670|P1|STARTED|Evaluation Period||42
8559008|NCT00079781|21102668|P3|NOT COMPLETED|Pre-implant Period||1
8559009|NCT00079781|21102669|P2|NOT COMPLETED|Pre-implant Period||1
8559010|NCT00079781|21102670|P1|NOT COMPLETED|Pre-implant Period||3
8559011|NCT00079781|21102668|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
8559012|NCT00079781|21102669|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
8559013|NCT00079781|21102670|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
8559014|NCT00079781|21102668|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
8559015|NCT00079781|21102669|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
8559016|NCT00079781|21102670|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
8559017|NCT00079677|21102679|P2|NOT COMPLETED|Overall Study||14
8559018|NCT00079677|21102680|P1|NOT COMPLETED|Overall Study||20
8559019|NCT00079677|21102679|P2|COMPLETED|Overall Study||118
8559020|NCT00079677|21102680|P1|COMPLETED|Overall Study||111
8559021|NCT00079677|21102679|P2|STARTED|Overall Study||132
8559022|NCT00079677|21102680|P1|STARTED|Overall Study||131
8559023|NCT00002601|21102688|P1|NOT COMPLETED|Overall Study||0
8559024|NCT00002601|21102688|P1|COMPLETED|Overall Study||13
8559025|NCT00002601|21102688|P1|STARTED|Overall Study||13
8559026|NCT00079417|21102696|P1|NOT COMPLETED|Overall Study||9
8559027|NCT00079417|21102696|P1|COMPLETED|Overall Study||19
8559028|NCT00079417|21102696|P1|STARTED|Overall Study||28
8559029|NCT00079391|21102704|P1|NOT COMPLETED|Overall Study||1
8559030|NCT00079391|21102704|P1|COMPLETED|Overall Study||49
8559031|NCT00079391|21102704|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
8559032|NCT00079339|21102716|P3|NOT COMPLETED|Overall Study||6
8559033|NCT00079339|21102717|P2|NOT COMPLETED|Overall Study||39
8559034|NCT00079339|21102718|P1|NOT COMPLETED|Overall Study||5
8559035|NCT00079339|21102716|P3|COMPLETED|Overall Study||0
8559036|NCT00079339|21102717|P2|COMPLETED|Overall Study||1
8559037|NCT00079339|21102718|P1|COMPLETED|Overall Study||0
8559038|NCT00079339|21102716|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
8559039|NCT00079339|21102717|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
8559040|NCT00079339|21102718|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
8559041|NCT00079339|21102716|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
8559042|NCT00079339|21102717|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
8559043|NCT00079339|21102718|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
8559044|NCT00079339|21102716|P3|Enrolled in Phase I|Overall Study||6
8559045|NCT00079339|21102717|P2|Enrolled in Phase I|Overall Study||6
8559046|NCT00079339|21102718|P1|Enrolled in Phase I|Overall Study||5
8559047|NCT00079339|21102716|P3|STARTED|Overall Study||6
8559048|NCT00079339|21102717|P2|STARTED|Overall Study||40
8559049|NCT00079339|21102718|P1|STARTED|Overall Study||5
8559050|NCT00079326|21102734|P2|NOT COMPLETED|Overall Study||0
8559051|NCT00079326|21102735|P1|NOT COMPLETED|Overall Study||0
8559052|NCT00079326|21102734|P2|COMPLETED|Overall Study||24
8559053|NCT00079326|21102735|P1|COMPLETED|Overall Study||15
8559054|NCT00079326|21102734|P2|STARTED|Overall Study||24
8559055|NCT00079326|21102735|P1|STARTED|Overall Study||15
8559056|NCT00079274|21102749|P7|NOT COMPLETED|Overall Study||0
8559057|NCT00079274|21102750|P6|NOT COMPLETED|Overall Study||20
8559058|NCT00079274|21102751|P5|NOT COMPLETED|Overall Study||15
8559059|NCT00079274|21102752|P4|NOT COMPLETED|Overall Study||444
8559060|NCT00079274|21102753|P3|NOT COMPLETED|Overall Study||27
8559061|NCT00079274|21102754|P2|NOT COMPLETED|Overall Study||27
8559062|NCT00079274|21102755|P1|NOT COMPLETED|Overall Study||321
8559063|NCT00079274|21102749|P7|COMPLETED|Overall Study||332
8559064|NCT00079274|21102750|P6|COMPLETED|Overall Study||26
8559065|NCT00079274|21102751|P5|COMPLETED|Overall Study||30
8559066|NCT00079274|21102752|P4|COMPLETED|Overall Study||906
8559067|NCT00079274|21102753|P3|COMPLETED|Overall Study||84
8559068|NCT00079274|21102754|P2|COMPLETED|Overall Study||84
8559069|NCT00079274|21102755|P1|COMPLETED|Overall Study||1081
8559070|NCT00079274|21102749|P7|STARTED|Overall Study||332
8559071|NCT00079274|21102750|P6|STARTED|Overall Study||46
8559072|NCT00079274|21102751|P5|STARTED|Overall Study||45
8559073|NCT00079274|21102752|P4|STARTED|Overall Study||1350
8559074|NCT00079274|21102753|P3|STARTED|Overall Study||111
8559075|NCT00079274|21102754|P2|STARTED|Overall Study||111
8559076|NCT00079274|21102755|P1|STARTED|Overall Study||1402
8559077|NCT00079183|21102776|P1|NOT COMPLETED|Overall Study||7
8559078|NCT00079183|21102776|P1|COMPLETED|Overall Study||37
8559079|NCT00079183|21102776|P1|Drop Outs|Overall Study||7
8559080|NCT00079183|21102776|P1|STARTED|Overall Study||44
8559081|NCT00079040|21102791|P1|NOT COMPLETED|Overall Study||2
8559082|NCT00079040|21102791|P1|COMPLETED|Overall Study||63
8559083|NCT00079040|21102791|P1|STARTED|Overall Study||65
8559084|NCT00079001|21102799|P2|NOT COMPLETED|Overall Study||0
8559085|NCT00079001|21102800|P1|NOT COMPLETED|Overall Study||0
8559086|NCT00079001|21102799|P2|COMPLETED|Overall Study||322
8559087|NCT00079001|21102800|P1|COMPLETED|Overall Study||323
8559088|NCT00079001|21102799|P2|STARTED|Overall Study||322
8559089|NCT00079001|21102800|P1|STARTED|Overall Study||323
8559090|NCT00078949|21102814|P4|NOT COMPLETED|Overall Study||3
8559091|NCT00078949|21102815|P3|NOT COMPLETED|Overall Study||3
8559092|NCT00078949|21102816|P2|NOT COMPLETED|Overall Study||5
8559093|NCT00078949|21102817|P1|NOT COMPLETED|Overall Study||4
8559094|NCT00078949|21102814|P4|COMPLETED|Overall Study||112
8559095|NCT00078949|21102815|P3|COMPLETED|Overall Study||112
8559096|NCT00078949|21102816|P2|COMPLETED|Overall Study||304
8559097|NCT00078949|21102817|P1|COMPLETED|Overall Study||306
8559098|NCT00078949|21102814|P4|STARTED|Overall Study||115
8559099|NCT00078949|21102815|P3|STARTED|Overall Study||115
8559100|NCT00078949|21102816|P2|STARTED|Overall Study||309
8559101|NCT00078949|21102817|P1|STARTED|Overall Study||310
8559102|NCT00078897|21102835|P2|NOT COMPLETED|Overall Study||123
8559103|NCT00078897|21102836|P1|NOT COMPLETED|Overall Study||124
8559104|NCT00078897|21102835|P2|COMPLETED|Overall Study||689
8559105|NCT00078897|21102836|P1|COMPLETED|Overall Study||685
8559106|NCT00078897|21102835|P2|STARTED|Overall Study||812
8559107|NCT00078897|21102836|P1|STARTED|Overall Study||809
8559108|NCT00078819|21102846|P4|NOT COMPLETED|Re-treatment Period||0
8559109|NCT00078819|21102847|P3|NOT COMPLETED|Re-treatment Period||0
8559110|NCT00078819|21102848|P2|NOT COMPLETED|Re-treatment Period||0
8559111|NCT00078819|21102849|P1|NOT COMPLETED|Re-treatment Period||0
8559112|NCT00078819|21102846|P4|COMPLETED|Re-treatment Period||13
8559113|NCT00078819|21102847|P3|COMPLETED|Re-treatment Period||29
8559114|NCT00078819|21102848|P2|COMPLETED|Re-treatment Period||0
8559115|NCT00078819|21102849|P1|COMPLETED|Re-treatment Period||0
8559116|NCT00078819|21102846|P4|Received Study Drug|Re-treatment Period||12
8559117|NCT00078819|21102847|P3|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
8559118|NCT00078819|21102848|P2|Received Study Drug|Re-treatment Period||0
8559119|NCT00078819|21102849|P1|Received Study Drug|Re-treatment Period||0
8559120|NCT00078819|21102846|P4|STARTED|Re-treatment Period||13
8559121|NCT00078819|21102847|P3|STARTED|Re-treatment Period||29
8559122|NCT00078819|21102848|P2|STARTED|Re-treatment Period||0
8559123|NCT00078819|21102849|P1|STARTED|Re-treatment Period||0
8559124|NCT00078819|21102846|P4|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
8559125|NCT00078819|21102847|P3|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
8559126|NCT00078819|21102848|P2|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
8559127|NCT00078819|21102849|P1|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
8559128|NCT00078819|21102846|P4|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
8559129|NCT00078819|21102847|P3|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
8559130|NCT00078819|21102848|P2|COMPLETED|Withdrawal Period: Weeks 37-48||0
8559131|NCT00078819|21102849|P1|COMPLETED|Withdrawal Period: Weeks 37-48||0
8559132|NCT00078819|21102846|P4|Received Study Drug|Withdrawal Period: Weeks 37-48||68
8559133|NCT00078819|21102847|P3|Received Study Drug|Withdrawal Period: Weeks 37-48||69
8559134|NCT00078819|21102848|P2|Received Study Drug|Withdrawal Period: Weeks 37-48||0
8559135|NCT00078819|21102849|P1|Received Study Drug|Withdrawal Period: Weeks 37-48||0
8559136|NCT00078819|21102846|P4|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
8559137|NCT00078819|21102847|P3|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
8559138|NCT00078819|21102848|P2|STARTED|Withdrawal Period: Weeks 37-48||0
8559139|NCT00078819|21102849|P1|STARTED|Withdrawal Period: Weeks 37-48||0
8559140|NCT00078819|21102846|P4|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559141|NCT00078819|21102847|P3|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559142|NCT00078819|21102848|P2|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
8559143|NCT00078819|21102849|P1|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
8559144|NCT00078819|21102846|P4|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559145|NCT00078819|21102847|P3|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559146|NCT00078819|21102848|P2|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
8559147|NCT00078819|21102849|P1|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
8559148|NCT00078819|21102846|P4|STARTED|Open-label Treatment Period: Weeks 13-36||0
8559149|NCT00078819|21102847|P3|STARTED|Open-label Treatment Period: Weeks 13-36||0
8559150|NCT00078819|21102848|P2|STARTED|Open-label Treatment Period: Weeks 13-36||105
8559151|NCT00078819|21102849|P1|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
8559152|NCT00078819|21102846|P4|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559153|NCT00078819|21102847|P3|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559154|NCT00078819|21102848|P2|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
8559155|NCT00078819|21102849|P1|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
8559156|NCT00078819|21102846|P4|COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559157|NCT00078819|21102847|P3|COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559158|NCT00078819|21102848|P2|COMPLETED|Double-blind Treatment Period: Week 1-12||105
8559159|NCT00078819|21102849|P1|COMPLETED|Double-blind Treatment Period: Week 1-12||104
8559160|NCT00078819|21102846|P4|Entered Escape|Double-blind Treatment Period: Week 1-12||0
8559161|NCT00078819|21102847|P3|Entered Escape|Double-blind Treatment Period: Week 1-12||0
8559162|NCT00078819|21102848|P2|Entered Escape|Double-blind Treatment Period: Week 1-12||5
8559163|NCT00078819|21102849|P1|Entered Escape|Double-blind Treatment Period: Week 1-12||27
8559164|NCT00078819|21102846|P4|STARTED|Double-blind Treatment Period: Week 1-12||0
8559165|NCT00078819|21102847|P3|STARTED|Double-blind Treatment Period: Week 1-12||0
8559166|NCT00078819|21102848|P2|STARTED|Double-blind Treatment Period: Week 1-12||106
8559167|NCT00078819|21102849|P1|STARTED|Double-blind Treatment Period: Week 1-12||105
8559168|NCT00078806|21102874|P4|NOT COMPLETED|Part 3||0
8559169|NCT00078806|21102875|P3|NOT COMPLETED|Part 3||0
8559170|NCT00078806|21102876|P2|NOT COMPLETED|Part 3||0
8559171|NCT00078806|21102877|P1|NOT COMPLETED|Part 3||0
8559172|NCT00078806|21102874|P4|COMPLETED|Part 3||9
8559173|NCT00078806|21102875|P3|COMPLETED|Part 3||0
8559174|NCT00078806|21102876|P2|COMPLETED|Part 3||0
8559175|NCT00078806|21102877|P1|COMPLETED|Part 3||0
8559176|NCT00078806|21102874|P4|STARTED|Part 3||9
8559177|NCT00078806|21102875|P3|STARTED|Part 3||0
8559178|NCT00078806|21102876|P2|STARTED|Part 3||0
8559179|NCT00078806|21102877|P1|STARTED|Part 3||0
8559180|NCT00078806|21102874|P4|NOT COMPLETED|Part 2||0
8559181|NCT00078806|21102875|P3|NOT COMPLETED|Part 2||0
8559182|NCT00078806|21102876|P2|NOT COMPLETED|Part 2||1
8559183|NCT00078806|21102877|P1|NOT COMPLETED|Part 2||0
8559184|NCT00078806|21102874|P4|COMPLETED|Part 2||0
8559185|NCT00078806|21102875|P3|COMPLETED|Part 2||4
8559186|NCT00078806|21102876|P2|COMPLETED|Part 2||5
8559187|NCT00078806|21102877|P1|COMPLETED|Part 2||0
8559188|NCT00078806|21102874|P4|Received Study Drug|Part 2||0
8559189|NCT00078806|21102875|P3|Received Study Drug|Part 2||4
8559190|NCT00078806|21102876|P2|Received Study Drug|Part 2||5
8559191|NCT00078806|21102877|P1|Received Study Drug|Part 2||0
8559192|NCT00078806|21102874|P4|STARTED|Part 2||0
8559193|NCT00078806|21102875|P3|STARTED|Part 2||4
8559194|NCT00078806|21102876|P2|STARTED|Part 2||6
8559195|NCT00078806|21102877|P1|STARTED|Part 2||0
8559196|NCT00078806|21102874|P4|NOT COMPLETED|Part 1B||0
8559197|NCT00078806|21102875|P3|NOT COMPLETED|Part 1B||0
8559198|NCT00078806|21102876|P2|NOT COMPLETED|Part 1B||0
8559199|NCT00078806|21102877|P1|NOT COMPLETED|Part 1B||8
8559200|NCT00078806|21102874|P4|COMPLETED|Part 1B||0
8559201|NCT00078806|21102875|P3|COMPLETED|Part 1B||0
8559202|NCT00078806|21102876|P2|COMPLETED|Part 1B||0
8559203|NCT00078806|21102877|P1|COMPLETED|Part 1B||2
8559204|NCT00078806|21102874|P4|STARTED|Part 1B||0
8559205|NCT00078806|21102875|P3|STARTED|Part 1B||0
8559206|NCT00078806|21102876|P2|STARTED|Part 1B||0
8559207|NCT00078806|21102877|P1|STARTED|Part 1B||10
8559208|NCT00078806|21102874|P4|NOT COMPLETED|Part 1A||0
8559209|NCT00078806|21102875|P3|NOT COMPLETED|Part 1A||0
8559210|NCT00078806|21102876|P2|NOT COMPLETED|Part 1A||0
8559211|NCT00078806|21102877|P1|NOT COMPLETED|Part 1A||10
8559212|NCT00078806|21102874|P4|COMPLETED|Part 1A||0
8559213|NCT00078806|21102875|P3|COMPLETED|Part 1A||0
8559214|NCT00078806|21102876|P2|COMPLETED|Part 1A||0
8559215|NCT00078806|21102877|P1|COMPLETED|Part 1A||9
8559216|NCT00078806|21102874|P4|STARTED|Part 1A||0
8559217|NCT00078806|21102875|P3|STARTED|Part 1A||0
8559218|NCT00078806|21102876|P2|STARTED|Part 1A||0
8559219|NCT00078806|21102877|P1|STARTED|Part 1A||19
8559220|NCT00078767|21102913|P2|NOT COMPLETED|Overall Study||1
8559221|NCT00078767|21102914|P1|NOT COMPLETED|Overall Study||1
8559222|NCT00078767|21102913|P2|COMPLETED|Overall Study||11
8559223|NCT00078767|21102914|P1|COMPLETED|Overall Study||11
8559224|NCT00078767|21102913|P2|STARTED|Overall Study||12
8559225|NCT00078767|21102914|P1|STARTED|Overall Study||12
8559226|NCT00078754|21102931|P3|NOT COMPLETED|Overall Study||15
8559227|NCT00078754|21102932|P2|NOT COMPLETED|Overall Study||19
8559228|NCT00078754|21102933|P1|NOT COMPLETED|Overall Study||15
8559229|NCT00078754|21102931|P3|COMPLETED|Overall Study||16
8559230|NCT00078754|21102932|P2|COMPLETED|Overall Study||11
8559231|NCT00078754|21102933|P1|COMPLETED|Overall Study||14
8559232|NCT00078754|21102931|P3|STARTED|Overall Study||31
8559233|NCT00078754|21102932|P2|STARTED|Overall Study||30
8559234|NCT00078754|21102933|P1|STARTED|Overall Study||29
8559235|NCT00078728|21102943|P2|NOT COMPLETED|Overall Study||3
8559236|NCT00078728|21102944|P1|NOT COMPLETED|Overall Study||4
8559237|NCT00078728|21102943|P2|COMPLETED|Overall Study||17
8559238|NCT00078728|21102944|P1|COMPLETED|Overall Study||16
8559239|NCT00078728|21102943|P2|STARTED|Overall Study||20
8559240|NCT00078728|21102944|P1|STARTED|Overall Study||20
8559241|NCT00078715|21102952|P2|NOT COMPLETED|Second Intervention||0
8559242|NCT00078715|21102953|P1|NOT COMPLETED|Second Intervention||0
8559243|NCT00078715|21102952|P2|COMPLETED|Second Intervention||4
8559244|NCT00078715|21102953|P1|COMPLETED|Second Intervention||2
8559245|NCT00078715|21102952|P2|STARTED|Second Intervention||4
8559246|NCT00078715|21102953|P1|STARTED|Second Intervention||2
8559247|NCT00078715|21102952|P2|NOT COMPLETED|First Intervention||0
8559248|NCT00078715|21102953|P1|NOT COMPLETED|First Intervention||0
8559249|NCT00078715|21102952|P2|COMPLETED|First Intervention||4
8559250|NCT00078715|21102953|P1|COMPLETED|First Intervention||2
8559251|NCT00078715|21102952|P2|STARTED|First Intervention||4
8559252|NCT00078715|21102953|P1|STARTED|First Intervention||2
8559253|NCT00005947|21102961|P2|NOT COMPLETED|Overall Study||41
8559254|NCT00005947|21102962|P1|NOT COMPLETED|Overall Study||57
8559255|NCT00005947|21102961|P2|COMPLETED|Overall Study||4
8559256|NCT00005947|21102962|P1|COMPLETED|Overall Study||25
8559257|NCT00005947|21102961|P2|STARTED|Overall Study||45
8559258|NCT00005947|21102962|P1|STARTED|Overall Study||82
8559259|NCT00078559|21102970|P1|NOT COMPLETED|Overall Study||0
8559260|NCT00078559|21102970|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
8559261|NCT00078559|21102970|P1|STARTED|Overall Study||10
8559262|NCT00002597|21102998|P2|NOT COMPLETED|Overall Study||23
8559263|NCT00002597|21102999|P1|NOT COMPLETED|Overall Study||26
8559264|NCT00002597|21102998|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
8559265|NCT00002597|21102999|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
8559266|NCT00002597|21102998|P2|STARTED|Overall Study||1015
8559267|NCT00002597|21102999|P1|STARTED|Overall Study||1013
8559268|NCT00078377|21103024|P3|NOT COMPLETED|Overall Study||9
8559269|NCT00078377|21103025|P2|NOT COMPLETED|Overall Study||16
8559270|NCT00078377|21103026|P1|NOT COMPLETED|Overall Study||11
8559271|NCT00078377|21103024|P3|COMPLETED|Overall Study||55
8559272|NCT00078377|21103025|P2|COMPLETED|Overall Study||49
8559273|NCT00078377|21103026|P1|COMPLETED|Overall Study||56
8559274|NCT00078377|21103024|P3|STARTED|Overall Study||64
8559275|NCT00078377|21103025|P2|STARTED|Overall Study||65
8559276|NCT00078377|21103026|P1|STARTED|Overall Study||67
8559277|NCT00078338|21103041|P2|NOT COMPLETED|Overall Study||54
8559278|NCT00078338|21103042|P1|NOT COMPLETED|Overall Study||85
8559279|NCT00078338|21103041|P2|COMPLETED|Overall Study||324
8559280|NCT00078338|21103042|P1|COMPLETED|Overall Study||301
8559281|NCT00078338|21103041|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
8559282|NCT00078338|21103042|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
8559283|NCT00078338|21103041|P2|STARTED|Overall Study||378
8559284|NCT00078338|21103042|P1|STARTED|Overall Study||386
8559285|NCT00076687|21103051|P3|NOT COMPLETED|Overall Study||4
8559286|NCT00076687|21103052|P2|NOT COMPLETED|Overall Study||5
8559287|NCT00076687|21103053|P1|NOT COMPLETED|Overall Study||6
8559288|NCT00076687|21103051|P3|COMPLETED|Overall Study||51
8559289|NCT00076687|21103052|P2|COMPLETED|Overall Study||47
8559290|NCT00076687|21103053|P1|COMPLETED|Overall Study||42
8559291|NCT00076687|21103051|P3|STARTED|Overall Study||55
8559292|NCT00076687|21103052|P2|STARTED|Overall Study||52
8559293|NCT00076687|21103053|P1|STARTED|Overall Study||48
8559294|NCT00078403|21103073|P3|NOT COMPLETED|Overall Study||28
8559295|NCT00078403|21103074|P2|NOT COMPLETED|Overall Study||16
8559296|NCT00078403|21103075|P1|NOT COMPLETED|Overall Study||18
8559297|NCT00078403|21103073|P3|COMPLETED|Overall Study||141
8559298|NCT00078403|21103074|P2|COMPLETED|Overall Study||26
8559299|NCT00078403|21103075|P1|COMPLETED|Overall Study||26
8559300|NCT00078403|21103073|P3|STARTED|Overall Study||169
8559301|NCT00078403|21103074|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
8559302|NCT00078403|21103075|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
8559303|NCT00078325|21103135|P3|NOT COMPLETED|Overall Study||11
8559304|NCT00078325|21103136|P2|NOT COMPLETED|Overall Study||19
8559305|NCT00078325|21103137|P1|NOT COMPLETED|Overall Study||21
8559306|NCT00078325|21103135|P3|COMPLETED|Overall Study||120
8559307|NCT00078325|21103136|P2|COMPLETED|Overall Study||114
8559308|NCT00078325|21103137|P1|COMPLETED|Overall Study||110
8559309|NCT00078325|21103135|P3|STARTED|Overall Study||131
8559310|NCT00078325|21103136|P2|STARTED|Overall Study||133
8559311|NCT00078325|21103137|P1|STARTED|Overall Study||131
8559312|NCT00078312|21103148|P1|NOT COMPLETED|Overall Study||177
8559313|NCT00078312|21103148|P1|COMPLETED|Overall Study||151
8559314|NCT00078312|21103148|P1|STARTED|Overall Study||328
8559315|NCT00078286|21103154|P2|NOT COMPLETED|Overall Study||83
8559316|NCT00078286|21103155|P1|NOT COMPLETED|Overall Study||96
8559317|NCT00078286|21103154|P2|COMPLETED|Overall Study||152
8559318|NCT00078286|21103155|P1|COMPLETED|Overall Study||138
8559319|NCT00078286|21103154|P2|STARTED|Overall Study||235
8559320|NCT00078286|21103155|P1|STARTED|Overall Study||234
8559321|NCT00077974|21103163|P1|NOT COMPLETED|Overall Study||104
8559322|NCT00077974|21103163|P1|COMPLETED|Overall Study||2
8559323|NCT00077974|21103163|P1|STARTED|Overall Study||106
8559324|NCT00077857|21103180|P2|NOT COMPLETED|Overall Study||204
8559325|NCT00077857|21103181|P1|NOT COMPLETED|Overall Study||201
8559326|NCT00077857|21103180|P2|COMPLETED|Overall Study||31
8559327|NCT00077857|21103181|P1|COMPLETED|Overall Study||34
8559328|NCT00077857|21103180|P2|Safety Population: Actual Dose Received|Overall Study||248
8559329|NCT00077857|21103181|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
8559330|NCT00077857|21103180|P2|Received Study Drug|Overall Study||234
8559331|NCT00077857|21103181|P1|Received Study Drug|Overall Study||231
8559332|NCT00077857|21103180|P2|STARTED|Overall Study||235
8559333|NCT00077857|21103181|P1|STARTED|Overall Study||235
8559334|NCT00077766|21103201|P2|NOT COMPLETED|Overall Study||25
8559335|NCT00077766|21103202|P1|NOT COMPLETED|Overall Study||39
8559336|NCT00077766|21103201|P2|COMPLETED|Overall Study||131
8559337|NCT00077766|21103202|P1|COMPLETED|Overall Study||118
8559338|NCT00077766|21103201|P2|STARTED|Overall Study||156
8559339|NCT00077766|21103202|P1|STARTED|Overall Study||157
8559340|NCT00077922|21103220|P1|NOT COMPLETED|Overall Study||0
8559341|NCT00077922|21103220|P1|COMPLETED|Overall Study||15
8559342|NCT00077922|21103220|P1|STARTED|Overall Study||15
8559343|NCT00077675|21103227|P2|NOT COMPLETED|Overall Study||9
8559344|NCT00077675|21103228|P1|NOT COMPLETED|Overall Study||11
8559345|NCT00077675|21103227|P2|COMPLETED|Overall Study||89
8559346|NCT00077675|21103228|P1|COMPLETED|Overall Study||92
8559347|NCT00077675|21103227|P2|STARTED|Overall Study||98
8559348|NCT00077675|21103228|P1|STARTED|Overall Study||103
8559349|NCT00077649|21103238|P4|NOT COMPLETED|Overall Study||17
8559350|NCT00077649|21103239|P3|NOT COMPLETED|Overall Study||15
8559351|NCT00077649|21103240|P2|NOT COMPLETED|Overall Study||9
8559352|NCT00077649|21103241|P1|NOT COMPLETED|Overall Study||14
8559353|NCT00077649|21103238|P4|COMPLETED|Overall Study||30
8559354|NCT00077649|21103239|P3|COMPLETED|Overall Study||32
8559355|NCT00077649|21103240|P2|COMPLETED|Overall Study||38
8559356|NCT00077649|21103241|P1|COMPLETED|Overall Study||33
8559357|NCT00077649|21103238|P4|Completed 24 Weeks of Follow-up|Overall Study||31
8559358|NCT00077649|21103239|P3|Completed 24 Weeks of Follow-up|Overall Study||36
8559359|NCT00077649|21103240|P2|Completed 24 Weeks of Follow-up|Overall Study||40
8559360|NCT00077649|21103241|P1|Completed 24 Weeks of Follow-up|Overall Study||36
8559361|NCT00077649|21103238|P4|STARTED|Overall Study||47
8559362|NCT00077649|21103239|P3|STARTED|Overall Study||47
8559363|NCT00077649|21103240|P2|STARTED|Overall Study||47
8559364|NCT00077649|21103241|P1|STARTED|Overall Study||47
8559365|NCT00077636|21103289|P2|NOT COMPLETED|Overall Study||92
8559366|NCT00077636|21103290|P1|NOT COMPLETED|Overall Study||44
8559367|NCT00077636|21103289|P2|COMPLETED|Overall Study||641
8559368|NCT00077636|21103290|P1|COMPLETED|Overall Study||692
8559369|NCT00077636|21103289|P2|STARTED|Overall Study||733
8559370|NCT00077636|21103290|P1|STARTED|Overall Study||736
8559371|NCT00077623|21103311|P3|NOT COMPLETED|Overall Study||32
8559372|NCT00077623|21103312|P2|NOT COMPLETED|Overall Study||43
8559373|NCT00077623|21103313|P1|NOT COMPLETED|Overall Study||36
8559374|NCT00077623|21103311|P3|COMPLETED|Overall Study||159
8559375|NCT00077623|21103312|P2|COMPLETED|Overall Study||148
8559376|NCT00077623|21103313|P1|COMPLETED|Overall Study||154
8559377|NCT00077623|21103311|P3|STARTED|Overall Study||191
8559378|NCT00077623|21103312|P2|STARTED|Overall Study||191
8559379|NCT00077623|21103313|P1|STARTED|Overall Study||190
8559380|NCT00077610|21103348|P3|NOT COMPLETED|Overall Study||46
8559381|NCT00077610|21103349|P2|NOT COMPLETED|Overall Study||56
8559382|NCT00077610|21103350|P1|NOT COMPLETED|Overall Study||54
8559383|NCT00077610|21103348|P3|COMPLETED|Overall Study||180
8559384|NCT00077610|21103349|P2|COMPLETED|Overall Study||168
8559385|NCT00077610|21103350|P1|COMPLETED|Overall Study||169
8559386|NCT00077610|21103348|P3|Started Treatment|Overall Study||225
8559387|NCT00077610|21103349|P2|Started Treatment|Overall Study||220
8559388|NCT00077610|21103350|P1|Started Treatment|Overall Study||221
8559389|NCT00077610|21103348|P3|STARTED|Overall Study||226
8559390|NCT00077610|21103349|P2|STARTED|Overall Study||224
8559391|NCT00077610|21103350|P1|STARTED|Overall Study||223
8559392|NCT00077376|21103379|P1|NOT COMPLETED|Overall Study||22
8559393|NCT00077376|21103379|P1|COMPLETED|Overall Study||39
8559394|NCT00077376|21103379|P1|HER2+ in Central Testing|Overall Study||39
8559395|NCT00077376|21103379|P1|Treated|Overall Study||59
8559396|NCT00077376|21103379|P1|STARTED|Overall Study||61
8559397|NCT00077207|21103390|P1|NOT COMPLETED|Overall Study||30
8559398|NCT00077207|21103390|P1|COMPLETED|Overall Study||36
8559399|NCT00077207|21103390|P1|STARTED|Overall Study||66
8559400|NCT00077064|21103402|P2|NOT COMPLETED|Overall Study||6
8559401|NCT00077064|21103403|P1|NOT COMPLETED|Overall Study||0
8559402|NCT00077064|21103402|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
8559403|NCT00077064|21103403|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
8559404|NCT00077064|21103402|P2|STARTED|Overall Study||16
8559405|NCT00077064|21103403|P1|STARTED|Overall Study||17
8559406|NCT00076999|21103419|P5|NOT COMPLETED|Overall Study||25
8559407|NCT00076999|21103420|P4|NOT COMPLETED|Overall Study||1
8559408|NCT00076999|21103421|P3|NOT COMPLETED|Overall Study||17
8559409|NCT00076999|21103422|P2|NOT COMPLETED|Overall Study||24
8559410|NCT00076999|21103423|P1|NOT COMPLETED|Overall Study||12
8559411|NCT00076999|21103419|P5|COMPLETED|Overall Study||9
8559412|NCT00076999|21103420|P4|COMPLETED|Overall Study||5
8559413|NCT00076999|21103421|P3|COMPLETED|Overall Study||2
8559414|NCT00076999|21103422|P2|COMPLETED|Overall Study||7
8559415|NCT00076999|21103423|P1|COMPLETED|Overall Study||13
8559416|NCT00076999|21103419|P5|STARTED|Overall Study||34
8559417|NCT00076999|21103420|P4|STARTED|Overall Study||6
8559418|NCT00076999|21103421|P3|STARTED|Overall Study||19
8559419|NCT00076999|21103422|P2|STARTED|Overall Study||31
8559420|NCT00076999|21103423|P1|STARTED|Overall Study||25
8559421|NCT00003222|21103542|P2|NOT COMPLETED|Overall Study||1
8559422|NCT00003222|21103543|P1|NOT COMPLETED|Overall Study||0
8559423|NCT00003222|21103542|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
8559424|NCT00003222|21103543|P1|COMPLETED|Overall Study||13
8559425|NCT00003222|21103542|P2|STARTED|Overall Study||28
8559426|NCT00003222|21103543|P1|STARTED|Overall Study||13
8559427|NCT00076804|21103555|P2|NOT COMPLETED|Overall Study||69
8559428|NCT00076804|21103556|P1|NOT COMPLETED|Overall Study||60
8559429|NCT00076804|21103555|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
8559430|NCT00076804|21103556|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
8559431|NCT00076804|21103555|P2|STARTED|Overall Study||137
8559432|NCT00076804|21103556|P1|STARTED|Overall Study||137
8559433|NCT00076752|21103568|P1|NOT COMPLETED|Overall Study||3
8559434|NCT00076752|21103568|P1|COMPLETED|Overall Study||6
8559435|NCT00076752|21103568|P1|STARTED|Overall Study||9
8559436|NCT00076622|21103591|P4|NOT COMPLETED|Overall Study||0
8559437|NCT00076622|21103592|P3|NOT COMPLETED|Overall Study||0
8559438|NCT00076622|21103593|P2|NOT COMPLETED|Overall Study||0
8559439|NCT00076622|21103594|P1|NOT COMPLETED|Overall Study||0
8559440|NCT00076622|21103591|P4|COMPLETED|Overall Study||18
8559441|NCT00076622|21103592|P3|COMPLETED|Overall Study||40
8559442|NCT00076622|21103593|P2|COMPLETED|Overall Study||13
8559443|NCT00076622|21103594|P1|COMPLETED|Overall Study||23
8559444|NCT00076622|21103591|P4|STARTED|Overall Study||18
8559445|NCT00076622|21103592|P3|STARTED|Overall Study||40
8559446|NCT00076622|21103593|P2|STARTED|Overall Study||13
8559447|NCT00076622|21103594|P1|STARTED|Overall Study||23
8559448|NCT00076570|21103614|P2|NOT COMPLETED|Overall Study||8
8559449|NCT00076570|21103615|P1|NOT COMPLETED|Overall Study||8
8559450|NCT00076570|21103614|P2|COMPLETED|Overall Study||8
8559451|NCT00076570|21103615|P1|COMPLETED|Overall Study||7
8559452|NCT00076570|21103614|P2|STARTED|Overall Study||16
8559453|NCT00076570|21103615|P1|STARTED|Overall Study||15
8559454|NCT00003298|21103623|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
8559455|NCT00003298|21103623|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
8559456|NCT00003298|21103623|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
8559457|NCT00003298|21103623|P1|STARTED|Step 2 (Adjuvant Therapy)||10
8559458|NCT00003298|21103623|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
8559459|NCT00003298|21103623|P1|COMPLETED|Re-register to Step 2 After Surgery||10
8559460|NCT00003298|21103623|P1|STARTED|Re-register to Step 2 After Surgery||28
8559461|NCT00003298|21103623|P1|NOT COMPLETED|Surgery||7
8559462|NCT00003298|21103623|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
8559463|NCT00003298|21103623|P1|STARTED|Surgery||35
8559464|NCT00003298|21103623|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
8559465|NCT00003298|21103623|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
8559466|NCT00003298|21103623|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
8559467|NCT00003298|21103623|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
8559468|NCT00003298|21103623|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
8559469|NCT00076336|21103633|P2|NOT COMPLETED|Overall Study||56
8559470|NCT00076336|21103634|P1|NOT COMPLETED|Overall Study||52
8559471|NCT00076336|21103633|P2|COMPLETED|Overall Study||60
8559472|NCT00076336|21103634|P1|COMPLETED|Overall Study||64
8559473|NCT00076336|21103633|P2|Completed Week 104|Overall Study||62
8559474|NCT00076336|21103634|P1|Completed Week 104|Overall Study||70
8559475|NCT00076336|21103633|P2|Completed Week 52|Overall Study||94
8559476|NCT00076336|21103634|P1|Completed Week 52|Overall Study||97
8559477|NCT00076336|21103633|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
8559478|NCT00076336|21103634|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
8559479|NCT00076336|21103633|P2|Safety Population|Overall Study||116
8559480|NCT00076336|21103634|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
8559481|NCT00076336|21103633|P2|STARTED|Overall Study||116
8559482|NCT00076336|21103634|P1|STARTED|Overall Study||116
8559483|NCT00076258|21103650|P2|NOT COMPLETED|Overall Study||3
8559484|NCT00076258|21103651|P1|NOT COMPLETED|Overall Study||1
8559485|NCT00076258|21103650|P2|COMPLETED|Overall Study||61
8559486|NCT00076258|21103651|P1|COMPLETED|Overall Study||61
8559487|NCT00076258|21103650|P2|STARTED|Overall Study||64
8559488|NCT00076258|21103651|P1|STARTED|Overall Study||62
8559489|NCT00076245|21103661|P4|NOT COMPLETED|Overall Study||1
8559490|NCT00076245|21103662|P3|NOT COMPLETED|Overall Study||0
8559491|NCT00076245|21103663|P2|NOT COMPLETED|Overall Study||0
8559492|NCT00076245|21103664|P1|NOT COMPLETED|Overall Study||0
8559493|NCT00076245|21103661|P4|COMPLETED|Overall Study||14
8559494|NCT00076245|21103662|P3|COMPLETED|Overall Study||15
8559495|NCT00076245|21103663|P2|COMPLETED|Overall Study||15
8559496|NCT00076245|21103664|P1|COMPLETED|Overall Study||16
8559497|NCT00076245|21103661|P4|STARTED|Overall Study||15
8559498|NCT00076245|21103662|P3|STARTED|Overall Study||15
8559499|NCT00076245|21103663|P2|STARTED|Overall Study||15
8559500|NCT00076245|21103664|P1|STARTED|Overall Study||16
8559501|NCT00076219|21103680|P2|NOT COMPLETED|Overall Study||11
8559502|NCT00076219|21103681|P1|NOT COMPLETED|Overall Study||18
8559503|NCT00076219|21103680|P2|COMPLETED|Overall Study||550
8559504|NCT00076219|21103681|P1|COMPLETED|Overall Study||545
8559505|NCT00076219|21103680|P2|STARTED|Overall Study||561
8559506|NCT00076219|21103681|P1|STARTED|Overall Study||563
8559507|NCT00076102|21103687|P1|NOT COMPLETED|Overall Study||5
8559508|NCT00076102|21103687|P1|COMPLETED|Overall Study||31
8559509|NCT00076102|21103687|P1|STARTED|Overall Study||36
8559510|NCT00076050|21103701|P2|NOT COMPLETED|Overall Study||43
8559511|NCT00076050|21103702|P1|NOT COMPLETED|Overall Study||23
8559512|NCT00076050|21103701|P2|COMPLETED|Overall Study||83
8559513|NCT00076050|21103702|P1|COMPLETED|Overall Study||99
8559514|NCT00076050|21103701|P2|STARTED|Overall Study||126
8559515|NCT00076050|21103702|P1|STARTED|Overall Study||122
8559516|NCT00076024|21103715|P4|NOT COMPLETED|Phase 2, Open-label||16
8559517|NCT00076024|21103716|P3|NOT COMPLETED|Phase 2, Open-label||0
8559518|NCT00076024|21103717|P2|NOT COMPLETED|Phase 2, Open-label||0
8559519|NCT00076024|21103718|P1|NOT COMPLETED|Phase 2, Open-label||0
8559520|NCT00076024|21103715|P4|COMPLETED|Phase 2, Open-label||0
8559521|NCT00076024|21103716|P3|COMPLETED|Phase 2, Open-label||0
8559522|NCT00076024|21103717|P2|COMPLETED|Phase 2, Open-label||0
8559523|NCT00076024|21103718|P1|COMPLETED|Phase 2, Open-label||0
8559524|NCT00076024|21103715|P4|STARTED|Phase 2, Open-label||16
8559525|NCT00076024|21103716|P3|STARTED|Phase 2, Open-label||0
8559526|NCT00076024|21103717|P2|STARTED|Phase 2, Open-label||0
8559527|NCT00076024|21103718|P1|STARTED|Phase 2, Open-label||0
8559528|NCT00076024|21103715|P4|NOT COMPLETED|Phase 2, Double-blind||0
8559529|NCT00076024|21103716|P3|NOT COMPLETED|Phase 2, Double-blind||56
8559530|NCT00076024|21103717|P2|NOT COMPLETED|Phase 2, Double-blind||112
8559531|NCT00076024|21103718|P1|NOT COMPLETED|Phase 2, Double-blind||0
8559532|NCT00076024|21103715|P4|COMPLETED|Phase 2, Double-blind||0
8559533|NCT00076024|21103716|P3|COMPLETED|Phase 2, Double-blind||0
8559534|NCT00076024|21103717|P2|COMPLETED|Phase 2, Double-blind||0
8559535|NCT00076024|21103718|P1|COMPLETED|Phase 2, Double-blind||0
8559536|NCT00076024|21103715|P4|Treated|Phase 2, Double-blind||0
8559537|NCT00076024|21103716|P3|Treated|Phase 2, Double-blind||56
8559538|NCT00076024|21103717|P2|Treated|Phase 2, Double-blind||111
8559539|NCT00076024|21103718|P1|Treated|Phase 2, Double-blind||0
8559540|NCT00076024|21103715|P4|STARTED|Phase 2, Double-blind||0
8559541|NCT00076024|21103716|P3|STARTED|Phase 2, Double-blind||56
8559542|NCT00076024|21103717|P2|STARTED|Phase 2, Double-blind||112
8559543|NCT00076024|21103718|P1|STARTED|Phase 2, Double-blind||0
8559544|NCT00076024|21103715|P4|NOT COMPLETED|Phase 1, Lead-in||0
8559545|NCT00076024|21103716|P3|NOT COMPLETED|Phase 1, Lead-in||0
8559546|NCT00076024|21103717|P2|NOT COMPLETED|Phase 1, Lead-in||0
8559547|NCT00076024|21103718|P1|NOT COMPLETED|Phase 1, Lead-in||6
8559548|NCT00076024|21103715|P4|COMPLETED|Phase 1, Lead-in||0
8559549|NCT00076024|21103716|P3|COMPLETED|Phase 1, Lead-in||0
8559550|NCT00076024|21103717|P2|COMPLETED|Phase 1, Lead-in||0
8559551|NCT00076024|21103718|P1|COMPLETED|Phase 1, Lead-in||0
8559552|NCT00076024|21103715|P4|STARTED|Phase 1, Lead-in||0
8559553|NCT00076024|21103716|P3|STARTED|Phase 1, Lead-in||0
8559554|NCT00076024|21103717|P2|STARTED|Phase 1, Lead-in||0
8559555|NCT00076024|21103718|P1|STARTED|Phase 1, Lead-in||6
8559556|NCT00076011|21103732|P1|NOT COMPLETED|Overall Study||52
8559557|NCT00076011|21103732|P1|COMPLETED|Overall Study||0
8559558|NCT00076011|21103732|P1|STARTED|Overall Study||52
8559559|NCT00075946|21103744|P5|NOT COMPLETED|Overall Study||188
8559560|NCT00075946|21103745|P4|NOT COMPLETED|Overall Study||30
8559561|NCT00075946|21103746|P3|NOT COMPLETED|Overall Study||28
8559562|NCT00075946|21103747|P2|NOT COMPLETED|Overall Study||151
8559563|NCT00075946|21103748|P1|NOT COMPLETED|Overall Study||148
8559564|NCT00075946|21103744|P5|COMPLETED|Overall Study||0
8559565|NCT00075946|21103745|P4|COMPLETED|Overall Study||0
8559566|NCT00075946|21103746|P3|COMPLETED|Overall Study||0
8559567|NCT00075946|21103747|P2|COMPLETED|Overall Study||0
8559568|NCT00075946|21103748|P1|COMPLETED|Overall Study||0
8559569|NCT00075946|21103744|P5|Included in Primary Analysis|Overall Study||0
8559570|NCT00075946|21103745|P4|Included in Primary Analysis|Overall Study||29
8559571|NCT00075946|21103746|P3|Included in Primary Analysis|Overall Study||23
8559572|NCT00075946|21103747|P2|Included in Primary Analysis|Overall Study||146
8559573|NCT00075946|21103748|P1|Included in Primary Analysis|Overall Study||143
8559574|NCT00075946|21103744|P5|Treated and With Toxicity Data Available|Overall Study||154
8559575|NCT00075946|21103745|P4|Treated and With Toxicity Data Available|Overall Study||29
8559576|NCT00075946|21103746|P3|Treated and With Toxicity Data Available|Overall Study||27
8559577|NCT00075946|21103747|P2|Treated and With Toxicity Data Available|Overall Study||148
8559578|NCT00075946|21103748|P1|Treated and With Toxicity Data Available|Overall Study||142
8559579|NCT00075946|21103744|P5|STARTED|Overall Study||188
8559580|NCT00075946|21103745|P4|STARTED|Overall Study||30
8559581|NCT00075946|21103746|P3|STARTED|Overall Study||28
8559582|NCT00075946|21103747|P2|STARTED|Overall Study||151
8559583|NCT00075946|21103748|P1|STARTED|Overall Study||148
8559584|NCT00075881|21103763|P1|NOT COMPLETED|Overall Study||43
8559585|NCT00075881|21103763|P1|COMPLETED|Overall Study||1
8559586|NCT00075881|21103763|P1|Reinduction Treatment|Overall Study||7
8559587|NCT00075881|21103763|P1|Maintenance Treatment|Overall Study||15
8559588|NCT00075881|21103763|P1|Induction Treatment|Overall Study||42
8559589|NCT00075881|21103763|P1|Treated|Overall Study||42
8559590|NCT00075881|21103763|P1|Eligible|Overall Study||43
8559591|NCT00075881|21103763|P1|STARTED|Overall Study||44
8559592|NCT00075829|21103774|P4|NOT COMPLETED|Overall Study||24
8559593|NCT00075829|21103775|P3|NOT COMPLETED|Overall Study||34
8559594|NCT00075829|21103776|P2|NOT COMPLETED|Overall Study||118
8559595|NCT00075829|21103777|P1|NOT COMPLETED|Overall Study||258
8559596|NCT00075829|21103774|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
8559597|NCT00075829|21103775|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
8559598|NCT00075829|21103776|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
8559599|NCT00075829|21103777|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
8559600|NCT00075829|21103774|P4|STARTED|Overall Study||37
8559601|NCT00075829|21103775|P3|STARTED|Overall Study||48
8559602|NCT00075829|21103776|P2|STARTED|Overall Study||189
8559603|NCT00075829|21103777|P1|STARTED|Overall Study||436
8559604|NCT00075816|21103807|P2|NOT COMPLETED|Overall Study||11
8559605|NCT00075816|21103808|P1|NOT COMPLETED|Overall Study||14
8559606|NCT00075816|21103807|P2|COMPLETED|Overall Study||262
8559607|NCT00075816|21103808|P1|COMPLETED|Overall Study||264
8559608|NCT00075816|21103807|P2|STARTED|Overall Study||273
8559609|NCT00075816|21103808|P1|STARTED|Overall Study||278
8559610|NCT00075803|21103848|P2|NOT COMPLETED|Overall Study||0
8559611|NCT00075803|21103849|P1|NOT COMPLETED|Overall Study||0
8559612|NCT00075803|21103848|P2|COMPLETED|Overall Study||305
8559613|NCT00075803|21103849|P1|COMPLETED|Overall Study||295
8559614|NCT00075803|21103848|P2|STARTED|Overall Study||305
8559615|NCT00075803|21103849|P1|STARTED|Overall Study||295
8559616|NCT00075764|21103877|P2|NOT COMPLETED|Overall Study||349
8559617|NCT00075764|21103878|P1|NOT COMPLETED|Overall Study||345
8559618|NCT00075764|21103877|P2|COMPLETED|Overall Study||0
8559619|NCT00075764|21103878|P1|COMPLETED|Overall Study||0
8559620|NCT00075764|21103877|P2|STARTED|Overall Study||349
8559621|NCT00075764|21103878|P1|STARTED|Overall Study||345
8559622|NCT00075725|21103902|P12|NOT COMPLETED|Overall Study||18
8559623|NCT00075725|21103903|P11|NOT COMPLETED|Overall Study||9
8559624|NCT00075725|21103904|P10|NOT COMPLETED|Overall Study||18
8559625|NCT00075725|21103905|P9|NOT COMPLETED|Overall Study||117
8559626|NCT00075725|21103906|P8|NOT COMPLETED|Overall Study||295
8559627|NCT00075725|21103907|P7|NOT COMPLETED|Overall Study||75
8559628|NCT00075725|21103908|P6|NOT COMPLETED|Overall Study||313
8559629|NCT00075725|21103909|P5|NOT COMPLETED|Overall Study||66
8559630|NCT00075725|21103910|P4|NOT COMPLETED|Overall Study||78
8559631|NCT00075725|21103911|P3|NOT COMPLETED|Overall Study||121
8559632|NCT00075725|21103912|P2|NOT COMPLETED|Overall Study||49
8559633|NCT00075725|21103913|P1|NOT COMPLETED|Overall Study||74
8559634|NCT00075725|21103902|P12|COMPLETED|Overall Study||10
8559635|NCT00075725|21103903|P11|COMPLETED|Overall Study||3
8559636|NCT00075725|21103904|P10|COMPLETED|Overall Study||16
8559637|NCT00075725|21103905|P9|COMPLETED|Overall Study||185
8559638|NCT00075725|21103906|P8|COMPLETED|Overall Study||401
8559639|NCT00075725|21103907|P7|COMPLETED|Overall Study||171
8559640|NCT00075725|21103908|P6|COMPLETED|Overall Study||397
8559641|NCT00075725|21103909|P5|COMPLETED|Overall Study||166
8559642|NCT00075725|21103910|P4|COMPLETED|Overall Study||168
8559643|NCT00075725|21103911|P3|COMPLETED|Overall Study||175
8559644|NCT00075725|21103912|P2|COMPLETED|Overall Study||57
8559645|NCT00075725|21103913|P1|COMPLETED|Overall Study||172
8559646|NCT00075725|21103902|P12|STARTED|Overall Study||28
8559647|NCT00075725|21103903|P11|STARTED|Overall Study||12
8559648|NCT00075725|21103904|P10|STARTED|Overall Study||34
8559649|NCT00075725|21103905|P9|STARTED|Overall Study||302
8559650|NCT00075725|21103906|P8|STARTED|Overall Study||696
8559651|NCT00075725|21103907|P7|STARTED|Overall Study||246
8559652|NCT00075725|21103908|P6|STARTED|Overall Study||710
8559653|NCT00075725|21103909|P5|STARTED|Overall Study||232
8559654|NCT00075725|21103910|P4|STARTED|Overall Study||246
8559655|NCT00075725|21103911|P3|STARTED|Overall Study||296
8559656|NCT00075725|21103912|P2|STARTED|Overall Study||106
8559657|NCT00075725|21103913|P1|STARTED|Overall Study||246
8559658|NCT00075608|21104002|P1|NOT COMPLETED|Overall Study||0
8559659|NCT00075608|21104002|P1|COMPLETED|Overall Study||12
8559660|NCT00075608|21104002|P1|STARTED|Overall Study||12
8559661|NCT00075582|21104010|P2|NOT COMPLETED|Overall Study||35
8559662|NCT00075582|21104011|P1|NOT COMPLETED|Overall Study||50
8559663|NCT00075582|21104010|P2|COMPLETED|Overall Study||50
8559664|NCT00075582|21104011|P1|COMPLETED|Overall Study||255
8559665|NCT00075582|21104010|P2|STARTED|Overall Study||85
8559666|NCT00075582|21104011|P1|STARTED|Overall Study||305
8559667|NCT00075504|21104025|P2|NOT COMPLETED|Overall Study||7
8559668|NCT00075504|21104026|P1|NOT COMPLETED|Overall Study||9
8559669|NCT00075504|21104025|P2|COMPLETED|Overall Study||3
8559670|NCT00075504|21104026|P1|COMPLETED|Overall Study||14
8559671|NCT00075504|21104025|P2|STARTED|Overall Study||10
8559672|NCT00075504|21104026|P1|STARTED|Overall Study||23
8559673|NCT00075478|21104038|P2|NOT COMPLETED|Overall Study||1
8559674|NCT00075478|21104039|P1|NOT COMPLETED|Overall Study||1
8559675|NCT00075478|21104038|P2|COMPLETED|Overall Study||44
8559676|NCT00075478|21104039|P1|COMPLETED|Overall Study||41
8559677|NCT00075478|21104038|P2|STARTED|Overall Study||45
8559678|NCT00075478|21104039|P1|STARTED|Overall Study||42
8559679|NCT00075400|21104059|P1|NOT COMPLETED|Overall Study||3
8559680|NCT00075400|21104059|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
8559681|NCT00075400|21104059|P1|STARTED|Overall Study||26
8559682|NCT00075335|21104073|P1|NOT COMPLETED|Overall Study||0
8559683|NCT00075335|21104073|P1|COMPLETED|Overall Study||8
8559684|NCT00075335|21104073|P1|STARTED|Overall Study||8
8559685|NCT00075270|21104080|P2|NOT COMPLETED|Overall Study||284
8559686|NCT00075270|21104081|P1|NOT COMPLETED|Overall Study||286
8559687|NCT00075270|21104080|P2|COMPLETED|Overall Study||4
8559688|NCT00075270|21104081|P1|COMPLETED|Overall Study||5
8559689|NCT00075270|21104080|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
8559690|NCT00075270|21104081|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
8559691|NCT00075270|21104080|P2|STARTED|Overall Study||288
8559692|NCT00075270|21104081|P1|STARTED|Overall Study||291
8559693|NCT00075218|21104127|P3|NOT COMPLETED|Open-Label Treatment||255
8559694|NCT00075218|21104128|P2|NOT COMPLETED|Open-Label Treatment||0
8559695|NCT00075218|21104129|P1|NOT COMPLETED|Open-Label Treatment||0
8559696|NCT00075218|21104127|P3|COMPLETED|Open-Label Treatment||0
8559697|NCT00075218|21104128|P2|COMPLETED|Open-Label Treatment||0
8559698|NCT00075218|21104129|P1|COMPLETED|Open-Label Treatment||0
8559699|NCT00075218|21104127|P3|STARTED|Open-Label Treatment||255
8559700|NCT00075218|21104128|P2|STARTED|Open-Label Treatment||0
8559701|NCT00075218|21104129|P1|STARTED|Open-Label Treatment||0
8559702|NCT00075218|21104127|P3|NOT COMPLETED|Double-Blind Treatment||0
8559703|NCT00075218|21104128|P2|NOT COMPLETED|Double-Blind Treatment||15
8559704|NCT00075218|21104129|P1|NOT COMPLETED|Double-Blind Treatment||91
8559705|NCT00075218|21104127|P3|COMPLETED|Double-Blind Treatment||0
8559706|NCT00075218|21104128|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
8559707|NCT00075218|21104129|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
8559708|NCT00075218|21104127|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
8559709|NCT00075218|21104128|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
8559710|NCT00075218|21104129|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
8559711|NCT00075218|21104127|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
8559712|NCT00075218|21104128|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
8559713|NCT00075218|21104129|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
8559714|NCT00075218|21104127|P3|STARTED|Double-Blind Treatment||0
8559715|NCT00075218|21104128|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
8559716|NCT00075218|21104129|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
8559717|NCT00075088|21104164|P2|NOT COMPLETED|Overall Study||0
8559718|NCT00075088|21104165|P1|NOT COMPLETED|Overall Study||0
8559719|NCT00075088|21104164|P2|COMPLETED|Overall Study||391
8559720|NCT00075088|21104165|P1|COMPLETED|Overall Study||403
8559721|NCT00075088|21104164|P2|STARTED|Overall Study||391
8559722|NCT00075088|21104165|P1|STARTED|Overall Study||403
8559723|NCT00075023|21104178|P2|NOT COMPLETED|Part Two||0
8559724|NCT00075023|21104179|P1|NOT COMPLETED|Part Two||0
8559725|NCT00075023|21104178|P2|COMPLETED|Part Two||0
8559726|NCT00075023|21104179|P1|COMPLETED|Part Two||0
8559727|NCT00075023|21104178|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8559728|NCT00075023|21104179|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8559729|NCT00075023|21104178|P2|NOT COMPLETED|Pilot Study||2
8559730|NCT00075023|21104179|P1|NOT COMPLETED|Pilot Study||2
8559731|NCT00075023|21104178|P2|COMPLETED|Pilot Study||3
8559732|NCT00075023|21104179|P1|COMPLETED|Pilot Study||3
8559733|NCT00075023|21104178|P2|STARTED|Pilot Study||5
8559734|NCT00075023|21104179|P1|STARTED|Pilot Study||5
8559735|NCT00074984|21104188|P2|NOT COMPLETED|Overall Study||8
8559736|NCT00074984|21104189|P1|NOT COMPLETED|Overall Study||3
8559737|NCT00074984|21104188|P2|COMPLETED|Overall Study||43
8559738|NCT00074984|21104189|P1|COMPLETED|Overall Study||28
8559739|NCT00074984|21104188|P2|STARTED|Overall Study||51
8559740|NCT00074984|21104189|P1|STARTED|Overall Study||31
8559741|NCT00074958|21104204|P1|NOT COMPLETED|Overall Study||1
8559742|NCT00074958|21104204|P1|COMPLETED|Overall Study||15
8559743|NCT00074958|21104204|P1|STARTED|Overall Study||16
8559744|NCT00074815|21104212|P3|NOT COMPLETED|Overall Study||12
8559745|NCT00074815|21104213|P2|NOT COMPLETED|Overall Study||6
8559746|NCT00074815|21104214|P1|NOT COMPLETED|Overall Study||5
8559747|NCT00074815|21104212|P3|COMPLETED|Overall Study||30
8559748|NCT00074815|21104213|P2|COMPLETED|Overall Study||34
8559749|NCT00074815|21104214|P1|COMPLETED|Overall Study||37
8559750|NCT00074815|21104212|P3|STARTED|Overall Study||42
8559751|NCT00074815|21104213|P2|STARTED|Overall Study||40
8559752|NCT00074815|21104214|P1|STARTED|Overall Study||42
8559753|NCT00074802|21104224|P2|NOT COMPLETED|Overall Study||7
8559754|NCT00074802|21104225|P1|NOT COMPLETED|Overall Study||9
8559755|NCT00074802|21104224|P2|COMPLETED|Overall Study||25
8559756|NCT00074802|21104225|P1|COMPLETED|Overall Study||20
8559757|NCT00074802|21104224|P2|STARTED|Overall Study||32
8559758|NCT00074802|21104225|P1|STARTED|Overall Study||29
8559759|NCT00074711|21104245|P2|NOT COMPLETED|Overall Study||15
8559760|NCT00074711|21104246|P1|NOT COMPLETED|Overall Study||15
8559761|NCT00074711|21104245|P2|COMPLETED|Overall Study||106
8559762|NCT00074711|21104246|P1|COMPLETED|Overall Study||105
8559763|NCT00074711|21104245|P2|STARTED|Overall Study||121
8559764|NCT00074711|21104246|P1|STARTED|Overall Study||120
8559765|NCT00074581|21104264|P2|NOT COMPLETED|Overall Study||226
8559766|NCT00074581|21104265|P1|NOT COMPLETED|Overall Study||244
8559767|NCT00074581|21104264|P2|COMPLETED|Overall Study||1541
8559768|NCT00074581|21104265|P1|COMPLETED|Overall Study||1545
8559769|NCT00074581|21104264|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
8559770|NCT00074581|21104265|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
8559771|NCT00074490|21104278|P6|NOT COMPLETED|Overall Study||0
8559772|NCT00074490|21104279|P5|NOT COMPLETED|Overall Study||3
8559773|NCT00074490|21104280|P4|NOT COMPLETED|Overall Study||0
8559774|NCT00074490|21104281|P3|NOT COMPLETED|Overall Study||0
8559775|NCT00074490|21104282|P2|NOT COMPLETED|Overall Study||7
8559776|NCT00074490|21104283|P1|NOT COMPLETED|Overall Study||0
8559777|NCT00074490|21104278|P6|COMPLETED|Overall Study||221
8559778|NCT00074490|21104279|P5|COMPLETED|Overall Study||42
8559779|NCT00074490|21104280|P4|COMPLETED|Overall Study||44
8559780|NCT00074490|21104281|P3|COMPLETED|Overall Study||40
8559781|NCT00074490|21104282|P2|COMPLETED|Overall Study||27
8559782|NCT00074490|21104283|P1|COMPLETED|Overall Study||1
8559783|NCT00074490|21104278|P6|STARTED|Overall Study||221
8559784|NCT00074490|21104279|P5|STARTED|Overall Study||45
8559785|NCT00074490|21104280|P4|STARTED|Overall Study||44
8559786|NCT00074490|21104281|P3|STARTED|Overall Study||40
8559787|NCT00074490|21104282|P2|STARTED|Overall Study||34
8559788|NCT00074490|21104283|P1|STARTED|Overall Study||1
8559789|NCT00074412|21104317|P2|NOT COMPLETED|Overall Study||84
8559790|NCT00074412|21104318|P1|NOT COMPLETED|Overall Study||82
8559791|NCT00074412|21104317|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
8559792|NCT00074412|21104318|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
8559793|NCT00074412|21104317|P2|Month 12 Visit|Overall Study||735
8559794|NCT00074412|21104318|P1|Month 12 Visit|Overall Study||733
8559795|NCT00074412|21104317|P2|Month 9 Visit|Overall Study||741
8559796|NCT00074412|21104318|P1|Month 9 Visit|Overall Study||741
8559797|NCT00074412|21104317|P2|Month 6 Visit|Overall Study||748
8559798|NCT00074412|21104318|P1|Month 6 Visit|Overall Study||748
8559799|NCT00074412|21104317|P2|Month 5 Visit|Overall Study||750
8559800|NCT00074412|21104318|P1|Month 5 Visit|Overall Study||756
8559801|NCT00074412|21104317|P2|Month 4 Visit|Overall Study||752
8559802|NCT00074412|21104318|P1|Month 4 Visit|Overall Study||758
8559803|NCT00074412|21104317|P2|Month 3 Visit|Overall Study||755
8559804|NCT00074412|21104318|P1|Month 3 Visit|Overall Study||759
8559805|NCT00074412|21104317|P2|Week 8 Visit|Overall Study||759
8559806|NCT00074412|21104318|P1|Week 8 Visit|Overall Study||759
8559807|NCT00074412|21104317|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
8559808|NCT00074412|21104318|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
8559809|NCT00074308|21104334|P5|NOT COMPLETED|Overall Study||0
8559810|NCT00074308|21104335|P4|NOT COMPLETED|Overall Study||0
8559811|NCT00074308|21104336|P3|NOT COMPLETED|Overall Study||0
8559812|NCT00074308|21104337|P2|NOT COMPLETED|Overall Study||0
8559813|NCT00074308|21104338|P1|NOT COMPLETED|Overall Study||0
8559814|NCT00074308|21104334|P5|COMPLETED|Overall Study||23
8559815|NCT00074308|21104335|P4|COMPLETED|Overall Study||8
8559816|NCT00074308|21104336|P3|COMPLETED|Overall Study||3
8559817|NCT00074308|21104337|P2|COMPLETED|Overall Study||3
8559818|NCT00074308|21104338|P1|COMPLETED|Overall Study||3
8559819|NCT00074308|21104334|P5|STARTED|Overall Study||23
8559820|NCT00074308|21104335|P4|STARTED|Overall Study||8
8559821|NCT00074308|21104336|P3|STARTED|Overall Study||3
8559822|NCT00074308|21104337|P2|STARTED|Overall Study||3
8559823|NCT00074308|21104338|P1|STARTED|Overall Study||3
8559824|NCT00074282|21104349|P3|NOT COMPLETED|Step 2||24
8559825|NCT00074282|21104350|P2|NOT COMPLETED|Step 2||2
8559826|NCT00074282|21104351|P1|NOT COMPLETED|Step 2||0
8559827|NCT00074282|21104349|P3|COMPLETED|Step 2||7
8559828|NCT00074282|21104350|P2|COMPLETED|Step 2||7
8559829|NCT00074282|21104351|P1|COMPLETED|Step 2||0
8559830|NCT00074282|21104349|P3|STARTED|Step 2||31
8559831|NCT00074282|21104350|P2|STARTED|Step 2||9
8559832|NCT00074282|21104351|P1|STARTED|Step 2||0
8559833|NCT00074282|21104349|P3|NOT COMPLETED|Step 1||0
8559834|NCT00074282|21104350|P2|NOT COMPLETED|Step 1||0
8559835|NCT00074282|21104351|P1|NOT COMPLETED|Step 1||58
8559836|NCT00074282|21104349|P3|COMPLETED|Step 1||0
8559837|NCT00074282|21104350|P2|COMPLETED|Step 1||0
8559838|NCT00074282|21104351|P1|COMPLETED|Step 1||44
8559839|NCT00074282|21104349|P3|Started Treatment|Step 1||0
8559840|NCT00074282|21104350|P2|Started Treatment|Step 1||0
8559841|NCT00074282|21104351|P1|Started Treatment|Step 1||96
8559842|NCT00074282|21104349|P3|Eligible|Step 1||0
8559843|NCT00074282|21104350|P2|Eligible|Step 1||0
8559844|NCT00074282|21104351|P1|Eligible|Step 1||98
8559845|NCT00074282|21104349|P3|STARTED|Step 1||0
8559846|NCT00074282|21104350|P2|STARTED|Step 1||0
8559847|NCT00074282|21104351|P1|STARTED|Step 1||102
8559848|NCT00074269|21104361|P1|NOT COMPLETED|Overall Study||0
8559849|NCT00074269|21104361|P1|COMPLETED|Overall Study||5
8559850|NCT00074269|21104361|P1|STARTED|Overall Study||5
8559851|NCT00074165|21104371|P1|NOT COMPLETED|Overall Study||0
8559852|NCT00074165|21104371|P1|COMPLETED|Overall Study||17
8559853|NCT00074165|21104371|P1|STARTED|Overall Study||17
8559854|NCT00074152|21104378|P2|NOT COMPLETED|Overall Study||33
8559855|NCT00074152|21104379|P1|NOT COMPLETED|Overall Study||55
8559856|NCT00074152|21104378|P2|COMPLETED|Overall Study||52
8559857|NCT00074152|21104379|P1|COMPLETED|Overall Study||22
8559858|NCT00074152|21104378|P2|STARTED|Overall Study||85
8559859|NCT00074152|21104379|P1|STARTED|Overall Study||77
8559860|NCT00074035|21104389|P1|NOT COMPLETED|Overall Study||0
8559861|NCT00074035|21104389|P1|COMPLETED|Overall Study||38
8559862|NCT00074035|21104389|P1|STARTED|Overall Study||38
8559863|NCT00073983|21104396|P1|NOT COMPLETED|Overall Study||1
8559864|NCT00073983|21104396|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
8559865|NCT00073983|21104396|P1|STARTED|Overall Study||54
8559866|NCT00073957|21104411|P1|NOT COMPLETED|Overall Study||0
8559867|NCT00073957|21104411|P1|COMPLETED|Overall Study||25
8559868|NCT00073957|21104411|P1|STARTED|Overall Study||25
8559869|NCT00073918|21104417|P1|NOT COMPLETED|Overall Study||4
8559870|NCT00073918|21104417|P1|COMPLETED|Overall Study||107
8559871|NCT00073918|21104417|P1|STARTED|Overall Study||111
8559872|NCT00073749|21104431|P7|NOT COMPLETED|Overall Study||40
8559873|NCT00073749|21104432|P6|NOT COMPLETED|Overall Study||6
8559874|NCT00073749|21104433|P5|NOT COMPLETED|Overall Study||6
8559875|NCT00073749|21104434|P4|NOT COMPLETED|Overall Study||6
8559876|NCT00073749|21104435|P3|NOT COMPLETED|Overall Study||11
8559877|NCT00073749|21104436|P2|NOT COMPLETED|Overall Study||5
8559878|NCT00073749|21104437|P1|NOT COMPLETED|Overall Study||2
8559879|NCT00073749|21104431|P7|COMPLETED|Overall Study||3
8559880|NCT00073749|21104432|P6|COMPLETED|Overall Study||0
8559881|NCT00073749|21104433|P5|COMPLETED|Overall Study||0
8559882|NCT00073749|21104434|P4|COMPLETED|Overall Study||0
8559883|NCT00073749|21104435|P3|COMPLETED|Overall Study||0
8559884|NCT00073749|21104436|P2|COMPLETED|Overall Study||0
8559885|NCT00073749|21104437|P1|COMPLETED|Overall Study||0
8559886|NCT00073749|21104431|P7|STARTED|Overall Study||43
8559887|NCT00073749|21104432|P6|STARTED|Overall Study||6
8559888|NCT00073749|21104433|P5|STARTED|Overall Study||6
8559889|NCT00073749|21104434|P4|STARTED|Overall Study||6
8559890|NCT00073749|21104435|P3|STARTED|Overall Study||11
8559891|NCT00073749|21104436|P2|STARTED|Overall Study||5
8559892|NCT00073749|21104437|P1|STARTED|Overall Study||2
8559901|NCT00073333|21104546|P3|NOT COMPLETED|Overall Study||0
8559902|NCT00073333|21104547|P2|NOT COMPLETED|Overall Study||14
8559903|NCT00073333|21104548|P1|NOT COMPLETED|Overall Study||14
8559904|NCT00073333|21104546|P3|COMPLETED|Overall Study||19
8559905|NCT00073333|21104547|P2|COMPLETED|Overall Study||27
8559906|NCT00073333|21104548|P1|COMPLETED|Overall Study||32
8559907|NCT00073333|21104546|P3|STARTED|Overall Study||19
8559908|NCT00073333|21104547|P2|STARTED|Overall Study||41
8559909|NCT00073333|21104548|P1|STARTED|Overall Study||46
8559910|NCT00073307|21104558|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
8559911|NCT00073307|21104559|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8559912|NCT00073307|21104560|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
8559913|NCT00073307|21104558|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
8559914|NCT00073307|21104559|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8559915|NCT00073307|21104560|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
8559916|NCT00073307|21104558|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
8559917|NCT00073307|21104559|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
8559918|NCT00073307|21104560|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
8559919|NCT00073307|21104558|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
8559920|NCT00073307|21104559|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
8559921|NCT00073307|21104560|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
8559922|NCT00073307|21104558|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8559923|NCT00073307|21104559|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
8559924|NCT00073307|21104560|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
8559925|NCT00073307|21104558|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8559926|NCT00073307|21104559|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
8559927|NCT00073307|21104560|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
8559928|NCT00073307|21104558|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
8559929|NCT00073307|21104559|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8559930|NCT00073307|21104560|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8559931|NCT00073307|21104558|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
8559932|NCT00073307|21104559|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
8559933|NCT00073307|21104560|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
8559934|NCT00073073|21104578|P1|NOT COMPLETED|Overall Study||4
8559935|NCT00073073|21104578|P1|COMPLETED|Overall Study||42
8559936|NCT00073073|21104578|P1|STARTED|Overall Study||46
8559937|NCT00073021|21104591|P2|NOT COMPLETED|Overall Study||16
8559938|NCT00073021|21104592|P1|NOT COMPLETED|Overall Study||26
8559939|NCT00073021|21104591|P2|COMPLETED|Overall Study||113
8559940|NCT00073021|21104592|P1|COMPLETED|Overall Study||113
8559941|NCT00073021|21104591|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
8559942|NCT00073021|21104592|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
8559943|NCT00073008|21104622|P2|NOT COMPLETED|Overall Study||63
8559944|NCT00073008|21104623|P1|NOT COMPLETED|Overall Study||62
8559945|NCT00073008|21104622|P2|COMPLETED|Overall Study||3
8559946|NCT00073008|21104623|P1|COMPLETED|Overall Study||3
8559947|NCT00073008|21104622|P2|STARTED|Overall Study||66
8559948|NCT00073008|21104623|P1|STARTED|Overall Study||65
8559949|NCT00072761|21104655|P2|NOT COMPLETED|Overall Study||2
8559950|NCT00072761|21104656|P1|NOT COMPLETED|Overall Study||9
8559951|NCT00072761|21104655|P2|COMPLETED|Overall Study||95
8559952|NCT00072761|21104656|P1|COMPLETED|Overall Study||90
8559953|NCT00072761|21104655|P2|STARTED|Overall Study||97
8559954|NCT00072761|21104656|P1|STARTED|Overall Study||99
8559955|NCT00072475|21104662|P1|NOT COMPLETED|Overall Study||97
8559956|NCT00072475|21104662|P1|COMPLETED|Overall Study||45
8559957|NCT00072475|21104662|P1|STARTED|Overall Study||142
8559958|NCT00072449|21104670|P1|NOT COMPLETED|Overall Study||0
8559959|NCT00072449|21104670|P1|COMPLETED|Overall Study||12
8559960|NCT00072449|21104670|P1|STARTED|Overall Study||12
8559961|NCT00072384|21104677|P1|NOT COMPLETED|Overall Study||9
8559962|NCT00072384|21104677|P1|COMPLETED|Overall Study||21
8559963|NCT00072384|21104677|P1|STARTED|Overall Study||30
8559964|NCT00072293|21104690|P2|NOT COMPLETED|Overall Study||2
8559965|NCT00072293|21104691|P1|NOT COMPLETED|Overall Study||1
8559966|NCT00072293|21104690|P2|COMPLETED|Overall Study||467
8559967|NCT00072293|21104691|P1|COMPLETED|Overall Study||464
8559968|NCT00072293|21104690|P2|STARTED|Overall Study||469
8559969|NCT00072293|21104691|P1|STARTED|Overall Study||465
8559970|NCT00072280|21104703|P2|NOT COMPLETED|Follow-up||2
8559971|NCT00072280|21104704|P1|NOT COMPLETED|Follow-up||2
8559972|NCT00072280|21104703|P2|COMPLETED|Follow-up||0
8559973|NCT00072280|21104704|P1|COMPLETED|Follow-up||0
8559974|NCT00072280|21104703|P2|STARTED|Follow-up||2
8559975|NCT00072280|21104704|P1|STARTED|Follow-up||2
8559976|NCT00072280|21104703|P2|NOT COMPLETED|Treatment||2
8559977|NCT00072280|21104704|P1|NOT COMPLETED|Treatment||1
8559978|NCT00072280|21104703|P2|COMPLETED|Treatment||2
8559979|NCT00072280|21104704|P1|COMPLETED|Treatment||2
8559980|NCT00072280|21104703|P2|STARTED|Treatment||4
8559981|NCT00072280|21104704|P1|STARTED|Treatment||3
8559982|NCT00072189|21104709|P1|NOT COMPLETED|Overall Study||1
8559983|NCT00072189|21104709|P1|COMPLETED|Overall Study||16
8559984|NCT00072189|21104709|P1|STARTED|Overall Study||17
8559985|NCT00072176|21104717|P2|NOT COMPLETED|Overall Study||1
8559986|NCT00072176|21104718|P1|NOT COMPLETED|Overall Study||1
8559987|NCT00072176|21104717|P2|COMPLETED|Overall Study||27
8559988|NCT00072176|21104718|P1|COMPLETED|Overall Study||33
8559989|NCT00072176|21104717|P2|STARTED|Overall Study||28
8559990|NCT00072176|21104718|P1|STARTED|Overall Study||34
8559991|NCT00071981|21104730|P4|NOT COMPLETED|Overall Study||45
8559992|NCT00071981|21104731|P3|NOT COMPLETED|Overall Study||37
8559993|NCT00071981|21104732|P2|NOT COMPLETED|Overall Study||41
8559994|NCT00071981|21104733|P1|NOT COMPLETED|Overall Study||46
8559995|NCT00071981|21104730|P4|COMPLETED|Overall Study||3
8559996|NCT00071981|21104731|P3|COMPLETED|Overall Study||0
8559997|NCT00071981|21104732|P2|COMPLETED|Overall Study||2
8559998|NCT00071981|21104733|P1|COMPLETED|Overall Study||1
8559999|NCT00071981|21104730|P4|Have Helper T Cell Response Data|Overall Study||39
8560000|NCT00071981|21104731|P3|Have Helper T Cell Response Data|Overall Study||25
8560001|NCT00071981|21104732|P2|Have Helper T Cell Response Data|Overall Study||27
8560002|NCT00071981|21104733|P1|Have Helper T Cell Response Data|Overall Study||37
8560003|NCT00071981|21104730|P4|Have CTL Response Data|Overall Study||41
8560004|NCT00071981|21104731|P3|Have CTL Response Data|Overall Study||29
8560005|NCT00071981|21104732|P2|Have CTL Response Data|Overall Study||30
8560006|NCT00071981|21104733|P1|Have CTL Response Data|Overall Study||40
8560007|NCT00071981|21104730|P4|Eligible and Treated|Overall Study||42
8560008|NCT00071981|21104731|P3|Eligible and Treated|Overall Study||32
8560009|NCT00071981|21104732|P2|Eligible and Treated|Overall Study||33
8560010|NCT00071981|21104733|P1|Eligible and Treated|Overall Study||41
8560011|NCT00071981|21104730|P4|Treated|Overall Study||48
8560012|NCT00071981|21104731|P3|Treated|Overall Study||36
8560013|NCT00071981|21104732|P2|Treated|Overall Study||38
8560014|NCT00071981|21104733|P1|Treated|Overall Study||45
8560015|NCT00071981|21104730|P4|Eligible|Overall Study||42
8560016|NCT00071981|21104731|P3|Eligible|Overall Study||33
8560017|NCT00071981|21104732|P2|Eligible|Overall Study||36
8560018|NCT00071981|21104733|P1|Eligible|Overall Study||43
8560019|NCT00071981|21104730|P4|STARTED|Overall Study||48
8560020|NCT00071981|21104731|P3|STARTED|Overall Study||37
8560021|NCT00071981|21104732|P2|STARTED|Overall Study||43
8560022|NCT00071981|21104733|P1|STARTED|Overall Study||47
8560023|NCT00072566|21104759|P1|NOT COMPLETED|Overall Study||0
8560024|NCT00072566|21104759|P1|COMPLETED|Overall Study||70
8560025|NCT00072566|21104759|P1|STARTED|Overall Study||70
8560026|NCT00072514|21104765|P1|NOT COMPLETED|Overall Study||4
8560027|NCT00072514|21104765|P1|COMPLETED|Overall Study||51
8560028|NCT00072514|21104765|P1|STARTED|Overall Study||55
8560029|NCT00071812|21104776|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
8560030|NCT00071812|21104777|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
8560031|NCT00071812|21104778|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560032|NCT00071812|21104779|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560033|NCT00071812|21104776|P4|COMPLETED|24-Week Open-Label Extension Period||178
8560034|NCT00071812|21104777|P3|COMPLETED|24-Week Open-Label Extension Period||7
8560035|NCT00071812|21104778|P2|COMPLETED|24-Week Open-Label Extension Period||11
8560036|NCT00071812|21104779|P1|COMPLETED|24-Week Open-Label Extension Period||0
8560111|NCT00071396|21105015|P1|NOT COMPLETED|Overall Study||3
8560037|NCT00071812|21104776|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
8560038|NCT00071812|21104777|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
8560039|NCT00071812|21104778|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
8560040|NCT00071812|21104779|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
8560041|NCT00071812|21104776|P4|NOT COMPLETED|24-Week Double-Blind Period||11
8560042|NCT00071812|21104777|P3|NOT COMPLETED|24-Week Double-Blind Period||8
8560043|NCT00071812|21104778|P2|NOT COMPLETED|24-Week Double-Blind Period||6
8560044|NCT00071812|21104779|P1|NOT COMPLETED|24-Week Double-Blind Period||10
8560045|NCT00071812|21104776|P4|COMPLETED|24-Week Double-Blind Period||60
8560046|NCT00071812|21104777|P3|COMPLETED|24-Week Double-Blind Period||63
8560047|NCT00071812|21104778|P2|COMPLETED|24-Week Double-Blind Period||66
8560048|NCT00071812|21104779|P1|COMPLETED|24-Week Double-Blind Period||59
8560049|NCT00071812|21104776|P4|STARTED|24-Week Double-Blind Period||71
8560050|NCT00071812|21104777|P3|STARTED|24-Week Double-Blind Period||71
8560051|NCT00071812|21104778|P2|STARTED|24-Week Double-Blind Period||72
8560052|NCT00071812|21104779|P1|STARTED|24-Week Double-Blind Period||69
8560053|NCT00071799|21104821|P2|NOT COMPLETED|Overall Study||98
8560054|NCT00071799|21104822|P1|NOT COMPLETED|Overall Study||70
8560055|NCT00071799|21104821|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
8560056|NCT00071799|21104822|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
8560057|NCT00071799|21104821|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
8560058|NCT00071799|21104822|P1|STARTED|Overall Study||179
8560059|NCT00071890|21104864|P2|NOT COMPLETED|Overall Study||0
8560060|NCT00071890|21104865|P1|NOT COMPLETED|Overall Study||0
8560061|NCT00071890|21104864|P2|COMPLETED|Overall Study|"1 withdrawal
~1 lost of follow-up
~1 death 67 patients analysed"|67
8560062|NCT00071890|21104865|P1|COMPLETED|Overall Study|"1 withdrawal
~1 death 81 patients analysed"|81
8560063|NCT00071890|21104864|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
8560064|NCT00071890|21104865|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
8560065|NCT00071760|21104875|P1|NOT COMPLETED|Overall Study||54
8560066|NCT00071760|21104875|P1|COMPLETED|Overall Study||0
8560067|NCT00071760|21104875|P1|Ongoing|Overall Study||25
8560068|NCT00071760|21104875|P1|STARTED|Overall Study||54
8560069|NCT00071721|21104936|P2|NOT COMPLETED|Overall Study||91
8560070|NCT00071721|21104937|P1|NOT COMPLETED|Overall Study||72
8560071|NCT00071721|21104936|P2|COMPLETED|Overall Study||69
8560072|NCT00071721|21104937|P1|COMPLETED|Overall Study||81
8560073|NCT00071721|21104936|P2|STARTED|Overall Study||160
8560074|NCT00071721|21104937|P1|STARTED|Overall Study||153
8560075|NCT00071513|21104955|P2|NOT COMPLETED|Follow-up Assessment||6
8560076|NCT00071513|21104956|P1|NOT COMPLETED|Follow-up Assessment||6
8560077|NCT00071513|21104955|P2|COMPLETED|Follow-up Assessment||247
8560078|NCT00071513|21104956|P1|COMPLETED|Follow-up Assessment||233
8560079|NCT00071513|21104955|P2|STARTED|Follow-up Assessment||253
8560080|NCT00071513|21104956|P1|STARTED|Follow-up Assessment||239
8560081|NCT00071513|21104955|P2|NOT COMPLETED|Intervention Component||3
8560082|NCT00071513|21104956|P1|NOT COMPLETED|Intervention Component||2
8560083|NCT00071513|21104955|P2|COMPLETED|Intervention Component||253
8560084|NCT00071513|21104956|P1|COMPLETED|Intervention Component||239
8560085|NCT00071513|21104955|P2|STARTED|Intervention Component||256
8560086|NCT00071513|21104956|P1|STARTED|Intervention Component||241
8560087|NCT00071487|21104968|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
8560088|NCT00071487|21104969|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
8560089|NCT00071487|21104970|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560090|NCT00071487|21104971|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560091|NCT00071487|21104968|P4|COMPLETED|24-Week Open-Label Extension Period||279
8560092|NCT00071487|21104969|P3|COMPLETED|24-Week Open-Label Extension Period||23
8560093|NCT00071487|21104970|P2|COMPLETED|24-Week Open-Label Extension Period||19
8560094|NCT00071487|21104971|P1|COMPLETED|24-Week Open-Label Extension Period||0
8560095|NCT00071487|21104968|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
8560096|NCT00071487|21104969|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
8560097|NCT00071487|21104970|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
8560098|NCT00071487|21104971|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
8560099|NCT00071487|21104968|P4|NOT COMPLETED|52-Week Double-Blind Period||21
8560100|NCT00071487|21104969|P3|NOT COMPLETED|52-Week Double-Blind Period||17
8560101|NCT00071487|21104970|P2|NOT COMPLETED|52-Week Double-Blind Period||27
8560102|NCT00071487|21104971|P1|NOT COMPLETED|52-Week Double-Blind Period||20
8560103|NCT00071487|21104968|P4|COMPLETED|52-Week Double-Blind Period||90
8560104|NCT00071487|21104969|P3|COMPLETED|52-Week Double-Blind Period||94
8560105|NCT00071487|21104970|P2|COMPLETED|52-Week Double-Blind Period||87
8560106|NCT00071487|21104971|P1|COMPLETED|52-Week Double-Blind Period||93
8560107|NCT00071487|21104968|P4|STARTED|52-Week Double-Blind Period||111
8560108|NCT00071487|21104969|P3|STARTED|52-Week Double-Blind Period||111
8560109|NCT00071487|21104970|P2|STARTED|52-Week Double-Blind Period||114
8560110|NCT00071487|21104971|P1|STARTED|52-Week Double-Blind Period||113
8560112|NCT00071396|21105015|P1|COMPLETED|Overall Study|Evaluable for response.|41
8560113|NCT00071396|21105015|P1|STARTED|Overall Study||44
8560114|NCT00071110|21105021|P2|NOT COMPLETED|Overall Study||4
8560115|NCT00071110|21105022|P1|NOT COMPLETED|Overall Study||0
8560116|NCT00071110|21105021|P2|COMPLETED|Overall Study||25
8560117|NCT00071110|21105022|P1|COMPLETED|Overall Study||28
8560118|NCT00071110|21105021|P2|STARTED|Overall Study||29
8560119|NCT00071110|21105022|P1|STARTED|Overall Study||28
8560120|NCT00071032|21105036|P2|NOT COMPLETED|Overall Study||8
8560121|NCT00071032|21105037|P1|NOT COMPLETED|Overall Study||9
8560122|NCT00071032|21105036|P2|COMPLETED|Overall Study||1001
8560123|NCT00071032|21105037|P1|COMPLETED|Overall Study||998
8560124|NCT00071032|21105036|P2|STARTED|Overall Study||1009
8560125|NCT00071032|21105037|P1|STARTED|Overall Study||1007
8560126|NCT00071006|21105073|P1|NOT COMPLETED|Overall Study||12
8560127|NCT00071006|21105073|P1|COMPLETED|Overall Study||0
8560128|NCT00071006|21105073|P1|STARTED|Overall Study||12
8560129|NCT00070941|21105086|P3|NOT COMPLETED|Overall Study||4
8560130|NCT00070941|21105087|P2|NOT COMPLETED|Overall Study||8
8560131|NCT00070941|21105088|P1|NOT COMPLETED|Overall Study||10
8560132|NCT00070941|21105086|P3|COMPLETED|Overall Study||2
8560133|NCT00070941|21105087|P2|COMPLETED|Overall Study||3
8560134|NCT00070941|21105088|P1|COMPLETED|Overall Study||2
8560135|NCT00070941|21105086|P3|STARTED|Overall Study||6
8560136|NCT00070941|21105087|P2|STARTED|Overall Study||11
8560137|NCT00070941|21105088|P1|STARTED|Overall Study||12
8560138|NCT00071058|21105096|P1|NOT COMPLETED|Overall Study||1
8560139|NCT00071058|21105096|P1|COMPLETED|Overall Study||49
8560140|NCT00071058|21105096|P1|STARTED|Overall Study||50
8560141|NCT00070707|21105103|P2|NOT COMPLETED|Overall Study||7
8560142|NCT00070707|21105104|P1|NOT COMPLETED|Overall Study||14
8560143|NCT00070707|21105103|P2|COMPLETED|Overall Study||68
8560144|NCT00070707|21105104|P1|COMPLETED|Overall Study||99
8560145|NCT00070707|21105103|P2|STARTED|Overall Study||75
8560146|NCT00070707|21105104|P1|STARTED|Overall Study||113
8560147|NCT00003907|21105152|P2|NOT COMPLETED|Overall Study||23
8560148|NCT00003907|21105153|P1|NOT COMPLETED|Overall Study||13
8560149|NCT00003907|21105152|P2|COMPLETED|Overall Study||8
8560150|NCT00003907|21105153|P1|COMPLETED|Overall Study||6
8560151|NCT00003907|21105152|P2|Eligible and Treated|Overall Study||29
8560152|NCT00003907|21105153|P1|Eligible and Treated|Overall Study||17
8560153|NCT00003907|21105152|P2|Received Protocol Therapy (Treated)|Overall Study||31
8560154|NCT00003907|21105153|P1|Received Protocol Therapy (Treated)|Overall Study||18
8560155|NCT00003907|21105152|P2|Eligible|Overall Study||29
8560156|NCT00003907|21105153|P1|Eligible|Overall Study||18
8560157|NCT00003907|21105152|P2|STARTED|Overall Study||31
8560158|NCT00003907|21105153|P1|STARTED|Overall Study||19
8560159|NCT00070564|21105169|P6|NOT COMPLETED|Overall Study||52
8560160|NCT00070564|21105170|P5|NOT COMPLETED|Overall Study||79
8560161|NCT00070564|21105171|P4|NOT COMPLETED|Overall Study||167
8560162|NCT00070564|21105172|P3|NOT COMPLETED|Overall Study||171
8560163|NCT00070564|21105173|P2|NOT COMPLETED|Overall Study||203
8560164|NCT00070564|21105174|P1|NOT COMPLETED|Overall Study||200
8560165|NCT00070564|21105169|P6|COMPLETED|Overall Study||244
8560166|NCT00070564|21105170|P5|COMPLETED|Overall Study||203
8560167|NCT00070564|21105171|P4|COMPLETED|Overall Study||481
8560168|NCT00070564|21105172|P3|COMPLETED|Overall Study||526
8560169|NCT00070564|21105173|P2|COMPLETED|Overall Study||490
8560170|NCT00070564|21105174|P1|COMPLETED|Overall Study||478
8560171|NCT00070564|21105169|P6|STARTED|Overall Study||296
8560172|NCT00070564|21105170|P5|STARTED|Overall Study||282
8560173|NCT00070564|21105171|P4|STARTED|Overall Study||648
8560174|NCT00070564|21105172|P3|STARTED|Overall Study||697
8560175|NCT00070564|21105173|P2|STARTED|Overall Study||693
8560176|NCT00070564|21105174|P1|STARTED|Overall Study||678
8560177|NCT00070499|21105228|P4|NOT COMPLETED|Overall Study||110
8560178|NCT00070499|21105229|P3|NOT COMPLETED|Overall Study||120
8560179|NCT00070499|21105230|P2|NOT COMPLETED|Overall Study||26
8560180|NCT00070499|21105231|P1|NOT COMPLETED|Overall Study||38
8560181|NCT00070499|21105228|P4|COMPLETED|Overall Study||17
8560182|NCT00070499|21105229|P3|COMPLETED|Overall Study||6
8560183|NCT00070499|21105230|P2|COMPLETED|Overall Study||52
8560184|NCT00070499|21105231|P1|COMPLETED|Overall Study||37
8560185|NCT00070499|21105228|P4|Eligible and Treated|Overall Study||123
8560186|NCT00070499|21105229|P3|Eligible and Treated|Overall Study||123
8560187|NCT00070499|21105230|P2|Eligible and Treated|Overall Study||73
8560188|NCT00070499|21105231|P1|Eligible and Treated|Overall Study||72
8560189|NCT00070499|21105228|P4|Eligible|Overall Study||125
8560190|NCT00070499|21105229|P3|Eligible|Overall Study||123
8560191|NCT00070499|21105230|P2|Eligible|Overall Study||73
8560192|NCT00070499|21105231|P1|Eligible|Overall Study||73
8560193|NCT00070499|21105228|P4|STARTED|Overall Study||127
8560194|NCT00070499|21105229|P3|STARTED|Overall Study||126
8560195|NCT00070499|21105230|P2|STARTED|Overall Study||78
8560196|NCT00070499|21105231|P1|STARTED|Overall Study||75
8560197|NCT00070317|21105257|P1|NOT COMPLETED|Overall Study||13
8560198|NCT00070317|21105257|P1|COMPLETED|Overall Study||89
8560199|NCT00070317|21105257|P1|STARTED|Overall Study||102
8560200|NCT00070291|21105262|P1|NOT COMPLETED|Step 2||1
8560201|NCT00070291|21105262|P1|COMPLETED|Step 2||0
8560202|NCT00070291|21105262|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
8560203|NCT00070291|21105262|P1|NOT COMPLETED|Step 1||2
8560204|NCT00070291|21105262|P1|COMPLETED|Step 1||2
8560205|NCT00070291|21105262|P1|Treated|Step 1||3
8560206|NCT00070291|21105262|P1|STARTED|Step 1||4
8560207|NCT00070135|21105267|P1|NOT COMPLETED|Overall Study||0
8560208|NCT00070135|21105267|P1|COMPLETED|Overall Study||114
8560209|NCT00070135|21105267|P1|STARTED|Overall Study||114
8560210|NCT00070109|21105278|P5|NOT COMPLETED|Overall Study||8
8560211|NCT00070109|21105279|P4|NOT COMPLETED|Overall Study||20
8560212|NCT00070109|21105280|P3|NOT COMPLETED|Overall Study||8
8560213|NCT00070109|21105281|P2|NOT COMPLETED|Overall Study||6
8560214|NCT00070109|21105282|P1|NOT COMPLETED|Overall Study||8
8560215|NCT00070109|21105278|P5|COMPLETED|Overall Study||0
8560216|NCT00070109|21105279|P4|COMPLETED|Overall Study||0
8560217|NCT00070109|21105280|P3|COMPLETED|Overall Study||0
8560218|NCT00070109|21105281|P2|COMPLETED|Overall Study||0
8560219|NCT00070109|21105282|P1|COMPLETED|Overall Study||0
8560220|NCT00070109|21105278|P5|STARTED|Overall Study||8
8560221|NCT00070109|21105279|P4|STARTED|Overall Study||20
8560222|NCT00070109|21105280|P3|STARTED|Overall Study||8
8560223|NCT00070109|21105281|P2|STARTED|Overall Study||6
8560224|NCT00070109|21105282|P1|STARTED|Overall Study||8
8560230|NCT00069953|21105314|P1|NOT COMPLETED|Overall Study||2
8560231|NCT00069953|21105314|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
8560232|NCT00069953|21105314|P1|STARTED|Overall Study||43
8560233|NCT00069784|21105320|P2|NOT COMPLETED|Overall Study||0
8560234|NCT00069784|21105321|P1|NOT COMPLETED|Overall Study||1212
8560235|NCT00069784|21105320|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
8560236|NCT00069784|21105321|P1|COMPLETED|Overall Study|completed study treatment|5052
8560237|NCT00069784|21105320|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
8560238|NCT00069784|21105321|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
8560239|NCT00069784|21105320|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
8560240|NCT00069784|21105321|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
8560241|NCT00069823|21105341|P2|NOT COMPLETED|Overall Study||3
8560242|NCT00069823|21105342|P1|NOT COMPLETED|Overall Study||6
8560243|NCT00069823|21105341|P2|COMPLETED|Overall Study||200
8560244|NCT00069823|21105342|P1|COMPLETED|Overall Study||193
8560245|NCT00069823|21105341|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
8560246|NCT00069823|21105342|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
8560247|NCT00069641|21105385|P3|NOT COMPLETED|Overall Study||1
8560248|NCT00069641|21105386|P2|NOT COMPLETED|Overall Study||0
8560249|NCT00069641|21105387|P1|NOT COMPLETED|Overall Study||1
8560250|NCT00069641|21105385|P3|COMPLETED|Overall Study||31
8560251|NCT00069641|21105386|P2|COMPLETED|Overall Study||32
8560252|NCT00069641|21105387|P1|COMPLETED|Overall Study||31
8560253|NCT00069641|21105385|P3|STARTED|Overall Study||32
8560254|NCT00069641|21105386|P2|STARTED|Overall Study||32
8560255|NCT00069641|21105387|P1|STARTED|Overall Study||32
8560256|NCT00069576|21105414|P2|NOT COMPLETED|Follow-up Study at 5-10 Years||204
8560257|NCT00069576|21105415|P1|NOT COMPLETED|Follow-up Study at 5-10 Years||196
8560258|NCT00069576|21105414|P2|COMPLETED|Follow-up Study at 5-10 Years||236
8560259|NCT00069576|21105415|P1|COMPLETED|Follow-up Study at 5-10 Years||264
8560260|NCT00069576|21105414|P2|STARTED|Follow-up Study at 5-10 Years||440
8560261|NCT00069576|21105415|P1|STARTED|Follow-up Study at 5-10 Years||460
8560262|NCT00069576|21105414|P2|NOT COMPLETED|Original Trial||33
8560263|NCT00069576|21105415|P1|NOT COMPLETED|Original Trial||25
8560264|NCT00069576|21105414|P2|COMPLETED|Original Trial||440
8560265|NCT00069576|21105415|P1|COMPLETED|Original Trial||460
8560266|NCT00069576|21105414|P2|STARTED|Original Trial||473
8560267|NCT00069576|21105415|P1|STARTED|Original Trial||485
8560268|NCT00069277|21105465|P1|NOT COMPLETED|Overall Study||21
8560269|NCT00069277|21105465|P1|COMPLETED|Overall Study||0
8560270|NCT00069277|21105465|P1|STARTED|Overall Study||21
8560271|NCT00069264|21105469|P1|NOT COMPLETED|Overall Study||32
8560272|NCT00069264|21105469|P1|COMPLETED|Overall Study||0
8560273|NCT00069264|21105469|P1|STARTED|Overall Study||32
8560274|NCT00069329|21105473|P1|NOT COMPLETED|Overall Study||2
8560275|NCT00069329|21105473|P1|COMPLETED|Overall Study||41
8560276|NCT00069329|21105473|P1|STARTED|Overall Study||43
8560277|NCT00069238|21105497|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
8560278|NCT00069238|21105498|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8560279|NCT00069238|21105499|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8560280|NCT00069238|21105497|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
8560281|NCT00069238|21105498|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8560282|NCT00069238|21105499|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8560283|NCT00069238|21105497|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
8560284|NCT00069238|21105498|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8560285|NCT00069238|21105499|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8560286|NCT00069238|21105497|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8560287|NCT00069238|21105498|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
8560288|NCT00069238|21105499|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8560289|NCT00069238|21105497|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8560290|NCT00069238|21105498|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
8560291|NCT00069238|21105499|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8560292|NCT00069238|21105497|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8560293|NCT00069238|21105498|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
8560294|NCT00069238|21105499|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8560295|NCT00069238|21105497|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8560296|NCT00069238|21105498|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8560297|NCT00069238|21105499|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
8560298|NCT00069238|21105497|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8560299|NCT00069238|21105498|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8560300|NCT00069238|21105499|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
8560301|NCT00069238|21105497|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8560302|NCT00069238|21105498|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8560303|NCT00069238|21105499|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
8560304|NCT00069121|21105507|P2|NOT COMPLETED|Overall Study||325
8560305|NCT00069121|21105508|P1|NOT COMPLETED|Overall Study||367
8560306|NCT00069121|21105507|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
8560307|NCT00069121|21105508|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
8560308|NCT00069121|21105507|P2|Received Treatment|Overall Study|Safety Population|938
8560309|NCT00069121|21105508|P1|Received Treatment|Overall Study|Safety Population|926
8560310|NCT00069121|21105507|P2|STARTED|Overall Study||944
8560311|NCT00069121|21105508|P1|STARTED|Overall Study||942
8560312|NCT00069108|21105530|P2|NOT COMPLETED|Overall Study||219
8560313|NCT00069108|21105531|P1|NOT COMPLETED|Overall Study||213
8560314|NCT00069108|21105530|P2|COMPLETED|Overall Study||95
8560315|NCT00069108|21105531|P1|COMPLETED|Overall Study||100
8560316|NCT00069108|21105530|P2|STARTED|Overall Study||314
8560317|NCT00069108|21105531|P1|STARTED|Overall Study||313
8560318|NCT00069095|21105563|P6|NOT COMPLETED|Follow-up Phase||101
8560319|NCT00069095|21105564|P5|NOT COMPLETED|Follow-up Phase||92
8560320|NCT00069095|21105565|P4|NOT COMPLETED|Follow-up Phase||112
8560321|NCT00069095|21105566|P3|NOT COMPLETED|Follow-up Phase||120
8560322|NCT00069095|21105567|P2|NOT COMPLETED|Follow-up Phase||206
8560323|NCT00069095|21105568|P1|NOT COMPLETED|Follow-up Phase||174
8560324|NCT00069095|21105563|P6|COMPLETED|Follow-up Phase||171
8560325|NCT00069095|21105564|P5|COMPLETED|Follow-up Phase||186
8560326|NCT00069095|21105565|P4|COMPLETED|Follow-up Phase||187
8560327|NCT00069095|21105566|P3|COMPLETED|Follow-up Phase||178
8560328|NCT00069095|21105567|P2|COMPLETED|Follow-up Phase||93
8560329|NCT00069095|21105568|P1|COMPLETED|Follow-up Phase||110
8560330|NCT00069095|21105563|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
8560331|NCT00069095|21105564|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
8560332|NCT00069095|21105565|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8560333|NCT00069095|21105566|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
8560334|NCT00069095|21105567|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8560335|NCT00069095|21105568|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
8560336|NCT00069095|21105563|P6|NOT COMPLETED|Post-study Treatment Phase||29
8560337|NCT00069095|21105564|P5|NOT COMPLETED|Post-study Treatment Phase||36
8560338|NCT00069095|21105565|P4|NOT COMPLETED|Post-study Treatment Phase||17
8560339|NCT00069095|21105566|P3|NOT COMPLETED|Post-study Treatment Phase||21
8560340|NCT00069095|21105567|P2|NOT COMPLETED|Post-study Treatment Phase||13
8560341|NCT00069095|21105568|P1|NOT COMPLETED|Post-study Treatment Phase||8
8560342|NCT00069095|21105563|P6|COMPLETED|Post-study Treatment Phase||0
8560343|NCT00069095|21105564|P5|COMPLETED|Post-study Treatment Phase||0
8560344|NCT00069095|21105565|P4|COMPLETED|Post-study Treatment Phase||0
8560345|NCT00069095|21105566|P3|COMPLETED|Post-study Treatment Phase||0
8560346|NCT00069095|21105567|P2|COMPLETED|Post-study Treatment Phase||0
8560347|NCT00069095|21105568|P1|COMPLETED|Post-study Treatment Phase||0
8560348|NCT00069095|21105563|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
8560349|NCT00069095|21105564|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
8560350|NCT00069095|21105565|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
8560351|NCT00069095|21105566|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
8560352|NCT00069095|21105567|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
8560353|NCT00069095|21105568|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
8560354|NCT00069095|21105563|P6|NOT COMPLETED|Primary Treatment Phase||301
8560355|NCT00069095|21105564|P5|NOT COMPLETED|Primary Treatment Phase||302
8560356|NCT00069095|21105565|P4|NOT COMPLETED|Primary Treatment Phase||320
8560357|NCT00069095|21105566|P3|NOT COMPLETED|Primary Treatment Phase||314
8560358|NCT00069095|21105567|P2|NOT COMPLETED|Primary Treatment Phase||302
8560359|NCT00069095|21105568|P1|NOT COMPLETED|Primary Treatment Phase||295
8560360|NCT00069095|21105563|P6|COMPLETED|Primary Treatment Phase||48
8560361|NCT00069095|21105564|P5|COMPLETED|Primary Treatment Phase||48
8560362|NCT00069095|21105565|P4|COMPLETED|Primary Treatment Phase||31
8560363|NCT00069095|21105566|P3|COMPLETED|Primary Treatment Phase||36
8560364|NCT00069095|21105567|P2|COMPLETED|Primary Treatment Phase||15
8560365|NCT00069095|21105568|P1|COMPLETED|Primary Treatment Phase||22
8560366|NCT00069095|21105563|P6|STARTED|Primary Treatment Phase||349
8560367|NCT00069095|21105564|P5|STARTED|Primary Treatment Phase||350
8560368|NCT00069095|21105565|P4|STARTED|Primary Treatment Phase||351
8560369|NCT00069095|21105566|P3|STARTED|Primary Treatment Phase||350
8560370|NCT00069095|21105567|P2|STARTED|Primary Treatment Phase||317
8560371|NCT00069095|21105568|P1|STARTED|Primary Treatment Phase||317
8560372|NCT00069160|21105622|P2|NOT COMPLETED|Overall Study||0
8560373|NCT00069160|21105623|P1|NOT COMPLETED|Overall Study||0
8560374|NCT00069160|21105622|P2|COMPLETED|Overall Study||25
8560375|NCT00069160|21105623|P1|COMPLETED|Overall Study||23
8560376|NCT00069160|21105622|P2|STARTED|Overall Study||25
8560377|NCT00069160|21105623|P1|STARTED|Overall Study||23
8560378|NCT00068822|21105638|P2|NOT COMPLETED|Optional Crossover Intervention||0
8560379|NCT00068822|21105639|P1|NOT COMPLETED|Optional Crossover Intervention||0
8560380|NCT00068822|21105638|P2|COMPLETED|Optional Crossover Intervention||29
8560381|NCT00068822|21105639|P1|COMPLETED|Optional Crossover Intervention||9
8560382|NCT00068822|21105638|P2|Crossover at Month 3|Optional Crossover Intervention||27
8560383|NCT00068822|21105639|P1|Crossover at Month 3|Optional Crossover Intervention||8
8560384|NCT00068822|21105638|P2|Crossover at Month 1|Optional Crossover Intervention||2
8560385|NCT00068822|21105639|P1|Crossover at Month 1|Optional Crossover Intervention||1
8560386|NCT00068822|21105638|P2|STARTED|Optional Crossover Intervention||29
8560387|NCT00068822|21105639|P1|STARTED|Optional Crossover Intervention||9
8560388|NCT00068822|21105638|P2|NOT COMPLETED|First Randomized Intervention||2
8560389|NCT00068822|21105639|P1|NOT COMPLETED|First Randomized Intervention||1
8560390|NCT00068822|21105638|P2|COMPLETED|First Randomized Intervention||61
8560391|NCT00068822|21105639|P1|COMPLETED|First Randomized Intervention||67
8560392|NCT00068822|21105638|P2|STARTED|First Randomized Intervention||63
8560393|NCT00068822|21105639|P1|STARTED|First Randomized Intervention||68
8560394|NCT00068770|21105651|P2|NOT COMPLETED|Overall Study||0
8560395|NCT00068770|21105652|P1|NOT COMPLETED|Overall Study||0
8560396|NCT00068770|21105651|P2|COMPLETED|Overall Study||22
8560397|NCT00068770|21105652|P1|COMPLETED|Overall Study||13
8560398|NCT00068770|21105651|P2|STARTED|Overall Study||22
8560399|NCT00068770|21105652|P1|STARTED|Overall Study||13
8560400|NCT00068718|21105660|P1|NOT COMPLETED|Overall Study||0
8560401|NCT00068718|21105660|P1|COMPLETED|Overall Study||35
8560402|NCT00068718|21105660|P1|STARTED|Overall Study||35
8560403|NCT00068692|21105673|P8|NOT COMPLETED|Step 2: Randomization||8
8560404|NCT00068692|21105674|P7|NOT COMPLETED|Step 2: Randomization||4
8560405|NCT00068692|21105675|P6|NOT COMPLETED|Step 2: Randomization||6
8560406|NCT00068692|21105676|P5|NOT COMPLETED|Step 2: Randomization||9
8560407|NCT00068692|21105677|P4|NOT COMPLETED|Step 2: Randomization||12
8560408|NCT00068692|21105678|P3|NOT COMPLETED|Step 2: Randomization||10
8560409|NCT00068692|21105679|P2|NOT COMPLETED|Step 2: Randomization||0
8560410|NCT00068692|21105680|P1|NOT COMPLETED|Step 2: Randomization||0
8560411|NCT00068692|21105673|P8|COMPLETED|Step 2: Randomization||24
8560412|NCT00068692|21105674|P7|COMPLETED|Step 2: Randomization||29
8560413|NCT00068692|21105675|P6|COMPLETED|Step 2: Randomization||25
8560414|NCT00068692|21105676|P5|COMPLETED|Step 2: Randomization||21
8560415|NCT00068692|21105677|P4|COMPLETED|Step 2: Randomization||13
8560416|NCT00068692|21105678|P3|COMPLETED|Step 2: Randomization||18
8560417|NCT00068692|21105679|P2|COMPLETED|Step 2: Randomization||0
8560418|NCT00068692|21105680|P1|COMPLETED|Step 2: Randomization||0
8560419|NCT00068692|21105673|P8|Reported AE Data|Step 2: Randomization||32
8560420|NCT00068692|21105674|P7|Reported AE Data|Step 2: Randomization||33
8560421|NCT00068692|21105675|P6|Reported AE Data|Step 2: Randomization||31
8560422|NCT00068692|21105676|P5|Reported AE Data|Step 2: Randomization||28
8560423|NCT00068692|21105677|P4|Reported AE Data|Step 2: Randomization||22
8560424|NCT00068692|21105678|P3|Reported AE Data|Step 2: Randomization||27
8560425|NCT00068692|21105679|P2|Reported AE Data|Step 2: Randomization||0
8560426|NCT00068692|21105680|P1|Reported AE Data|Step 2: Randomization||0
8560427|NCT00068692|21105673|P8|Had Sphincter Preservation|Step 2: Randomization||30
8560428|NCT00068692|21105674|P7|Had Sphincter Preservation|Step 2: Randomization||33
8560429|NCT00068692|21105675|P6|Had Sphincter Preservation|Step 2: Randomization||31
8560430|NCT00068692|21105676|P5|Had Sphincter Preservation|Step 2: Randomization||28
8560431|NCT00068692|21105677|P4|Had Sphincter Preservation|Step 2: Randomization||25
8560432|NCT00068692|21105678|P3|Had Sphincter Preservation|Step 2: Randomization||28
8560433|NCT00068692|21105679|P2|Had Sphincter Preservation|Step 2: Randomization||0
8560434|NCT00068692|21105680|P1|Had Sphincter Preservation|Step 2: Randomization||0
8560435|NCT00068692|21105673|P8|Treated|Step 2: Randomization||32
8560436|NCT00068692|21105674|P7|Treated|Step 2: Randomization||33
8560437|NCT00068692|21105675|P6|Treated|Step 2: Randomization||31
8560438|NCT00068692|21105676|P5|Treated|Step 2: Randomization||29
8560439|NCT00068692|21105677|P4|Treated|Step 2: Randomization||25
8560440|NCT00068692|21105678|P3|Treated|Step 2: Randomization||27
8560441|NCT00068692|21105679|P2|Treated|Step 2: Randomization||0
8560442|NCT00068692|21105680|P1|Treated|Step 2: Randomization||0
8560443|NCT00068692|21105673|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
8560444|NCT00068692|21105674|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
8560445|NCT00068692|21105675|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
8560446|NCT00068692|21105676|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
8560447|NCT00068692|21105677|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
8560448|NCT00068692|21105678|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
8560449|NCT00068692|21105679|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
8560450|NCT00068692|21105680|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
8560451|NCT00068692|21105673|P8|NOT COMPLETED|Step 1: Registration||0
8560452|NCT00068692|21105674|P7|NOT COMPLETED|Step 1: Registration||0
8560453|NCT00068692|21105675|P6|NOT COMPLETED|Step 1: Registration||0
8560454|NCT00068692|21105676|P5|NOT COMPLETED|Step 1: Registration||0
8560455|NCT00068692|21105677|P4|NOT COMPLETED|Step 1: Registration||0
8560456|NCT00068692|21105678|P3|NOT COMPLETED|Step 1: Registration||0
8560457|NCT00068692|21105679|P2|NOT COMPLETED|Step 1: Registration||1
8560458|NCT00068692|21105680|P1|NOT COMPLETED|Step 1: Registration||40
8560459|NCT00068692|21105673|P8|COMPLETED|Step 1: Registration||0
8560460|NCT00068692|21105674|P7|COMPLETED|Step 1: Registration||0
8560461|NCT00068692|21105675|P6|COMPLETED|Step 1: Registration||0
8560462|NCT00068692|21105676|P5|COMPLETED|Step 1: Registration||0
8560463|NCT00068692|21105677|P4|COMPLETED|Step 1: Registration||0
8560464|NCT00068692|21105678|P3|COMPLETED|Step 1: Registration||0
8560465|NCT00068692|21105679|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
8560466|NCT00068692|21105680|P1|COMPLETED|Step 1: Registration||88
8560467|NCT00068692|21105673|P8|Reported AE Data|Step 1: Registration||0
8560468|NCT00068692|21105674|P7|Reported AE Data|Step 1: Registration||0
8560469|NCT00068692|21105675|P6|Reported AE Data|Step 1: Registration||0
8560470|NCT00068692|21105676|P5|Reported AE Data|Step 1: Registration||0
8560471|NCT00068692|21105677|P4|Reported AE Data|Step 1: Registration||0
8560472|NCT00068692|21105678|P3|Reported AE Data|Step 1: Registration||0
8560473|NCT00068692|21105679|P2|Reported AE Data|Step 1: Registration||0
8560474|NCT00068692|21105680|P1|Reported AE Data|Step 1: Registration||123
8560475|NCT00068692|21105673|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560476|NCT00068692|21105674|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560477|NCT00068692|21105675|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560478|NCT00068692|21105676|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560479|NCT00068692|21105677|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560480|NCT00068692|21105678|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560481|NCT00068692|21105679|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
8560482|NCT00068692|21105680|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
8560483|NCT00068692|21105673|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8560484|NCT00068692|21105674|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8560485|NCT00068692|21105675|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8560486|NCT00068692|21105676|P5|STARTED|Step 1: Registration||0
8560487|NCT00068692|21105677|P4|STARTED|Step 1: Registration||0
8560488|NCT00068692|21105678|P3|STARTED|Step 1: Registration||0
8560489|NCT00068692|21105679|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
8560490|NCT00068692|21105680|P1|STARTED|Step 1: Registration||128
8560491|NCT00068601|21105703|P2|NOT COMPLETED|Overall Study||60
8560492|NCT00068601|21105704|P1|NOT COMPLETED|Overall Study||62
8560493|NCT00068601|21105703|P2|COMPLETED|Overall Study||66
8560494|NCT00068601|21105704|P1|COMPLETED|Overall Study||69
8560495|NCT00068601|21105703|P2|STARTED|Overall Study||126
8560496|NCT00068601|21105704|P1|STARTED|Overall Study||131
8560497|NCT00068588|21105717|P3|NOT COMPLETED|Overall Study||4
8560498|NCT00068588|21105718|P2|NOT COMPLETED|Overall Study||0
8560499|NCT00068588|21105719|P1|NOT COMPLETED|Overall Study||0
8560500|NCT00068588|21105717|P3|COMPLETED|Overall Study||17
8560501|NCT00068588|21105718|P2|COMPLETED|Overall Study||3
8560502|NCT00068588|21105719|P1|COMPLETED|Overall Study||0
8560503|NCT00068588|21105717|P3|STARTED|Overall Study||21
8560504|NCT00068588|21105718|P2|STARTED|Overall Study||3
8560505|NCT00068588|21105719|P1|STARTED|Overall Study||0
8560506|NCT00068575|21105729|P1|NOT COMPLETED|Overall Study||0
8560507|NCT00068575|21105729|P1|COMPLETED|Overall Study||28
8560508|NCT00068575|21105729|P1|STARTED|Overall Study||28
8560509|NCT00068445|21105735|P2|NOT COMPLETED|Treatment||16
8560510|NCT00068445|21105736|P1|NOT COMPLETED|Treatment||29
8560511|NCT00068445|21105735|P2|COMPLETED|Treatment||46
8560512|NCT00068445|21105736|P1|COMPLETED|Treatment||34
8560513|NCT00068445|21105735|P2|STARTED|Treatment||62
8560514|NCT00068445|21105736|P1|STARTED|Treatment||63
8560515|NCT00068445|21105735|P2|NOT COMPLETED|Randomization||4
8560516|NCT00068445|21105736|P1|NOT COMPLETED|Randomization||2
8560517|NCT00068445|21105735|P2|COMPLETED|Randomization||62
8560518|NCT00068445|21105736|P1|COMPLETED|Randomization||63
8560519|NCT00068445|21105735|P2|STARTED|Randomization||66
8560520|NCT00068445|21105736|P1|STARTED|Randomization||65
8560521|NCT00068419|21105760|P1|NOT COMPLETED|Overall Study||60
8560522|NCT00068419|21105760|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
8560523|NCT00068419|21105760|P1|STARTED|Overall Study||70
8560524|NCT00068406|21105769|P1|NOT COMPLETED|Overall Study||3
8560525|NCT00068406|21105769|P1|COMPLETED|Overall Study||58
8560526|NCT00068406|21105769|P1|STARTED|Overall Study||61
8560527|NCT00068393|21105774|P1|NOT COMPLETED|Overall Study||10
8560528|NCT00068393|21105774|P1|COMPLETED|Overall Study||29
8560529|NCT00068393|21105774|P1|Eligible and Treated|Overall Study||38
8560530|NCT00068393|21105774|P1|STARTED|Overall Study||39
8560531|NCT00068380|21105780|P1|NOT COMPLETED|Overall Study||5
8560532|NCT00068380|21105780|P1|COMPLETED|Overall Study||12
8560533|NCT00068380|21105780|P1|STARTED|Overall Study||17
8560534|NCT00068367|21105789|P1|NOT COMPLETED|Overall Study||0
8560535|NCT00068367|21105789|P1|COMPLETED|Overall Study||20
8560536|NCT00068367|21105789|P1|STARTED|Overall Study||20
8560537|NCT00068341|21105798|P3|NOT COMPLETED|Overall Study||0
8560538|NCT00068341|21105799|P2|NOT COMPLETED|Overall Study||0
8560539|NCT00068341|21105800|P1|NOT COMPLETED|Overall Study||0
8560540|NCT00068341|21105798|P3|COMPLETED|Overall Study||44
8560541|NCT00068341|21105799|P2|COMPLETED|Overall Study||15
8560542|NCT00068341|21105800|P1|COMPLETED|Overall Study||15
8560543|NCT00068341|21105798|P3|STARTED|Overall Study||44
8560544|NCT00068341|21105799|P2|STARTED|Overall Study||15
8560545|NCT00068341|21105800|P1|STARTED|Overall Study||15
8560546|NCT00068250|21105824|P4|NOT COMPLETED|Phase II: Dose Level 2||0
8560547|NCT00068250|21105825|P3|NOT COMPLETED|Phase II: Dose Level 2||0
8560548|NCT00068250|21105826|P2|NOT COMPLETED|Phase II: Dose Level 2||0
8560549|NCT00068250|21105827|P1|NOT COMPLETED|Phase II: Dose Level 2||0
8560550|NCT00068250|21105824|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
8560551|NCT00068250|21105825|P3|COMPLETED|Phase II: Dose Level 2||0
8560552|NCT00068250|21105826|P2|COMPLETED|Phase II: Dose Level 2||0
8560553|NCT00068250|21105827|P1|COMPLETED|Phase II: Dose Level 2||0
8560554|NCT00068250|21105824|P4|STARTED|Phase II: Dose Level 2||47
8560555|NCT00068250|21105825|P3|STARTED|Phase II: Dose Level 2||0
8560556|NCT00068250|21105826|P2|STARTED|Phase II: Dose Level 2||0
8560557|NCT00068250|21105827|P1|STARTED|Phase II: Dose Level 2||0
8560558|NCT00068250|21105824|P4|NOT COMPLETED|Phase I: Dose Level 2||0
8560559|NCT00068250|21105825|P3|NOT COMPLETED|Phase I: Dose Level 2||0
8560560|NCT00068250|21105826|P2|NOT COMPLETED|Phase I: Dose Level 2||1
8560561|NCT00068250|21105827|P1|NOT COMPLETED|Phase I: Dose Level 2||0
8560562|NCT00068250|21105824|P4|COMPLETED|Phase I: Dose Level 2||0
8560563|NCT00068250|21105825|P3|COMPLETED|Phase I: Dose Level 2||0
8560564|NCT00068250|21105826|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
8560565|NCT00068250|21105827|P1|COMPLETED|Phase I: Dose Level 2||0
8560566|NCT00068250|21105824|P4|STARTED|Phase I: Dose Level 2||0
8560567|NCT00068250|21105825|P3|STARTED|Phase I: Dose Level 2||0
8560568|NCT00068250|21105826|P2|STARTED|Phase I: Dose Level 2||7
8560569|NCT00068250|21105827|P1|STARTED|Phase I: Dose Level 2||0
8560570|NCT00068250|21105824|P4|NOT COMPLETED|Phase I: Dose Level 1||0
8560571|NCT00068250|21105825|P3|NOT COMPLETED|Phase I: Dose Level 1||0
8560572|NCT00068250|21105826|P2|NOT COMPLETED|Phase I: Dose Level 1||0
8560573|NCT00068250|21105827|P1|NOT COMPLETED|Phase I: Dose Level 1||0
8560574|NCT00068250|21105824|P4|COMPLETED|Phase I: Dose Level 1||0
8560575|NCT00068250|21105825|P3|COMPLETED|Phase I: Dose Level 1||0
8560576|NCT00068250|21105826|P2|COMPLETED|Phase I: Dose Level 1||0
8560577|NCT00068250|21105827|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
8560578|NCT00068250|21105824|P4|STARTED|Phase I: Dose Level 1||0
8560579|NCT00068250|21105825|P3|STARTED|Phase I: Dose Level 1||0
8560580|NCT00068250|21105826|P2|STARTED|Phase I: Dose Level 1||0
8560581|NCT00068250|21105827|P1|STARTED|Phase I: Dose Level 1||6
8560582|NCT00068237|21105837|P1|NOT COMPLETED|Overall Study||5
8560583|NCT00068237|21105837|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8560584|NCT00068237|21105837|P1|STARTED|Overall Study||49
8560585|NCT00068107|21105849|P1|NOT COMPLETED|Overall Study||9
8560586|NCT00068107|21105849|P1|COMPLETED|Overall Study||3
8560587|NCT00068107|21105849|P1|STARTED|Overall Study||12
8560588|NCT00067990|21105862|P2|NOT COMPLETED|Overall Study||22
8560589|NCT00067990|21105863|P1|NOT COMPLETED|Overall Study||10
8560590|NCT00067990|21105862|P2|COMPLETED|Overall Study||54
8560591|NCT00067990|21105863|P1|COMPLETED|Overall Study||67
8560592|NCT00067990|21105862|P2|STARTED|Overall Study||76
8560593|NCT00067990|21105863|P1|STARTED|Overall Study||77
8560594|NCT00067808|21105874|P3|NOT COMPLETED|Overall Study||0
8560595|NCT00067808|21105875|P2|NOT COMPLETED|Overall Study||0
8560596|NCT00067808|21105876|P1|NOT COMPLETED|Overall Study||0
8560597|NCT00067808|21105874|P3|COMPLETED|Overall Study||14
8560598|NCT00067808|21105875|P2|COMPLETED|Overall Study||93
8560599|NCT00067808|21105876|P1|COMPLETED|Overall Study||17
8560600|NCT00067808|21105874|P3|STARTED|Overall Study||14
8560601|NCT00067808|21105875|P2|STARTED|Overall Study||93
8560602|NCT00067808|21105876|P1|STARTED|Overall Study||17
8560603|NCT00067470|21105886|P2|NOT COMPLETED|Overall Study||1
8560604|NCT00067470|21105887|P1|NOT COMPLETED|Overall Study||0
8560605|NCT00067470|21105886|P2|COMPLETED|Overall Study||19
8560606|NCT00067470|21105887|P1|COMPLETED|Overall Study||19
8560607|NCT00067470|21105886|P2|STARTED|Overall Study||20
8560608|NCT00067470|21105887|P1|STARTED|Overall Study||19
8560609|NCT00067236|21105899|P2|NOT COMPLETED|Overall Study||26
8560610|NCT00067236|21105900|P1|NOT COMPLETED|Overall Study||20
8560611|NCT00067236|21105899|P2|COMPLETED|Overall Study||99
8560612|NCT00067236|21105900|P1|COMPLETED|Overall Study||108
8560613|NCT00067236|21105899|P2|STARTED|Overall Study||125
8560614|NCT00067236|21105900|P1|STARTED|Overall Study||128
8560615|NCT00067028|21105909|P3|NOT COMPLETED|Overall Study||0
8560616|NCT00067028|21105910|P2|NOT COMPLETED|Overall Study||0
8560617|NCT00067028|21105911|P1|NOT COMPLETED|Overall Study||0
8560618|NCT00067028|21105909|P3|COMPLETED|Overall Study||63
8560619|NCT00067028|21105910|P2|COMPLETED|Overall Study||36
8560620|NCT00067028|21105911|P1|COMPLETED|Overall Study||17
8560621|NCT00067028|21105909|P3|STARTED|Overall Study||63
8560622|NCT00067028|21105910|P2|STARTED|Overall Study||36
8560623|NCT00067028|21105911|P1|STARTED|Overall Study||17
8560624|NCT00067002|21105924|P2|NOT COMPLETED|Overall Study||9
8560625|NCT00067002|21105925|P1|NOT COMPLETED|Overall Study||7
8560626|NCT00067002|21105924|P2|COMPLETED|Overall Study||44
8560627|NCT00067002|21105925|P1|COMPLETED|Overall Study||45
8560628|NCT00067002|21105924|P2|STARTED|Overall Study||53
8560629|NCT00067002|21105925|P1|STARTED|Overall Study||52
8560630|NCT00066963|21105942|P3|NOT COMPLETED|Overall Study||39
8560631|NCT00066963|21105943|P2|NOT COMPLETED|Overall Study||31
8560632|NCT00066963|21105944|P1|NOT COMPLETED|Overall Study||26
8560633|NCT00066963|21105942|P3|COMPLETED|Overall Study||87
8560634|NCT00066963|21105943|P2|COMPLETED|Overall Study||93
8560635|NCT00066963|21105944|P1|COMPLETED|Overall Study|any follow-up|100
8560636|NCT00066963|21105942|P3|STARTED|Overall Study||126
8560637|NCT00066963|21105943|P2|STARTED|Overall Study||124
8560638|NCT00066963|21105944|P1|STARTED|Overall Study||126
8560639|NCT00066937|21105956|P4|NOT COMPLETED|6 Month Follow-up||1
8560640|NCT00066937|21105957|P3|NOT COMPLETED|6 Month Follow-up||3
8560641|NCT00066937|21105958|P2|NOT COMPLETED|6 Month Follow-up||3
8560642|NCT00066937|21105959|P1|NOT COMPLETED|6 Month Follow-up||7
8560643|NCT00066937|21105956|P4|COMPLETED|6 Month Follow-up||14
8560644|NCT00066937|21105957|P3|COMPLETED|6 Month Follow-up||22
8560645|NCT00066937|21105958|P2|COMPLETED|6 Month Follow-up||29
8560646|NCT00066937|21105959|P1|COMPLETED|6 Month Follow-up||26
8560647|NCT00066937|21105956|P4|STARTED|6 Month Follow-up||15
8560648|NCT00066937|21105957|P3|STARTED|6 Month Follow-up||25
8560649|NCT00066937|21105958|P2|STARTED|6 Month Follow-up||32
8560650|NCT00066937|21105959|P1|STARTED|6 Month Follow-up||33
8560651|NCT00066937|21105956|P4|NOT COMPLETED|3 Month Follow-up||4
8560652|NCT00066937|21105957|P3|NOT COMPLETED|3 Month Follow-up||1
8560653|NCT00066937|21105958|P2|NOT COMPLETED|3 Month Follow-up||1
8560654|NCT00066937|21105959|P1|NOT COMPLETED|3 Month Follow-up||5
8560655|NCT00066937|21105956|P4|COMPLETED|3 Month Follow-up||15
8560656|NCT00066937|21105957|P3|COMPLETED|3 Month Follow-up||25
8560657|NCT00066937|21105958|P2|COMPLETED|3 Month Follow-up||32
8560658|NCT00066937|21105959|P1|COMPLETED|3 Month Follow-up||33
8560659|NCT00066937|21105956|P4|STARTED|3 Month Follow-up||19
8560660|NCT00066937|21105957|P3|STARTED|3 Month Follow-up||26
8560661|NCT00066937|21105958|P2|STARTED|3 Month Follow-up||33
8560662|NCT00066937|21105959|P1|STARTED|3 Month Follow-up||38
8560663|NCT00066937|21105956|P4|NOT COMPLETED|Treatment Phase||5
8560664|NCT00066937|21105957|P3|NOT COMPLETED|Treatment Phase||11
8560665|NCT00066937|21105958|P2|NOT COMPLETED|Treatment Phase||5
8560666|NCT00066937|21105959|P1|NOT COMPLETED|Treatment Phase||3
8560667|NCT00066937|21105956|P4|COMPLETED|Treatment Phase||19
8560668|NCT00066937|21105957|P3|COMPLETED|Treatment Phase||26
8560669|NCT00066937|21105958|P2|COMPLETED|Treatment Phase||33
8560670|NCT00066937|21105959|P1|COMPLETED|Treatment Phase||38
8560671|NCT00066937|21105956|P4|STARTED|Treatment Phase||24
8560672|NCT00066937|21105957|P3|STARTED|Treatment Phase||37
8560673|NCT00066937|21105958|P2|STARTED|Treatment Phase||38
8560674|NCT00066937|21105959|P1|STARTED|Treatment Phase||41
8560675|NCT00066807|21105983|P2|NOT COMPLETED|Overall Study||15
8560676|NCT00066807|21105984|P1|NOT COMPLETED|Overall Study||14
8560677|NCT00066807|21105983|P2|COMPLETED|Overall Study||0
8560678|NCT00066807|21105984|P1|COMPLETED|Overall Study||0
8560679|NCT00066807|21105983|P2|STARTED|Overall Study||15
8560680|NCT00066807|21105984|P1|STARTED|Overall Study||14
8560681|NCT00066781|21105998|P2|NOT COMPLETED|Overall Study||0
8560682|NCT00066781|21105999|P1|NOT COMPLETED|Overall Study||0
8560683|NCT00066781|21105998|P2|COMPLETED|Overall Study||17
8560684|NCT00066781|21105999|P1|COMPLETED|Overall Study||14
8560685|NCT00066781|21105998|P2|STARTED|Overall Study||17
8560686|NCT00066781|21105999|P1|STARTED|Overall Study||14
8560687|NCT00066742|21106009|P1|NOT COMPLETED|Consolidation Chemotherapy||3
8560688|NCT00066742|21106009|P1|COMPLETED|Consolidation Chemotherapy||39
8560689|NCT00066742|21106009|P1|Eligible|Consolidation Chemotherapy||40
8560690|NCT00066742|21106009|P1|STARTED|Consolidation Chemotherapy||42
8560691|NCT00066742|21106009|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
8560692|NCT00066742|21106009|P1|COMPLETED|Induction Chemoradiotherapy||43
8560693|NCT00066742|21106009|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
8560694|NCT00066742|21106009|P1|Eligible|Induction Chemoradiotherapy||69
8560695|NCT00066742|21106009|P1|STARTED|Induction Chemoradiotherapy||72
8560696|NCT00066703|21106018|P2|NOT COMPLETED|Overall Study||582
8560697|NCT00066703|21106019|P1|NOT COMPLETED|Overall Study||612
8560698|NCT00066703|21106018|P2|COMPLETED|Overall Study||756
8560699|NCT00066703|21106019|P1|COMPLETED|Overall Study||722
8560700|NCT00066703|21106018|P2|STARTED|Overall Study||1338
8560701|NCT00066703|21106019|P1|STARTED|Overall Study||1334
8560702|NCT00066690|21106034|P3|NOT COMPLETED|Overall Study||564
8560703|NCT00066690|21106035|P2|NOT COMPLETED|Overall Study||522
8560704|NCT00066690|21106036|P1|NOT COMPLETED|Overall Study||598
8560705|NCT00066690|21106034|P3|COMPLETED|Overall Study||457
8560706|NCT00066690|21106035|P2|COMPLETED|Overall Study||502
8560707|NCT00066690|21106036|P1|COMPLETED|Overall Study||423
8560708|NCT00066690|21106034|P3|STARTED|Overall Study||1021
8560709|NCT00066690|21106035|P2|STARTED|Overall Study||1024
8560710|NCT00066690|21106036|P1|STARTED|Overall Study||1021
8560711|NCT00066573|21106055|P2|NOT COMPLETED|Overall Study||28
8560712|NCT00066573|21106056|P1|NOT COMPLETED|Overall Study||28
8560713|NCT00066573|21106055|P2|COMPLETED|Overall Study||3759
8560714|NCT00066573|21106056|P1|COMPLETED|Overall Study||3761
8560715|NCT00066573|21106055|P2|STARTED|Overall Study||3787
8560716|NCT00066573|21106056|P1|STARTED|Overall Study||3789
8560717|NCT00066469|21106068|P1|NOT COMPLETED|Overall Study||16
8560718|NCT00066469|21106068|P1|COMPLETED|Overall Study||39
8560719|NCT00066469|21106068|P1|STARTED|Overall Study||55
8560720|NCT00066365|21106074|P2|NOT COMPLETED|Overall Study||14
8560721|NCT00066365|21106075|P1|NOT COMPLETED|Overall Study||23
8560722|NCT00066365|21106074|P2|COMPLETED|Overall Study||4
8560723|NCT00066365|21106075|P1|COMPLETED|Overall Study||8
8560724|NCT00066365|21106074|P2|STARTED|Overall Study||18
8560725|NCT00066365|21106075|P1|STARTED|Overall Study||31
8560726|NCT00066222|21106103|P1|NOT COMPLETED|Overall Study||1
8560727|NCT00066222|21106103|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
8560728|NCT00066222|21106103|P1|STARTED|Overall Study||72
8560729|NCT00066170|21106116|P4|NOT COMPLETED|Overall Study||9
8560730|NCT00066170|21106117|P3|NOT COMPLETED|Overall Study||4
8560731|NCT00066170|21106118|P2|NOT COMPLETED|Overall Study||10
8560732|NCT00066170|21106119|P1|NOT COMPLETED|Overall Study||7
8560733|NCT00066170|21106116|P4|COMPLETED|Overall Study||48
8560734|NCT00066170|21106117|P3|COMPLETED|Overall Study||59
8560735|NCT00066170|21106118|P2|COMPLETED|Overall Study||45
8560736|NCT00066170|21106119|P1|COMPLETED|Overall Study||49
8560737|NCT00066170|21106116|P4|Intent to Treat|Overall Study||54
8560738|NCT00066170|21106117|P3|Intent to Treat|Overall Study||63
8560739|NCT00066170|21106118|P2|Intent to Treat|Overall Study||50
8560740|NCT00066170|21106119|P1|Intent to Treat|Overall Study||55
8560741|NCT00066170|21106116|P4|STARTED|Overall Study||57
8560742|NCT00066170|21106117|P3|STARTED|Overall Study||63
8560743|NCT00066170|21106118|P2|STARTED|Overall Study||55
8560744|NCT00066170|21106119|P1|STARTED|Overall Study||56
8560745|NCT00066066|21106132|P6|NOT COMPLETED|Overall Study||5
8560746|NCT00066066|21106133|P5|NOT COMPLETED|Overall Study||3
8560747|NCT00066066|21106134|P4|NOT COMPLETED|Overall Study||4
8560748|NCT00066066|21106135|P3|NOT COMPLETED|Overall Study||7
8560749|NCT00066066|21106136|P2|NOT COMPLETED|Overall Study||4
8560750|NCT00066066|21106137|P1|NOT COMPLETED|Overall Study||6
8560751|NCT00066066|21106132|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
8560752|NCT00066066|21106133|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
8560753|NCT00066066|21106134|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
8560754|NCT00066066|21106135|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
8560755|NCT00066066|21106136|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
8560756|NCT00066066|21106137|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
8560757|NCT00066066|21106132|P6|12 Month|Overall Study||9
8560758|NCT00066066|21106133|P5|12 Month|Overall Study||19
8560759|NCT00066066|21106134|P4|12 Month|Overall Study||11
8560760|NCT00066066|21106135|P3|12 Month|Overall Study||21
8560761|NCT00066066|21106136|P2|12 Month|Overall Study||11
8560762|NCT00066066|21106137|P1|12 Month|Overall Study||18
8560763|NCT00066066|21106132|P6|6 Month|Overall Study||14
8560764|NCT00066066|21106133|P5|6 Month|Overall Study||21
8560765|NCT00066066|21106134|P4|6 Month|Overall Study||13
8560766|NCT00066066|21106135|P3|6 Month|Overall Study||23
8560767|NCT00066066|21106136|P2|6 Month|Overall Study||13
8560768|NCT00066066|21106137|P1|6 Month|Overall Study||19
8560769|NCT00066066|21106132|P6|3 Month|Overall Study||15
8560770|NCT00066066|21106133|P5|3 Month|Overall Study||22
8560771|NCT00066066|21106134|P4|3 Month|Overall Study||16
8560772|NCT00066066|21106135|P3|3 Month|Overall Study||23
8560773|NCT00066066|21106136|P2|3 Month|Overall Study||17
8560774|NCT00066066|21106137|P1|3 Month|Overall Study||21
8560775|NCT00066066|21106132|P6|Baseline|Overall Study||20
8560776|NCT00066066|21106133|P5|Baseline|Overall Study||27
8560777|NCT00066066|21106134|P4|Baseline|Overall Study||20
8560778|NCT00066066|21106135|P3|Baseline|Overall Study||30
8560779|NCT00066066|21106136|P2|Baseline|Overall Study||22
8560780|NCT00066066|21106137|P1|Baseline|Overall Study||27
8560781|NCT00066066|21106132|P6|STARTED|Overall Study||20
8560782|NCT00066066|21106133|P5|STARTED|Overall Study||27
8560783|NCT00066066|21106134|P4|STARTED|Overall Study||20
8560784|NCT00066066|21106135|P3|STARTED|Overall Study||30
8560785|NCT00066066|21106136|P2|STARTED|Overall Study||22
8560786|NCT00066066|21106137|P1|STARTED|Overall Study||27
8560787|NCT00065806|21106153|P2|NOT COMPLETED|Overall Study||19
8560788|NCT00065806|21106154|P1|NOT COMPLETED|Overall Study||20
8560789|NCT00065806|21106153|P2|COMPLETED|Overall Study||89
8560790|NCT00065806|21106154|P1|COMPLETED|Overall Study||93
8560791|NCT00065806|21106153|P2|STARTED|Overall Study||108
8560792|NCT00065806|21106154|P1|STARTED|Overall Study||113
8560793|NCT00014560|21106196|P1|NOT COMPLETED|Overall Study||3
8560794|NCT00014560|21106196|P1|COMPLETED|Overall Study||0
8560795|NCT00014560|21106196|P1|STARTED|Overall Study||3
8560796|NCT00065611|21106202|P2|NOT COMPLETED|Overall Study||1
8560797|NCT00065611|21106203|P1|NOT COMPLETED|Overall Study||0
8560798|NCT00065611|21106202|P2|COMPLETED|Overall Study||3
8560799|NCT00065611|21106203|P1|COMPLETED|Overall Study||4
8560800|NCT00065611|21106202|P2|STARTED|Overall Study||4
8560801|NCT00065611|21106203|P1|STARTED|Overall Study||4
8560802|NCT00065507|21106215|P2|NOT COMPLETED|Overall Study||29
8560803|NCT00065507|21106216|P1|NOT COMPLETED|Overall Study||29
8560804|NCT00065507|21106215|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
8560805|NCT00065507|21106216|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
8560806|NCT00065507|21106215|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
8560807|NCT00065507|21106216|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
8560808|NCT00065507|21106215|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8560809|NCT00065507|21106216|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8560810|NCT00065507|21106215|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8560811|NCT00065507|21106216|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8560812|NCT00065507|21106215|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
8560813|NCT00065507|21106216|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
8560814|NCT00065507|21106215|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
8560815|NCT00065507|21106216|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
8560816|NCT00065468|21106281|P3|NOT COMPLETED|Overall Study||210
8560817|NCT00065468|21106282|P2|NOT COMPLETED|Overall Study||209
8560818|NCT00065468|21106283|P1|NOT COMPLETED|Overall Study||207
8560819|NCT00065468|21106281|P3|COMPLETED|Overall Study||0
8560820|NCT00065468|21106282|P2|COMPLETED|Overall Study||0
8560821|NCT00065468|21106283|P1|COMPLETED|Overall Study||0
8560822|NCT00065468|21106281|P3|Received Treatment|Overall Study||208
8560823|NCT00065468|21106282|P2|Received Treatment|Overall Study||208
8560824|NCT00065468|21106283|P1|Received Treatment|Overall Study||200
8560825|NCT00065468|21106281|P3|STARTED|Overall Study||210
8560826|NCT00065468|21106282|P2|STARTED|Overall Study||209
8560827|NCT00065468|21106283|P1|STARTED|Overall Study||207
8560828|NCT00065442|21106314|P2|NOT COMPLETED|Overall Study||220
8560829|NCT00065442|21106315|P1|NOT COMPLETED|Overall Study||125
8560830|NCT00065442|21106314|P2|COMPLETED|Overall Study||121
8560831|NCT00065442|21106315|P1|COMPLETED|Overall Study||46
8560832|NCT00065442|21106314|P2|STARTED|Overall Study||341
8560833|NCT00065442|21106315|P1|STARTED|Overall Study||171
8560834|NCT00065429|21106330|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560835|NCT00065429|21106331|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560836|NCT00065429|21106332|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
8560837|NCT00065429|21106333|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560838|NCT00065429|21106334|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560839|NCT00065429|21106335|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560840|NCT00065429|21106336|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560841|NCT00065429|21106330|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560842|NCT00065429|21106331|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560843|NCT00065429|21106332|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
8560844|NCT00065429|21106333|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560845|NCT00065429|21106334|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560846|NCT00065429|21106335|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560847|NCT00065429|21106336|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560848|NCT00065429|21106330|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560849|NCT00065429|21106331|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560850|NCT00065429|21106332|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
8560851|NCT00065429|21106333|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560852|NCT00065429|21106334|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560853|NCT00065429|21106335|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560854|NCT00065429|21106336|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560855|NCT00065429|21106330|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8560856|NCT00065429|21106331|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8560857|NCT00065429|21106332|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560858|NCT00065429|21106333|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560859|NCT00065429|21106334|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560860|NCT00065429|21106335|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
8560861|NCT00065429|21106336|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560862|NCT00065429|21106330|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
8560863|NCT00065429|21106331|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
8560864|NCT00065429|21106332|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
8560865|NCT00065429|21106333|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560866|NCT00065429|21106334|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560867|NCT00065429|21106335|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560868|NCT00065429|21106336|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560869|NCT00065429|21106330|P7|STARTED|Phase I - May 2001 - Oct 2002||4
8560870|NCT00065429|21106331|P6|STARTED|Phase I - May 2001 - Oct 2002||4
8560871|NCT00065429|21106332|P5|STARTED|Phase I - May 2001 - Oct 2002||9
8560872|NCT00065429|21106333|P4|STARTED|Phase I - May 2001 - Oct 2002||4
8560873|NCT00065429|21106334|P3|STARTED|Phase I - May 2001 - Oct 2002||4
8560874|NCT00065429|21106335|P2|STARTED|Phase I - May 2001 - Oct 2002||3
8560875|NCT00065429|21106336|P1|STARTED|Phase I - May 2001 - Oct 2002||4
8560876|NCT00065260|21106350|P2|NOT COMPLETED|Overall Study||1
8560877|NCT00065260|21106351|P1|NOT COMPLETED|Overall Study||0
8560878|NCT00065260|21106350|P2|COMPLETED|Overall Study||26
8560879|NCT00065260|21106351|P1|COMPLETED|Overall Study||27
8560880|NCT00065260|21106350|P2|STARTED|Overall Study||27
8560881|NCT00065260|21106351|P1|STARTED|Overall Study||27
8560882|NCT00065182|21106359|P2|NOT COMPLETED|Overall Study||37
8560883|NCT00065182|21106360|P1|NOT COMPLETED|Overall Study||48
8560884|NCT00065182|21106359|P2|COMPLETED|Overall Study||160
8560885|NCT00065182|21106360|P1|COMPLETED|Overall Study||154
8560886|NCT00065182|21106359|P2|STARTED|Overall Study||197
8560887|NCT00065182|21106360|P1|STARTED|Overall Study||202
8560888|NCT00065156|21106386|P1|NOT COMPLETED|Overall Study||124
8560889|NCT00065156|21106386|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
8560890|NCT00065156|21106386|P1|Modified Intent to Treat Population|Overall Study||94
8560891|NCT00065156|21106386|P1|STARTED|Overall Study||148
8560892|NCT00065065|21106403|P2|NOT COMPLETED|Overall Study||20
8560893|NCT00065065|21106404|P1|NOT COMPLETED|Overall Study||10
8560894|NCT00065065|21106403|P2|COMPLETED|Overall Study||33
8560895|NCT00065065|21106404|P1|COMPLETED|Overall Study||42
8560896|NCT00065065|21106403|P2|STARTED|Overall Study||53
8560897|NCT00065065|21106404|P1|STARTED|Overall Study||52
8560898|NCT00003895|21106416|P2|NOT COMPLETED|Overall Study||4
8560899|NCT00003895|21106417|P1|NOT COMPLETED|Overall Study||7
8560900|NCT00003895|21106416|P2|COMPLETED|Overall Study||14
8560901|NCT00003895|21106417|P1|COMPLETED|Overall Study||11
8560902|NCT00003895|21106416|P2|STARTED|Overall Study||18
8560903|NCT00003895|21106417|P1|STARTED|Overall Study||18
8560904|NCT00064987|21106425|P2|NOT COMPLETED|Overall Study||0
8560905|NCT00064987|21106426|P1|NOT COMPLETED|Overall Study||3
8560906|NCT00064987|21106425|P2|COMPLETED|Overall Study||6
8560907|NCT00064987|21106426|P1|COMPLETED|Overall Study||7
8560908|NCT00064987|21106425|P2|STARTED|Overall Study||6
8560909|NCT00064987|21106426|P1|STARTED|Overall Study||10
8560910|NCT00064844|21106446|P2|NOT COMPLETED|Overall Study||19
8560911|NCT00064844|21106447|P1|NOT COMPLETED|Overall Study||8
8560912|NCT00064844|21106446|P2|COMPLETED|Overall Study||32
8560913|NCT00064844|21106447|P1|COMPLETED|Overall Study||37
8560914|NCT00064844|21106446|P2|12 Month Follow-up|Overall Study||32
8560915|NCT00064844|21106447|P1|12 Month Follow-up|Overall Study||37
8560916|NCT00064844|21106446|P2|6 Month Follow-up|Overall Study||40
8560917|NCT00064844|21106447|P1|6 Month Follow-up|Overall Study||39
8560918|NCT00064844|21106446|P2|3 Month Follow-up|Overall Study||47
8560919|NCT00064844|21106447|P1|3 Month Follow-up|Overall Study||40
8560920|NCT00064844|21106446|P2|2 Week Follow-up|Overall Study||51
8560921|NCT00064844|21106447|P1|2 Week Follow-up|Overall Study||45
8560922|NCT00064844|21106446|P2|STARTED|Overall Study||51
8560923|NCT00064844|21106447|P1|STARTED|Overall Study||45
8560924|NCT00064753|21106457|P2|NOT COMPLETED|Overall Study||648
8560925|NCT00064753|21106458|P1|NOT COMPLETED|Overall Study||674
8560926|NCT00064753|21106457|P2|COMPLETED|Overall Study||1406
8560927|NCT00064753|21106458|P1|COMPLETED|Overall Study||1382
8560928|NCT00064753|21106457|P2|STARTED|Overall Study||2054
8560929|NCT00064753|21106458|P1|STARTED|Overall Study||2056
8560930|NCT00003645|21106488|P2|NOT COMPLETED|Overall Study||12
8560931|NCT00003645|21106489|P1|NOT COMPLETED|Overall Study||12
8560932|NCT00003645|21106488|P2|COMPLETED|Overall Study||22
8560933|NCT00003645|21106489|P1|COMPLETED|Overall Study||18
8560934|NCT00003645|21106488|P2|STARTED|Overall Study||34
8560935|NCT00003645|21106489|P1|STARTED|Overall Study||30
8560936|NCT00064792|21106503|P2|NOT COMPLETED|Overall Study||0
8560937|NCT00064792|21106504|P1|NOT COMPLETED|Overall Study||5
8560938|NCT00064792|21106503|P2|COMPLETED|Overall Study||10
8560939|NCT00064792|21106504|P1|COMPLETED|Overall Study||8
8560940|NCT00064792|21106503|P2|STARTED|Overall Study||10
8560941|NCT00064792|21106504|P1|STARTED|Overall Study||13
8560942|NCT00064701|21106515|P3|NOT COMPLETED|Clinical Continuation Phase||140
8560943|NCT00064701|21106516|P2|NOT COMPLETED|Clinical Continuation Phase||178
8560944|NCT00064701|21106517|P1|NOT COMPLETED|Clinical Continuation Phase||170
8560945|NCT00064701|21106515|P3|COMPLETED|Clinical Continuation Phase||11
8560946|NCT00064701|21106516|P2|COMPLETED|Clinical Continuation Phase||4
8560947|NCT00064701|21106517|P1|COMPLETED|Clinical Continuation Phase||9
8560948|NCT00064701|21106515|P3|STARTED|Clinical Continuation Phase||151
8560949|NCT00064701|21106516|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
8560950|NCT00064701|21106517|P1|STARTED|Clinical Continuation Phase||179
8560951|NCT00064701|21106515|P3|NOT COMPLETED|One Year Post-transplant||72
8560952|NCT00064701|21106516|P2|NOT COMPLETED|One Year Post-transplant||43
8560953|NCT00064701|21106517|P1|NOT COMPLETED|One Year Post-transplant||40
8560954|NCT00064701|21106515|P3|COMPLETED|One Year Post-transplant||151
8560955|NCT00064701|21106516|P2|COMPLETED|One Year Post-transplant||183
8560956|NCT00064701|21106517|P1|COMPLETED|One Year Post-transplant||179
8560957|NCT00064701|21106515|P3|Received Study Drug|One Year Post-transplant||212
8560958|NCT00064701|21106516|P2|Received Study Drug|One Year Post-transplant||214
8560959|NCT00064701|21106517|P1|Received Study Drug|One Year Post-transplant||212
8560960|NCT00064701|21106515|P3|STARTED|One Year Post-transplant||223
8560961|NCT00064701|21106516|P2|STARTED|One Year Post-transplant||226
8560962|NCT00064701|21106517|P1|STARTED|One Year Post-transplant||219
8560963|NCT00064662|21106569|P2|NOT COMPLETED|Overall Study||61
8560964|NCT00064662|21106570|P1|NOT COMPLETED|Overall Study||74
8560965|NCT00064662|21106569|P2|COMPLETED|Overall Study||265
8560966|NCT00064662|21106570|P1|COMPLETED|Overall Study||255
8560967|NCT00064662|21106569|P2|STARTED|Overall Study||326
8560968|NCT00064662|21106570|P1|STARTED|Overall Study||329
8560969|NCT00064350|21106581|P3|NOT COMPLETED|Cross-Over||0
8560970|NCT00064350|21106582|P2|NOT COMPLETED|Cross-Over||14
8560971|NCT00064350|21106583|P1|NOT COMPLETED|Cross-Over||6
8560972|NCT00064350|21106581|P3|COMPLETED|Cross-Over||0
8560973|NCT00064350|21106582|P2|COMPLETED|Cross-Over||13
8560974|NCT00064350|21106583|P1|COMPLETED|Cross-Over||4
8560975|NCT00064350|21106581|P3|Eligible and Treated|Cross-Over||0
8560976|NCT00064350|21106582|P2|Eligible and Treated|Cross-Over||21
8560977|NCT00064350|21106583|P1|Eligible and Treated|Cross-Over||7
8560978|NCT00064350|21106581|P3|Treated|Cross-Over||0
8560979|NCT00064350|21106582|P2|Treated|Cross-Over||26
8560980|NCT00064350|21106583|P1|Treated|Cross-Over||9
8560981|NCT00064350|21106581|P3|STARTED|Cross-Over||0
8560982|NCT00064350|21106582|P2|STARTED|Cross-Over||27
8560983|NCT00064350|21106583|P1|STARTED|Cross-Over||10
8560984|NCT00064350|21106581|P3|NOT COMPLETED|Randomization||0
8560985|NCT00064350|21106582|P2|NOT COMPLETED|Randomization||18
8560986|NCT00064350|21106583|P1|NOT COMPLETED|Randomization||26
8560987|NCT00064350|21106581|P3|COMPLETED|Randomization||0
8560988|NCT00064350|21106582|P2|COMPLETED|Randomization||28
8560989|NCT00064350|21106583|P1|COMPLETED|Randomization||33
8560990|NCT00064350|21106581|P3|Eligible and Treated|Randomization||0
8560991|NCT00064350|21106582|P2|Eligible and Treated|Randomization||31
8560992|NCT00064350|21106583|P1|Eligible and Treated|Randomization||50
8560993|NCT00064350|21106581|P3|Treated|Randomization||0
8560994|NCT00064350|21106582|P2|Treated|Randomization||40
8560995|NCT00064350|21106583|P1|Treated|Randomization||55
8560996|NCT00064350|21106581|P3|STARTED|Randomization||0
8560997|NCT00064350|21106582|P2|STARTED|Randomization||46
8560998|NCT00064350|21106583|P1|STARTED|Randomization||59
8560999|NCT00064350|21106581|P3|NOT COMPLETED|Induction Treatment||236
8561000|NCT00064350|21106582|P2|NOT COMPLETED|Induction Treatment||9
8561001|NCT00064350|21106583|P1|NOT COMPLETED|Induction Treatment||8
8561002|NCT00064350|21106581|P3|COMPLETED|Induction Treatment||1
8561003|NCT00064350|21106582|P2|COMPLETED|Induction Treatment||37
8561004|NCT00064350|21106583|P1|COMPLETED|Induction Treatment||51
8561005|NCT00064350|21106581|P3|Eligible and Treated|Induction Treatment||194
8561006|NCT00064350|21106582|P2|Eligible and Treated|Induction Treatment||46
8561007|NCT00064350|21106583|P1|Eligible and Treated|Induction Treatment||59
8561008|NCT00064350|21106581|P3|Treated|Induction Treatment||228
8561009|NCT00064350|21106582|P2|Treated|Induction Treatment||46
8561010|NCT00064350|21106583|P1|Treated|Induction Treatment||59
8561011|NCT00064350|21106581|P3|STARTED|Induction Treatment||237
8561012|NCT00064350|21106582|P2|STARTED|Induction Treatment||46
8561013|NCT00064350|21106583|P1|STARTED|Induction Treatment||59
8561014|NCT00064337|21106598|P1|NOT COMPLETED|Maintenance||10
8561015|NCT00064337|21106598|P1|COMPLETED|Maintenance||3
8561016|NCT00064337|21106598|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
8561017|NCT00064337|21106598|P1|NOT COMPLETED|Transplant||21
8561018|NCT00064337|21106598|P1|COMPLETED|Transplant||46
8561019|NCT00064337|21106598|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
8561020|NCT00064337|21106598|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
8561021|NCT00064337|21106598|P1|COMPLETED|PBSCC or Induction/PBSCC||73
8561022|NCT00064337|21106598|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
8561023|NCT00064298|21106607|P2|NOT COMPLETED|Overall Study||5
8561024|NCT00064298|21106608|P1|NOT COMPLETED|Overall Study||6
8561025|NCT00064298|21106607|P2|COMPLETED|Overall Study||57
8561026|NCT00064298|21106608|P1|COMPLETED|Overall Study||66
8561027|NCT00064298|21106607|P2|STARTED|Overall Study||62
8561028|NCT00064298|21106608|P1|STARTED|Overall Study||72
8561041|NCT00064077|21106627|P4|NOT COMPLETED|Overall Study||7
8561042|NCT00064077|21106628|P3|NOT COMPLETED|Overall Study||7
8561043|NCT00064077|21106629|P2|NOT COMPLETED|Overall Study||9
8561044|NCT00064077|21106630|P1|NOT COMPLETED|Overall Study||15
8561045|NCT00064077|21106627|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
8561046|NCT00064077|21106628|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
8561047|NCT00064077|21106629|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
8561048|NCT00064077|21106630|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
8561049|NCT00064077|21106627|P4|STARTED|Overall Study||118
8561050|NCT00064077|21106628|P3|STARTED|Overall Study||119
8561051|NCT00064077|21106629|P2|STARTED|Overall Study||117
8561052|NCT00064077|21106630|P1|STARTED|Overall Study||118
8561053|NCT00064038|21106662|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
8561054|NCT00064038|21106663|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8561055|NCT00064038|21106664|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8561056|NCT00064038|21106662|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
8561057|NCT00064038|21106663|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561058|NCT00064038|21106664|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8561059|NCT00064038|21106662|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
8561060|NCT00064038|21106663|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561061|NCT00064038|21106664|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
8561062|NCT00064038|21106662|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
8561063|NCT00064038|21106663|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561064|NCT00064038|21106664|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
8561065|NCT00064038|21106662|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
8561066|NCT00064038|21106663|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561067|NCT00064038|21106664|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
8561068|NCT00064038|21106662|P3|NOT COMPLETED|Initial Randomization||0
8561069|NCT00064038|21106663|P2|NOT COMPLETED|Initial Randomization||98
8561070|NCT00064038|21106664|P1|NOT COMPLETED|Initial Randomization||100
8561071|NCT00064038|21106662|P3|COMPLETED|Initial Randomization||0
8561072|NCT00064038|21106663|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8561073|NCT00064038|21106664|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8561074|NCT00064038|21106662|P3|Safety Population|Initial Randomization||0
8561075|NCT00064038|21106663|P2|Safety Population|Initial Randomization||94
8561076|NCT00064038|21106664|P1|Safety Population|Initial Randomization||96
8561077|NCT00064038|21106662|P3|Eligible and Analyzable|Initial Randomization||0
8561078|NCT00064038|21106663|P2|Eligible and Analyzable|Initial Randomization||95
8561079|NCT00064038|21106664|P1|Eligible and Analyzable|Initial Randomization||97
8561080|NCT00064038|21106662|P3|STARTED|Initial Randomization||0
8561081|NCT00064038|21106663|P2|STARTED|Initial Randomization||98
8561082|NCT00064038|21106664|P1|STARTED|Initial Randomization||100
8561083|NCT00064025|21106674|P1|NOT COMPLETED|Overall Study||7
8561084|NCT00064025|21106674|P1|COMPLETED|Overall Study||68
8561085|NCT00064025|21106674|P1|STARTED|Overall Study||75
8561086|NCT00063999|21106683|P2|NOT COMPLETED|Overall Study||24
8561087|NCT00063999|21106684|P1|NOT COMPLETED|Overall Study||45
8561088|NCT00063999|21106683|P2|COMPLETED|Overall Study||665
8561089|NCT00063999|21106684|P1|COMPLETED|Overall Study||647
8561090|NCT00063999|21106683|P2|STARTED|Overall Study||689
8561091|NCT00063999|21106684|P1|STARTED|Overall Study||692
8561092|NCT00063986|21106700|P1|NOT COMPLETED|Overall Study||6
8561093|NCT00063986|21106700|P1|COMPLETED|Overall Study||104
8561094|NCT00063986|21106700|P1|Eligible and Treated|Overall Study||104
8561095|NCT00063986|21106700|P1|Treated|Overall Study||105
8561096|NCT00063986|21106700|P1|STARTED|Overall Study||110
8561097|NCT00063934|21106712|P1|NOT COMPLETED|Overall Study||1
8561098|NCT00063934|21106712|P1|COMPLETED|Overall Study||30
8561099|NCT00063934|21106712|P1|STARTED|Overall Study||31
8561100|NCT00063882|21106721|P2|NOT COMPLETED|Overall Study||4
8561101|NCT00063882|21106722|P1|NOT COMPLETED|Overall Study||5
8561102|NCT00063882|21106721|P2|COMPLETED|Overall Study||292
8561103|NCT00063882|21106722|P1|COMPLETED|Overall Study||287
8561104|NCT00063882|21106721|P2|Eligible Patients|Overall Study||292
8561105|NCT00063882|21106722|P1|Eligible Patients|Overall Study||287
8561106|NCT00063882|21106721|P2|Has Baseline/24-month EPIC Data|Overall Study||219
8561107|NCT00063882|21106722|P1|Has Baseline/24-month EPIC Data|Overall Study||201
8561108|NCT00063882|21106721|P2|Has Baseline/4-month EPIC Data|Overall Study||241
8561109|NCT00063882|21106722|P1|Has Baseline/4-month EPIC Data|Overall Study||222
8561110|NCT00063882|21106721|P2|Has Late Adverse Event Data|Overall Study||287
8561111|NCT00063882|21106722|P1|Has Late Adverse Event Data|Overall Study||282
8561112|NCT00063882|21106721|P2|Has Acute Adverse Event Data|Overall Study||288
8561113|NCT00063882|21106722|P1|Has Acute Adverse Event Data|Overall Study||282
8561114|NCT00063882|21106721|P2|STARTED|Overall Study||296
8561115|NCT00063882|21106722|P1|STARTED|Overall Study||292
8561116|NCT00063635|21106753|P3|NOT COMPLETED|Overall Study||9
8561117|NCT00063635|21106754|P2|NOT COMPLETED|Overall Study||8
8561118|NCT00063635|21106755|P1|NOT COMPLETED|Overall Study||6
8561119|NCT00063635|21106753|P3|COMPLETED|Overall Study||49
8561120|NCT00063635|21106754|P2|COMPLETED|Overall Study||50
8561121|NCT00063635|21106755|P1|COMPLETED|Overall Study||51
8561122|NCT00063635|21106753|P3|STARTED|Overall Study||58
8561123|NCT00063635|21106754|P2|STARTED|Overall Study||58
8561124|NCT00063635|21106755|P1|STARTED|Overall Study||57
8561125|NCT00063622|21106796|P3|NOT COMPLETED|Overall Study||11
8561126|NCT00063622|21106797|P2|NOT COMPLETED|Overall Study||4
8561127|NCT00063622|21106798|P1|NOT COMPLETED|Overall Study||10
8561128|NCT00063622|21106796|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
8561129|NCT00063622|21106797|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
8561224|NCT00062868|21106893|P18|NOT COMPLETED|Dose Level 2||0
8561130|NCT00063622|21106798|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
8561131|NCT00063622|21106796|P3|STARTED|Overall Study||83
8561132|NCT00063622|21106797|P2|STARTED|Overall Study||84
8561133|NCT00063622|21106798|P1|STARTED|Overall Study||80
8561134|NCT00063570|21106823|P2|NOT COMPLETED|Overall Study||0
8561135|NCT00063570|21106824|P1|NOT COMPLETED|Overall Study||0
8561136|NCT00063570|21106823|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
8561137|NCT00063570|21106824|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
8561138|NCT00063570|21106823|P2|STARTED|Overall Study||21
8561139|NCT00063570|21106824|P1|STARTED|Overall Study||52
8561140|NCT00063362|21106840|P2|NOT COMPLETED|Overall Study||4
8561141|NCT00063362|21106841|P1|NOT COMPLETED|Overall Study||4
8561142|NCT00063362|21106840|P2|COMPLETED|Overall Study||22
8561143|NCT00063362|21106841|P1|COMPLETED|Overall Study||19
8561144|NCT00063362|21106840|P2|STARTED|Overall Study||26
8561145|NCT00063362|21106841|P1|STARTED|Overall Study||23
8561146|NCT00063258|21106849|P2|NOT COMPLETED|Overall Study||0
8561147|NCT00063258|21106850|P1|NOT COMPLETED|Overall Study||4
8561148|NCT00063258|21106849|P2|COMPLETED|Overall Study||0
8561149|NCT00063258|21106850|P1|COMPLETED|Overall Study||1
8561150|NCT00063258|21106849|P2|STARTED|Overall Study||0
8561151|NCT00063258|21106850|P1|STARTED|Overall Study||5
8561152|NCT00063154|21106856|P1|NOT COMPLETED|Overall Study||51
8561153|NCT00063154|21106856|P1|COMPLETED|Overall Study||0
8561154|NCT00063154|21106856|P1|STARTED|Overall Study||51
8561155|NCT00063232|21106863|P1|NOT COMPLETED|Overall Study||0
8561156|NCT00063232|21106863|P1|COMPLETED|Overall Study||26
8561157|NCT00063232|21106863|P1|STARTED|Overall Study||26
8561158|NCT00062868|21106890|P21|NOT COMPLETED|Dose Level 3||0
8561159|NCT00062868|21106891|P20|NOT COMPLETED|Dose Level 3||0
8561160|NCT00062868|21106892|P19|NOT COMPLETED|Dose Level 3||0
8561161|NCT00062868|21106893|P18|NOT COMPLETED|Dose Level 3||1
8561162|NCT00062868|21106894|P17|NOT COMPLETED|Dose Level 3||0
8561163|NCT00062868|21106895|P16|NOT COMPLETED|Dose Level 3||0
8561164|NCT00062868|21106896|P15|NOT COMPLETED|Dose Level 3||1
8561165|NCT00062868|21106897|P14|NOT COMPLETED|Dose Level 3||0
8561166|NCT00062868|21106898|P13|NOT COMPLETED|Dose Level 3||0
8561167|NCT00062868|21106899|P12|NOT COMPLETED|Dose Level 3||1
8561168|NCT00062868|21106900|P11|NOT COMPLETED|Dose Level 3||0
8561169|NCT00062868|21106901|P10|NOT COMPLETED|Dose Level 3||0
8561170|NCT00062868|21106902|P9|NOT COMPLETED|Dose Level 3||0
8561171|NCT00062868|21106903|P8|NOT COMPLETED|Dose Level 3||0
8561172|NCT00062868|21106904|P7|NOT COMPLETED|Dose Level 3||0
8561173|NCT00062868|21106905|P6|NOT COMPLETED|Dose Level 3||0
8561174|NCT00062868|21106906|P5|NOT COMPLETED|Dose Level 3||0
8561175|NCT00062868|21106907|P4|NOT COMPLETED|Dose Level 3||0
8561176|NCT00062868|21106908|P3|NOT COMPLETED|Dose Level 3||2
8561177|NCT00062868|21106909|P2|NOT COMPLETED|Dose Level 3||0
8561178|NCT00062868|21106910|P1|NOT COMPLETED|Dose Level 3||0
8561179|NCT00062868|21106890|P21|COMPLETED|Dose Level 3||0
8561180|NCT00062868|21106891|P20|COMPLETED|Dose Level 3||0
8561181|NCT00062868|21106892|P19|COMPLETED|Dose Level 3||0
8561182|NCT00062868|21106893|P18|COMPLETED|Dose Level 3||3
8561183|NCT00062868|21106894|P17|COMPLETED|Dose Level 3||0
8561184|NCT00062868|21106895|P16|COMPLETED|Dose Level 3||0
8561185|NCT00062868|21106896|P15|COMPLETED|Dose Level 3||2
8561186|NCT00062868|21106897|P14|COMPLETED|Dose Level 3||0
8561187|NCT00062868|21106898|P13|COMPLETED|Dose Level 3||0
8561188|NCT00062868|21106899|P12|COMPLETED|Dose Level 3||4
8561189|NCT00062868|21106900|P11|COMPLETED|Dose Level 3||0
8561190|NCT00062868|21106901|P10|COMPLETED|Dose Level 3||0
8561191|NCT00062868|21106902|P9|COMPLETED|Dose Level 3||0
8561192|NCT00062868|21106903|P8|COMPLETED|Dose Level 3||0
8561193|NCT00062868|21106904|P7|COMPLETED|Dose Level 3||0
8561194|NCT00062868|21106905|P6|COMPLETED|Dose Level 3||0
8561195|NCT00062868|21106906|P5|COMPLETED|Dose Level 3||0
8561196|NCT00062868|21106907|P4|COMPLETED|Dose Level 3||0
8561197|NCT00062868|21106908|P3|COMPLETED|Dose Level 3||1
8561198|NCT00062868|21106909|P2|COMPLETED|Dose Level 3||0
8561199|NCT00062868|21106910|P1|COMPLETED|Dose Level 3||0
8561200|NCT00062868|21106890|P21|STARTED|Dose Level 3||0
8561201|NCT00062868|21106891|P20|STARTED|Dose Level 3||0
8561202|NCT00062868|21106892|P19|STARTED|Dose Level 3||0
8561203|NCT00062868|21106893|P18|STARTED|Dose Level 3||4
8561204|NCT00062868|21106894|P17|STARTED|Dose Level 3||0
8561205|NCT00062868|21106895|P16|STARTED|Dose Level 3||0
8561206|NCT00062868|21106896|P15|STARTED|Dose Level 3||3
8561207|NCT00062868|21106897|P14|STARTED|Dose Level 3||0
8561208|NCT00062868|21106898|P13|STARTED|Dose Level 3||0
8561209|NCT00062868|21106899|P12|STARTED|Dose Level 3||5
8561210|NCT00062868|21106900|P11|STARTED|Dose Level 3||0
8561211|NCT00062868|21106901|P10|STARTED|Dose Level 3||0
8561212|NCT00062868|21106902|P9|STARTED|Dose Level 3||0
8561213|NCT00062868|21106903|P8|STARTED|Dose Level 3||0
8561214|NCT00062868|21106904|P7|STARTED|Dose Level 3||0
8561215|NCT00062868|21106905|P6|STARTED|Dose Level 3||0
8561216|NCT00062868|21106906|P5|STARTED|Dose Level 3||0
8561217|NCT00062868|21106907|P4|STARTED|Dose Level 3||0
8561218|NCT00062868|21106908|P3|STARTED|Dose Level 3||3
8561219|NCT00062868|21106909|P2|STARTED|Dose Level 3||0
8561220|NCT00062868|21106910|P1|STARTED|Dose Level 3||0
8561221|NCT00062868|21106890|P21|NOT COMPLETED|Dose Level 2||0
8561222|NCT00062868|21106891|P20|NOT COMPLETED|Dose Level 2||0
8561223|NCT00062868|21106892|P19|NOT COMPLETED|Dose Level 2||0
8561225|NCT00062868|21106894|P17|NOT COMPLETED|Dose Level 2||3
8561226|NCT00062868|21106895|P16|NOT COMPLETED|Dose Level 2||0
8561227|NCT00062868|21106896|P15|NOT COMPLETED|Dose Level 2||0
8561228|NCT00062868|21106897|P14|NOT COMPLETED|Dose Level 2||1
8561229|NCT00062868|21106898|P13|NOT COMPLETED|Dose Level 2||0
8561230|NCT00062868|21106899|P12|NOT COMPLETED|Dose Level 2||0
8561231|NCT00062868|21106900|P11|NOT COMPLETED|Dose Level 2||1
8561232|NCT00062868|21106901|P10|NOT COMPLETED|Dose Level 2||0
8561233|NCT00062868|21106902|P9|NOT COMPLETED|Dose Level 2||0
8561234|NCT00062868|21106903|P8|NOT COMPLETED|Dose Level 2||0
8561235|NCT00062868|21106904|P7|NOT COMPLETED|Dose Level 2||0
8561236|NCT00062868|21106905|P6|NOT COMPLETED|Dose Level 2||0
8561237|NCT00062868|21106906|P5|NOT COMPLETED|Dose Level 2||2
8561238|NCT00062868|21106907|P4|NOT COMPLETED|Dose Level 2||0
8561239|NCT00062868|21106908|P3|NOT COMPLETED|Dose Level 2||0
8561240|NCT00062868|21106909|P2|NOT COMPLETED|Dose Level 2||3
8561241|NCT00062868|21106910|P1|NOT COMPLETED|Dose Level 2||0
8561242|NCT00062868|21106890|P21|COMPLETED|Dose Level 2||0
8561243|NCT00062868|21106891|P20|COMPLETED|Dose Level 2||0
8561244|NCT00062868|21106892|P19|COMPLETED|Dose Level 2||0
8561245|NCT00062868|21106893|P18|COMPLETED|Dose Level 2||0
8561246|NCT00062868|21106894|P17|COMPLETED|Dose Level 2||0
8561247|NCT00062868|21106895|P16|COMPLETED|Dose Level 2||0
8561248|NCT00062868|21106896|P15|COMPLETED|Dose Level 2||0
8561249|NCT00062868|21106897|P14|COMPLETED|Dose Level 2||2
8561250|NCT00062868|21106898|P13|COMPLETED|Dose Level 2||0
8561251|NCT00062868|21106899|P12|COMPLETED|Dose Level 2||0
8561252|NCT00062868|21106900|P11|COMPLETED|Dose Level 2||3
8561253|NCT00062868|21106901|P10|COMPLETED|Dose Level 2||0
8561254|NCT00062868|21106902|P9|COMPLETED|Dose Level 2||0
8561255|NCT00062868|21106903|P8|COMPLETED|Dose Level 2||0
8561256|NCT00062868|21106904|P7|COMPLETED|Dose Level 2||0
8561257|NCT00062868|21106905|P6|COMPLETED|Dose Level 2||0
8561258|NCT00062868|21106906|P5|COMPLETED|Dose Level 2||1
8561259|NCT00062868|21106907|P4|COMPLETED|Dose Level 2||0
8561260|NCT00062868|21106908|P3|COMPLETED|Dose Level 2||0
8561261|NCT00062868|21106909|P2|COMPLETED|Dose Level 2||3
8561262|NCT00062868|21106910|P1|COMPLETED|Dose Level 2||0
8561263|NCT00062868|21106890|P21|STARTED|Dose Level 2||0
8561264|NCT00062868|21106891|P20|STARTED|Dose Level 2||0
8561265|NCT00062868|21106892|P19|STARTED|Dose Level 2||0
8561266|NCT00062868|21106893|P18|STARTED|Dose Level 2||0
8561267|NCT00062868|21106894|P17|STARTED|Dose Level 2||3
8561268|NCT00062868|21106895|P16|STARTED|Dose Level 2||0
8561269|NCT00062868|21106896|P15|STARTED|Dose Level 2||0
8561270|NCT00062868|21106897|P14|STARTED|Dose Level 2||3
8561271|NCT00062868|21106898|P13|STARTED|Dose Level 2||0
8561272|NCT00062868|21106899|P12|STARTED|Dose Level 2||0
8561273|NCT00062868|21106900|P11|STARTED|Dose Level 2||4
8561274|NCT00062868|21106901|P10|STARTED|Dose Level 2||0
8561275|NCT00062868|21106902|P9|STARTED|Dose Level 2||0
8561276|NCT00062868|21106903|P8|STARTED|Dose Level 2||0
8561277|NCT00062868|21106904|P7|STARTED|Dose Level 2||0
8561278|NCT00062868|21106905|P6|STARTED|Dose Level 2||0
8561279|NCT00062868|21106906|P5|STARTED|Dose Level 2||3
8561280|NCT00062868|21106907|P4|STARTED|Dose Level 2||0
8561281|NCT00062868|21106908|P3|STARTED|Dose Level 2||0
8561282|NCT00062868|21106909|P2|STARTED|Dose Level 2||6
8561283|NCT00062868|21106910|P1|STARTED|Dose Level 2||0
8561284|NCT00062868|21106890|P21|NOT COMPLETED|Dose Level 1||2
8561285|NCT00062868|21106891|P20|NOT COMPLETED|Dose Level 1||0
8561286|NCT00062868|21106892|P19|NOT COMPLETED|Dose Level 1||9
8561287|NCT00062868|21106893|P18|NOT COMPLETED|Dose Level 1||0
8561288|NCT00062868|21106894|P17|NOT COMPLETED|Dose Level 1||0
8561289|NCT00062868|21106895|P16|NOT COMPLETED|Dose Level 1||0
8561290|NCT00062868|21106896|P15|NOT COMPLETED|Dose Level 1||0
8561291|NCT00062868|21106897|P14|NOT COMPLETED|Dose Level 1||0
8561292|NCT00062868|21106898|P13|NOT COMPLETED|Dose Level 1||1
8561293|NCT00062868|21106899|P12|NOT COMPLETED|Dose Level 1||0
8561294|NCT00062868|21106900|P11|NOT COMPLETED|Dose Level 1||0
8561295|NCT00062868|21106901|P10|NOT COMPLETED|Dose Level 1||0
8561296|NCT00062868|21106902|P9|NOT COMPLETED|Dose Level 1||0
8561297|NCT00062868|21106903|P8|NOT COMPLETED|Dose Level 1||0
8561298|NCT00062868|21106904|P7|NOT COMPLETED|Dose Level 1||3
8561299|NCT00062868|21106905|P6|NOT COMPLETED|Dose Level 1||0
8561300|NCT00062868|21106906|P5|NOT COMPLETED|Dose Level 1||0
8561301|NCT00062868|21106907|P4|NOT COMPLETED|Dose Level 1||2
8561302|NCT00062868|21106908|P3|NOT COMPLETED|Dose Level 1||0
8561303|NCT00062868|21106909|P2|NOT COMPLETED|Dose Level 1||0
8561304|NCT00062868|21106910|P1|NOT COMPLETED|Dose Level 1||2
8561305|NCT00062868|21106890|P21|COMPLETED|Dose Level 1||1
8561306|NCT00062868|21106891|P20|COMPLETED|Dose Level 1||2
8561307|NCT00062868|21106892|P19|COMPLETED|Dose Level 1||7
8561308|NCT00062868|21106893|P18|COMPLETED|Dose Level 1||0
8561309|NCT00062868|21106894|P17|COMPLETED|Dose Level 1||0
8561310|NCT00062868|21106895|P16|COMPLETED|Dose Level 1||3
8561311|NCT00062868|21106896|P15|COMPLETED|Dose Level 1||0
8561312|NCT00062868|21106897|P14|COMPLETED|Dose Level 1||0
8561313|NCT00062868|21106898|P13|COMPLETED|Dose Level 1||2
8561314|NCT00062868|21106899|P12|COMPLETED|Dose Level 1||0
8561315|NCT00062868|21106900|P11|COMPLETED|Dose Level 1||0
8561316|NCT00062868|21106901|P10|COMPLETED|Dose Level 1||3
8561317|NCT00062868|21106902|P9|COMPLETED|Dose Level 1||0
8561318|NCT00062868|21106903|P8|COMPLETED|Dose Level 1||0
8561319|NCT00062868|21106904|P7|COMPLETED|Dose Level 1||1
8561320|NCT00062868|21106905|P6|COMPLETED|Dose Level 1||0
8561321|NCT00062868|21106906|P5|COMPLETED|Dose Level 1||0
8561322|NCT00062868|21106907|P4|COMPLETED|Dose Level 1||1
8561323|NCT00062868|21106908|P3|COMPLETED|Dose Level 1||0
8561324|NCT00062868|21106909|P2|COMPLETED|Dose Level 1||0
8561325|NCT00062868|21106910|P1|COMPLETED|Dose Level 1||1
8561326|NCT00062868|21106890|P21|STARTED|Dose Level 1||3
8561327|NCT00062868|21106891|P20|STARTED|Dose Level 1||2
8561328|NCT00062868|21106892|P19|STARTED|Dose Level 1||16
8561329|NCT00062868|21106893|P18|STARTED|Dose Level 1||0
8561330|NCT00062868|21106894|P17|STARTED|Dose Level 1||0
8561331|NCT00062868|21106895|P16|STARTED|Dose Level 1||3
8561332|NCT00062868|21106896|P15|STARTED|Dose Level 1||0
8561333|NCT00062868|21106897|P14|STARTED|Dose Level 1||0
8561334|NCT00062868|21106898|P13|STARTED|Dose Level 1||3
8561335|NCT00062868|21106899|P12|STARTED|Dose Level 1||0
8561336|NCT00062868|21106900|P11|STARTED|Dose Level 1||0
8561337|NCT00062868|21106901|P10|STARTED|Dose Level 1||3
8561338|NCT00062868|21106902|P9|STARTED|Dose Level 1||0
8561339|NCT00062868|21106903|P8|STARTED|Dose Level 1||0
8561340|NCT00062868|21106904|P7|STARTED|Dose Level 1||4
8561341|NCT00062868|21106905|P6|STARTED|Dose Level 1||0
8561342|NCT00062868|21106906|P5|STARTED|Dose Level 1||0
8561343|NCT00062868|21106907|P4|STARTED|Dose Level 1||3
8561344|NCT00062868|21106908|P3|STARTED|Dose Level 1||0
8561345|NCT00062868|21106909|P2|STARTED|Dose Level 1||0
8561346|NCT00062868|21106910|P1|STARTED|Dose Level 1||3
8561347|NCT00062764|21106996|P1|NOT COMPLETED|Overall Study||0
8561348|NCT00062764|21106996|P1|COMPLETED|Overall Study||18
8561349|NCT00062764|21106996|P1|STARTED|Overall Study||18
8561350|NCT00062751|21107009|P5|NOT COMPLETED|Overall Study||6
8561351|NCT00062751|21107010|P4|NOT COMPLETED|Overall Study||5
8561352|NCT00062751|21107011|P3|NOT COMPLETED|Overall Study||30
8561353|NCT00062751|21107012|P2|NOT COMPLETED|Overall Study||30
8561354|NCT00062751|21107013|P1|NOT COMPLETED|Overall Study||33
8561355|NCT00062751|21107009|P5|COMPLETED|Overall Study||0
8561356|NCT00062751|21107010|P4|COMPLETED|Overall Study||1
8561357|NCT00062751|21107011|P3|COMPLETED|Overall Study||3
8561358|NCT00062751|21107012|P2|COMPLETED|Overall Study||0
8561359|NCT00062751|21107013|P1|COMPLETED|Overall Study||0
8561360|NCT00062751|21107009|P5|STARTED|Overall Study||6
8561361|NCT00062751|21107010|P4|STARTED|Overall Study||6
8561362|NCT00062751|21107011|P3|STARTED|Overall Study||33
8561363|NCT00062751|21107012|P2|STARTED|Overall Study||30
8561364|NCT00062751|21107013|P1|STARTED|Overall Study||33
8561365|NCT00062738|21107084|P3|NOT COMPLETED|Overall Study||0
8561366|NCT00062738|21107085|P2|NOT COMPLETED|Overall Study||0
8561367|NCT00062738|21107086|P1|NOT COMPLETED|Overall Study||0
8561368|NCT00062738|21107084|P3|COMPLETED|Overall Study||17
8561369|NCT00062738|21107085|P2|COMPLETED|Overall Study||18
8561370|NCT00062738|21107086|P1|COMPLETED|Overall Study||17
8561371|NCT00062738|21107084|P3|STARTED|Overall Study||17
8561372|NCT00062738|21107085|P2|STARTED|Overall Study||18
8561373|NCT00062738|21107086|P1|STARTED|Overall Study||17
8561374|NCT00062647|21107099|P2|NOT COMPLETED|Overall Study||13
8561375|NCT00062647|21107100|P1|NOT COMPLETED|Overall Study||16
8561376|NCT00062647|21107099|P2|COMPLETED|Overall Study||17
8561377|NCT00062647|21107100|P1|COMPLETED|Overall Study||14
8561378|NCT00062647|21107099|P2|STARTED|Overall Study||30
8561379|NCT00062647|21107100|P1|STARTED|Overall Study||30
8561380|NCT00062439|21107106|P1|NOT COMPLETED|Consolidation Chemotherapy||2
8561381|NCT00062439|21107106|P1|COMPLETED|Consolidation Chemotherapy||20
8561382|NCT00062439|21107106|P1|STARTED|Consolidation Chemotherapy||22
8561383|NCT00062439|21107106|P1|NOT COMPLETED|Surgery||7
8561384|NCT00062439|21107106|P1|COMPLETED|Surgery||22
8561385|NCT00062439|21107106|P1|STARTED|Surgery||29
8561386|NCT00062439|21107106|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
8561387|NCT00062439|21107106|P1|COMPLETED|Post Chemoradiation Assessment||29
8561388|NCT00062439|21107106|P1|STARTED|Post Chemoradiation Assessment||38
8561389|NCT00062439|21107106|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
8561390|NCT00062439|21107106|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
8561391|NCT00062439|21107106|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
8561392|NCT00062374|21107118|P1|NOT COMPLETED|Overall Study||12
8561393|NCT00062374|21107118|P1|COMPLETED|Overall Study||43
8561394|NCT00062374|21107118|P1|STARTED|Overall Study||55
8561395|NCT00062166|21107123|P1|NOT COMPLETED|Overall Study||6
8561396|NCT00062166|21107123|P1|COMPLETED|Overall Study||334
8561397|NCT00062166|21107123|P1|STARTED|Overall Study||340
8561398|NCT00062010|21107131|P1|NOT COMPLETED|Overall Study||3
8561399|NCT00062010|21107131|P1|COMPLETED|Overall Study||34
8561400|NCT00062010|21107131|P1|Eligible and Treated|Overall Study||34
8561401|NCT00062010|21107131|P1|STARTED|Overall Study||37
8561402|NCT00061945|21107139|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
8561403|NCT00061945|21107140|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
8561404|NCT00061945|21107139|P2|COMPLETED|Course IV: Alemtuzumab||50
8561405|NCT00061945|21107140|P1|COMPLETED|Course IV: Alemtuzumab||18
8561406|NCT00061945|21107139|P2|STARTED|Course IV: Alemtuzumab||66
8561407|NCT00061945|21107140|P1|STARTED|Course IV: Alemtuzumab||25
8561408|NCT00061945|21107139|P2|NOT COMPLETED|Registration Through Course 3||115
8561409|NCT00061945|21107140|P1|NOT COMPLETED|Registration Through Course 3||94
8561410|NCT00061945|21107139|P2|COMPLETED|Registration Through Course 3||66
8561411|NCT00061945|21107140|P1|COMPLETED|Registration Through Course 3||25
8561412|NCT00061945|21107139|P2|STARTED|Registration Through Course 3||181
8561413|NCT00061945|21107140|P1|STARTED|Registration Through Course 3||119
8561420|NCT00061893|21107157|P1|NOT COMPLETED|Overall Study||18
8561421|NCT00061893|21107157|P1|COMPLETED|Overall Study||20
8561422|NCT00061893|21107157|P1|STARTED|Overall Study||38
8561423|NCT00061633|21107164|P2|NOT COMPLETED|Overall Study||11
8561424|NCT00061633|21107165|P1|NOT COMPLETED|Overall Study||5
8561425|NCT00061633|21107164|P2|COMPLETED|Overall Study||74
8561426|NCT00061633|21107165|P1|COMPLETED|Overall Study||79
8561427|NCT00061633|21107164|P2|STARTED|Overall Study||85
8561428|NCT00061633|21107165|P1|STARTED|Overall Study||84
8561429|NCT00061373|21107173|P2|NOT COMPLETED|Overall Study||0
8561430|NCT00061373|21107174|P1|NOT COMPLETED|Overall Study||0
8561431|NCT00061373|21107173|P2|COMPLETED|Overall Study||3
8561432|NCT00061373|21107174|P1|COMPLETED|Overall Study||15
8561433|NCT00061373|21107173|P2|Aspirin and Tinzaparin|Overall Study||3
8561434|NCT00061373|21107174|P1|Aspirin and Tinzaparin|Overall Study||15
8561435|NCT00061373|21107173|P2|STARTED|Overall Study||3
8561436|NCT00061373|21107174|P1|STARTED|Overall Study||15
8561437|NCT00061048|21107190|P1|NOT COMPLETED|Overall Study||22
8561438|NCT00061048|21107190|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
8561439|NCT00061048|21107190|P1|STARTED|Overall Study||29
8561440|NCT00060944|21107200|P2|NOT COMPLETED|Overall Study||134
8561441|NCT00060944|21107201|P1|NOT COMPLETED|Overall Study||136
8561442|NCT00060944|21107200|P2|COMPLETED|Overall Study||0
8561443|NCT00060944|21107201|P1|COMPLETED|Overall Study||0
8561444|NCT00060944|21107200|P2|Treated|Overall Study||130
8561445|NCT00060944|21107201|P1|Treated|Overall Study||130
8561446|NCT00060944|21107200|P2|STARTED|Overall Study||134
8561447|NCT00060944|21107201|P1|STARTED|Overall Study||136
8561448|NCT00060840|21107217|P2|NOT COMPLETED|Overall Study||9
8561449|NCT00060840|21107218|P1|NOT COMPLETED|Overall Study||4
8561450|NCT00060840|21107217|P2|COMPLETED|Overall Study||68
8561451|NCT00060840|21107218|P1|COMPLETED|Overall Study||69
8561452|NCT00060840|21107217|P2|STARTED|Overall Study||77
8561453|NCT00060840|21107218|P1|STARTED|Overall Study||73
8561454|NCT00060606|21107226|P2|NOT COMPLETED|Overall Study||1
8561455|NCT00060606|21107227|P1|NOT COMPLETED|Overall Study||0
8561456|NCT00060606|21107226|P2|COMPLETED|Overall Study||91
8561457|NCT00060606|21107227|P1|COMPLETED|Overall Study||91
8561458|NCT00060606|21107226|P2|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
8561459|NCT00060606|21107227|P1|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
8561460|NCT00060606|21107226|P2|STARTED|Overall Study||92
8561461|NCT00060606|21107227|P1|STARTED|Overall Study||91
8561462|NCT00060528|21107237|P4|NOT COMPLETED|Overall Study||0
8561463|NCT00060528|21107238|P3|NOT COMPLETED|Overall Study||0
8561464|NCT00060528|21107239|P2|NOT COMPLETED|Overall Study||0
8561465|NCT00060528|21107240|P1|NOT COMPLETED|Overall Study||0
8561466|NCT00060528|21107237|P4|COMPLETED|Overall Study||8
8561467|NCT00060528|21107238|P3|COMPLETED|Overall Study||7
8561468|NCT00060528|21107239|P2|COMPLETED|Overall Study||9
8561469|NCT00060528|21107240|P1|COMPLETED|Overall Study||8
8561470|NCT00060528|21107237|P4|STARTED|Overall Study||8
8561471|NCT00060528|21107238|P3|STARTED|Overall Study||7
8561472|NCT00060528|21107239|P2|STARTED|Overall Study||9
8561473|NCT00060528|21107240|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
8561474|NCT00060424|21107254|P1|NOT COMPLETED|Overall Study||0
8561475|NCT00060424|21107254|P1|COMPLETED|Overall Study||21
8561476|NCT00060424|21107254|P1|STARTED|Overall Study||21
8561477|NCT00060346|21107262|P1|NOT COMPLETED|Overall Study||0
8561478|NCT00060346|21107262|P1|COMPLETED|Overall Study||16
8561479|NCT00060346|21107262|P1|Eligible and Treated|Overall Study||16
8561480|NCT00060346|21107262|P1|STARTED|Overall Study||16
8561481|NCT00060333|21107266|P1|NOT COMPLETED|Overall Study||0
8561482|NCT00060333|21107266|P1|COMPLETED|Overall Study||20
8561483|NCT00060333|21107266|P1|STARTED|Overall Study||20
8561484|NCT00060008|21107277|P1|NOT COMPLETED|Overall Study||0
8561485|NCT00060008|21107277|P1|COMPLETED|Overall Study||18
8561486|NCT00060008|21107277|P1|STARTED|Overall Study||18
8561487|NCT00059839|21107284|P2|NOT COMPLETED|Overall Study||17
8561488|NCT00059839|21107285|P1|NOT COMPLETED|Overall Study||12
8561489|NCT00059839|21107284|P2|COMPLETED|Overall Study||47
8561490|NCT00059839|21107285|P1|COMPLETED|Overall Study||53
8561491|NCT00059839|21107284|P2|STARTED|Overall Study||64
8561492|NCT00059839|21107285|P1|STARTED|Overall Study||65
8561493|NCT00059787|21107291|P1|NOT COMPLETED|Overall Study||20
8561494|NCT00059787|21107291|P1|COMPLETED|Overall Study||36
8561495|NCT00059787|21107291|P1|STARTED|Overall Study||56
8561496|NCT00059475|21107307|P8|NOT COMPLETED|Overall Study||0
8561497|NCT00059475|21107308|P7|NOT COMPLETED|Overall Study||0
8561498|NCT00059475|21107309|P6|NOT COMPLETED|Overall Study||0
8561499|NCT00059475|21107310|P5|NOT COMPLETED|Overall Study||0
8561500|NCT00059475|21107311|P4|NOT COMPLETED|Overall Study||0
8561501|NCT00059475|21107312|P3|NOT COMPLETED|Overall Study||0
8561502|NCT00059475|21107313|P2|NOT COMPLETED|Overall Study||0
8561503|NCT00059475|21107314|P1|NOT COMPLETED|Overall Study||0
8561504|NCT00059475|21107307|P8|COMPLETED|Overall Study||7
8561505|NCT00059475|21107308|P7|COMPLETED|Overall Study||34
8561506|NCT00059475|21107309|P6|COMPLETED|Overall Study||2
8561507|NCT00059475|21107310|P5|COMPLETED|Overall Study||33
8561508|NCT00059475|21107311|P4|COMPLETED|Overall Study||3
8561509|NCT00059475|21107312|P3|COMPLETED|Overall Study||24
8561510|NCT00059475|21107313|P2|COMPLETED|Overall Study||2
8561511|NCT00059475|21107314|P1|COMPLETED|Overall Study||33
8561512|NCT00059475|21107307|P8|STARTED|Overall Study||7
8561513|NCT00059475|21107308|P7|STARTED|Overall Study||34
8561514|NCT00059475|21107309|P6|STARTED|Overall Study||2
8561515|NCT00059475|21107310|P5|STARTED|Overall Study||33
8561516|NCT00059475|21107311|P4|STARTED|Overall Study||3
8561517|NCT00059475|21107312|P3|STARTED|Overall Study||24
8561518|NCT00059475|21107313|P2|STARTED|Overall Study||2
8561519|NCT00059475|21107314|P1|STARTED|Overall Study||33
8561520|NCT00059332|21107342|P2|NOT COMPLETED|Overall Study||2
8561521|NCT00059332|21107343|P1|NOT COMPLETED|Overall Study||3
8561522|NCT00059332|21107342|P2|COMPLETED|Overall Study||855
8561523|NCT00059332|21107343|P1|COMPLETED|Overall Study||840
8561524|NCT00059332|21107342|P2|STARTED|Overall Study||857
8561525|NCT00059332|21107343|P1|STARTED|Overall Study||843
8561526|NCT00059215|21107369|P4|NOT COMPLETED|Overall Study||15
8561527|NCT00059215|21107370|P3|NOT COMPLETED|Overall Study||15
8561528|NCT00059215|21107371|P2|NOT COMPLETED|Overall Study||14
8561529|NCT00059215|21107372|P1|NOT COMPLETED|Overall Study||13
8561530|NCT00059215|21107369|P4|COMPLETED|Overall Study||239
8561531|NCT00059215|21107370|P3|COMPLETED|Overall Study||236
8561532|NCT00059215|21107371|P2|COMPLETED|Overall Study||186
8561533|NCT00059215|21107372|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
8561534|NCT00059215|21107369|P4|STARTED|Overall Study||254
8561535|NCT00059215|21107370|P3|STARTED|Overall Study||251
8561536|NCT00059215|21107371|P2|STARTED|Overall Study||200
8561537|NCT00059215|21107372|P1|STARTED|Overall Study||200
8561538|NCT00059228|21107400|P2|NOT COMPLETED|Overall Study||1
8561539|NCT00059228|21107401|P1|NOT COMPLETED|Overall Study||0
8561540|NCT00059228|21107400|P2|COMPLETED|Overall Study||5
8561541|NCT00059228|21107401|P1|COMPLETED|Overall Study||6
8561542|NCT00059228|21107400|P2|STARTED|Overall Study||6
8561543|NCT00059228|21107401|P1|STARTED|Overall Study||6
8561544|NCT00058825|21107409|P1|NOT COMPLETED|Overall Study||22
8561545|NCT00058825|21107409|P1|COMPLETED|Overall Study||5
8561546|NCT00058825|21107409|P1|STARTED|Overall Study||27
8561547|NCT00058552|21107425|P2|NOT COMPLETED|Overall Study||62
8561548|NCT00058552|21107426|P1|NOT COMPLETED|Overall Study||65
8561549|NCT00058552|21107425|P2|COMPLETED|Overall Study||2
8561550|NCT00058552|21107426|P1|COMPLETED|Overall Study||0
8561551|NCT00058552|21107425|P2|STARTED|Overall Study||64
8561552|NCT00058552|21107426|P1|STARTED|Overall Study||65
8561553|NCT00058539|21107444|P1|NOT COMPLETED|Overall Study||42
8561554|NCT00058539|21107444|P1|COMPLETED|Overall Study||0
8561555|NCT00058539|21107444|P1|STARTED|Overall Study||42
8561556|NCT00058422|21107454|P1|NOT COMPLETED|Overall Study||2
8561557|NCT00058422|21107454|P1|COMPLETED|Overall Study||63
8561558|NCT00058422|21107454|P1|STARTED|Overall Study||65
8561559|NCT00058370|21107462|P1|NOT COMPLETED|Overall Study||0
8561560|NCT00058370|21107462|P1|COMPLETED|Overall Study||6
8561561|NCT00058370|21107462|P1|STARTED|Overall Study||6
8561562|NCT00058240|21107472|P4|NOT COMPLETED|Second Dose Level||0
8561563|NCT00058240|21107473|P3|NOT COMPLETED|Second Dose Level||0
8561564|NCT00058240|21107474|P2|NOT COMPLETED|Second Dose Level||0
8561565|NCT00058240|21107475|P1|NOT COMPLETED|Second Dose Level||0
8561566|NCT00058240|21107472|P4|COMPLETED|Second Dose Level||4
8561567|NCT00058240|21107473|P3|COMPLETED|Second Dose Level||2
8561568|NCT00058240|21107474|P2|COMPLETED|Second Dose Level||0
8561569|NCT00058240|21107475|P1|COMPLETED|Second Dose Level||0
8561570|NCT00058240|21107472|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
8561571|NCT00058240|21107473|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
8561572|NCT00058240|21107474|P2|STARTED|Second Dose Level||0
8561573|NCT00058240|21107475|P1|STARTED|Second Dose Level||0
8561574|NCT00058240|21107472|P4|NOT COMPLETED|First Dose Level||0
8561575|NCT00058240|21107473|P3|NOT COMPLETED|First Dose Level||0
8561576|NCT00058240|21107474|P2|NOT COMPLETED|First Dose Level||0
8561577|NCT00058240|21107475|P1|NOT COMPLETED|First Dose Level||0
8561578|NCT00058240|21107472|P4|COMPLETED|First Dose Level||12
8561579|NCT00058240|21107473|P3|COMPLETED|First Dose Level||17
8561580|NCT00058240|21107474|P2|COMPLETED|First Dose Level||3
8561581|NCT00058240|21107475|P1|COMPLETED|First Dose Level||20
8561582|NCT00058240|21107472|P4|Treated|First Dose Level||12
8561583|NCT00058240|21107473|P3|Treated|First Dose Level||17
8561584|NCT00058240|21107474|P2|Treated|First Dose Level||3
8561585|NCT00058240|21107475|P1|Treated|First Dose Level||20
8561586|NCT00058240|21107472|P4|STARTED|First Dose Level||12
8561587|NCT00058240|21107473|P3|STARTED|First Dose Level||17
8561588|NCT00058240|21107474|P2|STARTED|First Dose Level||3
8561589|NCT00058240|21107475|P1|STARTED|First Dose Level||20
8561590|NCT00058214|21107485|P1|NOT COMPLETED|Overall Study||1
8561591|NCT00058214|21107485|P1|COMPLETED|Overall Study||24
8561592|NCT00058214|21107485|P1|STARTED|Overall Study||25
8561593|NCT00058188|21107492|P2|NOT COMPLETED|Overall Study||0
8561594|NCT00058188|21107493|P1|NOT COMPLETED|Overall Study||0
8561595|NCT00058188|21107492|P2|COMPLETED|Overall Study||0
8561596|NCT00058188|21107493|P1|COMPLETED|Overall Study||0
8561597|NCT00058188|21107492|P2|STARTED|Overall Study||0
8561598|NCT00058188|21107493|P1|STARTED|Overall Study||0
8561599|NCT00058123|21107507|P1|NOT COMPLETED|Overall Study||10
8561600|NCT00058123|21107507|P1|COMPLETED|Overall Study||45
8561601|NCT00058123|21107507|P1|STARTED|Overall Study||55
8561602|NCT00058058|21107514|P1|NOT COMPLETED|Overall Study||38
8561603|NCT00058058|21107514|P1|COMPLETED|Overall Study||969
8561604|NCT00058058|21107514|P1|STARTED|Overall Study||1007
8561605|NCT00058019|21107525|P2|NOT COMPLETED|Overall Study||0
8561606|NCT00058019|21107526|P1|NOT COMPLETED|Overall Study||0
8561607|NCT00058019|21107525|P2|COMPLETED|Overall Study||12
8561608|NCT00058019|21107526|P1|COMPLETED|Overall Study||39
8561609|NCT00058019|21107525|P2|STARTED|Overall Study||12
8561610|NCT00058019|21107526|P1|STARTED|Overall Study||39
8561611|NCT00057954|21107539|P1|NOT COMPLETED|Overall Study||2
8561612|NCT00057954|21107539|P1|COMPLETED|Overall Study||4
8561613|NCT00057954|21107539|P1|STARTED|Overall Study||6
8561614|NCT00057941|21107547|P2|NOT COMPLETED|Overall Study||74
8561615|NCT00057941|21107548|P1|NOT COMPLETED|Overall Study||74
8561616|NCT00057941|21107547|P2|COMPLETED|Overall Study||0
8561617|NCT00057941|21107548|P1|COMPLETED|Overall Study||0
8561618|NCT00057941|21107547|P2|Eligible|Overall Study||69
8561619|NCT00057941|21107548|P1|Eligible|Overall Study||72
8561620|NCT00057941|21107547|P2|Treated|Overall Study||74
8561621|NCT00057941|21107548|P1|Treated|Overall Study||74
8561622|NCT00057941|21107547|P2|STARTED|Overall Study||74
8561623|NCT00057941|21107548|P1|STARTED|Overall Study||74
8561624|NCT00057876|21107556|P2|NOT COMPLETED|Overall Study||27
8561625|NCT00057876|21107557|P1|NOT COMPLETED|Overall Study||29
8561626|NCT00057876|21107556|P2|COMPLETED|Overall Study||9
8561627|NCT00057876|21107557|P1|COMPLETED|Overall Study||9
8561628|NCT00057876|21107556|P2|Eligible and Treated|Overall Study||34
8561629|NCT00057876|21107557|P1|Eligible and Treated|Overall Study||34
8561630|NCT00057876|21107556|P2|Began Protocol Therapy|Overall Study||34
8561631|NCT00057876|21107557|P1|Began Protocol Therapy|Overall Study||35
8561632|NCT00057876|21107556|P2|Eligible|Overall Study||34
8561633|NCT00057876|21107557|P1|Eligible|Overall Study||37
8561634|NCT00057876|21107556|P2|STARTED|Overall Study||36
8561635|NCT00057876|21107557|P1|STARTED|Overall Study||38
8561636|NCT00057863|21107567|P1|NOT COMPLETED|Overall Study||3
8561637|NCT00057863|21107567|P1|COMPLETED|Overall Study||32
8561638|NCT00057863|21107567|P1|STARTED|Overall Study||35
8561639|NCT00057837|21107576|P2|NOT COMPLETED|Overall Study||39
8561640|NCT00057837|21107577|P1|NOT COMPLETED|Overall Study||31
8561641|NCT00057837|21107576|P2|COMPLETED|Overall Study||31
8561642|NCT00057837|21107577|P1|COMPLETED|Overall Study||39
8561643|NCT00057837|21107576|P2|Patients With Response|Overall Study||38
8561644|NCT00057837|21107577|P1|Patients With Response|Overall Study||46
8561645|NCT00057837|21107576|P2|Eligible and Treated|Overall Study||66
8561646|NCT00057837|21107577|P1|Eligible and Treated|Overall Study||66
8561647|NCT00057837|21107576|P2|Treated|Overall Study||68
8561648|NCT00057837|21107577|P1|Treated|Overall Study||69
8561649|NCT00057837|21107576|P2|STARTED|Overall Study||70
8561650|NCT00057837|21107577|P1|STARTED|Overall Study||70
8561651|NCT00057811|21107589|P2|NOT COMPLETED|Overall Study||12
8561652|NCT00057811|21107590|P1|NOT COMPLETED|Overall Study||10
8561653|NCT00057811|21107589|P2|COMPLETED|Overall Study||34
8561654|NCT00057811|21107590|P1|COMPLETED|Overall Study||41
8561655|NCT00057811|21107589|P2|STARTED|Overall Study||46
8561656|NCT00057811|21107590|P1|STARTED|Overall Study||51
8561657|NCT00057785|21107602|P1|NOT COMPLETED|Overall Study||0
8561658|NCT00057785|21107602|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
8561659|NCT00057785|21107602|P1|STARTED|Overall Study||68
8561660|NCT00057746|21107609|P3|NOT COMPLETED|Overall Study||1
8561661|NCT00057746|21107610|P2|NOT COMPLETED|Overall Study||0
8561662|NCT00057746|21107611|P1|NOT COMPLETED|Overall Study||0
8561663|NCT00057746|21107609|P3|COMPLETED|Overall Study||66
8561664|NCT00057746|21107610|P2|COMPLETED|Overall Study||67
8561665|NCT00057746|21107611|P1|COMPLETED|Overall Study||131
8561666|NCT00057746|21107609|P3|STARTED|Overall Study||67
8561667|NCT00057746|21107610|P2|STARTED|Overall Study||67
8561668|NCT00057746|21107611|P1|STARTED|Overall Study||131
8561669|NCT00023673|21107622|P4|NOT COMPLETED|Overall Study||2
8561670|NCT00023673|21107623|P3|NOT COMPLETED|Overall Study||0
8561671|NCT00023673|21107624|P2|NOT COMPLETED|Overall Study||0
8561672|NCT00023673|21107625|P1|NOT COMPLETED|Overall Study||0
8561673|NCT00023673|21107622|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
8561674|NCT00023673|21107623|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
8561675|NCT00023673|21107624|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
8561676|NCT00023673|21107625|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
8561677|NCT00023673|21107622|P4|STARTED|Overall Study||46
8561678|NCT00023673|21107623|P3|STARTED|Overall Study||0
8561679|NCT00023673|21107624|P2|STARTED|Overall Study||9
8561680|NCT00023673|21107625|P1|STARTED|Overall Study||8
8561681|NCT00057681|21107641|P3|NOT COMPLETED|Overall Study||34
8561682|NCT00057681|21107642|P2|NOT COMPLETED|Overall Study||72
8561683|NCT00057681|21107643|P1|NOT COMPLETED|Overall Study||65
8561684|NCT00057681|21107641|P3|COMPLETED|Overall Study||69
8561685|NCT00057681|21107642|P2|COMPLETED|Overall Study||67
8561686|NCT00057681|21107643|P1|COMPLETED|Overall Study||72
8561687|NCT00057681|21107641|P3|STARTED|Overall Study||103
8561688|NCT00057681|21107642|P2|STARTED|Overall Study||139
8561689|NCT00057681|21107643|P1|STARTED|Overall Study||137
8561690|NCT00057577|21107659|P2|NOT COMPLETED|Overall Study||0
8561691|NCT00057577|21107660|P1|NOT COMPLETED|Overall Study||0
8561692|NCT00057577|21107659|P2|COMPLETED|Overall Study||225
8561693|NCT00057577|21107660|P1|COMPLETED|Overall Study||227
8561694|NCT00057577|21107659|P2|STARTED|Overall Study||225
8561695|NCT00057577|21107660|P1|STARTED|Overall Study||227
8561696|NCT00057551|21107677|P3|NOT COMPLETED|Overall Study||16
8561697|NCT00057551|21107678|P2|NOT COMPLETED|Overall Study||27
8561698|NCT00057551|21107679|P1|NOT COMPLETED|Overall Study||25
8561699|NCT00057551|21107677|P3|COMPLETED|Overall Study||80
8561700|NCT00057551|21107678|P2|COMPLETED|Overall Study||168
8561701|NCT00057551|21107679|P1|COMPLETED|Overall Study||175
8561702|NCT00057551|21107677|P3|STARTED|Overall Study||96
8561703|NCT00057551|21107678|P2|STARTED|Overall Study||195
8561704|NCT00057551|21107679|P1|STARTED|Overall Study||200
8561705|NCT00057330|21107689|P2|NOT COMPLETED|Overall Study||920
8561706|NCT00057330|21107690|P1|NOT COMPLETED|Overall Study||1132
8561707|NCT00057330|21107689|P2|COMPLETED|Overall Study||2826
8561708|NCT00057330|21107690|P1|COMPLETED|Overall Study||3445
8561709|NCT00057330|21107689|P2|STARTED|Overall Study||3746
8561710|NCT00057330|21107690|P1|STARTED|Overall Study||4577
8561711|NCT00056862|21107720|P2|NOT COMPLETED|Overall Study||0
8561712|NCT00056862|21107721|P1|NOT COMPLETED|Overall Study||1
8561713|NCT00056862|21107720|P2|COMPLETED|Overall Study||27
8561714|NCT00056862|21107721|P1|COMPLETED|Overall Study||30
8561715|NCT00056862|21107720|P2|STARTED|Overall Study||27
8561716|NCT00056862|21107721|P1|STARTED|Overall Study||31
8561717|NCT00056563|21107737|P2|NOT COMPLETED|Overall Study||0
8561718|NCT00056563|21107738|P1|NOT COMPLETED|Overall Study||0
8561719|NCT00056563|21107737|P2|COMPLETED|Overall Study||134
8561720|NCT00056563|21107738|P1|COMPLETED|Overall Study||121
8561721|NCT00056563|21107737|P2|STARTED|Overall Study||134
8561722|NCT00056563|21107738|P1|STARTED|Overall Study||121
8561723|NCT00056550|21107746|P1|NOT COMPLETED|Overall Study||0
8561724|NCT00056550|21107746|P1|COMPLETED|Overall Study||14
8561725|NCT00056550|21107746|P1|STARTED|Overall Study||14
8561726|NCT00056498|21107753|P2|NOT COMPLETED|Overall Study||7
8561727|NCT00056498|21107754|P1|NOT COMPLETED|Overall Study||5
8561728|NCT00056498|21107753|P2|COMPLETED|Overall Study||28
8561729|NCT00056498|21107754|P1|COMPLETED|Overall Study||25
8561730|NCT00056498|21107753|P2|STARTED|Overall Study||35
8561731|NCT00056498|21107754|P1|STARTED|Overall Study||30
8561732|NCT00056472|21107766|P2|NOT COMPLETED|Overall Study||69
8561733|NCT00056472|21107767|P1|NOT COMPLETED|Overall Study||48
8561734|NCT00056472|21107766|P2|COMPLETED|Overall Study||61
8561735|NCT00056472|21107767|P1|COMPLETED|Overall Study||81
8561736|NCT00056472|21107766|P2|STARTED|Overall Study||130
8561737|NCT00056472|21107767|P1|STARTED|Overall Study||129
8561738|NCT00056407|21107779|P2|NOT COMPLETED|Overall Study||1193
8561739|NCT00056407|21107780|P1|NOT COMPLETED|Overall Study||1211
8561740|NCT00056407|21107779|P2|COMPLETED|Overall Study||2912
8561741|NCT00056407|21107780|P1|COMPLETED|Overall Study||2915
8561742|NCT00056407|21107779|P2|STARTED|Overall Study||4105
8561743|NCT00056407|21107780|P1|STARTED|Overall Study||4126
8561744|NCT00056316|21107838|P2|NOT COMPLETED|Overall Study||3
8561745|NCT00056316|21107839|P1|NOT COMPLETED|Overall Study||3
8561746|NCT00056316|21107838|P2|COMPLETED|Overall Study||38
8561747|NCT00056316|21107839|P1|COMPLETED|Overall Study||30
8561748|NCT00056316|21107838|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
8561749|NCT00056316|21107839|P1|STARTED|Overall Study||33
8561750|NCT00056160|21107853|P2|NOT COMPLETED|Final Follow-up||0
8561751|NCT00056160|21107854|P1|NOT COMPLETED|Final Follow-up||6
8561752|NCT00056160|21107853|P2|COMPLETED|Final Follow-up||0
8561753|NCT00056160|21107854|P1|COMPLETED|Final Follow-up||0
8561754|NCT00056160|21107853|P2|STARTED|Final Follow-up||0
8561755|NCT00056160|21107854|P1|STARTED|Final Follow-up||6
8561756|NCT00056160|21107853|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8561757|NCT00056160|21107854|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
8561758|NCT00056160|21107853|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8561759|NCT00056160|21107854|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
8561760|NCT00056160|21107853|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
8561761|NCT00056160|21107854|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
8561762|NCT00056160|21107853|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
8561763|NCT00056160|21107854|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
8561764|NCT00056160|21107853|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
8561765|NCT00056160|21107854|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
8561766|NCT00056160|21107853|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
8561767|NCT00056160|21107854|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
8561768|NCT00055692|21107866|P1|NOT COMPLETED|Overall Study||0
8561769|NCT00055692|21107866|P1|COMPLETED|Overall Study||46
8561770|NCT00055692|21107866|P1|STARTED|Overall Study||46
8561771|NCT00055601|21107877|P2|NOT COMPLETED|Overall Study||2
8561772|NCT00055601|21107878|P1|NOT COMPLETED|Overall Study||2
8561773|NCT00055601|21107877|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
8561774|NCT00055601|21107878|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
8561775|NCT00055601|21107877|P2|STARTED|Overall Study||49
8561776|NCT00055601|21107878|P1|STARTED|Overall Study||48
8561777|NCT00055497|21107892|P4|NOT COMPLETED|Overall Study||90
8561778|NCT00055497|21107893|P3|NOT COMPLETED|Overall Study||2
8561779|NCT00055497|21107894|P2|NOT COMPLETED|Overall Study||3
8561780|NCT00055497|21107895|P1|NOT COMPLETED|Overall Study||5
8561865|NCT00054327|21108241|P5|COMPLETED|Overall Study||10
8561781|NCT00055497|21107892|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
8561782|NCT00055497|21107893|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8561783|NCT00055497|21107894|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8561784|NCT00055497|21107895|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
8561785|NCT00055497|21107892|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
8561786|NCT00055497|21107893|P3|STARTED|Overall Study||18
8561787|NCT00055497|21107894|P2|STARTED|Overall Study||19
8561788|NCT00055497|21107895|P1|STARTED|Overall Study||18
8561789|NCT00055471|21107940|P3|NOT COMPLETED|Period 2: Extension Period||0
8561790|NCT00055471|21107941|P2|NOT COMPLETED|Period 2: Extension Period||0
8561791|NCT00055471|21107942|P1|NOT COMPLETED|Period 2: Extension Period||0
8561792|NCT00055471|21107940|P3|COMPLETED|Period 2: Extension Period||0
8561793|NCT00055471|21107941|P2|COMPLETED|Period 2: Extension Period||6
8561794|NCT00055471|21107942|P1|COMPLETED|Period 2: Extension Period||3
8561795|NCT00055471|21107940|P3|STARTED|Period 2: Extension Period||0
8561796|NCT00055471|21107941|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
8561797|NCT00055471|21107942|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
8561798|NCT00055471|21107940|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
8561799|NCT00055471|21107941|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
8561800|NCT00055471|21107942|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
8561801|NCT00055471|21107940|P3|COMPLETED|Period 1: Dose Escalation Period||0
8561802|NCT00055471|21107941|P2|COMPLETED|Period 1: Dose Escalation Period||8
8561803|NCT00055471|21107942|P1|COMPLETED|Period 1: Dose Escalation Period||3
8561804|NCT00055471|21107940|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
8561805|NCT00055471|21107941|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
8561806|NCT00055471|21107942|P1|STARTED|Period 1: Dose Escalation Period||3
8561807|NCT00055237|21107970|P2|NOT COMPLETED|Overall Study||0
8561808|NCT00055237|21107971|P1|NOT COMPLETED|Overall Study||0
8561809|NCT00055237|21107970|P2|COMPLETED|Overall Study||2
8561810|NCT00055237|21107971|P1|COMPLETED|Overall Study||17
8561811|NCT00055237|21107970|P2|STARTED|Overall Study||2
8561812|NCT00055237|21107971|P1|STARTED|Overall Study||17
8561813|NCT00054847|21107978|P2|NOT COMPLETED|Overall Study||100
8561814|NCT00054847|21107979|P1|NOT COMPLETED|Overall Study||98
8561815|NCT00054847|21107978|P2|COMPLETED|Overall Study||266
8561816|NCT00054847|21107979|P1|COMPLETED|Overall Study||269
8561817|NCT00054847|21107978|P2|STARTED|Overall Study||366
8561818|NCT00054847|21107979|P1|STARTED|Overall Study||367
8561819|NCT00054756|21107991|P1|NOT COMPLETED|Overall Study||2
8561820|NCT00054756|21107991|P1|COMPLETED|Overall Study||94
8561821|NCT00054756|21107991|P1|STARTED|Overall Study||96
8561822|NCT00054717|21107997|P2|NOT COMPLETED|Overall Study||299
8561823|NCT00054717|21107998|P1|NOT COMPLETED|Overall Study||262
8561824|NCT00054717|21107997|P2|COMPLETED|Overall Study||18
8561825|NCT00054717|21107998|P1|COMPLETED|Overall Study||51
8561826|NCT00054717|21107997|P2|STARTED|Overall Study||317
8561827|NCT00054717|21107998|P1|STARTED|Overall Study||313
8561828|NCT00054704|21108186|P2|NOT COMPLETED|Overall Study||5
8561829|NCT00054704|21108187|P1|NOT COMPLETED|Overall Study||5
8561830|NCT00054704|21108186|P2|COMPLETED|Overall Study||6
8561831|NCT00054704|21108187|P1|COMPLETED|Overall Study||3
8561832|NCT00054704|21108186|P2|STARTED|Overall Study||11
8561833|NCT00054704|21108187|P1|STARTED|Overall Study||8
8561834|NCT00054691|21108193|P1|NOT COMPLETED|Overall Study||3
8561835|NCT00054691|21108193|P1|COMPLETED|Overall Study||37
8561836|NCT00054691|21108193|P1|STARTED|Overall Study||40
8561837|NCT00054665|21108198|P2|NOT COMPLETED|Part B||0
8561838|NCT00054665|21108199|P1|NOT COMPLETED|Part B||0
8561839|NCT00054665|21108198|P2|COMPLETED|Part B||44
8561840|NCT00054665|21108199|P1|COMPLETED|Part B||0
8561841|NCT00054665|21108198|P2|STARTED|Part B|26 participants received only Part B|44
8561842|NCT00054665|21108199|P1|STARTED|Part B||0
8561843|NCT00054665|21108198|P2|NOT COMPLETED|Part A||0
8561844|NCT00054665|21108199|P1|NOT COMPLETED|Part A||0
8561845|NCT00054665|21108198|P2|COMPLETED|Part A||0
8561846|NCT00054665|21108199|P1|COMPLETED|Part A||23
8561847|NCT00054665|21108198|P2|STARTED|Part A||0
8561848|NCT00054665|21108199|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
8561849|NCT00054639|21108207|P1|NOT COMPLETED|Overall Study||2
8561850|NCT00054639|21108207|P1|COMPLETED|Overall Study||46
8561851|NCT00054639|21108207|P1|STARTED|Overall Study||48
8561852|NCT00054353|21108213|P2|NOT COMPLETED|Overall Study||0
8561853|NCT00054353|21108214|P1|NOT COMPLETED|Overall Study||0
8561854|NCT00054353|21108213|P2|COMPLETED|Overall Study||4
8561855|NCT00054353|21108214|P1|COMPLETED|Overall Study||12
8561856|NCT00054353|21108213|P2|STARTED|Overall Study||4
8561857|NCT00054353|21108214|P1|STARTED|Overall Study||12
8561858|NCT00054327|21108240|P6|NOT COMPLETED|Overall Study||0
8561859|NCT00054327|21108241|P5|NOT COMPLETED|Overall Study||0
8561860|NCT00054327|21108242|P4|NOT COMPLETED|Overall Study||0
8561861|NCT00054327|21108243|P3|NOT COMPLETED|Overall Study||0
8561862|NCT00054327|21108244|P2|NOT COMPLETED|Overall Study||0
8561863|NCT00054327|21108245|P1|NOT COMPLETED|Overall Study||1
8561864|NCT00054327|21108240|P6|COMPLETED|Overall Study||2
8561866|NCT00054327|21108242|P4|COMPLETED|Overall Study||4
8561867|NCT00054327|21108243|P3|COMPLETED|Overall Study||3
8561868|NCT00054327|21108244|P2|COMPLETED|Overall Study||4
8561869|NCT00054327|21108245|P1|COMPLETED|Overall Study||10
8561870|NCT00054327|21108240|P6|STARTED|Overall Study||2
8561871|NCT00054327|21108241|P5|STARTED|Overall Study||10
8561872|NCT00054327|21108242|P4|STARTED|Overall Study||4
8561873|NCT00054327|21108243|P3|STARTED|Overall Study||3
8561874|NCT00054327|21108244|P2|STARTED|Overall Study||4
8561875|NCT00054327|21108245|P1|STARTED|Overall Study||11
8561876|NCT00054275|21108283|P1|NOT COMPLETED|Overall Study||11
8561877|NCT00054275|21108283|P1|COMPLETED|Overall Study||28
8561878|NCT00054275|21108283|P1|STARTED|Overall Study||39
8561879|NCT00054132|21108289|P1|NOT COMPLETED|Overall Study||1
8561880|NCT00054132|21108289|P1|COMPLETED|Overall Study||37
8561881|NCT00054132|21108289|P1|STARTED|Overall Study||38
8561882|NCT00054028|21108300|P1|NOT COMPLETED|Overall Study||0
8561883|NCT00054028|21108300|P1|COMPLETED|Overall Study||31
8561884|NCT00054028|21108300|P1|Phase II|Overall Study||22
8561885|NCT00054028|21108300|P1|Phase I|Overall Study||9
8561886|NCT00054028|21108300|P1|STARTED|Overall Study||31
8561887|NCT00053989|21108306|P1|NOT COMPLETED|Overall Study||0
8561888|NCT00053989|21108306|P1|COMPLETED|Overall Study||41
8561889|NCT00053989|21108306|P1|STARTED|Overall Study||41
8561890|NCT00053898|21108316|P2|NOT COMPLETED|Overall Study||13
8561891|NCT00053898|21108317|P1|NOT COMPLETED|Overall Study||14
8561892|NCT00053898|21108316|P2|COMPLETED|Overall Study||1539
8561893|NCT00053898|21108317|P1|COMPLETED|Overall Study||1538
8561894|NCT00053898|21108316|P2|STARTED|Overall Study||1552
8561895|NCT00053898|21108317|P1|STARTED|Overall Study||1552
8561896|NCT00053846|21108343|P2|NOT COMPLETED|Overall Study||27
8561897|NCT00053846|21108344|P1|NOT COMPLETED|Overall Study||26
8561898|NCT00053846|21108343|P2|COMPLETED|Overall Study||192
8561899|NCT00053846|21108344|P1|COMPLETED|Overall Study||187
8561900|NCT00053846|21108343|P2|STARTED|Overall Study||219
8561901|NCT00053846|21108344|P1|STARTED|Overall Study||213
8561902|NCT00053703|21108353|P3|NOT COMPLETED|Overall Study||15
8561903|NCT00053703|21108354|P2|NOT COMPLETED|Overall Study||13
8561904|NCT00053703|21108355|P1|NOT COMPLETED|Overall Study||18
8561905|NCT00053703|21108353|P3|COMPLETED|Overall Study||25
8561906|NCT00053703|21108354|P2|COMPLETED|Overall Study||28
8561907|NCT00053703|21108355|P1|COMPLETED|Overall Study||17
8561908|NCT00053703|21108353|P3|STARTED|Overall Study||40
8561909|NCT00053703|21108354|P2|STARTED|Overall Study||41
8561910|NCT00053703|21108355|P1|STARTED|Overall Study||35
8561911|NCT00053677|21108380|P2|NOT COMPLETED|Overall Study||6
8561912|NCT00053677|21108381|P1|NOT COMPLETED|Overall Study||22
8561913|NCT00053677|21108380|P2|COMPLETED|Overall Study||13
8561914|NCT00053677|21108381|P1|COMPLETED|Overall Study||36
8561915|NCT00053677|21108380|P2|STARTED|Overall Study||19
8561916|NCT00053677|21108381|P1|STARTED|Overall Study||58
8561917|NCT00053495|21108392|P5|NOT COMPLETED|Overall Study||0
8561918|NCT00053495|21108393|P4|NOT COMPLETED|Overall Study||0
8561919|NCT00053495|21108394|P3|NOT COMPLETED|Overall Study||0
8561920|NCT00053495|21108395|P2|NOT COMPLETED|Overall Study||0
8561921|NCT00053495|21108396|P1|NOT COMPLETED|Overall Study||0
8561922|NCT00053495|21108392|P5|COMPLETED|Overall Study||49
8561923|NCT00053495|21108393|P4|COMPLETED|Overall Study||51
8561924|NCT00053495|21108394|P3|COMPLETED|Overall Study||101
8561925|NCT00053495|21108395|P2|COMPLETED|Overall Study||101
8561926|NCT00053495|21108396|P1|COMPLETED|Overall Study||51
8561927|NCT00053495|21108392|P5|STARTED|Overall Study||49
8561928|NCT00053495|21108393|P4|STARTED|Overall Study||51
8561929|NCT00053495|21108394|P3|STARTED|Overall Study||101
8561930|NCT00053495|21108395|P2|STARTED|Overall Study||101
8561931|NCT00053495|21108396|P1|STARTED|Overall Study||51
8561932|NCT00053482|21108448|P5|NOT COMPLETED|Overall Study||0
8561933|NCT00053482|21108449|P4|NOT COMPLETED|Overall Study||0
8561934|NCT00053482|21108450|P3|NOT COMPLETED|Overall Study||0
8561935|NCT00053482|21108451|P2|NOT COMPLETED|Overall Study||0
8561936|NCT00053482|21108452|P1|NOT COMPLETED|Overall Study||0
8561937|NCT00053482|21108448|P5|COMPLETED|Overall Study||52
8561938|NCT00053482|21108449|P4|COMPLETED|Overall Study||50
8561939|NCT00053482|21108450|P3|COMPLETED|Overall Study||102
8561940|NCT00053482|21108451|P2|COMPLETED|Overall Study||102
8561941|NCT00053482|21108452|P1|COMPLETED|Overall Study||51
8561942|NCT00053482|21108448|P5|STARTED|Overall Study||52
8561943|NCT00053482|21108449|P4|STARTED|Overall Study||50
8561944|NCT00053482|21108450|P3|STARTED|Overall Study||102
8561945|NCT00053482|21108451|P2|STARTED|Overall Study||102
8561946|NCT00053482|21108452|P1|STARTED|Overall Study||51
8561947|NCT00053417|21108503|P4|NOT COMPLETED|Overall Study||6
8561948|NCT00053417|21108504|P3|NOT COMPLETED|Overall Study||1
8561949|NCT00053417|21108505|P2|NOT COMPLETED|Overall Study||2
8561950|NCT00053417|21108506|P1|NOT COMPLETED|Overall Study||2
8561951|NCT00053417|21108503|P4|COMPLETED|Overall Study||51
8561952|NCT00053417|21108504|P3|COMPLETED|Overall Study||49
8561953|NCT00053417|21108505|P2|COMPLETED|Overall Study||50
8561954|NCT00053417|21108506|P1|COMPLETED|Overall Study||45
8561955|NCT00053417|21108503|P4|STARTED|Overall Study||57
8561956|NCT00053417|21108504|P3|STARTED|Overall Study||50
8561957|NCT00053417|21108505|P2|STARTED|Overall Study||52
8561958|NCT00053417|21108506|P1|STARTED|Overall Study||47
8561959|NCT00053365|21108516|P1|NOT COMPLETED|Overall Study||6
8561960|NCT00053365|21108516|P1|COMPLETED|Overall Study||55
8561961|NCT00053365|21108516|P1|STARTED|Overall Study||61
8561962|NCT00053352|21108525|P2|NOT COMPLETED|Overall Study||10
8561963|NCT00053352|21108526|P1|NOT COMPLETED|Overall Study||21
8561964|NCT00053352|21108525|P2|COMPLETED|Overall Study||102
8561965|NCT00053352|21108526|P1|COMPLETED|Overall Study||169
8561966|NCT00053352|21108525|P2|STARTED|Overall Study||112
8561967|NCT00053352|21108526|P1|STARTED|Overall Study||190
8561968|NCT00053014|21108535|P1|NOT COMPLETED|Overall Study||0
8561969|NCT00053014|21108535|P1|COMPLETED|Overall Study||5
8561970|NCT00053014|21108535|P1|STARTED|Overall Study||5
8561971|NCT00003830|21108542|P2|NOT COMPLETED|Overall Study||793
8561972|NCT00003830|21108543|P1|NOT COMPLETED|Overall Study||832
8561973|NCT00003830|21108542|P2|COMPLETED|Overall Study||2011
8561974|NCT00003830|21108543|P1|COMPLETED|Overall Study||1975
8561975|NCT00003830|21108542|P2|STARTED|Overall Study||2804
8561976|NCT00003830|21108543|P1|STARTED|Overall Study||2807
8561977|NCT00052962|21108569|P2|NOT COMPLETED|Overall Study||2
8561978|NCT00052962|21108570|P1|NOT COMPLETED|Overall Study||1
8561979|NCT00052962|21108569|P2|COMPLETED|Overall Study||15
8561980|NCT00052962|21108570|P1|COMPLETED|Overall Study||12
8561981|NCT00052962|21108569|P2|STARTED|Overall Study||17
8561982|NCT00052962|21108570|P1|STARTED|Overall Study||13
8561983|NCT00052910|21108580|P2|NOT COMPLETED|Overall Study||0
8561984|NCT00052910|21108581|P1|NOT COMPLETED|Overall Study||0
8561985|NCT00052910|21108580|P2|COMPLETED|Overall Study||266
8561986|NCT00052910|21108581|P1|COMPLETED|Overall Study||280
8561987|NCT00052910|21108580|P2|STARTED|Overall Study||266
8561988|NCT00052910|21108581|P1|STARTED|Overall Study||280
8561989|NCT00052715|21108589|P1|NOT COMPLETED|Overall Study||1
8561990|NCT00052715|21108589|P1|COMPLETED|Overall Study||30
8561991|NCT00052715|21108589|P1|STARTED|Overall Study||31
8561992|NCT00052429|21108598|P1|NOT COMPLETED|Overall Study||0
8561993|NCT00052429|21108598|P1|COMPLETED|Overall Study||25
8561994|NCT00052429|21108598|P1|STARTED|Overall Study||25
8561995|NCT00049673|21108605|P2|NOT COMPLETED|Overall Study||3
8561996|NCT00049673|21108606|P1|NOT COMPLETED|Overall Study||1
8561997|NCT00049673|21108605|P2|COMPLETED|Overall Study||163
8561998|NCT00049673|21108606|P1|COMPLETED|Overall Study||165
8561999|NCT00049673|21108605|P2|STARTED|Overall Study||166
8562000|NCT00049673|21108606|P1|STARTED|Overall Study||166
8562001|NCT00049543|21108616|P2|NOT COMPLETED|Overall Study||9
8562002|NCT00049543|21108617|P1|NOT COMPLETED|Overall Study||2
8562003|NCT00049543|21108616|P2|COMPLETED|Overall Study||243
8562004|NCT00049543|21108617|P1|COMPLETED|Overall Study||249
8562005|NCT00049543|21108616|P2|STARTED|Overall Study||252
8562006|NCT00049543|21108617|P1|STARTED|Overall Study||251
8562007|NCT00049530|21108627|P1|NOT COMPLETED|Overall Study||32
8562008|NCT00049530|21108627|P1|COMPLETED|Overall Study||0
8562009|NCT00049530|21108627|P1|Eligible and Treated|Overall Study||29
8562010|NCT00049530|21108627|P1|STARTED|Overall Study||32
8562011|NCT00049517|21108636|P6|NOT COMPLETED|Conditioning/Transplant||6
8562012|NCT00049517|21108637|P5|NOT COMPLETED|Conditioning/Transplant||6
8562013|NCT00049517|21108638|P4|NOT COMPLETED|Conditioning/Transplant||43
8562014|NCT00049517|21108639|P3|NOT COMPLETED|Conditioning/Transplant||38
8562015|NCT00049517|21108640|P2|NOT COMPLETED|Conditioning/Transplant||50
8562016|NCT00049517|21108641|P1|NOT COMPLETED|Conditioning/Transplant||52
8562017|NCT00049517|21108636|P6|COMPLETED|Conditioning/Transplant||18
8562018|NCT00049517|21108637|P5|COMPLETED|Conditioning/Transplant||15
8562019|NCT00049517|21108638|P4|COMPLETED|Conditioning/Transplant||32
8562020|NCT00049517|21108639|P3|COMPLETED|Conditioning/Transplant||25
8562021|NCT00049517|21108640|P2|COMPLETED|Conditioning/Transplant||40
8562022|NCT00049517|21108641|P1|COMPLETED|Conditioning/Transplant||27
8562023|NCT00049517|21108636|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
8562024|NCT00049517|21108637|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
8562025|NCT00049517|21108638|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
8562026|NCT00049517|21108639|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
8562027|NCT00049517|21108640|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
8562028|NCT00049517|21108641|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
8562029|NCT00049517|21108636|P6|STARTED|Conditioning/Transplant||24
8562030|NCT00049517|21108637|P5|STARTED|Conditioning/Transplant||21
8562031|NCT00049517|21108638|P4|STARTED|Conditioning/Transplant||75
8562032|NCT00049517|21108639|P3|STARTED|Conditioning/Transplant||63
8562033|NCT00049517|21108640|P2|STARTED|Conditioning/Transplant||90
8562034|NCT00049517|21108641|P1|STARTED|Conditioning/Transplant||79
8562035|NCT00049517|21108636|P6|NOT COMPLETED|Induction||54
8562036|NCT00049517|21108637|P5|NOT COMPLETED|Induction||60
8562037|NCT00049517|21108638|P4|NOT COMPLETED|Induction||0
8562038|NCT00049517|21108639|P3|NOT COMPLETED|Induction||0
8562039|NCT00049517|21108640|P2|NOT COMPLETED|Induction||0
8562040|NCT00049517|21108641|P1|NOT COMPLETED|Induction||0
8562041|NCT00049517|21108636|P6|COMPLETED|Induction||108
8562042|NCT00049517|21108637|P5|COMPLETED|Induction||128
8562043|NCT00049517|21108638|P4|COMPLETED|Induction||75
8562044|NCT00049517|21108639|P3|COMPLETED|Induction||63
8562045|NCT00049517|21108640|P2|COMPLETED|Induction||90
8562046|NCT00049517|21108641|P1|COMPLETED|Induction||79
8562047|NCT00049517|21108636|P6|Treated|Induction||160
8562048|NCT00049517|21108637|P5|Treated|Induction||186
8562049|NCT00049517|21108638|P4|Treated|Induction||75
8562050|NCT00049517|21108639|P3|Treated|Induction||63
8562051|NCT00049517|21108640|P2|Treated|Induction||90
8562052|NCT00049517|21108641|P1|Treated|Induction||79
8562053|NCT00049517|21108636|P6|STARTED|Induction||162
8562054|NCT00049517|21108637|P5|STARTED|Induction||188
8562055|NCT00049517|21108638|P4|STARTED|Induction||75
8562056|NCT00049517|21108639|P3|STARTED|Induction||63
8562057|NCT00049517|21108640|P2|STARTED|Induction||90
8562058|NCT00049517|21108641|P1|STARTED|Induction||79
8562059|NCT00049504|21108651|P1|NOT COMPLETED|Overall Study||0
8562060|NCT00049504|21108651|P1|COMPLETED|Overall Study||55
8562061|NCT00049504|21108651|P1|STARTED|Overall Study||55
8562062|NCT00049322|21108659|P2|NOT COMPLETED|Overall Study||6
8562063|NCT00049322|21108660|P1|NOT COMPLETED|Overall Study||1
8562064|NCT00049322|21108659|P2|COMPLETED|Overall Study||9
8562065|NCT00049322|21108660|P1|COMPLETED|Overall Study||14
8562066|NCT00049322|21108659|P2|STARTED|Overall Study||15
8562067|NCT00049322|21108660|P1|STARTED|Overall Study||15
8562068|NCT00049257|21108672|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
8562069|NCT00049257|21108672|P1|COMPLETED|Follow-up Period for Survival Status||41
8562070|NCT00049257|21108672|P1|STARTED|Follow-up Period for Survival Status||45
8562071|NCT00049257|21108672|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
8562072|NCT00049257|21108672|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
8562073|NCT00049257|21108672|P1|STARTED|Carboplatin, Paclitaxel||58
8562074|NCT00049127|21108684|P5|NOT COMPLETED|Overall Study||0
8562075|NCT00049127|21108685|P4|NOT COMPLETED|Overall Study||0
8562076|NCT00049127|21108686|P3|NOT COMPLETED|Overall Study||1
8562077|NCT00049127|21108687|P2|NOT COMPLETED|Overall Study||0
8562078|NCT00049127|21108688|P1|NOT COMPLETED|Overall Study||0
8562079|NCT00049127|21108684|P5|COMPLETED|Overall Study||12
8562080|NCT00049127|21108685|P4|COMPLETED|Overall Study||0
8562081|NCT00049127|21108686|P3|COMPLETED|Overall Study||39
8562082|NCT00049127|21108687|P2|COMPLETED|Overall Study||0
8562083|NCT00049127|21108688|P1|COMPLETED|Overall Study||12
8562084|NCT00049127|21108684|P5|STARTED|Overall Study||12
8562085|NCT00049127|21108685|P4|STARTED|Overall Study||0
8562086|NCT00049127|21108686|P3|STARTED|Overall Study||40
8562087|NCT00049127|21108687|P2|STARTED|Overall Study||0
8562088|NCT00049127|21108688|P1|STARTED|Overall Study||12
8562089|NCT00049036|21108717|P2|NOT COMPLETED|Overall Study||0
8562090|NCT00049036|21108718|P1|NOT COMPLETED|Overall Study||0
8562091|NCT00049036|21108717|P2|COMPLETED|Overall Study||55
8562092|NCT00049036|21108718|P1|COMPLETED|Overall Study||51
8562093|NCT00049036|21108717|P2|STARTED|Overall Study||55
8562094|NCT00049036|21108718|P1|STARTED|Overall Study||51
8562095|NCT00048997|21108726|P2|NOT COMPLETED|Overall Study||3
8562096|NCT00048997|21108727|P1|NOT COMPLETED|Overall Study||13
8562097|NCT00048997|21108726|P2|COMPLETED|Overall Study||177
8562098|NCT00048997|21108727|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
8562099|NCT00048997|21108726|P2|STARTED|Overall Study||180
8562100|NCT00048997|21108727|P1|STARTED|Overall Study||176
8562101|NCT00047385|21108750|P2|NOT COMPLETED|Overall Study||500
8562102|NCT00047385|21108751|P1|NOT COMPLETED|Overall Study||267
8562103|NCT00047385|21108750|P2|COMPLETED|Overall Study||26232
8562104|NCT00047385|21108751|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
8562105|NCT00047385|21108750|P2|STARTED|Overall Study||26732
8562106|NCT00047385|21108751|P1|STARTED|Overall Study||26722
8562107|NCT00047320|21108769|P1|NOT COMPLETED|Overall Study||28
8562108|NCT00047320|21108769|P1|COMPLETED|Overall Study||76
8562109|NCT00047320|21108769|P1|STARTED|Overall Study||104
8562110|NCT00047060|21108778|P1|NOT COMPLETED|Overall Study||2
8562111|NCT00047060|21108778|P1|COMPLETED|Overall Study||3
8562112|NCT00047060|21108778|P1|STARTED|Overall Study||5
8562113|NCT00047008|21108784|P2|NOT COMPLETED|Overall Study||11
8562114|NCT00047008|21108785|P1|NOT COMPLETED|Overall Study||11
8562115|NCT00047008|21108784|P2|COMPLETED|Overall Study||360
8562116|NCT00047008|21108785|P1|COMPLETED|Overall Study||361
8562117|NCT00047008|21108784|P2|STARTED|Overall Study||371
8562118|NCT00047008|21108785|P1|STARTED|Overall Study||372
8562119|NCT00046930|21108793|P2|NOT COMPLETED|Overall Study||4
8562120|NCT00046930|21108794|P1|NOT COMPLETED|Overall Study||12
8562121|NCT00046930|21108793|P2|COMPLETED|Overall Study||221
8562122|NCT00046930|21108794|P1|COMPLETED|Overall Study||212
8562123|NCT00046930|21108793|P2|STARTED|Overall Study||225
8562124|NCT00046930|21108794|P1|STARTED|Overall Study||224
8562125|NCT00046891|21108809|P2|NOT COMPLETED|Overall Study||30
8562126|NCT00046891|21108810|P1|NOT COMPLETED|Overall Study||29
8562127|NCT00046891|21108809|P2|COMPLETED|Overall Study||83
8562128|NCT00046891|21108810|P1|COMPLETED|Overall Study||84
8562129|NCT00046891|21108809|P2|STARTED|Overall Study||113
8562130|NCT00046891|21108810|P1|STARTED|Overall Study||113
8562131|NCT00046839|21108830|P2|NOT COMPLETED|Overall Study||2
8562132|NCT00046839|21108831|P1|NOT COMPLETED|Overall Study||1
8562133|NCT00046839|21108830|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
8562134|NCT00046839|21108831|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
8562135|NCT00046839|21108830|P2|STARTED|Overall Study||13
8562136|NCT00046839|21108831|P1|STARTED|Overall Study||8
8562137|NCT00045734|21108838|P1|NOT COMPLETED|Overall Study||1
8562138|NCT00045734|21108838|P1|COMPLETED|Overall Study||22
8562139|NCT00045734|21108838|P1|STARTED|Overall Study||23
8562140|NCT00045708|21108853|P3|NOT COMPLETED|Phase 2||0
8562141|NCT00045708|21108854|P2|NOT COMPLETED|Phase 2||0
8562142|NCT00045708|21108855|P1|NOT COMPLETED|Phase 2||0
8562143|NCT00045708|21108853|P3|COMPLETED|Phase 2||19
8562144|NCT00045708|21108854|P2|COMPLETED|Phase 2||0
8562145|NCT00045708|21108855|P1|COMPLETED|Phase 2||0
8562146|NCT00045708|21108853|P3|STARTED|Phase 2||19
8562147|NCT00045708|21108854|P2|STARTED|Phase 2||0
8562148|NCT00045708|21108855|P1|STARTED|Phase 2||0
8562149|NCT00045708|21108853|P3|NOT COMPLETED|Phase 1||0
8562150|NCT00045708|21108854|P2|NOT COMPLETED|Phase 1||1
8562151|NCT00045708|21108855|P1|NOT COMPLETED|Phase 1||0
8562152|NCT00045708|21108853|P3|COMPLETED|Phase 1||0
8562153|NCT00045708|21108854|P2|COMPLETED|Phase 1||16
8562154|NCT00045708|21108855|P1|COMPLETED|Phase 1||21
8562155|NCT00045708|21108853|P3|STARTED|Phase 1||0
8562156|NCT00045708|21108854|P2|STARTED|Phase 1||17
8562157|NCT00045708|21108855|P1|STARTED|Phase 1||21
8562158|NCT00045630|21108880|P1|NOT COMPLETED|Overall Study||6
8562159|NCT00045630|21108880|P1|COMPLETED|Overall Study||71
8562160|NCT00045630|21108880|P1|Eligible and Began Protocol Therapy|Overall Study||74
8562161|NCT00045630|21108880|P1|Eligible|Overall Study||75
8562162|NCT00045630|21108880|P1|STARTED|Overall Study||77
8562163|NCT00045487|21108886|P1|NOT COMPLETED|Overall Study||11
8562164|NCT00045487|21108886|P1|COMPLETED|Overall Study||30
8562165|NCT00045487|21108886|P1|STARTED|Overall Study||41
8562166|NCT00045435|21108890|P1|NOT COMPLETED|Overall Study||0
8562167|NCT00045435|21108890|P1|COMPLETED|Overall Study||17
8562168|NCT00045435|21108890|P1|STARTED|Overall Study||17
8562169|NCT00045305|21108899|P1|NOT COMPLETED|Overall Study||14
8562170|NCT00045305|21108899|P1|COMPLETED|Overall Study||3
8562171|NCT00045305|21108899|P1|Eligible and Treated|Overall Study||17
8562172|NCT00045305|21108899|P1|STARTED|Overall Study||17
8562173|NCT00045162|21108910|P2|NOT COMPLETED|Overall Study||118
8562174|NCT00045162|21108911|P1|NOT COMPLETED|Overall Study||142
8562175|NCT00045162|21108910|P2|COMPLETED|Overall Study||217
8562176|NCT00045162|21108911|P1|COMPLETED|Overall Study||194
8562177|NCT00045162|21108910|P2|STARTED|Overall Study||335
8562178|NCT00045162|21108911|P1|STARTED|Overall Study||336
8562179|NCT00045110|21108926|P3|NOT COMPLETED|775mg Dose Escalation||0
8562180|NCT00045110|21108927|P2|NOT COMPLETED|775mg Dose Escalation||0
8562181|NCT00045110|21108928|P1|NOT COMPLETED|775mg Dose Escalation||0
8562182|NCT00045110|21108926|P3|COMPLETED|775mg Dose Escalation||0
8562183|NCT00045110|21108927|P2|COMPLETED|775mg Dose Escalation||0
8562184|NCT00045110|21108928|P1|COMPLETED|775mg Dose Escalation||7
8562185|NCT00045110|21108926|P3|STARTED|775mg Dose Escalation||0
8562186|NCT00045110|21108927|P2|STARTED|775mg Dose Escalation||0
8562187|NCT00045110|21108928|P1|STARTED|775mg Dose Escalation||7
8562188|NCT00045110|21108926|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8562189|NCT00045110|21108927|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8562190|NCT00045110|21108928|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8562191|NCT00045110|21108926|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
8562192|NCT00045110|21108927|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
8562193|NCT00045110|21108928|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
8562194|NCT00045110|21108926|P3|STARTED|650mg Phase 1 Dose Escalation||0
8562195|NCT00045110|21108927|P2|STARTED|650mg Phase 1 Dose Escalation||0
8562196|NCT00045110|21108928|P1|STARTED|650mg Phase 1 Dose Escalation||6
8562197|NCT00045110|21108926|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8562198|NCT00045110|21108927|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8562199|NCT00045110|21108928|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8562200|NCT00045110|21108926|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
8562201|NCT00045110|21108927|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
8562202|NCT00045110|21108928|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
8562203|NCT00045110|21108926|P3|STARTED|525mg Phase 1 Dose Escalation||0
8562204|NCT00045110|21108927|P2|STARTED|525mg Phase 1 Dose Escalation||0
8562205|NCT00045110|21108928|P1|STARTED|525mg Phase 1 Dose Escalation||3
8562206|NCT00045110|21108926|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8562207|NCT00045110|21108927|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8562208|NCT00045110|21108928|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8562209|NCT00045110|21108926|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
8562210|NCT00045110|21108927|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
8562211|NCT00045110|21108928|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
8562212|NCT00045110|21108926|P3|STARTED|400mg Phase 1 Dose Escalation||0
8562213|NCT00045110|21108927|P2|STARTED|400mg Phase 1 Dose Escalation||0
8562214|NCT00045110|21108928|P1|STARTED|400mg Phase 1 Dose Escalation||3
8562215|NCT00045110|21108926|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8562216|NCT00045110|21108927|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8562217|NCT00045110|21108928|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8562218|NCT00045110|21108926|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
8562219|NCT00045110|21108927|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
8562220|NCT00045110|21108928|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
8562221|NCT00045110|21108926|P3|STARTED|275mg Phase 1 Dose Escalation||0
8562222|NCT00045110|21108927|P2|STARTED|275mg Phase 1 Dose Escalation||0
8562223|NCT00045110|21108928|P1|STARTED|275mg Phase 1 Dose Escalation||3
8562224|NCT00045110|21108926|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8562225|NCT00045110|21108927|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8562226|NCT00045110|21108928|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8562227|NCT00045110|21108926|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
8562228|NCT00045110|21108927|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
8562229|NCT00045110|21108928|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
8562230|NCT00045110|21108926|P3|STARTED|200mg Phase 1 Dose Escalation||0
8562231|NCT00045110|21108927|P2|STARTED|200mg Phase 1 Dose Escalation||0
8562232|NCT00045110|21108928|P1|STARTED|200mg Phase 1 Dose Escalation||4
8562233|NCT00045110|21108926|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
8562234|NCT00045110|21108927|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
8562235|NCT00045110|21108928|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
8562236|NCT00045110|21108926|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
8562237|NCT00045110|21108927|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
8562238|NCT00045110|21108928|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
8562239|NCT00045110|21108926|P3|STARTED|100mg Phase 1 Dose Escalalation||45
8562240|NCT00045110|21108927|P2|STARTED|100mg Phase 1 Dose Escalalation||59
8562241|NCT00045110|21108928|P1|STARTED|100mg Phase 1 Dose Escalalation||6
8562242|NCT00045032|21108977|P3|NOT COMPLETED|Overall Study||726
8562243|NCT00045032|21108978|P2|NOT COMPLETED|Overall Study||708
8562244|NCT00045032|21108979|P1|NOT COMPLETED|Overall Study||863
8562245|NCT00045032|21108977|P3|COMPLETED|Overall Study||974
8562246|NCT00045032|21108978|P2|COMPLETED|Overall Study||994
8562247|NCT00045032|21108979|P1|COMPLETED|Overall Study||834
8562248|NCT00045032|21108977|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8562249|NCT00045032|21108978|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8562250|NCT00045032|21108979|P1|Crossover to Adjuvant Herceptin|Overall Study||888
8562251|NCT00045032|21108977|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
8562252|NCT00045032|21108978|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
8562253|NCT00045032|21108979|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
8562254|NCT00042991|21109113|P7|NOT COMPLETED|Overall Study||2
8562255|NCT00042991|21109114|P6|NOT COMPLETED|Overall Study||5
8562256|NCT00042991|21109115|P5|NOT COMPLETED|Overall Study||3
8562257|NCT00042991|21109116|P4|NOT COMPLETED|Overall Study||2
8562258|NCT00042991|21109117|P3|NOT COMPLETED|Overall Study||6
8562259|NCT00042991|21109118|P2|NOT COMPLETED|Overall Study||40
8562260|NCT00042991|21109119|P1|NOT COMPLETED|Overall Study||6
8562261|NCT00042991|21109113|P7|COMPLETED|Overall Study||1
8562262|NCT00042991|21109114|P6|COMPLETED|Overall Study||0
8562263|NCT00042991|21109115|P5|COMPLETED|Overall Study||0
8562264|NCT00042991|21109116|P4|COMPLETED|Overall Study||0
8562265|NCT00042991|21109117|P3|COMPLETED|Overall Study||1
8562266|NCT00042991|21109118|P2|COMPLETED|Overall Study||3
8562267|NCT00042991|21109119|P1|COMPLETED|Overall Study||0
8562268|NCT00042991|21109113|P7|Phase-II Trial|Overall Study||0
8562269|NCT00042991|21109114|P6|Phase-II Trial|Overall Study||0
8562270|NCT00042991|21109115|P5|Phase-II Trial|Overall Study||0
8562271|NCT00042991|21109116|P4|Phase-II Trial|Overall Study||0
8562272|NCT00042991|21109117|P3|Phase-II Trial|Overall Study||0
8562273|NCT00042991|21109118|P2|Phase-II Trial|Overall Study||36
8562274|NCT00042991|21109119|P1|Phase-II Trial|Overall Study||0
8562275|NCT00042991|21109113|P7|Phase-I Trial|Overall Study||3
8562276|NCT00042991|21109114|P6|Phase-I Trial|Overall Study||5
8562277|NCT00042991|21109115|P5|Phase-I Trial|Overall Study||3
8562278|NCT00042991|21109116|P4|Phase-I Trial|Overall Study||2
8562279|NCT00042991|21109117|P3|Phase-I Trial|Overall Study||7
8562280|NCT00042991|21109118|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
8562281|NCT00042991|21109119|P1|Phase-I Trial|Overall Study||6
8562282|NCT00042991|21109113|P7|STARTED|Overall Study||3
8562283|NCT00042991|21109114|P6|STARTED|Overall Study||5
8562284|NCT00042991|21109115|P5|STARTED|Overall Study||3
8562285|NCT00042991|21109116|P4|STARTED|Overall Study||2
8562286|NCT00042991|21109117|P3|STARTED|Overall Study||7
8562287|NCT00042991|21109118|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
8562288|NCT00042991|21109119|P1|STARTED|Overall Study||6
8562289|NCT00042939|21109162|P2|NOT COMPLETED|Overall Study||21
8562290|NCT00042939|21109163|P1|NOT COMPLETED|Overall Study||24
8562291|NCT00042939|21109162|P2|COMPLETED|Overall Study||25
8562292|NCT00042939|21109163|P1|COMPLETED|Overall Study||24
8562293|NCT00042939|21109162|P2|Patients With EGFR Results Available|Overall Study||31
8562294|NCT00042939|21109163|P1|Patients With EGFR Results Available|Overall Study||30
8562295|NCT00042939|21109162|P2|Eligible and Began Protocol Therapy|Overall Study||43
8562296|NCT00042939|21109163|P1|Eligible and Began Protocol Therapy|Overall Study||44
8562297|NCT00042939|21109162|P2|Treated|Overall Study||45
8562298|NCT00042939|21109163|P1|Treated|Overall Study||46
8562299|NCT00042939|21109162|P2|STARTED|Overall Study||46
8562300|NCT00042939|21109163|P1|STARTED|Overall Study||48
8562301|NCT00041132|21109177|P1|NOT COMPLETED|Overall Study||30
8562302|NCT00041132|21109177|P1|COMPLETED|Overall Study||26
8562303|NCT00041132|21109177|P1|Eligible and Began Protocol Therapy|Overall Study||49
8562304|NCT00041132|21109177|P1|Eligible|Overall Study||49
8562305|NCT00041132|21109177|P1|STARTED|Overall Study||56
8562306|NCT00041119|21109187|P4|NOT COMPLETED|Overall Study||0
8562307|NCT00041119|21109188|P3|NOT COMPLETED|Overall Study||0
8562308|NCT00041119|21109189|P2|NOT COMPLETED|Overall Study||0
8562309|NCT00041119|21109190|P1|NOT COMPLETED|Overall Study||0
8562310|NCT00041119|21109187|P4|COMPLETED|Overall Study||789
8562311|NCT00041119|21109188|P3|COMPLETED|Overall Study||1151
8562312|NCT00041119|21109189|P2|COMPLETED|Overall Study||789
8562313|NCT00041119|21109190|P1|COMPLETED|Overall Study||1142
8562314|NCT00041119|21109187|P4|STARTED|Overall Study||789
8562315|NCT00041119|21109188|P3|STARTED|Overall Study||1151
8562316|NCT00041119|21109189|P2|STARTED|Overall Study||789
8562317|NCT00041119|21109190|P1|STARTED|Overall Study||1142
8562318|NCT00041080|21109212|P2|NOT COMPLETED|Overall Study||10
8562319|NCT00041080|21109213|P1|NOT COMPLETED|Overall Study||30
8562320|NCT00041080|21109212|P2|COMPLETED|Overall Study||60
8562321|NCT00041080|21109213|P1|COMPLETED|Overall Study||39
8562322|NCT00041080|21109212|P2|STARTED|Overall Study|number patients enrolled on study|70
8562323|NCT00041080|21109213|P1|STARTED|Overall Study|number patients enrolled on study|69
8562324|NCT00041067|21109219|P1|NOT COMPLETED|Overall Study||76
8562325|NCT00041067|21109219|P1|COMPLETED|Overall Study||0
8562326|NCT00041067|21109219|P1|Eligible|Overall Study||74
8562327|NCT00041067|21109219|P1|STARTED|Overall Study||76
8562328|NCT00040937|21109226|P1|NOT COMPLETED|Maintenance||0
8562329|NCT00040937|21109226|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
8562330|NCT00040937|21109226|P1|STARTED|Maintenance||76
8562331|NCT00040937|21109226|P1|NOT COMPLETED|Autologous PBSCT||31
8562332|NCT00040937|21109226|P1|COMPLETED|Autologous PBSCT||77
8562333|NCT00040937|21109226|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
8562334|NCT00040937|21109226|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
8562335|NCT00040937|21109226|P1|COMPLETED|Induction/PBSC Mobilization||110
8562336|NCT00040937|21109226|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
8562337|NCT00040846|21109239|P6|NOT COMPLETED|Overall Study||0
8562338|NCT00040846|21109240|P5|NOT COMPLETED|Overall Study||0
8562339|NCT00040846|21109241|P4|NOT COMPLETED|Overall Study||0
8562340|NCT00040846|21109242|P3|NOT COMPLETED|Overall Study||0
8562341|NCT00040846|21109243|P2|NOT COMPLETED|Overall Study||0
8562342|NCT00040846|21109244|P1|NOT COMPLETED|Overall Study||0
8562343|NCT00040846|21109239|P6|COMPLETED|Overall Study||0
8562344|NCT00040846|21109240|P5|COMPLETED|Overall Study||0
8562345|NCT00040846|21109241|P4|COMPLETED|Overall Study||0
8562346|NCT00040846|21109242|P3|COMPLETED|Overall Study||0
8562347|NCT00040846|21109243|P2|COMPLETED|Overall Study||0
8562348|NCT00040846|21109244|P1|COMPLETED|Overall Study||60
8562349|NCT00040846|21109239|P6|STARTED|Overall Study||0
8562350|NCT00040846|21109240|P5|STARTED|Overall Study||0
8562351|NCT00040846|21109241|P4|STARTED|Overall Study||0
8562352|NCT00040846|21109242|P3|STARTED|Overall Study||0
8562353|NCT00040846|21109243|P2|STARTED|Overall Study||0
8562354|NCT00040846|21109244|P1|STARTED|Overall Study||60
8562355|NCT00040742|21109286|P4|NOT COMPLETED|Overall Study||34
8562356|NCT00040742|21109287|P3|NOT COMPLETED|Overall Study||46
8562357|NCT00040742|21109288|P2|NOT COMPLETED|Overall Study||49
8562358|NCT00040742|21109289|P1|NOT COMPLETED|Overall Study||39
8562359|NCT00040742|21109286|P4|COMPLETED|Overall Study||152
8562360|NCT00040742|21109287|P3|COMPLETED|Overall Study||141
8562361|NCT00040742|21109288|P2|COMPLETED|Overall Study||134
8562362|NCT00040742|21109289|P1|COMPLETED|Overall Study||149
8562363|NCT00040742|21109286|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
8562364|NCT00040742|21109287|P3|STARTED|Overall Study||187
8562365|NCT00040742|21109288|P2|STARTED|Overall Study||183
8562366|NCT00040742|21109289|P1|STARTED|Overall Study||188
8562367|NCT00039377|21109303|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562368|NCT00039377|21109304|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562369|NCT00039377|21109305|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562370|NCT00039377|21109306|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562371|NCT00039377|21109303|P4|COMPLETED|Course 5 (Transplant Assignments)||1
8562372|NCT00039377|21109304|P3|COMPLETED|Course 5 (Transplant Assignments)||19
8562373|NCT00039377|21109305|P2|COMPLETED|Course 5 (Transplant Assignments)||15
8562374|NCT00039377|21109306|P1|COMPLETED|Course 5 (Transplant Assignments)||0
8562375|NCT00039377|21109303|P4|STARTED|Course 5 (Transplant Assignments)||1
8562376|NCT00039377|21109304|P3|STARTED|Course 5 (Transplant Assignments)||19
8562377|NCT00039377|21109305|P2|STARTED|Course 5 (Transplant Assignments)||15
8562378|NCT00039377|21109306|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
8562379|NCT00039377|21109303|P4|NOT COMPLETED|Initial Registration||0
8562380|NCT00039377|21109304|P3|NOT COMPLETED|Initial Registration||0
8562381|NCT00039377|21109305|P2|NOT COMPLETED|Initial Registration||0
8562382|NCT00039377|21109306|P1|NOT COMPLETED|Initial Registration||22
8562383|NCT00039377|21109303|P4|COMPLETED|Initial Registration||0
8562384|NCT00039377|21109304|P3|COMPLETED|Initial Registration||0
8562385|NCT00039377|21109305|P2|COMPLETED|Initial Registration||0
8562386|NCT00039377|21109306|P1|COMPLETED|Initial Registration||35
8562387|NCT00039377|21109303|P4|STARTED|Initial Registration||0
8562388|NCT00039377|21109304|P3|STARTED|Initial Registration||0
8562389|NCT00039377|21109305|P2|STARTED|Initial Registration||0
8562390|NCT00039377|21109306|P1|STARTED|Initial Registration||57
8562391|NCT00039195|21109318|P1|NOT COMPLETED|Overall Study||0
8562392|NCT00039195|21109318|P1|COMPLETED|Overall Study||98
8562393|NCT00039195|21109318|P1|STARTED|Overall Study||98
8562394|NCT00039130|21109322|P1|NOT COMPLETED|Overall Study||30
8562395|NCT00039130|21109322|P1|COMPLETED|Overall Study||75
8562396|NCT00039130|21109322|P1|STARTED|Overall Study||105
8562397|NCT00036738|21109328|P1|NOT COMPLETED|Overall Study||0
8562398|NCT00036738|21109328|P1|COMPLETED|Overall Study||28
8562399|NCT00036738|21109328|P1|STARTED|Overall Study||28
8562400|NCT00033657|21109338|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
8562401|NCT00033657|21109339|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
8562402|NCT00033657|21109338|P2|COMPLETED|Adjuvant Chemotherapy||16
8562403|NCT00033657|21109339|P1|COMPLETED|Adjuvant Chemotherapy||18
8562404|NCT00033657|21109338|P2|STARTED|Adjuvant Chemotherapy||33
8562405|NCT00033657|21109339|P1|STARTED|Adjuvant Chemotherapy||36
8562406|NCT00033657|21109338|P2|NOT COMPLETED|Surgical Resection||3
8562407|NCT00033657|21109339|P1|NOT COMPLETED|Surgical Resection||0
8562408|NCT00033657|21109338|P2|COMPLETED|Surgical Resection||33
8562409|NCT00033657|21109339|P1|COMPLETED|Surgical Resection||36
8562410|NCT00033657|21109338|P2|STARTED|Surgical Resection||36
8562411|NCT00033657|21109339|P1|STARTED|Surgical Resection||36
8562412|NCT00033657|21109338|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
8562413|NCT00033657|21109339|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
8562414|NCT00033657|21109338|P2|COMPLETED|Neoadjuvant Chemotherapy||36
8562415|NCT00033657|21109339|P1|COMPLETED|Neoadjuvant Chemotherapy||36
8562416|NCT00033657|21109338|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
8562417|NCT00033657|21109339|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
8562418|NCT00033657|21109338|P2|Eligible|Neoadjuvant Chemotherapy||43
8562419|NCT00033657|21109339|P1|Eligible|Neoadjuvant Chemotherapy||42
8562420|NCT00033657|21109338|P2|STARTED|Neoadjuvant Chemotherapy||47
8562421|NCT00033657|21109339|P1|STARTED|Neoadjuvant Chemotherapy||50
8562422|NCT00033631|21109353|P2|NOT COMPLETED|Overall Study||15
8562423|NCT00033631|21109354|P1|NOT COMPLETED|Overall Study||18
8562424|NCT00033631|21109353|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
8562425|NCT00033631|21109354|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
8562426|NCT00033631|21109353|P2|STARTED|Overall Study||763
8562427|NCT00033631|21109354|P1|STARTED|Overall Study||769
8562428|NCT00033540|21109372|P1|NOT COMPLETED|Overall Study||57
8562429|NCT00033540|21109372|P1|COMPLETED|Overall Study||0
8562430|NCT00033540|21109372|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
8562431|NCT00033540|21109372|P1|Eligible|Overall Study||54
8562432|NCT00033540|21109372|P1|STARTED|Overall Study||57
8562433|NCT00033514|21109382|P2|NOT COMPLETED|Overall Study||4
8562434|NCT00033514|21109383|P1|NOT COMPLETED|Overall Study||1
8562435|NCT00033514|21109382|P2|COMPLETED|Overall Study||7
8562436|NCT00033514|21109383|P1|COMPLETED|Overall Study||15
8562437|NCT00033514|21109382|P2|STARTED|Overall Study||11
8562438|NCT00033514|21109383|P1|STARTED|Overall Study||16
8562439|NCT00033371|21109393|P2|NOT COMPLETED|Overall Study||10
8562440|NCT00033371|21109394|P1|NOT COMPLETED|Overall Study||6
8562441|NCT00033371|21109393|P2|COMPLETED|Overall Study||47
8562442|NCT00033371|21109394|P1|COMPLETED|Overall Study||49
8562443|NCT00033371|21109393|P2|STARTED|Overall Study||57
8562444|NCT00033371|21109394|P1|STARTED|Overall Study||55
8562445|NCT00033293|21109412|P2|NOT COMPLETED|Overall Study||18
8562446|NCT00033293|21109413|P1|NOT COMPLETED|Overall Study||10
8562447|NCT00033293|21109412|P2|COMPLETED|Overall Study||9
8562448|NCT00033293|21109413|P1|COMPLETED|Overall Study||16
8562449|NCT00033293|21109412|P2|STARTED|Overall Study||27
8562450|NCT00033293|21109413|P1|STARTED|Overall Study||26
8562454|NCT00031590|21109435|P1|NOT COMPLETED|Overall Study||3
8562455|NCT00031590|21109435|P1|COMPLETED|Overall Study||25
8562456|NCT00031590|21109435|P1|STARTED|Overall Study||28
8562457|NCT00030901|21109442|P3|NOT COMPLETED|Randomization||88
8562458|NCT00030901|21109443|P2|NOT COMPLETED|Randomization||101
8562459|NCT00030901|21109444|P1|NOT COMPLETED|Randomization||0
8562460|NCT00030901|21109442|P3|COMPLETED|Randomization||137
8562461|NCT00030901|21109443|P2|COMPLETED|Randomization||126
8562462|NCT00030901|21109444|P1|COMPLETED|Randomization||0
8562463|NCT00030901|21109442|P3|Eligible|Randomization||211
8562464|NCT00030901|21109443|P2|Eligible|Randomization||212
8562465|NCT00030901|21109444|P1|Eligible|Randomization||0
8562466|NCT00030901|21109442|P3|STARTED|Randomization||225
8562467|NCT00030901|21109443|P2|STARTED|Randomization||227
8562468|NCT00030901|21109444|P1|STARTED|Randomization||0
8562469|NCT00030901|21109442|P3|NOT COMPLETED|Initial Registration||0
8562470|NCT00030901|21109443|P2|NOT COMPLETED|Initial Registration||0
8562471|NCT00030901|21109444|P1|NOT COMPLETED|Initial Registration||167
8562472|NCT00030901|21109442|P3|COMPLETED|Initial Registration||0
8562473|NCT00030901|21109443|P2|COMPLETED|Initial Registration||0
8562474|NCT00030901|21109444|P1|COMPLETED|Initial Registration||452
8562475|NCT00030901|21109442|P3|STARTED|Initial Registration||0
8562476|NCT00030901|21109443|P2|STARTED|Initial Registration||0
8562477|NCT00030901|21109444|P1|STARTED|Initial Registration||619
8562478|NCT00030823|21109452|P1|NOT COMPLETED|Overall Study||1
8562479|NCT00030823|21109452|P1|COMPLETED|Overall Study||13
8562480|NCT00030823|21109452|P1|STARTED|Overall Study||14
8562481|NCT00030264|21109456|P1|NOT COMPLETED|Overall Study||0
8562482|NCT00030264|21109456|P1|COMPLETED|Overall Study||23
8562483|NCT00030264|21109456|P1|STARTED|Overall Study||23
8562484|NCT00028769|21109460|P1|NOT COMPLETED|Overall Study||41
8562485|NCT00028769|21109460|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
8562486|NCT00028769|21109460|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
8562487|NCT00028769|21109460|P1|Eligible|Overall Study||36
8562488|NCT00028769|21109460|P1|STARTED|Overall Study||41
8562489|NCT00028002|21109466|P1|NOT COMPLETED|Overall Study||11
8562490|NCT00028002|21109466|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
8562491|NCT00028002|21109466|P1|STARTED|Overall Study||63
8562492|NCT00027846|21109476|P3|NOT COMPLETED|Overall Study||37
8562493|NCT00027846|21109477|P2|NOT COMPLETED|Overall Study||68
8562494|NCT00027846|21109478|P1|NOT COMPLETED|Overall Study||2
8562495|NCT00027846|21109476|P3|COMPLETED|Overall Study||41
8562496|NCT00027846|21109477|P2|COMPLETED|Overall Study||219
8562497|NCT00027846|21109478|P1|COMPLETED|Overall Study||11
8562498|NCT00027846|21109476|P3|STARTED|Overall Study||78
8562499|NCT00027846|21109477|P2|STARTED|Overall Study||287
8562500|NCT00027846|21109478|P1|STARTED|Overall Study||13
8562501|NCT00027560|21109496|P1|NOT COMPLETED|Overall Study||1
8562502|NCT00027560|21109496|P1|COMPLETED|Overall Study||50
8562503|NCT00027560|21109496|P1|STARTED|Overall Study||51
8562504|NCT00026494|21109509|P4|NOT COMPLETED|Overall Study||0
8562505|NCT00026494|21109510|P3|NOT COMPLETED|Overall Study||6
8562506|NCT00026494|21109511|P2|NOT COMPLETED|Overall Study||0
8562507|NCT00026494|21109512|P1|NOT COMPLETED|Overall Study||2
8562508|NCT00026494|21109509|P4|COMPLETED|Overall Study||16
8562509|NCT00026494|21109510|P3|COMPLETED|Overall Study||16
8562510|NCT00026494|21109511|P2|COMPLETED|Overall Study||4
8562511|NCT00026494|21109512|P1|COMPLETED|Overall Study||5
8562512|NCT00026494|21109509|P4|STARTED|Overall Study||16
8562513|NCT00026494|21109510|P3|STARTED|Overall Study||22
8562514|NCT00026494|21109511|P2|STARTED|Overall Study||4
8562515|NCT00026494|21109512|P1|STARTED|Overall Study||7
8562516|NCT00026312|21109524|P2|NOT COMPLETED|Overall Study||269
8562517|NCT00026312|21109525|P1|NOT COMPLETED|Overall Study||34
8562518|NCT00026312|21109524|P2|COMPLETED|Overall Study||1064
8562519|NCT00026312|21109525|P1|COMPLETED|Overall Study||82
8562520|NCT00026312|21109524|P2|STARTED|Overall Study||1333
8562521|NCT00026312|21109525|P1|STARTED|Overall Study||116
8562522|NCT00026221|21109543|P3|NOT COMPLETED|Overall Study||0
8562523|NCT00026221|21109544|P2|NOT COMPLETED|Overall Study||0
8562524|NCT00026221|21109545|P1|NOT COMPLETED|Overall Study||0
8562525|NCT00026221|21109543|P3|COMPLETED|Overall Study||25
8562526|NCT00026221|21109544|P2|COMPLETED|Overall Study||16
8562527|NCT00026221|21109545|P1|COMPLETED|Overall Study||16
8562528|NCT00026221|21109543|P3|STARTED|Overall Study||25
8562529|NCT00026221|21109544|P2|STARTED|Overall Study||16
8562530|NCT00026221|21109545|P1|STARTED|Overall Study||16
8562531|NCT00026208|21109564|P2|NOT COMPLETED|Overall Study||0
8562532|NCT00026208|21109565|P1|NOT COMPLETED|Overall Study||1
8562533|NCT00026208|21109564|P2|COMPLETED|Overall Study||4
8562534|NCT00026208|21109565|P1|COMPLETED|Overall Study||71
8562535|NCT00026208|21109564|P2|STARTED|Overall Study||4
8562536|NCT00026208|21109565|P1|STARTED|Overall Study||72
8562537|NCT00025662|21109583|P1|NOT COMPLETED|Overall Study||3
8562538|NCT00025662|21109583|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
8562539|NCT00025662|21109583|P1|STARTED|Overall Study||25
8562540|NCT00025506|21109591|P1|NOT COMPLETED|Overall Study||10
8562541|NCT00025506|21109591|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
8562542|NCT00025506|21109591|P1|STARTED|Overall Study||55
8562543|NCT00025259|21109612|P7|NOT COMPLETED|Overall Study||51
8562544|NCT00025259|21109613|P6|NOT COMPLETED|Overall Study||52
8562545|NCT00025259|21109614|P5|NOT COMPLETED|Overall Study||36
8562546|NCT00025259|21109615|P4|NOT COMPLETED|Overall Study||114
8562547|NCT00025259|21109616|P3|NOT COMPLETED|Overall Study||81
8562548|NCT00025259|21109617|P2|NOT COMPLETED|Overall Study||89
8562549|NCT00025259|21109618|P1|NOT COMPLETED|Overall Study||45
8562550|NCT00025259|21109612|P7|COMPLETED|Overall Study||102
8562551|NCT00025259|21109613|P6|COMPLETED|Overall Study||101
8562552|NCT00025259|21109614|P5|COMPLETED|Overall Study||6
8562553|NCT00025259|21109615|P4|COMPLETED|Overall Study||457
8562554|NCT00025259|21109616|P3|COMPLETED|Overall Study||301
8562555|NCT00025259|21109617|P2|COMPLETED|Overall Study||292
8562556|NCT00025259|21109618|P1|COMPLETED|Overall Study||7
8562557|NCT00025259|21109612|P7|STARTED|Overall Study||153
8562558|NCT00025259|21109613|P6|STARTED|Overall Study||153
8562559|NCT00025259|21109614|P5|STARTED|Overall Study||42
8562560|NCT00025259|21109615|P4|STARTED|Overall Study||571
8562561|NCT00025259|21109616|P3|STARTED|Overall Study||382
8562562|NCT00025259|21109617|P2|STARTED|Overall Study||381
8562563|NCT00025259|21109618|P1|STARTED|Overall Study||52
8562564|NCT00025233|21109654|P1|NOT COMPLETED|Overall Study||4
8562565|NCT00025233|21109654|P1|COMPLETED|Overall Study||46
8562566|NCT00025233|21109654|P1|STARTED|Overall Study||50
8562567|NCT00025155|21109669|P1|NOT COMPLETED|Overall Study||2
8562568|NCT00025155|21109669|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
8562569|NCT00025155|21109669|P1|STARTED|Overall Study||51
8562570|NCT00024258|21109680|P1|NOT COMPLETED|Overall Study||9
8562571|NCT00024258|21109680|P1|COMPLETED|Overall Study||13
8562572|NCT00024258|21109680|P1|STARTED|Overall Study||22
8562573|NCT00024167|21109687|P2|NOT COMPLETED|Overall Study||47
8562574|NCT00024167|21109688|P1|NOT COMPLETED|Overall Study||53
8562575|NCT00024167|21109687|P2|COMPLETED|Overall Study||15
8562576|NCT00024167|21109688|P1|COMPLETED|Overall Study||12
8562577|NCT00024167|21109687|P2|Induction Treatment Option 2 Completed|Overall Study||41
8562578|NCT00024167|21109688|P1|Induction Treatment Option 2 Completed|Overall Study||43
8562579|NCT00024167|21109687|P2|Induction Treatment Option 1 Completed|Overall Study||21
8562580|NCT00024167|21109688|P1|Induction Treatment Option 1 Completed|Overall Study||22
8562581|NCT00024167|21109687|P2|STARTED|Overall Study||62
8562582|NCT00024167|21109688|P1|STARTED|Overall Study||65
8562583|NCT00024102|21109699|P2|NOT COMPLETED|Overall Study||0
8562584|NCT00024102|21109700|P1|NOT COMPLETED|Overall Study||0
8562585|NCT00024102|21109699|P2|COMPLETED|Overall Study||307
8562586|NCT00024102|21109700|P1|COMPLETED|Overall Study||326
8562587|NCT00024102|21109699|P2|STARTED|Overall Study||307
8562588|NCT00024102|21109700|P1|STARTED|Overall Study||326
8562589|NCT00023764|21109712|P1|NOT COMPLETED|Overall Study||14
8562590|NCT00023764|21109712|P1|COMPLETED|Overall Study||89
8562591|NCT00023764|21109712|P1|STARTED|Overall Study||103
8562592|NCT00023712|21109719|P2|NOT COMPLETED|Overall Study||1
8562593|NCT00023712|21109720|P1|NOT COMPLETED|Overall Study||2
8562594|NCT00023712|21109719|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
8562595|NCT00023712|21109720|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
8562596|NCT00023712|21109719|P2|STARTED|Overall Study|total number of participants enrolled on study|30
8562597|NCT00023712|21109720|P1|STARTED|Overall Study|total number of participants enrolled on study|28
8562598|NCT00022698|21109744|P2|NOT COMPLETED|Overall Study||35
8562599|NCT00022698|21109745|P1|NOT COMPLETED|Overall Study||8
8562600|NCT00022698|21109744|P2|COMPLETED|Overall Study||17
8562601|NCT00022698|21109745|P1|COMPLETED|Overall Study||7
8562602|NCT00022698|21109744|P2|STARTED|Overall Study||52
8562603|NCT00022698|21109745|P1|STARTED|Overall Study||15
8562604|NCT00022672|21109770|P2|NOT COMPLETED|Extension Phase||51
8562605|NCT00022672|21109771|P1|NOT COMPLETED|Extension Phase||3
8562606|NCT00022672|21109770|P2|COMPLETED|Extension Phase||7
8562607|NCT00022672|21109771|P1|COMPLETED|Extension Phase||11
8562608|NCT00022672|21109770|P2|Safety Set: Received Study Drug|Extension Phase||58
8562609|NCT00022672|21109771|P1|Safety Set: Received Study Drug|Extension Phase||14
8562610|NCT00022672|21109770|P2|STARTED|Extension Phase||58
8562611|NCT00022672|21109771|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
8562612|NCT00022672|21109770|P2|NOT COMPLETED|Main Phase: 24 Months||100
8562613|NCT00022672|21109771|P1|NOT COMPLETED|Main Phase: 24 Months||87
8562614|NCT00022672|21109770|P2|COMPLETED|Main Phase: 24 Months||4
8562615|NCT00022672|21109771|P1|COMPLETED|Main Phase: 24 Months||16
8562616|NCT00022672|21109770|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
8562617|NCT00022672|21109771|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
8562618|NCT00022672|21109770|P2|STARTED|Main Phase: 24 Months||104
8562619|NCT00022672|21109771|P1|STARTED|Main Phase: 24 Months||103
8562620|NCT00022659|21109804|P1|NOT COMPLETED|Overall Study||2
8562621|NCT00022659|21109804|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
8562622|NCT00022659|21109804|P1|STARTED|Overall Study||64
8562623|NCT00022633|21109817|P2|NOT COMPLETED|Overall Study||5
8562624|NCT00022633|21109818|P1|NOT COMPLETED|Overall Study||32
8562625|NCT00022633|21109817|P2|COMPLETED|Overall Study||5
8562626|NCT00022633|21109818|P1|COMPLETED|Overall Study||23
8562627|NCT00022633|21109817|P2|Eligible|Overall Study||10
8562628|NCT00022633|21109818|P1|Eligible|Overall Study||51
8562629|NCT00022633|21109817|P2|STARTED|Overall Study||10
8562630|NCT00022633|21109818|P1|STARTED|Overall Study||55
8562631|NCT00022516|21109831|P2|NOT COMPLETED|Overall Study||230
8562632|NCT00022516|21109832|P1|NOT COMPLETED|Overall Study||3
8562633|NCT00022516|21109831|P2|COMPLETED|Overall Study||314
8562634|NCT00022516|21109832|P1|COMPLETED|Overall Study||539
8562635|NCT00022516|21109831|P2|STARTED|Overall Study||544
8562636|NCT00022516|21109832|P1|STARTED|Overall Study||542
8562637|NCT00022490|21109844|P1|NOT COMPLETED|Overall Study||0
8562638|NCT00022490|21109844|P1|COMPLETED|Overall Study||24
8562639|NCT00022490|21109844|P1|STARTED|Overall Study||24
8562640|NCT00021255|21109851|P3|NOT COMPLETED|Overall Study||149
8562641|NCT00021255|21109852|P2|NOT COMPLETED|Overall Study||270
8562642|NCT00021255|21109853|P1|NOT COMPLETED|Overall Study||121
8562643|NCT00021255|21109851|P3|COMPLETED|Overall Study||926
8562644|NCT00021255|21109852|P2|COMPLETED|Overall Study||804
8562645|NCT00021255|21109853|P1|COMPLETED|Overall Study||952
8562646|NCT00021255|21109851|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
8562647|NCT00021255|21109852|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
8562648|NCT00021255|21109853|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
8562649|NCT00021255|21109851|P3|Treated|Overall Study||1057
8562650|NCT00021255|21109852|P2|Treated|Overall Study||1072
8562651|NCT00021255|21109853|P1|Treated|Overall Study||1045
8562652|NCT00021255|21109851|P3|STARTED|Overall Study|Randomized|1075
8562653|NCT00021255|21109852|P2|STARTED|Overall Study|Randomized|1074
8562654|NCT00021255|21109853|P1|STARTED|Overall Study|Randomized|1073
8562655|NCT00021229|21109870|P3|NOT COMPLETED|Overall Study||16
8562656|NCT00021229|21109871|P2|NOT COMPLETED|Overall Study||33
8562657|NCT00021229|21109872|P1|NOT COMPLETED|Overall Study||35
8562658|NCT00021229|21109870|P3|COMPLETED|Overall Study||0
8562659|NCT00021229|21109871|P2|COMPLETED|Overall Study||0
8562660|NCT00021229|21109872|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
8562661|NCT00021229|21109870|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
8562662|NCT00021229|21109871|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
8562663|NCT00021229|21109872|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
8562664|NCT00021229|21109870|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
8562665|NCT00021229|21109871|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
8562666|NCT00021229|21109872|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
8562667|NCT00021229|21109870|P3|Enrolled in Phase I|Overall Study||16
8562668|NCT00021229|21109871|P2|Enrolled in Phase I|Overall Study||33
8562669|NCT00021229|21109872|P1|Enrolled in Phase I|Overall Study||35
8562670|NCT00021229|21109870|P3|STARTED|Overall Study||16
8562671|NCT00021229|21109871|P2|STARTED|Overall Study||33
8562672|NCT00021229|21109872|P1|STARTED|Overall Study||36
8562673|NCT00020722|21109898|P1|NOT COMPLETED|Overall Study||0
8562674|NCT00020722|21109898|P1|COMPLETED|Overall Study||7
8562675|NCT00020722|21109898|P1|STARTED|Overall Study||7
8562676|NCT00019747|21109905|P2|NOT COMPLETED|Overall Study||0
8562677|NCT00019747|21109906|P1|NOT COMPLETED|Overall Study||0
8562678|NCT00019747|21109905|P2|COMPLETED|Overall Study||16
8562679|NCT00019747|21109906|P1|COMPLETED|Overall Study||23
8562680|NCT00019747|21109905|P2|STARTED|Overall Study||16
8562681|NCT00019747|21109906|P1|STARTED|Overall Study||23
8562682|NCT00019682|21109914|P2|NOT COMPLETED|Overall Study||6
8562683|NCT00019682|21109915|P1|NOT COMPLETED|Overall Study||1
8562684|NCT00019682|21109914|P2|COMPLETED|Overall Study||85
8562685|NCT00019682|21109915|P1|COMPLETED|Overall Study||93
8562686|NCT00019682|21109914|P2|STARTED|Overall Study||91
8562687|NCT00019682|21109915|P1|STARTED|Overall Study||94
8562688|NCT00019604|21109927|P1|NOT COMPLETED|Overall Study||39
8562689|NCT00019604|21109927|P1|COMPLETED|Overall Study||5
8562690|NCT00019604|21109927|P1|STARTED|Overall Study||44
8562691|NCT00017563|21109940|P1|NOT COMPLETED|Overall Study||1
8562692|NCT00017563|21109940|P1|COMPLETED|Overall Study||56
8562693|NCT00017563|21109940|P1|STARTED|Overall Study||57
8562694|NCT00016913|21109944|P1|NOT COMPLETED|Overall Study||0
8562695|NCT00016913|21109944|P1|COMPLETED|Overall Study||27
8562696|NCT00016913|21109944|P1|STARTED|Overall Study||27
8562697|NCT00016354|21109950|P8|NOT COMPLETED|Overall Study||1
8562698|NCT00016354|21109951|P7|NOT COMPLETED|Overall Study||0
8562699|NCT00016354|21109952|P6|NOT COMPLETED|Overall Study||0
8562700|NCT00016354|21109953|P5|NOT COMPLETED|Overall Study||0
8562701|NCT00016354|21109954|P4|NOT COMPLETED|Overall Study||0
8562702|NCT00016354|21109955|P3|NOT COMPLETED|Overall Study||0
8562703|NCT00016354|21109956|P2|NOT COMPLETED|Overall Study||0
8562704|NCT00016354|21109957|P1|NOT COMPLETED|Overall Study||0
8562705|NCT00016354|21109950|P8|COMPLETED|Overall Study||6
8562706|NCT00016354|21109951|P7|COMPLETED|Overall Study||6
8562707|NCT00016354|21109952|P6|COMPLETED|Overall Study||1
8562708|NCT00016354|21109953|P5|COMPLETED|Overall Study||1
8562709|NCT00016354|21109954|P4|COMPLETED|Overall Study||1
8562710|NCT00016354|21109955|P3|COMPLETED|Overall Study||1
8562711|NCT00016354|21109956|P2|COMPLETED|Overall Study||1
8562712|NCT00016354|21109957|P1|COMPLETED|Overall Study||1
8562713|NCT00016354|21109950|P8|STARTED|Overall Study||7
8562714|NCT00016354|21109951|P7|STARTED|Overall Study||6
8562715|NCT00016354|21109952|P6|STARTED|Overall Study||1
8562716|NCT00016354|21109953|P5|STARTED|Overall Study||1
8562717|NCT00016354|21109954|P4|STARTED|Overall Study||1
8562718|NCT00016354|21109955|P3|STARTED|Overall Study||1
8562719|NCT00016354|21109956|P2|STARTED|Overall Study||1
8562720|NCT00016354|21109957|P1|STARTED|Overall Study||1
8562721|NCT00015847|21109961|P1|NOT COMPLETED|Overall Study||0
8562722|NCT00015847|21109961|P1|COMPLETED|Overall Study||25
8562723|NCT00015847|21109961|P1|STARTED|Overall Study||25
8562724|NCT00014495|21109971|P4|NOT COMPLETED|Overall Study||1
8562725|NCT00014495|21109972|P3|NOT COMPLETED|Overall Study||1
8562726|NCT00014495|21109973|P2|NOT COMPLETED|Overall Study||0
8562727|NCT00014495|21109974|P1|NOT COMPLETED|Overall Study||0
8562728|NCT00014495|21109971|P4|COMPLETED|Overall Study||5
8562729|NCT00014495|21109972|P3|COMPLETED|Overall Study||19
8562730|NCT00014495|21109973|P2|COMPLETED|Overall Study||3
8562731|NCT00014495|21109974|P1|COMPLETED|Overall Study||3
8562732|NCT00014495|21109971|P4|STARTED|Overall Study||6
8562733|NCT00014495|21109972|P3|STARTED|Overall Study||20
8562734|NCT00014495|21109973|P2|STARTED|Overall Study||3
8562735|NCT00014495|21109974|P1|STARTED|Overall Study||3
8562736|NCT00014222|21109984|P3|NOT COMPLETED|Overall Study||27
8562737|NCT00014222|21109985|P2|NOT COMPLETED|Overall Study||13
8562738|NCT00014222|21109986|P1|NOT COMPLETED|Overall Study||21
8562739|NCT00014222|21109984|P3|COMPLETED|Overall Study||675
8562740|NCT00014222|21109985|P2|COMPLETED|Overall Study||688
8562741|NCT00014222|21109986|P1|COMPLETED|Overall Study||680
8562742|NCT00014222|21109984|P3|STARTED|Overall Study||702
8562743|NCT00014222|21109985|P2|STARTED|Overall Study||701
8562744|NCT00014222|21109986|P1|STARTED|Overall Study||701
8562745|NCT00012298|21110004|P7|NOT COMPLETED|Overall Study||0
8562746|NCT00012298|21110005|P6|NOT COMPLETED|Overall Study||0
8562747|NCT00012298|21110006|P5|NOT COMPLETED|Overall Study||0
8562748|NCT00012298|21110007|P4|NOT COMPLETED|Overall Study||0
8562749|NCT00012298|21110008|P3|NOT COMPLETED|Overall Study||0
8562750|NCT00012298|21110009|P2|NOT COMPLETED|Overall Study||0
8562751|NCT00012298|21110010|P1|NOT COMPLETED|Overall Study||0
8562752|NCT00012298|21110004|P7|COMPLETED|Overall Study||39
8562753|NCT00012298|21110005|P6|COMPLETED|Overall Study||6
8562754|NCT00012298|21110006|P5|COMPLETED|Overall Study||5
8562755|NCT00012298|21110007|P4|COMPLETED|Overall Study||4
8562756|NCT00012298|21110008|P3|COMPLETED|Overall Study||9
8562757|NCT00012298|21110009|P2|COMPLETED|Overall Study||7
8562758|NCT00012298|21110010|P1|COMPLETED|Overall Study||11
8562759|NCT00012298|21110004|P7|STARTED|Overall Study||39
8562760|NCT00012298|21110005|P6|STARTED|Overall Study||6
8562761|NCT00012298|21110006|P5|STARTED|Overall Study||5
8562762|NCT00012298|21110007|P4|STARTED|Overall Study||4
8562763|NCT00012298|21110008|P3|STARTED|Overall Study||9
8562764|NCT00012298|21110009|P2|STARTED|Overall Study||7
8562765|NCT00012298|21110010|P1|STARTED|Overall Study||11
8562766|NCT00012012|21110040|P2|NOT COMPLETED|Overall Study||3
8562767|NCT00012012|21110041|P1|NOT COMPLETED|Overall Study||1
8562768|NCT00012012|21110040|P2|COMPLETED|Overall Study||15
8562769|NCT00012012|21110041|P1|COMPLETED|Overall Study||26
8562770|NCT00012012|21110040|P2|STARTED|Overall Study||18
8562771|NCT00012012|21110041|P1|STARTED|Overall Study||27
8562772|NCT00011986|21110052|P5|NOT COMPLETED|Overall Study||0
8562773|NCT00011986|21110053|P4|NOT COMPLETED|Overall Study||0
8562774|NCT00011986|21110054|P3|NOT COMPLETED|Overall Study||0
8562775|NCT00011986|21110055|P2|NOT COMPLETED|Overall Study||0
8562776|NCT00011986|21110056|P1|NOT COMPLETED|Overall Study||0
8562777|NCT00011986|21110052|P5|COMPLETED|Overall Study||861
8562778|NCT00011986|21110053|P4|COMPLETED|Overall Study||861
8562779|NCT00011986|21110054|P3|COMPLETED|Overall Study||862
8562780|NCT00011986|21110055|P2|COMPLETED|Overall Study||864
8562781|NCT00011986|21110056|P1|COMPLETED|Overall Study||864
8562782|NCT00011986|21110052|P5|Initiated Treatment|Overall Study||851
8562783|NCT00011986|21110053|P4|Initiated Treatment|Overall Study||846
8562784|NCT00011986|21110054|P3|Initiated Treatment|Overall Study||854
8562785|NCT00011986|21110055|P2|Initiated Treatment|Overall Study||860
8562786|NCT00011986|21110056|P1|Initiated Treatment|Overall Study||862
8562787|NCT00011986|21110052|P5|STARTED|Overall Study||861
8562788|NCT00011986|21110053|P4|STARTED|Overall Study||861
8562789|NCT00011986|21110054|P3|STARTED|Overall Study||862
8562790|NCT00011986|21110055|P2|STARTED|Overall Study||864
8562791|NCT00011986|21110056|P1|STARTED|Overall Study||864
8562792|NCT00010257|21110080|P2|NOT COMPLETED|Overall Study||0
8562793|NCT00010257|21110081|P1|NOT COMPLETED|Overall Study||1
8562794|NCT00010257|21110080|P2|COMPLETED|Overall Study||21
8562795|NCT00010257|21110081|P1|COMPLETED|Overall Study||24
8562796|NCT00010257|21110080|P2|STARTED|Overall Study||21
8562797|NCT00010257|21110081|P1|STARTED|Overall Study||25
8562798|NCT00009945|21110091|P2|NOT COMPLETED|Overall Study||5
8562799|NCT00009945|21110092|P1|NOT COMPLETED|Overall Study||7
8562800|NCT00009945|21110091|P2|COMPLETED|Overall Study||1656
8562801|NCT00009945|21110092|P1|COMPLETED|Overall Study||1655
8562802|NCT00009945|21110091|P2|STARTED|Overall Study||1661
8562803|NCT00009945|21110092|P1|STARTED|Overall Study||1662
8562804|NCT00008385|21110108|P2|NOT COMPLETED|Overall Study||802
8562805|NCT00008385|21110109|P1|NOT COMPLETED|Overall Study||387
8562806|NCT00008385|21110108|P2|COMPLETED|Overall Study||238
8562807|NCT00008385|21110109|P1|COMPLETED|Overall Study||134
8562808|NCT00008385|21110108|P2|Off Treatment Reasons Reported|Overall Study||795
8562809|NCT00008385|21110109|P1|Off Treatment Reasons Reported|Overall Study||398
8562810|NCT00008385|21110108|P2|Treated|Overall Study||865
8562811|NCT00008385|21110109|P1|Treated|Overall Study||477
8562812|NCT00008385|21110108|P2|STARTED|Overall Study||1040
8562813|NCT00008385|21110109|P1|STARTED|Overall Study||521
8562814|NCT00008138|21110119|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
8562815|NCT00008138|21110119|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
8562816|NCT00008138|21110119|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
8562817|NCT00008138|21110119|P1|NOT COMPLETED|Interval Debulking||2
8562818|NCT00008138|21110119|P1|COMPLETED|Interval Debulking||36
8562819|NCT00008138|21110119|P1|Received Protocol Surgery|Interval Debulking||36
8562820|NCT00008138|21110119|P1|STARTED|Interval Debulking||38
8562821|NCT00008138|21110119|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
8562822|NCT00008138|21110119|P1|COMPLETED|Neoadjuvant Chemotherapy||38
8562823|NCT00008138|21110119|P1|Eligible|Neoadjuvant Chemotherapy||58
8562824|NCT00008138|21110119|P1|STARTED|Neoadjuvant Chemotherapy||58
8562825|NCT00006916|21110125|P1|NOT COMPLETED|Overall Study||5
8562826|NCT00006916|21110125|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
8562827|NCT00006916|21110125|P1|STARTED|Overall Study||19
8562828|NCT00006903|21110131|P3|NOT COMPLETED|Overall Study||6
8562829|NCT00006903|21110132|P2|NOT COMPLETED|Overall Study||4
8562830|NCT00006903|21110133|P1|NOT COMPLETED|Overall Study||10
8562831|NCT00006903|21110131|P3|COMPLETED|Overall Study||27
8562832|NCT00006903|21110132|P2|COMPLETED|Overall Study||20
8562833|NCT00006903|21110133|P1|COMPLETED|Overall Study||0
8562834|NCT00006903|21110131|P3|STARTED|Overall Study||33
8562835|NCT00006903|21110132|P2|STARTED|Overall Study||24
8562836|NCT00006903|21110133|P1|STARTED|Overall Study||10
8562837|NCT00006721|21110146|P3|NOT COMPLETED|Overall Study||33
8562838|NCT00006721|21110147|P2|NOT COMPLETED|Overall Study||25
8562839|NCT00006721|21110148|P1|NOT COMPLETED|Overall Study||4
8562840|NCT00006721|21110146|P3|COMPLETED|Overall Study||242
8562841|NCT00006721|21110147|P2|COMPLETED|Overall Study||254
8562842|NCT00006721|21110148|P1|COMPLETED|Overall Study||13
8562843|NCT00006721|21110146|P3|Eligible and Began Protocol Therapy|Overall Study||265
8562844|NCT00006721|21110147|P2|Eligible and Began Protocol Therapy|Overall Study||267
8562845|NCT00006721|21110148|P1|Eligible and Began Protocol Therapy|Overall Study||14
8562846|NCT00006721|21110146|P3|Eligible|Overall Study||265
8562847|NCT00006721|21110147|P2|Eligible|Overall Study||267
8562848|NCT00006721|21110148|P1|Eligible|Overall Study||15
8562849|NCT00006721|21110146|P3|STARTED|Overall Study||275
8562850|NCT00006721|21110147|P2|STARTED|Overall Study||279
8562851|NCT00006721|21110148|P1|STARTED|Overall Study||17
8562852|NCT00006478|21110166|P1|NOT COMPLETED|Overall Study||7
8562853|NCT00006478|21110166|P1|COMPLETED|Overall Study||12
8562854|NCT00006478|21110166|P1|STARTED|Overall Study||19
8562855|NCT00006392|21110177|P4|NOT COMPLETED|Overall Study||160
8562856|NCT00006392|21110178|P3|NOT COMPLETED|Overall Study||160
8562857|NCT00006392|21110179|P2|NOT COMPLETED|Overall Study||158
8562858|NCT00006392|21110180|P1|NOT COMPLETED|Overall Study||167
8562859|NCT00006392|21110177|P4|COMPLETED|Overall Study||8696
8562860|NCT00006392|21110178|P3|COMPLETED|Overall Study||8703
8562861|NCT00006392|21110179|P2|COMPLETED|Overall Study||8752
8562862|NCT00006392|21110180|P1|COMPLETED|Overall Study||8737
8562863|NCT00006392|21110177|P4|STARTED|Overall Study||8856
8562864|NCT00006392|21110178|P3|STARTED|Overall Study||8863
8562865|NCT00006392|21110179|P2|STARTED|Overall Study||8910
8562866|NCT00006392|21110180|P1|STARTED|Overall Study||8904
8562867|NCT00006389|21110210|P1|NOT COMPLETED|Overall Study||1
8562868|NCT00006389|21110210|P1|COMPLETED|Overall Study||11
8562869|NCT00006389|21110210|P1|STARTED|Overall Study||12
8562870|NCT00006244|21110216|P1|NOT COMPLETED|Overall Study||0
8562871|NCT00006244|21110216|P1|COMPLETED|Overall Study||36
8562872|NCT00006244|21110216|P1|STARTED|Overall Study||36
8562873|NCT00006237|21110227|P2|NOT COMPLETED|Overall Study||61
8562874|NCT00006237|21110228|P1|NOT COMPLETED|Overall Study||125
8562875|NCT00006237|21110227|P2|COMPLETED|Overall Study||159
8562876|NCT00006237|21110228|P1|COMPLETED|Overall Study||87
8562877|NCT00006237|21110227|P2|Eligible and Treated|Overall Study||199
8562878|NCT00006237|21110228|P1|Eligible and Treated|Overall Study||203
8562879|NCT00006237|21110227|P2|Eligible|Overall Study||200
8562880|NCT00006237|21110228|P1|Eligible|Overall Study||203
8562881|NCT00006237|21110227|P2|STARTED|Overall Study||220
8562882|NCT00006237|21110228|P1|STARTED|Overall Study||212
8562883|NCT00006227|21110238|P1|NOT COMPLETED|Overall Study||0
8562884|NCT00006227|21110238|P1|COMPLETED|Overall Study||31
8562885|NCT00006227|21110238|P1|STARTED|Overall Study||31
8562886|NCT00006110|21110246|P2|NOT COMPLETED|Overall Study||0
8562887|NCT00006110|21110247|P1|NOT COMPLETED|Overall Study||0
8562888|NCT00006110|21110246|P2|COMPLETED|Overall Study||30
8562889|NCT00006110|21110247|P1|COMPLETED|Overall Study||52
8562890|NCT00006110|21110246|P2|STARTED|Overall Study||30
8562891|NCT00006110|21110247|P1|STARTED|Overall Study||52
8562892|NCT00006101|21110261|P2|NOT COMPLETED|Overall Study||5
8562893|NCT00006101|21110262|P1|NOT COMPLETED|Overall Study||5
8562894|NCT00006101|21110261|P2|COMPLETED|Overall Study||33
8562895|NCT00006101|21110262|P1|COMPLETED|Overall Study||33
8562896|NCT00006101|21110261|P2|STARTED|Overall Study||38
8562897|NCT00006101|21110262|P1|STARTED|Overall Study||38
8562898|NCT00006011|21110271|P3|NOT COMPLETED|Overall Study||73
8562899|NCT00006011|21110272|P2|NOT COMPLETED|Overall Study||77
8562900|NCT00006011|21110273|P1|NOT COMPLETED|Overall Study||65
8562901|NCT00006011|21110271|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
8562902|NCT00006011|21110272|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
8562903|NCT00006011|21110273|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
8562904|NCT00006011|21110271|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
8562905|NCT00006011|21110272|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
8562906|NCT00006011|21110273|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
8562907|NCT00005957|21110281|P2|NOT COMPLETED|Overall Study||28
8562908|NCT00005957|21110282|P1|NOT COMPLETED|Overall Study||8
8562909|NCT00005957|21110281|P2|COMPLETED|Overall Study||888
8562910|NCT00005957|21110282|P1|COMPLETED|Overall Study||908
8562911|NCT00005957|21110281|P2|STARTED|Overall Study||916
8562912|NCT00005957|21110282|P1|STARTED|Overall Study||916
8562913|NCT00005879|21110292|P2|NOT COMPLETED|Overall Study||10
8562914|NCT00005879|21110293|P1|NOT COMPLETED|Overall Study||8
8562915|NCT00005879|21110292|P2|COMPLETED|Overall Study||88
8562916|NCT00005879|21110293|P1|COMPLETED|Overall Study||93
8562917|NCT00005879|21110292|P2|STARTED|Overall Study||98
8562918|NCT00005879|21110293|P1|STARTED|Overall Study||101
8562919|NCT00005803|21110301|P1|NOT COMPLETED|Overall Study||22
8562920|NCT00005803|21110301|P1|COMPLETED|Overall Study||54
8562921|NCT00005803|21110301|P1|STARTED|Overall Study||76
8562922|NCT00005047|21110316|P4|NOT COMPLETED|Overall Study||0
8562923|NCT00005047|21110317|P3|NOT COMPLETED|Overall Study||0
8562924|NCT00005047|21110318|P2|NOT COMPLETED|Overall Study||0
8562925|NCT00005047|21110319|P1|NOT COMPLETED|Overall Study||19
8562926|NCT00005047|21110316|P4|COMPLETED|Overall Study||158
8562927|NCT00005047|21110317|P3|COMPLETED|Overall Study||227
8562928|NCT00005047|21110318|P2|COMPLETED|Overall Study||56
8562929|NCT00005047|21110319|P1|COMPLETED|Overall Study||39
8562930|NCT00005047|21110316|P4|STARTED|Overall Study||158
8562931|NCT00005047|21110317|P3|STARTED|Overall Study||227
8562932|NCT00005047|21110318|P2|STARTED|Overall Study||56
8562933|NCT00005047|21110319|P1|STARTED|Overall Study||58
8562934|NCT00005044|21110335|P2|NOT COMPLETED|Overall Study||52
8562935|NCT00005044|21110336|P1|NOT COMPLETED|Overall Study||38
8562936|NCT00005044|21110335|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
8562937|NCT00005044|21110336|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
8562938|NCT00005044|21110335|P2|STARTED|Overall Study||789
8562939|NCT00005044|21110336|P1|STARTED|Overall Study||790
8562940|NCT00004888|21110356|P2|NOT COMPLETED|Overall Study||24
8562941|NCT00004888|21110357|P1|NOT COMPLETED|Overall Study||11
8562942|NCT00004888|21110356|P2|COMPLETED|Overall Study||22
8562943|NCT00004888|21110357|P1|COMPLETED|Overall Study||27
8562944|NCT00004888|21110356|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
8562945|NCT00004888|21110357|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
8562946|NCT00004859|21110375|P2|NOT COMPLETED|Overall Study||282
8562947|NCT00004859|21110376|P1|NOT COMPLETED|Overall Study||118
8562948|NCT00004859|21110375|P2|COMPLETED|Overall Study||12
8562949|NCT00004859|21110376|P1|COMPLETED|Overall Study||177
8562950|NCT00004859|21110375|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
8562951|NCT00004859|21110376|P1|Treated and Having Toxicity Data|Overall Study||289
8562952|NCT00004859|21110375|P2|Treated|Overall Study||289
8562953|NCT00004859|21110376|P1|Treated|Overall Study||289
8562954|NCT00004859|21110375|P2|Eligible|Overall Study||271
8562955|NCT00004859|21110376|P1|Eligible|Overall Study||275
8562956|NCT00004859|21110375|P2|STARTED|Overall Study||294
8562957|NCT00004859|21110376|P1|STARTED|Overall Study||295
8562958|NCT00004259|21110390|P4|NOT COMPLETED|Overall Study||0
8562959|NCT00004259|21110391|P3|NOT COMPLETED|Overall Study||0
8562960|NCT00004259|21110392|P2|NOT COMPLETED|Overall Study||4
8562961|NCT00004259|21110393|P1|NOT COMPLETED|Overall Study||1
8562962|NCT00004259|21110390|P4|COMPLETED|Overall Study||14
8562963|NCT00004259|21110391|P3|COMPLETED|Overall Study||15
8562964|NCT00004259|21110392|P2|COMPLETED|Overall Study||99
8562965|NCT00004259|21110393|P1|COMPLETED|Overall Study||97
8562966|NCT00004259|21110390|P4|STARTED|Overall Study||14
8562967|NCT00004259|21110391|P3|STARTED|Overall Study||15
8562968|NCT00004259|21110392|P2|STARTED|Overall Study||103
8562969|NCT00004259|21110393|P1|STARTED|Overall Study||98
8562970|NCT00004228|21110418|P7|NOT COMPLETED|Overall Study||12
8562971|NCT00004228|21110419|P6|NOT COMPLETED|Overall Study||14
8562972|NCT00004228|21110420|P5|NOT COMPLETED|Overall Study||16
8562973|NCT00004228|21110421|P4|NOT COMPLETED|Overall Study||7
8562974|NCT00004228|21110422|P3|NOT COMPLETED|Overall Study||19
8562975|NCT00004228|21110423|P2|NOT COMPLETED|Overall Study||15
8562976|NCT00004228|21110424|P1|NOT COMPLETED|Overall Study||9
8562977|NCT00004228|21110418|P7|COMPLETED|Overall Study||45
8562978|NCT00004228|21110419|P6|COMPLETED|Overall Study||51
8562979|NCT00004228|21110420|P5|COMPLETED|Overall Study||51
8562980|NCT00004228|21110421|P4|COMPLETED|Overall Study||6
8562981|NCT00004228|21110422|P3|COMPLETED|Overall Study||46
8562982|NCT00004228|21110423|P2|COMPLETED|Overall Study||51
8562983|NCT00004228|21110424|P1|COMPLETED|Overall Study||51
8562984|NCT00004228|21110418|P7|STARTED|Overall Study||57
8562985|NCT00004228|21110419|P6|STARTED|Overall Study||65
8562986|NCT00004228|21110420|P5|STARTED|Overall Study||67
8562987|NCT00004228|21110421|P4|STARTED|Overall Study||13
8562988|NCT00004228|21110422|P3|STARTED|Overall Study||65
8562989|NCT00004228|21110423|P2|STARTED|Overall Study||66
8562990|NCT00004228|21110424|P1|STARTED|Overall Study||60
8562991|NCT00004143|21110447|P1|NOT COMPLETED|Overall Study||0
8562992|NCT00004143|21110447|P1|COMPLETED|Overall Study||2
8562993|NCT00004143|21110447|P1|STARTED|Overall Study||2
8562994|NCT00004124|21110458|P2|NOT COMPLETED|Overall Study||20
8562995|NCT00004124|21110459|P1|NOT COMPLETED|Overall Study||12
8562996|NCT00004124|21110458|P2|COMPLETED|Overall Study||460
8562997|NCT00004124|21110459|P1|COMPLETED|Overall Study||469
8562998|NCT00004124|21110458|P2|STARTED|Overall Study||480
8562999|NCT00004124|21110459|P1|STARTED|Overall Study||481
8563000|NCT00004092|21110475|P2|NOT COMPLETED|Overall Study||0
8563001|NCT00004092|21110476|P1|NOT COMPLETED|Overall Study||0
8563002|NCT00004092|21110475|P2|COMPLETED|Overall Study||51
8563003|NCT00004092|21110476|P1|COMPLETED|Overall Study||21
8563004|NCT00004092|21110475|P2|STARTED|Overall Study||51
8563005|NCT00004092|21110476|P1|STARTED|Overall Study||21
8563006|NCT00004088|21110484|P1|NOT COMPLETED|Overall Study||9
8563007|NCT00004088|21110484|P1|COMPLETED|Overall Study||68
8563008|NCT00004088|21110484|P1|STARTED|Overall Study||77
8563009|NCT00004054|21110495|P2|NOT COMPLETED|Overall Study||0
8563010|NCT00004054|21110496|P1|NOT COMPLETED|Overall Study||0
8563011|NCT00004054|21110495|P2|COMPLETED|Overall Study||200
8563012|NCT00004054|21110496|P1|COMPLETED|Overall Study||197
8563013|NCT00004054|21110495|P2|STARTED|Overall Study||200
8563014|NCT00004054|21110496|P1|STARTED|Overall Study||197
8563015|NCT00003910|21110510|P2|NOT COMPLETED|Step 2||0
8563016|NCT00003910|21110511|P1|NOT COMPLETED|Step 2||0
8563017|NCT00003910|21110510|P2|COMPLETED|Step 2||16
8563018|NCT00003910|21110511|P1|COMPLETED|Step 2||0
8563019|NCT00003910|21110510|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
8563020|NCT00003910|21110511|P1|STARTED|Step 2||0
8563021|NCT00003910|21110510|P2|NOT COMPLETED|Step 1||0
8563022|NCT00003910|21110511|P1|NOT COMPLETED|Step 1||0
8563023|NCT00003910|21110510|P2|COMPLETED|Step 1||0
8563024|NCT00003910|21110511|P1|COMPLETED|Step 1||55
8563025|NCT00003910|21110510|P2|STARTED|Step 1||0
8563026|NCT00003910|21110511|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
8563027|NCT00003901|21110517|P1|NOT COMPLETED|Overall Study||17
8563028|NCT00003901|21110517|P1|COMPLETED|Overall Study||1030
8563029|NCT00003901|21110517|P1|STARTED|Overall Study||1047
8563030|NCT00003896|21110528|P1|NOT COMPLETED|Overall Study||29
8563031|NCT00003896|21110528|P1|COMPLETED|Overall Study||39
8563032|NCT00003896|21110528|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
8563033|NCT00003896|21110528|P1|STARTED|Overall Study||68
8563034|NCT00003875|21110534|P1|NOT COMPLETED|Overall Study||1
8563035|NCT00003875|21110534|P1|COMPLETED|Overall Study||29
8563036|NCT00003875|21110534|P1|STARTED|Overall Study||30
8563037|NCT00003869|21110543|P2|NOT COMPLETED|Overall Study||12
8563038|NCT00003869|21110544|P1|NOT COMPLETED|Overall Study||41
8563039|NCT00003869|21110543|P2|COMPLETED|Overall Study||80
8563040|NCT00003869|21110544|P1|COMPLETED|Overall Study||53
8563041|NCT00003869|21110543|P2|STARTED|Overall Study||92
8563042|NCT00003869|21110544|P1|STARTED|Overall Study||94
8563043|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8563044|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8563045|NCT00003820|21110560|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
8563046|NCT00003820|21110561|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
8563047|NCT00003820|21110560|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
8563048|NCT00003820|21110561|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8563049|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8563050|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8563051|NCT00003820|21110560|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
8563052|NCT00003820|21110561|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
8563053|NCT00003820|21110560|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
8563054|NCT00003820|21110561|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8563055|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8563056|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8563057|NCT00003820|21110560|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
8563058|NCT00003820|21110561|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
8563059|NCT00003820|21110560|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
8563060|NCT00003820|21110561|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8563061|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8563062|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8563063|NCT00003820|21110560|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
8563064|NCT00003820|21110561|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
8563065|NCT00003820|21110560|P2|STARTED|Cycle 1 (Initial Treatment)||16
8563066|NCT00003820|21110561|P1|STARTED|Cycle 1 (Initial Treatment)||23
8563067|NCT00003782|21110570|P3|NOT COMPLETED|Overall Study||26
8563068|NCT00003782|21110571|P2|NOT COMPLETED|Overall Study||31
8563069|NCT00003782|21110572|P1|NOT COMPLETED|Overall Study||30
8563070|NCT00003782|21110570|P3|COMPLETED|Overall Study||1758
8563071|NCT00003782|21110571|P2|COMPLETED|Overall Study||1753
8563072|NCT00003782|21110572|P1|COMPLETED|Overall Study||1753
8563073|NCT00003782|21110570|P3|STARTED|Overall Study||1784
8563074|NCT00003782|21110571|P2|STARTED|Overall Study||1784
8563075|NCT00003782|21110572|P1|STARTED|Overall Study||1783
8563076|NCT00003702|21110582|P2|NOT COMPLETED|Overall Study||11
8563077|NCT00003702|21110583|P1|NOT COMPLETED|Overall Study||13
8563078|NCT00003702|21110582|P2|COMPLETED|Overall Study||109
8563079|NCT00003702|21110583|P1|COMPLETED|Overall Study||107
8563080|NCT00003702|21110582|P2|STARTED|Overall Study||120
8563081|NCT00003702|21110583|P1|STARTED|Overall Study||120
8563082|NCT00003659|21110592|P1|NOT COMPLETED|Overall Study||3
8563083|NCT00003659|21110592|P1|COMPLETED|Overall Study||36
8563084|NCT00003659|21110592|P1|STARTED|Overall Study||39
8563085|NCT00003644|21110600|P2|NOT COMPLETED|Overall Study||14
8563086|NCT00003644|21110601|P1|NOT COMPLETED|Overall Study||15
8563087|NCT00003644|21110600|P2|COMPLETED|Overall Study||268
8563088|NCT00003644|21110601|P1|COMPLETED|Overall Study||274
8563089|NCT00003644|21110600|P2|STARTED|Overall Study||282
8563090|NCT00003644|21110601|P1|STARTED|Overall Study||289
8563091|NCT00003641|21110613|P2|NOT COMPLETED|Overall Study||174
8563092|NCT00003641|21110614|P1|NOT COMPLETED|Overall Study||569
8563093|NCT00003641|21110613|P2|COMPLETED|Overall Study||407
8563094|NCT00003641|21110614|P1|COMPLETED|Overall Study||0
8563095|NCT00003641|21110613|P2|Toxicity Assessed|Overall Study||568
8563096|NCT00003641|21110614|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
8563097|NCT00003641|21110613|P2|Treated|Overall Study||569
8563098|NCT00003641|21110614|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
8563099|NCT00003641|21110613|P2|STARTED|Overall Study||581
8563100|NCT00003641|21110614|P1|STARTED|Overall Study||569
8563101|NCT00003631|21110625|P3|NOT COMPLETED|Overall Study||9
8563102|NCT00003631|21110626|P2|NOT COMPLETED|Overall Study||1
8563103|NCT00003631|21110627|P1|NOT COMPLETED|Overall Study||3
8563104|NCT00003631|21110625|P3|COMPLETED|Overall Study||15
8563105|NCT00003631|21110626|P2|COMPLETED|Overall Study||43
8563106|NCT00003631|21110627|P1|COMPLETED|Overall Study||47
8563107|NCT00003631|21110625|P3|STARTED|Overall Study||24
8563108|NCT00003631|21110626|P2|STARTED|Overall Study||44
8563109|NCT00003631|21110627|P1|STARTED|Overall Study||50
8563110|NCT00003590|21110635|P1|NOT COMPLETED|Overall Study||22
8563111|NCT00003590|21110635|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
8563112|NCT00003590|21110635|P1|Eligible and Began Protocol Therapy|Overall Study||28
8563113|NCT00003590|21110635|P1|Eligible|Overall Study||28
8563114|NCT00003590|21110635|P1|STARTED|Overall Study||29
8563115|NCT00003537|21110640|P1|NOT COMPLETED|Overall Study||1
8563116|NCT00003537|21110640|P1|COMPLETED|Overall Study||18
8563117|NCT00003537|21110640|P1|STARTED|Overall Study||19
8563118|NCT00003535|21110645|P1|NOT COMPLETED|Overall Study||5
8563119|NCT00003535|21110645|P1|COMPLETED|Overall Study||4
8563120|NCT00003535|21110645|P1|STARTED|Overall Study||9
8563121|NCT00003531|21110650|P1|NOT COMPLETED|Overall Study||10
8563122|NCT00003531|21110650|P1|COMPLETED|Overall Study||5
8563123|NCT00003531|21110650|P1|STARTED|Overall Study||15
8563124|NCT00003526|21110654|P1|NOT COMPLETED|Overall Study||6
8563125|NCT00003526|21110654|P1|COMPLETED|Overall Study||2
8563126|NCT00003526|21110654|P1|STARTED|Overall Study||8
8563127|NCT00003509|21110658|P1|NOT COMPLETED|Overall Study||5
8563128|NCT00003509|21110658|P1|COMPLETED|Overall Study||8
8563129|NCT00003509|21110658|P1|STARTED|Overall Study||13
8563130|NCT00003499|21110662|P1|NOT COMPLETED|Overall Study||8
8563131|NCT00003499|21110662|P1|COMPLETED|Overall Study||23
8563132|NCT00003499|21110662|P1|STARTED|Overall Study||31
8563133|NCT00003498|21110667|P1|NOT COMPLETED|Overall Study||4
8563134|NCT00003498|21110667|P1|COMPLETED|Overall Study||1
8563135|NCT00003498|21110667|P1|STARTED|Overall Study||5
8563136|NCT00003492|21110671|P1|NOT COMPLETED|Overall Study||6
8563137|NCT00003492|21110671|P1|COMPLETED|Overall Study||3
8563138|NCT00003492|21110671|P1|STARTED|Overall Study||9
8563139|NCT00003483|21110675|P1|NOT COMPLETED|Overall Study||1
8563140|NCT00003483|21110675|P1|COMPLETED|Overall Study||2
8563141|NCT00003483|21110675|P1|STARTED|Overall Study||3
8563142|NCT00003479|21110680|P1|NOT COMPLETED|Overall Study||3
8563143|NCT00003479|21110680|P1|COMPLETED|Overall Study||6
8563144|NCT00003479|21110680|P1|STARTED|Overall Study||9
8563145|NCT00003477|21110685|P1|NOT COMPLETED|Overall Study||4
8563146|NCT00003477|21110685|P1|COMPLETED|Overall Study||8
8563147|NCT00003477|21110685|P1|STARTED|Overall Study||12
8563148|NCT00003476|21110690|P1|NOT COMPLETED|Overall Study||1
8563149|NCT00003476|21110690|P1|COMPLETED|Overall Study||7
8563150|NCT00003476|21110690|P1|STARTED|Overall Study||8
8563151|NCT00003475|21110695|P1|NOT COMPLETED|Overall Study||13
8563152|NCT00003475|21110695|P1|COMPLETED|Overall Study||27
8563153|NCT00003475|21110695|P1|STARTED|Overall Study||40
8563154|NCT00003474|21110700|P1|NOT COMPLETED|Overall Study||14
8563155|NCT00003474|21110700|P1|COMPLETED|Overall Study||26
8563156|NCT00003474|21110700|P1|STARTED|Overall Study||40
8563157|NCT00003473|21110705|P1|NOT COMPLETED|Overall Study||3
8563158|NCT00003473|21110705|P1|COMPLETED|Overall Study||17
8563159|NCT00003473|21110705|P1|STARTED|Overall Study||20
8563160|NCT00003472|21110710|P1|NOT COMPLETED|Overall Study||3
8563161|NCT00003472|21110710|P1|COMPLETED|Overall Study||10
8563162|NCT00003472|21110710|P1|STARTED|Overall Study||13
8563163|NCT00003471|21110715|P1|NOT COMPLETED|Overall Study||4
8563164|NCT00003471|21110715|P1|COMPLETED|Overall Study||3
8563165|NCT00003471|21110715|P1|STARTED|Overall Study||7
8563166|NCT00003470|21110720|P1|NOT COMPLETED|Overall Study||6
8563167|NCT00003470|21110720|P1|COMPLETED|Overall Study||21
8563168|NCT00003470|21110720|P1|STARTED|Overall Study||27
8563169|NCT00003469|21110725|P1|NOT COMPLETED|Overall Study||0
8563170|NCT00003469|21110725|P1|COMPLETED|Overall Study||4
8563171|NCT00003469|21110725|P1|STARTED|Overall Study||4
8563172|NCT00003468|21110730|P1|NOT COMPLETED|Overall Study||2
8563173|NCT00003468|21110730|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
8563174|NCT00003468|21110730|P1|STARTED|Overall Study||11
8563175|NCT00003460|21110735|P1|NOT COMPLETED|Overall Study||1
8563176|NCT00003460|21110735|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
8563177|NCT00003460|21110735|P1|STARTED|Overall Study||13
8563178|NCT00003459|21110740|P1|NOT COMPLETED|Overall Study||9
8563179|NCT00003459|21110740|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
8563180|NCT00003459|21110740|P1|STARTED|Overall Study||40
8563181|NCT00003458|21110745|P1|NOT COMPLETED|Overall Study||4
8563182|NCT00003458|21110745|P1|COMPLETED|Overall Study||30
8563183|NCT00003458|21110745|P1|STARTED|Overall Study||34
8563184|NCT00003457|21110750|P1|NOT COMPLETED|Overall Study||9
8563185|NCT00003457|21110750|P1|COMPLETED|Overall Study||31
8563186|NCT00003457|21110750|P1|STARTED|Overall Study||40
8563187|NCT00003456|21110755|P1|NOT COMPLETED|Overall Study||8
8563188|NCT00003456|21110755|P1|COMPLETED|Overall Study||32
8563189|NCT00003456|21110755|P1|STARTED|Overall Study||40
8563190|NCT00003453|21110760|P1|NOT COMPLETED|Overall Study||1
8563191|NCT00003453|21110760|P1|COMPLETED|Overall Study|One patient was not evaluable|5
8563192|NCT00003453|21110760|P1|STARTED|Overall Study||6
8563193|NCT00003404|21110765|P1|NOT COMPLETED|Overall Study||0
8563194|NCT00003404|21110765|P1|COMPLETED|Overall Study||46
8563195|NCT00003404|21110765|P1|STARTED|Overall Study||46
8563196|NCT00003389|21110772|P2|NOT COMPLETED|Overall Study||60
8563197|NCT00003389|21110773|P1|NOT COMPLETED|Overall Study||98
8563198|NCT00003389|21110772|P2|COMPLETED|Overall Study||366
8563199|NCT00003389|21110773|P1|COMPLETED|Overall Study||330
8563200|NCT00003389|21110772|P2|Eligible Patients|Overall Study||399
8563201|NCT00003389|21110773|P1|Eligible Patients|Overall Study||395
8563202|NCT00003389|21110772|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
8563203|NCT00003389|21110773|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
8563204|NCT00003389|21110772|P2|STARTED|Overall Study||426
8563205|NCT00003389|21110773|P1|STARTED|Overall Study||428
8563206|NCT00003377|21110788|P5|NOT COMPLETED|Period II||1
8563207|NCT00003377|21110789|P4|NOT COMPLETED|Period II||0
8563208|NCT00003377|21110790|P3|NOT COMPLETED|Period II||0
8563209|NCT00003377|21110791|P2|NOT COMPLETED|Period II||0
8563210|NCT00003377|21110792|P1|NOT COMPLETED|Period II||0
8563211|NCT00003377|21110788|P5|COMPLETED|Period II||16
8563212|NCT00003377|21110789|P4|COMPLETED|Period II||0
8563213|NCT00003377|21110790|P3|COMPLETED|Period II||0
8563214|NCT00003377|21110791|P2|COMPLETED|Period II||0
8563215|NCT00003377|21110792|P1|COMPLETED|Period II||0
8563216|NCT00003377|21110788|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
8563217|NCT00003377|21110789|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563218|NCT00003377|21110790|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563219|NCT00003377|21110791|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563220|NCT00003377|21110792|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563221|NCT00003377|21110788|P5|NOT COMPLETED|Period I||0
8563222|NCT00003377|21110789|P4|NOT COMPLETED|Period I||1
8563223|NCT00003377|21110790|P3|NOT COMPLETED|Period I||1
8563224|NCT00003377|21110791|P2|NOT COMPLETED|Period I||0
8563225|NCT00003377|21110792|P1|NOT COMPLETED|Period I||0
8563226|NCT00003377|21110788|P5|COMPLETED|Period I||0
8563227|NCT00003377|21110789|P4|COMPLETED|Period I||2
8563228|NCT00003377|21110790|P3|COMPLETED|Period I||2
8563229|NCT00003377|21110791|P2|COMPLETED|Period I||3
8563230|NCT00003377|21110792|P1|COMPLETED|Period I||3
8563231|NCT00003377|21110788|P5|STARTED|Period I||0
8563232|NCT00003377|21110789|P4|STARTED|Period I||3
8563233|NCT00003377|21110790|P3|STARTED|Period I||3
8563234|NCT00003377|21110791|P2|STARTED|Period I||3
8563235|NCT00003377|21110792|P1|STARTED|Period I||3
8563236|NCT00003199|21110806|P1|NOT COMPLETED|Overall Study||22
8563237|NCT00003199|21110806|P1|COMPLETED|Overall Study||28
8563238|NCT00003199|21110806|P1|STARTED|Overall Study||50
8563239|NCT00003138|21110814|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8563240|NCT00003138|21110815|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8563241|NCT00003138|21110814|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8563242|NCT00003138|21110815|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8563243|NCT00003138|21110814|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8563244|NCT00003138|21110815|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8563245|NCT00003138|21110814|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8563246|NCT00003138|21110815|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8563247|NCT00003138|21110814|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8563248|NCT00003138|21110815|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8563249|NCT00003138|21110814|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
8563250|NCT00003138|21110815|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
8563251|NCT00003138|21110814|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8563252|NCT00003138|21110815|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8563253|NCT00003138|21110814|P2|NOT COMPLETED|Step 2 (Cross Over)||0
8563254|NCT00003138|21110815|P1|NOT COMPLETED|Step 2 (Cross Over)||26
8563255|NCT00003138|21110814|P2|COMPLETED|Step 2 (Cross Over)||0
8563256|NCT00003138|21110815|P1|COMPLETED|Step 2 (Cross Over)||0
8563257|NCT00003138|21110814|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
8563258|NCT00003138|21110815|P1|STARTED|Step 2 (Cross Over)||26
8563259|NCT00003138|21110814|P2|NOT COMPLETED|Step 1||57
8563260|NCT00003138|21110815|P1|NOT COMPLETED|Step 1||61
8563261|NCT00003138|21110814|P2|COMPLETED|Step 1||0
8563262|NCT00003138|21110815|P1|COMPLETED|Step 1||0
8563263|NCT00003138|21110814|P2|Patients With Transfusion Data|Step 1||42
8563264|NCT00003138|21110815|P1|Patients With Transfusion Data|Step 1||37
8563265|NCT00003138|21110814|P2|Patients With QOL Data at 4 Months|Step 1||42
8563266|NCT00003138|21110815|P1|Patients With QOL Data at 4 Months|Step 1||42
8563267|NCT00003138|21110814|P2|Eligible and Treated|Step 1||50
8563268|NCT00003138|21110815|P1|Eligible and Treated|Step 1||52
8563269|NCT00003138|21110814|P2|Treated|Step 1||53
8563270|NCT00003138|21110815|P1|Treated|Step 1||56
8563271|NCT00003138|21110814|P2|Patients With Complete Data|Step 1||53
8563272|NCT00003138|21110815|P1|Patients With Complete Data|Step 1||57
8563273|NCT00003138|21110814|P2|STARTED|Step 1||57
8563274|NCT00003138|21110815|P1|STARTED|Step 1||61
8563275|NCT00002975|21110828|P1|NOT COMPLETED|Overall Study||5
8563276|NCT00002975|21110828|P1|COMPLETED|Overall Study||175
8563277|NCT00002975|21110828|P1|Treated With Study Therapy|Overall Study||175
8563278|NCT00002975|21110828|P1|STARTED|Overall Study||180
8563279|NCT00002931|21110832|P1|NOT COMPLETED|Overall Study||2
8563280|NCT00002931|21110832|P1|COMPLETED|Overall Study||46
8563281|NCT00002931|21110832|P1|STARTED|Overall Study||48
8563282|NCT00002874|21110840|P2|NOT COMPLETED|Overall Study||35
8563283|NCT00002874|21110841|P1|NOT COMPLETED|Overall Study||45
8563284|NCT00002874|21110840|P2|COMPLETED|Overall Study||384
8563285|NCT00002874|21110841|P1|COMPLETED|Overall Study||376
8563286|NCT00002874|21110840|P2|STARTED|Overall Study||419
8563287|NCT00002874|21110841|P1|STARTED|Overall Study||421
8563288|NCT00002850|21110866|P3|NOT COMPLETED|Overall Study||4
8563289|NCT00002850|21110867|P2|NOT COMPLETED|Overall Study||2
8563290|NCT00002850|21110868|P1|NOT COMPLETED|Overall Study||5
8563291|NCT00002850|21110866|P3|COMPLETED|Overall Study||63
8563292|NCT00002850|21110867|P2|COMPLETED|Overall Study||74
8563293|NCT00002850|21110868|P1|COMPLETED|Overall Study||64
8563294|NCT00002850|21110866|P3|STARTED|Overall Study||67
8563295|NCT00002850|21110867|P2|STARTED|Overall Study||76
8563296|NCT00002850|21110868|P1|STARTED|Overall Study||69
8563297|NCT00002842|21110876|P1|NOT COMPLETED|Overall Study||27
8563298|NCT00002842|21110876|P1|COMPLETED|Overall Study||22
8563299|NCT00002842|21110876|P1|STARTED|Overall Study||49
8563300|NCT00002766|21110882|P2|NOT COMPLETED|Overall Study||4
8563301|NCT00002766|21110883|P1|NOT COMPLETED|Overall Study||3
8563302|NCT00002766|21110882|P2|COMPLETED|Overall Study||85
8563303|NCT00002766|21110883|P1|COMPLETED|Overall Study||78
8563304|NCT00002766|21110882|P2|STARTED|Overall Study||89
8563305|NCT00002766|21110883|P1|STARTED|Overall Study||81
8563306|NCT00002651|21110891|P3|NOT COMPLETED|Consolidation and Randomization||860
8563307|NCT00002651|21110892|P2|NOT COMPLETED|Consolidation and Randomization||838
8563308|NCT00002651|21110893|P1|NOT COMPLETED|Consolidation and Randomization||0
8563309|NCT00002651|21110891|P3|COMPLETED|Consolidation and Randomization||22
8563310|NCT00002651|21110892|P2|COMPLETED|Consolidation and Randomization||29
8563311|NCT00002651|21110893|P1|COMPLETED|Consolidation and Randomization||0
8563312|NCT00002651|21110891|P3|Assessable for Toxicity|Consolidation and Randomization||702
8563313|NCT00002651|21110892|P2|Assessable for Toxicity|Consolidation and Randomization||732
8563314|NCT00002651|21110893|P1|Assessable for Toxicity|Consolidation and Randomization||0
8563315|NCT00002651|21110891|P3|Eligible|Consolidation and Randomization||770
8563316|NCT00002651|21110892|P2|Eligible|Consolidation and Randomization||765
8563317|NCT00002651|21110893|P1|Eligible|Consolidation and Randomization||0
8563318|NCT00002651|21110891|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
8563319|NCT00002651|21110892|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
8563320|NCT00002651|21110893|P1|STARTED|Consolidation and Randomization||0
8563321|NCT00002651|21110891|P3|NOT COMPLETED|Induction||0
8563322|NCT00002651|21110892|P2|NOT COMPLETED|Induction||0
8563323|NCT00002651|21110893|P1|NOT COMPLETED|Induction||1343
8563324|NCT00002651|21110891|P3|COMPLETED|Induction||0
8563325|NCT00002651|21110892|P2|COMPLETED|Induction||0
8563326|NCT00002651|21110893|P1|COMPLETED|Induction||1697
8563327|NCT00002651|21110891|P3|Eligible and Began Protocol Therapy|Induction||0
8563328|NCT00002651|21110892|P2|Eligible and Began Protocol Therapy|Induction||0
8563329|NCT00002651|21110893|P1|Eligible and Began Protocol Therapy|Induction||2950
8563330|NCT00002651|21110891|P3|Eligible|Induction||0
8563331|NCT00002651|21110892|P2|Eligible|Induction||0
8563332|NCT00002651|21110893|P1|Eligible|Induction||2950
8563333|NCT00002651|21110891|P3|STARTED|Induction||0
8563334|NCT00002651|21110892|P2|STARTED|Induction||0
8563335|NCT00002651|21110893|P1|STARTED|Induction||3040
8563336|NCT00002558|21110911|P2|NOT COMPLETED|Overall Study||1
8563337|NCT00002558|21110912|P1|NOT COMPLETED|Overall Study||0
8563338|NCT00002558|21110911|P2|COMPLETED|Overall Study||15
8563339|NCT00002558|21110912|P1|COMPLETED|Overall Study||92
8563340|NCT00002558|21110911|P2|STARTED|Overall Study||16
8563341|NCT00002558|21110912|P1|STARTED|Overall Study||92
8563342|NCT00052078|21110922|P4|NOT COMPLETED|Overall Study||15
8563343|NCT00052078|21110923|P3|NOT COMPLETED|Overall Study||13
8563344|NCT00052078|21110924|P2|NOT COMPLETED|Overall Study||6
8563345|NCT00052078|21110925|P1|NOT COMPLETED|Overall Study||23
8563346|NCT00052078|21110922|P4|COMPLETED|Overall Study||61
8563347|NCT00052078|21110923|P3|COMPLETED|Overall Study||127
8563348|NCT00052078|21110924|P2|COMPLETED|Overall Study||133
8563349|NCT00052078|21110925|P1|COMPLETED|Overall Study||110
8563350|NCT00052078|21110922|P4|STARTED|Overall Study||76
8563351|NCT00052078|21110923|P3|STARTED|Overall Study||140
8563352|NCT00052078|21110924|P2|STARTED|Overall Study||139
8563353|NCT00052078|21110925|P1|STARTED|Overall Study||133
8563354|NCT00051636|21110937|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
8563355|NCT00051636|21110938|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
8563356|NCT00051636|21110937|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
8563357|NCT00051636|21110938|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
8563358|NCT00051636|21110937|P2|STARTED|Period 2- Extended Observation Period||52
8563359|NCT00051636|21110938|P1|STARTED|Period 2- Extended Observation Period||75
8563360|NCT00051636|21110937|P2|NOT COMPLETED|Period 1 - Core||6
8563361|NCT00051636|21110938|P1|NOT COMPLETED|Period 1 - Core||4
8563362|NCT00051636|21110937|P2|COMPLETED|Period 1 - Core||76
8563363|NCT00051636|21110938|P1|COMPLETED|Period 1 - Core||86
8563364|NCT00051636|21110937|P2|STARTED|Period 1 - Core||82
8563365|NCT00051636|21110938|P1|STARTED|Period 1 - Core||90
8563366|NCT00051558|21110966|P2|NOT COMPLETED|Overall Study||96
8563367|NCT00051558|21110967|P1|NOT COMPLETED|Overall Study||91
8563368|NCT00051558|21110966|P2|COMPLETED|Overall Study||118
8563369|NCT00051558|21110967|P1|COMPLETED|Overall Study||123
8563370|NCT00051558|21110966|P2|STARTED|Overall Study||214
8563371|NCT00051558|21110967|P1|STARTED|Overall Study||214
8563372|NCT00051363|21111003|P2|NOT COMPLETED|Overall Study||144
8563373|NCT00051363|21111004|P1|NOT COMPLETED|Overall Study||115
8563374|NCT00051363|21111003|P2|COMPLETED|Overall Study||403
8563375|NCT00051363|21111004|P1|COMPLETED|Overall Study||443
8563376|NCT00051363|21111003|P2|Completed 6M Vist On-Study|Overall Study||403
8563377|NCT00051363|21111004|P1|Completed 6M Vist On-Study|Overall Study||443
8563378|NCT00051363|21111003|P2|Completed 6M Visit On-Treatment|Overall Study||372
8563379|NCT00051363|21111004|P1|Completed 6M Visit On-Treatment|Overall Study||427
8563380|NCT00051363|21111003|P2|Completed 2M Visit On-Study|Overall Study||432
8563381|NCT00051363|21111004|P1|Completed 2M Visit On-Study|Overall Study||468
8563382|NCT00051363|21111003|P2|Completed 2M Visit On-Treatment|Overall Study||417
8563383|NCT00051363|21111004|P1|Completed 2M Visit On-Treatment|Overall Study||456
8563384|NCT00051363|21111003|P2|Randomized & Analyzed|Overall Study||542
8563385|NCT00051363|21111004|P1|Randomized & Analyzed|Overall Study||556
8563386|NCT00051363|21111003|P2|STARTED|Overall Study||547
8563387|NCT00051363|21111004|P1|STARTED|Overall Study||558
8563388|NCT00051168|21111038|P1|NOT COMPLETED|Overall Study||135
8563389|NCT00051168|21111038|P1|COMPLETED|Overall Study||367
8563390|NCT00051168|21111038|P1|STARTED|Overall Study||502
8563391|NCT00051025|21111044|P2|NOT COMPLETED|Overall Study||4
8563392|NCT00051025|21111045|P1|NOT COMPLETED|Overall Study||2
8563393|NCT00051025|21111044|P2|COMPLETED|Overall Study||0
8563394|NCT00051025|21111045|P1|COMPLETED|Overall Study||3
8563395|NCT00051025|21111044|P2|STARTED|Overall Study||4
8563396|NCT00051025|21111045|P1|STARTED|Overall Study||5
8563397|NCT00050986|21111053|P1|NOT COMPLETED|Overall Study||2
8563398|NCT00050986|21111053|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
8563399|NCT00050986|21111053|P1|STARTED|Overall Study||55
8563400|NCT00050960|21111059|P2|NOT COMPLETED|Overall Study||304
8563401|NCT00050960|21111060|P1|NOT COMPLETED|Overall Study||302
8563402|NCT00050960|21111059|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
8563403|NCT00050960|21111060|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
8563404|NCT00050960|21111059|P2|STARTED|Overall Study||306
8563405|NCT00050960|21111060|P1|STARTED|Overall Study||306
8563406|NCT00050778|21111069|P3|NOT COMPLETED|Overall Study||18
8563407|NCT00050778|21111070|P2|NOT COMPLETED|Overall Study||21
8563408|NCT00050778|21111071|P1|NOT COMPLETED|Overall Study||45
8563409|NCT00050778|21111069|P3|COMPLETED|Overall Study||92
8563410|NCT00050778|21111070|P2|COMPLETED|Overall Study||92
8563411|NCT00050778|21111071|P1|COMPLETED|Overall Study||66
8563412|NCT00050778|21111069|P3|Treated|Overall Study||108
8563413|NCT00050778|21111070|P2|Treated|Overall Study||108
8563414|NCT00050778|21111071|P1|Treated|Overall Study||107
8563415|NCT00050778|21111069|P3|STARTED|Overall Study||110
8563416|NCT00050778|21111070|P2|STARTED|Overall Study||113
8563417|NCT00050778|21111071|P1|STARTED|Overall Study|Randomized.|111
8563418|NCT00050622|21111097|P1|NOT COMPLETED|Overall Study||1
8563419|NCT00050622|21111097|P1|COMPLETED|Overall Study||153
8563420|NCT00050622|21111097|P1|STARTED|Overall Study||154
8563421|NCT00050167|21111135|P2|NOT COMPLETED|Overall Study||1
8563422|NCT00050167|21111136|P1|NOT COMPLETED|Overall Study||1
8563423|NCT00050167|21111135|P2|COMPLETED|Overall Study||300
8563424|NCT00050167|21111136|P1|COMPLETED|Overall Study||301
8563425|NCT00050167|21111135|P2|STARTED|Overall Study||301
8563426|NCT00050167|21111136|P1|STARTED|Overall Study||302
8563427|NCT00050089|21111146|P4|NOT COMPLETED|Overall Study||0
8563428|NCT00050089|21111147|P3|NOT COMPLETED|Overall Study||0
8563429|NCT00050089|21111148|P2|NOT COMPLETED|Overall Study||0
8563430|NCT00050089|21111149|P1|NOT COMPLETED|Overall Study||0
8563431|NCT00050089|21111146|P4|COMPLETED|Overall Study|For primary outcome assessment|78
8563432|NCT00050089|21111147|P3|COMPLETED|Overall Study|For primary outcome assessment|86
8563433|NCT00050089|21111148|P2|COMPLETED|Overall Study|For primary outcome assessment|98
8563434|NCT00050089|21111149|P1|COMPLETED|Overall Study|For primary outcome assessment|106
8563435|NCT00050089|21111146|P4|Baseline|Overall Study||78
8563436|NCT00050089|21111147|P3|Baseline|Overall Study||86
8563437|NCT00050089|21111148|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
8563438|NCT00050089|21111149|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
8563439|NCT00050089|21111146|P4|STARTED|Overall Study||78
8563440|NCT00050089|21111147|P3|STARTED|Overall Study||86
8563441|NCT00050089|21111148|P2|STARTED|Overall Study||98
8563442|NCT00050089|21111149|P1|STARTED|Overall Study||106
8563443|NCT00050011|21111169|P2|NOT COMPLETED|Overall Study||126
8563444|NCT00050011|21111170|P1|NOT COMPLETED|Overall Study||121
8563445|NCT00050011|21111169|P2|COMPLETED|Overall Study||175
8563446|NCT00050011|21111170|P1|COMPLETED|Overall Study||180
8563447|NCT00050011|21111169|P2|Intent-to-treat Population|Overall Study||300
8563448|NCT00050011|21111170|P1|Intent-to-treat Population|Overall Study||300
8563449|NCT00050011|21111169|P2|STARTED|Overall Study||301
8563450|NCT00050011|21111170|P1|STARTED|Overall Study||301
8563451|NCT00049842|21111192|P2|NOT COMPLETED|Follow-up Phase||5
8563452|NCT00049842|21111193|P1|NOT COMPLETED|Follow-up Phase||7
8563453|NCT00049842|21111192|P2|COMPLETED|Follow-up Phase||189
8563454|NCT00049842|21111193|P1|COMPLETED|Follow-up Phase||211
8563455|NCT00049842|21111192|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
8563456|NCT00049842|21111193|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
8563457|NCT00049842|21111192|P2|NOT COMPLETED|Treatment Phase||78
8563458|NCT00049842|21111193|P1|NOT COMPLETED|Treatment Phase||93
8563459|NCT00049842|21111192|P2|COMPLETED|Treatment Phase||192
8563460|NCT00049842|21111193|P1|COMPLETED|Treatment Phase||177
8563461|NCT00049842|21111192|P2|STARTED|Treatment Phase||270
8563462|NCT00049842|21111193|P1|STARTED|Treatment Phase||270
8563463|NCT00048932|21111211|P3|NOT COMPLETED|Open Label Period (OL)||441
8563464|NCT00048932|21111212|P2|NOT COMPLETED|Open Label Period (OL)||0
8563465|NCT00048932|21111213|P1|NOT COMPLETED|Open Label Period (OL)||0
8563466|NCT00048932|21111211|P3|COMPLETED|Open Label Period (OL)||743
8563467|NCT00048932|21111212|P2|COMPLETED|Open Label Period (OL)||0
8563468|NCT00048932|21111213|P1|COMPLETED|Open Label Period (OL)||0
8563469|NCT00048932|21111211|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
8563470|NCT00048932|21111212|P2|STARTED|Open Label Period (OL)||0
8563471|NCT00048932|21111213|P1|STARTED|Open Label Period (OL)||0
8563472|NCT00048932|21111211|P3|NOT COMPLETED|Double Blind Period (DB)||0
8563473|NCT00048932|21111212|P2|NOT COMPLETED|Double Blind Period (DB)||87
8563474|NCT00048932|21111213|P1|NOT COMPLETED|Double Blind Period (DB)||123
8563475|NCT00048932|21111211|P3|COMPLETED|Double Blind Period (DB)||0
8563476|NCT00048932|21111212|P2|COMPLETED|Double Blind Period (DB)||395
8563477|NCT00048932|21111213|P1|COMPLETED|Double Blind Period (DB)||836
8563478|NCT00048932|21111211|P3|STARTED|Double Blind Period (DB)||0
8563479|NCT00048932|21111212|P2|STARTED|Double Blind Period (DB)|Number Treated|482
8563480|NCT00048932|21111213|P1|STARTED|Double Blind Period (DB)|Number Treated|959
8563481|NCT00048815|21111240|P3|NOT COMPLETED|Overall Study||4
8563482|NCT00048815|21111241|P2|NOT COMPLETED|Overall Study||4
8563483|NCT00048815|21111242|P1|NOT COMPLETED|Overall Study||6
8563484|NCT00048815|21111240|P3|COMPLETED|Overall Study||19
8563485|NCT00048815|21111241|P2|COMPLETED|Overall Study||22
8563486|NCT00048815|21111242|P1|COMPLETED|Overall Study||18
8563487|NCT00048815|21111240|P3|STARTED|Overall Study||23
8563488|NCT00048815|21111241|P2|STARTED|Overall Study||26
8563489|NCT00048815|21111242|P1|STARTED|Overall Study||24
8563490|NCT00048581|21111255|P3|NOT COMPLETED|Open-Label Period||167
8563491|NCT00048581|21111256|P2|NOT COMPLETED|Open-Label Period||0
8563492|NCT00048581|21111257|P1|NOT COMPLETED|Open-Label Period||0
8563493|NCT00048581|21111255|P3|COMPLETED|Open-Label Period||150
8563494|NCT00048581|21111256|P2|COMPLETED|Open-Label Period||0
8563495|NCT00048581|21111257|P1|COMPLETED|Open-Label Period||0
8563496|NCT00048581|21111255|P3|STARTED|Open-Label Period||317
8563497|NCT00048581|21111256|P2|STARTED|Open-Label Period||0
8563498|NCT00048581|21111257|P1|STARTED|Open-Label Period||0
8563499|NCT00048581|21111255|P3|NOT COMPLETED|Double-Blind Period||0
8563500|NCT00048581|21111256|P2|NOT COMPLETED|Double-Blind Period||34
8563501|NCT00048581|21111257|P1|NOT COMPLETED|Double-Blind Period||35
8563502|NCT00048581|21111255|P3|COMPLETED|Double-Blind Period||0
8563503|NCT00048581|21111256|P2|COMPLETED|Double-Blind Period||99
8563504|NCT00048581|21111257|P1|COMPLETED|Double-Blind Period||223
8563505|NCT00048581|21111255|P3|STARTED|Double-Blind Period||0
8563506|NCT00048581|21111256|P2|STARTED|Double-Blind Period||133
8563507|NCT00048581|21111257|P1|STARTED|Double-Blind Period||258
8563508|NCT00048568|21111424|P3|NOT COMPLETED|Open-Label Period||160
8563509|NCT00048568|21111425|P2|NOT COMPLETED|Open-Label Period||0
8563510|NCT00048568|21111426|P1|NOT COMPLETED|Open-Label Period||0
8563511|NCT00048568|21111424|P3|COMPLETED|Open-Label Period||379
8563512|NCT00048568|21111425|P2|COMPLETED|Open-Label Period||0
8563513|NCT00048568|21111426|P1|COMPLETED|Open-Label Period||0
8563514|NCT00048568|21111424|P3|STARTED|Open-Label Period||539
8563515|NCT00048568|21111425|P2|STARTED|Open-Label Period||0
8563516|NCT00048568|21111426|P1|STARTED|Open-Label Period||0
8563517|NCT00048568|21111424|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
8563518|NCT00048568|21111425|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
8563519|NCT00048568|21111426|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
8563520|NCT00048568|21111424|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
8563521|NCT00048568|21111425|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
8563522|NCT00048568|21111426|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
8563523|NCT00048568|21111424|P3|STARTED|Double-Blind Period Days 170 to 365||0
8563524|NCT00048568|21111425|P2|STARTED|Double-Blind Period Days 170 to 365||174
8563525|NCT00048568|21111426|P1|STARTED|Double-Blind Period Days 170 to 365||401
8563526|NCT00048568|21111424|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
8563527|NCT00048568|21111425|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
8563528|NCT00048568|21111426|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
8563529|NCT00048568|21111424|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
8563530|NCT00048568|21111425|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
8563531|NCT00048568|21111426|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
8563532|NCT00048568|21111424|P3|STARTED|Double-Blind Period Days 1 to 169||0
8563533|NCT00048568|21111425|P2|STARTED|Double-Blind Period Days 1 to 169||219
8563534|NCT00048568|21111426|P1|STARTED|Double-Blind Period Days 1 to 169||433
8563535|NCT00048893|21111714|P1|NOT COMPLETED|Overall Study||0
8563536|NCT00048893|21111714|P1|COMPLETED|Overall Study||37
8563537|NCT00048893|21111714|P1|STARTED|Overall Study||37
8563538|NCT00048737|21111725|P1|NOT COMPLETED|Overall Study||0
8563539|NCT00048737|21111725|P1|COMPLETED|Overall Study||70
8563540|NCT00048737|21111725|P1|STARTED|Overall Study||70
8563541|NCT00048724|21111731|P2|NOT COMPLETED|Overall Study||118
8563542|NCT00048724|21111732|P1|NOT COMPLETED|Overall Study||116
8563543|NCT00048724|21111731|P2|COMPLETED|Overall Study||197
8563544|NCT00048724|21111732|P1|COMPLETED|Overall Study||195
8563545|NCT00048724|21111731|P2|STARTED|Overall Study||315
8563546|NCT00048724|21111732|P1|STARTED|Overall Study||311
8563547|NCT00048542|21111744|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8563548|NCT00048542|21111745|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8563549|NCT00048542|21111746|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563550|NCT00048542|21111747|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563551|NCT00048542|21111748|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563552|NCT00048542|21111749|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563553|NCT00048542|21111750|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563554|NCT00048542|21111751|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563555|NCT00048542|21111744|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
8563556|NCT00048542|21111745|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
8563557|NCT00048542|21111746|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563558|NCT00048542|21111747|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563559|NCT00048542|21111748|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563560|NCT00048542|21111749|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563561|NCT00048542|21111750|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563562|NCT00048542|21111751|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563563|NCT00048542|21111744|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
8563564|NCT00048542|21111745|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
8563565|NCT00048542|21111746|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
8563566|NCT00048542|21111747|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
8563567|NCT00048542|21111748|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
8563568|NCT00048542|21111749|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
8563569|NCT00048542|21111750|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
8563570|NCT00048542|21111751|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
8563571|NCT00048542|21111744|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563572|NCT00048542|21111745|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563573|NCT00048542|21111746|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
8563574|NCT00048542|21111747|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
8563575|NCT00048542|21111748|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563576|NCT00048542|21111749|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563577|NCT00048542|21111750|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563578|NCT00048542|21111751|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563579|NCT00048542|21111744|P8|COMPLETED|Open-Label Extension BSA Phase||0
8563580|NCT00048542|21111745|P7|COMPLETED|Open-Label Extension BSA Phase||0
8563581|NCT00048542|21111746|P6|COMPLETED|Open-Label Extension BSA Phase||47
8563582|NCT00048542|21111747|P5|COMPLETED|Open-Label Extension BSA Phase||59
8563583|NCT00048542|21111748|P4|COMPLETED|Open-Label Extension BSA Phase||0
8563584|NCT00048542|21111749|P3|COMPLETED|Open-Label Extension BSA Phase||0
8563585|NCT00048542|21111750|P2|COMPLETED|Open-Label Extension BSA Phase||0
8563586|NCT00048542|21111751|P1|COMPLETED|Open-Label Extension BSA Phase||0
8563587|NCT00048542|21111744|P8|STARTED|Open-Label Extension BSA Phase||0
8563588|NCT00048542|21111745|P7|STARTED|Open-Label Extension BSA Phase||0
8563589|NCT00048542|21111746|P6|STARTED|Open-Label Extension BSA Phase||57
8563590|NCT00048542|21111747|P5|STARTED|Open-Label Extension BSA Phase||71
8563591|NCT00048542|21111748|P4|STARTED|Open-Label Extension BSA Phase||0
8563592|NCT00048542|21111749|P3|STARTED|Open-Label Extension BSA Phase||0
8563593|NCT00048542|21111750|P2|STARTED|Open-Label Extension BSA Phase||0
8563594|NCT00048542|21111751|P1|STARTED|Open-Label Extension BSA Phase||0
8563595|NCT00048542|21111744|P8|NOT COMPLETED|Double-Blind Phase||0
8563596|NCT00048542|21111745|P7|NOT COMPLETED|Double-Blind Phase||0
8563597|NCT00048542|21111746|P6|NOT COMPLETED|Double-Blind Phase||0
8563598|NCT00048542|21111747|P5|NOT COMPLETED|Double-Blind Phase||0
8563599|NCT00048542|21111748|P4|NOT COMPLETED|Double-Blind Phase||0
8563600|NCT00048542|21111749|P3|NOT COMPLETED|Double-Blind Phase||1
8563601|NCT00048542|21111750|P2|NOT COMPLETED|Double-Blind Phase||1
8563602|NCT00048542|21111751|P1|NOT COMPLETED|Double-Blind Phase||3
8563603|NCT00048542|21111744|P8|COMPLETED|Double-Blind Phase||0
8563604|NCT00048542|21111745|P7|COMPLETED|Double-Blind Phase||0
8563605|NCT00048542|21111746|P6|COMPLETED|Double-Blind Phase||0
8563606|NCT00048542|21111747|P5|COMPLETED|Double-Blind Phase||0
8563607|NCT00048542|21111748|P4|COMPLETED|Double-Blind Phase||28
8563608|NCT00048542|21111749|P3|COMPLETED|Double-Blind Phase||29
8563609|NCT00048542|21111750|P2|COMPLETED|Double-Blind Phase||36
8563610|NCT00048542|21111751|P1|COMPLETED|Double-Blind Phase||35
8563611|NCT00048542|21111744|P8|STARTED|Double-Blind Phase||0
8563612|NCT00048542|21111745|P7|STARTED|Double-Blind Phase||0
8563613|NCT00048542|21111746|P6|STARTED|Double-Blind Phase||0
8563614|NCT00048542|21111747|P5|STARTED|Double-Blind Phase||0
8563615|NCT00048542|21111748|P4|STARTED|Double-Blind Phase||28
8563616|NCT00048542|21111749|P3|STARTED|Double-Blind Phase||30
8563617|NCT00048542|21111750|P2|STARTED|Double-Blind Phase||37
8563618|NCT00048542|21111751|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
8563619|NCT00048347|21111817|P1|NOT COMPLETED|Overall Study||2
8563620|NCT00048347|21111817|P1|COMPLETED|Overall Study||16
8563621|NCT00048347|21111817|P1|STARTED|Overall Study||18
8563622|NCT00048165|21111823|P2|NOT COMPLETED|Completed 12 Months Study||3
8563623|NCT00048165|21111824|P1|NOT COMPLETED|Completed 12 Months Study||3
8563624|NCT00048165|21111823|P2|COMPLETED|Completed 12 Months Study||167
8563625|NCT00048165|21111824|P1|COMPLETED|Completed 12 Months Study||162
8563626|NCT00048165|21111823|P2|STARTED|Completed 12 Months Study||170
8563627|NCT00048165|21111824|P1|STARTED|Completed 12 Months Study||165
8563628|NCT00048165|21111823|P2|NOT COMPLETED|Completed 6 Months Study||48
8563629|NCT00048165|21111824|P1|NOT COMPLETED|Completed 6 Months Study||51
8563630|NCT00048165|21111823|P2|COMPLETED|Completed 6 Months Study||170
8563631|NCT00048165|21111824|P1|COMPLETED|Completed 6 Months Study||165
8563632|NCT00048165|21111823|P2|STARTED|Completed 6 Months Study||218
8563633|NCT00048165|21111824|P1|STARTED|Completed 6 Months Study||216
8563634|NCT00048074|21111859|P3|NOT COMPLETED|Overall Study||97
8563635|NCT00048074|21111860|P2|NOT COMPLETED|Overall Study||87
8563636|NCT00048074|21111861|P1|NOT COMPLETED|Overall Study||81
8563637|NCT00048074|21111859|P3|COMPLETED|Overall Study||372
8563638|NCT00048074|21111860|P2|COMPLETED|Overall Study||361
8563639|NCT00048074|21111861|P1|COMPLETED|Overall Study||384
8563640|NCT00048074|21111859|P3|STARTED|Overall Study||469
8563641|NCT00048074|21111860|P2|STARTED|Overall Study||448
8563642|NCT00048074|21111861|P1|STARTED|Overall Study||465
8563643|NCT00048061|21111918|P4|NOT COMPLETED|Overall Study||79
8563644|NCT00048061|21111919|P3|NOT COMPLETED|Overall Study||84
8563645|NCT00048061|21111920|P2|NOT COMPLETED|Overall Study||73
8563646|NCT00048061|21111921|P1|NOT COMPLETED|Overall Study||75
8563647|NCT00048061|21111918|P4|COMPLETED|Overall Study||322
8563648|NCT00048061|21111919|P3|COMPLETED|Overall Study||316
8563649|NCT00048061|21111920|P2|COMPLETED|Overall Study||328
8563650|NCT00048061|21111921|P1|COMPLETED|Overall Study||325
8563651|NCT00048061|21111918|P4|STARTED|Overall Study||401
8563652|NCT00048061|21111919|P3|STARTED|Overall Study||400
8563653|NCT00048061|21111920|P2|STARTED|Overall Study||401
8563654|NCT00048061|21111921|P1|STARTED|Overall Study||400
8563655|NCT00048048|21112000|P12|NOT COMPLETED|Extension Year 2||2
8563656|NCT00048048|21112001|P11|NOT COMPLETED|Extension Year 2||4
8563657|NCT00048048|21112002|P10|NOT COMPLETED|Extension Year 2||0
8563658|NCT00048048|21112003|P9|NOT COMPLETED|Extension Year 2||0
8563659|NCT00048048|21112004|P8|NOT COMPLETED|Extension Year 2||0
8563660|NCT00048048|21112005|P7|NOT COMPLETED|Extension Year 2||0
8563661|NCT00048048|21112006|P6|NOT COMPLETED|Extension Year 2||0
8563662|NCT00048048|21112007|P5|NOT COMPLETED|Extension Year 2||0
8563663|NCT00048048|21112008|P4|NOT COMPLETED|Extension Year 2||0
8563664|NCT00048048|21112009|P3|NOT COMPLETED|Extension Year 2||0
8563665|NCT00048048|21112010|P2|NOT COMPLETED|Extension Year 2||0
8563666|NCT00048048|21112011|P1|NOT COMPLETED|Extension Year 2||0
8563667|NCT00048048|21112000|P12|COMPLETED|Extension Year 2||13
8563668|NCT00048048|21112001|P11|COMPLETED|Extension Year 2||19
8563669|NCT00048048|21112002|P10|COMPLETED|Extension Year 2||2
8563670|NCT00048048|21112003|P9|COMPLETED|Extension Year 2||0
8563671|NCT00048048|21112004|P8|COMPLETED|Extension Year 2||0
8563672|NCT00048048|21112005|P7|COMPLETED|Extension Year 2||0
8563673|NCT00048048|21112006|P6|COMPLETED|Extension Year 2||0
8563674|NCT00048048|21112007|P5|COMPLETED|Extension Year 2||0
8563675|NCT00048048|21112008|P4|COMPLETED|Extension Year 2||0
8563676|NCT00048048|21112009|P3|COMPLETED|Extension Year 2||0
8563677|NCT00048048|21112010|P2|COMPLETED|Extension Year 2||0
8563678|NCT00048048|21112011|P1|COMPLETED|Extension Year 2||0
8563679|NCT00048048|21112000|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
8563680|NCT00048048|21112001|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
8563681|NCT00048048|21112002|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
8563682|NCT00048048|21112003|P9|STARTED|Extension Year 2||0
8563683|NCT00048048|21112004|P8|STARTED|Extension Year 2||0
8563684|NCT00048048|21112005|P7|STARTED|Extension Year 2||0
8563685|NCT00048048|21112006|P6|STARTED|Extension Year 2||0
8563686|NCT00048048|21112007|P5|STARTED|Extension Year 2||0
8563687|NCT00048048|21112008|P4|STARTED|Extension Year 2||0
8563688|NCT00048048|21112009|P3|STARTED|Extension Year 2||0
8563689|NCT00048048|21112010|P2|STARTED|Extension Year 2||0
8563690|NCT00048048|21112011|P1|STARTED|Extension Year 2||0
8563691|NCT00048048|21112000|P12|NOT COMPLETED|Extension Year 1||4
8563692|NCT00048048|21112001|P11|NOT COMPLETED|Extension Year 1||2
8563693|NCT00048048|21112002|P10|NOT COMPLETED|Extension Year 1||2
8563694|NCT00048048|21112003|P9|NOT COMPLETED|Extension Year 1||0
8563695|NCT00048048|21112004|P8|NOT COMPLETED|Extension Year 1||0
8563696|NCT00048048|21112005|P7|NOT COMPLETED|Extension Year 1||0
8563697|NCT00048048|21112006|P6|NOT COMPLETED|Extension Year 1||0
8563698|NCT00048048|21112007|P5|NOT COMPLETED|Extension Year 1||0
8563699|NCT00048048|21112008|P4|NOT COMPLETED|Extension Year 1||0
8563700|NCT00048048|21112009|P3|NOT COMPLETED|Extension Year 1||0
8563701|NCT00048048|21112010|P2|NOT COMPLETED|Extension Year 1||0
8563702|NCT00048048|21112011|P1|NOT COMPLETED|Extension Year 1||0
8563703|NCT00048048|21112000|P12|COMPLETED|Extension Year 1||15
8563704|NCT00048048|21112001|P11|COMPLETED|Extension Year 1||14
8563705|NCT00048048|21112002|P10|COMPLETED|Extension Year 1||14
8563706|NCT00048048|21112003|P9|COMPLETED|Extension Year 1||0
8563707|NCT00048048|21112004|P8|COMPLETED|Extension Year 1||0
8563708|NCT00048048|21112005|P7|COMPLETED|Extension Year 1||0
8563709|NCT00048048|21112006|P6|COMPLETED|Extension Year 1||0
8563710|NCT00048048|21112007|P5|COMPLETED|Extension Year 1||0
8563711|NCT00048048|21112008|P4|COMPLETED|Extension Year 1||0
8563712|NCT00048048|21112009|P3|COMPLETED|Extension Year 1||0
8563713|NCT00048048|21112010|P2|COMPLETED|Extension Year 1||0
8563714|NCT00048048|21112011|P1|COMPLETED|Extension Year 1||0
8563715|NCT00048048|21112000|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
8563716|NCT00048048|21112001|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
8563717|NCT00048048|21112002|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
8563718|NCT00048048|21112003|P9|STARTED|Extension Year 1||0
8563719|NCT00048048|21112004|P8|STARTED|Extension Year 1||0
8563720|NCT00048048|21112005|P7|STARTED|Extension Year 1||0
8563721|NCT00048048|21112006|P6|STARTED|Extension Year 1||0
8563722|NCT00048048|21112007|P5|STARTED|Extension Year 1||0
8563723|NCT00048048|21112008|P4|STARTED|Extension Year 1||0
8563724|NCT00048048|21112009|P3|STARTED|Extension Year 1||0
8563725|NCT00048048|21112010|P2|STARTED|Extension Year 1||0
8563726|NCT00048048|21112011|P1|STARTED|Extension Year 1||0
8563727|NCT00048048|21112000|P12|NOT COMPLETED|Core Treatment||0
8563728|NCT00048048|21112001|P11|NOT COMPLETED|Core Treatment||0
8563729|NCT00048048|21112002|P10|NOT COMPLETED|Core Treatment||0
8563730|NCT00048048|21112003|P9|NOT COMPLETED|Core Treatment||0
8563731|NCT00048048|21112004|P8|NOT COMPLETED|Core Treatment||1
8563732|NCT00048048|21112005|P7|NOT COMPLETED|Core Treatment||0
8563733|NCT00048048|21112006|P6|NOT COMPLETED|Core Treatment||0
8563734|NCT00048048|21112007|P5|NOT COMPLETED|Core Treatment||0
8563735|NCT00048048|21112008|P4|NOT COMPLETED|Core Treatment||0
8563736|NCT00048048|21112009|P3|NOT COMPLETED|Core Treatment||1
8563737|NCT00048048|21112010|P2|NOT COMPLETED|Core Treatment||0
8563738|NCT00048048|21112011|P1|NOT COMPLETED|Core Treatment||0
8563739|NCT00048048|21112000|P12|COMPLETED|Core Treatment||0
8563740|NCT00048048|21112001|P11|COMPLETED|Core Treatment||0
8563741|NCT00048048|21112002|P10|COMPLETED|Core Treatment||0
8563742|NCT00048048|21112003|P9|COMPLETED|Core Treatment||10
8563743|NCT00048048|21112004|P8|COMPLETED|Core Treatment||5
8563744|NCT00048048|21112005|P7|COMPLETED|Core Treatment||6
8563745|NCT00048048|21112006|P6|COMPLETED|Core Treatment||9
8563746|NCT00048048|21112007|P5|COMPLETED|Core Treatment||6
8563747|NCT00048048|21112008|P4|COMPLETED|Core Treatment||6
8563748|NCT00048048|21112009|P3|COMPLETED|Core Treatment||9
8563749|NCT00048048|21112010|P2|COMPLETED|Core Treatment||6
8563750|NCT00048048|21112011|P1|COMPLETED|Core Treatment||6
8563751|NCT00048048|21112000|P12|STARTED|Core Treatment||0
8563752|NCT00048048|21112001|P11|STARTED|Core Treatment||0
8563753|NCT00048048|21112002|P10|STARTED|Core Treatment||0
8563754|NCT00048048|21112003|P9|STARTED|Core Treatment||10
8563755|NCT00048048|21112004|P8|STARTED|Core Treatment||6
8563756|NCT00048048|21112005|P7|STARTED|Core Treatment||6
8563757|NCT00048048|21112006|P6|STARTED|Core Treatment||9
8563758|NCT00048048|21112007|P5|STARTED|Core Treatment||6
8563759|NCT00048048|21112008|P4|STARTED|Core Treatment||6
8563760|NCT00048048|21112009|P3|STARTED|Core Treatment||10
8563761|NCT00048048|21112010|P2|STARTED|Core Treatment||6
8563762|NCT00048048|21112011|P1|STARTED|Core Treatment||6
8563763|NCT00048035|21112067|P8|NOT COMPLETED|Extension Year 2||3
8563764|NCT00048035|21112068|P7|NOT COMPLETED|Extension Year 2||3
8563765|NCT00048035|21112069|P6|NOT COMPLETED|Extension Year 2||0
8563766|NCT00048035|21112070|P5|NOT COMPLETED|Extension Year 2||0
8563767|NCT00048035|21112071|P4|NOT COMPLETED|Extension Year 2||0
8563768|NCT00048035|21112072|P3|NOT COMPLETED|Extension Year 2||0
8563769|NCT00048035|21112073|P2|NOT COMPLETED|Extension Year 2||0
8563770|NCT00048035|21112074|P1|NOT COMPLETED|Extension Year 2||0
8563771|NCT00048035|21112067|P8|COMPLETED|Extension Year 2||10
8563772|NCT00048035|21112068|P7|COMPLETED|Extension Year 2||11
8563773|NCT00048035|21112069|P6|COMPLETED|Extension Year 2||0
8563774|NCT00048035|21112070|P5|COMPLETED|Extension Year 2||0
8563775|NCT00048035|21112071|P4|COMPLETED|Extension Year 2||0
8563776|NCT00048035|21112072|P3|COMPLETED|Extension Year 2||0
8563777|NCT00048035|21112073|P2|COMPLETED|Extension Year 2||0
8563778|NCT00048035|21112074|P1|COMPLETED|Extension Year 2||0
8563779|NCT00048035|21112067|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
8563780|NCT00048035|21112068|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8563781|NCT00048035|21112069|P6|STARTED|Extension Year 2||0
8563782|NCT00048035|21112070|P5|STARTED|Extension Year 2||0
8563783|NCT00048035|21112071|P4|STARTED|Extension Year 2||0
8563784|NCT00048035|21112072|P3|STARTED|Extension Year 2||0
8563785|NCT00048035|21112073|P2|STARTED|Extension Year 2||0
8563786|NCT00048035|21112074|P1|STARTED|Extension Year 2||0
8563787|NCT00048035|21112067|P8|NOT COMPLETED|Extension Year 1||11
8563788|NCT00048035|21112068|P7|NOT COMPLETED|Extension Year 1||11
8563789|NCT00048035|21112069|P6|NOT COMPLETED|Extension Year 1||0
8563790|NCT00048035|21112070|P5|NOT COMPLETED|Extension Year 1||0
8563791|NCT00048035|21112071|P4|NOT COMPLETED|Extension Year 1||0
8563792|NCT00048035|21112072|P3|NOT COMPLETED|Extension Year 1||0
8563793|NCT00048035|21112073|P2|NOT COMPLETED|Extension Year 1||0
8563794|NCT00048035|21112074|P1|NOT COMPLETED|Extension Year 1||0
8563795|NCT00048035|21112067|P8|COMPLETED|Extension Year 1||15
8563796|NCT00048035|21112068|P7|COMPLETED|Extension Year 1||16
8563797|NCT00048035|21112069|P6|COMPLETED|Extension Year 1||0
8563798|NCT00048035|21112070|P5|COMPLETED|Extension Year 1||0
8563799|NCT00048035|21112071|P4|COMPLETED|Extension Year 1||0
8563800|NCT00048035|21112072|P3|COMPLETED|Extension Year 1||0
8563801|NCT00048035|21112073|P2|COMPLETED|Extension Year 1||0
8563802|NCT00048035|21112074|P1|COMPLETED|Extension Year 1||0
8563803|NCT00048035|21112067|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
8563804|NCT00048035|21112068|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
8563805|NCT00048035|21112069|P6|STARTED|Extension Year 1||0
8563806|NCT00048035|21112070|P5|STARTED|Extension Year 1||0
8563807|NCT00048035|21112071|P4|STARTED|Extension Year 1||0
8563808|NCT00048035|21112072|P3|STARTED|Extension Year 1||0
8563809|NCT00048035|21112073|P2|STARTED|Extension Year 1||0
8563810|NCT00048035|21112074|P1|STARTED|Extension Year 1||0
8563811|NCT00048035|21112067|P8|NOT COMPLETED|Core Period||0
8563812|NCT00048035|21112068|P7|NOT COMPLETED|Core Period||0
8563813|NCT00048035|21112069|P6|NOT COMPLETED|Core Period||1
8563814|NCT00048035|21112070|P5|NOT COMPLETED|Core Period||1
8563815|NCT00048035|21112071|P4|NOT COMPLETED|Core Period||1
8563816|NCT00048035|21112072|P3|NOT COMPLETED|Core Period||1
8563817|NCT00048035|21112073|P2|NOT COMPLETED|Core Period||2
8563818|NCT00048035|21112074|P1|NOT COMPLETED|Core Period||4
8563819|NCT00048035|21112067|P8|COMPLETED|Core Period||0
8563820|NCT00048035|21112068|P7|COMPLETED|Core Period||0
8563821|NCT00048035|21112069|P6|COMPLETED|Core Period||14
8563822|NCT00048035|21112070|P5|COMPLETED|Core Period||15
8563823|NCT00048035|21112071|P4|COMPLETED|Core Period||14
8563824|NCT00048035|21112072|P3|COMPLETED|Core Period||14
8563825|NCT00048035|21112073|P2|COMPLETED|Core Period||13
8563826|NCT00048035|21112074|P1|COMPLETED|Core Period||11
8563827|NCT00048035|21112067|P8|STARTED|Core Period||0
8563828|NCT00048035|21112068|P7|STARTED|Core Period||0
8563829|NCT00048035|21112069|P6|STARTED|Core Period||15
8563830|NCT00048035|21112070|P5|STARTED|Core Period||16
8563831|NCT00048035|21112071|P4|STARTED|Core Period||15
8563832|NCT00048035|21112072|P3|STARTED|Core Period||15
8563833|NCT00048035|21112073|P2|STARTED|Core Period||15
8563834|NCT00048035|21112074|P1|STARTED|Core Period||15
8563835|NCT00047879|21112112|P2|NOT COMPLETED|Overall Study||3
8563836|NCT00047879|21112113|P1|NOT COMPLETED|Overall Study||4
8563837|NCT00047879|21112112|P2|COMPLETED|Overall Study||0
8563838|NCT00047879|21112113|P1|COMPLETED|Overall Study||0
8563839|NCT00047879|21112112|P2|STARTED|Overall Study||3
8563840|NCT00047879|21112113|P1|STARTED|Overall Study||4
8563841|NCT00047697|21112125|P2|NOT COMPLETED|Overall Study||2
8563842|NCT00047697|21112126|P1|NOT COMPLETED|Overall Study||0
8563843|NCT00047697|21112125|P2|COMPLETED|Overall Study||14
8563844|NCT00047697|21112126|P1|COMPLETED|Overall Study||18
8563845|NCT00047697|21112125|P2|STARTED|Overall Study||16
8563846|NCT00047697|21112126|P1|STARTED|Overall Study||18
8563847|NCT00047619|21112138|P2|NOT COMPLETED|Overall Study||0
8563848|NCT00047619|21112139|P1|NOT COMPLETED|Overall Study||0
8563849|NCT00047619|21112138|P2|COMPLETED|Overall Study||14
8563850|NCT00047619|21112139|P1|COMPLETED|Overall Study||14
8563851|NCT00047619|21112138|P2|STARTED|Overall Study||14
8563852|NCT00047619|21112139|P1|STARTED|Overall Study||14
8563853|NCT00047463|21112149|P2|NOT COMPLETED|Overall Study||3
8563854|NCT00047463|21112150|P1|NOT COMPLETED|Overall Study||0
8563855|NCT00047463|21112149|P2|COMPLETED|Overall Study||19
8563856|NCT00047463|21112150|P1|COMPLETED|Overall Study||13
8563857|NCT00047463|21112149|P2|STARTED|Overall Study||22
8563858|NCT00047463|21112150|P1|STARTED|Overall Study||13
8563859|NCT00046475|21112161|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8563860|NCT00046475|21112162|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
8563861|NCT00046475|21112163|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8563862|NCT00046475|21112161|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
8563863|NCT00046475|21112162|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
8563864|NCT00046475|21112163|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8563865|NCT00046475|21112161|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
8563866|NCT00046475|21112162|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
8563867|NCT00046475|21112163|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
8563868|NCT00046475|21112161|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
8563869|NCT00046475|21112162|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8563870|NCT00046475|21112163|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8563871|NCT00046475|21112161|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
8563872|NCT00046475|21112162|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
8563873|NCT00046475|21112163|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8563874|NCT00046475|21112161|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
8563875|NCT00046475|21112162|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
8563876|NCT00046475|21112163|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
8563877|NCT00046475|21112161|P3|NOT COMPLETED|Titration (1 Week)||0
8563878|NCT00046475|21112162|P2|NOT COMPLETED|Titration (1 Week)||0
8563879|NCT00046475|21112163|P1|NOT COMPLETED|Titration (1 Week)||0
8563880|NCT00046475|21112161|P3|COMPLETED|Titration (1 Week)||0
8563881|NCT00046475|21112162|P2|COMPLETED|Titration (1 Week)||0
8563882|NCT00046475|21112163|P1|COMPLETED|Titration (1 Week)||136
8563883|NCT00046475|21112161|P3|STARTED|Titration (1 Week)||0
8563884|NCT00046475|21112162|P2|STARTED|Titration (1 Week)||0
8563885|NCT00046475|21112163|P1|STARTED|Titration (1 Week)||136
8563886|NCT00046475|21112161|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563887|NCT00046475|21112162|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563888|NCT00046475|21112163|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
8563889|NCT00046475|21112161|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563890|NCT00046475|21112162|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563891|NCT00046475|21112163|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
8563892|NCT00046475|21112161|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8563893|NCT00046475|21112162|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8563894|NCT00046475|21112163|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
8563895|NCT00046566|21112202|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563896|NCT00046566|21112203|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563897|NCT00046566|21112204|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563898|NCT00046566|21112202|P3|COMPLETED|Intervention 3 (8 Weeks)||88
8563899|NCT00046566|21112203|P2|COMPLETED|Intervention 3 (8 Weeks)||92
8563900|NCT00046566|21112204|P1|COMPLETED|Intervention 3 (8 Weeks)||93
8563901|NCT00046566|21112202|P3|STARTED|Intervention 3 (8 Weeks)||88
8563902|NCT00046566|21112203|P2|STARTED|Intervention 3 (8 Weeks)||92
8563903|NCT00046566|21112204|P1|STARTED|Intervention 3 (8 Weeks)||93
8563904|NCT00046566|21112202|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
8563905|NCT00046566|21112203|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
8563906|NCT00046566|21112204|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
8563907|NCT00046566|21112202|P3|COMPLETED|Intervention 2 (8 Weeks)||88
8563908|NCT00046566|21112203|P2|COMPLETED|Intervention 2 (8 Weeks)||92
8563909|NCT00046566|21112204|P1|COMPLETED|Intervention 2 (8 Weeks)||93
8563910|NCT00046566|21112202|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
8563911|NCT00046566|21112203|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
8563912|NCT00046566|21112204|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
8563913|NCT00046566|21112202|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
8563914|NCT00046566|21112203|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
8563915|NCT00046566|21112204|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
8563916|NCT00046566|21112202|P3|COMPLETED|Intervention 1 (8 Weeks)||101
8563917|NCT00046566|21112203|P2|COMPLETED|Intervention 1 (8 Weeks)||104
8563918|NCT00046566|21112204|P1|COMPLETED|Intervention 1 (8 Weeks)||101
8563919|NCT00046566|21112202|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
8563920|NCT00046566|21112203|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
8563921|NCT00046566|21112204|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
8563922|NCT00046228|21112221|P3|NOT COMPLETED|1 Year||12
8563923|NCT00046228|21112222|P2|NOT COMPLETED|1 Year||14
8563924|NCT00046228|21112223|P1|NOT COMPLETED|1 Year||19
8563925|NCT00046228|21112221|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
8563926|NCT00046228|21112222|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
8563927|NCT00046228|21112223|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
8563928|NCT00046228|21112221|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
8563929|NCT00046228|21112222|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
8563930|NCT00046228|21112223|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
8563931|NCT00046228|21112221|P3|NOT COMPLETED|90 Days||15
8563932|NCT00046228|21112222|P2|NOT COMPLETED|90 Days||8
8563933|NCT00046228|21112223|P1|NOT COMPLETED|90 Days||13
8563934|NCT00046228|21112221|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
8563935|NCT00046228|21112222|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
8563936|NCT00046228|21112223|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
8563937|NCT00046228|21112221|P3|STARTED|90 Days||828
8563938|NCT00046228|21112222|P2|STARTED|90 Days||818
8563939|NCT00046228|21112223|P1|STARTED|90 Days||806
8563940|NCT00045942|21112267|P9|NOT COMPLETED|PKC412A2104E2||6
8563941|NCT00045942|21112268|P8|NOT COMPLETED|PKC412A2104E2||7
8563942|NCT00045942|21112269|P7|NOT COMPLETED|PKC412A2104E2||7
8563943|NCT00045942|21112270|P6|NOT COMPLETED|PKC412A2104E2||9
8563944|NCT00045942|21112271|P5|NOT COMPLETED|PKC412A2104E2||0
8563945|NCT00045942|21112272|P4|NOT COMPLETED|PKC412A2104E2||0
8563946|NCT00045942|21112273|P3|NOT COMPLETED|PKC412A2104E2||0
8563947|NCT00045942|21112274|P2|NOT COMPLETED|PKC412A2104E2||0
8563948|NCT00045942|21112275|P1|NOT COMPLETED|PKC412A2104E2||0
8563949|NCT00045942|21112267|P9|COMPLETED|PKC412A2104E2||0
8563950|NCT00045942|21112268|P8|COMPLETED|PKC412A2104E2||0
8563951|NCT00045942|21112269|P7|COMPLETED|PKC412A2104E2||0
8563952|NCT00045942|21112270|P6|COMPLETED|PKC412A2104E2||0
8563953|NCT00045942|21112271|P5|COMPLETED|PKC412A2104E2||0
8563954|NCT00045942|21112272|P4|COMPLETED|PKC412A2104E2||0
8563955|NCT00045942|21112273|P3|COMPLETED|PKC412A2104E2||0
8563956|NCT00045942|21112274|P2|COMPLETED|PKC412A2104E2||0
8563957|NCT00045942|21112275|P1|COMPLETED|PKC412A2104E2||0
8563958|NCT00045942|21112267|P9|Primary Efficacy|PKC412A2104E2||6
8563959|NCT00045942|21112268|P8|Primary Efficacy|PKC412A2104E2||7
8563960|NCT00045942|21112269|P7|Primary Efficacy|PKC412A2104E2||7
8563961|NCT00045942|21112270|P6|Primary Efficacy|PKC412A2104E2||9
8563962|NCT00045942|21112271|P5|Primary Efficacy|PKC412A2104E2||0
8563963|NCT00045942|21112272|P4|Primary Efficacy|PKC412A2104E2||0
8563964|NCT00045942|21112273|P3|Primary Efficacy|PKC412A2104E2||0
8563965|NCT00045942|21112274|P2|Primary Efficacy|PKC412A2104E2||0
8563966|NCT00045942|21112275|P1|Primary Efficacy|PKC412A2104E2||0
8563967|NCT00045942|21112267|P9|STARTED|PKC412A2104E2||6
8563968|NCT00045942|21112268|P8|STARTED|PKC412A2104E2||7
8563969|NCT00045942|21112269|P7|STARTED|PKC412A2104E2||7
8563970|NCT00045942|21112270|P6|STARTED|PKC412A2104E2||9
8563971|NCT00045942|21112271|P5|STARTED|PKC412A2104E2||0
8563972|NCT00045942|21112272|P4|STARTED|PKC412A2104E2||0
8563973|NCT00045942|21112273|P3|STARTED|PKC412A2104E2||0
8563974|NCT00045942|21112274|P2|STARTED|PKC412A2104E2||0
8563975|NCT00045942|21112275|P1|STARTED|PKC412A2104E2||0
8563976|NCT00045942|21112267|P9|NOT COMPLETED|PKC412A2104E1||0
8563977|NCT00045942|21112268|P8|NOT COMPLETED|PKC412A2104E1||0
8563978|NCT00045942|21112269|P7|NOT COMPLETED|PKC412A2104E1||0
8563979|NCT00045942|21112270|P6|NOT COMPLETED|PKC412A2104E1||0
8563980|NCT00045942|21112271|P5|NOT COMPLETED|PKC412A2104E1||27
8563981|NCT00045942|21112272|P4|NOT COMPLETED|PKC412A2104E1||33
8563982|NCT00045942|21112273|P3|NOT COMPLETED|PKC412A2104E1||17
8563983|NCT00045942|21112274|P2|NOT COMPLETED|PKC412A2104E1||18
8563984|NCT00045942|21112275|P1|NOT COMPLETED|PKC412A2104E1||0
8563985|NCT00045942|21112267|P9|COMPLETED|PKC412A2104E1||0
8563986|NCT00045942|21112268|P8|COMPLETED|PKC412A2104E1||0
8563987|NCT00045942|21112269|P7|COMPLETED|PKC412A2104E1||0
8563988|NCT00045942|21112270|P6|COMPLETED|PKC412A2104E1||0
8563989|NCT00045942|21112271|P5|COMPLETED|PKC412A2104E1||0
8563990|NCT00045942|21112272|P4|COMPLETED|PKC412A2104E1||0
8563991|NCT00045942|21112273|P3|COMPLETED|PKC412A2104E1||0
8563992|NCT00045942|21112274|P2|COMPLETED|PKC412A2104E1||0
8563993|NCT00045942|21112275|P1|COMPLETED|PKC412A2104E1||0
8563994|NCT00045942|21112267|P9|Primary Efficacy|PKC412A2104E1||0
8563995|NCT00045942|21112268|P8|Primary Efficacy|PKC412A2104E1||0
8563996|NCT00045942|21112269|P7|Primary Efficacy|PKC412A2104E1||0
8563997|NCT00045942|21112270|P6|Primary Efficacy|PKC412A2104E1||0
8563998|NCT00045942|21112271|P5|Primary Efficacy|PKC412A2104E1||25
8563999|NCT00045942|21112272|P4|Primary Efficacy|PKC412A2104E1||32
8564000|NCT00045942|21112273|P3|Primary Efficacy|PKC412A2104E1||17
8564001|NCT00045942|21112274|P2|Primary Efficacy|PKC412A2104E1||18
8564002|NCT00045942|21112275|P1|Primary Efficacy|PKC412A2104E1||0
8564003|NCT00045942|21112267|P9|STARTED|PKC412A2104E1||0
8564004|NCT00045942|21112268|P8|STARTED|PKC412A2104E1||0
8564005|NCT00045942|21112269|P7|STARTED|PKC412A2104E1||0
8564006|NCT00045942|21112270|P6|STARTED|PKC412A2104E1||0
8564007|NCT00045942|21112271|P5|STARTED|PKC412A2104E1||27
8564008|NCT00045942|21112272|P4|STARTED|PKC412A2104E1||33
8564009|NCT00045942|21112273|P3|STARTED|PKC412A2104E1||17
8564010|NCT00045942|21112274|P2|STARTED|PKC412A2104E1||18
8564011|NCT00045942|21112275|P1|STARTED|PKC412A2104E1||0
8564012|NCT00045942|21112267|P9|NOT COMPLETED|PKC412A2104 (Core)||0
8564013|NCT00045942|21112268|P8|NOT COMPLETED|PKC412A2104 (Core)||0
8564014|NCT00045942|21112269|P7|NOT COMPLETED|PKC412A2104 (Core)||0
8564015|NCT00045942|21112270|P6|NOT COMPLETED|PKC412A2104 (Core)||0
8564016|NCT00045942|21112271|P5|NOT COMPLETED|PKC412A2104 (Core)||0
8564017|NCT00045942|21112272|P4|NOT COMPLETED|PKC412A2104 (Core)||0
8564018|NCT00045942|21112273|P3|NOT COMPLETED|PKC412A2104 (Core)||0
8564019|NCT00045942|21112274|P2|NOT COMPLETED|PKC412A2104 (Core)||0
8564020|NCT00045942|21112275|P1|NOT COMPLETED|PKC412A2104 (Core)||20
8564021|NCT00045942|21112267|P9|COMPLETED|PKC412A2104 (Core)||0
8564022|NCT00045942|21112268|P8|COMPLETED|PKC412A2104 (Core)||0
8564023|NCT00045942|21112269|P7|COMPLETED|PKC412A2104 (Core)||0
8564024|NCT00045942|21112270|P6|COMPLETED|PKC412A2104 (Core)||0
8564025|NCT00045942|21112271|P5|COMPLETED|PKC412A2104 (Core)||0
8564026|NCT00045942|21112272|P4|COMPLETED|PKC412A2104 (Core)||0
8564027|NCT00045942|21112273|P3|COMPLETED|PKC412A2104 (Core)||0
8564028|NCT00045942|21112274|P2|COMPLETED|PKC412A2104 (Core)||0
8564029|NCT00045942|21112275|P1|COMPLETED|PKC412A2104 (Core)||0
8564030|NCT00045942|21112267|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
8564031|NCT00045942|21112268|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
8564032|NCT00045942|21112269|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
8564033|NCT00045942|21112270|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
8564034|NCT00045942|21112271|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
8564035|NCT00045942|21112272|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
8564036|NCT00045942|21112273|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
8564037|NCT00045942|21112274|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
8564038|NCT00045942|21112275|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
8564039|NCT00045942|21112267|P9|STARTED|PKC412A2104 (Core)||0
8564040|NCT00045942|21112268|P8|STARTED|PKC412A2104 (Core)||0
8564041|NCT00045942|21112269|P7|STARTED|PKC412A2104 (Core)||0
8564042|NCT00045942|21112270|P6|STARTED|PKC412A2104 (Core)||0
8564043|NCT00045942|21112271|P5|STARTED|PKC412A2104 (Core)||0
8564044|NCT00045942|21112272|P4|STARTED|PKC412A2104 (Core)||0
8564045|NCT00045942|21112273|P3|STARTED|PKC412A2104 (Core)||0
8564046|NCT00045942|21112274|P2|STARTED|PKC412A2104 (Core)||0
8564047|NCT00045942|21112275|P1|STARTED|PKC412A2104 (Core)||20
8564048|NCT00044655|21112357|P2|NOT COMPLETED|Overall Study||38
8564049|NCT00044655|21112358|P1|NOT COMPLETED|Overall Study||20
8564050|NCT00044655|21112357|P2|COMPLETED|Overall Study||79
8564051|NCT00044655|21112358|P1|COMPLETED|Overall Study||82
8564052|NCT00044655|21112357|P2|STARTED|Overall Study||117
8564053|NCT00044655|21112358|P1|STARTED|Overall Study||102
8564054|NCT00044512|21112364|P1|NOT COMPLETED|Follow Up||2
8564055|NCT00044512|21112364|P1|COMPLETED|Follow Up||135
8564056|NCT00044512|21112364|P1|STARTED|Follow Up||137
8564057|NCT00044512|21112364|P1|NOT COMPLETED|Treatment||0
8564058|NCT00044512|21112364|P1|COMPLETED|Treatment||137
8564059|NCT00044512|21112364|P1|STARTED|Treatment||137
8564060|NCT00044213|21112379|P4|NOT COMPLETED|Overall Study||136
8564061|NCT00044213|21112380|P3|NOT COMPLETED|Overall Study||138
8564062|NCT00044213|21112381|P2|NOT COMPLETED|Overall Study||112
8564063|NCT00044213|21112382|P1|NOT COMPLETED|Overall Study||100
8564064|NCT00044213|21112379|P4|COMPLETED|Overall Study||301
8564065|NCT00044213|21112380|P3|COMPLETED|Overall Study||294
8564066|NCT00044213|21112381|P2|COMPLETED|Overall Study||306
8564067|NCT00044213|21112382|P1|COMPLETED|Overall Study||321
8564068|NCT00044213|21112379|P4|STARTED|Overall Study||437
8564069|NCT00044213|21112380|P3|STARTED|Overall Study||432
8564070|NCT00044213|21112381|P2|STARTED|Overall Study||418
8564071|NCT00044213|21112382|P1|STARTED|Overall Study||421
8564072|NCT00044044|21112401|P5|NOT COMPLETED|Overall Study||36
8564073|NCT00044044|21112402|P4|NOT COMPLETED|Overall Study||44
8564074|NCT00044044|21112403|P3|NOT COMPLETED|Overall Study||40
8564075|NCT00044044|21112404|P2|NOT COMPLETED|Overall Study||41
8564076|NCT00044044|21112405|P1|NOT COMPLETED|Overall Study||44
8564077|NCT00044044|21112401|P5|COMPLETED|Overall Study||36
8564078|NCT00044044|21112402|P4|COMPLETED|Overall Study||29
8564079|NCT00044044|21112403|P3|COMPLETED|Overall Study||31
8564080|NCT00044044|21112404|P2|COMPLETED|Overall Study||28
8564081|NCT00044044|21112405|P1|COMPLETED|Overall Study||27
8564082|NCT00044044|21112401|P5|STARTED|Overall Study||72
8564083|NCT00044044|21112402|P4|STARTED|Overall Study||73
8564084|NCT00044044|21112403|P3|STARTED|Overall Study||71
8564085|NCT00044044|21112404|P2|STARTED|Overall Study||69
8564086|NCT00044044|21112405|P1|STARTED|Overall Study||71
8564087|NCT00044005|21112435|P3|NOT COMPLETED|Overall Study||22
8564088|NCT00044005|21112436|P2|NOT COMPLETED|Overall Study||14
8564089|NCT00044005|21112437|P1|NOT COMPLETED|Overall Study||19
8564090|NCT00044005|21112435|P3|COMPLETED|Overall Study||11
8564091|NCT00044005|21112436|P2|COMPLETED|Overall Study||19
8564092|NCT00044005|21112437|P1|COMPLETED|Overall Study||13
8564093|NCT00044005|21112435|P3|STARTED|Overall Study||33
8564094|NCT00044005|21112436|P2|STARTED|Overall Study||33
8564095|NCT00044005|21112437|P1|STARTED|Overall Study||32
8564096|NCT00044083|21112447|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
8564097|NCT00044083|21112448|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
8564098|NCT00044083|21112447|P2|COMPLETED|Second Intervention (One Week) Patients||29
8564099|NCT00044083|21112448|P1|COMPLETED|Second Intervention (One Week) Patients||30
8564100|NCT00044083|21112447|P2|STARTED|Second Intervention (One Week) Patients||30
8564101|NCT00044083|21112448|P1|STARTED|Second Intervention (One Week) Patients||30
8564102|NCT00044083|21112447|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
8564103|NCT00044083|21112448|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
8564104|NCT00044083|21112447|P2|COMPLETED|First Intervention (One Week) Patients||30
8564105|NCT00044083|21112448|P1|COMPLETED|First Intervention (One Week) Patients||30
8564106|NCT00044083|21112447|P2|STARTED|First Intervention (One Week) Patients||32
8564107|NCT00044083|21112448|P1|STARTED|First Intervention (One Week) Patients||31
8564108|NCT00044083|21112447|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
8564109|NCT00044083|21112448|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
8564110|NCT00044083|21112447|P2|COMPLETED|Second Intervention (One Week) HV's||66
8564111|NCT00044083|21112448|P1|COMPLETED|Second Intervention (One Week) HV's||64
8564112|NCT00044083|21112447|P2|STARTED|Second Intervention (One Week) HV's||66
8564113|NCT00044083|21112448|P1|STARTED|Second Intervention (One Week) HV's||64
8564114|NCT00044083|21112447|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
8564115|NCT00044083|21112448|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
8564116|NCT00044083|21112447|P2|COMPLETED|First Intervention (One Week)- HV's||66
8564117|NCT00044083|21112448|P1|COMPLETED|First Intervention (One Week)- HV's||64
8564118|NCT00044083|21112447|P2|STARTED|First Intervention (One Week)- HV's||73
8564119|NCT00044083|21112448|P1|STARTED|First Intervention (One Week)- HV's||74
8564120|NCT00043979|21112486|P3|NOT COMPLETED|Period 2||0
8564121|NCT00043979|21112487|P2|NOT COMPLETED|Period 2||0
8564122|NCT00043979|21112488|P1|NOT COMPLETED|Period 2||0
8564123|NCT00043979|21112486|P3|COMPLETED|Period 2||10
8564124|NCT00043979|21112487|P2|COMPLETED|Period 2||13
8564125|NCT00043979|21112488|P1|COMPLETED|Period 2||0
8564126|NCT00043979|21112486|P3|STARTED|Period 2||10
8564127|NCT00043979|21112487|P2|STARTED|Period 2||13
8564128|NCT00043979|21112488|P1|STARTED|Period 2||0
8564129|NCT00043979|21112486|P3|NOT COMPLETED|Period 1||3
8564130|NCT00043979|21112487|P2|NOT COMPLETED|Period 1||4
8564131|NCT00043979|21112488|P1|NOT COMPLETED|Period 1||7
8564132|NCT00043979|21112486|P3|COMPLETED|Period 1||10
8564133|NCT00043979|21112487|P2|COMPLETED|Period 1||13
8564134|NCT00043979|21112488|P1|COMPLETED|Period 1||23
8564135|NCT00043979|21112486|P3|STARTED|Period 1||13
8564136|NCT00043979|21112487|P2|STARTED|Period 1||17
8564137|NCT00043979|21112488|P1|STARTED|Period 1||30
8564138|NCT00043550|21112509|P3|NOT COMPLETED|Overall Study||20
8564139|NCT00043550|21112510|P2|NOT COMPLETED|Overall Study||12
8564140|NCT00043550|21112511|P1|NOT COMPLETED|Overall Study||22
8564141|NCT00043550|21112509|P3|COMPLETED|Overall Study||30
8564142|NCT00043550|21112510|P2|COMPLETED|Overall Study||39
8564143|NCT00043550|21112511|P1|COMPLETED|Overall Study||33
8564144|NCT00043550|21112509|P3|Week 8 Completed|Overall Study||35
8564145|NCT00043550|21112510|P2|Week 8 Completed|Overall Study||40
8564146|NCT00043550|21112511|P1|Week 8 Completed|Overall Study||35
8564147|NCT00043550|21112509|P3|STARTED|Overall Study||50
8564148|NCT00043550|21112510|P2|STARTED|Overall Study||51
8564149|NCT00043550|21112511|P1|STARTED|Overall Study||55
8564150|NCT00043186|21112528|P9|NOT COMPLETED|Overall Study||17
8564151|NCT00043186|21112529|P8|NOT COMPLETED|Overall Study||16
8564152|NCT00043186|21112530|P7|NOT COMPLETED|Overall Study||17
8564153|NCT00043186|21112531|P6|NOT COMPLETED|Overall Study||8
8564154|NCT00043186|21112532|P5|NOT COMPLETED|Overall Study||18
8564155|NCT00043186|21112533|P4|NOT COMPLETED|Overall Study||22
8564156|NCT00043186|21112534|P3|NOT COMPLETED|Overall Study||20
8564157|NCT00043186|21112535|P2|NOT COMPLETED|Overall Study||15
8564158|NCT00043186|21112536|P1|NOT COMPLETED|Overall Study||17
8564159|NCT00043186|21112528|P9|COMPLETED|Overall Study||30
8564160|NCT00043186|21112529|P8|COMPLETED|Overall Study||31
8564161|NCT00043186|21112530|P7|COMPLETED|Overall Study||25
8564162|NCT00043186|21112531|P6|COMPLETED|Overall Study||39
8564163|NCT00043186|21112532|P5|COMPLETED|Overall Study||36
8564164|NCT00043186|21112533|P4|COMPLETED|Overall Study||19
8564165|NCT00043186|21112534|P3|COMPLETED|Overall Study||24
8564166|NCT00043186|21112535|P2|COMPLETED|Overall Study||29
8564167|NCT00043186|21112536|P1|COMPLETED|Overall Study||29
8564168|NCT00043186|21112528|P9|STARTED|Overall Study||47
8564169|NCT00043186|21112529|P8|STARTED|Overall Study||47
8564170|NCT00043186|21112530|P7|STARTED|Overall Study||42
8564171|NCT00043186|21112531|P6|STARTED|Overall Study||47
8564172|NCT00043186|21112532|P5|STARTED|Overall Study||54
8564173|NCT00043186|21112533|P4|STARTED|Overall Study||41
8564174|NCT00043186|21112534|P3|STARTED|Overall Study||44
8564175|NCT00043186|21112535|P2|STARTED|Overall Study||44
8564176|NCT00043186|21112536|P1|STARTED|Overall Study||46
8564177|NCT00042666|21112862|P1|NOT COMPLETED|Overall Study||54
8564178|NCT00042666|21112862|P1|COMPLETED|Overall Study||1
8564179|NCT00042666|21112862|P1|Completed at Least 1 Cycle of Study Drug|Overall Study||42
8564180|NCT00042666|21112862|P1|Received at Least 1 Dose of Study Drug|Overall Study||55
8564181|NCT00042666|21112862|P1|STARTED|Overall Study||55
8564182|NCT00042432|21112874|P2|NOT COMPLETED|Overall Study||7
8564183|NCT00042432|21112875|P1|NOT COMPLETED|Overall Study||9
8564184|NCT00042432|21112874|P2|COMPLETED|Overall Study||20
8564185|NCT00042432|21112875|P1|COMPLETED|Overall Study||18
8564186|NCT00042432|21112874|P2|STARTED|Overall Study||27
8564187|NCT00042432|21112875|P1|STARTED|Overall Study||27
8564188|NCT00042224|21112885|P2|NOT COMPLETED|Overall Study||3
8564189|NCT00042224|21112886|P1|NOT COMPLETED|Overall Study||3
8564190|NCT00042224|21112885|P2|COMPLETED|Overall Study||16
8564191|NCT00042224|21112886|P1|COMPLETED|Overall Study||17
8564192|NCT00042224|21112885|P2|STARTED|Overall Study||19
8564193|NCT00042224|21112886|P1|STARTED|Overall Study||20
8564194|NCT00041938|21112894|P2|NOT COMPLETED|Overall Study||31
8564195|NCT00041938|21112895|P1|NOT COMPLETED|Overall Study||38
8564196|NCT00041938|21112894|P2|COMPLETED|Overall Study||1111
8564197|NCT00041938|21112895|P1|COMPLETED|Overall Study||1125
8564198|NCT00041938|21112894|P2|Withdrew Consent|Overall Study||14
8564199|NCT00041938|21112895|P1|Withdrew Consent|Overall Study||20
8564200|NCT00041938|21112894|P2|Lost to Follow-up|Overall Study||17
8564201|NCT00041938|21112895|P1|Lost to Follow-up|Overall Study||18
8564202|NCT00041938|21112894|P2|Only Vital Status Known|Overall Study||46
8564203|NCT00041938|21112895|P1|Only Vital Status Known|Overall Study||44
8564204|NCT00041938|21112894|P2|Primary Endpoint|Overall Study||302
8564205|NCT00041938|21112895|P1|Primary Endpoint|Overall Study||320
8564206|NCT00041938|21112894|P2|Completed Follow-up|Overall Study||745
8564207|NCT00041938|21112895|P1|Completed Follow-up|Overall Study||761
8564208|NCT00041938|21112894|P2|STARTED|Overall Study||1142
8564209|NCT00041938|21112895|P1|STARTED|Overall Study||1163
8564210|NCT00041756|21112928|P5|NOT COMPLETED|Overall Study||60
8564211|NCT00041756|21112929|P4|NOT COMPLETED|Overall Study||16
8564212|NCT00041756|21112930|P3|NOT COMPLETED|Overall Study||13
8564213|NCT00041756|21112931|P2|NOT COMPLETED|Overall Study||15
8564214|NCT00041756|21112932|P1|NOT COMPLETED|Overall Study||8
8564215|NCT00041756|21112928|P5|COMPLETED|Overall Study||19
8564216|NCT00041756|21112929|P4|COMPLETED|Overall Study||64
8564217|NCT00041756|21112930|P3|COMPLETED|Overall Study||66
8564218|NCT00041756|21112931|P2|COMPLETED|Overall Study||65
8564219|NCT00041756|21112932|P1|COMPLETED|Overall Study||69
8564220|NCT00041756|21112928|P5|STARTED|Overall Study||79
8564221|NCT00041756|21112929|P4|STARTED|Overall Study||80
8564222|NCT00041756|21112930|P3|STARTED|Overall Study||79
8564223|NCT00041756|21112931|P2|STARTED|Overall Study||80
8564224|NCT00041756|21112932|P1|STARTED|Overall Study||77
8564225|NCT00041717|21112951|P2|NOT COMPLETED|Overall Study||12
8564226|NCT00041717|21112952|P1|NOT COMPLETED|Overall Study||33
8564227|NCT00041717|21112951|P2|COMPLETED|Overall Study||86
8564228|NCT00041717|21112952|P1|COMPLETED|Overall Study||81
8564229|NCT00041717|21112951|P2|STARTED|Overall Study||98
8564230|NCT00041717|21112952|P1|STARTED|Overall Study||114
8564231|NCT00041470|21112960|P1|NOT COMPLETED|Overall Study||38
8564232|NCT00041470|21112960|P1|COMPLETED|Overall Study||0
8564233|NCT00041470|21112960|P1|STARTED|Overall Study||38
8564234|NCT00040664|21112965|P4|NOT COMPLETED|Overall Study||27
8564235|NCT00040664|21112966|P3|NOT COMPLETED|Overall Study||13
8564236|NCT00040664|21112967|P2|NOT COMPLETED|Overall Study||13
8564237|NCT00040664|21112968|P1|NOT COMPLETED|Overall Study||53
8564238|NCT00040664|21112965|P4|COMPLETED|Overall Study||8
8564239|NCT00040664|21112966|P3|COMPLETED|Overall Study||4
8564240|NCT00040664|21112967|P2|COMPLETED|Overall Study||4
8564241|NCT00040664|21112968|P1|COMPLETED|Overall Study||16
8564242|NCT00040664|21112965|P4|STARTED|Overall Study||35
8564243|NCT00040664|21112966|P3|STARTED|Overall Study||17
8564244|NCT00040664|21112967|P2|STARTED|Overall Study||17
8564245|NCT00040664|21112968|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
8564246|NCT00041392|21113018|P2|NOT COMPLETED|Overall Study||0
8564247|NCT00041392|21113019|P1|NOT COMPLETED|Overall Study||0
8564248|NCT00041392|21113018|P2|COMPLETED|Overall Study||191
8564249|NCT00041392|21113019|P1|COMPLETED|Overall Study||198
8564250|NCT00041392|21113018|P2|STARTED|Overall Study||191
8564251|NCT00041392|21113019|P1|STARTED|Overall Study||198
8564252|NCT00040443|21113027|P2|NOT COMPLETED|Overall Study||0
8564253|NCT00040443|21113028|P1|NOT COMPLETED|Overall Study||0
8564254|NCT00040443|21113027|P2|COMPLETED|Overall Study||91
8564255|NCT00040443|21113028|P1|COMPLETED|Overall Study||84
8564256|NCT00040443|21113027|P2|STARTED|Overall Study||91
8564257|NCT00040443|21113028|P1|STARTED|Overall Study||84
8564258|NCT00040365|21113034|P1|NOT COMPLETED|Overall Study||11
8564259|NCT00040365|21113034|P1|COMPLETED|Overall Study||19
8564260|NCT00040365|21113034|P1|Completed Follow Up Phase|Overall Study||19
8564261|NCT00040365|21113034|P1|STARTED|Overall Study||30
8564262|NCT00039871|21113043|P1|NOT COMPLETED|Overall Study||1384
8564263|NCT00039871|21113043|P1|COMPLETED|Overall Study||928
8564264|NCT00039871|21113043|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
8564265|NCT00039741|21113053|P4|NOT COMPLETED|Overall Study||14
8564266|NCT00039741|21113054|P3|NOT COMPLETED|Overall Study||11
8564267|NCT00039741|21113055|P2|NOT COMPLETED|Overall Study||12
8564268|NCT00039741|21113056|P1|NOT COMPLETED|Overall Study||15
8564269|NCT00039741|21113053|P4|COMPLETED|Overall Study||50
8564270|NCT00039741|21113054|P3|COMPLETED|Overall Study||54
8564271|NCT00039741|21113055|P2|COMPLETED|Overall Study||56
8564272|NCT00039741|21113056|P1|COMPLETED|Overall Study||51
8564273|NCT00039741|21113053|P4|Death|Overall Study||0
8564274|NCT00039741|21113054|P3|Death|Overall Study||0
8564275|NCT00039741|21113055|P2|Death|Overall Study||1
8564276|NCT00039741|21113056|P1|Death|Overall Study||0
8564277|NCT00039741|21113053|P4|STARTED|Overall Study||64
8564278|NCT00039741|21113054|P3|STARTED|Overall Study||65
8564279|NCT00039741|21113055|P2|STARTED|Overall Study||68
8564280|NCT00039741|21113056|P1|STARTED|Overall Study||66
8564281|NCT00038948|21113100|P2|NOT COMPLETED|Overall Study||77
8564282|NCT00038948|21113101|P1|NOT COMPLETED|Overall Study||169
8564283|NCT00038948|21113100|P2|COMPLETED|Overall Study||198
8564284|NCT00038948|21113101|P1|COMPLETED|Overall Study||386
8564285|NCT00038948|21113100|P2|STARTED|Overall Study||275
8564286|NCT00038948|21113101|P1|STARTED|Overall Study||555
8564287|NCT00038857|21113113|P1|NOT COMPLETED|Overall Study||1
8564288|NCT00038857|21113113|P1|COMPLETED|Overall Study||28
8564289|NCT00038857|21113113|P1|STARTED|Overall Study||29
8564290|NCT00038727|21113120|P3|NOT COMPLETED|Overall Study||0
8564291|NCT00038727|21113121|P2|NOT COMPLETED|Overall Study||0
8564292|NCT00038727|21113122|P1|NOT COMPLETED|Overall Study||0
8564293|NCT00038727|21113120|P3|COMPLETED|Overall Study||936
8564294|NCT00038727|21113121|P2|COMPLETED|Overall Study||927
8564295|NCT00038727|21113122|P1|COMPLETED|Overall Study||916
8564296|NCT00038727|21113120|P3|DPPOS Phase 3 Enrolled|Overall Study||936
8564297|NCT00038727|21113121|P2|DPPOS Phase 3 Enrolled|Overall Study||927
8564298|NCT00038727|21113122|P1|DPPOS Phase 3 Enrolled|Overall Study||916
8564299|NCT00038727|21113120|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
8564300|NCT00038727|21113121|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
8564301|NCT00038727|21113122|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
8564302|NCT00038727|21113120|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
8564303|NCT00038727|21113121|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
8564304|NCT00038727|21113122|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
8564305|NCT00038727|21113120|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
8564306|NCT00038727|21113121|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
8564307|NCT00038727|21113122|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
8564308|NCT00038727|21113120|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
8564309|NCT00038727|21113121|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
8564310|NCT00038727|21113122|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
8564311|NCT00038649|21113136|P1|NOT COMPLETED|Overall Study||9
8564312|NCT00038649|21113136|P1|COMPLETED|Overall Study||105
8564313|NCT00038649|21113136|P1|STARTED|Overall Study||114
8564314|NCT00038610|21113141|P1|NOT COMPLETED|Overall Study||0
8564315|NCT00038610|21113141|P1|COMPLETED|Overall Study||54
8564316|NCT00038610|21113141|P1|STARTED|Overall Study||54
8564317|NCT00038467|21113149|P2|NOT COMPLETED|Overall Study||542
8564318|NCT00038467|21113150|P1|NOT COMPLETED|Overall Study||542
8564319|NCT00038467|21113149|P2|COMPLETED|Overall Study||1830
8564320|NCT00038467|21113150|P1|COMPLETED|Overall Study||1810
8564321|NCT00038467|21113149|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
8564322|NCT00038467|21113150|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
8564323|NCT00038467|21113149|P2|STARTED|Overall Study||2372
8564324|NCT00038467|21113150|P1|STARTED|Overall Study||2352
8564325|NCT00038142|21113212|P2|NOT COMPLETED|Overall Study||7
8564326|NCT00038142|21113213|P1|NOT COMPLETED|Overall Study||22
8564327|NCT00038142|21113212|P2|COMPLETED|Overall Study||7
8564328|NCT00038142|21113213|P1|COMPLETED|Overall Study||10
8564329|NCT00038142|21113212|P2|STARTED|Overall Study||14
8564330|NCT00038142|21113213|P1|STARTED|Overall Study||32
8564331|NCT00038103|21113221|P2|NOT COMPLETED|Overall Study||56
8564332|NCT00038103|21113222|P1|NOT COMPLETED|Overall Study||55
8564333|NCT00038103|21113221|P2|COMPLETED|Overall Study||0
8564334|NCT00038103|21113222|P1|COMPLETED|Overall Study||0
8564335|NCT00038103|21113221|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
8564336|NCT00038103|21113222|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
8564337|NCT00038103|21113221|P2|STARTED|Overall Study||56
8564338|NCT00038103|21113222|P1|STARTED|Overall Study||55
8564339|NCT00037830|21113245|P3|NOT COMPLETED|Overall Study||1
8564340|NCT00037830|21113246|P2|NOT COMPLETED|Overall Study||7
8564341|NCT00037830|21113247|P1|NOT COMPLETED|Overall Study||10
8564342|NCT00037830|21113245|P3|COMPLETED|Overall Study||16
8564343|NCT00037830|21113246|P2|COMPLETED|Overall Study||31
8564344|NCT00037830|21113247|P1|COMPLETED|Overall Study||29
8564345|NCT00037830|21113245|P3|STARTED|Overall Study||17
8564346|NCT00037830|21113246|P2|STARTED|Overall Study||38
8564347|NCT00037830|21113247|P1|STARTED|Overall Study||39
8564348|NCT00036569|21113268|P1|NOT COMPLETED|Overall Study||0
8564349|NCT00036569|21113268|P1|COMPLETED|Overall Study||32
8564350|NCT00036569|21113268|P1|STARTED|Overall Study||32
8564351|NCT00036270|21113279|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
8564352|NCT00036270|21113280|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
8564353|NCT00036270|21113279|P2|COMPLETED|Study Treatment to 5 Year Report||1380
8564354|NCT00036270|21113280|P1|COMPLETED|Study Treatment to 5 Year Report||2333
8564355|NCT00036270|21113279|P2|Treated|Study Treatment to 5 Year Report||4814
8564356|NCT00036270|21113280|P1|Treated|Study Treatment to 5 Year Report||4852
8564357|NCT00036270|21113279|P2|STARTED|Study Treatment to 5 Year Report||4868
8564358|NCT00036270|21113280|P1|STARTED|Study Treatment to 5 Year Report||4898
8564359|NCT00036270|21113279|P2|NOT COMPLETED|Randomized to Study Treatment||7
8564360|NCT00036270|21113280|P1|NOT COMPLETED|Randomized to Study Treatment||6
8564361|NCT00036270|21113279|P2|COMPLETED|Randomized to Study Treatment||4868
8564362|NCT00036270|21113280|P1|COMPLETED|Randomized to Study Treatment||4898
8564363|NCT00036270|21113279|P2|STARTED|Randomized to Study Treatment||4875
8564364|NCT00036270|21113280|P1|STARTED|Randomized to Study Treatment||4904
8564365|NCT00035932|21113299|P3|NOT COMPLETED|Overall Study||49
8564366|NCT00035932|21113300|P2|NOT COMPLETED|Overall Study||60
8564367|NCT00035932|21113301|P1|NOT COMPLETED|Overall Study||56
8564368|NCT00035932|21113299|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
8564369|NCT00035932|21113300|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
8564370|NCT00035932|21113301|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
8564371|NCT00035932|21113299|P3|Discontinued on or After Week 96|Overall Study||6
8564372|NCT00035932|21113300|P2|Discontinued on or After Week 96|Overall Study||4
8564373|NCT00035932|21113301|P1|Discontinued on or After Week 96|Overall Study||4
8564374|NCT00035932|21113299|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
8564375|NCT00035932|21113300|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
8564376|NCT00035932|21113301|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
8564377|NCT00035932|21113299|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
8564378|NCT00035932|21113300|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
8564379|NCT00035932|21113301|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
8564380|NCT00035932|21113299|P3|STARTED|Overall Study|123 randomized, 118 treated|118
8564381|NCT00035932|21113300|P2|STARTED|Overall Study|115 randomized, 110 treated|110
8564382|NCT00035932|21113301|P1|STARTED|Overall Study|120 randomized, 119 treated|119
8564383|NCT00035815|21113427|P2|NOT COMPLETED|Overall Study||11
8564384|NCT00035815|21113428|P1|NOT COMPLETED|Overall Study||17
8564385|NCT00035815|21113427|P2|COMPLETED|Overall Study||152
8564386|NCT00035815|21113428|P1|COMPLETED|Overall Study||150
8564387|NCT00035815|21113427|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
8564388|NCT00035815|21113428|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
8564389|NCT00035555|21113441|P3|NOT COMPLETED|Overall Study||22
8564390|NCT00035555|21113442|P2|NOT COMPLETED|Overall Study||16
8564391|NCT00035555|21113443|P1|NOT COMPLETED|Overall Study||16
8564392|NCT00035555|21113441|P3|COMPLETED|Overall Study||51
8564393|NCT00035555|21113442|P2|COMPLETED|Overall Study||55
8564394|NCT00035555|21113443|P1|COMPLETED|Overall Study||58
8564395|NCT00035555|21113441|P3|Number Who Received Study Drug|Overall Study||71
8564396|NCT00035555|21113442|P2|Number Who Received Study Drug|Overall Study||71
8564397|NCT00035555|21113443|P1|Number Who Received Study Drug|Overall Study||74
8564398|NCT00035555|21113441|P3|Number Who Had Undergone Transplantation|Overall Study||73
8564399|NCT00035555|21113442|P2|Number Who Had Undergone Transplantation|Overall Study||71
8564400|NCT00035555|21113443|P1|Number Who Had Undergone Transplantation|Overall Study||74
8564401|NCT00035555|21113441|P3|STARTED|Overall Study|Randomized patients|73
8564402|NCT00035555|21113442|P2|STARTED|Overall Study|Randomized patients|71
8564403|NCT00035555|21113443|P1|STARTED|Overall Study|Randomized patients|74
8564404|NCT00033917|21113486|P2|NOT COMPLETED|Overall Study||0
8564405|NCT00033917|21113487|P1|NOT COMPLETED|Overall Study||0
8564406|NCT00033917|21113486|P2|COMPLETED|Overall Study||222
8564407|NCT00033917|21113487|P1|COMPLETED|Overall Study||209
8564408|NCT00033917|21113486|P2|STARTED|Overall Study||222
8564409|NCT00033917|21113487|P1|STARTED|Overall Study||209
8564410|NCT00032630|21113499|P2|NOT COMPLETED|Overall Study||43
8564411|NCT00032630|21113500|P1|NOT COMPLETED|Overall Study||49
8564412|NCT00032630|21113499|P2|COMPLETED|Overall Study||1061
8564413|NCT00032630|21113500|P1|COMPLETED|Overall Study||1050
8564414|NCT00032630|21113499|P2|STARTED|Overall Study||1104
8564415|NCT00032630|21113500|P1|STARTED|Overall Study||1099
8564416|NCT00032591|21113510|P2|NOT COMPLETED|Follow-up||5
8564417|NCT00032591|21113511|P1|NOT COMPLETED|Follow-up||2
8564418|NCT00032591|21113510|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
8564419|NCT00032591|21113511|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
8564420|NCT00032591|21113510|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
8564421|NCT00032591|21113511|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
8564422|NCT00032591|21113510|P2|NOT COMPLETED|Randomization||0
8564423|NCT00032591|21113511|P1|NOT COMPLETED|Randomization||0
8564424|NCT00032591|21113510|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
8564425|NCT00032591|21113511|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
8564426|NCT00032591|21113510|P2|STARTED|Randomization||1457
8564427|NCT00032591|21113511|P1|STARTED|Randomization|2922 underwent randomization|1465
8564428|NCT00032591|21113510|P2|NOT COMPLETED|Screening||415
8564429|NCT00032591|21113511|P1|NOT COMPLETED|Screening||408
8564430|NCT00032591|21113510|P2|COMPLETED|Screening||1457
8564431|NCT00032591|21113511|P1|COMPLETED|Screening|823 were excluded from the study|1465
8564432|NCT00032591|21113510|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
8564433|NCT00032591|21113511|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
8564434|NCT00032487|21113527|P2|NOT COMPLETED|Overall Study||120
8564435|NCT00032487|21113528|P1|NOT COMPLETED|Overall Study||139
8564436|NCT00032487|21113527|P2|COMPLETED|Overall Study||772
8564437|NCT00032487|21113528|P1|COMPLETED|Overall Study||760
8564438|NCT00032487|21113527|P2|STARTED|Overall Study||892
8564439|NCT00032487|21113528|P1|STARTED|Overall Study||899
8564440|NCT00031551|21113538|P2|NOT COMPLETED|Overall Study||0
8564441|NCT00031551|21113539|P1|NOT COMPLETED|Overall Study||2
8564442|NCT00031551|21113538|P2|COMPLETED|Overall Study||25
8564443|NCT00031551|21113539|P1|COMPLETED|Overall Study||0
8564444|NCT00031551|21113538|P2|STARTED|Overall Study||25
8564445|NCT00031551|21113539|P1|STARTED|Overall Study||2
8564446|NCT00031486|21113551|P2|NOT COMPLETED|Overall Study||12
8564447|NCT00031486|21113552|P1|NOT COMPLETED|Overall Study||7
8564448|NCT00031486|21113551|P2|COMPLETED|Overall Study||35
8564449|NCT00031486|21113552|P1|COMPLETED|Overall Study||33
8564450|NCT00031486|21113551|P2|STARTED|Overall Study||47
8564451|NCT00031486|21113552|P1|STARTED|Overall Study||40
8564452|NCT00031460|21113578|P2|NOT COMPLETED|Overall Study||14
8564453|NCT00031460|21113579|P1|NOT COMPLETED|Overall Study||9
8564454|NCT00031460|21113578|P2|COMPLETED|Overall Study||8
8564455|NCT00031460|21113579|P1|COMPLETED|Overall Study||15
8564456|NCT00031460|21113578|P2|STARTED|Overall Study||22
8564457|NCT00031460|21113579|P1|STARTED|Overall Study||24
8564458|NCT00031447|21113593|P2|NOT COMPLETED|Overall Study||7
8564459|NCT00031447|21113594|P1|NOT COMPLETED|Overall Study||10
8564460|NCT00031447|21113593|P2|COMPLETED|Overall Study||8
8564461|NCT00031447|21113594|P1|COMPLETED|Overall Study||4
8564462|NCT00031447|21113593|P2|STARTED|Overall Study||15
8564463|NCT00031447|21113594|P1|STARTED|Overall Study||14
8564464|NCT00030992|21113606|P1|NOT COMPLETED|Overall Study||0
8564465|NCT00030992|21113606|P1|COMPLETED|Overall Study||102
8564466|NCT00030992|21113606|P1|STARTED|Overall Study||102
8564467|NCT00030147|21113615|P4|NOT COMPLETED|Overall Study||0
8564468|NCT00030147|21113616|P3|NOT COMPLETED|Overall Study||0
8564469|NCT00030147|21113617|P2|NOT COMPLETED|Overall Study||1
8564470|NCT00030147|21113618|P1|NOT COMPLETED|Overall Study||0
8564471|NCT00030147|21113615|P4|COMPLETED|Overall Study||11
8564472|NCT00030147|21113616|P3|COMPLETED|Overall Study||16
8564473|NCT00030147|21113617|P2|COMPLETED|Overall Study||18
8564474|NCT00030147|21113618|P1|COMPLETED|Overall Study||17
8564475|NCT00030147|21113615|P4|STARTED|Overall Study||11
8564476|NCT00030147|21113616|P3|STARTED|Overall Study||16
8564477|NCT00030147|21113617|P2|STARTED|Overall Study||19
8564478|NCT00030147|21113618|P1|STARTED|Overall Study||17
8564479|NCT00029536|21113636|P4|NOT COMPLETED|Overall Study||0
8564480|NCT00029536|21113637|P3|NOT COMPLETED|Overall Study||0
8564481|NCT00029536|21113638|P2|NOT COMPLETED|Overall Study||0
8564482|NCT00029536|21113639|P1|NOT COMPLETED|Overall Study||0
8564483|NCT00029536|21113636|P4|COMPLETED|Overall Study||59
8564484|NCT00029536|21113637|P3|COMPLETED|Overall Study||105
8564485|NCT00029536|21113638|P2|COMPLETED|Overall Study||45
8564486|NCT00029536|21113639|P1|COMPLETED|Overall Study||85
8564487|NCT00029536|21113636|P4|STARTED|Overall Study||59
8564488|NCT00029536|21113637|P3|STARTED|Overall Study||105
8564489|NCT00029536|21113638|P2|STARTED|Overall Study||45
8564490|NCT00029536|21113639|P1|STARTED|Overall Study||85
8564491|NCT00029172|21113663|P1|NOT COMPLETED|Overall Study||6
8564492|NCT00029172|21113663|P1|COMPLETED|Overall Study||182
8564493|NCT00029172|21113663|P1|STARTED|Overall Study||188
8564494|NCT00029146|21113669|P2|NOT COMPLETED|Overall Study||1
8564495|NCT00029146|21113670|P1|NOT COMPLETED|Overall Study||2
8564496|NCT00029146|21113669|P2|COMPLETED|Overall Study||97
8564497|NCT00029146|21113670|P1|COMPLETED|Overall Study||95
8564498|NCT00029146|21113669|P2|STARTED|Overall Study||98
8564499|NCT00029146|21113670|P1|STARTED|Overall Study||97
8564500|NCT00029107|21113699|P2|NOT COMPLETED|Overall Study||0
8564501|NCT00029107|21113700|P1|NOT COMPLETED|Overall Study||0
8564502|NCT00029107|21113699|P2|COMPLETED|Overall Study||12
8564503|NCT00029107|21113700|P1|COMPLETED|Overall Study||12
8564504|NCT00029107|21113699|P2|STARTED|Overall Study||12
8564505|NCT00029107|21113700|P1|STARTED|Overall Study||12
8564506|NCT00028262|21113706|P1|NOT COMPLETED|Overall Study||1
8564507|NCT00028262|21113706|P1|COMPLETED|Overall Study||9
8564508|NCT00028262|21113706|P1|STARTED|Overall Study||10
8564509|NCT00028093|21113712|P2|NOT COMPLETED|Overall Study||0
8564510|NCT00028093|21113713|P1|NOT COMPLETED|Overall Study||0
8564511|NCT00028093|21113712|P2|COMPLETED|Overall Study||25
8564512|NCT00028093|21113713|P1|COMPLETED|Overall Study||25
8564513|NCT00028093|21113712|P2|STARTED|Overall Study||25
8564514|NCT00028093|21113713|P1|STARTED|Overall Study||25
8564515|NCT00027378|21113721|P2|NOT COMPLETED|Overall Study||3
8564516|NCT00027378|21113722|P1|NOT COMPLETED|Overall Study||0
8564517|NCT00027378|21113721|P2|COMPLETED|Overall Study||23
8564518|NCT00027378|21113722|P1|COMPLETED|Overall Study||24
8564519|NCT00027378|21113721|P2|STARTED|Overall Study||26
8564520|NCT00027378|21113722|P1|STARTED|Overall Study||24
8564521|NCT00027027|21113735|P5|NOT COMPLETED|Overall Study||8
8564522|NCT00027027|21113736|P4|NOT COMPLETED|Overall Study||3
8564523|NCT00027027|21113737|P3|NOT COMPLETED|Overall Study||4
8564524|NCT00027027|21113738|P2|NOT COMPLETED|Overall Study||3
8564525|NCT00027027|21113739|P1|NOT COMPLETED|Overall Study||3
8564526|NCT00027027|21113735|P5|COMPLETED|Overall Study||0
8564527|NCT00027027|21113736|P4|COMPLETED|Overall Study||0
8564528|NCT00027027|21113737|P3|COMPLETED|Overall Study||0
8564529|NCT00027027|21113738|P2|COMPLETED|Overall Study||0
8564530|NCT00027027|21113739|P1|COMPLETED|Overall Study||0
8564531|NCT00027027|21113735|P5|Treated Beyond Cycle 2|Overall Study||4
8564532|NCT00027027|21113736|P4|Treated Beyond Cycle 2|Overall Study||2
8564533|NCT00027027|21113737|P3|Treated Beyond Cycle 2|Overall Study||2
8564534|NCT00027027|21113738|P2|Treated Beyond Cycle 2|Overall Study||1
8564535|NCT00027027|21113739|P1|Treated Beyond Cycle 2|Overall Study||1
8564536|NCT00027027|21113735|P5|Discontinued at Cycle 2|Overall Study||3
8564537|NCT00027027|21113736|P4|Discontinued at Cycle 2|Overall Study||1
8564538|NCT00027027|21113737|P3|Discontinued at Cycle 2|Overall Study||1
8564539|NCT00027027|21113738|P2|Discontinued at Cycle 2|Overall Study||2
8564540|NCT00027027|21113739|P1|Discontinued at Cycle 2|Overall Study||2
8564541|NCT00027027|21113735|P5|Completed 2 Cycles of Treatment|Overall Study||7
8564542|NCT00027027|21113736|P4|Completed 2 Cycles of Treatment|Overall Study||3
8564543|NCT00027027|21113737|P3|Completed 2 Cycles of Treatment|Overall Study||3
8564544|NCT00027027|21113738|P2|Completed 2 Cycles of Treatment|Overall Study||3
8564545|NCT00027027|21113739|P1|Completed 2 Cycles of Treatment|Overall Study||3
8564546|NCT00027027|21113735|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
8564547|NCT00027027|21113736|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
8564548|NCT00027027|21113737|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
8564549|NCT00027027|21113738|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
8564550|NCT00027027|21113739|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
8564551|NCT00027027|21113735|P5|STARTED|Overall Study||8
8564552|NCT00027027|21113736|P4|STARTED|Overall Study||3
8564553|NCT00027027|21113737|P3|STARTED|Overall Study||4
8564554|NCT00027027|21113738|P2|STARTED|Overall Study||3
8564555|NCT00027027|21113739|P1|STARTED|Overall Study||3
8564556|NCT00026793|21113784|P1|NOT COMPLETED|Overall Study||8
8564557|NCT00026793|21113784|P1|COMPLETED|Overall Study||21
8564558|NCT00026793|21113784|P1|STARTED|Overall Study||29
8564559|NCT00025883|21113794|P1|NOT COMPLETED|Overall Study||17
8564560|NCT00025883|21113794|P1|COMPLETED|Overall Study||86
8564561|NCT00025883|21113794|P1|Partial Lipodystrophy|Overall Study||40
8564562|NCT00025883|21113794|P1|Generalized Lipodystrophy|Overall Study||63
8564563|NCT00025883|21113794|P1|STARTED|Overall Study||103
8564564|NCT00023595|21113806|P5|NOT COMPLETED|10 Year Follow up||0
8564565|NCT00023595|21113807|P4|NOT COMPLETED|10 Year Follow up||0
8564566|NCT00023595|21113808|P3|NOT COMPLETED|10 Year Follow up||3
8564567|NCT00023595|21113809|P2|NOT COMPLETED|10 Year Follow up||10
8564568|NCT00023595|21113810|P1|NOT COMPLETED|10 Year Follow up||12
8564569|NCT00023595|21113806|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564570|NCT00023595|21113807|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564571|NCT00023595|21113808|P3|COMPLETED|10 Year Follow up||73
8564572|NCT00023595|21113809|P2|COMPLETED|10 Year Follow up||524
8564573|NCT00023595|21113810|P1|COMPLETED|10 Year Follow up||590
8564574|NCT00023595|21113806|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564575|NCT00023595|21113807|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564576|NCT00023595|21113808|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
8564577|NCT00023595|21113809|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
8564578|NCT00023595|21113810|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
8564579|NCT00023595|21113806|P5|NOT COMPLETED|5 Year Follow up||3
8564580|NCT00023595|21113807|P4|NOT COMPLETED|5 Year Follow up||7
8564581|NCT00023595|21113808|P3|NOT COMPLETED|5 Year Follow up||1
8564582|NCT00023595|21113809|P2|NOT COMPLETED|5 Year Follow up||2
8564583|NCT00023595|21113810|P1|NOT COMPLETED|5 Year Follow up||2
8564584|NCT00023595|21113806|P5|COMPLETED|5 Year Follow up||498
8564585|NCT00023595|21113807|P4|COMPLETED|5 Year Follow up||416
8564586|NCT00023595|21113808|P3|COMPLETED|5 Year Follow up||75
8564587|NCT00023595|21113809|P2|COMPLETED|5 Year Follow up||532
8564588|NCT00023595|21113810|P1|COMPLETED|5 Year Follow up||600
8564589|NCT00023595|21113806|P5|STARTED|5 Year Follow up||501
8564590|NCT00023595|21113807|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
8564591|NCT00023595|21113808|P3|STARTED|5 Year Follow up||76
8564592|NCT00023595|21113809|P2|STARTED|5 Year Follow up||534
8564593|NCT00023595|21113810|P1|STARTED|5 Year Follow up||602
8564594|NCT00023452|21114021|P2|NOT COMPLETED|Overall Study||872
8564595|NCT00023452|21114022|P1|NOT COMPLETED|Overall Study||1323
8564596|NCT00023452|21114021|P2|COMPLETED|Overall Study||3273
8564597|NCT00023452|21114022|P1|COMPLETED|Overall Study||2585
8564598|NCT00023452|21114021|P2|Completed Study|Overall Study||3475
8564599|NCT00023452|21114022|P1|Completed Study|Overall Study||3174
8564600|NCT00023452|21114021|P2|Not Treated|Overall Study||105
8564601|NCT00023452|21114022|P1|Not Treated|Overall Study||149
8564602|NCT00023452|21114021|P2|Completed Treatment|Overall Study||3273
8564603|NCT00023452|21114022|P1|Completed Treatment|Overall Study||2585
8564604|NCT00023452|21114021|P2|Enrolled as Part of a Cluster|Overall Study||971
8564605|NCT00023452|21114022|P1|Enrolled as Part of a Cluster|Overall Study||718
8564606|NCT00023452|21114021|P2|Randomized|Overall Study||3174
8564607|NCT00023452|21114022|P1|Randomized|Overall Study||3190
8564608|NCT00023452|21114021|P2|STARTED|Overall Study||4145
8564609|NCT00023452|21114022|P1|STARTED|Overall Study||3908
8564610|NCT00023322|21114046|P1|NOT COMPLETED|Overall Study||1
8564611|NCT00023322|21114046|P1|COMPLETED|Overall Study||12
8564612|NCT00023322|21114046|P1|STARTED|Overall Study||13
8564613|NCT00023309|21114053|P2|NOT COMPLETED|Overall Study||0
8564614|NCT00023309|21114054|P1|NOT COMPLETED|Overall Study||0
8564615|NCT00023309|21114053|P2|COMPLETED|Overall Study||19
8564616|NCT00023309|21114054|P1|COMPLETED|Overall Study||22
8564617|NCT00023309|21114053|P2|STARTED|Overall Study||19
8564618|NCT00023309|21114054|P1|STARTED|Overall Study||22
8564619|NCT00022763|21114070|P2|NOT COMPLETED|Overall Study||17
8564620|NCT00022763|21114071|P1|NOT COMPLETED|Overall Study||9
8564621|NCT00022763|21114070|P2|COMPLETED|Overall Study||11
8564622|NCT00022763|21114071|P1|COMPLETED|Overall Study||15
8564623|NCT00022763|21114070|P2|STARTED|Overall Study||28
8564624|NCT00022763|21114071|P1|STARTED|Overall Study||24
8564625|NCT00016718|21114097|P3|NOT COMPLETED|Overall Study||0
8564626|NCT00016718|21114098|P2|NOT COMPLETED|Overall Study||0
8564627|NCT00016718|21114099|P1|NOT COMPLETED|Overall Study||0
8564628|NCT00016718|21114097|P3|COMPLETED|Overall Study||16
8564629|NCT00016718|21114098|P2|COMPLETED|Overall Study||21
8564630|NCT00016718|21114099|P1|COMPLETED|Overall Study||6
8564631|NCT00016718|21114097|P3|STARTED|Overall Study||16
8564632|NCT00016718|21114098|P2|STARTED|Overall Study||21
8564633|NCT00016718|21114099|P1|STARTED|Overall Study||6
8564634|NCT00014911|21114113|P1|NOT COMPLETED|Overall Study||11
8564635|NCT00014911|21114113|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
8564636|NCT00014911|21114113|P1|STARTED|Overall Study||36
8564637|NCT00006604|21114129|P17|NOT COMPLETED|Overall Study||9
8564638|NCT00006604|21114130|P16|NOT COMPLETED|Overall Study||5
8564639|NCT00006604|21114131|P15|NOT COMPLETED|Overall Study||10
8564640|NCT00006604|21114132|P14|NOT COMPLETED|Overall Study||6
8564641|NCT00006604|21114133|P13|NOT COMPLETED|Overall Study||4
8564642|NCT00006604|21114134|P12|NOT COMPLETED|Overall Study||6
8564643|NCT00006604|21114135|P11|NOT COMPLETED|Overall Study||8
8564644|NCT00006604|21114136|P10|NOT COMPLETED|Overall Study||19
8564645|NCT00006604|21114137|P9|NOT COMPLETED|Overall Study||1
8564646|NCT00006604|21114138|P8|NOT COMPLETED|Overall Study||3
8564647|NCT00006604|21114139|P7|NOT COMPLETED|Overall Study||9
8564648|NCT00006604|21114140|P6|NOT COMPLETED|Overall Study||3
8564649|NCT00006604|21114141|P5|NOT COMPLETED|Overall Study||2
8564650|NCT00006604|21114142|P4|NOT COMPLETED|Overall Study||5
8564651|NCT00006604|21114143|P3|NOT COMPLETED|Overall Study||4
8564652|NCT00006604|21114144|P2|NOT COMPLETED|Overall Study||0
8564653|NCT00006604|21114145|P1|NOT COMPLETED|Overall Study||2
8564654|NCT00006604|21114129|P17|COMPLETED|Overall Study||6
8564655|NCT00006604|21114130|P16|COMPLETED|Overall Study||1
8564656|NCT00006604|21114131|P15|COMPLETED|Overall Study||14
8564657|NCT00006604|21114132|P14|COMPLETED|Overall Study||0
8564658|NCT00006604|21114133|P13|COMPLETED|Overall Study||22
8564659|NCT00006604|21114134|P12|COMPLETED|Overall Study||6
8564660|NCT00006604|21114135|P11|COMPLETED|Overall Study||13
8564661|NCT00006604|21114136|P10|COMPLETED|Overall Study||6
8564662|NCT00006604|21114137|P9|COMPLETED|Overall Study||4
8564663|NCT00006604|21114138|P8|COMPLETED|Overall Study||2
8564664|NCT00006604|21114139|P7|COMPLETED|Overall Study||12
8564665|NCT00006604|21114140|P6|COMPLETED|Overall Study||2
8564666|NCT00006604|21114141|P5|COMPLETED|Overall Study||3
8564667|NCT00006604|21114142|P4|COMPLETED|Overall Study||1
8564668|NCT00006604|21114143|P3|COMPLETED|Overall Study||1
8564669|NCT00006604|21114144|P2|COMPLETED|Overall Study||2
8564670|NCT00006604|21114145|P1|COMPLETED|Overall Study||4
8564671|NCT00006604|21114129|P17|STARTED|Overall Study||15
8564672|NCT00006604|21114130|P16|STARTED|Overall Study||6
8564673|NCT00006604|21114131|P15|STARTED|Overall Study||24
8564674|NCT00006604|21114132|P14|STARTED|Overall Study||6
8564675|NCT00006604|21114133|P13|STARTED|Overall Study||26
8564676|NCT00006604|21114134|P12|STARTED|Overall Study||12
8564677|NCT00006604|21114135|P11|STARTED|Overall Study||21
8564678|NCT00006604|21114136|P10|STARTED|Overall Study||25
8564679|NCT00006604|21114137|P9|STARTED|Overall Study||5
8564680|NCT00006604|21114138|P8|STARTED|Overall Study||5
8564681|NCT00006604|21114139|P7|STARTED|Overall Study||21
8564682|NCT00006604|21114140|P6|STARTED|Overall Study||5
8564683|NCT00006604|21114141|P5|STARTED|Overall Study||5
8564684|NCT00006604|21114142|P4|STARTED|Overall Study||6
8564685|NCT00006604|21114143|P3|STARTED|Overall Study||5
8564686|NCT00006604|21114144|P2|STARTED|Overall Study||2
8564687|NCT00006604|21114145|P1|STARTED|Overall Study||6
8564688|NCT00004978|21114261|P2|NOT COMPLETED|Overall Study||270
8564689|NCT00004978|21114262|P1|NOT COMPLETED|Overall Study||244
8564690|NCT00004978|21114261|P2|COMPLETED|Overall Study||1790
8564691|NCT00004978|21114262|P1|COMPLETED|Overall Study||1846
8564692|NCT00004978|21114261|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
8564693|NCT00004978|21114262|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
8564694|NCT00021541|21114288|P2|NOT COMPLETED|Period 2-crossover||11
8564695|NCT00021541|21114289|P1|NOT COMPLETED|Period 2-crossover||10
8564696|NCT00021541|21114288|P2|COMPLETED|Period 2-crossover||12
8564697|NCT00021541|21114289|P1|COMPLETED|Period 2-crossover||10
8564698|NCT00021541|21114288|P2|STARTED|Period 2-crossover||23
8564699|NCT00021541|21114289|P1|STARTED|Period 2-crossover||20
8564700|NCT00021541|21114288|P2|NOT COMPLETED|Period 1-First Treatment||8
8564701|NCT00021541|21114289|P1|NOT COMPLETED|Period 1-First Treatment||11
8564702|NCT00021541|21114288|P2|COMPLETED|Period 1-First Treatment||23
8564703|NCT00021541|21114289|P1|COMPLETED|Period 1-First Treatment||20
8564704|NCT00021541|21114288|P2|Ineligible Patients|Period 1-First Treatment||2
8564705|NCT00021541|21114289|P1|Ineligible Patients|Period 1-First Treatment||0
8564706|NCT00021541|21114288|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
8564707|NCT00021541|21114289|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
8564708|NCT00021541|21114288|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
8564709|NCT00021541|21114289|P1|STARTED|Period 1-First Treatment||31
8564710|NCT00018031|21114299|P1|NOT COMPLETED|Overall Study||0
8564711|NCT00018031|21114299|P1|COMPLETED|Overall Study||36
8564712|NCT00018031|21114299|P1|STARTED|Overall Study||36
8564713|NCT00015457|21114303|P2|NOT COMPLETED|Second Intervention||0
8564714|NCT00015457|21114304|P1|NOT COMPLETED|Second Intervention||1
8564715|NCT00015457|21114303|P2|COMPLETED|Second Intervention||5
8564716|NCT00015457|21114304|P1|COMPLETED|Second Intervention||7
8564717|NCT00015457|21114303|P2|STARTED|Second Intervention||5
8564718|NCT00015457|21114304|P1|STARTED|Second Intervention||8
8564719|NCT00015457|21114303|P2|NOT COMPLETED|First Intervention||3
8564720|NCT00015457|21114304|P1|NOT COMPLETED|First Intervention||0
8564721|NCT00015457|21114303|P2|COMPLETED|First Intervention||5
8564722|NCT00015457|21114304|P1|COMPLETED|First Intervention||8
8564723|NCT00015457|21114303|P2|STARTED|First Intervention||8
8564724|NCT00015457|21114304|P1|STARTED|First Intervention||8
8564725|NCT00013611|21114314|P2|NOT COMPLETED|Overall Study||100
8564726|NCT00013611|21114315|P1|NOT COMPLETED|Overall Study||91
8564727|NCT00013611|21114314|P2|COMPLETED|Overall Study||746
8564728|NCT00013611|21114315|P1|COMPLETED|Overall Study||758
8564729|NCT00013611|21114314|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
8564730|NCT00013611|21114315|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
8564731|NCT00010803|21114333|P2|NOT COMPLETED|Overall Study||98
8564732|NCT00010803|21114334|P1|NOT COMPLETED|Overall Study||97
8564733|NCT00010803|21114333|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
8564734|NCT00010803|21114334|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
8564735|NCT00010803|21114333|P2|STARTED|Overall Study|Randomized|1524
8564736|NCT00010803|21114334|P1|STARTED|Overall Study|Randomized|1545
8564737|NCT00010439|21114344|P1|NOT COMPLETED|Overall Study||0
8564738|NCT00010439|21114344|P1|COMPLETED|Overall Study||10
8564739|NCT00010439|21114344|P1|6 Months|Overall Study||10
8564740|NCT00010439|21114344|P1|STARTED|Overall Study||10
8564741|NCT00010374|21114349|P1|NOT COMPLETED|Overall Study||1
8564742|NCT00010374|21114349|P1|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
8564743|NCT00010374|21114349|P1|STARTED|Overall Study||54
8564744|NCT00007644|21114357|P2|NOT COMPLETED|Overall Study||0
8564745|NCT00007644|21114358|P1|NOT COMPLETED|Overall Study||0
8564746|NCT00007644|21114357|P2|COMPLETED|Overall Study||367
8564747|NCT00007644|21114358|P1|COMPLETED|Overall Study||364
8564748|NCT00007644|21114357|P2|STARTED|Overall Study||367
8564749|NCT00007644|21114358|P1|STARTED|Overall Study||364
8564750|NCT00007475|21114367|P4|NOT COMPLETED|Overall Study||0
8564751|NCT00007475|21114368|P3|NOT COMPLETED|Overall Study||0
8564752|NCT00007475|21114369|P2|NOT COMPLETED|Overall Study||0
8564753|NCT00007475|21114370|P1|NOT COMPLETED|Overall Study||4
8564754|NCT00007475|21114367|P4|COMPLETED|Overall Study||0
8564755|NCT00007475|21114368|P3|COMPLETED|Overall Study||2
8564756|NCT00007475|21114369|P2|COMPLETED|Overall Study||1
8564757|NCT00007475|21114370|P1|COMPLETED|Overall Study||8
8564758|NCT00007475|21114367|P4|Initiate Cyclophosphamide|Overall Study||0
8564759|NCT00007475|21114368|P3|Initiate Cyclophosphamide|Overall Study||2
8564760|NCT00007475|21114369|P2|Initiate Cyclophosphamide|Overall Study||1
8564761|NCT00007475|21114370|P1|Initiate Cyclophosphamide|Overall Study||12
8564762|NCT00007475|21114367|P4|Initial Plasma Exchange|Overall Study||0
8564763|NCT00007475|21114368|P3|Initial Plasma Exchange|Overall Study||2
8564764|NCT00007475|21114369|P2|Initial Plasma Exchange|Overall Study||1
8564765|NCT00007475|21114370|P1|Initial Plasma Exchange|Overall Study||12
8564766|NCT00007475|21114367|P4|Post-initial Transplant Proteinuria|Overall Study||0
8564767|NCT00007475|21114368|P3|Post-initial Transplant Proteinuria|Overall Study||2
8564768|NCT00007475|21114369|P2|Post-initial Transplant Proteinuria|Overall Study||1
8564769|NCT00007475|21114370|P1|Post-initial Transplant Proteinuria|Overall Study||12
8564770|NCT00007475|21114367|P4|Initial Transplant|Overall Study||0
8564771|NCT00007475|21114368|P3|Initial Transplant|Overall Study||2
8564772|NCT00007475|21114369|P2|Initial Transplant|Overall Study||1
8564773|NCT00007475|21114370|P1|Initial Transplant|Overall Study||12
8564774|NCT00007475|21114367|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
8564775|NCT00007475|21114368|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
8564776|NCT00007475|21114369|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
8564777|NCT00007475|21114370|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
8564778|NCT00007475|21114367|P4|STARTED|Overall Study||0
8564779|NCT00007475|21114368|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
8564780|NCT00007475|21114369|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
8564781|NCT00007475|21114370|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
8564782|NCT00007345|21114392|P2|NOT COMPLETED|Overall Study||11
8564783|NCT00007345|21114393|P1|NOT COMPLETED|Overall Study||2
8564784|NCT00007345|21114392|P2|COMPLETED|Overall Study||73
8564785|NCT00007345|21114393|P1|COMPLETED|Overall Study||45
8564786|NCT00007345|21114392|P2|STARTED|Overall Study||84
8564787|NCT00007345|21114393|P1|STARTED|Overall Study||47
8564788|NCT00007020|21114411|P1|NOT COMPLETED|Overall Study||44
8564789|NCT00007020|21114411|P1|COMPLETED|Overall Study||41
8564790|NCT00007020|21114411|P1|STARTED|Overall Study||85
8564791|NCT00006489|21114424|P4|NOT COMPLETED|Overall Study||11
8564792|NCT00006489|21114425|P3|NOT COMPLETED|Overall Study||15
8564793|NCT00006489|21114426|P2|NOT COMPLETED|Overall Study||14
8564794|NCT00006489|21114427|P1|NOT COMPLETED|Overall Study||13
8564795|NCT00006489|21114424|P4|COMPLETED|Overall Study||32
8564796|NCT00006489|21114425|P3|COMPLETED|Overall Study||25
8564797|NCT00006489|21114426|P2|COMPLETED|Overall Study||26
8564798|NCT00006489|21114427|P1|COMPLETED|Overall Study||29
8564799|NCT00006489|21114424|P4|STARTED|Overall Study||43
8564800|NCT00006489|21114425|P3|STARTED|Overall Study||40
8564801|NCT00006489|21114426|P2|STARTED|Overall Study||40
8564802|NCT00006489|21114427|P1|STARTED|Overall Study||42
8564803|NCT00006411|21114447|P2|NOT COMPLETED|Overall Study||0
8564804|NCT00006411|21114448|P1|NOT COMPLETED|Overall Study||0
8564805|NCT00006411|21114447|P2|COMPLETED|Overall Study||383
8564806|NCT00006411|21114448|P1|COMPLETED|Overall Study||707
8564807|NCT00006411|21114447|P2|STARTED|Overall Study||383
8564808|NCT00006411|21114448|P1|STARTED|Overall Study||707
8564809|NCT00006409|21114462|P6|NOT COMPLETED|Post-3 Year Intervention||62
8564810|NCT00006409|21114463|P5|NOT COMPLETED|Post-3 Year Intervention||62
8564811|NCT00006409|21114464|P4|NOT COMPLETED|Post-3 Year Intervention||0
8564812|NCT00006409|21114465|P3|NOT COMPLETED|Post-3 Year Intervention||0
8564813|NCT00006409|21114466|P2|NOT COMPLETED|Post-3 Year Intervention||0
8564814|NCT00006409|21114467|P1|NOT COMPLETED|Post-3 Year Intervention||0
8564815|NCT00006409|21114462|P6|COMPLETED|Post-3 Year Intervention||1714
8564816|NCT00006409|21114463|P5|COMPLETED|Post-3 Year Intervention||1664
8564817|NCT00006409|21114464|P4|COMPLETED|Post-3 Year Intervention||0
8564818|NCT00006409|21114465|P3|COMPLETED|Post-3 Year Intervention||0
8564819|NCT00006409|21114466|P2|COMPLETED|Post-3 Year Intervention||0
8564820|NCT00006409|21114467|P1|COMPLETED|Post-3 Year Intervention||0
8564821|NCT00006409|21114462|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
8564822|NCT00006409|21114463|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
8564823|NCT00006409|21114464|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8564824|NCT00006409|21114465|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8564825|NCT00006409|21114466|P2|STARTED|Post-3 Year Intervention||0
8564826|NCT00006409|21114467|P1|STARTED|Post-3 Year Intervention||0
8564827|NCT00006409|21114462|P6|NOT COMPLETED|Post-2 Year Intervention||0
8564828|NCT00006409|21114463|P5|NOT COMPLETED|Post-2 Year Intervention||0
8564829|NCT00006409|21114464|P4|NOT COMPLETED|Post-2 Year Intervention||168
8564830|NCT00006409|21114465|P3|NOT COMPLETED|Post-2 Year Intervention||251
8564831|NCT00006409|21114466|P2|NOT COMPLETED|Post-2 Year Intervention||0
8564832|NCT00006409|21114467|P1|NOT COMPLETED|Post-2 Year Intervention||0
8564833|NCT00006409|21114462|P6|COMPLETED|Post-2 Year Intervention||0
8564834|NCT00006409|21114463|P5|COMPLETED|Post-2 Year Intervention||0
8564835|NCT00006409|21114464|P4|COMPLETED|Post-2 Year Intervention||1545
8564836|NCT00006409|21114465|P3|COMPLETED|Post-2 Year Intervention||1540
8564837|NCT00006409|21114466|P2|COMPLETED|Post-2 Year Intervention||0
8564838|NCT00006409|21114467|P1|COMPLETED|Post-2 Year Intervention||0
8564839|NCT00006409|21114462|P6|STARTED|Post-2 Year Intervention||0
8564840|NCT00006409|21114463|P5|STARTED|Post-2 Year Intervention||0
8564841|NCT00006409|21114464|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
8564842|NCT00006409|21114465|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
8564843|NCT00006409|21114466|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8564844|NCT00006409|21114467|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8564845|NCT00006409|21114462|P6|NOT COMPLETED|Baseline||0
8564846|NCT00006409|21114463|P5|NOT COMPLETED|Baseline||0
8564847|NCT00006409|21114464|P4|NOT COMPLETED|Baseline||0
8564848|NCT00006409|21114465|P3|NOT COMPLETED|Baseline||0
8564849|NCT00006409|21114466|P2|NOT COMPLETED|Baseline||70
8564850|NCT00006409|21114467|P1|NOT COMPLETED|Baseline||48
8564851|NCT00006409|21114462|P6|COMPLETED|Baseline||0
8564852|NCT00006409|21114463|P5|COMPLETED|Baseline||0
8564853|NCT00006409|21114464|P4|COMPLETED|Baseline||0
8564854|NCT00006409|21114465|P3|COMPLETED|Baseline||0
8564855|NCT00006409|21114466|P2|COMPLETED|Baseline||786
8564856|NCT00006409|21114467|P1|COMPLETED|Baseline||817
8564857|NCT00006409|21114462|P6|STARTED|Baseline||0
8564858|NCT00006409|21114463|P5|STARTED|Baseline||0
8564859|NCT00006409|21114464|P4|STARTED|Baseline||0
8564860|NCT00006409|21114465|P3|STARTED|Baseline||0
8564861|NCT00006409|21114466|P2|STARTED|Baseline||856
8564862|NCT00006409|21114467|P1|STARTED|Baseline||865
8564863|NCT00006400|21114489|P2|NOT COMPLETED|Overall Study||13
8564864|NCT00006400|21114490|P1|NOT COMPLETED|Overall Study||13
8564865|NCT00006400|21114489|P2|COMPLETED|Overall Study||84
8564866|NCT00006400|21114490|P1|COMPLETED|Overall Study||83
8564867|NCT00006400|21114489|P2|STARTED|Overall Study||97
8564868|NCT00006400|21114490|P1|STARTED|Overall Study||96
8564869|NCT00006305|21114506|P4|NOT COMPLETED|Overall Study||14
8564870|NCT00006305|21114507|P3|NOT COMPLETED|Overall Study||15
8564871|NCT00006305|21114508|P2|NOT COMPLETED|Overall Study||10
8564872|NCT00006305|21114509|P1|NOT COMPLETED|Overall Study||17
8564873|NCT00006305|21114506|P4|COMPLETED|Overall Study||585
8564874|NCT00006305|21114507|P3|COMPLETED|Overall Study||578
8564875|NCT00006305|21114508|P2|COMPLETED|Overall Study||574
8564876|NCT00006305|21114509|P1|COMPLETED|Overall Study||575
8564877|NCT00006305|21114506|P4|STARTED|Overall Study||599
8564878|NCT00006305|21114507|P3|STARTED|Overall Study||593
8564879|NCT00006305|21114508|P2|STARTED|Overall Study||584
8564880|NCT00006305|21114509|P1|STARTED|Overall Study||592
8564881|NCT00006289|21114525|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
8564882|NCT00006289|21114526|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
8564883|NCT00006289|21114525|P2|COMPLETED|Second Intervention (5 Weeks)||9
8564884|NCT00006289|21114526|P1|COMPLETED|Second Intervention (5 Weeks)||9
8564885|NCT00006289|21114525|P2|STARTED|Second Intervention (5 Weeks)||10
8564886|NCT00006289|21114526|P1|STARTED|Second Intervention (5 Weeks)||10
8564887|NCT00006289|21114525|P2|NOT COMPLETED|Washout (>= 1 Week)||0
8564888|NCT00006289|21114526|P1|NOT COMPLETED|Washout (>= 1 Week)||0
8564889|NCT00006289|21114525|P2|COMPLETED|Washout (>= 1 Week)||10
8564890|NCT00006289|21114526|P1|COMPLETED|Washout (>= 1 Week)||10
8564891|NCT00006289|21114525|P2|STARTED|Washout (>= 1 Week)||10
8564892|NCT00006289|21114526|P1|STARTED|Washout (>= 1 Week)||10
8564893|NCT00006289|21114525|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
8564894|NCT00006289|21114526|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
8564895|NCT00006289|21114525|P2|COMPLETED|First Intervention (5 Weeks)||10
8564896|NCT00006289|21114526|P1|COMPLETED|First Intervention (5 Weeks)||10
8564897|NCT00006289|21114525|P2|STARTED|First Intervention (5 Weeks)||10
8564898|NCT00006289|21114526|P1|STARTED|First Intervention (5 Weeks)||11
8564899|NCT00006184|21114544|P2|NOT COMPLETED|Overall Study||0
8564900|NCT00006184|21114545|P1|NOT COMPLETED|Overall Study||1
8564901|NCT00006184|21114544|P2|COMPLETED|Overall Study||10
8564902|NCT00006184|21114545|P1|COMPLETED|Overall Study||9
8564903|NCT00006184|21114544|P2|STARTED|Overall Study||10
8564904|NCT00006184|21114545|P1|STARTED|Overall Study||10
8564905|NCT00006178|21114552|P1|NOT COMPLETED|Overall Study||0
8564906|NCT00006178|21114552|P1|COMPLETED|Overall Study||12
8564907|NCT00006178|21114552|P1|STARTED|Overall Study||12
8564908|NCT00006170|21114563|P4|NOT COMPLETED|Overall Study||39
8564909|NCT00006170|21114564|P3|NOT COMPLETED|Overall Study||43
8564910|NCT00006170|21114565|P2|NOT COMPLETED|Overall Study||50
8564911|NCT00006170|21114566|P1|NOT COMPLETED|Overall Study||49
8564912|NCT00006170|21114563|P4|COMPLETED|Overall Study||28
8564913|NCT00006170|21114564|P3|COMPLETED|Overall Study||46
8564914|NCT00006170|21114565|P2|COMPLETED|Overall Study||37
8564915|NCT00006170|21114566|P1|COMPLETED|Overall Study||57
8564916|NCT00006170|21114563|P4|STARTED|Overall Study||67
8564917|NCT00006170|21114564|P3|STARTED|Overall Study||89
8564918|NCT00006170|21114565|P2|STARTED|Overall Study||87
8564919|NCT00006170|21114566|P1|STARTED|Overall Study||106
8564920|NCT00006156|21114586|P2|NOT COMPLETED|Overall Study||0
8564921|NCT00006156|21114587|P1|NOT COMPLETED|Overall Study||0
8564922|NCT00006156|21114586|P2|COMPLETED|Overall Study||7
8564923|NCT00006156|21114587|P1|COMPLETED|Overall Study||42
8564924|NCT00006156|21114586|P2|STARTED|Overall Study||7
8564925|NCT00006156|21114587|P1|STARTED|Overall Study||42
8564926|NCT00006164|21114596|P2|NOT COMPLETED|Overall Study||81
8564927|NCT00006164|21114597|P1|NOT COMPLETED|Overall Study||70
8564928|NCT00006164|21114596|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
8564929|NCT00006164|21114597|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
8564930|NCT00006164|21114596|P2|STARTED|Overall Study||533
8564931|NCT00006164|21114597|P1|STARTED|Overall Study||517
8564932|NCT00006151|21114633|P2|NOT COMPLETED|Overall Study||14
8564933|NCT00006151|21114634|P1|NOT COMPLETED|Overall Study||13
8564934|NCT00006151|21114633|P2|COMPLETED|Overall Study||16
8564935|NCT00006151|21114634|P1|COMPLETED|Overall Study||17
8564936|NCT00006151|21114633|P2|STARTED|Overall Study||30
8564937|NCT00006151|21114634|P1|STARTED|Overall Study||30
8564938|NCT00005937|21114640|P1|NOT COMPLETED|Overall Study||5
8564939|NCT00005937|21114640|P1|COMPLETED|Overall Study||37
8564940|NCT00005937|21114640|P1|STARTED|Overall Study||42
8564941|NCT00005908|21114644|P2|NOT COMPLETED|Overall Study||0
8564942|NCT00005908|21114645|P1|NOT COMPLETED|Overall Study||1
8564943|NCT00005908|21114644|P2|COMPLETED|Overall Study||20
8564944|NCT00005908|21114645|P1|COMPLETED|Overall Study||9
8564945|NCT00005908|21114644|P2|STARTED|Overall Study||20
8564946|NCT00005908|21114645|P1|STARTED|Overall Study||10
8564947|NCT00005906|21114654|P1|NOT COMPLETED|Overall Study||3
8564948|NCT00005906|21114654|P1|COMPLETED|Overall Study||1
8564949|NCT00005906|21114654|P1|STARTED|Overall Study||4
8564950|NCT00005901|21114662|P2|NOT COMPLETED|Overall Study||0
8564951|NCT00005901|21114663|P1|NOT COMPLETED|Overall Study||0
8564952|NCT00005901|21114662|P2|COMPLETED|Overall Study||15
8564953|NCT00005901|21114663|P1|COMPLETED|Overall Study||19
8564954|NCT00005901|21114662|P2|STARTED|Overall Study||15
8564955|NCT00005901|21114663|P1|STARTED|Overall Study||19
8564956|NCT00005669|21114681|P2|NOT COMPLETED|Overall Study||7
8564957|NCT00005669|21114682|P1|NOT COMPLETED|Overall Study||8
8564958|NCT00005669|21114681|P2|COMPLETED|Overall Study||40
8564959|NCT00005669|21114682|P1|COMPLETED|Overall Study||45
8564960|NCT00005669|21114681|P2|STARTED|Overall Study||47
8564961|NCT00005669|21114682|P1|STARTED|Overall Study||53
8564962|NCT00004980|21114698|P2|NOT COMPLETED|Overall Study||2
8564963|NCT00004980|21114699|P1|NOT COMPLETED|Overall Study||2
8564964|NCT00004980|21114698|P2|COMPLETED|Overall Study||21
8564965|NCT00004980|21114699|P1|COMPLETED|Overall Study||25
8564966|NCT00004980|21114698|P2|STARTED|Overall Study||23
8564967|NCT00004980|21114699|P1|STARTED|Overall Study||27
8564968|NCT00004732|21114713|P2|NOT COMPLETED|Overall Study||111
8564969|NCT00004732|21114714|P1|NOT COMPLETED|Overall Study||69
8564970|NCT00004732|21114713|P2|COMPLETED|Overall Study||1129
8564971|NCT00004732|21114714|P1|COMPLETED|Overall Study||1193
8564972|NCT00004732|21114713|P2|STARTED|Overall Study||1240
8564973|NCT00004732|21114714|P1|STARTED|Overall Study||1262
8564974|NCT00004635|21114724|P2|NOT COMPLETED|Period Two||9
8564975|NCT00004635|21114725|P1|NOT COMPLETED|Period Two||6
8564976|NCT00004635|21114724|P2|COMPLETED|Period Two||50
8564977|NCT00004635|21114725|P1|COMPLETED|Period Two||38
8564978|NCT00004635|21114724|P2|STARTED|Period Two||59
8564979|NCT00004635|21114725|P1|STARTED|Period Two||44
8564980|NCT00004635|21114724|P2|NOT COMPLETED|Period One||6
8564981|NCT00004635|21114725|P1|NOT COMPLETED|Period One||6
8564982|NCT00004635|21114724|P2|COMPLETED|Period One||74
8564983|NCT00004635|21114725|P1|COMPLETED|Period One||73
8564984|NCT00004635|21114724|P2|Received Treatment|Period One||75
8564985|NCT00004635|21114725|P1|Received Treatment|Period One||73
8564986|NCT00004635|21114724|P2|STARTED|Period One||80
8564987|NCT00004635|21114725|P1|STARTED|Period One||79
8564988|NCT00004563|21114737|P2|NOT COMPLETED|Overall Study||24
8564989|NCT00004563|21114738|P1|NOT COMPLETED|Overall Study||25
8564990|NCT00004563|21114737|P2|COMPLETED|Overall Study||55
8564991|NCT00004563|21114738|P1|COMPLETED|Overall Study||54
8564992|NCT00004563|21114737|P2|STARTED|Overall Study||79
8564993|NCT00004563|21114738|P1|STARTED|Overall Study||79
8564994|NCT00004562|21114750|P2|NOT COMPLETED|Overall Study||91
8564995|NCT00004562|21114751|P1|NOT COMPLETED|Overall Study||102
8564996|NCT00004562|21114750|P2|COMPLETED|Overall Study||1009
8564997|NCT00004562|21114751|P1|COMPLETED|Overall Study||999
8564998|NCT00004562|21114750|P2|STARTED|Overall Study||1100
8564999|NCT00004562|21114751|P1|STARTED|Overall Study||1101
8565000|NCT00004547|21114762|P3|NOT COMPLETED|Overall Study||22
8565001|NCT00004547|21114763|P2|NOT COMPLETED|Overall Study||9
8565002|NCT00004547|21114764|P1|NOT COMPLETED|Overall Study||22
8565003|NCT00004547|21114762|P3|COMPLETED|Overall Study||35
8565004|NCT00004547|21114763|P2|COMPLETED|Overall Study||39
8565005|NCT00004547|21114764|P1|COMPLETED|Overall Study||61
8565006|NCT00004547|21114762|P3|Not Evaluable|Overall Study||23
8565007|NCT00004547|21114763|P2|Not Evaluable|Overall Study||9
8565008|NCT00004547|21114764|P1|Not Evaluable|Overall Study||21
8565009|NCT00004547|21114762|P3|STARTED|Overall Study||57
8565010|NCT00004547|21114763|P2|STARTED|Overall Study||48
8565011|NCT00004547|21114764|P1|STARTED|Overall Study||83
8565012|NCT00001984|21114782|P1|NOT COMPLETED|Overall Study||0
8565013|NCT00001984|21114782|P1|COMPLETED|Overall Study||5
8565014|NCT00001984|21114782|P1|STARTED|Overall Study||5
8565015|NCT00001962|21114792|P1|NOT COMPLETED|Overall Study||28
8565016|NCT00001962|21114792|P1|COMPLETED|Overall Study||72
8565017|NCT00001962|21114792|P1|STARTED|Overall Study||100
8565018|NCT00001959|21114796|P1|NOT COMPLETED|Overall Study||3
8565019|NCT00001959|21114796|P1|COMPLETED|Overall Study||18
8565020|NCT00001959|21114796|P1|STARTED|Overall Study||21
8565021|NCT00001941|21114802|P5|NOT COMPLETED|Overall Study||1
8565022|NCT00001941|21114803|P4|NOT COMPLETED|Overall Study||0
8565023|NCT00001941|21114804|P3|NOT COMPLETED|Overall Study||0
8565024|NCT00001941|21114805|P2|NOT COMPLETED|Overall Study||0
8565025|NCT00001941|21114806|P1|NOT COMPLETED|Overall Study||0
8565026|NCT00001941|21114802|P5|COMPLETED|Overall Study||19
8565027|NCT00001941|21114803|P4|COMPLETED|Overall Study||3
8565028|NCT00001941|21114804|P3|COMPLETED|Overall Study||3
8565029|NCT00001941|21114805|P2|COMPLETED|Overall Study||5
8565030|NCT00001941|21114806|P1|COMPLETED|Overall Study||3
8565031|NCT00001941|21114802|P5|STARTED|Overall Study||20
8565032|NCT00001941|21114803|P4|STARTED|Overall Study||3
8565033|NCT00001941|21114804|P3|STARTED|Overall Study||3
8565034|NCT00001941|21114805|P2|STARTED|Overall Study||5
8565035|NCT00001941|21114806|P1|STARTED|Overall Study||3
8565036|NCT00000392|21114815|P2|NOT COMPLETED|Overall Study||32
8565037|NCT00000392|21114816|P1|NOT COMPLETED|Overall Study||40
8565038|NCT00000392|21114815|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
8565039|NCT00000392|21114816|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
8565040|NCT00000392|21114815|P2|STARTED|Overall Study||109
8565041|NCT00000392|21114816|P1|STARTED|Overall Study||106
8565042|NCT00001849|21114824|P1|NOT COMPLETED|Overall Study||14
8565043|NCT00001849|21114824|P1|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
8565044|NCT00001849|21114824|P1|STARTED|Overall Study||68
8565045|NCT00001832|21114853|P15|NOT COMPLETED|Treatment Period||0
8565046|NCT00001832|21114854|P14|NOT COMPLETED|Treatment Period||0
8565047|NCT00001832|21114855|P13|NOT COMPLETED|Treatment Period||0
8565048|NCT00001832|21114856|P12|NOT COMPLETED|Treatment Period||0
8565049|NCT00001832|21114857|P11|NOT COMPLETED|Treatment Period||0
8565050|NCT00001832|21114858|P10|NOT COMPLETED|Treatment Period||0
8565051|NCT00001832|21114859|P9|NOT COMPLETED|Treatment Period||0
8565052|NCT00001832|21114860|P8|NOT COMPLETED|Treatment Period||1
8565053|NCT00001832|21114861|P7|NOT COMPLETED|Treatment Period||0
8565054|NCT00001832|21114862|P6|NOT COMPLETED|Treatment Period||1
8565055|NCT00001832|21114863|P5|NOT COMPLETED|Treatment Period||0
8565056|NCT00001832|21114864|P4|NOT COMPLETED|Treatment Period||0
8565057|NCT00001832|21114865|P3|NOT COMPLETED|Treatment Period||0
8565058|NCT00001832|21114866|P2|NOT COMPLETED|Treatment Period||0
8565059|NCT00001832|21114867|P1|NOT COMPLETED|Treatment Period||0
8565060|NCT00001832|21114853|P15|COMPLETED|Treatment Period||2
8565061|NCT00001832|21114854|P14|COMPLETED|Treatment Period||3
8565062|NCT00001832|21114855|P13|COMPLETED|Treatment Period||6
8565063|NCT00001832|21114856|P12|COMPLETED|Treatment Period||7
8565064|NCT00001832|21114857|P11|COMPLETED|Treatment Period||1
8565065|NCT00001832|21114858|P10|COMPLETED|Treatment Period||6
8565066|NCT00001832|21114859|P9|COMPLETED|Treatment Period||8
8565067|NCT00001832|21114860|P8|COMPLETED|Treatment Period||6
8565068|NCT00001832|21114861|P7|COMPLETED|Treatment Period||4
8565069|NCT00001832|21114862|P6|COMPLETED|Treatment Period||50
8565070|NCT00001832|21114863|P5|COMPLETED|Treatment Period||6
8565071|NCT00001832|21114864|P4|COMPLETED|Treatment Period||3
8565072|NCT00001832|21114865|P3|COMPLETED|Treatment Period||3
8565073|NCT00001832|21114866|P2|COMPLETED|Treatment Period||3
8565074|NCT00001832|21114867|P1|COMPLETED|Treatment Period||0
8565075|NCT00001832|21114853|P15|STARTED|Treatment Period||2
8565076|NCT00001832|21114854|P14|STARTED|Treatment Period||3
8565077|NCT00001832|21114855|P13|STARTED|Treatment Period||6
8565078|NCT00001832|21114856|P12|STARTED|Treatment Period||7
8565079|NCT00001832|21114857|P11|STARTED|Treatment Period||1
8565080|NCT00001832|21114858|P10|STARTED|Treatment Period||6
8565081|NCT00001832|21114859|P9|STARTED|Treatment Period||8
8565082|NCT00001832|21114860|P8|STARTED|Treatment Period||7
8565083|NCT00001832|21114861|P7|STARTED|Treatment Period||4
8565084|NCT00001832|21114862|P6|STARTED|Treatment Period||51
8565085|NCT00001832|21114863|P5|STARTED|Treatment Period||6
8565086|NCT00001832|21114864|P4|STARTED|Treatment Period||3
8565087|NCT00001832|21114865|P3|STARTED|Treatment Period||3
8565088|NCT00001832|21114866|P2|STARTED|Treatment Period||3
8565089|NCT00001832|21114867|P1|STARTED|Treatment Period||0
8565090|NCT00001832|21114853|P15|NOT COMPLETED|Apheresis Period||0
8565091|NCT00001832|21114854|P14|NOT COMPLETED|Apheresis Period||0
8565092|NCT00001832|21114855|P13|NOT COMPLETED|Apheresis Period||0
8565093|NCT00001832|21114856|P12|NOT COMPLETED|Apheresis Period||0
8565094|NCT00001832|21114857|P11|NOT COMPLETED|Apheresis Period||0
8565095|NCT00001832|21114858|P10|NOT COMPLETED|Apheresis Period||0
8565096|NCT00001832|21114859|P9|NOT COMPLETED|Apheresis Period||0
8565097|NCT00001832|21114860|P8|NOT COMPLETED|Apheresis Period||0
8565098|NCT00001832|21114861|P7|NOT COMPLETED|Apheresis Period||0
8565099|NCT00001832|21114862|P6|NOT COMPLETED|Apheresis Period||0
8565100|NCT00001832|21114863|P5|NOT COMPLETED|Apheresis Period||0
8565101|NCT00001832|21114864|P4|NOT COMPLETED|Apheresis Period||0
8565102|NCT00001832|21114865|P3|NOT COMPLETED|Apheresis Period||0
8565103|NCT00001832|21114866|P2|NOT COMPLETED|Apheresis Period||0
8565104|NCT00001832|21114867|P1|NOT COMPLETED|Apheresis Period||60
8565105|NCT00001832|21114853|P15|COMPLETED|Apheresis Period||0
8565106|NCT00001832|21114854|P14|COMPLETED|Apheresis Period||0
8565107|NCT00001832|21114855|P13|COMPLETED|Apheresis Period||0
8565108|NCT00001832|21114856|P12|COMPLETED|Apheresis Period||0
8565109|NCT00001832|21114857|P11|COMPLETED|Apheresis Period||0
8565110|NCT00001832|21114858|P10|COMPLETED|Apheresis Period||0
8565111|NCT00001832|21114859|P9|COMPLETED|Apheresis Period||0
8565112|NCT00001832|21114860|P8|COMPLETED|Apheresis Period||0
8565113|NCT00001832|21114861|P7|COMPLETED|Apheresis Period||0
8565114|NCT00001832|21114862|P6|COMPLETED|Apheresis Period||0
8565115|NCT00001832|21114863|P5|COMPLETED|Apheresis Period||0
8565116|NCT00001832|21114864|P4|COMPLETED|Apheresis Period||0
8565117|NCT00001832|21114865|P3|COMPLETED|Apheresis Period||0
8565118|NCT00001832|21114866|P2|COMPLETED|Apheresis Period||0
8565119|NCT00001832|21114867|P1|COMPLETED|Apheresis Period||110
8565120|NCT00001832|21114853|P15|STARTED|Apheresis Period||0
8565121|NCT00001832|21114854|P14|STARTED|Apheresis Period||0
8565122|NCT00001832|21114855|P13|STARTED|Apheresis Period||0
8565123|NCT00001832|21114856|P12|STARTED|Apheresis Period||0
8565124|NCT00001832|21114857|P11|STARTED|Apheresis Period||0
8565125|NCT00001832|21114858|P10|STARTED|Apheresis Period||0
8565126|NCT00001832|21114859|P9|STARTED|Apheresis Period||0
8565127|NCT00001832|21114860|P8|STARTED|Apheresis Period||0
8565128|NCT00001832|21114861|P7|STARTED|Apheresis Period||0
8565129|NCT00001832|21114862|P6|STARTED|Apheresis Period||0
8565130|NCT00001832|21114863|P5|STARTED|Apheresis Period||0
8565131|NCT00001832|21114864|P4|STARTED|Apheresis Period||0
8565132|NCT00001832|21114865|P3|STARTED|Apheresis Period||0
8565133|NCT00001832|21114866|P2|STARTED|Apheresis Period||0
8565134|NCT00001832|21114867|P1|STARTED|Apheresis Period||170
8565135|NCT00001723|21114913|P2|NOT COMPLETED|Overall Study||16
8565136|NCT00001723|21114914|P1|NOT COMPLETED|Overall Study||13
8565137|NCT00001723|21114913|P2|COMPLETED|Overall Study||84
8565138|NCT00001723|21114914|P1|COMPLETED|Overall Study||87
8565139|NCT00001723|21114913|P2|STARTED|Overall Study||100
8565140|NCT00001723|21114914|P1|STARTED|Overall Study||100
8565141|NCT00001703|21114930|P1|NOT COMPLETED|Overall Study||5
8565142|NCT00001703|21114930|P1|COMPLETED|Overall Study||1
8565143|NCT00001703|21114930|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
8565144|NCT00001703|21114930|P1|STARTED|Overall Study||6
8565145|NCT00001656|21114937|P2|NOT COMPLETED|Overall Study||0
8565146|NCT00001656|21114938|P1|NOT COMPLETED|Overall Study||1
8565147|NCT00001656|21114937|P2|COMPLETED|Overall Study||12
8565148|NCT00001656|21114938|P1|COMPLETED|Overall Study||12
8565149|NCT00001656|21114937|P2|STARTED|Overall Study||12
8565150|NCT00001656|21114938|P1|STARTED|Overall Study||13
8565151|NCT00001596|21114968|P2|NOT COMPLETED|Overall Study||10
8565152|NCT00001596|21114969|P1|NOT COMPLETED|Overall Study||17
8565153|NCT00001596|21114968|P2|COMPLETED|Overall Study||2
8565154|NCT00001596|21114969|P1|COMPLETED|Overall Study||6
8565155|NCT00001596|21114968|P2|STARTED|Overall Study||12
8565156|NCT00001596|21114969|P1|STARTED|Overall Study||23
8565157|NCT00001586|21114991|P2|NOT COMPLETED|Overall Study||0
8565158|NCT00001586|21114992|P1|NOT COMPLETED|Overall Study||0
8565159|NCT00001586|21114991|P2|COMPLETED|Overall Study||56
8565160|NCT00001586|21114992|P1|COMPLETED|Overall Study||49
8565161|NCT00001586|21114991|P2|STARTED|Overall Study||56
8565162|NCT00001586|21114992|P1|STARTED|Overall Study||49
8565163|NCT00001575|21115000|P1|NOT COMPLETED|Overall Study||45
8565164|NCT00001575|21115000|P1|COMPLETED|Overall Study||42
8565165|NCT00001575|21115000|P1|Treated|Overall Study||65
8565166|NCT00001575|21115000|P1|STARTED|Overall Study||87
8565167|NCT00001566|21115006|P1|NOT COMPLETED|Overall Study||19
8565168|NCT00001566|21115006|P1|COMPLETED|Overall Study||23
8565169|NCT00001566|21115006|P1|Completed Immunotherapy|Overall Study||23
8565170|NCT00001566|21115006|P1|STARTED|Overall Study||42
8565171|NCT00001305|21115018|P1|NOT COMPLETED|Overall Study||0
8565172|NCT00001305|21115018|P1|COMPLETED|Overall Study||42
8565173|NCT00001305|21115018|P1|STARTED|Overall Study||42
8565174|NCT00001304|21115024|P2|NOT COMPLETED|Overall Study||0
8565175|NCT00001304|21115025|P1|NOT COMPLETED|Overall Study||0
8565176|NCT00001304|21115024|P2|COMPLETED|Overall Study||14
8565177|NCT00001304|21115025|P1|COMPLETED|Overall Study||13
8565178|NCT00001304|21115024|P2|STARTED|Overall Study||14
8565179|NCT00001304|21115025|P1|STARTED|Overall Study||13
8565180|NCT00001262|21115046|P3|NOT COMPLETED|Overall Study||0
8565181|NCT00001262|21115047|P2|NOT COMPLETED|Overall Study||14
8565182|NCT00001262|21115048|P1|NOT COMPLETED|Overall Study||10
8565183|NCT00001262|21115046|P3|COMPLETED|Overall Study||3
8565184|NCT00001262|21115047|P2|COMPLETED|Overall Study||8
8565185|NCT00001262|21115048|P1|COMPLETED|Overall Study||25
8565186|NCT00001262|21115046|P3|STARTED|Overall Study||3
8565187|NCT00001262|21115047|P2|STARTED|Overall Study||22
8565188|NCT00001262|21115048|P1|STARTED|Overall Study||35
8565189|NCT00001213|21115074|P1|NOT COMPLETED|Overall Study||18
8565190|NCT00001213|21115074|P1|COMPLETED|Overall Study||310
8565191|NCT00001213|21115074|P1|STARTED|Overall Study||328
8565192|NCT00001151|21115079|P1|NOT COMPLETED|Overall Study||5
8565193|NCT00001151|21115079|P1|COMPLETED|Overall Study||1
8565194|NCT00001151|21115079|P1|STARTED|Overall Study||6
8565195|NCT00000378|21115085|P2|NOT COMPLETED|Overall Study||14
8565196|NCT00000378|21115086|P1|NOT COMPLETED|Overall Study||16
8565197|NCT00000378|21115085|P2|COMPLETED|Overall Study||38
8565198|NCT00000378|21115086|P1|COMPLETED|Overall Study||42
8565199|NCT00000378|21115085|P2|STARTED|Overall Study||52
8565200|NCT00000378|21115086|P1|STARTED|Overall Study||58
8565201|NCT00000371|21115094|P2|NOT COMPLETED|Overall Study||16
8565202|NCT00000371|21115095|P1|NOT COMPLETED|Overall Study||13
8565203|NCT00000371|21115094|P2|COMPLETED|Overall Study||12
8565204|NCT00000371|21115095|P1|COMPLETED|Overall Study||14
8565205|NCT00000371|21115094|P2|STARTED|Overall Study||28
8565206|NCT00000371|21115095|P1|STARTED|Overall Study||27
8565207|NCT00000620|21115103|P8|NOT COMPLETED|Overall Study||146
8565208|NCT00000620|21115104|P7|NOT COMPLETED|Overall Study||149
8565209|NCT00000620|21115105|P6|NOT COMPLETED|Overall Study||152
8565210|NCT00000620|21115106|P5|NOT COMPLETED|Overall Study||135
8565211|NCT00000620|21115107|P4|NOT COMPLETED|Overall Study||178
8565212|NCT00000620|21115108|P3|NOT COMPLETED|Overall Study||170
8565213|NCT00000620|21115109|P2|NOT COMPLETED|Overall Study||136
8565214|NCT00000620|21115110|P1|NOT COMPLETED|Overall Study||162
8565215|NCT00000620|21115103|P8|COMPLETED|Overall Study||1224
8565216|NCT00000620|21115104|P7|COMPLETED|Overall Study||1242
8565217|NCT00000620|21115105|P6|COMPLETED|Overall Study||1026
8565218|NCT00000620|21115106|P5|COMPLETED|Overall Study||1049
8565219|NCT00000620|21115107|P4|COMPLETED|Overall Study||1205
8565220|NCT00000620|21115108|P3|COMPLETED|Overall Study||1204
8565221|NCT00000620|21115109|P2|COMPLETED|Overall Study||1057
8565222|NCT00000620|21115110|P1|COMPLETED|Overall Study||1016
8565223|NCT00000620|21115103|P8|STARTED|Overall Study||1370
8565224|NCT00000620|21115104|P7|STARTED|Overall Study||1391
8565225|NCT00000620|21115105|P6|STARTED|Overall Study||1178
8565226|NCT00000620|21115106|P5|STARTED|Overall Study||1184
8565227|NCT00000620|21115107|P4|STARTED|Overall Study||1383
8565228|NCT00000620|21115108|P3|STARTED|Overall Study||1374
8565229|NCT00000620|21115109|P2|STARTED|Overall Study||1193
8565230|NCT00000620|21115110|P1|STARTED|Overall Study||1178
8565231|NCT00000575|21115129|P3|NOT COMPLETED|Overall Study||0
8565232|NCT00000575|21115130|P2|NOT COMPLETED|Overall Study||0
8565233|NCT00000575|21115131|P1|NOT COMPLETED|Overall Study||0
8565234|NCT00000575|21115129|P3|COMPLETED|Overall Study||418
8565235|NCT00000575|21115130|P2|COMPLETED|Overall Study||312
8565236|NCT00000575|21115131|P1|COMPLETED|Overall Study||311
8565237|NCT00000575|21115129|P3|STARTED|Overall Study||418
8565238|NCT00000575|21115130|P2|STARTED|Overall Study||312
8565239|NCT00000575|21115131|P1|STARTED|Overall Study||311
8565240|NCT00000479|21115161|P4|NOT COMPLETED|Overall Study||0
8565241|NCT00000479|21115162|P3|NOT COMPLETED|Overall Study||0
8565242|NCT00000479|21115163|P2|NOT COMPLETED|Overall Study||0
8565243|NCT00000479|21115164|P1|NOT COMPLETED|Overall Study||0
8565244|NCT00000479|21115161|P4|COMPLETED|Overall Study||9971
8565245|NCT00000479|21115162|P3|COMPLETED|Overall Study||9966
8565246|NCT00000479|21115163|P2|COMPLETED|Overall Study||9971
8565247|NCT00000479|21115164|P1|COMPLETED|Overall Study||9968
8565248|NCT00000479|21115161|P4|STARTED|Overall Study||9971
8565249|NCT00000479|21115162|P3|STARTED|Overall Study||9966
8565250|NCT00000479|21115163|P2|STARTED|Overall Study||9971
8565251|NCT00000479|21115164|P1|STARTED|Overall Study||9968
8565252|NCT00004500|21115180|P2|NOT COMPLETED|Overall Study||0
8565253|NCT00004500|21115181|P1|NOT COMPLETED|Overall Study||0
8565254|NCT00004500|21115180|P2|COMPLETED|Overall Study||31
8565255|NCT00004500|21115181|P1|COMPLETED|Overall Study||38
8565256|NCT00004500|21115180|P2|1 Year Follow-Up|Overall Study||24
8565257|NCT00004500|21115181|P1|1 Year Follow-Up|Overall Study||24
8565258|NCT00004500|21115180|P2|STARTED|Overall Study||31
8565259|NCT00004500|21115181|P1|STARTED|Overall Study||38
8565260|NCT00004445|21115191|P1|NOT COMPLETED|Overall Study||3
8565261|NCT00004445|21115191|P1|COMPLETED|Overall Study||15
8565262|NCT00004445|21115191|P1|STARTED|Overall Study||18
8565263|NCT00004418|21115196|P1|NOT COMPLETED|Overall Study||0
8565264|NCT00004418|21115196|P1|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
8565265|NCT00004418|21115196|P1|STARTED|Overall Study||126
8565266|NCT00004412|21115204|P3|NOT COMPLETED|Crossover Period||0
8565267|NCT00004412|21115205|P2|NOT COMPLETED|Crossover Period||0
8565268|NCT00004412|21115206|P1|NOT COMPLETED|Crossover Period||0
8565269|NCT00004412|21115204|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
8565270|NCT00004412|21115205|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
8565271|NCT00004412|21115206|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
8565272|NCT00004412|21115204|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
8565273|NCT00004412|21115205|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
8565274|NCT00004412|21115206|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
8565275|NCT00004412|21115204|P3|NOT COMPLETED|Randomized Period||0
8565276|NCT00004412|21115205|P2|NOT COMPLETED|Randomized Period||0
8565277|NCT00004412|21115206|P1|NOT COMPLETED|Randomized Period||3
8565278|NCT00004412|21115204|P3|COMPLETED|Randomized Period||0
8565279|NCT00004412|21115205|P2|COMPLETED|Randomized Period||12
8565280|NCT00004412|21115206|P1|COMPLETED|Randomized Period||8
8565281|NCT00004412|21115204|P3|STARTED|Randomized Period||0
8565282|NCT00004412|21115205|P2|STARTED|Randomized Period||12
8565283|NCT00004412|21115206|P1|STARTED|Randomized Period||11
8565284|NCT00000143|21115216|P2|NOT COMPLETED|Overall Study||0
8565285|NCT00000143|21115217|P1|NOT COMPLETED|Overall Study||0
8565286|NCT00000143|21115216|P2|COMPLETED|Overall Study||30
8565287|NCT00000143|21115217|P1|COMPLETED|Overall Study||31
8565288|NCT00000143|21115216|P2|STARTED|Overall Study||30
8565289|NCT00000143|21115217|P1|STARTED|Overall Study||31
8565290|NCT00000142|21115226|P3|NOT COMPLETED|Overall Study||0
8565291|NCT00000142|21115227|P2|NOT COMPLETED|Overall Study||0
8565292|NCT00000142|21115228|P1|NOT COMPLETED|Overall Study||0
8565293|NCT00000142|21115226|P3|COMPLETED|Overall Study||12
8565294|NCT00000142|21115227|P2|COMPLETED|Overall Study||26
8565295|NCT00000142|21115228|P1|COMPLETED|Overall Study||26
8565296|NCT00000142|21115226|P3|STARTED|Overall Study||12
8565297|NCT00000142|21115227|P2|STARTED|Overall Study||26
8565298|NCT00000142|21115228|P1|STARTED|Overall Study||26
8565299|NCT00000136|21115238|P2|NOT COMPLETED|Overall Study||0
8565300|NCT00000136|21115239|P1|NOT COMPLETED|Overall Study||0
8565301|NCT00000136|21115238|P2|COMPLETED|Overall Study||127
8565302|NCT00000136|21115239|P1|COMPLETED|Overall Study||107
8565303|NCT00000136|21115238|P2|STARTED|Overall Study||127
8565304|NCT00000136|21115239|P1|STARTED|Overall Study||107
8565305|NCT00000135|21115247|P2|NOT COMPLETED|Overall Study||14
8565306|NCT00000135|21115248|P1|NOT COMPLETED|Overall Study||27
8565307|NCT00000135|21115247|P2|COMPLETED|Overall Study||91
8565308|NCT00000135|21115248|P1|COMPLETED|Overall Study||77
8565309|NCT00000135|21115247|P2|STARTED|Overall Study||105
8565310|NCT00000135|21115248|P1|STARTED|Overall Study||104
8565311|NCT00000134|21115257|P3|NOT COMPLETED|Overall Study||0
8565312|NCT00000134|21115258|P2|NOT COMPLETED|Overall Study||0
8565313|NCT00000134|21115259|P1|NOT COMPLETED|Overall Study||0
8565314|NCT00000134|21115257|P3|COMPLETED|Overall Study||96
8565315|NCT00000134|21115258|P2|COMPLETED|Overall Study||94
8565316|NCT00000134|21115259|P1|COMPLETED|Overall Study||89
8565317|NCT00000134|21115257|P3|STARTED|Overall Study||96
8565318|NCT00000134|21115258|P2|STARTED|Overall Study||94
8565319|NCT00000134|21115259|P1|STARTED|Overall Study||89
8565320|NCT00000125|21115269|P2|NOT COMPLETED|Overall Study||238
8565321|NCT00000125|21115270|P1|NOT COMPLETED|Overall Study||239
8565322|NCT00000125|21115269|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
8565323|NCT00000125|21115270|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
8565324|NCT00000125|21115269|P2|Completed OHTS Phase I, June 2002|Overall Study||702
8565325|NCT00000125|21115270|P1|Completed OHTS Phase I, June 2002|Overall Study||706
8565326|NCT00000125|21115269|P2|STARTED|Overall Study||817
8565327|NCT00000125|21115270|P1|STARTED|Overall Study||819
8565357|NCT04160988|21115324|P1|NOT COMPLETED|Overall Study||28
8565358|NCT04160988|21115324|P1|COMPLETED|Overall Study||675
8565359|NCT04160988|21115324|P1|STARTED|Overall Study||703
8565366|NCT03972813|21115359|P18|NOT COMPLETED|Overall Study||2
8565367|NCT03972813|21115360|P17|NOT COMPLETED|Overall Study||3
8565368|NCT03972813|21115361|P16|NOT COMPLETED|Overall Study||6
8565369|NCT03972813|21115362|P15|NOT COMPLETED|Overall Study||2
8565370|NCT03972813|21115363|P14|NOT COMPLETED|Overall Study||3
8565371|NCT03972813|21115364|P13|NOT COMPLETED|Overall Study||3
8565372|NCT03972813|21115365|P12|NOT COMPLETED|Overall Study||4
8565373|NCT03972813|21115366|P11|NOT COMPLETED|Overall Study||5
8565374|NCT03972813|21115367|P10|NOT COMPLETED|Overall Study||2
8565375|NCT03972813|21115368|P9|NOT COMPLETED|Overall Study||5
8565376|NCT03972813|21115369|P8|NOT COMPLETED|Overall Study||3
8565377|NCT03972813|21115370|P7|NOT COMPLETED|Overall Study||4
8565378|NCT03972813|21115371|P6|NOT COMPLETED|Overall Study||2
8565379|NCT03972813|21115372|P5|NOT COMPLETED|Overall Study||4
8565380|NCT03972813|21115373|P4|NOT COMPLETED|Overall Study||4
8565381|NCT03972813|21115374|P3|NOT COMPLETED|Overall Study||6
8565382|NCT03972813|21115375|P2|NOT COMPLETED|Overall Study||4
8565383|NCT03972813|21115376|P1|NOT COMPLETED|Overall Study||6
8565384|NCT03972813|21115359|P18|COMPLETED|Overall Study||48
8565385|NCT03972813|21115360|P17|COMPLETED|Overall Study||48
8565386|NCT03972813|21115361|P16|COMPLETED|Overall Study||50
8565387|NCT03972813|21115362|P15|COMPLETED|Overall Study||56
8565388|NCT03972813|21115363|P14|COMPLETED|Overall Study||52
8565389|NCT03972813|21115364|P13|COMPLETED|Overall Study||55
8565390|NCT03972813|21115365|P12|COMPLETED|Overall Study||51
8565391|NCT03972813|21115366|P11|COMPLETED|Overall Study||57
8565392|NCT03972813|21115367|P10|COMPLETED|Overall Study||58
8565393|NCT03972813|21115368|P9|COMPLETED|Overall Study||53
8565394|NCT03972813|21115369|P8|COMPLETED|Overall Study||52
8565395|NCT03972813|21115370|P7|COMPLETED|Overall Study||49
8565396|NCT03972813|21115371|P6|COMPLETED|Overall Study||49
8565397|NCT03972813|21115372|P5|COMPLETED|Overall Study||48
8565398|NCT03972813|21115373|P4|COMPLETED|Overall Study||51
8565399|NCT03972813|21115374|P3|COMPLETED|Overall Study||52
8565400|NCT03972813|21115375|P2|COMPLETED|Overall Study||45
8565401|NCT03972813|21115376|P1|COMPLETED|Overall Study||79
8565402|NCT03972813|21115359|P18|STARTED|Overall Study||50
8565403|NCT03972813|21115360|P17|STARTED|Overall Study||51
8565404|NCT03972813|21115361|P16|STARTED|Overall Study||56
8565405|NCT03972813|21115362|P15|STARTED|Overall Study||58
8565406|NCT03972813|21115363|P14|STARTED|Overall Study||55
8565407|NCT03972813|21115364|P13|STARTED|Overall Study||58
8565408|NCT03972813|21115365|P12|STARTED|Overall Study||55
8565409|NCT03972813|21115366|P11|STARTED|Overall Study||62
8565410|NCT03972813|21115367|P10|STARTED|Overall Study||60
8565411|NCT03972813|21115368|P9|STARTED|Overall Study||58
8565412|NCT03972813|21115369|P8|STARTED|Overall Study||55
8565413|NCT03972813|21115370|P7|STARTED|Overall Study||53
8565414|NCT03972813|21115371|P6|STARTED|Overall Study||51
8565415|NCT03972813|21115372|P5|STARTED|Overall Study||52
8565416|NCT03972813|21115373|P4|STARTED|Overall Study||55
8565417|NCT03972813|21115374|P3|STARTED|Overall Study||58
8565418|NCT03972813|21115375|P2|STARTED|Overall Study||49
8565419|NCT03972813|21115376|P1|STARTED|Overall Study||85
8565420|NCT03888235|21115417|P3|NOT COMPLETED|Overall Study||0
8565421|NCT03888235|21115418|P2|NOT COMPLETED|Overall Study||0
8565422|NCT03888235|21115419|P1|NOT COMPLETED|Overall Study||0
8565423|NCT03888235|21115417|P3|COMPLETED|Overall Study||21
8565424|NCT03888235|21115418|P2|COMPLETED|Overall Study||20
8565425|NCT03888235|21115419|P1|COMPLETED|Overall Study||20
8565426|NCT03888235|21115417|P3|STARTED|Overall Study|1 participant dropped out after the first visit and was replaced. He completed the study after 5 mo,|21
8565518|NCT03377244|21115656|P2|COMPLETED|Baseline||14
8565427|NCT03888235|21115418|P2|STARTED|Overall Study|2 participants dropped out after the first visit and were replaced|20
8565428|NCT03888235|21115419|P1|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|20
8565436|NCT03792737|21115504|P3|NOT COMPLETED|Overall Study||9
8565437|NCT03792737|21115505|P2|NOT COMPLETED|Overall Study||8
8565438|NCT03792737|21115506|P1|NOT COMPLETED|Overall Study||6
8565439|NCT03792737|21115504|P3|COMPLETED|Overall Study||158
8565440|NCT03792737|21115505|P2|COMPLETED|Overall Study||159
8565441|NCT03792737|21115506|P1|COMPLETED|Overall Study||160
8565442|NCT03792737|21115504|P3|Full Analysis Set|Overall Study||162
8565443|NCT03792737|21115505|P2|Full Analysis Set|Overall Study||160
8565444|NCT03792737|21115506|P1|Full Analysis Set|Overall Study||162
8565445|NCT03792737|21115504|P3|Safety Analysis Set|Overall Study||162
8565446|NCT03792737|21115505|P2|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
8565447|NCT03792737|21115506|P1|Safety Analysis Set|Overall Study||162
8565448|NCT03792737|21115504|P3|STARTED|Overall Study||167
8565449|NCT03792737|21115505|P2|STARTED|Overall Study||167
8565450|NCT03792737|21115506|P1|STARTED|Overall Study||166
8565457|NCT03650192|21115552|P1|NOT COMPLETED|Overall Study||0
8565458|NCT03650192|21115552|P1|COMPLETED|Overall Study||40
8565459|NCT03650192|21115552|P1|STARTED|Overall Study||40
8565463|NCT03520998|21115565|P2|NOT COMPLETED|Overall Study||2
8565464|NCT03520998|21115566|P1|NOT COMPLETED|Overall Study||6
8565465|NCT03520998|21115565|P2|COMPLETED|Overall Study||21
8565466|NCT03520998|21115566|P1|COMPLETED|Overall Study||18
8565467|NCT03520998|21115565|P2|STARTED|Overall Study||23
8565468|NCT03520998|21115566|P1|STARTED|Overall Study||24
8565472|NCT03492398|21115597|P9|NOT COMPLETED|Overall Study||0
8565473|NCT03492398|21115598|P8|NOT COMPLETED|Overall Study||1
8565474|NCT03492398|21115599|P7|NOT COMPLETED|Overall Study||1
8565475|NCT03492398|21115600|P6|NOT COMPLETED|Overall Study||0
8565476|NCT03492398|21115601|P5|NOT COMPLETED|Overall Study||0
8565477|NCT03492398|21115602|P4|NOT COMPLETED|Overall Study||0
8565478|NCT03492398|21115603|P3|NOT COMPLETED|Overall Study||0
8565479|NCT03492398|21115604|P2|NOT COMPLETED|Overall Study||0
8565480|NCT03492398|21115605|P1|NOT COMPLETED|Overall Study||0
8565481|NCT03492398|21115597|P9|COMPLETED|Overall Study||6
8565482|NCT03492398|21115598|P8|COMPLETED|Overall Study||5
8565483|NCT03492398|21115599|P7|COMPLETED|Overall Study||5
8565484|NCT03492398|21115600|P6|COMPLETED|Overall Study||6
8565485|NCT03492398|21115601|P5|COMPLETED|Overall Study||6
8565486|NCT03492398|21115602|P4|COMPLETED|Overall Study||6
8565487|NCT03492398|21115603|P3|COMPLETED|Overall Study||6
8565488|NCT03492398|21115604|P2|COMPLETED|Overall Study||6
8565489|NCT03492398|21115605|P1|COMPLETED|Overall Study||8
8565490|NCT03492398|21115597|P9|STARTED|Overall Study||6
8565491|NCT03492398|21115598|P8|STARTED|Overall Study||6
8565492|NCT03492398|21115599|P7|STARTED|Overall Study||6
8565493|NCT03492398|21115600|P6|STARTED|Overall Study||6
8565494|NCT03492398|21115601|P5|STARTED|Overall Study||6
8565495|NCT03492398|21115602|P4|STARTED|Overall Study||6
8565496|NCT03492398|21115603|P3|STARTED|Overall Study||6
8565497|NCT03492398|21115604|P2|STARTED|Overall Study||6
8565498|NCT03492398|21115605|P1|STARTED|Overall Study||8
8565505|NCT03377244|21115655|P3|NOT COMPLETED|6 Months Post-intervention||14
8565506|NCT03377244|21115656|P2|NOT COMPLETED|6 Months Post-intervention||7
8565507|NCT03377244|21115657|P1|NOT COMPLETED|6 Months Post-intervention||6
8565508|NCT03377244|21115655|P3|COMPLETED|6 Months Post-intervention||55
8565509|NCT03377244|21115656|P2|COMPLETED|6 Months Post-intervention||7
8565510|NCT03377244|21115657|P1|COMPLETED|6 Months Post-intervention||13
8565511|NCT03377244|21115655|P3|STARTED|6 Months Post-intervention||69
8565512|NCT03377244|21115656|P2|STARTED|6 Months Post-intervention||14
8565513|NCT03377244|21115657|P1|STARTED|6 Months Post-intervention||19
8565514|NCT03377244|21115655|P3|NOT COMPLETED|Baseline||0
8565515|NCT03377244|21115656|P2|NOT COMPLETED|Baseline||0
8565516|NCT03377244|21115657|P1|NOT COMPLETED|Baseline||0
8565517|NCT03377244|21115655|P3|COMPLETED|Baseline||69
8565519|NCT03377244|21115657|P1|COMPLETED|Baseline||19
8565520|NCT03377244|21115655|P3|STARTED|Baseline||69
8565521|NCT03377244|21115656|P2|STARTED|Baseline||14
8565522|NCT03377244|21115657|P1|STARTED|Baseline||19
8565544|NCT03284398|21115856|P2|NOT COMPLETED|Overall Study||0
8565545|NCT03284398|21115857|P1|NOT COMPLETED|Overall Study||0
8565546|NCT03284398|21115856|P2|COMPLETED|Overall Study||970
8565547|NCT03284398|21115857|P1|COMPLETED|Overall Study||2753
8565548|NCT03284398|21115856|P2|STARTED|Overall Study||970
8565549|NCT03284398|21115857|P1|STARTED|Overall Study||2753
8565558|NCT03250182|21115914|P1|NOT COMPLETED|Overall Study||1
8565559|NCT03250182|21115914|P1|COMPLETED|Overall Study||29
8565560|NCT03250182|21115914|P1|STARTED|Overall Study||30
8565581|NCT03142451|21115986|P2|NOT COMPLETED|Overall Study||24
8565582|NCT03142451|21115987|P1|NOT COMPLETED|Overall Study||58
8565583|NCT03142451|21115986|P2|COMPLETED|Overall Study||232
8565584|NCT03142451|21115987|P1|COMPLETED|Overall Study||437
8565585|NCT03142451|21115986|P2|STARTED|Overall Study||256
8565586|NCT03142451|21115987|P1|STARTED|Overall Study||495
8565608|NCT03066947|21116216|P1|NOT COMPLETED|Overall Study||10
8565609|NCT03066947|21116216|P1|COMPLETED|Overall Study||14
8565610|NCT03066947|21116216|P1|STARTED|Overall Study||24
8565611|NCT02916498|21116227|P2|NOT COMPLETED|Second Intervention, 21 Days||0
8565612|NCT02916498|21116228|P1|NOT COMPLETED|Second Intervention, 21 Days||0
8565613|NCT02916498|21116227|P2|COMPLETED|Second Intervention, 21 Days||4
8565614|NCT02916498|21116228|P1|COMPLETED|Second Intervention, 21 Days||2
8565615|NCT02916498|21116227|P2|STARTED|Second Intervention, 21 Days||4
8565616|NCT02916498|21116228|P1|STARTED|Second Intervention, 21 Days||2
8565617|NCT02916498|21116227|P2|NOT COMPLETED|First Intervention, 21 Days||0
8565618|NCT02916498|21116228|P1|NOT COMPLETED|First Intervention, 21 Days||0
8565619|NCT02916498|21116227|P2|COMPLETED|First Intervention, 21 Days||4
8565620|NCT02916498|21116228|P1|COMPLETED|First Intervention, 21 Days||2
8565621|NCT02916498|21116227|P2|STARTED|First Intervention, 21 Days||4
8565622|NCT02916498|21116228|P1|STARTED|First Intervention, 21 Days||2
8565623|NCT02913222|21116236|P2|NOT COMPLETED|Overall Study||2
8565624|NCT02913222|21116237|P1|NOT COMPLETED|Overall Study||1
8565625|NCT02913222|21116236|P2|COMPLETED|Overall Study||21
8565626|NCT02913222|21116237|P1|COMPLETED|Overall Study||22
8565627|NCT02913222|21116236|P2|STARTED|Overall Study||23
8565628|NCT02913222|21116237|P1|STARTED|Overall Study||23
8565635|NCT02833844|21116272|P2|NOT COMPLETED|Open-Label Period||2
8565636|NCT02833844|21116273|P1|NOT COMPLETED|Open-Label Period||2
8565637|NCT02833844|21116272|P2|COMPLETED|Open-Label Period||301
8565638|NCT02833844|21116273|P1|COMPLETED|Open-Label Period||150
8565639|NCT02833844|21116272|P2|Received Open-Label Study Drug|Open-Label Period||299
8565640|NCT02833844|21116273|P1|Received Open-Label Study Drug|Open-Label Period||152
8565641|NCT02833844|21116272|P2|STARTED|Open-Label Period||303
8565642|NCT02833844|21116273|P1|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
8565643|NCT02833844|21116272|P2|NOT COMPLETED|Double-Blind Period||7
8565644|NCT02833844|21116273|P1|NOT COMPLETED|Double-Blind Period||2
8565645|NCT02833844|21116272|P2|COMPLETED|Double-Blind Period|completed double-blind period|303
8565646|NCT02833844|21116273|P1|COMPLETED|Double-Blind Period|completed double-blind period|155
8565647|NCT02833844|21116272|P2|Randomized and Treated|Double-Blind Period||307
8565648|NCT02833844|21116273|P1|Randomized and Treated|Double-Blind Period||157
8565649|NCT02833844|21116272|P2|STARTED|Double-Blind Period||310
8565650|NCT02833844|21116273|P1|STARTED|Double-Blind Period||157
8565651|NCT02754518|21116301|P1|NOT COMPLETED|Overall Study||0
8565652|NCT02754518|21116301|P1|COMPLETED|Overall Study||40
8565653|NCT02754518|21116301|P1|STARTED|Overall Study||40
8565654|NCT02730234|21116339|P1|NOT COMPLETED|Overall Study||8
8565655|NCT02730234|21116339|P1|COMPLETED|Overall Study|8 Deaths|52
8565656|NCT02730234|21116339|P1|STARTED|Overall Study||60
8565657|NCT02728258|21116358|P1|NOT COMPLETED|Overall Study||0
8565658|NCT02728258|21116358|P1|COMPLETED|Overall Study||11
8565659|NCT02728258|21116358|P1|STARTED|Overall Study||11
8565708|NCT02668393|21116664|P2|NOT COMPLETED|Overall Study||6
8565709|NCT02668393|21116665|P1|NOT COMPLETED|Overall Study||7
8565710|NCT02668393|21116664|P2|COMPLETED|Overall Study||1
8565711|NCT02668393|21116665|P1|COMPLETED|Overall Study||0
8565712|NCT02668393|21116664|P2|STARTED|Overall Study||7
8565713|NCT02668393|21116665|P1|STARTED|Overall Study||7
8565714|NCT02660827|21116674|P1|NOT COMPLETED|2-6 Years Old Age Group||1
8565715|NCT02660827|21116674|P1|COMPLETED|2-6 Years Old Age Group||45
8565716|NCT02660827|21116674|P1|STARTED|2-6 Years Old Age Group||46
8565717|NCT02660827|21116674|P1|NOT COMPLETED|7-13 Years Old Age Group||0
8565718|NCT02660827|21116674|P1|COMPLETED|7-13 Years Old Age Group||105
8565719|NCT02660827|21116674|P1|STARTED|7-13 Years Old Age Group||105
8565723|NCT02635386|21116702|P5|NOT COMPLETED|Overall Study||9
8565724|NCT02635386|21116703|P4|NOT COMPLETED|Overall Study||7
8565725|NCT02635386|21116704|P3|NOT COMPLETED|Overall Study||2
8565726|NCT02635386|21116705|P2|NOT COMPLETED|Overall Study||6
8565727|NCT02635386|21116706|P1|NOT COMPLETED|Overall Study||3
8565728|NCT02635386|21116702|P5|COMPLETED|Overall Study||16
8565729|NCT02635386|21116703|P4|COMPLETED|Overall Study||19
8565730|NCT02635386|21116704|P3|COMPLETED|Overall Study||20
8565731|NCT02635386|21116705|P2|COMPLETED|Overall Study||17
8565732|NCT02635386|21116706|P1|COMPLETED|Overall Study||20
8565733|NCT02635386|21116702|P5|STARTED|Overall Study||25
8565734|NCT02635386|21116703|P4|STARTED|Overall Study||26
8565735|NCT02635386|21116704|P3|STARTED|Overall Study||22
8565736|NCT02635386|21116705|P2|STARTED|Overall Study||23
8565737|NCT02635386|21116706|P1|STARTED|Overall Study||23
8565738|NCT02631577|21116830|P2|NOT COMPLETED|Overall Study||4
8565739|NCT02631577|21116831|P1|NOT COMPLETED|Overall Study||1
8565740|NCT02631577|21116830|P2|COMPLETED|Overall Study||30
8565741|NCT02631577|21116831|P1|COMPLETED|Overall Study||3
8565742|NCT02631577|21116830|P2|STARTED|Overall Study||34
8565743|NCT02631577|21116831|P1|STARTED|Overall Study||4
8565750|NCT02454075|21116859|P1|NOT COMPLETED|Overall Study||0
8565751|NCT02454075|21116859|P1|COMPLETED|Overall Study||3
8565752|NCT02454075|21116859|P1|STARTED|Overall Study||3
8565759|NCT02332590|21116966|P2|NOT COMPLETED|Overall Study||19
8565760|NCT02332590|21116967|P1|NOT COMPLETED|Overall Study||29
8565761|NCT02332590|21116966|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
8565762|NCT02332590|21116967|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
8565763|NCT02332590|21116966|P2|Treated|Overall Study||184
8565764|NCT02332590|21116967|P1|Treated|Overall Study||184
8565765|NCT02332590|21116966|P2|STARTED|Overall Study||184
8565766|NCT02332590|21116967|P1|STARTED|Overall Study||185
8565794|NCT02260258|21117182|P2|NOT COMPLETED|Overall Study||1
8565795|NCT02260258|21117183|P1|NOT COMPLETED|Overall Study||2
8565796|NCT02260258|21117182|P2|COMPLETED|Overall Study||43
8565797|NCT02260258|21117183|P1|COMPLETED|Overall Study||37
8565798|NCT02260258|21117182|P2|STARTED|Overall Study||44
8565799|NCT02260258|21117183|P1|STARTED|Overall Study||39
8565800|NCT02163824|21117205|P3|NOT COMPLETED|Overall Study||2
8565801|NCT02163824|21117206|P2|NOT COMPLETED|Overall Study||1
8565802|NCT02163824|21117207|P1|NOT COMPLETED|Overall Study||2
8565803|NCT02163824|21117205|P3|COMPLETED|Overall Study||124
8565804|NCT02163824|21117206|P2|COMPLETED|Overall Study||124
8565805|NCT02163824|21117207|P1|COMPLETED|Overall Study||127
8565806|NCT02163824|21117205|P3|STARTED|Overall Study||126
8565807|NCT02163824|21117206|P2|STARTED|Overall Study||125
8565808|NCT02163824|21117207|P1|STARTED|Overall Study||129
8565809|NCT01973283|21117230|P1|NOT COMPLETED|Overall Study||4
8565810|NCT01973283|21117230|P1|COMPLETED|Overall Study||96
8565811|NCT01973283|21117230|P1|STARTED|Overall Study||100
8565812|NCT01936519|21117258|P2|NOT COMPLETED|Overall Study||4
8565813|NCT01936519|21117259|P1|NOT COMPLETED|Overall Study||1
8565814|NCT01936519|21117258|P2|COMPLETED|Overall Study||8
8565815|NCT01936519|21117259|P1|COMPLETED|Overall Study||11
8565816|NCT01936519|21117258|P2|STARTED|Overall Study||12
8565817|NCT01936519|21117259|P1|STARTED|Overall Study||12
8565818|NCT01912456|21117277|P4|NOT COMPLETED|Period 2||1
8565819|NCT01912456|21117278|P3|NOT COMPLETED|Period 2||0
8565820|NCT01912456|21117279|P2|NOT COMPLETED|Period 2||2
8565821|NCT01912456|21117280|P1|NOT COMPLETED|Period 2||0
8565822|NCT01912456|21117277|P4|COMPLETED|Period 2||18
8565823|NCT01912456|21117278|P3|COMPLETED|Period 2||21
8565824|NCT01912456|21117279|P2|COMPLETED|Period 2||20
8565825|NCT01912456|21117280|P1|COMPLETED|Period 2||20
8565826|NCT01912456|21117277|P4|STARTED|Period 2||19
8565827|NCT01912456|21117278|P3|STARTED|Period 2||21
8565828|NCT01912456|21117279|P2|STARTED|Period 2||22
8565829|NCT01912456|21117280|P1|STARTED|Period 2||20
8565830|NCT01912456|21117277|P4|NOT COMPLETED|Period 1||3
8565831|NCT01912456|21117278|P3|NOT COMPLETED|Period 1||2
8565832|NCT01912456|21117279|P2|NOT COMPLETED|Period 1||1
8565833|NCT01912456|21117280|P1|NOT COMPLETED|Period 1||2
8565834|NCT01912456|21117277|P4|COMPLETED|Period 1||19
8565835|NCT01912456|21117278|P3|COMPLETED|Period 1||21
8565836|NCT01912456|21117279|P2|COMPLETED|Period 1||22
8565837|NCT01912456|21117280|P1|COMPLETED|Period 1||20
8565838|NCT01912456|21117277|P4|STARTED|Period 1||22
8565839|NCT01912456|21117278|P3|STARTED|Period 1||23
8565840|NCT01912456|21117279|P2|STARTED|Period 1||23
8565841|NCT01912456|21117280|P1|STARTED|Period 1||22
8565903|NCT01812109|21117428|P1|NOT COMPLETED|Overall Study||33
8565904|NCT01812109|21117428|P1|COMPLETED|Overall Study||121
8565905|NCT01812109|21117428|P1|Without Torsion|Overall Study||85
8565906|NCT01812109|21117428|P1|With Torsion|Overall Study||36
8565907|NCT01812109|21117428|P1|STARTED|Overall Study||154
8565908|NCT01804114|21117434|P2|NOT COMPLETED|Overall Study||0
8565909|NCT01804114|21117435|P1|NOT COMPLETED|Overall Study||0
8565910|NCT01804114|21117434|P2|COMPLETED|Overall Study||12
8565911|NCT01804114|21117435|P1|COMPLETED|Overall Study||17
8565912|NCT01804114|21117434|P2|STARTED|Overall Study||12
8565913|NCT01804114|21117435|P1|STARTED|Overall Study||17
8565984|NCT01467063|21117595|P2|NOT COMPLETED|Overall Study||0
8565985|NCT01467063|21117596|P1|NOT COMPLETED|Overall Study||1
8565986|NCT01467063|21117595|P2|COMPLETED|Overall Study||7
8565987|NCT01467063|21117596|P1|COMPLETED|Overall Study||5
8565988|NCT01467063|21117595|P2|STARTED|Overall Study||7
8565989|NCT01467063|21117596|P1|STARTED|Overall Study||6
8565990|NCT01380080|21117606|P2|NOT COMPLETED|Overall Study||83
8565991|NCT01380080|21117607|P1|NOT COMPLETED|Overall Study||85
8565992|NCT01380080|21117606|P2|COMPLETED|Overall Study||343
8565993|NCT01380080|21117607|P1|COMPLETED|Overall Study||339
8565994|NCT01380080|21117606|P2|STARTED|Overall Study||426
8565995|NCT01380080|21117607|P1|STARTED|Overall Study||424
8566011|NCT01271712|21117714|P2|NOT COMPLETED|Survival Follow-up||6
8566012|NCT01271712|21117715|P1|NOT COMPLETED|Survival Follow-up||15
8566013|NCT01271712|21117714|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
8566014|NCT01271712|21117715|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
8566015|NCT01271712|21117714|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
8566016|NCT01271712|21117715|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
8566017|NCT01271712|21117714|P2|NOT COMPLETED|Safety Follow-up||15
8566018|NCT01271712|21117715|P1|NOT COMPLETED|Safety Follow-up||21
8566019|NCT01271712|21117714|P2|COMPLETED|Safety Follow-up||37
8566020|NCT01271712|21117715|P1|COMPLETED|Safety Follow-up||97
8566021|NCT01271712|21117714|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
8566022|NCT01271712|21117715|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
8566023|NCT01271712|21117714|P2|NOT COMPLETED|Open Label Treatment||58
8566024|NCT01271712|21117715|P1|NOT COMPLETED|Open Label Treatment||91
8566025|NCT01271712|21117714|P2|COMPLETED|Open Label Treatment||0
8566026|NCT01271712|21117715|P1|COMPLETED|Open Label Treatment||0
8566027|NCT01271712|21117714|P2|STARTED|Open Label Treatment||58
8566028|NCT01271712|21117715|P1|STARTED|Open Label Treatment||91
8566029|NCT01271712|21117714|P2|NOT COMPLETED|Double Blind Treatment||8
8566030|NCT01271712|21117715|P1|NOT COMPLETED|Double Blind Treatment||42
8566031|NCT01271712|21117714|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
8566032|NCT01271712|21117715|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
8566033|NCT01271712|21117714|P2|Participants Received Treatment|Double Blind Treatment||66
8566034|NCT01271712|21117715|P1|Participants Received Treatment|Double Blind Treatment||132
8566035|NCT01271712|21117714|P2|STARTED|Double Blind Treatment||66
8566036|NCT01271712|21117715|P1|STARTED|Double Blind Treatment||133
8566091|NCT00923559|21117862|P2|NOT COMPLETED|Overall Study||3
8566092|NCT00923559|21117863|P1|NOT COMPLETED|Overall Study||2
8566093|NCT00923559|21117862|P2|COMPLETED|Overall Study||37
8566094|NCT00923559|21117863|P1|COMPLETED|Overall Study||38
8566095|NCT00923559|21117862|P2|STARTED|Overall Study||40
8566096|NCT00923559|21117863|P1|STARTED|Overall Study||40
8566130|NCT00664326|21117933|P1|NOT COMPLETED|Overall Study||48
8566131|NCT00664326|21117933|P1|COMPLETED|Overall Study|transitioned to rollover study|1
8566132|NCT00664326|21117933|P1|STARTED|Overall Study||49
8566213|NCT00125788|21118377|P2|NOT COMPLETED|Overall Study||4
8566214|NCT00125788|21118378|P1|NOT COMPLETED|Overall Study||4
8566215|NCT00125788|21118377|P2|COMPLETED|Overall Study||29
8566216|NCT00125788|21118378|P1|COMPLETED|Overall Study||33
8566217|NCT00125788|21118377|P2|STARTED|Overall Study||33
8566218|NCT00125788|21118378|P1|STARTED|Overall Study||37
8569887|NCT04674644|21129528|P1|NOT COMPLETED|Overall Study||37
8569888|NCT04674644|21129528|P1|COMPLETED|Overall Study||813
8569889|NCT04674644|21129528|P1|STARTED|Overall Study||850
8569890|NCT04633564|21129535|P2|NOT COMPLETED|Period 2||97
8569891|NCT04633564|21129536|P1|NOT COMPLETED|Period 2||93
8569892|NCT04633564|21129535|P2|COMPLETED|Period 2||102
8569893|NCT04633564|21129536|P1|COMPLETED|Period 2||107
8569894|NCT04633564|21129535|P2|STARTED|Period 2||199
8569895|NCT04633564|21129536|P1|STARTED|Period 2||200
8569896|NCT04633564|21129535|P2|NOT COMPLETED|Period 1||109
8569897|NCT04633564|21129536|P1|NOT COMPLETED|Period 1||108
8569898|NCT04633564|21129535|P2|COMPLETED|Period 1||220
8569899|NCT04633564|21129536|P1|COMPLETED|Period 1||227
8569900|NCT04633564|21129535|P2|STARTED|Period 1||329
8569901|NCT04633564|21129536|P1|STARTED|Period 1||335
8569920|NCT04194008|21129589|P1|NOT COMPLETED|Treatment Phase With Nerivio||8
8569921|NCT04194008|21129589|P1|COMPLETED|Treatment Phase With Nerivio||91
8569922|NCT04194008|21129589|P1|STARTED|Treatment Phase With Nerivio||99
8569923|NCT04194008|21129589|P1|NOT COMPLETED|Baseline (Run-in) Phase||27
8569924|NCT04194008|21129589|P1|COMPLETED|Baseline (Run-in) Phase||99
8569925|NCT04194008|21129589|P1|STARTED|Baseline (Run-in) Phase||126
8569926|NCT04177862|21129603|P2|NOT COMPLETED|Overall Study||3
8569927|NCT04177862|21129604|P1|NOT COMPLETED|Overall Study||0
8569928|NCT04177862|21129603|P2|COMPLETED|Overall Study||39
8569929|NCT04177862|21129604|P1|COMPLETED|Overall Study||37
8569930|NCT04177862|21129603|P2|STARTED|Overall Study||42
8569931|NCT04177862|21129604|P1|STARTED|Overall Study||37
8569935|NCT04152642|21129626|P1|NOT COMPLETED|Overall Study||7
8569936|NCT04152642|21129626|P1|COMPLETED|Overall Study||15
8569937|NCT04152642|21129626|P1|B (Experimental Rinse)|Overall Study||19
8569938|NCT04152642|21129626|P1|A (Marketed Rinse)|Overall Study||19
8569939|NCT04152642|21129626|P1|C (Water/Negative) Control|Overall Study||20
8569940|NCT04152642|21129626|P1|STARTED|Overall Study||22
8569941|NCT04144166|21129634|P1|NOT COMPLETED|Overall Study||3
8569942|NCT04144166|21129634|P1|COMPLETED|Overall Study||57
8569943|NCT04144166|21129634|P1|STARTED|Overall Study||60
8569947|NCT04086693|21129653|P2|NOT COMPLETED|Overall Study||4
8569948|NCT04086693|21129654|P1|NOT COMPLETED|Overall Study||1
8569949|NCT04086693|21129653|P2|COMPLETED|Overall Study||171
8569950|NCT04086693|21129654|P1|COMPLETED|Overall Study||174
8569951|NCT04086693|21129653|P2|STARTED|Overall Study||175
8569952|NCT04086693|21129654|P1|STARTED|Overall Study||175
8569953|NCT04011631|21129660|P1|NOT COMPLETED|Overall Study||0
8569954|NCT04011631|21129660|P1|COMPLETED|Overall Study||100
8569955|NCT04011631|21129660|P1|STARTED|Overall Study||100
8569974|NCT03862625|21129688|P2|NOT COMPLETED|Overall Study||1
8569975|NCT03862625|21129689|P1|NOT COMPLETED|Overall Study||0
8569976|NCT03862625|21129688|P2|COMPLETED|Overall Study||14
8569977|NCT03862625|21129689|P1|COMPLETED|Overall Study||15
8569978|NCT03862625|21129688|P2|STARTED|Overall Study||15
8569979|NCT03862625|21129689|P1|STARTED|Overall Study||15
8569980|NCT03821064|21129701|P1|NOT COMPLETED|Overall Study||1
8569981|NCT03821064|21129701|P1|COMPLETED|Overall Study||10
8569982|NCT03821064|21129701|P1|STARTED|Overall Study||11
8569983|NCT03807245|21129733|P3|NOT COMPLETED|Overall Study||0
8569984|NCT03807245|21129734|P2|NOT COMPLETED|Overall Study||0
8569985|NCT03807245|21129735|P1|NOT COMPLETED|Overall Study||1
8569986|NCT03807245|21129733|P3|COMPLETED|Overall Study||12
8569987|NCT03807245|21129734|P2|COMPLETED|Overall Study||24
8569988|NCT03807245|21129735|P1|COMPLETED|Overall Study||23
8569989|NCT03807245|21129733|P3|STARTED|Overall Study||12
8569990|NCT03807245|21129734|P2|STARTED|Overall Study||24
8569991|NCT03807245|21129735|P1|STARTED|Overall Study||24
8569992|NCT03801473|21129757|P2|NOT COMPLETED|Overall Study||2
8569993|NCT03801473|21129758|P1|NOT COMPLETED|Overall Study||3
8569994|NCT03801473|21129757|P2|COMPLETED|Overall Study||19
8569995|NCT03801473|21129758|P1|COMPLETED|Overall Study||18
8569996|NCT03801473|21129757|P2|STARTED|Overall Study||21
8569997|NCT03801473|21129758|P1|STARTED|Overall Study||21
8569998|NCT03799783|21129810|P1|NOT COMPLETED|Overall Study||0
8569999|NCT03799783|21129810|P1|COMPLETED|Overall Study||19
8570000|NCT03799783|21129810|P1|STARTED|Overall Study||19
8570001|NCT03798483|21129815|P1|NOT COMPLETED|Overall Study||2
8570002|NCT03798483|21129815|P1|COMPLETED|Overall Study||13
8570003|NCT03798483|21129815|P1|Returned All Follow-up Outcome Data|Overall Study||11
8570004|NCT03798483|21129815|P1|STARTED|Overall Study||15
8570017|NCT03751657|21129903|P2|NOT COMPLETED|Overall Study||3
8570018|NCT03751657|21129904|P1|NOT COMPLETED|Overall Study||3
8570019|NCT03751657|21129903|P2|COMPLETED|Overall Study||119
8570020|NCT03751657|21129904|P1|COMPLETED|Overall Study||122
8570021|NCT03751657|21129903|P2|STARTED|Overall Study||122
8570022|NCT03751657|21129904|P1|STARTED|Overall Study||125
8570071|NCT03629535|21130021|P1|NOT COMPLETED|Overall Study||0
8570072|NCT03629535|21130021|P1|COMPLETED|Overall Study||8
8570073|NCT03629535|21130021|P1|STARTED|Overall Study||8
8570074|NCT03629249|21130028|P3|NOT COMPLETED|Overall Study||202
8570075|NCT03629249|21130029|P2|NOT COMPLETED|Overall Study||201
8570076|NCT03629249|21130030|P1|NOT COMPLETED|Overall Study||201
8570077|NCT03629249|21130028|P3|COMPLETED|Overall Study||0
8570078|NCT03629249|21130029|P2|COMPLETED|Overall Study||0
8570079|NCT03629249|21130030|P1|COMPLETED|Overall Study||0
8570080|NCT03629249|21130028|P3|Safety Set (SAF)|Overall Study||201
8570081|NCT03629249|21130029|P2|Safety Set (SAF)|Overall Study||200
8570082|NCT03629249|21130030|P1|Safety Set (SAF)|Overall Study||201
8570083|NCT03629249|21130028|P3|Full Analysis Set (FAS)|Overall Study||201
8570084|NCT03629249|21130029|P2|Full Analysis Set (FAS)|Overall Study||200
8570085|NCT03629249|21130030|P1|Full Analysis Set (FAS)|Overall Study||201
8570086|NCT03629249|21130028|P3|STARTED|Overall Study||202
8570087|NCT03629249|21130029|P2|STARTED|Overall Study||201
8570088|NCT03629249|21130030|P1|STARTED|Overall Study||201
8570089|NCT03623373|21130062|P1|NOT COMPLETED|Overall Study||0
8570090|NCT03623373|21130062|P1|COMPLETED|Overall Study||13
8570091|NCT03623373|21130062|P1|STARTED|Overall Study||13
8570104|NCT03580343|21130090|P1|NOT COMPLETED|Overall Study||1
8570105|NCT03580343|21130090|P1|COMPLETED|Overall Study||4
8570106|NCT03580343|21130090|P1|STARTED|Overall Study||5
8570113|NCT03572634|21130111|P2|NOT COMPLETED|Overall Study||0
8570114|NCT03572634|21130112|P1|NOT COMPLETED|Overall Study||0
8570115|NCT03572634|21130111|P2|COMPLETED|Overall Study||2
8570116|NCT03572634|21130112|P1|COMPLETED|Overall Study||1
8570117|NCT03572634|21130111|P2|STARTED|Overall Study||2
8570118|NCT03572634|21130112|P1|STARTED|Overall Study||1
8570119|NCT03557125|21130130|P2|NOT COMPLETED|Overall Study||0
8570120|NCT03557125|21130131|P1|NOT COMPLETED|Overall Study||0
8570121|NCT03557125|21130130|P2|COMPLETED|Overall Study||24
8570122|NCT03557125|21130131|P1|COMPLETED|Overall Study||22
8570123|NCT03557125|21130130|P2|STARTED|Overall Study||24
8570124|NCT03557125|21130131|P1|STARTED|Overall Study||22
8570125|NCT03509974|21130149|P1|NOT COMPLETED|Overall Study||0
8570126|NCT03509974|21130149|P1|COMPLETED|Overall Study||14
8570127|NCT03509974|21130149|P1|STARTED|Overall Study||14
8570148|NCT03478956|21130184|P2|NOT COMPLETED|Overall Study||12
8570149|NCT03478956|21130185|P1|NOT COMPLETED|Overall Study||12
8570150|NCT03478956|21130184|P2|COMPLETED|Overall Study||0
8570151|NCT03478956|21130185|P1|COMPLETED|Overall Study||0
8570152|NCT03478956|21130184|P2|Started PML Safety Monitoring Phase|Overall Study||2
8570153|NCT03478956|21130185|P1|Started PML Safety Monitoring Phase|Overall Study||1
8570154|NCT03478956|21130184|P2|Completed OLE Treatment Phase|Overall Study||0
8570155|NCT03478956|21130185|P1|Completed OLE Treatment Phase|Overall Study||0
8570156|NCT03478956|21130184|P2|Started OLE Treatment Phase|Overall Study||10
8570157|NCT03478956|21130185|P1|Started OLE Treatment Phase|Overall Study||11
8570158|NCT03478956|21130184|P2|Completed Randomized Treatment Phase|Overall Study||10
8570159|NCT03478956|21130185|P1|Completed Randomized Treatment Phase|Overall Study||11
8570160|NCT03478956|21130184|P2|Received at Least One Dose of Study Drug|Overall Study||12
8570161|NCT03478956|21130185|P1|Received at Least One Dose of Study Drug|Overall Study||12
8570162|NCT03478956|21130184|P2|STARTED|Overall Study||12
8570163|NCT03478956|21130185|P1|STARTED|Overall Study||12
8570208|NCT03371355|21130354|P4|NOT COMPLETED|Overall Study||7
8570209|NCT03371355|21130355|P3|NOT COMPLETED|Overall Study||4
8570210|NCT03371355|21130356|P2|NOT COMPLETED|Overall Study||2
8570211|NCT03371355|21130357|P1|NOT COMPLETED|Overall Study||1
8570212|NCT03371355|21130354|P4|COMPLETED|Overall Study||19
8570213|NCT03371355|21130355|P3|COMPLETED|Overall Study||22
8570214|NCT03371355|21130356|P2|COMPLETED|Overall Study||24
8570215|NCT03371355|21130357|P1|COMPLETED|Overall Study||26
8570216|NCT03371355|21130354|P4|STARTED|Overall Study||26
8570217|NCT03371355|21130355|P3|STARTED|Overall Study||26
8570218|NCT03371355|21130356|P2|STARTED|Overall Study||26
8570219|NCT03371355|21130357|P1|STARTED|Overall Study||27
8570229|NCT03289455|21130531|P3|NOT COMPLETED|Overall Study||6
8570230|NCT03289455|21130532|P2|NOT COMPLETED|Overall Study||5
8570231|NCT03289455|21130533|P1|NOT COMPLETED|Overall Study||4
8570232|NCT03289455|21130531|P3|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
8570233|NCT03289455|21130532|P2|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
8570234|NCT03289455|21130533|P1|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
8570235|NCT03289455|21130531|P3|STARTED|Overall Study||6
8570236|NCT03289455|21130532|P2|STARTED|Overall Study||5
8570237|NCT03289455|21130533|P1|STARTED|Overall Study||4
8570248|NCT03277105|21130586|P2|NOT COMPLETED|Overall Study||263
8570249|NCT03277105|21130587|P1|NOT COMPLETED|Overall Study||259
8570250|NCT03277105|21130586|P2|COMPLETED|Overall Study||0
8570251|NCT03277105|21130587|P1|COMPLETED|Overall Study||0
8570252|NCT03277105|21130586|P2|Safety Analysis Set|Overall Study||260
8570253|NCT03277105|21130587|P1|Safety Analysis Set|Overall Study||258
8570254|NCT03277105|21130586|P2|STARTED|Overall Study||263
8570255|NCT03277105|21130587|P1|STARTED|Overall Study||259
8570268|NCT03227029|21130645|P3|NOT COMPLETED|Overall Study||4
8570269|NCT03227029|21130646|P2|NOT COMPLETED|Overall Study||4
8570270|NCT03227029|21130647|P1|NOT COMPLETED|Overall Study||4
8570271|NCT03227029|21130645|P3|COMPLETED|Overall Study||9
8570272|NCT03227029|21130646|P2|COMPLETED|Overall Study||22
8570273|NCT03227029|21130647|P1|COMPLETED|Overall Study||22
8570274|NCT03227029|21130645|P3|Received Inoculation|Overall Study||12
8570275|NCT03227029|21130646|P2|Received Inoculation|Overall Study||25
8570276|NCT03227029|21130647|P1|Received Inoculation|Overall Study||26
8570277|NCT03227029|21130645|P3|STARTED|Overall Study||13
8570278|NCT03227029|21130646|P2|STARTED|Overall Study||26
8570279|NCT03227029|21130647|P1|STARTED|Overall Study||26
8570289|NCT03178669|21130725|P5|NOT COMPLETED|Overall Study||4
8570290|NCT03178669|21130726|P4|NOT COMPLETED|Overall Study||4
8570291|NCT03178669|21130727|P3|NOT COMPLETED|Overall Study||7
8570292|NCT03178669|21130728|P2|NOT COMPLETED|Overall Study||1
8570293|NCT03178669|21130729|P1|NOT COMPLETED|Overall Study||5
8570294|NCT03178669|21130725|P5|COMPLETED|Overall Study||40
8570295|NCT03178669|21130726|P4|COMPLETED|Overall Study||38
8570296|NCT03178669|21130727|P3|COMPLETED|Overall Study||35
8570297|NCT03178669|21130728|P2|COMPLETED|Overall Study||42
8570298|NCT03178669|21130729|P1|COMPLETED|Overall Study||35
8570299|NCT03178669|21130725|P5|Completed Week 6|Overall Study||42
8570300|NCT03178669|21130726|P4|Completed Week 6|Overall Study||38
8570301|NCT03178669|21130727|P3|Completed Week 6|Overall Study||36
8570302|NCT03178669|21130728|P2|Completed Week 6|Overall Study||42
8570303|NCT03178669|21130729|P1|Completed Week 6|Overall Study||35
8570304|NCT03178669|21130725|P5|STARTED|Overall Study||44
8570305|NCT03178669|21130726|P4|STARTED|Overall Study||42
8570306|NCT03178669|21130727|P3|STARTED|Overall Study||42
8570307|NCT03178669|21130728|P2|STARTED|Overall Study||43
8570308|NCT03178669|21130729|P1|STARTED|Overall Study||40
8570309|NCT03172325|21130768|P2|NOT COMPLETED|Overall Study||4
8570310|NCT03172325|21130769|P1|NOT COMPLETED|Overall Study||4
8570311|NCT03172325|21130768|P2|COMPLETED|Overall Study||64
8570312|NCT03172325|21130769|P1|COMPLETED|Overall Study||64
8570313|NCT03172325|21130768|P2|STARTED|Overall Study||68
8570314|NCT03172325|21130769|P1|STARTED|Overall Study||68
8570342|NCT03125200|21131099|P7|NOT COMPLETED|Overall Study||3
8570343|NCT03125200|21131100|P6|NOT COMPLETED|Overall Study||3
8570344|NCT03125200|21131101|P5|NOT COMPLETED|Overall Study||4
8570345|NCT03125200|21131102|P4|NOT COMPLETED|Overall Study||5
8570346|NCT03125200|21131103|P3|NOT COMPLETED|Overall Study||2
8570347|NCT03125200|21131104|P2|NOT COMPLETED|Overall Study||2
8570348|NCT03125200|21131105|P1|NOT COMPLETED|Overall Study||2
8570349|NCT03125200|21131099|P7|COMPLETED|Overall Study||0
8570350|NCT03125200|21131100|P6|COMPLETED|Overall Study||0
8570351|NCT03125200|21131101|P5|COMPLETED|Overall Study||0
8570352|NCT03125200|21131102|P4|COMPLETED|Overall Study||0
8570353|NCT03125200|21131103|P3|COMPLETED|Overall Study||0
8570354|NCT03125200|21131104|P2|COMPLETED|Overall Study||0
8570355|NCT03125200|21131105|P1|COMPLETED|Overall Study||0
8570356|NCT03125200|21131099|P7|STARTED|Overall Study||3
8570357|NCT03125200|21131100|P6|STARTED|Overall Study||3
8570358|NCT03125200|21131101|P5|STARTED|Overall Study||4
8570359|NCT03125200|21131102|P4|STARTED|Overall Study||5
8570360|NCT03125200|21131103|P3|STARTED|Overall Study||2
8570361|NCT03125200|21131104|P2|STARTED|Overall Study||2
8570362|NCT03125200|21131105|P1|STARTED|Overall Study||2
8570413|NCT02957136|21131511|P2|NOT COMPLETED|Overall Study||1
8570414|NCT02957136|21131512|P1|NOT COMPLETED|Overall Study||2
8570415|NCT02957136|21131511|P2|COMPLETED|Overall Study||98
8570416|NCT02957136|21131512|P1|COMPLETED|Overall Study||93
8570417|NCT02957136|21131511|P2|STARTED|Overall Study||99
8570418|NCT02957136|21131512|P1|STARTED|Overall Study||95
8570419|NCT02956629|21131540|P6|NOT COMPLETED|Overall Study||1
8570420|NCT02956629|21131541|P5|NOT COMPLETED|Overall Study||0
8570421|NCT02956629|21131542|P4|NOT COMPLETED|Overall Study||1
8570422|NCT02956629|21131543|P3|NOT COMPLETED|Overall Study||4
8570423|NCT02956629|21131544|P2|NOT COMPLETED|Overall Study||6
8570424|NCT02956629|21131545|P1|NOT COMPLETED|Overall Study||5
8570425|NCT02956629|21131540|P6|COMPLETED|Overall Study||21
8570426|NCT02956629|21131541|P5|COMPLETED|Overall Study||18
8570427|NCT02956629|21131542|P4|COMPLETED|Overall Study||55
8570428|NCT02956629|21131543|P3|COMPLETED|Overall Study||57
8570429|NCT02956629|21131544|P2|COMPLETED|Overall Study||41
8570430|NCT02956629|21131545|P1|COMPLETED|Overall Study||73
8570431|NCT02956629|21131540|P6|STARTED|Overall Study||22
8570432|NCT02956629|21131541|P5|STARTED|Overall Study||18
8570433|NCT02956629|21131542|P4|STARTED|Overall Study||56
8570434|NCT02956629|21131543|P3|STARTED|Overall Study||61
8570435|NCT02956629|21131544|P2|STARTED|Overall Study||47
8570436|NCT02956629|21131545|P1|STARTED|Overall Study||78
8570479|NCT02889900|21131701|P1|NOT COMPLETED|Overall Study||57
8570480|NCT02889900|21131701|P1|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
8570481|NCT02889900|21131701|P1|Received Treatment|Overall Study||60
8570482|NCT02889900|21131701|P1|STARTED|Overall Study||62
8570491|NCT02865915|21131730|P2|NOT COMPLETED|Overall Study||30
8570492|NCT02865915|21131731|P1|NOT COMPLETED|Overall Study||25
8570493|NCT02865915|21131730|P2|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
8570494|NCT02865915|21131731|P1|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
8570495|NCT02865915|21131730|P2|STARTED|Overall Study||30
8570496|NCT02865915|21131731|P1|STARTED|Overall Study||25
8570506|NCT02810418|21131809|P7|NOT COMPLETED|Arm B Combination Therapy||0
8570507|NCT02810418|21131810|P6|NOT COMPLETED|Arm B Combination Therapy||0
8570508|NCT02810418|21131811|P5|NOT COMPLETED|Arm B Combination Therapy||0
8570509|NCT02810418|21131812|P4|NOT COMPLETED|Arm B Combination Therapy||0
8570510|NCT02810418|21131813|P3|NOT COMPLETED|Arm B Combination Therapy||0
8570511|NCT02810418|21131814|P2|NOT COMPLETED|Arm B Combination Therapy||0
8570512|NCT02810418|21131815|P1|NOT COMPLETED|Arm B Combination Therapy||0
8570513|NCT02810418|21131809|P7|COMPLETED|Arm B Combination Therapy||5
8570514|NCT02810418|21131810|P6|COMPLETED|Arm B Combination Therapy||0
8570515|NCT02810418|21131811|P5|COMPLETED|Arm B Combination Therapy||0
8570516|NCT02810418|21131812|P4|COMPLETED|Arm B Combination Therapy||0
8570517|NCT02810418|21131813|P3|COMPLETED|Arm B Combination Therapy||0
8570518|NCT02810418|21131814|P2|COMPLETED|Arm B Combination Therapy||0
8570519|NCT02810418|21131815|P1|COMPLETED|Arm B Combination Therapy||0
8570520|NCT02810418|21131809|P7|STARTED|Arm B Combination Therapy||5
8570521|NCT02810418|21131810|P6|STARTED|Arm B Combination Therapy||0
8570522|NCT02810418|21131811|P5|STARTED|Arm B Combination Therapy||0
8570523|NCT02810418|21131812|P4|STARTED|Arm B Combination Therapy||0
8570524|NCT02810418|21131813|P3|STARTED|Arm B Combination Therapy||0
8570525|NCT02810418|21131814|P2|STARTED|Arm B Combination Therapy||0
8570526|NCT02810418|21131815|P1|STARTED|Arm B Combination Therapy||0
8570527|NCT02810418|21131809|P7|NOT COMPLETED|Arm B Dose Escalation||0
8570528|NCT02810418|21131810|P6|NOT COMPLETED|Arm B Dose Escalation||2
8570529|NCT02810418|21131811|P5|NOT COMPLETED|Arm B Dose Escalation||1
8570530|NCT02810418|21131812|P4|NOT COMPLETED|Arm B Dose Escalation||0
8570531|NCT02810418|21131813|P3|NOT COMPLETED|Arm B Dose Escalation||0
8570532|NCT02810418|21131814|P2|NOT COMPLETED|Arm B Dose Escalation||0
8570533|NCT02810418|21131815|P1|NOT COMPLETED|Arm B Dose Escalation||0
8570534|NCT02810418|21131809|P7|COMPLETED|Arm B Dose Escalation||0
8570535|NCT02810418|21131810|P6|COMPLETED|Arm B Dose Escalation||4
8570536|NCT02810418|21131811|P5|COMPLETED|Arm B Dose Escalation||2
8570537|NCT02810418|21131812|P4|COMPLETED|Arm B Dose Escalation||6
8570538|NCT02810418|21131813|P3|COMPLETED|Arm B Dose Escalation||0
8570539|NCT02810418|21131814|P2|COMPLETED|Arm B Dose Escalation||0
8570540|NCT02810418|21131815|P1|COMPLETED|Arm B Dose Escalation||0
8570541|NCT02810418|21131809|P7|STARTED|Arm B Dose Escalation||0
8570542|NCT02810418|21131810|P6|STARTED|Arm B Dose Escalation||6
8570543|NCT02810418|21131811|P5|STARTED|Arm B Dose Escalation||3
8570544|NCT02810418|21131812|P4|STARTED|Arm B Dose Escalation||6
8570545|NCT02810418|21131813|P3|STARTED|Arm B Dose Escalation||0
8570546|NCT02810418|21131814|P2|STARTED|Arm B Dose Escalation||0
8570547|NCT02810418|21131815|P1|STARTED|Arm B Dose Escalation||0
8570548|NCT02810418|21131809|P7|NOT COMPLETED|Dose Expansion||0
8570549|NCT02810418|21131810|P6|NOT COMPLETED|Dose Expansion||0
8570550|NCT02810418|21131811|P5|NOT COMPLETED|Dose Expansion||0
8570551|NCT02810418|21131812|P4|NOT COMPLETED|Dose Expansion||0
8570552|NCT02810418|21131813|P3|NOT COMPLETED|Dose Expansion||3
8570553|NCT02810418|21131814|P2|NOT COMPLETED|Dose Expansion||1
8570554|NCT02810418|21131815|P1|NOT COMPLETED|Dose Expansion||0
8570555|NCT02810418|21131809|P7|COMPLETED|Dose Expansion||0
8570556|NCT02810418|21131810|P6|COMPLETED|Dose Expansion||0
8570557|NCT02810418|21131811|P5|COMPLETED|Dose Expansion||0
8570558|NCT02810418|21131812|P4|COMPLETED|Dose Expansion||0
8570559|NCT02810418|21131813|P3|COMPLETED|Dose Expansion||3
8570560|NCT02810418|21131814|P2|COMPLETED|Dose Expansion||7
8570561|NCT02810418|21131815|P1|COMPLETED|Dose Expansion||0
8570562|NCT02810418|21131809|P7|STARTED|Dose Expansion||0
8570563|NCT02810418|21131810|P6|STARTED|Dose Expansion||0
8570564|NCT02810418|21131811|P5|STARTED|Dose Expansion||0
8570565|NCT02810418|21131812|P4|STARTED|Dose Expansion||0
8570566|NCT02810418|21131813|P3|STARTED|Dose Expansion||6
8570567|NCT02810418|21131814|P2|STARTED|Dose Expansion||8
8570568|NCT02810418|21131815|P1|STARTED|Dose Expansion||0
8570569|NCT02810418|21131809|P7|NOT COMPLETED|Arm A Dose Escalation||0
8570570|NCT02810418|21131810|P6|NOT COMPLETED|Arm A Dose Escalation||0
8570571|NCT02810418|21131811|P5|NOT COMPLETED|Arm A Dose Escalation||0
8570572|NCT02810418|21131812|P4|NOT COMPLETED|Arm A Dose Escalation||0
8570573|NCT02810418|21131813|P3|NOT COMPLETED|Arm A Dose Escalation||0
8570574|NCT02810418|21131814|P2|NOT COMPLETED|Arm A Dose Escalation||1
8570575|NCT02810418|21131815|P1|NOT COMPLETED|Arm A Dose Escalation||2
8570576|NCT02810418|21131809|P7|COMPLETED|Arm A Dose Escalation||0
8570577|NCT02810418|21131810|P6|COMPLETED|Arm A Dose Escalation||0
8570578|NCT02810418|21131811|P5|COMPLETED|Arm A Dose Escalation||0
8570579|NCT02810418|21131812|P4|COMPLETED|Arm A Dose Escalation||0
8570580|NCT02810418|21131813|P3|COMPLETED|Arm A Dose Escalation||0
8570581|NCT02810418|21131814|P2|COMPLETED|Arm A Dose Escalation||7
8570582|NCT02810418|21131815|P1|COMPLETED|Arm A Dose Escalation||4
8570583|NCT02810418|21131809|P7|STARTED|Arm A Dose Escalation||0
8570584|NCT02810418|21131810|P6|STARTED|Arm A Dose Escalation||0
8570585|NCT02810418|21131811|P5|STARTED|Arm A Dose Escalation||0
8570586|NCT02810418|21131812|P4|STARTED|Arm A Dose Escalation||0
8570587|NCT02810418|21131813|P3|STARTED|Arm A Dose Escalation||0
8570588|NCT02810418|21131814|P2|STARTED|Arm A Dose Escalation||8
8570589|NCT02810418|21131815|P1|STARTED|Arm A Dose Escalation||6
8570590|NCT02782780|21131909|P2|NOT COMPLETED|Overall Study||7
8570591|NCT02782780|21131910|P1|NOT COMPLETED|Overall Study||7
8570592|NCT02782780|21131909|P2|COMPLETED|Overall Study||32
8570593|NCT02782780|21131910|P1|COMPLETED|Overall Study||39
8570594|NCT02782780|21131909|P2|STARTED|Overall Study||39
8570595|NCT02782780|21131910|P1|STARTED|Overall Study||46
8570635|NCT02746874|21131988|P2|NOT COMPLETED|Overall Study||3
8570636|NCT02746874|21131989|P1|NOT COMPLETED|Overall Study||0
8570637|NCT02746874|21131988|P2|COMPLETED|Overall Study||32
8570638|NCT02746874|21131989|P1|COMPLETED|Overall Study||35
8570639|NCT02746874|21131988|P2|STARTED|Overall Study||35
8570640|NCT02746874|21131989|P1|STARTED|Overall Study||35
8570647|NCT02708966|21132052|P2|NOT COMPLETED|Overall Study||2
8570648|NCT02708966|21132053|P1|NOT COMPLETED|Overall Study||2
8570649|NCT02708966|21132052|P2|COMPLETED|Overall Study||13
8570650|NCT02708966|21132053|P1|COMPLETED|Overall Study||13
8570651|NCT02708966|21132052|P2|STARTED|Overall Study||15
8570652|NCT02708966|21132053|P1|STARTED|Overall Study||15
8570674|NCT02688621|21132132|P2|NOT COMPLETED|Overall Study||18
8570675|NCT02688621|21132133|P1|NOT COMPLETED|Overall Study||40
8570676|NCT02688621|21132132|P2|COMPLETED|Overall Study||188
8570677|NCT02688621|21132133|P1|COMPLETED|Overall Study||172
8570678|NCT02688621|21132132|P2|STARTED|Overall Study||206
8570679|NCT02688621|21132133|P1|STARTED|Overall Study||212
8570680|NCT02669264|21132156|P7|NOT COMPLETED|Overall Study||5
8570681|NCT02669264|21132157|P6|NOT COMPLETED|Overall Study||6
8570682|NCT02669264|21132158|P5|NOT COMPLETED|Overall Study||5
8570683|NCT02669264|21132159|P4|NOT COMPLETED|Overall Study||3
8570684|NCT02669264|21132160|P3|NOT COMPLETED|Overall Study||3
8570685|NCT02669264|21132161|P2|NOT COMPLETED|Overall Study||6
8570686|NCT02669264|21132162|P1|NOT COMPLETED|Overall Study||5
8570687|NCT02669264|21132156|P7|COMPLETED|Overall Study||0
8570688|NCT02669264|21132157|P6|COMPLETED|Overall Study||0
8570689|NCT02669264|21132158|P5|COMPLETED|Overall Study||0
8570690|NCT02669264|21132159|P4|COMPLETED|Overall Study||1
8570691|NCT02669264|21132160|P3|COMPLETED|Overall Study||0
8570692|NCT02669264|21132161|P2|COMPLETED|Overall Study||1
8570693|NCT02669264|21132162|P1|COMPLETED|Overall Study||0
8570694|NCT02669264|21132156|P7|STARTED|Overall Study||5
8570695|NCT02669264|21132157|P6|STARTED|Overall Study||6
8570696|NCT02669264|21132158|P5|STARTED|Overall Study||5
8570697|NCT02669264|21132159|P4|STARTED|Overall Study||4
8570698|NCT02669264|21132160|P3|STARTED|Overall Study||3
8570699|NCT02669264|21132161|P2|STARTED|Overall Study||7
8570700|NCT02669264|21132162|P1|STARTED|Overall Study||5
8570701|NCT02669017|21132315|P9|NOT COMPLETED|Overall Study||25
8570702|NCT02669017|21132316|P8|NOT COMPLETED|Overall Study||62
8570703|NCT02669017|21132317|P7|NOT COMPLETED|Overall Study||11
8570704|NCT02669017|21132318|P6|NOT COMPLETED|Overall Study||19
8570705|NCT02669017|21132319|P5|NOT COMPLETED|Overall Study||12
8570706|NCT02669017|21132320|P4|NOT COMPLETED|Overall Study||4
8570707|NCT02669017|21132321|P3|NOT COMPLETED|Overall Study||2
8570708|NCT02669017|21132322|P2|NOT COMPLETED|Overall Study||2
8570709|NCT02669017|21132323|P1|NOT COMPLETED|Overall Study||1
8570710|NCT02669017|21132315|P9|COMPLETED|Overall Study||11
8570711|NCT02669017|21132316|P8|COMPLETED|Overall Study||7
8570712|NCT02669017|21132317|P7|COMPLETED|Overall Study||8
8570713|NCT02669017|21132318|P6|COMPLETED|Overall Study||7
8570714|NCT02669017|21132319|P5|COMPLETED|Overall Study||4
8570715|NCT02669017|21132320|P4|COMPLETED|Overall Study||1
8570716|NCT02669017|21132321|P3|COMPLETED|Overall Study||2
8570717|NCT02669017|21132322|P2|COMPLETED|Overall Study||2
8570718|NCT02669017|21132323|P1|COMPLETED|Overall Study||3
8570719|NCT02669017|21132315|P9|STARTED|Overall Study||36
8570720|NCT02669017|21132316|P8|STARTED|Overall Study||69
8570721|NCT02669017|21132317|P7|STARTED|Overall Study||19
8570722|NCT02669017|21132318|P6|STARTED|Overall Study||26
8570723|NCT02669017|21132319|P5|STARTED|Overall Study||16
8570724|NCT02669017|21132320|P4|STARTED|Overall Study||5
8570725|NCT02669017|21132321|P3|STARTED|Overall Study||4
8570726|NCT02669017|21132322|P2|STARTED|Overall Study||4
8570727|NCT02669017|21132323|P1|STARTED|Overall Study||4
8570731|NCT02658448|21132453|P1|NOT COMPLETED|Overall Study||1
8570732|NCT02658448|21132453|P1|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
8570733|NCT02658448|21132453|P1|STARTED|Overall Study||19
8570737|NCT02646423|21132475|P2|NOT COMPLETED|Overall Study||8
8570738|NCT02646423|21132476|P1|NOT COMPLETED|Overall Study||7
8570739|NCT02646423|21132475|P2|COMPLETED|Overall Study||735
8570740|NCT02646423|21132476|P1|COMPLETED|Overall Study||735
8570741|NCT02646423|21132475|P2|STARTED|Overall Study||743
8570742|NCT02646423|21132476|P1|STARTED|Overall Study||742
8570746|NCT02627963|21132521|P2|NOT COMPLETED|Overall Study||14
8570747|NCT02627963|21132522|P1|NOT COMPLETED|Overall Study||36
8570748|NCT02627963|21132521|P2|COMPLETED|Overall Study||161
8570749|NCT02627963|21132522|P1|COMPLETED|Overall Study||139
8570750|NCT02627963|21132521|P2|STARTED|Overall Study||175
8570751|NCT02627963|21132522|P1|STARTED|Overall Study||175
8570773|NCT02589977|21132560|P3|NOT COMPLETED|Overall Study||4
8570774|NCT02589977|21132561|P2|NOT COMPLETED|Overall Study||5
8570775|NCT02589977|21132562|P1|NOT COMPLETED|Overall Study||6
8570776|NCT02589977|21132560|P3|COMPLETED|Overall Study||8
8570777|NCT02589977|21132561|P2|COMPLETED|Overall Study||15
8570778|NCT02589977|21132562|P1|COMPLETED|Overall Study||17
8570779|NCT02589977|21132560|P3|STARTED|Overall Study||12
8570780|NCT02589977|21132561|P2|STARTED|Overall Study||20
8570781|NCT02589977|21132562|P1|STARTED|Overall Study||23
8570782|NCT02569632|21132582|P1|NOT COMPLETED|Overall Study||1
8570783|NCT02569632|21132582|P1|COMPLETED|Overall Study||17
8570784|NCT02569632|21132582|P1|STARTED|Overall Study||18
8570785|NCT02559687|21132587|P1|NOT COMPLETED|Overall Study||121
8570786|NCT02559687|21132587|P1|COMPLETED|Overall Study||0
8570787|NCT02559687|21132587|P1|STARTED|Overall Study||121
8570800|NCT02542397|21132625|P1|NOT COMPLETED|Overall Study||16
8570801|NCT02542397|21132625|P1|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
8570802|NCT02542397|21132625|P1|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
8570813|NCT02533934|21132672|P2|NOT COMPLETED|Overall Study||0
8570814|NCT02533934|21132673|P1|NOT COMPLETED|Overall Study||0
8570815|NCT02533934|21132672|P2|COMPLETED|Overall Study||26
8570816|NCT02533934|21132673|P1|COMPLETED|Overall Study||42
8570817|NCT02533934|21132672|P2|STARTED|Overall Study||26
8570818|NCT02533934|21132673|P1|STARTED|Overall Study||42
8570819|NCT02524288|21132686|P1|NOT COMPLETED|Overall Study||1941
8570820|NCT02524288|21132686|P1|COMPLETED|Overall Study||0
8570821|NCT02524288|21132686|P1|Treated|Overall Study||1936
8570822|NCT02524288|21132686|P1|STARTED|Overall Study||1941
8570823|NCT02524119|21132694|P1|NOT COMPLETED|Overall Study||0
8570824|NCT02524119|21132694|P1|COMPLETED|Overall Study||5
8570825|NCT02524119|21132694|P1|STARTED|Overall Study||5
8570826|NCT02498600|21132704|P2|NOT COMPLETED|Overall Study||0
8570827|NCT02498600|21132705|P1|NOT COMPLETED|Overall Study||0
8570828|NCT02498600|21132704|P2|COMPLETED|Overall Study||51
8570829|NCT02498600|21132705|P1|COMPLETED|Overall Study||49
8570830|NCT02498600|21132704|P2|STARTED|Overall Study||51
8570831|NCT02498600|21132705|P1|STARTED|Overall Study||49
8570832|NCT02465567|21132721|P4|NOT COMPLETED|Overall Study||508
8570833|NCT02465567|21132722|P3|NOT COMPLETED|Overall Study||563
8570834|NCT02465567|21132723|P2|NOT COMPLETED|Overall Study||424
8570835|NCT02465567|21132724|P1|NOT COMPLETED|Overall Study||449
8570836|NCT02465567|21132721|P4|COMPLETED|Overall Study||1643
8570837|NCT02465567|21132722|P3|COMPLETED|Overall Study||1580
8570838|NCT02465567|21132723|P2|COMPLETED|Overall Study||1713
8570839|NCT02465567|21132724|P1|COMPLETED|Overall Study||1708
8570840|NCT02465567|21132721|P4|STARTED|Overall Study||2151
8570841|NCT02465567|21132722|P3|STARTED|Overall Study||2143
8570842|NCT02465567|21132723|P2|STARTED|Overall Study||2137
8570843|NCT02465567|21132724|P1|STARTED|Overall Study||2157
8570844|NCT02460198|21132756|P2|NOT COMPLETED|Overall Study||63
8570845|NCT02460198|21132757|P1|NOT COMPLETED|Overall Study||61
8570846|NCT02460198|21132756|P2|COMPLETED|Overall Study||0
8570847|NCT02460198|21132757|P1|COMPLETED|Overall Study||0
8570848|NCT02460198|21132756|P2|STARTED|Overall Study||63
8570849|NCT02460198|21132757|P1|STARTED|Overall Study||61
8570850|NCT02455557|21132775|P1|NOT COMPLETED|Overall Study||2
8570851|NCT02455557|21132775|P1|COMPLETED|Overall Study||64
8570852|NCT02455557|21132775|P1|STARTED|Overall Study||66
8570865|NCT02428192|21132804|P2|NOT COMPLETED|Overall Study||1
8570866|NCT02428192|21132805|P1|NOT COMPLETED|Overall Study||12
8570867|NCT02428192|21132804|P2|COMPLETED|Overall Study||7
8570868|NCT02428192|21132805|P1|COMPLETED|Overall Study||0
8570869|NCT02428192|21132804|P2|STARTED|Overall Study||8
8570870|NCT02428192|21132805|P1|STARTED|Overall Study||12
8570871|NCT02367105|21132819|P2|NOT COMPLETED|Overall Study||8
8570872|NCT02367105|21132820|P1|NOT COMPLETED|Overall Study||5
8570873|NCT02367105|21132819|P2|COMPLETED|Overall Study||34
8570874|NCT02367105|21132820|P1|COMPLETED|Overall Study||36
8570875|NCT02367105|21132819|P2|STARTED|Overall Study||42
8570876|NCT02367105|21132820|P1|STARTED|Overall Study||41
8570886|NCT02292654|21132942|P3|NOT COMPLETED|Overall Study||0
8570887|NCT02292654|21132943|P2|NOT COMPLETED|Overall Study||0
8570888|NCT02292654|21132944|P1|NOT COMPLETED|Overall Study||0
8570889|NCT02292654|21132942|P3|COMPLETED|Overall Study||7
8570890|NCT02292654|21132943|P2|COMPLETED|Overall Study||9
8570891|NCT02292654|21132944|P1|COMPLETED|Overall Study||4
8570892|NCT02292654|21132942|P3|STARTED|Overall Study||7
8570893|NCT02292654|21132943|P2|STARTED|Overall Study||9
8570894|NCT02292654|21132944|P1|STARTED|Overall Study||4
8570895|NCT02286713|21133077|P2|NOT COMPLETED|Six Month Follow-Up||27
8570896|NCT02286713|21133078|P1|NOT COMPLETED|Six Month Follow-Up||32
8570897|NCT02286713|21133077|P2|COMPLETED|Six Month Follow-Up||225
8570898|NCT02286713|21133078|P1|COMPLETED|Six Month Follow-Up||218
8570899|NCT02286713|21133077|P2|STARTED|Six Month Follow-Up||252
8570900|NCT02286713|21133078|P1|STARTED|Six Month Follow-Up||250
8570901|NCT02286713|21133077|P2|NOT COMPLETED|Three Month Follow-Up||26
8570902|NCT02286713|21133078|P1|NOT COMPLETED|Three Month Follow-Up||28
8570903|NCT02286713|21133077|P2|COMPLETED|Three Month Follow-Up||228
8570904|NCT02286713|21133078|P1|COMPLETED|Three Month Follow-Up||224
8570905|NCT02286713|21133077|P2|STARTED|Three Month Follow-Up||254
8570906|NCT02286713|21133078|P1|STARTED|Three Month Follow-Up||252
8570907|NCT02286713|21133077|P2|NOT COMPLETED|One Week Follow-Up||24
8570908|NCT02286713|21133078|P1|NOT COMPLETED|One Week Follow-Up||24
8570909|NCT02286713|21133077|P2|COMPLETED|One Week Follow-Up||233
8570910|NCT02286713|21133078|P1|COMPLETED|One Week Follow-Up||235
8570911|NCT02286713|21133077|P2|STARTED|One Week Follow-Up||257
8570912|NCT02286713|21133078|P1|STARTED|One Week Follow-Up||259
8570913|NCT02283749|21133090|P1|NOT COMPLETED|Overall Study||0
8570914|NCT02283749|21133090|P1|COMPLETED|Overall Study||5
8570915|NCT02283749|21133090|P1|STARTED|Overall Study||5
8570930|NCT02272790|21133224|P6|NOT COMPLETED|Overall Study||0
8570931|NCT02272790|21133225|P5|NOT COMPLETED|Overall Study||0
8570932|NCT02272790|21133226|P4|NOT COMPLETED|Overall Study||0
8570933|NCT02272790|21133227|P3|NOT COMPLETED|Overall Study||0
8570934|NCT02272790|21133228|P2|NOT COMPLETED|Overall Study||1
8570935|NCT02272790|21133229|P1|NOT COMPLETED|Overall Study||0
8570936|NCT02272790|21133224|P6|COMPLETED|Overall Study||6
8570937|NCT02272790|21133225|P5|COMPLETED|Overall Study||6
8570938|NCT02272790|21133226|P4|COMPLETED|Overall Study||12
8570939|NCT02272790|21133227|P3|COMPLETED|Overall Study||23
8570940|NCT02272790|21133228|P2|COMPLETED|Overall Study||38
8570941|NCT02272790|21133229|P1|COMPLETED|Overall Study||9
8570942|NCT02272790|21133224|P6|STARTED|Overall Study||6
8570943|NCT02272790|21133225|P5|STARTED|Overall Study||6
8570944|NCT02272790|21133226|P4|STARTED|Overall Study||12
8570945|NCT02272790|21133227|P3|STARTED|Overall Study||23
8570946|NCT02272790|21133228|P2|STARTED|Overall Study||39
8570947|NCT02272790|21133229|P1|STARTED|Overall Study||9
8570948|NCT02260921|21133365|P2|NOT COMPLETED|Overall Study||4
8570949|NCT02260921|21133366|P1|NOT COMPLETED|Overall Study||14
8570950|NCT02260921|21133365|P2|COMPLETED|Overall Study||55
8570951|NCT02260921|21133366|P1|COMPLETED|Overall Study||107
8570952|NCT02260921|21133365|P2|Per-Protocol Population|Overall Study||56
8570953|NCT02260921|21133366|P1|Per-Protocol Population|Overall Study||112
8570954|NCT02260921|21133365|P2|STARTED|Overall Study||59
8570955|NCT02260921|21133366|P1|STARTED|Overall Study||121
8570956|NCT02210286|21133388|P1|NOT COMPLETED|Overall Study||2
8570957|NCT02210286|21133388|P1|COMPLETED|Overall Study||15
8570958|NCT02210286|21133388|P1|STARTED|Overall Study||17
8570959|NCT02196324|21133398|P2|NOT COMPLETED|Overall Study||8
8570960|NCT02196324|21133399|P1|NOT COMPLETED|Overall Study||15
8570961|NCT02196324|21133398|P2|COMPLETED|Overall Study||57
8570962|NCT02196324|21133399|P1|COMPLETED|Overall Study||48
8570963|NCT02196324|21133398|P2|STARTED|Overall Study||65
8570964|NCT02196324|21133399|P1|STARTED|Overall Study||63
8571046|NCT02114814|21133535|P2|NOT COMPLETED|Overall Study||9
8571047|NCT02114814|21133536|P1|NOT COMPLETED|Overall Study||15
8571048|NCT02114814|21133535|P2|COMPLETED|Overall Study||74
8571049|NCT02114814|21133536|P1|COMPLETED|Overall Study||88
8571050|NCT02114814|21133535|P2|STARTED|Overall Study||83
8571051|NCT02114814|21133536|P1|STARTED|Overall Study||103
8571063|NCT02049944|21133577|P1|NOT COMPLETED|Overall Study||2
8571064|NCT02049944|21133577|P1|COMPLETED|Overall Study||28
8571065|NCT02049944|21133577|P1|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
8571066|NCT02049944|21133577|P1|Obese (BMI 30-40kg/m^2)|Overall Study||14
8571067|NCT02049944|21133577|P1|STARTED|Overall Study||30
8571068|NCT02025985|21133586|P5|NOT COMPLETED|Overall Study||20
8571069|NCT02025985|21133587|P4|NOT COMPLETED|Overall Study||21
8571070|NCT02025985|21133588|P3|NOT COMPLETED|Overall Study||25
8571071|NCT02025985|21133589|P2|NOT COMPLETED|Overall Study||23
8571072|NCT02025985|21133590|P1|NOT COMPLETED|Overall Study||25
8571073|NCT02025985|21133586|P5|COMPLETED|Overall Study||0
8571074|NCT02025985|21133587|P4|COMPLETED|Overall Study||0
8571075|NCT02025985|21133588|P3|COMPLETED|Overall Study||0
8571076|NCT02025985|21133589|P2|COMPLETED|Overall Study||0
8571077|NCT02025985|21133590|P1|COMPLETED|Overall Study||0
8571078|NCT02025985|21133586|P5|Modified Intent-to-treat(mITT)Population|Overall Study||20
8571079|NCT02025985|21133587|P4|Modified Intent-to-treat(mITT)Population|Overall Study||21
8571080|NCT02025985|21133588|P3|Modified Intent-to-treat(mITT)Population|Overall Study||25
8571081|NCT02025985|21133589|P2|Modified Intent-to-treat(mITT)Population|Overall Study||22
8571082|NCT02025985|21133590|P1|Modified Intent-to-treat(mITT)Population|Overall Study||23
8571083|NCT02025985|21133586|P5|STARTED|Overall Study||20
8571084|NCT02025985|21133587|P4|STARTED|Overall Study||21
8571085|NCT02025985|21133588|P3|STARTED|Overall Study||25
8571086|NCT02025985|21133589|P2|STARTED|Overall Study||23
8571087|NCT02025985|21133590|P1|STARTED|Overall Study||25
8571088|NCT02024204|21133650|P2|NOT COMPLETED|Overall Study||0
8571089|NCT02024204|21133651|P1|NOT COMPLETED|Overall Study||0
8571090|NCT02024204|21133650|P2|COMPLETED|Overall Study||11
8571091|NCT02024204|21133651|P1|COMPLETED|Overall Study||49
8571092|NCT02024204|21133650|P2|STARTED|Overall Study||11
8571093|NCT02024204|21133651|P1|STARTED|Overall Study||49
8571184|NCT01945775|21133700|P2|NOT COMPLETED|Overall Study||144
8571185|NCT01945775|21133701|P1|NOT COMPLETED|Overall Study||287
8571186|NCT01945775|21133700|P2|COMPLETED|Overall Study||0
8571187|NCT01945775|21133701|P1|COMPLETED|Overall Study||0
8571188|NCT01945775|21133700|P2|Treated|Overall Study||126
8571189|NCT01945775|21133701|P1|Treated|Overall Study||286
8571190|NCT01945775|21133700|P2|STARTED|Overall Study||144
8571191|NCT01945775|21133701|P1|STARTED|Overall Study||287
8571204|NCT01927367|21133773|P2|NOT COMPLETED|Overall Study||5
8571205|NCT01927367|21133774|P1|NOT COMPLETED|Overall Study||7
8571206|NCT01927367|21133773|P2|COMPLETED|Overall Study||543
8571207|NCT01927367|21133774|P1|COMPLETED|Overall Study||590
8571208|NCT01927367|21133773|P2|STARTED|Overall Study||548
8571209|NCT01927367|21133774|P1|STARTED|Overall Study||597
8571210|NCT01904903|21133788|P1|NOT COMPLETED|Overall Study||1
8571211|NCT01904903|21133788|P1|COMPLETED|Overall Study||30
8571212|NCT01904903|21133788|P1|STARTED|Overall Study||31
8571213|NCT01901679|21133794|P2|NOT COMPLETED|Overall Study||0
8571214|NCT01901679|21133795|P1|NOT COMPLETED|Overall Study||0
8571215|NCT01901679|21133794|P2|COMPLETED|Overall Study||5
8571216|NCT01901679|21133795|P1|COMPLETED|Overall Study||5
8571217|NCT01901679|21133794|P2|STARTED|Overall Study||5
8571218|NCT01901679|21133795|P1|STARTED|Overall Study||5
8571219|NCT01875367|21133803|P2|NOT COMPLETED|Overall Study||2
8571220|NCT01875367|21133804|P1|NOT COMPLETED|Overall Study||5
8571221|NCT01875367|21133803|P2|COMPLETED|Overall Study||83
8571222|NCT01875367|21133804|P1|COMPLETED|Overall Study||76
8571223|NCT01875367|21133803|P2|STARTED|Overall Study||85
8571224|NCT01875367|21133804|P1|STARTED|Overall Study||81
8571249|NCT01850524|21133839|P2|NOT COMPLETED|Overall Study||351
8571250|NCT01850524|21133840|P1|NOT COMPLETED|Overall Study||354
8571251|NCT01850524|21133839|P2|COMPLETED|Overall Study||0
8571252|NCT01850524|21133840|P1|COMPLETED|Overall Study||0
8571253|NCT01850524|21133839|P2|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
8571254|NCT01850524|21133840|P1|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
8571255|NCT01850524|21133839|P2|Per Protocol (PP) Population|Overall Study||298
8571256|NCT01850524|21133840|P1|Per Protocol (PP) Population|Overall Study||295
8571257|NCT01850524|21133839|P2|Participants Completed Study Treatment Per Protocol|Overall Study||264
8571258|NCT01850524|21133840|P1|Participants Completed Study Treatment Per Protocol|Overall Study||270
8571259|NCT01850524|21133839|P2|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
8571260|NCT01850524|21133840|P1|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
8571261|NCT01850524|21133839|P2|Intent-to-Treat (ITT) Population|Overall Study||351
8571262|NCT01850524|21133840|P1|Intent-to-Treat (ITT) Population|Overall Study||354
8571263|NCT01850524|21133839|P2|STARTED|Overall Study||351
8571264|NCT01850524|21133840|P1|STARTED|Overall Study||354
8571265|NCT01833520|21133850|P4|NOT COMPLETED|Overall Study||3
8571266|NCT01833520|21133851|P3|NOT COMPLETED|Overall Study||8
8571267|NCT01833520|21133852|P2|NOT COMPLETED|Overall Study||3
8571268|NCT01833520|21133853|P1|NOT COMPLETED|Overall Study||3
8571269|NCT01833520|21133850|P4|COMPLETED|Overall Study||0
8571270|NCT01833520|21133851|P3|COMPLETED|Overall Study||1
8571271|NCT01833520|21133852|P2|COMPLETED|Overall Study||0
8571272|NCT01833520|21133853|P1|COMPLETED|Overall Study||0
8571273|NCT01833520|21133850|P4|STARTED|Overall Study||3
8571274|NCT01833520|21133851|P3|STARTED|Overall Study||9
8571275|NCT01833520|21133852|P2|STARTED|Overall Study||3
8571276|NCT01833520|21133853|P1|STARTED|Overall Study||3
8571277|NCT01831427|21133876|P11|NOT COMPLETED|Overall Study||3
8571278|NCT01831427|21133877|P10|NOT COMPLETED|Overall Study||1
8571279|NCT01831427|21133878|P9|NOT COMPLETED|Overall Study||0
8571280|NCT01831427|21133879|P8|NOT COMPLETED|Overall Study||1
8571281|NCT01831427|21133880|P7|NOT COMPLETED|Overall Study||2
8571282|NCT01831427|21133881|P6|NOT COMPLETED|Overall Study||1
8571283|NCT01831427|21133882|P5|NOT COMPLETED|Overall Study||0
8571284|NCT01831427|21133883|P4|NOT COMPLETED|Overall Study||1
8571285|NCT01831427|21133884|P3|NOT COMPLETED|Overall Study||0
8571286|NCT01831427|21133885|P2|NOT COMPLETED|Overall Study||1
8571287|NCT01831427|21133886|P1|NOT COMPLETED|Overall Study||0
8571288|NCT01831427|21133876|P11|COMPLETED|Overall Study||5
8571289|NCT01831427|21133877|P10|COMPLETED|Overall Study||9
8571290|NCT01831427|21133878|P9|COMPLETED|Overall Study||8
8571291|NCT01831427|21133879|P8|COMPLETED|Overall Study||7
8571292|NCT01831427|21133880|P7|COMPLETED|Overall Study||6
8571293|NCT01831427|21133881|P6|COMPLETED|Overall Study||7
8571294|NCT01831427|21133882|P5|COMPLETED|Overall Study||4
8571295|NCT01831427|21133883|P4|COMPLETED|Overall Study||4
8571296|NCT01831427|21133884|P3|COMPLETED|Overall Study||5
8571297|NCT01831427|21133885|P2|COMPLETED|Overall Study||4
8571298|NCT01831427|21133886|P1|COMPLETED|Overall Study||5
8571299|NCT01831427|21133876|P11|STARTED|Overall Study||8
8571300|NCT01831427|21133877|P10|STARTED|Overall Study||10
8571301|NCT01831427|21133878|P9|STARTED|Overall Study||8
8571302|NCT01831427|21133879|P8|STARTED|Overall Study||8
8571303|NCT01831427|21133880|P7|STARTED|Overall Study||8
8571304|NCT01831427|21133881|P6|STARTED|Overall Study||8
8571305|NCT01831427|21133882|P5|STARTED|Overall Study||4
8571306|NCT01831427|21133883|P4|STARTED|Overall Study||5
8571307|NCT01831427|21133884|P3|STARTED|Overall Study||5
8571308|NCT01831427|21133885|P2|STARTED|Overall Study||5
8571309|NCT01831427|21133886|P1|STARTED|Overall Study||5
8571310|NCT01801982|21133943|P1|NOT COMPLETED|Overall Study||1
8571311|NCT01801982|21133943|P1|COMPLETED|Overall Study||0
8571312|NCT01801982|21133943|P1|STARTED|Overall Study||1
8571319|NCT01784068|21133962|P2|NOT COMPLETED|TFR Phase||93
8571320|NCT01784068|21133963|P1|NOT COMPLETED|TFR Phase||0
8571321|NCT01784068|21133962|P2|COMPLETED|TFR Phase||97
8571322|NCT01784068|21133963|P1|COMPLETED|TFR Phase||0
8571323|NCT01784068|21133962|P2|STARTED|TFR Phase||190
8571324|NCT01784068|21133963|P1|STARTED|TFR Phase||0
8571325|NCT01784068|21133962|P2|NOT COMPLETED|NTCS Phase||0
8571326|NCT01784068|21133963|P1|NOT COMPLETED|NTCS Phase||215
8571327|NCT01784068|21133962|P2|COMPLETED|NTCS Phase||0
8571328|NCT01784068|21133963|P1|COMPLETED|NTCS Phase||0
8571329|NCT01784068|21133962|P2|NTRI-2|NTCS Phase||0
8571330|NCT01784068|21133963|P1|NTRI-2|NTCS Phase||0
8571331|NCT01784068|21133962|P2|NTCT-P Phase|NTCS Phase||0
8571332|NCT01784068|21133963|P1|NTCT-P Phase|NTCS Phase||2
8571333|NCT01784068|21133962|P2|TFR-2 Phase|NTCS Phase||0
8571334|NCT01784068|21133963|P1|TFR-2 Phase|NTCS Phase||8
8571335|NCT01784068|21133962|P2|NTCT Phase|NTCS Phase||0
8571336|NCT01784068|21133963|P1|NTCT Phase|NTCS Phase||13
8571337|NCT01784068|21133962|P2|NTRI Phase|NTCS Phase||0
8571338|NCT01784068|21133963|P1|NTRI Phase|NTCS Phase||86
8571339|NCT01784068|21133962|P2|STARTED|NTCS Phase||0
8571340|NCT01784068|21133963|P1|STARTED|NTCS Phase||215
8571374|NCT01751906|21134048|P2|NOT COMPLETED|Overall Study||131
8571375|NCT01751906|21134049|P1|NOT COMPLETED|Overall Study||263
8571376|NCT01751906|21134048|P2|COMPLETED|Overall Study||555
8571377|NCT01751906|21134049|P1|COMPLETED|Overall Study||1059
8571378|NCT01751906|21134048|P2|STARTED|Overall Study||686
8571379|NCT01751906|21134049|P1|STARTED|Overall Study||1322
8571405|NCT01698905|21134212|P1|NOT COMPLETED|Overall Study||11
8571406|NCT01698905|21134212|P1|COMPLETED|Overall Study||152
8571407|NCT01698905|21134212|P1|NTCT-P Phase Phase|Overall Study||6
8571408|NCT01698905|21134212|P1|NTRI-2 Phase|Overall Study||1
8571409|NCT01698905|21134212|P1|TFR-2 Phase|Overall Study||2
8571410|NCT01698905|21134212|P1|NTCT Phase|Overall Study||26
8571411|NCT01698905|21134212|P1|NTRI Phase|Overall Study||51
8571412|NCT01698905|21134212|P1|TFR Phase|Overall Study||126
8571413|NCT01698905|21134212|P1|Still on Study Phase|Overall Study||0
8571414|NCT01698905|21134212|P1|STARTED|Overall Study||163
8571425|NCT01642407|21134238|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
8571426|NCT01642407|21134238|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
8571427|NCT01642407|21134238|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
8571428|NCT01642407|21134238|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
8571429|NCT01642407|21134238|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
8571430|NCT01642407|21134238|P1|STARTED|Part 1 (Screening Till Week 16)||6
8571431|NCT01619865|21134283|P1|NOT COMPLETED|Overall Study||4
8571432|NCT01619865|21134283|P1|COMPLETED|Overall Study||219
8571433|NCT01619865|21134283|P1|STARTED|Overall Study||223
8571434|NCT01609790|21134291|P3|NOT COMPLETED|Overall Study||8
8571435|NCT01609790|21134292|P2|NOT COMPLETED|Overall Study||7
8571436|NCT01609790|21134293|P1|NOT COMPLETED|Overall Study||1
8571437|NCT01609790|21134291|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
8571438|NCT01609790|21134292|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
8571439|NCT01609790|21134293|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
8571440|NCT01609790|21134291|P3|STARTED|Overall Study||65
8571441|NCT01609790|21134292|P2|STARTED|Overall Study||65
8571442|NCT01609790|21134293|P1|STARTED|Overall Study||7
8571449|NCT01593917|21134331|P1|NOT COMPLETED|Overall Study||170
8571450|NCT01593917|21134331|P1|COMPLETED|Overall Study||159
8571451|NCT01593917|21134331|P1|STARTED|Overall Study||329
8571461|NCT01576523|21134371|P6|NOT COMPLETED|Dosing Period 2||0
8571462|NCT01576523|21134372|P5|NOT COMPLETED|Dosing Period 2||0
8571463|NCT01576523|21134373|P4|NOT COMPLETED|Dosing Period 2||0
8571464|NCT01576523|21134374|P3|NOT COMPLETED|Dosing Period 2||0
8571465|NCT01576523|21134375|P2|NOT COMPLETED|Dosing Period 2||0
8571466|NCT01576523|21134376|P1|NOT COMPLETED|Dosing Period 2||0
8571467|NCT01576523|21134371|P6|COMPLETED|Dosing Period 2||3
8571468|NCT01576523|21134372|P5|COMPLETED|Dosing Period 2||3
8571469|NCT01576523|21134373|P4|COMPLETED|Dosing Period 2||3
8571470|NCT01576523|21134374|P3|COMPLETED|Dosing Period 2||3
8571471|NCT01576523|21134375|P2|COMPLETED|Dosing Period 2||3
8571472|NCT01576523|21134376|P1|COMPLETED|Dosing Period 2||3
8571473|NCT01576523|21134371|P6|STARTED|Dosing Period 2||3
8571474|NCT01576523|21134372|P5|STARTED|Dosing Period 2||3
8571475|NCT01576523|21134373|P4|STARTED|Dosing Period 2||3
8571476|NCT01576523|21134374|P3|STARTED|Dosing Period 2||3
8571477|NCT01576523|21134375|P2|STARTED|Dosing Period 2||3
8571478|NCT01576523|21134376|P1|STARTED|Dosing Period 2||3
8571479|NCT01576523|21134371|P6|NOT COMPLETED|Dosing Period 1||0
8571480|NCT01576523|21134372|P5|NOT COMPLETED|Dosing Period 1||0
8571481|NCT01576523|21134373|P4|NOT COMPLETED|Dosing Period 1||0
8571482|NCT01576523|21134374|P3|NOT COMPLETED|Dosing Period 1||0
8571483|NCT01576523|21134375|P2|NOT COMPLETED|Dosing Period 1||0
8571484|NCT01576523|21134376|P1|NOT COMPLETED|Dosing Period 1||0
8571485|NCT01576523|21134371|P6|COMPLETED|Dosing Period 1||3
8571486|NCT01576523|21134372|P5|COMPLETED|Dosing Period 1||3
8571487|NCT01576523|21134373|P4|COMPLETED|Dosing Period 1||3
8571488|NCT01576523|21134374|P3|COMPLETED|Dosing Period 1||3
8571489|NCT01576523|21134375|P2|COMPLETED|Dosing Period 1||3
8571490|NCT01576523|21134376|P1|COMPLETED|Dosing Period 1||3
8571491|NCT01576523|21134371|P6|STARTED|Dosing Period 1||3
8571492|NCT01576523|21134372|P5|STARTED|Dosing Period 1||3
8571493|NCT01576523|21134373|P4|STARTED|Dosing Period 1||3
8571494|NCT01576523|21134374|P3|STARTED|Dosing Period 1||3
8571495|NCT01576523|21134375|P2|STARTED|Dosing Period 1||3
8571496|NCT01576523|21134376|P1|STARTED|Dosing Period 1||3
8571497|NCT01565941|21134405|P2|NOT COMPLETED|Overall Study||4
8571498|NCT01565941|21134406|P1|NOT COMPLETED|Overall Study||11
8571499|NCT01565941|21134405|P2|COMPLETED|Overall Study||349
8571500|NCT01565941|21134406|P1|COMPLETED|Overall Study||349
8571501|NCT01565941|21134405|P2|STARTED|Overall Study||353
8571502|NCT01565941|21134406|P1|STARTED|Overall Study||360
8571503|NCT01557244|21134457|P7|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8571504|NCT01557244|21134458|P6|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
8571505|NCT01557244|21134459|P5|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8571506|NCT01557244|21134460|P4|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
8571507|NCT01557244|21134461|P3|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8571508|NCT01557244|21134462|P2|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
8571509|NCT01557244|21134463|P1|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
8571510|NCT01557244|21134457|P7|COMPLETED|Safety Extension Phase: 12 Weeks||28
8571511|NCT01557244|21134458|P6|COMPLETED|Safety Extension Phase: 12 Weeks||20
8571512|NCT01557244|21134459|P5|COMPLETED|Safety Extension Phase: 12 Weeks||20
8571513|NCT01557244|21134460|P4|COMPLETED|Safety Extension Phase: 12 Weeks||15
8571514|NCT01557244|21134461|P3|COMPLETED|Safety Extension Phase: 12 Weeks||0
8571515|NCT01557244|21134462|P2|COMPLETED|Safety Extension Phase: 12 Weeks||36
8571516|NCT01557244|21134463|P1|COMPLETED|Safety Extension Phase: 12 Weeks||30
8571517|NCT01557244|21134457|P7|Treated|Safety Extension Phase: 12 Weeks||28
8571518|NCT01557244|21134458|P6|Treated|Safety Extension Phase: 12 Weeks||20
8571519|NCT01557244|21134459|P5|Treated|Safety Extension Phase: 12 Weeks||20
8571520|NCT01557244|21134460|P4|Treated|Safety Extension Phase: 12 Weeks||16
8571521|NCT01557244|21134461|P3|Treated|Safety Extension Phase: 12 Weeks||0
8571522|NCT01557244|21134462|P2|Treated|Safety Extension Phase: 12 Weeks||37
8571523|NCT01557244|21134463|P1|Treated|Safety Extension Phase: 12 Weeks||30
8571524|NCT01557244|21134457|P7|STARTED|Safety Extension Phase: 12 Weeks||28
8571525|NCT01557244|21134458|P6|STARTED|Safety Extension Phase: 12 Weeks||21
8571526|NCT01557244|21134459|P5|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
8571527|NCT01557244|21134460|P4|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
8571528|NCT01557244|21134461|P3|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
8571529|NCT01557244|21134462|P2|STARTED|Safety Extension Phase: 12 Weeks||40
8571530|NCT01557244|21134463|P1|STARTED|Safety Extension Phase: 12 Weeks||33
8571531|NCT01557244|21134457|P7|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
8571532|NCT01557244|21134458|P6|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
8571533|NCT01557244|21134459|P5|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571534|NCT01557244|21134460|P4|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571535|NCT01557244|21134461|P3|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
8571536|NCT01557244|21134462|P2|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
8571537|NCT01557244|21134463|P1|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
8571538|NCT01557244|21134457|P7|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
8571539|NCT01557244|21134458|P6|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
8571540|NCT01557244|21134459|P5|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571541|NCT01557244|21134460|P4|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571542|NCT01557244|21134461|P3|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
8571543|NCT01557244|21134462|P2|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
8571544|NCT01557244|21134463|P1|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
8571545|NCT01557244|21134457|P7|Treated|Active Comparator/Efficacy Phase:12Weeks||29
8571546|NCT01557244|21134458|P6|Treated|Active Comparator/Efficacy Phase:12Weeks||28
8571547|NCT01557244|21134459|P5|Treated|Active Comparator/Efficacy Phase:12Weeks||0
8571548|NCT01557244|21134460|P4|Treated|Active Comparator/Efficacy Phase:12Weeks||0
8571549|NCT01557244|21134461|P3|Treated|Active Comparator/Efficacy Phase:12Weeks||40
8571550|NCT01557244|21134462|P2|Treated|Active Comparator/Efficacy Phase:12Weeks||42
8571551|NCT01557244|21134463|P1|Treated|Active Comparator/Efficacy Phase:12Weeks||42
8571552|NCT01557244|21134457|P7|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
8571553|NCT01557244|21134458|P6|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
8571554|NCT01557244|21134459|P5|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
8571555|NCT01557244|21134460|P4|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
8571556|NCT01557244|21134461|P3|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
8571557|NCT01557244|21134462|P2|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
8571558|NCT01557244|21134463|P1|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
8571583|NCT01445080|21134797|P9|NOT COMPLETED|Overall Study||18
8571584|NCT01445080|21134798|P8|NOT COMPLETED|Overall Study||5
8571585|NCT01445080|21134799|P7|NOT COMPLETED|Overall Study||2
8571586|NCT01445080|21134800|P6|NOT COMPLETED|Overall Study||9
8571587|NCT01445080|21134801|P5|NOT COMPLETED|Overall Study||4
8571588|NCT01445080|21134802|P4|NOT COMPLETED|Overall Study||8
8571589|NCT01445080|21134803|P3|NOT COMPLETED|Overall Study||12
8571590|NCT01445080|21134804|P2|NOT COMPLETED|Overall Study||5
8571591|NCT01445080|21134805|P1|NOT COMPLETED|Overall Study||7
8571592|NCT01445080|21134797|P9|COMPLETED|Overall Study||0
8571593|NCT01445080|21134798|P8|COMPLETED|Overall Study||0
8571594|NCT01445080|21134799|P7|COMPLETED|Overall Study||0
8571595|NCT01445080|21134800|P6|COMPLETED|Overall Study||0
8571596|NCT01445080|21134801|P5|COMPLETED|Overall Study||0
8571597|NCT01445080|21134802|P4|COMPLETED|Overall Study||0
8571598|NCT01445080|21134803|P3|COMPLETED|Overall Study||0
8571599|NCT01445080|21134804|P2|COMPLETED|Overall Study||0
8571600|NCT01445080|21134805|P1|COMPLETED|Overall Study||0
8571601|NCT01445080|21134797|P9|STARTED|Overall Study||18
8571602|NCT01445080|21134798|P8|STARTED|Overall Study||5
8571603|NCT01445080|21134799|P7|STARTED|Overall Study||2
8571604|NCT01445080|21134800|P6|STARTED|Overall Study||9
8571605|NCT01445080|21134801|P5|STARTED|Overall Study||4
8571606|NCT01445080|21134802|P4|STARTED|Overall Study||8
8571607|NCT01445080|21134803|P3|STARTED|Overall Study||12
8571608|NCT01445080|21134804|P2|STARTED|Overall Study||5
8571609|NCT01445080|21134805|P1|STARTED|Overall Study||7
8571613|NCT01365585|21134915|P1|NOT COMPLETED|Overall Study||0
8571614|NCT01365585|21134915|P1|COMPLETED|Overall Study||227
8571615|NCT01365585|21134915|P1|STARTED|Overall Study||227
8571622|NCT01364389|21134941|P3|NOT COMPLETED|Overall Study||1
8571623|NCT01364389|21134942|P2|NOT COMPLETED|Overall Study||1
8571624|NCT01364389|21134943|P1|NOT COMPLETED|Overall Study||2
8571625|NCT01364389|21134941|P3|COMPLETED|Overall Study||4
8571626|NCT01364389|21134942|P2|COMPLETED|Overall Study||5
8571627|NCT01364389|21134943|P1|COMPLETED|Overall Study||3
8571628|NCT01364389|21134941|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
8571629|NCT01364389|21134942|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
8571630|NCT01364389|21134943|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
8571631|NCT01364389|21134941|P3|STARTED|Overall Study||5
8571632|NCT01364389|21134942|P2|STARTED|Overall Study||6
8571633|NCT01364389|21134943|P1|STARTED|Overall Study||5
8571634|NCT01351805|21134997|P4|NOT COMPLETED|Overall Study||0
8571635|NCT01351805|21134998|P3|NOT COMPLETED|Overall Study||0
8571636|NCT01351805|21134999|P2|NOT COMPLETED|Overall Study||0
8571637|NCT01351805|21135000|P1|NOT COMPLETED|Overall Study||0
8571638|NCT01351805|21134997|P4|COMPLETED|Overall Study||6474
8571639|NCT01351805|21134998|P3|COMPLETED|Overall Study||6470
8571640|NCT01351805|21134999|P2|COMPLETED|Overall Study||6464
8571641|NCT01351805|21135000|P1|COMPLETED|Overall Study||6463
8571642|NCT01351805|21134997|P4|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||385
8571643|NCT01351805|21134998|P3|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8571644|NCT01351805|21134999|P2|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8571645|NCT01351805|21135000|P1|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8571646|NCT01351805|21134997|P4|Knee Pain Cohort Within VITAL Trial|Overall Study||371
8571647|NCT01351805|21134998|P3|Knee Pain Cohort Within VITAL Trial|Overall Study||353
8571648|NCT01351805|21134999|P2|Knee Pain Cohort Within VITAL Trial|Overall Study||332
8571649|NCT01351805|21135000|P1|Knee Pain Cohort Within VITAL Trial|Overall Study||342
8571650|NCT01351805|21134997|P4|STARTED|Overall Study||6474
8571651|NCT01351805|21134998|P3|STARTED|Overall Study||6470
8571652|NCT01351805|21134999|P2|STARTED|Overall Study||6464
8571653|NCT01351805|21135000|P1|STARTED|Overall Study||6463
8571681|NCT01260324|21135128|P2|NOT COMPLETED|Overall Study||0
8571682|NCT01260324|21135129|P1|NOT COMPLETED|Overall Study||0
8571683|NCT01260324|21135128|P2|COMPLETED|Overall Study||20000
8571684|NCT01260324|21135129|P1|COMPLETED|Overall Study||1283
8571685|NCT01260324|21135128|P2|STARTED|Overall Study||20000
8571686|NCT01260324|21135129|P1|STARTED|Overall Study||1283
8571687|NCT01254396|21135143|P2|NOT COMPLETED|Second Intervention Period||0
8571688|NCT01254396|21135144|P1|NOT COMPLETED|Second Intervention Period||0
8571689|NCT01254396|21135143|P2|COMPLETED|Second Intervention Period||6
8571690|NCT01254396|21135144|P1|COMPLETED|Second Intervention Period||6
8571691|NCT01254396|21135143|P2|STARTED|Second Intervention Period||6
8571692|NCT01254396|21135144|P1|STARTED|Second Intervention Period||6
8571693|NCT01254396|21135143|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
8571694|NCT01254396|21135144|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
8571695|NCT01254396|21135143|P2|COMPLETED|Washout Period (at Least 1 Day)||6
8571696|NCT01254396|21135144|P1|COMPLETED|Washout Period (at Least 1 Day)||6
8571697|NCT01254396|21135143|P2|STARTED|Washout Period (at Least 1 Day)||6
8571698|NCT01254396|21135144|P1|STARTED|Washout Period (at Least 1 Day)||6
8571699|NCT01254396|21135143|P2|NOT COMPLETED|First Intervention Period||0
8571700|NCT01254396|21135144|P1|NOT COMPLETED|First Intervention Period||0
8571701|NCT01254396|21135143|P2|COMPLETED|First Intervention Period||6
8571702|NCT01254396|21135144|P1|COMPLETED|First Intervention Period||6
8571703|NCT01254396|21135143|P2|STARTED|First Intervention Period||6
8571704|NCT01254396|21135144|P1|STARTED|First Intervention Period||6
8571711|NCT01243177|21135173|P2|NOT COMPLETED|Overall Study||178
8571712|NCT01243177|21135174|P1|NOT COMPLETED|Overall Study||178
8571713|NCT01243177|21135173|P2|COMPLETED|Overall Study||264
8571714|NCT01243177|21135174|P1|COMPLETED|Overall Study||266
8571715|NCT01243177|21135173|P2|STARTED|Overall Study||442
8571716|NCT01243177|21135174|P1|STARTED|Overall Study||444
8571717|NCT01236560|21135196|P6|NOT COMPLETED|Overall Study||0
8571718|NCT01236560|21135197|P5|NOT COMPLETED|Overall Study||0
8571719|NCT01236560|21135198|P4|NOT COMPLETED|Overall Study||22
8571720|NCT01236560|21135199|P3|NOT COMPLETED|Overall Study||20
8571721|NCT01236560|21135200|P2|NOT COMPLETED|Overall Study||24
8571722|NCT01236560|21135201|P1|NOT COMPLETED|Overall Study||5
8571723|NCT01236560|21135196|P6|COMPLETED|Overall Study||0
8571724|NCT01236560|21135197|P5|COMPLETED|Overall Study||0
8571725|NCT01236560|21135198|P4|COMPLETED|Overall Study||10
8571726|NCT01236560|21135199|P3|COMPLETED|Overall Study||11
8571727|NCT01236560|21135200|P2|COMPLETED|Overall Study||8
8571728|NCT01236560|21135201|P1|COMPLETED|Overall Study||1
8571729|NCT01236560|21135196|P6|STARTED|Overall Study||0
8571730|NCT01236560|21135197|P5|STARTED|Overall Study||0
8571731|NCT01236560|21135198|P4|STARTED|Overall Study||32
8571732|NCT01236560|21135199|P3|STARTED|Overall Study||31
8571733|NCT01236560|21135200|P2|STARTED|Overall Study||32
8571734|NCT01236560|21135201|P1|STARTED|Overall Study||6
8571755|NCT01207440|21135265|P7|NOT COMPLETED|Overall Study||5
8571756|NCT01207440|21135266|P6|NOT COMPLETED|Overall Study||46
8571757|NCT01207440|21135267|P5|NOT COMPLETED|Overall Study||48
8571758|NCT01207440|21135268|P4|NOT COMPLETED|Overall Study||18
8571759|NCT01207440|21135269|P3|NOT COMPLETED|Overall Study||65
8571760|NCT01207440|21135270|P2|NOT COMPLETED|Overall Study||64
8571761|NCT01207440|21135271|P1|NOT COMPLETED|Overall Study||203
8571762|NCT01207440|21135265|P7|COMPLETED|Overall Study||0
8571763|NCT01207440|21135266|P6|COMPLETED|Overall Study||0
8571764|NCT01207440|21135267|P5|COMPLETED|Overall Study||0
8571765|NCT01207440|21135268|P4|COMPLETED|Overall Study||0
8571766|NCT01207440|21135269|P3|COMPLETED|Overall Study||0
8571767|NCT01207440|21135270|P2|COMPLETED|Overall Study||0
8571768|NCT01207440|21135271|P1|COMPLETED|Overall Study||0
8571769|NCT01207440|21135265|P7|STARTED|Overall Study||5
8571770|NCT01207440|21135266|P6|STARTED|Overall Study||46
8571771|NCT01207440|21135267|P5|STARTED|Overall Study||48
8571772|NCT01207440|21135268|P4|STARTED|Overall Study||18
8571773|NCT01207440|21135269|P3|STARTED|Overall Study||65
8571774|NCT01207440|21135270|P2|STARTED|Overall Study||64
8571775|NCT01207440|21135271|P1|STARTED|Overall Study||203
8571804|NCT01069861|21135396|P1|NOT COMPLETED|Overall Study||3
8571805|NCT01069861|21135396|P1|COMPLETED|Overall Study||1
8571806|NCT01069861|21135396|P1|STARTED|Overall Study||4
8571807|NCT01062113|21135412|P3|NOT COMPLETED|Overall Study||31
8571808|NCT01062113|21135413|P2|NOT COMPLETED|Overall Study||22
8571809|NCT01062113|21135414|P1|NOT COMPLETED|Overall Study||40
8571810|NCT01062113|21135412|P3|COMPLETED|Overall Study||27
8571811|NCT01062113|21135413|P2|COMPLETED|Overall Study||42
8571812|NCT01062113|21135414|P1|COMPLETED|Overall Study||93
8571813|NCT01062113|21135412|P3|STARTED|Overall Study||58
8571814|NCT01062113|21135413|P2|STARTED|Overall Study||64
8571815|NCT01062113|21135414|P1|STARTED|Overall Study||133
8571816|NCT01058070|21135427|P1|NOT COMPLETED|Overall Study||11
8571817|NCT01058070|21135427|P1|COMPLETED|Overall Study||33
8571818|NCT01058070|21135427|P1|STARTED|Overall Study||44
8571819|NCT01057381|21135436|P4|NOT COMPLETED|Overall Study||0
8571820|NCT01057381|21135437|P3|NOT COMPLETED|Overall Study||0
8571821|NCT01057381|21135438|P2|NOT COMPLETED|Overall Study||0
8571822|NCT01057381|21135439|P1|NOT COMPLETED|Overall Study||0
8571823|NCT01057381|21135436|P4|COMPLETED|Overall Study||26
8571824|NCT01057381|21135437|P3|COMPLETED|Overall Study||30
8571825|NCT01057381|21135438|P2|COMPLETED|Overall Study||27
8571826|NCT01057381|21135439|P1|COMPLETED|Overall Study||26
8571827|NCT01057381|21135436|P4|STARTED|Overall Study||26
8571828|NCT01057381|21135437|P3|STARTED|Overall Study||30
8571829|NCT01057381|21135438|P2|STARTED|Overall Study||27
8571830|NCT01057381|21135439|P1|STARTED|Overall Study||26
8571846|NCT00994461|21135498|P3|NOT COMPLETED|Overall Study||0
8571847|NCT00994461|21135499|P2|NOT COMPLETED|Overall Study||1
8571848|NCT00994461|21135500|P1|NOT COMPLETED|Overall Study||2
8571849|NCT00994461|21135498|P3|COMPLETED|Overall Study||37
8571850|NCT00994461|21135499|P2|COMPLETED|Overall Study||75
8571851|NCT00994461|21135500|P1|COMPLETED|Overall Study||74
8571852|NCT00994461|21135498|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
8571853|NCT00994461|21135499|P2|STARTED|Overall Study||76
8571854|NCT00994461|21135500|P1|STARTED|Overall Study||76
8571855|NCT00976716|21135526|P1|NOT COMPLETED|Overall Study||1
8571856|NCT00976716|21135526|P1|COMPLETED|Overall Study||79
8571857|NCT00976716|21135526|P1|STARTED|Overall Study||80
8571858|NCT00946114|21135544|P2|NOT COMPLETED|Overall Study||2
8571859|NCT00946114|21135545|P1|NOT COMPLETED|Overall Study||8
8571860|NCT00946114|21135544|P2|COMPLETED|Overall Study||10
8571861|NCT00946114|21135545|P1|COMPLETED|Overall Study||12
8571862|NCT00946114|21135544|P2|STARTED|Overall Study||12
8571863|NCT00946114|21135545|P1|STARTED|Overall Study||20
8571864|NCT00934934|21135553|P2|NOT COMPLETED|Overall Study||0
8571865|NCT00934934|21135554|P1|NOT COMPLETED|Overall Study||1
8571866|NCT00934934|21135553|P2|COMPLETED|Overall Study||31
8571867|NCT00934934|21135554|P1|COMPLETED|Overall Study||29
8571868|NCT00934934|21135553|P2|STARTED|Overall Study||31
8571869|NCT00934934|21135554|P1|STARTED|Overall Study||30
8571882|NCT00904748|21135611|P6|NOT COMPLETED|Overall Study||0
8571883|NCT00904748|21135612|P5|NOT COMPLETED|Overall Study||1
8571884|NCT00904748|21135613|P4|NOT COMPLETED|Overall Study||2
8571885|NCT00904748|21135614|P3|NOT COMPLETED|Overall Study||1
8571886|NCT00904748|21135615|P2|NOT COMPLETED|Overall Study||1
8571887|NCT00904748|21135616|P1|NOT COMPLETED|Overall Study||1
8571888|NCT00904748|21135611|P6|COMPLETED|Overall Study||8
8571889|NCT00904748|21135612|P5|COMPLETED|Overall Study||7
8571890|NCT00904748|21135613|P4|COMPLETED|Overall Study||6
8571891|NCT00904748|21135614|P3|COMPLETED|Overall Study||7
8571892|NCT00904748|21135615|P2|COMPLETED|Overall Study||7
8571893|NCT00904748|21135616|P1|COMPLETED|Overall Study||7
8571894|NCT00904748|21135611|P6|Received Treatment|Overall Study||8
8571895|NCT00904748|21135612|P5|Received Treatment|Overall Study||7
8571896|NCT00904748|21135613|P4|Received Treatment|Overall Study||8
8571897|NCT00904748|21135614|P3|Received Treatment|Overall Study||8
8571898|NCT00904748|21135615|P2|Received Treatment|Overall Study||8
8571899|NCT00904748|21135616|P1|Received Treatment|Overall Study||8
8571900|NCT00904748|21135611|P6|STARTED|Overall Study||8
8571901|NCT00904748|21135612|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
8571902|NCT00904748|21135613|P4|STARTED|Overall Study||8
8571903|NCT00904748|21135614|P3|STARTED|Overall Study||8
8571904|NCT00904748|21135615|P2|STARTED|Overall Study||8
8571905|NCT00904748|21135616|P1|STARTED|Overall Study||8
8571906|NCT00894790|21135642|P2|NOT COMPLETED|Overall Study||2
8571907|NCT00894790|21135643|P1|NOT COMPLETED|Overall Study||1
8571908|NCT00894790|21135642|P2|COMPLETED|Overall Study||2
8571909|NCT00894790|21135643|P1|COMPLETED|Overall Study||3
8571910|NCT00894790|21135642|P2|STARTED|Overall Study||4
8571911|NCT00894790|21135643|P1|STARTED|Overall Study||4
8571932|NCT00830180|21135813|P1|NOT COMPLETED|Overall Study||26
8571933|NCT00830180|21135813|P1|COMPLETED|Overall Study||15
8571934|NCT00830180|21135813|P1|STARTED|Overall Study||41
8571947|NCT00807846|21135866|P2|NOT COMPLETED|Overall Study||4
8571948|NCT00807846|21135867|P1|NOT COMPLETED|Overall Study||12
8571949|NCT00807846|21135866|P2|COMPLETED|Overall Study||94
8571950|NCT00807846|21135867|P1|COMPLETED|Overall Study||88
8571951|NCT00807846|21135866|P2|STARTED|Overall Study||98
8571952|NCT00807846|21135867|P1|STARTED|Overall Study||100
8571956|NCT00762463|21135907|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
8571957|NCT00762463|21135908|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
8571958|NCT00762463|21135909|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
8571959|NCT00762463|21135910|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
8571960|NCT00762463|21135907|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
8571961|NCT00762463|21135908|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
8571962|NCT00762463|21135909|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
8571963|NCT00762463|21135910|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
8571964|NCT00762463|21135907|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
8571965|NCT00762463|21135908|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
8571966|NCT00762463|21135909|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
8571967|NCT00762463|21135910|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
8571968|NCT00762463|21135907|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571969|NCT00762463|21135908|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571970|NCT00762463|21135909|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
8571971|NCT00762463|21135910|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
8571972|NCT00762463|21135907|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571973|NCT00762463|21135908|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571974|NCT00762463|21135909|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
8571975|NCT00762463|21135910|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
8571976|NCT00762463|21135907|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
8571977|NCT00762463|21135908|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
8571978|NCT00762463|21135909|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
8571979|NCT00762463|21135910|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
8571980|NCT00762463|21135907|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571981|NCT00762463|21135908|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571982|NCT00762463|21135909|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
8571983|NCT00762463|21135910|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
8571984|NCT00762463|21135907|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571985|NCT00762463|21135908|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571986|NCT00762463|21135909|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
8571987|NCT00762463|21135910|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
8571988|NCT00762463|21135907|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
8571989|NCT00762463|21135908|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
8571990|NCT00762463|21135909|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
8571991|NCT00762463|21135910|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
8571992|NCT00759174|21135994|P2|NOT COMPLETED|Overall Study||2
8571993|NCT00759174|21135995|P1|NOT COMPLETED|Overall Study||0
8571994|NCT00759174|21135994|P2|COMPLETED|Overall Study||595
8571995|NCT00759174|21135995|P1|COMPLETED|Overall Study||76
8571996|NCT00759174|21135994|P2|STARTED|Overall Study||597
8571997|NCT00759174|21135995|P1|STARTED|Overall Study||76
8571998|NCT00750919|21136004|P1|NOT COMPLETED|Overall Study||58
8571999|NCT00750919|21136004|P1|COMPLETED|Overall Study||126
8572000|NCT00750919|21136004|P1|STARTED|Overall Study||184
8572009|NCT00688545|21136041|P2|NOT COMPLETED|Overall Study||15
8572010|NCT00688545|21136042|P1|NOT COMPLETED|Overall Study||5
8572011|NCT00688545|21136041|P2|COMPLETED|Overall Study||204
8572012|NCT00688545|21136042|P1|COMPLETED|Overall Study||50
8572013|NCT00688545|21136041|P2|Switched Treatment at Least Once|Overall Study||13
8572014|NCT00688545|21136042|P1|Switched Treatment at Least Once|Overall Study||6
8572015|NCT00688545|21136041|P2|STARTED|Overall Study||219
8572016|NCT00688545|21136042|P1|STARTED|Overall Study||55
8572017|NCT00682448|21136052|P2|NOT COMPLETED|Overall Study||6
8572018|NCT00682448|21136053|P1|NOT COMPLETED|Overall Study||5
8572019|NCT00682448|21136052|P2|COMPLETED|Overall Study||7
8572020|NCT00682448|21136053|P1|COMPLETED|Overall Study||7
8572021|NCT00682448|21136052|P2|STARTED|Overall Study||13
8572022|NCT00682448|21136053|P1|STARTED|Overall Study||12
8572023|NCT00666198|21136061|P1|NOT COMPLETED|Overall Study||33
8572024|NCT00666198|21136061|P1|COMPLETED|Overall Study||3304
8572025|NCT00666198|21136061|P1|STARTED|Overall Study||3337
8572026|NCT00653068|21136078|P1|NOT COMPLETED|Overall Study||50
8572027|NCT00653068|21136078|P1|COMPLETED|Overall Study||20
8572028|NCT00653068|21136078|P1|STARTED|Overall Study||70
8572093|NCT00638157|21136264|P2|NOT COMPLETED|Overall Study||4
8572094|NCT00638157|21136265|P1|NOT COMPLETED|Overall Study||7
8572095|NCT00638157|21136264|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
8572096|NCT00638157|21136265|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
8572097|NCT00638157|21136264|P2|Treated|Overall Study||12
8572098|NCT00638157|21136265|P1|Treated|Overall Study||10
8572099|NCT00638157|21136264|P2|STARTED|Overall Study||12
8572100|NCT00638157|21136265|P1|STARTED|Overall Study||12
8572110|NCT00604500|21136295|P1|NOT COMPLETED|Overall Study||11
8572111|NCT00604500|21136295|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
8572112|NCT00604500|21136295|P1|STARTED|Overall Study||272
8572116|NCT00591630|21136312|P4|NOT COMPLETED|Overall Study||0
8572117|NCT00591630|21136313|P3|NOT COMPLETED|Overall Study||1
8572118|NCT00591630|21136314|P2|NOT COMPLETED|Overall Study||0
8572119|NCT00591630|21136315|P1|NOT COMPLETED|Overall Study||0
8572120|NCT00591630|21136312|P4|COMPLETED|Overall Study||6
8572121|NCT00591630|21136313|P3|COMPLETED|Overall Study||9
8572122|NCT00591630|21136314|P2|COMPLETED|Overall Study||8
8572123|NCT00591630|21136315|P1|COMPLETED|Overall Study||6
8572124|NCT00591630|21136312|P4|STARTED|Overall Study||6
8572125|NCT00591630|21136313|P3|STARTED|Overall Study||10
8572126|NCT00591630|21136314|P2|STARTED|Overall Study||8
8572127|NCT00591630|21136315|P1|STARTED|Overall Study||6
8572128|NCT00586209|21136327|P2|NOT COMPLETED|Overall Study||0
8572129|NCT00586209|21136328|P1|NOT COMPLETED|Overall Study||0
8572130|NCT00586209|21136327|P2|COMPLETED|Overall Study||10
8572131|NCT00586209|21136328|P1|COMPLETED|Overall Study||5
8572132|NCT00586209|21136327|P2|STARTED|Overall Study||10
8572133|NCT00586209|21136328|P1|STARTED|Overall Study||5
8572140|NCT00579878|21136356|P3|NOT COMPLETED|Overall Study||10
8572141|NCT00579878|21136357|P2|NOT COMPLETED|Overall Study||3
8572142|NCT00579878|21136358|P1|NOT COMPLETED|Overall Study||7
8572143|NCT00579878|21136356|P3|COMPLETED|Overall Study||14
8572144|NCT00579878|21136357|P2|COMPLETED|Overall Study||20
8572145|NCT00579878|21136358|P1|COMPLETED|Overall Study||15
8572146|NCT00579878|21136356|P3|STARTED|Overall Study||24
8572147|NCT00579878|21136357|P2|STARTED|Overall Study||23
8572148|NCT00579878|21136358|P1|STARTED|Overall Study||22
8572149|NCT00570765|21136369|P4|NOT COMPLETED|LTSE Phase||12
8572150|NCT00570765|21136370|P3|NOT COMPLETED|LTSE Phase||0
8572151|NCT00570765|21136371|P2|NOT COMPLETED|LTSE Phase||0
8572152|NCT00570765|21136372|P1|NOT COMPLETED|LTSE Phase||0
8572153|NCT00570765|21136369|P4|COMPLETED|LTSE Phase||16
8572154|NCT00570765|21136370|P3|COMPLETED|LTSE Phase||0
8572155|NCT00570765|21136371|P2|COMPLETED|LTSE Phase||0
8572156|NCT00570765|21136372|P1|COMPLETED|LTSE Phase||0
8572157|NCT00570765|21136369|P4|Safety Population|LTSE Phase||28
8572158|NCT00570765|21136370|P3|Safety Population|LTSE Phase||0
8572159|NCT00570765|21136371|P2|Safety Population|LTSE Phase||0
8572160|NCT00570765|21136372|P1|Safety Population|LTSE Phase||0
8572161|NCT00570765|21136369|P4|Received at Least 1 Dose of Study Drug|LTSE Phase||28
8572162|NCT00570765|21136370|P3|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8572163|NCT00570765|21136371|P2|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8572164|NCT00570765|21136372|P1|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8572165|NCT00570765|21136369|P4|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
8572166|NCT00570765|21136370|P3|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8572167|NCT00570765|21136371|P2|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8572168|NCT00570765|21136372|P1|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8572169|NCT00570765|21136369|P4|NOT COMPLETED|DB Phase||0
8572170|NCT00570765|21136370|P3|NOT COMPLETED|DB Phase||1
8572171|NCT00570765|21136371|P2|NOT COMPLETED|DB Phase||7
8572172|NCT00570765|21136372|P1|NOT COMPLETED|DB Phase||4
8572173|NCT00570765|21136369|P4|COMPLETED|DB Phase||0
8572174|NCT00570765|21136370|P3|COMPLETED|DB Phase||23
8572175|NCT00570765|21136371|P2|COMPLETED|DB Phase||9
8572176|NCT00570765|21136372|P1|COMPLETED|DB Phase||16
8572177|NCT00570765|21136369|P4|Safety Population|DB Phase||0
8572178|NCT00570765|21136370|P3|Safety Population|DB Phase||23
8572179|NCT00570765|21136371|P2|Safety Population|DB Phase||16
8572180|NCT00570765|21136372|P1|Safety Population|DB Phase||20
8572181|NCT00570765|21136369|P4|Received at Least 1 Dose of Study Drug|DB Phase||0
8572182|NCT00570765|21136370|P3|Received at Least 1 Dose of Study Drug|DB Phase||23
8572183|NCT00570765|21136371|P2|Received at Least 1 Dose of Study Drug|DB Phase||16
8572184|NCT00570765|21136372|P1|Received at Least 1 Dose of Study Drug|DB Phase||20
8572185|NCT00570765|21136369|P4|STARTED|DB Phase||0
8572186|NCT00570765|21136370|P3|STARTED|DB Phase||24
8572187|NCT00570765|21136371|P2|STARTED|DB Phase||16
8572188|NCT00570765|21136372|P1|STARTED|DB Phase||20
8572192|NCT00537017|21136449|P1|NOT COMPLETED|Follow-up Phase||9
8572193|NCT00537017|21136449|P1|COMPLETED|Follow-up Phase||126
8572194|NCT00537017|21136449|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
8572195|NCT00537017|21136449|P1|NOT COMPLETED|Treatment Phase||34
8572196|NCT00537017|21136449|P1|COMPLETED|Treatment Phase||106
8572197|NCT00537017|21136449|P1|STARTED|Treatment Phase||140
8572310|NCT00401986|21136499|P1|NOT COMPLETED|Overall Study||2
8572311|NCT00401986|21136499|P1|COMPLETED|Overall Study||12
8572312|NCT00401986|21136499|P1|STARTED|Overall Study||14
8572313|NCT00399490|21136509|P1|NOT COMPLETED|Overall Study||98
8572314|NCT00399490|21136509|P1|COMPLETED|Overall Study||183
8572315|NCT00399490|21136509|P1|STARTED|Overall Study||281
8572334|NCT00323297|21136600|P2|NOT COMPLETED|Part B (Open-label)||12
8572335|NCT00323297|21136601|P1|NOT COMPLETED|Part B (Open-label)||9
8572336|NCT00323297|21136600|P2|COMPLETED|Part B (Open-label)||31
8572337|NCT00323297|21136601|P1|COMPLETED|Part B (Open-label)||39
8572338|NCT00323297|21136600|P2|STARTED|Part B (Open-label)||43
8572339|NCT00323297|21136601|P1|STARTED|Part B (Open-label)||48
8572340|NCT00323297|21136600|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
8572341|NCT00323297|21136601|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
8572342|NCT00323297|21136600|P2|COMPLETED|Part A (Double Blind Randomized)||43
8572343|NCT00323297|21136601|P1|COMPLETED|Part A (Double Blind Randomized)||48
8572344|NCT00323297|21136600|P2|STARTED|Part A (Double Blind Randomized)||50
8572345|NCT00323297|21136601|P1|STARTED|Part A (Double Blind Randomized)||53
8572370|NCT00301262|21136656|P2|NOT COMPLETED|Open Label Phase (OL)||2
8572371|NCT00301262|21136657|P1|NOT COMPLETED|Open Label Phase (OL)||4
8572372|NCT00301262|21136656|P2|COMPLETED|Open Label Phase (OL)||67
8572373|NCT00301262|21136657|P1|COMPLETED|Open Label Phase (OL)||79
8572374|NCT00301262|21136656|P2|STARTED|Open Label Phase (OL)||69
8572375|NCT00301262|21136657|P1|STARTED|Open Label Phase (OL)||83
8572376|NCT00301262|21136656|P2|NOT COMPLETED|Double Blind Phase (DB)||13
8572377|NCT00301262|21136657|P1|NOT COMPLETED|Double Blind Phase (DB)||10
8572378|NCT00301262|21136656|P2|COMPLETED|Double Blind Phase (DB)||69
8572379|NCT00301262|21136657|P1|COMPLETED|Double Blind Phase (DB)||84
8572380|NCT00301262|21136656|P2|STARTED|Double Blind Phase (DB)||82
8572381|NCT00301262|21136657|P1|STARTED|Double Blind Phase (DB)||94
8572382|NCT00189436|21136817|P2|NOT COMPLETED|Overall Study||5
8572383|NCT00189436|21136818|P1|NOT COMPLETED|Overall Study||8
8572384|NCT00189436|21136817|P2|COMPLETED|Overall Study||25
8572385|NCT00189436|21136818|P1|COMPLETED|Overall Study||23
8572386|NCT00189436|21136817|P2|STARTED|Overall Study||30
8572387|NCT00189436|21136818|P1|STARTED|Overall Study||31
8572388|NCT00159874|21136835|P7|NOT COMPLETED|Overall Study||5
8572389|NCT00159874|21136836|P6|NOT COMPLETED|Overall Study||12
8572390|NCT00159874|21136837|P5|NOT COMPLETED|Overall Study||8
8572391|NCT00159874|21136838|P4|NOT COMPLETED|Overall Study||6
8572392|NCT00159874|21136839|P3|NOT COMPLETED|Overall Study||43
8572393|NCT00159874|21136840|P2|NOT COMPLETED|Overall Study||30
8572394|NCT00159874|21136841|P1|NOT COMPLETED|Overall Study||20
8572395|NCT00159874|21136835|P7|COMPLETED|Overall Study||0
8572396|NCT00159874|21136836|P6|COMPLETED|Overall Study||11
8572397|NCT00159874|21136837|P5|COMPLETED|Overall Study||11
8572398|NCT00159874|21136838|P4|COMPLETED|Overall Study||7
8572399|NCT00159874|21136839|P3|COMPLETED|Overall Study||34
8572400|NCT00159874|21136840|P2|COMPLETED|Overall Study||25
8572401|NCT00159874|21136841|P1|COMPLETED|Overall Study||22
8572402|NCT00159874|21136835|P7|Treated|Overall Study||5
8572403|NCT00159874|21136836|P6|Treated|Overall Study||23
8572404|NCT00159874|21136837|P5|Treated|Overall Study||19
8572405|NCT00159874|21136838|P4|Treated|Overall Study||13
8572406|NCT00159874|21136839|P3|Treated|Overall Study||77
8572407|NCT00159874|21136840|P2|Treated|Overall Study||55
8572408|NCT00159874|21136841|P1|Treated|Overall Study||42
8572409|NCT00159874|21136835|P7|STARTED|Overall Study||5
8572410|NCT00159874|21136836|P6|STARTED|Overall Study||23
8572411|NCT00159874|21136837|P5|STARTED|Overall Study||19
8572412|NCT00159874|21136838|P4|STARTED|Overall Study||13
8572413|NCT00159874|21136839|P3|STARTED|Overall Study||77
8572414|NCT00159874|21136840|P2|STARTED|Overall Study||55
8572415|NCT00159874|21136841|P1|STARTED|Overall Study||42
8572416|NCT00159861|21137011|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
8572417|NCT00159861|21137012|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
8572418|NCT00159861|21137011|P2|COMPLETED|Extension Study - up to 3 Years||56
8572419|NCT00159861|21137012|P1|COMPLETED|Extension Study - up to 3 Years||53
8572420|NCT00159861|21137011|P2|Treated|Extension Study - up to 3 Years||127
8572421|NCT00159861|21137012|P1|Treated|Extension Study - up to 3 Years||115
8572422|NCT00159861|21137011|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
8572423|NCT00159861|21137012|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
8572424|NCT00159861|21137011|P2|NOT COMPLETED|Core Study - 16 Weeks||12
8572425|NCT00159861|21137012|P1|NOT COMPLETED|Core Study - 16 Weeks||25
8572426|NCT00159861|21137011|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
8572427|NCT00159861|21137012|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
8572428|NCT00159861|21137011|P2|Treated|Core Study - 16 Weeks||134
8572429|NCT00159861|21137012|P1|Treated|Core Study - 16 Weeks||131
8572430|NCT00159861|21137011|P2|STARTED|Core Study - 16 Weeks||134
8572431|NCT00159861|21137012|P1|STARTED|Core Study - 16 Weeks||133
8572432|NCT00061932|21137035|P2|NOT COMPLETED|Overall Study||4
8572433|NCT00061932|21137036|P1|NOT COMPLETED|Overall Study||13
8572434|NCT00061932|21137035|P2|COMPLETED|Overall Study||8
8572435|NCT00061932|21137036|P1|COMPLETED|Overall Study||16
8572436|NCT00061932|21137035|P2|STARTED|Overall Study||12
8572437|NCT00061932|21137036|P1|STARTED|Overall Study||29
8572438|NCT00004031|21137046|P2|NOT COMPLETED|Overall Study||21
8572439|NCT00004031|21137047|P1|NOT COMPLETED|Overall Study||25
8572440|NCT00004031|21137046|P2|COMPLETED|Overall Study||104
8572441|NCT00004031|21137047|P1|COMPLETED|Overall Study||103
8572442|NCT00004031|21137046|P2|Assessed for Adverse Events|Overall Study||113
8572443|NCT00004031|21137047|P1|Assessed for Adverse Events|Overall Study||123
8572444|NCT00004031|21137046|P2|STARTED|Overall Study||125
8572445|NCT00004031|21137047|P1|STARTED|Overall Study||128
8572446|NCT00003511|21137057|P1|NOT COMPLETED|Overall Study||4
8572447|NCT00003511|21137057|P1|COMPLETED|Overall Study||1
8572448|NCT00003511|21137057|P1|STARTED|Overall Study||5
8572458|NCT04446429|21137082|P2|NOT COMPLETED|Overall Study||0
8572459|NCT04446429|21137083|P1|NOT COMPLETED|Overall Study||0
8572460|NCT04446429|21137082|P2|COMPLETED|Overall Study||134
8572461|NCT04446429|21137083|P1|COMPLETED|Overall Study||128
8572462|NCT04446429|21137082|P2|STARTED|Overall Study||134
8572463|NCT04446429|21137083|P1|STARTED|Overall Study||128
8572471|NCT04096365|21137109|P1|NOT COMPLETED|Overall Study||1
8572472|NCT04096365|21137109|P1|COMPLETED|Overall Study||11
8572473|NCT04096365|21137109|P1|STARTED|Overall Study||12
8572750|NCT03645954|21137308|P2|NOT COMPLETED|Overall Study||0
8572751|NCT03645954|21137309|P1|NOT COMPLETED|Overall Study||3
8572752|NCT03645954|21137308|P2|COMPLETED|Overall Study||40
8572753|NCT03645954|21137309|P1|COMPLETED|Overall Study||37
8572754|NCT03645954|21137308|P2|STARTED|Overall Study||40
8572755|NCT03645954|21137309|P1|STARTED|Overall Study||40
8572774|NCT03583372|21137391|P4|NOT COMPLETED|Overall Study||18
8572775|NCT03583372|21137392|P3|NOT COMPLETED|Overall Study||19
8572776|NCT03583372|21137393|P2|NOT COMPLETED|Overall Study||26
8572777|NCT03583372|21137394|P1|NOT COMPLETED|Overall Study||13
8572778|NCT03583372|21137391|P4|COMPLETED|Overall Study||123
8572779|NCT03583372|21137392|P3|COMPLETED|Overall Study||72
8572780|NCT03583372|21137393|P2|COMPLETED|Overall Study||156
8572781|NCT03583372|21137394|P1|COMPLETED|Overall Study||79
8572782|NCT03583372|21137391|P4|STARTED|Overall Study||141
8572783|NCT03583372|21137392|P3|STARTED|Overall Study||91
8572784|NCT03583372|21137393|P2|STARTED|Overall Study||182
8572785|NCT03583372|21137394|P1|STARTED|Overall Study||92
8572786|NCT03575754|21137410|P2|NOT COMPLETED|Overall Study||0
8572787|NCT03575754|21137411|P1|NOT COMPLETED|Overall Study||0
8572788|NCT03575754|21137410|P2|COMPLETED|Overall Study||25
8572789|NCT03575754|21137411|P1|COMPLETED|Overall Study||25
8572790|NCT03575754|21137410|P2|STARTED|Overall Study||25
8572791|NCT03575754|21137411|P1|STARTED|Overall Study||25
8572808|NCT03478982|21137447|P4|NOT COMPLETED|Overall Study||0
8572809|NCT03478982|21137448|P3|NOT COMPLETED|Overall Study||0
8572810|NCT03478982|21137449|P2|NOT COMPLETED|Overall Study||0
8572811|NCT03478982|21137450|P1|NOT COMPLETED|Overall Study||0
8572812|NCT03478982|21137447|P4|COMPLETED|Overall Study||48
8572813|NCT03478982|21137448|P3|COMPLETED|Overall Study||47
8572814|NCT03478982|21137449|P2|COMPLETED|Overall Study||50
8572815|NCT03478982|21137450|P1|COMPLETED|Overall Study||11
8572816|NCT03478982|21137447|P4|Intent-to-treat (ITT) Population|Overall Study||38
8572817|NCT03478982|21137448|P3|Intent-to-treat (ITT) Population|Overall Study||38
8572818|NCT03478982|21137449|P2|Intent-to-treat (ITT) Population|Overall Study||40
8572819|NCT03478982|21137450|P1|Intent-to-treat (ITT) Population|Overall Study||8
8572820|NCT03478982|21137447|P4|Enrolled Participants But Not Treated|Overall Study||10
8572821|NCT03478982|21137448|P3|Enrolled Participants But Not Treated|Overall Study||9
8572822|NCT03478982|21137449|P2|Enrolled Participants But Not Treated|Overall Study||10
8572823|NCT03478982|21137450|P1|Enrolled Participants But Not Treated|Overall Study||3
8572824|NCT03478982|21137447|P4|STARTED|Overall Study||48
8572825|NCT03478982|21137448|P3|STARTED|Overall Study||47
8572826|NCT03478982|21137449|P2|STARTED|Overall Study||50
8572827|NCT03478982|21137450|P1|STARTED|Overall Study||11
8572863|NCT03407313|21137575|P1|NOT COMPLETED|Overall Study||2
8572864|NCT03407313|21137575|P1|COMPLETED|Overall Study||66
8572865|NCT03407313|21137575|P1|STARTED|Overall Study||68
8572866|NCT03391765|21137585|P4|NOT COMPLETED|Overall Study||23
8572867|NCT03391765|21137586|P3|NOT COMPLETED|Overall Study||23
8572868|NCT03391765|21137587|P2|NOT COMPLETED|Overall Study||45
8572869|NCT03391765|21137588|P1|NOT COMPLETED|Overall Study||51
8572870|NCT03391765|21137585|P4|COMPLETED|Overall Study||0
8572871|NCT03391765|21137586|P3|COMPLETED|Overall Study||0
8572872|NCT03391765|21137587|P2|COMPLETED|Overall Study||0
8572873|NCT03391765|21137588|P1|COMPLETED|Overall Study||0
8572874|NCT03391765|21137585|P4|STARTED|Overall Study||23
8572875|NCT03391765|21137586|P3|STARTED|Overall Study||23
8572876|NCT03391765|21137587|P2|STARTED|Overall Study||45
8572877|NCT03391765|21137588|P1|STARTED|Overall Study||51
8572878|NCT03382847|21137626|P1|NOT COMPLETED|Overall Study||0
8572879|NCT03382847|21137626|P1|COMPLETED|Overall Study||25
8572880|NCT03382847|21137626|P1|STARTED|Overall Study||25
8572881|NCT03380624|21137630|P2|NOT COMPLETED|Overall Study||0
8572882|NCT03380624|21137631|P1|NOT COMPLETED|Overall Study||0
8572883|NCT03380624|21137630|P2|COMPLETED|Overall Study||9
8572884|NCT03380624|21137631|P1|COMPLETED|Overall Study||10
8572885|NCT03380624|21137630|P2|STARTED|Overall Study||9
8572886|NCT03380624|21137631|P1|STARTED|Overall Study||10
8572916|NCT03334630|21137729|P2|NOT COMPLETED|Overall Study||13
8572917|NCT03334630|21137730|P1|NOT COMPLETED|Overall Study||14
8572918|NCT03334630|21137729|P2|COMPLETED|Overall Study||230
8572919|NCT03334630|21137730|P1|COMPLETED|Overall Study||225
8572920|NCT03334630|21137729|P2|STARTED|Overall Study||243
8572921|NCT03334630|21137730|P1|STARTED|Overall Study||239
8572931|NCT03291379|21137784|P1|NOT COMPLETED|Overall Study||0
8572932|NCT03291379|21137784|P1|COMPLETED|Overall Study||8
8572933|NCT03291379|21137784|P1|STARTED|Overall Study||8
8572934|NCT03287843|21137798|P2|NOT COMPLETED|Overall Study||8
8572935|NCT03287843|21137799|P1|NOT COMPLETED|Overall Study||15
8572936|NCT03287843|21137798|P2|COMPLETED|Overall Study||167
8572937|NCT03287843|21137799|P1|COMPLETED|Overall Study||160
8572938|NCT03287843|21137798|P2|Lost to Follow up|Overall Study||0
8572939|NCT03287843|21137799|P1|Lost to Follow up|Overall Study||3
8572940|NCT03287843|21137798|P2|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
8572941|NCT03287843|21137799|P1|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
8572942|NCT03287843|21137798|P2|STARTED|Overall Study||175
8572943|NCT03287843|21137799|P1|STARTED|Overall Study||175
8572956|NCT03206749|21137839|P3|NOT COMPLETED|Overall Study||7
8572957|NCT03206749|21137840|P2|NOT COMPLETED|Overall Study||3
8572958|NCT03206749|21137841|P1|NOT COMPLETED|Overall Study||5
8572959|NCT03206749|21137839|P3|COMPLETED|Overall Study||75
8572960|NCT03206749|21137840|P2|COMPLETED|Overall Study||78
8572961|NCT03206749|21137841|P1|COMPLETED|Overall Study||75
8572962|NCT03206749|21137839|P3|STARTED|Overall Study||82
8572963|NCT03206749|21137840|P2|STARTED|Overall Study||81
8572964|NCT03206749|21137841|P1|STARTED|Overall Study||80
8572965|NCT03162796|21137871|P3|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
8572966|NCT03162796|21137872|P2|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
8572967|NCT03162796|21137873|P1|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
8572968|NCT03162796|21137871|P3|COMPLETED|Safety Follow-up: Week 52 - 60||123
8572969|NCT03162796|21137872|P2|COMPLETED|Safety Follow-up: Week 52 - 60||114
8572970|NCT03162796|21137873|P1|COMPLETED|Safety Follow-up: Week 52 - 60||106
8572971|NCT03162796|21137871|P3|STARTED|Safety Follow-up: Week 52 - 60||124
8572972|NCT03162796|21137872|P2|STARTED|Safety Follow-up: Week 52 - 60||116
8572973|NCT03162796|21137873|P1|STARTED|Safety Follow-up: Week 52 - 60||107
8572974|NCT03162796|21137871|P3|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
8572975|NCT03162796|21137872|P2|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8572976|NCT03162796|21137873|P1|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8572977|NCT03162796|21137871|P3|COMPLETED|Active Treatment Period: Week 24 - 52||124
8572978|NCT03162796|21137872|P2|COMPLETED|Active Treatment Period: Week 24 - 52||116
8572979|NCT03162796|21137873|P1|COMPLETED|Active Treatment Period: Week 24 - 52||107
8572980|NCT03162796|21137871|P3|STARTED|Active Treatment Period: Week 24 - 52||125
8572981|NCT03162796|21137872|P2|STARTED|Active Treatment Period: Week 24 - 52||123
8572982|NCT03162796|21137873|P1|STARTED|Active Treatment Period: Week 24 - 52||114
8572983|NCT03162796|21137871|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
8572984|NCT03162796|21137872|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
8572985|NCT03162796|21137873|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
8572986|NCT03162796|21137871|P3|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
8572987|NCT03162796|21137872|P2|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
8572988|NCT03162796|21137873|P1|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
8572989|NCT03162796|21137871|P3|STARTED|Placebo Controlled Period: Week 0 - 24||128
8572990|NCT03162796|21137872|P2|STARTED|Placebo Controlled Period: Week 0 - 24||127
8572991|NCT03162796|21137873|P1|STARTED|Placebo Controlled Period: Week 0 - 24||126
8572992|NCT03118466|21138177|P1|NOT COMPLETED|Overall Study||0
8572993|NCT03118466|21138177|P1|COMPLETED|Overall Study||40
8572994|NCT03118466|21138177|P1|STARTED|Overall Study||40
8572995|NCT03116152|21138188|P2|NOT COMPLETED|Overall Study||95
8572996|NCT03116152|21138189|P1|NOT COMPLETED|Overall Study||91
8572997|NCT03116152|21138188|P2|COMPLETED|Overall Study||0
8572998|NCT03116152|21138189|P1|COMPLETED|Overall Study||4
8572999|NCT03116152|21138188|P2|Treated|Overall Study||87
8573000|NCT03116152|21138189|P1|Treated|Overall Study||94
8573001|NCT03116152|21138188|P2|STARTED|Overall Study||95
8573002|NCT03116152|21138189|P1|STARTED|Overall Study||95
8573024|NCT02985879|21138286|P3|NOT COMPLETED|Overall Study||77
8573025|NCT02985879|21138287|P2|NOT COMPLETED|Overall Study||75
8573026|NCT02985879|21138288|P1|NOT COMPLETED|Overall Study||76
8573027|NCT02985879|21138286|P3|COMPLETED|Overall Study||48
8573028|NCT02985879|21138287|P2|COMPLETED|Overall Study||52
8573029|NCT02985879|21138288|P1|COMPLETED|Overall Study||50
8573030|NCT02985879|21138286|P3|STARTED|Overall Study||125
8573031|NCT02985879|21138287|P2|STARTED|Overall Study||127
8573032|NCT02985879|21138288|P1|STARTED|Overall Study||126
8573078|NCT02956486|21138526|P3|NOT COMPLETED|Extension Phase||19
8573079|NCT02956486|21138527|P2|NOT COMPLETED|Extension Phase||0
8573080|NCT02956486|21138528|P1|NOT COMPLETED|Extension Phase||0
8573081|NCT02956486|21138526|P3|COMPLETED|Extension Phase||0
8573082|NCT02956486|21138527|P2|COMPLETED|Extension Phase||0
8573083|NCT02956486|21138528|P1|COMPLETED|Extension Phase||0
8573084|NCT02956486|21138526|P3|Safety Analysis Set (SAS)|Extension Phase||18
8573085|NCT02956486|21138527|P2|Safety Analysis Set (SAS)|Extension Phase||0
8573086|NCT02956486|21138528|P1|Safety Analysis Set (SAS)|Extension Phase||0
8573087|NCT02956486|21138526|P3|Treated|Extension Phase||18
8573088|NCT02956486|21138527|P2|Treated|Extension Phase||0
8573089|NCT02956486|21138528|P1|Treated|Extension Phase||0
8573090|NCT02956486|21138526|P3|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
8573091|NCT02956486|21138527|P2|STARTED|Extension Phase||0
8573092|NCT02956486|21138528|P1|STARTED|Extension Phase||0
8573093|NCT02956486|21138526|P3|NOT COMPLETED|Core Phase||0
8573094|NCT02956486|21138527|P2|NOT COMPLETED|Core Phase||1072
8573095|NCT02956486|21138528|P1|NOT COMPLETED|Core Phase||1079
8573096|NCT02956486|21138526|P3|COMPLETED|Core Phase||0
8573097|NCT02956486|21138527|P2|COMPLETED|Core Phase||32
8573098|NCT02956486|21138528|P1|COMPLETED|Core Phase||29
8573099|NCT02956486|21138526|P3|Full Analysis Set (FAS)|Core Phase||0
8573100|NCT02956486|21138527|P2|Full Analysis Set (FAS)|Core Phase||1062
8573101|NCT02956486|21138528|P1|Full Analysis Set (FAS)|Core Phase||1084
8573102|NCT02956486|21138526|P3|Safety Analysis Set (SAS)|Core Phase||0
8573103|NCT02956486|21138527|P2|Safety Analysis Set (SAS)|Core Phase||1099
8573104|NCT02956486|21138528|P1|Safety Analysis Set (SAS)|Core Phase||1105
8573105|NCT02956486|21138526|P3|Treated|Core Phase||0
8573106|NCT02956486|21138527|P2|Treated|Core Phase||1101
8573107|NCT02956486|21138528|P1|Treated|Core Phase||1108
8573108|NCT02956486|21138526|P3|STARTED|Core Phase||0
8573109|NCT02956486|21138527|P2|STARTED|Core Phase||1104
8573110|NCT02956486|21138528|P1|STARTED|Core Phase||1108
8573124|NCT02891915|21138603|P2|NOT COMPLETED|Overall Study||12
8573125|NCT02891915|21138604|P1|NOT COMPLETED|Overall Study||13
8573126|NCT02891915|21138603|P2|COMPLETED|Overall Study||181
8573127|NCT02891915|21138604|P1|COMPLETED|Overall Study||179
8573128|NCT02891915|21138603|P2|STARTED|Overall Study||193
8573129|NCT02891915|21138604|P1|STARTED|Overall Study||192
8573130|NCT02873195|21138634|P2|NOT COMPLETED|Overall Study||0
8573131|NCT02873195|21138635|P1|NOT COMPLETED|Overall Study||5
8573132|NCT02873195|21138634|P2|COMPLETED|Overall Study||46
8573133|NCT02873195|21138635|P1|COMPLETED|Overall Study||82
8573134|NCT02873195|21138634|P2|Never Began Treatment (Cancel)|Overall Study||0
8573135|NCT02873195|21138635|P1|Never Began Treatment (Cancel)|Overall Study||1
8573136|NCT02873195|21138634|P2|STARTED|Overall Study||46
8573137|NCT02873195|21138635|P1|STARTED|Overall Study||87
8573138|NCT02861014|21138647|P1|NOT COMPLETED|Overall Study||39
8573139|NCT02861014|21138647|P1|COMPLETED|Overall Study||641
8573140|NCT02861014|21138647|P1|STARTED|Overall Study||680
8573144|NCT02813265|21138686|P2|NOT COMPLETED|Overall Study||3
8573145|NCT02813265|21138687|P1|NOT COMPLETED|Overall Study||4
8573146|NCT02813265|21138686|P2|COMPLETED|Overall Study||453
8573147|NCT02813265|21138687|P1|COMPLETED|Overall Study||455
8573148|NCT02813265|21138686|P2|STARTED|Overall Study||456
8573149|NCT02813265|21138687|P1|STARTED|Overall Study||459
8573159|NCT02767531|21138749|P2|NOT COMPLETED|Period 4||0
8573160|NCT02767531|21138750|P1|NOT COMPLETED|Period 4||0
8573161|NCT02767531|21138749|P2|COMPLETED|Period 4||1
8573162|NCT02767531|21138750|P1|COMPLETED|Period 4||1
8573163|NCT02767531|21138749|P2|STARTED|Period 4|Orlistat Therapy|1
8573164|NCT02767531|21138750|P1|STARTED|Period 4|Off Orlistat|1
8573165|NCT02767531|21138749|P2|NOT COMPLETED|Period 3||0
8573166|NCT02767531|21138750|P1|NOT COMPLETED|Period 3||0
8573167|NCT02767531|21138749|P2|COMPLETED|Period 3||1
8573168|NCT02767531|21138750|P1|COMPLETED|Period 3||1
8573169|NCT02767531|21138749|P2|STARTED|Period 3|Off Orlistat|1
8573170|NCT02767531|21138750|P1|STARTED|Period 3|Orlistat Therapy|1
8573171|NCT02767531|21138749|P2|NOT COMPLETED|Period 2||0
8573172|NCT02767531|21138750|P1|NOT COMPLETED|Period 2||0
8573173|NCT02767531|21138749|P2|COMPLETED|Period 2||1
8573174|NCT02767531|21138750|P1|COMPLETED|Period 2||1
8573175|NCT02767531|21138749|P2|STARTED|Period 2|Orlistat Therapy|1
8573176|NCT02767531|21138750|P1|STARTED|Period 2|Off Orlistat|1
8573177|NCT02767531|21138749|P2|NOT COMPLETED|Period 1||0
8573178|NCT02767531|21138750|P1|NOT COMPLETED|Period 1||0
8573179|NCT02767531|21138749|P2|COMPLETED|Period 1||1
8573180|NCT02767531|21138750|P1|COMPLETED|Period 1||1
8573181|NCT02767531|21138749|P2|STARTED|Period 1|Off Orlistat|1
8573182|NCT02767531|21138750|P1|STARTED|Period 1|Orlistat therapy|1
8573183|NCT02763566|21138760|P4|NOT COMPLETED|Overall Study||14
8573184|NCT02763566|21138761|P3|NOT COMPLETED|Overall Study||54
8573185|NCT02763566|21138762|P2|NOT COMPLETED|Overall Study||39
8573186|NCT02763566|21138763|P1|NOT COMPLETED|Overall Study||118
8573187|NCT02763566|21138760|P4|COMPLETED|Overall Study||39
8573188|NCT02763566|21138761|P3|COMPLETED|Overall Study||50
8573189|NCT02763566|21138762|P2|COMPLETED|Overall Study||60
8573190|NCT02763566|21138763|P1|COMPLETED|Overall Study||89
8573191|NCT02763566|21138760|P4|STARTED|Overall Study||53
8573192|NCT02763566|21138761|P3|STARTED|Overall Study||104
8573193|NCT02763566|21138762|P2|STARTED|Overall Study||99
8573194|NCT02763566|21138763|P1|STARTED|Overall Study||207
8573195|NCT02749799|21138791|P1|NOT COMPLETED|Overall Study||8
8573196|NCT02749799|21138791|P1|COMPLETED|Overall Study||37
8573197|NCT02749799|21138791|P1|STARTED|Overall Study||45
8573246|NCT02658630|21138910|P1|NOT COMPLETED|Overall Study||4
8573247|NCT02658630|21138910|P1|COMPLETED|Overall Study||42
8573248|NCT02658630|21138910|P1|STARTED|Overall Study||46
8573252|NCT02617589|21138934|P2|NOT COMPLETED|Treatment Period||274
8573253|NCT02617589|21138935|P1|NOT COMPLETED|Treatment Period||274
8573254|NCT02617589|21138934|P2|COMPLETED|Treatment Period||1
8573255|NCT02617589|21138935|P1|COMPLETED|Treatment Period||4
8573256|NCT02617589|21138934|P2|STARTED|Treatment Period||275
8573257|NCT02617589|21138935|P1|STARTED|Treatment Period||278
8573258|NCT02617589|21138934|P2|NOT COMPLETED|All Randomized||5
8573259|NCT02617589|21138935|P1|NOT COMPLETED|All Randomized||2
8573260|NCT02617589|21138934|P2|COMPLETED|All Randomized||275
8573261|NCT02617589|21138935|P1|COMPLETED|All Randomized||278
8573262|NCT02617589|21138934|P2|STARTED|All Randomized||280
8573263|NCT02617589|21138935|P1|STARTED|All Randomized||280
8573264|NCT02613884|21138949|P1|NOT COMPLETED|Overall Study||2
8573265|NCT02613884|21138949|P1|COMPLETED|Overall Study||24
8573266|NCT02613884|21138949|P1|Efficacy Timepoint 3|Overall Study||24
8573267|NCT02613884|21138949|P1|Efficacy Timepoint 2|Overall Study||25
8573268|NCT02613884|21138949|P1|Efficacy Endpoint 1|Overall Study||25
8573269|NCT02613884|21138949|P1|Safety Endpoint 2|Overall Study||26
8573270|NCT02613884|21138949|P1|Feasibility Questionnaire|Overall Study||26
8573271|NCT02613884|21138949|P1|Safety Endpoint 1|Overall Study||26
8573272|NCT02613884|21138949|P1|STARTED|Overall Study||26
8573294|NCT02550938|21139020|P4|NOT COMPLETED|Overall Study||11
8573295|NCT02550938|21139021|P3|NOT COMPLETED|Overall Study||12
8573296|NCT02550938|21139022|P2|NOT COMPLETED|Overall Study||7
8573297|NCT02550938|21139023|P1|NOT COMPLETED|Overall Study||8
8573298|NCT02550938|21139020|P4|COMPLETED|Overall Study||70
8573299|NCT02550938|21139021|P3|COMPLETED|Overall Study||31
8573300|NCT02550938|21139022|P2|COMPLETED|Overall Study||78
8573301|NCT02550938|21139023|P1|COMPLETED|Overall Study||36
8573302|NCT02550938|21139020|P4|STARTED|Overall Study||81
8573303|NCT02550938|21139021|P3|STARTED|Overall Study||43
8573304|NCT02550938|21139022|P2|STARTED|Overall Study||85
8573305|NCT02550938|21139023|P1|STARTED|Overall Study||44
8573306|NCT02536339|21139045|P1|NOT COMPLETED|Overall Study||31
8573307|NCT02536339|21139045|P1|COMPLETED|Overall Study||9
8573308|NCT02536339|21139045|P1|Received at Least One Dose of Study Drug|Overall Study||39
8573309|NCT02536339|21139045|P1|STARTED|Overall Study||40
8573395|NCT02273908|21139405|P2|NOT COMPLETED|Overall Study||5
8573396|NCT02273908|21139406|P1|NOT COMPLETED|Overall Study||33
8573397|NCT02273908|21139405|P2|COMPLETED|Overall Study||169
8573398|NCT02273908|21139406|P1|COMPLETED|Overall Study||124
8573399|NCT02273908|21139405|P2|STARTED|Overall Study||174
8573400|NCT02273908|21139406|P1|STARTED|Overall Study||157
8573425|NCT02145403|21139531|P4|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573426|NCT02145403|21139532|P3|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
8573427|NCT02145403|21139533|P2|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573428|NCT02145403|21139534|P1|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573429|NCT02145403|21139531|P4|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573430|NCT02145403|21139532|P3|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
8573431|NCT02145403|21139533|P2|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573432|NCT02145403|21139534|P1|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573433|NCT02145403|21139531|P4|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573434|NCT02145403|21139532|P3|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
8573435|NCT02145403|21139533|P2|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573436|NCT02145403|21139534|P1|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573437|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
8573438|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573439|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573440|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573441|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
8573442|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573443|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573444|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573445|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
8573446|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573447|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573448|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573449|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573450|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
8573451|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573452|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573453|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573454|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
8573455|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573456|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573457|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573458|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
8573459|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573460|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573461|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573462|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573463|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573464|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573465|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573466|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573467|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
8573468|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573469|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573470|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573471|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
8573472|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573473|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573474|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573475|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573476|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573477|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573478|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573479|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573480|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
8573481|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573482|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573483|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573484|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
8573547|NCT02075554|21139744|P1|NOT COMPLETED|Overall Study||15
8573548|NCT02075554|21139744|P1|COMPLETED|Overall Study||43
8573549|NCT02075554|21139744|P1|STARTED|Overall Study||58
8573550|NCT01993329|21139757|P6|NOT COMPLETED|Period 3||0
8573551|NCT01993329|21139758|P5|NOT COMPLETED|Period 3||0
8573552|NCT01993329|21139759|P4|NOT COMPLETED|Period 3||0
8573553|NCT01993329|21139760|P3|NOT COMPLETED|Period 3||0
8573554|NCT01993329|21139761|P2|NOT COMPLETED|Period 3||0
8573555|NCT01993329|21139762|P1|NOT COMPLETED|Period 3||0
8573556|NCT01993329|21139757|P6|COMPLETED|Period 3||3
8573557|NCT01993329|21139758|P5|COMPLETED|Period 3||3
8573558|NCT01993329|21139759|P4|COMPLETED|Period 3||3
8573559|NCT01993329|21139760|P3|COMPLETED|Period 3||3
8573560|NCT01993329|21139761|P2|COMPLETED|Period 3||3
8573561|NCT01993329|21139762|P1|COMPLETED|Period 3||3
8573562|NCT01993329|21139757|P6|STARTED|Period 3||3
8573563|NCT01993329|21139758|P5|STARTED|Period 3||3
8573564|NCT01993329|21139759|P4|STARTED|Period 3||3
8573565|NCT01993329|21139760|P3|STARTED|Period 3||3
8573566|NCT01993329|21139761|P2|STARTED|Period 3||3
8573567|NCT01993329|21139762|P1|STARTED|Period 3||3
8573568|NCT01993329|21139757|P6|NOT COMPLETED|Wash-out||0
8573569|NCT01993329|21139758|P5|NOT COMPLETED|Wash-out||0
8573570|NCT01993329|21139759|P4|NOT COMPLETED|Wash-out||0
8573571|NCT01993329|21139760|P3|NOT COMPLETED|Wash-out||0
8573572|NCT01993329|21139761|P2|NOT COMPLETED|Wash-out||1
8573573|NCT01993329|21139762|P1|NOT COMPLETED|Wash-out||0
8573574|NCT01993329|21139757|P6|COMPLETED|Wash-out||3
8573575|NCT01993329|21139758|P5|COMPLETED|Wash-out||3
8573576|NCT01993329|21139759|P4|COMPLETED|Wash-out||3
8573577|NCT01993329|21139760|P3|COMPLETED|Wash-out||3
8573578|NCT01993329|21139761|P2|COMPLETED|Wash-out||3
8573579|NCT01993329|21139762|P1|COMPLETED|Wash-out||3
8573580|NCT01993329|21139757|P6|STARTED|Wash-out||3
8573581|NCT01993329|21139758|P5|STARTED|Wash-out||3
8573582|NCT01993329|21139759|P4|STARTED|Wash-out||3
8573583|NCT01993329|21139760|P3|STARTED|Wash-out||3
8573584|NCT01993329|21139761|P2|STARTED|Wash-out||4
8573585|NCT01993329|21139762|P1|STARTED|Wash-out||3
8573586|NCT01993329|21139757|P6|NOT COMPLETED|Period 2||1
8573587|NCT01993329|21139758|P5|NOT COMPLETED|Period 2||0
8573588|NCT01993329|21139759|P4|NOT COMPLETED|Period 2||0
8573589|NCT01993329|21139760|P3|NOT COMPLETED|Period 2||0
8573590|NCT01993329|21139761|P2|NOT COMPLETED|Period 2||0
8573591|NCT01993329|21139762|P1|NOT COMPLETED|Period 2||0
8573592|NCT01993329|21139757|P6|COMPLETED|Period 2||3
8573593|NCT01993329|21139758|P5|COMPLETED|Period 2||3
8573594|NCT01993329|21139759|P4|COMPLETED|Period 2||3
8573595|NCT01993329|21139760|P3|COMPLETED|Period 2||3
8573596|NCT01993329|21139761|P2|COMPLETED|Period 2||4
8573597|NCT01993329|21139762|P1|COMPLETED|Period 2||3
8573598|NCT01993329|21139757|P6|STARTED|Period 2||4
8573599|NCT01993329|21139758|P5|STARTED|Period 2||3
8573600|NCT01993329|21139759|P4|STARTED|Period 2||3
8573601|NCT01993329|21139760|P3|STARTED|Period 2||3
8573602|NCT01993329|21139761|P2|STARTED|Period 2||4
8573603|NCT01993329|21139762|P1|STARTED|Period 2||3
8573604|NCT01993329|21139757|P6|NOT COMPLETED|Wash-out||0
8573605|NCT01993329|21139758|P5|NOT COMPLETED|Wash-out||0
8573606|NCT01993329|21139759|P4|NOT COMPLETED|Wash-out||0
8573607|NCT01993329|21139760|P3|NOT COMPLETED|Wash-out||0
8573608|NCT01993329|21139761|P2|NOT COMPLETED|Wash-out||0
8573609|NCT01993329|21139762|P1|NOT COMPLETED|Wash-out||0
8573610|NCT01993329|21139757|P6|COMPLETED|Wash-out||4
8573611|NCT01993329|21139758|P5|COMPLETED|Wash-out||3
8573612|NCT01993329|21139759|P4|COMPLETED|Wash-out||3
8573613|NCT01993329|21139760|P3|COMPLETED|Wash-out||3
8573614|NCT01993329|21139761|P2|COMPLETED|Wash-out||4
8573615|NCT01993329|21139762|P1|COMPLETED|Wash-out||3
8573616|NCT01993329|21139757|P6|STARTED|Wash-out||4
8573617|NCT01993329|21139758|P5|STARTED|Wash-out||3
8573618|NCT01993329|21139759|P4|STARTED|Wash-out||3
8573619|NCT01993329|21139760|P3|STARTED|Wash-out||3
8573620|NCT01993329|21139761|P2|STARTED|Wash-out||4
8573621|NCT01993329|21139762|P1|STARTED|Wash-out||3
8573622|NCT01993329|21139757|P6|NOT COMPLETED|Period 1||0
8573623|NCT01993329|21139758|P5|NOT COMPLETED|Period 1||0
8573624|NCT01993329|21139759|P4|NOT COMPLETED|Period 1||0
8573625|NCT01993329|21139760|P3|NOT COMPLETED|Period 1||0
8573626|NCT01993329|21139761|P2|NOT COMPLETED|Period 1||0
8573627|NCT01993329|21139762|P1|NOT COMPLETED|Period 1||0
8573628|NCT01993329|21139757|P6|COMPLETED|Period 1||4
8573629|NCT01993329|21139758|P5|COMPLETED|Period 1||3
8573630|NCT01993329|21139759|P4|COMPLETED|Period 1||3
8573631|NCT01993329|21139760|P3|COMPLETED|Period 1||3
8573632|NCT01993329|21139761|P2|COMPLETED|Period 1||4
8573633|NCT01993329|21139762|P1|COMPLETED|Period 1||3
8573634|NCT01993329|21139757|P6|STARTED|Period 1||4
8573635|NCT01993329|21139758|P5|STARTED|Period 1||3
8573636|NCT01993329|21139759|P4|STARTED|Period 1||3
8573637|NCT01993329|21139760|P3|STARTED|Period 1||3
8573638|NCT01993329|21139761|P2|STARTED|Period 1||4
8573639|NCT01993329|21139762|P1|STARTED|Period 1||3
8573760|NCT01790113|21139856|P2|NOT COMPLETED|Overall Study||75
8573761|NCT01790113|21139857|P1|NOT COMPLETED|Overall Study||3
8573762|NCT01790113|21139856|P2|COMPLETED|Overall Study||149
8573763|NCT01790113|21139857|P1|COMPLETED|Overall Study||76
8573764|NCT01790113|21139856|P2|STARTED|Overall Study||224
8573765|NCT01790113|21139857|P1|STARTED|Overall Study||79
8573904|NCT01608490|21140287|P2|NOT COMPLETED|Overall Study||15
8573905|NCT01608490|21140288|P1|NOT COMPLETED|Overall Study||17
8573906|NCT01608490|21140287|P2|COMPLETED|Overall Study||142
8573907|NCT01608490|21140288|P1|COMPLETED|Overall Study||141
8573908|NCT01608490|21140287|P2|STARTED|Overall Study||157
8573909|NCT01608490|21140288|P1|STARTED|Overall Study||158
8573919|NCT01554371|21140331|P3|NOT COMPLETED|Overall Study||0
8573920|NCT01554371|21140332|P2|NOT COMPLETED|Overall Study||0
8573921|NCT01554371|21140333|P1|NOT COMPLETED|Overall Study||0
8573922|NCT01554371|21140331|P3|COMPLETED|Overall Study||38
8573923|NCT01554371|21140332|P2|COMPLETED|Overall Study||3
8573924|NCT01554371|21140333|P1|COMPLETED|Overall Study||3
8573925|NCT01554371|21140331|P3|STARTED|Overall Study||38
8573926|NCT01554371|21140332|P2|STARTED|Overall Study||3
8573927|NCT01554371|21140333|P1|STARTED|Overall Study||3
8573956|NCT01496885|21140409|P1|NOT COMPLETED|Overall Study||23
8573957|NCT01496885|21140409|P1|COMPLETED|Overall Study||97
8573958|NCT01496885|21140409|P1|STARTED|Overall Study||120
8573959|NCT01481545|21140420|P2|NOT COMPLETED|Overall Study||6
8573960|NCT01481545|21140421|P1|NOT COMPLETED|Overall Study||5
8573961|NCT01481545|21140420|P2|COMPLETED|Overall Study||40
8573962|NCT01481545|21140421|P1|COMPLETED|Overall Study||11
8573963|NCT01481545|21140420|P2|STARTED|Overall Study||46
8573964|NCT01481545|21140421|P1|STARTED|Overall Study||16
8573965|NCT01441401|21140439|P1|NOT COMPLETED|Overall Study||0
8573966|NCT01441401|21140439|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
8573967|NCT01441401|21140439|P1|STARTED|Overall Study||82
8573968|NCT01365156|21140467|P2|NOT COMPLETED|Overall Study||0
8573969|NCT01365156|21140468|P1|NOT COMPLETED|Overall Study||0
8573970|NCT01365156|21140467|P2|COMPLETED|Overall Study||14
8573971|NCT01365156|21140468|P1|COMPLETED|Overall Study||14
8573972|NCT01365156|21140467|P2|STARTED|Overall Study||14
8573973|NCT01365156|21140468|P1|STARTED|Overall Study||14
8573974|NCT01349907|21140476|P2|NOT COMPLETED|Overall Study||43
8573975|NCT01349907|21140477|P1|NOT COMPLETED|Overall Study||139
8573976|NCT01349907|21140476|P2|COMPLETED|Overall Study||38
8573977|NCT01349907|21140477|P1|COMPLETED|Overall Study||102
8573978|NCT01349907|21140476|P2|STARTED|Overall Study|Enrolled and Treated|81
8573979|NCT01349907|21140477|P1|STARTED|Overall Study|Enrolled and Treated|241
8573980|NCT01279057|21140516|P3|NOT COMPLETED|Overall Study||3
8573981|NCT01279057|21140517|P2|NOT COMPLETED|Overall Study||5
8573982|NCT01279057|21140518|P1|NOT COMPLETED|Overall Study||6
8573983|NCT01279057|21140516|P3|COMPLETED|Overall Study||144
8573984|NCT01279057|21140517|P2|COMPLETED|Overall Study||287
8573985|NCT01279057|21140518|P1|COMPLETED|Overall Study||282
8573986|NCT01279057|21140516|P3|Intent-to-Treat (ITT) Population|Overall Study||144
8573987|NCT01279057|21140517|P2|Intent-to-Treat (ITT) Population|Overall Study||285
8573988|NCT01279057|21140518|P1|Intent-to-Treat (ITT) Population|Overall Study||284
8573989|NCT01279057|21140516|P3|Per-Protocol (PPP) Population|Overall Study||126
8573990|NCT01279057|21140517|P2|Per-Protocol (PPP) Population|Overall Study||245
8573991|NCT01279057|21140518|P1|Per-Protocol (PPP) Population|Overall Study||257
8573992|NCT01279057|21140516|P3|STARTED|Overall Study||147
8573993|NCT01279057|21140517|P2|STARTED|Overall Study||292
8573994|NCT01279057|21140518|P1|STARTED|Overall Study||288
8573995|NCT01265719|21140545|P2|NOT COMPLETED|Overall Study||13
8573996|NCT01265719|21140546|P1|NOT COMPLETED|Overall Study||14
8573997|NCT01265719|21140545|P2|COMPLETED|Overall Study||60
8573998|NCT01265719|21140546|P1|COMPLETED|Overall Study||88
8573999|NCT01265719|21140545|P2|STARTED|Overall Study||73
8574000|NCT01265719|21140546|P1|STARTED|Overall Study||102
8574007|NCT01231516|21140593|P2|NOT COMPLETED|Open-label Phase||26
8574008|NCT01231516|21140594|P1|NOT COMPLETED|Open-label Phase||295
8574009|NCT01231516|21140593|P2|COMPLETED|Open-label Phase||1
8574010|NCT01231516|21140594|P1|COMPLETED|Open-label Phase||0
8574011|NCT01231516|21140593|P2|Ongoing at the Time of Analysis|Open-label Phase||23
8574012|NCT01231516|21140594|P1|Ongoing at the Time of Analysis|Open-label Phase||282
8574013|NCT01231516|21140593|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
8574014|NCT01231516|21140594|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
8574015|NCT01231516|21140593|P2|NOT COMPLETED|48 Week Double-blind Phase||79
8574016|NCT01231516|21140594|P1|NOT COMPLETED|48 Week Double-blind Phase||58
8574017|NCT01231516|21140593|P2|COMPLETED|48 Week Double-blind Phase||283
8574018|NCT01231516|21140594|P1|COMPLETED|48 Week Double-blind Phase||299
8574019|NCT01231516|21140593|P2|STARTED|48 Week Double-blind Phase||362
8574020|NCT01231516|21140594|P1|STARTED|48 Week Double-blind Phase||357
8574033|NCT01190267|21140644|P2|NOT COMPLETED|Overall Study||4
8574034|NCT01190267|21140645|P1|NOT COMPLETED|Overall Study||41
8574035|NCT01190267|21140644|P2|COMPLETED|Overall Study||4
8574036|NCT01190267|21140645|P1|COMPLETED|Overall Study||155
8574037|NCT01190267|21140644|P2|STARTED|Overall Study||8
8574038|NCT01190267|21140645|P1|STARTED|Overall Study||196
8574097|NCT01038427|21140735|P3|NOT COMPLETED|Overall Study||4
8574098|NCT01038427|21140736|P2|NOT COMPLETED|Overall Study||6
8574099|NCT01038427|21140737|P1|NOT COMPLETED|Overall Study||3
8574100|NCT01038427|21140735|P3|COMPLETED|Overall Study||154
8574101|NCT01038427|21140736|P2|COMPLETED|Overall Study||314
8574102|NCT01038427|21140737|P1|COMPLETED|Overall Study||314
8574103|NCT01038427|21140735|P3|Intent-to-Treat (ITT) Population|Overall Study||156
8574104|NCT01038427|21140736|P2|Intent-to-Treat (ITT) Population|Overall Study||314
8574105|NCT01038427|21140737|P1|Intent-to-Treat (ITT) Population|Overall Study||314
8574106|NCT01038427|21140735|P3|Per-Protocol (PPP) Population|Overall Study||150
8574107|NCT01038427|21140736|P2|Per-Protocol (PPP) Population|Overall Study||307
8574108|NCT01038427|21140737|P1|Per-Protocol (PPP) Population|Overall Study||306
8574109|NCT01038427|21140735|P3|STARTED|Overall Study||158
8574110|NCT01038427|21140736|P2|STARTED|Overall Study||320
8574111|NCT01038427|21140737|P1|STARTED|Overall Study||317
8574112|NCT00914732|21140761|P3|NOT COMPLETED|Overall Study||11
8574113|NCT00914732|21140762|P2|NOT COMPLETED|Overall Study||7
8574114|NCT00914732|21140763|P1|NOT COMPLETED|Overall Study||10
8574115|NCT00914732|21140761|P3|COMPLETED|Overall Study||180
8574116|NCT00914732|21140762|P2|COMPLETED|Overall Study||160
8574117|NCT00914732|21140763|P1|COMPLETED|Overall Study||155
8574118|NCT00914732|21140761|P3|Received Second Vaccination|Overall Study||153
8574119|NCT00914732|21140762|P2|Received Second Vaccination|Overall Study||157
8574120|NCT00914732|21140763|P1|Received Second Vaccination|Overall Study||150
8574121|NCT00914732|21140761|P3|STARTED|Overall Study||191
8574122|NCT00914732|21140762|P2|STARTED|Overall Study||167
8574123|NCT00914732|21140763|P1|STARTED|Overall Study||165
8574136|NCT00810498|21140921|P2|NOT COMPLETED|Overall Study||0
8574137|NCT00810498|21140922|P1|NOT COMPLETED|Overall Study||0
8574138|NCT00810498|21140921|P2|COMPLETED|Overall Study||5
8574139|NCT00810498|21140922|P1|COMPLETED|Overall Study||6
8574140|NCT00810498|21140921|P2|STARTED|Overall Study||5
8574141|NCT00810498|21140922|P1|STARTED|Overall Study||6
8574142|NCT00810459|21140936|P2|NOT COMPLETED|Overall Study||0
8574143|NCT00810459|21140937|P1|NOT COMPLETED|Overall Study||0
8574144|NCT00810459|21140936|P2|COMPLETED|Overall Study||2
8574145|NCT00810459|21140937|P1|COMPLETED|Overall Study||4
8574146|NCT00810459|21140936|P2|STARTED|Overall Study||2
8574147|NCT00810459|21140937|P1|STARTED|Overall Study||4
8574148|NCT00785772|21140951|P1|NOT COMPLETED|Overall Study||0
8574149|NCT00785772|21140951|P1|COMPLETED|Overall Study||1
8574150|NCT00785772|21140951|P1|STARTED|Overall Study||1
8574151|NCT00716859|21140959|P2|NOT COMPLETED|Overall Study||5
8574152|NCT00716859|21140960|P1|NOT COMPLETED|Overall Study||9
8574153|NCT00716859|21140959|P2|COMPLETED|Overall Study||64
8574154|NCT00716859|21140960|P1|COMPLETED|Overall Study||61
8574155|NCT00716859|21140959|P2|Received Treatment|Overall Study||68
8574156|NCT00716859|21140960|P1|Received Treatment|Overall Study||69
8574157|NCT00716859|21140959|P2|STARTED|Overall Study||69
8574158|NCT00716859|21140960|P1|STARTED|Overall Study||70
8574187|NCT00642941|21141012|P12|NOT COMPLETED|Overall Study||11
8574188|NCT00642941|21141013|P11|NOT COMPLETED|Overall Study||12
8574189|NCT00642941|21141014|P10|NOT COMPLETED|Overall Study||9
8574190|NCT00642941|21141015|P9|NOT COMPLETED|Overall Study||11
8574191|NCT00642941|21141016|P8|NOT COMPLETED|Overall Study||14
8574192|NCT00642941|21141017|P7|NOT COMPLETED|Overall Study||23
8574193|NCT00642941|21141018|P6|NOT COMPLETED|Overall Study||41
8574194|NCT00642941|21141019|P5|NOT COMPLETED|Overall Study||25
8574195|NCT00642941|21141020|P4|NOT COMPLETED|Overall Study||40
8574196|NCT00642941|21141021|P3|NOT COMPLETED|Overall Study||7
8574197|NCT00642941|21141022|P2|NOT COMPLETED|Overall Study||54
8574198|NCT00642941|21141023|P1|NOT COMPLETED|Overall Study||70
8574199|NCT00642941|21141012|P12|COMPLETED|Overall Study||0
8574200|NCT00642941|21141013|P11|COMPLETED|Overall Study||0
8574201|NCT00642941|21141014|P10|COMPLETED|Overall Study||0
8574202|NCT00642941|21141015|P9|COMPLETED|Overall Study||0
8574203|NCT00642941|21141016|P8|COMPLETED|Overall Study||0
8574204|NCT00642941|21141017|P7|COMPLETED|Overall Study||0
8574205|NCT00642941|21141018|P6|COMPLETED|Overall Study||0
8574206|NCT00642941|21141019|P5|COMPLETED|Overall Study||0
8574207|NCT00642941|21141020|P4|COMPLETED|Overall Study||0
8574208|NCT00642941|21141021|P3|COMPLETED|Overall Study||0
8574209|NCT00642941|21141022|P2|COMPLETED|Overall Study||0
8574210|NCT00642941|21141023|P1|COMPLETED|Overall Study||0
8574211|NCT00642941|21141012|P12|STARTED|Overall Study||11
8574212|NCT00642941|21141013|P11|STARTED|Overall Study||12
8574213|NCT00642941|21141014|P10|STARTED|Overall Study||9
8574214|NCT00642941|21141015|P9|STARTED|Overall Study||11
8574215|NCT00642941|21141016|P8|STARTED|Overall Study||14
8574216|NCT00642941|21141017|P7|STARTED|Overall Study||23
8574217|NCT00642941|21141018|P6|STARTED|Overall Study||41
8574218|NCT00642941|21141019|P5|STARTED|Overall Study||25
8574219|NCT00642941|21141020|P4|STARTED|Overall Study||40
8574220|NCT00642941|21141021|P3|STARTED|Overall Study||7
8574221|NCT00642941|21141022|P2|STARTED|Overall Study||54
8574222|NCT00642941|21141023|P1|STARTED|Overall Study||70
8574223|NCT00635570|21141159|P2|NOT COMPLETED|Overall Study||11
8574224|NCT00635570|21141160|P1|NOT COMPLETED|Overall Study||15
8574225|NCT00635570|21141159|P2|COMPLETED|Overall Study||126
8574226|NCT00635570|21141160|P1|COMPLETED|Overall Study||121
8574227|NCT00635570|21141159|P2|STARTED|Overall Study||137
8574228|NCT00635570|21141160|P1|STARTED|Overall Study||136
8574229|NCT00620555|21141172|P1|NOT COMPLETED|Overall Study||21
8574230|NCT00620555|21141172|P1|COMPLETED|Overall Study||44
8574231|NCT00620555|21141172|P1|STARTED|Overall Study||65
8574232|NCT00603473|21141179|P1|NOT COMPLETED|Overall Study||9
8574233|NCT00603473|21141179|P1|COMPLETED|Overall Study||80
8574234|NCT00603473|21141179|P1|STARTED|Overall Study||89
8574235|NCT00583011|21141187|P2|NOT COMPLETED|Overall Study||0
8574236|NCT00583011|21141188|P1|NOT COMPLETED|Overall Study||0
8574237|NCT00583011|21141187|P2|COMPLETED|Overall Study||40
8574238|NCT00583011|21141188|P1|COMPLETED|Overall Study||36
8574239|NCT00583011|21141187|P2|STARTED|Overall Study||40
8574240|NCT00583011|21141188|P1|STARTED|Overall Study||36
8574241|NCT00567268|21141196|P1|NOT COMPLETED|Overall Study||50
8574242|NCT00567268|21141196|P1|COMPLETED|Overall Study||1144
8574243|NCT00567268|21141196|P1|STARTED|Overall Study||1194
8574403|NCT04467424|21141455|P2|NOT COMPLETED|Overall Study||0
8574404|NCT04467424|21141456|P1|NOT COMPLETED|Overall Study||0
8574405|NCT04467424|21141455|P2|COMPLETED|Overall Study||100
8574406|NCT04467424|21141456|P1|COMPLETED|Overall Study||100
8574407|NCT04467424|21141455|P2|STARTED|Overall Study||100
8574408|NCT04467424|21141456|P1|STARTED|Overall Study||100
8574413|NCT04162795|21141472|P1|NOT COMPLETED|Overall Study||26
8574414|NCT04162795|21141472|P1|COMPLETED|Overall Study||442
8574415|NCT04162795|21141472|P1|STARTED|Overall Study||468
8574626|NCT03913377|21141552|P3|NOT COMPLETED|Period 2||0
8574627|NCT03913377|21141553|P2|NOT COMPLETED|Period 2||0
8574628|NCT03913377|21141554|P1|NOT COMPLETED|Period 2||0
8574629|NCT03913377|21141552|P3|COMPLETED|Period 2||21
8574630|NCT03913377|21141553|P2|COMPLETED|Period 2||21
8574631|NCT03913377|21141554|P1|COMPLETED|Period 2||0
8574632|NCT03913377|21141552|P3|STARTED|Period 2||21
8574633|NCT03913377|21141553|P2|STARTED|Period 2||21
8574634|NCT03913377|21141554|P1|STARTED|Period 2||0
8574635|NCT03913377|21141552|P3|NOT COMPLETED|Period 1||1
8574636|NCT03913377|21141553|P2|NOT COMPLETED|Period 1||1
8574637|NCT03913377|21141554|P1|NOT COMPLETED|Period 1||0
8574638|NCT03913377|21141552|P3|COMPLETED|Period 1||21
8574639|NCT03913377|21141553|P2|COMPLETED|Period 1||21
8574640|NCT03913377|21141554|P1|COMPLETED|Period 1||21
8574641|NCT03913377|21141552|P3|STARTED|Period 1||22
8574642|NCT03913377|21141553|P2|STARTED|Period 1||22
8574643|NCT03913377|21141554|P1|STARTED|Period 1||21
8574647|NCT03782272|21141578|P2|NOT COMPLETED|Overall Study||0
8574648|NCT03782272|21141579|P1|NOT COMPLETED|Overall Study||0
8574649|NCT03782272|21141578|P2|COMPLETED|Overall Study||6
8574650|NCT03782272|21141579|P1|COMPLETED|Overall Study||6
8574651|NCT03782272|21141578|P2|STARTED|Overall Study||6
8574652|NCT03782272|21141579|P1|STARTED|Overall Study||6
8574653|NCT03760796|21141612|P2|NOT COMPLETED|Overall Study||0
8574654|NCT03760796|21141613|P1|NOT COMPLETED|Overall Study||0
8574655|NCT03760796|21141612|P2|COMPLETED|Overall Study||864
8574656|NCT03760796|21141613|P1|COMPLETED|Overall Study||200
8574657|NCT03760796|21141612|P2|STARTED|Overall Study||864
8574658|NCT03760796|21141613|P1|STARTED|Overall Study||200
8574659|NCT03725033|21141643|P2|NOT COMPLETED|Overall Study||0
8574660|NCT03725033|21141644|P1|NOT COMPLETED|Overall Study||0
8574661|NCT03725033|21141643|P2|COMPLETED|Overall Study||97
8574662|NCT03725033|21141644|P1|COMPLETED|Overall Study||105
8574663|NCT03725033|21141643|P2|STARTED|Overall Study||97
8574664|NCT03725033|21141644|P1|STARTED|Overall Study||105
8574668|NCT03680911|21141666|P2|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
8574669|NCT03680911|21141667|P1|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
8574670|NCT03680911|21141666|P2|COMPLETED|Visit 3 (4 Month Follow up)||0
8574671|NCT03680911|21141667|P1|COMPLETED|Visit 3 (4 Month Follow up)||0
8574672|NCT03680911|21141666|P2|STARTED|Visit 3 (4 Month Follow up)||1
8574673|NCT03680911|21141667|P1|STARTED|Visit 3 (4 Month Follow up)||0
8574674|NCT03680911|21141666|P2|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
8574675|NCT03680911|21141667|P1|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
8574676|NCT03680911|21141666|P2|COMPLETED|Visit 2 (1 Month Follow up)||1
8574677|NCT03680911|21141667|P1|COMPLETED|Visit 2 (1 Month Follow up)||0
8574678|NCT03680911|21141666|P2|STARTED|Visit 2 (1 Month Follow up)||1
8574679|NCT03680911|21141667|P1|STARTED|Visit 2 (1 Month Follow up)||0
8574680|NCT03680911|21141666|P2|NOT COMPLETED|At Home Treatment||3
8574681|NCT03680911|21141667|P1|NOT COMPLETED|At Home Treatment||3
8574682|NCT03680911|21141666|P2|COMPLETED|At Home Treatment||1
8574683|NCT03680911|21141667|P1|COMPLETED|At Home Treatment||0
8574684|NCT03680911|21141666|P2|STARTED|At Home Treatment||4
8574685|NCT03680911|21141667|P1|STARTED|At Home Treatment||3
8574686|NCT03680911|21141666|P2|NOT COMPLETED|Visit 1 (Baseline)||0
8574687|NCT03680911|21141667|P1|NOT COMPLETED|Visit 1 (Baseline)||0
8574688|NCT03680911|21141666|P2|COMPLETED|Visit 1 (Baseline)||4
8574689|NCT03680911|21141667|P1|COMPLETED|Visit 1 (Baseline)||3
8574690|NCT03680911|21141666|P2|STARTED|Visit 1 (Baseline)||4
8574691|NCT03680911|21141667|P1|STARTED|Visit 1 (Baseline)||3
8574692|NCT03630120|21141679|P4|NOT COMPLETED|Overall Study||1
8574693|NCT03630120|21141680|P3|NOT COMPLETED|Overall Study||1
8574694|NCT03630120|21141681|P2|NOT COMPLETED|Overall Study||1
8574695|NCT03630120|21141682|P1|NOT COMPLETED|Overall Study||0
8574696|NCT03630120|21141679|P4|COMPLETED|Overall Study||0
8574697|NCT03630120|21141680|P3|COMPLETED|Overall Study||0
8574698|NCT03630120|21141681|P2|COMPLETED|Overall Study||1
8574699|NCT03630120|21141682|P1|COMPLETED|Overall Study||2
8574700|NCT03630120|21141679|P4|STARTED|Overall Study||1
8574701|NCT03630120|21141680|P3|STARTED|Overall Study||1
8574702|NCT03630120|21141681|P2|STARTED|Overall Study||2
8574703|NCT03630120|21141682|P1|STARTED|Overall Study||2
8574729|NCT03468933|21141765|P2|NOT COMPLETED|Overall Study||0
8574730|NCT03468933|21141766|P1|NOT COMPLETED|Overall Study||0
8574731|NCT03468933|21141765|P2|COMPLETED|Overall Study||16
8574732|NCT03468933|21141766|P1|COMPLETED|Overall Study||16
8574733|NCT03468933|21141765|P2|STARTED|Overall Study||16
8574734|NCT03468933|21141766|P1|STARTED|Overall Study||16
8574741|NCT03430349|21141791|P2|NOT COMPLETED|Overall Study||0
8574742|NCT03430349|21141792|P1|NOT COMPLETED|Overall Study||0
8574743|NCT03430349|21141791|P2|COMPLETED|Overall Study||15
8574744|NCT03430349|21141792|P1|COMPLETED|Overall Study||15
8574745|NCT03430349|21141791|P2|Received nOPV Vaccination|Overall Study||15
8574746|NCT03430349|21141792|P1|Received nOPV Vaccination|Overall Study||15
8574747|NCT03430349|21141791|P2|STARTED|Overall Study||15
8574748|NCT03430349|21141792|P1|STARTED|Overall Study||15
8574755|NCT03413618|21141833|P2|NOT COMPLETED|Overall Study||0
8574756|NCT03413618|21141834|P1|NOT COMPLETED|Overall Study||0
8574757|NCT03413618|21141833|P2|COMPLETED|Overall Study||45
8574758|NCT03413618|21141834|P1|COMPLETED|Overall Study||45
8574759|NCT03413618|21141833|P2|STARTED|Overall Study||45
8574760|NCT03413618|21141834|P1|STARTED|Overall Study||45
8574799|NCT03245723|21141964|P2|NOT COMPLETED|Overall Study||1
8574800|NCT03245723|21141965|P1|NOT COMPLETED|Overall Study||5
8574801|NCT03245723|21141964|P2|COMPLETED|Overall Study||17
8574802|NCT03245723|21141965|P1|COMPLETED|Overall Study||27
8574803|NCT03245723|21141964|P2|STARTED|Overall Study||18
8574804|NCT03245723|21141965|P1|STARTED|Overall Study||32
8574805|NCT03242928|21141975|P2|NOT COMPLETED|Overall Study||5
8574806|NCT03242928|21141976|P1|NOT COMPLETED|Overall Study||9
8574807|NCT03242928|21141975|P2|COMPLETED|Overall Study||32
8574808|NCT03242928|21141976|P1|COMPLETED|Overall Study||22
8574809|NCT03242928|21141975|P2|STARTED|Overall Study||37
8574810|NCT03242928|21141976|P1|STARTED|Overall Study||31
8574811|NCT03073876|21141989|P2|NOT COMPLETED|Overall Study||0
8574812|NCT03073876|21141990|P1|NOT COMPLETED|Overall Study||0
8574813|NCT03073876|21141989|P2|COMPLETED|Overall Study||11
8574814|NCT03073876|21141990|P1|COMPLETED|Overall Study||12
8574815|NCT03073876|21141989|P2|STARTED|Overall Study||11
8574816|NCT03073876|21141990|P1|STARTED|Overall Study||12
8574817|NCT03044574|21142031|P2|NOT COMPLETED|Overall Study||45
8574818|NCT03044574|21142032|P1|NOT COMPLETED|Overall Study||37
8574819|NCT03044574|21142031|P2|COMPLETED|Overall Study||158
8574820|NCT03044574|21142032|P1|COMPLETED|Overall Study||167
8574821|NCT03044574|21142031|P2|180 Days After Surgery|Overall Study||158
8574822|NCT03044574|21142032|P1|180 Days After Surgery|Overall Study||167
8574823|NCT03044574|21142031|P2|30 Days After Surgery|Overall Study||194
8574824|NCT03044574|21142032|P1|30 Days After Surgery|Overall Study||193
8574825|NCT03044574|21142031|P2|Inpatient Period|Overall Study||203
8574826|NCT03044574|21142032|P1|Inpatient Period|Overall Study||204
8574827|NCT03044574|21142031|P2|STARTED|Overall Study||203
8574828|NCT03044574|21142032|P1|STARTED|Overall Study||204
8574829|NCT03020888|21142058|P1|NOT COMPLETED|Overall Study||13
8574830|NCT03020888|21142058|P1|COMPLETED|Overall Study||107
8574831|NCT03020888|21142058|P1|STARTED|Overall Study||120
8574832|NCT02979626|21142071|P2|NOT COMPLETED|Overall Study||0
8574833|NCT02979626|21142072|P1|NOT COMPLETED|Overall Study||0
8574834|NCT02979626|21142071|P2|COMPLETED|Overall Study||98
8574835|NCT02979626|21142072|P1|COMPLETED|Overall Study||313
8574836|NCT02979626|21142071|P2|STARTED|Overall Study||98
8574837|NCT02979626|21142072|P1|STARTED|Overall Study||313
8574874|NCT02964078|21142233|P1|NOT COMPLETED|Overall Study||0
8574875|NCT02964078|21142233|P1|COMPLETED|Overall Study||27
8574876|NCT02964078|21142233|P1|STARTED|Overall Study||27
8574887|NCT02921737|21142253|P1|NOT COMPLETED|Overall Study||0
8574888|NCT02921737|21142253|P1|COMPLETED|Overall Study||7
8574889|NCT02921737|21142253|P1|STARTED|Overall Study||7
8574908|NCT02696902|21142318|P3|NOT COMPLETED|Overall Study||28
8574909|NCT02696902|21142319|P2|NOT COMPLETED|Overall Study||4
8574910|NCT02696902|21142320|P1|NOT COMPLETED|Overall Study||22
8574911|NCT02696902|21142318|P3|COMPLETED|Overall Study||59
8574912|NCT02696902|21142319|P2|COMPLETED|Overall Study||12
8574913|NCT02696902|21142320|P1|COMPLETED|Overall Study||63
8574914|NCT02696902|21142318|P3|Modified Intent-to-treat (mITT) Population|Overall Study||85
8574915|NCT02696902|21142319|P2|Modified Intent-to-treat (mITT) Population|Overall Study||16
8574916|NCT02696902|21142320|P1|Modified Intent-to-treat (mITT) Population|Overall Study||83
8574917|NCT02696902|21142318|P3|As-treated Population|Overall Study||85
8574918|NCT02696902|21142319|P2|As-treated Population|Overall Study||16
8574919|NCT02696902|21142320|P1|As-treated Population|Overall Study||83
8574920|NCT02696902|21142318|P3|Intent-to-treat (ITT) Population|Overall Study||87
8574921|NCT02696902|21142319|P2|Intent-to-treat (ITT) Population|Overall Study||16
8574922|NCT02696902|21142320|P1|Intent-to-treat (ITT) Population|Overall Study||85
8574923|NCT02696902|21142318|P3|Treated|Overall Study||85
8574924|NCT02696902|21142319|P2|Treated|Overall Study||16
8574925|NCT02696902|21142320|P1|Treated|Overall Study||83
8574926|NCT02696902|21142318|P3|STARTED|Overall Study||87
8574927|NCT02696902|21142319|P2|STARTED|Overall Study||16
8574928|NCT02696902|21142320|P1|STARTED|Overall Study||85
8574950|NCT02655887|21142413|P1|NOT COMPLETED|Overall Study||14
8574951|NCT02655887|21142413|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|156
8574952|NCT02655887|21142413|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|170
8574974|NCT02535572|21142490|P2|NOT COMPLETED|Overall Study||3
8574975|NCT02535572|21142491|P1|NOT COMPLETED|Overall Study||4
8574976|NCT02535572|21142490|P2|COMPLETED|Overall Study||17
8574977|NCT02535572|21142491|P1|COMPLETED|Overall Study||17
8574978|NCT02535572|21142490|P2|STARTED|Overall Study||20
8574979|NCT02535572|21142491|P1|STARTED|Overall Study||21
8575015|NCT02447718|21142633|P2|NOT COMPLETED|Overall Study||0
8575016|NCT02447718|21142634|P1|NOT COMPLETED|Overall Study||12
8575017|NCT02447718|21142633|P2|COMPLETED|Overall Study||78
8575018|NCT02447718|21142634|P1|COMPLETED|Overall Study||66
8575019|NCT02447718|21142633|P2|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
8575020|NCT02447718|21142634|P1|Received Pneumovax® 23|Overall Study||73
8575021|NCT02447718|21142633|P2|Received Pediacel®|Overall Study|Do not receive vaccination|0
8575022|NCT02447718|21142634|P1|Received Pediacel®|Overall Study||73
8575023|NCT02447718|21142633|P2|Received Prevnar®13|Overall Study|Do not receive vaccination|0
8575024|NCT02447718|21142634|P1|Received Prevnar®13|Overall Study||74
8575025|NCT02447718|21142633|P2|STARTED|Overall Study||78
8575026|NCT02447718|21142634|P1|STARTED|Overall Study||78
8575042|NCT02340221|21142696|P2|NOT COMPLETED|Overall Study||417
8575043|NCT02340221|21142697|P1|NOT COMPLETED|Overall Study||214
8575044|NCT02340221|21142696|P2|COMPLETED|Overall Study||0
8575045|NCT02340221|21142697|P1|COMPLETED|Overall Study||0
8575046|NCT02340221|21142696|P2|STARTED|Overall Study||417
8575047|NCT02340221|21142697|P1|STARTED|Overall Study||214
8575048|NCT02298491|21142721|P1|NOT COMPLETED|Overall Study||1
8575049|NCT02298491|21142721|P1|COMPLETED|Overall Study||3
8575050|NCT02298491|21142721|P1|STARTED|Overall Study||4
8575051|NCT02278341|21142727|P2|NOT COMPLETED|Overall Study||92
8575052|NCT02278341|21142728|P1|NOT COMPLETED|Overall Study||118
8575053|NCT02278341|21142727|P2|COMPLETED|Overall Study||329
8575054|NCT02278341|21142728|P1|COMPLETED|Overall Study||297
8575055|NCT02278341|21142727|P2|Received Treatment|Overall Study||420
8575056|NCT02278341|21142728|P1|Received Treatment|Overall Study||414
8575057|NCT02278341|21142727|P2|STARTED|Overall Study||421
8575058|NCT02278341|21142728|P1|STARTED|Overall Study||415
8575065|NCT02162719|21142855|P2|NOT COMPLETED|Overall Study||62
8575066|NCT02162719|21142856|P1|NOT COMPLETED|Overall Study||62
8575067|NCT02162719|21142855|P2|COMPLETED|Overall Study||0
8575068|NCT02162719|21142856|P1|COMPLETED|Overall Study||0
8575069|NCT02162719|21142855|P2|STARTED|Overall Study||62
8575070|NCT02162719|21142856|P1|STARTED|Overall Study||62
8575071|NCT02151981|21142900|P2|NOT COMPLETED|Overall Study||140
8575072|NCT02151981|21142901|P1|NOT COMPLETED|Overall Study||279
8575073|NCT02151981|21142900|P2|COMPLETED|Overall Study||0
8575074|NCT02151981|21142901|P1|COMPLETED|Overall Study||0
8575075|NCT02151981|21142900|P2|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
8575076|NCT02151981|21142901|P1|Crossed Over Osimertinib|Overall Study||0
8575077|NCT02151981|21142900|P2|Did Not Receive Treatment|Overall Study||4
8575078|NCT02151981|21142901|P1|Did Not Receive Treatment|Overall Study||0
8575079|NCT02151981|21142900|P2|Received Randomised Treatment Only|Overall Study||136
8575080|NCT02151981|21142901|P1|Received Randomised Treatment Only|Overall Study||279
8575081|NCT02151981|21142900|P2|STARTED|Overall Study||140
8575082|NCT02151981|21142901|P1|STARTED|Overall Study||279
8575083|NCT02139358|21142921|P1|NOT COMPLETED|Overall Study||0
8575084|NCT02139358|21142921|P1|COMPLETED|Overall Study||15
8575085|NCT02139358|21142921|P1|STARTED|Overall Study||15
8575122|NCT02110108|21143067|P1|NOT COMPLETED|Overall Study||4
8575123|NCT02110108|21143067|P1|COMPLETED|Overall Study||6
8575124|NCT02110108|21143067|P1|RevLite Combo Wavelength|Overall Study||10
8575125|NCT02110108|21143067|P1|RevLite Single Wavelength|Overall Study||10
8575126|NCT02110108|21143067|P1|STARTED|Overall Study||10
8575127|NCT02108821|21143075|P1|NOT COMPLETED|Overall Study||0
8575128|NCT02108821|21143075|P1|COMPLETED|Overall Study||23
8575129|NCT02108821|21143075|P1|STARTED|Overall Study||23
8575145|NCT01932762|21143121|P4|NOT COMPLETED|Overall Study||1
8575146|NCT01932762|21143122|P3|NOT COMPLETED|Overall Study||0
8575147|NCT01932762|21143123|P2|NOT COMPLETED|Overall Study||2
8575148|NCT01932762|21143124|P1|NOT COMPLETED|Overall Study||6
8575149|NCT01932762|21143121|P4|COMPLETED|Overall Study||18
8575150|NCT01932762|21143122|P3|COMPLETED|Overall Study||19
8575151|NCT01932762|21143123|P2|COMPLETED|Overall Study||28
8575152|NCT01932762|21143124|P1|COMPLETED|Overall Study||24
8575153|NCT01932762|21143121|P4|STARTED|Overall Study||19
8575154|NCT01932762|21143122|P3|STARTED|Overall Study||19
8575155|NCT01932762|21143123|P2|STARTED|Overall Study||30
8575156|NCT01932762|21143124|P1|STARTED|Overall Study||30
8575265|NCT01781403|21143197|P3|NOT COMPLETED|Overall Study||0
8575266|NCT01781403|21143198|P2|NOT COMPLETED|Overall Study||0
8575267|NCT01781403|21143199|P1|NOT COMPLETED|Overall Study||0
8575268|NCT01781403|21143197|P3|COMPLETED|Overall Study||18
8575269|NCT01781403|21143198|P2|COMPLETED|Overall Study||2
8575270|NCT01781403|21143199|P1|COMPLETED|Overall Study||2
8575271|NCT01781403|21143197|P3|STARTED|Overall Study||18
8575272|NCT01781403|21143198|P2|STARTED|Overall Study||2
8575273|NCT01781403|21143199|P1|STARTED|Overall Study||2
8575274|NCT01776723|21143220|P5|NOT COMPLETED|Overall Study||0
8575275|NCT01776723|21143221|P4|NOT COMPLETED|Overall Study||0
8575276|NCT01776723|21143222|P3|NOT COMPLETED|Overall Study||0
8575277|NCT01776723|21143223|P2|NOT COMPLETED|Overall Study||0
8575278|NCT01776723|21143224|P1|NOT COMPLETED|Overall Study||0
8575279|NCT01776723|21143220|P5|COMPLETED|Overall Study||30
8575280|NCT01776723|21143221|P4|COMPLETED|Overall Study||5
8575281|NCT01776723|21143222|P3|COMPLETED|Overall Study||5
8575282|NCT01776723|21143223|P2|COMPLETED|Overall Study||4
8575283|NCT01776723|21143224|P1|COMPLETED|Overall Study||6
8575284|NCT01776723|21143220|P5|STARTED|Overall Study||30
8575285|NCT01776723|21143221|P4|STARTED|Overall Study||5
8575286|NCT01776723|21143222|P3|STARTED|Overall Study||5
8575287|NCT01776723|21143223|P2|STARTED|Overall Study||4
8575288|NCT01776723|21143224|P1|STARTED|Overall Study||6
8575289|NCT01757392|21143240|P1|NOT COMPLETED|Overall Study||4
8575290|NCT01757392|21143240|P1|COMPLETED|Overall Study||35
8575291|NCT01757392|21143240|P1|STARTED|Overall Study||39
8575372|NCT01710501|21143552|P3|NOT COMPLETED|Overall Study||0
8575373|NCT01710501|21143553|P2|NOT COMPLETED|Overall Study||0
8575374|NCT01710501|21143554|P1|NOT COMPLETED|Overall Study||2
8575375|NCT01710501|21143552|P3|COMPLETED|Overall Study||30
8575376|NCT01710501|21143553|P2|COMPLETED|Overall Study||28
8575377|NCT01710501|21143554|P1|COMPLETED|Overall Study||27
8575378|NCT01710501|21143552|P3|STARTED|Overall Study||30
8575379|NCT01710501|21143553|P2|STARTED|Overall Study||28
8575380|NCT01710501|21143554|P1|STARTED|Overall Study||29
8575406|NCT01538745|21143628|P2|NOT COMPLETED|Overall Study||0
8575407|NCT01538745|21143629|P1|NOT COMPLETED|Overall Study||0
8575408|NCT01538745|21143628|P2|COMPLETED|Overall Study||21
8575409|NCT01538745|21143629|P1|COMPLETED|Overall Study||24
8575410|NCT01538745|21143628|P2|STARTED|Overall Study||21
8575411|NCT01538745|21143629|P1|STARTED|Overall Study||24
8575431|NCT01243593|21143683|P2|NOT COMPLETED|Overall Study||0
8575432|NCT01243593|21143684|P1|NOT COMPLETED|Overall Study||0
8575433|NCT01243593|21143683|P2|COMPLETED|Overall Study||16
8575434|NCT01243593|21143684|P1|COMPLETED|Overall Study||16
8575435|NCT01243593|21143683|P2|STARTED|Overall Study||16
8575436|NCT01243593|21143684|P1|STARTED|Overall Study||16
8575443|NCT01211340|21143709|P2|NOT COMPLETED|Overall Study||0
8575444|NCT01211340|21143710|P1|NOT COMPLETED|Overall Study||0
8575445|NCT01211340|21143709|P2|COMPLETED|Overall Study||223
8575446|NCT01211340|21143710|P1|COMPLETED|Overall Study||223
8575447|NCT01211340|21143709|P2|STARTED|Overall Study||223
8575448|NCT01211340|21143710|P1|STARTED|Overall Study||223
8575449|NCT01134614|21143722|P2|NOT COMPLETED|Overall Study||122
8575450|NCT01134614|21143723|P1|NOT COMPLETED|Overall Study||123
8575451|NCT01134614|21143722|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
8575452|NCT01134614|21143723|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
8575453|NCT01134614|21143722|P2|Treated and Toxicity Assessed|Overall Study||120
8575454|NCT01134614|21143723|P1|Treated and Toxicity Assessed|Overall Study||118
8575455|NCT01134614|21143722|P2|Treated|Overall Study||121
8575456|NCT01134614|21143723|P1|Treated|Overall Study||119
8575457|NCT01134614|21143722|P2|STARTED|Overall Study||122
8575458|NCT01134614|21143723|P1|STARTED|Overall Study||123
8575459|NCT01081262|21143737|P4|NOT COMPLETED|Overall Study||0
8575460|NCT01081262|21143738|P3|NOT COMPLETED|Overall Study||0
8575461|NCT01081262|21143739|P2|NOT COMPLETED|Overall Study||0
8575462|NCT01081262|21143740|P1|NOT COMPLETED|Overall Study||0
8575463|NCT01081262|21143737|P4|COMPLETED|Overall Study||11
8575464|NCT01081262|21143738|P3|COMPLETED|Overall Study||13
8575465|NCT01081262|21143739|P2|COMPLETED|Overall Study||13
8575466|NCT01081262|21143740|P1|COMPLETED|Overall Study||13
8575467|NCT01081262|21143737|P4|STARTED|Overall Study||11
8575468|NCT01081262|21143738|P3|STARTED|Overall Study||13
8575469|NCT01081262|21143739|P2|STARTED|Overall Study||13
8575470|NCT01081262|21143740|P1|STARTED|Overall Study||13
8575507|NCT00863772|21143802|P3|NOT COMPLETED|Overall Study||61
8575508|NCT00863772|21143803|P2|NOT COMPLETED|Overall Study||65
8575509|NCT00863772|21143804|P1|NOT COMPLETED|Overall Study||68
8575510|NCT00863772|21143802|P3|COMPLETED|Overall Study||11
8575511|NCT00863772|21143803|P2|COMPLETED|Overall Study||9
8575512|NCT00863772|21143804|P1|COMPLETED|Overall Study||6
8575513|NCT00863772|21143802|P3|Treated|Overall Study||72
8575514|NCT00863772|21143803|P2|Treated|Overall Study||74
8575515|NCT00863772|21143804|P1|Treated|Overall Study||73
8575516|NCT00863772|21143802|P3|STARTED|Overall Study||72
8575517|NCT00863772|21143803|P2|STARTED|Overall Study||74
8575518|NCT00863772|21143804|P1|STARTED|Overall Study||74
8575519|NCT00644189|21143930|P4|NOT COMPLETED|Phase II||0
8575520|NCT00644189|21143931|P3|NOT COMPLETED|Phase II||0
8575521|NCT00644189|21143932|P2|NOT COMPLETED|Phase II||0
8575522|NCT00644189|21143933|P1|NOT COMPLETED|Phase II||0
8575523|NCT00644189|21143930|P4|COMPLETED|Phase II||50
8575524|NCT00644189|21143931|P3|COMPLETED|Phase II||0
8575525|NCT00644189|21143932|P2|COMPLETED|Phase II||0
8575526|NCT00644189|21143933|P1|COMPLETED|Phase II||0
8575527|NCT00644189|21143930|P4|Completed All 6 Cycles of Treatment|Phase II||19
8575528|NCT00644189|21143931|P3|Completed All 6 Cycles of Treatment|Phase II||0
8575529|NCT00644189|21143932|P2|Completed All 6 Cycles of Treatment|Phase II||0
8575530|NCT00644189|21143933|P1|Completed All 6 Cycles of Treatment|Phase II||0
8575531|NCT00644189|21143930|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
8575532|NCT00644189|21143931|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8575533|NCT00644189|21143932|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8575534|NCT00644189|21143933|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8575535|NCT00644189|21143930|P4|NOT COMPLETED|Phase I||0
8575536|NCT00644189|21143931|P3|NOT COMPLETED|Phase I||0
8575537|NCT00644189|21143932|P2|NOT COMPLETED|Phase I||0
8575538|NCT00644189|21143933|P1|NOT COMPLETED|Phase I||0
8575539|NCT00644189|21143930|P4|COMPLETED|Phase I||18
8575540|NCT00644189|21143931|P3|COMPLETED|Phase I||6
8575541|NCT00644189|21143932|P2|COMPLETED|Phase I||3
8575542|NCT00644189|21143933|P1|COMPLETED|Phase I||3
8575543|NCT00644189|21143930|P4|STARTED|Phase I||18
8575544|NCT00644189|21143931|P3|STARTED|Phase I||6
8575545|NCT00644189|21143932|P2|STARTED|Phase I||3
8575546|NCT00644189|21143933|P1|STARTED|Phase I||3
8575561|NCT00334815|21143961|P2|NOT COMPLETED|Overall Study||10
8575562|NCT00334815|21143962|P1|NOT COMPLETED|Overall Study||7
8575563|NCT00334815|21143961|P2|COMPLETED|Overall Study||3
8575564|NCT00334815|21143962|P1|COMPLETED|Overall Study||9
8575565|NCT00334815|21143961|P2|STARTED|Overall Study||13
8575566|NCT00334815|21143962|P1|STARTED|Overall Study||16
8575579|NCT04470375|21144054|P1|NOT COMPLETED|Overall Study||0
8575580|NCT04470375|21144054|P1|COMPLETED|Overall Study||20
8575581|NCT04470375|21144054|P1|STARTED|Overall Study||20
8575582|NCT04439110|21144060|P1|NOT COMPLETED|Overall Study||38
8575583|NCT04439110|21144060|P1|COMPLETED|Overall Study||0
8575584|NCT04439110|21144060|P1|Eligible|Overall Study||36
8575585|NCT04439110|21144060|P1|STARTED|Overall Study||38
8575592|NCT03996694|21144081|P6|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575593|NCT03996694|21144082|P5|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575594|NCT03996694|21144083|P4|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575595|NCT03996694|21144084|P3|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575596|NCT03996694|21144085|P2|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575597|NCT03996694|21144086|P1|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575598|NCT03996694|21144081|P6|COMPLETED|Sixth Intervention (1 Day)||3
8575599|NCT03996694|21144082|P5|COMPLETED|Sixth Intervention (1 Day)||2
8575600|NCT03996694|21144083|P4|COMPLETED|Sixth Intervention (1 Day)||3
8575601|NCT03996694|21144084|P3|COMPLETED|Sixth Intervention (1 Day)||2
8575602|NCT03996694|21144085|P2|COMPLETED|Sixth Intervention (1 Day)||2
8575603|NCT03996694|21144086|P1|COMPLETED|Sixth Intervention (1 Day)||3
8575604|NCT03996694|21144081|P6|STARTED|Sixth Intervention (1 Day)||3
8575605|NCT03996694|21144082|P5|STARTED|Sixth Intervention (1 Day)||2
8575606|NCT03996694|21144083|P4|STARTED|Sixth Intervention (1 Day)||3
8575607|NCT03996694|21144084|P3|STARTED|Sixth Intervention (1 Day)||2
8575608|NCT03996694|21144085|P2|STARTED|Sixth Intervention (1 Day)||2
8575609|NCT03996694|21144086|P1|STARTED|Sixth Intervention (1 Day)||3
8575610|NCT03996694|21144081|P6|NOT COMPLETED|Fifth Washout (7 Days)||0
8575611|NCT03996694|21144082|P5|NOT COMPLETED|Fifth Washout (7 Days)||0
8575612|NCT03996694|21144083|P4|NOT COMPLETED|Fifth Washout (7 Days)||0
8575613|NCT03996694|21144084|P3|NOT COMPLETED|Fifth Washout (7 Days)||0
8575614|NCT03996694|21144085|P2|NOT COMPLETED|Fifth Washout (7 Days)||0
8575615|NCT03996694|21144086|P1|NOT COMPLETED|Fifth Washout (7 Days)||0
8575616|NCT03996694|21144081|P6|COMPLETED|Fifth Washout (7 Days)||3
8575617|NCT03996694|21144082|P5|COMPLETED|Fifth Washout (7 Days)||2
8575618|NCT03996694|21144083|P4|COMPLETED|Fifth Washout (7 Days)||3
8575619|NCT03996694|21144084|P3|COMPLETED|Fifth Washout (7 Days)||2
8575620|NCT03996694|21144085|P2|COMPLETED|Fifth Washout (7 Days)||2
8575621|NCT03996694|21144086|P1|COMPLETED|Fifth Washout (7 Days)||3
8575622|NCT03996694|21144081|P6|STARTED|Fifth Washout (7 Days)||3
8575623|NCT03996694|21144082|P5|STARTED|Fifth Washout (7 Days)||2
8575624|NCT03996694|21144083|P4|STARTED|Fifth Washout (7 Days)||3
8575625|NCT03996694|21144084|P3|STARTED|Fifth Washout (7 Days)||2
8575626|NCT03996694|21144085|P2|STARTED|Fifth Washout (7 Days)||2
8575627|NCT03996694|21144086|P1|STARTED|Fifth Washout (7 Days)||3
8575628|NCT03996694|21144081|P6|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575629|NCT03996694|21144082|P5|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575630|NCT03996694|21144083|P4|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575631|NCT03996694|21144084|P3|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575632|NCT03996694|21144085|P2|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575633|NCT03996694|21144086|P1|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575634|NCT03996694|21144081|P6|COMPLETED|Fifth Intervention (1 Day)||3
8575635|NCT03996694|21144082|P5|COMPLETED|Fifth Intervention (1 Day)||2
8575636|NCT03996694|21144083|P4|COMPLETED|Fifth Intervention (1 Day)||3
8575637|NCT03996694|21144084|P3|COMPLETED|Fifth Intervention (1 Day)||2
8575638|NCT03996694|21144085|P2|COMPLETED|Fifth Intervention (1 Day)||2
8575639|NCT03996694|21144086|P1|COMPLETED|Fifth Intervention (1 Day)||3
8575640|NCT03996694|21144081|P6|STARTED|Fifth Intervention (1 Day)||3
8575641|NCT03996694|21144082|P5|STARTED|Fifth Intervention (1 Day)||2
8575642|NCT03996694|21144083|P4|STARTED|Fifth Intervention (1 Day)||3
8575643|NCT03996694|21144084|P3|STARTED|Fifth Intervention (1 Day)||2
8575644|NCT03996694|21144085|P2|STARTED|Fifth Intervention (1 Day)||2
8575645|NCT03996694|21144086|P1|STARTED|Fifth Intervention (1 Day)||3
8575646|NCT03996694|21144081|P6|NOT COMPLETED|Fourth Washout (7 Days)||0
8575647|NCT03996694|21144082|P5|NOT COMPLETED|Fourth Washout (7 Days)||0
8575648|NCT03996694|21144083|P4|NOT COMPLETED|Fourth Washout (7 Days)||0
8575649|NCT03996694|21144084|P3|NOT COMPLETED|Fourth Washout (7 Days)||0
8575650|NCT03996694|21144085|P2|NOT COMPLETED|Fourth Washout (7 Days)||0
8575651|NCT03996694|21144086|P1|NOT COMPLETED|Fourth Washout (7 Days)||0
8575652|NCT03996694|21144081|P6|COMPLETED|Fourth Washout (7 Days)||3
8575653|NCT03996694|21144082|P5|COMPLETED|Fourth Washout (7 Days)||2
8575654|NCT03996694|21144083|P4|COMPLETED|Fourth Washout (7 Days)||3
8575655|NCT03996694|21144084|P3|COMPLETED|Fourth Washout (7 Days)||2
8575656|NCT03996694|21144085|P2|COMPLETED|Fourth Washout (7 Days)||2
8575657|NCT03996694|21144086|P1|COMPLETED|Fourth Washout (7 Days)||3
8575658|NCT03996694|21144081|P6|STARTED|Fourth Washout (7 Days)||3
8575659|NCT03996694|21144082|P5|STARTED|Fourth Washout (7 Days)||2
8575660|NCT03996694|21144083|P4|STARTED|Fourth Washout (7 Days)||3
8575661|NCT03996694|21144084|P3|STARTED|Fourth Washout (7 Days)||2
8575662|NCT03996694|21144085|P2|STARTED|Fourth Washout (7 Days)||2
8575663|NCT03996694|21144086|P1|STARTED|Fourth Washout (7 Days)||3
8575664|NCT03996694|21144081|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575665|NCT03996694|21144082|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575666|NCT03996694|21144083|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575667|NCT03996694|21144084|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575668|NCT03996694|21144085|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575669|NCT03996694|21144086|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575670|NCT03996694|21144081|P6|COMPLETED|Fourth Intervention (1 Day)||3
8575671|NCT03996694|21144082|P5|COMPLETED|Fourth Intervention (1 Day)||2
8575672|NCT03996694|21144083|P4|COMPLETED|Fourth Intervention (1 Day)||3
8575673|NCT03996694|21144084|P3|COMPLETED|Fourth Intervention (1 Day)||2
8575674|NCT03996694|21144085|P2|COMPLETED|Fourth Intervention (1 Day)||2
8575675|NCT03996694|21144086|P1|COMPLETED|Fourth Intervention (1 Day)||3
8575676|NCT03996694|21144081|P6|STARTED|Fourth Intervention (1 Day)||3
8575677|NCT03996694|21144082|P5|STARTED|Fourth Intervention (1 Day)||2
8575678|NCT03996694|21144083|P4|STARTED|Fourth Intervention (1 Day)||3
8575679|NCT03996694|21144084|P3|STARTED|Fourth Intervention (1 Day)||2
8575680|NCT03996694|21144085|P2|STARTED|Fourth Intervention (1 Day)||2
8575681|NCT03996694|21144086|P1|STARTED|Fourth Intervention (1 Day)||3
8575682|NCT03996694|21144081|P6|NOT COMPLETED|Third Washout (7 Days)||0
8575683|NCT03996694|21144082|P5|NOT COMPLETED|Third Washout (7 Days)||1
8575684|NCT03996694|21144083|P4|NOT COMPLETED|Third Washout (7 Days)||0
8575685|NCT03996694|21144084|P3|NOT COMPLETED|Third Washout (7 Days)||0
8575686|NCT03996694|21144085|P2|NOT COMPLETED|Third Washout (7 Days)||0
8575687|NCT03996694|21144086|P1|NOT COMPLETED|Third Washout (7 Days)||0
8575688|NCT03996694|21144081|P6|COMPLETED|Third Washout (7 Days)||3
8575689|NCT03996694|21144082|P5|COMPLETED|Third Washout (7 Days)||2
8575690|NCT03996694|21144083|P4|COMPLETED|Third Washout (7 Days)||3
8575691|NCT03996694|21144084|P3|COMPLETED|Third Washout (7 Days)||2
8575692|NCT03996694|21144085|P2|COMPLETED|Third Washout (7 Days)||2
8575693|NCT03996694|21144086|P1|COMPLETED|Third Washout (7 Days)||3
8575694|NCT03996694|21144081|P6|STARTED|Third Washout (7 Days)||3
8575695|NCT03996694|21144082|P5|STARTED|Third Washout (7 Days)||3
8575696|NCT03996694|21144083|P4|STARTED|Third Washout (7 Days)||3
8575697|NCT03996694|21144084|P3|STARTED|Third Washout (7 Days)||2
8575698|NCT03996694|21144085|P2|STARTED|Third Washout (7 Days)||2
8575699|NCT03996694|21144086|P1|STARTED|Third Washout (7 Days)||3
8575700|NCT03996694|21144081|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8575701|NCT03996694|21144082|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8575702|NCT03996694|21144083|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8575703|NCT03996694|21144084|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8575704|NCT03996694|21144085|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8575705|NCT03996694|21144086|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8575706|NCT03996694|21144081|P6|COMPLETED|Third Intervention (1 Day)||3
8575707|NCT03996694|21144082|P5|COMPLETED|Third Intervention (1 Day)||3
8575708|NCT03996694|21144083|P4|COMPLETED|Third Intervention (1 Day)||3
8575709|NCT03996694|21144084|P3|COMPLETED|Third Intervention (1 Day)||2
8575710|NCT03996694|21144085|P2|COMPLETED|Third Intervention (1 Day)||2
8575711|NCT03996694|21144086|P1|COMPLETED|Third Intervention (1 Day)||3
8575712|NCT03996694|21144081|P6|STARTED|Third Intervention (1 Day)||3
8575713|NCT03996694|21144082|P5|STARTED|Third Intervention (1 Day)||3
8575714|NCT03996694|21144083|P4|STARTED|Third Intervention (1 Day)||3
8575715|NCT03996694|21144084|P3|STARTED|Third Intervention (1 Day)||2
8575716|NCT03996694|21144085|P2|STARTED|Third Intervention (1 Day)||2
8575717|NCT03996694|21144086|P1|STARTED|Third Intervention (1 Day)||3
8575718|NCT03996694|21144081|P6|NOT COMPLETED|Second Washout (7 Days)||0
8575719|NCT03996694|21144082|P5|NOT COMPLETED|Second Washout (7 Days)||0
8575720|NCT03996694|21144083|P4|NOT COMPLETED|Second Washout (7 Days)||0
8575721|NCT03996694|21144084|P3|NOT COMPLETED|Second Washout (7 Days)||0
8575722|NCT03996694|21144085|P2|NOT COMPLETED|Second Washout (7 Days)||0
8575723|NCT03996694|21144086|P1|NOT COMPLETED|Second Washout (7 Days)||0
8575724|NCT03996694|21144081|P6|COMPLETED|Second Washout (7 Days)||3
8575725|NCT03996694|21144082|P5|COMPLETED|Second Washout (7 Days)||3
8575726|NCT03996694|21144083|P4|COMPLETED|Second Washout (7 Days)||3
8575727|NCT03996694|21144084|P3|COMPLETED|Second Washout (7 Days)||2
8575728|NCT03996694|21144085|P2|COMPLETED|Second Washout (7 Days)||2
8575729|NCT03996694|21144086|P1|COMPLETED|Second Washout (7 Days)||3
8575730|NCT03996694|21144081|P6|STARTED|Second Washout (7 Days)||3
8575731|NCT03996694|21144082|P5|STARTED|Second Washout (7 Days)||3
8575732|NCT03996694|21144083|P4|STARTED|Second Washout (7 Days)||3
8575733|NCT03996694|21144084|P3|STARTED|Second Washout (7 Days)||2
8575734|NCT03996694|21144085|P2|STARTED|Second Washout (7 Days)||2
8575735|NCT03996694|21144086|P1|STARTED|Second Washout (7 Days)||3
8575736|NCT03996694|21144081|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8575737|NCT03996694|21144082|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8575738|NCT03996694|21144083|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8575739|NCT03996694|21144084|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8575740|NCT03996694|21144085|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8575741|NCT03996694|21144086|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8575742|NCT03996694|21144081|P6|COMPLETED|Second Intervention (1 Day)||3
8575743|NCT03996694|21144082|P5|COMPLETED|Second Intervention (1 Day)||3
8575744|NCT03996694|21144083|P4|COMPLETED|Second Intervention (1 Day)||3
8575745|NCT03996694|21144084|P3|COMPLETED|Second Intervention (1 Day)||2
8575746|NCT03996694|21144085|P2|COMPLETED|Second Intervention (1 Day)||2
8575747|NCT03996694|21144086|P1|COMPLETED|Second Intervention (1 Day)||3
8575748|NCT03996694|21144081|P6|STARTED|Second Intervention (1 Day)||3
8575749|NCT03996694|21144082|P5|STARTED|Second Intervention (1 Day)||3
8575750|NCT03996694|21144083|P4|STARTED|Second Intervention (1 Day)||3
8575751|NCT03996694|21144084|P3|STARTED|Second Intervention (1 Day)||2
8575752|NCT03996694|21144085|P2|STARTED|Second Intervention (1 Day)||2
8575753|NCT03996694|21144086|P1|STARTED|Second Intervention (1 Day)||3
8575754|NCT03996694|21144081|P6|NOT COMPLETED|First Washout (7 Days)||0
8575755|NCT03996694|21144082|P5|NOT COMPLETED|First Washout (7 Days)||0
8575756|NCT03996694|21144083|P4|NOT COMPLETED|First Washout (7 Days)||0
8575757|NCT03996694|21144084|P3|NOT COMPLETED|First Washout (7 Days)||2
8575758|NCT03996694|21144085|P2|NOT COMPLETED|First Washout (7 Days)||1
8575759|NCT03996694|21144086|P1|NOT COMPLETED|First Washout (7 Days)||0
8575760|NCT03996694|21144081|P6|COMPLETED|First Washout (7 Days)||3
8575761|NCT03996694|21144082|P5|COMPLETED|First Washout (7 Days)||3
8575762|NCT03996694|21144083|P4|COMPLETED|First Washout (7 Days)||3
8575763|NCT03996694|21144084|P3|COMPLETED|First Washout (7 Days)||2
8575764|NCT03996694|21144085|P2|COMPLETED|First Washout (7 Days)||2
8575765|NCT03996694|21144086|P1|COMPLETED|First Washout (7 Days)||3
8575766|NCT03996694|21144081|P6|STARTED|First Washout (7 Days)||3
8575767|NCT03996694|21144082|P5|STARTED|First Washout (7 Days)||3
8575768|NCT03996694|21144083|P4|STARTED|First Washout (7 Days)||3
8575769|NCT03996694|21144084|P3|STARTED|First Washout (7 Days)||4
8575770|NCT03996694|21144085|P2|STARTED|First Washout (7 Days)||3
8575771|NCT03996694|21144086|P1|STARTED|First Washout (7 Days)||3
8575772|NCT03996694|21144081|P6|NOT COMPLETED|First Intervention (1 Day)||0
8575773|NCT03996694|21144082|P5|NOT COMPLETED|First Intervention (1 Day)||0
8575774|NCT03996694|21144083|P4|NOT COMPLETED|First Intervention (1 Day)||0
8575775|NCT03996694|21144084|P3|NOT COMPLETED|First Intervention (1 Day)||0
8575776|NCT03996694|21144085|P2|NOT COMPLETED|First Intervention (1 Day)||0
8575777|NCT03996694|21144086|P1|NOT COMPLETED|First Intervention (1 Day)||0
8575778|NCT03996694|21144081|P6|COMPLETED|First Intervention (1 Day)||3
8575779|NCT03996694|21144082|P5|COMPLETED|First Intervention (1 Day)||3
8575780|NCT03996694|21144083|P4|COMPLETED|First Intervention (1 Day)||3
8575781|NCT03996694|21144084|P3|COMPLETED|First Intervention (1 Day)||4
8575782|NCT03996694|21144085|P2|COMPLETED|First Intervention (1 Day)||3
8575783|NCT03996694|21144086|P1|COMPLETED|First Intervention (1 Day)||3
8575784|NCT03996694|21144081|P6|STARTED|First Intervention (1 Day)||3
8575785|NCT03996694|21144082|P5|STARTED|First Intervention (1 Day)||3
8575786|NCT03996694|21144083|P4|STARTED|First Intervention (1 Day)||3
8575787|NCT03996694|21144084|P3|STARTED|First Intervention (1 Day)||4
8575788|NCT03996694|21144085|P2|STARTED|First Intervention (1 Day)||3
8575789|NCT03996694|21144086|P1|STARTED|First Intervention (1 Day)||3
8575790|NCT03979274|21144118|P2|NOT COMPLETED|Treatment Period 2||1
8575791|NCT03979274|21144119|P1|NOT COMPLETED|Treatment Period 2||0
8575792|NCT03979274|21144118|P2|COMPLETED|Treatment Period 2||21
8575793|NCT03979274|21144119|P1|COMPLETED|Treatment Period 2||22
8575794|NCT03979274|21144118|P2|STARTED|Treatment Period 2||22
8575795|NCT03979274|21144119|P1|STARTED|Treatment Period 2||22
8575796|NCT03979274|21144118|P2|NOT COMPLETED|Treatment Period 1||0
8575797|NCT03979274|21144119|P1|NOT COMPLETED|Treatment Period 1||0
8575798|NCT03979274|21144118|P2|COMPLETED|Treatment Period 1||22
8575799|NCT03979274|21144119|P1|COMPLETED|Treatment Period 1||22
8575800|NCT03979274|21144118|P2|STARTED|Treatment Period 1||22
8575801|NCT03979274|21144119|P1|STARTED|Treatment Period 1||22
8575802|NCT03812679|21144145|P1|NOT COMPLETED|Overall Study||8
8575803|NCT03812679|21144145|P1|COMPLETED|Overall Study||14
8575804|NCT03812679|21144145|P1|STARTED|Overall Study||22
8575805|NCT03714919|21144152|P1|NOT COMPLETED|Overall Study||0
8575806|NCT03714919|21144152|P1|COMPLETED|Overall Study||10
8575807|NCT03714919|21144152|P1|STARTED|Overall Study||10
8575832|NCT03610165|21144206|P2|NOT COMPLETED|Overall Study||1
8575833|NCT03610165|21144207|P1|NOT COMPLETED|Overall Study||0
8575834|NCT03610165|21144206|P2|COMPLETED|Overall Study||105
8575835|NCT03610165|21144207|P1|COMPLETED|Overall Study||108
8575836|NCT03610165|21144206|P2|STARTED|Overall Study||106
8575837|NCT03610165|21144207|P1|STARTED|Overall Study||108
8575860|NCT03477838|21144262|P1|NOT COMPLETED|Overall Study||14
8575861|NCT03477838|21144262|P1|COMPLETED|Overall Study||14
8575862|NCT03477838|21144262|P1|STARTED|Overall Study||28
8575871|NCT03437044|21144307|P2|NOT COMPLETED|Overall Study||2
8575872|NCT03437044|21144308|P1|NOT COMPLETED|Overall Study||3
8575873|NCT03437044|21144307|P2|COMPLETED|Overall Study||18
8575874|NCT03437044|21144308|P1|COMPLETED|Overall Study||17
8575875|NCT03437044|21144307|P2|STARTED|Overall Study||20
8575876|NCT03437044|21144308|P1|STARTED|Overall Study||20
8575877|NCT03429348|21144316|P2|NOT COMPLETED|Overall Study||0
8575878|NCT03429348|21144317|P1|NOT COMPLETED|Overall Study||0
8575879|NCT03429348|21144316|P2|COMPLETED|Overall Study||12
8575880|NCT03429348|21144317|P1|COMPLETED|Overall Study||12
8575881|NCT03429348|21144316|P2|STARTED|Overall Study||12
8575882|NCT03429348|21144317|P1|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
8575893|NCT03351608|21144385|P5|NOT COMPLETED|Overall Study||2
8575894|NCT03351608|21144386|P4|NOT COMPLETED|Overall Study||8
8575895|NCT03351608|21144387|P3|NOT COMPLETED|Overall Study||3
8575896|NCT03351608|21144388|P2|NOT COMPLETED|Overall Study||2
8575897|NCT03351608|21144389|P1|NOT COMPLETED|Overall Study||1
8575898|NCT03351608|21144385|P5|COMPLETED|Overall Study||33
8575899|NCT03351608|21144386|P4|COMPLETED|Overall Study||168
8575900|NCT03351608|21144387|P3|COMPLETED|Overall Study||32
8575901|NCT03351608|21144388|P2|COMPLETED|Overall Study||21
8575902|NCT03351608|21144389|P1|COMPLETED|Overall Study||18
8575903|NCT03351608|21144385|P5|Treated|Overall Study||34
8575904|NCT03351608|21144386|P4|Treated|Overall Study||169
8575905|NCT03351608|21144387|P3|Treated|Overall Study||33
8575906|NCT03351608|21144388|P2|Treated|Overall Study||22
8575907|NCT03351608|21144389|P1|Treated|Overall Study||18
8575908|NCT03351608|21144385|P5|STARTED|Overall Study||35
8575909|NCT03351608|21144386|P4|STARTED|Overall Study||176
8575910|NCT03351608|21144387|P3|STARTED|Overall Study||35
8575911|NCT03351608|21144388|P2|STARTED|Overall Study||23
8575912|NCT03351608|21144389|P1|STARTED|Overall Study||19
8575913|NCT03350542|21144442|P1|NOT COMPLETED|Overall Study||4
8575914|NCT03350542|21144442|P1|COMPLETED|Overall Study||96
8575915|NCT03350542|21144442|P1|Death With no 12-month F/U|Overall Study||4
8575916|NCT03350542|21144442|P1|Completed 12-Month Clinical F/U|Overall Study||96
8575917|NCT03350542|21144442|P1|STARTED|Overall Study||100
8575918|NCT03332498|21144462|P3|NOT COMPLETED|Overall Study||2
8575919|NCT03332498|21144463|P2|NOT COMPLETED|Overall Study||0
8575920|NCT03332498|21144464|P1|NOT COMPLETED|Overall Study||0
8575921|NCT03332498|21144462|P3|COMPLETED|Overall Study||30
8575922|NCT03332498|21144463|P2|COMPLETED|Overall Study||4
8575923|NCT03332498|21144464|P1|COMPLETED|Overall Study||4
8575924|NCT03332498|21144462|P3|STARTED|Overall Study||32
8575925|NCT03332498|21144463|P2|STARTED|Overall Study||4
8575926|NCT03332498|21144464|P1|STARTED|Overall Study||4
8575978|NCT02975349|21144597|P6|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
8575979|NCT02975349|21144598|P5|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
8575980|NCT02975349|21144599|P4|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
8575981|NCT02975349|21144600|P3|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
8575982|NCT02975349|21144601|P2|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
8575983|NCT02975349|21144602|P1|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
8575984|NCT02975349|21144597|P6|COMPLETED|Blinded Extension Period (24 Weeks)||52
8575985|NCT02975349|21144598|P5|COMPLETED|Blinded Extension Period (24 Weeks)||46
8575986|NCT02975349|21144599|P4|COMPLETED|Blinded Extension Period (24 Weeks)||44
8575987|NCT02975349|21144600|P3|COMPLETED|Blinded Extension Period (24 Weeks)||43
8575988|NCT02975349|21144601|P2|COMPLETED|Blinded Extension Period (24 Weeks)||42
8575989|NCT02975349|21144602|P1|COMPLETED|Blinded Extension Period (24 Weeks)||0
8575990|NCT02975349|21144597|P6|STARTED|Blinded Extension Period (24 Weeks)||52
8575991|NCT02975349|21144598|P5|STARTED|Blinded Extension Period (24 Weeks)||48
8575992|NCT02975349|21144599|P4|STARTED|Blinded Extension Period (24 Weeks)||48
8575993|NCT02975349|21144600|P3|STARTED|Blinded Extension Period (24 Weeks)||47
8575994|NCT02975349|21144601|P2|STARTED|Blinded Extension Period (24 Weeks)||49
8575995|NCT02975349|21144602|P1|STARTED|Blinded Extension Period (24 Weeks)||0
8575996|NCT02975349|21144597|P6|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
8575997|NCT02975349|21144598|P5|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
8575998|NCT02975349|21144599|P4|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
8575999|NCT02975349|21144600|P3|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
8576000|NCT02975349|21144601|P2|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
8576001|NCT02975349|21144602|P1|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
8576002|NCT02975349|21144597|P6|COMPLETED|Active Treatment Period (24 Weeks)||52
8576003|NCT02975349|21144598|P5|COMPLETED|Active Treatment Period (24 Weeks)||48
8576004|NCT02975349|21144599|P4|COMPLETED|Active Treatment Period (24 Weeks)||48
8576005|NCT02975349|21144600|P3|COMPLETED|Active Treatment Period (24 Weeks)||47
8576006|NCT02975349|21144601|P2|COMPLETED|Active Treatment Period (24 Weeks)||0
8576007|NCT02975349|21144602|P1|COMPLETED|Active Treatment Period (24 Weeks)||49
8576008|NCT02975349|21144597|P6|STARTED|Active Treatment Period (24 Weeks)||54
8576009|NCT02975349|21144598|P5|STARTED|Active Treatment Period (24 Weeks)||54
8576010|NCT02975349|21144599|P4|STARTED|Active Treatment Period (24 Weeks)||53
8576011|NCT02975349|21144600|P3|STARTED|Active Treatment Period (24 Weeks)||52
8576012|NCT02975349|21144601|P2|STARTED|Active Treatment Period (24 Weeks)||0
8576013|NCT02975349|21144602|P1|STARTED|Active Treatment Period (24 Weeks)||54
8576034|NCT02933489|21144781|P2|NOT COMPLETED|Overall Study||28
8576035|NCT02933489|21144782|P1|NOT COMPLETED|Overall Study||44
8576036|NCT02933489|21144781|P2|COMPLETED|Overall Study||731
8576037|NCT02933489|21144782|P1|COMPLETED|Overall Study||713
8576038|NCT02933489|21144781|P2|AB MR Performed|Overall Study||733
8576039|NCT02933489|21144782|P1|AB MR Performed|Overall Study||713
8576040|NCT02933489|21144781|P2|DBTperformed|Overall Study||737
8576041|NCT02933489|21144782|P1|DBTperformed|Overall Study||726
8576042|NCT02933489|21144781|P2|STARTED|Overall Study||759
8576043|NCT02933489|21144782|P1|STARTED|Overall Study||757
8576164|NCT02816398|21144863|P1|NOT COMPLETED|Overall Study||14
8576165|NCT02816398|21144863|P1|COMPLETED|Overall Study||12
8576166|NCT02816398|21144863|P1|STARTED|Overall Study||26
8576167|NCT02796144|21144873|P3|NOT COMPLETED|Overall Study||6
8576168|NCT02796144|21144874|P2|NOT COMPLETED|Overall Study||3
8576169|NCT02796144|21144875|P1|NOT COMPLETED|Overall Study||5
8576170|NCT02796144|21144873|P3|COMPLETED|Overall Study||18
8576171|NCT02796144|21144874|P2|COMPLETED|Overall Study||21
8576172|NCT02796144|21144875|P1|COMPLETED|Overall Study||18
8576173|NCT02796144|21144873|P3|STARTED|Overall Study||24
8576174|NCT02796144|21144874|P2|STARTED|Overall Study||24
8576175|NCT02796144|21144875|P1|STARTED|Overall Study||23
8576188|NCT02681523|21144926|P1|NOT COMPLETED|Overall Study||2
8576189|NCT02681523|21144926|P1|COMPLETED|Overall Study||6
8576190|NCT02681523|21144926|P1|STARTED|Overall Study||8
8576191|NCT02662582|21144934|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8576192|NCT02662582|21144935|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8576193|NCT02662582|21144934|P2|COMPLETED|Treatment Period 2 (14 Days)||19
8576194|NCT02662582|21144935|P1|COMPLETED|Treatment Period 2 (14 Days)||18
8576195|NCT02662582|21144934|P2|STARTED|Treatment Period 2 (14 Days)||19
8576196|NCT02662582|21144935|P1|STARTED|Treatment Period 2 (14 Days)||18
8576197|NCT02662582|21144934|P2|NOT COMPLETED|Washout Period (14 Days)||0
8576198|NCT02662582|21144935|P1|NOT COMPLETED|Washout Period (14 Days)||0
8576199|NCT02662582|21144934|P2|COMPLETED|Washout Period (14 Days)||19
8576200|NCT02662582|21144935|P1|COMPLETED|Washout Period (14 Days)||18
8576201|NCT02662582|21144934|P2|STARTED|Washout Period (14 Days)||19
8576202|NCT02662582|21144935|P1|STARTED|Washout Period (14 Days)||18
8576203|NCT02662582|21144934|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||4
8576204|NCT02662582|21144935|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||5
8576205|NCT02662582|21144934|P2|COMPLETED|Treatment Period 1 (14 Days)||19
8576206|NCT02662582|21144935|P1|COMPLETED|Treatment Period 1 (14 Days)||18
8576207|NCT02662582|21144934|P2|STARTED|Treatment Period 1 (14 Days)||23
8576208|NCT02662582|21144935|P1|STARTED|Treatment Period 1 (14 Days)||23
8576238|NCT02593006|21145189|P3|NOT COMPLETED|Overall Study||5
8576239|NCT02593006|21145190|P2|NOT COMPLETED|Overall Study||7
8576240|NCT02593006|21145191|P1|NOT COMPLETED|Overall Study||7
8576241|NCT02593006|21145189|P3|COMPLETED|Overall Study||38
8576242|NCT02593006|21145190|P2|COMPLETED|Overall Study||93
8576243|NCT02593006|21145191|P1|COMPLETED|Overall Study||250
8576244|NCT02593006|21145189|P3|STARTED|Overall Study||43
8576245|NCT02593006|21145190|P2|STARTED|Overall Study||100
8576246|NCT02593006|21145191|P1|STARTED|Overall Study||257
8576247|NCT02574481|21145206|P4|NOT COMPLETED|Overall Study||0
8576248|NCT02574481|21145207|P3|NOT COMPLETED|Overall Study||3
8576249|NCT02574481|21145208|P2|NOT COMPLETED|Overall Study||14
8576250|NCT02574481|21145209|P1|NOT COMPLETED|Overall Study||27
8576251|NCT02574481|21145206|P4|COMPLETED|Overall Study||13
8576252|NCT02574481|21145207|P3|COMPLETED|Overall Study||47
8576253|NCT02574481|21145208|P2|COMPLETED|Overall Study||142
8576254|NCT02574481|21145209|P1|COMPLETED|Overall Study||282
8576255|NCT02574481|21145206|P4|STARTED|Overall Study||13
8576256|NCT02574481|21145207|P3|STARTED|Overall Study||50
8576257|NCT02574481|21145208|P2|STARTED|Overall Study||156
8576258|NCT02574481|21145209|P1|STARTED|Overall Study||309
8576259|NCT02526160|21145249|P2|NOT COMPLETED|Open-Label Treatment Extension Period II||0
8576260|NCT02526160|21145250|P1|NOT COMPLETED|Open-Label Treatment Extension Period II||1
8576261|NCT02526160|21145249|P2|COMPLETED|Open-Label Treatment Extension Period II||49
8576262|NCT02526160|21145250|P1|COMPLETED|Open-Label Treatment Extension Period II||51
8576263|NCT02526160|21145249|P2|STARTED|Open-Label Treatment Extension Period II||49
8576264|NCT02526160|21145250|P1|STARTED|Open-Label Treatment Extension Period II||52
8576265|NCT02526160|21145249|P2|NOT COMPLETED|Open-Label Treatment Extension Period I||4
8576266|NCT02526160|21145250|P1|NOT COMPLETED|Open-Label Treatment Extension Period I||3
8576267|NCT02526160|21145249|P2|COMPLETED|Open-Label Treatment Extension Period I||59
8576268|NCT02526160|21145250|P1|COMPLETED|Open-Label Treatment Extension Period I||60
8576269|NCT02526160|21145249|P2|STARTED|Open-Label Treatment Extension Period I||63
8576270|NCT02526160|21145250|P1|STARTED|Open-Label Treatment Extension Period I||63
8576271|NCT02526160|21145249|P2|NOT COMPLETED|Open-label Treatment Continuation Period||4
8576272|NCT02526160|21145250|P1|NOT COMPLETED|Open-label Treatment Continuation Period||3
8576273|NCT02526160|21145249|P2|COMPLETED|Open-label Treatment Continuation Period||63
8576274|NCT02526160|21145250|P1|COMPLETED|Open-label Treatment Continuation Period||63
8576275|NCT02526160|21145249|P2|STARTED|Open-label Treatment Continuation Period||67
8576276|NCT02526160|21145250|P1|STARTED|Open-label Treatment Continuation Period||66
8576277|NCT02526160|21145249|P2|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
8576278|NCT02526160|21145250|P1|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
8576279|NCT02526160|21145249|P2|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
8576280|NCT02526160|21145250|P1|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
8576281|NCT02526160|21145249|P2|STARTED|Double-Blind (Placebo-Controlled) Period||68
8576282|NCT02526160|21145250|P1|STARTED|Double-Blind (Placebo-Controlled) Period||66
8576283|NCT02523196|21145322|P1|NOT COMPLETED|Overall Study||0
8576284|NCT02523196|21145322|P1|COMPLETED|Overall Study||20
8576285|NCT02523196|21145322|P1|Received HQ Shunt|Overall Study||20
8576286|NCT02523196|21145322|P1|Received HVPG|Overall Study||20
8576287|NCT02523196|21145322|P1|STARTED|Overall Study||20
8576288|NCT02481869|21145356|P2|NOT COMPLETED|Overall Study||4
8576289|NCT02481869|21145357|P1|NOT COMPLETED|Overall Study||5
8576290|NCT02481869|21145356|P2|COMPLETED|Overall Study||2
8576291|NCT02481869|21145357|P1|COMPLETED|Overall Study||0
8576292|NCT02481869|21145356|P2|STARTED|Overall Study||6
8576293|NCT02481869|21145357|P1|STARTED|Overall Study||5
8576318|NCT02432183|21145391|P4|NOT COMPLETED|Overall Study||0
8576319|NCT02432183|21145392|P3|NOT COMPLETED|Overall Study||0
8576320|NCT02432183|21145393|P2|NOT COMPLETED|Overall Study||0
8576321|NCT02432183|21145394|P1|NOT COMPLETED|Overall Study||0
8576322|NCT02432183|21145391|P4|COMPLETED|Overall Study||17
8576323|NCT02432183|21145392|P3|COMPLETED|Overall Study||26
8576324|NCT02432183|21145393|P2|COMPLETED|Overall Study||47
8576325|NCT02432183|21145394|P1|COMPLETED|Overall Study||44
8576326|NCT02432183|21145391|P4|STARTED|Overall Study||17
8576327|NCT02432183|21145392|P3|STARTED|Overall Study||26
8576328|NCT02432183|21145393|P2|STARTED|Overall Study||47
8576329|NCT02432183|21145394|P1|STARTED|Overall Study||44
8576366|NCT02363972|21145531|P1|NOT COMPLETED|Overall Study||26
8576367|NCT02363972|21145531|P1|COMPLETED|Overall Study||77
8576368|NCT02363972|21145531|P1|STARTED|Overall Study||103
8576381|NCT02212379|21145566|P1|NOT COMPLETED|From Week 48 to Week 96||4
8576382|NCT02212379|21145566|P1|COMPLETED|From Week 48 to Week 96||152
8576383|NCT02212379|21145566|P1|STARTED|From Week 48 to Week 96||156
8576384|NCT02212379|21145566|P1|NOT COMPLETED|From Baseline to Week 48||9
8576385|NCT02212379|21145566|P1|COMPLETED|From Baseline to Week 48||156
8576386|NCT02212379|21145566|P1|STARTED|From Baseline to Week 48||165
8576387|NCT02138890|21145599|P2|NOT COMPLETED|Overall Study||0
8576388|NCT02138890|21145600|P1|NOT COMPLETED|Overall Study||1
8576389|NCT02138890|21145599|P2|COMPLETED|Overall Study||15
8576390|NCT02138890|21145600|P1|COMPLETED|Overall Study||30
8576391|NCT02138890|21145599|P2|STARTED|Overall Study||15
8576392|NCT02138890|21145600|P1|STARTED|Overall Study||31
8576393|NCT02133131|21145647|P7|NOT COMPLETED|Overall Study||12
8576394|NCT02133131|21145648|P6|NOT COMPLETED|Overall Study||14
8576395|NCT02133131|21145649|P5|NOT COMPLETED|Overall Study||15
8576396|NCT02133131|21145650|P4|NOT COMPLETED|Overall Study||6
8576397|NCT02133131|21145651|P3|NOT COMPLETED|Overall Study||1
8576398|NCT02133131|21145652|P2|NOT COMPLETED|Overall Study||5
8576399|NCT02133131|21145653|P1|NOT COMPLETED|Overall Study||5
8576400|NCT02133131|21145647|P7|COMPLETED|Overall Study||0
8576401|NCT02133131|21145648|P6|COMPLETED|Overall Study||0
8576402|NCT02133131|21145649|P5|COMPLETED|Overall Study||0
8576403|NCT02133131|21145650|P4|COMPLETED|Overall Study||15
8576404|NCT02133131|21145651|P3|COMPLETED|Overall Study||19
8576405|NCT02133131|21145652|P2|COMPLETED|Overall Study||25
8576406|NCT02133131|21145653|P1|COMPLETED|Overall Study||26
8576407|NCT02133131|21145647|P7|STARTED|Overall Study||12
8576408|NCT02133131|21145648|P6|STARTED|Overall Study||14
8576409|NCT02133131|21145649|P5|STARTED|Overall Study||15
8576410|NCT02133131|21145650|P4|STARTED|Overall Study||21
8576411|NCT02133131|21145651|P3|STARTED|Overall Study||20
8576412|NCT02133131|21145652|P2|STARTED|Overall Study||30
8576413|NCT02133131|21145653|P1|STARTED|Overall Study||31
8576414|NCT02124746|21145693|P3|NOT COMPLETED|Overall Study||22
8576415|NCT02124746|21145694|P2|NOT COMPLETED|Overall Study||18
8576416|NCT02124746|21145695|P1|NOT COMPLETED|Overall Study||19
8576417|NCT02124746|21145693|P3|COMPLETED|Overall Study||0
8576418|NCT02124746|21145694|P2|COMPLETED|Overall Study||4
8576419|NCT02124746|21145695|P1|COMPLETED|Overall Study||11
8576420|NCT02124746|21145693|P3|STARTED|Overall Study||22
8576421|NCT02124746|21145694|P2|STARTED|Overall Study||22
8576422|NCT02124746|21145695|P1|STARTED|Overall Study||30
8576423|NCT02105701|21145740|P4|NOT COMPLETED|Overall Study||2
8576424|NCT02105701|21145741|P3|NOT COMPLETED|Overall Study||3
8576425|NCT02105701|21145742|P2|NOT COMPLETED|Overall Study||1
8576426|NCT02105701|21145743|P1|NOT COMPLETED|Overall Study||4
8576427|NCT02105701|21145740|P4|COMPLETED|Overall Study||104
8576428|NCT02105701|21145741|P3|COMPLETED|Overall Study||102
8576429|NCT02105701|21145742|P2|COMPLETED|Overall Study||103
8576430|NCT02105701|21145743|P1|COMPLETED|Overall Study||101
8576431|NCT02105701|21145740|P4|STARTED|Overall Study||106
8576432|NCT02105701|21145741|P3|STARTED|Overall Study||105
8576433|NCT02105701|21145742|P2|STARTED|Overall Study||104
8576434|NCT02105701|21145743|P1|STARTED|Overall Study||105
8576435|NCT02105662|21145765|P1|NOT COMPLETED|Overall Study||6
8576436|NCT02105662|21145765|P1|COMPLETED|Overall Study||212
8576437|NCT02105662|21145765|P1|STARTED|Overall Study||218
8576525|NCT01717326|21145818|P20|NOT COMPLETED|Overall Study||6
8576526|NCT01717326|21145819|P19|NOT COMPLETED|Overall Study||4
8576527|NCT01717326|21145820|P18|NOT COMPLETED|Overall Study||0
8576528|NCT01717326|21145821|P17|NOT COMPLETED|Overall Study||1
8576529|NCT01717326|21145822|P16|NOT COMPLETED|Overall Study||3
8576530|NCT01717326|21145823|P15|NOT COMPLETED|Overall Study||0
8576531|NCT01717326|21145824|P14|NOT COMPLETED|Overall Study||0
8576532|NCT01717326|21145825|P13|NOT COMPLETED|Overall Study||1
8576533|NCT01717326|21145826|P12|NOT COMPLETED|Overall Study||0
8576534|NCT01717326|21145827|P11|NOT COMPLETED|Overall Study||2
8576535|NCT01717326|21145828|P10|NOT COMPLETED|Overall Study||2
8576536|NCT01717326|21145829|P9|NOT COMPLETED|Overall Study||0
8576537|NCT01717326|21145830|P8|NOT COMPLETED|Overall Study||0
8576538|NCT01717326|21145831|P7|NOT COMPLETED|Overall Study||1
8576539|NCT01717326|21145832|P6|NOT COMPLETED|Overall Study||0
8576540|NCT01717326|21145833|P5|NOT COMPLETED|Overall Study||2
8576541|NCT01717326|21145834|P4|NOT COMPLETED|Overall Study||2
8576542|NCT01717326|21145835|P3|NOT COMPLETED|Overall Study||0
8576543|NCT01717326|21145836|P2|NOT COMPLETED|Overall Study||1
8576544|NCT01717326|21145837|P1|NOT COMPLETED|Overall Study||3
8576545|NCT01717326|21145818|P20|COMPLETED|Overall Study||15
8576546|NCT01717326|21145819|P19|COMPLETED|Overall Study||16
8576547|NCT01717326|21145820|P18|COMPLETED|Overall Study||31
8576548|NCT01717326|21145821|P17|COMPLETED|Overall Study||29
8576549|NCT01717326|21145822|P16|COMPLETED|Overall Study||27
8576550|NCT01717326|21145823|P15|COMPLETED|Overall Study||29
8576551|NCT01717326|21145824|P14|COMPLETED|Overall Study||32
8576552|NCT01717326|21145825|P13|COMPLETED|Overall Study||32
8576553|NCT01717326|21145826|P12|COMPLETED|Overall Study||33
8576554|NCT01717326|21145827|P11|COMPLETED|Overall Study||30
8576555|NCT01717326|21145828|P10|COMPLETED|Overall Study||29
8576556|NCT01717326|21145829|P9|COMPLETED|Overall Study||32
8576557|NCT01717326|21145830|P8|COMPLETED|Overall Study||29
8576558|NCT01717326|21145831|P7|COMPLETED|Overall Study||30
8576559|NCT01717326|21145832|P6|COMPLETED|Overall Study||31
8576560|NCT01717326|21145833|P5|COMPLETED|Overall Study||31
8576561|NCT01717326|21145834|P4|COMPLETED|Overall Study||28
8576562|NCT01717326|21145835|P3|COMPLETED|Overall Study||13
8576563|NCT01717326|21145836|P2|COMPLETED|Overall Study||26
8576564|NCT01717326|21145837|P1|COMPLETED|Overall Study||22
8576565|NCT01717326|21145818|P20|Treated|Overall Study||21
8576566|NCT01717326|21145819|P19|Treated|Overall Study||20
8576567|NCT01717326|21145820|P18|Treated|Overall Study||31
8576568|NCT01717326|21145821|P17|Treated|Overall Study||30
8576569|NCT01717326|21145822|P16|Treated|Overall Study||30
8576570|NCT01717326|21145823|P15|Treated|Overall Study||29
8576571|NCT01717326|21145824|P14|Treated|Overall Study||32
8576572|NCT01717326|21145825|P13|Treated|Overall Study||33
8576573|NCT01717326|21145826|P12|Treated|Overall Study||33
8576574|NCT01717326|21145827|P11|Treated|Overall Study||32
8576575|NCT01717326|21145828|P10|Treated|Overall Study||31
8576576|NCT01717326|21145829|P9|Treated|Overall Study||32
8576577|NCT01717326|21145830|P8|Treated|Overall Study||29
8576578|NCT01717326|21145831|P7|Treated|Overall Study||31
8576579|NCT01717326|21145832|P6|Treated|Overall Study||31
8576580|NCT01717326|21145833|P5|Treated|Overall Study||33
8576581|NCT01717326|21145834|P4|Treated|Overall Study||30
8576582|NCT01717326|21145835|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
8576583|NCT01717326|21145836|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
8576584|NCT01717326|21145837|P1|Treated|Overall Study||25
8576585|NCT01717326|21145818|P20|STARTED|Overall Study||21
8576586|NCT01717326|21145819|P19|STARTED|Overall Study||20
8576587|NCT01717326|21145820|P18|STARTED|Overall Study||31
8576588|NCT01717326|21145821|P17|STARTED|Overall Study||30
8576589|NCT01717326|21145822|P16|STARTED|Overall Study||30
8576590|NCT01717326|21145823|P15|STARTED|Overall Study||29
8576591|NCT01717326|21145824|P14|STARTED|Overall Study||32
8576592|NCT01717326|21145825|P13|STARTED|Overall Study||33
8576593|NCT01717326|21145826|P12|STARTED|Overall Study||33
8576594|NCT01717326|21145827|P11|STARTED|Overall Study||32
8576595|NCT01717326|21145828|P10|STARTED|Overall Study||31
8576596|NCT01717326|21145829|P9|STARTED|Overall Study||32
8576597|NCT01717326|21145830|P8|STARTED|Overall Study||29
8576598|NCT01717326|21145831|P7|STARTED|Overall Study||31
8576599|NCT01717326|21145832|P6|STARTED|Overall Study||31
8576600|NCT01717326|21145833|P5|STARTED|Overall Study||33
8576601|NCT01717326|21145834|P4|STARTED|Overall Study||30
8576602|NCT01717326|21145835|P3|STARTED|Overall Study||13
8576603|NCT01717326|21145836|P2|STARTED|Overall Study||27
8576604|NCT01717326|21145837|P1|STARTED|Overall Study||25
8576608|NCT01708941|21146110|P4|NOT COMPLETED|Overall Study||18
8576609|NCT01708941|21146111|P3|NOT COMPLETED|Overall Study||19
8576610|NCT01708941|21146112|P2|NOT COMPLETED|Overall Study||18
8576611|NCT01708941|21146113|P1|NOT COMPLETED|Overall Study||18
8576612|NCT01708941|21146110|P4|COMPLETED|Overall Study||4
8576613|NCT01708941|21146111|P3|COMPLETED|Overall Study||3
8576614|NCT01708941|21146112|P2|COMPLETED|Overall Study||5
8576615|NCT01708941|21146113|P1|COMPLETED|Overall Study||3
8576616|NCT01708941|21146110|P4|Eligible and Started Treatment|Overall Study||22
8576617|NCT01708941|21146111|P3|Eligible and Started Treatment|Overall Study||19
8576618|NCT01708941|21146112|P2|Eligible and Started Treatment|Overall Study||22
8576619|NCT01708941|21146113|P1|Eligible and Started Treatment|Overall Study||18
8576620|NCT01708941|21146110|P4|STARTED|Overall Study||22
8576621|NCT01708941|21146111|P3|STARTED|Overall Study||22
8576622|NCT01708941|21146112|P2|STARTED|Overall Study||23
8576623|NCT01708941|21146113|P1|STARTED|Overall Study||21
8576624|NCT01680640|21146129|P2|NOT COMPLETED|Overall Study||5
8576625|NCT01680640|21146130|P1|NOT COMPLETED|Overall Study||10
8576626|NCT01680640|21146129|P2|COMPLETED|Overall Study||44
8576627|NCT01680640|21146130|P1|COMPLETED|Overall Study||45
8576628|NCT01680640|21146129|P2|STARTED|Overall Study||49
8576629|NCT01680640|21146130|P1|STARTED|Overall Study||55
8576642|NCT01551745|21146179|P1|NOT COMPLETED|Overall Study||3
8576643|NCT01551745|21146179|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
8576644|NCT01551745|21146179|P1|STARTED|Overall Study||5
8576645|NCT01532908|21146188|P2|NOT COMPLETED|Overall Study||0
8576646|NCT01532908|21146189|P1|NOT COMPLETED|Overall Study||1
8576647|NCT01532908|21146188|P2|COMPLETED|Overall Study||2
8576648|NCT01532908|21146189|P1|COMPLETED|Overall Study||8
8576649|NCT01532908|21146188|P2|Transplanted|Overall Study||2
8576650|NCT01532908|21146189|P1|Transplanted|Overall Study||8
8576651|NCT01532908|21146188|P2|Infused|Overall Study||2
8576652|NCT01532908|21146189|P1|Infused|Overall Study||9
8576653|NCT01532908|21146188|P2|STARTED|Overall Study||2
8576654|NCT01532908|21146189|P1|STARTED|Overall Study||9
8576685|NCT01505166|21146259|P3|NOT COMPLETED|Overall Study||0
8576686|NCT01505166|21146260|P2|NOT COMPLETED|Overall Study||0
8576687|NCT01505166|21146261|P1|NOT COMPLETED|Overall Study||0
8576688|NCT01505166|21146259|P3|COMPLETED|Overall Study||0
8576689|NCT01505166|21146260|P2|COMPLETED|Overall Study||0
8576690|NCT01505166|21146261|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
8576691|NCT01505166|21146259|P3|STARTED|Overall Study||0
8576692|NCT01505166|21146260|P2|STARTED|Overall Study||0
8576693|NCT01505166|21146261|P1|STARTED|Overall Study||3
8576724|NCT01217437|21146293|P2|NOT COMPLETED|Overall Study||41
8576725|NCT01217437|21146294|P1|NOT COMPLETED|Overall Study||43
8576726|NCT01217437|21146293|P2|COMPLETED|Overall Study||12
8576727|NCT01217437|21146294|P1|COMPLETED|Overall Study||12
8576728|NCT01217437|21146293|P2|STARTED|Overall Study||53
8576729|NCT01217437|21146294|P1|STARTED|Overall Study||55
8576853|NCT00551642|21146480|P2|NOT COMPLETED|7-Year Follow-up||0
8576854|NCT00551642|21146481|P1|NOT COMPLETED|7-Year Follow-up||0
8576855|NCT00551642|21146480|P2|COMPLETED|7-Year Follow-up||153
8576856|NCT00551642|21146481|P1|COMPLETED|7-Year Follow-up||152
8576857|NCT00551642|21146480|P2|STARTED|7-Year Follow-up||153
8576858|NCT00551642|21146481|P1|STARTED|7-Year Follow-up||152
8576859|NCT00551642|21146480|P2|NOT COMPLETED|Treatment Period||63
8576860|NCT00551642|21146481|P1|NOT COMPLETED|Treatment Period||61
8576861|NCT00551642|21146480|P2|COMPLETED|Treatment Period||338
8576862|NCT00551642|21146481|P1|COMPLETED|Treatment Period||338
8576863|NCT00551642|21146480|P2|Safety Population|Treatment Period||397
8576864|NCT00551642|21146481|P1|Safety Population|Treatment Period||395
8576865|NCT00551642|21146480|P2|STARTED|Treatment Period||401
8576866|NCT00551642|21146481|P1|STARTED|Treatment Period||399
8576985|NCT00186888|21146553|P3|NOT COMPLETED|Overall Study||0
8576986|NCT00186888|21146554|P2|NOT COMPLETED|Overall Study||3
8576987|NCT00186888|21146555|P1|NOT COMPLETED|Overall Study||4
8576988|NCT00186888|21146553|P3|COMPLETED|Overall Study||55
8576989|NCT00186888|21146554|P2|COMPLETED|Overall Study||24
8576990|NCT00186888|21146555|P1|COMPLETED|Overall Study||19
8576991|NCT00186888|21146553|P3|Window Therapy|Overall Study||0
8576992|NCT00186888|21146554|P2|Window Therapy|Overall Study||27
8576993|NCT00186888|21146555|P1|Window Therapy|Overall Study||0
8576994|NCT00186888|21146553|P3|STARTED|Overall Study||55
8576995|NCT00186888|21146554|P2|STARTED|Overall Study||27
8576996|NCT00186888|21146555|P1|STARTED|Overall Study||23
8585005|NCT04334681|21168052|P2|NOT COMPLETED|Overall Study||0
8585006|NCT04334681|21168053|P1|NOT COMPLETED|Overall Study||0
8585007|NCT04334681|21168052|P2|COMPLETED|Overall Study||143
8585008|NCT04334681|21168053|P1|COMPLETED|Overall Study||135
8585009|NCT04334681|21168052|P2|STARTED|Overall Study||143
8585010|NCT04334681|21168053|P1|STARTED|Overall Study||135
8585026|NCT03941015|21168104|P2|NOT COMPLETED|Overall Study||3
8585027|NCT03941015|21168105|P1|NOT COMPLETED|Overall Study||0
8585028|NCT03941015|21168104|P2|COMPLETED|Overall Study||204
8585029|NCT03941015|21168105|P1|COMPLETED|Overall Study||38
8585030|NCT03941015|21168104|P2|STARTED|Overall Study||207
8585031|NCT03941015|21168105|P1|STARTED|Overall Study||38
8585038|NCT03918811|21168134|P2|NOT COMPLETED|Overall Study||13
8585039|NCT03918811|21168135|P1|NOT COMPLETED|Overall Study||4
8585040|NCT03918811|21168134|P2|COMPLETED|Overall Study||345
8585041|NCT03918811|21168135|P1|COMPLETED|Overall Study||363
8585042|NCT03918811|21168134|P2|STARTED|Overall Study||358
8585043|NCT03918811|21168135|P1|STARTED|Overall Study||367
8585044|NCT03896022|21168154|P3|NOT COMPLETED|Overall Study||0
8585045|NCT03896022|21168155|P2|NOT COMPLETED|Overall Study||0
8585046|NCT03896022|21168156|P1|NOT COMPLETED|Overall Study||4
8585047|NCT03896022|21168154|P3|COMPLETED|Overall Study||52
8585048|NCT03896022|21168155|P2|COMPLETED|Overall Study||51
8585049|NCT03896022|21168156|P1|COMPLETED|Overall Study||70
8585050|NCT03896022|21168154|P3|STARTED|Overall Study||52
8585051|NCT03896022|21168155|P2|STARTED|Overall Study||51
8585052|NCT03896022|21168156|P1|STARTED|Overall Study||74
8585107|NCT03681184|21168260|P2|NOT COMPLETED|Open-Label Extension Period||1
8585108|NCT03681184|21168261|P1|NOT COMPLETED|Open-Label Extension Period||1
8585109|NCT03681184|21168260|P2|COMPLETED|Open-Label Extension Period||0
8585110|NCT03681184|21168261|P1|COMPLETED|Open-Label Extension Period||0
8585111|NCT03681184|21168260|P2|STARTED|Open-Label Extension Period||1
8585112|NCT03681184|21168261|P1|STARTED|Open-Label Extension Period||1
8585113|NCT03681184|21168260|P2|NOT COMPLETED|3-Month Blinded Extension Period||23
8585114|NCT03681184|21168261|P1|NOT COMPLETED|3-Month Blinded Extension Period||12
8585115|NCT03681184|21168260|P2|COMPLETED|3-Month Blinded Extension Period||1
8585116|NCT03681184|21168261|P1|COMPLETED|3-Month Blinded Extension Period||1
8585117|NCT03681184|21168260|P2|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
8585118|NCT03681184|21168261|P1|STARTED|3-Month Blinded Extension Period||13
8585119|NCT03681184|21168260|P2|NOT COMPLETED|6-Month Double-Blind Period||1
8585120|NCT03681184|21168261|P1|NOT COMPLETED|6-Month Double-Blind Period||0
8585121|NCT03681184|21168260|P2|COMPLETED|6-Month Double-Blind Period||25
8585122|NCT03681184|21168261|P1|COMPLETED|6-Month Double-Blind Period||13
8585123|NCT03681184|21168260|P2|STARTED|6-Month Double-Blind Period||26
8585124|NCT03681184|21168261|P1|STARTED|6-Month Double-Blind Period||13
8585125|NCT03661346|21168287|P2|NOT COMPLETED|Overall Study||0
8585126|NCT03661346|21168288|P1|NOT COMPLETED|Overall Study||0
8585127|NCT03661346|21168287|P2|COMPLETED|Overall Study||15
8585128|NCT03661346|21168288|P1|COMPLETED|Overall Study||13
8585129|NCT03661346|21168287|P2|STARTED|Overall Study||15
8585130|NCT03661346|21168288|P1|STARTED|Overall Study|Esmolol administration|13
8585131|NCT03652610|21168304|P2|NOT COMPLETED|Overall Study||5
8585132|NCT03652610|21168305|P1|NOT COMPLETED|Overall Study||4
8585133|NCT03652610|21168304|P2|COMPLETED|Overall Study||484
8585134|NCT03652610|21168305|P1|COMPLETED|Overall Study||486
8585135|NCT03652610|21168304|P2|STARTED|Overall Study||489
8585136|NCT03652610|21168305|P1|STARTED|Overall Study||490
8585143|NCT03594071|21168350|P1|NOT COMPLETED|Overall Study||5
8585144|NCT03594071|21168350|P1|COMPLETED|Overall Study||289
8585145|NCT03594071|21168350|P1|STARTED|Overall Study||294
8585167|NCT03511053|21168430|P1|NOT COMPLETED|Overall Study||1
8585168|NCT03511053|21168430|P1|COMPLETED|Overall Study||10
8585169|NCT03511053|21168430|P1|STARTED|Overall Study||11
8585170|NCT03506386|21168436|P1|NOT COMPLETED|Overall Study||0
8585171|NCT03506386|21168436|P1|COMPLETED|Overall Study||943
8585172|NCT03506386|21168436|P1|STARTED|Overall Study||943
8585173|NCT03475056|21168445|P2|NOT COMPLETED|Overall Study||3
8585174|NCT03475056|21168446|P1|NOT COMPLETED|Overall Study||0
8585175|NCT03475056|21168445|P2|COMPLETED|Overall Study||17
8585176|NCT03475056|21168446|P1|COMPLETED|Overall Study||20
8585177|NCT03475056|21168445|P2|Received Product Administration|Overall Study||20
8585178|NCT03475056|21168446|P1|Received Product Administration|Overall Study||20
8585179|NCT03475056|21168445|P2|STARTED|Overall Study||20
8585180|NCT03475056|21168446|P1|STARTED|Overall Study||20
8585187|NCT03411902|21168505|P2|NOT COMPLETED|Overall Study||0
8585188|NCT03411902|21168506|P1|NOT COMPLETED|Overall Study||3
8585189|NCT03411902|21168505|P2|COMPLETED|Overall Study||13
8585190|NCT03411902|21168506|P1|COMPLETED|Overall Study||8
8585191|NCT03411902|21168505|P2|STARTED|Overall Study||13
8585192|NCT03411902|21168506|P1|STARTED|Overall Study||11
8585193|NCT03404648|21168524|P1|NOT COMPLETED|Overall Study||0
8585194|NCT03404648|21168524|P1|COMPLETED|Overall Study||19
8585195|NCT03404648|21168524|P1|STARTED|Overall Study||19
8585196|NCT03400787|21168531|P2|NOT COMPLETED|Overall Study||8
8585197|NCT03400787|21168532|P1|NOT COMPLETED|Overall Study||2
8585198|NCT03400787|21168531|P2|COMPLETED|Overall Study||63
8585199|NCT03400787|21168532|P1|COMPLETED|Overall Study||64
8585200|NCT03400787|21168531|P2|3-Month Follow-up|Overall Study||63
8585201|NCT03400787|21168532|P1|3-Month Follow-up|Overall Study||64
8585202|NCT03400787|21168531|P2|STARTED|Overall Study||71
8585203|NCT03400787|21168532|P1|STARTED|Overall Study||66
8585204|NCT03380091|21168540|P2|NOT COMPLETED|Overall Study||1
8585205|NCT03380091|21168541|P1|NOT COMPLETED|Overall Study||2
8585206|NCT03380091|21168540|P2|COMPLETED|Overall Study||1
8585207|NCT03380091|21168541|P1|COMPLETED|Overall Study||1
8585208|NCT03380091|21168540|P2|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
8585209|NCT03380091|21168541|P1|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
8585210|NCT03380091|21168540|P2|STARTED|Overall Study||2
8585211|NCT03380091|21168541|P1|STARTED|Overall Study||3
8585218|NCT03368859|21168576|P2|NOT COMPLETED|Overall Study||34
8585219|NCT03368859|21168577|P1|NOT COMPLETED|Overall Study||36
8585220|NCT03368859|21168576|P2|COMPLETED|Overall Study||0
8585221|NCT03368859|21168577|P1|COMPLETED|Overall Study||0
8585222|NCT03368859|21168576|P2|STARTED|Overall Study||34
8585223|NCT03368859|21168577|P1|STARTED|Overall Study||36
8585296|NCT03355742|21168649|P1|NOT COMPLETED|Overall Study||99
8585297|NCT03355742|21168649|P1|COMPLETED|Overall Study||864
8585298|NCT03355742|21168649|P1|STARTED|Overall Study||963
8585311|NCT03319953|21168723|P4|NOT COMPLETED|Period 2 (Day 49 to 154)||1
8585312|NCT03319953|21168724|P3|NOT COMPLETED|Period 2 (Day 49 to 154)||1
8585313|NCT03319953|21168725|P2|NOT COMPLETED|Period 2 (Day 49 to 154)||0
8585314|NCT03319953|21168726|P1|NOT COMPLETED|Period 2 (Day 49 to 154)||1
8585315|NCT03319953|21168723|P4|COMPLETED|Period 2 (Day 49 to 154)||6
8585316|NCT03319953|21168724|P3|COMPLETED|Period 2 (Day 49 to 154)||8
8585317|NCT03319953|21168725|P2|COMPLETED|Period 2 (Day 49 to 154)||4
8585318|NCT03319953|21168726|P1|COMPLETED|Period 2 (Day 49 to 154)||2
8585319|NCT03319953|21168723|P4|Treated|Period 2 (Day 49 to 154)||6
8585320|NCT03319953|21168724|P3|Treated|Period 2 (Day 49 to 154)||8
8585321|NCT03319953|21168725|P2|Treated|Period 2 (Day 49 to 154)||4
8585322|NCT03319953|21168726|P1|Treated|Period 2 (Day 49 to 154)||2
8585323|NCT03319953|21168723|P4|STARTED|Period 2 (Day 49 to 154)||7
8585324|NCT03319953|21168724|P3|STARTED|Period 2 (Day 49 to 154)||9
8585325|NCT03319953|21168725|P2|STARTED|Period 2 (Day 49 to 154)||4
8585326|NCT03319953|21168726|P1|STARTED|Period 2 (Day 49 to 154)||3
8585327|NCT03319953|21168723|P4|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8585328|NCT03319953|21168724|P3|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8585329|NCT03319953|21168725|P2|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8585330|NCT03319953|21168726|P1|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8585331|NCT03319953|21168723|P4|COMPLETED|Washout Period (Day 15 to 49)||7
8585332|NCT03319953|21168724|P3|COMPLETED|Washout Period (Day 15 to 49)||9
8585333|NCT03319953|21168725|P2|COMPLETED|Washout Period (Day 15 to 49)||4
8585334|NCT03319953|21168726|P1|COMPLETED|Washout Period (Day 15 to 49)||3
8585335|NCT03319953|21168723|P4|STARTED|Washout Period (Day 15 to 49)||7
8585336|NCT03319953|21168724|P3|STARTED|Washout Period (Day 15 to 49)||9
8585337|NCT03319953|21168725|P2|STARTED|Washout Period (Day 15 to 49)||4
8585338|NCT03319953|21168726|P1|STARTED|Washout Period (Day 15 to 49)||3
8585339|NCT03319953|21168723|P4|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8585340|NCT03319953|21168724|P3|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8585341|NCT03319953|21168725|P2|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8585342|NCT03319953|21168726|P1|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8585343|NCT03319953|21168723|P4|COMPLETED|Period 1 (Day 1 to 14)||7
8585344|NCT03319953|21168724|P3|COMPLETED|Period 1 (Day 1 to 14)||9
8585345|NCT03319953|21168725|P2|COMPLETED|Period 1 (Day 1 to 14)||4
8585346|NCT03319953|21168726|P1|COMPLETED|Period 1 (Day 1 to 14)||3
8585347|NCT03319953|21168723|P4|STARTED|Period 1 (Day 1 to 14)||7
8585348|NCT03319953|21168724|P3|STARTED|Period 1 (Day 1 to 14)||9
8585349|NCT03319953|21168725|P2|STARTED|Period 1 (Day 1 to 14)||4
8585350|NCT03319953|21168726|P1|STARTED|Period 1 (Day 1 to 14)||3
8585376|NCT03261336|21168814|P1|NOT COMPLETED|Overall Study||1
8585377|NCT03261336|21168814|P1|COMPLETED|Overall Study||0
8585378|NCT03261336|21168814|P1|STARTED|Overall Study||1
8585385|NCT03225859|21168829|P1|NOT COMPLETED|Overall Study||1
8585386|NCT03225859|21168829|P1|COMPLETED|Overall Study||11
8585387|NCT03225859|21168829|P1|STARTED|Overall Study||12
8585400|NCT03219840|21168874|P2|NOT COMPLETED|Overall Study||0
8585401|NCT03219840|21168875|P1|NOT COMPLETED|Overall Study||4
8585402|NCT03219840|21168874|P2|COMPLETED|Overall Study||31
8585403|NCT03219840|21168875|P1|COMPLETED|Overall Study||34
8585404|NCT03219840|21168874|P2|Day 22 Visit for 2nd Period|Overall Study||31
8585405|NCT03219840|21168875|P1|Day 22 Visit for 2nd Period|Overall Study||34
8585406|NCT03219840|21168874|P2|2nd Intervention Period of 21 Days|Overall Study||31
8585407|NCT03219840|21168875|P1|2nd Intervention Period of 21 Days|Overall Study||34
8585408|NCT03219840|21168874|P2|Day 1 Visit for 2nd Period|Overall Study||31
8585409|NCT03219840|21168875|P1|Day 1 Visit for 2nd Period|Overall Study||34
8585410|NCT03219840|21168874|P2|Washout Period of 21 Days|Overall Study||31
8585411|NCT03219840|21168875|P1|Washout Period of 21 Days|Overall Study||34
8585412|NCT03219840|21168874|P2|Day 22 Visit for 1st Period|Overall Study||31
8585413|NCT03219840|21168875|P1|Day 22 Visit for 1st Period|Overall Study||34
8585414|NCT03219840|21168874|P2|1st Intervention Period of 21 Days|Overall Study||31
8585415|NCT03219840|21168875|P1|1st Intervention Period of 21 Days|Overall Study||34
8585416|NCT03219840|21168874|P2|Day 1 Visit for 1st Period|Overall Study||31
8585417|NCT03219840|21168875|P1|Day 1 Visit for 1st Period|Overall Study||37
8585418|NCT03219840|21168874|P2|STARTED|Overall Study||31
8585419|NCT03219840|21168875|P1|STARTED|Overall Study||38
8585420|NCT03141242|21168897|P2|NOT COMPLETED|Overall Study||0
8585421|NCT03141242|21168898|P1|NOT COMPLETED|Overall Study||0
8585422|NCT03141242|21168897|P2|COMPLETED|Overall Study||55
8585423|NCT03141242|21168898|P1|COMPLETED|Overall Study||55
8585424|NCT03141242|21168897|P2|6 Month Interview|Overall Study||49
8585425|NCT03141242|21168898|P1|6 Month Interview|Overall Study||51
8585426|NCT03141242|21168897|P2|Received Allocated Intervenion|Overall Study||55
8585427|NCT03141242|21168898|P1|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
8585428|NCT03141242|21168897|P2|STARTED|Overall Study||55
8585429|NCT03141242|21168898|P1|STARTED|Overall Study||55
8585457|NCT03100149|21169005|P3|NOT COMPLETED|Overall Study||2
8585458|NCT03100149|21169006|P2|NOT COMPLETED|Overall Study||4
8585459|NCT03100149|21169007|P1|NOT COMPLETED|Overall Study||0
8585460|NCT03100149|21169005|P3|COMPLETED|Overall Study||104
8585461|NCT03100149|21169006|P2|COMPLETED|Overall Study||101
8585462|NCT03100149|21169007|P1|COMPLETED|Overall Study||105
8585463|NCT03100149|21169005|P3|STARTED|Overall Study||106
8585464|NCT03100149|21169006|P2|STARTED|Overall Study||105
8585465|NCT03100149|21169007|P1|STARTED|Overall Study||105
8585490|NCT03066804|21169106|P2|NOT COMPLETED|Overall Study||50
8585491|NCT03066804|21169107|P1|NOT COMPLETED|Overall Study||51
8585492|NCT03066804|21169106|P2|COMPLETED|Overall Study||1236
8585493|NCT03066804|21169107|P1|COMPLETED|Overall Study||1235
8585494|NCT03066804|21169106|P2|STARTED|Overall Study||1286
8585495|NCT03066804|21169107|P1|STARTED|Overall Study||1286
8585500|NCT03040986|21169136|P2|NOT COMPLETED|Overall Study||2
8585501|NCT03040986|21169137|P1|NOT COMPLETED|Overall Study||6
8585502|NCT03040986|21169136|P2|COMPLETED|Overall Study||0
8585503|NCT03040986|21169137|P1|COMPLETED|Overall Study||0
8585504|NCT03040986|21169136|P2|STARTED|Overall Study||2
8585505|NCT03040986|21169137|P1|STARTED|Overall Study||6
8585506|NCT03020992|21169176|P1|NOT COMPLETED|Overall Study||6
8585507|NCT03020992|21169176|P1|COMPLETED|Overall Study||83
8585508|NCT03020992|21169176|P1|STARTED|Overall Study||89
8585518|NCT02973321|21169319|P5|NOT COMPLETED|Overall Study||5
8585519|NCT02973321|21169320|P4|NOT COMPLETED|Overall Study||16
8585520|NCT02973321|21169321|P3|NOT COMPLETED|Overall Study||14
8585521|NCT02973321|21169322|P2|NOT COMPLETED|Overall Study||15
8585522|NCT02973321|21169323|P1|NOT COMPLETED|Overall Study||1
8585523|NCT02973321|21169319|P5|COMPLETED|Overall Study||62
8585524|NCT02973321|21169320|P4|COMPLETED|Overall Study||48
8585525|NCT02973321|21169321|P3|COMPLETED|Overall Study||52
8585526|NCT02973321|21169322|P2|COMPLETED|Overall Study||51
8585527|NCT02973321|21169323|P1|COMPLETED|Overall Study||32
8585528|NCT02973321|21169319|P5|STARTED|Overall Study||67
8585529|NCT02973321|21169320|P4|STARTED|Overall Study||64
8585530|NCT02973321|21169321|P3|STARTED|Overall Study||66
8585531|NCT02973321|21169322|P2|STARTED|Overall Study||66
8585532|NCT02973321|21169323|P1|STARTED|Overall Study||33
8585533|NCT02971228|21169381|P5|NOT COMPLETED|Overall Study||0
8585534|NCT02971228|21169382|P4|NOT COMPLETED|Overall Study||0
8585535|NCT02971228|21169383|P3|NOT COMPLETED|Overall Study||0
8585536|NCT02971228|21169384|P2|NOT COMPLETED|Overall Study||2
8585537|NCT02971228|21169385|P1|NOT COMPLETED|Overall Study||1
8585538|NCT02971228|21169381|P5|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8585539|NCT02971228|21169382|P4|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8585540|NCT02971228|21169383|P3|COMPLETED|Overall Study||5
8585541|NCT02971228|21169384|P2|COMPLETED|Overall Study||5
8585542|NCT02971228|21169385|P1|COMPLETED|Overall Study||0
8585543|NCT02971228|21169381|P5|Randomized and Treated|Overall Study||0
8585544|NCT02971228|21169382|P4|Randomized and Treated|Overall Study||0
8585545|NCT02971228|21169383|P3|Randomized and Treated|Overall Study||5
8585546|NCT02971228|21169384|P2|Randomized and Treated|Overall Study||7
8585547|NCT02971228|21169385|P1|Randomized and Treated|Overall Study||0
8585548|NCT02971228|21169381|P5|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8585549|NCT02971228|21169382|P4|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8585550|NCT02971228|21169383|P3|STARTED|Overall Study||5
8585551|NCT02971228|21169384|P2|STARTED|Overall Study||7
8585552|NCT02971228|21169385|P1|STARTED|Overall Study||1
8585553|NCT02953639|21169430|P3|NOT COMPLETED|Overall Study||16
8585554|NCT02953639|21169431|P2|NOT COMPLETED|Overall Study||14
8585555|NCT02953639|21169432|P1|NOT COMPLETED|Overall Study||20
8585556|NCT02953639|21169430|P3|COMPLETED|Overall Study||62
8585557|NCT02953639|21169431|P2|COMPLETED|Overall Study||40
8585558|NCT02953639|21169432|P1|COMPLETED|Overall Study||61
8585559|NCT02953639|21169430|P3|STARTED|Overall Study||78
8585560|NCT02953639|21169431|P2|STARTED|Overall Study||54
8585561|NCT02953639|21169432|P1|STARTED|Overall Study||81
8585619|NCT02911025|21169616|P1|NOT COMPLETED|Overall Study||3
8585620|NCT02911025|21169616|P1|COMPLETED|Overall Study||10
8585621|NCT02911025|21169616|P1|STARTED|Overall Study||13
8585622|NCT02901431|21169629|P13|NOT COMPLETED|Open Label Part||3
8585623|NCT02901431|21169630|P12|NOT COMPLETED|Open Label Part||39
8585624|NCT02901431|21169631|P11|NOT COMPLETED|Open Label Part||29
8585625|NCT02901431|21169632|P10|NOT COMPLETED|Open Label Part||24
8585626|NCT02901431|21169633|P9|NOT COMPLETED|Open Label Part||48
8585627|NCT02901431|21169634|P8|NOT COMPLETED|Open Label Part||0
8585628|NCT02901431|21169635|P7|NOT COMPLETED|Open Label Part||0
8585629|NCT02901431|21169636|P6|NOT COMPLETED|Open Label Part||0
8585630|NCT02901431|21169637|P5|NOT COMPLETED|Open Label Part||0
8585631|NCT02901431|21169638|P4|NOT COMPLETED|Open Label Part||0
8585632|NCT02901431|21169639|P3|NOT COMPLETED|Open Label Part||0
8585633|NCT02901431|21169640|P2|NOT COMPLETED|Open Label Part||0
8585634|NCT02901431|21169641|P1|NOT COMPLETED|Open Label Part||0
8585635|NCT02901431|21169629|P13|COMPLETED|Open Label Part||2
8585636|NCT02901431|21169630|P12|COMPLETED|Open Label Part||7
8585637|NCT02901431|21169631|P11|COMPLETED|Open Label Part||11
8585638|NCT02901431|21169632|P10|COMPLETED|Open Label Part||11
8585639|NCT02901431|21169633|P9|COMPLETED|Open Label Part||20
8585640|NCT02901431|21169634|P8|COMPLETED|Open Label Part||0
8585641|NCT02901431|21169635|P7|COMPLETED|Open Label Part||0
8585642|NCT02901431|21169636|P6|COMPLETED|Open Label Part||0
8585643|NCT02901431|21169637|P5|COMPLETED|Open Label Part||0
8585644|NCT02901431|21169638|P4|COMPLETED|Open Label Part||0
8585645|NCT02901431|21169639|P3|COMPLETED|Open Label Part||0
8585646|NCT02901431|21169640|P2|COMPLETED|Open Label Part||0
8585647|NCT02901431|21169641|P1|COMPLETED|Open Label Part||0
8585648|NCT02901431|21169629|P13|STARTED|Open Label Part||5
8585649|NCT02901431|21169630|P12|STARTED|Open Label Part||46
8585650|NCT02901431|21169631|P11|STARTED|Open Label Part||40
8585651|NCT02901431|21169632|P10|STARTED|Open Label Part||35
8585652|NCT02901431|21169633|P9|STARTED|Open Label Part||68
8585653|NCT02901431|21169634|P8|STARTED|Open Label Part||0
8585654|NCT02901431|21169635|P7|STARTED|Open Label Part||0
8585655|NCT02901431|21169636|P6|STARTED|Open Label Part||0
8585656|NCT02901431|21169637|P5|STARTED|Open Label Part||0
8585657|NCT02901431|21169638|P4|STARTED|Open Label Part||0
8585658|NCT02901431|21169639|P3|STARTED|Open Label Part||0
8585659|NCT02901431|21169640|P2|STARTED|Open Label Part||0
8585660|NCT02901431|21169641|P1|STARTED|Open Label Part||0
8585661|NCT02901431|21169629|P13|NOT COMPLETED|Main Treatment Part||0
8585662|NCT02901431|21169630|P12|NOT COMPLETED|Main Treatment Part||0
8585663|NCT02901431|21169631|P11|NOT COMPLETED|Main Treatment Part||0
8585664|NCT02901431|21169632|P10|NOT COMPLETED|Main Treatment Part||0
8585665|NCT02901431|21169633|P9|NOT COMPLETED|Main Treatment Part||0
8585666|NCT02901431|21169634|P8|NOT COMPLETED|Main Treatment Part||0
8585667|NCT02901431|21169635|P7|NOT COMPLETED|Main Treatment Part||11
8585668|NCT02901431|21169636|P6|NOT COMPLETED|Main Treatment Part||12
8585669|NCT02901431|21169637|P5|NOT COMPLETED|Main Treatment Part||7
8585670|NCT02901431|21169638|P4|NOT COMPLETED|Main Treatment Part||26
8585671|NCT02901431|21169639|P3|NOT COMPLETED|Main Treatment Part||0
8585672|NCT02901431|21169640|P2|NOT COMPLETED|Main Treatment Part||0
8585673|NCT02901431|21169641|P1|NOT COMPLETED|Main Treatment Part||0
8585674|NCT02901431|21169629|P13|COMPLETED|Main Treatment Part||0
8585675|NCT02901431|21169630|P12|COMPLETED|Main Treatment Part||0
8585676|NCT02901431|21169631|P11|COMPLETED|Main Treatment Part||0
8585677|NCT02901431|21169632|P10|COMPLETED|Main Treatment Part||0
8585678|NCT02901431|21169633|P9|COMPLETED|Main Treatment Part||0
8585679|NCT02901431|21169634|P8|COMPLETED|Main Treatment Part||7
8585680|NCT02901431|21169635|P7|COMPLETED|Main Treatment Part||55
8585681|NCT02901431|21169636|P6|COMPLETED|Main Treatment Part||54
8585682|NCT02901431|21169637|P5|COMPLETED|Main Treatment Part||50
8585683|NCT02901431|21169638|P4|COMPLETED|Main Treatment Part||86
8585684|NCT02901431|21169639|P3|COMPLETED|Main Treatment Part||0
8585685|NCT02901431|21169640|P2|COMPLETED|Main Treatment Part||0
8585686|NCT02901431|21169641|P1|COMPLETED|Main Treatment Part||0
8585687|NCT02901431|21169629|P13|STARTED|Main Treatment Part||0
8585688|NCT02901431|21169630|P12|STARTED|Main Treatment Part||0
8585689|NCT02901431|21169631|P11|STARTED|Main Treatment Part||0
8585690|NCT02901431|21169632|P10|STARTED|Main Treatment Part||0
8585691|NCT02901431|21169633|P9|STARTED|Main Treatment Part||0
8585692|NCT02901431|21169634|P8|STARTED|Main Treatment Part||7
8585693|NCT02901431|21169635|P7|STARTED|Main Treatment Part||66
8585694|NCT02901431|21169636|P6|STARTED|Main Treatment Part||66
8585695|NCT02901431|21169637|P5|STARTED|Main Treatment Part||57
8585696|NCT02901431|21169638|P4|STARTED|Main Treatment Part||112
8585697|NCT02901431|21169639|P3|STARTED|Main Treatment Part||0
8585698|NCT02901431|21169640|P2|STARTED|Main Treatment Part||0
8585699|NCT02901431|21169641|P1|STARTED|Main Treatment Part||0
8585700|NCT02901431|21169629|P13|NOT COMPLETED|PK Part||0
8585701|NCT02901431|21169630|P12|NOT COMPLETED|PK Part||0
8585702|NCT02901431|21169631|P11|NOT COMPLETED|PK Part||0
8585703|NCT02901431|21169632|P10|NOT COMPLETED|PK Part||0
8585704|NCT02901431|21169633|P9|NOT COMPLETED|PK Part||0
8585705|NCT02901431|21169634|P8|NOT COMPLETED|PK Part||0
8585706|NCT02901431|21169635|P7|NOT COMPLETED|PK Part||0
8585707|NCT02901431|21169636|P6|NOT COMPLETED|PK Part||0
8585708|NCT02901431|21169637|P5|NOT COMPLETED|PK Part||0
8585709|NCT02901431|21169638|P4|NOT COMPLETED|PK Part||0
8585710|NCT02901431|21169639|P3|NOT COMPLETED|PK Part||9
8585711|NCT02901431|21169640|P2|NOT COMPLETED|PK Part||6
8585712|NCT02901431|21169641|P1|NOT COMPLETED|PK Part||7
8585713|NCT02901431|21169629|P13|COMPLETED|PK Part||0
8585714|NCT02901431|21169630|P12|COMPLETED|PK Part||0
8585715|NCT02901431|21169631|P11|COMPLETED|PK Part||0
8585716|NCT02901431|21169632|P10|COMPLETED|PK Part||0
8585717|NCT02901431|21169633|P9|COMPLETED|PK Part||0
8585718|NCT02901431|21169634|P8|COMPLETED|PK Part||0
8585719|NCT02901431|21169635|P7|COMPLETED|PK Part||0
8585720|NCT02901431|21169636|P6|COMPLETED|PK Part||0
8585721|NCT02901431|21169637|P5|COMPLETED|PK Part||0
8585722|NCT02901431|21169638|P4|COMPLETED|PK Part||0
8585723|NCT02901431|21169639|P3|COMPLETED|PK Part||6
8585724|NCT02901431|21169640|P2|COMPLETED|PK Part||5
8585725|NCT02901431|21169641|P1|COMPLETED|PK Part||5
8585726|NCT02901431|21169629|P13|STARTED|PK Part||0
8585727|NCT02901431|21169630|P12|STARTED|PK Part||0
8585728|NCT02901431|21169631|P11|STARTED|PK Part||0
8585729|NCT02901431|21169632|P10|STARTED|PK Part||0
8585730|NCT02901431|21169633|P9|STARTED|PK Part||0
8585731|NCT02901431|21169634|P8|STARTED|PK Part||0
8585732|NCT02901431|21169635|P7|STARTED|PK Part||0
8585733|NCT02901431|21169636|P6|STARTED|PK Part||0
8585734|NCT02901431|21169637|P5|STARTED|PK Part||0
8585735|NCT02901431|21169638|P4|STARTED|PK Part||0
8585736|NCT02901431|21169639|P3|STARTED|PK Part||15
8585737|NCT02901431|21169640|P2|STARTED|PK Part||11
8585738|NCT02901431|21169641|P1|STARTED|PK Part||12
8585750|NCT02825849|21169715|P2|NOT COMPLETED|Overall Study||0
8585751|NCT02825849|21169716|P1|NOT COMPLETED|Overall Study||0
8585752|NCT02825849|21169715|P2|COMPLETED|Overall Study||5
8585753|NCT02825849|21169716|P1|COMPLETED|Overall Study||22
8585754|NCT02825849|21169715|P2|STARTED|Overall Study||5
8585755|NCT02825849|21169716|P1|STARTED|Overall Study||22
8585756|NCT02765256|21169726|P2|NOT COMPLETED|Overall Study||0
8585757|NCT02765256|21169727|P1|NOT COMPLETED|Overall Study||0
8585758|NCT02765256|21169726|P2|COMPLETED|Overall Study||4
8585759|NCT02765256|21169727|P1|COMPLETED|Overall Study||4
8585760|NCT02765256|21169726|P2|STARTED|Overall Study||4
8585761|NCT02765256|21169727|P1|STARTED|Overall Study||4
8585872|NCT02685995|21170260|P2|NOT COMPLETED|Overall Study||1
8585873|NCT02685995|21170261|P1|NOT COMPLETED|Overall Study||1
8585874|NCT02685995|21170260|P2|COMPLETED|Overall Study||49
8585875|NCT02685995|21170261|P1|COMPLETED|Overall Study||49
8585876|NCT02685995|21170260|P2|STARTED|Overall Study||50
8585877|NCT02685995|21170261|P1|STARTED|Overall Study||50
8585878|NCT02658734|21170267|P1|NOT COMPLETED|Overall Study||57
8585879|NCT02658734|21170267|P1|COMPLETED|Overall Study||13
8585880|NCT02658734|21170267|P1|STARTED|Overall Study||70
8585881|NCT02649218|21170286|P1|NOT COMPLETED|Overall Study||25
8585882|NCT02649218|21170286|P1|COMPLETED|Overall Study||201
8585883|NCT02649218|21170286|P1|STARTED|Overall Study||226
8585884|NCT02637895|21170295|P2|NOT COMPLETED|Overall Study||3
8585885|NCT02637895|21170296|P1|NOT COMPLETED|Overall Study||6
8585886|NCT02637895|21170295|P2|COMPLETED|Overall Study||17
8585887|NCT02637895|21170296|P1|COMPLETED|Overall Study||15
8585888|NCT02637895|21170295|P2|STARTED|Overall Study||20
8585889|NCT02637895|21170296|P1|STARTED|Overall Study||21
8585890|NCT02625974|21170310|P2|NOT COMPLETED|Overall Study||6
8585891|NCT02625974|21170311|P1|NOT COMPLETED|Overall Study||16
8585892|NCT02625974|21170310|P2|COMPLETED|Overall Study||105
8585893|NCT02625974|21170311|P1|COMPLETED|Overall Study||203
8585894|NCT02625974|21170310|P2|Received Treatment|Overall Study||111
8585895|NCT02625974|21170311|P1|Received Treatment|Overall Study||219
8585896|NCT02625974|21170310|P2|STARTED|Overall Study||111
8585897|NCT02625974|21170311|P1|STARTED|Overall Study||219
8585904|NCT02603432|21170438|P2|NOT COMPLETED|Overall Study||350
8585905|NCT02603432|21170439|P1|NOT COMPLETED|Overall Study||350
8585906|NCT02603432|21170438|P2|COMPLETED|Overall Study||0
8585907|NCT02603432|21170439|P1|COMPLETED|Overall Study||0
8585908|NCT02603432|21170438|P2|STARTED|Overall Study||350
8585909|NCT02603432|21170439|P1|STARTED|Overall Study||350
8585910|NCT02601313|21170490|P3|NOT COMPLETED|Overall Study||17
8585911|NCT02601313|21170491|P2|NOT COMPLETED|Overall Study||74
8585912|NCT02601313|21170492|P1|NOT COMPLETED|Overall Study||6
8585913|NCT02601313|21170490|P3|COMPLETED|Overall Study||0
8585914|NCT02601313|21170491|P2|COMPLETED|Overall Study||0
8585915|NCT02601313|21170492|P1|COMPLETED|Overall Study||8
8585916|NCT02601313|21170490|P3|STARTED|Overall Study||17
8585917|NCT02601313|21170491|P2|STARTED|Overall Study||74
8585918|NCT02601313|21170492|P1|STARTED|Overall Study||14
8585919|NCT02597478|21170513|P2|NOT COMPLETED|Overall Study||1
8585920|NCT02597478|21170514|P1|NOT COMPLETED|Overall Study||3
8585921|NCT02597478|21170513|P2|COMPLETED|Overall Study||17
8585922|NCT02597478|21170514|P1|COMPLETED|Overall Study||13
8585923|NCT02597478|21170513|P2|STARTED|Overall Study||18
8585924|NCT02597478|21170514|P1|STARTED|Overall Study||16
8585925|NCT02594111|21170530|P2|NOT COMPLETED|Overall Study||0
8585926|NCT02594111|21170531|P1|NOT COMPLETED|Overall Study||0
8585927|NCT02594111|21170530|P2|COMPLETED|Overall Study||348
8585928|NCT02594111|21170531|P1|COMPLETED|Overall Study||366
8585929|NCT02594111|21170530|P2|STARTED|Overall Study||348
8585930|NCT02594111|21170531|P1|STARTED|Overall Study||366
8585949|NCT02548949|21170558|P1|NOT COMPLETED|Overall Study||0
8585950|NCT02548949|21170558|P1|COMPLETED|Overall Study||700
8585951|NCT02548949|21170558|P1|STARTED|Overall Study||700
8585999|NCT02475369|21170774|P2|NOT COMPLETED|Treatment Period #2 (10 Days)||0
8586000|NCT02475369|21170775|P1|NOT COMPLETED|Treatment Period #2 (10 Days)||0
8586001|NCT02475369|21170774|P2|COMPLETED|Treatment Period #2 (10 Days)||9
8586002|NCT02475369|21170775|P1|COMPLETED|Treatment Period #2 (10 Days)||3
8586003|NCT02475369|21170774|P2|STARTED|Treatment Period #2 (10 Days)||9
8586004|NCT02475369|21170775|P1|STARTED|Treatment Period #2 (10 Days)||3
8586005|NCT02475369|21170774|P2|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
8586006|NCT02475369|21170775|P1|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
8586007|NCT02475369|21170774|P2|COMPLETED|Run-in Washout Period #2 (7 Days)||9
8586008|NCT02475369|21170775|P1|COMPLETED|Run-in Washout Period #2 (7 Days)||3
8586009|NCT02475369|21170774|P2|STARTED|Run-in Washout Period #2 (7 Days)||9
8586010|NCT02475369|21170775|P1|STARTED|Run-in Washout Period #2 (7 Days)||3
8586011|NCT02475369|21170774|P2|NOT COMPLETED|Treatment Period #1 (10 Days)||0
8586012|NCT02475369|21170775|P1|NOT COMPLETED|Treatment Period #1 (10 Days)||0
8586013|NCT02475369|21170774|P2|COMPLETED|Treatment Period #1 (10 Days)||9
8586014|NCT02475369|21170775|P1|COMPLETED|Treatment Period #1 (10 Days)||3
8586015|NCT02475369|21170774|P2|STARTED|Treatment Period #1 (10 Days)||9
8586016|NCT02475369|21170775|P1|STARTED|Treatment Period #1 (10 Days)||3
8586017|NCT02475369|21170774|P2|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
8586018|NCT02475369|21170775|P1|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
8586019|NCT02475369|21170774|P2|COMPLETED|Run-in Washout Period #1 (7 Days)||9
8586020|NCT02475369|21170775|P1|COMPLETED|Run-in Washout Period #1 (7 Days)||3
8586021|NCT02475369|21170774|P2|STARTED|Run-in Washout Period #1 (7 Days)||11
8586022|NCT02475369|21170775|P1|STARTED|Run-in Washout Period #1 (7 Days)||10
8586023|NCT02474199|21170788|P4|NOT COMPLETED|Overall Study||3
8586024|NCT02474199|21170789|P3|NOT COMPLETED|Overall Study||2
8586025|NCT02474199|21170790|P2|NOT COMPLETED|Overall Study||3
8586026|NCT02474199|21170791|P1|NOT COMPLETED|Overall Study||2
8586027|NCT02474199|21170788|P4|COMPLETED|Overall Study||0
8586028|NCT02474199|21170789|P3|COMPLETED|Overall Study||0
8586029|NCT02474199|21170790|P2|COMPLETED|Overall Study||2
8586030|NCT02474199|21170791|P1|COMPLETED|Overall Study||3
8586031|NCT02474199|21170788|P4|STARTED|Overall Study||3
8586032|NCT02474199|21170789|P3|STARTED|Overall Study||2
8586033|NCT02474199|21170790|P2|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
8586034|NCT02474199|21170791|P1|STARTED|Overall Study||5
8586055|NCT02450903|21170844|P1|NOT COMPLETED|Overall Study||20
8586056|NCT02450903|21170844|P1|COMPLETED|Overall Study||0
8586057|NCT02450903|21170844|P1|Entered Survival Follow-up Phase|Overall Study||15
8586058|NCT02450903|21170844|P1|Entered Post-treatment Effic. f/u Phase|Overall Study||4
8586059|NCT02450903|21170844|P1|STARTED|Overall Study||20
8586303|NCT02420821|21171079|P2|NOT COMPLETED|Overall Study||137
8586304|NCT02420821|21171080|P1|NOT COMPLETED|Overall Study||168
8586305|NCT02420821|21171079|P2|COMPLETED|Overall Study||317
8586306|NCT02420821|21171080|P1|COMPLETED|Overall Study||293
8586307|NCT02420821|21171079|P2|STARTED|Overall Study||454
8586308|NCT02420821|21171080|P1|STARTED|Overall Study||461
8586309|NCT02416453|21171159|P11|NOT COMPLETED|Overall Study||0
8586310|NCT02416453|21171160|P10|NOT COMPLETED|Overall Study||0
8586311|NCT02416453|21171161|P9|NOT COMPLETED|Overall Study||5
8586312|NCT02416453|21171162|P8|NOT COMPLETED|Overall Study||12
8586313|NCT02416453|21171163|P7|NOT COMPLETED|Overall Study||2
8586314|NCT02416453|21171164|P6|NOT COMPLETED|Overall Study||16
8586315|NCT02416453|21171165|P5|NOT COMPLETED|Overall Study||1
8586316|NCT02416453|21171166|P4|NOT COMPLETED|Overall Study||15
8586317|NCT02416453|21171167|P3|NOT COMPLETED|Overall Study||1
8586318|NCT02416453|21171168|P2|NOT COMPLETED|Overall Study||3
8586319|NCT02416453|21171169|P1|NOT COMPLETED|Overall Study||3
8586320|NCT02416453|21171159|P11|COMPLETED|Overall Study||2
8586321|NCT02416453|21171160|P10|COMPLETED|Overall Study||13
8586322|NCT02416453|21171161|P9|COMPLETED|Overall Study||13
8586323|NCT02416453|21171162|P8|COMPLETED|Overall Study||94
8586324|NCT02416453|21171163|P7|COMPLETED|Overall Study||11
8586325|NCT02416453|21171164|P6|COMPLETED|Overall Study||98
8586326|NCT02416453|21171165|P5|COMPLETED|Overall Study||12
8586327|NCT02416453|21171166|P4|COMPLETED|Overall Study||97
8586328|NCT02416453|21171167|P3|COMPLETED|Overall Study||9
8586329|NCT02416453|21171168|P2|COMPLETED|Overall Study||7
8586330|NCT02416453|21171169|P1|COMPLETED|Overall Study||7
8586331|NCT02416453|21171159|P11|STARTED|Overall Study||2
8586332|NCT02416453|21171160|P10|STARTED|Overall Study||13
8586333|NCT02416453|21171161|P9|STARTED|Overall Study||18
8586334|NCT02416453|21171162|P8|STARTED|Overall Study||106
8586335|NCT02416453|21171163|P7|STARTED|Overall Study||13
8586336|NCT02416453|21171164|P6|STARTED|Overall Study||114
8586337|NCT02416453|21171165|P5|STARTED|Overall Study||13
8586338|NCT02416453|21171166|P4|STARTED|Overall Study||112
8586339|NCT02416453|21171167|P3|STARTED|Overall Study||10
8586340|NCT02416453|21171168|P2|STARTED|Overall Study||10
8586341|NCT02416453|21171169|P1|STARTED|Overall Study||10
8586444|NCT02394548|21171413|P1|NOT COMPLETED|Overall Study||1
8586445|NCT02394548|21171413|P1|COMPLETED|Overall Study||25
8586446|NCT02394548|21171413|P1|STARTED|Overall Study||26
8586501|NCT02346708|21171574|P2|NOT COMPLETED|Overall Study||1
8586502|NCT02346708|21171575|P1|NOT COMPLETED|Overall Study||2
8586503|NCT02346708|21171574|P2|COMPLETED|Overall Study||24
8586504|NCT02346708|21171575|P1|COMPLETED|Overall Study||22
8586505|NCT02346708|21171574|P2|STARTED|Overall Study||25
8586506|NCT02346708|21171575|P1|STARTED|Overall Study||24
8586524|NCT02303704|21171692|P2|NOT COMPLETED|Overall Study||9
8586525|NCT02303704|21171693|P1|NOT COMPLETED|Overall Study||5
8586526|NCT02303704|21171692|P2|COMPLETED|Overall Study||219
8586527|NCT02303704|21171693|P1|COMPLETED|Overall Study||215
8586528|NCT02303704|21171692|P2|STARTED|Overall Study||228
8586529|NCT02303704|21171693|P1|STARTED|Overall Study||220
8586530|NCT02303184|21171711|P2|NOT COMPLETED|Overall Study||0
8586531|NCT02303184|21171712|P1|NOT COMPLETED|Overall Study||0
8586532|NCT02303184|21171711|P2|COMPLETED|Overall Study||23
8586533|NCT02303184|21171712|P1|COMPLETED|Overall Study||23
8586534|NCT02303184|21171711|P2|STARTED|Overall Study||23
8586535|NCT02303184|21171712|P1|STARTED|Overall Study||23
8586566|NCT02255032|21171789|P2|NOT COMPLETED|Overall Study||0
8586567|NCT02255032|21171790|P1|NOT COMPLETED|Overall Study||0
8586568|NCT02255032|21171789|P2|COMPLETED|Overall Study||5
8586569|NCT02255032|21171790|P1|COMPLETED|Overall Study||17
8586570|NCT02255032|21171789|P2|STARTED|Overall Study||5
8586571|NCT02255032|21171790|P1|STARTED|Overall Study||17
8586581|NCT02225665|21171835|P2|NOT COMPLETED|Overall Study||1
8586582|NCT02225665|21171836|P1|NOT COMPLETED|Overall Study||1
8586583|NCT02225665|21171835|P2|COMPLETED|Overall Study||4
8586584|NCT02225665|21171836|P1|COMPLETED|Overall Study||2
8586585|NCT02225665|21171835|P2|STARTED|Overall Study||5
8586586|NCT02225665|21171836|P1|STARTED|Overall Study||3
8586647|NCT02176382|21171948|P2|NOT COMPLETED|DATA-HD Extension||0
8586648|NCT02176382|21171949|P1|NOT COMPLETED|DATA-HD Extension||1
8586649|NCT02176382|21171948|P2|COMPLETED|DATA-HD Extension||26
8586650|NCT02176382|21171949|P1|COMPLETED|DATA-HD Extension||26
8586651|NCT02176382|21171948|P2|STARTED|DATA-HD Extension||26
8586652|NCT02176382|21171949|P1|STARTED|DATA-HD Extension||27
8586653|NCT02176382|21171948|P2|NOT COMPLETED|DATA-HD Study||8
8586654|NCT02176382|21171949|P1|NOT COMPLETED|DATA-HD Study||8
8586655|NCT02176382|21171948|P2|COMPLETED|DATA-HD Study||29
8586656|NCT02176382|21171949|P1|COMPLETED|DATA-HD Study||31
8586657|NCT02176382|21171948|P2|STARTED|DATA-HD Study||37
8586658|NCT02176382|21171949|P1|STARTED|DATA-HD Study||39
8586659|NCT02154672|21171955|P1|NOT COMPLETED|Overall Study||0
8586660|NCT02154672|21171955|P1|COMPLETED|Overall Study||1
8586661|NCT02154672|21171955|P1|STARTED|Overall Study||1
8586680|NCT02110121|21172001|P2|NOT COMPLETED|Overall Study||0
8586681|NCT02110121|21172002|P1|NOT COMPLETED|Overall Study||16
8586682|NCT02110121|21172001|P2|COMPLETED|Overall Study||5
8586683|NCT02110121|21172002|P1|COMPLETED|Overall Study||42
8586684|NCT02110121|21172001|P2|STARTED|Overall Study||5
8586685|NCT02110121|21172002|P1|STARTED|Overall Study||58
8586689|NCT02095678|21172019|P2|NOT COMPLETED|Overall Study||18
8586690|NCT02095678|21172020|P1|NOT COMPLETED|Overall Study||17
8586691|NCT02095678|21172019|P2|COMPLETED|Overall Study||0
8586692|NCT02095678|21172020|P1|COMPLETED|Overall Study||17
8586693|NCT02095678|21172019|P2|STARTED|Overall Study||18
8586694|NCT02095678|21172020|P1|STARTED|Overall Study||34
8586698|NCT02053077|21172043|P1|NOT COMPLETED|Overall Study||0
8586699|NCT02053077|21172043|P1|COMPLETED|Overall Study||150
8586700|NCT02053077|21172043|P1|STARTED|Overall Study||150
8586758|NCT01912274|21172203|P1|NOT COMPLETED|Overall Study||0
8586759|NCT01912274|21172203|P1|COMPLETED|Overall Study||50
8586760|NCT01912274|21172203|P1|STARTED|Overall Study||50
8586847|NCT01745211|21172522|P1|NOT COMPLETED|Overall Study||18
8586848|NCT01745211|21172522|P1|COMPLETED|Overall Study||27
8586849|NCT01745211|21172522|P1|STARTED|Overall Study||45
8586850|NCT01717053|21172526|P1|NOT COMPLETED|Overall Study||4
8586851|NCT01717053|21172526|P1|COMPLETED|Overall Study||33
8586852|NCT01717053|21172526|P1|STARTED|Overall Study||37
8586888|NCT01701674|21172578|P1|NOT COMPLETED|Overall Study||1
8586889|NCT01701674|21172578|P1|COMPLETED|Overall Study||12
8586890|NCT01701674|21172578|P1|STARTED|Overall Study||13
8586960|NCT01627288|21172710|P4|NOT COMPLETED|Overall Study||0
8586961|NCT01627288|21172711|P3|NOT COMPLETED|Overall Study||0
8586962|NCT01627288|21172712|P2|NOT COMPLETED|Overall Study||0
8586963|NCT01627288|21172713|P1|NOT COMPLETED|Overall Study||0
8586964|NCT01627288|21172710|P4|COMPLETED|Overall Study||0
8586965|NCT01627288|21172711|P3|COMPLETED|Overall Study||6
8586966|NCT01627288|21172712|P2|COMPLETED|Overall Study||3
8586967|NCT01627288|21172713|P1|COMPLETED|Overall Study||3
8586968|NCT01627288|21172710|P4|STARTED|Overall Study||0
8586969|NCT01627288|21172711|P3|STARTED|Overall Study||6
8586970|NCT01627288|21172712|P2|STARTED|Overall Study||3
8586971|NCT01627288|21172713|P1|STARTED|Overall Study||3
8586981|NCT01557751|21172772|P1|NOT COMPLETED|Overall Study||3
8586982|NCT01557751|21172772|P1|COMPLETED|Overall Study||153
8586983|NCT01557751|21172772|P1|STARTED|Overall Study||156
8586990|NCT01532687|21172795|P2|NOT COMPLETED|Overall Study||2
8586991|NCT01532687|21172796|P1|NOT COMPLETED|Overall Study||14
8586992|NCT01532687|21172795|P2|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
8586993|NCT01532687|21172796|P1|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
8586994|NCT01532687|21172795|P2|Crossover to Open-label Pazopanib|Overall Study||14
8586995|NCT01532687|21172796|P1|Crossover to Open-label Pazopanib|Overall Study||0
8586996|NCT01532687|21172795|P2|STARTED|Overall Study||25
8586997|NCT01532687|21172796|P1|STARTED|Overall Study||29
8586998|NCT01515319|21172818|P10|NOT COMPLETED|Overall Study||0
8586999|NCT01515319|21172819|P9|NOT COMPLETED|Overall Study||5
8587000|NCT01515319|21172820|P8|NOT COMPLETED|Overall Study||0
8587001|NCT01515319|21172821|P7|NOT COMPLETED|Overall Study||1
8587002|NCT01515319|21172822|P6|NOT COMPLETED|Overall Study||0
8587003|NCT01515319|21172823|P5|NOT COMPLETED|Overall Study||0
8587004|NCT01515319|21172824|P4|NOT COMPLETED|Overall Study||0
8587005|NCT01515319|21172825|P3|NOT COMPLETED|Overall Study||0
8587006|NCT01515319|21172826|P2|NOT COMPLETED|Overall Study||0
8587007|NCT01515319|21172827|P1|NOT COMPLETED|Overall Study||0
8587008|NCT01515319|21172818|P10|COMPLETED|Overall Study||8
8587009|NCT01515319|21172819|P9|COMPLETED|Overall Study||9
8587010|NCT01515319|21172820|P8|COMPLETED|Overall Study||6
8587011|NCT01515319|21172821|P7|COMPLETED|Overall Study||9
8587012|NCT01515319|21172822|P6|COMPLETED|Overall Study||6
8587013|NCT01515319|21172823|P5|COMPLETED|Overall Study||6
8587014|NCT01515319|21172824|P4|COMPLETED|Overall Study||6
8587015|NCT01515319|21172825|P3|COMPLETED|Overall Study||6
8587016|NCT01515319|21172826|P2|COMPLETED|Overall Study||3
8587017|NCT01515319|21172827|P1|COMPLETED|Overall Study||3
8587018|NCT01515319|21172818|P10|STARTED|Overall Study||8
8587019|NCT01515319|21172819|P9|STARTED|Overall Study||14
8587020|NCT01515319|21172820|P8|STARTED|Overall Study||6
8587021|NCT01515319|21172821|P7|STARTED|Overall Study||10
8587022|NCT01515319|21172822|P6|STARTED|Overall Study||6
8587023|NCT01515319|21172823|P5|STARTED|Overall Study||6
8587024|NCT01515319|21172824|P4|STARTED|Overall Study||6
8587025|NCT01515319|21172825|P3|STARTED|Overall Study||6
8587026|NCT01515319|21172826|P2|STARTED|Overall Study||3
8587027|NCT01515319|21172827|P1|STARTED|Overall Study||3
8587042|NCT01425203|21172906|P3|NOT COMPLETED|Follow-up Phase||0
8587043|NCT01425203|21172907|P2|NOT COMPLETED|Follow-up Phase||0
8587044|NCT01425203|21172908|P1|NOT COMPLETED|Follow-up Phase||0
8587045|NCT01425203|21172906|P3|COMPLETED|Follow-up Phase||27
8587046|NCT01425203|21172907|P2|COMPLETED|Follow-up Phase||49
8587047|NCT01425203|21172908|P1|COMPLETED|Follow-up Phase||153
8587048|NCT01425203|21172906|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
8587049|NCT01425203|21172907|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
8587050|NCT01425203|21172908|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
8587051|NCT01425203|21172906|P3|NOT COMPLETED|Crossover Phase||6
8587052|NCT01425203|21172907|P2|NOT COMPLETED|Crossover Phase||0
8587053|NCT01425203|21172908|P1|NOT COMPLETED|Crossover Phase||0
8587054|NCT01425203|21172906|P3|COMPLETED|Crossover Phase||21
8587055|NCT01425203|21172907|P2|COMPLETED|Crossover Phase||0
8587056|NCT01425203|21172908|P1|COMPLETED|Crossover Phase||0
8587057|NCT01425203|21172906|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
8587058|NCT01425203|21172907|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
8587059|NCT01425203|21172908|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
8587060|NCT01425203|21172906|P3|NOT COMPLETED|Treatment Phase||0
8587061|NCT01425203|21172907|P2|NOT COMPLETED|Treatment Phase||37
8587062|NCT01425203|21172908|P1|NOT COMPLETED|Treatment Phase||27
8587063|NCT01425203|21172906|P3|COMPLETED|Treatment Phase||0
8587064|NCT01425203|21172907|P2|COMPLETED|Treatment Phase||42
8587065|NCT01425203|21172908|P1|COMPLETED|Treatment Phase||132
8587066|NCT01425203|21172906|P3|Treated (FAS)|Treatment Phase||0
8587067|NCT01425203|21172907|P2|Treated (FAS)|Treatment Phase||78
8587068|NCT01425203|21172908|P1|Treated (FAS)|Treatment Phase||159
8587069|NCT01425203|21172906|P3|STARTED|Treatment Phase||0
8587070|NCT01425203|21172907|P2|STARTED|Treatment Phase||79
8587071|NCT01425203|21172908|P1|STARTED|Treatment Phase||159
8587131|NCT01233518|21173147|P1|NOT COMPLETED|Overall Study||33
8587132|NCT01233518|21173147|P1|COMPLETED|Overall Study||252
8587133|NCT01233518|21173147|P1|STARTED|Overall Study||285
8587155|NCT01170715|21173183|P1|NOT COMPLETED|Overall Study||7
8587156|NCT01170715|21173183|P1|COMPLETED|Overall Study||14
8587157|NCT01170715|21173183|P1|STARTED|Overall Study||21
8587170|NCT01167712|21173308|P2|NOT COMPLETED|Overall Study||0
8587171|NCT01167712|21173309|P1|NOT COMPLETED|Overall Study||0
8587172|NCT01167712|21173308|P2|COMPLETED|Overall Study||346
8587173|NCT01167712|21173309|P1|COMPLETED|Overall Study||346
8587174|NCT01167712|21173308|P2|STARTED|Overall Study||346
8587175|NCT01167712|21173309|P1|STARTED|Overall Study||346
8587182|NCT01150838|21173453|P6|NOT COMPLETED|Overall Study||0
8587183|NCT01150838|21173454|P5|NOT COMPLETED|Overall Study||0
8587184|NCT01150838|21173455|P4|NOT COMPLETED|Overall Study||0
8587185|NCT01150838|21173456|P3|NOT COMPLETED|Overall Study||0
8587186|NCT01150838|21173457|P2|NOT COMPLETED|Overall Study||0
8587187|NCT01150838|21173458|P1|NOT COMPLETED|Overall Study||0
8587188|NCT01150838|21173453|P6|COMPLETED|Overall Study||2
8587189|NCT01150838|21173454|P5|COMPLETED|Overall Study||16
8587190|NCT01150838|21173455|P4|COMPLETED|Overall Study||15
8587191|NCT01150838|21173456|P3|COMPLETED|Overall Study||24
8587192|NCT01150838|21173457|P2|COMPLETED|Overall Study||26
8587193|NCT01150838|21173458|P1|COMPLETED|Overall Study||19
8587194|NCT01150838|21173453|P6|STARTED|Overall Study||2
8587195|NCT01150838|21173454|P5|STARTED|Overall Study||16
8587196|NCT01150838|21173455|P4|STARTED|Overall Study||15
8587197|NCT01150838|21173456|P3|STARTED|Overall Study||24
8587198|NCT01150838|21173457|P2|STARTED|Overall Study||26
8587199|NCT01150838|21173458|P1|STARTED|Overall Study||19
8587200|NCT01146795|21173466|P1|NOT COMPLETED|Overall Study||20
8587201|NCT01146795|21173466|P1|COMPLETED|Overall Study||12
8587202|NCT01146795|21173466|P1|STARTED|Overall Study||32
8587843|NCT01065454|21173544|P4|NOT COMPLETED|Follow up||44
8587844|NCT01065454|21173545|P3|NOT COMPLETED|Follow up||17
8587845|NCT01065454|21173546|P2|NOT COMPLETED|Follow up||24
8587846|NCT01065454|21173547|P1|NOT COMPLETED|Follow up||39
8587847|NCT01065454|21173544|P4|COMPLETED|Follow up||13
8587848|NCT01065454|21173545|P3|COMPLETED|Follow up||6
8587849|NCT01065454|21173546|P2|COMPLETED|Follow up||4
8587850|NCT01065454|21173547|P1|COMPLETED|Follow up||15
8587851|NCT01065454|21173544|P4|Entering Follow-up|Follow up||51
8587852|NCT01065454|21173545|P3|Entering Follow-up|Follow up||23
8587853|NCT01065454|21173546|P2|Entering Follow-up|Follow up||27
8587854|NCT01065454|21173547|P1|Entering Follow-up|Follow up||49
8587855|NCT01065454|21173544|P4|STARTED|Follow up||57
8587856|NCT01065454|21173545|P3|STARTED|Follow up||23
8587857|NCT01065454|21173546|P2|STARTED|Follow up||28
8587858|NCT01065454|21173547|P1|STARTED|Follow up||54
8587859|NCT01065454|21173544|P4|NOT COMPLETED|Treatment||12
8587860|NCT01065454|21173545|P3|NOT COMPLETED|Treatment||9
8587861|NCT01065454|21173546|P2|NOT COMPLETED|Treatment||5
8587862|NCT01065454|21173547|P1|NOT COMPLETED|Treatment||13
8587863|NCT01065454|21173544|P4|COMPLETED|Treatment||57
8587864|NCT01065454|21173545|P3|COMPLETED|Treatment||23
8587865|NCT01065454|21173546|P2|COMPLETED|Treatment||28
8587866|NCT01065454|21173547|P1|COMPLETED|Treatment||54
8587867|NCT01065454|21173544|P4|STARTED|Treatment||69
8587868|NCT01065454|21173545|P3|STARTED|Treatment||32
8587869|NCT01065454|21173546|P2|STARTED|Treatment||33
8587870|NCT01065454|21173547|P1|STARTED|Treatment||67
8587916|NCT01023035|21173687|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
8587917|NCT01023035|21173688|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
8587918|NCT01023035|21173689|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
8587919|NCT01023035|21173687|P3|COMPLETED|Follow-up Period (up to Week 72)||108
8587920|NCT01023035|21173688|P2|COMPLETED|Follow-up Period (up to Week 72)||207
8587921|NCT01023035|21173689|P1|COMPLETED|Follow-up Period (up to Week 72)||210
8587922|NCT01023035|21173687|P3|STARTED|Follow-up Period (up to Week 72)||147
8587923|NCT01023035|21173688|P2|STARTED|Follow-up Period (up to Week 72)||235
8587924|NCT01023035|21173689|P1|STARTED|Follow-up Period (up to Week 72)||238
8587925|NCT01023035|21173687|P3|NOT COMPLETED|Treatment Period||118
8587926|NCT01023035|21173688|P2|NOT COMPLETED|Treatment Period||85
8587927|NCT01023035|21173689|P1|NOT COMPLETED|Treatment Period||72
8587928|NCT01023035|21173687|P3|COMPLETED|Treatment Period||69
8587929|NCT01023035|21173688|P2|COMPLETED|Treatment Period||166
8587930|NCT01023035|21173689|P1|COMPLETED|Treatment Period||177
8587931|NCT01023035|21173687|P3|STARTED|Treatment Period||187
8587932|NCT01023035|21173688|P2|STARTED|Treatment Period||251
8587933|NCT01023035|21173689|P1|STARTED|Treatment Period||249
8587943|NCT00977574|21173727|P3|NOT COMPLETED|Overall Study||4
8587944|NCT00977574|21173728|P2|NOT COMPLETED|Overall Study||2
8587945|NCT00977574|21173729|P1|NOT COMPLETED|Overall Study||4
8587946|NCT00977574|21173727|P3|COMPLETED|Overall Study||114
8587947|NCT00977574|21173728|P2|COMPLETED|Overall Study||113
8587948|NCT00977574|21173729|P1|COMPLETED|Overall Study||112
8587949|NCT00977574|21173727|P3|STARTED|Overall Study||118
8587950|NCT00977574|21173728|P2|STARTED|Overall Study||115
8587951|NCT00977574|21173729|P1|STARTED|Overall Study||116
8587952|NCT00960804|21173749|P3|NOT COMPLETED|Overall Study||10
8587953|NCT00960804|21173750|P2|NOT COMPLETED|Overall Study||4
8587954|NCT00960804|21173751|P1|NOT COMPLETED|Overall Study||7
8587955|NCT00960804|21173749|P3|COMPLETED|Overall Study||0
8587956|NCT00960804|21173750|P2|COMPLETED|Overall Study||0
8587957|NCT00960804|21173751|P1|COMPLETED|Overall Study||0
8587958|NCT00960804|21173749|P3|STARTED|Overall Study||10
8587959|NCT00960804|21173750|P2|STARTED|Overall Study||4
8587960|NCT00960804|21173751|P1|STARTED|Overall Study||7
8587976|NCT00944528|21173852|P3|NOT COMPLETED|Overall Study||0
8587977|NCT00944528|21173853|P2|NOT COMPLETED|Overall Study||2
8587978|NCT00944528|21173854|P1|NOT COMPLETED|Overall Study||1
8587979|NCT00944528|21173852|P3|COMPLETED|Overall Study||16
8587980|NCT00944528|21173853|P2|COMPLETED|Overall Study||8
8587981|NCT00944528|21173854|P1|COMPLETED|Overall Study||8
8587982|NCT00944528|21173852|P3|STARTED|Overall Study||16
8587983|NCT00944528|21173853|P2|STARTED|Overall Study||10
8587984|NCT00944528|21173854|P1|STARTED|Overall Study||9
8587985|NCT00943761|21173868|P2|NOT COMPLETED|Overall Study||1
8587986|NCT00943761|21173869|P1|NOT COMPLETED|Overall Study||4
8587987|NCT00943761|21173868|P2|COMPLETED|Overall Study||23
8587988|NCT00943761|21173869|P1|COMPLETED|Overall Study||17
8587989|NCT00943761|21173868|P2|STARTED|Overall Study||24
8587990|NCT00943761|21173869|P1|STARTED|Overall Study||21
8588021|NCT00942331|21173920|P2|NOT COMPLETED|Overall Study||22
8588022|NCT00942331|21173921|P1|NOT COMPLETED|Overall Study||15
8588023|NCT00942331|21173920|P2|COMPLETED|Overall Study||232
8588024|NCT00942331|21173921|P1|COMPLETED|Overall Study||237
8588025|NCT00942331|21173920|P2|STARTED|Overall Study||254
8588026|NCT00942331|21173921|P1|STARTED|Overall Study||252
8588033|NCT00910624|21173946|P4|NOT COMPLETED|Follow-Up Phase||0
8588034|NCT00910624|21173947|P3|NOT COMPLETED|Follow-Up Phase||4
8588035|NCT00910624|21173948|P2|NOT COMPLETED|Follow-Up Phase||4
8588036|NCT00910624|21173949|P1|NOT COMPLETED|Follow-Up Phase||6
8588037|NCT00910624|21173946|P4|COMPLETED|Follow-Up Phase||2
8588038|NCT00910624|21173947|P3|COMPLETED|Follow-Up Phase||25
8588039|NCT00910624|21173948|P2|COMPLETED|Follow-Up Phase||76
8588040|NCT00910624|21173949|P1|COMPLETED|Follow-Up Phase||42
8588041|NCT00910624|21173946|P4|STARTED|Follow-Up Phase||2
8588042|NCT00910624|21173947|P3|STARTED|Follow-Up Phase||29
8588043|NCT00910624|21173948|P2|STARTED|Follow-Up Phase||80
8588044|NCT00910624|21173949|P1|STARTED|Follow-Up Phase||48
8588045|NCT00910624|21173946|P4|NOT COMPLETED|Treatment Phase||0
8588046|NCT00910624|21173947|P3|NOT COMPLETED|Treatment Phase||9
8588047|NCT00910624|21173948|P2|NOT COMPLETED|Treatment Phase||21
8588048|NCT00910624|21173949|P1|NOT COMPLETED|Treatment Phase||30
8588049|NCT00910624|21173946|P4|COMPLETED|Treatment Phase||2
8588050|NCT00910624|21173947|P3|COMPLETED|Treatment Phase||20
8588051|NCT00910624|21173948|P2|COMPLETED|Treatment Phase||64
8588052|NCT00910624|21173949|P1|COMPLETED|Treatment Phase||22
8588053|NCT00910624|21173946|P4|STARTED|Treatment Phase||2
8588054|NCT00910624|21173947|P3|STARTED|Treatment Phase||29
8588055|NCT00910624|21173948|P2|STARTED|Treatment Phase||85
8588056|NCT00910624|21173949|P1|STARTED|Treatment Phase||52
8588057|NCT00861705|21173965|P4|NOT COMPLETED|Overall Study||1
8588058|NCT00861705|21173966|P3|NOT COMPLETED|Overall Study||0
8588059|NCT00861705|21173967|P2|NOT COMPLETED|Overall Study||3
8588060|NCT00861705|21173968|P1|NOT COMPLETED|Overall Study||7
8588061|NCT00861705|21173965|P4|COMPLETED|Overall Study||112
8588062|NCT00861705|21173966|P3|COMPLETED|Overall Study||113
8588063|NCT00861705|21173967|P2|COMPLETED|Overall Study||110
8588064|NCT00861705|21173968|P1|COMPLETED|Overall Study||108
8588065|NCT00861705|21173965|P4|STARTED|Overall Study||113
8588066|NCT00861705|21173966|P3|STARTED|Overall Study||113
8588067|NCT00861705|21173967|P2|STARTED|Overall Study||113
8588068|NCT00861705|21173968|P1|STARTED|Overall Study||115
8588099|NCT00785291|21174068|P3|NOT COMPLETED|Overall Study||106
8588100|NCT00785291|21174069|P2|NOT COMPLETED|Overall Study||149
8588101|NCT00785291|21174070|P1|NOT COMPLETED|Overall Study||136
8588102|NCT00785291|21174068|P3|COMPLETED|Overall Study||139
8588103|NCT00785291|21174069|P2|COMPLETED|Overall Study||122
8588104|NCT00785291|21174070|P1|COMPLETED|Overall Study||147
8588105|NCT00785291|21174068|P3|STARTED|Overall Study||245
8588106|NCT00785291|21174069|P2|STARTED|Overall Study||271
8588107|NCT00785291|21174070|P1|STARTED|Overall Study||283
8588108|NCT00768664|21174090|P1|NOT COMPLETED|Overall Study||69
8588109|NCT00768664|21174090|P1|COMPLETED|Overall Study||0
8588110|NCT00768664|21174090|P1|STARTED|Overall Study||69
8588135|NCT00654940|21174270|P2|NOT COMPLETED|Period 2||0
8588136|NCT00654940|21174271|P1|NOT COMPLETED|Period 2||0
8588137|NCT00654940|21174270|P2|COMPLETED|Period 2||11
8588138|NCT00654940|21174271|P1|COMPLETED|Period 2||12
8588139|NCT00654940|21174270|P2|STARTED|Period 2||11
8588140|NCT00654940|21174271|P1|STARTED|Period 2||12
8588141|NCT00654940|21174270|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8588142|NCT00654940|21174271|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8588143|NCT00654940|21174270|P2|COMPLETED|Washout Period of 2 Weeks||11
8588144|NCT00654940|21174271|P1|COMPLETED|Washout Period of 2 Weeks||12
8588145|NCT00654940|21174270|P2|STARTED|Washout Period of 2 Weeks||11
8588146|NCT00654940|21174271|P1|STARTED|Washout Period of 2 Weeks||12
8588147|NCT00654940|21174270|P2|NOT COMPLETED|Period 1||1
8588148|NCT00654940|21174271|P1|NOT COMPLETED|Period 1||1
8588149|NCT00654940|21174270|P2|COMPLETED|Period 1||11
8588150|NCT00654940|21174271|P1|COMPLETED|Period 1||12
8588151|NCT00654940|21174270|P2|Received Study Treatment|Period 1||12
8588152|NCT00654940|21174271|P1|Received Study Treatment|Period 1||12
8588153|NCT00654940|21174270|P2|STARTED|Period 1|Assigned to study treatment.|12
8588154|NCT00654940|21174271|P1|STARTED|Period 1|Assigned to study treatment.|13
8588155|NCT00610116|21174283|P1|NOT COMPLETED|Overall Study||0
8588156|NCT00610116|21174283|P1|COMPLETED|Overall Study||292
8588157|NCT00610116|21174283|P1|STARTED|Overall Study||292
8588192|NCT00553358|21174331|P3|NOT COMPLETED|Overall Study||88
8588193|NCT00553358|21174332|P2|NOT COMPLETED|Overall Study||96
8588194|NCT00553358|21174333|P1|NOT COMPLETED|Overall Study||79
8588195|NCT00553358|21174331|P3|COMPLETED|Overall Study||61
8588196|NCT00553358|21174332|P2|COMPLETED|Overall Study||58
8588197|NCT00553358|21174333|P1|COMPLETED|Overall Study||73
8588198|NCT00553358|21174331|P3|STARTED|Overall Study||149
8588199|NCT00553358|21174332|P2|STARTED|Overall Study||154
8588200|NCT00553358|21174333|P1|STARTED|Overall Study||152
8588225|NCT00467272|21174567|P1|NOT COMPLETED|Overall Study||3
8588226|NCT00467272|21174567|P1|COMPLETED|Overall Study||38
8588227|NCT00467272|21174567|P1|STARTED|Overall Study||41
8588288|NCT00437034|21174909|P1|NOT COMPLETED|Overall Study||6
8588289|NCT00437034|21174909|P1|COMPLETED|Overall Study||0
8588290|NCT00437034|21174909|P1|STARTED|Overall Study||6
8588311|NCT00408005|21175027|P8|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
8588312|NCT00408005|21175028|P7|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
8588313|NCT00408005|21175029|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
8588314|NCT00408005|21175030|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
8588315|NCT00408005|21175031|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
8588316|NCT00408005|21175032|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
8588317|NCT00408005|21175033|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
8588318|NCT00408005|21175034|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
8588319|NCT00408005|21175027|P8|COMPLETED|Post Induction Therapy by Tx Assignment||48
8588320|NCT00408005|21175028|P7|COMPLETED|Post Induction Therapy by Tx Assignment||115
8588321|NCT00408005|21175029|P6|COMPLETED|Post Induction Therapy by Tx Assignment||118
8588322|NCT00408005|21175030|P5|COMPLETED|Post Induction Therapy by Tx Assignment||319
8588323|NCT00408005|21175031|P4|COMPLETED|Post Induction Therapy by Tx Assignment||103
8588324|NCT00408005|21175032|P3|COMPLETED|Post Induction Therapy by Tx Assignment||287
8588325|NCT00408005|21175033|P2|COMPLETED|Post Induction Therapy by Tx Assignment||0
8588326|NCT00408005|21175034|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
8588327|NCT00408005|21175027|P8|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
8588328|NCT00408005|21175028|P7|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8588329|NCT00408005|21175029|P6|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8588330|NCT00408005|21175030|P5|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8588331|NCT00408005|21175031|P4|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8588332|NCT00408005|21175032|P3|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8588333|NCT00408005|21175033|P2|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8588334|NCT00408005|21175034|P1|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8588335|NCT00408005|21175027|P8|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
8588336|NCT00408005|21175028|P7|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
8588337|NCT00408005|21175029|P6|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8588338|NCT00408005|21175030|P5|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8588339|NCT00408005|21175031|P4|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8588340|NCT00408005|21175032|P3|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8588341|NCT00408005|21175033|P2|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8588342|NCT00408005|21175034|P1|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8588343|NCT00408005|21175027|P8|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8588344|NCT00408005|21175028|P7|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
8588345|NCT00408005|21175029|P6|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8588346|NCT00408005|21175030|P5|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8588347|NCT00408005|21175031|P4|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8588348|NCT00408005|21175032|P3|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8588349|NCT00408005|21175033|P2|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8588350|NCT00408005|21175034|P1|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8588351|NCT00408005|21175027|P8|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8588352|NCT00408005|21175028|P7|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8588353|NCT00408005|21175029|P6|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
8588354|NCT00408005|21175030|P5|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8588355|NCT00408005|21175031|P4|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8588356|NCT00408005|21175032|P3|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8588357|NCT00408005|21175033|P2|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8588358|NCT00408005|21175034|P1|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8588359|NCT00408005|21175027|P8|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8588360|NCT00408005|21175028|P7|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8588361|NCT00408005|21175029|P6|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
8588362|NCT00408005|21175030|P5|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
8588363|NCT00408005|21175031|P4|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8588364|NCT00408005|21175032|P3|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8588365|NCT00408005|21175033|P2|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8588366|NCT00408005|21175034|P1|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8588367|NCT00408005|21175027|P8|High Risk|Post Induction Therapy by Tx Assignment||0
8588368|NCT00408005|21175028|P7|High Risk|Post Induction Therapy by Tx Assignment||0
8588369|NCT00408005|21175029|P6|High Risk|Post Induction Therapy by Tx Assignment||52
8588370|NCT00408005|21175030|P5|High Risk|Post Induction Therapy by Tx Assignment||55
8588371|NCT00408005|21175031|P4|High Risk|Post Induction Therapy by Tx Assignment||52
8588372|NCT00408005|21175032|P3|High Risk|Post Induction Therapy by Tx Assignment||56
8588373|NCT00408005|21175033|P2|High Risk|Post Induction Therapy by Tx Assignment||0
8588374|NCT00408005|21175034|P1|High Risk|Post Induction Therapy by Tx Assignment||0
8588375|NCT00408005|21175027|P8|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8588376|NCT00408005|21175028|P7|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8588377|NCT00408005|21175029|P6|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
8588378|NCT00408005|21175030|P5|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
8588379|NCT00408005|21175031|P4|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
8588380|NCT00408005|21175032|P3|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
8588381|NCT00408005|21175033|P2|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8588382|NCT00408005|21175034|P1|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8588383|NCT00408005|21175027|P8|Low Risk|Post Induction Therapy by Tx Assignment||0
8588384|NCT00408005|21175028|P7|Low Risk|Post Induction Therapy by Tx Assignment||0
8588385|NCT00408005|21175029|P6|Low Risk|Post Induction Therapy by Tx Assignment||0
8588386|NCT00408005|21175030|P5|Low Risk|Post Induction Therapy by Tx Assignment||55
8588387|NCT00408005|21175031|P4|Low Risk|Post Induction Therapy by Tx Assignment||0
8588388|NCT00408005|21175032|P3|Low Risk|Post Induction Therapy by Tx Assignment||217
8588389|NCT00408005|21175033|P2|Low Risk|Post Induction Therapy by Tx Assignment||0
8588390|NCT00408005|21175034|P1|Low Risk|Post Induction Therapy by Tx Assignment||0
8588391|NCT00408005|21175027|P8|STARTED|Post Induction Therapy by Tx Assignment||62
8588392|NCT00408005|21175028|P7|STARTED|Post Induction Therapy by Tx Assignment||143
8588393|NCT00408005|21175029|P6|STARTED|Post Induction Therapy by Tx Assignment||219
8588394|NCT00408005|21175030|P5|STARTED|Post Induction Therapy by Tx Assignment||451
8588395|NCT00408005|21175031|P4|STARTED|Post Induction Therapy by Tx Assignment||147
8588396|NCT00408005|21175032|P3|STARTED|Post Induction Therapy by Tx Assignment||372
8588397|NCT00408005|21175033|P2|STARTED|Post Induction Therapy by Tx Assignment||0
8588398|NCT00408005|21175034|P1|STARTED|Post Induction Therapy by Tx Assignment||0
8588399|NCT00408005|21175027|P8|NOT COMPLETED|Induction||0
8588400|NCT00408005|21175028|P7|NOT COMPLETED|Induction||0
8588401|NCT00408005|21175029|P6|NOT COMPLETED|Induction||0
8588402|NCT00408005|21175030|P5|NOT COMPLETED|Induction||0
8588403|NCT00408005|21175031|P4|NOT COMPLETED|Induction||0
8588404|NCT00408005|21175032|P3|NOT COMPLETED|Induction||0
8588405|NCT00408005|21175033|P2|NOT COMPLETED|Induction||94
8588406|NCT00408005|21175034|P1|NOT COMPLETED|Induction||407
8588407|NCT00408005|21175027|P8|COMPLETED|Induction||0
8588408|NCT00408005|21175028|P7|COMPLETED|Induction||0
8588409|NCT00408005|21175029|P6|COMPLETED|Induction||0
8588410|NCT00408005|21175030|P5|COMPLETED|Induction||0
8588411|NCT00408005|21175031|P4|COMPLETED|Induction||0
8588412|NCT00408005|21175032|P3|COMPLETED|Induction||0
8588413|NCT00408005|21175033|P2|COMPLETED|Induction||205
8588414|NCT00408005|21175034|P1|COMPLETED|Induction||1189
8588415|NCT00408005|21175027|P8|STARTED|Induction||0
8588416|NCT00408005|21175028|P7|STARTED|Induction||0
8588417|NCT00408005|21175029|P6|STARTED|Induction||0
8588418|NCT00408005|21175030|P5|STARTED|Induction||0
8588419|NCT00408005|21175031|P4|STARTED|Induction||0
8588420|NCT00408005|21175032|P3|STARTED|Induction||0
8588421|NCT00408005|21175033|P2|STARTED|Induction||299
8588422|NCT00408005|21175034|P1|STARTED|Induction||1596
8588423|NCT00407511|21175064|P1|NOT COMPLETED|Overall Study||22
8588424|NCT00407511|21175064|P1|COMPLETED|Overall Study||99
8588425|NCT00407511|21175064|P1|STARTED|Overall Study||121
8588426|NCT00394901|21175082|P4|NOT COMPLETED|Double-blind Phase||27
8588427|NCT00394901|21175083|P3|NOT COMPLETED|Double-blind Phase||18
8588428|NCT00394901|21175084|P2|NOT COMPLETED|Double-blind Phase||14
8588429|NCT00394901|21175085|P1|NOT COMPLETED|Double-blind Phase||15
8588430|NCT00394901|21175082|P4|COMPLETED|Double-blind Phase||70
8588431|NCT00394901|21175083|P3|COMPLETED|Double-blind Phase||71
8588432|NCT00394901|21175084|P2|COMPLETED|Double-blind Phase||73
8588433|NCT00394901|21175085|P1|COMPLETED|Double-blind Phase||83
8588434|NCT00394901|21175082|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
8588435|NCT00394901|21175083|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
8588436|NCT00394901|21175084|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
8588437|NCT00394901|21175085|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
8588438|NCT00394901|21175082|P4|NOT COMPLETED|Baseline Phase||0
8588439|NCT00394901|21175083|P3|NOT COMPLETED|Baseline Phase||1
8588440|NCT00394901|21175084|P2|NOT COMPLETED|Baseline Phase||0
8588441|NCT00394901|21175085|P1|NOT COMPLETED|Baseline Phase||0
8588442|NCT00394901|21175082|P4|COMPLETED|Baseline Phase||97
8588443|NCT00394901|21175083|P3|COMPLETED|Baseline Phase||89
8588444|NCT00394901|21175084|P2|COMPLETED|Baseline Phase||87
8588445|NCT00394901|21175085|P1|COMPLETED|Baseline Phase||98
8588446|NCT00394901|21175082|P4|STARTED|Baseline Phase|Subjects randomized|97
8588447|NCT00394901|21175083|P3|STARTED|Baseline Phase|Subjects randomized|90
8588448|NCT00394901|21175084|P2|STARTED|Baseline Phase|Subjects randomized|87
8588449|NCT00394901|21175085|P1|STARTED|Baseline Phase|Subjects randomized|98
8588456|NCT00368745|21175331|P2|NOT COMPLETED|Double-blind Treatment Period||31
8588457|NCT00368745|21175332|P1|NOT COMPLETED|Double-blind Treatment Period||26
8588458|NCT00368745|21175331|P2|COMPLETED|Double-blind Treatment Period||19
8588459|NCT00368745|21175332|P1|COMPLETED|Double-blind Treatment Period||30
8588460|NCT00368745|21175331|P2|STARTED|Double-blind Treatment Period||50
8588461|NCT00368745|21175332|P1|STARTED|Double-blind Treatment Period||56
8588462|NCT00368745|21175331|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
8588463|NCT00368745|21175332|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
8588464|NCT00368745|21175331|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
8588465|NCT00368745|21175332|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
8588466|NCT00368745|21175331|P2|STARTED|Randomized to Double-blind Treatment||51
8588467|NCT00368745|21175332|P1|STARTED|Randomized to Double-blind Treatment||57
8588480|NCT00350298|21175419|P2|NOT COMPLETED|Overall Study||13
8588481|NCT00350298|21175420|P1|NOT COMPLETED|Overall Study||9
8588482|NCT00350298|21175419|P2|COMPLETED|Overall Study||86
8588483|NCT00350298|21175420|P1|COMPLETED|Overall Study||92
8588484|NCT00350298|21175419|P2|STARTED|Overall Study||99
8588485|NCT00350298|21175420|P1|STARTED|Overall Study||101
8588508|NCT00313820|21175524|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
8588509|NCT00313820|21175525|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
8588510|NCT00313820|21175524|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
8588511|NCT00313820|21175525|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
8588512|NCT00313820|21175524|P2|STARTED|Pregabalin or Placebo Treatment Period||109
8588513|NCT00313820|21175525|P1|STARTED|Pregabalin or Placebo Treatment Period||110
8588514|NCT00313820|21175524|P2|NOT COMPLETED|Assigned to Treatment||0
8588515|NCT00313820|21175525|P1|NOT COMPLETED|Assigned to Treatment||1
8588516|NCT00313820|21175524|P2|COMPLETED|Assigned to Treatment||109
8588517|NCT00313820|21175525|P1|COMPLETED|Assigned to Treatment||110
8588518|NCT00313820|21175524|P2|STARTED|Assigned to Treatment||109
8588519|NCT00313820|21175525|P1|STARTED|Assigned to Treatment||111
8588529|NCT00292188|21175724|P3|NOT COMPLETED|Double-Blind||29
8588530|NCT00292188|21175725|P2|NOT COMPLETED|Double-Blind||31
8588531|NCT00292188|21175726|P1|NOT COMPLETED|Double-Blind||0
8588532|NCT00292188|21175724|P3|COMPLETED|Double-Blind||98
8588533|NCT00292188|21175725|P2|COMPLETED|Double-Blind||96
8588534|NCT00292188|21175726|P1|COMPLETED|Double-Blind||0
8588535|NCT00292188|21175724|P3|STARTED|Double-Blind||127
8588536|NCT00292188|21175725|P2|STARTED|Double-Blind||127
8588537|NCT00292188|21175726|P1|STARTED|Double-Blind||0
8588538|NCT00292188|21175724|P3|NOT COMPLETED|Single-Blind||0
8588539|NCT00292188|21175725|P2|NOT COMPLETED|Single-Blind||0
8588540|NCT00292188|21175726|P1|NOT COMPLETED|Single-Blind||114
8588541|NCT00292188|21175724|P3|COMPLETED|Single-Blind||0
8588542|NCT00292188|21175725|P2|COMPLETED|Single-Blind||0
8588543|NCT00292188|21175726|P1|COMPLETED|Single-Blind||254
8588544|NCT00292188|21175724|P3|Received Treatment|Single-Blind||0
8588545|NCT00292188|21175725|P2|Received Treatment|Single-Blind||0
8588546|NCT00292188|21175726|P1|Received Treatment|Single-Blind||367
8588547|NCT00292188|21175724|P3|STARTED|Single-Blind||0
8588548|NCT00292188|21175725|P2|STARTED|Single-Blind||0
8588549|NCT00292188|21175726|P1|STARTED|Single-Blind||368
8588562|NCT00232141|21175809|P2|NOT COMPLETED|Overall Study||26
8588563|NCT00232141|21175810|P1|NOT COMPLETED|Overall Study||31
8588564|NCT00232141|21175809|P2|COMPLETED|Overall Study||125
8588565|NCT00232141|21175810|P1|COMPLETED|Overall Study||120
8588566|NCT00232141|21175809|P2|STARTED|Overall Study||151
8588567|NCT00232141|21175810|P1|STARTED|Overall Study||151
8588610|NCT00148733|21176052|P2|NOT COMPLETED|Overall Study||15
8588611|NCT00148733|21176053|P1|NOT COMPLETED|Overall Study||14
8588612|NCT00148733|21176052|P2|COMPLETED|Overall Study||1299
8588613|NCT00148733|21176053|P1|COMPLETED|Overall Study||1300
8588614|NCT00148733|21176052|P2|STARTED|Overall Study||1314
8588615|NCT00148733|21176053|P1|STARTED|Overall Study||1314
8588616|NCT00141219|21176061|P2|NOT COMPLETED|Overall Study||16
8588617|NCT00141219|21176062|P1|NOT COMPLETED|Overall Study||24
8588618|NCT00141219|21176061|P2|COMPLETED|Overall Study||62
8588619|NCT00141219|21176062|P1|COMPLETED|Overall Study||138
8588620|NCT00141219|21176061|P2|STARTED|Overall Study||78
8588621|NCT00141219|21176062|P1|STARTED|Overall Study||162
8588631|NCT00115076|21176140|P1|NOT COMPLETED|Overall Study||0
8588632|NCT00115076|21176140|P1|COMPLETED|Overall Study||30
8588633|NCT00115076|21176140|P1|STARTED|Overall Study||30
8588700|NCT03712852|21176269|P3|NOT COMPLETED|Overall Study||0
8588701|NCT03712852|21176270|P2|NOT COMPLETED|Overall Study||0
8588702|NCT03712852|21176271|P1|NOT COMPLETED|Overall Study||0
8588703|NCT03712852|21176269|P3|COMPLETED|Overall Study||20
8588704|NCT03712852|21176270|P2|COMPLETED|Overall Study||20
8588705|NCT03712852|21176271|P1|COMPLETED|Overall Study||20
8588706|NCT03712852|21176269|P3|STARTED|Overall Study||20
8588707|NCT03712852|21176270|P2|STARTED|Overall Study||20
8588708|NCT03712852|21176271|P1|STARTED|Overall Study||20
8588715|NCT03616600|21176308|P2|NOT COMPLETED|Overall Study||0
8588716|NCT03616600|21176309|P1|NOT COMPLETED|Overall Study||1
8588717|NCT03616600|21176308|P2|COMPLETED|Overall Study||15
8588718|NCT03616600|21176309|P1|COMPLETED|Overall Study||15
8588719|NCT03616600|21176308|P2|STARTED|Overall Study||15
8588720|NCT03616600|21176309|P1|STARTED|Overall Study||16
8588754|NCT03363854|21176440|P8|NOT COMPLETED|Safety Follow-up Period||216
8588755|NCT03363854|21176441|P7|NOT COMPLETED|Safety Follow-up Period||0
8588756|NCT03363854|21176442|P6|NOT COMPLETED|Safety Follow-up Period||0
8588757|NCT03363854|21176443|P5|NOT COMPLETED|Safety Follow-up Period||0
8588758|NCT03363854|21176444|P4|NOT COMPLETED|Safety Follow-up Period||0
8588759|NCT03363854|21176445|P3|NOT COMPLETED|Safety Follow-up Period||0
8588760|NCT03363854|21176446|P2|NOT COMPLETED|Safety Follow-up Period||0
8588761|NCT03363854|21176447|P1|NOT COMPLETED|Safety Follow-up Period||0
8588762|NCT03363854|21176440|P8|COMPLETED|Safety Follow-up Period||62
8588763|NCT03363854|21176441|P7|COMPLETED|Safety Follow-up Period||0
8588764|NCT03363854|21176442|P6|COMPLETED|Safety Follow-up Period||0
8588765|NCT03363854|21176443|P5|COMPLETED|Safety Follow-up Period||0
8588766|NCT03363854|21176444|P4|COMPLETED|Safety Follow-up Period||0
8588767|NCT03363854|21176445|P3|COMPLETED|Safety Follow-up Period||0
8588768|NCT03363854|21176446|P2|COMPLETED|Safety Follow-up Period||0
8588769|NCT03363854|21176447|P1|COMPLETED|Safety Follow-up Period||0
8588770|NCT03363854|21176440|P8|STARTED|Safety Follow-up Period||278
8588771|NCT03363854|21176441|P7|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588772|NCT03363854|21176442|P6|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588773|NCT03363854|21176443|P5|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588774|NCT03363854|21176444|P4|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588775|NCT03363854|21176445|P3|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588776|NCT03363854|21176446|P2|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
8588777|NCT03363854|21176447|P1|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
8588778|NCT03363854|21176440|P8|NOT COMPLETED|Continuation Treatment Period||0
8588779|NCT03363854|21176441|P7|NOT COMPLETED|Continuation Treatment Period||3
8588780|NCT03363854|21176442|P6|NOT COMPLETED|Continuation Treatment Period||7
8588781|NCT03363854|21176443|P5|NOT COMPLETED|Continuation Treatment Period||8
8588782|NCT03363854|21176444|P4|NOT COMPLETED|Continuation Treatment Period||4
8588783|NCT03363854|21176445|P3|NOT COMPLETED|Continuation Treatment Period||1
8588784|NCT03363854|21176446|P2|NOT COMPLETED|Continuation Treatment Period||0
8588785|NCT03363854|21176447|P1|NOT COMPLETED|Continuation Treatment Period||0
8588786|NCT03363854|21176440|P8|COMPLETED|Continuation Treatment Period||0
8588787|NCT03363854|21176441|P7|COMPLETED|Continuation Treatment Period||38
8588788|NCT03363854|21176442|P6|COMPLETED|Continuation Treatment Period||72
8588789|NCT03363854|21176443|P5|COMPLETED|Continuation Treatment Period||87
8588790|NCT03363854|21176444|P4|COMPLETED|Continuation Treatment Period||65
8588791|NCT03363854|21176445|P3|COMPLETED|Continuation Treatment Period||68
8588792|NCT03363854|21176446|P2|COMPLETED|Continuation Treatment Period||0
8588793|NCT03363854|21176447|P1|COMPLETED|Continuation Treatment Period||0
8588794|NCT03363854|21176440|P8|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
8588795|NCT03363854|21176441|P7|STARTED|Continuation Treatment Period||41
8588796|NCT03363854|21176442|P6|STARTED|Continuation Treatment Period||79
8588797|NCT03363854|21176443|P5|STARTED|Continuation Treatment Period||95
8588798|NCT03363854|21176444|P4|STARTED|Continuation Treatment Period||69
8588799|NCT03363854|21176445|P3|STARTED|Continuation Treatment Period||69
8588800|NCT03363854|21176446|P2|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
8588801|NCT03363854|21176447|P1|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
8588802|NCT03363854|21176440|P8|NOT COMPLETED|Initial Treatment Period||0
8588803|NCT03363854|21176441|P7|NOT COMPLETED|Initial Treatment Period||0
8588804|NCT03363854|21176442|P6|NOT COMPLETED|Initial Treatment Period||0
8588805|NCT03363854|21176443|P5|NOT COMPLETED|Initial Treatment Period||0
8588806|NCT03363854|21176444|P4|NOT COMPLETED|Initial Treatment Period||0
8588807|NCT03363854|21176445|P3|NOT COMPLETED|Initial Treatment Period||0
8588808|NCT03363854|21176446|P2|NOT COMPLETED|Initial Treatment Period||7
8588809|NCT03363854|21176447|P1|NOT COMPLETED|Initial Treatment Period||18
8588810|NCT03363854|21176440|P8|COMPLETED|Initial Treatment Period||0
8588811|NCT03363854|21176441|P7|COMPLETED|Initial Treatment Period||0
8588812|NCT03363854|21176442|P6|COMPLETED|Initial Treatment Period||0
8588813|NCT03363854|21176443|P5|COMPLETED|Initial Treatment Period||0
8588814|NCT03363854|21176444|P4|COMPLETED|Initial Treatment Period||0
8588815|NCT03363854|21176445|P3|COMPLETED|Initial Treatment Period||0
8588816|NCT03363854|21176446|P2|COMPLETED|Initial Treatment Period||120
8588817|NCT03363854|21176447|P1|COMPLETED|Initial Treatment Period||235
8588818|NCT03363854|21176440|P8|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
8588819|NCT03363854|21176441|P7|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588820|NCT03363854|21176442|P6|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588821|NCT03363854|21176443|P5|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588822|NCT03363854|21176444|P4|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588823|NCT03363854|21176445|P3|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588824|NCT03363854|21176446|P2|STARTED|Initial Treatment Period||127
8588825|NCT03363854|21176447|P1|STARTED|Initial Treatment Period||253
8588826|NCT03338816|21176502|P2|NOT COMPLETED|Open-Label Extension Period||47
8588827|NCT03338816|21176503|P1|NOT COMPLETED|Open-Label Extension Period||46
8588828|NCT03338816|21176502|P2|COMPLETED|Open-Label Extension Period||0
8588829|NCT03338816|21176503|P1|COMPLETED|Open-Label Extension Period||0
8588830|NCT03338816|21176502|P2|STARTED|Open-Label Extension Period||47
8588831|NCT03338816|21176503|P1|STARTED|Open-Label Extension Period||46
8588832|NCT03338816|21176502|P2|NOT COMPLETED|6-Month Double-blind Period||1
8588833|NCT03338816|21176503|P1|NOT COMPLETED|6-Month Double-blind Period||0
8588834|NCT03338816|21176502|P2|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
8588835|NCT03338816|21176503|P1|COMPLETED|6-Month Double-blind Period||46
8588836|NCT03338816|21176502|P2|STARTED|6-Month Double-blind Period||48
8588837|NCT03338816|21176503|P1|STARTED|6-Month Double-blind Period||46
8588848|NCT03280121|21176549|P1|NOT COMPLETED|Overall Study||6
8588849|NCT03280121|21176549|P1|COMPLETED|Overall Study||8
8588850|NCT03280121|21176549|P1|STARTED|Overall Study||14
8588851|NCT03274466|21176557|P2|NOT COMPLETED|Overall Study||29
8588852|NCT03274466|21176558|P1|NOT COMPLETED|Overall Study||23
8588853|NCT03274466|21176557|P2|COMPLETED|Overall Study||118
8588854|NCT03274466|21176558|P1|COMPLETED|Overall Study||124
8588855|NCT03274466|21176557|P2|STARTED|Overall Study||147
8588856|NCT03274466|21176558|P1|STARTED|Overall Study||147
8588869|NCT03224520|21176606|P4|NOT COMPLETED|Overall Study||173
8588870|NCT03224520|21176607|P3|NOT COMPLETED|Overall Study||184
8588871|NCT03224520|21176608|P2|NOT COMPLETED|Overall Study||163
8588872|NCT03224520|21176609|P1|NOT COMPLETED|Overall Study||166
8588873|NCT03224520|21176606|P4|COMPLETED|Overall Study||199
8588874|NCT03224520|21176607|P3|COMPLETED|Overall Study||190
8588875|NCT03224520|21176608|P2|COMPLETED|Overall Study||207
8588876|NCT03224520|21176609|P1|COMPLETED|Overall Study||205
8588877|NCT03224520|21176606|P4|STARTED|Overall Study||372
8588878|NCT03224520|21176607|P3|STARTED|Overall Study||374
8588879|NCT03224520|21176608|P2|STARTED|Overall Study||370
8588880|NCT03224520|21176609|P1|STARTED|Overall Study||371
8588899|NCT03106844|21176706|P1|NOT COMPLETED|Overall Study||1
8588900|NCT03106844|21176706|P1|COMPLETED|Overall Study||49
8588901|NCT03106844|21176706|P1|STARTED|Overall Study||50
8588932|NCT03057496|21176784|P1|NOT COMPLETED|Overall Study||18
8588933|NCT03057496|21176784|P1|COMPLETED|Overall Study||31
8588934|NCT03057496|21176784|P1|Started Home-use Trial|Overall Study||36
8588935|NCT03057496|21176784|P1|STARTED|Overall Study||49
8588936|NCT02981524|21176792|P1|NOT COMPLETED|Overall Study||17
8588937|NCT02981524|21176792|P1|COMPLETED|Overall Study||0
8588938|NCT02981524|21176792|P1|STARTED|Overall Study||17
8588939|NCT02980666|21176802|P2|NOT COMPLETED|Overall Study||0
8588940|NCT02980666|21176803|P1|NOT COMPLETED|Overall Study||0
8588941|NCT02980666|21176802|P2|COMPLETED|Overall Study||2
8588942|NCT02980666|21176803|P1|COMPLETED|Overall Study||8
8588943|NCT02980666|21176802|P2|STARTED|Overall Study||2
8588944|NCT02980666|21176803|P1|STARTED|Overall Study||8
8588945|NCT02949219|21176895|P1|NOT COMPLETED|Overall Study||1
8588946|NCT02949219|21176895|P1|COMPLETED|Overall Study||40
8588947|NCT02949219|21176895|P1|STARTED|Overall Study||41
8588948|NCT02940574|21176904|P2|NOT COMPLETED|1-year Follow-up||4
8588949|NCT02940574|21176905|P1|NOT COMPLETED|1-year Follow-up||3
8588950|NCT02940574|21176904|P2|COMPLETED|1-year Follow-up||14
8588951|NCT02940574|21176905|P1|COMPLETED|1-year Follow-up||18
8588952|NCT02940574|21176904|P2|STARTED|1-year Follow-up||18
8588953|NCT02940574|21176905|P1|STARTED|1-year Follow-up||21
8588954|NCT02940574|21176904|P2|NOT COMPLETED|From Study Start to 1-month Follow-up||0
8588955|NCT02940574|21176905|P1|NOT COMPLETED|From Study Start to 1-month Follow-up||1
8588956|NCT02940574|21176904|P2|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
8588957|NCT02940574|21176905|P1|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
8588958|NCT02940574|21176904|P2|STARTED|From Study Start to 1-month Follow-up||18
8588959|NCT02940574|21176905|P1|STARTED|From Study Start to 1-month Follow-up||22
8589002|NCT02890355|21177045|P2|NOT COMPLETED|Overall Study||58
8589003|NCT02890355|21177046|P1|NOT COMPLETED|Overall Study||59
8589004|NCT02890355|21177045|P2|COMPLETED|Overall Study||0
8589005|NCT02890355|21177046|P1|COMPLETED|Overall Study||0
8589006|NCT02890355|21177045|P2|Treated & Assessed for AEs|Overall Study||50
8589007|NCT02890355|21177046|P1|Treated & Assessed for AEs|Overall Study||56
8589008|NCT02890355|21177045|P2|STARTED|Overall Study||58
8589009|NCT02890355|21177046|P1|STARTED|Overall Study||59
8589013|NCT02758899|21177072|P2|NOT COMPLETED|Overall Study||1
8589014|NCT02758899|21177073|P1|NOT COMPLETED|Overall Study||2
8589015|NCT02758899|21177072|P2|COMPLETED|Overall Study||9
8589016|NCT02758899|21177073|P1|COMPLETED|Overall Study||9
8589017|NCT02758899|21177072|P2|STARTED|Overall Study||10
8589018|NCT02758899|21177073|P1|STARTED|Overall Study||11
8589173|NCT02454933|21177562|P2|NOT COMPLETED|Overall Study||8
8589174|NCT02454933|21177563|P1|NOT COMPLETED|Overall Study||8
8589175|NCT02454933|21177562|P2|COMPLETED|Overall Study||4
8589176|NCT02454933|21177563|P1|COMPLETED|Overall Study||9
8589177|NCT02454933|21177562|P2|Treatment Group Randomised to|Overall Study||14
8589178|NCT02454933|21177563|P1|Treatment Group Randomised to|Overall Study||15
8589179|NCT02454933|21177562|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
8589180|NCT02454933|21177563|P1|STARTED|Overall Study||17
8589337|NCT02369874|21177853|P3|NOT COMPLETED|Overall Study||61
8589338|NCT02369874|21177854|P2|NOT COMPLETED|Overall Study||57
8589339|NCT02369874|21177855|P1|NOT COMPLETED|Overall Study||44
8589340|NCT02369874|21177853|P3|COMPLETED|Overall Study||188
8589341|NCT02369874|21177854|P2|COMPLETED|Overall Study||183
8589342|NCT02369874|21177855|P1|COMPLETED|Overall Study||203
8589343|NCT02369874|21177853|P3|Received Treatment|Overall Study||240
8589344|NCT02369874|21177854|P2|Received Treatment|Overall Study||237
8589345|NCT02369874|21177855|P1|Received Treatment|Overall Study||246
8589346|NCT02369874|21177853|P3|STARTED|Overall Study||249
8589347|NCT02369874|21177854|P2|STARTED|Overall Study||240
8589348|NCT02369874|21177855|P1|STARTED|Overall Study||247
8589349|NCT02326363|21177904|P2|NOT COMPLETED|Overall Study||56
8589350|NCT02326363|21177905|P1|NOT COMPLETED|Overall Study||51
8589351|NCT02326363|21177904|P2|COMPLETED|Overall Study||50
8589352|NCT02326363|21177905|P1|COMPLETED|Overall Study||47
8589353|NCT02326363|21177904|P2|STARTED|Overall Study||106
8589354|NCT02326363|21177905|P1|STARTED|Overall Study||98
8589380|NCT02255513|21178050|P2|NOT COMPLETED|Double Blind, Placebo-controlled||0
8589381|NCT02255513|21178051|P1|NOT COMPLETED|Double Blind, Placebo-controlled||0
8589382|NCT02255513|21178050|P2|COMPLETED|Double Blind, Placebo-controlled||21
8589383|NCT02255513|21178051|P1|COMPLETED|Double Blind, Placebo-controlled||22
8589384|NCT02255513|21178050|P2|STARTED|Double Blind, Placebo-controlled||21
8589385|NCT02255513|21178051|P1|STARTED|Double Blind, Placebo-controlled||22
8589386|NCT02255513|21178050|P2|NOT COMPLETED|Open-label, Treatment Optimization||0
8589387|NCT02255513|21178051|P1|NOT COMPLETED|Open-label, Treatment Optimization||0
8589388|NCT02255513|21178050|P2|COMPLETED|Open-label, Treatment Optimization||0
8589389|NCT02255513|21178051|P1|COMPLETED|Open-label, Treatment Optimization||43
8589390|NCT02255513|21178050|P2|STARTED|Open-label, Treatment Optimization||0
8589391|NCT02255513|21178051|P1|STARTED|Open-label, Treatment Optimization||43
8589396|NCT02232061|21178078|P1|NOT COMPLETED|Overall Study||2
8589397|NCT02232061|21178078|P1|COMPLETED|Overall Study||4
8589398|NCT02232061|21178078|P1|STARTED|Overall Study||6
8589405|NCT02200614|21178117|P2|NOT COMPLETED|Open Label||23
8589406|NCT02200614|21178118|P1|NOT COMPLETED|Open Label||125
8589407|NCT02200614|21178117|P2|COMPLETED|Open Label||147
8589408|NCT02200614|21178118|P1|COMPLETED|Open Label||466
8589409|NCT02200614|21178117|P2|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
8589410|NCT02200614|21178118|P1|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
8589411|NCT02200614|21178117|P2|NOT COMPLETED|Double Blind Treatment||384
8589412|NCT02200614|21178118|P1|NOT COMPLETED|Double Blind Treatment||364
8589413|NCT02200614|21178117|P2|COMPLETED|Double Blind Treatment||170
8589414|NCT02200614|21178118|P1|COMPLETED|Double Blind Treatment||591
8589415|NCT02200614|21178117|P2|STARTED|Double Blind Treatment||554
8589416|NCT02200614|21178118|P1|STARTED|Double Blind Treatment||955
8589465|NCT02152345|21178215|P2|NOT COMPLETED|Overall Study||5
8589466|NCT02152345|21178216|P1|NOT COMPLETED|Overall Study||4
8589467|NCT02152345|21178215|P2|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
8589468|NCT02152345|21178216|P1|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
8589469|NCT02152345|21178215|P2|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
8589470|NCT02152345|21178216|P1|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
8589483|NCT02103153|21178253|P1|NOT COMPLETED|Overall Study||17
8589484|NCT02103153|21178253|P1|COMPLETED|Overall Study||27
8589485|NCT02103153|21178253|P1|STARTED|Overall Study||44
8589501|NCT02032810|21178316|P2|NOT COMPLETED|Overall Study||0
8589502|NCT02032810|21178317|P1|NOT COMPLETED|Overall Study||0
8589503|NCT02032810|21178316|P2|COMPLETED|Overall Study||11
8589504|NCT02032810|21178317|P1|COMPLETED|Overall Study||6
8589505|NCT02032810|21178316|P2|STARTED|Overall Study||11
8589506|NCT02032810|21178317|P1|STARTED|Overall Study||6
8589540|NCT01920152|21178386|P2|NOT COMPLETED|Overall Study||2
8589541|NCT01920152|21178387|P1|NOT COMPLETED|Overall Study||1
8589542|NCT01920152|21178386|P2|COMPLETED|Overall Study||13
8589543|NCT01920152|21178387|P1|COMPLETED|Overall Study||18
8589544|NCT01920152|21178386|P2|STARTED|Overall Study||15
8589545|NCT01920152|21178387|P1|STARTED|Overall Study||19
8589564|NCT01887600|21178450|P2|NOT COMPLETED|Overall Study||114
8589565|NCT01887600|21178451|P1|NOT COMPLETED|Overall Study||146
8589566|NCT01887600|21178450|P2|COMPLETED|Overall Study||89
8589567|NCT01887600|21178451|P1|COMPLETED|Overall Study||245
8589568|NCT01887600|21178450|P2|Treatment Received|Overall Study||203
8589569|NCT01887600|21178451|P1|Treatment Received|Overall Study||391
8589570|NCT01887600|21178450|P2|STARTED|Overall Study||203
8589571|NCT01887600|21178451|P1|STARTED|Overall Study||391
8589582|NCT01843374|21178610|P2|NOT COMPLETED|Overall Study||379
8589583|NCT01843374|21178611|P1|NOT COMPLETED|Overall Study||189
8589584|NCT01843374|21178610|P2|COMPLETED|Overall Study||3
8589585|NCT01843374|21178611|P1|COMPLETED|Overall Study||0
8589586|NCT01843374|21178610|P2|RANDOMIZED|Overall Study||382
8589587|NCT01843374|21178611|P1|RANDOMIZED|Overall Study||189
8589588|NCT01843374|21178610|P2|STARTED|Overall Study||382
8589589|NCT01843374|21178611|P1|STARTED|Overall Study||189
8589605|NCT01804816|21178676|P1|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
8589606|NCT01804816|21178676|P1|COMPLETED|Acupuncture (Second 5 Weeks)||10
8589607|NCT01804816|21178676|P1|STARTED|Acupuncture (Second 5 Weeks)||11
8589608|NCT01804816|21178676|P1|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
8589609|NCT01804816|21178676|P1|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
8589610|NCT01804816|21178676|P1|STARTED|No Acupuncture (Initial 5 Weeks)||14
8589611|NCT01784588|21178690|P2|NOT COMPLETED|Overall Study||32
8589612|NCT01784588|21178691|P1|NOT COMPLETED|Overall Study||37
8589613|NCT01784588|21178690|P2|COMPLETED|Overall Study||108
8589614|NCT01784588|21178691|P1|COMPLETED|Overall Study||104
8589615|NCT01784588|21178690|P2|STARTED|Overall Study||140
8589616|NCT01784588|21178691|P1|STARTED|Overall Study||141
8589640|NCT01708954|21178754|P3|NOT COMPLETED|Step 2||0
8589641|NCT01708954|21178755|P2|NOT COMPLETED|Step 2||7
8589642|NCT01708954|21178756|P1|NOT COMPLETED|Step 2||13
8589643|NCT01708954|21178754|P3|COMPLETED|Step 2||0
8589644|NCT01708954|21178755|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
8589645|NCT01708954|21178756|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
8589646|NCT01708954|21178754|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
8589647|NCT01708954|21178755|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
8589648|NCT01708954|21178756|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
8589649|NCT01708954|21178754|P3|NOT COMPLETED|Step 1||43
8589650|NCT01708954|21178755|P2|NOT COMPLETED|Step 1||40
8589651|NCT01708954|21178756|P1|NOT COMPLETED|Step 1||42
8589652|NCT01708954|21178754|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
8589653|NCT01708954|21178755|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
8589654|NCT01708954|21178756|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
8589655|NCT01708954|21178754|P3|Patients With MET Status Data Available|Step 1||24
8589656|NCT01708954|21178755|P2|Patients With MET Status Data Available|Step 1||32
8589657|NCT01708954|21178756|P1|Patients With MET Status Data Available|Step 1||30
8589658|NCT01708954|21178754|P3|Eligible and Treated|Step 1||35
8589659|NCT01708954|21178755|P2|Eligible and Treated|Step 1||38
8589660|NCT01708954|21178756|P1|Eligible and Treated|Step 1||38
8589661|NCT01708954|21178754|P3|Started Protocol Therapy|Step 1||39
8589662|NCT01708954|21178755|P2|Started Protocol Therapy|Step 1||40
8589663|NCT01708954|21178756|P1|Started Protocol Therapy|Step 1||40
8589664|NCT01708954|21178754|P3|STARTED|Step 1||43
8589665|NCT01708954|21178755|P2|STARTED|Step 1||40
8589666|NCT01708954|21178756|P1|STARTED|Step 1||42
8589673|NCT01671423|21178790|P2|NOT COMPLETED|Overall Study||11
8589674|NCT01671423|21178791|P1|NOT COMPLETED|Overall Study||6
8589675|NCT01671423|21178790|P2|COMPLETED|Overall Study||9
8589676|NCT01671423|21178791|P1|COMPLETED|Overall Study||14
8589677|NCT01671423|21178790|P2|STARTED|Overall Study||20
8589678|NCT01671423|21178791|P1|STARTED|Overall Study||20
8589736|NCT01619085|21178898|P1|NOT COMPLETED|Overall Study||369
8589737|NCT01619085|21178898|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
8589738|NCT01619085|21178898|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
8589788|NCT01297959|21179096|P2|NOT COMPLETED|Overall Study||16
8589789|NCT01297959|21179097|P1|NOT COMPLETED|Overall Study||20
8589790|NCT01297959|21179096|P2|COMPLETED|Overall Study||226
8589791|NCT01297959|21179097|P1|COMPLETED|Overall Study||241
8589792|NCT01297959|21179096|P2|STARTED|Overall Study||242
8589793|NCT01297959|21179097|P1|STARTED|Overall Study||261
8589809|NCT01251861|21179180|P2|NOT COMPLETED|Overall Study||28
8589810|NCT01251861|21179181|P1|NOT COMPLETED|Overall Study||18
8589811|NCT01251861|21179180|P2|COMPLETED|Overall Study||26
8589812|NCT01251861|21179181|P1|COMPLETED|Overall Study||36
8589813|NCT01251861|21179180|P2|Pts With PSA Response|Overall Study||36
8589814|NCT01251861|21179181|P1|Pts With PSA Response|Overall Study||44
8589815|NCT01251861|21179180|P2|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
8589816|NCT01251861|21179181|P1|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
8589817|NCT01251861|21179180|P2|Pts Who Received Protocol Therapy|Overall Study||53
8589818|NCT01251861|21179181|P1|Pts Who Received Protocol Therapy|Overall Study||50
8589819|NCT01251861|21179180|P2|STARTED|Overall Study||54
8589820|NCT01251861|21179181|P1|STARTED|Overall Study||54
8589824|NCT01206296|21179214|P1|NOT COMPLETED|Overall Study||0
8589825|NCT01206296|21179214|P1|COMPLETED|Overall Study||0
8589826|NCT01206296|21179214|P1|STARTED|Overall Study||0
8589851|NCT01165177|21179351|P2|NOT COMPLETED|Overall Study||902
8589852|NCT01165177|21179352|P1|NOT COMPLETED|Overall Study||922
8589853|NCT01165177|21179351|P2|COMPLETED|Overall Study||6808
8589854|NCT01165177|21179352|P1|COMPLETED|Overall Study||6773
8589855|NCT01165177|21179351|P2|STARTED|Overall Study||7710
8589856|NCT01165177|21179352|P1|STARTED|Overall Study||7695
8589857|NCT01142388|21179480|P2|NOT COMPLETED|Overall Study||47
8589858|NCT01142388|21179481|P1|NOT COMPLETED|Overall Study||47
8589859|NCT01142388|21179480|P2|COMPLETED|Overall Study||0
8589860|NCT01142388|21179481|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
8589861|NCT01142388|21179480|P2|Treated|Overall Study||44
8589862|NCT01142388|21179481|P1|Treated|Overall Study||40
8589863|NCT01142388|21179480|P2|Eligible|Overall Study||44
8589864|NCT01142388|21179481|P1|Eligible|Overall Study||43
8589865|NCT01142388|21179480|P2|STARTED|Overall Study||47
8589866|NCT01142388|21179481|P1|STARTED|Overall Study||47
8590551|NCT00951496|21179600|P3|NOT COMPLETED|Overall Study||13
8590552|NCT00951496|21179601|P2|NOT COMPLETED|Overall Study||8
8590553|NCT00951496|21179602|P1|NOT COMPLETED|Overall Study||10
8590554|NCT00951496|21179600|P3|COMPLETED|Overall Study||508
8590555|NCT00951496|21179601|P2|COMPLETED|Overall Study||510
8590556|NCT00951496|21179602|P1|COMPLETED|Overall Study||511
8590557|NCT00951496|21179600|P3|STARTED|Overall Study||521
8590558|NCT00951496|21179601|P2|STARTED|Overall Study||518
8590559|NCT00951496|21179602|P1|STARTED|Overall Study||521
8590596|NCT00928564|21179684|P2|NOT COMPLETED|Overall Study||0
8590597|NCT00928564|21179685|P1|NOT COMPLETED|Overall Study||6
8590598|NCT00928564|21179684|P2|COMPLETED|Overall Study||12
8590599|NCT00928564|21179685|P1|COMPLETED|Overall Study||22
8590600|NCT00928564|21179684|P2|STARTED|Overall Study||12
8590601|NCT00928564|21179685|P1|STARTED|Overall Study||28
8590608|NCT00843284|21179704|P1|NOT COMPLETED|Overall Study||72
8590609|NCT00843284|21179704|P1|COMPLETED|Overall Study||619
8590610|NCT00843284|21179704|P1|STARTED|Overall Study||691
8590632|NCT00684424|21179750|P1|NOT COMPLETED|Overall Study||5
8590633|NCT00684424|21179750|P1|COMPLETED|Overall Study||194
8590634|NCT00684424|21179750|P1|STARTED|Overall Study||199
8590635|NCT00676403|21179771|P6|NOT COMPLETED|Overall Study||5
8590636|NCT00676403|21179772|P5|NOT COMPLETED|Overall Study||1
8590637|NCT00676403|21179773|P4|NOT COMPLETED|Overall Study||5
8590638|NCT00676403|21179774|P3|NOT COMPLETED|Overall Study||1
8590639|NCT00676403|21179775|P2|NOT COMPLETED|Overall Study||2
8590640|NCT00676403|21179776|P1|NOT COMPLETED|Overall Study||2
8590641|NCT00676403|21179771|P6|COMPLETED|Overall Study||18
8590642|NCT00676403|21179772|P5|COMPLETED|Overall Study||23
8590643|NCT00676403|21179773|P4|COMPLETED|Overall Study||17
8590644|NCT00676403|21179774|P3|COMPLETED|Overall Study||22
8590645|NCT00676403|21179775|P2|COMPLETED|Overall Study||20
8590646|NCT00676403|21179776|P1|COMPLETED|Overall Study||21
8590647|NCT00676403|21179771|P6|STARTED|Overall Study||23
8590648|NCT00676403|21179772|P5|STARTED|Overall Study||24
8590649|NCT00676403|21179773|P4|STARTED|Overall Study||22
8590650|NCT00676403|21179774|P3|STARTED|Overall Study||23
8590651|NCT00676403|21179775|P2|STARTED|Overall Study||22
8590652|NCT00676403|21179776|P1|STARTED|Overall Study||23
8590690|NCT00546455|21179952|P2|NOT COMPLETED|Overall Study||0
8590691|NCT00546455|21179953|P1|NOT COMPLETED|Overall Study||0
8590692|NCT00546455|21179952|P2|COMPLETED|Overall Study||0
8590693|NCT00546455|21179953|P1|COMPLETED|Overall Study||0
8590694|NCT00546455|21179952|P2|STARTED|Overall Study||0
8590695|NCT00546455|21179953|P1|STARTED|Overall Study||0
8590696|NCT00494234|21179963|P2|NOT COMPLETED|Overall Study||10
8590697|NCT00494234|21179964|P1|NOT COMPLETED|Overall Study||15
8590698|NCT00494234|21179963|P2|COMPLETED|Overall Study||17
8590699|NCT00494234|21179964|P1|COMPLETED|Overall Study||12
8590700|NCT00494234|21179963|P2|STARTED|Overall Study||27
8590701|NCT00494234|21179964|P1|STARTED|Overall Study||27
8590702|NCT00468845|21179983|P3|NOT COMPLETED|Overall Study||30
8590703|NCT00468845|21179984|P2|NOT COMPLETED|Overall Study||34
8590704|NCT00468845|21179985|P1|NOT COMPLETED|Overall Study||21
8590705|NCT00468845|21179983|P3|COMPLETED|Overall Study||139
8590706|NCT00468845|21179984|P2|COMPLETED|Overall Study||136
8590707|NCT00468845|21179985|P1|COMPLETED|Overall Study||141
8590708|NCT00468845|21179983|P3|Received Treatment|Overall Study||167
8590709|NCT00468845|21179984|P2|Received Treatment|Overall Study||166
8590710|NCT00468845|21179985|P1|Received Treatment|Overall Study||161
8590711|NCT00468845|21179983|P3|STARTED|Overall Study||169
8590712|NCT00468845|21179984|P2|STARTED|Overall Study||170
8590713|NCT00468845|21179985|P1|STARTED|Overall Study||162
8590780|NCT00413010|21180481|P2|NOT COMPLETED|Overall Study||63
8590781|NCT00413010|21180482|P1|NOT COMPLETED|Overall Study||72
8590782|NCT00413010|21180481|P2|COMPLETED|Overall Study||113
8590783|NCT00413010|21180482|P1|COMPLETED|Overall Study||108
8590784|NCT00413010|21180481|P2|STARTED|Overall Study||176
8590785|NCT00413010|21180482|P1|STARTED|Overall Study||180
8590828|NCT00318591|21180698|P2|NOT COMPLETED|Overall Study||45
8590829|NCT00318591|21180699|P1|NOT COMPLETED|Overall Study||60
8590830|NCT00318591|21180698|P2|COMPLETED|Overall Study||69
8590831|NCT00318591|21180699|P1|COMPLETED|Overall Study||45
8590832|NCT00318591|21180698|P2|STARTED|Overall Study||114
8590833|NCT00318591|21180699|P1|STARTED|Overall Study||105
8590900|NCT00119106|21181079|P2|NOT COMPLETED|Overall Study||178
8590901|NCT00119106|21181080|P1|NOT COMPLETED|Overall Study||179
8590902|NCT00119106|21181079|P2|COMPLETED|Overall Study||1031
8590903|NCT00119106|21181080|P1|COMPLETED|Overall Study||1025
8590904|NCT00119106|21181079|P2|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
8590905|NCT00119106|21181080|P1|STARTED|Overall Study||1204
8592717|NCT04438785|21184383|P2|NOT COMPLETED|Overall Study||10
8592718|NCT04438785|21184384|P1|NOT COMPLETED|Overall Study||2
8592719|NCT04438785|21184383|P2|COMPLETED|Overall Study||10
8592720|NCT04438785|21184384|P1|COMPLETED|Overall Study||18
8592721|NCT04438785|21184383|P2|STARTED|Overall Study||20
8592722|NCT04438785|21184384|P1|STARTED|Overall Study||20
8592760|NCT04060654|21184495|P1|NOT COMPLETED|Overall Study||6
8592761|NCT04060654|21184495|P1|COMPLETED|Overall Study||11
8592762|NCT04060654|21184495|P1|STARTED|Overall Study||17
8592763|NCT03970395|21184501|P2|NOT COMPLETED|Overall Study||12
8592764|NCT03970395|21184502|P1|NOT COMPLETED|Overall Study||7
8592765|NCT03970395|21184501|P2|COMPLETED|Overall Study||36
8592766|NCT03970395|21184502|P1|COMPLETED|Overall Study||41
8592767|NCT03970395|21184501|P2|STARTED|Overall Study||48
8592768|NCT03970395|21184502|P1|STARTED|Overall Study||48
8592769|NCT03966924|21184518|P1|NOT COMPLETED|Overall Study||0
8592770|NCT03966924|21184518|P1|COMPLETED|Overall Study||2
8592771|NCT03966924|21184518|P1|STARTED|Overall Study||2
8592772|NCT03926208|21184526|P2|NOT COMPLETED|Overall Study||0
8592773|NCT03926208|21184527|P1|NOT COMPLETED|Overall Study||0
8592774|NCT03926208|21184526|P2|COMPLETED|Overall Study||123
8592775|NCT03926208|21184527|P1|COMPLETED|Overall Study||119
8592776|NCT03926208|21184526|P2|STARTED|Overall Study||123
8592777|NCT03926208|21184527|P1|STARTED|Overall Study||119
8592778|NCT03861000|21184535|P2|NOT COMPLETED|Overall Study||0
8592779|NCT03861000|21184536|P1|NOT COMPLETED|Overall Study||0
8592780|NCT03861000|21184535|P2|COMPLETED|Overall Study||1
8592781|NCT03861000|21184536|P1|COMPLETED|Overall Study||2
8592782|NCT03861000|21184535|P2|STARTED|Overall Study||1
8592783|NCT03861000|21184536|P1|STARTED|Overall Study||2
8592784|NCT03836677|21184545|P2|NOT COMPLETED|Period 2||0
8592785|NCT03836677|21184546|P1|NOT COMPLETED|Period 2||1
8592786|NCT03836677|21184545|P2|COMPLETED|Period 2||9
8592787|NCT03836677|21184546|P1|COMPLETED|Period 2||12
8592788|NCT03836677|21184545|P2|STARTED|Period 2||9
8592789|NCT03836677|21184546|P1|STARTED|Period 2||13
8592790|NCT03836677|21184545|P2|NOT COMPLETED|Washout||0
8592791|NCT03836677|21184546|P1|NOT COMPLETED|Washout||0
8592792|NCT03836677|21184545|P2|COMPLETED|Washout||9
8592793|NCT03836677|21184546|P1|COMPLETED|Washout||13
8592794|NCT03836677|21184545|P2|STARTED|Washout||9
8592795|NCT03836677|21184546|P1|STARTED|Washout||13
8592796|NCT03836677|21184545|P2|NOT COMPLETED|Period 1||1
8592797|NCT03836677|21184546|P1|NOT COMPLETED|Period 1||0
8592798|NCT03836677|21184545|P2|COMPLETED|Period 1||9
8592799|NCT03836677|21184546|P1|COMPLETED|Period 1||13
8592800|NCT03836677|21184545|P2|STARTED|Period 1||10
8592801|NCT03836677|21184546|P1|STARTED|Period 1||13
8592802|NCT03736928|21184567|P5|NOT COMPLETED|Overall Study||11
8592803|NCT03736928|21184568|P4|NOT COMPLETED|Overall Study||5
8592804|NCT03736928|21184569|P3|NOT COMPLETED|Overall Study||5
8592805|NCT03736928|21184570|P2|NOT COMPLETED|Overall Study||2
8592806|NCT03736928|21184571|P1|NOT COMPLETED|Overall Study||7
8592807|NCT03736928|21184567|P5|COMPLETED|Overall Study||67
8592808|NCT03736928|21184568|P4|COMPLETED|Overall Study||76
8592809|NCT03736928|21184569|P3|COMPLETED|Overall Study||75
8592810|NCT03736928|21184570|P2|COMPLETED|Overall Study||78
8592811|NCT03736928|21184571|P1|COMPLETED|Overall Study||73
8592812|NCT03736928|21184567|P5|STARTED|Overall Study||78
8592813|NCT03736928|21184568|P4|STARTED|Overall Study||81
8592814|NCT03736928|21184569|P3|STARTED|Overall Study||80
8592815|NCT03736928|21184570|P2|STARTED|Overall Study||80
8592816|NCT03736928|21184571|P1|STARTED|Overall Study||80
8592817|NCT03693742|21184585|P2|NOT COMPLETED|Overall Study||0
8592818|NCT03693742|21184586|P1|NOT COMPLETED|Overall Study||0
8592819|NCT03693742|21184585|P2|COMPLETED|Overall Study||3
8592820|NCT03693742|21184586|P1|COMPLETED|Overall Study||7
8592821|NCT03693742|21184585|P2|STARTED|Overall Study||3
8592822|NCT03693742|21184586|P1|STARTED|Overall Study||7
8592829|NCT03572478|21184607|P1|NOT COMPLETED|Overall Study||0
8592830|NCT03572478|21184607|P1|COMPLETED|Overall Study||12
8592831|NCT03572478|21184607|P1|STARTED|Overall Study||12
8592832|NCT03557333|21184618|P1|NOT COMPLETED|Overall Study||92
8592833|NCT03557333|21184618|P1|COMPLETED|Overall Study||262
8592834|NCT03557333|21184618|P1|STARTED|Overall Study||354
8592835|NCT03522948|21184630|P1|NOT COMPLETED|Overall Study||1
8592836|NCT03522948|21184630|P1|COMPLETED|Overall Study||7
8592837|NCT03522948|21184630|P1|STARTED|Overall Study||8
8592838|NCT03515824|21184641|P4|NOT COMPLETED|Overall Study||0
8592839|NCT03515824|21184642|P3|NOT COMPLETED|Overall Study||15
8592840|NCT03515824|21184643|P2|NOT COMPLETED|Overall Study||4
8592841|NCT03515824|21184644|P1|NOT COMPLETED|Overall Study||3
8592842|NCT03515824|21184641|P4|COMPLETED|Overall Study||0
8592843|NCT03515824|21184642|P3|COMPLETED|Overall Study||0
8592844|NCT03515824|21184643|P2|COMPLETED|Overall Study||0
8592845|NCT03515824|21184644|P1|COMPLETED|Overall Study||0
8592846|NCT03515824|21184641|P4|STARTED|Overall Study||0
8592847|NCT03515824|21184642|P3|STARTED|Overall Study||15
8592848|NCT03515824|21184643|P2|STARTED|Overall Study||4
8592849|NCT03515824|21184644|P1|STARTED|Overall Study||3
8592850|NCT03450083|21184678|P2|NOT COMPLETED|Overall Study||0
8592851|NCT03450083|21184679|P1|NOT COMPLETED|Overall Study||0
8592852|NCT03450083|21184678|P2|COMPLETED|Overall Study||12
8592853|NCT03450083|21184679|P1|COMPLETED|Overall Study||12
8592854|NCT03450083|21184678|P2|STARTED|Overall Study||12
8592855|NCT03450083|21184679|P1|STARTED|Overall Study||12
8592856|NCT03376061|21184701|P2|NOT COMPLETED|Overall Study||0
8592857|NCT03376061|21184702|P1|NOT COMPLETED|Overall Study||0
8592858|NCT03376061|21184701|P2|COMPLETED|Overall Study||48
8592859|NCT03376061|21184702|P1|COMPLETED|Overall Study||49
8592860|NCT03376061|21184701|P2|STARTED|Overall Study||48
8592861|NCT03376061|21184702|P1|STARTED|Overall Study||49
8592865|NCT03312218|21184729|P2|NOT COMPLETED|Overall Study||58
8592866|NCT03312218|21184730|P1|NOT COMPLETED|Overall Study||54
8592867|NCT03312218|21184729|P2|COMPLETED|Overall Study||241
8592868|NCT03312218|21184730|P1|COMPLETED|Overall Study||281
8592869|NCT03312218|21184729|P2|STARTED|Overall Study||299
8592870|NCT03312218|21184730|P1|STARTED|Overall Study||335
8592871|NCT03293485|21184736|P1|NOT COMPLETED|Overall Study||5
8592872|NCT03293485|21184736|P1|COMPLETED|Overall Study||78
8592873|NCT03293485|21184736|P1|Treated|Overall Study||81
8592874|NCT03293485|21184736|P1|STARTED|Overall Study||83
8592875|NCT03273153|21184747|P2|NOT COMPLETED|Overall Study||222
8592876|NCT03273153|21184748|P1|NOT COMPLETED|Overall Study||224
8592877|NCT03273153|21184747|P2|COMPLETED|Overall Study||0
8592878|NCT03273153|21184748|P1|COMPLETED|Overall Study||0
8592879|NCT03273153|21184747|P2|STARTED|Overall Study||222
8592880|NCT03273153|21184748|P1|STARTED|Overall Study||224
8592881|NCT03248037|21184770|P2|NOT COMPLETED|Overall Study||9
8592882|NCT03248037|21184771|P1|NOT COMPLETED|Overall Study||21
8592883|NCT03248037|21184770|P2|COMPLETED|Overall Study||87
8592884|NCT03248037|21184771|P1|COMPLETED|Overall Study||74
8592885|NCT03248037|21184770|P2|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
8592886|NCT03248037|21184771|P1|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
8592887|NCT03126370|21184777|P1|NOT COMPLETED|TAF With a Boosted PI||0
8592888|NCT03126370|21184777|P1|COMPLETED|TAF With a Boosted PI||10
8592889|NCT03126370|21184777|P1|STARTED|TAF With a Boosted PI||10
8592890|NCT03126370|21184777|P1|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
8592891|NCT03126370|21184777|P1|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
8592892|NCT03126370|21184777|P1|STARTED|TAF With a Boosted PI and LDV/SOF||10
8592893|NCT03126370|21184777|P1|NOT COMPLETED|TAF With a Boosted PI||0
8592894|NCT03126370|21184777|P1|COMPLETED|TAF With a Boosted PI||10
8592895|NCT03126370|21184777|P1|STARTED|TAF With a Boosted PI||10
8592896|NCT03126370|21184777|P1|NOT COMPLETED|TDF With a Boosted PI||0
8592897|NCT03126370|21184777|P1|COMPLETED|TDF With a Boosted PI||10
8592898|NCT03126370|21184777|P1|STARTED|TDF With a Boosted PI||10
8592899|NCT03125902|21184802|P2|NOT COMPLETED|Overall Study||431
8592900|NCT03125902|21184803|P1|NOT COMPLETED|Overall Study||220
8592901|NCT03125902|21184802|P2|COMPLETED|Overall Study||0
8592902|NCT03125902|21184803|P1|COMPLETED|Overall Study||0
8592903|NCT03125902|21184802|P2|STARTED|Overall Study||431
8592904|NCT03125902|21184803|P1|STARTED|Overall Study||220
8592905|NCT03102645|21184850|P2|NOT COMPLETED|Overall Study||0
8592906|NCT03102645|21184851|P1|NOT COMPLETED|Overall Study||0
8592907|NCT03102645|21184850|P2|COMPLETED|Overall Study||8
8592908|NCT03102645|21184851|P1|COMPLETED|Overall Study||8
8592909|NCT03102645|21184850|P2|STARTED|Overall Study||8
8592910|NCT03102645|21184851|P1|STARTED|Overall Study||8
8592911|NCT03093662|21184861|P2|NOT COMPLETED|Second Intervention (3 Minutes)||0
8592912|NCT03093662|21184862|P1|NOT COMPLETED|Second Intervention (3 Minutes)||0
8592913|NCT03093662|21184861|P2|COMPLETED|Second Intervention (3 Minutes)||19
8592914|NCT03093662|21184862|P1|COMPLETED|Second Intervention (3 Minutes)||18
8592915|NCT03093662|21184861|P2|STARTED|Second Intervention (3 Minutes)||19
8592916|NCT03093662|21184862|P1|STARTED|Second Intervention (3 Minutes)||18
8592917|NCT03093662|21184861|P2|NOT COMPLETED|Washout Period (5 Minutes)||0
8592918|NCT03093662|21184862|P1|NOT COMPLETED|Washout Period (5 Minutes)||0
8592919|NCT03093662|21184861|P2|COMPLETED|Washout Period (5 Minutes)||19
8592920|NCT03093662|21184862|P1|COMPLETED|Washout Period (5 Minutes)||18
8592921|NCT03093662|21184861|P2|STARTED|Washout Period (5 Minutes)||19
8592922|NCT03093662|21184862|P1|STARTED|Washout Period (5 Minutes)||18
8592923|NCT03093662|21184861|P2|NOT COMPLETED|First Intervention (3 Minutes)||0
8592924|NCT03093662|21184862|P1|NOT COMPLETED|First Intervention (3 Minutes)||0
8592925|NCT03093662|21184861|P2|COMPLETED|First Intervention (3 Minutes)||19
8592926|NCT03093662|21184862|P1|COMPLETED|First Intervention (3 Minutes)||18
8592927|NCT03093662|21184861|P2|STARTED|First Intervention (3 Minutes)||19
8592928|NCT03093662|21184862|P1|STARTED|First Intervention (3 Minutes)||18
8592929|NCT03072160|21184870|P2|NOT COMPLETED|Overall Study||4
8592930|NCT03072160|21184871|P1|NOT COMPLETED|Overall Study||11
8592931|NCT03072160|21184870|P2|COMPLETED|Overall Study||0
8592932|NCT03072160|21184871|P1|COMPLETED|Overall Study||2
8592933|NCT03072160|21184870|P2|STARTED|Overall Study||4
8592934|NCT03072160|21184871|P1|STARTED|Overall Study||13
8592941|NCT02933372|21184942|P2|NOT COMPLETED|Overall Study||0
8592942|NCT02933372|21184943|P1|NOT COMPLETED|Overall Study||0
8592943|NCT02933372|21184942|P2|COMPLETED|Overall Study||10
8592944|NCT02933372|21184943|P1|COMPLETED|Overall Study||15
8592945|NCT02933372|21184942|P2|STARTED|Overall Study||10
8592946|NCT02933372|21184943|P1|STARTED|Overall Study||15
8592947|NCT02930226|21184955|P6|NOT COMPLETED|Overall Study||0
8592948|NCT02930226|21184956|P5|NOT COMPLETED|Overall Study||1
8592949|NCT02930226|21184957|P4|NOT COMPLETED|Overall Study||0
8592950|NCT02930226|21184958|P3|NOT COMPLETED|Overall Study||0
8592951|NCT02930226|21184959|P2|NOT COMPLETED|Overall Study||0
8592952|NCT02930226|21184960|P1|NOT COMPLETED|Overall Study||0
8592953|NCT02930226|21184955|P6|COMPLETED|Overall Study||4
8592954|NCT02930226|21184956|P5|COMPLETED|Overall Study||3
8592955|NCT02930226|21184957|P4|COMPLETED|Overall Study||4
8592956|NCT02930226|21184958|P3|COMPLETED|Overall Study||4
8592957|NCT02930226|21184959|P2|COMPLETED|Overall Study||4
8592958|NCT02930226|21184960|P1|COMPLETED|Overall Study||4
8592959|NCT02930226|21184955|P6|STARTED|Overall Study||4
8592960|NCT02930226|21184956|P5|STARTED|Overall Study||4
8592961|NCT02930226|21184957|P4|STARTED|Overall Study||4
8592962|NCT02930226|21184958|P3|STARTED|Overall Study||4
8592963|NCT02930226|21184959|P2|STARTED|Overall Study||4
8592964|NCT02930226|21184960|P1|STARTED|Overall Study||4
8592965|NCT02929979|21184996|P2|NOT COMPLETED|Overall Study||10
8592966|NCT02929979|21184997|P1|NOT COMPLETED|Overall Study||27
8592967|NCT02929979|21184996|P2|COMPLETED|Overall Study||28
8592968|NCT02929979|21184997|P1|COMPLETED|Overall Study||25
8592969|NCT02929979|21184996|P2|STARTED|Overall Study||38
8592970|NCT02929979|21184997|P1|STARTED|Overall Study||52
8592971|NCT02920476|21185021|P1|NOT COMPLETED|Overall Study||1
8592972|NCT02920476|21185021|P1|COMPLETED|Overall Study||3
8592973|NCT02920476|21185021|P1|STARTED|Overall Study||4
8592974|NCT02918851|21185029|P3|NOT COMPLETED|Overall Study||4
8592975|NCT02918851|21185030|P2|NOT COMPLETED|Overall Study||4
8592976|NCT02918851|21185031|P1|NOT COMPLETED|Overall Study||4
8592977|NCT02918851|21185029|P3|COMPLETED|Overall Study||10
8592978|NCT02918851|21185030|P2|COMPLETED|Overall Study||10
8592979|NCT02918851|21185031|P1|COMPLETED|Overall Study||10
8592980|NCT02918851|21185029|P3|STARTED|Overall Study||14
8592981|NCT02918851|21185030|P2|STARTED|Overall Study||14
8592982|NCT02918851|21185031|P1|STARTED|Overall Study||14
8592983|NCT02832284|21185042|P1|NOT COMPLETED|Overall Study||0
8592984|NCT02832284|21185042|P1|COMPLETED|Overall Study||23
8592985|NCT02832284|21185042|P1|STARTED|Overall Study||23
8592986|NCT02737332|21185052|P2|NOT COMPLETED|Overall Study||1
8592987|NCT02737332|21185053|P1|NOT COMPLETED|Overall Study||1
8592988|NCT02737332|21185052|P2|COMPLETED|Overall Study||23
8592989|NCT02737332|21185053|P1|COMPLETED|Overall Study||28
8592990|NCT02737332|21185052|P2|STARTED|Overall Study||24
8592991|NCT02737332|21185053|P1|STARTED|Overall Study||29
8593004|NCT02706951|21185098|P3|NOT COMPLETED|Overall Study||10
8593005|NCT02706951|21185099|P2|NOT COMPLETED|Overall Study||16
8593006|NCT02706951|21185100|P1|NOT COMPLETED|Overall Study||14
8593007|NCT02706951|21185098|P3|COMPLETED|Overall Study||205
8593008|NCT02706951|21185099|P2|COMPLETED|Overall Study||201
8593009|NCT02706951|21185100|P1|COMPLETED|Overall Study||202
8593010|NCT02706951|21185098|P3|STARTED|Overall Study||215
8593011|NCT02706951|21185099|P2|STARTED|Overall Study||217
8593012|NCT02706951|21185100|P1|STARTED|Overall Study||216
8593013|NCT02706873|21185136|P4|NOT COMPLETED|Overall Study||33
8593014|NCT02706873|21185137|P3|NOT COMPLETED|Overall Study||27
8593015|NCT02706873|21185138|P2|NOT COMPLETED|Overall Study||4
8593016|NCT02706873|21185139|P1|NOT COMPLETED|Overall Study||47
8593017|NCT02706873|21185136|P4|COMPLETED|Overall Study||282
8593018|NCT02706873|21185137|P3|COMPLETED|Overall Study||290
8593019|NCT02706873|21185138|P2|COMPLETED|Overall Study||51
8593020|NCT02706873|21185139|P1|COMPLETED|Overall Study||268
8593021|NCT02706873|21185136|P4|Japan Sub-study|Overall Study||28
8593022|NCT02706873|21185137|P3|Japan Sub-study|Overall Study||27
8593023|NCT02706873|21185138|P2|Japan Sub-study|Overall Study||55
8593024|NCT02706873|21185139|P1|Japan Sub-study|Overall Study||28
8593025|NCT02706873|21185136|P4|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
8593026|NCT02706873|21185137|P3|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
8593027|NCT02706873|21185138|P2|Global Analysis Population|Overall Study||0
8593028|NCT02706873|21185139|P1|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
8593029|NCT02706873|21185136|P4|Received Study Drug|Overall Study||314
8593030|NCT02706873|21185137|P3|Received Study Drug|Overall Study||317
8593031|NCT02706873|21185138|P2|Received Study Drug|Overall Study||55
8593032|NCT02706873|21185139|P1|Received Study Drug|Overall Study||314
8593033|NCT02706873|21185136|P4|STARTED|Overall Study||315
8593034|NCT02706873|21185137|P3|STARTED|Overall Study||317
8593035|NCT02706873|21185138|P2|STARTED|Overall Study||55
8593036|NCT02706873|21185139|P1|STARTED|Overall Study||315
8593037|NCT02706847|21185239|P4|NOT COMPLETED|Week 12 to Week 24||14
8593038|NCT02706847|21185240|P3|NOT COMPLETED|Week 12 to Week 24||4
8593039|NCT02706847|21185241|P2|NOT COMPLETED|Week 12 to Week 24||2
8593040|NCT02706847|21185242|P1|NOT COMPLETED|Week 12 to Week 24||3
8593041|NCT02706847|21185239|P4|COMPLETED|Week 12 to Week 24||135
8593042|NCT02706847|21185240|P3|COMPLETED|Week 12 to Week 24||153
8593043|NCT02706847|21185241|P2|COMPLETED|Week 12 to Week 24||74
8593044|NCT02706847|21185242|P1|COMPLETED|Week 12 to Week 24||72
8593045|NCT02706847|21185239|P4|Received Study Treatment|Week 12 to Week 24||148
8593046|NCT02706847|21185240|P3|Received Study Treatment|Week 12 to Week 24||156
8593047|NCT02706847|21185241|P2|Received Study Treatment|Week 12 to Week 24||75
8593048|NCT02706847|21185242|P1|Received Study Treatment|Week 12 to Week 24||72
8593049|NCT02706847|21185239|P4|STARTED|Week 12 to Week 24||149
8593050|NCT02706847|21185240|P3|STARTED|Week 12 to Week 24||157
8593051|NCT02706847|21185241|P2|STARTED|Week 12 to Week 24||76
8593052|NCT02706847|21185242|P1|STARTED|Week 12 to Week 24||75
8593053|NCT02706847|21185239|P4|NOT COMPLETED|Day 1 to Week 12||16
8593054|NCT02706847|21185240|P3|NOT COMPLETED|Day 1 to Week 12||8
8593055|NCT02706847|21185241|P2|NOT COMPLETED|Day 1 to Week 12||8
8593056|NCT02706847|21185242|P1|NOT COMPLETED|Day 1 to Week 12||10
8593057|NCT02706847|21185239|P4|COMPLETED|Day 1 to Week 12||149
8593058|NCT02706847|21185240|P3|COMPLETED|Day 1 to Week 12||157
8593059|NCT02706847|21185241|P2|COMPLETED|Day 1 to Week 12||76
8593060|NCT02706847|21185242|P1|COMPLETED|Day 1 to Week 12||75
8593061|NCT02706847|21185239|P4|Received Study Treatment|Day 1 to Week 12||165
8593062|NCT02706847|21185240|P3|Received Study Treatment|Day 1 to Week 12||164
8593063|NCT02706847|21185241|P2|Received Study Treatment|Day 1 to Week 12||84
8593064|NCT02706847|21185242|P1|Received Study Treatment|Day 1 to Week 12||85
8593065|NCT02706847|21185239|P4|STARTED|Day 1 to Week 12||165
8593066|NCT02706847|21185240|P3|STARTED|Day 1 to Week 12||165
8593067|NCT02706847|21185241|P2|STARTED|Day 1 to Week 12||84
8593068|NCT02706847|21185242|P1|STARTED|Day 1 to Week 12||85
8593069|NCT02616146|21185275|P2|NOT COMPLETED|Overall Study||504
8593070|NCT02616146|21185276|P1|NOT COMPLETED|Overall Study||1512
8593071|NCT02616146|21185275|P2|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
8593072|NCT02616146|21185276|P1|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
8593073|NCT02616146|21185275|P2|STARTED|Overall Study||504
8593074|NCT02616146|21185276|P1|STARTED|Overall Study||1512
8593081|NCT02547987|21185303|P1|NOT COMPLETED|Overall Study||3
8593082|NCT02547987|21185303|P1|COMPLETED|Overall Study||22
8593083|NCT02547987|21185303|P1|STARTED|Overall Study||25
8593084|NCT02505425|21185311|P4|NOT COMPLETED|Overall Study||26
8593085|NCT02505425|21185312|P3|NOT COMPLETED|Overall Study||50
8593086|NCT02505425|21185313|P2|NOT COMPLETED|Overall Study||82
8593087|NCT02505425|21185314|P1|NOT COMPLETED|Overall Study||88
8593088|NCT02505425|21185311|P4|COMPLETED|Overall Study||50
8593089|NCT02505425|21185312|P3|COMPLETED|Overall Study||32
8593090|NCT02505425|21185313|P2|COMPLETED|Overall Study||125
8593091|NCT02505425|21185314|P1|COMPLETED|Overall Study||120
8593092|NCT02505425|21185311|P4|STARTED|Overall Study||76
8593093|NCT02505425|21185312|P3|STARTED|Overall Study||82
8593094|NCT02505425|21185313|P2|STARTED|Overall Study||207
8593095|NCT02505425|21185314|P1|STARTED|Overall Study||208
8593096|NCT02500797|21185448|P8|NOT COMPLETED|Overall Study||0
8593097|NCT02500797|21185449|P7|NOT COMPLETED|Overall Study||0
8593098|NCT02500797|21185450|P6|NOT COMPLETED|Overall Study||1
8593099|NCT02500797|21185451|P5|NOT COMPLETED|Overall Study||1
8593100|NCT02500797|21185452|P4|NOT COMPLETED|Overall Study||0
8593101|NCT02500797|21185453|P3|NOT COMPLETED|Overall Study||0
8593102|NCT02500797|21185454|P2|NOT COMPLETED|Overall Study||0
8593103|NCT02500797|21185455|P1|NOT COMPLETED|Overall Study||1
8593104|NCT02500797|21185448|P8|COMPLETED|Overall Study||11
8593105|NCT02500797|21185449|P7|COMPLETED|Overall Study||10
8593106|NCT02500797|21185450|P6|COMPLETED|Overall Study||14
8593107|NCT02500797|21185451|P5|COMPLETED|Overall Study||13
8593108|NCT02500797|21185452|P4|COMPLETED|Overall Study||14
8593109|NCT02500797|21185453|P3|COMPLETED|Overall Study||15
8593110|NCT02500797|21185454|P2|COMPLETED|Overall Study||42
8593111|NCT02500797|21185455|P1|COMPLETED|Overall Study||42
8593112|NCT02500797|21185448|P8|Arm I Crossover|Overall Study||0
8593113|NCT02500797|21185449|P7|Arm I Crossover|Overall Study||2
8593114|NCT02500797|21185450|P6|Arm I Crossover|Overall Study||0
8593115|NCT02500797|21185451|P5|Arm I Crossover|Overall Study||1
8593116|NCT02500797|21185452|P4|Arm I Crossover|Overall Study||0
8593117|NCT02500797|21185453|P3|Arm I Crossover|Overall Study||6
8593118|NCT02500797|21185454|P2|Arm I Crossover|Overall Study||0
8593119|NCT02500797|21185455|P1|Arm I Crossover|Overall Study||4
8593120|NCT02500797|21185448|P8|STARTED|Overall Study||11
8593121|NCT02500797|21185449|P7|STARTED|Overall Study||10
8593122|NCT02500797|21185450|P6|STARTED|Overall Study||15
8593123|NCT02500797|21185451|P5|STARTED|Overall Study||14
8593124|NCT02500797|21185452|P4|STARTED|Overall Study||14
8593125|NCT02500797|21185453|P3|STARTED|Overall Study||15
8593126|NCT02500797|21185454|P2|STARTED|Overall Study||42
8593127|NCT02500797|21185455|P1|STARTED|Overall Study||43
8593128|NCT02460991|21185515|P2|NOT COMPLETED|Overall Study||2
8593129|NCT02460991|21185516|P1|NOT COMPLETED|Overall Study||0
8593130|NCT02460991|21185515|P2|COMPLETED|Overall Study||0
8593131|NCT02460991|21185516|P1|COMPLETED|Overall Study||0
8593132|NCT02460991|21185515|P2|STARTED|Overall Study||2
8593133|NCT02460991|21185516|P1|STARTED|Overall Study||0
8593134|NCT02458092|21185532|P2|NOT COMPLETED|Overall Study||0
8593135|NCT02458092|21185533|P1|NOT COMPLETED|Overall Study||1
8593136|NCT02458092|21185532|P2|COMPLETED|Overall Study||10
8593137|NCT02458092|21185533|P1|COMPLETED|Overall Study||19
8593138|NCT02458092|21185532|P2|STARTED|Overall Study||10
8593139|NCT02458092|21185533|P1|STARTED|Overall Study||20
8593140|NCT02445963|21185549|P4|NOT COMPLETED|Overall Study||0
8593141|NCT02445963|21185550|P3|NOT COMPLETED|Overall Study||1
8593142|NCT02445963|21185551|P2|NOT COMPLETED|Overall Study||0
8593143|NCT02445963|21185552|P1|NOT COMPLETED|Overall Study||2
8593144|NCT02445963|21185549|P4|COMPLETED|Overall Study||10
8593145|NCT02445963|21185550|P3|COMPLETED|Overall Study||9
8593146|NCT02445963|21185551|P2|COMPLETED|Overall Study||9
8593147|NCT02445963|21185552|P1|COMPLETED|Overall Study||7
8593148|NCT02445963|21185549|P4|STARTED|Overall Study||10
8593149|NCT02445963|21185550|P3|STARTED|Overall Study||10
8593150|NCT02445963|21185551|P2|STARTED|Overall Study||9
8593151|NCT02445963|21185552|P1|STARTED|Overall Study||9
8593152|NCT02397889|21185576|P2|NOT COMPLETED|Overall Study||0
8593153|NCT02397889|21185577|P1|NOT COMPLETED|Overall Study||1
8593154|NCT02397889|21185576|P2|COMPLETED|Overall Study||15
8593155|NCT02397889|21185577|P1|COMPLETED|Overall Study||14
8593156|NCT02397889|21185576|P2|STARTED|Overall Study||15
8593157|NCT02397889|21185577|P1|STARTED|Overall Study||15
8593158|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 4||0
8593159|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 4||0
8593160|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 4||0
8593161|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 4||1
8593162|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 4||0
8593163|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 4||0
8593164|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 4||1
8593165|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 4||0
8593166|NCT02397460|21185601|P8|COMPLETED|Treatment Period 4||5
8593167|NCT02397460|21185602|P7|COMPLETED|Treatment Period 4||6
8593168|NCT02397460|21185603|P6|COMPLETED|Treatment Period 4||6
8593169|NCT02397460|21185604|P5|COMPLETED|Treatment Period 4||5
8593170|NCT02397460|21185605|P4|COMPLETED|Treatment Period 4||6
8593171|NCT02397460|21185606|P3|COMPLETED|Treatment Period 4||6
8593172|NCT02397460|21185607|P2|COMPLETED|Treatment Period 4||6
8593173|NCT02397460|21185608|P1|COMPLETED|Treatment Period 4||7
8593174|NCT02397460|21185601|P8|STARTED|Treatment Period 4||5
8593175|NCT02397460|21185602|P7|STARTED|Treatment Period 4||6
8593176|NCT02397460|21185603|P6|STARTED|Treatment Period 4||6
8593177|NCT02397460|21185604|P5|STARTED|Treatment Period 4||6
8593178|NCT02397460|21185605|P4|STARTED|Treatment Period 4||6
8593179|NCT02397460|21185606|P3|STARTED|Treatment Period 4||6
8593180|NCT02397460|21185607|P2|STARTED|Treatment Period 4||7
8593181|NCT02397460|21185608|P1|STARTED|Treatment Period 4||7
8593182|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 3||0
8593183|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 3||0
8593184|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 3||0
8593185|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 3||0
8593186|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 3||0
8593187|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 3||0
8593188|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 3||0
8593189|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 3||0
8593190|NCT02397460|21185601|P8|COMPLETED|Treatment Period 3||5
8593191|NCT02397460|21185602|P7|COMPLETED|Treatment Period 3||6
8593192|NCT02397460|21185603|P6|COMPLETED|Treatment Period 3||6
8593193|NCT02397460|21185604|P5|COMPLETED|Treatment Period 3||6
8593194|NCT02397460|21185605|P4|COMPLETED|Treatment Period 3||6
8593195|NCT02397460|21185606|P3|COMPLETED|Treatment Period 3||6
8593196|NCT02397460|21185607|P2|COMPLETED|Treatment Period 3||7
8593197|NCT02397460|21185608|P1|COMPLETED|Treatment Period 3||7
8593198|NCT02397460|21185601|P8|STARTED|Treatment Period 3||5
8593199|NCT02397460|21185602|P7|STARTED|Treatment Period 3||6
8593200|NCT02397460|21185603|P6|STARTED|Treatment Period 3||6
8593201|NCT02397460|21185604|P5|STARTED|Treatment Period 3||6
8593202|NCT02397460|21185605|P4|STARTED|Treatment Period 3||6
8593203|NCT02397460|21185606|P3|STARTED|Treatment Period 3||6
8593204|NCT02397460|21185607|P2|STARTED|Treatment Period 3||7
8593205|NCT02397460|21185608|P1|STARTED|Treatment Period 3||7
8593206|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 2||1
8593207|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 2||0
8593208|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 2||0
8593209|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 2||0
8593210|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 2||0
8593211|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 2||0
8593212|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 2||0
8593213|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 2||0
8593214|NCT02397460|21185601|P8|COMPLETED|Treatment Period 2||5
8593215|NCT02397460|21185602|P7|COMPLETED|Treatment Period 2||6
8593216|NCT02397460|21185603|P6|COMPLETED|Treatment Period 2||6
8593217|NCT02397460|21185604|P5|COMPLETED|Treatment Period 2||6
8593218|NCT02397460|21185605|P4|COMPLETED|Treatment Period 2||6
8593219|NCT02397460|21185606|P3|COMPLETED|Treatment Period 2||6
8593220|NCT02397460|21185607|P2|COMPLETED|Treatment Period 2||7
8593221|NCT02397460|21185608|P1|COMPLETED|Treatment Period 2||7
8593222|NCT02397460|21185601|P8|STARTED|Treatment Period 2||6
8593223|NCT02397460|21185602|P7|STARTED|Treatment Period 2||6
8593224|NCT02397460|21185603|P6|STARTED|Treatment Period 2||6
8593225|NCT02397460|21185604|P5|STARTED|Treatment Period 2||6
8593226|NCT02397460|21185605|P4|STARTED|Treatment Period 2||6
8593227|NCT02397460|21185606|P3|STARTED|Treatment Period 2||6
8593228|NCT02397460|21185607|P2|STARTED|Treatment Period 2||7
8593229|NCT02397460|21185608|P1|STARTED|Treatment Period 2||7
8593230|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 1||0
8593231|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 1||0
8593232|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 1||0
8593233|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 1||0
8593234|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 1||0
8593235|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 1||0
8593236|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 1||0
8593237|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 1||0
8593238|NCT02397460|21185601|P8|COMPLETED|Treatment Period 1||6
8593239|NCT02397460|21185602|P7|COMPLETED|Treatment Period 1||6
8593240|NCT02397460|21185603|P6|COMPLETED|Treatment Period 1||6
8593241|NCT02397460|21185604|P5|COMPLETED|Treatment Period 1||6
8593242|NCT02397460|21185605|P4|COMPLETED|Treatment Period 1||6
8593243|NCT02397460|21185606|P3|COMPLETED|Treatment Period 1||6
8593244|NCT02397460|21185607|P2|COMPLETED|Treatment Period 1||7
8593245|NCT02397460|21185608|P1|COMPLETED|Treatment Period 1||7
8593246|NCT02397460|21185601|P8|STARTED|Treatment Period 1||6
8593247|NCT02397460|21185602|P7|STARTED|Treatment Period 1||6
8593248|NCT02397460|21185603|P6|STARTED|Treatment Period 1||6
8593249|NCT02397460|21185604|P5|STARTED|Treatment Period 1||6
8593250|NCT02397460|21185605|P4|STARTED|Treatment Period 1||6
8593251|NCT02397460|21185606|P3|STARTED|Treatment Period 1||6
8593252|NCT02397460|21185607|P2|STARTED|Treatment Period 1||7
8593253|NCT02397460|21185608|P1|STARTED|Treatment Period 1||7
8593254|NCT02392351|21185728|P2|NOT COMPLETED|Overall Study||17
8593255|NCT02392351|21185729|P1|NOT COMPLETED|Overall Study||34
8593256|NCT02392351|21185728|P2|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
8593257|NCT02392351|21185729|P1|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
8593258|NCT02392351|21185728|P2|STARTED|Overall Study||17
8593259|NCT02392351|21185729|P1|STARTED|Overall Study||34
8593266|NCT02385318|21185793|P3|NOT COMPLETED|Overall Study||6
8593267|NCT02385318|21185794|P2|NOT COMPLETED|Overall Study||7
8593268|NCT02385318|21185795|P1|NOT COMPLETED|Overall Study||4
8593269|NCT02385318|21185793|P3|COMPLETED|Overall Study||99
8593270|NCT02385318|21185794|P2|COMPLETED|Overall Study||203
8593271|NCT02385318|21185795|P1|COMPLETED|Overall Study||200
8593272|NCT02385318|21185793|P3|STARTED|Overall Study||105
8593273|NCT02385318|21185794|P2|STARTED|Overall Study||210
8593274|NCT02385318|21185795|P1|STARTED|Overall Study||204
8593275|NCT02372383|21185805|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8593276|NCT02372383|21185806|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8593277|NCT02372383|21185807|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8593278|NCT02372383|21185805|P3|COMPLETED|Second Intervention (1 Day)||10
8593279|NCT02372383|21185806|P2|COMPLETED|Second Intervention (1 Day)||10
8593280|NCT02372383|21185807|P1|COMPLETED|Second Intervention (1 Day)||10
8593281|NCT02372383|21185805|P3|STARTED|Second Intervention (1 Day)||10
8593282|NCT02372383|21185806|P2|STARTED|Second Intervention (1 Day)||10
8593283|NCT02372383|21185807|P1|STARTED|Second Intervention (1 Day)||10
8593284|NCT02372383|21185805|P3|NOT COMPLETED|Washout (14 Days)||0
8593285|NCT02372383|21185806|P2|NOT COMPLETED|Washout (14 Days)||0
8593286|NCT02372383|21185807|P1|NOT COMPLETED|Washout (14 Days)||0
8593287|NCT02372383|21185805|P3|COMPLETED|Washout (14 Days)||10
8593288|NCT02372383|21185806|P2|COMPLETED|Washout (14 Days)||10
8593289|NCT02372383|21185807|P1|COMPLETED|Washout (14 Days)||10
8593290|NCT02372383|21185805|P3|STARTED|Washout (14 Days)||10
8593291|NCT02372383|21185806|P2|STARTED|Washout (14 Days)||10
8593292|NCT02372383|21185807|P1|STARTED|Washout (14 Days)||10
8593293|NCT02372383|21185805|P3|NOT COMPLETED|First Intervention (1 Day)||0
8593294|NCT02372383|21185806|P2|NOT COMPLETED|First Intervention (1 Day)||1
8593295|NCT02372383|21185807|P1|NOT COMPLETED|First Intervention (1 Day)||0
8593296|NCT02372383|21185805|P3|COMPLETED|First Intervention (1 Day)||10
8593297|NCT02372383|21185806|P2|COMPLETED|First Intervention (1 Day)||10
8593298|NCT02372383|21185807|P1|COMPLETED|First Intervention (1 Day)||10
8593299|NCT02372383|21185805|P3|STARTED|First Intervention (1 Day)||10
8593300|NCT02372383|21185806|P2|STARTED|First Intervention (1 Day)||11
8593301|NCT02372383|21185807|P1|STARTED|First Intervention (1 Day)||10
8593317|NCT02314000|21185885|P2|NOT COMPLETED|Overall Study||8
8593318|NCT02314000|21185886|P1|NOT COMPLETED|Overall Study||13
8593319|NCT02314000|21185885|P2|COMPLETED|Overall Study||57
8593320|NCT02314000|21185886|P1|COMPLETED|Overall Study||62
8593321|NCT02314000|21185885|P2|STARTED|Overall Study||65
8593322|NCT02314000|21185886|P1|STARTED|Overall Study||75
8593323|NCT02304367|21185893|P1|NOT COMPLETED|Overall Study||17
8593324|NCT02304367|21185893|P1|COMPLETED|Overall Study||0
8593325|NCT02304367|21185893|P1|Completed 144 Weeks of Study Drug|Overall Study||11
8593326|NCT02304367|21185893|P1|Completed 48 Weeks of Study Drug|Overall Study||16
8593327|NCT02304367|21185893|P1|STARTED|Overall Study||17
8593328|NCT02275780|21185953|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
8593329|NCT02275780|21185954|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
8593330|NCT02275780|21185953|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
8593331|NCT02275780|21185954|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
8593332|NCT02275780|21185953|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
8593333|NCT02275780|21185954|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
8593334|NCT02275780|21185953|P2|NOT COMPLETED|Base Study: 96 Weeks||111
8593335|NCT02275780|21185954|P1|NOT COMPLETED|Base Study: 96 Weeks||93
8593336|NCT02275780|21185953|P2|COMPLETED|Base Study: 96 Weeks||273
8593337|NCT02275780|21185954|P1|COMPLETED|Base Study: 96 Weeks||292
8593338|NCT02275780|21185953|P2|Treated|Base Study: 96 Weeks||383
8593339|NCT02275780|21185954|P1|Treated|Base Study: 96 Weeks||383
8593340|NCT02275780|21185953|P2|STARTED|Base Study: 96 Weeks||384
8593341|NCT02275780|21185954|P1|STARTED|Base Study: 96 Weeks||385
8593342|NCT02255097|21185990|P1|NOT COMPLETED|Overall Study||172
8593343|NCT02255097|21185990|P1|COMPLETED|Overall Study||0
8593344|NCT02255097|21185990|P1|Treated|Overall Study||171
8593345|NCT02255097|21185990|P1|STARTED|Overall Study||172
8593355|NCT02226159|21186026|P2|NOT COMPLETED|Overall Study||6
8593356|NCT02226159|21186027|P1|NOT COMPLETED|Overall Study||6
8593357|NCT02226159|21186026|P2|COMPLETED|Overall Study||26
8593358|NCT02226159|21186027|P1|COMPLETED|Overall Study||27
8593359|NCT02226159|21186026|P2|STARTED|Overall Study||32
8593360|NCT02226159|21186027|P1|STARTED|Overall Study||33
8593361|NCT02195921|21186061|P4|NOT COMPLETED|Overall Study||0
8593362|NCT02195921|21186062|P3|NOT COMPLETED|Overall Study||1
8593363|NCT02195921|21186063|P2|NOT COMPLETED|Overall Study||1
8593364|NCT02195921|21186064|P1|NOT COMPLETED|Overall Study||1
8593365|NCT02195921|21186061|P4|COMPLETED|Overall Study||40
8593366|NCT02195921|21186062|P3|COMPLETED|Overall Study||39
8593367|NCT02195921|21186063|P2|COMPLETED|Overall Study||39
8593368|NCT02195921|21186064|P1|COMPLETED|Overall Study||39
8593369|NCT02195921|21186061|P4|STARTED|Overall Study||40
8593370|NCT02195921|21186062|P3|STARTED|Overall Study||40
8593371|NCT02195921|21186063|P2|STARTED|Overall Study||40
8593372|NCT02195921|21186064|P1|STARTED|Overall Study||40
8593373|NCT02186834|21186114|P6|NOT COMPLETED|Treatment at RP2D||1
8593374|NCT02186834|21186115|P5|NOT COMPLETED|Treatment at RP2D||0
8593375|NCT02186834|21186116|P4|NOT COMPLETED|Treatment at RP2D||0
8593376|NCT02186834|21186117|P3|NOT COMPLETED|Treatment at RP2D||0
8593377|NCT02186834|21186118|P2|NOT COMPLETED|Treatment at RP2D||0
8593378|NCT02186834|21186119|P1|NOT COMPLETED|Treatment at RP2D||0
8593379|NCT02186834|21186114|P6|COMPLETED|Treatment at RP2D||13
8593380|NCT02186834|21186115|P5|COMPLETED|Treatment at RP2D||0
8593381|NCT02186834|21186116|P4|COMPLETED|Treatment at RP2D||0
8593382|NCT02186834|21186117|P3|COMPLETED|Treatment at RP2D||0
8593383|NCT02186834|21186118|P2|COMPLETED|Treatment at RP2D||0
8593384|NCT02186834|21186119|P1|COMPLETED|Treatment at RP2D||0
8593385|NCT02186834|21186114|P6|STARTED|Treatment at RP2D||14
8593386|NCT02186834|21186115|P5|STARTED|Treatment at RP2D||0
8593387|NCT02186834|21186116|P4|STARTED|Treatment at RP2D||0
8593388|NCT02186834|21186117|P3|STARTED|Treatment at RP2D||0
8593389|NCT02186834|21186118|P2|STARTED|Treatment at RP2D||0
8593390|NCT02186834|21186119|P1|STARTED|Treatment at RP2D||0
8593391|NCT02186834|21186114|P6|NOT COMPLETED|Dose Escalation||0
8593392|NCT02186834|21186115|P5|NOT COMPLETED|Dose Escalation||0
8593393|NCT02186834|21186116|P4|NOT COMPLETED|Dose Escalation||1
8593394|NCT02186834|21186117|P3|NOT COMPLETED|Dose Escalation||0
8593395|NCT02186834|21186118|P2|NOT COMPLETED|Dose Escalation||0
8593396|NCT02186834|21186119|P1|NOT COMPLETED|Dose Escalation||0
8593397|NCT02186834|21186114|P6|COMPLETED|Dose Escalation||0
8593398|NCT02186834|21186115|P5|COMPLETED|Dose Escalation||4
8593399|NCT02186834|21186116|P4|COMPLETED|Dose Escalation||6
8593400|NCT02186834|21186117|P3|COMPLETED|Dose Escalation||0
8593401|NCT02186834|21186118|P2|COMPLETED|Dose Escalation||3
8593402|NCT02186834|21186119|P1|COMPLETED|Dose Escalation||6
8593403|NCT02186834|21186114|P6|STARTED|Dose Escalation||0
8593404|NCT02186834|21186115|P5|STARTED|Dose Escalation||4
8593405|NCT02186834|21186116|P4|STARTED|Dose Escalation||7
8593406|NCT02186834|21186117|P3|STARTED|Dose Escalation||0
8593407|NCT02186834|21186118|P2|STARTED|Dose Escalation||3
8593408|NCT02186834|21186119|P1|STARTED|Dose Escalation||6
8593415|NCT02116205|21186155|P4|NOT COMPLETED|Overall Study||6
8593416|NCT02116205|21186156|P3|NOT COMPLETED|Overall Study||4
8593417|NCT02116205|21186157|P2|NOT COMPLETED|Overall Study||7
8593418|NCT02116205|21186158|P1|NOT COMPLETED|Overall Study||2
8593419|NCT02116205|21186155|P4|COMPLETED|Overall Study||27
8593420|NCT02116205|21186156|P3|COMPLETED|Overall Study||29
8593421|NCT02116205|21186157|P2|COMPLETED|Overall Study||26
8593422|NCT02116205|21186158|P1|COMPLETED|Overall Study||29
8593423|NCT02116205|21186155|P4|STARTED|Overall Study||33
8593424|NCT02116205|21186156|P3|STARTED|Overall Study||33
8593425|NCT02116205|21186157|P2|STARTED|Overall Study||33
8593426|NCT02116205|21186158|P1|STARTED|Overall Study||31
8593439|NCT02063724|21186217|P1|NOT COMPLETED|Overall Study||1
8593440|NCT02063724|21186217|P1|COMPLETED|Overall Study||14
8593441|NCT02063724|21186217|P1|STARTED|Overall Study||15
8593442|NCT02047734|21186226|P3|NOT COMPLETED|Overall Study||46
8593443|NCT02047734|21186227|P2|NOT COMPLETED|Overall Study||69
8593444|NCT02047734|21186228|P1|NOT COMPLETED|Overall Study||67
8593445|NCT02047734|21186226|P3|COMPLETED|Overall Study||388
8593446|NCT02047734|21186227|P2|COMPLETED|Overall Study||374
8593447|NCT02047734|21186228|P1|COMPLETED|Overall Study||376
8593448|NCT02047734|21186226|P3|Received Treatment|Overall Study||433
8593449|NCT02047734|21186227|P2|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
8593450|NCT02047734|21186228|P1|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
8593451|NCT02047734|21186226|P3|STARTED|Overall Study||434
8593452|NCT02047734|21186227|P2|STARTED|Overall Study||443
8593453|NCT02047734|21186228|P1|STARTED|Overall Study||443
8593454|NCT01995175|21186269|P1|NOT COMPLETED|Overall Study||253
8593455|NCT01995175|21186269|P1|COMPLETED|Overall Study||2148
8593456|NCT01995175|21186269|P1|STARTED|Overall Study||2401
8593478|NCT01951638|21186698|P5|NOT COMPLETED|Follow-up Period||5
8593479|NCT01951638|21186699|P4|NOT COMPLETED|Follow-up Period||8
8593480|NCT01951638|21186700|P3|NOT COMPLETED|Follow-up Period||5
8593481|NCT01951638|21186701|P2|NOT COMPLETED|Follow-up Period||9
8593482|NCT01951638|21186702|P1|NOT COMPLETED|Follow-up Period||2
8593483|NCT01951638|21186698|P5|COMPLETED|Follow-up Period||89
8593484|NCT01951638|21186699|P4|COMPLETED|Follow-up Period||80
8593485|NCT01951638|21186700|P3|COMPLETED|Follow-up Period||90
8593486|NCT01951638|21186701|P2|COMPLETED|Follow-up Period||86
8593487|NCT01951638|21186702|P1|COMPLETED|Follow-up Period||87
8593488|NCT01951638|21186698|P5|STARTED|Follow-up Period||94
8593489|NCT01951638|21186699|P4|STARTED|Follow-up Period||88
8593490|NCT01951638|21186700|P3|STARTED|Follow-up Period||95
8593491|NCT01951638|21186701|P2|STARTED|Follow-up Period||95
8593492|NCT01951638|21186702|P1|STARTED|Follow-up Period||89
8593493|NCT01951638|21186698|P5|NOT COMPLETED|Treatment Period||10
8593494|NCT01951638|21186699|P4|NOT COMPLETED|Treatment Period||16
8593495|NCT01951638|21186700|P3|NOT COMPLETED|Treatment Period||13
8593496|NCT01951638|21186701|P2|NOT COMPLETED|Treatment Period||14
8593497|NCT01951638|21186702|P1|NOT COMPLETED|Treatment Period||13
8593498|NCT01951638|21186698|P5|COMPLETED|Treatment Period||86
8593499|NCT01951638|21186699|P4|COMPLETED|Treatment Period||80
8593500|NCT01951638|21186700|P3|COMPLETED|Treatment Period||83
8593501|NCT01951638|21186701|P2|COMPLETED|Treatment Period||82
8593502|NCT01951638|21186702|P1|COMPLETED|Treatment Period||80
8593503|NCT01951638|21186698|P5|STARTED|Treatment Period||96
8593504|NCT01951638|21186699|P4|STARTED|Treatment Period||96
8593505|NCT01951638|21186700|P3|STARTED|Treatment Period||96
8593506|NCT01951638|21186701|P2|STARTED|Treatment Period||96
8593507|NCT01951638|21186702|P1|STARTED|Treatment Period||93
8593508|NCT01908634|21186734|P1|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
8593509|NCT01908634|21186734|P1|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
8593510|NCT01908634|21186734|P1|STARTED|Water-based Strawberry Beverage w/o Meal||4
8593511|NCT01908634|21186734|P1|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
8593512|NCT01908634|21186734|P1|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
8593513|NCT01908634|21186734|P1|STARTED|Milk-based Strawberry Beverage w/o Meal||9
8593514|NCT01908634|21186734|P1|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
8593515|NCT01908634|21186734|P1|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
8593516|NCT01908634|21186734|P1|STARTED|Water-based Strawberry Beverage Wit Meal||10
8593517|NCT01908634|21186734|P1|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
8593518|NCT01908634|21186734|P1|COMPLETED|Milk-based Strawberry Beverage With Meal||10
8593519|NCT01908634|21186734|P1|STARTED|Milk-based Strawberry Beverage With Meal||10
8593520|NCT01899300|21186742|P2|NOT COMPLETED|Overall Study||0
8593521|NCT01899300|21186743|P1|NOT COMPLETED|Overall Study||0
8593522|NCT01899300|21186742|P2|COMPLETED|Overall Study||0
8593523|NCT01899300|21186743|P1|COMPLETED|Overall Study||1
8593524|NCT01899300|21186742|P2|STARTED|Overall Study||0
8593525|NCT01899300|21186743|P1|STARTED|Overall Study||1
8593526|NCT01886378|21186759|P1|NOT COMPLETED|Overall Study||5
8593527|NCT01886378|21186759|P1|COMPLETED|Overall Study||24
8593528|NCT01886378|21186759|P1|Completed 24 Weeks of UX007 Treatment|Overall Study||25
8593529|NCT01886378|21186759|P1|STARTED|Overall Study||29
8593530|NCT01874353|21186782|P2|NOT COMPLETED|Overall Study||73
8593531|NCT01874353|21186783|P1|NOT COMPLETED|Overall Study||127
8593532|NCT01874353|21186782|P2|COMPLETED|Overall Study||26
8593533|NCT01874353|21186783|P1|COMPLETED|Overall Study||69
8593534|NCT01874353|21186782|P2|STARTED|Overall Study||99
8593535|NCT01874353|21186783|P1|STARTED|Overall Study||196
8593544|NCT01835158|21186822|P2|NOT COMPLETED|Overall Study||6
8593545|NCT01835158|21186823|P1|NOT COMPLETED|Overall Study||1
8593546|NCT01835158|21186822|P2|COMPLETED|Overall Study||72
8593547|NCT01835158|21186823|P1|COMPLETED|Overall Study||78
8593548|NCT01835158|21186822|P2|STARTED|Overall Study||78
8593549|NCT01835158|21186823|P1|STARTED|Overall Study||79
8593550|NCT01822353|21186836|P3|NOT COMPLETED|Overall Study||1
8593551|NCT01822353|21186837|P2|NOT COMPLETED|Overall Study||5
8593552|NCT01822353|21186838|P1|NOT COMPLETED|Overall Study||4
8593553|NCT01822353|21186836|P3|COMPLETED|Overall Study||3
8593554|NCT01822353|21186837|P2|COMPLETED|Overall Study||4
8593555|NCT01822353|21186838|P1|COMPLETED|Overall Study||6
8593556|NCT01822353|21186836|P3|STARTED|Overall Study||4
8593557|NCT01822353|21186837|P2|STARTED|Overall Study||9
8593558|NCT01822353|21186838|P1|STARTED|Overall Study||10
8593568|NCT01776424|21186887|P3|NOT COMPLETED|Overall Study||24
8593569|NCT01776424|21186888|P2|NOT COMPLETED|Overall Study||19
8593570|NCT01776424|21186889|P1|NOT COMPLETED|Overall Study||20
8593571|NCT01776424|21186887|P3|COMPLETED|Overall Study||9102
8593572|NCT01776424|21186888|P2|COMPLETED|Overall Study||9098
8593573|NCT01776424|21186889|P1|COMPLETED|Overall Study||9132
8593574|NCT01776424|21186887|P3|Treated|Overall Study||9107
8593575|NCT01776424|21186888|P2|Treated|Overall Study||9110
8593576|NCT01776424|21186889|P1|Treated|Overall Study||9134
8593577|NCT01776424|21186887|P3|STARTED|Overall Study||9126
8593578|NCT01776424|21186888|P2|STARTED|Overall Study||9117
8593579|NCT01776424|21186889|P1|STARTED|Overall Study||9152
8593580|NCT01767792|21186909|P1|NOT COMPLETED|Overall Study||2
8593581|NCT01767792|21186909|P1|COMPLETED|Overall Study||20
8593582|NCT01767792|21186909|P1|STARTED|Overall Study||22
8593589|NCT01709084|21186930|P2|NOT COMPLETED|Overall Study||15
8593590|NCT01709084|21186931|P1|NOT COMPLETED|Overall Study||16
8593591|NCT01709084|21186930|P2|COMPLETED|Overall Study||198
8593592|NCT01709084|21186931|P1|COMPLETED|Overall Study||197
8593593|NCT01709084|21186930|P2|Treated|Overall Study||211
8593594|NCT01709084|21186931|P1|Treated|Overall Study||213
8593595|NCT01709084|21186930|P2|STARTED|Overall Study||213
8593596|NCT01709084|21186931|P1|STARTED|Overall Study||213
8593597|NCT01685320|21186949|P2|NOT COMPLETED|Overall Study||0
8593598|NCT01685320|21186950|P1|NOT COMPLETED|Overall Study||0
8593599|NCT01685320|21186949|P2|COMPLETED|Overall Study||15
8593600|NCT01685320|21186950|P1|COMPLETED|Overall Study||15
8593601|NCT01685320|21186949|P2|STARTED|Overall Study||15
8593602|NCT01685320|21186950|P1|STARTED|Overall Study||15
8593603|NCT01644565|21186958|P9|NOT COMPLETED|Overall Study||1
8593604|NCT01644565|21186959|P8|NOT COMPLETED|Overall Study||2
8593605|NCT01644565|21186960|P7|NOT COMPLETED|Overall Study||0
8593606|NCT01644565|21186961|P6|NOT COMPLETED|Overall Study||0
8593607|NCT01644565|21186962|P5|NOT COMPLETED|Overall Study||1
8593608|NCT01644565|21186963|P4|NOT COMPLETED|Overall Study||1
8593609|NCT01644565|21186964|P3|NOT COMPLETED|Overall Study||0
8593610|NCT01644565|21186965|P2|NOT COMPLETED|Overall Study||0
8593611|NCT01644565|21186966|P1|NOT COMPLETED|Overall Study||1
8593612|NCT01644565|21186958|P9|COMPLETED|Overall Study||7
8593613|NCT01644565|21186959|P8|COMPLETED|Overall Study||8
8593614|NCT01644565|21186960|P7|COMPLETED|Overall Study||7
8593615|NCT01644565|21186961|P6|COMPLETED|Overall Study||7
8593616|NCT01644565|21186962|P5|COMPLETED|Overall Study||4
8593617|NCT01644565|21186963|P4|COMPLETED|Overall Study||4
8593618|NCT01644565|21186964|P3|COMPLETED|Overall Study||5
8593619|NCT01644565|21186965|P2|COMPLETED|Overall Study||5
8593620|NCT01644565|21186966|P1|COMPLETED|Overall Study||4
8593621|NCT01644565|21186958|P9|STARTED|Overall Study||8
8593622|NCT01644565|21186959|P8|STARTED|Overall Study||10
8593623|NCT01644565|21186960|P7|STARTED|Overall Study||7
8593624|NCT01644565|21186961|P6|STARTED|Overall Study||7
8593625|NCT01644565|21186962|P5|STARTED|Overall Study||5
8593626|NCT01644565|21186963|P4|STARTED|Overall Study||5
8593627|NCT01644565|21186964|P3|STARTED|Overall Study||5
8593628|NCT01644565|21186965|P2|STARTED|Overall Study||5
8593629|NCT01644565|21186966|P1|STARTED|Overall Study||5
8593630|NCT01628393|21187007|P5|NOT COMPLETED|Blinded Active Extension Period||6
8593631|NCT01628393|21187008|P4|NOT COMPLETED|Blinded Active Extension Period||4
8593632|NCT01628393|21187009|P3|NOT COMPLETED|Blinded Active Extension Period||6
8593633|NCT01628393|21187010|P2|NOT COMPLETED|Blinded Active Extension Period||10
8593634|NCT01628393|21187011|P1|NOT COMPLETED|Blinded Active Extension Period||0
8593635|NCT01628393|21187007|P5|COMPLETED|Blinded Active Extension Period||36
8593636|NCT01628393|21187008|P4|COMPLETED|Blinded Active Extension Period||37
8593637|NCT01628393|21187009|P3|COMPLETED|Blinded Active Extension Period||75
8593638|NCT01628393|21187010|P2|COMPLETED|Blinded Active Extension Period||75
8593639|NCT01628393|21187011|P1|COMPLETED|Blinded Active Extension Period||0
8593640|NCT01628393|21187007|P5|STARTED|Blinded Active Extension Period||42
8593641|NCT01628393|21187008|P4|STARTED|Blinded Active Extension Period||41
8593642|NCT01628393|21187009|P3|STARTED|Blinded Active Extension Period||81
8593643|NCT01628393|21187010|P2|STARTED|Blinded Active Extension Period||85
8593644|NCT01628393|21187011|P1|STARTED|Blinded Active Extension Period||0
8593645|NCT01628393|21187007|P5|NOT COMPLETED|Placebo-controlled Treatment Period||0
8593646|NCT01628393|21187008|P4|NOT COMPLETED|Placebo-controlled Treatment Period||0
8593647|NCT01628393|21187009|P3|NOT COMPLETED|Placebo-controlled Treatment Period||1
8593648|NCT01628393|21187010|P2|NOT COMPLETED|Placebo-controlled Treatment Period||2
8593649|NCT01628393|21187011|P1|NOT COMPLETED|Placebo-controlled Treatment Period||3
8593650|NCT01628393|21187007|P5|COMPLETED|Placebo-controlled Treatment Period||0
8593651|NCT01628393|21187008|P4|COMPLETED|Placebo-controlled Treatment Period||0
8593652|NCT01628393|21187009|P3|COMPLETED|Placebo-controlled Treatment Period||82
8593653|NCT01628393|21187010|P2|COMPLETED|Placebo-controlled Treatment Period||85
8593654|NCT01628393|21187011|P1|COMPLETED|Placebo-controlled Treatment Period||85
8593655|NCT01628393|21187007|P5|STARTED|Placebo-controlled Treatment Period||0
8593656|NCT01628393|21187008|P4|STARTED|Placebo-controlled Treatment Period||0
8593657|NCT01628393|21187009|P3|STARTED|Placebo-controlled Treatment Period||83
8593658|NCT01628393|21187010|P2|STARTED|Placebo-controlled Treatment Period||87
8593659|NCT01628393|21187011|P1|STARTED|Placebo-controlled Treatment Period||88
8593660|NCT01602380|21187047|P2|NOT COMPLETED|Overall Study||101
8593661|NCT01602380|21187048|P1|NOT COMPLETED|Overall Study||93
8593662|NCT01602380|21187047|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
8593663|NCT01602380|21187048|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
8593664|NCT01602380|21187047|P2|STARTED|Overall Study||232
8593665|NCT01602380|21187048|P1|STARTED|Overall Study||230
8593672|NCT01536795|21187081|P2|NOT COMPLETED|Overall Study||2
8593673|NCT01536795|21187082|P1|NOT COMPLETED|Overall Study||1
8593674|NCT01536795|21187081|P2|COMPLETED|Overall Study||22
8593675|NCT01536795|21187082|P1|COMPLETED|Overall Study||23
8593676|NCT01536795|21187081|P2|STARTED|Overall Study||24
8593677|NCT01536795|21187082|P1|STARTED|Overall Study||24
8593687|NCT01501955|21187111|P2|NOT COMPLETED|Overall Study||3
8593688|NCT01501955|21187112|P1|NOT COMPLETED|Overall Study||2
8593689|NCT01501955|21187111|P2|COMPLETED|Overall Study||6
8593690|NCT01501955|21187112|P1|COMPLETED|Overall Study||9
8593691|NCT01501955|21187111|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
8593692|NCT01501955|21187112|P1|2 Years Postop|Overall Study||9
8593693|NCT01501955|21187111|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
8593694|NCT01501955|21187112|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
8593695|NCT01501955|21187111|P2|6 Weeks Postop|Overall Study||9
8593696|NCT01501955|21187112|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
8593697|NCT01501955|21187111|P2|Surgery|Overall Study||9
8593698|NCT01501955|21187112|P1|Surgery|Overall Study||11
8593699|NCT01501955|21187111|P2|STARTED|Overall Study||9
8593700|NCT01501955|21187112|P1|STARTED|Overall Study||11
8593701|NCT01422304|21187156|P2|NOT COMPLETED|Overall Study||37
8593702|NCT01422304|21187157|P1|NOT COMPLETED|Overall Study||24
8593703|NCT01422304|21187156|P2|COMPLETED|Overall Study||563
8593704|NCT01422304|21187157|P1|COMPLETED|Overall Study||574
8593705|NCT01422304|21187156|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
8593706|NCT01422304|21187157|P1|Treated|Overall Study||595
8593707|NCT01422304|21187156|P2|STARTED|Overall Study|Randomized|600
8593708|NCT01422304|21187157|P1|STARTED|Overall Study|Randomized|598
8593709|NCT01383018|21187187|P1|NOT COMPLETED|Overall Study||375
8593710|NCT01383018|21187187|P1|COMPLETED|Overall Study||1082
8593711|NCT01383018|21187187|P1|STARTED|Overall Study||1457
8593712|NCT01347541|21187229|P2|NOT COMPLETED|Overall Study||0
8593713|NCT01347541|21187230|P1|NOT COMPLETED|Overall Study||0
8593714|NCT01347541|21187229|P2|COMPLETED|Overall Study||1
8593715|NCT01347541|21187230|P1|COMPLETED|Overall Study||3
8593716|NCT01347541|21187229|P2|STARTED|Overall Study||1
8593717|NCT01347541|21187230|P1|STARTED|Overall Study||3
8593718|NCT01321151|21187242|P2|NOT COMPLETED|Overall Study||0
8593719|NCT01321151|21187243|P1|NOT COMPLETED|Overall Study||0
8593720|NCT01321151|21187242|P2|COMPLETED|Overall Study||6
8593721|NCT01321151|21187243|P1|COMPLETED|Overall Study||6
8593722|NCT01321151|21187242|P2|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
8593723|NCT01321151|21187243|P1|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
8593724|NCT01275677|21187261|P2|NOT COMPLETED|Overall Study||42
8593725|NCT01275677|21187262|P1|NOT COMPLETED|Overall Study||28
8593726|NCT01275677|21187261|P2|COMPLETED|Overall Study||1598
8593727|NCT01275677|21187262|P1|COMPLETED|Overall Study||1602
8593728|NCT01275677|21187261|P2|STARTED|Overall Study||1640
8593729|NCT01275677|21187262|P1|STARTED|Overall Study||1630
8593730|NCT01272284|21187280|P1|NOT COMPLETED|12-month Follow-up Visit||4
8593731|NCT01272284|21187280|P1|COMPLETED|12-month Follow-up Visit||105
8593732|NCT01272284|21187280|P1|STARTED|12-month Follow-up Visit||109
8593733|NCT01272284|21187280|P1|NOT COMPLETED|6-month Follow-up Visit||3
8593734|NCT01272284|21187280|P1|COMPLETED|6-month Follow-up Visit||109
8593735|NCT01272284|21187280|P1|STARTED|6-month Follow-up Visit||112
8593736|NCT01272284|21187280|P1|NOT COMPLETED|3-month Follow-up Visit||1
8593737|NCT01272284|21187280|P1|COMPLETED|3-month Follow-up Visit||112
8593738|NCT01272284|21187280|P1|STARTED|3-month Follow-up Visit||113
8593739|NCT01250912|21187294|P1|NOT COMPLETED|Overall Study||1
8593740|NCT01250912|21187294|P1|COMPLETED|Overall Study||19
8593741|NCT01250912|21187294|P1|STARTED|Overall Study||20
8593742|NCT01199848|21187301|P1|NOT COMPLETED|40G STRB Arm||0
8593743|NCT01199848|21187301|P1|COMPLETED|40G STRB Arm||21
8593744|NCT01199848|21187301|P1|STARTED|40G STRB Arm||21
8593745|NCT01199848|21187301|P1|NOT COMPLETED|20G STRB Arm||0
8593746|NCT01199848|21187301|P1|COMPLETED|20G STRB Arm||21
8593747|NCT01199848|21187301|P1|STARTED|20G STRB Arm||21
8593748|NCT01199848|21187301|P1|NOT COMPLETED|10g STR Arm||0
8593749|NCT01199848|21187301|P1|COMPLETED|10g STR Arm||21
8593750|NCT01199848|21187301|P1|STARTED|10g STR Arm||21
8593751|NCT01199848|21187301|P1|NOT COMPLETED|Placebo Arm||8
8593752|NCT01199848|21187301|P1|COMPLETED|Placebo Arm||21
8593753|NCT01199848|21187301|P1|STARTED|Placebo Arm||29
8593754|NCT01169259|21187319|P4|NOT COMPLETED|Overall Study||0
8593755|NCT01169259|21187320|P3|NOT COMPLETED|Overall Study||0
8593756|NCT01169259|21187321|P2|NOT COMPLETED|Overall Study||0
8593757|NCT01169259|21187322|P1|NOT COMPLETED|Overall Study||0
8593758|NCT01169259|21187319|P4|COMPLETED|Overall Study||6474
8593759|NCT01169259|21187320|P3|COMPLETED|Overall Study||6470
8593760|NCT01169259|21187321|P2|COMPLETED|Overall Study||6464
8593761|NCT01169259|21187322|P1|COMPLETED|Overall Study||6463
8593762|NCT01169259|21187319|P4|STARTED|Overall Study||6474
8593763|NCT01169259|21187320|P3|STARTED|Overall Study||6470
8593764|NCT01169259|21187321|P2|STARTED|Overall Study||6464
8593765|NCT01169259|21187322|P1|STARTED|Overall Study||6463
8593766|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593767|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593768|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593769|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593770|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593771|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593772|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593773|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593774|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593775|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593776|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593777|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593778|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593779|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593780|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8593781|NCT01116648|21187447|P15|COMPLETED|Phase 1-T PKCed Expansion||7
8593782|NCT01116648|21187448|P14|COMPLETED|Phase 1-T PKCed Expansion||0
8593783|NCT01116648|21187449|P13|COMPLETED|Phase 1-T PKCed Expansion||0
8593784|NCT01116648|21187450|P12|COMPLETED|Phase 1-T PKCed Expansion||0
8593785|NCT01116648|21187451|P11|COMPLETED|Phase 1-T PKCed Expansion||0
8593786|NCT01116648|21187452|P10|COMPLETED|Phase 1-T PKCed Expansion||0
8593787|NCT01116648|21187453|P9|COMPLETED|Phase 1-T PKCed Expansion||0
8593788|NCT01116648|21187454|P8|COMPLETED|Phase 1-T PKCed Expansion||0
8593789|NCT01116648|21187455|P7|COMPLETED|Phase 1-T PKCed Expansion||0
8593790|NCT01116648|21187456|P6|COMPLETED|Phase 1-T PKCed Expansion||0
8593791|NCT01116648|21187457|P5|COMPLETED|Phase 1-T PKCed Expansion||0
8593792|NCT01116648|21187458|P4|COMPLETED|Phase 1-T PKCed Expansion||0
8593793|NCT01116648|21187459|P3|COMPLETED|Phase 1-T PKCed Expansion||0
8593794|NCT01116648|21187460|P2|COMPLETED|Phase 1-T PKCed Expansion||0
8593795|NCT01116648|21187461|P1|COMPLETED|Phase 1-T PKCed Expansion||0
8593796|NCT01116648|21187447|P15|STARTED|Phase 1-T PKCed Expansion||7
8593797|NCT01116648|21187448|P14|STARTED|Phase 1-T PKCed Expansion||0
8593798|NCT01116648|21187449|P13|STARTED|Phase 1-T PKCed Expansion||0
8593799|NCT01116648|21187450|P12|STARTED|Phase 1-T PKCed Expansion||0
8593800|NCT01116648|21187451|P11|STARTED|Phase 1-T PKCed Expansion||0
8593801|NCT01116648|21187452|P10|STARTED|Phase 1-T PKCed Expansion||0
8593802|NCT01116648|21187453|P9|STARTED|Phase 1-T PKCed Expansion||0
8593803|NCT01116648|21187454|P8|STARTED|Phase 1-T PKCed Expansion||0
8593804|NCT01116648|21187455|P7|STARTED|Phase 1-T PKCed Expansion||0
8593805|NCT01116648|21187456|P6|STARTED|Phase 1-T PKCed Expansion||0
8593806|NCT01116648|21187457|P5|STARTED|Phase 1-T PKCed Expansion||0
8593807|NCT01116648|21187458|P4|STARTED|Phase 1-T PKCed Expansion||0
8593808|NCT01116648|21187459|P3|STARTED|Phase 1-T PKCed Expansion||0
8593809|NCT01116648|21187460|P2|STARTED|Phase 1-T PKCed Expansion||0
8593810|NCT01116648|21187461|P1|STARTED|Phase 1-T PKCed Expansion||0
8593811|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593812|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593813|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593814|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593815|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593816|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593817|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593818|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593819|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593820|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593821|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593822|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593823|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593824|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593825|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8593826|NCT01116648|21187447|P15|COMPLETED|Phase 1-T PKOlap Expansion||0
8593827|NCT01116648|21187448|P14|COMPLETED|Phase 1-T PKOlap Expansion||6
8593828|NCT01116648|21187449|P13|COMPLETED|Phase 1-T PKOlap Expansion||0
8593829|NCT01116648|21187450|P12|COMPLETED|Phase 1-T PKOlap Expansion||0
8593830|NCT01116648|21187451|P11|COMPLETED|Phase 1-T PKOlap Expansion||0
8593831|NCT01116648|21187452|P10|COMPLETED|Phase 1-T PKOlap Expansion||0
8593832|NCT01116648|21187453|P9|COMPLETED|Phase 1-T PKOlap Expansion||0
8593833|NCT01116648|21187454|P8|COMPLETED|Phase 1-T PKOlap Expansion||0
8593834|NCT01116648|21187455|P7|COMPLETED|Phase 1-T PKOlap Expansion||0
8593835|NCT01116648|21187456|P6|COMPLETED|Phase 1-T PKOlap Expansion||0
8593836|NCT01116648|21187457|P5|COMPLETED|Phase 1-T PKOlap Expansion||0
8593837|NCT01116648|21187458|P4|COMPLETED|Phase 1-T PKOlap Expansion||0
8593838|NCT01116648|21187459|P3|COMPLETED|Phase 1-T PKOlap Expansion||0
8593839|NCT01116648|21187460|P2|COMPLETED|Phase 1-T PKOlap Expansion||0
8593840|NCT01116648|21187461|P1|COMPLETED|Phase 1-T PKOlap Expansion||0
8593841|NCT01116648|21187447|P15|STARTED|Phase 1-T PKOlap Expansion||0
8593842|NCT01116648|21187448|P14|STARTED|Phase 1-T PKOlap Expansion||6
8593843|NCT01116648|21187449|P13|STARTED|Phase 1-T PKOlap Expansion||0
8593844|NCT01116648|21187450|P12|STARTED|Phase 1-T PKOlap Expansion||0
8593845|NCT01116648|21187451|P11|STARTED|Phase 1-T PKOlap Expansion||0
8593846|NCT01116648|21187452|P10|STARTED|Phase 1-T PKOlap Expansion||0
8593847|NCT01116648|21187453|P9|STARTED|Phase 1-T PKOlap Expansion||0
8593848|NCT01116648|21187454|P8|STARTED|Phase 1-T PKOlap Expansion||0
8593849|NCT01116648|21187455|P7|STARTED|Phase 1-T PKOlap Expansion||0
8593850|NCT01116648|21187456|P6|STARTED|Phase 1-T PKOlap Expansion||0
8593851|NCT01116648|21187457|P5|STARTED|Phase 1-T PKOlap Expansion||0
8593852|NCT01116648|21187458|P4|STARTED|Phase 1-T PKOlap Expansion||0
8593853|NCT01116648|21187459|P3|STARTED|Phase 1-T PKOlap Expansion||0
8593854|NCT01116648|21187460|P2|STARTED|Phase 1-T PKOlap Expansion||0
8593855|NCT01116648|21187461|P1|STARTED|Phase 1-T PKOlap Expansion||0
8593856|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593857|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593858|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593859|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593860|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593861|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593862|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593863|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593864|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593865|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593866|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593867|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593868|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593869|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593870|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8593871|NCT01116648|21187447|P15|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593872|NCT01116648|21187448|P14|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593873|NCT01116648|21187449|P13|COMPLETED|Phase 1-T Dose Level 2-TB||6
8593874|NCT01116648|21187450|P12|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593875|NCT01116648|21187451|P11|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593876|NCT01116648|21187452|P10|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593877|NCT01116648|21187453|P9|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593878|NCT01116648|21187454|P8|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593879|NCT01116648|21187455|P7|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593880|NCT01116648|21187456|P6|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593881|NCT01116648|21187457|P5|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593882|NCT01116648|21187458|P4|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593883|NCT01116648|21187459|P3|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593884|NCT01116648|21187460|P2|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593885|NCT01116648|21187461|P1|COMPLETED|Phase 1-T Dose Level 2-TB||0
8593886|NCT01116648|21187447|P15|STARTED|Phase 1-T Dose Level 2-TB||0
8593887|NCT01116648|21187448|P14|STARTED|Phase 1-T Dose Level 2-TB||0
8593888|NCT01116648|21187449|P13|STARTED|Phase 1-T Dose Level 2-TB||6
8593889|NCT01116648|21187450|P12|STARTED|Phase 1-T Dose Level 2-TB||0
8593890|NCT01116648|21187451|P11|STARTED|Phase 1-T Dose Level 2-TB||0
8593891|NCT01116648|21187452|P10|STARTED|Phase 1-T Dose Level 2-TB||0
8593892|NCT01116648|21187453|P9|STARTED|Phase 1-T Dose Level 2-TB||0
8593893|NCT01116648|21187454|P8|STARTED|Phase 1-T Dose Level 2-TB||0
8593894|NCT01116648|21187455|P7|STARTED|Phase 1-T Dose Level 2-TB||0
8593895|NCT01116648|21187456|P6|STARTED|Phase 1-T Dose Level 2-TB||0
8593896|NCT01116648|21187457|P5|STARTED|Phase 1-T Dose Level 2-TB||0
8593897|NCT01116648|21187458|P4|STARTED|Phase 1-T Dose Level 2-TB||0
8593898|NCT01116648|21187459|P3|STARTED|Phase 1-T Dose Level 2-TB||0
8593899|NCT01116648|21187460|P2|STARTED|Phase 1-T Dose Level 2-TB||0
8593900|NCT01116648|21187461|P1|STARTED|Phase 1-T Dose Level 2-TB||0
8593901|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593902|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593903|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593904|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593905|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593906|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593907|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593908|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593909|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593910|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593911|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593912|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593913|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593914|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593915|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8593916|NCT01116648|21187447|P15|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593917|NCT01116648|21187448|P14|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593918|NCT01116648|21187449|P13|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593919|NCT01116648|21187450|P12|COMPLETED|Phase 1-T Dose Level 1-TB||3
8593920|NCT01116648|21187451|P11|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593921|NCT01116648|21187452|P10|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593922|NCT01116648|21187453|P9|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593923|NCT01116648|21187454|P8|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593924|NCT01116648|21187455|P7|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593925|NCT01116648|21187456|P6|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593926|NCT01116648|21187457|P5|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593927|NCT01116648|21187458|P4|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593928|NCT01116648|21187459|P3|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593929|NCT01116648|21187460|P2|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593930|NCT01116648|21187461|P1|COMPLETED|Phase 1-T Dose Level 1-TB||0
8593931|NCT01116648|21187447|P15|STARTED|Phase 1-T Dose Level 1-TB||0
8593932|NCT01116648|21187448|P14|STARTED|Phase 1-T Dose Level 1-TB||0
8593933|NCT01116648|21187449|P13|STARTED|Phase 1-T Dose Level 1-TB||0
8593934|NCT01116648|21187450|P12|STARTED|Phase 1-T Dose Level 1-TB||3
8593935|NCT01116648|21187451|P11|STARTED|Phase 1-T Dose Level 1-TB||0
8593936|NCT01116648|21187452|P10|STARTED|Phase 1-T Dose Level 1-TB||0
8593937|NCT01116648|21187453|P9|STARTED|Phase 1-T Dose Level 1-TB||0
8593938|NCT01116648|21187454|P8|STARTED|Phase 1-T Dose Level 1-TB||0
8593939|NCT01116648|21187455|P7|STARTED|Phase 1-T Dose Level 1-TB||0
8593940|NCT01116648|21187456|P6|STARTED|Phase 1-T Dose Level 1-TB||0
8593941|NCT01116648|21187457|P5|STARTED|Phase 1-T Dose Level 1-TB||0
8593942|NCT01116648|21187458|P4|STARTED|Phase 1-T Dose Level 1-TB||0
8593943|NCT01116648|21187459|P3|STARTED|Phase 1-T Dose Level 1-TB||0
8593944|NCT01116648|21187460|P2|STARTED|Phase 1-T Dose Level 1-TB||0
8593945|NCT01116648|21187461|P1|STARTED|Phase 1-T Dose Level 1-TB||0
8593946|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593947|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593948|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593949|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593950|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593951|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593952|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593953|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593954|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593955|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593956|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593957|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593958|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593959|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593960|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8593961|NCT01116648|21187447|P15|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593962|NCT01116648|21187448|P14|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593963|NCT01116648|21187449|P13|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593964|NCT01116648|21187450|P12|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593965|NCT01116648|21187451|P11|COMPLETED|Phase 1-T Dose Level 0-TB||3
8593966|NCT01116648|21187452|P10|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593967|NCT01116648|21187453|P9|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593968|NCT01116648|21187454|P8|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593969|NCT01116648|21187455|P7|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593970|NCT01116648|21187456|P6|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593971|NCT01116648|21187457|P5|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593972|NCT01116648|21187458|P4|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593973|NCT01116648|21187459|P3|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593974|NCT01116648|21187460|P2|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593975|NCT01116648|21187461|P1|COMPLETED|Phase 1-T Dose Level 0-TB||0
8593976|NCT01116648|21187447|P15|STARTED|Phase 1-T Dose Level 0-TB||0
8593977|NCT01116648|21187448|P14|STARTED|Phase 1-T Dose Level 0-TB||0
8593978|NCT01116648|21187449|P13|STARTED|Phase 1-T Dose Level 0-TB||0
8593979|NCT01116648|21187450|P12|STARTED|Phase 1-T Dose Level 0-TB||0
8593980|NCT01116648|21187451|P11|STARTED|Phase 1-T Dose Level 0-TB||3
8593981|NCT01116648|21187452|P10|STARTED|Phase 1-T Dose Level 0-TB||0
8593982|NCT01116648|21187453|P9|STARTED|Phase 1-T Dose Level 0-TB||0
8593983|NCT01116648|21187454|P8|STARTED|Phase 1-T Dose Level 0-TB||0
8593984|NCT01116648|21187455|P7|STARTED|Phase 1-T Dose Level 0-TB||0
8593985|NCT01116648|21187456|P6|STARTED|Phase 1-T Dose Level 0-TB||0
8593986|NCT01116648|21187457|P5|STARTED|Phase 1-T Dose Level 0-TB||0
8593987|NCT01116648|21187458|P4|STARTED|Phase 1-T Dose Level 0-TB||0
8593988|NCT01116648|21187459|P3|STARTED|Phase 1-T Dose Level 0-TB||0
8593989|NCT01116648|21187460|P2|STARTED|Phase 1-T Dose Level 0-TB||0
8593990|NCT01116648|21187461|P1|STARTED|Phase 1-T Dose Level 0-TB||0
8593991|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593992|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593993|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593994|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593995|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593996|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593997|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593998|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8593999|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8594000|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8594001|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8594002|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8594003|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8594004|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8594005|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8594006|NCT01116648|21187447|P15|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594007|NCT01116648|21187448|P14|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594008|NCT01116648|21187449|P13|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594009|NCT01116648|21187450|P12|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594010|NCT01116648|21187451|P11|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594011|NCT01116648|21187452|P10|COMPLETED|Phase 1-T Dose Level 2-TA||3
8594012|NCT01116648|21187453|P9|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594013|NCT01116648|21187454|P8|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594014|NCT01116648|21187455|P7|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594015|NCT01116648|21187456|P6|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594016|NCT01116648|21187457|P5|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594017|NCT01116648|21187458|P4|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594018|NCT01116648|21187459|P3|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594019|NCT01116648|21187460|P2|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594020|NCT01116648|21187461|P1|COMPLETED|Phase 1-T Dose Level 2-TA||0
8594021|NCT01116648|21187447|P15|STARTED|Phase 1-T Dose Level 2-TA||0
8594022|NCT01116648|21187448|P14|STARTED|Phase 1-T Dose Level 2-TA||0
8594023|NCT01116648|21187449|P13|STARTED|Phase 1-T Dose Level 2-TA||0
8594024|NCT01116648|21187450|P12|STARTED|Phase 1-T Dose Level 2-TA||0
8594025|NCT01116648|21187451|P11|STARTED|Phase 1-T Dose Level 2-TA||0
8594026|NCT01116648|21187452|P10|STARTED|Phase 1-T Dose Level 2-TA||3
8594027|NCT01116648|21187453|P9|STARTED|Phase 1-T Dose Level 2-TA||0
8594028|NCT01116648|21187454|P8|STARTED|Phase 1-T Dose Level 2-TA||0
8594029|NCT01116648|21187455|P7|STARTED|Phase 1-T Dose Level 2-TA||0
8594030|NCT01116648|21187456|P6|STARTED|Phase 1-T Dose Level 2-TA||0
8594031|NCT01116648|21187457|P5|STARTED|Phase 1-T Dose Level 2-TA||0
8594032|NCT01116648|21187458|P4|STARTED|Phase 1-T Dose Level 2-TA||0
8594033|NCT01116648|21187459|P3|STARTED|Phase 1-T Dose Level 2-TA||0
8594034|NCT01116648|21187460|P2|STARTED|Phase 1-T Dose Level 2-TA||0
8594035|NCT01116648|21187461|P1|STARTED|Phase 1-T Dose Level 2-TA||0
8594036|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594037|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594038|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594039|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594040|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594041|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594042|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594043|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594044|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594045|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594046|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594047|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594048|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594049|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594050|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8594051|NCT01116648|21187447|P15|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594052|NCT01116648|21187448|P14|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594053|NCT01116648|21187449|P13|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594054|NCT01116648|21187450|P12|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594055|NCT01116648|21187451|P11|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594056|NCT01116648|21187452|P10|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594057|NCT01116648|21187453|P9|COMPLETED|Phase 1-T Dose Level 1-TA||6
8594058|NCT01116648|21187454|P8|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594059|NCT01116648|21187455|P7|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594060|NCT01116648|21187456|P6|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594061|NCT01116648|21187457|P5|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594062|NCT01116648|21187458|P4|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594063|NCT01116648|21187459|P3|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594064|NCT01116648|21187460|P2|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594065|NCT01116648|21187461|P1|COMPLETED|Phase 1-T Dose Level 1-TA||0
8594066|NCT01116648|21187447|P15|STARTED|Phase 1-T Dose Level 1-TA||0
8594067|NCT01116648|21187448|P14|STARTED|Phase 1-T Dose Level 1-TA||0
8594068|NCT01116648|21187449|P13|STARTED|Phase 1-T Dose Level 1-TA||0
8594069|NCT01116648|21187450|P12|STARTED|Phase 1-T Dose Level 1-TA||0
8594070|NCT01116648|21187451|P11|STARTED|Phase 1-T Dose Level 1-TA||0
8594071|NCT01116648|21187452|P10|STARTED|Phase 1-T Dose Level 1-TA||0
8594072|NCT01116648|21187453|P9|STARTED|Phase 1-T Dose Level 1-TA||6
8594073|NCT01116648|21187454|P8|STARTED|Phase 1-T Dose Level 1-TA||0
8594074|NCT01116648|21187455|P7|STARTED|Phase 1-T Dose Level 1-TA||0
8594075|NCT01116648|21187456|P6|STARTED|Phase 1-T Dose Level 1-TA||0
8594076|NCT01116648|21187457|P5|STARTED|Phase 1-T Dose Level 1-TA||0
8594077|NCT01116648|21187458|P4|STARTED|Phase 1-T Dose Level 1-TA||0
8594078|NCT01116648|21187459|P3|STARTED|Phase 1-T Dose Level 1-TA||0
8594079|NCT01116648|21187460|P2|STARTED|Phase 1-T Dose Level 1-TA||0
8594080|NCT01116648|21187461|P1|STARTED|Phase 1-T Dose Level 1-TA||0
8594081|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594082|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594083|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594084|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594085|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594086|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594087|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594088|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594089|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594090|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594091|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594092|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594093|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594094|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594095|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8594096|NCT01116648|21187447|P15|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594097|NCT01116648|21187448|P14|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594098|NCT01116648|21187449|P13|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594099|NCT01116648|21187450|P12|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594100|NCT01116648|21187451|P11|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594101|NCT01116648|21187452|P10|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594102|NCT01116648|21187453|P9|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594103|NCT01116648|21187454|P8|COMPLETED|Phase 1-T Dose Level 0-TA||3
8594104|NCT01116648|21187455|P7|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594105|NCT01116648|21187456|P6|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594106|NCT01116648|21187457|P5|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594107|NCT01116648|21187458|P4|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594108|NCT01116648|21187459|P3|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594109|NCT01116648|21187460|P2|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594110|NCT01116648|21187461|P1|COMPLETED|Phase 1-T Dose Level 0-TA||0
8594111|NCT01116648|21187447|P15|STARTED|Phase 1-T Dose Level 0-TA||0
8594112|NCT01116648|21187448|P14|STARTED|Phase 1-T Dose Level 0-TA||0
8594113|NCT01116648|21187449|P13|STARTED|Phase 1-T Dose Level 0-TA||0
8594114|NCT01116648|21187450|P12|STARTED|Phase 1-T Dose Level 0-TA||0
8594115|NCT01116648|21187451|P11|STARTED|Phase 1-T Dose Level 0-TA||0
8594116|NCT01116648|21187452|P10|STARTED|Phase 1-T Dose Level 0-TA||0
8594117|NCT01116648|21187453|P9|STARTED|Phase 1-T Dose Level 0-TA||0
8594118|NCT01116648|21187454|P8|STARTED|Phase 1-T Dose Level 0-TA||3
8594119|NCT01116648|21187455|P7|STARTED|Phase 1-T Dose Level 0-TA||0
8594120|NCT01116648|21187456|P6|STARTED|Phase 1-T Dose Level 0-TA||0
8594121|NCT01116648|21187457|P5|STARTED|Phase 1-T Dose Level 0-TA||0
8594122|NCT01116648|21187458|P4|STARTED|Phase 1-T Dose Level 0-TA||0
8594123|NCT01116648|21187459|P3|STARTED|Phase 1-T Dose Level 0-TA||0
8594124|NCT01116648|21187460|P2|STARTED|Phase 1-T Dose Level 0-TA||0
8594125|NCT01116648|21187461|P1|STARTED|Phase 1-T Dose Level 0-TA||0
8594126|NCT01116648|21187447|P15|NOT COMPLETED|Phase 2||0
8594127|NCT01116648|21187448|P14|NOT COMPLETED|Phase 2||0
8594128|NCT01116648|21187449|P13|NOT COMPLETED|Phase 2||0
8594129|NCT01116648|21187450|P12|NOT COMPLETED|Phase 2||0
8594130|NCT01116648|21187451|P11|NOT COMPLETED|Phase 2||0
8594131|NCT01116648|21187452|P10|NOT COMPLETED|Phase 2||0
8594132|NCT01116648|21187453|P9|NOT COMPLETED|Phase 2||0
8594133|NCT01116648|21187454|P8|NOT COMPLETED|Phase 2||0
8594134|NCT01116648|21187455|P7|NOT COMPLETED|Phase 2||0
8594135|NCT01116648|21187456|P6|NOT COMPLETED|Phase 2||0
8594136|NCT01116648|21187457|P5|NOT COMPLETED|Phase 2||0
8594137|NCT01116648|21187458|P4|NOT COMPLETED|Phase 2||0
8594138|NCT01116648|21187459|P3|NOT COMPLETED|Phase 2||0
8594139|NCT01116648|21187460|P2|NOT COMPLETED|Phase 2||0
8594140|NCT01116648|21187461|P1|NOT COMPLETED|Phase 2||0
8594141|NCT01116648|21187447|P15|COMPLETED|Phase 2||0
8594142|NCT01116648|21187448|P14|COMPLETED|Phase 2||0
8594143|NCT01116648|21187449|P13|COMPLETED|Phase 2||0
8594144|NCT01116648|21187450|P12|COMPLETED|Phase 2||0
8594145|NCT01116648|21187451|P11|COMPLETED|Phase 2||0
8594146|NCT01116648|21187452|P10|COMPLETED|Phase 2||0
8594147|NCT01116648|21187453|P9|COMPLETED|Phase 2||0
8594148|NCT01116648|21187454|P8|COMPLETED|Phase 2||0
8594149|NCT01116648|21187455|P7|COMPLETED|Phase 2||44
8594150|NCT01116648|21187456|P6|COMPLETED|Phase 2||46
8594151|NCT01116648|21187457|P5|COMPLETED|Phase 2||0
8594152|NCT01116648|21187458|P4|COMPLETED|Phase 2||0
8594153|NCT01116648|21187459|P3|COMPLETED|Phase 2||0
8594154|NCT01116648|21187460|P2|COMPLETED|Phase 2||0
8594155|NCT01116648|21187461|P1|COMPLETED|Phase 2||0
8594156|NCT01116648|21187447|P15|STARTED|Phase 2||0
8594157|NCT01116648|21187448|P14|STARTED|Phase 2||0
8594158|NCT01116648|21187449|P13|STARTED|Phase 2||0
8594159|NCT01116648|21187450|P12|STARTED|Phase 2||0
8594160|NCT01116648|21187451|P11|STARTED|Phase 2||0
8594161|NCT01116648|21187452|P10|STARTED|Phase 2||0
8594162|NCT01116648|21187453|P9|STARTED|Phase 2||0
8594163|NCT01116648|21187454|P8|STARTED|Phase 2||0
8594164|NCT01116648|21187455|P7|STARTED|Phase 2||44
8594165|NCT01116648|21187456|P6|STARTED|Phase 2||46
8594166|NCT01116648|21187457|P5|STARTED|Phase 2||0
8594167|NCT01116648|21187458|P4|STARTED|Phase 2||0
8594168|NCT01116648|21187459|P3|STARTED|Phase 2||0
8594169|NCT01116648|21187460|P2|STARTED|Phase 2||0
8594170|NCT01116648|21187461|P1|STARTED|Phase 2||0
8594171|NCT01116648|21187447|P15|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594172|NCT01116648|21187448|P14|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594173|NCT01116648|21187449|P13|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594174|NCT01116648|21187450|P12|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594175|NCT01116648|21187451|P11|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594176|NCT01116648|21187452|P10|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594177|NCT01116648|21187453|P9|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594178|NCT01116648|21187454|P8|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594179|NCT01116648|21187455|P7|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594180|NCT01116648|21187456|P6|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594181|NCT01116648|21187457|P5|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594182|NCT01116648|21187458|P4|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594183|NCT01116648|21187459|P3|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594184|NCT01116648|21187460|P2|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594185|NCT01116648|21187461|P1|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8594186|NCT01116648|21187447|P15|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594187|NCT01116648|21187448|P14|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594188|NCT01116648|21187449|P13|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594189|NCT01116648|21187450|P12|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594190|NCT01116648|21187451|P11|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594191|NCT01116648|21187452|P10|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594192|NCT01116648|21187453|P9|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594193|NCT01116648|21187454|P8|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594194|NCT01116648|21187455|P7|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594195|NCT01116648|21187456|P6|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594196|NCT01116648|21187457|P5|COMPLETED|Expansion at Maximum Tolerated Dose||9
8594197|NCT01116648|21187458|P4|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594198|NCT01116648|21187459|P3|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594199|NCT01116648|21187460|P2|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594200|NCT01116648|21187461|P1|COMPLETED|Expansion at Maximum Tolerated Dose||0
8594201|NCT01116648|21187447|P15|STARTED|Expansion at Maximum Tolerated Dose||0
8594202|NCT01116648|21187448|P14|STARTED|Expansion at Maximum Tolerated Dose||0
8594203|NCT01116648|21187449|P13|STARTED|Expansion at Maximum Tolerated Dose||0
8594204|NCT01116648|21187450|P12|STARTED|Expansion at Maximum Tolerated Dose||0
8594205|NCT01116648|21187451|P11|STARTED|Expansion at Maximum Tolerated Dose||0
8594206|NCT01116648|21187452|P10|STARTED|Expansion at Maximum Tolerated Dose||0
8594207|NCT01116648|21187453|P9|STARTED|Expansion at Maximum Tolerated Dose||0
8594208|NCT01116648|21187454|P8|STARTED|Expansion at Maximum Tolerated Dose||0
8594209|NCT01116648|21187455|P7|STARTED|Expansion at Maximum Tolerated Dose||0
8594210|NCT01116648|21187456|P6|STARTED|Expansion at Maximum Tolerated Dose||0
8594211|NCT01116648|21187457|P5|STARTED|Expansion at Maximum Tolerated Dose||9
8594212|NCT01116648|21187458|P4|STARTED|Expansion at Maximum Tolerated Dose||0
8594213|NCT01116648|21187459|P3|STARTED|Expansion at Maximum Tolerated Dose||0
8594214|NCT01116648|21187460|P2|STARTED|Expansion at Maximum Tolerated Dose||0
8594215|NCT01116648|21187461|P1|STARTED|Expansion at Maximum Tolerated Dose||0
8594216|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1 Dose Level 3||0
8594217|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1 Dose Level 3||0
8594218|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1 Dose Level 3||0
8594219|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1 Dose Level 3||0
8594220|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1 Dose Level 3||0
8594221|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1 Dose Level 3||0
8594222|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1 Dose Level 3||0
8594223|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1 Dose Level 3||0
8594224|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1 Dose Level 3||0
8594225|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1 Dose Level 3||0
8594226|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1 Dose Level 3||0
8594227|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1 Dose Level 3||2
8594228|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1 Dose Level 3||0
8594229|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1 Dose Level 3||0
8594230|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1 Dose Level 3||0
8594231|NCT01116648|21187447|P15|COMPLETED|Phase 1 Dose Level 3||0
8594232|NCT01116648|21187448|P14|COMPLETED|Phase 1 Dose Level 3||0
8594233|NCT01116648|21187449|P13|COMPLETED|Phase 1 Dose Level 3||0
8594234|NCT01116648|21187450|P12|COMPLETED|Phase 1 Dose Level 3||0
8594235|NCT01116648|21187451|P11|COMPLETED|Phase 1 Dose Level 3||0
8594236|NCT01116648|21187452|P10|COMPLETED|Phase 1 Dose Level 3||0
8594237|NCT01116648|21187453|P9|COMPLETED|Phase 1 Dose Level 3||0
8594238|NCT01116648|21187454|P8|COMPLETED|Phase 1 Dose Level 3||0
8594239|NCT01116648|21187455|P7|COMPLETED|Phase 1 Dose Level 3||0
8594240|NCT01116648|21187456|P6|COMPLETED|Phase 1 Dose Level 3||0
8594241|NCT01116648|21187457|P5|COMPLETED|Phase 1 Dose Level 3||0
8594242|NCT01116648|21187458|P4|COMPLETED|Phase 1 Dose Level 3||4
8594243|NCT01116648|21187459|P3|COMPLETED|Phase 1 Dose Level 3||0
8594244|NCT01116648|21187460|P2|COMPLETED|Phase 1 Dose Level 3||0
8594245|NCT01116648|21187461|P1|COMPLETED|Phase 1 Dose Level 3||0
8594246|NCT01116648|21187447|P15|STARTED|Phase 1 Dose Level 3||0
8594247|NCT01116648|21187448|P14|STARTED|Phase 1 Dose Level 3||0
8594248|NCT01116648|21187449|P13|STARTED|Phase 1 Dose Level 3||0
8594249|NCT01116648|21187450|P12|STARTED|Phase 1 Dose Level 3||0
8594250|NCT01116648|21187451|P11|STARTED|Phase 1 Dose Level 3||0
8594251|NCT01116648|21187452|P10|STARTED|Phase 1 Dose Level 3||0
8594252|NCT01116648|21187453|P9|STARTED|Phase 1 Dose Level 3||0
8594253|NCT01116648|21187454|P8|STARTED|Phase 1 Dose Level 3||0
8594254|NCT01116648|21187455|P7|STARTED|Phase 1 Dose Level 3||0
8594255|NCT01116648|21187456|P6|STARTED|Phase 1 Dose Level 3||0
8594256|NCT01116648|21187457|P5|STARTED|Phase 1 Dose Level 3||0
8594257|NCT01116648|21187458|P4|STARTED|Phase 1 Dose Level 3||6
8594258|NCT01116648|21187459|P3|STARTED|Phase 1 Dose Level 3||0
8594259|NCT01116648|21187460|P2|STARTED|Phase 1 Dose Level 3||0
8594260|NCT01116648|21187461|P1|STARTED|Phase 1 Dose Level 3||0
8594261|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1 Dose Level 2||0
8594262|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1 Dose Level 2||0
8594263|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1 Dose Level 2||0
8594264|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1 Dose Level 2||0
8594265|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1 Dose Level 2||0
8594266|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1 Dose Level 2||0
8594267|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1 Dose Level 2||0
8594268|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1 Dose Level 2||0
8594269|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1 Dose Level 2||0
8594270|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1 Dose Level 2||0
8594271|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1 Dose Level 2||0
8594272|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1 Dose Level 2||0
8594273|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1 Dose Level 2||0
8594274|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1 Dose Level 2||0
8594275|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1 Dose Level 2||0
8594276|NCT01116648|21187447|P15|COMPLETED|Phase 1 Dose Level 2||0
8594277|NCT01116648|21187448|P14|COMPLETED|Phase 1 Dose Level 2||0
8594278|NCT01116648|21187449|P13|COMPLETED|Phase 1 Dose Level 2||0
8594279|NCT01116648|21187450|P12|COMPLETED|Phase 1 Dose Level 2||0
8594280|NCT01116648|21187451|P11|COMPLETED|Phase 1 Dose Level 2||0
8594281|NCT01116648|21187452|P10|COMPLETED|Phase 1 Dose Level 2||0
8594282|NCT01116648|21187453|P9|COMPLETED|Phase 1 Dose Level 2||0
8594283|NCT01116648|21187454|P8|COMPLETED|Phase 1 Dose Level 2||0
8594284|NCT01116648|21187455|P7|COMPLETED|Phase 1 Dose Level 2||0
8594285|NCT01116648|21187456|P6|COMPLETED|Phase 1 Dose Level 2||0
8594286|NCT01116648|21187457|P5|COMPLETED|Phase 1 Dose Level 2||0
8594287|NCT01116648|21187458|P4|COMPLETED|Phase 1 Dose Level 2||0
8594288|NCT01116648|21187459|P3|COMPLETED|Phase 1 Dose Level 2||7
8594289|NCT01116648|21187460|P2|COMPLETED|Phase 1 Dose Level 2||0
8594290|NCT01116648|21187461|P1|COMPLETED|Phase 1 Dose Level 2||0
8594291|NCT01116648|21187447|P15|STARTED|Phase 1 Dose Level 2||0
8594292|NCT01116648|21187448|P14|STARTED|Phase 1 Dose Level 2||0
8594293|NCT01116648|21187449|P13|STARTED|Phase 1 Dose Level 2||0
8594294|NCT01116648|21187450|P12|STARTED|Phase 1 Dose Level 2||0
8594295|NCT01116648|21187451|P11|STARTED|Phase 1 Dose Level 2||0
8594296|NCT01116648|21187452|P10|STARTED|Phase 1 Dose Level 2||0
8594297|NCT01116648|21187453|P9|STARTED|Phase 1 Dose Level 2||0
8594298|NCT01116648|21187454|P8|STARTED|Phase 1 Dose Level 2||0
8594299|NCT01116648|21187455|P7|STARTED|Phase 1 Dose Level 2||0
8594300|NCT01116648|21187456|P6|STARTED|Phase 1 Dose Level 2||0
8594301|NCT01116648|21187457|P5|STARTED|Phase 1 Dose Level 2||0
8594302|NCT01116648|21187458|P4|STARTED|Phase 1 Dose Level 2||0
8594303|NCT01116648|21187459|P3|STARTED|Phase 1 Dose Level 2||7
8594304|NCT01116648|21187460|P2|STARTED|Phase 1 Dose Level 2||0
8594305|NCT01116648|21187461|P1|STARTED|Phase 1 Dose Level 2||0
8594306|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1 Dose Level 1||0
8594307|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1 Dose Level 1||0
8594308|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1 Dose Level 1||0
8594309|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1 Dose Level 1||0
8594310|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1 Dose Level 1||0
8594311|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1 Dose Level 1||0
8594312|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1 Dose Level 1||0
8594313|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1 Dose Level 1||0
8594314|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1 Dose Level 1||0
8594315|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1 Dose Level 1||0
8594316|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1 Dose Level 1||0
8594317|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1 Dose Level 1||0
8594318|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1 Dose Level 1||0
8594319|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1 Dose Level 1||0
8594320|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1 Dose Level 1||0
8594321|NCT01116648|21187447|P15|COMPLETED|Phase 1 Dose Level 1||0
8594322|NCT01116648|21187448|P14|COMPLETED|Phase 1 Dose Level 1||0
8594323|NCT01116648|21187449|P13|COMPLETED|Phase 1 Dose Level 1||0
8594324|NCT01116648|21187450|P12|COMPLETED|Phase 1 Dose Level 1||0
8594325|NCT01116648|21187451|P11|COMPLETED|Phase 1 Dose Level 1||0
8594326|NCT01116648|21187452|P10|COMPLETED|Phase 1 Dose Level 1||0
8594327|NCT01116648|21187453|P9|COMPLETED|Phase 1 Dose Level 1||0
8594328|NCT01116648|21187454|P8|COMPLETED|Phase 1 Dose Level 1||0
8594329|NCT01116648|21187455|P7|COMPLETED|Phase 1 Dose Level 1||0
8594330|NCT01116648|21187456|P6|COMPLETED|Phase 1 Dose Level 1||0
8594331|NCT01116648|21187457|P5|COMPLETED|Phase 1 Dose Level 1||0
8594332|NCT01116648|21187458|P4|COMPLETED|Phase 1 Dose Level 1||0
8594333|NCT01116648|21187459|P3|COMPLETED|Phase 1 Dose Level 1||0
8594334|NCT01116648|21187460|P2|COMPLETED|Phase 1 Dose Level 1||3
8594335|NCT01116648|21187461|P1|COMPLETED|Phase 1 Dose Level 1||0
8594336|NCT01116648|21187447|P15|STARTED|Phase 1 Dose Level 1||0
8594337|NCT01116648|21187448|P14|STARTED|Phase 1 Dose Level 1||0
8594338|NCT01116648|21187449|P13|STARTED|Phase 1 Dose Level 1||0
8594339|NCT01116648|21187450|P12|STARTED|Phase 1 Dose Level 1||0
8594340|NCT01116648|21187451|P11|STARTED|Phase 1 Dose Level 1||0
8594341|NCT01116648|21187452|P10|STARTED|Phase 1 Dose Level 1||0
8594342|NCT01116648|21187453|P9|STARTED|Phase 1 Dose Level 1||0
8594343|NCT01116648|21187454|P8|STARTED|Phase 1 Dose Level 1||0
8594344|NCT01116648|21187455|P7|STARTED|Phase 1 Dose Level 1||0
8594345|NCT01116648|21187456|P6|STARTED|Phase 1 Dose Level 1||0
8594346|NCT01116648|21187457|P5|STARTED|Phase 1 Dose Level 1||0
8594347|NCT01116648|21187458|P4|STARTED|Phase 1 Dose Level 1||0
8594348|NCT01116648|21187459|P3|STARTED|Phase 1 Dose Level 1||0
8594349|NCT01116648|21187460|P2|STARTED|Phase 1 Dose Level 1||3
8594350|NCT01116648|21187461|P1|STARTED|Phase 1 Dose Level 1||0
8594351|NCT01116648|21187447|P15|NOT COMPLETED|Phase 1 Dose Level 0||0
8594352|NCT01116648|21187448|P14|NOT COMPLETED|Phase 1 Dose Level 0||0
8594353|NCT01116648|21187449|P13|NOT COMPLETED|Phase 1 Dose Level 0||0
8594354|NCT01116648|21187450|P12|NOT COMPLETED|Phase 1 Dose Level 0||0
8594355|NCT01116648|21187451|P11|NOT COMPLETED|Phase 1 Dose Level 0||0
8594356|NCT01116648|21187452|P10|NOT COMPLETED|Phase 1 Dose Level 0||0
8594357|NCT01116648|21187453|P9|NOT COMPLETED|Phase 1 Dose Level 0||0
8594358|NCT01116648|21187454|P8|NOT COMPLETED|Phase 1 Dose Level 0||0
8594359|NCT01116648|21187455|P7|NOT COMPLETED|Phase 1 Dose Level 0||0
8594360|NCT01116648|21187456|P6|NOT COMPLETED|Phase 1 Dose Level 0||0
8594361|NCT01116648|21187457|P5|NOT COMPLETED|Phase 1 Dose Level 0||0
8594362|NCT01116648|21187458|P4|NOT COMPLETED|Phase 1 Dose Level 0||0
8594363|NCT01116648|21187459|P3|NOT COMPLETED|Phase 1 Dose Level 0||0
8594364|NCT01116648|21187460|P2|NOT COMPLETED|Phase 1 Dose Level 0||0
8594365|NCT01116648|21187461|P1|NOT COMPLETED|Phase 1 Dose Level 0||0
8594366|NCT01116648|21187447|P15|COMPLETED|Phase 1 Dose Level 0||0
8594367|NCT01116648|21187448|P14|COMPLETED|Phase 1 Dose Level 0||0
8594368|NCT01116648|21187449|P13|COMPLETED|Phase 1 Dose Level 0||0
8594369|NCT01116648|21187450|P12|COMPLETED|Phase 1 Dose Level 0||0
8594370|NCT01116648|21187451|P11|COMPLETED|Phase 1 Dose Level 0||0
8594371|NCT01116648|21187452|P10|COMPLETED|Phase 1 Dose Level 0||0
8594372|NCT01116648|21187453|P9|COMPLETED|Phase 1 Dose Level 0||0
8594373|NCT01116648|21187454|P8|COMPLETED|Phase 1 Dose Level 0||0
8594374|NCT01116648|21187455|P7|COMPLETED|Phase 1 Dose Level 0||0
8594375|NCT01116648|21187456|P6|COMPLETED|Phase 1 Dose Level 0||0
8594376|NCT01116648|21187457|P5|COMPLETED|Phase 1 Dose Level 0||0
8594377|NCT01116648|21187458|P4|COMPLETED|Phase 1 Dose Level 0||0
8594378|NCT01116648|21187459|P3|COMPLETED|Phase 1 Dose Level 0||0
8594379|NCT01116648|21187460|P2|COMPLETED|Phase 1 Dose Level 0||0
8594380|NCT01116648|21187461|P1|COMPLETED|Phase 1 Dose Level 0||3
8594381|NCT01116648|21187447|P15|STARTED|Phase 1 Dose Level 0||0
8594382|NCT01116648|21187448|P14|STARTED|Phase 1 Dose Level 0||0
8594383|NCT01116648|21187449|P13|STARTED|Phase 1 Dose Level 0||0
8594384|NCT01116648|21187450|P12|STARTED|Phase 1 Dose Level 0||0
8594385|NCT01116648|21187451|P11|STARTED|Phase 1 Dose Level 0||0
8594386|NCT01116648|21187452|P10|STARTED|Phase 1 Dose Level 0||0
8594387|NCT01116648|21187453|P9|STARTED|Phase 1 Dose Level 0||0
8594388|NCT01116648|21187454|P8|STARTED|Phase 1 Dose Level 0||0
8594389|NCT01116648|21187455|P7|STARTED|Phase 1 Dose Level 0||0
8594390|NCT01116648|21187456|P6|STARTED|Phase 1 Dose Level 0||0
8594391|NCT01116648|21187457|P5|STARTED|Phase 1 Dose Level 0||0
8594392|NCT01116648|21187458|P4|STARTED|Phase 1 Dose Level 0||0
8594393|NCT01116648|21187459|P3|STARTED|Phase 1 Dose Level 0||0
8594394|NCT01116648|21187460|P2|STARTED|Phase 1 Dose Level 0||0
8594395|NCT01116648|21187461|P1|STARTED|Phase 1 Dose Level 0||3
8594396|NCT01052493|21187486|P3|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8594397|NCT01052493|21187487|P2|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8594398|NCT01052493|21187488|P1|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8594399|NCT01052493|21187486|P3|COMPLETED|Intervention 3 (up to 10 Days)||4
8594400|NCT01052493|21187487|P2|COMPLETED|Intervention 3 (up to 10 Days)||4
8594401|NCT01052493|21187488|P1|COMPLETED|Intervention 3 (up to 10 Days)||4
8594402|NCT01052493|21187486|P3|STARTED|Intervention 3 (up to 10 Days)||4
8594403|NCT01052493|21187487|P2|STARTED|Intervention 3 (up to 10 Days)||4
8594404|NCT01052493|21187488|P1|STARTED|Intervention 3 (up to 10 Days)||4
8594405|NCT01052493|21187486|P3|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8594406|NCT01052493|21187487|P2|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8594407|NCT01052493|21187488|P1|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8594408|NCT01052493|21187486|P3|COMPLETED|Washout Period 2 (up to 5 Days)||4
8594409|NCT01052493|21187487|P2|COMPLETED|Washout Period 2 (up to 5 Days)||4
8594410|NCT01052493|21187488|P1|COMPLETED|Washout Period 2 (up to 5 Days)||4
8594411|NCT01052493|21187486|P3|STARTED|Washout Period 2 (up to 5 Days)||4
8594412|NCT01052493|21187487|P2|STARTED|Washout Period 2 (up to 5 Days)||4
8594413|NCT01052493|21187488|P1|STARTED|Washout Period 2 (up to 5 Days)||4
8594414|NCT01052493|21187486|P3|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8594415|NCT01052493|21187487|P2|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8594416|NCT01052493|21187488|P1|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8594417|NCT01052493|21187486|P3|COMPLETED|Intervention 2 (up to 10 Days)||4
8594418|NCT01052493|21187487|P2|COMPLETED|Intervention 2 (up to 10 Days)||4
8594419|NCT01052493|21187488|P1|COMPLETED|Intervention 2 (up to 10 Days)||4
8594420|NCT01052493|21187486|P3|STARTED|Intervention 2 (up to 10 Days)||4
8594421|NCT01052493|21187487|P2|STARTED|Intervention 2 (up to 10 Days)||4
8594422|NCT01052493|21187488|P1|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
8594423|NCT01052493|21187486|P3|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8594424|NCT01052493|21187487|P2|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8594425|NCT01052493|21187488|P1|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8594426|NCT01052493|21187486|P3|COMPLETED|Washout Period 1 (up to 5 Days)||4
8594427|NCT01052493|21187487|P2|COMPLETED|Washout Period 1 (up to 5 Days)||4
8594428|NCT01052493|21187488|P1|COMPLETED|Washout Period 1 (up to 5 Days)||3
8594429|NCT01052493|21187486|P3|STARTED|Washout Period 1 (up to 5 Days)||4
8594430|NCT01052493|21187487|P2|STARTED|Washout Period 1 (up to 5 Days)||4
8594431|NCT01052493|21187488|P1|STARTED|Washout Period 1 (up to 5 Days)||3
8594432|NCT01052493|21187486|P3|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
8594433|NCT01052493|21187487|P2|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
8594434|NCT01052493|21187488|P1|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
8594435|NCT01052493|21187486|P3|COMPLETED|Intervention 1 (Up to 10 Days)||4
8594436|NCT01052493|21187487|P2|COMPLETED|Intervention 1 (Up to 10 Days)||4
8594437|NCT01052493|21187488|P1|COMPLETED|Intervention 1 (Up to 10 Days)||3
8594438|NCT01052493|21187486|P3|STARTED|Intervention 1 (Up to 10 Days)||4
8594439|NCT01052493|21187487|P2|STARTED|Intervention 1 (Up to 10 Days)||4
8594440|NCT01052493|21187488|P1|STARTED|Intervention 1 (Up to 10 Days)||4
8594441|NCT01015131|21187513|P1|NOT COMPLETED|Overall Study||8
8594442|NCT01015131|21187513|P1|COMPLETED|Overall Study||36
8594443|NCT01015131|21187513|P1|STARTED|Overall Study||44
8594534|NCT00979732|21187638|P2|NOT COMPLETED|Overall Study||1
8594535|NCT00979732|21187639|P1|NOT COMPLETED|Overall Study||3
8594536|NCT00979732|21187638|P2|COMPLETED|Overall Study||17
8594537|NCT00979732|21187639|P1|COMPLETED|Overall Study||12
8594538|NCT00979732|21187638|P2|STARTED|Overall Study||18
8594539|NCT00979732|21187639|P1|STARTED|Overall Study||15
8594540|NCT00948675|21187649|P2|NOT COMPLETED|Overall Study||4
8594541|NCT00948675|21187650|P1|NOT COMPLETED|Overall Study||7
8594542|NCT00948675|21187649|P2|COMPLETED|Overall Study||175
8594543|NCT00948675|21187650|P1|COMPLETED|Overall Study||175
8594544|NCT00948675|21187649|P2|STARTED|Overall Study||179
8594545|NCT00948675|21187650|P1|STARTED|Overall Study||182
8594546|NCT00943722|21187669|P5|NOT COMPLETED|Overall Study||22
8594547|NCT00943722|21187670|P4|NOT COMPLETED|Overall Study||22
8594548|NCT00943722|21187671|P3|NOT COMPLETED|Overall Study||13
8594549|NCT00943722|21187672|P2|NOT COMPLETED|Overall Study||22
8594550|NCT00943722|21187673|P1|NOT COMPLETED|Overall Study||25
8594551|NCT00943722|21187669|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
8594552|NCT00943722|21187670|P4|COMPLETED|Overall Study||647
8594553|NCT00943722|21187671|P3|COMPLETED|Overall Study||631
8594554|NCT00943722|21187672|P2|COMPLETED|Overall Study||621
8594555|NCT00943722|21187673|P1|COMPLETED|Overall Study||623
8594556|NCT00943722|21187669|P5|Vaccination 3|Overall Study||455
8594557|NCT00943722|21187670|P4|Vaccination 3|Overall Study||653
8594558|NCT00943722|21187671|P3|Vaccination 3|Overall Study||637
8594559|NCT00943722|21187672|P2|Vaccination 3|Overall Study||627
8594560|NCT00943722|21187673|P1|Vaccination 3|Overall Study||635
8594561|NCT00943722|21187669|P5|Vaccination 2|Overall Study||462
8594562|NCT00943722|21187670|P4|Vaccination 2|Overall Study||658
8594563|NCT00943722|21187671|P3|Vaccination 2|Overall Study||638
8594564|NCT00943722|21187672|P2|Vaccination 2|Overall Study||633
8594565|NCT00943722|21187673|P1|Vaccination 2|Overall Study||637
8594566|NCT00943722|21187669|P5|Vaccination 1|Overall Study||468
8594567|NCT00943722|21187670|P4|Vaccination 1|Overall Study||666
8594568|NCT00943722|21187671|P3|Vaccination 1|Overall Study||644
8594569|NCT00943722|21187672|P2|Vaccination 1|Overall Study||642
8594570|NCT00943722|21187673|P1|Vaccination 1|Overall Study||646
8594571|NCT00943722|21187669|P5|STARTED|Overall Study||470
8594572|NCT00943722|21187670|P4|STARTED|Overall Study||669
8594573|NCT00943722|21187671|P3|STARTED|Overall Study||644
8594574|NCT00943722|21187672|P2|STARTED|Overall Study||643
8594575|NCT00943722|21187673|P1|STARTED|Overall Study||648
8594576|NCT00847912|21187703|P2|NOT COMPLETED|Overall Study||13
8594577|NCT00847912|21187704|P1|NOT COMPLETED|Overall Study||9
8594578|NCT00847912|21187703|P2|COMPLETED|Overall Study||464
8594579|NCT00847912|21187704|P1|COMPLETED|Overall Study||468
8594580|NCT00847912|21187703|P2|STARTED|Overall Study||477
8594581|NCT00847912|21187704|P1|STARTED|Overall Study||477
8594582|NCT00813124|21187712|P1|NOT COMPLETED|Overall Study||12
8594583|NCT00813124|21187712|P1|COMPLETED|Overall Study||12
8594584|NCT00813124|21187712|P1|STARTED|Overall Study||24
8594585|NCT00794677|21187718|P2|NOT COMPLETED|Second Intervention||0
8594586|NCT00794677|21187719|P1|NOT COMPLETED|Second Intervention||0
8594587|NCT00794677|21187718|P2|COMPLETED|Second Intervention||13
8594588|NCT00794677|21187719|P1|COMPLETED|Second Intervention||11
8594589|NCT00794677|21187718|P2|STARTED|Second Intervention||13
8594590|NCT00794677|21187719|P1|STARTED|Second Intervention||11
8594591|NCT00794677|21187718|P2|NOT COMPLETED|First Intervention||0
8594592|NCT00794677|21187719|P1|NOT COMPLETED|First Intervention||2
8594593|NCT00794677|21187718|P2|COMPLETED|First Intervention||13
8594594|NCT00794677|21187719|P1|COMPLETED|First Intervention||11
8594595|NCT00794677|21187718|P2|STARTED|First Intervention||13
8594596|NCT00794677|21187719|P1|STARTED|First Intervention||13
8594597|NCT00790478|21187741|P2|NOT COMPLETED|Overall Study||0
8594598|NCT00790478|21187742|P1|NOT COMPLETED|Overall Study||0
8594599|NCT00790478|21187741|P2|COMPLETED|Overall Study||0
8594600|NCT00790478|21187742|P1|COMPLETED|Overall Study||0
8594601|NCT00790478|21187741|P2|STARTED|Overall Study||0
8594602|NCT00790478|21187742|P1|STARTED|Overall Study||0
8594603|NCT00662012|21187750|P1|NOT COMPLETED|Overall Study||87
8594604|NCT00662012|21187750|P1|COMPLETED|Overall Study||327
8594605|NCT00662012|21187750|P1|STARTED|Overall Study||414
8594606|NCT00602459|21187759|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8594607|NCT00602459|21187760|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8594608|NCT00602459|21187761|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8594609|NCT00602459|21187762|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8594610|NCT00602459|21187759|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
8594611|NCT00602459|21187760|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
8594612|NCT00602459|21187761|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
8594613|NCT00602459|21187762|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
8594614|NCT00602459|21187759|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
8594615|NCT00602459|21187760|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
8594616|NCT00602459|21187761|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
8594617|NCT00602459|21187762|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
8594618|NCT00602459|21187759|P4|NOT COMPLETED|Initial Registration/Randomization||0
8594619|NCT00602459|21187760|P3|NOT COMPLETED|Initial Registration/Randomization||3
8594620|NCT00602459|21187761|P2|NOT COMPLETED|Initial Registration/Randomization||10
8594621|NCT00602459|21187762|P1|NOT COMPLETED|Initial Registration/Randomization||5
8594622|NCT00602459|21187759|P4|COMPLETED|Initial Registration/Randomization||0
8594623|NCT00602459|21187760|P3|COMPLETED|Initial Registration/Randomization||137
8594624|NCT00602459|21187761|P2|COMPLETED|Initial Registration/Randomization||130
8594625|NCT00602459|21187762|P1|COMPLETED|Initial Registration/Randomization||133
8594626|NCT00602459|21187759|P4|STARTED|Initial Registration/Randomization||0
8594627|NCT00602459|21187760|P3|STARTED|Initial Registration/Randomization||140
8594628|NCT00602459|21187761|P2|STARTED|Initial Registration/Randomization||140
8594629|NCT00602459|21187762|P1|STARTED|Initial Registration/Randomization||138
8594636|NCT00437281|21187823|P20|NOT COMPLETED|Overall Study||1
8594637|NCT00437281|21187824|P19|NOT COMPLETED|Overall Study||1
8594638|NCT00437281|21187825|P18|NOT COMPLETED|Overall Study||0
8594639|NCT00437281|21187826|P17|NOT COMPLETED|Overall Study||0
8594640|NCT00437281|21187827|P16|NOT COMPLETED|Overall Study||0
8594641|NCT00437281|21187828|P15|NOT COMPLETED|Overall Study||1
8594642|NCT00437281|21187829|P14|NOT COMPLETED|Overall Study||1
8594643|NCT00437281|21187830|P13|NOT COMPLETED|Overall Study||0
8594644|NCT00437281|21187831|P12|NOT COMPLETED|Overall Study||0
8594645|NCT00437281|21187832|P11|NOT COMPLETED|Overall Study||0
8594646|NCT00437281|21187833|P10|NOT COMPLETED|Overall Study||1
8594647|NCT00437281|21187834|P9|NOT COMPLETED|Overall Study||0
8594648|NCT00437281|21187835|P8|NOT COMPLETED|Overall Study||0
8594649|NCT00437281|21187836|P7|NOT COMPLETED|Overall Study||0
8594650|NCT00437281|21187837|P6|NOT COMPLETED|Overall Study||1
8594651|NCT00437281|21187838|P5|NOT COMPLETED|Overall Study||0
8594652|NCT00437281|21187839|P4|NOT COMPLETED|Overall Study||1
8594653|NCT00437281|21187840|P3|NOT COMPLETED|Overall Study||0
8594654|NCT00437281|21187841|P2|NOT COMPLETED|Overall Study||0
8594655|NCT00437281|21187842|P1|NOT COMPLETED|Overall Study||0
8594656|NCT00437281|21187823|P20|COMPLETED|Overall Study||2
8594657|NCT00437281|21187824|P19|COMPLETED|Overall Study||1
8594658|NCT00437281|21187825|P18|COMPLETED|Overall Study||4
8594659|NCT00437281|21187826|P17|COMPLETED|Overall Study||3
8594660|NCT00437281|21187827|P16|COMPLETED|Overall Study||3
8594661|NCT00437281|21187828|P15|COMPLETED|Overall Study||4
8594662|NCT00437281|21187829|P14|COMPLETED|Overall Study||2
8594663|NCT00437281|21187830|P13|COMPLETED|Overall Study||2
8594664|NCT00437281|21187831|P12|COMPLETED|Overall Study||3
8594665|NCT00437281|21187832|P11|COMPLETED|Overall Study||3
8594666|NCT00437281|21187833|P10|COMPLETED|Overall Study||4
8594667|NCT00437281|21187834|P9|COMPLETED|Overall Study||3
8594668|NCT00437281|21187835|P8|COMPLETED|Overall Study||3
8594669|NCT00437281|21187836|P7|COMPLETED|Overall Study||3
8594670|NCT00437281|21187837|P6|COMPLETED|Overall Study||3
8594671|NCT00437281|21187838|P5|COMPLETED|Overall Study||4
8594672|NCT00437281|21187839|P4|COMPLETED|Overall Study||2
8594673|NCT00437281|21187840|P3|COMPLETED|Overall Study||3
8594674|NCT00437281|21187841|P2|COMPLETED|Overall Study||3
8594675|NCT00437281|21187842|P1|COMPLETED|Overall Study||3
8594676|NCT00437281|21187823|P20|STARTED|Overall Study||3
8594677|NCT00437281|21187824|P19|STARTED|Overall Study||2
8594678|NCT00437281|21187825|P18|STARTED|Overall Study||4
8594679|NCT00437281|21187826|P17|STARTED|Overall Study||3
8594680|NCT00437281|21187827|P16|STARTED|Overall Study||3
8594681|NCT00437281|21187828|P15|STARTED|Overall Study||5
8594682|NCT00437281|21187829|P14|STARTED|Overall Study||3
8594683|NCT00437281|21187830|P13|STARTED|Overall Study||2
8594684|NCT00437281|21187831|P12|STARTED|Overall Study||3
8594685|NCT00437281|21187832|P11|STARTED|Overall Study||3
8594686|NCT00437281|21187833|P10|STARTED|Overall Study||5
8594687|NCT00437281|21187834|P9|STARTED|Overall Study||3
8594688|NCT00437281|21187835|P8|STARTED|Overall Study||3
8594689|NCT00437281|21187836|P7|STARTED|Overall Study||3
8594690|NCT00437281|21187837|P6|STARTED|Overall Study||4
8594691|NCT00437281|21187838|P5|STARTED|Overall Study||4
8594692|NCT00437281|21187839|P4|STARTED|Overall Study||3
8594693|NCT00437281|21187840|P3|STARTED|Overall Study||3
8594694|NCT00437281|21187841|P2|STARTED|Overall Study||3
8594695|NCT00437281|21187842|P1|STARTED|Overall Study||3
8594696|NCT00415623|21188138|P2|NOT COMPLETED|Overall Study||5
8594697|NCT00415623|21188139|P1|NOT COMPLETED|Overall Study||5
8594698|NCT00415623|21188138|P2|COMPLETED|Overall Study||146
8594699|NCT00415623|21188139|P1|COMPLETED|Overall Study||149
8594700|NCT00415623|21188138|P2|STARTED|Overall Study||151
8594701|NCT00415623|21188139|P1|STARTED|Overall Study||154
8594702|NCT00412113|21188165|P2|NOT COMPLETED|Overall Study||15
8594703|NCT00412113|21188166|P1|NOT COMPLETED|Overall Study||12
8594704|NCT00412113|21188165|P2|COMPLETED|Overall Study|15-April-2008|107
8594705|NCT00412113|21188166|P1|COMPLETED|Overall Study|15-April-2008|111
8594706|NCT00412113|21188165|P2|Received Treatment|Overall Study||122
8594707|NCT00412113|21188166|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
8594708|NCT00412113|21188165|P2|STARTED|Overall Study|15-January-2007|122
8594709|NCT00412113|21188166|P1|STARTED|Overall Study|15-January-2007|123
8594710|NCT00380874|21188220|P2|NOT COMPLETED|Overall Study||10
8594711|NCT00380874|21188221|P1|NOT COMPLETED|Overall Study||13
8594712|NCT00380874|21188220|P2|COMPLETED|Overall Study||19
8594713|NCT00380874|21188221|P1|COMPLETED|Overall Study||19
8594714|NCT00380874|21188220|P2|STARTED|Overall Study||29
8594715|NCT00380874|21188221|P1|STARTED|Overall Study||32
8594716|NCT00350337|21188241|P4|NOT COMPLETED|Overall Study||0
8594717|NCT00350337|21188242|P3|NOT COMPLETED|Overall Study||3
8594718|NCT00350337|21188243|P2|NOT COMPLETED|Overall Study||3
8594719|NCT00350337|21188244|P1|NOT COMPLETED|Overall Study||5
8594720|NCT00350337|21188241|P4|COMPLETED|Overall Study||21
8594721|NCT00350337|21188242|P3|COMPLETED|Overall Study||18
8594722|NCT00350337|21188243|P2|COMPLETED|Overall Study||19
8594723|NCT00350337|21188244|P1|COMPLETED|Overall Study||17
8594724|NCT00350337|21188241|P4|STARTED|Overall Study||21
8594725|NCT00350337|21188242|P3|STARTED|Overall Study||21
8594726|NCT00350337|21188243|P2|STARTED|Overall Study||22
8594727|NCT00350337|21188244|P1|STARTED|Overall Study||22
8594728|NCT00333866|21188296|P4|NOT COMPLETED|Overall Study||66
8594729|NCT00333866|21188297|P3|NOT COMPLETED|Overall Study||51
8594730|NCT00333866|21188298|P2|NOT COMPLETED|Overall Study||64
8594731|NCT00333866|21188299|P1|NOT COMPLETED|Overall Study||48
8594732|NCT00333866|21188296|P4|COMPLETED|Overall Study||121
8594733|NCT00333866|21188297|P3|COMPLETED|Overall Study||133
8594734|NCT00333866|21188298|P2|COMPLETED|Overall Study||123
8594735|NCT00333866|21188299|P1|COMPLETED|Overall Study||141
8594736|NCT00333866|21188296|P4|TREATED|Overall Study||186
8594737|NCT00333866|21188297|P3|TREATED|Overall Study||182
8594738|NCT00333866|21188298|P2|TREATED|Overall Study||184
8594739|NCT00333866|21188299|P1|TREATED|Overall Study||184
8594740|NCT00333866|21188296|P4|STARTED|Overall Study||187
8594741|NCT00333866|21188297|P3|STARTED|Overall Study||184
8594742|NCT00333866|21188298|P2|STARTED|Overall Study||187
8594743|NCT00333866|21188299|P1|STARTED|Overall Study||189
8594753|NCT00283283|21188395|P4|NOT COMPLETED|Overall Study||0
8594754|NCT00283283|21188396|P3|NOT COMPLETED|Overall Study||0
8594755|NCT00283283|21188397|P2|NOT COMPLETED|Overall Study||0
8594756|NCT00283283|21188398|P1|NOT COMPLETED|Overall Study||0
8594757|NCT00283283|21188395|P4|COMPLETED|Overall Study||276
8594758|NCT00283283|21188396|P3|COMPLETED|Overall Study||280
8594759|NCT00283283|21188397|P2|COMPLETED|Overall Study||284
8594760|NCT00283283|21188398|P1|COMPLETED|Overall Study||274
8594761|NCT00283283|21188395|P4|STARTED|Overall Study||276
8594762|NCT00283283|21188396|P3|STARTED|Overall Study||280
8594763|NCT00283283|21188397|P2|STARTED|Overall Study||284
8594764|NCT00283283|21188398|P1|STARTED|Overall Study||274
8594765|NCT00223990|21188415|P2|NOT COMPLETED|Overall Study||9
8594766|NCT00223990|21188416|P1|NOT COMPLETED|Overall Study||7
8594767|NCT00223990|21188415|P2|COMPLETED|Overall Study||191
8594768|NCT00223990|21188416|P1|COMPLETED|Overall Study||193
8594769|NCT00223990|21188415|P2|STARTED|Overall Study||200
8594770|NCT00223990|21188416|P1|STARTED|Overall Study||200
8594771|NCT00214539|21188440|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
8594772|NCT00214539|21188441|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
8594773|NCT00214539|21188440|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
8594774|NCT00214539|21188441|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
8594775|NCT00214539|21188440|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
8594776|NCT00214539|21188441|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
8594777|NCT00214539|21188440|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
8594778|NCT00214539|21188441|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
8594779|NCT00214539|21188440|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
8594780|NCT00214539|21188441|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
8594781|NCT00214539|21188440|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
8594782|NCT00214539|21188441|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
8594783|NCT00214539|21188440|P2|NOT COMPLETED|Treatment Period||0
8594784|NCT00214539|21188441|P1|NOT COMPLETED|Treatment Period||0
8594785|NCT00214539|21188440|P2|COMPLETED|Treatment Period||17
8594786|NCT00214539|21188441|P1|COMPLETED|Treatment Period||15
8594787|NCT00214539|21188440|P2|STARTED|Treatment Period||17
8594788|NCT00214539|21188441|P1|STARTED|Treatment Period||15
8594789|NCT00214539|21188440|P2|NOT COMPLETED|Randomized||0
8594790|NCT00214539|21188441|P1|NOT COMPLETED|Randomized||2
8594791|NCT00214539|21188440|P2|COMPLETED|Randomized||17
8594792|NCT00214539|21188441|P1|COMPLETED|Randomized||15
8594793|NCT00214539|21188440|P2|STARTED|Randomized||17
8594794|NCT00214539|21188441|P1|STARTED|Randomized||17
8594795|NCT00197054|21188468|P3|NOT COMPLETED|Overall Study||12
8594796|NCT00197054|21188469|P2|NOT COMPLETED|Overall Study||21
8594797|NCT00197054|21188470|P1|NOT COMPLETED|Overall Study||17
8594798|NCT00197054|21188468|P3|COMPLETED|Overall Study||73
8594799|NCT00197054|21188469|P2|COMPLETED|Overall Study||64
8594800|NCT00197054|21188470|P1|COMPLETED|Overall Study||68
8594801|NCT00197054|21188468|P3|STARTED|Overall Study||85
8594802|NCT00197054|21188469|P2|STARTED|Overall Study||85
8594803|NCT00197054|21188470|P1|STARTED|Overall Study||85
8594804|NCT00180323|21188578|P1|NOT COMPLETED|Overall Study||0
8594805|NCT00180323|21188578|P1|COMPLETED|Overall Study||43
8594806|NCT00180323|21188578|P1|STARTED|Overall Study||43
8594807|NCT00135200|21188585|P1|NOT COMPLETED|Overall Study||0
8594808|NCT00135200|21188585|P1|COMPLETED|Overall Study||16
8594809|NCT00135200|21188585|P1|STARTED|Overall Study||16
8597207|NCT04071158|21196045|P5|NOT COMPLETED|Overall Study||5
8597208|NCT04071158|21196046|P4|NOT COMPLETED|Overall Study||3
8597209|NCT04071158|21196047|P3|NOT COMPLETED|Overall Study||3
8597210|NCT04071158|21196048|P2|NOT COMPLETED|Overall Study||4
8597211|NCT04071158|21196049|P1|NOT COMPLETED|Overall Study||3
8597212|NCT04071158|21196045|P5|COMPLETED|Overall Study||136
8597213|NCT04071158|21196046|P4|COMPLETED|Overall Study||140
8597214|NCT04071158|21196047|P3|COMPLETED|Overall Study||140
8597215|NCT04071158|21196048|P2|COMPLETED|Overall Study||139
8597216|NCT04071158|21196049|P1|COMPLETED|Overall Study||140
8597217|NCT04071158|21196045|P5|Safety Population|Overall Study||141
8597218|NCT04071158|21196046|P4|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
8597219|NCT04071158|21196047|P3|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
8597220|NCT04071158|21196048|P2|Safety Population|Overall Study||141
8597221|NCT04071158|21196049|P1|Safety Population|Overall Study||141
8597222|NCT04071158|21196045|P5|Treated|Overall Study||141
8597223|NCT04071158|21196046|P4|Treated|Overall Study||143
8597224|NCT04071158|21196047|P3|Treated|Overall Study||143
8597225|NCT04071158|21196048|P2|Treated|Overall Study||141
8597226|NCT04071158|21196049|P1|Treated|Overall Study||141
8597227|NCT04071158|21196045|P5|STARTED|Overall Study||141
8597228|NCT04071158|21196046|P4|STARTED|Overall Study||143
8597229|NCT04071158|21196047|P3|STARTED|Overall Study||143
8597230|NCT04071158|21196048|P2|STARTED|Overall Study||143
8597231|NCT04071158|21196049|P1|STARTED|Overall Study||143
8597232|NCT04066426|21196104|P4|NOT COMPLETED|Overall Study||3
8597233|NCT04066426|21196105|P3|NOT COMPLETED|Overall Study||8
8597234|NCT04066426|21196106|P2|NOT COMPLETED|Overall Study||10
8597235|NCT04066426|21196107|P1|NOT COMPLETED|Overall Study||10
8597236|NCT04066426|21196104|P4|COMPLETED|Overall Study||47
8597237|NCT04066426|21196105|P3|COMPLETED|Overall Study||42
8597238|NCT04066426|21196106|P2|COMPLETED|Overall Study||40
8597239|NCT04066426|21196107|P1|COMPLETED|Overall Study||40
8597240|NCT04066426|21196104|P4|STARTED|Overall Study||50
8597241|NCT04066426|21196105|P3|STARTED|Overall Study||50
8597242|NCT04066426|21196106|P2|STARTED|Overall Study||50
8597243|NCT04066426|21196107|P1|STARTED|Overall Study||50
8597352|NCT03626623|21196682|P2|NOT COMPLETED|Overall Study||10
8597353|NCT03626623|21196683|P1|NOT COMPLETED|Overall Study||5
8597354|NCT03626623|21196682|P2|COMPLETED|Overall Study||0
8597355|NCT03626623|21196683|P1|COMPLETED|Overall Study||0
8597356|NCT03626623|21196682|P2|STARTED|Overall Study||10
8597357|NCT03626623|21196683|P1|STARTED|Overall Study||5
8597520|NCT03332628|21197262|P1|NOT COMPLETED|Overall Study||2
8597521|NCT03332628|21197262|P1|COMPLETED|Overall Study||111
8597522|NCT03332628|21197262|P1|STARTED|Overall Study||113
8597717|NCT02934555|21197757|P2|NOT COMPLETED|Overall Study||3
8597718|NCT02934555|21197758|P1|NOT COMPLETED|Overall Study||2
8597719|NCT02934555|21197757|P2|COMPLETED|Overall Study||22
8597720|NCT02934555|21197758|P1|COMPLETED|Overall Study||21
8597721|NCT02934555|21197757|P2|STARTED|Overall Study||25
8597722|NCT02934555|21197758|P1|STARTED|Overall Study||23
8597816|NCT02713711|21198367|P4|NOT COMPLETED|Overall Study||0
8597817|NCT02713711|21198368|P3|NOT COMPLETED|Overall Study||0
8597818|NCT02713711|21198369|P2|NOT COMPLETED|Overall Study||0
8597819|NCT02713711|21198370|P1|NOT COMPLETED|Overall Study||0
8597820|NCT02713711|21198367|P4|COMPLETED|Overall Study||10
8597821|NCT02713711|21198368|P3|COMPLETED|Overall Study||6
8597822|NCT02713711|21198369|P2|COMPLETED|Overall Study||6
8597823|NCT02713711|21198370|P1|COMPLETED|Overall Study||9
8597824|NCT02713711|21198367|P4|STARTED|Overall Study||10
8597825|NCT02713711|21198368|P3|STARTED|Overall Study||6
8597826|NCT02713711|21198369|P2|STARTED|Overall Study||6
8597827|NCT02713711|21198370|P1|STARTED|Overall Study||9
8597924|NCT02607046|21198843|P2|NOT COMPLETED|Overall Study||3
8597925|NCT02607046|21198844|P1|NOT COMPLETED|Overall Study||8
8597926|NCT02607046|21198843|P2|COMPLETED|Overall Study||10
8597927|NCT02607046|21198844|P1|COMPLETED|Overall Study||14
8597928|NCT02607046|21198843|P2|STARTED|Overall Study||13
8597929|NCT02607046|21198844|P1|STARTED|Overall Study||22
8598267|NCT02389959|21199334|P2|NOT COMPLETED|Overall Study||1
8598268|NCT02389959|21199335|P1|NOT COMPLETED|Overall Study||2
8598269|NCT02389959|21199334|P2|COMPLETED|Overall Study||19
8598270|NCT02389959|21199335|P1|COMPLETED|Overall Study||18
8598271|NCT02389959|21199334|P2|STARTED|Overall Study||20
8598272|NCT02389959|21199335|P1|STARTED|Overall Study||20
8598289|NCT02369536|21199385|P2|NOT COMPLETED|Overall Study||6
8598290|NCT02369536|21199386|P1|NOT COMPLETED|Overall Study||7
8598291|NCT02369536|21199385|P2|COMPLETED|Overall Study||58
8598292|NCT02369536|21199386|P1|COMPLETED|Overall Study||55
8598293|NCT02369536|21199385|P2|STARTED|Overall Study||64
8598294|NCT02369536|21199386|P1|STARTED|Overall Study||62
8598301|NCT02314780|21199408|P3|NOT COMPLETED|Overall Study||0
8598302|NCT02314780|21199409|P2|NOT COMPLETED|Overall Study||3
8598303|NCT02314780|21199410|P1|NOT COMPLETED|Overall Study||0
8598304|NCT02314780|21199408|P3|COMPLETED|Overall Study||8
8598305|NCT02314780|21199409|P2|COMPLETED|Overall Study||7
8598306|NCT02314780|21199410|P1|COMPLETED|Overall Study||9
8598307|NCT02314780|21199408|P3|STARTED|Overall Study||8
8598308|NCT02314780|21199409|P2|STARTED|Overall Study||10
8598309|NCT02314780|21199410|P1|STARTED|Overall Study||9
8598339|NCT02237417|21199532|P3|NOT COMPLETED|Overall Study||9
8598340|NCT02237417|21199533|P2|NOT COMPLETED|Overall Study||6
8598341|NCT02237417|21199534|P1|NOT COMPLETED|Overall Study||0
8598342|NCT02237417|21199532|P3|COMPLETED|Overall Study||7
8598343|NCT02237417|21199533|P2|COMPLETED|Overall Study||9
8598344|NCT02237417|21199534|P1|COMPLETED|Overall Study||16
8598345|NCT02237417|21199532|P3|STARTED|Overall Study||16
8598346|NCT02237417|21199533|P2|STARTED|Overall Study||15
8598347|NCT02237417|21199534|P1|STARTED|Overall Study||16
8598435|NCT02147626|21199752|P2|NOT COMPLETED|Overall Study||7
8598436|NCT02147626|21199753|P1|NOT COMPLETED|Overall Study||5
8598437|NCT02147626|21199752|P2|COMPLETED|Overall Study||69
8598438|NCT02147626|21199753|P1|COMPLETED|Overall Study||70
8598439|NCT02147626|21199752|P2|STARTED|Overall Study||76
8598440|NCT02147626|21199753|P1|STARTED|Overall Study||75
8598453|NCT02094417|21199831|P4|NOT COMPLETED|Overall Study||7
8598454|NCT02094417|21199832|P3|NOT COMPLETED|Overall Study||5
8598455|NCT02094417|21199833|P2|NOT COMPLETED|Overall Study||8
8598456|NCT02094417|21199834|P1|NOT COMPLETED|Overall Study||5
8598457|NCT02094417|21199831|P4|COMPLETED|Overall Study||3
8598458|NCT02094417|21199832|P3|COMPLETED|Overall Study||4
8598459|NCT02094417|21199833|P2|COMPLETED|Overall Study||1
8598460|NCT02094417|21199834|P1|COMPLETED|Overall Study||2
8598461|NCT02094417|21199831|P4|STARTED|Overall Study||10
8598462|NCT02094417|21199832|P3|STARTED|Overall Study||9
8598463|NCT02094417|21199833|P2|STARTED|Overall Study||9
8598464|NCT02094417|21199834|P1|STARTED|Overall Study||7
8598527|NCT01986881|21200048|P3|NOT COMPLETED|Overall Study||358
8598528|NCT01986881|21200049|P2|NOT COMPLETED|Overall Study||346
8598529|NCT01986881|21200050|P1|NOT COMPLETED|Overall Study||330
8598530|NCT01986881|21200048|P3|COMPLETED|Overall Study||2389
8598531|NCT01986881|21200049|P2|COMPLETED|Overall Study||2401
8598532|NCT01986881|21200050|P1|COMPLETED|Overall Study||2422
8598533|NCT01986881|21200048|P3|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
8598534|NCT01986881|21200049|P2|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
8598535|NCT01986881|21200050|P1|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
8598536|NCT01986881|21200048|P3|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
8598537|NCT01986881|21200049|P2|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
8598538|NCT01986881|21200050|P1|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
8598539|NCT01986881|21200048|P3|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
8598540|NCT01986881|21200049|P2|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
8598541|NCT01986881|21200050|P1|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
8598542|NCT01986881|21200048|P3|Treated|Overall Study||2745
8598543|NCT01986881|21200049|P2|Treated|Overall Study||2747
8598544|NCT01986881|21200050|P1|Treated|Overall Study||2746
8598545|NCT01986881|21200048|P3|STARTED|Overall Study||2747
8598546|NCT01986881|21200049|P2|STARTED|Overall Study||2747
8598547|NCT01986881|21200050|P1|STARTED|Overall Study||2752
8598654|NCT01804465|21200682|P2|NOT COMPLETED|Overall Study||0
8598655|NCT01804465|21200683|P1|NOT COMPLETED|Overall Study||0
8598656|NCT01804465|21200682|P2|COMPLETED|Overall Study||26
8598657|NCT01804465|21200683|P1|COMPLETED|Overall Study||24
8598658|NCT01804465|21200682|P2|STARTED|Overall Study||26
8598659|NCT01804465|21200683|P1|STARTED|Overall Study||24
8598660|NCT01779856|21200691|P1|NOT COMPLETED|Overall Study||24
8598661|NCT01779856|21200691|P1|COMPLETED|Overall Study||57
8598662|NCT01779856|21200691|P1|STARTED|Overall Study||81
8598672|NCT01757067|21200735|P2|NOT COMPLETED|Overall Study||0
8598673|NCT01757067|21200736|P1|NOT COMPLETED|Overall Study||0
8598674|NCT01757067|21200735|P2|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
8598675|NCT01757067|21200736|P1|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
8598676|NCT01757067|21200735|P2|STARTED|Overall Study|The study was closed due to low enrollment.|1
8598677|NCT01757067|21200736|P1|STARTED|Overall Study||2
8598821|NCT01599286|21201016|P2|NOT COMPLETED|Overall Study||0
8598822|NCT01599286|21201017|P1|NOT COMPLETED|Overall Study||0
8598823|NCT01599286|21201016|P2|COMPLETED|Overall Study||23
8598824|NCT01599286|21201017|P1|COMPLETED|Overall Study||24
8598825|NCT01599286|21201016|P2|STARTED|Overall Study||23
8598826|NCT01599286|21201017|P1|STARTED|Overall Study||24
8598874|NCT01502072|21201155|P3|NOT COMPLETED|Overall Study||0
8598875|NCT01502072|21201156|P2|NOT COMPLETED|Overall Study||1
8598876|NCT01502072|21201157|P1|NOT COMPLETED|Overall Study||1
8598877|NCT01502072|21201155|P3|COMPLETED|Overall Study||20
8598878|NCT01502072|21201156|P2|COMPLETED|Overall Study||9
8598879|NCT01502072|21201157|P1|COMPLETED|Overall Study||13
8598880|NCT01502072|21201155|P3|STARTED|Overall Study||20
8598881|NCT01502072|21201156|P2|STARTED|Overall Study||10
8598882|NCT01502072|21201157|P1|STARTED|Overall Study||14
8599018|NCT00991276|21201419|P6|NOT COMPLETED|Third Intervention Period||1
8599019|NCT00991276|21201420|P5|NOT COMPLETED|Third Intervention Period||0
8599020|NCT00991276|21201421|P4|NOT COMPLETED|Third Intervention Period||1
8599021|NCT00991276|21201422|P3|NOT COMPLETED|Third Intervention Period||1
8599022|NCT00991276|21201423|P2|NOT COMPLETED|Third Intervention Period||0
8599023|NCT00991276|21201424|P1|NOT COMPLETED|Third Intervention Period||1
8599024|NCT00991276|21201419|P6|COMPLETED|Third Intervention Period||10
8599025|NCT00991276|21201420|P5|COMPLETED|Third Intervention Period||10
8599026|NCT00991276|21201421|P4|COMPLETED|Third Intervention Period||8
8599027|NCT00991276|21201422|P3|COMPLETED|Third Intervention Period||13
8599028|NCT00991276|21201423|P2|COMPLETED|Third Intervention Period||8
8599029|NCT00991276|21201424|P1|COMPLETED|Third Intervention Period||13
8599030|NCT00991276|21201419|P6|STARTED|Third Intervention Period||11
8599031|NCT00991276|21201420|P5|STARTED|Third Intervention Period||10
8599032|NCT00991276|21201421|P4|STARTED|Third Intervention Period||9
8599033|NCT00991276|21201422|P3|STARTED|Third Intervention Period||14
8599034|NCT00991276|21201423|P2|STARTED|Third Intervention Period||8
8599035|NCT00991276|21201424|P1|STARTED|Third Intervention Period||14
8599036|NCT00991276|21201419|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599037|NCT00991276|21201420|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599038|NCT00991276|21201421|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599039|NCT00991276|21201422|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599040|NCT00991276|21201423|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599041|NCT00991276|21201424|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599042|NCT00991276|21201419|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
8599043|NCT00991276|21201420|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
8599044|NCT00991276|21201421|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
8599045|NCT00991276|21201422|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
8599046|NCT00991276|21201423|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
8599047|NCT00991276|21201424|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
8599048|NCT00991276|21201419|P6|STARTED|Placebo Wash-out Period (7 Days)||11
8599049|NCT00991276|21201420|P5|STARTED|Placebo Wash-out Period (7 Days)||10
8599050|NCT00991276|21201421|P4|STARTED|Placebo Wash-out Period (7 Days)||9
8599051|NCT00991276|21201422|P3|STARTED|Placebo Wash-out Period (7 Days)||14
8599052|NCT00991276|21201423|P2|STARTED|Placebo Wash-out Period (7 Days)||8
8599053|NCT00991276|21201424|P1|STARTED|Placebo Wash-out Period (7 Days)||14
8599054|NCT00991276|21201419|P6|NOT COMPLETED|Second Intervention Period||1
8599055|NCT00991276|21201420|P5|NOT COMPLETED|Second Intervention Period||1
8599056|NCT00991276|21201421|P4|NOT COMPLETED|Second Intervention Period||2
8599057|NCT00991276|21201422|P3|NOT COMPLETED|Second Intervention Period||0
8599058|NCT00991276|21201423|P2|NOT COMPLETED|Second Intervention Period||2
8599059|NCT00991276|21201424|P1|NOT COMPLETED|Second Intervention Period||1
8599060|NCT00991276|21201419|P6|COMPLETED|Second Intervention Period||11
8599061|NCT00991276|21201420|P5|COMPLETED|Second Intervention Period||10
8599062|NCT00991276|21201421|P4|COMPLETED|Second Intervention Period||9
8599063|NCT00991276|21201422|P3|COMPLETED|Second Intervention Period||14
8599064|NCT00991276|21201423|P2|COMPLETED|Second Intervention Period||8
8599065|NCT00991276|21201424|P1|COMPLETED|Second Intervention Period||14
8599066|NCT00991276|21201419|P6|STARTED|Second Intervention Period||12
8599067|NCT00991276|21201420|P5|STARTED|Second Intervention Period||11
8599068|NCT00991276|21201421|P4|STARTED|Second Intervention Period||11
8599069|NCT00991276|21201422|P3|STARTED|Second Intervention Period||14
8599070|NCT00991276|21201423|P2|STARTED|Second Intervention Period||10
8599071|NCT00991276|21201424|P1|STARTED|Second Intervention Period||15
8599072|NCT00991276|21201419|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599073|NCT00991276|21201420|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599074|NCT00991276|21201421|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599075|NCT00991276|21201422|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599076|NCT00991276|21201423|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599077|NCT00991276|21201424|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599078|NCT00991276|21201419|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
8599079|NCT00991276|21201420|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
8599080|NCT00991276|21201421|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
8599081|NCT00991276|21201422|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
8599082|NCT00991276|21201423|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
8599083|NCT00991276|21201424|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
8599084|NCT00991276|21201419|P6|STARTED|Placebo Wash-out Period (7 Days)||12
8599085|NCT00991276|21201420|P5|STARTED|Placebo Wash-out Period (7 Days)||11
8599086|NCT00991276|21201421|P4|STARTED|Placebo Wash-out Period (7 Days)||11
8599087|NCT00991276|21201422|P3|STARTED|Placebo Wash-out Period (7 Days)||14
8599088|NCT00991276|21201423|P2|STARTED|Placebo Wash-out Period (7 Days)||10
8599089|NCT00991276|21201424|P1|STARTED|Placebo Wash-out Period (7 Days)||15
8599090|NCT00991276|21201419|P6|NOT COMPLETED|First Intervention Period||1
8599091|NCT00991276|21201420|P5|NOT COMPLETED|First Intervention Period||4
8599092|NCT00991276|21201421|P4|NOT COMPLETED|First Intervention Period||4
8599093|NCT00991276|21201422|P3|NOT COMPLETED|First Intervention Period||0
8599094|NCT00991276|21201423|P2|NOT COMPLETED|First Intervention Period||3
8599095|NCT00991276|21201424|P1|NOT COMPLETED|First Intervention Period||0
8599096|NCT00991276|21201419|P6|COMPLETED|First Intervention Period||12
8599097|NCT00991276|21201420|P5|COMPLETED|First Intervention Period||11
8599098|NCT00991276|21201421|P4|COMPLETED|First Intervention Period||11
8599099|NCT00991276|21201422|P3|COMPLETED|First Intervention Period||14
8599100|NCT00991276|21201423|P2|COMPLETED|First Intervention Period||10
8599101|NCT00991276|21201424|P1|COMPLETED|First Intervention Period||15
8599102|NCT00991276|21201419|P6|STARTED|First Intervention Period||13
8599103|NCT00991276|21201420|P5|STARTED|First Intervention Period||15
8599104|NCT00991276|21201421|P4|STARTED|First Intervention Period||15
8599105|NCT00991276|21201422|P3|STARTED|First Intervention Period||14
8599106|NCT00991276|21201423|P2|STARTED|First Intervention Period||13
8599107|NCT00991276|21201424|P1|STARTED|First Intervention Period||15
8599225|NCT00539981|21201830|P2|NOT COMPLETED|Overall Study||282
8599226|NCT00539981|21201831|P1|NOT COMPLETED|Overall Study||295
8599227|NCT00539981|21201830|P2|COMPLETED|Overall Study||2022
8599228|NCT00539981|21201831|P1|COMPLETED|Overall Study||2049
8599229|NCT00539981|21201830|P2|STARTED|Overall Study||2304
8599230|NCT00539981|21201831|P1|STARTED|Overall Study||2344
8599324|NCT00317369|21202061|P3|NOT COMPLETED|Overall Study||2
8599325|NCT00317369|21202062|P2|NOT COMPLETED|Overall Study||2
8599326|NCT00317369|21202063|P1|NOT COMPLETED|Overall Study||2
8599327|NCT00317369|21202061|P3|COMPLETED|Overall Study||8
8599328|NCT00317369|21202062|P2|COMPLETED|Overall Study||7
8599329|NCT00317369|21202063|P1|COMPLETED|Overall Study||8
8599330|NCT00317369|21202061|P3|STARTED|Overall Study||10
8599331|NCT00317369|21202062|P2|STARTED|Overall Study||9
8599332|NCT00317369|21202063|P1|STARTED|Overall Study||10
8599369|NCT04245202|21202199|P2|NOT COMPLETED|Overall Study||1
8599370|NCT04245202|21202200|P1|NOT COMPLETED|Overall Study||10
8599371|NCT04245202|21202199|P2|COMPLETED|Overall Study||38
8599372|NCT04245202|21202200|P1|COMPLETED|Overall Study||38
8599373|NCT04245202|21202199|P2|STARTED|Overall Study|After getting consent|39
8599374|NCT04245202|21202200|P1|STARTED|Overall Study|After getting consent.|48
8599405|NCT04184999|21202257|P2|NOT COMPLETED|Overall Study||0
8599406|NCT04184999|21202258|P1|NOT COMPLETED|Overall Study||0
8599407|NCT04184999|21202257|P2|COMPLETED|Overall Study||40
8599408|NCT04184999|21202258|P1|COMPLETED|Overall Study||40
8599409|NCT04184999|21202257|P2|3 Week Tear Film Osmolarity Testing|Overall Study||40
8599410|NCT04184999|21202258|P1|3 Week Tear Film Osmolarity Testing|Overall Study||40
8599411|NCT04184999|21202257|P2|STARTED|Overall Study||40
8599412|NCT04184999|21202258|P1|STARTED|Overall Study||40
8599413|NCT04170686|21202266|P2|NOT COMPLETED|Randomization and Treatment||15
8599414|NCT04170686|21202267|P1|NOT COMPLETED|Randomization and Treatment||26
8599415|NCT04170686|21202266|P2|COMPLETED|Randomization and Treatment||44
8599416|NCT04170686|21202267|P1|COMPLETED|Randomization and Treatment||36
8599417|NCT04170686|21202266|P2|STARTED|Randomization and Treatment||59
8599418|NCT04170686|21202267|P1|STARTED|Randomization and Treatment||62
8599419|NCT04170686|21202266|P2|NOT COMPLETED|Screening||13
8599420|NCT04170686|21202267|P1|NOT COMPLETED|Screening||12
8599421|NCT04170686|21202266|P2|COMPLETED|Screening||59
8599422|NCT04170686|21202267|P1|COMPLETED|Screening||62
8599423|NCT04170686|21202266|P2|STARTED|Screening||72
8599424|NCT04170686|21202267|P1|STARTED|Screening||74
8599425|NCT04161807|21202289|P1|NOT COMPLETED|Overall Study||4
8599426|NCT04161807|21202289|P1|COMPLETED|Overall Study||38
8599427|NCT04161807|21202289|P1|STARTED|Overall Study||42
8599428|NCT04093258|21202301|P2|NOT COMPLETED|Period 2||0
8599429|NCT04093258|21202302|P1|NOT COMPLETED|Period 2||1
8599430|NCT04093258|21202301|P2|COMPLETED|Period 2||20
8599431|NCT04093258|21202302|P1|COMPLETED|Period 2||20
8599432|NCT04093258|21202301|P2|STARTED|Period 2||20
8599433|NCT04093258|21202302|P1|STARTED|Period 2||21
8599434|NCT04093258|21202301|P2|NOT COMPLETED|Period 1||0
8599435|NCT04093258|21202302|P1|NOT COMPLETED|Period 1||0
8599436|NCT04093258|21202301|P2|COMPLETED|Period 1||20
8599437|NCT04093258|21202302|P1|COMPLETED|Period 1||21
8599438|NCT04093258|21202301|P2|STARTED|Period 1||20
8599439|NCT04093258|21202302|P1|STARTED|Period 1||21
8599494|NCT03784079|21202436|P7|NOT COMPLETED|Part 2: Up to Day 12||0
8599495|NCT03784079|21202437|P6|NOT COMPLETED|Part 2: Up to Day 12||0
8599496|NCT03784079|21202438|P5|NOT COMPLETED|Part 2: Up to Day 12||0
8599497|NCT03784079|21202439|P4|NOT COMPLETED|Part 2: Up to Day 12||0
8599498|NCT03784079|21202440|P3|NOT COMPLETED|Part 2: Up to Day 12||0
8599499|NCT03784079|21202441|P2|NOT COMPLETED|Part 2: Up to Day 12||0
8599500|NCT03784079|21202442|P1|NOT COMPLETED|Part 2: Up to Day 12||0
8599501|NCT03784079|21202436|P7|COMPLETED|Part 2: Up to Day 12||2
8599502|NCT03784079|21202437|P6|COMPLETED|Part 2: Up to Day 12||6
8599503|NCT03784079|21202438|P5|COMPLETED|Part 2: Up to Day 12||6
8599504|NCT03784079|21202439|P4|COMPLETED|Part 2: Up to Day 12||6
8599505|NCT03784079|21202440|P3|COMPLETED|Part 2: Up to Day 12||0
8599506|NCT03784079|21202441|P2|COMPLETED|Part 2: Up to Day 12||0
8599507|NCT03784079|21202442|P1|COMPLETED|Part 2: Up to Day 12||0
8599508|NCT03784079|21202436|P7|STARTED|Part 2: Up to Day 12||2
8599509|NCT03784079|21202437|P6|STARTED|Part 2: Up to Day 12||6
8599510|NCT03784079|21202438|P5|STARTED|Part 2: Up to Day 12||6
8599511|NCT03784079|21202439|P4|STARTED|Part 2: Up to Day 12||6
8599512|NCT03784079|21202440|P3|STARTED|Part 2: Up to Day 12||0
8599513|NCT03784079|21202441|P2|STARTED|Part 2: Up to Day 12||0
8599514|NCT03784079|21202442|P1|STARTED|Part 2: Up to Day 12||0
8599515|NCT03784079|21202436|P7|NOT COMPLETED|Part 1: Up to Day 24||0
8599516|NCT03784079|21202437|P6|NOT COMPLETED|Part 1: Up to Day 24||0
8599517|NCT03784079|21202438|P5|NOT COMPLETED|Part 1: Up to Day 24||0
8599518|NCT03784079|21202439|P4|NOT COMPLETED|Part 1: Up to Day 24||0
8599519|NCT03784079|21202440|P3|NOT COMPLETED|Part 1: Up to Day 24||0
8599520|NCT03784079|21202441|P2|NOT COMPLETED|Part 1: Up to Day 24||0
8599521|NCT03784079|21202442|P1|NOT COMPLETED|Part 1: Up to Day 24||0
8599522|NCT03784079|21202436|P7|COMPLETED|Part 1: Up to Day 24||0
8599523|NCT03784079|21202437|P6|COMPLETED|Part 1: Up to Day 24||0
8599524|NCT03784079|21202438|P5|COMPLETED|Part 1: Up to Day 24||0
8599525|NCT03784079|21202439|P4|COMPLETED|Part 1: Up to Day 24||0
8599526|NCT03784079|21202440|P3|COMPLETED|Part 1: Up to Day 24||2
8599527|NCT03784079|21202441|P2|COMPLETED|Part 1: Up to Day 24||6
8599528|NCT03784079|21202442|P1|COMPLETED|Part 1: Up to Day 24||6
8599529|NCT03784079|21202436|P7|STARTED|Part 1: Up to Day 24||0
8599530|NCT03784079|21202437|P6|STARTED|Part 1: Up to Day 24||0
8599531|NCT03784079|21202438|P5|STARTED|Part 1: Up to Day 24||0
8599532|NCT03784079|21202439|P4|STARTED|Part 1: Up to Day 24||0
8599533|NCT03784079|21202440|P3|STARTED|Part 1: Up to Day 24||2
8599534|NCT03784079|21202441|P2|STARTED|Part 1: Up to Day 24||6
8599535|NCT03784079|21202442|P1|STARTED|Part 1: Up to Day 24||6
8599536|NCT03769649|21202817|P1|NOT COMPLETED|Overall Study||4
8599537|NCT03769649|21202817|P1|COMPLETED|Overall Study||11
8599538|NCT03769649|21202817|P1|STARTED|Overall Study||15
8599560|NCT03607539|21202927|P2|NOT COMPLETED|Overall Study||131
8599561|NCT03607539|21202928|P1|NOT COMPLETED|Overall Study||266
8599562|NCT03607539|21202927|P2|COMPLETED|Overall Study||0
8599563|NCT03607539|21202928|P1|COMPLETED|Overall Study||0
8599564|NCT03607539|21202927|P2|STARTED|Overall Study||131
8599565|NCT03607539|21202928|P1|STARTED|Overall Study||266
8599584|NCT03521635|21203021|P2|NOT COMPLETED|Overall Study||6
8599585|NCT03521635|21203022|P1|NOT COMPLETED|Overall Study||4
8599586|NCT03521635|21203021|P2|COMPLETED|Overall Study||43
8599587|NCT03521635|21203022|P1|COMPLETED|Overall Study||45
8599588|NCT03521635|21203021|P2|STARTED|Overall Study||49
8599589|NCT03521635|21203022|P1|STARTED|Overall Study||49
8599590|NCT03514420|21203046|P1|NOT COMPLETED|Overall Study||0
8599591|NCT03514420|21203046|P1|COMPLETED|Overall Study||4
8599592|NCT03514420|21203046|P1|STARTED|Overall Study||4
8599602|NCT03499873|21203113|P3|NOT COMPLETED|Overall Study||27
8599603|NCT03499873|21203114|P2|NOT COMPLETED|Overall Study||20
8599604|NCT03499873|21203115|P1|NOT COMPLETED|Overall Study||20
8599605|NCT03499873|21203113|P3|COMPLETED|Overall Study||56
8599606|NCT03499873|21203114|P2|COMPLETED|Overall Study||162
8599607|NCT03499873|21203115|P1|COMPLETED|Overall Study||163
8599608|NCT03499873|21203113|P3|Modified-Intent-to-Treat|Overall Study||77
8599609|NCT03499873|21203114|P2|Modified-Intent-to-Treat|Overall Study||168
8599610|NCT03499873|21203115|P1|Modified-Intent-to-Treat|Overall Study||170
8599611|NCT03499873|21203113|P3|Per-Protocol Population|Overall Study||58
8599612|NCT03499873|21203114|P2|Per-Protocol Population|Overall Study||143
8599613|NCT03499873|21203115|P1|Per-Protocol Population|Overall Study||144
8599614|NCT03499873|21203113|P3|Safety Population|Overall Study||80
8599615|NCT03499873|21203114|P2|Safety Population|Overall Study||174
8599616|NCT03499873|21203115|P1|Safety Population|Overall Study||175
8599617|NCT03499873|21203113|P3|STARTED|Overall Study||83
8599618|NCT03499873|21203114|P2|STARTED|Overall Study||182
8599619|NCT03499873|21203115|P1|STARTED|Overall Study||183
8599683|NCT03389555|21203305|P2|NOT COMPLETED|Overall Study||3
8599684|NCT03389555|21203306|P1|NOT COMPLETED|Overall Study||2
8599685|NCT03389555|21203305|P2|COMPLETED|Overall Study||99
8599686|NCT03389555|21203306|P1|COMPLETED|Overall Study||101
8599687|NCT03389555|21203305|P2|STARTED|Overall Study||102
8599688|NCT03389555|21203306|P1|STARTED|Overall Study||103
8599701|NCT03361293|21203414|P2|NOT COMPLETED|Overall Study||5
8599702|NCT03361293|21203415|P1|NOT COMPLETED|Overall Study||1
8599703|NCT03361293|21203414|P2|COMPLETED|Overall Study||19
8599704|NCT03361293|21203415|P1|COMPLETED|Overall Study||19
8599705|NCT03361293|21203414|P2|STARTED|Overall Study||24
8599706|NCT03361293|21203415|P1|STARTED|Overall Study||20
8599707|NCT03359889|21203435|P1|NOT COMPLETED|Overall Study||0
8599708|NCT03359889|21203435|P1|COMPLETED|Overall Study||5
8599709|NCT03359889|21203435|P1|STARTED|Overall Study||5
8599747|NCT03216226|21203592|P2|NOT COMPLETED|Overall Study||5
8599748|NCT03216226|21203593|P1|NOT COMPLETED|Overall Study||5
8599749|NCT03216226|21203592|P2|COMPLETED|Overall Study||50
8599750|NCT03216226|21203593|P1|COMPLETED|Overall Study||52
8599751|NCT03216226|21203592|P2|Randomized and Treated|Overall Study||54
8599752|NCT03216226|21203593|P1|Randomized and Treated|Overall Study||57
8599753|NCT03216226|21203592|P2|STARTED|Overall Study||55
8599754|NCT03216226|21203593|P1|STARTED|Overall Study||57
8599755|NCT03197025|21203623|P1|NOT COMPLETED|Overall Study||0
8599756|NCT03197025|21203623|P1|COMPLETED|Overall Study||1
8599757|NCT03197025|21203623|P1|STARTED|Overall Study||1
8599762|NCT03173313|21203636|P2|NOT COMPLETED|Overall Study||5
8599763|NCT03173313|21203637|P1|NOT COMPLETED|Overall Study||9
8599764|NCT03173313|21203636|P2|COMPLETED|Overall Study||48
8599765|NCT03173313|21203637|P1|COMPLETED|Overall Study||49
8599766|NCT03173313|21203636|P2|12-month Follow-up|Overall Study||48
8599767|NCT03173313|21203637|P1|12-month Follow-up|Overall Study||49
8599768|NCT03173313|21203636|P2|30-day Follow-up|Overall Study||51
8599769|NCT03173313|21203637|P1|30-day Follow-up|Overall Study||52
8599770|NCT03173313|21203636|P2|4-6 Day Follow-up|Overall Study||53
8599771|NCT03173313|21203637|P1|4-6 Day Follow-up|Overall Study||57
8599772|NCT03173313|21203636|P2|Cooled|Overall Study||0
8599773|NCT03173313|21203637|P1|Cooled|Overall Study||54
8599774|NCT03173313|21203636|P2|Randomized|Overall Study||53
8599775|NCT03173313|21203637|P1|Randomized|Overall Study||58
8599776|NCT03173313|21203636|P2|Informed Consent Signed|Overall Study||53
8599777|NCT03173313|21203637|P1|Informed Consent Signed|Overall Study||58
8599778|NCT03173313|21203636|P2|STARTED|Overall Study||53
8599779|NCT03173313|21203637|P1|STARTED|Overall Study||58
8599801|NCT03078751|21203727|P2|NOT COMPLETED|Overall Study||28
8599802|NCT03078751|21203728|P1|NOT COMPLETED|Overall Study||13
8599803|NCT03078751|21203727|P2|COMPLETED|Overall Study||0
8599804|NCT03078751|21203728|P1|COMPLETED|Overall Study||13
8599805|NCT03078751|21203727|P2|Safety Set|Overall Study||24
8599806|NCT03078751|21203728|P1|Safety Set|Overall Study||26
8599807|NCT03078751|21203727|P2|Untreated Participants|Overall Study||4
8599808|NCT03078751|21203728|P1|Untreated Participants|Overall Study||0
8599809|NCT03078751|21203727|P2|STARTED|Overall Study||28
8599810|NCT03078751|21203728|P1|STARTED|Overall Study||26
8599811|NCT03017924|21203738|P2|NOT COMPLETED|Overall Study||3
8599812|NCT03017924|21203739|P1|NOT COMPLETED|Overall Study||2
8599813|NCT03017924|21203738|P2|COMPLETED|Overall Study||8
8599814|NCT03017924|21203739|P1|COMPLETED|Overall Study||10
8599815|NCT03017924|21203738|P2|STARTED|Overall Study||11
8599816|NCT03017924|21203739|P1|STARTED|Overall Study||12
8599880|NCT02971735|21203856|P2|NOT COMPLETED|Overall Study||0
8599881|NCT02971735|21203857|P1|NOT COMPLETED|Overall Study||0
8599882|NCT02971735|21203856|P2|COMPLETED|Overall Study||30
8599883|NCT02971735|21203857|P1|COMPLETED|Overall Study||30
8599884|NCT02971735|21203856|P2|STARTED|Overall Study||30
8599885|NCT02971735|21203857|P1|STARTED|Overall Study||30
8599886|NCT02964338|21203878|P3|NOT COMPLETED|Overall Study||19
8599887|NCT02964338|21203879|P2|NOT COMPLETED|Overall Study||24
8599888|NCT02964338|21203880|P1|NOT COMPLETED|Overall Study||17
8599889|NCT02964338|21203878|P3|COMPLETED|Overall Study||68
8599890|NCT02964338|21203879|P2|COMPLETED|Overall Study||64
8599891|NCT02964338|21203880|P1|COMPLETED|Overall Study||67
8599892|NCT02964338|21203878|P3|Full Analysis Set|Overall Study||87
8599893|NCT02964338|21203879|P2|Full Analysis Set|Overall Study||86
8599894|NCT02964338|21203880|P1|Full Analysis Set|Overall Study||81
8599895|NCT02964338|21203878|P3|Safety Analysis Set|Overall Study||87
8599896|NCT02964338|21203879|P2|Safety Analysis Set|Overall Study||88
8599897|NCT02964338|21203880|P1|Safety Analysis Set|Overall Study||83
8599898|NCT02964338|21203878|P3|STARTED|Overall Study||87
8599899|NCT02964338|21203879|P2|STARTED|Overall Study||88
8599900|NCT02964338|21203880|P1|STARTED|Overall Study||84
8599931|NCT02891681|21204090|P3|NOT COMPLETED|Overall Study||1
8599932|NCT02891681|21204091|P2|NOT COMPLETED|Overall Study||0
8599933|NCT02891681|21204092|P1|NOT COMPLETED|Overall Study||3
8599934|NCT02891681|21204090|P3|COMPLETED|Overall Study||0
8599935|NCT02891681|21204091|P2|COMPLETED|Overall Study||1
8599936|NCT02891681|21204092|P1|COMPLETED|Overall Study||36
8599937|NCT02891681|21204090|P3|STARTED|Overall Study||1
8599938|NCT02891681|21204091|P2|STARTED|Overall Study||1
8599939|NCT02891681|21204092|P1|STARTED|Overall Study||39
8599940|NCT02874742|21204103|P3|NOT COMPLETED|Overall Study||16
8599941|NCT02874742|21204104|P2|NOT COMPLETED|Overall Study||104
8599942|NCT02874742|21204105|P1|NOT COMPLETED|Overall Study||103
8599943|NCT02874742|21204103|P3|COMPLETED|Overall Study||0
8599944|NCT02874742|21204104|P2|COMPLETED|Overall Study||0
8599945|NCT02874742|21204105|P1|COMPLETED|Overall Study||0
8599946|NCT02874742|21204103|P3|Safety|Overall Study||16
8599947|NCT02874742|21204104|P2|Safety|Overall Study||99
8599948|NCT02874742|21204105|P1|Safety|Overall Study||102
8599949|NCT02874742|21204103|P3|STARTED|Overall Study||16
8599950|NCT02874742|21204104|P2|STARTED|Overall Study||104
8599951|NCT02874742|21204105|P1|STARTED|Overall Study||103
8599955|NCT02865538|21204171|P5|NOT COMPLETED|Overall Study||0
8599956|NCT02865538|21204172|P4|NOT COMPLETED|Overall Study||0
8599957|NCT02865538|21204173|P3|NOT COMPLETED|Overall Study||1
8599958|NCT02865538|21204174|P2|NOT COMPLETED|Overall Study||0
8599959|NCT02865538|21204175|P1|NOT COMPLETED|Overall Study||1
8599960|NCT02865538|21204171|P5|COMPLETED|Overall Study||13
8599961|NCT02865538|21204172|P4|COMPLETED|Overall Study||15
8599962|NCT02865538|21204173|P3|COMPLETED|Overall Study||14
8599963|NCT02865538|21204174|P2|COMPLETED|Overall Study||15
8599964|NCT02865538|21204175|P1|COMPLETED|Overall Study||17
8599965|NCT02865538|21204171|P5|STARTED|Overall Study||13
8599966|NCT02865538|21204172|P4|STARTED|Overall Study||15
8599967|NCT02865538|21204173|P3|STARTED|Overall Study||15
8599968|NCT02865538|21204174|P2|STARTED|Overall Study||15
8599969|NCT02865538|21204175|P1|STARTED|Overall Study||18
8599982|NCT02782065|21204493|P1|NOT COMPLETED|Overall Study||0
8599983|NCT02782065|21204493|P1|COMPLETED|Overall Study||58
8599984|NCT02782065|21204493|P1|STARTED|Overall Study||58
8599985|NCT02772978|21204501|P2|NOT COMPLETED|Overall Study||1
8599986|NCT02772978|21204502|P1|NOT COMPLETED|Overall Study||1
8599987|NCT02772978|21204501|P2|COMPLETED|Overall Study||8
8599988|NCT02772978|21204502|P1|COMPLETED|Overall Study|Last participant enrolled|9
8599989|NCT02772978|21204501|P2|STARTED|Overall Study||9
8599990|NCT02772978|21204502|P1|STARTED|Overall Study|First participant enrolled|10
8599997|NCT02734147|21204521|P2|NOT COMPLETED|Overall Study||1
8599998|NCT02734147|21204522|P1|NOT COMPLETED|Overall Study||3
8599999|NCT02734147|21204521|P2|COMPLETED|Overall Study||11
8600000|NCT02734147|21204522|P1|COMPLETED|Overall Study||9
8600001|NCT02734147|21204521|P2|STARTED|Overall Study||12
8600002|NCT02734147|21204522|P1|STARTED|Overall Study||12
8600003|NCT02704156|21204542|P2|NOT COMPLETED|Overall Study||0
8600004|NCT02704156|21204543|P1|NOT COMPLETED|Overall Study||0
8600005|NCT02704156|21204542|P2|COMPLETED|Overall Study||85
8600006|NCT02704156|21204543|P1|COMPLETED|Overall Study||85
8600007|NCT02704156|21204542|P2|STARTED|Overall Study||85
8600008|NCT02704156|21204543|P1|STARTED|Overall Study||85
8600042|NCT02652949|21204864|P1|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
8600043|NCT02652949|21204864|P1|COMPLETED|24-Month Follow-up Secondary Endpoint||52
8600044|NCT02652949|21204864|P1|STARTED|24-Month Follow-up Secondary Endpoint||87
8600045|NCT02652949|21204864|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
8600046|NCT02652949|21204864|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
8600047|NCT02652949|21204864|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
8600048|NCT02652949|21204864|P1|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
8600049|NCT02652949|21204864|P1|COMPLETED|6-Month Follow-up Secondary Endpoint||91
8600050|NCT02652949|21204864|P1|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
8600051|NCT02652949|21204864|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
8600052|NCT02652949|21204864|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
8600053|NCT02652949|21204864|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
8600054|NCT02652949|21204864|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
8600055|NCT02652949|21204864|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
8600056|NCT02652949|21204864|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
8600060|NCT02638207|21204917|P3|NOT COMPLETED|Overall Study||4
8600061|NCT02638207|21204918|P2|NOT COMPLETED|Overall Study||8
8600062|NCT02638207|21204919|P1|NOT COMPLETED|Overall Study||7
8600063|NCT02638207|21204917|P3|COMPLETED|Overall Study||34
8600064|NCT02638207|21204918|P2|COMPLETED|Overall Study||61
8600065|NCT02638207|21204919|P1|COMPLETED|Overall Study||28
8600066|NCT02638207|21204917|P3|STARTED|Overall Study||38
8600067|NCT02638207|21204918|P2|STARTED|Overall Study||69
8600068|NCT02638207|21204919|P1|STARTED|Overall Study||35
8600072|NCT02625324|21204965|P1|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
8600073|NCT02625324|21204965|P1|COMPLETED|24-Month Follow-up Secondary Endpoint||52
8600074|NCT02625324|21204965|P1|STARTED|24-Month Follow-up Secondary Endpoint||87
8600075|NCT02625324|21204965|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
8600076|NCT02625324|21204965|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
8600077|NCT02625324|21204965|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
8600078|NCT02625324|21204965|P1|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
8600079|NCT02625324|21204965|P1|COMPLETED|6-Month Follow-up Subject Accountability||91
8600080|NCT02625324|21204965|P1|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
8600081|NCT02625324|21204965|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
8600082|NCT02625324|21204965|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
8600083|NCT02625324|21204965|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
8600084|NCT02625324|21204965|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
8600085|NCT02625324|21204965|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
8600086|NCT02625324|21204965|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
8600130|NCT02583048|21205040|P3|NOT COMPLETED|Overall Study||1
8600131|NCT02583048|21205041|P2|NOT COMPLETED|Overall Study||1
8600132|NCT02583048|21205042|P1|NOT COMPLETED|Overall Study||0
8600133|NCT02583048|21205040|P3|COMPLETED|Overall Study||27
8600134|NCT02583048|21205041|P2|COMPLETED|Overall Study||27
8600135|NCT02583048|21205042|P1|COMPLETED|Overall Study||28
8600136|NCT02583048|21205040|P3|STARTED|Overall Study||28
8600137|NCT02583048|21205041|P2|STARTED|Overall Study||28
8600138|NCT02583048|21205042|P1|STARTED|Overall Study||28
8600151|NCT02528370|21205121|P2|NOT COMPLETED|Overall Study||1
8600152|NCT02528370|21205122|P1|NOT COMPLETED|Overall Study||17
8600153|NCT02528370|21205121|P2|COMPLETED|Overall Study||77
8600154|NCT02528370|21205122|P1|COMPLETED|Overall Study||102
8600155|NCT02528370|21205121|P2|STARTED|Overall Study||78
8600156|NCT02528370|21205122|P1|STARTED|Overall Study||119
8600157|NCT02499159|21205130|P2|NOT COMPLETED|30-Day Follow-Up Phone Call||2
8600158|NCT02499159|21205131|P1|NOT COMPLETED|30-Day Follow-Up Phone Call||7
8600159|NCT02499159|21205130|P2|COMPLETED|30-Day Follow-Up Phone Call||47
8600160|NCT02499159|21205131|P1|COMPLETED|30-Day Follow-Up Phone Call||42
8600161|NCT02499159|21205130|P2|STARTED|30-Day Follow-Up Phone Call||49
8600162|NCT02499159|21205131|P1|STARTED|30-Day Follow-Up Phone Call||49
8600163|NCT02499159|21205130|P2|NOT COMPLETED|Randomization||1
8600164|NCT02499159|21205131|P1|NOT COMPLETED|Randomization||1
8600165|NCT02499159|21205130|P2|COMPLETED|Randomization||49
8600166|NCT02499159|21205131|P1|COMPLETED|Randomization||49
8600167|NCT02499159|21205130|P2|STARTED|Randomization||50
8600168|NCT02499159|21205131|P1|STARTED|Randomization||50
8600487|NCT02235298|21205615|P2|NOT COMPLETED|Overall Study||8
8600488|NCT02235298|21205616|P1|NOT COMPLETED|Overall Study||8
8600489|NCT02235298|21205615|P2|COMPLETED|Overall Study||42
8600490|NCT02235298|21205616|P1|COMPLETED|Overall Study||42
8600491|NCT02235298|21205615|P2|STARTED|Overall Study||50
8600492|NCT02235298|21205616|P1|STARTED|Overall Study||50
8600528|NCT02206685|21205671|P2|NOT COMPLETED|Overall Study||7
8600529|NCT02206685|21205672|P1|NOT COMPLETED|Overall Study||5
8600530|NCT02206685|21205671|P2|COMPLETED|Overall Study||30
8600531|NCT02206685|21205672|P1|COMPLETED|Overall Study||32
8600532|NCT02206685|21205671|P2|STARTED|Overall Study||37
8600533|NCT02206685|21205672|P1|STARTED|Overall Study||37
8600544|NCT02190747|21205718|P3|NOT COMPLETED|Overall Study||0
8600545|NCT02190747|21205719|P2|NOT COMPLETED|Overall Study||0
8600546|NCT02190747|21205720|P1|NOT COMPLETED|Overall Study||0
8600547|NCT02190747|21205718|P3|COMPLETED|Overall Study||10
8600548|NCT02190747|21205719|P2|COMPLETED|Overall Study||9
8600549|NCT02190747|21205720|P1|COMPLETED|Overall Study||21
8600550|NCT02190747|21205718|P3|STARTED|Overall Study||10
8600551|NCT02190747|21205719|P2|STARTED|Overall Study||9
8600552|NCT02190747|21205720|P1|STARTED|Overall Study||21
8600559|NCT02178722|21205805|P5|NOT COMPLETED|Overall Study||382
8600560|NCT02178722|21205806|P4|NOT COMPLETED|Overall Study||20
8600561|NCT02178722|21205807|P3|NOT COMPLETED|Overall Study||18
8600562|NCT02178722|21205808|P2|NOT COMPLETED|Overall Study||20
8600563|NCT02178722|21205809|P1|NOT COMPLETED|Overall Study||4
8600564|NCT02178722|21205805|P5|COMPLETED|Overall Study||0
8600565|NCT02178722|21205806|P4|COMPLETED|Overall Study||0
8600566|NCT02178722|21205807|P3|COMPLETED|Overall Study||0
8600567|NCT02178722|21205808|P2|COMPLETED|Overall Study||0
8600568|NCT02178722|21205809|P1|COMPLETED|Overall Study||0
8600569|NCT02178722|21205805|P5|STARTED|Overall Study||382
8600570|NCT02178722|21205806|P4|STARTED|Overall Study||20
8600571|NCT02178722|21205807|P3|STARTED|Overall Study||18
8600572|NCT02178722|21205808|P2|STARTED|Overall Study||20
8600573|NCT02178722|21205809|P1|STARTED|Overall Study||4
8600574|NCT02139280|21205823|P2|NOT COMPLETED|Overall Study||0
8600575|NCT02139280|21205824|P1|NOT COMPLETED|Overall Study||2
8600576|NCT02139280|21205823|P2|COMPLETED|Overall Study||20
8600577|NCT02139280|21205824|P1|COMPLETED|Overall Study||32
8600578|NCT02139280|21205823|P2|STARTED|Overall Study||20
8600579|NCT02139280|21205824|P1|STARTED|Overall Study||34
8600586|NCT02068885|21205880|P3|NOT COMPLETED|Overall Study||8
8600587|NCT02068885|21205881|P2|NOT COMPLETED|Overall Study||5
8600588|NCT02068885|21205882|P1|NOT COMPLETED|Overall Study||3
8600589|NCT02068885|21205880|P3|COMPLETED|Overall Study||46
8600590|NCT02068885|21205881|P2|COMPLETED|Overall Study||48
8600591|NCT02068885|21205882|P1|COMPLETED|Overall Study||54
8600592|NCT02068885|21205880|P3|Included in Intention-to-treat Analysis|Overall Study||54
8600593|NCT02068885|21205881|P2|Included in Intention-to-treat Analysis|Overall Study||52
8600594|NCT02068885|21205882|P1|Included in Intention-to-treat Analysis|Overall Study||56
8600595|NCT02068885|21205880|P3|Provided Data at End of Test Phase|Overall Study||46
8600596|NCT02068885|21205881|P2|Provided Data at End of Test Phase|Overall Study||48
8600597|NCT02068885|21205882|P1|Provided Data at End of Test Phase|Overall Study||54
8600598|NCT02068885|21205880|P3|Provided Data at Midpoint Test Phase|Overall Study||48
8600599|NCT02068885|21205881|P2|Provided Data at Midpoint Test Phase|Overall Study||50
8600600|NCT02068885|21205882|P1|Provided Data at Midpoint Test Phase|Overall Study||56
8600601|NCT02068885|21205880|P3|STARTED|Overall Study||54
8600602|NCT02068885|21205881|P2|STARTED|Overall Study||53
8600603|NCT02068885|21205882|P1|STARTED|Overall Study||57
8600675|NCT01928524|21206121|P7|NOT COMPLETED|Overall Study||0
8600676|NCT01928524|21206122|P6|NOT COMPLETED|Overall Study||0
8600677|NCT01928524|21206123|P5|NOT COMPLETED|Overall Study||0
8600678|NCT01928524|21206124|P4|NOT COMPLETED|Overall Study||0
8600679|NCT01928524|21206125|P3|NOT COMPLETED|Overall Study||0
8600680|NCT01928524|21206126|P2|NOT COMPLETED|Overall Study||0
8600681|NCT01928524|21206127|P1|NOT COMPLETED|Overall Study||0
8600682|NCT01928524|21206121|P7|COMPLETED|Overall Study||5
8600683|NCT01928524|21206122|P6|COMPLETED|Overall Study||8
8600684|NCT01928524|21206123|P5|COMPLETED|Overall Study||3
8600685|NCT01928524|21206124|P4|COMPLETED|Overall Study||6
8600686|NCT01928524|21206125|P3|COMPLETED|Overall Study||6
8600687|NCT01928524|21206126|P2|COMPLETED|Overall Study||3
8600688|NCT01928524|21206127|P1|COMPLETED|Overall Study||3
8600689|NCT01928524|21206121|P7|STARTED|Overall Study||5
8600690|NCT01928524|21206122|P6|STARTED|Overall Study||8
8600691|NCT01928524|21206123|P5|STARTED|Overall Study||3
8600692|NCT01928524|21206124|P4|STARTED|Overall Study||6
8600693|NCT01928524|21206125|P3|STARTED|Overall Study||6
8600694|NCT01928524|21206126|P2|STARTED|Overall Study||3
8600695|NCT01928524|21206127|P1|STARTED|Overall Study||3
8600763|NCT01756898|21206314|P4|NOT COMPLETED|Overall Study||16
8600764|NCT01756898|21206315|P3|NOT COMPLETED|Overall Study||17
8600765|NCT01756898|21206316|P2|NOT COMPLETED|Overall Study||19
8600766|NCT01756898|21206317|P1|NOT COMPLETED|Overall Study||19
8600767|NCT01756898|21206314|P4|COMPLETED|Overall Study||77
8600768|NCT01756898|21206315|P3|COMPLETED|Overall Study||76
8600769|NCT01756898|21206316|P2|COMPLETED|Overall Study||73
8600770|NCT01756898|21206317|P1|COMPLETED|Overall Study||73
8600771|NCT01756898|21206314|P4|STARTED|Overall Study||93
8600772|NCT01756898|21206315|P3|STARTED|Overall Study||93
8600773|NCT01756898|21206316|P2|STARTED|Overall Study||92
8600774|NCT01756898|21206317|P1|STARTED|Overall Study||92
8600788|NCT01615120|21206384|P2|NOT COMPLETED|Overall Study||20
8600789|NCT01615120|21206385|P1|NOT COMPLETED|Overall Study||15
8600790|NCT01615120|21206384|P2|COMPLETED|Overall Study||19
8600791|NCT01615120|21206385|P1|COMPLETED|Overall Study||23
8600792|NCT01615120|21206384|P2|STARTED|Overall Study||39
8600793|NCT01615120|21206385|P1|STARTED|Overall Study||38
8600916|NCT01581593|21206609|P1|NOT COMPLETED|Overall Study||1
8600917|NCT01581593|21206609|P1|COMPLETED|Overall Study||44
8600918|NCT01581593|21206609|P1|STARTED|Overall Study||45
8600919|NCT01576783|21206629|P2|NOT COMPLETED|Overall Study||17
8600920|NCT01576783|21206630|P1|NOT COMPLETED|Overall Study||20
8600921|NCT01576783|21206629|P2|COMPLETED|Overall Study||171
8600922|NCT01576783|21206630|P1|COMPLETED|Overall Study||169
8600923|NCT01576783|21206629|P2|STARTED|Overall Study||188
8600924|NCT01576783|21206630|P1|STARTED|Overall Study||189
8600934|NCT01568320|21206668|P1|NOT COMPLETED|Overall Study||41
8600935|NCT01568320|21206668|P1|COMPLETED|Overall Study||32
8600936|NCT01568320|21206668|P1|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
8600937|NCT01568320|21206668|P1|STARTED|Overall Study||73
8601049|NCT01212627|21206882|P1|NOT COMPLETED|Overall Study||0
8601050|NCT01212627|21206882|P1|COMPLETED|Overall Study||12
8601051|NCT01212627|21206882|P1|STARTED|Overall Study||12
8601073|NCT01102231|21206927|P1|NOT COMPLETED|Overall Study||15
8601074|NCT01102231|21206927|P1|COMPLETED|Overall Study||91
8601075|NCT01102231|21206927|P1|STARTED|Overall Study||106
8601103|NCT00963911|21206990|P1|NOT COMPLETED|Overall Study||0
8601104|NCT00963911|21206990|P1|COMPLETED|Overall Study||1674
8601105|NCT00963911|21206990|P1|STARTED|Overall Study||1674
8601124|NCT00866697|21207027|P2|NOT COMPLETED|Overall Study||228
8601125|NCT00866697|21207028|P1|NOT COMPLETED|Overall Study||214
8601126|NCT00866697|21207027|P2|COMPLETED|Overall Study||244
8601127|NCT00866697|21207028|P1|COMPLETED|Overall Study||254
8601128|NCT00866697|21207027|P2|STARTED|Overall Study||472
8601129|NCT00866697|21207028|P1|STARTED|Overall Study||468
8601211|NCT00470301|21207284|P1|NOT COMPLETED|Overall Study||5
8601212|NCT00470301|21207284|P1|COMPLETED|Overall Study||55
8601213|NCT00470301|21207284|P1|STARTED|Overall Study||60
8601286|NCT00369564|21207446|P2|NOT COMPLETED|Overall Study||23
8601287|NCT00369564|21207447|P1|NOT COMPLETED|Overall Study||43
8601288|NCT00369564|21207446|P2|COMPLETED|Overall Study||100
8601289|NCT00369564|21207447|P1|COMPLETED|Overall Study||84
8601290|NCT00369564|21207446|P2|STARTED|Overall Study||123
8601291|NCT00369564|21207447|P1|STARTED|Overall Study||127
8601328|NCT04563767|21207567|P1|NOT COMPLETED|Overall Study||0
8601329|NCT04563767|21207567|P1|COMPLETED|Overall Study||4
8601330|NCT04563767|21207567|P1|STARTED|Overall Study||4
8601340|NCT04189848|21207591|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8601341|NCT04189848|21207592|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8601342|NCT04189848|21207593|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8601343|NCT04189848|21207594|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8601344|NCT04189848|21207591|P4|COMPLETED|Treatment Period 2 (Day 1)||27
8601345|NCT04189848|21207592|P3|COMPLETED|Treatment Period 2 (Day 1)||25
8601346|NCT04189848|21207593|P2|COMPLETED|Treatment Period 2 (Day 1)||26
8601347|NCT04189848|21207594|P1|COMPLETED|Treatment Period 2 (Day 1)||26
8601348|NCT04189848|21207591|P4|STARTED|Treatment Period 2 (Day 1)||27
8601349|NCT04189848|21207592|P3|STARTED|Treatment Period 2 (Day 1)||25
8601350|NCT04189848|21207593|P2|STARTED|Treatment Period 2 (Day 1)||26
8601351|NCT04189848|21207594|P1|STARTED|Treatment Period 2 (Day 1)||26
8601352|NCT04189848|21207591|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8601353|NCT04189848|21207592|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8601354|NCT04189848|21207593|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8601355|NCT04189848|21207594|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8601356|NCT04189848|21207591|P4|COMPLETED|Treatment Period 1 (Day 1)||27
8601357|NCT04189848|21207592|P3|COMPLETED|Treatment Period 1 (Day 1)||25
8601358|NCT04189848|21207593|P2|COMPLETED|Treatment Period 1 (Day 1)||26
8601359|NCT04189848|21207594|P1|COMPLETED|Treatment Period 1 (Day 1)||26
8601360|NCT04189848|21207591|P4|STARTED|Treatment Period 1 (Day 1)||27
8601361|NCT04189848|21207592|P3|STARTED|Treatment Period 1 (Day 1)||25
8601362|NCT04189848|21207593|P2|STARTED|Treatment Period 1 (Day 1)||26
8601363|NCT04189848|21207594|P1|STARTED|Treatment Period 1 (Day 1)||26
8601364|NCT04073823|21207601|P2|NOT COMPLETED|Overall Study||0
8601365|NCT04073823|21207602|P1|NOT COMPLETED|Overall Study||0
8601366|NCT04073823|21207601|P2|COMPLETED|Overall Study||1
8601367|NCT04073823|21207602|P1|COMPLETED|Overall Study||1
8601368|NCT04073823|21207601|P2|STARTED|Overall Study||1
8601369|NCT04073823|21207602|P1|STARTED|Overall Study||1
8601397|NCT03905096|21207673|P2|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
8601398|NCT03905096|21207674|P1|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
8601399|NCT03905096|21207673|P2|COMPLETED|Period 2 for Trial Part 1 and 2||14
8601400|NCT03905096|21207674|P1|COMPLETED|Period 2 for Trial Part 1 and 2||17
8601401|NCT03905096|21207673|P2|STARTED|Period 2 for Trial Part 1 and 2||14
8601402|NCT03905096|21207674|P1|STARTED|Period 2 for Trial Part 1 and 2||18
8601403|NCT03905096|21207673|P2|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
8601404|NCT03905096|21207674|P1|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
8601405|NCT03905096|21207673|P2|COMPLETED|Period 1 for Trial Part 1 and 2||14
8601406|NCT03905096|21207674|P1|COMPLETED|Period 1 for Trial Part 1 and 2||18
8601407|NCT03905096|21207673|P2|STARTED|Period 1 for Trial Part 1 and 2||14
8601408|NCT03905096|21207674|P1|STARTED|Period 1 for Trial Part 1 and 2||18
8601409|NCT03790865|21207697|P3|NOT COMPLETED|Overall Study||0
8601410|NCT03790865|21207698|P2|NOT COMPLETED|Overall Study||2
8601411|NCT03790865|21207699|P1|NOT COMPLETED|Overall Study||0
8601412|NCT03790865|21207697|P3|COMPLETED|Overall Study||54
8601413|NCT03790865|21207698|P2|COMPLETED|Overall Study||50
8601414|NCT03790865|21207699|P1|COMPLETED|Overall Study||52
8601415|NCT03790865|21207697|P3|STARTED|Overall Study||54
8601416|NCT03790865|21207698|P2|STARTED|Overall Study||52
8601417|NCT03790865|21207699|P1|STARTED|Overall Study||52
8601418|NCT03723447|21207718|P2|NOT COMPLETED|Overall Study||0
8601419|NCT03723447|21207719|P1|NOT COMPLETED|Overall Study||0
8601420|NCT03723447|21207718|P2|COMPLETED|Overall Study||51
8601421|NCT03723447|21207719|P1|COMPLETED|Overall Study||50
8601422|NCT03723447|21207718|P2|STARTED|Overall Study||51
8601423|NCT03723447|21207719|P1|STARTED|Overall Study||50
8601433|NCT03611777|21207768|P2|NOT COMPLETED|Overall Study||0
8601434|NCT03611777|21207769|P1|NOT COMPLETED|Overall Study||0
8601435|NCT03611777|21207768|P2|COMPLETED|Overall Study||469
8601436|NCT03611777|21207769|P1|COMPLETED|Overall Study||432
8601437|NCT03611777|21207768|P2|STARTED|Overall Study||469
8601438|NCT03611777|21207769|P1|STARTED|Overall Study||432
8601439|NCT03576066|21207805|P2|NOT COMPLETED|Overall Study||1
8601440|NCT03576066|21207806|P1|NOT COMPLETED|Overall Study||0
8601441|NCT03576066|21207805|P2|COMPLETED|Overall Study||27
8601442|NCT03576066|21207806|P1|COMPLETED|Overall Study||45
8601443|NCT03576066|21207805|P2|STARTED|Overall Study||28
8601444|NCT03576066|21207806|P1|STARTED|Overall Study||45
8601478|NCT03473301|21207952|P3|NOT COMPLETED|Overall Study||6
8601479|NCT03473301|21207953|P2|NOT COMPLETED|Overall Study||6
8601480|NCT03473301|21207954|P1|NOT COMPLETED|Overall Study||11
8601481|NCT03473301|21207952|P3|COMPLETED|Overall Study||25
8601482|NCT03473301|21207953|P2|COMPLETED|Overall Study||23
8601483|NCT03473301|21207954|P1|COMPLETED|Overall Study||20
8601484|NCT03473301|21207952|P3|STARTED|Overall Study||31
8601485|NCT03473301|21207953|P2|STARTED|Overall Study||29
8601486|NCT03473301|21207954|P1|STARTED|Overall Study||31
8601487|NCT03442036|21207970|P2|NOT COMPLETED|Overall Study||0
8601488|NCT03442036|21207971|P1|NOT COMPLETED|Overall Study||0
8601489|NCT03442036|21207970|P2|COMPLETED|Overall Study||35
8601490|NCT03442036|21207971|P1|COMPLETED|Overall Study||35
8601491|NCT03442036|21207970|P2|STARTED|Overall Study||35
8601492|NCT03442036|21207971|P1|STARTED|Overall Study||35
8601493|NCT03433482|21207987|P4|NOT COMPLETED|Overall Study||1
8601494|NCT03433482|21207988|P3|NOT COMPLETED|Overall Study||4
8601495|NCT03433482|21207989|P2|NOT COMPLETED|Overall Study||0
8601496|NCT03433482|21207990|P1|NOT COMPLETED|Overall Study||1
8601497|NCT03433482|21207987|P4|COMPLETED|Overall Study||418
8601498|NCT03433482|21207988|P3|COMPLETED|Overall Study||423
8601499|NCT03433482|21207989|P2|COMPLETED|Overall Study||424
8601500|NCT03433482|21207990|P1|COMPLETED|Overall Study||419
8601501|NCT03433482|21207987|P4|STARTED|Overall Study||419
8601502|NCT03433482|21207988|P3|STARTED|Overall Study||427
8601503|NCT03433482|21207989|P2|STARTED|Overall Study||424
8601504|NCT03433482|21207990|P1|STARTED|Overall Study||420
8601505|NCT03425097|21208040|P2|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
8601506|NCT03425097|21208041|P1|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
8601507|NCT03425097|21208040|P2|COMPLETED|Second Treatment Period (2 Weeks)||5
8601508|NCT03425097|21208041|P1|COMPLETED|Second Treatment Period (2 Weeks)||6
8601509|NCT03425097|21208040|P2|STARTED|Second Treatment Period (2 Weeks)||5
8601510|NCT03425097|21208041|P1|STARTED|Second Treatment Period (2 Weeks)||6
8601511|NCT03425097|21208040|P2|NOT COMPLETED|Washout Period (1 Week)||0
8601512|NCT03425097|21208041|P1|NOT COMPLETED|Washout Period (1 Week)||0
8601513|NCT03425097|21208040|P2|COMPLETED|Washout Period (1 Week)||5
8601514|NCT03425097|21208041|P1|COMPLETED|Washout Period (1 Week)||6
8601515|NCT03425097|21208040|P2|STARTED|Washout Period (1 Week)||5
8601516|NCT03425097|21208041|P1|STARTED|Washout Period (1 Week)||6
8601517|NCT03425097|21208040|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8601518|NCT03425097|21208041|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8601519|NCT03425097|21208040|P2|COMPLETED|Treatment Period 1 (2 Weeks)||5
8601520|NCT03425097|21208041|P1|COMPLETED|Treatment Period 1 (2 Weeks)||6
8601521|NCT03425097|21208040|P2|STARTED|Treatment Period 1 (2 Weeks)||5
8601522|NCT03425097|21208041|P1|STARTED|Treatment Period 1 (2 Weeks)||6
8601575|NCT03226652|21208304|P1|NOT COMPLETED|Overall Study||0
8601576|NCT03226652|21208304|P1|COMPLETED|Overall Study||101
8601577|NCT03226652|21208304|P1|STARTED|Overall Study||101
8601578|NCT03193736|21208308|P1|NOT COMPLETED|Overall Study||5
8601579|NCT03193736|21208308|P1|COMPLETED|Overall Study||21
8601580|NCT03193736|21208308|P1|Received Implant|Overall Study||25
8601581|NCT03193736|21208308|P1|STARTED|Overall Study||26
8601603|NCT03008915|21208392|P2|NOT COMPLETED|Treatment 2||0
8601604|NCT03008915|21208393|P1|NOT COMPLETED|Treatment 2||0
8601605|NCT03008915|21208392|P2|COMPLETED|Treatment 2||6
8601606|NCT03008915|21208393|P1|COMPLETED|Treatment 2||8
8601607|NCT03008915|21208392|P2|STARTED|Treatment 2||6
8601608|NCT03008915|21208393|P1|STARTED|Treatment 2||8
8601609|NCT03008915|21208392|P2|NOT COMPLETED|Treatment 1||1
8601610|NCT03008915|21208393|P1|NOT COMPLETED|Treatment 1||0
8601611|NCT03008915|21208392|P2|COMPLETED|Treatment 1||6
8601612|NCT03008915|21208393|P1|COMPLETED|Treatment 1||8
8601613|NCT03008915|21208392|P2|STARTED|Treatment 1||7
8601614|NCT03008915|21208393|P1|STARTED|Treatment 1||8
8601621|NCT02978781|21208423|P5|NOT COMPLETED|Part C||4
8601622|NCT02978781|21208424|P4|NOT COMPLETED|Part C||0
8601623|NCT02978781|21208425|P3|NOT COMPLETED|Part C||0
8601624|NCT02978781|21208426|P2|NOT COMPLETED|Part C||0
8601625|NCT02978781|21208427|P1|NOT COMPLETED|Part C||0
8601626|NCT02978781|21208423|P5|COMPLETED|Part C||14
8601627|NCT02978781|21208424|P4|COMPLETED|Part C||0
8601628|NCT02978781|21208425|P3|COMPLETED|Part C||0
8601629|NCT02978781|21208426|P2|COMPLETED|Part C||0
8601630|NCT02978781|21208427|P1|COMPLETED|Part C||0
8601631|NCT02978781|21208423|P5|STARTED|Part C||18
8601632|NCT02978781|21208424|P4|STARTED|Part C||0
8601633|NCT02978781|21208425|P3|STARTED|Part C||0
8601634|NCT02978781|21208426|P2|STARTED|Part C||0
8601635|NCT02978781|21208427|P1|STARTED|Part C||0
8601636|NCT02978781|21208423|P5|NOT COMPLETED|Part B||0
8601637|NCT02978781|21208424|P4|NOT COMPLETED|Part B||1
8601638|NCT02978781|21208425|P3|NOT COMPLETED|Part B||0
8601639|NCT02978781|21208426|P2|NOT COMPLETED|Part B||0
8601640|NCT02978781|21208427|P1|NOT COMPLETED|Part B||0
8601641|NCT02978781|21208423|P5|COMPLETED|Part B||0
8601642|NCT02978781|21208424|P4|COMPLETED|Part B||3
8601643|NCT02978781|21208425|P3|COMPLETED|Part B||4
8601644|NCT02978781|21208426|P2|COMPLETED|Part B||0
8601645|NCT02978781|21208427|P1|COMPLETED|Part B||0
8601646|NCT02978781|21208423|P5|STARTED|Part B||0
8601647|NCT02978781|21208424|P4|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
8601648|NCT02978781|21208425|P3|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
8601649|NCT02978781|21208426|P2|STARTED|Part B||0
8601650|NCT02978781|21208427|P1|STARTED|Part B||0
8601651|NCT02978781|21208423|P5|NOT COMPLETED|Part A||0
8601652|NCT02978781|21208424|P4|NOT COMPLETED|Part A||0
8601653|NCT02978781|21208425|P3|NOT COMPLETED|Part A||0
8601654|NCT02978781|21208426|P2|NOT COMPLETED|Part A||2
8601655|NCT02978781|21208427|P1|NOT COMPLETED|Part A||1
8601656|NCT02978781|21208423|P5|COMPLETED|Part A||0
8601657|NCT02978781|21208424|P4|COMPLETED|Part A||0
8601658|NCT02978781|21208425|P3|COMPLETED|Part A||0
8601659|NCT02978781|21208426|P2|COMPLETED|Part A||12
8601660|NCT02978781|21208427|P1|COMPLETED|Part A||1
8601661|NCT02978781|21208423|P5|STARTED|Part A||0
8601662|NCT02978781|21208424|P4|STARTED|Part A||0
8601663|NCT02978781|21208425|P3|STARTED|Part A||0
8601664|NCT02978781|21208426|P2|STARTED|Part A||14
8601665|NCT02978781|21208427|P1|STARTED|Part A||2
8601669|NCT02935452|21208505|P2|NOT COMPLETED|Overall Study||1
8601670|NCT02935452|21208506|P1|NOT COMPLETED|Overall Study||3
8601671|NCT02935452|21208505|P2|COMPLETED|Overall Study||29
8601672|NCT02935452|21208506|P1|COMPLETED|Overall Study||27
8601673|NCT02935452|21208505|P2|STARTED|Overall Study||30
8601674|NCT02935452|21208506|P1|STARTED|Overall Study||30
8601678|NCT02928224|21208526|P4|NOT COMPLETED|Overall Study||221
8601679|NCT02928224|21208527|P3|NOT COMPLETED|Overall Study||220
8601680|NCT02928224|21208528|P2|NOT COMPLETED|Overall Study||224
8601681|NCT02928224|21208529|P1|NOT COMPLETED|Overall Study||37
8601682|NCT02928224|21208526|P4|COMPLETED|Overall Study||0
8601683|NCT02928224|21208527|P3|COMPLETED|Overall Study||0
8601684|NCT02928224|21208528|P2|COMPLETED|Overall Study||0
8601685|NCT02928224|21208529|P1|COMPLETED|Overall Study||0
8601686|NCT02928224|21208526|P4|STARTED|Overall Study||221
8601687|NCT02928224|21208527|P3|STARTED|Overall Study||220
8601688|NCT02928224|21208528|P2|STARTED|Overall Study||224
8601689|NCT02928224|21208529|P1|STARTED|Overall Study||37
8601690|NCT02924883|21208633|P2|NOT COMPLETED|Overall Study||69
8601691|NCT02924883|21208634|P1|NOT COMPLETED|Overall Study||133
8601692|NCT02924883|21208633|P2|COMPLETED|Overall Study||0
8601693|NCT02924883|21208634|P1|COMPLETED|Overall Study||0
8601694|NCT02924883|21208633|P2|STARTED|Overall Study||69
8601695|NCT02924883|21208634|P1|STARTED|Overall Study||133
8601705|NCT02832622|21208686|P1|NOT COMPLETED|Overall Study||1736
8601706|NCT02832622|21208686|P1|COMPLETED|Overall Study||433
8601707|NCT02832622|21208686|P1|STARTED|Overall Study||2169
8601708|NCT02804178|21208699|P1|NOT COMPLETED|Overall Study||1
8601709|NCT02804178|21208699|P1|COMPLETED|Overall Study||9
8601710|NCT02804178|21208699|P1|STARTED|Overall Study||10
8601711|NCT02748616|21208703|P1|NOT COMPLETED|Overall Study||7
8601712|NCT02748616|21208703|P1|COMPLETED|Overall Study||2
8601713|NCT02748616|21208703|P1|STARTED|Overall Study||9
8601717|NCT02691702|21208725|P11|NOT COMPLETED|Overall Study||2
8601718|NCT02691702|21208726|P10|NOT COMPLETED|Overall Study||2
8601719|NCT02691702|21208727|P9|NOT COMPLETED|Overall Study||2
8601720|NCT02691702|21208728|P8|NOT COMPLETED|Overall Study||0
8601721|NCT02691702|21208729|P7|NOT COMPLETED|Overall Study||3
8601722|NCT02691702|21208730|P6|NOT COMPLETED|Overall Study||3
8601723|NCT02691702|21208731|P5|NOT COMPLETED|Overall Study||0
8601724|NCT02691702|21208732|P4|NOT COMPLETED|Overall Study||0
8601725|NCT02691702|21208733|P3|NOT COMPLETED|Overall Study||1
8601726|NCT02691702|21208734|P2|NOT COMPLETED|Overall Study||1
8601727|NCT02691702|21208735|P1|NOT COMPLETED|Overall Study||2
8601728|NCT02691702|21208725|P11|COMPLETED|Overall Study||6
8601729|NCT02691702|21208726|P10|COMPLETED|Overall Study||6
8601730|NCT02691702|21208727|P9|COMPLETED|Overall Study||6
8601731|NCT02691702|21208728|P8|COMPLETED|Overall Study||12
8601732|NCT02691702|21208729|P7|COMPLETED|Overall Study||5
8601733|NCT02691702|21208730|P6|COMPLETED|Overall Study||5
8601734|NCT02691702|21208731|P5|COMPLETED|Overall Study||8
8601735|NCT02691702|21208732|P4|COMPLETED|Overall Study||8
8601736|NCT02691702|21208733|P3|COMPLETED|Overall Study||7
8601737|NCT02691702|21208734|P2|COMPLETED|Overall Study||10
8601738|NCT02691702|21208735|P1|COMPLETED|Overall Study||8
8601739|NCT02691702|21208725|P11|STARTED|Overall Study||8
8601740|NCT02691702|21208726|P10|STARTED|Overall Study||8
8601741|NCT02691702|21208727|P9|STARTED|Overall Study||8
8601742|NCT02691702|21208728|P8|STARTED|Overall Study||12
8601743|NCT02691702|21208729|P7|STARTED|Overall Study||8
8601744|NCT02691702|21208730|P6|STARTED|Overall Study||8
8601745|NCT02691702|21208731|P5|STARTED|Overall Study||8
8601746|NCT02691702|21208732|P4|STARTED|Overall Study||8
8601747|NCT02691702|21208733|P3|STARTED|Overall Study||8
8601748|NCT02691702|21208734|P2|STARTED|Overall Study||11
8601749|NCT02691702|21208735|P1|STARTED|Overall Study||10
8601753|NCT02633540|21209058|P1|NOT COMPLETED|Overall Study||0
8601754|NCT02633540|21209058|P1|COMPLETED|Overall Study||2
8601755|NCT02633540|21209058|P1|STARTED|Overall Study||2
8601771|NCT02586025|21209088|P2|NOT COMPLETED|Treatment-Free Follow-Up||35
8601772|NCT02586025|21209089|P1|NOT COMPLETED|Treatment-Free Follow-Up||56
8601773|NCT02586025|21209088|P2|COMPLETED|Treatment-Free Follow-Up||3
8601774|NCT02586025|21209089|P1|COMPLETED|Treatment-Free Follow-Up||3
8601775|NCT02586025|21209088|P2|STARTED|Treatment-Free Follow-Up||38
8601776|NCT02586025|21209089|P1|STARTED|Treatment-Free Follow-Up||59
8601777|NCT02586025|21209088|P2|NOT COMPLETED|Adjuvant Treatment||69
8601778|NCT02586025|21209089|P1|NOT COMPLETED|Adjuvant Treatment||139
8601779|NCT02586025|21209088|P2|COMPLETED|Adjuvant Treatment||34
8601780|NCT02586025|21209089|P1|COMPLETED|Adjuvant Treatment||69
8601781|NCT02586025|21209088|P2|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
8601782|NCT02586025|21209089|P1|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
8601783|NCT02586025|21209088|P2|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
8601784|NCT02586025|21209089|P1|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
8601785|NCT02586025|21209088|P2|STARTED|Adjuvant Treatment||103
8601786|NCT02586025|21209089|P1|STARTED|Adjuvant Treatment||208
8601787|NCT02586025|21209088|P2|NOT COMPLETED|Neoadjuvant Treatment||7
8601788|NCT02586025|21209089|P1|NOT COMPLETED|Neoadjuvant Treatment||11
8601789|NCT02586025|21209088|P2|COMPLETED|Neoadjuvant Treatment||103
8601790|NCT02586025|21209089|P1|COMPLETED|Neoadjuvant Treatment||208
8601791|NCT02586025|21209088|P2|Underwent Surgery|Neoadjuvant Treatment||105
8601792|NCT02586025|21209089|P1|Underwent Surgery|Neoadjuvant Treatment||210
8601793|NCT02586025|21209088|P2|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
8601794|NCT02586025|21209089|P1|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
8601795|NCT02586025|21209088|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
8601796|NCT02586025|21209089|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
8601797|NCT02586025|21209088|P2|STARTED|Neoadjuvant Treatment||110
8601798|NCT02586025|21209089|P1|STARTED|Neoadjuvant Treatment||219
8601799|NCT02539459|21209125|P1|NOT COMPLETED|Overall Study||2
8601800|NCT02539459|21209125|P1|COMPLETED|Overall Study||18
8601801|NCT02539459|21209125|P1|STARTED|Overall Study||20
8601817|NCT02462759|21209158|P3|NOT COMPLETED|Part 2: Open-Label Phase||0
8601818|NCT02462759|21209159|P2|NOT COMPLETED|Part 2: Open-Label Phase||0
8601819|NCT02462759|21209160|P1|NOT COMPLETED|Part 2: Open-Label Phase||0
8601820|NCT02462759|21209158|P3|COMPLETED|Part 2: Open-Label Phase||20
8601821|NCT02462759|21209159|P2|COMPLETED|Part 2: Open-Label Phase||0
8601822|NCT02462759|21209160|P1|COMPLETED|Part 2: Open-Label Phase||0
8601823|NCT02462759|21209158|P3|STARTED|Part 2: Open-Label Phase||20
8601824|NCT02462759|21209159|P2|STARTED|Part 2: Open-Label Phase||0
8601825|NCT02462759|21209160|P1|STARTED|Part 2: Open-Label Phase||0
8601826|NCT02462759|21209158|P3|NOT COMPLETED|Part 1: Double Blind||0
8601827|NCT02462759|21209159|P2|NOT COMPLETED|Part 1: Double Blind||0
8601828|NCT02462759|21209160|P1|NOT COMPLETED|Part 1: Double Blind||1
8601829|NCT02462759|21209158|P3|COMPLETED|Part 1: Double Blind||0
8601830|NCT02462759|21209159|P2|COMPLETED|Part 1: Double Blind||14
8601831|NCT02462759|21209160|P1|COMPLETED|Part 1: Double Blind||6
8601832|NCT02462759|21209158|P3|STARTED|Part 1: Double Blind||0
8601833|NCT02462759|21209159|P2|STARTED|Part 1: Double Blind||14
8601834|NCT02462759|21209160|P1|STARTED|Part 1: Double Blind||7
8601835|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601836|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601837|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601838|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601839|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601840|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601841|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601842|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601843|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601844|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601845|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601846|NCT02443740|21209212|P11|COMPLETED|Intervention Period 4 (3 Days)||0
8601847|NCT02443740|21209213|P10|COMPLETED|Intervention Period 4 (3 Days)||0
8601848|NCT02443740|21209214|P9|COMPLETED|Intervention Period 4 (3 Days)||0
8601849|NCT02443740|21209215|P8|COMPLETED|Intervention Period 4 (3 Days)||2
8601850|NCT02443740|21209216|P7|COMPLETED|Intervention Period 4 (3 Days)||2
8601851|NCT02443740|21209217|P6|COMPLETED|Intervention Period 4 (3 Days)||2
8601852|NCT02443740|21209218|P5|COMPLETED|Intervention Period 4 (3 Days)||2
8601853|NCT02443740|21209219|P4|COMPLETED|Intervention Period 4 (3 Days)||3
8601854|NCT02443740|21209220|P3|COMPLETED|Intervention Period 4 (3 Days)||2
8601855|NCT02443740|21209221|P2|COMPLETED|Intervention Period 4 (3 Days)||2
8601856|NCT02443740|21209222|P1|COMPLETED|Intervention Period 4 (3 Days)||1
8601857|NCT02443740|21209212|P11|STARTED|Intervention Period 4 (3 Days)||0
8601858|NCT02443740|21209213|P10|STARTED|Intervention Period 4 (3 Days)||0
8601859|NCT02443740|21209214|P9|STARTED|Intervention Period 4 (3 Days)||0
8601860|NCT02443740|21209215|P8|STARTED|Intervention Period 4 (3 Days)||2
8601861|NCT02443740|21209216|P7|STARTED|Intervention Period 4 (3 Days)||2
8601862|NCT02443740|21209217|P6|STARTED|Intervention Period 4 (3 Days)||2
8601863|NCT02443740|21209218|P5|STARTED|Intervention Period 4 (3 Days)||2
8601864|NCT02443740|21209219|P4|STARTED|Intervention Period 4 (3 Days)||3
8601865|NCT02443740|21209220|P3|STARTED|Intervention Period 4 (3 Days)||2
8601866|NCT02443740|21209221|P2|STARTED|Intervention Period 4 (3 Days)||2
8601867|NCT02443740|21209222|P1|STARTED|Intervention Period 4 (3 Days)||1
8601868|NCT02443740|21209212|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601869|NCT02443740|21209213|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601870|NCT02443740|21209214|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601871|NCT02443740|21209215|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601872|NCT02443740|21209216|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601873|NCT02443740|21209217|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601874|NCT02443740|21209218|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601875|NCT02443740|21209219|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601876|NCT02443740|21209220|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601877|NCT02443740|21209221|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601878|NCT02443740|21209222|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601879|NCT02443740|21209212|P11|COMPLETED|Washout Period 3 (7 Days)||0
8601880|NCT02443740|21209213|P10|COMPLETED|Washout Period 3 (7 Days)||0
8601881|NCT02443740|21209214|P9|COMPLETED|Washout Period 3 (7 Days)||0
8601882|NCT02443740|21209215|P8|COMPLETED|Washout Period 3 (7 Days)||2
8601883|NCT02443740|21209216|P7|COMPLETED|Washout Period 3 (7 Days)||2
8601884|NCT02443740|21209217|P6|COMPLETED|Washout Period 3 (7 Days)||2
8601885|NCT02443740|21209218|P5|COMPLETED|Washout Period 3 (7 Days)||2
8601886|NCT02443740|21209219|P4|COMPLETED|Washout Period 3 (7 Days)||3
8601887|NCT02443740|21209220|P3|COMPLETED|Washout Period 3 (7 Days)||2
8601888|NCT02443740|21209221|P2|COMPLETED|Washout Period 3 (7 Days)||2
8601889|NCT02443740|21209222|P1|COMPLETED|Washout Period 3 (7 Days)||1
8601890|NCT02443740|21209212|P11|STARTED|Washout Period 3 (7 Days)||0
8601891|NCT02443740|21209213|P10|STARTED|Washout Period 3 (7 Days)||0
8601892|NCT02443740|21209214|P9|STARTED|Washout Period 3 (7 Days)||0
8601893|NCT02443740|21209215|P8|STARTED|Washout Period 3 (7 Days)||2
8601894|NCT02443740|21209216|P7|STARTED|Washout Period 3 (7 Days)||2
8601895|NCT02443740|21209217|P6|STARTED|Washout Period 3 (7 Days)||2
8601896|NCT02443740|21209218|P5|STARTED|Washout Period 3 (7 Days)||2
8601897|NCT02443740|21209219|P4|STARTED|Washout Period 3 (7 Days)||3
8601898|NCT02443740|21209220|P3|STARTED|Washout Period 3 (7 Days)||2
8601899|NCT02443740|21209221|P2|STARTED|Washout Period 3 (7 Days)||2
8601900|NCT02443740|21209222|P1|STARTED|Washout Period 3 (7 Days)||1
8601901|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601902|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601903|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601904|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601905|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601906|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601907|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601908|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601909|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601910|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601911|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601912|NCT02443740|21209212|P11|COMPLETED|Intervention Period 3 (3 Days)||0
8601913|NCT02443740|21209213|P10|COMPLETED|Intervention Period 3 (3 Days)||0
8601914|NCT02443740|21209214|P9|COMPLETED|Intervention Period 3 (3 Days)||0
8601915|NCT02443740|21209215|P8|COMPLETED|Intervention Period 3 (3 Days)||2
8601916|NCT02443740|21209216|P7|COMPLETED|Intervention Period 3 (3 Days)||2
8601917|NCT02443740|21209217|P6|COMPLETED|Intervention Period 3 (3 Days)||2
8601918|NCT02443740|21209218|P5|COMPLETED|Intervention Period 3 (3 Days)||2
8601919|NCT02443740|21209219|P4|COMPLETED|Intervention Period 3 (3 Days)||3
8601920|NCT02443740|21209220|P3|COMPLETED|Intervention Period 3 (3 Days)||2
8601921|NCT02443740|21209221|P2|COMPLETED|Intervention Period 3 (3 Days)||2
8601922|NCT02443740|21209222|P1|COMPLETED|Intervention Period 3 (3 Days)||1
8601923|NCT02443740|21209212|P11|STARTED|Intervention Period 3 (3 Days)||0
8601924|NCT02443740|21209213|P10|STARTED|Intervention Period 3 (3 Days)||0
8601925|NCT02443740|21209214|P9|STARTED|Intervention Period 3 (3 Days)||0
8601926|NCT02443740|21209215|P8|STARTED|Intervention Period 3 (3 Days)||2
8601927|NCT02443740|21209216|P7|STARTED|Intervention Period 3 (3 Days)||2
8601928|NCT02443740|21209217|P6|STARTED|Intervention Period 3 (3 Days)||2
8601929|NCT02443740|21209218|P5|STARTED|Intervention Period 3 (3 Days)||2
8601930|NCT02443740|21209219|P4|STARTED|Intervention Period 3 (3 Days)||3
8601931|NCT02443740|21209220|P3|STARTED|Intervention Period 3 (3 Days)||2
8601932|NCT02443740|21209221|P2|STARTED|Intervention Period 3 (3 Days)||2
8601933|NCT02443740|21209222|P1|STARTED|Intervention Period 3 (3 Days)||1
8601934|NCT02443740|21209212|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601935|NCT02443740|21209213|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601936|NCT02443740|21209214|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601937|NCT02443740|21209215|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601938|NCT02443740|21209216|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601939|NCT02443740|21209217|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601940|NCT02443740|21209218|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601941|NCT02443740|21209219|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601942|NCT02443740|21209220|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601943|NCT02443740|21209221|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601944|NCT02443740|21209222|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601945|NCT02443740|21209212|P11|COMPLETED|Washout Period 2 (7 Days)||0
8601946|NCT02443740|21209213|P10|COMPLETED|Washout Period 2 (7 Days)||0
8601947|NCT02443740|21209214|P9|COMPLETED|Washout Period 2 (7 Days)||0
8601948|NCT02443740|21209215|P8|COMPLETED|Washout Period 2 (7 Days)||2
8601949|NCT02443740|21209216|P7|COMPLETED|Washout Period 2 (7 Days)||2
8601950|NCT02443740|21209217|P6|COMPLETED|Washout Period 2 (7 Days)||2
8601951|NCT02443740|21209218|P5|COMPLETED|Washout Period 2 (7 Days)||2
8601952|NCT02443740|21209219|P4|COMPLETED|Washout Period 2 (7 Days)||3
8601953|NCT02443740|21209220|P3|COMPLETED|Washout Period 2 (7 Days)||2
8601954|NCT02443740|21209221|P2|COMPLETED|Washout Period 2 (7 Days)||2
8601955|NCT02443740|21209222|P1|COMPLETED|Washout Period 2 (7 Days)||1
8601956|NCT02443740|21209212|P11|STARTED|Washout Period 2 (7 Days)||0
8601957|NCT02443740|21209213|P10|STARTED|Washout Period 2 (7 Days)||0
8601958|NCT02443740|21209214|P9|STARTED|Washout Period 2 (7 Days)||0
8601959|NCT02443740|21209215|P8|STARTED|Washout Period 2 (7 Days)||2
8601960|NCT02443740|21209216|P7|STARTED|Washout Period 2 (7 Days)||2
8601961|NCT02443740|21209217|P6|STARTED|Washout Period 2 (7 Days)||2
8601962|NCT02443740|21209218|P5|STARTED|Washout Period 2 (7 Days)||2
8601963|NCT02443740|21209219|P4|STARTED|Washout Period 2 (7 Days)||3
8601964|NCT02443740|21209220|P3|STARTED|Washout Period 2 (7 Days)||2
8601965|NCT02443740|21209221|P2|STARTED|Washout Period 2 (7 Days)||2
8601966|NCT02443740|21209222|P1|STARTED|Washout Period 2 (7 Days)||1
8601967|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601968|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601969|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601970|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601971|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601972|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601973|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601974|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601975|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601976|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601977|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601978|NCT02443740|21209212|P11|COMPLETED|Intervention Period 2 (3 Days)||3
8601979|NCT02443740|21209213|P10|COMPLETED|Intervention Period 2 (3 Days)||3
8601980|NCT02443740|21209214|P9|COMPLETED|Intervention Period 2 (3 Days)||0
8601981|NCT02443740|21209215|P8|COMPLETED|Intervention Period 2 (3 Days)||2
8601982|NCT02443740|21209216|P7|COMPLETED|Intervention Period 2 (3 Days)||2
8601983|NCT02443740|21209217|P6|COMPLETED|Intervention Period 2 (3 Days)||2
8601984|NCT02443740|21209218|P5|COMPLETED|Intervention Period 2 (3 Days)||2
8601985|NCT02443740|21209219|P4|COMPLETED|Intervention Period 2 (3 Days)||3
8601986|NCT02443740|21209220|P3|COMPLETED|Intervention Period 2 (3 Days)||2
8601987|NCT02443740|21209221|P2|COMPLETED|Intervention Period 2 (3 Days)||2
8601988|NCT02443740|21209222|P1|COMPLETED|Intervention Period 2 (3 Days)||1
8601989|NCT02443740|21209212|P11|STARTED|Intervention Period 2 (3 Days)||3
8601990|NCT02443740|21209213|P10|STARTED|Intervention Period 2 (3 Days)||3
8601991|NCT02443740|21209214|P9|STARTED|Intervention Period 2 (3 Days)||0
8601992|NCT02443740|21209215|P8|STARTED|Intervention Period 2 (3 Days)||2
8601993|NCT02443740|21209216|P7|STARTED|Intervention Period 2 (3 Days)||2
8601994|NCT02443740|21209217|P6|STARTED|Intervention Period 2 (3 Days)||2
8601995|NCT02443740|21209218|P5|STARTED|Intervention Period 2 (3 Days)||2
8601996|NCT02443740|21209219|P4|STARTED|Intervention Period 2 (3 Days)||3
8601997|NCT02443740|21209220|P3|STARTED|Intervention Period 2 (3 Days)||2
8601998|NCT02443740|21209221|P2|STARTED|Intervention Period 2 (3 Days)||2
8601999|NCT02443740|21209222|P1|STARTED|Intervention Period 2 (3 Days)||1
8602000|NCT02443740|21209212|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602001|NCT02443740|21209213|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602002|NCT02443740|21209214|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602003|NCT02443740|21209215|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602004|NCT02443740|21209216|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602005|NCT02443740|21209217|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602006|NCT02443740|21209218|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602007|NCT02443740|21209219|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602008|NCT02443740|21209220|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602009|NCT02443740|21209221|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602010|NCT02443740|21209222|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602011|NCT02443740|21209212|P11|COMPLETED|Washout Period 1 (7 Days)||3
8602012|NCT02443740|21209213|P10|COMPLETED|Washout Period 1 (7 Days)||3
8602013|NCT02443740|21209214|P9|COMPLETED|Washout Period 1 (7 Days)||0
8602014|NCT02443740|21209215|P8|COMPLETED|Washout Period 1 (7 Days)||2
8602015|NCT02443740|21209216|P7|COMPLETED|Washout Period 1 (7 Days)||2
8602016|NCT02443740|21209217|P6|COMPLETED|Washout Period 1 (7 Days)||2
8602017|NCT02443740|21209218|P5|COMPLETED|Washout Period 1 (7 Days)||2
8602018|NCT02443740|21209219|P4|COMPLETED|Washout Period 1 (7 Days)||3
8602019|NCT02443740|21209220|P3|COMPLETED|Washout Period 1 (7 Days)||2
8602020|NCT02443740|21209221|P2|COMPLETED|Washout Period 1 (7 Days)||2
8602021|NCT02443740|21209222|P1|COMPLETED|Washout Period 1 (7 Days)||1
8602022|NCT02443740|21209212|P11|STARTED|Washout Period 1 (7 Days)||3
8602023|NCT02443740|21209213|P10|STARTED|Washout Period 1 (7 Days)||3
8602024|NCT02443740|21209214|P9|STARTED|Washout Period 1 (7 Days)||0
8602025|NCT02443740|21209215|P8|STARTED|Washout Period 1 (7 Days)||2
8602026|NCT02443740|21209216|P7|STARTED|Washout Period 1 (7 Days)||2
8602027|NCT02443740|21209217|P6|STARTED|Washout Period 1 (7 Days)||2
8602028|NCT02443740|21209218|P5|STARTED|Washout Period 1 (7 Days)||2
8602029|NCT02443740|21209219|P4|STARTED|Washout Period 1 (7 Days)||3
8602030|NCT02443740|21209220|P3|STARTED|Washout Period 1 (7 Days)||2
8602031|NCT02443740|21209221|P2|STARTED|Washout Period 1 (7 Days)||2
8602032|NCT02443740|21209222|P1|STARTED|Washout Period 1 (7 Days)||1
8602033|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602034|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602035|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602036|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602037|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
8602038|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
8602039|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602040|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602041|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602042|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602043|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
8602044|NCT02443740|21209212|P11|COMPLETED|Intervention Period 1 (3 Days)||3
8602045|NCT02443740|21209213|P10|COMPLETED|Intervention Period 1 (3 Days)||3
8602046|NCT02443740|21209214|P9|COMPLETED|Intervention Period 1 (3 Days)||6
8602047|NCT02443740|21209215|P8|COMPLETED|Intervention Period 1 (3 Days)||2
8602048|NCT02443740|21209216|P7|COMPLETED|Intervention Period 1 (3 Days)||2
8602049|NCT02443740|21209217|P6|COMPLETED|Intervention Period 1 (3 Days)||2
8602050|NCT02443740|21209218|P5|COMPLETED|Intervention Period 1 (3 Days)||2
8602051|NCT02443740|21209219|P4|COMPLETED|Intervention Period 1 (3 Days)||3
8602052|NCT02443740|21209220|P3|COMPLETED|Intervention Period 1 (3 Days)||2
8602053|NCT02443740|21209221|P2|COMPLETED|Intervention Period 1 (3 Days)||2
8602054|NCT02443740|21209222|P1|COMPLETED|Intervention Period 1 (3 Days)||1
8602055|NCT02443740|21209212|P11|STARTED|Intervention Period 1 (3 Days)||3
8602056|NCT02443740|21209213|P10|STARTED|Intervention Period 1 (3 Days)||3
8602057|NCT02443740|21209214|P9|STARTED|Intervention Period 1 (3 Days)||6
8602058|NCT02443740|21209215|P8|STARTED|Intervention Period 1 (3 Days)||2
8602059|NCT02443740|21209216|P7|STARTED|Intervention Period 1 (3 Days)||3
8602060|NCT02443740|21209217|P6|STARTED|Intervention Period 1 (3 Days)||4
8602061|NCT02443740|21209218|P5|STARTED|Intervention Period 1 (3 Days)||2
8602062|NCT02443740|21209219|P4|STARTED|Intervention Period 1 (3 Days)||3
8602063|NCT02443740|21209220|P3|STARTED|Intervention Period 1 (3 Days)||2
8602064|NCT02443740|21209221|P2|STARTED|Intervention Period 1 (3 Days)||2
8602065|NCT02443740|21209222|P1|STARTED|Intervention Period 1 (3 Days)||2
8602078|NCT02377752|21209464|P4|NOT COMPLETED|Overall Study||0
8602079|NCT02377752|21209465|P3|NOT COMPLETED|Overall Study||0
8602080|NCT02377752|21209466|P2|NOT COMPLETED|Overall Study||0
8602081|NCT02377752|21209467|P1|NOT COMPLETED|Overall Study||0
8602082|NCT02377752|21209464|P4|COMPLETED|Overall Study||6
8602083|NCT02377752|21209465|P3|COMPLETED|Overall Study||6
8602084|NCT02377752|21209466|P2|COMPLETED|Overall Study||6
8602085|NCT02377752|21209467|P1|COMPLETED|Overall Study||7
8602086|NCT02377752|21209464|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8602087|NCT02377752|21209465|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8602088|NCT02377752|21209466|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8602089|NCT02377752|21209467|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8602090|NCT02377752|21209464|P4|STARTED|Overall Study||6
8602091|NCT02377752|21209465|P3|STARTED|Overall Study||6
8602092|NCT02377752|21209466|P2|STARTED|Overall Study||6
8602093|NCT02377752|21209467|P1|STARTED|Overall Study||7
8602109|NCT02292537|21209520|P2|NOT COMPLETED|Overall Study||0
8602110|NCT02292537|21209521|P1|NOT COMPLETED|Overall Study||0
8602111|NCT02292537|21209520|P2|COMPLETED|Overall Study||84
8602112|NCT02292537|21209521|P1|COMPLETED|Overall Study||42
8602113|NCT02292537|21209520|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
8602114|NCT02292537|21209521|P1|Completed Treatment|Overall Study||42
8602115|NCT02292537|21209520|P2|STARTED|Overall Study||84
8602116|NCT02292537|21209521|P1|STARTED|Overall Study||42
8602164|NCT02193074|21209648|P2|NOT COMPLETED|Overall Study||15
8602165|NCT02193074|21209649|P1|NOT COMPLETED|Overall Study||17
8602166|NCT02193074|21209648|P2|COMPLETED|Overall Study||65
8602167|NCT02193074|21209649|P1|COMPLETED|Overall Study||24
8602168|NCT02193074|21209648|P2|Completed Due to Early Study Termination|Overall Study||39
8602169|NCT02193074|21209649|P1|Completed Due to Early Study Termination|Overall Study||13
8602170|NCT02193074|21209648|P2|Completed During Follow-Up Period|Overall Study||26
8602171|NCT02193074|21209649|P1|Completed During Follow-Up Period|Overall Study||11
8602172|NCT02193074|21209648|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
8602173|NCT02193074|21209649|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
8602183|NCT02114606|21209717|P1|NOT COMPLETED|Overall Study||6
8602184|NCT02114606|21209717|P1|COMPLETED|Overall Study||80
8602185|NCT02114606|21209717|P1|STARTED|Overall Study||86
8602222|NCT02005471|21209798|P2|NOT COMPLETED|Overall Study||194
8602223|NCT02005471|21209799|P1|NOT COMPLETED|Overall Study||195
8602224|NCT02005471|21209798|P2|COMPLETED|Overall Study||0
8602225|NCT02005471|21209799|P1|COMPLETED|Overall Study||0
8602226|NCT02005471|21209798|P2|Treated|Overall Study||194
8602227|NCT02005471|21209799|P1|Treated|Overall Study||188
8602228|NCT02005471|21209798|P2|STARTED|Overall Study||194
8602229|NCT02005471|21209799|P1|STARTED|Overall Study||195
8602287|NCT01844986|21209976|P2|NOT COMPLETED|Overall Study||40
8602288|NCT01844986|21209977|P1|NOT COMPLETED|Overall Study||77
8602289|NCT01844986|21209976|P2|COMPLETED|Overall Study||91
8602290|NCT01844986|21209977|P1|COMPLETED|Overall Study||183
8602291|NCT01844986|21209976|P2|STARTED|Overall Study||131
8602292|NCT01844986|21209977|P1|STARTED|Overall Study||260
8602293|NCT01841736|21210001|P2|NOT COMPLETED|Overall Study||0
8602294|NCT01841736|21210002|P1|NOT COMPLETED|Overall Study||0
8602295|NCT01841736|21210001|P2|COMPLETED|Overall Study||74
8602296|NCT01841736|21210002|P1|COMPLETED|Overall Study||97
8602297|NCT01841736|21210001|P2|Crossover|Overall Study||49
8602298|NCT01841736|21210002|P1|Crossover|Overall Study||0
8602299|NCT01841736|21210001|P2|STARTED|Overall Study||74
8602300|NCT01841736|21210002|P1|STARTED|Overall Study||97
8602301|NCT01839656|21210015|P2|NOT COMPLETED|Overall Study||16
8602302|NCT01839656|21210016|P1|NOT COMPLETED|Overall Study||3
8602303|NCT01839656|21210015|P2|COMPLETED|Overall Study||0
8602304|NCT01839656|21210016|P1|COMPLETED|Overall Study||2
8602305|NCT01839656|21210015|P2|Completed Loading Dose Period|Overall Study||15
8602306|NCT01839656|21210016|P1|Completed Loading Dose Period|Overall Study||4
8602307|NCT01839656|21210015|P2|STARTED|Overall Study||16
8602308|NCT01839656|21210016|P1|STARTED|Overall Study||5
8602327|NCT01670097|21210085|P2|NOT COMPLETED|Overall Study||4
8602328|NCT01670097|21210086|P1|NOT COMPLETED|Overall Study||2
8602329|NCT01670097|21210085|P2|COMPLETED|Overall Study||17
8602330|NCT01670097|21210086|P1|COMPLETED|Overall Study||18
8602331|NCT01670097|21210085|P2|Completed Week 2 Intervention|Overall Study||15
8602332|NCT01670097|21210086|P1|Completed Week 2 Intervention|Overall Study||13
8602333|NCT01670097|21210085|P2|Completed Week 1 Intervention|Overall Study||17
8602334|NCT01670097|21210086|P1|Completed Week 1 Intervention|Overall Study||18
8602335|NCT01670097|21210085|P2|STARTED|Overall Study||21
8602336|NCT01670097|21210086|P1|STARTED|Overall Study||20
8602337|NCT01609556|21210114|P16|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
8602338|NCT01609556|21210115|P15|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
8602339|NCT01609556|21210116|P14|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
8602340|NCT01609556|21210117|P13|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
8602341|NCT01609556|21210118|P12|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602342|NCT01609556|21210119|P11|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602343|NCT01609556|21210120|P10|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602344|NCT01609556|21210121|P9|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602345|NCT01609556|21210122|P8|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602346|NCT01609556|21210123|P7|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602347|NCT01609556|21210124|P6|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602348|NCT01609556|21210125|P5|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602349|NCT01609556|21210126|P4|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602350|NCT01609556|21210127|P3|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602351|NCT01609556|21210128|P2|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602352|NCT01609556|21210129|P1|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602353|NCT01609556|21210114|P16|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602354|NCT01609556|21210115|P15|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602355|NCT01609556|21210116|P14|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602356|NCT01609556|21210117|P13|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602357|NCT01609556|21210118|P12|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602358|NCT01609556|21210119|P11|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602359|NCT01609556|21210120|P10|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602360|NCT01609556|21210121|P9|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602361|NCT01609556|21210122|P8|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602362|NCT01609556|21210123|P7|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602363|NCT01609556|21210124|P6|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602364|NCT01609556|21210125|P5|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602365|NCT01609556|21210126|P4|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602366|NCT01609556|21210127|P3|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602367|NCT01609556|21210128|P2|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602368|NCT01609556|21210129|P1|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602369|NCT01609556|21210114|P16|STARTED|Dose Expansion: Maximum 124 Weeks||40
8602370|NCT01609556|21210115|P15|STARTED|Dose Expansion: Maximum 124 Weeks||27
8602371|NCT01609556|21210116|P14|STARTED|Dose Expansion: Maximum 124 Weeks||24
8602372|NCT01609556|21210117|P13|STARTED|Dose Expansion: Maximum 124 Weeks||46
8602373|NCT01609556|21210118|P12|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602374|NCT01609556|21210119|P11|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602375|NCT01609556|21210120|P10|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602376|NCT01609556|21210121|P9|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602377|NCT01609556|21210122|P8|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602378|NCT01609556|21210123|P7|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602379|NCT01609556|21210124|P6|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602380|NCT01609556|21210125|P5|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602381|NCT01609556|21210126|P4|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602382|NCT01609556|21210127|P3|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602383|NCT01609556|21210128|P2|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602384|NCT01609556|21210129|P1|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602385|NCT01609556|21210114|P16|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602386|NCT01609556|21210115|P15|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602387|NCT01609556|21210116|P14|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602388|NCT01609556|21210117|P13|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602389|NCT01609556|21210118|P12|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
8602390|NCT01609556|21210119|P11|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
8602391|NCT01609556|21210120|P10|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
8602392|NCT01609556|21210121|P9|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
8602393|NCT01609556|21210122|P8|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
8602394|NCT01609556|21210123|P7|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
8602395|NCT01609556|21210124|P6|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
8602396|NCT01609556|21210125|P5|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
8602397|NCT01609556|21210126|P4|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8602398|NCT01609556|21210127|P3|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8602399|NCT01609556|21210128|P2|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8602400|NCT01609556|21210129|P1|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
8602401|NCT01609556|21210114|P16|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602402|NCT01609556|21210115|P15|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602403|NCT01609556|21210116|P14|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602404|NCT01609556|21210117|P13|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602405|NCT01609556|21210118|P12|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602406|NCT01609556|21210119|P11|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602407|NCT01609556|21210120|P10|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602408|NCT01609556|21210121|P9|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602409|NCT01609556|21210122|P8|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602410|NCT01609556|21210123|P7|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602411|NCT01609556|21210124|P6|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602412|NCT01609556|21210125|P5|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602413|NCT01609556|21210126|P4|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602414|NCT01609556|21210127|P3|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602415|NCT01609556|21210128|P2|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602416|NCT01609556|21210129|P1|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602417|NCT01609556|21210114|P16|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602418|NCT01609556|21210115|P15|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602419|NCT01609556|21210116|P14|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602420|NCT01609556|21210117|P13|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602421|NCT01609556|21210118|P12|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
8602422|NCT01609556|21210119|P11|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
8602423|NCT01609556|21210120|P10|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
8602424|NCT01609556|21210121|P9|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
8602425|NCT01609556|21210122|P8|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
8602426|NCT01609556|21210123|P7|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
8602427|NCT01609556|21210124|P6|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
8602428|NCT01609556|21210125|P5|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
8602429|NCT01609556|21210126|P4|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8602430|NCT01609556|21210127|P3|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8602431|NCT01609556|21210128|P2|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8602432|NCT01609556|21210129|P1|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
8602433|NCT01609556|21210114|P16|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602434|NCT01609556|21210115|P15|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602435|NCT01609556|21210116|P14|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602436|NCT01609556|21210117|P13|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602437|NCT01609556|21210118|P12|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
8602438|NCT01609556|21210119|P11|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
8602439|NCT01609556|21210120|P10|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
8602440|NCT01609556|21210121|P9|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
8602441|NCT01609556|21210122|P8|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
8602442|NCT01609556|21210123|P7|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
8602443|NCT01609556|21210124|P6|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
8602444|NCT01609556|21210125|P5|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
8602445|NCT01609556|21210126|P4|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8602446|NCT01609556|21210127|P3|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8602447|NCT01609556|21210128|P2|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8602448|NCT01609556|21210129|P1|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
8602449|NCT01584648|21210291|P2|NOT COMPLETED|Overall Study||212
8602450|NCT01584648|21210292|P1|NOT COMPLETED|Overall Study||211
8602451|NCT01584648|21210291|P2|COMPLETED|Overall Study||0
8602452|NCT01584648|21210292|P1|COMPLETED|Overall Study||0
8602453|NCT01584648|21210291|P2|Crossover Population|Overall Study||28
8602454|NCT01584648|21210292|P1|Crossover Population|Overall Study||0
8602455|NCT01584648|21210291|P2|Safety Set|Overall Study||211
8602456|NCT01584648|21210292|P1|Safety Set|Overall Study||209
8602457|NCT01584648|21210291|P2|STARTED|Overall Study||212
8602458|NCT01584648|21210292|P1|STARTED|Overall Study||211
8602459|NCT01571596|21210319|P3|NOT COMPLETED|Overall Study||1
8602460|NCT01571596|21210320|P2|NOT COMPLETED|Overall Study||1
8602461|NCT01571596|21210321|P1|NOT COMPLETED|Overall Study||2
8602462|NCT01571596|21210319|P3|COMPLETED|Overall Study||0
8602463|NCT01571596|21210320|P2|COMPLETED|Overall Study||0
8602464|NCT01571596|21210321|P1|COMPLETED|Overall Study||19
8602465|NCT01571596|21210319|P3|STARTED|Overall Study||1
8602466|NCT01571596|21210320|P2|STARTED|Overall Study||1
8602467|NCT01571596|21210321|P1|STARTED|Overall Study||21
8602477|NCT01530256|21210356|P1|NOT COMPLETED|Overall Study||2
8602478|NCT01530256|21210356|P1|COMPLETED|Overall Study||1
8602479|NCT01530256|21210356|P1|STARTED|Overall Study||3
8602528|NCT01470248|21210425|P1|NOT COMPLETED|Overall Study||1
8602529|NCT01470248|21210425|P1|COMPLETED|Overall Study||19
8602530|NCT01470248|21210425|P1|STARTED|Overall Study||20
8602561|NCT01292252|21210508|P2|NOT COMPLETED|Overall Study||1
8602562|NCT01292252|21210509|P1|NOT COMPLETED|Overall Study||0
8602563|NCT01292252|21210508|P2|COMPLETED|Overall Study||14
8602564|NCT01292252|21210509|P1|COMPLETED|Overall Study||21
8602565|NCT01292252|21210508|P2|STARTED|Overall Study||15
8602566|NCT01292252|21210509|P1|STARTED|Overall Study||21
8602567|NCT01270321|21210524|P3|NOT COMPLETED|Overall Study||9
8602568|NCT01270321|21210525|P2|NOT COMPLETED|Overall Study||10
8602569|NCT01270321|21210526|P1|NOT COMPLETED|Overall Study||10
8602570|NCT01270321|21210524|P3|COMPLETED|Overall Study||3
8602571|NCT01270321|21210525|P2|COMPLETED|Overall Study||1
8602572|NCT01270321|21210526|P1|COMPLETED|Overall Study||9
8602573|NCT01270321|21210524|P3|STARTED|Overall Study||12
8602574|NCT01270321|21210525|P2|STARTED|Overall Study||11
8602575|NCT01270321|21210526|P1|STARTED|Overall Study||19
8602585|NCT01178411|21210552|P1|NOT COMPLETED|Overall Study||60
8602586|NCT01178411|21210552|P1|COMPLETED|Overall Study||0
8602587|NCT01178411|21210552|P1|STARTED|Overall Study||60
8602588|NCT01146704|21210560|P2|NOT COMPLETED|Overall Study||0
8602589|NCT01146704|21210561|P1|NOT COMPLETED|Overall Study||0
8602590|NCT01146704|21210560|P2|COMPLETED|Overall Study||15
8602591|NCT01146704|21210561|P1|COMPLETED|Overall Study||16
8602592|NCT01146704|21210560|P2|STARTED|Overall Study||15
8602593|NCT01146704|21210561|P1|STARTED|Overall Study||16
8602663|NCT00696761|21210699|P4|NOT COMPLETED|Overall Study||10
8602664|NCT00696761|21210700|P3|NOT COMPLETED|Overall Study||11
8602665|NCT00696761|21210701|P2|NOT COMPLETED|Overall Study||26
8602666|NCT00696761|21210702|P1|NOT COMPLETED|Overall Study||20
8602667|NCT00696761|21210699|P4|COMPLETED|Overall Study||44
8602668|NCT00696761|21210700|P3|COMPLETED|Overall Study||30
8602669|NCT00696761|21210701|P2|COMPLETED|Overall Study||50
8602670|NCT00696761|21210702|P1|COMPLETED|Overall Study||41
8602671|NCT00696761|21210699|P4|STARTED|Overall Study||54
8602672|NCT00696761|21210700|P3|STARTED|Overall Study||41
8602673|NCT00696761|21210701|P2|STARTED|Overall Study||76
8602674|NCT00696761|21210702|P1|STARTED|Overall Study||61
8602693|NCT00616967|21210789|P3|NOT COMPLETED|Overall Study||1
8602694|NCT00616967|21210790|P2|NOT COMPLETED|Overall Study||0
8602695|NCT00616967|21210791|P1|NOT COMPLETED|Overall Study||0
8602696|NCT00616967|21210789|P3|COMPLETED|Overall Study||30
8602697|NCT00616967|21210790|P2|COMPLETED|Overall Study||31
8602698|NCT00616967|21210791|P1|COMPLETED|Overall Study||6
8602699|NCT00616967|21210789|P3|STARTED|Overall Study||31
8602700|NCT00616967|21210790|P2|STARTED|Overall Study||31
8602701|NCT00616967|21210791|P1|STARTED|Overall Study||6
8602720|NCT00497874|21210860|P2|NOT COMPLETED|Overall Study||116
8602721|NCT00497874|21210861|P1|NOT COMPLETED|Overall Study||147
8602722|NCT00497874|21210860|P2|COMPLETED|Overall Study||343
8602723|NCT00497874|21210861|P1|COMPLETED|Overall Study||296
8602724|NCT00497874|21210860|P2|STARTED|Overall Study||459
8602725|NCT00497874|21210861|P1|STARTED|Overall Study||443
8602729|NCT00448812|21210923|P2|NOT COMPLETED|Year 5||0
8602730|NCT00448812|21210924|P1|NOT COMPLETED|Year 5||1
8602731|NCT00448812|21210923|P2|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
8602732|NCT00448812|21210924|P1|COMPLETED|Year 5||42
8602733|NCT00448812|21210923|P2|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
8602734|NCT00448812|21210924|P1|STARTED|Year 5||43
8602735|NCT00448812|21210923|P2|NOT COMPLETED|Year 4||0
8602736|NCT00448812|21210924|P1|NOT COMPLETED|Year 4||0
8602737|NCT00448812|21210923|P2|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
8602738|NCT00448812|21210924|P1|COMPLETED|Year 4||43
8602739|NCT00448812|21210923|P2|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
8602740|NCT00448812|21210924|P1|STARTED|Year 4||43
8602741|NCT00448812|21210923|P2|NOT COMPLETED|Year 3||3
8602742|NCT00448812|21210924|P1|NOT COMPLETED|Year 3||4
8602743|NCT00448812|21210923|P2|COMPLETED|Year 3||21
8602744|NCT00448812|21210924|P1|COMPLETED|Year 3||41
8602745|NCT00448812|21210923|P2|STARTED|Year 3||24
8602746|NCT00448812|21210924|P1|STARTED|Year 3||45
8602747|NCT00448812|21210923|P2|NOT COMPLETED|Year 2||1
8602748|NCT00448812|21210924|P1|NOT COMPLETED|Year 2||4
8602749|NCT00448812|21210923|P2|COMPLETED|Year 2||23
8602750|NCT00448812|21210924|P1|COMPLETED|Year 2||41
8602751|NCT00448812|21210923|P2|STARTED|Year 2||24
8602752|NCT00448812|21210924|P1|STARTED|Year 2||45
8602753|NCT00448812|21210923|P2|NOT COMPLETED|Year 1||0
8602754|NCT00448812|21210924|P1|NOT COMPLETED|Year 1||0
8602755|NCT00448812|21210923|P2|COMPLETED|Year 1||24
8602756|NCT00448812|21210924|P1|COMPLETED|Year 1||45
8602757|NCT00448812|21210923|P2|STARTED|Year 1||24
8602758|NCT00448812|21210924|P1|STARTED|Year 1||45
8602819|NCT00064259|21211128|P4|NOT COMPLETED|Overall Study||1
8602820|NCT00064259|21211129|P3|NOT COMPLETED|Overall Study||0
8602821|NCT00064259|21211130|P2|NOT COMPLETED|Overall Study||0
8602822|NCT00064259|21211131|P1|NOT COMPLETED|Overall Study||1
8602823|NCT00064259|21211128|P4|COMPLETED|Overall Study||0
8602824|NCT00064259|21211129|P3|COMPLETED|Overall Study||6
8602825|NCT00064259|21211130|P2|COMPLETED|Overall Study||4
8602826|NCT00064259|21211131|P1|COMPLETED|Overall Study||3
8602827|NCT00064259|21211128|P4|STARTED|Overall Study||1
8602828|NCT00064259|21211129|P3|STARTED|Overall Study||6
8602829|NCT00064259|21211130|P2|STARTED|Overall Study||4
8602830|NCT00064259|21211131|P1|STARTED|Overall Study||4
8602831|NCT00031694|21211136|P1|NOT COMPLETED|Overall Study||19
8602832|NCT00031694|21211136|P1|COMPLETED|Overall Study||0
8602833|NCT00031694|21211136|P1|STARTED|Overall Study||19
8602840|NCT04331366|21211181|P1|NOT COMPLETED|Overall Study||0
8602841|NCT04331366|21211181|P1|COMPLETED|Overall Study||2
8602842|NCT04331366|21211181|P1|STARTED|Overall Study||2
8602843|NCT04203225|21211191|P2|NOT COMPLETED|Overall Study||0
8602844|NCT04203225|21211192|P1|NOT COMPLETED|Overall Study||0
8602845|NCT04203225|21211191|P2|COMPLETED|Overall Study||27
8602846|NCT04203225|21211192|P1|COMPLETED|Overall Study||21
8602847|NCT04203225|21211191|P2|STARTED|Overall Study||27
8602848|NCT04203225|21211192|P1|STARTED|Overall Study||21
8602852|NCT04005404|21211210|P3|NOT COMPLETED|Overall Study||0
8602853|NCT04005404|21211211|P2|NOT COMPLETED|Overall Study||1
8602854|NCT04005404|21211212|P1|NOT COMPLETED|Overall Study||1
8602855|NCT04005404|21211210|P3|COMPLETED|Overall Study||3
8602856|NCT04005404|21211211|P2|COMPLETED|Overall Study||33
8602857|NCT04005404|21211212|P1|COMPLETED|Overall Study||42
8602858|NCT04005404|21211210|P3|STARTED|Overall Study||3
8602859|NCT04005404|21211211|P2|STARTED|Overall Study||34
8602860|NCT04005404|21211212|P1|STARTED|Overall Study||43
8602861|NCT03944785|21211229|P3|NOT COMPLETED|4 Month Study Optional Extension||23
8602862|NCT03944785|21211230|P2|NOT COMPLETED|4 Month Study Optional Extension||2
8602863|NCT03944785|21211231|P1|NOT COMPLETED|4 Month Study Optional Extension||1
8602864|NCT03944785|21211229|P3|COMPLETED|4 Month Study Optional Extension||41
8602865|NCT03944785|21211230|P2|COMPLETED|4 Month Study Optional Extension||8
8602866|NCT03944785|21211231|P1|COMPLETED|4 Month Study Optional Extension||0
8602867|NCT03944785|21211229|P3|STARTED|4 Month Study Optional Extension||64
8602868|NCT03944785|21211230|P2|STARTED|4 Month Study Optional Extension||10
8602869|NCT03944785|21211231|P1|STARTED|4 Month Study Optional Extension||1
8602870|NCT03944785|21211229|P3|NOT COMPLETED|2 Month Study Completion||5
8602871|NCT03944785|21211230|P2|NOT COMPLETED|2 Month Study Completion||4
8602872|NCT03944785|21211231|P1|NOT COMPLETED|2 Month Study Completion||0
8602873|NCT03944785|21211229|P3|COMPLETED|2 Month Study Completion||123
8602874|NCT03944785|21211230|P2|COMPLETED|2 Month Study Completion||30
8602875|NCT03944785|21211231|P1|COMPLETED|2 Month Study Completion||2
8602876|NCT03944785|21211229|P3|STARTED|2 Month Study Completion||128
8602877|NCT03944785|21211230|P2|STARTED|2 Month Study Completion||34
8602878|NCT03944785|21211231|P1|STARTED|2 Month Study Completion||2
8602933|NCT03676972|21211429|P1|NOT COMPLETED|Overall Study||2
8602934|NCT03676972|21211429|P1|COMPLETED|Overall Study||58
8602935|NCT03676972|21211429|P1|STARTED|Overall Study||60
8602942|NCT03650452|21211450|P2|NOT COMPLETED|Overall Study||5
8602943|NCT03650452|21211451|P1|NOT COMPLETED|Overall Study||10
8602944|NCT03650452|21211450|P2|COMPLETED|Overall Study||66
8602945|NCT03650452|21211451|P1|COMPLETED|Overall Study||60
8602946|NCT03650452|21211450|P2|STARTED|Overall Study||71
8602947|NCT03650452|21211451|P1|STARTED|Overall Study||70
8602960|NCT03574181|21211530|P1|NOT COMPLETED|Overall Study||9
8602961|NCT03574181|21211530|P1|COMPLETED|Overall Study||0
8602962|NCT03574181|21211530|P1|STARTED|Overall Study||9
8602975|NCT03540147|21211595|P1|NOT COMPLETED|Overall Study||0
8602976|NCT03540147|21211595|P1|COMPLETED|Overall Study||20
8602977|NCT03540147|21211595|P1|STARTED|Overall Study||20
8602978|NCT03538678|21211614|P2|NOT COMPLETED|Overall Study||11
8602979|NCT03538678|21211615|P1|NOT COMPLETED|Overall Study||15
8602980|NCT03538678|21211614|P2|COMPLETED|Overall Study||9
8602981|NCT03538678|21211615|P1|COMPLETED|Overall Study||5
8602982|NCT03538678|21211614|P2|STARTED|Overall Study||20
8602983|NCT03538678|21211615|P1|STARTED|Overall Study||20
8602984|NCT03511326|21211631|P1|NOT COMPLETED|Overall Study||1
8602985|NCT03511326|21211631|P1|COMPLETED|Overall Study||49
8602986|NCT03511326|21211631|P1|STARTED|Overall Study||50
8602987|NCT03502798|21211638|P2|NOT COMPLETED|Overall Study||7
8602988|NCT03502798|21211639|P1|NOT COMPLETED|Overall Study||0
8602989|NCT03502798|21211638|P2|COMPLETED|Overall Study||33
8602990|NCT03502798|21211639|P1|COMPLETED|Overall Study||5
8602991|NCT03502798|21211638|P2|STARTED|Overall Study||40
8602992|NCT03502798|21211639|P1|STARTED|Overall Study||5
8603002|NCT03489369|21211666|P4|NOT COMPLETED|Overall Study||6
8603003|NCT03489369|21211667|P3|NOT COMPLETED|Overall Study||3
8603004|NCT03489369|21211668|P2|NOT COMPLETED|Overall Study||3
8603005|NCT03489369|21211669|P1|NOT COMPLETED|Overall Study||3
8603006|NCT03489369|21211666|P4|COMPLETED|Overall Study||0
8603007|NCT03489369|21211667|P3|COMPLETED|Overall Study||0
8603008|NCT03489369|21211668|P2|COMPLETED|Overall Study||0
8603009|NCT03489369|21211669|P1|COMPLETED|Overall Study||0
8603010|NCT03489369|21211666|P4|STARTED|Overall Study||6
8603011|NCT03489369|21211667|P3|STARTED|Overall Study||3
8603012|NCT03489369|21211668|P2|STARTED|Overall Study||3
8603013|NCT03489369|21211669|P1|STARTED|Overall Study||3
8603032|NCT03391115|21211741|P2|NOT COMPLETED|Overall Study||0
8603033|NCT03391115|21211742|P1|NOT COMPLETED|Overall Study||0
8603034|NCT03391115|21211741|P2|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
8603035|NCT03391115|21211742|P1|COMPLETED|Overall Study||20
8603036|NCT03391115|21211741|P2|STARTED|Overall Study||18
8603037|NCT03391115|21211742|P1|STARTED|Overall Study||20
8603044|NCT03364751|21211763|P4|NOT COMPLETED|Overall Study||0
8603045|NCT03364751|21211764|P3|NOT COMPLETED|Overall Study||0
8603046|NCT03364751|21211765|P2|NOT COMPLETED|Overall Study||1
8603047|NCT03364751|21211766|P1|NOT COMPLETED|Overall Study||1
8603048|NCT03364751|21211763|P4|COMPLETED|Overall Study||1
8603049|NCT03364751|21211764|P3|COMPLETED|Overall Study||17
8603050|NCT03364751|21211765|P2|COMPLETED|Overall Study||83
8603051|NCT03364751|21211766|P1|COMPLETED|Overall Study||69
8603052|NCT03364751|21211763|P4|STARTED|Overall Study||1
8603053|NCT03364751|21211764|P3|STARTED|Overall Study||17
8603054|NCT03364751|21211765|P2|STARTED|Overall Study||84
8603055|NCT03364751|21211766|P1|STARTED|Overall Study||70
8603076|NCT03334903|21211850|P2|NOT COMPLETED|Overall Study||5
8603077|NCT03334903|21211851|P1|NOT COMPLETED|Overall Study||4
8603078|NCT03334903|21211850|P2|COMPLETED|Overall Study||33
8603079|NCT03334903|21211851|P1|COMPLETED|Overall Study||35
8603080|NCT03334903|21211850|P2|STARTED|Overall Study||38
8603081|NCT03334903|21211851|P1|STARTED|Overall Study||39
8603122|NCT03284710|21212296|P4|NOT COMPLETED|Overall Study||8
8603123|NCT03284710|21212297|P3|NOT COMPLETED|Overall Study||4
8603124|NCT03284710|21212298|P2|NOT COMPLETED|Overall Study||5
8603125|NCT03284710|21212299|P1|NOT COMPLETED|Overall Study||6
8603126|NCT03284710|21212296|P4|COMPLETED|Overall Study||16
8603127|NCT03284710|21212297|P3|COMPLETED|Overall Study||32
8603128|NCT03284710|21212298|P2|COMPLETED|Overall Study||31
8603129|NCT03284710|21212299|P1|COMPLETED|Overall Study||30
8603130|NCT03284710|21212296|P4|Month 18 Immunogenicity Timepoint|Overall Study||0
8603131|NCT03284710|21212297|P3|Month 18 Immunogenicity Timepoint|Overall Study||0
8603132|NCT03284710|21212298|P2|Month 18 Immunogenicity Timepoint|Overall Study||0
8603133|NCT03284710|21212299|P1|Month 18 Immunogenicity Timepoint|Overall Study||0
8603134|NCT03284710|21212296|P4|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603135|NCT03284710|21212297|P3|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603136|NCT03284710|21212298|P2|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603137|NCT03284710|21212299|P1|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603138|NCT03284710|21212296|P4|Month 12 Immunogenicity Timepoint|Overall Study||17
8603139|NCT03284710|21212297|P3|Month 12 Immunogenicity Timepoint|Overall Study||31
8603140|NCT03284710|21212298|P2|Month 12 Immunogenicity Timepoint|Overall Study||31
8603141|NCT03284710|21212299|P1|Month 12 Immunogenicity Timepoint|Overall Study||30
8603142|NCT03284710|21212296|P4|Month 6.5 Immunogenicity Timepoint|Overall Study||18
8603143|NCT03284710|21212297|P3|Month 6.5 Immunogenicity Timepoint|Overall Study||31
8603144|NCT03284710|21212298|P2|Month 6.5 Immunogenicity Timepoint|Overall Study||31
8603145|NCT03284710|21212299|P1|Month 6.5 Immunogenicity Timepoint|Overall Study||31
8603146|NCT03284710|21212296|P4|STARTED|Overall Study||24
8603147|NCT03284710|21212297|P3|STARTED|Overall Study||36
8603148|NCT03284710|21212298|P2|STARTED|Overall Study||36
8603149|NCT03284710|21212299|P1|STARTED|Overall Study||36
8603171|NCT03168711|21212461|P2|NOT COMPLETED|Overall Study||2
8603172|NCT03168711|21212462|P1|NOT COMPLETED|Overall Study||2
8603173|NCT03168711|21212461|P2|COMPLETED|Overall Study||7
8603174|NCT03168711|21212462|P1|COMPLETED|Overall Study||12
8603175|NCT03168711|21212461|P2|STARTED|Overall Study||9
8603176|NCT03168711|21212462|P1|STARTED|Overall Study||14
8603183|NCT03161483|21212526|P4|NOT COMPLETED|Overall Study||8
8603184|NCT03161483|21212527|P3|NOT COMPLETED|Overall Study||20
8603185|NCT03161483|21212528|P2|NOT COMPLETED|Overall Study||3
8603186|NCT03161483|21212529|P1|NOT COMPLETED|Overall Study||10
8603187|NCT03161483|21212526|P4|COMPLETED|Overall Study||73
8603188|NCT03161483|21212527|P3|COMPLETED|Overall Study||62
8603189|NCT03161483|21212528|P2|COMPLETED|Overall Study||39
8603190|NCT03161483|21212529|P1|COMPLETED|Overall Study||73
8603191|NCT03161483|21212526|P4|STARTED|Overall Study||81
8603192|NCT03161483|21212527|P3|STARTED|Overall Study||82
8603193|NCT03161483|21212528|P2|STARTED|Overall Study||42
8603194|NCT03161483|21212529|P1|STARTED|Overall Study||83
8603280|NCT03078868|21212808|P1|NOT COMPLETED|Overall Study||3
8603281|NCT03078868|21212808|P1|COMPLETED|Overall Study||0
8603282|NCT03078868|21212808|P1|STARTED|Overall Study||3
8603283|NCT02994940|21212814|P2|NOT COMPLETED|Overall Study||1
8603284|NCT02994940|21212815|P1|NOT COMPLETED|Overall Study||7
8603285|NCT02994940|21212814|P2|COMPLETED|Overall Study||36
8603286|NCT02994940|21212815|P1|COMPLETED|Overall Study||30
8603287|NCT02994940|21212814|P2|STARTED|Overall Study||37
8603288|NCT02994940|21212815|P1|STARTED|Overall Study||37
8603298|NCT02957123|21212857|P1|NOT COMPLETED|Overall Study||0
8603299|NCT02957123|21212857|P1|COMPLETED|Overall Study||30
8603300|NCT02957123|21212857|P1|STARTED|Overall Study||30
8603337|NCT02932267|21213058|P1|NOT COMPLETED|Overall Study||8
8603338|NCT02932267|21213058|P1|COMPLETED|Overall Study||42
8603339|NCT02932267|21213058|P1|STARTED|Overall Study||50
8603340|NCT02870309|21213062|P1|NOT COMPLETED|Overall Study||0
8603341|NCT02870309|21213062|P1|COMPLETED|Overall Study||4
8603342|NCT02870309|21213062|P1|STARTED|Overall Study||4
8603343|NCT02836249|21213073|P2|NOT COMPLETED|Overall Study||58
8603344|NCT02836249|21213074|P1|NOT COMPLETED|Overall Study||123
8603345|NCT02836249|21213073|P2|COMPLETED|Overall Study||0
8603346|NCT02836249|21213074|P1|COMPLETED|Overall Study||0
8603347|NCT02836249|21213073|P2|STARTED|Overall Study||58
8603348|NCT02836249|21213074|P1|STARTED|Overall Study||123
8603355|NCT02735421|21213109|P1|NOT COMPLETED|Overall Study||13
8603356|NCT02735421|21213109|P1|COMPLETED|Overall Study||54
8603357|NCT02735421|21213109|P1|STARTED|Overall Study||67
8603433|NCT02641691|21213487|P1|NOT COMPLETED|Overall Study||0
8603434|NCT02641691|21213487|P1|COMPLETED|Overall Study||20
8603435|NCT02641691|21213487|P1|STARTED|Overall Study||20
8603436|NCT02620904|21213528|P2|NOT COMPLETED|Overall Study||0
8603437|NCT02620904|21213529|P1|NOT COMPLETED|Overall Study||0
8603438|NCT02620904|21213528|P2|COMPLETED|Overall Study||5
8603439|NCT02620904|21213529|P1|COMPLETED|Overall Study||4
8603440|NCT02620904|21213528|P2|STARTED|Overall Study||5
8603441|NCT02620904|21213529|P1|STARTED|Overall Study||4
8603442|NCT02616250|21213537|P2|NOT COMPLETED|Overall Study||9
8603443|NCT02616250|21213538|P1|NOT COMPLETED|Overall Study||10
8603444|NCT02616250|21213537|P2|COMPLETED|Overall Study||86
8603445|NCT02616250|21213538|P1|COMPLETED|Overall Study||85
8603446|NCT02616250|21213537|P2|STARTED|Overall Study||95
8603447|NCT02616250|21213538|P1|STARTED|Overall Study||95
8603448|NCT02589405|21213544|P1|NOT COMPLETED|Overall Study||4
8603449|NCT02589405|21213544|P1|COMPLETED|Overall Study||46
8603450|NCT02589405|21213544|P1|STARTED|Overall Study||50
8603471|NCT02536196|21213672|P3|NOT COMPLETED|Overall Study||0
8603472|NCT02536196|21213673|P2|NOT COMPLETED|Overall Study||14
8603473|NCT02536196|21213674|P1|NOT COMPLETED|Overall Study||29
8603474|NCT02536196|21213672|P3|COMPLETED|Overall Study||95
8603475|NCT02536196|21213673|P2|COMPLETED|Overall Study||107
8603476|NCT02536196|21213674|P1|COMPLETED|Overall Study||233
8603477|NCT02536196|21213672|P3|STARTED|Overall Study||95
8603478|NCT02536196|21213673|P2|STARTED|Overall Study||121
8603479|NCT02536196|21213674|P1|STARTED|Overall Study||262
8603480|NCT02480114|21213684|P2|NOT COMPLETED|Overall Study||8
8603481|NCT02480114|21213685|P1|NOT COMPLETED|Overall Study||9
8603482|NCT02480114|21213684|P2|COMPLETED|Overall Study||30
8603483|NCT02480114|21213685|P1|COMPLETED|Overall Study||32
8603484|NCT02480114|21213684|P2|STARTED|Overall Study||38
8603485|NCT02480114|21213685|P1|STARTED|Overall Study||41
8603500|NCT02396849|21213763|P2|NOT COMPLETED|Overall Study||2
8603501|NCT02396849|21213764|P1|NOT COMPLETED|Overall Study||2
8603502|NCT02396849|21213763|P2|COMPLETED|Overall Study||28
8603503|NCT02396849|21213764|P1|COMPLETED|Overall Study||27
8603504|NCT02396849|21213763|P2|STARTED|Overall Study||30
8603505|NCT02396849|21213764|P1|STARTED|Overall Study||29
8603512|NCT02366312|21213791|P2|NOT COMPLETED|Overall Study||1
8603513|NCT02366312|21213792|P1|NOT COMPLETED|Overall Study||0
8603514|NCT02366312|21213791|P2|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
8603515|NCT02366312|21213792|P1|COMPLETED|Overall Study||1
8603516|NCT02366312|21213791|P2|STARTED|Overall Study||1
8603517|NCT02366312|21213792|P1|STARTED|Overall Study||1
8603584|NCT02307266|21213921|P3|NOT COMPLETED|Overall Study||6
8603585|NCT02307266|21213922|P2|NOT COMPLETED|Overall Study||1
8603586|NCT02307266|21213923|P1|NOT COMPLETED|Overall Study||8
8603587|NCT02307266|21213921|P3|COMPLETED|Overall Study||25
8603588|NCT02307266|21213922|P2|COMPLETED|Overall Study||32
8603589|NCT02307266|21213923|P1|COMPLETED|Overall Study||25
8603590|NCT02307266|21213921|P3|STARTED|Overall Study||31
8603591|NCT02307266|21213922|P2|STARTED|Overall Study||33
8603592|NCT02307266|21213923|P1|STARTED|Overall Study||33
8603596|NCT02287493|21213947|P2|NOT COMPLETED|Overall Study||0
8603597|NCT02287493|21213948|P1|NOT COMPLETED|Overall Study||0
8603598|NCT02287493|21213947|P2|COMPLETED|Overall Study||16
8603599|NCT02287493|21213948|P1|COMPLETED|Overall Study||19
8603600|NCT02287493|21213947|P2|STARTED|Overall Study||16
8603601|NCT02287493|21213948|P1|STARTED|Overall Study||19
8603602|NCT02283333|21213962|P2|NOT COMPLETED|Overall Study||14
8603603|NCT02283333|21213963|P1|NOT COMPLETED|Overall Study||14
8603604|NCT02283333|21213962|P2|COMPLETED|Overall Study||64
8603605|NCT02283333|21213963|P1|COMPLETED|Overall Study||63
8603606|NCT02283333|21213962|P2|STARTED|Overall Study||78
8603607|NCT02283333|21213963|P1|STARTED|Overall Study||77
8603608|NCT02226796|21213991|P2|NOT COMPLETED|Second Intervention Phase (Week 6)||0
8603609|NCT02226796|21213992|P1|NOT COMPLETED|Second Intervention Phase (Week 6)||0
8603610|NCT02226796|21213991|P2|COMPLETED|Second Intervention Phase (Week 6)||1
8603611|NCT02226796|21213992|P1|COMPLETED|Second Intervention Phase (Week 6)||2
8603612|NCT02226796|21213991|P2|Follow Up Assessment|Second Intervention Phase (Week 6)||1
8603613|NCT02226796|21213992|P1|Follow Up Assessment|Second Intervention Phase (Week 6)||2
8603614|NCT02226796|21213991|P2|Baseline Assessment|Second Intervention Phase (Week 6)||1
8603615|NCT02226796|21213992|P1|Baseline Assessment|Second Intervention Phase (Week 6)||2
8603616|NCT02226796|21213991|P2|STARTED|Second Intervention Phase (Week 6)||1
8603617|NCT02226796|21213992|P1|STARTED|Second Intervention Phase (Week 6)||2
8603618|NCT02226796|21213991|P2|NOT COMPLETED|Washout (Weeks 2-5)||0
8603619|NCT02226796|21213992|P1|NOT COMPLETED|Washout (Weeks 2-5)||0
8603620|NCT02226796|21213991|P2|COMPLETED|Washout (Weeks 2-5)||1
8603621|NCT02226796|21213992|P1|COMPLETED|Washout (Weeks 2-5)||2
8603622|NCT02226796|21213991|P2|STARTED|Washout (Weeks 2-5)||1
8603623|NCT02226796|21213992|P1|STARTED|Washout (Weeks 2-5)||2
8603624|NCT02226796|21213991|P2|NOT COMPLETED|First Intervention Phase (Week 1)||0
8603625|NCT02226796|21213992|P1|NOT COMPLETED|First Intervention Phase (Week 1)||0
8603626|NCT02226796|21213991|P2|COMPLETED|First Intervention Phase (Week 1)||1
8603627|NCT02226796|21213992|P1|COMPLETED|First Intervention Phase (Week 1)||2
8603628|NCT02226796|21213991|P2|Follow Up Assessment|First Intervention Phase (Week 1)||1
8603629|NCT02226796|21213992|P1|Follow Up Assessment|First Intervention Phase (Week 1)||2
8603630|NCT02226796|21213991|P2|Baseline Assessment|First Intervention Phase (Week 1)||1
8603631|NCT02226796|21213992|P1|Baseline Assessment|First Intervention Phase (Week 1)||2
8603632|NCT02226796|21213991|P2|STARTED|First Intervention Phase (Week 1)||1
8603633|NCT02226796|21213992|P1|STARTED|First Intervention Phase (Week 1)||2
8603634|NCT02225925|21214006|P1|NOT COMPLETED|Overall Study||0
8603635|NCT02225925|21214006|P1|COMPLETED|Overall Study||45
8603636|NCT02225925|21214006|P1|STARTED|Overall Study||45
8603652|NCT02207946|21214049|P2|NOT COMPLETED|Overall Study||1
8603653|NCT02207946|21214050|P1|NOT COMPLETED|Overall Study||1
8603654|NCT02207946|21214049|P2|COMPLETED|Overall Study||10
8603655|NCT02207946|21214050|P1|COMPLETED|Overall Study||18
8603656|NCT02207946|21214049|P2|STARTED|Overall Study||11
8603657|NCT02207946|21214050|P1|STARTED|Overall Study||19
8603667|NCT02186665|21214081|P2|NOT COMPLETED|Overall Study||1
8603668|NCT02186665|21214082|P1|NOT COMPLETED|Overall Study||0
8603669|NCT02186665|21214081|P2|COMPLETED|Overall Study||10
8603670|NCT02186665|21214082|P1|COMPLETED|Overall Study||8
8603671|NCT02186665|21214081|P2|STARTED|Overall Study||11
8603672|NCT02186665|21214082|P1|STARTED|Overall Study||8
8603679|NCT02125279|21214129|P1|NOT COMPLETED|Overall Study||13
8603680|NCT02125279|21214129|P1|COMPLETED|Overall Study||41
8603681|NCT02125279|21214129|P1|STARTED|Overall Study||54
8603688|NCT02065570|21214173|P4|NOT COMPLETED|Maintenance Study||19
8603689|NCT02065570|21214174|P3|NOT COMPLETED|Maintenance Study||22
8603690|NCT02065570|21214175|P2|NOT COMPLETED|Maintenance Study||0
8603691|NCT02065570|21214176|P1|NOT COMPLETED|Maintenance Study||0
8603692|NCT02065570|21214173|P4|COMPLETED|Maintenance Study||90
8603693|NCT02065570|21214174|P3|COMPLETED|Maintenance Study||87
8603694|NCT02065570|21214175|P2|COMPLETED|Maintenance Study||0
8603695|NCT02065570|21214176|P1|COMPLETED|Maintenance Study||0
8603696|NCT02065570|21214173|P4|STARTED|Maintenance Study||109
8603697|NCT02065570|21214174|P3|STARTED|Maintenance Study||109
8603698|NCT02065570|21214175|P2|STARTED|Maintenance Study||0
8603699|NCT02065570|21214176|P1|STARTED|Maintenance Study||0
8603700|NCT02065570|21214173|P4|NOT COMPLETED|Induction Study||0
8603701|NCT02065570|21214174|P3|NOT COMPLETED|Induction Study||0
8603702|NCT02065570|21214175|P2|NOT COMPLETED|Induction Study||21
8603703|NCT02065570|21214176|P1|NOT COMPLETED|Induction Study||14
8603704|NCT02065570|21214173|P4|COMPLETED|Induction Study||0
8603705|NCT02065570|21214174|P3|COMPLETED|Induction Study||0
8603706|NCT02065570|21214175|P2|COMPLETED|Induction Study||287
8603707|NCT02065570|21214176|P1|COMPLETED|Induction Study||192
8603708|NCT02065570|21214173|P4|STARTED|Induction Study||0
8603709|NCT02065570|21214174|P3|STARTED|Induction Study||0
8603710|NCT02065570|21214175|P2|STARTED|Induction Study||308
8603711|NCT02065570|21214176|P1|STARTED|Induction Study||206
8603712|NCT02063828|21214223|P3|NOT COMPLETED|Overall Study||4
8603713|NCT02063828|21214224|P2|NOT COMPLETED|Overall Study||6
8603714|NCT02063828|21214225|P1|NOT COMPLETED|Overall Study||4
8603715|NCT02063828|21214223|P3|COMPLETED|Overall Study||14
8603716|NCT02063828|21214224|P2|COMPLETED|Overall Study||8
8603717|NCT02063828|21214225|P1|COMPLETED|Overall Study||10
8603718|NCT02063828|21214223|P3|Week 6|Overall Study||14
8603719|NCT02063828|21214224|P2|Week 6|Overall Study||9
8603720|NCT02063828|21214225|P1|Week 6|Overall Study||11
8603721|NCT02063828|21214223|P3|STARTED|Overall Study||18
8603722|NCT02063828|21214224|P2|STARTED|Overall Study||14
8603723|NCT02063828|21214225|P1|STARTED|Overall Study||14
8603810|NCT01948427|21214766|P5|NOT COMPLETED|Overall Study||14
8603811|NCT01948427|21214767|P4|NOT COMPLETED|Overall Study||0
8603812|NCT01948427|21214768|P3|NOT COMPLETED|Overall Study||0
8603813|NCT01948427|21214769|P2|NOT COMPLETED|Overall Study||17
8603814|NCT01948427|21214770|P1|NOT COMPLETED|Overall Study||7
8603815|NCT01948427|21214766|P5|COMPLETED|Overall Study||46
8603816|NCT01948427|21214767|P4|COMPLETED|Overall Study||1
8603817|NCT01948427|21214768|P3|COMPLETED|Overall Study||4
8603818|NCT01948427|21214769|P2|COMPLETED|Overall Study||72
8603819|NCT01948427|21214770|P1|COMPLETED|Overall Study||42
8603820|NCT01948427|21214766|P5|STARTED|Overall Study||60
8603821|NCT01948427|21214767|P4|STARTED|Overall Study||1
8603822|NCT01948427|21214768|P3|STARTED|Overall Study||4
8603823|NCT01948427|21214769|P2|STARTED|Overall Study||89
8603824|NCT01948427|21214770|P1|STARTED|Overall Study||49
8603831|NCT01940471|21214818|P2|NOT COMPLETED|Open-Label Extension||8
8603832|NCT01940471|21214819|P1|NOT COMPLETED|Open-Label Extension||14
8603833|NCT01940471|21214818|P2|COMPLETED|Open-Label Extension||0
8603834|NCT01940471|21214819|P1|COMPLETED|Open-Label Extension||0
8603835|NCT01940471|21214818|P2|STARTED|Open-Label Extension||8
8603836|NCT01940471|21214819|P1|STARTED|Open-Label Extension||14
8603837|NCT01940471|21214818|P2|NOT COMPLETED|Double-Blind Phase||285
8603838|NCT01940471|21214819|P1|NOT COMPLETED|Double-Blind Phase||568
8603839|NCT01940471|21214818|P2|COMPLETED|Double-Blind Phase||8
8603840|NCT01940471|21214819|P1|COMPLETED|Double-Blind Phase||14
8603841|NCT01940471|21214818|P2|STARTED|Double-Blind Phase||293
8603842|NCT01940471|21214819|P1|STARTED|Double-Blind Phase||582
8603843|NCT01927341|21214840|P5|NOT COMPLETED|Phase 2||8
8603844|NCT01927341|21214841|P4|NOT COMPLETED|Phase 2||15
8603845|NCT01927341|21214842|P3|NOT COMPLETED|Phase 2||5
8603846|NCT01927341|21214843|P2|NOT COMPLETED|Phase 2||15
8603847|NCT01927341|21214844|P1|NOT COMPLETED|Phase 2||0
8603848|NCT01927341|21214840|P5|COMPLETED|Phase 2||0
8603849|NCT01927341|21214841|P4|COMPLETED|Phase 2||0
8603850|NCT01927341|21214842|P3|COMPLETED|Phase 2||0
8603851|NCT01927341|21214843|P2|COMPLETED|Phase 2||0
8603852|NCT01927341|21214844|P1|COMPLETED|Phase 2||0
8603853|NCT01927341|21214840|P5|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
8603854|NCT01927341|21214841|P4|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
8603855|NCT01927341|21214842|P3|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
8603856|NCT01927341|21214843|P2|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
8603857|NCT01927341|21214844|P1|STARTED|Phase 2||0
8603858|NCT01927341|21214840|P5|NOT COMPLETED|Phase 1b||0
8603859|NCT01927341|21214841|P4|NOT COMPLETED|Phase 1b||0
8603860|NCT01927341|21214842|P3|NOT COMPLETED|Phase 1b||0
8603861|NCT01927341|21214843|P2|NOT COMPLETED|Phase 1b||0
8603862|NCT01927341|21214844|P1|NOT COMPLETED|Phase 1b||10
8603863|NCT01927341|21214840|P5|COMPLETED|Phase 1b||0
8603864|NCT01927341|21214841|P4|COMPLETED|Phase 1b||0
8603865|NCT01927341|21214842|P3|COMPLETED|Phase 1b||0
8603866|NCT01927341|21214843|P2|COMPLETED|Phase 1b||0
8603867|NCT01927341|21214844|P1|COMPLETED|Phase 1b||0
8603868|NCT01927341|21214840|P5|STARTED|Phase 1b||0
8603869|NCT01927341|21214841|P4|STARTED|Phase 1b||0
8603870|NCT01927341|21214842|P3|STARTED|Phase 1b||0
8603871|NCT01927341|21214843|P2|STARTED|Phase 1b||0
8603872|NCT01927341|21214844|P1|STARTED|Phase 1b||10
8603960|NCT01821391|21214938|P2|NOT COMPLETED|Overall Study||0
8603961|NCT01821391|21214939|P1|NOT COMPLETED|Overall Study||1
8603962|NCT01821391|21214938|P2|COMPLETED|Overall Study||23
8603963|NCT01821391|21214939|P1|COMPLETED|Overall Study||107
8603964|NCT01821391|21214938|P2|STARTED|Overall Study||23
8603965|NCT01821391|21214939|P1|STARTED|Overall Study||108
8603969|NCT01766440|21214954|P1|NOT COMPLETED|Overall Study||1
8603970|NCT01766440|21214954|P1|COMPLETED|Overall Study||17
8603971|NCT01766440|21214954|P1|STARTED|Overall Study||18
8603972|NCT01759277|21214965|P2|NOT COMPLETED|Overall Study||0
8603973|NCT01759277|21214966|P1|NOT COMPLETED|Overall Study||0
8603974|NCT01759277|21214965|P2|COMPLETED|Overall Study||39
8603975|NCT01759277|21214966|P1|COMPLETED|Overall Study||41
8603976|NCT01759277|21214965|P2|STARTED|Overall Study||39
8603977|NCT01759277|21214966|P1|STARTED|Overall Study||41
8603978|NCT01734512|21214984|P1|NOT COMPLETED|Overall Study||0
8603979|NCT01734512|21214984|P1|COMPLETED|Overall Study||65
8603980|NCT01734512|21214984|P1|STARTED|Overall Study||65
8603987|NCT01545765|21215004|P1|NOT COMPLETED|Overall Study||0
8603988|NCT01545765|21215004|P1|COMPLETED|Overall Study||31
8603989|NCT01545765|21215004|P1|STARTED|Overall Study||31
8603990|NCT01531803|21215017|P2|NOT COMPLETED|Overall Study||0
8603991|NCT01531803|21215018|P1|NOT COMPLETED|Overall Study||0
8603992|NCT01531803|21215017|P2|COMPLETED|Overall Study||2
8603993|NCT01531803|21215018|P1|COMPLETED|Overall Study||1
8603994|NCT01531803|21215017|P2|STARTED|Overall Study||2
8603995|NCT01531803|21215018|P1|STARTED|Overall Study||1
8603996|NCT01529203|21215028|P1|NOT COMPLETED|Overall Study||3
8603997|NCT01529203|21215028|P1|COMPLETED|Overall Study||57
8603998|NCT01529203|21215028|P1|STARTED|Overall Study||60
8603999|NCT01494467|21215036|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8604000|NCT01494467|21215037|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8604001|NCT01494467|21215036|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
8604002|NCT01494467|21215037|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
8604003|NCT01494467|21215036|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
8604004|NCT01494467|21215037|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
8604005|NCT01494467|21215036|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
8604006|NCT01494467|21215037|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
8604007|NCT01494467|21215036|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
8604008|NCT01494467|21215037|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
8604009|NCT01494467|21215036|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
8604010|NCT01494467|21215037|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
8604011|NCT01494467|21215036|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
8604012|NCT01494467|21215037|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
8604013|NCT01494467|21215036|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
8604014|NCT01494467|21215037|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
8604015|NCT01494467|21215036|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
8604016|NCT01494467|21215037|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
8604017|NCT01493687|21215055|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
8604018|NCT01493687|21215056|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8604019|NCT01493687|21215055|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
8604020|NCT01493687|21215056|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
8604021|NCT01493687|21215055|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
8604022|NCT01493687|21215056|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
8604023|NCT01493687|21215055|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
8604024|NCT01493687|21215056|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
8604025|NCT01493687|21215055|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
8604026|NCT01493687|21215056|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
8604027|NCT01493687|21215055|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
8604028|NCT01493687|21215056|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
8604029|NCT01493687|21215055|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
8604030|NCT01493687|21215056|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
8604031|NCT01493687|21215055|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
8604032|NCT01493687|21215056|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
8604033|NCT01493687|21215055|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
8604034|NCT01493687|21215056|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
8604035|NCT01475071|21215072|P1|NOT COMPLETED|Overall Study||8
8604036|NCT01475071|21215072|P1|COMPLETED|Overall Study||92
8604037|NCT01475071|21215072|P1|STARTED|Overall Study||100
8604038|NCT01474590|21215082|P2|NOT COMPLETED|Overall Study||17
8604039|NCT01474590|21215083|P1|NOT COMPLETED|Overall Study||28
8604040|NCT01474590|21215082|P2|COMPLETED|Overall Study||116
8604041|NCT01474590|21215083|P1|COMPLETED|Overall Study||105
8604042|NCT01474590|21215082|P2|STARTED|Overall Study||133
8604043|NCT01474590|21215083|P1|STARTED|Overall Study||133
8604050|NCT01361633|21215108|P2|NOT COMPLETED|Overall Study||3
8604051|NCT01361633|21215109|P1|NOT COMPLETED|Overall Study||6
8604052|NCT01361633|21215108|P2|COMPLETED|Overall Study||23
8604053|NCT01361633|21215109|P1|COMPLETED|Overall Study||19
8604054|NCT01361633|21215108|P2|STARTED|Overall Study||26
8604055|NCT01361633|21215109|P1|STARTED|Overall Study||25
8604056|NCT01355471|21215129|P2|NOT COMPLETED|Overall Study||3
8604057|NCT01355471|21215130|P1|NOT COMPLETED|Overall Study||7
8604058|NCT01355471|21215129|P2|COMPLETED|Overall Study||142
8604059|NCT01355471|21215130|P1|COMPLETED|Overall Study||141
8604060|NCT01355471|21215129|P2|STARTED|Overall Study||145
8604061|NCT01355471|21215130|P1|STARTED|Overall Study||148
8604062|NCT01355458|21215138|P2|NOT COMPLETED|Overall Study||4
8604063|NCT01355458|21215139|P1|NOT COMPLETED|Overall Study||2
8604064|NCT01355458|21215138|P2|COMPLETED|Overall Study||127
8604065|NCT01355458|21215139|P1|COMPLETED|Overall Study||127
8604066|NCT01355458|21215138|P2|STARTED|Overall Study||131
8604067|NCT01355458|21215139|P1|STARTED|Overall Study||129
8604089|NCT01320033|21215219|P3|NOT COMPLETED|Overall Study||53
8604090|NCT01320033|21215220|P2|NOT COMPLETED|Overall Study||64
8604091|NCT01320033|21215221|P1|NOT COMPLETED|Overall Study||58
8604092|NCT01320033|21215219|P3|COMPLETED|Overall Study||169
8604093|NCT01320033|21215220|P2|COMPLETED|Overall Study||160
8604094|NCT01320033|21215221|P1|COMPLETED|Overall Study||158
8604095|NCT01320033|21215219|P3|STARTED|Overall Study||222
8604096|NCT01320033|21215220|P2|STARTED|Overall Study||224
8604097|NCT01320033|21215221|P1|STARTED|Overall Study||216
8604098|NCT01318733|21215247|P1|NOT COMPLETED|Overall Study||170
8604099|NCT01318733|21215247|P1|COMPLETED|Overall Study||279
8604100|NCT01318733|21215247|P1|STARTED|Overall Study||449
8604113|NCT01213199|21215285|P1|NOT COMPLETED|Overall Study||4
8604114|NCT01213199|21215285|P1|COMPLETED|Overall Study||16
8604115|NCT01213199|21215285|P1|STARTED|Overall Study||20
8604131|NCT01188538|21215316|P2|NOT COMPLETED|Overall Study||1
8604132|NCT01188538|21215317|P1|NOT COMPLETED|Overall Study||0
8604133|NCT01188538|21215316|P2|COMPLETED|Overall Study||19
8604134|NCT01188538|21215317|P1|COMPLETED|Overall Study||20
8604135|NCT01188538|21215316|P2|STARTED|Overall Study||20
8604136|NCT01188538|21215317|P1|STARTED|Overall Study||20
8604146|NCT01138735|21215344|P2|NOT COMPLETED|Overall Study||17
8604147|NCT01138735|21215345|P1|NOT COMPLETED|Overall Study||8
8604148|NCT01138735|21215344|P2|COMPLETED|Overall Study||126
8604149|NCT01138735|21215345|P1|COMPLETED|Overall Study||134
8604150|NCT01138735|21215344|P2|STARTED|Overall Study||143
8604151|NCT01138735|21215345|P1|STARTED|Overall Study||142
8604155|NCT01014871|21215363|P1|NOT COMPLETED|Overall Study||0
8604156|NCT01014871|21215363|P1|COMPLETED|Overall Study||30
8604157|NCT01014871|21215363|P1|STARTED|Overall Study||30
8604158|NCT01014689|21215371|P2|NOT COMPLETED|Overall Study||13
8604159|NCT01014689|21215372|P1|NOT COMPLETED|Overall Study||13
8604160|NCT01014689|21215371|P2|COMPLETED|Overall Study||174
8604161|NCT01014689|21215372|P1|COMPLETED|Overall Study||178
8604162|NCT01014689|21215371|P2|STARTED|Overall Study||187
8604163|NCT01014689|21215372|P1|STARTED|Overall Study||191
8604164|NCT00993915|21215380|P1|NOT COMPLETED|Overall Study||9
8604165|NCT00993915|21215380|P1|COMPLETED|Overall Study||678
8604166|NCT00993915|21215380|P1|STARTED|Overall Study||687
8604167|NCT00989014|21215393|P4|NOT COMPLETED|Overall Study||0
8604168|NCT00989014|21215394|P3|NOT COMPLETED|Overall Study||0
8604169|NCT00989014|21215395|P2|NOT COMPLETED|Overall Study||0
8604170|NCT00989014|21215396|P1|NOT COMPLETED|Overall Study||0
8604171|NCT00989014|21215393|P4|COMPLETED|Overall Study||32
8604172|NCT00989014|21215394|P3|COMPLETED|Overall Study||28
8604173|NCT00989014|21215395|P2|COMPLETED|Overall Study||31
8604174|NCT00989014|21215396|P1|COMPLETED|Overall Study||31
8604175|NCT00989014|21215393|P4|STARTED|Overall Study||32
8604176|NCT00989014|21215394|P3|STARTED|Overall Study||28
8604177|NCT00989014|21215395|P2|STARTED|Overall Study||31
8604178|NCT00989014|21215396|P1|STARTED|Overall Study||31
8604179|NCT00971282|21215406|P1|NOT COMPLETED|Overall Study||0
8604180|NCT00971282|21215406|P1|COMPLETED|Overall Study||30
8604181|NCT00971282|21215406|P1|STARTED|Overall Study||30
8604188|NCT00919763|21215463|P2|NOT COMPLETED|Overall Study||4
8604189|NCT00919763|21215464|P1|NOT COMPLETED|Overall Study||12
8604190|NCT00919763|21215463|P2|COMPLETED|Overall Study||45
8604191|NCT00919763|21215464|P1|COMPLETED|Overall Study||41
8604192|NCT00919763|21215463|P2|STARTED|Overall Study||49
8604193|NCT00919763|21215464|P1|STARTED|Overall Study||53
8604212|NCT00883233|21215489|P4|NOT COMPLETED|Overall Study||5
8604213|NCT00883233|21215490|P3|NOT COMPLETED|Overall Study||4
8604214|NCT00883233|21215491|P2|NOT COMPLETED|Overall Study||4
8604215|NCT00883233|21215492|P1|NOT COMPLETED|Overall Study||5
8604216|NCT00883233|21215489|P4|COMPLETED|Overall Study||25
8604217|NCT00883233|21215490|P3|COMPLETED|Overall Study||25
8604218|NCT00883233|21215491|P2|COMPLETED|Overall Study||28
8604219|NCT00883233|21215492|P1|COMPLETED|Overall Study||27
8604220|NCT00883233|21215489|P4|STARTED|Overall Study||30
8604221|NCT00883233|21215490|P3|STARTED|Overall Study||29
8604222|NCT00883233|21215491|P2|STARTED|Overall Study||32
8604223|NCT00883233|21215492|P1|STARTED|Overall Study||32
8604227|NCT00862654|21215514|P4|NOT COMPLETED|Overall Study||6
8604228|NCT00862654|21215515|P3|NOT COMPLETED|Overall Study||6
8604229|NCT00862654|21215516|P2|NOT COMPLETED|Overall Study||8
8604230|NCT00862654|21215517|P1|NOT COMPLETED|Overall Study||6
8604231|NCT00862654|21215514|P4|COMPLETED|Overall Study||74
8604232|NCT00862654|21215515|P3|COMPLETED|Overall Study||76
8604233|NCT00862654|21215516|P2|COMPLETED|Overall Study||74
8604234|NCT00862654|21215517|P1|COMPLETED|Overall Study||76
8604235|NCT00862654|21215514|P4|STARTED|Overall Study||80
8604236|NCT00862654|21215515|P3|STARTED|Overall Study||82
8604237|NCT00862654|21215516|P2|STARTED|Overall Study||82
8604238|NCT00862654|21215517|P1|STARTED|Overall Study||82
8604321|NCT00697541|21215680|P2|NOT COMPLETED|Overall Study||1
8604322|NCT00697541|21215681|P1|NOT COMPLETED|Overall Study||2
8604323|NCT00697541|21215680|P2|COMPLETED|Overall Study||9
8604324|NCT00697541|21215681|P1|COMPLETED|Overall Study||8
8604325|NCT00697541|21215680|P2|STARTED|Overall Study||10
8604326|NCT00697541|21215681|P1|STARTED|Overall Study||10
8604327|NCT00688064|21215693|P2|NOT COMPLETED|Overall Study||26
8604328|NCT00688064|21215694|P1|NOT COMPLETED|Overall Study||21
8604329|NCT00688064|21215693|P2|COMPLETED|Overall Study||201
8604330|NCT00688064|21215694|P1|COMPLETED|Overall Study||211
8604331|NCT00688064|21215693|P2|STARTED|Overall Study||227
8604332|NCT00688064|21215694|P1|STARTED|Overall Study||232
8604333|NCT00687908|21215710|P2|NOT COMPLETED|Overall Study||42
8604334|NCT00687908|21215711|P1|NOT COMPLETED|Overall Study||18
8604335|NCT00687908|21215710|P2|COMPLETED|Overall Study||78
8604336|NCT00687908|21215711|P1|COMPLETED|Overall Study||105
8604337|NCT00687908|21215710|P2|STARTED|Overall Study||120
8604338|NCT00687908|21215711|P1|STARTED|Overall Study||123
8604416|NCT00660985|21216171|P2|NOT COMPLETED|Overall Study||0
8604417|NCT00660985|21216172|P1|NOT COMPLETED|Overall Study||1
8604418|NCT00660985|21216171|P2|COMPLETED|Overall Study||25
8604419|NCT00660985|21216172|P1|COMPLETED|Overall Study||25
8604420|NCT00660985|21216171|P2|STARTED|Overall Study||25
8604421|NCT00660985|21216172|P1|STARTED|Overall Study||26
8604430|NCT00599521|21216211|P2|NOT COMPLETED|Overall Study||69
8604431|NCT00599521|21216212|P1|NOT COMPLETED|Overall Study||60
8604432|NCT00599521|21216211|P2|COMPLETED|Overall Study||462
8604433|NCT00599521|21216212|P1|COMPLETED|Overall Study||475
8604434|NCT00599521|21216211|P2|STARTED|Overall Study||531
8604435|NCT00599521|21216212|P1|STARTED|Overall Study||535
8604436|NCT00598832|21216228|P2|NOT COMPLETED|Overall Study||82
8604437|NCT00598832|21216229|P1|NOT COMPLETED|Overall Study||62
8604438|NCT00598832|21216228|P2|COMPLETED|Overall Study||460
8604439|NCT00598832|21216229|P1|COMPLETED|Overall Study||471
8604440|NCT00598832|21216228|P2|STARTED|Overall Study||542
8604441|NCT00598832|21216229|P1|STARTED|Overall Study||533
8604450|NCT00560703|21216260|P2|NOT COMPLETED|Overall Study||6
8604451|NCT00560703|21216261|P1|NOT COMPLETED|Overall Study||0
8604452|NCT00560703|21216260|P2|COMPLETED|Overall Study||18
8604453|NCT00560703|21216261|P1|COMPLETED|Overall Study||46
8604454|NCT00560703|21216260|P2|STARTED|Overall Study||24
8604455|NCT00560703|21216261|P1|STARTED|Overall Study||46
8604472|NCT00468650|21216342|P1|NOT COMPLETED|Overall Study||7
8604473|NCT00468650|21216342|P1|COMPLETED|Overall Study||110
8604474|NCT00468650|21216342|P1|STARTED|Overall Study||117
8604499|NCT00438399|21216534|P6|NOT COMPLETED|Overall Study||6
8604500|NCT00438399|21216535|P5|NOT COMPLETED|Overall Study||3
8604501|NCT00438399|21216536|P4|NOT COMPLETED|Overall Study||4
8604502|NCT00438399|21216537|P3|NOT COMPLETED|Overall Study||7
8604503|NCT00438399|21216538|P2|NOT COMPLETED|Overall Study||8
8604504|NCT00438399|21216539|P1|NOT COMPLETED|Overall Study||8
8604505|NCT00438399|21216534|P6|COMPLETED|Overall Study||31
8604506|NCT00438399|21216535|P5|COMPLETED|Overall Study||30
8604507|NCT00438399|21216536|P4|COMPLETED|Overall Study||32
8604508|NCT00438399|21216537|P3|COMPLETED|Overall Study||28
8604509|NCT00438399|21216538|P2|COMPLETED|Overall Study||32
8604510|NCT00438399|21216539|P1|COMPLETED|Overall Study||30
8604511|NCT00438399|21216534|P6|TREATED & ANALYZED|Overall Study||31
8604512|NCT00438399|21216535|P5|TREATED & ANALYZED|Overall Study||30
8604513|NCT00438399|21216536|P4|TREATED & ANALYZED|Overall Study||32
8604514|NCT00438399|21216537|P3|TREATED & ANALYZED|Overall Study||28
8604515|NCT00438399|21216538|P2|TREATED & ANALYZED|Overall Study||32
8604516|NCT00438399|21216539|P1|TREATED & ANALYZED|Overall Study||30
8604517|NCT00438399|21216534|P6|STARTED|Overall Study||37
8604518|NCT00438399|21216535|P5|STARTED|Overall Study||33
8604519|NCT00438399|21216536|P4|STARTED|Overall Study||36
8604520|NCT00438399|21216537|P3|STARTED|Overall Study||35
8604521|NCT00438399|21216538|P2|STARTED|Overall Study||40
8604522|NCT00438399|21216539|P1|STARTED|Overall Study||38
8604523|NCT00421993|21216552|P4|NOT COMPLETED|Overall Study||57
8604524|NCT00421993|21216553|P3|NOT COMPLETED|Overall Study||52
8604525|NCT00421993|21216554|P2|NOT COMPLETED|Overall Study||49
8604526|NCT00421993|21216555|P1|NOT COMPLETED|Overall Study||53
8604527|NCT00421993|21216552|P4|COMPLETED|Overall Study||361
8604528|NCT00421993|21216553|P3|COMPLETED|Overall Study||363
8604529|NCT00421993|21216554|P2|COMPLETED|Overall Study||369
8604530|NCT00421993|21216555|P1|COMPLETED|Overall Study||366
8604531|NCT00421993|21216552|P4|STARTED|Overall Study||418
8604532|NCT00421993|21216553|P3|STARTED|Overall Study||415
8604533|NCT00421993|21216554|P2|STARTED|Overall Study||418
8604534|NCT00421993|21216555|P1|STARTED|Overall Study||419
8604535|NCT00419666|21216585|P1|NOT COMPLETED|Overall Study||0
8604536|NCT00419666|21216585|P1|COMPLETED|Overall Study||25
8604537|NCT00419666|21216585|P1|STARTED|Overall Study||25
8604552|NCT00335738|21216624|P2|NOT COMPLETED|Overall Study||4
8604553|NCT00335738|21216625|P1|NOT COMPLETED|Overall Study||11
8604554|NCT00335738|21216624|P2|COMPLETED|Overall Study||219
8604555|NCT00335738|21216625|P1|COMPLETED|Overall Study||97
8604556|NCT00335738|21216624|P2|STARTED|Overall Study||223
8604557|NCT00335738|21216625|P1|STARTED|Overall Study||108
8604582|NCT00244933|21216677|P1|NOT COMPLETED|Overall Study||2
8604583|NCT00244933|21216677|P1|COMPLETED|Overall Study||17
8604584|NCT00244933|21216677|P1|STARTED|Overall Study||19
8604585|NCT00159913|21216685|P4|NOT COMPLETED|Overall Study||2
8604586|NCT00159913|21216686|P3|NOT COMPLETED|Overall Study||2
8604587|NCT00159913|21216687|P2|NOT COMPLETED|Overall Study||0
8604588|NCT00159913|21216688|P1|NOT COMPLETED|Overall Study||2
8604589|NCT00159913|21216685|P4|COMPLETED|Overall Study||58
8604590|NCT00159913|21216686|P3|COMPLETED|Overall Study||75
8604591|NCT00159913|21216687|P2|COMPLETED|Overall Study||55
8604592|NCT00159913|21216688|P1|COMPLETED|Overall Study||40
8604593|NCT00159913|21216685|P4|STARTED|Overall Study||60
8604594|NCT00159913|21216686|P3|STARTED|Overall Study||77
8604595|NCT00159913|21216687|P2|STARTED|Overall Study||55
8604596|NCT00159913|21216688|P1|STARTED|Overall Study||42
8607535|NCT04419311|21226732|P2|NOT COMPLETED|Overall Study||0
8607536|NCT04419311|21226733|P1|NOT COMPLETED|Overall Study||1
8607537|NCT04419311|21226732|P2|COMPLETED|Overall Study||33
8607538|NCT04419311|21226733|P1|COMPLETED|Overall Study||32
8607539|NCT04419311|21226732|P2|STARTED|Overall Study||33
8607540|NCT04419311|21226733|P1|STARTED|Overall Study||33
8607562|NCT04155567|21226849|P1|NOT COMPLETED|Overall Study||0
8607563|NCT04155567|21226849|P1|COMPLETED|Overall Study||10
8607564|NCT04155567|21226849|P1|STARTED|Overall Study||10
8607609|NCT03920865|21227014|P3|NOT COMPLETED|Overall Study||0
8607610|NCT03920865|21227015|P2|NOT COMPLETED|Overall Study||0
8607611|NCT03920865|21227016|P1|NOT COMPLETED|Overall Study||0
8607612|NCT03920865|21227014|P3|COMPLETED|Overall Study||10
8607613|NCT03920865|21227015|P2|COMPLETED|Overall Study||8
8607614|NCT03920865|21227016|P1|COMPLETED|Overall Study||8
8607615|NCT03920865|21227014|P3|STARTED|Overall Study||10
8607616|NCT03920865|21227015|P2|STARTED|Overall Study||8
8607617|NCT03920865|21227016|P1|STARTED|Overall Study||8
8607624|NCT03835975|21227127|P5|NOT COMPLETED|Overall Study||0
8607625|NCT03835975|21227128|P4|NOT COMPLETED|Overall Study||1
8607626|NCT03835975|21227129|P3|NOT COMPLETED|Overall Study||3
8607627|NCT03835975|21227130|P2|NOT COMPLETED|Overall Study||3
8607628|NCT03835975|21227131|P1|NOT COMPLETED|Overall Study||3
8607629|NCT03835975|21227127|P5|COMPLETED|Overall Study||125
8607630|NCT03835975|21227128|P4|COMPLETED|Overall Study||126
8607631|NCT03835975|21227129|P3|COMPLETED|Overall Study||245
8607632|NCT03835975|21227130|P2|COMPLETED|Overall Study||119
8607633|NCT03835975|21227131|P1|COMPLETED|Overall Study||250
8607634|NCT03835975|21227127|P5|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
8607635|NCT03835975|21227128|P4|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
8607636|NCT03835975|21227129|P3|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
8607637|NCT03835975|21227130|P2|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
8607638|NCT03835975|21227131|P1|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
8607639|NCT03835975|21227127|P5|Safety Population|Overall Study||125
8607640|NCT03835975|21227128|P4|Safety Population|Overall Study||127
8607641|NCT03835975|21227129|P3|Safety Population|Overall Study||246
8607642|NCT03835975|21227130|P2|Safety Population|Overall Study||122
8607643|NCT03835975|21227131|P1|Safety Population|Overall Study||253
8607644|NCT03835975|21227127|P5|Vaccinated|Overall Study||125
8607645|NCT03835975|21227128|P4|Vaccinated|Overall Study||127
8607646|NCT03835975|21227129|P3|Vaccinated|Overall Study||246
8607647|NCT03835975|21227130|P2|Vaccinated|Overall Study||122
8607648|NCT03835975|21227131|P1|Vaccinated|Overall Study||253
8607649|NCT03835975|21227127|P5|STARTED|Overall Study||125
8607650|NCT03835975|21227128|P4|STARTED|Overall Study||127
8607651|NCT03835975|21227129|P3|STARTED|Overall Study||248
8607652|NCT03835975|21227130|P2|STARTED|Overall Study||122
8607653|NCT03835975|21227131|P1|STARTED|Overall Study||253
8607663|NCT03819218|21227209|P1|NOT COMPLETED|Overall Study||1
8607664|NCT03819218|21227209|P1|COMPLETED|Overall Study||6
8607665|NCT03819218|21227209|P1|STARTED|Overall Study||7
8607705|NCT03805386|21227294|P2|NOT COMPLETED|Overall Study||0
8607706|NCT03805386|21227295|P1|NOT COMPLETED|Overall Study||0
8607707|NCT03805386|21227294|P2|COMPLETED|Overall Study||33
8607708|NCT03805386|21227295|P1|COMPLETED|Overall Study||32
8607709|NCT03805386|21227294|P2|STARTED|Overall Study||33
8607710|NCT03805386|21227295|P1|STARTED|Overall Study||32
8607729|NCT03712189|21227369|P2|NOT COMPLETED|Overall Study||0
8607730|NCT03712189|21227370|P1|NOT COMPLETED|Overall Study||0
8607731|NCT03712189|21227369|P2|COMPLETED|Overall Study||15
8607732|NCT03712189|21227370|P1|COMPLETED|Overall Study||15
8607733|NCT03712189|21227369|P2|STARTED|Overall Study||15
8607734|NCT03712189|21227370|P1|STARTED|Overall Study||15
8607735|NCT03663283|21227382|P2|NOT COMPLETED|Overall Study||0
8607736|NCT03663283|21227383|P1|NOT COMPLETED|Overall Study||0
8607737|NCT03663283|21227382|P2|COMPLETED|Overall Study||52
8607738|NCT03663283|21227383|P1|COMPLETED|Overall Study||52
8607739|NCT03663283|21227382|P2|STARTED|Overall Study||52
8607740|NCT03663283|21227383|P1|STARTED|Overall Study||52
8607741|NCT03645785|21227395|P1|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
8607742|NCT03645785|21227395|P1|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
8607743|NCT03645785|21227395|P1|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
8607744|NCT03645785|21227395|P1|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
8607745|NCT03645785|21227395|P1|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
8607746|NCT03645785|21227395|P1|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
8607747|NCT03638622|21227435|P1|NOT COMPLETED|Overall Study||1
8607748|NCT03638622|21227435|P1|COMPLETED|Overall Study||29
8607749|NCT03638622|21227435|P1|STARTED|Overall Study||30
8607756|NCT03617913|21227452|P1|NOT COMPLETED|Overall Study||0
8607757|NCT03617913|21227452|P1|COMPLETED|Overall Study||2
8607758|NCT03617913|21227452|P1|STARTED|Overall Study||2
8607784|NCT03542305|21227502|P4|NOT COMPLETED|Overall Study||0
8607785|NCT03542305|21227503|P3|NOT COMPLETED|Overall Study||0
8607786|NCT03542305|21227504|P2|NOT COMPLETED|Overall Study||0
8607787|NCT03542305|21227505|P1|NOT COMPLETED|Overall Study||0
8607788|NCT03542305|21227502|P4|COMPLETED|Overall Study||5
8607789|NCT03542305|21227503|P3|COMPLETED|Overall Study||8
8607790|NCT03542305|21227504|P2|COMPLETED|Overall Study||8
8607791|NCT03542305|21227505|P1|COMPLETED|Overall Study||8
8607792|NCT03542305|21227502|P4|STARTED|Overall Study||5
8607793|NCT03542305|21227503|P3|STARTED|Overall Study||8
8607794|NCT03542305|21227504|P2|STARTED|Overall Study||8
8607795|NCT03542305|21227505|P1|STARTED|Overall Study||8
8607796|NCT03490942|21227562|P3|NOT COMPLETED|Overall Study||7
8607797|NCT03490942|21227563|P2|NOT COMPLETED|Overall Study||10
8607798|NCT03490942|21227564|P1|NOT COMPLETED|Overall Study||10
8607799|NCT03490942|21227562|P3|COMPLETED|Overall Study||9
8607800|NCT03490942|21227563|P2|COMPLETED|Overall Study||8
8607801|NCT03490942|21227564|P1|COMPLETED|Overall Study||5
8607802|NCT03490942|21227562|P3|STARTED|Overall Study||16
8607803|NCT03490942|21227563|P2|STARTED|Overall Study||18
8607804|NCT03490942|21227564|P1|STARTED|Overall Study||15
8607828|NCT03400852|21227618|P3|NOT COMPLETED|Open Label Period||22
8607829|NCT03400852|21227619|P2|NOT COMPLETED|Open Label Period||0
8607830|NCT03400852|21227620|P1|NOT COMPLETED|Open Label Period||0
8607831|NCT03400852|21227618|P3|COMPLETED|Open Label Period||2
8607832|NCT03400852|21227619|P2|COMPLETED|Open Label Period||0
8607833|NCT03400852|21227620|P1|COMPLETED|Open Label Period||0
8607834|NCT03400852|21227618|P3|STARTED|Open Label Period||24
8607835|NCT03400852|21227619|P2|STARTED|Open Label Period||0
8607836|NCT03400852|21227620|P1|STARTED|Open Label Period||0
8607837|NCT03400852|21227618|P3|NOT COMPLETED|Blinded Treatment Period||0
8607838|NCT03400852|21227619|P2|NOT COMPLETED|Blinded Treatment Period||6
8607839|NCT03400852|21227620|P1|NOT COMPLETED|Blinded Treatment Period||9
8607840|NCT03400852|21227618|P3|COMPLETED|Blinded Treatment Period||0
8607841|NCT03400852|21227619|P2|COMPLETED|Blinded Treatment Period||9
8607842|NCT03400852|21227620|P1|COMPLETED|Blinded Treatment Period||20
8607843|NCT03400852|21227618|P3|STARTED|Blinded Treatment Period||0
8607844|NCT03400852|21227619|P2|STARTED|Blinded Treatment Period||15
8607845|NCT03400852|21227620|P1|STARTED|Blinded Treatment Period||29
8607846|NCT03390114|21227642|P2|NOT COMPLETED|Overall Study||2
8607847|NCT03390114|21227643|P1|NOT COMPLETED|Overall Study||4
8607848|NCT03390114|21227642|P2|COMPLETED|Overall Study||8
8607849|NCT03390114|21227643|P1|COMPLETED|Overall Study||6
8607850|NCT03390114|21227642|P2|STARTED|Overall Study||10
8607851|NCT03390114|21227643|P1|STARTED|Overall Study||10
8607856|NCT03359590|21227660|P2|NOT COMPLETED|Second Intervention||0
8607857|NCT03359590|21227661|P1|NOT COMPLETED|Second Intervention||0
8607858|NCT03359590|21227660|P2|COMPLETED|Second Intervention||8
8607859|NCT03359590|21227661|P1|COMPLETED|Second Intervention||9
8607860|NCT03359590|21227660|P2|Discontinued|Second Intervention||0
8607861|NCT03359590|21227661|P1|Discontinued|Second Intervention||0
8607862|NCT03359590|21227660|P2|Exposed|Second Intervention||8
8607863|NCT03359590|21227661|P1|Exposed|Second Intervention||9
8607864|NCT03359590|21227660|P2|STARTED|Second Intervention||8
8607865|NCT03359590|21227661|P1|STARTED|Second Intervention||9
8607866|NCT03359590|21227660|P2|NOT COMPLETED|First Intervention||2
8607867|NCT03359590|21227661|P1|NOT COMPLETED|First Intervention||1
8607868|NCT03359590|21227660|P2|COMPLETED|First Intervention||8
8607869|NCT03359590|21227661|P1|COMPLETED|First Intervention||9
8607870|NCT03359590|21227660|P2|Discontinued|First Intervention||2
8607871|NCT03359590|21227661|P1|Discontinued|First Intervention||1
8607872|NCT03359590|21227660|P2|Exposed|First Intervention||10
8607873|NCT03359590|21227661|P1|Exposed|First Intervention||9
8607874|NCT03359590|21227660|P2|STARTED|First Intervention||10
8607875|NCT03359590|21227661|P1|STARTED|First Intervention||10
8607910|NCT03308097|21227781|P2|NOT COMPLETED|Overall Study||1
8607911|NCT03308097|21227782|P1|NOT COMPLETED|Overall Study||2
8607912|NCT03308097|21227781|P2|COMPLETED|Overall Study||31
8607913|NCT03308097|21227782|P1|COMPLETED|Overall Study||31
8607914|NCT03308097|21227781|P2|STARTED|Overall Study||32
8607915|NCT03308097|21227782|P1|STARTED|Overall Study||33
8607916|NCT03303469|21227806|P1|NOT COMPLETED|Overall Study||2
8607917|NCT03303469|21227806|P1|COMPLETED|Overall Study||1
8607918|NCT03303469|21227806|P1|STARTED|Overall Study||3
8607919|NCT03300570|21227814|P2|NOT COMPLETED|Overall Study||1
8607920|NCT03300570|21227815|P1|NOT COMPLETED|Overall Study||2
8607921|NCT03300570|21227814|P2|COMPLETED|Overall Study||13
8607922|NCT03300570|21227815|P1|COMPLETED|Overall Study||11
8607923|NCT03300570|21227814|P2|STARTED|Overall Study||14
8607924|NCT03300570|21227815|P1|STARTED|Overall Study||13
8607925|NCT03300050|21227830|P5|NOT COMPLETED|Overall Study||1
8607926|NCT03300050|21227831|P4|NOT COMPLETED|Overall Study||1
8607927|NCT03300050|21227832|P3|NOT COMPLETED|Overall Study||3
8607928|NCT03300050|21227833|P2|NOT COMPLETED|Overall Study||2
8607929|NCT03300050|21227834|P1|NOT COMPLETED|Overall Study||3
8607930|NCT03300050|21227830|P5|COMPLETED|Overall Study||9
8607931|NCT03300050|21227831|P4|COMPLETED|Overall Study||15
8607932|NCT03300050|21227832|P3|COMPLETED|Overall Study||2
8607933|NCT03300050|21227833|P2|COMPLETED|Overall Study||13
8607934|NCT03300050|21227834|P1|COMPLETED|Overall Study||17
8607935|NCT03300050|21227830|P5|Received All Scheduled Treatments|Overall Study||10
8607936|NCT03300050|21227831|P4|Received All Scheduled Treatments|Overall Study||15
8607937|NCT03300050|21227832|P3|Received All Scheduled Treatments|Overall Study||2
8607938|NCT03300050|21227833|P2|Received All Scheduled Treatments|Overall Study||13
8607939|NCT03300050|21227834|P1|Received All Scheduled Treatments|Overall Study||16
8607940|NCT03300050|21227830|P5|Received Treatment|Overall Study||10
8607941|NCT03300050|21227831|P4|Received Treatment|Overall Study||15
8607942|NCT03300050|21227832|P3|Received Treatment|Overall Study||3
8607943|NCT03300050|21227833|P2|Received Treatment|Overall Study||14
8607944|NCT03300050|21227834|P1|Received Treatment|Overall Study||19
8607945|NCT03300050|21227830|P5|STARTED|Overall Study||10
8607946|NCT03300050|21227831|P4|STARTED|Overall Study||16
8607947|NCT03300050|21227832|P3|STARTED|Overall Study||5
8607948|NCT03300050|21227833|P2|STARTED|Overall Study||15
8607949|NCT03300050|21227834|P1|STARTED|Overall Study||20
8607960|NCT03263780|21228244|P1|NOT COMPLETED|Overall Study||10
8607961|NCT03263780|21228244|P1|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
8607962|NCT03263780|21228244|P1|STARTED|Overall Study||21
8607981|NCT03205566|21228283|P2|NOT COMPLETED|Phase 2||0
8607982|NCT03205566|21228284|P1|NOT COMPLETED|Phase 2||0
8607983|NCT03205566|21228283|P2|COMPLETED|Phase 2||18
8607984|NCT03205566|21228284|P1|COMPLETED|Phase 2||18
8607985|NCT03205566|21228283|P2|STARTED|Phase 2||18
8607986|NCT03205566|21228284|P1|STARTED|Phase 2||18
8607987|NCT03205566|21228283|P2|NOT COMPLETED|Phase 1||1
8607988|NCT03205566|21228284|P1|NOT COMPLETED|Phase 1||1
8607989|NCT03205566|21228283|P2|COMPLETED|Phase 1||18
8607990|NCT03205566|21228284|P1|COMPLETED|Phase 1||18
8607991|NCT03205566|21228283|P2|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
8607992|NCT03205566|21228284|P1|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
8607999|NCT03170661|21228318|P2|NOT COMPLETED|Overall Study||0
8608000|NCT03170661|21228319|P1|NOT COMPLETED|Overall Study||0
8608001|NCT03170661|21228318|P2|COMPLETED|Overall Study||49
8608002|NCT03170661|21228319|P1|COMPLETED|Overall Study||49
8608003|NCT03170661|21228318|P2|STARTED|Overall Study||49
8608004|NCT03170661|21228319|P1|STARTED|Overall Study||49
8608005|NCT03164538|21228337|P2|NOT COMPLETED|Overall Study||6
8608006|NCT03164538|21228338|P1|NOT COMPLETED|Overall Study||7
8608007|NCT03164538|21228337|P2|COMPLETED|Overall Study||29
8608008|NCT03164538|21228338|P1|COMPLETED|Overall Study||28
8608009|NCT03164538|21228337|P2|STARTED|Overall Study||35
8608010|NCT03164538|21228338|P1|STARTED|Overall Study||35
8608028|NCT03146663|21228435|P2|NOT COMPLETED|Overall Study||1
8608029|NCT03146663|21228436|P1|NOT COMPLETED|Overall Study||1
8608030|NCT03146663|21228435|P2|COMPLETED|Overall Study||27
8608031|NCT03146663|21228436|P1|COMPLETED|Overall Study||24
8608032|NCT03146663|21228435|P2|STARTED|Overall Study||28
8608033|NCT03146663|21228436|P1|STARTED|Overall Study||25
8608034|NCT03145766|21228449|P5|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
8608035|NCT03145766|21228450|P4|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
8608036|NCT03145766|21228451|P3|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
8608037|NCT03145766|21228452|P2|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
8608038|NCT03145766|21228453|P1|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
8608039|NCT03145766|21228449|P5|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
8608040|NCT03145766|21228450|P4|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
8608041|NCT03145766|21228451|P3|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
8608042|NCT03145766|21228452|P2|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
8608043|NCT03145766|21228453|P1|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
8608044|NCT03145766|21228449|P5|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
8608045|NCT03145766|21228450|P4|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
8608046|NCT03145766|21228451|P3|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
8608047|NCT03145766|21228452|P2|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
8608048|NCT03145766|21228453|P1|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
8608049|NCT03145766|21228449|P5|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
8608050|NCT03145766|21228450|P4|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
8608051|NCT03145766|21228451|P3|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
8608052|NCT03145766|21228452|P2|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
8608053|NCT03145766|21228453|P1|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
8608054|NCT03145766|21228449|P5|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
8608055|NCT03145766|21228450|P4|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
8608056|NCT03145766|21228451|P3|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
8608057|NCT03145766|21228452|P2|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
8608058|NCT03145766|21228453|P1|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
8608059|NCT03145766|21228449|P5|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
8608060|NCT03145766|21228450|P4|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
8608061|NCT03145766|21228451|P3|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
8608062|NCT03145766|21228452|P2|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
8608063|NCT03145766|21228453|P1|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
8608064|NCT03145766|21228449|P5|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
8608065|NCT03145766|21228450|P4|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
8608066|NCT03145766|21228451|P3|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
8608067|NCT03145766|21228452|P2|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
8608068|NCT03145766|21228453|P1|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
8608069|NCT03145766|21228449|P5|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
8608070|NCT03145766|21228450|P4|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
8608071|NCT03145766|21228451|P3|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
8608072|NCT03145766|21228452|P2|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
8608073|NCT03145766|21228453|P1|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
8608074|NCT03145766|21228449|P5|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
8608075|NCT03145766|21228450|P4|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
8608076|NCT03145766|21228451|P3|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
8608077|NCT03145766|21228452|P2|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
8608078|NCT03145766|21228453|P1|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
8608079|NCT03145766|21228449|P5|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
8608080|NCT03145766|21228450|P4|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
8608081|NCT03145766|21228451|P3|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
8608082|NCT03145766|21228452|P2|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
8608083|NCT03145766|21228453|P1|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
8608084|NCT03145766|21228449|P5|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
8608085|NCT03145766|21228450|P4|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
8608086|NCT03145766|21228451|P3|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
8608087|NCT03145766|21228452|P2|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
8608088|NCT03145766|21228453|P1|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
8608089|NCT03140722|21228582|P2|NOT COMPLETED|Overall Study||0
8608090|NCT03140722|21228583|P1|NOT COMPLETED|Overall Study||0
8608091|NCT03140722|21228582|P2|COMPLETED|Overall Study||2
8608092|NCT03140722|21228583|P1|COMPLETED|Overall Study||0
8608093|NCT03140722|21228582|P2|STARTED|Overall Study||2
8608094|NCT03140722|21228583|P1|STARTED|Overall Study||0
8608095|NCT03137693|21228607|P1|NOT COMPLETED|Overall Study||0
8608096|NCT03137693|21228607|P1|COMPLETED|Overall Study||20
8608097|NCT03137693|21228607|P1|STARTED|Overall Study||20
8608098|NCT03135210|21228613|P2|NOT COMPLETED|Overall Study||1
8608099|NCT03135210|21228614|P1|NOT COMPLETED|Overall Study||0
8608100|NCT03135210|21228613|P2|COMPLETED|Overall Study||1
8608101|NCT03135210|21228614|P1|COMPLETED|Overall Study||2
8608102|NCT03135210|21228613|P2|STARTED|Overall Study||2
8608103|NCT03135210|21228614|P1|STARTED|Overall Study||2
8608104|NCT03087851|21228623|P3|NOT COMPLETED|Overall Study||2
8608105|NCT03087851|21228624|P2|NOT COMPLETED|Overall Study||1
8608106|NCT03087851|21228625|P1|NOT COMPLETED|Overall Study||0
8608107|NCT03087851|21228623|P3|COMPLETED|Overall Study||19
8608108|NCT03087851|21228624|P2|COMPLETED|Overall Study||19
8608109|NCT03087851|21228625|P1|COMPLETED|Overall Study||20
8608110|NCT03087851|21228623|P3|STARTED|Overall Study||21
8608111|NCT03087851|21228624|P2|STARTED|Overall Study||20
8608112|NCT03087851|21228625|P1|STARTED|Overall Study||20
8608165|NCT02980705|21228832|P2|NOT COMPLETED|Overall Study||11
8608166|NCT02980705|21228833|P1|NOT COMPLETED|Overall Study||8
8608167|NCT02980705|21228832|P2|COMPLETED|Overall Study||40
8608168|NCT02980705|21228833|P1|COMPLETED|Overall Study||42
8608169|NCT02980705|21228832|P2|STARTED|Overall Study||51
8608170|NCT02980705|21228833|P1|STARTED|Overall Study||50
8608171|NCT02975700|21228842|P1|NOT COMPLETED|Overall Study||6
8608172|NCT02975700|21228842|P1|COMPLETED|Overall Study||0
8608173|NCT02975700|21228842|P1|STARTED|Overall Study||6
8608233|NCT02937116|21228998|P12|NOT COMPLETED|Overall Study||7
8608234|NCT02937116|21228999|P11|NOT COMPLETED|Overall Study||7
8608235|NCT02937116|21229000|P10|NOT COMPLETED|Overall Study||20
8608236|NCT02937116|21229001|P9|NOT COMPLETED|Overall Study||20
8608237|NCT02937116|21229002|P8|NOT COMPLETED|Overall Study||21
8608238|NCT02937116|21229003|P7|NOT COMPLETED|Overall Study||37
8608239|NCT02937116|21229004|P6|NOT COMPLETED|Overall Study||87
8608240|NCT02937116|21229005|P5|NOT COMPLETED|Overall Study||22
8608241|NCT02937116|21229006|P4|NOT COMPLETED|Overall Study||3
8608242|NCT02937116|21229007|P3|NOT COMPLETED|Overall Study||3
8608243|NCT02937116|21229008|P2|NOT COMPLETED|Overall Study||3
8608244|NCT02937116|21229009|P1|NOT COMPLETED|Overall Study||3
8608245|NCT02937116|21228998|P12|COMPLETED|Overall Study||0
8608246|NCT02937116|21228999|P11|COMPLETED|Overall Study||0
8608247|NCT02937116|21229000|P10|COMPLETED|Overall Study||0
8608248|NCT02937116|21229001|P9|COMPLETED|Overall Study||0
8608249|NCT02937116|21229002|P8|COMPLETED|Overall Study||0
8608250|NCT02937116|21229003|P7|COMPLETED|Overall Study||0
8608251|NCT02937116|21229004|P6|COMPLETED|Overall Study||0
8608252|NCT02937116|21229005|P5|COMPLETED|Overall Study||0
8608253|NCT02937116|21229006|P4|COMPLETED|Overall Study||0
8608254|NCT02937116|21229007|P3|COMPLETED|Overall Study||0
8608255|NCT02937116|21229008|P2|COMPLETED|Overall Study||0
8608256|NCT02937116|21229009|P1|COMPLETED|Overall Study||0
8608257|NCT02937116|21228998|P12|STARTED|Overall Study||7
8608258|NCT02937116|21228999|P11|STARTED|Overall Study||7
8608259|NCT02937116|21229000|P10|STARTED|Overall Study||20
8608260|NCT02937116|21229001|P9|STARTED|Overall Study||20
8608261|NCT02937116|21229002|P8|STARTED|Overall Study||21
8608262|NCT02937116|21229003|P7|STARTED|Overall Study||37
8608263|NCT02937116|21229004|P6|STARTED|Overall Study||87
8608264|NCT02937116|21229005|P5|STARTED|Overall Study||22
8608265|NCT02937116|21229006|P4|STARTED|Overall Study||3
8608266|NCT02937116|21229007|P3|STARTED|Overall Study||3
8608267|NCT02937116|21229008|P2|STARTED|Overall Study||3
8608268|NCT02937116|21229009|P1|STARTED|Overall Study||3
8608346|NCT02799667|21229343|P2|NOT COMPLETED|Overall Study||1
8608347|NCT02799667|21229344|P1|NOT COMPLETED|Overall Study||1
8608348|NCT02799667|21229343|P2|COMPLETED|Overall Study||54
8608349|NCT02799667|21229344|P1|COMPLETED|Overall Study||54
8608350|NCT02799667|21229343|P2|STARTED|Overall Study||55
8608351|NCT02799667|21229344|P1|STARTED|Overall Study||55
8608376|NCT02734433|21229433|P2|NOT COMPLETED|Overall Study||8
8608377|NCT02734433|21229434|P1|NOT COMPLETED|Overall Study||2
8608378|NCT02734433|21229433|P2|COMPLETED|Overall Study||0
8608379|NCT02734433|21229434|P1|COMPLETED|Overall Study||1
8608380|NCT02734433|21229433|P2|STARTED|Overall Study||8
8608381|NCT02734433|21229434|P1|STARTED|Overall Study||3
8608382|NCT02731729|21229468|P2|NOT COMPLETED|Overall Study||8
8608383|NCT02731729|21229469|P1|NOT COMPLETED|Overall Study||9
8608384|NCT02731729|21229468|P2|COMPLETED|Overall Study||2
8608385|NCT02731729|21229469|P1|COMPLETED|Overall Study||1
8608386|NCT02731729|21229468|P2|STARTED|Overall Study||10
8608387|NCT02731729|21229469|P1|STARTED|Overall Study||10
8608391|NCT02724020|21229495|P3|NOT COMPLETED|Overall Study||32
8608392|NCT02724020|21229496|P2|NOT COMPLETED|Overall Study||32
8608393|NCT02724020|21229497|P1|NOT COMPLETED|Overall Study||32
8608394|NCT02724020|21229495|P3|COMPLETED|Overall Study||0
8608395|NCT02724020|21229496|P2|COMPLETED|Overall Study||0
8608396|NCT02724020|21229497|P1|COMPLETED|Overall Study||0
8608397|NCT02724020|21229495|P3|Treated (Safety Analysis Set)|Overall Study||31
8608398|NCT02724020|21229496|P2|Treated (Safety Analysis Set)|Overall Study||32
8608399|NCT02724020|21229497|P1|Treated (Safety Analysis Set)|Overall Study||32
8608400|NCT02724020|21229495|P3|STARTED|Overall Study||32
8608401|NCT02724020|21229496|P2|STARTED|Overall Study||32
8608402|NCT02724020|21229497|P1|STARTED|Overall Study||32
8608403|NCT02699749|21229537|P14|NOT COMPLETED|Overall Study||6
8608404|NCT02699749|21229538|P13|NOT COMPLETED|Overall Study||3
8608405|NCT02699749|21229539|P12|NOT COMPLETED|Overall Study||4
8608406|NCT02699749|21229540|P11|NOT COMPLETED|Overall Study||6
8608407|NCT02699749|21229541|P10|NOT COMPLETED|Overall Study||6
8608408|NCT02699749|21229542|P9|NOT COMPLETED|Overall Study||6
8608409|NCT02699749|21229543|P8|NOT COMPLETED|Overall Study||6
8608410|NCT02699749|21229544|P7|NOT COMPLETED|Overall Study||6
8608411|NCT02699749|21229545|P6|NOT COMPLETED|Overall Study||9
8608412|NCT02699749|21229546|P5|NOT COMPLETED|Overall Study||3
8608413|NCT02699749|21229547|P4|NOT COMPLETED|Overall Study||3
8608414|NCT02699749|21229548|P3|NOT COMPLETED|Overall Study||16
8608415|NCT02699749|21229549|P2|NOT COMPLETED|Overall Study||3
8608416|NCT02699749|21229550|P1|NOT COMPLETED|Overall Study||3
8608417|NCT02699749|21229537|P14|COMPLETED|Overall Study||0
8608418|NCT02699749|21229538|P13|COMPLETED|Overall Study||0
8608419|NCT02699749|21229539|P12|COMPLETED|Overall Study||0
8608420|NCT02699749|21229540|P11|COMPLETED|Overall Study||0
8608421|NCT02699749|21229541|P10|COMPLETED|Overall Study||0
8608422|NCT02699749|21229542|P9|COMPLETED|Overall Study||0
8608423|NCT02699749|21229543|P8|COMPLETED|Overall Study||0
8608424|NCT02699749|21229544|P7|COMPLETED|Overall Study||0
8608425|NCT02699749|21229545|P6|COMPLETED|Overall Study||0
8608426|NCT02699749|21229546|P5|COMPLETED|Overall Study||0
8608427|NCT02699749|21229547|P4|COMPLETED|Overall Study||0
8608428|NCT02699749|21229548|P3|COMPLETED|Overall Study||0
8608429|NCT02699749|21229549|P2|COMPLETED|Overall Study||0
8608430|NCT02699749|21229550|P1|COMPLETED|Overall Study||0
8608431|NCT02699749|21229537|P14|STARTED|Overall Study||6
8608432|NCT02699749|21229538|P13|STARTED|Overall Study||3
8608433|NCT02699749|21229539|P12|STARTED|Overall Study||4
8608434|NCT02699749|21229540|P11|STARTED|Overall Study||6
8608435|NCT02699749|21229541|P10|STARTED|Overall Study||6
8608436|NCT02699749|21229542|P9|STARTED|Overall Study||6
8608437|NCT02699749|21229543|P8|STARTED|Overall Study||6
8608438|NCT02699749|21229544|P7|STARTED|Overall Study||6
8608439|NCT02699749|21229545|P6|STARTED|Overall Study||9
8608440|NCT02699749|21229546|P5|STARTED|Overall Study||3
8608441|NCT02699749|21229547|P4|STARTED|Overall Study||3
8608442|NCT02699749|21229548|P3|STARTED|Overall Study||16
8608443|NCT02699749|21229549|P2|STARTED|Overall Study||3
8608444|NCT02699749|21229550|P1|STARTED|Overall Study||3
8608445|NCT02679560|21229786|P2|NOT COMPLETED|Overall Study||0
8608446|NCT02679560|21229787|P1|NOT COMPLETED|Overall Study||0
8608447|NCT02679560|21229786|P2|COMPLETED|Overall Study||2
8608448|NCT02679560|21229787|P1|COMPLETED|Overall Study||1
8608449|NCT02679560|21229786|P2|STARTED|Overall Study||2
8608450|NCT02679560|21229787|P1|STARTED|Overall Study||1
8608469|NCT02667392|21230025|P1|NOT COMPLETED|Overall Study||0
8608470|NCT02667392|21230025|P1|COMPLETED|Overall Study||11
8608471|NCT02667392|21230025|P1|STARTED|Overall Study||11
8608592|NCT02565615|21230227|P5|NOT COMPLETED|Overall Study||1601
8608593|NCT02565615|21230228|P4|NOT COMPLETED|Overall Study||3
8608594|NCT02565615|21230229|P3|NOT COMPLETED|Overall Study||0
8608595|NCT02565615|21230230|P2|NOT COMPLETED|Overall Study||36
8608596|NCT02565615|21230231|P1|NOT COMPLETED|Overall Study||3
8608597|NCT02565615|21230227|P5|COMPLETED|Overall Study||21
8608598|NCT02565615|21230228|P4|COMPLETED|Overall Study||98
8608599|NCT02565615|21230229|P3|COMPLETED|Overall Study||21
8608600|NCT02565615|21230230|P2|COMPLETED|Overall Study||3044
8608601|NCT02565615|21230231|P1|COMPLETED|Overall Study||288
8608602|NCT02565615|21230227|P5|Treated|Overall Study||1055
8608603|NCT02565615|21230228|P4|Treated|Overall Study||101
8608604|NCT02565615|21230229|P3|Treated|Overall Study||21
8608605|NCT02565615|21230230|P2|Treated|Overall Study||3080
8608606|NCT02565615|21230231|P1|Treated|Overall Study||291
8608607|NCT02565615|21230227|P5|STARTED|Overall Study||1622
8608608|NCT02565615|21230228|P4|STARTED|Overall Study||101
8608609|NCT02565615|21230229|P3|STARTED|Overall Study||21
8608610|NCT02565615|21230230|P2|STARTED|Overall Study||3080
8608611|NCT02565615|21230231|P1|STARTED|Overall Study||291
8608641|NCT02470091|21230551|P2|NOT COMPLETED|Overall Study||2
8608642|NCT02470091|21230552|P1|NOT COMPLETED|Overall Study||1
8608643|NCT02470091|21230551|P2|COMPLETED|Overall Study||38
8608644|NCT02470091|21230552|P1|COMPLETED|Overall Study||15
8608645|NCT02470091|21230551|P2|Follow-up Report|Overall Study||10
8608646|NCT02470091|21230552|P1|Follow-up Report|Overall Study||1
8608647|NCT02470091|21230551|P2|STARTED|Overall Study||40
8608648|NCT02470091|21230552|P1|STARTED|Overall Study||16
8608759|NCT02324504|21230938|P1|STARTED|Overall Study||60
8608697|NCT02371889|21230800|P2|NOT COMPLETED|Overall Study||14
8608698|NCT02371889|21230801|P1|NOT COMPLETED|Overall Study||19
8608699|NCT02371889|21230800|P2|COMPLETED|Overall Study||71
8608700|NCT02371889|21230801|P1|COMPLETED|Overall Study||66
8608701|NCT02371889|21230800|P2|STARTED|Overall Study||85
8608702|NCT02371889|21230801|P1|STARTED|Overall Study||85
8608703|NCT02352948|21230821|P6|NOT COMPLETED|Overall Study||49
8608704|NCT02352948|21230822|P5|NOT COMPLETED|Overall Study||88
8608705|NCT02352948|21230823|P4|NOT COMPLETED|Overall Study||99
8608706|NCT02352948|21230824|P3|NOT COMPLETED|Overall Study||129
8608707|NCT02352948|21230825|P2|NOT COMPLETED|Overall Study||59
8608708|NCT02352948|21230826|P1|NOT COMPLETED|Overall Study||49
8608709|NCT02352948|21230821|P6|COMPLETED|Overall Study||11
8608710|NCT02352948|21230822|P5|COMPLETED|Overall Study||29
8608711|NCT02352948|21230823|P4|COMPLETED|Overall Study||19
8608712|NCT02352948|21230824|P3|COMPLETED|Overall Study||45
8608713|NCT02352948|21230825|P2|COMPLETED|Overall Study||5
8608714|NCT02352948|21230826|P1|COMPLETED|Overall Study||13
8608715|NCT02352948|21230821|P6|Completed Study Treatment|Overall Study||4
8608716|NCT02352948|21230822|P5|Completed Study Treatment|Overall Study||23
8608717|NCT02352948|21230823|P4|Completed Study Treatment|Overall Study||0
8608718|NCT02352948|21230824|P3|Completed Study Treatment|Overall Study||36
8608719|NCT02352948|21230825|P2|Completed Study Treatment|Overall Study||0
8608720|NCT02352948|21230826|P1|Completed Study Treatment|Overall Study||15
8608721|NCT02352948|21230821|P6|Received Treatment|Overall Study||60
8608722|NCT02352948|21230822|P5|Received Treatment|Overall Study||117
8608723|NCT02352948|21230823|P4|Received Treatment|Overall Study||110
8608724|NCT02352948|21230824|P3|Received Treatment|Overall Study||173
8608725|NCT02352948|21230825|P2|Received Treatment|Overall Study||63
8608726|NCT02352948|21230826|P1|Received Treatment|Overall Study||62
8608727|NCT02352948|21230821|P6|STARTED|Overall Study||60
8608728|NCT02352948|21230822|P5|STARTED|Overall Study||117
8608729|NCT02352948|21230823|P4|STARTED|Overall Study||118
8608730|NCT02352948|21230824|P3|STARTED|Overall Study||174
8608731|NCT02352948|21230825|P2|STARTED|Overall Study||64
8608732|NCT02352948|21230826|P1|STARTED|Overall Study||62
8608733|NCT02348775|21230884|P2|NOT COMPLETED|Overall Study||0
8608734|NCT02348775|21230885|P1|NOT COMPLETED|Overall Study||0
8608735|NCT02348775|21230884|P2|COMPLETED|Overall Study||8
8608736|NCT02348775|21230885|P1|COMPLETED|Overall Study||8
8608737|NCT02348775|21230884|P2|STARTED|Overall Study||8
8608738|NCT02348775|21230885|P1|STARTED|Overall Study||8
8608757|NCT02324504|21230938|P1|NOT COMPLETED|Overall Study||0
8608758|NCT02324504|21230938|P1|COMPLETED|Overall Study||60
8608760|NCT02322814|21230950|P5|NOT COMPLETED|Overall Study||31
8608761|NCT02322814|21230951|P4|NOT COMPLETED|Overall Study||32
8608762|NCT02322814|21230952|P3|NOT COMPLETED|Overall Study||47
8608763|NCT02322814|21230953|P2|NOT COMPLETED|Overall Study||43
8608764|NCT02322814|21230954|P1|NOT COMPLETED|Overall Study||16
8608765|NCT02322814|21230950|P5|COMPLETED|Overall Study||0
8608766|NCT02322814|21230951|P4|COMPLETED|Overall Study||0
8608767|NCT02322814|21230952|P3|COMPLETED|Overall Study||0
8608768|NCT02322814|21230953|P2|COMPLETED|Overall Study||0
8608769|NCT02322814|21230954|P1|COMPLETED|Overall Study||0
8608770|NCT02322814|21230950|P5|STARTED|Overall Study||31
8608771|NCT02322814|21230951|P4|STARTED|Overall Study||32
8608772|NCT02322814|21230952|P3|STARTED|Overall Study||47
8608773|NCT02322814|21230953|P2|STARTED|Overall Study||43
8608774|NCT02322814|21230954|P1|STARTED|Overall Study||16
8608778|NCT02308735|21230974|P4|NOT COMPLETED|Overall Study||2
8608779|NCT02308735|21230975|P3|NOT COMPLETED|Overall Study||0
8608780|NCT02308735|21230976|P2|NOT COMPLETED|Overall Study||0
8608781|NCT02308735|21230977|P1|NOT COMPLETED|Overall Study||2
8608782|NCT02308735|21230974|P4|COMPLETED|Overall Study||0
8608783|NCT02308735|21230975|P3|COMPLETED|Overall Study||0
8608784|NCT02308735|21230976|P2|COMPLETED|Overall Study||0
8608785|NCT02308735|21230977|P1|COMPLETED|Overall Study||0
8608786|NCT02308735|21230974|P4|STARTED|Overall Study||2
8608787|NCT02308735|21230975|P3|STARTED|Overall Study||0
8608788|NCT02308735|21230976|P2|STARTED|Overall Study||0
8608789|NCT02308735|21230977|P1|STARTED|Overall Study||2
8608790|NCT02299141|21230987|P1|NOT COMPLETED|Overall Study||0
8608791|NCT02299141|21230987|P1|COMPLETED|Overall Study||20
8608792|NCT02299141|21230987|P1|STARTED|Overall Study||20
8608960|NCT02217501|21231503|P2|NOT COMPLETED|Overall Study||4
8608961|NCT02217501|21231504|P1|NOT COMPLETED|Overall Study||3
8608962|NCT02217501|21231503|P2|COMPLETED|Overall Study||78
8608963|NCT02217501|21231504|P1|COMPLETED|Overall Study||74
8608964|NCT02217501|21231503|P2|STARTED|Overall Study||82
8608965|NCT02217501|21231504|P1|STARTED|Overall Study||77
8608966|NCT02208466|21231515|P3|NOT COMPLETED|Overall Study||0
8608967|NCT02208466|21231516|P2|NOT COMPLETED|Overall Study||0
8608968|NCT02208466|21231517|P1|NOT COMPLETED|Overall Study||0
8608969|NCT02208466|21231515|P3|COMPLETED|Overall Study||8
8608970|NCT02208466|21231516|P2|COMPLETED|Overall Study||10
8608971|NCT02208466|21231517|P1|COMPLETED|Overall Study||9
8608972|NCT02208466|21231515|P3|STARTED|Overall Study||8
8608973|NCT02208466|21231516|P2|STARTED|Overall Study||10
8608974|NCT02208466|21231517|P1|STARTED|Overall Study||9
8608975|NCT02206061|21231534|P3|NOT COMPLETED|Overall Study||12
8608976|NCT02206061|21231535|P2|NOT COMPLETED|Overall Study||14
8608977|NCT02206061|21231536|P1|NOT COMPLETED|Overall Study||18
8608978|NCT02206061|21231534|P3|COMPLETED|Overall Study||118
8608979|NCT02206061|21231535|P2|COMPLETED|Overall Study||128
8608980|NCT02206061|21231536|P1|COMPLETED|Overall Study||131
8608981|NCT02206061|21231534|P3|STARTED|Overall Study||130
8608982|NCT02206061|21231535|P2|STARTED|Overall Study||142
8608983|NCT02206061|21231536|P1|STARTED|Overall Study||149
8609008|NCT02172911|21231707|P2|NOT COMPLETED|Overall Study||2
8609009|NCT02172911|21231708|P1|NOT COMPLETED|Overall Study||1
8609010|NCT02172911|21231707|P2|COMPLETED|Overall Study||1
8609011|NCT02172911|21231708|P1|COMPLETED|Overall Study||6
8609012|NCT02172911|21231707|P2|STARTED|Overall Study||3
8609013|NCT02172911|21231708|P1|STARTED|Overall Study||7
8609023|NCT02078102|21231766|P2|NOT COMPLETED|Overall Study||1
8609024|NCT02078102|21231767|P1|NOT COMPLETED|Overall Study||2
8609025|NCT02078102|21231766|P2|COMPLETED|Overall Study||12
8609026|NCT02078102|21231767|P1|COMPLETED|Overall Study||23
8609027|NCT02078102|21231766|P2|STARTED|Overall Study||13
8609028|NCT02078102|21231767|P1|STARTED|Overall Study||25
8609040|NCT02059239|21231815|P2|NOT COMPLETED|Overall Study||3
8609041|NCT02059239|21231816|P1|NOT COMPLETED|Overall Study||2
8609042|NCT02059239|21231815|P2|COMPLETED|Overall Study||13
8609043|NCT02059239|21231816|P1|COMPLETED|Overall Study||16
8609044|NCT02059239|21231815|P2|STARTED|Overall Study||16
8609045|NCT02059239|21231816|P1|STARTED|Overall Study||18
8609092|NCT01984164|21231963|P2|NOT COMPLETED|Overall Study||25
8609093|NCT01984164|21231964|P1|NOT COMPLETED|Overall Study||10
8609094|NCT01984164|21231963|P2|COMPLETED|Overall Study||64
8609095|NCT01984164|21231964|P1|COMPLETED|Overall Study||77
8609096|NCT01984164|21231963|P2|STARTED|Overall Study||89
8609097|NCT01984164|21231964|P1|STARTED|Overall Study||87
8609098|NCT01970865|21232001|P17|NOT COMPLETED|Overall Study||3
8609099|NCT01970865|21232002|P16|NOT COMPLETED|Overall Study||47
8609100|NCT01970865|21232003|P15|NOT COMPLETED|Overall Study||46
8609101|NCT01970865|21232004|P14|NOT COMPLETED|Overall Study||66
8609102|NCT01970865|21232005|P13|NOT COMPLETED|Overall Study||60
8609103|NCT01970865|21232006|P12|NOT COMPLETED|Overall Study||27
8609104|NCT01970865|21232007|P11|NOT COMPLETED|Overall Study||30
8609105|NCT01970865|21232008|P10|NOT COMPLETED|Overall Study||4
8609106|NCT01970865|21232009|P9|NOT COMPLETED|Overall Study||3
8609107|NCT01970865|21232010|P8|NOT COMPLETED|Overall Study||3
8609108|NCT01970865|21232011|P7|NOT COMPLETED|Overall Study||3
8609109|NCT01970865|21232012|P6|NOT COMPLETED|Overall Study||3
8609110|NCT01970865|21232013|P5|NOT COMPLETED|Overall Study||17
8609111|NCT01970865|21232014|P4|NOT COMPLETED|Overall Study||13
8609112|NCT01970865|21232015|P3|NOT COMPLETED|Overall Study||3
8609113|NCT01970865|21232016|P2|NOT COMPLETED|Overall Study||3
8609114|NCT01970865|21232017|P1|NOT COMPLETED|Overall Study||3
8609115|NCT01970865|21232001|P17|COMPLETED|Overall Study||0
8609116|NCT01970865|21232002|P16|COMPLETED|Overall Study||0
8609117|NCT01970865|21232003|P15|COMPLETED|Overall Study||0
8609118|NCT01970865|21232004|P14|COMPLETED|Overall Study||0
8609119|NCT01970865|21232005|P13|COMPLETED|Overall Study||0
8609120|NCT01970865|21232006|P12|COMPLETED|Overall Study||0
8609121|NCT01970865|21232007|P11|COMPLETED|Overall Study||0
8609122|NCT01970865|21232008|P10|COMPLETED|Overall Study||0
8609123|NCT01970865|21232009|P9|COMPLETED|Overall Study||0
8609124|NCT01970865|21232010|P8|COMPLETED|Overall Study||0
8609125|NCT01970865|21232011|P7|COMPLETED|Overall Study||0
8609126|NCT01970865|21232012|P6|COMPLETED|Overall Study||0
8609127|NCT01970865|21232013|P5|COMPLETED|Overall Study||0
8609128|NCT01970865|21232014|P4|COMPLETED|Overall Study||0
8609129|NCT01970865|21232015|P3|COMPLETED|Overall Study||0
8609130|NCT01970865|21232016|P2|COMPLETED|Overall Study||0
8609131|NCT01970865|21232017|P1|COMPLETED|Overall Study||0
8609132|NCT01970865|21232001|P17|Received Treatment|Overall Study||3
8609133|NCT01970865|21232002|P16|Received Treatment|Overall Study||47
8609134|NCT01970865|21232003|P15|Received Treatment|Overall Study||46
8609135|NCT01970865|21232004|P14|Received Treatment|Overall Study||65
8609136|NCT01970865|21232005|P13|Received Treatment|Overall Study||60
8609137|NCT01970865|21232006|P12|Received Treatment|Overall Study||27
8609138|NCT01970865|21232007|P11|Received Treatment|Overall Study||30
8609139|NCT01970865|21232008|P10|Received Treatment|Overall Study||4
8609140|NCT01970865|21232009|P9|Received Treatment|Overall Study||3
8609141|NCT01970865|21232010|P8|Received Treatment|Overall Study||3
8609142|NCT01970865|21232011|P7|Received Treatment|Overall Study||3
8609143|NCT01970865|21232012|P6|Received Treatment|Overall Study||3
8609144|NCT01970865|21232013|P5|Received Treatment|Overall Study||17
8609145|NCT01970865|21232014|P4|Received Treatment|Overall Study||12
8609146|NCT01970865|21232015|P3|Received Treatment|Overall Study||3
8609147|NCT01970865|21232016|P2|Received Treatment|Overall Study||3
8609148|NCT01970865|21232017|P1|Received Treatment|Overall Study||3
8609149|NCT01970865|21232001|P17|STARTED|Overall Study||3
8609150|NCT01970865|21232002|P16|STARTED|Overall Study||47
8609151|NCT01970865|21232003|P15|STARTED|Overall Study||46
8609152|NCT01970865|21232004|P14|STARTED|Overall Study||66
8609153|NCT01970865|21232005|P13|STARTED|Overall Study||60
8609154|NCT01970865|21232006|P12|STARTED|Overall Study||27
8609155|NCT01970865|21232007|P11|STARTED|Overall Study||30
8609156|NCT01970865|21232008|P10|STARTED|Overall Study||4
8609157|NCT01970865|21232009|P9|STARTED|Overall Study||3
8609158|NCT01970865|21232010|P8|STARTED|Overall Study||3
8609159|NCT01970865|21232011|P7|STARTED|Overall Study||3
8609160|NCT01970865|21232012|P6|STARTED|Overall Study||3
8609161|NCT01970865|21232013|P5|STARTED|Overall Study||17
8609162|NCT01970865|21232014|P4|STARTED|Overall Study||13
8609163|NCT01970865|21232015|P3|STARTED|Overall Study||3
8609164|NCT01970865|21232016|P2|STARTED|Overall Study||3
8609165|NCT01970865|21232017|P1|STARTED|Overall Study||3
8609166|NCT01969916|21232441|P1|NOT COMPLETED|Overall Study||45
8609167|NCT01969916|21232441|P1|COMPLETED|Overall Study||105
8609168|NCT01969916|21232441|P1|STARTED|Overall Study||150
8609169|NCT01964326|21232445|P1|NOT COMPLETED|Overall Study||297
8609170|NCT01964326|21232445|P1|COMPLETED|Overall Study||1014
8609171|NCT01964326|21232445|P1|STARTED|Overall Study||1311
8609172|NCT01945021|21232452|P1|NOT COMPLETED|Overall Study||83
8609173|NCT01945021|21232452|P1|COMPLETED|Overall Study||44
8609174|NCT01945021|21232452|P1|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
8609175|NCT01945021|21232452|P1|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
8609176|NCT01945021|21232452|P1|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
8609177|NCT01945021|21232452|P1|STARTED|Overall Study||127
8609194|NCT01888497|21232504|P4|NOT COMPLETED|Fourth Intervention Period||0
8609195|NCT01888497|21232505|P3|NOT COMPLETED|Fourth Intervention Period||0
8609196|NCT01888497|21232506|P2|NOT COMPLETED|Fourth Intervention Period||0
8609197|NCT01888497|21232507|P1|NOT COMPLETED|Fourth Intervention Period||0
8609198|NCT01888497|21232504|P4|COMPLETED|Fourth Intervention Period||14
8609199|NCT01888497|21232505|P3|COMPLETED|Fourth Intervention Period||14
8609200|NCT01888497|21232506|P2|COMPLETED|Fourth Intervention Period||14
8609201|NCT01888497|21232507|P1|COMPLETED|Fourth Intervention Period||13
8609202|NCT01888497|21232504|P4|STARTED|Fourth Intervention Period||14
8609203|NCT01888497|21232505|P3|STARTED|Fourth Intervention Period||14
8609204|NCT01888497|21232506|P2|STARTED|Fourth Intervention Period||14
8609205|NCT01888497|21232507|P1|STARTED|Fourth Intervention Period||13
8609206|NCT01888497|21232504|P4|NOT COMPLETED|Washout Period 3||0
8609207|NCT01888497|21232505|P3|NOT COMPLETED|Washout Period 3||0
8609208|NCT01888497|21232506|P2|NOT COMPLETED|Washout Period 3||0
8609209|NCT01888497|21232507|P1|NOT COMPLETED|Washout Period 3||0
8609210|NCT01888497|21232504|P4|COMPLETED|Washout Period 3||14
8609211|NCT01888497|21232505|P3|COMPLETED|Washout Period 3||14
8609212|NCT01888497|21232506|P2|COMPLETED|Washout Period 3||14
8609213|NCT01888497|21232507|P1|COMPLETED|Washout Period 3||13
8609214|NCT01888497|21232504|P4|STARTED|Washout Period 3||14
8609215|NCT01888497|21232505|P3|STARTED|Washout Period 3||14
8609216|NCT01888497|21232506|P2|STARTED|Washout Period 3||14
8609217|NCT01888497|21232507|P1|STARTED|Washout Period 3||13
8609218|NCT01888497|21232504|P4|NOT COMPLETED|Third Intervention Period||0
8609219|NCT01888497|21232505|P3|NOT COMPLETED|Third Intervention Period||0
8609220|NCT01888497|21232506|P2|NOT COMPLETED|Third Intervention Period||0
8609221|NCT01888497|21232507|P1|NOT COMPLETED|Third Intervention Period||0
8609222|NCT01888497|21232504|P4|COMPLETED|Third Intervention Period||14
8609223|NCT01888497|21232505|P3|COMPLETED|Third Intervention Period||14
8609224|NCT01888497|21232506|P2|COMPLETED|Third Intervention Period||14
8609225|NCT01888497|21232507|P1|COMPLETED|Third Intervention Period||13
8609226|NCT01888497|21232504|P4|STARTED|Third Intervention Period||14
8609227|NCT01888497|21232505|P3|STARTED|Third Intervention Period||14
8609228|NCT01888497|21232506|P2|STARTED|Third Intervention Period||14
8609229|NCT01888497|21232507|P1|STARTED|Third Intervention Period||13
8609230|NCT01888497|21232504|P4|NOT COMPLETED|Washout Period 2||2
8609231|NCT01888497|21232505|P3|NOT COMPLETED|Washout Period 2||0
8609232|NCT01888497|21232506|P2|NOT COMPLETED|Washout Period 2||0
8609233|NCT01888497|21232507|P1|NOT COMPLETED|Washout Period 2||0
8609234|NCT01888497|21232504|P4|COMPLETED|Washout Period 2||14
8609235|NCT01888497|21232505|P3|COMPLETED|Washout Period 2||14
8609236|NCT01888497|21232506|P2|COMPLETED|Washout Period 2||14
8609237|NCT01888497|21232507|P1|COMPLETED|Washout Period 2||13
8609238|NCT01888497|21232504|P4|STARTED|Washout Period 2||16
8609239|NCT01888497|21232505|P3|STARTED|Washout Period 2||14
8609240|NCT01888497|21232506|P2|STARTED|Washout Period 2||14
8609241|NCT01888497|21232507|P1|STARTED|Washout Period 2||13
8609242|NCT01888497|21232504|P4|NOT COMPLETED|Second Intervention Period||0
8609243|NCT01888497|21232505|P3|NOT COMPLETED|Second Intervention Period||0
8609244|NCT01888497|21232506|P2|NOT COMPLETED|Second Intervention Period||0
8609245|NCT01888497|21232507|P1|NOT COMPLETED|Second Intervention Period||0
8609246|NCT01888497|21232504|P4|COMPLETED|Second Intervention Period||16
8609247|NCT01888497|21232505|P3|COMPLETED|Second Intervention Period||14
8609248|NCT01888497|21232506|P2|COMPLETED|Second Intervention Period||14
8609249|NCT01888497|21232507|P1|COMPLETED|Second Intervention Period||13
8609250|NCT01888497|21232504|P4|STARTED|Second Intervention Period||16
8609251|NCT01888497|21232505|P3|STARTED|Second Intervention Period||14
8609252|NCT01888497|21232506|P2|STARTED|Second Intervention Period||14
8609253|NCT01888497|21232507|P1|STARTED|Second Intervention Period||13
8609254|NCT01888497|21232504|P4|NOT COMPLETED|Washout Period 1||1
8609255|NCT01888497|21232505|P3|NOT COMPLETED|Washout Period 1||1
8609256|NCT01888497|21232506|P2|NOT COMPLETED|Washout Period 1||0
8609257|NCT01888497|21232507|P1|NOT COMPLETED|Washout Period 1||0
8609258|NCT01888497|21232504|P4|COMPLETED|Washout Period 1||16
8609259|NCT01888497|21232505|P3|COMPLETED|Washout Period 1||14
8609260|NCT01888497|21232506|P2|COMPLETED|Washout Period 1||14
8609261|NCT01888497|21232507|P1|COMPLETED|Washout Period 1||13
8609262|NCT01888497|21232504|P4|STARTED|Washout Period 1||17
8609263|NCT01888497|21232505|P3|STARTED|Washout Period 1||15
8609264|NCT01888497|21232506|P2|STARTED|Washout Period 1||14
8609265|NCT01888497|21232507|P1|STARTED|Washout Period 1||13
8609266|NCT01888497|21232504|P4|NOT COMPLETED|First Intervention Period||0
8609267|NCT01888497|21232505|P3|NOT COMPLETED|First Intervention Period||0
8609268|NCT01888497|21232506|P2|NOT COMPLETED|First Intervention Period||0
8609269|NCT01888497|21232507|P1|NOT COMPLETED|First Intervention Period||0
8609270|NCT01888497|21232504|P4|COMPLETED|First Intervention Period||17
8609271|NCT01888497|21232505|P3|COMPLETED|First Intervention Period||15
8609272|NCT01888497|21232506|P2|COMPLETED|First Intervention Period||14
8609273|NCT01888497|21232507|P1|COMPLETED|First Intervention Period||13
8609274|NCT01888497|21232504|P4|STARTED|First Intervention Period||17
8609275|NCT01888497|21232505|P3|STARTED|First Intervention Period||15
8609276|NCT01888497|21232506|P2|STARTED|First Intervention Period||14
8609277|NCT01888497|21232507|P1|STARTED|First Intervention Period||13
8609278|NCT01885195|21232525|P1|NOT COMPLETED|Overall Study||110
8609279|NCT01885195|21232525|P1|COMPLETED|Overall Study||0
8609280|NCT01885195|21232525|P1|STARTED|Overall Study||110
8609323|NCT01789320|21232586|P1|NOT COMPLETED|Overall Study||2
8609324|NCT01789320|21232586|P1|COMPLETED|Overall Study||9
8609325|NCT01789320|21232586|P1|STARTED|Overall Study||11
8609386|NCT01616563|21232693|P1|NOT COMPLETED|Overall Study||40
8609387|NCT01616563|21232693|P1|COMPLETED|Overall Study||253
8609388|NCT01616563|21232693|P1|STARTED|Overall Study||293
8609431|NCT01596595|21232909|P1|NOT COMPLETED|Overall Study||965
8609432|NCT01596595|21232909|P1|COMPLETED|Overall Study||814
8609433|NCT01596595|21232909|P1|STARTED|Overall Study||1779
8609446|NCT01420926|21232948|P2|NOT COMPLETED|Overall Study||65
8609447|NCT01420926|21232949|P1|NOT COMPLETED|Overall Study||60
8609448|NCT01420926|21232948|P2|COMPLETED|Overall Study||16
8609449|NCT01420926|21232949|P1|COMPLETED|Overall Study||22
8609450|NCT01420926|21232948|P2|STARTED|Overall Study||81
8609451|NCT01420926|21232949|P1|STARTED|Overall Study||82
8609467|NCT01327612|21232994|P7|NOT COMPLETED|Overall Study||2
8609468|NCT01327612|21232995|P6|NOT COMPLETED|Overall Study||3
8609469|NCT01327612|21232996|P5|NOT COMPLETED|Overall Study||2
8609470|NCT01327612|21232997|P4|NOT COMPLETED|Overall Study||1
8609471|NCT01327612|21232998|P3|NOT COMPLETED|Overall Study||1
8609472|NCT01327612|21232999|P2|NOT COMPLETED|Overall Study||1
8609473|NCT01327612|21233000|P1|NOT COMPLETED|Overall Study||1
8609474|NCT01327612|21232994|P7|COMPLETED|Overall Study||0
8609475|NCT01327612|21232995|P6|COMPLETED|Overall Study||0
8609476|NCT01327612|21232996|P5|COMPLETED|Overall Study||0
8609477|NCT01327612|21232997|P4|COMPLETED|Overall Study||0
8609478|NCT01327612|21232998|P3|COMPLETED|Overall Study||0
8609479|NCT01327612|21232999|P2|COMPLETED|Overall Study||0
8609480|NCT01327612|21233000|P1|COMPLETED|Overall Study||1
8609481|NCT01327612|21232994|P7|STARTED|Overall Study||2
8609482|NCT01327612|21232995|P6|STARTED|Overall Study||3
8609483|NCT01327612|21232996|P5|STARTED|Overall Study||2
8609484|NCT01327612|21232997|P4|STARTED|Overall Study||1
8609485|NCT01327612|21232998|P3|STARTED|Overall Study||1
8609486|NCT01327612|21232999|P2|STARTED|Overall Study||1
8609487|NCT01327612|21233000|P1|STARTED|Overall Study||2
8609488|NCT01304641|21233060|P2|NOT COMPLETED|Overall Study||0
8609489|NCT01304641|21233061|P1|NOT COMPLETED|Overall Study||0
8609490|NCT01304641|21233060|P2|COMPLETED|Overall Study||20132
8609491|NCT01304641|21233061|P1|COMPLETED|Overall Study||11470
8609492|NCT01304641|21233060|P2|STARTED|Overall Study||20132
8609493|NCT01304641|21233061|P1|STARTED|Overall Study||11470
8609532|NCT01229943|21233147|P2|NOT COMPLETED|Overall Study||17
8609533|NCT01229943|21233148|P1|NOT COMPLETED|Overall Study||18
8609534|NCT01229943|21233147|P2|COMPLETED|Overall Study||58
8609535|NCT01229943|21233148|P1|COMPLETED|Overall Study||57
8609536|NCT01229943|21233147|P2|STARTED|Overall Study||75
8609537|NCT01229943|21233148|P1|STARTED|Overall Study||75
8609568|NCT01191541|21233237|P2|NOT COMPLETED|the Randomized Patients||0
8609569|NCT01191541|21233238|P1|NOT COMPLETED|the Randomized Patients||0
8609570|NCT01191541|21233237|P2|COMPLETED|the Randomized Patients||35
8609571|NCT01191541|21233238|P1|COMPLETED|the Randomized Patients||30
8609572|NCT01191541|21233237|P2|STARTED|the Randomized Patients||35
8609573|NCT01191541|21233238|P1|STARTED|the Randomized Patients||30
8609574|NCT01191541|21233237|P2|NOT COMPLETED|All the Patients||0
8609575|NCT01191541|21233238|P1|NOT COMPLETED|All the Patients||1
8609576|NCT01191541|21233237|P2|COMPLETED|All the Patients||35
8609577|NCT01191541|21233238|P1|COMPLETED|All the Patients||30
8609578|NCT01191541|21233237|P2|STARTED|All the Patients||35
8609579|NCT01191541|21233238|P1|STARTED|All the Patients||31
8609580|NCT01191008|21233254|P1|NOT COMPLETED|Overall Study||15
8609581|NCT01191008|21233254|P1|COMPLETED|Overall Study||618
8609582|NCT01191008|21233254|P1|STARTED|Overall Study||633
8609583|NCT01187095|21233262|P2|NOT COMPLETED|Overall Study||34
8609584|NCT01187095|21233263|P1|NOT COMPLETED|Overall Study||45
8609585|NCT01187095|21233262|P2|COMPLETED|Overall Study||108
8609586|NCT01187095|21233263|P1|COMPLETED|Overall Study||108
8609587|NCT01187095|21233262|P2|STARTED|Overall Study||142
8609588|NCT01187095|21233263|P1|STARTED|Overall Study||153
8609589|NCT01169532|21233271|P1|NOT COMPLETED|Overall Study||1
8609590|NCT01169532|21233271|P1|COMPLETED|Overall Study||15
8609591|NCT01169532|21233271|P1|STARTED|Overall Study||16
8609637|NCT01041638|21233418|P1|NOT COMPLETED|Overall Study||27
8609638|NCT01041638|21233418|P1|COMPLETED|Overall Study||78
8609639|NCT01041638|21233418|P1|STARTED|Overall Study||105
8609652|NCT00924170|21233455|P2|NOT COMPLETED|Overall Study||8
8609653|NCT00924170|21233456|P1|NOT COMPLETED|Overall Study||7
8609654|NCT00924170|21233455|P2|COMPLETED|Overall Study||0
8609655|NCT00924170|21233456|P1|COMPLETED|Overall Study||3
8609656|NCT00924170|21233455|P2|STARTED|Overall Study||8
8609657|NCT00924170|21233456|P1|STARTED|Overall Study||10
8609658|NCT00917644|21233494|P2|NOT COMPLETED|Period 2: Second Intervention||0
8609659|NCT00917644|21233495|P1|NOT COMPLETED|Period 2: Second Intervention||1
8609660|NCT00917644|21233494|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
8609661|NCT00917644|21233495|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
8609662|NCT00917644|21233494|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
8609663|NCT00917644|21233495|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
8609664|NCT00917644|21233494|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
8609665|NCT00917644|21233495|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
8609666|NCT00917644|21233494|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
8609667|NCT00917644|21233495|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
8609668|NCT00917644|21233494|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
8609669|NCT00917644|21233495|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
8609670|NCT00917644|21233494|P2|NOT COMPLETED|Period 1: First Intervention||0
8609671|NCT00917644|21233495|P1|NOT COMPLETED|Period 1: First Intervention||0
8609672|NCT00917644|21233494|P2|COMPLETED|Period 1: First Intervention||37
8609673|NCT00917644|21233495|P1|COMPLETED|Period 1: First Intervention||39
8609674|NCT00917644|21233494|P2|STARTED|Period 1: First Intervention||37
8609675|NCT00917644|21233495|P1|STARTED|Period 1: First Intervention||39
8609680|NCT00879879|21233520|P1|NOT COMPLETED|Overall Study||3
8609681|NCT00879879|21233520|P1|COMPLETED|Overall Study||17
8609682|NCT00879879|21233520|P1|STARTED|Overall Study||20
8609691|NCT00840177|21233548|P3|NOT COMPLETED|Overall Study||11
8609692|NCT00840177|21233549|P2|NOT COMPLETED|Overall Study||9
8609693|NCT00840177|21233550|P1|NOT COMPLETED|Overall Study||18
8609694|NCT00840177|21233548|P3|COMPLETED|Overall Study||39
8609695|NCT00840177|21233549|P2|COMPLETED|Overall Study||20
8609696|NCT00840177|21233550|P1|COMPLETED|Overall Study||18
8609697|NCT00840177|21233548|P3|Assessed for AEs|Overall Study||46
8609698|NCT00840177|21233549|P2|Assessed for AEs|Overall Study||29
8609699|NCT00840177|21233550|P1|Assessed for AEs|Overall Study||35
8609700|NCT00840177|21233548|P3|Treated|Overall Study||46
8609701|NCT00840177|21233549|P2|Treated|Overall Study||29
8609702|NCT00840177|21233550|P1|Treated|Overall Study||36
8609703|NCT00840177|21233548|P3|STARTED|Overall Study||50
8609704|NCT00840177|21233549|P2|STARTED|Overall Study||29
8609705|NCT00840177|21233550|P1|STARTED|Overall Study||36
8609706|NCT00828945|21233567|P1|NOT COMPLETED|Overall Study||41
8609707|NCT00828945|21233567|P1|COMPLETED|Overall Study||216
8609708|NCT00828945|21233567|P1|STARTED|Overall Study||257
8609709|NCT00827606|21233583|P2|NOT COMPLETED|Overall Study||38
8609710|NCT00827606|21233584|P1|NOT COMPLETED|Overall Study||27
8609711|NCT00827606|21233583|P2|COMPLETED|Overall Study||94
8609712|NCT00827606|21233584|P1|COMPLETED|Overall Study||112
8609713|NCT00827606|21233583|P2|STARTED|Overall Study||132
8609714|NCT00827606|21233584|P1|STARTED|Overall Study||139
8609719|NCT00822120|21233654|P6|NOT COMPLETED|PET-directed Therapy||0
8609720|NCT00822120|21233655|P5|NOT COMPLETED|PET-directed Therapy||0
8609721|NCT00822120|21233656|P4|NOT COMPLETED|PET-directed Therapy||10
8609722|NCT00822120|21233657|P3|NOT COMPLETED|PET-directed Therapy||0
8609723|NCT00822120|21233658|P2|NOT COMPLETED|PET-directed Therapy||0
8609724|NCT00822120|21233659|P1|NOT COMPLETED|PET-directed Therapy||0
8609725|NCT00822120|21233654|P6|COMPLETED|PET-directed Therapy||1
8609726|NCT00822120|21233655|P5|COMPLETED|PET-directed Therapy||10
8609727|NCT00822120|21233656|P4|COMPLETED|PET-directed Therapy||45
8609728|NCT00822120|21233657|P3|COMPLETED|PET-directed Therapy||270
8609729|NCT00822120|21233658|P2|COMPLETED|PET-directed Therapy||0
8609730|NCT00822120|21233659|P1|COMPLETED|PET-directed Therapy||0
8609731|NCT00822120|21233654|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
8609732|NCT00822120|21233655|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
8609733|NCT00822120|21233656|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
8609734|NCT00822120|21233657|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
8609735|NCT00822120|21233658|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
8609736|NCT00822120|21233659|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
8609737|NCT00822120|21233654|P6|STARTED|PET-directed Therapy||1
8609738|NCT00822120|21233655|P5|STARTED|PET-directed Therapy||10
8609739|NCT00822120|21233656|P4|STARTED|PET-directed Therapy||55
8609740|NCT00822120|21233657|P3|STARTED|PET-directed Therapy||270
8609741|NCT00822120|21233658|P2|STARTED|PET-directed Therapy||0
8609742|NCT00822120|21233659|P1|STARTED|PET-directed Therapy||0
8609743|NCT00822120|21233654|P6|NOT COMPLETED|Initial Registration||0
8609744|NCT00822120|21233655|P5|NOT COMPLETED|Initial Registration||0
8609745|NCT00822120|21233656|P4|NOT COMPLETED|Initial Registration||0
8609746|NCT00822120|21233657|P3|NOT COMPLETED|Initial Registration||0
8609747|NCT00822120|21233658|P2|NOT COMPLETED|Initial Registration||1
8609748|NCT00822120|21233659|P1|NOT COMPLETED|Initial Registration||26
8609749|NCT00822120|21233654|P6|COMPLETED|Initial Registration||0
8609750|NCT00822120|21233655|P5|COMPLETED|Initial Registration||0
8609751|NCT00822120|21233656|P4|COMPLETED|Initial Registration||0
8609752|NCT00822120|21233657|P3|COMPLETED|Initial Registration||0
8609753|NCT00822120|21233658|P2|COMPLETED|Initial Registration||12
8609754|NCT00822120|21233659|P1|COMPLETED|Initial Registration||332
8609755|NCT00822120|21233654|P6|Eligible and Evaluable Patients|Initial Registration||0
8609756|NCT00822120|21233655|P5|Eligible and Evaluable Patients|Initial Registration||0
8609757|NCT00822120|21233656|P4|Eligible and Evaluable Patients|Initial Registration||0
8609758|NCT00822120|21233657|P3|Eligible and Evaluable Patients|Initial Registration||0
8609759|NCT00822120|21233658|P2|Eligible and Evaluable Patients|Initial Registration||12
8609760|NCT00822120|21233659|P1|Eligible and Evaluable Patients|Initial Registration||336
8609761|NCT00822120|21233654|P6|STARTED|Initial Registration||0
8609762|NCT00822120|21233655|P5|STARTED|Initial Registration||0
8609763|NCT00822120|21233656|P4|STARTED|Initial Registration||0
8609764|NCT00822120|21233657|P3|STARTED|Initial Registration||0
8609765|NCT00822120|21233658|P2|STARTED|Initial Registration||13
8609766|NCT00822120|21233659|P1|STARTED|Initial Registration||358
8609794|NCT00728988|21233757|P2|NOT COMPLETED|Overall Study||88
8609795|NCT00728988|21233758|P1|NOT COMPLETED|Overall Study||93
8609796|NCT00728988|21233757|P2|COMPLETED|Overall Study||164
8609797|NCT00728988|21233758|P1|COMPLETED|Overall Study||154
8609798|NCT00728988|21233757|P2|Full Analysis Set|Overall Study||172
8609799|NCT00728988|21233758|P1|Full Analysis Set|Overall Study||163
8609800|NCT00728988|21233757|P2|Treated|Overall Study||250
8609801|NCT00728988|21233758|P1|Treated|Overall Study||245
8609802|NCT00728988|21233757|P2|STARTED|Overall Study||252
8609803|NCT00728988|21233758|P1|STARTED|Overall Study||247
8609810|NCT00673660|21233815|P1|NOT COMPLETED|Overall Study||107
8609811|NCT00673660|21233815|P1|COMPLETED|Overall Study||268
8609812|NCT00673660|21233815|P1|STARTED|Overall Study||375
8609813|NCT00669409|21233832|P11|NOT COMPLETED|Part 2||0
8609814|NCT00669409|21233833|P10|NOT COMPLETED|Part 2||1
8609815|NCT00669409|21233834|P9|NOT COMPLETED|Part 2||0
8609816|NCT00669409|21233835|P8|NOT COMPLETED|Part 2||0
8609817|NCT00669409|21233836|P7|NOT COMPLETED|Part 2||0
8609818|NCT00669409|21233837|P6|NOT COMPLETED|Part 2||0
8609819|NCT00669409|21233838|P5|NOT COMPLETED|Part 2||0
8609820|NCT00669409|21233839|P4|NOT COMPLETED|Part 2||0
8609821|NCT00669409|21233840|P3|NOT COMPLETED|Part 2||0
8609822|NCT00669409|21233841|P2|NOT COMPLETED|Part 2||0
8609823|NCT00669409|21233842|P1|NOT COMPLETED|Part 2||0
8609824|NCT00669409|21233832|P11|COMPLETED|Part 2||4
8609825|NCT00669409|21233833|P10|COMPLETED|Part 2||9
8609826|NCT00669409|21233834|P9|COMPLETED|Part 2||9
8609827|NCT00669409|21233835|P8|COMPLETED|Part 2||9
8609828|NCT00669409|21233836|P7|COMPLETED|Part 2||9
8609829|NCT00669409|21233837|P6|COMPLETED|Part 2||0
8609830|NCT00669409|21233838|P5|COMPLETED|Part 2||0
8609831|NCT00669409|21233839|P4|COMPLETED|Part 2||0
8609832|NCT00669409|21233840|P3|COMPLETED|Part 2||0
8609833|NCT00669409|21233841|P2|COMPLETED|Part 2||0
8609834|NCT00669409|21233842|P1|COMPLETED|Part 2||0
8609835|NCT00669409|21233832|P11|STARTED|Part 2||4
8609836|NCT00669409|21233833|P10|STARTED|Part 2||10
8609837|NCT00669409|21233834|P9|STARTED|Part 2||9
8609838|NCT00669409|21233835|P8|STARTED|Part 2||9
8609839|NCT00669409|21233836|P7|STARTED|Part 2||9
8609840|NCT00669409|21233837|P6|STARTED|Part 2||0
8609841|NCT00669409|21233838|P5|STARTED|Part 2||0
8609842|NCT00669409|21233839|P4|STARTED|Part 2||0
8609843|NCT00669409|21233840|P3|STARTED|Part 2||0
8609844|NCT00669409|21233841|P2|STARTED|Part 2||0
8609845|NCT00669409|21233842|P1|STARTED|Part 2||0
8609846|NCT00669409|21233832|P11|NOT COMPLETED|Part 1||0
8609847|NCT00669409|21233833|P10|NOT COMPLETED|Part 1||0
8609848|NCT00669409|21233834|P9|NOT COMPLETED|Part 1||0
8609849|NCT00669409|21233835|P8|NOT COMPLETED|Part 1||0
8609850|NCT00669409|21233836|P7|NOT COMPLETED|Part 1||0
8609851|NCT00669409|21233837|P6|NOT COMPLETED|Part 1||0
8609852|NCT00669409|21233838|P5|NOT COMPLETED|Part 1||0
8609853|NCT00669409|21233839|P4|NOT COMPLETED|Part 1||0
8609854|NCT00669409|21233840|P3|NOT COMPLETED|Part 1||0
8609855|NCT00669409|21233841|P2|NOT COMPLETED|Part 1||0
8609856|NCT00669409|21233842|P1|NOT COMPLETED|Part 1||0
8609857|NCT00669409|21233832|P11|COMPLETED|Part 1||0
8609858|NCT00669409|21233833|P10|COMPLETED|Part 1||0
8609859|NCT00669409|21233834|P9|COMPLETED|Part 1||0
8609860|NCT00669409|21233835|P8|COMPLETED|Part 1||0
8609861|NCT00669409|21233836|P7|COMPLETED|Part 1||0
8609862|NCT00669409|21233837|P6|COMPLETED|Part 1||12
8609863|NCT00669409|21233838|P5|COMPLETED|Part 1||6
8609864|NCT00669409|21233839|P4|COMPLETED|Part 1||6
8609865|NCT00669409|21233840|P3|COMPLETED|Part 1||6
8609866|NCT00669409|21233841|P2|COMPLETED|Part 1||6
8609867|NCT00669409|21233842|P1|COMPLETED|Part 1||6
8609868|NCT00669409|21233832|P11|STARTED|Part 1||0
8609869|NCT00669409|21233833|P10|STARTED|Part 1||0
8609870|NCT00669409|21233834|P9|STARTED|Part 1||0
8609871|NCT00669409|21233835|P8|STARTED|Part 1||0
8609872|NCT00669409|21233836|P7|STARTED|Part 1||0
8609873|NCT00669409|21233837|P6|STARTED|Part 1||12
8609874|NCT00669409|21233838|P5|STARTED|Part 1||6
8609875|NCT00669409|21233839|P4|STARTED|Part 1||6
8609876|NCT00669409|21233840|P3|STARTED|Part 1||6
8609877|NCT00669409|21233841|P2|STARTED|Part 1||6
8609878|NCT00669409|21233842|P1|STARTED|Part 1||6
8609879|NCT00662558|21234226|P2|NOT COMPLETED|Overall Study||110
8609880|NCT00662558|21234227|P1|NOT COMPLETED|Overall Study||56
8609881|NCT00662558|21234226|P2|COMPLETED|Overall Study||294
8609882|NCT00662558|21234227|P1|COMPLETED|Overall Study||342
8609883|NCT00662558|21234226|P2|Received Treatment|Overall Study||396
8609884|NCT00662558|21234227|P1|Received Treatment|Overall Study||396
8609885|NCT00662558|21234226|P2|STARTED|Overall Study||404
8609886|NCT00662558|21234227|P1|STARTED|Overall Study||398
8609887|NCT00602641|21234261|P2|NOT COMPLETED|Overall Study||152
8609888|NCT00602641|21234262|P1|NOT COMPLETED|Overall Study||154
8609889|NCT00602641|21234261|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
8609890|NCT00602641|21234262|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
8609891|NCT00602641|21234261|P2|Started Protocol Therapy|Overall Study||150
8609892|NCT00602641|21234262|P1|Started Protocol Therapy|Overall Study||148
8609893|NCT00602641|21234261|P2|STARTED|Overall Study||152
8609894|NCT00602641|21234262|P1|STARTED|Overall Study||154
8609895|NCT00585312|21234276|P2|NOT COMPLETED|Overall Study||44
8609896|NCT00585312|21234277|P1|NOT COMPLETED|Overall Study||51
8609897|NCT00585312|21234276|P2|COMPLETED|Overall Study||7
8609898|NCT00585312|21234277|P1|COMPLETED|Overall Study||4
8609899|NCT00585312|21234276|P2|Treated|Overall Study||48
8609900|NCT00585312|21234277|P1|Treated|Overall Study||53
8609901|NCT00585312|21234276|P2|STARTED|Overall Study|STARTED=Randomized|51
8609902|NCT00585312|21234277|P1|STARTED|Overall Study|STARTED=Randomized|55
8609903|NCT00549549|21234293|P4|NOT COMPLETED|Overall Study||25
8609904|NCT00549549|21234294|P3|NOT COMPLETED|Overall Study||17
8609905|NCT00549549|21234295|P2|NOT COMPLETED|Overall Study||22
8609906|NCT00549549|21234296|P1|NOT COMPLETED|Overall Study||24
8609907|NCT00549549|21234293|P4|COMPLETED|Overall Study||78
8609908|NCT00549549|21234294|P3|COMPLETED|Overall Study||82
8609909|NCT00549549|21234295|P2|COMPLETED|Overall Study||77
8609910|NCT00549549|21234296|P1|COMPLETED|Overall Study||77
8609911|NCT00549549|21234293|P4|Treated|Overall Study||102
8609912|NCT00549549|21234294|P3|Treated|Overall Study||98
8609913|NCT00549549|21234295|P2|Treated|Overall Study||99
8609914|NCT00549549|21234296|P1|Treated|Overall Study||101
8609915|NCT00549549|21234293|P4|STARTED|Overall Study||103
8609916|NCT00549549|21234294|P3|STARTED|Overall Study||99
8609917|NCT00549549|21234295|P2|STARTED|Overall Study||99
8609918|NCT00549549|21234296|P1|STARTED|Overall Study||101
8609925|NCT00462020|21234379|P2|NOT COMPLETED|Overall Study||0
8609926|NCT00462020|21234380|P1|NOT COMPLETED|Overall Study||0
8609927|NCT00462020|21234379|P2|COMPLETED|Overall Study||50
8609928|NCT00462020|21234380|P1|COMPLETED|Overall Study||52
8609929|NCT00462020|21234379|P2|STARTED|Overall Study||50
8609930|NCT00462020|21234380|P1|STARTED|Overall Study||52
8609931|NCT00454207|21234396|P2|NOT COMPLETED|Overall Study||2
8609932|NCT00454207|21234397|P1|NOT COMPLETED|Overall Study||4
8609933|NCT00454207|21234396|P2|COMPLETED|Overall Study||21
8609934|NCT00454207|21234397|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
8609935|NCT00454207|21234396|P2|STARTED|Overall Study||23
8609936|NCT00454207|21234397|P1|STARTED|Overall Study||21
8609937|NCT00446797|21234442|P2|NOT COMPLETED|Overall Study||12
8609938|NCT00446797|21234443|P1|NOT COMPLETED|Overall Study||8
8609939|NCT00446797|21234442|P2|COMPLETED|Overall Study||125
8609940|NCT00446797|21234443|P1|COMPLETED|Overall Study||133
8609941|NCT00446797|21234442|P2|STARTED|Overall Study||137
8609942|NCT00446797|21234443|P1|STARTED|Overall Study||141
8609943|NCT00443599|21234489|P2|NOT COMPLETED|Overall Study||3
8609944|NCT00443599|21234490|P1|NOT COMPLETED|Overall Study||6
8609945|NCT00443599|21234489|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
8609946|NCT00443599|21234490|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
8609947|NCT00443599|21234489|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
8609948|NCT00443599|21234490|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
8609949|NCT00378105|21234524|P2|NOT COMPLETED|Overall Study||30
8609950|NCT00378105|21234525|P1|NOT COMPLETED|Overall Study||20
8609951|NCT00378105|21234524|P2|COMPLETED|Overall Study||5
8609952|NCT00378105|21234525|P1|COMPLETED|Overall Study||11
8609953|NCT00378105|21234524|P2|STARTED|Overall Study||35
8609954|NCT00378105|21234525|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
8609955|NCT00351611|21234536|P2|NOT COMPLETED|Overall Study||10
8609956|NCT00351611|21234537|P1|NOT COMPLETED|Overall Study||14
8609957|NCT00351611|21234536|P2|COMPLETED|Overall Study||88
8609958|NCT00351611|21234537|P1|COMPLETED|Overall Study||75
8609959|NCT00351611|21234536|P2|Treated|Overall Study||98
8609960|NCT00351611|21234537|P1|Treated|Overall Study||89
8609961|NCT00351611|21234536|P2|STARTED|Overall Study||98
8609962|NCT00351611|21234537|P1|STARTED|Overall Study||89
8609972|NCT00310180|21234563|P4|NOT COMPLETED|Overall Study||348
8609973|NCT00310180|21234564|P3|NOT COMPLETED|Overall Study||137
8609974|NCT00310180|21234565|P2|NOT COMPLETED|Overall Study||59
8609975|NCT00310180|21234566|P1|NOT COMPLETED|Overall Study||10
8609976|NCT00310180|21234563|P4|COMPLETED|Overall Study||1389
8609977|NCT00310180|21234564|P3|COMPLETED|Overall Study||3312
8609978|NCT00310180|21234565|P2|COMPLETED|Overall Study||3399
8609979|NCT00310180|21234566|P1|COMPLETED|Overall Study||1619
8609980|NCT00310180|21234563|P4|No Follow-up Data|Overall Study||245
8609981|NCT00310180|21234564|P3|No Follow-up Data|Overall Study||131
8609982|NCT00310180|21234565|P2|No Follow-up Data|Overall Study||55
8609983|NCT00310180|21234566|P1|No Follow-up Data|Overall Study||7
8609984|NCT00310180|21234563|P4|Ineligible|Overall Study||7
8609985|NCT00310180|21234564|P3|Ineligible|Overall Study||6
8609986|NCT00310180|21234565|P2|Ineligible|Overall Study||4
8609987|NCT00310180|21234566|P1|Ineligible|Overall Study||3
8609988|NCT00310180|21234563|P4|No On-study Data|Overall Study||172
8609989|NCT00310180|21234564|P3|No On-study Data|Overall Study||10
8609990|NCT00310180|21234565|P2|No On-study Data|Overall Study||2
8609991|NCT00310180|21234566|P1|No On-study Data|Overall Study||0
8609992|NCT00310180|21234563|P4|STARTED|Overall Study||1737
8609993|NCT00310180|21234564|P3|STARTED|Overall Study||3449
8609994|NCT00310180|21234565|P2|STARTED|Overall Study||3458
8609995|NCT00310180|21234566|P1|STARTED|Overall Study||1629
8610002|NCT00070018|21234671|P1|NOT COMPLETED|Overall Study||4
8610003|NCT00070018|21234671|P1|COMPLETED|Overall Study||42
8610004|NCT00070018|21234671|P1|Eligible and Began Protocol Therapy|Overall Study||46
8610005|NCT00070018|21234671|P1|Eligible|Overall Study||46
8610006|NCT00070018|21234671|P1|STARTED|Overall Study||46
8610007|NCT00003508|21234675|P1|NOT COMPLETED|Overall Study||5
8610008|NCT00003508|21234675|P1|COMPLETED|Overall Study||3
8610009|NCT00003508|21234675|P1|STARTED|Overall Study||8
8614244|NCT04174638|21248531|P2|NOT COMPLETED|Overall Study||0
8614245|NCT04174638|21248532|P1|NOT COMPLETED|Overall Study||0
8614246|NCT04174638|21248531|P2|COMPLETED|Overall Study||28
8614247|NCT04174638|21248532|P1|COMPLETED|Overall Study||32
8614248|NCT04174638|21248531|P2|STARTED|Overall Study||28
8614249|NCT04174638|21248532|P1|STARTED|Overall Study||32
8614250|NCT04149925|21248552|P2|NOT COMPLETED|Overall Study||0
8614251|NCT04149925|21248553|P1|NOT COMPLETED|Overall Study||0
8614252|NCT04149925|21248552|P2|COMPLETED|Overall Study||30
8614253|NCT04149925|21248553|P1|COMPLETED|Overall Study||30
8614254|NCT04149925|21248552|P2|STARTED|Overall Study||30
8614255|NCT04149925|21248553|P1|STARTED|Overall Study||30
8614274|NCT04076787|21248617|P3|NOT COMPLETED|Overall Study||0
8614275|NCT04076787|21248618|P2|NOT COMPLETED|Overall Study||0
8614276|NCT04076787|21248619|P1|NOT COMPLETED|Overall Study||0
8614277|NCT04076787|21248617|P3|COMPLETED|Overall Study||420
8614278|NCT04076787|21248618|P2|COMPLETED|Overall Study||1031
8614279|NCT04076787|21248619|P1|COMPLETED|Overall Study||318
8614280|NCT04076787|21248617|P3|STARTED|Overall Study||420
8614281|NCT04076787|21248618|P2|STARTED|Overall Study||1031
8614282|NCT04076787|21248619|P1|STARTED|Overall Study||318
8614301|NCT03981861|21248711|P1|NOT COMPLETED|Overall Study||3
8614302|NCT03981861|21248711|P1|COMPLETED|Overall Study||9
8614303|NCT03981861|21248711|P1|STARTED|Overall Study||12
8614315|NCT03867838|21248757|P1|NOT COMPLETED|Overall Study||0
8614316|NCT03867838|21248757|P1|COMPLETED|Overall Study||6
8614317|NCT03867838|21248757|P1|STARTED|Overall Study||6
8614357|NCT03820388|21248966|P3|NOT COMPLETED|Overall Study||0
8614358|NCT03820388|21248967|P2|NOT COMPLETED|Overall Study||0
8614359|NCT03820388|21248968|P1|NOT COMPLETED|Overall Study||0
8614360|NCT03820388|21248966|P3|COMPLETED|Overall Study||25
8614361|NCT03820388|21248967|P2|COMPLETED|Overall Study||25
8614362|NCT03820388|21248968|P1|COMPLETED|Overall Study||25
8614363|NCT03820388|21248966|P3|STARTED|Overall Study||25
8614364|NCT03820388|21248967|P2|STARTED|Overall Study||25
8614365|NCT03820388|21248968|P1|STARTED|Overall Study||25
8614366|NCT03815292|21248999|P2|NOT COMPLETED|Overall Study||0
8614367|NCT03815292|21249000|P1|NOT COMPLETED|Overall Study||0
8614368|NCT03815292|21248999|P2|COMPLETED|Overall Study||140
8614369|NCT03815292|21249000|P1|COMPLETED|Overall Study||135
8614370|NCT03815292|21248999|P2|STARTED|Overall Study||140
8614371|NCT03815292|21249000|P1|STARTED|Overall Study||135
8614372|NCT03809052|21249033|P11|NOT COMPLETED|Overall Study||0
8614373|NCT03809052|21249034|P10|NOT COMPLETED|Overall Study||0
8614374|NCT03809052|21249035|P9|NOT COMPLETED|Overall Study||0
8614375|NCT03809052|21249036|P8|NOT COMPLETED|Overall Study||0
8614376|NCT03809052|21249037|P7|NOT COMPLETED|Overall Study||0
8614377|NCT03809052|21249038|P6|NOT COMPLETED|Overall Study||0
8614378|NCT03809052|21249039|P5|NOT COMPLETED|Overall Study||0
8614379|NCT03809052|21249040|P4|NOT COMPLETED|Overall Study||0
8614380|NCT03809052|21249041|P3|NOT COMPLETED|Overall Study||0
8614381|NCT03809052|21249042|P2|NOT COMPLETED|Overall Study||0
8614382|NCT03809052|21249043|P1|NOT COMPLETED|Overall Study||0
8614383|NCT03809052|21249033|P11|COMPLETED|Overall Study||6
8614384|NCT03809052|21249034|P10|COMPLETED|Overall Study||8
8614385|NCT03809052|21249035|P9|COMPLETED|Overall Study||8
8614386|NCT03809052|21249036|P8|COMPLETED|Overall Study||14
8614387|NCT03809052|21249037|P7|COMPLETED|Overall Study||6
8614388|NCT03809052|21249038|P6|COMPLETED|Overall Study||6
8614389|NCT03809052|21249039|P5|COMPLETED|Overall Study||6
8614390|NCT03809052|21249040|P4|COMPLETED|Overall Study||6
8614391|NCT03809052|21249041|P3|COMPLETED|Overall Study||6
8614392|NCT03809052|21249042|P2|COMPLETED|Overall Study||6
8614393|NCT03809052|21249043|P1|COMPLETED|Overall Study||6
8614394|NCT03809052|21249033|P11|STARTED|Overall Study||6
8614395|NCT03809052|21249034|P10|STARTED|Overall Study||8
8614396|NCT03809052|21249035|P9|STARTED|Overall Study||8
8614397|NCT03809052|21249036|P8|STARTED|Overall Study||14
8614398|NCT03809052|21249037|P7|STARTED|Overall Study||6
8614399|NCT03809052|21249038|P6|STARTED|Overall Study||6
8614400|NCT03809052|21249039|P5|STARTED|Overall Study||6
8614401|NCT03809052|21249040|P4|STARTED|Overall Study||6
8614402|NCT03809052|21249041|P3|STARTED|Overall Study||6
8614403|NCT03809052|21249042|P2|STARTED|Overall Study||6
8614404|NCT03809052|21249043|P1|STARTED|Overall Study||6
8614414|NCT03760068|21249090|P2|NOT COMPLETED|Overall Study||23
8614415|NCT03760068|21249091|P1|NOT COMPLETED|Overall Study||14
8614416|NCT03760068|21249090|P2|COMPLETED|Overall Study||217
8614417|NCT03760068|21249091|P1|COMPLETED|Overall Study||224
8614418|NCT03760068|21249090|P2|STARTED|Overall Study||240
8614419|NCT03760068|21249091|P1|STARTED|Overall Study||238
8614420|NCT03743038|21249109|P1|NOT COMPLETED|Overall Study||1
8614421|NCT03743038|21249109|P1|COMPLETED|Overall Study||11
8614422|NCT03743038|21249109|P1|STARTED|Overall Study||12
8614530|NCT03483935|21249417|P1|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
8614531|NCT03483935|21249417|P1|COMPLETED|Stage 2: Randomised Controlled Trial||11
8614532|NCT03483935|21249417|P1|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
8614533|NCT03483935|21249417|P1|AKs Treated|Stage 2: Randomised Controlled Trial||11
8614534|NCT03483935|21249417|P1|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
8614535|NCT03483935|21249417|P1|NOT COMPLETED|Stage 1: Dose Setting Study||0
8614536|NCT03483935|21249417|P1|COMPLETED|Stage 1: Dose Setting Study||7
8614537|NCT03483935|21249417|P1|STARTED|Stage 1: Dose Setting Study||7
8614553|NCT03415022|21249477|P2|NOT COMPLETED|Overall Study||5
8614554|NCT03415022|21249478|P1|NOT COMPLETED|Overall Study||5
8614555|NCT03415022|21249477|P2|COMPLETED|Overall Study||15
8614556|NCT03415022|21249478|P1|COMPLETED|Overall Study||16
8614557|NCT03415022|21249477|P2|STARTED|Overall Study||20
8614558|NCT03415022|21249478|P1|STARTED|Overall Study||21
8614599|NCT03335150|21249593|P2|NOT COMPLETED|Overall Study||5
8614600|NCT03335150|21249594|P1|NOT COMPLETED|Overall Study||10
8614601|NCT03335150|21249593|P2|COMPLETED|Overall Study||50
8614602|NCT03335150|21249594|P1|COMPLETED|Overall Study||45
8614603|NCT03335150|21249593|P2|POST Testing Session|Overall Study||50
8614604|NCT03335150|21249594|P1|POST Testing Session|Overall Study||45
8614605|NCT03335150|21249593|P2|Commenced Group|Overall Study||52
8614606|NCT03335150|21249594|P1|Commenced Group|Overall Study||47
8614607|NCT03335150|21249593|P2|PRE Testing Session|Overall Study||55
8614608|NCT03335150|21249594|P1|PRE Testing Session|Overall Study||53
8614609|NCT03335150|21249593|P2|Enrolled + Assigned Group|Overall Study||55
8614610|NCT03335150|21249594|P1|Enrolled + Assigned Group|Overall Study||54
8614611|NCT03335150|21249593|P2|STARTED|Overall Study||55
8614612|NCT03335150|21249594|P1|STARTED|Overall Study||55
8614613|NCT03329690|21249621|P5|NOT COMPLETED|Overall Study||22
8614614|NCT03329690|21249622|P4|NOT COMPLETED|Overall Study||21
8614615|NCT03329690|21249623|P3|NOT COMPLETED|Overall Study||6
8614616|NCT03329690|21249624|P2|NOT COMPLETED|Overall Study||53
8614617|NCT03329690|21249625|P1|NOT COMPLETED|Overall Study||98
8614618|NCT03329690|21249621|P5|COMPLETED|Overall Study||2
8614619|NCT03329690|21249622|P4|COMPLETED|Overall Study||0
8614620|NCT03329690|21249623|P3|COMPLETED|Overall Study||1
8614621|NCT03329690|21249624|P2|COMPLETED|Overall Study||2
8614622|NCT03329690|21249625|P1|COMPLETED|Overall Study||28
8614623|NCT03329690|21249621|P5|Received Treatment|Overall Study||24
8614624|NCT03329690|21249622|P4|Received Treatment|Overall Study||20
8614625|NCT03329690|21249623|P3|Received Treatment|Overall Study||7
8614626|NCT03329690|21249624|P2|Received Treatment|Overall Study||55
8614627|NCT03329690|21249625|P1|Received Treatment|Overall Study||125
8614628|NCT03329690|21249621|P5|STARTED|Overall Study||24
8614629|NCT03329690|21249622|P4|STARTED|Overall Study||21
8614630|NCT03329690|21249623|P3|STARTED|Overall Study||7
8614631|NCT03329690|21249624|P2|STARTED|Overall Study||55
8614632|NCT03329690|21249625|P1|STARTED|Overall Study||126
8614633|NCT03282357|21249703|P1|NOT COMPLETED|Overall Study||17
8614634|NCT03282357|21249703|P1|COMPLETED|Overall Study||164
8614635|NCT03282357|21249703|P1|Safety Evaluation Set|Overall Study||176
8614636|NCT03282357|21249703|P1|STARTED|Overall Study||181
8614637|NCT03277794|21249712|P2|NOT COMPLETED|Overall Study||4
8614638|NCT03277794|21249713|P1|NOT COMPLETED|Overall Study||3
8614639|NCT03277794|21249712|P2|COMPLETED|Overall Study||30
8614640|NCT03277794|21249713|P1|COMPLETED|Overall Study||28
8614641|NCT03277794|21249712|P2|STARTED|Overall Study||34
8614642|NCT03277794|21249713|P1|STARTED|Overall Study||31
8614658|NCT03224585|21249779|P2|NOT COMPLETED|Overall Study||0
8614659|NCT03224585|21249780|P1|NOT COMPLETED|Overall Study||0
8614660|NCT03224585|21249779|P2|COMPLETED|Overall Study||3
8614661|NCT03224585|21249780|P1|COMPLETED|Overall Study||2
8614662|NCT03224585|21249779|P2|STARTED|Overall Study||3
8614663|NCT03224585|21249780|P1|STARTED|Overall Study||2
8614664|NCT03213210|21249786|P1|NOT COMPLETED|Overall Study||5
8614665|NCT03213210|21249786|P1|COMPLETED|Overall Study||0
8614666|NCT03213210|21249786|P1|STARTED|Overall Study||5
8614670|NCT03202134|21249805|P2|NOT COMPLETED|Overall Study||0
8614671|NCT03202134|21249806|P1|NOT COMPLETED|Overall Study||0
8614672|NCT03202134|21249805|P2|COMPLETED|Overall Study||149
8614673|NCT03202134|21249806|P1|COMPLETED|Overall Study||55
8614674|NCT03202134|21249805|P2|STARTED|Overall Study||149
8614675|NCT03202134|21249806|P1|STARTED|Overall Study||55
8614676|NCT03157089|21249824|P2|NOT COMPLETED|Overall Study||12
8614677|NCT03157089|21249825|P1|NOT COMPLETED|Overall Study||12
8614678|NCT03157089|21249824|P2|COMPLETED|Overall Study||0
8614679|NCT03157089|21249825|P1|COMPLETED|Overall Study||0
8614680|NCT03157089|21249824|P2|Treated|Overall Study||12
8614681|NCT03157089|21249825|P1|Treated|Overall Study||12
8614682|NCT03157089|21249824|P2|STARTED|Overall Study||12
8614683|NCT03157089|21249825|P1|STARTED|Overall Study||12
8614723|NCT03078907|21249917|P2|NOT COMPLETED|Overall Study||1
8614724|NCT03078907|21249918|P1|NOT COMPLETED|Overall Study||3
8614725|NCT03078907|21249917|P2|COMPLETED|Overall Study||54
8614726|NCT03078907|21249918|P1|COMPLETED|Overall Study||50
8614727|NCT03078907|21249917|P2|STARTED|Overall Study||55
8614728|NCT03078907|21249918|P1|STARTED|Overall Study||53
8614729|NCT03077646|21249955|P3|NOT COMPLETED|Overall Study||31
8614730|NCT03077646|21249956|P2|NOT COMPLETED|Overall Study||30
8614731|NCT03077646|21249957|P1|NOT COMPLETED|Overall Study||29
8614732|NCT03077646|21249955|P3|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
8614733|NCT03077646|21249956|P2|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
8614734|NCT03077646|21249957|P1|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
8614735|NCT03077646|21249955|P3|STARTED|Overall Study||74
8614736|NCT03077646|21249956|P2|STARTED|Overall Study||75
8614737|NCT03077646|21249957|P1|STARTED|Overall Study||76
8614747|NCT03061812|21249987|P2|NOT COMPLETED|Overall Study||0
8614748|NCT03061812|21249988|P1|NOT COMPLETED|Overall Study||0
8614749|NCT03061812|21249987|P2|COMPLETED|Overall Study||296
8614750|NCT03061812|21249988|P1|COMPLETED|Overall Study||148
8614751|NCT03061812|21249987|P2|STARTED|Overall Study||296
8614752|NCT03061812|21249988|P1|STARTED|Overall Study||148
8614753|NCT03045653|21250004|P1|NOT COMPLETED|Overall Study||0
8614754|NCT03045653|21250004|P1|COMPLETED|Overall Study||30
8614755|NCT03045653|21250004|P1|STARTED|Overall Study||30
8614762|NCT03018223|21250023|P1|NOT COMPLETED|Overall Study||0
8614763|NCT03018223|21250023|P1|COMPLETED|Overall Study||32
8614764|NCT03018223|21250023|P1|STARTED|Overall Study||32
8614811|NCT02968563|21250276|P2|NOT COMPLETED|Overall Study||23
8614812|NCT02968563|21250277|P1|NOT COMPLETED|Overall Study||1
8614813|NCT02968563|21250276|P2|COMPLETED|Overall Study||7
8614814|NCT02968563|21250277|P1|COMPLETED|Overall Study||4
8614815|NCT02968563|21250276|P2|STARTED|Overall Study||30
8614816|NCT02968563|21250277|P1|STARTED|Overall Study||5
8614951|NCT02875080|21250558|P3|NOT COMPLETED|Overall Study||0
8614952|NCT02875080|21250559|P2|NOT COMPLETED|Overall Study||0
8614953|NCT02875080|21250560|P1|NOT COMPLETED|Overall Study||2
8614954|NCT02875080|21250558|P3|COMPLETED|Overall Study||6
8614955|NCT02875080|21250559|P2|COMPLETED|Overall Study||6
8614956|NCT02875080|21250560|P1|COMPLETED|Overall Study||4
8614957|NCT02875080|21250558|P3|STARTED|Overall Study||6
8614958|NCT02875080|21250559|P2|STARTED|Overall Study||6
8614959|NCT02875080|21250560|P1|STARTED|Overall Study||6
8614960|NCT02859454|21250571|P1|NOT COMPLETED|Overall Study||1
8614961|NCT02859454|21250571|P1|COMPLETED|Overall Study||12
8614962|NCT02859454|21250571|P1|STARTED|Overall Study||13
8614963|NCT02840474|21250584|P2|NOT COMPLETED|Overall Study||0
8614964|NCT02840474|21250585|P1|NOT COMPLETED|Overall Study||1
8614965|NCT02840474|21250584|P2|COMPLETED|Overall Study||9
8614966|NCT02840474|21250585|P1|COMPLETED|Overall Study||6
8614967|NCT02840474|21250584|P2|Received Study Product|Overall Study||9
8614968|NCT02840474|21250585|P1|Received Study Product|Overall Study||7
8614969|NCT02840474|21250584|P2|STARTED|Overall Study||9
8614970|NCT02840474|21250585|P1|STARTED|Overall Study||7
8615007|NCT02774226|21250760|P2|NOT COMPLETED|Overall Study||0
8615008|NCT02774226|21250761|P1|NOT COMPLETED|Overall Study||0
8615009|NCT02774226|21250760|P2|COMPLETED|Overall Study||7
8615010|NCT02774226|21250761|P1|COMPLETED|Overall Study||8
8615011|NCT02774226|21250760|P2|STARTED|Overall Study||7
8615012|NCT02774226|21250761|P1|STARTED|Overall Study||8
8615013|NCT02755818|21250777|P4|NOT COMPLETED|Overall Study||3
8615014|NCT02755818|21250778|P3|NOT COMPLETED|Overall Study||1
8615015|NCT02755818|21250779|P2|NOT COMPLETED|Overall Study||0
8615016|NCT02755818|21250780|P1|NOT COMPLETED|Overall Study||0
8615017|NCT02755818|21250777|P4|COMPLETED|Overall Study||14
8615018|NCT02755818|21250778|P3|COMPLETED|Overall Study||1
8615019|NCT02755818|21250779|P2|COMPLETED|Overall Study||2
8615020|NCT02755818|21250780|P1|COMPLETED|Overall Study||30
8615021|NCT02755818|21250777|P4|STARTED|Overall Study||17
8615022|NCT02755818|21250778|P3|STARTED|Overall Study||2
8615023|NCT02755818|21250779|P2|STARTED|Overall Study||2
8615024|NCT02755818|21250780|P1|STARTED|Overall Study||30
8615025|NCT02737553|21250816|P2|NOT COMPLETED|Overall Study||0
8615026|NCT02737553|21250817|P1|NOT COMPLETED|Overall Study||0
8615027|NCT02737553|21250816|P2|COMPLETED|Overall Study||48
8615028|NCT02737553|21250817|P1|COMPLETED|Overall Study||49
8615029|NCT02737553|21250816|P2|STARTED|Overall Study||48
8615030|NCT02737553|21250817|P1|STARTED|Overall Study||49
8615031|NCT02728830|21250829|P1|NOT COMPLETED|Overall Study||24
8615032|NCT02728830|21250829|P1|COMPLETED|Overall Study||15
8615033|NCT02728830|21250829|P1|STARTED|Overall Study||39
8615098|NCT02674061|21251039|P2|NOT COMPLETED|Overall Study||91
8615099|NCT02674061|21251040|P1|NOT COMPLETED|Overall Study||285
8615100|NCT02674061|21251039|P2|COMPLETED|Overall Study||0
8615101|NCT02674061|21251040|P1|COMPLETED|Overall Study||0
8615102|NCT02674061|21251039|P2|STARTED|Overall Study||91
8615103|NCT02674061|21251040|P1|STARTED|Overall Study||285
8615110|NCT02659150|21251251|P1|NOT COMPLETED|Follow-up Imaging||0
8615111|NCT02659150|21251251|P1|COMPLETED|Follow-up Imaging||8
8615112|NCT02659150|21251251|P1|STARTED|Follow-up Imaging||8
8615113|NCT02659150|21251251|P1|NOT COMPLETED|Study Drug Dosing||1
8615114|NCT02659150|21251251|P1|COMPLETED|Study Drug Dosing||8
8615115|NCT02659150|21251251|P1|STARTED|Study Drug Dosing||9
8615116|NCT02659150|21251251|P1|NOT COMPLETED|Baseline Imaging||2
8615117|NCT02659150|21251251|P1|COMPLETED|Baseline Imaging||9
8615118|NCT02659150|21251251|P1|STARTED|Baseline Imaging||11
8615119|NCT02659150|21251251|P1|NOT COMPLETED|Subject Enrollment||5
8615120|NCT02659150|21251251|P1|COMPLETED|Subject Enrollment||11
8615121|NCT02659150|21251251|P1|STARTED|Subject Enrollment||16
8615146|NCT02642042|21251333|P1|NOT COMPLETED|Overall Study||54
8615147|NCT02642042|21251333|P1|COMPLETED|Overall Study||0
8615148|NCT02642042|21251333|P1|STARTED|Overall Study||54
8615149|NCT02628444|21251349|P9|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
8615150|NCT02628444|21251350|P8|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
8615151|NCT02628444|21251351|P7|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
8615152|NCT02628444|21251352|P6|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
8615153|NCT02628444|21251353|P5|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
8615154|NCT02628444|21251354|P4|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
8615155|NCT02628444|21251355|P3|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615156|NCT02628444|21251356|P2|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615157|NCT02628444|21251357|P1|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615158|NCT02628444|21251349|P9|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
8615159|NCT02628444|21251350|P8|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
8615160|NCT02628444|21251351|P7|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
8615161|NCT02628444|21251352|P6|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
8615162|NCT02628444|21251353|P5|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
8615163|NCT02628444|21251354|P4|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
8615164|NCT02628444|21251355|P3|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615165|NCT02628444|21251356|P2|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615166|NCT02628444|21251357|P1|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615167|NCT02628444|21251349|P9|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
8615168|NCT02628444|21251350|P8|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
8615169|NCT02628444|21251351|P7|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
8615170|NCT02628444|21251352|P6|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
8615171|NCT02628444|21251353|P5|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
8615172|NCT02628444|21251354|P4|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
8615173|NCT02628444|21251355|P3|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615174|NCT02628444|21251356|P2|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615175|NCT02628444|21251357|P1|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615176|NCT02628444|21251349|P9|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
8615177|NCT02628444|21251350|P8|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
8615178|NCT02628444|21251351|P7|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
8615179|NCT02628444|21251352|P6|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
8615180|NCT02628444|21251353|P5|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
8615181|NCT02628444|21251354|P4|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
8615182|NCT02628444|21251355|P3|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615183|NCT02628444|21251356|P2|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615184|NCT02628444|21251357|P1|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615185|NCT02628444|21251349|P9|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615186|NCT02628444|21251350|P8|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615187|NCT02628444|21251351|P7|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615188|NCT02628444|21251352|P6|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615189|NCT02628444|21251353|P5|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615190|NCT02628444|21251354|P4|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615191|NCT02628444|21251355|P3|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
8615192|NCT02628444|21251356|P2|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
8615193|NCT02628444|21251357|P1|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
8615194|NCT02628444|21251349|P9|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615195|NCT02628444|21251350|P8|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615196|NCT02628444|21251351|P7|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615197|NCT02628444|21251352|P6|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615198|NCT02628444|21251353|P5|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615199|NCT02628444|21251354|P4|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615200|NCT02628444|21251355|P3|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
8615201|NCT02628444|21251356|P2|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
8615202|NCT02628444|21251357|P1|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
8615203|NCT02628444|21251349|P9|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615204|NCT02628444|21251350|P8|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615205|NCT02628444|21251351|P7|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615206|NCT02628444|21251352|P6|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615207|NCT02628444|21251353|P5|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615208|NCT02628444|21251354|P4|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615209|NCT02628444|21251355|P3|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
8615210|NCT02628444|21251356|P2|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
8615211|NCT02628444|21251357|P1|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
8615212|NCT02628444|21251349|P9|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615213|NCT02628444|21251350|P8|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615214|NCT02628444|21251351|P7|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615215|NCT02628444|21251352|P6|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615216|NCT02628444|21251353|P5|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615217|NCT02628444|21251354|P4|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615218|NCT02628444|21251355|P3|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
8615219|NCT02628444|21251356|P2|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
8615220|NCT02628444|21251357|P1|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
8615221|NCT02628444|21251349|P9|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615222|NCT02628444|21251350|P8|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615223|NCT02628444|21251351|P7|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615224|NCT02628444|21251352|P6|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615225|NCT02628444|21251353|P5|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615226|NCT02628444|21251354|P4|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615227|NCT02628444|21251355|P3|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
8615228|NCT02628444|21251356|P2|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
8615229|NCT02628444|21251357|P1|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
8615242|NCT02586207|21251463|P1|NOT COMPLETED|Overall Study||2
8615243|NCT02586207|21251463|P1|COMPLETED|Overall Study||57
8615244|NCT02586207|21251463|P1|STARTED|Overall Study||59
8615278|NCT02535065|21251512|P1|NOT COMPLETED|Overall Study||62
8615279|NCT02535065|21251512|P1|COMPLETED|Overall Study||0
8615280|NCT02535065|21251512|P1|12-Month Follow-up|Overall Study||61
8615281|NCT02535065|21251512|P1|1-Month Follow-up|Overall Study||62
8615282|NCT02535065|21251512|P1|STARTED|Overall Study||62
8615283|NCT02520310|21251517|P1|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
8615284|NCT02520310|21251517|P1|COMPLETED|AT 4 Year Clinical Follow-up||22
8615285|NCT02520310|21251517|P1|STARTED|AT 4 Year Clinical Follow-up||24
8615286|NCT02520310|21251517|P1|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
8615287|NCT02520310|21251517|P1|COMPLETED|AT 3 Year Clinical Follow-up||24
8615288|NCT02520310|21251517|P1|STARTED|AT 3 Year Clinical Follow-up||28
8615289|NCT02520310|21251517|P1|NOT COMPLETED|At 2 Year Clinical Follow-up||0
8615290|NCT02520310|21251517|P1|COMPLETED|At 2 Year Clinical Follow-up||28
8615291|NCT02520310|21251517|P1|STARTED|At 2 Year Clinical Follow-up||28
8615292|NCT02520310|21251517|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||1
8615293|NCT02520310|21251517|P1|COMPLETED|At 1 Year Clinical Follow-up||28
8615294|NCT02520310|21251517|P1|STARTED|At 1 Year Clinical Follow-up||29
8615295|NCT02520310|21251517|P1|NOT COMPLETED|At 6 Months Clinical Follow-up||1
8615296|NCT02520310|21251517|P1|COMPLETED|At 6 Months Clinical Follow-up||29
8615297|NCT02520310|21251517|P1|STARTED|At 6 Months Clinical Follow-up||30
8615298|NCT02520310|21251517|P1|NOT COMPLETED|At 30 Days Clinical Follow-up||0
8615299|NCT02520310|21251517|P1|COMPLETED|At 30 Days Clinical Follow-up||30
8615300|NCT02520310|21251517|P1|STARTED|At 30 Days Clinical Follow-up||30
8615301|NCT02457910|21251713|P6|NOT COMPLETED|Overall Study||11
8615302|NCT02457910|21251714|P5|NOT COMPLETED|Overall Study||5
8615303|NCT02457910|21251715|P4|NOT COMPLETED|Overall Study||2
8615304|NCT02457910|21251716|P3|NOT COMPLETED|Overall Study||3
8615305|NCT02457910|21251717|P2|NOT COMPLETED|Overall Study||5
8615306|NCT02457910|21251718|P1|NOT COMPLETED|Overall Study||3
8615307|NCT02457910|21251713|P6|COMPLETED|Overall Study||1
8615308|NCT02457910|21251714|P5|COMPLETED|Overall Study||0
8615309|NCT02457910|21251715|P4|COMPLETED|Overall Study||0
8615310|NCT02457910|21251716|P3|COMPLETED|Overall Study||0
8615311|NCT02457910|21251717|P2|COMPLETED|Overall Study||0
8615312|NCT02457910|21251718|P1|COMPLETED|Overall Study||0
8615313|NCT02457910|21251713|P6|STARTED|Overall Study||12
8615314|NCT02457910|21251714|P5|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
8615315|NCT02457910|21251715|P4|STARTED|Overall Study||2
8615316|NCT02457910|21251716|P3|STARTED|Overall Study||3
8615317|NCT02457910|21251717|P2|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
8615318|NCT02457910|21251718|P1|STARTED|Overall Study||3
8615407|NCT02403622|21252414|P1|NOT COMPLETED|Overall Study||2
8615408|NCT02403622|21252414|P1|COMPLETED|Overall Study||13
8615409|NCT02403622|21252414|P1|STARTED|Overall Study||15
8615410|NCT02380612|21252419|P1|NOT COMPLETED|Overall Study||3
8615411|NCT02380612|21252419|P1|COMPLETED|Overall Study||27
8615412|NCT02380612|21252419|P1|STARTED|Overall Study||30
8615413|NCT02376790|21252434|P3|NOT COMPLETED|Overall Study||53
8615414|NCT02376790|21252435|P2|NOT COMPLETED|Overall Study||47
8615415|NCT02376790|21252436|P1|NOT COMPLETED|Overall Study||60
8615416|NCT02376790|21252434|P3|COMPLETED|Overall Study||230
8615417|NCT02376790|21252435|P2|COMPLETED|Overall Study||237
8615418|NCT02376790|21252436|P1|COMPLETED|Overall Study||224
8615419|NCT02376790|21252434|P3|Received Treatment|Overall Study||282
8615420|NCT02376790|21252435|P2|Received Treatment|Overall Study||284
8615421|NCT02376790|21252436|P1|Received Treatment|Overall Study||282
8615422|NCT02376790|21252434|P3|STARTED|Overall Study||283
8615423|NCT02376790|21252435|P2|STARTED|Overall Study||284
8615424|NCT02376790|21252436|P1|STARTED|Overall Study||284
8615425|NCT02376361|21252554|P2|NOT COMPLETED|Overall Study||117
8615426|NCT02376361|21252555|P1|NOT COMPLETED|Overall Study||171
8615427|NCT02376361|21252554|P2|COMPLETED|Overall Study||90
8615428|NCT02376361|21252555|P1|COMPLETED|Overall Study||58
8615429|NCT02376361|21252554|P2|STARTED|Overall Study||207
8615430|NCT02376361|21252555|P1|STARTED|Overall Study||229
8615440|NCT02337465|21252597|P1|NOT COMPLETED|Overall Study||0
8615441|NCT02337465|21252597|P1|COMPLETED|Overall Study||30
8615442|NCT02337465|21252597|P1|STARTED|Overall Study||30
8615627|NCT02242942|21253086|P2|COMPLETED|Overall Study||0
8615601|NCT02273739|21252970|P4|NOT COMPLETED|Overall Study||7
8615602|NCT02273739|21252971|P3|NOT COMPLETED|Overall Study||7
8615603|NCT02273739|21252972|P2|NOT COMPLETED|Overall Study||4
8615604|NCT02273739|21252973|P1|NOT COMPLETED|Overall Study||3
8615605|NCT02273739|21252970|P4|COMPLETED|Overall Study||0
8615606|NCT02273739|21252971|P3|COMPLETED|Overall Study||0
8615607|NCT02273739|21252972|P2|COMPLETED|Overall Study||0
8615608|NCT02273739|21252973|P1|COMPLETED|Overall Study||0
8615609|NCT02273739|21252970|P4|STARTED|Overall Study||7
8615610|NCT02273739|21252971|P3|STARTED|Overall Study||7
8615611|NCT02273739|21252972|P2|STARTED|Overall Study||4
8615612|NCT02273739|21252973|P1|STARTED|Overall Study||3
8615623|NCT02242942|21253085|P3|NOT COMPLETED|Overall Study||13
8615624|NCT02242942|21253086|P2|NOT COMPLETED|Overall Study||216
8615625|NCT02242942|21253087|P1|NOT COMPLETED|Overall Study||216
8615626|NCT02242942|21253085|P3|COMPLETED|Overall Study||0
8615628|NCT02242942|21253087|P1|COMPLETED|Overall Study||0
8615629|NCT02242942|21253085|P3|Treated|Overall Study||13
8615630|NCT02242942|21253086|P2|Treated|Overall Study||212
8615631|NCT02242942|21253087|P1|Treated|Overall Study||214
8615632|NCT02242942|21253085|P3|STARTED|Overall Study||13
8615633|NCT02242942|21253086|P2|STARTED|Overall Study||216
8615634|NCT02242942|21253087|P1|STARTED|Overall Study||216
8615638|NCT02227238|21253122|P2|NOT COMPLETED|Overall Study||67
8615639|NCT02227238|21253123|P1|NOT COMPLETED|Overall Study||37
8615640|NCT02227238|21253122|P2|COMPLETED|Overall Study||245
8615641|NCT02227238|21253123|P1|COMPLETED|Overall Study||275
8615642|NCT02227238|21253122|P2|STARTED|Overall Study||312
8615643|NCT02227238|21253123|P1|STARTED|Overall Study||312
8615674|NCT02123485|21253358|P2|NOT COMPLETED|Overall Study||0
8615675|NCT02123485|21253359|P1|NOT COMPLETED|Overall Study||1
8615676|NCT02123485|21253358|P2|COMPLETED|Overall Study||17
8615677|NCT02123485|21253359|P1|COMPLETED|Overall Study||17
8615678|NCT02123485|21253358|P2|STARTED|Overall Study||17
8615679|NCT02123485|21253359|P1|STARTED|Overall Study||18
8615686|NCT02094261|21253392|P1|NOT COMPLETED|Overall Study||210
8615687|NCT02094261|21253392|P1|COMPLETED|Overall Study||0
8615688|NCT02094261|21253392|P1|STARTED|Overall Study||210
8615699|NCT02076009|21253488|P2|NOT COMPLETED|Overall Study||286
8615700|NCT02076009|21253489|P1|NOT COMPLETED|Overall Study||283
8615701|NCT02076009|21253488|P2|COMPLETED|Overall Study||0
8615702|NCT02076009|21253489|P1|COMPLETED|Overall Study||0
8615703|NCT02076009|21253488|P2|Treated|Overall Study||283
8615704|NCT02076009|21253489|P1|Treated|Overall Study||281
8615705|NCT02076009|21253488|P2|STARTED|Overall Study||286
8615706|NCT02076009|21253489|P1|STARTED|Overall Study||283
8615725|NCT02003924|21253557|P3|NOT COMPLETED|Long-term Follow-up Phase||7
8615726|NCT02003924|21253558|P2|NOT COMPLETED|Long-term Follow-up Phase||237
8615727|NCT02003924|21253559|P1|NOT COMPLETED|Long-term Follow-up Phase||367
8615728|NCT02003924|21253557|P3|COMPLETED|Long-term Follow-up Phase||80
8615729|NCT02003924|21253558|P2|COMPLETED|Long-term Follow-up Phase||144
8615730|NCT02003924|21253559|P1|COMPLETED|Long-term Follow-up Phase||566
8615731|NCT02003924|21253557|P3|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
8615732|NCT02003924|21253558|P2|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
8615733|NCT02003924|21253559|P1|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
8615734|NCT02003924|21253557|P3|NOT COMPLETED|Open-label Phase||17
8615735|NCT02003924|21253558|P2|NOT COMPLETED|Open-label Phase||0
8615736|NCT02003924|21253559|P1|NOT COMPLETED|Open-label Phase||100
8615737|NCT02003924|21253557|P3|COMPLETED|Open-label Phase||70
8615738|NCT02003924|21253558|P2|COMPLETED|Open-label Phase||0
8615739|NCT02003924|21253559|P1|COMPLETED|Open-label Phase||378
8615740|NCT02003924|21253557|P3|Treated|Open-label Phase||87
8615741|NCT02003924|21253558|P2|Treated|Open-label Phase||0
8615742|NCT02003924|21253559|P1|Treated|Open-label Phase||478
8615743|NCT02003924|21253557|P3|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
8615744|NCT02003924|21253558|P2|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
8615745|NCT02003924|21253559|P1|STARTED|Open-label Phase||478
8615746|NCT02003924|21253557|P3|NOT COMPLETED|Double-blind Phase||0
8615747|NCT02003924|21253558|P2|NOT COMPLETED|Double-blind Phase||381
8615748|NCT02003924|21253559|P1|NOT COMPLETED|Double-blind Phase||455
8615749|NCT02003924|21253557|P3|COMPLETED|Double-blind Phase||0
8615750|NCT02003924|21253558|P2|COMPLETED|Double-blind Phase||87
8615751|NCT02003924|21253559|P1|COMPLETED|Double-blind Phase||478
8615752|NCT02003924|21253557|P3|Treated|Double-blind Phase||0
8615753|NCT02003924|21253558|P2|Treated|Double-blind Phase||465
8615754|NCT02003924|21253559|P1|Treated|Double-blind Phase||930
8615755|NCT02003924|21253557|P3|STARTED|Double-blind Phase||0
8615756|NCT02003924|21253558|P2|STARTED|Double-blind Phase||468
8615757|NCT02003924|21253559|P1|STARTED|Double-blind Phase||933
8615764|NCT01989546|21253667|P1|NOT COMPLETED|Overall Study||9
8615765|NCT01989546|21253667|P1|COMPLETED|Overall Study||0
8615766|NCT01989546|21253667|P1|STARTED|Overall Study||9
8615767|NCT01938001|21253675|P2|NOT COMPLETED|Overall Study||47
8615768|NCT01938001|21253676|P1|NOT COMPLETED|Overall Study||43
8615769|NCT01938001|21253675|P2|COMPLETED|Overall Study||133
8615770|NCT01938001|21253676|P1|COMPLETED|Overall Study||135
8615771|NCT01938001|21253675|P2|Completed Treatment|Overall Study||110
8615772|NCT01938001|21253676|P1|Completed Treatment|Overall Study||124
8615773|NCT01938001|21253675|P2|Participants Received Treatment|Overall Study||180
8615774|NCT01938001|21253676|P1|Participants Received Treatment|Overall Study||176
8615775|NCT01938001|21253675|P2|STARTED|Overall Study||180
8615776|NCT01938001|21253676|P1|STARTED|Overall Study||178
8615879|NCT01754753|21253890|P2|NOT COMPLETED|Overall Study||49
8615880|NCT01754753|21253891|P1|NOT COMPLETED|Overall Study||52
8615881|NCT01754753|21253890|P2|COMPLETED|Overall Study||30
8615882|NCT01754753|21253891|P1|COMPLETED|Overall Study||26
8615883|NCT01754753|21253890|P2|STARTED|Overall Study||79
8615884|NCT01754753|21253891|P1|STARTED|Overall Study||78
8615888|NCT01736124|21253917|P2|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
8615889|NCT01736124|21253918|P1|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
8615890|NCT01736124|21253917|P2|COMPLETED|12 Mo. Post-Intervention Assessment||50
8615891|NCT01736124|21253918|P1|COMPLETED|12 Mo. Post-Intervention Assessment||46
8615892|NCT01736124|21253917|P2|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
8615893|NCT01736124|21253918|P1|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
8615894|NCT01736124|21253917|P2|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
8615895|NCT01736124|21253918|P1|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
8615896|NCT01736124|21253917|P2|COMPLETED|6 Mo. Post-Intervention Assessment||58
8615897|NCT01736124|21253918|P1|COMPLETED|6 Mo. Post-Intervention Assessment||57
8615898|NCT01736124|21253917|P2|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
8615899|NCT01736124|21253918|P1|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
8615900|NCT01736124|21253917|P2|NOT COMPLETED|Post-intervention Assessment||21
8615901|NCT01736124|21253918|P1|NOT COMPLETED|Post-intervention Assessment||31
8615902|NCT01736124|21253917|P2|COMPLETED|Post-intervention Assessment||69
8615903|NCT01736124|21253918|P1|COMPLETED|Post-intervention Assessment||59
8615904|NCT01736124|21253917|P2|STARTED|Post-intervention Assessment||90
8615905|NCT01736124|21253918|P1|STARTED|Post-intervention Assessment||90
8615906|NCT01736124|21253917|P2|NOT COMPLETED|Baseline||0
8615907|NCT01736124|21253918|P1|NOT COMPLETED|Baseline||0
8615908|NCT01736124|21253917|P2|COMPLETED|Baseline||90
8615909|NCT01736124|21253918|P1|COMPLETED|Baseline||90
8615910|NCT01736124|21253917|P2|STARTED|Baseline||90
8615911|NCT01736124|21253918|P1|STARTED|Baseline||90
8615953|NCT01660451|21254061|P3|NOT COMPLETED|Overall Study||105
8615954|NCT01660451|21254062|P2|NOT COMPLETED|Overall Study||17
8615955|NCT01660451|21254063|P1|NOT COMPLETED|Overall Study||17
8615956|NCT01660451|21254061|P3|COMPLETED|Overall Study||37
8615957|NCT01660451|21254062|P2|COMPLETED|Overall Study||34
8615958|NCT01660451|21254063|P1|COMPLETED|Overall Study||16
8615959|NCT01660451|21254061|P3|STARTED|Overall Study||142
8615960|NCT01660451|21254062|P2|STARTED|Overall Study||51
8615961|NCT01660451|21254063|P1|STARTED|Overall Study||33
8615968|NCT01609842|21254106|P2|NOT COMPLETED|Concurrent Intervention Control||0
8615969|NCT01609842|21254107|P1|NOT COMPLETED|Concurrent Intervention Control||2
8615970|NCT01609842|21254106|P2|COMPLETED|Concurrent Intervention Control||4869
8615971|NCT01609842|21254107|P1|COMPLETED|Concurrent Intervention Control||706
8615972|NCT01609842|21254106|P2|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
8615973|NCT01609842|21254107|P1|STARTED|Concurrent Intervention Control||708
8615974|NCT01609842|21254106|P2|NOT COMPLETED|Post-Intervention Control||0
8615975|NCT01609842|21254107|P1|NOT COMPLETED|Post-Intervention Control||0
8615976|NCT01609842|21254106|P2|COMPLETED|Post-Intervention Control||2917
8615977|NCT01609842|21254107|P1|COMPLETED|Post-Intervention Control||0
8615978|NCT01609842|21254106|P2|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
8615979|NCT01609842|21254107|P1|STARTED|Post-Intervention Control||0
8615980|NCT01609842|21254106|P2|NOT COMPLETED|Pre-Intervention Control||0
8615981|NCT01609842|21254107|P1|NOT COMPLETED|Pre-Intervention Control||0
8615982|NCT01609842|21254106|P2|COMPLETED|Pre-Intervention Control||6081
8615983|NCT01609842|21254107|P1|COMPLETED|Pre-Intervention Control||0
8615984|NCT01609842|21254106|P2|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
8615985|NCT01609842|21254107|P1|STARTED|Pre-Intervention Control||0
8616010|NCT01591733|21254306|P1|NOT COMPLETED|Overall Study||0
8616011|NCT01591733|21254306|P1|COMPLETED|Overall Study||48
8616012|NCT01591733|21254306|P1|STARTED|Overall Study||48
8616039|NCT01338987|21254386|P5|NOT COMPLETED|Overall Study||0
8616040|NCT01338987|21254387|P4|NOT COMPLETED|Overall Study||0
8616041|NCT01338987|21254388|P3|NOT COMPLETED|Overall Study||2
8616042|NCT01338987|21254389|P2|NOT COMPLETED|Overall Study||1
8616043|NCT01338987|21254390|P1|NOT COMPLETED|Overall Study||2
8616044|NCT01338987|21254386|P5|COMPLETED|Overall Study||2
8616045|NCT01338987|21254387|P4|COMPLETED|Overall Study||31
8616046|NCT01338987|21254388|P3|COMPLETED|Overall Study||20
8616047|NCT01338987|21254389|P2|COMPLETED|Overall Study||8
8616048|NCT01338987|21254390|P1|COMPLETED|Overall Study||10
8616049|NCT01338987|21254386|P5|STARTED|Overall Study||2
8616050|NCT01338987|21254387|P4|STARTED|Overall Study||31
8616051|NCT01338987|21254388|P3|STARTED|Overall Study||22
8616052|NCT01338987|21254389|P2|STARTED|Overall Study||9
8616053|NCT01338987|21254390|P1|STARTED|Overall Study||12
8616054|NCT01302834|21254407|P2|NOT COMPLETED|Overall Study||26
8616055|NCT01302834|21254408|P1|NOT COMPLETED|Overall Study||18
8616056|NCT01302834|21254407|P2|COMPLETED|Overall Study||399
8616057|NCT01302834|21254408|P1|COMPLETED|Overall Study||406
8616058|NCT01302834|21254407|P2|Progressed|Overall Study||122
8616059|NCT01302834|21254408|P1|Progressed|Overall Study||76
8616060|NCT01302834|21254407|P2|Feeding Tube Assessed|Overall Study||356
8616061|NCT01302834|21254408|P1|Feeding Tube Assessed|Overall Study||368
8616062|NCT01302834|21254407|P2|Dental Health Assessed 5 Years PT|Overall Study||43
8616063|NCT01302834|21254408|P1|Dental Health Assessed 5 Years PT|Overall Study||44
8616064|NCT01302834|21254407|P2|Dental Health Assessed 2 Years PT|Overall Study||201
8616065|NCT01302834|21254408|P1|Dental Health Assessed 2 Years PT|Overall Study||208
8616066|NCT01302834|21254407|P2|Dental Health Assessed 1 Year PT|Overall Study||267
8616067|NCT01302834|21254408|P1|Dental Health Assessed 1 Year PT|Overall Study||267
8616068|NCT01302834|21254407|P2|AE Assessed 5 Years PT|Overall Study||86
8616069|NCT01302834|21254408|P1|AE Assessed 5 Years PT|Overall Study||92
8616070|NCT01302834|21254407|P2|AE Assessed 2 Years PT|Overall Study||303
8616071|NCT01302834|21254408|P1|AE Assessed 2 Years PT|Overall Study||311
8616072|NCT01302834|21254407|P2|AE Assessment 1 Year PT|Overall Study||351
8616073|NCT01302834|21254408|P1|AE Assessment 1 Year PT|Overall Study||360
8616074|NCT01302834|21254407|P2|AE Assessed 6 Months PT|Overall Study||352
8616075|NCT01302834|21254408|P1|AE Assessed 6 Months PT|Overall Study||361
8616076|NCT01302834|21254407|P2|AE Assessed 3 Months PT|Overall Study||367
8616077|NCT01302834|21254408|P1|AE Assessed 3 Months PT|Overall Study||359
8616078|NCT01302834|21254407|P2|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
8616079|NCT01302834|21254408|P1|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
8616080|NCT01302834|21254407|P2|Started Treatment|Overall Study||394
8616081|NCT01302834|21254408|P1|Started Treatment|Overall Study||398
8616082|NCT01302834|21254407|P2|Eligible|Overall Study||399
8616083|NCT01302834|21254408|P1|Eligible|Overall Study||406
8616084|NCT01302834|21254407|P2|STARTED|Overall Study||425
8616085|NCT01302834|21254408|P1|STARTED|Overall Study||424
8616104|NCT01216683|21254533|P3|NOT COMPLETED|Continuation||43
8616105|NCT01216683|21254534|P2|NOT COMPLETED|Continuation||15
8616106|NCT01216683|21254535|P1|NOT COMPLETED|Continuation||15
8616107|NCT01216683|21254533|P3|COMPLETED|Continuation||51
8616108|NCT01216683|21254534|P2|COMPLETED|Continuation||56
8616109|NCT01216683|21254535|P1|COMPLETED|Continuation||44
8616110|NCT01216683|21254533|P3|Received Continuation Treatment|Continuation||89
8616111|NCT01216683|21254534|P2|Received Continuation Treatment|Continuation||70
8616112|NCT01216683|21254535|P1|Received Continuation Treatment|Continuation||59
8616113|NCT01216683|21254533|P3|STARTED|Continuation||94
8616114|NCT01216683|21254534|P2|STARTED|Continuation||71
8616115|NCT01216683|21254535|P1|STARTED|Continuation||59
8616116|NCT01216683|21254533|P3|NOT COMPLETED|Induction||21
8616117|NCT01216683|21254534|P2|NOT COMPLETED|Induction||19
8616118|NCT01216683|21254535|P1|NOT COMPLETED|Induction||4
8616119|NCT01216683|21254533|P3|COMPLETED|Induction||104
8616120|NCT01216683|21254534|P2|COMPLETED|Induction||80
8616121|NCT01216683|21254535|P1|COMPLETED|Induction||61
8616122|NCT01216683|21254533|P3|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
8616123|NCT01216683|21254534|P2|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
8616124|NCT01216683|21254535|P1|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
8616125|NCT01216683|21254533|P3|Eligible and Treated|Induction||114
8616126|NCT01216683|21254534|P2|Eligible and Treated|Induction||85
8616127|NCT01216683|21254535|P1|Eligible and Treated|Induction||59
8616128|NCT01216683|21254533|P3|Received Treatment and Assessed for Toxicities|Induction||122
8616129|NCT01216683|21254534|P2|Received Treatment and Assessed for Toxicities|Induction||93
8616130|NCT01216683|21254535|P1|Received Treatment and Assessed for Toxicities|Induction||65
8616131|NCT01216683|21254533|P3|STARTED|Induction||125
8616132|NCT01216683|21254534|P2|STARTED|Induction||99
8616133|NCT01216683|21254535|P1|STARTED|Induction||65
8616159|NCT01107626|21254689|P4|NOT COMPLETED|Step 2: Maintenance Therapy||292
8616160|NCT01107626|21254690|P3|NOT COMPLETED|Step 2: Maintenance Therapy||294
8616161|NCT01107626|21254691|P2|NOT COMPLETED|Step 2: Maintenance Therapy||286
8616162|NCT01107626|21254692|P1|NOT COMPLETED|Step 2: Maintenance Therapy||0
8616163|NCT01107626|21254689|P4|COMPLETED|Step 2: Maintenance Therapy||1
8616164|NCT01107626|21254690|P3|COMPLETED|Step 2: Maintenance Therapy||0
8616165|NCT01107626|21254691|P2|COMPLETED|Step 2: Maintenance Therapy||1
8616166|NCT01107626|21254692|P1|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
8616167|NCT01107626|21254689|P4|STARTED|Step 2: Maintenance Therapy||293
8616168|NCT01107626|21254690|P3|STARTED|Step 2: Maintenance Therapy||294
8616169|NCT01107626|21254691|P2|STARTED|Step 2: Maintenance Therapy||287
8616170|NCT01107626|21254692|P1|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
8616171|NCT01107626|21254689|P4|NOT COMPLETED|Step 1: Induction Therapy||0
8616172|NCT01107626|21254690|P3|NOT COMPLETED|Step 1: Induction Therapy||0
8616173|NCT01107626|21254691|P2|NOT COMPLETED|Step 1: Induction Therapy||0
8616174|NCT01107626|21254692|P1|NOT COMPLETED|Step 1: Induction Therapy||577
8616175|NCT01107626|21254689|P4|COMPLETED|Step 1: Induction Therapy||293
8616176|NCT01107626|21254690|P3|COMPLETED|Step 1: Induction Therapy||294
8616177|NCT01107626|21254691|P2|COMPLETED|Step 1: Induction Therapy||287
8616178|NCT01107626|21254692|P1|COMPLETED|Step 1: Induction Therapy||65
8616179|NCT01107626|21254689|P4|STARTED|Step 1: Induction Therapy||293
8616180|NCT01107626|21254690|P3|STARTED|Step 1: Induction Therapy||294
8616181|NCT01107626|21254691|P2|STARTED|Step 1: Induction Therapy||287
8616182|NCT01107626|21254692|P1|STARTED|Step 1: Induction Therapy||642
8616237|NCT01054144|21254846|P1|NOT COMPLETED|Overall Study||2
8616238|NCT01054144|21254846|P1|COMPLETED|Overall Study||25
8616239|NCT01054144|21254846|P1|STARTED|Overall Study||27
8616270|NCT01004874|21255106|P1|NOT COMPLETED|Overall Study||0
8616271|NCT01004874|21255106|P1|COMPLETED|Overall Study||80
8616272|NCT01004874|21255106|P1|STARTED|Overall Study||80
8616347|NCT00794339|21255393|P1|NOT COMPLETED|Overall Study||14
8616348|NCT00794339|21255393|P1|COMPLETED|Overall Study||59
8616349|NCT00794339|21255393|P1|Evaluable|Overall Study||59
8616350|NCT00794339|21255393|P1|Eligible|Overall Study||69
8616351|NCT00794339|21255393|P1|STARTED|Overall Study||73
8616352|NCT00777491|21255447|P2|NOT COMPLETED|Overall Study||2
8616353|NCT00777491|21255448|P1|NOT COMPLETED|Overall Study||2
8616354|NCT00777491|21255447|P2|COMPLETED|Overall Study||33
8616355|NCT00777491|21255448|P1|COMPLETED|Overall Study||33
8616356|NCT00777491|21255447|P2|Has 3 Year AUASI Data|Overall Study||6
8616357|NCT00777491|21255448|P1|Has 3 Year AUASI Data|Overall Study||6
8616358|NCT00777491|21255447|P2|Has Adverse Event Data (Late)|Overall Study||31
8616359|NCT00777491|21255448|P1|Has Adverse Event Data (Late)|Overall Study||32
8616360|NCT00777491|21255447|P2|Has Adverse Event Data (Treatment)|Overall Study||33
8616361|NCT00777491|21255448|P1|Has Adverse Event Data (Treatment)|Overall Study||33
8616362|NCT00777491|21255447|P2|Started Adjuvant Therapy|Overall Study||31
8616363|NCT00777491|21255448|P1|Started Adjuvant Therapy|Overall Study||32
8616364|NCT00777491|21255447|P2|Started Consolidation Therapy|Overall Study||25
8616365|NCT00777491|21255448|P1|Started Consolidation Therapy|Overall Study||29
8616366|NCT00777491|21255447|P2|Started Induction Therapy|Overall Study||33
8616367|NCT00777491|21255448|P1|Started Induction Therapy|Overall Study||33
8616368|NCT00777491|21255447|P2|Has 3-year Efficacy Data|Overall Study||25
8616369|NCT00777491|21255448|P1|Has 3-year Efficacy Data|Overall Study||27
8616370|NCT00777491|21255447|P2|Eligible|Overall Study||33
8616371|NCT00777491|21255448|P1|Eligible|Overall Study||33
8616372|NCT00777491|21255447|P2|STARTED|Overall Study||35
8616373|NCT00777491|21255448|P1|STARTED|Overall Study||35
8616515|NCT00537095|21255829|P2|NOT COMPLETED|Overall Study||57
8616516|NCT00537095|21255830|P1|NOT COMPLETED|Overall Study||51
8616517|NCT00537095|21255829|P2|COMPLETED|Overall Study||16
8616518|NCT00537095|21255830|P1|COMPLETED|Overall Study||21
8616519|NCT00537095|21255829|P2|STARTED|Overall Study||73
8616520|NCT00537095|21255830|P1|STARTED|Overall Study||72
8616539|NCT00324740|21256125|P3|NOT COMPLETED|Overall Study||1
8616540|NCT00324740|21256126|P2|NOT COMPLETED|Overall Study||0
8616541|NCT00324740|21256127|P1|NOT COMPLETED|Overall Study||1
8616542|NCT00324740|21256125|P3|COMPLETED|Overall Study||3
8616543|NCT00324740|21256126|P2|COMPLETED|Overall Study||3
8616544|NCT00324740|21256127|P1|COMPLETED|Overall Study||6
8616545|NCT00324740|21256125|P3|STARTED|Overall Study||4
8616546|NCT00324740|21256126|P2|STARTED|Overall Study||3
8616547|NCT00324740|21256127|P1|STARTED|Overall Study||7
8616593|NCT04238663|21256466|P3|NOT COMPLETED|Overall Study||0
8616594|NCT04238663|21256467|P2|NOT COMPLETED|Overall Study||1
8616595|NCT04238663|21256468|P1|NOT COMPLETED|Overall Study||0
8616596|NCT04238663|21256466|P3|COMPLETED|Overall Study||38
8616597|NCT04238663|21256467|P2|COMPLETED|Overall Study||37
8616598|NCT04238663|21256468|P1|COMPLETED|Overall Study||38
8616599|NCT04238663|21256466|P3|STARTED|Overall Study||38
8616600|NCT04238663|21256467|P2|STARTED|Overall Study||38
8616601|NCT04238663|21256468|P1|STARTED|Overall Study||38
8616602|NCT04238650|21256499|P2|NOT COMPLETED|Overall Study||1
8616603|NCT04238650|21256500|P1|NOT COMPLETED|Overall Study||0
8616604|NCT04238650|21256499|P2|COMPLETED|Overall Study||24
8616605|NCT04238650|21256500|P1|COMPLETED|Overall Study||24
8616606|NCT04238650|21256499|P2|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
8616607|NCT04238650|21256500|P1|STARTED|Overall Study||24
8616613|NCT04102345|21256530|P2|NOT COMPLETED|Overall Study||0
8616614|NCT04102345|21256531|P1|NOT COMPLETED|Overall Study||1
8616615|NCT04102345|21256530|P2|COMPLETED|Overall Study||32
8616616|NCT04102345|21256531|P1|COMPLETED|Overall Study||25
8616617|NCT04102345|21256530|P2|STARTED|Overall Study||32
8616618|NCT04102345|21256531|P1|STARTED|Overall Study||26
8616628|NCT04082663|21256566|P1|NOT COMPLETED|Overall Study||7
8616629|NCT04082663|21256566|P1|COMPLETED|Overall Study||13
8616630|NCT04082663|21256566|P1|STARTED|Overall Study||20
8616640|NCT04017754|21256589|P3|NOT COMPLETED|Overall Study||0
8616641|NCT04017754|21256590|P2|NOT COMPLETED|Overall Study||0
8616642|NCT04017754|21256591|P1|NOT COMPLETED|Overall Study||0
8616643|NCT04017754|21256589|P3|COMPLETED|Overall Study||3354
8616644|NCT04017754|21256590|P2|COMPLETED|Overall Study||185
8616645|NCT04017754|21256591|P1|COMPLETED|Overall Study||267
8616646|NCT04017754|21256589|P3|STARTED|Overall Study||3354
8616647|NCT04017754|21256590|P2|STARTED|Overall Study||185
8616648|NCT04017754|21256591|P1|STARTED|Overall Study||267
8616649|NCT03974334|21256642|P1|NOT COMPLETED|Overall Study||1
8616650|NCT03974334|21256642|P1|COMPLETED|Overall Study||24
8616651|NCT03974334|21256642|P1|STARTED|Overall Study||25
8616652|NCT03944668|21256650|P1|NOT COMPLETED|Overall Study||9
8616653|NCT03944668|21256650|P1|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
8616654|NCT03944668|21256650|P1|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
8616655|NCT03944668|21256650|P1|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
8616656|NCT03944668|21256650|P1|STARTED|Overall Study|Enrolled in Study|17
8616657|NCT03881163|21256659|P1|NOT COMPLETED|Overall Study||0
8616658|NCT03881163|21256659|P1|COMPLETED|Overall Study||24
8616659|NCT03881163|21256659|P1|STARTED|Overall Study||24
8616699|NCT03790878|21256884|P3|NOT COMPLETED|Overall Study||0
8616700|NCT03790878|21256885|P2|NOT COMPLETED|Overall Study||0
8616701|NCT03790878|21256886|P1|NOT COMPLETED|Overall Study||0
8616702|NCT03790878|21256884|P3|COMPLETED|Overall Study||27
8616703|NCT03790878|21256885|P2|COMPLETED|Overall Study||27
8616704|NCT03790878|21256886|P1|COMPLETED|Overall Study||26
8616705|NCT03790878|21256884|P3|STARTED|Overall Study||27
8616706|NCT03790878|21256885|P2|STARTED|Overall Study||27
8616707|NCT03790878|21256886|P1|STARTED|Overall Study||26
8616757|NCT03631355|21257031|P2|NOT COMPLETED|Overall Study||2
8616758|NCT03631355|21257032|P1|NOT COMPLETED|Overall Study||1
8616759|NCT03631355|21257031|P2|COMPLETED|Overall Study||53
8616760|NCT03631355|21257032|P1|COMPLETED|Overall Study||54
8616761|NCT03631355|21257031|P2|STARTED|Overall Study||55
8616762|NCT03631355|21257032|P1|STARTED|Overall Study||55
8616763|NCT03615144|21257044|P2|NOT COMPLETED|Overall Study||0
8616764|NCT03615144|21257045|P1|NOT COMPLETED|Overall Study||1
8616765|NCT03615144|21257044|P2|COMPLETED|Overall Study||0
8616766|NCT03615144|21257045|P1|COMPLETED|Overall Study||0
8616767|NCT03615144|21257044|P2|STARTED|Overall Study||0
8616768|NCT03615144|21257045|P1|STARTED|Overall Study||1
8616782|NCT03567382|21257076|P4|NOT COMPLETED|Overall Study||33
8616783|NCT03567382|21257077|P3|NOT COMPLETED|Overall Study||2
8616784|NCT03567382|21257078|P2|NOT COMPLETED|Overall Study||35
8616785|NCT03567382|21257079|P1|NOT COMPLETED|Overall Study||3
8616786|NCT03567382|21257076|P4|COMPLETED|Overall Study||46
8616787|NCT03567382|21257077|P3|COMPLETED|Overall Study||7
8616788|NCT03567382|21257078|P2|COMPLETED|Overall Study||46
8616789|NCT03567382|21257079|P1|COMPLETED|Overall Study||7
8616790|NCT03567382|21257076|P4|Received Tenofovir|Overall Study||0
8616791|NCT03567382|21257077|P3|Received Tenofovir|Overall Study||0
8616792|NCT03567382|21257078|P2|Received Tenofovir|Overall Study||0
8616793|NCT03567382|21257079|P1|Received Tenofovir|Overall Study||9
8616794|NCT03567382|21257076|P4|STARTED|Overall Study||79
8616795|NCT03567382|21257077|P3|STARTED|Overall Study||9
8616796|NCT03567382|21257078|P2|STARTED|Overall Study||81
8616797|NCT03567382|21257079|P1|STARTED|Overall Study||10
8616804|NCT03547687|21257103|P1|NOT COMPLETED|Overall Study||2
8616805|NCT03547687|21257103|P1|COMPLETED|Overall Study||7
8616806|NCT03547687|21257103|P1|STARTED|Overall Study||9
8616821|NCT03416621|21257214|P3|NOT COMPLETED|Overall Study||5
8616822|NCT03416621|21257215|P2|NOT COMPLETED|Overall Study||1
8616823|NCT03416621|21257216|P1|NOT COMPLETED|Overall Study||0
8616824|NCT03416621|21257214|P3|COMPLETED|Overall Study||1
8616825|NCT03416621|21257215|P2|COMPLETED|Overall Study||11
8616826|NCT03416621|21257216|P1|COMPLETED|Overall Study||13
8616827|NCT03416621|21257214|P3|STARTED|Overall Study||6
8616828|NCT03416621|21257215|P2|STARTED|Overall Study||12
8616829|NCT03416621|21257216|P1|STARTED|Overall Study||13
8616854|NCT03372096|21257287|P1|NOT COMPLETED|Overall Study||8
8616855|NCT03372096|21257287|P1|COMPLETED|Overall Study||10
8616856|NCT03372096|21257287|P1|Received Intervention|Overall Study||10
8616857|NCT03372096|21257287|P1|STARTED|Overall Study||18
8616876|NCT03241342|21257355|P3|NOT COMPLETED|Overall Study||27
8616877|NCT03241342|21257356|P2|NOT COMPLETED|Overall Study||31
8616878|NCT03241342|21257357|P1|NOT COMPLETED|Overall Study||22
8616879|NCT03241342|21257355|P3|COMPLETED|Overall Study||138
8616880|NCT03241342|21257356|P2|COMPLETED|Overall Study||132
8616881|NCT03241342|21257357|P1|COMPLETED|Overall Study||141
8616882|NCT03241342|21257355|P3|STARTED|Overall Study||165
8616883|NCT03241342|21257356|P2|STARTED|Overall Study||163
8616884|NCT03241342|21257357|P1|STARTED|Overall Study||163
8616888|NCT03154658|21257376|P2|NOT COMPLETED|Overall Study||1
8616889|NCT03154658|21257377|P1|NOT COMPLETED|Overall Study||1
8616890|NCT03154658|21257376|P2|COMPLETED|Overall Study||32
8616891|NCT03154658|21257377|P1|COMPLETED|Overall Study||32
8616892|NCT03154658|21257376|P2|STARTED|Overall Study||33
8616893|NCT03154658|21257377|P1|STARTED|Overall Study||33
8616894|NCT03150043|21257395|P1|NOT COMPLETED|Overall Study||0
8616895|NCT03150043|21257395|P1|COMPLETED|Overall Study||65
8616896|NCT03150043|21257395|P1|STARTED|Overall Study||65
8616936|NCT03028896|21257466|P2|NOT COMPLETED|Overall Study||0
8616937|NCT03028896|21257467|P1|NOT COMPLETED|Overall Study||3
8616938|NCT03028896|21257466|P2|COMPLETED|Overall Study||66
8616939|NCT03028896|21257467|P1|COMPLETED|Overall Study||63
8616940|NCT03028896|21257466|P2|STARTED|Overall Study||66
8616941|NCT03028896|21257467|P1|STARTED|Overall Study||66
8616942|NCT03009396|21257479|P2|NOT COMPLETED|Overall Study||17
8616943|NCT03009396|21257480|P1|NOT COMPLETED|Overall Study||7
8616944|NCT03009396|21257479|P2|COMPLETED|Overall Study||21
8616945|NCT03009396|21257480|P1|COMPLETED|Overall Study||9
8616946|NCT03009396|21257479|P2|STARTED|Overall Study||38
8616947|NCT03009396|21257480|P1|STARTED|Overall Study||16
8616960|NCT02990338|21257643|P2|NOT COMPLETED|Overall Study||89
8616961|NCT02990338|21257644|P1|NOT COMPLETED|Overall Study||118
8616962|NCT02990338|21257643|P2|COMPLETED|Overall Study||65
8616963|NCT02990338|21257644|P1|COMPLETED|Overall Study||35
8616964|NCT02990338|21257643|P2|Ongoing|Overall Study||65
8616965|NCT02990338|21257644|P1|Ongoing|Overall Study||35
8616966|NCT02990338|21257643|P2|Treated|Overall Study||152
8616967|NCT02990338|21257644|P1|Treated|Overall Study||149
8616968|NCT02990338|21257643|P2|STARTED|Overall Study||154
8616969|NCT02990338|21257644|P1|STARTED|Overall Study||153
8616970|NCT02987959|21257690|P1|NOT COMPLETED|Overall Study||6
8616971|NCT02987959|21257690|P1|COMPLETED|Overall Study||0
8616972|NCT02987959|21257690|P1|STARTED|Overall Study||6
8616994|NCT02952586|21257740|P2|NOT COMPLETED|LT Follow-up (up to Approx. 40 Months)||201
8616995|NCT02952586|21257741|P1|NOT COMPLETED|LT Follow-up (up to Approx. 40 Months)||209
8616996|NCT02952586|21257740|P2|COMPLETED|LT Follow-up (up to Approx. 40 Months)||0
8616997|NCT02952586|21257741|P1|COMPLETED|LT Follow-up (up to Approx. 40 Months)||0
8616998|NCT02952586|21257740|P2|STARTED|LT Follow-up (up to Approx. 40 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase|201
8616999|NCT02952586|21257741|P1|STARTED|LT Follow-up (up to Approx. 40 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase|209
8617000|NCT02952586|21257740|P2|NOT COMPLETED|Follow-Up Phase (90 Days)||57
8617001|NCT02952586|21257741|P1|NOT COMPLETED|Follow-Up Phase (90 Days)||59
8617002|NCT02952586|21257740|P2|COMPLETED|Follow-Up Phase (90 Days)||179
8617003|NCT02952586|21257741|P1|COMPLETED|Follow-Up Phase (90 Days)||172
8617004|NCT02952586|21257740|P2|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase|236
8617005|NCT02952586|21257741|P1|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase|231
8617006|NCT02952586|21257740|P2|NOT COMPLETED|Maintenance Phase (12 Months)||167
8617007|NCT02952586|21257741|P1|NOT COMPLETED|Maintenance Phase (12 Months)||184
8617008|NCT02952586|21257740|P2|COMPLETED|Maintenance Phase (12 Months)||137
8617009|NCT02952586|21257741|P1|COMPLETED|Maintenance Phase (12 Months)||107
8617010|NCT02952586|21257740|P2|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase|304
8617011|NCT02952586|21257741|P1|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase|291
8617012|NCT02952586|21257740|P2|NOT COMPLETED|CRT for IMRT (63 Days)||20
8617013|NCT02952586|21257741|P1|NOT COMPLETED|CRT for IMRT (63 Days)||23
8617014|NCT02952586|21257740|P2|COMPLETED|CRT for IMRT (63 Days)||320
8617015|NCT02952586|21257741|P1|COMPLETED|CRT for IMRT (63 Days)||322
8617016|NCT02952586|21257740|P2|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
8617017|NCT02952586|21257741|P1|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
8617018|NCT02952586|21257740|P2|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
8617019|NCT02952586|21257741|P1|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
8617020|NCT02952586|21257740|P2|COMPLETED|CRT for Cisplatin (63 Days)||236
8617021|NCT02952586|21257741|P1|COMPLETED|CRT for Cisplatin (63 Days)||234
8617022|NCT02952586|21257740|P2|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
8617023|NCT02952586|21257741|P1|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
8617024|NCT02952586|21257740|P2|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
8617025|NCT02952586|21257741|P1|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
8617026|NCT02952586|21257740|P2|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
8617027|NCT02952586|21257741|P1|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
8617028|NCT02952586|21257740|P2|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase|340
8617029|NCT02952586|21257741|P1|STARTED|CRT for Avelumab or Placebo (63 Days)||345
8617030|NCT02952586|21257740|P2|NOT COMPLETED|Lead-In Phase (7 Days)||4
8617031|NCT02952586|21257741|P1|NOT COMPLETED|Lead-In Phase (7 Days)||5
8617032|NCT02952586|21257740|P2|COMPLETED|Lead-In Phase (7 Days)||343
8617033|NCT02952586|21257741|P1|COMPLETED|Lead-In Phase (7 Days)||345
8617034|NCT02952586|21257740|P2|Treated|Lead-In Phase (7 Days)||344
8617035|NCT02952586|21257741|P1|Treated|Lead-In Phase (7 Days)||348
8617036|NCT02952586|21257740|P2|STARTED|Lead-In Phase (7 Days)||347
8617037|NCT02952586|21257741|P1|STARTED|Lead-In Phase (7 Days)||350
8617038|NCT02943070|21257779|P1|NOT COMPLETED|Overall Study||43
8617039|NCT02943070|21257779|P1|COMPLETED|Overall Study||7
8617040|NCT02943070|21257779|P1|STARTED|Overall Study||50
8617041|NCT02939014|21257813|P2|NOT COMPLETED|Overall Study||3
8617042|NCT02939014|21257814|P1|NOT COMPLETED|Overall Study||5
8617043|NCT02939014|21257813|P2|COMPLETED|Overall Study||6
8617044|NCT02939014|21257814|P1|COMPLETED|Overall Study||25
8617045|NCT02939014|21257813|P2|STARTED|Overall Study||9
8617046|NCT02939014|21257814|P1|STARTED|Overall Study||30
8617056|NCT02894502|21257866|P3|NOT COMPLETED|Third Follow up||3
8617057|NCT02894502|21257867|P2|NOT COMPLETED|Third Follow up||7
8617058|NCT02894502|21257868|P1|NOT COMPLETED|Third Follow up||6
8617059|NCT02894502|21257866|P3|COMPLETED|Third Follow up||76
8617060|NCT02894502|21257867|P2|COMPLETED|Third Follow up||89
8617061|NCT02894502|21257868|P1|COMPLETED|Third Follow up||73
8617062|NCT02894502|21257866|P3|STARTED|Third Follow up||79
8617063|NCT02894502|21257867|P2|STARTED|Third Follow up||96
8617064|NCT02894502|21257868|P1|STARTED|Third Follow up||79
8617065|NCT02894502|21257866|P3|NOT COMPLETED|Second Follow up||14
8617066|NCT02894502|21257867|P2|NOT COMPLETED|Second Follow up||18
8617067|NCT02894502|21257868|P1|NOT COMPLETED|Second Follow up||15
8617068|NCT02894502|21257866|P3|COMPLETED|Second Follow up||79
8617069|NCT02894502|21257867|P2|COMPLETED|Second Follow up||96
8617070|NCT02894502|21257868|P1|COMPLETED|Second Follow up||79
8617071|NCT02894502|21257866|P3|STARTED|Second Follow up||93
8617072|NCT02894502|21257867|P2|STARTED|Second Follow up||114
8617073|NCT02894502|21257868|P1|STARTED|Second Follow up||94
8617074|NCT02894502|21257866|P3|NOT COMPLETED|First Follow up||40
8617075|NCT02894502|21257867|P2|NOT COMPLETED|First Follow up||31
8617076|NCT02894502|21257868|P1|NOT COMPLETED|First Follow up||34
8617077|NCT02894502|21257866|P3|COMPLETED|First Follow up||93
8617078|NCT02894502|21257867|P2|COMPLETED|First Follow up||114
8617079|NCT02894502|21257868|P1|COMPLETED|First Follow up||94
8617080|NCT02894502|21257866|P3|STARTED|First Follow up||133
8617081|NCT02894502|21257867|P2|STARTED|First Follow up||145
8617082|NCT02894502|21257868|P1|STARTED|First Follow up||128
8617083|NCT02894502|21257866|P3|NOT COMPLETED|Baseline||45
8617084|NCT02894502|21257867|P2|NOT COMPLETED|Baseline||32
8617085|NCT02894502|21257868|P1|NOT COMPLETED|Baseline||27
8617086|NCT02894502|21257866|P3|COMPLETED|Baseline||133
8617087|NCT02894502|21257867|P2|COMPLETED|Baseline||145
8617088|NCT02894502|21257868|P1|COMPLETED|Baseline||128
8617089|NCT02894502|21257866|P3|STARTED|Baseline||178
8617090|NCT02894502|21257867|P2|STARTED|Baseline||177
8617091|NCT02894502|21257868|P1|STARTED|Baseline||155
8617122|NCT02832037|21257992|P5|NOT COMPLETED|Overall Study||19
8617123|NCT02832037|21257993|P4|NOT COMPLETED|Overall Study||7
8617124|NCT02832037|21257994|P3|NOT COMPLETED|Overall Study||8
8617125|NCT02832037|21257995|P2|NOT COMPLETED|Overall Study||12
8617126|NCT02832037|21257996|P1|NOT COMPLETED|Overall Study||19
8617127|NCT02832037|21257992|P5|COMPLETED|Overall Study||151
8617128|NCT02832037|21257993|P4|COMPLETED|Overall Study||78
8617129|NCT02832037|21257994|P3|COMPLETED|Overall Study||77
8617130|NCT02832037|21257995|P2|COMPLETED|Overall Study||72
8617131|NCT02832037|21257996|P1|COMPLETED|Overall Study||66
8617132|NCT02832037|21257992|P5|STARTED|Overall Study||170
8617133|NCT02832037|21257993|P4|STARTED|Overall Study||85
8617134|NCT02832037|21257994|P3|STARTED|Overall Study||85
8617135|NCT02832037|21257995|P2|STARTED|Overall Study||84
8617136|NCT02832037|21257996|P1|STARTED|Overall Study||85
8617146|NCT02807857|21258067|P1|NOT COMPLETED|Follow-Up Set||184
8617147|NCT02807857|21258067|P1|COMPLETED|Follow-Up Set||680
8617148|NCT02807857|21258067|P1|STARTED|Follow-Up Set||864
8617149|NCT02807857|21258067|P1|NOT COMPLETED|Enrolled Set||551
8617150|NCT02807857|21258067|P1|COMPLETED|Enrolled Set||864
8617151|NCT02807857|21258067|P1|STARTED|Enrolled Set||1415
8617210|NCT02675231|21258289|P3|NOT COMPLETED|Overall Study||26
8617211|NCT02675231|21258290|P2|NOT COMPLETED|Overall Study||36
8617212|NCT02675231|21258291|P1|NOT COMPLETED|Overall Study||26
8617213|NCT02675231|21258289|P3|COMPLETED|Overall Study||53
8617214|NCT02675231|21258290|P2|COMPLETED|Overall Study||43
8617215|NCT02675231|21258291|P1|COMPLETED|Overall Study||53
8617216|NCT02675231|21258289|P3|Received at Least One Dose of Drug|Overall Study||72
8617217|NCT02675231|21258290|P2|Received at Least One Dose of Drug|Overall Study||77
8617218|NCT02675231|21258291|P1|Received at Least One Dose of Drug|Overall Study||78
8617219|NCT02675231|21258289|P3|STARTED|Overall Study||79
8617220|NCT02675231|21258290|P2|STARTED|Overall Study||79
8617221|NCT02675231|21258291|P1|STARTED|Overall Study||79
8617231|NCT02649608|21258373|P7|NOT COMPLETED|Overall Study||0
8617232|NCT02649608|21258374|P6|NOT COMPLETED|Overall Study||0
8617233|NCT02649608|21258375|P5|NOT COMPLETED|Overall Study||0
8617234|NCT02649608|21258376|P4|NOT COMPLETED|Overall Study||0
8617235|NCT02649608|21258377|P3|NOT COMPLETED|Overall Study||0
8617236|NCT02649608|21258378|P2|NOT COMPLETED|Overall Study||0
8617237|NCT02649608|21258379|P1|NOT COMPLETED|Overall Study||0
8617238|NCT02649608|21258373|P7|COMPLETED|Overall Study||1
8617239|NCT02649608|21258374|P6|COMPLETED|Overall Study||2
8617240|NCT02649608|21258375|P5|COMPLETED|Overall Study||3
8617241|NCT02649608|21258376|P4|COMPLETED|Overall Study||3
8617242|NCT02649608|21258377|P3|COMPLETED|Overall Study||3
8617243|NCT02649608|21258378|P2|COMPLETED|Overall Study||1
8617244|NCT02649608|21258379|P1|COMPLETED|Overall Study||2
8617245|NCT02649608|21258373|P7|STARTED|Overall Study||1
8617246|NCT02649608|21258374|P6|STARTED|Overall Study||2
8617247|NCT02649608|21258375|P5|STARTED|Overall Study||3
8617248|NCT02649608|21258376|P4|STARTED|Overall Study||3
8617249|NCT02649608|21258377|P3|STARTED|Overall Study||3
8617250|NCT02649608|21258378|P2|STARTED|Overall Study||1
8617251|NCT02649608|21258379|P1|STARTED|Overall Study||2
8617282|NCT02557178|21258449|P2|NOT COMPLETED|Overall Study||11
8617283|NCT02557178|21258450|P1|NOT COMPLETED|Overall Study||16
8617284|NCT02557178|21258449|P2|COMPLETED|Overall Study||63
8617285|NCT02557178|21258450|P1|COMPLETED|Overall Study||56
8617286|NCT02557178|21258449|P2|STARTED|Overall Study||74
8617287|NCT02557178|21258450|P1|STARTED|Overall Study||72
8617379|NCT02409342|21259107|P2|NOT COMPLETED|Overall Study||285
8617380|NCT02409342|21259108|P1|NOT COMPLETED|Overall Study||287
8617381|NCT02409342|21259107|P2|COMPLETED|Overall Study||0
8617382|NCT02409342|21259108|P1|COMPLETED|Overall Study||0
8617383|NCT02409342|21259107|P2|STARTED|Overall Study||285
8617384|NCT02409342|21259108|P1|STARTED|Overall Study||287
8617394|NCT02336165|21259186|P5|NOT COMPLETED|Overall Study||22
8617395|NCT02336165|21259187|P4|NOT COMPLETED|Overall Study||31
8617396|NCT02336165|21259188|P3|NOT COMPLETED|Overall Study||31
8617397|NCT02336165|21259189|P2|NOT COMPLETED|Overall Study||25
8617398|NCT02336165|21259190|P1|NOT COMPLETED|Overall Study||34
8617399|NCT02336165|21259186|P5|COMPLETED|Overall Study||0
8617400|NCT02336165|21259187|P4|COMPLETED|Overall Study||2
8617401|NCT02336165|21259188|P3|COMPLETED|Overall Study||2
8617402|NCT02336165|21259189|P2|COMPLETED|Overall Study||6
8617403|NCT02336165|21259190|P1|COMPLETED|Overall Study||6
8617404|NCT02336165|21259186|P5|STARTED|Overall Study||22
8617405|NCT02336165|21259187|P4|STARTED|Overall Study||33
8617406|NCT02336165|21259188|P3|STARTED|Overall Study||33
8617407|NCT02336165|21259189|P2|STARTED|Overall Study||31
8617408|NCT02336165|21259190|P1|STARTED|Overall Study||40
8617412|NCT02312986|21259235|P1|NOT COMPLETED|Overall Study||0
8617413|NCT02312986|21259235|P1|COMPLETED|Overall Study||1
8617414|NCT02312986|21259235|P1|STARTED|Overall Study||1
8617415|NCT02291614|21259251|P11|NOT COMPLETED|Overall Study||2
8617416|NCT02291614|21259252|P10|NOT COMPLETED|Overall Study||2
8617417|NCT02291614|21259253|P9|NOT COMPLETED|Overall Study||0
8617418|NCT02291614|21259254|P8|NOT COMPLETED|Overall Study||1
8617419|NCT02291614|21259255|P7|NOT COMPLETED|Overall Study||1
8617420|NCT02291614|21259256|P6|NOT COMPLETED|Overall Study||1
8617421|NCT02291614|21259257|P5|NOT COMPLETED|Overall Study||1
8617422|NCT02291614|21259258|P4|NOT COMPLETED|Overall Study||1
8617423|NCT02291614|21259259|P3|NOT COMPLETED|Overall Study||1
8617424|NCT02291614|21259260|P2|NOT COMPLETED|Overall Study||1
8617425|NCT02291614|21259261|P1|NOT COMPLETED|Overall Study||0
8617426|NCT02291614|21259251|P11|COMPLETED|Overall Study||0
8617427|NCT02291614|21259252|P10|COMPLETED|Overall Study||9
8617428|NCT02291614|21259253|P9|COMPLETED|Overall Study||3
8617429|NCT02291614|21259254|P8|COMPLETED|Overall Study||2
8617430|NCT02291614|21259255|P7|COMPLETED|Overall Study||5
8617431|NCT02291614|21259256|P6|COMPLETED|Overall Study||2
8617432|NCT02291614|21259257|P5|COMPLETED|Overall Study||2
8617433|NCT02291614|21259258|P4|COMPLETED|Overall Study||4
8617434|NCT02291614|21259259|P3|COMPLETED|Overall Study||2
8617435|NCT02291614|21259260|P2|COMPLETED|Overall Study||2
8617436|NCT02291614|21259261|P1|COMPLETED|Overall Study||3
8617437|NCT02291614|21259251|P11|Received AMG 211|Overall Study||2
8617438|NCT02291614|21259252|P10|Received AMG 211|Overall Study||10
8617439|NCT02291614|21259253|P9|Received AMG 211|Overall Study||3
8617440|NCT02291614|21259254|P8|Received AMG 211|Overall Study||3
8617441|NCT02291614|21259255|P7|Received AMG 211|Overall Study||6
8617442|NCT02291614|21259256|P6|Received AMG 211|Overall Study||3
8617443|NCT02291614|21259257|P5|Received AMG 211|Overall Study||3
8617444|NCT02291614|21259258|P4|Received AMG 211|Overall Study||5
8617445|NCT02291614|21259259|P3|Received AMG 211|Overall Study||3
8617446|NCT02291614|21259260|P2|Received AMG 211|Overall Study||3
8617447|NCT02291614|21259261|P1|Received AMG 211|Overall Study||3
8617448|NCT02291614|21259251|P11|STARTED|Overall Study||2
8617449|NCT02291614|21259252|P10|STARTED|Overall Study||11
8617450|NCT02291614|21259253|P9|STARTED|Overall Study||3
8617451|NCT02291614|21259254|P8|STARTED|Overall Study||3
8617452|NCT02291614|21259255|P7|STARTED|Overall Study||6
8617453|NCT02291614|21259256|P6|STARTED|Overall Study||3
8617454|NCT02291614|21259257|P5|STARTED|Overall Study||3
8617455|NCT02291614|21259258|P4|STARTED|Overall Study||5
8617456|NCT02291614|21259259|P3|STARTED|Overall Study||3
8617457|NCT02291614|21259260|P2|STARTED|Overall Study||3
8617458|NCT02291614|21259261|P1|STARTED|Overall Study||3
8617459|NCT02291289|21259443|P12|NOT COMPLETED|Maintenance Treatment Phase||16
8617460|NCT02291289|21259444|P11|NOT COMPLETED|Maintenance Treatment Phase||31
8617461|NCT02291289|21259445|P10|NOT COMPLETED|Maintenance Treatment Phase||0
8617462|NCT02291289|21259446|P9|NOT COMPLETED|Maintenance Treatment Phase||2
8617463|NCT02291289|21259447|P8|NOT COMPLETED|Maintenance Treatment Phase||2
8617464|NCT02291289|21259448|P7|NOT COMPLETED|Maintenance Treatment Phase||0
8617465|NCT02291289|21259449|P6|NOT COMPLETED|Maintenance Treatment Phase||129
8617466|NCT02291289|21259450|P5|NOT COMPLETED|Maintenance Treatment Phase||252
8617467|NCT02291289|21259451|P4|NOT COMPLETED|Maintenance Treatment Phase||0
8617468|NCT02291289|21259452|P3|NOT COMPLETED|Maintenance Treatment Phase||16
8617469|NCT02291289|21259453|P2|NOT COMPLETED|Maintenance Treatment Phase||24
8617470|NCT02291289|21259454|P1|NOT COMPLETED|Maintenance Treatment Phase||0
8617471|NCT02291289|21259443|P12|COMPLETED|Maintenance Treatment Phase||18
8617472|NCT02291289|21259444|P11|COMPLETED|Maintenance Treatment Phase||34
8617473|NCT02291289|21259445|P10|COMPLETED|Maintenance Treatment Phase||0
8617474|NCT02291289|21259446|P9|COMPLETED|Maintenance Treatment Phase||0
8617475|NCT02291289|21259447|P8|COMPLETED|Maintenance Treatment Phase||1
8617476|NCT02291289|21259448|P7|COMPLETED|Maintenance Treatment Phase||0
8617477|NCT02291289|21259449|P6|COMPLETED|Maintenance Treatment Phase||19
8617478|NCT02291289|21259450|P5|COMPLETED|Maintenance Treatment Phase||45
8617479|NCT02291289|21259451|P4|COMPLETED|Maintenance Treatment Phase||0
8617480|NCT02291289|21259452|P3|COMPLETED|Maintenance Treatment Phase||4
8617481|NCT02291289|21259453|P2|COMPLETED|Maintenance Treatment Phase||16
8617482|NCT02291289|21259454|P1|COMPLETED|Maintenance Treatment Phase||0
8617483|NCT02291289|21259443|P12|Dosed|Maintenance Treatment Phase||34
8617484|NCT02291289|21259444|P11|Dosed|Maintenance Treatment Phase||64
8617485|NCT02291289|21259445|P10|Dosed|Maintenance Treatment Phase||0
8617486|NCT02291289|21259446|P9|Dosed|Maintenance Treatment Phase||2
8617487|NCT02291289|21259447|P8|Dosed|Maintenance Treatment Phase||3
8617488|NCT02291289|21259448|P7|Dosed|Maintenance Treatment Phase||0
8617489|NCT02291289|21259449|P6|Dosed|Maintenance Treatment Phase||143
8617490|NCT02291289|21259450|P5|Dosed|Maintenance Treatment Phase||293
8617491|NCT02291289|21259451|P4|Dosed|Maintenance Treatment Phase||0
8617492|NCT02291289|21259452|P3|Dosed|Maintenance Treatment Phase||18
8617493|NCT02291289|21259453|P2|Dosed|Maintenance Treatment Phase||40
8617494|NCT02291289|21259454|P1|Dosed|Maintenance Treatment Phase||0
8617495|NCT02291289|21259443|P12|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
8617496|NCT02291289|21259444|P11|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
8617497|NCT02291289|21259445|P10|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8617498|NCT02291289|21259446|P9|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
8617499|NCT02291289|21259447|P8|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
8617500|NCT02291289|21259448|P7|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8617501|NCT02291289|21259449|P6|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
8617502|NCT02291289|21259450|P5|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
8617503|NCT02291289|21259451|P4|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8617504|NCT02291289|21259452|P3|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
8617505|NCT02291289|21259453|P2|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
8617506|NCT02291289|21259454|P1|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8617507|NCT02291289|21259443|P12|NOT COMPLETED|Induction Treatment||0
8617508|NCT02291289|21259444|P11|NOT COMPLETED|Induction Treatment||0
8617509|NCT02291289|21259445|P10|NOT COMPLETED|Induction Treatment||1
8617510|NCT02291289|21259446|P9|NOT COMPLETED|Induction Treatment||0
8617511|NCT02291289|21259447|P8|NOT COMPLETED|Induction Treatment||0
8617512|NCT02291289|21259448|P7|NOT COMPLETED|Induction Treatment||0
8617513|NCT02291289|21259449|P6|NOT COMPLETED|Induction Treatment||0
8617514|NCT02291289|21259450|P5|NOT COMPLETED|Induction Treatment||0
8617515|NCT02291289|21259451|P4|NOT COMPLETED|Induction Treatment||9
8617516|NCT02291289|21259452|P3|NOT COMPLETED|Induction Treatment||0
8617517|NCT02291289|21259453|P2|NOT COMPLETED|Induction Treatment||0
8617518|NCT02291289|21259454|P1|NOT COMPLETED|Induction Treatment||2
8617519|NCT02291289|21259443|P12|COMPLETED|Induction Treatment||0
8617520|NCT02291289|21259444|P11|COMPLETED|Induction Treatment||0
8617521|NCT02291289|21259445|P10|COMPLETED|Induction Treatment||98
8617522|NCT02291289|21259446|P9|COMPLETED|Induction Treatment||0
8617523|NCT02291289|21259447|P8|COMPLETED|Induction Treatment||0
8617524|NCT02291289|21259448|P7|COMPLETED|Induction Treatment||5
8617525|NCT02291289|21259449|P6|COMPLETED|Induction Treatment||0
8617526|NCT02291289|21259450|P5|COMPLETED|Induction Treatment||0
8617527|NCT02291289|21259451|P4|COMPLETED|Induction Treatment||436
8617528|NCT02291289|21259452|P3|COMPLETED|Induction Treatment||0
8617529|NCT02291289|21259453|P2|COMPLETED|Induction Treatment||0
8617530|NCT02291289|21259454|P1|COMPLETED|Induction Treatment||58
8617531|NCT02291289|21259443|P12|STARTED|Induction Treatment||0
8617532|NCT02291289|21259444|P11|STARTED|Induction Treatment||0
8617533|NCT02291289|21259445|P10|STARTED|Induction Treatment||99
8617534|NCT02291289|21259446|P9|STARTED|Induction Treatment||0
8617535|NCT02291289|21259447|P8|STARTED|Induction Treatment||0
8617536|NCT02291289|21259448|P7|STARTED|Induction Treatment||5
8617537|NCT02291289|21259449|P6|STARTED|Induction Treatment||0
8617538|NCT02291289|21259450|P5|STARTED|Induction Treatment||0
8617539|NCT02291289|21259451|P4|STARTED|Induction Treatment||445
8617540|NCT02291289|21259452|P3|STARTED|Induction Treatment||0
8617541|NCT02291289|21259453|P2|STARTED|Induction Treatment||0
8617542|NCT02291289|21259454|P1|STARTED|Induction Treatment||60
8617543|NCT02285361|21259516|P1|NOT COMPLETED|Overall Study||51
8617544|NCT02285361|21259516|P1|COMPLETED|Overall Study||1221
8617545|NCT02285361|21259516|P1|STARTED|Overall Study||1272
8617546|NCT02278289|21259525|P2|NOT COMPLETED|Overall Study||7
8617547|NCT02278289|21259526|P1|NOT COMPLETED|Overall Study||6
8617548|NCT02278289|21259525|P2|COMPLETED|Overall Study||23
8617549|NCT02278289|21259526|P1|COMPLETED|Overall Study||24
8617550|NCT02278289|21259525|P2|STARTED|Overall Study||30
8617551|NCT02278289|21259526|P1|STARTED|Overall Study||30
8617580|NCT02178358|21259707|P3|NOT COMPLETED|Overall Study||4
8617581|NCT02178358|21259708|P2|NOT COMPLETED|Overall Study||3
8617582|NCT02178358|21259709|P1|NOT COMPLETED|Overall Study||0
8617583|NCT02178358|21259707|P3|COMPLETED|Overall Study||34
8617584|NCT02178358|21259708|P2|COMPLETED|Overall Study||71
8617585|NCT02178358|21259709|P1|COMPLETED|Overall Study||20
8617586|NCT02178358|21259707|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
8617587|NCT02178358|21259708|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
8617588|NCT02178358|21259709|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
8617589|NCT02178358|21259707|P3|STARTED|Overall Study||38
8617590|NCT02178358|21259708|P2|STARTED|Overall Study||74
8617591|NCT02178358|21259709|P1|STARTED|Overall Study||20
8617608|NCT02076997|21259839|P1|NOT COMPLETED|Overall Study||1
8617609|NCT02076997|21259839|P1|COMPLETED|Overall Study||22
8617610|NCT02076997|21259839|P1|STARTED|Overall Study||23
8617619|NCT02039726|21259887|P2|NOT COMPLETED|Overall Study||16
8617620|NCT02039726|21259888|P1|NOT COMPLETED|Overall Study||45
8617621|NCT02039726|21259887|P2|COMPLETED|Overall Study||106
8617622|NCT02039726|21259888|P1|COMPLETED|Overall Study||200
8617623|NCT02039726|21259887|P2|Did Not Receive Treatment|Overall Study||28
8617624|NCT02039726|21259888|P1|Did Not Receive Treatment|Overall Study||4
8617625|NCT02039726|21259887|P2|Ongoing (as of Data Cutoff)|Overall Study||16
8617626|NCT02039726|21259888|P1|Ongoing (as of Data Cutoff)|Overall Study||45
8617627|NCT02039726|21259887|P2|STARTED|Overall Study||122
8617628|NCT02039726|21259888|P1|STARTED|Overall Study||245
8617635|NCT01894620|21259907|P2|NOT COMPLETED|Overall Study||1
8617636|NCT01894620|21259908|P1|NOT COMPLETED|Overall Study||0
8617637|NCT01894620|21259907|P2|COMPLETED|Overall Study||4
8617638|NCT01894620|21259908|P1|COMPLETED|Overall Study||6
8617639|NCT01894620|21259907|P2|STARTED|Overall Study||5
8617640|NCT01894620|21259908|P1|STARTED|Overall Study||6
8617641|NCT01863186|21259919|P4|NOT COMPLETED|Open-label Phase||13
8617642|NCT01863186|21259920|P3|NOT COMPLETED|Open-label Phase||0
8617643|NCT01863186|21259921|P2|NOT COMPLETED|Open-label Phase||0
8617644|NCT01863186|21259922|P1|NOT COMPLETED|Open-label Phase||0
8617645|NCT01863186|21259919|P4|COMPLETED|Open-label Phase||70
8617646|NCT01863186|21259920|P3|COMPLETED|Open-label Phase||0
8617647|NCT01863186|21259921|P2|COMPLETED|Open-label Phase||0
8617648|NCT01863186|21259922|P1|COMPLETED|Open-label Phase||0
8617649|NCT01863186|21259919|P4|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
8617650|NCT01863186|21259920|P3|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
8617651|NCT01863186|21259921|P2|STARTED|Open-label Phase||0
8617652|NCT01863186|21259922|P1|STARTED|Open-label Phase||0
8617653|NCT01863186|21259919|P4|NOT COMPLETED|Double-blind Phase||0
8617654|NCT01863186|21259920|P3|NOT COMPLETED|Double-blind Phase||109
8617655|NCT01863186|21259921|P2|NOT COMPLETED|Double-blind Phase||134
8617656|NCT01863186|21259922|P1|NOT COMPLETED|Double-blind Phase||134
8617657|NCT01863186|21259919|P4|COMPLETED|Double-blind Phase||0
8617658|NCT01863186|21259920|P3|COMPLETED|Double-blind Phase||42
8617659|NCT01863186|21259921|P2|COMPLETED|Double-blind Phase||88
8617660|NCT01863186|21259922|P1|COMPLETED|Double-blind Phase||95
8617661|NCT01863186|21259919|P4|STARTED|Double-blind Phase||0
8617662|NCT01863186|21259920|P3|STARTED|Double-blind Phase||151
8617663|NCT01863186|21259921|P2|STARTED|Double-blind Phase||222
8617664|NCT01863186|21259922|P1|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
8617686|NCT01802632|21260014|P6|NOT COMPLETED|Overall Study||28
8617687|NCT01802632|21260015|P5|NOT COMPLETED|Overall Study||12
8617688|NCT01802632|21260016|P4|NOT COMPLETED|Overall Study||60
8617689|NCT01802632|21260017|P3|NOT COMPLETED|Overall Study||271
8617690|NCT01802632|21260018|P2|NOT COMPLETED|Overall Study||31
8617691|NCT01802632|21260019|P1|NOT COMPLETED|Overall Study||201
8617692|NCT01802632|21260014|P6|COMPLETED|Overall Study||0
8617693|NCT01802632|21260015|P5|COMPLETED|Overall Study||0
8617694|NCT01802632|21260016|P4|COMPLETED|Overall Study||0
8617695|NCT01802632|21260017|P3|COMPLETED|Overall Study||0
8617696|NCT01802632|21260018|P2|COMPLETED|Overall Study||0
8617697|NCT01802632|21260019|P1|COMPLETED|Overall Study||0
8617698|NCT01802632|21260014|P6|STARTED|Overall Study||28
8617699|NCT01802632|21260015|P5|STARTED|Overall Study||12
8617700|NCT01802632|21260016|P4|STARTED|Overall Study||60
8617701|NCT01802632|21260017|P3|STARTED|Overall Study||271
8617702|NCT01802632|21260018|P2|STARTED|Overall Study||31
8617703|NCT01802632|21260019|P1|STARTED|Overall Study||201
8617737|NCT01736943|21260093|P1|NOT COMPLETED|Overall Study||0
8617738|NCT01736943|21260093|P1|COMPLETED|Overall Study||25
8617739|NCT01736943|21260093|P1|STARTED|Overall Study||25
8617740|NCT01728805|21260101|P3|NOT COMPLETED|Crossover Period||0
8617741|NCT01728805|21260102|P2|NOT COMPLETED|Crossover Period||0
8617742|NCT01728805|21260103|P1|NOT COMPLETED|Crossover Period||0
8617743|NCT01728805|21260101|P3|COMPLETED|Crossover Period||136
8617744|NCT01728805|21260102|P2|COMPLETED|Crossover Period||0
8617745|NCT01728805|21260103|P1|COMPLETED|Crossover Period||0
8617746|NCT01728805|21260101|P3|STARTED|Crossover Period||136
8617747|NCT01728805|21260102|P2|STARTED|Crossover Period||0
8617748|NCT01728805|21260103|P1|STARTED|Crossover Period||0
8617749|NCT01728805|21260101|P3|NOT COMPLETED|Randomization Period||0
8617750|NCT01728805|21260102|P2|NOT COMPLETED|Randomization Period||0
8617751|NCT01728805|21260103|P1|NOT COMPLETED|Randomization Period||0
8617752|NCT01728805|21260101|P3|COMPLETED|Randomization Period||0
8617753|NCT01728805|21260102|P2|COMPLETED|Randomization Period||186
8617754|NCT01728805|21260103|P1|COMPLETED|Randomization Period||186
8617755|NCT01728805|21260101|P3|STARTED|Randomization Period||0
8617756|NCT01728805|21260102|P2|STARTED|Randomization Period||186
8617757|NCT01728805|21260103|P1|STARTED|Randomization Period||186
8617787|NCT01609296|21260230|P1|NOT COMPLETED|Overall Study||488
8617788|NCT01609296|21260230|P1|COMPLETED|Overall Study||918
8617789|NCT01609296|21260230|P1|STARTED|Overall Study||1406
8617790|NCT01597908|21260386|P3|NOT COMPLETED|Crossover Phase||34
8617791|NCT01597908|21260387|P2|NOT COMPLETED|Crossover Phase||0
8617792|NCT01597908|21260388|P1|NOT COMPLETED|Crossover Phase||0
8617793|NCT01597908|21260386|P3|COMPLETED|Crossover Phase||0
8617794|NCT01597908|21260387|P2|COMPLETED|Crossover Phase||0
8617795|NCT01597908|21260388|P1|COMPLETED|Crossover Phase||0
8617796|NCT01597908|21260386|P3|STARTED|Crossover Phase||34
8617797|NCT01597908|21260387|P2|STARTED|Crossover Phase||0
8617798|NCT01597908|21260388|P1|STARTED|Crossover Phase||0
8617799|NCT01597908|21260386|P3|NOT COMPLETED|Randomized Phase||0
8617800|NCT01597908|21260387|P2|NOT COMPLETED|Randomized Phase||352
8617801|NCT01597908|21260388|P1|NOT COMPLETED|Randomized Phase||351
8617802|NCT01597908|21260386|P3|COMPLETED|Randomized Phase||0
8617803|NCT01597908|21260387|P2|COMPLETED|Randomized Phase||0
8617804|NCT01597908|21260388|P1|COMPLETED|Randomized Phase||1
8617805|NCT01597908|21260386|P3|Safety Set|Randomized Phase||0
8617806|NCT01597908|21260387|P2|Safety Set|Randomized Phase||349
8617807|NCT01597908|21260388|P1|Safety Set|Randomized Phase||350
8617808|NCT01597908|21260386|P3|STARTED|Randomized Phase||0
8617809|NCT01597908|21260387|P2|STARTED|Randomized Phase||352
8617810|NCT01597908|21260388|P1|STARTED|Randomized Phase||352
8617811|NCT01586871|21260408|P3|NOT COMPLETED|Overall Study||0
8617812|NCT01586871|21260409|P2|NOT COMPLETED|Overall Study||0
8617813|NCT01586871|21260410|P1|NOT COMPLETED|Overall Study||0
8617814|NCT01586871|21260408|P3|COMPLETED|Overall Study||33
8617815|NCT01586871|21260409|P2|COMPLETED|Overall Study||554
8617816|NCT01586871|21260410|P1|COMPLETED|Overall Study||560
8617817|NCT01586871|21260408|P3|STARTED|Overall Study||33
8617818|NCT01586871|21260409|P2|STARTED|Overall Study||554
8617819|NCT01586871|21260410|P1|STARTED|Overall Study||560
8617837|NCT01258075|21260471|P2|NOT COMPLETED|Overall Study||23
8617838|NCT01258075|21260472|P1|NOT COMPLETED|Overall Study||42
8617839|NCT01258075|21260471|P2|COMPLETED|Overall Study||72
8617840|NCT01258075|21260472|P1|COMPLETED|Overall Study||99
8617841|NCT01258075|21260471|P2|STARTED|Overall Study||95
8617842|NCT01258075|21260472|P1|STARTED|Overall Study||141
8617880|NCT01087203|21260629|P2|NOT COMPLETED|Overall Study||35
8617881|NCT01087203|21260630|P1|NOT COMPLETED|Overall Study||32
8617882|NCT01087203|21260629|P2|COMPLETED|Overall Study||3
8617883|NCT01087203|21260630|P1|COMPLETED|Overall Study||3
8617884|NCT01087203|21260629|P2|STARTED|Overall Study||38
8617885|NCT01087203|21260630|P1|STARTED|Overall Study||35
8617922|NCT01054443|21260719|P4|NOT COMPLETED|Overall Study||1
8617923|NCT01054443|21260720|P3|NOT COMPLETED|Overall Study||0
8617924|NCT01054443|21260721|P2|NOT COMPLETED|Overall Study||0
8617925|NCT01054443|21260722|P1|NOT COMPLETED|Overall Study||0
8617926|NCT01054443|21260719|P4|COMPLETED|Overall Study||4
8617927|NCT01054443|21260720|P3|COMPLETED|Overall Study||5
8617928|NCT01054443|21260721|P2|COMPLETED|Overall Study||5
8617929|NCT01054443|21260722|P1|COMPLETED|Overall Study||5
8617930|NCT01054443|21260719|P4|STARTED|Overall Study||5
8617931|NCT01054443|21260720|P3|STARTED|Overall Study||5
8617932|NCT01054443|21260721|P2|STARTED|Overall Study||5
8617933|NCT01054443|21260722|P1|STARTED|Overall Study||5
8617952|NCT01038778|21260958|P3|NOT COMPLETED|Overall Study||3
8617953|NCT01038778|21260959|P2|NOT COMPLETED|Overall Study||2
8617954|NCT01038778|21260960|P1|NOT COMPLETED|Overall Study||0
8617955|NCT01038778|21260958|P3|COMPLETED|Overall Study||33
8617956|NCT01038778|21260959|P2|COMPLETED|Overall Study||6
8617957|NCT01038778|21260960|P1|COMPLETED|Overall Study||3
8617958|NCT01038778|21260958|P3|STARTED|Overall Study||36
8617959|NCT01038778|21260959|P2|STARTED|Overall Study||8
8617960|NCT01038778|21260960|P1|STARTED|Overall Study||3
8618003|NCT00904345|21261140|P1|NOT COMPLETED|Overall Study||3
8618004|NCT00904345|21261140|P1|COMPLETED|Overall Study||18
8618005|NCT00904345|21261140|P1|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
8618006|NCT00904345|21261140|P1|STARTED|Overall Study||21
8618007|NCT00871858|21261153|P2|NOT COMPLETED|Overall Study||7
8618008|NCT00871858|21261154|P1|NOT COMPLETED|Overall Study||5
8618009|NCT00871858|21261153|P2|COMPLETED|Overall Study||52
8618010|NCT00871858|21261154|P1|COMPLETED|Overall Study||56
8618011|NCT00871858|21261153|P2|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
8618012|NCT00871858|21261154|P1|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
8618013|NCT00871858|21261153|P2|STARTED|Overall Study||59
8618014|NCT00871858|21261154|P1|STARTED|Overall Study||61
8618034|NCT00827359|21261288|P1|NOT COMPLETED|Overall Study||25
8618035|NCT00827359|21261288|P1|COMPLETED|Overall Study||0
8618036|NCT00827359|21261288|P1|Treated|Overall Study||24
8618037|NCT00827359|21261288|P1|STARTED|Overall Study||25
8618054|NCT00711880|21261430|P2|NOT COMPLETED|Overall Study||7
8618055|NCT00711880|21261431|P1|NOT COMPLETED|Overall Study||13
8618056|NCT00711880|21261430|P2|COMPLETED|Overall Study||55
8618057|NCT00711880|21261431|P1|COMPLETED|Overall Study||50
8618058|NCT00711880|21261430|P2|STARTED|Overall Study||62
8618059|NCT00711880|21261431|P1|STARTED|Overall Study||63
8618230|NCT00073528|21262181|P2|NOT COMPLETED|Overall Study||628
8618231|NCT00073528|21262182|P1|NOT COMPLETED|Overall Study||630
8618232|NCT00073528|21262181|P2|COMPLETED|Overall Study||14
8618233|NCT00073528|21262182|P1|COMPLETED|Overall Study||14
8618234|NCT00073528|21262181|P2|STARTED|Overall Study||642
8618235|NCT00073528|21262182|P1|STARTED|Overall Study||644
8618236|NCT04240678|21262256|P2|NOT COMPLETED|Overall Study||0
8618237|NCT04240678|21262257|P1|NOT COMPLETED|Overall Study||0
8618238|NCT04240678|21262256|P2|COMPLETED|Overall Study||4158
8618239|NCT04240678|21262257|P1|COMPLETED|Overall Study||4141
8618240|NCT04240678|21262256|P2|STARTED|Overall Study||4158
8618241|NCT04240678|21262257|P1|STARTED|Overall Study||4141
8618242|NCT04186481|21262265|P1|NOT COMPLETED|Overall Study||0
8618243|NCT04186481|21262265|P1|COMPLETED|Overall Study||32
8618244|NCT04186481|21262265|P1|Completed 12 Month Visit|Overall Study||4
8618245|NCT04186481|21262265|P1|Completed 6 Month Visit|Overall Study||31
8618246|NCT04186481|21262265|P1|STARTED|Overall Study||32
8618247|NCT04102956|21262273|P2|NOT COMPLETED|Overall Study||0
8618248|NCT04102956|21262274|P1|NOT COMPLETED|Overall Study||0
8618249|NCT04102956|21262273|P2|COMPLETED|Overall Study||38
8618250|NCT04102956|21262274|P1|COMPLETED|Overall Study||42
8618251|NCT04102956|21262273|P2|STARTED|Overall Study||38
8618252|NCT04102956|21262274|P1|STARTED|Overall Study||42
8618253|NCT04089761|21262292|P1|NOT COMPLETED|"Follow Up Phase (Optional)"||0
8618254|NCT04089761|21262292|P1|COMPLETED|"Follow Up Phase (Optional)"||27
8618255|NCT04089761|21262292|P1|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
8618256|NCT04089761|21262292|P1|NOT COMPLETED|"Treatment Phase"||6
8618257|NCT04089761|21262292|P1|COMPLETED|"Treatment Phase"||39
8618258|NCT04089761|21262292|P1|STARTED|"Treatment Phase"||45
8618259|NCT04089761|21262292|P1|NOT COMPLETED|"Run In Phase"||15
8618260|NCT04089761|21262292|P1|COMPLETED|"Run In Phase"||45
8618261|NCT04089761|21262292|P1|STARTED|"Run In Phase"||60
8618262|NCT04043728|21262310|P3|NOT COMPLETED|Overall Study||0
8618263|NCT04043728|21262311|P2|NOT COMPLETED|Overall Study||2
8618264|NCT04043728|21262312|P1|NOT COMPLETED|Overall Study||1
8618265|NCT04043728|21262310|P3|COMPLETED|Overall Study||6
8618266|NCT04043728|21262311|P2|COMPLETED|Overall Study||4
8618267|NCT04043728|21262312|P1|COMPLETED|Overall Study||5
8618268|NCT04043728|21262310|P3|STARTED|Overall Study||6
8618269|NCT04043728|21262311|P2|STARTED|Overall Study||6
8618270|NCT04043728|21262312|P1|STARTED|Overall Study||6
8618271|NCT03967444|21262325|P2|NOT COMPLETED|Overall Study||2
8618272|NCT03967444|21262326|P1|NOT COMPLETED|Overall Study||1
8618273|NCT03967444|21262325|P2|COMPLETED|Overall Study||38
8618274|NCT03967444|21262326|P1|COMPLETED|Overall Study||18
8618275|NCT03967444|21262325|P2|STARTED|Overall Study||40
8618276|NCT03967444|21262326|P1|STARTED|Overall Study||19
8618277|NCT03859323|21262345|P13|NOT COMPLETED|Overall Study||1
8618278|NCT03859323|21262346|P12|NOT COMPLETED|Overall Study||2
8618279|NCT03859323|21262347|P11|NOT COMPLETED|Overall Study||1
8618280|NCT03859323|21262348|P10|NOT COMPLETED|Overall Study||2
8618281|NCT03859323|21262349|P9|NOT COMPLETED|Overall Study||0
8618282|NCT03859323|21262350|P8|NOT COMPLETED|Overall Study||0
8618283|NCT03859323|21262351|P7|NOT COMPLETED|Overall Study||1
8618284|NCT03859323|21262352|P6|NOT COMPLETED|Overall Study||1
8618285|NCT03859323|21262353|P5|NOT COMPLETED|Overall Study||0
8618286|NCT03859323|21262354|P4|NOT COMPLETED|Overall Study||0
8618287|NCT03859323|21262355|P3|NOT COMPLETED|Overall Study||1
8618288|NCT03859323|21262356|P2|NOT COMPLETED|Overall Study||0
8618289|NCT03859323|21262357|P1|NOT COMPLETED|Overall Study||0
8618290|NCT03859323|21262345|P13|COMPLETED|Overall Study||9
8618291|NCT03859323|21262346|P12|COMPLETED|Overall Study||10
8618292|NCT03859323|21262347|P11|COMPLETED|Overall Study||9
8618293|NCT03859323|21262348|P10|COMPLETED|Overall Study||8
8618294|NCT03859323|21262349|P9|COMPLETED|Overall Study||10
8618295|NCT03859323|21262350|P8|COMPLETED|Overall Study||10
8618296|NCT03859323|21262351|P7|COMPLETED|Overall Study||11
8618297|NCT03859323|21262352|P6|COMPLETED|Overall Study||4
8618298|NCT03859323|21262353|P5|COMPLETED|Overall Study||5
8618299|NCT03859323|21262354|P4|COMPLETED|Overall Study||5
8618300|NCT03859323|21262355|P3|COMPLETED|Overall Study||4
8618301|NCT03859323|21262356|P2|COMPLETED|Overall Study||5
8618302|NCT03859323|21262357|P1|COMPLETED|Overall Study||5
8618303|NCT03859323|21262345|P13|STARTED|Overall Study||10
8618304|NCT03859323|21262346|P12|STARTED|Overall Study||12
8618305|NCT03859323|21262347|P11|STARTED|Overall Study||10
8618306|NCT03859323|21262348|P10|STARTED|Overall Study||10
8618307|NCT03859323|21262349|P9|STARTED|Overall Study||10
8618308|NCT03859323|21262350|P8|STARTED|Overall Study||10
8618309|NCT03859323|21262351|P7|STARTED|Overall Study||12
8618310|NCT03859323|21262352|P6|STARTED|Overall Study||5
8618311|NCT03859323|21262353|P5|STARTED|Overall Study||5
8618312|NCT03859323|21262354|P4|STARTED|Overall Study||5
8618313|NCT03859323|21262355|P3|STARTED|Overall Study||5
8618314|NCT03859323|21262356|P2|STARTED|Overall Study||5
8618315|NCT03859323|21262357|P1|STARTED|Overall Study||5
8618316|NCT03741088|21262533|P1|NOT COMPLETED|Overall Study||3
8618317|NCT03741088|21262533|P1|COMPLETED|Overall Study||5
8618318|NCT03741088|21262533|P1|STARTED|Overall Study||8
8618319|NCT03730961|21262556|P2|NOT COMPLETED|Overall Study||1
8618320|NCT03730961|21262557|P1|NOT COMPLETED|Overall Study||0
8618321|NCT03730961|21262556|P2|COMPLETED|Overall Study||10
8618322|NCT03730961|21262557|P1|COMPLETED|Overall Study||12
8618323|NCT03730961|21262556|P2|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
8618324|NCT03730961|21262557|P1|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
8618325|NCT03730961|21262556|P2|Period 1 Completion|Overall Study||11
8618326|NCT03730961|21262557|P1|Period 1 Completion|Overall Study||12
8618327|NCT03730961|21262556|P2|STARTED|Overall Study||11
8618328|NCT03730961|21262557|P1|STARTED|Overall Study||12
8618329|NCT03696758|21262593|P2|NOT COMPLETED|Second Intervention||0
8618330|NCT03696758|21262594|P1|NOT COMPLETED|Second Intervention||0
8618331|NCT03696758|21262593|P2|COMPLETED|Second Intervention||6
8618332|NCT03696758|21262594|P1|COMPLETED|Second Intervention||3
8618333|NCT03696758|21262593|P2|STARTED|Second Intervention||6
8618334|NCT03696758|21262594|P1|STARTED|Second Intervention||3
8618335|NCT03696758|21262593|P2|NOT COMPLETED|Wash Out>12 Hours||0
8618336|NCT03696758|21262594|P1|NOT COMPLETED|Wash Out>12 Hours||0
8618337|NCT03696758|21262593|P2|COMPLETED|Wash Out>12 Hours||6
8618338|NCT03696758|21262594|P1|COMPLETED|Wash Out>12 Hours||3
8618339|NCT03696758|21262593|P2|STARTED|Wash Out>12 Hours||6
8618340|NCT03696758|21262594|P1|STARTED|Wash Out>12 Hours||3
8618341|NCT03696758|21262593|P2|NOT COMPLETED|First Intervention||0
8618342|NCT03696758|21262594|P1|NOT COMPLETED|First Intervention||0
8618343|NCT03696758|21262593|P2|COMPLETED|First Intervention||6
8618344|NCT03696758|21262594|P1|COMPLETED|First Intervention||3
8618345|NCT03696758|21262593|P2|STARTED|First Intervention||6
8618346|NCT03696758|21262594|P1|STARTED|First Intervention||3
8618347|NCT03682965|21262620|P2|NOT COMPLETED|Overall Study||0
8618348|NCT03682965|21262621|P1|NOT COMPLETED|Overall Study||0
8618349|NCT03682965|21262620|P2|COMPLETED|Overall Study||10
8618350|NCT03682965|21262621|P1|COMPLETED|Overall Study||11
8618351|NCT03682965|21262620|P2|STARTED|Overall Study||10
8618352|NCT03682965|21262621|P1|STARTED|Overall Study||11
8618353|NCT03635775|21262645|P4|NOT COMPLETED|Overall Study||1
8618354|NCT03635775|21262646|P3|NOT COMPLETED|Overall Study||0
8618355|NCT03635775|21262647|P2|NOT COMPLETED|Overall Study||0
8618356|NCT03635775|21262648|P1|NOT COMPLETED|Overall Study||0
8618357|NCT03635775|21262645|P4|COMPLETED|Overall Study||9
8618358|NCT03635775|21262646|P3|COMPLETED|Overall Study||5
8618359|NCT03635775|21262647|P2|COMPLETED|Overall Study||0
8618360|NCT03635775|21262648|P1|COMPLETED|Overall Study||5
8618361|NCT03635775|21262645|P4|STARTED|Overall Study||10
8618362|NCT03635775|21262646|P3|STARTED|Overall Study||5
8618363|NCT03635775|21262647|P2|STARTED|Overall Study||0
8618364|NCT03635775|21262648|P1|STARTED|Overall Study||5
8618365|NCT03600428|21262664|P2|NOT COMPLETED|Overall Study||4
8618366|NCT03600428|21262665|P1|NOT COMPLETED|Overall Study||5
8618367|NCT03600428|21262664|P2|COMPLETED|Overall Study||68
8618368|NCT03600428|21262665|P1|COMPLETED|Overall Study||74
8618369|NCT03600428|21262664|P2|43-day Follow-up|Overall Study||68
8618370|NCT03600428|21262665|P1|43-day Follow-up|Overall Study||74
8618371|NCT03600428|21262664|P2|15-day Follow-up|Overall Study||70
8618372|NCT03600428|21262665|P1|15-day Follow-up|Overall Study||76
8618373|NCT03600428|21262664|P2|STARTED|Overall Study||72
8618374|NCT03600428|21262665|P1|STARTED|Overall Study||79
8618375|NCT03599193|21262681|P2|NOT COMPLETED|Overall Study||3
8618376|NCT03599193|21262682|P1|NOT COMPLETED|Overall Study||2
8618377|NCT03599193|21262681|P2|COMPLETED|Overall Study||21
8618378|NCT03599193|21262682|P1|COMPLETED|Overall Study||32
8618379|NCT03599193|21262681|P2|STARTED|Overall Study||24
8618380|NCT03599193|21262682|P1|STARTED|Overall Study||34
8618381|NCT03579290|21262694|P1|NOT COMPLETED|Overall Study||9
8618382|NCT03579290|21262694|P1|COMPLETED|Overall Study||31
8618383|NCT03579290|21262694|P1|STARTED|Overall Study||40
8618384|NCT03553823|21262702|P2|NOT COMPLETED|Overall Study||1
8618385|NCT03553823|21262703|P1|NOT COMPLETED|Overall Study||0
8618386|NCT03553823|21262702|P2|COMPLETED|Overall Study||19
8618387|NCT03553823|21262703|P1|COMPLETED|Overall Study||20
8618388|NCT03553823|21262702|P2|STARTED|Overall Study||20
8618389|NCT03553823|21262703|P1|STARTED|Overall Study||20
8618390|NCT03494725|21262711|P2|NOT COMPLETED|Overall Study||2
8618391|NCT03494725|21262712|P1|NOT COMPLETED|Overall Study||1
8618392|NCT03494725|21262711|P2|COMPLETED|Overall Study||58
8618393|NCT03494725|21262712|P1|COMPLETED|Overall Study||59
8618394|NCT03494725|21262711|P2|Intervention (Post 2 Weeks run-in)|Overall Study||59
8618395|NCT03494725|21262712|P1|Intervention (Post 2 Weeks run-in)|Overall Study||59
8618396|NCT03494725|21262711|P2|STARTED|Overall Study||60
8618397|NCT03494725|21262712|P1|STARTED|Overall Study||60
8618398|NCT03432819|21262784|P2|NOT COMPLETED|Overall Study||5
8618399|NCT03432819|21262785|P1|NOT COMPLETED|Overall Study||7
8618400|NCT03432819|21262784|P2|COMPLETED|Overall Study||33
8618401|NCT03432819|21262785|P1|COMPLETED|Overall Study||31
8618402|NCT03432819|21262784|P2|STARTED|Overall Study||38
8618403|NCT03432819|21262785|P1|STARTED|Overall Study||38
8618404|NCT03404375|21262811|P2|NOT COMPLETED|Overall Study||0
8618405|NCT03404375|21262812|P1|NOT COMPLETED|Overall Study||0
8618406|NCT03404375|21262811|P2|COMPLETED|Overall Study||172
8618407|NCT03404375|21262812|P1|COMPLETED|Overall Study||70
8618408|NCT03404375|21262811|P2|STARTED|Overall Study||172
8618409|NCT03404375|21262812|P1|STARTED|Overall Study||70
8618410|NCT03400163|21262826|P2|NOT COMPLETED|Follow-up Period||0
8618411|NCT03400163|21262827|P1|NOT COMPLETED|Follow-up Period||0
8618412|NCT03400163|21262826|P2|COMPLETED|Follow-up Period||2
8618413|NCT03400163|21262827|P1|COMPLETED|Follow-up Period||1
8618414|NCT03400163|21262826|P2|STARTED|Follow-up Period||2
8618415|NCT03400163|21262827|P1|STARTED|Follow-up Period||1
8618416|NCT03400163|21262826|P2|NOT COMPLETED|Treatment Period||0
8618417|NCT03400163|21262827|P1|NOT COMPLETED|Treatment Period||0
8618418|NCT03400163|21262826|P2|COMPLETED|Treatment Period||2
8618419|NCT03400163|21262827|P1|COMPLETED|Treatment Period||1
8618420|NCT03400163|21262826|P2|STARTED|Treatment Period||2
8618421|NCT03400163|21262827|P1|STARTED|Treatment Period||1
8618422|NCT03396432|21262861|P2|NOT COMPLETED|Overall Study||6
8618423|NCT03396432|21262862|P1|NOT COMPLETED|Overall Study||9
8618424|NCT03396432|21262861|P2|COMPLETED|Overall Study||277
8618425|NCT03396432|21262862|P1|COMPLETED|Overall Study||274
8618426|NCT03396432|21262861|P2|STARTED|Overall Study||283
8618427|NCT03396432|21262862|P1|STARTED|Overall Study||283
8618428|NCT03387033|21262868|P1|NOT COMPLETED|Overall Study||0
8618429|NCT03387033|21262868|P1|COMPLETED|Overall Study||20
8618430|NCT03387033|21262868|P1|STARTED|Overall Study||20
8618431|NCT03361137|21262880|P5|NOT COMPLETED|Overall Study||0
8618432|NCT03361137|21262881|P4|NOT COMPLETED|Overall Study||0
8618433|NCT03361137|21262882|P3|NOT COMPLETED|Overall Study||0
8618434|NCT03361137|21262883|P2|NOT COMPLETED|Overall Study||0
8618435|NCT03361137|21262884|P1|NOT COMPLETED|Overall Study||1
8618436|NCT03361137|21262880|P5|COMPLETED|Overall Study||1
8618437|NCT03361137|21262881|P4|COMPLETED|Overall Study||2
8618438|NCT03361137|21262882|P3|COMPLETED|Overall Study||1
8618439|NCT03361137|21262883|P2|COMPLETED|Overall Study||9
8618440|NCT03361137|21262884|P1|COMPLETED|Overall Study||0
8618441|NCT03361137|21262880|P5|STARTED|Overall Study||1
8618442|NCT03361137|21262881|P4|STARTED|Overall Study||2
8618443|NCT03361137|21262882|P3|STARTED|Overall Study||1
8618444|NCT03361137|21262883|P2|STARTED|Overall Study||9
8618445|NCT03361137|21262884|P1|STARTED|Overall Study||1
8618446|NCT03341975|21262925|P2|NOT COMPLETED|Overall Study||0
8618447|NCT03341975|21262926|P1|NOT COMPLETED|Overall Study||0
8618448|NCT03341975|21262925|P2|COMPLETED|Overall Study||47
8618449|NCT03341975|21262926|P1|COMPLETED|Overall Study||44
8618450|NCT03341975|21262925|P2|STARTED|Overall Study||47
8618451|NCT03341975|21262926|P1|STARTED|Overall Study||44
8618452|NCT03340961|21262936|P4|NOT COMPLETED|Overall Study||18
8618453|NCT03340961|21262937|P3|NOT COMPLETED|Overall Study||9
8618454|NCT03340961|21262938|P2|NOT COMPLETED|Overall Study||12
8618455|NCT03340961|21262939|P1|NOT COMPLETED|Overall Study||6
8618456|NCT03340961|21262936|P4|COMPLETED|Overall Study||35
8618457|NCT03340961|21262937|P3|COMPLETED|Overall Study||40
8618458|NCT03340961|21262938|P2|COMPLETED|Overall Study||38
8618459|NCT03340961|21262939|P1|COMPLETED|Overall Study||47
8618460|NCT03340961|21262936|P4|STARTED|Overall Study||53
8618461|NCT03340961|21262937|P3|STARTED|Overall Study||49
8618462|NCT03340961|21262938|P2|STARTED|Overall Study||50
8618463|NCT03340961|21262939|P1|STARTED|Overall Study||53
8618464|NCT03338062|21262959|P2|NOT COMPLETED|Overall Study||0
8618465|NCT03338062|21262960|P1|NOT COMPLETED|Overall Study||1
8618466|NCT03338062|21262959|P2|COMPLETED|Overall Study||5
8618467|NCT03338062|21262960|P1|COMPLETED|Overall Study||9
8618468|NCT03338062|21262959|P2|STARTED|Overall Study||5
8618469|NCT03338062|21262960|P1|STARTED|Overall Study||10
8618470|NCT03292640|21262985|P2|NOT COMPLETED|Overall Study||42
8618471|NCT03292640|21262986|P1|NOT COMPLETED|Overall Study||61
8618472|NCT03292640|21262985|P2|COMPLETED|Overall Study||230
8618473|NCT03292640|21262986|P1|COMPLETED|Overall Study||214
8618474|NCT03292640|21262985|P2|STARTED|Overall Study||272
8618475|NCT03292640|21262986|P1|STARTED|Overall Study||275
8618476|NCT03290027|21262998|P2|NOT COMPLETED|Overall Study||45
8618477|NCT03290027|21262999|P1|NOT COMPLETED|Overall Study||58
8618478|NCT03290027|21262998|P2|COMPLETED|Overall Study||228
8618479|NCT03290027|21262999|P1|COMPLETED|Overall Study||219
8618480|NCT03290027|21262998|P2|STARTED|Overall Study||273
8618481|NCT03290027|21262999|P1|STARTED|Overall Study||277
8618482|NCT03287310|21263015|P6|NOT COMPLETED|Overall Study||0
8618483|NCT03287310|21263016|P5|NOT COMPLETED|Overall Study||0
8618484|NCT03287310|21263017|P4|NOT COMPLETED|Overall Study||0
8618485|NCT03287310|21263018|P3|NOT COMPLETED|Overall Study||0
8618486|NCT03287310|21263019|P2|NOT COMPLETED|Overall Study||0
8618487|NCT03287310|21263020|P1|NOT COMPLETED|Overall Study||0
8618488|NCT03287310|21263015|P6|COMPLETED|Overall Study||6
8618489|NCT03287310|21263016|P5|COMPLETED|Overall Study||9
8618490|NCT03287310|21263017|P4|COMPLETED|Overall Study||9
8618491|NCT03287310|21263018|P3|COMPLETED|Overall Study||6
8618492|NCT03287310|21263019|P2|COMPLETED|Overall Study||6
8618493|NCT03287310|21263020|P1|COMPLETED|Overall Study||12
8618494|NCT03287310|21263015|P6|STARTED|Overall Study||6
8618495|NCT03287310|21263016|P5|STARTED|Overall Study||9
8618496|NCT03287310|21263017|P4|STARTED|Overall Study||9
8618497|NCT03287310|21263018|P3|STARTED|Overall Study||6
8618498|NCT03287310|21263019|P2|STARTED|Overall Study||6
8618499|NCT03287310|21263020|P1|STARTED|Overall Study||12
8618500|NCT03264066|21263255|P6|NOT COMPLETED|Overall Study||3
8618501|NCT03264066|21263256|P5|NOT COMPLETED|Overall Study||7
8618502|NCT03264066|21263257|P4|NOT COMPLETED|Overall Study||20
8618503|NCT03264066|21263258|P3|NOT COMPLETED|Overall Study||17
8618504|NCT03264066|21263259|P2|NOT COMPLETED|Overall Study||20
8618505|NCT03264066|21263260|P1|NOT COMPLETED|Overall Study||20
8618506|NCT03264066|21263255|P6|COMPLETED|Overall Study||0
8618507|NCT03264066|21263256|P5|COMPLETED|Overall Study||0
8618508|NCT03264066|21263257|P4|COMPLETED|Overall Study||0
8618509|NCT03264066|21263258|P3|COMPLETED|Overall Study||0
8618510|NCT03264066|21263259|P2|COMPLETED|Overall Study||0
8618511|NCT03264066|21263260|P1|COMPLETED|Overall Study||0
8618512|NCT03264066|21263255|P6|STARTED|Overall Study||3
8618513|NCT03264066|21263256|P5|STARTED|Overall Study||7
8618514|NCT03264066|21263257|P4|STARTED|Overall Study||20
8618515|NCT03264066|21263258|P3|STARTED|Overall Study||17
8618516|NCT03264066|21263259|P2|STARTED|Overall Study||20
8618517|NCT03264066|21263260|P1|STARTED|Overall Study||20
8618518|NCT03247322|21263316|P2|NOT COMPLETED|Overall Study||0
8618519|NCT03247322|21263317|P1|NOT COMPLETED|Overall Study||2
8618520|NCT03247322|21263316|P2|COMPLETED|Overall Study||68
8618521|NCT03247322|21263317|P1|COMPLETED|Overall Study||66
8618522|NCT03247322|21263316|P2|STARTED|Overall Study||68
8618523|NCT03247322|21263317|P1|STARTED|Overall Study||68
8618524|NCT03208530|21263333|P1|NOT COMPLETED|Overall Study||27
8618525|NCT03208530|21263333|P1|COMPLETED|Overall Study||48
8618526|NCT03208530|21263333|P1|STARTED|Overall Study||75
8618527|NCT03125226|21263342|P1|NOT COMPLETED|Overall Study||0
8618528|NCT03125226|21263342|P1|COMPLETED|Overall Study||12
8618529|NCT03125226|21263342|P1|STARTED|Overall Study||12
8618530|NCT03103438|21263358|P7|NOT COMPLETED|Overall Study||0
8618531|NCT03103438|21263359|P6|NOT COMPLETED|Overall Study||0
8618532|NCT03103438|21263360|P5|NOT COMPLETED|Overall Study||0
8618533|NCT03103438|21263361|P4|NOT COMPLETED|Overall Study||0
8618534|NCT03103438|21263362|P3|NOT COMPLETED|Overall Study||0
8618535|NCT03103438|21263363|P2|NOT COMPLETED|Overall Study||0
8618536|NCT03103438|21263364|P1|NOT COMPLETED|Overall Study||0
8618537|NCT03103438|21263358|P7|COMPLETED|Overall Study||3
8618538|NCT03103438|21263359|P6|COMPLETED|Overall Study||3
8618539|NCT03103438|21263360|P5|COMPLETED|Overall Study||3
8618540|NCT03103438|21263361|P4|COMPLETED|Overall Study||3
8618541|NCT03103438|21263362|P3|COMPLETED|Overall Study||3
8618542|NCT03103438|21263363|P2|COMPLETED|Overall Study||3
8618543|NCT03103438|21263364|P1|COMPLETED|Overall Study||1
8618544|NCT03103438|21263358|P7|STARTED|Overall Study||3
8618545|NCT03103438|21263359|P6|STARTED|Overall Study||3
8618546|NCT03103438|21263360|P5|STARTED|Overall Study||3
8618547|NCT03103438|21263361|P4|STARTED|Overall Study||3
8618548|NCT03103438|21263362|P3|STARTED|Overall Study||3
8618549|NCT03103438|21263363|P2|STARTED|Overall Study||3
8618550|NCT03103438|21263364|P1|STARTED|Overall Study||1
8618551|NCT03083093|21263382|P2|NOT COMPLETED|Overall Study||0
8618552|NCT03083093|21263383|P1|NOT COMPLETED|Overall Study||0
8618553|NCT03083093|21263382|P2|COMPLETED|Overall Study||50
8618554|NCT03083093|21263383|P1|COMPLETED|Overall Study||50
8618555|NCT03083093|21263382|P2|STARTED|Overall Study||50
8618556|NCT03083093|21263383|P1|STARTED|Overall Study||50
8618557|NCT03072043|21263392|P3|NOT COMPLETED|Overall Study||9
8618558|NCT03072043|21263393|P2|NOT COMPLETED|Overall Study||0
8618559|NCT03072043|21263394|P1|NOT COMPLETED|Overall Study||0
8618560|NCT03072043|21263392|P3|COMPLETED|Overall Study||40
8618561|NCT03072043|21263393|P2|COMPLETED|Overall Study||3
8618562|NCT03072043|21263394|P1|COMPLETED|Overall Study||3
8618563|NCT03072043|21263392|P3|STARTED|Overall Study||49
8618564|NCT03072043|21263393|P2|STARTED|Overall Study||3
8618565|NCT03072043|21263394|P1|STARTED|Overall Study||3
8618566|NCT03067441|21263408|P2|NOT COMPLETED|Overall Study||57
8618567|NCT03067441|21263409|P1|NOT COMPLETED|Overall Study||33
8618568|NCT03067441|21263408|P2|COMPLETED|Overall Study||913
8618569|NCT03067441|21263409|P1|COMPLETED|Overall Study||459
8618570|NCT03067441|21263408|P2|STARTED|Overall Study||970
8618571|NCT03067441|21263409|P1|STARTED|Overall Study||492
8618572|NCT02997176|21263469|P4|NOT COMPLETED|Overall Study||11
8618573|NCT02997176|21263470|P3|NOT COMPLETED|Overall Study||2
8618574|NCT02997176|21263471|P2|NOT COMPLETED|Overall Study||2
8618575|NCT02997176|21263472|P1|NOT COMPLETED|Overall Study||1
8618576|NCT02997176|21263469|P4|COMPLETED|Overall Study||5
8618577|NCT02997176|21263470|P3|COMPLETED|Overall Study||3
8618578|NCT02997176|21263471|P2|COMPLETED|Overall Study||8
8618579|NCT02997176|21263472|P1|COMPLETED|Overall Study||6
8618580|NCT02997176|21263469|P4|STARTED|Overall Study||16
8618581|NCT02997176|21263470|P3|STARTED|Overall Study||5
8618582|NCT02997176|21263471|P2|STARTED|Overall Study||10
8618583|NCT02997176|21263472|P1|STARTED|Overall Study||7
8618584|NCT02987543|21263610|P4|NOT COMPLETED|Overall Study||48
8618585|NCT02987543|21263611|P3|NOT COMPLETED|Overall Study||94
8618586|NCT02987543|21263612|P2|NOT COMPLETED|Overall Study||83
8618587|NCT02987543|21263613|P1|NOT COMPLETED|Overall Study||162
8618588|NCT02987543|21263610|P4|COMPLETED|Overall Study||0
8618589|NCT02987543|21263611|P3|COMPLETED|Overall Study||0
8618590|NCT02987543|21263612|P2|COMPLETED|Overall Study||0
8618591|NCT02987543|21263613|P1|COMPLETED|Overall Study||0
8618592|NCT02987543|21263610|P4|STARTED|Overall Study||48
8618593|NCT02987543|21263611|P3|STARTED|Overall Study||94
8618594|NCT02987543|21263612|P2|STARTED|Overall Study||83
8618595|NCT02987543|21263613|P1|STARTED|Overall Study||162
8618596|NCT02970981|21263627|P1|NOT COMPLETED|Overall Study||0
8618597|NCT02970981|21263627|P1|COMPLETED|Overall Study||16
8618598|NCT02970981|21263627|P1|STARTED|Overall Study||16
8618599|NCT02965989|21263633|P2|NOT COMPLETED|Overall Study||0
8618600|NCT02965989|21263634|P1|NOT COMPLETED|Overall Study||0
8618601|NCT02965989|21263633|P2|COMPLETED|Overall Study||22
8618602|NCT02965989|21263634|P1|COMPLETED|Overall Study||26
8618603|NCT02965989|21263633|P2|STARTED|Overall Study||22
8618604|NCT02965989|21263634|P1|STARTED|Overall Study||26
8618685|NCT02888106|21263798|P1|COMPLETED|Overall Study||10
8618605|NCT02953782|21263654|P8|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
8618606|NCT02953782|21263655|P7|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
8618607|NCT02953782|21263656|P6|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
8618608|NCT02953782|21263657|P5|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618609|NCT02953782|21263658|P4|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618610|NCT02953782|21263659|P3|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618611|NCT02953782|21263660|P2|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618612|NCT02953782|21263661|P1|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618613|NCT02953782|21263654|P8|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618614|NCT02953782|21263655|P7|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618615|NCT02953782|21263656|P6|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618616|NCT02953782|21263657|P5|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618617|NCT02953782|21263658|P4|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618618|NCT02953782|21263659|P3|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618619|NCT02953782|21263660|P2|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618620|NCT02953782|21263661|P1|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618621|NCT02953782|21263654|P8|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
8618622|NCT02953782|21263655|P7|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
8618623|NCT02953782|21263656|P6|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
8618624|NCT02953782|21263657|P5|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618625|NCT02953782|21263658|P4|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618626|NCT02953782|21263659|P3|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618627|NCT02953782|21263660|P2|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618628|NCT02953782|21263661|P1|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8618629|NCT02953782|21263654|P8|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618630|NCT02953782|21263655|P7|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618631|NCT02953782|21263656|P6|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618632|NCT02953782|21263657|P5|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
8618633|NCT02953782|21263658|P4|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
8618634|NCT02953782|21263659|P3|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
8618635|NCT02953782|21263660|P2|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
8618636|NCT02953782|21263661|P1|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
8618637|NCT02953782|21263654|P8|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618638|NCT02953782|21263655|P7|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618639|NCT02953782|21263656|P6|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618640|NCT02953782|21263657|P5|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618641|NCT02953782|21263658|P4|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618642|NCT02953782|21263659|P3|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618643|NCT02953782|21263660|P2|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618644|NCT02953782|21263661|P1|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618645|NCT02953782|21263654|P8|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618646|NCT02953782|21263655|P7|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618647|NCT02953782|21263656|P6|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
8618648|NCT02953782|21263657|P5|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
8618649|NCT02953782|21263658|P4|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
8618650|NCT02953782|21263659|P3|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
8618651|NCT02953782|21263660|P2|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
8618652|NCT02953782|21263661|P1|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
8618653|NCT02913521|21263736|P3|NOT COMPLETED|Overall Study||45
8618654|NCT02913521|21263737|P2|NOT COMPLETED|Overall Study||50
8618655|NCT02913521|21263738|P1|NOT COMPLETED|Overall Study||53
8618656|NCT02913521|21263736|P3|COMPLETED|Overall Study||261
8618657|NCT02913521|21263737|P2|COMPLETED|Overall Study||262
8618658|NCT02913521|21263738|P1|COMPLETED|Overall Study||263
8618659|NCT02913521|21263736|P3|STARTED|Overall Study||306
8618660|NCT02913521|21263737|P2|STARTED|Overall Study||312
8618661|NCT02913521|21263738|P1|STARTED|Overall Study||316
8618662|NCT02891850|21263751|P2|NOT COMPLETED|Overall Study||7
8618663|NCT02891850|21263752|P1|NOT COMPLETED|Overall Study||7
8618664|NCT02891850|21263751|P2|COMPLETED|Overall Study||107
8618665|NCT02891850|21263752|P1|COMPLETED|Overall Study||104
8618666|NCT02891850|21263751|P2|STARTED|Overall Study||114
8618667|NCT02891850|21263752|P1|STARTED|Overall Study||111
8618668|NCT02889510|21263766|P2|NOT COMPLETED|Overall Study||5
8618669|NCT02889510|21263767|P1|NOT COMPLETED|Overall Study||8
8618670|NCT02889510|21263766|P2|COMPLETED|Overall Study||32
8618671|NCT02889510|21263767|P1|COMPLETED|Overall Study||27
8618672|NCT02889510|21263766|P2|STARTED|Overall Study||37
8618673|NCT02889510|21263767|P1|STARTED|Overall Study||35
8618674|NCT02888106|21263793|P6|NOT COMPLETED|Overall Study||1
8618675|NCT02888106|21263794|P5|NOT COMPLETED|Overall Study||1
8618676|NCT02888106|21263795|P4|NOT COMPLETED|Overall Study||2
8618677|NCT02888106|21263796|P3|NOT COMPLETED|Overall Study||0
8618678|NCT02888106|21263797|P2|NOT COMPLETED|Overall Study||2
8618679|NCT02888106|21263798|P1|NOT COMPLETED|Overall Study||5
8618680|NCT02888106|21263793|P6|COMPLETED|Overall Study||14
8618681|NCT02888106|21263794|P5|COMPLETED|Overall Study||14
8618682|NCT02888106|21263795|P4|COMPLETED|Overall Study||13
8618683|NCT02888106|21263796|P3|COMPLETED|Overall Study||15
8618684|NCT02888106|21263797|P2|COMPLETED|Overall Study||13
8618686|NCT02888106|21263793|P6|STARTED|Overall Study||15
8618687|NCT02888106|21263794|P5|STARTED|Overall Study||15
8618688|NCT02888106|21263795|P4|STARTED|Overall Study||15
8618689|NCT02888106|21263796|P3|STARTED|Overall Study||15
8618690|NCT02888106|21263797|P2|STARTED|Overall Study||15
8618691|NCT02888106|21263798|P1|STARTED|Overall Study||15
8618692|NCT02808429|21263857|P3|NOT COMPLETED|Overall Study||2
8618693|NCT02808429|21263858|P2|NOT COMPLETED|Overall Study||1
8618694|NCT02808429|21263859|P1|NOT COMPLETED|Overall Study||3
8618695|NCT02808429|21263857|P3|COMPLETED|Overall Study||3
8618696|NCT02808429|21263858|P2|COMPLETED|Overall Study||5
8618697|NCT02808429|21263859|P1|COMPLETED|Overall Study||2
8618698|NCT02808429|21263857|P3|STARTED|Overall Study||5
8618699|NCT02808429|21263858|P2|STARTED|Overall Study||6
8618700|NCT02808429|21263859|P1|STARTED|Overall Study||5
8618701|NCT02787850|21263905|P2|NOT COMPLETED|Overall Study||1
8618702|NCT02787850|21263906|P1|NOT COMPLETED|Overall Study||0
8618703|NCT02787850|21263905|P2|COMPLETED|Overall Study||9
8618704|NCT02787850|21263906|P1|COMPLETED|Overall Study||10
8618705|NCT02787850|21263905|P2|STARTED|Overall Study||10
8618706|NCT02787850|21263906|P1|STARTED|Overall Study||10
8618707|NCT02783950|21263923|P2|NOT COMPLETED|Overall Study||9
8618708|NCT02783950|21263924|P1|NOT COMPLETED|Overall Study||7
8618709|NCT02783950|21263923|P2|COMPLETED|Overall Study||165
8618710|NCT02783950|21263924|P1|COMPLETED|Overall Study||175
8618711|NCT02783950|21263923|P2|STARTED|Overall Study||174
8618712|NCT02783950|21263924|P1|STARTED|Overall Study||182
8618713|NCT02748694|21263947|P15|NOT COMPLETED|Overall Study||2
8618714|NCT02748694|21263948|P14|NOT COMPLETED|Overall Study||0
8618715|NCT02748694|21263949|P13|NOT COMPLETED|Overall Study||0
8618716|NCT02748694|21263950|P12|NOT COMPLETED|Overall Study||0
8618717|NCT02748694|21263951|P11|NOT COMPLETED|Overall Study||0
8618718|NCT02748694|21263952|P10|NOT COMPLETED|Overall Study||0
8618719|NCT02748694|21263953|P9|NOT COMPLETED|Overall Study||0
8618720|NCT02748694|21263954|P8|NOT COMPLETED|Overall Study||0
8618721|NCT02748694|21263955|P7|NOT COMPLETED|Overall Study||0
8618722|NCT02748694|21263956|P6|NOT COMPLETED|Overall Study||0
8618723|NCT02748694|21263957|P5|NOT COMPLETED|Overall Study||0
8618724|NCT02748694|21263958|P4|NOT COMPLETED|Overall Study||0
8618725|NCT02748694|21263959|P3|NOT COMPLETED|Overall Study||0
8618726|NCT02748694|21263960|P2|NOT COMPLETED|Overall Study||0
8618727|NCT02748694|21263961|P1|NOT COMPLETED|Overall Study||0
8618728|NCT02748694|21263947|P15|COMPLETED|Overall Study||14
8618729|NCT02748694|21263948|P14|COMPLETED|Overall Study||8
8618730|NCT02748694|21263949|P13|COMPLETED|Overall Study||9
8618731|NCT02748694|21263950|P12|COMPLETED|Overall Study||9
8618732|NCT02748694|21263951|P11|COMPLETED|Overall Study||6
8618733|NCT02748694|21263952|P10|COMPLETED|Overall Study||6
8618734|NCT02748694|21263953|P9|COMPLETED|Overall Study||6
8618735|NCT02748694|21263954|P8|COMPLETED|Overall Study||6
8618736|NCT02748694|21263955|P7|COMPLETED|Overall Study||8
8618737|NCT02748694|21263956|P6|COMPLETED|Overall Study||6
8618738|NCT02748694|21263957|P5|COMPLETED|Overall Study||6
8618739|NCT02748694|21263958|P4|COMPLETED|Overall Study||6
8618740|NCT02748694|21263959|P3|COMPLETED|Overall Study||6
8618741|NCT02748694|21263960|P2|COMPLETED|Overall Study||6
8618742|NCT02748694|21263961|P1|COMPLETED|Overall Study||10
8618743|NCT02748694|21263947|P15|STARTED|Overall Study||16
8618744|NCT02748694|21263948|P14|STARTED|Overall Study||8
8618745|NCT02748694|21263949|P13|STARTED|Overall Study||9
8618746|NCT02748694|21263950|P12|STARTED|Overall Study||9
8618747|NCT02748694|21263951|P11|STARTED|Overall Study||6
8618748|NCT02748694|21263952|P10|STARTED|Overall Study||6
8618749|NCT02748694|21263953|P9|STARTED|Overall Study||6
8618750|NCT02748694|21263954|P8|STARTED|Overall Study||6
8618751|NCT02748694|21263955|P7|STARTED|Overall Study||8
8618752|NCT02748694|21263956|P6|STARTED|Overall Study||6
8618753|NCT02748694|21263957|P5|STARTED|Overall Study||6
8618754|NCT02748694|21263958|P4|STARTED|Overall Study||6
8618755|NCT02748694|21263959|P3|STARTED|Overall Study||6
8618756|NCT02748694|21263960|P2|STARTED|Overall Study||6
8618757|NCT02748694|21263961|P1|STARTED|Overall Study||10
8618758|NCT02729740|21264169|P1|NOT COMPLETED|Overall Study||131
8618759|NCT02729740|21264169|P1|COMPLETED|Overall Study||864
8618760|NCT02729740|21264169|P1|STARTED|Overall Study||995
8618761|NCT02711553|21264180|P4|NOT COMPLETED|Overall Study||7
8618762|NCT02711553|21264181|P3|NOT COMPLETED|Overall Study||27
8618763|NCT02711553|21264182|P2|NOT COMPLETED|Overall Study||15
8618764|NCT02711553|21264183|P1|NOT COMPLETED|Overall Study||18
8618765|NCT02711553|21264180|P4|COMPLETED|Overall Study||42
8618766|NCT02711553|21264181|P3|COMPLETED|Overall Study||75
8618767|NCT02711553|21264182|P2|COMPLETED|Overall Study||37
8618768|NCT02711553|21264183|P1|COMPLETED|Overall Study||88
8618769|NCT02711553|21264180|P4|Received at Least 1 Dose of Study Drug|Overall Study||48
8618770|NCT02711553|21264181|P3|Received at Least 1 Dose of Study Drug|Overall Study||102
8618771|NCT02711553|21264182|P2|Received at Least 1 Dose of Study Drug|Overall Study||52
8618772|NCT02711553|21264183|P1|Received at Least 1 Dose of Study Drug|Overall Study||104
8618773|NCT02711553|21264180|P4|STARTED|Overall Study||49
8618774|NCT02711553|21264181|P3|STARTED|Overall Study||102
8618775|NCT02711553|21264182|P2|STARTED|Overall Study||52
8618776|NCT02711553|21264183|P1|STARTED|Overall Study||106
8618777|NCT02697591|21264213|P10|NOT COMPLETED|Overall Study||20
8618778|NCT02697591|21264214|P9|NOT COMPLETED|Overall Study||9
8618779|NCT02697591|21264215|P8|NOT COMPLETED|Overall Study||3
8618780|NCT02697591|21264216|P7|NOT COMPLETED|Overall Study||16
8618781|NCT02697591|21264217|P6|NOT COMPLETED|Overall Study||16
8618782|NCT02697591|21264218|P5|NOT COMPLETED|Overall Study||13
8618783|NCT02697591|21264219|P4|NOT COMPLETED|Overall Study||3
8618784|NCT02697591|21264220|P3|NOT COMPLETED|Overall Study||3
8618785|NCT02697591|21264221|P2|NOT COMPLETED|Overall Study||4
8618786|NCT02697591|21264222|P1|NOT COMPLETED|Overall Study||4
8618787|NCT02697591|21264213|P10|COMPLETED|Overall Study||2
8618788|NCT02697591|21264214|P9|COMPLETED|Overall Study||1
8618789|NCT02697591|21264215|P8|COMPLETED|Overall Study||1
8618790|NCT02697591|21264216|P7|COMPLETED|Overall Study||0
8618791|NCT02697591|21264217|P6|COMPLETED|Overall Study||2
8618792|NCT02697591|21264218|P5|COMPLETED|Overall Study||2
8618793|NCT02697591|21264219|P4|COMPLETED|Overall Study||0
8618794|NCT02697591|21264220|P3|COMPLETED|Overall Study||1
8618795|NCT02697591|21264221|P2|COMPLETED|Overall Study||0
8618796|NCT02697591|21264222|P1|COMPLETED|Overall Study||0
8618797|NCT02697591|21264213|P10|STARTED|Overall Study||22
8618798|NCT02697591|21264214|P9|STARTED|Overall Study||10
8618799|NCT02697591|21264215|P8|STARTED|Overall Study||4
8618800|NCT02697591|21264216|P7|STARTED|Overall Study||16
8618801|NCT02697591|21264217|P6|STARTED|Overall Study||18
8618802|NCT02697591|21264218|P5|STARTED|Overall Study||15
8618803|NCT02697591|21264219|P4|STARTED|Overall Study||3
8618804|NCT02697591|21264220|P3|STARTED|Overall Study||4
8618805|NCT02697591|21264221|P2|STARTED|Overall Study||4
8618806|NCT02697591|21264222|P1|STARTED|Overall Study||4
8618807|NCT02697071|21264327|P2|NOT COMPLETED|Overall Study||0
8618808|NCT02697071|21264328|P1|NOT COMPLETED|Overall Study||0
8618809|NCT02697071|21264327|P2|COMPLETED|Overall Study||16
8618810|NCT02697071|21264328|P1|COMPLETED|Overall Study||18
8618811|NCT02697071|21264327|P2|STARTED|Overall Study||16
8618812|NCT02697071|21264328|P1|STARTED|Overall Study||18
8618813|NCT02684617|21264341|P3|NOT COMPLETED|Overall Study||40
8618814|NCT02684617|21264342|P2|NOT COMPLETED|Overall Study||17
8618815|NCT02684617|21264343|P1|NOT COMPLETED|Overall Study||18
8618816|NCT02684617|21264341|P3|COMPLETED|Overall Study||0
8618817|NCT02684617|21264342|P2|COMPLETED|Overall Study||0
8618818|NCT02684617|21264343|P1|COMPLETED|Overall Study||0
8618819|NCT02684617|21264341|P3|Treated|Overall Study||38
8618820|NCT02684617|21264342|P2|Treated|Overall Study||17
8618821|NCT02684617|21264343|P1|Treated|Overall Study||17
8618822|NCT02684617|21264341|P3|STARTED|Overall Study||40
8618823|NCT02684617|21264342|P2|STARTED|Overall Study||17
8618824|NCT02684617|21264343|P1|STARTED|Overall Study||18
8618825|NCT02677701|21264371|P2|NOT COMPLETED|Overall Study||5
8618826|NCT02677701|21264372|P1|NOT COMPLETED|Overall Study||6
8618827|NCT02677701|21264371|P2|COMPLETED|Overall Study||52
8618828|NCT02677701|21264372|P1|COMPLETED|Overall Study||56
8618829|NCT02677701|21264371|P2|STARTED|Overall Study||57
8618830|NCT02677701|21264372|P1|STARTED|Overall Study||62
8618831|NCT02660489|21264382|P2|NOT COMPLETED|Overall Study||8
8618832|NCT02660489|21264383|P1|NOT COMPLETED|Overall Study||6
8618833|NCT02660489|21264382|P2|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
8618834|NCT02660489|21264383|P1|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
8618835|NCT02660489|21264382|P2|STARTED|Overall Study||22
8618836|NCT02660489|21264383|P1|STARTED|Overall Study||22
8618837|NCT02654691|21264403|P1|NOT COMPLETED|Overall Study||0
8618838|NCT02654691|21264403|P1|COMPLETED|Overall Study||63
8618839|NCT02654691|21264403|P1|STARTED|Overall Study||63
8618840|NCT02586857|21264430|P2|NOT COMPLETED|Overall Study||0
8618841|NCT02586857|21264431|P1|NOT COMPLETED|Overall Study||1
8618842|NCT02586857|21264430|P2|COMPLETED|Overall Study||9
8618843|NCT02586857|21264431|P1|COMPLETED|Overall Study||14
8618844|NCT02586857|21264430|P2|Discontinued Study|Overall Study||9
8618845|NCT02586857|21264431|P1|Discontinued Study|Overall Study||14
8618846|NCT02586857|21264430|P2|Received Study Medication|Overall Study||9
8618847|NCT02586857|21264431|P1|Received Study Medication|Overall Study||15
8618848|NCT02586857|21264430|P2|Enrolled|Overall Study||9
8618849|NCT02586857|21264431|P1|Enrolled|Overall Study||15
8618850|NCT02586857|21264430|P2|STARTED|Overall Study||9
8618851|NCT02586857|21264431|P1|STARTED|Overall Study||15
8618852|NCT02576509|21264439|P2|NOT COMPLETED|Follow-up Period||52
8618853|NCT02576509|21264440|P1|NOT COMPLETED|Follow-up Period||49
8618854|NCT02576509|21264439|P2|COMPLETED|Follow-up Period||311
8618855|NCT02576509|21264440|P1|COMPLETED|Follow-up Period||318
8618856|NCT02576509|21264439|P2|STARTED|Follow-up Period||363
8618857|NCT02576509|21264440|P1|STARTED|Follow-up Period||367
8618858|NCT02576509|21264439|P2|NOT COMPLETED|Treatment Period||355
8618859|NCT02576509|21264440|P1|NOT COMPLETED|Treatment Period||329
8618860|NCT02576509|21264439|P2|COMPLETED|Treatment Period||8
8618861|NCT02576509|21264440|P1|COMPLETED|Treatment Period||38
8618862|NCT02576509|21264439|P2|STARTED|Treatment Period||363
8618863|NCT02576509|21264440|P1|STARTED|Treatment Period||367
8618864|NCT02576509|21264439|P2|NOT COMPLETED|Pre-Treatment Period||9
8618865|NCT02576509|21264440|P1|NOT COMPLETED|Pre-Treatment Period||4
8618866|NCT02576509|21264439|P2|COMPLETED|Pre-Treatment Period||363
8618867|NCT02576509|21264440|P1|COMPLETED|Pre-Treatment Period||367
8618868|NCT02576509|21264439|P2|STARTED|Pre-Treatment Period||372
8618869|NCT02576509|21264440|P1|STARTED|Pre-Treatment Period||371
8618870|NCT02536508|21264457|P3|NOT COMPLETED|Overall Study||23
8618871|NCT02536508|21264458|P2|NOT COMPLETED|Overall Study||44
8618872|NCT02536508|21264459|P1|NOT COMPLETED|Overall Study||52
8618873|NCT02536508|21264457|P3|COMPLETED|Overall Study||65
8618874|NCT02536508|21264458|P2|COMPLETED|Overall Study||130
8618875|NCT02536508|21264459|P1|COMPLETED|Overall Study||142
8618876|NCT02536508|21264457|P3|STARTED|Overall Study||88
8618877|NCT02536508|21264458|P2|STARTED|Overall Study||174
8618878|NCT02536508|21264459|P1|STARTED|Overall Study||194
8618879|NCT02443155|21264474|P4|NOT COMPLETED|Overall Study||16
8618880|NCT02443155|21264475|P3|NOT COMPLETED|Overall Study||9
8618881|NCT02443155|21264476|P2|NOT COMPLETED|Overall Study||14
8618882|NCT02443155|21264477|P1|NOT COMPLETED|Overall Study||12
8618883|NCT02443155|21264474|P4|COMPLETED|Overall Study||61
8618884|NCT02443155|21264475|P3|COMPLETED|Overall Study||67
8618885|NCT02443155|21264476|P2|COMPLETED|Overall Study||63
8618886|NCT02443155|21264477|P1|COMPLETED|Overall Study||65
8618887|NCT02443155|21264474|P4|Safety Analysis Set|Overall Study||77
8618888|NCT02443155|21264475|P3|Safety Analysis Set|Overall Study||76
8618889|NCT02443155|21264476|P2|Safety Analysis Set|Overall Study||77
8618890|NCT02443155|21264477|P1|Safety Analysis Set|Overall Study||77
8618891|NCT02443155|21264474|P4|PK Analysis Set|Overall Study||20
8618892|NCT02443155|21264475|P3|PK Analysis Set|Overall Study||22
8618893|NCT02443155|21264476|P2|PK Analysis Set|Overall Study||21
8618894|NCT02443155|21264477|P1|PK Analysis Set|Overall Study||21
8618895|NCT02443155|21264474|P4|Full Analysis Set|Overall Study||77
8618896|NCT02443155|21264475|P3|Full Analysis Set|Overall Study||76
8618897|NCT02443155|21264476|P2|Full Analysis Set|Overall Study||77
8618898|NCT02443155|21264477|P1|Full Analysis Set|Overall Study||77
8618899|NCT02443155|21264474|P4|STARTED|Overall Study||77
8618900|NCT02443155|21264475|P3|STARTED|Overall Study||76
8618901|NCT02443155|21264476|P2|STARTED|Overall Study||77
8618902|NCT02443155|21264477|P1|STARTED|Overall Study||77
8618903|NCT02442869|21264927|P6|NOT COMPLETED|Overall Study||0
8618904|NCT02442869|21264928|P5|NOT COMPLETED|Overall Study||2
8618905|NCT02442869|21264929|P4|NOT COMPLETED|Overall Study||1
8618906|NCT02442869|21264930|P3|NOT COMPLETED|Overall Study||0
8618907|NCT02442869|21264931|P2|NOT COMPLETED|Overall Study||9
8618908|NCT02442869|21264932|P1|NOT COMPLETED|Overall Study||5
8618909|NCT02442869|21264927|P6|COMPLETED|Overall Study||2
8618910|NCT02442869|21264928|P5|COMPLETED|Overall Study||3
8618911|NCT02442869|21264929|P4|COMPLETED|Overall Study||1
8618912|NCT02442869|21264930|P3|COMPLETED|Overall Study||6
8618913|NCT02442869|21264931|P2|COMPLETED|Overall Study||20
8618914|NCT02442869|21264932|P1|COMPLETED|Overall Study||13
8618915|NCT02442869|21264927|P6|STARTED|Overall Study||2
8618916|NCT02442869|21264928|P5|STARTED|Overall Study||5
8618917|NCT02442869|21264929|P4|STARTED|Overall Study||2
8618918|NCT02442869|21264930|P3|STARTED|Overall Study||6
8618919|NCT02442869|21264931|P2|STARTED|Overall Study||29
8618920|NCT02442869|21264932|P1|STARTED|Overall Study||18
8618921|NCT02432274|21264986|P8|NOT COMPLETED|Overall Study||20
8618922|NCT02432274|21264987|P7|NOT COMPLETED|Overall Study||15
8618923|NCT02432274|21264988|P6|NOT COMPLETED|Overall Study||7
8618924|NCT02432274|21264989|P5|NOT COMPLETED|Overall Study||31
8618925|NCT02432274|21264990|P4|NOT COMPLETED|Overall Study||1
8618926|NCT02432274|21264991|P3|NOT COMPLETED|Overall Study||11
8618927|NCT02432274|21264992|P2|NOT COMPLETED|Overall Study||9
8618928|NCT02432274|21264993|P1|NOT COMPLETED|Overall Study||3
8618929|NCT02432274|21264986|P8|COMPLETED|Overall Study||0
8618930|NCT02432274|21264987|P7|COMPLETED|Overall Study||0
8618931|NCT02432274|21264988|P6|COMPLETED|Overall Study||0
8618932|NCT02432274|21264989|P5|COMPLETED|Overall Study||0
8618933|NCT02432274|21264990|P4|COMPLETED|Overall Study||0
8618934|NCT02432274|21264991|P3|COMPLETED|Overall Study||0
8618935|NCT02432274|21264992|P2|COMPLETED|Overall Study||0
8618936|NCT02432274|21264993|P1|COMPLETED|Overall Study||0
8618937|NCT02432274|21264986|P8|Treated (Safety Population)|Overall Study||20
8618938|NCT02432274|21264987|P7|Treated (Safety Population)|Overall Study||11
8618939|NCT02432274|21264988|P6|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
8618940|NCT02432274|21264989|P5|Treated (Safety Population)|Overall Study||31
8618941|NCT02432274|21264990|P4|Treated (Safety Population)|Overall Study||1
8618942|NCT02432274|21264991|P3|Treated (Safety Population)|Overall Study||7
8618943|NCT02432274|21264992|P2|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
8618944|NCT02432274|21264993|P1|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
8618945|NCT02432274|21264986|P8|Underwent Run-in Period|Overall Study||0
8618946|NCT02432274|21264987|P7|Underwent Run-in Period|Overall Study||0
8618947|NCT02432274|21264988|P6|Underwent Run-in Period|Overall Study||0
8618948|NCT02432274|21264989|P5|Underwent Run-in Period|Overall Study||0
8618949|NCT02432274|21264990|P4|Underwent Run-in Period|Overall Study||0
8618950|NCT02432274|21264991|P3|Underwent Run-in Period|Overall Study||0
8618951|NCT02432274|21264992|P2|Underwent Run-in Period|Overall Study||1
8618952|NCT02432274|21264993|P1|Underwent Run-in Period|Overall Study||1
8618953|NCT02432274|21264986|P8|STARTED|Overall Study||20
8618954|NCT02432274|21264987|P7|STARTED|Overall Study||15
8618955|NCT02432274|21264988|P6|STARTED|Overall Study||7
8618956|NCT02432274|21264989|P5|STARTED|Overall Study||31
8618957|NCT02432274|21264990|P4|STARTED|Overall Study||1
8618958|NCT02432274|21264991|P3|STARTED|Overall Study||11
8618959|NCT02432274|21264992|P2|STARTED|Overall Study||9
8618960|NCT02432274|21264993|P1|STARTED|Overall Study||3
8618961|NCT02413372|21265109|P3|NOT COMPLETED|Follow-up||2
8618962|NCT02413372|21265110|P2|NOT COMPLETED|Follow-up||1
8618963|NCT02413372|21265111|P1|NOT COMPLETED|Follow-up||2
8618964|NCT02413372|21265109|P3|COMPLETED|Follow-up||23
8618965|NCT02413372|21265110|P2|COMPLETED|Follow-up||20
8618966|NCT02413372|21265111|P1|COMPLETED|Follow-up||20
8618967|NCT02413372|21265109|P3|STARTED|Follow-up||25
8618968|NCT02413372|21265110|P2|STARTED|Follow-up||21
8618969|NCT02413372|21265111|P1|STARTED|Follow-up||22
8618970|NCT02413372|21265109|P3|NOT COMPLETED|Treatment||1
8618971|NCT02413372|21265110|P2|NOT COMPLETED|Treatment||2
8618972|NCT02413372|21265111|P1|NOT COMPLETED|Treatment||1
8618973|NCT02413372|21265109|P3|COMPLETED|Treatment||25
8618974|NCT02413372|21265110|P2|COMPLETED|Treatment||22
8618975|NCT02413372|21265111|P1|COMPLETED|Treatment||24
8618976|NCT02413372|21265109|P3|STARTED|Treatment||26
8618977|NCT02413372|21265110|P2|STARTED|Treatment||24
8618978|NCT02413372|21265111|P1|STARTED|Treatment||25
8618979|NCT02356705|21265161|P3|NOT COMPLETED|Overall Study||0
8618980|NCT02356705|21265162|P2|NOT COMPLETED|Overall Study||0
8618981|NCT02356705|21265163|P1|NOT COMPLETED|Overall Study||0
8618982|NCT02356705|21265161|P3|COMPLETED|Overall Study||14
8618983|NCT02356705|21265162|P2|COMPLETED|Overall Study||14
8618984|NCT02356705|21265163|P1|COMPLETED|Overall Study||14
8618985|NCT02356705|21265161|P3|STARTED|Overall Study||14
8618986|NCT02356705|21265162|P2|STARTED|Overall Study||14
8618987|NCT02356705|21265163|P1|STARTED|Overall Study||14
8618988|NCT02327351|21265186|P1|NOT COMPLETED|Overall Study||0
8618989|NCT02327351|21265186|P1|COMPLETED|Overall Study||98
8618990|NCT02327351|21265186|P1|STARTED|Overall Study||98
8618991|NCT02264990|21265201|P2|NOT COMPLETED|Overall Study||259
8618992|NCT02264990|21265202|P1|NOT COMPLETED|Overall Study||260
8618993|NCT02264990|21265201|P2|COMPLETED|Overall Study||39
8618994|NCT02264990|21265202|P1|COMPLETED|Overall Study||37
8618995|NCT02264990|21265201|P2|Received Maintenance Therapy|Overall Study||123
8618996|NCT02264990|21265202|P1|Received Maintenance Therapy|Overall Study||148
8618997|NCT02264990|21265201|P2|Received Treatment|Overall Study||293
8618998|NCT02264990|21265202|P1|Received Treatment|Overall Study||288
8618999|NCT02264990|21265201|P2|STARTED|Overall Study||298
8619000|NCT02264990|21265202|P1|STARTED|Overall Study||297
8619001|NCT02239263|21265218|P1|NOT COMPLETED|Overall Study||6
8619002|NCT02239263|21265218|P1|COMPLETED|Overall Study||34
8619003|NCT02239263|21265218|P1|STARTED|Overall Study||40
8619004|NCT02202434|21265228|P4|NOT COMPLETED|Overall Study||37
8619005|NCT02202434|21265229|P3|NOT COMPLETED|Overall Study||15
8619006|NCT02202434|21265230|P2|NOT COMPLETED|Overall Study||69
8619007|NCT02202434|21265231|P1|NOT COMPLETED|Overall Study||109
8619008|NCT02202434|21265228|P4|COMPLETED|Overall Study||258
8619009|NCT02202434|21265229|P3|COMPLETED|Overall Study||87
8619010|NCT02202434|21265230|P2|COMPLETED|Overall Study||236
8619011|NCT02202434|21265231|P1|COMPLETED|Overall Study||498
8619012|NCT02202434|21265228|P4|STARTED|Overall Study||295
8619013|NCT02202434|21265229|P3|STARTED|Overall Study||102
8619014|NCT02202434|21265230|P2|STARTED|Overall Study||305
8619015|NCT02202434|21265231|P1|STARTED|Overall Study||607
8619016|NCT02199743|21265357|P2|NOT COMPLETED|Overall Study||2
8619017|NCT02199743|21265358|P1|NOT COMPLETED|Overall Study||0
8619018|NCT02199743|21265357|P2|COMPLETED|Overall Study||8
8619019|NCT02199743|21265358|P1|COMPLETED|Overall Study||14
8619020|NCT02199743|21265357|P2|STARTED|Overall Study||10
8619021|NCT02199743|21265358|P1|STARTED|Overall Study||14
8619022|NCT02198794|21265366|P3|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
8619023|NCT02198794|21265367|P2|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
8619024|NCT02198794|21265368|P1|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
8619025|NCT02198794|21265366|P3|COMPLETED|Part B: Randomized (13 Weeks)||68
8619026|NCT02198794|21265367|P2|COMPLETED|Part B: Randomized (13 Weeks)||66
8619027|NCT02198794|21265368|P1|COMPLETED|Part B: Randomized (13 Weeks)||0
8619028|NCT02198794|21265366|P3|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
8619029|NCT02198794|21265367|P2|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
8619030|NCT02198794|21265368|P1|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
8619031|NCT02198794|21265366|P3|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
8619032|NCT02198794|21265367|P2|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
8619033|NCT02198794|21265368|P1|STARTED|Part B: Randomized (13 Weeks)||0
8619034|NCT02198794|21265366|P3|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
8619035|NCT02198794|21265367|P2|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
8619036|NCT02198794|21265368|P1|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
8619037|NCT02198794|21265366|P3|COMPLETED|Part A: Open-Label (158 Weeks)||0
8619038|NCT02198794|21265367|P2|COMPLETED|Part A: Open-Label (158 Weeks)||0
8619039|NCT02198794|21265368|P1|COMPLETED|Part A: Open-Label (158 Weeks)||32
8619040|NCT02198794|21265366|P3|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
8619041|NCT02198794|21265367|P2|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
8619042|NCT02198794|21265368|P1|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
8619043|NCT02198794|21265366|P3|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
8619044|NCT02198794|21265367|P2|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
8619045|NCT02198794|21265368|P1|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
8619046|NCT02198794|21265366|P3|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
8619047|NCT02198794|21265367|P2|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
8619048|NCT02198794|21265368|P1|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
8619226|NCT01254409|21265954|P1|COMPLETED|Overall Study||6
8619049|NCT02198794|21265366|P3|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
8619050|NCT02198794|21265367|P2|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
8619051|NCT02198794|21265368|P1|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
8619052|NCT02198794|21265366|P3|STARTED|Part A: Open-Label (158 Weeks)||0
8619053|NCT02198794|21265367|P2|STARTED|Part A: Open-Label (158 Weeks)||0
8619054|NCT02198794|21265368|P1|STARTED|Part A: Open-Label (158 Weeks)||337
8619055|NCT02194439|21265384|P1|NOT COMPLETED|Overall Study||0
8619056|NCT02194439|21265384|P1|COMPLETED|Overall Study||415
8619057|NCT02194439|21265384|P1|STARTED|Overall Study||415
8619058|NCT02152670|21265388|P1|NOT COMPLETED|Overall Study||0
8619059|NCT02152670|21265388|P1|COMPLETED|Overall Study||1
8619060|NCT02152670|21265388|P1|STARTED|Overall Study||1
8619061|NCT02112877|21265394|P2|NOT COMPLETED|Overall Study||13
8619062|NCT02112877|21265395|P1|NOT COMPLETED|Overall Study||2
8619063|NCT02112877|21265394|P2|COMPLETED|Overall Study||157
8619064|NCT02112877|21265395|P1|COMPLETED|Overall Study||28
8619065|NCT02112877|21265394|P2|STARTED|Overall Study||170
8619066|NCT02112877|21265395|P1|STARTED|Overall Study||30
8619067|NCT02087046|21265417|P1|NOT COMPLETED|Overall Study||11
8619068|NCT02087046|21265417|P1|COMPLETED|Overall Study||116
8619069|NCT02087046|21265417|P1|Primary Endpoint|Overall Study||121
8619070|NCT02087046|21265417|P1|STARTED|Overall Study||127
8619071|NCT02086175|21265487|P1|NOT COMPLETED|Overall Study||0
8619072|NCT02086175|21265487|P1|COMPLETED|Overall Study||25
8619073|NCT02086175|21265487|P1|STARTED|Overall Study||25
8619074|NCT02081196|21265493|P1|NOT COMPLETED|Overall Study||1
8619075|NCT02081196|21265493|P1|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
8619076|NCT02081196|21265493|P1|Untreated Control Flank|Overall Study||45
8619077|NCT02081196|21265493|P1|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
8619078|NCT02064855|21265502|P1|NOT COMPLETED|Overall Study||55
8619079|NCT02064855|21265502|P1|COMPLETED|Overall Study||53
8619080|NCT02064855|21265502|P1|STARTED|Overall Study||108
8619081|NCT02043678|21265551|P2|NOT COMPLETED|Overall Study||405
8619082|NCT02043678|21265552|P1|NOT COMPLETED|Overall Study||401
8619083|NCT02043678|21265551|P2|COMPLETED|Overall Study||0
8619084|NCT02043678|21265552|P1|COMPLETED|Overall Study||0
8619085|NCT02043678|21265551|P2|Treated|Overall Study||396
8619086|NCT02043678|21265552|P1|Treated|Overall Study||390
8619087|NCT02043678|21265551|P2|STARTED|Overall Study||405
8619088|NCT02043678|21265552|P1|STARTED|Overall Study||401
8619089|NCT01995487|21265586|P2|NOT COMPLETED|Overall Study||83
8619090|NCT01995487|21265587|P1|NOT COMPLETED|Overall Study||74
8619091|NCT01995487|21265586|P2|COMPLETED|Overall Study||878
8619092|NCT01995487|21265587|P1|COMPLETED|Overall Study||884
8619093|NCT01995487|21265586|P2|STARTED|Overall Study||961
8619094|NCT01995487|21265587|P1|STARTED|Overall Study||958
8619095|NCT01859403|21265595|P2|NOT COMPLETED|Overall Study||4
8619096|NCT01859403|21265596|P1|NOT COMPLETED|Overall Study||1
8619097|NCT01859403|21265595|P2|COMPLETED|Overall Study||26
8619098|NCT01859403|21265596|P1|COMPLETED|Overall Study||20
8619099|NCT01859403|21265595|P2|STARTED|Overall Study||30
8619100|NCT01859403|21265596|P1|STARTED|Overall Study||21
8619101|NCT01839799|21265606|P2|NOT COMPLETED|Overall Study||0
8619102|NCT01839799|21265607|P1|NOT COMPLETED|Overall Study||0
8619103|NCT01839799|21265606|P2|COMPLETED|Overall Study||15
8619104|NCT01839799|21265607|P1|COMPLETED|Overall Study||17
8619105|NCT01839799|21265606|P2|STARTED|Overall Study||15
8619106|NCT01839799|21265607|P1|STARTED|Overall Study||17
8619107|NCT01838317|21265615|P2|NOT COMPLETED|Overall Study||0
8619108|NCT01838317|21265616|P1|NOT COMPLETED|Overall Study||0
8619109|NCT01838317|21265615|P2|COMPLETED|Overall Study||5
8619110|NCT01838317|21265616|P1|COMPLETED|Overall Study||9
8619111|NCT01838317|21265615|P2|STARTED|Overall Study||5
8619112|NCT01838317|21265616|P1|STARTED|Overall Study||9
8619113|NCT01835470|21265640|P1|NOT COMPLETED|Long Term Treatment Period||4
8619114|NCT01835470|21265640|P1|COMPLETED|Long Term Treatment Period|Completed LT period|16
8619115|NCT01835470|21265640|P1|STARTED|Long Term Treatment Period||20
8619116|NCT01835470|21265640|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
8619117|NCT01835470|21265640|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
8619118|NCT01835470|21265640|P1|STARTED|Short Term Treatment Period (to Week 16)||20
8619119|NCT01820754|21265650|P1|NOT COMPLETED|Overall Study||0
8619120|NCT01820754|21265650|P1|COMPLETED|Overall Study||24
8619121|NCT01820754|21265650|P1|STARTED|Overall Study||24
8619122|NCT01817959|21265660|P2|NOT COMPLETED|Overall Study||3
8619123|NCT01817959|21265661|P1|NOT COMPLETED|Overall Study||4
8619124|NCT01817959|21265660|P2|COMPLETED|Overall Study||16
8619125|NCT01817959|21265661|P1|COMPLETED|Overall Study||25
8619126|NCT01817959|21265660|P2|STARTED|Overall Study||19
8619127|NCT01817959|21265661|P1|STARTED|Overall Study||29
8619128|NCT01801930|21265709|P4|NOT COMPLETED|Overall Study||6
8619129|NCT01801930|21265710|P3|NOT COMPLETED|Overall Study||6
8619130|NCT01801930|21265711|P2|NOT COMPLETED|Overall Study||6
8619131|NCT01801930|21265712|P1|NOT COMPLETED|Overall Study||6
8619132|NCT01801930|21265709|P4|COMPLETED|Overall Study||0
8619133|NCT01801930|21265710|P3|COMPLETED|Overall Study||0
8619134|NCT01801930|21265711|P2|COMPLETED|Overall Study||0
8619135|NCT01801930|21265712|P1|COMPLETED|Overall Study||0
8619136|NCT01801930|21265709|P4|STARTED|Overall Study||6
8619137|NCT01801930|21265710|P3|STARTED|Overall Study||6
8619138|NCT01801930|21265711|P2|STARTED|Overall Study||6
8619139|NCT01801930|21265712|P1|STARTED|Overall Study||6
8619140|NCT01783444|21265733|P3|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
8619141|NCT01783444|21265734|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
8619142|NCT01783444|21265735|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
8619143|NCT01783444|21265733|P3|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8619144|NCT01783444|21265734|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8619145|NCT01783444|21265735|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8619146|NCT01783444|21265733|P3|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
8619147|NCT01783444|21265734|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
8619148|NCT01783444|21265735|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
8619149|NCT01783444|21265733|P3|NOT COMPLETED|Treatment Phase||102
8619150|NCT01783444|21265734|P2|NOT COMPLETED|Treatment Phase||103
8619151|NCT01783444|21265735|P1|NOT COMPLETED|Treatment Phase||104
8619152|NCT01783444|21265733|P3|COMPLETED|Treatment Phase||0
8619153|NCT01783444|21265734|P2|COMPLETED|Treatment Phase||0
8619154|NCT01783444|21265735|P1|COMPLETED|Treatment Phase||0
8619155|NCT01783444|21265733|P3|Safety Set|Treatment Phase||102
8619156|NCT01783444|21265734|P2|Safety Set|Treatment Phase||103
8619157|NCT01783444|21265735|P1|Safety Set|Treatment Phase||104
8619158|NCT01783444|21265733|P3|STARTED|Treatment Phase||102
8619159|NCT01783444|21265734|P2|STARTED|Treatment Phase||103
8619160|NCT01783444|21265735|P1|STARTED|Treatment Phase||104
8619161|NCT01716195|21265765|P1|NOT COMPLETED|Overall Study||1
8619162|NCT01716195|21265765|P1|COMPLETED|Overall Study||17
8619163|NCT01716195|21265765|P1|STARTED|Overall Study||18
8619164|NCT01714817|21265773|P2|NOT COMPLETED|Long-Term Extension (LTE) Period||70
8619165|NCT01714817|21265774|P1|NOT COMPLETED|Long-Term Extension (LTE) Period||67
8619166|NCT01714817|21265773|P2|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
8619167|NCT01714817|21265774|P1|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
8619168|NCT01714817|21265773|P2|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
8619169|NCT01714817|21265774|P1|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
8619170|NCT01714817|21265773|P2|NOT COMPLETED|Year 2 Period||38
8619171|NCT01714817|21265774|P1|NOT COMPLETED|Year 2 Period||26
8619172|NCT01714817|21265773|P2|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
8619173|NCT01714817|21265774|P1|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
8619174|NCT01714817|21265773|P2|STARTED|Year 2 Period|Started = Completed Year 1|161
8619175|NCT01714817|21265774|P1|STARTED|Year 2 Period|Started = Completed Year 1|155
8619176|NCT01714817|21265773|P2|NOT COMPLETED|Year 1 Period||42
8619177|NCT01714817|21265774|P1|NOT COMPLETED|Year 1 Period||48
8619178|NCT01714817|21265773|P2|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
8619179|NCT01714817|21265774|P1|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
8619180|NCT01714817|21265773|P2|Treated|Year 1 Period||203
8619181|NCT01714817|21265774|P1|Treated|Year 1 Period||202
8619182|NCT01714817|21265773|P2|STARTED|Year 1 Period||203
8619183|NCT01714817|21265774|P1|STARTED|Year 1 Period||203
8619184|NCT01610206|21265870|P2|NOT COMPLETED|Overall Study||30
8619185|NCT01610206|21265871|P1|NOT COMPLETED|Overall Study||10
8619186|NCT01610206|21265870|P2|COMPLETED|Overall Study||45
8619187|NCT01610206|21265871|P1|COMPLETED|Overall Study||63
8619188|NCT01610206|21265870|P2|STARTED|Overall Study||75
8619189|NCT01610206|21265871|P1|STARTED|Overall Study||73
8619190|NCT01605071|21265881|P2|NOT COMPLETED|Overall Study||2
8619191|NCT01605071|21265882|P1|NOT COMPLETED|Overall Study||3
8619192|NCT01605071|21265881|P2|COMPLETED|Overall Study||24
8619193|NCT01605071|21265882|P1|COMPLETED|Overall Study||24
8619194|NCT01605071|21265881|P2|STARTED|Overall Study||26
8619195|NCT01605071|21265882|P1|STARTED|Overall Study||27
8619196|NCT01429454|21265898|P2|NOT COMPLETED|Overall Study||30
8619197|NCT01429454|21265899|P1|NOT COMPLETED|Overall Study||27
8619198|NCT01429454|21265898|P2|COMPLETED|Overall Study||35
8619199|NCT01429454|21265899|P1|COMPLETED|Overall Study||35
8619200|NCT01429454|21265898|P2|STARTED|Overall Study||65
8619201|NCT01429454|21265899|P1|STARTED|Overall Study||62
8619202|NCT01401582|21265909|P2|NOT COMPLETED|Overall Study||117
8619203|NCT01401582|21265910|P1|NOT COMPLETED|Overall Study||110
8619204|NCT01401582|21265909|P2|COMPLETED|Overall Study||291
8619205|NCT01401582|21265910|P1|COMPLETED|Overall Study||116
8619206|NCT01401582|21265909|P2|Baseline Completed|Overall Study||348
8619207|NCT01401582|21265910|P1|Baseline Completed|Overall Study||168
8619208|NCT01401582|21265909|P2|STARTED|Overall Study||408
8619209|NCT01401582|21265910|P1|STARTED|Overall Study||226
8619210|NCT01379573|21265926|P1|NOT COMPLETED|Overall Study||11
8619211|NCT01379573|21265926|P1|COMPLETED|Overall Study||63
8619212|NCT01379573|21265926|P1|STARTED|Overall Study||74
8619213|NCT01311024|21265940|P2|NOT COMPLETED|Overall Study||22
8619214|NCT01311024|21265941|P1|NOT COMPLETED|Overall Study||35
8619215|NCT01311024|21265940|P2|COMPLETED|Overall Study||789
8619216|NCT01311024|21265941|P1|COMPLETED|Overall Study||1495
8619217|NCT01311024|21265940|P2|STARTED|Overall Study||811
8619218|NCT01311024|21265941|P1|STARTED|Overall Study||1530
8619219|NCT01254409|21265951|P4|NOT COMPLETED|Overall Study||0
8619220|NCT01254409|21265952|P3|NOT COMPLETED|Overall Study||0
8619221|NCT01254409|21265953|P2|NOT COMPLETED|Overall Study||1
8619222|NCT01254409|21265954|P1|NOT COMPLETED|Overall Study||0
8619223|NCT01254409|21265951|P4|COMPLETED|Overall Study||4
8619224|NCT01254409|21265952|P3|COMPLETED|Overall Study||5
8619225|NCT01254409|21265953|P2|COMPLETED|Overall Study||5
8619227|NCT01254409|21265951|P4|STARTED|Overall Study||4
8619228|NCT01254409|21265952|P3|STARTED|Overall Study||5
8619229|NCT01254409|21265953|P2|STARTED|Overall Study||6
8619230|NCT01254409|21265954|P1|STARTED|Overall Study||6
8619231|NCT01209624|21266006|P1|NOT COMPLETED|Overall Study||326
8619232|NCT01209624|21266006|P1|COMPLETED|Overall Study||576
8619233|NCT01209624|21266006|P1|Per Protocol Population|Overall Study||469
8619234|NCT01209624|21266006|P1|STARTED|Overall Study||902
8619235|NCT01174030|21266042|P5|NOT COMPLETED|Overall Study||1
8619236|NCT01174030|21266043|P4|NOT COMPLETED|Overall Study||2
8619237|NCT01174030|21266044|P3|NOT COMPLETED|Overall Study||2
8619238|NCT01174030|21266045|P2|NOT COMPLETED|Overall Study||2
8619239|NCT01174030|21266046|P1|NOT COMPLETED|Overall Study||2
8619240|NCT01174030|21266042|P5|COMPLETED|Overall Study||52
8619241|NCT01174030|21266043|P4|COMPLETED|Overall Study||53
8619242|NCT01174030|21266044|P3|COMPLETED|Overall Study||52
8619243|NCT01174030|21266045|P2|COMPLETED|Overall Study||52
8619244|NCT01174030|21266046|P1|COMPLETED|Overall Study||51
8619245|NCT01174030|21266042|P5|STARTED|Overall Study||53
8619246|NCT01174030|21266043|P4|STARTED|Overall Study||55
8619247|NCT01174030|21266044|P3|STARTED|Overall Study||54
8619248|NCT01174030|21266045|P2|STARTED|Overall Study||54
8619249|NCT01174030|21266046|P1|STARTED|Overall Study||53
8619250|NCT01136811|21266068|P1|NOT COMPLETED|Overall Study||11
8619251|NCT01136811|21266068|P1|COMPLETED|Overall Study||0
8619252|NCT01136811|21266068|P1|STARTED|Overall Study||11
8619253|NCT01129024|21266075|P1|NOT COMPLETED|Overall Study||19
8619254|NCT01129024|21266075|P1|COMPLETED|Overall Study||0
8619255|NCT01129024|21266075|P1|STARTED|Overall Study||19
8619256|NCT01064648|21266087|P4|NOT COMPLETED|Phase II||48
8619257|NCT01064648|21266088|P3|NOT COMPLETED|Phase II||49
8619258|NCT01064648|21266089|P2|NOT COMPLETED|Phase II||0
8619259|NCT01064648|21266090|P1|NOT COMPLETED|Phase II||0
8619260|NCT01064648|21266087|P4|COMPLETED|Phase II||0
8619261|NCT01064648|21266088|P3|COMPLETED|Phase II||0
8619262|NCT01064648|21266089|P2|COMPLETED|Phase II||0
8619263|NCT01064648|21266090|P1|COMPLETED|Phase II||0
8619264|NCT01064648|21266087|P4|STARTED|Phase II||48
8619265|NCT01064648|21266088|P3|STARTED|Phase II||49
8619266|NCT01064648|21266089|P2|STARTED|Phase II||0
8619267|NCT01064648|21266090|P1|STARTED|Phase II||0
8619268|NCT01064648|21266087|P4|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
8619269|NCT01064648|21266088|P3|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
8619270|NCT01064648|21266089|P2|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
8619271|NCT01064648|21266090|P1|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
8619272|NCT01064648|21266087|P4|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8619273|NCT01064648|21266088|P3|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8619274|NCT01064648|21266089|P2|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8619275|NCT01064648|21266090|P1|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8619276|NCT01064648|21266087|P4|STARTED|Phase I Cohort 2: Dose Level 2||0
8619277|NCT01064648|21266088|P3|STARTED|Phase I Cohort 2: Dose Level 2||0
8619278|NCT01064648|21266089|P2|STARTED|Phase I Cohort 2: Dose Level 2||13
8619279|NCT01064648|21266090|P1|STARTED|Phase I Cohort 2: Dose Level 2||0
8619280|NCT01064648|21266087|P4|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
8619281|NCT01064648|21266088|P3|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
8619282|NCT01064648|21266089|P2|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
8619283|NCT01064648|21266090|P1|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
8619284|NCT01064648|21266087|P4|COMPLETED|Phase I Cohort1: Dose Level 1||0
8619285|NCT01064648|21266088|P3|COMPLETED|Phase I Cohort1: Dose Level 1||0
8619286|NCT01064648|21266089|P2|COMPLETED|Phase I Cohort1: Dose Level 1||0
8619287|NCT01064648|21266090|P1|COMPLETED|Phase I Cohort1: Dose Level 1||0
8619288|NCT01064648|21266087|P4|STARTED|Phase I Cohort1: Dose Level 1||0
8619289|NCT01064648|21266088|P3|STARTED|Phase I Cohort1: Dose Level 1||0
8619290|NCT01064648|21266089|P2|STARTED|Phase I Cohort1: Dose Level 1||0
8619291|NCT01064648|21266090|P1|STARTED|Phase I Cohort1: Dose Level 1||7
8619292|NCT01051661|21266119|P6|NOT COMPLETED|Overall Study||67
8619293|NCT01051661|21266120|P5|NOT COMPLETED|Overall Study||35
8619294|NCT01051661|21266121|P4|NOT COMPLETED|Overall Study||56
8619295|NCT01051661|21266122|P3|NOT COMPLETED|Overall Study||39
8619296|NCT01051661|21266123|P2|NOT COMPLETED|Overall Study||63
8619297|NCT01051661|21266124|P1|NOT COMPLETED|Overall Study||34
8619298|NCT01051661|21266119|P6|COMPLETED|Overall Study||1369
8619299|NCT01051661|21266120|P5|COMPLETED|Overall Study||578
8619300|NCT01051661|21266121|P4|COMPLETED|Overall Study||1380
8619301|NCT01051661|21266122|P3|COMPLETED|Overall Study||573
8619302|NCT01051661|21266123|P2|COMPLETED|Overall Study||1375
8619303|NCT01051661|21266124|P1|COMPLETED|Overall Study||576
8619304|NCT01051661|21266119|P6|STARTED|Overall Study||1436
8619305|NCT01051661|21266120|P5|STARTED|Overall Study||613
8619306|NCT01051661|21266121|P4|STARTED|Overall Study||1436
8619307|NCT01051661|21266122|P3|STARTED|Overall Study||612
8619308|NCT01051661|21266123|P2|STARTED|Overall Study||1438
8619309|NCT01051661|21266124|P1|STARTED|Overall Study||610
8619310|NCT01012245|21266307|P1|NOT COMPLETED|Overall Study||2427
8619311|NCT01012245|21266307|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
8619312|NCT01012245|21266307|P1|STARTED|Overall Study||28812
8619313|NCT00955682|21266346|P2|NOT COMPLETED|Year 5 Period||0
8619314|NCT00955682|21266347|P1|NOT COMPLETED|Year 5 Period||0
8619315|NCT00955682|21266346|P2|COMPLETED|Year 5 Period||47
8619316|NCT00955682|21266347|P1|COMPLETED|Year 5 Period||239
8619317|NCT00955682|21266346|P2|STARTED|Year 5 Period||47
8619318|NCT00955682|21266347|P1|STARTED|Year 5 Period||239
8619319|NCT00955682|21266346|P2|NOT COMPLETED|Booster Period (Month 48- 49)||1
8619320|NCT00955682|21266347|P1|NOT COMPLETED|Booster Period (Month 48- 49)||1
8619321|NCT00955682|21266346|P2|COMPLETED|Booster Period (Month 48- 49)||47
8619322|NCT00955682|21266347|P1|COMPLETED|Booster Period (Month 48- 49)||244
8619323|NCT00955682|21266346|P2|STARTED|Booster Period (Month 48- 49)||48
8619324|NCT00955682|21266347|P1|STARTED|Booster Period (Month 48- 49)||245
8619325|NCT00955682|21266346|P2|NOT COMPLETED|Year 4 Period||0
8619326|NCT00955682|21266347|P1|NOT COMPLETED|Year 4 Period||0
8619327|NCT00955682|21266346|P2|COMPLETED|Year 4 Period||48
8619328|NCT00955682|21266347|P1|COMPLETED|Year 4 Period||246
8619329|NCT00955682|21266346|P2|STARTED|Year 4 Period||48
8619330|NCT00955682|21266347|P1|STARTED|Year 4 Period||246
8619331|NCT00955682|21266346|P2|NOT COMPLETED|Year 3 Period||0
8619332|NCT00955682|21266347|P1|NOT COMPLETED|Year 3 Period||0
8619333|NCT00955682|21266346|P2|COMPLETED|Year 3 Period||47
8619334|NCT00955682|21266347|P1|COMPLETED|Year 3 Period||273
8619335|NCT00955682|21266346|P2|STARTED|Year 3 Period||47
8619336|NCT00955682|21266347|P1|STARTED|Year 3 Period||273
8619337|NCT00955682|21266346|P2|NOT COMPLETED|Year 2 Period||0
8619338|NCT00955682|21266347|P1|NOT COMPLETED|Year 2 Period||0
8619339|NCT00955682|21266346|P2|COMPLETED|Year 2 Period||42
8619340|NCT00955682|21266347|P1|COMPLETED|Year 2 Period||253
8619341|NCT00955682|21266346|P2|STARTED|Year 2 Period||42
8619342|NCT00955682|21266347|P1|STARTED|Year 2 Period||253
8619343|NCT00950690|21266453|P1|NOT COMPLETED|Overall Study||244
8619344|NCT00950690|21266453|P1|COMPLETED|Overall Study||1105
8619345|NCT00950690|21266453|P1|STARTED|Overall Study||1349
8619346|NCT00910481|21266460|P2|NOT COMPLETED|Overall Study||0
8619347|NCT00910481|21266461|P1|NOT COMPLETED|Overall Study||0
8619348|NCT00910481|21266460|P2|COMPLETED|Overall Study||150
8619349|NCT00910481|21266461|P1|COMPLETED|Overall Study||151
8619350|NCT00910481|21266460|P2|STARTED|Overall Study||150
8619351|NCT00910481|21266461|P1|STARTED|Overall Study||151
8619352|NCT00864097|21266471|P4|NOT COMPLETED|Overall Study||125
8619353|NCT00864097|21266472|P3|NOT COMPLETED|Overall Study||132
8619354|NCT00864097|21266473|P2|NOT COMPLETED|Overall Study||137
8619355|NCT00864097|21266474|P1|NOT COMPLETED|Overall Study||139
8619356|NCT00864097|21266471|P4|COMPLETED|Overall Study||20
8619357|NCT00864097|21266472|P3|COMPLETED|Overall Study||19
8619358|NCT00864097|21266473|P2|COMPLETED|Overall Study||20
8619359|NCT00864097|21266474|P1|COMPLETED|Overall Study||15
8619360|NCT00864097|21266471|P4|Treated|Overall Study||145
8619361|NCT00864097|21266472|P3|Treated|Overall Study||150
8619362|NCT00864097|21266473|P2|Treated|Overall Study||157
8619363|NCT00864097|21266474|P1|Treated|Overall Study||152
8619364|NCT00864097|21266471|P4|STARTED|Overall Study||145
8619365|NCT00864097|21266472|P3|STARTED|Overall Study||151
8619366|NCT00864097|21266473|P2|STARTED|Overall Study||157
8619367|NCT00864097|21266474|P1|STARTED|Overall Study||154
8619368|NCT00860574|21266576|P1|NOT COMPLETED|Overall Study||3
8619369|NCT00860574|21266576|P1|COMPLETED|Overall Study||93
8619370|NCT00860574|21266576|P1|STARTED|Overall Study||96
8619371|NCT00744471|21266591|P4|NOT COMPLETED|Overall Study||148
8619372|NCT00744471|21266592|P3|NOT COMPLETED|Overall Study||152
8619373|NCT00744471|21266593|P2|NOT COMPLETED|Overall Study||145
8619374|NCT00744471|21266594|P1|NOT COMPLETED|Overall Study||143
8619375|NCT00744471|21266591|P4|COMPLETED|Overall Study||9
8619376|NCT00744471|21266592|P3|COMPLETED|Overall Study||6
8619377|NCT00744471|21266593|P2|COMPLETED|Overall Study||11
8619378|NCT00744471|21266594|P1|COMPLETED|Overall Study||13
8619379|NCT00744471|21266591|P4|Treated|Overall Study||157
8619380|NCT00744471|21266592|P3|Treated|Overall Study||154
8619381|NCT00744471|21266593|P2|Treated|Overall Study||155
8619382|NCT00744471|21266594|P1|Treated|Overall Study||155
8619383|NCT00744471|21266591|P4|STARTED|Overall Study||157
8619384|NCT00744471|21266592|P3|STARTED|Overall Study||158
8619385|NCT00744471|21266593|P2|STARTED|Overall Study||156
8619386|NCT00744471|21266594|P1|STARTED|Overall Study||156
8619387|NCT00688181|21266720|P1|NOT COMPLETED|Overall Study||23
8619388|NCT00688181|21266720|P1|COMPLETED|Overall Study||13
8619389|NCT00688181|21266720|P1|STARTED|Overall Study||36
8619390|NCT00590681|21266727|P1|NOT COMPLETED|Overall Study||20
8619391|NCT00590681|21266727|P1|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
8619392|NCT00590681|21266727|P1|STARTED|Overall Study||62
8619393|NCT00588770|21266738|P2|NOT COMPLETED|Overall Study||200
8619394|NCT00588770|21266739|P1|NOT COMPLETED|Overall Study||159
8619395|NCT00588770|21266738|P2|COMPLETED|Overall Study||3
8619396|NCT00588770|21266739|P1|COMPLETED|Overall Study||41
8619397|NCT00588770|21266738|P2|Start Protocol Therapy|Overall Study||194
8619398|NCT00588770|21266739|P1|Start Protocol Therapy|Overall Study||200
8619399|NCT00588770|21266738|P2|Eligible|Overall Study||183
8619400|NCT00588770|21266739|P1|Eligible|Overall Study||188
8619401|NCT00588770|21266738|P2|STARTED|Overall Study||203
8619402|NCT00588770|21266739|P1|STARTED|Overall Study||200
8619403|NCT00571519|21266756|P7|NOT COMPLETED|Overall Study||24
8619404|NCT00571519|21266757|P6|NOT COMPLETED|Overall Study||10
8619405|NCT00571519|21266758|P5|NOT COMPLETED|Overall Study||9
8619406|NCT00571519|21266759|P4|NOT COMPLETED|Overall Study||27
8619407|NCT00571519|21266760|P3|NOT COMPLETED|Overall Study||12
8619408|NCT00571519|21266761|P2|NOT COMPLETED|Overall Study||9
8619409|NCT00571519|21266762|P1|NOT COMPLETED|Overall Study||3
8619410|NCT00571519|21266756|P7|COMPLETED|Overall Study||0
8619411|NCT00571519|21266757|P6|COMPLETED|Overall Study||0
8619412|NCT00571519|21266758|P5|COMPLETED|Overall Study||0
8619413|NCT00571519|21266759|P4|COMPLETED|Overall Study||0
8619414|NCT00571519|21266760|P3|COMPLETED|Overall Study||0
8619415|NCT00571519|21266761|P2|COMPLETED|Overall Study||0
8619416|NCT00571519|21266762|P1|COMPLETED|Overall Study||0
8619417|NCT00571519|21266756|P7|STARTED|Overall Study||24
8619418|NCT00571519|21266757|P6|STARTED|Overall Study||10
8619419|NCT00571519|21266758|P5|STARTED|Overall Study||9
8619420|NCT00571519|21266759|P4|STARTED|Overall Study||27
8619421|NCT00571519|21266760|P3|STARTED|Overall Study||12
8619422|NCT00571519|21266761|P2|STARTED|Overall Study||9
8619423|NCT00571519|21266762|P1|STARTED|Overall Study||3
8619424|NCT00565851|21266884|P8|NOT COMPLETED|Chemotherapy Assignment||3
8619425|NCT00565851|21266885|P7|NOT COMPLETED|Chemotherapy Assignment||0
8619426|NCT00565851|21266886|P6|NOT COMPLETED|Chemotherapy Assignment||3
8619427|NCT00565851|21266887|P5|NOT COMPLETED|Chemotherapy Assignment||0
8619428|NCT00565851|21266888|P4|NOT COMPLETED|Chemotherapy Assignment||36
8619429|NCT00565851|21266889|P3|NOT COMPLETED|Chemotherapy Assignment||3
8619430|NCT00565851|21266890|P2|NOT COMPLETED|Chemotherapy Assignment||23
8619431|NCT00565851|21266891|P1|NOT COMPLETED|Chemotherapy Assignment||9
8619432|NCT00565851|21266884|P8|COMPLETED|Chemotherapy Assignment||34
8619433|NCT00565851|21266885|P7|COMPLETED|Chemotherapy Assignment||5
8619434|NCT00565851|21266886|P6|COMPLETED|Chemotherapy Assignment||31
8619435|NCT00565851|21266887|P5|COMPLETED|Chemotherapy Assignment||6
8619436|NCT00565851|21266888|P4|COMPLETED|Chemotherapy Assignment||129
8619437|NCT00565851|21266889|P3|COMPLETED|Chemotherapy Assignment||30
8619438|NCT00565851|21266890|P2|COMPLETED|Chemotherapy Assignment||433
8619439|NCT00565851|21266891|P1|COMPLETED|Chemotherapy Assignment||307
8619440|NCT00565851|21266884|P8|Pre-specified Chemo|Chemotherapy Assignment||37
8619441|NCT00565851|21266885|P7|Pre-specified Chemo|Chemotherapy Assignment||5
8619442|NCT00565851|21266886|P6|Pre-specified Chemo|Chemotherapy Assignment||34
8619443|NCT00565851|21266887|P5|Pre-specified Chemo|Chemotherapy Assignment||6
8619444|NCT00565851|21266888|P4|Pre-specified Chemo|Chemotherapy Assignment||139
8619445|NCT00565851|21266889|P3|Pre-specified Chemo|Chemotherapy Assignment||6
8619446|NCT00565851|21266890|P2|Pre-specified Chemo|Chemotherapy Assignment||145
8619447|NCT00565851|21266891|P1|Pre-specified Chemo|Chemotherapy Assignment||6
8619448|NCT00565851|21266884|P8|Randomized to Chemo|Chemotherapy Assignment||0
8619449|NCT00565851|21266885|P7|Randomized to Chemo|Chemotherapy Assignment||0
8619450|NCT00565851|21266886|P6|Randomized to Chemo|Chemotherapy Assignment||0
8619451|NCT00565851|21266887|P5|Randomized to Chemo|Chemotherapy Assignment||0
8619452|NCT00565851|21266888|P4|Randomized to Chemo|Chemotherapy Assignment||26
8619453|NCT00565851|21266889|P3|Randomized to Chemo|Chemotherapy Assignment||27
8619454|NCT00565851|21266890|P2|Randomized to Chemo|Chemotherapy Assignment||311
8619455|NCT00565851|21266891|P1|Randomized to Chemo|Chemotherapy Assignment||310
8619456|NCT00565851|21266884|P8|STARTED|Chemotherapy Assignment||37
8619457|NCT00565851|21266885|P7|STARTED|Chemotherapy Assignment||5
8619458|NCT00565851|21266886|P6|STARTED|Chemotherapy Assignment||34
8619459|NCT00565851|21266887|P5|STARTED|Chemotherapy Assignment||6
8619460|NCT00565851|21266888|P4|STARTED|Chemotherapy Assignment||165
8619461|NCT00565851|21266889|P3|STARTED|Chemotherapy Assignment||33
8619462|NCT00565851|21266890|P2|STARTED|Chemotherapy Assignment||456
8619463|NCT00565851|21266891|P1|STARTED|Chemotherapy Assignment||316
8619464|NCT00565851|21266884|P8|NOT COMPLETED|Surgical Assignment||2
8619465|NCT00565851|21266885|P7|NOT COMPLETED|Surgical Assignment||0
8619466|NCT00565851|21266886|P6|NOT COMPLETED|Surgical Assignment||0
8619467|NCT00565851|21266887|P5|NOT COMPLETED|Surgical Assignment||0
8619468|NCT00565851|21266888|P4|NOT COMPLETED|Surgical Assignment||11
8619469|NCT00565851|21266889|P3|NOT COMPLETED|Surgical Assignment||2
8619470|NCT00565851|21266890|P2|NOT COMPLETED|Surgical Assignment||2
8619471|NCT00565851|21266891|P1|NOT COMPLETED|Surgical Assignment||3
8619472|NCT00565851|21266884|P8|COMPLETED|Surgical Assignment||35
8619473|NCT00565851|21266885|P7|COMPLETED|Surgical Assignment||5
8619474|NCT00565851|21266886|P6|COMPLETED|Surgical Assignment||34
8619475|NCT00565851|21266887|P5|COMPLETED|Surgical Assignment||6
8619476|NCT00565851|21266888|P4|COMPLETED|Surgical Assignment||154
8619477|NCT00565851|21266889|P3|COMPLETED|Surgical Assignment||31
8619478|NCT00565851|21266890|P2|COMPLETED|Surgical Assignment||454
8619479|NCT00565851|21266891|P1|COMPLETED|Surgical Assignment||313
8619480|NCT00565851|21266884|P8|Not Surgical Candidate|Surgical Assignment||0
8619481|NCT00565851|21266885|P7|Not Surgical Candidate|Surgical Assignment||0
8619482|NCT00565851|21266886|P6|Not Surgical Candidate|Surgical Assignment||0
8619483|NCT00565851|21266887|P5|Not Surgical Candidate|Surgical Assignment||0
8619484|NCT00565851|21266888|P4|Not Surgical Candidate|Surgical Assignment||0
8619485|NCT00565851|21266889|P3|Not Surgical Candidate|Surgical Assignment||0
8619486|NCT00565851|21266890|P2|Not Surgical Candidate|Surgical Assignment||284
8619487|NCT00565851|21266891|P1|Not Surgical Candidate|Surgical Assignment||283
8619488|NCT00565851|21266884|P8|Randomized - no Surgery|Surgical Assignment||0
8619489|NCT00565851|21266885|P7|Randomized - no Surgery|Surgical Assignment||0
8619490|NCT00565851|21266886|P6|Randomized - no Surgery|Surgical Assignment||34
8619491|NCT00565851|21266887|P5|Randomized - no Surgery|Surgical Assignment||6
8619492|NCT00565851|21266888|P4|Randomized - no Surgery|Surgical Assignment||0
8619493|NCT00565851|21266889|P3|Randomized - no Surgery|Surgical Assignment||0
8619494|NCT00565851|21266890|P2|Randomized - no Surgery|Surgical Assignment||172
8619495|NCT00565851|21266891|P1|Randomized - no Surgery|Surgical Assignment||33
8619496|NCT00565851|21266884|P8|Randomized - Yes Surgery|Surgical Assignment||37
8619497|NCT00565851|21266885|P7|Randomized - Yes Surgery|Surgical Assignment||5
8619498|NCT00565851|21266886|P6|Randomized - Yes Surgery|Surgical Assignment||0
8619499|NCT00565851|21266887|P5|Randomized - Yes Surgery|Surgical Assignment||0
8619500|NCT00565851|21266888|P4|Randomized - Yes Surgery|Surgical Assignment||165
8619501|NCT00565851|21266889|P3|Randomized - Yes Surgery|Surgical Assignment||33
8619502|NCT00565851|21266890|P2|Randomized - Yes Surgery|Surgical Assignment||0
8619503|NCT00565851|21266891|P1|Randomized - Yes Surgery|Surgical Assignment||0
8619504|NCT00565851|21266884|P8|STARTED|Surgical Assignment||37
8619505|NCT00565851|21266885|P7|STARTED|Surgical Assignment||5
8619506|NCT00565851|21266886|P6|STARTED|Surgical Assignment||34
8619507|NCT00565851|21266887|P5|STARTED|Surgical Assignment||6
8619508|NCT00565851|21266888|P4|STARTED|Surgical Assignment||165
8619509|NCT00565851|21266889|P3|STARTED|Surgical Assignment||33
8619510|NCT00565851|21266890|P2|STARTED|Surgical Assignment||456
8619511|NCT00565851|21266891|P1|STARTED|Surgical Assignment||316
8619512|NCT00486252|21266925|P1|NOT COMPLETED|Overall Study||58
8619513|NCT00486252|21266925|P1|COMPLETED|Overall Study||938
8619514|NCT00486252|21266925|P1|STARTED|Overall Study||996
8619515|NCT00445978|21266940|P1|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
8619516|NCT00445978|21266940|P1|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
8619517|NCT00445978|21266940|P1|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
8619518|NCT00445978|21266940|P1|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
8619519|NCT00445978|21266940|P1|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
8619520|NCT00445978|21266940|P1|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
8619521|NCT00445978|21266940|P1|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
8619522|NCT00445978|21266940|P1|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
8619523|NCT00445978|21266940|P1|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
8619524|NCT00445978|21266940|P1|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
8619525|NCT00445978|21266940|P1|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
8619526|NCT00445978|21266940|P1|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
8619527|NCT00445978|21266940|P1|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
8619528|NCT00445978|21266940|P1|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
8619529|NCT00445978|21266940|P1|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
8619530|NCT00427193|21266956|P2|NOT COMPLETED|Overall Study||4
8619531|NCT00427193|21266957|P1|NOT COMPLETED|Overall Study||26
8619532|NCT00427193|21266956|P2|COMPLETED|Overall Study||71
8619533|NCT00427193|21266957|P1|COMPLETED|Overall Study||117
8619534|NCT00427193|21266956|P2|STARTED|Overall Study||75
8619535|NCT00427193|21266957|P1|STARTED|Overall Study||143
8619536|NCT00376948|21266975|P1|NOT COMPLETED|Overall Study||0
8619537|NCT00376948|21266975|P1|COMPLETED|Overall Study||20
8619538|NCT00376948|21266975|P1|STARTED|Overall Study||20
8619539|NCT00352027|21266986|P1|NOT COMPLETED|Overall Study||3
8619540|NCT00352027|21266986|P1|COMPLETED|Overall Study||77
8619541|NCT00352027|21266986|P1|STARTED|Overall Study||80
8619542|NCT00306202|21267258|P3|NOT COMPLETED|Overall Study||0
8619543|NCT00306202|21267259|P2|NOT COMPLETED|Overall Study||0
8619544|NCT00306202|21267260|P1|NOT COMPLETED|Overall Study||0
8619545|NCT00306202|21267258|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
8619546|NCT00306202|21267259|P2|COMPLETED|Overall Study|Completed = Off-treatment|17
8619547|NCT00306202|21267260|P1|COMPLETED|Overall Study|Completed = Off-treatment|17
8619548|NCT00306202|21267258|P3|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
8619549|NCT00306202|21267259|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
8619550|NCT00306202|21267260|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
8619551|NCT00112827|21267421|P5|NOT COMPLETED|Overall Study||0
8619552|NCT00112827|21267422|P4|NOT COMPLETED|Overall Study||0
8619553|NCT00112827|21267423|P3|NOT COMPLETED|Overall Study||0
8619554|NCT00112827|21267424|P2|NOT COMPLETED|Overall Study||0
8619555|NCT00112827|21267425|P1|NOT COMPLETED|Overall Study||0
8619556|NCT00112827|21267421|P5|COMPLETED|Overall Study||7
8619557|NCT00112827|21267422|P4|COMPLETED|Overall Study||36
8619558|NCT00112827|21267423|P3|COMPLETED|Overall Study||4
8619559|NCT00112827|21267424|P2|COMPLETED|Overall Study||4
8619560|NCT00112827|21267425|P1|COMPLETED|Overall Study||3
8619561|NCT00112827|21267421|P5|STARTED|Overall Study||7
8619562|NCT00112827|21267422|P4|STARTED|Overall Study||36
8619563|NCT00112827|21267423|P3|STARTED|Overall Study||4
8619564|NCT00112827|21267424|P2|STARTED|Overall Study||4
8619565|NCT00112827|21267425|P1|STARTED|Overall Study||3
8619566|NCT00085735|21267445|P6|NOT COMPLETED|Overall Study||31
8619567|NCT00085735|21267446|P5|NOT COMPLETED|Overall Study||42
8619568|NCT00085735|21267447|P4|NOT COMPLETED|Overall Study||19
8619569|NCT00085735|21267448|P3|NOT COMPLETED|Overall Study||17
8619570|NCT00085735|21267449|P2|NOT COMPLETED|Overall Study||10
8619571|NCT00085735|21267450|P1|NOT COMPLETED|Overall Study||12
8619572|NCT00085735|21267445|P6|COMPLETED|Overall Study||115
8619573|NCT00085735|21267446|P5|COMPLETED|Overall Study||105
8619574|NCT00085735|21267447|P4|COMPLETED|Overall Study||46
8619575|NCT00085735|21267448|P3|COMPLETED|Overall Study||46
8619576|NCT00085735|21267449|P2|COMPLETED|Overall Study||54
8619577|NCT00085735|21267450|P1|COMPLETED|Overall Study||52
8619578|NCT00085735|21267445|P6|STARTED|Overall Study||146
8619579|NCT00085735|21267446|P5|STARTED|Overall Study||147
8619580|NCT00085735|21267447|P4|STARTED|Overall Study||65
8619581|NCT00085735|21267448|P3|STARTED|Overall Study||63
8619582|NCT00085735|21267449|P2|STARTED|Overall Study||64
8619583|NCT00085735|21267450|P1|STARTED|Overall Study||64
8619584|NCT00084552|21267505|P2|NOT COMPLETED|Overall Study||0
8619585|NCT00084552|21267506|P1|NOT COMPLETED|Overall Study||0
8619586|NCT00084552|21267505|P2|COMPLETED|Overall Study||62
8619587|NCT00084552|21267506|P1|COMPLETED|Overall Study||54
8619588|NCT00084552|21267505|P2|STARTED|Overall Study||62
8619589|NCT00084552|21267506|P1|STARTED|Overall Study||54
